<SEC-DOCUMENT>0001367644-20-000010.txt : 20200225
<SEC-HEADER>0001367644-20-000010.hdr.sgml : 20200225
<ACCEPTANCE-DATETIME>20200224182644
ACCESSION NUMBER:		0001367644-20-000010
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		187
CONFORMED PERIOD OF REPORT:	20191231
FILED AS OF DATE:		20200225
DATE AS OF CHANGE:		20200224

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Emergent BioSolutions Inc.
		CENTRAL INDEX KEY:			0001367644
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				141902018
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33137
		FILM NUMBER:		20646275

	BUSINESS ADDRESS:	
		STREET 1:		400 PROFESSIONAL DR, SUITE 400
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20879
		BUSINESS PHONE:		240-631-3200

	MAIL ADDRESS:	
		STREET 1:		400 PROFESSIONAL DR, SUITE 400
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20879
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>ebs-2019123110k.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:1634CCC3CCBC568089A2D9883DB65F2B,x:dc2e0d841d4041afb967caf483cc178a-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2018-01-31" xmlns:con="http://fasb.org/dis/con/2018-01-31" xmlns:nt="http://fasb.org/dis/nt/2018-01-31" xmlns:dr="http://fasb.org/dis/dr/2018-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2018-01-31" xmlns:ei="http://fasb.org/dis/ei/2018-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:invco="http://fasb.org/dis/invco/2018-01-31" xmlns:soi="http://fasb.org/stm/soi/2018-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:ides="http://fasb.org/dis/ides/2018-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2018-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2018-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:ni="http://fasb.org/dis/ni/2018-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2018-01-31" xmlns:srt-all="http://fasb.org/srt-all/2018-01-31" xmlns:rd="http://fasb.org/dis/rd/2018-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:debt="http://fasb.org/dis/debt/2018-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2018-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2018-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2018-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:aro="http://fasb.org/dis/aro/2018-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:equity="http://fasb.org/dis/equity/2018-01-31" xmlns:ero="http://fasb.org/dis/ero/2018-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2018-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2018-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:rlnro="http://fasb.org/dis/rlnro/2018-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2018-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2018-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2018-01-31" xmlns:tin-part="http://fasb.org/tin-part/2018-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2018-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:inv="http://fasb.org/dis/inv/2018-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2017-01-31" xmlns:acec="http://fasb.org/dis/acec/2018-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2018-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2018-01-31" xmlns:eui="http://fasb.org/dis/eui/2018-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2018-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2018-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2018-01-31" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2018-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2018-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2018-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2017-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2017-01-31" xmlns:invest-all="http://xbrl.sec.gov/invest-all/2013-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2018-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2018-01-31" xmlns:ts="http://fasb.org/dis/ts/2018-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2018-01-31" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2018-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2018-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:foct="http://fasb.org/dis/foct/2018-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2018-01-31" xmlns:ap="http://fasb.org/dis/ap/2018-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2018-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2018-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2018-01-31" xmlns:oi="http://fasb.org/dis/oi/2018-01-31" xmlns:invest-std="http://xbrl.sec.gov/invest-std/2013-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-roles="http://fasb.org/us-roles/2018-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:srt-std="http://fasb.org/srt-std/2018-01-31" xmlns:invest-ent-all="http://xbrl.sec.gov/invest-ent-all/2013-01-31" xmlns:cce="http://fasb.org/dis/cce/2018-01-31" xmlns:edco="http://fasb.org/dis/edco/2018-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2018-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2018-01-31" xmlns:pay="http://fasb.org/dis/pay/2018-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2018-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2018-01-31" xmlns:com="http://fasb.org/stm/com/2018-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:re="http://fasb.org/dis/re/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2018-01-31" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2018-01-31" xmlns:diha="http://fasb.org/dis/diha/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2018-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2018-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2018-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2018-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2018-01-31" xmlns:lea="http://fasb.org/dis/lea/2018-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2018-01-31" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2018-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2018-01-31" xmlns:sr="http://fasb.org/dis/sr/2018-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2018-01-31" xmlns:ir="http://fasb.org/dis/ir/2018-01-31" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:eps="http://fasb.org/dis/eps/2018-01-31" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2018-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2018-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2018-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2018-01-31" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2018-01-31" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2018-01-31" xmlns:cc="http://fasb.org/dis/cc/2018-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2018-01-31" xmlns:hco="http://fasb.org/dis/hco/2018-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2018-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2018-01-31" xmlns:ru="http://fasb.org/dis/ru/2018-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2018-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2018-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2018-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2018-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2018-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:te="http://fasb.org/dis/te/2018-01-31" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2018-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:regop="http://fasb.org/dis/regop/2018-01-31" xmlns:ebs="http://emergentbiosolutions.com/20191231" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2017-01-31" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2018-01-31" xmlns:spc="http://fasb.org/stm/spc/2018-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2018-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2018-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:invest-ent-std="http://xbrl.sec.gov/invest-ent-std/2013-01-31" xmlns:bc="http://fasb.org/dis/bc/2018-01-31" xmlns:soc="http://fasb.org/stm/soc/2018-01-31" xmlns:sec-re="http://fasb.org/dis/sec-re/2018-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2018-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:codification-part="http://fasb.org/codification-part/2018-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2018-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2018-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2018-01-31" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2018-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:disops="http://fasb.org/dis/disops/2018-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2018-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2018-01-31" xmlns:se="http://fasb.org/dis/se/2018-01-31" xmlns:guar="http://fasb.org/dis/guar/2018-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:exch="http://xbrl.sec.gov/exch/2018-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="FD2019Q4YTD" name="dei:AmendmentFlag" id="Fact-0BD3C0995FA0484776C2CCD31321C490-wk-Fact-0BD3C0995FA0484776C2CCD31321C490" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="dei:CurrentFiscalYearEndDate" id="Fact-DCE61C9A1BB8C9987DB2CCD31324739A-wk-Fact-DCE61C9A1BB8C9987DB2CCD31324739A">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="dei:DocumentFiscalPeriodFocus" id="Fact-AE8528EB878831920FF3CCD3131E8F3F-wk-Fact-AE8528EB878831920FF3CCD3131E8F3F">FY</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="dei:DocumentFiscalYearFocus" id="Fact-4FCB2F0288357E5449D1CCD313234BD3-wk-Fact-4FCB2F0288357E5449D1CCD313234BD3">2019</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="dei:EntityCentralIndexKey" id="Fact-5858D59267F6E2794B37CCD31322D850-wk-Fact-5858D59267F6E2794B37CCD31322D850">0001367644</ix:nonNumeric><ix:nonNumeric contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" name="ebs:LockUpPeriodForAdjustmentOfFairValue" id="Fact-004147C9F8445EB2BEE4CD12CCF57622-wk-Fact-004147C9F8445EB2BEE4CD12CCF57622">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentPlansMember" name="ebs:ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod" id="Fact-1F13E31BA271685985F5ECB9841B3E98-wk-Fact-1F13E31BA271685985F5ECB9841B3E98">P7Y</ix:nonNumeric><ix:nonFraction decimals="INF" unitRef="usdPerShare" contextRef="FI2017Q4" name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact-293DD5B35ECCBBAFB261CCD3136283AF-wk-Fact-293DD5B35ECCBBAFB261CCD3136283AF">0.001</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usdPerShare" contextRef="FI2018Q4" name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact-7811F32207A98A796167CCD313702799-wk-Fact-7811F32207A98A796167CCD313702799">0.001</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2018Q4" name="us-gaap:CommonStockSharesAuthorized" id="Fact-1D6F086D4D730C48E35CCCD3136D8E7E-wk-Fact-1D6F086D4D730C48E35CCCD3136D8E7E">200000000.0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:CommonStockSharesAuthorized" id="Fact-F2905976DA944122F402CCD3136FF2F9-wk-Fact-F2905976DA944122F402CCD3136FF2F9">200000000.0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2018Q4" name="us-gaap:CommonStockSharesIssued" id="Fact-DD95BCD1181424E576E0CCD3136CAA51-wk-Fact-DD95BCD1181424E576E0CCD3136CAA51">52400000.0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:CommonStockSharesIssued" id="Fact-7FE9F9723523DC0043F2CCD3136C79D7-wk-Fact-7FE9F9723523DC0043F2CCD3136C79D7">52900000.0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2018Q4" name="us-gaap:CommonStockSharesOutstanding" id="Fact-A1C409E685456649E735CCD31370DC0C-wk-Fact-A1C409E685456649E735CCD31370DC0C">51200000.0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:CommonStockSharesOutstanding" id="Fact-196B6DE27D4E81101FEACCD31370F3F1-wk-Fact-196B6DE27D4E81101FEACCD31370F3F1">51700000.0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="number" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember" name="us-gaap:ConcentrationRiskPercentage1" id="Fact-347FFE0406F003AB91AEECAB60A9A2D2-wk-Fact-347FFE0406F003AB91AEECAB60A9A2D2">0.459767570558937</ix:nonFraction><ix:nonNumeric contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact-F4305E1A35255CC0747C1182B2E987E4-wk-Fact-F4305E1A35255CC0747C1182B2E987E4">P22Y</ix:nonNumeric><ix:nonNumeric contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact-A40FE3312D13E9FBFBED1182CBDE25CF-wk-Fact-A40FE3312D13E9FBFBED1182CBDE25CF">P9Y</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact-E5C82AF26E47037CFB931182A87A8332-wk-Fact-E5C82AF26E47037CFB931182A87A8332">P22Y</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact-0C024E0B0659F69AEB7D1182D657EBE0-wk-Fact-0C024E0B0659F69AEB7D1182D657EBE0">P9Y</ix:nonNumeric><ix:nonFraction decimals="INF" unitRef="usd" contextRef="FD2018Q4YTD" name="us-gaap:GoodwillImpairmentLoss" id="Fact-562BAC791DC7B83530F8F202354F7420-wk-Fact-562BAC791DC7B83530F8F202354F7420">0</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="usd" contextRef="FD2017Q4YTD" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" id="Fact-4979D8A8D1024B56EFA65F9AA5C02129-wk-Fact-4979D8A8D1024B56EFA65F9AA5C02129">0</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="usd" contextRef="FD2018Q4YTD" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" id="Fact-976CFE354E8527CB44CF5DF4CDDEEE88-wk-Fact-976CFE354E8527CB44CF5DF4CDDEEE88">0</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="usd" contextRef="FD2019Q4YTD" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" id="Fact-ED9CB847D28D83AA05234AC58FB530C3-wk-Fact-ED9CB847D28D83AA05234AC58FB530C3">500000</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="usd" contextRef="FD2017Q4YTD" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" id="Fact-936F3640C118636448225F9AA505A598-wk-Fact-936F3640C118636448225F9AA505A598">0</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="usd" contextRef="FD2018Q4YTD" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" id="Fact-D250607EE6BEB8FAD0EC5DF4CD029AE5-wk-Fact-D250607EE6BEB8FAD0EC5DF4CD029AE5">0</ix:nonFraction><ix:nonFraction decimals="-5" unitRef="usd" contextRef="FD2019Q4YTD" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" id="Fact-EA45B2CA5409D6BBA84E4AC417F89181-wk-Fact-EA45B2CA5409D6BBA84E4AC417F89181">400000</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="usdPerShare" contextRef="FI2018Q4" name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact-70FDBD81F69D5ADF0DFACCD3136E5F36-wk-Fact-70FDBD81F69D5ADF0DFACCD3136E5F36">0.001</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2018Q4" name="us-gaap:PreferredStockSharesAuthorized" id="Fact-A50348F11EEC4D07B433CCD3136CABAF-wk-Fact-A50348F11EEC4D07B433CCD3136CABAF">15000000.0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:PreferredStockSharesAuthorized" id="Fact-907333815B126E0B2816CCD3136DCBCC-wk-Fact-907333815B126E0B2816CCD3136DCBCC">15000000.0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2018Q4" name="us-gaap:PreferredStockSharesIssued" id="Fact-1F31BF76CF678FC6F441CCD3136A4C32-wk-Fact-1F31BF76CF678FC6F441CCD3136A4C32">0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:PreferredStockSharesIssued" id="Fact-E5D72D4750CCFE6DAB38CCD3136EEB2C-wk-Fact-E5D72D4750CCFE6DAB38CCD3136EEB2C">0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2018Q4" name="us-gaap:PreferredStockSharesOutstanding" id="Fact-38CC27C3E3DA0E8C180DCCD3136B8AD3-wk-Fact-38CC27C3E3DA0E8C180DCCD3136B8AD3">0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:PreferredStockSharesOutstanding" id="Fact-6D312E089507DEFF5DA9CCD3136DCF7C-wk-Fact-6D312E089507DEFF5DA9CCD3136DCF7C">0</ix:nonFraction><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingImprovementsMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="Fact-85BBBC89E6799713C2A7F1AB5E070225-wk-Fact-85BBBC89E6799713C2A7F1AB5E070225">P39Y</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="Fact-BA785462645B3804DB7BF1AAAB36A198-wk-Fact-BA785462645B3804DB7BF1AAAB36A198">P39Y</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="Fact-7A7AF3494B045A10B280F1AD41750F97-wk-Fact-7A7AF3494B045A10B280F1AD41750F97">P7Y</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="Fact-7A20C7F94EDA8FC173B8F1ACC3C48B76-wk-Fact-7A20C7F94EDA8FC173B8F1ACC3C48B76">P15Y</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingImprovementsMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="Fact-BBADBF699DF252DD9BEBCCD3134D871B-wk-Fact-BBADBF699DF252DD9BEBCCD3134D871B">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="Fact-A9FF5A6677376C7180BECCD313524D84-wk-Fact-A9FF5A6677376C7180BECCD313524D84">P31Y</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="Fact-B5B87BA286EB74C576D5CCD313897398-wk-Fact-B5B87BA286EB74C576D5CCD313897398">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="Fact-4D9BFC05D89504802A0ACCD3134BBB40-wk-Fact-4D9BFC05D89504802A0ACCD3134BBB40">P3Y</ix:nonNumeric><ix:nonFraction decimals="-5" unitRef="shares" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact-35C53CD6878F4E0438CFB73D91D6552B-wk-Fact-35C53CD6878F4E0438CFB73D91D6552B">100000</ix:nonFraction><ix:nonFraction decimals="2" unitRef="number" contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact-D274CB885E51A5CCA887CCD3139630F8-wk-Fact-D274CB885E51A5CCA887CCD3139630F8">0.40</ix:nonFraction><ix:nonFraction decimals="2" unitRef="number" contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact-D71195EC48BBA45BD22BCCD313A5F092-wk-Fact-D71195EC48BBA45BD22BCCD313A5F092">0.37</ix:nonFraction><ix:nonFraction decimals="2" unitRef="number" contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact-406A455B4715867B9EABCCD313446694-wk-Fact-406A455B4715867B9EABCCD313446694">0.39</ix:nonFraction><ix:nonFraction decimals="2" unitRef="number" contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact-F20A4A37133F9F2454E4CCD3139DEFE0-wk-Fact-F20A4A37133F9F2454E4CCD3139DEFE0">0.38</ix:nonFraction><ix:nonFraction decimals="2" unitRef="number" contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact-7B9B74C9A4D0FF83BAEBCCD313453DA8-wk-Fact-7B9B74C9A4D0FF83BAEBCCD313453DA8">0.39</ix:nonFraction><ix:nonFraction decimals="2" unitRef="number" contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact-64135B4AAD205C77A58FCCD31342922B-wk-Fact-64135B4AAD205C77A58FCCD31342922B">0.37</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact-16508A648A3DC0310FD3CCD3134485BF-wk-Fact-16508A648A3DC0310FD3CCD3134485BF">0.0188</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact-629B0FFAB96DFB424D35CCD3131D40A4-wk-Fact-629B0FFAB96DFB424D35CCD3131D40A4">0.0166</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact-53883476781D1C65E799CCD31344EC3C-wk-Fact-53883476781D1C65E799CCD31344EC3C">0.0303</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact-173F687093CBB7CC100FCCD313AF8F9B-wk-Fact-173F687093CBB7CC100FCCD313AF8F9B">0.0254</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact-D92536EC643587187093CCD3138C82BD-wk-Fact-D92536EC643587187093CCD3138C82BD">0.0248</ix:nonFraction><ix:nonFraction decimals="4" unitRef="number" contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact-6EFB4B82730F48A98309CCD3139B28D9-wk-Fact-6EFB4B82730F48A98309CCD3139B28D9">0.0157</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2018Q4" name="us-gaap:TreasuryStockShares" id="Fact-2FA95B5F2ECE1E31C4E4CCD3136F45A0-wk-Fact-2FA95B5F2ECE1E31C4E4CCD3136F45A0">1200000.0</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:TreasuryStockShares" id="Fact-BA2EB120ECBC1819D5D5CCD3136A2DC5-wk-Fact-BA2EB120ECBC1819D5D5CCD3136A2DC5">1200000.0</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:href="ebs-20191231.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="FD2019Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q2">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q1Feb14">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-02-14</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractDevelopmentAndManufacturingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractDevelopmentAndManufacturingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractDevelopmentAndManufacturingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2016Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1Jan01">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">ebs:CIADMMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">ebs:CIADMMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">ebs:CIADMMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentPlansMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentPlansMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentPlansMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentPlansMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentPlansMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentPlansMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain_2020-01-01">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
					<us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
				</xbrldi:typedMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_MajorCustomersAxis_ebs_UnitedStatesGovernmentMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_MajorCustomersAxis_ebs_UnitedStatesGovernmentMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct15-Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-15</xbrli:startDate>
			<xbrli:endDate>2018-10-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-15</xbrli:startDate>
			<xbrli:endDate>2018-10-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-15</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:ACAM2000Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-06</xbrli:startDate>
			<xbrli:endDate>2017-10-06</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:ACAM2000Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-10-06</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-04</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-04</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q3Oct5-Sep30_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-05</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-04</xbrli:startDate>
			<xbrli:endDate>2018-10-04</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct04-Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-04</xbrli:startDate>
			<xbrli:endDate>2018-10-04</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-15</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-15</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_VivotifMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:VivotifMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-04</xbrli:startDate>
			<xbrli:endDate>2018-10-04</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2017Q4Oct2_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:RaxibacumabMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-10-02</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-15</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:ACAM2000Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-15</xbrli:startDate>
			<xbrli:endDate>2018-10-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2017Q4Oct2_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:RaxibacumabMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-02</xbrli:startDate>
			<xbrli:endDate>2017-10-02</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:ACAM2000Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_VaxchoraMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:VaxchoraMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-04</xbrli:startDate>
			<xbrli:endDate>2018-10-04</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:RaxibacumabMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_CashAndCashEquivalentsAxis_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_CashAndCashEquivalentsAxis_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandAndLandImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandAndLandImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-15</xbrli:startDate>
			<xbrli:endDate>2018-10-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ebs:TermLoanFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-15</xbrli:startDate>
			<xbrli:endDate>2018-10-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2017Q4Dec28_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-15</xbrli:startDate>
			<xbrli:endDate>2018-10-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2017Q4Nov14-Nov14_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-14</xbrli:startDate>
			<xbrli:endDate>2017-11-14</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-15</xbrli:startDate>
			<xbrli:endDate>2018-10-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4Oct15_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ebs:TermLoanFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-15</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4Oct31_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q2Jun01-Jun30_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2016Q3Aug12-Aug12_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-08-12</xbrli:startDate>
			<xbrli:endDate>2016-08-12</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2017Q4Nov15-Dec28_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-11-15</xbrli:startDate>
			<xbrli:endDate>2017-12-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2017Q3Sep29_us-gaap_DebtInstrumentAxis_ebs_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4Oct15_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-15</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-15</xbrli:startDate>
			<xbrli:endDate>2018-10-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q2Jun01-Jun30_srt_RangeAxis_srt_MinimumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-06-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-15</xbrli:startDate>
			<xbrli:endDate>2018-10-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-15</xbrli:startDate>
			<xbrli:endDate>2018-10-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q2QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct15-Oct15_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-15</xbrli:startDate>
			<xbrli:endDate>2018-10-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct15-Oct15_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_FederalFundsEffectiveSwapRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-15</xbrli:startDate>
			<xbrli:endDate>2018-10-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-10-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2017Q3Sep29-Sep29_us-gaap_DebtInstrumentAxis_ebs_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-09-29</xbrli:startDate>
			<xbrli:endDate>2017-09-29</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q4Oct31_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ebs:TermLoanFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2014Q1Jan29_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-01-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2017Q4Nov14_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-11-14</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-15</xbrli:startDate>
			<xbrli:endDate>2018-10-15</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ebs:TermLoanFacilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_DebtInstrumentAxis_ebs_OtherLongTermDebtFacilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:OtherLongTermDebtFacilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ebs:TermLoanFacilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_ebs_OtherLongTermDebtFacilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:OtherLongTermDebtFacilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_TaxCreditCarryforwardAxis_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">ebs:ManitobaScientificResearchAndExperimentalDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_TaxCreditCarryforwardAxis_us-gaap_ResearchMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_RangeAxis_srt_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_RangeAxis_srt_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:BiothraxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_OtherMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:OtherMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_OtherMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:OtherMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ACAM2000Member_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ACAM2000Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ACAM2000Member_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ACAM2000Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:BiothraxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:BiothraxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_NARCANNasalSprayMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:NARCANNasalSprayMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ACAM2000Member_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ACAM2000Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_NARCANNasalSprayMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:NARCANNasalSprayMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_NARCANNasalSprayMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:NARCANNasalSprayMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_OtherMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:OtherMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:BiothraxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:BiothraxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:BiothraxMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q3QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-04-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-10-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-04-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ebs:SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ebs:SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ebs:SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ebs:SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ebs:SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ebs:SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ebs:SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:unit id="category">
		<xbrli:measure>ebs:category</xbrli:measure>
	</xbrli:unit><xbrli:unit id="segment">
		<xbrli:measure>ebs:segment</xbrli:measure>
	</xbrli:unit><xbrli:unit id="usdPerShare">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit><xbrli:unit id="usd">
		<xbrli:measure>iso4217:USD</xbrli:measure>
	</xbrli:unit><xbrli:unit id="employee">
		<xbrli:measure>ebs:employee</xbrli:measure>
	</xbrli:unit><xbrli:unit id="U004">
		<xbrli:measure>ebs:Period</xbrli:measure>
	</xbrli:unit><xbrli:unit id="product">
		<xbrli:measure>ebs:product</xbrli:measure>
	</xbrli:unit><xbrli:unit id="shares">
		<xbrli:measure>xbrli:shares</xbrli:measure>
	</xbrli:unit><xbrli:unit id="number">
		<xbrli:measure>xbrli:pure</xbrli:measure>
	</xbrli:unit><xbrli:unit id="plan">
		<xbrli:measure>ebs:plan</xbrli:measure>
	</xbrli:unit><xbrli:unit id="lending_institution">
		<xbrli:measure>ebs:lending_institution</xbrli:measure>
	</xbrli:unit><xbrli:unit id="vote">
		<xbrli:measure>ebs:vote</xbrli:measure>
	</xbrli:unit><xbrli:unit id="instrument">
		<xbrli:measure>ebs:instrument</xbrli:measure>
	</xbrli:unit></ix:resources></ix:header></div><div><a id="sE980E885B0065D83B2FC466E290D2306"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">UNITED STATES</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">WASHINGTON, D.C. 20549</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">FORM </span><span><ix:nonNumeric id="d45214558e733-wk-Fact-6915A4AE9C59E1DC5952CCFBC9C49D24" name="dei:DocumentType" contextRef="FD2019Q4YTD"><span style="color:#00497f;font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;font-style:normal;font-weight:bold;text-decoration:none;">10-K</span></ix:nonNumeric></span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:12px;text-align:center;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">(Mark One)</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:20px;"></td><td style="width:662px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial Unicode MS;font-size:10pt;"><span><ix:nonNumeric id="d45214558e753-wk-Fact-693BCF7D8D116EBDC427CCE866F62D76" name="dei:DocumentAnnualReport" contextRef="FD2019Q4YTD" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">For the fiscal year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d45214558e763-wk-Fact-E300F256C7F110839A82A53BAFD86470" name="dei:DocumentPeriodEndDate" contextRef="FD2019Q4YTD" format="ixt:datemonthdayyearen">December 31, 2019</ix:nonNumeric></span></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">OR</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:20px;"></td><td style="width:662px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial Unicode MS;font-size:10pt;"><span><ix:nonNumeric id="d45214558e782-wk-Fact-E636F38F1EE47C855200CCE8E1F0624A" name="dei:DocumentTransitionReport" contextRef="FD2019Q4YTD" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">For the transition period from&#160;to</span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Commission file number: </span><span><ix:nonNumeric id="d45214558e795-wk-Fact-E899CAA77B9E401E871DCCE92F818FB1" name="dei:EntityFileNumber" contextRef="FD2019Q4YTD"><span style="color:#000000;font-family:Franklin Gothic Book,sans-serif;font-weight:bold;">001-33137</span></ix:nonNumeric></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;"><img src="emergentheaderjuste2.jpg" alt="emergentheaderjuste2.jpg" style="height:96px;width:209px;"></img></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:12pt;"><span><ix:nonNumeric id="d45214558e804-wk-Fact-4E795D19D19EAF5C3836CCE98191EB9D" name="dei:EntityRegistrantName" contextRef="FD2019Q4YTD"><span style="color:#000000;font-family:Franklin Gothic Book,sans-serif;font-size:12pt;font-weight:bold;">EMERGENT BIOSOLUTIONS INC.</span></ix:nonNumeric></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">(Exact Name of Registrant as Specified in Its Charter)</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:46%;"></td><td style="width:8%;"></td><td style="width:46%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d45214558e825-wk-Fact-BA59EE6256C07CE71BBDCCEB6EADD9D7" name="dei:EntityIncorporationStateCountryCode" contextRef="FD2019Q4YTD" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d45214558e835-wk-Fact-801B622281BE96521169CCEBDE635904" name="dei:EntityTaxIdentificationNumber" contextRef="FD2019Q4YTD">14-1902018</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(State or Other Jurisdiction of Incorporation or Organization)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(IRS Employer Identification No.)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:46%;"></td><td style="width:8%;"></td><td style="width:46%;"></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d45214558e866-wk-Fact-E0DFB4A0C859EBFB98EDFC9DCFD1C917" name="dei:EntityAddressAddressLine1" contextRef="FD2019Q4YTD">400 Professional Drive, Suite 400</ix:nonNumeric></span></span></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(Address of Principal Executive Offices)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonNumeric id="d45214558e898-wk-Fact-B10D018D7C26FA21BA06FC9E0882CD16" name="dei:EntityAddressCityOrTown" contextRef="FD2019Q4YTD">Gaithersburg</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonNumeric id="d45214558e903-wk-Fact-98952A7DA5E7C2952664FC9E40640E3B" name="dei:EntityAddressStateOrProvince" contextRef="FD2019Q4YTD">MD</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonNumeric id="d45214558e908-wk-Fact-328062924879A1689C18FC9E7E79567C" name="dei:EntityAddressPostalZipCode" contextRef="FD2019Q4YTD">21079</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(City)</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(State)</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(Zip Code)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:center;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Registrant's Telephone Number, Including Area Code: (</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45214558e929-wk-Fact-5F084B75A5C1D344DABCCCEC99888A4B" name="dei:CityAreaCode" contextRef="FD2019Q4YTD">240</ix:nonNumeric></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">) </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45214558e933-wk-Fact-99B2F5BCF4615D79624BCCECD937CE20" name="dei:LocalPhoneNumber" contextRef="FD2019Q4YTD">631-3200</ix:nonNumeric></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Title of Each Class</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Trading Symbol(s)</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Name of Each Exchange on Which Registered</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d45214558e969-wk-Fact-9F258F8E97448394D5ACCCFC47027A3D" name="dei:Security12bTitle" contextRef="FD2019Q4YTD">Common stock, $0.001 par value per share</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d45214558e974-wk-Fact-1810D63F51CB0066585C21DCF9C60367" name="dei:TradingSymbol" contextRef="FD2019Q4YTD">EBS</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d45214558e979-wk-Fact-EF6F148D2B4701E4386BCCFD624727F1" name="dei:SecurityExchangeName" contextRef="FD2019Q4YTD" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Securities registered pursuant to Section 12(g) of the Act: </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">None</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of Securities Act. </span><span><ix:nonNumeric id="d45214558e989-wk-Fact-132B7CCB4887299ADBA7CCFDB5D3069C" name="dei:EntityWellKnownSeasonedIssuer" contextRef="FD2019Q4YTD"><span style="color:#000000;font-family:Franklin Gothic Book,sans-serif;">Yes</span></ix:nonNumeric></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Unicode MS;font-size:10pt;color:#000000;">&#9746;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> No </span><span style="font-family:Arial Unicode MS;font-size:10pt;color:#000000;">&#9744;</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span><span style="font-family:Arial Unicode MS;font-size:10pt;color:#000000;">&#9744;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><span><ix:nonNumeric id="d45214558e1007-wk-Fact-B8315FECC9EBBB0F0B79CCFE422F5DFA" name="dei:EntityVoluntaryFilers" contextRef="FD2019Q4YTD"><span style="color:#000000;font-family:Franklin Gothic Book,sans-serif;">No</span></ix:nonNumeric></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Unicode MS;font-size:10pt;color:#000000;">&#9746;</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. </span><span><ix:nonNumeric id="d45214558e1018-wk-Fact-6F3A6897B9FBB6745E71CCFEA0FD7CFB" name="dei:EntityCurrentReportingStatus" contextRef="FD2019Q4YTD"><span style="color:#000000;font-family:Franklin Gothic Book,sans-serif;">Yes</span></ix:nonNumeric></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Unicode MS;font-size:10pt;color:#000000;">&#9746;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> No </span><span style="font-family:Arial Unicode MS;font-size:10pt;color:#000000;">&#9744;</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><span><ix:nonNumeric id="d45214558e1032-wk-Fact-2368A95E242F37E5B3A6CCFF0F27E4BF" name="dei:EntityInteractiveDataCurrent" contextRef="FD2019Q4YTD"><span style="color:#000000;font-family:Franklin Gothic Book,sans-serif;">Yes</span></ix:nonNumeric></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Unicode MS;font-size:10pt;color:#000000;">&#9746;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> No </span><span style="font-family:Arial Unicode MS;font-size:10pt;color:#000000;">&#9744;</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">See definitions of "large accelerated filer," "accelerated filer," "non-accelerated filer", "smaller reporting company" and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check on):</span></div><div style="line-height:120%;padding-bottom:24px;text-align:justify;padding-left:24px;text-indent:0px;font-size:10pt;"><span><ix:nonNumeric id="d45214558e1050-wk-Fact-B7761F48EAAFE4B33171CCFFDCAFD21F" name="dei:EntityFilerCategory" contextRef="FD2019Q4YTD" format="ixt-sec:entityfilercategoryen"><span style="color:#000000;font-family:Franklin Gothic Book,sans-serif;">Large accelerated filer</span></ix:nonNumeric></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Unicode MS;font-size:10pt;color:#000000;">&#9746;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Accelerated filer </span><span style="font-family:Arial Unicode MS;font-size:10pt;color:#000000;">&#9744;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Non-accelerated filer </span><span style="font-family:Arial Unicode MS;font-size:10pt;color:#000000;">&#9744;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Smaller reporting company </span><span><ix:nonNumeric id="d45214558e1067-wk-Fact-44772163A2E0AD6B4352CD00606D9AA8" name="dei:EntitySmallBusiness" contextRef="FD2019Q4YTD" format="ixt-sec:boolballotbox"><span style="color:#000000;font-family:Franklin Gothic Book,sans-serif;">&#9744;</span></ix:nonNumeric></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Emerging growth company </span><span><ix:nonNumeric id="d45214558e1072-wk-Fact-BD2552FE77C2806DEC4ACD00B13D5D12" name="dei:EntityEmergingGrowthCompany" contextRef="FD2019Q4YTD" format="ixt-sec:boolballotbox"><span style="color:#000000;font-family:Franklin Gothic Book,sans-serif;">&#9744;</span></ix:nonNumeric></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to section 13(a) of the Exchange Act. </span><span style="font-family:Arial Unicode MS;font-size:10pt;color:#000000;">&#9744;</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span><ix:nonNumeric id="d45214558e1086-wk-Fact-51474DEE08236CC8D367CD0132DDB690" name="dei:EntityShellCompany" contextRef="FD2019Q4YTD" format="ixt-sec:boolballotbox"><span style="color:#000000;font-family:Franklin Gothic Book,sans-serif;">&#9744;</span></ix:nonNumeric></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> No </span><span style="font-family:Arial Unicode MS;font-size:10pt;color:#000000;">&#9746;</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The aggregate market value of voting and non-voting common equity held by non-affiliates of the registrant as of June 30, 2019 was approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45214558e1096-wk-Fact-9694610AD90073E2173F11766F52FC74" name="dei:EntityPublicFloat" contextRef="FI2019Q2" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">2.5</ix:nonFraction> billion</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> based on the price at which the registrant's common stock was last sold on that date as reported on the New York Stock Exchange.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">February&#160;14, 2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the registrant had </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45214558e1107-wk-Fact-02AF5B97929A8AFC581E5558B0CD6B07" name="dei:EntityCommonStockSharesOutstanding" contextRef="I2020Q1Feb14" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">52.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares of common stock outstanding.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">DOCUMENTS INCORPORATED BY REFERENCE</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="TextSelection-36DE45B87865F1A879C4B216C88C081F-0-wk-Fact-0F6B22398EF1CE50F6ABB219ECE45A82" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Portions of the registrant's definitive proxy statement for its </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> annual meeting of stockholders scheduled to be held in May </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, which is expected to be filed with the Securities and Exchange Commission not later than 120 days after the end of the registrant's fiscal year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, are incorporated by reference into Part II, Item 5. and Part III of this annual report on Form 10-K. With the exception of the portions of the registrant's definitive proxy statement for its </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> annual meeting of stockholders that are expressly incorporated by reference into this annual report on Form 10-K, such proxy statement shall not be deemed filed as part of this annual report on Form 10-K.</span></div></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1</span></div></div><hr style="page-break-after:always"></hr><div><a id="s8419B9C6E0D353E5A52EFCDA47FA6D35"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">EMERGENT BIOSOLUTIONS INC.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ANNUAL REPORT ON FORM 10-K</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">FOR THE FISCAL YEAR ENDED </span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">December&#160;31, 2019</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:10%;"></td><td style="width:9%;"></td><td style="width:81%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;" href="#s8419B9C6E0D353E5A52EFCDA47FA6D35"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">INDEX</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;" href="#s27D5441E5B8356CAAFC233093F0AB318"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">PART I</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s9FEFB7CC572850479EB80F6DF79892E6"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 1.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s9FEFB7CC572850479EB80F6DF79892E6"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Business</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s01D0907685BE51D19E91A054A5F77189"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 1A.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s01D0907685BE51D19E91A054A5F77189"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Risk Factors</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s55BF7CC9268051C1AC4852159FAF6D05"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 1B.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s55BF7CC9268051C1AC4852159FAF6D05"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unresolved Staff Comments</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s5D8AB018A609509798B0A6F29B50BAA3"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 2.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s5D8AB018A609509798B0A6F29B50BAA3"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Properties</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#sCC5F567C1C2D53769F91B5B49B10FDDA"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 3.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#sCC5F567C1C2D53769F91B5B49B10FDDA"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Legal Proceedings</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s92A62307C10F587B84A9927423863601"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 4.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s92A62307C10F587B84A9927423863601"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mine Safety Disclosures</span></a></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;" href="#sC682F34B15A95EC686DC8E835895C2D8"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">PART II</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s29457D6E33685BF984D07623CE0D7F04"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 5.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s29457D6E33685BF984D07623CE0D7F04"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s50179E2663755C02AA78D55D15B1FBB4"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 6.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s50179E2663755C02AA78D55D15B1FBB4"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Selected Financial Data</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s3029F4D167AE50C88785B4296C3D90BF"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 7.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s3029F4D167AE50C88785B4296C3D90BF"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s8D267077AD035ABDAFF80513C8794D37"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 7A.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s8D267077AD035ABDAFF80513C8794D37"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Quantitative and Qualitative Disclosures About Market Risk</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s9887C129DCC954A99D5BC11296975F97"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 8.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s9887C129DCC954A99D5BC11296975F97"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Financial Statements and Supplementary Data</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s9C10CCCF0BB9553DAE63123FF8EC71A7"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 9.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s9C10CCCF0BB9553DAE63123FF8EC71A7"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s835A27FCE2A9513F9AADF5A203D040F8"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 9A.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s835A27FCE2A9513F9AADF5A203D040F8"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Controls and Procedures</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s643154A5110E5AA4AC249A9EA6045960"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 9B.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s643154A5110E5AA4AC249A9EA6045960"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other Information</span></a></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;" href="#s98E7AE21F0B65D84A2D86A64ACD96766"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">PART III</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s51F76A5E97EC5C05A9FC691E9ACFB37A"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 10.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s51F76A5E97EC5C05A9FC691E9ACFB37A"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Directors, Executive Officers and Corporate Governance</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s58DCDE4288655F51B846CE77DDD1AA14"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 11.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s58DCDE4288655F51B846CE77DDD1AA14"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Executive Compensation</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s5205FFA349ED54FE91FFB006E95CA6B8"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 12.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s5205FFA349ED54FE91FFB006E95CA6B8"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s71357499738C5BC5ADF6E142AD5378C7"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 13.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s71357499738C5BC5ADF6E142AD5378C7"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Certain Relationships and Related Transactions, and Director Independence</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s589D7086DEDC512886EE7FB920167E24"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 14.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s589D7086DEDC512886EE7FB920167E24"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Principal Accountant Fees and Services</span></a></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;" href="#s7F10361C3D1D5C9D8EE369EBCEE62B62"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">PART IV</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#sF956533D9DBB505087BD52D1AF8F89CB"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Item 15.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#sF956533D9DBB505087BD52D1AF8F89CB"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Exhibits and Financial Statement Schedules</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#s1DB612A5477651F682EDD321AC111FD6"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Signatures</span></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;" href="#sF10B7624EFAA56D0A93E86657C6169D6"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Exhibit Index</span></a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2</span></div></div><hr style="page-break-after:always"></hr><div><a id="s3FA088767C7F503BA0C5FFA37B745D89"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="line-height:120%;padding-bottom:12px;text-align:start;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">This annual report on Form 10-K and the documents we incorporate by reference include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">All statements, other than statements of historical fact, including statements regarding the future earnings and performance of Emergent BioSolutions Inc. or any of our businesses, our strategy, future operations, future financial position, future revenues, projected costs, prospects, plans and objectives of management, are forward-looking statements. We generally identify forward-looking statements by using words like "will," "believes," "expects," "anticipates," "intends," "plans," "forecasts," "estimates" and similar expressions in conjunction with, among other things, discussions of financial performance or financial condition, growth strategy, product sales, manufacturing capabilities, product development, regulatory approvals or expenditures. These forward-looking statements are based on our current intentions, beliefs and expectations regarding future events. We cannot guarantee that any forward-looking statement will be accurate. You should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from our expectations. You are, therefore, cautioned not to place undue reliance on any forward-looking statement. Any forward-looking statement speaks only as of the date on which such statement is made, and, except as required by law, we do not undertake to update any forward-looking statement to reflect new information, events or circumstances.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:start;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">There are a number of important factors that could cause our actual results to differ materially from those indicated by such forward-looking statements, including, among others:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the availability of U.S. government (USG) funding for procurement for our products; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">our ability to perform under our contracts with the USG including the timing of and specifications relating to deliveries;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the continued exercise of discretion by the&#160;Biomedical Advanced Research and Development Authority (BARDA)&#160;to procure additional doses of AV7909 (anthrax vaccine adsorbed with adjuvant) prior to approval by the&#160;U.S. Food and Drug Administration (FDA);</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">our ability to secure licensure of AV7909 from the FDA within the anticipated timeframe, if at all;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">our ability to secure follow-on procurement contracts for our public health threat (PHT) products that are under procurement contracts that have expired or will be expiring;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">our ability and the ability of our collaborators to enforce patents related to NARCAN Nasal Spray against potential generic entrants;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">our ability to identify and acquire companies, businesses, products or product candidates that satisfy our selection criteria;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">our ability and the ability of our contractors and suppliers to maintain compliance with current good manufacturing practices and other regulatory obligations;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">our ability to comply with the operating and financial covenants required by our senior secured credit facilities;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">our ability to obtain and maintain regulatory approvals for our product candidates and the timing of any such approvals</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the procurement of products by USG entities under regulatory exemptions prior to approval by the FDA and corresponding procurement by government entities outside of the United States under regulatory exemptions prior to approval by the corresponding regulatory authorities in the applicable country;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the success of our commercialization, marketing and manufacturing capabilities and strategy; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the accuracy of our estimates regarding future revenues, expenses, capital requirements and needs for additional financing.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:48px;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from our expectations in any forward-looking statement. New factors emerge from time to time and it is not possible for management to predict all such factors, nor can it assess the impact of any such factor on the business or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. You should consider this cautionary statement, the risk factors identified in the section entitled &#8220;Risk Factors&#8221; in this annual report on Form 10-K and the risk factors identified in our periodic reports filed with the Securities and Exchange Commission when evaluating our forward-looking statements.</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">NOTE REGARDING COMPANY REFERENCES</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">References in this report to &#8220;Emergent,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Emergent BioSolutions Inc. and its consolidated subsidiaries.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">3</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">NOTE REGARDING TRADENAMES</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">BioThrax&#174; (Anthrax Vaccine Adsorbed), RSDL&#174; (Reactive Skin Decontamination Lotion Kit), BAT&#174; (Botulism Antitoxin Heptavalent (A,B,C,D,E,F,G)-(Equine)), Anthrasil&#174; (Anthrax Immune Globulin Intravenous (Human)), VIGIV (Vaccinia Immune Globulin Intravenous (Human)), Trobigard&#174; (atropine sulfate, obidoxime chloride), ACAM2000&#174; (Smallpox (Vaccinia) Vaccine, Live), Vivotif&#174; (Typhoid Vaccine Live Oral Ty21a), Vaxchora&#174; (Cholera Vaccine, Live, Oral), NARCAN&#174; (naloxone HCI) Nasal Spray and any and all Emergent brands, products, services and feature names, logos and slogans are trademarks or registered trademarks of Emergent or its subsidiaries in the United States or other countries. All other brands, products, services and feature names or trademarks are the property of their respective owners.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">4</span></div></div><hr style="page-break-after:always"></hr><div><a id="s27D5441E5B8356CAAFC233093F0AB318"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">PART I</span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div><a id="s9FEFB7CC572850479EB80F6DF79892E6"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 1.&#160;BUSINESS</span></div><div style="line-height:120%;padding-bottom:12px;text-align:left;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">OVERVIEW</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Emergent BioSolutions Inc. is a global life sciences company focused on providing a portfolio of innovative preparedness and response products and solutions to civilian and military populations that address accidental, deliberate and naturally occurring public health threats (PHTs). We were incorporated in the State of Michigan in May 1998 and subsequently reorganized as a Delaware corporation in June 2004.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We are currently focused on innovative preparedness and response products and solutions that address the following six distinct PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives (CBRNE); emerging infectious diseases (EID); travel health; emerging health crises; acute/emergency care; and contract development and manufacturing (CDMO). We have a product portfolio of ten marketed products (vaccines, therapeutics, and drug-device combination products) that have been approved by the FDA, and a clinical-stage vaccine product candidate, currently being procured by the U.S. Government (USG) under specific authorization for delivery to the Strategic National Stockpile (SNS) that collectively generate the majority of our revenue. We also have a development pipeline consisting of a diversified mix of both pre-clinical and clinical-stage product candidates, including Trobigard</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174; </sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">a combination drug-device auto injector product candidate. In addition, we have a fully integrated molecule-to-market biologics CDMO business offerings (development services, drug substance and drug product) for the pharma and biotech industry and government agencies, as well as non-government organizations. The USG is our largest customer and also provides us with substantial funding for the development of a number of our product candidates. We continue to pursue acquiring and developing products and solutions that provide an opportunity to serve both government customers and commercial (non-government) customers.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:left;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">STRATEGY</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our core strategy to drive the business is focused on addressing a PHT market that includes CBRNE, EID, travel health, emerging health crises, acute/emergency care, and CDMO services. Our 2020-2024 growth strategy contemplates that we continue to:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Execute on the core business, building leadership positions across this expanded landscape of PHTs;</span></div></td></tr></table></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Grow through a disciplined approach toward acquiring products and businesses that are strategically aligned;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Build and strengthen our research and development (R&amp;D) portfolio for it to become a meaningful contributor to growth after 2024;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Build scalable capabilities by investing in operational excellence and innovation to support a growing enterprise that will deliver greater impact; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Continue to evolve our culture as we grow to support even greater employee engagement and empowerment.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In executing on our strategy, we are leveraging our core competencies that we have developed and honed over the last 21 years. These competencies include:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Quality development and manufacturing services across a spectrum of specialized and complex manufacturing processes, using multiple platform technologies;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Specialized federal, state, and local government relations and contracting operations to support the enterprise; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Successful execution and integration of business and product acquisitions.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:left;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">GROWTH THROUGH ACQUISITIONS AND COLLABORATIONS</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We have a track record of growth through the acquisition of businesses, products and technologies that are aligned with our long-term strategic objectives. Our goal is to continue our development activity by seeking and entering into acquisition and collaboration transactions that we believe will allow us to achieve our 2024 strategic goals. Below is a summary of our recent significant acquisitions, transactions and collaborations.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Adapt Pharma Limited</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In October 2018, we completed the acquisition of Adapt, and its NARCAN</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (naloxone HCl) Nasal Spray marketed product, the first needle-free formulation of naloxone approved by the FDA, and Health Canada, for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. This acquisition included the NARCAN</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Nasal Spray marketed product and a development pipeline of new treatment and delivery options to address opioid overdose, and approximately 50 employees, located in the U.S., Canada, and Ireland, </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">5</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">including those responsible for supply chain management, research and development, government affairs, and commercial operations.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">PaxVax Holding Company Ltd.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In October 2018, we completed the acquisition of PaxVax, a company focused on developing, manufacturing, and commercializing specialty vaccines that protect against existing and emerging infectious diseases. This acquisition included Vivotif</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (Typhoid Vaccine Live Oral Ty21a), the only oral vaccine licensed by the FDA for the prevention of typhoid fever; Vaxchora</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (Cholera Vaccine, Live, Oral), the only FDA-licensed vaccine for the prevention of cholera; and additional clinical-stage vaccine candidates targeting chikungunya and other EIDs; European-based current good manufacturing practices (cGMP) biologics manufacturing facilities; and approximately 250 employees including those in research and development, manufacturing, and commercial operations with a specialty vaccines salesforce in the U.S. and in select European countries.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">ACAM2000</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:none;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup>&#160;</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In October 2017, we completed the acquisition of the ACAM2000</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (Smallpox (Vaccinia) Vaccine, Live) business of Sanofi Pasteur Biologics, LLC. This acquisition included ACAM2000, a vaccine licensed by the FDA for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection; a licensed, live-viral manufacturing facility and office and warehouse space, both in Canton, Massachusetts (for which we received FDA manufacturing approval for the transfer of the upstream portion of the manufacturing process of ACAM2000 in November 2017); and a live-viral fill/finish facility in </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Rockville, Maryland. With this acquisition, we also acquired a 10-year contract with the Centers for Disease Control and Prevention (CDC), which expired in March 2018. This contract was originally valued at up to $425 million, and upon acquisition had a remaining value at acquisition of up to approximately $160 million, reflecting the value of doses of ACAM2000 remaining to be delivered to the SNS, all of which have been delivered to date. On September 3, 2019, we announced the award by the U.S. Department of Health and Human Services (HHS) of a new contract valued at approximately $2 billion over 10 years for the continued supply of ACAM2000 into the SNS.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">raxibacumab</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In October 2017, we completed the acquisition of raxibacumab from Human Genome Sciences, Inc. and GlaxoSmithKline LLC (collectively GSK). Our raxibacumab product is the first fully human monoclonal antibody product licensed by the FDA for the treatment and prophylaxis of inhalational anthrax.  With the acquisition, we assumed responsibility for a multi-year contract with BARDA with a remaining value at acquisition of up to approximately $130 million and all deliveries of raxibacumab to the SNS under this contract have been completed. We intend to submit a proposal for a follow-on contract with the USG to continue to supply this medical countermeasure (MCM) to the SNS. </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We are currently in the process of pursuing FDA licensure for the transfer of bulk manufacturing of raxibacumab to our Bayview facility and the fill/finish process to our Camden facility.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:48px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">OUR BUSINESS UNITS</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We are organized into four business units: Vaccines, Devices, Therapeutics and Contract Development and Manufacturing.</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Vaccines</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Products</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our Vaccines business unit contains a portfolio of specialty vaccines that address existing and emerging PHTs. The current portfolio of marketed or procured products consists of the following products:</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">6</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:1px solid #000000;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">VACCINES BUSINESS UNIT</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">Product</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">Indication(s)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">Regulatory Approvals</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;font-weight:bold;">BioThrax</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(Anthrax Vaccine Adsorbed)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Vaccine for active immunization for the prevention of disease caused by Bacillus anthracis in persons 18 through 65 years of age</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">United States, Germany, Singapore, UK, the Netherlands, France (where it is known as BaciThrax&#174;), Poland, Italy, Canada</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;font-weight:bold;">ACAM2000</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(Smallpox (Vaccinia) Vaccine, Live)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Vaccine for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">United States, Australia, Singapore</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;font-weight:bold;">Vivotif&#174;</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(Typhoid Vaccine Live Oral Ty21a)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Oral vaccine for the prevention of typhoid fever in adults and children greater than 6 years of age</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">United States Canada, Australia, New Zealand, Singapore, South Korea, Hong Kong, Malaysia, UK, France, Italy, Portugal, Spain, Switzerland, Belgium, Luxembourg, the Netherlands, Germany, Austria, Norway, Denmark, Finland, Sweden, the Czech Republic, Slovakia</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">Vaxchora&#174;</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(Cholera Vaccine Live Oral)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Oral vaccine for the prevention of cholera in adults 18 through 64 years of age traveling to cholera-affected areas</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">United States</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">BioThrax</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> (Anthrax Vaccine Adsorbed).</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> BioThrax is the only vaccine licensed by the FDA for pre-exposure prophylaxis (PrEP) of anthrax disease in persons at high risk of exposure. In April 2014, the FDA granted orphan drug designation to BioThrax for post-exposure prophylaxis (PEP) of disease following suspected or confirmed </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Bacillus anthracis</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> exposure, when administered in conjunction with recommended antibacterial drugs (please see &#8220;Regulation - Marketing Approval - Biologics, Drugs and Vaccines - Orphan Drugs&#8221;), giving it market exclusivity in the United States until November 2022. In November 2015, the FDA approved our supplemental Biologics License Application (BLA), to expand the BioThrax label to include the PEP indication for BioThrax administered in combination with antimicrobial therapy. Anthrax is a potentially fatal disease caused by the spore-forming bacterium, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Bacillus anthracis</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. Inhalational anthrax is the most lethal form of anthrax. Death due to inhalational anthrax infection often occurs within 24-36 hours of the onset of advanced respiratory complications. In the U.S., BioThrax is administered in a PrEP setting by intramuscular injection as a three-dose primary series over a six-month period. The vaccine is considered protective after completion of this three-dose primary series. Per the US label, booster doses are administered 6 and 12 months after completion of the primary series and at 12 month intervals thereafter. BioThrax is administered in a PEP setting in conjunction with recommended antibacterial drugs following suspected or confirmed </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Bacillus anthracis</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> exposure. The vaccination schedule for PEP consists of three doses of BioThrax administered subcutaneously at zero, two and four-weeks post-exposure combined with antimicrobial therapy. </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In December 2016, we signed a follow-on contract with the CDC, an agency within the U.S. Department of Health and Human Services (HHS) for the supply of up to approximately 29.4 million doses of BioThrax for delivery into the SNS, over a five-year period ending in September 2021. The potential value of this contract is approximately $911 million, if all procurement options are exercised. In March 2017, we entered into an additional contract with BARDA, originally valued at up to $100 million, for the delivery of BioThrax to the SNS, over a two-year period of performance. We completed the remainder of deliveries under this contract in 2017. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">ACAM2000</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> (Smallpox (Vaccinia) Vaccine, Live)</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> ACAM2000 is a smallpox vaccine licensed by the FDA and is the primary smallpox vaccine designated&#160;for use in a bioterrorism emergency. ACAM2000 is also licensed in Australia and Singapore and is currently stockpiled both in the United States and internationally.&#160;Smallpox is a highly contagious disease caused by the variola virus, a member of the orthopox virus genus.&#160;According to the CDC, it is one of the most devastating diseases with a mortality rate as high as 30%. ACAM2000 is administered by the percutaneous route in one dose with a bifurcated needle using the multiple-puncture method. The vaccine stimulates a person's immune system to develop antibodies and cells in the blood and elsewhere that can then help the body fight off a smallpox infection if exposure to smallpox occurs.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Despite being eradicated in 1979, smallpox poses a significant risk to national security and public health due to its ease of transmission, high mortality rate, and potential for major public health impact and social disruption. It remains a continued threat to the U.S. population if it were to reemerge naturally or due to an intentional act. Recent advances in synthetic biology </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">7</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">have enabled easier access to the smallpox virus. Smallpox vaccines have been foundational to the USG&#8217;s preparedness and response efforts as documented in legislation such as the Project BioShield Act of 2004 and its predecessor, the Public Health Security and Bioterrorism Act of 2002.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Upon the closing of the ACAM2000 acquisition, we acquired a 10-year CDC contract, which expired in March 2018. The original contract, valued at up to $425 million, called for the delivery of ACAM2000 to the SNS and establishing U.S.-based manufacturing of ACAM2000, specifically the transfer of the upstream portion of the ACAM2000 production process from Austria to a U.S.-based manufacturing facility. This technology transfer was completed and approved by the FDA in November 2017. At acquisition, there was $160 million of remaining value on the prior contract, all doses of which have been delivered to date.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On September 3, 2019, we announced the award by the USG of a new contract valued at approximately $2 billion over 10 years for the continued supply of ACAM2000 into the SNS. This multiple-year contract is intended to support the replacement of the smallpox vaccine stockpile and included a one-year base period of performance in 2019 valued at approximately $170 million, and nine option years. The number of doses under the base period were delivered by year end 2019. The actual number of ACAM2000 doses to be procured is dependent on certain timing and tiered-pricing terms that are subject to the discretion of HHS.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Vivotif</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> (Typhoid Vaccine Live Oral Ty21a)</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">. </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Vivotif is a live attenuated vaccine for oral administration to </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">prevent typhoid fever. The vaccine contains the attenuated strain </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Salmonella </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Typhi Ty21a (1,2). Typhoid fever is a potentially severe and occasionally life-threatening febrile illness caused by&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Salmonella enterica</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;serotype Typhi, a bacterium that only lives in humans. It is usually acquired by consumption of water or food that has been contaminated by feces of an infected person. Typhoid fever is uncommon in North America and Europe. However, travelers from North America and Europe going to Asia, Africa, and Latin America have been particularly at risk. Even short-term travel to high-incidence areas is associated with risk for typhoid fever. In the U.S., Vivotif is indicated for immunization of adults and children greater than 6 years of age against disease caused by </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Salmonella </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Typhi.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Vaxchora</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"><sub style="vertical-align:bottom;line-height:120%;font-size:pt"> </sub></span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">(Cholera Vaccine Live Oral)</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Vaxchora is a live attenuated cholera vaccine for oral administration and the first vaccine approved by the FDA for the prevention of cholera infection. Cholera, a potentially life-threatening bacterial infection that occurs in the intestines and causes severe diarrhea and dehydration, has a low incidence in the U.S., but a high incidence in Africa, Southeast Asia, and other locations around the world. These areas draw travelers from the U.S., so cholera can occur in patients who return to the U.S. from visits to these regions. Vaxchora is indicated for active immunization against cholera caused by the bacterium </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">V. cholerae </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">serogroup O1. Vaxchora is approved for use in patients 18-64 years of age who are traveling to known cholera-infected areas.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Product Candidates</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The chart below highlights our primary Vaccines product candidates:</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:37%;"></td><td style="width:21%;"></td><td style="width:21%;"></td><td style="width:21%;"></td></tr><tr><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">Product Candidate</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">Partner</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">Platform</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">Threat Type</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">AV7909*</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Next-generation anthrax vaccine</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">HHS - BARDA</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">Vaccine</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">Biological</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">CHIKV VLP</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Chikungunya virus VLP vaccine</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">--</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">Vaccine</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">EID</span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">AV7909 is not approved by the FDA or any other health regulatory agency, but it is being procured by BARDA under special circumstances under government authorization.</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">AV7909 (anthrax vaccine adsorbed with CPG 7909 adjuvant)</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. We are developing AV7909, an anthrax vaccine product candidate based on BioThrax combined with CPG 7909. We are developing AV7909, in part with funding from the National Institute of Allergy and Infectious Diseases (NIAID) and BARDA, to potentially elicit a more rapid onset of immune response using fewer doses than BioThrax while still providing protective immunity in patients. In October 2014, we completed a Phase 2 clinical trial of AV7909 in which all endpoints </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">were successfully met, including a two-dose regimen (versus the BioThrax three-dose regimen) for anthrax post-exposure prophylaxis. In September 2014, we obtained funding through a five-year development contract with NIAID of up to $29 million to support the development of a dry formulation of AV7909, which includes  the preparation of an Investigational New Drug (IND) application to the FDA. The objective of the dry formulation is to eliminate the need for cold chain during shipping and storage. In March 2015, we signed a </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">8</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">development contract with BARDA valued at $31 million to develop AV7909 for post-exposure prophylaxis of anthrax disease. In September 2016, we signed a combination development and procurement contract with BARDA for up to approximately $1.5 billion, including a five-year base period of performance valued initially at approximately $200 million to develop AV7909 for post-exposure prophylaxis of anthrax disease and to deliver to the SNS an initial two million doses, subsequently modified to three million doses in March 2017. The contract also includes procurement options for the delivery of an additional 7.5 million to 50 million doses of AV7909 into the SNS, valued from approximately $255 million to up to $1.3 billion, respectively, and options for an additional clinical study and post marketing commitments valued at $48 million, which, if all were to be exercised in full, could increase the total contract value to approximately $1.5 billion. In 2019, we initiated and completed enrollment of a Phase 3 study; a 3,850 subject trial evaluating safety and lot consistency. We also initiated a Phase 2 study exploring drug-drug interaction of AV7909 and antibiotics. In collaboration with us, the CDC filed with the FDA a submission package related to AV7909, which triggered BARDA to begin procurement of AV7909 in 2019. On May 15, 2019, we announced that BARDA had informed us that it would begin procuring AV7909 for delivery into the SNS and on July 30, 2019, BARDA exercised its first contract option valued at approximately $261 million to procure doses to be delivered to the SNS through June of 2020. See &#8220;Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations - Overview - Highlights and Business Accomplishments for 2019&#8221; for additional details.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">CHIKV VLP</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. We licensed the chikungunya virus (CHIKV), a virus-like particle (VLP), vaccine product candidate from the Vaccine Research Center (VRC) at the National Institutes of Health (NIH). VLPs for alphaviruses are comparable to the physical structure of the native virus, and contain repetitive, high density displays of viral surface proteins that present </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">conformational viral epitopes that elicit strong B- and T-cell immune responses. Since VLPs cannot replicate, they provide a potentially safer alternative to attenuated and inactivated vaccines throughout production and use and can likely be administered in unrestricted target populations. VRC has previously evaluated in this product candidate both nonclinical and clinical (Phase 1 and Phase 2) safety, immunogenicity and efficacy data. Key nonclinical studies suggested protective efficacy in nonhuman primates (NHPs) and a passive transfer study demonstrated that mice dosed with purified antibody from the VLP-immunized NHPs were protected from an otherwise lethal CHIKV infection. The NIH recently completed a Phase 2 clinical study with 200 subjects that was conducted at multiple endemic sites in the Caribbean, which suggested that protective levels of antibodies can persist at least 18 months post-vaccination. Emergent&#8217;s CHIKV VLP vaccine candidate is currently being investigated in a Phase 2 clinical study of approximately 430 healthy adults at three U.S. sites. Upcoming development activities include Phase 3 development, including process validation and manufacture, and licensure-enabling nonclinical toxicity and efficacy studies. Collectively, these studies are intended to support regulatory filings in both the U.S. and European Union. The CHIKV VLP vaccine received FDA Fast Track designation in May 2018 and EMA PRIority MEdicines (PRIME) designation in September 2019. In January 2020, the Company received agreement from the European Medicines Agency (EMA) to pursue its proposed development plan for CHIKV VLP. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">Additional Pipeline Candidates</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. Our Vaccines business unit also has other discovery and preclinical product candidates addressing PHTs, including viral hemorrhagic fevers caused by Ebola, Marburg, Sudan and Lassa viruses, prevention of diarrheal disease caused by Shigella and heat-labile toxin producing enterotoxigenic Escherichia coli, among others.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Devices</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Products</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our Devices business unit contains a broad portfolio of products that incorporate convergent technologies that address PHTs. The current portfolio consists of the following products:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:32%;"></td><td style="width:46%;"></td><td style="width:22%;"></td></tr><tr><td colspan="3" style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">DEVICES UNIT</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">Product</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">Indication(s)</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">Regulatory Approvals</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">NARCAN&#174; (naloxone HCl) Nasal Spray</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression.</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">United States, Canada</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">RSDL&#174;</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(Reactive Skin Decontamination Lotion Kit)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Removal or neutralization of chemical warfare agents from the skin: tabun, sarin, soman, cyclohexyl sarin, VR, VX, mustard gas and T-2 toxin.</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">United States (510k), Canada, Australia, European Union, Israel</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">9</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">NARCAN</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> (naloxone HCl) Nasal Spray.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> NARCAN</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (naloxone HCl) Nasal Spray is the first needle-free formulation of naloxone approved by the FDA and Health Canada for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. The primary customers for NARCAN Nasal Spray are state health departments, local law enforcement agencies, community-based organizations, substance abuse centers, federal agencies and consumers through pharmacies fulfilling physician-directed or standing order prescriptions.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">RSDL</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> (Reactive Skin Decontamination Lotion Kit)</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. RSDL is the only medical device cleared by the FDA that is intended to remove or neutralize chemical warfare agents from the skin, including tabun, sarin, soman, cyclohexyl sarin, VR, VX, mustard gas and T-2 toxin. RSDL has also been cleared as a medical device by Health Canada, has a current European Conformity (CE) mark under European Directives, and is licensed by the Israel Ministry of Health and by Australia's Therapeutics Goods Administration. To date, the principal customers for RSDL have been agencies of the USG, including the Department of Defense (DoD) and the National Guard. Our current contract with the DoD, awarded in September 2017 after the expiration of our initial DoD contract, is a five-year follow-on contract valued at up to approximately $171 million to supply RSDL for use by all branches of the U.S. military. In addition to the DoD and other USG agencies, beginning in 2017, we made RSDL available for the first time for purchase by civilians in the U.S. We have also sold RSDL to 35 foreign countries outside the United States since the device was cleared in 2003. We intend to continue our sales to USG agencies and the DoD and to identify new markets where RSDL can be promoted and sold under its current FDA clearance.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Product Candidates</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Within our Devices business unit, we develop several investigational stage product candidates, including:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">Auto-Injector Drug-Device Product Candidates </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We have been developing a suite of drug-device combination product candidates in an auto-injector platform based on our proprietary technology, primarily for military and other government use. Included in these are Trobigard</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174; </sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">(atropine sulfate and obidoxime chloride), which is currently under review for approval by the health regulatory authority in Belgium; D4 (atropine and pralidoxime chloride), for which we received a $23 million development award from the U.S. Department of Defense (DoD); and PC2A (diazepam), for which we received a $20 million development award from the DoD. Trobigard has not been approved by the FDA or any other health regulatory authority but has been procured by </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">various government buyers under special circumstances. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">SIAN (stabilized isoamyl nitrite)</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. In September 2017, we were awarded a contract by BARDA valued at approximately $63 million to develop an antidote intranasal spray device for the treatment of known or suspected acute cyanide poisoning. The single-use intranasal spray device is being developed to deliver a stabilized form of isoamyl nitrite (SIAN) and is intended to be developed for use by first responders and medical personnel following a cyanide incident.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">Development Candidates from Adapt Acquisition</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> We acquired from Adapt multiple constructs in various stages of development focused on new treatments and delivery options for opioid overdose response, including the following: </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">AP004 (Naloxone prefilled syringe)</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">. </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">A naloxone pre-filled syringe for emergency care providers, offering a titratable dose. We expect to launch this product in the second half of 2020. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">AP003 (Naloxone multidose nasal spray). </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">A nasal delivery device which can deliver multiple 4mg doses to treat acute opioid overdose. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">AP007 (Sustained release Nalmefene injectable). </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In September we were awarded an NIH grant of approximately $6.3 million over two years, to develop the company&#8217;s sustained release nalmefene formulation. This formulation will be administered through intramuscular (IM) injection and is designed to continually release an effective dose of nalmefene for up to three months. It is intended to treat addiction and reduce the potential for relapse in patients undergoing treatment for opioid use disorder (OUD). The award is being made under the Helping to End Addiction Long-term Initiative, or the NIH HEAL Initiative, to improve prevention and treatment strategies for opioid misuse and addiction and enhance pain management. Upon meeting milestones there is an opportunity to exercise a further three years funding taking the product through early stage clinical development.</span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">10</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Therapeutics</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;font-weight:bold;text-decoration:underline;">Products</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our Therapeutics business unit contains a broad portfolio of specialty antibody-based therapeutics that address various existing and emerging PHTs. The current portfolio consists of the following marketed products:</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:32%;"></td><td style="width:46%;"></td><td style="width:22%;"></td></tr><tr><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:1.5px solid #000000;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">THERAPEUTICS BUSINESS UNIT</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">Product</span></div></td><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">Indication(s)</span></div></td><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">Regulatory Approvals</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">VIGIV</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">CNJ-016&#174;</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">[Vaccinia Immune Globulin Intravenous (Human)]</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Treatment of complications due to vaccinia vaccination, including:</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;Eczema vaccinatum;</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;Progressive vaccinia;</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;Severe generalized vaccinia;</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;Vaccinia infections in individuals who have skin conditions;</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;Aberrant infections induced by vaccinia virus (except in cases of isolated keratitis).</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">United States, Canada</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">BAT&#174;</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">[Botulism Antitoxin Heptavalent (A,B,C,D,E,F,G)-(Equine)]</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes A, B, C, D, E, F, or G in adults and pediatric patients.</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">United States, Canada, Ukraine, Singapore</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">raxibacumab </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Treatment of inhalational anthrax in adult and pediatric patients in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">United States</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;">Anthrasil&#174;</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">[Anthrax Immune Globulin Intravenous (Human)]</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Treatment of inhalational anthrax in adult and pediatric patients in combination with appropriate antibacterial drugs.</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">United States, Canada&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">raxibacumab</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. Our raxibacumab product is the first fully human monoclonal antibody therapeutic licensed by the FDA for the treatment and prophylaxis of inhalational anthrax due to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Bacillus anthracis</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. It was licensed by the FDA in December 2012. Our raxibacumab product is indicated for the treatment of adult and pediatric patients with inhalational anthrax in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or not appropriate. Our raxibacumab product has been supplied to the SNS since 2009 under contracts with BARDA. Upon the closing of our acquisition of raxibacumab from GSK, we assumed responsibility for a multi-year contract with BARDA, valued at up to approximately $130 million at acquisition, to supply the product to the SNS through November 2019. All deliveries under this contract are complete. We intend to submit a proposal for a follow-on contract with the USG to continue the supply of this medical countermeasure (MCM) to the SNS.  We have initiated the process of the transfer of raxibacumab bulk manufacturing from GSK to our Bayview facility and fill/finish activities to our Camden facility.</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">Anthrasil</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> [Anthrax Immune Globulin Intravenous (Human)]</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. Anthrasil is the only polyclonal antibody therapeutic licensed by the FDA for the treatment of inhalational anthrax. Anthrasil is comprised of purified human polyclonal immune globulin G (IgG) containing </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">polyclonal antibodies directed to the anthrax toxins of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Bacillus anthracis</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the bacteria that causes anthrax disease, and is prepared using plasma collected from healthy, screened donors who have been immunized with our BioThrax vaccine. Anthrasil was licensed by the FDA in March 2015 for the treatment of inhalational anthrax in adult and pediatric patients in combination with appropriate antibacterial drugs. Simultaneous with FDA approval in 2015, Anthrasil also received orphan drug designation for that indication, resulting in market exclusivity in the United States until March 2022. To date, the principal customer for Anthrasil has been the USG, specifically HHS. Anthrasil is procured by HHS for delivery into the SNS. We have two current contracts with HHS: a development and procurement contract that expires in April 2021 and a multiple award, indefinite delivery/indefinite quantity contract for the collection of anti-anthrax plasma, as well as the manufacture of such plasma into bulk drug substance and finished drug product and delivery of finished product into the SNS under this contract to extend the plasma collection storage, and to include options for manufacturing and product delivery; this contract is available to be exercised by HHS through September 2023. </span></div><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition to domestic government sales, Anthrasil has been sold to several foreign governments. In December 2017, we were awarded a contract by the Canadian Department of National Defense, valued at approximately $8 million, to deliver Anthrasil to the </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">11</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Canadian government. This contract award follows the December 2017 approval of Anthrasil by Health Canada under the Extraordinary Use New Drug (EUND) Regulations, which provide a regulatory pathway in Canada for products for which collecting clinical information for its intended use in humans is logistically or ethically not possible.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">BAT</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> [Botulism Antitoxin Heptavalent (A,B,C,D,E,F,G)(Equine)]</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. BAT is the only heptavalent antibody therapeutic licensed by the FDA and Health Canada for the treatment of botulism. BAT is comprised of purified polyclonal equine immune globulins (antibodies) directed to the seven toxins (A through G) produced by </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Clostridium botulinum</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. BAT was licensed by the FDA in the United States in March 2013 for the treatment of symptomatic botulism following suspected or documented exposure to botulinum neurotoxin serotypes A, B, C, D, E, F or G in adults and pediatric patients. It was also licensed in Canada in December 2016 pursuant to Health Canada&#8217;s EUND regulations. Simultaneous with FDA licensure in 2013, BAT also received orphan drug designation for the FDA-licensed indication, resulting in market exclusivity in the United States until March 2020. BAT was also approved in Singapore and Ukraine in 2019. BAT is the only heptavalent botulism antitoxin available in the United States or Canada for treating naturally occurring botulism in adults or pediatric patients. Botulinum toxin is a nerve toxin produced by the bacterium </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Clostridium botulinum</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> that causes botulism, a serious paralytic illness. Naturally occurring cases are mainly seen in infants or in adults who have consumed improperly processed foods. Botulinum toxin can also be used as a bioterrorism agent and has been identified in the United States as one of the highest priority bioterrorism threats. To date, the principal customer for BAT has been the USG, specifically HHS. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We are currently operating under two procurement contracts.  The first contract is with BARDA, and Emergent is currently executing on the manufacturing and supply of the bulk drug until 2022 valued at $53 million. The second contract was awarded by ASPR in </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">HHS in 2019, and is valued at up to $490 million over 10 years ($90 million agreed to now and the remaining $400 million to be negotiated and finalized over the next 6 months) for the continued supply of BAT into the SNS in support of botulism preparedness and response capability. In addition to domestic government sales, BAT continues to be sold internationally, with deliveries to over 20 foreign governments in 2019. For example, we have a 10-year contract, executed in 2012, to supply BAT to the Canadian Department of National Defense as well as the Public Health Agency of Canada and individual provincial health authorities.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">VIGIV [Vaccinia Immune Globulin Intravenous (Human)]</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.&#160;VIGIV is the only polyclonal antibody therapeutic licensed by the FDA to address certain complications from replicating virus smallpox vaccination. VIGIV is comprised of purified polyclonal human immune globulins (antibodies) directed to the vaccinia virus, which is the virus used in replicating smallpox virus vaccines, such as&#160;ACAM2000.  VIGIV is currently being procured and delivered into the SNS. VIGIV is prepared using plasma collected from healthy, screened donors who have been immunized with our ACAM2000 vaccine or previously immunized with the DryVax vaccine. Vaccinia is not the virus that causes smallpox, but it is similar enough to elicit a protective immune response when used as a smallpox vaccine. Individuals who are susceptible to vaccinia may develop a specific type of reaction or infection from ACAM2000&#160;or other similar replicating virus vaccines, and these patients may benefit from treatment with VIGIV. VIGIV was licensed by the FDA in May 2005 and by Health Canada in May 2007 for counteracting certain complications that can be associated with replicating virus smallpox vaccination. Although VIGIV has been sold to foreign governments, to date, the principal customer for VIGIV has been the USG, specifically HHS. On June 3, 2019, we announced a contract award by HHS valued at approximately $535 million over 10 years for the continued supply of VIGIV into the SNS for smallpox preparedness.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;font-weight:bold;text-decoration:underline;">Product Candidates</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The chart below highlights our primary Therapeutics product candidates:</span></div><div style="line-height:120%;padding-bottom:5px;padding-top:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">Product Candidate</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-weight:bold;">Target Indication</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">FLU-IGIV Seasonal influenza therapeutic</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Treatment of serious Influenza A infection in hospitalized patients.</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ZIKV-IG Zika therapeutic</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:2px solid #000000;border-right:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prophylaxis for Zika infections in at risk populations.</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-top:9px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">FLU-IGIV (NP025)</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. We are utilizing our hyperimmune platform to develop NP025, a human polyclonal antibody therapeutic enriched with influenza antibodies for the treatment of serious illness caused by influenza A infection in hospitalized patients. Development of an </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-top:9px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">influenza immune globulin product could address the significant public health burden for severe hospitalized influenza. In 2017, a Phase 2 study was initiated as a randomized, double-blind, placebo-controlled dose ranging study evaluating the safety, pharmacokinetics </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">12</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-top:9px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">and clinical benefit of FLU-IGIV in a targeted hospitalized influenza patient population. This study has completed enrollment and data analysis is ongoing. </span></div><div style="line-height:120%;padding-bottom:12px;padding-top:9px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">ZIKV-IG&#160;(NP024)</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. NP024 is also being developed based on our hyperimmune platform and is an immunoglobulin preparation containing a standardized amount of neutralizing antibody to Zika Virus. It is produced from plasma collected from healthy donors who have recovered from Zika infection (convalescent) or vaccinated donors that have high levels of neutralizing antibody for ZIKV.  The Phase 1 trial to evaluate the safety of ZIKV-IG has been completed. Several non-clinical studies are ongoing to evaluate efficacy and safety of ZIKV-IG in collaboration with several academic partners who have received funding from NIAID and other agencies. Fast Track designation for prophylaxis of Zika virus in at-risk populations, including women of child-bearing potential and pregnant women was granted by FDA in December 2017. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our Therapeutics business unit also has other product candidates addressing PHTs, including viral hemorrhagic fevers caused by Filoviruses (Ebola, Marburg and Sudan), among others.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Contract Development and Manufacturing (CDMO)</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our CDMO business unit, which is based on our established development and manufacturing infrastructure, technology platforms and expertise, consists of a fully integrated molecule-to-market contract development and manufacturing services business offering across development services, drug substance and drug product for the for small to mid to large pharma and biotech industry and government agencies/non-governmental organizations. These services include process development, formulation and analytical development, drug substance manufacturing and drug product manufacturing and packaging for supply through launch and commercial supply pharma and biotech. The biologics technology platforms consist of mammalian, microbial, viral, plasma and advanced therapies. </span></div><div style="line-height:120%;padding-bottom:5px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">See &#8220;Item 2 Properties&#8221; below for additional information on our development and manufacturing facilities.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Marketing and Sales</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our product sales can be divided into two primary categories: i) sales to governments; and ii) commercial sales.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Government Procurement</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For our Vaccines, Therapeutics and Devices business units, our largest customers are the USG and domestic non-government organizations. We also sell certain products to state governments, local governments and emergency management teams. All </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">three business units share a team of dedicated marketing and sales personnel. We intend to use a similar approach to the marketing and sales of other product candidates that we either successfully develop or acquire. In addition to domestic sales, we sell our products to allied foreign governments as well as non-governmental organizations in foreign jurisdictions. For our non-U.S. sales, we use a combination of our employees as well as third-party marketing distributors and representatives to sell our products in key international markets, including Europe, the Middle East, Asia and the Pacific Rim. We anticipate engaging additional representatives as interest in countermeasures addressing PHTs increases outside the United States.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our Contract Development and Manufacturing business unit is supported by a dedicated group of sales and business development, marketing and customer experience, and commercial development professionals qualified to represent our full breadth of service offerings to the global pharma and biotech industry.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Commercial Sales</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">NARCAN</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Nasal Spray is sold commercially through physician-directed or standing order prescriptions at retail pharmacies and first responders including police, fire fighters and emergency medical teams. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Vivotif and Vaxchora are vaccines intended for use by travelers heading to regions where there is a risk of exposure to certain infectious diseases and, therefore, are sold to channels that address travel health. We sell to both wholesalers and distributors as well as directly to healthcare practitioners. The primary commercial customers of Vivotif and Vaxchora are private travel clinics, retail pharmacies and integrated hospital networks.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Competition</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our products and product candidates intended for the treatment or prevention of CBRNE, EID threats, travel health emerging health crises, acute/emergency care and opioid overdose face competition. Our products and any product or product candidate that we acquire or successfully develop and commercialize are likely to compete with current products and product candidates that are in development for the same indications. Specifically, the competition for our products and product candidates includes the following:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">AV7909 and BioThrax</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">. </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">BioThrax</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is the only vaccine licensed by the FDA for the prevention of anthrax disease. However, we face potential future competition for the supply of anthrax vaccines to the USG if such products are approved. Altimmune, Inc., Pfenex Inc., Soligenix, Inc., Immunovaccine Inc. and </span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">13</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-left:48px;padding-bottom:12px;text-align:justify;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">NanoBio Corporation are each currently developing anthrax vaccine product candidates. The majority of these product candidates are in Phase 2 and we will continue to monitor the competitive landscape as we move AV7909 into Phase 3 and through licensure.</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">NARCAN</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> (naloxone HCl) Nasal Spray</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">.&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">With respect to NARCAN</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Nasal Spray, we face competition from injectable naloxone, auto-injectors and improvised nasal kits. Amphastar Pharmaceuticals, Inc. competes with NARCAN</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Nasal Spray with their naloxone injection product. Kal&#233;o competes with NARCAN</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Nasal Spray with their auto-injector known as EVZIO&#8482; (naloxone HCl injection) Auto-Injector. In 2016, Teva Pharmaceuticals Industries Ltd. (Teva), and in 2018 Perrigo UK FINCO Limited Partnership (Perrigo), filed Abbreviated New Drug Applications (ANDAs, each an ANDA) with the FDA seeking regulatory approval to market a generic version of NARCAN</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Nasal Spray. Teva may also decide to launch its approved generic product although the launch would be at risk since the litigation we instituted against Teva is still ongoing. Although NARCAN</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Nasal Spray was the first FDA-approved needle-free naloxone nasal spray for the emergency reversal of opioid overdoses and has advantages over certain other treatments, we expect the treatment to face additional competition. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">ACAM2000</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> ACAM2000 now faces competition from JYNNEOS</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">TM</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, which was licensed by the FDA in September 2019 for the prevention of smallpox disease in adults 18 years of age and older determined to be at high risk for smallpox infection.  JYNNEOS is approved in Canada and in the European Union where it is marketed under the trade name Imvanex</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">raxibacumab and Anthrasil</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. Our raxibacumab product is the first FDA licensed fully human anthrax monoclonal antibody therapeutic and Anthrasil is the only polyclonal antibody therapeutic licensed by the FDA and Health Canada for the treatment of inhalational anthrax in adult and pediatric patients in combination with appropriate antibacterial drugs. However, Elusys Therapeutics, Inc. has obtained FDA licensure for Anthim&#174; (obiltoxaximab) injection, a monoclonal antibody indicated for the treatment and prophylaxis of inhalational anthrax.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">BAT</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Our botulinum antitoxin immune globulin product is the only heptavalent therapeutic licensed by the FDA and Health Canada for the </span></div></td></tr></table></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-left:48px;padding-bottom:12px;text-align:justify;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">treatment of symptomatic botulism and has orphan drug designation. Other companies may be developing therapies aimed at treating or preventing botulism infections, however, direct competition is currently limited.</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">VIGIV</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Our VIGIV product is the only therapeutic licensed by the FDA and Health Canada to address adverse events from smallpox vaccination with replicating virus smallpox vaccines. Other companies may be developing therapies aimed at treating or preventing vaccinia infections; however, direct competition is currently limited. SIGA Technologies, Inc. is developing Tecovirimat (Arestvyr&#8482;, ST-26), an oral therapy that targets orthopox viruses such as vaccinia and smallpox. Chimerix is also developing brincidofovir, a nucleotide analog lipid conjugate for treatment of smallpox.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">RSDL</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> In the United States, the RSDL Kit is the only medical device cleared by the FDA to remove or neutralize chemical warfare agents and T-2 toxin from the skin. Internationally, various Ministries of Defense have procured Fullers Earth, Dutch Powder and French Powder as a preparedness countermeasure for the decontamination of liquid chemical weapons from the skin.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Vivotif</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. Vivotif is the only FDA-approved oral typhoid vaccine. In the markets where Vivotif is licensed, it competes with Sanofi Pasteur&#8217;s Typhim VI</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> vaccine, an injectable polysaccharide typhoid vaccine.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Vaxchora</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. In the United States, Vaxchora is the only FDA-licensed vaccine available indicated to prevent cholera. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Contract Development and Manufacturing Services Business</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> We compete for contract manufacturing service business with a number of biopharmaceutical product development organizations, contract manufacturers of biopharmaceutical products and university research laboratories, including, among others: Lonza Group Ltd., Par Pharmaceutical Companies, Inc., Thermo Fisher Scientific, Hospira Inc., Ajinomoto Bio-Pharma Services, Inc. (a subsidiary of Ajinomoto Co., Inc.), Cook Pharmica LLC (a subsidiary of Cook Group Inc.), and Albany Molecular Research, Inc. We also compete with in-house research, development and support service departments of other biopharmaceutical companies.</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">14</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Geographical Reliance</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended December 31, 2019, 2018 and 2017, the Company's revenue from U.S. customers as a percentage of total revenues were </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">90%</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">91%</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">89%</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">MANUFACTURING OPERATIONS</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our development and manufacturing network allows us to deploy capabilities and capacity for clinical and commercial supply needs. Please refer to "Item 2. Properties" for a description of our development and manufacturing facilities.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Supplies and Raw Materials</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We currently rely on contract manufacturers and other third parties to manufacture some of the supplies we require for pre-clinical studies and clinical trials, as well as supplies and raw materials used in the production of our products. Typically, we acquire these supplies and raw materials on a purchase order basis and, when possible, in quantities we believe adequate to meet our needs. We obtain Alhydrogel</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> adjuvant 2%, used to manufacture BioThrax and AV7909, from a single-source supplier for which we have no alternative source of supply. However, we maintain stored supplies of this adjuvant sufficient to meet our expected manufacturing needs for these products. We also utilize single-source suppliers for other raw materials in our manufacturing processes.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We utilize single source suppliers for all components of NARCAN</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Nasal Spray. It is manufactured by a third party, which operates a full service offering from formulation to final packaging. Materials for production of NARCAN</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Nasal Spray, such as the naloxone active pharmaceutical ingredient and other excipients, along with the vial, stopper and device are produced around the world by other third parties and delivered to the primary manufacturer and released to manufacturing following appropriate testing.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We rely on single source suppliers for our plasma collection to support the VIGIV and BAT programs.  We work closely with our suppliers for these specialty programs and operate under long term agreements.  We order quantities of material in advance in quantities believed to be sufficient to meet upcoming demand requirements.   </span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">INTELLECTUAL PROPERTY</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We actively seek to protect the intellectual property that arises from our activities. It is our policy to respect the intellectual property rights of others. In general, and where practicable, we pursue patent protection for new and innovative processes and products that we develop. The duration of and the type of protection afforded by a patent varies on a product-by-product basis and country-</span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">to-country basis and depends upon many factors including the type of patent, the scope of its coverage, the availability of regulatory-related extensions or administrative term adjustments, the availability of legal remedies in a particular country, and the validity and enforceability of the patents. In some cases, we may decide that the best way to protect certain intellectual property is to retain proprietary information as trade secrets rather than apply for patent protection, which requires disclosure of the proprietary information to the public. We take a number of measures to protect our trade secrets and other confidential information, including entering into confidentiality agreements with employees and third parties. In general, and where practicable, we also pursue registered trademarks for our products and product candidates. We are a party to a number of license agreements under which we license patents, patent applications, trademarks, and other intellectual property. We enter into these agreements to augment our own intellectual property and to secure freedom to operate where necessary. These agreements sometimes impose various commercial diligence and financial payment obligations on us. We expect to continue to enter into these types of agreements in the future.</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">REGULATION</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Regulations in the United States and other countries have a significant impact on our product development, manufacturing and marketing activities.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Government Contracting</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our status as a USG contractor means that we are subject to various statutes and regulations, including:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the Federal Acquisition Regulation (FAR) and agency-specific regulations supplemental to FAR, which comprehensively regulate the award, formation, administration and performance of government contracts;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the Defense Federal Acquisition Regulations (DFARs) and agency-specific regulations supplemental to DFARs, which comprehensively regulate the award, formation, administration and performance of DoD government contracts;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the Department of State Acquisition Regulation (DOSAR) which regulates the relationship between a Department of State organization and a contractor or potential contractor;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">business ethics and public integrity obligations, which govern conflicts of interest and the hiring of former government employees, restrict the granting of gratuities and funding of lobbying activities and incorporate other requirements such as the Anti-Kickback Act, the Procurement </span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">15</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-left:48px;padding-bottom:12px;text-align:justify;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Integrity Act, the False Claims Act and the Foreign Corrupt Practices Act;</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">export and import control laws and regulations, including but not limited to ITAR (International Traffic in Arms Regulations); and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">laws, regulations and executive orders restricting the use and dissemination of information classified for national security purposes and the exportation of certain products and technical data.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">USG agencies routinely audit and investigate government contractors for compliance with applicable laws and standards. These regulations can impose stricter penalties than those normally applicable to commercial contracts, such as criminal and civil liability and suspension and debarment from future government contracting. In addition, pursuant to various regulations, our government contracts can be subject to unilateral termination or modification by the government for convenience, detailed auditing and accounting systems requirements, statutorily controlled pricing, sourcing and subcontracting restrictions and statutorily mandated processes for adjudicating contract disputes.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Project BioShield.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> The Project BioShield Act of 2004 (Project BioShield) provides expedited procedures for bioterrorism-related procurement and the awarding of research grants, making it easier for HHS to rapidly commit funds to countermeasure projects. Project BioShield relaxes procedures under the FAR for procuring property or services used in performing, administering or supporting biomedical countermeasure research and development. In addition, if the Secretary of HHS deems that there is a pressing need, Project BioShield authorizes the Secretary to use an expedited award process, rather than the normal peer review process, for grants, contracts and cooperative agreements related to biomedical countermeasure research and development activity. Under Project BioShield, in limited specified circumstances, HHS can contract to purchase unapproved countermeasures for the SNS and authorize the emergency use of medical products that have not yet been approved by the FDA.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">First Responders Act.</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The First Responder Anthrax Preparedness Act of 2016 directs the Secretary of Homeland Security, in consultation with the Secretary of HHS, to establish a pilot program to provide short-dated vaccines from the SNS to emergency response providers on a voluntary basis.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Public Readiness and Emergency Preparedness Act.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> The Public Readiness and Emergency Preparedness Act (PREP Act) was signed into law in December 2005. The PREP Act creates liability protection for manufacturers of biodefense countermeasures when the Secretary of HHS issues a declaration for their manufacture, </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">administration or use. A PREP Act declaration is intended to provide liability protection from claims under federal or state law for loss arising out of the administration or use of a covered countermeasure under a government contract. The Secretary of HHS has issued PREP Act declarations identifying BioThrax, ACAM2000, raxibacumab, Anthrasil, BAT and VIGIV, as covered countermeasures. These declarations expire in 2022. Manufacturers are not entitled to protection under the PREP Act in cases of willful misconduct or for cases brought in non-U.S. tribunals or under non-U.S. law, and, accordingly, the PREP Act may not provide adequate protection from all claims made against us.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Support Anti-Terrorism by Fostering Effective Technology Act of 2002</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> The Support Anti-Terrorism by Fostering Effective Technology Act of 2002 (SAFETY Act) is intended to create product liability limitations for qualifying anti-terrorism technologies for claims arising from or related to an act of terrorism. Certain of our products, namely BioThrax and RSDL, are certified anti-terrorism products covered under the protections of the SAFETY Act. Although we are covered by the benefits of the SAFETY Act for BioThrax and RSDL, the SAFETY Act may not provide adequate protection from all claims made against us.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Product Development for Therapeutics and Vaccines</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Pre-Clinical Testing</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Before beginning testing of compounds in human subjects in the United States, stringent government requirements for pre-clinical data must be satisfied. Pre-clinical testing generally includes both in vitro (i.e. in an artificial environment outside of a living organism), and in&#160;vivo (i.e. within a living organism), laboratory evaluation and characterization of the safety and efficacy of a drug and its formulation. We generally perform pre-clinical safety and efficacy testing on our product candidates before we initiate clinical trials.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Animal Rule.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> For product candidates that are intended to treat or prevent serious or life-threatening conditions caused by exposure to lethal or permanently disabling toxic biological, chemical, radiological, or nuclear substances, conducting controlled clinical trials with human patients to determine efficacy may be unethical or unfeasible. Under regulations issued by the FDA in 2002, often referred to as the &#8220;Animal Rule,&#8221; under some circumstances, approval of such product candidates can be based on clinical data from trials in healthy subjects that demonstrate adequate safety and immunogenicity as well as efficacy data from adequate and well-controlled animal studies. Among other requirements, the animal studies must establish that the drug or biological product is reasonably likely to produce clinical benefit in humans. Because the FDA must agree that data derived from animal studies may be extrapolated to establish safety and efficacy in humans, these studies add complexity and uncertainty </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">16</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">to the testing and approval process. In addition, products approved under the Animal Rule are subject to additional requirements, including post-marketing study requirements, restrictions imposed on marketing or distribution or requirements to provide information to patients.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Investigational New Drug Application.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Before clinical testing may begin, the results of pre-clinical testing, together with manufacturing information, analytical data and any other available clinical data or literature, must be submitted to the FDA as part of an IND application. The sponsor must also include an initial clinical protocol detailing the first phase of the proposed clinical investigation as well as information on the qualifications of clinical investigators. The&#160;pre-clinical data must provide an adequate basis for evaluating both the safety and the scientific rationale for the initial clinical studies in human&#160;volunteers. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA imposes a clinical hold within that 30-day period.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Clinical Trials</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Clinical trials generally involve the administration of the product candidate to healthy human volunteers or to patients under the supervision of a qualified physician (also called an investigator)&#160;pursuant to an FDA-reviewed protocol. In certain cases, described below, animal studies may be used in place of human studies. Human clinical trials typically are conducted in three sequential phases, although the phases may overlap&#160;with one another and trial designs vary depending on the Therapeutic or Prophylactic nature of the product. Clinical trials must be conducted under protocols that detail the objectives of the study, the parameters to be used to monitor&#160;safety and the efficacy criteria, if any, to be evaluated. Each protocol must be submitted to the FDA as part of the IND. The protocol must also be reviewed and approved by an institutional review board (IRB), and all study subjects must provide informed consent.</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Phase 1 clinical trials test the candidate in a small group (typically 20-100) of healthy volunteers and/or patients with the target disease or condition to evaluate its safety, dose tolerance, absorption, bio-distribution, metabolism, excretion and clinical pharmacology and, if possible, for early evidence regarding efficacy.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Phase 2 clinical trials involve a larger group of patients (typically several hundred) with the target disease or condition to assess the efficacy of the drug for specific indications to determine dose response and the optimal dose range and to gather additional information relating to safety and potential adverse effects.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Phase 3 clinical trials consist of expanded, larger-scale studies of patients with the target </span></div></td></tr></table></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-left:48px;padding-bottom:12px;text-align:justify;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">disease or disorder to obtain definitive statistical evidence of the efficacy and safety of the proposed product candidate using a specific dosing regimen. The safety and efficacy data generated from Phase 3 clinical trials typically form the basis for FDA review and potential approval of the product candidate.</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Phase 4 clinical trials are sometimes conducted after a product has been approved. These trials can be conducted for a number of purposes, including to collect long-term safety information or to collect additional data about a specific patient population. As part of a product approval, the FDA may require that certain Phase 4 studies, which are sometimes called post-marketing commitment studies, be conducted post-approval.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Progress reports with the results of the clinical trials must be submitted at least annually to the FDA and there are additional, more frequent reporting requirements for certain adverse events.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The FDA may impose a temporary or permanent clinical hold, or other sanctions, if it believes that the clinical trial either is not being conducted in accordance with the FDA requirements or presents an unacceptable risk to the clinical trial subjects. An IRB also may require the clinical trial at the site to be halted, either temporarily or permanently, for failure to comply with the IRB's requirements, or may impose other conditions.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Good Clinical Practice</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> All phases of clinical studies must be conducted in conformance with the FDA&#8217;s bioresearch monitoring regulations and Good Clinical Practices (GCP) which are ethical and scientific quality standards for conducting, recording and reporting clinical trials to assure that the data and reported results are credible and accurate and that the rights, safety and well-being of trial participants are protected.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Marketing Approval &#8211; Biologics, Drugs and Vaccines</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Biologics License Application/New Drug Application</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> For large molecule products, including products such as vaccines, products derived from blood and blood components, and antibodies and other recombinant proteins, all data obtained from a development program, including research and product development, manufacturing, pre-clinical and clinical trials, labeling and related information are submitted in a biologics license application (BLA) to the FDA and in similar regulatory filings with the corresponding agencies in other countries for review and approval. For small molecule drugs, this information is submitted in a new drug application (NDA) filing. The submission of an application is not a guarantee that the FDA will find the application complete and accept it for filing. The FDA may refuse to file the application and request additional </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">17</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">information rather than accept the application for filing, in which case the application must be resubmitted with the supplemental information. Once an application is accepted for filing, the Prescription Drug User Fee Act (PDUFA) requires the FDA to review the application within 10 months of its 60-day filing date, although in practice, longer review times may occur.  Most applications are subject to a substantial application fee and, if approved, will be assessed an annual fee, both of which are adjusted annually. Applications for orphan drugs are not subject to an application fee, unless the application includes an indication other than the orphan-designated indication. Under the U.S. Food, Drug, and Cosmetic Act (FDCA), the FDA also has the authority to grant waivers of certain user fees.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition, under the Pediatric Research Equity Act of 2003 (PREA), BLAs, NDAs and certain supplements must contain data to assess the safety and efficacy of the drug for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA may grant deferrals for submission of data or full or partial waivers. Unless otherwise required by regulation, PREA does not apply to any drug or biologic for an indication for which orphan drug designation has been granted.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In reviewing a BLA or NDA, the FDA may grant approval, request more information or data, or deny the application if it determines the application does not provide substantial evidence of effectiveness for the proposed indication and/or that the drug is not safe for use under the conditions of use in the proposed labeling. Even if such additional information and data are submitted, the FDA may ultimately decide that the BLA or NDA does not satisfy the criteria for approval. The FDA will also typically inspect one or more clinical sites to ensure compliance with GCPs as well as the facility or facilities at which the candidate is manufactured to ensure compliance with current good manufacturing practices (cGMPs).</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The receipt of regulatory approval often takes many years, involving the expenditure of substantial financial resources. The speed with which approval is granted often depends on a number of factors, including the severity of the disease in question, the availability of alternative treatments and the risks and benefits of the product candidate as demonstrated in clinical trials. The FDA may also impose conditions upon approval. For example, it may require a Risk Evaluation and Mitigation Strategy (REMS) for a product. This can include various required elements, such as publication of a medication guide, patient package inserts, a communication plan to educate health care providers of the drug&#8217;s risks and/or restrictions on distribution and use such as limitations on who may prescribe or dispense the drug. The FDA may also significantly limit the indications </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">approved for a given product and/or require, as a condition of approval, enhanced labeling, special packaging or labeling, post-approval clinical trials, expedited reporting of certain adverse events, pre-approval of promotional materials or restrictions on direct-to-consumer advertising, any of which could negatively impact the commercial success of a product.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Abbreviated New Drug Applications and Section 505(b)(2) New Drug Applications.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Most drug products obtain FDA marketing approval pursuant to an NDA for innovator products, or an abbreviated new drug application (ANDA) for generic products. Relevant to ANDAs, the Hatch-Waxman amendments to the FDCA established a statutory procedure for submission and FDA review and approval of ANDAs for generic versions of branded drugs previously approved by the FDA (such previously approved drugs are also referred to as reference listed drugs (RLDs)). Because the safety and efficacy of RLDs have already been established by the brand company (sometimes referred to as the innovator), the FDA does not require ANDA applicants to independently demonstrate safety and efficacy of generic products. However, a generic manufacturer is typically required to conduct bioequivalence studies of its test product against the RLD in order to demonstrate that their product performs in the same manner as the RLD. The bioequivalence studies for orally administered, systemically available drug products assess the rate and extent to which the API is absorbed into the bloodstream from the drug product and becomes available at the site of action. Bioequivalence is established when there is an absence of a significant difference in the rate and extent for absorption of the generic product and the listed drug. In addition to the bioequivalence data, an ANDA must contain patent certifications and chemistry, manufacturing, labeling and stability data.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The third alternative is commonly referred to as a Section 505(b)(2) NDA, which enables the applicant to rely, in part, on the FDA&#8217;s findings of safety and efficacy of an existing product, or published literature, in support of its application. Section 505(b)(2) NDAs often provide an alternate path to FDA approval for new or improved formulations or new uses of previously approved products. Section 505(b)(2) permits the filing of an NDA where at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference. The applicant may rely upon the FDA&#8217;s findings with respect to certain preclinical or clinical studies conducted for an approved product. The FDA may also require companies to perform additional studies or measurements to support the change from the approved product. The FDA may then approve the new product candidate for certain label indications for which the referenced product has been </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">18</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">approved, as well as for any new indication sought by the Section 505(b)(2) applicant.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In seeking approval for a drug through an NDA, including a 505(b)(2) NDA, applicants are required to list with the FDA certain patents of the applicant or that are held by third parties whose claims cover the applicant&#8217;s product. Upon approval of an NDA, each of the patents listed in the application for the drug is then published in the Orange Book. Any subsequent applicant who files an ANDA seeking approval of a generic equivalent version of a drug listed in the Orange Book or a 505(b)(2) NDA referencing a drug listed in the Orange Book must make one of the following certifications to the FDA concerning patents: (1) the patent information concerning the RLD has not been submitted to the FDA; (2) any such patent that was filed has expired; (3) the date on which such patent will expire; or (4) such patent is invalid or will not be infringed upon by the manufacture, use or sale of the drug product for which the application is submitted. This last certification is known as a paragraph IV certification. A notice of the paragraph IV certification must be provided to each owner of the patent that is the subject of the certification and to the holder of the approved NDA to which the ANDA or 505(b)(2) application refers. The applicant may also elect to submit a &#8220;section viii&#8221; statement certifying that its proposed label does not contain (or carves out) any language regarding the patented method-of-use rather than certify to a listed method-of-use patent.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">If the RLD&#8217;s NDA holder or patent owners assert a patent challenge directed to one of the Orange Book listed patents within 45 days of the receipt of the paragraph IV certification notice, the FDA is prohibited from approving the application until the earlier of 30 months from the receipt of the paragraph IV certification expiration of the patent, settlement of the lawsuit or a decision in the infringement case that is favorable to the applicant. The ANDA or 505(b)(2) application also will not be approved until any applicable non-patent exclusivity listed in the Orange Book for the branded reference drug has expired. Thus approval of a Section 505(b)(2) NDA or ANDA can be stalled until all the listed patents claiming the referenced product have expired; until any non-patent exclusivity, such as exclusivity for obtaining approval of a new chemical entity, listed in the Orange Book for the referenced product has expired; and, in the case of a Paragraph IV certification and subsequent patent infringement suit, until the earlier of 30 months, settlement of the lawsuit or a decision in the infringement case that is favorable to the ANDA or Section 505(b)(2) applicant.  </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Fast Track Designation</span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> The FDA may designate a product as a fast track drug if it is intended for the treatment of a serious or life-threatening disease or condition and demonstrates the potential to address </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">unmet medical needs for this disease or condition. Sponsors granted a fast track designation for a drug are granted more frequent opportunities to interact with the FDA during the approval process and are eligible for FDA review of the application on a rolling basis, before the application has been completed. The FDA granted fast track status to AV7909 in June 2011, to CHIKV VLP in 2018 and to ZIKV-IG in December 2017.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Orphan Drugs</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;Under the Orphan Drug Act, an applicant can request the FDA to designate a product as an &#8220;orphan drug&#8217;&#8217; in the United States if the drug is intended to treat an orphan, or rare, disease or condition. A disease or condition is considered orphan if it affects fewer than 200,000 people in the United States. A manufacturer must request orphan drug designation prior to submitting a BLA or NDA. Products designated as orphan drugs are eligible for special grant funding for research and development, FDA assistance with the review of clinical trial protocols, potential tax credits for research, reduced filing fees for marketing applications and a special seven-year period of market exclusivity after marketing approval. Orphan drug exclusivity, which is afforded to the first applicant to receive approval for an orphan designated drug for an indication covered by the orphan drug designation prevents FDA approval of applications by other applicants for the same drug for the designated orphan disease or condition. The FDA may approve a subsequent application from another applicant if the FDA determines that the application is for a different drug for the same disease or condition or the same drug for a different use, or if the FDA determines that the subsequent product is clinically superior, or that the holder of the initial orphan drug approval cannot assure the availability of sufficient quantities of the drug to meet the public&#8217;s need. A grant of an orphan designation is not a guarantee that a product will be approved.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our products with current orphan drug exclusivity in the United States include the following:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">BioThrax</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (anthrax vaccine adsorbed) for post-exposure prophylaxis of disease following suspected or confirmed </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Bacillus anthracis</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> exposure, when administered in conjunction with recommended antibacterial drugs, with exclusivity though November 2022;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Anthrasil</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174; </sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">(Anthrax Immune Globulin Intravenous (Human)) for the treatment of inhalational anthrax in adult and pediatric patients in combination with appropriate antibacterial drugs, with exclusivity through March 2022; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">BAT for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes A, B, C, D, E, </span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">19</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-left:48px;padding-bottom:12px;text-align:justify;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">F, or G in adults and pediatric patients, with exclusivity through March 2020.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Post-Approval Requirements.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Any drug, biologic or medical device product for which we receive FDA approval will be subject to continuing regulation by the FDA, including, among other things, record keeping requirements, reporting of adverse experiences, providing the FDA with updated safety and efficacy information, product sampling and distribution requirements, cGMPs and restrictions on advertising and promotion. Adverse&#160;events that are reported after marketing approval can result in additional limitations being placed on the product&#8217;s distribution or use and, potentially, withdrawal&#160;or suspension of the product from the market. In addition, the FDA has post-approval authority to require post-approval clinical trials and/or safety labeling changes if warranted by the appearance of new safety information. In certain circumstances, the FDA may impose a REMS after a product has been approved. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Facilities involved in the manufacture and distribution of approved products are required to register their facility with the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA for compliance with cGMP and other laws. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The FDA regulates the content and format of prescription drug labeling, advertising, and promotion, as well as permissible non-promotional communications between industry and the medical community (e.g., industry-supported scientific and educational activities). The FDA closely monitors advertising and promotional materials we may disseminate for our products for compliance with restrictions on off-label promotion and other laws. We may not promote our investigational products and we may not promote our approved products for conditions of use that are not included in the approved package inserts for our products. Certain additional restrictions on advertising and promotion exist for products that have so-called &#8220;black box warnings&#8221; in their approved package inserts, such as Anthrasil and VIGIV in the United States. The FDA and other agencies actively enforce these laws and regulations, and a company that is found to have improperly promoted unapproved or off-label uses or otherwise not to have met applicable promotion rules may be subject to significant liability under both the FDCA and other statutes, including the False Claims Act.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Vaccine and Therapeutic Product Lot Release and FDA Review.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Because the manufacturing process for biological products is complex, the FDA requires for many biologics, including most vaccines and immune globulin products, that each product lot undergo thorough testing for purity, potency, identity and sterility. Several of our vaccines are subject to lot release protocols by the FDA and other regulatory agencies. The length of the review process depends on a number of </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">factors, including reviewer questions, license supplement approval, reviewer availability and whether our internal testing of product samples is completed before or concurrently with regulatory agency testing, if applicable.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition, if changes are made to the manufacturing process, we may be required to provide pre-clinical and clinical data showing the comparable identity, strength, quality, purity or potency of the products before and after the changes.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Priority Review Vouchers</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> In 2007, the Food and Drug Administration Amendments Act added Section 524 to the FDCA and established the Neglected Tropical Disease Priority Review Voucher (PRV) program. This PRV program was expanded in 2012 by the Food and Drug Administration Safety and Innovation Act to include rare pediatric diseases. In December 2016, the 21</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">st</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Century Cures Act established a PRV program within the FDA for MCMs for chemical, biological, radiological or nuclear threats, and those vaccines, therapeutics and MCMs, that prevent or treat material threat agents as identified in the Public Health Service Act (PHSA). Under the PRV program, upon approval of a qualified product, companies receive a special voucher which allows them to have a drug reviewed under FDA&#8217;s priority review system, with the anticipation that it will accelerate the regulatory review to get the product to market more rapidly.&#160;Recipients of a PRV may transfer that voucher to another party for consideration.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Several of our investigational stage product candidates may be eligible for PRV under multiple PRV programs upon the product approval. We believe that ZIKV-IG (NP024), a human polyclonal antibody therapeutic being developed as a prophylaxis and treatment for Zika infections in at risk populations may have the potential for a PRV under the Neglected Tropical Disease PRV program. We believe that the Chikungunya VLP vaccine, being developed for prevention of disease caused by chikungunya infections, may have the potential for a PRV under the Neglected Tropical Disease PRV program and under the MCM PRV program. However, there can be no assurances that any of these candidates will obtain PRV status.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Marketing Approval &#8211; Devices</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Devices may fall within the definition of a Medical Device or may be a Combination Product including both a device for delivery of a drug product and the drug product itself. Medical Devices are also subject to FDA clearance or approval and extensive regulation under the FDCA. Under the FDCA, medical devices are classified into one of three classes: Class I, Class II or Class III. The classification of a device generally depends on the degree of risk associated with the medical device and the extent of control needed to </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">20</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ensure safety and effectiveness. The RSDL kit is regulated as a non-restricted Class II medical device. </span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Class I devices are those that present minimal potential for harm to the user and for which safety and effectiveness can be assured by adherence to a set of general controls. These general controls include compliance with the applicable portions of the FDA&#8217;s Quality System Regulation (QSR) which sets forth requirements for manufacturing practices, record keeping, reporting of adverse medical events, labeling and promotion only for cleared or approved intended uses.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Class II devices are those that generally present a moderate potential for harm to the user and are also subject to these general controls and to any other special controls as deemed necessary by the FDA to ensure the safety and effectiveness of the device. Review and clearance by the FDA for these devices is typically accomplished through the 510(k)-pre-market notification procedure. When 510(k) clearance is sought, a sponsor must submit a pre-market notification demonstrating that the proposed device is substantially equivalent to a device approved by the FDA after May 28, 1976. This previously cleared device is called the predicate device. If the FDA agrees that the proposed device is substantially equivalent to the predicate device, then 510(k) clearance to market will be granted. After a device receives 510(k) clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, requires a new 510(k) clearance or could require pre-market approval.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">If a proposed device is substantially equivalent to a predicate device that was cleared prior to May 28, 1976, the proposed device is cleared based on a pre-amendment and is cleared as an unclassified device.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Class III devices are those that sustains or supports life, is implanted, or presents high risk of illness or injury. A Class III device requires approval of a pre-market application (PMA), which must demonstrate that the device is safe and effective when used. The PMA process is an expensive, lengthy and uncertain process requiring many years to complete. Clinical trials are almost always required to support a PMA. These trials generally require submission of an application for an investigational device exemption (IDE). An IDE must be supported by pre-clinical data, such as animal and laboratory testing results, which show that the device is safe to test in humans and that the study </span></div></td></tr></table></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-left:48px;padding-bottom:12px;text-align:justify;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">protocols are scientifically sound. The IDE must be approved in advance by the FDA for a specified number of patients, unless the product is deemed a non-significant risk device and is eligible for more abbreviated investigational device exemption requirements.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Both before and after a medical device is commercially distributed, manufacturers and marketers of the device have ongoing responsibilities under FDA regulations. The FDA reviews design and manufacturing practices, record keeping, reports of adverse events, labeling and other information to identify potential problems with marketed medical devices. Device manufacturers are subject to periodic and unannounced inspection by the FDA for compliance with cGMP requirements that govern the methods used in, and the facilities and controls used for, the design, manufacture, packaging, servicing, labeling, storage, installation and distribution of all finished medical devices intended for human use. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The FDA also has the authority to require repair, replacement or refund of the cost of any medical device. The FDA also administers certain controls over the export of medical devices from the United States, as international sales of medical devices that have not received FDA approval are subject to FDA export requirements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Combination products are therapeutic and diagnostic products that combine drugs, devices, and/or biological products. The FDA determines whether a combination product is regulated as a drug, device, or biologic based on the product&#8217;s primary mode of action.  Our Trobigard auto-injector is not currently approved or cleared by the FDA or any similar regulatory body and is only distributed to authorized government buyers for use outside the United States. It is not manufactured or distributed in the United States.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Emergency Use Authorization</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As amended by Project BioShield and subsequent legislation, including the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA) and the 21st Century Cures Act, the FDCA permits the Secretary of HHS to authorize the introduction into interstate commerce of unapproved MCMs, or approved MCMs for unapproved uses, in the context of an actual or potential emergency that has been declared by designated government officials (known as &#8220;emergency use&#8221;). The types of emergencies that trigger these authorities include public health emergencies announced by the Secretary of HHS, military emergencies announced by the Secretary of Defense, domestic emergencies announced by the Secretary of Homeland Security, and the identification of a material threat pursuant to Section 319-F-2 of the PHSA that is sufficient to affect national security or the health and </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">21</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">security of United States citizens living abroad.  After one of the emergencies has been announced, the Secretary of HHS may authorize the issuance of, and the FDA Commissioner may issue, Emergency Use Authorizations (EUAs) for the use of specific products based on criteria established by statute, including that the product at issue may be effective in diagnosing, treating, or preventing serious or life-threatening diseases or conditions caused by CBRN threat agents when there are no adequate, approved, and available alternatives. EUAs are subject to additional conditions and restrictions, are product-specific, and terminate when the emergency determination underlying the EUA terminates. An EUA is not a long-term alternative to obtaining FDA approval, licensure, or clearance for a product.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Potential Sanctions.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For all FDA-regulated products, if the FDA finds that a manufacturer has failed to comply with applicable laws and regulations, or that a product is ineffective or poses an unreasonable health risk, it can institute or seek a wide variety of enforcement actions and remedies, including but not limited to:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">restrictions on such products, manufacturers or manufacturing processes;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">restrictions on the labeling or marketing of a product;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">restrictions on distribution or use of a product;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">requirements to conduct post-marketing studies or clinical trials;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">warning letters or untitled letters;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">withdrawal of the products from the market;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">refusal to approve pending applications or supplements to approved applications that are submitted;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">recall of products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">fines, restitution or disgorgement of profits or revenues;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">suspension or withdrawal of marketing approvals;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">refusal to permit the import or export of our products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">product seizure; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">injunctions or the imposition of civil or criminal penalties.</span></div></td></tr></table></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Foreign Regulation</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Currently, we maintain a commercial presence in the United States and Canada as well as select foreign countries. We intend to further expand our commercial presence to additional foreign countries and territories. In the European Union, medicinal products are authorized following a process similarly demanding as the process required in the United States. Medicinal products must be</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">authorized in one of two ways, either through the decentralized procedure, which provides for the mutual recognition procedure of national</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">approval decisions by the competent authorities of the European Union (EU) Member States or through the centralized procedure by the European Commission,</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">which provides for the grant of a single marketing authorization that is valid for all EU member states. The authorization process is essentially the</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">same irrespective of which route is used. We are also subject to many of the same continuing post-approval requirements in the EU as we are in the United States (</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">e.g.,</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> good manufacturing practices). Additionally, each foreign country subjects medical devices to its own regulatory requirements. In the European Union, a harmonized medical device directive legislates approval requirements. Within this framework, the CE Mark, an attestation of conformity with the essential health, safety and environmental requirements and compliance with relevant European Union legislation, allows for the legal marketing of the product in all European Economic Area member states. Additionally, to the extent that a product is marketed outside of the United States, a facility may also be registered with applicable ex-U.S. regulatory authorities, who may also require inspections for compliance with local marketing regulations.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Fraud, Abuse and Anti-Corruption Laws</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The U.S. and most other jurisdictions have detailed requirements that apply to government and private health care programs, and a broad range of fraud and abuse laws, transparency laws, and other laws. Relevant U.S. federal and state healthcare laws and regulations include:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The federal Anti-Kickback Statute;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The federal civil False Claims Act;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The federal Health Insurance Portability and Accountability Act of 1996 (HIPAA), as amended by the Health Information Technology for Economic and Clinical Health (HITECH) Act;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The federal criminal False Claims Act;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The price reporting requirements under the Medicaid Drug Rebate Program and the Veterans Health Care Act of 1992;</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">22</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The federal Physician Payment Sunshine Act, being implemented as the Open Payments Program; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Analogous and similar state laws and regulations. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Failure to comply with these laws and regulations could subject us to criminal or civil penalties.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our operations are also subject to compliance with the Foreign Corrupt Practices Act (FCPA) which prohibits corporations and individuals from paying, offering to pay, or authorizing the payment of anything of value to any foreign government official, government staff member, political party or political candidate in an attempt to obtain or retain business or to otherwise influence a person working in an official capacity. We also may be implicated under the FCPA by the activities of our partners, collaborators, contract research organizations, vendors or other agents. As a public company, the FCPA also requires us to make and keep books and records that accurately and fairly reflect all of our transactions and to devise and maintain an adequate system of internal accounting controls. Our operations are also subject to compliance with the U.K. Bribery Act, which applies to bribery activities both in the public and private sector, Canada&#8217;s Corruption of Foreign Public Officials Act and similar laws in other countries.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Regulations Governing Reimbursement</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The marketing practices of U.S. pharmaceutical manufacturers are also subject to federal and state healthcare laws related to government funded healthcare programs.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In the United States, certain of our products are reimbursed under federal and state health care programs such as Medicaid, Medicare, TriCare, and or state pharmaceutical assistance programs. Many foreign countries have similar laws.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Various U.S. federal health care laws apply when we or customers submit claims for items or services that are reimbursed under federally funded health care programs, including federal and state anti-kickback laws, false claims laws, and anti-self-referral laws, which may apply to federal and state-funded Medicaid and other health care programs and private third-party payers.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Failure to comply with these laws and regulations could subject us to criminal or civil penalties.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Additionally, drug pricing is an active area for regulatory reform at the federal and state levels, and significant changes to current drug pricing and reimbursement structures in the U.S. continue to be enacted and considered.</span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Other Industry Regulation</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our present and future business has been and will continue to be subject to various other laws and regulations. Various laws, regulations and recommendations relating to the use of data, safe working conditions, laboratory practices, the experimental use of animals, and the purchase, storage, movement, import, export, use and disposal of hazardous or potentially hazardous substances, including radioactive compounds and infectious disease agents used in connection with our product development, are or may be applicable to our activities.</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">EMPLOYEES</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">February&#160;14, 2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, we had 1,834 full-time employees. None of our employees are represented by a labor union or covered by collective bargaining agreements. We believe that our relations with our employees are good.</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">AVAILABLE INFORMATION</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our common stock is traded on the New York Stock Exchange under the ticker symbol &#8220;EBS.&#8221; Our principal executive offices are located at 400 Professional Drive, Suite 400, Gaithersburg, Maryland 20879. Our telephone number is (240) 631-3200, and our website address is www.emergentbiosolutions.com. We make available, free of charge on our website, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and all amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the Exchange Act) as soon as reasonably practicable after we electronically file those reports with, or furnish them to, the Securities and Exchange Commission (the SEC).</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We also make available, free of charge on our website, the reports filed with the SEC by our executive officers, directors and 10% stockholders pursuant to Section 16 under the Exchange Act as soon as reasonably practicable after copies of those filings are provided to us by those persons. In addition, we intend to make available on our website all disclosures that are required to be posted by applicable law, the rules of the SEC or the New York Stock Exchange listing standards regarding any amendment to, or waiver of, our code of business conduct and ethics. We have included our website address as an inactive textual reference only. The information contained on, or that can be accessed through, our website is not a part of, or incorporated by reference into, this Annual Report on Form 10-K.</span></div><div><a id="s01D0907685BE51D19E91A054A5F77189"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 1A. RISK FACTORS</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">You should carefully consider the following risk factors in addition to the other information in this Annual </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">23</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Report on Form 10-K when evaluating our business because these risk factors may have a significant impact on our business, financial condition, operating results or cash flows. If any of the risks described below or in subsequent reports, we file with the SEC actually occur, they may materially harm our business, financial condition, operating results or cash flows. Additional risks and uncertainties that we have not yet identified or that we presently consider to be immaterial may also materially harm our business, financial condition, operating results or cash flows. The discussion of these factors is incorporated by reference into and considered an integral part of Part&#160;II,&#160;Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations.&#8221;</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">GOVERNMENT CONTRACTING RISKS</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">  </span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;"> We currently derive a substantial portion of our revenue from USG procurement of AV7909, BioThrax and ACAM2000. If the USG&#8217;s demand for and/or funding for procurement of AV7909, BioThrax or ACAM2000 is substantially reduced, our business, financial condition, operating results and cash flows would be materially harmed.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">   We derive a substantial portion of our current and expected future revenues from USG procurement of AV7909 and BioThrax. As AV7909 is a product development candidate, there is a higher level of risk that we may encounter challenges causing delays or an inability to deliver AV7909 than with BioThrax, which may have a material effect on our ability to generate and recognize revenue.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> The success of our business and our future operating results are significantly dependent on anticipated funding for the procurement of our anthrax vaccines and the terms of our BioThrax and AV7909 sales to the USG, including the price per dose, the number of doses and the timing of deliveries.  We have no certainty that funding will be made available for the procurement of these vaccines. If priorities for the SNS change with respect to our anthrax vaccines, funding to procure future doses of BioThrax or AV7909 may be limited or not available, BARDA may never complete the anticipated full transition to stockpiling AV7909 in support of anthrax preparedness, and our future business, financial condition, operating results and cash flows could be materially harmed</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">In addition, we currently derive a substantial portion of our revenues from sales of ACAM2000 to the USG. If priorities for the SNS change with respect to ACAM2000 or the USG decides not to exercise options under our ACAM2000 contract our future business, financial condition, operating results and cash flows could be materially harmed. </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">   </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">  </span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Although a pre-EUA submission package related to AV7909 has been submitted to the FDA, we may not </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">receive an EUA and eventual FDA licensure in a timely manner or at all. Delays in our ability to achieve a favorable outcome from the FDA could prevent us from realizing the full potential value of our BARDA contract for the advanced development and procurement of AV7909.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In collaboration with us, the CDC filed with the FDA a pre-EUA submission package related to AV7909, which enables FDA review of data in anticipation of a request for an EUA. This submission triggered BARDA to exercise its first contract option (valued at $261M) in July 2019 to procure 10M doses of AV7909 for inclusion into the SNS in support of anthrax preparedness.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:12pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#000000;font-weight:bold;">     </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Notwithstanding, the FDA may decide that our data are insufficient and require additional pre-clinical, clinical or other studies. If we are unsuccessful in obtaining an EUA and, ultimately, FDA licensure, in a timely manner or at all, we may not be able to realize the full potential value of the contract, which could have a material adverse effect on our future business, financial condition, operating results and cash flows. Furthermore, prior to FDA licensure, if we obtain an EUA, the EUA could be terminated if the emergency determination underlying the EUA terminates.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Our USG procurement and development contracts require ongoing funding decisions by the USG. Simultaneous reduction or discontinuation of funding of these contracts could cause our business, financial condition, operating results and cash flows to suffer materially.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The USG is the principal customer for our PHT-focused MCMs and is the primary source of funds for the development of most of our product candidates in our development pipeline, most notably our AV7909 product candidate. We anticipate that the USG will also be a principal customer for those MCMs that we successfully develop within our existing product development pipeline, as well as those we acquire in the future. Additionally, a significant portion of our revenue comes from USG development contracts and grants. Over its lifetime, a USG procurement or development program may be implemented through the award of many different individual contracts and subcontracts. The funding for such government programs is subject to Congressional appropriations, generally made on a fiscal year basis, even for programs designed to continue for several years. For example, sales of BioThrax to be supplied under our procurement contract with the CDC are subject to the availability of funding, mostly from annual appropriations. These appropriations can be subject to political considerations and stringent budgetary constraints.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Additionally, our government-funded development contracts typically give the USG the right, exercisable in its sole discretion, to extend these contracts for successive option periods following a base period of </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">24</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">performance. The value of the services to be performed during these option periods may constitute the majority of the total value of the underlying contract. For example, the September 2016 contract award from BARDA for the development and delivery to the SNS of AV7909 for post-exposure prophylaxis of anthrax disease consists of a five-year base period of performance valued at approximately $200 million. The contract award also includes options for the delivery of additional doses of AV7909 to the SNS and options for an additional clinical study and post-marketing commitments, which, if both were to be exercised in full, would increase the total contract value to up to $1.5 billion. If levels of government expenditures and authorizations for public health countermeasure preparedness decrease or shift to programs in areas where we do not offer products or are not developing product candidates, or if the USG otherwise declines to exercise its options under our existing contracts, our revenues would suffer, as well as our business, financial condition, operating results and cash flows</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">There can be no assurance that we will be able to secure follow-on procurement contracts with the USG upon the expiration of any of our current product procurement contracts.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The majority of our revenue is substantially dependent upon product procurement contracts with the USG and foreign governments for our PHT products. Upon the expiration of a procurement contract, we may not be able to negotiate a follow-on procurement contract for the particular product for a similar product volume, period of performance, pricing or other terms, or at all. The inability to secure a similar or increased procurement contract could materially affect our revenues and our business, financial condition, operating results and cash flows could be harmed. For example, the BARDA procurement contract for raxibacumab that we acquired in our acquisition of raxibacumab from Human Genome Sciences, Inc. and GlaxoSmithKline LLC (collectively referred to as GSK), expired in November 2019. We intend to negotiate follow-on procurement contracts for most of our PHT products upon the expiration of a related procurement contract, including our procurement contract for raxibacumab, but there can be no assurance that we will be successful obtaining any follow-on contracts. Even if we are successful in negotiating a follow-on procurement contract, it may be for a lower product volume, over a shorter period of performance or be on less favorable pricing or other terms. An inability to secure follow-on procurement contracts for our products could materially and adversely affect our revenues, and our business, financial condition, operating results and cash flows could be harmed.</span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">The government contracting process is typically a competitive bidding process and involves unique risks and requirements.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our business involves government contracts and grants, which may be awarded through competitive bidding. Competitive bidding for government contracts presents many risks and requirements, including:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the possibility that we may be ineligible to respond to a request for proposal issued by the government;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the commitment of substantial time and attention of management and key employees to the preparation of bids and proposals for contracts that may not be awarded to us;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the need to accurately estimate the resources and cost structure that will be required to perform any contract that we might be awarded;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the submission by third parties of protests to our responses to requests for proposal that could result in delays or withdrawals of those requests for proposal; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">in the event our competitors protest or challenge contract or grant awards made to us pursuant to competitive bidding, the potential that we may incur expenses or delays, and that any such protest or challenge could result in the resubmission of bids based on modified specifications, or in the termination, reduction or modification of the awarded contract.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The USG may choose not to award us future contracts for either the development of our new product candidates or for the procurement of our existing products addressing PHTs and may instead award such contracts to our competitors. If we are unable to secure particular contracts, we may not be able to operate in the market for products that are provided under those contracts. Additionally, if we are unable to consistently win new contract awards over an extended period, or if we fail to anticipate all of the costs or resources that we will be required to secure and, if applicable, perform under such contract awards, our growth strategy and our business, financial condition and operating results and cash flows could be materially and adversely affected.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">There are a number of laws and regulations that pertain to government contracts and compliance with those laws and regulations require significant time and cost, which could have a material adverse effect on our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As a manufacturer and supplier of MCMs to the USG addressing PHTs, we must comply with numerous laws and regulations relating to the procurement, formation, administration and performance of government </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">25</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">contracts. These laws and regulations govern how we transact business with our government clients and, in some instances, impose additional costs and related obligations on our business operations. Among the most significant government contracting regulations that affect our business are:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the Federal Acquisition Regulation (FAR), and agency-specific regulations supplemental to FAR, which comprehensively regulate the award, formation, administration and performance of government contracts;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the Defense Federal Acquisition Regulations (DFARs), and agency-specific regulations supplemental to DFARs, which comprehensively regulate the award, formation, administration and performance of U.S. Department of Defense (DoD) government contracts;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the Department of State Acquisition Regulation (DOSAR), which regulates the relationship between a Department of State organization and a contractor or potential contractor;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">business ethics and public integrity obligations, which govern conflicts of interest and the hiring of former government employees, restrict the granting of gratuities and funding of lobbying activities and incorporate other requirements such as the Anti-Kickback Act, the Procurement Integrity Act, the False Claims Act and the Foreign Corrupt Practices Act;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">trade controls, including export and import control laws, International Traffic in Arms Regulations (ITAR), U.S. sanctions programs, and anti-boycott laws and regulations; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">laws, regulations and executive orders restricting the use and dissemination of information classified for national security purposes and the exportation of certain products and technical data.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We may be subject to government investigations of business practices and compliance with government acquisition regulations. USG agencies routinely audit and investigate government contractors for compliance with applicable laws and standards. Even though we take significant precautions to identify, prevent and deter fraud, misconduct and non-compliance, we face the risk that our personnel or outside partners may engage in misconduct, fraud or improper activities. If we are audited or investigated and such audit or</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">investigation were to uncover improper or illegal activities, we could be subject to civil and criminal fines and penalties, administrative sanctions, including suspension or debarment from government contracting, and suffer significant reputational harm. The loss of our status as </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">an eligible government contractor or significant fines or penalties associated with contract non-compliance or resulting from investigations could have a material adverse effect on our business.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">The amount we are paid under our fixed price government procurement contracts is based on estimates we have made of the time, resources and expenses required for us to perform under those contracts. If our actual costs exceed our estimates, we may not be able to earn an adequate return or may incur a loss under these contracts, which could harm our operating results and materially reduce our net income.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our current procurement contracts with HHS and the DoD are generally fixed price contracts. We expect that future procurement contracts we successfully secure with the USG would also be fixed price contracts. Under a fixed price contract, we are required to deliver our products at a fixed price regardless of the actual costs we incur. Estimating costs that are related to performance in accordance with contract specifications is difficult, particularly where the period of performance is over several years. Our failure to anticipate technical problems, estimate costs accurately or control costs during performance of a fixed price contract could reduce the profitability of such a contract or cause a loss, which could harm our operating results and materially reduce our net income.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Unfavorable provisions in government contracts, some of which may be customary, may subject our business to material limitations, restrictions and uncertainties and may have a material adverse impact on our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Government contracts customarily contain provisions that give the USG substantial rights and remedies, many of which are not typically found in commercial contracts, including provisions that allow the USG to:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">terminate existing contracts, in whole or in part, for any reason or no reason;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">unilaterally reduce or modify contracts or subcontracts, including by imposing equitable price adjustments;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">cancel multi-year contracts and related orders, if funds for contract performance for any subsequent year become unavailable;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">decline, in whole or in part, to exercise an option to purchase product under a procurement contract or to fund additional development under a development contract;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">decline to renew a procurement contract;</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">26</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">claim rights to facilities or to products, including intellectual property, developed under the contract;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">require repayment of contract funds spent on construction of facilities in the event of contract default;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">take actions that result in a longer development timeline than expected;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">direct the course of a development program in a manner not chosen by the government contractor;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">suspend or debar the contractor from doing business with the government or a specific government agency;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">pursue civil or criminal remedies under acts such as the False Claims Act and False Statements Act; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">control or prohibit the export of products.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Generally, government contracts contain provisions permitting unilateral termination or modification, in whole or in part, at the USG&#8217;s convenience. Under general principles of government contracting law, if the USG terminates a contract for convenience, the government contractor may recover only its incurred or committed costs, settlement expenses and profit on work completed prior to the termination. If the USG terminates a contract for default, the government contractor is entitled to recover costs incurred and associated profits on accepted items only and may be liable for excess costs incurred by the government in procuring undelivered items from another source. All of our contracts, both development and procurement, with the USG, are</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">terminable at the USG&#8217;s convenience with these potential consequences.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition, our USG contracts grant the USG the right to use technologies developed by us under the government contract or the right to share data related to our technologies, for or on behalf of the USG. Under our USG contracts, we might not be able to prohibit third parties, including our competitors, from accessing such technology or data, including intellectual property, in providing products and services to the USG.</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">REGULATORY AND COMPLIANCE RISKS</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Our long-term success depends, in part, upon our ability to develop, receive regulatory approval for and commercialize product candidates we develop or acquire and, if we are not successful, our business, financial condition, operating results and cash flows may suffer.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our product candidates and the activities associated with them are subject to extensive FDA regulation and oversight, as well as oversight by other </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">regulatory agencies in the United States and by comparable authorities in other countries. This includes, but is not limited to, laws and regulations governing product development, including testing, manufacturing, record keeping, storage and approval, as well as advertising and promotion. In limited circumstances, governments may procure products that have not obtained regulatory approval.  In all other circumstances, failure to obtain regulatory approval for a product candidate will prevent us from selling and commercializing the product candidate.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In the United States, to obtain approval from the FDA to market any of our future drug, biologic, or vaccine products, we will be required to submit a new drug application (NDA) or biologics license application (BLA) to the FDA. Ordinarily, the FDA requires a company to support an NDA or BLA with substantial evidence of the product candidate&#8217;s effectiveness, safety, purity and potency in treating the targeted indication based on data derived from adequate and well-controlled clinical trials, including Phase 3 trials conducted in patients with the disease or condition being targeted. </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">However, many of our MCM product candidates, for example, may take advantage of a different regulatory approval pathway under the FDA&#8217;s &#8220;Animal Rule.&#8221; The Animal Rule provides a regulatory pathway for drug and</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">biologic products targeting indications for which human efficacy studies are not feasible or would be unethical. Instead, efficacy must be demonstrated, in part, by utilizing animal models rather than testing in humans. We cannot guarantee that the FDA will permit us to proceed with licensure of any of our PHT MCM candidates under the Animal Rule. Even if we are able to proceed pursuant to the Animal Rule, it can be a very long process, and the FDA may decide that our data are insufficient to support approval and require additional preclinical, clinical or other studies, refuse to approve our products, or place restrictions on our ability to commercialize those products. Furthermore, products approved under the Animal Rule are subject to certain additional post-marketing requirements. For example, to the extent feasible and ethical, manufacturers of products approved pursuant to the Animal Rule must conduct post-marketing studies, such as field studies, to verify and describe the product candidate's clinical benefit and to assess its safety when used as indicated. We cannot guarantee that we will be able to meet this regulatory requirement even if one or more of our product candidates are approved under the Animal Rule.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The process of obtaining these regulatory approvals is expensive, often takes many years if approval is obtained at all, and can vary substantially based upon the type, complexity and novelty of the product candidate involved. Changes in the regulatory approval process during the development period, changes in or the enactment of additional statutes or regulations, or changes in the regulatory review process generally may </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">27</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">cause delays in the approval or rejection of an application. There is a high rate of failure inherent in this process, and potential products that appear promising at early stages of development may fail for a number of reasons, and positive results from preclinical studies may not be predictive of similar results in human clinical trials. Similarly, promising results from earlier clinical trials of a product candidate may not be replicated in later clinical trials.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">There are many other difficulties and uncertainties inherent in pharmaceutical research and development that could significantly delay or otherwise materially delay our ability to develop future product candidates.  These include, but are not limited to: </span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Conditions imposed by regulators, ethics committees, or IRBs for preclinical testing and clinical trials relating to the scope or design of our clinical trials;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Restrictions placed upon, or other difficulties with respect to, clinical trials and clinical trial sites, such as clinical holds or suspension or termination of clinical trials due to, among other things, potential safety or ethical concerns or noncompliance with regulatory requirements;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Delayed or reduced enrollment in clinical trials, or high discontinuation rates;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Failure by third-party contractors, contract research organizations (CROs), clinical investigators, clinical laboratories, or suppliers to comply with regulatory requirements or meet their contractual obligations in a timely manner;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Greater than anticipated cost of or time required to complete our clinical trials; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Insufficient product supply or inadequate product quality.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Failure to successfully develop future product candidates for any of these or other reasons may materially adversely affect our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Once an NDA or BLA is submitted, the FDA has substantial discretion in the approval process and may refuse to accept any application or may decide that our data are insufficient to support approval and require additional preclinical, clinical or other studies. In addition, varying interpretations of the data obtained from preclinical and clinical testing could delay, limit or prevent regulatory approval of a product candidate.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Unapproved and investigational products are also subject to FDA's laws and regulations governing advertising and promotion, which prohibit the promotion of both unapproved products and unapproved uses of approved products. &#160;There is some risk that the FDA </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">could conclude that our communications relating to unapproved products or unapproved uses of approved products constitute the promotion of an unapproved product or product use in violation of FDA laws and regulations.&#160; There is also a risk that a regulatory authority in another country could take a similar position under that country's laws and regulations and conclude that we have violated the laws and regulations related to product development, approval, or promotion in that country.&#160; Therefore, there is a risk that we could be subject to enforcement actions if found to be in violation of such laws or regulations.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Even if we or our collaborators obtain marketing approvals for our product candidates, the terms of approvals and ongoing regulation of our products may limit how we manufacture and market our products, which could materially impair our ability to generate revenue.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Once approval has been granted, an approved product and its manufacturer and marketer remain subject to ongoing review and extensive regulation. </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We and our collaborators must therefore comply with requirements concerning advertising and promotion for any of our product candidates for which we obtain marketing approval. Promotional communications with respect to FDA-regulated products are subject to a variety of legal and regulatory restrictions and must be consistent with the information in the product&#8217;s approved labeling. Thus, we will not be able to promote any products we develop for indications or uses for which they are not approved.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition, manufacturers of approved products and those manufacturers&#8217; facilities are required to comply with extensive FDA requirements, including ensuring that quality control and manufacturing procedures conform to cGMPs, which include requirements relating to quality control and quality assurance as well as the corresponding maintenance of records and documentation and reporting requirements. We and our collaborators and our contract manufacturers could be subject to periodic unannounced inspections by the FDA to monitor and ensure compliance with cGMPs.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Accordingly, were we to receive marketing approval for one or more of our product candidates, we would continue to expend time, money and effort in all areas of regulatory compliance, including manufacturing, production, product surveillance and quality control.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">If we and our collaborators are not able to comply with post-approval regulatory requirements, we could have the marketing approvals for our products</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">withdrawn by regulatory authorities and our ability to market any products could be limited, which could adversely affect our ability to achieve or sustain profitability. Further, the cost of compliance with post-approval regulations may </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">28</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">have a negative effect on our operating results and financial condition.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Any product candidate for which we or our collaborators obtain marketing approval could be subject to restrictions or withdrawal from the market and we may be subject to substantial penalties if we fail to comply with regulatory requirements or if we experience unanticipated problems with our product candidates, when and if any of them are approved.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Any product candidate for which we or our collaborators obtain marketing approval, along with the manufacturing processes, post-approval clinical data, labeling, advertising and promotional activities for such product, will be subject to continual requirements of and review by the FDA and other regulatory authorities. These requirements include submissions of safety and other post-marketing information and reports, registration and listing requirements, cGMP requirements relating to quality control and manufacturing, quality assurance and corresponding maintenance of records and documents, and requirements regarding the distribution of samples to physicians and recordkeeping. Even if marketing approval of a product candidate is granted, the approval may be subject to limitations on the indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for costly post-marketing testing and surveillance to monitor the safety or efficacy of the medicine, including the requirement to implement a risk evaluation and mitigation strategy.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Certain of our products are subject to postmarketing requirements (PMRs), which we are required to conduct, and postmarketing commitments (PMCs), which we have agreed to conduct. The FDA has the authority to take action against sponsors who fail to meet the obligations of a PMR, including civil monetary penalties and/or misbranding charges.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The FDA and other agencies, including the U.S. Department of Justice (DOJ) and the HHS Office of Inspector General (OIG), closely regulate and monitor the pre-approval and post-approval marketing and promotion of products to ensure that they are marketed and distributed only for the approved indications and in accordance with the provisions of the approved labeling. The FDA, DOJ, and OIG impose stringent restrictions on manufacturers&#8217; communications regarding unapproved products and unapproved uses of approved products and if we market unapproved products or market our approved products for unapproved indications, we may be subject to enforcement action for marketing of unapproved products or unapproved uses of approved products. Violations of the Federal Food, Drug, and Cosmetic Act (FDCA) and other statutes, including the False Claims Act, relating to the promotion and advertising of prescription products may lead to investigations and enforcement actions alleging </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">violations of federal and state health care fraud and abuse laws, as well as state consumer protection laws.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition, later discovery of previously unknown adverse events or other problems with our products, manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may yield various results, including:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">restrictions on such products, manufacturers or manufacturing processes;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">restrictions on the labeling or marketing of a product;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">restrictions on distribution or use of a product;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">requirements to conduct post-marketing studies or clinical trials;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">warning letters or untitled letters;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">withdrawal of the products from the market;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">refusal to approve pending applications or supplements to approved applications that we submit;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">recall of products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">damage to relationships with collaborators;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">unfavorable press coverage and damage to our reputation;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">fines, restitution or disgorgement of profits or revenues;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">suspension or withdrawal of marketing approvals;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">refusal to permit the import or export of our products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">product seizure;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">injunctions or the imposition of civil or criminal penalties; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">litigation involving patients using our products.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Non-compliance with EU requirements regarding safety monitoring or pharmacovigilance, and with requirements related to the development of products for the pediatric population, can also result in significant financial penalties. Similarly, failure to comply with the EU and other legal and regulatory requirements regarding the protection of personal information can also lead to significant penalties and sanctions.  Non-compliance with similar requirements in other jurisdictions can also result in enforcement actions and significant penalties.</span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">29</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Current and future legislation may increase the difficulty and cost for us and any collaborators to obtain marketing approval of and commercialize our product candidates and affect the prices we, or they, may obtain.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In the United States and foreign jurisdictions, there have been a number of legislative and regulatory changes and proposed changes regarding the health care system that could prevent or delay marketing approval of our product candidates, restrict or regulate post-approval activities and affect our ability to profitably sell any product candidates for which we obtain marketing approval. We expect that current laws, as well as other health care reform measures that may be adopted in the future, may result in more rigorous coverage criteria and in additional downward pressure on the price that we, or any collaborators, may receive for any approved products.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act (collectively, the ACA), passed in 2010, contains the following provisions of potential importance to our business and our product candidates:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">an annual, non-deductible fee on any entity that manufactures or imports specified branded prescription products and biologic agents;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">an increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">a</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for products that are inhaled, infused, instilled, implanted or injected;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">expansion</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of health care fraud and abuse laws, including the civil False Claims Act and the federal Anti-Kickback Statute, new government investigative powers and enhanced penalties for noncompliance;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">a new Medicare Part D coverage gap discount program, in which manufacturers must agree to offer 50% point-of-sale discounts off negotiated prices of applicable brand products to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#8217;s outpatient products to be covered under Medicare Part D;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">extension of manufacturers&#8217; Medicaid rebate liability to individuals enrolled in Medicaid managed care organizations;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">expansion of eligibility criteria for Medicaid programs;</span></div></td></tr></table></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">expansion of the entities eligible for discounts under the Public Health Service pharmaceutical pricing program;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">new requirements to report certain financial arrangements with physicians and teaching hospitals;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">a new requirement to annually report product samples that manufacturers and distributors provide to physicians;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">a new Independent Payment Advisory Board (IPAB), which has authority to recommend certain changes to the Medicare program to reduce expenditures by the program that could result in reduced payments for prescription products; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">established the Center for Medicare and Medicaid Innovation within the Centers for Medicare &amp; Medicaid Services (CMS) to test innovative payment and service delivery models.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition, other legislative changes have been proposed and adopted since the ACA was enacted. In</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">August 2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several government programs. These changes included aggregate reductions to Medicare payments to providers of up to 2% per fiscal year, which went into effect in April 2013 and will remain in effect through 2024 unless additional Congressional action is taken. The American Taxpayer Relief Act of 2012, among other things, reduced Medicare payments to several providers and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. These new laws may result in additional reductions in Medicare and other health care funding and otherwise affect the prices we may obtain for any of our product candidates for which we may obtain regulatory approval or the frequency with which any such product candidate is prescribed or used.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Since enactment of the ACA, there have been numerous legal challenges and Congressional actions to repeal and replace provisions of the law. For example, with enactment of the Tax Cuts and Jobs Act of 2017, which was signed by the President on December 22, 2017, Congress repealed the &#8220;individual mandate.&#8221; The </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">30</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">repeal of this provision, which required most Americans to carry a minimal level of health insurance, became effective on January 1, 2019. In addition, Congress will likely consider other legislation to replace elements of the ACA, during the next Congressional session. It is possible that such initiatives, if enacted into law, could ultimately result in fewer individuals having health insurance coverage or in individuals having insurance coverage with less generous benefits. We will continue to evaluate the effect that the ACA and its possible repeal and replacement could have on our business.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">There have been executive actions to challenge or delay implementation of the ACA. Since January 2017, there have been two Executive Orders issued designed to delay the implementation of certain provisions of the ACA or otherwise circumvent some of the requirements for health insurance mandated by the ACA. One Executive Order directs federal agencies with authorities and responsibilities under the ACA to waive, defer, grant exemptions from, or delay the implementation of any</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">provision of the ACA that would impose a fiscal or regulatory burden on states, individuals, health care providers, health insurers, or manufacturers of pharmaceuticals or medical devices. The second Executive Order terminates the cost-sharing subsidies that reimburse insurers under the ACA. In addition, the CMS has proposed regulations that would give states greater flexibility in setting benchmarks for insurers in the individual and small group marketplaces, which may have the effect of relaxing the essential health benefits required under the ACA for plans sold through such marketplaces. On May 16, 2019, CMS finalized a rule that amends the Medicare Advantage and Medicare Part D prescription drug benefit regulations to reduce out of pocket costs for plan enrollees and allow Medicare plans to negotiate lower rates for certain drugs. Among other things, the rule changes allow Medicare Advantage plans to use preauthorization (PA) and step therapy (ST) for six protected classes of drugs and, with certain exceptions, permit plans to implement PA and ST in Medicare Part B drugs.  The first change took effect in January 2020, while the second change will take effect in January 2021. Litigation and legislation over the ACA are likely to continue, with unpredictable and uncertain results.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The costs of prescription pharmaceuticals have also been the subject of considerable discussion in the United States, and members of legislative and executive branches have stated that they will address such costs through new legislative and administrative measures. While any proposed measures will require authorization through additional legislation to become effective, there may be new legislative and/or administrative measures to control drug costs. At the state level, legislatures are increasingly passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">At the state level, individual states are increasingly aggressive in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. In addition, regional health care authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other health care programs. These measures could reduce the ultimate demand for our products, once approved, or put pressure on our product pricing. We expect that additional state and federal health care reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for health care products and services, which could result in reduced demand for our product candidates or additional pricing pressures.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">If we fail to comply with foreign, federal, state and local health care laws, including fraud and abuse and health information privacy and security laws, and antitrust laws, we could face substantial&#160;penalties and our business, results of operations, financial condition and prospects could be adversely affected.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In the United States, certain of our products are reimbursed under federal and state health care programs such as Medicaid, Medicare, TriCare, and/or state pharmaceutical assistance programs. Many foreign countries have similar laws. Federal and state laws designed to prevent fraud and abuse under these programs prohibit pharmaceutical companies from offering valuable items or services to customers or potential customers to induce them to buy, prescribe, or recommend our product (the so-called &#8220;anti-kickback&#8221; laws). Exceptions are provided for discounts and certain other arrangements if specified requirements are met. Other federal and state laws, and similar foreign laws, not only prohibit us from submitting any false information to government reimbursement programs but also prohibit us, our employees, or any third party acting on our behalf from doing anything to cause, assist, or encourage our customers to submit false claims for payment to these programs. We are also subject to various federal, state and foreign antitrust and competition laws that prohibit certain activities that may have an impact against potential competitors. Violations of the various fraud and abuse and antitrust laws may result in severe penalties against the responsible employees and us, including jail sentences, large fines, </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">31</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">and the exclusion of our products from reimbursement under federal and state programs. Some of the laws that may affect our ability to operate include:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:18px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the federal Anti-Kickback Statute makes it illegal for any person or entity, including a prescription drug manufacturer (or a party</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">acting on its behalf) to knowingly and willfully solicit, receive, offer or pay remuneration, directly or indirectly, overtly or covertly, to induce, or in return for, either the referral of an individual, or the purchase, lease, prescribing or recommendation of an item, good, facility or service reimbursable by a federally funded health care program, such as the Medicare or Medicaid program. The term &#8220;remuneration&#8221; has been interpreted broadly and may constrain our marketing practices, educational programs, pricing policies and relationships with health care providers or other entities, among other activities;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:18px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the federal False Claims Act imposes criminal and civil penalties, including through civil whistleblower or qui tam actions, against individuals or entities for, among other things, knowingly presenting, or causing to be presented, false or fraudulent claims for payment by a federal health care program or making a false statement or record material to payment of a false claim or avoiding, decreasing or concealing an obligation to pay money to the federal government, with potential liability including mandatory treble damages and significant per-claim penalties, currently set at $11,181 to $22,363 per false claim;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:18px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the U.S. federal Health Insurance Portability and Accountability Act of 1996 (HIPAA), which imposes criminal and civil liability for, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any health care benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control of, any health care benefit program, regardless of the payor (e.g., public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false statement, in connection with the delivery of, or payment for, health care benefits, items or services. Similar to the U.S. federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:18px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act </span></div></td></tr></table></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-left:42px;padding-bottom:12px;text-align:justify;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">(HITECH), and their respective implementing regulations mandates, among other things, the adoption of uniform standards for the electronic exchange of information in common health care transactions, as well as standards relating to the privacy, security and transmission of individually identifiable health information, which require the adoption of administrative, physical and technical safeguards to protect such information. Among other things, HITECH makes HIPAA's security standards directly applicable to &#8220;business associates,&#8221; or independent contractors or agents of covered entities that create, receive or obtain protected health information in connection with providing a service for or on behalf of a covered entity;</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:18px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the Physician Payments Sunshine Act and its implementing regulations, which require certain manufacturers of drugs, biologics, medical devices and medical supplies for which payment is available under Medicare, Medicaid or the Centers for Medicare&#160;&amp; Medicaid Services (CMS), certain payments and transfers of value made to U.S. physicians and teaching hospitals, and ownership or investment interests held by physicians and their immediate family members. Beginning in 2022, applicable manufacturers will also be required to report information regarding payments and transfers of value provided to U.S. physician assistants, nurse practitioners, clinical nurse specialists, certified nurse anesthetists, and certified nurse-midwives; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:18px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">state law equivalents of each of the above federal laws, such as anti-kickback and false claims laws, which may apply to items or services reimbursed by any third-party payor, including commercial insurers; state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts; state, local and foreign laws that require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">compliance guidance promulgated by the</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">federal government, obtain pharmaceutical agent licensure, and/or otherwise restrict payments that may be made to health care providers and entities; and state, local and foreign laws that require drug manufacturers to report information related to payments and other transfers of value to health care providers or entities, or marketing expenditures.</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">32</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available under the federal Anti-Kickback Statute, it is possible that some of our business activities could be subject to challenge under one or more of such laws. Moreover, recent health care reform legislation has strengthened these laws. For example, the ACA, among other things, amends the intent requirement of the federal Anti-Kickback Statute and criminal health care fraud statutes, so that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it. In addition, the ACA provides that the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">If our operations are found to be in violation of any of the laws described above or any governmental regulations that apply to us, we may be subject to penalties, including civil and criminal penalties, damages, fines, individual imprisonment, integrity obligations, exclusion from funded health care programs and the curtailment or restructuring of our operations. Any such penalties could adversely affect our financial results. We continue to improve our corporate compliance program designed to ensure that our development, marketing, and sales of existing and future products and product candidates are in compliance with all applicable laws and regulations, but we cannot guarantee that this program will protect us from governmental investigations or other actions or lawsuits stemming from a failure to comply with such laws or regulations. If any such actions are instituted against us and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant fines or other sanctions.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Efforts to ensure that our business arrangements with third parties will comply with applicable health care laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other health care laws and regulations. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, individual imprisonment, integrity obligations, exclusion from government funded health care programs, such as Medicare and Medicaid, and the curtailment or restructuring of our operations. If any of the physicians or other health care providers or entities with whom we expect to do business is found to be not in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusion from government funded health care programs. If a third party fails to comply with applicable </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">laws and regulations while acting on our behalf, we may also be subject to criminal, civil, and administrative penalties, including those listed above.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We are committed to conducting the development, sale and marketing of our applicable products and product candidates and all our activities in compliance with all applicable laws and regulations, but certain applicable laws and regulations may impose liability even in the absence of specific intent to defraud. Furthermore, should there be ambiguity, a governmental authority may take a position contrary to a position we have taken, or should an employee or third party acting on our behalf violate these laws without our knowledge, a governmental authority may impose civil and/or criminal sanctions.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The United States government, state governments and private payors regularly investigate the pricing and competitive practices of pharmaceutical companies and biotechnology companies, and many file actions alleging that inaccurate reporting of prices has improperly inflated reimbursement rates. We may also be subject to investigations related to our pricing practices. Regardless of merit or eventual outcome, these types of investigations and related litigation can result in:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Diversion of management time and attention;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Expenditure of large amounts of cash on legal fees, costs and payment of damages or penalties;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Limitations on our ability to continue some of our operations;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Decreased demand for our products; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Injury to our reputation.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Moreover, an adverse outcome, or the imposition of penalties or sanctions for failing to comply with the fraud and abuse and antitrust laws, could adversely affect us and may have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">If we fail to comply with our obligations under U.S. governmental pricing programs, we could&#160;be required to reimburse government programs for underpayments and could pay penalties, sanctions and fines.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The issuance of regulations and coverage expansion by various governmental agencies relating to the Medicaid rebate program will continue to increase our costs and the complexity of compliance and will be time-consuming. Changes to the definition of &#8220;average manufacturer price&#8221; (AMP), and the Medicaid rebate amount under the ACA and CMS and the issuance of final regulations implementing those changes has affected and could further affect our 340B &#8220;ceiling price&#8221; calculations. Because we participate in the Medicaid rebate program, we are required to report &#8220;average sales </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">33</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">price&#8221; (ASP), information to CMS for certain categories of drugs that are paid for under Part B of the Medicare program. Future statutory or regulatory changes or CMS binding guidance could affect the ASP calculations for our products and the resulting Medicare payment rate and could negatively impact our results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Pricing and rebate calculations vary among products and programs, involve complex calculations and are often subject to interpretation by us, governmental or regulatory agencies and the courts. The Medicaid rebate amount is computed each quarter based on our submission to CMS of our current AMP and &#8220;best price&#8221; for the quarter. If we become aware that our reporting for a prior quarter was incorrect, or has changed as a result of recalculation of the pricing data, we are obligated to resubmit the corrected data for a period not to exceed twelve quarters from the quarter in which the data originally were due. Any such revisions could have the impact of increasing or decreasing our rebate liability for prior quarters, depending on the direction of the revision. Such restatements and recalculations increase our costs for complying with the laws and regulations governing the Medicaid rebate program. Price recalculations also may affect the &#8220;ceiling price&#8221; at which we are required to offer our products to certain covered entities, such</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">as safety-net providers, under the 340B/Public Health Service (PHS) drug pricing program.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition to retroactive rebate liability and the potential for 340B program refunds, if we are found to have made a misrepresentation in the reporting of ASP, we are subject to civil monetary penalties for each such price misrepresentation and for each day in which such price misrepresentation was applied. If we are found to have knowingly submitted false AMP or &#8220;best price&#8221; information to the government, we may be liable for civil monetary penalties per item of false information. Any refusal of a request for information or knowing provision of false information in connection with an AMP survey verification also would subject us to civil monetary penalties. In addition, our failure to submit monthly/quarterly AMP or &#8220;best price&#8221; information on a timely basis could result in a civil monetary penalty per day for each day the information is late beyond the due date. Such failure also could be grounds for CMS to terminate our Medicaid drug rebate agreement, pursuant to which we participate in the Medicaid program. In the event that CMS terminates our rebate agreement, no federal payments would be available under Medicaid or Medicare Part B for our covered outpatient drugs. Governmental agencies may also make changes in program interpretations, requirements or conditions of participation, some of which may have implications for amounts previously estimated or paid. We cannot assure that our submissions will not be found by CMS to be incomplete or incorrect.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In order for our products to be reimbursed by the primary federal governmental programs, we must report </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">certain pricing data to the USG. Compliance with reporting and other requirements of these federal programs is a pre-condition to: (i)&#160;the availability of federal funds to pay for our products under Medicaid and Medicare Part B; and (ii)&#160;procurement of our products by the Department of Veterans Affairs (DVA), and by covered entities under the 340B/PHS program. The pricing data reported are used as the basis for establishing Federal Supply Schedule (FSS), and 340B/PHS program contract pricing and payment and rebate rates under the Medicare Part B and Medicaid programs, respectively. Pharmaceutical companies have been prosecuted under federal and state false claims laws for submitting inaccurate and/or incomplete pricing information to the government that resulted in increased payments made by these programs. The rules governing the calculation of certain reported prices are highly complex. Although we</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">maintain and follow strict procedures to ensure the maximum possible integrity for our federal pricing calculations, the process for making the required calculations involves some subjective judgments and the risk of errors always exists, which creates the potential for exposure under the false claims laws. If we become subject to investigations or other inquiries concerning our compliance with price reporting laws and regulations, and our methodologies for calculating federal prices are found to include flaws or to have been incorrectly applied, we could be required to pay or be subject to additional reimbursements, penalties, sanctions or fines, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">To be eligible to have our products paid for with federal funds under the Medicaid and Medicare Part B programs as well as to be purchased by certain federal agencies and certain federal grantees, we also must participate in the DVA FSS pricing program. To participate, we are required to enter into an&#160;FSS contract with the DVA, under which we must make our innovator &#8220;covered drugs&#8221; available to the &#8220;Big Four&#8221; federal agencies-the DVA, the DoD, the Public Health Service (including the Indian Health Service), and the Coast Guard-at pricing that is capped pursuant to a statutory federal ceiling price (FCP), formula set forth in Section&#160;603 of the Veterans Health Care Act of 1992 (VHCA). The FCP is based on a weighted average wholesale price known as the Non-Federal Average Manufacturer Price (Non-FAMP), which manufacturers are required to report on a quarterly and annual basis to the DVA. Pursuant to the VHCA, knowing provision of false information in connection with a Non-FAMP filing can subject us to significant penalties for each item of false information. If we overcharge the government in connection with our FSS contract or Section&#160;703 Agreement, whether due to a misstated FCP or otherwise, we are required to disclose the error and refund the difference to the government. The failure to make necessary disclosures and/or to identify contract </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">34</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">overcharges can result in allegations against us under the False Claims Act and other laws and regulations. Unexpected refunds to the government, and responding to a government&#160;investigation or enforcement action, can be expensive and time-consuming, and could have a material adverse effect on our business, financial condition, results of operations and growth prospects.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Under certain circumstances, we might sell unapproved MCMs to government entities. While this is permissible in some cases, the extent to which we may be able to lawfully market and sell unapproved products in many jurisdictions may be unclear or ambiguous. Such sales could subject us to regulatory enforcement action, product liability and reputational risk.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Under certain circumstances, MCMs may be procured by government entities prior to approval by the FDA or other regulatory authorities, a practice which we follow in connection with AV7909 and Trobigard. In the United States, the Project BioShield Act of 2004 (Project BioShield) permits the Secretary of HHS to contract to purchase MCMs for the SNS prior to FDA approval of the countermeasure in specified circumstances. Project BioShield and the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 also allow the FDA Commissioner to authorize the emergency use of medical products that have not yet been approved by the FDA under an EUA. An EUA terminates when the emergency determination underlying the EUA terminates. An EUA is not a long-term alternative to obtaining FDA approval, licensure, or clearance for a product. Absent an applicable exception, our MCM product candidates generally will have to be approved by the FDA or other regulatory authorities in the relevant country through traditional pathways before we can sell those products to governments. Additionally, the laws in certain jurisdictions regarding the ability of government entities to purchase unapproved product candidates</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">are ambiguous, and the permissibility of exporting unapproved products from the United States and importing them to foreign countries may be unclear. Nevertheless, government bodies, such as U.S. federal entities other than HHS, state and local governments within the United States, and foreign governments, may seek to procure our MCM product candidates that are not yet approved. If so, we would expect to assess the permissibility and liability implications of supplying our product candidates to such entities on a case-by-case basis, which presents certain challenges, both in the case of U.S. and foreign governments, and particularly under emergency conditions. In addition, agencies or branches of one country&#8217;s government may take different positions regarding the permissibility of such sales than another country&#8217;s government or even other agencies or branches of the same government. If we determine that we believe such activities are permissible, local enforcement authorities could disagree with our conclusion and take enforcement action against us.</span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition, the sale of unapproved products also could give rise to product liability claims for which we may not be able to obtain indemnification or insurance coverage. For example, liability protections applicable to claims arising under U.S. law and resulting from the use of certain unlicensed products, such as a declaration issued under the Public Readiness and Emergency Preparedness Act (the PREP Act) do not cover claims arising under non-U.S. law.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Regardless of the permissibility and liability risks, in the event a user of one or more of our products suffers an adverse event, we may be subject to additional reputational risk if the product has not been approved by the FDA or the corresponding regulatory authority of another country, particularly because we will not have approved labeling regarding the safety or efficacy of those products. In addition, legislatures and other governmental bodies that have oversight responsibility for procuring agencies may raise concerns after the fact, even if procurement was permissible at the time, which could result in negative publicity, reputational risk and harm to our business prospects.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">There is also a risk that our communications with governments about our unapproved products, such as in the procurement context, could be considered promotion of an unapproved product or unapproved use of an approved product. Therefore, there is a risk that we could be subject to enforcement actions if found to be in violation of such laws or regulations.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Even after regulatory approval is received, if we fail to comply with regulatory requirements, or if we experience unanticipated problems with our approved products, they could be subject to restrictions, penalties or withdrawal from the market.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition to the requirements and uncertainties related to pre-approval activities discussed previously, any vaccine, therapeutic product or medical device for which we obtain marketing approval, along with the manufacturing processes, post-approval clinical data, labeling, advertising and promotional activities for such product, will be subject to continual requirements of and review by the FDA and other regulatory bodies. Our approved products are subject to these requirements and ongoing review. These requirements include submissions of safety and other post-marketing information and reports, plasma donor testing, registration requirements, cGMP, requirements relating to potency and stability, quality control, quality assurance, restrictions on advertising and promotion, import and export restrictions and recordkeeping requirements. In addition, various state laws require that companies that manufacture and/or distribute drug products within the state obtain and maintain a manufacturer or distributor license, as appropriate. Because of the breadth of these laws, it is possible that some of our business activities could be subject to challenge under one or more of such laws.</span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">35</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Government regulators enforce cGMP and other requirements through periodic unannounced inspections of manufacturing facilities. The FDA is authorized to inspect domestic and foreign manufacturing facilities without prior notice at reasonable times and in a reasonable manner. Health Canada may conduct similar inspections of our domestic and foreign facilities where Canadian marketed products are produced, or related formulation and filling operations are conducted. The FDA, Health Canada, and other foreign regulatory agencies conduct periodic inspections of our facilities. Following several of these inspections, regulatory authorities have issued inspectional observations, some of which were significant, but all of which are being, or have been, addressed through corrective actions. If, in connection with any future inspection, regulatory authorities find that we are not in substantial compliance with all applicable requirements, or if they are not satisfied with the corrective actions we take, our regulators may undertake enforcement action against us, which may include:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">warning letters and other communications;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">product seizure or withdrawal of the product from the market;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">restrictions on the marketing or manufacturing of a product;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">suspension or withdrawal of regulatory approvals or refusal to approve pending applications or supplements to approved applications;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">fines or disgorgement of profits or revenue; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">injunctions or the imposition of civil or criminal penalties.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Similar action may be taken against us should we fail to comply with regulatory requirements, or later discover previously unknown problems with our products or manufacturing processes. For instance, our products are tested regularly to determine if they satisfy potency and stability requirements for their required shelf lives. Failure to meet potency, stability or other specification requirements could result in delays in distributions, recalls or other consequences.  Even if regulatory approval of a product is granted, the approval may be subject to limitations on the indicated uses for which the product may be marketed or to the conditions of approval. Regulatory approval may also contain requirements for costly post-marketing testing and surveillance to monitor the safety or efficacy of the product. If we experience any of these post-approval events, our business, financial condition, operating </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">results and cash flows could be materially and adversely affected.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Additionally, companies may not promote unapproved products or unapproved uses of approved products (i.e. &#8220;off-label&#8221; uses or uses that are not described in the product&#8217;s approved labeling and that differ from the uses approved by the applicable regulatory agencies). A company that is found to have improperly promoted an unapproved product or unapproved use of an approved product may be subject to significant liability, including civil and administrative remedies (such as entering into corporate integrity agreements with the USG), as well as criminal sanctions. If our employees or agents engage in marketing of an unapproved product or the unapproved use of an approved product, we could be subject to civil or criminal investigations and monetary and injunctive penalties, which could adversely impact our ability to conduct business in certain markets, negatively affect our business, financial condition, operating results and cash flows, and damage our reputation.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Failure to obtain or maintain regulatory approval in international jurisdictions could prevent us from marketing our products abroad and could limit the growth of our business.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We intend to sell certain of our products, outside the United States and received market authorization under the mutual recognition procedure to sell BioThrax in France, Italy, the Netherlands, Poland, and the United Kingdom. To market our products in foreign jurisdictions under normal circumstances, we generally need to obtain separate regulatory approvals and comply with numerous and varying requirements or use alternative &#8220;emergency use&#8221; or other exemptions from general approval and import requirements. Approval by the FDA in the United States or the mutual recognition procedure in the European member states does not ensure approval by all foreign regulatory authorities. The approval procedures in foreign jurisdictions can vary widely and can involve additional clinical trials and data review beyond that required by the FDA or under the mutual recognition procedure. There is also a risk that a regulatory authority in another country could conclude that we have violated the rules and regulations related to product development, approval or promotion in that country.  Therefore, there is a risk that we could be subject to a foreign enforcement action if found to be in violation of such laws and regulations.  We and our collaborators may not be able to obtain foreign regulatory approvals on a timely basis, if at all, and we may be unable to successfully commercialize our products internationally if no alternate procurement pathway is identified for authorized government customers in a particular jurisdiction. We have limited experience in preparing, filing and prosecuting the applications necessary to gain foreign regulatory approvals and expect to rely on third-party contract </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">36</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">research organizations and consultants to assist us in this process. Our reliance on third parties can introduce additional uncertainty into the process.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On January 31, 2020, the United Kingdom formally withdrew from the European Union and entered into a transition period through December 31, 2020 pursuant to a Withdrawal Agreement. Since a significant proportion of the regulatory framework in the United Kingdom is derived from European Union directives and regulations, Brexit could materially impact the regulatory regime with respect to the</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">approval of our products or product candidates in the United Kingdom or the European Union. Any delay in obtaining, or an inability to obtain, any marketing approvals, as a result of Brexit or otherwise, would prevent us from commercializing product candidates in the United Kingdom and/or the European Union and could restrict our ability to generate revenue and achieve and sustain profitability. There is also a risk that a regulatory authority in another country could conclude that we have violated the rules and regulations related to product development, approval, or promotion in that country.&#160; Therefore, there is a risk that we could be subject to an enforcement action if found to be in violation of such laws or regulations.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Laws and regulations governing international operations may preclude us from developing, manufacturing and selling certain products outside of the United States and require us to develop and implement costly compliance programs.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As we continue to expand our commercialization activities outside of the United States, we are subject to an increased risk of, and must dedicate additional resources towards avoiding inadvertently conducting activities in a manner that violates the U.S. Foreign Corrupt Practices Act (FCPA), the U.K. Bribery Act, Canada's Corruption of Foreign Public Officials Act, and other similar foreign laws, which prohibit corporations and individuals from paying, offering to pay, or authorizing the payment of anything of value to any foreign government official, government staff member, political party, or political candidate in an attempt to obtain or retain business or to otherwise influence a person working in an official capacity. The FCPA also obligates companies whose securities are listed in the United States to comply with certain accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations.  Compliance with the FCPA is expensive and difficult, particularly in countries in which corruption is a recognized problem. In addition, the FCPA presents particular challenges in the pharmaceutical industry, because, in many countries, hospitals are operated by the government, and doctors and other hospital employees are considered foreign officials. Certain </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">payments to hospitals in connection with clinical trials and other work have been deemed to be improper payments to government officials and have led to FCPA enforcement actions.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Many countries, including the United States, also have various lobbying laws and regulations governing the conduct of individuals and companies who interact with government officials. These laws and regulations typically include certain restrictions and disclosure obligations. If we, our employees, or third parties acting on our behalf do not comply with these laws and regulations, we may be subject to civil and criminal penalties.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Many countries, including the United States, restrict the export or import of products to or from certain countries through, for example, bans, sanction programs, and boycotts. Such restrictions may preclude us from supplying products in certain countries, which could limit our growth potential. Furthermore, if we, or third parties acting on our behalf, do not comply with these restrictions, we may be subject to civil and criminal penalties.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Various laws, regulations and executive orders also restrict the use and dissemination outside of the United States, or the sharing with certain non-U.S. nationals, of information classified for national security purposes, as well as certain products and technical data relating to those products. If we continue to expand our presence outside of the United States, it will require us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing, or selling certain products and product candidates outside of the United States, which could limit our growth potential and increase our development costs.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The failure to comply with laws governing international business practices may result in substantial civil and criminal penalties and suspension or debarment from government contracting. The SEC also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#8217;s accounting provisions.</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">MANUFACTURING RISKS</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Disruption at, damage to or destruction of our manufacturing facilities could impede our ability to manufacture AV7909, BioThrax, ACAM2000 or our other products, as well as deliver our contract development and manufacturing services, which would harm our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">An interruption in our manufacturing operations could result in our inability to produce our products for delivery to satisfy the product demands of our customers in a timely manner, which would reduce our revenues and materially harm our business, financial </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">37</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">condition, operating results and cash flows. A number of factors could cause interruptions, including:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">equipment malfunctions or failures;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">technology malfunctions;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">cyber-attacks;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">work stoppages or slow downs;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">protests, including by animal rights activists;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">injunctions;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">damage to or destruction of the facility; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">product contamination or tampering.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Providers of PHT countermeasures could be subject to an increased risk of terrorist activities. The USG has designated both our Lansing, Michigan and our Bayview bulk manufacturing facility in Baltimore, Maryland as facilities requiring additional security. Although we continually evaluate and update security measures, there can be no assurance that any additional security measures would protect these facilities from terrorist efforts determined to disrupt our manufacturing activities.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The factors listed above could also cause disruptions at our other facilities, including our manufacturing facilities in Winnipeg, Manitoba, Canada; other Baltimore, Maryland facilities in Camden; facilities in Canton, Massachusetts; Rockville, Maryland, Bern, Switzerland; and Hattiesburg, Mississippi. We do not have any redundant manufacturing facilities for any of our marketed products. Accordingly, any disruption, damage, or destruction of these facilities could impede our ability to manufacture our marketed products, our product candidates and our ability to produce products for external customers, result in losses and delays, including delay in the performance of our contractual obligations or delay in our clinical trials, any of which could be costly to us and materially harm our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">We may not be able to utilize the full manufacturing capacity of our manufacturing facilities, which could impact our future revenues and materially harm our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Despite our ongoing efforts to optimize the utilization of our manufacturing infrastructure (including bulk, fill/finish, support, aseptic filling, lyophilization, final packaging), we may not be able to realize full utilization, which could adversely affect our future revenues, financial condition, operating results and cash flows.</span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Problems may arise during the production of our marketed products and product candidates due to the complexity of the processes involved in their manufacturing and shipment. Significant delays in product manufacturing or development could cause delays in revenues, which would harm our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Several of our products, including BioThrax and ACAM2000 and many of our current product candidates, including AV7909, are biologics.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Manufacturing biologic products, especially in large quantities, is complex. The products must be made consistently and in compliance with a clearly defined manufacturing process. Problems during manufacturing may arise for a variety of reasons, including problems with raw materials, equipment malfunction and failure to follow specific protocols and procedures. In addition, slight deviations anywhere in the manufacturing process, including obtaining materials, maintaining master seed or cell banks and preventing genetic drift, seed or cell growth, fermentation, contamination including from particulates among other things, filtration, filling, labeling, packaging, storage and shipping, potency and stability issues and other quality control testing, may result in lot failures or manufacturing shut-downs, delays in the release of lots, product recalls, spoilage or regulatory action. Such deviations may require us to revise manufacturing processes or change manufacturers. Additionally, as our equipment ages, it will need to be replaced. Replacement of equipment has the potential to introduce variations in the manufacturing process that may result in lot failures or manufacturing shut-downs, delay in the release of lots, product recalls, spoilage or regulatory action. Success rates can also vary dramatically at different stages of the manufacturing process, which can reduce yields and increase costs. From time to time, we may experience deviations in the manufacturing process that may take significant time and resources to resolve and, if unresolved, may affect manufacturing output and could cause us to fail to satisfy customer orders or contractual commitments, lead to a termination of one or more of our contracts, lead to delays in our clinical trials, result in litigation or regulatory action against us, including warning letters and other restrictions on the marketing or manufacturing of a product, or cause the FDA to cease releasing product until the deviations are explained and corrected, any of which could be costly to us, damage our reputation and negatively impact our business.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Additionally, if changes are made to the manufacturing process, we may be required to provide the FDA with pre-clinical and clinical data showing the comparable identity, strength, quality, purity or potency of any impacted products before and after the changes.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We are contractually required to ship our biologic products at a prescribed temperature range and variations from that temperature range could result in </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">38</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">loss of product and could significantly and adversely impact our revenues, which would harm our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Manufacturing delays, lot failures, shipping deviations, spoilage or other loss during shipping could cause us to fail to satisfy customer orders or contractual commitments, lead to a termination of one</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">or more of our contracts, lead to delays in potential clinical trials or result in litigation or regulatory action against us, any of which could be costly to us and otherwise harm our business.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Our products and product candidates procured by the USG and other customers require us to perform tests for and meet certain potency and lot release standards prescribed by the FDA and other agencies, which may not be met on a timely basis or at all.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our products and product candidates procured by the USG and other customers require us to perform tests for and meet certain potency and lot release standards prescribed by the FDA and other agencies, which may not be met on a timely basis or at all. We are unable to sell any products and product candidates that fail to satisfy such testing specifications. For example, we must provide the FDA with the results of certain tests, including potency tests, before certain lots are released for sale. Potency testing of each applicable lot is performed against qualified control lots that we maintain. We continually monitor the status of such reference lots for FDA compliance and periodically produce and qualify a new reference lot to replace the existing reference lot. If we are unable to satisfy USG requirements for the release of our products or product candidates, our ability to supply such products and product candidates to authorized buyers would be impaired until such time as we become able to meet such requirements, which could materially harm our future business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Our operations, including our use of hazardous materials, chemicals, bacteria and viruses, require us to comply with regulatory requirements and expose us to significant potential liabilities.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our operations involve the use of hazardous materials, including chemicals, bacteria and viruses, and may produce dangerous waste products. Accordingly, we, along with the third parties that conduct clinical trials and manufacture our products and product candidates on our behalf, are subject to federal, state, local and foreign laws and regulations that govern the use, manufacture, distribution, storage, handling, exposure, disposal and recordkeeping with respect to these materials. Under the Federal Select Agent Program, pursuant to the Public Health Security and Bioterrorism Preparedness and Response Act, we are required to register with and be inspected by the CDC and the Animal and Plant Health Inspection Service if </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">we have in our possession, or if we use or transfer, select biological agents or toxins that could pose a threat to public health and safety, to animal or plant health or to animal or plant products. This legislation requires stringent safeguards and security measures for these select agents and toxins, including</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">controlled access and the screening of entities and personnel and establishes a comprehensive national database of registered entities. We are also subject to a variety of environmental and occupational health and safety laws. Compliance with current or future laws and regulations can require significant costs and we could be subject to substantial fines and penalties in the event of noncompliance. In addition, the risk of contamination or injury from these materials cannot be completely eliminated. In such event, we could be held liable for substantial civil damages or costs associated with the cleanup of hazardous materials. From time to time, we have been involved in remediation activities and may be so involved in the future. Any related cost or liability might not be fully covered by insurance, could exceed our resources and could have a material adverse effect on our business, financial condition, operating results and cash flows. In addition to complying with environmental and occupational health and safety laws, we must comply with special regulations relating to biosafety administered by the CDC, HHS, U.S. Department of Agriculture and the DoD, as well as regulatory authorities in Canada.</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">RELIANCE ON THIRD PARTIES</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">The loss of any of our non-exclusive, sole-source or single source suppliers or an increase in the price of inventory supplied to us could have an adverse effect on our business, financial condition and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We purchase certain supplies used in our manufacturing processes from non-exclusive, or single sources due to quality considerations, costs or constraints resulting from regulatory requirements, including key components for NARCAN&#174; Nasal Spray. Where a particular single-source supply relationship is terminated, we may not be able to establish additional or replacement suppliers for certain components or materials quickly. This is largely due to the FDA approval system, which mandates validation of materials prior to use in our products, and the complex nature of manufacturing processes. In addition, we may lose a sole-source supplier due to, among other things, the acquisition of such a supplier by a competitor (which may cause the supplier to stop selling its products to us) or the bankruptcy of such a supplier, which may cause the supplier to cease operations. Any reduction or interruption by a sole-source supplier of the supply of materials or key components used in the manufacturing of our products</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">or an increase in the price of those materials or components could adversely affect </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">39</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">our business, financial condition and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Additionally, any failure by us to forecast demand for, or our suppliers to maintain an adequate supply of, the raw material and finished product for producing NARCAN&#174; Nasal Spray could result in an interruption in the supply of NARCAN&#174; Nasal Spray and a decline in sales of the product.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">If we are unable to obtain supplies for the manufacture of our products and product candidates in sufficient quantities, at an acceptable cost and in acceptable quality, our ability to manufacture or to develop and commercialize our products and product candidates could be impaired, which could materially harm our revenues, lead to a termination of one or more of our contracts, lead to delays in clinical trials or otherwise materially harm our business.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We depend on certain single-source suppliers for key materials and services necessary for the manufacture of AV7909, BioThrax, ACAM2000, NARCAN Nasal Spray and our other products and product candidates. For example, we rely on a single-source supplier to provide us with Alhydrogel in sufficient quantities to meet our needs to manufacture BioThrax and AV7909. We also rely on single-source suppliers for the specialty plasma in our hyperimmune specialty plasma products and certain ingredients for ACAM2000. A disruption in the availability of such materials or services from these suppliers or in the quality of the material provided by such suppliers could require us to qualify and validate alternative suppliers. If we are unable to locate or establish alternative suppliers, our ability to manufacture our products and product candidates could be adversely affected and could harm our revenues, cause us to fail to satisfy contractual commitments, lead to a termination of one or more of our contracts or lead to delays in our clinical trials, any of which could be costly to us and otherwise materially harm our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">We depend on third parties to conduct many of our clinical and non-clinical trials. If these third parties do not perform as contractually required or as we expect, we may not be able to obtain regulatory approval for or commercialize our product candidates and, as a result, our business, financial condition, operating results and cash flows may suffer.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We rely on third parties to conduct many of our clinical and non-clinical trials required to obtain regulatory approval for our product candidates. We depend on third parties, such as independent clinical investigators, contract research organizations and other third-party service providers to conduct the clinical and non-clinical trials of our product candidates and expect to continue to do so. We rely heavily on these third parties for successful execution of our clinical and non-</span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">clinical trials, but do not exercise day-to-day control over their activities. Our reliance on these service providers does not relieve us of our regulatory responsibilities, including ensuring that our trials are conducted in accordance with good clinical practice regulations and the plan and protocols contained in the relevant regulatory application. In addition, these organizations may not complete these activities on our anticipated or desired timeframe. We also may experience unexpected cost increases that are beyond our control. Problems with the timeliness or quality of the work of a contract research organization may lead us to seek to terminate the relationship and use an alternative service provider, which may prove difficult, costly and result in a delay of our trials. Any delay in or inability to complete our trials could delay or prevent the development, approval and commercialization of our product candidates.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In certain cases, government entities and non-government organizations conduct studies of our product candidates, and we may seek to rely on these studies in applying for marketing approval for certain of our product candidates. These government entities and non-government organizations have no obligation or commitment to us to conduct or complete any of these studies or clinical trials and may choose to discontinue these development efforts at any time. Furthermore, government entities depend on annual Congressional appropriations to fund their development efforts, which may not be approved.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">If we are unable to obtain any necessary third-party services on acceptable terms or if these service providers do not successfully carry out their contractual duties or meet expected deadlines, our efforts to obtain regulatory approvals for our product candidates may be delayed or prevented.</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">RISKS RELATED TO STRATEGIC ACQUISITIONS AND COLLABORATIONS</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Our strategy of generating growth through acquisitions may not be successful.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our business strategy includes growing our business through acquisition and in-licensing transactions. We may not be successful in identifying, effectively evaluating, structuring, acquiring or in-licensing, and developing and commercializing additional products on favorable terms, or at all. Competition for attractive product opportunities is intense and may require us to devote substantial resources, both managerial and financial, to an acquisition opportunity. A number of more established companies are also pursuing strategies to acquire or in-license products in the biopharmaceutical field. These companies may have a competitive advantage over us due to their size, cash resources, cost of capital, effective tax rate and greater clinical development and commercialization capabilities.</span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">40</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Acquisition efforts can consume significant management attention and require substantial expenditures, which could detract from our other programs. In addition, we may devote significant resources to potential acquisitions that are never completed. Even if we are successful in acquiring a company or product, it may not result in a successfully developed or commercialized product or, even if an acquired product is commercialized, competing products or technologies could render a product noncompetitive, uneconomical or obsolete. Moreover, the cost of acquiring other companies or in-licensing products could be substantial, and in order to acquire companies or new products, we may need to incur substantial debt or issue dilutive securities.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">If we are unsuccessful in our efforts to acquire other companies or in-license and develop additional products, or if we acquire or in-license unproductive assets, it could have a material adverse effect on the growth of our business, and we could be compelled to record significant impairment charges to write-down the carrying value of our acquired intangible assets, which could materially harm our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Our failure to successfully integrate acquired businesses and/or assets into our operations could adversely affect our ability to realize the benefits of such acquisitions and, therefore, to grow our business.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We may not be able to integrate any acquired business successfully or operate any acquired business profitably, including our acquisitions of Adapt and PaxVax. In addition, cost synergies, if achieved at all, may be less than we expect, or may take greater time to achieve than we anticipate.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Issues that could delay or prevent successful integration or cost synergies of an acquired business or products include, among others:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">retaining existing customers and attracting new customers;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">retaining key employees;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">diversion of management attention and resources;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">conforming internal controls, policies and procedures, business cultures and compensation programs;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">consolidating corporate and administrative infrastructures;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">successfully executing technology transfers and obtaining required regulatory approvals;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">consolidating sales and marketing operations;</span></div></td></tr></table></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">identifying and eliminating redundant and underperforming operations and assets;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">assumption of known and unknown liabilities;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">coordinating geographically dispersed organizations; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">managing tax costs or inefficiencies associated with integrating operations.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">If we are unable to successfully integrate pending and future acquisitions with our existing businesses, or operate any acquired business profitably, we may not obtain the advantages that the acquisitions were intended to create, which may materially adversely affect the growth of our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">COMPETITIVE AND POLITICAL RISKS</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">We face substantial competition, which may result in others developing or commercializing products before or more successfully than we do.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The development and commercialization of new biopharmaceutical and medical technology products is highly competitive and subject to rapid technological advances. We may face future competition from other companies and governments, universities and other non-profit research organizations in respect to our products, any products that we acquire, our current product candidates and any products we may seek to develop or commercialize in the future. Our competitors may develop products that are safer, more effective, more convenient or less costly than any products that we may develop or market. Our competitors may have greater resources to devote to marketing or selling their products, adapt more quickly to new technologies, scientific advances or patient preferences and needs, initiate or withstand substantial price competition more successfully than we can, or more effectively negotiate third-party licensing and collaborative arrangements.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">There are a number of companies with products or product candidates addressing PHT preparedness that are competing with us for both USG procurement and development resources. Many of our competitors have greater financial, technical and marketing resources than we do. Our competitors may receive patent protection that dominates, blocks or adversely affects our products or product candidates.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Any reduction in demand for our products or reduction or loss of development funding for our products or product candidates in favor of a competing product could lead to a loss of market share for our products and cause reduced revenues, margins and levels of profitability for us, which could adversely affect our business, financial condition, operating results and cash flows.</span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">41</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Our Biologic Products may face risks of competition from biosimilar manufacturers.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Competition for BioThrax, ACAM2000, and our other biological products and product candidates, including AV7909, otherwise referred to as our &#8220;Biologic Products,&#8221; may be affected by follow-on biologics, or &#8220;biosimilars,&#8221; in the United States and other jurisdictions. Regulatory and legislative activity in the United States and other countries may make it easier for generic drug manufacturers to manufacture and sell biological drugs similar or identical to our Biologic Products, which might affect the profitability or commercial viability of our Biologic Products. Under the Biologics Price Competition and Innovation Act of 2010, the FDA cannot approve a biosimilar application until the 12-year exclusivity period for the innovator biologic has</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">expired. Regulators in the European Union and in other foreign jurisdictions have already approved biosimilars. The specific regulatory framework for this biosimilar approval path and the extent to which an approved biosimilar would be substituted for the innovator biologic are not yet clear and will depend on many factors. If a biosimilar version of one of our Biologic Products were approved, it could have a material adverse effect on the sales and gross profits of the affected Biologic Product and could adversely affect our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">We expect our NARCAN&#174; Nasal Spray marketed product to face future competition from other treatments.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our marketed product NARCAN&#174; Nasal Spray faces potentially substantial competition from other treatments, including injectable naloxone, auto-injectors, nasal sprays or improvised nasal spray kits. In addition, other entrants may seek approval to market generic versions of NARCAN&#174; Nasal Spray before the underlying patents expire. For example, in 2016 Teva filed, and in 2018 Perrigo filed, Abbreviated new Drug Applications with the FDA (ANDAs) which seek</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> regulatory approval to market generic versions of NARCAN&#174; Nasal Spray before the expiration of certain underlying patents and in April 2019, Teva received FDA approval to market its generic version of NARCAN&#174; Nasal Spray. Teva may decide to sell its approved generic product in the market, although we have sued Teva and the litigation has not yet been resolved, so any market launch could subject Teva to the risk of damages for patent infringement. </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Additionally, we are aware that other companies are developing other product candidates containing naloxone that, if successful, would compete with NARCAN Nasal Spray and reduce our market share. In January 2019, the FDA released new proposed template Drug Facts Labels to assist sponsors of investigational naloxone nasal sprays and auto-injectors seeking approval from the FDA for over-the-counter naloxone products. Any reduction in demand for NARCAN&#174; Nasal Spray in favor of a competing product, or unsuccessful </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">efforts to defend underlying patents from infringement by generic entrants, could lead to a loss of market share and cause reduced revenues, margins and levels of profitability for us, which could adversely affect our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Political or social factors may delay or impair our ability to market our products and may require us to spend significant management time and financial resources to address these issues.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Products developed to counter the potential impact of PHTs are subject to changing political and social environments. The political responses and social awareness of the risks of these threats on military personnel or civilians may vary over time. If the threat of terrorism were to decline, then the public perception of the risk on public health and safety may be reduced. This perception, as well as political or social pressures, could delay or cause resistance to bringing our products in development to market or limit pricing or purchases of our products, any of which could negatively affect our revenues and our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition, substantial delays or cancellations of purchases could result from protests or challenges from third parties. Lawsuits brought against us by third parties or activists, even if not successful, could require us to spend significant management time and financial resources defending the related litigation and could potentially damage the public's perception of us and our products. Any publicity campaigns or other negative publicity may adversely affect the degree of market acceptance of our PHT countermeasures and thereby limit the demand for our products, which would adversely affect our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">PRODUCT DEVELOPMENT AND COMMERCIALIZATION RISKS</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Our growth depends on our success in developing and commercializing our product candidates. If we are unable to commercialize these product candidates, or experience significant delays or unanticipated costs in doing so, our business would be materially and adversely affected.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We have invested significant effort and financial resources in the development of our vaccines, therapeutics and medical device product candidates and the acquisition of additional product candidates. In addition to our product sales, our ability to generate revenue is dependent on a number of factors, including the success of our development programs, the USG's interest in providing development funding for or procuring certain of our product candidates, and the commercial viability of our acquired or developed product candidates. The commercial success of our </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">42</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">product candidates will depend on many factors, including accomplishing the following in an economical manner:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">successful development, formulation and cGMP scale-up of manufacturing that meets FDA or other foreign regulatory requirements;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">successful program partnering;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">successful completion of clinical or non-clinical development, including toxicology studies and studies in approved animal models;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">receipt of marketing approvals from the FDA and equivalent foreign regulatory authorities;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">establishment of commercial manufacturing processes and product supply arrangements;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">training of a commercial sales force for the product, whether alone or in collaboration with others;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">successful registration and maintenance of relevant patent and/or other proprietary protection; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">acceptance of the product by potential government and other customers.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Clinical trials of product candidates are expensive and time-consuming, and their outcome is uncertain. We must invest substantial amounts of time and financial resources in these trials, which may not yield viable products. Failure to obtain regulatory approval for product candidates, particularly in the United States, could materially and adversely affect our financial resources, which would adversely affect our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Before obtaining regulatory approval for the marketing of our product candidates, we and our collaborative partners, where applicable, must conduct preclinical studies and clinical trials to establish proof of concept and demonstrate the safety and efficacy of our product candidates. Preclinical and clinical testing is expensive, difficult to design and implement, can take many years to complete and is uncertain as to outcome. Success in preclinical testing and early clinical trials does not ensure that later clinical trials or animal efficacy studies will be successful, and interim results of a clinical trial or animal efficacy study do not necessarily predict final results. An unexpected result in one or more of our clinical trials can occur at any stage of testing.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Preclinical and clinical testing for certain of our product candidates addressing CBRNE threats may face additional difficulties and uncertainties because they cannot ethically or feasibly be tested in human subjects. We therefore expect to rely on the Animal Rule to obtain regulatory approval. The Animal Rule permits, in certain </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">limited circumstances, the use of animal efficacy studies, together with human clinical safety and immunogenicity trials, to support an application for marketing approval. For a product approved under the Animal Rule, certain additional post-marketing requirements apply. For example, to the extent feasible and ethical, applicants must conduct post-marketing studies, such as field studies, to verify and describe the drug's clinical benefit and to assess its safety when used as indicated. We have limited experience in the application of these rules to the product candidates that we are developing. It is possible that results from these animal efficacy studies may not be predictive of the actual efficacy of our product candidates in humans.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Under Project BioShield, the Secretary of HHS can contract to purchase MCMs for the SNS prior to FDA approval of the countermeasure in specified circumstances. Project BioShield also allows the FDA commissioner to authorize the emergency use of medical products that have not yet been approved by the FDA under an EUA. If our product candidates are not selected under this Project BioShield authority, they generally will have to be approved by the FDA through traditional regulatory mechanisms for distribution in the United States.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We may experience unforeseen events or issues during, or as a result of, preclinical testing, clinical trials</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">or animal efficacy studies. These issues and events, which could delay or prevent our ability to receive regulatory approval for a product candidate, include, among others:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;&#160;&#160;&#160;</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">our inability to manufacture sufficient quantities of materials for use in trials;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the unavailability or variability in the number and types of subjects for each study;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">safety issues or inconclusive or incomplete testing, trial or study results;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">drug immunogenicity;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">lack of efficacy of product candidates during the trials;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">government or regulatory restrictions or delays; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">greater than anticipated costs of trials.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">We may fail to select or capitalize on the most scientifically, clinically or commercially promising or profitable product candidates.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We continue to evaluate our product development strategy and, as a result, may modify our strategy in the future. In this regard, we may, from time to time, focus our product development efforts on different product candidates or may delay or halt the development of </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">43</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">various product candidates. We may change or refocus our existing product development, commercialization and manufacturing activities based on government funding decisions. This could require changes in our facilities and our personnel. Any product development changes that we implement may not be successful. In particular, we may fail to select or capitalize on the most scientifically, clinically or commercially promising or profitable product candidates or choose candidates for which government development funds are not available. Our decisions to allocate our research and development, management and financial resources toward particular product candidates or therapeutic areas may not lead to the development of viable commercial products and may divert resources from better business opportunities. Similarly, our decisions to delay or terminate product development programs may also prove to be incorrect and could cause us to miss valuable opportunities.</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">INTELLECTUAL PROPERTY RISKS</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">If we are unable to protect our proprietary rights, our business, financial condition, operating results, and cash flows could be materially harmed.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our success will depend, in large part, on our ability to obtain and maintain protection in the United States and other countries for the intellectual property incorporated into or covering our technology, products, and product candidates. Obtaining and maintaining protection of our intellectual property is very costly. The patentability of technology in the biopharmaceutical field generally is highly uncertain and involves complex legal and scientific questions.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We may not be able to obtain additional issued patents relating to our technology or products. Even if issued, patents may inadvertently lapse or be challenged, narrowed, invalidated, or circumvented, and such happenings could limit our ability to stop competitors from marketing similar products or limit the duration of patent protection we may have for our products. In the past, we have abandoned the prosecution and/or maintenance of patent applications related to patent families in the ordinary course of business. In the future we may choose to abandon such prosecution and/or maintenance in a similar fashion. If these patent rights are later determined to be valuable or necessary to our business, our competitive position may be adversely affected. Changes in patent laws or administrative patent office rules or changes in interpretations of patent laws in the United States and in other countries may diminish the value of our intellectual property, narrow the scope of our patent protection, or result in costly defensive measures. In addition, some countries do not grant patent claims directed to methods of treating humans and, in these countries, patent protection may not be available at all to protect our products or product candidates.</span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Changes to the U.S. patent system under the Leahy-Smith America Invents Act (the America Invents Act), affected the way patent applications are filed, prosecuted and litigated. For example, the America Invents Act enacted proceedings involving post-issuance patent review procedures, such as inter parties review (IPR) post-grant review (PGR) and covered business methods review (CBM). These proceedings are conducted before the Patent Trial and Appeal Board (the PTAB) of the U.S. Patent and Trademark Office. Each proceeding has different eligibility criteria and different patentability challenges</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">that can be raised. In this regard, the IPR process permits any person (except a party who has been litigating the patent for more than a year) to challenge the validity of some patents on the grounds that it was anticipated or made obvious by prior art. As a result, non-practicing entities associated with hedge funds, pharmaceutical companies who may be our competitors and others have challenged certain valuable pharmaceutical U.S. patents based on prior art through the IPR process. A decision in such a proceeding adverse to our interests could result in the loss of valuable patent rights which would have a material adverse effect on our business, financial condition, results of operations and growth prospects. The America Invents Act and any other potential future changes to the U.S. patent system could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations and growth prospects.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The cost of litigation to uphold the validity of patents to prevent or stop infringement or to otherwise protect or enforce our proprietary rights could be substantial and, from time to time, our patents may be subjected to opposition proceedings or validity challenges. Some of our competitors may choose to or be better able to sustain the costs of complex patent litigation. Intellectual property lawsuits are expensive and unpredictable and consume management's time and attention and other resources, even if the outcome is successful. In addition, there is a risk that a court could decide that our patents are not valid, are unenforceable, or are not infringed by a competitor product. There is also a risk that, even if the validity of a patent is upheld, a court could refuse to stop the other party from using the invention(s), including on the grounds that its activities do not infringe the patent. If any of these events occur, our business, financial condition, operating results and cash flows could be materially and adversely affected.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our collaborators and licensors may not adequately protect our intellectual property rights. These third parties may have the first right to maintain or defend intellectual property rights in which we have an interest and, although we may have the right to assume the </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">44</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">maintenance and defense of such intellectual property rights if these third parties do not do so, our ability to maintain and defend such intellectual property rights may be compromised by the acts or omissions of these third parties. For example, we license from Opiant Pharmaceuticals, Inc. formulations of naloxone used in our NARCAN&#174; Nasal Spray.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We also will rely on current and future trademarks to establish and maintain recognized brands. If we fail to acquire and protect such trademarks, our ability to market and sell our products, and therefore our business, financial condition, operating results, and cash flows could be materially and adversely affected.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Third parties may choose to file patent infringement claims against us; defending ourselves from such allegations could be costly, time-consuming, distracting to management, and could materially and adversely affect our business, financial condition, operating results, and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our development and commercialization activities, as well as any product candidates or products resulting from these activities, may infringe or be claimed to infringe patents and other intellectual property rights of third parties for which we do not hold sufficient licenses or other rights. Additionally, third parties may be successful in obtaining patent protection for technologies that cover development and commercialization activities in which we are already engaged. Third parties may own or control these patents and intellectual property rights in the United States and abroad. These third parties could bring claims against us that could cause us to incur substantial expenses to defend against these claims and, if successful against us, could cause us to pay substantial damages. Further, if a patent infringement or other similar suit is brought against us, we could be forced to stop or delay development, manufacturing, or sales of the product or product candidate that is the subject of the suit. Intellectual property litigation in the biopharmaceutical industry is common, and we expect this trend to continue.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As a result of patent infringement or other similar claims, or to avoid potential claims, we may choose or be required to seek a license from a third party and be required to pay license fees or royalties or both. These licenses may not be available on acceptable terms, or at all. Even if we are able to obtain a license, the rights may be non-exclusive, which could result in our competitors gaining access to the same intellectual property. Ultimately, we could be prevented from commercializing a product, or be forced to cease some aspect of our business operations. If, as a result of actual or threatened patent infringement claims, we</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">are unable to enter into licenses on acceptable terms, if at all, or if an injunction is granted against us, these could materially harm our business, financial condition, operating results, and cash flows.</span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">If we fail to comply with our obligations in our intellectual property licenses with third parties, we could lose license rights that are important to our business.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We are a party to a number of license agreements and expect to enter into additional license agreements in the future. Our existing licenses impose, and we expect future licenses will impose, various diligence, milestone payment, royalty, insurance, and other obligations on us. If we fail to comply with these obligations, the licensor may have the right to terminate the license and/or sue us for breach, which could cause us to not be able to market any product that is covered by the license and subject us to damages, which may be material.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">If we are unable to protect the confidentiality of our proprietary information and know-how, the value of our technology and products could be adversely affected.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We also rely upon unpatented proprietary technology, processes, and know-how, particularly as to our proprietary manufacturing processes. Because we do not have patent protection for all of our current products, our only other intellectual property protection for products, other than trademarks, is confidentiality regarding our manufacturing capability and specialty know-how, such as techniques, processes, and unique starting materials. However, these types of confidential information and trade secrets can be difficult to protect. We seek to protect this confidential information, in part, through agreements with our employees, consultants, and third parties, as well as confidentiality policies and audits, although these may not be successful in protecting our trade secrets and confidential information.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">These agreements may be breached, and we may not have adequate remedies for any such breach. In addition, our trade secrets may otherwise become known, including through a potential cyber security breach, or may be independently developed by competitors. If we are unable to protect the confidentiality of our proprietary information and know-how, or if others independently develop our proprietary information or processes, competitors may be able to use this information to develop products that compete with our products, which could materially and adversely impact our business.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">One or more of our products could be subject to early competition from generic drugs and biosimilars.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">One or more of our products is approved as a drug product under the provisions of the U.S. Food, Drug and Cosmetic Act (FDCA), which renders it susceptible to potential competition from generic manufacturers via the Hatch-Waxman Act and ANDA process. Generic manufacturers pursuing ANDA approval are not required to conduct costly and time-consuming clinical trials to establish the safety and efficacy of their products; rather, they are permitted to rely on the innovator&#8217;s data </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">45</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">regarding safety and efficacy. Additionally, generic drug companies generally do not expend significant sums on sales and marketing activities, instead relying on pharmacists or payers to substitute the generic form of a drug for the branded form. Thus, generic manufacturers can sell their products at prices much lower than those charged by the innovative pharmaceutical or biotechnology companies who have incurred substantial expenses associated with the research and development of the drug product and who must spend significant sums marketing a new drug.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The ANDA procedure includes provisions allowing generic manufacturers to challenge the innovator&#8217;s patent protection by submitting &#8220;Paragraph IV&#8221; certifications to the FDA in which the generic manufacturer claims that the innovator&#8217;s patents are invalid, unenforceable, and/or will not be infringed by the manufacture, use, or sale of the generic product. A patent owner who receives a Paragraph IV certification may choose to sue the generic applicant for patent infringement. If the patent owner files suit within 45 days of receiving notice from an ANDA filer, the patent owner is entitled to receive a 30 month stay on the FDA&#8217;s ability to give final approval for the generic product that is the subject of the ANDA.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In recent years, generic manufacturers have used Paragraph IV certifications extensively to challenge the validity of patents listed in the FDA&#8217;s Approved Drug Products List with Therapeutic Equivalence Evaluations, commonly referred to as the Orange Book, on a wide array of innovative therapeutic products. We expect this trend to continue and to affect drug products with even relatively modest revenues.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Although we intend to vigorously enforce our intellectual property rights, there can be no assurance</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">that we will prevail in our enforcement or defense of our patent rights. Our existing patents could be invalidated, found unenforceable, or found not to cover a generic form of our product.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Further, the 2010 Patient Protection and Affordable Care Act, which was signed into law on March 23, 2010, included a subtitle called the Biologics Price Competition and Innovation Act of 2009 (BPCIA). That Act established a regulatory scheme authorizing the FDA to approve biosimilars and interchangeable biosimilars. As of January 15, 2020, the FDA has approved thirty six biosimilar products for use in the United States. No interchangeable biosimilars, have been approved. The FDA has issued several guidance documents outlining approaches for review and approval of biosimilars. </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Under the Act, a manufacturer may apply for licensure of a biologic product that is &#8220;biosimilar to&#8221; or &#8220;interchangeable with&#8221; a previously approved biological product or &#8220;reference product.&#8221; In order for the FDA to approve a biosimilar product, it must find that there are no clinically meaningful differences between the </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">reference product and proposed biosimilar product in terms of safety, purity and potency. For the FDA to approve a biosimilar product as interchangeable with a reference product, the agency must find that the biosimilar product can be expected to produce the same clinical results as the reference product, and (for products administered multiple times) that the biologic and the reference biologic may be switched after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive use of the reference biologic.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four years following the date of approval of the reference product. The FDA may not approve a biosimilar product until 12 years from the date on which the reference product was approved. Even if a product is considered to be a reference product eligible for exclusivity, another company could market a competing version of that product if the FDA approves a full BLA for such product containing the sponsor&#8217;s own preclinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity and potency of their product. The BPCIA also created certain exclusivity periods for biosimilars approved as interchangeable products. At this juncture, it is unclear whether products deemed &#8220;interchangeable&#8221; by the FDA will, in fact, be readily substituted by pharmacies, which are governed by state pharmacy law.</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">FINANCIAL RISKS</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">We have incurred significant indebtedness in connection with our acquisitions and servicing our debt requires a significant amount of cash. We may not have sufficient cash flow from our operations to pay our substantial debt.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our ability to make scheduled payments of the principal of, to pay interest on or to refinance our indebtedness depends on our future performance, which is subject to economic, financial, competitive and other factors beyond our control. We may also seek additional debt financing to support our ongoing activities or to provide additional financial flexibility. Debt financing could have significant adverse consequences for our business, including:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">requiring us to dedicate a substantial portion of any cash flow from operations to payment on our debt, which would reduce the amounts available to fund other corporate initiatives;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">increasing the amount of interest that we have to pay on debt with variable interest rates, if market rates of interest increase, to the extent we are unable to offset the risk of such increases through our hedging instruments;</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">46</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">subjecting us, as under our senior secured credit facilities, to restrictive covenants that may reduce our ability to take certain corporate actions, acquire companies, products or technology, or obtain further debt financing;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">requiring us to pledge our assets as collateral, which could limit our ability to obtain additional debt financing;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">limiting our flexibility in planning for, or reacting to, general adverse economic and industry conditions; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">placing us at a competitive disadvantage compared to our competitors that have less debt, better debt servicing options or stronger debt servicing capacity.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We may not have sufficient funds or be able to obtain additional financing to pay the amounts due under our indebtedness. In addition, failure to comply with the covenants under our senior secured credit facilities and other debt agreements could result in an</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">event of default under those agreements. An event of default could result in the acceleration of amounts due under a particular debt agreement and a cross default and acceleration under other debt agreements, and we may not have sufficient funds to pay or be able to obtain additional financing to make any accelerated payments. Under these circumstances, our lenders could seek to enforce security interests in our assets securing our indebtedness.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Our current indebtedness and any additional debt financing may restrict the operation of our business and limit the cash available for investment in our&#160;business operations.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In connection with the acquisition of Adapt, we entered into an amendment and restatement of our 2017 credit agreement to provide for new five-year syndicated senior secured credit facilities that replaced our existing facility. The senior secured credit facilities include a </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$450 million</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Term Loan and the ability to borrow up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$600 million</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> with a revolving credit facility, of which we had outstanding borrowings of approximately $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">436 million</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">373 million</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, as of December 31, 2019. We may also seek additional debt financing to support our ongoing activities or to provide additional financial flexibility. Debt financing could have significant adverse consequences for our business, including:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the level, timing and cost of product sales and contract development and manufacturing services;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the extent to which we acquire or invest in and integrate companies, businesses, products or technologies;</span></div></td></tr></table></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the acquisition of new facilities and capital improvements to new or existing facilities;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the payment obligations under our indebtedness;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the scope, progress, results and costs of our development activities;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">our ability to obtain funding from collaborative partners, government entities and non-governmental organizations for our development programs;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the extent to which we repurchase additional common stock under a new</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> share repurchase program; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the costs of commercialization activities, including product marketing, sales and distribution.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We may not have sufficient funds or be able to obtain additional financing to pay the amounts due under our indebtedness. In addition, failure to comply with the covenants under our debt agreements could result in an event of default under those instruments. An event of default could result in the acceleration of amounts due under a particular debt agreement and a cross default and acceleration under other debt agreements, and we may not have sufficient funds or be able to obtain additional financing to make any accelerated payments. Under these circumstances, our lenders could seek to enforce security interests in our assets securing our indebtedness.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">Our </span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">hedging </span><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">program is subject to counterparty default risk.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We manage our interest rate risk in part by entering into interest rate swaps with a number of counterparties to swap a portion of our indebtedness that is based on variable interest rates to a fixed rate. As a result, we are subject to the risk that the counterparty to one or more of these contracts defaults on its performance under the contract. During an economic downturn, the counterparty's financial condition may deteriorate rapidly and with little notice and we may be unable to take action to protect our exposure. In the event of a counterparty default, we could incur losses, which may harm our business and financial condition. In the event that one or more of our counterparties becomes insolvent or files for bankruptcy, our ability to eventually recover any losses suffered as a result of that counterparty's default may be limited by the liquidity of the counterparty.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">We may require significant additional funding and may be unable to raise capital when&#160;needed or on acceptable terms, which would harm our ability to grow </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">47</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">our business, and our results of operations and financial condition.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">If our capital resources are insufficient to meet our future capital requirements, we will need to finance our cash needs through public or private equity or debt offerings, bank loans or collaboration and licensing arrangements. In August 2018, we filed an automatic shelf registration statement, which immediately became effective under SEC rules. For so long as we continue to satisfy the requirements to be deemed a &#8220;well-known seasoned issuer&#8221; under SEC rules (which</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">include, among other things, the timely filing of our reports under the Exchange Act and maintenance of at least $700 million of public float or issuing an aggregate amount of $1 billion of non-convertible securities, other than common stock, in registered offerings for cash during the past three years), this shelf registration statement, effective until August 8, 2021, allows us to issue an unrestricted amount of equity, debt and certain other types of securities through one or more future primary or secondary offerings. If we do not file a new shelf registration statement prior to August 8, 2021, the existing shelf registration statement will expire, and we will not be able to publicly raise capital or issue debt until a new registration statement is filed and becomes effective. There can be no assurance that we will be eligible to file an automatically effective shelf registration statement at a future date when we may need to raise funds publicly.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">If we raise funds by issuing equity securities, our stockholders may experience dilution. Public or bank debt financing, if available, may involve agreements that include covenants, like those contained in our senior secured credit facilities, limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, pursuing acquisition opportunities or declaring dividends. If we raise funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish valuable rights to our technologies or product candidates or grant licenses on terms that may not be favorable to us. We are not restricted under the terms of the indenture governing our 2.875% Convertible Senior Notes due 2021 (Senior Convertible Notes) from incurring additional debt, securing existing or future debt, recapitalizing our debt or taking a number of other actions that could have the effect of diminishing our ability to make payments on our indebtedness. However, our senior secured credit facilities restrict our ability to incur additional indebtedness, including secured indebtedness.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Economic conditions may make it difficult to obtain financing on attractive terms, or at all. If financing is unavailable or lost, our business, operating results, financial condition and cash flows would be adversely affected, and we could be forced to delay, reduce the scope of or eliminate many of our planned activities.</span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">We may not maintain profitability in future periods or on a consistent basis.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Although we have been profitable for each of the last five fiscal years, we have not been profitable for every quarter during that time. Our profitability has been substantially dependent on product sales, which historically have fluctuated significantly from quarter to quarter, and we expect that they will continue to fluctuate significantly based primarily on the timing of our fulfillment of orders from the USG. We may not be able to achieve consistent profitability on a quarterly basis or sustain or increase profitability on an annual basis.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">The expansion of our international operations increases our risk of exposure to credit losses.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As we continue to expand our business activities with foreign governments in certain countries that have experienced deterioration in credit and economic conditions or otherwise, our exposure to uncollectible accounts will rise. Global economic conditions and liquidity issues in certain countries have resulted and may continue to result in delays in the collection of accounts receivables and may result in credit losses. Future governmental actions and customer specific actions may require us to re-evaluate the collectability of our accounts receivable and we may potentially incur credit losses that may materially impact our operating results.</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">OTHER BUSINESS RISKS</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">We face product liability exposure, which could cause us to incur substantial liabilities and negatively affect our business, financial condition and results of operations.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We face an inherent risk of product liability exposure related to the sale of our products, any other products that we successfully acquire or develop and the testing of our product candidates in clinical trials.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">One measure of protection against such lawsuits is coverage under the PREP Act, which was signed into law in December 2005. The PREP Act creates liability protection for manufacturers of biodefense countermeasures when the Secretary of HHS issues a declaration for their manufacture, administration or use. A PREP Act declaration is meant to provide liability protection from all claims under federal or state law for loss arising out of the administration or use of a covered countermeasure under a government contract. The Secretary of HHS has issued PREP Act declarations identifying certain of our products, namely BioThrax, ACAM2000, raxibacumab, Anthrasil, BAT and VIGIV, as covered countermeasures. These declarations expire</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">in</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2022. Manufacturers are not entitled to protection under the PREP Act in cases of willful misconduct or for cases brought in non-U.S. tribunals or under non-U.S. law. We cannot predict whether the Secretary of HHS will renew the declarations when they expire, whether Congress will fund the relevant PREP Act compensation </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">48</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">programs, or whether the necessary prerequisites for immunity would be triggered with respect to our products or product candidates.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Additionally, certain of our products, namely BioThrax and RSDL, are certified anti-terrorism products covered under the protections of the Support Anti-Terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). The SAFETY Act creates product liability limitations for qualifying anti-terrorism technologies for claims arising from or related to an act of terrorism. Although we are entitled to the benefits of the SAFETY Act for BioThrax and RSDL, the SAFETY Act may not provide adequate protection from claims made against us.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">If we cannot successfully defend ourselves against future claims that our products or product candidates caused injuries and if we are not entitled to indemnity by the USG, or the USG does not honor its obligations to us under the PREP Act or SAFETY Act, or if the liability protections under the PREP Act and SAFETY Act are not adequate to cover all claims, we may incur substantial liabilities. Regardless of merit or eventual outcome, product liability claims may result in:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">decreased demand or withdrawal of a product;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">injury to our reputation;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">withdrawal of clinical trial participants;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">costs to defend the related litigation;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">substantial monetary awards to trial participants or patients;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">loss of revenue; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">an inability to commercialize products that we may develop.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The amount of insurance that we currently hold may not be adequate to cover all liabilities that we may incur. Further product liability insurance may be difficult and expensive to obtain. We may not be able to maintain insurance coverage at a reasonable cost and we may not be able to obtain insurance coverage that will be adequate to satisfy all potential liabilities. For example, we may not have sufficient insurance against potential liabilities associated with a possible large-scale deployment of BioThrax as a countermeasure to a bioterrorism threat. We rely on PREP Act protection for BioThrax, raxibacumab, ACAM2000, Anthrasil, BAT and VIGIV, and SAFETY Act protection for BioThrax and RSDL in addition to our insurance coverage to help mitigate our product liability exposure for these products. Additionally, potential product liability claims related to our commercial products, including NARCAN&#174; Nasal Spray, Vivotif and Vaxchora, may be made by patients, </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">health care providers or others who sell or consume these products. Such claims may be made even with respect to those products that possess regulatory approval for commercial sale. Claims or losses in excess of our product liability insurance coverage could have a material adverse effect on our business, financial condition, operating results and cash flows.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">The accuracy of our financial reporting depends on the effectiveness of our internal control over financial reporting. A material weakness in our internal control over financial reporting could have an adverse effect on our business and financial results and our ability to meet our reporting obligations could be negatively affected, each of which could negatively affect the trading price of our common stock.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Internal control over financial reporting can provide only reasonable assurance with respect to the preparation and fair presentation of financial statements and may not prevent or detect misstatements. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. Failure to maintain effective internal control over financial reporting, or lapses in disclosure controls and procedures, could impact our financial information and disclosures, require significant resources to remediate, and expose us to legal or regulatory proceedings.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We regularly review and update our internal controls and disclosure controls and procedures. In addition, we are required under the Sarbanes-Oxley Act of 2002 to report annually on our internal control over financial reporting. Our system of internal controls, however well-designed, can provide only reasonable, not absolute, assurances that the objectives of the system are met. If we, or our independent registered public accounting firm, determine that our internal controls over financial reporting, or the internal controls of other companies we may acquire, are not effective, or we discover areas that need improvement in the future, these shortcomings could have an adverse effect on our business and financial reporting, and the trading price of our common stock could be negatively affected.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">We rely significantly on information technology systems and any failure, inadequacy, interruption or security lapse of that technology, including any cyber security incidents, could harm our ability to operate our business effectively or result in data leakage of proprietary and confidential business and employee information.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our business is increasingly dependent on critical, complex and interdependent information technology systems, including Internet-based systems, to support business processes as well as internal and external </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">49</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">communications. The size and complexity of our computer systems make them potentially vulnerable to interruption, invasion, computer viruses, destruction, malicious intrusion and additional related disruptions, which may result in the impairment of production and key business processes.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition, our systems are potentially vulnerable to data security breaches-whether by employee error, malfeasance or other disruption-which may expose sensitive data to unauthorized persons. Such data security breaches could lead to the loss of trade secrets or other intellectual property or could lead to the public exposure of personal information, including sensitive personal information, of our employees, clinical trial patients, customers and others.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">A significant business disruption or a breach in security resulting in misappropriation, theft or sabotage with respect to our proprietary and confidential business and employee information could result in financial, legal, business or reputational harm to us, any of which could materially and adversely affect our business, financial condition and operating results.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Our success is dependent on our continued ability to attract, motivate and retain key personnel, and any failure to attract or retain key personnel may negatively affect our business.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Because of the specialized scientific nature of our business, our ability to develop products and to compete with our current and future competitors largely depends upon our ability to attract, retain and motivate highly qualified managerial and key scientific and technical personnel. If we are unable to retain the services of one or more of the principal members of senior management or other key employees, our ability to implement our business strategy could be materially harmed. We face intense competition for qualified employees from biopharmaceutical companies, research organizations and academic institutions. Attracting, retaining or replacing these personnel on acceptable terms may be difficult and time-consuming given the high demand in our industry for similar personnel. We believe part of being able to attract, motivate and retain personnel is our ability to offer a competitive compensation package, including equity incentive awards.  If we cannot offer a competitive compensation package to attract and retain the qualified personnel necessary for the continued development of our business, we may not be able to maintain our operations or grow our business.</span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">RISKS RELATED TO OWNERSHIP OF OUR COMMON STOCK</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Fuad El-Hibri, executive chairman of our Board of Directors, has significant influence over us through his substantial beneficial ownership of our common stock, including an ability to influence the election of the </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">members of our Board of Directors, or delay or prevent a change of control of us.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Mr. El-Hibri has the ability to significantly influence the election of the members of our Board of Directors due to his substantial beneficial ownership of our common stock. As of January 31, 2020, Mr. El-Hibri was the beneficial owner of approximately 11% of our outstanding common stock. As a result, Mr. El-Hibri could exercise substantial influence over all corporate actions requiring board or stockholder approval, including a change of control, or any amendment of our certificate of incorporation or by-laws. The control by Mr. El-Hibri may prevent other stockholders from influencing significant corporate decisions. In addition, Mr. El-Hibri's significant beneficial ownership of our shares could present the potential for a conflict of interest.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Provisions in our certificate of incorporation and by-laws and under Delaware law may discourage acquisition proposals, delay a change in control or prevent transactions that stockholders may consider favorable.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Provisions in our certificate of incorporation and by-laws may discourage, delay or prevent a merger, acquisition or other changes in control that stockholders may consider favorable, including transactions in which stockholders might otherwise receive a premium for their shares. These provisions may also prevent or frustrate attempts by our stockholders to replace or remove our management.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">These provisions include:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the classification of our directors;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">limitations on changing the number of directors then in office;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">limitations on the removal of directors;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">limitations on filling vacancies on the board;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">advance notice requirements for stockholder nominations of candidates for election to the Board of Directors and other proposals;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the inability of stockholders to act by written consent;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the inability of stockholders to call special meetings; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:5px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the ability of our Board of Directors to designate the terms of and issue a new series of preferred stock without stockholder approval.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The affirmative vote of holders of our capital stock representing at least 75% of the voting power of all outstanding stock entitled to vote is required to amend or repeal the above provisions of our certificate of incorporation. The affirmative vote of either a majority of the directors present at a meeting of our Board of </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">50</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Directors or holders of our capital stock representing at least 75% of the voting power of all outstanding stock entitled to vote is required to amend or repeal our by-laws.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition, we are subject to Section 203 of the Delaware General Corporation Law (Section 203). In general and subject to certain exceptions, Section 203 prohibits a publicly-held corporation from engaging in a business combination with an interested stockholder, generally a person which, together with its affiliates, owns or within the last three years has owned 15% or more of the corporation's voting stock, for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. Accordingly, Section 203 may discourage, delay or prevent a change in control of us.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Our Board of Directors may implement a new stockholder rights plan without stockholder approval, which could prevent a change in control of us in instances in which some stockholders may believe a change in control is in their best interests.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our Board of Directors may implement a stockholder rights plan without stockholder approval. We previously implemented a stockholder rights plan, which expired on November 14, 2016. Under our prior stockholder rights plan, we issued to each of our stockholders one preferred stock purchase right for each outstanding share of our common stock. Each right, when exercisable, would have entitled its holder to purchase from us a unit consisting of one one-thousandth of a share of series A junior participating preferred stock at a purchase price of $150 in cash, subject to adjustments. Our stockholder rights plan was intended to protect stockholders in the event of an unfair or coercive offer to acquire us and to provide our Board of Directors with adequate time to evaluate unsolicited offers.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our Board of Directors may implement a new stockholder rights plan, which may have anti-takeover effects, potentially preventing a change in control of us in instances in which some stockholders may believe a change in control is in their best interests. This could cause substantial dilution to a person or group that attempts to acquire us on terms that our Board of Directors does not believe are in our best interests or those of our stockholders and may discourage, delay or prevent a merger or acquisition that stockholders may consider favorable, including transactions in which stockholders might otherwise receive a premium for their shares.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Our stock price is volatile, and purchasers of our common stock could incur substantial losses.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our stock price has been, and is likely to continue to be, volatile. The market price of our common stock could fluctuate significantly for many reasons, including </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">in response to the risks described in this &#8220;Risk Factors&#8221; section, or for reasons unrelated to our operations, such as reports by industry analysts, investor perceptions or negative announcements by our customers, competitors or suppliers regarding their own performance, as well as industry conditions and general financial, economic and political instability. From November 15, 2006, when our common stock</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">first began trading on the New York Stock Exchange, through February 14, 2020, our common stock has traded as high as $73.89 per share and as low as $4.17 per share. The stock market in general as well as the market for biopharmaceutical companies in particular has experienced extreme volatility that has often been unrelated to the operating performance of particular companies. The market price of our common stock may be influenced by many factors, including, among others:</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">contracts, decisions and procurement policies by the USG affecting BioThrax and our other products and product candidates;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the success of competitive products or technologies;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">results of clinical and non-clinical trials of our product candidates;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">announcements of acquisitions, financings or other transactions by us;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">litigation or legal proceedings;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">public concern as to the safety of our products;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">termination or delay of a development program;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the recruitment or departure of key personnel;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">variations in our product revenue and profitability; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the other factors described in this &#8220;Risk Factors&#8221; section.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">Because we currently do not pay dividends, investors will benefit from an investment in our common stock only if it appreciates in value.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We currently do not pay dividends on our common stock. Our senior secured credit facilities limit and any future debt agreements that we enter into may limit our ability to pay dividends. As a result, capital appreciation, if any, of our common stock will be the sole source of gain for our stockholders for the foreseeable future.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Medium,sans-serif;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;">A significant portion of our shares may be sold into the market at any time. This could cause the market price of our common stock to drop significantly.</span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">51</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Sales of a substantial number of shares of our common stock in the public market could occur at any time. These sales or the perception in the market that the holders of a large number of shares intend to sell shares could reduce the market price of our common stock. Moreover, holders of an aggregate of approximately 6 million shares of our common stock </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">outstanding as of December 31, 2019, have the right to require us to register these shares of common stock under specified circumstances.</span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div><a id="s55BF7CC9268051C1AC4852159FAF6D05"></a></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 1B. UNRESOLVED STAFF COMMENTS</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Not applicable.</span></div></div></div><div><a id="s5D8AB018A609509798B0A6F29B50BAA3"></a></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 2. PROPERTIES</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We own and lease approximately 1.8 million square feet of building space for development and manufacturing, laboratories, fill/finish facility services, offices and warehouse space for the conduct of our businesses at 19 locations in North America and Europe. Properties that have been leased expire on various dates between 2020 to 2034. Principal locations include:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:26%;"></td><td style="width:49%;"></td><td style="width:13%;"></td><td style="width:12%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Location</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Use</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Approximate square feet</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Owned/leased</span></div></td></tr><tr><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Bern, Switzerland</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">This location houses manufacturing operations for our Vaccines business unit and drug substance for our CDMO business unit, as well as office and laboratory space.</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">511,000</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Owned</span></div></td></tr><tr><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lansing, Michigan </span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">This location houses manufacturing operations, office space and laboratory space. The manufacturing capabilities are central to our Vaccines business unit and provide our CDMO business unit with capability for both small- and large- scale biologics bulk product manufacturing. </span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">336,000</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Owned</span></div></td></tr><tr><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Winnipeg, Manitoba, Canada</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">This location houses manufacturing operations, office space and laboratory space.  It is the primary location for product development and manufacturing for our Therapeutics business unit, supports our Devices business unit and is actively engaged in plasma-derived hyperimmune therapeutics manufacturing, chromatography-based plasma fractionation, downstream processing, aseptic filling, packaging and warehousing, quality assurance and control.  It also supports our CDMO business unit.</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">315,000</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Owned</span></div></td></tr><tr><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gaithersburg, Maryland </span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">This location houses research operations and office space for our facilities and laboratory space for our CDMO business unit.</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">173,000</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Owned</span></div></td></tr><tr><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Baltimore, Maryland (Bayview)</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">This location houses manufacturing facilities, office and laboratory space.  The facilities at this location are designed to take advantage of single-use bioreactor technology and to be capable of manufacturing several different products, including products derived from cell culture or microbial systems.  It focuses primarily on disposable manufacturing for viral and non-viral products and is one of three centers designated by HHS as a CIADM facility to provide advanced development and manufacturing of MCMs to support the USG&#8217;s national security and public health emergency needs. It has also been and will continue to be marketed to non-USG CDMO clients in need of bulk manufacturing services.</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">112,000</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Owned</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">52</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:26%;"></td><td style="width:49%;"></td><td style="width:13%;"></td><td style="width:12%;"></td></tr><tr><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Baltimore, Maryland (Camden)</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">This location houses fill/finish manufacturing facilities for our CDMO business unit.  It provides pharmaceutical product development and filling services for injectable and other sterile products, as well as process design, technical transfer, manufacturing validations, laboratory support, aseptic filling, lyophilization, final packaging and accelerated and ongoing stability studies support. It is an approved manufacturing facility under the regulatory regimes in the United States, Canada, Japan, Brazil, the Middle East and various other countries and has provided manufacturing services. The facility includes warehousing space used for cold-storage and freezer capacity to support contract manufacturing customers.  </span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">86,900 (Owned); 41,000 (Leased)</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Owned/Leased</span></div></td></tr><tr><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Rockville, Maryland</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">This facility is a cGMP live viral fill/finish facility, which is an FDA-registered manufacturing facility under the regulatory regimes of the United States, Australia and Singapore, which supports our Therapeutics and CDMO business units. It also houses office and warehouse space.</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">59,000</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Leased</span></div></td></tr><tr><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Canton, Massachusetts</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">This location houses manufacturing operations for our Vaccines and CDMO business units. </span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">57,000</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Owned</span></div></td></tr><tr><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">San Diego, California</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">This location houses fill/finish manufacturing facilities for our Vaccines business unit.</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">30,000</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Leased</span></div></td></tr><tr><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Canton, Massachusetts</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">This location houses warehouse space.</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">27,000</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Leased</span></div></td></tr><tr><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Hattiesburg, Mississippi</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">This location houses a packaging facility for our Devices and CDMO business units.</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8,900</span></div></td><td style="vertical-align:top;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Leased</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Each property is considered to be in good condition, adequate for its purpose, and suitably utilized according to the individual nature and requirements of the relevant operations. Our policy is to improve and replace property as considered appropriate to meet the needs of the individual operations.</span></div><div><a id="sCC5F567C1C2D53769F91B5B49B10FDDA"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 3.&#160; LEGAL PROCEEDINGS</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">ANDA Litigation - Perrigo 4mg</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On September 14, 2018,  Adapt Pharma Inc.,  Adapt Pharma Operations Limited and Adapt Pharma Ltd., (collectively, Adapt Pharma), and Opiant Pharmaceuticals, Inc. (Opiant), received notice from Perrigo UK FINCO Limited Partnership (Perrigo), that Perrigo had filed an Abbreviated New Drug Application, (ANDA), with the United States Food and Drug Administration, seeking regulatory approval to market a generic version of NARCAN&#174;(naloxone hydrochloride) Nasal Spray 4mg/spray before the expiration of U.S. Patent Nos. 9,211,253, (the '253 Patent), 9,468,747 (the &#8216;747 Patent), 9,561,177, (the &#8216;177 Patent), 9,629,965, (the &#8216;965 Patent) and 9,775,838 (the &#8216;838 Patent). On or about October 25, 2018, Perrigo sent a subsequent notice letter relating to U.S. Patent No. 10,085,937 (the 937 Patent). Perrigo&#8217;s notice letters assert that its generic product will not infringe any valid and enforceable claim of these patents.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On October 25, 2018, Emergent BioSolutions&#8217; Adapt Pharma subsidiaries and Opiant (collectively, Plaintiffs) filed a complaint for patent infringement of </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the &#8216;253, &#8216;747, &#8216;177, &#8216;965, and the &#8216;838 Patents against Perrigo in the United States District Court for the District of New Jersey arising from Perrigo&#8217;s ANDA filing with the FDA. Plaintiffs filed a second complaint against Perrigo on December 7, 2018, for the infringement of the &#8216;937 Patent.&#160; On February 12, 2020, Adapt Pharma and Perrigo entered into a settlement agreement to resolve  the ongoing litigation. Under the terms of the settlement, Perrigo has received a non-exclusive license under Adapt Phama's patents to make, have made, and market its generic naxolone hydrochloride nasal spray under its own ANDA.  Perrigo's license will be effective as of January 5, 2033 or earlier under certain circumstances including circumstances related to the outcome of the current litigation against Teva (as defined below) or litigation against future ANDA filers. The Perrigo settlement agreement is subject to review by the U.S. Department of Justice and the Federal Trade Commission, and entry of an order dismissing the litigation by the U.S. District Court for the District of New Jersey. </span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">ANDA Litigation - Teva 2mg</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On or about February 27, 2018, Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant received notice from Teva Pharmaceuticals Industries Ltd. and Teva Pharmaceuticals USA, Inc. (collectively, Teva) that Teva had filed an ANDA with the FDA seeking regulatory approval to market a generic version of NARCAN&#174; (naloxone hydrochloride) Nasal Spray 2 mg/spray before the expiration of U.S. Patent No. 9,480,644, (the '644 Patent) and U.S. Patent No. </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">53</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">9,707,226, (the '226 Patent). Teva's notice letter asserts that the commercial manufacture, use or sale of its generic drug product described in its ANDA will not infringe the '644 Patent or the '226 Patent, or that the '644 Patent and '226 Patent are invalid or unenforceable. Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant filed a complaint for patent infringement against Teva in the United States District Court for the District of New Jersey.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">ANDA Litigation - Teva 4mg</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On or about September 13, 2016, Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant received notice from Teva that Teva had filed an ANDA with the FDA seeking regulatory approval to market a generic version of NARCAN&#174; (naloxone hydrochloride) Nasal Spray 4 mg/spray before the expiration of U.S. Patent No. 9,211,253 (the '253 Patent). Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant received additional notices from Teva relating to the '747, the '177, the '965, the '838, and the &#8216;937 Patents. Teva's notice letters assert that the commercial manufacture, use or sale of its generic drug product described in its ANDA will not infringe the '253, the '747, the '177, the '965, the '838, or the &#8216;937 Patent, or that the '253, the '747, the '177, the '965, the '838, and the &#8216;937 Patents are invalid or unenforceable. Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant filed a complaint for patent infringement against Teva in the United States District Court for the District of New Jersey with respect to the '253 Patent. Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant also filed complaints for patent infringement against Teva in the United States District Court for the District of New Jersey with respect to the '747, the '177, the '965, and the '838 Patents. All five proceedings have been consolidated. As of the date of this filing, Adapt Pharma Inc., Adapt Pharma Operations Limited, and Opiant, have not filed a complaint related to the &#8216;937 Patent. Closing arguments  are scheduled for February 26, 2020.  </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In the complaints described in the paragraphs above, the Plaintiffs seek, among other relief, orders that the effective date of FDA approvals of the Teva ANDA products and the Perrigo ANDA product be a date not earlier than the expiration of the patents listed for each product,&#160; equitable relief enjoining Teva and Perrigo from making, using, offering to sell, selling, or importing the products that are the subject of Teva and Perrigo&#8217;s respective ANDAs, until after the expiration of the patents listed for each product, and monetary relief or other relief as deemed just and proper by the court.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Nalox-1 Pharmaceuticals, a non-practicing entity, filed petitions with the United States Patent and Trademark Office Patent Trial and Appeal Board ("PTAB") requesting inter parties review (IPR) of five of the six patents listed in the Orange Book related to NARCAN&#174; </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Nasal Spray 4mg/spray. In a series of decisions, the PTAB agreed to institute a review of the '253 Patent, the '747 Patent and the '965 Patent but denied review of the '177 Patent and the '838 Patent. Nalox-1 did not request review of the '937 Patent.</span></div><div><a id="s92A62307C10F587B84A9927423863601"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Not applicable.</span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">54</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div></div><div><a id="sC682F34B15A95EC686DC8E835895C2D8"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">PART II</span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div><a id="s29457D6E33685BF984D07623CE0D7F04"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Market Information and Holders</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our common stock trades on the New York Stock Exchange under the symbol "EBS".</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">February&#160;14, 2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the closing price per share of our common stock on the New York Stock Exchange was $63.17 and we had 25 holders of record of our common stock. This number does not include beneficial owners whose shares are held by nominees in street name.</span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Dividend Policy</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We have not declared or paid any cash dividends on our common stock since becoming a publicly traded company in November 2006. We currently have no plans to pay dividends.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Recent Sales of Unregistered Securities</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Not applicable.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Use of Proceeds</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Not applicable.</span></div></div></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Purchases of Equity Securities</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">There were no repurchases of common stock that were made through open market transactions during the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">three months ended December 31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The Company previously had a share repurchase program, which expired as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">55</span></div></div><hr style="page-break-after:always"></hr><div><a id="s50179E2663755C02AA78D55D15B1FBB4"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 6. SELECTED  CONSOLIDATED FINANCIAL DATA</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions, except per share data)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2016</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2015</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">Statements of operations data:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenues:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Product sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">903.5</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">606.5</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">421.5</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">296.3</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">329.0</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contract development and manufacturing services</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">80.0</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">98.9</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">68.9</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">49.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">43.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contracts and grants</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">122.5</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">77.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">70.5</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">143.4</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">117.3</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total revenues</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">1,106.0</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">782.4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">560.9</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">488.8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">489.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating expenses:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cost of product sales and contract development and manufacturing services</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">433.5</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">322.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">187.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">126.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">102.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">226.2</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">142.8</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">97.4</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">106.9</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">117.8</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Selling, general &amp; administrative</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">273.5</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">202.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">142.9</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">143.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">120.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amortization of intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">58.7</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">25.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8.6</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7.3</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total operating expenses</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">991.9</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">692.6</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">436.6</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">383.3</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">347.8</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income from operations</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">114.1</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">89.8</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">124.3</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">105.5</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">141.5</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense):</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest expense</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">(38.4</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(9.9</span></div></td><td style="vertical-align:bottom;background-color:;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(6.6</span></div></td><td style="vertical-align:bottom;background-color:;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(7.6</span></div></td><td style="vertical-align:bottom;background-color:;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(6.5</span></div></td><td style="vertical-align:bottom;background-color:;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense), net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">1.7</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.6</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.9</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.3</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.7</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total other income (expense), net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">(36.7</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(8.3</span></div></td><td style="vertical-align:bottom;background-color:;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.7</span></div></td><td style="vertical-align:bottom;background-color:;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(6.3</span></div></td><td style="vertical-align:bottom;background-color:;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.8</span></div></td><td style="vertical-align:bottom;background-color:;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income before provision for income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">77.4</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">81.5</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">118.6</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">99.2</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">135.7</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Provision for income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">22.9</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">18.8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">36.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">36.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">44.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">54.5</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">62.7</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">82.6</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">51.8</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">62.9</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income per share-basic</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">1.06</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.25</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.98</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.29</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.63</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income per share-diluted </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">1.04</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.22</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.71</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.13</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.41</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted average number of shares &#8212; basic</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">51.5</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">50.1</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">41.8</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">40.2</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">38.6</span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted average number of shares &#8212; diluted</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">52.4</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">51.4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">50.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">49.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">47.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">As of December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2016</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2015</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">Balance Sheet Data:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">167.8</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">112.2</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">178.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">271.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">308.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Working capital</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">469.9</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">420.4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">385.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">404.4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">425.9</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">2,327.3</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,229.4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,070.2</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">970.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">931.8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total long-term liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">1,022.5</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,018.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">57.8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">268.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">274.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total stockholders&#8217; equity</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">1,088.5</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,010.9</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">912.2</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">596.2</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">575.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> See "Earnings per share" footnote for details on calculation.</span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div><a id="s3029F4D167AE50C88785B4296C3D90BF"></a></div></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and the related notes and other financial information included elsewhere in this annual report on Form 10-K. Some of the information contained in this discussion and analysis or </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">set forth elsewhere in this annual report on Form 10-K, including information with respect to our plans and strategy for our business and financing, includes forward-looking statements that involve risks and uncertainties. You should carefully review the "Cautionary Note Regarding Forward-Looking Statements" and "Risk Factors" sections of this annual report on Form 10-K for a discussion of important factors that could cause actual results to differ materially from the results described in </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">56</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">or implied by the forward-looking statements contained in the following discussion and analysis.</span></div><div><a id="s576AE0C65EC95615B45D6743AD69CDFC"></a></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Business Overview</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We a</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">re a global life scienc</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">es company focused on providing to civilian and military populations a portfolio of innovative preparedness and response products and solutions that address accidental, deliberate and naturally occurring PHTs.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We are currently focused on the following six distinct PHT categories: CBRNE; EID; travel health; emerging health crises; acute/emergency care; and CDMO. We have a product portfolio of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ten</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> products (vaccines, therapeutics, and drug-device combination products) </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;that contribute a substantial portion of our revenue. We also have two product candidates that are not approved by the FDA or any other health agency that are procured by certain government agencies under special circumstances. Additionally, we have a development pipeline consisting of a diversified mix of both pre-clinical and clinical stage product candidates (vaccines, therapeutics, devices and combination products). Finally, we have a fully-integrated portfolio of contract development and manufacturing services. We continue to pursue acquiring and developing products and solutions that provide an opportunity to serve both government and commercial (non-government) customers globally. The majority of revenue comes from the following products and product candidates:</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Vaccines</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Anthrax Vaccines, including our AV7909 (Anthrax Vaccine Adsorbed with Adjuvant) product candidate being developed as a next-generation anthrax vaccine for post-exposure prophylaxis and BioThrax&#174; (Anthrax Vaccine Adsorbed), the only vaccine licensed by the FDA for the general use prophylaxis and post-exposure prophylaxis of anthrax disease;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ACAM2000&#174; (Smallpox (Vaccinia) Vaccine, Live), the only single-dose smallpox vaccine licensed by the FDA for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Vivotif&#174; (Typhoid Vaccine Live Oral Ty21a), the only oral vaccine licensed by the FDA for the prevention of typhoid fever; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Vaxchora&#174; (Cholera Vaccine, Live, Oral), the only FDA-licensed vaccine for the prevention of cholera.</span></div></td></tr></table></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Devices</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">NARCAN&#174; (naloxone HCl) Nasal Spray, the first needle-free formulation of naloxone approved by the FDA and Health Canada, for the emergency treatment&#160;of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">RSDL&#174; (Reactive Skin Decontamination Lotion Kit), the only medical device cleared by the FDA to remove or neutralize the following chemical warfare agents from the skin: tabun, sarin, soman, cyclohexyl sarin, VR, VX, mustard gas and T-2 toxin; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Trobigard&#174;, a combination drug-device auto-injector product candidate that contains atropine sulfate and obidoxime chloride. It has not been approved by the FDA or any similar health regulatory body, but is procured by certain authorized government buyers under special circumstances for potential use as a nerve agent countermeasure.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Therapeutics</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">raxibacumab (Anthrax Monoclonal), the first fully human monoclonal antibody therapeutic licensed by the FDA for the treatment and prophylaxis of inhalational anthrax;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Anthrasil&#174; (Anthrax Immune Globulin Intravenous (Human)), the only polyclonal antibody therapeutic licensed by the FDA and Health Canada for the treatment of inhalational anthrax;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">BAT&#174; (Botulism Antitoxin Heptavalent (A,B,C,D,E,F,G)-(Equine)), the only heptavalent antibody therapeutic licensed by the FDA and Health Canada for the treatment of botulism;&#160;and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">VIGIV (Vaccinia Immune Globulin Intravenous (Human)), the only polyclonal antibody therapeutic licensed by the FDA and Health Canada to address certain complications from smallpox vaccination.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Contract Development and Manufacturing Services</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:24px;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We compete for CDMO service business with a number of biopharmaceutical product development organizations, contract manufacturers of biopharmaceutical products and university research laboratories. We also compete with in-house research, development and support service departments of other biopharmaceutical companies.</span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">57</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Highlights and Business Accomplishments for 2019</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On November 22, 2019, the Company announced updated results from the interim analysis of its Phase 2 clinical study evaluating the safety and immunogenicity of its chikungunya virus (CHIKV) virus-like particle (VLP) vaccine candidate, CHIKV VLP, across a series of dosing regimens. The interim analysis has shown that after the first dose is administered, up to 98% of study participants produced a neutralizing antibody response against CHIKV within seven days of vaccination and that the immune response persisted for at least one year for subjects who received a single dose.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On November 21, 2019, we outlined our growth strategy over the next five years and announced our 2024 financial and operational goals during the Company's Analyst and Investor Day. Senior management shared their vision for continuing to build leadership positions in select public health threat markets and CDMO.   </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On October 10, 2019, we announced that our  CHIKV VLP was granted PRIME designation by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines  Agency (EMA) during its September meeting. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On September 30, 2019, we were awarded a letter contract for the continued supply of BAT&#174; [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] into the SNS in support of botulism preparedness and response activity. The maximum value of this 10-year contract is $490 million, with approximately $90 million of deliverables agreed to and the potential value for the remaining deliverable to be negotiated and agreed upon within 180 days from the time of the award.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On September 27, 2019, we announced the research grant awarded by the National Institute on Drug Abuse, a component of NIH,  valued at approximately $6.3 million over two years, for the continued development of AP007, the Company's sustained-release nalmefene formulation for the treatment of addiction in opioid use disorder (OUD). </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On September 25, 2019, we announced our agreement with the Department of Defense (DoD) through the Medical CBRN Defense Consortium (MCDC) to develop and manufacture an auto-injector containing diazepam to treat nerve agent-induced seizures;</span></div></td></tr></table></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On September 3, 2019, we announced the contract award by HHS valued at approximately $2 billion over 10 years for the continued supply of ACAM2000&#174;, (Smallpox (Vaccinia) Vaccine, Live) into SNS in support of smallpox preparedness.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On June 3, 2019, we announced a contract award by HHS valued at approximately&#160;$535 million&#160;over 10 years for the continued supply of VIGIV into the SNS in support of smallpox preparedness.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On May 15, 2019, we announced that BARDA informed the Company that it will begin procuring AV7909 (anthrax vaccine adsorbed with CPG 7909 adjuvant) for delivery into the SNS. On July 30, 2019, BARDA exercised its first contract option valued at $261 million to procure doses to be delivered to the SNS through June of 2020.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On April 16, 2019, we announced results from an interim analysis of our Phase 2 clinical study evaluating the safety and immunogenicity of our CHIKV VLP product candidate across a series of dosing regimens. The interim analysis has shown that with a single dose administered, up to 98% of study participants produced a neutralizing antibody response against the chikungunya virus by day 7. Further, the immune response was shown to be persistent through the six-month visit, following the one-dose regimen.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On March 19, 2019, we announced the initiation of a Phase 3 trial to evaluate the lot consistency, immunogenicity, and safety of AV7909 (anthrax vaccine adsorbed with adjuvant) following a two-dose schedule administered intramuscularly in healthy adults. AV7909 is being developed for post-exposure prophylaxis of disease resulting from suspected or confirmed Bacillus anthracis exposure.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On February 28, 2019, we announced that we had signed an indefinite-delivery, indefinite-quantity contract with the U.S. Department of State to establish a long-term, reliable, and stable supply chain for MCMs intended to remove or neutralize chemical warfare agents and certain related toxins from the skin. The contract is comprised of a five-year base period of performance along with five one-year option periods with a total contract value of a minimum of approximately $7 million to a maximum of $100 million over the contract&#8217;s period of performance.&#160;We will be supplying two of our current medical countermeasures addressing chemical threats.</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">58</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Financial Operations Overview</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Revenues</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We generate revenues from the sale of our marketed products and product candidates which include Vaccines, Therapeutics and Devices which have been described above. Additionally, revenue is generated from the performance of CDMO services, and our performance of research and development services under contracts and grants. The USG is the largest purchaser of our CBRNE products and primarily purchases our products for the SNS, a national repository of medical countermeasures including critical antibiotics, vaccines, chemical antidotes, antitoxins, and other critical medical supplies. The USG primarily purchases our products under long-term, firm fixed-price procurement contracts. </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our opioid overdose reversal product, NARCAN&#174; Nasal Spray and our travel health products, comprising Vivotif and Vaxchora, are sold commercially through wholesalers and distributors, physician-directed or standing order prescriptions at retail pharmacies, as well as to other state and local community healthcare agencies, practitioners and hospitals.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We also generate revenue from the performance of CDMO services for third-parties. Our services include fill/finish activities as well as the production of bulk drug substances on behalf of our customers.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We have received contracts and grants funding from the USG and other non-governmental organizations to perform research and development activities, particularly related to programs addressing certain CBRNE threats and EIDs.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our revenue, operating results and profitability have varied, and we expect that they will continue to vary on a quarterly basis.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Cost of Product Sales and Contract Development and Manufacturing Services</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The primary expenses that we incur to deliver our products and to perform CDMO services consist of fixed and variable costs. We determine the cost of product sales for products sold during a reporting period based on the average manufacturing cost per unit in the period those units were manufactured. Fixed manufacturing costs include facilities, utilities and amortization of intangible assets. Variable manufacturing costs primarily consist of costs for materials and personnel-related expenses for direct and indirect manufacturing support staff, contract manufacturing operations, sales-based royalties, shipping and logistics. In addition to the fixed and variable manufacturing costs described above, the cost of product sales depends on utilization of available manufacturing capacity. For our commercial sales, o</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ther associated expenses include sales-based </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">royalties (which include fair value adjustments associated with contingent consideration), shipping, and logistics.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We use the same manufacturing facilities and methods of production for our own products as well as for fulfillment of our contract manufacturing contracts. We operate nine manufacturing facilities, five of which perform manufacturing activities for contract manufacturing customers. As a result, management reviews expenses associated with manufacturing our own products as well contract manufacturing contracts on an aggregate basis when analyzing the financial performance of its manufacturing facilities. Our manufacturing process for our own products and our contract manufacturing business includes the production of bulk material and performing &#8220;fill finish&#8221; work for containment and distribution of biological products. For &#8220;fill finish&#8221; customers, we receive work in process inventory to be prepared for distribution. When producing bulk material, we generally procure raw materials, manufacture the product and retain the risk of loss through the manufacturing and review process until delivery.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Research and Development Expenses</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We expense research and development costs as incurred. Our research and development expenses consist primarily of:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">personnel-related expenses;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">fees to professional service providers for, among other things, analytical testing, independent monitoring or other administration of our clinical trials and obtaining and evaluating data from our clinical trials and non-clinical studies;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">costs of contract manufacturing services for clinical trial material; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">costs of materials used in clinical trials and research and development.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In many cases, we plan to seek funding for development activities from external sources and third parties, such as governments and non-governmental organizations, or through collaborative partnerships. We expect our research and development spending will be dependent upon such factors as the results from our clinical trials, the availability of reimbursement of research and development spending, the number of product candidates under development, the size, structure and duration of any clinical programs that we may initiate, the costs associated with manufacturing our product candidates on a large-scale basis for later stage clinical trials, and our ability to use or rely on data generated by government agencies.</span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">59</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Selling, General and Administrative Expenses</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Selling, general and administrative expenses consist primarily of personnel-related costs and professional fees in support of our executives, sales and marketing, business development, government affairs, finance, accounting, information technology, legal, human resource functions and other corporate functions. Other costs include facility costs not otherwise included in cost of product sales and contract development and manufacturing or research and development expense.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Income Taxes</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Uncertainty in income taxes is accounted for using a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">return. We recognize in our financial statements the impact of a tax position if that position is more likely than not of being sustained on audit, based on the technical merits of the position.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Management believes that the assumptions and estimates related to the provision for income taxes are critical to the Company&#8217;s results of operations. For the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, income tax expense totaled $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">22.9</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million. For every 1% change in the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> effective rate, income tax expense would have changed by approximately $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">0.8</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For additional information on our uncertain tax positions and income tax expense, please see note </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">12</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">,   </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Income taxes</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to our consolidated financial statements included in this report. </span></div></div></div><div><a id="s6C2F01861314590C912C935D6A264394"></a></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Results of Operations</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:49%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year ended December 31,</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">$ Change</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">% Change</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Product sales net:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">NARCAN Nasal Spray</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">280.4</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">41.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">238.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">572</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ACAM2000</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">242.6</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">116.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">125.9</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">108</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Anthrax vaccines</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">172.8</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">278.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(105.2</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(38</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">207.7</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">170.1</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37.6</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">22</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total product sales, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">903.5</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">606.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">297.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">49</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contract development and manufacturing services</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">80.0</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">98.9</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(18.9</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(19</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contracts and grants</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">122.5</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">77.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">45.5</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">59</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total revenues</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">1,106.0</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">782.4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">323.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">41</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating expenses:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cost of product sales and contract development and manufacturing services</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">433.5</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">322.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">111.2</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">226.2</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">142.8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">83.4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">58</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Selling, general and administrative </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">273.5</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">202.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">71.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amortization of intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">58.7</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">25.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">33.7</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">135</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total operating expenses</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">991.9</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">692.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">299.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">43</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income from operations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">114.1</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">89.8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24.3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">27</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense):</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest expense</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">(38.4</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(9.9</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(28.5</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">288</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense), net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">1.7</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.6</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total other expense, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">(36.7</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(8.3</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(28.4</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">342</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income before income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">77.4</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">81.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(4.1</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax expense</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">22.9</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">18.8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">22</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">54.5</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">62.7</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(8.2</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(13</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)%</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">60</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Total Revenues</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;"><img src="chart-72427e25e1fe46f7dc1.jpg" alt="chart-72427e25e1fe46f7dc1.jpg" style="height:637px;width:324px;"></img></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.47899159663865%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:4%;"></td><td style="width:43%;"></td><td style="width:5%;"></td><td style="width:48%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#006ebf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">NARCAN Nasal Spray</span></div></td><td style="vertical-align:bottom;background-color:#abcde5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other Product Sales</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ACAM2000</span></div></td><td style="vertical-align:bottom;background-color:#a0a0a0;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contract Development and Manufacturing</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Anthrax vaccines</span></div></td><td style="vertical-align:bottom;background-color:#656565;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contracts and Grants</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Product Sales, net</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">NARCAN Nasal Spray </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">NARCAN Nasal Spray was acquired in October 2018 in connection with the Company's acquisition of Adapt resulting in an increase in product sales in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> compared to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">ACAM2000</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">increase</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in ACAM2000 sales for the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">year ended December 31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was primarily due to the volume and contractual per unit pricing increases of ACAM2000 delivered to the SNS as a result of the contract awarded by the USG in September 2019. Deliveries under this contract began in September.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Anthrax Vaccines (BioThrax</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"> and AV7909</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">)</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">decrease</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in anthrax vaccine sales for the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">year ended December 31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was primarily due to the lower number of BioThrax deliveries to the SNS during the period as compared to the prior comparable period partially offset by the unit deliveries of AV7909. The USG purchased fewer units of BioThrax during the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">year ended December 31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, in connection with the transition to the next-generation anthrax vaccine, AV7909. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Deliveries of AV7909 to the USG began in September of 2019 under the base period and option period executed by the USG in July 2019 and continued throughout the remainder of 2019. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Substantially all of the anthrax vaccine product sale revenues are made to the USG under long-term procurement contracts. The fluctuations in anthrax vaccine revenues is largely related to changes in volume depending on when the USG requests delivery, how much product the Company has ready in inventory to ship and the timing of funding available from the USG. The USG delivery schedule varies based on funding and management of the SNS inventory. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Volume is also contingent on the availability of product based on timing of manufacturing.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Other Product Sales </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">increase</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in the Company's other product sales during the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">year ended December 31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, was primarily due to the contribution of products associated with the PaxVax acquisition as well as increased sales of raxibacumab and BAT</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">&#174;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, which were partially offset by a decrease in other sales, largely Trobigard, compared to the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">year ended December 31, 2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Contract Development and Manufacturing Services</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">decrease</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in CDMO services revenue for the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:normal;">year ended December 31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is due to contract services performed during the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">year ended December 31, 2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to design, construct and validate manufacturing capability at our Lansing, Michigan site and contract manufacturing activities at our Canton, Massachusetts site for which no similar services were provided during in the current year. </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">61</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Contracts and Grants</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">increase</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in contracts and grants revenue for the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:normal;">year ended December 31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> primarily reflects research and development activities related to clinical trial activities for AV7909. These increases were partially offset by a reduction in development funding for ACAM2000 stability testing which was performed during the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">year ended December 31, 2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for which no similar services were provided in the current period.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:normal;text-decoration:none;">Cost of Product Sales and Contract Manufacturing</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;"><img src="chart-9deb655d727f202e4f8.jpg" alt="chart-9deb655d727f202e4f8.jpg" style="height:300px;width:298px;"></img></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#006ebf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cost of Product Sales and Contract Development and Manufacturing Services</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Wingdings;font-size:10pt;">l</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gross profit margin for product sales and contract development and manufacturing services</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Cost of product sales and contract development and manufacturing services </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">increased</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:normal;">year ended December 31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> primarily due to the acquisitions of Adapt and PaxVax, both acquired in October 2018. The increases are proportional to the increase in product sales and contract development and manufacturing services revenues during the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:normal;">year ended December 31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:normal;text-decoration:none;">Research and Development Expenses (Gross and Net)</span><img src="chart-8b39ed0292bc17f2549.jpg" alt="chart-8b39ed0292bc17f2549.jpg" style="height:300px;width:298px;"></img><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.53781512605042%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#006ebf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and Development expense</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Wingdings;font-size:10pt;">l</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and Development expense, net of contracts and grants revenue</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">increase</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in research and development expenses  during the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:normal;">year ended December 31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is primarily due to expenses incurred at Adapt and PaxVax, costs associated with the development of the CHIK VLP vaccine candidate, timing of manufacturing development activities for our AV7909 product candidate and the impairment of our IPR&amp;D intangible asset acquired as part of the Adapt acquisition. Both Adapt and PaxVax were acquired in October 2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">. </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">62</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:normal;text-decoration:none;">Selling, General and Administrative Expenses </span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;"><img src="chart-1798924266f5ba1ad03.jpg" alt="chart-1798924266f5ba1ad03.jpg" style="height:301px;width:298px;"></img></div><div style="line-height:120%;padding-bottom:12px;text-align:center;padding-left:24px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.69747899159664%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:7%;"></td><td style="width:93%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#006ebf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Selling, General and Administrative</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Wingdings;font-size:10pt;">l</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">SG&amp;A as a percentage of total revenue</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Selling, general and administrative expenses </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">increased</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">year ended December 31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> primarily due to an increase of $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">62.8</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million of expenses related to the consolidation of entities acquired in October 2018. The remaining increase is due to an increase in professional services and staffing to support the Company's growth.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Amortization of intangible Assets</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;"><img src="chart-b81c50169b2ce7059cc.jpg" alt="chart-b81c50169b2ce7059cc.jpg" style="height:208px;width:300px;"></img></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#006ebf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amortization expense</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;"><br/></span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">increase</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in amortization of intangible assets to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$58.7 million</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$25.0 million</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">year ended December 31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> compared to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:normal;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, was primarily due to the amortization of intangible assets resulting from the acquisitions of Adapt and PaxVax acquired in October 2018.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:normal;text-decoration:none;">Total Other Income (Expense), Net</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;"><img src="chart-e1643913cacfb05a2b5.jpg" alt="chart-e1643913cacfb05a2b5.jpg" style="height:361px;width:298px;"></img></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:86.1344537815126%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:7%;"></td><td style="width:93%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#006ebf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest expense</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Total other expense, net </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">increased</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> due primarily to an increase in borrowings on our senior secured credit facilities established in October 2018 to fund our acquisitions of Adapt and PaxVax.</span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">63</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Income Tax Expense</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;"><img src="chart-415206c664c75dff352.jpg" alt="chart-415206c664c75dff352.jpg" style="height:188px;width:300px;"></img></div><div style="line-height:120%;padding-bottom:12px;text-align:center;padding-left:24px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.53781512605042%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:7%;"></td><td style="width:93%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#006ebf;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax expense</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Wingdings;font-size:10pt;">l</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Effective tax rate</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">increase</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in income tax expense during the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">year ended December 31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is primarily due an increase in state taxes in 2019. The increase in the effective tax rate to 30% in 2019 is mainly due to the impact of non-deductible expenses. Excluding these non-deductible expenses, our effective tax rate would be approximately 23% in 2019. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Discussion and analysis of the year ended December 31, 2018 compared to the year ended December 31, 2017 is included under the heading "Item 7 Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC on February 21, 2019. </span></div><div><a id="s4E8B9DDFFB0F5B588FE8838BED5FA7C7"></a></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Liquidity and Capital Resources</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:normal;text-decoration:none;">Sources of Liquidity</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We have historically financed our operating and capital expenditures through cash on hand, cash from operations, debt financing and development funding. We also obtain financing from the sale of our common stock upon exercise of stock options. We have operated profitably for each of the last five years for the period ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, we had cash and cash equivalents of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$167.8 million</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, we believe that we have sufficient liquidity to fund our operations over the next 12 months.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Cash Flows</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table provides information regarding our cash flows for the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:42%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net cash provided by (used in):</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating activities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">188.0</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">41.8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">208.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Investing activities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">(96.9</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(897.2</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(249.9</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Financing activities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">(35.9</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">788.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(51.4</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Effect of exchange rate changes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">0.4</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net increase (decrease) in cash and cash equivalents</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">55.6</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(66.9</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(93.2</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Certain significant cash flows were as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;text-decoration:underline;">Operating Activities:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Net cash provided by operating activities of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$188.0 million</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in 2019 was primarily due to net income excluding non-cash items of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$230.4 million</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> offset by working capital changes of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$42.4 million</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Net cash provided by operating activities of $41.8 million in 2018 was primarily due to our net income excluding non-cash items of $160.9 million, offset by $119.1 million of negative changes in working capital. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Net cash provided by operating activities of $208.1 million in 2017 was primarily due to our net income excluding non-cash items of $154.4 million and changes in working capital which resulted in a net cash inflow of $53.7 million. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;text-decoration:underline;">Investing Activities:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Net cash used in investing activities of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$96.9 million</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in 2019 was primarily due to infrastructure and equipment investments.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Net cash used in investing activities of $897.2 million in 2018 was primarily due to our acquisitions of Adapt and PaxVax, along with software, infrastructure and equipment investments.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Net cash used in investing activities of $249.9 million in 2017 was primarily due to our acquisitions of ACAM2000 and raxibacumab, along with software, infrastructure and equipment investments.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;text-decoration:underline;">Financing Activities:</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Net cash used in financing activities of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$35.9 million</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in 2019 was primarily due to contingent consideration payments of $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">50.4</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million mostly in relation to our recent acquisition of Adapt offset by $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">13.7</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of net proceeds from debt.</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Net cash provided by financing activities of $788.7 million in 2018 was primarily due to $798.0 million of proceeds from long-term debt borrowings used to </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">64</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">finance a portion of the Adapt and PaxVax acquisitions and for general corporate purposes and $15.9 million in proceeds from the issuance of common stock pursuant to our employee equity awards plan, partially offset by $6.6 million associated with the taxes paid on behalf of employees for equity activity.</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Net cash used by financing activities of $51.4 million in 2017 was primarily due to $33.1 million utilized to purchase treasury stock, the payment of a $20.0 million note payable to Aptevo in conjunction with the spin-off, $4.3 million associated with the taxes paid on behalf of employees for equity activity and $10.9 million in contingent obligation payments, partially offset by $19.3 million in proceeds from the issuance of common stock pursuant to our employee equity awards plan.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Long-term debt</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;text-decoration:underline;">2017 Credit Agreement</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On September 29, 2017, we entered into a senior secured credit agreement (the 2017 Credit Agreement) with four lending financial institutions. The 2017 Credit Agreement provided for a senior secured credit facility of up to $200 million through September 29, 2022.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;text-decoration:underline;">Amended and Restated Credit Agreement</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On October 15, 2018, we entered into an Amended and Restated Credit Agreement (the Amended Credit Agreement), which modified the 2017 Credit Agreement. The Amended Credit Agreement (i) increased the revolving credit facility (the Revolving Credit Facility) from $200 million to $600 million, (ii) extended the maturity of the Revolving Credit Facility from September 29, 2022 to October 13, 2023, (iii) provided for a term loan in the original principal amount of $450 million (the Term Loan Facility, and together with the Revolving Credit Facility, the Senior Secured Credit Facilities), (iv) added several additional lenders, (v) amended the applicable margin such that borrowings with respect to the Revolving Credit Facility will bear interest at the annual rate described below, (vi) amended the provision relating to incremental credit facilities such that we may request one or more incremental term loan facilities, or one or more increases in the commitments under the Revolving Credit Facility (each an Incremental Loan), in any amount if, on a pro forma basis, our consolidated secured net leverage ratio does not exceed 2.50 to 1.00 after such occurrence, plus $200 million and (vii) amended our debt covenant ratios as described below.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended December 31, 2019, 2018 and 2017, we capitalized $0, $13.4 million and $1.4 million, respectively, of debt issuance costs.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Borrowings under the Revolving Credit Facility and the Term Loan Facility will bear interest at a rate per annum equal to (a) a eurocurrency rate plus a margin ranging from 1.25% to 2.00% per annum, depending on </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">our consolidated net leverage ratio or (b) a base rate (which is the highest of the prime rate, the federal funds rate plus 0.50%, and a eurocurrency rate for an interest period of one month plus 1%) plus a margin ranging from 0.25% to 1.00%, depending on our consolidated net leverage ratio. We are required to make quarterly payments under the Amended Credit Agreement for accrued and unpaid interest on the outstanding principal balance, based on the above interest rates. In addition, we are required to pay commitment fees ranging from 0.15% to 0.30% per annum, depending on our consolidated net leverage ratio, in respect of the average daily unused commitments under the Revolving Credit Facility. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We are to repay the outstanding principal amount of the Term Loan Facility in quarterly installments based on an annual percentage equal to 2.5% of the original principal amount of the Term Loan Facility during each of the first two years of the Term Loan Facility, 5% of the original principal amount of the Term Loan Facility during the third year of the Term Loan Facility and 7.5% of the original principal amount of the Term Loan Facility during each year of the remainder of the term of the Term Loan Facility until the maturity date of the Term Loan Facility, at which time the entire unpaid principal balance of the Term Loan Facility will be due and payable. We have the right to prepay the Term Loan Facility without premium or penalty. The Revolving Credit Facility and the Term Loan Facility mature (unless earlier terminated) on October 13, 2023.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Amended Credit Agreement also requires mandatory prepayments of the Term Loan Facility in the event that we or our Subsidiaries (a) incur indebtedness not otherwise permitted under the Amended Credit Agreement or (b) receive cash proceeds in excess of $100 million during the term of the Amended Credit Agreement from certain dispositions of property or from casualty events involving their property, subject to certain reinvestment rights.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Amended Credit Agreement contains financial covenants, which were amended in June 2019. The Amended Credit Agreement contains financial covenants which require the quarterly presentation of a minimum consolidated 12-month rolling debt service coverage ratio of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2.50</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and an amended maximum consolidated net leverage ratio of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">4.95</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the quarter ended June 30, 2019, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">4.75</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the quarter ending September 30, 2019, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">3.75</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the quarterly filing periods from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">October&#160;1, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> through </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">September&#160;29, 2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">3.50</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.0</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, thereafter, which may be adjusted to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">4.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for a four quarter period in connection with a material permitted acquisition. The Amended Credit Agreement also contains affirmative and negative covenants, which were also amended in June 2019 to limit the amount of restricted payments as defined in the Amended Credit </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">65</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Agreement to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$25 million</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> until the filing of the Company's December 31, 2019 Form 10-K. Negative covenants in the Amended Credit Agreement, among other things, limit the ability of the Company to incur indebtedness and liens, dispose of assets, make investments and enter into certain merger or consolidation transactions. As of the date of these financial statements, the Company is in compliance with all affirmative and negative covenants. </span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Funding Requirements</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We expect to continue to fund our anticipated operating expenses, capital expenditures, debt service requirements and any future repurchase of our common stock from the following sources:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">existing cash and cash equivalents;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">net proceeds from the sale of our products and contract development and manufacturing services;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">development contracts and grants funding; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">our senior secured credit facilities and any other lines of credit we may establish from time to time.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">There are numerous risks and uncertainties associated with product sales and with the development and commercialization of our product candidates. We may seek additional external financing to provide additional financial flexibility. Our future capital requirements will depend on many factors, including (but not limited to):</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the level, timing and cost of product sales and contract development and manufacturing services;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:2px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the extent to which we acquire or invest in and integrate companies, businesses, products or technologies;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:2px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the acquisition of new facilities and capital improvements to new or existing facilities;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:2px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the payment obligations under our indebtedness;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:2px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the scope, progress, results and costs of our development activities;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:2px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">our ability to obtain funding from collaborative partners, government entities and non-governmental organizations for our development programs;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:2px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the extent to which we adopt a share repurchase program and repurchase shares of our common stock and;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the costs of commercialization activities, including product marketing, sales and distribution.</span></div></td></tr></table></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">If our capital resources are insufficient to meet our future capital requirements, we will need to finance our cash needs through public or private equity or debt offerings, bank loans or collaboration and licensing arrangements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">If we raise funds by issuing equity securities, our stockholders may experience dilution. Public or bank debt financing, if available, may involve agreements that include covenants, like those contained in our Senior Secured Credit Facilities, which could limit or restrict our ability to take specific actions, such as incurring additional debt, making capital expenditures, pursuing acquisition opportunities, buying back shares or declaring dividends. If we raise funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish valuable rights to our technologies or product candidates or grant licenses on terms that may not be favorable to us.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We are not restricted under the terms of the indenture governing our 2.875% Convertible Senior Notes due 2021 from incurring additional debt, securing existing or future debt, recapitalizing our debt or taking a number of other actions that are not limited by the terms of the indenture governing our notes that could have the effect of diminishing our ability to make payments on our indebtedness. However, our Senior Secured Credit Facilities restricts our ability to incur additional indebtedness, including secured indebtedness.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Economic conditions may make it difficult to obtain financing on attractive terms, or at all. If financing is unavailable or lost, our business, operating results, financial condition and cash flows would be adversely affected, and we could be forced to delay, reduce the scope of or eliminate many of our planned activities.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Unused Credit Capacity</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Available room under the revolving credit facility for the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:normal;text-decoration:none;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:normal;text-decoration:none;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was: </span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:1%;"></td><td style="width:22%;"></td><td style="width:1%;"></td><td style="width:25%;"></td><td style="width:1%;"></td><td style="width:27%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:20%;"></td><td style="width:1%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31, 2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Total Capacity</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Outstanding Letters of Credit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Outstanding Indebtedness</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Unused Capacity</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">600.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">2.2</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">373.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">224.8</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31, 2018</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">600.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.4</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">348.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">250.6</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">66</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Contractual Obligations</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table summarizes our contractual obligations at </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:36%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Payments due by period</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Less than</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">1 year</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">1 to 3</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Years</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">3 to 5</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Years</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">More than</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">5 years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">Contractual obligations:&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Long-term indebtedness</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">822.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">14.1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">69.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">735.8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.0</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lease obligations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">30.6</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">13.7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.9</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Purchase commitments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">59.7</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">59.7</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">Total contractual obligations</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">912.7</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">78.2</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">83.3</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">741.7</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9.5</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div><a id="s98846D3B205B511A89417EDAE531EF67"></a></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Critical Accounting Policies and Estimates</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our consolidated financial statements are prepared in accordance with GAAP, which requires management to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements included in Item 8, "Financial Statements and Supplementary Data" in this Annual Report on Form 10-K and accompanying notes. Management considers an accounting policy to be critical if it is important to reporting our financial condition and results of operations, and if it requires significant judgment and estimates on the part of management in its application. We consider policies relating to the following matters to be critical accounting policies:</span></div><div style="line-height:120%;padding-left:24px;padding-bottom:5px;padding-top:0px;text-align:justify;text-indent:0px;"><span style="padding-bottom:5px;padding-top:0px;text-align:justify;font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;padding-right:24px;">&#9642;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Revenue recognition;</span></div><div style="line-height:120%;padding-left:24px;padding-bottom:5px;padding-top:0px;text-align:justify;text-indent:0px;"><span style="padding-bottom:5px;padding-top:0px;text-align:justify;font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;padding-right:24px;">&#9642;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Mergers and acquisitions;</span></div><div style="line-height:120%;padding-left:24px;padding-bottom:5px;padding-top:0px;text-align:justify;text-indent:0px;"><span style="padding-bottom:5px;padding-top:0px;text-align:justify;font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;padding-right:24px;">&#9642;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Contingent consideration; and</span></div><div style="line-height:120%;padding-left:24px;padding-bottom:12px;padding-top:0px;text-align:justify;text-indent:0px;"><span style="padding-bottom:12px;padding-top:0px;text-align:justify;font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;padding-right:24px;">&#9642;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Income taxes.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the reported amounts of revenues and expenses that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. </span></div><div><a id="s8D267077AD035ABDAFF80513C8794D37"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">&#160;&#160;&#160;&#160;</span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">67</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For a discussion of additional risks arising from our operations, see &#8220;Item&#160;1A&#8212;Business&#8212;Risk Factors&#8221; in this&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;Annual Report.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Market Risks</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We have interest rate and foreign currency market risk. We manage our interest rate risk in part by entering into interest rate swaps to swap a portion of our indebtedness that is based on variable interest rates to a fixed rate. We currently do not hedge our foreign currency exchange exposure, and the movement of foreign currency exchange rates could have an adverse or positive impact on our results of operations. We have not used derivative financial instruments for speculation or trading purposes. Because of the short-term maturities of our cash and cash equivalents, we believe that an increase in market rates would likely not have a significant impact on the realized value of our investments, but any increase in market rates would likely increase the interest expense associated with our debt.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Interest Rate Risk</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We have debt with a mix of fixed and variable rates of interest. Floating rate debt carries interest based generally on the eurocurrency, as defined in our Amended Credit Agreement, plus an applicable margin. We manage the impact of interest rate changes on our variable debt through derivative instruments such as interest rate swap arrangements. For debt that we have not hedged through our interest rate swap arrangements increases in interest rates could therefore increase the associated interest payments that we are required to make on this debt. See&#160;Note </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">9</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, "</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Long-term debt</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">," to the Notes of our consolidated financial statements included in this&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;Annual Report under the caption Item 8, "Financial Statements and Supplementary Data.&#8221;</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We have assessed our exposure to changes in interest rates by analyzing the sensitivity to our operating results assuming various changes in market interest rates. A hypothetical increase of one percentage point in the eurocurrency rate as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> would increase our interest expense by approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$4.6 million</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> annually.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Foreign Currency Exchange Rate Risk</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We have exposure to foreign currency exchange rate fluctuations worldwide and primarily with respect to the Euro, Canadian dollar, Swiss franc and British pound. We manage our foreign currency exchange rate risk primarily by incurring, to the extent practicable, operating and financing expenses in the local currency in the countries in which we operate.</span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">68</span></div></div><hr style="page-break-after:always"></hr><div><a id="s9887C129DCC954A99D5BC11296975F97"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div style="line-height:120%;padding-bottom:12px;text-align:left;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Report of Independent Registered Public Accounting Firm</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">To the Shareholders and the Board of Directors of Emergent BioSolutions Inc. and subsidiaries</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;font-weight:bold;text-decoration:underline;">Opinion on the Financial Statements</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We have audited the accompanying consolidated balance sheets of Emergent BioSolutions Inc. and subsidiaries (the Company) as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the related consolidated statements of operations, comprehensive income, changes in stockholders' equity and cash flows for each of the three years in the period ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and the related notes and financial statement schedule listed in the Index at Item 15 (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and the results of its operations and its cash flows for each of the three years in the period ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, in conformity with U.S. generally accepted accounting principles.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">February&#160;24, 2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> expressed an unqualified opinion ther</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">eon.</span></div><div style="line-height:120%;padding-bottom:5px;padding-top:5px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;font-weight:bold;text-decoration:underline;">Adoption of ASU No. 2014-09</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As discussed in Note 2 to the consolidated financial statements, the Company changed its method for accounting for revenue in 2018 due to the adoption of Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606), and the amendments in ASUs 2015-14, 2016-08, 2016-10, 2016-12, 2016-20 and 2017-14.</span></div><div style="line-height:120%;padding-bottom:5px;padding-top:5px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;font-weight:bold;text-decoration:underline;">Basis for Opinion</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">se financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">W</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">e conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;font-weight:bold;text-decoration:underline;">Critical Audit Matter</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">69</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:none;">Revenue recognition - identifying performance obligations and variable consideration</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:14%;"></td><td style="width:2%;"></td><td style="width:84%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Description of the Matter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As described in Note 3 to the consolidated financial statements, the Company recognized revenues of</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#ff0000;">&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1,106.0 million for the year ended December&#160;31, 2019. The Company enters into or periodically modifies revenue contracts whose terms are complex and require a significant level of judgment related to management&#8217;s identification of performance obligations and determination of transaction price including variable consideration.  At contract inception, management assesses the products or services promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a product or service that is distinct including evaluating whether the contract includes a customer option for additional goods or services which could represent a material right. In addition, the Company estimates the transaction price of the contract, including variable consideration that is subject to a constraint. The Company&#8217;s estimation of variable consideration is subject to management&#8217;s judgment and assumptions including returns, certain fees, discounts and rebates. </span></div><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Auditing management&#8217;s identification of the performance obligations and determination of the variable consideration in certain contracts involved judgment due to the subjective nature of the evaluation of customer options for additional goods or services as a material right and the estimation uncertainty in management&#8217;s determination of the variable consideration and the related constraint (or lack thereof). For example, the estimated rebates and returns is subject to significant judgment because their expected value is based on assumptions including sales or invoice data, contractual terms, historical utilization rates and the related product program&#8217;s regulations and guidelines. The estimated rebates and returns are forward-looking and could be affected by future economic conditions and the competitive environment. </span></div><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">How We Addressed the Matter in Our Audit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We obtained an understanding, evaluated the design, and tested the operating effectiveness of the Company&#8217;s internal controls addressing revenue recognition including identification of performance obligations, and estimation of variable consideration. For example, we tested controls over management&#8217;s review of the identification of performance obligations and management&#8217;s review over the assumptions used in the estimation of the rebates and returns. We also tested management&#8217;s controls over the completeness and accuracy of the data used in the underlying calculations. </span></div><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">To test management&#8217;s identification of performance obligations, and variable consideration, our audit procedures included, among others, reading certain executed contracts, understanding the methodologies utilized and testing the completeness and accuracy of the information used in management&#8217;s assessment. For example, in evaluating the estimate for rebates and returns, we reviewed the historical data available and compared to management&#8217;s estimated rebates and returns related to current period sales. In addition, we recalculated the estimated rebates and returns, and we compared management&#8217;s assumptions to industry standards and trends for comparable products. </span></div><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">/s/ Ernst &amp; Young LLP</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We have served as the Company&#8217;s auditor since 2004.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Baltimore, Maryland</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">February&#160;24, 2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">70</span></div></div><hr style="page-break-after:always"></hr><div><a id="sA79C4C4401A35724A58F1392A74A9341"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Emergent BioSolutions Inc. and Subsidiaries</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Consolidated Balance Sheets</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">(in millions, except per share data)</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ASSETS</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e922-wk-Fact-5336B3A0808E295F0F9ACCD313516FB8" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">167.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e941-wk-Fact-C850578AFC61C3CD2C52CCD313602FC1" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">112.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Restricted cash</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e956-wk-Fact-7D6350B9DCF7F0111A28CCD31365A60F" name="us-gaap:RestrictedCashCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e975-wk-Fact-E144E7602026284DE3B5CCD3135AA1A0" name="us-gaap:RestrictedCashCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts receivable, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e995-wk-Fact-8E63B5B6EE5EB579E66FCCD31378EC92" name="us-gaap:AccountsReceivableNetCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">270.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1014-wk-Fact-0A8EDAB4A88157AF37E1CCD3136590C8" name="us-gaap:AccountsReceivableNetCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">262.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1034-wk-Fact-9E7A6321764CCA011270CCD3135EBFCB" name="us-gaap:InventoryNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">222.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1053-wk-Fact-9BE8FA4DD47B7E5F9DB4CCD31363B9B9" name="us-gaap:InventoryNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">205.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax receivable, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1073-wk-Fact-7CF3B381E5B3B0C5CE28CCD3135B583C" name="us-gaap:IncomeTaxesReceivable" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1092-wk-Fact-C35A4CA04DDB71D4CFEFCCD313632F6A" name="us-gaap:IncomeTaxesReceivable" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1112-wk-Fact-FB52AFB0B296536D08DBCCD313662B20" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">20.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1131-wk-Fact-A1EFFB4329FBD17570DACCD3134EA78B" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">31.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total current assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1151-wk-Fact-151DC1949FADB06E4A7BCCD3134BEBC8" name="us-gaap:AssetsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">686.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1170-wk-Fact-3C94BD3322A10D90DDC3CCD3135DAD1B" name="us-gaap:AssetsCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">620.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Property, plant and equipment, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1232-wk-Fact-899C00B0608B636FBD8FCCD3135FCC56" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">542.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1251-wk-Fact-B7B7C9765C1C2455B6F1CCD3135E93E8" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">510.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Intangible assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1271-wk-Fact-23DCBB460AF8A0ACBBE7CCD3135B1023" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">712.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1290-wk-Fact-7B0EEA06D43CF1A4D27DCCD3135E9C23" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">761.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1310-wk-Fact-2B0343D7D345B2E16A1ACCD31364046E" name="ebs:InProcessResearchAndDevelopment" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">29.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1329-wk-Fact-2A654F2FE5B913B49F31CCD3135C7D21" name="ebs:InProcessResearchAndDevelopment" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">50.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1349-wk-Fact-C76E5389C37865AFD040CCD31368C9CE" name="us-gaap:Goodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">266.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1368-wk-Fact-5C9C3DE9C91BA7971D23CCD31385ABAA" name="us-gaap:Goodwill" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">259.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1388-wk-Fact-B4860D2049F842006F6DCCD31359362A" name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1407-wk-Fact-4810C830DE23A4ABCB7DCCD3138204CB" name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1427-wk-Fact-7FCE1A7F977633CA61C6CCD3135169F2" name="us-gaap:OtherAssetsNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">76.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1446-wk-Fact-536D348900D24C3F7762CCD31344BBDF" name="us-gaap:OtherAssetsNoncurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1466-wk-Fact-1EA27C25A586FC51A656CCD313530225" name="us-gaap:Assets" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,327.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1485-wk-Fact-85DB590568FD23FC26E9CCD3138391FB" name="us-gaap:Assets" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,229.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">LIABILITIES AND STOCKHOLDERS' EQUITY</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1634-wk-Fact-84D541D5E03415DF4535CCD313518995" name="us-gaap:AccountsPayableCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">94.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1653-wk-Fact-4DCDB7EF87AB975796DDCCD3135C1B6D" name="us-gaap:AccountsPayableCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">80.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1668-wk-Fact-00378ECED7A8D9C18EC8CCD31358120F" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">39.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1687-wk-Fact-141EE5B8E68DEBB46841CCD3135F9C9D" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1707-wk-Fact-09D363D31AFF605BE8D7CCD3135550AA" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1726-wk-Fact-48546A54ACE6E8D86951CCD31367440C" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">58.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Debt, current portion</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1746-wk-Fact-1020D890222BC2C85069CCD3135A4D97" name="us-gaap:NotesPayableCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1765-wk-Fact-E4FA23442C7530649177CCD31356CD22" name="us-gaap:NotesPayableCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration, current portion</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1785-wk-Fact-D9896AC4336730797F99CCD31363C697" name="ebs:ContingentConsiderationCurrentPortion" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1804-wk-Fact-E38AA87ED30245FFE5A1CCD313542315" name="ebs:ContingentConsiderationCurrentPortion" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1824-wk-Fact-A7ADE41022942BAB2731CCD3135EC5C3" name="us-gaap:OtherLiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1843-wk-Fact-0F08F0A7A07DB94CE8E5CCD3134F3619" name="us-gaap:OtherLiabilitiesCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1863-wk-Fact-03B8082E9C77E15C2DA1CCD313679814" name="us-gaap:LiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">216.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1882-wk-Fact-03F6F4EA8F3939850287CCD31383C673" name="us-gaap:LiabilitiesCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">200.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration, net of current portion</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1943-wk-Fact-A9E3703BEE571B9E45A7CCD31362AEB4" name="ebs:ContingentConsiderationNetOfCurrentPortion" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e1962-wk-Fact-7F9482301B2A33C64259CCD31357772E" name="ebs:ContingentConsiderationNetOfCurrentPortion" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Debt, net of current portion</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e1982-wk-Fact-0163307C7DD7CD378E59CCD31360AD48" name="us-gaap:LongTermDebtNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">798.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e2001-wk-Fact-6EFA9A3FEB39B8EF4FC4CCD313587151" name="us-gaap:LongTermDebtNoncurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">784.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax liability</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e2021-wk-Fact-282CAC6196A96CDFDFABCCD313572CE7" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">63.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e2040-wk-Fact-473A3A2E14986DA3749FCCD313847061" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">67.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contract liabilities, net of current portion</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e2061-wk-Fact-E84BA4D84777937FDC2ACCD31354A380" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">85.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e2080-wk-Fact-FDF258FBD155CE931D7ECCD3135563AE" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e2100-wk-Fact-55823CB2410564CDB287CCD3136485E8" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">48.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e2119-wk-Fact-AF27DB7F93A5F2DEEFD8CCD3136675D4" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">49.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e2139-wk-Fact-2ACA55C535E89FCEEF99CCD3135815A7" name="us-gaap:Liabilities" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,238.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e2158-wk-Fact-6B468270AF1582984F05CCD31351A58C" name="us-gaap:Liabilities" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,218.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Preferred stock, $0.001 par value; 15.0 shares authorized, 0 shares issued and outstanding at both December 31, 2019 and 2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e2260-wk-Fact-424B0C2E8B14A5378EECCCD313544555" name="us-gaap:PreferredStockValue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e2279-wk-Fact-76A133ADF7E0A02AE353CCD313811089" name="us-gaap:PreferredStockValue" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Common stock, $0.001 par value; 200.0 shares authorized, 52.9 shares issued and 51.7 shares outstanding at December 31, 2019; 52.4 shares issued and 51.2 shares outstanding at December 31, 2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e2299-wk-Fact-2E6F3C493879F596FC67CCD313620373" name="us-gaap:CommonStockValue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e2318-wk-Fact-2916B05A2D4ED2260DFBCCD3135AD4DC" name="us-gaap:CommonStockValue" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Treasury stock, at cost, 1.2 common shares at December 31, 2019 and 2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45224251e2338-wk-Fact-E0263BE513DF033898BACCD31360CF40" name="us-gaap:TreasuryStockValue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">39.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45224251e2358-wk-Fact-D2DD65E797AD45B1FCFCCCD3135526EA" name="us-gaap:TreasuryStockValue" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">39.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Additional paid-in capital</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e2379-wk-Fact-3EA1755D2F188C56A786CCD3134FD3EE" name="us-gaap:AdditionalPaidInCapital" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">716.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e2398-wk-Fact-6AFDEFB0F56B65D8EBB7CCD31361CCB7" name="us-gaap:AdditionalPaidInCapital" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">688.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accumulated other comprehensive loss, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45224251e2418-wk-Fact-17B79BDB5B7BBBC71297CCD313657C2F" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">9.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45224251e2438-wk-Fact-FCE9974F1DB16F154351CCD3135C560E" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">5.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Retained earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e2459-wk-Fact-3A03B529B6C6A592A3A6CCD3135EE2E5" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">421.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e2478-wk-Fact-A306E97D3D239A3D354FCCD3135C9792" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">367.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total stockholders&#8217; equity</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e2499-wk-Fact-0B3690615016B293BE9FCCD3135F817C" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,088.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e2518-wk-Fact-AFEDF1DE0BEA35BDB75FCCD313596B2B" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,010.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total liabilities and stockholders&#8217; equity</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45224251e2543-wk-Fact-C0A242398559F24FB376CCD3136399FA" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,327.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45224251e2562-wk-Fact-08C73019DD676487846ACCD31359BD1C" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2,229.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">71</span></div></div><hr style="page-break-after:always"></hr><div><a id="sEF66BCA64F53568FAF60C20BB0DEC051"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Emergent BioSolutions Inc. and Subsidiaries</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Consolidated Statements of Operations</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">(in millions, except per share data)</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenues:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Product sales, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e949-wk-Fact-550DB7545370460F2298CCD31390DFC6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">903.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e968-wk-Fact-3810A958B43C733CFB24CCD3138A0CA4" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">606.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e987-wk-Fact-E3F5520D7C718745B7DFCCD3138C7AFB" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">421.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contract development and manufacturing services</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e1003-wk-Fact-EB42D93755BA6257EE81CCD31389177D" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractDevelopmentAndManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">80.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1022-wk-Fact-904BD4C0F92F891BCF1FCCD3137C85C8" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractDevelopmentAndManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">98.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1041-wk-Fact-16361A9FD27C7C14B912CCD3137DFB76" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractDevelopmentAndManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">68.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contracts and grants</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e1062-wk-Fact-5F00D21AD433133B00D3CCD313757E7C" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">122.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1081-wk-Fact-B30465A8C2F3A2E082CECCD3138D3955" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">77.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1100-wk-Fact-9AD0A541FEBE16626E99CCD31378BB04" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">70.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total revenues</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e1121-wk-Fact-94CAA3BE61215202AE0CCCD3138C57F6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,106.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1140-wk-Fact-E5CE75B1C99F6C4E48F4CCD31371D6BF" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">782.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1159-wk-Fact-85CDAEF339CB7AEE40B1CCD3138717AC" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">560.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating expenses:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cost of product sales and contract development and manufacturing services</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e1304-wk-Fact-1A17B919655248A478E6CCD3137C25B5" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">433.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1323-wk-Fact-0BD5F5131BBA62715B14CCD3137D83D8" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">322.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1342-wk-Fact-2D01B99AAE4512BE7D14CCD3137863F0" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">187.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e1363-wk-Fact-BB99500874D827111E94CCD313734577" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">226.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1382-wk-Fact-192DC0603EFF1E62BD18CCD313791315" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">142.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1401-wk-Fact-55D5D9EE3A86D99320CECCD3137E1784" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">97.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Selling, general and administrative</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e1423-wk-Fact-6DC68E6B8F7ED1B32B53CCD31386366A" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">273.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1442-wk-Fact-9178D87C78320892421CCCD313853D3A" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">202.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1461-wk-Fact-606ED401806C2E5BE08DCCD31387060A" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">142.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amortization of intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e1482-wk-Fact-6CC25FDAD57AD605F0EFEE0DD6E4C0A9" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">58.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1501-wk-Fact-13AE45AAD591A38D64EBCCD313882444" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1520-wk-Fact-1225424380838E1DB578CCD31376D614" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total operating expenses</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e1541-wk-Fact-9C63E17D0E9E2EB7B07ACCD31374D235" name="us-gaap:OperatingExpenses" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">991.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1560-wk-Fact-D862905C5CBC0C43A582CCD313745728" name="us-gaap:OperatingExpenses" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">692.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1579-wk-Fact-9B9EEB604312E2E1C251CCD31375F246" name="us-gaap:OperatingExpenses" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">436.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income from operations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e1662-wk-Fact-5EAB37A75F982F7A9C3DCCD3137A6859" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">114.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1681-wk-Fact-450A2B99937449611C98CCD31386669F" name="us-gaap:OperatingIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">89.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1700-wk-Fact-88A83CAADC155D683453CCD3138500BF" name="us-gaap:OperatingIncomeLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">124.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense):</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest expense</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45227565e1845-wk-Fact-7CBF4D87B27968819869CCD31372F3CF" name="us-gaap:InterestExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">38.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45227565e1865-wk-Fact-242972BC4070FEAC319CCCD31379135C" name="us-gaap:InterestExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45227565e1885-wk-Fact-877211EB9E49BA449B4ACCD3137E2218" name="us-gaap:InterestExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense), net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e1907-wk-Fact-EFAF683CA24BADEB8065CCD3137AFDE3" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1926-wk-Fact-6671A1D4F503CBCB1C99CCD313879C25" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e1945-wk-Fact-B20F2D9332F409310848CCD3138412B3" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total other income (expense), net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45227565e1966-wk-Fact-81DAC95D090A7A600B2CCCD31375D9C1" name="us-gaap:NonoperatingIncomeExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">36.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45227565e1986-wk-Fact-30971FC148524C20DFD7CCD3138916B9" name="us-gaap:NonoperatingIncomeExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">8.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45227565e2006-wk-Fact-59B2701692826D03179CCCD3137D7C9F" name="us-gaap:NonoperatingIncomeExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">5.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income before provision for income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e2091-wk-Fact-15849D8BF637472B8ADECCD31379DEFF" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">77.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e2110-wk-Fact-E99100EAFF39BE9F20A8CCD313844D4A" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">81.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e2129-wk-Fact-3C7C65F6526D0FE54F6FCCD31383F49F" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">118.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Provision for income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e2150-wk-Fact-815A1535A7EA25FCCD27CCD31380042F" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e2169-wk-Fact-4D13AEFC5D9B488A367CCCD3137B2702" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e2188-wk-Fact-9218D9AEEE0D40961A99CCD313765A05" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e2214-wk-Fact-7DC5791E3DA27455A6AECCD31377CEF0" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e2233-wk-Fact-2233E7AC5FE7EADFA0A9CCD3137B1D77" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e2252-wk-Fact-E93855FEF0C5D1679E3DCCD313722951" name="us-gaap:NetIncomeLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">82.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income per share-basic</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e2335-wk-Fact-86DB00C3EBD85B656393CCD3138EDEB2" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.06</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e2354-wk-Fact-87E66476E07C4C47E84FCCD3138767B9" name="us-gaap:EarningsPerShareBasic" contextRef="FD2018Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.25</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e2373-wk-Fact-7509B93E651C38CE4A6CCCD3138CB254" name="us-gaap:EarningsPerShareBasic" contextRef="FD2017Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.98</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income per share-diluted (Note 15) </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e2456-wk-Fact-3D47F2A0E1F49321A098CCD313819F36" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.04</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e2475-wk-Fact-1C4F6F61BDFC84790364CCD3137FF970" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2018Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e2494-wk-Fact-9E773D140AC5081CC2BDCCD3138E79BE" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2017Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.71</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted-average number of shares - basic</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e2572-wk-Fact-6C476F7FC811DEF066C8CCD313726405" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">51.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e2591-wk-Fact-AA3A26AF9233B4E47F37CCD31384CE40" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">50.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e2610-wk-Fact-FC3D132112BD46DA7C18CCD3137FB2FE" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2017Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">41.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted-average number of shares - diluted</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45227565e2631-wk-Fact-26467B8874FB56A63BF6CCD3137FA89C" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">52.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e2650-wk-Fact-49D658F4DEFA67C8563CCCD31381661E" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">51.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45227565e2669-wk-Fact-888877977CEDD432DA63CCD3136C30C8" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2017Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">50.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">72</span></div></div><hr style="page-break-after:always"></hr><div><a id="sE718E9C31E7B51E985D5218B9B854942"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Emergent BioSolutions Inc. and Subsidiaries</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Consolidated Statements of Comprehensive Income</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">(in millions)</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45232163e886-wk-Fact-7DC5791E3DA27455A6AECCD31377CEF0" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45232163e905-wk-Fact-2233E7AC5FE7EADFA0A9CCD3137B1D77" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45232163e924-wk-Fact-E93855FEF0C5D1679E3DCCD313722951" name="us-gaap:NetIncomeLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">82.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive income (loss), net of tax:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Foreign currency translation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45232163e1002-wk-Fact-1491B4B773CC46B33FF6CCD31382A48C" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45232163e1021-wk-Fact-AC5605D73790C0A328EFCCD3138217EE" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45232163e1041-wk-Fact-5417BA53613C505A2DE0CCD313821B9D" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unrealized losses on hedging activities, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45232163e1062-wk-Fact-637E7E91168467F87D0CB2246394E792" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45232163e1082-wk-Fact-D725BD2999FDA69C0E15B22463741A23" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45232163e1101-wk-Fact-176111CD532B4B190C1CB2246406B555" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unrealized losses on pension benefit obligation, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45232163e1122-wk-Fact-C297ADD0A24247ED3AD3CCD31384C669" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45232163e1142-wk-Fact-6F15219A9C09561F63F2CCD31383291F" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45232163e1162-wk-Fact-A37500CD25575D912628CCD313854406" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total other comprehensive income (loss), net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45232163e1183-wk-Fact-F702E6116BA005717710CCD3137114A2" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45232163e1203-wk-Fact-85089016933E47A775DDCCD3138523AA" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45232163e1223-wk-Fact-5B21670B6A453CD2AA06CCD313812342" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Comprehensive income</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45232163e1249-wk-Fact-2167B38B07773525CADFCCD31383D724" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">50.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45232163e1268-wk-Fact-CFBD7BFD40A59A99F3CFCCD313830053" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">60.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45232163e1287-wk-Fact-930FAC0A0BCAA75EE229CCD3136C57D3" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">83.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="12" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="12" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:9pt;">During 2019, there were tax benefits related to unrealized losses on hedging activities and the pension benefit obligation of $0.4 million and $0.5 million, respectively. During 2018 and 2017, the tax effect of the amounts presented was de minimus.  </span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">73</span></div></div><hr style="page-break-after:always"></hr><div><a id="sB02C9FD983A25A8494AAEA94E9913BBC"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Emergent BioSolutions Inc. and Subsidiaries</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Consolidated Statements of Cash Flows</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">(in millions)</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash flows from operating activities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e949-wk-Fact-7DC5791E3DA27455A6AECCD31377CEF0" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e968-wk-Fact-2233E7AC5FE7EADFA0A9CCD3137B1D77" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e987-wk-Fact-E93855FEF0C5D1679E3DCCD313722951" name="us-gaap:NetIncomeLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">82.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adjustments to reconcile to net cash provided by operating activities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e1065-wk-Fact-94934C6F39F7F4F3628DCCD313748029" name="us-gaap:ShareBasedCompensation" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1084-wk-Fact-3D09F5A8BBC3B6CBDCDCCCD3136A8EA4" name="us-gaap:ShareBasedCompensation" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">23.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1103-wk-Fact-B352691FC99E659B929ECCD3136F5CDC" name="us-gaap:ShareBasedCompensation" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e1124-wk-Fact-0BF09E44B53E6659DF58CCD3134374AF" name="us-gaap:OtherDepreciationAndAmortization" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">110.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1143-wk-Fact-12BAC36B254B0EFA23CCCCD3137AF674" name="us-gaap:OtherDepreciationAndAmortization" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1162-wk-Fact-982E26B456D9E3F9E885CCD3134A87C4" name="us-gaap:OtherDepreciationAndAmortization" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">42.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45235985e1183-wk-Fact-58405A0E79843DEA0ECECCD3134923A8" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1203-wk-Fact-96DD44DB927FC4D6C560CCD313826897" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1222-wk-Fact-0EDED9EEF79E4387F35FCCD3137C7249" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Change in fair value of contingent consideration, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e1243-wk-Fact-BF841B970C5DDEBA3D0CCCD3134589B9" name="ebs:ChangeInFairValueOfContingentConsideration" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">24.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1262-wk-Fact-75ACA1418E71750AB209CCD31344B66C" name="ebs:ChangeInFairValueOfContingentConsideration" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1281-wk-Fact-D93E9BCECF0813230248CCD31343B354" name="ebs:ChangeInFairValueOfContingentConsideration" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Impairment of IPR&amp;D intangible asset</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e1302-wk-Fact-410CCC0BC56F753EE8DAEC913479F2C7" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1321-wk-Fact-0C2E1AC86B7FBF1D0CC8B24403622FB4" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1340-wk-Fact-4467221FA4513B6B4338B2440382EC05" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amortization of deferred financing costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e1361-wk-Fact-EF015AB34B024808ED05B236552ABB25" name="us-gaap:AmortizationOfFinancingCosts" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1380-wk-Fact-B07CB3D41CB501F0A207B23655780D6C" name="us-gaap:AmortizationOfFinancingCosts" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1399-wk-Fact-111076F67CA8D4FE51CCB23654EC43E5" name="us-gaap:AmortizationOfFinancingCosts" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45235985e1421-wk-Fact-3B7F821E0291B8CF40C2CCD3136E6122" name="us-gaap:OtherNoncashIncomeExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1441-wk-Fact-4C838F6D592AC9EAB240CCD313784045" name="us-gaap:OtherNoncashIncomeExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1460-wk-Fact-22C91D675F8BBC825960CCD3137CD927" name="us-gaap:OtherNoncashIncomeExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Changes in operating assets and liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts receivable</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45235985e1543-wk-Fact-39F29B2DA439E2657D68CCD31387B4D7" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e1563-wk-Fact-0C907D58620779ADD5AACCD31351C4C9" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">94.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e1583-wk-Fact-7AF02E2F3D61FF9AF91BCCD31375CDBD" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45235985e1605-wk-Fact-EF9D01F8B5A0F7566C07CCD3134A2C22" name="us-gaap:IncreaseDecreaseInInventories" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e1625-wk-Fact-A8E40C414DA8253E59D0CCD3136DBA7F" name="us-gaap:IncreaseDecreaseInInventories" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1645-wk-Fact-49C9654D515BC588D967CCD3138371A9" name="us-gaap:IncreaseDecreaseInInventories" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">6.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45235985e1666-wk-Fact-F06A2049E6AE72AFB485CCD31372D69C" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e1686-wk-Fact-98C46523DAF37C119CADCCD3136EDF8C" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1706-wk-Fact-7925E4CC482FDC4C5E16CCD3136B374B" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">20.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prepaid expenses and other assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45235985e1727-wk-Fact-B82096D5D28E0E1DE4BDCCD3137FB99C" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">27.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e1747-wk-Fact-98EF8A1B3A643BFE9843CCD313847B40" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e1767-wk-Fact-1CA1898DFEA051CCC492CCD3137D6E97" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts payable</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e1789-wk-Fact-F0D532250AAE4B7C6A14CCD3134DF5F7" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e1808-wk-Fact-5A08E62E6E41549A5FC6CCD31380B55A" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">7.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1828-wk-Fact-E4535CD1D6175E24CA18CCD31373B402" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45235985e1849-wk-Fact-4D8D27694AF018AB0990CCD313460D92" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">15.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e1869-wk-Fact-E3FFECAECD63424330EACCD31369B036" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">11.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1889-wk-Fact-52F31EC555CC6927540ECCD31350D9B2" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e1910-wk-Fact-683ED368AC822C62D4C8CCD313728C4A" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1929-wk-Fact-E9DA993C3A24E6CB860ECCD313480ACE" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1948-wk-Fact-C101306649B286203633CCD313760C19" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e1969-wk-Fact-5D9C5E6DB7D689A0579CCCD313819A20" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e1988-wk-Fact-A82EC91FD22E1BBB3D88CCD3137B3C2B" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2007-wk-Fact-CF6C24A0DDABE6F1512ECCD313794D26" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net cash provided by operating activities:</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e2028-wk-Fact-53C9BB28553649FC0CD8CCD3134F7B72" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">188.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2047-wk-Fact-B038FC8723F050A6992FCCD3134C32D9" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">41.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2066-wk-Fact-D7AC0456F3EE40DFBFB5CCD3134270BB" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">208.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash flows from investing activities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Purchases of property, plant and equipment and other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45235985e2150-wk-Fact-387E17842BFDF7B7716ECCD31376156F" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">86.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e2170-wk-Fact-BE41ABBC9324FF2F9553CCD3137C54B9" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">72.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e2190-wk-Fact-4553EDA6A617050DEF50CCD31345D6C6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Milestone payment from asset acquisition</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45235985e2212-wk-Fact-551A63B91C0F4C6524EAB2471762EA05" name="us-gaap:PaymentsForPreviousAcquisition" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2232-wk-Fact-D1C41757F2969CAEB863B247176621F4" name="us-gaap:PaymentsForPreviousAcquisition" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2251-wk-Fact-E22AD20BC8103B14A1F4B247176E41B2" name="us-gaap:PaymentsForPreviousAcquisition" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset acquisitions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e2272-wk-Fact-E1043AC3A990DF5FD434CCD31368770B" name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2291-wk-Fact-750372074957FF5FEDC4CCD3134C315B" name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e2310-wk-Fact-59972506EA00BF28E716CCD31345528D" name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">77.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Business acquisitions, net of cash acquired</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e2332-wk-Fact-55700B24378B27D9E671CCD313474628" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e2351-wk-Fact-FFD96083DB4B1B46ACD4CCD3136B350F" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">827.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e2371-wk-Fact-313B53E38CA2B0CC7E12CCD31377A474" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">117.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Proceeds from sale of assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e2393-wk-Fact-28FB304AE074BC3C7F9DCCD313736AC6" name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2412-wk-Fact-6D4693CDB7FAE2EA2606CCD3137D23A8" name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2431-wk-Fact-2A1613503F0E4F0DB0FDCCD31352DA48" name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net cash used in investing activities:</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45235985e2452-wk-Fact-4E291D2A5FA2EB763F37CCD31343DC5D" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">96.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e2472-wk-Fact-0215D706357DC82A6917CCD3136D9A70" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">897.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e2492-wk-Fact-A726DE34176E5E635AFECCD313420215" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">249.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash flows from financing activities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Proceeds from revolving credit facility</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e2576-wk-Fact-D633A029C3501AD564ACCCD31381B1F2" name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">130.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2595-wk-Fact-7A64CE5EAF7E71AC4236CCD31378CEF8" name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">348.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2614-wk-Fact-E8C3C906E106EF501852CCD3137B19B9" name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Proceeds from term loan facility</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e2635-wk-Fact-2BE56630115CA57D9FB4B26E441146E9" name="us-gaap:ProceedsFromIssuanceOfMediumTermNotes" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2654-wk-Fact-D3292182412046937463B26E446FA64B" name="us-gaap:ProceedsFromIssuanceOfMediumTermNotes" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">450.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2673-wk-Fact-A69CF00FBDFF70980446B26E44024D4B" name="us-gaap:ProceedsFromIssuanceOfMediumTermNotes" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Principal payments on revolving credit facility</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45235985e2694-wk-Fact-9278D98977991691F95ACCD3136E9345" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">105.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2714-wk-Fact-F47F1BD282674F26494BCCD313562E55" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2733-wk-Fact-964AEB5817E8AC949B2FCCD31347628D" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Principal payments on term loan facility</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45235985e2755-wk-Fact-6A5A67159C1899AE4F2CB25B7B750163" name="us-gaap:RepaymentsOfMediumTermNotes" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e2775-wk-Fact-F71CF115BBECDCB9C1EBB25B7B84D65B" name="us-gaap:RepaymentsOfMediumTermNotes" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2795-wk-Fact-62AB7ECA474FDCB8913AB25B7B75D72E" name="us-gaap:RepaymentsOfMediumTermNotes" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Proceeds from issuance of common stock upon exercise of stock options</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e2816-wk-Fact-A12423419BD191002F73CCD3137001D6" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2835-wk-Fact-5F8B0E5489921F995B75CCD31348902F" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e2854-wk-Fact-8B14458631D53DB40A39CCD3137173FE" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e2875-wk-Fact-A3595B6028B2A42D258CCCD3136CA2EC" name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e2894-wk-Fact-B215D15B55351D7CB4C7CCD3137E5096" name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e2914-wk-Fact-C029EE29A4F11E0F17FCCCD31378CB86" name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Taxes paid on behalf of employees for equity activity</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45235985e2936-wk-Fact-43266921E26168FAA933CCD3134ABB00" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e2956-wk-Fact-CD6648998DCD8CF30B3FCCD313426C6E" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e2976-wk-Fact-F23152A6FEF177B6DF20CCD31380FDDB" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payment of notes payable to Aptevo</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e2998-wk-Fact-E4899C990CADE1FAD58BCCD313736D22" name="us-gaap:RepaymentsOfNotesPayable" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3017-wk-Fact-FDC331B7D24198480D7CCCD31384AA43" name="us-gaap:RepaymentsOfNotesPayable" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e3036-wk-Fact-B11E57073939A46E0D59CCD3137ECBE9" name="us-gaap:RepaymentsOfNotesPayable" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">20.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration payments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45235985e3058-wk-Fact-4219B44957785334849ACCD3136913DE" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">50.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e3078-wk-Fact-146F9646A8DD1AC5981ECCD31370A103" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e3098-wk-Fact-A88BE54C33F2D133B3B1CCD3136B347E" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Receipts and payments of restricted cash</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e3120-wk-Fact-C7838F4FB983869D9025CCD313757A3D" name="us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3139-wk-Fact-DCEBA7D4764C2E6841AFCCD31377A171" name="us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e3158-wk-Fact-3C765009B34E95622207CCD313502632" name="us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Purchase of treasury stock</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e3180-wk-Fact-8C54E772E26C005C521FCCD31353787E" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e3199-wk-Fact-4762F6CA7095406D62C2CCD313777C5F" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e3219-wk-Fact-D67BF7D56A8441D196BCCCD31341F595" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">33.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net cash (used in) provided by financing activities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45235985e3241-wk-Fact-D3E1729E330380D2C26CCCD3134E2EEE" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">35.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3261-wk-Fact-D7399057B96F67FC7AF3CCD31379CE82" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">788.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e3280-wk-Fact-ED3955D537C6C2E45CF7CCD31349A38C" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">51.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Effect of exchange rate changes on cash and cash equivalents</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e3302-wk-Fact-450254A0C36445CBE13CCCD31380F855" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e3321-wk-Fact-A97F4C9278A4CFE98AC9CCD313778FF7" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3341-wk-Fact-7FD7E93DE538F6EBEB13CCD313837BC0" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net increase (decrease) in cash and cash equivalents and restricted cash</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e3362-wk-Fact-BB5679B21BAEAF2ED2E2CCD31350EFBE" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">55.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e3381-wk-Fact-FDB49301E0EC16DE9256CCD3137AF1DE" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">66.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45235985e3401-wk-Fact-892EF083B175DB87061DCCD313504A09" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">93.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash and cash equivalents and restricted cash at beginning of year</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e3424-wk-Fact-7890970BA71EE684CCADCCD313509117" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">112.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3443-wk-Fact-3AE99597F8F935C48246CCD3136DD405" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">179.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3462-wk-Fact-156823373026275E77CCCCD313554131" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2016Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">272.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash and cash equivalents and restricted cash at end of year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e3488-wk-Fact-DC2EA43DC3E3189D364B5F9B81EFD3C5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">168.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3507-wk-Fact-7890970BA71EE684CCADCCD313509117" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">112.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3526-wk-Fact-3AE99597F8F935C48246CCD3136DD405" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">179.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Supplemental disclosure of cash flow information:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash paid during the year for interest</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e3609-wk-Fact-113AC9216554653399B4CCD3137A6AD8" name="us-gaap:InterestPaidNet" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">34.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3628-wk-Fact-8916F0CB3B55A9D3CFFECCD3137FFC25" name="us-gaap:InterestPaidNet" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3647-wk-Fact-04494E4F1552BB4E6D55CCD3137D7209" name="us-gaap:InterestPaidNet" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash paid during the year for income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e3668-wk-Fact-80E364F204890CD01FBFCCD31371AAD0" name="us-gaap:IncomeTaxesPaid" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3687-wk-Fact-4B66BF050AEE45A96CB3CCD313526A6D" name="us-gaap:IncomeTaxesPaid" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3706-wk-Fact-DBDAFE28FF958DFF016ECCD313805D20" name="us-gaap:IncomeTaxesPaid" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Supplemental information on non-cash investing and financing activities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Issuance of common stock to acquire Adapt Pharma</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e3789-wk-Fact-5AE8431AD2BB023B5A9ACCD3137053EF" name="us-gaap:StockIssued1" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3808-wk-Fact-AF882D82582536BF3F23CCD3136F53E1" name="us-gaap:StockIssued1" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">37.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3827-wk-Fact-5D737C3E5E2858EA3903CCD3134CA771" name="us-gaap:StockIssued1" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Purchases of property, plant and equipment unpaid at year end</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e3848-wk-Fact-33F140E38FA1A7D9BF9BCCD3134DCE42" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3867-wk-Fact-07B63CF9A3E48A65C40ECCD3137EF194" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3886-wk-Fact-07AEC17B039D11BE1D85CCD3136DD001" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Reconciliation of cash and cash equivalents and restricted cash:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e3969-wk-Fact-5336B3A0808E295F0F9ACCD313516FB8" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">167.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e3988-wk-Fact-C850578AFC61C3CD2C52CCD313602FC1" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">112.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e4007-wk-Fact-0375FEEE05AEBD8C47B75F9E0534052E" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">178.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Restricted cash</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e4023-wk-Fact-7D6350B9DCF7F0111A28CCD31365A60F" name="us-gaap:RestrictedCashCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e4042-wk-Fact-E144E7602026284DE3B5CCD3135AA1A0" name="us-gaap:RestrictedCashCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e4061-wk-Fact-E2A1DB7DEA588AAACDCF5F9E962AC974" name="us-gaap:RestrictedCashCurrent" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45235985e4088-wk-Fact-DC2EA43DC3E3189D364B5F9B81EFD3C5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">168.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e4107-wk-Fact-7890970BA71EE684CCADCCD313509117" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">112.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45235985e4126-wk-Fact-3AE99597F8F935C48246CCD3136DD405" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">179.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">74</span></div></div><hr style="page-break-after:always"></hr><div><a id="sFCB9F9D3716A54C0B77FD905BC48D233"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Emergent BioSolutions Inc. and Subsidiaries</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Consolidated Statement of Changes in Stockholders' Equity</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">(in millions, except per share data)</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="31"></td></tr><tr><td style="width:24%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:0%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">$0.001 Par Value Common Stock</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Additional Paid-In</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Capital</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Treasury Stock</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Accumulated Other Comprehensive</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Loss</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Retained</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Earnings</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Total Stockholders'</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Equity</span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Shares</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Shares</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Amount</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2016</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1105-wk-Fact-CCD60CBB29558FA48B74CCD313A25B9E" name="us-gaap:CommonStockSharesIssued" contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">41.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1129-wk-Fact-00728D5DE9D4A72A6063CCD313AA3E7F" name="us-gaap:StockholdersEquity" contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1148-wk-Fact-3F78537B1F7AD2DDAB80CCD3139CB2AB" name="us-gaap:StockholdersEquity" contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">352.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e1163-wk-Fact-7CA8441C5E731C286468CCD313A5CD6B" name="us-gaap:CommonStockSharesIssued" contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e1183-wk-Fact-7DC9B1A65457438E80BBCCD3139B924F" name="us-gaap:StockholdersEquity" contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">6.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e1203-wk-Fact-0046BC6B7B32C6EE7626CCD3138F1BA9" name="us-gaap:StockholdersEquity" contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1224-wk-Fact-5EDD27243B580B362C22CCD3138EA61A" name="us-gaap:StockholdersEquity" contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">254.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1243-wk-Fact-F2E7C25177615B0EC7ECCCD3138DDD25" name="us-gaap:StockholdersEquity" contextRef="FI2016Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">596.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee equity plans activity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1258-wk-Fact-53CC5DEAE9276C242410CCD3138F0304" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1296-wk-Fact-8AFE519BBDF814C323FACCD31399B1D2" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">28.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1388-wk-Fact-6081051CD8ED522120B7CCD31393997D" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">28.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Shares issued to extinguish convertible notes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1408-wk-Fact-29B4D68DD690658528DF8EAC7608313B" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">8.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1427-wk-Fact-074E3FABB56BC63D90E68EAAB7B42AB7" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1446-wk-Fact-E3C3276AB6C7A55B4C4C8EAAB7C201C8" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">237.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1538-wk-Fact-40EF030AC4F137886252CCD313AC18B0" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">238.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Treasury stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e1615-wk-Fact-ACCC04DD0642C76F63548EC28880990F" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e1630-wk-Fact-E1579B86D479235412738EC0FE18FCA8" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">33.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e1689-wk-Fact-B58D20645014DCA1AA198E7B21C76981" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">33.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1821-wk-Fact-35FDB15319750DD940D8CCD3139D7749" name="us-gaap:NetIncomeLoss" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">82.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1840-wk-Fact-E93855FEF0C5D1679E3DCCD313722951" name="us-gaap:NetIncomeLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">82.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive income</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1951-wk-Fact-10F899BE1F10F659984BCCD313A84DD0" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e1990-wk-Fact-5B21670B6A453CD2AA06CCD313812342" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2017</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2010-wk-Fact-4A8002F2822CD3C742B1CCD313917AD5" name="us-gaap:CommonStockSharesIssued" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">50.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2034-wk-Fact-6914AF6510155DAC0F38CCD313A52D35" name="us-gaap:StockholdersEquity" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2053-wk-Fact-9F98F15CF0FEBB183283CCD3138BC2CA" name="us-gaap:StockholdersEquity" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">618.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e2068-wk-Fact-09081519B3BB4F0C9DCBCCD31395847F" name="us-gaap:CommonStockSharesIssued" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e2088-wk-Fact-39CD732B8F388C87FEAFCCD31395427B" name="us-gaap:StockholdersEquity" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">39.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e2108-wk-Fact-5FF3FC7F515F0A0BE3F8CCD3139B14AE" name="us-gaap:StockholdersEquity" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">3.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2129-wk-Fact-8529E12375C7DEE4B9FACCD313AEF3FE" name="us-gaap:StockholdersEquity" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">337.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2148-wk-Fact-3691C94D49348CC7919BCCD313A8578F" name="us-gaap:StockholdersEquity" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">912.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adoption of new accounting standard (ASC 606), net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e2274-wk-Fact-9DFFDDBD36F0FAE4E7278E7B21E05F55" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">32.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e2294-wk-Fact-0CA92E946AECE131C2378E7B21C4194D" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" contextRef="I2018Q1Jan01" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">32.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at January 1, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2315-wk-Fact-787E01F3F8D21F6D91458E7B21CE0332" name="us-gaap:CommonStockSharesIssued" contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">50.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2334-wk-Fact-0BD4462D6C8B5D2F32CD8E7B21BC19FF" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2353-wk-Fact-6C0B336B2ED2308717398E7B21DCD7FD" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">618.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e2373-wk-Fact-DA67CBB2B1FC957BBE228E7B21CAC1E5" name="us-gaap:CommonStockSharesIssued" contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e2388-wk-Fact-5936900494BB07B0189D8E7B21D9266A" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">39.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e2408-wk-Fact-E74AF32DC7D0DE3C21708E7B21D5B3E3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">3.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2429-wk-Fact-4FB41CF48E82EC9B9C318E7B21C08BEF" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">304.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2448-wk-Fact-95A219BCBEAEA76AE5648E7B21B4F6A6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" contextRef="I2018Q1Jan01" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">879.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee equity plans activity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2469-wk-Fact-1D21B0C149F2A18880F0CCD31394E823" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2507-wk-Fact-7453DCADFE19DAC48660CCD3139A2978" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2599-wk-Fact-241CD17F4BE6F7BDEC3FCCD3139ADCB5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Issuance of common stock in acquisition</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2619-wk-Fact-F666003E41D3CD59DFD6CCD313A1D62B" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2657-wk-Fact-B77330C49B5FBED0E54ACCD313A04AD1" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">37.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e2749-wk-Fact-8031858837B14DEF41F5CCD31391F41E" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">37.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Treasury stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e2841-wk-Fact-F08E9AA8E7AD50C3BE84CCD313A4F689" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e2900-wk-Fact-94FB638730F1D282AE87CCD3138A1AAF" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e3032-wk-Fact-DE54BD21E499093EEA13CCD31394DBDE" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e3051-wk-Fact-2233E7AC5FE7EADFA0A9CCD3137B1D77" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive loss</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e3162-wk-Fact-B471399577DB095DFF5BCCD313975DAB" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e3202-wk-Fact-85089016933E47A775DDCCD3138523AA" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e3223-wk-Fact-DED86EF4F36D82A01FA4CCD313AC3E39" name="us-gaap:CommonStockSharesIssued" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">52.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e3247-wk-Fact-FCAC0EC3B7E436D643C1CCD3139E7DC2" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e3266-wk-Fact-0EB92831F9E22B18DD3DCCD3138727EC" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">688.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e3281-wk-Fact-48FEF34C2C831A416B1CCCD313A7F728" name="us-gaap:CommonStockSharesIssued" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e3301-wk-Fact-1795BAA72F3AB427C7B6CCD313ACE63E" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">39.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45239726e3321-wk-Fact-BD1E9E43ECA910844A10CCD313A65287" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">5.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e3342-wk-Fact-6AB7EC4B62E2D8F0CFE3CCD313AB88C4" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">367.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45239726e3361-wk-Fact-AFEDF1DE0BEA35BDB75FCCD313596B2B" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,010.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee equity plans activity</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45239726e3376-wk-Fact-93E8AAB64F9FB4A88FBDCCD3139F2CB0" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45239726e3414-wk-Fact-5520DE461494CBC14C5DCCD313912422" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">27.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45239726e3506-wk-Fact-9B0807055A10FA8AF8C0CCD313AA00FE" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">27.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45239726e3637-wk-Fact-E2F999AC3F63F0949223CCD3139F87F8" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45239726e3656-wk-Fact-7DC5791E3DA27455A6AECCD31377CEF0" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive loss</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45239726e3767-wk-Fact-A29F6BE908AA44DDFCD6CCD313A0AAD0" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45239726e3807-wk-Fact-F702E6116BA005717710CCD3137114A2" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45239726e3828-wk-Fact-D225C48870F32709B42FCCD31388821B" name="us-gaap:CommonStockSharesIssued" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">53.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45239726e3852-wk-Fact-21E6102EEEC1D45C8932CCD313910A0B" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45239726e3871-wk-Fact-5BD09B64F3308D2DDD59CCD31398B5FA" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">716.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45239726e3886-wk-Fact-AA5DA49F7E8D4B6DC131CCD313A5D3ED" name="us-gaap:CommonStockSharesIssued" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45239726e3906-wk-Fact-8FF657C5FA99D972123ECCD313A95FC5" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">39.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45239726e3926-wk-Fact-8B694F970B5C4D0AAE3CCCD313AE3FE8" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">9.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45239726e3947-wk-Fact-F1CF84916BC5E1CB212ECCD3138D3F90" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">421.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45239726e3966-wk-Fact-0B3690615016B293BE9FCCD3135F817C" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,088.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">75</span></div></div><hr style="page-break-after:always"></hr><div><a id="s06B42CEF61745D40B40980F26FB6ABAC"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Emergent BioSolutions Inc. and Subsidiaries</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Notes to consolidated financial statements</span></div><div><a id="sEF7941C838105654B5A1486CAAD5484A"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">1</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">&#160;</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;"> </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:NatureOfOperations" id="TextSelection-A800F1C4D27C28FCD7F4CCD313BBA2AA-0-wk-Fact-9DB5AD1689EDB6E531CECCD3133173FA" continuedAt="TextSelection-A800F1C4D27C28FCD7F4CCD313BBA2AA-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Nature of the business and organization</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-A800F1C4D27C28FCD7F4CCD313BBA2AA-1" continuedAt="TextSelection-A800F1C4D27C28FCD7F4CCD313BBA2AA-2"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Organization and business</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Emergent BioSolutions Inc. (the "Company" or "Emergent") is a global life sciences company focused on providing specialty products for civilian and military populations that address accidental, deliberate and naturally occurring public health threats ("PHTs," each a &#8220;PHT&#8221;).</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company is focused on innovative preparedness and response products and solutions addressing the following </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45239790e745-wk-Fact-8C0EA2876B98364DF72C4B70294D8DE7" name="ebs:NumberOfCategoriesOfPublicHealthThreats" contextRef="FD2019Q4YTD" unitRef="category" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> distinct PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives ("CBRNE"); emerging infectious diseases ("EID"); travel health; </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">emerging health crises, acute/emergency care, and contract development and manufacturing ("CDMO")</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The Company has a product portfolio of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45239790e753-wk-Fact-AFC4D7FEC1B69D9268EC53E9045A3EE9" name="ebs:NumberOfRevenueGeneratingProducts" contextRef="FD2019Q4YTD" unitRef="product" decimals="INF" scale="0" format="ixt-sec:numwordsen">twelve</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> products and product candidates (vaccines, therapeutics, and drug-device combination products) that generate a majority of our revenue. The U.S. government (the "USG') is the Company's largest customer and provides us with substantial funding for the development of a number of it</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">s product candidates.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">The Company's product portfolio includes:</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Vaccines</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ACAM2000</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (Smallpox (Vaccinia) Vaccine, Live), the only single-dose smallpox vaccine licensed by the FDA for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">BioThrax</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (Anthrax Vaccine Adsorbed), the only vaccine licensed by the U.S. Food and Drug Administration ("FDA"), for the general use prophylaxis and post-exposure prophylaxis of anthrax disease;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Vaxchora&#174; (Cholera Vaccine, Live, Oral), the only FDA-licensed vaccine for the prevention of cholera, it is orally delivered; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Vivotif&#174; (Typhoid Vaccine Live Oral Ty21a), the only oral vaccine licensed by the FDA for the prevention of typhoid fever.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Devices</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">NARCAN&#174; (naloxone HCl) Nasal Spray, the first and only needle-free formulation of naloxone approved by the FDA and Health Canada, for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">RSDL</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (Reactive Skin Decontamination Lotion Kit), the only medical device cleared by the FDA to remove or neutralize the following chemical warfare agents from the skin: tabun, sarin, soman, cyclohexyl sarin, VR, VX, mustard gas and T-2 toxin; and</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Therapeutics</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">raxibacumab (Anthrax Monoclonal), the first fully human monoclonal antibody therapeutic licensed by the FDA for the treatment and prophylaxis of inhalational anthrax;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Anthrasil</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (Anthrax Immune Globulin Intravenous (Human)), the only polyclonal antibody therapeutic licensed by the FDA and Health Canada for the treatment of inhalational anthrax;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">BAT&#174; (Botulism Antitoxin Heptavalent (A,B,C,D,E,F,G)-(Equine)), the only heptavalent antibody therapeutic licensed by the FDA and Health Canada for the treatment of botulism; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">VIGIV (Vaccinia Immune Globulin Intravenous (Human)), the only polyclonal antibody therapeutic licensed by the FDA and Health Canada to address certain complications from smallpox vaccination.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Product Candidates</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">AV7909</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;  </sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">(Anthrax Vaccine Absorbed with Adjuvant), is a product candidate being developed as a next generation anthrax vaccine for post-exposure prophylaxis of disease resulting from suspected or confirmed Bacillus antracis exposure. The USG has started procuring AV7909 for the SNS prior to its approval by the FDA and has been reducing its purchases of BioThrax as a result; </span></div></td></tr></table></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">76</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-A800F1C4D27C28FCD7F4CCD313BBA2AA-2"><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Trobigard&#174; is a combination drug-device auto-injector product candidate that contains atropine sulfate and obidoxime chloride. It has not been approved by the FDA or any similar health regulatory body, but is procured by certain authorized government buyers under special circumstances for potential use as a nerve agent countermeasure. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company also generates revenue from contract development and manufacturing services on a clinical and commercial (small and large) scale by providing such services to the pharmaceutical and biotechnology industry.&#160; These services include process development and bulk drug substance and drug product manufacturing of biologics, fill/finish formulation and analytical development services for injectable and other sterile products, inclusive of process design, technical transfer, manufacturing validations, aseptic filling, lyophilization, final packaging and stability studies, as well as manufacturing of vial and pre-filled syringe formats across bacterial, viral and mammalian therapy technology platforms. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We operate as </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:normal;"><span><ix:nonFraction id="d45239790e886-wk-Fact-20F8B8EEF5B456B8A214AA36B150B705" name="us-gaap:NumberOfOperatingSegments" contextRef="FD2019Q3YTD" unitRef="segment" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> operating segment.</span></div></ix:continuation><div><a id="s9276B907D6EE5813B7D0A181822E50A0"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">2</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-0-wk-Fact-28382D9B1EA77F59D98ACCD31363FF32" continuedAt="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Summary of significant accounting policies</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-1" continuedAt="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-2"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ConsolidationPolicyTextBlock" id="TextSelection-A746A1A3ACD1894585E8F18F1CD7BDA1-0-wk-Fact-4E5172CE3A1F196CB33EF18F3B5DDE3B" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Basis of presentation and consolidation</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The accompanying consolidated financial statements include the accounts of Emergent and its wholly owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:UseOfEstimates" id="TextSelection-15F4DECB56F8495F2E72F1903D6CD905-0-wk-Fact-FF7E0328EC6B48BC11A9F1904A956FB5" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Use of estimates</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The preparation of financial statements in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) requires management to make estimates, judgments and assumptions that affect the amounts and disclosures reported in the consolidated financial statements and accompanying notes. Management continually re-evaluates its estimates, judgments and assumptions, and management&#8217;s evaluations could change. These estimates are sometimes complex, sensitive to changes in assumptions and require fair value determinations using Level 3 fair value measurements. Actual results may differ materially from those estimates.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Estimates and judgments inherent in the preparation of the consolidated financial statements include accounting for asset impairments, revenue recognition, allowances for doubtful accounts, inventory, depreciation and amortization, business comb</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">inations, contingent consideration, stock-based compensation, income taxes, and other contingencies.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="TextSelection-515400D39367EAFE22DFF1909EFB2911-0-wk-Fact-92F0304C327D43E1A838F190B0B2F09D" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Cash, cash equivalents and restricted cash</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Cash equivalents are highly liquid investments with a maturity of 90 days or less at the date of purchase and consist of time deposits and investments in money market funds with commercial banks and financial institutions. Also, the Company maintains cash balances with financial institutions in excess of insured limits. The Company does not anticipate any losses with such cash balances. Restricted cash includes cash that is not readily available for use in the Company's operating activities. Restricted cash is primarily comprised of cash pledged under letters of credit.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="TextSelection-2A185E3F0D0046D625C4F190F09BB031-0-wk-Fact-C9FAA12CB0C3DE3A89B1F190FC81D251" continuedAt="TextSelection-2A185E3F0D0046D625C4F190F09BB031-1" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Fair value measurements</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, an exit price, in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value include:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:left;padding-left:24px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:11%;"></td><td style="width:89%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Level 1 &#8212;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Observable inputs for identical assets or liabilities such as quoted prices in active markets;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Level 2 &#8212;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inputs other than quoted prices in active markets that are either directly or indirectly observable; and</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Level 3 &#8212;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unobservable inputs in which little or no market data exists, which are therefore developed by the Company using estimates and assumptions that reflect those that a market participant would use.</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On a recurring basis, the Company measures and records money market funds (level 1), contingent purchase considerations (level 3) and interest-rate swap arrangements (level 2) using fair value measurements in the accompanying financial statements. On a non-recurring basis, the Company measures its IPR&amp;D assets (level 3) using fair value measurements. The carrying amounts of the Company's short-term financial instruments, which include cash and cash equivalents, accounts receivable and accounts payable, approximate their fair values due to their short maturities. The </span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">77</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-2" continuedAt="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-3"><ix:continuation id="TextSelection-2A185E3F0D0046D625C4F190F09BB031-1"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">carrying amounts of the Company&#8217;s long-term debt arrangements approximates their fair values due to variable interest rates which fluctuate with changes in market rates.</span></div></ix:continuation><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:MajorCustomersPolicyPolicyTextBlock" id="TextSelection-58A3DC8EAEAD0002B27FF191B4D75717-0-wk-Fact-D8345FEA3554FAC2D246F191C17CE1F3" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Significant customers and accounts receivable</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Billed accounts receivable are stated at invoice amounts and consist mostly of amounts due from the USG, as well as amounts due under reimbursement contracts with other government entities and non-government organizations. Our opioid overdose reversal product is sold commercially through physician-directed or standing order prescriptions at retail pharmacies, as well as state health departments, law enforcement agencies, state and local community based organizations, substance abuse centers and federal agencies. If necessary, the Company records a provision for doubtful receivables to allow for amounts which may be unrecoverable. This provision is based upon an analysis of the Company's prior collection experience, customer creditworthiness and current economic trends. Unbilled accounts receivable relates to various service contracts for which work has been performed, though invoicing has not yet occurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="ebs:ConcentrationsRiskPolicyTextBlock" id="TextSelection-200B47B32D34AB251077F192CFDEE5DB-0-wk-Fact-8D99252F6AC97F67A0F1F192E1A5D1D5" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Concentration Risk</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Customers</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has long-term contracts with the USG that expire at various times from 2020 through 2029. The Company has derived a significant portion of its revenue from sales of ACAM2000 and Anthrax Vaccines under contracts with the USG. The Company's current USG contracts do not necessarily increase the likelihood that it will secure future comparable contracts with the USG. The Company expects that a significant portion of the business will continue to be under government contracts that present a number of risks that are not typically present in the commercial contracting process. USG contracts for ACAM 2000 and Anthrax Vaccines are subject to unilateral termination or modification by the government. The Company may fail to achieve significant sales of ACAM 2000 and Anthrax Vaccines to customers in addition to the USG, which would harm its growth opportunities. The Company may not be able to manufacture Anthrax Vaccines consistently in accordance with FDA specifications. The Company's other product sales are largely sold commercially through physician-directed or standing order prescriptions at retail pharmacies, as well as to state health departments, local law enforcement agencies, community-based organizations, substance abuse centers and other federal agencies. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Although the Company seeks expand its customer base and to renew its agreements with its customers prior to expiration of a contract, a delay in securing a renewal or a failure to secure a renewal or a renewal on less favorable terms may have a material adverse effect on the Company&#8217;s financial condition and results of operations.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company&#8217;s trade receivables do not represent a significant concentration of credit risk. The USG accounted for approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45240615e845-wk-Fact-20E74D71369AB31921ABCCD3133D13DD" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2019Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">61</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45240615e849-wk-Fact-4749A820B80A9EA996D8CCD31332D2F3" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">76</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45240615e853-wk-Fact-D0D72AD2F7EF4FAFD7E1CCD3133E812F" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2017Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">78</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of total revenues for </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, and approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45240615e870-wk-Fact-BABCA966275889EC24C2CCD313699766" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2019Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">69</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45240615e874-wk-Fact-D099732EAB399864CDB1CCD3136A355C" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">76</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of total accounts receivable as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively. Because accounts receivable consists primarily of am</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ounts due from the USG for product sales and from government agencies under government grants and development contracts, management does not deem the credit risk to be significant.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Financial Institutions</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Cash and cash equivalents are maintained with several financial institutions. The Company has deposits held with banks that exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with financial institutions of reputable credit and, therefore, bear minimal credit risk.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Lender Counterparties</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">There is lender counterparty risk associated with the Company's revolving credit facility and derivatives instruments. There is risk that the Company&#8217;s revolving credit facility investors and derivative counterparties will not be available to fund as obligated. If funding under the revolving credit facility is unavailable, the Company may have to acquire a replacement credit facility from different counterparties at a higher cost or may be unable to find a suitable replacement. The Company seeks to manage risks from its revolving credit facility and derivative instruments by contracting with experienced large financial institutions and monitoring the credit quality of its lenders. As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company did not anticipate nonperformance by any of its counterparties.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:InventoryPolicyTextBlock" id="TextSelection-CC789D15256543043027F19361C748A5-0-wk-Fact-B58488A6BFA5ADEDF047F1936C428DD2" continuedAt="TextSelection-CC789D15256543043027F19361C748A5-1" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Inventories</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Inventories are stated at the lower of cost or net realizable value with cost being determined using a standard cost method, which approximates average cost. Average cost consists primarily of material, labor and manufacturing overhead expenses (including fixed production-overhead costs) and includes the services and products of third-party suppliers. </span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">78</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-3" continuedAt="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-4"><ix:continuation id="TextSelection-CC789D15256543043027F19361C748A5-1"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company analyzes its inventory levels quarterly and writes down, in the applicable period, inventory that has become obsolete, inventory that has a cost basis in excess of its expected net realizable value and inventory in excess of expected customer demand. The Company also writes off, in the applicable period, the costs related to expired inventory.&#160;Costs of purchased inventories are recorded using weighted-average costing. The Company determines normal capacity for each production facility and allocates fixed production-overhead costs on that basis.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company records inventory acquired in business acquisitions utilizing the comparative sales method, which estimates the expected sales price reduced for all costs expected to be incurred to complete/dispose of the inventory with a profit on those costs.</span></div></ix:continuation><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="TextSelection-323780F717CBF4DF833BF193C3C7D3E4-0-wk-Fact-A9E0C61A8B8C934FC6E4F193D084FB5E" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Property, plant and equipment</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="TextSelection-B0B0A514FF698F398244B1BFD31465F7-0-wk-Fact-006A5E33EE6989AB4A33B1C4F31293B7" continuedAt="TextSelection-31580DDCE09488D758FFCCD313BCA4D7-0" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Property, plant and equipment are stated at cost less accumulated depreciation and impairments. Depreciation is computed using the straight-line method over the following estimated useful lives:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:52%;"></td><td style="width:48%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Buildings</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">31-39 years</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Building improvements</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10-39 years</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Furniture and equipment</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3-15 years</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Software</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3-7 years or product life</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Leasehold improvements</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lesser of the asset life or lease term</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is credited or charged to operations. Repairs and maintenance costs are expensed as incurred.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company capitalizes internal-use software when both (a) the software is internally developed, acquired, or modified solely to meet the entity&#8217;s internal needs and (b) during the software&#8217;s development or modification, no substantive plan either exists or is being developed to market the software externally. Capitalization of qualifying internal-use software costs begins when the preliminary project stage is completed, management with the relevant authority, implicitly or explicitly, authorizes and commits to the funding of the software project, and it is probable that the project will be completed and the software will be used to perform the function intended.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determines the fair value of the property, plant and equipment acquired in a business combination utilizing either the cost approach or the sales comparison approach. The cost approach is determined by establishing replacement cost of the ass</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">et and then subtracting any value that has been lost due to economic obsolescence, functional obsolescence, or physical deterioration. The sales comparison approach determines an asset is equal to the market price of an asset of comparable features such as design, location, size, construction, materials, use, capacity, specification, operational characteristics and other features or descriptions.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:IncomeTaxPolicyTextBlock" id="TextSelection-59F20EBE867EC8FDF910F19430CB454B-0-wk-Fact-E30DB2E59C60ABB56EB7F1943BF47664" continuedAt="TextSelection-59F20EBE867EC8FDF910F19430CB454B-1" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Income taxes</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Income taxes are accounted for using the liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss and research and development tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Deferred income tax effects of transactions reported in different periods for financial reporting and income tax return purposes are recognized under the asset and liability method of accounting for income taxes. This method gives consideration to the future tax consequences of the deferred income tax items and immediately recognizes changes in income tax laws in the year of enactment. On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (the &#8220;Tax Reform Act&#8221;). Further information on the tax impacts of the Tax Reform Act is included in Note </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">12</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of the Company&#8217;s consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's ability to realize deferred tax assets depends upon future taxable income as well as the limitations discussed below. For financial reporting purposes, a deferred tax asset must be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax assets will not be realized prior to expiration. The Company considers future taxable income and ongoing tax planning strategies in assessing the need for valuation allowances. In general, if the Company determines that it is more likely than not to realize more than the recorded amounts of net deferred tax assets in the future, the Company will reverse all or a portion of the valuation allowance </span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">79</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-4" continuedAt="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-5"><ix:continuation id="TextSelection-59F20EBE867EC8FDF910F19430CB454B-1"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">established against its deferred tax assets, resulting in a decrease to the provision for income taxes in the period in which the determination is made. Likewise, if the Company determines that it is not more likely than not to realize all or part of the net deferred tax asset in the future, the Company will establish a valuation allowance against deferred tax assets, with an offsetting increase to the provision for income taxes, in the period in which the determination is made.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Under sections 382 and 383 of the Internal Revenue Code, if an ownership change occurs with respect to a "loss corporation", as defined therein, there are annual limitations on the amount of net operating losses and deductions that are available. The Company has recognized the portion of net operating losses and research and development tax credits acquired that will not be limited and are more likely than not to be realized.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Because tax laws are complex and subject to different interpretations, significant judgment is required. As a result, the Company makes certain estimates and assumptions, in (1)&#160;calculating the Company's income tax expense, deferred tax assets and deferred tax liabilities, (2)&#160;determining any valuation allowance recorded against deferred tax assets and (3)&#160;evaluating the amount of u</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">nrecognized tax benefits, as well as the interest and penalties related to such uncertain tax positions. The Company's estimates and assumptions may differ significantly from tax benefits ultimately realized.</span></div></ix:continuation><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:InProcessResearchAndDevelopmentPolicy" id="TextSelection-FDF821C3F6296D86BEB7F194A7D69284-0-wk-Fact-E2D5BE550E485113F1A7F194B36C4113" continuedAt="TextSelection-FDF821C3F6296D86BEB7F194A7D69284-1" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Acquisitions</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In determining whether an acquisition is a business combination versus an asset acquisition, the accounting guidance requires an entity to first evaluate whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If that threshold is met, the set of assets and activities is not a business and therefore treated as an asset acquisition. If that threshold is not met, the entity evaluates whether the set meets the definition of a business. If an acquired asset or asset group does not meet the definition of a business, the transaction is accounted for as an asset acquisition. Otherwise, the acquisition is treated as a business combination.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In a business combination, the acquisition method of accounting requires that the assets acquired and liabilities assumed be recorded as of the date of the merger or acquisition at their respective fair values with limited exceptions and generally use Level 3 fair value measurements. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Accordingly, the Company may be required to value assets at fair values that do not reflect the Company's intended use of those assets. Any excess of the purchase price (consideration transferred) over the estimated fair values of net assets acquired is recorded as goodwill. Transaction costs and costs to restructure the acquired company are expensed as incurred. The operating results of the acquired business are reflected in the Company's consolidated financial statements after the date of the merger or acquisition. If the Company determines the assets acquired do not meet the definition of a business under the acquisition method of accounting, the transaction will be accounted for as an asset acquisition and recorded at cost rather than a business combination and, therefore, no goodwill will be recorded.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair values of intangible assets, including acquired in-process research and development ("IPR&amp;D"), are determined utilizing information available at or near the merger or acquisition date based on expectations and assumptions that are deemed reasonable by management. Given the considerable judgment involved in determining fair values, the Company typically obtains assistance from third-party valuation specialists for significant items. Amounts allocated to acquired IPR&amp;D are capitalized and accounted for as indefinite-lived intangible assets. Upon successful completion of each project, the Company will make a separate determination as to the remaining useful life of the asset and begin amortization. The judgments made in determining estimated fair values assigned to assets acquired and liabilities assumed in a business combination, as well as asset lives, can materially affect the Company&#8217;s results of operations.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair values of identifiable intangible assets related to current products and product rights are primarily determined by using an income approach through which fair value is estimated based on each asset&#8217;s discounted projected net cash flows. The Company's estimates of market participant net cash flows consider historical and projected pricing, margins and expense levels, the performance of competing products where applicable, relevant industry and therapeutic area growth drivers and factors, current and expected trends in technology and product life cycles, the time and investment that will be required to develop products and technologies, the ability to obtain marketing and regulatory approvals, the ability to manufacture and commercialize the products, the extent and timing of potential new product introductions by the Company&#8217;s competitors, and the life of each asset&#8217;s underlying patent, if any. The net cash flows are then probability-adjusted where appropriate to consider the uncertainties associated with the underlying assumptions, as well as the </span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">80</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-5" continuedAt="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-6"><ix:continuation id="TextSelection-FDF821C3F6296D86BEB7F194A7D69284-1"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">risk profile of the net cash flows utilized in the valuation. The probability-adjusted future net cash flows of each product are then discounted to present value utilizing an appropriate discount rate.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair values of identifiable intangible assets related to IPR&amp;D are determined using an income approach, through which fair value is estimated based on each asset&#8217;s probability-adjusted future net cash flows, which reflect the different stages of development of each product and the associated probability of successful completion. The net cash flows are then discounted to present value using an appropriate discount rate. Indefinite-lived intangible assets are tested for impairment annually or whenever events or changes in circumstances indicate that its carrying amount may not be recoverable.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Assets acquired and liabilities assumed in a business combination that arise from contingencies are recognized at fair value if fair value can reasonably be estimated. If the acquisition date fair value of an asset acquired or liability assumed that arises from a contingency cannot be determined, the asset or liability is recognized if probable and reasonably estimable</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">; if these criteria are not met, no asset or liability is recognized.</span></div></ix:continuation><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="TextSelection-768B7F1FE0988BB1C632F19631BF40A9-0-wk-Fact-8D5821EC7982CB8B0B34F1965A8163A1" continuedAt="TextSelection-768B7F1FE0988BB1C632F19631BF40A9-1" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Asset Impairment Analysis</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Goodwill and Indefinite-lived Intangible Assets</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Goodwill is allocated to the Company's reporting units, which are one level below its operating segment. The Company evaluates goodwill and other indefinite-lived intangible assets for impairment annually as of October&#160;1 and earlier if an event or other circumstance indicates that we may not recover the carrying value of the asset. If the Company believes that as a result of its qualitative assessment it is more likely than not that the fair value of a reporting unit or other indefinite-lived intangible asset is greater than its carrying amount, the quantitative impairment test is not required. If however it is determined that it is not more likely than not that the fair value of a reporting unit or other indefinite-lived intangible asset is greater than its carrying amount, a quantitative test is required.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The quantitative goodwill impairment test is performed using a two-step process. The first step of the process is to compare the fair value of a reporting unit with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is not impaired and the second step of the quantitative impairment test is not necessary. If the carrying amount of a reporting unit exceeds its fair value, the second step of the quantitative goodwill impairment test is required to be performed to measure the amount of impairment loss, if any. The second step of the quantitative goodwill impairment test compares the implied fair value of the reporting unit&#8217;s goodwill with the carrying amount of that goodwill. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination. In other words, the estimated fair value of the reporting unit&#8217;s identifiable net assets excluding goodwill is compared to the fair value of the reporting unit as if the reporting unit had been acquired in a business combination and the fair value of the reporting unit was the purchase price paid. If the carrying amount of the reporting unit&#8217;s goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to that excess. The Company used a qualitative assessment for our goodwill impairment testing for </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The qualitative evaluation completed during the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> indicated </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45240615e1099-wk-Fact-AFB6BE6361EF0042208EF200ABD1AEF4" name="us-gaap:GoodwillImpairmentLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> impairment losses. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has mater</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ial indefinite lived intangible assets associated with in-process research and development (IPR&amp;D) which were acquired as part of the acquisitions completed in the fourth quarter of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Following a qualitative assessment indicating that it is not more likely than not that the fair value of the indefinite lived intangible asset exceeds its carrying amount, impairment of other intangible assets not subject to amortization involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. Determining fair value requires the exercise of judgment about appropriate discount rates, perpetual growth rates and the amount and timing of expected future cash flows.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> The Company used a quantitative assessment for our IPR&amp;D impairment testing for </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and determined there was an impairment loss of $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45240615e1120-wk-Fact-C32FD711B872DB8478CBB1501BA3B71C" name="us-gaap:GoodwillImpairmentLoss" contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.0</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million, which was recorded as a component of R&amp;D expense (see Notes </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">4</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Acquisitions</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">5</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Fair value measurements</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">). </span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Long-lived Assets</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Long-lived assets such as intangible assets and property, plant and equipment are not required to be tested for impairment annually. Instead, long-lived assets are tested for impairment whenever circumstances indicate that the carrying amount of the asset may not be recoverable, such as when the disposal of such assets is likely or there is an adverse change in the market involving the business employing the related assets. If an impairment analysis is required, the impairment test employed is based on whether the Company&#8217;s intent is to hold the asset for continued use or to hold the asset for sale. If the intent is to hold the asset for continued use, the impairment test first requires a comparison </span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">81</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-6" continuedAt="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-7"><ix:continuation id="TextSelection-768B7F1FE0988BB1C632F19631BF40A9-1"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">of undiscounted future cash flows to the carrying value of the asset. If the carrying value of the asset exceeds the undiscounted cash flows, the asset would not be deemed to be recoverable. Impairment would then be measured as the excess of the asset&#8217;s carrying value over its fair value. Fair value is typically determined by discounting the future cash flows associated with that asset. If the intent is to hold the asset for sale and certain other criteria are met, the impairment test involves comparing the asset&#8217;s carrying value to its fair value less costs to sell. To the extent the carrying value is greater than the asset&#8217;s fair value less costs to sell, an impairment loss is recognized in an amount equal to the difference. Significant judgments used for long-lived asset impairment assessments include identifying the appropriate asset groupings and primary assets within those groupings, determining whether events or circumstances indicate that the carrying amount of the asset may not be recoverable, determining the future cash flows for the assets involved and assumptions applied in determining fair value, which include, reasonable discount rates, growth rates, market risk premiums and other assumptions about the economic environment.</span></div></ix:continuation><ix:nonNumeric contextRef="FD2019Q4YTD" name="ebs:ContingentConsiderationObligationsPolicyTextBlock" id="TextSelection-D9C7E11492424F7DC88CF196BF73B22D-0-wk-Fact-377C44902BE1BB80C62CF196CC47C085" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Contingent Consideration</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In connection with the Company's acquisitions accounted for as business combinations, the Company records contingent consideration associated with sales-based royalties, sales-based milestones and development and regulatory milestones at fair value. The fair value model used to calculate these obligations is based on the income approach (a discounted cash flow model) that has been risk adjusted based on the probability of achievement of net sales and achievement of the milestones. The inputs the Company uses for determining the fair value of the contingent consideration associated with sales-based royalties, sales-based milestones and development and regulatory milestones are Level 3 fair value measurements. The Company re-evaluates the fair value on a quarterly basis. Changes in the fair value can result from adjustments to the discount rates and updates in the assumed timing of or achievement of net sales and/or the achievement of development and regulatory milestones. Any future increase in the fair value of the contingent consideration associated with sales-based royalties and sales-based milestones along with development and regulatory milestones are based on an increased likelihood that the underlying net sales or milestones will be achieved.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The associated payments which will become due and payable for sales-based royalties and milestones result in a charge to cost of product sales and contract development and manufacturing in the period in which the increase is determined. Similarly, any future decrease in the fair value of contingent consideration associated with sales-based royalties and sales-based milestones will result in a reduction in cost of product sales and contract development and manufacturing. The changes in fair value for potential future sales-based royalties associated with product candidates in development will result in a charge to cost o</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">f product sales and contract development and manufacturing services </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">expense in the period in which the increase is determined. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The associated payment or payments which will become due and payable for development and regulatory milestones will result in a charge to research and development expense in the period in which the increase is determined. Similarly, any future decrease i</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">n the fair value for development and regulatory milestones will result in a reduction in research and development expense.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="TextSelection-0110B4198BD9556F81CFF19771237D7F-0-wk-Fact-A256E164467882FF9ED5F1977FD26BEF" continuedAt="TextSelection-0110B4198BD9556F81CFF19771237D7F-1" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Revenue recognition</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On January 1, 2018 the Company adopted ASC topic 606 using the modified retrospective approach applied to those contracts in effect as of January 1, 2018. Under this transition method, results for reporting periods beginning after January 1, 2018 are presented under the new standard, while prior period amounts are not adjusted and continue to be reported in accordance with historical accounting under Topic 605. See further discussion of the adoption of Topic 606, including the impact to our 2018 financial statements within the recently issued accounting standards section below.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company recognizes revenue when the Company's customers obtain control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services by analyzing the following five steps: (1) identify the contract with a customer(s); (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">contract; and (5) recognize revenue when (or as) the entity satisfies a performance obligation. To indicate the transfer of control for the Company&#8217;s product sales and contract development and manufacturing services, it must have a present right to payment, legal title must have passed to the customer, and the customer must have the significant risks and rewards of ownership. Revenue for long-term development contracts is generally recognized based upon the cost-to-cost measure of progress, provided that the Company meets the criteria associated with transferring control of the good or service over time.</span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">82</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-0110B4198BD9556F81CFF19771237D7F-1" continuedAt="TextSelection-0110B4198BD9556F81CFF19771237D7F-2"><ix:continuation id="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-7" continuedAt="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-8"><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Multiple performance obligations</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. Contracts sometimes include options for customers to purchase additional products or services in the future. Customer options that provide a material right to the customer, such as free or discounted products or services, give rise to a separate performance obligation. For contracts with multiple performance obligations, the Company allocates the contract price to each performance obligation on a relative standalone selling price basis using the Company&#8217;s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers, however when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the contracts&#8217; inception.  </span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Transaction price and variable consideration</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Once the performance obligations in the contract have been identified, the Company estimates the transaction price of the contract. The estimate includes amounts that are fixed as well as those that can vary based on expected outcomes of the activities or contractual terms. The Company's variable consideration includes for example consideration transferred under its development contracts with the USG as consideration received can vary based on developmental progression of the product candidate(s). When a contract's transaction price includes variable consideration, the Company evaluates the variable consideration to determine whether the estimate needs to be constrained; therefore, the Company includes the variable consideration in the transaction price only to the extent that it is probable that a significant reversal of the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Variable consideration estimates are updated at each reporting date. There were </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">no</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> significant constraints or material changes to the Company's variable consideration estimates as of or during the twelve months ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Contract financing</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money if the timing of payments agreed to by the parties to the contract (either explicitly or implicitly) provides the customer with a significant benefit of financing the transfer of goods or services to the customer, which is called a significant financing component. The Company does not adjust transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Product sales</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">CBRNE</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The primary customer for the Company's CBRNE&#160;products and the primary source of funding for the development of its CBNRE product candidate portfolio is the USG. The Company's contracts for the sale of CBRNE products generally have a single performance obligation. Certain product sales contracts with the USG include multiple performance obligations, which generally include the marketed product, stability testing associated with that product, expiry extensions and plasma collection. The USG contracts for the sale of the Company's CBRNE&#160;products are normally multi-year contracts. AV7909 and Trobigard are product candidates that are not approved by the FDA or any other health agency, but are procured by certain government agencies under special circumstances. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The transaction price for product sales are based on a cost build-up model with a mark-up. For our product sales, we recognize revenue at a "point in time" when the Company&#8217;s performance obligations have been satisfied and control of the products transfer to the customer. This &#8220;point in time&#8221; depends on several factors, including delivery, transfer of legal title, transition of risk and rewards of the product to the customer and the Company's right to payment. The USG contracts for the sale of the Company's CBRNE products also include certain acceptance criteria before title passes to the USG.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Opioid and travel health products </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Revenues are recognized when control of the goods are transferred to our customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Prior to recognizing revenue, the Company makes estimates of the transaction price, including variable consideration that is subject to a constraint. Allowances for returns, specialty distributor fees, wholesaler fees, prompt payment discounts, government </span></div></ix:continuation></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">83</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-8" continuedAt="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-9"><ix:continuation id="TextSelection-0110B4198BD9556F81CFF19771237D7F-2" continuedAt="TextSelection-0110B4198BD9556F81CFF19771237D7F-3"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">rebates, chargebacks and rebates under managed care plans are considered in determining the variable consideration. Revenues from sales of products is recognized to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with such variable consideration is subsequently resolved. Product sales revenue is recognized when control has transferred to the customer, which occurs at a point in time, which is typically upon delivery to the customer. Provisions for variable consideration revenues from sales of products are recorded at the net sales price, which includes estimates of variable consideration for which provisions are established and which relate to returns, specialty distributor fees, wholesaler fees, prompt payment discounts, government rebates, chargebacks and rebates under managed care plans. Calculating certain of these provisions involves estimates and judgments and the Company determines their expected value based on sales or invoice data, contractual terms, historical utilization rates, new information regarding changes in these programs&#8217; regulations and guidelines that would impact the amount of the actual rebates, the Company's expectations regarding future utilization rates for these programs and channel inventory data. These provisions reflect the Company's best estimate of the amount of consideration to which the Company is entitled based on the terms of the contract. The amount of variable consideration that is included in the transaction price may be constrained and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. The Company reassesses the Company's provisions for variable consideration at each reporting date. Historically, adjustments to estimates for these provisions have not been material.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Provisions for returns, specialty distributor fees, wholesaler fees, government rebates and rebates under managed care plans are included within current liabilities in the Company's consolidated balance sheets. Provisions for chargebacks and prompt payment discounts are shown as a reduction in accounts receivable.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:normal;">Contract development and manufacturing services</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company performs contract development and manufacturing services for third parties. Under these contracts, activities can include pharmaceutical product process development, manufacturing and filling services for injectable and other sterile products, inclusive of process design, technical transfer, manufacturing validations, laboratory analytical development support, aseptic filling, lyophilization, final packaging and accelerated and ongoing stability studies. These contracts, with a duration that is less than one year, generally include a single performance obligation as the customer benefits from our performance upon full completion of our services. The performance obligation is satisfied when the Company must have a present right to payment because legal title has passed to the customer, the goods are in the customer&#8217;s possession with all the risks and rewards of ownership, and the efficacy of the goods has been confirmed. The Company recognizes revenue at a "point in time" based on when the performance obligation to the customer is satisfied.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:normal;">Contracts and grants</span></div></ix:continuation><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><ix:continuation id="TextSelection-0110B4198BD9556F81CFF19771237D7F-3">The Company generates contract and grant revenue primarily from cost-plus-fee contracts associated with development of certain product candidates. Revenues from reimbursable contracts are recognized as costs are incurred, generally based on allowable costs incurred during the period, plus any recognizable earned fee. The Company uses this input method to measure progress as the customer has the benefit of access to the development research under these projects and therefore benefits from the Company's performance incrementally as research and development activities occur under each project. We consider fixed fees under cost-plus-fee contracts to be earned in proportion to the allowable costs incurred in performance of the contract. We analyze costs for contracts and reimbursable grants to ensure reporting of revenues gross versus net is appropriate. Revenue for long-term development contracts is considered variable consideration, because the deliverable is dependent on the successful completion of development and is generally recognized based upon the cost-to-cost measure of progress, provided that the Company meets the criteria associated with satisfying the performance obligation over time. The USG contracts for the development of the Company's CBRNE product candidates are normally multi-year contracts.</ix:continuation> </span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="TextSelection-FBD13A00EEB20DE07F85F197F2FFCF2C-0-wk-Fact-3D2A1D70C7A71F0E9F1AF19820FF678D" continuedAt="TextSelection-FBD13A00EEB20DE07F85F197F2FFCF2C-1" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Research and development</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We expense research and development costs as incurred. The Company's research and development expenses consist primarily of:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">personnel-related expenses;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">fees to professional service providers for, among other things, analytical testing, independent monitoring or other administration of the Company's clinical trials and obtaining and evaluating data from the Company's clinical trials and non-clinical studies;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">costs of contract development and manufacturing services for clinical trial material; and</span></div></td></tr></table></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">84</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-9" continuedAt="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-10"><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-FBD13A00EEB20DE07F85F197F2FFCF2C-1" continuedAt="TextSelection-FBD13A00EEB20DE07F85F197F2FFCF2C-2"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-FBD13A00EEB20DE07F85F197F2FFCF2C-2"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">costs of materials used in clinical trials and research and development.</span></div></ix:continuation></td></tr></table><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="TextSelection-EA765559BFCEAD3EB914F198568C9AB5-0-wk-Fact-6CA20C41BBC439B0EE71F1986B37C57A" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Comprehensive income</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Comprehensive income is comprised of net income and other changes in equity that are excluded from net income. The Company includes translation gains and losses incurred when converting its subsidiaries' financial statements from their functional currency to the U.S. dollar in accumulated other comprehensive income as well as gains and losses on its pension benefit obligation and derivative instruments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="TextSelection-0262A720728023542CC8F198ABACDF53-0-wk-Fact-FF3664D3AEAA7426C0C3F198B5B1AC21" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Translation of Foreign Currencies</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For our non-U.S. subsidiaries that transact in a functional currency other than the U.S. dollar, assets and liabilities are translated at current rates of exchange at the balance sheet date. Income and expense items are translated at the average foreign currency exchange rates for the period. Adjustments resulting from the translation of the financial statements of our foreign operations into U.S.&#160;dollars are excluded from the determination of net income and are recorded in accumulated other comprehensive income, a separate component of equity. For subsidiaries where the functional currency of the assets and liabilities differ from the local currency, non-monetary assets and liabilities are translated at the rate of exchange in effect on the date assets were acquired while monetary assets and liabilities are translated at current rates of exchange as of the balance sheet date. Income and expense items are translated at the average foreign currency rates for the period. Translation adjustments of these subsidiaries are included in other income (expense), net in our consolidated statements of income.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:EarningsPerSharePolicyTextBlock" id="TextSelection-F52CD9519909335380A3F1996165CB30-0-wk-Fact-082A626E6BC6D6F9FCC9F1996FFBCB5B" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Earnings per share</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company calculates basic earnings per share by dividing net income by the weighted average number of shares of common stock outstanding during the period.</span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company calculated diluted earnings per share using the treasury method by dividing net income by the weighted average number of shares of common stock outstanding during the period. For the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company calculated diluted earnings per share using the if-converted method by dividing the adjusted net income by the adjusted weighted average number of shares of common stock outstanding during the period. The adjusted net income was adjusted for interest expense and amortization of debt issuance cost, both net of tax, associated with the Company's </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45240615e1328-wk-Fact-B6C5D12B6E07FF53C461F1B2EE69E907" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">2.875</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Convertible Senior Notes due 2021 (the "Notes"). The weighted average number of diluted shares was adjusted for the potential dilutive effect of the exercise of stock options and the vesting of restricted stock units along with the assumption of the conversion of the Notes, each at the beginning of the period. During the fourth quarter of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company issued a notice of termination of conversion rights related to the Notes and issued </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45240615e1337-wk-Fact-DF35E9F91486E3617F7D18CF7F2B187C" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="FD2017Q4QTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">8.5</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares of common stock due to conversions that occurred in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. After the date of conversion and during the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Notes are strictly debt instruments and, therefore, no longer impact the diluted earnings per share calculation. </span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="TextSelection-17E83EAFEBC2D78963C9F199EF33BDF3-0-wk-Fact-35B4737EF649724ADC84F199FAACD799" continuedAt="TextSelection-17E83EAFEBC2D78963C9F199EF33BDF3-1" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Accounting for stock-based compensation</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45240615e1360-wk-Fact-B838AB8DB68657D87615CCD3133826AD" name="ebs:NumberOfStockbasedEmployeeCompensationPlans" contextRef="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentPlansMember" unitRef="plan" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> stock-based employee compensation plan, the Emergent BioSolutions Inc. Stock Incentive Plan (the "Emergent Plan"), under which the Company may grant various types of equity awards including stock options,  restricted stock units and performance stock units.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The terms and conditions of equity awards (such as price, vesting schedule, term and number of shares) under the Emergent Plan is determined by the compensation committee of the Company's board of directors, which administers the Emergent Plan. Each equity award granted under the Emergent Plan vests as specified in the relevant agreement with the award recipient and no option can be exercised after either </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">seven</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> or </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45240615e1371-wk-Fact-776E5A2BF027BCC1F056CCD3131E699D" name="ebs:ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod" contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentPlansMember" format="ixt-sec:durwordsen">ten years</ix:nonNumeric></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> from the date of grant depending on the grant date. The Company charges the estimated fair value of awards against income on a straight-line basis over the requisite service period, which is generally the vesting period. Where awards are made with non-substantive vesting periods (for instance, where a portion of the award vests upon retirement eligibility), the Company estimate and recognize expense based on the period from the grant date to the date the employee becomes retirement eligible.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determines the fair value of restricted stock units using the closing market price of the Company's common stock on the day prior to the date of grant. The Company's performance stock units settle in stock. The fair value is determined on the date of the grant using the number of shares expected to be earned and the ending market value of the stock on the grant date. The number of shares expected to vest is determined by assessing the probability that the performance criteria will be met and the associated targeted payout level that is forecasted will be achieved. </span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">85</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-10" continuedAt="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-11"><ix:continuation id="TextSelection-17E83EAFEBC2D78963C9F199EF33BDF3-1" continuedAt="TextSelection-17E83EAFEBC2D78963C9F199EF33BDF3-2"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company utilizes the Black-Scholes valuation model for estimating the fair value of all stock options granted. Set forth below is a discussion of the Company's methodology for developing each of the assumptions used:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Expected dividend yield &#8212; the Company does not pay regular dividends on its common stock and does not anticipate paying any dividends in the foreseeable future.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Expected volatility &#8212; a measure of the amount by which a financial variable, such as share price, has fluctuated (historical volatility) or is expected to fluctuate (implied volatility) during a period. The Company analyzed its own historical volatility to estimate expected volatility over the same period as the expected average life of the options.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Risk-free interest rate &#8212; the range of U.S. Treasury rates with a term that most closely resembles the expected life of the option as of the date on which the option is granted.</span></div></td></tr></table></ix:continuation><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-17E83EAFEBC2D78963C9F199EF33BDF3-2" continuedAt="TextSelection-17E83EAFEBC2D78963C9F199EF33BDF3-3"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-17E83EAFEBC2D78963C9F199EF33BDF3-3"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Expected average life of options &#8212; the period of time that options granted are expected to remain outstanding, based primarily on the Company's expectation of optionee exercise behavior subsequent to vesting of options.</span></div></ix:continuation></td></tr></table><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:PensionAndOtherPostretirementPlansPensionsPolicy" id="TextSelection-77FFA221F131277FCB5EF19A5AE62FC9-0-wk-Fact-5660FC91CA75E642F7E5F19A65E0E7AE" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Pension plans</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company maintains defined benefit plans for employees in certain countries outside the U.S., including retirement benefit plans required by applicable local law. The plans are valued by independent actuaries using the projected unit credit method. The liabilities correspond to the projected benefit obligations of which the discounted net present value is calculated based on years of employment, expected salary increase, and pension adjustments. The Company reviews its actuarial assumptions on an annual basis and makes modifications to the assumptions based on current rates and trends. Actuarial gains and losses are deferred in accumulated other comprehensive income, net of tax and are amortized over the remaining service attribution periods of the employees under the corridor method. Differences between the expected long-term return on plan assets and the actual annual return are amortized to net periodic benefit cost over the estimated remaining life as a component of selling, general and administrative expenses in the consolidated statements of operations.</span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Derivative Instruments and Hedging Activities</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's interest rate swaps qualify for hedge accounting as cash flow hedges. All derivatives are recorded on the balance sheet at fair value.&#160;Hedge accounting provides for the matching of the timing of gain or loss recognition on these interest rate swaps with the recognition of the changes in interest expense on the Company's variable rate debt. For derivatives designated as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt. The cash flows from the designated interest rate swaps are classified as a component of operating cash flows, similar to interest expense.&#160;</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="TextSelection-0250C4B1801341933685F19B0C87590E-0-wk-Fact-BF5DF0E44CB8C6F7130CF19B1A0DCF82" continuedAt="TextSelection-0250C4B1801341933685F19B0C87590E-1" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Recently issued accounting standards</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Recently Adopted</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2016-2,&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Leases (Topic 842)</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;("ASU 2016-2")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In February 2016, the FASB issued ASU 2016-2. ASU 2016-2 increased transparency and comparability among organizations by requiring the recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements for both lessees and lessors. The Company adopted the new standard effective January 1, 2019 using the modified retrospective approach. An entity that applies the transition provisions at the beginning of the period of adoption records its cumulative adjustment to the opening balance of retained earnings in the period of adoption rather than in the earliest period presented (i.e., January 1, 2019). In this case, an entity continues to apply the legacy guidance in ASC 840, including its disclosure requirements, in the comparative periods presented in the year it adopts the standard.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company utilized the transition package of certain practical expedients permitted: ASC 842-10-65-1(f) and ASC 842-10-65-1(g). The Company made an accounting policy election that kept leases with an initial term of 12 months or less off of the balance sheet which resulted in recognizing those lease payments in the consolidated statements of operations on a straight-line basis over the lease term. In addition, the Company has made an accounting policy election, by class of underlying asset, to not separate non-lease components from lease components and instead to account </span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">86</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-0250C4B1801341933685F19B0C87590E-1" continuedAt="TextSelection-0250C4B1801341933685F19B0C87590E-2"><ix:continuation id="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-11" continuedAt="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-12"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">for each separate lease component, and the non-lease components associated with that lease component, as a single lease component.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">January&#160;1, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> the total right of use assets increased </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45240615e1456-wk-Fact-533B1E946F42F1C2DFA99268D858489C" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="I2019Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.4</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, while total operating lease liabilities increased </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45240615e1460-wk-Fact-2347D449B77A8E9C11B0926921CB2E33" name="us-gaap:OperatingLeaseLiability" contextRef="I2019Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. There was no adjustment to the opening balance of retained earnings as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">January&#160;1, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The standard has not materially affect the Company's consolidated net earnings. The Company continues to apply the legacy guidance from the old lease accounting standard, including its disclosure requirements, in the comparative periods presented (see Note </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">14</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">).</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU No. 2014-9, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Revenue from Contracts with Customers (Topic 606)</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> ("ASU 2014-9")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In May 2014, the Financial Accounting Standards Board ("FASB") issued ASU No. 2014-9. ASU No. 2014-9 (known as ASC 606) supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, as well as most industry-specific guidance, and significantly enhances comparability of revenue recognition practices across entities and industries by providing a principles-based, comprehensive framework for addressing revenue recognition issues. The Company adopted ASC 606 as of January 1, 2018 using the modified retrospective method resulting in an adjustment to opening retained earnings of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45240615e1488-wk-Fact-6E4D9BB564ADA5C9B891CCD3136BC891" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" contextRef="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.5</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the cumulative effect of initially applying the new standard.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Under ASC 606, the Company finalized the review of its portfolio of revenue contracts that were not complete as of the adoption date and made its determination of its revenue streams as well as completed extensive contract specific reviews to determine the impact of the new standard on its historical and prospective revenue recognition. Because many of the Company's significant contracts with customers have unique contract terms, the Company reviewed all its non-standard agreements in order to determine the effect of adoption. The Company tested a sample of remaining agreements to verify that there were no changes in accounting based on the assumption that these contracts had similar characteristics and that the effects on the financial statements would not differ materially from applying this guidance to the individual contracts. To estimate the financial impacts of the adoption, the Company did not apply the contract modification practical expedient and retrospectively restated long-term contracts for any contract modifications.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The opening balance sheet adjustment as of January 1, 2018, was the result of the Centers for Innovation in Advanced Development and Manufacturing ("CIADM") contract with the Biomedical Advanced Research and Development Authority ("BARDA"). Under ASC 606 at January 1, 2018, the Company determined that the performance obligation under the arrangement is to provide ongoing manufacturing capability to the USG and would recognize the consideration received in the initial </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45240615e1499-wk-Fact-4AE058FD8E574C283C34CCD31367B3CF" name="ebs:BasePeriod" contextRef="FD2019Q4YTD_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember" format="ixt-sec:duryear">7</ix:nonNumeric> years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> year base period on a straight-line basis over a </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45240615e1503-wk-Fact-2A28AB43CD87391F920AF1F66176E3A2" name="ebs:TermofContract" contextRef="FD2019Q4YTD_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember" format="ixt-sec:duryear">24</ix:nonNumeric></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">-year period as the capability being created during the base period of the contract is being provided to the customer over both the base period contract term as well as </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45240615e1507-wk-Fact-05ED3174192790F5AD0ECCD3133F8AD0" name="ebs:NumberofAdditionalOptionPeriods" contextRef="FD2019Q4YTD_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember" unitRef="U004" decimals="INF" scale="0" format="ixt:numdotdecimal">17</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> additional option periods. As the Company&#8217;s performance obligation is providing the USG with continuous access to its production capabilities throughout the contract duration, a time-based measure resulting in straight-line revenue recognition is proportionate to the Company&#8217;s progress in satisfying the performance obligation when compared to the total progress. This measure of progress is most reflective of the Company satisfying the performance obligation over time. Beginning in June 2013, the Company was expected to be able to stand ready and be available to respond to the USG and importantly to respond to any task orders that may be issued during the base period and additional option periods. Being able to stand ready to perform in the event of an outbreak is of importance to the USG and by entering into this arrangement with the Company, the USG expected to receive the benefit of having access to Company&#8217;s readiness and its capability to immediately respond to public health threats. The Company concluded the identified stand-ready performance obligations represent a series of distinct services that are substantially the same and have the same pattern of transfer to the customer.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition, the Company determined the CIADM contract includes a significant financing component which is included in the transaction price. The Company calculated the financing component using an interest rate the Company had on its other debt obligations at inception of the contract. The difference in revenue recognized under ASC 605 vs. ASC 606, as of the adoption date, was primarily attributable to the difference in the overall consideration or transaction price resulting from different accounting treatment related to options within the contract and the inclusion of a significant financing component under ASC 606.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Prior to the adoption of ASC 606, the Company recognized revenue under the CIADM contract on a straight-line basis, based upon its estimate of the total payments to be received under the contract. The Company analyzes the estimated payments to be received on a quarterly basis to determine if an adjustment to revenue was required. As a result of the adoption of ASC 606, as of January 1, 2018, there was an increase in the deferred revenue liability of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45240615e1520-wk-Fact-C52B0DF8896ACB8EDE95926D9E7AC34A" name="us-gaap:ContractWithCustomerLiability" contextRef="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">42.4</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and an increase in deferred tax assets of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45240615e1524-wk-Fact-70ED0A7A6B58E29D31C8926D435B3E9C" name="us-gaap:DeferredTaxAssetsNet" contextRef="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.9</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> with an offsetting reduction to retained earnings of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45240615e1528-wk-Fact-C06F1F343DA3910F7C59926EDC4B8A12" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" contextRef="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.5</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div></ix:continuation></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">87</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-0250C4B1801341933685F19B0C87590E-2" continuedAt="TextSelection-0250C4B1801341933685F19B0C87590E-3"><ix:continuation id="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-12" continuedAt="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-13"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2018-2,&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Income Statement - Reporting Comprehensive Income (Topic 220):&#160;Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> ("ASU 2018-2")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In February 2018, the FASB issued ASU 2018-2. ASU 2018-2 provides the option to reclassify certain income tax effects related to the Tax Cuts and Jobs Act passed in December of 2017 between accumulated other comprehensive income and retained earnings and also requires additional disclosures.&#160;ASU 2018-2 is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted.&#160;Adoption of ASU 2018-2 is to be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the tax laws or rates were recognized.&#160;The adoption of ASU 2018-2 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Not Yet Adopted</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2016-13,&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">("ASU 2016-13")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In June 2016, the FASB issued ASU 2016-13. ASU 2016-13 provides guidance on measurement of credit losses on financial instruments that changes the impairment model for most financial assets and certain other instruments, including trade and other receivables, held-to-maturity debt securities and loans, and that requires entities to use a new, forward-looking &#8220;expected loss&#8221; model that is expected to generally result in the earlier recognition of allowances for losses. The guidance&#160;became effective for annual periods beginning after December 15, 2019, including interim periods within those years, but early adoption is permitted. The Company has evaluated the effects of this standard and determined that the adoption will not have a material impact on the Company's consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2017-4,&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> ("ASU 2017-4")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In January 2017, the FASB issued ASU 2017-4. ASU 2017-4 simplifies the subsequent measurement of goodwill and eliminates Step 2 from the goodwill impairment test. ASU 2017-4 is effective for annual and interim goodwill tests beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates on or after January 1, 2017. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2018-13,</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">&#160;Fair Value Measurement - Disclosure Framework (Topic 820)&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">("ASU 2018-13")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In August 2018, the FASB issued ASU 2018-13. ASU 2018-13 improves the disclosure requirements on fair value measurements. The updated guidance if effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted for any removed or modified disclosures. The Company is currently assessing the timing and impact of adopting the updated provisions.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2018-14,</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">&#160;Compensation -</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Retirement Benefits - Defined Benefit Plans - General (Topic 715-20):&#160;Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;("ASU 2018-14")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In August 2018, the FASB issued ASU 2018-14. ASU 2018-14 modifies the disclosure requirements for defined benefit pension plans and other post-retirement plans. ASU 2018-14 is effective for all entities for fiscal years ending after December 15, 2020, and earlier adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2018-14 on its consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2018-15,&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> ("ASU 2018-15")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In August 2018, the FASB issued ASU 2018-15. ASU 2018-15 clarifies the accounting for implementation costs in cloud computing arrangements. ASU 2018-15 is effective for all entities for fiscal years beginning after December 15, 2019, and earlier adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2018-15 on its consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2019-12, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Simplifications to Accounting for Income Taxes </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">("ASU 2019-12")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In December 2019, the FASB issued ASU 2019-12. ASU 2019-12 removes certain exceptions for recognizing deferred taxes for investments, performing intra-period allocation and calculating income taxes in interim periods. The ASU also adds guidance to reduce complexity in certain areas, including deferred taxes for goodwill and allocating taxes for members of a consolidated group. ASU 2019-12 is effective for all entities for fiscal years beginning after December </span></div></ix:continuation></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">88</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><ix:continuation id="TextSelection-0250C4B1801341933685F19B0C87590E-3"><ix:continuation id="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-13">15, 2020, and earlier adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2019-12 on its consolidated financial statements.</ix:continuation></ix:continuation> </span></div><div><a id="sC455879DC9545E6A9FF787557777B823"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">3</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="TextSelection-644A3C695C3906857B9CCCD313BB17C8-0-wk-Fact-96673CB49BBCB1A2593FCCD31359A038" continuedAt="TextSelection-644A3C695C3906857B9CCCD313BB17C8-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Revenue recognition</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-644A3C695C3906857B9CCCD313BB17C8-1" continuedAt="TextSelection-644A3C695C3906857B9CCCD313BB17C8-2"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company operates in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45242871e735-wk-Fact-2D4184C2A4BFC1DCCBE4CCD3135C647E" name="us-gaap:NumberOfOperatingSegments" contextRef="FD2019Q4YTD" unitRef="segment" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> business segment. Therefore, results of the Company's operations are reported on a consolidated basis for purposes of segment reporting, consistent with internal management reporting.&#160;</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="TextSelection-F9483EF5767AE9F862EBCCD313BB7640-0-wk-Fact-646987C387ECE45176BBCCD31346D431" continuedAt="TextSelection-F9483EF5767AE9F862EBCCD313BB7640-1" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> the Company's&#160;revenues disaggregated by the major sources was as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="36"></td></tr><tr><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="35" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">U.S</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Non-U.S.</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">U.S</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Non-U.S.</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">U.S</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Non-U.S.</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">Product sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e1382-wk-Fact-87C800322451665605A8EC944BE6C164" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">568.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e1401-wk-Fact-9B3F3FB68206F1D842DEEC944C03CE60" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">334.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e1420-wk-Fact-550DB7545370460F2298CCD31390DFC6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">903.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1440-wk-Fact-ED65F311E8CF9CB97757CDB6789016C4" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">526.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1459-wk-Fact-D7CC21FD5E6BB5E18120CDB6785E0F1F" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">80.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1479-wk-Fact-3810A958B43C733CFB24CCD3138A0CA4" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">606.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1498-wk-Fact-B7CEC24876BFDBAEBB64CDB678D39BA8" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">374.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1517-wk-Fact-9481E316B235E5CC24EECDB678E226B3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">46.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1537-wk-Fact-E3F5520D7C718745B7DFCCD3138C7AFB" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">421.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">Contract development and manufacturing services</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e1552-wk-Fact-BD5F9ED73A8506F29649EC944BEB8C83" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e1571-wk-Fact-7CFAED2889DB1AB95E9CEC944C088D9B" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">80.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e1590-wk-Fact-338F6F1A2F49501FCC4DEC944BFEC414" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">80.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1610-wk-Fact-ABB990842A3DDD4AF3DECDB678C31A23" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1629-wk-Fact-A580107786B450897E6ACDB6797F63DB" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">98.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1648-wk-Fact-9B2D5691B6EBA991A1A1CDB6798F69DC" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">98.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1668-wk-Fact-0E01588E930268065A2FCDB678F21F84" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1687-wk-Fact-F1D3A8C00F6C989DDCEACDB6787EC3C9" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">68.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1707-wk-Fact-CFD425AFAD9D362B460BCDB679B5F895" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">68.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">Contracts and grants</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e1727-wk-Fact-844E01A51EE668409D98EC944BD7BCB9" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">105.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e1746-wk-Fact-E37F1D5FDE82017EFD53EC944BC5992C" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e1765-wk-Fact-5F00D21AD433133B00D3CCD313757E7C" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">122.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1785-wk-Fact-9C6C9109F73A5DF2646DCDB679500529" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">71.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1804-wk-Fact-942B12187A93B792B0D1CDB6792114D6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1823-wk-Fact-B30465A8C2F3A2E082CECCD3138D3955" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">77.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1843-wk-Fact-B6237A10225D5B82C82ACDB6799F7232" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">65.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1862-wk-Fact-91C4DA1BFB527AC25B26CDB6793148E3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1882-wk-Fact-9AD0A541FEBE16626E99CCD31378BB04" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">70.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">Total revenues</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e1907-wk-Fact-642376D34BCECBF589F2EC944BDD81B7" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">674.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e1926-wk-Fact-B7858D6709B7236A3EC0EC944BF073CE" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">431.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e1945-wk-Fact-94CAA3BE61215202AE0CCCD3138C57F6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1,106.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1965-wk-Fact-1FB3253B51EFBB6ACAD3CDB67902BEB1" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">597.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e1984-wk-Fact-A6C1F133EBBF060FD64ACDB679AA3878" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">184.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e2004-wk-Fact-E5CE75B1C99F6C4E48F4CCD31371D6BF" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">782.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e2023-wk-Fact-E88DC0919E321E8A0AEDCDB67911E7E7" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">439.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e2042-wk-Fact-E34015F07D6527A22272CDB678A4F540" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">121.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span><ix:nonFraction id="d45242871e2062-wk-Fact-85CDAEF339CB7AEE40B1CCD3138717AC" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">560.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"><ix:continuation id="TextSelection-F9483EF5767AE9F862EBCCD313BB7640-1"></ix:continuation>Contract liabilities</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">When performance obligations are not transferred to a customer at the end of a reporting period, the amount allocated to those performance obligations are reflected as contract liabilities on the consolidated balance sheets and are deferred until control of these performance obligations is transferred to the customer. <ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="TextSelection-A21FD06DC624B97C276CCCD313BB4135-0-wk-Fact-B278B9B59075409FFCE9CCD313621BDA" continuedAt="TextSelection-A21FD06DC624B97C276CCCD313BB4135-1" escape="true">The following table presents the rollforward of contract liabilities:</ix:nonNumeric></span></div><ix:continuation id="TextSelection-A21FD06DC624B97C276CCCD313BB4135-1"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:88%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45242871e2125-wk-Fact-6CFFD3A7DB1D0EDD52BF21E423C263DD" name="us-gaap:ContractWithCustomerLiability" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adoption of new accounting standard (ASC 606)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45242871e2140-wk-Fact-995AA6AE591D4B1466C021E6FAE07362" name="us-gaap:ContractWithCustomerLiability" contextRef="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">42.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">January 1, 2018</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45242871e2160-wk-Fact-A9365FAE5398BA4496CF21E709815361" name="us-gaap:ContractWithCustomerLiability" contextRef="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">72.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferral of revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45242871e2180-wk-Fact-09D2F43329F2B6CB2D1621E3F8C3B6AC" name="ebs:ContractWithCustomerLiabilityAdditions" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">29.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue recognized</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45242871e2200-wk-Fact-AEEE3B83D0D8CA173D7421E3FA0C33B4" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">29.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e2221-wk-Fact-32CD898261F5C2CF1A6ECCD3132C63F1" name="us-gaap:ContractWithCustomerLiability" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">73.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferral of revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e2241-wk-Fact-0C52014E1FC2F7A47570CCD31329A808" name="ebs:ContractWithCustomerLiabilityAdditions" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">46.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue recognized</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45242871e2261-wk-Fact-AA1E3FF9D22E5B61FEE6CCD3132FEEF2" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">30.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e2287-wk-Fact-09F346A22D9AC3BF1CE2CCD3131C94FA" name="us-gaap:ContractWithCustomerLiability" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">88.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Transaction price allocated to remaining performance obligations</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company had expected future revenues of approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45242871e2306-wk-Fact-6A4EC8C6FF858B3B897BCCD3134FE850" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">600</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> associated with performance obligations that have not been satisfied. The Company expects to recognize a majority of these revenues within the next </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45242871e2310-wk-Fact-0BAE98A03B37759EC9FCCCD3135A8FCA" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" contextRef="FI2019Q4_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain_2020-01-01" format="ixt-sec:durmonth">24</ix:nonNumeric> months</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, with the remainder recognized thereafter. However, the amount and timing of revenue recognition for unsatisfied performance obligations can materially change due to timing of funding appropriations from the USG and the overall success of the Company's development activities associated with its PHT product candidates that are then receiving development funding support from the USG under development contracts. In addition, the amount of future revenues associated with unsatisfied performance obligations excludes the value associated with unexercised option periods in the Company's contracts (which are not performance obligations as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">).</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">89</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-644A3C695C3906857B9CCCD313BB17C8-2"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Contract assets</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company considers unbilled accounts receivables and deferred costs associated with revenue generating contracts, which are not included in inventory or property, plant and equipments, as contract assets. As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company had contract assets associated with deferred costs of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45242871e2332-wk-Fact-3DC65CE4DF34CC6AD669CCD313571990" name="us-gaap:DeferredCostsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">34.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45242871e2336-wk-Fact-6CB75151180C16AD53DECCD3135B039A" name="us-gaap:DeferredCostsCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, which is included in prepaid expenses and other current assets and other assets on the Company's consolidated balance sheets.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Accounts receivable</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="ebs:ScheduleofAccountsReceivableNetTableTextBlock" id="TextSelection-DEB76CBC7BCB0D6BB962F5602128F79A-0-wk-Fact-376F875BA2C4AD8BD384F5606070CFA4" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Accounts receivable including unbilled accounts receivable contract assets consist of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Billed, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e2459-wk-Fact-3778D939BF3DF4C0867ACCD313561809" name="us-gaap:BilledContractReceivables" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">227.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45242871e2478-wk-Fact-B9E036D8ED63CDFFA725CCD313517506" name="us-gaap:BilledContractReceivables" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">234.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unbilled</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e2493-wk-Fact-0D9F1AD3D42755C69BCDCCD31356E645" name="us-gaap:UnbilledContractsReceivable" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">43.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45242871e2512-wk-Fact-4BD74A9A3E8DA3253499CCD313948CB6" name="us-gaap:UnbilledContractsReceivable" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">28.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45242871e2537-wk-Fact-8E63B5B6EE5EB579E66FCCD31378EC92" name="us-gaap:AccountsReceivableNetCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">270.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45242871e2556-wk-Fact-0A8EDAB4A88157AF37E1CCD3136590C8" name="us-gaap:AccountsReceivableNetCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">262.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company's accounts receivable balances were comprised of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45242871e2576-wk-Fact-C1FEF904A65ACAE271BACCD3134B769F" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_ebs_UnitedStatesGovernmentMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">69</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45242871e2580-wk-Fact-8AA9DD13A06C7A514A52CCD31359B8F8" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_ebs_UnitedStatesGovernmentMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">76</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, from the USG. As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> allowance for doubtful accounts were de minimis.</span></div></ix:continuation><div><a id="sBB409CBEBE885CC98896A524CDC20F6B"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">4</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-0-wk-Fact-2F8BC131A6A64DAC6674CCD313254D85" continuedAt="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Acquisitions</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-1" continuedAt="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-2"><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:normal;font-weight:bold;text-decoration:none;">Adapt</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On October 15, 2018, the Company acquired Adapt, a company focused on developing new treatment options and commercializing products addressing opioid overdose and addiction. Adapt's NARCAN&#174; (naloxone HCI) Nasal Spray marketed product is the first needle-free formulation of naloxone approved by the FDA and Health Canada for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. This acquisition included approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45245159e738-wk-Fact-9FB86D68CCD4C01714DFCCD31381A3AF" name="ebs:NumberOfEmployees" contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="employee" decimals="INF" scale="0" format="ixt:numdotdecimal">50</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> employees, located in the U.S., Canada, and Ireland, including those responsible for supply chain management, research and development, government affairs, and commercial operations. The products and product candidates within Adapt's portfolio are consistent with the Company's mission and expand the Company's core business of addressing public health threats.</span></div><ix:continuation id="TextSelection-F83F056E8166E0D5ADC2CCD313BBD780-0"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The total purchase price revised for adjustments is summarized below:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:79%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in&#160;millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">October 15, 2018</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e793-wk-Fact-5004B19712F48B301276CCD3136414B4" name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">581.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Equity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e808-wk-Fact-1D3D91B3BB3478A46B5ECCD313628B57" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">37.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of contingent purchase consideration</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e828-wk-Fact-D3BCBE7FDED6ABF702DFCCD3136196BB" name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">48.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Preliminary purchase consideration</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e848-wk-Fact-ADC131A3958DC98B5E7D1C7A71E6188E" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="D2018Q4Oct15-Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">667.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e868-wk-Fact-061F2B0484F1EDF5CED01C7AD060D130" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Final purchase consideration</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e893-wk-Fact-A7EB867C5DB3C46275C3CCD31366C702" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">668.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company issued </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45245159e905-wk-Fact-5B6E4FD29D347BF19B8DCCD313866162" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">733,309</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares of Common Stock at </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e909-wk-Fact-0C09B89C86AEC3BCB728CCD3137BD046" name="us-gaap:BusinessAcquisitionSharePrice" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usdPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">60.44</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> per share, the closing price of Emergent's share price on October 15, 2018, for a total of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e913-wk-Fact-587FAD4752FB048CC22ACCD3138B3BAC" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">44.3</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (inclusive of adjustments). The </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e917-wk-Fact-587FAD4752FB048CC22ACCD3138B3BAC" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">44.3</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> value of the common stock shares issued has been adjusted to a fair value of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e921-wk-Fact-1D3D91B3BB3478A46B5ECCD313628B57" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">37.7</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> considering a discount for lack of marketability due to a </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">two</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">-year lock-up period beginning on October 15, 2018. The remaining consideration payable for the acquisition consists of up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e930-wk-Fact-3A9A4CF685D73E536719CCD3137F1473" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" contextRef="I2018Q4Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">100</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in cash based on the achievement of certain sales milestones through 2022 which the Company has determined the fair value of to be </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e934-wk-Fact-D3BCBE7FDED6ABF702DFCCD3136196BB" name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">48.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> as of the acquisition date. The fair value of the contingent purchase consideration is based on management&#8217;s assessment of the potential future realization of the contingent purchase consideration payments. This assessment is based on inputs that have no observable market (Level 3). The obligation is measured using a discounted cash flow model.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">This transaction was accounted for by the Company under the acquisition method of accounting, with the Company as the acquirer. Under the acquisition method of accounting, the assets and liabilities of Adapt were recorded as of October 15, 2018, the acquisition date, at their respective fair values, and combined with those of the Company. The </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">90</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-2" continuedAt="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-3"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Company reflects measurement period adjustments in the period in which the adjustments occur. The adjustments during the measurement period resulted from receipt of additional financial information associated with certain acquired contract assets and the value of associated contingent purchase consideration. These adjustments did not impact the Company's statements of operations. </span></div><ix:continuation id="TextSelection-63C64A0442D0A8B2E840CCD313BB5237-0"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The table below summarizes the final allocation of the purchase price based upon fair values of assets acquired and liabilities assumed at October 15, 2018.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:64%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">October 15, 2018</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Measurement Period Adjustments</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Updated  October 15, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of tangible assets acquired and liabilities assumed:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1082-wk-Fact-1188D993CB232C0AB69DCCD3136BE09C" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1110-wk-Fact-24E2BEE25CECA47251B1B690521C77C7" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts receivable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1125-wk-Fact-42FA4FC1259B27C255B6CCD3137BF1FE" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1153-wk-Fact-A0643B350B24B6450AC7B690541A874C" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1173-wk-Fact-6870F38100CDFD1C23ACCCD3136D10D8" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">41.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1201-wk-Fact-E2AF0D398A450669C9DDB69055DF4D2E" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">41.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prepaid expenses and other assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1221-wk-Fact-9DAF4D95FA6D2C0B2026CCD3137268D5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1235-wk-Fact-AD6A4EB6229D8D4D4CBEB68DF6BBA866" name="ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets" contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1249-wk-Fact-61DD5595E055E3C0C1AEB690578CB484" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts payable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e1269-wk-Fact-FA33531313E137C2946CCCD31378B99B" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e1298-wk-Fact-4547E2148C27EEB45865B6905917092D" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e1319-wk-Fact-3C08496C4C021A50D0BBCCD31377DD31" name="ebs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities" contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">50.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e1348-wk-Fact-1F22308CABE839BE3088B6905ADCDE5F" name="ebs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">50.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax liability, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e1369-wk-Fact-14B0DB4D044CDC4DB85ACCD3136E4114" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e1384-wk-Fact-38B3E8D05A122D644175B68DFB1DBD87" name="ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e1399-wk-Fact-E1AE23A4553862A3632AB6905CF0ADB8" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total fair value of tangible assets acquired and liabilities assumed</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e1420-wk-Fact-8D6BF9530C4403298FAECCD31372611D" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">56.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1435-wk-Fact-B93153ADD2971620D292B68DFE30AC97" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e1449-wk-Fact-DD5AA485D2EC7307D198B6905E980161" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">54.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired in-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1522-wk-Fact-92DBED2BC6CCF7F45E9BCCD31376E43C" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">41.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1550-wk-Fact-C5DBCDE47C701BC2A1DEB690608BA3FD" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">41.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired intangible asset</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1570-wk-Fact-D4270AAC9257163A36E8CCD31373ED98" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">534.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1598-wk-Fact-9C9B863E98E4D79950BDB690622E0084" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">534.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1618-wk-Fact-B23A99E1F28843760122CCD31374CDC5" name="us-gaap:Goodwill" contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">149.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e1632-wk-Fact-F3C51CA7E29296147D24B68E01680445" name="us-gaap:GoodwillPurchaseAccountingAdjustments" contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1647-wk-Fact-F27A08E197428454F225B69063BD30F9" name="us-gaap:Goodwill" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">148.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase price</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1672-wk-Fact-ADC131A3958DC98B5E7D1C7A71E6188E" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="D2018Q4Oct15-Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">667.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1686-wk-Fact-043DD5900466FA1A0059B68E02779AFE" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1700-wk-Fact-A7EB867C5DB3C46275C3CCD31366C702" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">668.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determined the fair value of the intangible asset using the income approach, which is based on the present value of future cash flows. The fair value measurements are based on significant unobservable inputs that are developed by the Company using estimates and assumptions of the respective market and market penetration of the Company's products.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair value of the intangible asset acquired for Adapt's marketed product NARCAN&#174; Nasal Spray was valued at </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e1716-wk-Fact-9C9B863E98E4D79950BDB690622E0084" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">534.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The Company has determined the useful life of the NARCAN&#174; Nasal Spray intangible asset to be </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45245159e1720-wk-Fact-14BCAD1CF8992B579F91CCD313228019" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" format="ixt-sec:duryear">15</ix:nonNumeric></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> years. The Company calculated the fair value of the NARCAN&#174; Nasal Spray intangible asset using the income approach with a present value discount rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45245159e1724-wk-Fact-7C2F7CD4A245DB20391CCCD31393E600" name="ebs:PresentValueDiscountRate" contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">10.5</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, which is based on the weighted-average cost of capital for companies with profiles substantially similar to that of Adapt. This is comparable to the internal rate of return for the acquisition and represents the rate that market participants would use to value these intangible assets. The projected cash flows from the NARCAN&#174; Nasal Spray intangible asset were based on key assumptions including: estimates of revenues and operating profits; and risks related to the viability of and potential alternative treatments in any future target markets.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The intangible asset associated with IPR&amp;D acquired from Adapt is related to a product candidate. Management determined that the acquisition-date fair value of intangible assets related to IPR&amp;D was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e1731-wk-Fact-C5DBCDE47C701BC2A1DEB690608BA3FD" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">41.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The fair value was determined using the income approach, which discounts expected future cash flows to present value. The Company calculated the fair value using a present value discount rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45245159e1735-wk-Fact-736E022F1DEB92C9693ECCD3138E54DC" name="ebs:PresentValueDiscountRate" contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">11</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, which is based on the weighted-average cost of capital for companies with that profiles substantially similar to that of Adapt and IPR&amp;D assets at a similar stage of development as the product candidate. This is comparable to the internal rate of return for the acquisition and represents the rate that market participants would use to value the IPR&amp;D. The projected cash flows for the product candidate&#160; were based on key assumptions including: estimates of revenues and operating profits, considering its stage of development on the acquisition date; the time and resources needed to complete the development and approval of the product candidate; the life of the potential commercialized product and associated risks, including the inherent difficulties and uncertainties in developing a product candidate, such as obtaining marketing approval from the FDA and other regulatory agencies; and risks related to the viability of and potential for alternative treatments in any future target markets. Non-amortizing IPR&amp;D assets are considered to be indefinite-lived until the completion or abandonment of the associated research and development effort and are evaluated for impairment annually. During the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company recorded an impairment charge of $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45245159e1743-wk-Fact-C32FD711B872DB8478CBB1501BA3B71C" name="us-gaap:GoodwillImpairmentLoss" contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.0</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million to the IPR&amp;D asset. The fair value of the IPR&amp;D intangible asset is $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45245159e1747-wk-Fact-CEC5494F14C151866514EC9541C6D101" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="FI2019Q4_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">29.0</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million at December 31, 2019 (see Note </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">8</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">).</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">91</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-3" continuedAt="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-4"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determined the fair value of the inventory using the comparative sales method, which estimates the expected sales price reduced for all costs expected to be incurred to complete/dispose of the inventory with a profit on those costs.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company recorded approximately $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45245159e1762-wk-Fact-F27A08E197428454F225B69063BD30F9" name="us-gaap:Goodwill" contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">148.0</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million in goodwill related to the Adapt acquisition, which is calculated as the purchase price paid in excess of the fair value of the tangible and intangible assets acquired representing the future economic benefits the Company expects to receive as a result of the acquisition. The goodwill created from the Adapt acquisition is associated with early stage pipeline products. The goodwill generated from the Adapt acquisition is not expected to be deductible for tax purposes.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:normal;font-weight:bold;text-decoration:none;">PaxVax</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On October 4, 2018, the Company completed the acquisition of PaxVax Holding Company Ltd. ("PaxVax"), a company focused on developing, manufacturing, and commercializing specialty vaccines that protect against existing and emerging infectious diseases. This acquisition includes Vivotif&#174; (Typhoid Vaccine Live Oral Ty21a), the only oral vaccine licensed by the FDA for the prevention of typhoid fever, Vaxchora&#174; (Cholera Vaccine, Live, Oral), the only FDA-licensed vaccine for the prevention of cholera, adenovirus 4/7 and additional clinical-stage vaccine candidates targeting chikungunya and other emerging infectious diseases, European-based current good manufacturing practices ("cGMP") biologics manufacturing facilities, and approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45245159e1772-wk-Fact-80979D521F8563EB96C8CCD3137CA596" name="ebs:NumberOfEmployees" contextRef="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="employee" decimals="-1" scale="0" format="ixt:numdotdecimal">250</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> employees including those in research and development, manufacturing, and commercial operations with a specialty vaccines sales force in the U.S. and in select European countries. The products and product candidates within PaxVax's portfolio are consistent with the Company&#8217;s mission and will expand the Company&#8217;s core business of addressing PHTs. In addition, the acquisition expands the Company's manufacturing capabilities.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">At the closing, the Company paid a cash consideration of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e1779-wk-Fact-E55DCDCAE2272CF5C658B6A0050A1B07" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">273.1</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (inclusive of closing adjustments). This transaction was accounted for by the Company under the acquisition method of accounting, with the Company as the acquirer. Under the acquisition method of accounting, the assets and liabilities of PaxVax were recorded as of October 4, 2018, the acquisition date, at their respective fair values, and combined with those of the Company. </span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="TextSelection-A07E8B05B0B320FB3040CCD313BB51AE-0-wk-Fact-0059C8DCC0DB354EA587CCD3137EEF14" continuedAt="TextSelection-7D278034275D58FE162CCCD313BB24B3-0" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The table below summarizes the final allocation of the purchase consideration based upon the fair values of assets acquired and liabilities assumed at October 4, 2018.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">October 4, 2018</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Measurement Period Adjustments</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Updated October 4, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of tangible assets acquired and liabilities assumed:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e1972-wk-Fact-A482B828B4D74188D94BCCD313316F33" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2000-wk-Fact-35B9407472C378449AFBB6A110B235EF" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts receivable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2015-wk-Fact-56DAF271A7A1015ED659CCD3135D26FC" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2043-wk-Fact-C1DE7CA91112FD34AC2DB6A113A91927" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2063-wk-Fact-529BA5ADCF122823A776CCD31321637E" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2091-wk-Fact-482B8CE495CFAF06AC71B6A1168B967D" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prepaid expenses and other assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2111-wk-Fact-20B58D0EFBD9D1E9E331CCD3131E1D6D" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e2125-wk-Fact-93DF9C8D747F2A17EAC6B6A0A1B23514" name="ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets" contextRef="D2019Q3Oct5-Sep30_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2140-wk-Fact-72F26374D84ACE672C06B69FEA330388" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2160-wk-Fact-C92B2275A0BEE063D3DDCCD3133176C4" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">57.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2188-wk-Fact-6617F6414A4EFC1215DBB6A11BC357A2" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">57.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2208-wk-Fact-1DD0CD03EDF28BB0F14BCCD3131EFA3A" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2222-wk-Fact-E103B720240114A460F0B6A0A448D4DD" name="ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" contextRef="D2019Q3Oct5-Sep30_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2236-wk-Fact-C54654F324908C232056B69FF115B71A" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts payable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e2256-wk-Fact-EC3522B503B4BBA35E28CCD3132AC285" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e2285-wk-Fact-154228A3C146A737B022B6A11F4D9147" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e2306-wk-Fact-55A539F8AE85664520D9CCD3135E5AB2" name="ebs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities" contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">33.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e2321-wk-Fact-D9EB7599F1E68308E77CB6A0A6C0054C" name="ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities" contextRef="D2019Q3Oct5-Sep30_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e2336-wk-Fact-CEC8B5B9B420C21745F3B69FF8043B4E" name="ebs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities" contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">34.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total fair value of tangible assets acquired and liabilities assumed</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2358-wk-Fact-BEF3CCE312010817AAABCCD31329E743" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">69.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2372-wk-Fact-DA3E4EF8C80B7180B0AAB6A0A8D5643E" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" contextRef="D2019Q3Oct5-Sep30_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2386-wk-Fact-21693F0FAEBE876F676CB69FFC2C0CB5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">70.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired in-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2457-wk-Fact-FE971225ED9252D4E01CCCD313605E61" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245159e2471-wk-Fact-8C1390A5A7D865FDBF2BB6A0AB766975" name="ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets" contextRef="D2019Q3Oct5-Sep30_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">9.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2486-wk-Fact-F80FFC9F8F6510F10776B6A000C300BB" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2506-wk-Fact-9B321BDDC93A5853AB25CCD3135F29FB" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">133.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2534-wk-Fact-D302DA4BE0548B477B08B6A1268A2E85" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">133.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2554-wk-Fact-BF14365023700C0DD8B0CCD3131F9D9B" name="us-gaap:Goodwill" contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">61.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2568-wk-Fact-7F532CE7ABFD40FF84AFB6A0AD96D48E" name="us-gaap:GoodwillPurchaseAccountingAdjustments" contextRef="D2019Q3Oct5-Sep30_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2582-wk-Fact-63E99590CCA82F9BA027B6A002F29BF7" name="us-gaap:Goodwill" contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">69.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase consideration</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2607-wk-Fact-AB7889E74C10BF182703CCD31335F3FE" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="D2018Q4Oct04-Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">273.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2621-wk-Fact-DA562DA6CBD42C0361B2B6A0AF892920" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245159e2635-wk-Fact-E55DCDCAE2272CF5C658B6A0050A1B07" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">273.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair value of the intangible assets acquired for PaxVax's marketed products are valued at a total of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e2647-wk-Fact-D302DA4BE0548B477B08B6A1268A2E85" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">133.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The Company has determined that the weighted average useful lives of the intangible assets to be </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45245159e2651-wk-Fact-BC4D2DA34F9A22D83BFACCD3138AEFCC" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" format="ixt-sec:duryear">19</ix:nonNumeric></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> years.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determined the fair value of the intangible assets using the income approach, which is based on the present value of future cash flows. The fair value measurements are based on significant unobservable inputs that are </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">92</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-4" continuedAt="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-5"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">developed by the Company using estimates and assumptions of the respective market and market penetration of the Company's products.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company calculated the fair value of the Vivotif and Vaxchora intangible assets using the income approach with a present value discount rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45245159e2665-wk-Fact-55E22B8FDB34E1E24E07CCD31379F65A" name="ebs:PresentValueDiscountRate" contextRef="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_VivotifMember" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">14.5</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45245159e2669-wk-Fact-9DC3904E192B4C532D47CCD3137C3CE3" name="ebs:PresentValueDiscountRate" contextRef="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_VaxchoraMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">15</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, which is based on the weighted-average cost of capital for companies with profiles substantially similar to that of PaxVax. This is comparable to the internal rate of return for the acquisition and represents the rate that market participants would use to value these intangible assets. The projected cash flows from these intangible assets were based on key assumptions including: estimates of revenues and operating profits; and risks related to the viability of and potential alternative treatments in any future target markets.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The intangible asset associated with IPR&amp;D acquired from PaxVax is related to a product candidate.  The Company has adjusted the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. The Company estimates the fair value based on the income approach. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determined the fair value of the inventory using the comparative sales method, which estimates the expected sales price reduced for all costs expected to be incurred to complete/dispose of the inventory with a profit on those costs.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determined the fair value of the property, plant and equipment utilizing either the cost approach or the sales comparison approach. The cost approach is determined by establishing replacement cost of the asset and then subtracting any value that has been lost due to economic obsolescence, functional obsolescence, or physical deterioration. The sales comparison approach determines an asset is equal to the market price of an asset of comparable features such as design, location, size, construction, materials, use, capacity, specification, operational characteristics and other features or descriptions.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company recorded approximately $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45245159e2685-wk-Fact-63E99590CCA82F9BA027B6A002F29BF7" name="us-gaap:Goodwill" contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">69.5</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million in goodwill related to the PaxVax acquisition, calculated as the purchase price paid in the acquisition that was in excess of the fair value of the tangible and intangible assets acquired representing the future economic benefits the Company expects to receive as a result of the acquisition. The goodwill created from the PaxVax acquisition is associated with early stage pipeline products along with potential contract development and manufacturing services. The majority of the goodwill generated from the PaxVax acquisition is expected to be deductible for tax purposes.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has incurred transaction costs related to the PaxVax acquisition of approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e2692-wk-Fact-C2F0EF7DA1780A73C60ECCD3131D9B4E" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.5</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, which have been recorded in selling, general and administrative expenses.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Acquisition of ACAM2000 business</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On October 6, 2017, the Company completed the acquisition of the ACAM2000&#174; (Smallpox (Vaccinia) Vaccine, Live) business of Sanofi Pasteur Biologics, LLC ("Sanofi"). This acquisition includes ACAM2000, the only smallpox vaccine licensed by the FDA, a current good manufacturing practices ("cGMP") live viral manufacturing facility and office and warehouse space, both in Canton, Massachusetts, and a cGMP viral fill/finish facility in Rockville, Maryland. With this acquisition, the Company also acquired an existing </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45245159e2711-wk-Fact-1B082A7CF602B3B4CCFCCCD31375671B" name="ebs:TermofContractUnderAcquisition" contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" format="ixt-sec:duryear">10</ix:nonNumeric></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">-year contract with the CDC, which expired in March 2018. This contract had a stated value up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e2715-wk-Fact-B7DEF7390453164A905FCCD3131F8FDB" name="ebs:ValueofContract" contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">425</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, with a remaining contract value of up to approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e2719-wk-Fact-469723C98504D59238ABCCD31388356D" name="ebs:AmountforDeliveriesofProduct" contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">160</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> as of the acquisition date, for the delivery of ACAM2000 to the SNS and establishing U.S.-based manufacturing of ACAM2000. This acquisition added to the Company's product portfolio and expanded the Company's manufacturing capabilities.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">At the closing, the Company paid </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e2726-wk-Fact-580D31E9D62D9130F8A8CCD313220B34" name="ebs:UpfrontPayments" contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">97.5</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in an upfront payment and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e2730-wk-Fact-B3343B8A93A7892A9A10CCD31379FA2E" name="ebs:AmountOfPaymentForManufacturingRelatedMilestones" contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in milestone payments earned as of the closing date tied to the achievement of certain regulatory and manufacturing-related milestones, for a total payment in cash of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e2734-wk-Fact-89FFE5626C5ED5169D02CCD3134EFBAC" name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">117.5</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million. The agreement includes an additional milestone payment of up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e2738-wk-Fact-9D16AC4CDE54C8F2A62DCCD31320E670" name="ebs:AmountOfPaymentForRegulatoryRelatedMilestones" contextRef="FI2019Q4_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.5</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> upon achievement of a regulatory milestone, which was achieved in November 2017. The </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e2742-wk-Fact-FE07B1AE2B3F1237ADC4CCD3132464B0" name="ebs:AmountOfPaymentForRegulatoryRelatedMilestones" contextRef="FI2018Q4_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.5</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> milestone payment was made during the fourth quarter of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and is reflected as a component of financing activities in the consolidated statement of cash flows. This transaction was accounted for by the Company under the acquisition method of accounting, with the Company as the acquirer. Under the acquisition method of accounting, the assets and liabilities of the ACAM2000 business were recorded as of October 6, 2017, the acquisition date, at their respective fair values, and combined with those of the Company.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The contingent purchase consideration obligation is based on a regulatory milestone. At October 6, 2017, the contingent purchase consideration obligation related to the regulatory milestone was recorded at a fair value of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e2754-wk-Fact-E40B3F82DBC0C960D929CCD31357708C" name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.2</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million. The Level 3 fair value of this obligation was based on a present value model of management's assessment of </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">93</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-5" continuedAt="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-6"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the probability of achievement of the regulatory milestone as of the acquisition date. This assessment is based on inputs that have no observable market.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="TextSelection-54EBA914C2462247E29BCCD313BCA4E8-0-wk-Fact-E8A83525C5587B051AFFCCD3137F0F74" continuedAt="TextSelection-F83F056E8166E0D5ADC2CCD313BBD780-0" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The total purchase price is summarized below:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:85%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Purchase Price</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amount of cash paid</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245159e2813-wk-Fact-89FFE5626C5ED5169D02CCD3134EFBAC" name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">117.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of contingent purchase consideration</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245159e2828-wk-Fact-E40B3F82DBC0C960D929CCD31357708C" name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase price</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245159e2853-wk-Fact-7965A2493E578771B8C2CCD3134D5E92" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">119.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:continuation id="TextSelection-7D278034275D58FE162CCCD313BB24B3-0" continuedAt="TextSelection-63C64A0442D0A8B2E840CCD313BB5237-0"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The table below summarizes the allocation of the purchase price based upon the fair values of assets acquired at October 6, 2017. The Company did not assume any liabilities in the acquisition. The Company has finalized the purchase price allocation related to this acquisition.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:85%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Purchase Price</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of tangible assets acquired:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245159e2934-wk-Fact-1E2B365E3E3EFE3A58EDCCD31359CF76" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">74.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245159e2949-wk-Fact-D820D09D9E2E8763BD26CCD3135B81C9" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">20.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total fair value of tangible assets acquired</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245159e2969-wk-Fact-0C9DC01E7B64EE0628A4CCD31359B921" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">94.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired intangible asset</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245159e3010-wk-Fact-A8608293A9F966D7A995CCD3135A2E35" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245159e3030-wk-Fact-36B36519B299EB164851CCD31357797C" name="us-gaap:Goodwill" contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase price</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245159e3055-wk-Fact-7965A2493E578771B8C2CCD3134D5E92" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">119.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair value measurements are based on significant unobservable inputs that are developed by the Company using estimates and assumptions of the respective market and market penetration of the Company's products. The Company determined the fair value of the ACAM2000 intangible asset using the income approach, which is based on the present value of future cash flows, with a present value discount rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45245159e3067-wk-Fact-8109781596F9CCE7A3A1CCD313241CF5" name="ebs:PresentValueDiscountRate" contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="number" decimals="4" scale="-2" format="ixt:numdotdecimal">15.50</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, based on the weighted-average cost of capital for substantially similar companies. This is comparable to the internal rate of return for the acquisition and represents the rate that market participants would use to value these intangible assets. The projected cash flows from ACAM2000 intangible asset were based on key assumptions, including: estimates of revenues and operating profits, the life of the potential commercialized product and associated risks, and risks related to the viability of and potential alternative treatments in any future target markets. The Company has determined the ACAM2000 intangible asset will be amortized over </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45245159e3071-wk-Fact-67A7940BC42A914C5E07CCD3137CF0A0" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" format="ixt-sec:duryear">10</ix:nonNumeric> years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determined the fair value of the inventory using the probability adjusted comparative sales method, which estimates the expected sales price reduced for all costs expected to be incurred to complete/dispose of the inventory with a profit on those costs.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determined the fair value of the property, plant and equipment utilizing either the cost approach or the sales comparison approach. The cost approach is determined based on the replacement cost of the asset and then subtracting any value that has been lost due to economic obsolescence, functional obsolescence, or physical deterioration. The sales comparison approach&#160;determines an asset is equal to the market price of an asset of comparable features such as design, location, size, construction, materials, use, capacity, specification, operational characteristics and other features or descriptions.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company recorded approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e3084-wk-Fact-36B36519B299EB164851CCD31357797C" name="us-gaap:Goodwill" contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.1</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million in goodwill related to the ACAM2000 acquisition, calculated as the purchase price paid in the acquisition that was in excess of the fair value of the tangible and intangible assets acquired and represents the future economic benefits the Company expects to receive as a result of the acquisition. Goodwill generated from the ACAM2000 acquisition is not expected to be deductible for tax purposes.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Acquisition of raxibacumab asset</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On October 2, 2017, the Company completed the acquisition of raxibacumab, a fully human monoclonal antibody therapeutic product approved by the U.S. Food and Drug Administration ("FDA") for the treatment and prophylaxis of inhalational anthrax, from Human Genome Sciences, Inc. and GlaxoSmithKline LLC (collectively referred to as "GSK"). The all-cash transaction consists of a </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e3098-wk-Fact-355023AEF965CC59F8F5CCD3132673D0" name="ebs:UpfrontPayments" contextRef="D2017Q4Oct2_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">76</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> upfront payment and up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e3102-wk-Fact-2160EAB50904F32CD233CCD313906EBA" name="ebs:AmountOfPaymentForManufacturingRelatedMilestones" contextRef="I2017Q4Oct2_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in product sale and </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">94</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><ix:continuation id="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-6" continuedAt="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-7"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">manufacturing-related milestone payments. The Company recorded an asset (including transaction costs) of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245159e3110-wk-Fact-DD19AC7C0DB145156A30F5B8B9BB79DA" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" contextRef="D2017Q4Oct2_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">77.6</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, at date of acquisition, which is recorded within intangible assets, net line item of the consolidated balance sheets. The Company has determined that substantially all of the value of raxibacumab is attributed to the raxibacumab asset and therefore the raxibacumab acquisition is considered an asset acquisition. During the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">twelve months ended</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, a contingent milestone was achieved which resulted in a payment of $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45245159e3122-wk-Fact-345A1473599D5177CF4DEC99CDB03042" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.0</ix:nonFraction></span></span></ix:continuation><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><ix:continuation id="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-7"> million with a corresponding increase in intangible assets.</ix:continuation> </span></div><div><a id="s861AD745BE5A50048210C7CE2FEF6E64"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">5</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:FairValueDisclosuresTextBlock" id="TextSelection-52953495809D84304ABECCD313BC05E6-0-wk-Fact-EB235D54A8BAE64EC877CCD31347CC27" continuedAt="TextSelection-52953495809D84304ABECCD313BC05E6-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Fair value measurements</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-52953495809D84304ABECCD313BC05E6-1" continuedAt="TextSelection-52953495809D84304ABECCD313BC05E6-2"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company&#8217;s recurring fair value measurement items recorded on a recurring basis primarily consist of contingent consideration liabilities, interest rate swaps and investments in money market funds. </span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Contingent consideration</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The contingent consideration liabilities have been generated from our acquisitions. These liabilities represent an obligation of the Company to transfer additional assets to the selling shareholders if future events occur or conditions are met. The Company&#8217;s contingent consideration is measured initially and subsequently at each reporting date at fair value.&#160; The changes in the fair value of contingent consideration obligations are primarily due to the expected amount and timing of future net sales and achieving regulatory milestones, which are inputs that have no observable market (Level 3). Any changes in expectations for the Company&#8217;s products are classified in the Company's statement of operations as cost of product sales and contract development and manufacturing. Any changes in expectations for the Company&#8217;s product candidates are recorded in research and development expense for regulatory and development milestones.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="TextSelection-B4AB4B5DCB5360B18DE5CCD313BCC824-0-wk-Fact-D416678294825737F290CCD313481072" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table is a reconciliation of the beginning and ending balance of the contingent consideration liabilities measured at fair value using significant unobservable inputs (Level 3) during the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:88%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2017</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245832e800-wk-Fact-637AD56D0886D317A68CCCD3139212EA" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expense included in earnings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245832e815-wk-Fact-8FB2D740C2EFA786E47BCCD31385EBD4" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45245832e835-wk-Fact-90CA06A26412CE3561F5CCD313997134" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Additions due to acquisition</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245832e856-wk-Fact-966220F0626779C6BBE2CCD3138E0C58" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">48.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245832e881-wk-Fact-51E9570A56EF1F947366CCD3139421F0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">60.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expense included in earnings</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245832e896-wk-Fact-3E612A3313CB77A8D382CCD313807538" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">24.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Milestone achievement - asset acquisition</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245832e916-wk-Fact-80277A338CEA1C893A04CCD31386BFF0" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Measurement period adjustment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245832e936-wk-Fact-E71C6A6CCD60FDA28557B2B2DA31E55F" name="ebs:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45245832e956-wk-Fact-D15034ADF973B2CB3434CCD3137E1D23" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">67.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245832e982-wk-Fact-593086BF0DE886F0BF73CCD313919718" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">29.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Interest rate swaps</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The valuation of the interest rate swaps is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each interest rate swap. This analysis reflects the contractual terms of the interest rate swaps, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash payments (or receipts) and the discounted expected variable cash receipts (or payments). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. To comply with the provisions of ASC 820, Fair Value Measurement, we incorporate credit valuation adjustments in the fair value measurements to appropriately reflect both our own nonperformance risk and the respective counterparty&#8217;s nonperformance risk. These credit valuation adjustments were concluded to not be significant inputs for the fair value calculations for the periods presented. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we have considered the impact of netting and any applicable credit enhancements, such as the posting of collateral, thresholds, mutual puts and guarantees. The valuation of interest rate swaps fall into Level 2 in the fair value hierarchy. See note </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">10</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> "</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Derivative Instruments</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> " for further details on the interest rate swaps. </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">95</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-52953495809D84304ABECCD313BC05E6-2"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Money market funds</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair values of the Company's money market funds are based on quoted prices in active markets for identical assets (level 1). As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company held cash in money market accounts of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245832e1019-wk-Fact-064A3991F63C071F53FF3F438704D5A2" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_CashAndCashEquivalentsAxis_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">52.2</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45245832e1023-wk-Fact-0998DC6D6C9E04155B852CCDC03C601F" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2018Q4_us-gaap_CashAndCashEquivalentsAxis_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively. These amounts are included in cash and cash equivalents in the consolidated balance sheets.   </span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Non-recurring fair value measurements</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Separate disclosure is required for assets and liabilities measured at fair value on a recurring basis from those measured at fair value on a non-recurring basis. As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, there were </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">no</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> assets or liabilities measured at fair value on a non-recurring basis, except for the IPR&amp;D assets acquired with the Adapt acquisition and the assets acquired from PaxVax, Adapt. See Note </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">4</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. "</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Acquisitions</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">" and Note 8. "Intangible assets and goodwill" for further details on the IPR&amp;D assets.</span></div></ix:continuation><div><a id="sC1BDF2C141CA56B2A18761299095BF37"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">6</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:InventoryDisclosureTextBlock" id="TextSelection-63DC0FF3F5C3B60044E2CCD313BC9F03-0-wk-Fact-0C212F8921E7910A8A38CCD31358E0A9" continuedAt="TextSelection-63DC0FF3F5C3B60044E2CCD313BC9F03-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Inventories</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="TextSelection-C8ECBBE4ECAC594DD0BCCCD313BC4CBC-0-wk-Fact-A20BDBC3726ECDCE67ACCCD31364A9A9" escape="true"><ix:continuation id="TextSelection-63DC0FF3F5C3B60044E2CCD313BC9F03-1"><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Inventories consist of the following:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #ffffff;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Raw materials and supplies</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245537e846-wk-Fact-7850538D9C43C5AE003BCCD3137D6445" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">70.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245537e865-wk-Fact-8ECBA0BF2A49313E94D4CCD3138CDA8D" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">51.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Work-in-process</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245537e880-wk-Fact-74F48BDC00BE7E544133CCD3139213C9" name="us-gaap:InventoryWorkInProcessNetOfReserves" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">89.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245537e899-wk-Fact-9EFA53F48F94481BBAEDCCD3138892E9" name="us-gaap:InventoryWorkInProcessNetOfReserves" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">103.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Finished goods</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245537e919-wk-Fact-18AA258CCCAD4E7D6A7DCCD31399F784" name="us-gaap:InventoryFinishedGoodsNetOfReserves" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245537e938-wk-Fact-F2E2E060AECFD41D31A5CCD3138C934F" name="us-gaap:InventoryFinishedGoodsNetOfReserves" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">50.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total inventories</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45245537e963-wk-Fact-9E7A6321764CCA011270CCD3135EBFCB" name="us-gaap:InventoryNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">222.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45245537e982-wk-Fact-9BE8FA4DD47B7E5F9DB4CCD31363B9B9" name="us-gaap:InventoryNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">205.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:continuation></ix:nonNumeric><div><a id="s612EA560DFC1505BB83F47AF4F76C752"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">7</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="TextSelection-C0657CF3A369C9F7D157CCD313BC3598-0-wk-Fact-38D8EE95CA4E3D9A96D0CCD31348F6E8" continuedAt="TextSelection-C0657CF3A369C9F7D157CCD313BC3598-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Property, plant and equipment</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-C0657CF3A369C9F7D157CCD313BC3598-1"><ix:continuation id="TextSelection-31580DDCE09488D758FFCCD313BCA4D7-0"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Property, plant and equipment consist of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #ffffff;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Land and improvements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45246361e847-wk-Fact-2CD507A72F402AEEA720CCD3135FC5EA" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandAndLandImprovementsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">46.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45246361e866-wk-Fact-BD39275200601330B022CCD31332F4F4" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandAndLandImprovementsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">44.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Buildings, building improvements and leasehold improvements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45246361e881-wk-Fact-5952CAB40DC98F2DB65FCCD3133568AB" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">234.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45246361e900-wk-Fact-4607CD7A1242BB13E295CCD3132A9C38" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">216.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Furniture and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45246361e920-wk-Fact-E90F96DB0D54B0B1F03BCCD3132C7EF7" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">334.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45246361e939-wk-Fact-F867F8EF437983321241CCD31323B2AB" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">293.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Software</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45246361e959-wk-Fact-3173EA625E51F36F0583CCD313617439" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">55.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45246361e978-wk-Fact-9A0A91C46D340595B450CCD3132B5BA6" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">55.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Construction-in-progress</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45246361e998-wk-Fact-49EE4615C3951E2EB444CCD3133247E8" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">81.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45246361e1017-wk-Fact-25F2414AFA3528F10186CCD31333E7B5" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">71.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45246361e1037-wk-Fact-ECA0ED6EA7E0D82DE419CCD3132DD2DB" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">752.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45246361e1056-wk-Fact-E0416796D2277F2997D7CCD3133205A5" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">681.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Less: Accumulated depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45246361e1076-wk-Fact-CF641EBDB256DF126646CCD3132E5F41" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">210.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45246361e1096-wk-Fact-B5EAB04BB3CD63080320CCD3132F2DBB" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">171.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total property, plant and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45246361e1122-wk-Fact-899C00B0608B636FBD8FCCD3135FCC56" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">542.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45246361e1141-wk-Fact-B7B7C9765C1C2455B6F1CCD3135E93E8" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">510.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, construction-in-progress primarily includes costs related to construction of manufacturing capabilities.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Depreciation and amortization expense associated with property, plant and equipment was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45246361e1164-wk-Fact-BFF9DD13E5B1758A9F88CCD3134ED24E" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">49.5</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45246361e1168-wk-Fact-09F0E22509DF348E9361CCD31349261C" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.3</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45246361e1172-wk-Fact-4D19F32ACA591CE6F38FCCD3135A1541" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.2</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively.</span></div></ix:continuation><div><a id="sA7966D24B1AA5638B8A50C14409F7449"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">8</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="TextSelection-4D71F65C18591F6B9305CCD313BD8DED-0-wk-Fact-74AED7C7E71A4A72F0BCCCD3132ABC80" continuedAt="TextSelection-4D71F65C18591F6B9305CCD313BD8DED-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Intangible assets and goodwill</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="TextSelection-99D15BF460908D2FBDF9B2C200C299D7-0-wk-Fact-A6FC41FDF4910D9410EAB2C218584A07" continuedAt="TextSelection-99D15BF460908D2FBDF9B2C200C299D7-1" escape="true"><ix:continuation id="TextSelection-4D71F65C18591F6B9305CCD313BD8DED-1" continuedAt="TextSelection-4D71F65C18591F6B9305CCD313BD8DED-2"><div style="line-height:120%;padding-bottom:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's intangible assets were acquired via business combinations or asset acquisitions. Changes in the Company&#8217;s intangible assets, excluding IPR&amp;D and goodwill, consisted of the following:</span></div></ix:continuation></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">96</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-4D71F65C18591F6B9305CCD313BD8DED-2"><div style="line-height:120%;padding-bottom:12px;text-align:center;padding-left:0px;font-size:10pt;"><ix:continuation id="TextSelection-99D15BF460908D2FBDF9B2C200C299D7-1"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:32%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Estimated Life</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Cost</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Additions</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Accumulated Amortization</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Net</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">Products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9-22 years</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e938-wk-Fact-BFBFDEBCF30B1983CA10B2C592FFBF09" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">778.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e952-wk-Fact-AC36B9A93966685C87AC117D2F3BE9C3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e966-wk-Fact-AB69DDDAC11D1E38AC68B2CAD89C81C0" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">82.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e981-wk-Fact-C598645C9A0AB717A024B2CC9010D762" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">705.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate trade name</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonNumeric id="d45249685e996-wk-Fact-413118B55B2FD4FEEF93B2CE751A5928" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" format="ixt-sec:duryear">5</ix:nonNumeric> years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1006-wk-Fact-1DCA591912805E7DBBBCB2C5931E20B0" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1034-wk-Fact-F939615548440E2831F1B2CADAFF0648" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1049-wk-Fact-ECD134AC14121777FA13B2CC951EB39E" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Customer relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonNumeric id="d45249685e1069-wk-Fact-950BCE73811A080E1AF2B2CE75347213" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear">8</ix:nonNumeric> years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1079-wk-Fact-7FDCE7981FD591E531E9B2C5930F9F58" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">28.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1107-wk-Fact-B89EDD6AE6527A81A627B2CAD42F9F10" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">23.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1122-wk-Fact-911B5E4A129494F648DBB2CC984F8233" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contract development and manufacturing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonNumeric id="d45249685e1142-wk-Fact-F3041CD0D296821E0C65B2CE7595DB8B" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember" format="ixt-sec:duryear">8</ix:nonNumeric> years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1152-wk-Fact-51C182416B9F0C55288DB2C595111164" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1180-wk-Fact-6217D83DC72C03ECF3CDB2CAD4921ECE" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1195-wk-Fact-F48D38E4F302593AD2F9B2CC929378AC" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;&#160;&#160;&#160;Total intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1230-wk-Fact-A2E8C74583DFEC0018C1B2C592FF1D37" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">814.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1244-wk-Fact-AC975C7B2571E2934370117D2F35EE25" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1258-wk-Fact-E8601FC07D6276C8611CB2CADB22BA84" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">112.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1273-wk-Fact-27F900C72C5D1EA89EB6CCD3134DEE83" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">712.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></ix:continuation><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:32%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Estimated Life</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Cost</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Additions</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Accumulated Amortization</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Net</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">Products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9-22 years</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1481-wk-Fact-EC8A143F235A6F0F7253B2C59B4A30E9" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">111.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1495-wk-Fact-2FABCFDF5269BB27AC17117E648BF639" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">667.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1509-wk-Fact-0F0F8EA90A1AF9276F4CB2CAD4489F6F" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">27.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1524-wk-Fact-7C125A3865F22BFE55F4B2CC901478EE" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">750.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate trade name</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonNumeric id="d45249685e1539-wk-Fact-C6E243487BCD0214212E117ED525CA4D" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" format="ixt-sec:duryear">5</ix:nonNumeric> years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1549-wk-Fact-CDAF5E2B6DE1E57C5DC3B2C592F04569" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1577-wk-Fact-64D53D2F5AF3FB833119B2CAD9595EF5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1592-wk-Fact-73703E399EF976D571F5B2CC901ADA02" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Customer relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonNumeric id="d45249685e1612-wk-Fact-CD4378D6F7450143246F117ED8D333E4" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear">8</ix:nonNumeric> years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1622-wk-Fact-D72E8258418E57FFC1BAB2C597DF63AA" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">28.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1650-wk-Fact-305E0617212D1F594E90B2CAD70A5C8D" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1665-wk-Fact-B0C45DAF9D3CB7A9BD6FB2CC99FF8C15" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contract development and manufacturing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonNumeric id="d45249685e1685-wk-Fact-64D97DDA4BC4DB90DBF1117EDC446A02" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember" format="ixt-sec:duryear">8</ix:nonNumeric> years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1695-wk-Fact-44E29B67C799D6C0D4B7B2C5930F42ED" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1723-wk-Fact-AD66A8592DA8854D0785B2CAD517287C" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1738-wk-Fact-058F5D538EEBEF2E4535B2CC90238CC5" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;&#160;&#160;&#160;Total intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1773-wk-Fact-2C732840137CB3B2FF36B2C59CD1B67C" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">147.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1787-wk-Fact-1393705FAE48B2721C12117E690541DA" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">667.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1801-wk-Fact-ADEB9F714F64237D4AA7B2CAD5E2CAEC" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">53.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e1816-wk-Fact-FAAFDFA256E7EC5FA786B2CC90A00B07" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">761.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company recorded amortization expense for intangible assets of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45249685e1837-wk-Fact-6CC25FDAD57AD605F0EFEE0DD6E4C0A9" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">58.7</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45249685e1841-wk-Fact-13AE45AAD591A38D64EBCCD313882444" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45249685e1846-wk-Fact-1225424380838E1DB578CCD31376D614" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.6</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, which is included in the amortization of intangible assets line item of the consolidated statements of operations. As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the weighted average amortization period remaining for intangible assets is </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45249685e1854-wk-Fact-0B32C5E48D3C222BC071CCD3132FC219" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="FD2019Q4YTD" format="ixt-sec:duryear">13.6</ix:nonNumeric> years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="TextSelection-CCAF55F5B6EFD38C048CCCD313BD9EA2-0-wk-Fact-B373E238564E120EBC1FCCD3132D61FB" escape="true"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Future amortization expense as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:88%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1913-wk-Fact-6D500E7FD456923A15AECCD31352C727" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">58.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1928-wk-Fact-F0B99759E42FFC6F5489CCD313515422" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">57.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1948-wk-Fact-EDE1B983CBBB6515BA44CCD3134F85F1" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1968-wk-Fact-326F2DD95817A1A002FCCCD31350E5BF" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2024 and beyond</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e1988-wk-Fact-1DC12762781C2042F850CCD31350630F" name="ebs:FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">487.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total remaining amortization</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e2013-wk-Fact-27F900C72C5D1EA89EB6CCD3134DEE83" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">712.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">During the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company recorded the impact of an impairment charge of $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45249685e2029-wk-Fact-C32FD711B872DB8478CBB1501BA3B71C" name="us-gaap:GoodwillImpairmentLoss" contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.0</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million related to our intangible assets associated with the IPR&amp;D acquired as part of our acquisition of Adapt. The $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45249685e2033-wk-Fact-C32FD711B872DB8478CBB1501BA3B71C" name="us-gaap:GoodwillImpairmentLoss" contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.0</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million impairment charge is reflected as a component of  research and development expense on the consolidated statement of operations. The IPR&amp;D intangible asset balance on the consolidated balance sheet at </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45249685e2041-wk-Fact-2B0343D7D345B2E16A1ACCD31364046E" name="ebs:InProcessResearchAndDevelopment" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">29.0</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million. </span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfGoodwillTextBlock" id="TextSelection-FD5A1F6D594701F60B61CCD313BDE017-0-wk-Fact-A448FA4A4935B8A36DD8CCD3132D9F3C" escape="true"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table is a summary of changes in goodwill:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #ffffff;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at beginning of the year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e2160-wk-Fact-0476B91EA1574A23DB9ACCD313714CA2" name="us-gaap:GoodwillGross" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">259.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e2179-wk-Fact-CDE103C943F4EE8ED4EFCCD3136D2849" name="us-gaap:GoodwillGross" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">49.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Measurement period adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e2194-wk-Fact-C19E4A5946048D3A90BE118577654EEA" name="us-gaap:GoodwillPurchaseAccountingAdjustments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e2213-wk-Fact-89FF224DC8C7EAC96B6E1185775D971A" name="us-gaap:GoodwillPurchaseAccountingAdjustments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e2233-wk-Fact-3473E66A365C19F30831CCD313709C48" name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e2252-wk-Fact-E5772E3B577B60892A85CCD3136FA612" name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">210.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at end of the year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45249685e2277-wk-Fact-9C366BA98887F810A6D5CCD3137087AE" name="us-gaap:GoodwillGross" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">266.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249685e2296-wk-Fact-0476B91EA1574A23DB9ACCD313714CA2" name="us-gaap:GoodwillGross" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">259.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">97</span></div></div><hr style="page-break-after:always"></hr><div><a id="s4B0E784A11975137A3C651DE97FE1376"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">9</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:DebtDisclosureTextBlock" id="TextSelection-93E28B14392F783DFB4ACCD313BDA4A2-0-wk-Fact-1E2C353D239840263BEECCD3132CA173" continuedAt="TextSelection-93E28B14392F783DFB4ACCD313BDA4A2-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Long-term debt</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">  </span></ix:nonNumeric></div><ix:continuation id="TextSelection-93E28B14392F783DFB4ACCD313BDA4A2-1" continuedAt="TextSelection-93E28B14392F783DFB4ACCD313BDA4A2-2"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfDebtTableTextBlock" id="TextSelection-7F42964A222271EB3AB1CCD313BD3CA0-0-wk-Fact-F39E4B0B45AAF9D702DACCD31329EBAA" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The components of debt are as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:top;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Senior secured credit agreement - Term loan due 2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45247219e847-wk-Fact-78ABF6E6789609E38069CCD313653515" name="us-gaap:LongTermDebt" contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">435.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45247219e866-wk-Fact-6F80D437FD970B6DA8BCCCD31363457A" name="us-gaap:LongTermDebt" contextRef="FI2018Q4_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">447.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Senior secured credit agreement - Revolver loan due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45247219e881-wk-Fact-011B577331FA8DD6BF5CCCD3136805F2" name="us-gaap:LongTermDebt" contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">373.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45247219e900-wk-Fact-FDEA481EE18755F0B87BCCD31367BB51" name="us-gaap:LongTermDebt" contextRef="FI2018Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">348.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.875% Convertible Senior Notes due 2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45247219e920-wk-Fact-B37055ADD09BB78884E8CCD31365468D" name="us-gaap:LongTermDebt" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45247219e939-wk-Fact-C4CA6435D3985A942597CCD31364A4C7" name="us-gaap:LongTermDebt" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45247219e959-wk-Fact-08B22B915247E4658515CCD313683ABE" name="us-gaap:LongTermDebt" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_ebs_OtherLongTermDebtFacilityMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45247219e978-wk-Fact-11F606BB695065012BE5CCD31367F678" name="us-gaap:LongTermDebt" contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_ebs_OtherLongTermDebtFacilityMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45247219e1003-wk-Fact-5386E050AFE659B4A21ECCD313659993" name="us-gaap:LongTermDebt" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">822.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45247219e1022-wk-Fact-8DAE5579866B62C08D91CCD313645010" name="us-gaap:LongTermDebt" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">808.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current portion of debt, net of debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45247219e1037-wk-Fact-E4E353421F6CF0F1D415CCD31366C1C9" name="us-gaap:LongTermDebtCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45247219e1057-wk-Fact-B88CB1FA3CCB30D69E6FCCD3136804F6" name="us-gaap:LongTermDebtCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unamortized debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45247219e1078-wk-Fact-BF4A209FA00AA7B96FDBCCD31365D653" name="us-gaap:DeferredFinanceCostsNoncurrentNet" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45247219e1098-wk-Fact-4E9AD266589779509EBFCCD31365B621" name="us-gaap:DeferredFinanceCostsNoncurrentNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Debt, net of current portion</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45247219e1124-wk-Fact-0163307C7DD7CD378E59CCD31360AD48" name="us-gaap:LongTermDebtNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">798.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45247219e1143-wk-Fact-6EFA9A3FEB39B8EF4FC4CCD313587151" name="us-gaap:LongTermDebtNoncurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">784.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Senior secured credit agreement</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On September 29, 2017, the Company entered into a senior secured credit agreement (the &#8220;2017 Credit Agreement&#8221;) with </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1158-wk-Fact-C0C462B43319DDE848CBCCD3135573B2" name="ebs:NumberOfLendingInstitutions" contextRef="D2017Q3Sep29-Sep29_us-gaap_DebtInstrumentAxis_ebs_CreditAgreementMember" unitRef="lending_institution" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> lending financial institutions, which replaced the Company's prior senior secured credit agreement (the "2013 Credit Agreement").</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On October 15, 2018, the Company entered into an Amended and Restated Credit Agreement (the "Amended Credit Agreement"), which modified the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Credit Agreement. The Amended Credit Agreement (i) increased the revolving credit facility (the "Revolving Credit Facility") from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45247219e1169-wk-Fact-952BBF05FD8612C11E46CCD3134E009C" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" contextRef="I2017Q3Sep29_us-gaap_DebtInstrumentAxis_ebs_CreditAgreementMember" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">200</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45247219e1173-wk-Fact-91E85509F8F2B7B32D82CCD3134DD5EB" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" contextRef="I2018Q4Oct15_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">600</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, (ii) extended the maturity of the Revolving Credit Facility from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">September&#160;29, 2022</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">October&#160;13, 2023</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, (iii) provided for a term loan in the original principal amount of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45247219e1186-wk-Fact-89420427D00DC1294C00CCD3134A2401" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" contextRef="I2018Q4Oct15_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">450</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (the "Term Loan Facility," and together with the Revolving Credit Facility, the "Senior Secured Credit Facilities"), (iv) added several additional lenders, (v) amended the applicable margin such that borrowings with respect to the Revolving Credit Facility will bear interest at the annual rate described below, (vi) amended the provision relating to incremental credit facilities such that the Company may request one or more incremental term loan facilities, or one or more increases in the commitments under the Revolving Credit Facility (each an "Incremental Loan"), in any amount if, on a pro forma basis, the Company's consolidated secured net leverage ratio does not exceed </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1190-wk-Fact-A8A1C0D6F9908651BF2CF713D52FCE59" name="ebs:ConsolidatedSecuredNetLeverageRatio" contextRef="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="number" decimals="INF" scale="0" format="ixt:numdotdecimal">2.50</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> after such incurrence, plus </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45247219e1198-wk-Fact-A3830A92E6BDAA3E7784CCD3134C91E9" name="ebs:AmountRequiredForNetLeverageRatio" contextRef="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">200</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and (vii) amended the maximum consolidated net leverage ratio financial covenant from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1202-wk-Fact-B2DDC27A29F4A23D9AFCF71F631C3DAA" name="ebs:DebtInstrumentCovenantLeverageRatio" contextRef="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="number" decimals="INF" scale="0" format="ixt:numdotdecimal">3.50</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.0</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (subject to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1211-wk-Fact-ADAFEA9E088E61A8D357CCD31352C005" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="D2018Q4Oct15-Oct15_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_FederalFundsEffectiveSwapRateMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">0.50</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> step up in connection with material acquisitions) to the maximum consolidated net leverage ratio described below.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In October 2018, the Company borrowed </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45247219e1218-wk-Fact-5F8728DA86B9DA59CE91CCD313492C1E" name="us-gaap:LineOfCredit" contextRef="I2018Q4Oct31_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">318.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> under the Revolving Credit Facility and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45247219e1222-wk-Fact-AF553393B9E0D3CAB4C7CCD3134D04A8" name="us-gaap:LineOfCredit" contextRef="I2018Q4Oct31_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">450</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> under the Term Loan Facility to finance a portion of the consideration for the PaxVax and Adapt acquisitions and related expenses.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, we did </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1233-wk-Fact-44B2AC52F1CDE611977CB70C1887C954" name="us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet" contextRef="FI2019Q4" unitRef="usd" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">t capitalize debt issuance costs. For the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> we capitalized </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45247219e1241-wk-Fact-D1E772395E0853AAB701CCD3134FD89E" name="us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.4</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, as a direct reduction to the Term Loan and the revolver.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Borrowings under the Revolving Credit Facility and the Term Loan Facility will bear interest at a rate per annum equal to (a) a eurocurrency rate plus a margin ranging from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1248-wk-Fact-172AF64C2CC8EC189821CCD31353A52D" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">1.25</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1252-wk-Fact-BDB64F927918F4D8D10BCCD31353B43A" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">2.00</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> per annum, depending on the Company's consolidated net leverage ratio or (b) a base rate (which is the highest of the prime rate, the federal funds rate plus </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1256-wk-Fact-ADAFEA9E088E61A8D357CCD31352C005" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="D2018Q4Oct15-Oct15_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_FederalFundsEffectiveSwapRateMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">0.50</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and a eurocurrency rate for an interest period of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45247219e1260-wk-Fact-07670D62DC78A408943DCCD313547D84" name="ebs:DebtInstrumentTermOfVariableRate" contextRef="D2018Q4Oct15-Oct15_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" format="ixt-sec:durwordsen">one month</ix:nonNumeric></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> plus </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1264-wk-Fact-FFC42CAC3B9378376DFACCD3134E2268" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="D2018Q4Oct15-Oct15_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">) plus a margin ranging from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1269-wk-Fact-5846259A1C5A70FB1025CCD3134FC182" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">0.25</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1273-wk-Fact-0117A704357629F217D4CCD3134A1D7F" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">1.00</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, depending on the Company's consolidated net leverage ratio. The Company is required to make quarterly payments under the Amended Credit Agreement for accrued and unpaid interest on the outstanding principal balance, based on the above interest rates. In addition, the Company is required to pay commitment fees ranging from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1277-wk-Fact-5EA4B9128E15729C9C4FCCD31354CC93" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" contextRef="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">0.15</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1281-wk-Fact-774D9941A0A53B8EB464CCD3134BC155" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" contextRef="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">0.30</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> per annum, depending on the Company's consolidated net leverage ratio, in respect of the average daily unused commitments under the Revolving Credit Facility. The Company is to repay the outstanding principal amount of the Term Loan Facility in quarterly installments based on an annual percentage equal to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1285-wk-Fact-690F4CAFD3F12CCE1A5BCCD313489B93" name="ebs:PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears" contextRef="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">2.5</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of the original principal amount of the Term Loan Facility during each of the first two years of the Term Loan Facility, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1289-wk-Fact-CFEA0A816E9EA107A568CCD3134E0570" name="ebs:PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear" contextRef="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">5</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of the original principal amount of the Term Loan Facility during the third year of the Term Loan Facility and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1294-wk-Fact-347DA37033EED93BAB8DCCD3134C2EB6" name="ebs:PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears" contextRef="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">7.5</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of the original principal amount of the Term Loan Facility during each year of the remainder of the term of the Term Loan Facility until the maturity date of the Term Loan Facility, at which time the entire unpaid principal balance of the Term Loan Facility will be due and payable. The Company has the right to prepay the Term Loan Facility without premium or penalty. The Revolving Credit Facility and the Term Loan Facility mature (unless earlier terminated) on </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">October&#160;13, 2023</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">98</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-93E28B14392F783DFB4ACCD313BDA4A2-2"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Amended Credit Agreement also requires mandatory prepayments of the Term Loan Facility in the event the Company or its Subsidiaries (a) incur indebtedness not otherwise permitted under the Amended Credit Agreement or (b) receive cash proceeds in excess of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45247219e1305-wk-Fact-7F3D506C648ACA981B37CCD313548328" name="ebs:CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight" contextRef="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">100</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> during the term of the Amended Credit Agreement from certain dispositions of property or from casualty events involving their property, subject to certain reinvestment rights.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Amended Credit Agreement contains financial covenants, which were then further amended in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">June 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The financial covenants require the quarterly presentation of a minimum consolidated 12-month rolling debt service coverage ratio of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1316-wk-Fact-43DEF740AB6C4569CF2EF71E34FF558B" name="ebs:DebtInstrumentCovenantDebtServiceCoverageRatio" contextRef="D2019Q2Jun01-Jun30_srt_RangeAxis_srt_MinimumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="number" decimals="INF" scale="0" format="ixt:numdotdecimal">2.50</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and an amended maximum consolidated net leverage ratio of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1324-wk-Fact-9C0F97ECDA8A8BBE9E24F71E5E9FAFD1" name="ebs:DebtCovenantNetLeverageRatioOne" contextRef="FD2019Q2QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="number" decimals="INF" scale="0" format="ixt:numdotdecimal">4.95</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the quarter ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1337-wk-Fact-666AEACC188D8F7284F3CCD313564179" name="ebs:DebtCovenantNetLeverageRatioTwo" contextRef="FD2019Q3QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="number" decimals="INF" scale="0" format="ixt:numdotdecimal">4.75</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the quarter ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and  </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1349-wk-Fact-287333B8E8978D1E8C4CF71EB26BE4A4" name="ebs:DebtCovenantNetLeverageRatioThree" contextRef="FD2019Q4QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="number" decimals="INF" scale="0" format="ixt:numdotdecimal">3.75</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to 1.00, thereafter, which may be adjusted to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1353-wk-Fact-C344F1401B1D4EFFC78BF71F0D0BBDCC" name="ebs:DebtCovenantNetLeverageRatioFour" contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="number" decimals="INF" scale="0" format="ixt:numdotdecimal">4.00</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for a four quarter period in connection with a material permitted acquisition. The Amended Credit Agreement also contains affirmative and negative covenants, which were also amended in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">June 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to limit the amount of restricted payments as defined in the Amended Credit agreement to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45247219e1366-wk-Fact-1778F1660A70F19662C1936BAEC8FE94" name="ebs:DebtInstrumentRestrictedPaymentsLimitAmount" contextRef="D2019Q2Jun01-Jun30_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">25</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> until the filing of the Company's </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Form 10-K. Negative covenants in the Amended Credit Agreement, among other things, limit the ability of the Company to incur indebtedness and liens, dispose of assets, make investments and enter into certain merger or consolidation transactions. As of the date of these financial statements, the Company is in compliance with affirmative and negative covenants.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"><span><ix:nonFraction id="d45247219e1376-wk-Fact-C03F1A46AF219A1B4359F6FFD39DB952" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="I2014Q1Jan29_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">2.875</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"> Convertible senior notes due 2021</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On November 14, 2017, the Company issued a notice of termination of conversion rights for its outstanding Notes, of which </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45247219e1383-wk-Fact-07272BB5CC8741E962EECCD313481203" name="us-gaap:DebtInstrumentFaceAmount" contextRef="I2017Q4Nov14_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">250.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was outstanding as of the notice date. In connection with the notice of termination, bondholders were given the option to convert their notes into the Company&#8217;s stock at a rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1387-wk-Fact-235528EE95CCDD9CED1BCCD313527907" name="ebs:DebtInstrumentNumberOfEquityInstruments" contextRef="D2016Q3Aug12-Aug12_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member" unitRef="shares" decimals="3" scale="0" format="ixt:numdotdecimal">32.386</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> per </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$1,000</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of principal outstanding, plus a make-whole of an additional </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1395-wk-Fact-A85E82461E05E111D969CCD31347E2ED" name="ebs:DebtInstrumentNumberOfAdditionalEquityInstruments" contextRef="D2017Q4Nov14-Nov14_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member" unitRef="shares" decimals="4" scale="0" format="ixt:numdotdecimal">3.1556</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares per </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$1,000</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> principal outstanding, in accordance with the terms of the indenture. The Company was not obligated to pay accrued or unpaid interest on converted notes, and bondholders who did not convert by the deadline of December 28, 2017 would retain their bonds but lose the conversion rights associated with the Notes and be paid interest of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1404-wk-Fact-5AD0266C3EE765ADCEABCCD31353BC27" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="I2017Q4Nov14_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">2.875</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> until the earlier of maturity of the Notes in 2021 or the bonds being called and repaid in full by the Company. Between July 15, 2017 and the notification of termination of conversion rights, the Company accrued interest on the converted Notes of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45247219e1408-wk-Fact-5A30BFE4A5FEAB5585E1CCD3134943B0" name="ebs:DebtInstrumentAccruedInterestOnConvertedNotes" contextRef="D2017Q4Nov14-Nov14_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.4</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> which was recorded as an increase in additional paid-in-capital on the balance sheet. Between November 14, 2017 and December 28, 2017 (the &#8220;conversion period&#8221;), approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45247219e1412-wk-Fact-79CC0B7784F3EA2DBC61CCD31355D8D8" name="us-gaap:DebtInstrumentFaceAmount" contextRef="I2017Q4Dec28_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">239.4</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of bonds were converted into </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45247219e1416-wk-Fact-233F839CE7DA44E58868CCD3134A33F7" name="ebs:DebtInstrumentNumberOfEquityInstruments" contextRef="D2017Q4Nov15-Dec28_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">8.5</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares of the Company&#8217;s common stock, inclusive of shares issued as part of the make-whole provision. In addition, the Company recorded a reduction in additional paid-in-capital on the Company&#8217;s balance sheet of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45247219e1420-wk-Fact-83DA0568A4F540F2D457CCD31354EC57" name="us-gaap:DeferredFinanceCostsNet" contextRef="I2017Q4Dec28_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.6</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> associated with debt issuance costs attributable to the converted notes. After giving effect to the converted bonds, the outstanding principal balance of the Notes as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45247219e1429-wk-Fact-E9A3848C2DBAE5012526CCD313561EA7" name="us-gaap:DebtInstrumentFaceAmount" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">10.6</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="TextSelection-D14E63530B6D4AAA33C5CCD313BDE974-0-wk-Fact-065EC1BF2EC8B14B5EB0CCD3132A7985" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Future debt payments of long-term indebtedness are as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:81%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45247219e1484-wk-Fact-92A9D4435C6AFCBCDAE6CCD313932ACB" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45247219e1499-wk-Fact-5988940D9D52326949D6CCD31388E470" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">35.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45247219e1519-wk-Fact-C7044F22A3673358C39DCCD31392CD98" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">33.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45247219e1539-wk-Fact-CE3D3881B1F49549AC7ACCD313776233" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">735.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2024 and thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45247219e1559-wk-Fact-ABB01064E0CC85BF3207CCD313763D86" name="ebs:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total debt</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45247219e1584-wk-Fact-5386E050AFE659B4A21ECCD313659993" name="us-gaap:LongTermDebt" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">822.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div><a id="secca57be7e02404aa712d7083129912b"></a></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">   </span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">10</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">&#160;</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="TextSelection-72A89327CFC045CFA4A893A69E05A3C1-0-wk-Fact-ABC3EFDD1696ABE21F5893A7C40A28B2" continuedAt="TextSelection-72A89327CFC045CFA4A893A69E05A3C1-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Derivative Instruments</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-72A89327CFC045CFA4A893A69E05A3C1-1" continuedAt="TextSelection-72A89327CFC045CFA4A893A69E05A3C1-2"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company is exposed to certain risk arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company has entered into interest rate swaps to manage exposures that arise from the Company's senior secured credit agreement's payments of variable interest rate debt. All outstanding cash flow hedges mature in October 2023. </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">99</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-72A89327CFC045CFA4A893A69E05A3C1-2"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="TextSelection-D21F456DA0DB4089511593A97B8A38F2-0-wk-Fact-33D22958724AA0544ECC93AABCB94311" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company had the following outstanding interest rate swap derivatives that were designated as cash flow hedges of interest rate risk: </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:61%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:19%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Number of Instruments</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Notional amount                  (in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest Rate Swaps</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"><span><ix:nonFraction id="d45249230e791-wk-Fact-782EDDB1DF99CB6212CB93D09787B070" name="us-gaap:NumberOfInterestRateDerivativesHeld" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="instrument" decimals="INF" scale="0" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#00497f;"><span><ix:nonFraction id="d45249230e801-wk-Fact-D764E2AF101AFC78C7DB93D09E5F590D" name="invest:DerivativeNotionalAmount" contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="INF" scale="6" format="ixt:numdotdecimal">350.0</ix:nonFraction></span></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="TextSelection-EE4492BC59D9D677EBBE93AAE2DF2EBF-0-wk-Fact-10A65DC92274E6CD752E93AB30F2EF99" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The table below presents the fair value of the Company&#8217;s derivative financial instruments designated as hedges as well as their classification on the balance sheet. If current fair values of designated interest rate swaps remained static over the next twelve months, the Company would reclassify $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45249230e809-wk-Fact-5C7F0750F05BBE6AADBBECA01244FAF2" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million of net deferred losses from accumulated other comprehensive loss to the statement of operations over the next twelve months. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:11%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td colspan="8" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Asset Derivatives</span></div></td><td colspan="8" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Liability Derivatives</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="4" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td><td colspan="4" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Fair Value</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Fair Value</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Fair Value</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest Rate Swaps</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">Other Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"><span><ix:nonFraction id="d45249230e1102-wk-Fact-8D2C8569C2151AD1BA1D93D6CC6F5777" name="us-gaap:DerivativeFairValueOfDerivativeAsset" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249230e1116-wk-Fact-0D81E06B4E77BDBCDE0193D6D1CE47F7" name="us-gaap:DerivativeFairValueOfDerivativeAsset" contextRef="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">Other Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"><span><ix:nonFraction id="d45249230e1135-wk-Fact-22342397583B82597F3B93D6D69706ED" name="us-gaap:DerivativeFairValueOfDerivativeLiability" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249230e1155-wk-Fact-7FE75A9CC3B05D30BFF293D7E3D658B0" name="us-gaap:DerivativeFairValueOfDerivativeLiability" contextRef="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="TextSelection-5878A207866FB090105C98BA473E6C8F-0-wk-Fact-ACF76D79D163BBBF35A298BACC4626BF" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> The table below presents the effect of cash flow hedge accounting on accumulated other comprehensive income.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:30%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:22%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Hedging derivatives</span></div></td><td colspan="5" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Amount of Gain/(Loss) Recognized in OCI on Derivative</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income </span></div></td><td colspan="6" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest Rate Swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"><span><ix:nonFraction id="d45249230e1334-wk-Fact-71062B02773D93D42D7193D9A212FB8A" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249230e1343-wk-Fact-B9435A39AB4005C3D95293D9A463F7CB" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax" contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"><span><ix:nonFraction id="d45249230e1362-wk-Fact-88E454B848F6750A5B4298AD83E02B28" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45249230e1377-wk-Fact-897726E659C1BF7600A793D9A9E88091" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div><a id="sBEE9975C2C64595A9A40162F4C496B03"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">11</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="TextSelection-A102C2AD0293933B3CFACCD313BE0269-0-wk-Fact-7406BA55A8A88BD18BE6CCD313687C45" continuedAt="TextSelection-A102C2AD0293933B3CFACCD313BE0269-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Stockholders' equity</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-A102C2AD0293933B3CFACCD313BE0269-1" continuedAt="TextSelection-A102C2AD0293933B3CFACCD313BE0269-2"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Preferred stock</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company is authorized to issue up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45252404e738-wk-Fact-4C57654DA23897ACB2EAF6BD074F89ED" name="us-gaap:PreferredStockSharesAuthorized" contextRef="FI2019Q4" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">15.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares of preferred stock, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45252404e742-wk-Fact-1CC3C94A937B33F5EB4CCCD3136F00CF" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="FI2019Q4" unitRef="usdPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.001</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> par value per share ("Preferred Stock"). Any Preferred Stock issued may have dividend rights, voting rights, conversion privileges, redemption characteristics, and sinking fund requirements as approved by the Company's board of directors.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Common stock</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company currently has one class of common stock, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45252404e752-wk-Fact-1AB42C1C80CE1D400F65CCD3136C58E8" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="FI2019Q4" unitRef="usdPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.001</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> par value per share common stock ("Common Stock"), authorized and outstanding. The Company is authorized to issue up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45252404e756-wk-Fact-A4276C7329AF217B728CF6BD407A1630" name="us-gaap:CommonStockSharesAuthorized" contextRef="FI2019Q4" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">200.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares of Common Stock. Holders of Common Stock are entitled to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45252404e760-wk-Fact-1057361E2C611395F0CFB1B10865B086" name="ebs:CommonStockNumberofVotesPerCommonShare" contextRef="FD2019Q4YTD" unitRef="vote" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> vote for each share of Common Stock held on all matters, except as may be provided by law.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Accounting for stock-based compensation</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has one stock-based employee compensation plan, the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan (the "Emergent Plan"), which includes both stock options and restricted stock units.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, an aggregate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45252404e777-wk-Fact-01C9452B7F7D346CB788CCD313A97C34" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="INF" scale="6" format="ixt:numdotdecimal">21.9</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares of common stock were authorized for issuance under the Emergent Plan, of which a total of approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45252404e781-wk-Fact-53FDDCC8B3EF67D272FBCCD313A6F912" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">5.8</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares of common stock remain available for future awards to be made to plan participants. The exercise price of each option must be not less than </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45252404e785-wk-Fact-A8435198BE54DAB7BA3ACCD3137361FB" name="ebs:ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of the fair market value of the shares underlying such option on the date of grant. Awards granted under the Emergent Plan have a contractual life of no more than </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45252404e789-wk-Fact-4C6BB05A911AA395D7C0CCD3135E5D4E" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">10</ix:nonNumeric> years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">100</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-A102C2AD0293933B3CFACCD313BE0269-2" continuedAt="TextSelection-A102C2AD0293933B3CFACCD313BE0269-3"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="TextSelection-A20CE09B9DE0357A7AA8CCD313BD0429-0-wk-Fact-9B84D274E406DED16713CCD313448E96" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company utilizes the Black-Scholes valuation model for estimating the fair value of all stock options granted. Set forth below are the assumptions used in valuing the stock options granted:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:62%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:top;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expected dividend yield</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e914-wk-Fact-DB83BC4B671746420ADDCCD31335E8DC" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e929-wk-Fact-388F3C5582E6EF548814CCD3132FDB9E" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e944-wk-Fact-43666FF84299922E8A82CCD3133606EF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expected volatility</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37-39%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">38-39%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37-40%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Risk-free interest rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.57-2.48%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.54-3.03%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.66-1.88%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expected average life of options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonNumeric id="d45252404e1046-wk-Fact-8B8AE862F962FD361602CCD3132B218C" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">4.5</ix:nonNumeric> years</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonNumeric id="d45252404e1060-wk-Fact-4B53F2A3A077FE23E44ACCD313371655" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">4.5</ix:nonNumeric> years</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonNumeric id="d45252404e1074-wk-Fact-88A7EC2E11F047D31CE6CCD31339A238" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">4.3</ix:nonNumeric> years</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Stock options, restricted and performance stock units</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="TextSelection-5A568097EADAA68623F5CCD313BE79C6-0-wk-Fact-D5ADB7DA945DEFDB11D6CCD31367AD98" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following is a summary of stock option award activity under the Emergent Plan:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:62%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Emergent Plan</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions, except share and per share data)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Number of Shares</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Weighted-Average Exercise Price</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Aggregate Intrinsic Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Outstanding at December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1230-wk-Fact-AB56AEE6FF4B76D66B19CCD3133B69D0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="FI2018Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">1,871,468</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1249-wk-Fact-18DC5725006FE2F7481BCCD3133A516B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="FI2018Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">32.59</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1268-wk-Fact-0BDE5FB8A0E5AF4DADFACCD31338F8A2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="FI2018Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">50.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1283-wk-Fact-102EB811C9CBE276EDC6CCD31333A469" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">295,770</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1297-wk-Fact-CAA6F410AE276A3BBD54CCD313317A72" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">60.16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Exercised</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45252404e1337-wk-Fact-AA90A95B647FF5DDDDBDCCD31339B91F" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">199,352</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1352-wk-Fact-8E599FD3095F21CA890DCCD31337BD60" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">25.98</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45252404e1392-wk-Fact-9379DD4743690B40308CCCD313341CC4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">84,011</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1407-wk-Fact-4F82DF5D104907ABC4DCCCD31330D7ED" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">52.26</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Outstanding at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1447-wk-Fact-E2EA0CDD4B5BA5D1B5F2CCD313323A89" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">1,883,875</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1466-wk-Fact-3249FED9BCE69D6E38CFCCD3133C3AE4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">36.74</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1485-wk-Fact-5842B74A58212652CCEECCD31332D8E4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">34.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Exercisable at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1500-wk-Fact-43E21B5DC8B32B8F4731CCD313391DE1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">1,253,658</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1519-wk-Fact-95EBD3F095B9937243EBCCD3132F3B8C" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">29.46</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1538-wk-Fact-7737E6C3D5C1FF3BDE3BCCD313385DC1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">30.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The weighted average remaining contractual term of options outstanding as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was  </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45252404e1558-wk-Fact-895D81B3066ABC97C49155720D5969FF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="FD2019Q4YTD" format="ixt-sec:duryear">3.3</ix:nonNumeric> years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45252404e1562-wk-Fact-2FDB40624AE79D3A6A3B557219A34C3F" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="FD2018Q4YTD" format="ixt-sec:duryear">4.0</ix:nonNumeric> years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively. The weighted average remaining contractual term of options exercisable as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45252404e1575-wk-Fact-FCB8D524068A8F0BDF78CCD313AB95BB" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="FD2019Q4YTD" format="ixt-sec:duryear">2.3</ix:nonNumeric> years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45252404e1579-wk-Fact-89FD030CBEC41A7DF091CCD313AE4F44" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="FD2018Q4YTD" format="ixt-sec:duryear">3.0</ix:nonNumeric> years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The weighted average grant date fair value of options granted during the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45252404e1598-wk-Fact-848124C7B1EA80D919F2CCD31362CCC1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">21.13</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45252404e1602-wk-Fact-6410F6616A9ED23887EBCCD313ACCCB3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2018Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">18.48</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45252404e1607-wk-Fact-8208C7DAF673BB02C9C5CCD3135B4245" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2017Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">10.53</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> per share, respectively. The total intrinsic value of options exercised during the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45252404e1623-wk-Fact-B8AC7865DBA288E7E361CCD3131BAAD6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.3</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45252404e1627-wk-Fact-182CAF4752AEF80BFE35CCD313641A64" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">24.4</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45252404e1632-wk-Fact-404EAD494934D0FE4D85CCD3135DF052" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.9</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively. The total fair value of awards vested during </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45252404e1648-wk-Fact-B1F3C1A4C874526DD163CCD313A9927B" name="ebs:ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.9</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45252404e1653-wk-Fact-602018009611D15D966ECCD31346AB65" name="ebs:ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue" contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.9</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45252404e1657-wk-Fact-DC37BA0434D6D600385ACCD3135CAFD6" name="ebs:ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue" contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.9</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively. As of the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the total compensation cost and weighted average period over which total compensation is expected to be recognized related to unvested equity awards was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45252404e1665-wk-Fact-C40A3A62D59AEE4AAB98CCD31361C660" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">37.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45252404e1669-wk-Fact-03A57996C275BB033FB3CCD3135C135C" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2019Q4YTD" format="ixt-sec:duryear">1.5</ix:nonNumeric> years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="TextSelection-4DC71DE0E89FEEA5A8DACCD313BEB7ED-0-wk-Fact-E911D29B7CA8042BABFFCCD313A795A5" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following is a summary of performance stock and restricted stock unit award activity under the Emergent Plan. Performance stock units of approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45252404e1678-wk-Fact-2005BA463FB5B1598FF8B73652B917CA" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million shares were granted and remain outstanding the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and are included in the table below.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:62%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions, except share and per share data)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Number of Shares</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Weighted-Average Grant Price</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Aggregate Intrinsic Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Outstanding at December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1769-wk-Fact-07EA5EB4787027E20E4BCCD31395D81E" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">921,093</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1788-wk-Fact-15B7FE6EB9A2479BA82CCCD3139591EC" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">42.82</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1807-wk-Fact-B9C79E611F8A7114FD0ECCD3138B181A" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1822-wk-Fact-128AA9C7B9C6E9B8CBDDCCD313914AEC" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">594,752</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1836-wk-Fact-A65C5577BAD207556663CCD313928BF5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">57.94</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Vested</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45252404e1876-wk-Fact-808211C2B87C48C910BBCCD3138F9384" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">434,629</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1891-wk-Fact-796F4F95268330325FBFCCD31393730F" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">38.81</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45252404e1931-wk-Fact-C7C99C803C030562A52DCCD3138C2FC7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">128,364</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1946-wk-Fact-9DBEFFC55966C5244D5ACCD31392C6C3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">53.17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Outstanding at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e1986-wk-Fact-7A9427D0AE39999A98F0CCD31394BDC8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="shares" decimals="INF" scale="0" format="ixt:numdotdecimal">952,852</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e2005-wk-Fact-0553EBD0B096778303A5CCD31396B36B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">52.77</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e2024-wk-Fact-D1C1C23FF6C44097BA7FCCD3139310CF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">51.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">101</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-A102C2AD0293933B3CFACCD313BE0269-3"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="TextSelection-81EFEA2E3F9AAA695A69CCD313BD6440-0-wk-Fact-E9E998EDB32DA0F5C4FACCD313866285" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Stock-based compensation expense was recorded in the following financial statement line items:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:61%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cost of product sales</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252404e2211-wk-Fact-7A377D174377B3F842F5CCD31360D3EF" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e2230-wk-Fact-7D3579472B1C9DC7653CCCD313534DF8" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e2250-wk-Fact-423A62D64E476AAFF73DCCD31352EC1B" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252404e2270-wk-Fact-AF4FB6AFAA07E8CE00E9CCD313594C7E" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e2289-wk-Fact-4837F88019812866084DCCD3135B9DD7" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e2308-wk-Fact-93BA592857BAB5465F51CCD3135BB115" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Selling, general and administrative</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252404e2334-wk-Fact-6F78FBCDDC8DC96ADF11CCD31357763C" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e2353-wk-Fact-16337646A54BC8AD5E3FCCD313583FCC" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e2372-wk-Fact-D4FC9A913C74DDE3D794CCD3134B24DD" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total stock-based compensation expense</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252404e2403-wk-Fact-47670159802E59A32337CCD3134B196D" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">26.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e2422-wk-Fact-8C135B12BD2E7A2C60DACCD31355CE19" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">23.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e2442-wk-Fact-3D982D2C34F119DA1DE6CCD31353C607" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">15.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Accumulated Other Comprehensive Loss</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="TextSelection-707FBF80FD8D3A1A60495FB4B9F59223-0-wk-Fact-75F991765D18477B10505FB5057A52EF" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table includes changes in accumulated other comprehensive loss by component, net of tax:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td style="width:54%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Defined Benefit Pension Plan</span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Derivative Instruments</span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Foreign Currency Translation Losses</span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, January 1, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e2676-wk-Fact-1F73B2DA76F484B3F36B5FAC1689E096" name="us-gaap:StockholdersEquity" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e2695-wk-Fact-2692F63EA36CC9FC0E715FAC164A3FAA" name="us-gaap:StockholdersEquity" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45252404e2715-wk-Fact-5FB2B9E37F1A5AE8ABB65FAC15ED5E0B" name="us-gaap:StockholdersEquity" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">3.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45252404e2735-wk-Fact-5FF3FC7F515F0A0BE3F8CCD3139B14AE" name="us-gaap:StockholdersEquity" contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">3.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive loss </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45252404e2756-wk-Fact-9AE6EE2A3A935D4FFEC35FAFC07EB649" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e2776-wk-Fact-084B0F138774D7B207465FAFC0B5EFB2" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45252404e2795-wk-Fact-0B6F258D8003B35248455FAFC0DEF3E6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45252404e2816-wk-Fact-85089016933E47A775DDCCD3138523AA" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45252404e2847-wk-Fact-2EC0C2E5A65D05E873155FAC160C7E56" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45252404e2867-wk-Fact-2C84210288E677071E4F5FAC1570FD05" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45252404e2887-wk-Fact-C23550B8EECA0A781E6E5FAC162B2362" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">5.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45252404e2902-wk-Fact-BD1E9E43ECA910844A10CCD313A65287" name="us-gaap:StockholdersEquity" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">5.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive (loss) income before reclassifications</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45252404e2933-wk-Fact-8C35A1539E2642FC67D45FAFC185A608" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">3.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45252404e2953-wk-Fact-F1A98F163E3F46077D705FAFC12305F9" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252404e2974-wk-Fact-8454309FD6B485D180435FAFC2844354" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45252404e2993-wk-Fact-7A5404A7C44D85C0676A5FAFC0872466" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">5.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252404e3014-wk-Fact-0100F3CDF9680847AF9F5FB1FA4278F6" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252404e3033-wk-Fact-DB2DF6C5D105177F9A615FB1FA1A250A" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252404e3052-wk-Fact-E387B33DA48FCA40975D5FB1FA25EC53" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252404e3072-wk-Fact-3C2F102C4495AF9500AF5FB1FA740D27" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net current period other comprehensive loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45252404e3102-wk-Fact-D6C9CA23F16885A466015FB24D721FDC" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">3.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45252404e3122-wk-Fact-C76C6CC52546B8B4FD685FB24D1D620B" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252404e3143-wk-Fact-9DE61487E00899D9BD6D5FB24D13C879" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45252404e3162-wk-Fact-F702E6116BA005717710CCD3137114A2" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45252404e3188-wk-Fact-844C0A60A87AE6488B275FAC161CA266" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">3.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45252404e3208-wk-Fact-ACE33BC83F7BAD968A595FAC15DDB2F8" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45252404e3229-wk-Fact-F90530F0790ECB04F4F55FAC17A3432E" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45252404e3249-wk-Fact-8B694F970B5C4D0AAE3CCCD313AE3FE8" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">9.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div><a id="sC2587B7D2CB452F98A9853E873D4ADBE"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">12</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:IncomeTaxDisclosureTextBlock" id="TextSelection-2D1B5092F7357C0114EBCCD313BE1C94-0-wk-Fact-F440AD2372EBC655C50FCCD31326CE51" continuedAt="TextSelection-2D1B5092F7357C0114EBCCD313BE1C94-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Income taxes</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-2D1B5092F7357C0114EBCCD313BE1C94-1" continuedAt="TextSelection-2D1B5092F7357C0114EBCCD313BE1C94-2"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to reverse. Valuation allowances are recorded as appropriate to reduce deferred tax assets to the amount considered likely to be realized. As a result of the reduction in the U.S. corporate income tax rate from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45257978e735-wk-Fact-A1EC10E2907AED2FE7EB9921AEEBC0DA" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="FD2018Q4YTD" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">35</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45257978e739-wk-Fact-CFC7FB7C1D8E3B59B64C9921FC16FA50" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="FD2019Q4YTD" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">21</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> under the Tax Reform Act, the Company revalued its ending net deferred tax liabilities in the United States at </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and recognized a provisional </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e747-wk-Fact-267187EAABD6C9FE84D7CCD3139C845E" name="ebs:TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">13.4</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> tax benefit in the Company&#8217;s consolidated statement of income for the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. During </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, we adjusted the provisional estimate by approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e760-wk-Fact-69171786ACAD119EA1F0CCD3133C6275" name="ebs:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.5</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, bringing the total tax benefit recorded to date to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e764-wk-Fact-F9B8C5078CE116C0848DCCD31323B73D" name="ebs:TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">17.9</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> related to the revaluation of our deferred tax assets and liabilities.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Tax Reform Act provided for a one-time deemed mandatory repatriation of post-1986 undistributed foreign subsidiary earnings and profits (&#8220;E&amp;P&#8221;) through the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The Company had an estimated </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e775-wk-Fact-A3CAD7910A3246E70476CCD31328619B" name="ebs:TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">95.4</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of undistributed foreign E&amp;P subject to the deemed mandatory repatriation and recognized a provisional transition tax of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e779-wk-Fact-9B177448C7B84FB44AEBCCD3133A7CEB" name="ebs:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.6</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of income tax expense in the Company&#8217;s consolidated statement of income for the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. During </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> we reduced the provisional transition tax by </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e792-wk-Fact-EEE56E84815F086A4EFACCD31327D563" name="ebs:TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, bringing the total transition tax to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e796-wk-Fact-AC6D7F703178621A3C97CCD3139BBD6D" name="ebs:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.3</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">While the Tax Reform Act provides for a territorial tax system and it includes two new U.S. tax base erosion provisions, the global intangible low-taxed income (&#8220;GILTI&#8221;) provisions and the base-erosion and anti-abuse tax (&#8220;BEAT&#8221;) provisions.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The GILTI provisions require the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary&#8217;s tangible assets. The Company is subject to incremental U.S. tax on GILTI income. The Company has elected to account for GILTI tax in the period in which it is incurred, and therefore has not provided any deferred tax impacts of GILTI in its consolidated financial statements for the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="TextSelection-5EBC093CAFEEC78B9595CCD313BEDA36-0-wk-Fact-184B82A339BC399E8832CCD313306A6A" continuedAt="TextSelection-5EBC093CAFEEC78B9595CCD313BEDA36-1" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Significant components of the provisions for income taxes attributable to operations consist of the following:</span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">102</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-2D1B5092F7357C0114EBCCD313BE1C94-2" continuedAt="TextSelection-2D1B5092F7357C0114EBCCD313BE1C94-3"><ix:continuation id="TextSelection-5EBC093CAFEEC78B9595CCD313BEDA36-1"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e1033-wk-Fact-00F7A3527F40BBF0BB72CCD31398E174" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1052-wk-Fact-5B048CB8B8391AC79B8ECCD313A083F6" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1071-wk-Fact-9DBD1128E19683DD0F9DCCD313A49F1C" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">29.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e1087-wk-Fact-19CA1FE04F0A078DEBDBCCD3139AE1F2" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1106-wk-Fact-992EF6A4AB046EE4C28DCCD313A26D95" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1125-wk-Fact-E6C5A9017AF74834DD7BCCD31394EF2E" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e1146-wk-Fact-CA2F271EC9908236A23DCCD313A1912A" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1165-wk-Fact-F62160E90669534F19A8CCD313927EE8" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1184-wk-Fact-9A6C6628DAE8AF4E627CCCD3139C1255" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total current</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e1205-wk-Fact-FFD18DA9C5B6FE90C0D9CCD313A300F6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">24.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1224-wk-Fact-41B024510CC3E059F5F6CCD3139F8E6C" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1243-wk-Fact-6223FFE7E68160BDC2A5CCD3139B0FB4" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">32.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Federal</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e1326-wk-Fact-82C62F495DDABB2A5751CCD313921B80" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1345-wk-Fact-F8238B496476B9A22E53CCD3139D616F" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e1364-wk-Fact-3E5C45F49D5757076CDCCCD313A4FDA9" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">6.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e1386-wk-Fact-87335E7292EC5F9BE465CCD3139ACB36" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1405-wk-Fact-CDABDCD8E21A05A54B86CCD313A1903B" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e1424-wk-Fact-30F425FC1BAEF20D5F78CCD3139A9F62" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45257978e1446-wk-Fact-59158AF8CED40AFE8829CCD3139D68FD" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e1466-wk-Fact-D2710A5A1DCD26632BCBCCD31399FAE5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1486-wk-Fact-FE315517CCA27794E9D3CCD313997C2A" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total deferred</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45257978e1508-wk-Fact-DC0AFF649CFECD224358CCD313A23579" name="ebs:DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1528-wk-Fact-A52875A8912998262707CCD3139EFCC2" name="ebs:DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1547-wk-Fact-80B4472A1E1F2B6FAED2CCD3139C39E4" name="ebs:DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total provision for income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e1573-wk-Fact-815A1535A7EA25FCCD27CCD31380042F" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1592-wk-Fact-4D13AEFC5D9B488A367CCCD3137B2702" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1611-wk-Fact-9218D9AEEE0D40961A99CCD313765A05" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:continuation><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="TextSelection-E67A5EDD0C208C0D4910CCD313BE4BCB-0-wk-Fact-2D87E2EA331CD9FE767ECCD31325DA37" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's net deferred tax asset (liability) consists of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Federal losses carryforward</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e1736-wk-Fact-851353CCF69139692574CCD3136E2F79" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1755-wk-Fact-A068DFCE49EBF1C3CFC2CCD31371E346" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State losses carryforward</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e1770-wk-Fact-7D1E4E148C950E4B63EFCCD31369BA26" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1789-wk-Fact-5093F314E6A4C09D608BCCD313712641" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development carryforward</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e1809-wk-Fact-FC0DBC7CBEBA6EF559BECCD3136869E8" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1828-wk-Fact-7BBC9FE4B2D1293F494CCCD31373090B" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State research and development carryforward</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e1848-wk-Fact-6CFEDD158E15F68299C5CCD3136A9A49" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1867-wk-Fact-320FF9ADE0C0874447C6CCD31398CD84" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Scientific research and experimental development credit carryforward</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e1887-wk-Fact-7499BC1896851524FF5ECCD313699EE9" name="ebs:DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1906-wk-Fact-DA457076BC9D9235A5B3CCD3136AE69E" name="ebs:DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Stock compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e1926-wk-Fact-C7B2F698628DD1FFB7EECCD31370790F" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1945-wk-Fact-4118AF55F6E881CD27A4CCD3136B2B62" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Foreign NOLs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e1965-wk-Fact-8D21E85B3DC0F13517D9CCD3139A4F24" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e1984-wk-Fact-85E97B31A33AF1080A40CCD3139C12F8" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">35.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e2004-wk-Fact-070D77321BDCFC931EA8CCD313951447" name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e2023-wk-Fact-A887FDD65D0D0E06F773CCD3137450C1" name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory reserves</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e2043-wk-Fact-03A3149E85F5EA242910CCD3136678AF" name="us-gaap:DeferredTaxAssetsInventory" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e2062-wk-Fact-EEEB2B9CDF6D3AA3F9E6CCD31369793F" name="us-gaap:DeferredTaxAssetsInventory" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lease liability</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e2083-wk-Fact-C313CC873895D8F2F43B3F487C7A4643" name="ebs:DeferredTaxAssetsOperatingLeaseLiability" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e2122-wk-Fact-B870DBC5AC3CCDD7F647CCD31397A61F" name="us-gaap:DeferredTaxAssetsOther" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e2141-wk-Fact-C4DFC29EAC573BCCDAAFCCD313651963" name="us-gaap:DeferredTaxAssetsOther" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax asset</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e2161-wk-Fact-3E4DC24741CB1DE474BACCD313685626" name="us-gaap:DeferredTaxAssetsGross" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">128.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e2180-wk-Fact-AFF9BEEA038D11765368CCD3136C6E30" name="us-gaap:DeferredTaxAssetsGross" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">119.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fixed assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45257978e2200-wk-Fact-1FA54F737C6FBF99C12BCCD313945525" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">51.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e2220-wk-Fact-B5F1D0CAD6E61F507B5DCCD31369C885" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">46.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45257978e2241-wk-Fact-C3F961AE004D5B623282CCD313A2C090" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e2261-wk-Fact-FD2E667512F3FC963DC6CCD31367281E" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">60.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Right-of-use asset</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45257978e2282-wk-Fact-C4446092D3585EEE788C3F49F098A0EC" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45257978e2322-wk-Fact-5692974508F42B4D8C20CCD3138A9D79" name="us-gaap:DeferredTaxLiabilitiesOther" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e2342-wk-Fact-768507A580C073937B0FCCD3138F9BB1" name="us-gaap:DeferredTaxLiabilitiesOther" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax liability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45257978e2363-wk-Fact-CC27C94ED174E2E4DC5ACCD3136986A6" name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">114.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e2383-wk-Fact-C71197419775F35A1062CCD313724B0B" name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">107.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45257978e2404-wk-Fact-B13A87F9C0BB60FBB3D0CCD3136F48FA" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">64.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e2424-wk-Fact-2F564953CF3FB7386DB9CCD313965140" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">66.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net deferred tax asset (liability)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45257978e2450-wk-Fact-56C6CDFC8F78977D7464CCD3139B6462" name="us-gaap:DeferredTaxLiabilities" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">50.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e2470-wk-Fact-0F5D9D1132F9C627A52FCCD3136A413C" name="us-gaap:DeferredTaxLiabilities" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company has a net U.S. deferred tax liability in the amount of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2487-wk-Fact-C051ECDB61F990F2B9A9CCD3132328D8" name="us-gaap:DeferredTaxLiabilities" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.7</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and a foreign net deferred tax liability in the amount of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2491-wk-Fact-CD135974A43F035BE9CFCCD31331484B" name="us-gaap:DeferredTaxLiabilities" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">42.8</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The Company had a net U.S. deferred tax liability in the amount of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2495-wk-Fact-CA75286BF1717280D14ECCD3132CA01A" name="us-gaap:DeferredTaxLiabilities" contextRef="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.8</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and a foreign net deferred tax asset in the amount of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2499-wk-Fact-01D409166E5877DFFB71CCD3132A6F76" name="us-gaap:DeferredTaxAssetsNet" contextRef="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">49.3</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company currently has approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2515-wk-Fact-ACC06E9C301627AD7D70CCD3138B77B4" name="us-gaap:OperatingLossCarryforwards" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">40.5</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2519-wk-Fact-54F39BC07F765FFE7D3ECCD3139E7CDC" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.5</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> tax effected) in U.S. federal net operating loss carryforwards along with </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2523-wk-Fact-C5517D7ABC3B74BDFB74CCD313916323" name="us-gaap:TaxCreditCarryforwardAmount" contextRef="FI2019Q4_us-gaap_TaxCreditCarryforwardAxis_us-gaap_ResearchMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in research and development tax credit carryforwards for U.S. federal and state tax purposes that will begin to expire in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2027</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2024</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively. The U.S. federal net operating loss carryforwards are recorded with a </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2536-wk-Fact-C8AD4D60CEAE6D2DEB54CCD3133C0BB2" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.7</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> valuation allowance. The research and development tax credit carryforwards have a valuation allowance in the amount of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2540-wk-Fact-317AE198D66BE85EB7E5CCD3132654DA" name="us-gaap:TaxCreditCarryforwardValuationAllowance" contextRef="FI2019Q4_us-gaap_TaxCreditCarryforwardAxis_us-gaap_ResearchMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">9.1</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The Company has </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2544-wk-Fact-E6B9C4F1FAF7BCA1C694CCD3132B643C" name="us-gaap:OperatingLossCarryforwards" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">280.7</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2548-wk-Fact-1A7627ACBB6453DDAEE4CCD3133DA475" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.4</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> tax effected) in state net operating loss carryforwards, primarily in Maryland and California, that will begin to expire in 2025. The U.S. state tax loss carryforwards are recorded with a valuation allowance of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2552-wk-Fact-FFBCC395DAD3FBD10D81CCD3133A8AB4" name="us-gaap:OperatingLossCarryforwardsValuationAllowance" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">245.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2557-wk-Fact-D819B02072DBED69022ACCD3132F813F" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.4</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> tax effected). The Company has approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2561-wk-Fact-6D3BF62DD5BE9CA2D95CCCD31326097A" name="us-gaap:OperatingLossCarryforwards" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">199.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2565-wk-Fact-3942CAE671EBC2159B4BCCD3139DC6C0" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">37.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> tax effected) in net operating losses from foreign jurisdictions, some of which have an indefinite life (unless the foreign entities have a change in the nature or conduct of the business in the three years following a change in ownership), and some of which begin to expire in 2022. A valuation allowance in respect to these foreign losses has been recorded in the tax effected </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">103</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-2D1B5092F7357C0114EBCCD313BE1C94-3" continuedAt="TextSelection-2D1B5092F7357C0114EBCCD313BE1C94-4"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">amount of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2573-wk-Fact-3B6F338238C9055419E2CCD31330CAA9" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">34.3</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The Company currently has approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e2577-wk-Fact-01F0FFFBBFD157257912CCD31332A857" name="us-gaap:TaxCreditCarryforwardAmount" contextRef="FI2019Q4_us-gaap_TaxCreditCarryforwardAxis_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in Manitoba scientific research and experimental development credit carryforwards that will begin to expire in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2027</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The use of any of these net operating losses and research and development tax credit carryforwards may be restricted due to future changes in the Company's ownership.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="TextSelection-DE857BDF90656B97A20ECCD313BE6983-0-wk-Fact-71A285AB80CA6F75823ACCD3133ABD8B" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The provision for income taxes differs from the amount of taxes determined by applying the U.S. federal statutory rate to income before the provision for income taxes as a result of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">US</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e2747-wk-Fact-F002EB2677DC09B4A877CCD313A4E570" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">63.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e2766-wk-Fact-E5B6F15CAA81C428D2FDCCD313A7B326" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">71.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e2785-wk-Fact-D234687DBF056F805613CCD3139C7E78" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">80.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e2801-wk-Fact-5F83BA5205FB0366F0EDCCD31396DB7B" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e2820-wk-Fact-42F7F2A672FFD5AB79D8CCD313899461" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e2839-wk-Fact-FBD514B7131B7CD9A459CCD313A79C54" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">37.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Earnings before taxes on income</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e2860-wk-Fact-DC2754897D980D8CEF7FCCD313A73026" name="us-gaap:IncomeLossAttributableToParent" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">77.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e2879-wk-Fact-11988081782A138CBC93CCD3139DC924" name="us-gaap:IncomeLossAttributableToParent" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">81.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e2898-wk-Fact-891A803E6264A7918C65CCD3139762AF" name="us-gaap:IncomeLossAttributableToParent" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">118.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Federal tax at statutory rates</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e2924-wk-Fact-CA3738127F9D52322777CCD3139F7390" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">16.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e2943-wk-Fact-1A8F897FC76D275FA46ECCD313A9EC3B" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e2962-wk-Fact-E4C56B5B056CDBC43DEDCCD313A28388" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">41.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State taxes, net of federal benefit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e2978-wk-Fact-BFB841208CC73C75AB5ECCD313956995" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e2997-wk-Fact-BEE9AA41337049556771CCD31395BE8A" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3016-wk-Fact-918D2F850E0B86E07A83CCD313A1D056" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Impact of foreign operations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45257978e3037-wk-Fact-770A2604FEDC68E6250BCCD3138E9352" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">6.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3057-wk-Fact-7EC3F2C8BC3A09460302CCD313A9E280" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e3076-wk-Fact-46EF7D2127EDFAE2A26FCCD3139B4695" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Change in valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45257978e3098-wk-Fact-D98281A0796EA07F390FCCD313907546" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e3118-wk-Fact-572D3AB2B6F1AA610CE7CCD3138B9CA3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3138-wk-Fact-75D674F1C43EA9D8F893CCD313897009" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Tax credits</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45257978e3159-wk-Fact-844D8A554B270233C156CCD3139227D9" name="us-gaap:IncomeTaxReconciliationTaxCredits" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e3179-wk-Fact-07B39085859A7C28960BCCD3139EE901" name="us-gaap:IncomeTaxReconciliationTaxCredits" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e3199-wk-Fact-F08AE17C5D645A3980F1CCD3138FC6C6" name="us-gaap:IncomeTaxReconciliationTaxCredits" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Transition tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e3221-wk-Fact-A2F76D95347EAD7DD3DFCCD3138FD584" name="ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e3240-wk-Fact-F9012B163A32C77CFD8ACCD31396FFFA" name="ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3260-wk-Fact-C74D19A637EDF8D8A7A9CCD313A52C61" name="ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Change in U.S. tax rate</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e3282-wk-Fact-760DA48B1F2C108BB29CCCD31399FCB1" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e3301-wk-Fact-9C88F7068382292CF34FCCD313A8CF96" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e3321-wk-Fact-9263566D669B507B67ADCCD31397F03A" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">13.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Stock compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45257978e3343-wk-Fact-DA2AB288F37B71351613CCD313A141AE" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e3363-wk-Fact-B966B9AD01B5E3F80CD7CCD313A5AC07" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">5.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e3383-wk-Fact-7E6631E5F7508C51860BCCD313A5F60B" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other differences</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e3405-wk-Fact-455F74D526515ECE9076CCD313A07E0F" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e3424-wk-Fact-08BE2D82BE0380B54084CCD313879962" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e3444-wk-Fact-F661E11B0178E254119ECCD3139AEAA5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Return to provision true-ups</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45257978e3466-wk-Fact-49E108CC1508C9430206CCD3138A6308" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">2.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3486-wk-Fact-A14B45A822C3730A5A5ECCD3139EB9E4" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3505-wk-Fact-CDD68777EA4C4F3A3BBACCD31398664B" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Transaction costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e3526-wk-Fact-7283B32F4C8A049BFCA5CCD31398150B" name="ebs:EffectiveIncomeTaxRateReconciliationTransactionCosts" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3545-wk-Fact-402116147DA7114A143BCCD3139AF2CD" name="ebs:EffectiveIncomeTaxRateReconciliationTransactionCosts" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3564-wk-Fact-FE484D15E6DDA9CD9F93CCD313A10831" name="ebs:EffectiveIncomeTaxRateReconciliationTransactionCosts" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e3585-wk-Fact-C66CC80F134581326D5C4B4C4CE10ED9" name="ebs:EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;"><span><ix:nonFraction id="d45257978e3603-wk-Fact-5D6AA9482AEB0A9F36804B4C4B42DB70" name="ebs:EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;"><span><ix:nonFraction id="d45257978e3621-wk-Fact-88C8A87580EEDBCA542B4B4C4B5A2744" name="ebs:EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Compensation limitation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e3642-wk-Fact-46BBED23D9C9EFB3D3133F5059077535" name="ebs:EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3661-wk-Fact-AC5402A698B8AB818A6B3F5059585B2B" name="ebs:EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3680-wk-Fact-CC147A0E5C3EA046239E3F5058D747F7" name="ebs:EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">FIN 48</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e3701-wk-Fact-7D697E7CC25BB55BF8B93F520E5C139B" name="ebs:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3720-wk-Fact-DA53DA0D67B14C9EB7F33F520DE2051E" name="ebs:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3739-wk-Fact-0857DBAA367D10490C823F520E07403B" name="ebs:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">GILTI, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e3760-wk-Fact-64585C067AE0F4007750CCD313722318" name="ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3779-wk-Fact-DF6D5A2058A136B1D07CCCD31391DCD6" name="ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3798-wk-Fact-8AC472AF92540A726C10CCD313A67786" name="ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Permanent differences</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e3819-wk-Fact-D7537EEF0BA925704662CCD3139838FC" name="ebs:EffectiveIncomeTaxRateReconciliationPermanentDifference" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3838-wk-Fact-FC725F7434F99245F0F9CCD313968484" name="ebs:EffectiveIncomeTaxRateReconciliationPermanentDifference" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e3857-wk-Fact-C54EF7615B4C72915C32CCD3139921CA" name="ebs:EffectiveIncomeTaxRateReconciliationPermanentDifference" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Provision for income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e3884-wk-Fact-815A1535A7EA25FCCD27CCD31380042F" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3903-wk-Fact-4D13AEFC5D9B488A367CCCD3137B2702" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e3922-wk-Fact-9218D9AEEE0D40961A99CCD313765A05" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">36.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The effective annual tax rate for the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45257978e3947-wk-Fact-9ADCB7CB9269F8543BD0CCD3131ED915" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2019Q4YTD" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">30</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45257978e3951-wk-Fact-4D53EC28A15236599E99F6A1C2FE5647" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2018Q4YTD" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">23</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45257978e3956-wk-Fact-3E29EF9EAE47CB65E595CCD313A27073" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2017Q4YTD" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">30</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The effective annual tax rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45257978e3963-wk-Fact-9ADCB7CB9269F8543BD0CCD3131ED915" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2019Q4YTD" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">30</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is higher than the statutory rate primarily due to the impact of state taxes, GILTI, contingent consideration and other non-deductible items. This is partially offset by stock option deduction benefits, tax credits, and favorable rates in foreign jurisdictions. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The effective annual tax rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45257978e3974-wk-Fact-4D53EC28A15236599E99F6A1C2FE5647" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2018Q4YTD" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">23</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is higher than the statutory rate primarily due to the impact of state taxes, GILTI, acquisition transaction costs and other non-deductible items, and the jurisdictional mix of earnings. This is partially offset by the impact of the SAB 118 benefit and the stock option deduction benefit.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The effective annual tax rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45257978e3985-wk-Fact-79513A24644DC8DFAD1A9920961FB0CC" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2017Q4YTD" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">30</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> differs from statutory rate primarily due to the jurisdictional mix of earnings. Due to the impact of the Tax Reform Act enacted on December 22, 2017, the Company recognized a $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">13.4</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million tax benefit as a result of revaluing the U.S. ending net deferred tax liabilities from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">35%</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to the newly enacted U.S. corporate income tax rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">21%</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The tax benefit was fully offset by tax expense of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e4006-wk-Fact-A03EE79A5129F083A677F6A45AB3E2EE" name="ebs:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">13.6</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the transition tax on the deemed mandatory repatriation of undistributed earnings.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company recognizes interest in interest expense and recognizes potential penalties related to unrecognized tax benefits in selling, general and administrative expense. Of the total unrecognized tax benefits recorded at </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e4021-wk-Fact-AB969EA365EC2DE4F6D8CCD3133D50CE" name="ebs:UnrecognizedTaxBenefitsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e4025-wk-Fact-B38EE8DB234CDBF8CF3ACCD3133F5CBB" name="ebs:UnrecognizedTaxBenefitsCurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, is classified as a current liability and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e4029-wk-Fact-68451D6D6C12A6151B40CCD3138F12D7" name="ebs:UnrecognizedTaxBenefitsNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.4</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e4034-wk-Fact-89F2669C5A2BA70B8751CCD3132E0A34" name="ebs:UnrecognizedTaxBenefitsNoncurrent" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.4</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, is classified as a non-current liability on the balance sheet.</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">104</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-2D1B5092F7357C0114EBCCD313BE1C94-4"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="TextSelection-65339A9D3D6CDA9485EACCD313BEBC40-0-wk-Fact-949C0A7619FA586E74FECCD31397BF2E" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The table below presents the gross unrecognized tax benefits activity for </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:88%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gross unrecognized tax benefits at December&#160;31, 2016</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e4101-wk-Fact-A325DF1CF1C36155DEA6CCD313AC7239" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2016Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e4116-wk-Fact-6F8367DCDDF510CFB02ECCD313AC5878" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Decreases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e4136-wk-Fact-80C31CAA01C7AB8E3782CCD313AC2382" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for current year</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e4156-wk-Fact-CC9254AEBB1B18D99E3ACCD313426C69" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45257978e4176-wk-Fact-8D038110126C3F90B731CCD313458A6F" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lapse of statute of limitations</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e4197-wk-Fact-F624E910D5425B413F9ECCD313206193" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gross unrecognized tax benefits at December&#160;31, 2017</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e4222-wk-Fact-13A2639039475E1836AACCD313AC3D4E" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unrecognized tax benefits acquired in business combinations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e4237-wk-Fact-BD50A74C4AE98C82EECB3F5307BDE172" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e4257-wk-Fact-BDB5131E614326517A83CCD313AC2836" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Decreases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e4277-wk-Fact-D9483685D4FE2A25006DCCD313498207" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for current year</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e4298-wk-Fact-CCA63EA928EF7BDB5963CCD313461952" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e4318-wk-Fact-5D43332E61CE3B60A3BBCCD313ACF251" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lapse of statute of limitations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e4338-wk-Fact-A2315D70D863BD9A1938CCD31347BD20" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gross unrecognized tax benefits at December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257978e4363-wk-Fact-77A9B07E18CCB21B24FDCCD3131B1833" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e4378-wk-Fact-51EF1CC11CB11CE425A8CCD3131BE2B1" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unrecognized tax benefits acquired in business combinations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e4398-wk-Fact-4146481F1F63C883A91CCCD313AEE415" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Decreases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e4418-wk-Fact-07F4AB85B6B3A157CED0CCD31345E50E" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for current year</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e4438-wk-Fact-EF2AA339B5EA43911EC0CCD31348C288" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45257978e4458-wk-Fact-A619174718DCC6A69548CCD313491F43" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lapse of statute of limitations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e4479-wk-Fact-6C45581688575CC24CA9CCD31346EF56" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gross unrecognized tax benefits at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257978e4504-wk-Fact-E5CB52672D78F63A5C2DCCD31346E1C8" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The total gross unrecognized tax benefit of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e4516-wk-Fact-E5CB52672D78F63A5C2DCCD31346E1C8" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">10.4</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of which </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45257978e4520-wk-Fact-74642D14BB00D3D40685CCD31327A742" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">7.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> relates to the acquisition of PaxVax is entirely offset by a receivable pursuant to a Tax Indemnity Agreement that became effective as at the close of the acquisition.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">When resolved, substantially all of these reserves would impact the effective tax rate.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's federal and state income tax returns for the tax years 2016 to 2018 remain open to examination. The Company's tax returns in the United Kingdom remain open to examination for the tax years 2012 to 2018, and tax returns in Germany remain open indefinitely. The Company's tax returns for Canada remain open to examination for the tax years 2012 to 2018. The Company's Swiss tax returns remain open to federal examination for 2018. The Company's Irish tax returns remain open to examination for the tax years 2013 to 2018.  </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company&#8217;s Canadian </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Scientific Research and Experimental Development Claim is under audit. As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company's 2017 Canadian and US federal income tax returns for the Adapt entities prior to acquisition are under audit.</span></div></ix:continuation><div><a id="sF64C0D1715EC5128838170FD4F7DC9A5"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">13</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="TextSelection-54E00AE3322A68B09018CCD313BF8CE7-0-wk-Fact-34F43F72780C1A6C7E5CCCD313AAABF7" continuedAt="TextSelection-54E00AE3322A68B09018CCD313BF8CE7-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Defined benefit and 401(k) savings plan</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-54E00AE3322A68B09018CCD313BF8CE7-1" continuedAt="TextSelection-54E00AE3322A68B09018CCD313BF8CE7-2"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company sponsors a defined benefit pension plan covering eligible employees in Switzerland (the "Swiss Plan"). Under the Swiss Plan, the Company and certain of its employees with annual earnings in excess of government determined amounts are required to make contributions into a fund managed by an independent investment fiduciary. Employer contributions must be in an amount at least equal to the employee&#8217;s contribution. The Swiss Plan assets are comprised of an insurance contract that has a fair value consistent with its contract value based on the practicability exception using level 3 inputs. The entire liability is listed as non-current, because plan assets are greater than the expected benefit payments over the next year. The Company recognizes pension expense as a component of selling, general and administrative expense. The Company recognized pension expense related to the Swiss Plan of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45260012e735-wk-Fact-018DB323553AB2682FE1CCD313A9E036" name="us-gaap:PensionExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> reflected as a component of selling, general and administrative for the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">105</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-54E00AE3322A68B09018CCD313BF8CE7-2" continuedAt="TextSelection-54E00AE3322A68B09018CCD313BF8CE7-3"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" id="TextSelection-E2EC471C29C70CEF447BCCD313BFE7EB-0-wk-Fact-B3C7BDC6887772AC652ACCD313AAC347" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The funded status of the Swiss Plan is as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of plan assets, beginning of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e818-wk-Fact-42EEA5A8E340FED23675B6BF080CE7DC" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e837-wk-Fact-A5A44087DDD4252DB503B6BEFB6B5114" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquisitions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e852-wk-Fact-42E7D2D83EE63404C7BBCCD313285D9C" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e871-wk-Fact-D20F3672E2B1BAFEA7D0B6BEFCF32409" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employer contributions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e891-wk-Fact-3AF8A66C4CE05F1DFB50CCD3132970BE" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e910-wk-Fact-7D2B24B494B6FB0AF0F8B6BEFE506F14" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee contributions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e930-wk-Fact-32032BD991E05F772312CCD3132D8F90" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e949-wk-Fact-C157863D187DB279FBF6B6BF00078F18" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net benefits received (paid)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e969-wk-Fact-0B4CABCACAA771DDCC93CCD31329F2B2" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e988-wk-Fact-928506CF90E3BD3DD830B6BF01B87F2C" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Actual return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1008-wk-Fact-B2E64195F23691BA4846CCD313354BBD" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1027-wk-Fact-A7994694BFF16CA0598FB6BF0338191C" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45260012e1047-wk-Fact-61F76A421A38F97365FACCD31322D65A" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45260012e1067-wk-Fact-D48F8D0612F3C3FBFA94B6BF04F4C991" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Currency impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1088-wk-Fact-4364FF8DCBC30304FEA8CCD31327CF10" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1107-wk-Fact-17C6F8105BA9D7A83426B6BF067CFAC6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of plan assets, end of year</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1132-wk-Fact-BE857D1BCA81C9ED1610CCD313258D26" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">20.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1151-wk-Fact-42EEA5A8E340FED23675B6BF080CE7DC" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">18.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Projected benefit obligation, beginning of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1171-wk-Fact-12C5FC87DA2BF4BA3081CCD31326B381" name="us-gaap:DefinedBenefitPlanBenefitObligation" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">28.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1190-wk-Fact-9B1ACBB09D34968E40D4B6BF09AE29B9" name="us-gaap:DefinedBenefitPlanBenefitObligation" contextRef="FI2017Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquisitions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1206-wk-Fact-EAB6481E0F9A625A4407CCD3132886B3" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1225-wk-Fact-6EE6963219252B8CC395B6BF0B79B9DC" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">28.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Service cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1245-wk-Fact-775257FF8A3DCC01AAA0CCD3132948D1" name="us-gaap:DefinedBenefitPlanServiceCost" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1264-wk-Fact-9367DB171AA268679EAEB6BF0D199AD8" name="us-gaap:DefinedBenefitPlanServiceCost" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest Cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1284-wk-Fact-74F51C64095247854CA9CCD3132724F6" name="us-gaap:DefinedBenefitPlanInterestCost" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1303-wk-Fact-90D48C0C11968A8F25DEB6BF0E87C8D7" name="us-gaap:DefinedBenefitPlanInterestCost" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee contributions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1323-wk-Fact-473385EB52085F19D59DCCD3132D5BF4" name="ebs:DefinedBenefitPlanPlanAssetsContributionsByEmployee" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1342-wk-Fact-D673FE4517B4EDAFF8BBB6BF0FF751F1" name="ebs:DefinedBenefitPlanPlanAssetsContributionsByEmployee" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Actuarial loss</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1362-wk-Fact-BED7AC0D8D3763DD2315CCD3132C3044" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">7.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1381-wk-Fact-1FF715C3C70C419FC1FCB6BF1187F761" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net benefits received (paid)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1401-wk-Fact-27E38B37FA17CFD9EFD1CCD3132867DE" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45260012e1420-wk-Fact-6624CDC69D56C20C898DB6BF13CCD5F0" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Plan amendment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45260012e1441-wk-Fact-25EFEA5B54E709C2714ACCD3132E0C41" name="us-gaap:DefinedBenefitPlanPlanAmendments" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1461-wk-Fact-99CB0A1B5579E2CF0987B6BF1542B4F0" name="us-gaap:DefinedBenefitPlanPlanAmendments" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45260012e1481-wk-Fact-C515109E6BE976E21934CCD3132911BE" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45260012e1501-wk-Fact-F574F05071062B4691DCB6BF16BACA7A" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Currency impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1522-wk-Fact-D2FAC2388B22281FD11ECCD3132D7324" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1541-wk-Fact-E5F117D8E596A15417E9B6BF185EDBB6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Projected benefit obligation, end of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1566-wk-Fact-DC396EC69515B07DBE5DCCD313258FAA" name="us-gaap:DefinedBenefitPlanBenefitObligation" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">35.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1585-wk-Fact-12C5FC87DA2BF4BA3081CCD31326B381" name="us-gaap:DefinedBenefitPlanBenefitObligation" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">28.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Funded status, end of year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45260012e1605-wk-Fact-2165BA5D560F311C6E78CCD31327BB27" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">14.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45260012e1625-wk-Fact-82BD23E44480927CE39BB6BF1B4E0213" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">10.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accumulated benefit obligation, end of year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1647-wk-Fact-76FD0799A048E86E0EA3CCD3132EB538" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">31.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1666-wk-Fact-F595BE45A207DB26D1E2B6BF1CE38650" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Since assets exceed the present value of expected benefit payments for the next twelve months, all of the liability is classified as non-current.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="TextSelection-A7B4F4E7C299AAF46696CCD313BF4B80-0-wk-Fact-35F6225893B9CB81DD7DCCD313AAF48B" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Components of net periodic pension cost incurred during the year are as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1753-wk-Fact-775257FF8A3DCC01AAA0CCD3132948D1" name="us-gaap:DefinedBenefitPlanServiceCost" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1772-wk-Fact-9367DB171AA268679EAEB6BF0D199AD8" name="us-gaap:DefinedBenefitPlanServiceCost" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1787-wk-Fact-74F51C64095247854CA9CCD3132724F6" name="us-gaap:DefinedBenefitPlanInterestCost" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1806-wk-Fact-90D48C0C11968A8F25DEB6BF0E87C8D7" name="us-gaap:DefinedBenefitPlanInterestCost" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expected return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45260012e1826-wk-Fact-61474BABA116F8CF13DE9949A8E10562" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45260012e1846-wk-Fact-770B319E37A1FF2C46B3B6C03FB15A58" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net periodic benefit cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1872-wk-Fact-9B67EA1A8E3447210D789949A8E99C86" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1891-wk-Fact-1C4686F3FBDF51ED315AB6C0410BB83F" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="TextSelection-4D4CAFE4BF9C3ACE0D14CCD313BFCA1F-0-wk-Fact-18610A76D24E4A19173CCCD313AFCEEB" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The weighted average assumptions used to calculate the projected benefit obligations are as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:65%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Discount rate</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1958-wk-Fact-CFC667B12F6C773A3F4C9949B2A9907C" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e1973-wk-Fact-9BCEF0748423ED268D13B6C1FBC24C34" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expected rate of return</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e1989-wk-Fact-C615ABFE23A0BD92B26F9949B2B8A032" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e2004-wk-Fact-DA0B29B909C898EAB57BB6C1FD959539" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Rate of future compensation increases</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e2020-wk-Fact-7E58D527C295C48292819949B2A91900" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" contextRef="FD2019Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e2035-wk-Fact-2E29176EE7A999949A16B6C1FEFAE31F" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" contextRef="FD2018Q4YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The overall expected long-term rate of return on assets assumption considers historical returns, as well as expected future returns based on the fact that investment returns are insured, and the legal minimum interest crediting rate as applicable. Total contributions expected to be made into the plan for the year-ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45260012e2052-wk-Fact-9F7ADA9E695242747DE2CCD313AC8C0B" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="TextSelection-DC032CA169DCD9087FF1CCD313BF15EA-0-wk-Fact-01033F2174C6806520ADCCD313AB3B63" continuedAt="TextSelection-DC032CA169DCD9087FF1CCD313BF15EA-1" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table presents losses recognized in accumulated other comprehensive loss before income tax related to the Company&#8217;s defined benefit pension plans:</span></div></ix:nonNumeric></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">106</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-54E00AE3322A68B09018CCD313BF8CE7-3"><ix:continuation id="TextSelection-DC032CA169DCD9087FF1CCD313BF15EA-1"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net actuarial loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e2132-wk-Fact-322E530CBC58A5A613789949A3826885" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">5.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e2151-wk-Fact-96B512CD29B6B9F93D6CB6C2C8A554DF" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prior service cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45260012e2166-wk-Fact-8A639732C548D59D59629949A386F41E" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">1.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e2186-wk-Fact-268740A85C3F32E6B873B6C2CA74B8E9" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total recognized in accumulated other comprehensive loss</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e2211-wk-Fact-4E050BB8AFB21D44BB1B9949A37D4372" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260012e2230-wk-Fact-A05C53568BDE9F5A9DBEB6C2CC1B8672" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" contextRef="FI2018Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Actuarial losses in accumulated other comprehensive loss related to the Company&#8217;s defined benefit pension plans expected to be recognized as components of net periodic benefit cost over the year ending&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;are de minimis.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="TextSelection-8276738AC5B662A56806CCD313BF0BAE-0-wk-Fact-398F0A2864F3E47BCCD1CCD313AAB3EB" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Future benefits expected to be paid as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> are as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:86%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e2301-wk-Fact-B3E86B4E3D12A7BAD854CCD313A4AAE8" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e2316-wk-Fact-AC8F3E8B8F9C1CB57285CCD313A9BC1B" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e2336-wk-Fact-71C940229CDF7720BB3ACCD3139F192D" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e2356-wk-Fact-6BF70156D08B3935AA99CCD3139C2628" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e2376-wk-Fact-245BD44631A016A1A484CCD313A3B9B6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e2396-wk-Fact-6638265978E7E1D905B3CCD31398068A" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">6.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260012e2421-wk-Fact-4182A9FD34715C2017F1CCD313A98DE5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">401(k) savings plan</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has established a defined contribution savings plan under Section 401(k) of the Internal Revenue Code. The 401(k) Plan covers substantially all U.S. employees. Under the 401(k) Plan, employees may make elective salary deferrals. During the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company made matching contributions of approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45260012e2448-wk-Fact-C62C7507CA56C406EF51CCD313AC50FB" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.1</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45260012e2452-wk-Fact-9E805C14DE4390A30D4BCCD313AAAE6B" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.1</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45260012e2457-wk-Fact-6E274D4241CFBE8B1685CCD313ABA0BB" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.7</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively.</span></div></ix:continuation><div><a id="s7E6EA577AADB59A988F5802E27860358"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">14</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:LesseeOperatingLeasesTextBlock" id="TextSelection-92266C75B52E22FAED28CCD313BFBB50-0-wk-Fact-2D9A468682AC41A6E673CCD313A3538A" continuedAt="TextSelection-92266C75B52E22FAED28CCD313BFBB50-1" escape="true"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:LesseeFinanceLeasesTextBlock" id="TextSelection-83198D0477ADA4677A3BCB3A15E4D048-0-wk-Fact-C3AF9E72431952489EECCB3C04A4B116" continuedAt="TextSelection-83198D0477ADA4677A3BCB3A15E4D048-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Leases</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="TextSelection-92266C75B52E22FAED28CCD313BFBB50-1" continuedAt="TextSelection-92266C75B52E22FAED28CCD313BFBB50-2"><ix:continuation id="TextSelection-83198D0477ADA4677A3BCB3A15E4D048-1" continuedAt="TextSelection-83198D0477ADA4677A3BCB3A15E4D048-2"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has operating leases for corporate offices, research and development facilities and manufacturing facilities. We determine if an arrangement is a lease at inception. Operating leases are included in right-of-use ("ROU") assets and liabilities.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">represent the Company's obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company's leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company uses an implicit rate when readily determinable. At the beginning of a lease, the operating lease ROU asset also includes any concentrated lease payments expected to be paid and excludes lease incentives. The Company's lease ROU asset may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise those options.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for separately. The Company's leases have remaining lease terms of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45252988e749-wk-Fact-0BDDA559C88E17A93208B1EE93E60E7D" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="FI2019Q4_srt_RangeAxis_srt_MinimumMember" format="ixt-sec:duryear">1</ix:nonNumeric> year</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45252988e753-wk-Fact-38F72F9446B60A6CA4DDECA6802DDD40" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="FI2019Q4_srt_RangeAxis_srt_MaximumMember" format="ixt-sec:duryear">14</ix:nonNumeric> years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, some of which include options to extend the leases for up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45252988e757-wk-Fact-00DFCA9EF18E080F2121A0D7F594D3CE" name="us-gaap:LesseeOperatingLeaseRenewalTerm" contextRef="FI2019Q4" format="ixt-sec:duryear">5</ix:nonNumeric> years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and some of which include options to terminate the leases within </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45252988e761-wk-Fact-0844F3121E2333ECB5FFB1EE60BCCDEB" name="ebs:LesseeOperatingLeaseTerminationPeriod" contextRef="FD2019Q4YTD" format="ixt-sec:duryear">1</ix:nonNumeric> year</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div></ix:continuation></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">107</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-92266C75B52E22FAED28CCD313BFBB50-2"><ix:continuation id="TextSelection-83198D0477ADA4677A3BCB3A15E4D048-2"><ix:continuation id="TextSelection-2AB2EC04D79D1F0D6B669966F602765B-0"><div style="line-height:120%;padding-bottom:10px;padding-top:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The components of lease expense were as follows:&#160;</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:81%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease cost:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amortization of right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252988e837-wk-Fact-3A2099065765BB9F6352997B0050B119" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest on lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252988e852-wk-Fact-4D09F7680BAC91240F10997E65F28936" name="us-gaap:FinanceLeaseInterestExpense" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total operating lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252988e877-wk-Fact-5090AB901FBE0D366926997F2972F5A7" name="us-gaap:LeaseCost" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;padding-bottom:0px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> total lease expense was $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45252988e900-wk-Fact-DBE0084A49F49E706B65B6C48A520E22" name="us-gaap:LeaseAndRentalExpense" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.3</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million and $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45252988e904-wk-Fact-17419BA1C24018F1F3F8B6C489B0AB73" name="us-gaap:LeaseAndRentalExpense" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million, respectively. </span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:LeaseCostTableTextBlock" id="TextSelection-1B164940B113E60EEB5E99678C2AF611-0-wk-Fact-FF61C89274D594084B3F996C54FB5941" continuedAt="TextSelection-2AB2EC04D79D1F0D6B669966F602765B-0" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Supplemental balance sheet information related to leases was as follows as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:49%;"></td><td style="width:27%;"></td><td style="width:1%;"></td><td style="width:22%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-style:italic;">(In millions, except lease term and discount rate)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252988e974-wk-Fact-C86A0D4140A5DEE769FB998167312912" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">24.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease liabilities, current portion</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252988e1020-wk-Fact-C971CCBCE1C40F02D1169981BE329EF1" name="ebs:OperatingLeaseOtherLiabilityCurrent" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252988e1045-wk-Fact-98C676E70D36951D845A9981FA3D5BCB" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">22.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252988e1070-wk-Fact-9AD4E61F96FE5F85751F998240B98D1B" name="us-gaap:OperatingLeaseLiability" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">25.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating leases:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted average remaining lease term (years)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonNumeric id="d45252988e1147-wk-Fact-4D6760446F002CF79116FCE39D8E5DCB" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="FI2019Q4" format="ixt-sec:duryear">8.0</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted average discount rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45252988e1172-wk-Fact-B9C97A9AF25494F7CEA8998B0A47C674" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="FI2019Q4" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">4.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:continuation></ix:continuation><div><a id="sE3C7BCA684AA538F926736FB837257B0"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">15</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:EarningsPerShareTextBlock" id="TextSelection-C12C729E1D42A21EF832CCD313BF925F-0-wk-Fact-47B993DE30E089BFB515CCD31330D095" continuedAt="TextSelection-C12C729E1D42A21EF832CCD313BF925F-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Earnings per share</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-C12C729E1D42A21EF832CCD313BF925F-1"><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="TextSelection-FE8692B1FA5B9CEDD313CCD313BF311F-0-wk-Fact-EF9F20A2F9EFA3E37C7ACCD31334B37C" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table presents the calculation of basic and diluted net income per share:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions, except per share data)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Numerator:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257953e956-wk-Fact-7DC5791E3DA27455A6AECCD31377CEF0" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e975-wk-Fact-2233E7AC5FE7EADFA0A9CCD3137B1D77" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e994-wk-Fact-E93855FEF0C5D1679E3DCCD313722951" name="us-gaap:NetIncomeLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">82.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest expense, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257953e1010-wk-Fact-B5FBD4527A27D849BCB1CCD3133733EC" name="us-gaap:InterestOnConvertibleDebtNetOfTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1029-wk-Fact-BBD983D8EED01ADD1A66CCD3133D3AF7" name="us-gaap:InterestOnConvertibleDebtNetOfTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1048-wk-Fact-D8B74E3DCBF9B165C04FCCD31338D4C2" name="us-gaap:InterestOnConvertibleDebtNetOfTax" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">2.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amortization of debt issuance costs, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257953e1069-wk-Fact-1AFD3B276107C8238E98CCD3132C70EB" name="ebs:AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1088-wk-Fact-31F3C792CB788650929BCCD3133ADCE8" name="ebs:AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1107-wk-Fact-2E0CE53F008B6536ED3DCCD3132F1611" name="ebs:AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income, adjusted</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257953e1133-wk-Fact-8C8ED074934EFB310BB2CCD3133D08CA" name="ebs:AdjustedNetLoss" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">54.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1152-wk-Fact-F3865CD7E3981BEAC3B2CCD3133331D7" name="ebs:AdjustedNetLoss" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">62.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1171-wk-Fact-EA5E6B10521F0FF507D7CCD3132A9325" name="ebs:AdjustedNetLoss" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">85.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Denominator:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted-average number of shares-basic</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257953e1249-wk-Fact-6C476F7FC811DEF066C8CCD313726405" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">51.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1268-wk-Fact-AA3A26AF9233B4E47F37CCD31384CE40" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">50.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1287-wk-Fact-FC3D132112BD46DA7C18CCD3137FB2FE" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2017Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">41.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Dilutive securities-equity awards</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257953e1308-wk-Fact-EB153DA46E9E3AD647E8CCD313394900" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1327-wk-Fact-EA66C4B7F8BCC56DF46ACCD313398692" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1346-wk-Fact-F61283E14943D6E41F65CCD3133A5118" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="FD2017Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Dilutive securities-convertible debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257953e1367-wk-Fact-59E7FB21D61CDD267EB7CCD313352CD9" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1386-wk-Fact-883DE3136848682D6F29CCD31330A1F4" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1405-wk-Fact-0889C99C0E0104F75BB0CCD3132E4248" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="FD2017Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">7.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted-average number of shares-diluted</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257953e1427-wk-Fact-26467B8874FB56A63BF6CCD3137FA89C" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">52.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1446-wk-Fact-49D658F4DEFA67C8563CCCD31381661E" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2018Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">51.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1465-wk-Fact-888877977CEDD432DA63CCD3136C30C8" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2017Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">50.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income per share-basic</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257953e1491-wk-Fact-86DB00C3EBD85B656393CCD3138EDEB2" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.06</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1510-wk-Fact-87E66476E07C4C47E84FCCD3138767B9" name="us-gaap:EarningsPerShareBasic" contextRef="FD2018Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.25</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1529-wk-Fact-7509B93E651C38CE4A6CCCD3138CB254" name="us-gaap:EarningsPerShareBasic" contextRef="FD2017Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.98</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income per share-diluted</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45257953e1550-wk-Fact-3D47F2A0E1F49321A098CCD313819F36" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.04</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1569-wk-Fact-1C4F6F61BDFC84790364CCD3137FF970" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2018Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45257953e1588-wk-Fact-9E773D140AC5081CC2BDCCD3138E79BE" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2017Q4YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.71</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the year ending </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45257953e1605-wk-Fact-BF1471644548C124B686ECA862B4EC5D" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2019Q4YTD" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">  million shares of common stock are not considered in the diluted earnings per share calculation because the exercise price of these options is greater than the average per share closing price during the year and their effect would be anti-dilutive. For the years ending </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, substantially all of the outstanding stock options to purchase shares of common stock were included in the calculation of diluted earnings per share.</span></div></ix:continuation><div><a id="s560450608D545EDB96D4FDAD0E820E54"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">16</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock" id="TextSelection-4E76B290A2BD9E00AB6FCCD313C19898-0-wk-Fact-EF5C2A0B99E163E24E62CCD313660590" continuedAt="TextSelection-4E76B290A2BD9E00AB6FCCD313C19898-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Purchase commitments</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-4E76B290A2BD9E00AB6FCCD313C19898-1" continuedAt="TextSelection-4E76B290A2BD9E00AB6FCCD313C19898-2"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> the Company has approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45258050e739-wk-Fact-50FD17B825DD6E574EF5CCD31361082A" name="us-gaap:PurchaseObligation" contextRef="FI2019Q4" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">59.7</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of purchase commitments associated with raw materials and contract development and manufacturing services that will be purchased in the next </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d45258050e743-wk-Fact-4C190CFB2A47BE1B288ECCD31362DB2A" name="us-gaap:LongtermPurchaseCommitmentPeriod" contextRef="FD2019Q4YTD" format="ixt-sec:durwordsen">three years</ix:nonNumeric></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">108</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><ix:continuation id="TextSelection-4E76B290A2BD9E00AB6FCCD313C19898-2"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company purchased </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45258050e762-wk-Fact-AB4B992868B84091A0C0CCD31363D47B" name="us-gaap:LongTermPurchaseCommitmentAmount" contextRef="FD2019Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">51.3</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45258050e766-wk-Fact-A9929A0833BB872D6819CCD313641784" name="us-gaap:LongTermPurchaseCommitmentAmount" contextRef="FD2018Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">12.1</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45258050e771-wk-Fact-5A49ED9E3A4F29D1C6B4CCD313633B7C" name="us-gaap:LongTermPurchaseCommitmentAmount" contextRef="FD2017Q4YTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.0</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, of materials under this commitment.</span></div></ix:continuation><div><a id="s7D6AF43734605EACA89FD7EA5B903C61"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">17</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:SegmentReportingDisclosureTextBlock" id="TextSelection-7BD9E46096C5D44DC081CCD313C1B3D3-0-wk-Fact-395012045990372DE1BDCCD313348AA5" continuedAt="TextSelection-7BD9E46096C5D44DC081CCD313C1B3D3-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Segment information</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-7BD9E46096C5D44DC081CCD313C1B3D3-1"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For financial reporting purposes, the Company reports financial information for </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45260430e735-wk-Fact-64CE13581DD8FCAB6553CCD31340C16D" name="us-gaap:NumberOfReportableSegments" contextRef="FD2019Q4YTD" unitRef="segment" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> reportable segment. This reportable segment engages in business activities based on financial information that is provided to and resources which are allocated by the Chief Operating Decision Maker. The accounting policies of the reportable segment is the same as those described in the summary of significant accounting policies.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company&#8217;s revenues within the United States comprised </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45260430e758-wk-Fact-0E4694001CE2D952FDC4CCD3133C1C05" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">90</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45260430e762-wk-Fact-9C40FEFFCBC4F633C2C9CCD313346940" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">91</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45260430e767-wk-Fact-601F771A60C21092D9BACCD3133D9317" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">89</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, of total revenues. For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, product sales from ACAM 2000 and Anthrax Vaccines to the USG comprised approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">43%</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45260430e787-wk-Fact-6B7AA742FD7F4E6EB59FECAB78813832" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">65</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d45260430e792-wk-Fact-F75EEA128B55BFFC91C1ECAB8C500909" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">68</ix:nonFraction>%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, of total product sales.</span></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" id="TextSelection-CC8030FD9F8953221785CCD313C1708D-0-wk-Fact-172CDBAF8AF0929C5AA7CCD3133F6EFF" escape="true"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's product sales from Anthrax Vaccines, ACAM2000, NARCAN Nasal Spray and Other comprised approximately:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:62%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">% of product sales:</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Anthrax Vaccines</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260430e917-wk-Fact-F78FCD40361B58612EF1CCD3138B4E07" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260430e932-wk-Fact-DDFDF68EA714615CF62DCCD3138C11CE" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">46</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260430e947-wk-Fact-3A151730FB3AA3A63AADCCD31393CA9B" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">68</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ACAM2000</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260430e963-wk-Fact-04E6E4CCDC58C031E9E6CCD3138E3903" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ACAM2000Member_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">27</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260430e978-wk-Fact-335D230D9988EE7A55F3CCD313A52932" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ACAM2000Member_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260430e993-wk-Fact-C15B74FD0C24CB8B89FFCCD31390A86E" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ACAM2000Member_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember" unitRef="number" decimals="INF" scale="-2" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">NARCAN Nasal Spray</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260430e1009-wk-Fact-A5E2B3388BCEF47B15E7ECACCCBFF8A8" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_NARCANNasalSprayMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">31</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260430e1024-wk-Fact-D6189E9FB1FD57A70A41ECACD23DE224" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_NARCANNasalSprayMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260430e1039-wk-Fact-5060D9E81275FD82A445ECACD746C8EF" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_NARCANNasalSprayMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember" unitRef="number" decimals="INF" scale="-2" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45260430e1055-wk-Fact-314C29E4288041BBC712CCD3139203AD" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_OtherMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">23</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260430e1070-wk-Fact-EEE7C923E77CB2479B07CCD31393A8B0" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_OtherMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">28</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45260430e1085-wk-Fact-0EE0E2F949A83D2450BDCCD31390962B" name="us-gaap:ConcentrationRiskPercentage1" contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_OtherMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember" unitRef="number" decimals="INF" scale="-2" format="ixt:numdotdecimal">32</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, aside from Anthrax Vaccines and ACAM2000, there were </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">no</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> other product sales to an individual customer or for an individual product in excess of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">10%</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of total revenues.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company had long-lived assets outside of the United States of approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45260430e1129-wk-Fact-D61AB776E16054E971BECCD3132FF0CB" name="us-gaap:NoncurrentAssets" contextRef="FI2019Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">90.6</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d45260430e1133-wk-Fact-735C9174412621830998CCD31331932E" name="us-gaap:NoncurrentAssets" contextRef="FI2018Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">82.9</ix:nonFraction> million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, which are primarily located within Canada and Switzerland.</span></div></ix:continuation><div><a id="sA5676F95C81C54989BAD01624C520692"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">18</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="TextSelection-BB6375B692FEBE28AA4ACCD313C1B0F4-0-wk-Fact-5DC0DF92D65C654CC6CFCCD313A62424" continuedAt="TextSelection-BB6375B692FEBE28AA4ACCD313C1B0F4-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Quarterly financial data (unaudited)</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="TextSelection-D0BC7159C53E2D787ECDCCD313C1E990-0-wk-Fact-9CD774E4B7D73BD90A6CCCD313A53BCA" escape="true"><ix:continuation id="TextSelection-BB6375B692FEBE28AA4ACCD313C1B0F4-1"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Quarterly financial information for the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is presented in the following tables:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Quarter Ended</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions, except per share data)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">March 31,</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">June 30,</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">September 30,</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">2019:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45262055e1024-wk-Fact-6EC6F021F61939DDD280CCD3133084AF" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">190.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45262055e1043-wk-Fact-C1E446403A54C32BAB13CCD313A86BA6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">243.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45262055e1062-wk-Fact-D3BB37626B5BB17C4AF9CCD313419AFD" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">311.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45262055e1082-wk-Fact-B5ED9EBA54125765CA8DCCD3133803C7" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2019Q4QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">360.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income (loss) from operations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45262055e1097-wk-Fact-E38C72D31F1F7F54176BCCD3131B1577" name="us-gaap:GrossProfit" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">27.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45262055e1117-wk-Fact-47FE07C6521BCE3F81D3CCD3139F6924" name="us-gaap:GrossProfit" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">7.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45262055e1137-wk-Fact-86C1256CA35F926D5D58CCD31332EF8B" name="us-gaap:GrossProfit" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">70.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45262055e1157-wk-Fact-7B705D380D8C11C3B61DCCD313402DF9" name="us-gaap:GrossProfit" contextRef="FD2019Q4QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">77.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45262055e1177-wk-Fact-84AEA0A472C2C70E3266CCD31338F70D" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">26.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45262055e1197-wk-Fact-32A4DC4298C817BAAFEACCD31332016F" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q2QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">9.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45262055e1217-wk-Fact-1F94CB94F7CA515A1302CCD3133462BD" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">43.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45262055e1237-wk-Fact-81A3FE19A16184259141CCD3133977C0" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q4QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">46.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) per share-basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45262055e1344-wk-Fact-283574E78E942BAEA00FCCD3133A3E08" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q1QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.51</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45262055e1364-wk-Fact-66286533481F2F70879CCCD3134144DE" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q2QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.18</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45262055e1384-wk-Fact-B73A896822ADF730AB9BCCD313A0BADA" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.84</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45262055e1404-wk-Fact-4E5D7A63BAE8C450BB96CCD3138FE7DA" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q4QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.91</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) per share-diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45262055e1424-wk-Fact-0D56F29D548E02AFCD40CCD3131C971E" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q1QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.51</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(<ix:nonFraction id="d45262055e1444-wk-Fact-16C39AC10A25AAE86784CCD3131C0482" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q2QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.18</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45262055e1464-wk-Fact-29CF5B68493400146F77CCD313A48233" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.83</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span><ix:nonFraction id="d45262055e1484-wk-Fact-4AE5C4BEF348EC72C8C1CCD3133784BF" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q4QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.90</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">2018:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45262055e1669-wk-Fact-227C8B2D8179E780A180CCD313A368B8" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q1QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">117.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45262055e1688-wk-Fact-8E72C67A6CFF4C8E01BACCD313378A78" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">220.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45262055e1707-wk-Fact-24102AAD8A5998594409CCD3131C90C7" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">173.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45262055e1727-wk-Fact-3DAB7800EC8B2BE4502CCCD3134301D0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="FD2018Q4QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">270.7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income (loss) from operations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45262055e1742-wk-Fact-D4B19E943CAF3091A7B4CCD313419542" name="us-gaap:GrossProfit" contextRef="FD2018Q1QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">9.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45262055e1762-wk-Fact-0D308D9870B18B7FF97FCCD31336FA4C" name="us-gaap:GrossProfit" contextRef="FD2018Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">66.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45262055e1781-wk-Fact-8E97C8E20AA6F7DC7E0BCCD3133B0345" name="us-gaap:GrossProfit" contextRef="FD2018Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">21.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45262055e1801-wk-Fact-A51ED508838B349F46FACCD3133EDCEA" name="us-gaap:GrossProfit" contextRef="FD2018Q4QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">11.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45262055e1821-wk-Fact-F80A04A8C4E7AE31BC59CCD31339BEF9" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q1QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">4.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45262055e1841-wk-Fact-EE6931F40629924BBB3DCCD3133B6536" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q2QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">50.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45262055e1860-wk-Fact-4EB29DA0A6BE67A46E36CCD3133CFFE8" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q3QTD" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">20.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45262055e1880-wk-Fact-7DA4E33EBB93C65184C0CCD313416306" name="us-gaap:NetIncomeLoss" contextRef="FD2018Q4QTD" unitRef="usd" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">3.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) per share-basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45262055e1988-wk-Fact-88CDF1A8BF89278B2845CCD31337684B" name="us-gaap:EarningsPerShareBasic" contextRef="FD2018Q1QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45262055e2008-wk-Fact-86DA83AA14CFF7ADD3B2CCD3131FAD0B" name="us-gaap:EarningsPerShareBasic" contextRef="FD2018Q2QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.00</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45262055e2027-wk-Fact-2297018600F3FAD02532CCD313A0BAA1" name="us-gaap:EarningsPerShareBasic" contextRef="FD2018Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.42</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45262055e2047-wk-Fact-B27D4E90A9323F9AFDE1CCD31340325E" name="us-gaap:EarningsPerShareBasic" contextRef="FD2018Q4QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.07</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) per share-diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45262055e2068-wk-Fact-24B7D36B1E4ECDD08F94CCD31323E9B5" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2018Q1QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45262055e2088-wk-Fact-2C2129A967B423B2EA8CCCD3134000EE" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2018Q2QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.98</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45262055e2107-wk-Fact-8E9E54ECABE5DADE841ACCD3133F7317" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2018Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.41</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45262055e2127-wk-Fact-66A0554F354AAFB66AC7CCD3131F00CB" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2018Q4QTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.07</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:continuation></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">109</span></div></div><hr style="page-break-after:always"></hr><div><a id="s6FFA3BD815AF597A9A4CB36EDFA0F908"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">19</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">.&#160; </span><ix:nonNumeric contextRef="FD2019Q4YTD" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="TextSelection-4718ED41BD42CC7BD561CCD313C1F284-0-wk-Fact-73DCB0E6EB1D965318ACCCD313A2BB17" continuedAt="TextSelection-4718ED41BD42CC7BD561CCD313C1F284-1" escape="true"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Litigation</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span></ix:nonNumeric></div><ix:continuation id="TextSelection-4718ED41BD42CC7BD561CCD313C1F284-1" continuedAt="TextSelection-4718ED41BD42CC7BD561CCD313C1F284-2"><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">ANDA Litigation</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On September 14, 2018,  Adapt Pharma Inc.,  Adapt Pharma Operations Limited and Adapt Pharma Ltd. (collectively, "Adapt Pharma"), and Opiant Pharmaceuticals, Inc. ("Opiant"), received notice from Perrigo UK FINCO Limited Partnership ("Perrigo"), that Perrigo had filed an Abbreviated New Drug Application ("ANDA"), with the United States Food and Drug Administration seeking regulatory approval to market a generic version of NARCAN&#174;(naloxone hydrochloride) Nasal Spray 4mg/spray before the expiration of U.S. Patent Nos. 9,211,253, (the "&#8216;253 Patent"), 9,468,747 (the "&#8216;747 Patent"), 9,561,177, (the "&#8216;177 Patent"), 9,629,965, (the "&#8216;965 Patent") and 9,775,838 (the "&#8216;838 Patent"). On or about October 25, 2018, Perrigo sent a subsequent notice letter relating to U.S. Patent No. 10,085,937 (the "937 Patent"). Perrigo&#8217;s notice letters assert that its generic product will not infringe any valid and enforceable claim of these patents.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On October 25, 2018, Emergent BioSolutions&#8217; Adapt Pharma subsidiaries and Opiant, (collectively, the "Plaintiffs"), filed a complaint for patent infringement of the &#8216;253, &#8216;747, &#8216;177, &#8216;965, and the &#8216;838 Patents against Perrigo in the United States District Court for the District of New Jersey arising from Perrigo&#8217;s ANDA filing with the FDA. Plaintiffs filed a second complaint against Perrigo on December 7, 2018, for the infringement of the &#8216;937 Patent. On February 12, 2020, Adapt Pharma and Perrigo entered into a settlement agreement to resolve the ongoing litigation.  Under the terms of the settlement, Perrigo has received a non-exclusive license under Adapt&#8217;s patents to make, have made and market its generic naloxone hydrochloride nasal spray under its own ANDA. Perrigo&#8217;s license will be effective as of January 5, 2033 or earlier under certain circumstances including circumstances related to the outcome of the current litigation against Teva (as defined below) or litigation against future ANDA filers.  The Perrigo settlement agreement is subject to review by the U.S. Department of Justice and the Federal Trade Commission, and entry of an order dismissing the litigation by the U.S. District Court for the District of New Jersey. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On or about February 27, 2018, Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant received notice from Teva Pharmaceuticals Industries Ltd. and Teva Pharmaceuticals USA, Inc. (collectively "Teva"), that Teva had filed an ANDA with the FDA seeking regulatory approval to market a generic version of NARCAN&#174; (naloxone hydrochloride) Nasal Spray 2 mg/spray before the expiration of U.S. Patent No. 9,480,644, (the "&#8216;644 Patent"), and U.S. Patent No. 9,707,226, (the "'226 Patent"). Teva's notice letter asserts that the commercial manufacture, use or sale of its generic drug product described in its ANDA will not infringe the '644 Patent or the '226 Patent, or that the '644 Patent and '226 Patent are invalid or unenforceable. Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant filed a complaint for patent infringement against Teva in the United States District Court for the District of New Jersey.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On or about September 13, 2016, Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant received notice from Teva that Teva had filed an ANDA with the FDA seeking regulatory approval to market a generic version of NARCAN&#174; (naloxone hydrochloride) Nasal Spray 4 mg/spray before the expiration of U.S. Patent No. 9,211,253 (the "'253 Patent"). Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant received additional notices from Teva relating to the '747, the '177, the '965, the '838, and the &#8216;937 Patents. Teva's notice letters assert that the commercial manufacture, use or sale of its generic drug product described in its ANDA will not infringe the '253, the '747, the '177, the '965, the '838, or the &#8216;937 Patent, or that the '253, the '747, the '177, the '965, the '838, and the &#8216;937 Patents are invalid or unenforceable. Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant filed a complaint for patent infringement against Teva in the United States District Court for the District of New Jersey with respect to the '253 Patent. Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant also filed complaints for patent infringement against Teva in the United States District Court for the District of New Jersey with respect to the '747, the '177, the '965, and the '838 Patents. All five proceedings have been consolidated. As of the date of this filing, Adapt Pharma Inc., Adapt Pharma Operations Limited, and Opiant, have not filed a complaint related to the &#8216;937 Patent. Closing arguments are scheduled for February 26, 2020. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In the complaints described in the paragraphs above, the Plaintiffs seek, among other relief, orders that the effective date of FDA approvals of the Teva ANDA products and the Perrigo ANDA product be a date not earlier than the expiration of the patents listed for each product, equitable relief enjoining Teva and Perrigo from making, using, offering to sell, selling, or importing the products that are the subject of Teva and Perrigo&#8217;s respective ANDAs, until after the expiration of the patents listed for each product, and monetary relief or other relief as deemed just and proper by the court.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Nalox-1 Pharmaceuticals, a non-practicing entity, filed petitions with the United States Patent and Trademark Office Patent Trial and Appeal Board (the "PTAB") requesting inter parties review ("IPR") of five of the six patents listed in the Orange Book related to NARCAN&#174; Nasal Spray 4mg/spray. In a series of decisions, the PTAB agreed to institute a review </span></div></ix:continuation><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">110</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><ix:continuation id="TextSelection-4718ED41BD42CC7BD561CCD313C1F284-2">of the '253 Patent, the '747 Patent and the '965 Patent but denied review of the '177 Patent and the '838 Patent. Nalox-1 did not request review of the '937 Patent.</ix:continuation> </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">111</span></div></div><hr style="page-break-after:always"></hr><div><a id="s9C10CCCF0BB9553DAE63123FF8EC71A7"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Not applicable.</span></div><div><a id="s835A27FCE2A9513F9AADF5A203D040F8"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 9 A.&#160; CONTROLS AND PROCEDURES</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Evaluation of Disclosure Controls and Procedures</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, our chief executive officer and chief financial officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Management's Report on Internal Control Over Financial Reporting</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Because of its inherent limitations, internal control over financial reporting may</span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Our management assessed the effectiveness of our internal control over financial reporting as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Internal Control-Integrated Framework</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (2013 Framework).</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Based on this assessment, our management concluded that, as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, our internal control over financial reporting was effective based on those criteria.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Ernst &amp; Young LLP,  the independent registered public accounting firm that has audited our consolidated financial statements included herein, has issued an attestation report on the effectiveness of our internal control over financial reporting as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, a copy of which is included in this annual report on Form 10-K.</span></div><div style="line-height:120%;padding-bottom:8px;padding-left:0px;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Changes in Internal Control Over Financial Reporting</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">There have been changes in our internal control over financial reporting (as defined in Rule 13a-15(f)) identified in connection with the evaluation required by Rule 13a-15(d) of the Exchange Act that occurred during the period covered by this report that have materially affected our internal control over financial reporting. These changes pertained to the integration of the acquired companies in 2018, Adapt and PaxVax, onto the Company's information technology platforms during the fourth quarter of 2019. </span></div></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">112</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:8px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Report of Independent Registered Public Accounting Firm</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">To the Stockholders and the Board of Directors of Emergent BioSolutions Inc. and subsidiaries</span></div><div style="line-height:120%;padding-bottom:8px;padding-left:0px;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Opinion on Internal Control over Financial Reporting</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We have audited Emergent BioSolutions Inc. and subsidiaries&#8217; internal control over financial reporting as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, based on criteria established in Internal Control &#8212; Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Emergent BioSolutions Inc. and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> based on the COSO criteria.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the related consolidated statements of operations, comprehensive income</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:bold;">,</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> changes in stockholders' equity and cash flows for each of the three years in the period ended December 31, 2018, and the related notes and financial statement schedule listed in the Index at Item 15 and our report dated </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">February&#160;24, 2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> expressed an unqualified opinion thereon.</span></div><div style="line-height:120%;padding-bottom:8px;padding-left:0px;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Basis for Opinion</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="line-height:120%;padding-bottom:8px;padding-left:0px;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">/s/ Ernst &amp; Young LLP</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Baltimore, Maryland</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:0px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">February&#160;24, 2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">113</span></div></div><hr style="page-break-after:always"></hr><div><a id="s643154A5110E5AA4AC249A9EA6045960"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 9B. OTHER INFORMATION</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Not applicable.</span></div></div></div><div><a id="s98E7AE21F0B65D84A2D86A64ACD96766"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">PART III</span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div><a id="s51F76A5E97EC5C05A9FC691E9ACFB37A"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Code of Ethics</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We have adopted a code of business conduct and ethics that applies to our directors, officers (including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions), as well as our other employees. A copy of our code of business conduct and ethics is available on our website at </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;text-decoration:underline;">www.emergentbiosolutions.com</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. We intend to post on our website all disclosures that are required by applicable law, the rules of the Securities and Exchange Commission or the New York Stock Exchange concerning any amendment to, or waiver of, our code of business conduct and ethics.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The remaining information required by Item 10 is hereby incorporated by reference from our Definitive Proxy Statement relating to our </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Annual Meeting of Stockholders, to be filed with the SEC within 120 days following the end of our fiscal year.</span></div><div><a id="s58DCDE4288655F51B846CE77DDD1AA14"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 11. EXECUTIVE COMPENSATION</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The information required by Item 11 is hereby incorporated by reference from our Definitive Proxy Statement relating to our </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> annual meeting of stockholders, to be filed with the SEC within 120 days following the end of our fiscal year.</span></div><div><a id="s5205FFA349ED54FE91FFB006E95CA6B8"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The information required by Item 12 is hereby incorporated by reference from our Definitive Proxy Statement relating to our </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Annual Meeting of Stockholders, to be filed with the SEC within 120 days following the end of our fiscal year.</span></div><div><a id="s71357499738C5BC5ADF6E142AD5378C7"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The information required by Item 13 is hereby incorporated by reference from our Definitive Proxy Statement relating to our </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Annual Meeting of Stockholders, to be filed with the SEC within 120 days following the end of our fiscal year.</span></div><div><a id="s589D7086DEDC512886EE7FB920167E24"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The information required by Item 14 is hereby incorporated by reference from our Definitive Proxy </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Statement relating to our </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Annual Meeting of Stockholders, to be filed with the SEC within 120 days following the end of our fiscal year.</span></div><div><a id="s7F10361C3D1D5C9D8EE369EBCEE62B62"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">PART IV</span></div><div><a id="sF956533D9DBB505087BD52D1AF8F89CB"></a></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">ITEM 15. EXHIBITS AND  FINANCIAL STATEMENT SCHEDULES</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Financial Statements</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following financial statements and supplementary data are filed as a part of this annual report on Form 10-K in Part I, Item 8.</span></div><div style="line-height:120%;padding-bottom:5px;padding-top:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Report of Independent Registered Public Accounting Firm</span></div><div style="line-height:120%;padding-bottom:5px;padding-top:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Consolidated Balance Sheets at </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:5px;padding-top:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Consolidated Statements of Operations for the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;padding-bottom:5px;padding-top:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Consolidated Statements of Comprehensive Income for the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:5px;padding-top:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Consolidated Statements of Cash Flows for the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:5px;padding-top:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Consolidated Statement of Changes in Stockholders' Equity for the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:5px;padding-top:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Notes to Consolidated Financial Statements</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Financial Statement Schedules</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Schedule II - Valuation and Qualifying Accounts for the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> has been filed as part of this annual report on Form 10-K. All other financial statement schedules are omitted because they are not applicable or the required information is included in the financial statements or notes thereto.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Exhibits</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Those exhibits required to be filed by Item 601 of Regulation S-K are listed in the Exhibit Index immediately preceding the exhibits hereto and such listing is incorporated herein by reference.</span></div></div></div><ix:nonNumeric contextRef="FD2019Q4YTD" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="TextSelection-217D97A19B706B785CBACCD313C111DB-0-wk-Fact-359250E6B5C3D0D968A9CCD313A08F9E" escape="true"><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"></td></tr><tr><td style="width:35%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Beginning Balance</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Additions from Acquisition</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Charged to costs and expenses</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Deductions</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Ending Balance</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Year Ended December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1099-wk-Fact-0DD31D376D328B622FAA99D5BAAB56F5" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1118-wk-Fact-FC0BF8231D967664280778674C5584C5" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1138-wk-Fact-1E7EF2C50762028A6F6699D5BAC64FC5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">23.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45264290e1157-wk-Fact-656E69047FC941F1F16299D5BAC139D2" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">19.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1177-wk-Fact-4A326107C44BBDB8117299D5BAB97FF0" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">17.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prepaid expenses and other current assets allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1197-wk-Fact-014106C37CC40BDE49DF99D5BAEB33B7" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1216-wk-Fact-60AC3B69A0751F23684F78674DFB2A7B" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1235-wk-Fact-DBC4572D309E689FC1F199D5BACA2517" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45264290e1255-wk-Fact-5520D5FE65894D619F7699D5BAD77BB9" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1275-wk-Fact-0D205A4868CDD1184D8C99D5BAB2A642" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Year Ended December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1515-wk-Fact-E0FEA6FBE506BFA2772099D5BAA7A9C2" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1534-wk-Fact-79D13253727F263C48637846E040041E" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1554-wk-Fact-97C8301501777EF4AA1A99D5BA820ECB" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45264290e1573-wk-Fact-2B45DA06EFCF2B4BD68E99D5BAD3BF65" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1593-wk-Fact-0DD31D376D328B622FAA99D5BAAB56F5" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">14.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prepaid expenses and other current assets allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1613-wk-Fact-7F1AE09A558CADE5422B99D5BAF05819" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1632-wk-Fact-CB90DA871E496D90605D786752E0148D" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1651-wk-Fact-2FC6EA20944F6F2B895099D5BA9FCF75" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45264290e1671-wk-Fact-104B2005F5C7EEFD14F799D5BAE4DC40" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1691-wk-Fact-014106C37CC40BDE49DF99D5BAEB33B7" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Year Ended December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1931-wk-Fact-A03BA5267DE6067FF6D799D5BAA3EB7E" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1950-wk-Fact-B13A1D4337235906443878675462A3D9" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e1970-wk-Fact-46715A333E627DC81B5099D5BA9B4244" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(<ix:nonFraction id="d45264290e1989-wk-Fact-D158CF9D9C75F1A9EF0199D5BAE04443" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">8.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e2009-wk-Fact-E0FEA6FBE506BFA2772099D5BAA7A9C2" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">3.8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prepaid expenses and other current assets allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e2030-wk-Fact-B62AE626319F4831D6CF99D5BAE84C5A" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">4.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e2049-wk-Fact-856BF181CEC1BE6EAE62786755702E01" name="us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired" contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e2068-wk-Fact-0DD4B7C61C3B1CA1E6AE99D5BABD05F1" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e2088-wk-Fact-7D762B82E66A936CCF3699D5BAAE9643" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span><ix:nonFraction id="d45264290e2107-wk-Fact-7F1AE09A558CADE5422B99D5BAF05819" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">5.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></ix:nonNumeric><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">114</span></div></div><hr style="page-break-after:always"></hr><div><a id="sF10B7624EFAA56D0A93E86657C6169D6"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;text-align:center;-sec-extract:summary;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Exhibit Index</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">All documents referenced below were filed pursuant to the Securities Exchange Act of 1934 by the Company, (File No. 001-33137), unless otherwise indicated.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:8%;"></td><td style="width:8%;"></td><td style="width:84%;"></td></tr><tr><td style="vertical-align:middle;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Exhibit</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Number</span></div></td><td style="vertical-align:middle;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #ffffff;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Description</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000110465918060601/a18-36350_1ex2d1.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Merger Agreement, dated August 8, 2018, by and among Emergent BioSolutions Inc., PaxVax Holding Company Ltd., Panama Merger Sub Ltd., and PaxVax SH Representative LLC</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 2 to the Company's Current Report on Form 8-K, filed on October 5, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000110465918062153/a18-36350_2ex2.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share Purchase Agreement, dated August 28, 2018, by and among Emergent BioSolutions Inc., the Sellers identified therein, Seamus Mulligan and Adapt Pharma Limited</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 2 to the Company's Current Report on Form 8-K, filed on October 15, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764416000074/ex3.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Third Restated Certificate of Incorporation of the Company</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 3 to the Company's Quarterly Report on Form 10-Q filed on August 5, 2016).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764412000042/exhibit3.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amended and Restated By-laws of the Company</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 3 to the Company's Current Report on Form 8-K filed on August 16, 2012).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000095013306004496/w20323a3exv4w1.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Specimen Common Stock Certificate </span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(incorporated by reference to Exhibit 4.1 to Amendment No. 3 to the Company's Registration Statement on Form S-1 filed on October 20, 2006) (Registration No. 333-136622).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000095013306004169/w20323a1exv4w3.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Registration Rights Agreement, dated as of September 22, 2006, among the Company and the stockholders listed on Schedule 1 thereto</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 4.3 to Amendment No. 1 to the Company's Registration Statement on Form S-1 filed on September 25, 2006) (Registration No. 333-136622).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.3</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764414000007/exhibit4-1.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Indenture, dated as of January 29, 2014, between the Company and Wells Fargo Bank, National Association, including the form of 2.875% Convertible Senior Notes due 2021</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on January 29, 2014).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.4</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit44descriptionof.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Description of the Company's Securities.</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000095013306003817/w20323exv9w1.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Voting and Right of First Refusal Agreement, dated as of October 21, 2005, between the William J. Crowe, Jr. Revocable Living Trust and Fuad El-Hibri </span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(incorporated by reference to Exhibit 9.1 to the Company's Registration Statement on Form S-1 filed on August 14, 2006) (Registration No. 333-136622).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000110465918062153/a18-36350_2ex10.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amended and Restated Credit Agreement, dated October 15, 2018, by and among Emergent BioSolutions Inc., the lenders party thereto from time to time, and Wells Fargo Bank, National Association, as the Administrative Agent</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10 to the Company's Current Report on Form 8-K, filed on October 15, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000095013306004611/w20323a5exv10w3.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Emergent BioSolutions Inc. 2006 Stock Incentive Plan </span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(incorporated by reference to Exhibit 10.3 to Amendment No. 5 to the Company's Registration Statement on Form S-1 filed on October 30, 2006) (Registration No. 001-33137).</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">115</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:8%;"></td><td style="width:8%;"></td><td style="width:84%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.3</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764409000055/ex10.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed on August 7, 2009).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.4</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000119312512153604/d288376ddef14a.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Second Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Appendix A to the Company's definitive proxy statement on Schedule 14A filed on April 6, 2012).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.5</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000119312514133581/d703513ddef14a.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Third Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Appendix A to the Company's definitive proxy statement on Schedule 14A filed on April 7, 2014).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.6</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764416000074/ex10_2.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed on August 5, 2016).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.7</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764418000027/exhibit99.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Emergent BioSolutions Inc. Stock Incentive Plan</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 99 to Registration Statement on Form S-8, filed on May 30, 2018.)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.8</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764419000016/exhibit10-10.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Form of Director Nonstatutory Stock Option Agreement</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.10 to the Company&#8217;s Annual Report on Form 10-K filed on February 22, 2019).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.9</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764419000016/exhibit10-11.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Form of Director Restricted Stock Unit Agreement</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.11 to the Company&#8217;s Annual Report on Form 10-K filed on February 22, 2019).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.10</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ebs-20191231exhibit1010.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Global Form of Restricted Stock Unit Award Agreement. </span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.11</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ebs-20191231exhibit1011.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Global Form of Non-Qualified Stock Option Agreement. </span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.12</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764417000005/exhibit-10-psuagreement.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Form of 2017-2019 Performance-Based Stock Unit Award Agreement</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10 to the Company&#8217;s Current Report on Form 8-K filed on February 21, 2017).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.13</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764418000008/exhibit10.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Form of 2018-2020 Performance-Based Stock Unit Award Agreement </span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(incorporated by reference to Exhibit 10 to the Company&#8217;s Current Report on Form 8-K filed on February 14, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.14</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764419000012/exhibit_10.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Form of 2019-2021 Performance-Based Stock Unit Award Agreement</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10 to the Company&#8217;s Current Report on Form 8-K filed on February 12, 2019).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.15</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764420000006/ex102020-2022psuagreement.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Form of 2020-2022 Performance-Based Stock Unit Award Agreement</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10 to the Company&#8217;s Current Report on Form 8-K filed on February 18, 2020).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.16</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764413000004/exhibit10.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Form of Indemnity Agreement for directors and senior officers</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10 to the Company's Current Report on Form 8-K filed on January 18, 2013).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.17</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764413000016/exhibit10-1.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Director Compensation Program</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.10 to the Company's Annual Report on Form 10-K filed on March 8, 2013).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.18</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764410000008/ex10_7.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Annual Bonus Plan for Executive Officers </span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(incorporated by reference to Exhibit 10.7 to the Company's Annual Report on Form 10-K filed on March 5, 2010).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.19</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764411000068/ex10-1.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amended and Restated Senior Management Severance Plan</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on December 22, 2011).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.20</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764415000033/ex_10.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Second Amended and Restated Senior Management Severance Plan</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10 to the Company's Current Report on Form 8-K filed on July 16, 2015).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.21</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764417000014/exhibit10-24.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Solicitation/Contract/Order for Commercial Items (the CDC BioThrax Procurement Contract), effective December 8, 2016, from the Centers for Disease Control and Prevention to Emergent Biodefense Operations Lansing LLC</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.24 to the Company&#8217;s Annual Report on Form 10-K, filed on February 28, 2017).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.22</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764418000014/exhibit10-22.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 1, effective January 27, 2017, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.22 to the Company's Annual Report on Form 10-K filed on February 23, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.23</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764418000014/exhibit10-23.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 2, effective February 23,2017, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.23 to the Company's Annual Report on Form 10-K filed on February 23, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.24</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764418000014/exhibit10-24.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 3, effective March 22, 2017, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.24 to the Company's Annual Report on Form 10-K filed on February 23, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.25</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764418000014/exhibit10-25.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 4, effective April 5, 2017, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.25 to the Company's Annual Report on Form 10-K filed on February 23, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.26</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764417000048/exhibit10_2.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 5, effective September 8, 2017, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.26 to the Company's Quarterly Report on Form 10-Q filed on November 3, 2017).</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">116</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:8%;"></td><td style="width:8%;"></td><td style="width:84%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.27</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764418000014/exhibit10-27.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 6, effective September 21, 2017, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.27 the Company&#8217;s Annual Report on Form 10-K filed on February 23, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.28</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764418000023/exhibit10_1.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 7, effective February 26, 2018, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed on May 4, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.29</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764418000023/exhibit10_2.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 8, effective March 6, 2018, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed on May 4, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.30</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764418000033/exhibit10_2.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 9, effective June 6, 2018, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed on August 3, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.31</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764418000033/exhibit10_3.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 10, effective June 18, 2018, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.3 to the Company's Quarterly Report on Form 10-Q filed on August 3, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.32</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764418000033/exhitbit10_4.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 11, effective June 20, 2018, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.4 to the Company's Quarterly Report on Form 10-Q filed on August 3, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.33</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764418000033/exhibit10_5.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 12, effective June 21, 2018, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.5 to the Company's Quarterly Report on Form 10-Q filed on August 3, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.34</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764418000044/exhibit10_2.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 13, effective December 6, 2018 to the CDC BioThrax Procurement</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed on November 2, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.35</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764419000016/exhibit10-45.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 14, effective October 1, 2018, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.45 the Company&#8217;s Annual Report on Form 10-K filed on February 22, 2019).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.36</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764419000016/exhibit10-46.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 15, effective December 7, 2018, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.46 the Company&#8217;s Annual Report on Form 10-K filed on February 22, 2019).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.37</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764419000016/exhibit10-47.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 16, effective December 8, 2018, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.47 the Company&#8217;s Annual Report on Form 10-K filed on February 22, 2019).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.38</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;&#8224;&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764419000038/ebs-20190630xex101.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 17, effective June 13, 2019, to the CDC BioThrax Procurement Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.12 to the Company's Quarterly Report on Form 10-Q filed on August 2, 2019).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.39</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#&#8224;&#8224;&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ebs20191231exhibit1039.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 18, effective September 11, 2019, to the CDC BioThrax Procurement Contract</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.40</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#&#8224;&#8224;&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ebs20191231exhibit1040.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 19, effective January 6, 2020, to the CDC BioThrax Procurement Contract.</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.41</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#&#8224;&#8224;&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ebs20191231exhibit1041.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 20, effective January 7, 2020, to the CDC BioThrax Procurement Contract.</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.42</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ebs20191231exhibit1042.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Award/Contract (the BARDA AV7909 Contract), effective September 30, 2016, from the BioMedical Advanced Research and Development Authority to Emergent Product Development Gaithersburg Inc.</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed on November 9, 2016).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.43</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764417000022/exhibit10_2.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 1, effective March 16, 2017, to the BARDA AV7909 Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed on November 9, 2016) (incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed on May 5, 2017).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.44</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764418000044/exhibit10_3.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification No. 2, effective August 29, 2018, to the BARDA AV7909 Contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.3 to the Company's Quarterly Report on Form 10-Q filed on November 2, 2018).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.45</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;&#8224;&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764419000053/bardassleditsv4.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Modification #3, effective July 30, 2019, to the BARDA AV7909 contract</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed on November 9, 2019).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.46</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#&#8224;&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764419000016/exhibit10-51.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">License Agreement, dated as of December 15, 2014, by and between Opiant Pharmaceuticals, Inc. (formerly known as Lightlake Therapeutics Inc.) and Adapt Pharma Operations Limited.</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.51 the Company&#8217;s Annual Report on Form 10-K filed on February 22, 2019).</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.47</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#&#8224;&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1367644/000136764419000016/exhibit10-52.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amendment No. 1 to License Agreement, dated as of December 13, 2016, by and between Opiant Pharmaceuticals, Inc. and Adapt Pharma Operations Limited.</span></a><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;(incorporated by reference to Exhibit 10.52 the Company&#8217;s Annual Report on Form 10-K filed on February 22, 2019).</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">117</span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:8%;"></td><td style="width:8%;"></td><td style="width:84%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.48</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#&#8224;&#8224;&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ebs20191231exhibit1048.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Award/Contract, effective August 30, 2019 (ACAM 2000 Contract), from the Assistant Secretary, U.S. Department of Health and Human Services (ASPR/OPM) to Emergent Product Development Gaithersburg Inc.</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">21</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ebs-20191231exhibit21.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Subsidiaries of the Company.</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">23</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ebs-20191231exhibit23.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Consent of Independent Registered Public Accounting Firm.</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">31.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="esb-20191231x10kxex311.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Certification of the Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a).</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">31.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="esb-20191231x10kxex312.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Certification of the Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a).</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">32.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="esb-20191231x10kxex321.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">32.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="esb-20191231x10kxex322.htm"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">101</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following financial information related to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Cash Flows, (v) the Consolidated Statement of Changes in Stockholders' Equity; and (vi) the related Notes to Consolidated Financial Statements.</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">104</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101.</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">#</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Filed herewith</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Confidential treatment granted by the Securities and Exchange Commission as to certain portions. Confidential materials omitted and filed separately with the Securities and Exchange Commission.</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Confidential treatment requested by the Securities and Exchange Commission as to certain portions. Confidential materials omitted and filed separately with the Securities and Exchange Commission.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8224;&#8224;&#8224;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Certain confidential portions of this exhibit were omitted by means of marking such portions with asterisks because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">*</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Management contract or compensatory plan or arrangement filed herewith in response to Item 15(a) of Form 10-K.</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Attached as Exhibit 101 to this Annual Report on Form 10-K are the following formatted in XBRL (Extensible Business Reporting Language): (i) Consolidated Balance Sheets as of December 31, 2019 and 2018, (ii) Consolidated Statements of Operations for the Years Ended December 31, 2019, 2018 and 2017, (iii) Consolidated Statements of Comprehensive Income for the Years Ended December 31, 2019, 2018 and 2017 (iv) Consolidated Statements of Cash Flows for the Years Ended December 31, 2019, 2018 and 2017, (v) Consolidated Statements of Changes in Stockholders' Equity for the Years ended December 31, 2019, 2018 and 2017, and (vi) Notes to Consolidated Financial Statements.</span></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">118</span></div></div><hr style="page-break-after:always"></hr><div><a id="s1DB612A5477651F682EDD321AC111FD6"></a></div><div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">SIGNATURES</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">EMERGENT BIOSOLUTIONS INC.</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">By: </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;text-decoration:underline;">/s/RICHARD S. LINDAHL</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Richard S. Lindahl</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Executive Vice President, Chief Financial Officer and Treasurer</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Date: February&#160;24, 2020</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:24%;"></td><td style="width:3%;"></td><td style="width:54%;"></td><td style="width:2%;"></td><td style="width:17%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Signature</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Title</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Date</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;text-decoration:underline;">/s/Robert G. Kramer Sr. </span></div><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Robert G. Kramer Sr. </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">President, Chief Executive Officer and Director</span></div><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(Principal Executive Officer)</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">February&#160;24, 2020</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;text-decoration:underline;">/s/Richard S. Lindahl</span></div><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Richard S. Lindahl</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Executive Vice President, Chief Financial Officer and Treasurer</span></div><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(Principal Financial and Accounting Officer)</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">February&#160;24, 2020</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;text-decoration:underline;">/s/Fuad El-Hibri</span></div><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fuad El-Hibri</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Executive Chairman of the Board of Directors</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">February&#160;24, 2020</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;text-decoration:underline;">/s/Zsolt Harsanyi, Ph.D.</span></div><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Zsolt Harsanyi, Ph.D.</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Director</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">February&#160;24, 2020</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;text-decoration:underline;">/s/Kathryn Zoon, Ph.D.</span></div><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Kathryn Zoon, Ph.D.</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Director</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">February&#160;24, 2020</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;text-decoration:underline;">/s/Ronald B. Richard</span></div><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Ronald B. Richard</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Director</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">February&#160;24, 2020</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;text-decoration:underline;">/s/Louis W. Sullivan, M.D.</span></div><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Louis W. Sullivan, M.D.</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Director</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">February&#160;24, 2020</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;text-decoration:underline;">/s/Dr. Sue Bailey</span></div><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Dr. Sue Bailey</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Director</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">February&#160;24, 2020</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;text-decoration:underline;">/s/George Joulwan</span></div><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">George Joulwan</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Director</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">February&#160;24, 2020</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;text-decoration:underline;">/s/Jerome Hauer, Ph.D.</span></div><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Jerome Hauer, Ph.D.</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Director</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">February&#160;24, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;text-decoration:underline;">/s/Seamus Mulligan</span></div><div style="font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Seamus Mulligan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Director</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">February&#160;24, 2020</span></div></td></tr></table></div></div><div><br/></div><div style="text-align:center;"><div style="line-height:120%;padding-bottom:12px;text-align:center;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">119</span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>2
<FILENAME>exhibit44descriptionof.htm
<DESCRIPTION>EXHIBIT 4.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sF6659CA689343176B1643FCA0F7DD539"></a></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Exhibit 4.4</font></div></div><div><br></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">EMERGENT BIOSOLUTIONS INC. </font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">DESCRIPTION OF SECURITIES</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The following description of our capital stock is intended as a summary only and therefore is not a complete description of our capital stock. This description is based upon, and is qualified by reference to, our certificate of incorporation, our by-laws and applicable provisions of Delaware corporate law. You should read our certificate of incorporation and by-laws, which are filed as exhibits to the Annual Report on Form 10-K to which this exhibit is attached.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Our authorized capital stock consists of 200,000,000 shares of common stock, $0.001 par value per share, and 15,000,000 shares of preferred stock, $0.001 par value per share, of which 100,000 shares have been designated as series&#160;A junior participating preferred stock. As of December 31, 2019, no shares of preferred stock were outstanding.</font></div><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Common Stock</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">Voting Rights.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;The holders of our common stock are entitled to one vote per share with respect to each matter presented to our stockholders on which the holders of common stock are entitled to vote and do not have cumulative voting rights. An election of directors by our stockholders is determined by a plurality of the votes cast by the stockholders entitled to vote on the election.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">Dividends.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;Holders of common stock are entitled to receive proportionately any dividends as may be declared by our Board of Directors, subject to any preferential dividend rights of outstanding preferred stock.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">Liquidation and Dissolution.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;In the event of our liquidation or dissolution, the holders of common stock are entitled to receive ratably all assets available for distribution to stockholders after the payment of all debts and other liabilities and subject to the prior rights of any outstanding preferred stock.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">Other Rights.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;Holders of common stock have no preemptive, subscription, redemption or conversion rights. The rights, preferences and privileges of holders of common stock are subject to and may be adversely affected by the rights of the holders of shares of any series of preferred stock that we may designate and issue in the future.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">Listing.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;Our common stock is listed on the New York Stock Exchange under the symbol &#8220;EBS.&#8221;</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">Transfer Agent and Registrar.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;The transfer agent and registrar for our common stock is Broadridge Corporate Issuer Solutions, Inc.</font></div><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Preferred Stock</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Under the terms of our certificate of incorporation, our Board of Directors is authorized to issue shares of preferred stock in one or more series without stockholder approval. Our Board of Directors has the discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock. Authorizing our Board of Directors to issue preferred stock and determine its rights and preferences has the effect of eliminating delays associated with a stockholder vote on specific issuances. Currently, we have no shares of preferred stock outstanding. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:33px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">If we decide to issue any preferred stock, we will describe in a prospectus or supplement thereto the specific terms of the preferred stock, including, if applicable, the following:</font></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the title and stated value;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the number of shares we are offering;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the liquidation preference per share;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the purchase price;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the dividend rate, period and payment date, and method of calculation for dividends;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">whether dividends will be cumulative and, if cumulative, the date from which dividends will accumulate;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the relative ranking and preference of the preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the procedures for any auction and remarketing;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the provisions for a sinking fund;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the provisions for redemption or repurchase and any restrictions on our ability to exercise those redemption and repurchase rights;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the listing of the preferred stock on any securities exchange or market;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">whether the preferred stock will be convertible into our common stock and, if convertible, the conversion price, or how it will be calculated, and the conversion period;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">whether the preferred stock will be exchangeable into debt securities and, if exchangeable, the exchange price, or how it will be calculated, and the exchange period;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">voting rights of the preferred stock;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">preemptive rights;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">restrictions on transfer, sale or other assignment;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">whether interests in the preferred stock will be represented by depositary shares;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">a discussion of any material U.S. federal income tax considerations applicable to the preferred stock;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any limitations on issuance of any class or series of preferred stock ranking senior to or on a parity with the series of preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs; and</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:4.5pt;"><font style="font-family:inherit;font-size:4.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:9%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any other specific terms, preferences, rights or limitations of, or restrictions on, the preferred stock.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The preferred stock could have other rights, including economic rights that are senior to our common stock that could adversely affect the market value of our common stock. The issuance of the preferred stock may also have the effect of delaying, deferring or preventing a change in control of us without any action by the shareholders.</font></div><div style="line-height:120%;text-align:justify;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;background-color:#ffffff;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2.875% Convertible&#160;Senior Notes Due 2021</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We currently have approximately $10.6 million of 2.875% senior notes due 2021. The notes bear cash interest at a rate of 2.875% per year until maturity. Interest is payable semiannually in arrears on January 15 and July 15 of each year.  </font><font style="font-family:inherit;font-size:10pt;">On November 14, 2017, we issued a notice of termination of conversion rights for our outstanding notes, (which were previously convertible), of which $250.0 million was outstanding as of the notice date. In connection with the notice of termination, bondholders were given the option to convert their notes into our stock at a rate of 32.386 per $1,000 of principal outstanding, plus a make-whole of an additional 3.1556 shares per $1,000 principal outstanding, in accordance with the terms of the indenture. We were not obligated to pay accrued or unpaid interest on converted notes, and bondholders who did not convert by the deadline of December 28, 2017 retained their bonds but lost the conversion rights associated with the notes and will be paid interest of 2.875% until the earlier of maturity of the Notes in 2021 or the bonds being called and repaid in full by us. Between November 14, 2017 and December 28, 2017, approximately $239.4 million of bonds were converted into 8.5 million shares of our common stock. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:130%;padding-bottom:10px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Ranking</font><font style="font-family:inherit;font-size:10pt;">.  The notes are our general unsecured obligations that rank senior in right of payment to all of our indebtedness that is expressly subordinated in right of payment to the notes. The notes rank equal in right of payment with all of our liabilities that are not so subordinated. The notes will effectively rank junior to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness. In the event of our bankruptcy, liquidation, reorganization or other winding up, our assets that secure secured debt will be available to pay obligations on the notes only after all indebtedness under such secured debt has been repaid in full from such assets. The notes will rank structurally junior to all indebtedness and other liabilities of our subsidiaries (including trade payables but excluding intercompany obligations and liabilities of a type not required to be reflected on a balance sheet of such subsidiaries in accordance with GAAP). </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">Optional Redemption. </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">No &#8220;sinking fund&#8221; is provided for the notes, which means that we are not required to redeem or retire the notes periodically. However, we may, at our election, redeem for cash all or part of the notes, at our option, at any time or from time to time thereafter. In the case of any optional redemption, we will provide not less than 30 nor more than 60 calendar days&#8217; notice before the redemption date to the trustee, the paying agent and each holder of notes, and the redemption price will be equal to 100% of the principal amount of the notes to be redeemed, </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">plus </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">accrued and unpaid interest to, but excluding, the redemption date (unless the redemption date falls after a regular record date but on or prior to the immediately succeeding interest payment date, in which case we will pay the full amount of accrued and unpaid interest as of such interest payment date to the holder of record as of the close of business on such regular record date, and the redemption price will be equal to 100% of the principal amount of the notes to be redeemed). The redemption date must be a business day.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If we decide to redeem fewer than all of the outstanding notes, the trustee will select the notes to be redeemed (in principal amounts of $1,000 or multiples thereof) by lot, on a </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">pro rata </font><font style="font-family:inherit;font-size:10pt;">basis or by another method the trustee considers to be fair and appropriate.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event of any redemption in part, we will not be required to register the transfer of or exchange any</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">note so selected for redemption, in whole or in part, except the unredeemed portion of any note being redeemed</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">in part.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No notes may be redeemed if the principal amount of the notes has been accelerated, and such acceleration</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">has not been rescinded, on or prior to the redemption date (except in the case of an acceleration resulting from a</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">default by us in the payment of the redemption price with respect to such notes).</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Stockholder Rights Plan</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Our Board of Directors may implement a stockholder rights plan without stockholder approval, which may have anti-takeover effects. We previously implemented a stockholder rights plan, which expired on November&#160;14, 2016. Under our prior stockholder rights plan, we issued to each of our stockholders one preferred stock purchase right for each outstanding share of our common stock. Each right, when exercisable, would have entitled its holder to purchase from us a unit consisting of one one-thousandth of a share of series&#160;A junior participating preferred stock at a purchase price of $150 in cash, subject to adjustments. Our stockholder rights plan was intended to protect stockholders in the event of an unfair or coercive offer to acquire us and to provide our Board of Directors with adequate time to evaluate unsolicited offers.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Provisions of Our Certificate of Incorporation and By-laws and Delaware Law That May Have Anti-Takeover Effects</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Our certificate of incorporation and by-laws and Delaware law contain provisions that could have the effect of delaying, deferring or discouraging another party from acquiring control of us. These provisions, which are summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our Board of Directors.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As of January 31, 2020, Fuad El-Hibri, our executive chairman, was the beneficial owner of approximately 11% of our outstanding common stock. As a result, Mr.&#160;El-Hibri has significant influence over the election of the members of our Board of Directors. This control could discourage others from initiating a potential merger, takeover or other change of control transaction that other stockholders may view as beneficial.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Number of Directors.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;Subject to the rights of holders of any series of preferred stock to elect directors, our Board of Directors will establish the number of directors.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Staggered Board; Removal of Directors.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;Our certificate of incorporation and our by-laws divide our directors into three classes with staggered three-year terms. Our directors may be removed from office only for cause and only by the affirmative vote of holders of our capital stock representing at least 75% of the voting power of all outstanding stock entitled to vote.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any vacancy on our Board of Directors, including a vacancy resulting from an enlargement of our Board of Directors, may be filled only by the affirmative vote of a majority of our directors present at a meeting duly held at which a quorum is present.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The classification of our Board of Directors and the limitations on the removal of directors and filling of vacancies could make it more difficult for a third party to acquire, or discourage a third party from seeking to acquire, control of our company.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Stockholder Action by Written Consent; Special Meetings.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;Our certificate of incorporation and our by-laws provide that any action required or permitted to be taken by our stockholders must be effected at a duly called annual or special meeting of such holders and may not be effected by any consent in writing by such holders. Our certificate of incorporation and our by-laws also provide that, except as otherwise required by law, special meetings of our stockholders can only be called by our Board of Directors, our chairman of the board or our president.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Advance Notice Requirements.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;Our by-laws establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of stockholders, including proposed nominations of persons for election to the Board of Directors. Stockholders at an annual meeting may only consider proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of the Board of Directors or by a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has delivered timely written notice in proper form to our secretary of the stockholder's intention to bring such business before the meeting. These provisions could have the effect of delaying until the next stockholder meeting stockholder actions that are favored by the holders of a majority of our outstanding voting securities.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Delaware Business Combination Statute.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;Section&#160;203 of the General Corporation Law of the State of Delaware, which we refer to as the DGCL, is applicable to us. Section&#160;203 of the DGCL restricts some types of transactions and business combinations between a corporation and a 15% stockholder. A 15% stockholder is generally considered by Section&#160;203 to be a person owning 15% or more of the corporation's outstanding voting stock. Section&#160;203 refers to a 15% stockholder as an &#8220;interested stockholder.&#8221; Section&#160;203 restricts these transactions for a period of three years from the date the stockholder acquires 15% or more of our outstanding voting stock. With some exceptions, unless the transaction is approved by the board of directors and the holders of at least two-thirds of the outstanding voting stock of the corporation, Section&#160;203 prohibits significant business transactions such as:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">a merger with, disposition of significant assets to or receipt of disproportionate financial benefits by the interested stockholder, and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">any other transaction that would increase the interested stockholder's proportionate ownership of any class or series of our capital stock.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The shares held by the interested stockholder are not counted as outstanding when calculating the two-thirds of the outstanding voting stock needed for approval.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The prohibition against these transactions does not apply if:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">prior to the time that any stockholder became an interested stockholder, the board of directors approved either the business combination or the transaction in which such stockholder acquired 15% or more of our outstanding voting stock, or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the interested stockholder owns at least 85% of our outstanding voting stock as a result of a transaction in which such stockholder acquired 15% or more of our outstanding voting stock. Shares held by persons who are both directors and officers or by some types of employee stock plans are not counted as outstanding when making this calculation.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Super-Majority Voting.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;The DGCL provides generally that the affirmative vote of a majority of the shares entitled to vote on any matter is required to amend a corporation's certificate of incorporation or by-laws, unless a corporation's certificate of incorporation or by-laws, as the case may be, requires a greater percentage. The affirmative vote of holders of our capital stock representing at least 75% of the voting power of all outstanding stock entitled to vote is required to amend or repeal the provisions of our certificate of incorporation described in this section entitled "Provisions of Our Certificate of Incorporation and By-laws and Delaware Law That May Have Anti-Takeover Effects." The affirmative vote of either a majority of the directors present at a meeting of our board of directors or holders of our capital stock representing at least 75% of the voting power of all outstanding stock entitled to vote is required to amend or repeal our by-laws.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Limitation of Liability and Indemnification of Officers and Directors</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Our certificate of incorporation contains provisions permitted under the DGCL relating to the liability of directors. The provisions eliminate a director's liability for monetary damages for a breach of fiduciary duty, except in circumstances involving wrongful acts, such as the breach of a director's duty of loyalty or acts or omissions that involve intentional misconduct or a knowing violation of law. Further, our certificate of incorporation contains provisions to indemnify our directors and officers to the fullest extent permitted by the DGCL. We have entered into agreements to indemnify our directors and executive officers. These agreements, among other things, provide that we will indemnify the director or executive officer to the fullest extent permitted by law for claims arising in his or her capacity as a director, officer, manager, employee, agent or representative of us. The indemnification agreements also establish the procedures that will apply in the event a director or officer makes a claim for indemnification.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;padding-left:13px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Registration Rights</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Biovac, L.L.C. and Intervac, L.L.C. hold an aggregate of approximately 6 million shares of our common stock as of December 31, 2019 and have the right to require us to register these shares of common stock under the Securities Act under specified circumstances, including any additional shares issued or distributed by way of a dividend, stock split or other distribution in respect of these shares.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Demand Registration Rights.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;Subject to specified limitations, holders of these registrations rights may require that we register all or part of our common stock subject to the registration rights for sale under the Securities Act. These holders may demand registration of our common stock so long as the offering price to the public of the shares requested to be registered is at least $25,000,000. We are required to effect only one demand registration, subject to specified exceptions.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Incidental Registration Rights.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;If we propose to file&#160;a registration statement under the Securities Act either for our own account or for the account of other stockholders (other than in connection with a registration statement on Form&#160;S-8 or Form&#160;S-4 or to cover securities proposed to be issued in exchange for securities or assets of another corporation), the holders of registrable shares will be entitled to notice of the registration and we will be required to use our commercially reasonable efforts to register all or a portion of any registrable shares then held by such holders that they request that we register. In the event that any registration in which the holders of registrable shares participate pursuant to our stockholders agreement is an underwritten public offering, we agree to enter into an underwriting agreement containing such terms as are customary.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Limitations and Expenses.</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#160;&#160;&#160;&#160;With specified exceptions, the right to include shares in a registration is subject to the right of underwriters for the offering to limit the number of shares included in the offering. We are required to pay one-half of all fees, costs and expenses of any demand registration, other than underwriting discounts and commissions.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>3
<FILENAME>ebs-20191231exhibit1010.htm
<DESCRIPTION>EXHIBIT 10.10
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s24B04D6F686DA46CD1D43BBBCCE3107A"></a></div><div><div style="line-height:138%;padding-top:17px;text-align:justify;padding-left:9px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Exhibit 10.10</font></div><div style="line-height:120%;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Emergent BioSolutions Inc.</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Global Restricted Stock Unit Award Agreement </font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;padding-bottom:16px;text-align:justify;text-indent:48px;"><font style="padding-bottom:16px;text-align:justify;font-family:inherit;font-size:14pt;padding-right:48px;">1.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Grant of RSUs</font><font style="font-family:inherit;font-size:12pt;">. In consideration of services rendered to the Company by the Participant, the Company has granted to the Participant, subject to the terms and conditions set forth in the Global Restricted Stock Unit Award Agreement, including any additional terms and conditions for the Participant&#8217;s country set forth in the addendum attached hereto (the &#8220;Addendum&#8221; and collectively with the Global Restricted Stock Unit Award Agreement, the &#8220;Agreement&#8221;) and the Company&#8217;s Stock Incentive Plan (the &#8220;Plan&#8221;), an award of Restricted Stock Units (the &#8220;RSUs&#8221;), representing the number of RSUs set forth under the Participant&#8217;s account in the Company&#8217;s third-party electronic stock administrative platform (the &#8220;Grant Summary). The RSUs entitle the Participant to receive, upon and subject to the vesting of the RSUs (as described in Section 2 below), one (1) share of common stock, $0.001 par value per share, of the Company (the &#8220;Common Stock&#8221;) for each RSU that vests. The shares of Common Stock that are issuable upon vesting of the RSUs are referred to herein as the &#8220;Shares.&#8221; </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">2.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Vesting and Settlement of RSUs</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">General</font><font style="font-family:inherit;font-size:12pt;">. Except as provided in this Section 2, or otherwise indicated in the Grant Summary, the RSUs shall vest one-third per year over three (3) years on the day immediately prior to the applicable anniversary of the grant date, in accordance with the future vesting schedule (the &#8220;Vesting Schedule&#8221;) set forth in the Grant Summary. The Company will issue to the Participant such number of Shares as is equal to the number of RSUs that vested on such vesting date shown in the Vesting Schedule (each, a &#8220;Vesting Date&#8221;), subject to withholding of any Tax-Related Items (as defined in Section 4 below). Such delivery shall take place as soon as administratively practicable after each Vesting Date, but in no event more than 75 days after the Vesting Date. </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Notwithstanding the foregoing, if the Participant resides or provides services outside of the United States, the Company, in its sole discretion, may provide for settlement of the RSUs in the form of (i) a cash payment in an amount equal to the fair market value of the Shares as of the Vesting Date that corresponds to the number of vested RSUs, to the extent that settlement in Shares (a) is prohibited under local law, (b) would require the Participant, the Company or any of its affiliates to obtain the approval of any governmental or regulatory body in the Participant&#8217;s country, (c) would result in adverse tax consequences for the Participant, the Company or any of its affiliates, or (d) is administratively burdensome; or (ii) Shares but require the Participant to sell such Shares immediately or within a specified period following the Participant&#8217;s termination of service (in which case, the Participant hereby agrees that the Company shall have the authority to issue sale instructions in relation to such shares on the Participant&#8217;s behalf). </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Service Termination</font><font style="font-family:inherit;font-size:12pt;">. Except as set forth in Section 2(c) below, upon the cessation of the Participant&#8217;s service with the Company or one of its affiliates as an employee, consultant or director of the Company or one of its affiliates for any reason, all unvested RSUs shall be automatically forfeited as of such cessation of service. </font><font style="font-family:inherit;font-size:12pt;">For purposes of this Agreement, the Participant&#8217;s service will be deemed to terminate as of the date the Participant is no longer actively providing services to the Company or any of its affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment or other laws in the jurisdiction where the Participant is employed or otherwise rendering services or the terms of the Participant&#8217;s employment or other service agreement, if any) and will not be extended by any notice period (e.g., the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment or other laws in the jurisdiction where the Participant is employed or otherwise rendering services or the terms of the Participant&#8217;s employment or other service agreement, if any). The Company shall have the exclusive discretion to determine when the Participant is no longer actively providing services for purposes of this RSU grant (including whether the Participant may still be considered to be providing services while on a leave of absence).</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Change in Control Event</font><font style="font-family:inherit;font-size:12pt;">. Upon a Change in Control Event (as defined in the Plan), the RSUs shall be treated in the manner provided in Section 9(b)(iii)(B) of the Plan.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">3.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Dividend Equivalents</font><font style="font-family:inherit;font-size:12pt;">. The Participant will be entitled to a cash payment equal to any cash dividends paid by the Company between the grant date and the Vesting Date, with respect to the number of Shares underlying the vested RSUs. If the Participant forfeits the RSUs, then the related dividend equivalents will also be forfeited. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">4.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Responsibility for Taxes</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Participant acknowledges that, regardless of any action taken by the Company or, if different, the affiliate for which the Participant provides services (the &#8220;Service Recipient&#8221;), the ultimate liability for all income tax, social insurance, payroll tax, fringe benefit tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;) is and remains the Participant&#8217;s responsibility and may exceed the amount actually withheld, if any, by the Company or the Service Recipient. The Participant further acknowledges that the Company and/or the Service Recipient (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including, but not limited to, the grant, vesting or the subsequent sale of Shares acquired upon the vesting of the RSUs and the receipt of any dividends or dividend equivalents; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and/or the Service Recipient (or former service recipient, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Prior to any relevant taxable or tax withholding event, as applicable, the Participant agrees to make adequate arrangements satisfactory to the Company and/or the Service Recipient to satisfy all Tax-Related Items. In this regard, the Participant authorizes the Company and/or the Service Recipient, or their respective agents, at their discretion, to satisfy any applicable withholding obligations with regard to all Tax-Related Items by one or a combination of the following: (i) withholding from the Participant&#8217;s wages or other compensation payable to the Participant by the Company or the Service Recipient, (ii) withholding from proceeds of the sale of Shares acquired upon vesting of the RSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant&#8217;s behalf pursuant to this authorization without further consent), (iii) withholding from the Shares (or equivalent cash payment) otherwise issuable at settlement of the RSUs, or (iv) any method determined by the Company to be in compliance with applicable laws.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Depending on the withholding method, the Company and/or Service Recipient may withhold or account for Tax-Related Items by considering statutory withholding rates or other applicable withholding rates, including maximum rates applicable in the Participant&#8217;s jurisdiction, in which case the Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the Common Stock equivalent. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant is deemed to have been issued the full number of Shares subject to RSUs, notwithstanding that a number of Shares is held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(d)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Finally, the Participant agrees to pay to the Company or the Service Recipient any amount of Tax-Related Items that the Company or the Service Recipient may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the underlying Shares or the proceeds from the sale of Shares acquired upon settlement of RSUs, if the Participant fails to comply with his or her obligations in connection with the Tax-Related Items.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">5.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Restrictions on Transfer</font><font style="font-family:inherit;font-size:12pt;">. Neither the RSUs, nor any interest therein (including the right to receive dividend equivalent payments in accordance with Section 3), may be transferred by the Participant except to the extent specifically permitted in Section 10(a) of the Plan if permitted by the Company and valid under applicable law. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">6.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Nature of Grant</font><font style="font-family:inherit;font-size:12pt;">. In accepting the RSUs, the Participant acknowledges and agrees that:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the Plan is established voluntarily by the Company, it is discretionary in nature, and may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted under the Plan;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the grant of the RSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of restricted stock units, or benefits in lieu of restricted stock units, even if restricted stock units have been granted in the past;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">all decisions with respect to future restricted stock units, if any, will be at the sole discretion of the Company;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(d)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the grant of the RSUs and the Participant&#8217;s participation in the Plan shall not create a right to employment or be interpreted as forming a service relationship with the Company or any of its affiliates and shall not interfere with the ability of the Service Recipient to terminate the Participant&#8217;s service relationship (if any);</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(e)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the Participant is voluntarily participating in the Plan;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(f)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the RSUs and any Shares acquired under the Plan, and the income from and value of the same, are not intended to replace any pension rights or compensation;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(g)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the RSUs and any Shares acquired under the Plan, and the income from and value of the same, are not part of normal or expected compensation for any purpose, including, without limitation, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(h)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the future value of the Shares underlying the RSUs is unknown, indeterminable, and cannot be predicted with certainty;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(i)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">no claim or entitlement to compensation or damages shall arise from the forfeiture of the RSUs resulting from the Participant ceasing to provide services to the Company or any of its affiliates (for any reason whatsoever, whether or not later found to be invalid or in breach of employment or other laws in the jurisdiction where the Participant is employed or otherwise rendering services or the terms of the Participant&#8217;s employment or other service agreement, if any);</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(j)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">unless otherwise agreed to by the Company, the RSUs and any Shares acquired under the Plan, and the income from and value of the same, are not granted as consideration for, or in connection with, the service the Participant may provide as a director of any of the Company&#8217;s affiliates; </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(k)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">unless otherwise provided in the Plan or by the Company in its discretion, the RSUs and the benefits evidenced by this Agreement do not create any entitlement to have the RSUs or any such benefits transferred to, or assumed by, another company, nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the Common Stock; and</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(l)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">neither the Company, the Service Recipient nor any other affiliate of the Company shall be liable for any foreign exchange rate fluctuation between the Participant&#8217;s local currency and the United States Dollar that may affect the value of the RSUs or of any amounts due to the Participant pursuant to the RSUs or the subsequent sale of Shares acquired upon vesting of the RSUs.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">7.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">No Advice Regarding Grant</font><font style="font-family:inherit;font-size:12pt;">. The Company is not providing any tax, legal or financial advice, nor is the Company making recommendations regarding the Participant&#8217;s participation in the Plan, or the Participant&#8217;s acquisition or sale of Shares acquired upon exercise. The Participant should consult with his or her own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">8.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Data Privacy</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant&#8217;s personal data as described in any RSU award grant materials by and among, as applicable, the Service Recipient, the Company, and any of its affiliates for the exclusive purpose of implementing, administering and managing the Participant&#8217;s participation in the Plan.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">The Participant understands that the Company and the Service Recipient may hold certain personal information about the Participant, including but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance, passport or other identification number (e.g., resident registration number), salary, nationality, job title, any Shares or directorships held in the Company, details of all awards or any other entitlement to Shares awarded, cancelled, exercised, vested, unvested or outstanding in the Participant&#8217;s favor (&#8220;Data&#8221;), for the exclusive purpose of implementing, administering and managing the Plan. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">The Participant understands that Data will be transferred to the Company&#8217;s designated broker and/or stock plan service provider that is assisting the Company (presently or in the future) with the implementation, administration and management of the Plan. The Participant understands that the recipients of Data may be located in the United States or elsewhere, and that the recipients&#8217; country (e.g., the United States) may have different data privacy laws and protections than the Participant&#8217;s country. The Participant understands that he or she may request a list with the names and addresses of any potential recipients of the Data by contacting the Ethics and Compliance Officer at </font><a style="font-family:inherit;font-size:12pt;color:#0000ff;font-style:italic;font-weight:bold;text-decoration:underline;" href="#"><font style="font-family:inherit;font-size:12pt;color:#0000ff;font-style:italic;font-weight:bold;text-decoration:underline;">Complianceofficer@ebsi.com</font></a><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">.</font><font style="font-family:inherit;font-size:12pt;color:#0000ff;font-style:italic;font-weight:bold;">&#32;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">The Participant authorizes the Company, the Service Recipient and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing the Participant&#8217;s participation in the Plan. The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan. The Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting </font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">the Ethics and Compliance Officer at </font><a style="font-family:inherit;font-size:12pt;color:#0000ff;font-style:italic;font-weight:bold;text-decoration:underline;" href="#"><font style="font-family:inherit;font-size:12pt;color:#0000ff;font-style:italic;font-weight:bold;text-decoration:underline;">Complianceofficer@ebsi.com</font></a><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">.</font><font style="font-family:inherit;font-size:12pt;color:#0000ff;font-style:italic;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Further, the Participant understands that he or she is providing the consents herein on a purely voluntary basis</font><font style="font-family:inherit;font-size:14pt;font-style:italic;font-weight:bold;">. </font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">If the Participant does not consent, or later seeks to revoke the Participant</font><font style="font-family:inherit;font-size:14pt;font-style:italic;font-weight:bold;">&#8217;</font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">s consent, the Participant</font><font style="font-family:inherit;font-size:14pt;font-style:italic;font-weight:bold;">&#8217;</font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">s employment or service status with the Service Recipient will not be affected</font><font style="font-family:inherit;font-size:14pt;font-style:italic;font-weight:bold;">. </font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">The only consequence of refusing or withdrawing consent is that the Company would not be able to grant RSUs or other equity awards to the Participant or administer or maintain such awards</font><font style="font-family:inherit;font-size:14pt;font-style:italic;font-weight:bold;">. </font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Therefore, the Participant understands that refusing or withdrawing the Participant</font><font style="font-family:inherit;font-size:14pt;font-style:italic;font-weight:bold;">&#8217;</font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">s consent may affect the Participant</font><font style="font-family:inherit;font-size:14pt;font-style:italic;font-weight:bold;">&#8217;</font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">s ability to participate in the Plan</font><font style="font-family:inherit;font-size:14pt;font-style:italic;font-weight:bold;">. </font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">For more information on the consequences of the Participant</font><font style="font-family:inherit;font-size:14pt;font-style:italic;font-weight:bold;">&#8217;</font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">s refusal to consent or withdrawal of consent, the Participant understands that he or she may contact</font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">&#32;the Ethics and Compliance Officer at </font><a style="font-family:inherit;font-size:14pt;color:#0000ff;font-style:italic;font-weight:bold;text-decoration:underline;" href="#"><font style="font-family:inherit;font-size:14pt;color:#0000ff;font-style:italic;font-weight:bold;text-decoration:underline;">Complianceofficer@ebsi.com</font></a><font style="font-family:inherit;font-size:14pt;font-style:italic;font-weight:bold;">.</font><font style="font-family:inherit;font-size:14pt;color:#0000ff;font-style:italic;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">9.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Not a Public Offering</font><font style="font-family:inherit;font-size:12pt;">. If the Participant resides outside of the United States, the grant of the RSUs is not intended to be a public offering of securities in his or her country of residence (or country of service, if different). The Company has not submitted any registration statement, prospectus or other filings with the local securities authorities (unless otherwise required under local law), and the grant of the RSUs is not subject to the supervision of the local securities authorities.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">10.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Insider Trading Restrictions / Market Abuse Laws</font><font style="font-family:inherit;font-size:12pt;">. The Participant understands that he or she is subject to the Company&#8217;s Insider Trading Policy and may be subject to various insider trading restrictions and/or market abuse laws in applicable jurisdictions, including but not limited to the U.S., the Participant&#8217;s country and the broker&#8217;s country, which affect the Participant&#8217;s ability, directly or indirectly, to purchase or sell or attempt to sell or otherwise dispose of Shares acquired upon the vesting of the RSUs or any other securities of the Company while in possession  of material non-public or &#8220;inside information&#8221; regarding the Company (as defined by the laws in the applicable jurisdiction(s)). The Company&#8217; Insider Trading Policy as well as local insider trading laws and regulations prohibit the cancellation or amendment of orders by the Participant while in possession of inside information. Furthermore, the Participant understands that he or she is prohibited from (i) disclosing inside information to any third party, including fellow employees (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties by sharing with them Company inside information, or otherwise causing third parties to buy or sell Company securities on the basis of inside information. Any restrictions under laws or regulations are separate from and in addition to any restrictions imposed under the Company&#8217;s Insider Trading Policy. It is the Participant&#8217;s responsibility to comply with any applicable restrictions and the Participant should consult with his or her personal legal advisor on this matter. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">11.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Foreign Asset / Account Reporting Requirements</font><font style="font-family:inherit;font-size:12pt;">. The Participant acknowledges that there may be certain foreign asset and/or account reporting requirements which may affect the Participant&#8217;s ability to acquire or hold Shares or cash received from participating in the Plan (including from any dividends paid on Shares) in a brokerage or bank account outside the Participant&#8217;s country. The Participant may be required to report such accounts, assets, or related transactions to the tax or other authorities in the Participant&#8217;s country. The Participant may also be required to repatriate sale proceeds or other funds received as a result of the Participant&#8217;s participation in the Plan to the Participant&#8217;s country within a certain time after receipt. The Participant acknowledges that it is the Participant&#8217;s responsibility to comply with such regulations and that the Participant should speak with a personal legal advisor on this matter.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">12.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Electronic Delivery and Acceptance</font><font style="font-family:inherit;font-size:12pt;">. The Company may, in its sole discretion, decide to deliver documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">13.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Language</font><font style="font-family:inherit;font-size:12pt;">. The Participant acknowledges that he or she is sufficiently proficient in English or has consulted with an advisor who is sufficiently proficient in English so as to allow the Participant to understand the terms and conditions of this Agreement. If the Participant has received this Agreement or any other document(s) related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">14.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Addendum</font><font style="font-family:inherit;font-size:12pt;">. Notwithstanding any provisions in this Global Restricted Stock Unit Award Agreement, the RSUs shall be subject to any additional terms and conditions for the Participant&#8217;s country set forth in the Addendum attached hereto. Moreover, if the Participant relocates to one of the countries included in the Addendum, the special terms and conditions for such country will apply to the Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. The Addendum constitutes part of this Agreement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">15.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Imposition of Other Requirements</font><font style="font-family:inherit;font-size:12pt;">. The Company reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on the RSUs and on any Shares acquired upon vesting of the RSUs, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">16.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 409A</font><font style="font-family:inherit;font-size:12pt;">. This RSU award is intended to comply with or be exempt from Section 409A of the U.S. Internal Revenue Code of 1986, as amended, and the guidance issued thereunder (&#8220;Section 409A&#8221;) and shall be interpreted and construed consistently therewith. In no event shall either the Participant or the Company have the right to accelerate or defer delivery of the Shares to a date or event other than as set forth herein except to the extent specifically permitted or required by Section 409A. In the event that the Participant is a &#8220;specified employee&#8221; within the meaning of Section 409A and the Shares are to be delivered in connection with the termination of the Participant&#8217;s employment, the delivery of the Shares and any dividend equivalents payable under Section 3 in connection with such delivery shall be delayed until the date that is six months and one day following the date of the Participant&#8217;s termination of employment if required to avoid the imposition of additional taxes under Section 409A. Solely for purposes of determining when the Shares (and any dividend equivalents payable under Section 3) may be delivered in connection with the Participant&#8217;s termination of employment, such termination of employment must constitute a &#8220;separation from service&#8221; within the meaning of Section 409A.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">17.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Governing Plan Document</font><font style="font-family:inherit;font-size:12pt;">. The RSU award is subject to the Agreement and all the provisions of the Plan, the provisions of which are hereby made a part of this Agreement, and is further subject to all interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan. In the event of any conflict between the provisions of this Agreement and those of the Plan, the provisions of the Plan shall control. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">18.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Governing Law</font><font style="font-family:inherit;font-size:12pt;">. This RSU award shall be construed, interpreted and enforced in accordance with the internal laws of the State of Delaware in the United States of America without regard to any applicable conflict of law principles.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">19.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Entire Agreement</font><font style="font-family:inherit;font-size:12pt;">. These terms and the Plan constitute the entire agreement between the parties, and supersede all prior agreements and understandings, relating to the subject matter of this RSU award; provided that any separate employment, consulting, or severance plan or agreement between the Company and the Participant that includes terms relating to the acceleration of vesting of equity awards shall not be superseded by these terms.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">20.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Interpretation</font><font style="font-family:inherit;font-size:12pt;">. The interpretation and construction of any terms or conditions of the Plan or this RSU award by the Compensation Committee shall be final and conclusive.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">21.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Severability</font><font style="font-family:inherit;font-size:12pt;">. If any provision of this Agreement is held to be unenforceable for any reason, it shall be adjusted rather than voided, if possible, in order to achieve the intent of the parties to the extent possible. In any event, all other provisions of this Agreement shall be deemed valid and enforceable to the full extent possible.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">22.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Waiver</font><font style="font-family:inherit;font-size:12pt;">. The waiver by the Company with respect to the Participant (or any other participant&#8217;s) compliance of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by such party of a provision of this Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ADDENDUM TO </font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">THE GLOBAL RESTRICTED STOCK UNIT AWARD AGREEMENT</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font></div><div style="line-height:120%;padding-bottom:16px;padding-top:6px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Capitalized terms, unless explicitly defined in this Addendum, shall have the meanings given to them in the Global Restricted Stock Unit Award Agreement (the &#8220;RSU Agreement&#8221;) or in the Plan.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:6px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Addendum includes additional terms and conditions that govern the Participant&#8217;s RSUs if the Participant resides and/or works in one of the countries listed below. If the Participant is a citizen or resident (or is considered as such for local law purposes) of a country other than the country in which the Participant is currently residing and/or working, or if the Participant transfers to another country after the grant of the RSUs, the Company shall, in its discretion, determine to what extent the additional terms and conditions contained herein shall be applicable to the Participant.</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">EUROPEAN UNION / EUROPEAN ECONOMIC AREA</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Data Privacy</font><font style="font-family:inherit;font-size:12pt;">. The Company, with its registered address at 400 Professional Drive, Gaithersburg, Maryland, 20879, U.S.A. is the controller responsible for the processing of the Participant&#8217;s personal data by the Company and the third parties noted below.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:29px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Data Collection and Usage</font><font style="font-family:inherit;font-size:12pt;">. Pursuant to applicable data protection laws, the Participant is hereby notified that the Company collects, processes and uses certain personal information about the Participant for the legitimate purpose of implementing, administering and managing the Plan and generally administering awards; which may specifically include: the Participant&#8217;s name, home address, email address and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any shares or directorships held in the Company, and details of all stock RSUs, any entitlement to shares of Common Stock awarded, canceled, exercised, vested, or outstanding in the Participant&#8217;s favor, which the Company receives from the Participant or the Service Recipient (&#8220;Personal Data&#8221;). In granting the RSUs under the Plan, the Company will collect, process, use, disclose and transfer (collectively, &#8220;Processing&#8221;) Personal Data for purposes of implementing, administering and managing the Plan. The Company&#8217;s legal basis for the Processing of Personal Data is the Company&#8217;s legitimate business interests of managing the Plan, administering employee awards and complying with its contractual and statutory obligations, as well as the necessity of the Processing for the Company to perform its contractual obligations under the Agreement and the Plan. The Participant&#8217;s refusal to provide Personal Data would make it impossible for the Company to perform its contractual obligations and may affect the Participant&#8217;s ability to participate in the Plan. As such, by accepting the RSUs, the Participant voluntarily acknowledges the Processing of Personal Data as described herein. </font></div><div style="line-height:120%;text-align:justify;padding-left:29px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Stock Plan Administration Service Provider</font><font style="font-family:inherit;font-size:12pt;">. The Company may transfer Personal Data to the Company&#8217;s designated broker and/or stock plan service provider which may assist the Company with the implementation, administration and management of the Plan. In the future, the Company may select a different service provider and share Personal Data with another company that serves in a similar manner. The Company&#8217;s service provider will open an account for the Participant to receive and trade Shares pursuant to the RSUs. The Processing of Personal Data will take place through both electronic and non-electronic means. Personal Data will only be accessible by those individuals requiring access to it for purposes of implementing, administering and operating the Plan. When receiving Personal Data, if applicable, the service provider provides appropriate safeguards in accordance with the EU Standard Contractual Clauses or other appropriate cross-border transfer solutions. By participating in the Plan, the Participant understands that the service provider will Process the Participant&#8217;s Personal Data for the purposes of implementing, administering and managing the Participant&#8217;s participation in the Plan. </font></div><div style="line-height:120%;text-align:justify;padding-left:30px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">International Data Transfers</font><font style="font-family:inherit;font-size:12pt;">. The Company is based in the United States, which means it will be necessary for Personal Data to be transferred to, and Processed in the United States. When transferring Personal Data to the United States, the Company provides appropriate safeguards in accordance with the EU Standard Contractual Clauses, and other appropriate cross-border transfer solutions. The Participant may request a copy of the appropriate safeguards with the designated broker and/or stock plan administrator or the Company by contacting the Ethics and Compliance Officer at </font><a style="font-family:inherit;font-size:11pt;" href="#"><font style="font-family:inherit;font-size:11pt;">Complianceofficer@ebsi.com. </font></a></div><div style="line-height:120%;text-align:justify;padding-left:30px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(d)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Data Retention</font><font style="font-family:inherit;font-size:12pt;">. The Company will use Personal Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan or as required to comply with legal or regulatory obligations, including tax and securities laws. When the Company no longer needs Personal Data related to the Plan, the Company will remove it from its systems. If the Company keeps Personal Data longer, it would be to satisfy legal or regulatory obligations and the Company&#8217;s legal basis would be for compliance with relevant laws or regulations.</font></div><div style="line-height:120%;text-align:justify;padding-left:30px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">(e)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Data Subject Rights</font><font style="font-family:inherit;font-size:12pt;">.</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:12pt;">To the extent provided by law, the Participant has the right to, subject to certain exceptions: (i)&#160;request access or copies of Personal Data the Company Processes, (ii)&#160;request rectification of incorrect Personal Data, (iii)&#160;request deletion of Personal Data, (iv)&#160;place restrictions on Processing of Personal Data, (v)&#160;lodge complaints with competent authorities in the Participant&#8217;s country, and/or (vi) request a list with the names and addresses of any potential recipients of Personal Data. To receive clarification regarding the Participant&#8217;s rights or to exercise his or her rights, the Participant may contact the Ethics and Compliance Officer at </font><a style="font-family:inherit;font-size:11pt;" href="#"><font style="font-family:inherit;font-size:11pt;">Complianceofficer@ebsi.com. </font></a><font style="font-family:inherit;font-size:12pt;">The Participant also has the right to object, on grounds related to a particular situation, to the Processing of Personal Data, as well as opt-out of the Plan herein, in any case without cost. The Participant&#8217;s provision of Personal Data is a contractual requirement. The Participant understands, however, that the only consequence of refusing to provide Personal Data is that the Company may not be able to administer the RSUs, or grant other awards or administer or maintain such awards. </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">CANADA</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Settlement of RSUs</font><font style="font-family:inherit;font-size:12pt;">. Notwithstanding any terms and conditions in the Plan, the RSU Agreement or any other grant materials, the RSUs will only be settled in Shares. </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Securities Law Information</font><font style="font-family:inherit;font-size:12pt;">. The Participant is permitted to sell Shares acquired under the Plan through the designated broker, provided the resale of such Shares takes place outside Canada through the facilities of a stock exchange on which the Shares are listed (</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">i.e.</font><font style="font-family:inherit;font-size:12pt;">, the New York Stock Exchange). </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">The following provisions apply if the Participant is a resident of Quebec:</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Data Privacy</font><font style="font-family:inherit;font-size:12pt;">. The following supplements Section 8 to the RSU Agreement: </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Participant hereby authorizes the Company and the Company&#8217;s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan. The Participant further authorizes the Company or any of its affiliates and the administrator of the Plan to disclose and discuss the Plan with their advisors. The Participant further authorizes the Company or any of its affiliates to record such information and to keep such information in the Participant&#8217;s employee file.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Language Consent</font><font style="font-family:inherit;font-size:12pt;">. The parties acknowledge that it is their express wish that the Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">Les parties reconnaissent avoir exig&#233; la r&#233;daction en anglais de cette convention, ainsi que de tous documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaries intent&#233;es, directement ou indirectement, relativement &#224; ou suite &#224; la pr&#233;sente convention.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">GERMANY</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">No country-specific provisions. </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">IRELAND</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">No country-specific provisions. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">ITALY</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">No country-specific provisions.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">SINGAPORE</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Securities Law Information</font><font style="font-family:inherit;font-size:12pt;">. The grant of the RSUs under the Plan is being made pursuant to the &#8220;Qualifying Person&#8221; exemption under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;SFA&#8221;). The Plan has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore and is not regulated by any financial supervisory authority pursuant to any legislation in Singapore. Accordingly, statutory liability under the SFA in relation to the content of prospectuses would not apply. The Participant should note that the RSUs are subject to section 257 of the SFA and the Participant will not be able to make any subsequent sale of the Shares in Singapore, or any offer of such subsequent sale of the Shares subject to the RSUs in Singapore, unless such sale or offer is made (i) after six (6) months from the date of grant or (ii) pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">SPAIN</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Employment Law Acknowledgment</font><font style="font-family:inherit;font-size:12pt;">. In accepting the RSUs, the Participant acknowledges that he or she consents to participation in the Plan and has received a copy of the Plan. Further, the Participant understands that the Company, in its sole discretion, has unilaterally and gratuitously decided to grant RSUs under the Plan to individuals who may be employees of the Company or any of its affiliates throughout the world.  The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not bind the Company or any of its affiliates except to the extent set forth in this Agreement.  Consequently, the Participant understands that the RSUs are granted on the assumption and condition that such RSUs and any Shares acquired upon vesting of the RSUs shall not become a part of any employment contract (either with the Company or any of its affiliates) and shall not be considered a mandatory benefit, or salary for any purposes (including severance compensation) or any other right whatsoever.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Further, as a condition of the grant of the RSUs, unless otherwise expressly provided for by the Company or set forth in this Agreement, the RSUs will be cancelled without entitlement to any Shares if the Participant&#8217;s service terminates by reason of, including, but not limited to: resignation, retirement, disciplinary dismissal adjudged to be with cause, disciplinary dismissal adjudged or recognized to be without cause (i.e., subject to a &#8220;despido improcedente&#8221;), material modification of the terms of employment under Article 41 of the Workers&#8217; Statute, relocation under Article 40 of the Workers&#8217; Statute, Article 50 of the Workers&#8217; Statute, or under Article 10.3 of Royal Decree 1382/1985.  The Company, in its sole discretion, shall determine the date when the Participant&#8217;s service has terminated for purposes of the RSUs.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Participant understands that the RSUs would not be granted but for the assumptions and conditions referred to above; thus, the Participant acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of, or right to, the RSUs shall be null and void.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">SWITZERLAND</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Securities Law Information</font><font style="font-family:inherit;font-size:12pt;">. The grant of the RSUs and issuance of Shares is considered a private offering in Switzerland. Neither this document nor any other materials relating to the RSU constitute a prospectus as such term is understood pursuant to article 652a of the Swiss Code of Obligations, and neither this document nor any other materials relating to the RSUs may be publicly available in Switzerland. Neither this document nor any other offering or marketing materials relating to the RSUs have been or will be filed with, approved or supervised by any Swiss regulatory authority (in particular, the Swiss Financial Market Supervisory Authority (FINMA)).</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">UNITED KINGDOM</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Responsibility for Taxes</font><font style="font-family:inherit;font-size:12pt;">. The following provisions shall supplement Section 4 of the RSU Agreement:</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Without limitation to Section 4 of the RSU Agreement, the Participant agrees that he or she is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company, the Service Recipient or by Her Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority). The Participant also agrees to indemnify and keep indemnified the Company and the Service Recipient against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC on the Participant&#8217;s behalf (or any other tax authority or any other relevant authority).</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Notwithstanding the foregoing, if the Participant is a director or executive officer (as within the meaning of Section 13(k) of the U.S. Securities Exchange Act of 1934, as amended), the terms of the immediately foregoing provision will not apply.&#160;In the event that the Participant is a director or executive officer and income tax due is not collected from or paid by the Participant within 90 days after the U.K. tax year in which an event giving rise to the indemnification described above occurs, the amount of any uncollected tax may constitute a benefit to the Participant on which additional income tax and national insurance contributions may be payable. The Participant acknowledges that the Participant ultimately will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for reimbursing the Company or the Service Recipient (as applicable) for the value of any employee national insurance contributions due on this additional benefit, which the Company and/or the Service Recipient may recover from the Participant at any time thereafter by any of the means referred to in Section 4 of the RSU Agreement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exclusion of Claim</font><font style="font-family:inherit;font-size:12pt;">. The Participant acknowledges and agrees that he or she will have no entitlement to compensation or damages insofar as such entitlement arises or may arise from the Participant ceasing to have rights under or to be entitled to the RSUs, whether or not as a result of the termination of the Participant&#8217;s service (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of the RSUs. Upon the grant of the RSU, the Participant will be deemed to have waived irrevocably any such entitlement.</font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Global Restricted Stock Unit Award Agreement </font></div><div style="line-height:120%;text-align:left;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>4
<FILENAME>ebs-20191231exhibit1011.htm
<DESCRIPTION>EXHIBIT 10.11
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s9C6F961F88B1317185CA3BA4D76F534B"></a></div><div><div style="line-height:138%;padding-top:17px;text-align:justify;padding-left:9px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Exhibit 10.11</font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Emergent BioSolutions Inc.</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Global Non-Qualified Stock Option Award Agreement</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;">1.</font></div></td><td style="vertical-align:top;padding-left:96px;"><div style="line-height:120%;text-align:justify;font-size:12pt;text-indent:-96px;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Grant of Option</font><font style="font-family:inherit;font-size:12pt;">. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Non-Qualified Stock Option Award Agreement evidences the grant by Emergent BioSolutions Inc., a Delaware corporation (the &#8220;Company&#8221;), to an employee of the Company (the &#8220;Participant&#8221;), of an option to purchase, in whole or in part, that number of shares (the &#8220;Shares&#8221;) of common stock, with a $0.001 par value per share, of the Company (&#8220;Common Stock&#8221;) set forth under the summary of the grant in the Participant&#8217;s account in the Company&#8217;s third-party electronic stock administrative platform (the &#8220;Grant Summary&#8221;) at the Grant Price identified on the Grant Summary (the &#8220;Option&#8221;), subject to the terms and conditions set forth in the Global Non-Qualified Stock Option Award Agreement, including any additional terms and conditions for the Participant&#8217;s country set forth in the addendum attached hereto (the &#8220;Addendum&#8221; and, collectively with the Global Non-Qualified Stock Option Award Agreement, the &#8220;Agreement&#8221;), and the Company&#8217;s Stock Incentive Plan, as amended (the &#8220;Plan&#8221;). Unless earlier terminated, this Option shall expire at 5:00 p.m., U.S. Eastern time, on the expiration date identified on the Grant Summary (the &#8220;Expiration Date&#8221;).</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Option shall not be an incentive stock option as defined in Section 422 of the U.S. Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the &#8220;Code&#8221;). Except as otherwise indicated by the context, the term &#8220;Participant&#8221;, as used in this Agreement, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;">2.</font></div></td><td style="vertical-align:top;padding-left:96px;"><div style="line-height:120%;text-align:justify;font-size:12pt;text-indent:-96px;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Vesting Schedule</font><font style="font-family:inherit;font-size:12pt;">. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Option shall vest in the aggregate in three (3) equal annual installments on the day immediately prior to each anniversary of the grant date identified in the Grant Summary, unless otherwise provided therein. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The right of exercise shall be cumulative so that to the extent the Option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Expiration Date or the termination of this Option under Section 3 of the Agreement or the Plan.</font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">3.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Continuous Relationship Requirement</font><font style="font-family:inherit;font-size:12pt;">. Except as otherwise provided in this Section 3, this Option may not be exercised unless the Participant, at the time he or she exercises this Option, is, and has been at all times since the grant date, an employee, officer or director of, or consultant or advisor to, the Company or any of its affiliates the employees, officers, directors, consultants, or advisors of which are eligible to receive option grants under the Plan (an &#8220;Eligible Participant&#8221;). </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Termination of Relationship</font><font style="font-family:inherit;font-size:12pt;">. If the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs&#160;(b) and (c) below, the right to exercise this Option shall terminate 90 days after such cessation (but in no event after the Expiration Date), </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">that</font><font style="font-family:inherit;font-size:12pt;">&#32;this Option shall be exercisable only to the extent that the Participant was entitled to exercise this Option on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the Expiration Date, violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this Option shall terminate immediately upon such violation. For purpose of this Agreement, the Participant&#8217;s service will be deemed to terminate as of the date the Participant is no longer actively providing services to the Company or any of its affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment or other laws in the jurisdiction where the Participant is employed or otherwise rendering services or the terms of the Participant&#8217;s employment or other service agreement, if any) and will not be extended by any notice period (e.g., the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment or other laws in the jurisdiction where the Participant is employed or otherwise rendering services or the terms of the Participant&#8217;s employment or other service agreement, if any). The Company shall have the exclusive discretion to determine when the Participant is no longer actively providing services for purposes of this Option grant (including whether the Participant may still be considered to be providing services while on a leave of absence).</font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Death or Disability</font><font style="font-family:inherit;font-size:12pt;">. If the Participant dies or becomes disabled as determined in good faith by the Company prior to the Expiration Date while he or she is an Eligible Participant and the Company has not terminated such relationship for &#8220;cause&#8221; as specified in paragraph (c) below, this Option shall be exercisable, within the period of one (1) year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">that</font><font style="font-family:inherit;font-size:12pt;">&#32;this Option shall be exercisable only to the extent that this Option was exercisable by the Participant on the date of his or her death or disability, and further provided that this Option shall not be exercisable after the Expiration Date.</font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Cause</font><font style="font-family:inherit;font-size:12pt;">. If, prior to the Expiration Date, the Participant&#8217;s employment or other relationship with the Company or any of its affiliates is terminated by the Company or any of its affiliates for Cause (as defined in the Plan), the right to exercise this Option shall terminate immediately upon the effective date of such termination of employment or other relationship. </font></div><div style="line-height:120%;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">4.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Form of Exercise</font><font style="font-family:inherit;font-size:12pt;">. Each election to exercise this option shall be in accordance with the Company&#8217;s policies and procedures. The Participant may purchase less than the number of Shares covered hereby, provided that no partial exercise of this option may be for any fractional Share. </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">5.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Method of Payment</font><font style="font-family:inherit;font-size:12pt;">. The exercise price and any Tax-Related Items (as defined in Section 6 of the Agreement) may be paid by the Participant by one of the following methods available under the Company&#8217;s exercise procedures, which may include: (i) payment by cash or check, (ii) payment by transfer to the Company of shares of Common Stock owned by the Participant having a fair market value at the time of exercise equal to the exercise price and any Tax-Related Items; (iii) a &#8220;same day sale&#8221; transaction pursuant to which a third party loans funds to the Participant to enable the Participant to purchase Shares and pay any Tax-Related Items, and then sells a sufficient number of Shares on the Participant&#8217;s behalf to repay the loan and fees; (iv) a &#8220;net exercise&#8221; transaction, pursuant to which the Company delivers to the Participant the net number of Shares remaining from the portion of the Option being exercised after deduction of a number of shares of Common Stock with a fair market value equal to the exercise price and any Tax-Related Items; or (v) any other method that is established by the Company from time to time. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Company may suspend, or eliminate, various forms of permissible payment of the exercise price from time to time in its sole discretion. Further, notwithstanding any provision within this Agreement to the contrary, if the Participant resides or provides services outside of the United States, the Company may require that the Participant (or in the event of the Participant&#8217;s death, the Participant&#8217;s authorized transferee, as the case may be) exercise the Option in a method other than as specified above, may require the Participant to exercise the Option only by means of a &#8220;same day sale&#8221; transaction (either a &#8220;sell-all&#8221; transaction or a &#8220;sell-to-cover&#8221; transaction) as it determines in its sole discretion, or may require the Participant to sell any Shares acquired under the Plan immediately or within a specified period following the Participant&#8217;s termination of service from the Company or any of its affiliates (in which case, the Participant hereby agrees that the Company shall have the authority to issue sale instructions in relation to such Shares on the Participant&#8217;s behalf).</font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">6.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Responsibility for Taxes</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;padding-left:9px;padding-bottom:16px;text-align:justify;text-indent:96px;"><font style="padding-bottom:16px;text-align:justify;font-family:inherit;font-size:12pt;padding-right:96px;">(a)</font><font style="font-family:inherit;font-size:12pt;">&#32;The Participant acknowledges that, regardless of any action taken by the Company or, if different, the affiliate for which the Participant provides services (the &#8220;Service Recipient&#8221;), the ultimate liability for all income tax, social insurance, payroll tax, fringe benefit tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;) is and remains the Participant&#8217;s responsibility and may exceed the amount actually withheld, if any, by the Company or the Service Recipient. The Participant further acknowledges that the Company and/or the Service Recipient (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this Option, including, but not limited to, the grant, vesting or exercise of this Option, the subsequent sale of Shares acquired upon the exercise of this Option and the receipt of any dividends; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of this Option to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and/or the Service Recipient (or former service recipient, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Prior to any relevant taxable or tax withholding event, as applicable, the Participant agrees to make adequate arrangements satisfactory to the Company and/or the Service Recipient to satisfy all Tax-Related Items. In this regard, the Participant authorizes the Company and/or the Service Recipient, or their respective agents, at their discretion, to satisfy any applicable withholding obligations with regard to all Tax-Related Items by one or a combination of the following: (i) withholding from the Participant&#8217;s wages or other compensation payable to the Participant by the Company or the Service Recipient, (ii) withholding from proceeds of the sale of Shares acquired upon exercise of this Option either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant&#8217;s behalf pursuant to this authorization without further consent), (iii) withholding from the Shares otherwise issuable at exercise of this Option, or (iv) any method determined by the Company to be in compliance with applicable laws.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Depending on the withholding method, the Company and/or Service Recipient may withhold or account for Tax-Related Items by considering statutory withholding rates or other applicable withholding rates, including maximum rates applicable in the Participant&#8217;s jurisdiction, in which case the Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the Common Stock equivalent. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant is deemed to have been issued the full number of Shares subject to the exercised Option, notwithstanding that a number of Shares is held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Finally, the Participant agrees to pay to the Company or the Service Recipient any amount of Tax-Related Items that the Company or the Service Recipient may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the underlying Shares or the proceeds from the sale of Shares acquired upon exercise of this Option, if the Participant fails to comply with his or her obligations in connection with the Tax-Related Items.</font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">7.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Non-Transferability of Option</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, shall be exercisable only by the Participant; provided, however, that if permitted by the Company and valid under applicable law, the gratuitous transfer of this Option by the Participant to or for the benefit of any immediate family member, domestic partner, family trust or other entity established for the benefit of the Participant and/or an immediate family member thereof if, with respect to such proposed transferee, the Company would be eligible to use a Registration Statement on Form S-8 for the registration of the sale of the Common Stock subject to such Option under the U.S. Securities Act of 1933, as amended; provided, further, that the Company shall not be required to recognize any such transfer until such time as the Participant and such authorized transferee shall, as a condition to such transfer, deliver to the Company a written instrument in form and substance satisfactory to the Company confirming that such transferee shall be bound by all of the terms and conditions of the Option.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">8.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Nature of Grant</font><font style="font-family:inherit;font-size:12pt;">. In accepting this option, the Participant acknowledges and agrees that:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the Plan is established voluntarily by the Company, it is discretionary in nature, and may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted under the Plan;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the grant of this Option is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of stock options, or benefits in lieu of stock options, even if stock options have been granted in the past;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">all decisions with respect to future stock options, if any, will be at the sole discretion of the Company;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(d)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the grant of this Option and the Participant&#8217;s participation in the Plan shall not create a right to employment or be interpreted as forming a service relationship with the Company or any of its affiliates and shall not interfere with the ability of the Service Recipient to terminate the Participant&#8217;s service relationship (if any);</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(e)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the Participant is voluntarily participating in the Plan;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(f)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">this Option and any Shares acquired under the Plan, and the income from and value of the same, are not intended to replace any pension rights or compensation;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(g)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">this Option and any Shares acquired under the Plan, and the income from and value of the same, are not part of normal or expected compensation for any purpose, including, without limitation, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(h)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the future value of the Shares underlying this Option is unknown, indeterminable, and cannot be predicted with certainty;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(i)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">if the Shares underlying this Option do not increase in value, this Option will have no value;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(j)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">if the Participant exercises this Option and acquires Shares, the value of such Shares may increase or decrease, even below the Option exercise price;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(k)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">no claim or entitlement to compensation or damages shall arise from the forfeiture of this Option resulting from the Participant ceasing to be an Eligible Participant (for any reason whatsoever, whether or not later found to be invalid or in breach of employment or other laws in the jurisdiction where the Participant is employed or otherwise rendering services or the terms of the Participant&#8217;s employment or other service agreement, if any);</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(l)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">unless otherwise agreed to by the Company, this Option and any Shares acquired under the Plan, and the income from and value of the same, are not granted as consideration for, or in connection with, the service the Participant may provide as a director of any of the Company&#8217;s affiliates; </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(m)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">unless otherwise provided in the Plan or by the Company in its discretion, this Option and the benefits evidenced by this Agreement do not create any entitlement to have this Option or any such benefits transferred to, or assumed by, another company, nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the Common Stock; and</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(n)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">neither the Company, the Service Recipient nor any other affiliate of the Company shall be liable for any foreign exchange rate fluctuation between the Participant&#8217;s local currency and the United States Dollar that may affect the value of this Option or of any amounts due to the Participant pursuant to the exercise of this Option or the subsequent sale of Shares acquired upon exercise.</font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">9.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">No Advice Regarding Grant</font><font style="font-family:inherit;font-size:12pt;">. The Company is not providing any tax, legal or financial advice, nor is the Company making recommendations regarding the Participant&#8217;s participation in the Plan, or the Participant&#8217;s acquisition or sale of Shares acquired upon exercise. The Participant should consult with his or her own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">10.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Data Privacy</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant&#8217;s personal data as described in any Option award grant materials by and among, as applicable, the Service Recipient, the Company, and any of its affiliates for the exclusive purpose of implementing, administering and managing the Participant&#8217;s participation in the Plan.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">The Participant understands that the Company and the Service Recipient may hold certain personal information about the Participant, including but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance, passport or other identification number (e.g., resident registration number), salary, nationality, job title, any Shares or directorships held in the Company, details of all awards or any other entitlement to Shares awarded, cancelled, exercised, vested, unvested or outstanding in the Participant&#8217;s favor (&#8220;Data&#8221;), for the exclusive purpose of implementing, administering and managing the Plan. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">The Participant understands that Data will be transferred to the Company&#8217;s designated broker and/or stock plan service provider that is assisting the Company (presently or in the future) with the implementation, administration and management of the Plan. The Participant understands that the recipients of Data may be located in the United States or elsewhere, and that the recipients&#8217; country (e.g., the United States) may have different data privacy laws and protections than the Participant&#8217;s country. The Participant understands that he or she may request a list with the names and addresses of any potential recipients of the Data by contacting the Ethics and Compliance Officer at </font><a style="font-family:inherit;font-size:12pt;color:#0000ff;font-style:italic;font-weight:bold;text-decoration:underline;" href="#"><font style="font-family:inherit;font-size:12pt;color:#0000ff;font-style:italic;font-weight:bold;text-decoration:underline;">Complianceofficer@ebsi.com. </font></a></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">The Participant authorizes the Company, the Service Recipient and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing the Participant&#8217;s participation in the Plan. The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan. The Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting </font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">the Ethics and Compliance Officer at </font><a style="font-family:inherit;font-size:12pt;color:#0000ff;font-style:italic;font-weight:bold;text-decoration:underline;" href="#"><font style="font-family:inherit;font-size:12pt;color:#0000ff;font-style:italic;font-weight:bold;text-decoration:underline;">Complianceofficer@ebsi.com. </font></a></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:9px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Further, the Participant understands that he or she is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s employment or service status with the Service Recipient will not be affected. The only consequence of refusing or withdrawing consent is that the Company would not be able to grant stock options or other equity awards to the Participant or administer or maintain such awards. Therefore, the Participant understands that refusing or withdrawing the Participant&#8217;s consent may affect the Participant&#8217;s ability to participate in the Plan. For more information on the consequences of the Participant&#8217;s refusal to consent or withdrawal of consent, the Participant understands that he or she may contact</font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">&#32;the Ethics and Compliance Officer at </font><a style="font-family:inherit;font-size:12pt;color:#0000ff;font-style:italic;font-weight:bold;text-decoration:underline;" href="#"><font style="font-family:inherit;font-size:12pt;color:#0000ff;font-style:italic;font-weight:bold;text-decoration:underline;">Complianceofficer@ebsi.com. </font></a></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">11.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Not a Public Offering</font><font style="font-family:inherit;font-size:12pt;">. If the Participant resides outside of the United States, the grant of the Option is not intended to be a public offering of securities in his or her country of residence (or country of service, if different). The Company has not submitted any registration statement, prospectus or other filings with the local securities authorities (unless otherwise required under local law), and the grant of the Option is not subject to the supervision of the local securities authorities.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">12.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Insider Trading Restrictions / Market Abuse Laws</font><font style="font-family:inherit;font-size:12pt;">. The Participant understands that he or she is subject to the Company&#8217;s Insider Trading Policy and may be subject to various insider trading restrictions and/or market abuse laws in applicable jurisdictions, including but not limited to the U.S., the Participant&#8217;s country and the broker&#8217;s country, which affect the Participant&#8217;s ability, directly or indirectly, to purchase or sell or attempt to sell or otherwise dispose of Shares issuable upon the exercise of this Option or any other securities of the Company while in possession  of material non-public or &#8220;inside information&#8221; regarding the Company (as defined by the laws in the applicable jurisdiction(s)). The Company&#8217; Insider Trading Policy as well as local insider trading laws and regulations prohibit the cancellation or amendment of orders by the Participant while in possession of inside information. Furthermore, the Participant understands that he or she is prohibited from (i) disclosing inside information to any third party, including fellow employees (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties by sharing with them Company inside information, or otherwise causing third parties to buy or sell Company securities on the basis of inside information. Any restrictions under laws or regulations are separate from and in addition to any restrictions imposed under the Company&#8217;s Insider Trading Policy. It is the Participant&#8217;s responsibility to comply with any applicable restrictions and the Participant should consult with his or her personal legal advisor on this matter. </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">13.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Foreign Asset / Account Reporting Requirements</font><font style="font-family:inherit;font-size:12pt;">. The Participant acknowledges that there may be certain foreign asset and/or account reporting requirements which may affect the Participant&#8217;s ability to acquire or hold Shares or cash received from participating in the Plan (including from any dividends paid on Shares) in a brokerage or bank account outside the Participant&#8217;s country. The Participant may be required to report such accounts, assets, or related transactions to the tax or other authorities in the Participant&#8217;s country. The Participant may also be required to repatriate sale proceeds or other funds received as a result of the Participant&#8217;s participation in the Plan to the Participant&#8217;s country within a certain time after receipt. The Participant acknowledges that it is the Participant&#8217;s responsibility to comply with such regulations and that the Participant should speak with a personal legal advisor on this matter.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">14.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Electronic Delivery and Acceptance</font><font style="font-family:inherit;font-size:12pt;">. The Company may, in its sole discretion, decide to deliver documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">15.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Language</font><font style="font-family:inherit;font-size:12pt;">. The Participant acknowledges that he or she is sufficiently proficient in English or has consulted with an advisor who is sufficiently proficient in English so as to allow the Participant to understand the terms and conditions of this Agreement. If the Participant has received this Agreement or any other document(s) related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">16.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Addendum</font><font style="font-family:inherit;font-size:12pt;">. Notwithstanding any provisions in this Global Non-Qualified Stock Option Agreement, this Option shall be subject to any additional terms and conditions for the Participant&#8217;s country set forth in the Addendum attached hereto. Moreover, if the Participant relocates to one of the countries included in the Addendum, the special terms and conditions for such country will apply to the Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. The Addendum constitutes part of this Agreement. </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">17.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Imposition of Other Requirements</font><font style="font-family:inherit;font-size:12pt;">. The Company reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on this Option and on any Shares acquired upon exercise of this Option, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">18.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Governing Plan Document</font><font style="font-family:inherit;font-size:12pt;">. The Option is subject to the Grant Summary, this Agreement and all the provisions of the Plan, the provisions of which are hereby made a part of this Agreement, and is further subject to all interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan. In the event of any conflict between the provisions of the Grant Summary, this Agreement and those of the Plan, the provisions of the Plan shall control. </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">19.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Entire Agreement</font><font style="font-family:inherit;font-size:12pt;">.  These terms and the Plan constitute the entire agreement between the parties, and supersede all prior agreements and understandings, relating to the subject matter of this Option award; provided that any separate employment, consulting, or severance plan or agreement between the Company and the Participant that includes terms relating to the acceleration of vesting of equity awards shall not be superseded by these terms.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">20.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Governing Law</font><font style="font-family:inherit;font-size:12pt;">. This Option award shall be construed, interpreted and enforced in accordance with the internal laws of the State of Delaware in the United States of America without regard to any applicable conflict of law principles.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">21.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Interpretation</font><font style="font-family:inherit;font-size:12pt;">. The interpretation and construction of any terms or conditions of the Plan or this Option award by the Compensation Committee shall be final and conclusive.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">22.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Severability</font><font style="font-family:inherit;font-size:12pt;">. If any provision of this Agreement is held to be unenforceable for any reason, it shall be adjusted rather than voided, if possible, in order to achieve the intent of the parties to the extent possible. In any event, all other provisions of this Agreement shall be deemed valid and enforceable to the full extent possible.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:0px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:24px;">23.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Waiver</font><font style="font-family:inherit;font-size:12pt;">. The waiver by the Company with respect to the Participant (or any other participant&#8217;s) compliance of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by such party of a provision of this Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ADDENDUM <br>TO THE GLOBAL NON-QUALIFIED STOCK OPTION AGREEMENT</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:6px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Capitalized terms, unless explicitly defined in this Addendum, shall have the meanings given to them in the Global Non-Qualified Stock Option Agreement (the &#8220;Agreement&#8221;) or in the Plan.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:6px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Addendum includes additional terms and conditions that govern the Participant&#8217;s Option if the Participant resides and/or works in one of the countries listed below. If the Participant is a citizen or resident (or is considered as such for local law purposes) of a country other than the country in which the Participant is currently residing and/or working, or if the Participant transfers to another country after the grant of this Option, the Company shall, in its discretion, determine to what extent the additional terms and conditions contained herein shall be applicable to the Participant.</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">EUROPEAN UNION / EUROPEAN ECONOMIC AREA </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Data Privacy</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Company, with its registered address at 400 Professional Drive, Gaithersburg, Maryland, 20879 U.S.A. is the controller responsible for the processing of the Participant&#8217;s personal data by the Company and the third parties noted below.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:29px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Data Collection and Usage</font><font style="font-family:inherit;font-size:12pt;">. Pursuant to applicable data protection laws, the Participant is hereby notified that the Company collects, processes and uses certain personal information about the Participant for the legitimate purpose of implementing, administering and managing the Plan and generally administering awards, which may specifically include: the Participant&#8217;s name, home address, email address and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any shares or directorships held in the Company, and details of all stock options, any entitlement to shares of Common Stock awarded, canceled, exercised, vested, or outstanding in the Participant&#8217;s favor, which the Company receives from the Participant or the Service Recipient (&#8220;Personal Data&#8221;). In granting the Option under the Plan, the Company will collect, process, use, disclose and transfer (collectively, &#8220;Processing&#8221;) Personal Data for purposes of implementing, administering and managing the Plan. The Company&#8217;s legal basis for the Processing of Personal Data is the Company&#8217;s legitimate business interests of managing the Plan, administering employee awards and complying with its contractual and statutory obligations, as well as the necessity of the Processing for the Company to perform its contractual obligations under the Agreement and the Plan. The Participant&#8217;s refusal to provide Personal Data would make it impossible for the Company to perform its contractual obligations and may affect the Participant&#8217;s ability to participate in the Plan. As such, by accepting the Option, the Participant voluntarily acknowledges the Processing of Personal Data as described herein. </font></div><div style="line-height:120%;text-align:justify;padding-left:29px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Stock Plan Administration Service Provider</font><font style="font-family:inherit;font-size:12pt;">. The Company may transfer Personal Data to the Company&#8217;s designated broker and/or stock plan service provider which may assist the Company with the implementation, administration and management of the Plan. In the future, the Company may select a different service provider and share Personal Data with another company that serves in a similar manner. The Company&#8217;s service provider will open an account for the Participant to receive and trade Shares pursuant to the Option. The Processing of Personal Data will take place through both electronic and non-electronic means. Personal Data will only be accessible by those individuals requiring access to it for purposes of implementing, administering and operating the Plan. When receiving Personal Data, if applicable, the service provider provides appropriate safeguards in accordance with the EU Standard Contractual Clauses or other appropriate cross-border transfer solutions. By participating in the Plan, the Participant understands that the service provider will Process the Participant's Personal Data for the purposes of implementing, administering and managing the Participant&#8217;s participation in the Plan. </font></div><div style="line-height:120%;text-align:justify;padding-left:30px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">International Data Transfers</font><font style="font-family:inherit;font-size:12pt;">. The Company is based in the United States, which means it will be necessary for Personal Data to be transferred to, and Processed in the United States. When transferring Personal Data to the United States, the Company provides appropriate safeguards in accordance with the EU Standard Contractual Clauses, and other appropriate cross-border transfer solutions. The Participant may request a copy of the appropriate safeguards with the designated broker and/or stock plan administrator or the Company by contacting the Ethics and Compliance Officer at </font><a style="font-family:inherit;font-size:11pt;" href="#"><font style="font-family:inherit;font-size:11pt;">Complianceofficer@ebsi.com. </font></a></div><div style="line-height:120%;text-align:justify;padding-left:30px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(d)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Data Retention</font><font style="font-family:inherit;font-size:12pt;">. The Company will use Personal Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan or as required to comply with legal or regulatory obligations, including tax and securities laws. When the Company no longer needs Personal Data related to the Plan, the Company will remove it from its systems. If the Company keeps Personal Data longer, it would be to satisfy legal or regulatory obligations and the Company&#8217;s legal basis would be for compliance with relevant laws or regulations.</font></div><div style="line-height:120%;text-align:justify;padding-left:30px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:12pt;"><font style="font-family:inherit;font-size:11pt;">(e)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Data Subject Rights</font><font style="font-family:inherit;font-size:12pt;">.</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:12pt;">To the extent provided by law, the Participant has the right to subject to certain exceptions: (1) request access or copies of Personal Data the Company Processes, (ii)&#160;request rectification of incorrect Personal Data, (iii)&#160;request deletion of Personal Data, (iv)&#160;place restrictions on Processing of Personal Data, (v)&#160;lodge complaints with competent authorities in the Participant&#8217;s country, and/or (vi) request a list with the names and addresses of any potential recipients of Personal Data. To receive clarification regarding the Participant&#8217;s rights or to exercise his or her rights, the Participant may contact the Ethics and Compliance Officer at </font><a style="font-family:inherit;font-size:11pt;" href="#"><font style="font-family:inherit;font-size:11pt;">Complianceofficer@ebsi.com. </font></a><font style="font-family:inherit;font-size:12pt;">The Participant also has the right to object, on grounds related to a particular situation, to the Processing of Personal Data, as well as opt-out of the Plan herein, in any case without cost. The Participant&#8217;s provision of Personal Data is a contractual requirement. The Participant understands, however, that the only consequence of refusing to provide Personal Data is that the Company may not be able to administer the Option, or grant other awards or administer or maintain such awards. </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">CANADA</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Method of Payment</font><font style="font-family:inherit;font-size:12pt;">. Notwithstanding any terms and conditions in this Agreement or the Plan to the contrary, the Participant is prohibited from surrendering Shares that he or she already owns to pay the Option exercise price or any Tax-Related Items in connection with the exercise of the Option. The Company reserves the right to permit this method of payment depending upon the development of local law. </font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Securities Law Information</font><font style="font-family:inherit;font-size:12pt;">. The Participant is permitted to sell Shares acquired under the Plan through the designated broker, provided the resale of such Shares takes place outside Canada through the facilities of a stock exchange on which the Shares are listed (</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">i.e.</font><font style="font-family:inherit;font-size:12pt;">, the New York Stock Exchange). </font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">The following provisions apply if the Participant is a resident of Quebec:</font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Data Privacy</font><font style="font-family:inherit;font-size:12pt;">. The following supplements Section 10 to the Agreement: </font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Participant hereby authorizes the Company and the Company&#8217;s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan. The Participant further authorizes the Company or any of its affiliates and the administrator of the Plan to disclose and discuss the Plan with their advisors. The Participant further authorizes the Company or any of its affiliates to record such information and to keep such information in the Participant&#8217;s employee file.</font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Language Consent</font><font style="font-family:inherit;font-size:12pt;">. The parties acknowledge that it is their express wish that the Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.</font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">Les parties reconnaissent avoir exig&#233; la r&#233;daction en anglais de cette convention, ainsi que de tous documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaries intent&#233;es, directement ou indirectement, relativement &#224; ou suite &#224; la pr&#233;sente convention.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">GERMANY</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">No country-specific provisions. </font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">IRELAND</font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">No country-specific provisions. </font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">ITALY</font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">No country-specific provisions.</font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">SINGAPORE</font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Securities Law Information</font><font style="font-family:inherit;font-size:12pt;">. The grant of the Option under the Plan is being made pursuant to the &#8220;Qualifying Person&#8221; exemption under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;SFA&#8221;). The Plan has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore and is not regulated by any financial supervisory authority pursuant to any legislation in Singapore. Accordingly, statutory liability under the SFA in relation to the content of prospectuses would not apply. The Participant should note that the Option is subject to section 257 of the SFA and the Participant will not be able to make any subsequent sale of the Shares in Singapore, or any offer of such subsequent sale of the Shares subject to the Option in Singapore, unless such sale or offer is made (i) after six (6) months from the date of grant or (ii) pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA.</font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">SPAIN</font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Employment Law Acknowledgment</font><font style="font-family:inherit;font-size:12pt;">. In accepting this Option, the Participant acknowledges that he or she consents to participation in the Plan and has received a copy of the Plan. Further, the Participant understands that the Company, in its sole discretion, has unilaterally and gratuitously decided to grant options under the Plan to individuals who may be employees of the Company or any of its affiliates throughout the world.  The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not bind the Company or any of its affiliate except to the extent set forth in this Agreement.  Consequently, the Participant understands that the Option is granted on the assumption and condition that such Option and any Shares acquired upon exercise of the Option shall not become a part of any employment contract (either with the Company or any of its affiliate) and shall not be considered a mandatory benefit, or salary for any purposes (including severance compensation) or any other right whatsoever.</font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Further, as a condition of the grant of the Option, unless otherwise expressly provided for by the Company or set forth in this Agreement, the Option will be cancelled without entitlement to any Shares if the Participant&#8217;s service terminates by reason of, including, but not limited to: resignation, retirement, disciplinary dismissal adjudged to be with cause, disciplinary dismissal adjudged or recognized to be without cause (i.e., subject to a &#8220;despido improcedente&#8221;), material modification of the terms of employment under Article 41 of the Workers&#8217; Statute, relocation under Article 40 of the Workers&#8217; Statute, Article 50 of the Workers&#8217; Statute, or under Article 10.3 of Royal Decree 1382/1985.  The Company, in its sole discretion, shall determine the date when the Participant&#8217;s service has terminated for purposes of the Option.</font></div><div style="line-height:120%;padding-top:17px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Participant understands that the Option would not be granted but for the assumptions and conditions referred to above; thus, the Participant acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of, or right to, the Option shall be null and void.</font></div><div style="line-height:120%;padding-top:17px;text-align:justify;padding-left:9px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">SWITZERLAND</font></div><div style="line-height:120%;padding-top:17px;text-align:justify;padding-left:9px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Securities Law Information</font><font style="font-family:inherit;font-size:12pt;">. The grant of the Option and issuance of Shares is considered a private offering in Switzerland. Neither this document nor any other materials relating to the Option constitute a prospectus as such term is understood pursuant to article 652a of the Swiss Code of Obligations, and neither this document nor any other materials relating to the Option may be publicly available in Switzerland. Neither this document nor any other offering or marketing materials relating to the Option have been or will be filed with, approved or supervised by any Swiss regulatory authority (in particular, the Swiss Financial Market Supervisory Authority (FINMA)).</font></div><div style="line-height:120%;padding-top:17px;text-align:justify;padding-left:9px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">UNITED KINGDOM</font></div><div style="line-height:120%;padding-top:17px;text-align:justify;padding-left:9px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Responsibility for Taxes</font><font style="font-family:inherit;font-size:12pt;">. The following provisions shall supplement Section 6 of the Agreement:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:17px;text-align:justify;padding-left:9px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Without limitation to Section 6 of the Agreement, the Participant agrees that he or she is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company, the Service Recipient or by Her Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority). The Participant also agrees to indemnify and keep indemnified the Company and the Service Recipient against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC on the Participant&#8217;s behalf (or any other tax authority or any other relevant authority).</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:17px;text-align:justify;padding-left:9px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Notwithstanding the foregoing, if the Participant is a director or executive officer (as within the meaning of Section 13(k) of the U.S. Securities Exchange Act of 1934, as amended), the terms of the immediately foregoing provision will not apply.&#160;In the event that the Participant is a director or executive officer and income tax due is not collected from or paid by the Participant within 90 days after the U.K. tax year in which an event giving rise to the indemnification described above occurs, the amount of any uncollected tax may constitute a benefit to the Participant on which additional income tax and national insurance contributions may be payable. The Participant acknowledges that the Participant ultimately will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for reimbursing the Company or the Service Recipient (as applicable) for the value of any employee national insurance contributions due on this additional benefit, which the Company and/or the Service Recipient may recover from the Participant at any time thereafter by any of the means referred to in Section 6 of the Agreement. </font></div><div style="line-height:120%;padding-top:17px;text-align:justify;padding-left:9px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exclusion of Claim</font><font style="font-family:inherit;font-size:12pt;">. The Participant acknowledges and agrees that he or she will have no entitlement to compensation or damages insofar as such entitlement arises or may arise from the Participant ceasing to have rights under or to be entitled to the Option, whether or not as a result of the termination of the Participant&#8217;s service (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of the Option. Upon the grant of the Option, the Participant will be deemed to have waived irrevocably any such entitlement.</font></div><div><br></div><div><div style="line-height:138%;padding-top:17px;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Global Non-Qualified Stock Option Award Agreement</font></div><div style="line-height:138%;padding-top:17px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.39
<SEQUENCE>5
<FILENAME>ebs20191231exhibit1039.htm
<DESCRIPTION>EXHIBIT 10.39
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ebs20191231exhibit1039</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ebs20191231exhibit1039001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1039001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely                  cause competitive harm to the Company, if publicly disclosed.  Double asterisks denote omissions.                                                                                                                                                             Exhibit 10.39__  AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT                                                             1. CONTRACT ID CODE                       PAGE OF PAGES                                                                                                                                                                                                                                                                              1             2  2. AMENDMENT/MODIFICATION NO.                      3.    EFFECTIVE DATE                  4. REQUISITION/PURCHASE REQ. NO.                   5. PROJECT NO. (If applicable)  P00018                                                   09/11/2019                      OS246121   6. ISSUED BY                        CODE           ASPR-BARDA                            7. ADMINISTERED BY (If other than Item 6)    CODE              ASPR-BARDA02   ASPR-BARDA                                                                               US DEPT OF HEALTH &amp; HUMAN SERVICES  200 Independence Ave., S.W.                                                              ASST SEC OF PREPAREDNESS &amp; RESPONSE  Room 640-G                                                                               ACQ MANAGEMENT, CONTRACTS, &amp; GRANTS  Washington DC 20201                                                                      O&#8217;NEILL HOUSE OFFICE BUILDING                                                                                           Washington DC 20515  8.    NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)                                 (x)    9A. AMENDMENT OF SOLICITATION NO.  EMERGENT BIODEFENSE OPERATIONS LANSING LLC 330303                                                                       Attn:  DIANA  EMERGENT BIODEFENSE OPERATIONS LANS                                                                                   9B. DATED (SEE ITEM 11)  3500 N MARTIN LUTHER KING JR BLVD                                                                                       LANSING MI 489062933                                                                                                                  x     10A. MODIFICATION OF CONTRACT/ORDER NO.                                                                                                                        HHSD200201792634C                                                                                                                        10B. DATED (SEE ITEM 13)  CODE    330303                                     FACILITY CODE                                                      12/08/2016                                               11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS         The above numbered solicitation is amended as set forth in Item 14.  The hour and date specified for receipt of Offers          is extended,       is not extended.  Offers  must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods: (a) By completing Items  8 and 15, and returning _________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the                               offer submitted; or   (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers.  FAILURE OF YOUR ACKNOWLEDGMENT TO  BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR  OFFER.  If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each  letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.  12. ACCOUNTING AND APPROPRIATION DATA (If required)     See Schedule                                          13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.                                                IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.   CHECK ONE                   A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT                     ORDER NO. IN ITEM 10A.                   B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office,                     appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).                   C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:                                 D. OTHER (Specify type of modification and authority)                E. IMPORTANT:  Contractor                 is not,      is required to sign this document and return ________ copies to the issuing office.  14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)  Tax ID Number: [**]  DUNS Number: [**]  The purpose of this no-cost, administrative modification is to move $[**] from CAN  199SNS1 to CAN 1991029 as indicated in the accounting information below. This does not  have any effect on overall contract funding for Item 3, which remains $[**].  Delivery Location Code: HHS  HHS  200 Independence Avenue, SW  Washington DC 20201 US  FOB: Origin  Continued ...&#8230;   Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.  15A. NAME AND TITLE OF SIGNER (Type or print)                                            16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)  .                                                                                        Caleb W. Owen  15B. CONTRACTOR/OFFEROR                                       15C. DATE                  16B. UNITED STATES OF AMERICA                                  16C. DATE SIGNED                                                                                                                                           Digitally signed by Caleb W. Owen -S                                                                SIGNED                     /s/ Caleb W. Owen                               DN: c-US, o-U.S. Government,  ou-HHS, ou-OS, ou-People,                                                                                                                                           cn=Caleb W. Owen -S, 0.9.2342.19200300.100.1.1=1001618335                                                                                                                                           Date: 2019.09.11 16:49:45 -04&#8217;00&#8217;           (Signature of person authorized to sign)                                                    (Signature of Contracting Officer)                               </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1039002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1039002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">                                                                                                         STANDARD FORM 30 (Rev. 11/2016)  Previous edition unusable                                                                      Prescribed by GSA                                                                                                 FAR (48 CFR) 53.243     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1039003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1039003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">     CONTINUATION   REFERENCE NO. OF DOCUMENT BEING CONTINUED                              PAGE OF        SHEET                  HHSD200201792634C/P00018                                               2         2   NAME OF OFFEROR OR CONTRACTOR   EMERGENT BIODEFENSE OPERATIONS LANSING LLC 330303                                                                                           UNIT      ITEM No.                     SUPPLIES/SERVICES                   QUANTITY   UNIT    PRICE        AMOUNT        (A)                               (B)                             (C)      (D)      (E)          (F)                  Period of Performance: 01/19/2017 to 09/30/2021                                                           Change Item 3 to read as follows (amount shown is                                                                                                                            the obligated amount):         3        Optional Line Item 0003                                                                [**]                  BioThrax [**] product                  [**] upon date of delivery:                  [**] at a unit price of $[**]                  Quantity [**]                  Unit Price: $[**]                  Total value: $[**]                  Total dollar value ordered under item 3 is increased by                  $[**] from $[**] to $[**]                  Delivery Address: Contractor&#8217;s Facility                   Delivery is estimated to occur by NLT [**]                  Amount: $[**]                  Accounting Info:                   2019.1990050.26402 Appr. Yr.: 2019 CAN: 1990050                  Object Class: 26402                  Funded: $[**]                  Amount: $[**]                  Accounting Info:                   Object Class: 26402 2019.1990050.26402 Appr. Yr.:                  2019 CAN: 1990050                  Funded: $[**]                  Amount: $[**]                  Accounting Info:                   Object Class: 26402 2019.199SNS1.26402 Appr. Yr.:                  2019 CAN: 199SNS1                  Funded: [**]                  Amount: $[**]                  Accounting Info:                   2019.1991029.26402 Appr. Yr.: 2019 CAN: 1991029                  Object Class: 26402                  Funded: $[**]                                                        NSN 7540-01-152-8067                                                                      OPTIONAL FORM 336 (4-86)                                                                                            Sponsored by GSA                                                                                            FAR (48 CFR) 53.110     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.40
<SEQUENCE>6
<FILENAME>ebs20191231exhibit1040.htm
<DESCRIPTION>EXHIBIT 10.40
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ebs20191231exhibit1040</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ebs20191231exhibit1040001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1040001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely                   cause competitive harm to the Company, if publicly disclosed.  Double asterisks denote omissions.                                                                                                                                                                Exhibit 10.40_   AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT                                                             1. CONTRACT ID CODE                       PAGE OF PAGES                                                                                                                                                                                                                                                                                1             2   2. AMENDMENT/MODIFICATION NO.                      3.    EFFECTIVE DATE                  4. REQUISITION/PURCHASE REQ. NO.                   5. PROJECT NO. (If applicable)   P00019                                                   See Block 16C                   OS251972    6. ISSUED BY                        CODE           ASPR/SNS                              7. ADMINISTERED BY (If other than Item 6)    CODE              ASPR/SNS    ASPR/SNS                                                                                 US DEPT OF HEALTH &amp; HUMAN SERVICES   ASPR/SNS                                                                                 ASPR/SNS   2945 Flowers Road                                                                        2945 Flowers Road   ATLANTA, GA 30341                                                                        ATLANTA, GA 30341                                                                                               8.    NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)                                 (x)    9A. AMENDMENT OF SOLICITATION NO.   EMERGENT BIODEFENSE OPERATIONS LANSING LLC 330303                                                                        Attn:  DIANA   EMERGENT BIODEFENSE OPERATIONS LANS                                                                                   9B. DATED (SEE ITEM 11)   3500 N MARTIN LUTHER KING JR BLVD                                                                                        LANSING MI 489062933                                                                                                                   x     10A. MODIFICATION OF CONTRACT/ORDER NO.                                                                                                                         HHSD200201792634C                                                                                                                         10B. DATED (SEE ITEM 13)   CODE    330303                                     FACILITY CODE                                                      12/08/2016                                                11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS          The above numbered solicitation is amended as set forth in Item 14.  The hour and date specified for receipt of Offers          is extended,       is not extended.  Offers   must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods: (a) By completing Items   8 and 15, and returning _________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the                               offer submitted; or    (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers.  FAILURE OF YOUR ACKNOWLEDGMENT TO   BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR   OFFER.  If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each   letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.    12. ACCOUNTING AND APPROPRIATION DATA (If required)                                 Net Increase:                                               $[**]   2020.199SN20.26088                                           13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.                                                 IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.    CHECK ONE                    A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT                      ORDER NO. IN ITEM 10A.                    B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office,                      appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).                    C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:                                  FAR. 52.217-7, Option for Increased Quantity-Separately Price Line Item                    D. OTHER (Specify type of modification and authority)                                      E. IMPORTANT:  Contractor                 is not,      is required to sign this document and return ____1____ copies to the issuing office.   14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)   Tax ID Number: [**]   DUNS Number: [**]   This modification is issued to:   1.  Order an increased quantity of [**] doses of Bio Thrax [**] product at unit price   of $[**] per dose for a total costs of $[**].   2.  Accordingly, total contract value is hereby increased from $[**] by   $[**] to $[**]   Continued &#8230;   Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.   15A. NAME AND TITLE OF SIGNER (Type or print).                                           16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)   Michael Mann Sr. Man, Contract Ops                                                       ANNETTE R. WRIGHT   15B. CONTRACTOR/OFFEROR                                       15C. DATE                  16B. UNITED STATES OF AMERICA                                  16C. DATE SIGNED                                                                 SIGNED                     /s/ Annette Wright         Digitally signed by Annette Wright-S                                                                                                                        Date: 2020.01.06 16:12:28 -05&#8217;00&#8217;                                                                 30 DEC 19                                                                               /s/ J. Michael Mann II                                                                               (Signature of Contracting Officer)            (Signature of person authorized to sign)                                                                                                                                      STANDARD FORM 30 (Rev. 11/2016)    SWDocID </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1040002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1040002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Previous edition unusable                                                                     Prescribed by GSA                                                                                                FAR (48 CFR) 53.243     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1040003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1040003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">     CONTINUATION   REFERENCE NO. OF DOCUMENT BEING CONTINUED                              PAGE OF        SHEET                  HHSD200201792634C/P00019                                               2         2   NAME OF OFFEROR OR CONTRACTOR   EMERGENT BIODEFENSE OPERATIONS LANSING LLC 330303                                                                                           UNIT      ITEM No.                     SUPPLIES/SERVICES                   QUANTITY   UNIT    PRICE        AMOUNT        (A)                               (B)                             (C)      (D)      (E)          (F)                  Appr . Yr.: 2020 CAN: 199SN20 Object Class: 26088                                                  Period of Performance: 01/19/2017 to 09/30/2021                                                                                                                     Add Item 4 as follows:                                                                                                                     ASPR-20-00467 AVA Purchase 2018 Modification         4        request to add funding to purchase AVA SNS funds     [**]       EA     [**]      [**]                  Emergent Contract 200-2017-92634 CLIN 0004                  Deliver to Contractor's Facility on [**] Obligated                  Amount: $[**]                   FOB: Origin                   Appr.Yr.: 2019 CAN: 199SN20, Object Class                  Code:26088                   [**] upon date of delivery: [**] at a unit price of $[**].                   Delivery Address: Contractor's Facility                   Delivery is estimated to occur by NLT [**]                   Period of Performance: October 1, 2019- September                  30, 2020                   Vendor agrees to maintain this product up to [**] after                  delivery and acceptance at no charge to the                  Government.                   Title to product and risk of loss transfers to USG at                  point of delivery, Contractor's facility                   Obligation Amount: $[**]                   Requisition No.: OS251972                                                            NSN 7540-01-152-8067                                                                      OPTIONAL FORM 336 (4-86)                                                                                            Sponsored by GSA                                                                                            FAR (48 CFR) 53.110     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.41
<SEQUENCE>7
<FILENAME>ebs20191231exhibit1041.htm
<DESCRIPTION>EXHIBIT 10.41
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ebs20191231exhibit1041</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ebs20191231exhibit1041001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1041001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely                  cause competitive harm to the Company, if publicly disclosed.  Double asterisks denote omissions.                                                                                                                                                             Exhibit 10.41__  AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT                                                             1. CONTRACT ID CODE                       PAGE OF PAGES                                                                                                                                                                                                                                                                              1             2  2. AMENDMENT/MODIFICATION NO.                      3.    EFFECTIVE DATE                  4. REQUISITION/PURCHASE REQ. NO.                   5. PROJECT NO. (If applicable)  P00020                                                   See Block 16C                      6. ISSUED BY                        CODE           ASPR/SNS                              7. ADMINISTERED BY (If other than Item 6)    CODE              ASPR-/ SNS   ASPR/SNS                                                                                 US DEPT OF HEALTH &amp; HUMAN SERVICES  ASPR/SNS                                                                                 ASPR/SNS  2945 FLOWERS ROAD                                                                        2945 FLOWERS ROAD  ATLANTA, GA 30341                                                                        ATLANTA, GA 30341                                                                                             8.    NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)                                 (x)    9A. AMENDMENT OF SOLICITATION NO.  EMERGENT BIODEFENSE OPERATIONS LANSING LLC 330303                                                                       Attn:  DIANA  EMERGENT BIODEFENSE OPERATIONS LANS                                                                                   9B. DATED (SEE ITEM 11)  3500 N MARTIN LUTHER KING JR BLVD                                                                                       LANSING MI 489062933                                                                                                                  x     10A. MODIFICATION OF CONTRACT/ORDER NO.                                                                                                                        HHSD200201792634C                                                                                                                        10B. DATED (SEE ITEM 13)  CODE    330303                                     FACILITY CODE                                                      12/08/2016                                               11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS         The above numbered solicitation is amended as set forth in Item 14.  The hour and date specified for receipt of Offers          is extended,       is not extended.  Offers  must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods: (a) By completing Items  8 and 15, and returning _________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the                               offer submitted; or   (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers.  FAILURE OF YOUR ACKNOWLEDGMENT TO  BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR  OFFER.  If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each  letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.   12. ACCOUNTING AND APPROPRIATION DATA (If required)                                             NET DECREASE: -$[**]  2020.199SN20.26088                                         13. THIS ITEM ONLY APPLIES TO MODIFICATIONS OF CONTRACTS/ORDERS.                                                IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.   CHECK ONE                   A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT                     ORDER NO. IN ITEM 10A.                   B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office,                     appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).                   C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:                                FAR 52.217-7, Option for Increased Quantity-Separately Price Line Item                   D. OTHER (Specify type of modification and authority)                                   E. IMPORTANT:  Contractor                 is not,      is required to sign this document and return ____1____ copies to the issuing office.  14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)  Tax ID Number: [**]  DUNS Number: [**]  This modification is issued to:  1.  Order an increased quantity of [**] doses of BioThrax [**] product at unit price of $[**]. per dose for a total costs of $[**]    Quantity increased from [**] by [**] to a revised total of [**].  Unit price decreased from $[**] by -$[**] a revised unit price of $[**]  2.  Task order contract value decreased from $[**] by -$[**] to a revised task order total of $[**]    Continued &#8230;     Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.  15A. NAME AND TITLE OF SIGNER (Type or print)                                            16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)  Michael Mann, Sr. Manager Contract Ops.                                                  ANNETTE R. WRIGHT  15B. CONTRACTOR/OFFEROR                                       15C. DATE                  16B. UNITED STATES OF AMERICA                                  16C. DATE SIGNED                                                                SIGNED                       /s/ J. Michael Mann II                                        07 JAN 2020                                           Digitally signed by Annette Wright -S                                                                                                                      Date: 2020.01.06 16:46:45 -05&#8217;00&#8217;           (Signature of person authorized to sign)                                        /s/ Annette Wright                                                                                                        (Signature of Contracting Officer) </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1041002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1041002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">NSN 7540-01-152-8070                                                                          STANDARD FORM 30 (Rev. 11-2016)  Previous edition unusable                                                                     Prescribed by GSA                                                                                                FAR (48 CFR) 53.243     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1041003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1041003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">     CONTINUATION   REFERENCE NO. OF DOCUMENT BEING CONTINUED                                 PAGE OF        SHEET                  HHSD200201792634C/P00020                                                  2        2   NAME OF OFFEROR OR CONTRACTOR   EMERGENT BIODEFENSE OPERATIONS LANSING LLC 330303                                                                                             UNIT      ITEM No.                       SUPPLIES/SERVICES                     QUANTITY   UNIT   PRICE     AMOUNT        (A)                                 (B)                               (C)      (D)    (E)         (F)                  3. Administrative change: Modification P00019 Description                                            2 revised to &quot;2. Accordingly, total contract value is hereby                  increased from $[**] by $[**] to $[**]&quot;                  4. Accordingly, total contract value is hereby decreased                  from $[**] by - $[**] to $[**]                  Delivery: [**] After Award                  Delivery Location Code: ASPR/BARDA01                  ASPR/BARDA01                  200 C St SW                  Washington DC 20201 US                  Appr. Yr.: 2020 CAN: 199SN20 Object Class: 26088                  Period of Performance: 01/19/2017 to 09/30/2021                  Change Item 4 to read as follows(amount shown is the                  obligated amount):   4              ASPR- 20-00467 AVA Purchase 2018 Modification            [**]       D6    [**]     -[**]                  request to add funding to purchase AVA SNS funds                  Emergent Contract 200- 2017-92634 CLIN 0004 Deliver to                  Contractor's Facility on [**] Obligated Amount: -$[**]                  FOB: Origin                  Appr.Yr.: 2019 CAN: 199SN20, Object Class                  Code:26088                  [**] upon date of delivery: [**] at a unit price of $[**].                  Delivery Address: Contractor's Facility                  Delivery is estimated to occur by NLT [**]                  Period of Performance: October 1, 2019- September 30,                  2020                  Vendor agrees to maintain this product up to [**] after                  delivery and acceptance at no charge to the Government.                  Title to product and risk of loss transfers to USG at point of                  delivery, Contractor's facility                  Vendor agrees to maintain this product up to [**] after                  delivery and acceptance at no charge to the Government.   NSN 7540-01-152-8067                                                                      OPTIONAL FORM 336 (4-86)                                                                                            Sponsored by GSA                                                                                            FAR (48 CFR) 53.110     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.42
<SEQUENCE>8
<FILENAME>ebs20191231exhibit1042.htm
<DESCRIPTION>EXHIBIT 10.42
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ebs20191231exhibit1042</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ebs20191231exhibit1042001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1042001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely                  cause competitive harm to the Company, if publicly disclosed.  Double asterisks denote omissions.                                                                                                                                                             Exhibit 10.42__  AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT                                                             1. CONTRACT ID CODE                       PAGE OF PAGES                                                                                                                                                                                                                                                                              1             2  2. AMENDMENT/MODIFICATION NO.                      3.    EFFECTIVE DATE                  4. REQUISITION/PURCHASE REQ. NO.                   5. PROJECT NO. (If applicable)  P00020                                                   See Block 16C                      6. ISSUED BY                        CODE           ASPR/SNS                              7. ADMINISTERED BY (If other than Item 6)    CODE              ASPR-/ SNS   ASPR/SNS                                                                                 US DEPT OF HEALTH &amp; HUMAN SERVICES  ASPR/SNS                                                                                 ASPR/SNS  2945 FLOWERS ROAD                                                                        2945 FLOWERS ROAD  ATLANTA, GA 30341                                                                        ATLANTA, GA 30341                                                                                             8.    NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)                                 (x)    9A. AMENDMENT OF SOLICITATION NO.  EMERGENT BIODEFENSE OPERATIONS LANSING LLC 330303                                                                       Attn:  DIANA  EMERGENT BIODEFENSE OPERATIONS LANS                                                                                   9B. DATED (SEE ITEM 11)  3500 N MARTIN LUTHER KING JR BLVD                                                                                       LANSING MI 489062933                                                                                                                  x     10A. MODIFICATION OF CONTRACT/ORDER NO.                                                                                                                        HHSD200201792634C                                                                                                                        10B. DATED (SEE ITEM 13)  CODE    330303                                     FACILITY CODE                                                      12/08/2016                                               11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS         The above numbered solicitation is amended as set forth in Item 14.  The hour and date specified for receipt of Offers          is extended,       is not extended.  Offers  must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods: (a) By completing Items  8 and 15, and returning _________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the                               offer submitted; or   (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers.  FAILURE OF YOUR ACKNOWLEDGMENT TO  BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR  OFFER.  If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each  letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.   12. ACCOUNTING AND APPROPRIATION DATA (If required)                                             NET DECREASE: -$[**]  2020.199SN20.26088                                         13. THIS ITEM ONLY APPLIES TO MODIFICATIONS OF CONTRACTS/ORDERS.                                                IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.   CHECK ONE                   A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT                     ORDER NO. IN ITEM 10A.                   B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office,                     appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).                   C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:                                FAR 52.217-7, Option for Increased Quantity-Separately Price Line Item                   D. OTHER (Specify type of modification and authority)                                   E. IMPORTANT:  Contractor                 is not,      is required to sign this document and return ____1____ copies to the issuing office.  14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)  Tax ID Number: [**]  DUNS Number: [**]  This modification is issued to:  1.  Order an increased quantity of [**] doses of BioThrax [**] product at unit price of $[**]. per dose for a total costs of $[**]    Quantity increased from [**] by [**] to a revised total of [**].  Unit price decreased from $[**] by -$[**] a revised unit price of $[**]  2.  Task order contract value decreased from $[**] by -$[**] to a revised task order total of $[**]    Continued &#8230;     Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.  15A. NAME AND TITLE OF SIGNER (Type or print)                                            16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)  Michael Mann, Sr. Manager Contract Ops.                                                  ANNETTE R. WRIGHT  15B. CONTRACTOR/OFFEROR                                       15C. DATE                  16B. UNITED STATES OF AMERICA                                  16C. DATE SIGNED                                                                SIGNED                       /s/ J. Michael Mann II                                        07 JAN 2020                                           Digitally signed by Annette Wright -S                                                                                                                      Date: 2020.01.06 16:46:45 -05&#8217;00&#8217;           (Signature of person authorized to sign)                                        /s/ Annette Wright                                                                                                        (Signature of Contracting Officer) </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1042002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1042002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">NSN 7540-01-152-8070                                                                          STANDARD FORM 30 (Rev. 11-2016)  Previous edition unusable                                                                     Prescribed by GSA                                                                                                FAR (48 CFR) 53.243     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1042003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1042003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">     CONTINUATION   REFERENCE NO. OF DOCUMENT BEING CONTINUED                                 PAGE OF        SHEET                  HHSD200201792634C/P00020                                                  2        2   NAME OF OFFEROR OR CONTRACTOR   EMERGENT BIODEFENSE OPERATIONS LANSING LLC 330303                                                                                             UNIT      ITEM No.                       SUPPLIES/SERVICES                     QUANTITY   UNIT   PRICE     AMOUNT        (A)                                 (B)                               (C)      (D)    (E)         (F)                  3. Administrative change: Modification P00019 Description                                            2 revised to &quot;2. Accordingly, total contract value is hereby                  increased from $[**] by $[**] to $[**]&quot;                  4. Accordingly, total contract value is hereby decreased                  from $[**] by - $[**] to $[**]                  Delivery: [**] After Award                  Delivery Location Code: ASPR/BARDA01                  ASPR/BARDA01                  200 C St SW                  Washington DC 20201 US                  Appr. Yr.: 2020 CAN: 199SN20 Object Class: 26088                  Period of Performance: 01/19/2017 to 09/30/2021                  Change Item 4 to read as follows(amount shown is the                  obligated amount):   4              ASPR- 20-00467 AVA Purchase 2018 Modification            [**]       D6    [**]     -[**]                  request to add funding to purchase AVA SNS funds                  Emergent Contract 200- 2017-92634 CLIN 0004 Deliver to                  Contractor's Facility on [**] Obligated Amount: -$[**]                  FOB: Origin                  Appr.Yr.: 2019 CAN: 199SN20, Object Class                  Code:26088                  [**] upon date of delivery: [**] at a unit price of $[**].                  Delivery Address: Contractor's Facility                  Delivery is estimated to occur by NLT [**]                  Period of Performance: October 1, 2019- September 30,                  2020                  Vendor agrees to maintain this product up to [**] after                  delivery and acceptance at no charge to the Government.                  Title to product and risk of loss transfers to USG at point of                  delivery, Contractor's facility                  Vendor agrees to maintain this product up to [**] after                  delivery and acceptance at no charge to the Government.   NSN 7540-01-152-8067                                                                      OPTIONAL FORM 336 (4-86)                                                                                            Sponsored by GSA                                                                                            FAR (48 CFR) 53.110     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.48
<SEQUENCE>9
<FILENAME>ebs20191231exhibit1048.htm
<DESCRIPTION>EXHIBIT 10.48
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ebs20191231exhibit1048</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ebs20191231exhibit1048001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">                                                                 Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely              cause competitive harm to the Company, if publicly disclosed.  Double asterisks denote omissions.                                                                                                                    Exhibit 10.48          AWARD/CONTRACT                                       1.   THIS CONTRACT IS A RATED ORDER        RATING         PAGE OF                                                                                                                                                                                                                                                                           UNDER DPAS (15 CFR 700)                                              1       26  2. CONTRACT (Proc. Inst. Ident.) NO.                             3. EFFECTIVE DATE   4. REQUISITION/PURCHASE REQUEST/PROJECT NO.   75A50119C00071                                                   08/30/2019                           OS247977                                                                                                                 5. ISSUED BY              CODE     ASPR-BARDA               6. ADMINISTERED BY (If other than Item 5)     CODE ASPR-BARDA02  ASPR-BARDA                                                  US DEPT OF HEALTH &amp; HUMAN SERVICES  200 Independence Ave., S.W. Room                            ASPR/ORM  640-G                                                       O&#8217;NEILL HOUSE OFFICE BUILDING  Washington DC 20201                                         Washington DC 20515                                                                               8. DELIVERY   7. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)                                             SCD-C.    EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. 1365869                                                                                &#61608;                            &#61523; OTHER (See below)  Attn: Mike Mann                                                                  FOB ORIGIN  300 PROFESSIONAL DRIVE                                                        9. DISCOUNT FOR PROMPT PAYMENT  SUITE 100  GAITHERSBURG MD 208793419                                                                                10. SUBMIT INVOICES                                                                                (4 copies unless otherwise specified) ITEM                                                                                TO THE ADDRESS SHOWN IN  CODE  1365869                          FACILITY CODE                                                            11. SHIP TO/MARK FOR           CODE                OS                 12. PAYMENT WILL BE MADE BY     CODE    ASPR-BARDA02  Office of the Secretary                                               ASPR-BARDA02  200 Independence Ave. S.W.                                            200 C St SW  Washington DC 20201                                                   Washington DC 20201  13. AUTHORITY FOR USING OTHER THAN FULL AND OPEN COMPETITION    14. ACCOUNTING AND APPROPRIATION DATA     &#61603; 10 U.S.C. 2304 (c)(       )   &#61523; 41 U.S.C. 3304(a)(          )                     2019.199SNS1.26088                                                                            15C.      15D.  15A. ITEM NO    15B. SUPPLIES/SERVICES                                                      15E. UNIT PRICE     15F. AMOUNT                                                                         QUANTITY     UNIT  (Base Year)     ACAM Doses                                            [**]                 $[**]              $169,988,000.00                                    Continued                                                                   15G. TOTAL AMOUNT OF CONTRAC                                                                                                          $2,007,468,366.00                                                      16. TABLE OF CONTENTS  (X)    SEC   DESCRIPTION                              PAGE(S)     (X)   SEC   DESCRIPTION                               PAGE(S)         PART I &#8211; THE SCHEDULE                                            PART II &#8211; CONTRACT CLAUSES    X     A    SOLICITATION/CONTRACT FORM               1            X     I    CONTRACT CLAUSES                          23    X     B    SUPPLIES OR SERVICES AND                 5                 PART III &#8211; LIST OF DOCUMENTS, EXHIBITS AND OTHER               PRICES/COSTS                                               ATTACH.    X     C    DESCRIPTION/SPECS./WORK                  9            X     J    LIST OF ATTACHMENTS                       26               STATEMENT    X     D    PACKAGING AND MARKING                    16                PART IV &#8211; REPRESENTATIONS AND INSTRUCTIONS    X     E    INSPECTION AND ACCEPTANCE                16                 K    REPRESENTATIONS, CERTIFICATIONS               X     F    DELIVERIES OR PERFORMANCE                17                      AND OTHER STATEMENTS OF                                                                                OFFERORS    X     G    CONTRACT ADMINISTRATION DATA             18                 L    INSTRS., CONDS., AND NOTICES TO                                                                                           OFFERORS    X     H    SPECIAL CONTRACT REQUIREMENTS            19                 M    EVALUATION FACTORS FOR AWARD                 CONTRACTING OFFICER WILL COMPLETE ITEM 17 (SEALED-BID OR NEGOTIATED PROCUREMENT) OR 18 (SEALED-BID PROCUREMENT) AS APPLICABLE  17. &#61523; Contractor&#8217;s Negotiated Agreement (Contractor is required to sign 18. &#61603; SEALED-BID AWARD (Contractor is not required to sign  this  this document and return one copy to issuing office.) Contractor agrees to document.) Your bid on Solicitation Number ________, including the  furnish and deliver all items or perform all the services set forth or additions or changes made by you which additions or changes are set  otherwise identified above and on any continuation sheets for the forth in full above, is hereby accepted as to the items listed above and on  consideration stated herein. The rights and obligations of the parties to any continuation sheets. This award consummates the contract which  this contract shall be subject to and governed by the following  consists of the following documents: (a) the Government&#8217;s solicitation and  documents: (a) this award/contract, (b) the solicitation, if any, and (c) your bid, and (b) this award/contract.                       </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> such provisions, representation, certifications, and specifications, as are No further contractual document is necessary. (Block 18 should be   attached or incorporated by reference herein. (Attachments are listed checked only when awarding a sealed-bid contract.)   herein.)   19A. NAME AND TITLE OF SIGNER (Type or print)                    20A. NAME OF CONTRACTING OFFICER   Adam Havey, EVP Operations                                                         [**]   19B. NAME OF CONTRACTOR                     19C. DATE SIGNED     20B. UNITED STATES OF AMERICA               20C. DATE SIGNED                                                                                                                   16 Dec 19            BY /s/ [**]                                  BY /s/ Adam Havey                                                                           Digitally signed by      (Signature of person authorized to sign)                                                          [**] &#8211; S                                                                                  Date: 2019.12.17 09:22:47-05&#8217;00&#8217;                                                                        (Signature of the Contracting Officer)  AUTHORIZED FOR LOCAL REPRODUCTION  Previous edition is NOT usable      ACAM 10-Yr 75A50119C00071                        Page 2 of 33   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   CONTINUATION SHEET    REFERENCE NO. OF DOCUMENT BEING CONTINUED                       PAGE OF                          75A50119C00071                                                  2             26   NAME OF OFFEROR OR CONTRACTOR   EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. 1365869      ITEM No.                     SUPPLIES/SERVICES                   QUANTITY   UNIT    UNIT PRICE    AMOUNT        (A)                               (B)                             (C)      (D)       (E)           (F)                  Tax ID Number: [**]                                                                                    DUNS Number: [**]                  ACAM2000, Smallpox (Vaccinia) Vaccine, Live                  (ACAM) Delivery: 12/30/2019                  Appr. Yr.: 2019 CAN: 199SNS1 Object Class: 26402                  Period of Performance: 08/30/2019 to 08/29/2029 - All                  Dollar Amounts based on Target Amounts of Products                  CLINs X0001 through X0004 as stated on Page 3.                     1              Base Year ACAM2000, Smallpox (Vaccinia) Vaccine,                  Live (ACAM)                  See Section B below for further details.                  Obligated Amount: $169,988,000.00                     2              Option Year 1 ACAM2000, Smallpox (Vaccinia)                  Vaccine, Live (ACAM)                  See Section B below for further details.                  NTE: $[**]                     3              Option Year 2 ACAM2000, Smallpox (Vaccinia)                  Vaccine, Live (ACAM)                  See Section B below for further details.                  NTE: $[**]                     4              Option Year 3 ACAM2000, Smallpox (Vaccinia)                  Vaccine, Live (ACAM)                  See Section B below for further details.                  NTE: $[**]                     5              Option Year 4 ACAM2000, Smallpox (Vaccinia)                  Vaccine, Live (ACAM)                  See Section B below for further details.                  NTE: $[**]                     6              Option Year 5 ACAM2000, Smallpox (Vaccinia)                  Vaccine, Live (ACAM)                  See Section B below for further details.                  NTE: $[**]                     7              Option Year 6 ACAM2000, Smallpox (Vaccinia)                  Vaccine, Live (ACAM)                  See Section B below for further details.                  NTE: $[**]                     8              Option Year 7 ACAM2000, Smallpox (Vaccinia)                  Vaccine, Live (ACAM)                  See Section B below for further details.                  NTE: $[**]                     9              Option Year 8 ACAM2000, Smallpox (Vaccinia)                  Vaccine, Live (ACAM)     ACAM 10-Yr 75A50119C00071                 Page 3 of 33   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">                  See Section B below for further details.                  NTE: $[**]                     10             Option Year 9 ACAM2000, Smallpox (Vaccinia)                  Vaccine, Live (ACAM)                  See Section B below for further details.                  NTE: $[**]                    This Contract award document finalizes the Notice of Award Letter issued by Contracting Officer [**] on August  30, 2019, which established an effective date of August 30, 2019.      AUTHORIZED FOR LOCAL REPR                                                               OPTIONAL FORM 336 (4-86)                                                                                          Sponsored by GSA                                                                                          FAR (48 CFR) 53.11      ACAM 10-Yr 75A50119C00071                 Page 4 of 33   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">                                    Table of Contents   Section B - Supplies or Services and Cost/Price ..........................................................................8   Section C - Statement of Work (SOW) ......................................................................................12       C.1 &#8211; Background and Need ..................................................................................................12       C.2 &#8211; Purpose .........................................................................................................................12       C.3 &#8211; Scope of Work ..............................................................................................................12       C.4 &#8211; Task 1:  Manufacturing and Delivery of ACAM2000 Vaccine ...................................13         Manufacture of Bulk Vaccine ............................................................................................13         Vaccine Fill and Finish ......................................................................................................13         Requirements for Packaging &amp; Delivery ...........................................................................13         SNS Locations ...................................................................................................................14         Warranties ..........................................................................................................................15         Historical Lots - Testing Program and Quarantine ............................................................15         Task 2: Diluent Replacement .............................................................................................17         Task 3: Syringe Replacement ............................................................................................17         Task 4:  ACAM2000 Vaccine Limited Re-Labeling Activities ........................................17       C-5 &#8211; Reporting Requirements (Emergent) ...........................................................................19       C.6 &#8211; Reporting Requirements (SNS) ....................................................................................19       C.7. &#8211; Delivery Notifications .................................................................................................20       C.8 &#8211; Quality Inspections .......................................................................................................20   Section D - Packaging And Marking ..........................................................................................20   Section E - Inspection And Acceptance .....................................................................................20       E.1.  &#8211; FAR 52.252-2 Clauses Incorporated by Reference (1998) .....................................20       E.2.  &#8211; Inspection and Acceptance .....................................................................................21       E.3.  &#8211; Shipment Acceptance..............................................................................................21   Section F - Deliveries Or Performance ......................................................................................22       F.1. &#8211; Period of Performance .................................................................................................22       F.2. &#8211; Delivery Locations.......................................................................................................22   Section G - Contract Administration Data ................................................................................22       G.1. &#8211; Electronic Subcontracting Reporting System (eSRS) .................................................22       G.2. &#8211; Invoice Submission .....................................................................................................23       G.3. &#8211; Contracting Officer .....................................................................................................23       G.4. &#8211; Contracting Officer&#8217;s Representative ..........................................................................24       G.5 &#8211; Contract Communications/Correspondence ................................................................24    ACAM 10-Yr 75A50119C00071        Page 5 of 33    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   Section H - Special Contract Requirements ..............................................................................24      H.1. &#8211; Evaluation of Contractor Performance Utilizing CPARS (April 2015) .....................24      H.2. &#8211; CDC37.0001 Non-Personal Services (April 2015) .....................................................25      H.3. &#8211; Restrictions on Disclosure of Information and Rights in Data ...................................26      H.4. &#8211; Liability Protection under the PREP Act ....................................................................26      H.5. &#8211; SNS Responsibilities ...................................................................................................27      H.6. &#8211; Rights of the Contractor to Market Smallpox Vaccine ...............................................27      H.7. &#8211; Expired Doses in the SNS ...........................................................................................27      H.8 &#8211; Testing of Quarantined Product ...................................................................................27  Section I - Contract Clauses ........................................................................................................29      I.1 - Clauses Incorporated By Reference ...............................................................................29      I.1 - Clauses Incorporated By Reference ...............................................................................30      FAR 52.217-9 Option to Extend the Term of the Contract (Mar 2000) .........................32  Section J - List Of Attachments ..................................................................................................33    Table 8:  Kit Reference (including Shelf Life) ..........................................................................33                                 ACAM 10-Yr 75A50119C00071        Page 6 of 33   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">                                         Tables   Table 1:  Overall Price Summary .....................................................................................................5   Table 2:  Task 1 - ACAM2000 Vaccine Manufacture and Provision to the SNS ...........................6   Table 3:  Task 2 - Diluent Replacement and Provision to the SNS .................................................7   Table 4:  Task 3 - Transfer Syringe Replacement and Provision to the SNS1F ..............................7   Table 5:  Task 4 - Vaccine Limited Re-Labeling Program ..............................................................7   Table 6:  Strategy for managing expiring ACAM2000 vaccine ....................................................12   Table 7:  Re-labeling of Rockville MD Manufactured Lots with [**] expiry ...............................14   Table 8:  Kit Reference (including Shelf Life) ..............................................................................26                                ACAM 10-Yr 75A50119C00071        Page 7 of 33    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">            Section B - Supplies or Services and Cost/Price   Table 1:  Overall Price Summary           ITEM                CLIN X001- Doses           CLIN X002- Diluent     CLIN X003- Syringe    CLIN X004-                                                            Replacement             Replacement       Re-labelling                                                                                                                      Grand Total       Contract Year      ACAM Doses    EXTENDED        Diluent   EXTENDED      Transfer EXTENDE         Target                                           PRICE         Vials      PRICE       Syringes  D PRICE   1          Base Year       [**]      $169,988,000                                                                  $169,988,000   100X     Option Year 1     [**]         [**]                                                          [**]            [**]   200X     Option Year 2     [**]         [**]                                                          [**]            [**]   300X     Option Year 3     [**]         [**]                                                                          [**]   400X     Option Year 4     [**]         [**]       [**]        [**]            [**]      [**]         [**]            [**]   500X     Option Year 5     [**]         [**]       [**]        [**]            [**]      [**]                         [**]   600X     Option Year 6     [**]         [**]       [**]        [**]            [**]      [**]         [**]            [**]   700X     Option Year 7     [**]         [**]       [**]        [**]            [**]      [**]                         [**]   800X     Option Year 8     [**]         [**]       [**]        [**]            [**]      [**]         [**]            [**]   900X     Option Year 9     [**]         [**]       [**]        [**]            [**]      [**]                         [**]          Overall             [**]         [**]       [**]        [**]            [**]      [**]         [**]        $2,007,468,366   Note:  Values based on delivery of target amounts of product and relabeling of inventory at the time of  contract preparation.                                                           ACAM 10-Yr 75A50119C00071                       Page 8 of 33            </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">            Price Summary with Tiered Pricing details   Table 2:  Task 1 - ACAM2000 Vaccine Manufacture and Provision to the SNS                             0001 (Base)         1001 (Option)         2001 (Option)         3001 (Option)         4001 (Option)   Contract Year         08/15/19-09/30/19     10/01/19-09/30/20    10/01/20-09/30/21     10/01/21-09/30/22     10/01/22-09/30/23   Target Exercise-By        8/15/2019               [**]                 [**]                  [**]                  [**]   Date   Delivery Target          12/30/2019               [**]                 [**]                  [**]                  [**]   [**] Doses                   [**]                 [**]                 [**]                  [**]                  [**]   Extended Price               [**]                 [**]                 [**]                  [**]                  [**]   [**] Doses                   [**]                 [**]                 [**]                  [**]                  [**]   Extended Price**        $169,988,000              [**]                 [**]                  [**]                  [**]   [**] Doses                   [**]                 [**]                 [**]                  [**]                  [**]   Extended Price               [**]                 [**]                 [**]                  [**]                  [**]   [**] Doses                   [**]                 [**]                 [**]                  [**]                  [**]   Extended Price               [**]                 [**]                 [**]                  [**]                  [**]                           5001 (Option)        6001 (Option)         7001 (Option)         8001 (Option)         9001 (Option)   Contract Year         10/01/23&#8211;09/30/24    10/01/24&#8211;09/30/25     10/01/25&#8211;09/30/26     10/01/26&#8211;09/30/27     10/01/27&#8211;09/30/28   Target Exercise-             [**]                 [**]                 [**]                  [**]                  [**]   By Date   Delivery Target              [**]                 [**]                 [**]                  [**]                  [**]   [**] Doses                   [**]                 [**]                 [**]                  [**]                  [**]   Extended Price               [**]                 [**]                 [**]                  [**]                  [**]   [**] Doses                   [**]                 [**]                 [**]                  [**]                  [**]   Extended Price               [**]                 [**]                 [**]                  [**]                  [**]   [**] Doses                   [**]                 [**]                 [**]                  [**]                  [**]   Extended Price               [**]                 [**]                 [**]                  [**]                  [**]   [**] Doses                   [**]                 [**]                 [**]                  [**]                  [**]   Extended Price               [**]                 [**]                 [**]                  [**]                  [**]   ** Extended Price on base period 0001 is for order quantity of [**] doses   Supplies, Services, and Requirements:   &#61550;   ACAM2000 doses supplied as part of a palletized kit. 1 Kit includes 1 ACAM2000 vial, 1 diluent vial, 1 transfer syringe and 100 bifurcated       needles. Package Insert and Medication Guide to be supplied as digital PDF and posted on Daily Med. (Electronic Medication Guide/Package       Insert is contingent upon FDA approval). The kit components are provided on separate pallets. Each kit supports [**] doses.   &#61550;   This is a firm-fixed price line item.   &#61550;   The unit price listed next to each quantity is a price per dose.   &#61550;   The exercise of each CLIN must be completed prior to any obligation to perform work under that CLIN.   &#61550;   The Delivery Target is expected to occur by [**] within the same contract year. Due to the variability in order quantities, long lead times for       certain raw materials, and uncertainties related to manufacturing and release, any expected changes to the delivery target date will be       negotiated and mutually agreed upon.   &#61550;   Guaranteed shelf life at time of delivery is [**] of the [**] from the date of manufacture for vaccine.   &#61550;   Target Exercise-By Date: Both parties agree that the U.S. Government will work to meet the date as closely as possible within allowable       confines of budget cycles. Emergent recognizes that in the event of a continuing resolution or other delayed U.S. Government budgeting       scenario that this may be delayed into the next calendar year. The U.S. Government and Emergent intend to work in good faith to clearly       articulate annual production planning expectations and the U.S. Government may provide a non-binding notice of intent to communicate its       intentions, in the event of a delayed annual budget.   &#61550;   The minimum order quantity per contract year is [**] doses.   &#61550;   For the nine option years, an order may be placed once per contract year in a quantity of [**] doses. For the base year of the contract, the       Government chooses to procure a quantity between the tiers at the tier below the determined amount. For example, in the base year the       Government is procuring [**] doses at the price of $[**].              ACAM 10-Yr 75A50119C00071                       Page 9 of 33            </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">            Table 3:  Task 2 - Diluent Replacement and Provision to the SNS                           4002 (Option)     5002 (Option)      6002 (Option)     7002 (Option)     8002 (Option)    9002 (Option)   Contract Year            10/01/22&#8211;         10/01/23&#8211;          10/01/24&#8211;         10/01/25&#8211;         10/01/26&#8211;        10/01/27&#8211;                            09/30/23          09/30/24          09/30/25          09/30/26          09/30/27         09/30/28   Target Exercise-By          [**]              [**]              [**]               [**]             [**]             [**]   Date   Delivery Target                                                         [**]   [**] Vials                  [**]              [**]              [**]               [**]             [**]             [**]   Extended Price              [**]              [**]              [**]               [**]             [**]             [**]   [**] Vials                  [**]              [**]              [**]               [**]             [**]             [**]   Extended Price              [**]              [**]              [**]               [**]             [**]             [**]   [**] Vials                  [**]              [**]              [**]               [**]             [**]             [**]   Extended Price              [**]              [**]              [**]               [**]             [**]             [**]   [**] Vials                  [**]              [**]              [**]               [**]             [**]             [**]   Extended Price              [**]              [**]              [**]               [**]             [**]             [**]   Supplies, Services, and Requirements:   &#61550;   Diluent replacement for ACAM2000 vaccine kits provided under this contract.   &#61550;   Expiry is [**] from date of manufacture.   &#61550;   This is a firm-fixed price line item.   &#61550;   Guaranteed shelf life from delivery is [**] from the date of manufacture for vials of diluent.   &#61550;   Provision of diluent replacement under prior contracts is available under separate contract.   Table 4:  Task 3 - Transfer Syringe Replacement and Provision to the SNS1                           4003 (Option)     5003 (Option)      6003 (Option)     7003 (Option)     8003 (Option)   9003 (Option)   Contract Year            10/01/22&#8211;         10/01/23&#8211;          10/01/24&#8211;         10/01/25&#8211;         10/01/26&#8211;       10/01/27&#8211;                            09/30/23          09/30/24          09/30/25          09/30/26          09/30/27         09/30/28   Target Exercise-By          [**]              [**]              [**]              [**]              [**]             [**]   Date   Delivery Target                                                         [**]   [**] Transfer               [**]              [**]              [**]               [**]             [**]             [**]   Syringes   Extended Price              [**]              [**]              [**]               [**]             [**]             [**]   [**] Transfer               [**]              [**]              [**]               [**]             [**]             [**]   Syringes   Extended Price              [**]              [**]              [**]               [**]             [**]             [**]   [**] Transfer               [**]              [**]              [**]               [**]             [**]             [**]   Syringes   Extended Price              [**]              [**]              [**]               [**]             [**]             [**]   [**] Transfer               [**]              [**]              [**]               [**]             [**]             [**]   Syringes   Extended Price              [**]              [**]              [**]               [**]             [**]             [**]   Supplies, Services, and Requirements:   &#61550;   Transfer syringe replacement for ACAM2000 vaccine kits.   &#61550;   Expiry is [**] from date of manufacture.   &#61550;   This is a firm-fixed price line item.   &#61550;   Guaranteed shelf life from delivery is [**] from the date of manufacture for transfer syringes.   &#61550;   Provision of transfer syringe replacement under prior contracts is available under separate contract.             ACAM 10-Yr 75A50119C00071                      Page 10 of 33            </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">         Table 5: Task 4 - Vaccine Limited Re-Labeling Program                    1004 (Option)  2004 (Option)  4004 (Option)  6004 (Option)   8004 (Option)  Contract Year  10/01/19&#8211;09/30/20 10/01/20&#8211;09/30/21 10/01/22&#8211;09/30/23 10/01/24&#8211;09/30/25 10/01/26&#8211;09/30/27  Target Exercise-By  [**]           [**]           [**]           [**]            [**]  Date  Delivery Target                                   [**]  Number of Vials     [**]           [**]           [**]            [**]           [**]                      [**]           [**]           [**]            [**]           [**]  Unit Price (per vial) [**]         [**]           [**]            [**]           [**]  Extended Price      [**]           [**]           [**]            [**]           [**]  Supplies, Services, and Requirements:  &#61550;  This is a firm-fixed price line item.  &#61550;  Complete prior to expiry at site; the number of vials is approximate.  &#61550;  Annual stability testing of representative lots is incorporated into the unit price for ACAM2000 vaccine.     Notes:   B.1   As shown in the chart above, the Government agrees to purchase at least [**] doses of product in  the base year for a total amount of $169,988,000, and to purchase a minimum of [**] doses (with a  target amount of [**] doses) in each option year, if exercised. The Government maintains the right to  purchase up to [**] doses per option year.   B.2   As shown in the chart above, the pricing accounts for both annual escalation and tiered pricing,  which is based on the quantity of the Government&#8217;s order.   B.3   Delivery of product shall be FOB Destination. An updated and detailed delivery schedule will be  provided to the SNS within [**] of annual award. Following delivery, SNS will provide Emergent  written notification that it either accepts or rejects the delivered lot(s) within [**] of receipt. If formal  acceptance or rejection is not received in the [**] period it shall be deemed to have been accepted.                                           ACAM 10-Yr 75A50119C00071        Page 11 of 33         </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   Section C - Statement of Work (SOW)   Title: Warm based manufacturing and license maintenance for ACAM2000 Vaccine   C.1 &#8211; Background and Need   As a direct result of the September 11, 2001 tragedy and the increased perceived threat of bio-  terrorist activities against the United States, the Department of Health and Human Services  (DHHS) and the Assistant Secretary for Preparedness and Response (ASPR) have a need to  maintain a contract with the experienced manufacturer to supply its Food &amp; Drug Administration  (FDA) licensed ACAM2000, Smallpox (Vaccinia) Vaccine, Live; the only domestically- produced such vaccine, to maintain its ability to manufacture and deliver the licensed vaccine up  to [**] doses annually.   C.2 &#8211; Purpose   The purpose of this project is to maintain the ability to manufacture and deliver licensed  ACAM2000, Smallpox (Vaccinia) Vaccine, Live. The ACAM2000 vaccine shall be  manufactured within the United States (US) in accordance with current Good Manufacturing  Practices (cGMP) guidelines and palletized kits of ACAM2000 Vaccine, diluent, bifurcated  needles and transfer syringes delivered to the ASPR Strategic National Stockpile (SNS).   C.3 &#8211; Scope of Work   The Contractor, as an independent organization and not as an agent of the Government, shall  furnish all labor, materials, supplies, facilities, equipment, transportation and travel necessary to  manufacture and deliver listed doses of licensed ACAM2000 vaccine, in accordance with C.10.  The contractor shall deliver an equivalent quantity of ancillaries (ACAM2000 diluent, bifurcated  needles and transfer syringes for use in the administration of the ACAM2000 vaccine. The  contractor shall comply with the following objectives:      &#8226;  (Task 1) Manufacture and deliver, Food &amp; Drug Administration (FDA) licensed        ACAM2000 under Biologic License Application (BLA) Submission Tracking Number        (STN) 125158 from approved facilities with the timeframe and quantities in accordance        with Task 1.     &#8226;  (Task 1) Maintain the agency-approved Stability testing structure which assesses the        long-term safety and efficacy of the ACAM2000 Lyophilized Drug Product at the        Strategic National Stockpile and supports [**] of shelf life [**] from the time of product        manufacture.     &#8226;  (Task 1) Perform qualified vaccinia vaccine potency assay on ACAM2000.     &#8226;  (Task 2) Replace expiring ACAM2000 diluent as related to new doses supplied under        this contract     &#8226;  (Task 3) Replace expiring transfer syringes as related to new doses supplied under this        contract     &#8226;  (Task 4) Relabel vaccine to [**] shelf-life   ACAM 10-Yr 75A50119C00071        Page 12 of 33   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">        &#8226;  (C.5.) Provide quarterly reports and update meetings by the [**] following the end of the         quarter.    C.4 &#8211; Task 1:  Manufacturing and Delivery of ACAM2000 Vaccine    The Contractor shall manufacture and deliver, in accordance with this Task 1, licensed   ACAM2000, including ancillary components which shall be delivered to the SNS [**], and   produced entirely in the US in accordance with this Statement of Work. The product shall meet   all requirements as specified in the approved FDA license and any approved supplements or   amendments thereto. Ancillary components include diluent, syringe and bifurcated needle for   reconstitution of vaccine. One vial of diluent will be provided for USP for each vial of vaccine;   one syringe for reconstitution of each vial of vaccine; and one bifurcated needle for each dose of   vaccine. The vaccine and diluent will be labeled and packaged as outlined in the BLA and   subsequently approved FDA license.    Manufacture of Bulk Vaccine    The contractor shall manufacture the cell cultures required for the domestic production of   ACAM2000 at its US bulk vaccine manufacturing facility at the [**] bioreactor scale.    The contractor shall perform all Installation Qualification (IQ), Operational Qualification (OQ),   and Performance Qualification (PQ) on any equipment required to produce the vaccine. The   domestic manufacturing of the ACAM2000 vaccine in Vero cells grown on micro carrier beads   at the [**] scale shall be in accordance with the approved ACAM2000 BLA on file with the   FDA.    Vaccine Fill and Finish    The Contractor shall maintain a validated filling, lyophilization, labeling and packaging of   ACAM2000 at its US fill and finish facility and shall perform all IQ, OQ, and PQ on any   additional equipment required at that facility and associated process development.    Requirements for Packaging &amp; Delivery    The products shall be delivered as follows: ACAM2000, (Smallpox (Vaccinia) Vaccine, Live),   shall be provided in a multiple dose [**]. Each vial shall contain [**]. Each vaccine box shall   contain [**].  Each case shall contain [**].  The ACAM2000 vaccine shall have &gt;[**] shelf life   remaining at the time of delivery.    ACAM2000 Diluent shall be provided as [**]. Each diluent box shall contain [**]. Each case   shall contain [**]. The diluent shall have a [**] shelf life. The diluent should have &gt; [**] of shelf   life remaining at the time of delivery    Bifurcated needles shall be supplied in boxes containing [**] needles each. Each case shall  contain [**] bifurcated needles with an expiry date of [**] from date of manufacture. Transfer  Syringes shall be provided as [**]needles for vaccine reconstitution. Each box shall contain [**]  syringes and [**] syringes per case. Transfer syringes have an expiry date of [**] from the date    ACAM 10-Yr 75A50119C00071        Page 13 of 33    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048014.jpg" title="slide14" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">     of manufacture.  The transfer syringes should have &#8805;[**] of shelf life remaining at the time of   delivery.    Complete, unopened cases of bifurcated needles and syringes will be provided.  The additional   quantity required to provide complete cases (rounded up quantity in excess of kit requirements)   will be provided at no additional cost to the Government). The provided kit summary should note   both the Emergent lot number and the manufacturer&#8217;s lot number for needles and syringes.    FDA-approved ACAM2000 Package Insert and Medication Guides shall be provided per the   license as a compact disk (CD). Emergent will work with the FDA to phase-out the CDs and  provide a suitable electronic solution. The contractor shall notify the Contracting Officer&#8217;s  Representative (COR) when the Package Insert or Medication Guide are revised and will ship the  current PDF version with each delivery order.   Boxes, cases and shelf cartons shall not contain mixed lot numbers. All pallets are to have the  identical TiHi stack pattern except for the last final pallet per lot number. All ACAM2000  vaccine product shall be delivered on standard 48&quot; by 40&quot; pallet, not to exceed 60&#8221; in height,  stretch wrapped and secured to pallet for safe transport.   Prior to an ACAM2000 vaccine and ancillary delivery, the Kit Component Inventory Summary  Sheet which provides the ACAM2000 Kit (vaccine, diluent, bifurcated needle and transfer  syringe) Inventory Summary, shall be provided outlining the products in each delivery; lot  numbers of each items; number of full and partial boxes, cases and pallets; and the total  quantities of each items in vials or each.   The contractor shall provide Certificates of Analysis and Certificates of Conformance for the  vaccine at least [**] prior to shipment arriving at the SNS facility.  The contractor shall also  provide Certificates of Analysis and Vendor Certificate of Manufacturing (or Conformance) for  the diluent prior to shipment arriving at the SNS facility.   Driver information for each delivery truck shall be provided as soon as available to the SNS site.   After the delivery, a documented review of the temperature data from the vaccine and diluent   shipments will be provided.    SNS Locations    Delivery location shall be in accordance with United States Government (USG) instructions   provided [**] prior to the shipment and are specific exclusively to Continental US (CONUS)  locations. Locations outside CONUS may incur additional shipping/validation charges which  will result in a contract modification to be performed prior to shipment.  No more than [**]  shipments [**]. Vaccine relabeling shall occur at current inventory locations unless otherwise  agreed upon.   Delivery shall also include ancillary items for reconstitution of each vial of vaccine (diluent,  transfer syringe) as well as a bifurcated needle for administration of each dose of vaccine.  Packaging, labeling and delivery shall be done according to the methodology and specifications    ACAM 10-Yr 75A50119C00071        Page 14 of 33    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048015.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048015.jpg" title="slide15" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   outlined in the current BLA filed with the FDA and as outlined in Section C.6, C.8. Section D,  Section E.   Warranties   A warranty shall be provided for vaccines, diluent, transfer syringes, and bifurcated needles  delivered to the USG during this 10-year contract.      &#8226;  Vaccine will have &#8805; [**] of shelf-life remaining at time of delivery     &#8226;  Diluent will have &gt;[**] of shelf-life remaining at time of delivery.     &#8226;  The transfer syringes should have &#8805;[**] of shelf life remaining at the time of delivery.     &#8226;  Transfer Syringes and Needles are commercial products. In the event of supplier and/or        delivery issues that result in shelf life not meeting minimum requirements, the parties will        develop suitable alternatives in delivery and pricing.   For ACAM2000 delivered during this contract, if it is determined that the ACAM2000 vials  delivered do not meet the shelf life standard of [**] expiry from the date of manufacture (with a  minimum of [**] of shelf life remaining at the time of delivery) and that USG has met its storage  and handling obligations for such products pursuant to a separate Quality Agreement, then the  Contractor will provide an equitable remedy based on the remaining shelf life of the non- conforming product(s), which will include one of the following: (a) replacement product (only  during the contract period), (b) a credit against future purchases under the contract, or (c)  reimbursement.   Historical Lots-Testing Program and Quarantine    Doses manufactured and distributed prior to 2018 had labeled expiry periods of less than the  current [**] expiry. As these lots approach their labeled expiry dates, Emergent will coordinate  with SNS and the SNS sites to re-label impacted lots with [**] expiry, per STN 103821/203  (approved 15 Dec 2017). Once lots have exceeded the FDA approved [**] expiry, they will be  quarantined by SNS and will not be distributed for any use.   Given the commitment for a long-term contract to replace the stockpile, Emergent will agree to  test representative lots of quarantined product on an [**] basis and provide the data as For  Information Only (FIO) to SNS until replenished stockpile inventory levels meet the desired  threat assessment level. This information will be provided as soon as it is available and following  the Government placing its annual optional CLIN order for at least [**] ACAM2000 doses.  Under this Vaccine Testing Program, Emergent understands that, in the event of an emergency,  the SNS would be responsible for seeking an appropriate regulatory mechanism to deploy for use  quarantined product.      &#8226;  Emergent would follow our procedures in the event of an OOS (out of specification)        result. Upon confirmation of an OOS, that information would be shared with the SNS;     &#8226;  Testing would continue only with the concurrent exercise of the option for product        delivery;   ACAM 10-Yr 75A50119C00071        Page 15 of 33   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048016.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048016.jpg" title="slide16" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      &#8226;  Testing would only continue until the stockpile reaches the threat assessment level ([**]        doses);     &#8226;  Based on the lots tested and the proposed delivery schedule, the maximum that lots        would be tested is anticipated to be no more than [**] from the date of manufacture;   The product expiration will remain at [**]. This testing will not be used to support any further  extension to the product expiry dating. Under this agreement, the product maintained in the SNS  stockpile beyond the shelf life of [**] is no longer considered to be under our license. Emergent  is not making any representation or guarantees that the testing will support extensions to the  shelf life and the testing data is not being provided to the SNS in support of expiry extensions.  As a result, Emergent will also no longer be performing any activities beyond the submission of  the data to the SNS. The testing data is not being provided to the SNS in support of expiry  extensions, and any discussions with the FDA regarding the use of the stockpile in an emergency  event or any use of this product will be captured under a different regulatory mechanism outside  of Emergent&#8217; s license and will be the responsibility of the SNS.   The following table provides a summary detailing the strategy for managing expiring  ACAM2000 vaccine:   Table 6:  Strategy for managing expiring ACAM2000 vaccine   Category                      Proposed Strategy  Older lots with &lt; [**] expiry All lots can be managed as having [**] expiry per STN  labeling and &lt; [**] since date of 125158/203 (approved 15 Dec 2017). These lots will be  manufacture                   re-labeled with [**] expiry per the schedule in Section C                                below. Once these lots exceed [**], the lots will be                                quarantined by SNS, per below.  Older lots that have &#8805; [**] since These lots have, or will have, exceeded the FDA approved  date of manufacture           expiry period and will be quarantined by SNS. The lots                                will not be distributed by ASPR for any purpose                                (vaccination, research, etc.) except under an approved                                appropriate regulatory mechanism. Once SNS has                                achieved its inventory goal for ACAM2000 vaccine, all                                quarantined expired doses should be destroyed.  New lots with [**] expiry*    All newly manufactured lots under this contract will be  *It is expected the U.S.      labeled with [**] expiry. Therefore, none of these lots will  Government will deploy in date expire during the 10- year period of this contract. When  vaccine first and quarantined the lots do expire in the future, the expired materials  vaccine would only be deployed should be destroyed.  after all in date product is  depleted (and with the  appropriate regulatory oversight).    ACAM 10-Yr 75A50119C00071        Page 16 of 33   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048017.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048017.jpg" title="slide17" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">     Task 2: Diluent Replacement    The contractor shall replace expiring ACAM2000 diluent related this contract (see Task 2 table).   Government to provide forecast [**] to confirm the quantity to be delivered Options may be   exercised after the base year is awarded through year 10 at the quantities also outlined herein. If   the quantity of diluent requiring replacement changes from the quantity outlined in Section C.6,   both parties shall agree to the change.  Note timing listed in C.6 are approximations as   replacement timing is dependent of the manufacturing date of shipped quantities. The contractor   shall deliver [**].  The diluent shall be packaged in [**] per case.  The diluent shall have a [**]  shelf life. At the time of delivery to the SNS the diluent should have &gt;[**] of shelf life   remaining.    Task 3: Syringe Replacement       &#8226;  Transfer Syringe quantities will be in increments of a full case box (divisible by [**]).      &#8226;  Replacement of transfer syringes sold prior to this contract are outside the scope of this         proposal and can be quoted separately upon request.    Task 4:  ACAM2000 Vaccine Limited Re-Labeling Activities    The ACAM2000 vaccine currently has an expiration date of [**]. Emergent will re-label vaccine  lots located at the Strategic National Stockpile (SNS) for lots produced by the [**] facility which  have less than an expiry of [**] as they approach their current labeled expiration. (See table  below).  Quantities are estimates and will be verified prior to relabeling efforts.                                ACAM 10-Yr 75A50119C00071        Page 17 of 33    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048018.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048018.jpg" title="slide18" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   Table 7:  Re-labeling of [**] Manufactured Lots with [**] expiry               Over-label   Expire        Lot                                                             Grand   Location                                          2020      2021       2023      2025       2027                Year        Date       Number                                                            Total                         [**]         [**]           [**]                                                 [**]                [**]     [**]         [**]           [**]                                                 [**]                         [**]         [**]           [**]                                                 [**]                [**]     [**]         [**]                      [**]                                      [**]                         [**]         [**]                      [**]                                      [**]     [**]                         [**]         [**]                      [**]                                      [**]                         [**]         [**]                      [**]                                      [**]                         [**]         [**]                      [**]                                      [**]                         [**]         [**]                      [**]                                      [**]                         [**]         [**]                      [**]                                      [**]     [**]       [**]                     [**]        [**]       [**]                                      [**]     [**]       [**]     [**]         [**]                      [**]                                      [**]                [**]     [**]         [**]                                [**]                            [**]                         [**]         [**]                                [**]                            [**]                         [**]         [**]                                [**]                            [**]                         [**]         [**]                                [**]                            [**]                         [**]         [**]                                [**]                            [**]                         [**]         [**]                                [**]                            [**]                         [**]         [**]                                [**]                            [**]                         [**]         [**]                                [**]                            [**]                         [**]         [**]                                [**]                            [**]                         [**]         [**]                                           [**]                 [**]                [**]     [**]         [**]                                           [**]                 [**]                         [**]         [**]                                           [**]                 [**]                         [**]         [**]                                           [**]                 [**]                         [**]         [**]                                           [**]                 [**]                         [**]         [**]                                           [**]                 [**]                         [**]         [**]                                           [**]                 [**]                         [**]         [**]                                           [**]                 [**]     [**]       [**]                     [**]                   [**]      [**]       [**]                 [**]     [**]       [**]     [**]         [**]                                                     [**]       [**]                         [**]         [**]                                                     [**]       [**]                         [**]         [**]                                                     [**]       [**]                         [**]         [**]                                                     [**]       [**]                         [**]         [**]                                                     [**]       [**]                         [**]         [**]                                                     [**]       [**]                         [**]         [**]                                                     [**]       [**]     [**]       [**]                     [**]                                                  [**]       [**]    Grand       [**]                     [**]        [**]       [**]      [**]       [**]      [**]       [**]     Total                                           ACAM 10-Yr 75A50119C00071                      Page 18 of 33   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048019.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048019.jpg" title="slide19" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   C-5 &#8211; Reporting Requirements (Emergent)   The contractor shall submit a Quarterly Progress Report, which shall include the information  listed below that is applicable for the performance period during the quarter being reported. The  contractor shall provide the Contracting Officer&#8217;s Representative (COR) with one electronic  copy of the Quarterly Progress Report via e-mail. Any attachments to the report shall be  submitted in Microsoft Word, Adobe Acrobat, or similar files. The contractor shall meet with the  COR quarterly to discuss the Quarterly Progress Report. The contractor shall submit the  Quarterly Reports and schedule the meetings by the [**] following the end of the quarter. The  following shall be included in the quarterly report.         1.    Quarterly Reporting Requirements Manufacturing and Delivery of ACAM2000&reg;              Kits               a.    Procurement and Production               b.    Quality Control Testing and Potency               c.    Quality Manufacturing Deviations (major)         2.    FDA inspections, consultation results or recommendations and any files to the              FDA concerning the ACAM2000 BLA         3.    Security Assessment         4.    Stability Program Assessment (Provided [**])         5.    Overall Project Assessment               a.    Delivery Summary               b.    Projected Deliveries for next reporting period               c.    Plan vs. Actual and Specific problems to address   C.6 &#8211; Reporting Requirements (SNS)   SNS shall provide the following information to Emergent at the frequency described below:         1.    Doses delivered from SNS. This number is needed for safety reporting ([**])         2.    Destruction of expired lots of ACAM Vaccine.  ([**] for record retention)         3.    ACAM Vaccine lots in inventory, number of vials, and quantity in quarantine.              ([**] for over-labelling planning)         4.    ACAM Diluent lots in inventory, number of vials. ([**])    ACAM 10-Yr 75A50119C00071        Page 19 of 33   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048020.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048020.jpg" title="slide20" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">         5.    Note: Updated inventory on specific lots may be required as part of investigations              throughout the contract.   C.7. &#8211; Delivery Notifications   Emergent shall notify the COR of the total quantity of product(s) and pallet count that will be  delivered utilizing the Kit Component Inventory Summary Sheet, which provides the  ACAM2000 Kit (vaccine, diluent, bifurcated needle and transfer syringe) Inventory Summary to  the SNS at least [**] prior to each delivery.   C.8 &#8211; Quality Inspections      &#8226;  Site Visits/Audits: The Government shall perform [**] site visits/security audits as        deemed necessary by the Government throughout the period of performance of the        contract.     &#8226;  Quality: The Government reserves the right to visit the contractor&#8217;s site for purposes of        assessing quality on an [**] basis or as deemed necessary by the Government throughout        the period of performance of the contract.     &#8226;  Notice: The Government will provide [**] advance notice prior to the Contractor of all        site visits and audits. The notice will include a statement concerning the intended scope        of the audit and a list of the required documents or access to personnel. Note: Facilities        with live vaccine is in use (core production/testing areas) require vaccinations or waivers        prior to entry.     &#8226;  All audits will be conducted between normal business hours i.e. 8 a.m. through 4 p.m.,        Monday through Friday.     &#8226;  Report to be provided by the Government as to any observations associated with site        visits/audits.   The government reserves the right to inspect any contractor or subcontractor facility used for the  manufacture, packaging, storage, transportation or any other handling of products ordered as a  result of this solicitation without prior notice. These inspections do not replace any required  inspections conducted by the FDA but are in addition to such inspections. The contractor will be  required to respond to any finding&#8217;s resultant from these inspections with remediation plans or an  explanation of why no remediation is required.   Section D - Packaging And Marking   Packaging shall be consistent with the FDA approved labeling and packaging for this product at  the time of manufacture.   Section E - Inspection And Acceptance   E.1.  &#8211; FAR 52.252-2 Clauses Incorporated by Reference (1998)    ACAM 10-Yr 75A50119C00071        Page 20 of 33   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048021.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048021.jpg" title="slide21" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">     This contract incorporates one or more clauses by reference, with the same force and effect as if   they were given in full text. Upon request, the Contracting Officer will make their full text   available. Also, the full text of a clause may be accessed electronically at this/these address (es):    https://www.acquisition.gov    FAR SOURCE          TITLE AND DATE   52.246-1            Contractor Inspection Requirements (Apr 1984)   52.246-2            Inspection of Supplies &#8211; Fixed Price (Aug 1996)   52.246-4            Inspection of Services &#8211; Fixed Price (Aug 1996)   52.246-16           Responsibility for Supplies (Apr 1984)    E.2.  &#8211; Inspection and Acceptance    Inspection and acceptance of the articles, services, and documentation called for herein shall be   accomplished by the Contracting Officer, or his duly authorized representative (who for the   purposes of this contract shall be the Project Officer/COR) at the destination of the articles,   services or documentation.    The Contractor shall only tender for acceptance those items that conform to the requirements of  this contract. The Government reserves the right to inspect or test any supplies or services that  have been tendered for acceptance. The Government may require repair or replacement of  nonconforming supplies or re-performance of nonconforming services at no increase in contract  price. The Government must exercise its post-acceptance rights:       &#8226;  Within a reasonable time after the defect was discovered or should have been discovered;         and      &#8226;  Before any substantial change occurs in the condition of the item, unless the change is         due to the defect in the item.      &#8226;  Goods damaged by Government personnel during product receipt is not covered under         warranty.      &#8226;  Note: Needles and Syringes are provided as complete, unopened cases. As such, excess         quantities required due to rounding to the nearest whole case will be supplied as no cost         to the government.    E.3.  &#8211; Shipment Acceptance    Shipment Acceptance is defined by two activities:    1)    Signed review of delivered materials by SNS (FRM041013 or other written notification)       &#8226;  Confirmation of quantity of all kit components      &#8226;  Confirmation that the materials are labeled correctly (with lot #, date of manufacture         and/or expiration date)    ACAM 10-Yr 75A50119C00071        Page 21 of 33    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048022.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048022.jpg" title="slide22" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">        &#8226;  Confirmation that CoAs are available for each lot      &#8226;  Confirmation there is no damage, leakage or moisture, or any other defects associated         with the pallets and boxes.    2)    Review of shipping temperature for the ACAM2000 vaccine and diluent by Emergent         Quality Assurance. (FRM044234)   Emergent may provide staff to assist in the delivery inspection at no additional cost to the  government.  This activity is not a requirement of delivery.   SNS will provide Emergent written notification (either by signed FRM041013 or other written  notification) that it either accepts or rejects the delivered lot(s) within [**] of receipt.   If formal acceptance or rejection is not received in the [**] period, it shall be deemed the  shipment is accepted.   Section F - Deliveries Or Performance    FAR SOURCE          TITLE AND DATE   52.211-17           Delivery of Excess Quantities (Sept 1989)   52.242-15           Stop-Work Order (Aug 1989)   52.242-17           Government Delay of Work (Apr 1984)   52.247-34           FOB Destination (Nov 1991)    F.1. &#8211; Period of Performance    The period of performance of this contract shall be a base period and nine 12-month option   periods as follows:   08/30/2019 &#8211; 08/29/2020 (Base)          08/30/2024 &#8211; 08/29/2025 (Option Year 5)  08/30/2020 &#8211; 08/29/2021 (Option Year 1) 08/30/2025 &#8211; 08/29/2026 (Option Year 6)  08/30/2021 &#8211; 08/29/2022 (Option Year 2) 08/30/2026 &#8211; 08/29/2027 (Option Year 7)  08/30/2022 &#8211; 08/29/2023 (Option Year 3) 08/30/2027 &#8211; 08/29/2028 (Option Year 8)  08/30/2023 &#8211; 08/29/2024 (Option Year 4) 08/30/2028 &#8211; 08/29/2029 (Option Year 9)    F.2. &#8211; Delivery Locations    Finished products shall be delivered by the Contractor to any one of the [**] current SNS sites.   Site Locations to be provided [**] in advance of delivery.   Section G - Contract Administration Data   G.1. &#8211; Electronic Subcontracting Reporting System (eSRS)   The Contractor shall register with the Electronic Subcontracts Reporting System (eSRS) for the  submission of its Individual Subcontract Report (SF 294) and the Annual Summary Reports (SF  295). Before registering in eSRS, the Contractor information must be correct in the System for    ACAM 10-Yr 75A50119C00071        Page 22 of 33    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048023.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048023.jpg" title="slide23" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">     Award Management database. The eSRS is a world wide web-based application available at:  http://www.esrs.gov.  The eSRS website provides training and instruction for data submission.    G.2. &#8211; Invoice Submission    Invoices should be submitted electronically (.pdf) simultaneously to [**], Contracting Officer   (CO) at ([**]), [**], Contracting Officer&#8217;s Representative (COR) at ([**]), and the Program   Support Center (PSC) at psc_invoices@psc.hhs.gov.    Invoice requirements (from FAR 32.905)    (a)   General. Payment will be based on receipt of a proper invoice and satisfactory contract   performance.    (b)   content of invoices.          (1)   A proper invoice must include the following items:                (i)   Name and address of the contractor.                (ii)  invoice date and invoice number. (Contractors should date invoices as               close as possible to the date of mailing or transmission.)                (iii) Contract number or other authorization for supplies delivered or services               performed (including order number and line item number).                (iv)  Description, quantity, unit of measure, unit price, and extended price of               supplies delivered, or services performed.                (v)   Shipping and payment terms (e.g., shipment number and date of shipment,               discount for prompt payment terms). Bill of lading number and weight of               shipment will be shown for shipments on government bills of lading.                (vi)  Name and address of contractor official to whom payment is to be sent               (must be the same as that in the contract or in a proper notice of assignment).                (vii) Name (where practicable), title, phone number, and mailing address of               person to notify in the event of a defective invoice.                (viii) Taxpayer identification number (TIN). The contractor must include its tin               on the invoice.                (ix)  Electronic funds transfer (EFT) banking information.    G.3. &#8211; Contracting Officer    The Contracting Officer is the only individual who can legally commit the Government to the   expenditure of public funds. No person other than the Contracting Officer can make any changes   to the terms, conditions, general provisions, or other stipulations of this contract. No information,    ACAM 10-Yr 75A50119C00071        Page 23 of 33    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048024.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048024.jpg" title="slide24" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">     other than that which may be contained in an authorized modification to this contract, duly   issued by the Contracting Officer, which may be received from any person employed by the   United States Government, or otherwise, shall be considered grounds for deviation from any   stipulation of this contract.    G.4. &#8211; Contracting Officer&#8217;s Representative    Performance of the work hereunder shall be subject to the technical directions of the designated   Contracting Officer&#8217;s Representative (COR) for this contract.    As used herein, technical directions are directions to the Contractor which fill in details, suggests   possible lines of inquiry, or otherwise completes the general scope of work set forth herein.   These technical directions must be within the general scope of work and may not alter the scope   of work or cause changes of such a nature as to justify an adjustment in the stated contract   price/cost, or any stated limitation thereof.    In the event that the Contractor feels that full implementation of any of these directions may   exceed the scope of the contract, he or she shall notify the originator of the technical direction   and the Contracting Officer in a letter separate of any required report(s) within [**] of the date of   receipt of the technical direction and no action shall be taken pursuant to the direction. If the   Contractor fails to provide the required notification within the said [**] period that any technical   direction exceeds the scope of the contract, then it shall be deemed for purposes of this contract   that the technical direction was within the scope. No technical direction, nor its fulfillment, shall   alter or abrogate the rights and obligations fixed in this contract.    The Government COR is not authorized to change any of the terms and conditions of this   contract. Changes shall be made only by the Contracting Officer by properly written   modification(s) to the contract. The Government will provide the Contractor with a copy of the   delegation memorandum for the COR. Any changes in COR delegation will be made by the   Contracting Officer in writing with a copy being furnished to the Contractor.    G.5 &#8211; Contract Communications/Correspondence    The Contractor shall identify all correspondence, reports, and other data pertinent to this contract   by imprinting thereon the contract number from Page 1 of the contract 75A50119C00071.    Section H - Special Contract Requirements   H.1. &#8211; Evaluation of Contractor Performance Utilizing CPARS (April 2015)    In accordance with FAR 42.15, the SNS will review and evaluate contract performance. FAR   42.1502 and 42.1503 requires agencies to prepare evaluations of contractor performance and   submit them to the Past Performance Information Retrieval System (PPIRS). The SNS utilizes   the Department of Defense (DOD) web-based Contractor Performance Assessment Reporting   System (CPARS) to prepare and report these contractor performance evaluations. All   information contained in these assessments may be used by the Government, within the   limitations of FAR 42.15, for future source selections in accordance with FAR 15.304 where past   performance is an evaluation factor.    ACAM 10-Yr 75A50119C00071        Page 24 of 33    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048025.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048025.jpg" title="slide25" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">     The CPARS system requires a contractor representative to be assigned so that the contractor has   appropriate input into the performance evaluation process. The CPARS contractor representative   will be given access to CPARS and will be given the opportunity to concur or not-concur with   performance evaluations before the evaluations are complete. The CPARS contractor   representative will also have the opportunity to add comments to performance evaluations.    The assessment is not subject to the Disputes clause of the contract, nor is it subject to appeal   beyond the review and comment procedures described in the guides on the CPARS website.   Refer to: www.cpars.gov for details and additional information related to CPARS, CPARS user   access, how contract performance assessments are conducted, and how Contractors participate.   Access and training for all persons responsible for the preparation and review of performance   assessments is also available at the CPARS website.    The contractor must provide the SNS contracting office with the name, e-mail address, and   phone number of their designated CPARS representative who will be responsible for logging   into CPARS and reviewing and commenting on performance evaluations. The contractor must   maintain a current representative to serve as the contractor representative in CPARS. It is the   contractor&#8217;s responsibility to notify the SNS contracting office, in writing (letter or email), when   their CPARS representative information needs to be changed or updated. Failure to maintain   current CPARS contractor representative information will result in the loss of an opportunity to   review and comment on performance evaluations.    H.2. &#8211; CDC37.0001 Non-Personal Services (April 2015)    Personal services shall not be performed under this contract. Although the Government may   provide sporadic or occasional instructions within the scope of the contract, the Contractor is   responsible for control and supervision of its employees. If the Contractor (including its   employees) believes any Government action or communication has been given that would create   a personal services relationship between the Government and any Contractor employee, the   Contractor shall promptly notify the Contracting Officer of this communication or action.    The contractor shall comply with, and ensure their employees and subcontractors comply with,   SNS Policy titled &#8220;Identification of Contractors' Employees and Safeguarding Government   Information.&#8221; No Contractor employee shall hold him or herself out to be a Government   employee, agent, or representative. No Contractor employee shall state orally or in writing at any   time that he or she is acting on behalf of the Government. In all communications with third   parties in connection with this contract, Contractor employees shall identify themselves as   Contractor employees and specify the name of the company for which they work. The contractor   is limited to performing the services identified in the contract statement of work and shall not   interpret any communication with anyone as a permissible change in contract scope or as   authorization to perform work not described in the contract. All contract changes will be   incorporated by a modification signed by the Contracting Officer.    The Contractor shall ensure that all of its employees and subcontractor employees working on   this contract are informed of the substance of this clause. The Contractor agrees that this is a  non-personal services contract; and that for all the purposes of the contract, the Contractor is not,  nor shall it hold itself out to be an agent or partner of, or joint venture with, the Government. The    ACAM 10-Yr 75A50119C00071        Page 25 of 33    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048026.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048026.jpg" title="slide26" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">     Contractor shall notify its employees that they shall neither supervise nor accept supervision   from Government employees. The substance of this clause shall be included in all subcontracts at   any tier.    Nothing in this clause shall limit the Government's rights in any way under any other provision   of the contract, including those related to the Government's right to inspect and accept or reject   the services performed under this contract.    H.3. &#8211; Restrictions on Disclosure of Information and Rights in Data    Information made available to the Contractor by the Government for the performance or   administration of this effort shall be used only for those purposes and shall not be used in any   other way without the written agreement of the Contracting Officer.    The Contractor agrees to assume responsibility for protecting the confidentiality of Government   records, which are not public information. Each Contractor or employee of the Contractor to   whom information may be made available or disclosed shall be notified in writing by the   Contractor that such information may be disclosed only for a purpose and to the extent   authorized herein.    Contractor and/or contractor personnel shall not divulge or release data or information developed   or obtained in performance of this effort, until made public by the Government, except to   authorize Government personnel or upon written approval of the Contracting Officer or COR.   The contractor shall not use, disclose, or reproduce proprietary data that bears a restrictive   legend, other than as required in the performance of this effort. Nothing herein shall preclude the   use of any data independently acquired by the contractor without such limitations or prohibit an   agreement at no cost to the Government between the contractor and the data owner which   provides for greater rights to the contractor.   H.4. &#8211; Liability Protection under the PREP Act   The Public Readiness &amp; Emergency Preparedness Act (PREP Act), Pub. L. 109-148, Division C,  119 Stat. 2818 to 2832, amended the Public Health Service Act, 42, U.S.C. 243 et seq., to  provide targeted liability protections. The Government agrees that the medical countermeasure  delivered by the Contractor under this contract will be administered in humans, in accordance  with the declaration under the PREP Act issued by the Secretary of the Department of Health and  Human Services on December 9, 2015 pursuant to section 319F-3(b) of the Public Health  Service Act, 42, U.S.C 247-d-6d regarding Smallpox Medical Countermeasures- Amendment.  The declaration provides targeted liability protections for smallpox countermeasures based on a  credible risk that the threat of exposure to smallpox and the resulting disease constitutes a public  health emergency. For purposes of this provision, &#8220;Vaccine&#8221; means ACAM2000 vaccine with its  labeling, packaging, diluent, needles, and any other of their respective components as well as any  other deliverable under this contract. The Vaccine may not be used outside of the United States  until the Contractor and the Government agree to reasonable liability protections for outside the  United States and the Contract has been modified to reflect that agreement; such contract  modification will be a change for which the Contractor will be entitled to an equitable  adjustment in accordance with FAR 52.243-1. Additionally, the USG further agrees, in    ACAM 10-Yr 75A50119C00071        Page 26 of 33    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048027.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048027.jpg" title="slide27" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">     accordance with Federal rules and regulations, to provide written notice to the Contractor of any   intended use of the Vaccine delivered under this contract. In the event that a claim or suit for   damages is brought against the Contractor by a third party arising out of its performance of this   contract, the USG will provide reasonable and timely access to documents and information   potentially relevant to the Contractor&#8217;s assertion of defenses to any dispute with a third party,   including, but not limited to, a claim for bodily injury or other damages allegedly arising out of   the use of the Vaccine delivered to the USG under this contract to the extent permitted by   Federal rules and regulations. The USG will consider any request from the Contractor to assist   the Contractor in litigation, including a request to support the Contractor&#8217;s assertion of   appropriate defenses. If and when appropriate, the USG will file papers in support of the   Contractor&#8217;s assertion of its defenses in such disputes.    H.5. &#8211; SNS Responsibilities    Please refer to QUAL40041 (Quality Agreement, SNS) for Emergent and USG responsibilities   regarding the availability of the most current FDA approved Package Insert and Medication   Guide. Emergent and SNS agree that this Quality Agreement is applicable to this contract. Note   that after contract award the Quality Agreement will be updated to reflect any changes in the   SNS organizational structure, COR and items no longer applicable to SNS.    H.6. &#8211; Rights of the Contractor to Market Smallpox Vaccine   The Contractor is not prohibited from marketing the Smallpox Vaccine being sold to SNS under  this Contract provided that such marketing does not interfere with performance under this  Contract.   H.7. &#8211; Expired Doses in the SNS   During the term of this contract, any and all expired doses will be held in quarantine by SNS and  will not be distributed for any purpose (e.g., vaccination, research, etc.) except under an  appropriate regulatory mechanism. SNS will be solely responsible for obtaining said appropriate   regulatory mechanism and maintaining it as may be required. Once SNS inventory needs are met   with non-expired doses, SNS will be responsible for the destruction of the expired doses under   the appropriate regulatory mechanism and any future expiring lots of ACAM2000 vaccine. This   Provision does not diminish any Contractor protection granted by Special Provision H.4 above   and is in addition to it.  Accordingly, all protections to Emergent granted by Special Provision   H.4 are fully applicable to any and all Government use of such expired doses held in quarantine   by SNS.    H.8 &#8211; Testing of Quarantined Product    Given the commitment for a long-term contract to replace the stockpile, Emergent will agree to   test representative lots of quarantined product on an [**] basis and provide the data as &#8220;For  Information Only&#8221; (FIO) to SNS until replenished stockpile inventory levels meet the desired  threat assessment level. Under this Vaccine Testing Program, Emergent understands that, in the  event of an emergency, the SNS would be responsible for seeking an appropriate regulatory  mechanism from the FDA to deploy for use Quarantined product.    ACAM 10-Yr 75A50119C00071        Page 27 of 33    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048028.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048028.jpg" title="slide28" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">        &#8226;  Emergent would follow our procedures in the event of an OOS result. Upon confirmation         of an OOS, that information would be shared with the SNS.      &#8226;  Testing would continue only with the concurrent exercise of the option for product         delivery.      &#8226;  Testing would only continue until the stockpile reaches the threat assessment level.      &#8226;  Based on the lots tested and the proposed delivery schedule, the maximum that lots         would be tested is anticipated to be no more than [**] from the date of manufacture.     &#8226;  The product expiration will remain at [**]. This testing will not be used to support any        further extension to the product expiry dating.   Under this agreement, the product maintained in the SNS stockpile beyond the shelf life of [**]  is no longer considered to be under our license. Emergent is not making any representation or  guarantees that the testing will support extensions to the shelf life and the testing data is not  being provided to the SNS in support of expiry extensions. As a result, Emergent will also no  longer be performing any activities beyond the submission of the data to the SNS. Any  discussions with the FDA regarding the use of the stockpile in an emergency event or any use of  this product will be captured under a different regulatory mechanism outside of Emergent&#8217; s  license and will be the responsibility of the SNS.                                ACAM 10-Yr 75A50119C00071        Page 28 of 33    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048029.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048029.jpg" title="slide29" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   Section I - Contract Clauses   I.1 - Clauses Incorporated By Reference    FAR REFERENCE                       TITLE                         DATE  52.202-1            Definitions                                Nov 2013  52.203-3            Gratuities                                 April 1984  52.203-5            Covenant Against Contingent Fees           May 2014  52.203-6            Restrictions on Subcontractor Sales to the Sep 2006                      Government  52.203-7            Anti-Kickback Procedures                   May 2014  52.203-8            Cancellation, Rescission, and Recovery of Funds May 2014                      for Illegal or Improper Activity  52.203-10           Price or Fee Adjustment for Illegal or Improper May 2014                      Activity  52.203-12           Limitation on Payments to Influence Certain Oct 2010                      Federal Transactions  52.203-17           Contractor Employee Whistleblower Rights and Apr 2014                      Requirements to Inform Employees of                      Whistleblower Rights  52.204-4            Printed or Copied Double-Sided on Recycled May 2011                      Paper  52.204-10           Reporting Executive Compensation and First-Tier Oct 2018                      Subcontract Awards  52.204-13           System for Award Management Maintenance    Oct 2018  52.209-6            Protecting the Government's Interests When Oct 2015                      Subcontracting With Contractors Debarred,                      Suspended, or Proposed for Debarment  52.211-5            Material Requirements                      Aug 2000  52.215-8            Order of Precedence - Uniform Contract Format Oct 1997  52.215-10           Price Reduction for Defective Certified Cost or Aug 2011                      Pricing Data  52.215-11           Price Reduction for Defective Certified Cost or Aug 2011                      Pricing Data Modifications  52.215-12           Subcontractor Cost or Pricing Data         Oct 2010  52.215-13           Subcontractor Cost or Pricing Data-Modifications Oct 2010  52.215-14, Alt 1    Integrity of Unit Prices                   Oct 2010  52.215-15           Pension Adjustments and Asset Reversions   Oct 2010  52.215-18           Reversion or Adjustment of Plans for Post- July 2005                      Retirement Benefits (PRB) other than Pensions  52.215-19           Notification of Ownership Changes          Oct 1997  52.215-21           Requirements for Certified Cost or Pricing Data Oct 2010                      and Data Other Than Certified Cost or Pricing                      Data - Modifications  52.222-3            Convict Labor                              Jun 2003     ACAM 10-Yr 75A50119C00071        Page 29 of 33   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048030.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048030.jpg" title="slide30" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   I.1 - Clauses Incorporated By Reference (continued)   FAR REFERENCE       TITLE                                      DATE  52.222-20           Contracts for Materials, Supplies, Articles, and May 2014                      Equipment Exceeding $15,000  52.222-21           Prohibition of Segregated Facilities       Apr 2015  52.222-50           Combating Trafficking in Persons           Jan 2019  52.222-54           Employment Eligibility Verification        Oct 2015  52.223-3            Hazardous Material Identification and Material Jan 1997                      Safety Data  52.223-18           Encouraging Contractor Policies to Ban Text Aug 2011                      Messaging While Driving  52.225-13           Restrictions on Certain Foreign Purchases  Jun 2008  52.227-1            Authorization and Consent                  Dec 2007  52.227-2            Notice and Assistance Regarding Patent and Dec 2007                      Copyright Infringement  52.229-3            Federal, State and Local Taxes             Feb 2013  52.232-1            Payments                                   Apr 1984  52.232-8            Discounts for Prompt Payment               Feb 2002  52.232-9            Limitation on Withholding of Payments      Apr 1984  52.232-11           Extras                                     Apr 1984  52.232-17           Interest                                   May 2014  52.232-23           Assignment of Claims                       May 2014  52.232-25           Prompt Payment                             Jan 2017  52.232-33           Payment by Electronic Funds Transfer&#8212;System Oct 2018                      for Award Management  52.232-39           Unenforceability of Unauthorized Obligations Jun 2013  52.232-40           Providing Accelerated Payments to Small Business Dec 2013                      Subcontractors  52.233-1            Disputes                                   May 2014  52.233-3            Protest After Award                        Aug 1996  52.233-4            Applicable Law for Breach of Contract Claim Oct 2004  52.242-13           Bankruptcy                                 Jul 1995  52.243-1            Changes - Fixed-Price                      Aug 1987  52.244-5            Competition in Subcontracting              Dec 1996  52.244-6            Subcontracts for Commercial Items          Aug 2019  52.246-25           Limitation of Liability - Services         Feb 1997  52.247-34           F.O.B. Destination                         Nov 1991  52.247-68           Report of Shipment (REPSHIP)               Feb 2006  52.249-2            Termination for the Convenience of the     Apr 2012                      Government (Fixed Price)  52.249-8            Default (Fixed-Price Supply and Service)   Apr 1984  52.253-1            Computer Generated Forms                   Jan 1991      ACAM 10-Yr 75A50119C00071        Page 30 of 33   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048031.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048031.jpg" title="slide31" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   HHSAR Reference       TITLE                                    DATE  HHSAR 352.203-70      Anti-Lobbying                            Dec 2015  HHSAR 352.208-70      Printing and Duplication                 Dec 2015  HHSAR 352.224-71      Confidential Information                 Dec 2015  HHSAR 352.239-74      Electronic and Information Technology    Dec 2015                        Accessibility                                 ACAM 10-Yr 75A50119C00071        Page 31 of 33   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048032.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048032.jpg" title="slide32" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">     FAR 52.217-8 Option to Extend Services (NOV 1999)    The Government may require continued performance of any services within the limits and at the   rates specified in the contract. These rates may be adjusted only as a result of revisions to   prevailing labor rates provided by the Secretary of Labor. The option provision may be exercised   more than once, but the total extension of performance hereunder shall not exceed [**]. The   Contracting Officer may exercise the option by written notice to the Contractor within [**].    (End of Clause)    FAR 52.217-9 Option to Extend the Term of the Contract (Mar 2000)         (a)   The Government may extend the term of this contract by written notice to the  Contractor within [**] provided that the Government gives the Contractor a preliminary written  notice of its intent to extend at least [**] before the contract expires. The preliminary notice does  not commit the Government to an extension.         (b)   If the Government exercises this option, the extended contract shall be considered  to include this option clause.          (c)   The total duration of this contract, including the exercise of any options under this   clause, shall not exceed [**].    (End of Clause)                                 ACAM 10-Yr 75A50119C00071        Page 32 of 33    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ebs20191231exhibit1048033.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ebs20191231exhibit1048033.jpg" title="slide33" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   Section J - List Of Attachments   Table 8:  Kit Reference (including Shelf Life)      Component         Quantity     Expiry    Shelf life    Part#/       Box and Case     Pallet      Product                                              at time of   Supplier                                Location and                                              Delivery                                             Temperature                                                                                                   Requirements   ACAM2000          [**]          [**]       [**]       [**]           [**]             [**]      [**]   Vaccine [**]   ACAM2000          [**]          [**]       [**]       [**]           [**]             [**]      [**]   Diluent [**]   Bifurcated        [**]          [**]       [**]       [**]           [**]             [**]      [**]   Needle   Transfer          [**]          [**]       [**]       [**]           [**]             [**]      [**]   Syringe   [**]      ACAM 10-Yr 75A50119C00071                      Page 33 of 33   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>10
<FILENAME>ebs-20191231exhibit21.htm
<DESCRIPTION>EXHIBIT 21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sC56672178B5D679AEE5D3BB561F948DC"></a></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Exhibit 21</font></div></div><div><br></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:13px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LIST OF SUBSIDIARIES <br>(As of December 31, 2019)</font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:90.38461538461539%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:65%;"></td><td style="width:35%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Name of Subsidiary</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Jurisdiction of Incorporation or Organization</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Domestic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">400 Professional LLC</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adapt Pharma Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cangene bioPharma LLC</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Maryland</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Commercial Operations Frederick Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Maryland</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Biodefense Operations Lansing LLC</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Europe Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent International Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Manufacturing Operations Baltimore LLC</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Product Development Gaithersburg Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Protective Products USA Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Travel Health Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Virology LLC</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">International</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adapt Pharma Limited</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ireland</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adapt Pharma Canada Ltd.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canada</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adapt Pharma Operations Limited</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ireland</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Acquisition Limited</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ireland</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent BioSolutions Berna GmbH</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Switzerland</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent BioSolutions Canada Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ontario</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent BioSolutions Malaysia SDN. BHD.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Malaysia</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent BioSolutions Portugal, Lda.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Portugal</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent BioSolutions Spain, S.L.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Spain</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Countermeasures International Ltd.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">England</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Global Health Foundation Limited</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">England</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Italy S.r.l.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Italy</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Netherlands B.V.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Netherlands</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Product Development Germany GmbH</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Germany</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Product Development UK Limited</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">England</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Sales and Marketing Australia Pty Ltd.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Australia</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Sales and Marketing France S.A.S.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">France</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Sales and Marketing Germany GmbH</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Germany</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emergent Sales and Marketing Singapore Pte. Ltd.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Singapore</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PaxVax Ltd.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">England</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PaxVax AUS Pty. Ltd.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Australia</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PaxVax Bermuda Ltd.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bermuda</font></div></td></tr></table></div></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>11
<FILENAME>ebs-20191231exhibit23.htm
<DESCRIPTION>EXHIBIT 23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sFE3475CA87F5CE1EB3996917890308B8"></a></div><div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 23</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We consent to the incorporation by reference in the following Registration Statements:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-8 No. 333-139190) pertaining to the Employee Stock Option Plan, as amended and restated, the 2006 Stock Incentive Plan and individual director options agreements of Emergent BioSolutions, Inc.,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-8 No. 333-161154) pertaining to the Amended and Restated 2006 Stock Incentive Plan of Emergent BioSolutions Inc.,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-4 No. 333-169351) of Emergent BioSolutions Inc. and Subsidiaries,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-3 No. 333-181133) of Emergent BioSolutions Inc. and Subsidiaries,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-8 No. 333-184699) pertaining to the 2012 Employee Stock Purchase Plan and the Second Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-8 No. 333-196232) pertaining to the Third Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">(7)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-3 No. 333-204405) of Emergent BioSolutions Inc. and Subsidiaries, and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">(8)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-8 No. 333-216294) pertaining to the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">(9)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-8 No. 333-225283) pertaining to the Emergent BioSolutions Inc. Stock Incentive Plan, and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">(10)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registration Statement (Form S-3 No. 333-226544) of Emergent BioSolutions Inc. and Subsidiaries.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">of our reports dated February 24, 2020, with respect to the consolidated financial statements and schedule of Emergent BioSolutions Inc. and subsidiaries and the effectiveness of internal control over financial reporting of Emergent BioSolutions Inc. and subsidiaries included in this Annual Report (Form 10-K) of Emergent BioSolutions Inc. and subsidiaries for the year ended December 31, 2019.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">/s/ Ernst &amp; Young LLP</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Baltimore, Maryland</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 24, 2020</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>12
<FILENAME>esb-20191231x10kxex311.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sCC879AD84A695F449070C72A1EEB7677"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:12px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT 31.1</font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CERTIFICATION</font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, Robert G. Kramer, Sr., certify that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I have reviewed this&#160;Annual Report on Form 10-K of Emergent BioSolutions Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information, and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: February&#160;24, 2020</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">/s/ROBERT G. KRAMER, SR.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Robert G. Kramer, Sr.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President, Chief Executive Officer and Director</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>13
<FILENAME>esb-20191231x10kxex312.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sF1A087D31A07538CA005C6120EEC00B9"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:12px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT 31.2</font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CERTIFICATION</font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, Richard S. Lindahl, certify that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I have reviewed this Annual Report on Form 10-K of Emergent BioSolutions Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information, and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: February&#160;24, 2020</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">/s/RICHARD S. LINDAHL</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Richard S. Lindahl</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Executive Vice President, Chief Financial Officer and Treasurer</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>14
<FILENAME>esb-20191231x10kxex321.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s34D48C3DB6FD5DE1821A35047D15A26A"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:12px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT 32.1</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the&#160;Annual Report on Form 10-K of Emergent BioSolutions Inc. (the "Company") for the period ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Robert G. Kramer, Sr., Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: February&#160;24, 2020</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">/s/ROBERT G. KRAMER, SR.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Robert G. Kramer, Sr.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President, Chief Executive Officer and Director</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>15
<FILENAME>esb-20191231x10kxex322.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s23B5400F50CD543B80D1BFF163A8D61F"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:12px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT 32.2</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002&#160;</font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the Annual Report on Form 10-K of Emergent BioSolutions Inc. (the "Company") for the period ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Richard S. Lindahl, Chief&#160;Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:&#160;</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: February&#160;24, 2020</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">&#160;/s/RICHARD S. LINDAHL</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Richard S. Lindahl</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Executive Vice President, Chief Financial Officer and Treasurer</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>16
<FILENAME>ebs-20191231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://emergentbiosolutions.com/20191231" xmlns:ebs="http://emergentbiosolutions.com/20191231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt/2018-01-31" schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-roles-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2017-01-31" schemaLocation="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2018-01-31" schemaLocation="https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ebs-20191231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ebs-20191231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ebs-20191231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ebs-20191231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="Acquisitions" roleURI="http://emergentbiosolutions.com/role/Acquisitions">
        <link:definition>2104100 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAcquisitionOfAcam2000BusinessDetails" roleURI="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails">
        <link:definition>2404408 - Disclosure - Acquisitions - Acquisition of ACAM2000 Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAcquisitionOfAcam2000NarrativeDetails" roleURI="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails">
        <link:definition>2404407 - Disclosure - Acquisitions - Acquisition of ACAM2000 Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAcquisitionOfRaxibacumabAssetDetails" roleURI="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails">
        <link:definition>2404409 - Disclosure - Acquisitions - Acquisition of Raxibacumab Asset (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAdaptNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails">
        <link:definition>2404402 - Disclosure - Acquisitions - Adapt Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails" roleURI="http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails">
        <link:definition>2404404 - Disclosure - Acquisitions - Adapt Preliminary Allocation of Purchase Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails" roleURI="http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails">
        <link:definition>2404403 - Disclosure - Acquisitions - Adapt Preliminary Purchase Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsPaxvaxNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails">
        <link:definition>2404405 - Disclosure - Acquisitions - PaxVax Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails" roleURI="http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails">
        <link:definition>2404406 - Disclosure - Acquisitions - PaxVax Preliminary Allocation of Purchase Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://emergentbiosolutions.com/role/AcquisitionsTables">
        <link:definition>2304301 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001000 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1001501 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementOfChangesInStockholdersEquity" roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity">
        <link:definition>1005000 - Statement - Consolidated Statement of Changes in Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementOfChangesInStockholdersEquityParenthetical" roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquityParenthetical">
        <link:definition>1005501 - Statement - Consolidated Statement of Changes in Stockholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfCashFlows" roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows">
        <link:definition>1004000 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfComprehensiveIncome" roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome">
        <link:definition>1003000 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfOperations" roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations">
        <link:definition>1002000 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CoverPage" roleURI="http://emergentbiosolutions.com/role/CoverPage">
        <link:definition>0001000 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedBenefitAnd401KSavingsPlan" roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlan">
        <link:definition>2113100 - Disclosure - Defined benefit and 401(k) savings plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails" roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails">
        <link:definition>2413405 - Disclosure - Defined benefit and 401(k) savings plan - Accumulated Other Comprehensive Loss Before Income Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails" roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails">
        <link:definition>2413403 - Disclosure - Defined benefit and 401(k) savings plan - Components of Net Periodic Pension Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails" roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails">
        <link:definition>2413406 - Disclosure - Defined benefit and 401(k) savings plan - Expected Future Benefits Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedBenefitAnd401KSavingsPlanNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanNarrativeDetails">
        <link:definition>2413407 - Disclosure - Defined benefit and 401(k) savings plan - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails" roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails">
        <link:definition>2413402 - Disclosure - Defined benefit and 401(k) savings plan - Swiss Plan Funded Status (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedBenefitAnd401KSavingsPlanTables" roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanTables">
        <link:definition>2313301 - Disclosure - Defined benefit and 401(k) savings plan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails" roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails">
        <link:definition>2413404 - Disclosure - Defined benefit and 401(k) savings plan - Weighted Average Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstruments" roleURI="http://emergentbiosolutions.com/role/DerivativeInstruments">
        <link:definition>2110100 - Disclosure - Derivative Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsCashFlowHedgingOnAociDetails" roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails">
        <link:definition>2410405 - Disclosure - Derivative Instruments - Cash Flow Hedging on AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails" roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails">
        <link:definition>2410402 - Disclosure - Derivative Instruments - Derivative Designated as Cash Flow Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsFairValueByBalanceSheetLocationDetails" roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails">
        <link:definition>2410404 - Disclosure - Derivative Instruments - Fair Value by Balance Sheet Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsNarrativeDetails">
        <link:definition>2410403 - Disclosure - Derivative Instruments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsTables" roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsTables">
        <link:definition>2310301 - Disclosure - Derivative Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://emergentbiosolutions.com/role/EarningsPerShare">
        <link:definition>2115100 - Disclosure - Earnings per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://emergentbiosolutions.com/role/EarningsPerShareDetails">
        <link:definition>2415402 - Disclosure - Earnings per share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://emergentbiosolutions.com/role/EarningsPerShareTables">
        <link:definition>2315301 - Disclosure - Earnings per share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://emergentbiosolutions.com/role/FairValueMeasurements">
        <link:definition>2105100 - Disclosure - Fair value measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://emergentbiosolutions.com/role/FairValueMeasurementsDetails">
        <link:definition>2405402 - Disclosure - Fair value measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2405403 - Disclosure - Fair value measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://emergentbiosolutions.com/role/FairValueMeasurementsTables">
        <link:definition>2305301 - Disclosure - Fair value measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://emergentbiosolutions.com/role/IncomeTaxes">
        <link:definition>2112100 - Disclosure - Income taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails" roleURI="http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails">
        <link:definition>2412403 - Disclosure - Income taxes - Components of the Provisions for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2412402 - Disclosure - Income taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNetDeferredTaxAssetLiabilityDetails" roleURI="http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails">
        <link:definition>2412404 - Disclosure - Income taxes - Net Deferred Tax Asset (Liability) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationDetails" roleURI="http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails">
        <link:definition>2412405 - Disclosure - Income taxes - Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://emergentbiosolutions.com/role/IncomeTaxesTables">
        <link:definition>2312301 - Disclosure - Income taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
        <link:definition>2412406 - Disclosure - Income taxes - Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAndGoodwill" roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwill">
        <link:definition>2108100 - Disclosure - Intangible assets and goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails" roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails">
        <link:definition>2408404 - Disclosure - Intangible assets and goodwill - Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAndGoodwillNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails">
        <link:definition>2408403 - Disclosure - Intangible assets and goodwill - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails" roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails">
        <link:definition>2408402 - Disclosure - Intangible assets and goodwill - Schedule of Finite-lived Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails" roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails">
        <link:definition>2408405 - Disclosure - Intangible assets and goodwill - Summary Changes in Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAndGoodwillTables" roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillTables">
        <link:definition>2308301 - Disclosure - Intangible assets and goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://emergentbiosolutions.com/role/Inventories">
        <link:definition>2106100 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://emergentbiosolutions.com/role/InventoriesDetails">
        <link:definition>2406402 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://emergentbiosolutions.com/role/InventoriesTables">
        <link:definition>2306301 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://emergentbiosolutions.com/role/Leases">
        <link:definition>2114100 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesComponentsOfLeaseExpenseDetails" roleURI="http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails">
        <link:definition>2414403 - Disclosure - Leases - Components of Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/LeasesNarrativeDetails">
        <link:definition>2414402 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>2414404 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://emergentbiosolutions.com/role/LeasesTables">
        <link:definition>2314301 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Litigation" roleURI="http://emergentbiosolutions.com/role/Litigation">
        <link:definition>2119100 - Disclosure - Litigation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://emergentbiosolutions.com/role/LongTermDebt">
        <link:definition>2109100 - Disclosure - Long-term debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtComponentsOfLongTermIndebtednessDetails" roleURI="http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails">
        <link:definition>2409402 - Disclosure - Long-term debt - Components of Long-term Indebtedness (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtConvertibleSeniorNotesDetails" roleURI="http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails">
        <link:definition>2409404 - Disclosure - Long-term debt - Convertible Senior Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails" roleURI="http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails">
        <link:definition>2409405 - Disclosure - Long-term debt - Future Debt Payments of Long-term Indebtedness (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtSeniorSecuredCreditAgreementDetails" roleURI="http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails">
        <link:definition>2409403 - Disclosure - Long-term debt - Senior Secured Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://emergentbiosolutions.com/role/LongTermDebtTables">
        <link:definition>2309301 - Disclosure - Long-term debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureOfBusinessAndOrganization" roleURI="http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganization">
        <link:definition>2101100 - Disclosure - Nature of the business and organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureOfBusinessAndOrganizationDetails" roleURI="http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganizationDetails">
        <link:definition>2401401 - Disclosure - Nature of the business and organization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantAndEquipment" roleURI="http://emergentbiosolutions.com/role/PropertyPlantAndEquipment">
        <link:definition>2107100 - Disclosure - Property, plant and equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantAndEquipmentDetails" roleURI="http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails">
        <link:definition>2407402 - Disclosure - Property, plant and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantAndEquipmentTables" roleURI="http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentTables">
        <link:definition>2307301 - Disclosure - Property, plant and equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PurchaseCommitments" roleURI="http://emergentbiosolutions.com/role/PurchaseCommitments">
        <link:definition>2116100 - Disclosure - Purchase commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PurchaseCommitmentsDetails" roleURI="http://emergentbiosolutions.com/role/PurchaseCommitmentsDetails">
        <link:definition>2416401 - Disclosure - Purchase commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialDataUnaudited" roleURI="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnaudited">
        <link:definition>2118100 - Disclosure - Quarterly financial data (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialDataUnauditedDetails" roleURI="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedDetails">
        <link:definition>2418402 - Disclosure - Quarterly financial data (unaudited) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialDataUnauditedTables" roleURI="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedTables">
        <link:definition>2318301 - Disclosure - Quarterly financial data (unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://emergentbiosolutions.com/role/RevenueRecognition">
        <link:definition>2103100 - Disclosure - Revenue recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionAccountsReceivableDetails" roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails">
        <link:definition>2403406 - Disclosure - Revenue recognition - Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionContractLiabilitiesDetails" roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails">
        <link:definition>2403405 - Disclosure - Revenue recognition - Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregationOfRevenueDetails" roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails">
        <link:definition>2403404 - Disclosure - Revenue recognition - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails">
        <link:definition>2403402 - Disclosure - Revenue recognition - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionRemainingPerformanceObligationDetails" roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionRemainingPerformanceObligationDetails">
        <link:definition>2403403 - Disclosure - Revenue recognition - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionTables">
        <link:definition>2303301 - Disclosure - Revenue recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIiValuationAndQualifyingAccounts" roleURI="http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccounts">
        <link:definition>2120100 - Disclosure - Schedule II - Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIiValuationAndQualifyingAccountsDetails" roleURI="http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails">
        <link:definition>2420401 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://emergentbiosolutions.com/role/SegmentInformation">
        <link:definition>2117100 - Disclosure - Segment information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails">
        <link:definition>2417402 - Disclosure - Segment information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationProductSalesDetails" roleURI="http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails">
        <link:definition>2417403 - Disclosure - Segment information - Product Sales (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://emergentbiosolutions.com/role/SegmentInformationTables">
        <link:definition>2317301 - Disclosure - Segment information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://emergentbiosolutions.com/role/StockholdersEquity">
        <link:definition>2111100 - Disclosure - Stockholders' equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails" roleURI="http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails">
        <link:definition>2411406 - Disclosure - Stockholders' equity - Changes in Accumulated Other Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>2411402 - Disclosure - Stockholders' equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockBasedCompensationExpenseDetails" roleURI="http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails">
        <link:definition>2411405 - Disclosure - Stockholders' equity - Stock-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails" roleURI="http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails">
        <link:definition>2411404 - Disclosure - Stockholders' equity - Stock Options and Restricted Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionsValuationAssumptionsDetails" roleURI="http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails">
        <link:definition>2411403 - Disclosure - Stockholders' equity - Stock Options Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://emergentbiosolutions.com/role/StockholdersEquityTables">
        <link:definition>2311301 - Disclosure - Stockholders' equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPolicies" roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPolicies">
        <link:definition>2102100 - Disclosure - Summary of significant accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails" roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails">
        <link:definition>2402407 - Disclosure - Summary of significant accounting policies - Accounting for Stock-based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails" roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails">
        <link:definition>2402405 - Disclosure - Summary of significant accounting policies - Asset Impairment Analysis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails" roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails">
        <link:definition>2402403 - Disclosure - Summary of significant accounting policies - Concentration Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails" roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails">
        <link:definition>2402406 - Disclosure - Summary of significant accounting policies - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails" roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails">
        <link:definition>2402404 - Disclosure - Summary of significant accounting policies - Estimated Useful Lives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Summary of significant accounting policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails" roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails">
        <link:definition>2402408 - Disclosure - Summary of significant accounting policies - Recently Issued Accounting Standards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesTables" roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesTables">
        <link:definition>2302302 - Disclosure - Summary of significant accounting policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="ebs_ACAM2000Member" name="ACAM2000Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_AdaptPharmaMember" name="AdaptPharmaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_AdjustedNetLoss" name="AdjustedNetLoss" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_AmendedCreditAgreementMember" name="AmendedCreditAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax" name="AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ebs_AmountOfPaymentForManufacturingRelatedMilestones" name="AmountOfPaymentForManufacturingRelatedMilestones" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ebs_AmountOfPaymentForRegulatoryRelatedMilestones" name="AmountOfPaymentForRegulatoryRelatedMilestones" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ebs_AmountRequiredForNetLeverageRatio" name="AmountRequiredForNetLeverageRatio" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_AmountforDeliveriesofProduct" name="AmountforDeliveriesofProduct" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ebs_BasePeriod" name="BasePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_BiothraxMember" name="BiothraxMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ebs_CIADMMember" name="CIADMMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight" name="CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_ChangeInFairValueOfContingentConsideration" name="ChangeInFairValueOfContingentConsideration" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_ChangeinContractWithCustomerLiabilityRollForward" name="ChangeinContractWithCustomerLiabilityRollForward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_CommonStockNumberofVotesPerCommonShare" name="CommonStockNumberofVotesPerCommonShare" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_ConcentrationsRiskPolicyTextBlock" name="ConcentrationsRiskPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_ConsolidatedSecuredNetLeverageRatio" name="ConsolidatedSecuredNetLeverageRatio" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_ContingentConsiderationCurrentPortion" name="ContingentConsiderationCurrentPortion" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ebs_ContingentConsiderationNetOfCurrentPortion" name="ContingentConsiderationNetOfCurrentPortion" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ebs_ContingentConsiderationObligationsPolicyTextBlock" name="ContingentConsiderationObligationsPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_ContractDevelopmentAndManufacturingMember" name="ContractDevelopmentAndManufacturingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_ContractManufacturingMember" name="ContractManufacturingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_ContractWithCustomerLiabilityAdditions" name="ContractWithCustomerLiabilityAdditions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_ContractsAndGrantsMember" name="ContractsAndGrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_ConvertibleSeniorNotesDue2021Member" name="ConvertibleSeniorNotesDue2021Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_CreditAgreementMember" name="CreditAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_DebtCovenantNetLeverageRatioFour" name="DebtCovenantNetLeverageRatioFour" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_DebtCovenantNetLeverageRatioOne" name="DebtCovenantNetLeverageRatioOne" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_DebtCovenantNetLeverageRatioThree" name="DebtCovenantNetLeverageRatioThree" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_DebtCovenantNetLeverageRatioTwo" name="DebtCovenantNetLeverageRatioTwo" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_DebtInstrumentAccruedInterestOnConvertedNotes" name="DebtInstrumentAccruedInterestOnConvertedNotes" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ebs_DebtInstrumentCovenantDebtServiceCoverageRatio" name="DebtInstrumentCovenantDebtServiceCoverageRatio" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_DebtInstrumentCovenantLeverageRatio" name="DebtInstrumentCovenantLeverageRatio" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_DebtInstrumentNumberOfAdditionalEquityInstruments" name="DebtInstrumentNumberOfAdditionalEquityInstruments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_DebtInstrumentNumberOfEquityInstruments" name="DebtInstrumentNumberOfEquityInstruments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_DebtInstrumentRestrictedPaymentsLimitAmount" name="DebtInstrumentRestrictedPaymentsLimitAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ebs_DebtInstrumentTermOfVariableRate" name="DebtInstrumentTermOfVariableRate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment" name="DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_DeferredTaxAssetsOperatingLeaseLiability" name="DeferredTaxAssetsOperatingLeaseLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment" name="DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee" name="DefinedBenefitPlanPlanAssetsContributionsByEmployee" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount" name="EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount" name="EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference" name="EffectiveIncomeTaxRateReconciliationPermanentDifference" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet" name="EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" name="EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts" name="EffectiveIncomeTaxRateReconciliationTransactionCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" name="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" name="EmergentBiosolutionsInc2006StockIncentivePlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_EmergentPlansMember" name="EmergentPlansMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum" name="ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element id="ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment" name="FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter" name="FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="ebs_InProcessResearchAndDevelopment" name="InProcessResearchAndDevelopment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="ebs_LesseeOperatingLeaseTerminationPeriod" name="LesseeOperatingLeaseTerminationPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_LockUpPeriodForAdjustmentOfFairValue" name="LockUpPeriodForAdjustmentOfFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter" name="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember" name="ManitobaScientificResearchAndExperimentalDevelopmentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_NARCANNasalSprayMember" name="NARCANNasalSprayMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_NumberOfCategoriesOfPublicHealthThreats" name="NumberOfCategoriesOfPublicHealthThreats" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_NumberOfEmployees" name="NumberOfEmployees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_NumberOfLendingInstitutions" name="NumberOfLendingInstitutions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_NumberOfRevenueGeneratingProducts" name="NumberOfRevenueGeneratingProducts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_NumberOfStockbasedEmployeeCompensationPlans" name="NumberOfStockbasedEmployeeCompensationPlans" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="ebs_NumberofAdditionalOptionPeriods" name="NumberofAdditionalOptionPeriods" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_OperatingLeaseOtherLiabilityCurrent" name="OperatingLeaseOtherLiabilityCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ebs_OtherLongTermDebtFacilityMember" name="OtherLongTermDebtFacilityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_OtherMember" name="OtherMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_PaxVaxMember" name="PaxVaxMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear" name="PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears" name="PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears" name="PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_PresentValueDiscountRate" name="PresentValueDiscountRate" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_RaxibacumabMember" name="RaxibacumabMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" name="SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_ScheduleofAccountsReceivableNetTableTextBlock" name="ScheduleofAccountsReceivableNetTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue" name="ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod" name="ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit" name="TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit" name="TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary" name="TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense" name="TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" name="TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_TermLoanFacilityMember" name="TermLoanFacilityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_TermofContract" name="TermofContract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_TermofContractUnderAcquisition" name="TermofContractUnderAcquisition" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_UnitedStatesGovernmentMember" name="UnitedStatesGovernmentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ebs_UnrecognizedTaxBenefitsCurrent" name="UnrecognizedTaxBenefitsCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ebs_UnrecognizedTaxBenefitsNoncurrent" name="UnrecognizedTaxBenefitsNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ebs_UpfrontPayments" name="UpfrontPayments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ebs_ValueofContract" name="ValueofContract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ebs_VaxchoraMember" name="VaxchoraMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ebs_VivotifMember" name="VivotifMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>17
<FILENAME>ebs-20191231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Acquisitions" xlink:href="ebs-20191231.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAcquisitionOfAcam2000BusinessDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAcquisitionOfAcam2000NarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAcquisitionOfRaxibacumabAssetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAdaptNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails" xlink:href="ebs-20191231.xsd#AcquisitionsPaxvaxNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails" xlink:href="ebs-20191231.xsd#AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsTables" xlink:href="ebs-20191231.xsd#AcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets" xlink:href="ebs-20191231.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="ebs-20191231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" xlink:href="ebs-20191231.xsd#ConsolidatedStatementOfChangesInStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquityParenthetical" xlink:href="ebs-20191231.xsd#ConsolidatedStatementOfChangesInStockholdersEquityParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="ebs-20191231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="ebs-20191231.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations" xlink:href="ebs-20191231.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CoverPage" xlink:href="ebs-20191231.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlan" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlan" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanNarrativeDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanTables" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstruments" xlink:href="ebs-20191231.xsd#DerivativeInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails" xlink:href="ebs-20191231.xsd#DerivativeInstrumentsCashFlowHedgingOnAociDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails" xlink:href="ebs-20191231.xsd#DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails" xlink:href="ebs-20191231.xsd#DerivativeInstrumentsFairValueByBalanceSheetLocationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsNarrativeDetails" xlink:href="ebs-20191231.xsd#DerivativeInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsTables" xlink:href="ebs-20191231.xsd#DerivativeInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/EarningsPerShare" xlink:href="ebs-20191231.xsd#EarningsPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/EarningsPerShareDetails" xlink:href="ebs-20191231.xsd#EarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/EarningsPerShareTables" xlink:href="ebs-20191231.xsd#EarningsPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairValueMeasurements" xlink:href="ebs-20191231.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairValueMeasurementsDetails" xlink:href="ebs-20191231.xsd#FairValueMeasurementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="ebs-20191231.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairValueMeasurementsTables" xlink:href="ebs-20191231.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxes" xlink:href="ebs-20191231.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails" xlink:href="ebs-20191231.xsd#IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails" xlink:href="ebs-20191231.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails" xlink:href="ebs-20191231.xsd#IncomeTaxesNetDeferredTaxAssetLiabilityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails" xlink:href="ebs-20191231.xsd#IncomeTaxesReconciliationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesTables" xlink:href="ebs-20191231.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:href="ebs-20191231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwill" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwillNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillTables" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Inventories" xlink:href="ebs-20191231.xsd#Inventories" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/InventoriesDetails" xlink:href="ebs-20191231.xsd#InventoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/InventoriesTables" xlink:href="ebs-20191231.xsd#InventoriesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Leases" xlink:href="ebs-20191231.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails" xlink:href="ebs-20191231.xsd#LeasesComponentsOfLeaseExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesNarrativeDetails" xlink:href="ebs-20191231.xsd#LeasesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:href="ebs-20191231.xsd#LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesTables" xlink:href="ebs-20191231.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Litigation" xlink:href="ebs-20191231.xsd#Litigation" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebt" xlink:href="ebs-20191231.xsd#LongTermDebt" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails" xlink:href="ebs-20191231.xsd#LongTermDebtComponentsOfLongTermIndebtednessDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails" xlink:href="ebs-20191231.xsd#LongTermDebtConvertibleSeniorNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails" xlink:href="ebs-20191231.xsd#LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails" xlink:href="ebs-20191231.xsd#LongTermDebtSeniorSecuredCreditAgreementDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebtTables" xlink:href="ebs-20191231.xsd#LongTermDebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganization" xlink:href="ebs-20191231.xsd#NatureOfBusinessAndOrganization" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganizationDetails" xlink:href="ebs-20191231.xsd#NatureOfBusinessAndOrganizationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyPlantAndEquipment" xlink:href="ebs-20191231.xsd#PropertyPlantAndEquipment" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails" xlink:href="ebs-20191231.xsd#PropertyPlantAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentTables" xlink:href="ebs-20191231.xsd#PropertyPlantAndEquipmentTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PurchaseCommitments" xlink:href="ebs-20191231.xsd#PurchaseCommitments" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PurchaseCommitmentsDetails" xlink:href="ebs-20191231.xsd#PurchaseCommitmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnaudited" xlink:href="ebs-20191231.xsd#QuarterlyFinancialDataUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedDetails" xlink:href="ebs-20191231.xsd#QuarterlyFinancialDataUnauditedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedTables" xlink:href="ebs-20191231.xsd#QuarterlyFinancialDataUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognition" xlink:href="ebs-20191231.xsd#RevenueRecognition" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails" xlink:href="ebs-20191231.xsd#RevenueRecognitionAccountsReceivableDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails" xlink:href="ebs-20191231.xsd#RevenueRecognitionContractLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:href="ebs-20191231.xsd#RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails" xlink:href="ebs-20191231.xsd#RevenueRecognitionNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionRemainingPerformanceObligationDetails" xlink:href="ebs-20191231.xsd#RevenueRecognitionRemainingPerformanceObligationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionTables" xlink:href="ebs-20191231.xsd#RevenueRecognitionTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:href="ebs-20191231.xsd#ScheduleIiValuationAndQualifyingAccounts" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:href="ebs-20191231.xsd#ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentInformation" xlink:href="ebs-20191231.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails" xlink:href="ebs-20191231.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails" xlink:href="ebs-20191231.xsd#SegmentInformationProductSalesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentInformationTables" xlink:href="ebs-20191231.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquity" xlink:href="ebs-20191231.xsd#StockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails" xlink:href="ebs-20191231.xsd#StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails" xlink:href="ebs-20191231.xsd#StockholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails" xlink:href="ebs-20191231.xsd#StockholdersEquityStockBasedCompensationExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails" xlink:href="ebs-20191231.xsd#StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails" xlink:href="ebs-20191231.xsd#StockholdersEquityStockOptionsValuationAssumptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityTables" xlink:href="ebs-20191231.xsd#StockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Acquisitions" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:type="locator" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9ad6eb0b-0be8-3959-8888-f510808da951" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9ad6eb0b-0be8-3959-8888-f510808da951" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_395f9bb0-2492-f247-ce6b-39e67453292c" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_395f9bb0-2492-f247-ce6b-39e67453292c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8ce68675-8129-3ab4-cbd9-33127f150e28" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8ce68675-8129-3ab4-cbd9-33127f150e28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_4969e367-c531-0df1-f44b-bfbc106efa7e" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_4969e367-c531-0df1-f44b-bfbc106efa7e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_fbe331bf-e36a-7435-2eec-e3249b6c0997" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_fbe331bf-e36a-7435-2eec-e3249b6c0997" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities" xlink:label="loc_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_808c8606-0f95-b16b-a9dd-d849aca21643" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_808c8606-0f95-b16b-a9dd-d849aca21643" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ca5b5f1d-dfc3-4674-aee8-5c9edec064b4" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ca5b5f1d-dfc3-4674-aee8-5c9edec064b4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_9fd4e909-6e77-b96d-24a2-93ffef186798" xlink:type="locator" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_5840b857-19b3-74ef-161f-d849ac88ad7a" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_9fd4e909-6e77-b96d-24a2-93ffef186798" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_5840b857-19b3-74ef-161f-d849ac88ad7a" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_028BDF7D738A6ECFC1D137878FEB1871" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_9fd4e909-6e77-b96d-24a2-93ffef186798" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_028BDF7D738A6ECFC1D137878FEB1871" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_395f9bb0-2492-f247-ce6b-39e67453292c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_395f9bb0-2492-f247-ce6b-39e67453292c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8ce68675-8129-3ab4-cbd9-33127f150e28" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8ce68675-8129-3ab4-cbd9-33127f150e28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9ad6eb0b-0be8-3959-8888-f510808da951" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9ad6eb0b-0be8-3959-8888-f510808da951" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_4969e367-c531-0df1-f44b-bfbc106efa7e" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_4969e367-c531-0df1-f44b-bfbc106efa7e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_090d08a1-b8fd-3634-47b8-7dcb68699de1" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_090d08a1-b8fd-3634-47b8-7dcb68699de1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_03034168-0c29-957e-9b7e-01ea7f13c7d8" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_03034168-0c29-957e-9b7e-01ea7f13c7d8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_fbe331bf-e36a-7435-2eec-e3249b6c0997" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_fbe331bf-e36a-7435-2eec-e3249b6c0997" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities" xlink:label="loc_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_808c8606-0f95-b16b-a9dd-d849aca21643" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_808c8606-0f95-b16b-a9dd-d849aca21643" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_9fd4e909-6e77-b96d-24a2-93ffef186798" xlink:type="locator" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_5840b857-19b3-74ef-161f-d849ac88ad7a" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_9fd4e909-6e77-b96d-24a2-93ffef186798" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_5840b857-19b3-74ef-161f-d849ac88ad7a" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_3D3B5C5BE8A0FEF0583932D80C6DDC16" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_9fd4e909-6e77-b96d-24a2-93ffef186798" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_3D3B5C5BE8A0FEF0583932D80C6DDC16" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities_3D993A064359BEB40A2F206FE70A3C79" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_9fd4e909-6e77-b96d-24a2-93ffef186798" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities_3D993A064359BEB40A2F206FE70A3C79" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_af012273-e8ee-655c-daa2-86b96989d377" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_af012273-e8ee-655c-daa2-86b96989d377" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_831ad0b9-9dba-3997-20e6-e99a19aa28db" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_Goodwill_831ad0b9-9dba-3997-20e6-e99a19aa28db" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_InProcessResearchAndDevelopment" xlink:label="loc_ebs_InProcessResearchAndDevelopment_a4801d57-38f8-116d-9e2d-d849ac7c6e2d" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_ebs_InProcessResearchAndDevelopment_a4801d57-38f8-116d-9e2d-d849ac7c6e2d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_6544a746-9524-1b61-e235-04d48d39f116" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_6544a746-9524-1b61-e235-04d48d39f116" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32f41ea9-05c6-e713-464b-586a571d1c1f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32f41ea9-05c6-e713-464b-586a571d1c1f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_928a1618-af56-709a-989c-a303706b8ca2" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_928a1618-af56-709a-989c-a303706b8ca2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_81b308b1-c4ff-480c-3942-2317dfd5262a" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_RestrictedCashCurrent_81b308b1-c4ff-480c-3942-2317dfd5262a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ce9014ac-0ac4-6ed2-b53f-a0edc046d6b4" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ce9014ac-0ac4-6ed2-b53f-a0edc046d6b4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="loc_us-gaap_IncomeTaxesReceivable_ebb94f1a-1386-5eed-9402-f0f0e2cd300b" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_IncomeTaxesReceivable_ebb94f1a-1386-5eed-9402-f0f0e2cd300b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ddb0d184-2205-2a10-5b0e-faf2ccd717ae" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ddb0d184-2205-2a10-5b0e-faf2ccd717ae" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:to="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_c2c48170-d0ff-2c37-effc-ff5f53e30dcb" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_AccountsPayableCurrent_c2c48170-d0ff-2c37-effc-ff5f53e30dcb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8422f2c5-408e-d123-b935-f3115e023941" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8422f2c5-408e-d123-b935-f3115e023941" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e2721e-44a1-957d-5aaa-294b580a15e3" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e2721e-44a1-957d-5aaa-294b580a15e3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent_cd826f20-6b4c-b457-3189-ea81282fdd01" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_NotesPayableCurrent_cd826f20-6b4c-b457-3189-ea81282fdd01" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContingentConsiderationCurrentPortion" xlink:label="loc_ebs_ContingentConsiderationCurrentPortion_69d7f0b2-3f30-6d19-b688-ccd32dd32615" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_ebs_ContingentConsiderationCurrentPortion_69d7f0b2-3f30-6d19-b688-ccd32dd32615" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_4bcdb937-432e-7a7e-23c2-a441d7b89da5" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_4bcdb937-432e-7a7e-23c2-a441d7b89da5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c575cd94-2e5c-db53-1e93-d54553800310" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c575cd94-2e5c-db53-1e93-d54553800310" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContingentConsiderationNetOfCurrentPortion" xlink:label="loc_ebs_ContingentConsiderationNetOfCurrentPortion_75633206-d707-baa3-498c-ccd32e0cf556" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_ebs_ContingentConsiderationNetOfCurrentPortion_75633206-d707-baa3-498c-ccd32e0cf556" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d3ba3006-9df7-8186-2eb2-dc5094562cfe" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d3ba3006-9df7-8186-2eb2-dc5094562cfe" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_fcfc6b17-bfc5-2ebc-3fc1-751aa446a572" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_fcfc6b17-bfc5-2ebc-3fc1-751aa446a572" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bba08e5f-78e8-6c25-01a4-6720051135cc" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_bba08e5f-78e8-6c25-01a4-6720051135cc" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:to="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_ea289a9d-deba-2cde-21e4-3d0ae7a1f011" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_PreferredStockValue_ea289a9d-deba-2cde-21e4-3d0ae7a1f011" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_aefe3f0c-abe4-5b83-9a64-da77d8e253dd" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_CommonStockValue_aefe3f0c-abe4-5b83-9a64-da77d8e253dd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_70b30340-b55c-aed7-73f5-36d397294f84" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_TreasuryStockValue_70b30340-b55c-aed7-73f5-36d397294f84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_6dca832a-861c-478d-b1a0-396533beb40d" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_AdditionalPaidInCapital_6dca832a-861c-478d-b1a0-396533beb40d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_798442bf-12e1-d944-3fa1-8b797b67482e" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_798442bf-12e1-d944-3fa1-8b797b67482e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a59bc5ae-63a0-c9bc-32f7-e2bd9f32bd26" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a59bc5ae-63a0-c9bc-32f7-e2bd9f32bd26" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquityParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9743d583-dfae-6ae9-f133-a1e331df792c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9743d583-dfae-6ae9-f133-a1e331df792c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_90cbc3ab-f555-6407-b3b4-b2bfa84c9f18" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_ShareBasedCompensation_90cbc3ab-f555-6407-b3b4-b2bfa84c9f18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_cad51b02-4985-8a39-fe32-340b8f368d21" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_cad51b02-4985-8a39-fe32-340b8f368d21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e8a9abf2-38d3-77d1-fb6b-693fef632294" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e8a9abf2-38d3-77d1-fb6b-693fef632294" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ChangeInFairValueOfContingentConsideration" xlink:label="loc_ebs_ChangeInFairValueOfContingentConsideration_99273215-35dd-5190-d206-d849ac823586" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_ebs_ChangeInFairValueOfContingentConsideration_99273215-35dd-5190-d206-d849ac823586" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_fbe4b42b-bf72-1baa-3dd5-f86601e9aa75" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_fbe4b42b-bf72-1baa-3dd5-f86601e9aa75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_b412c390-dfec-d4c8-f13e-036e3b49278c" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_b412c390-dfec-d4c8-f13e-036e3b49278c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_29b0a481-c653-23c1-27cf-114dadcce1af" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_29b0a481-c653-23c1-27cf-114dadcce1af" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f96c19e-85fe-99f6-cec0-c2c9d7470ed4" xlink:type="locator" />
    <link:calculationArc order="9" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f96c19e-85fe-99f6-cec0-c2c9d7470ed4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_334f1d33-7cae-7fd2-9d83-bb387fc2f3dd" xlink:type="locator" />
    <link:calculationArc order="10" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_334f1d33-7cae-7fd2-9d83-bb387fc2f3dd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_18d902bc-637c-7a0c-8048-153419aa295b" xlink:type="locator" />
    <link:calculationArc order="11" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_18d902bc-637c-7a0c-8048-153419aa295b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0e4168a9-901d-abb5-15c0-3622e9e2c070" xlink:type="locator" />
    <link:calculationArc order="12" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0e4168a9-901d-abb5-15c0-3622e9e2c070" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0a39d2ee-656d-ead5-a676-41794b4da8f4" xlink:type="locator" />
    <link:calculationArc order="13" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0a39d2ee-656d-ead5-a676-41794b4da8f4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2d76eef5-dce5-0152-632e-9bab39da698c" xlink:type="locator" />
    <link:calculationArc order="14" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2d76eef5-dce5-0152-632e-9bab39da698c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_bb8c0c41-60b6-6ad9-c835-6a671aae07c5" xlink:type="locator" />
    <link:calculationArc order="15" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_bb8c0c41-60b6-6ad9-c835-6a671aae07c5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_7d3f88de-7d0f-fe63-f176-2a8af9ecbcbd" xlink:type="locator" />
    <link:calculationArc order="16" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_7d3f88de-7d0f-fe63-f176-2a8af9ecbcbd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9743d583-dfae-6ae9-f133-a1e331df792c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6d89f221-3ede-36b2-fcad-4a4ce1606f6a" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6d89f221-3ede-36b2-fcad-4a4ce1606f6a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForPreviousAcquisition" xlink:label="loc_us-gaap_PaymentsForPreviousAcquisition_15e0d59c-694f-a85a-bf05-43f9a919374e" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:to="loc_us-gaap_PaymentsForPreviousAcquisition_15e0d59c-694f-a85a-bf05-43f9a919374e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_8cec699e-eb8f-7a25-49e6-e52d81fe4f5f" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_8cec699e-eb8f-7a25-49e6-e52d81fe4f5f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_80abba07-181c-6ed2-349d-9d7dfc078eab" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_80abba07-181c-6ed2-349d-9d7dfc078eab" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_22d4264a-c9a9-de0b-92b4-2261a21c1a6a" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_22d4264a-c9a9-de0b-92b4-2261a21c1a6a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9743d583-dfae-6ae9-f133-a1e331df792c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_632129be-5229-a7d0-e53b-c34bdd2c2b9a" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_632129be-5229-a7d0-e53b-c34bdd2c2b9a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_f0ad11b7-f6de-91e3-5733-361b56cc8307" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_f0ad11b7-f6de-91e3-5733-361b56cc8307" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_ffdfa640-a405-1cf4-b7ca-4f26d8d30e65" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_ffdfa640-a405-1cf4-b7ca-4f26d8d30e65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfMediumTermNotes" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes_365325f2-cb4b-9d57-d769-4a5672f16cd9" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_RepaymentsOfMediumTermNotes_365325f2-cb4b-9d57-d769-4a5672f16cd9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_706d3cc5-3df5-1e1a-5067-c02728407eb6" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_706d3cc5-3df5-1e1a-5067-c02728407eb6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_6accd1a2-f190-7888-29dd-29802af49bdc" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_6accd1a2-f190-7888-29dd-29802af49bdc" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_43305c85-41ff-3d0f-c464-dc8983363bce" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_43305c85-41ff-3d0f-c464-dc8983363bce" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_0875b2e3-27c1-eb02-1003-25cd8f923808" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_0875b2e3-27c1-eb02-1003-25cd8f923808" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_8ca40fc7-564f-832a-56a7-2cfd188fe573" xlink:type="locator" />
    <link:calculationArc order="9" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_8ca40fc7-564f-832a-56a7-2cfd188fe573" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_2aa7093e-1edf-5753-4f15-d35ff09db82b" xlink:type="locator" />
    <link:calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_2aa7093e-1edf-5753-4f15-d35ff09db82b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d4a92697-d008-996b-823a-bd9a56a04b3a" xlink:type="locator" />
    <link:calculationArc order="11" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d4a92697-d008-996b-823a-bd9a56a04b3a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_714a30d1-878f-1497-8ad1-4b1e113da228" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9743d583-dfae-6ae9-f133-a1e331df792c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_714a30d1-878f-1497-8ad1-4b1e113da228" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1ce4b89e-fa52-7101-5bea-622168a4559a" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32f41ea9-05c6-e713-464b-586a571d1c1f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1ce4b89e-fa52-7101-5bea-622168a4559a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32f41ea9-05c6-e713-464b-586a571d1c1f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_81b308b1-c4ff-480c-3942-2317dfd5262a" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1ce4b89e-fa52-7101-5bea-622168a4559a" xlink:to="loc_us-gaap_RestrictedCashCurrent_81b308b1-c4ff-480c-3942-2317dfd5262a" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_cf605d39-9067-2f07-a6b5-7dfa6481009e" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cf605d39-9067-2f07-a6b5-7dfa6481009e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_29b707e4-876d-47bd-8655-71c027f42964" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_29b707e4-876d-47bd-8655-71c027f42964" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_740d7ae2-7793-6003-66da-fd16a2cbdae4" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_740d7ae2-7793-6003-66da-fd16a2cbdae4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_f4d6d45b-88d2-a3a4-8afc-7883224dc7d6" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_f4d6d45b-88d2-a3a4-8afc-7883224dc7d6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_048ec802-2790-a30d-0e9a-5c6f3e54d390" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_048ec802-2790-a30d-0e9a-5c6f3e54d390" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cf605d39-9067-2f07-a6b5-7dfa6481009e" xlink:to="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:to="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1c65a201-fd8e-32d7-dad9-c6d1d5719594" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1c65a201-fd8e-32d7-dad9-c6d1d5719594" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_11c9d7e5-c56e-e78a-ae7b-17989a817204" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_11c9d7e5-c56e-e78a-ae7b-17989a817204" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_693c47dd-e6fa-9c85-6a65-7baa26f76b5e" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_693c47dd-e6fa-9c85-6a65-7baa26f76b5e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_afd0f625-a29a-3806-bad0-ad0ca19e7015" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_afd0f625-a29a-3806-bad0-ad0ca19e7015" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1c604cfe-da19-5194-72b6-98be0130cfb7" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1c604cfe-da19-5194-72b6-98be0130cfb7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c5398800-6e68-ed86-a47c-16106e0730c2" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_c5398800-6e68-ed86-a47c-16106e0730c2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_a56b34b7-57ab-a07c-7f03-8366849a14f0" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c5398800-6e68-ed86-a47c-16106e0730c2" xlink:to="loc_us-gaap_InterestExpense_a56b34b7-57ab-a07c-7f03-8366849a14f0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_41e96f8d-e499-8de8-69a8-27f1c7d4df6e" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c5398800-6e68-ed86-a47c-16106e0730c2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_41e96f8d-e499-8de8-69a8-27f1c7d4df6e" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/CoverPage" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlan" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0f27487e-3d5a-f377-0098-b0e848cdad0f" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_489d8e73-cdae-5246-456e-868aff0fc625" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0f27487e-3d5a-f377-0098-b0e848cdad0f" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_489d8e73-cdae-5246-456e-868aff0fc625" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_5cad856d-5bc0-8a6d-8833-76680f9c72f2" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0f27487e-3d5a-f377-0098-b0e848cdad0f" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_5cad856d-5bc0-8a6d-8833-76680f9c72f2" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f8c4af80-3396-31ad-927b-214035fcad4c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_50c65441-5a4a-7b70-8a6f-4bdf84901dd7" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f8c4af80-3396-31ad-927b-214035fcad4c" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_50c65441-5a4a-7b70-8a6f-4bdf84901dd7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_cc5d4539-1440-3488-daaf-595604d399d2" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f8c4af80-3396-31ad-927b-214035fcad4c" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_cc5d4539-1440-3488-daaf-595604d399d2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_9eb8402e-17f1-615b-f0e0-f772c38d36ef" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f8c4af80-3396-31ad-927b-214035fcad4c" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_9eb8402e-17f1-615b-f0e0-f772c38d36ef" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_b67af07e-08c9-8a9d-7819-af0ab2e3dd91" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_429eb129-c17f-441f-1e56-ffc07d73f2a7" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_b67af07e-08c9-8a9d-7819-af0ab2e3dd91" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_429eb129-c17f-441f-1e56-ffc07d73f2a7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_51db897c-3518-ee77-5f85-d8e97d6ddfe0" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_b67af07e-08c9-8a9d-7819-af0ab2e3dd91" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_51db897c-3518-ee77-5f85-d8e97d6ddfe0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_76b31f87-c7ba-4950-d150-9dedc09b0255" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_b67af07e-08c9-8a9d-7819-af0ab2e3dd91" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_76b31f87-c7ba-4950-d150-9dedc09b0255" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_a3749a0d-37f1-d4f5-7041-12bc385c3859" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_b67af07e-08c9-8a9d-7819-af0ab2e3dd91" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_a3749a0d-37f1-d4f5-7041-12bc385c3859" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_cb9367d7-29a1-2921-b488-070af81839d7" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_b67af07e-08c9-8a9d-7819-af0ab2e3dd91" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_cb9367d7-29a1-2921-b488-070af81839d7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_d41cb414-9687-caef-68f0-55adce184cc8" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_b67af07e-08c9-8a9d-7819-af0ab2e3dd91" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_d41cb414-9687-caef-68f0-55adce184cc8" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstruments" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstrumentsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/EarningsPerShare" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AdjustedNetLoss" xlink:label="loc_ebs_AdjustedNetLoss_7c556b0b-6141-1a59-226a-ccd32e9ce6d4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ebs_AdjustedNetLoss_7c556b0b-6141-1a59-226a-ccd32e9ce6d4" xlink:to="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_7738fb07-0685-e2bb-65c3-202464dd1243" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ebs_AdjustedNetLoss_7c556b0b-6141-1a59-226a-ccd32e9ce6d4" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_7738fb07-0685-e2bb-65c3-202464dd1243" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax" xlink:label="loc_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax_32429c7d-502d-e663-1891-ccd32d7de8d0" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ebs_AdjustedNetLoss_7c556b0b-6141-1a59-226a-ccd32e9ce6d4" xlink:to="loc_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax_32429c7d-502d-e663-1891-ccd32d7de8d0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21ce4f2f-397c-6c02-8635-7c94146a06a0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e52bef3f-d63a-d129-8b6a-48192f5d97b3" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21ce4f2f-397c-6c02-8635-7c94146a06a0" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e52bef3f-d63a-d129-8b6a-48192f5d97b3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_d81633a3-dcc9-02ed-c932-69afb6c98911" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21ce4f2f-397c-6c02-8635-7c94146a06a0" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_d81633a3-dcc9-02ed-c932-69afb6c98911" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2dd9a981-e559-d141-f1c2-4db79f71a7ef" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21ce4f2f-397c-6c02-8635-7c94146a06a0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2dd9a981-e559-d141-f1c2-4db79f71a7ef" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/EarningsPerShareTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/FairValueMeasurementsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxes" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_816edbc5-9d4b-113c-7ce2-6c08dd555314" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_816edbc5-9d4b-113c-7ce2-6c08dd555314" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b975ff9b-a11f-f2b5-e104-e0266dbbbfc6" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_816edbc5-9d4b-113c-7ce2-6c08dd555314" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b975ff9b-a11f-f2b5-e104-e0266dbbbfc6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4d365c95-da3d-c3cb-6f6b-7945d285af9f" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_816edbc5-9d4b-113c-7ce2-6c08dd555314" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4d365c95-da3d-c3cb-6f6b-7945d285af9f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_bbb5a6cc-fe5e-18f1-e9f0-76884d58b714" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_816edbc5-9d4b-113c-7ce2-6c08dd555314" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_bbb5a6cc-fe5e-18f1-e9f0-76884d58b714" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment" xlink:label="loc_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_a267290f-69e6-bbd9-1488-ccd32e709e8a" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_a267290f-69e6-bbd9-1488-ccd32e709e8a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_650e6c8f-1409-4de1-126f-784909f82e64" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_a267290f-69e6-bbd9-1488-ccd32e709e8a" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_650e6c8f-1409-4de1-126f-784909f82e64" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_10aa09ac-60b4-bd88-6c3b-c85b3f0fbf0a" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_a267290f-69e6-bbd9-1488-ccd32e709e8a" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_10aa09ac-60b4-bd88-6c3b-c85b3f0fbf0a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_840ca4a2-1542-fad2-992c-40136594b396" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_a267290f-69e6-bbd9-1488-ccd32e709e8a" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_840ca4a2-1542-fad2-992c-40136594b396" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_cee36967-7b64-56b0-03ea-66fbd4d14899" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_cee36967-7b64-56b0-03ea-66fbd4d14899" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment" xlink:label="loc_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment_35a3df31-25b8-0550-2e28-ccd32defa45f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment_35a3df31-25b8-0550-2e28-ccd32defa45f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_187bb760-9cde-c4af-d9e1-306e7a6330eb" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_187bb760-9cde-c4af-d9e1-306e7a6330eb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_4b11660d-aa03-e72b-b3a5-729db9810471" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_4b11660d-aa03-e72b-b3a5-729db9810471" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_0e2dc226-85ed-d782-cf37-e83741c371ce" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_0e2dc226-85ed-d782-cf37-e83741c371ce" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_475c85ca-97e4-c8e8-9ee2-6c534eb18ace" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_475c85ca-97e4-c8e8-9ee2-6c534eb18ace" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_0cc13c2f-6b23-b741-4f28-07325c7e7169" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_0cc13c2f-6b23-b741-4f28-07325c7e7169" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_8941e567-ec6e-8c30-1508-66a8372d1715" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_8941e567-ec6e-8c30-1508-66a8372d1715" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_dd649c25-f9b5-12c4-fe90-ee7c9cba6a1f" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_dd649c25-f9b5-12c4-fe90-ee7c9cba6a1f" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DeferredTaxAssetsOperatingLeaseLiability" xlink:label="loc_ebs_DeferredTaxAssetsOperatingLeaseLiability_906E9900C33C7AD1EF133F48728ABDAD" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_ebs_DeferredTaxAssetsOperatingLeaseLiability_906E9900C33C7AD1EF133F48728ABDAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8d3f7f58-e2d6-8ff0-86f5-8d249c7b8257" xlink:type="locator" />
    <link:calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8d3f7f58-e2d6-8ff0-86f5-8d249c7b8257" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d9af76c3-a64a-3b37-1d7d-4e9be8c70af6" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_cee36967-7b64-56b0-03ea-66fbd4d14899" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d9af76c3-a64a-3b37-1d7d-4e9be8c70af6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_5ca8e732-540c-5527-8ee3-c835dafc5838" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_cee36967-7b64-56b0-03ea-66fbd4d14899" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_5ca8e732-540c-5527-8ee3-c835dafc5838" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_4ed01819-014a-ce74-957e-ddc9b0c1d62e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5ca8e732-540c-5527-8ee3-c835dafc5838" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_4ed01819-014a-ce74-957e-ddc9b0c1d62e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_42b61cde-44f6-df44-52b0-1b84b1e28a47" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5ca8e732-540c-5527-8ee3-c835dafc5838" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_42b61cde-44f6-df44-52b0-1b84b1e28a47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_66d26f67-ac52-9636-4917-e96a0564fe70" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5ca8e732-540c-5527-8ee3-c835dafc5838" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_66d26f67-ac52-9636-4917-e96a0564fe70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_3e7fd080-3ec6-50fa-98f3-b61bc68dbdcf" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5ca8e732-540c-5527-8ee3-c835dafc5838" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_3e7fd080-3ec6-50fa-98f3-b61bc68dbdcf" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossAttributableToParent" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_390dfadc-5cbd-cf5c-2869-4af95ab63efc" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e6f9d43e-fcd6-745d-b634-9ed4792095b2" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_390dfadc-5cbd-cf5c-2869-4af95ab63efc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e6f9d43e-fcd6-745d-b634-9ed4792095b2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_a4e74316-f31b-80bc-a44a-3464e9dcdb33" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_390dfadc-5cbd-cf5c-2869-4af95ab63efc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_a4e74316-f31b-80bc-a44a-3464e9dcdb33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_46fd3e47-b379-3d5b-dad7-1fdc5e88b67f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_46fd3e47-b379-3d5b-dad7-1fdc5e88b67f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_147896db-b2dd-402f-9f5b-8c57c745a45a" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_147896db-b2dd-402f-9f5b-8c57c745a45a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e9804aa2-0190-55cd-01a9-85d659cee6b2" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e9804aa2-0190-55cd-01a9-85d659cee6b2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_403b8245-2a5c-b405-4865-11cfdebd2992" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_403b8245-2a5c-b405-4865-11cfdebd2992" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits_a3f26c1e-91b7-2880-1113-1647820fec09" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCredits_a3f26c1e-91b7-2880-1113-1647820fec09" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_e9430693-bf08-1b08-560f-ccd32e8314dd" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_e9430693-bf08-1b08-560f-ccd32e8314dd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_b8a6f67f-d570-db88-37fa-3568c826ebc5" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_b8a6f67f-d570-db88-37fa-3568c826ebc5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2fc8d554-3ed0-9aae-a23b-3842180d9904" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2fc8d554-3ed0-9aae-a23b-3842180d9904" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_7c88fa1f-0edb-d24c-9b87-0646da5010cf" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_7c88fa1f-0edb-d24c-9b87-0646da5010cf" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_a796cbdf-aaac-9f7e-6bbb-bc756ba4beb0" xlink:type="locator" />
    <link:calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_a796cbdf-aaac-9f7e-6bbb-bc756ba4beb0" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts_a41fd023-5f67-b5af-9dcf-ccd32e81e54f" xlink:type="locator" />
    <link:calculationArc order="11" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts_a41fd023-5f67-b5af-9dcf-ccd32e81e54f" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount_9E16F722781EE18AACB45DF32C7945A4" xlink:type="locator" />
    <link:calculationArc order="12" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount_9E16F722781EE18AACB45DF32C7945A4" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount_FE754F8ADB5414505C543F504C5F8F0D" xlink:type="locator" />
    <link:calculationArc order="13" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount_FE754F8ADB5414505C543F504C5F8F0D" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_B61171D5311AECD8A24C3F52066DCDC9" xlink:type="locator" />
    <link:calculationArc order="14" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_B61171D5311AECD8A24C3F52066DCDC9" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet_9b9ee802-6da2-d5e6-fe2b-ccd32eb14558" xlink:type="locator" />
    <link:calculationArc order="15" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet_9b9ee802-6da2-d5e6-fe2b-ccd32eb14558" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference_2ba09720-12dd-88fc-b93c-ccd32dd06b8c" xlink:type="locator" />
    <link:calculationArc order="16" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference_2ba09720-12dd-88fc-b93c-ccd32dd06b8c" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwill" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_423e6bba-f43d-931c-5711-51d5522b2aaa" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_423e6bba-f43d-931c-5711-51d5522b2aaa" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_28c91f3b-370e-e76f-4199-69e4166aabc6" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_28c91f3b-370e-e76f-4199-69e4166aabc6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f7796428-4176-97fe-5145-79a026d8547a" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f7796428-4176-97fe-5145-79a026d8547a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_71fd8e03-8eaf-f20c-786b-5e0492fb281b" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_71fd8e03-8eaf-f20c-786b-5e0492fb281b" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter" xlink:label="loc_ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter_5b3f21d4-8695-ac47-8bf5-ccd32e7605d1" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter_5b3f21d4-8695-ac47-8bf5-ccd32e7605d1" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:type="locator" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Inventories" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_b1399fc2-f1bd-2a05-e4cb-8c363da2af9e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_b1399fc2-f1bd-2a05-e4cb-8c363da2af9e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_02cb866c-0b1c-51f5-8ed3-3272dfc8c769" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_02cb866c-0b1c-51f5-8ed3-3272dfc8c769" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c2dd0840-de07-383b-bde9-fb229532490d" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c2dd0840-de07-383b-bde9-fb229532490d" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/InventoriesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Leases" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_d5a06061-b83d-0d55-b7d3-e1229681b86d" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_0c835b1b-073b-1726-45ed-7f72b8f658d6" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_d5a06061-b83d-0d55-b7d3-e1229681b86d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_0c835b1b-073b-1726-45ed-7f72b8f658d6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_ebcb44d8-f146-8715-996b-062bb9d8d43e" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_d5a06061-b83d-0d55-b7d3-e1229681b86d" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_ebcb44d8-f146-8715-996b-062bb9d8d43e" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LeasesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_41784c6f-4555-af92-3354-8f8701c77f60" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_09c9f846-159b-1776-fceb-d1cad0eb94ab" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_41784c6f-4555-af92-3354-8f8701c77f60" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_09c9f846-159b-1776-fceb-d1cad0eb94ab" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_OperatingLeaseOtherLiabilityCurrent" xlink:label="loc_ebs_OperatingLeaseOtherLiabilityCurrent_c852416c-cb3a-2033-50a0-d849acba1a53" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_41784c6f-4555-af92-3354-8f8701c77f60" xlink:to="loc_ebs_OperatingLeaseOtherLiabilityCurrent_c852416c-cb3a-2033-50a0-d849acba1a53" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LeasesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Litigation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebt" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_5cb3949c-1d57-8f66-f002-a3389de7aec0" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_5cb3949c-1d57-8f66-f002-a3389de7aec0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_53634569-cdf7-3d1b-42b0-596cb4175c67" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_53634569-cdf7-3d1b-42b0-596cb4175c67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c4573bf7-1f66-8dfe-59b9-b6903f55406f" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c4573bf7-1f66-8dfe-59b9-b6903f55406f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e00da32d-ed06-bb21-8b28-7e7ede769972" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e00da32d-ed06-bb21-8b28-7e7ede769972" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter" xlink:label="loc_ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter_25aaad20-854a-8afc-4cb0-ccd32e6370c3" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:to="loc_ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter_25aaad20-854a-8afc-4cb0-ccd32e6370c3" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebtTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganization" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganizationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/PropertyPlantAndEquipment" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_78662f7f-2a6a-5d68-ba8a-7947ed287be5" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_78662f7f-2a6a-5d68-ba8a-7947ed287be5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0a08cda9-11b3-e7ac-3fc9-3a23c67d9b96" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0a08cda9-11b3-e7ac-3fc9-3a23c67d9b96" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/PurchaseCommitments" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/PurchaseCommitmentsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnaudited" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognition" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_928a1618-af56-709a-989c-a303706b8ca2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BilledContractReceivables" xlink:label="loc_us-gaap_BilledContractReceivables_17edd2f4-dc10-b559-a189-a4160ac43b09" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_928a1618-af56-709a-989c-a303706b8ca2" xlink:to="loc_us-gaap_BilledContractReceivables_17edd2f4-dc10-b559-a189-a4160ac43b09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnbilledContractsReceivable" xlink:label="loc_us-gaap_UnbilledContractsReceivable_23384b56-6cf2-724a-29ad-e9ae99b07b45" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_928a1618-af56-709a-989c-a303706b8ca2" xlink:to="loc_us-gaap_UnbilledContractsReceivable_23384b56-6cf2-724a-29ad-e9ae99b07b45" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionRemainingPerformanceObligationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/SegmentInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/SegmentInformationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_4ae0592f-ae75-1c8e-3b68-d52f89374b9f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_4ae0592f-ae75-1c8e-3b68-d52f89374b9f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_122fa1c0-1a28-405c-1e3a-c537cfd612c7" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_122fa1c0-1a28-405c-1e3a-c537cfd612c7" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>18
<FILENAME>ebs-20191231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Acquisitions" xlink:href="ebs-20191231.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAcquisitionOfAcam2000BusinessDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAcquisitionOfAcam2000NarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAcquisitionOfRaxibacumabAssetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAdaptNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails" xlink:href="ebs-20191231.xsd#AcquisitionsPaxvaxNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails" xlink:href="ebs-20191231.xsd#AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsTables" xlink:href="ebs-20191231.xsd#AcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets" xlink:href="ebs-20191231.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="ebs-20191231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" xlink:href="ebs-20191231.xsd#ConsolidatedStatementOfChangesInStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquityParenthetical" xlink:href="ebs-20191231.xsd#ConsolidatedStatementOfChangesInStockholdersEquityParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="ebs-20191231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="ebs-20191231.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations" xlink:href="ebs-20191231.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CoverPage" xlink:href="ebs-20191231.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlan" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlan" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanNarrativeDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanTables" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstruments" xlink:href="ebs-20191231.xsd#DerivativeInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails" xlink:href="ebs-20191231.xsd#DerivativeInstrumentsCashFlowHedgingOnAociDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails" xlink:href="ebs-20191231.xsd#DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails" xlink:href="ebs-20191231.xsd#DerivativeInstrumentsFairValueByBalanceSheetLocationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsNarrativeDetails" xlink:href="ebs-20191231.xsd#DerivativeInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsTables" xlink:href="ebs-20191231.xsd#DerivativeInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/EarningsPerShare" xlink:href="ebs-20191231.xsd#EarningsPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/EarningsPerShareDetails" xlink:href="ebs-20191231.xsd#EarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/EarningsPerShareTables" xlink:href="ebs-20191231.xsd#EarningsPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairValueMeasurements" xlink:href="ebs-20191231.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairValueMeasurementsDetails" xlink:href="ebs-20191231.xsd#FairValueMeasurementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="ebs-20191231.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairValueMeasurementsTables" xlink:href="ebs-20191231.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxes" xlink:href="ebs-20191231.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails" xlink:href="ebs-20191231.xsd#IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails" xlink:href="ebs-20191231.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails" xlink:href="ebs-20191231.xsd#IncomeTaxesNetDeferredTaxAssetLiabilityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails" xlink:href="ebs-20191231.xsd#IncomeTaxesReconciliationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesTables" xlink:href="ebs-20191231.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:href="ebs-20191231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwill" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwillNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillTables" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Inventories" xlink:href="ebs-20191231.xsd#Inventories" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/InventoriesDetails" xlink:href="ebs-20191231.xsd#InventoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/InventoriesTables" xlink:href="ebs-20191231.xsd#InventoriesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Leases" xlink:href="ebs-20191231.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails" xlink:href="ebs-20191231.xsd#LeasesComponentsOfLeaseExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesNarrativeDetails" xlink:href="ebs-20191231.xsd#LeasesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:href="ebs-20191231.xsd#LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesTables" xlink:href="ebs-20191231.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Litigation" xlink:href="ebs-20191231.xsd#Litigation" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebt" xlink:href="ebs-20191231.xsd#LongTermDebt" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails" xlink:href="ebs-20191231.xsd#LongTermDebtComponentsOfLongTermIndebtednessDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails" xlink:href="ebs-20191231.xsd#LongTermDebtConvertibleSeniorNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails" xlink:href="ebs-20191231.xsd#LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails" xlink:href="ebs-20191231.xsd#LongTermDebtSeniorSecuredCreditAgreementDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebtTables" xlink:href="ebs-20191231.xsd#LongTermDebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganization" xlink:href="ebs-20191231.xsd#NatureOfBusinessAndOrganization" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganizationDetails" xlink:href="ebs-20191231.xsd#NatureOfBusinessAndOrganizationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyPlantAndEquipment" xlink:href="ebs-20191231.xsd#PropertyPlantAndEquipment" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails" xlink:href="ebs-20191231.xsd#PropertyPlantAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentTables" xlink:href="ebs-20191231.xsd#PropertyPlantAndEquipmentTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PurchaseCommitments" xlink:href="ebs-20191231.xsd#PurchaseCommitments" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PurchaseCommitmentsDetails" xlink:href="ebs-20191231.xsd#PurchaseCommitmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnaudited" xlink:href="ebs-20191231.xsd#QuarterlyFinancialDataUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedDetails" xlink:href="ebs-20191231.xsd#QuarterlyFinancialDataUnauditedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedTables" xlink:href="ebs-20191231.xsd#QuarterlyFinancialDataUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognition" xlink:href="ebs-20191231.xsd#RevenueRecognition" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails" xlink:href="ebs-20191231.xsd#RevenueRecognitionAccountsReceivableDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails" xlink:href="ebs-20191231.xsd#RevenueRecognitionContractLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:href="ebs-20191231.xsd#RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails" xlink:href="ebs-20191231.xsd#RevenueRecognitionNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionRemainingPerformanceObligationDetails" xlink:href="ebs-20191231.xsd#RevenueRecognitionRemainingPerformanceObligationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionTables" xlink:href="ebs-20191231.xsd#RevenueRecognitionTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:href="ebs-20191231.xsd#ScheduleIiValuationAndQualifyingAccounts" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:href="ebs-20191231.xsd#ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentInformation" xlink:href="ebs-20191231.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails" xlink:href="ebs-20191231.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails" xlink:href="ebs-20191231.xsd#SegmentInformationProductSalesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentInformationTables" xlink:href="ebs-20191231.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquity" xlink:href="ebs-20191231.xsd#StockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails" xlink:href="ebs-20191231.xsd#StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails" xlink:href="ebs-20191231.xsd#StockholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails" xlink:href="ebs-20191231.xsd#StockholdersEquityStockBasedCompensationExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails" xlink:href="ebs-20191231.xsd#StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails" xlink:href="ebs-20191231.xsd#StockholdersEquityStockOptionsValuationAssumptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityTables" xlink:href="ebs-20191231.xsd#StockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/Acquisitions" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_976511B7371CCCBAAF5A3F3C374FC180" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3F84439C46AFD2D3F2DB3F3C374ED654" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_976511B7371CCCBAAF5A3F3C374FC180" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3F84439C46AFD2D3F2DB3F3C374ED654" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_BA6999DCA812580560343F3C374E12F9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3F84439C46AFD2D3F2DB3F3C374ED654" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_BA6999DCA812580560343F3C374E12F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1E4271AB3C3C09D943153F3C374EB42D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_BA6999DCA812580560343F3C374E12F9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1E4271AB3C3C09D943153F3C374EB42D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1E4271AB3C3C09D943153F3C374EB42D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_BA6999DCA812580560343F3C374E12F9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1E4271AB3C3C09D943153F3C374EB42D" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ACAM2000Member" xlink:label="loc_ebs_ACAM2000Member_FE64380D84965EAD85273F3C374F3C27" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1E4271AB3C3C09D943153F3C374EB42D" xlink:to="loc_ebs_ACAM2000Member_FE64380D84965EAD85273F3C374F3C27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_976511B7371CCCBAAF5A3F3C374FC180" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_0012872FCD60A14C37013F3C374FC74A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_0012872FCD60A14C37013F3C374FC74A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_41E5B83E1AAAB86D1CC63F3C3750C06A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_41E5B83E1AAAB86D1CC63F3C3750C06A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5B42266E9AF641C2D6A93F3C37505B6E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5B42266E9AF641C2D6A93F3C37505B6E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_976511B7371CCCBAAF5A3F3C374FC180" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_C13833204712206A4DB13F3C375011D3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_C13833204712206A4DB13F3C375011D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E7DD9D4634A461F424163F3C375015D5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E7DD9D4634A461F424163F3C375015D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_785CDB0754D3A2A120393F3C37511030" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_785CDB0754D3A2A120393F3C37511030" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_78BE7819DA0674095D3F3F3C3751DC1E" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_78BE7819DA0674095D3F3F3C3751DC1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_A066F32AA7E5855A4D183F3C3751A4DA" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:to="loc_us-gaap_Goodwill_A066F32AA7E5855A4D183F3C3751A4DA" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D8806F6CB8D597176A49A55DF3217141" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D8806F6CB8D597176A49A55DF3217141" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5E651031D4BA6D32F24CA55DF3221802" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D8806F6CB8D597176A49A55DF3217141" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5E651031D4BA6D32F24CA55DF3221802" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9394F3A9D83D1783BF5EA55DF3224A3A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5E651031D4BA6D32F24CA55DF3221802" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9394F3A9D83D1783BF5EA55DF3224A3A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9394F3A9D83D1783BF5EA55DF3224A3A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5E651031D4BA6D32F24CA55DF3221802" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9394F3A9D83D1783BF5EA55DF3224A3A" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ACAM2000Member" xlink:label="loc_ebs_ACAM2000Member_34125DF43474ECDF13A6A55DF3225CE8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9394F3A9D83D1783BF5EA55DF3224A3A" xlink:to="loc_ebs_ACAM2000Member_34125DF43474ECDF13A6A55DF3225CE8" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TermofContractUnderAcquisition" xlink:label="loc_ebs_TermofContractUnderAcquisition_1F4F5AF422D223AE9B47A55DF323CE4B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_ebs_TermofContractUnderAcquisition_1F4F5AF422D223AE9B47A55DF323CE4B" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ValueofContract" xlink:label="loc_ebs_ValueofContract_6528643F0EF9C5B84299A55DF323130B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_ebs_ValueofContract_6528643F0EF9C5B84299A55DF323130B" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmountforDeliveriesofProduct" xlink:label="loc_ebs_AmountforDeliveriesofProduct_D214C28795C5A59E835CA55DF3233218" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_ebs_AmountforDeliveriesofProduct_D214C28795C5A59E835CA55DF3233218" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_UpfrontPayments" xlink:label="loc_ebs_UpfrontPayments_C1B3A1C926326A53BBA9A55DF3239083" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_ebs_UpfrontPayments_C1B3A1C926326A53BBA9A55DF3239083" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmountOfPaymentForManufacturingRelatedMilestones" xlink:label="loc_ebs_AmountOfPaymentForManufacturingRelatedMilestones_FC936D1F926A67B02103A55DF3244ED6" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_ebs_AmountOfPaymentForManufacturingRelatedMilestones_FC936D1F926A67B02103A55DF3244ED6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_A6D0062DA5233C870084A55DF324D63C" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_A6D0062DA5233C870084A55DF324D63C" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmountOfPaymentForRegulatoryRelatedMilestones" xlink:label="loc_ebs_AmountOfPaymentForRegulatoryRelatedMilestones_B3A83591AEB68DAFEDE2A55DF324B244" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_ebs_AmountOfPaymentForRegulatoryRelatedMilestones_B3A83591AEB68DAFEDE2A55DF324B244" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_92C135C33B06E1585705A55DF324EBB1" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_92C135C33B06E1585705A55DF324EBB1" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PresentValueDiscountRate" xlink:label="loc_ebs_PresentValueDiscountRate_AB5E68892125DF98C9DEA55DF32419BD" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_ebs_PresentValueDiscountRate_AB5E68892125DF98C9DEA55DF32419BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_EC75B99827347C01B447A55DF3249588" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_EC75B99827347C01B447A55DF3249588" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_CE2F3FCDF08558512CF0A55DF324AB04" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_us-gaap_Goodwill_CE2F3FCDF08558512CF0A55DF324AB04" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_0735F3FB9C9BE2D2D6ECEC8A3E46AFD9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_747E8925654B759C8231EC8A3E458ED2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0735F3FB9C9BE2D2D6ECEC8A3E46AFD9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_747E8925654B759C8231EC8A3E458ED2" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3C9F6496B59624B1BE0DEC8A3E459B3B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_747E8925654B759C8231EC8A3E458ED2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3C9F6496B59624B1BE0DEC8A3E459B3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6F484511B8524454CA41EC8A3E45B301_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3C9F6496B59624B1BE0DEC8A3E459B3B" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6F484511B8524454CA41EC8A3E45B301_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6F484511B8524454CA41EC8A3E45B301" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3C9F6496B59624B1BE0DEC8A3E459B3B" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6F484511B8524454CA41EC8A3E45B301" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_RaxibacumabMember" xlink:label="loc_ebs_RaxibacumabMember_4B013105806BD9D0F489EC8A3E46B884" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6F484511B8524454CA41EC8A3E45B301" xlink:to="loc_ebs_RaxibacumabMember_4B013105806BD9D0F489EC8A3E46B884" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_UpfrontPayments" xlink:label="loc_ebs_UpfrontPayments_E327B8920521B8A22A74EC8A3E46D7CB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0735F3FB9C9BE2D2D6ECEC8A3E46AFD9" xlink:to="loc_ebs_UpfrontPayments_E327B8920521B8A22A74EC8A3E46D7CB" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmountOfPaymentForManufacturingRelatedMilestones" xlink:label="loc_ebs_AmountOfPaymentForManufacturingRelatedMilestones_18D8700838ADA3AFDC92EC8A3E46E469" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0735F3FB9C9BE2D2D6ECEC8A3E46AFD9" xlink:to="loc_ebs_AmountOfPaymentForManufacturingRelatedMilestones_18D8700838ADA3AFDC92EC8A3E46E469" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_3B0A9BBA89CCC8357660EC8A3E46B81A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0735F3FB9C9BE2D2D6ECEC8A3E46AFD9" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_3B0A9BBA89CCC8357660EC8A3E46B81A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3C148C7555CF2711B500EC99CD82EA5B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0735F3FB9C9BE2D2D6ECEC8A3E46AFD9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3C148C7555CF2711B500EC99CD82EA5B" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A231923551A6B0B321A22CB8059911DD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A231923551A6B0B321A22CB8059911DD" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B351BDE6D8FB247011152CC36E823450" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A231923551A6B0B321A22CB8059911DD" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B351BDE6D8FB247011152CC36E823450" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_F9BEFA057C94DC870A472CC36E844D10_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B351BDE6D8FB247011152CC36E823450" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_F9BEFA057C94DC870A472CC36E844D10_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_F9BEFA057C94DC870A472CC36E844D10" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B351BDE6D8FB247011152CC36E823450" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_F9BEFA057C94DC870A472CC36E844D10" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_5941A3E5FFACF341B4B42CC36FF24770" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_F9BEFA057C94DC870A472CC36E844D10" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_5941A3E5FFACF341B4B42CC36FF24770" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E23084C2CB6BC5AAB4F62CB805993111" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A231923551A6B0B321A22CB8059911DD" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E23084C2CB6BC5AAB4F62CB805993111" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5FF99798F6CC7C8AB9D62CB8059AC29B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E23084C2CB6BC5AAB4F62CB805993111" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5FF99798F6CC7C8AB9D62CB8059AC29B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5FF99798F6CC7C8AB9D62CB8059AC29B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E23084C2CB6BC5AAB4F62CB805993111" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5FF99798F6CC7C8AB9D62CB8059AC29B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_BB1125ABB4053BF7F2982CB8059A0085" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5FF99798F6CC7C8AB9D62CB8059AC29B" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_BB1125ABB4053BF7F2982CB8059A0085" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_B63BFD8C3E4AA9412BFB2CB8059A7963" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A231923551A6B0B321A22CB8059911DD" xlink:to="loc_srt_RangeAxis_B63BFD8C3E4AA9412BFB2CB8059A7963" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_D41FE173AC84238B191B2CB8059B515E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_B63BFD8C3E4AA9412BFB2CB8059A7963" xlink:to="loc_srt_RangeMember_D41FE173AC84238B191B2CB8059B515E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_D41FE173AC84238B191B2CB8059B515E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_B63BFD8C3E4AA9412BFB2CB8059A7963" xlink:to="loc_srt_RangeMember_D41FE173AC84238B191B2CB8059B515E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_5BDD89DDA5830A7FA1F42CB8059B9910" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_D41FE173AC84238B191B2CB8059B515E" xlink:to="loc_srt_MaximumMember_5BDD89DDA5830A7FA1F42CB8059B9910" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_517314B0C5282BFA9EC92CB8059BF95F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A231923551A6B0B321A22CB8059911DD" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_517314B0C5282BFA9EC92CB8059BF95F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FB45AE215D6D6F73DFBB2CB8059BA816_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_517314B0C5282BFA9EC92CB8059BF95F" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FB45AE215D6D6F73DFBB2CB8059BA816_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FB45AE215D6D6F73DFBB2CB8059BA816" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_517314B0C5282BFA9EC92CB8059BF95F" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FB45AE215D6D6F73DFBB2CB8059BA816" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AdaptPharmaMember" xlink:label="loc_ebs_AdaptPharmaMember_4105463F727A65C6EED22CB8059B4943" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FB45AE215D6D6F73DFBB2CB8059BA816" xlink:to="loc_ebs_AdaptPharmaMember_4105463F727A65C6EED22CB8059B4943" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberOfEmployees" xlink:label="loc_ebs_NumberOfEmployees_9C77E98263A9F0819C8D2CB8059B9F90" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_ebs_NumberOfEmployees_9C77E98263A9F0819C8D2CB8059B9F90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8C56A3516ECD3D5E34972CB8059B5AE9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8C56A3516ECD3D5E34972CB8059B5AE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_4D4146A0D050A49439892CB8059BD94A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_4D4146A0D050A49439892CB8059BD94A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_18D16F4819A47E68D22E2CB8059B41C2" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_18D16F4819A47E68D22E2CB8059B41C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_89BC8DB9DA36846DE4BF2CB8059B9CDF" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_89BC8DB9DA36846DE4BF2CB8059B9CDF" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_LockUpPeriodForAdjustmentOfFairValue" xlink:label="loc_ebs_LockUpPeriodForAdjustmentOfFairValue_8A145E844BB3A7267DFE2CB8059BFDCB" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_ebs_LockUpPeriodForAdjustmentOfFairValue_8A145E844BB3A7267DFE2CB8059BFDCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_414004A4EC10D76F608A2CB8059B0956" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_414004A4EC10D76F608A2CB8059B0956" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_A7975685A5ABED7B70BA2CB8059BEFDF" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_A7975685A5ABED7B70BA2CB8059BEFDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_C771245FC5F8EF5142DF2CB8059B5146" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_C771245FC5F8EF5142DF2CB8059B5146" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7441A3D8679886A102D32CB8059B8991" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7441A3D8679886A102D32CB8059B8991" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PresentValueDiscountRate" xlink:label="loc_ebs_PresentValueDiscountRate_81B4B36AE4044166E6C42CB8059B4E77" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_ebs_PresentValueDiscountRate_81B4B36AE4044166E6C42CB8059B4E77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_F23354F74802A2C90E7E2CB8276F2B7B" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_F23354F74802A2C90E7E2CB8276F2B7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_3C4718E01349B03D6A482CB8059BBB6B" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_3C4718E01349B03D6A482CB8059BBB6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_0220B1D9F14EE8F380472CB8059B06EE" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_Goodwill_0220B1D9F14EE8F380472CB8059B06EE" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_46DE460FEFB7BFF2138F78A5A0C3CEF6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46DE460FEFB7BFF2138F78A5A0C3CEF6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_776067A367A0502B2D2078A5A0C1716D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_776067A367A0502B2D2078A5A0C1716D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889579D389F152FBC55778A5A0C1D62A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_776067A367A0502B2D2078A5A0C1716D" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889579D389F152FBC55778A5A0C1D62A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889579D389F152FBC55778A5A0C1D62A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_776067A367A0502B2D2078A5A0C1716D" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889579D389F152FBC55778A5A0C1D62A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_855B894C6156E51D559F78A5A0C19ACE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889579D389F152FBC55778A5A0C1D62A" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_855B894C6156E51D559F78A5A0C19ACE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_22EF379549C4455F7E3B78A5A0C203AF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:to="loc_srt_RestatementAxis_22EF379549C4455F7E3B78A5A0C203AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_CC6242758C11B230620C78A5A0C23A2E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_22EF379549C4455F7E3B78A5A0C203AF" xlink:to="loc_srt_RestatementDomain_CC6242758C11B230620C78A5A0C23A2E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_CC6242758C11B230620C78A5A0C23A2E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_22EF379549C4455F7E3B78A5A0C203AF" xlink:to="loc_srt_RestatementDomain_CC6242758C11B230620C78A5A0C23A2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_E442CFA407B5AEFB007278A5A0C24042" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_CC6242758C11B230620C78A5A0C23A2E" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_E442CFA407B5AEFB007278A5A0C24042" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_90056D3C3F7C5381813D78A5A0C2A899" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_90056D3C3F7C5381813D78A5A0C2A899" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C6652765AAAAAA4F85AD78A5A0C2CE55_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_90056D3C3F7C5381813D78A5A0C2A899" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C6652765AAAAAA4F85AD78A5A0C2CE55_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C6652765AAAAAA4F85AD78A5A0C2CE55" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_90056D3C3F7C5381813D78A5A0C2A899" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C6652765AAAAAA4F85AD78A5A0C2CE55" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AdaptPharmaMember" xlink:label="loc_ebs_AdaptPharmaMember_D25B7DB535082F9B85CF78A5A0C3F69E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C6652765AAAAAA4F85AD78A5A0C2CE55" xlink:to="loc_ebs_AdaptPharmaMember_D25B7DB535082F9B85CF78A5A0C3F69E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46DE460FEFB7BFF2138F78A5A0C3CEF6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_334B8CEBC84DB290C01B78A5A0C327F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_334B8CEBC84DB290C01B78A5A0C327F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_210DE10EE087E80AD30F78A5A0C4F6DE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_210DE10EE087E80AD30F78A5A0C4F6DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_EE7477DB1DCEB380F9C078A5A0C46AAE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_EE7477DB1DCEB380F9C078A5A0C46AAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_D407DA6A3CB22E454D7D78A5A0C45569" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_D407DA6A3CB22E454D7D78A5A0C45569" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_7394C847495BA0A5B9EE78A5A0C4CBF8" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_7394C847495BA0A5B9EE78A5A0C4CBF8" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities" xlink:label="loc_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_38C47F7CB643FDBFAADB78A5A0C4A703" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_38C47F7CB643FDBFAADB78A5A0C4A703" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_DC26F61B2CD956694B2A78A5A0C51B28" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_DC26F61B2CD956694B2A78A5A0C51B28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_64B57A3AEC33EC04B92078A5A0C5C714" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_64B57A3AEC33EC04B92078A5A0C5C714" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_EA853FF0713147BA1BA578A5A0C52135" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_EA853FF0713147BA1BA578A5A0C52135" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6F52E47E6453E473465878A5A0C51898" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6F52E47E6453E473465878A5A0C51898" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_684164133FC006836BDB78A5A0C56918" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_Goodwill_684164133FC006836BDB78A5A0C56918" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_E9531609F985A5DABAE278A5A0C535F5" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_E9531609F985A5DABAE278A5A0C535F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_D664DED65987589E01C778A5A0C69779" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_D664DED65987589E01C778A5A0C69779" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_1C4C24F33C6CE96350FD78A5A0C6A660" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_1C4C24F33C6CE96350FD78A5A0C6A660" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_2799AD2B05632D345CE778A5A0C6C130" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_2799AD2B05632D345CE778A5A0C6C130" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_B1AB405603B65BF3641B78A5A0C61E3B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_B1AB405603B65BF3641B78A5A0C61E3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_73ECE0530D3D40A9B9B378A5A0C7E9C5" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_73ECE0530D3D40A9B9B378A5A0C7E9C5" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5EA6F35FF758ADCB4506A55DF34CD5D5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BC4C63A34C86DC5C4C07A55DF34B6717" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5EA6F35FF758ADCB4506A55DF34CD5D5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BC4C63A34C86DC5C4C07A55DF34B6717" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_951DDCE2D67FEB7A5CDDA5BE0F4D3047" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BC4C63A34C86DC5C4C07A55DF34B6717" xlink:to="loc_srt_RestatementAxis_951DDCE2D67FEB7A5CDDA5BE0F4D3047" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_879031711CDECEB89748A5BE5BBB3589_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_951DDCE2D67FEB7A5CDDA5BE0F4D3047" xlink:to="loc_srt_RestatementDomain_879031711CDECEB89748A5BE5BBB3589_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_879031711CDECEB89748A5BE5BBB3589" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_951DDCE2D67FEB7A5CDDA5BE0F4D3047" xlink:to="loc_srt_RestatementDomain_879031711CDECEB89748A5BE5BBB3589" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_65CF31D06D2EDF5AC3AEA5BE0E1BC654" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_879031711CDECEB89748A5BE5BBB3589" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_65CF31D06D2EDF5AC3AEA5BE0E1BC654" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_A6A04165DBA14E70B0BAA55DF34CF005" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BC4C63A34C86DC5C4C07A55DF34B6717" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_A6A04165DBA14E70B0BAA55DF34CF005" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3455B1BFB3629BA15812A55DF34CDE7B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_A6A04165DBA14E70B0BAA55DF34CF005" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3455B1BFB3629BA15812A55DF34CDE7B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3455B1BFB3629BA15812A55DF34CDE7B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_A6A04165DBA14E70B0BAA55DF34CF005" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3455B1BFB3629BA15812A55DF34CDE7B" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AdaptPharmaMember" xlink:label="loc_ebs_AdaptPharmaMember_BB1CA7A47761DC911AB6A55DF34CA13E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3455B1BFB3629BA15812A55DF34CDE7B" xlink:to="loc_ebs_AdaptPharmaMember_BB1CA7A47761DC911AB6A55DF34CA13E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_8D9D9DDA340F1F388E2BA55DF34C881C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5EA6F35FF758ADCB4506A55DF34CD5D5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_8D9D9DDA340F1F388E2BA55DF34C881C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_3D79082DC15E4BA785EDA55DF34D2D72" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5EA6F35FF758ADCB4506A55DF34CD5D5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_3D79082DC15E4BA785EDA55DF34D2D72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8CC2145327EA3979F9A7A55DF34D41BB" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5EA6F35FF758ADCB4506A55DF34CD5D5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8CC2145327EA3979F9A7A55DF34D41BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_F5E395DBFCBD48D62F71A55DF34D7270" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5EA6F35FF758ADCB4506A55DF34CD5D5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_F5E395DBFCBD48D62F71A55DF34D7270" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_68C5849A6FE70A536F3EA55DF34D3D18" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5EA6F35FF758ADCB4506A55DF34CD5D5" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_68C5849A6FE70A536F3EA55DF34D3D18" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DDB268C54322D5A53CBF23C57F55C0EE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DDB268C54322D5A53CBF23C57F55C0EE" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DBB1C072EA3F2FA4A22623C57F5507D7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DDB268C54322D5A53CBF23C57F55C0EE" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DBB1C072EA3F2FA4A22623C57F5507D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9E7FE69144E8140220B923C57F5593D3_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DBB1C072EA3F2FA4A22623C57F5507D7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9E7FE69144E8140220B923C57F5593D3_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9E7FE69144E8140220B923C57F5593D3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DBB1C072EA3F2FA4A22623C57F5507D7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9E7FE69144E8140220B923C57F5593D3" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_VivotifMember" xlink:label="loc_ebs_VivotifMember_226D1478ABA2EDEACEA223C57F56C922" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9E7FE69144E8140220B923C57F5593D3" xlink:to="loc_ebs_VivotifMember_226D1478ABA2EDEACEA223C57F56C922" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_VaxchoraMember" xlink:label="loc_ebs_VaxchoraMember_8AD53D5315B1CB9F875323C57F564267" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9E7FE69144E8140220B923C57F5593D3" xlink:to="loc_ebs_VaxchoraMember_8AD53D5315B1CB9F875323C57F564267" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_17CB17FED8B046B9CFCD23C57F56FD0C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9E7FE69144E8140220B923C57F5593D3" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_17CB17FED8B046B9CFCD23C57F56FD0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_F00C43CC93236BE3C2CE23C57F56C2CC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DDB268C54322D5A53CBF23C57F55C0EE" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_F00C43CC93236BE3C2CE23C57F56C2CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D6021D79C855A8816F7E23C57F567C99_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_F00C43CC93236BE3C2CE23C57F56C2CC" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D6021D79C855A8816F7E23C57F567C99_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D6021D79C855A8816F7E23C57F567C99" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_F00C43CC93236BE3C2CE23C57F56C2CC" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D6021D79C855A8816F7E23C57F567C99" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PaxVaxMember" xlink:label="loc_ebs_PaxVaxMember_54DF2798932C25AA699F23C57F5776B0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D6021D79C855A8816F7E23C57F567C99" xlink:to="loc_ebs_PaxVaxMember_54DF2798932C25AA699F23C57F5776B0" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberOfEmployees" xlink:label="loc_ebs_NumberOfEmployees_D0C887958E151E10588A23C57F5759D4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_ebs_NumberOfEmployees_D0C887958E151E10588A23C57F5759D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_81583FEE08BFF703913423C57F57191F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_81583FEE08BFF703913423C57F57191F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6A5F5021E00C1EF0D99623C57F57C273" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6A5F5021E00C1EF0D99623C57F57C273" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_AC807FF1C112A89D940A23C57F5872D5" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_AC807FF1C112A89D940A23C57F5872D5" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PresentValueDiscountRate" xlink:label="loc_ebs_PresentValueDiscountRate_8E5EBA0339AEE3940FA823C57F585317" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_ebs_PresentValueDiscountRate_8E5EBA0339AEE3940FA823C57F585317" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0F56C9C13BA008E8C370245A788CE90A" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0F56C9C13BA008E8C370245A788CE90A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_9D626500C0B0A3435DB023C57F580B3B" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_us-gaap_Goodwill_9D626500C0B0A3435DB023C57F580B3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_40D09045C01A2025BFE823C57F58214B" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_40D09045C01A2025BFE823C57F58214B" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_D65A011F74CFFB89C18678A56C54D359" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24700F28BA1477D2D66278A56C512081" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D65A011F74CFFB89C18678A56C54D359" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24700F28BA1477D2D66278A56C512081" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_7D0A8ECE9CFE8BBF03C078A56C527F35" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24700F28BA1477D2D66278A56C512081" xlink:to="loc_srt_RestatementAxis_7D0A8ECE9CFE8BBF03C078A56C527F35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_F5F88946063D5859BD1078A56C52BA1A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_7D0A8ECE9CFE8BBF03C078A56C527F35" xlink:to="loc_srt_RestatementDomain_F5F88946063D5859BD1078A56C52BA1A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_F5F88946063D5859BD1078A56C52BA1A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_7D0A8ECE9CFE8BBF03C078A56C527F35" xlink:to="loc_srt_RestatementDomain_F5F88946063D5859BD1078A56C52BA1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_63F25970EC7B3CC087E578A56C5216BA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_F5F88946063D5859BD1078A56C52BA1A" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_63F25970EC7B3CC087E578A56C5216BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4C780C8035243D472D1B78A56C5307FE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24700F28BA1477D2D66278A56C512081" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4C780C8035243D472D1B78A56C5307FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3C5C32D3314D4340B15C78A56C53E817_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4C780C8035243D472D1B78A56C5307FE" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3C5C32D3314D4340B15C78A56C53E817_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3C5C32D3314D4340B15C78A56C53E817" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4C780C8035243D472D1B78A56C5307FE" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3C5C32D3314D4340B15C78A56C53E817" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PaxVaxMember" xlink:label="loc_ebs_PaxVaxMember_484945B7E551458CF74B78A56C533D35" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3C5C32D3314D4340B15C78A56C53E817" xlink:to="loc_ebs_PaxVaxMember_484945B7E551458CF74B78A56C533D35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D65A011F74CFFB89C18678A56C54D359" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_C42A9A505DDDE0225CB578A56C54FC3C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_C42A9A505DDDE0225CB578A56C54FC3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_E72B67253DFC786AC45F78A56C54E314" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_E72B67253DFC786AC45F78A56C54E314" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_77F3F0E8D4C1732B48AA78A56C5549BF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_77F3F0E8D4C1732B48AA78A56C5549BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_44CE3F98E509B129C71D78A56C55CC32" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_44CE3F98E509B129C71D78A56C55CC32" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_2DE8B2DB6D2E063D70C978A56C55048C" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_2DE8B2DB6D2E063D70C978A56C55048C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_00D554619E8878AE0BAB78A56C55F417" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_00D554619E8878AE0BAB78A56C55F417" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_70E29E6C2A0861C5202D78A56C57EF82" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_70E29E6C2A0861C5202D78A56C57EF82" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_F538D23AEB3D2EDDD4B578A56C57D7AB" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_F538D23AEB3D2EDDD4B578A56C57D7AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_F906CBA4F6C3437FFC5178A56C57D74A" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_F906CBA4F6C3437FFC5178A56C57D74A" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities" xlink:label="loc_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_9DE35FA81C86828DD85878A56C5713CC" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_9DE35FA81C86828DD85878A56C5713CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_757ACA86B800799EAC3C78A56C5845E0" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_757ACA86B800799EAC3C78A56C5845E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9AA0ECE159B4C3489F6478A56C58C1AE" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9AA0ECE159B4C3489F6478A56C58C1AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_58778FF13A4F48FA8E3278A56C587679" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_58778FF13A4F48FA8E3278A56C587679" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_F7E92C3889FC1EE20C0078A56C589A61" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_Goodwill_F7E92C3889FC1EE20C0078A56C589A61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7CB8D472C419DD3D320C78A56C582B3F" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7CB8D472C419DD3D320C78A56C582B3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_F0E37977D91D6D7692B878A56C58F4F5" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_F0E37977D91D6D7692B878A56C58F4F5" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities_B7FD0945EB2528BA210478A56C59758A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_F0E37977D91D6D7692B878A56C58F4F5" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities_B7FD0945EB2528BA210478A56C59758A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_5464C9C2959B3D71868878A56C59543F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_F0E37977D91D6D7692B878A56C58F4F5" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_5464C9C2959B3D71868878A56C59543F" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets_7AD753AE33880E55C29078A56C59B27D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_F0E37977D91D6D7692B878A56C58F4F5" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets_7AD753AE33880E55C29078A56C59B27D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_BAF7CFF893BA7A97A19878A56C59F0A5" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_F0E37977D91D6D7692B878A56C58F4F5" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_BAF7CFF893BA7A97A19878A56C59F0A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_F41DB9BB6EF85CBD6FD478A56C59E736" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_F0E37977D91D6D7692B878A56C58F4F5" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_F41DB9BB6EF85CBD6FD478A56C59E736" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_11560B74F0E25C0F32705F9BB73FF144" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_8C1C6CC113CF66E680EA5F9BB73D10C5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_11560B74F0E25C0F32705F9BB73FF144" xlink:to="loc_us-gaap_StatementTable_8C1C6CC113CF66E680EA5F9BB73D10C5" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5FED7534DAE800575B865F9BB73DDD6F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8C1C6CC113CF66E680EA5F9BB73D10C5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5FED7534DAE800575B865F9BB73DDD6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5FED7534DAE800575B865F9BB73DDD6F" xlink:to="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5FED7534DAE800575B865F9BB73DDD6F" xlink:to="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_7A9DEA414B8227D104735F9BB73E7AB2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D" xlink:to="loc_us-gaap_CommonStockMember_7A9DEA414B8227D104735F9BB73E7AB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1DF796F7501C9C3D7A855F9BB73E1A09" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1DF796F7501C9C3D7A855F9BB73E1A09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_6B4E24D7BC056C7705AE5F9BB73EED37" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D" xlink:to="loc_us-gaap_TreasuryStockMember_6B4E24D7BC056C7705AE5F9BB73EED37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_18E133B213D2F930B6FC5F9BB73EB449" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_18E133B213D2F930B6FC5F9BB73EB449" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_DE17C73F7E435B2FAE265F9BB73E7D5D" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D" xlink:to="loc_us-gaap_RetainedEarningsMember_DE17C73F7E435B2FAE265F9BB73E7D5D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_11560B74F0E25C0F32705F9BB73FF144" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_6FEF6BD3DC5C6A5B4AC95F9BB73F93E8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_CommonStockSharesIssued_6FEF6BD3DC5C6A5B4AC95F9BB73F93E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_DACB0CCC4E053584724E5F9BB73F92CF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockholdersEquity_DACB0CCC4E053584724E5F9BB73F92CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_AD7894C46CD7384725FC5F9BB73F99E3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_AD7894C46CD7384725FC5F9BB73F99E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_48BB9862E97DA52406545F9BB740C62D" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_48BB9862E97DA52406545F9BB740C62D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2AEFFDB50435C248EA4D5F9BB7402C5E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2AEFFDB50435C248EA4D5F9BB7402C5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_DA16A530BDEEA8476F5D5F9BB740D7D8" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_DA16A530BDEEA8476F5D5F9BB740D7D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_7ED92063EBF3C49B83FD5F9BB7401C05" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_7ED92063EBF3C49B83FD5F9BB7401C05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_33078A5F5FA3EAADB9565F9BB74086DD" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_33078A5F5FA3EAADB9565F9BB74086DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C5B29BB6139024B3E7885F9BB7403585" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C5B29BB6139024B3E7885F9BB7403585" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_2EBC5F6490365B4C59B95F9BB740A479" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_2EBC5F6490365B4C59B95F9BB740A479" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_409BA26535F4B3F24C365F9BB74174FE" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_409BA26535F4B3F24C365F9BB74174FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_949B4788A25DFF6033D25F9BB741C532" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_949B4788A25DFF6033D25F9BB741C532" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_9EB5843DA397ADCB0EF15F9BB74165ED" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_NetIncomeLoss_9EB5843DA397ADCB0EF15F9BB74165ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_E1774D4E236A8FB905975F9BB741862F" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_E1774D4E236A8FB905975F9BB741862F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquityParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_2B21D2A769CC02A9590911727359B924" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_StatementTable_2B21D2A769CC02A9590911727359B924" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_3D0F15E40AD7370DC56A11727359853B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2B21D2A769CC02A9590911727359B924" xlink:to="loc_srt_ProductOrServiceAxis_3D0F15E40AD7370DC56A11727359853B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_2F4BF9207B3D4F7F0CC51172735A7A8F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_3D0F15E40AD7370DC56A11727359853B" xlink:to="loc_srt_ProductsAndServicesDomain_2F4BF9207B3D4F7F0CC51172735A7A8F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_2F4BF9207B3D4F7F0CC51172735A7A8F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_3D0F15E40AD7370DC56A11727359853B" xlink:to="loc_srt_ProductsAndServicesDomain_2F4BF9207B3D4F7F0CC51172735A7A8F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaap_ProductMember_AC7FA78588A10C8FFC601172735ABE29" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2F4BF9207B3D4F7F0CC51172735A7A8F" xlink:to="loc_us-gaap_ProductMember_AC7FA78588A10C8FFC601172735ABE29" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractDevelopmentAndManufacturingMember" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingMember_F8CD4A3009BBE42C3C7A1172735A80A8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2F4BF9207B3D4F7F0CC51172735A7A8F" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingMember_F8CD4A3009BBE42C3C7A1172735A80A8" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractsAndGrantsMember" xlink:label="loc_ebs_ContractsAndGrantsMember_78621CFC9F42E58339801172735A3862" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2F4BF9207B3D4F7F0CC51172735A7A8F" xlink:to="loc_ebs_ContractsAndGrantsMember_78621CFC9F42E58339801172735A3862" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_E016321A949F25CCE6A71172735B4F6D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_RevenuesAbstract_E016321A949F25CCE6A71172735B4F6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_B08B21895D5277C6E97A1172735BBEFB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_E016321A949F25CCE6A71172735B4F6D" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_B08B21895D5277C6E97A1172735BBEFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_605494F48A072B7396831172735BA2EC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_605494F48A072B7396831172735BA2EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_EBEE6DC72485B47A2A5C1172735CF986" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_EBEE6DC72485B47A2A5C1172735CF986" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1BEC591FD9F8014A22FF1172735C98E8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1BEC591FD9F8014A22FF1172735C98E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_884CB031393A31D2C3131172735CFC2C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_884CB031393A31D2C3131172735CFC2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_B836312A1AC6E27112971172735C7E7A" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:to="loc_us-gaap_OperatingExpenses_B836312A1AC6E27112971172735C7E7A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_1D7166201D7465CD6F4B1172735D540B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_OperatingIncomeLoss_1D7166201D7465CD6F4B1172735D540B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_D4D4F9BC9633C7FD67EB1172735DA0CD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6" xlink:to="loc_us-gaap_InterestExpense_D4D4F9BC9633C7FD67EB1172735DA0CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_36AA2048A61866EF05FD1172735DB8CB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_36AA2048A61866EF05FD1172735DB8CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1603A6B8918EA66996B21172735DF641" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1603A6B8918EA66996B21172735DF641" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_576B03EDBDAAD2736C1E1172735E39D8" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_576B03EDBDAAD2736C1E1172735E39D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1FBA462BA54B26B650A31172735E2173" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1FBA462BA54B26B650A31172735E2173" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_4BAC67EA53F93D8415EF1172735EE8B9" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_NetIncomeLoss_4BAC67EA53F93D8415EF1172735EE8B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_0B46CFEC2F87C17D68151172735E02F3" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_EarningsPerShareBasic_0B46CFEC2F87C17D68151172735E02F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_C10D8E180E62CD957F431172735EF344" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_EarningsPerShareDiluted_C10D8E180E62CD957F431172735EF344" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1EA1D440EDC83A07D0F21172735E438E" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1EA1D440EDC83A07D0F21172735E438E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3101F3934AB9D783F06E1172735F51EB" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3101F3934AB9D783F06E1172735F51EB" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/CoverPage" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlan" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanNarrativeDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstruments" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_F32DF5655FABD0EF9581CE2D5FB4E13E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_B3778FDCA538A3E1A896CE2D5FB14155" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_F32DF5655FABD0EF9581CE2D5FB4E13E" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_B3778FDCA538A3E1A896CE2D5FB14155" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_AFDFB461B939CAAA7BADCE2D5FB1C055" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_B3778FDCA538A3E1A896CE2D5FB14155" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_AFDFB461B939CAAA7BADCE2D5FB1C055" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2230FD81416D1A05FA09CE2D5FB15F04_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_AFDFB461B939CAAA7BADCE2D5FB1C055" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2230FD81416D1A05FA09CE2D5FB15F04_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2230FD81416D1A05FA09CE2D5FB15F04" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_AFDFB461B939CAAA7BADCE2D5FB1C055" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2230FD81416D1A05FA09CE2D5FB15F04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="loc_us-gaap_InterestExpenseMember_EC66E808FF4C86C9B48ECE2D5FB26987" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2230FD81416D1A05FA09CE2D5FB15F04" xlink:to="loc_us-gaap_InterestExpenseMember_EC66E808FF4C86C9B48ECE2D5FB26987" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_FFF4E6D46A52DEF860CBCE2D5FB23DAC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_B3778FDCA538A3E1A896CE2D5FB14155" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_FFF4E6D46A52DEF860CBCE2D5FB23DAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_A89F266A79591BA81913CE2D5FB25D6F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_FFF4E6D46A52DEF860CBCE2D5FB23DAC" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_A89F266A79591BA81913CE2D5FB25D6F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_A89F266A79591BA81913CE2D5FB25D6F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_FFF4E6D46A52DEF860CBCE2D5FB23DAC" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_A89F266A79591BA81913CE2D5FB25D6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_F096A9A0A6839645AA1ECE2D5FB3028D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_A89F266A79591BA81913CE2D5FB25D6F" xlink:to="loc_us-gaap_InterestRateSwapMember_F096A9A0A6839645AA1ECE2D5FB3028D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E57781409008F6D2CAFBCE2D5FB3EC73" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_B3778FDCA538A3E1A896CE2D5FB14155" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E57781409008F6D2CAFBCE2D5FB3EC73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8B3D3FE538EE850041B0CE2D5FB3DE61_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E57781409008F6D2CAFBCE2D5FB3EC73" xlink:to="loc_us-gaap_HedgingRelationshipDomain_8B3D3FE538EE850041B0CE2D5FB3DE61_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8B3D3FE538EE850041B0CE2D5FB3DE61" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E57781409008F6D2CAFBCE2D5FB3EC73" xlink:to="loc_us-gaap_HedgingRelationshipDomain_8B3D3FE538EE850041B0CE2D5FB3DE61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_386FF310EB38C51E6173CE2D5FB440B1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8B3D3FE538EE850041B0CE2D5FB3DE61" xlink:to="loc_us-gaap_CashFlowHedgingMember_386FF310EB38C51E6173CE2D5FB440B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_78F7D77C33E8BE79B2CACE2D5FB467BD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_F32DF5655FABD0EF9581CE2D5FB4E13E" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_78F7D77C33E8BE79B2CACE2D5FB467BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_47C638CC6614672ADA5ECE2D5FB431BE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_F32DF5655FABD0EF9581CE2D5FB4E13E" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_47C638CC6614672ADA5ECE2D5FB431BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_07E1F9EBC807543E8EC7CE2D5FB50221" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_F32DF5655FABD0EF9581CE2D5FB4E13E" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_07E1F9EBC807543E8EC7CE2D5FB50221" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_F657AC71E267D4C33F83CE2D5FB5B7B4" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_F32DF5655FABD0EF9581CE2D5FB4E13E" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_F657AC71E267D4C33F83CE2D5FB5B7B4" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5F6C0856B82FC90E8E8198A7607FBC16" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5F6C0856B82FC90E8E8198A7607FBC16" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9D6A61BB547E900192D698A7607DFE61" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9D6A61BB547E900192D698A7607DFE61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_DAB657989DE195990F4F98A7DC3110E1_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9D6A61BB547E900192D698A7607DFE61" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_DAB657989DE195990F4F98A7DC3110E1_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_DAB657989DE195990F4F98A7DC3110E1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9D6A61BB547E900192D698A7607DFE61" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_DAB657989DE195990F4F98A7DC3110E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_480A3EF25EEB67DF35AA98A7607D883B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_DAB657989DE195990F4F98A7DC3110E1" xlink:to="loc_us-gaap_InterestRateSwapMember_480A3EF25EEB67DF35AA98A7607D883B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_1564BC293522C577E31D98A7607D9FDC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B" xlink:to="loc_us-gaap_HedgingDesignationAxis_1564BC293522C577E31D98A7607D9FDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_83A5B37274D84779682298A7607D7F63_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_1564BC293522C577E31D98A7607D9FDC" xlink:to="loc_us-gaap_HedgingDesignationDomain_83A5B37274D84779682298A7607D7F63_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_83A5B37274D84779682298A7607D7F63" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_1564BC293522C577E31D98A7607D9FDC" xlink:to="loc_us-gaap_HedgingDesignationDomain_83A5B37274D84779682298A7607D7F63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7D68440FA54AFB52B95F98A7607EA617" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_83A5B37274D84779682298A7607D7F63" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7D68440FA54AFB52B95F98A7607EA617" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_906A240D4677B8C378AA98A7607F9C46" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5F6C0856B82FC90E8E8198A7607FBC16" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_906A240D4677B8C378AA98A7607F9C46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="loc_invest_DerivativeNotionalAmount_6B7F9C9263B09674415898A7607F9A99" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5F6C0856B82FC90E8E8198A7607FBC16" xlink:to="loc_invest_DerivativeNotionalAmount_6B7F9C9263B09674415898A7607F9A99" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_A9964C5396EF59B64E5998A75E61D38D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96C90B2339B396870DA398A75E5D6F3E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_A9964C5396EF59B64E5998A75E61D38D" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96C90B2339B396870DA398A75E5D6F3E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_953A691559CDB56DFC4B98A75E5DBD4D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96C90B2339B396870DA398A75E5D6F3E" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_953A691559CDB56DFC4B98A75E5DBD4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_65E5FCF14E28258B36DA98A75E5EC78F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_953A691559CDB56DFC4B98A75E5DBD4D" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_65E5FCF14E28258B36DA98A75E5EC78F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_65E5FCF14E28258B36DA98A75E5EC78F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_953A691559CDB56DFC4B98A75E5DBD4D" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_65E5FCF14E28258B36DA98A75E5EC78F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_28B90306EB5F1E8214E398A75E5E192D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_65E5FCF14E28258B36DA98A75E5EC78F" xlink:to="loc_us-gaap_InterestRateSwapMember_28B90306EB5F1E8214E398A75E5E192D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_26EB18A2C4EC9886167398A75E5EAE7B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96C90B2339B396870DA398A75E5D6F3E" xlink:to="loc_us-gaap_HedgingDesignationAxis_26EB18A2C4EC9886167398A75E5EAE7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_2F17268A996510D92F9A98A75E5EC384_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_26EB18A2C4EC9886167398A75E5EAE7B" xlink:to="loc_us-gaap_HedgingDesignationDomain_2F17268A996510D92F9A98A75E5EC384_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_2F17268A996510D92F9A98A75E5EC384" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_26EB18A2C4EC9886167398A75E5EAE7B" xlink:to="loc_us-gaap_HedgingDesignationDomain_2F17268A996510D92F9A98A75E5EC384" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_30AC58B6383B09AE903898A75E5F1DF6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_2F17268A996510D92F9A98A75E5EC384" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_30AC58B6383B09AE903898A75E5F1DF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3421A26EF63AFB3F214A98A75E5F1A9C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96C90B2339B396870DA398A75E5D6F3E" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3421A26EF63AFB3F214A98A75E5F1A9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1A61FC847E713D8D51AB98A75E5F57B4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3421A26EF63AFB3F214A98A75E5F1A9C" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1A61FC847E713D8D51AB98A75E5F57B4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1A61FC847E713D8D51AB98A75E5F57B4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3421A26EF63AFB3F214A98A75E5F1A9C" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1A61FC847E713D8D51AB98A75E5F57B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember_0547D5340A53B8139AD598A75E60F3BC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1A61FC847E713D8D51AB98A75E5F57B4" xlink:to="loc_us-gaap_OtherAssetsMember_0547D5340A53B8139AD598A75E60F3BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="loc_us-gaap_OtherLiabilitiesMember_C5E17A8CECB1883FF84A98A75E600DCE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1A61FC847E713D8D51AB98A75E5F57B4" xlink:to="loc_us-gaap_OtherLiabilitiesMember_C5E17A8CECB1883FF84A98A75E600DCE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_77339F6A70C00742EDF698A75E6195E3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_A9964C5396EF59B64E5998A75E61D38D" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_77339F6A70C00742EDF698A75E6195E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_707A641E62245248CC9E98A75E61B2BC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_A9964C5396EF59B64E5998A75E61D38D" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_707A641E62245248CC9E98A75E61B2BC" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_B3EF80FCB6C4D37E9F4CECA09E48957B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1460F22E6CF76D66B84AECA09E3C50DD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_B3EF80FCB6C4D37E9F4CECA09E48957B" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1460F22E6CF76D66B84AECA09E3C50DD" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8DD7A0ACCF17E80C681CECA09E3DDB67" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1460F22E6CF76D66B84AECA09E3C50DD" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8DD7A0ACCF17E80C681CECA09E3DDB67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_E1B963C1F488EE52D89CECA09E3E779E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8DD7A0ACCF17E80C681CECA09E3DDB67" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_E1B963C1F488EE52D89CECA09E3E779E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_E1B963C1F488EE52D89CECA09E3E779E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8DD7A0ACCF17E80C681CECA09E3DDB67" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_E1B963C1F488EE52D89CECA09E3E779E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_4FF6223269821A361A51ECA0E6C4050B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_E1B963C1F488EE52D89CECA09E3E779E" xlink:to="loc_us-gaap_InterestRateSwapMember_4FF6223269821A361A51ECA0E6C4050B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_BA6CA543622E83C5DA06ECA0123C9539" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_B3EF80FCB6C4D37E9F4CECA09E48957B" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_BA6CA543622E83C5DA06ECA0123C9539" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstrumentsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/EarningsPerShare" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_F94E079CD3C2EB9C3695EC8A3CFFEBE8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_F94E079CD3C2EB9C3695EC8A3CFFEBE8" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52C57732E6097B802C62EC8A3CFFE4AE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_F94E079CD3C2EB9C3695EC8A3CFFEBE8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52C57732E6097B802C62EC8A3CFFE4AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4B4A5AEB5CECE8AB38CEEC8A3CFF1F03_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52C57732E6097B802C62EC8A3CFFE4AE" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4B4A5AEB5CECE8AB38CEEC8A3CFF1F03_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4B4A5AEB5CECE8AB38CEEC8A3CFF1F03" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52C57732E6097B802C62EC8A3CFFE4AE" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4B4A5AEB5CECE8AB38CEEC8A3CFF1F03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_87558DEAB630A6E17807EC8A3D0098B6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4B4A5AEB5CECE8AB38CEEC8A3CFF1F03" xlink:to="loc_us-gaap_EmployeeStockOptionMember_87558DEAB630A6E17807EC8A3D0098B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_81ED6C3053FC7CC22A88EC8A3D0050AE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:to="loc_us-gaap_NetIncomeLoss_81ED6C3053FC7CC22A88EC8A3D0050AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_41ED5747ACACCA3E2F56EC8A3D015582" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_41ED5747ACACCA3E2F56EC8A3D015582" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax" xlink:label="loc_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax_2AC824E1B403F9DB5D49EC8A3D01F39D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:to="loc_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax_2AC824E1B403F9DB5D49EC8A3D01F39D" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AdjustedNetLoss" xlink:label="loc_ebs_AdjustedNetLoss_A5E90A64140891A5DC41EC8A3D01E263" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:to="loc_ebs_AdjustedNetLoss_A5E90A64140891A5DC41EC8A3D01E263" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4CE5FD1A09C2D3B827CAEC8A3D01E957" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4CE5FD1A09C2D3B827CAEC8A3D01E957" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8FE55850D87F35115C24EC8A3D0289B5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8FE55850D87F35115C24EC8A3D0289B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_035E480F1DBE893A8FEDEC8A3D02E25B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_035E480F1DBE893A8FEDEC8A3D02E25B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_093B0550D9EF1B7480C1EC8A3D02D02E" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_093B0550D9EF1B7480C1EC8A3D02D02E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_4DD06C43039657C16706EC8A3D022FD7" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:to="loc_us-gaap_EarningsPerShareBasic_4DD06C43039657C16706EC8A3D022FD7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_243587040EBD32C702CEEC8A3D028406" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:to="loc_us-gaap_EarningsPerShareDiluted_243587040EBD32C702CEEC8A3D028406" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0AFD735776B873AAD050EC8A3D027648" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0AFD735776B873AAD050EC8A3D027648" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/EarningsPerShareTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/FairValueMeasurementsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_DFBEB6875C777EFA79214B481577A95A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_DFBEB6875C777EFA79214B481577A95A" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_19BDF9A84F030D34EBAB4B4E8EB6960B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_19BDF9A84F030D34EBAB4B4E8EB6960B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8E175349D1F783DCECBD4B4F421FD00F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_19BDF9A84F030D34EBAB4B4E8EB6960B" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8E175349D1F783DCECBD4B4F421FD00F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8E175349D1F783DCECBD4B4F421FD00F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_19BDF9A84F030D34EBAB4B4E8EB6960B" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8E175349D1F783DCECBD4B4F421FD00F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_44CEFC30941D7FD1F99F4B4EB5A0E19E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8E175349D1F783DCECBD4B4F421FD00F" xlink:to="loc_us-gaap_MoneyMarketFundsMember_44CEFC30941D7FD1F99F4B4EB5A0E19E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34FE717B56D0800FB6794B4815670D97" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34FE717B56D0800FB6794B4815670D97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2BB840685AB555312AFC4B4815771A1F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34FE717B56D0800FB6794B4815670D97" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2BB840685AB555312AFC4B4815771A1F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2BB840685AB555312AFC4B4815771A1F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34FE717B56D0800FB6794B4815670D97" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2BB840685AB555312AFC4B4815771A1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ED91AF6F4B73BC0206694B481577661D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2BB840685AB555312AFC4B4815771A1F" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_ED91AF6F4B73BC0206694B481577661D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_254CC12BBF59B0D0529E4B4E61712A53" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_DFBEB6875C777EFA79214B481577A95A" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_254CC12BBF59B0D0529E4B4E61712A53" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxes" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_20E01E04E2373BF5167C68849E79ABAF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_20E01E04E2373BF5167C68849E79ABAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ED17B046A0A2C4BF93568849E797BED_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_20E01E04E2373BF5167C68849E79ABAF" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ED17B046A0A2C4BF93568849E797BED_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ED17B046A0A2C4BF93568849E797BED" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_20E01E04E2373BF5167C68849E79ABAF" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ED17B046A0A2C4BF93568849E797BED" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PaxVaxMember" xlink:label="loc_ebs_PaxVaxMember_93E77041D394C8303F2868849E795C28" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ED17B046A0A2C4BF93568849E797BED" xlink:to="loc_ebs_PaxVaxMember_93E77041D394C8303F2868849E795C28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_DE528ECB8BCEB4FC51F968849E7A2898" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_DE528ECB8BCEB4FC51F968849E7A2898" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_0CF01641DB65D29BD46D68849E7A3E1C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_DE528ECB8BCEB4FC51F968849E7A2898" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_0CF01641DB65D29BD46D68849E7A3E1C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_0CF01641DB65D29BD46D68849E7A3E1C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_DE528ECB8BCEB4FC51F968849E7A2898" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_0CF01641DB65D29BD46D68849E7A3E1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_E76890D621E3CE7D585E68849E7A202E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0CF01641DB65D29BD46D68849E7A3E1C" xlink:to="loc_us-gaap_DomesticCountryMember_E76890D621E3CE7D585E68849E7A202E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_22EE51F28644202D9E8768849E7ACE78" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0CF01641DB65D29BD46D68849E7A3E1C" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_22EE51F28644202D9E8768849E7ACE78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_9348AC5A8A48F4F36C0868849E7B7CA4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0CF01641DB65D29BD46D68849E7A3E1C" xlink:to="loc_us-gaap_ForeignCountryMember_9348AC5A8A48F4F36C0868849E7B7CA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_7B31D78517659D00DC7068849E7B2311" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_7B31D78517659D00DC7068849E7B2311" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_7B31D78517659D00DC7068849E7B2311" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_7B31D78517659D00DC7068849E7B2311" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchMember" xlink:label="loc_us-gaap_ResearchMember_FB199BC0E844BFF3E43A68849E7B6189" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5" xlink:to="loc_us-gaap_ResearchMember_FB199BC0E844BFF3E43A68849E7B6189" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember" xlink:label="loc_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember_09A6E34A62AA695572C768849E7B3088" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5" xlink:to="loc_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember_09A6E34A62AA695572C768849E7B3088" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_D533C4D855C7ED1CF6E768849E7CAA78" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_D533C4D855C7ED1CF6E768849E7CAA78" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_0C3474705F4CC8AA7DA168849E7CDED7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_0C3474705F4CC8AA7DA168849E7CDED7" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:label="loc_ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_1A376FAB93A3B22084F568849E7CEFA6" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_1A376FAB93A3B22084F568849E7CEFA6" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary" xlink:label="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary_72D51EFDF3EA2EDCB9ED68849E7C33E9" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary_72D51EFDF3EA2EDCB9ED68849E7C33E9" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense" xlink:label="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_953728B4732D8166A92568849E7D2C41" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_953728B4732D8166A92568849E7D2C41" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit_45586F338644DB9F986768849E7D1059" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit_45586F338644DB9F986768849E7D1059" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_9219720C2BBB59E2B23268849E7D4743" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_DeferredTaxLiabilities_9219720C2BBB59E2B23268849E7D4743" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_712FD255A2A53443D27A68849E7DCDAA" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_712FD255A2A53443D27A68849E7DCDAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_035C00A7AEC1F675E65668849E7D01A3" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_OperatingLossCarryforwards_035C00A7AEC1F675E65668849E7D01A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_1293CA7069F6270BDDB368849E7D4965" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_1293CA7069F6270BDDB368849E7D4965" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_818D781BA093F15C215468849E7E5F55" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_818D781BA093F15C215468849E7E5F55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_B59D7BC57FFB2831B9B368849E7E4704" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_B59D7BC57FFB2831B9B368849E7E4704" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0B7B18B809BD00BC7C1668849E7EB87F" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0B7B18B809BD00BC7C1668849E7EB87F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_F50B9A462B4CF78EDD3768849E7E88FE" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_F50B9A462B4CF78EDD3768849E7E88FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_F46564B122A5DCFF54DD68849E7EFA4B" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_F46564B122A5DCFF54DD68849E7EFA4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_3555BE85DD10D2A7A7D768849E7E6ED2" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_3555BE85DD10D2A7A7D768849E7E6ED2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B1A8FB8321FD951FD8E868849E7EC661" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B1A8FB8321FD951FD8E868849E7EC661" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_UnrecognizedTaxBenefitsCurrent" xlink:label="loc_ebs_UnrecognizedTaxBenefitsCurrent_80EDCCAABDA8EC469E9C68849E7F0889" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_ebs_UnrecognizedTaxBenefitsCurrent_80EDCCAABDA8EC469E9C68849E7F0889" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_UnrecognizedTaxBenefitsNoncurrent" xlink:label="loc_ebs_UnrecognizedTaxBenefitsNoncurrent_36F1D640361DDECFA62C68849E7F7A15" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_ebs_UnrecognizedTaxBenefitsNoncurrent_36F1D640361DDECFA62C68849E7F7A15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_53607FD6CA4A9DDC9850688C70DCBDA7" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_53607FD6CA4A9DDC9850688C70DCBDA7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_EB6BE8108EE2AE58F3A768849E7FE22B" xlink:type="locator" />
    <link:definitionArc order="21" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_EB6BE8108EE2AE58F3A768849E7FE22B" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_87A251EEA786BB87ECA54B4814BB0C65" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_87A251EEA786BB87ECA54B4814BB0C65" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_C6FBDD6DE9F69B1EA3D34B4814BB9A8C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_87A251EEA786BB87ECA54B4814BB0C65" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_C6FBDD6DE9F69B1EA3D34B4814BB9A8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_C6FBDD6DE9F69B1EA3D34B4814BB9A8C" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_C6FBDD6DE9F69B1EA3D34B4814BB9A8C" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_711852B6DDD2933244794B4814BBA980" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984" xlink:to="loc_us-gaap_DomesticCountryMember_711852B6DDD2933244794B4814BBA980" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_0CBFE598D4E9A1F140634B4814BB2B6A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_0CBFE598D4E9A1F140634B4814BB2B6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_09DFDBE0236FDFD57BFA4B4814BBECCB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_09DFDBE0236FDFD57BFA4B4814BBECCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_93AF71A861741DE8F7C64B4814BB26E4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_93AF71A861741DE8F7C64B4814BB26E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_104FBE2C69FE303A6DB74B4814BBC685" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_104FBE2C69FE303A6DB74B4814BBC685" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment" xlink:label="loc_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment_BC0F6806D389395CDF794B4814BB15A1" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment_BC0F6806D389395CDF794B4814BB15A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_B1FDCBFE27C38EB8E6C14B4814BBE177" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_B1FDCBFE27C38EB8E6C14B4814BBE177" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_8A901592CABC2A1DC9484B4814BBFAA3" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_8A901592CABC2A1DC9484B4814BBFAA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_AD107A2EB20F634F4D594B4814BB8CAE" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_AD107A2EB20F634F4D594B4814BB8CAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_014BF48470426E9EF3314B4814BB3D12" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_014BF48470426E9EF3314B4814BB3D12" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DeferredTaxAssetsOperatingLeaseLiability" xlink:label="loc_ebs_DeferredTaxAssetsOperatingLeaseLiability_F9B49AE71E37E618FD114B4814BB5E82" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_ebs_DeferredTaxAssetsOperatingLeaseLiability_F9B49AE71E37E618FD114B4814BB5E82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_6434DE5DD33225F0B8BD4B4814BB8F09" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_6434DE5DD33225F0B8BD4B4814BB8F09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_7028F87188D2D783C9504B4814BB5903" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_7028F87188D2D783C9504B4814BB5903" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2F50B1C3C73796EA81EE4B4814BB9040" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2F50B1C3C73796EA81EE4B4814BB9040" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_E3F4E2BBD59B49DD75B44B4814BB09CC" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_E3F4E2BBD59B49DD75B44B4814BB09CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_19890C9844CCE1C3FD224B4B39FF9C27" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_19890C9844CCE1C3FD224B4B39FF9C27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_A3191D56C7C7E0C6DA054B4814BB59E0" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_A3191D56C7C7E0C6DA054B4814BB59E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_76F5285D13D5EDD75FBA4B4814BBEBBF" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_76F5285D13D5EDD75FBA4B4814BBEBBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_C9109A1410571082A8814B4814BBF614" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_C9109A1410571082A8814B4814BBF614" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_B06D27E6BD2A133450954B4814BB4F7E" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxLiabilities_B06D27E6BD2A133450954B4814BB4F7E" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwill" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_A0F00ECB0FD7EDE8604D2CB9590559B1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_A63F04B69C977153E2B92CB95901CEE1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_A0F00ECB0FD7EDE8604D2CB9590559B1" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_A63F04B69C977153E2B92CB95901CEE1" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6273226F57E0EE29B6532CB959011212" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_A63F04B69C977153E2B92CB95901CEE1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6273226F57E0EE29B6532CB959011212" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_B731FEC3044ECD3477732CB95905EF58_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6273226F57E0EE29B6532CB959011212" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_B731FEC3044ECD3477732CB95905EF58_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_B731FEC3044ECD3477732CB95905EF58" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6273226F57E0EE29B6532CB959011212" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_B731FEC3044ECD3477732CB95905EF58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_80D824D5720E4F42BDDD2CB95905CD67" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_B731FEC3044ECD3477732CB95905EF58" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_80D824D5720E4F42BDDD2CB95905CD67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7D78676F5BC02E7F89792CB959055EC3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_A0F00ECB0FD7EDE8604D2CB9590559B1" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7D78676F5BC02E7F89792CB959055EC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_165E3ADF76B76B17F9E12CB95905C70C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_A0F00ECB0FD7EDE8604D2CB9590559B1" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_165E3ADF76B76B17F9E12CB95905C70C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_80BD38DB68A4C18278522CB95905100B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_A0F00ECB0FD7EDE8604D2CB9590559B1" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_80BD38DB68A4C18278522CB95905100B" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_InProcessResearchAndDevelopment" xlink:label="loc_ebs_InProcessResearchAndDevelopment_51156B183A711C65C3D12CD13F32470F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_A0F00ECB0FD7EDE8604D2CB9590559B1" xlink:to="loc_ebs_InProcessResearchAndDevelopment_51156B183A711C65C3D12CD13F32470F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_AF07CB06B6EE100A2B7A4B48155815E9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_AF07CB06B6EE100A2B7A4B48155815E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_A0FD31FF5A7017B6F1EA4B481558E03A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_AF07CB06B6EE100A2B7A4B48155815E9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_A0FD31FF5A7017B6F1EA4B481558E03A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_A0FD31FF5A7017B6F1EA4B481558E03A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_AF07CB06B6EE100A2B7A4B48155815E9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_A0FD31FF5A7017B6F1EA4B481558E03A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaap_ProductMember_D1748887BAD36C539F794B4815586D0E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_A0FD31FF5A7017B6F1EA4B481558E03A" xlink:to="loc_us-gaap_ProductMember_D1748887BAD36C539F794B4815586D0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_DA86BDA965FE8D3123054B481558AA08" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_A0FD31FF5A7017B6F1EA4B481558E03A" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_DA86BDA965FE8D3123054B481558AA08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_72C006E0A59B626F5CF64B4815588643" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_A0FD31FF5A7017B6F1EA4B481558E03A" xlink:to="loc_us-gaap_CustomerRelationshipsMember_72C006E0A59B626F5CF64B4815588643" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractManufacturingMember" xlink:label="loc_ebs_ContractManufacturingMember_E81EF9CB5FB142516F284B4815584EFA" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_A0FD31FF5A7017B6F1EA4B481558E03A" xlink:to="loc_ebs_ContractManufacturingMember_E81EF9CB5FB142516F284B4815584EFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_3A776CEAC6008900844F4B4815589DFB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC" xlink:to="loc_srt_RangeAxis_3A776CEAC6008900844F4B4815589DFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_6E1A2E6EC4FB70B63FA14B4815580DAB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3A776CEAC6008900844F4B4815589DFB" xlink:to="loc_srt_RangeMember_6E1A2E6EC4FB70B63FA14B4815580DAB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_6E1A2E6EC4FB70B63FA14B4815580DAB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3A776CEAC6008900844F4B4815589DFB" xlink:to="loc_srt_RangeMember_6E1A2E6EC4FB70B63FA14B4815580DAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_F7CB79C6E44D44869AA64B4815586528" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6E1A2E6EC4FB70B63FA14B4815580DAB" xlink:to="loc_srt_MinimumMember_F7CB79C6E44D44869AA64B4815586528" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_FF842FF82A14DE5E316B4B481558673F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6E1A2E6EC4FB70B63FA14B4815580DAB" xlink:to="loc_srt_MaximumMember_FF842FF82A14DE5E316B4B481558673F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9B4FB02BF6A4A39D188C4B481558F25A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9B4FB02BF6A4A39D188C4B481558F25A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_84318A6F007659560F4E4B4815587977" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_84318A6F007659560F4E4B4815587977" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_F23EA491AB81BDBB55F64B4815587A14" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_F23EA491AB81BDBB55F64B4815587A14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_A0427B3B26F8BB4B5E4B4B4815581E3D" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_A0427B3B26F8BB4B5E4B4B4815581E3D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1A7370B5C9E8567728484B481558999C" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1A7370B5C9E8567728484B481558999C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/Inventories" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/InventoriesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/InventoriesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/Leases" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_DA31B9356BFE0AE52EC1EC8A3D1FC849" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_A9237BC4BC3B0C45331DEC8A3D1DFCA6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_DA31B9356BFE0AE52EC1EC8A3D1FC849" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_A9237BC4BC3B0C45331DEC8A3D1DFCA6" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_B476685131292651CD00EC8A3D1E02C0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_A9237BC4BC3B0C45331DEC8A3D1DFCA6" xlink:to="loc_srt_RangeAxis_B476685131292651CD00EC8A3D1E02C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_B476685131292651CD00EC8A3D1E02C0" xlink:to="loc_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_B476685131292651CD00EC8A3D1E02C0" xlink:to="loc_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_42A13985B49F72B63592EC8A3D1E1CDA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69" xlink:to="loc_srt_MinimumMember_42A13985B49F72B63592EC8A3D1E1CDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_45AC55A79D8113A385ECEC8A3D1FC2CB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69" xlink:to="loc_srt_MaximumMember_45AC55A79D8113A385ECEC8A3D1FC2CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_EDF416FBBA9830A1306CEC8A3D1F1FDF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_DA31B9356BFE0AE52EC1EC8A3D1FC849" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_EDF416FBBA9830A1306CEC8A3D1F1FDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_65F9F93E810DE00D3726EC8A3D1F75E1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_DA31B9356BFE0AE52EC1EC8A3D1FC849" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_65F9F93E810DE00D3726EC8A3D1F75E1" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_LesseeOperatingLeaseTerminationPeriod" xlink:label="loc_ebs_LesseeOperatingLeaseTerminationPeriod_41547FD182AAAF3A399BEC8A3D1FCEB2" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_DA31B9356BFE0AE52EC1EC8A3D1FC849" xlink:to="loc_ebs_LesseeOperatingLeaseTerminationPeriod_41547FD182AAAF3A399BEC8A3D1FCEB2" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_80E5DFCAEB0BCBC4D55C21D7F7A5404A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_80E5DFCAEB0BCBC4D55C21D7F7A5404A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8EAB9FA6BEC4AA687A0221D7F7A5A9F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_80E5DFCAEB0BCBC4D55C21D7F7A5404A" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8EAB9FA6BEC4AA687A0221D7F7A5A9F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8EAB9FA6BEC4AA687A0221D7F7A5A9F4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8EAB9FA6BEC4AA687A0221D7F7A5A9F4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember_59DFCC03AEDDD2CA5F6C21D7F7A6FC99" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D" xlink:to="loc_us-gaap_OtherAssetsMember_59DFCC03AEDDD2CA5F6C21D7F7A6FC99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_8A661ED86EC3649DCDD021D7F7A683AD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_8A661ED86EC3649DCDD021D7F7A683AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="loc_us-gaap_OtherLiabilitiesMember_4E9F1C41A3964BED46B821D7F7A6F0C1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D" xlink:to="loc_us-gaap_OtherLiabilitiesMember_4E9F1C41A3964BED46B821D7F7A6F0C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6FC1F6DD3246B6A2256921D7F7A7421D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6FC1F6DD3246B6A2256921D7F7A7421D" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_OperatingLeaseOtherLiabilityCurrent" xlink:label="loc_ebs_OperatingLeaseOtherLiabilityCurrent_7A704BA9C4FBD46899B521D7F7A7D765" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:to="loc_ebs_OperatingLeaseOtherLiabilityCurrent_7A704BA9C4FBD46899B521D7F7A7D765" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_CD95F80DB467243E609721D7F7A7C704" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_CD95F80DB467243E609721D7F7A7C704" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_F20A931FA5ACC85F17C821D7F7A77BC4" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:to="loc_us-gaap_OperatingLeaseLiability_F20A931FA5ACC85F17C821D7F7A77BC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="loc_us-gaap_LeaseCostAbstract_F21F9DBCA1A75A0EE97F21D7F7A7F6AB" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:to="loc_us-gaap_LeaseCostAbstract_F21F9DBCA1A75A0EE97F21D7F7A7F6AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5ADA7432315F8CA2E3AB21D7F7A8C6FA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseCostAbstract_F21F9DBCA1A75A0EE97F21D7F7A7F6AB" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5ADA7432315F8CA2E3AB21D7F7A8C6FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_D792260D4696DEF954B121D7F7A8CBE0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseCostAbstract_F21F9DBCA1A75A0EE97F21D7F7A7F6AB" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_D792260D4696DEF954B121D7F7A8CBE0" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/LeasesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/Litigation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebt" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_41F1A8563D87976D9E1521D7F8D66C15" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_C83325BE09C4D2719EE321D7F8D3681E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41F1A8563D87976D9E1521D7F8D66C15" xlink:to="loc_us-gaap_DebtInstrumentTable_C83325BE09C4D2719EE321D7F8D3681E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_E79B1EB0BEFDD780337921D7F8D46710" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_C83325BE09C4D2719EE321D7F8D3681E" xlink:to="loc_us-gaap_CreditFacilityAxis_E79B1EB0BEFDD780337921D7F8D46710" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_9FACF0D357296DFC155121D7F8D4708E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_E79B1EB0BEFDD780337921D7F8D46710" xlink:to="loc_us-gaap_CreditFacilityDomain_9FACF0D357296DFC155121D7F8D4708E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_9FACF0D357296DFC155121D7F8D4708E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_E79B1EB0BEFDD780337921D7F8D46710" xlink:to="loc_us-gaap_CreditFacilityDomain_9FACF0D357296DFC155121D7F8D4708E" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TermLoanFacilityMember" xlink:label="loc_ebs_TermLoanFacilityMember_ED32608D203D926A92E621D7F8D408BF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_9FACF0D357296DFC155121D7F8D4708E" xlink:to="loc_ebs_TermLoanFacilityMember_ED32608D203D926A92E621D7F8D408BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_19A3136BB9AC72FE3B8821D7F8D52590" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_9FACF0D357296DFC155121D7F8D4708E" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_19A3136BB9AC72FE3B8821D7F8D52590" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_7F08AC53BDCDDBDCA15421D7F8D5E4DD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_C83325BE09C4D2719EE321D7F8D3681E" xlink:to="loc_us-gaap_DebtInstrumentAxis_7F08AC53BDCDDBDCA15421D7F8D5E4DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_829F8A7F8608FF2714DE21D7F8D5C4C4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7F08AC53BDCDDBDCA15421D7F8D5E4DD" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_829F8A7F8608FF2714DE21D7F8D5C4C4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_829F8A7F8608FF2714DE21D7F8D5C4C4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7F08AC53BDCDDBDCA15421D7F8D5E4DD" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_829F8A7F8608FF2714DE21D7F8D5C4C4" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ConvertibleSeniorNotesDue2021Member" xlink:label="loc_ebs_ConvertibleSeniorNotesDue2021Member_AAE31836BBD36966DFF521D7F8D582F0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_829F8A7F8608FF2714DE21D7F8D5C4C4" xlink:to="loc_ebs_ConvertibleSeniorNotesDue2021Member_AAE31836BBD36966DFF521D7F8D582F0" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_OtherLongTermDebtFacilityMember" xlink:label="loc_ebs_OtherLongTermDebtFacilityMember_E10634234ACFCA832EF721D7F8D6CF90" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_829F8A7F8608FF2714DE21D7F8D5C4C4" xlink:to="loc_ebs_OtherLongTermDebtFacilityMember_E10634234ACFCA832EF721D7F8D6CF90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_48CE3B512138D637804E21D7F8D64009" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41F1A8563D87976D9E1521D7F8D66C15" xlink:to="loc_us-gaap_LongTermDebt_48CE3B512138D637804E21D7F8D64009" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_A2598B751FEE87951C4D21D7F8D6B2B5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41F1A8563D87976D9E1521D7F8D66C15" xlink:to="loc_us-gaap_LongTermDebtCurrent_A2598B751FEE87951C4D21D7F8D6B2B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_22C12ED5BE08C4D7739721D7F8DB785D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41F1A8563D87976D9E1521D7F8D66C15" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_22C12ED5BE08C4D7739721D7F8DB785D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2138128412F1AB9DF1B321D7F8DC0825" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41F1A8563D87976D9E1521D7F8D66C15" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2138128412F1AB9DF1B321D7F8DC0825" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ED255BBF13281518FBEE21D7F8DC9085" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41F1A8563D87976D9E1521D7F8D66C15" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ED255BBF13281518FBEE21D7F8DC9085" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_EC49BC79C1AA8F762E9AECB148357714" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:to="loc_us-gaap_DebtInstrumentTable_EC49BC79C1AA8F762E9AECB148357714" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_81EDC1390333B903A61AECB148356F8D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_EC49BC79C1AA8F762E9AECB148357714" xlink:to="loc_us-gaap_DebtInstrumentAxis_81EDC1390333B903A61AECB148356F8D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7AD9AA7BA36CF5EB57E5ECB14836E09B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_81EDC1390333B903A61AECB148356F8D" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7AD9AA7BA36CF5EB57E5ECB14836E09B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7AD9AA7BA36CF5EB57E5ECB14836E09B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_81EDC1390333B903A61AECB148356F8D" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7AD9AA7BA36CF5EB57E5ECB14836E09B" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ConvertibleSeniorNotesDue2021Member" xlink:label="loc_ebs_ConvertibleSeniorNotesDue2021Member_D501B86D1213FFBCAD0CECB14836E200" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7AD9AA7BA36CF5EB57E5ECB14836E09B" xlink:to="loc_ebs_ConvertibleSeniorNotesDue2021Member_D501B86D1213FFBCAD0CECB14836E200" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_15BAD47422637DA3AEE2ECB14836D1E9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_15BAD47422637DA3AEE2ECB14836D1E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2BC00F171F978F0B4765ECB148376FE6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_2BC00F171F978F0B4765ECB148376FE6" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentNumberOfEquityInstruments" xlink:label="loc_ebs_DebtInstrumentNumberOfEquityInstruments_D4AC74724DD4B6B485F5ECB14837A438" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:to="loc_ebs_DebtInstrumentNumberOfEquityInstruments_D4AC74724DD4B6B485F5ECB14837A438" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_9CF4A65FA8B24E84F229ECB14837C917" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_9CF4A65FA8B24E84F229ECB14837C917" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentNumberOfAdditionalEquityInstruments" xlink:label="loc_ebs_DebtInstrumentNumberOfAdditionalEquityInstruments_EA38522F86D2D289BD4AECB1483716D9" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:to="loc_ebs_DebtInstrumentNumberOfAdditionalEquityInstruments_EA38522F86D2D289BD4AECB1483716D9" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentAccruedInterestOnConvertedNotes" xlink:label="loc_ebs_DebtInstrumentAccruedInterestOnConvertedNotes_4C6CFEE543380ECCD3F2ECB1483835DE" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:to="loc_ebs_DebtInstrumentAccruedInterestOnConvertedNotes_4C6CFEE543380ECCD3F2ECB1483835DE" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_A04A965C7B9983AC9505CAFC0478CD80" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_us-gaap_DebtInstrumentTable_A04A965C7B9983AC9505CAFC0478CD80" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_31AEF38E557016C84823CAFC047920A5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_A04A965C7B9983AC9505CAFC0478CD80" xlink:to="loc_us-gaap_CreditFacilityAxis_31AEF38E557016C84823CAFC047920A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_31AEF38E557016C84823CAFC047920A5" xlink:to="loc_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_31AEF38E557016C84823CAFC047920A5" xlink:to="loc_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_2D45880B7EEB016D6331CAFC047BC2DF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_2D45880B7EEB016D6331CAFC047BC2DF" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TermLoanFacilityMember" xlink:label="loc_ebs_TermLoanFacilityMember_8530EA1406435A78361FCAFC047CCFAB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8" xlink:to="loc_ebs_TermLoanFacilityMember_8530EA1406435A78361FCAFC047CCFAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_E3FEDE033A4DB128BC05CAFC047CCE68" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_A04A965C7B9983AC9505CAFC0478CD80" xlink:to="loc_us-gaap_DebtInstrumentAxis_E3FEDE033A4DB128BC05CAFC047CCE68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_EDF82D77A59DD252AF80CAFC047C3E2E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_E3FEDE033A4DB128BC05CAFC047CCE68" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_EDF82D77A59DD252AF80CAFC047C3E2E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_EDF82D77A59DD252AF80CAFC047C3E2E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_E3FEDE033A4DB128BC05CAFC047CCE68" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_EDF82D77A59DD252AF80CAFC047C3E2E" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_CreditAgreementMember" xlink:label="loc_ebs_CreditAgreementMember_A77EAB942115FD26B666CAFC047CF395" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_EDF82D77A59DD252AF80CAFC047C3E2E" xlink:to="loc_ebs_CreditAgreementMember_A77EAB942115FD26B666CAFC047CF395" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmendedCreditAgreementMember" xlink:label="loc_ebs_AmendedCreditAgreementMember_6771FBDC1E3E83A57840CAFC047C152E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_EDF82D77A59DD252AF80CAFC047C3E2E" xlink:to="loc_ebs_AmendedCreditAgreementMember_6771FBDC1E3E83A57840CAFC047C152E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_179DE93828794C3B1198CAFC047D66BA" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_A04A965C7B9983AC9505CAFC0478CD80" xlink:to="loc_us-gaap_VariableRateAxis_179DE93828794C3B1198CAFC047D66BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_179DE93828794C3B1198CAFC047D66BA" xlink:to="loc_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_179DE93828794C3B1198CAFC047D66BA" xlink:to="loc_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_43778BF338B232E545D1CAFC047D4729" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_43778BF338B232E545D1CAFC047D4729" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_DAD68CEE51F61ECF5CB3CAFC047D293D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A" xlink:to="loc_us-gaap_EurodollarMember_DAD68CEE51F61ECF5CB3CAFC047D293D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_E2DC69E842E8B7AD7C4CCAFC047D90C4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A" xlink:to="loc_us-gaap_BaseRateMember_E2DC69E842E8B7AD7C4CCAFC047D90C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_41FBF5FD92F0B01E6DAECAFC047ECA3A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_A04A965C7B9983AC9505CAFC0478CD80" xlink:to="loc_srt_RangeAxis_41FBF5FD92F0B01E6DAECAFC047ECA3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_D1F53980804BDF3477E5CAFC047ECE54_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_41FBF5FD92F0B01E6DAECAFC047ECA3A" xlink:to="loc_srt_RangeMember_D1F53980804BDF3477E5CAFC047ECE54_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_D1F53980804BDF3477E5CAFC047ECE54" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_41FBF5FD92F0B01E6DAECAFC047ECA3A" xlink:to="loc_srt_RangeMember_D1F53980804BDF3477E5CAFC047ECE54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_64014F23307587959C61CAFC047EBD25" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_D1F53980804BDF3477E5CAFC047ECE54" xlink:to="loc_srt_MinimumMember_64014F23307587959C61CAFC047EBD25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_D827B6F3E623BE15A2C8CAFC047F3987" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_D1F53980804BDF3477E5CAFC047ECE54" xlink:to="loc_srt_MaximumMember_D827B6F3E623BE15A2C8CAFC047F3987" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberOfLendingInstitutions" xlink:label="loc_ebs_NumberOfLendingInstitutions_93320350272D92778C70CAFC047F6A3C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_NumberOfLendingInstitutions_93320350272D92778C70CAFC047F6A3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_FADDE567C96DCD7AE4D7CAFC047FD7B3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_FADDE567C96DCD7AE4D7CAFC047FD7B3" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ConsolidatedSecuredNetLeverageRatio" xlink:label="loc_ebs_ConsolidatedSecuredNetLeverageRatio_C5AD19B1528BC438EAE3CAFC047F8521" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_ConsolidatedSecuredNetLeverageRatio_C5AD19B1528BC438EAE3CAFC047F8521" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmountRequiredForNetLeverageRatio" xlink:label="loc_ebs_AmountRequiredForNetLeverageRatio_8AD94C6847D2851A946ECAFC047F6543" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_AmountRequiredForNetLeverageRatio_8AD94C6847D2851A946ECAFC047F6543" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentCovenantLeverageRatio" xlink:label="loc_ebs_DebtInstrumentCovenantLeverageRatio_8C8D9A026D52AB7DCDE7CAFC047F9330" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtInstrumentCovenantLeverageRatio_8C8D9A026D52AB7DCDE7CAFC047F9330" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_FFE8D11AE460032B8EEFCAFC0480EE7D" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_FFE8D11AE460032B8EEFCAFC0480EE7D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_9E72E384DEEABC55D698CAFC04807770" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_us-gaap_LineOfCredit_9E72E384DEEABC55D698CAFC04807770" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_91ECA200A9D405CA8FF7CB3F899A83B8" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_91ECA200A9D405CA8FF7CB3F899A83B8" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentTermOfVariableRate" xlink:label="loc_ebs_DebtInstrumentTermOfVariableRate_93F1364DE9146D07DA8CCAFC0480318E" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtInstrumentTermOfVariableRate_93F1364DE9146D07DA8CCAFC0480318E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_266180886526170CAEB4CAFC0480EEED" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_266180886526170CAEB4CAFC0480EEED" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears" xlink:label="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears_0E705EAE1F881981A716CAFC0480A901" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears_0E705EAE1F881981A716CAFC0480A901" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear" xlink:label="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear_F5F8A9DAADD7C8552B27CAFC04815E64" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear_F5F8A9DAADD7C8552B27CAFC04815E64" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears" xlink:label="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears_D09FB84475CA6BAE4CF6CAFC04819352" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears_D09FB84475CA6BAE4CF6CAFC04819352" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight" xlink:label="loc_ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight_5FEFACA487D67312CD63CAFC04816F40" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight_5FEFACA487D67312CD63CAFC04816F40" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentCovenantDebtServiceCoverageRatio" xlink:label="loc_ebs_DebtInstrumentCovenantDebtServiceCoverageRatio_D6B327F17D77BB426F47CAFC04813DE8" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtInstrumentCovenantDebtServiceCoverageRatio_D6B327F17D77BB426F47CAFC04813DE8" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtCovenantNetLeverageRatioOne" xlink:label="loc_ebs_DebtCovenantNetLeverageRatioOne_90E03C57BA90CDAA89B8CAFC048103D9" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtCovenantNetLeverageRatioOne_90E03C57BA90CDAA89B8CAFC048103D9" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtCovenantNetLeverageRatioTwo" xlink:label="loc_ebs_DebtCovenantNetLeverageRatioTwo_6C64B885D1127AD6A229CAFC0481EFC4" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtCovenantNetLeverageRatioTwo_6C64B885D1127AD6A229CAFC0481EFC4" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtCovenantNetLeverageRatioThree" xlink:label="loc_ebs_DebtCovenantNetLeverageRatioThree_C695B5D73808D2D10005CAFC04816715" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtCovenantNetLeverageRatioThree_C695B5D73808D2D10005CAFC04816715" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtCovenantNetLeverageRatioFour" xlink:label="loc_ebs_DebtCovenantNetLeverageRatioFour_5BEC22CCB9F996A0D42BCAFC048285BD" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtCovenantNetLeverageRatioFour_5BEC22CCB9F996A0D42BCAFC048285BD" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentRestrictedPaymentsLimitAmount" xlink:label="loc_ebs_DebtInstrumentRestrictedPaymentsLimitAmount_C154665C9E4100CEAD6FCAFC0482A051" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtInstrumentRestrictedPaymentsLimitAmount_C154665C9E4100CEAD6FCAFC0482A051" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebtTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganization" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganizationDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/PropertyPlantAndEquipment" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_A1E18711A16CEB09D65A92A2889838C4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_A1E18711A16CEB09D65A92A2889838C4" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5306579058FEB8DB829692A28898E546" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_A1E18711A16CEB09D65A92A2889838C4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5306579058FEB8DB829692A28898E546" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5306579058FEB8DB829692A28898E546" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5306579058FEB8DB829692A28898E546" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LandAndLandImprovementsMember" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_9E8049E08E54378338B692A288981D11" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_9E8049E08E54378338B692A288981D11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_E8978B1BEAFCCECFE4BF92A28898E2C6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_E8978B1BEAFCCECFE4BF92A28898E2C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_48978C2B8549FD69DB1792A28898DC69" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_48978C2B8549FD69DB1792A28898DC69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_8CB8DABBFFC506867AF092A28898BA50" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_8CB8DABBFFC506867AF092A28898BA50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaap_ConstructionInProgressMember_DA932CF88D1944CFDDCB92A28898B80A" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:to="loc_us-gaap_ConstructionInProgressMember_DA932CF88D1944CFDDCB92A28898B80A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_B33819844A125B58BE4B92A288984295" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_B33819844A125B58BE4B92A288984295" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6E491FDED89720A5A9E692A288982520" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6E491FDED89720A5A9E692A288982520" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_D080B346CF85C4F29F3D92A2889837E5" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_D080B346CF85C4F29F3D92A2889837E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_CAB8785EC54E483372F292A288989003" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_CAB8785EC54E483372F292A288989003" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/PurchaseCommitments" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/PurchaseCommitmentsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnaudited" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognition" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_98667276A1D64B3A5BBF21E7CBDF7AE6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_98667276A1D64B3A5BBF21E7CBDF7AE6" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_D4B539CFC2EF98C8E1F721E7CBD78BF6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_D4B539CFC2EF98C8E1F721E7CBD78BF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_84B9BAA591D2A058431B21E7CBD70CDA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_D4B539CFC2EF98C8E1F721E7CBD78BF6" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_84B9BAA591D2A058431B21E7CBD70CDA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_84B9BAA591D2A058431B21E7CBD70CDA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_D4B539CFC2EF98C8E1F721E7CBD78BF6" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_84B9BAA591D2A058431B21E7CBD70CDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_BCDD4FED32676C88486621E9227EE2C7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_84B9BAA591D2A058431B21E7CBD70CDA" xlink:to="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_BCDD4FED32676C88486621E9227EE2C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_323B37B2EA9847757B2C21E7CBD88DEF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_323B37B2EA9847757B2C21E7CBD88DEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_E028D9F90A91EC17CD4D21E7CBD936C5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_323B37B2EA9847757B2C21E7CBD88DEF" xlink:to="loc_us-gaap_TypeOfAdoptionMember_E028D9F90A91EC17CD4D21E7CBD936C5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_E028D9F90A91EC17CD4D21E7CBD936C5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_323B37B2EA9847757B2C21E7CBD88DEF" xlink:to="loc_us-gaap_TypeOfAdoptionMember_E028D9F90A91EC17CD4D21E7CBD936C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_B5EBC9421F3D4551482A21E83ABE50C7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_E028D9F90A91EC17CD4D21E7CBD936C5" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_B5EBC9421F3D4551482A21E83ABE50C7" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ChangeinContractWithCustomerLiabilityRollForward" xlink:label="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_98667276A1D64B3A5BBF21E7CBDF7AE6" xlink:to="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_3B91D4B25F34A9E37EB121D7FA1B89C9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:to="loc_us-gaap_ContractWithCustomerLiability_3B91D4B25F34A9E37EB121D7FA1B89C9" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractWithCustomerLiabilityAdditions" xlink:label="loc_ebs_ContractWithCustomerLiabilityAdditions_4200D378910DDA764D4321D7FA1B558E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:to="loc_ebs_ContractWithCustomerLiabilityAdditions_4200D378910DDA764D4321D7FA1B558E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8B2A503B49EC3B484BEF21D7FA1BD214" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8B2A503B49EC3B484BEF21D7FA1BD214" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_F9671210CB419FAEA9B1117272C0781F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_F9671210CB419FAEA9B1117272C0781F" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_A469FB0E140B595D117C117272BE9A0E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95" xlink:to="loc_srt_ProductOrServiceAxis_A469FB0E140B595D117C117272BE9A0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_7EE8ACD9D4D60E42D980117272BE2410_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_A469FB0E140B595D117C117272BE9A0E" xlink:to="loc_srt_ProductsAndServicesDomain_7EE8ACD9D4D60E42D980117272BE2410_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_7EE8ACD9D4D60E42D980117272BE2410" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_A469FB0E140B595D117C117272BE9A0E" xlink:to="loc_srt_ProductsAndServicesDomain_7EE8ACD9D4D60E42D980117272BE2410" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaap_ProductMember_0323A4CB8856B650E254117272BFA4E8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7EE8ACD9D4D60E42D980117272BE2410" xlink:to="loc_us-gaap_ProductMember_0323A4CB8856B650E254117272BFA4E8" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractManufacturingMember" xlink:label="loc_ebs_ContractManufacturingMember_99B29BAF5B850B040046117272BF9C83" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7EE8ACD9D4D60E42D980117272BE2410" xlink:to="loc_ebs_ContractManufacturingMember_99B29BAF5B850B040046117272BF9C83" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractsAndGrantsMember" xlink:label="loc_ebs_ContractsAndGrantsMember_F030F123804824FC71D3117272BF045A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7EE8ACD9D4D60E42D980117272BE2410" xlink:to="loc_ebs_ContractsAndGrantsMember_F030F123804824FC71D3117272BF045A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_2C6B41430C8BF805D810117272BFB57E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95" xlink:to="loc_srt_StatementGeographicalAxis_2C6B41430C8BF805D810117272BFB57E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_2C6B41430C8BF805D810117272BFB57E" xlink:to="loc_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_2C6B41430C8BF805D810117272BFB57E" xlink:to="loc_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_CD1F0BC164631B7F0581117272C05650" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0" xlink:to="loc_country_US_CD1F0BC164631B7F0581117272C05650" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_BA18E932125E5CA10CBA117272C07C1C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0" xlink:to="loc_us-gaap_NonUsMember_BA18E932125E5CA10CBA117272C07C1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6EE90EAFA3AD5ADA810C117272C10623" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_F9671210CB419FAEA9B1117272C0781F" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6EE90EAFA3AD5ADA810C117272C10623" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:to="loc_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_3EB68F1E9F0349D29A344FB8494BED5E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_3EB68F1E9F0349D29A344FB8494BED5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5C07E67F953A9DE139B24FB8494B1F49_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_3EB68F1E9F0349D29A344FB8494BED5E" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5C07E67F953A9DE139B24FB8494B1F49_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5C07E67F953A9DE139B24FB8494B1F49" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_3EB68F1E9F0349D29A344FB8494BED5E" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5C07E67F953A9DE139B24FB8494B1F49" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_2FE7F148126E5BF49D2A4FB8494B02B7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5C07E67F953A9DE139B24FB8494B1F49" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_2FE7F148126E5BF49D2A4FB8494B02B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6C9FEF18CD64959EAC6E4FB8494BFBF0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6C9FEF18CD64959EAC6E4FB8494BFBF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ADE295B0B9A54009D6244FB8494BDD95_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6C9FEF18CD64959EAC6E4FB8494BFBF0" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ADE295B0B9A54009D6244FB8494BDD95_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ADE295B0B9A54009D6244FB8494BDD95" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6C9FEF18CD64959EAC6E4FB8494BFBF0" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ADE295B0B9A54009D6244FB8494BDD95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_CD903B13118194E0265D4FB8494FAF19" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ADE295B0B9A54009D6244FB8494BDD95" xlink:to="loc_us-gaap_AccountsReceivableMember_CD903B13118194E0265D4FB8494FAF19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_18797490A71AD8E09CFE4FB8494F2AA7" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:to="loc_srt_MajorCustomersAxis_18797490A71AD8E09CFE4FB8494F2AA7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_4478BC7D1B9118FDA8894FB8494F7FAE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_18797490A71AD8E09CFE4FB8494F2AA7" xlink:to="loc_srt_NameOfMajorCustomerDomain_4478BC7D1B9118FDA8894FB8494F7FAE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_4478BC7D1B9118FDA8894FB8494F7FAE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_18797490A71AD8E09CFE4FB8494F2AA7" xlink:to="loc_srt_NameOfMajorCustomerDomain_4478BC7D1B9118FDA8894FB8494F7FAE" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_UnitedStatesGovernmentMember" xlink:label="loc_ebs_UnitedStatesGovernmentMember_448672890942447AB3E74FB8494F95CA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_4478BC7D1B9118FDA8894FB8494F7FAE" xlink:to="loc_ebs_UnitedStatesGovernmentMember_448672890942447AB3E74FB8494F95CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_F08C71E4549CAA4D7B634FB8494B5FE2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:to="loc_us-gaap_NumberOfOperatingSegments_F08C71E4549CAA4D7B634FB8494B5FE2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_3BC7B989FCD0165E537D4FB8494B60FF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_3BC7B989FCD0165E537D4FB8494B60FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCostsCurrent" xlink:label="loc_us-gaap_DeferredCostsCurrent_904DB716AF974FA61F0C4FB8494BBDCB" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:to="loc_us-gaap_DeferredCostsCurrent_904DB716AF974FA61F0C4FB8494BBDCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_67589C77AE3A271885334FB8494FE6B1" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_67589C77AE3A271885334FB8494FE6B1" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionRemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_71021F2D7C76038B97754FC66BD6ABE2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_53B15E4EB53263EB01524FC427E8D70E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_71021F2D7C76038B97754FC66BD6ABE2" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_53B15E4EB53263EB01524FC427E8D70E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_15047297E8F952F93E774FC427E89D0B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_53B15E4EB53263EB01524FC427E8D70E" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_15047297E8F952F93E774FC427E89D0B" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3520D23E2C34DDE7110E7876E50D4B0C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1E0A9E053BBC6CB6E87B7876E50C43BF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3520D23E2C34DDE7110E7876E50D4B0C" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1E0A9E053BBC6CB6E87B7876E50C43BF" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_476639990BD0C3AA23CA7876E50CAED9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1E0A9E053BBC6CB6E87B7876E50C43BF" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_476639990BD0C3AA23CA7876E50CAED9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_476639990BD0C3AA23CA7876E50CAED9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_476639990BD0C3AA23CA7876E50CAED9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryValuationReserveMember" xlink:label="loc_us-gaap_InventoryValuationReserveMember_DD17983F385EBE58531F7876E50DBB7C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720" xlink:to="loc_us-gaap_InventoryValuationReserveMember_DD17983F385EBE58531F7876E50DBB7C" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember_FB1573497F90AB9ADCD97876E50D463F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720" xlink:to="loc_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember_FB1573497F90AB9ADCD97876E50D463F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3520D23E2C34DDE7110E7876E50D4B0C" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_C9A128A899718AC7C1237876E50E3083" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_C9A128A899718AC7C1237876E50E3083" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_0694368D499E4ED39D2C78774D8C67FE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_0694368D499E4ED39D2C78774D8C67FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_69AB24819D1C8CD647307876E50EC5CD" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_69AB24819D1C8CD647307876E50EC5CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_4206EBADABA977B4F5287876E50FF562" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_4206EBADABA977B4F5287876E50FF562" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SegmentInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_AC93C6B7A0BAD7F089BDEC8A3CEE1ED0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E477982F5E03FF942CBFEC8A3CEA2819" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_AC93C6B7A0BAD7F089BDEC8A3CEE1ED0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E477982F5E03FF942CBFEC8A3CEA2819" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_3788931D4369B076CF31EC8A3CEAAF4E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E477982F5E03FF942CBFEC8A3CEA2819" xlink:to="loc_srt_StatementGeographicalAxis_3788931D4369B076CF31EC8A3CEAAF4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_B82BDF64DBB151D81152EC8A3CEB5DC5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_3788931D4369B076CF31EC8A3CEAAF4E" xlink:to="loc_srt_SegmentGeographicalDomain_B82BDF64DBB151D81152EC8A3CEB5DC5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_B82BDF64DBB151D81152EC8A3CEB5DC5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_3788931D4369B076CF31EC8A3CEAAF4E" xlink:to="loc_srt_SegmentGeographicalDomain_B82BDF64DBB151D81152EC8A3CEB5DC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_7717C3F96FB4F06960A2EC8A3CEB138C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_B82BDF64DBB151D81152EC8A3CEB5DC5" xlink:to="loc_country_US_7717C3F96FB4F06960A2EC8A3CEB138C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_38FCA506FC9E8259DC8CEC8A3CEBF7DD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_B82BDF64DBB151D81152EC8A3CEB5DC5" xlink:to="loc_us-gaap_NonUsMember_38FCA506FC9E8259DC8CEC8A3CEBF7DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_12364E9279ECE50452ECEC8A3CEB1237" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E477982F5E03FF942CBFEC8A3CEA2819" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_12364E9279ECE50452ECEC8A3CEB1237" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_B14A6072F605826A479EEC8A3CEC5073_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_12364E9279ECE50452ECEC8A3CEB1237" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_B14A6072F605826A479EEC8A3CEC5073_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_B14A6072F605826A479EEC8A3CEC5073" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_12364E9279ECE50452ECEC8A3CEB1237" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_B14A6072F605826A479EEC8A3CEC5073" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_ED9521750C10DD56F1CEEC8A3CECD7C7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_B14A6072F605826A479EEC8A3CEC5073" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_ED9521750C10DD56F1CEEC8A3CECD7C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_A706FD74D86C993D9C22EC8A3CEC5E3E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_B14A6072F605826A479EEC8A3CEC5073" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_A706FD74D86C993D9C22EC8A3CEC5E3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_0D6B099A4D189A6DDDB7EC8A3CEC886D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E477982F5E03FF942CBFEC8A3CEA2819" xlink:to="loc_srt_ProductOrServiceAxis_0D6B099A4D189A6DDDB7EC8A3CEC886D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_4E7FE348D04427158959EC8A3CED0AE5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0D6B099A4D189A6DDDB7EC8A3CEC886D" xlink:to="loc_srt_ProductsAndServicesDomain_4E7FE348D04427158959EC8A3CED0AE5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_4E7FE348D04427158959EC8A3CED0AE5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0D6B099A4D189A6DDDB7EC8A3CEC886D" xlink:to="loc_srt_ProductsAndServicesDomain_4E7FE348D04427158959EC8A3CED0AE5" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BiothraxMember" xlink:label="loc_ebs_BiothraxMember_F8CA7E5AA757A5E64EC2EC8A3CED7BA3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4E7FE348D04427158959EC8A3CED0AE5" xlink:to="loc_ebs_BiothraxMember_F8CA7E5AA757A5E64EC2EC8A3CED7BA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5ABC7B40FC6D9ED2D506EC8A3CEDE788" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E477982F5E03FF942CBFEC8A3CEA2819" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5ABC7B40FC6D9ED2D506EC8A3CEDE788" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F340E08BD4FAE8A9CF2FEC8A3CED933F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5ABC7B40FC6D9ED2D506EC8A3CEDE788" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F340E08BD4FAE8A9CF2FEC8A3CED933F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F340E08BD4FAE8A9CF2FEC8A3CED933F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5ABC7B40FC6D9ED2D506EC8A3CEDE788" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F340E08BD4FAE8A9CF2FEC8A3CED933F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_8E8CD938E63F517B2A60EC8A3CEE8FAF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F340E08BD4FAE8A9CF2FEC8A3CED933F" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_8E8CD938E63F517B2A60EC8A3CEE8FAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_4030646812828980E1C1EC8A3CEE9708" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_AC93C6B7A0BAD7F089BDEC8A3CEE1ED0" xlink:to="loc_us-gaap_NumberOfReportableSegments_4030646812828980E1C1EC8A3CEE9708" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_7D07F52E57D3F376DE6BEC8A3CEE392D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_AC93C6B7A0BAD7F089BDEC8A3CEE1ED0" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_7D07F52E57D3F376DE6BEC8A3CEE392D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaap_NoncurrentAssets_C7EBC766E6A19D9ED181EC8A3CEF7E62" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_AC93C6B7A0BAD7F089BDEC8A3CEE1ED0" xlink:to="loc_us-gaap_NoncurrentAssets_C7EBC766E6A19D9ED181EC8A3CEF7E62" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_EE1EB9443DB470E03178EC8A3CE65168" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_EE1EB9443DB470E03178EC8A3CE65168" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0B20F11B85071302C10AEC8A3CE425A5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0B20F11B85071302C10AEC8A3CE425A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_200DD88A6C70EB046423EC8A3CE4C116_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0B20F11B85071302C10AEC8A3CE425A5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_200DD88A6C70EB046423EC8A3CE4C116_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_200DD88A6C70EB046423EC8A3CE4C116" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0B20F11B85071302C10AEC8A3CE425A5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_200DD88A6C70EB046423EC8A3CE4C116" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesRevenueProductLineMember" xlink:label="loc_us-gaap_SalesRevenueProductLineMember_EB5B00912AE7BFD1F1A0EC8A3CE46816" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_200DD88A6C70EB046423EC8A3CE4C116" xlink:to="loc_us-gaap_SalesRevenueProductLineMember_EB5B00912AE7BFD1F1A0EC8A3CE46816" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_530E8BEDD12B99B5F604EC8A3CE516CD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C" xlink:to="loc_srt_ProductOrServiceAxis_530E8BEDD12B99B5F604EC8A3CE516CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_530E8BEDD12B99B5F604EC8A3CE516CD" xlink:to="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_530E8BEDD12B99B5F604EC8A3CE516CD" xlink:to="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BiothraxMember" xlink:label="loc_ebs_BiothraxMember_E0472900E9212DCC3E27EC8A3CE5926F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:to="loc_ebs_BiothraxMember_E0472900E9212DCC3E27EC8A3CE5926F" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ACAM2000Member" xlink:label="loc_ebs_ACAM2000Member_20E1FB2F441874566B25EC8A3CE52717" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:to="loc_ebs_ACAM2000Member_20E1FB2F441874566B25EC8A3CE52717" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NARCANNasalSprayMember" xlink:label="loc_ebs_NARCANNasalSprayMember_9777E8818F83C2D31D26ECAD58F8F470" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:to="loc_ebs_NARCANNasalSprayMember_9777E8818F83C2D31D26ECAD58F8F470" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_OtherMember" xlink:label="loc_ebs_OtherMember_E6B1CF851568DCE60D8CEC8A3CE50D54" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:to="loc_ebs_OtherMember_E6B1CF851568DCE60D8CEC8A3CE50D54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_116177BC5EC727E5D1AFEC8A3CE6B8DF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_EE1EB9443DB470E03178EC8A3CE65168" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_116177BC5EC727E5D1AFEC8A3CE6B8DF" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SegmentInformationTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquity" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C515D1F65F269428CF2688F6015CF91" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_D1C07F90B51F07F01F53688F601593FB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C515D1F65F269428CF2688F6015CF91" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_D1C07F90B51F07F01F53688F601593FB" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8BAC98384EBB4C4C21EE688F6015BDB2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_D1C07F90B51F07F01F53688F601593FB" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8BAC98384EBB4C4C21EE688F6015BDB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_F9FC0E704FF99773340D688F6015B7B0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8BAC98384EBB4C4C21EE688F6015BDB2" xlink:to="loc_us-gaap_EquityComponentDomain_F9FC0E704FF99773340D688F6015B7B0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_F9FC0E704FF99773340D688F6015B7B0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8BAC98384EBB4C4C21EE688F6015BDB2" xlink:to="loc_us-gaap_EquityComponentDomain_F9FC0E704FF99773340D688F6015B7B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_F9FC0E704FF99773340D688F6015B7B0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_54E6B224DB28B426FA7E688F6015F575" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_54E6B224DB28B426FA7E688F6015F575" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_6735A278CCDF57505FC4688F60155497" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_6735A278CCDF57505FC4688F60155497" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_B3C605000BF6406D2355688F60152747" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_B3C605000BF6406D2355688F60152747" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_DC2669E6DEFC60BA42A3688F601590FD" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_DC2669E6DEFC60BA42A3688F601590FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C515D1F65F269428CF2688F6015CF91" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_87E15AFD9D2FDAC9CEA8689219CE3210" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:to="loc_us-gaap_StockholdersEquity_87E15AFD9D2FDAC9CEA8689219CE3210" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_B3D0B89DC91662B398DF689219CEABAA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_B3D0B89DC91662B398DF689219CEABAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8DE36AD3687AA970646A689219CE52D0" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8DE36AD3687AA970646A689219CE52D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_15A565B8126D7C8FD7A4689219CEE0C2" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_15A565B8126D7C8FD7A4689219CEE0C2" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_878EC97F40F5F7A6A243556D6037ADC9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_878EC97F40F5F7A6A243556D6037ADC9" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_9FF8C879B7CA6D21840B556D6037CE52" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_878EC97F40F5F7A6A243556D6037ADC9" xlink:to="loc_us-gaap_AwardTypeAxis_9FF8C879B7CA6D21840B556D6037CE52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9D026CD5DA4FD653639A556D60370114_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9FF8C879B7CA6D21840B556D6037CE52" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9D026CD5DA4FD653639A556D60370114_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9D026CD5DA4FD653639A556D60370114" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9FF8C879B7CA6D21840B556D6037CE52" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9D026CD5DA4FD653639A556D60370114" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_EFDB12455CB08F2A456F556D603785BB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9D026CD5DA4FD653639A556D60370114" xlink:to="loc_us-gaap_EmployeeStockOptionMember_EFDB12455CB08F2A456F556D603785BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2360AF33ECC6539E0C38556D60377F6A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2360AF33ECC6539E0C38556D60377F6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0D34DF7C57D853E23788556D6037EA66" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0D34DF7C57D853E23788556D6037EA66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_F0B8F7B606CF3505C92F556D60372950" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_F0B8F7B606CF3505C92F556D60372950" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7EFB26CAAF62C2FDE6EB556D6037EF5F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7EFB26CAAF62C2FDE6EB556D6037EF5F" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_CommonStockNumberofVotesPerCommonShare" xlink:label="loc_ebs_CommonStockNumberofVotesPerCommonShare_C367597176DBBBB9D300556D603733BB" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_ebs_CommonStockNumberofVotesPerCommonShare_C367597176DBBBB9D300556D603733BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_E33FB26D740A196927D8556D6037256E" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_E33FB26D740A196927D8556D6037256E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D57A5A1A96253D5CA107556D60370B35" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D57A5A1A96253D5CA107556D60370B35" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum" xlink:label="loc_ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum_C348C987BA21759ED43E556D60379DBA" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum_C348C987BA21759ED43E556D60379DBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0411A5B1D831A02831A8556D60374E3A" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0411A5B1D831A02831A8556D60374E3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_BF7E0567434C146903D5556D60370C55" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_BF7E0567434C146903D5556D60370C55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_BC9B3B23EE096623804B556D6037EEB7" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_BC9B3B23EE096623804B556D6037EEB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_C2065170B35E5C3EA3CE556D6037940C" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_C2065170B35E5C3EA3CE556D6037940C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_C66044ADA297E36C3DEB556D603715E5" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_C66044ADA297E36C3DEB556D603715E5" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue" xlink:label="loc_ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue_3B5487ECBEA212B633D2556D6037A54F" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue_3B5487ECBEA212B633D2556D6037A54F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_F9789D8D71473B2F5D78556D603753D8" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_F9789D8D71473B2F5D78556D603753D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_B4CD8282C87AA52DB0BF556D60378F2C" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_B4CD8282C87AA52DB0BF556D60378F2C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0733146079A4CC702E44CDFBFC0E4E72" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D936911A70AE094F5E73CDFBFC0B309B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0733146079A4CC702E44CDFBFC0E4E72" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D936911A70AE094F5E73CDFBFC0B309B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_BCC6F4970E25C48B0129CDFBFC0C73DA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D936911A70AE094F5E73CDFBFC0B309B" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_BCC6F4970E25C48B0129CDFBFC0C73DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_BCC6F4970E25C48B0129CDFBFC0C73DA" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_BCC6F4970E25C48B0129CDFBFC0C73DA" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_7C69213A726BD4B05640CDFBFC0D7B1C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7" xlink:to="loc_us-gaap_CostOfSalesMember_7C69213A726BD4B05640CDFBFC0D7B1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_AE05AE760D68973273FECDFBFC0DDBD5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_AE05AE760D68973273FECDFBFC0DDBD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_CA7C97D59559A82C517BCDFBFC0DA2C2" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_CA7C97D59559A82C517BCDFBFC0DA2C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_209F8AAB0E4367EABB05CDFBFC0E4AA4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0733146079A4CC702E44CDFBFC0E4E72" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_209F8AAB0E4367EABB05CDFBFC0E4AA4" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4D557A8A08A4496FE84BCDFBFC1CE974" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4D557A8A08A4496FE84BCDFBFC1CE974" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_A51D679007992EDF7AB6CDFBFC1CD61C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4D557A8A08A4496FE84BCDFBFC1CE974" xlink:to="loc_us-gaap_PlanNameAxis_A51D679007992EDF7AB6CDFBFC1CD61C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_825455FFE3CEEC77FA87CDFBFC1CD2FA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_A51D679007992EDF7AB6CDFBFC1CD61C" xlink:to="loc_us-gaap_PlanNameDomain_825455FFE3CEEC77FA87CDFBFC1CD2FA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_825455FFE3CEEC77FA87CDFBFC1CD2FA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_A51D679007992EDF7AB6CDFBFC1CD61C" xlink:to="loc_us-gaap_PlanNameDomain_825455FFE3CEEC77FA87CDFBFC1CD2FA" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" xlink:label="loc_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember_D9B08F49B7C8677794A6CDFBFC1D2D41" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_825455FFE3CEEC77FA87CDFBFC1CD2FA" xlink:to="loc_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember_D9B08F49B7C8677794A6CDFBFC1D2D41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_878BDAEBB11E2FFE1944CDFBFC1D903B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4D557A8A08A4496FE84BCDFBFC1CE974" xlink:to="loc_us-gaap_AwardTypeAxis_878BDAEBB11E2FFE1944CDFBFC1D903B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1567EC3B370B993DA805CDFBFC1D1547_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_878BDAEBB11E2FFE1944CDFBFC1D903B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1567EC3B370B993DA805CDFBFC1D1547_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1567EC3B370B993DA805CDFBFC1D1547" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_878BDAEBB11E2FFE1944CDFBFC1D903B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1567EC3B370B993DA805CDFBFC1D1547" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_BDAECCA876A09A75F2DFCDFBFC1E89AE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1567EC3B370B993DA805CDFBFC1D1547" xlink:to="loc_us-gaap_PerformanceSharesMember_BDAECCA876A09A75F2DFCDFBFC1E89AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_49819F1C35801956B9E4CDFBFC1E92ED" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1567EC3B370B993DA805CDFBFC1D1547" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_49819F1C35801956B9E4CDFBFC1E92ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_B63A947CFE919922B768CDFBFC1F8C46" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_B63A947CFE919922B768CDFBFC1F8C46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_A987CE0DD319789674D9CDFBFC2025CC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_A987CE0DD319789674D9CDFBFC2025CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6B831C794909F0BFF2F8CDFBFC20F014" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6B831C794909F0BFF2F8CDFBFC20F014" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_987742821D4D9E6EE296CDFBFC2038AE" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_987742821D4D9E6EE296CDFBFC2038AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4F4F70474BEE07CA3369CDFBFC205B4D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4F4F70474BEE07CA3369CDFBFC205B4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4E8523F18F04E66A200FCDFBFC218DF9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4E8523F18F04E66A200FCDFBFC218DF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_25A696A84BC16A308297CDFBFC2156CD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_25A696A84BC16A308297CDFBFC2156CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_C1DB69C49F3835363182CDFBFC22BF36" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_C1DB69C49F3835363182CDFBFC22BF36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_21E8FEF6F12845520E5ACDFBFC221243" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_21E8FEF6F12845520E5ACDFBFC221243" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_778A70C591D1EE8196AFCDFBFC228F02" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_778A70C591D1EE8196AFCDFBFC228F02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8806F1B2A65D960F979CCDFBFC2220C2" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8806F1B2A65D960F979CCDFBFC2220C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F6B08BE840F18787657FCDFBFC2230B5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8806F1B2A65D960F979CCDFBFC2220C2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F6B08BE840F18787657FCDFBFC2230B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_FA8AC59131D892E3CD54CDFBFC23A8D6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8806F1B2A65D960F979CCDFBFC2220C2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_FA8AC59131D892E3CD54CDFBFC23A8D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5EA17F10F5A310333B34CDFBFC249824" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5EA17F10F5A310333B34CDFBFC249824" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76FBCD32D2B296A8BDEECDFBFC24ADEC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76FBCD32D2B296A8BDEECDFBFC24ADEC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20AD2DDE3606284D4E8BCDFBFC245CD6" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20AD2DDE3606284D4E8BCDFBFC245CD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_F1394F46A2C1DFB6F430CDFBFC24C222" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_F1394F46A2C1DFB6F430CDFBFC24C222" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_BC04FB706EC8C7DEBE84CDFBFC252524" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_BC04FB706EC8C7DEBE84CDFBFC252524" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_DE51418A3D823A9E969ECDFBFC259363" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_DE51418A3D823A9E969ECDFBFC259363" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_DCBD9E80F2F00460F69CCDFBFC26CB45" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_DCBD9E80F2F00460F69CCDFBFC26CB45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_A15971922AEC8BF07B4DCDFBFC26FD89" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_A15971922AEC8BF07B4DCDFBFC26FD89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_38CA1F854B8387ECF8C3CDFBFC266018" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_38CA1F854B8387ECF8C3CDFBFC266018" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_937841E4F4D895AE0424CDFBFC26B344" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_38CA1F854B8387ECF8C3CDFBFC266018" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_937841E4F4D895AE0424CDFBFC26B344" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97B0F0AEAB685D86FE5A9A28D01326DE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_CC4C58BA4C890089F1079A28D0115641" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97B0F0AEAB685D86FE5A9A28D01326DE" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_CC4C58BA4C890089F1079A28D0115641" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_67ABC31E4D4A09A8933F9A28D011FDB9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_CC4C58BA4C890089F1079A28D0115641" xlink:to="loc_srt_RangeAxis_67ABC31E4D4A09A8933F9A28D011FDB9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_734945E8CA260E23AA4F9A28D0111581_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_67ABC31E4D4A09A8933F9A28D011FDB9" xlink:to="loc_srt_RangeMember_734945E8CA260E23AA4F9A28D0111581_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_734945E8CA260E23AA4F9A28D0111581" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_67ABC31E4D4A09A8933F9A28D011FDB9" xlink:to="loc_srt_RangeMember_734945E8CA260E23AA4F9A28D0111581" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_D916807749D628318D029A28D011B708" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_734945E8CA260E23AA4F9A28D0111581" xlink:to="loc_srt_MinimumMember_D916807749D628318D029A28D011B708" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_07E57E0088FE48404AB59A28D0120A21" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_734945E8CA260E23AA4F9A28D0111581" xlink:to="loc_srt_MaximumMember_07E57E0088FE48404AB59A28D0120A21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_9E8F712E27737B7AA1FA9A28D012E3A5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_CC4C58BA4C890089F1079A28D0115641" xlink:to="loc_us-gaap_AwardTypeAxis_9E8F712E27737B7AA1FA9A28D012E3A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BAACFD3ECA68186F35259A28D012E64F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9E8F712E27737B7AA1FA9A28D012E3A5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BAACFD3ECA68186F35259A28D012E64F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BAACFD3ECA68186F35259A28D012E64F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9E8F712E27737B7AA1FA9A28D012E3A5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BAACFD3ECA68186F35259A28D012E64F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_C7E55D21388BB589A0339A28D01273ED" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BAACFD3ECA68186F35259A28D012E64F" xlink:to="loc_us-gaap_EmployeeStockOptionMember_C7E55D21388BB589A0339A28D01273ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_608EEDB1AD72638F9BDF9A28D01325A8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97B0F0AEAB685D86FE5A9A28D01326DE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_608EEDB1AD72638F9BDF9A28D01325A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_38C0395707A85E0902D49A28D01382DA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97B0F0AEAB685D86FE5A9A28D01326DE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_38C0395707A85E0902D49A28D01382DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6D8720B48761C24EE1DD9A28D013891E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97B0F0AEAB685D86FE5A9A28D01326DE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6D8720B48761C24EE1DD9A28D013891E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9842DAD6EDF4C09F7CC49A28D0131B92" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97B0F0AEAB685D86FE5A9A28D01326DE" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9842DAD6EDF4C09F7CC49A28D0131B92" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_370E041618C456B9FD62ECB14922B373" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_62CA95C82835A7CFAEC6ECB14920B790" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_370E041618C456B9FD62ECB14922B373" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_62CA95C82835A7CFAEC6ECB14920B790" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_EA8EF403B78AC83B21C2ECB149212B18" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_62CA95C82835A7CFAEC6ECB14920B790" xlink:to="loc_us-gaap_PlanNameAxis_EA8EF403B78AC83B21C2ECB149212B18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_A808052F44AE0B4622D7ECB1492171FD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_EA8EF403B78AC83B21C2ECB149212B18" xlink:to="loc_us-gaap_PlanNameDomain_A808052F44AE0B4622D7ECB1492171FD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_A808052F44AE0B4622D7ECB1492171FD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_EA8EF403B78AC83B21C2ECB149212B18" xlink:to="loc_us-gaap_PlanNameDomain_A808052F44AE0B4622D7ECB1492171FD" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EmergentPlansMember" xlink:label="loc_ebs_EmergentPlansMember_1EDC5134F427931A54A5ECB14921B885" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_A808052F44AE0B4622D7ECB1492171FD" xlink:to="loc_ebs_EmergentPlansMember_1EDC5134F427931A54A5ECB14921B885" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberOfStockbasedEmployeeCompensationPlans" xlink:label="loc_ebs_NumberOfStockbasedEmployeeCompensationPlans_D5C9C95E1074CD5C2A50ECB14922E69D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_370E041618C456B9FD62ECB14922B373" xlink:to="loc_ebs_NumberOfStockbasedEmployeeCompensationPlans_D5C9C95E1074CD5C2A50ECB14922E69D" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod" xlink:label="loc_ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod_292FD3CA63820F5B6986ECB14922B268" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_370E041618C456B9FD62ECB14922B373" xlink:to="loc_ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod_292FD3CA63820F5B6986ECB14922B268" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2DEFB701E2A867497983B156072072E7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_374D41F9CC79809C4922B156071EB234" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2DEFB701E2A867497983B156072072E7" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_374D41F9CC79809C4922B156071EB234" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_13EADB5C9B2C1D185845B1567E6D1A22" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_374D41F9CC79809C4922B156071EB234" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_13EADB5C9B2C1D185845B1567E6D1A22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4B57DE2507E0B2960D33B157879DD97B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_13EADB5C9B2C1D185845B1567E6D1A22" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4B57DE2507E0B2960D33B157879DD97B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4B57DE2507E0B2960D33B157879DD97B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_13EADB5C9B2C1D185845B1567E6D1A22" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4B57DE2507E0B2960D33B157879DD97B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_FFAAA2B10C95139453BDB15855EA8C2C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4B57DE2507E0B2960D33B157879DD97B" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_FFAAA2B10C95139453BDB15855EA8C2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_91F55A6E9EEBA0734DA5B129D6BEB75E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2DEFB701E2A867497983B156072072E7" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_91F55A6E9EEBA0734DA5B129D6BEB75E" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_38956092F485AD537AECA55DF39E752A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_B27A6DA26D5D161BE107A55DF39C8C8A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_38956092F485AD537AECA55DF39E752A" xlink:to="loc_us-gaap_ConcentrationRiskTable_B27A6DA26D5D161BE107A55DF39C8C8A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_37527088C001B37C329BA55DF39CC5D3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_B27A6DA26D5D161BE107A55DF39C8C8A" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_37527088C001B37C329BA55DF39CC5D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_E8BC3D7A6ED8AC1D799FA55DF39D5DFA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_37527088C001B37C329BA55DF39CC5D3" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_E8BC3D7A6ED8AC1D799FA55DF39D5DFA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_E8BC3D7A6ED8AC1D799FA55DF39D5DFA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_37527088C001B37C329BA55DF39CC5D3" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_E8BC3D7A6ED8AC1D799FA55DF39D5DFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_1C41995437496D8194FBA5983629C833" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_E8BC3D7A6ED8AC1D799FA55DF39D5DFA" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_1C41995437496D8194FBA5983629C833" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_6DCF51538578E029E73BA55DF39D1837" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_E8BC3D7A6ED8AC1D799FA55DF39D5DFA" xlink:to="loc_us-gaap_AccountsReceivableMember_6DCF51538578E029E73BA55DF39D1837" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1D72BBC8D1A1F58048D7A55DF39D35E5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_B27A6DA26D5D161BE107A55DF39C8C8A" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1D72BBC8D1A1F58048D7A55DF39D35E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_D07697E3F161187AF60CA55DF39D4CAC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1D72BBC8D1A1F58048D7A55DF39D35E5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_D07697E3F161187AF60CA55DF39D4CAC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_D07697E3F161187AF60CA55DF39D4CAC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1D72BBC8D1A1F58048D7A55DF39D35E5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_D07697E3F161187AF60CA55DF39D4CAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_A96AB20E6067563A39F4A55DF39ED3FE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_D07697E3F161187AF60CA55DF39D4CAC" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_A96AB20E6067563A39F4A55DF39ED3FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_4E8363C49B332E278869A55DF39E07D5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_38956092F485AD537AECA55DF39E752A" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_4E8363C49B332E278869A55DF39E07D5" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_D725134A6B11B0510BCA188D8CB627EF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_78E6381D54E5B8764CA2188D8CB6D013" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D725134A6B11B0510BCA188D8CB627EF" xlink:to="loc_us-gaap_DebtInstrumentTable_78E6381D54E5B8764CA2188D8CB6D013" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_836F0E12059820E14C1C188D8CB6799F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_78E6381D54E5B8764CA2188D8CB6D013" xlink:to="loc_us-gaap_DebtInstrumentAxis_836F0E12059820E14C1C188D8CB6799F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_255797088B9C1A5A2F8C188D8CB6B6E3_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_836F0E12059820E14C1C188D8CB6799F" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_255797088B9C1A5A2F8C188D8CB6B6E3_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_255797088B9C1A5A2F8C188D8CB6B6E3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_836F0E12059820E14C1C188D8CB6799F" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_255797088B9C1A5A2F8C188D8CB6B6E3" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ConvertibleSeniorNotesDue2021Member" xlink:label="loc_ebs_ConvertibleSeniorNotesDue2021Member_144FBB8B5A955B9D34EF188D8CB6373F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_255797088B9C1A5A2F8C188D8CB6B6E3" xlink:to="loc_ebs_ConvertibleSeniorNotesDue2021Member_144FBB8B5A955B9D34EF188D8CB6373F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3776747DE54BEDFF2546188D8CB6F59F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D725134A6B11B0510BCA188D8CB627EF" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3776747DE54BEDFF2546188D8CB6F59F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1DED6B5557FD9D774C86188D8CB69D61" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D725134A6B11B0510BCA188D8CB627EF" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1DED6B5557FD9D774C86188D8CB69D61" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ED4B6DEBABC7F3E7E0139238C533CE75" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80AA8BDC454336CCC90A9238C531F42D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ED4B6DEBABC7F3E7E0139238C533CE75" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80AA8BDC454336CCC90A9238C531F42D" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7C775D0C53EB299F732C9238C5312C66" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80AA8BDC454336CCC90A9238C531F42D" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7C775D0C53EB299F732C9238C5312C66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_821F449AE0CF960B1DEC9238C531D3BE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7C775D0C53EB299F732C9238C5312C66" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_821F449AE0CF960B1DEC9238C531D3BE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_821F449AE0CF960B1DEC9238C531D3BE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7C775D0C53EB299F732C9238C5312C66" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_821F449AE0CF960B1DEC9238C531D3BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaap_BuildingMember_0E5EF1C63822221574349238C5320A19" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_821F449AE0CF960B1DEC9238C531D3BE" xlink:to="loc_us-gaap_BuildingMember_0E5EF1C63822221574349238C5320A19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingImprovementsMember_64BCA18DA4F5A2D6706E9238C53270FF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_821F449AE0CF960B1DEC9238C531D3BE" xlink:to="loc_us-gaap_BuildingImprovementsMember_64BCA18DA4F5A2D6706E9238C53270FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_D93A22FBD9273AA60F869238C532948F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_821F449AE0CF960B1DEC9238C531D3BE" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_D93A22FBD9273AA60F869238C532948F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_B418E0B5B419B5310F809238C5329559" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_821F449AE0CF960B1DEC9238C531D3BE" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_B418E0B5B419B5310F809238C5329559" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_9F2B65F4FE6D25EACEC19238C53308FA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80AA8BDC454336CCC90A9238C531F42D" xlink:to="loc_srt_RangeAxis_9F2B65F4FE6D25EACEC19238C53308FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_27E3CD19FF6A4E656C4A9238C5337D1E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9F2B65F4FE6D25EACEC19238C53308FA" xlink:to="loc_srt_RangeMember_27E3CD19FF6A4E656C4A9238C5337D1E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_27E3CD19FF6A4E656C4A9238C5337D1E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9F2B65F4FE6D25EACEC19238C53308FA" xlink:to="loc_srt_RangeMember_27E3CD19FF6A4E656C4A9238C5337D1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_827A4FD99D37BA050CEC9238C5338442" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_27E3CD19FF6A4E656C4A9238C5337D1E" xlink:to="loc_srt_MinimumMember_827A4FD99D37BA050CEC9238C5338442" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_38C05B56B1910578D6689238C533B8AF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_27E3CD19FF6A4E656C4A9238C5337D1E" xlink:to="loc_srt_MaximumMember_38C05B56B1910578D6689238C533B8AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_FA643E3879B632DBA9AD9238C534D6AF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ED4B6DEBABC7F3E7E0139238C533CE75" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_FA643E3879B632DBA9AD9238C534D6AF" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_BAE2D87B24659FDBBE59A5A57BB60E70" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_BAE2D87B24659FDBBE59A5A57BB60E70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_92B37B80CF0BACF3BA0DA5A57BBA7882_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_BAE2D87B24659FDBBE59A5A57BB60E70" xlink:to="loc_us-gaap_EquityComponentDomain_92B37B80CF0BACF3BA0DA5A57BBA7882_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_92B37B80CF0BACF3BA0DA5A57BBA7882" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_BAE2D87B24659FDBBE59A5A57BB60E70" xlink:to="loc_us-gaap_EquityComponentDomain_92B37B80CF0BACF3BA0DA5A57BBA7882" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_538D7B62802D531D0C06A5A5CA047025" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_92B37B80CF0BACF3BA0DA5A57BBA7882" xlink:to="loc_us-gaap_RetainedEarningsMember_538D7B62802D531D0C06A5A5CA047025" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_6AB7C1232E9ADC75F9A5A55DF37D9155" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_6AB7C1232E9ADC75F9A5A55DF37D9155" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_8C3FC0F81597CCAF9302A55DF37D6FAA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_6AB7C1232E9ADC75F9A5A55DF37D9155" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_8C3FC0F81597CCAF9302A55DF37D6FAA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_8C3FC0F81597CCAF9302A55DF37D6FAA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_6AB7C1232E9ADC75F9A5A55DF37D9155" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_8C3FC0F81597CCAF9302A55DF37D6FAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_E37C1340C080568D2810A55DF37D36F7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_8C3FC0F81597CCAF9302A55DF37D6FAA" xlink:to="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_E37C1340C080568D2810A55DF37D36F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7E10B2C0414D6B34D5A3A55DF37D3168" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7E10B2C0414D6B34D5A3A55DF37D3168" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7E10B2C0414D6B34D5A3A55DF37D3168" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7E10B2C0414D6B34D5A3A55DF37D3168" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_A833DC93BB2C8879E7F3A55DF37EE6E2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_A833DC93BB2C8879E7F3A55DF37EE6E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_FDCF61E2170CB2DA893CA55DF37E2F60" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_FDCF61E2170CB2DA893CA55DF37E2F60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_87B29D18BB1CE4751BA8A55DF37E2E2E" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_87B29D18BB1CE4751BA8A55DF37E2E2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9F227EF453AFDE9DB7AAA55DF37FF296_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_87B29D18BB1CE4751BA8A55DF37E2E2E" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9F227EF453AFDE9DB7AAA55DF37FF296_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9F227EF453AFDE9DB7AAA55DF37FF296" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_87B29D18BB1CE4751BA8A55DF37E2E2E" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9F227EF453AFDE9DB7AAA55DF37FF296" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_CIADMMember" xlink:label="loc_ebs_CIADMMember_05749AE73651C4ADFBB8A55DF37F7944" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9F227EF453AFDE9DB7AAA55DF37FF296" xlink:to="loc_ebs_CIADMMember_05749AE73651C4ADFBB8A55DF37F7944" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_38A117E9A0A72C99D23EA55DF37F8033" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_38A117E9A0A72C99D23EA55DF37F8033" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_B49AC0B090BECFEA0835A55DF37FAB2D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_us-gaap_OperatingLeaseLiability_B49AC0B090BECFEA0835A55DF37FAB2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_518BAFAD0C930EC6FF33A5A512C4AE37" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_518BAFAD0C930EC6FF33A5A512C4AE37" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BasePeriod" xlink:label="loc_ebs_BasePeriod_524E979B93CDB5DDE356A55DF380E080" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_ebs_BasePeriod_524E979B93CDB5DDE356A55DF380E080" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TermofContract" xlink:label="loc_ebs_TermofContract_BD16CA57F812937B996DA55DF3801417" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_ebs_TermofContract_BD16CA57F812937B996DA55DF3801417" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberofAdditionalOptionPeriods" xlink:label="loc_ebs_NumberofAdditionalOptionPeriods_09E0DDEBFA9E0F87E5CFA55DF380564B" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_ebs_NumberofAdditionalOptionPeriods_09E0DDEBFA9E0F87E5CFA55DF380564B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_CBFC8D04E76B1AF370BFA55DF3800526" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_us-gaap_ContractWithCustomerLiability_CBFC8D04E76B1AF370BFA55DF3800526" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_642469FF312DA92F9C8EA55DF380B41C" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_642469FF312DA92F9C8EA55DF380B41C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>19
<FILENAME>ebs-20191231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_164FFEAF13068FD2ED3DCCD36F7B799E_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract_164FFEAF13068FD2ED3DCCD36F7B799E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_164FFEAF13068FD2ED3DCCD36F7B799E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_164FFEAF13068FD2ED3DCCD36F7B799E" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract_164FFEAF13068FD2ED3DCCD36F7B799E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_2BA84820774EEBED7729CCD36F7BF44A_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock_2BA84820774EEBED7729CCD36F7BF44A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_2BA84820774EEBED7729CCD36F7BF44A_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock_2BA84820774EEBED7729CCD36F7BF44A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_2BA84820774EEBED7729CCD36F7BF44A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock_2BA84820774EEBED7729CCD36F7BF44A" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock_2BA84820774EEBED7729CCD36F7BF44A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1257ED019B4E9574190DF5EBD5F43EBB_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1257ED019B4E9574190DF5EBD5F43EBB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1257ED019B4E9574190DF5EBD5F43EBB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1257ED019B4E9574190DF5EBD5F43EBB" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1257ED019B4E9574190DF5EBD5F43EBB" xlink:type="arc" />
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_DC2968EFF478EFAE7FA6F5EBD5F4A021_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock_DC2968EFF478EFAE7FA6F5EBD5F4A021" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_DC2968EFF478EFAE7FA6F5EBD5F4A021_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock_DC2968EFF478EFAE7FA6F5EBD5F4A021" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_DC2968EFF478EFAE7FA6F5EBD5F4A021" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock_DC2968EFF478EFAE7FA6F5EBD5F4A021" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock_DC2968EFF478EFAE7FA6F5EBD5F4A021" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_F80F53A5E77D547584E12CB959299144_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_F80F53A5E77D547584E12CB959299144" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance, beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_F80F53A5E77D547584E12CB959299144_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_F80F53A5E77D547584E12CB959299144" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_F80F53A5E77D547584E12CB959299144" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_F80F53A5E77D547584E12CB959299144" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_F80F53A5E77D547584E12CB959299144" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7305D01F6C94447D04452CB959290431_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7305D01F6C94447D04452CB959290431" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expense included in earnings</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7305D01F6C94447D04452CB959290431_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7305D01F6C94447D04452CB959290431" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7305D01F6C94447D04452CB959290431" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7305D01F6C94447D04452CB959290431" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7305D01F6C94447D04452CB959290431" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_48A40C06BF22D30555582CB9592911DB_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_48A40C06BF22D30555582CB9592911DB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone achievement - asset acquisition</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_48A40C06BF22D30555582CB9592911DB_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_48A40C06BF22D30555582CB9592911DB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_48A40C06BF22D30555582CB9592911DB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_48A40C06BF22D30555582CB9592911DB" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_48A40C06BF22D30555582CB9592911DB" xlink:type="arc" />
    <link:label id="lab_ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment_F45834DF6A538A43C6962CB959293040_terseLabel_en-US" xlink:label="lab_ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment_F45834DF6A538A43C6962CB959293040" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement period adjustment</link:label>
    <link:label id="lab_ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment_F45834DF6A538A43C6962CB959293040_label_en-US" xlink:label="lab_ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment_F45834DF6A538A43C6962CB959293040" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Measurement Period Adjustment</link:label>
    <link:label id="lab_ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment_F45834DF6A538A43C6962CB959293040_documentation_en-US" xlink:label="lab_ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment_F45834DF6A538A43C6962CB959293040" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Measurement Period Adjustment</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment" xlink:label="loc_ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment_F45834DF6A538A43C6962CB959293040" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment_F45834DF6A538A43C6962CB959293040" xlink:to="lab_ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment_F45834DF6A538A43C6962CB959293040" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2A5705643A52F5B49E6B2CB959296638_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2A5705643A52F5B49E6B2CB959296638" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2A5705643A52F5B49E6B2CB959296638_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2A5705643A52F5B49E6B2CB959296638" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2A5705643A52F5B49E6B2CB959296638" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2A5705643A52F5B49E6B2CB959296638" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2A5705643A52F5B49E6B2CB959296638" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_81876E9F610DCEF8F3A62CB95929AE74_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_81876E9F610DCEF8F3A62CB95929AE74" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Additions due to acquisition</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_81876E9F610DCEF8F3A62CB95929AE74_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_81876E9F610DCEF8F3A62CB95929AE74" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_81876E9F610DCEF8F3A62CB95929AE74" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_81876E9F610DCEF8F3A62CB95929AE74" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_81876E9F610DCEF8F3A62CB95929AE74" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8C2B2C15EB5A8D7588192CB959290695_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8C2B2C15EB5A8D7588192CB959290695" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance, end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8C2B2C15EB5A8D7588192CB959290695" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8C2B2C15EB5A8D7588192CB959290695" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8C2B2C15EB5A8D7588192CB959290695" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_73CC894F38002F8760F4F5EBD6EEC274_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract_73CC894F38002F8760F4F5EBD6EEC274" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_73CC894F38002F8760F4F5EBD6EEC274" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_73CC894F38002F8760F4F5EBD6EEC274" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract_73CC894F38002F8760F4F5EBD6EEC274" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7AB59E573242C5433656F5EBD6EF4591_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7AB59E573242C5433656F5EBD6EF4591" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7AB59E573242C5433656F5EBD6EF4591_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7AB59E573242C5433656F5EBD6EF4591" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7AB59E573242C5433656F5EBD6EF4591" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7AB59E573242C5433656F5EBD6EF4591" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7AB59E573242C5433656F5EBD6EF4591" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_935CDFFCF1229B5799C69238C5159F9E_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract_935CDFFCF1229B5799C69238C5159F9E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_935CDFFCF1229B5799C69238C5159F9E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_935CDFFCF1229B5799C69238C5159F9E" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract_935CDFFCF1229B5799C69238C5159F9E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_CC1A8268DEAD74701EE09238C5162F4C_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_CC1A8268DEAD74701EE09238C5162F4C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_CC1A8268DEAD74701EE09238C5162F4C_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_CC1A8268DEAD74701EE09238C5162F4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_CC1A8268DEAD74701EE09238C5162F4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_CC1A8268DEAD74701EE09238C5162F4C" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_CC1A8268DEAD74701EE09238C5162F4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_48D55B2C7B8856B42BCD9238C5162358_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_48D55B2C7B8856B42BCD9238C5162358" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Deferred Revenue Contract Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_48D55B2C7B8856B42BCD9238C5162358_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_48D55B2C7B8856B42BCD9238C5162358" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset and Liability [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_48D55B2C7B8856B42BCD9238C5162358" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_48D55B2C7B8856B42BCD9238C5162358" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_48D55B2C7B8856B42BCD9238C5162358" xlink:type="arc" />
    <link:label id="lab_ebs_ScheduleofAccountsReceivableNetTableTextBlock_7BE40DF0B4B5A5D858279238C5166BE3_terseLabel_en-US" xlink:label="lab_ebs_ScheduleofAccountsReceivableNetTableTextBlock_7BE40DF0B4B5A5D858279238C5166BE3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Receivable, Net</link:label>
    <link:label id="lab_ebs_ScheduleofAccountsReceivableNetTableTextBlock_7BE40DF0B4B5A5D858279238C5166BE3_label_en-US" xlink:label="lab_ebs_ScheduleofAccountsReceivableNetTableTextBlock_7BE40DF0B4B5A5D858279238C5166BE3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Receivable, Net [Table Text Block]</link:label>
    <link:label id="lab_ebs_ScheduleofAccountsReceivableNetTableTextBlock_7BE40DF0B4B5A5D858279238C5166BE3_documentation_en-US" xlink:label="lab_ebs_ScheduleofAccountsReceivableNetTableTextBlock_7BE40DF0B4B5A5D858279238C5166BE3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Receivable, Net [Table Text Block]</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ScheduleofAccountsReceivableNetTableTextBlock" xlink:label="loc_ebs_ScheduleofAccountsReceivableNetTableTextBlock_7BE40DF0B4B5A5D858279238C5166BE3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ScheduleofAccountsReceivableNetTableTextBlock_7BE40DF0B4B5A5D858279238C5166BE3" xlink:to="lab_ebs_ScheduleofAccountsReceivableNetTableTextBlock_7BE40DF0B4B5A5D858279238C5166BE3" xlink:type="arc" />
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_F82FB5D4BA43C3F73B7FCE2D5EC2B834_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_F82FB5D4BA43C3F73B7FCE2D5EC2B834" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_F82FB5D4BA43C3F73B7FCE2D5EC2B834" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_F82FB5D4BA43C3F73B7FCE2D5EC2B834" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_F82FB5D4BA43C3F73B7FCE2D5EC2B834" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_A6CB8EA2894776EC9463CE2D5EC4FDFE_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_A6CB8EA2894776EC9463CE2D5EC4FDFE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_A6CB8EA2894776EC9463CE2D5EC4FDFE_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_A6CB8EA2894776EC9463CE2D5EC4FDFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_A6CB8EA2894776EC9463CE2D5EC4FDFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_A6CB8EA2894776EC9463CE2D5EC4FDFE" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_A6CB8EA2894776EC9463CE2D5EC4FDFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3456AFEF5908A03696D3CE2D5EC5144A_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3456AFEF5908A03696D3CE2D5EC5144A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3456AFEF5908A03696D3CE2D5EC5144A_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3456AFEF5908A03696D3CE2D5EC5144A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3456AFEF5908A03696D3CE2D5EC5144A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3456AFEF5908A03696D3CE2D5EC5144A" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3456AFEF5908A03696D3CE2D5EC5144A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_F7F9254047DBF68EF419CE2D5EC5E4DE_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_F7F9254047DBF68EF419CE2D5EC5E4DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_F7F9254047DBF68EF419CE2D5EC5E4DE_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_F7F9254047DBF68EF419CE2D5EC5E4DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_F7F9254047DBF68EF419CE2D5EC5E4DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_F7F9254047DBF68EF419CE2D5EC5E4DE" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_F7F9254047DBF68EF419CE2D5EC5E4DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_89BB9D3FDA823ADE7271CE2D5EC5F612_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_89BB9D3FDA823ADE7271CE2D5EC5F612" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_89BB9D3FDA823ADE7271CE2D5EC5F612_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_89BB9D3FDA823ADE7271CE2D5EC5F612" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_89BB9D3FDA823ADE7271CE2D5EC5F612" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_89BB9D3FDA823ADE7271CE2D5EC5F612" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_89BB9D3FDA823ADE7271CE2D5EC5F612" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_E0AE0575D4378CBE9D93CE2D5EC580A7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_E0AE0575D4378CBE9D93CE2D5EC580A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_E0AE0575D4378CBE9D93CE2D5EC580A7_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_E0AE0575D4378CBE9D93CE2D5EC580A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_E0AE0575D4378CBE9D93CE2D5EC580A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_E0AE0575D4378CBE9D93CE2D5EC580A7" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_E0AE0575D4378CBE9D93CE2D5EC580A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_AA64D8EBEC770BD2E456CE2D5EC57F7B_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_AA64D8EBEC770BD2E456CE2D5EC57F7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_AA64D8EBEC770BD2E456CE2D5EC57F7B_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_AA64D8EBEC770BD2E456CE2D5EC57F7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_AA64D8EBEC770BD2E456CE2D5EC57F7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_AA64D8EBEC770BD2E456CE2D5EC57F7B" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_AA64D8EBEC770BD2E456CE2D5EC57F7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_3A4748829231906A2C58CE2D5EC57E31_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_3A4748829231906A2C58CE2D5EC57E31" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_3A4748829231906A2C58CE2D5EC57E31_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_3A4748829231906A2C58CE2D5EC57E31" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_3A4748829231906A2C58CE2D5EC57E31" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_3A4748829231906A2C58CE2D5EC57E31" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_3A4748829231906A2C58CE2D5EC57E31" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_363CC20EA691FEDEE4915F9BB60738F3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_363CC20EA691FEDEE4915F9BB60738F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Payment Award, Valuation Assumptions, Stock Options Granted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_363CC20EA691FEDEE4915F9BB60738F3_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_363CC20EA691FEDEE4915F9BB60738F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_363CC20EA691FEDEE4915F9BB60738F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_363CC20EA691FEDEE4915F9BB60738F3" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_363CC20EA691FEDEE4915F9BB60738F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_C17D8A88C93F5ED992105F9BB6078428_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_C17D8A88C93F5ED992105F9BB6078428" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Stock Option Award Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_C17D8A88C93F5ED992105F9BB6078428_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_C17D8A88C93F5ED992105F9BB6078428" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_C17D8A88C93F5ED992105F9BB6078428" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_C17D8A88C93F5ED992105F9BB6078428" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_C17D8A88C93F5ED992105F9BB6078428" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_CC511C957A54B55367055F9BB60806B8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_CC511C957A54B55367055F9BB60806B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Restricted Stock Unit Award Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_CC511C957A54B55367055F9BB60806B8_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_CC511C957A54B55367055F9BB60806B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_CC511C957A54B55367055F9BB60806B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_CC511C957A54B55367055F9BB60806B8" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_CC511C957A54B55367055F9BB60806B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_55E2C194B6D43DF073755F9BB60891A5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_55E2C194B6D43DF073755F9BB60891A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_55E2C194B6D43DF073755F9BB60891A5_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_55E2C194B6D43DF073755F9BB60891A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_55E2C194B6D43DF073755F9BB60891A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_55E2C194B6D43DF073755F9BB60891A5" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_55E2C194B6D43DF073755F9BB60891A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_B128FBCB661B0616C3BF5FB505706B2E_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_B128FBCB661B0616C3BF5FB505706B2E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_B128FBCB661B0616C3BF5FB505706B2E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_B128FBCB661B0616C3BF5FB505706B2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_B128FBCB661B0616C3BF5FB505706B2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_B128FBCB661B0616C3BF5FB505706B2E" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_B128FBCB661B0616C3BF5FB505706B2E" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_A4DADDD3AC196AB1AEBA8E408B3D9D27_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_A4DADDD3AC196AB1AEBA8E408B3D9D27" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_A4DADDD3AC196AB1AEBA8E408B3D9D27" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A4DADDD3AC196AB1AEBA8E408B3D9D27" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_A4DADDD3AC196AB1AEBA8E408B3D9D27" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_E125FD8493381ECA449B8E408B3DE7E8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare_E125FD8493381ECA449B8E408B3DE7E8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_E125FD8493381ECA449B8E408B3DE7E8_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare_E125FD8493381ECA449B8E408B3DE7E8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_E125FD8493381ECA449B8E408B3DE7E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare_E125FD8493381ECA449B8E408B3DE7E8" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare_E125FD8493381ECA449B8E408B3DE7E8" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_6F02DCDC8414521C86168E408B3DB250_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_6F02DCDC8414521C86168E408B3DB250" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_6F02DCDC8414521C86168E408B3DB250_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_6F02DCDC8414521C86168E408B3DB250" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_6F02DCDC8414521C86168E408B3DB250" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized_6F02DCDC8414521C86168E408B3DB250" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized_6F02DCDC8414521C86168E408B3DB250" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_D93BEF681D44B7CF2EA38E408B3EA899_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_D93BEF681D44B7CF2EA38E408B3EA899" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_D93BEF681D44B7CF2EA38E408B3EA899_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_D93BEF681D44B7CF2EA38E408B3EA899" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_D93BEF681D44B7CF2EA38E408B3EA899" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued_D93BEF681D44B7CF2EA38E408B3EA899" xlink:to="lab_us-gaap_PreferredStockSharesIssued_D93BEF681D44B7CF2EA38E408B3EA899" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_A37E19094DB9CDF7ED358E408B3E51C5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding_A37E19094DB9CDF7ED358E408B3E51C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_A37E19094DB9CDF7ED358E408B3E51C5_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding_A37E19094DB9CDF7ED358E408B3E51C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_A37E19094DB9CDF7ED358E408B3E51C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding_A37E19094DB9CDF7ED358E408B3E51C5" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding_A37E19094DB9CDF7ED358E408B3E51C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_E0DE7AF2C83A7B9D4DC78E408B3E2E1F_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_E0DE7AF2C83A7B9D4DC78E408B3E2E1F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_E0DE7AF2C83A7B9D4DC78E408B3E2E1F_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_E0DE7AF2C83A7B9D4DC78E408B3E2E1F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_E0DE7AF2C83A7B9D4DC78E408B3E2E1F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_E0DE7AF2C83A7B9D4DC78E408B3E2E1F" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_E0DE7AF2C83A7B9D4DC78E408B3E2E1F" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_A0D4DC2D08693EAAC2EE8E408B3EE929_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_A0D4DC2D08693EAAC2EE8E408B3EE929" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_A0D4DC2D08693EAAC2EE8E408B3EE929_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_A0D4DC2D08693EAAC2EE8E408B3EE929" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_A0D4DC2D08693EAAC2EE8E408B3EE929" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_A0D4DC2D08693EAAC2EE8E408B3EE929" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_A0D4DC2D08693EAAC2EE8E408B3EE929" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_6301C2BC74E21A0B4C5A8E408B3E7085_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_6301C2BC74E21A0B4C5A8E408B3E7085" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_6301C2BC74E21A0B4C5A8E408B3E7085_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_6301C2BC74E21A0B4C5A8E408B3E7085" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_6301C2BC74E21A0B4C5A8E408B3E7085" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_6301C2BC74E21A0B4C5A8E408B3E7085" xlink:to="lab_us-gaap_CommonStockSharesIssued_6301C2BC74E21A0B4C5A8E408B3E7085" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_46B4B70DC82922951D578E408B3E3CE5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_46B4B70DC82922951D578E408B3E3CE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_46B4B70DC82922951D578E408B3E3CE5_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_46B4B70DC82922951D578E408B3E3CE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_46B4B70DC82922951D578E408B3E3CE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_46B4B70DC82922951D578E408B3E3CE5" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_46B4B70DC82922951D578E408B3E3CE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockShares_164FEF04723A2F13C2B38E408B3ECB5D_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_164FEF04723A2F13C2B38E408B3ECB5D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_164FEF04723A2F13C2B38E408B3ECB5D_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_164FEF04723A2F13C2B38E408B3ECB5D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_164FEF04723A2F13C2B38E408B3ECB5D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_164FEF04723A2F13C2B38E408B3ECB5D" xlink:to="lab_us-gaap_TreasuryStockShares_164FEF04723A2F13C2B38E408B3ECB5D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingAbstract_482A769F67F329646AF0EC8A3CE36AA5_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract_482A769F67F329646AF0EC8A3CE36AA5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_482A769F67F329646AF0EC8A3CE36AA5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract_482A769F67F329646AF0EC8A3CE36AA5" xlink:to="lab_us-gaap_SegmentReportingAbstract_482A769F67F329646AF0EC8A3CE36AA5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_0B20F11B85071302C10AEC8A3CE425A5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_0B20F11B85071302C10AEC8A3CE425A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_0B20F11B85071302C10AEC8A3CE425A5_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_0B20F11B85071302C10AEC8A3CE425A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0B20F11B85071302C10AEC8A3CE425A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0B20F11B85071302C10AEC8A3CE425A5" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_0B20F11B85071302C10AEC8A3CE425A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_200DD88A6C70EB046423EC8A3CE4C116_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain_200DD88A6C70EB046423EC8A3CE4C116" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_200DD88A6C70EB046423EC8A3CE4C116_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain_200DD88A6C70EB046423EC8A3CE4C116" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_200DD88A6C70EB046423EC8A3CE4C116" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_200DD88A6C70EB046423EC8A3CE4C116" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain_200DD88A6C70EB046423EC8A3CE4C116" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesRevenueProductLineMember_EB5B00912AE7BFD1F1A0EC8A3CE46816_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueProductLineMember_EB5B00912AE7BFD1F1A0EC8A3CE46816" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales Revenue, Product Line</link:label>
    <link:label id="lab_us-gaap_SalesRevenueProductLineMember_EB5B00912AE7BFD1F1A0EC8A3CE46816_label_en-US" xlink:label="lab_us-gaap_SalesRevenueProductLineMember_EB5B00912AE7BFD1F1A0EC8A3CE46816" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Revenue, Product Line [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesRevenueProductLineMember" xlink:label="loc_us-gaap_SalesRevenueProductLineMember_EB5B00912AE7BFD1F1A0EC8A3CE46816" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueProductLineMember_EB5B00912AE7BFD1F1A0EC8A3CE46816" xlink:to="lab_us-gaap_SalesRevenueProductLineMember_EB5B00912AE7BFD1F1A0EC8A3CE46816" xlink:type="arc" />
    <link:label id="lab_srt_ProductOrServiceAxis_530E8BEDD12B99B5F604EC8A3CE516CD_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis_530E8BEDD12B99B5F604EC8A3CE516CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_530E8BEDD12B99B5F604EC8A3CE516CD_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis_530E8BEDD12B99B5F604EC8A3CE516CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_530E8BEDD12B99B5F604EC8A3CE516CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis_530E8BEDD12B99B5F604EC8A3CE516CD" xlink:to="lab_srt_ProductOrServiceAxis_530E8BEDD12B99B5F604EC8A3CE516CD" xlink:type="arc" />
    <link:label id="lab_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:to="lab_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:type="arc" />
    <link:label id="lab_ebs_BiothraxMember_E0472900E9212DCC3E27EC8A3CE5926F_terseLabel_en-US" xlink:label="lab_ebs_BiothraxMember_E0472900E9212DCC3E27EC8A3CE5926F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Anthrax Vaccines</link:label>
    <link:label id="lab_ebs_BiothraxMember_E0472900E9212DCC3E27EC8A3CE5926F_label_en-US" xlink:label="lab_ebs_BiothraxMember_E0472900E9212DCC3E27EC8A3CE5926F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Biothrax [Member]</link:label>
    <link:label id="lab_ebs_BiothraxMember_E0472900E9212DCC3E27EC8A3CE5926F_documentation_en-US" xlink:label="lab_ebs_BiothraxMember_E0472900E9212DCC3E27EC8A3CE5926F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Refers to NuThrax which is sold by the company.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BiothraxMember" xlink:label="loc_ebs_BiothraxMember_E0472900E9212DCC3E27EC8A3CE5926F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_BiothraxMember_E0472900E9212DCC3E27EC8A3CE5926F" xlink:to="lab_ebs_BiothraxMember_E0472900E9212DCC3E27EC8A3CE5926F" xlink:type="arc" />
    <link:label id="lab_ebs_ACAM2000Member_20E1FB2F441874566B25EC8A3CE52717_terseLabel_en-US" xlink:label="lab_ebs_ACAM2000Member_20E1FB2F441874566B25EC8A3CE52717" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ACAM2000</link:label>
    <link:label id="lab_ebs_ACAM2000Member_20E1FB2F441874566B25EC8A3CE52717_label_en-US" xlink:label="lab_ebs_ACAM2000Member_20E1FB2F441874566B25EC8A3CE52717" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ACAM2000 [Member]</link:label>
    <link:label id="lab_ebs_ACAM2000Member_20E1FB2F441874566B25EC8A3CE52717_documentation_en-US" xlink:label="lab_ebs_ACAM2000Member_20E1FB2F441874566B25EC8A3CE52717" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business acquisition in October of 2017.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ACAM2000Member" xlink:label="loc_ebs_ACAM2000Member_20E1FB2F441874566B25EC8A3CE52717" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ACAM2000Member_20E1FB2F441874566B25EC8A3CE52717" xlink:to="lab_ebs_ACAM2000Member_20E1FB2F441874566B25EC8A3CE52717" xlink:type="arc" />
    <link:label id="lab_ebs_NARCANNasalSprayMember_9777E8818F83C2D31D26ECAD58F8F470_terseLabel_en-US" xlink:label="lab_ebs_NARCANNasalSprayMember_9777E8818F83C2D31D26ECAD58F8F470" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NARCAN Nasal Spray</link:label>
    <link:label id="lab_ebs_NARCANNasalSprayMember_9777E8818F83C2D31D26ECAD58F8F470_label_en-US" xlink:label="lab_ebs_NARCANNasalSprayMember_9777E8818F83C2D31D26ECAD58F8F470" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NARCAN Nasal Spray [Member]</link:label>
    <link:label id="lab_ebs_NARCANNasalSprayMember_9777E8818F83C2D31D26ECAD58F8F470_documentation_en-US" xlink:label="lab_ebs_NARCANNasalSprayMember_9777E8818F83C2D31D26ECAD58F8F470" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NARCAN Nasal Spray [Member]</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NARCANNasalSprayMember" xlink:label="loc_ebs_NARCANNasalSprayMember_9777E8818F83C2D31D26ECAD58F8F470" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_NARCANNasalSprayMember_9777E8818F83C2D31D26ECAD58F8F470" xlink:to="lab_ebs_NARCANNasalSprayMember_9777E8818F83C2D31D26ECAD58F8F470" xlink:type="arc" />
    <link:label id="lab_ebs_OtherMember_E6B1CF851568DCE60D8CEC8A3CE50D54_terseLabel_en-US" xlink:label="lab_ebs_OtherMember_E6B1CF851568DCE60D8CEC8A3CE50D54" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ebs_OtherMember_E6B1CF851568DCE60D8CEC8A3CE50D54_label_en-US" xlink:label="lab_ebs_OtherMember_E6B1CF851568DCE60D8CEC8A3CE50D54" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_ebs_OtherMember_E6B1CF851568DCE60D8CEC8A3CE50D54_documentation_en-US" xlink:label="lab_ebs_OtherMember_E6B1CF851568DCE60D8CEC8A3CE50D54" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Refers to product sales from other products.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_OtherMember" xlink:label="loc_ebs_OtherMember_E6B1CF851568DCE60D8CEC8A3CE50D54" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_OtherMember_E6B1CF851568DCE60D8CEC8A3CE50D54" xlink:to="lab_ebs_OtherMember_E6B1CF851568DCE60D8CEC8A3CE50D54" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_EE1EB9443DB470E03178EC8A3CE65168_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_EE1EB9443DB470E03178EC8A3CE65168" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_EE1EB9443DB470E03178EC8A3CE65168_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_EE1EB9443DB470E03178EC8A3CE65168" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_EE1EB9443DB470E03178EC8A3CE65168" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_EE1EB9443DB470E03178EC8A3CE65168" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems_EE1EB9443DB470E03178EC8A3CE65168" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_116177BC5EC727E5D1AFEC8A3CE6B8DF_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1_116177BC5EC727E5D1AFEC8A3CE6B8DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_116177BC5EC727E5D1AFEC8A3CE6B8DF_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1_116177BC5EC727E5D1AFEC8A3CE6B8DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_116177BC5EC727E5D1AFEC8A3CE6B8DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1_116177BC5EC727E5D1AFEC8A3CE6B8DF" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1_116177BC5EC727E5D1AFEC8A3CE6B8DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D936911A70AE094F5E73CDFBFC0B309B_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D936911A70AE094F5E73CDFBFC0B309B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D936911A70AE094F5E73CDFBFC0B309B_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D936911A70AE094F5E73CDFBFC0B309B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D936911A70AE094F5E73CDFBFC0B309B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D936911A70AE094F5E73CDFBFC0B309B" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D936911A70AE094F5E73CDFBFC0B309B" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_BCC6F4970E25C48B0129CDFBFC0C73DA_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_BCC6F4970E25C48B0129CDFBFC0C73DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_BCC6F4970E25C48B0129CDFBFC0C73DA_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_BCC6F4970E25C48B0129CDFBFC0C73DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_BCC6F4970E25C48B0129CDFBFC0C73DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_BCC6F4970E25C48B0129CDFBFC0C73DA" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_BCC6F4970E25C48B0129CDFBFC0C73DA" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7" xlink:to="lab_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfSalesMember_7C69213A726BD4B05640CDFBFC0D7B1C_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember_7C69213A726BD4B05640CDFBFC0D7B1C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of product sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_7C69213A726BD4B05640CDFBFC0D7B1C_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember_7C69213A726BD4B05640CDFBFC0D7B1C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_7C69213A726BD4B05640CDFBFC0D7B1C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember_7C69213A726BD4B05640CDFBFC0D7B1C" xlink:to="lab_us-gaap_CostOfSalesMember_7C69213A726BD4B05640CDFBFC0D7B1C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_AE05AE760D68973273FECDFBFC0DDBD5_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember_AE05AE760D68973273FECDFBFC0DDBD5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_AE05AE760D68973273FECDFBFC0DDBD5_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember_AE05AE760D68973273FECDFBFC0DDBD5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_AE05AE760D68973273FECDFBFC0DDBD5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember_AE05AE760D68973273FECDFBFC0DDBD5" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember_AE05AE760D68973273FECDFBFC0DDBD5" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_CA7C97D59559A82C517BCDFBFC0DA2C2_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_CA7C97D59559A82C517BCDFBFC0DA2C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_CA7C97D59559A82C517BCDFBFC0DA2C2_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_CA7C97D59559A82C517BCDFBFC0DA2C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_CA7C97D59559A82C517BCDFBFC0DA2C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_CA7C97D59559A82C517BCDFBFC0DA2C2" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_CA7C97D59559A82C517BCDFBFC0DA2C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0733146079A4CC702E44CDFBFC0E4E72_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0733146079A4CC702E44CDFBFC0E4E72" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0733146079A4CC702E44CDFBFC0E4E72_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0733146079A4CC702E44CDFBFC0E4E72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0733146079A4CC702E44CDFBFC0E4E72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0733146079A4CC702E44CDFBFC0E4E72" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0733146079A4CC702E44CDFBFC0E4E72" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_209F8AAB0E4367EABB05CDFBFC0E4AA4_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_209F8AAB0E4367EABB05CDFBFC0E4AA4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_209F8AAB0E4367EABB05CDFBFC0E4AA4_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_209F8AAB0E4367EABB05CDFBFC0E4AA4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allocated Share-based Compensation Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_209F8AAB0E4367EABB05CDFBFC0E4AA4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_209F8AAB0E4367EABB05CDFBFC0E4AA4" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_209F8AAB0E4367EABB05CDFBFC0E4AA4" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_5F2557691908C9F4BD99188D8CB69FC6_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_5F2557691908C9F4BD99188D8CB69FC6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5F2557691908C9F4BD99188D8CB69FC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5F2557691908C9F4BD99188D8CB69FC6" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_5F2557691908C9F4BD99188D8CB69FC6" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentTable_78E6381D54E5B8764CA2188D8CB6D013_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_78E6381D54E5B8764CA2188D8CB6D013" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_78E6381D54E5B8764CA2188D8CB6D013_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_78E6381D54E5B8764CA2188D8CB6D013" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_78E6381D54E5B8764CA2188D8CB6D013" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable_78E6381D54E5B8764CA2188D8CB6D013" xlink:to="lab_us-gaap_DebtInstrumentTable_78E6381D54E5B8764CA2188D8CB6D013" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentAxis_836F0E12059820E14C1C188D8CB6799F_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_836F0E12059820E14C1C188D8CB6799F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_836F0E12059820E14C1C188D8CB6799F_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_836F0E12059820E14C1C188D8CB6799F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_836F0E12059820E14C1C188D8CB6799F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis_836F0E12059820E14C1C188D8CB6799F" xlink:to="lab_us-gaap_DebtInstrumentAxis_836F0E12059820E14C1C188D8CB6799F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_255797088B9C1A5A2F8C188D8CB6B6E3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_255797088B9C1A5A2F8C188D8CB6B6E3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_255797088B9C1A5A2F8C188D8CB6B6E3_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_255797088B9C1A5A2F8C188D8CB6B6E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_255797088B9C1A5A2F8C188D8CB6B6E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_255797088B9C1A5A2F8C188D8CB6B6E3" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_255797088B9C1A5A2F8C188D8CB6B6E3" xlink:type="arc" />
    <link:label id="lab_ebs_ConvertibleSeniorNotesDue2021Member_144FBB8B5A955B9D34EF188D8CB6373F_terseLabel_en-US" xlink:label="lab_ebs_ConvertibleSeniorNotesDue2021Member_144FBB8B5A955B9D34EF188D8CB6373F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2.875% Convertible Senior Notes Due 2021</link:label>
    <link:label id="lab_ebs_ConvertibleSeniorNotesDue2021Member_144FBB8B5A955B9D34EF188D8CB6373F_label_en-US" xlink:label="lab_ebs_ConvertibleSeniorNotesDue2021Member_144FBB8B5A955B9D34EF188D8CB6373F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Senior Notes Due 2021 [Member]</link:label>
    <link:label id="lab_ebs_ConvertibleSeniorNotesDue2021Member_144FBB8B5A955B9D34EF188D8CB6373F_documentation_en-US" xlink:label="lab_ebs_ConvertibleSeniorNotesDue2021Member_144FBB8B5A955B9D34EF188D8CB6373F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Senior Notes Due 2021 [Member]</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ConvertibleSeniorNotesDue2021Member" xlink:label="loc_ebs_ConvertibleSeniorNotesDue2021Member_144FBB8B5A955B9D34EF188D8CB6373F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ConvertibleSeniorNotesDue2021Member_144FBB8B5A955B9D34EF188D8CB6373F" xlink:to="lab_ebs_ConvertibleSeniorNotesDue2021Member_144FBB8B5A955B9D34EF188D8CB6373F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_D725134A6B11B0510BCA188D8CB627EF_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_D725134A6B11B0510BCA188D8CB627EF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_D725134A6B11B0510BCA188D8CB627EF_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_D725134A6B11B0510BCA188D8CB627EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_D725134A6B11B0510BCA188D8CB627EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D725134A6B11B0510BCA188D8CB627EF" xlink:to="lab_us-gaap_DebtInstrumentLineItems_D725134A6B11B0510BCA188D8CB627EF" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_3776747DE54BEDFF2546188D8CB6F59F_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_3776747DE54BEDFF2546188D8CB6F59F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_3776747DE54BEDFF2546188D8CB6F59F_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_3776747DE54BEDFF2546188D8CB6F59F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3776747DE54BEDFF2546188D8CB6F59F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3776747DE54BEDFF2546188D8CB6F59F" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_3776747DE54BEDFF2546188D8CB6F59F" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1DED6B5557FD9D774C86188D8CB69D61_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1DED6B5557FD9D774C86188D8CB69D61" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares of common stock due to conversions (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1DED6B5557FD9D774C86188D8CB69D61_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1DED6B5557FD9D774C86188D8CB69D61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1DED6B5557FD9D774C86188D8CB69D61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1DED6B5557FD9D774C86188D8CB69D61" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1DED6B5557FD9D774C86188D8CB69D61" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_A918E31E0F50EDCA9F9498A7607CF049_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_A918E31E0F50EDCA9F9498A7607CF049" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_A918E31E0F50EDCA9F9498A7607CF049" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_A918E31E0F50EDCA9F9498A7607CF049" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_A918E31E0F50EDCA9F9498A7607CF049" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_9D6A61BB547E900192D698A7607DFE61_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_9D6A61BB547E900192D698A7607DFE61" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_9D6A61BB547E900192D698A7607DFE61_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_9D6A61BB547E900192D698A7607DFE61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9D6A61BB547E900192D698A7607DFE61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9D6A61BB547E900192D698A7607DFE61" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis_9D6A61BB547E900192D698A7607DFE61" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_DAB657989DE195990F4F98A7DC3110E1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_DAB657989DE195990F4F98A7DC3110E1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_DAB657989DE195990F4F98A7DC3110E1_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_DAB657989DE195990F4F98A7DC3110E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_DAB657989DE195990F4F98A7DC3110E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_DAB657989DE195990F4F98A7DC3110E1" xlink:to="lab_us-gaap_DerivativeContractTypeDomain_DAB657989DE195990F4F98A7DC3110E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestRateSwapMember_480A3EF25EEB67DF35AA98A7607D883B_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember_480A3EF25EEB67DF35AA98A7607D883B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_480A3EF25EEB67DF35AA98A7607D883B_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember_480A3EF25EEB67DF35AA98A7607D883B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_480A3EF25EEB67DF35AA98A7607D883B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember_480A3EF25EEB67DF35AA98A7607D883B" xlink:to="lab_us-gaap_InterestRateSwapMember_480A3EF25EEB67DF35AA98A7607D883B" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationAxis_1564BC293522C577E31D98A7607D9FDC_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_1564BC293522C577E31D98A7607D9FDC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_1564BC293522C577E31D98A7607D9FDC_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_1564BC293522C577E31D98A7607D9FDC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_1564BC293522C577E31D98A7607D9FDC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis_1564BC293522C577E31D98A7607D9FDC" xlink:to="lab_us-gaap_HedgingDesignationAxis_1564BC293522C577E31D98A7607D9FDC" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationDomain_83A5B37274D84779682298A7607D7F63_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_83A5B37274D84779682298A7607D7F63" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_83A5B37274D84779682298A7607D7F63_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_83A5B37274D84779682298A7607D7F63" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_83A5B37274D84779682298A7607D7F63" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain_83A5B37274D84779682298A7607D7F63" xlink:to="lab_us-gaap_HedgingDesignationDomain_83A5B37274D84779682298A7607D7F63" xlink:type="arc" />
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_7D68440FA54AFB52B95F98A7607EA617_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember_7D68440FA54AFB52B95F98A7607EA617" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_7D68440FA54AFB52B95F98A7607EA617_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember_7D68440FA54AFB52B95F98A7607EA617" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7D68440FA54AFB52B95F98A7607EA617" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7D68440FA54AFB52B95F98A7607EA617" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember_7D68440FA54AFB52B95F98A7607EA617" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5F6C0856B82FC90E8E8198A7607FBC16_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5F6C0856B82FC90E8E8198A7607FBC16" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5F6C0856B82FC90E8E8198A7607FBC16_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5F6C0856B82FC90E8E8198A7607FBC16" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5F6C0856B82FC90E8E8198A7607FBC16" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5F6C0856B82FC90E8E8198A7607FBC16" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5F6C0856B82FC90E8E8198A7607FBC16" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_906A240D4677B8C378AA98A7607F9C46_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld_906A240D4677B8C378AA98A7607F9C46" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Instruments</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_906A240D4677B8C378AA98A7607F9C46_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld_906A240D4677B8C378AA98A7607F9C46" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_906A240D4677B8C378AA98A7607F9C46" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld_906A240D4677B8C378AA98A7607F9C46" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld_906A240D4677B8C378AA98A7607F9C46" xlink:type="arc" />
    <link:label id="lab_invest_DerivativeNotionalAmount_6B7F9C9263B09674415898A7607F9A99_terseLabel_en-US" xlink:label="lab_invest_DerivativeNotionalAmount_6B7F9C9263B09674415898A7607F9A99" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_invest_DerivativeNotionalAmount_6B7F9C9263B09674415898A7607F9A99_label_en-US" xlink:label="lab_invest_DerivativeNotionalAmount_6B7F9C9263B09674415898A7607F9A99" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="loc_invest_DerivativeNotionalAmount_6B7F9C9263B09674415898A7607F9A99" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_invest_DerivativeNotionalAmount_6B7F9C9263B09674415898A7607F9A99" xlink:to="lab_invest_DerivativeNotionalAmount_6B7F9C9263B09674415898A7607F9A99" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeasesAbstract_7B72D8884E67550330B121D7F7A58473_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract_7B72D8884E67550330B121D7F7A58473" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_7B72D8884E67550330B121D7F7A58473" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract_7B72D8884E67550330B121D7F7A58473" xlink:to="lab_us-gaap_LeasesAbstract_7B72D8884E67550330B121D7F7A58473" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_80E5DFCAEB0BCBC4D55C21D7F7A5404A_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable_80E5DFCAEB0BCBC4D55C21D7F7A5404A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_80E5DFCAEB0BCBC4D55C21D7F7A5404A_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable_80E5DFCAEB0BCBC4D55C21D7F7A5404A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_80E5DFCAEB0BCBC4D55C21D7F7A5404A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_80E5DFCAEB0BCBC4D55C21D7F7A5404A" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable_80E5DFCAEB0BCBC4D55C21D7F7A5404A" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_8EAB9FA6BEC4AA687A0221D7F7A5A9F4_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_8EAB9FA6BEC4AA687A0221D7F7A5A9F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_8EAB9FA6BEC4AA687A0221D7F7A5A9F4_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_8EAB9FA6BEC4AA687A0221D7F7A5A9F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8EAB9FA6BEC4AA687A0221D7F7A5A9F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8EAB9FA6BEC4AA687A0221D7F7A5A9F4" xlink:to="lab_us-gaap_BalanceSheetLocationAxis_8EAB9FA6BEC4AA687A0221D7F7A5A9F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D" xlink:to="lab_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsMember_59DFCC03AEDDD2CA5F6C21D7F7A6FC99_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember_59DFCC03AEDDD2CA5F6C21D7F7A6FC99" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_59DFCC03AEDDD2CA5F6C21D7F7A6FC99_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember_59DFCC03AEDDD2CA5F6C21D7F7A6FC99" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember_59DFCC03AEDDD2CA5F6C21D7F7A6FC99" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember_59DFCC03AEDDD2CA5F6C21D7F7A6FC99" xlink:to="lab_us-gaap_OtherAssetsMember_59DFCC03AEDDD2CA5F6C21D7F7A6FC99" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_8A661ED86EC3649DCDD021D7F7A683AD_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember_8A661ED86EC3649DCDD021D7F7A683AD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_8A661ED86EC3649DCDD021D7F7A683AD_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember_8A661ED86EC3649DCDD021D7F7A683AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_8A661ED86EC3649DCDD021D7F7A683AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember_8A661ED86EC3649DCDD021D7F7A683AD" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember_8A661ED86EC3649DCDD021D7F7A683AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_4E9F1C41A3964BED46B821D7F7A6F0C1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember_4E9F1C41A3964BED46B821D7F7A6F0C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_4E9F1C41A3964BED46B821D7F7A6F0C1_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember_4E9F1C41A3964BED46B821D7F7A6F0C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="loc_us-gaap_OtherLiabilitiesMember_4E9F1C41A3964BED46B821D7F7A6F0C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember_4E9F1C41A3964BED46B821D7F7A6F0C1" xlink:to="lab_us-gaap_OtherLiabilitiesMember_4E9F1C41A3964BED46B821D7F7A6F0C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_6FC1F6DD3246B6A2256921D7F7A7421D_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_6FC1F6DD3246B6A2256921D7F7A7421D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_6FC1F6DD3246B6A2256921D7F7A7421D_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_6FC1F6DD3246B6A2256921D7F7A7421D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6FC1F6DD3246B6A2256921D7F7A7421D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_6FC1F6DD3246B6A2256921D7F7A7421D" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_6FC1F6DD3246B6A2256921D7F7A7421D" xlink:type="arc" />
    <link:label id="lab_ebs_OperatingLeaseOtherLiabilityCurrent_7A704BA9C4FBD46899B521D7F7A7D765_terseLabel_en-US" xlink:label="lab_ebs_OperatingLeaseOtherLiabilityCurrent_7A704BA9C4FBD46899B521D7F7A7D765" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, current portion</link:label>
    <link:label id="lab_ebs_OperatingLeaseOtherLiabilityCurrent_7A704BA9C4FBD46899B521D7F7A7D765_label_en-US" xlink:label="lab_ebs_OperatingLeaseOtherLiabilityCurrent_7A704BA9C4FBD46899B521D7F7A7D765" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Other Liability, Current</link:label>
    <link:label id="lab_ebs_OperatingLeaseOtherLiabilityCurrent_7A704BA9C4FBD46899B521D7F7A7D765_documentation_en-US" xlink:label="lab_ebs_OperatingLeaseOtherLiabilityCurrent_7A704BA9C4FBD46899B521D7F7A7D765" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease, Other Liability, Current</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_OperatingLeaseOtherLiabilityCurrent" xlink:label="loc_ebs_OperatingLeaseOtherLiabilityCurrent_7A704BA9C4FBD46899B521D7F7A7D765" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_OperatingLeaseOtherLiabilityCurrent_7A704BA9C4FBD46899B521D7F7A7D765" xlink:to="lab_ebs_OperatingLeaseOtherLiabilityCurrent_7A704BA9C4FBD46899B521D7F7A7D765" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_CD95F80DB467243E609721D7F7A7C704_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_CD95F80DB467243E609721D7F7A7C704" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_CD95F80DB467243E609721D7F7A7C704_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_CD95F80DB467243E609721D7F7A7C704" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_CD95F80DB467243E609721D7F7A7C704" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_CD95F80DB467243E609721D7F7A7C704" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_CD95F80DB467243E609721D7F7A7C704" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiability_F20A931FA5ACC85F17C821D7F7A77BC4_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_F20A931FA5ACC85F17C821D7F7A77BC4" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_F20A931FA5ACC85F17C821D7F7A77BC4_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_F20A931FA5ACC85F17C821D7F7A77BC4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_F20A931FA5ACC85F17C821D7F7A77BC4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_F20A931FA5ACC85F17C821D7F7A77BC4" xlink:to="lab_us-gaap_OperatingLeaseLiability_F20A931FA5ACC85F17C821D7F7A77BC4" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseCostAbstract_F21F9DBCA1A75A0EE97F21D7F7A7F6AB_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract_F21F9DBCA1A75A0EE97F21D7F7A7F6AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating leases:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_F21F9DBCA1A75A0EE97F21D7F7A7F6AB_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract_F21F9DBCA1A75A0EE97F21D7F7A7F6AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="loc_us-gaap_LeaseCostAbstract_F21F9DBCA1A75A0EE97F21D7F7A7F6AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract_F21F9DBCA1A75A0EE97F21D7F7A7F6AB" xlink:to="lab_us-gaap_LeaseCostAbstract_F21F9DBCA1A75A0EE97F21D7F7A7F6AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5ADA7432315F8CA2E3AB21D7F7A8C6FA_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5ADA7432315F8CA2E3AB21D7F7A8C6FA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining lease term (years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5ADA7432315F8CA2E3AB21D7F7A8C6FA_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5ADA7432315F8CA2E3AB21D7F7A8C6FA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5ADA7432315F8CA2E3AB21D7F7A8C6FA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5ADA7432315F8CA2E3AB21D7F7A8C6FA" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5ADA7432315F8CA2E3AB21D7F7A8C6FA" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_D792260D4696DEF954B121D7F7A8CBE0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_D792260D4696DEF954B121D7F7A8CBE0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_D792260D4696DEF954B121D7F7A8CBE0_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_D792260D4696DEF954B121D7F7A8CBE0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_D792260D4696DEF954B121D7F7A8CBE0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_D792260D4696DEF954B121D7F7A8CBE0" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_D792260D4696DEF954B121D7F7A8CBE0" xlink:type="arc" />
    <link:label id="lab_srt_RangeAxis_B476685131292651CD00EC8A3D1E02C0_terseLabel_en-US" xlink:label="lab_srt_RangeAxis_B476685131292651CD00EC8A3D1E02C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_B476685131292651CD00EC8A3D1E02C0_label_en-US" xlink:label="lab_srt_RangeAxis_B476685131292651CD00EC8A3D1E02C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_B476685131292651CD00EC8A3D1E02C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_B476685131292651CD00EC8A3D1E02C0" xlink:to="lab_srt_RangeAxis_B476685131292651CD00EC8A3D1E02C0" xlink:type="arc" />
    <link:label id="lab_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69_terseLabel_en-US" xlink:label="lab_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69_label_en-US" xlink:label="lab_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69" xlink:to="lab_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69" xlink:type="arc" />
    <link:label id="lab_srt_MinimumMember_42A13985B49F72B63592EC8A3D1E1CDA_terseLabel_en-US" xlink:label="lab_srt_MinimumMember_42A13985B49F72B63592EC8A3D1E1CDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_42A13985B49F72B63592EC8A3D1E1CDA_label_en-US" xlink:label="lab_srt_MinimumMember_42A13985B49F72B63592EC8A3D1E1CDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_42A13985B49F72B63592EC8A3D1E1CDA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_42A13985B49F72B63592EC8A3D1E1CDA" xlink:to="lab_srt_MinimumMember_42A13985B49F72B63592EC8A3D1E1CDA" xlink:type="arc" />
    <link:label id="lab_srt_MaximumMember_45AC55A79D8113A385ECEC8A3D1FC2CB_terseLabel_en-US" xlink:label="lab_srt_MaximumMember_45AC55A79D8113A385ECEC8A3D1FC2CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_45AC55A79D8113A385ECEC8A3D1FC2CB_label_en-US" xlink:label="lab_srt_MaximumMember_45AC55A79D8113A385ECEC8A3D1FC2CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_45AC55A79D8113A385ECEC8A3D1FC2CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_45AC55A79D8113A385ECEC8A3D1FC2CB" xlink:to="lab_srt_MaximumMember_45AC55A79D8113A385ECEC8A3D1FC2CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_EDF416FBBA9830A1306CEC8A3D1F1FDF_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract_EDF416FBBA9830A1306CEC8A3D1F1FDF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_EDF416FBBA9830A1306CEC8A3D1F1FDF_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract_EDF416FBBA9830A1306CEC8A3D1F1FDF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_EDF416FBBA9830A1306CEC8A3D1F1FDF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract_EDF416FBBA9830A1306CEC8A3D1F1FDF" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract_EDF416FBBA9830A1306CEC8A3D1F1FDF" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_65F9F93E810DE00D3726EC8A3D1F75E1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_65F9F93E810DE00D3726EC8A3D1F75E1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_65F9F93E810DE00D3726EC8A3D1F75E1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_65F9F93E810DE00D3726EC8A3D1F75E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_65F9F93E810DE00D3726EC8A3D1F75E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_65F9F93E810DE00D3726EC8A3D1F75E1" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_65F9F93E810DE00D3726EC8A3D1F75E1" xlink:type="arc" />
    <link:label id="lab_ebs_LesseeOperatingLeaseTerminationPeriod_41547FD182AAAF3A399BEC8A3D1FCEB2_terseLabel_en-US" xlink:label="lab_ebs_LesseeOperatingLeaseTerminationPeriod_41547FD182AAAF3A399BEC8A3D1FCEB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, termination period</link:label>
    <link:label id="lab_ebs_LesseeOperatingLeaseTerminationPeriod_41547FD182AAAF3A399BEC8A3D1FCEB2_label_en-US" xlink:label="lab_ebs_LesseeOperatingLeaseTerminationPeriod_41547FD182AAAF3A399BEC8A3D1FCEB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Termination Period</link:label>
    <link:label id="lab_ebs_LesseeOperatingLeaseTerminationPeriod_41547FD182AAAF3A399BEC8A3D1FCEB2_documentation_en-US" xlink:label="lab_ebs_LesseeOperatingLeaseTerminationPeriod_41547FD182AAAF3A399BEC8A3D1FCEB2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Termination Period</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_LesseeOperatingLeaseTerminationPeriod" xlink:label="loc_ebs_LesseeOperatingLeaseTerminationPeriod_41547FD182AAAF3A399BEC8A3D1FCEB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_LesseeOperatingLeaseTerminationPeriod_41547FD182AAAF3A399BEC8A3D1FCEB2" xlink:to="lab_ebs_LesseeOperatingLeaseTerminationPeriod_41547FD182AAAF3A399BEC8A3D1FCEB2" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_19BDF9A84F030D34EBAB4B4E8EB6960B_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis_19BDF9A84F030D34EBAB4B4E8EB6960B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_19BDF9A84F030D34EBAB4B4E8EB6960B_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis_19BDF9A84F030D34EBAB4B4E8EB6960B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_19BDF9A84F030D34EBAB4B4E8EB6960B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_19BDF9A84F030D34EBAB4B4E8EB6960B" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis_19BDF9A84F030D34EBAB4B4E8EB6960B" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8E175349D1F783DCECBD4B4F421FD00F_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8E175349D1F783DCECBD4B4F421FD00F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8E175349D1F783DCECBD4B4F421FD00F_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8E175349D1F783DCECBD4B4F421FD00F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8E175349D1F783DCECBD4B4F421FD00F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8E175349D1F783DCECBD4B4F421FD00F" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8E175349D1F783DCECBD4B4F421FD00F" xlink:type="arc" />
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_44CEFC30941D7FD1F99F4B4EB5A0E19E_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember_44CEFC30941D7FD1F99F4B4EB5A0E19E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money Market Funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_44CEFC30941D7FD1F99F4B4EB5A0E19E_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember_44CEFC30941D7FD1F99F4B4EB5A0E19E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_44CEFC30941D7FD1F99F4B4EB5A0E19E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember_44CEFC30941D7FD1F99F4B4EB5A0E19E" xlink:to="lab_us-gaap_MoneyMarketFundsMember_44CEFC30941D7FD1F99F4B4EB5A0E19E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_34FE717B56D0800FB6794B4815670D97_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_34FE717B56D0800FB6794B4815670D97" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_34FE717B56D0800FB6794B4815670D97_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_34FE717B56D0800FB6794B4815670D97" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34FE717B56D0800FB6794B4815670D97" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34FE717B56D0800FB6794B4815670D97" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_34FE717B56D0800FB6794B4815670D97" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2BB840685AB555312AFC4B4815771A1F_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2BB840685AB555312AFC4B4815771A1F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2BB840685AB555312AFC4B4815771A1F_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2BB840685AB555312AFC4B4815771A1F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2BB840685AB555312AFC4B4815771A1F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2BB840685AB555312AFC4B4815771A1F" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2BB840685AB555312AFC4B4815771A1F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_ED91AF6F4B73BC0206694B481577661D_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_ED91AF6F4B73BC0206694B481577661D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_ED91AF6F4B73BC0206694B481577661D_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_ED91AF6F4B73BC0206694B481577661D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ED91AF6F4B73BC0206694B481577661D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member_ED91AF6F4B73BC0206694B481577661D" xlink:to="lab_us-gaap_FairValueInputsLevel1Member_ED91AF6F4B73BC0206694B481577661D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_DFBEB6875C777EFA79214B481577A95A_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_DFBEB6875C777EFA79214B481577A95A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_DFBEB6875C777EFA79214B481577A95A_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_DFBEB6875C777EFA79214B481577A95A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_DFBEB6875C777EFA79214B481577A95A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_DFBEB6875C777EFA79214B481577A95A" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_DFBEB6875C777EFA79214B481577A95A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_254CC12BBF59B0D0529E4B4E61712A53_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_254CC12BBF59B0D0529E4B4E61712A53" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash held in money market accounts</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_254CC12BBF59B0D0529E4B4E61712A53_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_254CC12BBF59B0D0529E4B4E61712A53" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_254CC12BBF59B0D0529E4B4E61712A53" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_254CC12BBF59B0D0529E4B4E61712A53" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_254CC12BBF59B0D0529E4B4E61712A53" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_0592EA94AD357E03E03FCCD36FBED737_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_0592EA94AD357E03E03FCCD36FBED737" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0592EA94AD357E03E03FCCD36FBED737" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0592EA94AD357E03E03FCCD36FBED737" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_0592EA94AD357E03E03FCCD36FBED737" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_E76050D4F992E9869BDECCD36FBEE30C_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_E76050D4F992E9869BDECCD36FBEE30C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_E76050D4F992E9869BDECCD36FBEE30C_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_E76050D4F992E9869BDECCD36FBEE30C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_E76050D4F992E9869BDECCD36FBEE30C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_E76050D4F992E9869BDECCD36FBEE30C" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_E76050D4F992E9869BDECCD36FBEE30C" xlink:type="arc" />
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_85412624A64BE18549C753E694239300_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_85412624A64BE18549C753E694239300" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_85412624A64BE18549C753E694239300" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_85412624A64BE18549C753E694239300" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_85412624A64BE18549C753E694239300" xlink:type="arc" />
    <link:label id="lab_ebs_NumberOfCategoriesOfPublicHealthThreats_B14A790EC24091A19B6F53E69423FFB3_terseLabel_en-US" xlink:label="lab_ebs_NumberOfCategoriesOfPublicHealthThreats_B14A790EC24091A19B6F53E69423FFB3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of categories of public health threats</link:label>
    <link:label id="lab_ebs_NumberOfCategoriesOfPublicHealthThreats_B14A790EC24091A19B6F53E69423FFB3_label_en-US" xlink:label="lab_ebs_NumberOfCategoriesOfPublicHealthThreats_B14A790EC24091A19B6F53E69423FFB3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Categories Of Public Health Threats</link:label>
    <link:label id="lab_ebs_NumberOfCategoriesOfPublicHealthThreats_B14A790EC24091A19B6F53E69423FFB3_documentation_en-US" xlink:label="lab_ebs_NumberOfCategoriesOfPublicHealthThreats_B14A790EC24091A19B6F53E69423FFB3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Refers to the number of categories of public health threats.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberOfCategoriesOfPublicHealthThreats" xlink:label="loc_ebs_NumberOfCategoriesOfPublicHealthThreats_B14A790EC24091A19B6F53E69423FFB3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_NumberOfCategoriesOfPublicHealthThreats_B14A790EC24091A19B6F53E69423FFB3" xlink:to="lab_ebs_NumberOfCategoriesOfPublicHealthThreats_B14A790EC24091A19B6F53E69423FFB3" xlink:type="arc" />
    <link:label id="lab_ebs_NumberOfRevenueGeneratingProducts_C5B15B144221B82B4B8053E694237931_terseLabel_en-US" xlink:label="lab_ebs_NumberOfRevenueGeneratingProducts_C5B15B144221B82B4B8053E694237931" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of revenue generating products</link:label>
    <link:label id="lab_ebs_NumberOfRevenueGeneratingProducts_C5B15B144221B82B4B8053E694237931_label_en-US" xlink:label="lab_ebs_NumberOfRevenueGeneratingProducts_C5B15B144221B82B4B8053E694237931" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Revenue Generating Products</link:label>
    <link:label id="lab_ebs_NumberOfRevenueGeneratingProducts_C5B15B144221B82B4B8053E694237931_documentation_en-US" xlink:label="lab_ebs_NumberOfRevenueGeneratingProducts_C5B15B144221B82B4B8053E694237931" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Refers to the number of revenue generating products.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberOfRevenueGeneratingProducts" xlink:label="loc_ebs_NumberOfRevenueGeneratingProducts_C5B15B144221B82B4B8053E694237931" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_NumberOfRevenueGeneratingProducts_C5B15B144221B82B4B8053E694237931" xlink:to="lab_ebs_NumberOfRevenueGeneratingProducts_C5B15B144221B82B4B8053E694237931" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_7210AAFE16652335A58053E69423B523_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_7210AAFE16652335A58053E69423B523" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_7210AAFE16652335A58053E69423B523_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_7210AAFE16652335A58053E69423B523" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_7210AAFE16652335A58053E69423B523" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments_7210AAFE16652335A58053E69423B523" xlink:to="lab_us-gaap_NumberOfOperatingSegments_7210AAFE16652335A58053E69423B523" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_A6F287E072D1161ABAA799767243EA70_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_A6F287E072D1161ABAA799767243EA70" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_A6F287E072D1161ABAA799767243EA70" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_A6F287E072D1161ABAA799767243EA70" xlink:to="lab_us-gaap_EarningsPerShareAbstract_A6F287E072D1161ABAA799767243EA70" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9D1C281E2C45DC0E8914997672432D93_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9D1C281E2C45DC0E8914997672432D93" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Net Income Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9D1C281E2C45DC0E8914997672432D93_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9D1C281E2C45DC0E8914997672432D93" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9D1C281E2C45DC0E8914997672432D93" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9D1C281E2C45DC0E8914997672432D93" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9D1C281E2C45DC0E8914997672432D93" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_3453FF15877F8E5D2CA192A28898CB4B_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_3453FF15877F8E5D2CA192A28898CB4B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property Plant and Equipment Income Statement Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_3453FF15877F8E5D2CA192A28898CB4B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_3453FF15877F8E5D2CA192A28898CB4B" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_3453FF15877F8E5D2CA192A28898CB4B" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_ADF93221CEA37A210C1792A288989C47_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_ADF93221CEA37A210C1792A288989C47" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_ADF93221CEA37A210C1792A288989C47_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_ADF93221CEA37A210C1792A288989C47" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ADF93221CEA37A210C1792A288989C47" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ADF93221CEA37A210C1792A288989C47" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_ADF93221CEA37A210C1792A288989C47" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_38A43AEF348BC8E72A4778A5A0C060D4_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract_38A43AEF348BC8E72A4778A5A0C060D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_38A43AEF348BC8E72A4778A5A0C060D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_38A43AEF348BC8E72A4778A5A0C060D4" xlink:to="lab_us-gaap_BusinessCombinationsAbstract_38A43AEF348BC8E72A4778A5A0C060D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_776067A367A0502B2D2078A5A0C1716D_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_776067A367A0502B2D2078A5A0C1716D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_776067A367A0502B2D2078A5A0C1716D_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_776067A367A0502B2D2078A5A0C1716D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_776067A367A0502B2D2078A5A0C1716D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_776067A367A0502B2D2078A5A0C1716D" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_776067A367A0502B2D2078A5A0C1716D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889579D389F152FBC55778A5A0C1D62A_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889579D389F152FBC55778A5A0C1D62A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889579D389F152FBC55778A5A0C1D62A_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889579D389F152FBC55778A5A0C1D62A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889579D389F152FBC55778A5A0C1D62A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889579D389F152FBC55778A5A0C1D62A" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889579D389F152FBC55778A5A0C1D62A" xlink:type="arc" />
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_855B894C6156E51D559F78A5A0C19ACE_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember_855B894C6156E51D559F78A5A0C19ACE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In Process Research and Development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_855B894C6156E51D559F78A5A0C19ACE_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember_855B894C6156E51D559F78A5A0C19ACE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_855B894C6156E51D559F78A5A0C19ACE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember_855B894C6156E51D559F78A5A0C19ACE" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember_855B894C6156E51D559F78A5A0C19ACE" xlink:type="arc" />
    <link:label id="lab_srt_RestatementAxis_22EF379549C4455F7E3B78A5A0C203AF_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis_22EF379549C4455F7E3B78A5A0C203AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_22EF379549C4455F7E3B78A5A0C203AF_label_en-US" xlink:label="lab_srt_RestatementAxis_22EF379549C4455F7E3B78A5A0C203AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_22EF379549C4455F7E3B78A5A0C203AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis_22EF379549C4455F7E3B78A5A0C203AF" xlink:to="lab_srt_RestatementAxis_22EF379549C4455F7E3B78A5A0C203AF" xlink:type="arc" />
    <link:label id="lab_srt_RestatementDomain_CC6242758C11B230620C78A5A0C23A2E_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain_CC6242758C11B230620C78A5A0C23A2E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_CC6242758C11B230620C78A5A0C23A2E_label_en-US" xlink:label="lab_srt_RestatementDomain_CC6242758C11B230620C78A5A0C23A2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_CC6242758C11B230620C78A5A0C23A2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain_CC6242758C11B230620C78A5A0C23A2E" xlink:to="lab_srt_RestatementDomain_CC6242758C11B230620C78A5A0C23A2E" xlink:type="arc" />
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_E442CFA407B5AEFB007278A5A0C24042_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember_E442CFA407B5AEFB007278A5A0C24042" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_E442CFA407B5AEFB007278A5A0C24042_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember_E442CFA407B5AEFB007278A5A0C24042" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_E442CFA407B5AEFB007278A5A0C24042" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember_E442CFA407B5AEFB007278A5A0C24042" xlink:to="lab_srt_ScenarioPreviouslyReportedMember_E442CFA407B5AEFB007278A5A0C24042" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_90056D3C3F7C5381813D78A5A0C2A899_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_90056D3C3F7C5381813D78A5A0C2A899" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_90056D3C3F7C5381813D78A5A0C2A899_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_90056D3C3F7C5381813D78A5A0C2A899" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_90056D3C3F7C5381813D78A5A0C2A899" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_90056D3C3F7C5381813D78A5A0C2A899" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_90056D3C3F7C5381813D78A5A0C2A899" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_C6652765AAAAAA4F85AD78A5A0C2CE55_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_C6652765AAAAAA4F85AD78A5A0C2CE55" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_C6652765AAAAAA4F85AD78A5A0C2CE55_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_C6652765AAAAAA4F85AD78A5A0C2CE55" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C6652765AAAAAA4F85AD78A5A0C2CE55" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C6652765AAAAAA4F85AD78A5A0C2CE55" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain_C6652765AAAAAA4F85AD78A5A0C2CE55" xlink:type="arc" />
    <link:label id="lab_ebs_AdaptPharmaMember_D25B7DB535082F9B85CF78A5A0C3F69E_terseLabel_en-US" xlink:label="lab_ebs_AdaptPharmaMember_D25B7DB535082F9B85CF78A5A0C3F69E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adapt Pharma</link:label>
    <link:label id="lab_ebs_AdaptPharmaMember_D25B7DB535082F9B85CF78A5A0C3F69E_label_en-US" xlink:label="lab_ebs_AdaptPharmaMember_D25B7DB535082F9B85CF78A5A0C3F69E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adapt Pharma [Member]</link:label>
    <link:label id="lab_ebs_AdaptPharmaMember_D25B7DB535082F9B85CF78A5A0C3F69E_documentation_en-US" xlink:label="lab_ebs_AdaptPharmaMember_D25B7DB535082F9B85CF78A5A0C3F69E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business acquisition on October 15, 2018.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AdaptPharmaMember" xlink:label="loc_ebs_AdaptPharmaMember_D25B7DB535082F9B85CF78A5A0C3F69E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_AdaptPharmaMember_D25B7DB535082F9B85CF78A5A0C3F69E" xlink:to="lab_ebs_AdaptPharmaMember_D25B7DB535082F9B85CF78A5A0C3F69E" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_46DE460FEFB7BFF2138F78A5A0C3CEF6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_46DE460FEFB7BFF2138F78A5A0C3CEF6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_46DE460FEFB7BFF2138F78A5A0C3CEF6_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_46DE460FEFB7BFF2138F78A5A0C3CEF6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_46DE460FEFB7BFF2138F78A5A0C3CEF6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46DE460FEFB7BFF2138F78A5A0C3CEF6" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems_46DE460FEFB7BFF2138F78A5A0C3CEF6" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of tangible assets acquired and liabilities assumed:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_334B8CEBC84DB290C01B78A5A0C327F4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_334B8CEBC84DB290C01B78A5A0C327F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_334B8CEBC84DB290C01B78A5A0C327F4_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_334B8CEBC84DB290C01B78A5A0C327F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_334B8CEBC84DB290C01B78A5A0C327F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_334B8CEBC84DB290C01B78A5A0C327F4" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_334B8CEBC84DB290C01B78A5A0C327F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_210DE10EE087E80AD30F78A5A0C4F6DE_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_210DE10EE087E80AD30F78A5A0C4F6DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_210DE10EE087E80AD30F78A5A0C4F6DE_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_210DE10EE087E80AD30F78A5A0C4F6DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_210DE10EE087E80AD30F78A5A0C4F6DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_210DE10EE087E80AD30F78A5A0C4F6DE" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_210DE10EE087E80AD30F78A5A0C4F6DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_EE7477DB1DCEB380F9C078A5A0C46AAE_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_EE7477DB1DCEB380F9C078A5A0C46AAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_EE7477DB1DCEB380F9C078A5A0C46AAE_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_EE7477DB1DCEB380F9C078A5A0C46AAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_EE7477DB1DCEB380F9C078A5A0C46AAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_EE7477DB1DCEB380F9C078A5A0C46AAE" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_EE7477DB1DCEB380F9C078A5A0C46AAE" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_D407DA6A3CB22E454D7D78A5A0C45569_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_D407DA6A3CB22E454D7D78A5A0C45569" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_D407DA6A3CB22E454D7D78A5A0C45569_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_D407DA6A3CB22E454D7D78A5A0C45569" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_D407DA6A3CB22E454D7D78A5A0C45569" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_D407DA6A3CB22E454D7D78A5A0C45569" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_D407DA6A3CB22E454D7D78A5A0C45569" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_7394C847495BA0A5B9EE78A5A0C4CBF8_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_7394C847495BA0A5B9EE78A5A0C4CBF8" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_7394C847495BA0A5B9EE78A5A0C4CBF8_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_7394C847495BA0A5B9EE78A5A0C4CBF8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_7394C847495BA0A5B9EE78A5A0C4CBF8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_7394C847495BA0A5B9EE78A5A0C4CBF8" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_7394C847495BA0A5B9EE78A5A0C4CBF8" xlink:type="arc" />
    <link:label id="lab_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_38C47F7CB643FDBFAADB78A5A0C4A703_negatedLabel_en-US" xlink:label="lab_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_38C47F7CB643FDBFAADB78A5A0C4A703" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_38C47F7CB643FDBFAADB78A5A0C4A703_label_en-US" xlink:label="lab_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_38C47F7CB643FDBFAADB78A5A0C4A703" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Expenses and Other Liabilities</link:label>
    <link:label id="lab_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_38C47F7CB643FDBFAADB78A5A0C4A703_documentation_en-US" xlink:label="lab_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_38C47F7CB643FDBFAADB78A5A0C4A703" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of accrued expenses and other liabilities, assumed at the acquisition date.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities" xlink:label="loc_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_38C47F7CB643FDBFAADB78A5A0C4A703" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_38C47F7CB643FDBFAADB78A5A0C4A703" xlink:to="lab_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_38C47F7CB643FDBFAADB78A5A0C4A703" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_DC26F61B2CD956694B2A78A5A0C51B28_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_DC26F61B2CD956694B2A78A5A0C51B28" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_DC26F61B2CD956694B2A78A5A0C51B28_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_DC26F61B2CD956694B2A78A5A0C51B28" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_DC26F61B2CD956694B2A78A5A0C51B28" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_DC26F61B2CD956694B2A78A5A0C51B28" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_DC26F61B2CD956694B2A78A5A0C51B28" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_64B57A3AEC33EC04B92078A5A0C5C714_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_64B57A3AEC33EC04B92078A5A0C5C714" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total fair value of tangible assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_64B57A3AEC33EC04B92078A5A0C5C714_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_64B57A3AEC33EC04B92078A5A0C5C714" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_64B57A3AEC33EC04B92078A5A0C5C714" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_64B57A3AEC33EC04B92078A5A0C5C714" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_64B57A3AEC33EC04B92078A5A0C5C714" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_EA853FF0713147BA1BA578A5A0C52135_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_EA853FF0713147BA1BA578A5A0C52135" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired in-process research and development</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_EA853FF0713147BA1BA578A5A0C52135_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_EA853FF0713147BA1BA578A5A0C52135" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_EA853FF0713147BA1BA578A5A0C52135" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_EA853FF0713147BA1BA578A5A0C52135" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_EA853FF0713147BA1BA578A5A0C52135" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6F52E47E6453E473465878A5A0C51898_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6F52E47E6453E473465878A5A0C51898" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Acquired intangible asset</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6F52E47E6453E473465878A5A0C51898_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6F52E47E6453E473465878A5A0C51898" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6F52E47E6453E473465878A5A0C51898" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6F52E47E6453E473465878A5A0C51898" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6F52E47E6453E473465878A5A0C51898" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_684164133FC006836BDB78A5A0C56918_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_684164133FC006836BDB78A5A0C56918" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_684164133FC006836BDB78A5A0C56918_label_en-US" xlink:label="lab_us-gaap_Goodwill_684164133FC006836BDB78A5A0C56918" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_684164133FC006836BDB78A5A0C56918" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_684164133FC006836BDB78A5A0C56918" xlink:to="lab_us-gaap_Goodwill_684164133FC006836BDB78A5A0C56918" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_E9531609F985A5DABAE278A5A0C535F5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_E9531609F985A5DABAE278A5A0C535F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_E9531609F985A5DABAE278A5A0C535F5_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_E9531609F985A5DABAE278A5A0C535F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_E9531609F985A5DABAE278A5A0C535F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_E9531609F985A5DABAE278A5A0C535F5" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1_E9531609F985A5DABAE278A5A0C535F5" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Period Adjustments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:type="arc" />
    <link:label id="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_D664DED65987589E01C778A5A0C69779_terseLabel_en-US" xlink:label="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_D664DED65987589E01C778A5A0C69779" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets, measurements period adjustments</link:label>
    <link:label id="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_D664DED65987589E01C778A5A0C69779_label_en-US" xlink:label="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_D664DED65987589E01C778A5A0C69779" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Expenses and Other Assets</link:label>
    <link:label id="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_D664DED65987589E01C778A5A0C69779_documentation_en-US" xlink:label="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_D664DED65987589E01C778A5A0C69779" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Expenses and Other Assets</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_D664DED65987589E01C778A5A0C69779" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_D664DED65987589E01C778A5A0C69779" xlink:to="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_D664DED65987589E01C778A5A0C69779" xlink:type="arc" />
    <link:label id="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_1C4C24F33C6CE96350FD78A5A0C6A660_negatedTerseLabel_en-US" xlink:label="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_1C4C24F33C6CE96350FD78A5A0C6A660" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability, net, measurement period adjustments</link:label>
    <link:label id="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_1C4C24F33C6CE96350FD78A5A0C6A660_label_en-US" xlink:label="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_1C4C24F33C6CE96350FD78A5A0C6A660" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities</link:label>
    <link:label id="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_1C4C24F33C6CE96350FD78A5A0C6A660_documentation_en-US" xlink:label="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_1C4C24F33C6CE96350FD78A5A0C6A660" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_1C4C24F33C6CE96350FD78A5A0C6A660" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_1C4C24F33C6CE96350FD78A5A0C6A660" xlink:to="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_1C4C24F33C6CE96350FD78A5A0C6A660" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_2799AD2B05632D345CE778A5A0C6C130_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_2799AD2B05632D345CE778A5A0C6C130" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total fair value of tangible assets acquired and liabilities assumed, measurement period adjustments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_2799AD2B05632D345CE778A5A0C6C130_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_2799AD2B05632D345CE778A5A0C6C130" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_2799AD2B05632D345CE778A5A0C6C130" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_2799AD2B05632D345CE778A5A0C6C130" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_2799AD2B05632D345CE778A5A0C6C130" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_B1AB405603B65BF3641B78A5A0C61E3B_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_B1AB405603B65BF3641B78A5A0C61E3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement period adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_B1AB405603B65BF3641B78A5A0C61E3B_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_B1AB405603B65BF3641B78A5A0C61E3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_B1AB405603B65BF3641B78A5A0C61E3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_B1AB405603B65BF3641B78A5A0C61E3B" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_B1AB405603B65BF3641B78A5A0C61E3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_73ECE0530D3D40A9B9B378A5A0C7E9C5_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_73ECE0530D3D40A9B9B378A5A0C7E9C5" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_73ECE0530D3D40A9B9B378A5A0C7E9C5_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_73ECE0530D3D40A9B9B378A5A0C7E9C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_73ECE0530D3D40A9B9B378A5A0C7E9C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_73ECE0530D3D40A9B9B378A5A0C7E9C5" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_73ECE0530D3D40A9B9B378A5A0C7E9C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_B53D10B9F842BD5904AE12BD04E48272_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_B53D10B9F842BD5904AE12BD04E48272" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_B53D10B9F842BD5904AE12BD04E48272_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_B53D10B9F842BD5904AE12BD04E48272" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_B53D10B9F842BD5904AE12BD04E48272" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_B53D10B9F842BD5904AE12BD04E48272" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_B53D10B9F842BD5904AE12BD04E48272" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_BBDA2F31E17216FAA27BCE2D5ECF93C3_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_BBDA2F31E17216FAA27BCE2D5ECF93C3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Net actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_BBDA2F31E17216FAA27BCE2D5ECF93C3_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_BBDA2F31E17216FAA27BCE2D5ECF93C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_BBDA2F31E17216FAA27BCE2D5ECF93C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_BBDA2F31E17216FAA27BCE2D5ECF93C3" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_BBDA2F31E17216FAA27BCE2D5ECF93C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_47E3FDC48035C1D6104ECE2D5ECF7762_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_47E3FDC48035C1D6104ECE2D5ECF7762" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_47E3FDC48035C1D6104ECE2D5ECF7762_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_47E3FDC48035C1D6104ECE2D5ECF7762" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_47E3FDC48035C1D6104ECE2D5ECF7762" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_47E3FDC48035C1D6104ECE2D5ECF7762" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_47E3FDC48035C1D6104ECE2D5ECF7762" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0CF9F4869852566A37FBCE2D5ED07177_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0CF9F4869852566A37FBCE2D5ED07177" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total recognized in accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0CF9F4869852566A37FBCE2D5ED07177_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0CF9F4869852566A37FBCE2D5ED07177" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0CF9F4869852566A37FBCE2D5ED07177" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0CF9F4869852566A37FBCE2D5ED07177" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0CF9F4869852566A37FBCE2D5ED07177" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_329FD05C1FAA3B43B503F5530CC0784D_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract_329FD05C1FAA3B43B503F5530CC0784D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_329FD05C1FAA3B43B503F5530CC0784D_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract_329FD05C1FAA3B43B503F5530CC0784D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Net [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetAbstract" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_329FD05C1FAA3B43B503F5530CC0784D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_329FD05C1FAA3B43B503F5530CC0784D" xlink:to="lab_us-gaap_AccountsReceivableNetAbstract_329FD05C1FAA3B43B503F5530CC0784D" xlink:type="arc" />
    <link:label id="lab_us-gaap_BilledContractReceivables_303E1113B2A7BD6B234AF5530CC1757C_terseLabel_en-US" xlink:label="lab_us-gaap_BilledContractReceivables_303E1113B2A7BD6B234AF5530CC1757C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Billed, net</link:label>
    <link:label id="lab_us-gaap_BilledContractReceivables_303E1113B2A7BD6B234AF5530CC1757C_label_en-US" xlink:label="lab_us-gaap_BilledContractReceivables_303E1113B2A7BD6B234AF5530CC1757C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Billed Contracts Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BilledContractReceivables" xlink:label="loc_us-gaap_BilledContractReceivables_303E1113B2A7BD6B234AF5530CC1757C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BilledContractReceivables_303E1113B2A7BD6B234AF5530CC1757C" xlink:to="lab_us-gaap_BilledContractReceivables_303E1113B2A7BD6B234AF5530CC1757C" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_598AA01BF0A4D36C0905F5530CC24FDB_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable_598AA01BF0A4D36C0905F5530CC24FDB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unbilled</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_598AA01BF0A4D36C0905F5530CC24FDB_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable_598AA01BF0A4D36C0905F5530CC24FDB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnbilledContractsReceivable" xlink:label="loc_us-gaap_UnbilledContractsReceivable_598AA01BF0A4D36C0905F5530CC24FDB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable_598AA01BF0A4D36C0905F5530CC24FDB" xlink:to="lab_us-gaap_UnbilledContractsReceivable_598AA01BF0A4D36C0905F5530CC24FDB" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_543CA0B85154160A28B7F5530CC24FA8_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_543CA0B85154160A28B7F5530CC24FA8" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_543CA0B85154160A28B7F5530CC24FA8_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_543CA0B85154160A28B7F5530CC24FA8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Net, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_543CA0B85154160A28B7F5530CC24FA8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_543CA0B85154160A28B7F5530CC24FA8" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_543CA0B85154160A28B7F5530CC24FA8" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_0012872FCD60A14C37013F3C374FC74A_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_0012872FCD60A14C37013F3C374FC74A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of cash paid</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_0012872FCD60A14C37013F3C374FC74A_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_0012872FCD60A14C37013F3C374FC74A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_0012872FCD60A14C37013F3C374FC74A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross_0012872FCD60A14C37013F3C374FC74A" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross_0012872FCD60A14C37013F3C374FC74A" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_41E5B83E1AAAB86D1CC63F3C3750C06A_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_41E5B83E1AAAB86D1CC63F3C3750C06A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of contingent purchase consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_41E5B83E1AAAB86D1CC63F3C3750C06A_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_41E5B83E1AAAB86D1CC63F3C3750C06A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_41E5B83E1AAAB86D1CC63F3C3750C06A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_41E5B83E1AAAB86D1CC63F3C3750C06A" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_41E5B83E1AAAB86D1CC63F3C3750C06A" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value of tangible assets acquired:</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E7DD9D4634A461F424163F3C375015D5_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E7DD9D4634A461F424163F3C375015D5" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E7DD9D4634A461F424163F3C375015D5_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E7DD9D4634A461F424163F3C375015D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E7DD9D4634A461F424163F3C375015D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E7DD9D4634A461F424163F3C375015D5" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E7DD9D4634A461F424163F3C375015D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_78BE7819DA0674095D3F3F3C3751DC1E_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_78BE7819DA0674095D3F3F3C3751DC1E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired intangible assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_78BE7819DA0674095D3F3F3C3751DC1E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_78BE7819DA0674095D3F3F3C3751DC1E" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_78BE7819DA0674095D3F3F3C3751DC1E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_A64F149FD2173012E4E32CB808C9F089_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_A64F149FD2173012E4E32CB808C9F089" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_A64F149FD2173012E4E32CB808C9F089_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_A64F149FD2173012E4E32CB808C9F089" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_A64F149FD2173012E4E32CB808C9F089" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_A64F149FD2173012E4E32CB808C9F089" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_A64F149FD2173012E4E32CB808C9F089" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_DF6A252E86D8C73058DA2CB808C9D9E7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_DF6A252E86D8C73058DA2CB808C9D9E7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_DF6A252E86D8C73058DA2CB808C9D9E7_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_DF6A252E86D8C73058DA2CB808C9D9E7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_DF6A252E86D8C73058DA2CB808C9D9E7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_DF6A252E86D8C73058DA2CB808C9D9E7" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_DF6A252E86D8C73058DA2CB808C9D9E7" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_BAE2D87B24659FDBBE59A5A57BB60E70_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_BAE2D87B24659FDBBE59A5A57BB60E70" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_BAE2D87B24659FDBBE59A5A57BB60E70_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_BAE2D87B24659FDBBE59A5A57BB60E70" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_BAE2D87B24659FDBBE59A5A57BB60E70" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_BAE2D87B24659FDBBE59A5A57BB60E70" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_BAE2D87B24659FDBBE59A5A57BB60E70" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityComponentDomain_92B37B80CF0BACF3BA0DA5A57BBA7882_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_92B37B80CF0BACF3BA0DA5A57BBA7882" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_92B37B80CF0BACF3BA0DA5A57BBA7882_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_92B37B80CF0BACF3BA0DA5A57BBA7882" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_92B37B80CF0BACF3BA0DA5A57BBA7882" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_92B37B80CF0BACF3BA0DA5A57BBA7882" xlink:to="lab_us-gaap_EquityComponentDomain_92B37B80CF0BACF3BA0DA5A57BBA7882" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsMember_538D7B62802D531D0C06A5A5CA047025_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_538D7B62802D531D0C06A5A5CA047025" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_538D7B62802D531D0C06A5A5CA047025_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_538D7B62802D531D0C06A5A5CA047025" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_538D7B62802D531D0C06A5A5CA047025" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_538D7B62802D531D0C06A5A5CA047025" xlink:to="lab_us-gaap_RetainedEarningsMember_538D7B62802D531D0C06A5A5CA047025" xlink:type="arc" />
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_6AB7C1232E9ADC75F9A5A55DF37D9155_terseLabel_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_6AB7C1232E9ADC75F9A5A55DF37D9155" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Axis]</link:label>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_6AB7C1232E9ADC75F9A5A55DF37D9155_label_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_6AB7C1232E9ADC75F9A5A55DF37D9155" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_6AB7C1232E9ADC75F9A5A55DF37D9155" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_6AB7C1232E9ADC75F9A5A55DF37D9155" xlink:to="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_6AB7C1232E9ADC75F9A5A55DF37D9155" xlink:type="arc" />
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_8C3FC0F81597CCAF9302A55DF37D6FAA_terseLabel_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_8C3FC0F81597CCAF9302A55DF37D6FAA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Domain]</link:label>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_8C3FC0F81597CCAF9302A55DF37D6FAA_label_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_8C3FC0F81597CCAF9302A55DF37D6FAA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_8C3FC0F81597CCAF9302A55DF37D6FAA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_8C3FC0F81597CCAF9302A55DF37D6FAA" xlink:to="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_8C3FC0F81597CCAF9302A55DF37D6FAA" xlink:type="arc" />
    <link:label id="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_E37C1340C080568D2810A55DF37D36F7_terseLabel_en-US" xlink:label="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_E37C1340C080568D2810A55DF37D36F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Difference between Revenue Guidance in Effect before and after Topic 606</link:label>
    <link:label id="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_E37C1340C080568D2810A55DF37D36F7_label_en-US" xlink:label="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_E37C1340C080568D2810A55DF37D36F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Difference between Revenue Guidance in Effect before and after Topic 606 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_E37C1340C080568D2810A55DF37D36F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_E37C1340C080568D2810A55DF37D36F7" xlink:to="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_E37C1340C080568D2810A55DF37D36F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7E10B2C0414D6B34D5A3A55DF37D3168_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7E10B2C0414D6B34D5A3A55DF37D3168" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7E10B2C0414D6B34D5A3A55DF37D3168_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7E10B2C0414D6B34D5A3A55DF37D3168" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7E10B2C0414D6B34D5A3A55DF37D3168" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7E10B2C0414D6B34D5A3A55DF37D3168" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7E10B2C0414D6B34D5A3A55DF37D3168" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B" xlink:to="lab_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_A833DC93BB2C8879E7F3A55DF37EE6E2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member_A833DC93BB2C8879E7F3A55DF37EE6E2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2016-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_A833DC93BB2C8879E7F3A55DF37EE6E2_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member_A833DC93BB2C8879E7F3A55DF37EE6E2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_A833DC93BB2C8879E7F3A55DF37EE6E2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member_A833DC93BB2C8879E7F3A55DF37EE6E2" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member_A833DC93BB2C8879E7F3A55DF37EE6E2" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_FDCF61E2170CB2DA893CA55DF37E2F60_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member_FDCF61E2170CB2DA893CA55DF37E2F60" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2014-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_FDCF61E2170CB2DA893CA55DF37E2F60_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member_FDCF61E2170CB2DA893CA55DF37E2F60" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_FDCF61E2170CB2DA893CA55DF37E2F60" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member_FDCF61E2170CB2DA893CA55DF37E2F60" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member_FDCF61E2170CB2DA893CA55DF37E2F60" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_87B29D18BB1CE4751BA8A55DF37E2E2E_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_87B29D18BB1CE4751BA8A55DF37E2E2E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_87B29D18BB1CE4751BA8A55DF37E2E2E_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_87B29D18BB1CE4751BA8A55DF37E2E2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_87B29D18BB1CE4751BA8A55DF37E2E2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_87B29D18BB1CE4751BA8A55DF37E2E2E" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_87B29D18BB1CE4751BA8A55DF37E2E2E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9F227EF453AFDE9DB7AAA55DF37FF296_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9F227EF453AFDE9DB7AAA55DF37FF296" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9F227EF453AFDE9DB7AAA55DF37FF296_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9F227EF453AFDE9DB7AAA55DF37FF296" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9F227EF453AFDE9DB7AAA55DF37FF296" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9F227EF453AFDE9DB7AAA55DF37FF296" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9F227EF453AFDE9DB7AAA55DF37FF296" xlink:type="arc" />
    <link:label id="lab_ebs_CIADMMember_05749AE73651C4ADFBB8A55DF37F7944_terseLabel_en-US" xlink:label="lab_ebs_CIADMMember_05749AE73651C4ADFBB8A55DF37F7944" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CIADM</link:label>
    <link:label id="lab_ebs_CIADMMember_05749AE73651C4ADFBB8A55DF37F7944_label_en-US" xlink:label="lab_ebs_CIADMMember_05749AE73651C4ADFBB8A55DF37F7944" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CIADM [Member]</link:label>
    <link:label id="lab_ebs_CIADMMember_05749AE73651C4ADFBB8A55DF37F7944_documentation_en-US" xlink:label="lab_ebs_CIADMMember_05749AE73651C4ADFBB8A55DF37F7944" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Refers to the Center for Innovation in Advanced Development and Manufacturing contract.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_CIADMMember" xlink:label="loc_ebs_CIADMMember_05749AE73651C4ADFBB8A55DF37F7944" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_CIADMMember_05749AE73651C4ADFBB8A55DF37F7944" xlink:to="lab_ebs_CIADMMember_05749AE73651C4ADFBB8A55DF37F7944" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiability_B49AC0B090BECFEA0835A55DF37FAB2D_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_B49AC0B090BECFEA0835A55DF37FAB2D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_B49AC0B090BECFEA0835A55DF37FAB2D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_B49AC0B090BECFEA0835A55DF37FAB2D" xlink:to="lab_us-gaap_OperatingLeaseLiability_B49AC0B090BECFEA0835A55DF37FAB2D" xlink:type="arc" />
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_518BAFAD0C930EC6FF33A5A512C4AE37_terseLabel_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_518BAFAD0C930EC6FF33A5A512C4AE37" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption of new accounting standard (ASC 606), net of tax</link:label>
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_518BAFAD0C930EC6FF33A5A512C4AE37_label_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_518BAFAD0C930EC6FF33A5A512C4AE37" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Effect of New Accounting Principle in Period of Adoption</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_518BAFAD0C930EC6FF33A5A512C4AE37" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_518BAFAD0C930EC6FF33A5A512C4AE37" xlink:to="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_518BAFAD0C930EC6FF33A5A512C4AE37" xlink:type="arc" />
    <link:label id="lab_ebs_BasePeriod_524E979B93CDB5DDE356A55DF380E080_terseLabel_en-US" xlink:label="lab_ebs_BasePeriod_524E979B93CDB5DDE356A55DF380E080" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Base period</link:label>
    <link:label id="lab_ebs_BasePeriod_524E979B93CDB5DDE356A55DF380E080_label_en-US" xlink:label="lab_ebs_BasePeriod_524E979B93CDB5DDE356A55DF380E080" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Base Period</link:label>
    <link:label id="lab_ebs_BasePeriod_524E979B93CDB5DDE356A55DF380E080_documentation_en-US" xlink:label="lab_ebs_BasePeriod_524E979B93CDB5DDE356A55DF380E080" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Refers to the base period of contract term.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BasePeriod" xlink:label="loc_ebs_BasePeriod_524E979B93CDB5DDE356A55DF380E080" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_BasePeriod_524E979B93CDB5DDE356A55DF380E080" xlink:to="lab_ebs_BasePeriod_524E979B93CDB5DDE356A55DF380E080" xlink:type="arc" />
    <link:label id="lab_ebs_TermofContract_BD16CA57F812937B996DA55DF3801417_terseLabel_en-US" xlink:label="lab_ebs_TermofContract_BD16CA57F812937B996DA55DF3801417" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of contract</link:label>
    <link:label id="lab_ebs_TermofContract_BD16CA57F812937B996DA55DF3801417_label_en-US" xlink:label="lab_ebs_TermofContract_BD16CA57F812937B996DA55DF3801417" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term of Contract</link:label>
    <link:label id="lab_ebs_TermofContract_BD16CA57F812937B996DA55DF3801417_documentation_en-US" xlink:label="lab_ebs_TermofContract_BD16CA57F812937B996DA55DF3801417" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Refers to the term of contract with BARDA.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TermofContract" xlink:label="loc_ebs_TermofContract_BD16CA57F812937B996DA55DF3801417" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_TermofContract_BD16CA57F812937B996DA55DF3801417" xlink:to="lab_ebs_TermofContract_BD16CA57F812937B996DA55DF3801417" xlink:type="arc" />
    <link:label id="lab_ebs_NumberofAdditionalOptionPeriods_09E0DDEBFA9E0F87E5CFA55DF380564B_terseLabel_en-US" xlink:label="lab_ebs_NumberofAdditionalOptionPeriods_09E0DDEBFA9E0F87E5CFA55DF380564B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of additional option periods</link:label>
    <link:label id="lab_ebs_NumberofAdditionalOptionPeriods_09E0DDEBFA9E0F87E5CFA55DF380564B_label_en-US" xlink:label="lab_ebs_NumberofAdditionalOptionPeriods_09E0DDEBFA9E0F87E5CFA55DF380564B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Additional Option Periods</link:label>
    <link:label id="lab_ebs_NumberofAdditionalOptionPeriods_09E0DDEBFA9E0F87E5CFA55DF380564B_documentation_en-US" xlink:label="lab_ebs_NumberofAdditionalOptionPeriods_09E0DDEBFA9E0F87E5CFA55DF380564B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Refers to the number of additional option periods.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberofAdditionalOptionPeriods" xlink:label="loc_ebs_NumberofAdditionalOptionPeriods_09E0DDEBFA9E0F87E5CFA55DF380564B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_NumberofAdditionalOptionPeriods_09E0DDEBFA9E0F87E5CFA55DF380564B" xlink:to="lab_ebs_NumberofAdditionalOptionPeriods_09E0DDEBFA9E0F87E5CFA55DF380564B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_CBFC8D04E76B1AF370BFA55DF3800526_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability_CBFC8D04E76B1AF370BFA55DF3800526" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_CBFC8D04E76B1AF370BFA55DF3800526_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability_CBFC8D04E76B1AF370BFA55DF3800526" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_CBFC8D04E76B1AF370BFA55DF3800526" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability_CBFC8D04E76B1AF370BFA55DF3800526" xlink:to="lab_us-gaap_ContractWithCustomerLiability_CBFC8D04E76B1AF370BFA55DF3800526" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_642469FF312DA92F9C8EA55DF380B41C_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet_642469FF312DA92F9C8EA55DF380B41C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_642469FF312DA92F9C8EA55DF380B41C_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet_642469FF312DA92F9C8EA55DF380B41C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_642469FF312DA92F9C8EA55DF380B41C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_642469FF312DA92F9C8EA55DF380B41C" xlink:to="lab_us-gaap_DeferredTaxAssetsNet_642469FF312DA92F9C8EA55DF380B41C" xlink:type="arc" />
    <link:label id="lab_us-gaap_PensionExpense_73949FB6D3216DFD6DD95E02A7D6A133_terseLabel_en-US" xlink:label="lab_us-gaap_PensionExpense_73949FB6D3216DFD6DD95E02A7D6A133" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension expense</link:label>
    <link:label id="lab_us-gaap_PensionExpense_73949FB6D3216DFD6DD95E02A7D6A133_label_en-US" xlink:label="lab_us-gaap_PensionExpense_73949FB6D3216DFD6DD95E02A7D6A133" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Cost (Reversal of Cost)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PensionExpense" xlink:label="loc_us-gaap_PensionExpense_73949FB6D3216DFD6DD95E02A7D6A133" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionExpense_73949FB6D3216DFD6DD95E02A7D6A133" xlink:to="lab_us-gaap_PensionExpense_73949FB6D3216DFD6DD95E02A7D6A133" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_085AAD9D3A254DF70D655E02A7D6FCDC_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_085AAD9D3A254DF70D655E02A7D6FCDC" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Fair value of plan assets, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_085AAD9D3A254DF70D655E02A7D6FCDC_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_085AAD9D3A254DF70D655E02A7D6FCDC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_085AAD9D3A254DF70D655E02A7D6FCDC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_085AAD9D3A254DF70D655E02A7D6FCDC" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_085AAD9D3A254DF70D655E02A7D6FCDC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_9A34BA0FA183DFB2D6C85E02A7D6E893_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_9A34BA0FA183DFB2D6C85E02A7D6E893" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_9A34BA0FA183DFB2D6C85E02A7D6E893_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_9A34BA0FA183DFB2D6C85E02A7D6E893" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Business Combination</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_9A34BA0FA183DFB2D6C85E02A7D6E893" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_9A34BA0FA183DFB2D6C85E02A7D6E893" xlink:to="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_9A34BA0FA183DFB2D6C85E02A7D6E893" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_310711306FBC38B3100F5E02A7D70C7D_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_310711306FBC38B3100F5E02A7D70C7D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_310711306FBC38B3100F5E02A7D70C7D_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_310711306FBC38B3100F5E02A7D70C7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_310711306FBC38B3100F5E02A7D70C7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_310711306FBC38B3100F5E02A7D70C7D" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_310711306FBC38B3100F5E02A7D70C7D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_BB03B70EC6DA8EB800805E02A7D7404A_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_BB03B70EC6DA8EB800805E02A7D7404A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_BB03B70EC6DA8EB800805E02A7D7404A_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_BB03B70EC6DA8EB800805E02A7D7404A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_BB03B70EC6DA8EB800805E02A7D7404A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_BB03B70EC6DA8EB800805E02A7D7404A" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_BB03B70EC6DA8EB800805E02A7D7404A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_085F710AB51FDEECA6D55E02A7D76A12_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_085F710AB51FDEECA6D55E02A7D76A12" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net benefits received (paid)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_085F710AB51FDEECA6D55E02A7D76A12_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_085F710AB51FDEECA6D55E02A7D76A12" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_085F710AB51FDEECA6D55E02A7D76A12" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_085F710AB51FDEECA6D55E02A7D76A12" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_085F710AB51FDEECA6D55E02A7D76A12" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_CD88AA467BDC9E8ED8685E02A7D733CB_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_CD88AA467BDC9E8ED8685E02A7D733CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_CD88AA467BDC9E8ED8685E02A7D733CB_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_CD88AA467BDC9E8ED8685E02A7D733CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_CD88AA467BDC9E8ED8685E02A7D733CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_CD88AA467BDC9E8ED8685E02A7D733CB" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_CD88AA467BDC9E8ED8685E02A7D733CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3C0648645EE35BC4CA4E5E02A7D7019A_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3C0648645EE35BC4CA4E5E02A7D7019A" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3C0648645EE35BC4CA4E5E02A7D7019A_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3C0648645EE35BC4CA4E5E02A7D7019A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3C0648645EE35BC4CA4E5E02A7D7019A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3C0648645EE35BC4CA4E5E02A7D7019A" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3C0648645EE35BC4CA4E5E02A7D7019A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_A1DF03EF2D18F665FB805E02A7DC38B8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_A1DF03EF2D18F665FB805E02A7DC38B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency impact</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_A1DF03EF2D18F665FB805E02A7DC38B8_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_A1DF03EF2D18F665FB805E02A7DC38B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_A1DF03EF2D18F665FB805E02A7DC38B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_A1DF03EF2D18F665FB805E02A7DC38B8" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_A1DF03EF2D18F665FB805E02A7DC38B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_BDC6588D1C69EB7D7A155E02A7DD1E5C_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_BDC6588D1C69EB7D7A155E02A7DD1E5C" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Fair value of plan assets, end of year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_BDC6588D1C69EB7D7A155E02A7DD1E5C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_BDC6588D1C69EB7D7A155E02A7DD1E5C" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_BDC6588D1C69EB7D7A155E02A7DD1E5C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_15A7B56D32AA809BA4E25E02A7DDB298_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation_15A7B56D32AA809BA4E25E02A7DDB298" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Projected benefit obligation, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_15A7B56D32AA809BA4E25E02A7DDB298_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation_15A7B56D32AA809BA4E25E02A7DDB298" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_15A7B56D32AA809BA4E25E02A7DDB298" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation_15A7B56D32AA809BA4E25E02A7DDB298" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation_15A7B56D32AA809BA4E25E02A7DDB298" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_4F9E7F17C492B89C038C5E02A7DD85E6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_4F9E7F17C492B89C038C5E02A7DD85E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_4F9E7F17C492B89C038C5E02A7DD85E6_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_4F9E7F17C492B89C038C5E02A7DD85E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Business Combination</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_4F9E7F17C492B89C038C5E02A7DD85E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_4F9E7F17C492B89C038C5E02A7DD85E6" xlink:to="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_4F9E7F17C492B89C038C5E02A7DD85E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_E743C40DC965C8CAB7575E02A7DD4033_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost_E743C40DC965C8CAB7575E02A7DD4033" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_E743C40DC965C8CAB7575E02A7DD4033_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost_E743C40DC965C8CAB7575E02A7DD4033" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_E743C40DC965C8CAB7575E02A7DD4033" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost_E743C40DC965C8CAB7575E02A7DD4033" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost_E743C40DC965C8CAB7575E02A7DD4033" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_8D339C6E9D2C36A5BD105E02A7DEA466_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost_8D339C6E9D2C36A5BD105E02A7DEA466" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_8D339C6E9D2C36A5BD105E02A7DEA466_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost_8D339C6E9D2C36A5BD105E02A7DEA466" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_8D339C6E9D2C36A5BD105E02A7DEA466" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost_8D339C6E9D2C36A5BD105E02A7DEA466" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost_8D339C6E9D2C36A5BD105E02A7DEA466" xlink:type="arc" />
    <link:label id="lab_ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee_9CE81CAB55661B2EC5655E02A7DECF97_terseLabel_en-US" xlink:label="lab_ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee_9CE81CAB55661B2EC5655E02A7DECF97" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee contributions</link:label>
    <link:label id="lab_ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee_9CE81CAB55661B2EC5655E02A7DECF97_label_en-US" xlink:label="lab_ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee_9CE81CAB55661B2EC5655E02A7DECF97" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employee</link:label>
    <link:label id="lab_ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee_9CE81CAB55661B2EC5655E02A7DECF97_documentation_en-US" xlink:label="lab_ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee_9CE81CAB55661B2EC5655E02A7DECF97" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of contribution received by defined benefit plan from employee which increases plan assets.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee" xlink:label="loc_ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee_9CE81CAB55661B2EC5655E02A7DECF97" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee_9CE81CAB55661B2EC5655E02A7DECF97" xlink:to="lab_ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee_9CE81CAB55661B2EC5655E02A7DECF97" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_3A0A919EC7CA1FA8C1D65E02A7DE8A4B_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_3A0A919EC7CA1FA8C1D65E02A7DE8A4B" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_3A0A919EC7CA1FA8C1D65E02A7DE8A4B_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_3A0A919EC7CA1FA8C1D65E02A7DE8A4B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_3A0A919EC7CA1FA8C1D65E02A7DE8A4B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_3A0A919EC7CA1FA8C1D65E02A7DE8A4B" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_3A0A919EC7CA1FA8C1D65E02A7DE8A4B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_C81A4254557B0A1E8A0E5E02A7DEF9AB_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_C81A4254557B0A1E8A0E5E02A7DEF9AB" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net benefits received (paid)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_C81A4254557B0A1E8A0E5E02A7DEF9AB_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_C81A4254557B0A1E8A0E5E02A7DEF9AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_C81A4254557B0A1E8A0E5E02A7DEF9AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_C81A4254557B0A1E8A0E5E02A7DEF9AB" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_C81A4254557B0A1E8A0E5E02A7DEF9AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_A03A1F4B429806005C535E02A7DE0126_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments_A03A1F4B429806005C535E02A7DE0126" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan amendment</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_A03A1F4B429806005C535E02A7DE0126_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments_A03A1F4B429806005C535E02A7DE0126" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_A03A1F4B429806005C535E02A7DE0126" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendments_A03A1F4B429806005C535E02A7DE0126" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAmendments_A03A1F4B429806005C535E02A7DE0126" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_448EB5A7217A8C3B6CE65E02A7DE8552_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_448EB5A7217A8C3B6CE65E02A7DE8552" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_448EB5A7217A8C3B6CE65E02A7DE8552_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_448EB5A7217A8C3B6CE65E02A7DE8552" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_448EB5A7217A8C3B6CE65E02A7DE8552" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_448EB5A7217A8C3B6CE65E02A7DE8552" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_448EB5A7217A8C3B6CE65E02A7DE8552" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_CFE1D2DDAF86C8AB17265E02A7DF1E69_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_CFE1D2DDAF86C8AB17265E02A7DF1E69" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency impact</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_CFE1D2DDAF86C8AB17265E02A7DF1E69_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_CFE1D2DDAF86C8AB17265E02A7DF1E69" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_CFE1D2DDAF86C8AB17265E02A7DF1E69" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_CFE1D2DDAF86C8AB17265E02A7DF1E69" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_CFE1D2DDAF86C8AB17265E02A7DF1E69" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_C44BFA4812470272A8245E02A7DFD2DB_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation_C44BFA4812470272A8245E02A7DFD2DB" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Projected benefit obligation, end of year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_C44BFA4812470272A8245E02A7DFD2DB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation_C44BFA4812470272A8245E02A7DFD2DB" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation_C44BFA4812470272A8245E02A7DFD2DB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_77748CF607A4868BEA695E02A7DFAC4D_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_77748CF607A4868BEA695E02A7DFAC4D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Funded status, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_77748CF607A4868BEA695E02A7DFAC4D_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_77748CF607A4868BEA695E02A7DFAC4D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_77748CF607A4868BEA695E02A7DFAC4D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_77748CF607A4868BEA695E02A7DFAC4D" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_77748CF607A4868BEA695E02A7DFAC4D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_64A43B8A32515BF8D6345E02A7DF07CC_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_64A43B8A32515BF8D6345E02A7DF07CC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated benefit obligation, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_64A43B8A32515BF8D6345E02A7DF07CC_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_64A43B8A32515BF8D6345E02A7DF07CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_64A43B8A32515BF8D6345E02A7DF07CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_64A43B8A32515BF8D6345E02A7DF07CC" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_64A43B8A32515BF8D6345E02A7DF07CC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_90C8CBE4EE5C87C04D50EC8A3DD1E1AF_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_90C8CBE4EE5C87C04D50EC8A3DD1E1AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_90C8CBE4EE5C87C04D50EC8A3DD1E1AF_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_90C8CBE4EE5C87C04D50EC8A3DD1E1AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_90C8CBE4EE5C87C04D50EC8A3DD1E1AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_90C8CBE4EE5C87C04D50EC8A3DD1E1AF" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_90C8CBE4EE5C87C04D50EC8A3DD1E1AF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_447C423928950EF42AE798AA82920E7B_terseLabel_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_447C423928950EF42AE798AA82920E7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Funded Status of the Swiss Plan</link:label>
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_447C423928950EF42AE798AA82920E7B_label_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_447C423928950EF42AE798AA82920E7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_447C423928950EF42AE798AA82920E7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_447C423928950EF42AE798AA82920E7B" xlink:to="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_447C423928950EF42AE798AA82920E7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_786C77B5D789E4E2C1E498AA82923B1C_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_786C77B5D789E4E2C1E498AA82923B1C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of Net Periodic Pension Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_786C77B5D789E4E2C1E498AA82923B1C_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_786C77B5D789E4E2C1E498AA82923B1C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_786C77B5D789E4E2C1E498AA82923B1C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_786C77B5D789E4E2C1E498AA82923B1C" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_786C77B5D789E4E2C1E498AA82923B1C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_A37850F7A7DD84A3418498AA829236FB_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_A37850F7A7DD84A3418498AA829236FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Weighted Average Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_A37850F7A7DD84A3418498AA829236FB_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_A37850F7A7DD84A3418498AA829236FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Assumptions Used [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_A37850F7A7DD84A3418498AA829236FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_A37850F7A7DD84A3418498AA829236FB" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_A37850F7A7DD84A3418498AA829236FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_2BD470BE9A961DD6B3E398AA82922325_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_2BD470BE9A961DD6B3E398AA82922325" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Loss Before Income Tax</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_2BD470BE9A961DD6B3E398AA82922325_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_2BD470BE9A961DD6B3E398AA82922325" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_2BD470BE9A961DD6B3E398AA82922325" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_2BD470BE9A961DD6B3E398AA82922325" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_2BD470BE9A961DD6B3E398AA82922325" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_D266215547F9800554B698AA8292D9A3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_D266215547F9800554B698AA8292D9A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Expected Future Benefits Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_D266215547F9800554B698AA8292D9A3_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_D266215547F9800554B698AA8292D9A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_D266215547F9800554B698AA8292D9A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_D266215547F9800554B698AA8292D9A3" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_D266215547F9800554B698AA8292D9A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_2C21945828E7C0D2B7B3CCD36FDE2DA1_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_2C21945828E7C0D2B7B3CCD36FDE2DA1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_2C21945828E7C0D2B7B3CCD36FDE2DA1_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_2C21945828E7C0D2B7B3CCD36FDE2DA1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_2C21945828E7C0D2B7B3CCD36FDE2DA1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_2C21945828E7C0D2B7B3CCD36FDE2DA1" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_2C21945828E7C0D2B7B3CCD36FDE2DA1" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_F0B893AEC310F21F0795F5678070DA1B_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract_F0B893AEC310F21F0795F5678070DA1B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_F0B893AEC310F21F0795F5678070DA1B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_F0B893AEC310F21F0795F5678070DA1B" xlink:to="lab_us-gaap_InventoryDisclosureAbstract_F0B893AEC310F21F0795F5678070DA1B" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_B53EC1FE0A5202E5E0DBF5678070D7D3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_B53EC1FE0A5202E5E0DBF5678070D7D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raw materials and supplies</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_B53EC1FE0A5202E5E0DBF5678070D7D3_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_B53EC1FE0A5202E5E0DBF5678070D7D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_B53EC1FE0A5202E5E0DBF5678070D7D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_B53EC1FE0A5202E5E0DBF5678070D7D3" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_B53EC1FE0A5202E5E0DBF5678070D7D3" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_92AC21929B6AB8BB0499F5678071189F_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves_92AC21929B6AB8BB0499F5678071189F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_92AC21929B6AB8BB0499F5678071189F_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves_92AC21929B6AB8BB0499F5678071189F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_92AC21929B6AB8BB0499F5678071189F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves_92AC21929B6AB8BB0499F5678071189F" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves_92AC21929B6AB8BB0499F5678071189F" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_0C691F4C21BB8A62EDBAF56780718CB7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_0C691F4C21BB8A62EDBAF56780718CB7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_0C691F4C21BB8A62EDBAF56780718CB7_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_0C691F4C21BB8A62EDBAF56780718CB7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0C691F4C21BB8A62EDBAF56780718CB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0C691F4C21BB8A62EDBAF56780718CB7" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_0C691F4C21BB8A62EDBAF56780718CB7" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_A551AB3FCB9D5D3E1123F5678071E9CD_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_A551AB3FCB9D5D3E1123F5678071E9CD" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_A551AB3FCB9D5D3E1123F5678071E9CD_label_en-US" xlink:label="lab_us-gaap_InventoryNet_A551AB3FCB9D5D3E1123F5678071E9CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_A551AB3FCB9D5D3E1123F5678071E9CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_A551AB3FCB9D5D3E1123F5678071E9CD" xlink:to="lab_us-gaap_InventoryNet_A551AB3FCB9D5D3E1123F5678071E9CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_D1C07F90B51F07F01F53688F601593FB_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_D1C07F90B51F07F01F53688F601593FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_D1C07F90B51F07F01F53688F601593FB_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_D1C07F90B51F07F01F53688F601593FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_D1C07F90B51F07F01F53688F601593FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_D1C07F90B51F07F01F53688F601593FB" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_D1C07F90B51F07F01F53688F601593FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_54E6B224DB28B426FA7E688F6015F575_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_54E6B224DB28B426FA7E688F6015F575" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Pension Plan</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_54E6B224DB28B426FA7E688F6015F575_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_54E6B224DB28B426FA7E688F6015F575" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_54E6B224DB28B426FA7E688F6015F575" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_54E6B224DB28B426FA7E688F6015F575" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_54E6B224DB28B426FA7E688F6015F575" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_6735A278CCDF57505FC4688F60155497_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_6735A278CCDF57505FC4688F60155497" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_6735A278CCDF57505FC4688F60155497_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_6735A278CCDF57505FC4688F60155497" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_6735A278CCDF57505FC4688F60155497" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_6735A278CCDF57505FC4688F60155497" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_6735A278CCDF57505FC4688F60155497" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_B3C605000BF6406D2355688F60152747_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_B3C605000BF6406D2355688F60152747" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_B3C605000BF6406D2355688F60152747_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_B3C605000BF6406D2355688F60152747" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_B3C605000BF6406D2355688F60152747" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_B3C605000BF6406D2355688F60152747" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_B3C605000BF6406D2355688F60152747" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_DC2669E6DEFC60BA42A3688F601590FD_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember_DC2669E6DEFC60BA42A3688F601590FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Translation Losses</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_DC2669E6DEFC60BA42A3688F601590FD_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember_DC2669E6DEFC60BA42A3688F601590FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_DC2669E6DEFC60BA42A3688F601590FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember_DC2669E6DEFC60BA42A3688F601590FD" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember_DC2669E6DEFC60BA42A3688F601590FD" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C515D1F65F269428CF2688F6015CF91_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C515D1F65F269428CF2688F6015CF91" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C515D1F65F269428CF2688F6015CF91_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C515D1F65F269428CF2688F6015CF91" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C515D1F65F269428CF2688F6015CF91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C515D1F65F269428CF2688F6015CF91" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C515D1F65F269428CF2688F6015CF91" xlink:type="arc" />
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_87E15AFD9D2FDAC9CEA8689219CE3210_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_87E15AFD9D2FDAC9CEA8689219CE3210" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_87E15AFD9D2FDAC9CEA8689219CE3210_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity_87E15AFD9D2FDAC9CEA8689219CE3210" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_87E15AFD9D2FDAC9CEA8689219CE3210" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_87E15AFD9D2FDAC9CEA8689219CE3210" xlink:to="lab_us-gaap_StockholdersEquity_87E15AFD9D2FDAC9CEA8689219CE3210" xlink:type="arc" />
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_B3D0B89DC91662B398DF689219CEABAA_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_B3D0B89DC91662B398DF689219CEABAA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_B3D0B89DC91662B398DF689219CEABAA_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_B3D0B89DC91662B398DF689219CEABAA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_B3D0B89DC91662B398DF689219CEABAA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_B3D0B89DC91662B398DF689219CEABAA" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_B3D0B89DC91662B398DF689219CEABAA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8DE36AD3687AA970646A689219CE52D0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8DE36AD3687AA970646A689219CE52D0" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8DE36AD3687AA970646A689219CE52D0_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8DE36AD3687AA970646A689219CE52D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8DE36AD3687AA970646A689219CE52D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8DE36AD3687AA970646A689219CE52D0" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_8DE36AD3687AA970646A689219CE52D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_15A565B8126D7C8FD7A4689219CEE0C2_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_15A565B8126D7C8FD7A4689219CEE0C2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_15A565B8126D7C8FD7A4689219CEE0C2_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_15A565B8126D7C8FD7A4689219CEE0C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_15A565B8126D7C8FD7A4689219CEE0C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_15A565B8126D7C8FD7A4689219CEE0C2" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_15A565B8126D7C8FD7A4689219CEE0C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_BCBF85F3CA417416B2F9689219CE358C_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_BCBF85F3CA417416B2F9689219CE358C" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_BCBF85F3CA417416B2F9689219CE358C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_BCBF85F3CA417416B2F9689219CE358C" xlink:to="lab_us-gaap_StockholdersEquity_BCBF85F3CA417416B2F9689219CE358C" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_87A251EEA786BB87ECA54B4814BB0C65_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable_87A251EEA786BB87ECA54B4814BB0C65" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_87A251EEA786BB87ECA54B4814BB0C65_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable_87A251EEA786BB87ECA54B4814BB0C65" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_87A251EEA786BB87ECA54B4814BB0C65" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_87A251EEA786BB87ECA54B4814BB0C65" xlink:to="lab_us-gaap_TaxCreditCarryforwardTable_87A251EEA786BB87ECA54B4814BB0C65" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_C6FBDD6DE9F69B1EA3D34B4814BB9A8C_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_C6FBDD6DE9F69B1EA3D34B4814BB9A8C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_C6FBDD6DE9F69B1EA3D34B4814BB9A8C_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_C6FBDD6DE9F69B1EA3D34B4814BB9A8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_C6FBDD6DE9F69B1EA3D34B4814BB9A8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_C6FBDD6DE9F69B1EA3D34B4814BB9A8C" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis_C6FBDD6DE9F69B1EA3D34B4814BB9A8C" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984" xlink:type="arc" />
    <link:label id="lab_us-gaap_DomesticCountryMember_711852B6DDD2933244794B4814BBA980_verboseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember_711852B6DDD2933244794B4814BBA980" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_711852B6DDD2933244794B4814BBA980_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember_711852B6DDD2933244794B4814BBA980" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_711852B6DDD2933244794B4814BBA980" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember_711852B6DDD2933244794B4814BBA980" xlink:to="lab_us-gaap_DomesticCountryMember_711852B6DDD2933244794B4814BBA980" xlink:type="arc" />
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_0CBFE598D4E9A1F140634B4814BB2B6A_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_0CBFE598D4E9A1F140634B4814BB2B6A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_0CBFE598D4E9A1F140634B4814BB2B6A_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_0CBFE598D4E9A1F140634B4814BB2B6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_0CBFE598D4E9A1F140634B4814BB2B6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember_0CBFE598D4E9A1F140634B4814BB2B6A" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember_0CBFE598D4E9A1F140634B4814BB2B6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="lab_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_09DFDBE0236FDFD57BFA4B4814BBECCB_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_09DFDBE0236FDFD57BFA4B4814BBECCB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal losses carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_09DFDBE0236FDFD57BFA4B4814BBECCB_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_09DFDBE0236FDFD57BFA4B4814BBECCB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_09DFDBE0236FDFD57BFA4B4814BBECCB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_09DFDBE0236FDFD57BFA4B4814BBECCB" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_09DFDBE0236FDFD57BFA4B4814BBECCB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_93AF71A861741DE8F7C64B4814BB26E4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_93AF71A861741DE8F7C64B4814BB26E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State losses carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_93AF71A861741DE8F7C64B4814BB26E4_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_93AF71A861741DE8F7C64B4814BB26E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_93AF71A861741DE8F7C64B4814BB26E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_93AF71A861741DE8F7C64B4814BB26E4" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_93AF71A861741DE8F7C64B4814BB26E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_104FBE2C69FE303A6DB74B4814BBC685_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_104FBE2C69FE303A6DB74B4814BBC685" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_104FBE2C69FE303A6DB74B4814BBC685_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_104FBE2C69FE303A6DB74B4814BBC685" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_104FBE2C69FE303A6DB74B4814BBC685" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_104FBE2C69FE303A6DB74B4814BBC685" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_104FBE2C69FE303A6DB74B4814BBC685" xlink:type="arc" />
    <link:label id="lab_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment_BC0F6806D389395CDF794B4814BB15A1_terseLabel_en-US" xlink:label="lab_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment_BC0F6806D389395CDF794B4814BB15A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scientific research and experimental development credit carryforward</link:label>
    <link:label id="lab_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment_BC0F6806D389395CDF794B4814BB15A1_label_en-US" xlink:label="lab_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment_BC0F6806D389395CDF794B4814BB15A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Scientific Research and Experimental Development</link:label>
    <link:label id="lab_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment_BC0F6806D389395CDF794B4814BB15A1_documentation_en-US" xlink:label="lab_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment_BC0F6806D389395CDF794B4814BB15A1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible scientific research and experimental development tax credit carryforwards.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment" xlink:label="loc_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment_BC0F6806D389395CDF794B4814BB15A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment_BC0F6806D389395CDF794B4814BB15A1" xlink:to="lab_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment_BC0F6806D389395CDF794B4814BB15A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_B1FDCBFE27C38EB8E6C14B4814BBE177_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_B1FDCBFE27C38EB8E6C14B4814BBE177" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_B1FDCBFE27C38EB8E6C14B4814BBE177_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_B1FDCBFE27C38EB8E6C14B4814BBE177" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_B1FDCBFE27C38EB8E6C14B4814BBE177" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_B1FDCBFE27C38EB8E6C14B4814BBE177" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_B1FDCBFE27C38EB8E6C14B4814BBE177" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_8A901592CABC2A1DC9484B4814BBFAA3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_8A901592CABC2A1DC9484B4814BBFAA3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign NOLs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_8A901592CABC2A1DC9484B4814BBFAA3_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_8A901592CABC2A1DC9484B4814BBFAA3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_8A901592CABC2A1DC9484B4814BBFAA3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_8A901592CABC2A1DC9484B4814BBFAA3" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_8A901592CABC2A1DC9484B4814BBFAA3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_AD107A2EB20F634F4D594B4814BB8CAE_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome_AD107A2EB20F634F4D594B4814BB8CAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_AD107A2EB20F634F4D594B4814BB8CAE_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome_AD107A2EB20F634F4D594B4814BB8CAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_AD107A2EB20F634F4D594B4814BB8CAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsDeferredIncome_AD107A2EB20F634F4D594B4814BB8CAE" xlink:to="lab_us-gaap_DeferredTaxAssetsDeferredIncome_AD107A2EB20F634F4D594B4814BB8CAE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_014BF48470426E9EF3314B4814BB3D12_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory_014BF48470426E9EF3314B4814BB3D12" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_014BF48470426E9EF3314B4814BB3D12_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory_014BF48470426E9EF3314B4814BB3D12" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_014BF48470426E9EF3314B4814BB3D12" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory_014BF48470426E9EF3314B4814BB3D12" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory_014BF48470426E9EF3314B4814BB3D12" xlink:type="arc" />
    <link:label id="lab_ebs_DeferredTaxAssetsOperatingLeaseLiability_F9B49AE71E37E618FD114B4814BB5E82_terseLabel_en-US" xlink:label="lab_ebs_DeferredTaxAssetsOperatingLeaseLiability_F9B49AE71E37E618FD114B4814BB5E82" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_ebs_DeferredTaxAssetsOperatingLeaseLiability_F9B49AE71E37E618FD114B4814BB5E82_label_en-US" xlink:label="lab_ebs_DeferredTaxAssetsOperatingLeaseLiability_F9B49AE71E37E618FD114B4814BB5E82" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:label id="lab_ebs_DeferredTaxAssetsOperatingLeaseLiability_F9B49AE71E37E618FD114B4814BB5E82_documentation_en-US" xlink:label="lab_ebs_DeferredTaxAssetsOperatingLeaseLiability_F9B49AE71E37E618FD114B4814BB5E82" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DeferredTaxAssetsOperatingLeaseLiability" xlink:label="loc_ebs_DeferredTaxAssetsOperatingLeaseLiability_F9B49AE71E37E618FD114B4814BB5E82" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DeferredTaxAssetsOperatingLeaseLiability_F9B49AE71E37E618FD114B4814BB5E82" xlink:to="lab_ebs_DeferredTaxAssetsOperatingLeaseLiability_F9B49AE71E37E618FD114B4814BB5E82" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_6434DE5DD33225F0B8BD4B4814BB8F09_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther_6434DE5DD33225F0B8BD4B4814BB8F09" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_6434DE5DD33225F0B8BD4B4814BB8F09_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther_6434DE5DD33225F0B8BD4B4814BB8F09" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_6434DE5DD33225F0B8BD4B4814BB8F09" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther_6434DE5DD33225F0B8BD4B4814BB8F09" xlink:to="lab_us-gaap_DeferredTaxAssetsOther_6434DE5DD33225F0B8BD4B4814BB8F09" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_7028F87188D2D783C9504B4814BB5903_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_7028F87188D2D783C9504B4814BB5903" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_7028F87188D2D783C9504B4814BB5903_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_7028F87188D2D783C9504B4814BB5903" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_7028F87188D2D783C9504B4814BB5903" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7028F87188D2D783C9504B4814BB5903" xlink:to="lab_us-gaap_DeferredTaxAssetsGross_7028F87188D2D783C9504B4814BB5903" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2F50B1C3C73796EA81EE4B4814BB9040_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2F50B1C3C73796EA81EE4B4814BB9040" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Fixed assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2F50B1C3C73796EA81EE4B4814BB9040_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2F50B1C3C73796EA81EE4B4814BB9040" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2F50B1C3C73796EA81EE4B4814BB9040" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2F50B1C3C73796EA81EE4B4814BB9040" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2F50B1C3C73796EA81EE4B4814BB9040" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_E3F4E2BBD59B49DD75B44B4814BB09CC_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_E3F4E2BBD59B49DD75B44B4814BB09CC" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_E3F4E2BBD59B49DD75B44B4814BB09CC_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_E3F4E2BBD59B49DD75B44B4814BB09CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_E3F4E2BBD59B49DD75B44B4814BB09CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_E3F4E2BBD59B49DD75B44B4814BB09CC" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_E3F4E2BBD59B49DD75B44B4814BB09CC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_19890C9844CCE1C3FD224B4B39FF9C27_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_19890C9844CCE1C3FD224B4B39FF9C27" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_19890C9844CCE1C3FD224B4B39FF9C27_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_19890C9844CCE1C3FD224B4B39FF9C27" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_19890C9844CCE1C3FD224B4B39FF9C27" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_19890C9844CCE1C3FD224B4B39FF9C27" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_19890C9844CCE1C3FD224B4B39FF9C27" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_A3191D56C7C7E0C6DA054B4814BB59E0_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther_A3191D56C7C7E0C6DA054B4814BB59E0" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_A3191D56C7C7E0C6DA054B4814BB59E0_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther_A3191D56C7C7E0C6DA054B4814BB59E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_A3191D56C7C7E0C6DA054B4814BB59E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther_A3191D56C7C7E0C6DA054B4814BB59E0" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther_A3191D56C7C7E0C6DA054B4814BB59E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_76F5285D13D5EDD75FBA4B4814BBEBBF_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities_76F5285D13D5EDD75FBA4B4814BBEBBF" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_76F5285D13D5EDD75FBA4B4814BBEBBF_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities_76F5285D13D5EDD75FBA4B4814BBEBBF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_76F5285D13D5EDD75FBA4B4814BBEBBF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_76F5285D13D5EDD75FBA4B4814BBEBBF" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities_76F5285D13D5EDD75FBA4B4814BBEBBF" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_C9109A1410571082A8814B4814BBF614_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_C9109A1410571082A8814B4814BBF614" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_C9109A1410571082A8814B4814BBF614_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_C9109A1410571082A8814B4814BBF614" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_C9109A1410571082A8814B4814BBF614" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_C9109A1410571082A8814B4814BBF614" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_C9109A1410571082A8814B4814BBF614" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_B06D27E6BD2A133450954B4814BB4F7E_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities_B06D27E6BD2A133450954B4814BB4F7E" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax asset (liability)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_B06D27E6BD2A133450954B4814BB4F7E_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities_B06D27E6BD2A133450954B4814BB4F7E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_B06D27E6BD2A133450954B4814BB4F7E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities_B06D27E6BD2A133450954B4814BB4F7E" xlink:to="lab_us-gaap_DeferredTaxLiabilities_B06D27E6BD2A133450954B4814BB4F7E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_A610955688A7A2AEC831CAFC0478393A_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract_A610955688A7A2AEC831CAFC0478393A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_A610955688A7A2AEC831CAFC0478393A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract_A610955688A7A2AEC831CAFC0478393A" xlink:to="lab_us-gaap_DebtDisclosureAbstract_A610955688A7A2AEC831CAFC0478393A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityAxis_31AEF38E557016C84823CAFC047920A5_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_31AEF38E557016C84823CAFC047920A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_31AEF38E557016C84823CAFC047920A5_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_31AEF38E557016C84823CAFC047920A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_31AEF38E557016C84823CAFC047920A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis_31AEF38E557016C84823CAFC047920A5" xlink:to="lab_us-gaap_CreditFacilityAxis_31AEF38E557016C84823CAFC047920A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8" xlink:to="lab_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_2D45880B7EEB016D6331CAFC047BC2DF_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_2D45880B7EEB016D6331CAFC047BC2DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_2D45880B7EEB016D6331CAFC047BC2DF_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_2D45880B7EEB016D6331CAFC047BC2DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_2D45880B7EEB016D6331CAFC047BC2DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember_2D45880B7EEB016D6331CAFC047BC2DF" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember_2D45880B7EEB016D6331CAFC047BC2DF" xlink:type="arc" />
    <link:label id="lab_ebs_TermLoanFacilityMember_8530EA1406435A78361FCAFC047CCFAB_terseLabel_en-US" xlink:label="lab_ebs_TermLoanFacilityMember_8530EA1406435A78361FCAFC047CCFAB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_ebs_TermLoanFacilityMember_8530EA1406435A78361FCAFC047CCFAB_label_en-US" xlink:label="lab_ebs_TermLoanFacilityMember_8530EA1406435A78361FCAFC047CCFAB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_ebs_TermLoanFacilityMember_8530EA1406435A78361FCAFC047CCFAB_documentation_en-US" xlink:label="lab_ebs_TermLoanFacilityMember_8530EA1406435A78361FCAFC047CCFAB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term loan dated December 2013.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TermLoanFacilityMember" xlink:label="loc_ebs_TermLoanFacilityMember_8530EA1406435A78361FCAFC047CCFAB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_TermLoanFacilityMember_8530EA1406435A78361FCAFC047CCFAB" xlink:to="lab_ebs_TermLoanFacilityMember_8530EA1406435A78361FCAFC047CCFAB" xlink:type="arc" />
    <link:label id="lab_ebs_CreditAgreementMember_A77EAB942115FD26B666CAFC047CF395_terseLabel_en-US" xlink:label="lab_ebs_CreditAgreementMember_A77EAB942115FD26B666CAFC047CF395" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_ebs_CreditAgreementMember_A77EAB942115FD26B666CAFC047CF395_label_en-US" xlink:label="lab_ebs_CreditAgreementMember_A77EAB942115FD26B666CAFC047CF395" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_ebs_CreditAgreementMember_A77EAB942115FD26B666CAFC047CF395_documentation_en-US" xlink:label="lab_ebs_CreditAgreementMember_A77EAB942115FD26B666CAFC047CF395" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Credit agreement dated September 2017.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_CreditAgreementMember" xlink:label="loc_ebs_CreditAgreementMember_A77EAB942115FD26B666CAFC047CF395" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_CreditAgreementMember_A77EAB942115FD26B666CAFC047CF395" xlink:to="lab_ebs_CreditAgreementMember_A77EAB942115FD26B666CAFC047CF395" xlink:type="arc" />
    <link:label id="lab_ebs_AmendedCreditAgreementMember_6771FBDC1E3E83A57840CAFC047C152E_terseLabel_en-US" xlink:label="lab_ebs_AmendedCreditAgreementMember_6771FBDC1E3E83A57840CAFC047C152E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amended Credit Agreement</link:label>
    <link:label id="lab_ebs_AmendedCreditAgreementMember_6771FBDC1E3E83A57840CAFC047C152E_label_en-US" xlink:label="lab_ebs_AmendedCreditAgreementMember_6771FBDC1E3E83A57840CAFC047C152E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amended Credit Agreement [Member]</link:label>
    <link:label id="lab_ebs_AmendedCreditAgreementMember_6771FBDC1E3E83A57840CAFC047C152E_documentation_en-US" xlink:label="lab_ebs_AmendedCreditAgreementMember_6771FBDC1E3E83A57840CAFC047C152E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amended credit agreement dated October 15, 2018.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmendedCreditAgreementMember" xlink:label="loc_ebs_AmendedCreditAgreementMember_6771FBDC1E3E83A57840CAFC047C152E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_AmendedCreditAgreementMember_6771FBDC1E3E83A57840CAFC047C152E" xlink:to="lab_ebs_AmendedCreditAgreementMember_6771FBDC1E3E83A57840CAFC047C152E" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableRateAxis_179DE93828794C3B1198CAFC047D66BA_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis_179DE93828794C3B1198CAFC047D66BA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_179DE93828794C3B1198CAFC047D66BA_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis_179DE93828794C3B1198CAFC047D66BA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_179DE93828794C3B1198CAFC047D66BA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis_179DE93828794C3B1198CAFC047D66BA" xlink:to="lab_us-gaap_VariableRateAxis_179DE93828794C3B1198CAFC047D66BA" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A" xlink:to="lab_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_43778BF338B232E545D1CAFC047D4729_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember_43778BF338B232E545D1CAFC047D4729" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal Funds Rate</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_43778BF338B232E545D1CAFC047D4729_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember_43778BF338B232E545D1CAFC047D4729" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Federal Funds Effective Swap Rate [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_43778BF338B232E545D1CAFC047D4729" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember_43778BF338B232E545D1CAFC047D4729" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember_43778BF338B232E545D1CAFC047D4729" xlink:type="arc" />
    <link:label id="lab_us-gaap_EurodollarMember_DAD68CEE51F61ECF5CB3CAFC047D293D_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember_DAD68CEE51F61ECF5CB3CAFC047D293D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Eurodollar</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_DAD68CEE51F61ECF5CB3CAFC047D293D_label_en-US" xlink:label="lab_us-gaap_EurodollarMember_DAD68CEE51F61ECF5CB3CAFC047D293D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_DAD68CEE51F61ECF5CB3CAFC047D293D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember_DAD68CEE51F61ECF5CB3CAFC047D293D" xlink:to="lab_us-gaap_EurodollarMember_DAD68CEE51F61ECF5CB3CAFC047D293D" xlink:type="arc" />
    <link:label id="lab_us-gaap_BaseRateMember_E2DC69E842E8B7AD7C4CCAFC047D90C4_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember_E2DC69E842E8B7AD7C4CCAFC047D90C4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_E2DC69E842E8B7AD7C4CCAFC047D90C4_label_en-US" xlink:label="lab_us-gaap_BaseRateMember_E2DC69E842E8B7AD7C4CCAFC047D90C4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_E2DC69E842E8B7AD7C4CCAFC047D90C4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember_E2DC69E842E8B7AD7C4CCAFC047D90C4" xlink:to="lab_us-gaap_BaseRateMember_E2DC69E842E8B7AD7C4CCAFC047D90C4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="lab_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:type="arc" />
    <link:label id="lab_ebs_NumberOfLendingInstitutions_93320350272D92778C70CAFC047F6A3C_terseLabel_en-US" xlink:label="lab_ebs_NumberOfLendingInstitutions_93320350272D92778C70CAFC047F6A3C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of lending institutions</link:label>
    <link:label id="lab_ebs_NumberOfLendingInstitutions_93320350272D92778C70CAFC047F6A3C_label_en-US" xlink:label="lab_ebs_NumberOfLendingInstitutions_93320350272D92778C70CAFC047F6A3C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Lending Institutions</link:label>
    <link:label id="lab_ebs_NumberOfLendingInstitutions_93320350272D92778C70CAFC047F6A3C_documentation_en-US" xlink:label="lab_ebs_NumberOfLendingInstitutions_93320350272D92778C70CAFC047F6A3C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of lending institutions in which the entity has a credit facility.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberOfLendingInstitutions" xlink:label="loc_ebs_NumberOfLendingInstitutions_93320350272D92778C70CAFC047F6A3C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_NumberOfLendingInstitutions_93320350272D92778C70CAFC047F6A3C" xlink:to="lab_ebs_NumberOfLendingInstitutions_93320350272D92778C70CAFC047F6A3C" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_FADDE567C96DCD7AE4D7CAFC047FD7B3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_FADDE567C96DCD7AE4D7CAFC047FD7B3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_FADDE567C96DCD7AE4D7CAFC047FD7B3_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_FADDE567C96DCD7AE4D7CAFC047FD7B3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_FADDE567C96DCD7AE4D7CAFC047FD7B3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_FADDE567C96DCD7AE4D7CAFC047FD7B3" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_FADDE567C96DCD7AE4D7CAFC047FD7B3" xlink:type="arc" />
    <link:label id="lab_ebs_ConsolidatedSecuredNetLeverageRatio_C5AD19B1528BC438EAE3CAFC047F8521_terseLabel_en-US" xlink:label="lab_ebs_ConsolidatedSecuredNetLeverageRatio_C5AD19B1528BC438EAE3CAFC047F8521" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net leverage ratio</link:label>
    <link:label id="lab_ebs_ConsolidatedSecuredNetLeverageRatio_C5AD19B1528BC438EAE3CAFC047F8521_label_en-US" xlink:label="lab_ebs_ConsolidatedSecuredNetLeverageRatio_C5AD19B1528BC438EAE3CAFC047F8521" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Secured, Net Leverage Ratio</link:label>
    <link:label id="lab_ebs_ConsolidatedSecuredNetLeverageRatio_C5AD19B1528BC438EAE3CAFC047F8521_documentation_en-US" xlink:label="lab_ebs_ConsolidatedSecuredNetLeverageRatio_C5AD19B1528BC438EAE3CAFC047F8521" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum consolidated net leverage ratio required to be maintained under a debt covenant agreement.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ConsolidatedSecuredNetLeverageRatio" xlink:label="loc_ebs_ConsolidatedSecuredNetLeverageRatio_C5AD19B1528BC438EAE3CAFC047F8521" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ConsolidatedSecuredNetLeverageRatio_C5AD19B1528BC438EAE3CAFC047F8521" xlink:to="lab_ebs_ConsolidatedSecuredNetLeverageRatio_C5AD19B1528BC438EAE3CAFC047F8521" xlink:type="arc" />
    <link:label id="lab_ebs_AmountRequiredForNetLeverageRatio_8AD94C6847D2851A946ECAFC047F6543_terseLabel_en-US" xlink:label="lab_ebs_AmountRequiredForNetLeverageRatio_8AD94C6847D2851A946ECAFC047F6543" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount required for net leverage ratio</link:label>
    <link:label id="lab_ebs_AmountRequiredForNetLeverageRatio_8AD94C6847D2851A946ECAFC047F6543_label_en-US" xlink:label="lab_ebs_AmountRequiredForNetLeverageRatio_8AD94C6847D2851A946ECAFC047F6543" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount Required for Net Leverage Ratio</link:label>
    <link:label id="lab_ebs_AmountRequiredForNetLeverageRatio_8AD94C6847D2851A946ECAFC047F6543_documentation_en-US" xlink:label="lab_ebs_AmountRequiredForNetLeverageRatio_8AD94C6847D2851A946ECAFC047F6543" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of leverage ratio required to be maintained under a debt covenant agreement.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmountRequiredForNetLeverageRatio" xlink:label="loc_ebs_AmountRequiredForNetLeverageRatio_8AD94C6847D2851A946ECAFC047F6543" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_AmountRequiredForNetLeverageRatio_8AD94C6847D2851A946ECAFC047F6543" xlink:to="lab_ebs_AmountRequiredForNetLeverageRatio_8AD94C6847D2851A946ECAFC047F6543" xlink:type="arc" />
    <link:label id="lab_ebs_DebtInstrumentCovenantLeverageRatio_8C8D9A026D52AB7DCDE7CAFC047F9330_terseLabel_en-US" xlink:label="lab_ebs_DebtInstrumentCovenantLeverageRatio_8C8D9A026D52AB7DCDE7CAFC047F9330" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Covenant, leverage ratio</link:label>
    <link:label id="lab_ebs_DebtInstrumentCovenantLeverageRatio_8C8D9A026D52AB7DCDE7CAFC047F9330_label_en-US" xlink:label="lab_ebs_DebtInstrumentCovenantLeverageRatio_8C8D9A026D52AB7DCDE7CAFC047F9330" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio</link:label>
    <link:label id="lab_ebs_DebtInstrumentCovenantLeverageRatio_8C8D9A026D52AB7DCDE7CAFC047F9330_documentation_en-US" xlink:label="lab_ebs_DebtInstrumentCovenantLeverageRatio_8C8D9A026D52AB7DCDE7CAFC047F9330" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentCovenantLeverageRatio" xlink:label="loc_ebs_DebtInstrumentCovenantLeverageRatio_8C8D9A026D52AB7DCDE7CAFC047F9330" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtInstrumentCovenantLeverageRatio_8C8D9A026D52AB7DCDE7CAFC047F9330" xlink:to="lab_ebs_DebtInstrumentCovenantLeverageRatio_8C8D9A026D52AB7DCDE7CAFC047F9330" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_FFE8D11AE460032B8EEFCAFC0480EE7D_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_FFE8D11AE460032B8EEFCAFC0480EE7D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_FFE8D11AE460032B8EEFCAFC0480EE7D_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_FFE8D11AE460032B8EEFCAFC0480EE7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_FFE8D11AE460032B8EEFCAFC0480EE7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_FFE8D11AE460032B8EEFCAFC0480EE7D" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_FFE8D11AE460032B8EEFCAFC0480EE7D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCredit_9E72E384DEEABC55D698CAFC04807770_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit_9E72E384DEEABC55D698CAFC04807770" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_9E72E384DEEABC55D698CAFC04807770_label_en-US" xlink:label="lab_us-gaap_LineOfCredit_9E72E384DEEABC55D698CAFC04807770" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_9E72E384DEEABC55D698CAFC04807770" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit_9E72E384DEEABC55D698CAFC04807770" xlink:to="lab_us-gaap_LineOfCredit_9E72E384DEEABC55D698CAFC04807770" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_91ECA200A9D405CA8FF7CB3F899A83B8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_91ECA200A9D405CA8FF7CB3F899A83B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt issuance capitalized costs</link:label>
    <link:label id="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_91ECA200A9D405CA8FF7CB3F899A83B8_label_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_91ECA200A9D405CA8FF7CB3F899A83B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Issuance Costs, Line of Credit Arrangements, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_91ECA200A9D405CA8FF7CB3F899A83B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_91ECA200A9D405CA8FF7CB3F899A83B8" xlink:to="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_91ECA200A9D405CA8FF7CB3F899A83B8" xlink:type="arc" />
    <link:label id="lab_ebs_DebtInstrumentTermOfVariableRate_93F1364DE9146D07DA8CCAFC0480318E_terseLabel_en-US" xlink:label="lab_ebs_DebtInstrumentTermOfVariableRate_93F1364DE9146D07DA8CCAFC0480318E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, term of variable rate</link:label>
    <link:label id="lab_ebs_DebtInstrumentTermOfVariableRate_93F1364DE9146D07DA8CCAFC0480318E_label_en-US" xlink:label="lab_ebs_DebtInstrumentTermOfVariableRate_93F1364DE9146D07DA8CCAFC0480318E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Term of Variable Rate</link:label>
    <link:label id="lab_ebs_DebtInstrumentTermOfVariableRate_93F1364DE9146D07DA8CCAFC0480318E_documentation_en-US" xlink:label="lab_ebs_DebtInstrumentTermOfVariableRate_93F1364DE9146D07DA8CCAFC0480318E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term of the interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentTermOfVariableRate" xlink:label="loc_ebs_DebtInstrumentTermOfVariableRate_93F1364DE9146D07DA8CCAFC0480318E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtInstrumentTermOfVariableRate_93F1364DE9146D07DA8CCAFC0480318E" xlink:to="lab_ebs_DebtInstrumentTermOfVariableRate_93F1364DE9146D07DA8CCAFC0480318E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_266180886526170CAEB4CAFC0480EEED_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_266180886526170CAEB4CAFC0480EEED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_266180886526170CAEB4CAFC0480EEED_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_266180886526170CAEB4CAFC0480EEED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_266180886526170CAEB4CAFC0480EEED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_266180886526170CAEB4CAFC0480EEED" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_266180886526170CAEB4CAFC0480EEED" xlink:type="arc" />
    <link:label id="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears_0E705EAE1F881981A716CAFC0480A901_terseLabel_en-US" xlink:label="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears_0E705EAE1F881981A716CAFC0480A901" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of original principal amount required to repay in the first two years</link:label>
    <link:label id="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears_0E705EAE1F881981A716CAFC0480A901_label_en-US" xlink:label="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears_0E705EAE1F881981A716CAFC0480A901" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of Original Principal Amount Required to Repay in First Two Years</link:label>
    <link:label id="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears_0E705EAE1F881981A716CAFC0480A901_documentation_en-US" xlink:label="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears_0E705EAE1F881981A716CAFC0480A901" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The rate of interest that was being paid on the original debt issue that is to repay in the first two years.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears" xlink:label="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears_0E705EAE1F881981A716CAFC0480A901" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears_0E705EAE1F881981A716CAFC0480A901" xlink:to="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears_0E705EAE1F881981A716CAFC0480A901" xlink:type="arc" />
    <link:label id="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear_F5F8A9DAADD7C8552B27CAFC04815E64_terseLabel_en-US" xlink:label="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear_F5F8A9DAADD7C8552B27CAFC04815E64" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of original principal amount required to repay during the third year</link:label>
    <link:label id="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear_F5F8A9DAADD7C8552B27CAFC04815E64_label_en-US" xlink:label="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear_F5F8A9DAADD7C8552B27CAFC04815E64" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of Original Principal Amount Required to Repay During the Third Year</link:label>
    <link:label id="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear_F5F8A9DAADD7C8552B27CAFC04815E64_documentation_en-US" xlink:label="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear_F5F8A9DAADD7C8552B27CAFC04815E64" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The rate of interest that was being paid on the original debt issue that is to repay in the third year.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear" xlink:label="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear_F5F8A9DAADD7C8552B27CAFC04815E64" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear_F5F8A9DAADD7C8552B27CAFC04815E64" xlink:to="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear_F5F8A9DAADD7C8552B27CAFC04815E64" xlink:type="arc" />
    <link:label id="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears_D09FB84475CA6BAE4CF6CAFC04819352_terseLabel_en-US" xlink:label="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears_D09FB84475CA6BAE4CF6CAFC04819352" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of original principal amount required to repay remaining year</link:label>
    <link:label id="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears_D09FB84475CA6BAE4CF6CAFC04819352_label_en-US" xlink:label="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears_D09FB84475CA6BAE4CF6CAFC04819352" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of Original Principal Amount Required to Repay Remaining Years</link:label>
    <link:label id="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears_D09FB84475CA6BAE4CF6CAFC04819352_documentation_en-US" xlink:label="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears_D09FB84475CA6BAE4CF6CAFC04819352" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The rate of interest that was being paid on the original debt issue that is to repay in remaining years.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears" xlink:label="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears_D09FB84475CA6BAE4CF6CAFC04819352" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears_D09FB84475CA6BAE4CF6CAFC04819352" xlink:to="lab_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears_D09FB84475CA6BAE4CF6CAFC04819352" xlink:type="arc" />
    <link:label id="lab_ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight_5FEFACA487D67312CD63CAFC04816F40_terseLabel_en-US" xlink:label="lab_ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight_5FEFACA487D67312CD63CAFC04816F40" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash proceeds excess amount from dispositions of property or casualty events subject to certain reinvestment right</link:label>
    <link:label id="lab_ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight_5FEFACA487D67312CD63CAFC04816F40_label_en-US" xlink:label="lab_ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight_5FEFACA487D67312CD63CAFC04816F40" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Proceeds Excess Amount from Dispositions of Property or Casualty Events Subject to Certain Reinvestment Right</link:label>
    <link:label id="lab_ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight_5FEFACA487D67312CD63CAFC04816F40_documentation_en-US" xlink:label="lab_ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight_5FEFACA487D67312CD63CAFC04816F40" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash proceeds in excess during the term of the Senior Secured Credit Facility from certain dispositions of property or from casualty events involving their property, subject to certain reinvestment rights.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight" xlink:label="loc_ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight_5FEFACA487D67312CD63CAFC04816F40" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight_5FEFACA487D67312CD63CAFC04816F40" xlink:to="lab_ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight_5FEFACA487D67312CD63CAFC04816F40" xlink:type="arc" />
    <link:label id="lab_ebs_DebtInstrumentCovenantDebtServiceCoverageRatio_D6B327F17D77BB426F47CAFC04813DE8_terseLabel_en-US" xlink:label="lab_ebs_DebtInstrumentCovenantDebtServiceCoverageRatio_D6B327F17D77BB426F47CAFC04813DE8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt service coverage ratio</link:label>
    <link:label id="lab_ebs_DebtInstrumentCovenantDebtServiceCoverageRatio_D6B327F17D77BB426F47CAFC04813DE8_label_en-US" xlink:label="lab_ebs_DebtInstrumentCovenantDebtServiceCoverageRatio_D6B327F17D77BB426F47CAFC04813DE8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant, Debt Service Coverage Ratio</link:label>
    <link:label id="lab_ebs_DebtInstrumentCovenantDebtServiceCoverageRatio_D6B327F17D77BB426F47CAFC04813DE8_documentation_en-US" xlink:label="lab_ebs_DebtInstrumentCovenantDebtServiceCoverageRatio_D6B327F17D77BB426F47CAFC04813DE8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant, Debt Service Coverage Ratio</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentCovenantDebtServiceCoverageRatio" xlink:label="loc_ebs_DebtInstrumentCovenantDebtServiceCoverageRatio_D6B327F17D77BB426F47CAFC04813DE8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtInstrumentCovenantDebtServiceCoverageRatio_D6B327F17D77BB426F47CAFC04813DE8" xlink:to="lab_ebs_DebtInstrumentCovenantDebtServiceCoverageRatio_D6B327F17D77BB426F47CAFC04813DE8" xlink:type="arc" />
    <link:label id="lab_ebs_DebtCovenantNetLeverageRatioOne_90E03C57BA90CDAA89B8CAFC048103D9_terseLabel_en-US" xlink:label="lab_ebs_DebtCovenantNetLeverageRatioOne_90E03C57BA90CDAA89B8CAFC048103D9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net leverage ratio one</link:label>
    <link:label id="lab_ebs_DebtCovenantNetLeverageRatioOne_90E03C57BA90CDAA89B8CAFC048103D9_label_en-US" xlink:label="lab_ebs_DebtCovenantNetLeverageRatioOne_90E03C57BA90CDAA89B8CAFC048103D9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Covenant, Net Leverage Ratio, One</link:label>
    <link:label id="lab_ebs_DebtCovenantNetLeverageRatioOne_90E03C57BA90CDAA89B8CAFC048103D9_documentation_en-US" xlink:label="lab_ebs_DebtCovenantNetLeverageRatioOne_90E03C57BA90CDAA89B8CAFC048103D9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtCovenantNetLeverageRatioOne" xlink:label="loc_ebs_DebtCovenantNetLeverageRatioOne_90E03C57BA90CDAA89B8CAFC048103D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtCovenantNetLeverageRatioOne_90E03C57BA90CDAA89B8CAFC048103D9" xlink:to="lab_ebs_DebtCovenantNetLeverageRatioOne_90E03C57BA90CDAA89B8CAFC048103D9" xlink:type="arc" />
    <link:label id="lab_ebs_DebtCovenantNetLeverageRatioTwo_6C64B885D1127AD6A229CAFC0481EFC4_terseLabel_en-US" xlink:label="lab_ebs_DebtCovenantNetLeverageRatioTwo_6C64B885D1127AD6A229CAFC0481EFC4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt covenant, leverage ratio from September 30, 2019 to September 29, 2020</link:label>
    <link:label id="lab_ebs_DebtCovenantNetLeverageRatioTwo_6C64B885D1127AD6A229CAFC0481EFC4_label_en-US" xlink:label="lab_ebs_DebtCovenantNetLeverageRatioTwo_6C64B885D1127AD6A229CAFC0481EFC4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Covenant, Net Leverage Ratio, Two</link:label>
    <link:label id="lab_ebs_DebtCovenantNetLeverageRatioTwo_6C64B885D1127AD6A229CAFC0481EFC4_documentation_en-US" xlink:label="lab_ebs_DebtCovenantNetLeverageRatioTwo_6C64B885D1127AD6A229CAFC0481EFC4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtCovenantNetLeverageRatioTwo" xlink:label="loc_ebs_DebtCovenantNetLeverageRatioTwo_6C64B885D1127AD6A229CAFC0481EFC4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtCovenantNetLeverageRatioTwo_6C64B885D1127AD6A229CAFC0481EFC4" xlink:to="lab_ebs_DebtCovenantNetLeverageRatioTwo_6C64B885D1127AD6A229CAFC0481EFC4" xlink:type="arc" />
    <link:label id="lab_ebs_DebtCovenantNetLeverageRatioThree_C695B5D73808D2D10005CAFC04816715_terseLabel_en-US" xlink:label="lab_ebs_DebtCovenantNetLeverageRatioThree_C695B5D73808D2D10005CAFC04816715" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net leverage ratio three</link:label>
    <link:label id="lab_ebs_DebtCovenantNetLeverageRatioThree_C695B5D73808D2D10005CAFC04816715_label_en-US" xlink:label="lab_ebs_DebtCovenantNetLeverageRatioThree_C695B5D73808D2D10005CAFC04816715" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Covenant, Net Leverage Ratio, Three</link:label>
    <link:label id="lab_ebs_DebtCovenantNetLeverageRatioThree_C695B5D73808D2D10005CAFC04816715_documentation_en-US" xlink:label="lab_ebs_DebtCovenantNetLeverageRatioThree_C695B5D73808D2D10005CAFC04816715" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtCovenantNetLeverageRatioThree" xlink:label="loc_ebs_DebtCovenantNetLeverageRatioThree_C695B5D73808D2D10005CAFC04816715" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtCovenantNetLeverageRatioThree_C695B5D73808D2D10005CAFC04816715" xlink:to="lab_ebs_DebtCovenantNetLeverageRatioThree_C695B5D73808D2D10005CAFC04816715" xlink:type="arc" />
    <link:label id="lab_ebs_DebtCovenantNetLeverageRatioFour_5BEC22CCB9F996A0D42BCAFC048285BD_terseLabel_en-US" xlink:label="lab_ebs_DebtCovenantNetLeverageRatioFour_5BEC22CCB9F996A0D42BCAFC048285BD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net leverage ratio four</link:label>
    <link:label id="lab_ebs_DebtCovenantNetLeverageRatioFour_5BEC22CCB9F996A0D42BCAFC048285BD_label_en-US" xlink:label="lab_ebs_DebtCovenantNetLeverageRatioFour_5BEC22CCB9F996A0D42BCAFC048285BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Covenant, Net Leverage Ratio, Four</link:label>
    <link:label id="lab_ebs_DebtCovenantNetLeverageRatioFour_5BEC22CCB9F996A0D42BCAFC048285BD_documentation_en-US" xlink:label="lab_ebs_DebtCovenantNetLeverageRatioFour_5BEC22CCB9F996A0D42BCAFC048285BD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtCovenantNetLeverageRatioFour" xlink:label="loc_ebs_DebtCovenantNetLeverageRatioFour_5BEC22CCB9F996A0D42BCAFC048285BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtCovenantNetLeverageRatioFour_5BEC22CCB9F996A0D42BCAFC048285BD" xlink:to="lab_ebs_DebtCovenantNetLeverageRatioFour_5BEC22CCB9F996A0D42BCAFC048285BD" xlink:type="arc" />
    <link:label id="lab_ebs_DebtInstrumentRestrictedPaymentsLimitAmount_C154665C9E4100CEAD6FCAFC0482A051_terseLabel_en-US" xlink:label="lab_ebs_DebtInstrumentRestrictedPaymentsLimitAmount_C154665C9E4100CEAD6FCAFC0482A051" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, restricted payments limit, amount</link:label>
    <link:label id="lab_ebs_DebtInstrumentRestrictedPaymentsLimitAmount_C154665C9E4100CEAD6FCAFC0482A051_label_en-US" xlink:label="lab_ebs_DebtInstrumentRestrictedPaymentsLimitAmount_C154665C9E4100CEAD6FCAFC0482A051" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Restricted Payments Limit, Amount</link:label>
    <link:label id="lab_ebs_DebtInstrumentRestrictedPaymentsLimitAmount_C154665C9E4100CEAD6FCAFC0482A051_documentation_en-US" xlink:label="lab_ebs_DebtInstrumentRestrictedPaymentsLimitAmount_C154665C9E4100CEAD6FCAFC0482A051" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Restricted Payments Limit, Amount</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentRestrictedPaymentsLimitAmount" xlink:label="loc_ebs_DebtInstrumentRestrictedPaymentsLimitAmount_C154665C9E4100CEAD6FCAFC0482A051" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtInstrumentRestrictedPaymentsLimitAmount_C154665C9E4100CEAD6FCAFC0482A051" xlink:to="lab_ebs_DebtInstrumentRestrictedPaymentsLimitAmount_C154665C9E4100CEAD6FCAFC0482A051" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1460F22E6CF76D66B84AECA09E3C50DD_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1460F22E6CF76D66B84AECA09E3C50DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1460F22E6CF76D66B84AECA09E3C50DD_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1460F22E6CF76D66B84AECA09E3C50DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1460F22E6CF76D66B84AECA09E3C50DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1460F22E6CF76D66B84AECA09E3C50DD" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1460F22E6CF76D66B84AECA09E3C50DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_B3EF80FCB6C4D37E9F4CECA09E48957B_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems_B3EF80FCB6C4D37E9F4CECA09E48957B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_B3EF80FCB6C4D37E9F4CECA09E48957B_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems_B3EF80FCB6C4D37E9F4CECA09E48957B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_B3EF80FCB6C4D37E9F4CECA09E48957B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_B3EF80FCB6C4D37E9F4CECA09E48957B" xlink:to="lab_us-gaap_DerivativesFairValueLineItems_B3EF80FCB6C4D37E9F4CECA09E48957B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_BA6CA543622E83C5DA06ECA0123C9539_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_BA6CA543622E83C5DA06ECA0123C9539" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of net deferred losses from accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_BA6CA543622E83C5DA06ECA0123C9539_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_BA6CA543622E83C5DA06ECA0123C9539" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_BA6CA543622E83C5DA06ECA0123C9539" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_BA6CA543622E83C5DA06ECA0123C9539" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_BA6CA543622E83C5DA06ECA0123C9539" xlink:type="arc" />
    <link:label id="lab_ebs_PaxVaxMember_484945B7E551458CF74B78A56C533D35_terseLabel_en-US" xlink:label="lab_ebs_PaxVaxMember_484945B7E551458CF74B78A56C533D35" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PaxVax</link:label>
    <link:label id="lab_ebs_PaxVaxMember_484945B7E551458CF74B78A56C533D35_label_en-US" xlink:label="lab_ebs_PaxVaxMember_484945B7E551458CF74B78A56C533D35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PaxVax [Member]</link:label>
    <link:label id="lab_ebs_PaxVaxMember_484945B7E551458CF74B78A56C533D35_documentation_en-US" xlink:label="lab_ebs_PaxVaxMember_484945B7E551458CF74B78A56C533D35" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business acquisition on October 4, 2018.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PaxVaxMember" xlink:label="loc_ebs_PaxVaxMember_484945B7E551458CF74B78A56C533D35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_PaxVaxMember_484945B7E551458CF74B78A56C533D35" xlink:to="lab_ebs_PaxVaxMember_484945B7E551458CF74B78A56C533D35" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_70E29E6C2A0861C5202D78A56C57EF82_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_70E29E6C2A0861C5202D78A56C57EF82" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_70E29E6C2A0861C5202D78A56C57EF82_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_70E29E6C2A0861C5202D78A56C57EF82" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_70E29E6C2A0861C5202D78A56C57EF82" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_70E29E6C2A0861C5202D78A56C57EF82" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_70E29E6C2A0861C5202D78A56C57EF82" xlink:type="arc" />
    <link:label id="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_F538D23AEB3D2EDDD4B578A56C57D7AB_terseLabel_en-US" xlink:label="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_F538D23AEB3D2EDDD4B578A56C57D7AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets, measurement period adjustments</link:label>
    <link:label id="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_F538D23AEB3D2EDDD4B578A56C57D7AB_label_en-US" xlink:label="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_F538D23AEB3D2EDDD4B578A56C57D7AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</link:label>
    <link:label id="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_F538D23AEB3D2EDDD4B578A56C57D7AB_documentation_en-US" xlink:label="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_F538D23AEB3D2EDDD4B578A56C57D7AB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_F538D23AEB3D2EDDD4B578A56C57D7AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_F538D23AEB3D2EDDD4B578A56C57D7AB" xlink:to="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_F538D23AEB3D2EDDD4B578A56C57D7AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_F7E92C3889FC1EE20C0078A56C589A61_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_F7E92C3889FC1EE20C0078A56C589A61" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_F7E92C3889FC1EE20C0078A56C589A61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_F7E92C3889FC1EE20C0078A56C589A61" xlink:to="lab_us-gaap_Goodwill_F7E92C3889FC1EE20C0078A56C589A61" xlink:type="arc" />
    <link:label id="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities_B7FD0945EB2528BA210478A56C59758A_negatedTerseLabel_en-US" xlink:label="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities_B7FD0945EB2528BA210478A56C59758A" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities, measurement period adjustment</link:label>
    <link:label id="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities_B7FD0945EB2528BA210478A56C59758A_label_en-US" xlink:label="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities_B7FD0945EB2528BA210478A56C59758A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses And Other Liabilities</link:label>
    <link:label id="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities_B7FD0945EB2528BA210478A56C59758A_documentation_en-US" xlink:label="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities_B7FD0945EB2528BA210478A56C59758A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses And Other Liabilities</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities_B7FD0945EB2528BA210478A56C59758A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities_B7FD0945EB2528BA210478A56C59758A" xlink:to="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities_B7FD0945EB2528BA210478A56C59758A" xlink:type="arc" />
    <link:label id="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets_7AD753AE33880E55C29078A56C59B27D_terseLabel_en-US" xlink:label="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets_7AD753AE33880E55C29078A56C59B27D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired in-process research and development, measurement period adjustment</link:label>
    <link:label id="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets_7AD753AE33880E55C29078A56C59B27D_label_en-US" xlink:label="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets_7AD753AE33880E55C29078A56C59B27D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Finite-lived Intangible Assets</link:label>
    <link:label id="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets_7AD753AE33880E55C29078A56C59B27D_documentation_en-US" xlink:label="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets_7AD753AE33880E55C29078A56C59B27D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Finite-lived Intangible Assets</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets_7AD753AE33880E55C29078A56C59B27D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets_7AD753AE33880E55C29078A56C59B27D" xlink:to="lab_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets_7AD753AE33880E55C29078A56C59B27D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_ECDC1A19016FBFF17EE6CB38A82687A3_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock_ECDC1A19016FBFF17EE6CB38A82687A3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_ECDC1A19016FBFF17EE6CB38A82687A3_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock_ECDC1A19016FBFF17EE6CB38A82687A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_ECDC1A19016FBFF17EE6CB38A82687A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock_ECDC1A19016FBFF17EE6CB38A82687A3" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock_ECDC1A19016FBFF17EE6CB38A82687A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_A3745F27CF793AA56CFFCB3BEDB77732_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock_A3745F27CF793AA56CFFCB3BEDB77732" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_A3745F27CF793AA56CFFCB3BEDB77732_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock_A3745F27CF793AA56CFFCB3BEDB77732" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_A3745F27CF793AA56CFFCB3BEDB77732" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock_A3745F27CF793AA56CFFCB3BEDB77732" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock_A3745F27CF793AA56CFFCB3BEDB77732" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_D25D6B0757FF4D8F8E965F9AA8F106B2_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_D25D6B0757FF4D8F8E965F9AA8F106B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_D25D6B0757FF4D8F8E965F9AA8F106B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_D25D6B0757FF4D8F8E965F9AA8F106B2" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_D25D6B0757FF4D8F8E965F9AA8F106B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_B237A02E354FCAB41E6C5F9AA8F43EE3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_B237A02E354FCAB41E6C5F9AA8F43EE3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_B237A02E354FCAB41E6C5F9AA8F43EE3_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_B237A02E354FCAB41E6C5F9AA8F43EE3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_B237A02E354FCAB41E6C5F9AA8F43EE3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_B237A02E354FCAB41E6C5F9AA8F43EE3" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_B237A02E354FCAB41E6C5F9AA8F43EE3" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_2F7FC9E3FDCE72FC23E65F9AA8F5DEE8_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_2F7FC9E3FDCE72FC23E65F9AA8F5DEE8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2F7FC9E3FDCE72FC23E65F9AA8F5DEE8_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_2F7FC9E3FDCE72FC23E65F9AA8F5DEE8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_2F7FC9E3FDCE72FC23E65F9AA8F5DEE8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_2F7FC9E3FDCE72FC23E65F9AA8F5DEE8" xlink:to="lab_us-gaap_NetIncomeLoss_2F7FC9E3FDCE72FC23E65F9AA8F5DEE8" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98C8F4D01F9E30ADB6145F9AA8F5201A_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98C8F4D01F9E30ADB6145F9AA8F5201A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98C8F4D01F9E30ADB6145F9AA8F5201A_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98C8F4D01F9E30ADB6145F9AA8F5201A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98C8F4D01F9E30ADB6145F9AA8F5201A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98C8F4D01F9E30ADB6145F9AA8F5201A" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98C8F4D01F9E30ADB6145F9AA8F5201A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8D99A24C81C0EE6176675F9AA8F79F94_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8D99A24C81C0EE6176675F9AA8F79F94" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8D99A24C81C0EE6176675F9AA8F79F94_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8D99A24C81C0EE6176675F9AA8F79F94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8D99A24C81C0EE6176675F9AA8F79F94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8D99A24C81C0EE6176675F9AA8F79F94" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8D99A24C81C0EE6176675F9AA8F79F94" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8F12DF06A7C2D2A2C1AA5F9AA8F74062_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8F12DF06A7C2D2A2C1AA5F9AA8F74062" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized losses on hedging activities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8F12DF06A7C2D2A2C1AA5F9AA8F74062_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8F12DF06A7C2D2A2C1AA5F9AA8F74062" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8F12DF06A7C2D2A2C1AA5F9AA8F74062" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8F12DF06A7C2D2A2C1AA5F9AA8F74062" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8F12DF06A7C2D2A2C1AA5F9AA8F74062" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_D70E628121D44F6790025F9AA8F8C893_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_D70E628121D44F6790025F9AA8F8C893" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized losses on hedging activities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_D70E628121D44F6790025F9AA8F8C893_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_D70E628121D44F6790025F9AA8F8C893" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_D70E628121D44F6790025F9AA8F8C893" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_D70E628121D44F6790025F9AA8F8C893" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_D70E628121D44F6790025F9AA8F8C893" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_564E56B4451DD940FD1B5F9AA8F83C21_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_564E56B4451DD940FD1B5F9AA8F83C21" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Unrealized losses on pension benefit obligation, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_564E56B4451DD940FD1B5F9AA8F83C21_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_564E56B4451DD940FD1B5F9AA8F83C21" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_564E56B4451DD940FD1B5F9AA8F83C21" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_564E56B4451DD940FD1B5F9AA8F83C21" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_564E56B4451DD940FD1B5F9AA8F83C21" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_F363DB8AB411B543CBFA5F9AA8F84AFE_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_F363DB8AB411B543CBFA5F9AA8F84AFE" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_F363DB8AB411B543CBFA5F9AA8F84AFE_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_F363DB8AB411B543CBFA5F9AA8F84AFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_F363DB8AB411B543CBFA5F9AA8F84AFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_F363DB8AB411B543CBFA5F9AA8F84AFE" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_F363DB8AB411B543CBFA5F9AA8F84AFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_C4EBFA91874D058082F95F9AA8F80B6A_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_C4EBFA91874D058082F95F9AA8F80B6A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_C4EBFA91874D058082F95F9AA8F80B6A_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_C4EBFA91874D058082F95F9AA8F80B6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_C4EBFA91874D058082F95F9AA8F80B6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_C4EBFA91874D058082F95F9AA8F80B6A" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_C4EBFA91874D058082F95F9AA8F80B6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_7A3D84E431C7EF78A8913F3C35C04791_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_7A3D84E431C7EF78A8913F3C35C04791" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_7A3D84E431C7EF78A8913F3C35C04791" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_7A3D84E431C7EF78A8913F3C35C04791" xlink:to="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_7A3D84E431C7EF78A8913F3C35C04791" xlink:type="arc" />
    <link:label id="lab_us-gaap_PurchaseObligation_4D0705ED5987E966D25E3F3C35C0C45E_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation_4D0705ED5987E966D25E3F3C35C0C45E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total purchase commitment</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_4D0705ED5987E966D25E3F3C35C0C45E_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation_4D0705ED5987E966D25E3F3C35C0C45E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaap_PurchaseObligation_4D0705ED5987E966D25E3F3C35C0C45E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation_4D0705ED5987E966D25E3F3C35C0C45E" xlink:to="lab_us-gaap_PurchaseObligation_4D0705ED5987E966D25E3F3C35C0C45E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermPurchaseCommitmentPeriod_CEBE6318BCAF2E85923A3F3C35C14638_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermPurchaseCommitmentPeriod_CEBE6318BCAF2E85923A3F3C35C14638" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase commitment period</link:label>
    <link:label id="lab_us-gaap_LongtermPurchaseCommitmentPeriod_CEBE6318BCAF2E85923A3F3C35C14638_label_en-US" xlink:label="lab_us-gaap_LongtermPurchaseCommitmentPeriod_CEBE6318BCAF2E85923A3F3C35C14638" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment, Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod_CEBE6318BCAF2E85923A3F3C35C14638" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermPurchaseCommitmentPeriod_CEBE6318BCAF2E85923A3F3C35C14638" xlink:to="lab_us-gaap_LongtermPurchaseCommitmentPeriod_CEBE6318BCAF2E85923A3F3C35C14638" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_3FBBA153F1443990D9133F3C35C1CFBB_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount_3FBBA153F1443990D9133F3C35C1CFBB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Materials purchased under commitment, amount</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_3FBBA153F1443990D9133F3C35C1CFBB_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount_3FBBA153F1443990D9133F3C35C1CFBB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_3FBBA153F1443990D9133F3C35C1CFBB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentAmount_3FBBA153F1443990D9133F3C35C1CFBB" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentAmount_3FBBA153F1443990D9133F3C35C1CFBB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_7D57128CC2E88463C7CECE2D5EE34A89_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost_7D57128CC2E88463C7CECE2D5EE34A89" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Service cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_7D57128CC2E88463C7CECE2D5EE34A89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost_7D57128CC2E88463C7CECE2D5EE34A89" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost_7D57128CC2E88463C7CECE2D5EE34A89" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_74D81F1DEA1A1E55A390CE2D5EE3A22E_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost_74D81F1DEA1A1E55A390CE2D5EE3A22E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_74D81F1DEA1A1E55A390CE2D5EE3A22E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost_74D81F1DEA1A1E55A390CE2D5EE3A22E" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost_74D81F1DEA1A1E55A390CE2D5EE3A22E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_977EEF6F9EDFB9A87B38CE2D5EE45A39_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_977EEF6F9EDFB9A87B38CE2D5EE45A39" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_977EEF6F9EDFB9A87B38CE2D5EE45A39_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_977EEF6F9EDFB9A87B38CE2D5EE45A39" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_977EEF6F9EDFB9A87B38CE2D5EE45A39" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_977EEF6F9EDFB9A87B38CE2D5EE45A39" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_977EEF6F9EDFB9A87B38CE2D5EE45A39" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_E2A21959F93A01752444CE2D5EE4EB97_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_E2A21959F93A01752444CE2D5EE4EB97" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_E2A21959F93A01752444CE2D5EE4EB97_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_E2A21959F93A01752444CE2D5EE4EB97" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_E2A21959F93A01752444CE2D5EE4EB97" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_E2A21959F93A01752444CE2D5EE4EB97" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_E2A21959F93A01752444CE2D5EE4EB97" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95" xlink:type="arc" />
    <link:label id="lab_srt_ProductOrServiceAxis_A469FB0E140B595D117C117272BE9A0E_verboseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis_A469FB0E140B595D117C117272BE9A0E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Products and Services [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_A469FB0E140B595D117C117272BE9A0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis_A469FB0E140B595D117C117272BE9A0E" xlink:to="lab_srt_ProductOrServiceAxis_A469FB0E140B595D117C117272BE9A0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProductMember_0323A4CB8856B650E254117272BFA4E8_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember_0323A4CB8856B650E254117272BFA4E8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product sales, net</link:label>
    <link:label id="lab_us-gaap_ProductMember_0323A4CB8856B650E254117272BFA4E8_label_en-US" xlink:label="lab_us-gaap_ProductMember_0323A4CB8856B650E254117272BFA4E8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaap_ProductMember_0323A4CB8856B650E254117272BFA4E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember_0323A4CB8856B650E254117272BFA4E8" xlink:to="lab_us-gaap_ProductMember_0323A4CB8856B650E254117272BFA4E8" xlink:type="arc" />
    <link:label id="lab_ebs_ContractManufacturingMember_99B29BAF5B850B040046117272BF9C83_verboseLabel_en-US" xlink:label="lab_ebs_ContractManufacturingMember_99B29BAF5B850B040046117272BF9C83" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contract development and manufacturing services</link:label>
    <link:label id="lab_ebs_ContractManufacturingMember_99B29BAF5B850B040046117272BF9C83_label_en-US" xlink:label="lab_ebs_ContractManufacturingMember_99B29BAF5B850B040046117272BF9C83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Manufacturing [Member]</link:label>
    <link:label id="lab_ebs_ContractManufacturingMember_99B29BAF5B850B040046117272BF9C83_documentation_en-US" xlink:label="lab_ebs_ContractManufacturingMember_99B29BAF5B850B040046117272BF9C83" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue earned during the period arising from manufacturing sale under the terms of a contract.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractManufacturingMember" xlink:label="loc_ebs_ContractManufacturingMember_99B29BAF5B850B040046117272BF9C83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ContractManufacturingMember_99B29BAF5B850B040046117272BF9C83" xlink:to="lab_ebs_ContractManufacturingMember_99B29BAF5B850B040046117272BF9C83" xlink:type="arc" />
    <link:label id="lab_ebs_ContractsAndGrantsMember_F030F123804824FC71D3117272BF045A_terseLabel_en-US" xlink:label="lab_ebs_ContractsAndGrantsMember_F030F123804824FC71D3117272BF045A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contracts and grants</link:label>
    <link:label id="lab_ebs_ContractsAndGrantsMember_F030F123804824FC71D3117272BF045A_label_en-US" xlink:label="lab_ebs_ContractsAndGrantsMember_F030F123804824FC71D3117272BF045A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contracts and Grants [Member]</link:label>
    <link:label id="lab_ebs_ContractsAndGrantsMember_F030F123804824FC71D3117272BF045A_documentation_en-US" xlink:label="lab_ebs_ContractsAndGrantsMember_F030F123804824FC71D3117272BF045A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of revenue earned from products sold or services provided under the terms of a contract, including, but not limited to, government contracts and grants.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractsAndGrantsMember" xlink:label="loc_ebs_ContractsAndGrantsMember_F030F123804824FC71D3117272BF045A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ContractsAndGrantsMember_F030F123804824FC71D3117272BF045A" xlink:to="lab_ebs_ContractsAndGrantsMember_F030F123804824FC71D3117272BF045A" xlink:type="arc" />
    <link:label id="lab_srt_StatementGeographicalAxis_2C6B41430C8BF805D810117272BFB57E_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis_2C6B41430C8BF805D810117272BFB57E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_2C6B41430C8BF805D810117272BFB57E_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis_2C6B41430C8BF805D810117272BFB57E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_2C6B41430C8BF805D810117272BFB57E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis_2C6B41430C8BF805D810117272BFB57E" xlink:to="lab_srt_StatementGeographicalAxis_2C6B41430C8BF805D810117272BFB57E" xlink:type="arc" />
    <link:label id="lab_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0" xlink:to="lab_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0" xlink:type="arc" />
    <link:label id="lab_country_US_CD1F0BC164631B7F0581117272C05650_terseLabel_en-US" xlink:label="lab_country_US_CD1F0BC164631B7F0581117272C05650" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S Government</link:label>
    <link:label id="lab_country_US_CD1F0BC164631B7F0581117272C05650_label_en-US" xlink:label="lab_country_US_CD1F0BC164631B7F0581117272C05650" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_CD1F0BC164631B7F0581117272C05650" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US_CD1F0BC164631B7F0581117272C05650" xlink:to="lab_country_US_CD1F0BC164631B7F0581117272C05650" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonUsMember_BA18E932125E5CA10CBA117272C07C1C_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember_BA18E932125E5CA10CBA117272C07C1C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-U.S. Government</link:label>
    <link:label id="lab_us-gaap_NonUsMember_BA18E932125E5CA10CBA117272C07C1C_label_en-US" xlink:label="lab_us-gaap_NonUsMember_BA18E932125E5CA10CBA117272C07C1C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_BA18E932125E5CA10CBA117272C07C1C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember_BA18E932125E5CA10CBA117272C07C1C" xlink:to="lab_us-gaap_NonUsMember_BA18E932125E5CA10CBA117272C07C1C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_F9671210CB419FAEA9B1117272C0781F_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems_F9671210CB419FAEA9B1117272C0781F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_F9671210CB419FAEA9B1117272C0781F_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems_F9671210CB419FAEA9B1117272C0781F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_F9671210CB419FAEA9B1117272C0781F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_F9671210CB419FAEA9B1117272C0781F" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems_F9671210CB419FAEA9B1117272C0781F" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6EE90EAFA3AD5ADA810C117272C10623_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6EE90EAFA3AD5ADA810C117272C10623" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6EE90EAFA3AD5ADA810C117272C10623_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6EE90EAFA3AD5ADA810C117272C10623" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6EE90EAFA3AD5ADA810C117272C10623" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6EE90EAFA3AD5ADA810C117272C10623" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6EE90EAFA3AD5ADA810C117272C10623" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B351BDE6D8FB247011152CC36E823450_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B351BDE6D8FB247011152CC36E823450" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B351BDE6D8FB247011152CC36E823450_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B351BDE6D8FB247011152CC36E823450" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B351BDE6D8FB247011152CC36E823450" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B351BDE6D8FB247011152CC36E823450" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B351BDE6D8FB247011152CC36E823450" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_F9BEFA057C94DC870A472CC36E844D10_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_F9BEFA057C94DC870A472CC36E844D10" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_F9BEFA057C94DC870A472CC36E844D10_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_F9BEFA057C94DC870A472CC36E844D10" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_F9BEFA057C94DC870A472CC36E844D10" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_F9BEFA057C94DC870A472CC36E844D10" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_F9BEFA057C94DC870A472CC36E844D10" xlink:type="arc" />
    <link:label id="lab_ebs_NumberOfEmployees_9C77E98263A9F0819C8D2CB8059B9F90_terseLabel_en-US" xlink:label="lab_ebs_NumberOfEmployees_9C77E98263A9F0819C8D2CB8059B9F90" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of employees</link:label>
    <link:label id="lab_ebs_NumberOfEmployees_9C77E98263A9F0819C8D2CB8059B9F90_label_en-US" xlink:label="lab_ebs_NumberOfEmployees_9C77E98263A9F0819C8D2CB8059B9F90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Employees</link:label>
    <link:label id="lab_ebs_NumberOfEmployees_9C77E98263A9F0819C8D2CB8059B9F90_documentation_en-US" xlink:label="lab_ebs_NumberOfEmployees_9C77E98263A9F0819C8D2CB8059B9F90" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of persons employed by the entity</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberOfEmployees" xlink:label="loc_ebs_NumberOfEmployees_9C77E98263A9F0819C8D2CB8059B9F90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_NumberOfEmployees_9C77E98263A9F0819C8D2CB8059B9F90" xlink:to="lab_ebs_NumberOfEmployees_9C77E98263A9F0819C8D2CB8059B9F90" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8C56A3516ECD3D5E34972CB8059B5AE9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8C56A3516ECD3D5E34972CB8059B5AE9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for acquisition (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8C56A3516ECD3D5E34972CB8059B5AE9_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8C56A3516ECD3D5E34972CB8059B5AE9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8C56A3516ECD3D5E34972CB8059B5AE9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8C56A3516ECD3D5E34972CB8059B5AE9" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8C56A3516ECD3D5E34972CB8059B5AE9" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_4D4146A0D050A49439892CB8059BD94A_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice_4D4146A0D050A49439892CB8059BD94A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_4D4146A0D050A49439892CB8059BD94A_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice_4D4146A0D050A49439892CB8059BD94A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_4D4146A0D050A49439892CB8059BD94A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice_4D4146A0D050A49439892CB8059BD94A" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice_4D4146A0D050A49439892CB8059BD94A" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_18D16F4819A47E68D22E2CB8059B41C2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_18D16F4819A47E68D22E2CB8059B41C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of common stock issued for acquisition including adjustments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_18D16F4819A47E68D22E2CB8059B41C2_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_18D16F4819A47E68D22E2CB8059B41C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_18D16F4819A47E68D22E2CB8059B41C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_18D16F4819A47E68D22E2CB8059B41C2" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_18D16F4819A47E68D22E2CB8059B41C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_89BC8DB9DA36846DE4BF2CB8059B9CDF_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_89BC8DB9DA36846DE4BF2CB8059B9CDF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock in acquisition</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_89BC8DB9DA36846DE4BF2CB8059B9CDF_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_89BC8DB9DA36846DE4BF2CB8059B9CDF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_89BC8DB9DA36846DE4BF2CB8059B9CDF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_89BC8DB9DA36846DE4BF2CB8059B9CDF" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_89BC8DB9DA36846DE4BF2CB8059B9CDF" xlink:type="arc" />
    <link:label id="lab_ebs_LockUpPeriodForAdjustmentOfFairValue_8A145E844BB3A7267DFE2CB8059BFDCB_terseLabel_en-US" xlink:label="lab_ebs_LockUpPeriodForAdjustmentOfFairValue_8A145E844BB3A7267DFE2CB8059BFDCB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lock-up period for adjustment of fair value</link:label>
    <link:label id="lab_ebs_LockUpPeriodForAdjustmentOfFairValue_8A145E844BB3A7267DFE2CB8059BFDCB_label_en-US" xlink:label="lab_ebs_LockUpPeriodForAdjustmentOfFairValue_8A145E844BB3A7267DFE2CB8059BFDCB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lock-up Period for Adjustment of Fair Value</link:label>
    <link:label id="lab_ebs_LockUpPeriodForAdjustmentOfFairValue_8A145E844BB3A7267DFE2CB8059BFDCB_documentation_en-US" xlink:label="lab_ebs_LockUpPeriodForAdjustmentOfFairValue_8A145E844BB3A7267DFE2CB8059BFDCB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The lock-up period considered for adjustment of fair value, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_LockUpPeriodForAdjustmentOfFairValue" xlink:label="loc_ebs_LockUpPeriodForAdjustmentOfFairValue_8A145E844BB3A7267DFE2CB8059BFDCB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_LockUpPeriodForAdjustmentOfFairValue_8A145E844BB3A7267DFE2CB8059BFDCB" xlink:to="lab_ebs_LockUpPeriodForAdjustmentOfFairValue_8A145E844BB3A7267DFE2CB8059BFDCB" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_414004A4EC10D76F608A2CB8059B0956_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_414004A4EC10D76F608A2CB8059B0956" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining consideration payable for acquisition cash amount</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_414004A4EC10D76F608A2CB8059B0956_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_414004A4EC10D76F608A2CB8059B0956" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_414004A4EC10D76F608A2CB8059B0956" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_414004A4EC10D76F608A2CB8059B0956" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_414004A4EC10D76F608A2CB8059B0956" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7441A3D8679886A102D32CB8059B8991_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7441A3D8679886A102D32CB8059B8991" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization period of intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7441A3D8679886A102D32CB8059B8991_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7441A3D8679886A102D32CB8059B8991" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7441A3D8679886A102D32CB8059B8991" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7441A3D8679886A102D32CB8059B8991" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7441A3D8679886A102D32CB8059B8991" xlink:type="arc" />
    <link:label id="lab_ebs_PresentValueDiscountRate_81B4B36AE4044166E6C42CB8059B4E77_terseLabel_en-US" xlink:label="lab_ebs_PresentValueDiscountRate_81B4B36AE4044166E6C42CB8059B4E77" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Present value discount rate</link:label>
    <link:label id="lab_ebs_PresentValueDiscountRate_81B4B36AE4044166E6C42CB8059B4E77_label_en-US" xlink:label="lab_ebs_PresentValueDiscountRate_81B4B36AE4044166E6C42CB8059B4E77" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Present Value, Discount Rate</link:label>
    <link:label id="lab_ebs_PresentValueDiscountRate_81B4B36AE4044166E6C42CB8059B4E77_documentation_en-US" xlink:label="lab_ebs_PresentValueDiscountRate_81B4B36AE4044166E6C42CB8059B4E77" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure present value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PresentValueDiscountRate" xlink:label="loc_ebs_PresentValueDiscountRate_81B4B36AE4044166E6C42CB8059B4E77" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_PresentValueDiscountRate_81B4B36AE4044166E6C42CB8059B4E77" xlink:to="lab_ebs_PresentValueDiscountRate_81B4B36AE4044166E6C42CB8059B4E77" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_F23354F74802A2C90E7E2CB8276F2B7B_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss_F23354F74802A2C90E7E2CB8276F2B7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_F23354F74802A2C90E7E2CB8276F2B7B_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss_F23354F74802A2C90E7E2CB8276F2B7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_F23354F74802A2C90E7E2CB8276F2B7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss_F23354F74802A2C90E7E2CB8276F2B7B" xlink:to="lab_us-gaap_GoodwillImpairmentLoss_F23354F74802A2C90E7E2CB8276F2B7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_9B13074F75723663E0C2CCD36F29D962_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract_9B13074F75723663E0C2CCD36F29D962" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_9B13074F75723663E0C2CCD36F29D962" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_9B13074F75723663E0C2CCD36F29D962" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract_9B13074F75723663E0C2CCD36F29D962" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_CC4C58BA4C890089F1079A28D0115641_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_CC4C58BA4C890089F1079A28D0115641" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_CC4C58BA4C890089F1079A28D0115641_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_CC4C58BA4C890089F1079A28D0115641" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_CC4C58BA4C890089F1079A28D0115641" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_CC4C58BA4C890089F1079A28D0115641" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_CC4C58BA4C890089F1079A28D0115641" xlink:type="arc" />
    <link:label id="lab_us-gaap_AwardTypeAxis_9E8F712E27737B7AA1FA9A28D012E3A5_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_9E8F712E27737B7AA1FA9A28D012E3A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_9E8F712E27737B7AA1FA9A28D012E3A5_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_9E8F712E27737B7AA1FA9A28D012E3A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_9E8F712E27737B7AA1FA9A28D012E3A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis_9E8F712E27737B7AA1FA9A28D012E3A5" xlink:to="lab_us-gaap_AwardTypeAxis_9E8F712E27737B7AA1FA9A28D012E3A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BAACFD3ECA68186F35259A28D012E64F_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BAACFD3ECA68186F35259A28D012E64F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BAACFD3ECA68186F35259A28D012E64F_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BAACFD3ECA68186F35259A28D012E64F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BAACFD3ECA68186F35259A28D012E64F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BAACFD3ECA68186F35259A28D012E64F" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BAACFD3ECA68186F35259A28D012E64F" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_C7E55D21388BB589A0339A28D01273ED_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_C7E55D21388BB589A0339A28D01273ED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_C7E55D21388BB589A0339A28D01273ED_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_C7E55D21388BB589A0339A28D01273ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_C7E55D21388BB589A0339A28D01273ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_C7E55D21388BB589A0339A28D01273ED" xlink:to="lab_us-gaap_EmployeeStockOptionMember_C7E55D21388BB589A0339A28D01273ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97B0F0AEAB685D86FE5A9A28D01326DE_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97B0F0AEAB685D86FE5A9A28D01326DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97B0F0AEAB685D86FE5A9A28D01326DE_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97B0F0AEAB685D86FE5A9A28D01326DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97B0F0AEAB685D86FE5A9A28D01326DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97B0F0AEAB685D86FE5A9A28D01326DE" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_97B0F0AEAB685D86FE5A9A28D01326DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_608EEDB1AD72638F9BDF9A28D01325A8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_608EEDB1AD72638F9BDF9A28D01325A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_608EEDB1AD72638F9BDF9A28D01325A8_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_608EEDB1AD72638F9BDF9A28D01325A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_608EEDB1AD72638F9BDF9A28D01325A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_608EEDB1AD72638F9BDF9A28D01325A8" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_608EEDB1AD72638F9BDF9A28D01325A8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_38C0395707A85E0902D49A28D01382DA_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_38C0395707A85E0902D49A28D01382DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_38C0395707A85E0902D49A28D01382DA_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_38C0395707A85E0902D49A28D01382DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_38C0395707A85E0902D49A28D01382DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_38C0395707A85E0902D49A28D01382DA" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_38C0395707A85E0902D49A28D01382DA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6D8720B48761C24EE1DD9A28D013891E_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6D8720B48761C24EE1DD9A28D013891E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6D8720B48761C24EE1DD9A28D013891E_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6D8720B48761C24EE1DD9A28D013891E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6D8720B48761C24EE1DD9A28D013891E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6D8720B48761C24EE1DD9A28D013891E" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6D8720B48761C24EE1DD9A28D013891E" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9842DAD6EDF4C09F7CC49A28D0131B92_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9842DAD6EDF4C09F7CC49A28D0131B92" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected average life of options</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9842DAD6EDF4C09F7CC49A28D0131B92_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9842DAD6EDF4C09F7CC49A28D0131B92" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9842DAD6EDF4C09F7CC49A28D0131B92" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9842DAD6EDF4C09F7CC49A28D0131B92" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9842DAD6EDF4C09F7CC49A28D0131B92" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_EA48CDED68A10E7C78C24FB849716315_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_EA48CDED68A10E7C78C24FB849716315" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Property, Plant and Equipment Useful Lives</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_EA48CDED68A10E7C78C24FB849716315" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_EA48CDED68A10E7C78C24FB849716315" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_EA48CDED68A10E7C78C24FB849716315" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_4ED9988E13ABC5F20957CCD36F7920B2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock_4ED9988E13ABC5F20957CCD36F7920B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_4ED9988E13ABC5F20957CCD36F7920B2_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock_4ED9988E13ABC5F20957CCD36F7920B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_4ED9988E13ABC5F20957CCD36F7920B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock_4ED9988E13ABC5F20957CCD36F7920B2" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock_4ED9988E13ABC5F20957CCD36F7920B2" xlink:type="arc" />
    <link:label id="lab_ebs_RaxibacumabMember_4B013105806BD9D0F489EC8A3E46B884_terseLabel_en-US" xlink:label="lab_ebs_RaxibacumabMember_4B013105806BD9D0F489EC8A3E46B884" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raxibacumab</link:label>
    <link:label id="lab_ebs_RaxibacumabMember_4B013105806BD9D0F489EC8A3E46B884_label_en-US" xlink:label="lab_ebs_RaxibacumabMember_4B013105806BD9D0F489EC8A3E46B884" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Raxibacumab [Member]</link:label>
    <link:label id="lab_ebs_RaxibacumabMember_4B013105806BD9D0F489EC8A3E46B884_documentation_en-US" xlink:label="lab_ebs_RaxibacumabMember_4B013105806BD9D0F489EC8A3E46B884" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Raxibacumab [Member]</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_RaxibacumabMember" xlink:label="loc_ebs_RaxibacumabMember_4B013105806BD9D0F489EC8A3E46B884" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_RaxibacumabMember_4B013105806BD9D0F489EC8A3E46B884" xlink:to="lab_ebs_RaxibacumabMember_4B013105806BD9D0F489EC8A3E46B884" xlink:type="arc" />
    <link:label id="lab_ebs_UpfrontPayments_E327B8920521B8A22A74EC8A3E46D7CB_terseLabel_en-US" xlink:label="lab_ebs_UpfrontPayments_E327B8920521B8A22A74EC8A3E46D7CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Upfront payments</link:label>
    <link:label id="lab_ebs_UpfrontPayments_E327B8920521B8A22A74EC8A3E46D7CB_label_en-US" xlink:label="lab_ebs_UpfrontPayments_E327B8920521B8A22A74EC8A3E46D7CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Upfront Payments</link:label>
    <link:label id="lab_ebs_UpfrontPayments_E327B8920521B8A22A74EC8A3E46D7CB_documentation_en-US" xlink:label="lab_ebs_UpfrontPayments_E327B8920521B8A22A74EC8A3E46D7CB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Refers to upfront payments by the entity.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_UpfrontPayments" xlink:label="loc_ebs_UpfrontPayments_E327B8920521B8A22A74EC8A3E46D7CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_UpfrontPayments_E327B8920521B8A22A74EC8A3E46D7CB" xlink:to="lab_ebs_UpfrontPayments_E327B8920521B8A22A74EC8A3E46D7CB" xlink:type="arc" />
    <link:label id="lab_ebs_AmountOfPaymentForManufacturingRelatedMilestones_18D8700838ADA3AFDC92EC8A3E46E469_terseLabel_en-US" xlink:label="lab_ebs_AmountOfPaymentForManufacturingRelatedMilestones_18D8700838ADA3AFDC92EC8A3E46E469" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of payment for manufacturing related milestones</link:label>
    <link:label id="lab_ebs_AmountOfPaymentForManufacturingRelatedMilestones_18D8700838ADA3AFDC92EC8A3E46E469_label_en-US" xlink:label="lab_ebs_AmountOfPaymentForManufacturingRelatedMilestones_18D8700838ADA3AFDC92EC8A3E46E469" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount Of Payment For Manufacturing Related Milestones</link:label>
    <link:label id="lab_ebs_AmountOfPaymentForManufacturingRelatedMilestones_18D8700838ADA3AFDC92EC8A3E46E469_documentation_en-US" xlink:label="lab_ebs_AmountOfPaymentForManufacturingRelatedMilestones_18D8700838ADA3AFDC92EC8A3E46E469" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash outflow associated with manufacturing related milestones.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmountOfPaymentForManufacturingRelatedMilestones" xlink:label="loc_ebs_AmountOfPaymentForManufacturingRelatedMilestones_18D8700838ADA3AFDC92EC8A3E46E469" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_AmountOfPaymentForManufacturingRelatedMilestones_18D8700838ADA3AFDC92EC8A3E46E469" xlink:to="lab_ebs_AmountOfPaymentForManufacturingRelatedMilestones_18D8700838ADA3AFDC92EC8A3E46E469" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_3B0A9BBA89CCC8357660EC8A3E46B81A_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_3B0A9BBA89CCC8357660EC8A3E46B81A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_3B0A9BBA89CCC8357660EC8A3E46B81A_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_3B0A9BBA89CCC8357660EC8A3E46B81A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_3B0A9BBA89CCC8357660EC8A3E46B81A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_3B0A9BBA89CCC8357660EC8A3E46B81A" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_3B0A9BBA89CCC8357660EC8A3E46B81A" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3C148C7555CF2711B500EC99CD82EA5B_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3C148C7555CF2711B500EC99CD82EA5B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase to contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3C148C7555CF2711B500EC99CD82EA5B_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3C148C7555CF2711B500EC99CD82EA5B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3C148C7555CF2711B500EC99CD82EA5B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3C148C7555CF2711B500EC99CD82EA5B" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3C148C7555CF2711B500EC99CD82EA5B" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_EFBCB576AC0A3FF1DE9F4B48155846E8_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_EFBCB576AC0A3FF1DE9F4B48155846E8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_EFBCB576AC0A3FF1DE9F4B48155846E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_EFBCB576AC0A3FF1DE9F4B48155846E8" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_EFBCB576AC0A3FF1DE9F4B48155846E8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProductMember_D1748887BAD36C539F794B4815586D0E_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductMember_D1748887BAD36C539F794B4815586D0E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Products</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaap_ProductMember_D1748887BAD36C539F794B4815586D0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember_D1748887BAD36C539F794B4815586D0E" xlink:to="lab_us-gaap_ProductMember_D1748887BAD36C539F794B4815586D0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_DA86BDA965FE8D3123054B481558AA08_verboseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember_DA86BDA965FE8D3123054B481558AA08" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Corporate trade name</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_DA86BDA965FE8D3123054B481558AA08_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember_DA86BDA965FE8D3123054B481558AA08" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_DA86BDA965FE8D3123054B481558AA08" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember_DA86BDA965FE8D3123054B481558AA08" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember_DA86BDA965FE8D3123054B481558AA08" xlink:type="arc" />
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_72C006E0A59B626F5CF64B4815588643_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_72C006E0A59B626F5CF64B4815588643" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_72C006E0A59B626F5CF64B4815588643_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_72C006E0A59B626F5CF64B4815588643" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_72C006E0A59B626F5CF64B4815588643" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember_72C006E0A59B626F5CF64B4815588643" xlink:to="lab_us-gaap_CustomerRelationshipsMember_72C006E0A59B626F5CF64B4815588643" xlink:type="arc" />
    <link:label id="lab_ebs_ContractManufacturingMember_E81EF9CB5FB142516F284B4815584EFA_terseLabel_en-US" xlink:label="lab_ebs_ContractManufacturingMember_E81EF9CB5FB142516F284B4815584EFA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract development and manufacturing services</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractManufacturingMember" xlink:label="loc_ebs_ContractManufacturingMember_E81EF9CB5FB142516F284B4815584EFA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ContractManufacturingMember_E81EF9CB5FB142516F284B4815584EFA" xlink:to="lab_ebs_ContractManufacturingMember_E81EF9CB5FB142516F284B4815584EFA" xlink:type="arc" />
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9B4FB02BF6A4A39D188C4B481558F25A_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9B4FB02BF6A4A39D188C4B481558F25A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Estimated Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9B4FB02BF6A4A39D188C4B481558F25A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9B4FB02BF6A4A39D188C4B481558F25A" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9B4FB02BF6A4A39D188C4B481558F25A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_84318A6F007659560F4E4B4815587977_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_84318A6F007659560F4E4B4815587977" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_84318A6F007659560F4E4B4815587977_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_84318A6F007659560F4E4B4815587977" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_84318A6F007659560F4E4B4815587977" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross_84318A6F007659560F4E4B4815587977" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross_84318A6F007659560F4E4B4815587977" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_F23EA491AB81BDBB55F64B4815587A14_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_F23EA491AB81BDBB55F64B4815587A14" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_F23EA491AB81BDBB55F64B4815587A14_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_F23EA491AB81BDBB55F64B4815587A14" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_F23EA491AB81BDBB55F64B4815587A14" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_F23EA491AB81BDBB55F64B4815587A14" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_F23EA491AB81BDBB55F64B4815587A14" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_A0427B3B26F8BB4B5E4B4B4815581E3D_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_A0427B3B26F8BB4B5E4B4B4815581E3D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_A0427B3B26F8BB4B5E4B4B4815581E3D_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_A0427B3B26F8BB4B5E4B4B4815581E3D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_A0427B3B26F8BB4B5E4B4B4815581E3D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_A0427B3B26F8BB4B5E4B4B4815581E3D" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_A0427B3B26F8BB4B5E4B4B4815581E3D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_1A7370B5C9E8567728484B481558999C_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_1A7370B5C9E8567728484B481558999C" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_1A7370B5C9E8567728484B481558999C_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_1A7370B5C9E8567728484B481558999C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1A7370B5C9E8567728484B481558999C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1A7370B5C9E8567728484B481558999C" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_1A7370B5C9E8567728484B481558999C" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpenseMember_EC66E808FF4C86C9B48ECE2D5FB26987_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember_EC66E808FF4C86C9B48ECE2D5FB26987" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_EC66E808FF4C86C9B48ECE2D5FB26987_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember_EC66E808FF4C86C9B48ECE2D5FB26987" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="loc_us-gaap_InterestExpenseMember_EC66E808FF4C86C9B48ECE2D5FB26987" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember_EC66E808FF4C86C9B48ECE2D5FB26987" xlink:to="lab_us-gaap_InterestExpenseMember_EC66E808FF4C86C9B48ECE2D5FB26987" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E57781409008F6D2CAFBCE2D5FB3EC73_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E57781409008F6D2CAFBCE2D5FB3EC73" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E57781409008F6D2CAFBCE2D5FB3EC73_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E57781409008F6D2CAFBCE2D5FB3EC73" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E57781409008F6D2CAFBCE2D5FB3EC73" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E57781409008F6D2CAFBCE2D5FB3EC73" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E57781409008F6D2CAFBCE2D5FB3EC73" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_8B3D3FE538EE850041B0CE2D5FB3DE61_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain_8B3D3FE538EE850041B0CE2D5FB3DE61" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_8B3D3FE538EE850041B0CE2D5FB3DE61_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain_8B3D3FE538EE850041B0CE2D5FB3DE61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8B3D3FE538EE850041B0CE2D5FB3DE61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8B3D3FE538EE850041B0CE2D5FB3DE61" xlink:to="lab_us-gaap_HedgingRelationshipDomain_8B3D3FE538EE850041B0CE2D5FB3DE61" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashFlowHedgingMember_386FF310EB38C51E6173CE2D5FB440B1_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember_386FF310EB38C51E6173CE2D5FB440B1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_386FF310EB38C51E6173CE2D5FB440B1_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember_386FF310EB38C51E6173CE2D5FB440B1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_386FF310EB38C51E6173CE2D5FB440B1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember_386FF310EB38C51E6173CE2D5FB440B1" xlink:to="lab_us-gaap_CashFlowHedgingMember_386FF310EB38C51E6173CE2D5FB440B1" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_78F7D77C33E8BE79B2CACE2D5FB467BD_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_78F7D77C33E8BE79B2CACE2D5FB467BD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of Gain/(Loss) Recognized in OCI on Derivative</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_78F7D77C33E8BE79B2CACE2D5FB467BD_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_78F7D77C33E8BE79B2CACE2D5FB467BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_78F7D77C33E8BE79B2CACE2D5FB467BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_78F7D77C33E8BE79B2CACE2D5FB467BD" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_78F7D77C33E8BE79B2CACE2D5FB467BD" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_47C638CC6614672ADA5ECE2D5FB431BE_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_47C638CC6614672ADA5ECE2D5FB431BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of Gain/(Loss) Recognized in OCI on Derivative</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_47C638CC6614672ADA5ECE2D5FB431BE_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_47C638CC6614672ADA5ECE2D5FB431BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_47C638CC6614672ADA5ECE2D5FB431BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_47C638CC6614672ADA5ECE2D5FB431BE" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_47C638CC6614672ADA5ECE2D5FB431BE" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_07E1F9EBC807543E8EC7CE2D5FB50221_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_07E1F9EBC807543E8EC7CE2D5FB50221" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_07E1F9EBC807543E8EC7CE2D5FB50221_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_07E1F9EBC807543E8EC7CE2D5FB50221" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_07E1F9EBC807543E8EC7CE2D5FB50221" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_07E1F9EBC807543E8EC7CE2D5FB50221" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_07E1F9EBC807543E8EC7CE2D5FB50221" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_F657AC71E267D4C33F83CE2D5FB5B7B4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_F657AC71E267D4C33F83CE2D5FB5B7B4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_F657AC71E267D4C33F83CE2D5FB5B7B4_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_F657AC71E267D4C33F83CE2D5FB5B7B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_F657AC71E267D4C33F83CE2D5FB5B7B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_F657AC71E267D4C33F83CE2D5FB5B7B4" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_F657AC71E267D4C33F83CE2D5FB5B7B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_251AE853E91DF8D8458CF56780618A5F_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_251AE853E91DF8D8458CF56780618A5F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets and goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_251AE853E91DF8D8458CF56780618A5F_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_251AE853E91DF8D8458CF56780618A5F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_251AE853E91DF8D8458CF56780618A5F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_251AE853E91DF8D8458CF56780618A5F" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_251AE853E91DF8D8458CF56780618A5F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_35B4A3AA0D74791D323498AA8304176A_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_35B4A3AA0D74791D323498AA8304176A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Components of the Provisions for Income Taxes Attributable to Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_35B4A3AA0D74791D323498AA8304176A_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_35B4A3AA0D74791D323498AA8304176A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_35B4A3AA0D74791D323498AA8304176A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_35B4A3AA0D74791D323498AA8304176A" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_35B4A3AA0D74791D323498AA8304176A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_D7071DA107B0C5D767F698AA8305114E_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_D7071DA107B0C5D767F698AA8305114E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_D7071DA107B0C5D767F698AA8305114E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_D7071DA107B0C5D767F698AA8305114E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_D7071DA107B0C5D767F698AA8305114E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_D7071DA107B0C5D767F698AA8305114E" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_D7071DA107B0C5D767F698AA8305114E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_E6C992A8567043F5070398AA83058AEF_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_E6C992A8567043F5070398AA83058AEF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Income Before the Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_E6C992A8567043F5070398AA83058AEF_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_E6C992A8567043F5070398AA83058AEF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_E6C992A8567043F5070398AA83058AEF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_E6C992A8567043F5070398AA83058AEF" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_E6C992A8567043F5070398AA83058AEF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_A908050DE9E09E289AB898AA8305AF7A_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_A908050DE9E09E289AB898AA8305AF7A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_A908050DE9E09E289AB898AA8305AF7A_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_A908050DE9E09E289AB898AA8305AF7A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_A908050DE9E09E289AB898AA8305AF7A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_A908050DE9E09E289AB898AA8305AF7A" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_A908050DE9E09E289AB898AA8305AF7A" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameAxis_EA8EF403B78AC83B21C2ECB149212B18_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis_EA8EF403B78AC83B21C2ECB149212B18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_EA8EF403B78AC83B21C2ECB149212B18_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis_EA8EF403B78AC83B21C2ECB149212B18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_EA8EF403B78AC83B21C2ECB149212B18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis_EA8EF403B78AC83B21C2ECB149212B18" xlink:to="lab_us-gaap_PlanNameAxis_EA8EF403B78AC83B21C2ECB149212B18" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameDomain_A808052F44AE0B4622D7ECB1492171FD_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain_A808052F44AE0B4622D7ECB1492171FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_A808052F44AE0B4622D7ECB1492171FD_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain_A808052F44AE0B4622D7ECB1492171FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_A808052F44AE0B4622D7ECB1492171FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain_A808052F44AE0B4622D7ECB1492171FD" xlink:to="lab_us-gaap_PlanNameDomain_A808052F44AE0B4622D7ECB1492171FD" xlink:type="arc" />
    <link:label id="lab_ebs_EmergentPlansMember_1EDC5134F427931A54A5ECB14921B885_terseLabel_en-US" xlink:label="lab_ebs_EmergentPlansMember_1EDC5134F427931A54A5ECB14921B885" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Emergent Plans</link:label>
    <link:label id="lab_ebs_EmergentPlansMember_1EDC5134F427931A54A5ECB14921B885_label_en-US" xlink:label="lab_ebs_EmergentPlansMember_1EDC5134F427931A54A5ECB14921B885" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Emergent Plans [Member]</link:label>
    <link:label id="lab_ebs_EmergentPlansMember_1EDC5134F427931A54A5ECB14921B885_documentation_en-US" xlink:label="lab_ebs_EmergentPlansMember_1EDC5134F427931A54A5ECB14921B885" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Refers to the Company's two stock-based employee compensation plans, the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan (the "2006 Plan") and the Emergent BioSolutions Employee Stock Option Plan (the "2004 Plan").</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EmergentPlansMember" xlink:label="loc_ebs_EmergentPlansMember_1EDC5134F427931A54A5ECB14921B885" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_EmergentPlansMember_1EDC5134F427931A54A5ECB14921B885" xlink:to="lab_ebs_EmergentPlansMember_1EDC5134F427931A54A5ECB14921B885" xlink:type="arc" />
    <link:label id="lab_ebs_NumberOfStockbasedEmployeeCompensationPlans_D5C9C95E1074CD5C2A50ECB14922E69D_terseLabel_en-US" xlink:label="lab_ebs_NumberOfStockbasedEmployeeCompensationPlans_D5C9C95E1074CD5C2A50ECB14922E69D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of stock based employee compensation plans</link:label>
    <link:label id="lab_ebs_NumberOfStockbasedEmployeeCompensationPlans_D5C9C95E1074CD5C2A50ECB14922E69D_label_en-US" xlink:label="lab_ebs_NumberOfStockbasedEmployeeCompensationPlans_D5C9C95E1074CD5C2A50ECB14922E69D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Stock-based Employee Compensation Plans</link:label>
    <link:label id="lab_ebs_NumberOfStockbasedEmployeeCompensationPlans_D5C9C95E1074CD5C2A50ECB14922E69D_documentation_en-US" xlink:label="lab_ebs_NumberOfStockbasedEmployeeCompensationPlans_D5C9C95E1074CD5C2A50ECB14922E69D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of stock-based compensation plans the company maintains.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberOfStockbasedEmployeeCompensationPlans" xlink:label="loc_ebs_NumberOfStockbasedEmployeeCompensationPlans_D5C9C95E1074CD5C2A50ECB14922E69D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_NumberOfStockbasedEmployeeCompensationPlans_D5C9C95E1074CD5C2A50ECB14922E69D" xlink:to="lab_ebs_NumberOfStockbasedEmployeeCompensationPlans_D5C9C95E1074CD5C2A50ECB14922E69D" xlink:type="arc" />
    <link:label id="lab_ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod_292FD3CA63820F5B6986ECB14922B268_terseLabel_en-US" xlink:label="lab_ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod_292FD3CA63820F5B6986ECB14922B268" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise period of options</link:label>
    <link:label id="lab_ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod_292FD3CA63820F5B6986ECB14922B268_label_en-US" xlink:label="lab_ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod_292FD3CA63820F5B6986ECB14922B268" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement by Share-based Payment Award, Options, Exercise Period</link:label>
    <link:label id="lab_ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod_292FD3CA63820F5B6986ECB14922B268_documentation_en-US" xlink:label="lab_ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod_292FD3CA63820F5B6986ECB14922B268" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the period over which options can be exercised from the date of grant.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod" xlink:label="loc_ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod_292FD3CA63820F5B6986ECB14922B268" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod_292FD3CA63820F5B6986ECB14922B268" xlink:to="lab_ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod_292FD3CA63820F5B6986ECB14922B268" xlink:type="arc" />
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_A5A06D8F7729FE99FA17997671D2895E_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_A5A06D8F7729FE99FA17997671D2895E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_A5A06D8F7729FE99FA17997671D2895E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_A5A06D8F7729FE99FA17997671D2895E" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_A5A06D8F7729FE99FA17997671D2895E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_F3B0B5203E206D0E3B15997671D28E31_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_F3B0B5203E206D0E3B15997671D28E31" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Quarterly Financial Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_F3B0B5203E206D0E3B15997671D28E31_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_F3B0B5203E206D0E3B15997671D28E31" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_F3B0B5203E206D0E3B15997671D28E31" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_F3B0B5203E206D0E3B15997671D28E31" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_F3B0B5203E206D0E3B15997671D28E31" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40B1F265E0DAD923F2A9688F6296C1F3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40B1F265E0DAD923F2A9688F6296C1F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40B1F265E0DAD923F2A9688F6296C1F3_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40B1F265E0DAD923F2A9688F6296C1F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40B1F265E0DAD923F2A9688F6296C1F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40B1F265E0DAD923F2A9688F6296C1F3" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40B1F265E0DAD923F2A9688F6296C1F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensation_EA869048670F3BFD816D688F62966A38_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_EA869048670F3BFD816D688F62966A38" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_EA869048670F3BFD816D688F62966A38_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_EA869048670F3BFD816D688F62966A38" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_EA869048670F3BFD816D688F62966A38" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_EA869048670F3BFD816D688F62966A38" xlink:to="lab_us-gaap_ShareBasedCompensation_EA869048670F3BFD816D688F62966A38" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_F910FB75654D6975448A688F6296DCCB_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization_F910FB75654D6975448A688F6296DCCB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_F910FB75654D6975448A688F6296DCCB_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization_F910FB75654D6975448A688F6296DCCB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_F910FB75654D6975448A688F6296DCCB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization_F910FB75654D6975448A688F6296DCCB" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization_F910FB75654D6975448A688F6296DCCB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_EF9CC1324586BA935D46688F6296343E_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_EF9CC1324586BA935D46688F6296343E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_EF9CC1324586BA935D46688F6296343E_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_EF9CC1324586BA935D46688F6296343E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_EF9CC1324586BA935D46688F6296343E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_EF9CC1324586BA935D46688F6296343E" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_EF9CC1324586BA935D46688F6296343E" xlink:type="arc" />
    <link:label id="lab_ebs_ChangeInFairValueOfContingentConsideration_129F1619F30BACEF3F6B688F62966E7C_terseLabel_en-US" xlink:label="lab_ebs_ChangeInFairValueOfContingentConsideration_129F1619F30BACEF3F6B688F62966E7C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of contingent consideration, net</link:label>
    <link:label id="lab_ebs_ChangeInFairValueOfContingentConsideration_129F1619F30BACEF3F6B688F62966E7C_label_en-US" xlink:label="lab_ebs_ChangeInFairValueOfContingentConsideration_129F1619F30BACEF3F6B688F62966E7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change In Fair Value Of Contingent Consideration</link:label>
    <link:label id="lab_ebs_ChangeInFairValueOfContingentConsideration_129F1619F30BACEF3F6B688F62966E7C_documentation_en-US" xlink:label="lab_ebs_ChangeInFairValueOfContingentConsideration_129F1619F30BACEF3F6B688F62966E7C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair value measurement of contingent value rights and contingent purchase considerations granted under purchase agreements.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ChangeInFairValueOfContingentConsideration" xlink:label="loc_ebs_ChangeInFairValueOfContingentConsideration_129F1619F30BACEF3F6B688F62966E7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ChangeInFairValueOfContingentConsideration_129F1619F30BACEF3F6B688F62966E7C" xlink:to="lab_ebs_ChangeInFairValueOfContingentConsideration_129F1619F30BACEF3F6B688F62966E7C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6B02A76A58EC7CE5DFC1688F62969247_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6B02A76A58EC7CE5DFC1688F62969247" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of IPR&amp;D intangible asset</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6B02A76A58EC7CE5DFC1688F62969247_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6B02A76A58EC7CE5DFC1688F62969247" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6B02A76A58EC7CE5DFC1688F62969247" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6B02A76A58EC7CE5DFC1688F62969247" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6B02A76A58EC7CE5DFC1688F62969247" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_9FE4CAB26120110F8009688F6296CCE3_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts_9FE4CAB26120110F8009688F6296CCE3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of deferred financing costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_9FE4CAB26120110F8009688F6296CCE3_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts_9FE4CAB26120110F8009688F6296CCE3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_9FE4CAB26120110F8009688F6296CCE3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts_9FE4CAB26120110F8009688F6296CCE3" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts_9FE4CAB26120110F8009688F6296CCE3" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_75F07D2D023DF7F44921688F62963244_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense_75F07D2D023DF7F44921688F62963244" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_75F07D2D023DF7F44921688F62963244_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense_75F07D2D023DF7F44921688F62963244" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_75F07D2D023DF7F44921688F62963244" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense_75F07D2D023DF7F44921688F62963244" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense_75F07D2D023DF7F44921688F62963244" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_9D550F80665B120CD491688F6296C058_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_9D550F80665B120CD491688F6296C058" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_9D550F80665B120CD491688F6296C058_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_9D550F80665B120CD491688F6296C058" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9D550F80665B120CD491688F6296C058" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9D550F80665B120CD491688F6296C058" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_9D550F80665B120CD491688F6296C058" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_419D7B108F8600BEFA3D688F6296C5E6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_419D7B108F8600BEFA3D688F6296C5E6" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_419D7B108F8600BEFA3D688F6296C5E6_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_419D7B108F8600BEFA3D688F6296C5E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_419D7B108F8600BEFA3D688F6296C5E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories_419D7B108F8600BEFA3D688F6296C5E6" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories_419D7B108F8600BEFA3D688F6296C5E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_70FBED39526C788CAC0C688F6296BC28_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_70FBED39526C788CAC0C688F6296BC28" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_70FBED39526C788CAC0C688F6296BC28_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_70FBED39526C788CAC0C688F6296BC28" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Income Taxes Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_70FBED39526C788CAC0C688F6296BC28" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_70FBED39526C788CAC0C688F6296BC28" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_70FBED39526C788CAC0C688F6296BC28" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_D58FC06F5220307F0397688F62967DAC_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_D58FC06F5220307F0397688F62967DAC" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_D58FC06F5220307F0397688F62967DAC_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_D58FC06F5220307F0397688F62967DAC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_D58FC06F5220307F0397688F62967DAC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_D58FC06F5220307F0397688F62967DAC" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_D58FC06F5220307F0397688F62967DAC" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_6D3111418353C427B325688F62965007_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_6D3111418353C427B325688F62965007" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_6D3111418353C427B325688F62965007_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_6D3111418353C427B325688F62965007" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6D3111418353C427B325688F62965007" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6D3111418353C427B325688F62965007" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable_6D3111418353C427B325688F62965007" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_21BDFF425F2EBABFF4B2688F629621BD_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_21BDFF425F2EBABFF4B2688F629621BD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_21BDFF425F2EBABFF4B2688F629621BD_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_21BDFF425F2EBABFF4B2688F629621BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_21BDFF425F2EBABFF4B2688F629621BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_21BDFF425F2EBABFF4B2688F629621BD" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_21BDFF425F2EBABFF4B2688F629621BD" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_60AF8E7234B6F4403D8E688F6296AD13_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_60AF8E7234B6F4403D8E688F6296AD13" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_60AF8E7234B6F4403D8E688F6296AD13_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_60AF8E7234B6F4403D8E688F6296AD13" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_60AF8E7234B6F4403D8E688F6296AD13" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_60AF8E7234B6F4403D8E688F6296AD13" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_60AF8E7234B6F4403D8E688F6296AD13" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4DCA2DE141EE50791392688F62966567_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4DCA2DE141EE50791392688F62966567" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4DCA2DE141EE50791392688F62966567_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4DCA2DE141EE50791392688F62966567" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4DCA2DE141EE50791392688F62966567" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4DCA2DE141EE50791392688F62966567" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4DCA2DE141EE50791392688F62966567" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_737EFDD7740C9773D7E7688F6296D561_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_737EFDD7740C9773D7E7688F6296D561" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_737EFDD7740C9773D7E7688F6296D561_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_737EFDD7740C9773D7E7688F6296D561" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_737EFDD7740C9773D7E7688F6296D561" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_737EFDD7740C9773D7E7688F6296D561" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_737EFDD7740C9773D7E7688F6296D561" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FE8163555A63E227F5D1688F6296602F_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FE8163555A63E227F5D1688F6296602F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FE8163555A63E227F5D1688F6296602F_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FE8163555A63E227F5D1688F6296602F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FE8163555A63E227F5D1688F6296602F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FE8163555A63E227F5D1688F6296602F" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FE8163555A63E227F5D1688F6296602F" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8D54F34D1EBE4981FB12688F62964C20_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8D54F34D1EBE4981FB12688F62964C20" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of property, plant and equipment and other</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8D54F34D1EBE4981FB12688F62964C20_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8D54F34D1EBE4981FB12688F62964C20" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8D54F34D1EBE4981FB12688F62964C20" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8D54F34D1EBE4981FB12688F62964C20" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8D54F34D1EBE4981FB12688F62964C20" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForPreviousAcquisition_8092275D8AA796DD9305688F62963734_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForPreviousAcquisition_8092275D8AA796DD9305688F62963734" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Milestone payment from asset acquisition</link:label>
    <link:label id="lab_us-gaap_PaymentsForPreviousAcquisition_8092275D8AA796DD9305688F62963734_label_en-US" xlink:label="lab_us-gaap_PaymentsForPreviousAcquisition_8092275D8AA796DD9305688F62963734" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Previous Acquisition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForPreviousAcquisition" xlink:label="loc_us-gaap_PaymentsForPreviousAcquisition_8092275D8AA796DD9305688F62963734" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForPreviousAcquisition_8092275D8AA796DD9305688F62963734" xlink:to="lab_us-gaap_PaymentsForPreviousAcquisition_8092275D8AA796DD9305688F62963734" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_37BFA155C8FCAE1A230E688F62966BD9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets_37BFA155C8FCAE1A230E688F62966BD9" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Asset acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_37BFA155C8FCAE1A230E688F62966BD9_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets_37BFA155C8FCAE1A230E688F62966BD9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_37BFA155C8FCAE1A230E688F62966BD9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets_37BFA155C8FCAE1A230E688F62966BD9" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets_37BFA155C8FCAE1A230E688F62966BD9" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D8DB095B5D89A3C39FA4688F62961496_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D8DB095B5D89A3C39FA4688F62961496" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D8DB095B5D89A3C39FA4688F62961496_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D8DB095B5D89A3C39FA4688F62961496" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D8DB095B5D89A3C39FA4688F62961496" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D8DB095B5D89A3C39FA4688F62961496" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D8DB095B5D89A3C39FA4688F62961496" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_B288BAAE094A2C6CC5A8688F62967AD4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_B288BAAE094A2C6CC5A8688F62967AD4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_B288BAAE094A2C6CC5A8688F62967AD4_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_B288BAAE094A2C6CC5A8688F62967AD4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Productive Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_B288BAAE094A2C6CC5A8688F62967AD4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_B288BAAE094A2C6CC5A8688F62967AD4" xlink:to="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_B288BAAE094A2C6CC5A8688F62967AD4" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_5080FDCB7BB5EA44B67A688F6296AF0F_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_5080FDCB7BB5EA44B67A688F6296AF0F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_5080FDCB7BB5EA44B67A688F6296AF0F_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_5080FDCB7BB5EA44B67A688F6296AF0F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5080FDCB7BB5EA44B67A688F6296AF0F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5080FDCB7BB5EA44B67A688F6296AF0F" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_5080FDCB7BB5EA44B67A688F6296AF0F" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_39030B8539130EEACE9E688F6296DEFB_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_39030B8539130EEACE9E688F6296DEFB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_39030B8539130EEACE9E688F6296DEFB_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_39030B8539130EEACE9E688F6296DEFB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_39030B8539130EEACE9E688F6296DEFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_39030B8539130EEACE9E688F6296DEFB" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_39030B8539130EEACE9E688F6296DEFB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_0397055E8BC0A7940D82688F629655B1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_0397055E8BC0A7940D82688F629655B1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from term loan facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_0397055E8BC0A7940D82688F629655B1_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_0397055E8BC0A7940D82688F629655B1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Medium-term Notes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_0397055E8BC0A7940D82688F629655B1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_0397055E8BC0A7940D82688F629655B1" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_0397055E8BC0A7940D82688F629655B1" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_37096707663FC9ECCAD3688F62962636_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_37096707663FC9ECCAD3688F62962636" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Principal payments on revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_37096707663FC9ECCAD3688F62962636_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_37096707663FC9ECCAD3688F62962636" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-term Lines of Credit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_37096707663FC9ECCAD3688F62962636" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_37096707663FC9ECCAD3688F62962636" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_37096707663FC9ECCAD3688F62962636" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfMediumTermNotes_5F290BCCCF1058A00DFD688F62960445_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfMediumTermNotes_5F290BCCCF1058A00DFD688F62960445" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Principal payments on term loan facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfMediumTermNotes_5F290BCCCF1058A00DFD688F62960445_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfMediumTermNotes_5F290BCCCF1058A00DFD688F62960445" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Medium-term Notes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfMediumTermNotes" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes_5F290BCCCF1058A00DFD688F62960445" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfMediumTermNotes_5F290BCCCF1058A00DFD688F62960445" xlink:to="lab_us-gaap_RepaymentsOfMediumTermNotes_5F290BCCCF1058A00DFD688F62960445" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_53A4BC2B6EA7A7279E8B688F6296F8DC_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_53A4BC2B6EA7A7279E8B688F6296F8DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_53A4BC2B6EA7A7279E8B688F6296F8DC_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_53A4BC2B6EA7A7279E8B688F6296F8DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_53A4BC2B6EA7A7279E8B688F6296F8DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_53A4BC2B6EA7A7279E8B688F6296F8DC" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_53A4BC2B6EA7A7279E8B688F6296F8DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_F5ABB9FE6D3B7A19DF46688F62960C93_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts_F5ABB9FE6D3B7A19DF46688F62960C93" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_F5ABB9FE6D3B7A19DF46688F62960C93_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts_F5ABB9FE6D3B7A19DF46688F62960C93" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_F5ABB9FE6D3B7A19DF46688F62960C93" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts_F5ABB9FE6D3B7A19DF46688F62960C93" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts_F5ABB9FE6D3B7A19DF46688F62960C93" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_D2F7D69180EA9040A433688F629646AB_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_D2F7D69180EA9040A433688F629646AB" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Taxes paid on behalf of employees for equity activity</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_D2F7D69180EA9040A433688F629646AB_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_D2F7D69180EA9040A433688F629646AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments Related to Tax Withholding for Share-based Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_D2F7D69180EA9040A433688F629646AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_D2F7D69180EA9040A433688F629646AB" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_D2F7D69180EA9040A433688F629646AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_6CDC6FDD0F7C37D4927A688F629608F9_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable_6CDC6FDD0F7C37D4927A688F629608F9" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payment of notes payable to Aptevo</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_6CDC6FDD0F7C37D4927A688F629608F9_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable_6CDC6FDD0F7C37D4927A688F629608F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_6CDC6FDD0F7C37D4927A688F629608F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable_6CDC6FDD0F7C37D4927A688F629608F9" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable_6CDC6FDD0F7C37D4927A688F629608F9" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_685A1E881900D51E6702688F629601AC_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_685A1E881900D51E6702688F629601AC" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration payments</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_685A1E881900D51E6702688F629601AC_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_685A1E881900D51E6702688F629601AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_685A1E881900D51E6702688F629601AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_685A1E881900D51E6702688F629601AC" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_685A1E881900D51E6702688F629601AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_8C5F6D6D4EECAFF342D6688F629634DA_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_8C5F6D6D4EECAFF342D6688F629634DA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Receipts and payments of restricted cash</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_8C5F6D6D4EECAFF342D6688F629634DA_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_8C5F6D6D4EECAFF342D6688F629634DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Repayments of) Restricted Cash, Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_8C5F6D6D4EECAFF342D6688F629634DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_8C5F6D6D4EECAFF342D6688F629634DA" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_8C5F6D6D4EECAFF342D6688F629634DA" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1C09BBDC4D27D830AF96688F629634C1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1C09BBDC4D27D830AF96688F629634C1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1C09BBDC4D27D830AF96688F629634C1_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1C09BBDC4D27D830AF96688F629634C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1C09BBDC4D27D830AF96688F629634C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1C09BBDC4D27D830AF96688F629634C1" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1C09BBDC4D27D830AF96688F629634C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5CE13DEE0F07AF6A1829688F6296A8C3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5CE13DEE0F07AF6A1829688F6296A8C3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5CE13DEE0F07AF6A1829688F6296A8C3_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5CE13DEE0F07AF6A1829688F6296A8C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5CE13DEE0F07AF6A1829688F6296A8C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5CE13DEE0F07AF6A1829688F6296A8C3" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5CE13DEE0F07AF6A1829688F6296A8C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8EA848BF5A90B12FF8BF688F6296470B_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8EA848BF5A90B12FF8BF688F6296470B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8EA848BF5A90B12FF8BF688F6296470B_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8EA848BF5A90B12FF8BF688F6296470B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8EA848BF5A90B12FF8BF688F6296470B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8EA848BF5A90B12FF8BF688F6296470B" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8EA848BF5A90B12FF8BF688F6296470B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_FEF39B2DCFAA873212BF688F6296B76D_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_FEF39B2DCFAA873212BF688F6296B76D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_FEF39B2DCFAA873212BF688F6296B76D_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_FEF39B2DCFAA873212BF688F6296B76D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_FEF39B2DCFAA873212BF688F6296B76D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_FEF39B2DCFAA873212BF688F6296B76D" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_FEF39B2DCFAA873212BF688F6296B76D" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_309AB2E3FDAA84408E10688F6296EFA1_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_309AB2E3FDAA84408E10688F6296EFA1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents and restricted cash at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_309AB2E3FDAA84408E10688F6296EFA1_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_309AB2E3FDAA84408E10688F6296EFA1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_309AB2E3FDAA84408E10688F6296EFA1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_309AB2E3FDAA84408E10688F6296EFA1" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_309AB2E3FDAA84408E10688F6296EFA1" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D8DAFE9C626EF98303B2688F6296836D_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D8DAFE9C626EF98303B2688F6296836D" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents and restricted cash at end of year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D8DAFE9C626EF98303B2688F6296836D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D8DAFE9C626EF98303B2688F6296836D" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D8DAFE9C626EF98303B2688F6296836D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_78046F99D267396BA272688F6296A286_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract_78046F99D267396BA272688F6296A286" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_78046F99D267396BA272688F6296A286_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract_78046F99D267396BA272688F6296A286" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_78046F99D267396BA272688F6296A286" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_78046F99D267396BA272688F6296A286" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract_78046F99D267396BA272688F6296A286" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestPaidNet_8B147C46E4DC33E879C0688F6296AF05_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet_8B147C46E4DC33E879C0688F6296AF05" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid during the year for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_8B147C46E4DC33E879C0688F6296AF05_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet_8B147C46E4DC33E879C0688F6296AF05" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_8B147C46E4DC33E879C0688F6296AF05" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet_8B147C46E4DC33E879C0688F6296AF05" xlink:to="lab_us-gaap_InterestPaidNet_8B147C46E4DC33E879C0688F6296AF05" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxesPaid_28947AC25683FCBE3195688F62965785_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid_28947AC25683FCBE3195688F62965785" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid during the year for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_28947AC25683FCBE3195688F62965785_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid_28947AC25683FCBE3195688F62965785" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_28947AC25683FCBE3195688F62965785" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid_28947AC25683FCBE3195688F62965785" xlink:to="lab_us-gaap_IncomeTaxesPaid_28947AC25683FCBE3195688F62965785" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_69EDE03111FE7B3B1D1A688F6296BC4C_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_69EDE03111FE7B3B1D1A688F6296BC4C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental information on non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_69EDE03111FE7B3B1D1A688F6296BC4C_label_en-US" xlink:label="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_69EDE03111FE7B3B1D1A688F6296BC4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_69EDE03111FE7B3B1D1A688F6296BC4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_69EDE03111FE7B3B1D1A688F6296BC4C" xlink:to="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_69EDE03111FE7B3B1D1A688F6296BC4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssued1_3DAC2249178B85828F48688F62961E72_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1_3DAC2249178B85828F48688F62961E72" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock to acquire Adapt Pharma</link:label>
    <link:label id="lab_us-gaap_StockIssued1_3DAC2249178B85828F48688F62961E72_label_en-US" xlink:label="lab_us-gaap_StockIssued1_3DAC2249178B85828F48688F62961E72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaap_StockIssued1_3DAC2249178B85828F48688F62961E72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1_3DAC2249178B85828F48688F62961E72" xlink:to="lab_us-gaap_StockIssued1_3DAC2249178B85828F48688F62961E72" xlink:type="arc" />
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_F316A4993439D6A761CD688F6296CCF7_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_F316A4993439D6A761CD688F6296CCF7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchases of property, plant and equipment unpaid at year end</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_F316A4993439D6A761CD688F6296CCF7_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_F316A4993439D6A761CD688F6296CCF7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_F316A4993439D6A761CD688F6296CCF7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_F316A4993439D6A761CD688F6296CCF7" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_F316A4993439D6A761CD688F6296CCF7" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_7A9EEF517DBCAC8E20E6688F62A5AFFB_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_7A9EEF517DBCAC8E20E6688F62A5AFFB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of cash and cash equivalents and restricted cash:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_7A9EEF517DBCAC8E20E6688F62A5AFFB_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_7A9EEF517DBCAC8E20E6688F62A5AFFB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_7A9EEF517DBCAC8E20E6688F62A5AFFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_7A9EEF517DBCAC8E20E6688F62A5AFFB" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_7A9EEF517DBCAC8E20E6688F62A5AFFB" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3930898C18A748B9B928688F62A52EBE_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3930898C18A748B9B928688F62A52EBE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3930898C18A748B9B928688F62A52EBE_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3930898C18A748B9B928688F62A52EBE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3930898C18A748B9B928688F62A52EBE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3930898C18A748B9B928688F62A52EBE" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3930898C18A748B9B928688F62A52EBE" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedCashCurrent_179911342BA74D92D60868953541C0E3_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent_179911342BA74D92D60868953541C0E3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_179911342BA74D92D60868953541C0E3_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent_179911342BA74D92D60868953541C0E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_179911342BA74D92D60868953541C0E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent_179911342BA74D92D60868953541C0E3" xlink:to="lab_us-gaap_RestrictedCashCurrent_179911342BA74D92D60868953541C0E3" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20A2D2C65AD60BDE4002688F62A5AA35_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20A2D2C65AD60BDE4002688F62A5AA35" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20A2D2C65AD60BDE4002688F62A5AA35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20A2D2C65AD60BDE4002688F62A5AA35" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20A2D2C65AD60BDE4002688F62A5AA35" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E_label_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E" xlink:to="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_B5EBC9421F3D4551482A21E83ABE50C7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member_B5EBC9421F3D4551482A21E83ABE50C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2014-09</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_B5EBC9421F3D4551482A21E83ABE50C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member_B5EBC9421F3D4551482A21E83ABE50C7" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member_B5EBC9421F3D4551482A21E83ABE50C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_98667276A1D64B3A5BBF21E7CBDF7AE6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_98667276A1D64B3A5BBF21E7CBDF7AE6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_98667276A1D64B3A5BBF21E7CBDF7AE6_label_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_98667276A1D64B3A5BBF21E7CBDF7AE6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_98667276A1D64B3A5BBF21E7CBDF7AE6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_98667276A1D64B3A5BBF21E7CBDF7AE6" xlink:to="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_98667276A1D64B3A5BBF21E7CBDF7AE6" xlink:type="arc" />
    <link:label id="lab_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11_terseLabel_en-US" xlink:label="lab_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11_label_en-US" xlink:label="lab_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11_documentation_en-US" xlink:label="lab_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Change in Contract With Customer, Liability [Roll Forward]</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ChangeinContractWithCustomerLiabilityRollForward" xlink:label="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:to="lab_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_3B91D4B25F34A9E37EB121D7FA1B89C9_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability_3B91D4B25F34A9E37EB121D7FA1B89C9" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_3B91D4B25F34A9E37EB121D7FA1B89C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability_3B91D4B25F34A9E37EB121D7FA1B89C9" xlink:to="lab_us-gaap_ContractWithCustomerLiability_3B91D4B25F34A9E37EB121D7FA1B89C9" xlink:type="arc" />
    <link:label id="lab_ebs_ContractWithCustomerLiabilityAdditions_4200D378910DDA764D4321D7FA1B558E_terseLabel_en-US" xlink:label="lab_ebs_ContractWithCustomerLiabilityAdditions_4200D378910DDA764D4321D7FA1B558E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferral of revenue</link:label>
    <link:label id="lab_ebs_ContractWithCustomerLiabilityAdditions_4200D378910DDA764D4321D7FA1B558E_label_en-US" xlink:label="lab_ebs_ContractWithCustomerLiabilityAdditions_4200D378910DDA764D4321D7FA1B558E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Additions</link:label>
    <link:label id="lab_ebs_ContractWithCustomerLiabilityAdditions_4200D378910DDA764D4321D7FA1B558E_documentation_en-US" xlink:label="lab_ebs_ContractWithCustomerLiabilityAdditions_4200D378910DDA764D4321D7FA1B558E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable recorded during the current reporting period.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractWithCustomerLiabilityAdditions" xlink:label="loc_ebs_ContractWithCustomerLiabilityAdditions_4200D378910DDA764D4321D7FA1B558E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ContractWithCustomerLiabilityAdditions_4200D378910DDA764D4321D7FA1B558E" xlink:to="lab_ebs_ContractWithCustomerLiabilityAdditions_4200D378910DDA764D4321D7FA1B558E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8B2A503B49EC3B484BEF21D7FA1BD214_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8B2A503B49EC3B484BEF21D7FA1BD214" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8B2A503B49EC3B484BEF21D7FA1BD214_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8B2A503B49EC3B484BEF21D7FA1BD214" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8B2A503B49EC3B484BEF21D7FA1BD214" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8B2A503B49EC3B484BEF21D7FA1BD214" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8B2A503B49EC3B484BEF21D7FA1BD214" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_74241E1615E0761B5D9221D7FA1B7348_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability_74241E1615E0761B5D9221D7FA1B7348" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_74241E1615E0761B5D9221D7FA1B7348" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability_74241E1615E0761B5D9221D7FA1B7348" xlink:to="lab_us-gaap_ContractWithCustomerLiability_74241E1615E0761B5D9221D7FA1B7348" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_78CC24DEE2EAEF74B55421D7F88E7B61_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_78CC24DEE2EAEF74B55421D7F88E7B61" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_78CC24DEE2EAEF74B55421D7F88E7B61_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_78CC24DEE2EAEF74B55421D7F88E7B61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_78CC24DEE2EAEF74B55421D7F88E7B61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_78CC24DEE2EAEF74B55421D7F88E7B61" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_78CC24DEE2EAEF74B55421D7F88E7B61" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6B2778A3D5402774709E21D7F88E40E5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6B2778A3D5402774709E21D7F88E40E5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6B2778A3D5402774709E21D7F88E40E5_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6B2778A3D5402774709E21D7F88E40E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6B2778A3D5402774709E21D7F88E40E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6B2778A3D5402774709E21D7F88E40E5" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6B2778A3D5402774709E21D7F88E40E5" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_C5BE127DFF018FF231BB21D7F88E179D_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_C5BE127DFF018FF231BB21D7F88E179D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_C5BE127DFF018FF231BB21D7F88E179D_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_C5BE127DFF018FF231BB21D7F88E179D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_C5BE127DFF018FF231BB21D7F88E179D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_C5BE127DFF018FF231BB21D7F88E179D" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_C5BE127DFF018FF231BB21D7F88E179D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_64A3FE31B4838ACD6A6F21D7F88E47F2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_64A3FE31B4838ACD6A6F21D7F88E47F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_64A3FE31B4838ACD6A6F21D7F88E47F2_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_64A3FE31B4838ACD6A6F21D7F88E47F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_64A3FE31B4838ACD6A6F21D7F88E47F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_64A3FE31B4838ACD6A6F21D7F88E47F2" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_64A3FE31B4838ACD6A6F21D7F88E47F2" xlink:type="arc" />
    <link:label id="lab_ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter_0429FB14D7C407C2DBE421D7F88FB06A_terseLabel_en-US" xlink:label="lab_ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter_0429FB14D7C407C2DBE421D7F88FB06A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 and thereafter</link:label>
    <link:label id="lab_ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter_0429FB14D7C407C2DBE421D7F88FB06A_label_en-US" xlink:label="lab_ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter_0429FB14D7C407C2DBE421D7F88FB06A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Five and Thereafter</link:label>
    <link:label id="lab_ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter_0429FB14D7C407C2DBE421D7F88FB06A_documentation_en-US" xlink:label="lab_ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter_0429FB14D7C407C2DBE421D7F88FB06A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year and thereafter following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter" xlink:label="loc_ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter_0429FB14D7C407C2DBE421D7F88FB06A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter_0429FB14D7C407C2DBE421D7F88FB06A" xlink:to="lab_ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter_0429FB14D7C407C2DBE421D7F88FB06A" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebt_A809F213E0C8AAB4933B21D7F88F1222_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt_A809F213E0C8AAB4933B21D7F88F1222" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_A809F213E0C8AAB4933B21D7F88F1222_label_en-US" xlink:label="lab_us-gaap_LongTermDebt_A809F213E0C8AAB4933B21D7F88F1222" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_A809F213E0C8AAB4933B21D7F88F1222" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt_A809F213E0C8AAB4933B21D7F88F1222" xlink:to="lab_us-gaap_LongTermDebt_A809F213E0C8AAB4933B21D7F88F1222" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:to="lab_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:type="arc" />
    <link:label id="lab_us-gaap_DomesticCountryMember_E76890D621E3CE7D585E68849E7A202E_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember_E76890D621E3CE7D585E68849E7A202E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_E76890D621E3CE7D585E68849E7A202E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember_E76890D621E3CE7D585E68849E7A202E" xlink:to="lab_us-gaap_DomesticCountryMember_E76890D621E3CE7D585E68849E7A202E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCountryMember_9348AC5A8A48F4F36C0868849E7B7CA4_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember_9348AC5A8A48F4F36C0868849E7B7CA4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_9348AC5A8A48F4F36C0868849E7B7CA4_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember_9348AC5A8A48F4F36C0868849E7B7CA4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_9348AC5A8A48F4F36C0868849E7B7CA4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember_9348AC5A8A48F4F36C0868849E7B7CA4" xlink:to="lab_us-gaap_ForeignCountryMember_9348AC5A8A48F4F36C0868849E7B7CA4" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_7B31D78517659D00DC7068849E7B2311_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis_7B31D78517659D00DC7068849E7B2311" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_7B31D78517659D00DC7068849E7B2311_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis_7B31D78517659D00DC7068849E7B2311" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_7B31D78517659D00DC7068849E7B2311" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_7B31D78517659D00DC7068849E7B2311" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis_7B31D78517659D00DC7068849E7B2311" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchMember_FB199BC0E844BFF3E43A68849E7B6189_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember_FB199BC0E844BFF3E43A68849E7B6189" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Tax Credit Carryforward</link:label>
    <link:label id="lab_us-gaap_ResearchMember_FB199BC0E844BFF3E43A68849E7B6189_label_en-US" xlink:label="lab_us-gaap_ResearchMember_FB199BC0E844BFF3E43A68849E7B6189" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchMember" xlink:label="loc_us-gaap_ResearchMember_FB199BC0E844BFF3E43A68849E7B6189" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember_FB199BC0E844BFF3E43A68849E7B6189" xlink:to="lab_us-gaap_ResearchMember_FB199BC0E844BFF3E43A68849E7B6189" xlink:type="arc" />
    <link:label id="lab_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember_09A6E34A62AA695572C768849E7B3088_terseLabel_en-US" xlink:label="lab_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember_09A6E34A62AA695572C768849E7B3088" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Manitoba Scientific Research and Experimental Development</link:label>
    <link:label id="lab_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember_09A6E34A62AA695572C768849E7B3088_label_en-US" xlink:label="lab_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember_09A6E34A62AA695572C768849E7B3088" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Manitoba Scientific Research And Experimental Development [Member]</link:label>
    <link:label id="lab_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember_09A6E34A62AA695572C768849E7B3088_documentation_en-US" xlink:label="lab_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember_09A6E34A62AA695572C768849E7B3088" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Refers to Manitoba Scientific Research And Experimental Development.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember" xlink:label="loc_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember_09A6E34A62AA695572C768849E7B3088" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember_09A6E34A62AA695572C768849E7B3088" xlink:to="lab_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember_09A6E34A62AA695572C768849E7B3088" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_D533C4D855C7ED1CF6E768849E7CAA78_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_D533C4D855C7ED1CF6E768849E7CAA78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal corporate tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_D533C4D855C7ED1CF6E768849E7CAA78_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_D533C4D855C7ED1CF6E768849E7CAA78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_D533C4D855C7ED1CF6E768849E7CAA78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_D533C4D855C7ED1CF6E768849E7CAA78" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_D533C4D855C7ED1CF6E768849E7CAA78" xlink:type="arc" />
    <link:label id="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_0C3474705F4CC8AA7DA168849E7CDED7_negatedTerseLabel_en-US" xlink:label="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_0C3474705F4CC8AA7DA168849E7CDED7" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Provisional tax benefit</link:label>
    <link:label id="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_0C3474705F4CC8AA7DA168849E7CDED7_label_en-US" xlink:label="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_0C3474705F4CC8AA7DA168849E7CDED7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Cuts And Jobs Act Of2017 Incomplete Accounting Provisional Income Tax Expense Benefit</link:label>
    <link:label id="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_0C3474705F4CC8AA7DA168849E7CDED7_documentation_en-US" xlink:label="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_0C3474705F4CC8AA7DA168849E7CDED7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of reasonable estimate for income tax expense (benefit) from effect of Tax Cuts and Jobs Act of 2017 for which accounting for tax effect is incomplete.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_0C3474705F4CC8AA7DA168849E7CDED7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_0C3474705F4CC8AA7DA168849E7CDED7" xlink:to="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_0C3474705F4CC8AA7DA168849E7CDED7" xlink:type="arc" />
    <link:label id="lab_ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_1A376FAB93A3B22084F568849E7CEFA6_terseLabel_en-US" xlink:label="lab_ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_1A376FAB93A3B22084F568849E7CEFA6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisional tax benefit, adjustment</link:label>
    <link:label id="lab_ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_1A376FAB93A3B22084F568849E7CEFA6_label_en-US" xlink:label="lab_ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_1A376FAB93A3B22084F568849E7CEFA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Cuts and Jobs Act of 2017, Measurement Period Adjustment, Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_1A376FAB93A3B22084F568849E7CEFA6_documentation_en-US" xlink:label="lab_ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_1A376FAB93A3B22084F568849E7CEFA6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of income tax expense (benefit) for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act of 2017.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:label="loc_ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_1A376FAB93A3B22084F568849E7CEFA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_1A376FAB93A3B22084F568849E7CEFA6" xlink:to="lab_ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_1A376FAB93A3B22084F568849E7CEFA6" xlink:type="arc" />
    <link:label id="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary_72D51EFDF3EA2EDCB9ED68849E7C33E9_terseLabel_en-US" xlink:label="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary_72D51EFDF3EA2EDCB9ED68849E7C33E9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated undistributed foreign E&amp;P</link:label>
    <link:label id="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary_72D51EFDF3EA2EDCB9ED68849E7C33E9_label_en-US" xlink:label="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary_72D51EFDF3EA2EDCB9ED68849E7C33E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Provisional Undistributed Accumulated Earnings of Foreign Subsidiary</link:label>
    <link:label id="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary_72D51EFDF3EA2EDCB9ED68849E7C33E9_documentation_en-US" xlink:label="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary_72D51EFDF3EA2EDCB9ED68849E7C33E9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of reasonable estimate for undistributed accumulated earnings of foreign subsidiary intended to be permanently reinvested outside country of domicile for which accounting for tax effect is incomplete pursuant to Tax Cuts and Jobs Act of 2017.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary" xlink:label="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary_72D51EFDF3EA2EDCB9ED68849E7C33E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary_72D51EFDF3EA2EDCB9ED68849E7C33E9" xlink:to="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary_72D51EFDF3EA2EDCB9ED68849E7C33E9" xlink:type="arc" />
    <link:label id="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_953728B4732D8166A92568849E7D2C41_terseLabel_en-US" xlink:label="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_953728B4732D8166A92568849E7D2C41" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisional tax expense</link:label>
    <link:label id="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_953728B4732D8166A92568849E7D2C41_label_en-US" xlink:label="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_953728B4732D8166A92568849E7D2C41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Cuts And Jobs Act Of 2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense</link:label>
    <link:label id="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_953728B4732D8166A92568849E7D2C41_documentation_en-US" xlink:label="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_953728B4732D8166A92568849E7D2C41" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of reasonable estimate for income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017 for which accounting for tax effect is incomplete.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense" xlink:label="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_953728B4732D8166A92568849E7D2C41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_953728B4732D8166A92568849E7D2C41" xlink:to="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_953728B4732D8166A92568849E7D2C41" xlink:type="arc" />
    <link:label id="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit_45586F338644DB9F986768849E7D1059_terseLabel_en-US" xlink:label="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit_45586F338644DB9F986768849E7D1059" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisional transition tax amount reduction</link:label>
    <link:label id="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit_45586F338644DB9F986768849E7D1059_label_en-US" xlink:label="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit_45586F338644DB9F986768849E7D1059" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit_45586F338644DB9F986768849E7D1059_documentation_en-US" xlink:label="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit_45586F338644DB9F986768849E7D1059" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of reasonable estimate for income tax expense (benefit) for remeasurement of deferred tax from change in tax rate pursuant to Tax Cuts and Jobs Act of 2017 for which accounting for tax effect is incomplete.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit_45586F338644DB9F986768849E7D1059" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit_45586F338644DB9F986768849E7D1059" xlink:to="lab_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit_45586F338644DB9F986768849E7D1059" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_9219720C2BBB59E2B23268849E7D4743_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities_9219720C2BBB59E2B23268849E7D4743" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_9219720C2BBB59E2B23268849E7D4743" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities_9219720C2BBB59E2B23268849E7D4743" xlink:to="lab_us-gaap_DeferredTaxLiabilities_9219720C2BBB59E2B23268849E7D4743" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_035C00A7AEC1F675E65668849E7D01A3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards_035C00A7AEC1F675E65668849E7D01A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_035C00A7AEC1F675E65668849E7D01A3_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards_035C00A7AEC1F675E65668849E7D01A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_035C00A7AEC1F675E65668849E7D01A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards_035C00A7AEC1F675E65668849E7D01A3" xlink:to="lab_us-gaap_OperatingLossCarryforwards_035C00A7AEC1F675E65668849E7D01A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_B59D7BC57FFB2831B9B368849E7E4704_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount_B59D7BC57FFB2831B9B368849E7E4704" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carryforward, amount</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_B59D7BC57FFB2831B9B368849E7E4704_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount_B59D7BC57FFB2831B9B368849E7E4704" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_B59D7BC57FFB2831B9B368849E7E4704" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount_B59D7BC57FFB2831B9B368849E7E4704" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount_B59D7BC57FFB2831B9B368849E7E4704" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0B7B18B809BD00BC7C1668849E7EB87F_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0B7B18B809BD00BC7C1668849E7EB87F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0B7B18B809BD00BC7C1668849E7EB87F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0B7B18B809BD00BC7C1668849E7EB87F" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0B7B18B809BD00BC7C1668849E7EB87F" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCreditCarryforwardValuationAllowance_F50B9A462B4CF78EDD3768849E7E88FE_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardValuationAllowance_F50B9A462B4CF78EDD3768849E7E88FE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carryforward, valuation allowance</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardValuationAllowance_F50B9A462B4CF78EDD3768849E7E88FE_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardValuationAllowance_F50B9A462B4CF78EDD3768849E7E88FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Valuation Allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_F50B9A462B4CF78EDD3768849E7E88FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_F50B9A462B4CF78EDD3768849E7E88FE" xlink:to="lab_us-gaap_TaxCreditCarryforwardValuationAllowance_F50B9A462B4CF78EDD3768849E7E88FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_3555BE85DD10D2A7A7D768849E7E6ED2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_3555BE85DD10D2A7A7D768849E7E6ED2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss carryforwards, valuation allowance</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_3555BE85DD10D2A7A7D768849E7E6ED2_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_3555BE85DD10D2A7A7D768849E7E6ED2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards, Valuation Allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_3555BE85DD10D2A7A7D768849E7E6ED2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_3555BE85DD10D2A7A7D768849E7E6ED2" xlink:to="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_3555BE85DD10D2A7A7D768849E7E6ED2" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B1A8FB8321FD951FD8E868849E7EC661_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B1A8FB8321FD951FD8E868849E7EC661" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate reconciliation, percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B1A8FB8321FD951FD8E868849E7EC661_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B1A8FB8321FD951FD8E868849E7EC661" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B1A8FB8321FD951FD8E868849E7EC661" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B1A8FB8321FD951FD8E868849E7EC661" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B1A8FB8321FD951FD8E868849E7EC661" xlink:type="arc" />
    <link:label id="lab_ebs_UnrecognizedTaxBenefitsCurrent_80EDCCAABDA8EC469E9C68849E7F0889_terseLabel_en-US" xlink:label="lab_ebs_UnrecognizedTaxBenefitsCurrent_80EDCCAABDA8EC469E9C68849E7F0889" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, current</link:label>
    <link:label id="lab_ebs_UnrecognizedTaxBenefitsCurrent_80EDCCAABDA8EC469E9C68849E7F0889_label_en-US" xlink:label="lab_ebs_UnrecognizedTaxBenefitsCurrent_80EDCCAABDA8EC469E9C68849E7F0889" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Current</link:label>
    <link:label id="lab_ebs_UnrecognizedTaxBenefitsCurrent_80EDCCAABDA8EC469E9C68849E7F0889_documentation_en-US" xlink:label="lab_ebs_UnrecognizedTaxBenefitsCurrent_80EDCCAABDA8EC469E9C68849E7F0889" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The gross amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns, and classified as a current liability as of the balance sheet date.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_UnrecognizedTaxBenefitsCurrent" xlink:label="loc_ebs_UnrecognizedTaxBenefitsCurrent_80EDCCAABDA8EC469E9C68849E7F0889" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_UnrecognizedTaxBenefitsCurrent_80EDCCAABDA8EC469E9C68849E7F0889" xlink:to="lab_ebs_UnrecognizedTaxBenefitsCurrent_80EDCCAABDA8EC469E9C68849E7F0889" xlink:type="arc" />
    <link:label id="lab_ebs_UnrecognizedTaxBenefitsNoncurrent_36F1D640361DDECFA62C68849E7F7A15_terseLabel_en-US" xlink:label="lab_ebs_UnrecognizedTaxBenefitsNoncurrent_36F1D640361DDECFA62C68849E7F7A15" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, noncurrent</link:label>
    <link:label id="lab_ebs_UnrecognizedTaxBenefitsNoncurrent_36F1D640361DDECFA62C68849E7F7A15_label_en-US" xlink:label="lab_ebs_UnrecognizedTaxBenefitsNoncurrent_36F1D640361DDECFA62C68849E7F7A15" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Noncurrent</link:label>
    <link:label id="lab_ebs_UnrecognizedTaxBenefitsNoncurrent_36F1D640361DDECFA62C68849E7F7A15_documentation_en-US" xlink:label="lab_ebs_UnrecognizedTaxBenefitsNoncurrent_36F1D640361DDECFA62C68849E7F7A15" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The gross amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns, and classified as a non-current liability as of the balance sheet date.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_UnrecognizedTaxBenefitsNoncurrent" xlink:label="loc_ebs_UnrecognizedTaxBenefitsNoncurrent_36F1D640361DDECFA62C68849E7F7A15" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_UnrecognizedTaxBenefitsNoncurrent_36F1D640361DDECFA62C68849E7F7A15" xlink:to="lab_ebs_UnrecognizedTaxBenefitsNoncurrent_36F1D640361DDECFA62C68849E7F7A15" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_53607FD6CA4A9DDC9850688C70DCBDA7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_53607FD6CA4A9DDC9850688C70DCBDA7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_53607FD6CA4A9DDC9850688C70DCBDA7_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_53607FD6CA4A9DDC9850688C70DCBDA7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_53607FD6CA4A9DDC9850688C70DCBDA7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_53607FD6CA4A9DDC9850688C70DCBDA7" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_53607FD6CA4A9DDC9850688C70DCBDA7" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_EB6BE8108EE2AE58F3A768849E7FE22B_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_EB6BE8108EE2AE58F3A768849E7FE22B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits acquired in business combinations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_EB6BE8108EE2AE58F3A768849E7FE22B_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_EB6BE8108EE2AE58F3A768849E7FE22B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Acquisition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_EB6BE8108EE2AE58F3A768849E7FE22B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_EB6BE8108EE2AE58F3A768849E7FE22B" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_EB6BE8108EE2AE58F3A768849E7FE22B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_77339F6A70C00742EDF698A75E6195E3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_77339F6A70C00742EDF698A75E6195E3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_77339F6A70C00742EDF698A75E6195E3_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_77339F6A70C00742EDF698A75E6195E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_77339F6A70C00742EDF698A75E6195E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_77339F6A70C00742EDF698A75E6195E3" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_77339F6A70C00742EDF698A75E6195E3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_707A641E62245248CC9E98A75E61B2BC_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_707A641E62245248CC9E98A75E61B2BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_707A641E62245248CC9E98A75E61B2BC_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_707A641E62245248CC9E98A75E61B2BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_707A641E62245248CC9E98A75E61B2BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_707A641E62245248CC9E98A75E61B2BC" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_707A641E62245248CC9E98A75E61B2BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_C69C8D78118437C2A0784FB846CDFD91_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_C69C8D78118437C2A0784FB846CDFD91" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_C69C8D78118437C2A0784FB846CDFD91_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_C69C8D78118437C2A0784FB846CDFD91" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_C69C8D78118437C2A0784FB846CDFD91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_C69C8D78118437C2A0784FB846CDFD91" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_C69C8D78118437C2A0784FB846CDFD91" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_134C9D366803A31940854FB846CD605B_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_134C9D366803A31940854FB846CD605B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected rate of return</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_134C9D366803A31940854FB846CD605B_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_134C9D366803A31940854FB846CD605B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_134C9D366803A31940854FB846CD605B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_134C9D366803A31940854FB846CD605B" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_134C9D366803A31940854FB846CD605B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_50D38BB71925F7860EAC4FB846CDA0D6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_50D38BB71925F7860EAC4FB846CDA0D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rate of future compensation increases</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_50D38BB71925F7860EAC4FB846CDA0D6_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_50D38BB71925F7860EAC4FB846CDA0D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_50D38BB71925F7860EAC4FB846CDA0D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_50D38BB71925F7860EAC4FB846CDA0D6" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_50D38BB71925F7860EAC4FB846CDA0D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_B221FC896A93EC9A4B534FB846CD4E02_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_B221FC896A93EC9A4B534FB846CD4E02" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total contributions expected</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_B221FC896A93EC9A4B534FB846CD4E02_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_B221FC896A93EC9A4B534FB846CD4E02" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_B221FC896A93EC9A4B534FB846CD4E02" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_B221FC896A93EC9A4B534FB846CD4E02" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_B221FC896A93EC9A4B534FB846CD4E02" xlink:type="arc" />
    <link:label id="lab_ebs_VivotifMember_226D1478ABA2EDEACEA223C57F56C922_terseLabel_en-US" xlink:label="lab_ebs_VivotifMember_226D1478ABA2EDEACEA223C57F56C922" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vivotif</link:label>
    <link:label id="lab_ebs_VivotifMember_226D1478ABA2EDEACEA223C57F56C922_label_en-US" xlink:label="lab_ebs_VivotifMember_226D1478ABA2EDEACEA223C57F56C922" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vivotif [Member]</link:label>
    <link:label id="lab_ebs_VivotifMember_226D1478ABA2EDEACEA223C57F56C922_documentation_en-US" xlink:label="lab_ebs_VivotifMember_226D1478ABA2EDEACEA223C57F56C922" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">This is a live attenuated vaccine for oral administration to prevent typhoid fever.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_VivotifMember" xlink:label="loc_ebs_VivotifMember_226D1478ABA2EDEACEA223C57F56C922" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_VivotifMember_226D1478ABA2EDEACEA223C57F56C922" xlink:to="lab_ebs_VivotifMember_226D1478ABA2EDEACEA223C57F56C922" xlink:type="arc" />
    <link:label id="lab_ebs_VaxchoraMember_8AD53D5315B1CB9F875323C57F564267_terseLabel_en-US" xlink:label="lab_ebs_VaxchoraMember_8AD53D5315B1CB9F875323C57F564267" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vaxchora</link:label>
    <link:label id="lab_ebs_VaxchoraMember_8AD53D5315B1CB9F875323C57F564267_label_en-US" xlink:label="lab_ebs_VaxchoraMember_8AD53D5315B1CB9F875323C57F564267" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vaxchora [Member]</link:label>
    <link:label id="lab_ebs_VaxchoraMember_8AD53D5315B1CB9F875323C57F564267_documentation_en-US" xlink:label="lab_ebs_VaxchoraMember_8AD53D5315B1CB9F875323C57F564267" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">This is a live attenuated cholera vaccine and the first vaccine approved by the FDA for the prevention of cholera infection</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_VaxchoraMember" xlink:label="loc_ebs_VaxchoraMember_8AD53D5315B1CB9F875323C57F564267" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_VaxchoraMember_8AD53D5315B1CB9F875323C57F564267" xlink:to="lab_ebs_VaxchoraMember_8AD53D5315B1CB9F875323C57F564267" xlink:type="arc" />
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_AC807FF1C112A89D940A23C57F5872D5_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_AC807FF1C112A89D940A23C57F5872D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, weighted average useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_AC807FF1C112A89D940A23C57F5872D5_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_AC807FF1C112A89D940A23C57F5872D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_AC807FF1C112A89D940A23C57F5872D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_AC807FF1C112A89D940A23C57F5872D5" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_AC807FF1C112A89D940A23C57F5872D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_32F199C5EB8A0A129CC2C5AFB4D6C643_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock_32F199C5EB8A0A129CC2C5AFB4D6C643" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Lease Expense Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_32F199C5EB8A0A129CC2C5AFB4D6C643_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock_32F199C5EB8A0A129CC2C5AFB4D6C643" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_32F199C5EB8A0A129CC2C5AFB4D6C643" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock_32F199C5EB8A0A129CC2C5AFB4D6C643" xlink:to="lab_us-gaap_LeaseCostTableTextBlock_32F199C5EB8A0A129CC2C5AFB4D6C643" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillRollForward_A9B273966D4DF1189072118212586CB0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_A9B273966D4DF1189072118212586CB0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_A9B273966D4DF1189072118212586CB0_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_A9B273966D4DF1189072118212586CB0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_A9B273966D4DF1189072118212586CB0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward_A9B273966D4DF1189072118212586CB0" xlink:to="lab_us-gaap_GoodwillRollForward_A9B273966D4DF1189072118212586CB0" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillGross_226E5BD07BFC1F5F343211821259395D_periodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross_226E5BD07BFC1F5F343211821259395D" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_226E5BD07BFC1F5F343211821259395D_label_en-US" xlink:label="lab_us-gaap_GoodwillGross_226E5BD07BFC1F5F343211821259395D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillGross" xlink:label="loc_us-gaap_GoodwillGross_226E5BD07BFC1F5F343211821259395D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross_226E5BD07BFC1F5F343211821259395D" xlink:to="lab_us-gaap_GoodwillGross_226E5BD07BFC1F5F343211821259395D" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_EAD11F8B8C5C9C5554411182125936F5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod_EAD11F8B8C5C9C5554411182125936F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_EAD11F8B8C5C9C5554411182125936F5_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod_EAD11F8B8C5C9C5554411182125936F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_EAD11F8B8C5C9C5554411182125936F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod_EAD11F8B8C5C9C5554411182125936F5" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod_EAD11F8B8C5C9C5554411182125936F5" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillGross_DACD301272ED92174C011182125939CD_periodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross_DACD301272ED92174C011182125939CD" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillGross" xlink:label="loc_us-gaap_GoodwillGross_DACD301272ED92174C011182125939CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross_DACD301272ED92174C011182125939CD" xlink:to="lab_us-gaap_GoodwillGross_DACD301272ED92174C011182125939CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementTable_8C1C6CC113CF66E680EA5F9BB73D10C5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable_8C1C6CC113CF66E680EA5F9BB73D10C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_8C1C6CC113CF66E680EA5F9BB73D10C5_label_en-US" xlink:label="lab_us-gaap_StatementTable_8C1C6CC113CF66E680EA5F9BB73D10C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_8C1C6CC113CF66E680EA5F9BB73D10C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_8C1C6CC113CF66E680EA5F9BB73D10C5" xlink:to="lab_us-gaap_StatementTable_8C1C6CC113CF66E680EA5F9BB73D10C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockMember_7A9DEA414B8227D104735F9BB73E7AB2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember_7A9DEA414B8227D104735F9BB73E7AB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">$0.001 Par Value Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_7A9DEA414B8227D104735F9BB73E7AB2_label_en-US" xlink:label="lab_us-gaap_CommonStockMember_7A9DEA414B8227D104735F9BB73E7AB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_7A9DEA414B8227D104735F9BB73E7AB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_7A9DEA414B8227D104735F9BB73E7AB2" xlink:to="lab_us-gaap_CommonStockMember_7A9DEA414B8227D104735F9BB73E7AB2" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1DF796F7501C9C3D7A855F9BB73E1A09_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_1DF796F7501C9C3D7A855F9BB73E1A09" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1DF796F7501C9C3D7A855F9BB73E1A09_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_1DF796F7501C9C3D7A855F9BB73E1A09" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1DF796F7501C9C3D7A855F9BB73E1A09" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember_1DF796F7501C9C3D7A855F9BB73E1A09" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember_1DF796F7501C9C3D7A855F9BB73E1A09" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockMember_6B4E24D7BC056C7705AE5F9BB73EED37_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember_6B4E24D7BC056C7705AE5F9BB73EED37" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_6B4E24D7BC056C7705AE5F9BB73EED37_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember_6B4E24D7BC056C7705AE5F9BB73EED37" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_6B4E24D7BC056C7705AE5F9BB73EED37" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember_6B4E24D7BC056C7705AE5F9BB73EED37" xlink:to="lab_us-gaap_TreasuryStockMember_6B4E24D7BC056C7705AE5F9BB73EED37" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_18E133B213D2F930B6FC5F9BB73EB449_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_18E133B213D2F930B6FC5F9BB73EB449" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_18E133B213D2F930B6FC5F9BB73EB449" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_18E133B213D2F930B6FC5F9BB73EB449" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_18E133B213D2F930B6FC5F9BB73EB449" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementLineItems_11560B74F0E25C0F32705F9BB73FF144_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems_11560B74F0E25C0F32705F9BB73FF144" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_11560B74F0E25C0F32705F9BB73FF144_label_en-US" xlink:label="lab_us-gaap_StatementLineItems_11560B74F0E25C0F32705F9BB73FF144" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_11560B74F0E25C0F32705F9BB73FF144" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_11560B74F0E25C0F32705F9BB73FF144" xlink:to="lab_us-gaap_StatementLineItems_11560B74F0E25C0F32705F9BB73FF144" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_6FEF6BD3DC5C6A5B4AC95F9BB73F93E8_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_6FEF6BD3DC5C6A5B4AC95F9BB73F93E8" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_6FEF6BD3DC5C6A5B4AC95F9BB73F93E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_6FEF6BD3DC5C6A5B4AC95F9BB73F93E8" xlink:to="lab_us-gaap_CommonStockSharesIssued_6FEF6BD3DC5C6A5B4AC95F9BB73F93E8" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_48BB9862E97DA52406545F9BB740C62D_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_48BB9862E97DA52406545F9BB740C62D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance, as adjusted</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_48BB9862E97DA52406545F9BB740C62D_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_48BB9862E97DA52406545F9BB740C62D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_48BB9862E97DA52406545F9BB740C62D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_48BB9862E97DA52406545F9BB740C62D" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_48BB9862E97DA52406545F9BB740C62D" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2AEFFDB50435C248EA4D5F9BB7402C5E_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2AEFFDB50435C248EA4D5F9BB7402C5E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee equity plans activity (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2AEFFDB50435C248EA4D5F9BB7402C5E_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2AEFFDB50435C248EA4D5F9BB7402C5E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2AEFFDB50435C248EA4D5F9BB7402C5E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2AEFFDB50435C248EA4D5F9BB7402C5E" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2AEFFDB50435C248EA4D5F9BB7402C5E" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_DA16A530BDEEA8476F5D5F9BB740D7D8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_DA16A530BDEEA8476F5D5F9BB740D7D8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee equity plans activity</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_DA16A530BDEEA8476F5D5F9BB740D7D8_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_DA16A530BDEEA8476F5D5F9BB740D7D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_DA16A530BDEEA8476F5D5F9BB740D7D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_DA16A530BDEEA8476F5D5F9BB740D7D8" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_DA16A530BDEEA8476F5D5F9BB740D7D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_7ED92063EBF3C49B83FD5F9BB7401C05_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_7ED92063EBF3C49B83FD5F9BB7401C05" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued to extinguish convertible notes (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_7ED92063EBF3C49B83FD5F9BB7401C05" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_7ED92063EBF3C49B83FD5F9BB7401C05" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_7ED92063EBF3C49B83FD5F9BB7401C05" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_33078A5F5FA3EAADB9565F9BB74086DD_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_33078A5F5FA3EAADB9565F9BB74086DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued to extinguish convertible notes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_33078A5F5FA3EAADB9565F9BB74086DD_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_33078A5F5FA3EAADB9565F9BB74086DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_33078A5F5FA3EAADB9565F9BB74086DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_33078A5F5FA3EAADB9565F9BB74086DD" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_33078A5F5FA3EAADB9565F9BB74086DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C5B29BB6139024B3E7885F9BB7403585_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C5B29BB6139024B3E7885F9BB7403585" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock in acquisitions (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C5B29BB6139024B3E7885F9BB7403585_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C5B29BB6139024B3E7885F9BB7403585" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C5B29BB6139024B3E7885F9BB7403585" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C5B29BB6139024B3E7885F9BB7403585" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C5B29BB6139024B3E7885F9BB7403585" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_409BA26535F4B3F24C365F9BB74174FE_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_409BA26535F4B3F24C365F9BB74174FE" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_409BA26535F4B3F24C365F9BB74174FE_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_409BA26535F4B3F24C365F9BB74174FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_409BA26535F4B3F24C365F9BB74174FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_409BA26535F4B3F24C365F9BB74174FE" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired_409BA26535F4B3F24C365F9BB74174FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_949B4788A25DFF6033D25F9BB741C532_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_949B4788A25DFF6033D25F9BB741C532" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_949B4788A25DFF6033D25F9BB741C532_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_949B4788A25DFF6033D25F9BB741C532" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_949B4788A25DFF6033D25F9BB741C532" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_949B4788A25DFF6033D25F9BB741C532" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_949B4788A25DFF6033D25F9BB741C532" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_9EB5843DA397ADCB0EF15F9BB74165ED_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_9EB5843DA397ADCB0EF15F9BB74165ED" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_9EB5843DA397ADCB0EF15F9BB74165ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_9EB5843DA397ADCB0EF15F9BB74165ED" xlink:to="lab_us-gaap_NetIncomeLoss_9EB5843DA397ADCB0EF15F9BB74165ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_E1774D4E236A8FB905975F9BB741862F_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_E1774D4E236A8FB905975F9BB741862F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_E1774D4E236A8FB905975F9BB741862F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_E1774D4E236A8FB905975F9BB741862F" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_E1774D4E236A8FB905975F9BB741862F" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_228EB9B55FE75993AD575F9BB741CE72_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_228EB9B55FE75993AD575F9BB741CE72" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_228EB9B55FE75993AD575F9BB741CE72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_228EB9B55FE75993AD575F9BB741CE72" xlink:to="lab_us-gaap_CommonStockSharesIssued_228EB9B55FE75993AD575F9BB741CE72" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_374D41F9CC79809C4922B156071EB234_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_374D41F9CC79809C4922B156071EB234" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_374D41F9CC79809C4922B156071EB234_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_374D41F9CC79809C4922B156071EB234" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_374D41F9CC79809C4922B156071EB234" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_374D41F9CC79809C4922B156071EB234" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_374D41F9CC79809C4922B156071EB234" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2DEFB701E2A867497983B156072072E7_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2DEFB701E2A867497983B156072072E7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2DEFB701E2A867497983B156072072E7_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2DEFB701E2A867497983B156072072E7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2DEFB701E2A867497983B156072072E7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2DEFB701E2A867497983B156072072E7" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2DEFB701E2A867497983B156072072E7" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_49F16ECA3E0E165CC7915DEBAE2C5723_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_49F16ECA3E0E165CC7915DEBAE2C5723" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">US</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_49F16ECA3E0E165CC7915DEBAE2C5723_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_49F16ECA3E0E165CC7915DEBAE2C5723" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_49F16ECA3E0E165CC7915DEBAE2C5723" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_49F16ECA3E0E165CC7915DEBAE2C5723" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_49F16ECA3E0E165CC7915DEBAE2C5723" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_EDB89D9CCA32D066EE585DEBAE2C5119_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_EDB89D9CCA32D066EE585DEBAE2C5119" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_EDB89D9CCA32D066EE585DEBAE2C5119_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_EDB89D9CCA32D066EE585DEBAE2C5119" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_EDB89D9CCA32D066EE585DEBAE2C5119" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_EDB89D9CCA32D066EE585DEBAE2C5119" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_EDB89D9CCA32D066EE585DEBAE2C5119" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_2DC8C91228F2ED20E3AD5DEBAE2CC876_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent_2DC8C91228F2ED20E3AD5DEBAE2CC876" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Earnings before taxes on income</link:label>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_2DC8C91228F2ED20E3AD5DEBAE2CC876_label_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent_2DC8C91228F2ED20E3AD5DEBAE2CC876" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) Attributable to Parent, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossAttributableToParent" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_2DC8C91228F2ED20E3AD5DEBAE2CC876" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_2DC8C91228F2ED20E3AD5DEBAE2CC876" xlink:to="lab_us-gaap_IncomeLossAttributableToParent_2DC8C91228F2ED20E3AD5DEBAE2CC876" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3FB2A7CE91540AF9F8555DEBAE2C8B19_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3FB2A7CE91540AF9F8555DEBAE2C8B19" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal tax at statutory rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3FB2A7CE91540AF9F8555DEBAE2C8B19_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3FB2A7CE91540AF9F8555DEBAE2C8B19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3FB2A7CE91540AF9F8555DEBAE2C8B19" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3FB2A7CE91540AF9F8555DEBAE2C8B19" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3FB2A7CE91540AF9F8555DEBAE2C8B19" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_6CE107740853AF0EB8155DEBAE2C83C6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_6CE107740853AF0EB8155DEBAE2C83C6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_6CE107740853AF0EB8155DEBAE2C83C6_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_6CE107740853AF0EB8155DEBAE2C83C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_6CE107740853AF0EB8155DEBAE2C83C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_6CE107740853AF0EB8155DEBAE2C83C6" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_6CE107740853AF0EB8155DEBAE2C83C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_03B65CFEF7B854C82B255DEBAE2DDDF2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_03B65CFEF7B854C82B255DEBAE2DDDF2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of foreign operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_03B65CFEF7B854C82B255DEBAE2DDDF2_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_03B65CFEF7B854C82B255DEBAE2DDDF2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_03B65CFEF7B854C82B255DEBAE2DDDF2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_03B65CFEF7B854C82B255DEBAE2DDDF2" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_03B65CFEF7B854C82B255DEBAE2DDDF2" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_8BB8974E9069FC8E021C5DEBAE2D7D75_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_8BB8974E9069FC8E021C5DEBAE2D7D75" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_8BB8974E9069FC8E021C5DEBAE2D7D75_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_8BB8974E9069FC8E021C5DEBAE2D7D75" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_8BB8974E9069FC8E021C5DEBAE2D7D75" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_8BB8974E9069FC8E021C5DEBAE2D7D75" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_8BB8974E9069FC8E021C5DEBAE2D7D75" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCredits_1610509FF19974CC628D5DEBAE2DB4F6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCredits_1610509FF19974CC628D5DEBAE2DB4F6" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCredits_1610509FF19974CC628D5DEBAE2DB4F6_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCredits_1610509FF19974CC628D5DEBAE2DB4F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits_1610509FF19974CC628D5DEBAE2DB4F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCredits_1610509FF19974CC628D5DEBAE2DB4F6" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCredits_1610509FF19974CC628D5DEBAE2DB4F6" xlink:type="arc" />
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_549EED64DB802AFAC6EC5DEBAE2D24AB_terseLabel_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_549EED64DB802AFAC6EC5DEBAE2D24AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transition tax</link:label>
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_549EED64DB802AFAC6EC5DEBAE2D24AB_label_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_549EED64DB802AFAC6EC5DEBAE2D24AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act of 2017, Transition Tax on Accumulated Foreign Earnings, Amount</link:label>
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_549EED64DB802AFAC6EC5DEBAE2D24AB_documentation_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_549EED64DB802AFAC6EC5DEBAE2D24AB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_549EED64DB802AFAC6EC5DEBAE2D24AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_549EED64DB802AFAC6EC5DEBAE2D24AB" xlink:to="lab_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_549EED64DB802AFAC6EC5DEBAE2D24AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_A066A947B16DF37907335DEBAE2D5DFD_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_A066A947B16DF37907335DEBAE2D5DFD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in U.S. tax rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_A066A947B16DF37907335DEBAE2D5DFD_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_A066A947B16DF37907335DEBAE2D5DFD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_A066A947B16DF37907335DEBAE2D5DFD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_A066A947B16DF37907335DEBAE2D5DFD" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_A066A947B16DF37907335DEBAE2D5DFD" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_814CF6D123C2089616FD5DEBAE2E68E9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_814CF6D123C2089616FD5DEBAE2E68E9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_814CF6D123C2089616FD5DEBAE2E68E9_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_814CF6D123C2089616FD5DEBAE2E68E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_814CF6D123C2089616FD5DEBAE2E68E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_814CF6D123C2089616FD5DEBAE2E68E9" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_814CF6D123C2089616FD5DEBAE2E68E9" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_08E99536E07F8CEFFFD85DEBAE2EC601_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_08E99536E07F8CEFFFD85DEBAE2EC601" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other differences</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_08E99536E07F8CEFFFD85DEBAE2EC601_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_08E99536E07F8CEFFFD85DEBAE2EC601" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_08E99536E07F8CEFFFD85DEBAE2EC601" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_08E99536E07F8CEFFFD85DEBAE2EC601" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_08E99536E07F8CEFFFD85DEBAE2EC601" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7A71F4771E8E3FA2844E5DEBAE2E4B00_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7A71F4771E8E3FA2844E5DEBAE2E4B00" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Return to provision true-ups</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7A71F4771E8E3FA2844E5DEBAE2E4B00_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7A71F4771E8E3FA2844E5DEBAE2E4B00" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7A71F4771E8E3FA2844E5DEBAE2E4B00" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7A71F4771E8E3FA2844E5DEBAE2E4B00" xlink:to="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7A71F4771E8E3FA2844E5DEBAE2E4B00" xlink:type="arc" />
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts_4BAA99E428D2298969005DEBAE2E1CCA_terseLabel_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts_4BAA99E428D2298969005DEBAE2E1CCA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts_4BAA99E428D2298969005DEBAE2E1CCA_label_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts_4BAA99E428D2298969005DEBAE2E1CCA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Transaction Costs</link:label>
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts_4BAA99E428D2298969005DEBAE2E1CCA_documentation_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts_4BAA99E428D2298969005DEBAE2E1CCA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to transaction costs.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts_4BAA99E428D2298969005DEBAE2E1CCA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts_4BAA99E428D2298969005DEBAE2E1CCA" xlink:to="lab_ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts_4BAA99E428D2298969005DEBAE2E1CCA" xlink:type="arc" />
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount_0983980A7FE3526DC8C45DF338D20AD1_terseLabel_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount_0983980A7FE3526DC8C45DF338D20AD1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount_0983980A7FE3526DC8C45DF338D20AD1_label_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount_0983980A7FE3526DC8C45DF338D20AD1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Contingent Consideration, Amount</link:label>
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount_0983980A7FE3526DC8C45DF338D20AD1_documentation_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount_0983980A7FE3526DC8C45DF338D20AD1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Contingent Consideration, Amount</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount_0983980A7FE3526DC8C45DF338D20AD1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount_0983980A7FE3526DC8C45DF338D20AD1" xlink:to="lab_ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount_0983980A7FE3526DC8C45DF338D20AD1" xlink:type="arc" />
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount_4C73B8FD4C41D67D73575DEBAE2EC7B4_terseLabel_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount_4C73B8FD4C41D67D73575DEBAE2EC7B4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation limitation</link:label>
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount_4C73B8FD4C41D67D73575DEBAE2EC7B4_label_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount_4C73B8FD4C41D67D73575DEBAE2EC7B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Compensation Limitation, Amount</link:label>
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount_4C73B8FD4C41D67D73575DEBAE2EC7B4_documentation_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount_4C73B8FD4C41D67D73575DEBAE2EC7B4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Compensation Limitation, Amount</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount_4C73B8FD4C41D67D73575DEBAE2EC7B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount_4C73B8FD4C41D67D73575DEBAE2EC7B4" xlink:to="lab_ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount_4C73B8FD4C41D67D73575DEBAE2EC7B4" xlink:type="arc" />
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_CA61A5BF3A8BED2BDAE05DEBAE2F8D95_terseLabel_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_CA61A5BF3A8BED2BDAE05DEBAE2F8D95" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FIN 48</link:label>
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_CA61A5BF3A8BED2BDAE05DEBAE2F8D95_label_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_CA61A5BF3A8BED2BDAE05DEBAE2F8D95" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Uncertain Tax Positions, Amount</link:label>
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_CA61A5BF3A8BED2BDAE05DEBAE2F8D95_documentation_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_CA61A5BF3A8BED2BDAE05DEBAE2F8D95" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Uncertain Tax Positions, Amount</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_CA61A5BF3A8BED2BDAE05DEBAE2F8D95" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_CA61A5BF3A8BED2BDAE05DEBAE2F8D95" xlink:to="lab_ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_CA61A5BF3A8BED2BDAE05DEBAE2F8D95" xlink:type="arc" />
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet_65D63EDAB7BB53BF2F3D5DEBAE2F3BCA_terseLabel_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet_65D63EDAB7BB53BF2F3D5DEBAE2F3BCA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GILTI, net</link:label>
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet_65D63EDAB7BB53BF2F3D5DEBAE2F3BCA_label_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet_65D63EDAB7BB53BF2F3D5DEBAE2F3BCA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act of 2017,Global Intangible Low-taxed Income Tax, net</link:label>
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet_65D63EDAB7BB53BF2F3D5DEBAE2F3BCA_documentation_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet_65D63EDAB7BB53BF2F3D5DEBAE2F3BCA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) from Gilti (Global Intangible Low-taxed Income) tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet_65D63EDAB7BB53BF2F3D5DEBAE2F3BCA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet_65D63EDAB7BB53BF2F3D5DEBAE2F3BCA" xlink:to="lab_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet_65D63EDAB7BB53BF2F3D5DEBAE2F3BCA" xlink:type="arc" />
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference_65638797353011D76D1E5DEBAE2FDE36_negatedLabel_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference_65638797353011D76D1E5DEBAE2FDE36" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Permanent differences</link:label>
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference_65638797353011D76D1E5DEBAE2FDE36_label_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference_65638797353011D76D1E5DEBAE2FDE36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Permanent Difference</link:label>
    <link:label id="lab_ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference_65638797353011D76D1E5DEBAE2FDE36_documentation_en-US" xlink:label="lab_ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference_65638797353011D76D1E5DEBAE2FDE36" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to permanent differences.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference_65638797353011D76D1E5DEBAE2FDE36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference_65638797353011D76D1E5DEBAE2FDE36" xlink:to="lab_ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference_65638797353011D76D1E5DEBAE2FDE36" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_2BC24A19A84C3CC86DAC5DEBAE2FEF55_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_2BC24A19A84C3CC86DAC5DEBAE2FEF55" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_2BC24A19A84C3CC86DAC5DEBAE2FEF55_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_2BC24A19A84C3CC86DAC5DEBAE2FEF55" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2BC24A19A84C3CC86DAC5DEBAE2FEF55" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_2BC24A19A84C3CC86DAC5DEBAE2FEF55" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_2BC24A19A84C3CC86DAC5DEBAE2FEF55" xlink:type="arc" />
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_7F3345EF058FBA5A261823C57C685A18_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract_7F3345EF058FBA5A261823C57C685A18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_7F3345EF058FBA5A261823C57C685A18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_7F3345EF058FBA5A261823C57C685A18" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract_7F3345EF058FBA5A261823C57C685A18" xlink:type="arc" />
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_C814E19424E9D7FB259723C57C685741_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_C814E19424E9D7FB259723C57C685741" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule II - Valuation and Qualifying Accounts</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_C814E19424E9D7FB259723C57C685741_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_C814E19424E9D7FB259723C57C685741" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_C814E19424E9D7FB259723C57C685741" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_C814E19424E9D7FB259723C57C685741" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_C814E19424E9D7FB259723C57C685741" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_09173B8562964DE8FDE9CCD36DEE3E76_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_09173B8562964DE8FDE9CCD36DEE3E76" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_09173B8562964DE8FDE9CCD36DEE3E76_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_09173B8562964DE8FDE9CCD36DEE3E76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_09173B8562964DE8FDE9CCD36DEE3E76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_09173B8562964DE8FDE9CCD36DEE3E76" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_09173B8562964DE8FDE9CCD36DEE3E76" xlink:type="arc" />
    <link:label id="lab_ebs_OtherLongTermDebtFacilityMember_E10634234ACFCA832EF721D7F8D6CF90_terseLabel_en-US" xlink:label="lab_ebs_OtherLongTermDebtFacilityMember_E10634234ACFCA832EF721D7F8D6CF90" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ebs_OtherLongTermDebtFacilityMember_E10634234ACFCA832EF721D7F8D6CF90_label_en-US" xlink:label="lab_ebs_OtherLongTermDebtFacilityMember_E10634234ACFCA832EF721D7F8D6CF90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Long Term Debt Facility [Member]</link:label>
    <link:label id="lab_ebs_OtherLongTermDebtFacilityMember_E10634234ACFCA832EF721D7F8D6CF90_documentation_en-US" xlink:label="lab_ebs_OtherLongTermDebtFacilityMember_E10634234ACFCA832EF721D7F8D6CF90" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Long Term Debt Facility [Member]</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_OtherLongTermDebtFacilityMember" xlink:label="loc_ebs_OtherLongTermDebtFacilityMember_E10634234ACFCA832EF721D7F8D6CF90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_OtherLongTermDebtFacilityMember_E10634234ACFCA832EF721D7F8D6CF90" xlink:to="lab_ebs_OtherLongTermDebtFacilityMember_E10634234ACFCA832EF721D7F8D6CF90" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebt_48CE3B512138D637804E21D7F8D64009_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt_48CE3B512138D637804E21D7F8D64009" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_48CE3B512138D637804E21D7F8D64009" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt_48CE3B512138D637804E21D7F8D64009" xlink:to="lab_us-gaap_LongTermDebt_48CE3B512138D637804E21D7F8D64009" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtCurrent_A2598B751FEE87951C4D21D7F8D6B2B5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent_A2598B751FEE87951C4D21D7F8D6B2B5" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Current portion of debt, net of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_A2598B751FEE87951C4D21D7F8D6B2B5_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent_A2598B751FEE87951C4D21D7F8D6B2B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_A2598B751FEE87951C4D21D7F8D6B2B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent_A2598B751FEE87951C4D21D7F8D6B2B5" xlink:to="lab_us-gaap_LongTermDebtCurrent_A2598B751FEE87951C4D21D7F8D6B2B5" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_22C12ED5BE08C4D7739721D7F8DB785D_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_22C12ED5BE08C4D7739721D7F8DB785D" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_22C12ED5BE08C4D7739721D7F8DB785D_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_22C12ED5BE08C4D7739721D7F8DB785D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_22C12ED5BE08C4D7739721D7F8DB785D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_22C12ED5BE08C4D7739721D7F8DB785D" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_22C12ED5BE08C4D7739721D7F8DB785D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_2138128412F1AB9DF1B321D7F8DC0825_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent_2138128412F1AB9DF1B321D7F8DC0825" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_2138128412F1AB9DF1B321D7F8DC0825_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent_2138128412F1AB9DF1B321D7F8DC0825" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2138128412F1AB9DF1B321D7F8DC0825" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_2138128412F1AB9DF1B321D7F8DC0825" xlink:to="lab_us-gaap_LongTermDebtNoncurrent_2138128412F1AB9DF1B321D7F8DC0825" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_B3BEA467D84163F992ABCCD36F7DA40C_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock_B3BEA467D84163F992ABCCD36F7DA40C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_B3BEA467D84163F992ABCCD36F7DA40C_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock_B3BEA467D84163F992ABCCD36F7DA40C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_B3BEA467D84163F992ABCCD36F7DA40C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock_B3BEA467D84163F992ABCCD36F7DA40C" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock_B3BEA467D84163F992ABCCD36F7DA40C" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2CD5F016DE25B19E92BE23C57D53CDA6_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2CD5F016DE25B19E92BE23C57D53CDA6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2CD5F016DE25B19E92BE23C57D53CDA6_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2CD5F016DE25B19E92BE23C57D53CDA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2CD5F016DE25B19E92BE23C57D53CDA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2CD5F016DE25B19E92BE23C57D53CDA6" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2CD5F016DE25B19E92BE23C57D53CDA6" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_4127D95788E9FA1DF60F23C57D533B3B_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit_4127D95788E9FA1DF60F23C57D533B3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_4127D95788E9FA1DF60F23C57D533B3B_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit_4127D95788E9FA1DF60F23C57D533B3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4127D95788E9FA1DF60F23C57D533B3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4127D95788E9FA1DF60F23C57D533B3B" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit_4127D95788E9FA1DF60F23C57D533B3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_DA843E0AA23D1575597823C57D53B0DE_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_DA843E0AA23D1575597823C57D53B0DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_DA843E0AA23D1575597823C57D53B0DE_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_DA843E0AA23D1575597823C57D53B0DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_DA843E0AA23D1575597823C57D53B0DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_DA843E0AA23D1575597823C57D53B0DE" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_DA843E0AA23D1575597823C57D53B0DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_C6C142665641D75A5B0823C57D543375_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit_C6C142665641D75A5B0823C57D543375" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_C6C142665641D75A5B0823C57D543375_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit_C6C142665641D75A5B0823C57D543375" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_C6C142665641D75A5B0823C57D543375" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit_C6C142665641D75A5B0823C57D543375" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit_C6C142665641D75A5B0823C57D543375" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_44A13A0C9C7949B6BD3423C57D542919_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_44A13A0C9C7949B6BD3423C57D542919" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_44A13A0C9C7949B6BD3423C57D542919_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_44A13A0C9C7949B6BD3423C57D542919" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_44A13A0C9C7949B6BD3423C57D542919" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_44A13A0C9C7949B6BD3423C57D542919" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_44A13A0C9C7949B6BD3423C57D542919" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3F9F315C9304EEB77C1D23C57D5417EB_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3F9F315C9304EEB77C1D23C57D5417EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3F9F315C9304EEB77C1D23C57D5417EB_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3F9F315C9304EEB77C1D23C57D5417EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3F9F315C9304EEB77C1D23C57D5417EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3F9F315C9304EEB77C1D23C57D5417EB" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3F9F315C9304EEB77C1D23C57D5417EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_E3C9B771E0B9C18FAE0D23C57D54BE74_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_E3C9B771E0B9C18FAE0D23C57D54BE74" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_E3C9B771E0B9C18FAE0D23C57D54BE74_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_E3C9B771E0B9C18FAE0D23C57D54BE74" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_E3C9B771E0B9C18FAE0D23C57D54BE74" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_E3C9B771E0B9C18FAE0D23C57D54BE74" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_E3C9B771E0B9C18FAE0D23C57D54BE74" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_E01E5FF466ACCEA6B37E23C57D54BD0E_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_E01E5FF466ACCEA6B37E23C57D54BD0E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_E01E5FF466ACCEA6B37E23C57D54BD0E_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_E01E5FF466ACCEA6B37E23C57D54BD0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_E01E5FF466ACCEA6B37E23C57D54BD0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_E01E5FF466ACCEA6B37E23C57D54BD0E" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_E01E5FF466ACCEA6B37E23C57D54BD0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_39184CCF35C2115D8ED723C57D548FB5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_39184CCF35C2115D8ED723C57D548FB5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_39184CCF35C2115D8ED723C57D548FB5_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_39184CCF35C2115D8ED723C57D548FB5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_39184CCF35C2115D8ED723C57D548FB5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_39184CCF35C2115D8ED723C57D548FB5" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_39184CCF35C2115D8ED723C57D548FB5" xlink:type="arc" />
    <link:label id="lab_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_FD4083DB87B96000194E23C57D5537AE_totalLabel_en-US" xlink:label="lab_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_FD4083DB87B96000194E23C57D5537AE" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_FD4083DB87B96000194E23C57D5537AE_label_en-US" xlink:label="lab_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_FD4083DB87B96000194E23C57D5537AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit) before purchase price adjustment</link:label>
    <link:label id="lab_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_FD4083DB87B96000194E23C57D5537AE_documentation_en-US" xlink:label="lab_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_FD4083DB87B96000194E23C57D5537AE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to continuing operations before purchase price adjustment.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment" xlink:label="loc_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_FD4083DB87B96000194E23C57D5537AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_FD4083DB87B96000194E23C57D5537AE" xlink:to="lab_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_FD4083DB87B96000194E23C57D5537AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_961A5B897D44B507E213CAFC04A7B4C5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_961A5B897D44B507E213CAFC04A7B4C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_961A5B897D44B507E213CAFC04A7B4C5_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_961A5B897D44B507E213CAFC04A7B4C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_961A5B897D44B507E213CAFC04A7B4C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_961A5B897D44B507E213CAFC04A7B4C5" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_961A5B897D44B507E213CAFC04A7B4C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FC03C573D22B88A5BE27CAFC04A7F704_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FC03C573D22B88A5BE27CAFC04A7F704" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FC03C573D22B88A5BE27CAFC04A7F704_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FC03C573D22B88A5BE27CAFC04A7F704" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FC03C573D22B88A5BE27CAFC04A7F704" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FC03C573D22B88A5BE27CAFC04A7F704" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FC03C573D22B88A5BE27CAFC04A7F704" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_EDB9AD3704FCE5BD0569CAFC04A794E0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_EDB9AD3704FCE5BD0569CAFC04A794E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_EDB9AD3704FCE5BD0569CAFC04A794E0_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_EDB9AD3704FCE5BD0569CAFC04A794E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_EDB9AD3704FCE5BD0569CAFC04A794E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_EDB9AD3704FCE5BD0569CAFC04A794E0" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_EDB9AD3704FCE5BD0569CAFC04A794E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_365065BCF79714E3F25FCAFC04A8D527_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_365065BCF79714E3F25FCAFC04A8D527" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_365065BCF79714E3F25FCAFC04A8D527_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_365065BCF79714E3F25FCAFC04A8D527" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_365065BCF79714E3F25FCAFC04A8D527" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_365065BCF79714E3F25FCAFC04A8D527" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_365065BCF79714E3F25FCAFC04A8D527" xlink:type="arc" />
    <link:label id="lab_ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter_556008D11630C0A5DFC4CAFC04A87B90_terseLabel_en-US" xlink:label="lab_ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter_556008D11630C0A5DFC4CAFC04A87B90" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 and beyond</link:label>
    <link:label id="lab_ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter_556008D11630C0A5DFC4CAFC04A87B90_label_en-US" xlink:label="lab_ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter_556008D11630C0A5DFC4CAFC04A87B90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite Lived Intangible Assets Amortization Expense Year Five and After</link:label>
    <link:label id="lab_ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter_556008D11630C0A5DFC4CAFC04A87B90_documentation_en-US" xlink:label="lab_ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter_556008D11630C0A5DFC4CAFC04A87B90" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of amortization expense expected to be recognized during the fifth fiscal year and after following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter" xlink:label="loc_ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter_556008D11630C0A5DFC4CAFC04A87B90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter_556008D11630C0A5DFC4CAFC04A87B90" xlink:to="lab_ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter_556008D11630C0A5DFC4CAFC04A87B90" xlink:type="arc" />
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_E0FFF4D9138FAE405AD2CCD36E418774_verboseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_E0FFF4D9138FAE405AD2CCD36E418774" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of significant accounting policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_E0FFF4D9138FAE405AD2CCD36E418774_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_E0FFF4D9138FAE405AD2CCD36E418774" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_E0FFF4D9138FAE405AD2CCD36E418774" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock_E0FFF4D9138FAE405AD2CCD36E418774" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock_E0FFF4D9138FAE405AD2CCD36E418774" xlink:type="arc" />
    <link:label id="lab_ebs_CommonStockNumberofVotesPerCommonShare_C367597176DBBBB9D300556D603733BB_terseLabel_en-US" xlink:label="lab_ebs_CommonStockNumberofVotesPerCommonShare_C367597176DBBBB9D300556D603733BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, voting rights</link:label>
    <link:label id="lab_ebs_CommonStockNumberofVotesPerCommonShare_C367597176DBBBB9D300556D603733BB_label_en-US" xlink:label="lab_ebs_CommonStockNumberofVotesPerCommonShare_C367597176DBBBB9D300556D603733BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Number of Votes Per Common Share</link:label>
    <link:label id="lab_ebs_CommonStockNumberofVotesPerCommonShare_C367597176DBBBB9D300556D603733BB_documentation_en-US" xlink:label="lab_ebs_CommonStockNumberofVotesPerCommonShare_C367597176DBBBB9D300556D603733BB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Number of Votes Per Common Share</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_CommonStockNumberofVotesPerCommonShare" xlink:label="loc_ebs_CommonStockNumberofVotesPerCommonShare_C367597176DBBBB9D300556D603733BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_CommonStockNumberofVotesPerCommonShare_C367597176DBBBB9D300556D603733BB" xlink:to="lab_ebs_CommonStockNumberofVotesPerCommonShare_C367597176DBBBB9D300556D603733BB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_E33FB26D740A196927D8556D6037256E_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_E33FB26D740A196927D8556D6037256E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock authorized for issuance under the plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_E33FB26D740A196927D8556D6037256E_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_E33FB26D740A196927D8556D6037256E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_E33FB26D740A196927D8556D6037256E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_E33FB26D740A196927D8556D6037256E" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_E33FB26D740A196927D8556D6037256E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D57A5A1A96253D5CA107556D60370B35_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D57A5A1A96253D5CA107556D60370B35" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock available for future awards (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D57A5A1A96253D5CA107556D60370B35_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D57A5A1A96253D5CA107556D60370B35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D57A5A1A96253D5CA107556D60370B35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D57A5A1A96253D5CA107556D60370B35" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D57A5A1A96253D5CA107556D60370B35" xlink:type="arc" />
    <link:label id="lab_ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum_C348C987BA21759ED43E556D60379DBA_terseLabel_en-US" xlink:label="lab_ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum_C348C987BA21759ED43E556D60379DBA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price of option as percentage of fair market value at grant date, minimum</link:label>
    <link:label id="lab_ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum_C348C987BA21759ED43E556D60379DBA_label_en-US" xlink:label="lab_ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum_C348C987BA21759ED43E556D60379DBA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Of Option As Percentage Of Fair Market Value At Grant Date, Minimum</link:label>
    <link:label id="lab_ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum_C348C987BA21759ED43E556D60379DBA_documentation_en-US" xlink:label="lab_ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum_C348C987BA21759ED43E556D60379DBA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Minimum exercise price of option as percentage of the fair market value of the shares underlying such option on the date of grant.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum" xlink:label="loc_ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum_C348C987BA21759ED43E556D60379DBA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum_C348C987BA21759ED43E556D60379DBA" xlink:to="lab_ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum_C348C987BA21759ED43E556D60379DBA" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0411A5B1D831A02831A8556D60374E3A_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0411A5B1D831A02831A8556D60374E3A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contractual life of awards</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0411A5B1D831A02831A8556D60374E3A_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0411A5B1D831A02831A8556D60374E3A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0411A5B1D831A02831A8556D60374E3A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0411A5B1D831A02831A8556D60374E3A" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0411A5B1D831A02831A8556D60374E3A" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_BF7E0567434C146903D5556D60370C55_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_BF7E0567434C146903D5556D60370C55" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual term of options outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_BF7E0567434C146903D5556D60370C55_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_BF7E0567434C146903D5556D60370C55" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_BF7E0567434C146903D5556D60370C55" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_BF7E0567434C146903D5556D60370C55" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_BF7E0567434C146903D5556D60370C55" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_BC9B3B23EE096623804B556D6037EEB7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_BC9B3B23EE096623804B556D6037EEB7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual term of options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_BC9B3B23EE096623804B556D6037EEB7_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_BC9B3B23EE096623804B556D6037EEB7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_BC9B3B23EE096623804B556D6037EEB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_BC9B3B23EE096623804B556D6037EEB7" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_BC9B3B23EE096623804B556D6037EEB7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_C2065170B35E5C3EA3CE556D6037940C_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_C2065170B35E5C3EA3CE556D6037940C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value of options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_C2065170B35E5C3EA3CE556D6037940C_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_C2065170B35E5C3EA3CE556D6037940C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_C2065170B35E5C3EA3CE556D6037940C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_C2065170B35E5C3EA3CE556D6037940C" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_C2065170B35E5C3EA3CE556D6037940C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_C66044ADA297E36C3DEB556D603715E5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_C66044ADA297E36C3DEB556D603715E5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_C66044ADA297E36C3DEB556D603715E5_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_C66044ADA297E36C3DEB556D603715E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_C66044ADA297E36C3DEB556D603715E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_C66044ADA297E36C3DEB556D603715E5" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_C66044ADA297E36C3DEB556D603715E5" xlink:type="arc" />
    <link:label id="lab_ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue_3B5487ECBEA212B633D2556D6037A54F_terseLabel_en-US" xlink:label="lab_ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue_3B5487ECBEA212B633D2556D6037A54F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total fair value of awards vested</link:label>
    <link:label id="lab_ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue_3B5487ECBEA212B633D2556D6037A54F_label_en-US" xlink:label="lab_ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue_3B5487ECBEA212B633D2556D6037A54F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share based Compensation Arrangement Share based Payment Award, Awards Vested in Period, Fair Value</link:label>
    <link:label id="lab_ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue_3B5487ECBEA212B633D2556D6037A54F_documentation_en-US" xlink:label="lab_ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue_3B5487ECBEA212B633D2556D6037A54F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair value of share-based compensation awards vested. Includes options, share units, stock appreciation rights, and restricted stock.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue" xlink:label="loc_ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue_3B5487ECBEA212B633D2556D6037A54F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue_3B5487ECBEA212B633D2556D6037A54F" xlink:to="lab_ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue_3B5487ECBEA212B633D2556D6037A54F" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_F9789D8D71473B2F5D78556D603753D8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_F9789D8D71473B2F5D78556D603753D8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation cost expected to be recognized related to unvested equity awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_F9789D8D71473B2F5D78556D603753D8_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_F9789D8D71473B2F5D78556D603753D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_F9789D8D71473B2F5D78556D603753D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_F9789D8D71473B2F5D78556D603753D8" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_F9789D8D71473B2F5D78556D603753D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_B4CD8282C87AA52DB0BF556D60378F2C_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_B4CD8282C87AA52DB0BF556D60378F2C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average period expected to be recognized related to unvested equity awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_B4CD8282C87AA52DB0BF556D60378F2C_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_B4CD8282C87AA52DB0BF556D60378F2C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_B4CD8282C87AA52DB0BF556D60378F2C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_B4CD8282C87AA52DB0BF556D60378F2C" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_B4CD8282C87AA52DB0BF556D60378F2C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:to="lab_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_3EB68F1E9F0349D29A344FB8494BED5E_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis_3EB68F1E9F0349D29A344FB8494BED5E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_3EB68F1E9F0349D29A344FB8494BED5E_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis_3EB68F1E9F0349D29A344FB8494BED5E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_3EB68F1E9F0349D29A344FB8494BED5E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_3EB68F1E9F0349D29A344FB8494BED5E" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis_3EB68F1E9F0349D29A344FB8494BED5E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_5C07E67F953A9DE139B24FB8494B1F49_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain_5C07E67F953A9DE139B24FB8494B1F49" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_5C07E67F953A9DE139B24FB8494B1F49_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain_5C07E67F953A9DE139B24FB8494B1F49" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5C07E67F953A9DE139B24FB8494B1F49" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5C07E67F953A9DE139B24FB8494B1F49" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain_5C07E67F953A9DE139B24FB8494B1F49" xlink:type="arc" />
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_2FE7F148126E5BF49D2A4FB8494B02B7_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember_2FE7F148126E5BF49D2A4FB8494B02B7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_2FE7F148126E5BF49D2A4FB8494B02B7_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember_2FE7F148126E5BF49D2A4FB8494B02B7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_2FE7F148126E5BF49D2A4FB8494B02B7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember_2FE7F148126E5BF49D2A4FB8494B02B7" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember_2FE7F148126E5BF49D2A4FB8494B02B7" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableMember_CD903B13118194E0265D4FB8494FAF19_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember_CD903B13118194E0265D4FB8494FAF19" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_CD903B13118194E0265D4FB8494FAF19_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember_CD903B13118194E0265D4FB8494FAF19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_CD903B13118194E0265D4FB8494FAF19" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember_CD903B13118194E0265D4FB8494FAF19" xlink:to="lab_us-gaap_AccountsReceivableMember_CD903B13118194E0265D4FB8494FAF19" xlink:type="arc" />
    <link:label id="lab_srt_MajorCustomersAxis_18797490A71AD8E09CFE4FB8494F2AA7_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis_18797490A71AD8E09CFE4FB8494F2AA7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_18797490A71AD8E09CFE4FB8494F2AA7_label_en-US" xlink:label="lab_srt_MajorCustomersAxis_18797490A71AD8E09CFE4FB8494F2AA7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_18797490A71AD8E09CFE4FB8494F2AA7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis_18797490A71AD8E09CFE4FB8494F2AA7" xlink:to="lab_srt_MajorCustomersAxis_18797490A71AD8E09CFE4FB8494F2AA7" xlink:type="arc" />
    <link:label id="lab_srt_NameOfMajorCustomerDomain_4478BC7D1B9118FDA8894FB8494F7FAE_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain_4478BC7D1B9118FDA8894FB8494F7FAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_4478BC7D1B9118FDA8894FB8494F7FAE_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain_4478BC7D1B9118FDA8894FB8494F7FAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_4478BC7D1B9118FDA8894FB8494F7FAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain_4478BC7D1B9118FDA8894FB8494F7FAE" xlink:to="lab_srt_NameOfMajorCustomerDomain_4478BC7D1B9118FDA8894FB8494F7FAE" xlink:type="arc" />
    <link:label id="lab_ebs_UnitedStatesGovernmentMember_448672890942447AB3E74FB8494F95CA_terseLabel_en-US" xlink:label="lab_ebs_UnitedStatesGovernmentMember_448672890942447AB3E74FB8494F95CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">USG</link:label>
    <link:label id="lab_ebs_UnitedStatesGovernmentMember_448672890942447AB3E74FB8494F95CA_label_en-US" xlink:label="lab_ebs_UnitedStatesGovernmentMember_448672890942447AB3E74FB8494F95CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">United States Government [Member]</link:label>
    <link:label id="lab_ebs_UnitedStatesGovernmentMember_448672890942447AB3E74FB8494F95CA_documentation_en-US" xlink:label="lab_ebs_UnitedStatesGovernmentMember_448672890942447AB3E74FB8494F95CA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">United States Government [Member]</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_UnitedStatesGovernmentMember" xlink:label="loc_ebs_UnitedStatesGovernmentMember_448672890942447AB3E74FB8494F95CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_UnitedStatesGovernmentMember_448672890942447AB3E74FB8494F95CA" xlink:to="lab_ebs_UnitedStatesGovernmentMember_448672890942447AB3E74FB8494F95CA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:to="lab_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_3BC7B989FCD0165E537D4FB8494B60FF_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation_3BC7B989FCD0165E537D4FB8494B60FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, remaining performance obligation, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_3BC7B989FCD0165E537D4FB8494B60FF_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation_3BC7B989FCD0165E537D4FB8494B60FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_3BC7B989FCD0165E537D4FB8494B60FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation_3BC7B989FCD0165E537D4FB8494B60FF" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation_3BC7B989FCD0165E537D4FB8494B60FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredCostsCurrent_904DB716AF974FA61F0C4FB8494BBDCB_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCurrent_904DB716AF974FA61F0C4FB8494BBDCB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred costs, current</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCurrent_904DB716AF974FA61F0C4FB8494BBDCB_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCurrent_904DB716AF974FA61F0C4FB8494BBDCB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Costs, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCostsCurrent" xlink:label="loc_us-gaap_DeferredCostsCurrent_904DB716AF974FA61F0C4FB8494BBDCB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCurrent_904DB716AF974FA61F0C4FB8494BBDCB" xlink:to="lab_us-gaap_DeferredCostsCurrent_904DB716AF974FA61F0C4FB8494BBDCB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_36EA8116402F5FE46312F5EBD631AC75_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_36EA8116402F5FE46312F5EBD631AC75" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Matching contributions made by employer</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_36EA8116402F5FE46312F5EBD631AC75_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_36EA8116402F5FE46312F5EBD631AC75" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_36EA8116402F5FE46312F5EBD631AC75" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_36EA8116402F5FE46312F5EBD631AC75" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_36EA8116402F5FE46312F5EBD631AC75" xlink:type="arc" />
    <link:label id="lab_us-gaap_NatureOfOperations_60CE9C62C299BC03ED6202ED01693897_verboseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations_60CE9C62C299BC03ED6202ED01693897" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Nature of the business and organization</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_60CE9C62C299BC03ED6202ED01693897_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations_60CE9C62C299BC03ED6202ED01693897" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_60CE9C62C299BC03ED6202ED01693897" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations_60CE9C62C299BC03ED6202ED01693897" xlink:to="lab_us-gaap_NatureOfOperations_60CE9C62C299BC03ED6202ED01693897" xlink:type="arc" />
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_AECBE960BF805B6412C1997671D90374_verboseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock_AECBE960BF805B6412C1997671D90374" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Quarterly financial data (Unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_AECBE960BF805B6412C1997671D90374_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock_AECBE960BF805B6412C1997671D90374" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_AECBE960BF805B6412C1997671D90374" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock_AECBE960BF805B6412C1997671D90374" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock_AECBE960BF805B6412C1997671D90374" xlink:type="arc" />
    <link:label id="lab_us-gaap_SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock_04D71DAB7E116A60CC0E3F3C35C3DC89_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock_04D71DAB7E116A60CC0E3F3C35C3DC89" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase commitment</link:label>
    <link:label id="lab_us-gaap_SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock_04D71DAB7E116A60CC0E3F3C35C3DC89_label_en-US" xlink:label="lab_us-gaap_SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock_04D71DAB7E116A60CC0E3F3C35C3DC89" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase and Supply Commitment, Excluding Long-term Commitment [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock" xlink:label="loc_us-gaap_SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock_04D71DAB7E116A60CC0E3F3C35C3DC89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock_04D71DAB7E116A60CC0E3F3C35C3DC89" xlink:to="lab_us-gaap_SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock_04D71DAB7E116A60CC0E3F3C35C3DC89" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_F94E079CD3C2EB9C3695EC8A3CFFEBE8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_F94E079CD3C2EB9C3695EC8A3CFFEBE8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_F94E079CD3C2EB9C3695EC8A3CFFEBE8_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_F94E079CD3C2EB9C3695EC8A3CFFEBE8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_F94E079CD3C2EB9C3695EC8A3CFFEBE8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_F94E079CD3C2EB9C3695EC8A3CFFEBE8" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_F94E079CD3C2EB9C3695EC8A3CFFEBE8" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52C57732E6097B802C62EC8A3CFFE4AE_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52C57732E6097B802C62EC8A3CFFE4AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52C57732E6097B802C62EC8A3CFFE4AE_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52C57732E6097B802C62EC8A3CFFE4AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52C57732E6097B802C62EC8A3CFFE4AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52C57732E6097B802C62EC8A3CFFE4AE" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52C57732E6097B802C62EC8A3CFFE4AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_4B4A5AEB5CECE8AB38CEEC8A3CFF1F03_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain_4B4A5AEB5CECE8AB38CEEC8A3CFF1F03" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_4B4A5AEB5CECE8AB38CEEC8A3CFF1F03_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain_4B4A5AEB5CECE8AB38CEEC8A3CFF1F03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4B4A5AEB5CECE8AB38CEEC8A3CFF1F03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4B4A5AEB5CECE8AB38CEEC8A3CFF1F03" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain_4B4A5AEB5CECE8AB38CEEC8A3CFF1F03" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_41ED5747ACACCA3E2F56EC8A3D015582_terseLabel_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_41ED5747ACACCA3E2F56EC8A3D015582" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense, net of tax</link:label>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_41ED5747ACACCA3E2F56EC8A3D015582_label_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_41ED5747ACACCA3E2F56EC8A3D015582" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest on Convertible Debt, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_41ED5747ACACCA3E2F56EC8A3D015582" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_41ED5747ACACCA3E2F56EC8A3D015582" xlink:to="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_41ED5747ACACCA3E2F56EC8A3D015582" xlink:type="arc" />
    <link:label id="lab_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax_2AC824E1B403F9DB5D49EC8A3D01F39D_terseLabel_en-US" xlink:label="lab_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax_2AC824E1B403F9DB5D49EC8A3D01F39D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt issuance costs, net of tax</link:label>
    <link:label id="lab_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax_2AC824E1B403F9DB5D49EC8A3D01F39D_label_en-US" xlink:label="lab_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax_2AC824E1B403F9DB5D49EC8A3D01F39D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of issuance cost on convertible debt net of tax</link:label>
    <link:label id="lab_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax_2AC824E1B403F9DB5D49EC8A3D01F39D_documentation_en-US" xlink:label="lab_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax_2AC824E1B403F9DB5D49EC8A3D01F39D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The after-tax amount of amortization of issuance costs recognized in the period associated with any convertible debt.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax" xlink:label="loc_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax_2AC824E1B403F9DB5D49EC8A3D01F39D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax_2AC824E1B403F9DB5D49EC8A3D01F39D" xlink:to="lab_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax_2AC824E1B403F9DB5D49EC8A3D01F39D" xlink:type="arc" />
    <link:label id="lab_ebs_AdjustedNetLoss_A5E90A64140891A5DC41EC8A3D01E263_totalLabel_en-US" xlink:label="lab_ebs_AdjustedNetLoss_A5E90A64140891A5DC41EC8A3D01E263" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income, adjusted</link:label>
    <link:label id="lab_ebs_AdjustedNetLoss_A5E90A64140891A5DC41EC8A3D01E263_label_en-US" xlink:label="lab_ebs_AdjustedNetLoss_A5E90A64140891A5DC41EC8A3D01E263" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjusted net loss</link:label>
    <link:label id="lab_ebs_AdjustedNetLoss_A5E90A64140891A5DC41EC8A3D01E263_documentation_en-US" xlink:label="lab_ebs_AdjustedNetLoss_A5E90A64140891A5DC41EC8A3D01E263" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The portion of profit or loss for the period, net of income taxes and other adjustments.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AdjustedNetLoss" xlink:label="loc_ebs_AdjustedNetLoss_A5E90A64140891A5DC41EC8A3D01E263" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_AdjustedNetLoss_A5E90A64140891A5DC41EC8A3D01E263" xlink:to="lab_ebs_AdjustedNetLoss_A5E90A64140891A5DC41EC8A3D01E263" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4CE5FD1A09C2D3B827CAEC8A3D01E957_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4CE5FD1A09C2D3B827CAEC8A3D01E957" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average number of shares - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4CE5FD1A09C2D3B827CAEC8A3D01E957_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4CE5FD1A09C2D3B827CAEC8A3D01E957" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4CE5FD1A09C2D3B827CAEC8A3D01E957" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4CE5FD1A09C2D3B827CAEC8A3D01E957" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4CE5FD1A09C2D3B827CAEC8A3D01E957" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8FE55850D87F35115C24EC8A3D0289B5_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8FE55850D87F35115C24EC8A3D0289B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dilutive securities-equity awards (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8FE55850D87F35115C24EC8A3D0289B5_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8FE55850D87F35115C24EC8A3D0289B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8FE55850D87F35115C24EC8A3D0289B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8FE55850D87F35115C24EC8A3D0289B5" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8FE55850D87F35115C24EC8A3D0289B5" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_035E480F1DBE893A8FEDEC8A3D02E25B_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_035E480F1DBE893A8FEDEC8A3D02E25B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dilutive securities-convertible debt (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_035E480F1DBE893A8FEDEC8A3D02E25B_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_035E480F1DBE893A8FEDEC8A3D02E25B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_035E480F1DBE893A8FEDEC8A3D02E25B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_035E480F1DBE893A8FEDEC8A3D02E25B" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_035E480F1DBE893A8FEDEC8A3D02E25B" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_093B0550D9EF1B7480C1EC8A3D02D02E_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_093B0550D9EF1B7480C1EC8A3D02D02E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted-average number of shares-diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_093B0550D9EF1B7480C1EC8A3D02D02E_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_093B0550D9EF1B7480C1EC8A3D02D02E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_093B0550D9EF1B7480C1EC8A3D02D02E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_093B0550D9EF1B7480C1EC8A3D02D02E" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_093B0550D9EF1B7480C1EC8A3D02D02E" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasic_4DD06C43039657C16706EC8A3D022FD7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_4DD06C43039657C16706EC8A3D022FD7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income per share-basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_4DD06C43039657C16706EC8A3D022FD7_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_4DD06C43039657C16706EC8A3D022FD7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_4DD06C43039657C16706EC8A3D022FD7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_4DD06C43039657C16706EC8A3D022FD7" xlink:to="lab_us-gaap_EarningsPerShareBasic_4DD06C43039657C16706EC8A3D022FD7" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_243587040EBD32C702CEEC8A3D028406_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_243587040EBD32C702CEEC8A3D028406" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income per share-diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_243587040EBD32C702CEEC8A3D028406_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_243587040EBD32C702CEEC8A3D028406" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_243587040EBD32C702CEEC8A3D028406" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_243587040EBD32C702CEEC8A3D028406" xlink:to="lab_us-gaap_EarningsPerShareDiluted_243587040EBD32C702CEEC8A3D028406" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0AFD735776B873AAD050EC8A3D027648_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0AFD735776B873AAD050EC8A3D027648" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive shares excluded from calculation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0AFD735776B873AAD050EC8A3D027648_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0AFD735776B873AAD050EC8A3D027648" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0AFD735776B873AAD050EC8A3D027648" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0AFD735776B873AAD050EC8A3D027648" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0AFD735776B873AAD050EC8A3D027648" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F645D61CB0F221DE0EC9CE2D5E42B25D_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F645D61CB0F221DE0EC9CE2D5E42B25D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F645D61CB0F221DE0EC9CE2D5E42B25D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F645D61CB0F221DE0EC9CE2D5E42B25D" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F645D61CB0F221DE0EC9CE2D5E42B25D" xlink:type="arc" />
    <link:label id="lab_us-gaap_GrossProfit_58D6DD51CD58345F69BBCE2D5E42E2C4_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit_58D6DD51CD58345F69BBCE2D5E42E2C4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_GrossProfit_58D6DD51CD58345F69BBCE2D5E42E2C4_label_en-US" xlink:label="lab_us-gaap_GrossProfit_58D6DD51CD58345F69BBCE2D5E42E2C4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_58D6DD51CD58345F69BBCE2D5E42E2C4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_58D6DD51CD58345F69BBCE2D5E42E2C4" xlink:to="lab_us-gaap_GrossProfit_58D6DD51CD58345F69BBCE2D5E42E2C4" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_C78A547BEFB505818FB4CE2D5E435BC0_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_C78A547BEFB505818FB4CE2D5E435BC0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) per share-diluted (in dollar per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_C78A547BEFB505818FB4CE2D5E435BC0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_C78A547BEFB505818FB4CE2D5E435BC0" xlink:to="lab_us-gaap_EarningsPerShareDiluted_C78A547BEFB505818FB4CE2D5E435BC0" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0EA2E0088F6ECC62AD264FC42813FE81_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0EA2E0088F6ECC62AD264FC42813FE81" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, remaining performance obligation, expected timing of satisfaction, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0EA2E0088F6ECC62AD264FC42813FE81_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0EA2E0088F6ECC62AD264FC42813FE81" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0EA2E0088F6ECC62AD264FC42813FE81" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0EA2E0088F6ECC62AD264FC42813FE81" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0EA2E0088F6ECC62AD264FC42813FE81" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_53B15E4EB53263EB01524FC427E8D70E_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_53B15E4EB53263EB01524FC427E8D70E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_53B15E4EB53263EB01524FC427E8D70E_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_53B15E4EB53263EB01524FC427E8D70E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_53B15E4EB53263EB01524FC427E8D70E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_53B15E4EB53263EB01524FC427E8D70E" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_53B15E4EB53263EB01524FC427E8D70E" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_15047297E8F952F93E774FC427E89D0B_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_15047297E8F952F93E774FC427E89D0B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_15047297E8F952F93E774FC427E89D0B_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_15047297E8F952F93E774FC427E89D0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_15047297E8F952F93E774FC427E89D0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_15047297E8F952F93E774FC427E89D0B" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_15047297E8F952F93E774FC427E89D0B" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_71021F2D7C76038B97754FC66BD6ABE2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_71021F2D7C76038B97754FC66BD6ABE2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_71021F2D7C76038B97754FC66BD6ABE2_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_71021F2D7C76038B97754FC66BD6ABE2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_71021F2D7C76038B97754FC66BD6ABE2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_71021F2D7C76038B97754FC66BD6ABE2" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_71021F2D7C76038B97754FC66BD6ABE2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_BB392146B431A78EB09598B98C2D4938_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_BB392146B431A78EB09598B98C2D4938" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_BB392146B431A78EB09598B98C2D4938_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_BB392146B431A78EB09598B98C2D4938" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_BB392146B431A78EB09598B98C2D4938" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_BB392146B431A78EB09598B98C2D4938" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_BB392146B431A78EB09598B98C2D4938" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_BA85733A3B562B51F45E98B958E6BF3E_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_BA85733A3B562B51F45E98B958E6BF3E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_BA85733A3B562B51F45E98B958E6BF3E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_BA85733A3B562B51F45E98B958E6BF3E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_BA85733A3B562B51F45E98B958E6BF3E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_BA85733A3B562B51F45E98B958E6BF3E" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_BA85733A3B562B51F45E98B958E6BF3E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_1448008A098540796CE998BAB242E1F3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_1448008A098540796CE998BAB242E1F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_1448008A098540796CE998BAB242E1F3_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_1448008A098540796CE998BAB242E1F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_1448008A098540796CE998BAB242E1F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_1448008A098540796CE998BAB242E1F3" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_1448008A098540796CE998BAB242E1F3" xlink:type="arc" />
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_1E0A9E053BBC6CB6E87B7876E50C43BF_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_1E0A9E053BBC6CB6E87B7876E50C43BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_1E0A9E053BBC6CB6E87B7876E50C43BF_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_1E0A9E053BBC6CB6E87B7876E50C43BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1E0A9E053BBC6CB6E87B7876E50C43BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1E0A9E053BBC6CB6E87B7876E50C43BF" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_1E0A9E053BBC6CB6E87B7876E50C43BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_476639990BD0C3AA23CA7876E50CAED9_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_476639990BD0C3AA23CA7876E50CAED9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_476639990BD0C3AA23CA7876E50CAED9_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_476639990BD0C3AA23CA7876E50CAED9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_476639990BD0C3AA23CA7876E50CAED9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_476639990BD0C3AA23CA7876E50CAED9" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_476639990BD0C3AA23CA7876E50CAED9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryValuationReserveMember_DD17983F385EBE58531F7876E50DBB7C_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserveMember_DD17983F385EBE58531F7876E50DBB7C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory allowance</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserveMember_DD17983F385EBE58531F7876E50DBB7C_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserveMember_DD17983F385EBE58531F7876E50DBB7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Reserve, Inventory [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryValuationReserveMember" xlink:label="loc_us-gaap_InventoryValuationReserveMember_DD17983F385EBE58531F7876E50DBB7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserveMember_DD17983F385EBE58531F7876E50DBB7C" xlink:to="lab_us-gaap_InventoryValuationReserveMember_DD17983F385EBE58531F7876E50DBB7C" xlink:type="arc" />
    <link:label id="lab_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember_FB1573497F90AB9ADCD97876E50D463F_terseLabel_en-US" xlink:label="lab_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember_FB1573497F90AB9ADCD97876E50D463F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets allowance</link:label>
    <link:label id="lab_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember_FB1573497F90AB9ADCD97876E50D463F_label_en-US" xlink:label="lab_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember_FB1573497F90AB9ADCD97876E50D463F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Prepaid Expenses And Other Current Assets [Member]</link:label>
    <link:label id="lab_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember_FB1573497F90AB9ADCD97876E50D463F_documentation_en-US" xlink:label="lab_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember_FB1573497F90AB9ADCD97876E50D463F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">A valuation allowance relating to prepaid expenses and other current assets.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember_FB1573497F90AB9ADCD97876E50D463F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember_FB1573497F90AB9ADCD97876E50D463F" xlink:to="lab_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember_FB1573497F90AB9ADCD97876E50D463F" xlink:type="arc" />
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3520D23E2C34DDE7110E7876E50D4B0C_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3520D23E2C34DDE7110E7876E50D4B0C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3520D23E2C34DDE7110E7876E50D4B0C_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3520D23E2C34DDE7110E7876E50D4B0C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3520D23E2C34DDE7110E7876E50D4B0C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3520D23E2C34DDE7110E7876E50D4B0C" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3520D23E2C34DDE7110E7876E50D4B0C" xlink:type="arc" />
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_C9A128A899718AC7C1237876E50E3083_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_C9A128A899718AC7C1237876E50E3083" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_C9A128A899718AC7C1237876E50E3083_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_C9A128A899718AC7C1237876E50E3083" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_C9A128A899718AC7C1237876E50E3083" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance_C9A128A899718AC7C1237876E50E3083" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance_C9A128A899718AC7C1237876E50E3083" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_0694368D499E4ED39D2C78774D8C67FE_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_0694368D499E4ED39D2C78774D8C67FE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions from Acquisition</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_0694368D499E4ED39D2C78774D8C67FE_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_0694368D499E4ED39D2C78774D8C67FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_0694368D499E4ED39D2C78774D8C67FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_0694368D499E4ED39D2C78774D8C67FE" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_0694368D499E4ED39D2C78774D8C67FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_69AB24819D1C8CD647307876E50EC5CD_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_69AB24819D1C8CD647307876E50EC5CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Charged to costs and expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_69AB24819D1C8CD647307876E50EC5CD_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_69AB24819D1C8CD647307876E50EC5CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_69AB24819D1C8CD647307876E50EC5CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_69AB24819D1C8CD647307876E50EC5CD" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_69AB24819D1C8CD647307876E50EC5CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_4206EBADABA977B4F5287876E50FF562_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions_4206EBADABA977B4F5287876E50FF562" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_4206EBADABA977B4F5287876E50FF562_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions_4206EBADABA977B4F5287876E50FF562" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_4206EBADABA977B4F5287876E50FF562" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions_4206EBADABA977B4F5287876E50FF562" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions_4206EBADABA977B4F5287876E50FF562" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_E91A523A3BB37A4A4F907876E50FE008_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_E91A523A3BB37A4A4F907876E50FE008" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_E91A523A3BB37A4A4F907876E50FE008" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance_E91A523A3BB37A4A4F907876E50FE008" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance_E91A523A3BB37A4A4F907876E50FE008" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_A1E18711A16CEB09D65A92A2889838C4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_A1E18711A16CEB09D65A92A2889838C4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_A1E18711A16CEB09D65A92A2889838C4_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_A1E18711A16CEB09D65A92A2889838C4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_A1E18711A16CEB09D65A92A2889838C4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_A1E18711A16CEB09D65A92A2889838C4" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_A1E18711A16CEB09D65A92A2889838C4" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5306579058FEB8DB829692A28898E546_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5306579058FEB8DB829692A28898E546" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5306579058FEB8DB829692A28898E546_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5306579058FEB8DB829692A28898E546" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5306579058FEB8DB829692A28898E546" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5306579058FEB8DB829692A28898E546" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5306579058FEB8DB829692A28898E546" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:type="arc" />
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_9E8049E08E54378338B692A288981D11_terseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember_9E8049E08E54378338B692A288981D11" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Land and improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_9E8049E08E54378338B692A288981D11_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember_9E8049E08E54378338B692A288981D11" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land and Land Improvements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LandAndLandImprovementsMember" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_9E8049E08E54378338B692A288981D11" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovementsMember_9E8049E08E54378338B692A288981D11" xlink:to="lab_us-gaap_LandAndLandImprovementsMember_9E8049E08E54378338B692A288981D11" xlink:type="arc" />
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_E8978B1BEAFCCECFE4BF92A28898E2C6_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember_E8978B1BEAFCCECFE4BF92A28898E2C6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Buildings, building improvements and leasehold improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_E8978B1BEAFCCECFE4BF92A28898E2C6_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember_E8978B1BEAFCCECFE4BF92A28898E2C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_E8978B1BEAFCCECFE4BF92A28898E2C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember_E8978B1BEAFCCECFE4BF92A28898E2C6" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember_E8978B1BEAFCCECFE4BF92A28898E2C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_48978C2B8549FD69DB1792A28898DC69_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember_48978C2B8549FD69DB1792A28898DC69" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_48978C2B8549FD69DB1792A28898DC69_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember_48978C2B8549FD69DB1792A28898DC69" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_48978C2B8549FD69DB1792A28898DC69" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember_48978C2B8549FD69DB1792A28898DC69" xlink:to="lab_us-gaap_FurnitureAndFixturesMember_48978C2B8549FD69DB1792A28898DC69" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_8CB8DABBFFC506867AF092A28898BA50_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_8CB8DABBFFC506867AF092A28898BA50" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_8CB8DABBFFC506867AF092A28898BA50_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_8CB8DABBFFC506867AF092A28898BA50" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_8CB8DABBFFC506867AF092A28898BA50" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_8CB8DABBFFC506867AF092A28898BA50" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_8CB8DABBFFC506867AF092A28898BA50" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConstructionInProgressMember_DA932CF88D1944CFDDCB92A28898B80A_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember_DA932CF88D1944CFDDCB92A28898B80A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Construction-in-progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_DA932CF88D1944CFDDCB92A28898B80A_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember_DA932CF88D1944CFDDCB92A28898B80A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaap_ConstructionInProgressMember_DA932CF88D1944CFDDCB92A28898B80A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember_DA932CF88D1944CFDDCB92A28898B80A" xlink:to="lab_us-gaap_ConstructionInProgressMember_DA932CF88D1944CFDDCB92A28898B80A" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_B33819844A125B58BE4B92A288984295_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_B33819844A125B58BE4B92A288984295" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_B33819844A125B58BE4B92A288984295_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_B33819844A125B58BE4B92A288984295" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_B33819844A125B58BE4B92A288984295" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_B33819844A125B58BE4B92A288984295" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross_B33819844A125B58BE4B92A288984295" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6E491FDED89720A5A9E692A288982520_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6E491FDED89720A5A9E692A288982520" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6E491FDED89720A5A9E692A288982520_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6E491FDED89720A5A9E692A288982520" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6E491FDED89720A5A9E692A288982520" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6E491FDED89720A5A9E692A288982520" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6E491FDED89720A5A9E692A288982520" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_D080B346CF85C4F29F3D92A2889837E5_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_D080B346CF85C4F29F3D92A2889837E5" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_D080B346CF85C4F29F3D92A2889837E5_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_D080B346CF85C4F29F3D92A2889837E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_D080B346CF85C4F29F3D92A2889837E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_D080B346CF85C4F29F3D92A2889837E5" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_D080B346CF85C4F29F3D92A2889837E5" xlink:type="arc" />
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_CAB8785EC54E483372F292A288989003_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_CAB8785EC54E483372F292A288989003" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_CAB8785EC54E483372F292A288989003_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_CAB8785EC54E483372F292A288989003" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_CAB8785EC54E483372F292A288989003" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_CAB8785EC54E483372F292A288989003" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_CAB8785EC54E483372F292A288989003" xlink:type="arc" />
    <link:label id="lab_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E_label_en-US" xlink:label="lab_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover page.</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="lab_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_A7F4D58C193B913E0727555E21819AAF_terseLabel_en-US" xlink:label="lab_dei_DocumentType_A7F4D58C193B913E0727555E21819AAF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_A7F4D58C193B913E0727555E21819AAF_label_en-US" xlink:label="lab_dei_DocumentType_A7F4D58C193B913E0727555E21819AAF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_A7F4D58C193B913E0727555E21819AAF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_A7F4D58C193B913E0727555E21819AAF" xlink:to="lab_dei_DocumentType_A7F4D58C193B913E0727555E21819AAF" xlink:type="arc" />
    <link:label id="lab_dei_DocumentAnnualReport_0A0B81FD660E525A3687555E21815E33_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport_0A0B81FD660E525A3687555E21815E33" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_0A0B81FD660E525A3687555E21815E33_label_en-US" xlink:label="lab_dei_DocumentAnnualReport_0A0B81FD660E525A3687555E21815E33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_0A0B81FD660E525A3687555E21815E33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport_0A0B81FD660E525A3687555E21815E33" xlink:to="lab_dei_DocumentAnnualReport_0A0B81FD660E525A3687555E21815E33" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_21DE64FFBAEA6837173D555E218175F4_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_21DE64FFBAEA6837173D555E218175F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_21DE64FFBAEA6837173D555E218175F4_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_21DE64FFBAEA6837173D555E218175F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_21DE64FFBAEA6837173D555E218175F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_21DE64FFBAEA6837173D555E218175F4" xlink:to="lab_dei_DocumentPeriodEndDate_21DE64FFBAEA6837173D555E218175F4" xlink:type="arc" />
    <link:label id="lab_dei_DocumentTransitionReport_BB0B0F5B59CE885AAD15555E2181166C_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport_BB0B0F5B59CE885AAD15555E2181166C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_BB0B0F5B59CE885AAD15555E2181166C_label_en-US" xlink:label="lab_dei_DocumentTransitionReport_BB0B0F5B59CE885AAD15555E2181166C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_BB0B0F5B59CE885AAD15555E2181166C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_BB0B0F5B59CE885AAD15555E2181166C" xlink:to="lab_dei_DocumentTransitionReport_BB0B0F5B59CE885AAD15555E2181166C" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_1D03C3BCA8EB87AF9DBF555E21818B9E_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_1D03C3BCA8EB87AF9DBF555E21818B9E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_1D03C3BCA8EB87AF9DBF555E21818B9E_label_en-US" xlink:label="lab_dei_EntityFileNumber_1D03C3BCA8EB87AF9DBF555E21818B9E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_1D03C3BCA8EB87AF9DBF555E21818B9E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_1D03C3BCA8EB87AF9DBF555E21818B9E" xlink:to="lab_dei_EntityFileNumber_1D03C3BCA8EB87AF9DBF555E21818B9E" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_2223ADEA9BE479F6A293555E2181734C_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_2223ADEA9BE479F6A293555E2181734C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_2223ADEA9BE479F6A293555E2181734C_label_en-US" xlink:label="lab_dei_EntityRegistrantName_2223ADEA9BE479F6A293555E2181734C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_2223ADEA9BE479F6A293555E2181734C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_2223ADEA9BE479F6A293555E2181734C" xlink:to="lab_dei_EntityRegistrantName_2223ADEA9BE479F6A293555E2181734C" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_C8122B61EC86D8F94D43555E218152CC_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_C8122B61EC86D8F94D43555E218152CC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_C8122B61EC86D8F94D43555E218152CC_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_C8122B61EC86D8F94D43555E218152CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_C8122B61EC86D8F94D43555E218152CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_C8122B61EC86D8F94D43555E218152CC" xlink:to="lab_dei_EntityIncorporationStateCountryCode_C8122B61EC86D8F94D43555E218152CC" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1623850C236BBE695196555E21812E0E_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_1623850C236BBE695196555E21812E0E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1623850C236BBE695196555E21812E0E_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_1623850C236BBE695196555E21812E0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_1623850C236BBE695196555E21812E0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_1623850C236BBE695196555E21812E0E" xlink:to="lab_dei_EntityTaxIdentificationNumber_1623850C236BBE695196555E21812E0E" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_754A85D34532CBB0439A555E21811D1D_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_754A85D34532CBB0439A555E21811D1D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_754A85D34532CBB0439A555E21811D1D_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_754A85D34532CBB0439A555E21811D1D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_754A85D34532CBB0439A555E21811D1D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_754A85D34532CBB0439A555E21811D1D" xlink:to="lab_dei_EntityAddressAddressLine1_754A85D34532CBB0439A555E21811D1D" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_01254503031B46DB1F20555E2181D582_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_01254503031B46DB1F20555E2181D582" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_01254503031B46DB1F20555E2181D582_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_01254503031B46DB1F20555E2181D582" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_01254503031B46DB1F20555E2181D582" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_01254503031B46DB1F20555E2181D582" xlink:to="lab_dei_EntityAddressCityOrTown_01254503031B46DB1F20555E2181D582" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_72AA1F52CD2E05056088555E2181CCB9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_72AA1F52CD2E05056088555E2181CCB9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_72AA1F52CD2E05056088555E2181CCB9_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_72AA1F52CD2E05056088555E2181CCB9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_72AA1F52CD2E05056088555E2181CCB9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_72AA1F52CD2E05056088555E2181CCB9" xlink:to="lab_dei_EntityAddressStateOrProvince_72AA1F52CD2E05056088555E2181CCB9" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_80B4D7A079C5050B850E555E21817D1B_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_80B4D7A079C5050B850E555E21817D1B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_80B4D7A079C5050B850E555E21817D1B_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_80B4D7A079C5050B850E555E21817D1B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_80B4D7A079C5050B850E555E21817D1B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_80B4D7A079C5050B850E555E21817D1B" xlink:to="lab_dei_EntityAddressPostalZipCode_80B4D7A079C5050B850E555E21817D1B" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_99894238B852566FAB10555E21812C1C_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_99894238B852566FAB10555E21812C1C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_99894238B852566FAB10555E21812C1C_label_en-US" xlink:label="lab_dei_CityAreaCode_99894238B852566FAB10555E21812C1C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_99894238B852566FAB10555E21812C1C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_99894238B852566FAB10555E21812C1C" xlink:to="lab_dei_CityAreaCode_99894238B852566FAB10555E21812C1C" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_FD210740A98D42A51C07555E21810A3A_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_FD210740A98D42A51C07555E21810A3A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_FD210740A98D42A51C07555E21810A3A_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_FD210740A98D42A51C07555E21810A3A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_FD210740A98D42A51C07555E21810A3A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_FD210740A98D42A51C07555E21810A3A" xlink:to="lab_dei_LocalPhoneNumber_FD210740A98D42A51C07555E21810A3A" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_BB677D7C3A84CC0232AC555E2181DD32_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_BB677D7C3A84CC0232AC555E2181DD32" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_BB677D7C3A84CC0232AC555E2181DD32_label_en-US" xlink:label="lab_dei_Security12bTitle_BB677D7C3A84CC0232AC555E2181DD32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_BB677D7C3A84CC0232AC555E2181DD32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_BB677D7C3A84CC0232AC555E2181DD32" xlink:to="lab_dei_Security12bTitle_BB677D7C3A84CC0232AC555E2181DD32" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_1C3C5BC6938524CD6023555E2181DBD3_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_1C3C5BC6938524CD6023555E2181DBD3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_1C3C5BC6938524CD6023555E2181DBD3_label_en-US" xlink:label="lab_dei_SecurityExchangeName_1C3C5BC6938524CD6023555E2181DBD3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_1C3C5BC6938524CD6023555E2181DBD3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_1C3C5BC6938524CD6023555E2181DBD3" xlink:to="lab_dei_SecurityExchangeName_1C3C5BC6938524CD6023555E2181DBD3" xlink:type="arc" />
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_C4CD330FFC1E06DA4D5D555E2185DE04_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_C4CD330FFC1E06DA4D5D555E2185DE04" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_C4CD330FFC1E06DA4D5D555E2185DE04_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_C4CD330FFC1E06DA4D5D555E2185DE04" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_C4CD330FFC1E06DA4D5D555E2185DE04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer_C4CD330FFC1E06DA4D5D555E2185DE04" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer_C4CD330FFC1E06DA4D5D555E2185DE04" xlink:type="arc" />
    <link:label id="lab_dei_EntityVoluntaryFilers_23560CA25BFF4141DB72555E21853B34_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers_23560CA25BFF4141DB72555E21853B34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_23560CA25BFF4141DB72555E21853B34_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers_23560CA25BFF4141DB72555E21853B34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_23560CA25BFF4141DB72555E21853B34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers_23560CA25BFF4141DB72555E21853B34" xlink:to="lab_dei_EntityVoluntaryFilers_23560CA25BFF4141DB72555E21853B34" xlink:type="arc" />
    <link:label id="lab_dei_EntityCurrentReportingStatus_3A0F02CA8DC33FB10847555E2185AB0A_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_3A0F02CA8DC33FB10847555E2185AB0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_3A0F02CA8DC33FB10847555E2185AB0A_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_3A0F02CA8DC33FB10847555E2185AB0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_3A0F02CA8DC33FB10847555E2185AB0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_3A0F02CA8DC33FB10847555E2185AB0A" xlink:to="lab_dei_EntityCurrentReportingStatus_3A0F02CA8DC33FB10847555E2185AB0A" xlink:type="arc" />
    <link:label id="lab_dei_EntityInteractiveDataCurrent_D0451126E55FC647215F555E2185A746_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent_D0451126E55FC647215F555E2185A746" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_D0451126E55FC647215F555E2185A746_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent_D0451126E55FC647215F555E2185A746" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_D0451126E55FC647215F555E2185A746" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_D0451126E55FC647215F555E2185A746" xlink:to="lab_dei_EntityInteractiveDataCurrent_D0451126E55FC647215F555E2185A746" xlink:type="arc" />
    <link:label id="lab_dei_EntityFilerCategory_7126A79F76A547A9E243555E2185F57B_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory_7126A79F76A547A9E243555E2185F57B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_7126A79F76A547A9E243555E2185F57B_label_en-US" xlink:label="lab_dei_EntityFilerCategory_7126A79F76A547A9E243555E2185F57B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_7126A79F76A547A9E243555E2185F57B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_7126A79F76A547A9E243555E2185F57B" xlink:to="lab_dei_EntityFilerCategory_7126A79F76A547A9E243555E2185F57B" xlink:type="arc" />
    <link:label id="lab_dei_EntitySmallBusiness_3F370041F998BBFEEF3E555E21850F2E_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness_3F370041F998BBFEEF3E555E21850F2E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_3F370041F998BBFEEF3E555E21850F2E_label_en-US" xlink:label="lab_dei_EntitySmallBusiness_3F370041F998BBFEEF3E555E21850F2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_3F370041F998BBFEEF3E555E21850F2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness_3F370041F998BBFEEF3E555E21850F2E" xlink:to="lab_dei_EntitySmallBusiness_3F370041F998BBFEEF3E555E21850F2E" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_9F41D3494622389E5B81555E2185B49F_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_9F41D3494622389E5B81555E2185B49F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_9F41D3494622389E5B81555E2185B49F_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_9F41D3494622389E5B81555E2185B49F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_9F41D3494622389E5B81555E2185B49F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_9F41D3494622389E5B81555E2185B49F" xlink:to="lab_dei_EntityEmergingGrowthCompany_9F41D3494622389E5B81555E2185B49F" xlink:type="arc" />
    <link:label id="lab_dei_EntityShellCompany_319CA8C529AB8ED0BA0D555E21850A0C_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany_319CA8C529AB8ED0BA0D555E21850A0C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_319CA8C529AB8ED0BA0D555E21850A0C_label_en-US" xlink:label="lab_dei_EntityShellCompany_319CA8C529AB8ED0BA0D555E21850A0C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_319CA8C529AB8ED0BA0D555E21850A0C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_319CA8C529AB8ED0BA0D555E21850A0C" xlink:to="lab_dei_EntityShellCompany_319CA8C529AB8ED0BA0D555E21850A0C" xlink:type="arc" />
    <link:label id="lab_dei_EntityPublicFloat_7572D955265F414F5F58555E21858DCD_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat_7572D955265F414F5F58555E21858DCD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_7572D955265F414F5F58555E21858DCD_label_en-US" xlink:label="lab_dei_EntityPublicFloat_7572D955265F414F5F58555E21858DCD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_7572D955265F414F5F58555E21858DCD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat_7572D955265F414F5F58555E21858DCD" xlink:to="lab_dei_EntityPublicFloat_7572D955265F414F5F58555E21858DCD" xlink:type="arc" />
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_2DDC2F46451D2C53FC09555E2185FC85_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_2DDC2F46451D2C53FC09555E2185FC85" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_2DDC2F46451D2C53FC09555E2185FC85_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_2DDC2F46451D2C53FC09555E2185FC85" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2DDC2F46451D2C53FC09555E2185FC85" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_2DDC2F46451D2C53FC09555E2185FC85" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_2DDC2F46451D2C53FC09555E2185FC85" xlink:type="arc" />
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_C9C5C40B1769B4C3F9EC555E218537BF_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock_C9C5C40B1769B4C3F9EC555E218537BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_C9C5C40B1769B4C3F9EC555E218537BF_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock_C9C5C40B1769B4C3F9EC555E218537BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_C9C5C40B1769B4C3F9EC555E218537BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock_C9C5C40B1769B4C3F9EC555E218537BF" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock_C9C5C40B1769B4C3F9EC555E218537BF" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_F2663F8D25EEA3912123555E21857BA6_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_F2663F8D25EEA3912123555E21857BA6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_F2663F8D25EEA3912123555E21857BA6_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_F2663F8D25EEA3912123555E21857BA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_F2663F8D25EEA3912123555E21857BA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_F2663F8D25EEA3912123555E21857BA6" xlink:to="lab_dei_EntityCentralIndexKey_F2663F8D25EEA3912123555E21857BA6" xlink:type="arc" />
    <link:label id="lab_dei_CurrentFiscalYearEndDate_B7E0380D7D77E4DB887A555E21852896_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_B7E0380D7D77E4DB887A555E21852896" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_B7E0380D7D77E4DB887A555E21852896_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_B7E0380D7D77E4DB887A555E21852896" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_B7E0380D7D77E4DB887A555E21852896" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_B7E0380D7D77E4DB887A555E21852896" xlink:to="lab_dei_CurrentFiscalYearEndDate_B7E0380D7D77E4DB887A555E21852896" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_547F6353F00871071C45555E2185A690_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_547F6353F00871071C45555E2185A690" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_547F6353F00871071C45555E2185A690_label_en-US" xlink:label="lab_dei_AmendmentFlag_547F6353F00871071C45555E2185A690" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_547F6353F00871071C45555E2185A690" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_547F6353F00871071C45555E2185A690" xlink:to="lab_dei_AmendmentFlag_547F6353F00871071C45555E2185A690" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalYearFocus_E5CA9D79EC208F1D4CB4555E2185B10F_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_E5CA9D79EC208F1D4CB4555E2185B10F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_E5CA9D79EC208F1D4CB4555E2185B10F_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_E5CA9D79EC208F1D4CB4555E2185B10F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_E5CA9D79EC208F1D4CB4555E2185B10F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_E5CA9D79EC208F1D4CB4555E2185B10F" xlink:to="lab_dei_DocumentFiscalYearFocus_E5CA9D79EC208F1D4CB4555E2185B10F" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_DB0DD486201A78BB2050555E2185D0A8_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_DB0DD486201A78BB2050555E2185D0A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_DB0DD486201A78BB2050555E2185D0A8_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_DB0DD486201A78BB2050555E2185D0A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_DB0DD486201A78BB2050555E2185D0A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_DB0DD486201A78BB2050555E2185D0A8" xlink:to="lab_dei_DocumentFiscalPeriodFocus_DB0DD486201A78BB2050555E2185D0A8" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_CA6F061C8F09305AC98A555E2185CC29_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_CA6F061C8F09305AC98A555E2185CC29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_CA6F061C8F09305AC98A555E2185CC29_label_en-US" xlink:label="lab_dei_TradingSymbol_CA6F061C8F09305AC98A555E2185CC29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_CA6F061C8F09305AC98A555E2185CC29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_CA6F061C8F09305AC98A555E2185CC29" xlink:to="lab_dei_TradingSymbol_CA6F061C8F09305AC98A555E2185CC29" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_01440F52678A7A137DBACCD3701D1C08_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_01440F52678A7A137DBACCD3701D1C08" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Segment information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_01440F52678A7A137DBACCD3701D1C08_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_01440F52678A7A137DBACCD3701D1C08" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_01440F52678A7A137DBACCD3701D1C08" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock_01440F52678A7A137DBACCD3701D1C08" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock_01440F52678A7A137DBACCD3701D1C08" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_790FF5FEC214578665213F3C361C27B3_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_790FF5FEC214578665213F3C361C27B3" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Gross unrecognized tax benefits, beginning balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_790FF5FEC214578665213F3C361C27B3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_790FF5FEC214578665213F3C361C27B3" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_790FF5FEC214578665213F3C361C27B3" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_400A8B12441B9A30A9813F3C361CA52D_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_400A8B12441B9A30A9813F3C361CA52D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increases for tax positions for prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_400A8B12441B9A30A9813F3C361CA52D_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_400A8B12441B9A30A9813F3C361CA52D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_400A8B12441B9A30A9813F3C361CA52D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_400A8B12441B9A30A9813F3C361CA52D" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_400A8B12441B9A30A9813F3C361CA52D" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_92CC9FA4C5BA579FA7C93F3C361CC8C9_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_92CC9FA4C5BA579FA7C93F3C361CC8C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decreases for tax positions for prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_92CC9FA4C5BA579FA7C93F3C361CC8C9_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_92CC9FA4C5BA579FA7C93F3C361CC8C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_92CC9FA4C5BA579FA7C93F3C361CC8C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_92CC9FA4C5BA579FA7C93F3C361CC8C9" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_92CC9FA4C5BA579FA7C93F3C361CC8C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_891A4F051A7B625416213F3C361D10A5_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_891A4F051A7B625416213F3C361D10A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increases for tax positions for current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_891A4F051A7B625416213F3C361D10A5_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_891A4F051A7B625416213F3C361D10A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_891A4F051A7B625416213F3C361D10A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_891A4F051A7B625416213F3C361D10A5" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_891A4F051A7B625416213F3C361D10A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_F07B71F5C2DE7B8527CF3F3C361D95A2_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_F07B71F5C2DE7B8527CF3F3C361D95A2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_F07B71F5C2DE7B8527CF3F3C361D95A2_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_F07B71F5C2DE7B8527CF3F3C361D95A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_F07B71F5C2DE7B8527CF3F3C361D95A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_F07B71F5C2DE7B8527CF3F3C361D95A2" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_F07B71F5C2DE7B8527CF3F3C361D95A2" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2B7E24AB79903E71B79D3F3C361D9068_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2B7E24AB79903E71B79D3F3C361D9068" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lapse of statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2B7E24AB79903E71B79D3F3C361D9068_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2B7E24AB79903E71B79D3F3C361D9068" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2B7E24AB79903E71B79D3F3C361D9068" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2B7E24AB79903E71B79D3F3C361D9068" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2B7E24AB79903E71B79D3F3C361D9068" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_49B4362E0B50728737653F3C361DFC47_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_49B4362E0B50728737653F3C361DFC47" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Gross unrecognized tax benefits, ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_49B4362E0B50728737653F3C361DFC47" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_49B4362E0B50728737653F3C361DFC47" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_49B4362E0B50728737653F3C361DFC47" xlink:type="arc" />
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5C87B29E1336B70D0066F5EBD6657163_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5C87B29E1336B70D0066F5EBD6657163" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit and 401(k) savings plan</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5C87B29E1336B70D0066F5EBD6657163_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5C87B29E1336B70D0066F5EBD6657163" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension and Other Postretirement Benefits Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5C87B29E1336B70D0066F5EBD6657163" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5C87B29E1336B70D0066F5EBD6657163" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5C87B29E1336B70D0066F5EBD6657163" xlink:type="arc" />
    <link:label id="lab_ebs_TermofContractUnderAcquisition_1F4F5AF422D223AE9B47A55DF323CE4B_terseLabel_en-US" xlink:label="lab_ebs_TermofContractUnderAcquisition_1F4F5AF422D223AE9B47A55DF323CE4B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of contract under acquisition</link:label>
    <link:label id="lab_ebs_TermofContractUnderAcquisition_1F4F5AF422D223AE9B47A55DF323CE4B_label_en-US" xlink:label="lab_ebs_TermofContractUnderAcquisition_1F4F5AF422D223AE9B47A55DF323CE4B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term of Contract Under Acquisition</link:label>
    <link:label id="lab_ebs_TermofContractUnderAcquisition_1F4F5AF422D223AE9B47A55DF323CE4B_documentation_en-US" xlink:label="lab_ebs_TermofContractUnderAcquisition_1F4F5AF422D223AE9B47A55DF323CE4B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term of contract under acquisition.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TermofContractUnderAcquisition" xlink:label="loc_ebs_TermofContractUnderAcquisition_1F4F5AF422D223AE9B47A55DF323CE4B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_TermofContractUnderAcquisition_1F4F5AF422D223AE9B47A55DF323CE4B" xlink:to="lab_ebs_TermofContractUnderAcquisition_1F4F5AF422D223AE9B47A55DF323CE4B" xlink:type="arc" />
    <link:label id="lab_ebs_ValueofContract_6528643F0EF9C5B84299A55DF323130B_terseLabel_en-US" xlink:label="lab_ebs_ValueofContract_6528643F0EF9C5B84299A55DF323130B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Value of contract</link:label>
    <link:label id="lab_ebs_ValueofContract_6528643F0EF9C5B84299A55DF323130B_label_en-US" xlink:label="lab_ebs_ValueofContract_6528643F0EF9C5B84299A55DF323130B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Value of Contract</link:label>
    <link:label id="lab_ebs_ValueofContract_6528643F0EF9C5B84299A55DF323130B_documentation_en-US" xlink:label="lab_ebs_ValueofContract_6528643F0EF9C5B84299A55DF323130B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Refers to the value of contract.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ValueofContract" xlink:label="loc_ebs_ValueofContract_6528643F0EF9C5B84299A55DF323130B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ValueofContract_6528643F0EF9C5B84299A55DF323130B" xlink:to="lab_ebs_ValueofContract_6528643F0EF9C5B84299A55DF323130B" xlink:type="arc" />
    <link:label id="lab_ebs_AmountforDeliveriesofProduct_D214C28795C5A59E835CA55DF3233218_terseLabel_en-US" xlink:label="lab_ebs_AmountforDeliveriesofProduct_D214C28795C5A59E835CA55DF3233218" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount for deliveries of product</link:label>
    <link:label id="lab_ebs_AmountforDeliveriesofProduct_D214C28795C5A59E835CA55DF3233218_label_en-US" xlink:label="lab_ebs_AmountforDeliveriesofProduct_D214C28795C5A59E835CA55DF3233218" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount for Deliveries of Product</link:label>
    <link:label id="lab_ebs_AmountforDeliveriesofProduct_D214C28795C5A59E835CA55DF3233218_documentation_en-US" xlink:label="lab_ebs_AmountforDeliveriesofProduct_D214C28795C5A59E835CA55DF3233218" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount for deliveries of product to the Strategic National Stockpile ("SNS").</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmountforDeliveriesofProduct" xlink:label="loc_ebs_AmountforDeliveriesofProduct_D214C28795C5A59E835CA55DF3233218" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_AmountforDeliveriesofProduct_D214C28795C5A59E835CA55DF3233218" xlink:to="lab_ebs_AmountforDeliveriesofProduct_D214C28795C5A59E835CA55DF3233218" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_A6D0062DA5233C870084A55DF324D63C_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_A6D0062DA5233C870084A55DF324D63C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_A6D0062DA5233C870084A55DF324D63C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross_A6D0062DA5233C870084A55DF324D63C" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross_A6D0062DA5233C870084A55DF324D63C" xlink:type="arc" />
    <link:label id="lab_ebs_AmountOfPaymentForRegulatoryRelatedMilestones_B3A83591AEB68DAFEDE2A55DF324B244_terseLabel_en-US" xlink:label="lab_ebs_AmountOfPaymentForRegulatoryRelatedMilestones_B3A83591AEB68DAFEDE2A55DF324B244" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of payment for regulatory related milestones</link:label>
    <link:label id="lab_ebs_AmountOfPaymentForRegulatoryRelatedMilestones_B3A83591AEB68DAFEDE2A55DF324B244_label_en-US" xlink:label="lab_ebs_AmountOfPaymentForRegulatoryRelatedMilestones_B3A83591AEB68DAFEDE2A55DF324B244" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount Of Payment For Regulatory Related Milestones</link:label>
    <link:label id="lab_ebs_AmountOfPaymentForRegulatoryRelatedMilestones_B3A83591AEB68DAFEDE2A55DF324B244_documentation_en-US" xlink:label="lab_ebs_AmountOfPaymentForRegulatoryRelatedMilestones_B3A83591AEB68DAFEDE2A55DF324B244" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash outflow associated with regulatory related milestones.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmountOfPaymentForRegulatoryRelatedMilestones" xlink:label="loc_ebs_AmountOfPaymentForRegulatoryRelatedMilestones_B3A83591AEB68DAFEDE2A55DF324B244" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_AmountOfPaymentForRegulatoryRelatedMilestones_B3A83591AEB68DAFEDE2A55DF324B244" xlink:to="lab_ebs_AmountOfPaymentForRegulatoryRelatedMilestones_B3A83591AEB68DAFEDE2A55DF324B244" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_1C41995437496D8194FBA5983629C833_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember_1C41995437496D8194FBA5983629C833" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_1C41995437496D8194FBA5983629C833_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember_1C41995437496D8194FBA5983629C833" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_1C41995437496D8194FBA5983629C833" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember_1C41995437496D8194FBA5983629C833" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember_1C41995437496D8194FBA5983629C833" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_17E1F8FD6875EC77FFFC92A288A76D75_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_17E1F8FD6875EC77FFFC92A288A76D75" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Reconciliation of Contingent Consideration Liabilities Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_17E1F8FD6875EC77FFFC92A288A76D75_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_17E1F8FD6875EC77FFFC92A288A76D75" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_17E1F8FD6875EC77FFFC92A288A76D75" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_17E1F8FD6875EC77FFFC92A288A76D75" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_17E1F8FD6875EC77FFFC92A288A76D75" xlink:type="arc" />
    <link:label id="lab_us-gaap_BuildingMember_0E5EF1C63822221574349238C5320A19_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember_0E5EF1C63822221574349238C5320A19" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingMember_0E5EF1C63822221574349238C5320A19_label_en-US" xlink:label="lab_us-gaap_BuildingMember_0E5EF1C63822221574349238C5320A19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaap_BuildingMember_0E5EF1C63822221574349238C5320A19" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember_0E5EF1C63822221574349238C5320A19" xlink:to="lab_us-gaap_BuildingMember_0E5EF1C63822221574349238C5320A19" xlink:type="arc" />
    <link:label id="lab_us-gaap_BuildingImprovementsMember_64BCA18DA4F5A2D6706E9238C53270FF_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember_64BCA18DA4F5A2D6706E9238C53270FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Building improvements</link:label>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_64BCA18DA4F5A2D6706E9238C53270FF_label_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember_64BCA18DA4F5A2D6706E9238C53270FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building Improvements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingImprovementsMember_64BCA18DA4F5A2D6706E9238C53270FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingImprovementsMember_64BCA18DA4F5A2D6706E9238C53270FF" xlink:to="lab_us-gaap_BuildingImprovementsMember_64BCA18DA4F5A2D6706E9238C53270FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_B418E0B5B419B5310F809238C5329559_verboseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_B418E0B5B419B5310F809238C5329559" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Software product life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_B418E0B5B419B5310F809238C5329559" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_B418E0B5B419B5310F809238C5329559" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_B418E0B5B419B5310F809238C5329559" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_FA643E3879B632DBA9AD9238C534D6AF_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_FA643E3879B632DBA9AD9238C534D6AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_FA643E3879B632DBA9AD9238C534D6AF_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_FA643E3879B632DBA9AD9238C534D6AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Estimated Useful Lives</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_FA643E3879B632DBA9AD9238C534D6AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_FA643E3879B632DBA9AD9238C534D6AF" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_FA643E3879B632DBA9AD9238C534D6AF" xlink:type="arc" />
    <link:label id="lab_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember_D9B08F49B7C8677794A6CDFBFC1D2D41_terseLabel_en-US" xlink:label="lab_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember_D9B08F49B7C8677794A6CDFBFC1D2D41" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2006 Stock Incentive Plan</link:label>
    <link:label id="lab_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember_D9B08F49B7C8677794A6CDFBFC1D2D41_label_en-US" xlink:label="lab_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember_D9B08F49B7C8677794A6CDFBFC1D2D41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Emergent BioSolutions Inc. 2006 Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember_D9B08F49B7C8677794A6CDFBFC1D2D41_documentation_en-US" xlink:label="lab_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember_D9B08F49B7C8677794A6CDFBFC1D2D41" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">A share-based compensation plan adopted by the Company in 2006.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" xlink:label="loc_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember_D9B08F49B7C8677794A6CDFBFC1D2D41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember_D9B08F49B7C8677794A6CDFBFC1D2D41" xlink:to="lab_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember_D9B08F49B7C8677794A6CDFBFC1D2D41" xlink:type="arc" />
    <link:label id="lab_us-gaap_PerformanceSharesMember_BDAECCA876A09A75F2DFCDFBFC1E89AE_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_BDAECCA876A09A75F2DFCDFBFC1E89AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_BDAECCA876A09A75F2DFCDFBFC1E89AE_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_BDAECCA876A09A75F2DFCDFBFC1E89AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_BDAECCA876A09A75F2DFCDFBFC1E89AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember_BDAECCA876A09A75F2DFCDFBFC1E89AE" xlink:to="lab_us-gaap_PerformanceSharesMember_BDAECCA876A09A75F2DFCDFBFC1E89AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_49819F1C35801956B9E4CDFBFC1E92ED_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_49819F1C35801956B9E4CDFBFC1E92ED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_49819F1C35801956B9E4CDFBFC1E92ED_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_49819F1C35801956B9E4CDFBFC1E92ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_49819F1C35801956B9E4CDFBFC1E92ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_49819F1C35801956B9E4CDFBFC1E92ED" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_49819F1C35801956B9E4CDFBFC1E92ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_B63A947CFE919922B768CDFBFC1F8C46_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_B63A947CFE919922B768CDFBFC1F8C46" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_B63A947CFE919922B768CDFBFC1F8C46_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_B63A947CFE919922B768CDFBFC1F8C46" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_B63A947CFE919922B768CDFBFC1F8C46" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_B63A947CFE919922B768CDFBFC1F8C46" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_B63A947CFE919922B768CDFBFC1F8C46" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_A987CE0DD319789674D9CDFBFC2025CC_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_A987CE0DD319789674D9CDFBFC2025CC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_A987CE0DD319789674D9CDFBFC2025CC_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_A987CE0DD319789674D9CDFBFC2025CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_A987CE0DD319789674D9CDFBFC2025CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_A987CE0DD319789674D9CDFBFC2025CC" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_A987CE0DD319789674D9CDFBFC2025CC" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6B831C794909F0BFF2F8CDFBFC20F014_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6B831C794909F0BFF2F8CDFBFC20F014" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6B831C794909F0BFF2F8CDFBFC20F014_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6B831C794909F0BFF2F8CDFBFC20F014" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6B831C794909F0BFF2F8CDFBFC20F014" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6B831C794909F0BFF2F8CDFBFC20F014" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6B831C794909F0BFF2F8CDFBFC20F014" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_987742821D4D9E6EE296CDFBFC2038AE_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_987742821D4D9E6EE296CDFBFC2038AE" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_987742821D4D9E6EE296CDFBFC2038AE_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_987742821D4D9E6EE296CDFBFC2038AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_987742821D4D9E6EE296CDFBFC2038AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_987742821D4D9E6EE296CDFBFC2038AE" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_987742821D4D9E6EE296CDFBFC2038AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_203FD0C1A3DBD349A7B9CDFBFC204CA1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_203FD0C1A3DBD349A7B9CDFBFC204CA1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_203FD0C1A3DBD349A7B9CDFBFC204CA1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_203FD0C1A3DBD349A7B9CDFBFC204CA1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_203FD0C1A3DBD349A7B9CDFBFC204CA1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4F4F70474BEE07CA3369CDFBFC205B4D_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4F4F70474BEE07CA3369CDFBFC205B4D" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Exercisable, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4F4F70474BEE07CA3369CDFBFC205B4D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4F4F70474BEE07CA3369CDFBFC205B4D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4F4F70474BEE07CA3369CDFBFC205B4D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4F4F70474BEE07CA3369CDFBFC205B4D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4F4F70474BEE07CA3369CDFBFC205B4D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4E8523F18F04E66A200FCDFBFC218DF9_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4E8523F18F04E66A200FCDFBFC218DF9" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4E8523F18F04E66A200FCDFBFC218DF9_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4E8523F18F04E66A200FCDFBFC218DF9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4E8523F18F04E66A200FCDFBFC218DF9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4E8523F18F04E66A200FCDFBFC218DF9" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4E8523F18F04E66A200FCDFBFC218DF9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_25A696A84BC16A308297CDFBFC2156CD_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_25A696A84BC16A308297CDFBFC2156CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options grant price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_25A696A84BC16A308297CDFBFC2156CD_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_25A696A84BC16A308297CDFBFC2156CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_25A696A84BC16A308297CDFBFC2156CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_25A696A84BC16A308297CDFBFC2156CD" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_25A696A84BC16A308297CDFBFC2156CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_C1DB69C49F3835363182CDFBFC22BF36_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_C1DB69C49F3835363182CDFBFC22BF36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_C1DB69C49F3835363182CDFBFC22BF36_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_C1DB69C49F3835363182CDFBFC22BF36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_C1DB69C49F3835363182CDFBFC22BF36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_C1DB69C49F3835363182CDFBFC22BF36" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_C1DB69C49F3835363182CDFBFC22BF36" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_21E8FEF6F12845520E5ACDFBFC221243_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_21E8FEF6F12845520E5ACDFBFC221243" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_21E8FEF6F12845520E5ACDFBFC221243_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_21E8FEF6F12845520E5ACDFBFC221243" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_21E8FEF6F12845520E5ACDFBFC221243" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_21E8FEF6F12845520E5ACDFBFC221243" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_21E8FEF6F12845520E5ACDFBFC221243" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_EF1582B172B5973F678CCDFBFC223B56_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_EF1582B172B5973F678CCDFBFC223B56" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, end of period (in dollars per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_EF1582B172B5973F678CCDFBFC223B56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_EF1582B172B5973F678CCDFBFC223B56" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_EF1582B172B5973F678CCDFBFC223B56" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_778A70C591D1EE8196AFCDFBFC228F02_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_778A70C591D1EE8196AFCDFBFC228F02" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Exercisable, end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_778A70C591D1EE8196AFCDFBFC228F02_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_778A70C591D1EE8196AFCDFBFC228F02" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_778A70C591D1EE8196AFCDFBFC228F02" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_778A70C591D1EE8196AFCDFBFC228F02" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_778A70C591D1EE8196AFCDFBFC228F02" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8806F1B2A65D960F979CCDFBFC2220C2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8806F1B2A65D960F979CCDFBFC2220C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8806F1B2A65D960F979CCDFBFC2220C2_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8806F1B2A65D960F979CCDFBFC2220C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8806F1B2A65D960F979CCDFBFC2220C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8806F1B2A65D960F979CCDFBFC2220C2" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8806F1B2A65D960F979CCDFBFC2220C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F6B08BE840F18787657FCDFBFC2230B5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F6B08BE840F18787657FCDFBFC2230B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F6B08BE840F18787657FCDFBFC2230B5_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F6B08BE840F18787657FCDFBFC2230B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F6B08BE840F18787657FCDFBFC2230B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F6B08BE840F18787657FCDFBFC2230B5" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F6B08BE840F18787657FCDFBFC2230B5" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_FA8AC59131D892E3CD54CDFBFC23A8D6_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_FA8AC59131D892E3CD54CDFBFC23A8D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_FA8AC59131D892E3CD54CDFBFC23A8D6_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_FA8AC59131D892E3CD54CDFBFC23A8D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_FA8AC59131D892E3CD54CDFBFC23A8D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_FA8AC59131D892E3CD54CDFBFC23A8D6" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_FA8AC59131D892E3CD54CDFBFC23A8D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5EA17F10F5A310333B34CDFBFC249824_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5EA17F10F5A310333B34CDFBFC249824" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5EA17F10F5A310333B34CDFBFC249824_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5EA17F10F5A310333B34CDFBFC249824" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5EA17F10F5A310333B34CDFBFC249824" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5EA17F10F5A310333B34CDFBFC249824" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5EA17F10F5A310333B34CDFBFC249824" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76FBCD32D2B296A8BDEECDFBFC24ADEC_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76FBCD32D2B296A8BDEECDFBFC24ADEC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76FBCD32D2B296A8BDEECDFBFC24ADEC_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76FBCD32D2B296A8BDEECDFBFC24ADEC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76FBCD32D2B296A8BDEECDFBFC24ADEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76FBCD32D2B296A8BDEECDFBFC24ADEC" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76FBCD32D2B296A8BDEECDFBFC24ADEC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20AD2DDE3606284D4E8BCDFBFC245CD6_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20AD2DDE3606284D4E8BCDFBFC245CD6" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20AD2DDE3606284D4E8BCDFBFC245CD6_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20AD2DDE3606284D4E8BCDFBFC245CD6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20AD2DDE3606284D4E8BCDFBFC245CD6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20AD2DDE3606284D4E8BCDFBFC245CD6" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20AD2DDE3606284D4E8BCDFBFC245CD6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_F1394F46A2C1DFB6F430CDFBFC24C222_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_F1394F46A2C1DFB6F430CDFBFC24C222" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_F1394F46A2C1DFB6F430CDFBFC24C222_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_F1394F46A2C1DFB6F430CDFBFC24C222" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_F1394F46A2C1DFB6F430CDFBFC24C222" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_F1394F46A2C1DFB6F430CDFBFC24C222" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_F1394F46A2C1DFB6F430CDFBFC24C222" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_DF28FA40323733200FC9CDFBFC24CE4C_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_DF28FA40323733200FC9CDFBFC24CE4C" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_DF28FA40323733200FC9CDFBFC24CE4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_DF28FA40323733200FC9CDFBFC24CE4C" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_DF28FA40323733200FC9CDFBFC24CE4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Grant Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_BC04FB706EC8C7DEBE84CDFBFC252524_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_BC04FB706EC8C7DEBE84CDFBFC252524" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_BC04FB706EC8C7DEBE84CDFBFC252524_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_BC04FB706EC8C7DEBE84CDFBFC252524" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_BC04FB706EC8C7DEBE84CDFBFC252524" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_BC04FB706EC8C7DEBE84CDFBFC252524" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_BC04FB706EC8C7DEBE84CDFBFC252524" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_DE51418A3D823A9E969ECDFBFC259363_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_DE51418A3D823A9E969ECDFBFC259363" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units grant price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_DE51418A3D823A9E969ECDFBFC259363_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_DE51418A3D823A9E969ECDFBFC259363" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_DE51418A3D823A9E969ECDFBFC259363" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_DE51418A3D823A9E969ECDFBFC259363" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_DE51418A3D823A9E969ECDFBFC259363" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_DCBD9E80F2F00460F69CCDFBFC26CB45_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_DCBD9E80F2F00460F69CCDFBFC26CB45" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_DCBD9E80F2F00460F69CCDFBFC26CB45_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_DCBD9E80F2F00460F69CCDFBFC26CB45" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_DCBD9E80F2F00460F69CCDFBFC26CB45" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_DCBD9E80F2F00460F69CCDFBFC26CB45" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_DCBD9E80F2F00460F69CCDFBFC26CB45" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_A15971922AEC8BF07B4DCDFBFC26FD89_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_A15971922AEC8BF07B4DCDFBFC26FD89" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_A15971922AEC8BF07B4DCDFBFC26FD89_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_A15971922AEC8BF07B4DCDFBFC26FD89" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_A15971922AEC8BF07B4DCDFBFC26FD89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_A15971922AEC8BF07B4DCDFBFC26FD89" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_A15971922AEC8BF07B4DCDFBFC26FD89" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_E7F1B125A0D56604C9BDCDFBFC26D317_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_E7F1B125A0D56604C9BDCDFBFC26D317" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, end of period (in dollars per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_E7F1B125A0D56604C9BDCDFBFC26D317" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_E7F1B125A0D56604C9BDCDFBFC26D317" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_E7F1B125A0D56604C9BDCDFBFC26D317" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_38CA1F854B8387ECF8C3CDFBFC266018_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_38CA1F854B8387ECF8C3CDFBFC266018" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_38CA1F854B8387ECF8C3CDFBFC266018_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_38CA1F854B8387ECF8C3CDFBFC266018" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_38CA1F854B8387ECF8C3CDFBFC266018" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_38CA1F854B8387ECF8C3CDFBFC266018" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_38CA1F854B8387ECF8C3CDFBFC266018" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_937841E4F4D895AE0424CDFBFC26B344_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_937841E4F4D895AE0424CDFBFC26B344" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_937841E4F4D895AE0424CDFBFC26B344_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_937841E4F4D895AE0424CDFBFC26B344" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_937841E4F4D895AE0424CDFBFC26B344" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_937841E4F4D895AE0424CDFBFC26B344" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_937841E4F4D895AE0424CDFBFC26B344" xlink:type="arc" />
    <link:label id="lab_country_US_7717C3F96FB4F06960A2EC8A3CEB138C_verboseLabel_en-US" xlink:label="lab_country_US_7717C3F96FB4F06960A2EC8A3CEB138C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_7717C3F96FB4F06960A2EC8A3CEB138C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US_7717C3F96FB4F06960A2EC8A3CEB138C" xlink:to="lab_country_US_7717C3F96FB4F06960A2EC8A3CEB138C" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonUsMember_38FCA506FC9E8259DC8CEC8A3CEBF7DD_verboseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember_38FCA506FC9E8259DC8CEC8A3CEBF7DD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-US</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_38FCA506FC9E8259DC8CEC8A3CEBF7DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember_38FCA506FC9E8259DC8CEC8A3CEBF7DD" xlink:to="lab_us-gaap_NonUsMember_38FCA506FC9E8259DC8CEC8A3CEBF7DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_ED9521750C10DD56F1CEEC8A3CECD7C7_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember_ED9521750C10DD56F1CEEC8A3CECD7C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_ED9521750C10DD56F1CEEC8A3CECD7C7_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember_ED9521750C10DD56F1CEEC8A3CECD7C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_ED9521750C10DD56F1CEEC8A3CECD7C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember_ED9521750C10DD56F1CEEC8A3CECD7C7" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember_ED9521750C10DD56F1CEEC8A3CECD7C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_A706FD74D86C993D9C22EC8A3CEC5E3E_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember_A706FD74D86C993D9C22EC8A3CEC5E3E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_A706FD74D86C993D9C22EC8A3CEC5E3E_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember_A706FD74D86C993D9C22EC8A3CEC5E3E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_A706FD74D86C993D9C22EC8A3CEC5E3E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember_A706FD74D86C993D9C22EC8A3CEC5E3E" xlink:to="lab_us-gaap_ProductConcentrationRiskMember_A706FD74D86C993D9C22EC8A3CEC5E3E" xlink:type="arc" />
    <link:label id="lab_ebs_BiothraxMember_F8CA7E5AA757A5E64EC2EC8A3CED7BA3_verboseLabel_en-US" xlink:label="lab_ebs_BiothraxMember_F8CA7E5AA757A5E64EC2EC8A3CED7BA3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">BioThrax</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BiothraxMember" xlink:label="loc_ebs_BiothraxMember_F8CA7E5AA757A5E64EC2EC8A3CED7BA3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_BiothraxMember_F8CA7E5AA757A5E64EC2EC8A3CED7BA3" xlink:to="lab_ebs_BiothraxMember_F8CA7E5AA757A5E64EC2EC8A3CED7BA3" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfReportableSegments_4030646812828980E1C1EC8A3CEE9708_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_4030646812828980E1C1EC8A3CEE9708" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_4030646812828980E1C1EC8A3CEE9708_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_4030646812828980E1C1EC8A3CEE9708" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_4030646812828980E1C1EC8A3CEE9708" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments_4030646812828980E1C1EC8A3CEE9708" xlink:to="lab_us-gaap_NumberOfReportableSegments_4030646812828980E1C1EC8A3CEE9708" xlink:type="arc" />
    <link:label id="lab_us-gaap_NoncurrentAssets_C7EBC766E6A19D9ED181EC8A3CEF7E62_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets_C7EBC766E6A19D9ED181EC8A3CEF7E62" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_C7EBC766E6A19D9ED181EC8A3CEF7E62_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets_C7EBC766E6A19D9ED181EC8A3CEF7E62" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaap_NoncurrentAssets_C7EBC766E6A19D9ED181EC8A3CEF7E62" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets_C7EBC766E6A19D9ED181EC8A3CEF7E62" xlink:to="lab_us-gaap_NoncurrentAssets_C7EBC766E6A19D9ED181EC8A3CEF7E62" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_423B12D64A5A312217D021D7FA8909EC_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock_423B12D64A5A312217D021D7FA8909EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of presentation and consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_423B12D64A5A312217D021D7FA8909EC_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock_423B12D64A5A312217D021D7FA8909EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_423B12D64A5A312217D021D7FA8909EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock_423B12D64A5A312217D021D7FA8909EC" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock_423B12D64A5A312217D021D7FA8909EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_UseOfEstimates_FBC209600BD2A472DCA621D7FA8A9350_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates_FBC209600BD2A472DCA621D7FA8A9350" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_FBC209600BD2A472DCA621D7FA8A9350_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates_FBC209600BD2A472DCA621D7FA8A9350" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_FBC209600BD2A472DCA621D7FA8A9350" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates_FBC209600BD2A472DCA621D7FA8A9350" xlink:to="lab_us-gaap_UseOfEstimates_FBC209600BD2A472DCA621D7FA8A9350" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_B896F31AC2254828409121D7FA8A88A4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_B896F31AC2254828409121D7FA8A88A4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_B896F31AC2254828409121D7FA8A88A4_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_B896F31AC2254828409121D7FA8A88A4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_B896F31AC2254828409121D7FA8A88A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_B896F31AC2254828409121D7FA8A88A4" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_B896F31AC2254828409121D7FA8A88A4" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_33A6369AF214E123AA1221D7FA8A79D4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_33A6369AF214E123AA1221D7FA8A79D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_33A6369AF214E123AA1221D7FA8A79D4_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_33A6369AF214E123AA1221D7FA8A79D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_33A6369AF214E123AA1221D7FA8A79D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_33A6369AF214E123AA1221D7FA8A79D4" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_33A6369AF214E123AA1221D7FA8A79D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_5D3ECE593C225166354B21D7FA8A8C77_terseLabel_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_5D3ECE593C225166354B21D7FA8A8C77" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant customers and accounting receivable</link:label>
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_5D3ECE593C225166354B21D7FA8A8C77_label_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_5D3ECE593C225166354B21D7FA8A8C77" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Customers, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_5D3ECE593C225166354B21D7FA8A8C77" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_5D3ECE593C225166354B21D7FA8A8C77" xlink:to="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_5D3ECE593C225166354B21D7FA8A8C77" xlink:type="arc" />
    <link:label id="lab_ebs_ConcentrationsRiskPolicyTextBlock_7070238BE40C4F5C78C921D7FA8A41F0_terseLabel_en-US" xlink:label="lab_ebs_ConcentrationsRiskPolicyTextBlock_7070238BE40C4F5C78C921D7FA8A41F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration risk</link:label>
    <link:label id="lab_ebs_ConcentrationsRiskPolicyTextBlock_7070238BE40C4F5C78C921D7FA8A41F0_label_en-US" xlink:label="lab_ebs_ConcentrationsRiskPolicyTextBlock_7070238BE40C4F5C78C921D7FA8A41F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentrations Risk [Policy Text Block]</link:label>
    <link:label id="lab_ebs_ConcentrationsRiskPolicyTextBlock_7070238BE40C4F5C78C921D7FA8A41F0_documentation_en-US" xlink:label="lab_ebs_ConcentrationsRiskPolicyTextBlock_7070238BE40C4F5C78C921D7FA8A41F0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for concentrations risk.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ConcentrationsRiskPolicyTextBlock" xlink:label="loc_ebs_ConcentrationsRiskPolicyTextBlock_7070238BE40C4F5C78C921D7FA8A41F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ConcentrationsRiskPolicyTextBlock_7070238BE40C4F5C78C921D7FA8A41F0" xlink:to="lab_ebs_ConcentrationsRiskPolicyTextBlock_7070238BE40C4F5C78C921D7FA8A41F0" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_7148B3AA98E9B43BB21B21D7FA8B9BCA_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock_7148B3AA98E9B43BB21B21D7FA8B9BCA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_7148B3AA98E9B43BB21B21D7FA8B9BCA_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock_7148B3AA98E9B43BB21B21D7FA8B9BCA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_7148B3AA98E9B43BB21B21D7FA8B9BCA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock_7148B3AA98E9B43BB21B21D7FA8B9BCA" xlink:to="lab_us-gaap_InventoryPolicyTextBlock_7148B3AA98E9B43BB21B21D7FA8B9BCA" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_D4E13DEE628418EFD05B21D7FA8B7461_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_D4E13DEE628418EFD05B21D7FA8B7461" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_D4E13DEE628418EFD05B21D7FA8B7461_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_D4E13DEE628418EFD05B21D7FA8B7461" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_D4E13DEE628418EFD05B21D7FA8B7461" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_D4E13DEE628418EFD05B21D7FA8B7461" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_D4E13DEE628418EFD05B21D7FA8B7461" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_2E11F13370F89DAB5C7E21D7FA8BCD00_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock_2E11F13370F89DAB5C7E21D7FA8BCD00" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_2E11F13370F89DAB5C7E21D7FA8BCD00_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock_2E11F13370F89DAB5C7E21D7FA8BCD00" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_2E11F13370F89DAB5C7E21D7FA8BCD00" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock_2E11F13370F89DAB5C7E21D7FA8BCD00" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock_2E11F13370F89DAB5C7E21D7FA8BCD00" xlink:type="arc" />
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentPolicy_CAEEAA7F986D8A0C0C1421D7FA8B4B60_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentPolicy_CAEEAA7F986D8A0C0C1421D7FA8B4B60" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentPolicy_CAEEAA7F986D8A0C0C1421D7FA8B4B60_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentPolicy_CAEEAA7F986D8A0C0C1421D7FA8B4B60" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Process Research and Development, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentPolicy_CAEEAA7F986D8A0C0C1421D7FA8B4B60" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentPolicy_CAEEAA7F986D8A0C0C1421D7FA8B4B60" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentPolicy_CAEEAA7F986D8A0C0C1421D7FA8B4B60" xlink:type="arc" />
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_89F8E4302AEF1C42117E21D7FA8B5DDC_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_89F8E4302AEF1C42117E21D7FA8B5DDC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset impairment analysis</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_89F8E4302AEF1C42117E21D7FA8B5DDC_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_89F8E4302AEF1C42117E21D7FA8B5DDC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_89F8E4302AEF1C42117E21D7FA8B5DDC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_89F8E4302AEF1C42117E21D7FA8B5DDC" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_89F8E4302AEF1C42117E21D7FA8B5DDC" xlink:type="arc" />
    <link:label id="lab_ebs_ContingentConsiderationObligationsPolicyTextBlock_F4B7CD1A08D35FDD1A6221D7FA8B0166_terseLabel_en-US" xlink:label="lab_ebs_ContingentConsiderationObligationsPolicyTextBlock_F4B7CD1A08D35FDD1A6221D7FA8B0166" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_ebs_ContingentConsiderationObligationsPolicyTextBlock_F4B7CD1A08D35FDD1A6221D7FA8B0166_label_en-US" xlink:label="lab_ebs_ContingentConsiderationObligationsPolicyTextBlock_F4B7CD1A08D35FDD1A6221D7FA8B0166" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Obligations [Policy Text Block]</link:label>
    <link:label id="lab_ebs_ContingentConsiderationObligationsPolicyTextBlock_F4B7CD1A08D35FDD1A6221D7FA8B0166_documentation_en-US" xlink:label="lab_ebs_ContingentConsiderationObligationsPolicyTextBlock_F4B7CD1A08D35FDD1A6221D7FA8B0166" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for contingent consideration obligations.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContingentConsiderationObligationsPolicyTextBlock" xlink:label="loc_ebs_ContingentConsiderationObligationsPolicyTextBlock_F4B7CD1A08D35FDD1A6221D7FA8B0166" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ContingentConsiderationObligationsPolicyTextBlock_F4B7CD1A08D35FDD1A6221D7FA8B0166" xlink:to="lab_ebs_ContingentConsiderationObligationsPolicyTextBlock_F4B7CD1A08D35FDD1A6221D7FA8B0166" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_D62451249F7E05D230E521D7FA8B71CD_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_D62451249F7E05D230E521D7FA8B71CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_D62451249F7E05D230E521D7FA8B71CD_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_D62451249F7E05D230E521D7FA8B71CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_D62451249F7E05D230E521D7FA8B71CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_D62451249F7E05D230E521D7FA8B71CD" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_D62451249F7E05D230E521D7FA8B71CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_07125FFE500BAAFFE59621D7FA8CB0E6_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_07125FFE500BAAFFE59621D7FA8CB0E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_07125FFE500BAAFFE59621D7FA8CB0E6_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_07125FFE500BAAFFE59621D7FA8CB0E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_07125FFE500BAAFFE59621D7FA8CB0E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_07125FFE500BAAFFE59621D7FA8CB0E6" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_07125FFE500BAAFFE59621D7FA8CB0E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_639C476D27378D91BE2721D7FA8CBBA1_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_639C476D27378D91BE2721D7FA8CBBA1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_639C476D27378D91BE2721D7FA8CBBA1_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_639C476D27378D91BE2721D7FA8CBBA1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_639C476D27378D91BE2721D7FA8CBBA1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_639C476D27378D91BE2721D7FA8CBBA1" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_639C476D27378D91BE2721D7FA8CBBA1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2DBB51D64978622CC15121D7FA8C4CD5_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2DBB51D64978622CC15121D7FA8C4CD5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Translation of foreign currencies</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2DBB51D64978622CC15121D7FA8C4CD5_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2DBB51D64978622CC15121D7FA8C4CD5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2DBB51D64978622CC15121D7FA8C4CD5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2DBB51D64978622CC15121D7FA8C4CD5" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2DBB51D64978622CC15121D7FA8C4CD5" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_4AA42DABC4B2E3A322EF21D7FA8C6190_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock_4AA42DABC4B2E3A322EF21D7FA8C6190" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_4AA42DABC4B2E3A322EF21D7FA8C6190_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock_4AA42DABC4B2E3A322EF21D7FA8C6190" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_4AA42DABC4B2E3A322EF21D7FA8C6190" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock_4AA42DABC4B2E3A322EF21D7FA8C6190" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock_4AA42DABC4B2E3A322EF21D7FA8C6190" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3A535DB9F85A0675EA6721D7FA8CB622_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3A535DB9F85A0675EA6721D7FA8CB622" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting for stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3A535DB9F85A0675EA6721D7FA8CB622_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3A535DB9F85A0675EA6721D7FA8CB622" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3A535DB9F85A0675EA6721D7FA8CB622" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3A535DB9F85A0675EA6721D7FA8CB622" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3A535DB9F85A0675EA6721D7FA8CB622" xlink:type="arc" />
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_B7B929281BDA6906466421D7FA8CA804_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_B7B929281BDA6906466421D7FA8CA804" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_B7B929281BDA6906466421D7FA8CA804_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_B7B929281BDA6906466421D7FA8CA804" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_B7B929281BDA6906466421D7FA8CA804" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_B7B929281BDA6906466421D7FA8CA804" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_B7B929281BDA6906466421D7FA8CA804" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_B9ED56B33DC7F0C86B8121D7FA8D0BA0_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_B9ED56B33DC7F0C86B8121D7FA8D0BA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently issued accounting standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_B9ED56B33DC7F0C86B8121D7FA8D0BA0_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_B9ED56B33DC7F0C86B8121D7FA8D0BA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_B9ED56B33DC7F0C86B8121D7FA8D0BA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_B9ED56B33DC7F0C86B8121D7FA8D0BA0" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_B9ED56B33DC7F0C86B8121D7FA8D0BA0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_CE831996F2C6F8FB583A92A28879CC1A_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock_CE831996F2C6F8FB583A92A28879CC1A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_CE831996F2C6F8FB583A92A28879CC1A_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock_CE831996F2C6F8FB583A92A28879CC1A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_CE831996F2C6F8FB583A92A28879CC1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock_CE831996F2C6F8FB583A92A28879CC1A" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock_CE831996F2C6F8FB583A92A28879CC1A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ED5326D833018305663492A28879A75E_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ED5326D833018305663492A28879A75E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Future Debt Payments of Long-Term Indebtedness</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ED5326D833018305663492A28879A75E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ED5326D833018305663492A28879A75E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ED5326D833018305663492A28879A75E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ED5326D833018305663492A28879A75E" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ED5326D833018305663492A28879A75E" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_3D79082DC15E4BA785EDA55DF34D2D72_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_3D79082DC15E4BA785EDA55DF34D2D72" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_3D79082DC15E4BA785EDA55DF34D2D72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_3D79082DC15E4BA785EDA55DF34D2D72" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_3D79082DC15E4BA785EDA55DF34D2D72" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_68C5849A6FE70A536F3EA55DF34D3D18_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_68C5849A6FE70A536F3EA55DF34D3D18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_68C5849A6FE70A536F3EA55DF34D3D18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_68C5849A6FE70A536F3EA55DF34D3D18" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_68C5849A6FE70A536F3EA55DF34D3D18" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseCostAbstract_B1D024352273B2DB6343CDD07918FE76_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseCostAbstract_B1D024352273B2DB6343CDD07918FE76" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease cost:</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseCostAbstract_B1D024352273B2DB6343CDD07918FE76_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseCostAbstract_B1D024352273B2DB6343CDD07918FE76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Cost [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinanceLeaseCostAbstract" xlink:label="loc_us-gaap_FinanceLeaseCostAbstract_B1D024352273B2DB6343CDD07918FE76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseCostAbstract_B1D024352273B2DB6343CDD07918FE76" xlink:to="lab_us-gaap_FinanceLeaseCostAbstract_B1D024352273B2DB6343CDD07918FE76" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_61DF4F5A423F57ED609DCDD07918F480_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_61DF4F5A423F57ED609DCDD07918F480" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_61DF4F5A423F57ED609DCDD07918F480_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_61DF4F5A423F57ED609DCDD07918F480" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_61DF4F5A423F57ED609DCDD07918F480" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_61DF4F5A423F57ED609DCDD07918F480" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_61DF4F5A423F57ED609DCDD07918F480" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_A765198F2334B86B03B1CDD0791968BA_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense_A765198F2334B86B03B1CDD0791968BA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_A765198F2334B86B03B1CDD0791968BA_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense_A765198F2334B86B03B1CDD0791968BA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_A765198F2334B86B03B1CDD0791968BA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense_A765198F2334B86B03B1CDD0791968BA" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense_A765198F2334B86B03B1CDD0791968BA" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseCost_F2963D37E52C65B4EB17CDE5104FD432_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost_F2963D37E52C65B4EB17CDE5104FD432" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_F2963D37E52C65B4EB17CDE5104FD432_label_en-US" xlink:label="lab_us-gaap_LeaseCost_F2963D37E52C65B4EB17CDE5104FD432" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_F2963D37E52C65B4EB17CDE5104FD432" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost_F2963D37E52C65B4EB17CDE5104FD432" xlink:to="lab_us-gaap_LeaseCost_F2963D37E52C65B4EB17CDE5104FD432" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_42CB0CBADE47A0C1D394CDE45F49DF1B_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense_42CB0CBADE47A0C1D394CDE45F49DF1B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_42CB0CBADE47A0C1D394CDE45F49DF1B_label_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense_42CB0CBADE47A0C1D394CDE45F49DF1B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Rent Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_42CB0CBADE47A0C1D394CDE45F49DF1B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseAndRentalExpense_42CB0CBADE47A0C1D394CDE45F49DF1B" xlink:to="lab_us-gaap_LeaseAndRentalExpense_42CB0CBADE47A0C1D394CDE45F49DF1B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_FCD11F05E260F51DD03792A2889898EC_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_FCD11F05E260F51DD03792A2889898EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_FCD11F05E260F51DD03792A2889898EC_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_FCD11F05E260F51DD03792A2889898EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_FCD11F05E260F51DD03792A2889898EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_FCD11F05E260F51DD03792A2889898EC" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_FCD11F05E260F51DD03792A2889898EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_EC845823910C5F7D2E14B2C1D93E23C8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_EC845823910C5F7D2E14B2C1D93E23C8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_EC845823910C5F7D2E14B2C1D93E23C8_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_EC845823910C5F7D2E14B2C1D93E23C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_EC845823910C5F7D2E14B2C1D93E23C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_EC845823910C5F7D2E14B2C1D93E23C8" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_EC845823910C5F7D2E14B2C1D93E23C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3D665CC6319D7639184DB29110799F68_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3D665CC6319D7639184DB29110799F68" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3D665CC6319D7639184DB29110799F68_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3D665CC6319D7639184DB29110799F68" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3D665CC6319D7639184DB29110799F68" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3D665CC6319D7639184DB29110799F68" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3D665CC6319D7639184DB29110799F68" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_B75AD5EF538B8340B9DFB291107967D4_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_B75AD5EF538B8340B9DFB291107967D4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_B75AD5EF538B8340B9DFB291107967D4_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_B75AD5EF538B8340B9DFB291107967D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_B75AD5EF538B8340B9DFB291107967D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock_B75AD5EF538B8340B9DFB291107967D4" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock_B75AD5EF538B8340B9DFB291107967D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_37A6243527D7DEF972ACCCD37032BA23_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_37A6243527D7DEF972ACCCD37032BA23" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_37A6243527D7DEF972ACCCD37032BA23_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_37A6243527D7DEF972ACCCD37032BA23" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_37A6243527D7DEF972ACCCD37032BA23" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock_37A6243527D7DEF972ACCCD37032BA23" xlink:to="lab_us-gaap_DebtDisclosureTextBlock_37A6243527D7DEF972ACCCD37032BA23" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementAbstract_5470D25FDA2B6812C61C117273597EB4_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract_5470D25FDA2B6812C61C117273597EB4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_5470D25FDA2B6812C61C117273597EB4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_5470D25FDA2B6812C61C117273597EB4" xlink:to="lab_us-gaap_IncomeStatementAbstract_5470D25FDA2B6812C61C117273597EB4" xlink:type="arc" />
    <link:label id="lab_ebs_ContractDevelopmentAndManufacturingMember_F8CD4A3009BBE42C3C7A1172735A80A8_terseLabel_en-US" xlink:label="lab_ebs_ContractDevelopmentAndManufacturingMember_F8CD4A3009BBE42C3C7A1172735A80A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract development and manufacturing services</link:label>
    <link:label id="lab_ebs_ContractDevelopmentAndManufacturingMember_F8CD4A3009BBE42C3C7A1172735A80A8_label_en-US" xlink:label="lab_ebs_ContractDevelopmentAndManufacturingMember_F8CD4A3009BBE42C3C7A1172735A80A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Development And Manufacturing [Member]</link:label>
    <link:label id="lab_ebs_ContractDevelopmentAndManufacturingMember_F8CD4A3009BBE42C3C7A1172735A80A8_documentation_en-US" xlink:label="lab_ebs_ContractDevelopmentAndManufacturingMember_F8CD4A3009BBE42C3C7A1172735A80A8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract Development And Manufacturing [Member]</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractDevelopmentAndManufacturingMember" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingMember_F8CD4A3009BBE42C3C7A1172735A80A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ContractDevelopmentAndManufacturingMember_F8CD4A3009BBE42C3C7A1172735A80A8" xlink:to="lab_ebs_ContractDevelopmentAndManufacturingMember_F8CD4A3009BBE42C3C7A1172735A80A8" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenuesAbstract_E016321A949F25CCE6A71172735B4F6D_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract_E016321A949F25CCE6A71172735B4F6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_E016321A949F25CCE6A71172735B4F6D_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract_E016321A949F25CCE6A71172735B4F6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_E016321A949F25CCE6A71172735B4F6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract_E016321A949F25CCE6A71172735B4F6D" xlink:to="lab_us-gaap_RevenuesAbstract_E016321A949F25CCE6A71172735B4F6D" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:to="lab_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_605494F48A072B7396831172735BA2EC_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_605494F48A072B7396831172735BA2EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of product sales and contract development and manufacturing services</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_605494F48A072B7396831172735BA2EC_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_605494F48A072B7396831172735BA2EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_605494F48A072B7396831172735BA2EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold_605494F48A072B7396831172735BA2EC" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold_605494F48A072B7396831172735BA2EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_EBEE6DC72485B47A2A5C1172735CF986_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_EBEE6DC72485B47A2A5C1172735CF986" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_EBEE6DC72485B47A2A5C1172735CF986_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_EBEE6DC72485B47A2A5C1172735CF986" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_EBEE6DC72485B47A2A5C1172735CF986" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_EBEE6DC72485B47A2A5C1172735CF986" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_EBEE6DC72485B47A2A5C1172735CF986" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_1BEC591FD9F8014A22FF1172735C98E8_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_1BEC591FD9F8014A22FF1172735C98E8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_1BEC591FD9F8014A22FF1172735C98E8_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_1BEC591FD9F8014A22FF1172735C98E8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1BEC591FD9F8014A22FF1172735C98E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1BEC591FD9F8014A22FF1172735C98E8" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense_1BEC591FD9F8014A22FF1172735C98E8" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_884CB031393A31D2C3131172735CFC2C_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_884CB031393A31D2C3131172735CFC2C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_884CB031393A31D2C3131172735CFC2C_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_884CB031393A31D2C3131172735CFC2C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_884CB031393A31D2C3131172735CFC2C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_884CB031393A31D2C3131172735CFC2C" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_884CB031393A31D2C3131172735CFC2C" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpenses_B836312A1AC6E27112971172735C7E7A_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses_B836312A1AC6E27112971172735C7E7A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_B836312A1AC6E27112971172735C7E7A_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses_B836312A1AC6E27112971172735C7E7A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_B836312A1AC6E27112971172735C7E7A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_B836312A1AC6E27112971172735C7E7A" xlink:to="lab_us-gaap_OperatingExpenses_B836312A1AC6E27112971172735C7E7A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_1D7166201D7465CD6F4B1172735D540B_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_1D7166201D7465CD6F4B1172735D540B" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_1D7166201D7465CD6F4B1172735D540B_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_1D7166201D7465CD6F4B1172735D540B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_1D7166201D7465CD6F4B1172735D540B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_1D7166201D7465CD6F4B1172735D540B" xlink:to="lab_us-gaap_OperatingIncomeLoss_1D7166201D7465CD6F4B1172735D540B" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpense_D4D4F9BC9633C7FD67EB1172735DA0CD_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense_D4D4F9BC9633C7FD67EB1172735DA0CD" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_D4D4F9BC9633C7FD67EB1172735DA0CD_label_en-US" xlink:label="lab_us-gaap_InterestExpense_D4D4F9BC9633C7FD67EB1172735DA0CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_D4D4F9BC9633C7FD67EB1172735DA0CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense_D4D4F9BC9633C7FD67EB1172735DA0CD" xlink:to="lab_us-gaap_InterestExpense_D4D4F9BC9633C7FD67EB1172735DA0CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_36AA2048A61866EF05FD1172735DB8CB_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_36AA2048A61866EF05FD1172735DB8CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_36AA2048A61866EF05FD1172735DB8CB_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_36AA2048A61866EF05FD1172735DB8CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_36AA2048A61866EF05FD1172735DB8CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_36AA2048A61866EF05FD1172735DB8CB" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense_36AA2048A61866EF05FD1172735DB8CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_1603A6B8918EA66996B21172735DF641_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_1603A6B8918EA66996B21172735DF641" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_1603A6B8918EA66996B21172735DF641_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_1603A6B8918EA66996B21172735DF641" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1603A6B8918EA66996B21172735DF641" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1603A6B8918EA66996B21172735DF641" xlink:to="lab_us-gaap_NonoperatingIncomeExpense_1603A6B8918EA66996B21172735DF641" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_576B03EDBDAAD2736C1E1172735E39D8_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_576B03EDBDAAD2736C1E1172735E39D8" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_576B03EDBDAAD2736C1E1172735E39D8_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_576B03EDBDAAD2736C1E1172735E39D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_576B03EDBDAAD2736C1E1172735E39D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_576B03EDBDAAD2736C1E1172735E39D8" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_576B03EDBDAAD2736C1E1172735E39D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1FBA462BA54B26B650A31172735E2173_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_1FBA462BA54B26B650A31172735E2173" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for income taxes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1FBA462BA54B26B650A31172735E2173" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1FBA462BA54B26B650A31172735E2173" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_1FBA462BA54B26B650A31172735E2173" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3101F3934AB9D783F06E1172735F51EB_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3101F3934AB9D783F06E1172735F51EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average number of shares - diluted (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3101F3934AB9D783F06E1172735F51EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3101F3934AB9D783F06E1172735F51EB" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3101F3934AB9D783F06E1172735F51EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01" xlink:to="lab_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156" xlink:to="lab_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_6B36F1338DE0157E9575688F62C53973_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_6B36F1338DE0157E9575688F62C53973" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6B36F1338DE0157E9575688F62C53973" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_6B36F1338DE0157E9575688F62C53973" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_6B36F1338DE0157E9575688F62C53973" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_B9A69F9CD7B5125BBF39688F62C56469_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_B9A69F9CD7B5125BBF39688F62C56469" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_B9A69F9CD7B5125BBF39688F62C56469" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_B9A69F9CD7B5125BBF39688F62C56469" xlink:to="lab_us-gaap_InventoryNet_B9A69F9CD7B5125BBF39688F62C56469" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_C84EE24174CB755BFE32688F62C5B51D_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable_C84EE24174CB755BFE32688F62C5B51D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax receivable, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_C84EE24174CB755BFE32688F62C5B51D_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable_C84EE24174CB755BFE32688F62C5B51D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="loc_us-gaap_IncomeTaxesReceivable_C84EE24174CB755BFE32688F62C5B51D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable_C84EE24174CB755BFE32688F62C5B51D" xlink:to="lab_us-gaap_IncomeTaxesReceivable_C84EE24174CB755BFE32688F62C5B51D" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_626D1D61B072187703BF688F62C50A6A_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_626D1D61B072187703BF688F62C50A6A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_626D1D61B072187703BF688F62C50A6A_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_626D1D61B072187703BF688F62C50A6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_626D1D61B072187703BF688F62C50A6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_626D1D61B072187703BF688F62C50A6A" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_626D1D61B072187703BF688F62C50A6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrent_1CEF40D2496A86A9CBB1688F62C59C08_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent_1CEF40D2496A86A9CBB1688F62C59C08" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_1CEF40D2496A86A9CBB1688F62C59C08_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent_1CEF40D2496A86A9CBB1688F62C59C08" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_1CEF40D2496A86A9CBB1688F62C59C08" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_1CEF40D2496A86A9CBB1688F62C59C08" xlink:to="lab_us-gaap_AssetsCurrent_1CEF40D2496A86A9CBB1688F62C59C08" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_AEB4D906D154F864C936688F62C597E9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_AEB4D906D154F864C936688F62C597E9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_AEB4D906D154F864C936688F62C597E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_AEB4D906D154F864C936688F62C597E9" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_AEB4D906D154F864C936688F62C597E9" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_9EF3AE7BD19AC6BD00EF688F62C55979_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_9EF3AE7BD19AC6BD00EF688F62C55979" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_9EF3AE7BD19AC6BD00EF688F62C55979_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_9EF3AE7BD19AC6BD00EF688F62C55979" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9EF3AE7BD19AC6BD00EF688F62C55979" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9EF3AE7BD19AC6BD00EF688F62C55979" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_9EF3AE7BD19AC6BD00EF688F62C55979" xlink:type="arc" />
    <link:label id="lab_ebs_InProcessResearchAndDevelopment_252E431F8CF92A732185688F62C5CD4F_terseLabel_en-US" xlink:label="lab_ebs_InProcessResearchAndDevelopment_252E431F8CF92A732185688F62C5CD4F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_ebs_InProcessResearchAndDevelopment_252E431F8CF92A732185688F62C5CD4F_label_en-US" xlink:label="lab_ebs_InProcessResearchAndDevelopment_252E431F8CF92A732185688F62C5CD4F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Process Research And Development</link:label>
    <link:label id="lab_ebs_InProcessResearchAndDevelopment_252E431F8CF92A732185688F62C5CD4F_documentation_en-US" xlink:label="lab_ebs_InProcessResearchAndDevelopment_252E431F8CF92A732185688F62C5CD4F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying amount of purchased research and development assets acquired in a business combination that have an indefinite life until completion or abandonment of the associated research and development efforts.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_InProcessResearchAndDevelopment" xlink:label="loc_ebs_InProcessResearchAndDevelopment_252E431F8CF92A732185688F62C5CD4F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_InProcessResearchAndDevelopment_252E431F8CF92A732185688F62C5CD4F" xlink:to="lab_ebs_InProcessResearchAndDevelopment_252E431F8CF92A732185688F62C5CD4F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_80C4F2DBC349F36D740F688F62C55635_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet_80C4F2DBC349F36D740F688F62C55635" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_80C4F2DBC349F36D740F688F62C55635_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet_80C4F2DBC349F36D740F688F62C55635" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_80C4F2DBC349F36D740F688F62C55635" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet_80C4F2DBC349F36D740F688F62C55635" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet_80C4F2DBC349F36D740F688F62C55635" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_EA91D83FBBA421C1AF07688F62C5DFC2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_EA91D83FBBA421C1AF07688F62C5DFC2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_EA91D83FBBA421C1AF07688F62C5DFC2_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_EA91D83FBBA421C1AF07688F62C5DFC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_EA91D83FBBA421C1AF07688F62C5DFC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_EA91D83FBBA421C1AF07688F62C5DFC2" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_EA91D83FBBA421C1AF07688F62C5DFC2" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_D09BC50FDB4D8AF00790688F62C5E4CC_totalLabel_en-US" xlink:label="lab_us-gaap_Assets_D09BC50FDB4D8AF00790688F62C5E4CC" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_D09BC50FDB4D8AF00790688F62C5E4CC_label_en-US" xlink:label="lab_us-gaap_Assets_D09BC50FDB4D8AF00790688F62C5E4CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_D09BC50FDB4D8AF00790688F62C5E4CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_D09BC50FDB4D8AF00790688F62C5E4CC" xlink:to="lab_us-gaap_Assets_D09BC50FDB4D8AF00790688F62C5E4CC" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableCurrent_1907D8C76A8E63D8EE3D688F62C52AE6_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_1907D8C76A8E63D8EE3D688F62C52AE6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_1907D8C76A8E63D8EE3D688F62C52AE6_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_1907D8C76A8E63D8EE3D688F62C52AE6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_1907D8C76A8E63D8EE3D688F62C52AE6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_1907D8C76A8E63D8EE3D688F62C52AE6" xlink:to="lab_us-gaap_AccountsPayableCurrent_1907D8C76A8E63D8EE3D688F62C52AE6" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_5E679AC175F3628315BF688F62C54BC5_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent_5E679AC175F3628315BF688F62C54BC5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_5E679AC175F3628315BF688F62C54BC5_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent_5E679AC175F3628315BF688F62C54BC5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_5E679AC175F3628315BF688F62C54BC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_5E679AC175F3628315BF688F62C54BC5" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent_5E679AC175F3628315BF688F62C54BC5" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_B08DCAED8CA73211BAD5688F62C56AA0_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_B08DCAED8CA73211BAD5688F62C56AA0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_B08DCAED8CA73211BAD5688F62C56AA0_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_B08DCAED8CA73211BAD5688F62C56AA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_B08DCAED8CA73211BAD5688F62C56AA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_B08DCAED8CA73211BAD5688F62C56AA0" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_B08DCAED8CA73211BAD5688F62C56AA0" xlink:type="arc" />
    <link:label id="lab_us-gaap_NotesPayableCurrent_512C22484107C8A53F49688F62C5397D_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent_512C22484107C8A53F49688F62C5397D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt, current portion</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_512C22484107C8A53F49688F62C5397D_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent_512C22484107C8A53F49688F62C5397D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent_512C22484107C8A53F49688F62C5397D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent_512C22484107C8A53F49688F62C5397D" xlink:to="lab_us-gaap_NotesPayableCurrent_512C22484107C8A53F49688F62C5397D" xlink:type="arc" />
    <link:label id="lab_ebs_ContingentConsiderationCurrentPortion_4DD730800468DE0FF972688F62C58725_terseLabel_en-US" xlink:label="lab_ebs_ContingentConsiderationCurrentPortion_4DD730800468DE0FF972688F62C58725" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration, current portion</link:label>
    <link:label id="lab_ebs_ContingentConsiderationCurrentPortion_4DD730800468DE0FF972688F62C58725_label_en-US" xlink:label="lab_ebs_ContingentConsiderationCurrentPortion_4DD730800468DE0FF972688F62C58725" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Current Portion</link:label>
    <link:label id="lab_ebs_ContingentConsiderationCurrentPortion_4DD730800468DE0FF972688F62C58725_documentation_en-US" xlink:label="lab_ebs_ContingentConsiderationCurrentPortion_4DD730800468DE0FF972688F62C58725" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value as of the balance sheet date of the current portion of liabilities incurred and payable to former shareholders and stock option holders for certain developmental, regulatory or commercial milestones.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContingentConsiderationCurrentPortion" xlink:label="loc_ebs_ContingentConsiderationCurrentPortion_4DD730800468DE0FF972688F62C58725" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ContingentConsiderationCurrentPortion_4DD730800468DE0FF972688F62C58725" xlink:to="lab_ebs_ContingentConsiderationCurrentPortion_4DD730800468DE0FF972688F62C58725" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_91716E0B3C986F9A54A0688F62C506AF_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent_91716E0B3C986F9A54A0688F62C506AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_91716E0B3C986F9A54A0688F62C506AF_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent_91716E0B3C986F9A54A0688F62C506AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_91716E0B3C986F9A54A0688F62C506AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_91716E0B3C986F9A54A0688F62C506AF" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent_91716E0B3C986F9A54A0688F62C506AF" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrent_E991490D3898DB573ADB688F62C550B8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_E991490D3898DB573ADB688F62C550B8" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_E991490D3898DB573ADB688F62C550B8_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_E991490D3898DB573ADB688F62C550B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_E991490D3898DB573ADB688F62C550B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_E991490D3898DB573ADB688F62C550B8" xlink:to="lab_us-gaap_LiabilitiesCurrent_E991490D3898DB573ADB688F62C550B8" xlink:type="arc" />
    <link:label id="lab_ebs_ContingentConsiderationNetOfCurrentPortion_354B49A89D081842541E688F62C54064_terseLabel_en-US" xlink:label="lab_ebs_ContingentConsiderationNetOfCurrentPortion_354B49A89D081842541E688F62C54064" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration, net of current portion</link:label>
    <link:label id="lab_ebs_ContingentConsiderationNetOfCurrentPortion_354B49A89D081842541E688F62C54064_label_en-US" xlink:label="lab_ebs_ContingentConsiderationNetOfCurrentPortion_354B49A89D081842541E688F62C54064" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Net Of Current Portion</link:label>
    <link:label id="lab_ebs_ContingentConsiderationNetOfCurrentPortion_354B49A89D081842541E688F62C54064_documentation_en-US" xlink:label="lab_ebs_ContingentConsiderationNetOfCurrentPortion_354B49A89D081842541E688F62C54064" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value as of the balance sheet date of the noncurrent portion of liabilities incurred and payable to former shareholders and stock option holders for certain developmental, regulatory or commercial milestones.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContingentConsiderationNetOfCurrentPortion" xlink:label="loc_ebs_ContingentConsiderationNetOfCurrentPortion_354B49A89D081842541E688F62C54064" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_ContingentConsiderationNetOfCurrentPortion_354B49A89D081842541E688F62C54064" xlink:to="lab_ebs_ContingentConsiderationNetOfCurrentPortion_354B49A89D081842541E688F62C54064" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_D848FD8D89ABFB4C12EE688F62C5B949_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent_D848FD8D89ABFB4C12EE688F62C5B949" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt, net of current portion</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_D848FD8D89ABFB4C12EE688F62C5B949" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_D848FD8D89ABFB4C12EE688F62C5B949" xlink:to="lab_us-gaap_LongTermDebtNoncurrent_D848FD8D89ABFB4C12EE688F62C5B949" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_5962BF3E60E876DD7856688F62D4FB3B_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_5962BF3E60E876DD7856688F62D4FB3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_5962BF3E60E876DD7856688F62D4FB3B_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_5962BF3E60E876DD7856688F62D4FB3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5962BF3E60E876DD7856688F62D4FB3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5962BF3E60E876DD7856688F62D4FB3B" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_5962BF3E60E876DD7856688F62D4FB3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_10268F93F48618F11D4E688F62D4E047_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_10268F93F48618F11D4E688F62D4E047" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_10268F93F48618F11D4E688F62D4E047_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_10268F93F48618F11D4E688F62D4E047" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_10268F93F48618F11D4E688F62D4E047" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_10268F93F48618F11D4E688F62D4E047" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_10268F93F48618F11D4E688F62D4E047" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_4781CCC54BFA1925C253688F62D43689_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_4781CCC54BFA1925C253688F62D43689" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_4781CCC54BFA1925C253688F62D43689_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_4781CCC54BFA1925C253688F62D43689" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4781CCC54BFA1925C253688F62D43689" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_4781CCC54BFA1925C253688F62D43689" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent_4781CCC54BFA1925C253688F62D43689" xlink:type="arc" />
    <link:label id="lab_us-gaap_Liabilities_85119F999F091A2B313B688F62D4EF2D_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities_85119F999F091A2B313B688F62D4EF2D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_85119F999F091A2B313B688F62D4EF2D_label_en-US" xlink:label="lab_us-gaap_Liabilities_85119F999F091A2B313B688F62D4EF2D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_85119F999F091A2B313B688F62D4EF2D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_85119F999F091A2B313B688F62D4EF2D" xlink:to="lab_us-gaap_Liabilities_85119F999F091A2B313B688F62D4EF2D" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF" xlink:to="lab_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockValue_2FA1504D0D08B4D1777C688F62D4EF54_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue_2FA1504D0D08B4D1777C688F62D4EF54" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, $0.001 par value; 15.0 shares authorized, 0 shares issued and outstanding at both December 31, 2019 and 2018</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_2FA1504D0D08B4D1777C688F62D4EF54_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue_2FA1504D0D08B4D1777C688F62D4EF54" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_2FA1504D0D08B4D1777C688F62D4EF54" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue_2FA1504D0D08B4D1777C688F62D4EF54" xlink:to="lab_us-gaap_PreferredStockValue_2FA1504D0D08B4D1777C688F62D4EF54" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockValue_00A081A7E7CD6154D240688F62D48665_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue_00A081A7E7CD6154D240688F62D48665" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.001 par value; 200.0 shares authorized, 52.9 shares issued and 51.7 shares outstanding at December 31, 2019; 52.4 shares issued and 51.2 shares outstanding at December 31, 2018</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_00A081A7E7CD6154D240688F62D48665_label_en-US" xlink:label="lab_us-gaap_CommonStockValue_00A081A7E7CD6154D240688F62D48665" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_00A081A7E7CD6154D240688F62D48665" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_00A081A7E7CD6154D240688F62D48665" xlink:to="lab_us-gaap_CommonStockValue_00A081A7E7CD6154D240688F62D48665" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValue_E473E84F8C7E8097D8E2688F62D4E0AD_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_E473E84F8C7E8097D8E2688F62D4E0AD" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost, 1.2 common shares at December 31, 2019 and 2018</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_E473E84F8C7E8097D8E2688F62D4E0AD_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_E473E84F8C7E8097D8E2688F62D4E0AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_E473E84F8C7E8097D8E2688F62D4E0AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_E473E84F8C7E8097D8E2688F62D4E0AD" xlink:to="lab_us-gaap_TreasuryStockValue_E473E84F8C7E8097D8E2688F62D4E0AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_C5E5A4B5169336502D6C688F62D40475_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital_C5E5A4B5169336502D6C688F62D40475" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_C5E5A4B5169336502D6C688F62D40475_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital_C5E5A4B5169336502D6C688F62D40475" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_C5E5A4B5169336502D6C688F62D40475" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital_C5E5A4B5169336502D6C688F62D40475" xlink:to="lab_us-gaap_AdditionalPaidInCapital_C5E5A4B5169336502D6C688F62D40475" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7F6E60CE810155A083DF688F62D45922_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7F6E60CE810155A083DF688F62D45922" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss, net</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7F6E60CE810155A083DF688F62D45922_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7F6E60CE810155A083DF688F62D45922" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7F6E60CE810155A083DF688F62D45922" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7F6E60CE810155A083DF688F62D45922" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7F6E60CE810155A083DF688F62D45922" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_264E51814C1CF290DE09688F62D432CB_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_264E51814C1CF290DE09688F62D432CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_264E51814C1CF290DE09688F62D432CB_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_264E51814C1CF290DE09688F62D432CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_264E51814C1CF290DE09688F62D432CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_264E51814C1CF290DE09688F62D432CB" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_264E51814C1CF290DE09688F62D432CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_CD49A604F811503B1B8E688F62D421E4_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_CD49A604F811503B1B8E688F62D421E4" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_CD49A604F811503B1B8E688F62D421E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_CD49A604F811503B1B8E688F62D421E4" xlink:to="lab_us-gaap_StockholdersEquity_CD49A604F811503B1B8E688F62D421E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_C3856BC722C2C08DE339688F62D42CA1_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_C3856BC722C2C08DE339688F62D42CA1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_C3856BC722C2C08DE339688F62D42CA1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_C3856BC722C2C08DE339688F62D42CA1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_C3856BC722C2C08DE339688F62D42CA1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_C3856BC722C2C08DE339688F62D42CA1" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_C3856BC722C2C08DE339688F62D42CA1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_12A135C52B152B08085D997672130417_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_12A135C52B152B08085D997672130417" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Product Sales</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_12A135C52B152B08085D997672130417_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_12A135C52B152B08085D997672130417" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_12A135C52B152B08085D997672130417" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_12A135C52B152B08085D997672130417" xlink:to="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_12A135C52B152B08085D997672130417" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_2BC00F171F978F0B4765ECB148376FE6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount_2BC00F171F978F0B4765ECB148376FE6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_2BC00F171F978F0B4765ECB148376FE6_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount_2BC00F171F978F0B4765ECB148376FE6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2BC00F171F978F0B4765ECB148376FE6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount_2BC00F171F978F0B4765ECB148376FE6" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount_2BC00F171F978F0B4765ECB148376FE6" xlink:type="arc" />
    <link:label id="lab_ebs_DebtInstrumentNumberOfEquityInstruments_D4AC74724DD4B6B485F5ECB14837A438_terseLabel_en-US" xlink:label="lab_ebs_DebtInstrumentNumberOfEquityInstruments_D4AC74724DD4B6B485F5ECB14837A438" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion rate of notes per $1,000 principal amount (in shares)</link:label>
    <link:label id="lab_ebs_DebtInstrumentNumberOfEquityInstruments_D4AC74724DD4B6B485F5ECB14837A438_label_en-US" xlink:label="lab_ebs_DebtInstrumentNumberOfEquityInstruments_D4AC74724DD4B6B485F5ECB14837A438" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number Of Equity Instruments</link:label>
    <link:label id="lab_ebs_DebtInstrumentNumberOfEquityInstruments_D4AC74724DD4B6B485F5ECB14837A438_documentation_en-US" xlink:label="lab_ebs_DebtInstrumentNumberOfEquityInstruments_D4AC74724DD4B6B485F5ECB14837A438" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number Of Equity Instruments</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentNumberOfEquityInstruments" xlink:label="loc_ebs_DebtInstrumentNumberOfEquityInstruments_D4AC74724DD4B6B485F5ECB14837A438" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtInstrumentNumberOfEquityInstruments_D4AC74724DD4B6B485F5ECB14837A438" xlink:to="lab_ebs_DebtInstrumentNumberOfEquityInstruments_D4AC74724DD4B6B485F5ECB14837A438" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_9CF4A65FA8B24E84F229ECB14837C917_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet_9CF4A65FA8B24E84F229ECB14837C917" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_9CF4A65FA8B24E84F229ECB14837C917_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet_9CF4A65FA8B24E84F229ECB14837C917" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_9CF4A65FA8B24E84F229ECB14837C917" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet_9CF4A65FA8B24E84F229ECB14837C917" xlink:to="lab_us-gaap_DeferredFinanceCostsNet_9CF4A65FA8B24E84F229ECB14837C917" xlink:type="arc" />
    <link:label id="lab_ebs_DebtInstrumentNumberOfAdditionalEquityInstruments_EA38522F86D2D289BD4AECB1483716D9_terseLabel_en-US" xlink:label="lab_ebs_DebtInstrumentNumberOfAdditionalEquityInstruments_EA38522F86D2D289BD4AECB1483716D9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional conversion rate of notes per $1,000 principal amount (in shares)</link:label>
    <link:label id="lab_ebs_DebtInstrumentNumberOfAdditionalEquityInstruments_EA38522F86D2D289BD4AECB1483716D9_label_en-US" xlink:label="lab_ebs_DebtInstrumentNumberOfAdditionalEquityInstruments_EA38522F86D2D289BD4AECB1483716D9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Number Of Additional Equity Instruments</link:label>
    <link:label id="lab_ebs_DebtInstrumentNumberOfAdditionalEquityInstruments_EA38522F86D2D289BD4AECB1483716D9_documentation_en-US" xlink:label="lab_ebs_DebtInstrumentNumberOfAdditionalEquityInstruments_EA38522F86D2D289BD4AECB1483716D9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of additional equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentNumberOfAdditionalEquityInstruments" xlink:label="loc_ebs_DebtInstrumentNumberOfAdditionalEquityInstruments_EA38522F86D2D289BD4AECB1483716D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtInstrumentNumberOfAdditionalEquityInstruments_EA38522F86D2D289BD4AECB1483716D9" xlink:to="lab_ebs_DebtInstrumentNumberOfAdditionalEquityInstruments_EA38522F86D2D289BD4AECB1483716D9" xlink:type="arc" />
    <link:label id="lab_ebs_DebtInstrumentAccruedInterestOnConvertedNotes_4C6CFEE543380ECCD3F2ECB1483835DE_terseLabel_en-US" xlink:label="lab_ebs_DebtInstrumentAccruedInterestOnConvertedNotes_4C6CFEE543380ECCD3F2ECB1483835DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest on converted notes</link:label>
    <link:label id="lab_ebs_DebtInstrumentAccruedInterestOnConvertedNotes_4C6CFEE543380ECCD3F2ECB1483835DE_label_en-US" xlink:label="lab_ebs_DebtInstrumentAccruedInterestOnConvertedNotes_4C6CFEE543380ECCD3F2ECB1483835DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Accrued interest on converted notes</link:label>
    <link:label id="lab_ebs_DebtInstrumentAccruedInterestOnConvertedNotes_4C6CFEE543380ECCD3F2ECB1483835DE_documentation_en-US" xlink:label="lab_ebs_DebtInstrumentAccruedInterestOnConvertedNotes_4C6CFEE543380ECCD3F2ECB1483835DE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount for accrued, but unpaid interest on the converted notes for the period.</link:label>
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentAccruedInterestOnConvertedNotes" xlink:label="loc_ebs_DebtInstrumentAccruedInterestOnConvertedNotes_4C6CFEE543380ECCD3F2ECB1483835DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ebs_DebtInstrumentAccruedInterestOnConvertedNotes_4C6CFEE543380ECCD3F2ECB1483835DE" xlink:to="lab_ebs_DebtInstrumentAccruedInterestOnConvertedNotes_4C6CFEE543380ECCD3F2ECB1483835DE" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>20
<FILENAME>ebs-20191231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Acquisitions" xlink:href="ebs-20191231.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAcquisitionOfAcam2000BusinessDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAcquisitionOfAcam2000NarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAcquisitionOfRaxibacumabAssetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAdaptNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails" xlink:href="ebs-20191231.xsd#AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails" xlink:href="ebs-20191231.xsd#AcquisitionsPaxvaxNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails" xlink:href="ebs-20191231.xsd#AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/AcquisitionsTables" xlink:href="ebs-20191231.xsd#AcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets" xlink:href="ebs-20191231.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="ebs-20191231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" xlink:href="ebs-20191231.xsd#ConsolidatedStatementOfChangesInStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquityParenthetical" xlink:href="ebs-20191231.xsd#ConsolidatedStatementOfChangesInStockholdersEquityParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="ebs-20191231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="ebs-20191231.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations" xlink:href="ebs-20191231.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CoverPage" xlink:href="ebs-20191231.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlan" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlan" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanNarrativeDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanTables" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails" xlink:href="ebs-20191231.xsd#DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstruments" xlink:href="ebs-20191231.xsd#DerivativeInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails" xlink:href="ebs-20191231.xsd#DerivativeInstrumentsCashFlowHedgingOnAociDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails" xlink:href="ebs-20191231.xsd#DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails" xlink:href="ebs-20191231.xsd#DerivativeInstrumentsFairValueByBalanceSheetLocationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsNarrativeDetails" xlink:href="ebs-20191231.xsd#DerivativeInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeInstrumentsTables" xlink:href="ebs-20191231.xsd#DerivativeInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/EarningsPerShare" xlink:href="ebs-20191231.xsd#EarningsPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/EarningsPerShareDetails" xlink:href="ebs-20191231.xsd#EarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/EarningsPerShareTables" xlink:href="ebs-20191231.xsd#EarningsPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairValueMeasurements" xlink:href="ebs-20191231.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairValueMeasurementsDetails" xlink:href="ebs-20191231.xsd#FairValueMeasurementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="ebs-20191231.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/FairValueMeasurementsTables" xlink:href="ebs-20191231.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxes" xlink:href="ebs-20191231.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails" xlink:href="ebs-20191231.xsd#IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails" xlink:href="ebs-20191231.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails" xlink:href="ebs-20191231.xsd#IncomeTaxesNetDeferredTaxAssetLiabilityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails" xlink:href="ebs-20191231.xsd#IncomeTaxesReconciliationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesTables" xlink:href="ebs-20191231.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:href="ebs-20191231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwill" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwillNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillTables" xlink:href="ebs-20191231.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Inventories" xlink:href="ebs-20191231.xsd#Inventories" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/InventoriesDetails" xlink:href="ebs-20191231.xsd#InventoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/InventoriesTables" xlink:href="ebs-20191231.xsd#InventoriesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Leases" xlink:href="ebs-20191231.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails" xlink:href="ebs-20191231.xsd#LeasesComponentsOfLeaseExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesNarrativeDetails" xlink:href="ebs-20191231.xsd#LeasesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:href="ebs-20191231.xsd#LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesTables" xlink:href="ebs-20191231.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Litigation" xlink:href="ebs-20191231.xsd#Litigation" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebt" xlink:href="ebs-20191231.xsd#LongTermDebt" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails" xlink:href="ebs-20191231.xsd#LongTermDebtComponentsOfLongTermIndebtednessDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails" xlink:href="ebs-20191231.xsd#LongTermDebtConvertibleSeniorNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails" xlink:href="ebs-20191231.xsd#LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails" xlink:href="ebs-20191231.xsd#LongTermDebtSeniorSecuredCreditAgreementDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LongTermDebtTables" xlink:href="ebs-20191231.xsd#LongTermDebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganization" xlink:href="ebs-20191231.xsd#NatureOfBusinessAndOrganization" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganizationDetails" xlink:href="ebs-20191231.xsd#NatureOfBusinessAndOrganizationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyPlantAndEquipment" xlink:href="ebs-20191231.xsd#PropertyPlantAndEquipment" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails" xlink:href="ebs-20191231.xsd#PropertyPlantAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentTables" xlink:href="ebs-20191231.xsd#PropertyPlantAndEquipmentTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PurchaseCommitments" xlink:href="ebs-20191231.xsd#PurchaseCommitments" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PurchaseCommitmentsDetails" xlink:href="ebs-20191231.xsd#PurchaseCommitmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnaudited" xlink:href="ebs-20191231.xsd#QuarterlyFinancialDataUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedDetails" xlink:href="ebs-20191231.xsd#QuarterlyFinancialDataUnauditedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedTables" xlink:href="ebs-20191231.xsd#QuarterlyFinancialDataUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognition" xlink:href="ebs-20191231.xsd#RevenueRecognition" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails" xlink:href="ebs-20191231.xsd#RevenueRecognitionAccountsReceivableDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails" xlink:href="ebs-20191231.xsd#RevenueRecognitionContractLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:href="ebs-20191231.xsd#RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails" xlink:href="ebs-20191231.xsd#RevenueRecognitionNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionRemainingPerformanceObligationDetails" xlink:href="ebs-20191231.xsd#RevenueRecognitionRemainingPerformanceObligationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenueRecognitionTables" xlink:href="ebs-20191231.xsd#RevenueRecognitionTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:href="ebs-20191231.xsd#ScheduleIiValuationAndQualifyingAccounts" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:href="ebs-20191231.xsd#ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentInformation" xlink:href="ebs-20191231.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails" xlink:href="ebs-20191231.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails" xlink:href="ebs-20191231.xsd#SegmentInformationProductSalesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SegmentInformationTables" xlink:href="ebs-20191231.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquity" xlink:href="ebs-20191231.xsd#StockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails" xlink:href="ebs-20191231.xsd#StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails" xlink:href="ebs-20191231.xsd#StockholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails" xlink:href="ebs-20191231.xsd#StockholdersEquityStockBasedCompensationExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails" xlink:href="ebs-20191231.xsd#StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails" xlink:href="ebs-20191231.xsd#StockholdersEquityStockOptionsValuationAssumptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockholdersEquityTables" xlink:href="ebs-20191231.xsd#StockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ebs-20191231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_BA133C6506217F9813E9CCD36F79BC25" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_4ED9988E13ABC5F20957CCD36F7920B2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_BA133C6506217F9813E9CCD36F79BC25" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_4ED9988E13ABC5F20957CCD36F7920B2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_B127072DE9C95011AF523F3C374D14AE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3F84439C46AFD2D3F2DB3F3C374ED654" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_B127072DE9C95011AF523F3C374D14AE" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3F84439C46AFD2D3F2DB3F3C374ED654" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_BA6999DCA812580560343F3C374E12F9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3F84439C46AFD2D3F2DB3F3C374ED654" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_BA6999DCA812580560343F3C374E12F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1E4271AB3C3C09D943153F3C374EB42D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_BA6999DCA812580560343F3C374E12F9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1E4271AB3C3C09D943153F3C374EB42D" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ACAM2000Member" xlink:label="loc_ebs_ACAM2000Member_FE64380D84965EAD85273F3C374F3C27" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1E4271AB3C3C09D943153F3C374EB42D" xlink:to="loc_ebs_ACAM2000Member_FE64380D84965EAD85273F3C374F3C27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_976511B7371CCCBAAF5A3F3C374FC180" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3F84439C46AFD2D3F2DB3F3C374ED654" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_976511B7371CCCBAAF5A3F3C374FC180" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_976511B7371CCCBAAF5A3F3C374FC180" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_0012872FCD60A14C37013F3C374FC74A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_0012872FCD60A14C37013F3C374FC74A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_41E5B83E1AAAB86D1CC63F3C3750C06A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_41E5B83E1AAAB86D1CC63F3C3750C06A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5B42266E9AF641C2D6A93F3C37505B6E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_71CCBDE9FE5DBC98007D3F3C374FF0D7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5B42266E9AF641C2D6A93F3C37505B6E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_976511B7371CCCBAAF5A3F3C374FC180" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_C13833204712206A4DB13F3C375011D3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_C13833204712206A4DB13F3C375011D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E7DD9D4634A461F424163F3C375015D5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E7DD9D4634A461F424163F3C375015D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_785CDB0754D3A2A120393F3C37511030" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_785CDB0754D3A2A120393F3C37511030" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_78BE7819DA0674095D3F3F3C3751DC1E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_78BE7819DA0674095D3F3F3C3751DC1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_A066F32AA7E5855A4D183F3C3751A4DA" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:to="loc_us-gaap_Goodwill_A066F32AA7E5855A4D183F3C3751A4DA" xlink:type="arc" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_D2CDA1E4DC0DCC48E8B43F3C3750E996" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5B42266E9AF641C2D6A93F3C37505B6E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_3C7496A11EF22DBFE75CA55DF3210C26" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D8806F6CB8D597176A49A55DF3217141" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3C7496A11EF22DBFE75CA55DF3210C26" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D8806F6CB8D597176A49A55DF3217141" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5E651031D4BA6D32F24CA55DF3221802" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D8806F6CB8D597176A49A55DF3217141" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5E651031D4BA6D32F24CA55DF3221802" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9394F3A9D83D1783BF5EA55DF3224A3A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5E651031D4BA6D32F24CA55DF3221802" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9394F3A9D83D1783BF5EA55DF3224A3A" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ACAM2000Member" xlink:label="loc_ebs_ACAM2000Member_34125DF43474ECDF13A6A55DF3225CE8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9394F3A9D83D1783BF5EA55DF3224A3A" xlink:to="loc_ebs_ACAM2000Member_34125DF43474ECDF13A6A55DF3225CE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D8806F6CB8D597176A49A55DF3217141" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TermofContractUnderAcquisition" xlink:label="loc_ebs_TermofContractUnderAcquisition_1F4F5AF422D223AE9B47A55DF323CE4B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_ebs_TermofContractUnderAcquisition_1F4F5AF422D223AE9B47A55DF323CE4B" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ValueofContract" xlink:label="loc_ebs_ValueofContract_6528643F0EF9C5B84299A55DF323130B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_ebs_ValueofContract_6528643F0EF9C5B84299A55DF323130B" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmountforDeliveriesofProduct" xlink:label="loc_ebs_AmountforDeliveriesofProduct_D214C28795C5A59E835CA55DF3233218" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_ebs_AmountforDeliveriesofProduct_D214C28795C5A59E835CA55DF3233218" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_UpfrontPayments" xlink:label="loc_ebs_UpfrontPayments_C1B3A1C926326A53BBA9A55DF3239083" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_ebs_UpfrontPayments_C1B3A1C926326A53BBA9A55DF3239083" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmountOfPaymentForManufacturingRelatedMilestones" xlink:label="loc_ebs_AmountOfPaymentForManufacturingRelatedMilestones_FC936D1F926A67B02103A55DF3244ED6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_ebs_AmountOfPaymentForManufacturingRelatedMilestones_FC936D1F926A67B02103A55DF3244ED6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_A6D0062DA5233C870084A55DF324D63C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_A6D0062DA5233C870084A55DF324D63C" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmountOfPaymentForRegulatoryRelatedMilestones" xlink:label="loc_ebs_AmountOfPaymentForRegulatoryRelatedMilestones_B3A83591AEB68DAFEDE2A55DF324B244" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_ebs_AmountOfPaymentForRegulatoryRelatedMilestones_B3A83591AEB68DAFEDE2A55DF324B244" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_92C135C33B06E1585705A55DF324EBB1" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_92C135C33B06E1585705A55DF324EBB1" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PresentValueDiscountRate" xlink:label="loc_ebs_PresentValueDiscountRate_AB5E68892125DF98C9DEA55DF32419BD" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_ebs_PresentValueDiscountRate_AB5E68892125DF98C9DEA55DF32419BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_EC75B99827347C01B447A55DF3249588" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_EC75B99827347C01B447A55DF3249588" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_CE2F3FCDF08558512CF0A55DF324AB04" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_255FA4035B2F24FDFB88A55DF32312C0" xlink:to="loc_us-gaap_Goodwill_CE2F3FCDF08558512CF0A55DF324AB04" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_8CAC74C07B366F84815BEC8A3E3B2B7D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_747E8925654B759C8231EC8A3E458ED2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8CAC74C07B366F84815BEC8A3E3B2B7D" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_747E8925654B759C8231EC8A3E458ED2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3C9F6496B59624B1BE0DEC8A3E459B3B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_747E8925654B759C8231EC8A3E458ED2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3C9F6496B59624B1BE0DEC8A3E459B3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6F484511B8524454CA41EC8A3E45B301" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3C9F6496B59624B1BE0DEC8A3E459B3B" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6F484511B8524454CA41EC8A3E45B301" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_RaxibacumabMember" xlink:label="loc_ebs_RaxibacumabMember_4B013105806BD9D0F489EC8A3E46B884" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6F484511B8524454CA41EC8A3E45B301" xlink:to="loc_ebs_RaxibacumabMember_4B013105806BD9D0F489EC8A3E46B884" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_0735F3FB9C9BE2D2D6ECEC8A3E46AFD9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_747E8925654B759C8231EC8A3E458ED2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_0735F3FB9C9BE2D2D6ECEC8A3E46AFD9" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_UpfrontPayments" xlink:label="loc_ebs_UpfrontPayments_E327B8920521B8A22A74EC8A3E46D7CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0735F3FB9C9BE2D2D6ECEC8A3E46AFD9" xlink:to="loc_ebs_UpfrontPayments_E327B8920521B8A22A74EC8A3E46D7CB" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmountOfPaymentForManufacturingRelatedMilestones" xlink:label="loc_ebs_AmountOfPaymentForManufacturingRelatedMilestones_18D8700838ADA3AFDC92EC8A3E46E469" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0735F3FB9C9BE2D2D6ECEC8A3E46AFD9" xlink:to="loc_ebs_AmountOfPaymentForManufacturingRelatedMilestones_18D8700838ADA3AFDC92EC8A3E46E469" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_3B0A9BBA89CCC8357660EC8A3E46B81A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0735F3FB9C9BE2D2D6ECEC8A3E46AFD9" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_3B0A9BBA89CCC8357660EC8A3E46B81A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3C148C7555CF2711B500EC99CD82EA5B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0735F3FB9C9BE2D2D6ECEC8A3E46AFD9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3C148C7555CF2711B500EC99CD82EA5B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_AE9E0A2A86F2FF75451F2CB80599EBBE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A231923551A6B0B321A22CB8059911DD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_AE9E0A2A86F2FF75451F2CB80599EBBE" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A231923551A6B0B321A22CB8059911DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B351BDE6D8FB247011152CC36E823450" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A231923551A6B0B321A22CB8059911DD" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B351BDE6D8FB247011152CC36E823450" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_F9BEFA057C94DC870A472CC36E844D10" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B351BDE6D8FB247011152CC36E823450" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_F9BEFA057C94DC870A472CC36E844D10" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_BB1125ABB4053BF7F2982CB8059A0085" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_F9BEFA057C94DC870A472CC36E844D10" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_BB1125ABB4053BF7F2982CB8059A0085" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E23084C2CB6BC5AAB4F62CB805993111" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A231923551A6B0B321A22CB8059911DD" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E23084C2CB6BC5AAB4F62CB805993111" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5FF99798F6CC7C8AB9D62CB8059AC29B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E23084C2CB6BC5AAB4F62CB805993111" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5FF99798F6CC7C8AB9D62CB8059AC29B" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5FF99798F6CC7C8AB9D62CB8059AC29B" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_BB1125ABB4053BF7F2982CB8059A0085" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_B63BFD8C3E4AA9412BFB2CB8059A7963" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A231923551A6B0B321A22CB8059911DD" xlink:to="loc_srt_RangeAxis_B63BFD8C3E4AA9412BFB2CB8059A7963" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_D41FE173AC84238B191B2CB8059B515E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_B63BFD8C3E4AA9412BFB2CB8059A7963" xlink:to="loc_srt_RangeMember_D41FE173AC84238B191B2CB8059B515E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_5BDD89DDA5830A7FA1F42CB8059B9910" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_D41FE173AC84238B191B2CB8059B515E" xlink:to="loc_srt_MaximumMember_5BDD89DDA5830A7FA1F42CB8059B9910" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_517314B0C5282BFA9EC92CB8059BF95F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A231923551A6B0B321A22CB8059911DD" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_517314B0C5282BFA9EC92CB8059BF95F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FB45AE215D6D6F73DFBB2CB8059BA816" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_517314B0C5282BFA9EC92CB8059BF95F" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FB45AE215D6D6F73DFBB2CB8059BA816" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AdaptPharmaMember" xlink:label="loc_ebs_AdaptPharmaMember_4105463F727A65C6EED22CB8059B4943" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FB45AE215D6D6F73DFBB2CB8059BA816" xlink:to="loc_ebs_AdaptPharmaMember_4105463F727A65C6EED22CB8059B4943" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_A231923551A6B0B321A22CB8059911DD" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberOfEmployees" xlink:label="loc_ebs_NumberOfEmployees_9C77E98263A9F0819C8D2CB8059B9F90" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_ebs_NumberOfEmployees_9C77E98263A9F0819C8D2CB8059B9F90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8C56A3516ECD3D5E34972CB8059B5AE9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8C56A3516ECD3D5E34972CB8059B5AE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_4D4146A0D050A49439892CB8059BD94A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_4D4146A0D050A49439892CB8059BD94A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_18D16F4819A47E68D22E2CB8059B41C2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_18D16F4819A47E68D22E2CB8059B41C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_89BC8DB9DA36846DE4BF2CB8059B9CDF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_89BC8DB9DA36846DE4BF2CB8059B9CDF" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_LockUpPeriodForAdjustmentOfFairValue" xlink:label="loc_ebs_LockUpPeriodForAdjustmentOfFairValue_8A145E844BB3A7267DFE2CB8059BFDCB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_ebs_LockUpPeriodForAdjustmentOfFairValue_8A145E844BB3A7267DFE2CB8059BFDCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_414004A4EC10D76F608A2CB8059B0956" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_414004A4EC10D76F608A2CB8059B0956" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_A7975685A5ABED7B70BA2CB8059BEFDF" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_A7975685A5ABED7B70BA2CB8059BEFDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_C771245FC5F8EF5142DF2CB8059B5146" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_C771245FC5F8EF5142DF2CB8059B5146" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7441A3D8679886A102D32CB8059B8991" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7441A3D8679886A102D32CB8059B8991" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PresentValueDiscountRate" xlink:label="loc_ebs_PresentValueDiscountRate_81B4B36AE4044166E6C42CB8059B4E77" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_ebs_PresentValueDiscountRate_81B4B36AE4044166E6C42CB8059B4E77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_F23354F74802A2C90E7E2CB8276F2B7B" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_F23354F74802A2C90E7E2CB8276F2B7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_3C4718E01349B03D6A482CB8059BBB6B" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_3C4718E01349B03D6A482CB8059BBB6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_0220B1D9F14EE8F380472CB8059B06EE" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_62806AF82EE272B543002CB8059BB54E" xlink:to="loc_us-gaap_Goodwill_0220B1D9F14EE8F380472CB8059B06EE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_38A43AEF348BC8E72A4778A5A0C060D4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_38A43AEF348BC8E72A4778A5A0C060D4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_776067A367A0502B2D2078A5A0C1716D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_776067A367A0502B2D2078A5A0C1716D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889579D389F152FBC55778A5A0C1D62A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_776067A367A0502B2D2078A5A0C1716D" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889579D389F152FBC55778A5A0C1D62A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_855B894C6156E51D559F78A5A0C19ACE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_889579D389F152FBC55778A5A0C1D62A" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_855B894C6156E51D559F78A5A0C19ACE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_22EF379549C4455F7E3B78A5A0C203AF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:to="loc_srt_RestatementAxis_22EF379549C4455F7E3B78A5A0C203AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_CC6242758C11B230620C78A5A0C23A2E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_22EF379549C4455F7E3B78A5A0C203AF" xlink:to="loc_srt_RestatementDomain_CC6242758C11B230620C78A5A0C23A2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_E442CFA407B5AEFB007278A5A0C24042" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_CC6242758C11B230620C78A5A0C23A2E" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_E442CFA407B5AEFB007278A5A0C24042" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_90056D3C3F7C5381813D78A5A0C2A899" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_90056D3C3F7C5381813D78A5A0C2A899" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C6652765AAAAAA4F85AD78A5A0C2CE55" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_90056D3C3F7C5381813D78A5A0C2A899" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C6652765AAAAAA4F85AD78A5A0C2CE55" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AdaptPharmaMember" xlink:label="loc_ebs_AdaptPharmaMember_D25B7DB535082F9B85CF78A5A0C3F69E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C6652765AAAAAA4F85AD78A5A0C2CE55" xlink:to="loc_ebs_AdaptPharmaMember_D25B7DB535082F9B85CF78A5A0C3F69E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_46DE460FEFB7BFF2138F78A5A0C3CEF6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CFE1499193F3BF50120178A5A0C02366" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_46DE460FEFB7BFF2138F78A5A0C3CEF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46DE460FEFB7BFF2138F78A5A0C3CEF6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_334B8CEBC84DB290C01B78A5A0C327F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_334B8CEBC84DB290C01B78A5A0C327F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_210DE10EE087E80AD30F78A5A0C4F6DE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_210DE10EE087E80AD30F78A5A0C4F6DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_EE7477DB1DCEB380F9C078A5A0C46AAE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_EE7477DB1DCEB380F9C078A5A0C46AAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_D407DA6A3CB22E454D7D78A5A0C45569" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_D407DA6A3CB22E454D7D78A5A0C45569" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_7394C847495BA0A5B9EE78A5A0C4CBF8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_7394C847495BA0A5B9EE78A5A0C4CBF8" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities" xlink:label="loc_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_38C47F7CB643FDBFAADB78A5A0C4A703" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_38C47F7CB643FDBFAADB78A5A0C4A703" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_DC26F61B2CD956694B2A78A5A0C51B28" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_DC26F61B2CD956694B2A78A5A0C51B28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_64B57A3AEC33EC04B92078A5A0C5C714" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_64B57A3AEC33EC04B92078A5A0C5C714" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_EA853FF0713147BA1BA578A5A0C52135" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_EA853FF0713147BA1BA578A5A0C52135" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6F52E47E6453E473465878A5A0C51898" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6F52E47E6453E473465878A5A0C51898" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_684164133FC006836BDB78A5A0C56918" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_Goodwill_684164133FC006836BDB78A5A0C56918" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_E9531609F985A5DABAE278A5A0C535F5" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_E9531609F985A5DABAE278A5A0C535F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_F25420B227D46BD13D8E78A5A0C35B73" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_D664DED65987589E01C778A5A0C69779" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_D664DED65987589E01C778A5A0C69779" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_1C4C24F33C6CE96350FD78A5A0C6A660" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities_1C4C24F33C6CE96350FD78A5A0C6A660" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_2799AD2B05632D345CE778A5A0C6C130" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_2799AD2B05632D345CE778A5A0C6C130" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_B1AB405603B65BF3641B78A5A0C61E3B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_B1AB405603B65BF3641B78A5A0C61E3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_73ECE0530D3D40A9B9B378A5A0C7E9C5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_683D9185155B91FD8A2078A5A0C65CC1" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_73ECE0530D3D40A9B9B378A5A0C7E9C5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7E2A49785FB84F6EBFF8A55DF34BEFCF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BC4C63A34C86DC5C4C07A55DF34B6717" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7E2A49785FB84F6EBFF8A55DF34BEFCF" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BC4C63A34C86DC5C4C07A55DF34B6717" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_951DDCE2D67FEB7A5CDDA5BE0F4D3047" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BC4C63A34C86DC5C4C07A55DF34B6717" xlink:to="loc_srt_RestatementAxis_951DDCE2D67FEB7A5CDDA5BE0F4D3047" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_879031711CDECEB89748A5BE5BBB3589" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_951DDCE2D67FEB7A5CDDA5BE0F4D3047" xlink:to="loc_srt_RestatementDomain_879031711CDECEB89748A5BE5BBB3589" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_65CF31D06D2EDF5AC3AEA5BE0E1BC654" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_879031711CDECEB89748A5BE5BBB3589" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_65CF31D06D2EDF5AC3AEA5BE0E1BC654" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_A6A04165DBA14E70B0BAA55DF34CF005" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BC4C63A34C86DC5C4C07A55DF34B6717" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_A6A04165DBA14E70B0BAA55DF34CF005" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3455B1BFB3629BA15812A55DF34CDE7B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_A6A04165DBA14E70B0BAA55DF34CF005" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3455B1BFB3629BA15812A55DF34CDE7B" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AdaptPharmaMember" xlink:label="loc_ebs_AdaptPharmaMember_BB1CA7A47761DC911AB6A55DF34CA13E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3455B1BFB3629BA15812A55DF34CDE7B" xlink:to="loc_ebs_AdaptPharmaMember_BB1CA7A47761DC911AB6A55DF34CA13E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5EA6F35FF758ADCB4506A55DF34CD5D5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_BC4C63A34C86DC5C4C07A55DF34B6717" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5EA6F35FF758ADCB4506A55DF34CD5D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_8D9D9DDA340F1F388E2BA55DF34C881C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5EA6F35FF758ADCB4506A55DF34CD5D5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_8D9D9DDA340F1F388E2BA55DF34C881C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_3D79082DC15E4BA785EDA55DF34D2D72" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5EA6F35FF758ADCB4506A55DF34CD5D5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_3D79082DC15E4BA785EDA55DF34D2D72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8CC2145327EA3979F9A7A55DF34D41BB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5EA6F35FF758ADCB4506A55DF34CD5D5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8CC2145327EA3979F9A7A55DF34D41BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_F5E395DBFCBD48D62F71A55DF34D7270" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5EA6F35FF758ADCB4506A55DF34CD5D5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_F5E395DBFCBD48D62F71A55DF34D7270" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_68C5849A6FE70A536F3EA55DF34D3D18" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5EA6F35FF758ADCB4506A55DF34CD5D5" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_68C5849A6FE70A536F3EA55DF34D3D18" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_04553C106220BD7914A723C57F54C935" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DDB268C54322D5A53CBF23C57F55C0EE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_04553C106220BD7914A723C57F54C935" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DDB268C54322D5A53CBF23C57F55C0EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DBB1C072EA3F2FA4A22623C57F5507D7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DDB268C54322D5A53CBF23C57F55C0EE" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DBB1C072EA3F2FA4A22623C57F5507D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9E7FE69144E8140220B923C57F5593D3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_DBB1C072EA3F2FA4A22623C57F5507D7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9E7FE69144E8140220B923C57F5593D3" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_VivotifMember" xlink:label="loc_ebs_VivotifMember_226D1478ABA2EDEACEA223C57F56C922" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9E7FE69144E8140220B923C57F5593D3" xlink:to="loc_ebs_VivotifMember_226D1478ABA2EDEACEA223C57F56C922" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_VaxchoraMember" xlink:label="loc_ebs_VaxchoraMember_8AD53D5315B1CB9F875323C57F564267" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9E7FE69144E8140220B923C57F5593D3" xlink:to="loc_ebs_VaxchoraMember_8AD53D5315B1CB9F875323C57F564267" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_17CB17FED8B046B9CFCD23C57F56FD0C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9E7FE69144E8140220B923C57F5593D3" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_17CB17FED8B046B9CFCD23C57F56FD0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_F00C43CC93236BE3C2CE23C57F56C2CC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DDB268C54322D5A53CBF23C57F55C0EE" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_F00C43CC93236BE3C2CE23C57F56C2CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D6021D79C855A8816F7E23C57F567C99" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_F00C43CC93236BE3C2CE23C57F56C2CC" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D6021D79C855A8816F7E23C57F567C99" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PaxVaxMember" xlink:label="loc_ebs_PaxVaxMember_54DF2798932C25AA699F23C57F5776B0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_D6021D79C855A8816F7E23C57F567C99" xlink:to="loc_ebs_PaxVaxMember_54DF2798932C25AA699F23C57F5776B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_DDB268C54322D5A53CBF23C57F55C0EE" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberOfEmployees" xlink:label="loc_ebs_NumberOfEmployees_D0C887958E151E10588A23C57F5759D4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_ebs_NumberOfEmployees_D0C887958E151E10588A23C57F5759D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_81583FEE08BFF703913423C57F57191F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_81583FEE08BFF703913423C57F57191F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6A5F5021E00C1EF0D99623C57F57C273" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6A5F5021E00C1EF0D99623C57F57C273" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_AC807FF1C112A89D940A23C57F5872D5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_AC807FF1C112A89D940A23C57F5872D5" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PresentValueDiscountRate" xlink:label="loc_ebs_PresentValueDiscountRate_8E5EBA0339AEE3940FA823C57F585317" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_ebs_PresentValueDiscountRate_8E5EBA0339AEE3940FA823C57F585317" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0F56C9C13BA008E8C370245A788CE90A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0F56C9C13BA008E8C370245A788CE90A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_9D626500C0B0A3435DB023C57F580B3B" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_us-gaap_Goodwill_9D626500C0B0A3435DB023C57F580B3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_40D09045C01A2025BFE823C57F58214B" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9F77879A4A96729F40EA23C57F579FE0" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_40D09045C01A2025BFE823C57F58214B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_4CC1F3184C624ACE68F078A56C4EF822" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24700F28BA1477D2D66278A56C512081" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_4CC1F3184C624ACE68F078A56C4EF822" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24700F28BA1477D2D66278A56C512081" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_7D0A8ECE9CFE8BBF03C078A56C527F35" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24700F28BA1477D2D66278A56C512081" xlink:to="loc_srt_RestatementAxis_7D0A8ECE9CFE8BBF03C078A56C527F35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_F5F88946063D5859BD1078A56C52BA1A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_7D0A8ECE9CFE8BBF03C078A56C527F35" xlink:to="loc_srt_RestatementDomain_F5F88946063D5859BD1078A56C52BA1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_63F25970EC7B3CC087E578A56C5216BA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_F5F88946063D5859BD1078A56C52BA1A" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_63F25970EC7B3CC087E578A56C5216BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4C780C8035243D472D1B78A56C5307FE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24700F28BA1477D2D66278A56C512081" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4C780C8035243D472D1B78A56C5307FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3C5C32D3314D4340B15C78A56C53E817" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4C780C8035243D472D1B78A56C5307FE" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3C5C32D3314D4340B15C78A56C53E817" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PaxVaxMember" xlink:label="loc_ebs_PaxVaxMember_484945B7E551458CF74B78A56C533D35" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3C5C32D3314D4340B15C78A56C53E817" xlink:to="loc_ebs_PaxVaxMember_484945B7E551458CF74B78A56C533D35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_D65A011F74CFFB89C18678A56C54D359" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_24700F28BA1477D2D66278A56C512081" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_D65A011F74CFFB89C18678A56C54D359" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D65A011F74CFFB89C18678A56C54D359" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_C42A9A505DDDE0225CB578A56C54FC3C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_C42A9A505DDDE0225CB578A56C54FC3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_E72B67253DFC786AC45F78A56C54E314" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_E72B67253DFC786AC45F78A56C54E314" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_77F3F0E8D4C1732B48AA78A56C5549BF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_77F3F0E8D4C1732B48AA78A56C5549BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_44CE3F98E509B129C71D78A56C55CC32" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_44CE3F98E509B129C71D78A56C55CC32" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_2DE8B2DB6D2E063D70C978A56C55048C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets_2DE8B2DB6D2E063D70C978A56C55048C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_00D554619E8878AE0BAB78A56C55F417" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_00D554619E8878AE0BAB78A56C55F417" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_70E29E6C2A0861C5202D78A56C57EF82" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_70E29E6C2A0861C5202D78A56C57EF82" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_F538D23AEB3D2EDDD4B578A56C57D7AB" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_F538D23AEB3D2EDDD4B578A56C57D7AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_F906CBA4F6C3437FFC5178A56C57D74A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_F906CBA4F6C3437FFC5178A56C57D74A" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities" xlink:label="loc_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_9DE35FA81C86828DD85878A56C5713CC" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities_9DE35FA81C86828DD85878A56C5713CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_757ACA86B800799EAC3C78A56C5845E0" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_757ACA86B800799EAC3C78A56C5845E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9AA0ECE159B4C3489F6478A56C58C1AE" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9AA0ECE159B4C3489F6478A56C58C1AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_58778FF13A4F48FA8E3278A56C587679" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_58778FF13A4F48FA8E3278A56C587679" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_F7E92C3889FC1EE20C0078A56C589A61" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_Goodwill_F7E92C3889FC1EE20C0078A56C589A61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7CB8D472C419DD3D320C78A56C582B3F" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7CB8D472C419DD3D320C78A56C582B3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_F0E37977D91D6D7692B878A56C58F4F5" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_230C536754F40DB497F878A56C54716C" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_F0E37977D91D6D7692B878A56C58F4F5" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities_B7FD0945EB2528BA210478A56C59758A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_F0E37977D91D6D7692B878A56C58F4F5" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities_B7FD0945EB2528BA210478A56C59758A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_5464C9C2959B3D71868878A56C59543F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_F0E37977D91D6D7692B878A56C58F4F5" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_5464C9C2959B3D71868878A56C59543F" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets" xlink:label="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets_7AD753AE33880E55C29078A56C59B27D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_F0E37977D91D6D7692B878A56C58F4F5" xlink:to="loc_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets_7AD753AE33880E55C29078A56C59B27D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_BAF7CFF893BA7A97A19878A56C59F0A5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_F0E37977D91D6D7692B878A56C58F4F5" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_BAF7CFF893BA7A97A19878A56C59F0A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_F41DB9BB6EF85CBD6FD478A56C59E736" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_F0E37977D91D6D7692B878A56C58F4F5" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_F41DB9BB6EF85CBD6FD478A56C59E736" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_15DDB1681733719380252CB808C70BA9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_A64F149FD2173012E4E32CB808C9F089" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_15DDB1681733719380252CB808C70BA9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_A64F149FD2173012E4E32CB808C9F089" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_DF6A252E86D8C73058DA2CB808C9D9E7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_15DDB1681733719380252CB808C70BA9" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_DF6A252E86D8C73058DA2CB808C9D9E7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_FB940823165A5E12159C688F62C5850E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_FB940823165A5E12159C688F62C5850E" xlink:to="loc_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01" xlink:to="loc_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_EBC059FFADDA97284D21688F62C58C13" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_EBC059FFADDA97284D21688F62C58C13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_D26667876A73291AE98368951DA28417" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156" xlink:to="loc_us-gaap_RestrictedCashCurrent_D26667876A73291AE98368951DA28417" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6B36F1338DE0157E9575688F62C53973" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_6B36F1338DE0157E9575688F62C53973" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_B9A69F9CD7B5125BBF39688F62C56469" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156" xlink:to="loc_us-gaap_InventoryNet_B9A69F9CD7B5125BBF39688F62C56469" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="loc_us-gaap_IncomeTaxesReceivable_C84EE24174CB755BFE32688F62C5B51D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156" xlink:to="loc_us-gaap_IncomeTaxesReceivable_C84EE24174CB755BFE32688F62C5B51D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_626D1D61B072187703BF688F62C50A6A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_626D1D61B072187703BF688F62C50A6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_1CEF40D2496A86A9CBB1688F62C59C08" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_C16DB522345D3EBCFB75688F62C57156" xlink:to="loc_us-gaap_AssetsCurrent_1CEF40D2496A86A9CBB1688F62C59C08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_AEB4D906D154F864C936688F62C597E9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_AEB4D906D154F864C936688F62C597E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9EF3AE7BD19AC6BD00EF688F62C55979" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9EF3AE7BD19AC6BD00EF688F62C55979" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_InProcessResearchAndDevelopment" xlink:label="loc_ebs_InProcessResearchAndDevelopment_252E431F8CF92A732185688F62C5CD4F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01" xlink:to="loc_ebs_InProcessResearchAndDevelopment_252E431F8CF92A732185688F62C5CD4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_DBAFFF1884710AF83036688F62C5B541" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01" xlink:to="loc_us-gaap_Goodwill_DBAFFF1884710AF83036688F62C5B541" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_80C4F2DBC349F36D740F688F62C55635" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_80C4F2DBC349F36D740F688F62C55635" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_EA91D83FBBA421C1AF07688F62C5DFC2" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_EA91D83FBBA421C1AF07688F62C5DFC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_D09BC50FDB4D8AF00790688F62C5E4CC" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_DBC74ABE37B3CCEED8FD688F62C5AA01" xlink:to="loc_us-gaap_Assets_D09BC50FDB4D8AF00790688F62C5E4CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_FB940823165A5E12159C688F62C5850E" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_1907D8C76A8E63D8EE3D688F62C52AE6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB" xlink:to="loc_us-gaap_AccountsPayableCurrent_1907D8C76A8E63D8EE3D688F62C52AE6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_5E679AC175F3628315BF688F62C54BC5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_5E679AC175F3628315BF688F62C54BC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_B08DCAED8CA73211BAD5688F62C56AA0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_B08DCAED8CA73211BAD5688F62C56AA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent_512C22484107C8A53F49688F62C5397D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB" xlink:to="loc_us-gaap_NotesPayableCurrent_512C22484107C8A53F49688F62C5397D" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContingentConsiderationCurrentPortion" xlink:label="loc_ebs_ContingentConsiderationCurrentPortion_4DD730800468DE0FF972688F62C58725" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB" xlink:to="loc_ebs_ContingentConsiderationCurrentPortion_4DD730800468DE0FF972688F62C58725" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_91716E0B3C986F9A54A0688F62C506AF" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_91716E0B3C986F9A54A0688F62C506AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_E991490D3898DB573ADB688F62C550B8" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_35EBEB4E476C351901E7688F62C5C0BB" xlink:to="loc_us-gaap_LiabilitiesCurrent_E991490D3898DB573ADB688F62C550B8" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContingentConsiderationNetOfCurrentPortion" xlink:label="loc_ebs_ContingentConsiderationNetOfCurrentPortion_354B49A89D081842541E688F62C54064" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:to="loc_ebs_ContingentConsiderationNetOfCurrentPortion_354B49A89D081842541E688F62C54064" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_D848FD8D89ABFB4C12EE688F62C5B949" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_D848FD8D89ABFB4C12EE688F62C5B949" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5962BF3E60E876DD7856688F62D4FB3B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5962BF3E60E876DD7856688F62D4FB3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_10268F93F48618F11D4E688F62D4E047" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_10268F93F48618F11D4E688F62D4E047" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4781CCC54BFA1925C253688F62D43689" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_4781CCC54BFA1925C253688F62D43689" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_85119F999F091A2B313B688F62D4EF2D" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:to="loc_us-gaap_Liabilities_85119F999F091A2B313B688F62D4EF2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:to="loc_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_2FA1504D0D08B4D1777C688F62D4EF54" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF" xlink:to="loc_us-gaap_PreferredStockValue_2FA1504D0D08B4D1777C688F62D4EF54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_00A081A7E7CD6154D240688F62D48665" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF" xlink:to="loc_us-gaap_CommonStockValue_00A081A7E7CD6154D240688F62D48665" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_E473E84F8C7E8097D8E2688F62D4E0AD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF" xlink:to="loc_us-gaap_TreasuryStockValue_E473E84F8C7E8097D8E2688F62D4E0AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_C5E5A4B5169336502D6C688F62D40475" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF" xlink:to="loc_us-gaap_AdditionalPaidInCapital_C5E5A4B5169336502D6C688F62D40475" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7F6E60CE810155A083DF688F62D45922" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7F6E60CE810155A083DF688F62D45922" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_264E51814C1CF290DE09688F62D432CB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_264E51814C1CF290DE09688F62D432CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_CD49A604F811503B1B8E688F62D421E4" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8E2A7B6BAFE04B6F024D688F62D4C9FF" xlink:to="loc_us-gaap_StockholdersEquity_CD49A604F811503B1B8E688F62D421E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_C3856BC722C2C08DE339688F62D42CA1" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_FF6A754E1E8015E06596688F62C5BE8C" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_C3856BC722C2C08DE339688F62D42CA1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_A4DADDD3AC196AB1AEBA8E408B3D9D27" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_E125FD8493381ECA449B8E408B3DE7E8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A4DADDD3AC196AB1AEBA8E408B3D9D27" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_E125FD8493381ECA449B8E408B3DE7E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_6F02DCDC8414521C86168E408B3DB250" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A4DADDD3AC196AB1AEBA8E408B3D9D27" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_6F02DCDC8414521C86168E408B3DB250" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_D93BEF681D44B7CF2EA38E408B3EA899" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A4DADDD3AC196AB1AEBA8E408B3D9D27" xlink:to="loc_us-gaap_PreferredStockSharesIssued_D93BEF681D44B7CF2EA38E408B3EA899" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_A37E19094DB9CDF7ED358E408B3E51C5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A4DADDD3AC196AB1AEBA8E408B3D9D27" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_A37E19094DB9CDF7ED358E408B3E51C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_E0DE7AF2C83A7B9D4DC78E408B3E2E1F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A4DADDD3AC196AB1AEBA8E408B3D9D27" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_E0DE7AF2C83A7B9D4DC78E408B3E2E1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_A0D4DC2D08693EAAC2EE8E408B3EE929" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A4DADDD3AC196AB1AEBA8E408B3D9D27" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_A0D4DC2D08693EAAC2EE8E408B3EE929" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_6301C2BC74E21A0B4C5A8E408B3E7085" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A4DADDD3AC196AB1AEBA8E408B3D9D27" xlink:to="loc_us-gaap_CommonStockSharesIssued_6301C2BC74E21A0B4C5A8E408B3E7085" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_46B4B70DC82922951D578E408B3E3CE5" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A4DADDD3AC196AB1AEBA8E408B3D9D27" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_46B4B70DC82922951D578E408B3E3CE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_164FEF04723A2F13C2B38E408B3ECB5D" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_A4DADDD3AC196AB1AEBA8E408B3D9D27" xlink:to="loc_us-gaap_TreasuryStockShares_164FEF04723A2F13C2B38E408B3ECB5D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_883F75A66831C59F26B45F9BB73D0B68" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_8C1C6CC113CF66E680EA5F9BB73D10C5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_883F75A66831C59F26B45F9BB73D0B68" xlink:to="loc_us-gaap_StatementTable_8C1C6CC113CF66E680EA5F9BB73D10C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5FED7534DAE800575B865F9BB73DDD6F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8C1C6CC113CF66E680EA5F9BB73D10C5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5FED7534DAE800575B865F9BB73DDD6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5FED7534DAE800575B865F9BB73DDD6F" xlink:to="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_7A9DEA414B8227D104735F9BB73E7AB2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D" xlink:to="loc_us-gaap_CommonStockMember_7A9DEA414B8227D104735F9BB73E7AB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1DF796F7501C9C3D7A855F9BB73E1A09" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1DF796F7501C9C3D7A855F9BB73E1A09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_6B4E24D7BC056C7705AE5F9BB73EED37" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D" xlink:to="loc_us-gaap_TreasuryStockMember_6B4E24D7BC056C7705AE5F9BB73EED37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_18E133B213D2F930B6FC5F9BB73EB449" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_18E133B213D2F930B6FC5F9BB73EB449" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_DE17C73F7E435B2FAE265F9BB73E7D5D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_AD37761612D57E199C5F5F9BB73D806D" xlink:to="loc_us-gaap_RetainedEarningsMember_DE17C73F7E435B2FAE265F9BB73E7D5D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_11560B74F0E25C0F32705F9BB73FF144" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8C1C6CC113CF66E680EA5F9BB73D10C5" xlink:to="loc_us-gaap_StatementLineItems_11560B74F0E25C0F32705F9BB73FF144" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11560B74F0E25C0F32705F9BB73FF144" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_6FEF6BD3DC5C6A5B4AC95F9BB73F93E8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_CommonStockSharesIssued_6FEF6BD3DC5C6A5B4AC95F9BB73F93E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_DACB0CCC4E053584724E5F9BB73F92CF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockholdersEquity_DACB0CCC4E053584724E5F9BB73F92CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_AD7894C46CD7384725FC5F9BB73F99E3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_AD7894C46CD7384725FC5F9BB73F99E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_48BB9862E97DA52406545F9BB740C62D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_48BB9862E97DA52406545F9BB740C62D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2AEFFDB50435C248EA4D5F9BB7402C5E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2AEFFDB50435C248EA4D5F9BB7402C5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_DA16A530BDEEA8476F5D5F9BB740D7D8" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_DA16A530BDEEA8476F5D5F9BB740D7D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_7ED92063EBF3C49B83FD5F9BB7401C05" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_7ED92063EBF3C49B83FD5F9BB7401C05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_33078A5F5FA3EAADB9565F9BB74086DD" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_33078A5F5FA3EAADB9565F9BB74086DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C5B29BB6139024B3E7885F9BB7403585" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_C5B29BB6139024B3E7885F9BB7403585" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_2EBC5F6490365B4C59B95F9BB740A479" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_2EBC5F6490365B4C59B95F9BB740A479" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_409BA26535F4B3F24C365F9BB74174FE" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_409BA26535F4B3F24C365F9BB74174FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_949B4788A25DFF6033D25F9BB741C532" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_949B4788A25DFF6033D25F9BB741C532" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_9EB5843DA397ADCB0EF15F9BB74165ED" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_NetIncomeLoss_9EB5843DA397ADCB0EF15F9BB74165ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_E1774D4E236A8FB905975F9BB741862F" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_E1774D4E236A8FB905975F9BB741862F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_228EB9B55FE75993AD575F9BB741CE72" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_CommonStockSharesIssued_228EB9B55FE75993AD575F9BB741CE72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_CF0522927075A627897D5F9BB741096C" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_78F949AB6AAEFFD5451D5F9BB73FA11F" xlink:to="loc_us-gaap_StockholdersEquity_CF0522927075A627897D5F9BB741096C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_9B13074F75723663E0C2CCD36F29D962" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_EBDB152FFC3191B14D5BCCD36F299509" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_9B13074F75723663E0C2CCD36F29D962" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_EBDB152FFC3191B14D5BCCD36F299509" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40B1F265E0DAD923F2A9688F6296C1F3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40B1F265E0DAD923F2A9688F6296C1F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_0854A874599A70FCEC50688F62966C5D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40B1F265E0DAD923F2A9688F6296C1F3" xlink:to="loc_us-gaap_NetIncomeLoss_0854A874599A70FCEC50688F62966C5D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40B1F265E0DAD923F2A9688F6296C1F3" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_EA869048670F3BFD816D688F62966A38" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB" xlink:to="loc_us-gaap_ShareBasedCompensation_EA869048670F3BFD816D688F62966A38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_F910FB75654D6975448A688F6296DCCB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_F910FB75654D6975448A688F6296DCCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_EF9CC1324586BA935D46688F6296343E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_EF9CC1324586BA935D46688F6296343E" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ChangeInFairValueOfContingentConsideration" xlink:label="loc_ebs_ChangeInFairValueOfContingentConsideration_129F1619F30BACEF3F6B688F62966E7C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB" xlink:to="loc_ebs_ChangeInFairValueOfContingentConsideration_129F1619F30BACEF3F6B688F62966E7C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6B02A76A58EC7CE5DFC1688F62969247" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6B02A76A58EC7CE5DFC1688F62969247" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_9FE4CAB26120110F8009688F6296CCE3" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_9FE4CAB26120110F8009688F6296CCE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_75F07D2D023DF7F44921688F62963244" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_75F07D2D023DF7F44921688F62963244" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_BDE42209A0529859A5F6688F629641FB" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9D550F80665B120CD491688F6296C058" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9D550F80665B120CD491688F6296C058" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_419D7B108F8600BEFA3D688F6296C5E6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_419D7B108F8600BEFA3D688F6296C5E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_70FBED39526C788CAC0C688F6296BC28" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_70FBED39526C788CAC0C688F6296BC28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_D58FC06F5220307F0397688F62967DAC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_D58FC06F5220307F0397688F62967DAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6D3111418353C427B325688F62965007" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_6D3111418353C427B325688F62965007" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_21BDFF425F2EBABFF4B2688F629621BD" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_21BDFF425F2EBABFF4B2688F629621BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_60AF8E7234B6F4403D8E688F6296AD13" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_60AF8E7234B6F4403D8E688F6296AD13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4DCA2DE141EE50791392688F62966567" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1DEC0923761D56FA2171688F62963BF3" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4DCA2DE141EE50791392688F62966567" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_737EFDD7740C9773D7E7688F6296D561" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40B1F265E0DAD923F2A9688F6296C1F3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_737EFDD7740C9773D7E7688F6296D561" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FE8163555A63E227F5D1688F6296602F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FE8163555A63E227F5D1688F6296602F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8D54F34D1EBE4981FB12688F62964C20" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FE8163555A63E227F5D1688F6296602F" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8D54F34D1EBE4981FB12688F62964C20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForPreviousAcquisition" xlink:label="loc_us-gaap_PaymentsForPreviousAcquisition_8092275D8AA796DD9305688F62963734" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FE8163555A63E227F5D1688F6296602F" xlink:to="loc_us-gaap_PaymentsForPreviousAcquisition_8092275D8AA796DD9305688F62963734" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_37BFA155C8FCAE1A230E688F62966BD9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FE8163555A63E227F5D1688F6296602F" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_37BFA155C8FCAE1A230E688F62966BD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D8DB095B5D89A3C39FA4688F62961496" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FE8163555A63E227F5D1688F6296602F" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_D8DB095B5D89A3C39FA4688F62961496" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_B288BAAE094A2C6CC5A8688F62967AD4" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FE8163555A63E227F5D1688F6296602F" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_B288BAAE094A2C6CC5A8688F62967AD4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5080FDCB7BB5EA44B67A688F6296AF0F" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FE8163555A63E227F5D1688F6296602F" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5080FDCB7BB5EA44B67A688F6296AF0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_39030B8539130EEACE9E688F6296DEFB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_39030B8539130EEACE9E688F6296DEFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_0397055E8BC0A7940D82688F629655B1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_0397055E8BC0A7940D82688F629655B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_37096707663FC9ECCAD3688F62962636" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_37096707663FC9ECCAD3688F62962636" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfMediumTermNotes" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes_5F290BCCCF1058A00DFD688F62960445" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:to="loc_us-gaap_RepaymentsOfMediumTermNotes_5F290BCCCF1058A00DFD688F62960445" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_53A4BC2B6EA7A7279E8B688F6296F8DC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_53A4BC2B6EA7A7279E8B688F6296F8DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_F5ABB9FE6D3B7A19DF46688F62960C93" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_F5ABB9FE6D3B7A19DF46688F62960C93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_D2F7D69180EA9040A433688F629646AB" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_D2F7D69180EA9040A433688F629646AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_6CDC6FDD0F7C37D4927A688F629608F9" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_6CDC6FDD0F7C37D4927A688F629608F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_685A1E881900D51E6702688F629601AC" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_685A1E881900D51E6702688F629601AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_8C5F6D6D4EECAFF342D6688F629634DA" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_8C5F6D6D4EECAFF342D6688F629634DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1C09BBDC4D27D830AF96688F629634C1" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1C09BBDC4D27D830AF96688F629634C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5CE13DEE0F07AF6A1829688F6296A8C3" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1BB8ED18E39AE669738C688F629666C1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5CE13DEE0F07AF6A1829688F6296A8C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8EA848BF5A90B12FF8BF688F6296470B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8EA848BF5A90B12FF8BF688F6296470B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_FEF39B2DCFAA873212BF688F6296B76D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_FEF39B2DCFAA873212BF688F6296B76D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_309AB2E3FDAA84408E10688F6296EFA1" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_309AB2E3FDAA84408E10688F6296EFA1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D8DAFE9C626EF98303B2688F6296836D" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_D8DAFE9C626EF98303B2688F6296836D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_78046F99D267396BA272688F6296A286" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_78046F99D267396BA272688F6296A286" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_8B147C46E4DC33E879C0688F6296AF05" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_78046F99D267396BA272688F6296A286" xlink:to="loc_us-gaap_InterestPaidNet_8B147C46E4DC33E879C0688F6296AF05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_28947AC25683FCBE3195688F62965785" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_78046F99D267396BA272688F6296A286" xlink:to="loc_us-gaap_IncomeTaxesPaid_28947AC25683FCBE3195688F62965785" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_69EDE03111FE7B3B1D1A688F6296BC4C" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1" xlink:to="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_69EDE03111FE7B3B1D1A688F6296BC4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaap_StockIssued1_3DAC2249178B85828F48688F62961E72" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_69EDE03111FE7B3B1D1A688F6296BC4C" xlink:to="loc_us-gaap_StockIssued1_3DAC2249178B85828F48688F62961E72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_F316A4993439D6A761CD688F6296CCF7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_69EDE03111FE7B3B1D1A688F6296BC4C" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_F316A4993439D6A761CD688F6296CCF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_7A9EEF517DBCAC8E20E6688F62A5AFFB" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_DBEFB6E4CFD0D587321C688F629616B1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_7A9EEF517DBCAC8E20E6688F62A5AFFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3930898C18A748B9B928688F62A52EBE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_7A9EEF517DBCAC8E20E6688F62A5AFFB" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3930898C18A748B9B928688F62A52EBE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_179911342BA74D92D60868953541C0E3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_7A9EEF517DBCAC8E20E6688F62A5AFFB" xlink:to="loc_us-gaap_RestrictedCashCurrent_179911342BA74D92D60868953541C0E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20A2D2C65AD60BDE4002688F62A5AA35" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_7A9EEF517DBCAC8E20E6688F62A5AFFB" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20A2D2C65AD60BDE4002688F62A5AA35" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_D25D6B0757FF4D8F8E965F9AA8F106B2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_B237A02E354FCAB41E6C5F9AA8F43EE3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_D25D6B0757FF4D8F8E965F9AA8F106B2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_B237A02E354FCAB41E6C5F9AA8F43EE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_2F7FC9E3FDCE72FC23E65F9AA8F5DEE8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_D25D6B0757FF4D8F8E965F9AA8F106B2" xlink:to="loc_us-gaap_NetIncomeLoss_2F7FC9E3FDCE72FC23E65F9AA8F5DEE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98C8F4D01F9E30ADB6145F9AA8F5201A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_D25D6B0757FF4D8F8E965F9AA8F106B2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98C8F4D01F9E30ADB6145F9AA8F5201A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8D99A24C81C0EE6176675F9AA8F79F94" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98C8F4D01F9E30ADB6145F9AA8F5201A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8D99A24C81C0EE6176675F9AA8F79F94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8F12DF06A7C2D2A2C1AA5F9AA8F74062" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98C8F4D01F9E30ADB6145F9AA8F5201A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8F12DF06A7C2D2A2C1AA5F9AA8F74062" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_D70E628121D44F6790025F9AA8F8C893" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98C8F4D01F9E30ADB6145F9AA8F5201A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_D70E628121D44F6790025F9AA8F8C893" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_564E56B4451DD940FD1B5F9AA8F83C21" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98C8F4D01F9E30ADB6145F9AA8F5201A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_564E56B4451DD940FD1B5F9AA8F83C21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ACCEDAB9693F395100E45F9AA8F874A1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_98C8F4D01F9E30ADB6145F9AA8F5201A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ACCEDAB9693F395100E45F9AA8F874A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_F363DB8AB411B543CBFA5F9AA8F84AFE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_D25D6B0757FF4D8F8E965F9AA8F106B2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_F363DB8AB411B543CBFA5F9AA8F84AFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_C4EBFA91874D058082F95F9AA8F80B6A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_D25D6B0757FF4D8F8E965F9AA8F106B2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_C4EBFA91874D058082F95F9AA8F80B6A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_5470D25FDA2B6812C61C117273597EB4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_2B21D2A769CC02A9590911727359B924" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5470D25FDA2B6812C61C117273597EB4" xlink:to="loc_us-gaap_StatementTable_2B21D2A769CC02A9590911727359B924" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_3D0F15E40AD7370DC56A11727359853B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2B21D2A769CC02A9590911727359B924" xlink:to="loc_srt_ProductOrServiceAxis_3D0F15E40AD7370DC56A11727359853B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_2F4BF9207B3D4F7F0CC51172735A7A8F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3D0F15E40AD7370DC56A11727359853B" xlink:to="loc_srt_ProductsAndServicesDomain_2F4BF9207B3D4F7F0CC51172735A7A8F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaap_ProductMember_AC7FA78588A10C8FFC601172735ABE29" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2F4BF9207B3D4F7F0CC51172735A7A8F" xlink:to="loc_us-gaap_ProductMember_AC7FA78588A10C8FFC601172735ABE29" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractDevelopmentAndManufacturingMember" xlink:label="loc_ebs_ContractDevelopmentAndManufacturingMember_F8CD4A3009BBE42C3C7A1172735A80A8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2F4BF9207B3D4F7F0CC51172735A7A8F" xlink:to="loc_ebs_ContractDevelopmentAndManufacturingMember_F8CD4A3009BBE42C3C7A1172735A80A8" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractsAndGrantsMember" xlink:label="loc_ebs_ContractsAndGrantsMember_78621CFC9F42E58339801172735A3862" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2F4BF9207B3D4F7F0CC51172735A7A8F" xlink:to="loc_ebs_ContractsAndGrantsMember_78621CFC9F42E58339801172735A3862" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2B21D2A769CC02A9590911727359B924" xlink:to="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_E016321A949F25CCE6A71172735B4F6D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_RevenuesAbstract_E016321A949F25CCE6A71172735B4F6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_B08B21895D5277C6E97A1172735BBEFB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_E016321A949F25CCE6A71172735B4F6D" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_B08B21895D5277C6E97A1172735BBEFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_605494F48A072B7396831172735BA2EC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_605494F48A072B7396831172735BA2EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_EBEE6DC72485B47A2A5C1172735CF986" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_EBEE6DC72485B47A2A5C1172735CF986" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1BEC591FD9F8014A22FF1172735C98E8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1BEC591FD9F8014A22FF1172735C98E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_884CB031393A31D2C3131172735CFC2C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_884CB031393A31D2C3131172735CFC2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_B836312A1AC6E27112971172735C7E7A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_026C2596202BDEA8EFE31172735B4C05" xlink:to="loc_us-gaap_OperatingExpenses_B836312A1AC6E27112971172735C7E7A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_1D7166201D7465CD6F4B1172735D540B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_OperatingIncomeLoss_1D7166201D7465CD6F4B1172735D540B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_D4D4F9BC9633C7FD67EB1172735DA0CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6" xlink:to="loc_us-gaap_InterestExpense_D4D4F9BC9633C7FD67EB1172735DA0CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_36AA2048A61866EF05FD1172735DB8CB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_36AA2048A61866EF05FD1172735DB8CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1603A6B8918EA66996B21172735DF641" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_C9C799ADA05AA63D5A921172735D4CB6" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1603A6B8918EA66996B21172735DF641" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_576B03EDBDAAD2736C1E1172735E39D8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_576B03EDBDAAD2736C1E1172735E39D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1FBA462BA54B26B650A31172735E2173" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1FBA462BA54B26B650A31172735E2173" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_4BAC67EA53F93D8415EF1172735EE8B9" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_NetIncomeLoss_4BAC67EA53F93D8415EF1172735EE8B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_0B46CFEC2F87C17D68151172735E02F3" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_EarningsPerShareBasic_0B46CFEC2F87C17D68151172735E02F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_C10D8E180E62CD957F431172735EF344" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_EarningsPerShareDiluted_C10D8E180E62CD957F431172735EF344" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1EA1D440EDC83A07D0F21172735E438E" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1EA1D440EDC83A07D0F21172735E438E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3101F3934AB9D783F06E1172735F51EB" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_C82B20ADA300D783AB571172735BF082" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3101F3934AB9D783F06E1172735F51EB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_A7F4D58C193B913E0727555E21819AAF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_DocumentType_A7F4D58C193B913E0727555E21819AAF" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_0A0B81FD660E525A3687555E21815E33" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_DocumentAnnualReport_0A0B81FD660E525A3687555E21815E33" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_21DE64FFBAEA6837173D555E218175F4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_DocumentPeriodEndDate_21DE64FFBAEA6837173D555E218175F4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_BB0B0F5B59CE885AAD15555E2181166C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_DocumentTransitionReport_BB0B0F5B59CE885AAD15555E2181166C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_1D03C3BCA8EB87AF9DBF555E21818B9E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityFileNumber_1D03C3BCA8EB87AF9DBF555E21818B9E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_2223ADEA9BE479F6A293555E2181734C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityRegistrantName_2223ADEA9BE479F6A293555E2181734C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_C8122B61EC86D8F94D43555E218152CC" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityIncorporationStateCountryCode_C8122B61EC86D8F94D43555E218152CC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_1623850C236BBE695196555E21812E0E" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityTaxIdentificationNumber_1623850C236BBE695196555E21812E0E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_754A85D34532CBB0439A555E21811D1D" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityAddressAddressLine1_754A85D34532CBB0439A555E21811D1D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_01254503031B46DB1F20555E2181D582" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityAddressCityOrTown_01254503031B46DB1F20555E2181D582" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_72AA1F52CD2E05056088555E2181CCB9" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityAddressStateOrProvince_72AA1F52CD2E05056088555E2181CCB9" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_80B4D7A079C5050B850E555E21817D1B" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityAddressPostalZipCode_80B4D7A079C5050B850E555E21817D1B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_99894238B852566FAB10555E21812C1C" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_CityAreaCode_99894238B852566FAB10555E21812C1C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_FD210740A98D42A51C07555E21810A3A" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_LocalPhoneNumber_FD210740A98D42A51C07555E21810A3A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_BB677D7C3A84CC0232AC555E2181DD32" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_Security12bTitle_BB677D7C3A84CC0232AC555E2181DD32" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_1C3C5BC6938524CD6023555E2181DBD3" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_SecurityExchangeName_1C3C5BC6938524CD6023555E2181DBD3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_C4CD330FFC1E06DA4D5D555E2185DE04" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_C4CD330FFC1E06DA4D5D555E2185DE04" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_23560CA25BFF4141DB72555E21853B34" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityVoluntaryFilers_23560CA25BFF4141DB72555E21853B34" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_3A0F02CA8DC33FB10847555E2185AB0A" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityCurrentReportingStatus_3A0F02CA8DC33FB10847555E2185AB0A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_D0451126E55FC647215F555E2185A746" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityInteractiveDataCurrent_D0451126E55FC647215F555E2185A746" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_7126A79F76A547A9E243555E2185F57B" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityFilerCategory_7126A79F76A547A9E243555E2185F57B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_3F370041F998BBFEEF3E555E21850F2E" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntitySmallBusiness_3F370041F998BBFEEF3E555E21850F2E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_9F41D3494622389E5B81555E2185B49F" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityEmergingGrowthCompany_9F41D3494622389E5B81555E2185B49F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_319CA8C529AB8ED0BA0D555E21850A0C" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityShellCompany_319CA8C529AB8ED0BA0D555E21850A0C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_7572D955265F414F5F58555E21858DCD" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityPublicFloat_7572D955265F414F5F58555E21858DCD" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2DDC2F46451D2C53FC09555E2185FC85" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_2DDC2F46451D2C53FC09555E2185FC85" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_C9C5C40B1769B4C3F9EC555E218537BF" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_C9C5C40B1769B4C3F9EC555E218537BF" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_F2663F8D25EEA3912123555E21857BA6" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_EntityCentralIndexKey_F2663F8D25EEA3912123555E21857BA6" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_B7E0380D7D77E4DB887A555E21852896" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_CurrentFiscalYearEndDate_B7E0380D7D77E4DB887A555E21852896" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_547F6353F00871071C45555E2185A690" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_AmendmentFlag_547F6353F00871071C45555E2185A690" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_E5CA9D79EC208F1D4CB4555E2185B10F" xlink:type="locator" />
    <link:presentationArc order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_DocumentFiscalYearFocus_E5CA9D79EC208F1D4CB4555E2185B10F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_DB0DD486201A78BB2050555E2185D0A8" xlink:type="locator" />
    <link:presentationArc order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_DocumentFiscalPeriodFocus_DB0DD486201A78BB2050555E2185D0A8" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_CA6F061C8F09305AC98A555E2185CC29" xlink:type="locator" />
    <link:presentationArc order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_25E0159CE93D171CE2EE555E21818B2E" xlink:to="loc_dei_TradingSymbol_CA6F061C8F09305AC98A555E2185CC29" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlan" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_028695C9AC2A63EF9793F5EBD665ACEA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5C87B29E1336B70D0066F5EBD6657163" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_028695C9AC2A63EF9793F5EBD665ACEA" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5C87B29E1336B70D0066F5EBD6657163" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0E5E7B3CC4A7FD602454CE2D5ECC0C13" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_BBDA2F31E17216FAA27BCE2D5ECF93C3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0E5E7B3CC4A7FD602454CE2D5ECC0C13" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_BBDA2F31E17216FAA27BCE2D5ECF93C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_47E3FDC48035C1D6104ECE2D5ECF7762" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0E5E7B3CC4A7FD602454CE2D5ECC0C13" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_47E3FDC48035C1D6104ECE2D5ECF7762" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0CF9F4869852566A37FBCE2D5ED07177" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0E5E7B3CC4A7FD602454CE2D5ECC0C13" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0CF9F4869852566A37FBCE2D5ED07177" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_31E4496E64F1DDFE3E74CE2D5EE1F1EA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_7D57128CC2E88463C7CECE2D5EE34A89" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_31E4496E64F1DDFE3E74CE2D5EE1F1EA" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_7D57128CC2E88463C7CECE2D5EE34A89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_74D81F1DEA1A1E55A390CE2D5EE3A22E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_31E4496E64F1DDFE3E74CE2D5EE1F1EA" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_74D81F1DEA1A1E55A390CE2D5EE3A22E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_977EEF6F9EDFB9A87B38CE2D5EE45A39" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_31E4496E64F1DDFE3E74CE2D5EE1F1EA" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_977EEF6F9EDFB9A87B38CE2D5EE45A39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_E2A21959F93A01752444CE2D5EE4EB97" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_31E4496E64F1DDFE3E74CE2D5EE1F1EA" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_E2A21959F93A01752444CE2D5EE4EB97" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_F82FB5D4BA43C3F73B7FCE2D5EC2B834" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_A6CB8EA2894776EC9463CE2D5EC4FDFE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_F82FB5D4BA43C3F73B7FCE2D5EC2B834" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_A6CB8EA2894776EC9463CE2D5EC4FDFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3456AFEF5908A03696D3CE2D5EC5144A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_F82FB5D4BA43C3F73B7FCE2D5EC2B834" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3456AFEF5908A03696D3CE2D5EC5144A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_F7F9254047DBF68EF419CE2D5EC5E4DE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_F82FB5D4BA43C3F73B7FCE2D5EC2B834" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_F7F9254047DBF68EF419CE2D5EC5E4DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_89BB9D3FDA823ADE7271CE2D5EC5F612" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_F82FB5D4BA43C3F73B7FCE2D5EC2B834" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_89BB9D3FDA823ADE7271CE2D5EC5F612" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_E0AE0575D4378CBE9D93CE2D5EC580A7" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_F82FB5D4BA43C3F73B7FCE2D5EC2B834" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_E0AE0575D4378CBE9D93CE2D5EC580A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_AA64D8EBEC770BD2E456CE2D5EC57F7B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_F82FB5D4BA43C3F73B7FCE2D5EC2B834" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_AA64D8EBEC770BD2E456CE2D5EC57F7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_3A4748829231906A2C58CE2D5EC57E31" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_F82FB5D4BA43C3F73B7FCE2D5EC2B834" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear_3A4748829231906A2C58CE2D5EC57E31" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_A479C00A08286CF63AB7F5EBD631D90F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_36EA8116402F5FE46312F5EBD631AC75" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_A479C00A08286CF63AB7F5EBD631D90F" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_36EA8116402F5FE46312F5EBD631AC75" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0A1E864140060B2D84A45E02A7D5CB90" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PensionExpense" xlink:label="loc_us-gaap_PensionExpense_73949FB6D3216DFD6DD95E02A7D6A133" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0A1E864140060B2D84A45E02A7D5CB90" xlink:to="loc_us-gaap_PensionExpense_73949FB6D3216DFD6DD95E02A7D6A133" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0A1E864140060B2D84A45E02A7D5CB90" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_085AAD9D3A254DF70D655E02A7D6FCDC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_085AAD9D3A254DF70D655E02A7D6FCDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_9A34BA0FA183DFB2D6C85E02A7D6E893" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_9A34BA0FA183DFB2D6C85E02A7D6E893" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_310711306FBC38B3100F5E02A7D70C7D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_310711306FBC38B3100F5E02A7D70C7D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_BB03B70EC6DA8EB800805E02A7D7404A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_BB03B70EC6DA8EB800805E02A7D7404A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_085F710AB51FDEECA6D55E02A7D76A12" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_085F710AB51FDEECA6D55E02A7D76A12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_CD88AA467BDC9E8ED8685E02A7D733CB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_CD88AA467BDC9E8ED8685E02A7D733CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3C0648645EE35BC4CA4E5E02A7D7019A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_3C0648645EE35BC4CA4E5E02A7D7019A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_A1DF03EF2D18F665FB805E02A7DC38B8" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_A1DF03EF2D18F665FB805E02A7DC38B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_BDC6588D1C69EB7D7A155E02A7DD1E5C" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_30030571434F70E0959C5E02A7D6DA21" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_BDC6588D1C69EB7D7A155E02A7DD1E5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0A1E864140060B2D84A45E02A7D5CB90" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_15A7B56D32AA809BA4E25E02A7DDB298" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_15A7B56D32AA809BA4E25E02A7DDB298" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_4F9E7F17C492B89C038C5E02A7DD85E6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_4F9E7F17C492B89C038C5E02A7DD85E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_E743C40DC965C8CAB7575E02A7DD4033" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_E743C40DC965C8CAB7575E02A7DD4033" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_8D339C6E9D2C36A5BD105E02A7DEA466" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_8D339C6E9D2C36A5BD105E02A7DEA466" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee" xlink:label="loc_ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee_9CE81CAB55661B2EC5655E02A7DECF97" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:to="loc_ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee_9CE81CAB55661B2EC5655E02A7DECF97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_3A0A919EC7CA1FA8C1D65E02A7DE8A4B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_3A0A919EC7CA1FA8C1D65E02A7DE8A4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_C81A4254557B0A1E8A0E5E02A7DEF9AB" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_C81A4254557B0A1E8A0E5E02A7DEF9AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_A03A1F4B429806005C535E02A7DE0126" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_A03A1F4B429806005C535E02A7DE0126" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_448EB5A7217A8C3B6CE65E02A7DE8552" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_448EB5A7217A8C3B6CE65E02A7DE8552" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_CFE1D2DDAF86C8AB17265E02A7DF1E69" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_CFE1D2DDAF86C8AB17265E02A7DF1E69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_C44BFA4812470272A8245E02A7DFD2DB" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3F9DA4F7A207EF605F0C5E02A7DD976B" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_C44BFA4812470272A8245E02A7DFD2DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_77748CF607A4868BEA695E02A7DFAC4D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0A1E864140060B2D84A45E02A7D5CB90" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_77748CF607A4868BEA695E02A7DFAC4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_64A43B8A32515BF8D6345E02A7DF07CC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0A1E864140060B2D84A45E02A7D5CB90" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_64A43B8A32515BF8D6345E02A7DF07CC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1E99287EDC69BBA6EB6798AA8291A5C8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_447C423928950EF42AE798AA82920E7B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1E99287EDC69BBA6EB6798AA8291A5C8" xlink:to="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_447C423928950EF42AE798AA82920E7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_786C77B5D789E4E2C1E498AA82923B1C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1E99287EDC69BBA6EB6798AA8291A5C8" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_786C77B5D789E4E2C1E498AA82923B1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_A37850F7A7DD84A3418498AA829236FB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1E99287EDC69BBA6EB6798AA8291A5C8" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_A37850F7A7DD84A3418498AA829236FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_2BD470BE9A961DD6B3E398AA82922325" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1E99287EDC69BBA6EB6798AA8291A5C8" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_2BD470BE9A961DD6B3E398AA82922325" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_D266215547F9800554B698AA8292D9A3" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1E99287EDC69BBA6EB6798AA8291A5C8" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_D266215547F9800554B698AA8292D9A3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_266A451F99D1691A12704FB846CD1BFB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_C69C8D78118437C2A0784FB846CDFD91" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_266A451F99D1691A12704FB846CD1BFB" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_C69C8D78118437C2A0784FB846CDFD91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_134C9D366803A31940854FB846CD605B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_266A451F99D1691A12704FB846CD1BFB" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_134C9D366803A31940854FB846CD605B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_50D38BB71925F7860EAC4FB846CDA0D6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_266A451F99D1691A12704FB846CD1BFB" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_50D38BB71925F7860EAC4FB846CDA0D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_B221FC896A93EC9A4B534FB846CD4E02" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_266A451F99D1691A12704FB846CD1BFB" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_B221FC896A93EC9A4B534FB846CD4E02" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstruments" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7329FFF087C006E35857EC8A3DD1ABB2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_90C8CBE4EE5C87C04D50EC8A3DD1E1AF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7329FFF087C006E35857EC8A3DD1ABB2" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_90C8CBE4EE5C87C04D50EC8A3DD1E1AF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_CF9EC389552829C816CECE2D5FB03809" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_B3778FDCA538A3E1A896CE2D5FB14155" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_CF9EC389552829C816CECE2D5FB03809" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_B3778FDCA538A3E1A896CE2D5FB14155" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_AFDFB461B939CAAA7BADCE2D5FB1C055" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_B3778FDCA538A3E1A896CE2D5FB14155" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_AFDFB461B939CAAA7BADCE2D5FB1C055" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2230FD81416D1A05FA09CE2D5FB15F04" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_AFDFB461B939CAAA7BADCE2D5FB1C055" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2230FD81416D1A05FA09CE2D5FB15F04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpenseMember" xlink:label="loc_us-gaap_InterestExpenseMember_EC66E808FF4C86C9B48ECE2D5FB26987" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2230FD81416D1A05FA09CE2D5FB15F04" xlink:to="loc_us-gaap_InterestExpenseMember_EC66E808FF4C86C9B48ECE2D5FB26987" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_FFF4E6D46A52DEF860CBCE2D5FB23DAC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_B3778FDCA538A3E1A896CE2D5FB14155" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_FFF4E6D46A52DEF860CBCE2D5FB23DAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_A89F266A79591BA81913CE2D5FB25D6F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_FFF4E6D46A52DEF860CBCE2D5FB23DAC" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_A89F266A79591BA81913CE2D5FB25D6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_F096A9A0A6839645AA1ECE2D5FB3028D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_A89F266A79591BA81913CE2D5FB25D6F" xlink:to="loc_us-gaap_InterestRateSwapMember_F096A9A0A6839645AA1ECE2D5FB3028D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E57781409008F6D2CAFBCE2D5FB3EC73" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_B3778FDCA538A3E1A896CE2D5FB14155" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E57781409008F6D2CAFBCE2D5FB3EC73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8B3D3FE538EE850041B0CE2D5FB3DE61" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_E57781409008F6D2CAFBCE2D5FB3EC73" xlink:to="loc_us-gaap_HedgingRelationshipDomain_8B3D3FE538EE850041B0CE2D5FB3DE61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_386FF310EB38C51E6173CE2D5FB440B1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8B3D3FE538EE850041B0CE2D5FB3DE61" xlink:to="loc_us-gaap_CashFlowHedgingMember_386FF310EB38C51E6173CE2D5FB440B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_F32DF5655FABD0EF9581CE2D5FB4E13E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_B3778FDCA538A3E1A896CE2D5FB14155" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_F32DF5655FABD0EF9581CE2D5FB4E13E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_78F7D77C33E8BE79B2CACE2D5FB467BD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_F32DF5655FABD0EF9581CE2D5FB4E13E" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_78F7D77C33E8BE79B2CACE2D5FB467BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_47C638CC6614672ADA5ECE2D5FB431BE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_F32DF5655FABD0EF9581CE2D5FB4E13E" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_47C638CC6614672ADA5ECE2D5FB431BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_07E1F9EBC807543E8EC7CE2D5FB50221" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_F32DF5655FABD0EF9581CE2D5FB4E13E" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_07E1F9EBC807543E8EC7CE2D5FB50221" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_F657AC71E267D4C33F83CE2D5FB5B7B4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_F32DF5655FABD0EF9581CE2D5FB4E13E" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_F657AC71E267D4C33F83CE2D5FB5B7B4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_A918E31E0F50EDCA9F9498A7607CF049" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_A918E31E0F50EDCA9F9498A7607CF049" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9D6A61BB547E900192D698A7607DFE61" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9D6A61BB547E900192D698A7607DFE61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_DAB657989DE195990F4F98A7DC3110E1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9D6A61BB547E900192D698A7607DFE61" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_DAB657989DE195990F4F98A7DC3110E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_480A3EF25EEB67DF35AA98A7607D883B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_DAB657989DE195990F4F98A7DC3110E1" xlink:to="loc_us-gaap_InterestRateSwapMember_480A3EF25EEB67DF35AA98A7607D883B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_1564BC293522C577E31D98A7607D9FDC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B" xlink:to="loc_us-gaap_HedgingDesignationAxis_1564BC293522C577E31D98A7607D9FDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_83A5B37274D84779682298A7607D7F63" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_1564BC293522C577E31D98A7607D9FDC" xlink:to="loc_us-gaap_HedgingDesignationDomain_83A5B37274D84779682298A7607D7F63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7D68440FA54AFB52B95F98A7607EA617" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_83A5B37274D84779682298A7607D7F63" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7D68440FA54AFB52B95F98A7607EA617" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5F6C0856B82FC90E8E8198A7607FBC16" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_65FE273064A1E311C8B898A7607CE13B" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5F6C0856B82FC90E8E8198A7607FBC16" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_906A240D4677B8C378AA98A7607F9C46" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5F6C0856B82FC90E8E8198A7607FBC16" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_906A240D4677B8C378AA98A7607F9C46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="loc_invest_DerivativeNotionalAmount_6B7F9C9263B09674415898A7607F9A99" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_5F6C0856B82FC90E8E8198A7607FBC16" xlink:to="loc_invest_DerivativeNotionalAmount_6B7F9C9263B09674415898A7607F9A99" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3E1944B44A44BFD6A63598A75E5B7F0B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96C90B2339B396870DA398A75E5D6F3E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3E1944B44A44BFD6A63598A75E5B7F0B" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96C90B2339B396870DA398A75E5D6F3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_953A691559CDB56DFC4B98A75E5DBD4D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96C90B2339B396870DA398A75E5D6F3E" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_953A691559CDB56DFC4B98A75E5DBD4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_65E5FCF14E28258B36DA98A75E5EC78F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_953A691559CDB56DFC4B98A75E5DBD4D" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_65E5FCF14E28258B36DA98A75E5EC78F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_28B90306EB5F1E8214E398A75E5E192D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_65E5FCF14E28258B36DA98A75E5EC78F" xlink:to="loc_us-gaap_InterestRateSwapMember_28B90306EB5F1E8214E398A75E5E192D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_26EB18A2C4EC9886167398A75E5EAE7B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96C90B2339B396870DA398A75E5D6F3E" xlink:to="loc_us-gaap_HedgingDesignationAxis_26EB18A2C4EC9886167398A75E5EAE7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_2F17268A996510D92F9A98A75E5EC384" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_26EB18A2C4EC9886167398A75E5EAE7B" xlink:to="loc_us-gaap_HedgingDesignationDomain_2F17268A996510D92F9A98A75E5EC384" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_30AC58B6383B09AE903898A75E5F1DF6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_2F17268A996510D92F9A98A75E5EC384" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_30AC58B6383B09AE903898A75E5F1DF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3421A26EF63AFB3F214A98A75E5F1A9C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96C90B2339B396870DA398A75E5D6F3E" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3421A26EF63AFB3F214A98A75E5F1A9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1A61FC847E713D8D51AB98A75E5F57B4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3421A26EF63AFB3F214A98A75E5F1A9C" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1A61FC847E713D8D51AB98A75E5F57B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember_0547D5340A53B8139AD598A75E60F3BC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1A61FC847E713D8D51AB98A75E5F57B4" xlink:to="loc_us-gaap_OtherAssetsMember_0547D5340A53B8139AD598A75E60F3BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="loc_us-gaap_OtherLiabilitiesMember_C5E17A8CECB1883FF84A98A75E600DCE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1A61FC847E713D8D51AB98A75E5F57B4" xlink:to="loc_us-gaap_OtherLiabilitiesMember_C5E17A8CECB1883FF84A98A75E600DCE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_A9964C5396EF59B64E5998A75E61D38D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_96C90B2339B396870DA398A75E5D6F3E" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_A9964C5396EF59B64E5998A75E61D38D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_77339F6A70C00742EDF698A75E6195E3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_A9964C5396EF59B64E5998A75E61D38D" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_77339F6A70C00742EDF698A75E6195E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_707A641E62245248CC9E98A75E61B2BC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_A9964C5396EF59B64E5998A75E61D38D" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_707A641E62245248CC9E98A75E61B2BC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_A7F9C7AC85EC8BC73779EC9FFD756FDF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1460F22E6CF76D66B84AECA09E3C50DD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_A7F9C7AC85EC8BC73779EC9FFD756FDF" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1460F22E6CF76D66B84AECA09E3C50DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8DD7A0ACCF17E80C681CECA09E3DDB67" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1460F22E6CF76D66B84AECA09E3C50DD" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8DD7A0ACCF17E80C681CECA09E3DDB67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_E1B963C1F488EE52D89CECA09E3E779E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8DD7A0ACCF17E80C681CECA09E3DDB67" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_E1B963C1F488EE52D89CECA09E3E779E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_4FF6223269821A361A51ECA0E6C4050B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_E1B963C1F488EE52D89CECA09E3E779E" xlink:to="loc_us-gaap_InterestRateSwapMember_4FF6223269821A361A51ECA0E6C4050B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_B3EF80FCB6C4D37E9F4CECA09E48957B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_1460F22E6CF76D66B84AECA09E3C50DD" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_B3EF80FCB6C4D37E9F4CECA09E48957B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_BA6CA543622E83C5DA06ECA0123C9539" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_B3EF80FCB6C4D37E9F4CECA09E48957B" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_BA6CA543622E83C5DA06ECA0123C9539" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeInstrumentsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_855D154E37AAF5FD97C898B9582F8C28" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_BB392146B431A78EB09598B98C2D4938" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_855D154E37AAF5FD97C898B9582F8C28" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_BB392146B431A78EB09598B98C2D4938" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_BA85733A3B562B51F45E98B958E6BF3E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_855D154E37AAF5FD97C898B9582F8C28" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_BA85733A3B562B51F45E98B958E6BF3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_1448008A098540796CE998BAB242E1F3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_855D154E37AAF5FD97C898B9582F8C28" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_1448008A098540796CE998BAB242E1F3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_59F2A97F9D01C9B1D66CCCD36DED948C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_09173B8562964DE8FDE9CCD36DEE3E76" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_59F2A97F9D01C9B1D66CCCD36DED948C" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_09173B8562964DE8FDE9CCD36DEE3E76" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_62D1D79254F6F0A7146CEC8A3CFF01BA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_F94E079CD3C2EB9C3695EC8A3CFFEBE8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_62D1D79254F6F0A7146CEC8A3CFF01BA" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_F94E079CD3C2EB9C3695EC8A3CFFEBE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52C57732E6097B802C62EC8A3CFFE4AE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_F94E079CD3C2EB9C3695EC8A3CFFEBE8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52C57732E6097B802C62EC8A3CFFE4AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4B4A5AEB5CECE8AB38CEEC8A3CFF1F03" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52C57732E6097B802C62EC8A3CFFE4AE" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4B4A5AEB5CECE8AB38CEEC8A3CFF1F03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_87558DEAB630A6E17807EC8A3D0098B6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4B4A5AEB5CECE8AB38CEEC8A3CFF1F03" xlink:to="loc_us-gaap_EmployeeStockOptionMember_87558DEAB630A6E17807EC8A3D0098B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_F94E079CD3C2EB9C3695EC8A3CFFEBE8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_81ED6C3053FC7CC22A88EC8A3D0050AE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:to="loc_us-gaap_NetIncomeLoss_81ED6C3053FC7CC22A88EC8A3D0050AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_41ED5747ACACCA3E2F56EC8A3D015582" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_41ED5747ACACCA3E2F56EC8A3D015582" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax" xlink:label="loc_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax_2AC824E1B403F9DB5D49EC8A3D01F39D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:to="loc_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax_2AC824E1B403F9DB5D49EC8A3D01F39D" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AdjustedNetLoss" xlink:label="loc_ebs_AdjustedNetLoss_A5E90A64140891A5DC41EC8A3D01E263" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_259710ED987F87A48295EC8A3D001035" xlink:to="loc_ebs_AdjustedNetLoss_A5E90A64140891A5DC41EC8A3D01E263" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4CE5FD1A09C2D3B827CAEC8A3D01E957" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4CE5FD1A09C2D3B827CAEC8A3D01E957" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8FE55850D87F35115C24EC8A3D0289B5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8FE55850D87F35115C24EC8A3D0289B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_035E480F1DBE893A8FEDEC8A3D02E25B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_035E480F1DBE893A8FEDEC8A3D02E25B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_093B0550D9EF1B7480C1EC8A3D02D02E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_B8C57676F4324F08D630EC8A3D01B407" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_093B0550D9EF1B7480C1EC8A3D02D02E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_4DD06C43039657C16706EC8A3D022FD7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:to="loc_us-gaap_EarningsPerShareBasic_4DD06C43039657C16706EC8A3D022FD7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_243587040EBD32C702CEEC8A3D028406" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:to="loc_us-gaap_EarningsPerShareDiluted_243587040EBD32C702CEEC8A3D028406" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0AFD735776B873AAD050EC8A3D027648" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4E41B35B0525765A85E1EC8A3D008C8C" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0AFD735776B873AAD050EC8A3D027648" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_A6F287E072D1161ABAA799767243EA70" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9D1C281E2C45DC0E8914997672432D93" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_A6F287E072D1161ABAA799767243EA70" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9D1C281E2C45DC0E8914997672432D93" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_164FFEAF13068FD2ED3DCCD36F7B799E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_2BA84820774EEBED7729CCD36F7BF44A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_164FFEAF13068FD2ED3DCCD36F7B799E" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_2BA84820774EEBED7729CCD36F7BF44A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_CEC2357551C5937BF64C2CB959299164" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_CEC2357551C5937BF64C2CB959299164" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_F80F53A5E77D547584E12CB959299144" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_F80F53A5E77D547584E12CB959299144" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7305D01F6C94447D04452CB959290431" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7305D01F6C94447D04452CB959290431" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_48A40C06BF22D30555582CB9592911DB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_48A40C06BF22D30555582CB9592911DB" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment" xlink:label="loc_ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment_F45834DF6A538A43C6962CB959293040" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A" xlink:to="loc_ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment_F45834DF6A538A43C6962CB959293040" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2A5705643A52F5B49E6B2CB959296638" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2A5705643A52F5B49E6B2CB959296638" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_81876E9F610DCEF8F3A62CB95929AE74" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_81876E9F610DCEF8F3A62CB95929AE74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8C2B2C15EB5A8D7588192CB959290695" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F30C9AE9B84D7130C4602CB95929288A" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8C2B2C15EB5A8D7588192CB959290695" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3D5BACDB2ECE834955B64B481567CE13" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3D5BACDB2ECE834955B64B481567CE13" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_19BDF9A84F030D34EBAB4B4E8EB6960B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_19BDF9A84F030D34EBAB4B4E8EB6960B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8E175349D1F783DCECBD4B4F421FD00F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_19BDF9A84F030D34EBAB4B4E8EB6960B" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8E175349D1F783DCECBD4B4F421FD00F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_44CEFC30941D7FD1F99F4B4EB5A0E19E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8E175349D1F783DCECBD4B4F421FD00F" xlink:to="loc_us-gaap_MoneyMarketFundsMember_44CEFC30941D7FD1F99F4B4EB5A0E19E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34FE717B56D0800FB6794B4815670D97" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34FE717B56D0800FB6794B4815670D97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2BB840685AB555312AFC4B4815771A1F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34FE717B56D0800FB6794B4815670D97" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2BB840685AB555312AFC4B4815771A1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ED91AF6F4B73BC0206694B481577661D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2BB840685AB555312AFC4B4815771A1F" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_ED91AF6F4B73BC0206694B481577661D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_DFBEB6875C777EFA79214B481577A95A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_057DF5796C182FF9E29C4B48156716DC" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_DFBEB6875C777EFA79214B481577A95A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_254CC12BBF59B0D0529E4B4E61712A53" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_DFBEB6875C777EFA79214B481577A95A" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_254CC12BBF59B0D0529E4B4E61712A53" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_05D031BE3EB65E3FA3BA92A288A794A0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_17E1F8FD6875EC77FFFC92A288A76D75" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_05D031BE3EB65E3FA3BA92A288A794A0" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_17E1F8FD6875EC77FFFC92A288A76D75" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0592EA94AD357E03E03FCCD36FBED737" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_E76050D4F992E9869BDECCD36FBEE30C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0592EA94AD357E03E03FCCD36FBED737" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_E76050D4F992E9869BDECCD36FBEE30C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_C76961764B85DA4F8D2423C57D531C3D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2CD5F016DE25B19E92BE23C57D53CDA6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_C76961764B85DA4F8D2423C57D531C3D" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2CD5F016DE25B19E92BE23C57D53CDA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4127D95788E9FA1DF60F23C57D533B3B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2CD5F016DE25B19E92BE23C57D53CDA6" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4127D95788E9FA1DF60F23C57D533B3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_DA843E0AA23D1575597823C57D53B0DE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2CD5F016DE25B19E92BE23C57D53CDA6" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_DA843E0AA23D1575597823C57D53B0DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_C6C142665641D75A5B0823C57D543375" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2CD5F016DE25B19E92BE23C57D53CDA6" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_C6C142665641D75A5B0823C57D543375" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_44A13A0C9C7949B6BD3423C57D542919" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2CD5F016DE25B19E92BE23C57D53CDA6" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_44A13A0C9C7949B6BD3423C57D542919" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3F9F315C9304EEB77C1D23C57D5417EB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_C76961764B85DA4F8D2423C57D531C3D" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3F9F315C9304EEB77C1D23C57D5417EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_E3C9B771E0B9C18FAE0D23C57D54BE74" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3F9F315C9304EEB77C1D23C57D5417EB" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_E3C9B771E0B9C18FAE0D23C57D54BE74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_E01E5FF466ACCEA6B37E23C57D54BD0E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3F9F315C9304EEB77C1D23C57D5417EB" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_E01E5FF466ACCEA6B37E23C57D54BD0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_39184CCF35C2115D8ED723C57D548FB5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3F9F315C9304EEB77C1D23C57D5417EB" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_39184CCF35C2115D8ED723C57D548FB5" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment" xlink:label="loc_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_FD4083DB87B96000194E23C57D5537AE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3F9F315C9304EEB77C1D23C57D5417EB" xlink:to="loc_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment_FD4083DB87B96000194E23C57D5537AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_47AFB88C8E2CA6F0919123C57D55A29A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_C76961764B85DA4F8D2423C57D531C3D" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_47AFB88C8E2CA6F0919123C57D55A29A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_F24C8D6AD69EAF017F0668849E79B6D9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_F24C8D6AD69EAF017F0668849E79B6D9" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_20E01E04E2373BF5167C68849E79ABAF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_20E01E04E2373BF5167C68849E79ABAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ED17B046A0A2C4BF93568849E797BED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_20E01E04E2373BF5167C68849E79ABAF" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ED17B046A0A2C4BF93568849E797BED" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PaxVaxMember" xlink:label="loc_ebs_PaxVaxMember_93E77041D394C8303F2868849E795C28" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ED17B046A0A2C4BF93568849E797BED" xlink:to="loc_ebs_PaxVaxMember_93E77041D394C8303F2868849E795C28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_DE528ECB8BCEB4FC51F968849E7A2898" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_DE528ECB8BCEB4FC51F968849E7A2898" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_0CF01641DB65D29BD46D68849E7A3E1C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_DE528ECB8BCEB4FC51F968849E7A2898" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_0CF01641DB65D29BD46D68849E7A3E1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_E76890D621E3CE7D585E68849E7A202E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0CF01641DB65D29BD46D68849E7A3E1C" xlink:to="loc_us-gaap_DomesticCountryMember_E76890D621E3CE7D585E68849E7A202E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_22EE51F28644202D9E8768849E7ACE78" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0CF01641DB65D29BD46D68849E7A3E1C" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_22EE51F28644202D9E8768849E7ACE78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_9348AC5A8A48F4F36C0868849E7B7CA4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0CF01641DB65D29BD46D68849E7A3E1C" xlink:to="loc_us-gaap_ForeignCountryMember_9348AC5A8A48F4F36C0868849E7B7CA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_7B31D78517659D00DC7068849E7B2311" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_7B31D78517659D00DC7068849E7B2311" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_7B31D78517659D00DC7068849E7B2311" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchMember" xlink:label="loc_us-gaap_ResearchMember_FB199BC0E844BFF3E43A68849E7B6189" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5" xlink:to="loc_us-gaap_ResearchMember_FB199BC0E844BFF3E43A68849E7B6189" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember" xlink:label="loc_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember_09A6E34A62AA695572C768849E7B3088" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_D3BBDB182BAF55A1140F68849E7B02D5" xlink:to="loc_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember_09A6E34A62AA695572C768849E7B3088" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_F14FED89C3EF22B4326D68849E795A72" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_D533C4D855C7ED1CF6E768849E7CAA78" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_D533C4D855C7ED1CF6E768849E7CAA78" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_0C3474705F4CC8AA7DA168849E7CDED7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_0C3474705F4CC8AA7DA168849E7CDED7" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:label="loc_ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_1A376FAB93A3B22084F568849E7CEFA6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_1A376FAB93A3B22084F568849E7CEFA6" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary" xlink:label="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary_72D51EFDF3EA2EDCB9ED68849E7C33E9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary_72D51EFDF3EA2EDCB9ED68849E7C33E9" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense" xlink:label="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_953728B4732D8166A92568849E7D2C41" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_953728B4732D8166A92568849E7D2C41" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit_45586F338644DB9F986768849E7D1059" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit_45586F338644DB9F986768849E7D1059" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_9219720C2BBB59E2B23268849E7D4743" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_DeferredTaxLiabilities_9219720C2BBB59E2B23268849E7D4743" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_712FD255A2A53443D27A68849E7DCDAA" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_712FD255A2A53443D27A68849E7DCDAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_035C00A7AEC1F675E65668849E7D01A3" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_OperatingLossCarryforwards_035C00A7AEC1F675E65668849E7D01A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_1293CA7069F6270BDDB368849E7D4965" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_1293CA7069F6270BDDB368849E7D4965" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_818D781BA093F15C215468849E7E5F55" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_818D781BA093F15C215468849E7E5F55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_B59D7BC57FFB2831B9B368849E7E4704" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_B59D7BC57FFB2831B9B368849E7E4704" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0B7B18B809BD00BC7C1668849E7EB87F" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0B7B18B809BD00BC7C1668849E7EB87F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_F50B9A462B4CF78EDD3768849E7E88FE" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_F50B9A462B4CF78EDD3768849E7E88FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_F46564B122A5DCFF54DD68849E7EFA4B" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_F46564B122A5DCFF54DD68849E7EFA4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_3555BE85DD10D2A7A7D768849E7E6ED2" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_3555BE85DD10D2A7A7D768849E7E6ED2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B1A8FB8321FD951FD8E868849E7EC661" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B1A8FB8321FD951FD8E868849E7EC661" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_UnrecognizedTaxBenefitsCurrent" xlink:label="loc_ebs_UnrecognizedTaxBenefitsCurrent_80EDCCAABDA8EC469E9C68849E7F0889" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_ebs_UnrecognizedTaxBenefitsCurrent_80EDCCAABDA8EC469E9C68849E7F0889" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_UnrecognizedTaxBenefitsNoncurrent" xlink:label="loc_ebs_UnrecognizedTaxBenefitsNoncurrent_36F1D640361DDECFA62C68849E7F7A15" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_ebs_UnrecognizedTaxBenefitsNoncurrent_36F1D640361DDECFA62C68849E7F7A15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_53607FD6CA4A9DDC9850688C70DCBDA7" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_53607FD6CA4A9DDC9850688C70DCBDA7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_EB6BE8108EE2AE58F3A768849E7FE22B" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_91755D53A596D235E44A68849E7C5865" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_EB6BE8108EE2AE58F3A768849E7FE22B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5A4D777FBDC3046E77834B4814BBF92E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_87A251EEA786BB87ECA54B4814BB0C65" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5A4D777FBDC3046E77834B4814BBF92E" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_87A251EEA786BB87ECA54B4814BB0C65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_C6FBDD6DE9F69B1EA3D34B4814BB9A8C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_87A251EEA786BB87ECA54B4814BB0C65" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_C6FBDD6DE9F69B1EA3D34B4814BB9A8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_C6FBDD6DE9F69B1EA3D34B4814BB9A8C" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_711852B6DDD2933244794B4814BBA980" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984" xlink:to="loc_us-gaap_DomesticCountryMember_711852B6DDD2933244794B4814BBA980" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_0CBFE598D4E9A1F140634B4814BB2B6A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0DD30E3BFDAB38453B464B4814BB7984" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_0CBFE598D4E9A1F140634B4814BB2B6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_87A251EEA786BB87ECA54B4814BB0C65" xlink:to="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_09DFDBE0236FDFD57BFA4B4814BBECCB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_09DFDBE0236FDFD57BFA4B4814BBECCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_93AF71A861741DE8F7C64B4814BB26E4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_93AF71A861741DE8F7C64B4814BB26E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_104FBE2C69FE303A6DB74B4814BBC685" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_104FBE2C69FE303A6DB74B4814BBC685" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment" xlink:label="loc_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment_BC0F6806D389395CDF794B4814BB15A1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment_BC0F6806D389395CDF794B4814BB15A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_B1FDCBFE27C38EB8E6C14B4814BBE177" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_B1FDCBFE27C38EB8E6C14B4814BBE177" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_8A901592CABC2A1DC9484B4814BBFAA3" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_8A901592CABC2A1DC9484B4814BBFAA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_AD107A2EB20F634F4D594B4814BB8CAE" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_AD107A2EB20F634F4D594B4814BB8CAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_014BF48470426E9EF3314B4814BB3D12" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_014BF48470426E9EF3314B4814BB3D12" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DeferredTaxAssetsOperatingLeaseLiability" xlink:label="loc_ebs_DeferredTaxAssetsOperatingLeaseLiability_F9B49AE71E37E618FD114B4814BB5E82" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_ebs_DeferredTaxAssetsOperatingLeaseLiability_F9B49AE71E37E618FD114B4814BB5E82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_6434DE5DD33225F0B8BD4B4814BB8F09" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_6434DE5DD33225F0B8BD4B4814BB8F09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_7028F87188D2D783C9504B4814BB5903" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_7028F87188D2D783C9504B4814BB5903" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2F50B1C3C73796EA81EE4B4814BB9040" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2F50B1C3C73796EA81EE4B4814BB9040" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_E3F4E2BBD59B49DD75B44B4814BB09CC" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_E3F4E2BBD59B49DD75B44B4814BB09CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_19890C9844CCE1C3FD224B4B39FF9C27" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_19890C9844CCE1C3FD224B4B39FF9C27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_A3191D56C7C7E0C6DA054B4814BB59E0" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_A3191D56C7C7E0C6DA054B4814BB59E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_76F5285D13D5EDD75FBA4B4814BBEBBF" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_76F5285D13D5EDD75FBA4B4814BBEBBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_C9109A1410571082A8814B4814BBF614" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_C9109A1410571082A8814B4814BBF614" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_B06D27E6BD2A133450954B4814BB4F7E" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_442C013E38D8ADA50CC34B4814BB64A0" xlink:to="loc_us-gaap_DeferredTaxLiabilities_B06D27E6BD2A133450954B4814BB4F7E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_49F16ECA3E0E165CC7915DEBAE2C5723" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_49F16ECA3E0E165CC7915DEBAE2C5723" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_EDB89D9CCA32D066EE585DEBAE2C5119" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_EDB89D9CCA32D066EE585DEBAE2C5119" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossAttributableToParent" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_2DC8C91228F2ED20E3AD5DEBAE2CC876" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_2DC8C91228F2ED20E3AD5DEBAE2CC876" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3FB2A7CE91540AF9F8555DEBAE2C8B19" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3FB2A7CE91540AF9F8555DEBAE2C8B19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_6CE107740853AF0EB8155DEBAE2C83C6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_6CE107740853AF0EB8155DEBAE2C83C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_03B65CFEF7B854C82B255DEBAE2DDDF2" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_03B65CFEF7B854C82B255DEBAE2DDDF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_8BB8974E9069FC8E021C5DEBAE2D7D75" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_8BB8974E9069FC8E021C5DEBAE2D7D75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits_1610509FF19974CC628D5DEBAE2DB4F6" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCredits_1610509FF19974CC628D5DEBAE2DB4F6" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_549EED64DB802AFAC6EC5DEBAE2D24AB" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount_549EED64DB802AFAC6EC5DEBAE2D24AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_A066A947B16DF37907335DEBAE2D5DFD" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_A066A947B16DF37907335DEBAE2D5DFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_814CF6D123C2089616FD5DEBAE2E68E9" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_814CF6D123C2089616FD5DEBAE2E68E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_08E99536E07F8CEFFFD85DEBAE2EC601" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_08E99536E07F8CEFFFD85DEBAE2EC601" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7A71F4771E8E3FA2844E5DEBAE2E4B00" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7A71F4771E8E3FA2844E5DEBAE2E4B00" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts_4BAA99E428D2298969005DEBAE2E1CCA" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts_4BAA99E428D2298969005DEBAE2E1CCA" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount_0983980A7FE3526DC8C45DF338D20AD1" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount_0983980A7FE3526DC8C45DF338D20AD1" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount_4C73B8FD4C41D67D73575DEBAE2EC7B4" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount_4C73B8FD4C41D67D73575DEBAE2EC7B4" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_CA61A5BF3A8BED2BDAE05DEBAE2F8D95" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount_CA61A5BF3A8BED2BDAE05DEBAE2F8D95" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet_65D63EDAB7BB53BF2F3D5DEBAE2F3BCA" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet_65D63EDAB7BB53BF2F3D5DEBAE2F3BCA" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference" xlink:label="loc_ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference_65638797353011D76D1E5DEBAE2FDE36" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference_65638797353011D76D1E5DEBAE2FDE36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2BC24A19A84C3CC86DAC5DEBAE2FEF55" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9DDA643BEB1A16FC32A55DEBAE2B0331" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2BC24A19A84C3CC86DAC5DEBAE2FEF55" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6DEEF4CA03819C8DCA5B98AA830444C3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_35B4A3AA0D74791D323498AA8304176A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6DEEF4CA03819C8DCA5B98AA830444C3" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_35B4A3AA0D74791D323498AA8304176A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_D7071DA107B0C5D767F698AA8305114E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6DEEF4CA03819C8DCA5B98AA830444C3" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_D7071DA107B0C5D767F698AA8305114E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_E6C992A8567043F5070398AA83058AEF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6DEEF4CA03819C8DCA5B98AA830444C3" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_E6C992A8567043F5070398AA83058AEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_A908050DE9E09E289AB898AA8305AF7A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6DEEF4CA03819C8DCA5B98AA830444C3" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_A908050DE9E09E289AB898AA8305AF7A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_A4B053D2EB191B4559D13F3C361BC143" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_A4B053D2EB191B4559D13F3C361BC143" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_790FF5FEC214578665213F3C361C27B3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_790FF5FEC214578665213F3C361C27B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_400A8B12441B9A30A9813F3C361CA52D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_400A8B12441B9A30A9813F3C361CA52D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_0ECA23D26196B67938DA3F3C361CEA30" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_0ECA23D26196B67938DA3F3C361CEA30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_92CC9FA4C5BA579FA7C93F3C361CC8C9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_92CC9FA4C5BA579FA7C93F3C361CC8C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_891A4F051A7B625416213F3C361D10A5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_891A4F051A7B625416213F3C361D10A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_F07B71F5C2DE7B8527CF3F3C361D95A2" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_F07B71F5C2DE7B8527CF3F3C361D95A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2B7E24AB79903E71B79D3F3C361D9068" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2B7E24AB79903E71B79D3F3C361D9068" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_49B4362E0B50728737653F3C361DFC47" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_C697BDE4AB19DB3EA63B3F3C361B8F06" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_49B4362E0B50728737653F3C361DFC47" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwill" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_B8521EBD926BFDEBDB7DF56780612CCA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_251AE853E91DF8D8458CF56780618A5F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_B8521EBD926BFDEBDB7DF56780612CCA" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_251AE853E91DF8D8458CF56780618A5F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2B32287566653EE9C494CAFC04A762E9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_961A5B897D44B507E213CAFC04A7B4C5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2B32287566653EE9C494CAFC04A762E9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_961A5B897D44B507E213CAFC04A7B4C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FC03C573D22B88A5BE27CAFC04A7F704" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2B32287566653EE9C494CAFC04A762E9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FC03C573D22B88A5BE27CAFC04A7F704" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_EDB9AD3704FCE5BD0569CAFC04A794E0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2B32287566653EE9C494CAFC04A762E9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_EDB9AD3704FCE5BD0569CAFC04A794E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_365065BCF79714E3F25FCAFC04A8D527" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2B32287566653EE9C494CAFC04A762E9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_365065BCF79714E3F25FCAFC04A8D527" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter" xlink:label="loc_ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter_556008D11630C0A5DFC4CAFC04A87B90" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2B32287566653EE9C494CAFC04A762E9" xlink:to="loc_ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter_556008D11630C0A5DFC4CAFC04A87B90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_13D3C95FB84DFE158EEECAFC04A8D778" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2B32287566653EE9C494CAFC04A762E9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_13D3C95FB84DFE158EEECAFC04A8D778" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0B9E58CE5BAAB3C6A28B2CB95901081D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_A63F04B69C977153E2B92CB95901CEE1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0B9E58CE5BAAB3C6A28B2CB95901081D" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_A63F04B69C977153E2B92CB95901CEE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6273226F57E0EE29B6532CB959011212" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_A63F04B69C977153E2B92CB95901CEE1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6273226F57E0EE29B6532CB959011212" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_B731FEC3044ECD3477732CB95905EF58" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6273226F57E0EE29B6532CB959011212" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_B731FEC3044ECD3477732CB95905EF58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_80D824D5720E4F42BDDD2CB95905CD67" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_B731FEC3044ECD3477732CB95905EF58" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_80D824D5720E4F42BDDD2CB95905CD67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_A0F00ECB0FD7EDE8604D2CB9590559B1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_A63F04B69C977153E2B92CB95901CEE1" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_A0F00ECB0FD7EDE8604D2CB9590559B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7D78676F5BC02E7F89792CB959055EC3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_A0F00ECB0FD7EDE8604D2CB9590559B1" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7D78676F5BC02E7F89792CB959055EC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_165E3ADF76B76B17F9E12CB95905C70C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_A0F00ECB0FD7EDE8604D2CB9590559B1" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_165E3ADF76B76B17F9E12CB95905C70C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_80BD38DB68A4C18278522CB95905100B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_A0F00ECB0FD7EDE8604D2CB9590559B1" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_80BD38DB68A4C18278522CB95905100B" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_InProcessResearchAndDevelopment" xlink:label="loc_ebs_InProcessResearchAndDevelopment_51156B183A711C65C3D12CD13F32470F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_A0F00ECB0FD7EDE8604D2CB9590559B1" xlink:to="loc_ebs_InProcessResearchAndDevelopment_51156B183A711C65C3D12CD13F32470F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_EFBCB576AC0A3FF1DE9F4B48155846E8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_EFBCB576AC0A3FF1DE9F4B48155846E8" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_AF07CB06B6EE100A2B7A4B48155815E9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_AF07CB06B6EE100A2B7A4B48155815E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_A0FD31FF5A7017B6F1EA4B481558E03A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_AF07CB06B6EE100A2B7A4B48155815E9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_A0FD31FF5A7017B6F1EA4B481558E03A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaap_ProductMember_D1748887BAD36C539F794B4815586D0E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_A0FD31FF5A7017B6F1EA4B481558E03A" xlink:to="loc_us-gaap_ProductMember_D1748887BAD36C539F794B4815586D0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_DA86BDA965FE8D3123054B481558AA08" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_A0FD31FF5A7017B6F1EA4B481558E03A" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_DA86BDA965FE8D3123054B481558AA08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_72C006E0A59B626F5CF64B4815588643" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_A0FD31FF5A7017B6F1EA4B481558E03A" xlink:to="loc_us-gaap_CustomerRelationshipsMember_72C006E0A59B626F5CF64B4815588643" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractManufacturingMember" xlink:label="loc_ebs_ContractManufacturingMember_E81EF9CB5FB142516F284B4815584EFA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_A0FD31FF5A7017B6F1EA4B481558E03A" xlink:to="loc_ebs_ContractManufacturingMember_E81EF9CB5FB142516F284B4815584EFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_3A776CEAC6008900844F4B4815589DFB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC" xlink:to="loc_srt_RangeAxis_3A776CEAC6008900844F4B4815589DFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_6E1A2E6EC4FB70B63FA14B4815580DAB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3A776CEAC6008900844F4B4815589DFB" xlink:to="loc_srt_RangeMember_6E1A2E6EC4FB70B63FA14B4815580DAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_F7CB79C6E44D44869AA64B4815586528" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6E1A2E6EC4FB70B63FA14B4815580DAB" xlink:to="loc_srt_MinimumMember_F7CB79C6E44D44869AA64B4815586528" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_FF842FF82A14DE5E316B4B481558673F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6E1A2E6EC4FB70B63FA14B4815580DAB" xlink:to="loc_srt_MaximumMember_FF842FF82A14DE5E316B4B481558673F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1DDE7F53172CEE79A8C04B481558A3FC" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9B4FB02BF6A4A39D188C4B481558F25A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9B4FB02BF6A4A39D188C4B481558F25A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_84318A6F007659560F4E4B4815587977" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_84318A6F007659560F4E4B4815587977" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_F23EA491AB81BDBB55F64B4815587A14" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_F23EA491AB81BDBB55F64B4815587A14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_A0427B3B26F8BB4B5E4B4B4815581E3D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_A0427B3B26F8BB4B5E4B4B4815581E3D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1A7370B5C9E8567728484B481558999C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_4BA1BC92E96795C6F0BB4B48155852F8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1A7370B5C9E8567728484B481558999C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_E9C9E033770586FC63D6118212581943" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_A9B273966D4DF1189072118212586CB0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_E9C9E033770586FC63D6118212581943" xlink:to="loc_us-gaap_GoodwillRollForward_A9B273966D4DF1189072118212586CB0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillGross" xlink:label="loc_us-gaap_GoodwillGross_226E5BD07BFC1F5F343211821259395D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_A9B273966D4DF1189072118212586CB0" xlink:to="loc_us-gaap_GoodwillGross_226E5BD07BFC1F5F343211821259395D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_ACF5DD36568E8787D07C11857B9D9541" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_A9B273966D4DF1189072118212586CB0" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_ACF5DD36568E8787D07C11857B9D9541" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_EAD11F8B8C5C9C5554411182125936F5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_A9B273966D4DF1189072118212586CB0" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_EAD11F8B8C5C9C5554411182125936F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillGross" xlink:label="loc_us-gaap_GoodwillGross_DACD301272ED92174C011182125939CD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_A9B273966D4DF1189072118212586CB0" xlink:to="loc_us-gaap_GoodwillGross_DACD301272ED92174C011182125939CD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3DC99F93BB1F5DED32DDB29110781B7D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_EC845823910C5F7D2E14B2C1D93E23C8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3DC99F93BB1F5DED32DDB29110781B7D" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_EC845823910C5F7D2E14B2C1D93E23C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3D665CC6319D7639184DB29110799F68" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3DC99F93BB1F5DED32DDB29110781B7D" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3D665CC6319D7639184DB29110799F68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_B75AD5EF538B8340B9DFB291107967D4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3DC99F93BB1F5DED32DDB29110781B7D" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_B75AD5EF538B8340B9DFB291107967D4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_9155444E7856F162AEB7CCD36F7DC3AA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_B3BEA467D84163F992ABCCD36F7DA40C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_9155444E7856F162AEB7CCD36F7DC3AA" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_B3BEA467D84163F992ABCCD36F7DA40C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_F0B893AEC310F21F0795F5678070DA1B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_B53EC1FE0A5202E5E0DBF5678070D7D3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_F0B893AEC310F21F0795F5678070DA1B" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_B53EC1FE0A5202E5E0DBF5678070D7D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_92AC21929B6AB8BB0499F5678071189F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_F0B893AEC310F21F0795F5678070DA1B" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_92AC21929B6AB8BB0499F5678071189F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0C691F4C21BB8A62EDBAF56780718CB7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_F0B893AEC310F21F0795F5678070DA1B" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0C691F4C21BB8A62EDBAF56780718CB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_A551AB3FCB9D5D3E1123F5678071E9CD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_F0B893AEC310F21F0795F5678070DA1B" xlink:to="loc_us-gaap_InventoryNet_A551AB3FCB9D5D3E1123F5678071E9CD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_3DF2679C6D3200E4911B92A288987312" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_FCD11F05E260F51DD03792A2889898EC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_3DF2679C6D3200E4911B92A288987312" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_FCD11F05E260F51DD03792A2889898EC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Leases" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_261D44E94F9469CBC656CAFC0369126B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_ECDC1A19016FBFF17EE6CB38A82687A3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_261D44E94F9469CBC656CAFC0369126B" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_ECDC1A19016FBFF17EE6CB38A82687A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_A3745F27CF793AA56CFFCB3BEDB77732" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_261D44E94F9469CBC656CAFC0369126B" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_A3745F27CF793AA56CFFCB3BEDB77732" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_41268780C6CE7F776BC5CDD07917EC33" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinanceLeaseCostAbstract" xlink:label="loc_us-gaap_FinanceLeaseCostAbstract_B1D024352273B2DB6343CDD07918FE76" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41268780C6CE7F776BC5CDD07917EC33" xlink:to="loc_us-gaap_FinanceLeaseCostAbstract_B1D024352273B2DB6343CDD07918FE76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_61DF4F5A423F57ED609DCDD07918F480" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseCostAbstract_B1D024352273B2DB6343CDD07918FE76" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_61DF4F5A423F57ED609DCDD07918F480" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_A765198F2334B86B03B1CDD0791968BA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseCostAbstract_B1D024352273B2DB6343CDD07918FE76" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_A765198F2334B86B03B1CDD0791968BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_F2963D37E52C65B4EB17CDE5104FD432" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseCostAbstract_B1D024352273B2DB6343CDD07918FE76" xlink:to="loc_us-gaap_LeaseCost_F2963D37E52C65B4EB17CDE5104FD432" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_42CB0CBADE47A0C1D394CDE45F49DF1B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41268780C6CE7F776BC5CDD07917EC33" xlink:to="loc_us-gaap_LeaseAndRentalExpense_42CB0CBADE47A0C1D394CDE45F49DF1B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_F18FCCB7F0561B337B53EC8A3D1DDA28" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_A9237BC4BC3B0C45331DEC8A3D1DFCA6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F18FCCB7F0561B337B53EC8A3D1DDA28" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_A9237BC4BC3B0C45331DEC8A3D1DFCA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_B476685131292651CD00EC8A3D1E02C0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_A9237BC4BC3B0C45331DEC8A3D1DFCA6" xlink:to="loc_srt_RangeAxis_B476685131292651CD00EC8A3D1E02C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_B476685131292651CD00EC8A3D1E02C0" xlink:to="loc_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_42A13985B49F72B63592EC8A3D1E1CDA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69" xlink:to="loc_srt_MinimumMember_42A13985B49F72B63592EC8A3D1E1CDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_45AC55A79D8113A385ECEC8A3D1FC2CB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_67C181A987F5F263E98CEC8A3D1E1E69" xlink:to="loc_srt_MaximumMember_45AC55A79D8113A385ECEC8A3D1FC2CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_DA31B9356BFE0AE52EC1EC8A3D1FC849" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_A9237BC4BC3B0C45331DEC8A3D1DFCA6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_DA31B9356BFE0AE52EC1EC8A3D1FC849" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_EDF416FBBA9830A1306CEC8A3D1F1FDF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_DA31B9356BFE0AE52EC1EC8A3D1FC849" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_EDF416FBBA9830A1306CEC8A3D1F1FDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_65F9F93E810DE00D3726EC8A3D1F75E1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_DA31B9356BFE0AE52EC1EC8A3D1FC849" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_65F9F93E810DE00D3726EC8A3D1F75E1" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_LesseeOperatingLeaseTerminationPeriod" xlink:label="loc_ebs_LesseeOperatingLeaseTerminationPeriod_41547FD182AAAF3A399BEC8A3D1FCEB2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_DA31B9356BFE0AE52EC1EC8A3D1FC849" xlink:to="loc_ebs_LesseeOperatingLeaseTerminationPeriod_41547FD182AAAF3A399BEC8A3D1FCEB2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_7B72D8884E67550330B121D7F7A58473" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_80E5DFCAEB0BCBC4D55C21D7F7A5404A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7B72D8884E67550330B121D7F7A58473" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_80E5DFCAEB0BCBC4D55C21D7F7A5404A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8EAB9FA6BEC4AA687A0221D7F7A5A9F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_80E5DFCAEB0BCBC4D55C21D7F7A5404A" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8EAB9FA6BEC4AA687A0221D7F7A5A9F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8EAB9FA6BEC4AA687A0221D7F7A5A9F4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember_59DFCC03AEDDD2CA5F6C21D7F7A6FC99" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D" xlink:to="loc_us-gaap_OtherAssetsMember_59DFCC03AEDDD2CA5F6C21D7F7A6FC99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_8A661ED86EC3649DCDD021D7F7A683AD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_8A661ED86EC3649DCDD021D7F7A683AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="loc_us-gaap_OtherLiabilitiesMember_4E9F1C41A3964BED46B821D7F7A6F0C1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_64FAD6C32483433785AC21D7F7A6348D" xlink:to="loc_us-gaap_OtherLiabilitiesMember_4E9F1C41A3964BED46B821D7F7A6F0C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_80E5DFCAEB0BCBC4D55C21D7F7A5404A" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6FC1F6DD3246B6A2256921D7F7A7421D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6FC1F6DD3246B6A2256921D7F7A7421D" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_OperatingLeaseOtherLiabilityCurrent" xlink:label="loc_ebs_OperatingLeaseOtherLiabilityCurrent_7A704BA9C4FBD46899B521D7F7A7D765" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:to="loc_ebs_OperatingLeaseOtherLiabilityCurrent_7A704BA9C4FBD46899B521D7F7A7D765" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_CD95F80DB467243E609721D7F7A7C704" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_CD95F80DB467243E609721D7F7A7C704" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_F20A931FA5ACC85F17C821D7F7A77BC4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:to="loc_us-gaap_OperatingLeaseLiability_F20A931FA5ACC85F17C821D7F7A77BC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="loc_us-gaap_LeaseCostAbstract_F21F9DBCA1A75A0EE97F21D7F7A7F6AB" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5194A5C3AE20608F21E221D7F7A79803" xlink:to="loc_us-gaap_LeaseCostAbstract_F21F9DBCA1A75A0EE97F21D7F7A7F6AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5ADA7432315F8CA2E3AB21D7F7A8C6FA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_F21F9DBCA1A75A0EE97F21D7F7A7F6AB" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5ADA7432315F8CA2E3AB21D7F7A8C6FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_D792260D4696DEF954B121D7F7A8CBE0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_F21F9DBCA1A75A0EE97F21D7F7A7F6AB" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_D792260D4696DEF954B121D7F7A8CBE0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_4CD6D72CBBD5CB25D1B9C5AFB4D654C1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_32F199C5EB8A0A129CC2C5AFB4D6C643" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4CD6D72CBBD5CB25D1B9C5AFB4D654C1" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_32F199C5EB8A0A129CC2C5AFB4D6C643" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/Litigation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1257ED019B4E9574190DF5EBD5F43EBB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_DC2968EFF478EFAE7FA6F5EBD5F4A021" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1257ED019B4E9574190DF5EBD5F43EBB" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_DC2968EFF478EFAE7FA6F5EBD5F4A021" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_B50060897150578AD0CACCD370326B78" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_37A6243527D7DEF972ACCCD37032BA23" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_B50060897150578AD0CACCD370326B78" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_37A6243527D7DEF972ACCCD37032BA23" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8BF1A2F96FE3A8FDEC7D21D7F8D306E2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_C83325BE09C4D2719EE321D7F8D3681E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8BF1A2F96FE3A8FDEC7D21D7F8D306E2" xlink:to="loc_us-gaap_DebtInstrumentTable_C83325BE09C4D2719EE321D7F8D3681E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_E79B1EB0BEFDD780337921D7F8D46710" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_C83325BE09C4D2719EE321D7F8D3681E" xlink:to="loc_us-gaap_CreditFacilityAxis_E79B1EB0BEFDD780337921D7F8D46710" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_9FACF0D357296DFC155121D7F8D4708E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_E79B1EB0BEFDD780337921D7F8D46710" xlink:to="loc_us-gaap_CreditFacilityDomain_9FACF0D357296DFC155121D7F8D4708E" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TermLoanFacilityMember" xlink:label="loc_ebs_TermLoanFacilityMember_ED32608D203D926A92E621D7F8D408BF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_9FACF0D357296DFC155121D7F8D4708E" xlink:to="loc_ebs_TermLoanFacilityMember_ED32608D203D926A92E621D7F8D408BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_19A3136BB9AC72FE3B8821D7F8D52590" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_9FACF0D357296DFC155121D7F8D4708E" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_19A3136BB9AC72FE3B8821D7F8D52590" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_7F08AC53BDCDDBDCA15421D7F8D5E4DD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_C83325BE09C4D2719EE321D7F8D3681E" xlink:to="loc_us-gaap_DebtInstrumentAxis_7F08AC53BDCDDBDCA15421D7F8D5E4DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_829F8A7F8608FF2714DE21D7F8D5C4C4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7F08AC53BDCDDBDCA15421D7F8D5E4DD" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_829F8A7F8608FF2714DE21D7F8D5C4C4" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ConvertibleSeniorNotesDue2021Member" xlink:label="loc_ebs_ConvertibleSeniorNotesDue2021Member_AAE31836BBD36966DFF521D7F8D582F0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_829F8A7F8608FF2714DE21D7F8D5C4C4" xlink:to="loc_ebs_ConvertibleSeniorNotesDue2021Member_AAE31836BBD36966DFF521D7F8D582F0" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_OtherLongTermDebtFacilityMember" xlink:label="loc_ebs_OtherLongTermDebtFacilityMember_E10634234ACFCA832EF721D7F8D6CF90" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_829F8A7F8608FF2714DE21D7F8D5C4C4" xlink:to="loc_ebs_OtherLongTermDebtFacilityMember_E10634234ACFCA832EF721D7F8D6CF90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_41F1A8563D87976D9E1521D7F8D66C15" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_C83325BE09C4D2719EE321D7F8D3681E" xlink:to="loc_us-gaap_DebtInstrumentLineItems_41F1A8563D87976D9E1521D7F8D66C15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_48CE3B512138D637804E21D7F8D64009" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41F1A8563D87976D9E1521D7F8D66C15" xlink:to="loc_us-gaap_LongTermDebt_48CE3B512138D637804E21D7F8D64009" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_A2598B751FEE87951C4D21D7F8D6B2B5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41F1A8563D87976D9E1521D7F8D66C15" xlink:to="loc_us-gaap_LongTermDebtCurrent_A2598B751FEE87951C4D21D7F8D6B2B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_22C12ED5BE08C4D7739721D7F8DB785D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41F1A8563D87976D9E1521D7F8D66C15" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_22C12ED5BE08C4D7739721D7F8DB785D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2138128412F1AB9DF1B321D7F8DC0825" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41F1A8563D87976D9E1521D7F8D66C15" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2138128412F1AB9DF1B321D7F8DC0825" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ED255BBF13281518FBEE21D7F8DC9085" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41F1A8563D87976D9E1521D7F8D66C15" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ED255BBF13281518FBEE21D7F8DC9085" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_05D7D8966170348366EDECB14835FCD1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_EC49BC79C1AA8F762E9AECB148357714" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_05D7D8966170348366EDECB14835FCD1" xlink:to="loc_us-gaap_DebtInstrumentTable_EC49BC79C1AA8F762E9AECB148357714" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_81EDC1390333B903A61AECB148356F8D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_EC49BC79C1AA8F762E9AECB148357714" xlink:to="loc_us-gaap_DebtInstrumentAxis_81EDC1390333B903A61AECB148356F8D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7AD9AA7BA36CF5EB57E5ECB14836E09B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_81EDC1390333B903A61AECB148356F8D" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7AD9AA7BA36CF5EB57E5ECB14836E09B" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ConvertibleSeniorNotesDue2021Member" xlink:label="loc_ebs_ConvertibleSeniorNotesDue2021Member_D501B86D1213FFBCAD0CECB14836E200" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7AD9AA7BA36CF5EB57E5ECB14836E09B" xlink:to="loc_ebs_ConvertibleSeniorNotesDue2021Member_D501B86D1213FFBCAD0CECB14836E200" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_EC49BC79C1AA8F762E9AECB148357714" xlink:to="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_15BAD47422637DA3AEE2ECB14836D1E9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_15BAD47422637DA3AEE2ECB14836D1E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2BC00F171F978F0B4765ECB148376FE6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_2BC00F171F978F0B4765ECB148376FE6" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentNumberOfEquityInstruments" xlink:label="loc_ebs_DebtInstrumentNumberOfEquityInstruments_D4AC74724DD4B6B485F5ECB14837A438" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:to="loc_ebs_DebtInstrumentNumberOfEquityInstruments_D4AC74724DD4B6B485F5ECB14837A438" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_9CF4A65FA8B24E84F229ECB14837C917" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_9CF4A65FA8B24E84F229ECB14837C917" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentNumberOfAdditionalEquityInstruments" xlink:label="loc_ebs_DebtInstrumentNumberOfAdditionalEquityInstruments_EA38522F86D2D289BD4AECB1483716D9" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:to="loc_ebs_DebtInstrumentNumberOfAdditionalEquityInstruments_EA38522F86D2D289BD4AECB1483716D9" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentAccruedInterestOnConvertedNotes" xlink:label="loc_ebs_DebtInstrumentAccruedInterestOnConvertedNotes_4C6CFEE543380ECCD3F2ECB1483835DE" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46DADDFE4DD859C0AFACECB14836E941" xlink:to="loc_ebs_DebtInstrumentAccruedInterestOnConvertedNotes_4C6CFEE543380ECCD3F2ECB1483835DE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_BACE38B64A0C13696B0D21D7F88E2125" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_78CC24DEE2EAEF74B55421D7F88E7B61" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_BACE38B64A0C13696B0D21D7F88E2125" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_78CC24DEE2EAEF74B55421D7F88E7B61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6B2778A3D5402774709E21D7F88E40E5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_BACE38B64A0C13696B0D21D7F88E2125" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6B2778A3D5402774709E21D7F88E40E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_C5BE127DFF018FF231BB21D7F88E179D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_BACE38B64A0C13696B0D21D7F88E2125" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_C5BE127DFF018FF231BB21D7F88E179D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_64A3FE31B4838ACD6A6F21D7F88E47F2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_BACE38B64A0C13696B0D21D7F88E2125" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_64A3FE31B4838ACD6A6F21D7F88E47F2" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter" xlink:label="loc_ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter_0429FB14D7C407C2DBE421D7F88FB06A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_BACE38B64A0C13696B0D21D7F88E2125" xlink:to="loc_ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter_0429FB14D7C407C2DBE421D7F88FB06A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_A809F213E0C8AAB4933B21D7F88F1222" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_BACE38B64A0C13696B0D21D7F88E2125" xlink:to="loc_us-gaap_LongTermDebt_A809F213E0C8AAB4933B21D7F88F1222" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_A610955688A7A2AEC831CAFC0478393A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_A04A965C7B9983AC9505CAFC0478CD80" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_A610955688A7A2AEC831CAFC0478393A" xlink:to="loc_us-gaap_DebtInstrumentTable_A04A965C7B9983AC9505CAFC0478CD80" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_31AEF38E557016C84823CAFC047920A5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_A04A965C7B9983AC9505CAFC0478CD80" xlink:to="loc_us-gaap_CreditFacilityAxis_31AEF38E557016C84823CAFC047920A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_31AEF38E557016C84823CAFC047920A5" xlink:to="loc_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_2D45880B7EEB016D6331CAFC047BC2DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_2D45880B7EEB016D6331CAFC047BC2DF" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TermLoanFacilityMember" xlink:label="loc_ebs_TermLoanFacilityMember_8530EA1406435A78361FCAFC047CCFAB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_032B943F4F015639379FCAFC047B05F8" xlink:to="loc_ebs_TermLoanFacilityMember_8530EA1406435A78361FCAFC047CCFAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_E3FEDE033A4DB128BC05CAFC047CCE68" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_A04A965C7B9983AC9505CAFC0478CD80" xlink:to="loc_us-gaap_DebtInstrumentAxis_E3FEDE033A4DB128BC05CAFC047CCE68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_EDF82D77A59DD252AF80CAFC047C3E2E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_E3FEDE033A4DB128BC05CAFC047CCE68" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_EDF82D77A59DD252AF80CAFC047C3E2E" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_CreditAgreementMember" xlink:label="loc_ebs_CreditAgreementMember_A77EAB942115FD26B666CAFC047CF395" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_EDF82D77A59DD252AF80CAFC047C3E2E" xlink:to="loc_ebs_CreditAgreementMember_A77EAB942115FD26B666CAFC047CF395" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmendedCreditAgreementMember" xlink:label="loc_ebs_AmendedCreditAgreementMember_6771FBDC1E3E83A57840CAFC047C152E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_EDF82D77A59DD252AF80CAFC047C3E2E" xlink:to="loc_ebs_AmendedCreditAgreementMember_6771FBDC1E3E83A57840CAFC047C152E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_179DE93828794C3B1198CAFC047D66BA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_A04A965C7B9983AC9505CAFC0478CD80" xlink:to="loc_us-gaap_VariableRateAxis_179DE93828794C3B1198CAFC047D66BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_179DE93828794C3B1198CAFC047D66BA" xlink:to="loc_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_43778BF338B232E545D1CAFC047D4729" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_43778BF338B232E545D1CAFC047D4729" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_DAD68CEE51F61ECF5CB3CAFC047D293D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A" xlink:to="loc_us-gaap_EurodollarMember_DAD68CEE51F61ECF5CB3CAFC047D293D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_E2DC69E842E8B7AD7C4CCAFC047D90C4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_73152AF8A7ED42DB0ECACAFC047D8E2A" xlink:to="loc_us-gaap_BaseRateMember_E2DC69E842E8B7AD7C4CCAFC047D90C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_41FBF5FD92F0B01E6DAECAFC047ECA3A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_A04A965C7B9983AC9505CAFC0478CD80" xlink:to="loc_srt_RangeAxis_41FBF5FD92F0B01E6DAECAFC047ECA3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_D1F53980804BDF3477E5CAFC047ECE54" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_41FBF5FD92F0B01E6DAECAFC047ECA3A" xlink:to="loc_srt_RangeMember_D1F53980804BDF3477E5CAFC047ECE54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_64014F23307587959C61CAFC047EBD25" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_D1F53980804BDF3477E5CAFC047ECE54" xlink:to="loc_srt_MinimumMember_64014F23307587959C61CAFC047EBD25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_D827B6F3E623BE15A2C8CAFC047F3987" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_D1F53980804BDF3477E5CAFC047ECE54" xlink:to="loc_srt_MaximumMember_D827B6F3E623BE15A2C8CAFC047F3987" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_A04A965C7B9983AC9505CAFC0478CD80" xlink:to="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberOfLendingInstitutions" xlink:label="loc_ebs_NumberOfLendingInstitutions_93320350272D92778C70CAFC047F6A3C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_NumberOfLendingInstitutions_93320350272D92778C70CAFC047F6A3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_FADDE567C96DCD7AE4D7CAFC047FD7B3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_FADDE567C96DCD7AE4D7CAFC047FD7B3" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ConsolidatedSecuredNetLeverageRatio" xlink:label="loc_ebs_ConsolidatedSecuredNetLeverageRatio_C5AD19B1528BC438EAE3CAFC047F8521" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_ConsolidatedSecuredNetLeverageRatio_C5AD19B1528BC438EAE3CAFC047F8521" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_AmountRequiredForNetLeverageRatio" xlink:label="loc_ebs_AmountRequiredForNetLeverageRatio_8AD94C6847D2851A946ECAFC047F6543" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_AmountRequiredForNetLeverageRatio_8AD94C6847D2851A946ECAFC047F6543" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentCovenantLeverageRatio" xlink:label="loc_ebs_DebtInstrumentCovenantLeverageRatio_8C8D9A026D52AB7DCDE7CAFC047F9330" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtInstrumentCovenantLeverageRatio_8C8D9A026D52AB7DCDE7CAFC047F9330" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_FFE8D11AE460032B8EEFCAFC0480EE7D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_FFE8D11AE460032B8EEFCAFC0480EE7D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_9E72E384DEEABC55D698CAFC04807770" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_us-gaap_LineOfCredit_9E72E384DEEABC55D698CAFC04807770" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_91ECA200A9D405CA8FF7CB3F899A83B8" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_91ECA200A9D405CA8FF7CB3F899A83B8" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentTermOfVariableRate" xlink:label="loc_ebs_DebtInstrumentTermOfVariableRate_93F1364DE9146D07DA8CCAFC0480318E" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtInstrumentTermOfVariableRate_93F1364DE9146D07DA8CCAFC0480318E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_266180886526170CAEB4CAFC0480EEED" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_266180886526170CAEB4CAFC0480EEED" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears" xlink:label="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears_0E705EAE1F881981A716CAFC0480A901" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears_0E705EAE1F881981A716CAFC0480A901" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear" xlink:label="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear_F5F8A9DAADD7C8552B27CAFC04815E64" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear_F5F8A9DAADD7C8552B27CAFC04815E64" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears" xlink:label="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears_D09FB84475CA6BAE4CF6CAFC04819352" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears_D09FB84475CA6BAE4CF6CAFC04819352" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight" xlink:label="loc_ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight_5FEFACA487D67312CD63CAFC04816F40" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight_5FEFACA487D67312CD63CAFC04816F40" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentCovenantDebtServiceCoverageRatio" xlink:label="loc_ebs_DebtInstrumentCovenantDebtServiceCoverageRatio_D6B327F17D77BB426F47CAFC04813DE8" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtInstrumentCovenantDebtServiceCoverageRatio_D6B327F17D77BB426F47CAFC04813DE8" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtCovenantNetLeverageRatioOne" xlink:label="loc_ebs_DebtCovenantNetLeverageRatioOne_90E03C57BA90CDAA89B8CAFC048103D9" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtCovenantNetLeverageRatioOne_90E03C57BA90CDAA89B8CAFC048103D9" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtCovenantNetLeverageRatioTwo" xlink:label="loc_ebs_DebtCovenantNetLeverageRatioTwo_6C64B885D1127AD6A229CAFC0481EFC4" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtCovenantNetLeverageRatioTwo_6C64B885D1127AD6A229CAFC0481EFC4" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtCovenantNetLeverageRatioThree" xlink:label="loc_ebs_DebtCovenantNetLeverageRatioThree_C695B5D73808D2D10005CAFC04816715" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtCovenantNetLeverageRatioThree_C695B5D73808D2D10005CAFC04816715" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtCovenantNetLeverageRatioFour" xlink:label="loc_ebs_DebtCovenantNetLeverageRatioFour_5BEC22CCB9F996A0D42BCAFC048285BD" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtCovenantNetLeverageRatioFour_5BEC22CCB9F996A0D42BCAFC048285BD" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_DebtInstrumentRestrictedPaymentsLimitAmount" xlink:label="loc_ebs_DebtInstrumentRestrictedPaymentsLimitAmount_C154665C9E4100CEAD6FCAFC0482A051" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A4E2715F57C6ACFBAF02CAFC047FF3BD" xlink:to="loc_ebs_DebtInstrumentRestrictedPaymentsLimitAmount_C154665C9E4100CEAD6FCAFC0482A051" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_747C8A4383FA5EFA4E2D92A288791AD9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_CE831996F2C6F8FB583A92A28879CC1A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_747C8A4383FA5EFA4E2D92A288791AD9" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_CE831996F2C6F8FB583A92A28879CC1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ED5326D833018305663492A28879A75E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_747C8A4383FA5EFA4E2D92A288791AD9" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ED5326D833018305663492A28879A75E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganization" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5F7C0165110CF1A7A17202ED01697CA2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_60CE9C62C299BC03ED6202ED01693897" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5F7C0165110CF1A7A17202ED01697CA2" xlink:to="loc_us-gaap_NatureOfOperations_60CE9C62C299BC03ED6202ED01693897" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganizationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_85412624A64BE18549C753E694239300" xlink:type="locator" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberOfCategoriesOfPublicHealthThreats" xlink:label="loc_ebs_NumberOfCategoriesOfPublicHealthThreats_B14A790EC24091A19B6F53E69423FFB3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_85412624A64BE18549C753E694239300" xlink:to="loc_ebs_NumberOfCategoriesOfPublicHealthThreats_B14A790EC24091A19B6F53E69423FFB3" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberOfRevenueGeneratingProducts" xlink:label="loc_ebs_NumberOfRevenueGeneratingProducts_C5B15B144221B82B4B8053E694237931" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_85412624A64BE18549C753E694239300" xlink:to="loc_ebs_NumberOfRevenueGeneratingProducts_C5B15B144221B82B4B8053E694237931" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_7210AAFE16652335A58053E69423B523" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_85412624A64BE18549C753E694239300" xlink:to="loc_us-gaap_NumberOfOperatingSegments_7210AAFE16652335A58053E69423B523" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/PropertyPlantAndEquipment" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_A6DF23789475D4AA720ECCD36FDEAC89" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_2C21945828E7C0D2B7B3CCD36FDE2DA1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_A6DF23789475D4AA720ECCD36FDEAC89" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_2C21945828E7C0D2B7B3CCD36FDE2DA1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_4DA16ACB32F49751A88192A288982874" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_A1E18711A16CEB09D65A92A2889838C4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_4DA16ACB32F49751A88192A288982874" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_A1E18711A16CEB09D65A92A2889838C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5306579058FEB8DB829692A28898E546" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_A1E18711A16CEB09D65A92A2889838C4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5306579058FEB8DB829692A28898E546" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5306579058FEB8DB829692A28898E546" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LandAndLandImprovementsMember" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_9E8049E08E54378338B692A288981D11" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_9E8049E08E54378338B692A288981D11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_E8978B1BEAFCCECFE4BF92A28898E2C6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_E8978B1BEAFCCECFE4BF92A28898E2C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_48978C2B8549FD69DB1792A28898DC69" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_48978C2B8549FD69DB1792A28898DC69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_8CB8DABBFFC506867AF092A28898BA50" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_8CB8DABBFFC506867AF092A28898BA50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaap_ConstructionInProgressMember_DA932CF88D1944CFDDCB92A28898B80A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_512F9A89123616BBAB3092A288980A28" xlink:to="loc_us-gaap_ConstructionInProgressMember_DA932CF88D1944CFDDCB92A28898B80A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_A1E18711A16CEB09D65A92A2889838C4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_B33819844A125B58BE4B92A288984295" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_B33819844A125B58BE4B92A288984295" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6E491FDED89720A5A9E692A288982520" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6E491FDED89720A5A9E692A288982520" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_D080B346CF85C4F29F3D92A2889837E5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_D080B346CF85C4F29F3D92A2889837E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_CAB8785EC54E483372F292A288989003" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_06D17444CCCC07E1A17392A28898FF8D" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_CAB8785EC54E483372F292A288989003" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_3453FF15877F8E5D2CA192A28898CB4B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ADF93221CEA37A210C1792A288989C47" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract_3453FF15877F8E5D2CA192A28898CB4B" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ADF93221CEA37A210C1792A288989C47" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/PurchaseCommitments" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_298CC8CB185B91BBA3413F3C35C32B6C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock" xlink:label="loc_us-gaap_SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock_04D71DAB7E116A60CC0E3F3C35C3DC89" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_298CC8CB185B91BBA3413F3C35C32B6C" xlink:to="loc_us-gaap_SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock_04D71DAB7E116A60CC0E3F3C35C3DC89" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/PurchaseCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_7A3D84E431C7EF78A8913F3C35C04791" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaap_PurchaseObligation_4D0705ED5987E966D25E3F3C35C0C45E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_7A3D84E431C7EF78A8913F3C35C04791" xlink:to="loc_us-gaap_PurchaseObligation_4D0705ED5987E966D25E3F3C35C0C45E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod_CEBE6318BCAF2E85923A3F3C35C14638" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_7A3D84E431C7EF78A8913F3C35C04791" xlink:to="loc_us-gaap_LongtermPurchaseCommitmentPeriod_CEBE6318BCAF2E85923A3F3C35C14638" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_3FBBA153F1443990D9133F3C35C1CFBB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_7A3D84E431C7EF78A8913F3C35C04791" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_3FBBA153F1443990D9133F3C35C1CFBB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_848B5FB18FA251DB1D0F997671D97767" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_AECBE960BF805B6412C1997671D90374" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_848B5FB18FA251DB1D0F997671D97767" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_AECBE960BF805B6412C1997671D90374" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_46320234E7C56081AAD6CE2D5E416EB1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F645D61CB0F221DE0EC9CE2D5E42B25D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_46320234E7C56081AAD6CE2D5E416EB1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_F645D61CB0F221DE0EC9CE2D5E42B25D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_58D6DD51CD58345F69BBCE2D5E42E2C4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_46320234E7C56081AAD6CE2D5E416EB1" xlink:to="loc_us-gaap_GrossProfit_58D6DD51CD58345F69BBCE2D5E42E2C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_D34F3F3D4AA0DD7113F7CE2D5E4226D3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_46320234E7C56081AAD6CE2D5E416EB1" xlink:to="loc_us-gaap_NetIncomeLoss_D34F3F3D4AA0DD7113F7CE2D5E4226D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_EA6B6F09524B195929FDCE2D5E425DEF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_46320234E7C56081AAD6CE2D5E416EB1" xlink:to="loc_us-gaap_EarningsPerShareBasic_EA6B6F09524B195929FDCE2D5E425DEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_C78A547BEFB505818FB4CE2D5E435BC0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_46320234E7C56081AAD6CE2D5E416EB1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_C78A547BEFB505818FB4CE2D5E435BC0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_A5A06D8F7729FE99FA17997671D2895E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_F3B0B5203E206D0E3B15997671D28E31" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_A5A06D8F7729FE99FA17997671D2895E" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_F3B0B5203E206D0E3B15997671D28E31" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_DB8A2AA0778B78FB1D6E12BD04E3EFAB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_B53D10B9F842BD5904AE12BD04E48272" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_DB8A2AA0778B78FB1D6E12BD04E3EFAB" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_B53D10B9F842BD5904AE12BD04E48272" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_A4C9329B8FCE3146A00DF5530CBF7B72" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetAbstract" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_329FD05C1FAA3B43B503F5530CC0784D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_A4C9329B8FCE3146A00DF5530CBF7B72" xlink:to="loc_us-gaap_AccountsReceivableNetAbstract_329FD05C1FAA3B43B503F5530CC0784D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BilledContractReceivables" xlink:label="loc_us-gaap_BilledContractReceivables_303E1113B2A7BD6B234AF5530CC1757C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_329FD05C1FAA3B43B503F5530CC0784D" xlink:to="loc_us-gaap_BilledContractReceivables_303E1113B2A7BD6B234AF5530CC1757C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnbilledContractsReceivable" xlink:label="loc_us-gaap_UnbilledContractsReceivable_598AA01BF0A4D36C0905F5530CC24FDB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_329FD05C1FAA3B43B503F5530CC0784D" xlink:to="loc_us-gaap_UnbilledContractsReceivable_598AA01BF0A4D36C0905F5530CC24FDB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_543CA0B85154160A28B7F5530CC24FA8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_329FD05C1FAA3B43B503F5530CC0784D" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_543CA0B85154160A28B7F5530CC24FA8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_DC2E97650DA28299D0D721D7FA1AD9A6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_DC2E97650DA28299D0D721D7FA1AD9A6" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_D4B539CFC2EF98C8E1F721E7CBD78BF6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_D4B539CFC2EF98C8E1F721E7CBD78BF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_84B9BAA591D2A058431B21E7CBD70CDA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_D4B539CFC2EF98C8E1F721E7CBD78BF6" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_84B9BAA591D2A058431B21E7CBD70CDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_BCDD4FED32676C88486621E9227EE2C7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_84B9BAA591D2A058431B21E7CBD70CDA" xlink:to="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_BCDD4FED32676C88486621E9227EE2C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_323B37B2EA9847757B2C21E7CBD88DEF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_323B37B2EA9847757B2C21E7CBD88DEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_E028D9F90A91EC17CD4D21E7CBD936C5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_323B37B2EA9847757B2C21E7CBD88DEF" xlink:to="loc_us-gaap_TypeOfAdoptionMember_E028D9F90A91EC17CD4D21E7CBD936C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_B5EBC9421F3D4551482A21E83ABE50C7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_E028D9F90A91EC17CD4D21E7CBD936C5" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_B5EBC9421F3D4551482A21E83ABE50C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_98667276A1D64B3A5BBF21E7CBDF7AE6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_DF45F7CE8B9D36B389AB21E7CBD52D1E" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_98667276A1D64B3A5BBF21E7CBDF7AE6" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ChangeinContractWithCustomerLiabilityRollForward" xlink:label="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_98667276A1D64B3A5BBF21E7CBDF7AE6" xlink:to="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_3B91D4B25F34A9E37EB121D7FA1B89C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:to="loc_us-gaap_ContractWithCustomerLiability_3B91D4B25F34A9E37EB121D7FA1B89C9" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractWithCustomerLiabilityAdditions" xlink:label="loc_ebs_ContractWithCustomerLiabilityAdditions_4200D378910DDA764D4321D7FA1B558E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:to="loc_ebs_ContractWithCustomerLiabilityAdditions_4200D378910DDA764D4321D7FA1B558E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8B2A503B49EC3B484BEF21D7FA1BD214" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8B2A503B49EC3B484BEF21D7FA1BD214" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_74241E1615E0761B5D9221D7FA1B7348" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ebs_ChangeinContractWithCustomerLiabilityRollForward_4C17E7E226CF2908D2BC21D7FA1A6D11" xlink:to="loc_us-gaap_ContractWithCustomerLiability_74241E1615E0761B5D9221D7FA1B7348" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_768B57B5F99E31345B96117272BD9D8B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_768B57B5F99E31345B96117272BD9D8B" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_A469FB0E140B595D117C117272BE9A0E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95" xlink:to="loc_srt_ProductOrServiceAxis_A469FB0E140B595D117C117272BE9A0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_7EE8ACD9D4D60E42D980117272BE2410" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_A469FB0E140B595D117C117272BE9A0E" xlink:to="loc_srt_ProductsAndServicesDomain_7EE8ACD9D4D60E42D980117272BE2410" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaap_ProductMember_0323A4CB8856B650E254117272BFA4E8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7EE8ACD9D4D60E42D980117272BE2410" xlink:to="loc_us-gaap_ProductMember_0323A4CB8856B650E254117272BFA4E8" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractManufacturingMember" xlink:label="loc_ebs_ContractManufacturingMember_99B29BAF5B850B040046117272BF9C83" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7EE8ACD9D4D60E42D980117272BE2410" xlink:to="loc_ebs_ContractManufacturingMember_99B29BAF5B850B040046117272BF9C83" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContractsAndGrantsMember" xlink:label="loc_ebs_ContractsAndGrantsMember_F030F123804824FC71D3117272BF045A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7EE8ACD9D4D60E42D980117272BE2410" xlink:to="loc_ebs_ContractsAndGrantsMember_F030F123804824FC71D3117272BF045A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_2C6B41430C8BF805D810117272BFB57E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95" xlink:to="loc_srt_StatementGeographicalAxis_2C6B41430C8BF805D810117272BFB57E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_2C6B41430C8BF805D810117272BFB57E" xlink:to="loc_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_CD1F0BC164631B7F0581117272C05650" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0" xlink:to="loc_country_US_CD1F0BC164631B7F0581117272C05650" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_BA18E932125E5CA10CBA117272C07C1C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_696BF3EBDD508360E0F2117272C042F0" xlink:to="loc_us-gaap_NonUsMember_BA18E932125E5CA10CBA117272C07C1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_F9671210CB419FAEA9B1117272C0781F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_11CD45BF09A66F1A977F117272BE8C95" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_F9671210CB419FAEA9B1117272C0781F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6EE90EAFA3AD5ADA810C117272C10623" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_F9671210CB419FAEA9B1117272C0781F" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6EE90EAFA3AD5ADA810C117272C10623" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4C7AD490495AC802C31D4FB8494B9100" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4C7AD490495AC802C31D4FB8494B9100" xlink:to="loc_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_3EB68F1E9F0349D29A344FB8494BED5E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_3EB68F1E9F0349D29A344FB8494BED5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5C07E67F953A9DE139B24FB8494B1F49" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_3EB68F1E9F0349D29A344FB8494BED5E" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5C07E67F953A9DE139B24FB8494B1F49" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_2FE7F148126E5BF49D2A4FB8494B02B7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5C07E67F953A9DE139B24FB8494B1F49" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_2FE7F148126E5BF49D2A4FB8494B02B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6C9FEF18CD64959EAC6E4FB8494BFBF0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6C9FEF18CD64959EAC6E4FB8494BFBF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ADE295B0B9A54009D6244FB8494BDD95" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6C9FEF18CD64959EAC6E4FB8494BFBF0" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ADE295B0B9A54009D6244FB8494BDD95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_CD903B13118194E0265D4FB8494FAF19" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ADE295B0B9A54009D6244FB8494BDD95" xlink:to="loc_us-gaap_AccountsReceivableMember_CD903B13118194E0265D4FB8494FAF19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_18797490A71AD8E09CFE4FB8494F2AA7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:to="loc_srt_MajorCustomersAxis_18797490A71AD8E09CFE4FB8494F2AA7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_4478BC7D1B9118FDA8894FB8494F7FAE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_18797490A71AD8E09CFE4FB8494F2AA7" xlink:to="loc_srt_NameOfMajorCustomerDomain_4478BC7D1B9118FDA8894FB8494F7FAE" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_UnitedStatesGovernmentMember" xlink:label="loc_ebs_UnitedStatesGovernmentMember_448672890942447AB3E74FB8494F95CA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4478BC7D1B9118FDA8894FB8494F7FAE" xlink:to="loc_ebs_UnitedStatesGovernmentMember_448672890942447AB3E74FB8494F95CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_45BBC691C8C55D5A71B14FB8494BB002" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_F08C71E4549CAA4D7B634FB8494B5FE2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:to="loc_us-gaap_NumberOfOperatingSegments_F08C71E4549CAA4D7B634FB8494B5FE2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_3BC7B989FCD0165E537D4FB8494B60FF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_3BC7B989FCD0165E537D4FB8494B60FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCostsCurrent" xlink:label="loc_us-gaap_DeferredCostsCurrent_904DB716AF974FA61F0C4FB8494BBDCB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:to="loc_us-gaap_DeferredCostsCurrent_904DB716AF974FA61F0C4FB8494BBDCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_67589C77AE3A271885334FB8494FE6B1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_FAB2F142961EBAA1EC1D4FB8494F9380" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_67589C77AE3A271885334FB8494FE6B1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionRemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5E6007F6C4DBE0E23ED84FC4245DCFB7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0EA2E0088F6ECC62AD264FC42813FE81" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5E6007F6C4DBE0E23ED84FC4245DCFB7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0EA2E0088F6ECC62AD264FC42813FE81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_53B15E4EB53263EB01524FC427E8D70E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5E6007F6C4DBE0E23ED84FC4245DCFB7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_53B15E4EB53263EB01524FC427E8D70E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_15047297E8F952F93E774FC427E89D0B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_53B15E4EB53263EB01524FC427E8D70E" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_15047297E8F952F93E774FC427E89D0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_71021F2D7C76038B97754FC66BD6ABE2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_53B15E4EB53263EB01524FC427E8D70E" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_71021F2D7C76038B97754FC66BD6ABE2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_935CDFFCF1229B5799C69238C5159F9E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_CC1A8268DEAD74701EE09238C5162F4C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_935CDFFCF1229B5799C69238C5159F9E" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_CC1A8268DEAD74701EE09238C5162F4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_48D55B2C7B8856B42BCD9238C5162358" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_935CDFFCF1229B5799C69238C5159F9E" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_48D55B2C7B8856B42BCD9238C5162358" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ScheduleofAccountsReceivableNetTableTextBlock" xlink:label="loc_ebs_ScheduleofAccountsReceivableNetTableTextBlock_7BE40DF0B4B5A5D858279238C5166BE3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_935CDFFCF1229B5799C69238C5159F9E" xlink:to="loc_ebs_ScheduleofAccountsReceivableNetTableTextBlock_7BE40DF0B4B5A5D858279238C5166BE3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_7F3345EF058FBA5A261823C57C685A18" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_C814E19424E9D7FB259723C57C685741" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_7F3345EF058FBA5A261823C57C685A18" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_C814E19424E9D7FB259723C57C685741" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_670528A81E417F8EA48F7876E50CBFA5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1E0A9E053BBC6CB6E87B7876E50C43BF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_670528A81E417F8EA48F7876E50CBFA5" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1E0A9E053BBC6CB6E87B7876E50C43BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_476639990BD0C3AA23CA7876E50CAED9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1E0A9E053BBC6CB6E87B7876E50C43BF" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_476639990BD0C3AA23CA7876E50CAED9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_476639990BD0C3AA23CA7876E50CAED9" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryValuationReserveMember" xlink:label="loc_us-gaap_InventoryValuationReserveMember_DD17983F385EBE58531F7876E50DBB7C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720" xlink:to="loc_us-gaap_InventoryValuationReserveMember_DD17983F385EBE58531F7876E50DBB7C" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember_FB1573497F90AB9ADCD97876E50D463F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_DB5D364F8D546EA862217876E50D0720" xlink:to="loc_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember_FB1573497F90AB9ADCD97876E50D463F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3520D23E2C34DDE7110E7876E50D4B0C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1E0A9E053BBC6CB6E87B7876E50C43BF" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3520D23E2C34DDE7110E7876E50D4B0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3520D23E2C34DDE7110E7876E50D4B0C" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_C9A128A899718AC7C1237876E50E3083" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_C9A128A899718AC7C1237876E50E3083" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_0694368D499E4ED39D2C78774D8C67FE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired_0694368D499E4ED39D2C78774D8C67FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_69AB24819D1C8CD647307876E50EC5CD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_69AB24819D1C8CD647307876E50EC5CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_4206EBADABA977B4F5287876E50FF562" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_4206EBADABA977B4F5287876E50FF562" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_E91A523A3BB37A4A4F907876E50FE008" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_301A74287860EDF50CBB7876E50E03FC" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_E91A523A3BB37A4A4F907876E50FE008" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_C25A32A653EB619D50C7CCD3701DD19F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_01440F52678A7A137DBACCD3701D1C08" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_C25A32A653EB619D50C7CCD3701DD19F" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_01440F52678A7A137DBACCD3701D1C08" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_2A784CEE5948B2E702E8EC8A3CEA6C3C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E477982F5E03FF942CBFEC8A3CEA2819" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2A784CEE5948B2E702E8EC8A3CEA6C3C" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E477982F5E03FF942CBFEC8A3CEA2819" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_3788931D4369B076CF31EC8A3CEAAF4E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E477982F5E03FF942CBFEC8A3CEA2819" xlink:to="loc_srt_StatementGeographicalAxis_3788931D4369B076CF31EC8A3CEAAF4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_B82BDF64DBB151D81152EC8A3CEB5DC5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_3788931D4369B076CF31EC8A3CEAAF4E" xlink:to="loc_srt_SegmentGeographicalDomain_B82BDF64DBB151D81152EC8A3CEB5DC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_7717C3F96FB4F06960A2EC8A3CEB138C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_B82BDF64DBB151D81152EC8A3CEB5DC5" xlink:to="loc_country_US_7717C3F96FB4F06960A2EC8A3CEB138C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_38FCA506FC9E8259DC8CEC8A3CEBF7DD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_B82BDF64DBB151D81152EC8A3CEB5DC5" xlink:to="loc_us-gaap_NonUsMember_38FCA506FC9E8259DC8CEC8A3CEBF7DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_12364E9279ECE50452ECEC8A3CEB1237" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E477982F5E03FF942CBFEC8A3CEA2819" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_12364E9279ECE50452ECEC8A3CEB1237" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_B14A6072F605826A479EEC8A3CEC5073" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_12364E9279ECE50452ECEC8A3CEB1237" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_B14A6072F605826A479EEC8A3CEC5073" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeographicConcentrationRiskMember" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_ED9521750C10DD56F1CEEC8A3CECD7C7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_B14A6072F605826A479EEC8A3CEC5073" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_ED9521750C10DD56F1CEEC8A3CECD7C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_A706FD74D86C993D9C22EC8A3CEC5E3E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_B14A6072F605826A479EEC8A3CEC5073" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_A706FD74D86C993D9C22EC8A3CEC5E3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_0D6B099A4D189A6DDDB7EC8A3CEC886D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E477982F5E03FF942CBFEC8A3CEA2819" xlink:to="loc_srt_ProductOrServiceAxis_0D6B099A4D189A6DDDB7EC8A3CEC886D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_4E7FE348D04427158959EC8A3CED0AE5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0D6B099A4D189A6DDDB7EC8A3CEC886D" xlink:to="loc_srt_ProductsAndServicesDomain_4E7FE348D04427158959EC8A3CED0AE5" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BiothraxMember" xlink:label="loc_ebs_BiothraxMember_F8CA7E5AA757A5E64EC2EC8A3CED7BA3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4E7FE348D04427158959EC8A3CED0AE5" xlink:to="loc_ebs_BiothraxMember_F8CA7E5AA757A5E64EC2EC8A3CED7BA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5ABC7B40FC6D9ED2D506EC8A3CEDE788" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E477982F5E03FF942CBFEC8A3CEA2819" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5ABC7B40FC6D9ED2D506EC8A3CEDE788" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F340E08BD4FAE8A9CF2FEC8A3CED933F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5ABC7B40FC6D9ED2D506EC8A3CEDE788" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F340E08BD4FAE8A9CF2FEC8A3CED933F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_8E8CD938E63F517B2A60EC8A3CEE8FAF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_F340E08BD4FAE8A9CF2FEC8A3CED933F" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_8E8CD938E63F517B2A60EC8A3CEE8FAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_AC93C6B7A0BAD7F089BDEC8A3CEE1ED0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E477982F5E03FF942CBFEC8A3CEA2819" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_AC93C6B7A0BAD7F089BDEC8A3CEE1ED0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_4030646812828980E1C1EC8A3CEE9708" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_AC93C6B7A0BAD7F089BDEC8A3CEE1ED0" xlink:to="loc_us-gaap_NumberOfReportableSegments_4030646812828980E1C1EC8A3CEE9708" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_7D07F52E57D3F376DE6BEC8A3CEE392D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_AC93C6B7A0BAD7F089BDEC8A3CEE1ED0" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_7D07F52E57D3F376DE6BEC8A3CEE392D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaap_NoncurrentAssets_C7EBC766E6A19D9ED181EC8A3CEF7E62" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_AC93C6B7A0BAD7F089BDEC8A3CEE1ED0" xlink:to="loc_us-gaap_NoncurrentAssets_C7EBC766E6A19D9ED181EC8A3CEF7E62" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_482A769F67F329646AF0EC8A3CE36AA5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_482A769F67F329646AF0EC8A3CE36AA5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0B20F11B85071302C10AEC8A3CE425A5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0B20F11B85071302C10AEC8A3CE425A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_200DD88A6C70EB046423EC8A3CE4C116" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0B20F11B85071302C10AEC8A3CE425A5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_200DD88A6C70EB046423EC8A3CE4C116" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesRevenueProductLineMember" xlink:label="loc_us-gaap_SalesRevenueProductLineMember_EB5B00912AE7BFD1F1A0EC8A3CE46816" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_200DD88A6C70EB046423EC8A3CE4C116" xlink:to="loc_us-gaap_SalesRevenueProductLineMember_EB5B00912AE7BFD1F1A0EC8A3CE46816" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_530E8BEDD12B99B5F604EC8A3CE516CD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C" xlink:to="loc_srt_ProductOrServiceAxis_530E8BEDD12B99B5F604EC8A3CE516CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_530E8BEDD12B99B5F604EC8A3CE516CD" xlink:to="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BiothraxMember" xlink:label="loc_ebs_BiothraxMember_E0472900E9212DCC3E27EC8A3CE5926F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:to="loc_ebs_BiothraxMember_E0472900E9212DCC3E27EC8A3CE5926F" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ACAM2000Member" xlink:label="loc_ebs_ACAM2000Member_20E1FB2F441874566B25EC8A3CE52717" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:to="loc_ebs_ACAM2000Member_20E1FB2F441874566B25EC8A3CE52717" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NARCANNasalSprayMember" xlink:label="loc_ebs_NARCANNasalSprayMember_9777E8818F83C2D31D26ECAD58F8F470" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:to="loc_ebs_NARCANNasalSprayMember_9777E8818F83C2D31D26ECAD58F8F470" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_OtherMember" xlink:label="loc_ebs_OtherMember_E6B1CF851568DCE60D8CEC8A3CE50D54" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_C1AB9CC2C2E5ABE480C4EC8A3CE54F66" xlink:to="loc_ebs_OtherMember_E6B1CF851568DCE60D8CEC8A3CE50D54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_EE1EB9443DB470E03178EC8A3CE65168" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_E8FCA8FD5C03483363F6EC8A3CE3E20C" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_EE1EB9443DB470E03178EC8A3CE65168" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_116177BC5EC727E5D1AFEC8A3CE6B8DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_EE1EB9443DB470E03178EC8A3CE65168" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_116177BC5EC727E5D1AFEC8A3CE6B8DF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_0BA3E709E2EA5D625E32997672138D25" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_12A135C52B152B08085D997672130417" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0BA3E709E2EA5D625E32997672138D25" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_12A135C52B152B08085D997672130417" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_73CC894F38002F8760F4F5EBD6EEC274" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7AB59E573242C5433656F5EBD6EF4591" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_73CC894F38002F8760F4F5EBD6EEC274" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7AB59E573242C5433656F5EBD6EF4591" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_A662FEDBD1893A594532688F60150CA8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_D1C07F90B51F07F01F53688F601593FB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_A662FEDBD1893A594532688F60150CA8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_D1C07F90B51F07F01F53688F601593FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8BAC98384EBB4C4C21EE688F6015BDB2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_D1C07F90B51F07F01F53688F601593FB" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8BAC98384EBB4C4C21EE688F6015BDB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_F9FC0E704FF99773340D688F6015B7B0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8BAC98384EBB4C4C21EE688F6015BDB2" xlink:to="loc_us-gaap_EquityComponentDomain_F9FC0E704FF99773340D688F6015B7B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_F9FC0E704FF99773340D688F6015B7B0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_54E6B224DB28B426FA7E688F6015F575" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_54E6B224DB28B426FA7E688F6015F575" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_6735A278CCDF57505FC4688F60155497" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_6735A278CCDF57505FC4688F60155497" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_B3C605000BF6406D2355688F60152747" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_B3C605000BF6406D2355688F60152747" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_DC2669E6DEFC60BA42A3688F601590FD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_822F8984219991882370688F6015380C" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_DC2669E6DEFC60BA42A3688F601590FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C515D1F65F269428CF2688F6015CF91" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_D1C07F90B51F07F01F53688F601593FB" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C515D1F65F269428CF2688F6015CF91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0C515D1F65F269428CF2688F6015CF91" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_2B3B22343D2DC3E0B6EF688F6015D717" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:to="loc_us-gaap_StockholdersEquity_2B3B22343D2DC3E0B6EF688F6015D717" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_B5FE454C0E04E9A4B239688F601586B6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_B5FE454C0E04E9A4B239688F601586B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_748F8F240388CAEC1BE1688F601565D1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_748F8F240388CAEC1BE1688F601565D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_968898B764B12C5C1DBF688F6025F153" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_968898B764B12C5C1DBF688F6025F153" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_BC4701E48D3DB4FADD7B688F60256277" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_6B070B8FD01C0AEB8E29689219BE12DF" xlink:to="loc_us-gaap_StockholdersEquity_BC4701E48D3DB4FADD7B688F60256277" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_C4C9C0A2B380FA223917556D6037FF84" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_878EC97F40F5F7A6A243556D6037ADC9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_C4C9C0A2B380FA223917556D6037FF84" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_878EC97F40F5F7A6A243556D6037ADC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_9FF8C879B7CA6D21840B556D6037CE52" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_878EC97F40F5F7A6A243556D6037ADC9" xlink:to="loc_us-gaap_AwardTypeAxis_9FF8C879B7CA6D21840B556D6037CE52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9D026CD5DA4FD653639A556D60370114" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9FF8C879B7CA6D21840B556D6037CE52" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9D026CD5DA4FD653639A556D60370114" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_EFDB12455CB08F2A456F556D603785BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9D026CD5DA4FD653639A556D60370114" xlink:to="loc_us-gaap_EmployeeStockOptionMember_EFDB12455CB08F2A456F556D603785BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_878EC97F40F5F7A6A243556D6037ADC9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2360AF33ECC6539E0C38556D60377F6A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2360AF33ECC6539E0C38556D60377F6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0D34DF7C57D853E23788556D6037EA66" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0D34DF7C57D853E23788556D6037EA66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_F0B8F7B606CF3505C92F556D60372950" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_F0B8F7B606CF3505C92F556D60372950" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7EFB26CAAF62C2FDE6EB556D6037EF5F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7EFB26CAAF62C2FDE6EB556D6037EF5F" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_CommonStockNumberofVotesPerCommonShare" xlink:label="loc_ebs_CommonStockNumberofVotesPerCommonShare_C367597176DBBBB9D300556D603733BB" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_ebs_CommonStockNumberofVotesPerCommonShare_C367597176DBBBB9D300556D603733BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_E33FB26D740A196927D8556D6037256E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_E33FB26D740A196927D8556D6037256E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D57A5A1A96253D5CA107556D60370B35" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_D57A5A1A96253D5CA107556D60370B35" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum" xlink:label="loc_ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum_C348C987BA21759ED43E556D60379DBA" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum_C348C987BA21759ED43E556D60379DBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0411A5B1D831A02831A8556D60374E3A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0411A5B1D831A02831A8556D60374E3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_BF7E0567434C146903D5556D60370C55" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_BF7E0567434C146903D5556D60370C55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_BC9B3B23EE096623804B556D6037EEB7" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_BC9B3B23EE096623804B556D6037EEB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_C2065170B35E5C3EA3CE556D6037940C" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_C2065170B35E5C3EA3CE556D6037940C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_C66044ADA297E36C3DEB556D603715E5" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_C66044ADA297E36C3DEB556D603715E5" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue" xlink:label="loc_ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue_3B5487ECBEA212B633D2556D6037A54F" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue_3B5487ECBEA212B633D2556D6037A54F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_F9789D8D71473B2F5D78556D603753D8" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_F9789D8D71473B2F5D78556D603753D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_B4CD8282C87AA52DB0BF556D60378F2C" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_35555450960E340573AF556D603738F6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_B4CD8282C87AA52DB0BF556D60378F2C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_2CFDDEA57409B828A470CDFBFC0B2194" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D936911A70AE094F5E73CDFBFC0B309B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_2CFDDEA57409B828A470CDFBFC0B2194" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D936911A70AE094F5E73CDFBFC0B309B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_BCC6F4970E25C48B0129CDFBFC0C73DA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D936911A70AE094F5E73CDFBFC0B309B" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_BCC6F4970E25C48B0129CDFBFC0C73DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_BCC6F4970E25C48B0129CDFBFC0C73DA" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_7C69213A726BD4B05640CDFBFC0D7B1C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7" xlink:to="loc_us-gaap_CostOfSalesMember_7C69213A726BD4B05640CDFBFC0D7B1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_AE05AE760D68973273FECDFBFC0DDBD5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_AE05AE760D68973273FECDFBFC0DDBD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_CA7C97D59559A82C517BCDFBFC0DA2C2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_93B7400709D3A6C4D6FACDFBFC0C7AE7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_CA7C97D59559A82C517BCDFBFC0DA2C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0733146079A4CC702E44CDFBFC0E4E72" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_D936911A70AE094F5E73CDFBFC0B309B" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0733146079A4CC702E44CDFBFC0E4E72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_209F8AAB0E4367EABB05CDFBFC0E4AA4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0733146079A4CC702E44CDFBFC0E4E72" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_209F8AAB0E4367EABB05CDFBFC0E4AA4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_E8C12C8601AAD9A78828CDFBFC1B1631" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4D557A8A08A4496FE84BCDFBFC1CE974" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_E8C12C8601AAD9A78828CDFBFC1B1631" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4D557A8A08A4496FE84BCDFBFC1CE974" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_A51D679007992EDF7AB6CDFBFC1CD61C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4D557A8A08A4496FE84BCDFBFC1CE974" xlink:to="loc_us-gaap_PlanNameAxis_A51D679007992EDF7AB6CDFBFC1CD61C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_825455FFE3CEEC77FA87CDFBFC1CD2FA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_A51D679007992EDF7AB6CDFBFC1CD61C" xlink:to="loc_us-gaap_PlanNameDomain_825455FFE3CEEC77FA87CDFBFC1CD2FA" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember" xlink:label="loc_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember_D9B08F49B7C8677794A6CDFBFC1D2D41" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_825455FFE3CEEC77FA87CDFBFC1CD2FA" xlink:to="loc_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember_D9B08F49B7C8677794A6CDFBFC1D2D41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_878BDAEBB11E2FFE1944CDFBFC1D903B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4D557A8A08A4496FE84BCDFBFC1CE974" xlink:to="loc_us-gaap_AwardTypeAxis_878BDAEBB11E2FFE1944CDFBFC1D903B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1567EC3B370B993DA805CDFBFC1D1547" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_878BDAEBB11E2FFE1944CDFBFC1D903B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1567EC3B370B993DA805CDFBFC1D1547" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_BDAECCA876A09A75F2DFCDFBFC1E89AE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1567EC3B370B993DA805CDFBFC1D1547" xlink:to="loc_us-gaap_PerformanceSharesMember_BDAECCA876A09A75F2DFCDFBFC1E89AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_49819F1C35801956B9E4CDFBFC1E92ED" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1567EC3B370B993DA805CDFBFC1D1547" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_49819F1C35801956B9E4CDFBFC1E92ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4D557A8A08A4496FE84BCDFBFC1CE974" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_B63A947CFE919922B768CDFBFC1F8C46" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_B63A947CFE919922B768CDFBFC1F8C46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_A987CE0DD319789674D9CDFBFC2025CC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_A987CE0DD319789674D9CDFBFC2025CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6B831C794909F0BFF2F8CDFBFC20F014" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6B831C794909F0BFF2F8CDFBFC20F014" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_987742821D4D9E6EE296CDFBFC2038AE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_987742821D4D9E6EE296CDFBFC2038AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_203FD0C1A3DBD349A7B9CDFBFC204CA1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_AE200973AB48EEFF4ED0CDFBFC1F2334" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_203FD0C1A3DBD349A7B9CDFBFC204CA1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4F4F70474BEE07CA3369CDFBFC205B4D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4F4F70474BEE07CA3369CDFBFC205B4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4E8523F18F04E66A200FCDFBFC218DF9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4E8523F18F04E66A200FCDFBFC218DF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_25A696A84BC16A308297CDFBFC2156CD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_25A696A84BC16A308297CDFBFC2156CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_C1DB69C49F3835363182CDFBFC22BF36" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_C1DB69C49F3835363182CDFBFC22BF36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_21E8FEF6F12845520E5ACDFBFC221243" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_21E8FEF6F12845520E5ACDFBFC221243" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_EF1582B172B5973F678CCDFBFC223B56" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_285B470B7FC009292680CDFBFC2135EC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_EF1582B172B5973F678CCDFBFC223B56" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_778A70C591D1EE8196AFCDFBFC228F02" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_778A70C591D1EE8196AFCDFBFC228F02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8806F1B2A65D960F979CCDFBFC2220C2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8806F1B2A65D960F979CCDFBFC2220C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F6B08BE840F18787657FCDFBFC2230B5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8806F1B2A65D960F979CCDFBFC2220C2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F6B08BE840F18787657FCDFBFC2230B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_FA8AC59131D892E3CD54CDFBFC23A8D6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8806F1B2A65D960F979CCDFBFC2220C2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_FA8AC59131D892E3CD54CDFBFC23A8D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5EA17F10F5A310333B34CDFBFC249824" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5EA17F10F5A310333B34CDFBFC249824" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76FBCD32D2B296A8BDEECDFBFC24ADEC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76FBCD32D2B296A8BDEECDFBFC24ADEC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20AD2DDE3606284D4E8BCDFBFC245CD6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20AD2DDE3606284D4E8BCDFBFC245CD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_F1394F46A2C1DFB6F430CDFBFC24C222" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_F1394F46A2C1DFB6F430CDFBFC24C222" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_DF28FA40323733200FC9CDFBFC24CE4C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_178F1DF11D120F86F786CDFBFC23B107" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_DF28FA40323733200FC9CDFBFC24CE4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_BC04FB706EC8C7DEBE84CDFBFC252524" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_BC04FB706EC8C7DEBE84CDFBFC252524" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_DE51418A3D823A9E969ECDFBFC259363" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_DE51418A3D823A9E969ECDFBFC259363" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_DCBD9E80F2F00460F69CCDFBFC26CB45" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_DCBD9E80F2F00460F69CCDFBFC26CB45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_A15971922AEC8BF07B4DCDFBFC26FD89" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_A15971922AEC8BF07B4DCDFBFC26FD89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_E7F1B125A0D56604C9BDCDFBFC26D317" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3E0472181A796092FE64CDFBFC25FA58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_E7F1B125A0D56604C9BDCDFBFC26D317" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_38CA1F854B8387ECF8C3CDFBFC266018" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_BD4E1478215668A3EB11CDFBFC1E90D6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_38CA1F854B8387ECF8C3CDFBFC266018" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_937841E4F4D895AE0424CDFBFC26B344" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_38CA1F854B8387ECF8C3CDFBFC266018" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_937841E4F4D895AE0424CDFBFC26B344" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_BB615A7EB678FA68179D9A28D003FF11" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C64B12E6DBFE466332EB9976738A7E84" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_BB615A7EB678FA68179D9A28D003FF11" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C64B12E6DBFE466332EB9976738A7E84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_11FB6A18102F8E47269F9976738A0F2C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C64B12E6DBFE466332EB9976738A7E84" xlink:to="loc_srt_RangeAxis_11FB6A18102F8E47269F9976738A0F2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_BEB01EFDCE7B9C29F6C89976738B0684" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_11FB6A18102F8E47269F9976738A0F2C" xlink:to="loc_srt_RangeMember_BEB01EFDCE7B9C29F6C89976738B0684" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_86B023A014AF613BF56B9976738B4601" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_BEB01EFDCE7B9C29F6C89976738B0684" xlink:to="loc_srt_MinimumMember_86B023A014AF613BF56B9976738B4601" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_0D2D79375EE6618F5DF79976738B8F07" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_BEB01EFDCE7B9C29F6C89976738B0684" xlink:to="loc_srt_MaximumMember_0D2D79375EE6618F5DF79976738B8F07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_FE45FF1E1DCECB8A05E49976738B3E17" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C64B12E6DBFE466332EB9976738A7E84" xlink:to="loc_us-gaap_AwardTypeAxis_FE45FF1E1DCECB8A05E49976738B3E17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8A7B6A00B086F6710F8F9976738CC027" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_FE45FF1E1DCECB8A05E49976738B3E17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8A7B6A00B086F6710F8F9976738CC027" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_B566C61FA1F472C9C4EC9976738CB817" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8A7B6A00B086F6710F8F9976738CC027" xlink:to="loc_us-gaap_EmployeeStockOptionMember_B566C61FA1F472C9C4EC9976738CB817" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E6712348DCEDCBFA00A9976738CD3B6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C64B12E6DBFE466332EB9976738A7E84" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E6712348DCEDCBFA00A9976738CD3B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4EC50BEAF4660B0D36569976738C75BA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E6712348DCEDCBFA00A9976738CD3B6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4EC50BEAF4660B0D36569976738C75BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_03BB53C8DAA2C1AD6DD09976738DC955" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E6712348DCEDCBFA00A9976738CD3B6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_03BB53C8DAA2C1AD6DD09976738DC955" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_DC858FCCA6BB8AAFD09F9976738DDFF7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E6712348DCEDCBFA00A9976738CD3B6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_DC858FCCA6BB8AAFD09F9976738DDFF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_548BB91D6D8DF2A931169976738D6A4C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3E6712348DCEDCBFA00A9976738CD3B6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_548BB91D6D8DF2A931169976738D6A4C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_73A9C75B9BC405AD21255F9BB607B7A6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_363CC20EA691FEDEE4915F9BB60738F3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_73A9C75B9BC405AD21255F9BB607B7A6" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_363CC20EA691FEDEE4915F9BB60738F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_C17D8A88C93F5ED992105F9BB6078428" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_73A9C75B9BC405AD21255F9BB607B7A6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_C17D8A88C93F5ED992105F9BB6078428" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_CC511C957A54B55367055F9BB60806B8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_73A9C75B9BC405AD21255F9BB607B7A6" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_CC511C957A54B55367055F9BB60806B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_55E2C194B6D43DF073755F9BB60891A5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_73A9C75B9BC405AD21255F9BB607B7A6" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_55E2C194B6D43DF073755F9BB60891A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_B128FBCB661B0616C3BF5FB505706B2E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_73A9C75B9BC405AD21255F9BB607B7A6" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_B128FBCB661B0616C3BF5FB505706B2E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3A0E9BA5A0CFD04405A1CCD36E410AAB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_E0FFF4D9138FAE405AD2CCD36E418774" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3A0E9BA5A0CFD04405A1CCD36E410AAB" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_E0FFF4D9138FAE405AD2CCD36E418774" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_C83F9EB63705BEF44BAAECB14920ABB0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_62CA95C82835A7CFAEC6ECB14920B790" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_C83F9EB63705BEF44BAAECB14920ABB0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_62CA95C82835A7CFAEC6ECB14920B790" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_EA8EF403B78AC83B21C2ECB149212B18" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_62CA95C82835A7CFAEC6ECB14920B790" xlink:to="loc_us-gaap_PlanNameAxis_EA8EF403B78AC83B21C2ECB149212B18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_A808052F44AE0B4622D7ECB1492171FD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_EA8EF403B78AC83B21C2ECB149212B18" xlink:to="loc_us-gaap_PlanNameDomain_A808052F44AE0B4622D7ECB1492171FD" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_EmergentPlansMember" xlink:label="loc_ebs_EmergentPlansMember_1EDC5134F427931A54A5ECB14921B885" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_A808052F44AE0B4622D7ECB1492171FD" xlink:to="loc_ebs_EmergentPlansMember_1EDC5134F427931A54A5ECB14921B885" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_370E041618C456B9FD62ECB14922B373" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_62CA95C82835A7CFAEC6ECB14920B790" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_370E041618C456B9FD62ECB14922B373" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberOfStockbasedEmployeeCompensationPlans" xlink:label="loc_ebs_NumberOfStockbasedEmployeeCompensationPlans_D5C9C95E1074CD5C2A50ECB14922E69D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_370E041618C456B9FD62ECB14922B373" xlink:to="loc_ebs_NumberOfStockbasedEmployeeCompensationPlans_D5C9C95E1074CD5C2A50ECB14922E69D" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod" xlink:label="loc_ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod_292FD3CA63820F5B6986ECB14922B268" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_370E041618C456B9FD62ECB14922B373" xlink:to="loc_ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod_292FD3CA63820F5B6986ECB14922B268" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_BCC44989D84B4D8DD7F9B129D6BDF730" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_374D41F9CC79809C4922B156071EB234" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_BCC44989D84B4D8DD7F9B129D6BDF730" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_374D41F9CC79809C4922B156071EB234" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_13EADB5C9B2C1D185845B1567E6D1A22" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_374D41F9CC79809C4922B156071EB234" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_13EADB5C9B2C1D185845B1567E6D1A22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4B57DE2507E0B2960D33B157879DD97B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_13EADB5C9B2C1D185845B1567E6D1A22" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4B57DE2507E0B2960D33B157879DD97B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_FFAAA2B10C95139453BDB15855EA8C2C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4B57DE2507E0B2960D33B157879DD97B" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_FFAAA2B10C95139453BDB15855EA8C2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2DEFB701E2A867497983B156072072E7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_374D41F9CC79809C4922B156071EB234" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2DEFB701E2A867497983B156072072E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_91F55A6E9EEBA0734DA5B129D6BEB75E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2DEFB701E2A867497983B156072072E7" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_91F55A6E9EEBA0734DA5B129D6BEB75E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_C6715A5208ACD47B6C6BA55DF39C4CF5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_B27A6DA26D5D161BE107A55DF39C8C8A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_C6715A5208ACD47B6C6BA55DF39C4CF5" xlink:to="loc_us-gaap_ConcentrationRiskTable_B27A6DA26D5D161BE107A55DF39C8C8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_37527088C001B37C329BA55DF39CC5D3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_B27A6DA26D5D161BE107A55DF39C8C8A" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_37527088C001B37C329BA55DF39CC5D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_E8BC3D7A6ED8AC1D799FA55DF39D5DFA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_37527088C001B37C329BA55DF39CC5D3" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_E8BC3D7A6ED8AC1D799FA55DF39D5DFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_1C41995437496D8194FBA5983629C833" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_E8BC3D7A6ED8AC1D799FA55DF39D5DFA" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_1C41995437496D8194FBA5983629C833" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_6DCF51538578E029E73BA55DF39D1837" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_E8BC3D7A6ED8AC1D799FA55DF39D5DFA" xlink:to="loc_us-gaap_AccountsReceivableMember_6DCF51538578E029E73BA55DF39D1837" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1D72BBC8D1A1F58048D7A55DF39D35E5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_B27A6DA26D5D161BE107A55DF39C8C8A" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1D72BBC8D1A1F58048D7A55DF39D35E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_D07697E3F161187AF60CA55DF39D4CAC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1D72BBC8D1A1F58048D7A55DF39D35E5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_D07697E3F161187AF60CA55DF39D4CAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_A96AB20E6067563A39F4A55DF39ED3FE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_D07697E3F161187AF60CA55DF39D4CAC" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_A96AB20E6067563A39F4A55DF39ED3FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_38956092F485AD537AECA55DF39E752A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_B27A6DA26D5D161BE107A55DF39C8C8A" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_38956092F485AD537AECA55DF39E752A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_4E8363C49B332E278869A55DF39E07D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_38956092F485AD537AECA55DF39E752A" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_4E8363C49B332E278869A55DF39E07D5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5F2557691908C9F4BD99188D8CB69FC6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_78E6381D54E5B8764CA2188D8CB6D013" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5F2557691908C9F4BD99188D8CB69FC6" xlink:to="loc_us-gaap_DebtInstrumentTable_78E6381D54E5B8764CA2188D8CB6D013" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_836F0E12059820E14C1C188D8CB6799F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_78E6381D54E5B8764CA2188D8CB6D013" xlink:to="loc_us-gaap_DebtInstrumentAxis_836F0E12059820E14C1C188D8CB6799F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_255797088B9C1A5A2F8C188D8CB6B6E3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_836F0E12059820E14C1C188D8CB6799F" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_255797088B9C1A5A2F8C188D8CB6B6E3" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ConvertibleSeniorNotesDue2021Member" xlink:label="loc_ebs_ConvertibleSeniorNotesDue2021Member_144FBB8B5A955B9D34EF188D8CB6373F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_255797088B9C1A5A2F8C188D8CB6B6E3" xlink:to="loc_ebs_ConvertibleSeniorNotesDue2021Member_144FBB8B5A955B9D34EF188D8CB6373F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_D725134A6B11B0510BCA188D8CB627EF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_78E6381D54E5B8764CA2188D8CB6D013" xlink:to="loc_us-gaap_DebtInstrumentLineItems_D725134A6B11B0510BCA188D8CB627EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3776747DE54BEDFF2546188D8CB6F59F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D725134A6B11B0510BCA188D8CB627EF" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3776747DE54BEDFF2546188D8CB6F59F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1DED6B5557FD9D774C86188D8CB69D61" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D725134A6B11B0510BCA188D8CB627EF" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1DED6B5557FD9D774C86188D8CB69D61" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_283AF38BB3AEB8467CB19238C5313FAC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80AA8BDC454336CCC90A9238C531F42D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_283AF38BB3AEB8467CB19238C5313FAC" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80AA8BDC454336CCC90A9238C531F42D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7C775D0C53EB299F732C9238C5312C66" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80AA8BDC454336CCC90A9238C531F42D" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7C775D0C53EB299F732C9238C5312C66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_821F449AE0CF960B1DEC9238C531D3BE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7C775D0C53EB299F732C9238C5312C66" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_821F449AE0CF960B1DEC9238C531D3BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaap_BuildingMember_0E5EF1C63822221574349238C5320A19" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_821F449AE0CF960B1DEC9238C531D3BE" xlink:to="loc_us-gaap_BuildingMember_0E5EF1C63822221574349238C5320A19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingImprovementsMember_64BCA18DA4F5A2D6706E9238C53270FF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_821F449AE0CF960B1DEC9238C531D3BE" xlink:to="loc_us-gaap_BuildingImprovementsMember_64BCA18DA4F5A2D6706E9238C53270FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_D93A22FBD9273AA60F869238C532948F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_821F449AE0CF960B1DEC9238C531D3BE" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_D93A22FBD9273AA60F869238C532948F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_B418E0B5B419B5310F809238C5329559" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_821F449AE0CF960B1DEC9238C531D3BE" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_B418E0B5B419B5310F809238C5329559" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_9F2B65F4FE6D25EACEC19238C53308FA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80AA8BDC454336CCC90A9238C531F42D" xlink:to="loc_srt_RangeAxis_9F2B65F4FE6D25EACEC19238C53308FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_27E3CD19FF6A4E656C4A9238C5337D1E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9F2B65F4FE6D25EACEC19238C53308FA" xlink:to="loc_srt_RangeMember_27E3CD19FF6A4E656C4A9238C5337D1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_827A4FD99D37BA050CEC9238C5338442" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_27E3CD19FF6A4E656C4A9238C5337D1E" xlink:to="loc_srt_MinimumMember_827A4FD99D37BA050CEC9238C5338442" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_38C05B56B1910578D6689238C533B8AF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_27E3CD19FF6A4E656C4A9238C5337D1E" xlink:to="loc_srt_MaximumMember_38C05B56B1910578D6689238C533B8AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ED4B6DEBABC7F3E7E0139238C533CE75" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_80AA8BDC454336CCC90A9238C531F42D" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ED4B6DEBABC7F3E7E0139238C533CE75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_FA643E3879B632DBA9AD9238C534D6AF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ED4B6DEBABC7F3E7E0139238C533CE75" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_FA643E3879B632DBA9AD9238C534D6AF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_423B12D64A5A312217D021D7FA8909EC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_423B12D64A5A312217D021D7FA8909EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_FBC209600BD2A472DCA621D7FA8A9350" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_UseOfEstimates_FBC209600BD2A472DCA621D7FA8A9350" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_B896F31AC2254828409121D7FA8A88A4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_B896F31AC2254828409121D7FA8A88A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_33A6369AF214E123AA1221D7FA8A79D4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_33A6369AF214E123AA1221D7FA8A79D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_5D3ECE593C225166354B21D7FA8A8C77" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_5D3ECE593C225166354B21D7FA8A8C77" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ConcentrationsRiskPolicyTextBlock" xlink:label="loc_ebs_ConcentrationsRiskPolicyTextBlock_7070238BE40C4F5C78C921D7FA8A41F0" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_ebs_ConcentrationsRiskPolicyTextBlock_7070238BE40C4F5C78C921D7FA8A41F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_7148B3AA98E9B43BB21B21D7FA8B9BCA" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_7148B3AA98E9B43BB21B21D7FA8B9BCA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_D4E13DEE628418EFD05B21D7FA8B7461" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_D4E13DEE628418EFD05B21D7FA8B7461" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_2E11F13370F89DAB5C7E21D7FA8BCD00" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_2E11F13370F89DAB5C7E21D7FA8BCD00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentPolicy_CAEEAA7F986D8A0C0C1421D7FA8B4B60" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentPolicy_CAEEAA7F986D8A0C0C1421D7FA8B4B60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_89F8E4302AEF1C42117E21D7FA8B5DDC" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_89F8E4302AEF1C42117E21D7FA8B5DDC" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_ContingentConsiderationObligationsPolicyTextBlock" xlink:label="loc_ebs_ContingentConsiderationObligationsPolicyTextBlock_F4B7CD1A08D35FDD1A6221D7FA8B0166" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_ebs_ContingentConsiderationObligationsPolicyTextBlock_F4B7CD1A08D35FDD1A6221D7FA8B0166" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_D62451249F7E05D230E521D7FA8B71CD" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_D62451249F7E05D230E521D7FA8B71CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_07125FFE500BAAFFE59621D7FA8CB0E6" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_07125FFE500BAAFFE59621D7FA8CB0E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_639C476D27378D91BE2721D7FA8CBBA1" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_639C476D27378D91BE2721D7FA8CBBA1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2DBB51D64978622CC15121D7FA8C4CD5" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2DBB51D64978622CC15121D7FA8C4CD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_4AA42DABC4B2E3A322EF21D7FA8C6190" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_4AA42DABC4B2E3A322EF21D7FA8C6190" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3A535DB9F85A0675EA6721D7FA8CB622" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3A535DB9F85A0675EA6721D7FA8CB622" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_B7B929281BDA6906466421D7FA8CA804" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_B7B929281BDA6906466421D7FA8CA804" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_B9ED56B33DC7F0C86B8121D7FA8D0BA0" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_07B2ABFE323CE23A35D521D7FA899AB1" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_B9ED56B33DC7F0C86B8121D7FA8D0BA0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5402294C40D17AD93B67A55DF37CBC91" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5402294C40D17AD93B67A55DF37CBC91" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_BAE2D87B24659FDBBE59A5A57BB60E70" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_BAE2D87B24659FDBBE59A5A57BB60E70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_92B37B80CF0BACF3BA0DA5A57BBA7882" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_BAE2D87B24659FDBBE59A5A57BB60E70" xlink:to="loc_us-gaap_EquityComponentDomain_92B37B80CF0BACF3BA0DA5A57BBA7882" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_538D7B62802D531D0C06A5A5CA047025" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_92B37B80CF0BACF3BA0DA5A57BBA7882" xlink:to="loc_us-gaap_RetainedEarningsMember_538D7B62802D531D0C06A5A5CA047025" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_6AB7C1232E9ADC75F9A5A55DF37D9155" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_6AB7C1232E9ADC75F9A5A55DF37D9155" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_8C3FC0F81597CCAF9302A55DF37D6FAA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_6AB7C1232E9ADC75F9A5A55DF37D9155" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_8C3FC0F81597CCAF9302A55DF37D6FAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_E37C1340C080568D2810A55DF37D36F7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_8C3FC0F81597CCAF9302A55DF37D6FAA" xlink:to="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_E37C1340C080568D2810A55DF37D36F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7E10B2C0414D6B34D5A3A55DF37D3168" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7E10B2C0414D6B34D5A3A55DF37D3168" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7E10B2C0414D6B34D5A3A55DF37D3168" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_A833DC93BB2C8879E7F3A55DF37EE6E2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_A833DC93BB2C8879E7F3A55DF37EE6E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_FDCF61E2170CB2DA893CA55DF37E2F60" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6F5F2C6AD1F4F5046788A55DF37E029B" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_FDCF61E2170CB2DA893CA55DF37E2F60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_87B29D18BB1CE4751BA8A55DF37E2E2E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_87B29D18BB1CE4751BA8A55DF37E2E2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9F227EF453AFDE9DB7AAA55DF37FF296" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_87B29D18BB1CE4751BA8A55DF37E2E2E" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9F227EF453AFDE9DB7AAA55DF37FF296" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_CIADMMember" xlink:label="loc_ebs_CIADMMember_05749AE73651C4ADFBB8A55DF37F7944" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9F227EF453AFDE9DB7AAA55DF37FF296" xlink:to="loc_ebs_CIADMMember_05749AE73651C4ADFBB8A55DF37F7944" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_AA84B97A0370CC9BD792A55DF37CB96E" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_38A117E9A0A72C99D23EA55DF37F8033" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_38A117E9A0A72C99D23EA55DF37F8033" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_B49AC0B090BECFEA0835A55DF37FAB2D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_us-gaap_OperatingLeaseLiability_B49AC0B090BECFEA0835A55DF37FAB2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_518BAFAD0C930EC6FF33A5A512C4AE37" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_518BAFAD0C930EC6FF33A5A512C4AE37" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_BasePeriod" xlink:label="loc_ebs_BasePeriod_524E979B93CDB5DDE356A55DF380E080" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_ebs_BasePeriod_524E979B93CDB5DDE356A55DF380E080" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_TermofContract" xlink:label="loc_ebs_TermofContract_BD16CA57F812937B996DA55DF3801417" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_ebs_TermofContract_BD16CA57F812937B996DA55DF3801417" xlink:type="arc" />
    <link:loc xlink:href="ebs-20191231.xsd#ebs_NumberofAdditionalOptionPeriods" xlink:label="loc_ebs_NumberofAdditionalOptionPeriods_09E0DDEBFA9E0F87E5CFA55DF380564B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_ebs_NumberofAdditionalOptionPeriods_09E0DDEBFA9E0F87E5CFA55DF380564B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_CBFC8D04E76B1AF370BFA55DF3800526" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_us-gaap_ContractWithCustomerLiability_CBFC8D04E76B1AF370BFA55DF3800526" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_642469FF312DA92F9C8EA55DF380B41C" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ABA1F2918AE754614A10A55DF37F1A46" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_642469FF312DA92F9C8EA55DF380B41C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5953214CB05E9BF5C4104FB849714326" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_EA48CDED68A10E7C78C24FB849716315" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5953214CB05E9BF5C4104FB849714326" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_EA48CDED68A10E7C78C24FB849716315" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>chart-8b39ed0292bc17f2549.jpg
<TEXT>
begin 644 chart-8b39ed0292bc17f2549.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $L 2H# 2(  A$! Q$!_\0
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MH_9"_P##)^$?_D.OU'HH _+C_AR7_P $D/\ I'1^R%_X9/PC_P#(='_#DO\
MX)(?](Z/V0O_  R?A'_Y#K]1Z* /RX_X<E_\$D/^D='[(7_AD_"/_P AT?\
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M]MS_ +.[_:3_ /5R^-*_W.I/NC_?C_\ 1BU_AB_\%!/^3]/VW/\ L[O]I/\
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M -7F>'^E_P!"_P#Y-SQ#_P!EGC?_ %2Y$.HHHK^1C^P0HHHH **** "BBB@
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MM]'\0_$K4_A=^TG\/O@_X:^/'B'QU+I^H:_I/@OXT)KOBK4OAOH.G6=Q8?\
M"H$\%?$:_P!+N->\32:?IX!^\E%?@W\$?VBOV]?AG_P4#_9I_96_:&^-_P %
M?VD?$?[07P)^,/QE_:>^$7P;^$UKX.TW]@=O"6E>'=1^&FKZ'X\L]?U+Q3XS
M^%'Q#\9:IK/P;T"Z^,.F6?C'QSKFDIX[\-R:7ID&L>&].\'_ ."L?_!2[X]?
MLI?M)^,_A]:?'B/]F'X6^"/V5=(^-WPL\3>&/V6[/]K.U^,OQ9O/$?C/0]6\
M"?M":K;>)[6Y_9E^&EO?:;X!T;PIXF\0:9X!T#QG+XC\7:T?C;H<7@^[TF
M_I<HKR?X"^,O%7Q%^!WP;\?^.K;P59^-_''PJ^'GB_QE9?#;Q1:^-_AW9^*_
M$OA#1]:\1VG@/QI93W-GXO\ !EMK-[>P^%_%%I/-;:]H:6.JP2RQ72R/ZQ0
M4444 %%%% !1110 R3[H_P!^/_T8M?X8O_!03_D_3]MS_L[O]I/_ -7+XTK_
M '.I/NC_ 'X__1BU_AB_\%!/^3]/VW/^SN_VD_\ U<OC2@#_ %]_^")G_*)'
M_@G1_P!F@_!'_P!0^RK]1J_+G_@B9_RB1_X)T?\ 9H/P1_\ 4/LJ_4:@ HHH
MH X?XF_\DY\>_P#8E^*__4?U&O\ +MC_ -5!_P!>]O\ ^B(Z_P!1+XF_\DY\
M>_\ 8E^*_P#U']1K_+MC_P!5!_U[V_\ Z(CK^]OH6?[EXA_]A7#'_IG/3_/_
M .FY_O7AY_UYXE_]+R,=1117]Q'\'A1110 4444 %%%% !1110!^D7_!(?\
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M_P#U<OC2@#_7W_X(F?\ *)'_ ()T?]F@_!'_ -0^RK]1J_+G_@B9_P HD?\
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M_97_ (1_^GR]K]KZ_%#_ (+\_P#*/C7/^RO_  C_ /3Y>U^(^#?_ "=7P_\
M^RKR7_U.HG[MXR_\FI\0?^R4SC_U$J'\,U%%%?[&G^+04444 %%%% !1110
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MXF_\DY\>_P#8E^*__4?U&O\ +MC_ -5!_P!>]O\ ^B(Z_P!1+XF_\DY\>_\
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M7U^*'_!?G_E'QKG_ &5_X1_^GR]K\1\&_P#DZOA__P!E7DO_ *G43]V\9?\
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M:5_N=2?='^_'_P"C%K_#%_X*"?\ )^G[;G_9W?[2?_JY?&E '^OO_P $3/\
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M_E_HKPAOA;\3](D23PA^T/XU,,;%AI?Q)\+^$/B-8R X"Q2:BEIX7\0K&J@
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M2?\ ZN7QI0!_K[_\$3/^42/_  3H_P"S0?@C_P"H?95^HU?ES_P1,_Y1(_\
M!.C_ +-!^"/_ *A]E7ZC4 %%%% '#_$W_DG/CW_L2_%?_J/ZC7^7;'_JH/\
MKWM__1$=?ZB7Q-_Y)SX]_P"Q+\5_^H_J-?Y=L?\ JH/^O>W_ /1$=?WM]"S_
M '+Q#_["N&/_ $SGI_G_ /3<_P!Z\//^O/$O_I>1CJ***_N(_@\**** "BBB
M@ HHHH **** /TB_X)#_ /*1W]E?_L=O$7_JM/'5?Z$B?<7_ '5_D*_SV_\
M@D/_ ,I'?V5_^QV\1?\ JM/'5?Z$B?<7_=7^0K_.#Z9'_)P^'/\ LC,+_P"K
MS/#_ $O^A?\ \FYXA_[+/&_^J7(AU?BA_P %^?\ E'QKG_97_A'_ .GR]K]K
MZ_%#_@OS_P H^-<_[*_\(_\ T^7M?B/@W_R=7P__ .RKR7_U.HG[MXR_\FI\
M0?\ LE,X_P#42H?PS4445_L:?XM!3S)(R&-I':,C!C9F:,CT*$E".F01@X -
M,HH3:O9VOO;KZ]PWWUM9KR:V?RZ=CCM9^'7P\\1?\C!\/_ NN?.DF=6\'^';
M]B\9B*,7N=.DD./(A'+\K$B'Y% 'YJ^._P#@G1K>K_$74=2\&>,/"^B^ -8U
M:XU%;*^M-236/#5K>SO<3Z5I^G6-DVG:C;V!D>#26.H:>#:I;170B9))&_5N
MBOSOC7PJX%\0*.$I<29)1KRP>*CBZ6)P<YY?C)/EY*E"MBL(Z5:MAJ\$HU:5
M23LTITI4ZJ4U^D<#^+7'OAY6Q=7AG/*U"&-PCPE;#8V$,QP<8\RE3KT<+C%6
MH4<31E=TZL(*ZE*%6-6E*4'C>'-"L?"_A[0/#.F&9M.\.:)I.@V#7#![A[/1
M]/M].MI)W  ::2&V1Y2H"F1FV@+@#9HHK] HT:6'HTL/0A&E1H4J=&C2@K0I
MTJ4%"G3@ND80C&,5T22/SRO6JXFM5Q%>I*K7KU:E:M5F[SJ5:LG.I4F^LISD
MY2?5ML****T,@K^I3_@VC_Y"O[8G_8/^!/\ Z4_%>OY:Z_J4_P"#:/\ Y"O[
M8G_8/^!/_I3\5Z_#?I)?\F5XU_P\/_\ K59&?O7T8_\ D]_!/^+/_P#UE\Z/
MZM****_R9/\ 78**** &2?='^_'_ .C%K_#%_P""@G_)^G[;G_9W?[2?_JY?
M&E?[G4GW1_OQ_P#HQ:_PQ?\ @H)_R?I^VY_V=W^TG_ZN7QI0!_K[_P#!$S_E
M$C_P3H_[-!^"/_J'V5?J-7Y<_P#!$S_E$C_P3H_[-!^"/_J'V5?J-0 4444
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M ,G5\/\ _LJ\E_\ 4ZB?NWC+_P FI\0?^R4SC_U$J'\,U%%%?[&G^+04444
M%%%% !1110 4444 %?U*?\&T?_(5_;$_[!_P)_\ 2GXKU_+77]2G_!M'_P A
M7]L3_L'_  )_]*?BO7X;])+_ ),KQK_AX?\ _6JR,_>OHQ_\GOX)_P 6?_\
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M  7Y_P"4?&N?]E?^$?\ Z?+VOQ'P;_Y.KX?_ /95Y+_ZG43]V\9?^34^(/\
MV2F<?^HE0_AFHHHK_8T_Q:"BBB@ HHHH **** "BBB@ K^I3_@VC_P"0K^V)
M_P!@_P"!/_I3\5Z_EKK^I3_@VC_Y"O[8G_8/^!/_ *4_%>OPWZ27_)E>-?\
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MD=3U5B*^1!_P:S_L)@ #]I'_ (*(@ !0!^T]HX 50  !_P *IZ   >PK^CO
M7QKR;PDH<3T<VR;-,U>>ULHJ4)9=/!P5!9=#,(5%66*K4FW4^NP<.3F2Y)<U
MKQO_ #;X^^"&<>,%;ABIE6=Y9E"R*GFL*ZS&EBZCKO,)9>X.E]5IU+*FL'/G
MY[7<X\M[,_D1HK^N[_B%H_84_P"CD?\ @HE_XD]H_P#\ZFC_ (A:/V%/^CD?
M^"B7_B3VC_\ SJ:_H+_B<W@__HD.)^G_ "^RGRO_ ,QGK]WW_P [?\23\7?]
M%IPST_YA<V\K_P#,/Z_=]_\ (C17]=W_ !"T?L*?]'(_\%$O_$GM'_\ G4T?
M\0M'["G_ $<C_P %$O\ Q)[1_P#YU-'_ !.;P?\ ]$AQ/T_Y?93Y7_YC/7[O
MO/\ B2?B[_HM.&>G_,+FWE?_ )A_7[OO_D1HK^N[_B%H_84_Z.1_X*)?^)/:
M/_\ .IH_XA:/V%/^CD?^"B7_ (D]H_\ \ZFC_B<W@_\ Z)#B?I_R^RGRO_S&
M>OW?>?\ $D_%W_1:<,]/^87-O*__ ##^OW??_(C17]=W_$+1^PI_T<C_ ,%$
MO_$GM'_^=31_Q"T?L*?]'(_\%$O_ !)[1_\ YU-'_$YO!_\ T2'$_3_E]E/E
M?_F,]?N^\_XDGXN_Z+3AGI_S"YMY7_YA_7[OO_D1HK^N[_B%H_84_P"CD?\
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M<9QL[II?LMO3^\O_ 'T/\:_%#_@ORRG_ ()\ZYAE/_%W_A'T(_Z#=[[UL_\
M#G%_^DJ'_!93_P 3D/\ \ZVN"^)'_!![X;_&+PS+X+^+'_!13_@K9\1_"$][
M9:E-X9\8?MGPZSHLNH:;*9]/O9+"Y^%AA>YLIB9;:1@3%)AU^8 CX#@7B'#\
M)\8\-<2XK#UL5ALCSG 9G7P^'=-5ZU+"8B%:=.DZLH4U4FH-1<Y1C=ZL_0^.
M>'J_%G!W$O#6&Q%'"8C/,GQV64<3B%.5"A4Q=&5*-6K&G&51P@Y7DH1<FEHF
MS^(RBOZ[O^(6C]A3_HY'_@HE_P")/:/_ /.IH_XA:/V%/^CD?^"B7_B3VC__
M #J:_N7_ (G-X/\ ^B0XGZ?\OLI\K_\ ,9Z_=]_\'_\ $D_%W_1:<,]/^87-
MO*__ ##^OW??_(C17]=W_$+1^PI_T<C_ ,%$O_$GM'_^=31_Q"T?L*?]'(_\
M%$O_ !)[1_\ YU-'_$YO!_\ T2'$_3_E]E/E?_F,]?N^\_XDGXN_Z+3AGI_S
M"YMY7_YA_7[OO_D1HK^N[_B%H_84_P"CD?\ @HE_XD]H_P#\ZFC_ (A:/V%/
M^CD?^"B7_B3VC_\ SJ:/^)S>#_\ HD.)^G_+[*?*_P#S&>OW?>?\23\7?]%I
MPST_YA<V\K_\P_K]WW_R(T5_7=_Q"T?L*?\ 1R/_  42_P#$GM'_ /G4T?\
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M%P:_>:KX8T"^OG?4-.\*:[%X7\6:OX/U:\T^ST'XA:+X3\37%MX=\5:U\/\
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MK2_'_P"-TLO@NR\9_$GQI\-+Z#X$^%=(^&WAVX\,Z99ZOXX2:^_J>H ****
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MS7[_ ,)ZY<Z0NIZ?JOACQ7ID%I=ZAX6\7^%_$.GZ-XJ\'^)K.RU#3[ZX\/\
MBC1-(U:.PU"POC:&TO;::7^0[X+7^I?$G_@C5^P5^SE;?"/]L3P?\4_V3OVE
M_A5X]^.7Q-\)_LJ_M-Z?\;/V+K9/'O[1'C'PO^T)\%_ >K_#S1+7]H36K>*2
MQ^'?B;1O!=A\6="\!^$OBIJ/B[QSX&U>UTFUTR;]J/\ @C!H7QKM+G]N#Q=\
M5[?XC?$K1OB1^T-X1\8_#_\ ;)^.'P,\3_LP_'+]K/1S\%?!'AZYU/QW\ /%
M5IH,_@K1_@E!H6C?!CP!K>@>!OAQX3\<>&_#O]O:5X(LKTZMJVL '[BT444
M%%%% !1110 4444 ,D^Z/]^/_P!&+7^&+_P4$_Y/T_;<_P"SN_VD_P#U<OC2
MO]SJ3[H_WX__ $8M?X8O_!03_D_3]MS_ +.[_:3_ /5R^-* /]??_@B9_P H
MD?\ @G1_V:#\$?\ U#[*OU&K\N?^")G_ "B1_P""='_9H/P1_P#4/LJ_4:@
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F1>._$>I>*-;32;"2>Z>RTQ-3U6Z6PM'N;A[:U$4+3S%#(P!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>chart-9deb655d727f202e4f8.jpg
<TEXT>
begin 644 chart-9deb655d727f202e4f8.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $L 2H# 2(  A$! Q$!_\0
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MH_9"_P##)^$?_D.OU'HH _+C_AR7_P $D/\ I'1^R%_X9/PC_P#(='_#DO\
MX)(?](Z/V0O_  R?A'_Y#K]1Z* /RX_X<E_\$D/^D='[(7_AD_"/_P AT?\
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M)M<OO"47@#PU*FBS:G& ?O+1110 4444 %%%% !1110 4444 %%%% !1110
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M*_S%?Y;'BS_D:?$W_8R>(?\ T]7]?ZDYZ?BO\Q7^6QXL_P"1I\3?]C)XA_\
M3U?U_<_T*OX_B/\ ]>N$_P#TOB0_@_Z;W^Z^&_\ U^XL_P#2.&SGZ***_O$_
MS_"BBB@ HHHH **** "BBB@!\?\ K(_]]?\ T(5_HT?\$V/^3!_V0O\ LW[X
M:?\ J/6U?YR\?^LC_P!]?_0A7^C1_P $V/\ DP?]D+_LW[X:?^H];5_'7TR_
M^2-X3_[*6K_ZK,2?VG]"G_DL.,/^R:H?^K3"GV[1117^=A_HZ%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 R3[H_P!^/_T8M?X8O_!03_D_3]MS
M_L[O]I/_ -7+XTK_ '.I/NC_ 'X__1BU_AB_\%!/^3]/VW/^SN_VD_\ U<OC
M2@#_ %]_^")G_*)'_@G1_P!F@_!'_P!0^RK]1J_+G_@B9_RB1_X)T?\ 9H/P
M1_\ 4/LJ_4:@ HHHH 0]/Q7^8K_+8\6?\C3XF_[&3Q#_ .GJ_K_4G/3\5_F*
M_P MCQ9_R-/B;_L9/$/_ *>K^O[G^A5_'\1_^O7"?_I?$A_!_P!-[_=?#?\
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M"ZI?:5\3/ACH_P 6_A'\6/#3:'KNCZQ\)_BOX3O+W1-?C\&^)1J]M?\ ]O\
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M_9N_:R^ OPC\8_M'?M-^,?C_ /M"6'@3X6_$[X1?##PMX0\2>$_!'A<? O\
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M_LW7Y\_\/6/^"=W_ $=M\(?_  <:A_\ *NC_ (>L?\$[O^CMOA#_ .#C4/\
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M3]MS_L[O]I/_ -7+XTK_ '.I/NC_ 'X__1BU_AB_\%!/^3]/VW/^SN_VD_\
MU<OC2@#_ %]_^")G_*)'_@G1_P!F@_!'_P!0^RK]1J_+G_@B9_RB1_X)T?\
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M&_\ U^XL_P#2.&SGZ***_O$_S_"BBB@ HHHH **** "BBB@!\?\ K(_]]?\
MT(5_HT?\$V/^3!_V0O\ LW[X:?\ J/6U?YR\?^LC_P!]?_0A7^C1_P $V/\
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MA_\ 3U?U_J3GI^*_S%?Y;'BS_D:?$W_8R>(?_3U?U_<_T*OX_B/_ ->N$_\
MTOB0_@_Z;W^Z^&__ %^XL_\ 2.&SGZ***_O$_P _PHHHH **** "BBB@ HHH
MH ?'_K(_]]?_ $(5_HT?\$V/^3!_V0O^S?OAI_ZCUM7^<O'_ *R/_?7_ -"%
M?Z-'_!-C_DP?]D+_ +-^^&G_ *CUM7\=?3+_ .2-X3_[*6K_ .JS$G]I_0I_
MY+#C#_LFJ'_JTPI]NTC=#]#_ "I:1NA^A_E7^=A_HZ?YQ/\ P48_Y/Q_:_\
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M)]T?[\?_ *,6O\,7_@H)_P GZ?MN?]G=_M)_^KE\:4 ?Z^__  1,_P"42/\
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MF."S'B? U\;.6!RRDL LPP$,7/,H>RPL5AXQS/UF_N[^"2SMM,T.]UN[OFN
M@AN+73]/LDM4B=I-3U.Z\Q;4W+2I#86]O:7UU>2B=E@CMK2ZN8.9L?'=AJ5I
MIE_::9J36UY+/#J7G26$5QH4UOXS/P]EMY[>.YN!JDR>+TET]CIDTELUG"VI
MP7,ZR6UI</NY-;U;2+=-8\%":WN9M135=#M/%=O'K%L^G:VG_"/7EE?V]SHV
MGWMGJ=G:)JE_;+K>FWVFO<VU@Z:@J:C&N'IW@Z_'AS1M#U6SL/,M_$&KQVES
M#/;WE_X(\!W>IW=Y::/IVKM!;RZIK]OHD5GX?MM8BA+6VHW<6N-<75SH-OJU
M]TYMF?$]3,*RR'^T)82IE53%4*>+R7$X:%/'.ID<L#A5/&Y'3]G]9I8G&_6_
MK&-Q-6G*6)PN)P_#W]G5\UH\N3Y7PK2RVA_K!_9RQE/-J>%KU<)GF&Q4ZF 5
M//%C\5*&!SVI[58:IA\$\)]7P.'I3C'#8K#8CB+^TJ&55N_TO4X-7M9+VT23
M[&;R\MK.Y<QF/4K>RG:U;4[,(S$Z=<W45U'8S/M-Y!;K?Q+]DN[5Y-&N-\':
M7K.E6UQ;:L)$2*WT^UB3^T1>65Q>V;ZBESJ.BV0DF_L#0Y].DT6RL-$#6JVH
MTUXTTRQ$?GZAV5?7</XO&X_)\#BLRPU?!X^K2DL7A\11EAJD*U.K.G-JA.%.
MI2I3</:4(34IJA*GS5L0_P!_4^-XBP>!P&=8["99B:&,R^E4@\)B,/7CB:<Z
M%2C3J03Q$)U*=6M!3Y,1.FXP=>-11HX>WU>D4445[!XI_=Y_P0B_Y1T?#7_L
M?/C%_P"K$UFOV,K\<_\ @A%_RCH^&O\ V/GQB_\ 5B:S7[&5_C9XO?\ )T_$
M/_LL>(?_ %9XD_VJ\(/^36^'W_9'\/?^JO"A1117YT?HPR3[H_WX_P#T8M?X
M8O\ P4$_Y/T_;<_[.[_:3_\ 5R^-*_W.I/NC_?C_ /1BU_AB_P#!03_D_3]M
MS_L[O]I/_P!7+XTH _U]_P#@B9_RB1_X)T?]F@_!'_U#[*OU&K\N?^")G_*)
M'_@G1_V:#\$?_4/LJ_4:@ HHHH 0]/Q7^8K_ "V/%G_(T^)O^QD\0_\ IZOZ
M_P!2<]/Q7^8K_+8\6?\ (T^)O^QD\0_^GJ_K^Y_H5?Q_$?\ Z]<)_P#I?$A_
M!_TWO]U\-_\ K]Q9_P"D<-G/T445_>)_G^%%%% 'QK^W%\1?B#\-_A%I^H?#
M^\O=&GUKQ1!HFN^(]-5A?Z-I<FG7EU!':W: MIDFK7L"6G]HJ4EC2)K2&6.6
M]1J^<?V(OC=\=O$]QXRT"^L-;^+>BZ7IUCJ,-UKWB^PTN\\/ZC<W_P!G2W3Q
M#XBBNWO(=4MS<R#1WEDFB>Q:^M?)A6\6;]3-0T[3]7L;K3-6L++5--OH6M[W
M3M2M+>_L;R!B"T-U9W<<UO/&656V2QNH=5< ,JD4- \->&_"=A_97A;P_HGA
MK3/.>X.GZ!I5CI%FUQ( 'G>WL(((I)F4!3+(K2;%5-VU0!^-9SX;<3YGXIY;
MQUA/$#-\IR/!Y=]4J\.X.*FG-8>M0E"C3QGUO*9X?%5:D,9B)8S+,35C7IVI
M)26'K83]KR7Q.X5ROPHS+@+%^'F3YMGV,S/ZY2XDQDG!^S>)P]>,ZU3!_5,W
MAB,+2I3P6'C@\TPU&5"I>JW%XFAB^&/B[XJ#_FB1/7@?%SP1DX&<#-@!D]!D
M@9/) R0O_"<_$+O\"/%8/I_PL#X5G'X_\).,_7 SZ"O4Z*_1_P"Q\Q_Z*WB'
MIOA>$/+^7A2/;^M;_FG]LY;_ -$APXO3%<8_^W<6R_"WG<\L_P"$X^(7_1"?
M%?\ X7_PJ_\ FHH_X3CXA?\ 1"?%?_A?_"K_ .:BO4Z*/['S'_HK.(/_  EX
M2\O^J6\OQ?<7]LY;_P!$CP[_ .%7%_\ ]%?E^?=GEJ^//'T;(\OP)\:>6'7=
M]C\:_"J]N ">#':GQ?;"7!QN!GCVKELMMVG^]+]@#]K7X]:#^Q/^RUHVE_\
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M6\N:;2]9U33)9$86>H7*#S#\F?\ "RM8_P"B+?&G_P $?@G_ .>#7Z2?\%&
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M?&+_ -6)K-?L97^-GB]_R=/Q#_[+'B'_ -6>)/\ :KP@_P"36^'W_9'\/?\
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M /G4T?\ $YO!_P#T2'$_3_E]E/E?_F,]?N^\_P"))^+O^BTX9Z?\PN;>5_\
MF']?N^_^1&BOZ[O^(6C]A3_HY'_@HE_XD]H__P ZFC_B%H_84_Z.1_X*)?\
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M/<YS:EQAPY1I9GFF/Q].C4PV:.I2IXO%5*\:<W'#N+G"-1QDXMQ<HW3:M?\
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M))^+O^BTX9Z?\PN;>5_^8?U^[[_Y$:*_KN_XA:/V%/\ HY'_ (*)?^)/:/\
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M+*3P_IVH)>6K3?:38VMD9&#D8SD8Y&.^1QCOTK^57_@H!\;?@M\=_C#\:O\
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M;/C'K7Q-\;?L2?LY>+/VL!X0\?\ _!3+X;_M=Z=\/?%_[#>I>'/!/P[FU?\
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M^DC@?D& 'X"G44 )@9S_ %..N<XZ9SSG&:6BB@ HHHH **** "BBB@ HHHH
M**** &E 3DEOP=U'Y!@/THVJ>HSQCDGD $8;GYAR>&SR2>M.HH :4!.26_!W
M4?D& _2C8OH??D_-QCYN?FXX^;.:=10 4444 %%%% !1110 4444 ,D^Z/\
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M?\1CG_!6_P#Z%_\ 9"_\,OXN_P#GL4 ?ZH=%?Y7G_$8Y_P %;_\ H7_V0O\
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M?Y7G_$8Y_P %;_\ H7_V0O\ PR_B[_Y[%'_$8Y_P5O\ ^A?_ &0O_#+^+O\
MY[% '^J'17^5Y_Q&.?\ !6__ *%_]D+_ ,,OXN_^>Q1_Q&.?\%;_ /H7_P!D
M+_PR_B[_ .>Q0!_JAT5_E>?\1CG_  5O_P"A?_9"_P##+^+O_GL4?\1CG_!6
M_P#Z%_\ 9"_\,OXN_P#GL4 ?ZH=%?Y7G_$8Y_P %;_\ H7_V0O\ PR_B[_Y[
M%'_$8Y_P5O\ ^A?_ &0O_#+^+O\ Y[% '^J'17^5Y_Q&.?\ !6__ *%_]D+_
M ,,OXN_^>Q1_Q&.?\%;_ /H7_P!D+_PR_B[_ .>Q0!_JAT5_E>?\1CG_  5O
M_P"A?_9"_P##+^+O_GL4?\1CG_!6_P#Z%_\ 9"_\,OXN_P#GL4 ?ZH=%?Y7G
M_$8Y_P %;_\ H7_V0O\ PR_B[_Y[%'_$8Y_P5O\ ^A?_ &0O_#+^+O\ Y[%
M'^J!)]T?[\?_ *,6O\,7_@H)_P GZ?MN?]G=_M)_^KE\:5^_)_X/&_\ @K<?
M^9?_ &0NH/\ R1;Q=V((Z_%@]Q]1U&#S7\QGQ:^)?B+XT?%7XF?&+Q@FF1>+
M?BQ\0?&?Q+\41Z+:/I^C1^(O'?B/4O%&MII-A)/=/9:8FIZK=+86CW-P]M:B
)*%IYBAD8 __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>chart-72427e25e1fe46f7dc1.jpg
<TEXT>
begin 644 chart-72427e25e1fe46f7dc1.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" )] 40# 2(  A$! Q$!_\0
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M.3/^"2/_ $CH_9!_\,CX/_\ D*C_ (<F?\$D?^D='[(/_AD?!_\ \A5^HU%
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MJMEH/AGX+?MJ> ?CK+\*/B?\3/%7Q+^%'B/Q5\1;;X:_#W2[76-3\'^"-0\
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MJ^-[7XW3_&_X<ZIX*\0?#SX<^&O#OPWUGPUXGAN_!.M_\)IHVCZ1K:V'].B
M@8/=F;TQN8L <=P#@GN<F@!U%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 ?Y7G_  >.?\I;_#__ &:%\%__ %+OBQ11
M_P 'CG_*6_P__P!FA?!?_P!2[XL44 ?W^?\ !$O_ )1(?\$Z/^S0O@G_ .HC
M9U^H]?EQ_P $2_\ E$A_P3H_[-"^"?\ ZB-G7ZCT %%%%  >/T_4XK^=#XV_
M\'!WA3X,?&3XL?"&X_9;\3^(+CX6_$?QI\/)M>@^+&A:;!K4O@[Q!?Z#)JL.
MGS^#+F6RBOWL6N4M)+FXDMUD$3SRLI<_T7'I^*_S%?YL/[='_)ZG[6__ &<K
M\;O_ %8OB&OZ8^C1X=\(^(F>\38+B[+)YGALNRG"8K!TX8_,, Z5>KC'2J3<
M\OQ6%G4YJ:Y>6I*<5NHIZG\P_2>\2.+_  WR'AC'<(9G3RW$YEFV+PN,G4P&
M QZJT*.$C5A!0Q^&Q,*=IMMRIQC)[-M:']$/_$2SX._Z-#\6?^'E\.__ #"T
M?\1+/@[_ *-#\6?^'E\._P#S"U_)K17]A_\ $L7@M_T2=;_Q(>)?+_J;^3^_
MR/XR_P")IO&W_HJL-T_YI[ASR_ZE7D_O9_64?^#ECP<>O[(?BS_P\OAW_P"8
M7\_4<'BFG_@Y7\&-][]D'Q4WU^,GAP_S\"U_)O11_P 2Q>"W_1)UO_$AXE\O
M^IOY/[_(/^)IO&W_ **K#=/^:>X<\O\ J5>3^]G]8@_X.4? ZRO,O['OB<32
MQQ0R2CXP^&A))%"TKPQ.X\";GCB>>9HT8E8VFE9 #(Y:0?\ !RMX,4Y7]D'Q
M4IZ9'QC\. X]./ M?R;T4?\ $L7@M_T2=;_Q(>)?+_J;^3^_R#_B:;QM_P"B
MJPW3_FGN'/+_ *E7D_O9_62/^#ECP:.G[(?BL=^/C)X=')ZG_D1>]'_$2QX-
MQC_AD+Q7C.<?\+D\.8SG.<?\(+USS]:_DVHH_P")8O!;_HDZW_B0\2^7_4W\
MG]_D'_$TWC;_ -%5ANG_ #3W#GE_U*O)_>S^LG_B)8\&YS_PR'XKR. ?^%R>
M'<@'J,_\(+2_\1+/@[_HT/Q9_P"'E\.__,+7\FM%'_$L7@M_T2=;_P 2'B7R
M_P"IOY/[_(/^)IO&W_HJL-T_YI[ASR_ZE7D_O9_65_Q$L^#O^C0_%G_AY?#O
M_P PM*O_  <L>#F8#_AD3Q9R0/\ DLOAT]3C_H1:_DTI\?\ K(_]]?\ T(4?
M\2Q>"W_1)UO_ !(>)?+_ *F_D_O\AKZ4WC:VE_K7AMTO^2=X<\O^I5Y/[V?Z
M6_[(_P"T-:_M6_LZ?"_]H.Q\*W/@FU^)FCZCJT/A:\U>#7KG1QI_B'6= :"7
M5K:QTV"],KZ0UR)([*W"+.L10M&SM]'5^:7_  1Y_P"4;/[*W_8G>)?_ %8_
MC6OTMK_,KC7+L'D_&7%N49?2=# 97Q-GV78&BZE2JZ.#P.:XO#8:DZM:4ZM1
MTZ-*$'4JSG4G;FG*4FV_]1."LQQF<<&\)9OF%55\?FG#.0YCCJRITZ2K8S'9
M5A,5B:JI4HPI4U4K59S5.E"%."?+",8I)%%%%?,GTP4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!_E>?\ !XY_REO\/_\ 9H7P7_\ 4N^+
M%%'_  >.?\I;_#__ &:%\%__ %+OBQ10!_?Y_P $2_\ E$A_P3H_[-"^"?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_E>?\'CG_*6_P_\
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M^?\ !$O_ )1(?\$Z/^S0O@G_ .HC9U^H]?EQ_P $2_\ E$A_P3H_[-"^"?\
MZB-G7ZCT %%%% "'I^*_S%?YL/[='_)ZG[6__9ROQN_]6+XAK_2>/3\5_F*_
MS8?VZ/\ D]3]K?\ [.5^-W_JQ?$-?V=]#'_DI^-/^Q#@/_5@S^)_IL?\DMP5
M_P!C[,/_ %7P/E:BBBO]"C_.<**** "BBB@ HHHH **** "GQ_ZR/_?7_P!"
M%,I\?^LC_P!]?_0A0..Z]5^9_H,?\$>?^4;/[*W_ &)WB7_U8_C6OTMK\TO^
M"//_ "C9_96_[$[Q+_ZL?QK7Z6U_BWXD?\G$X]_[+3BG_P!7F./]N_#?_DW?
M 7_9%\+?^J/ A1117Q9]H%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 ?Y7G_!XY_REO\/_ /9H7P7_ /4N^+%%'_!XY_REO\/_ /9H7P7_
M /4N^+%% ']_G_!$O_E$A_P3H_[-"^"?_J(V=?J/7Y<?\$2_^42'_!.C_LT+
MX)_^HC9U^H] !1110 AZ?BO\Q7^;#^W1_P GJ?M;_P#9ROQN_P#5B^(:_P!)
MX]/Q7^8K_-A_;H_Y/4_:W_[.5^-W_JQ?$-?V=]#'_DI^-/\ L0X#_P!6#/XG
M^FQ_R2W!7_8^S#_U7P/E:BBBO]"C_.<*. "6(55#,S,<*JJ"S,Q[*J@LQ[ $
MT4A+*K,BAI%5FC4OY8>0*2B-*$D,2LX56E$<AC4EQ'(5",I-J,FMTFU[KEJE
MI[L6I2_PQ:;V33944G**>SDD_>4-&U?WY)QC_BDFH[M-(Y7_ (330TC:2Z36
M; O;V%Y80ZAHE[:7>MV>J:E8Z/IUQH=HP>XOC>:MJ>G:?':2QVFI03ZA8-?6
M-G;W<,[66\36:(D9T_7SJSWLFG?\(TNDLWB5+V"QM]4N89-.%R+=4MM,N[74
M);H:@UD;:ZMEAN9KJY@MI>'B\/\ C7Q#;:TGC31?"L%YJ]II]K>2V/BK4]7T
M^^T>#5H;[4?!<%NWA31[S0M&U.'SWNO$$-SJ>OW6H^3>W"8CLX--T-&\)ZQH
M#V>IZ;#I$<UC>ZS+9^$YM:U:[TJTT_Q%9Z'_ &Q:1>*KW2[K6'NI->T2'7HY
M)M,FMHHI[S2+816\L,T'YE3SKC>>(PR67<V7U:>%=;$SRG&X?,,-2J9E7IX_
M$SRZ;G2G6PN6PHUL/AJ&+Q&)>)J0H4<NSBA4JX["?J<\CX$A0Q#>8I9A2J8G
MV&&AG&"Q.78JK#+,/4R_"PS&GRU8T<7F<ZU&OB:V#P^&6&A.O7S+)J].E@,9
MW]E?6>HV-MJ5G<)+87=L+N"Z8/ GV<AF>29+A(I;4P;)%NXKF.&6SDAFBNDB
MDAE1*NB:U8^(=-35M--P;.2\U2Q0W5NUK,9M(U2\TBZ8P2$R+$]U8S26SN%:
M:U:&=HXC)Y:\HOA/5_\ A'I/"4>KP:;8RVBWL_B"P@CO=0N-=U#Q1?\ B#Q!
M8'0=9M;G2U\,WJ7(M(DEN9;J2TN;JPEMH8XUGFT/ _A_6?#6CWUAKGB!O$=W
M=>)_%6MQWATW3=,$-KKOB'4M7AA,.EVMI"\T@O3=W>^)A;7EQ/96DKV%O:X^
MDP&8<15\=DU+%Y3+#X.MDDJV;XE1H*%#/?\ 9_:82$9XYXFEAZ#CB(4:D,/C
M:>-^L4YPQ-.GA95,1\QF&6\-X?+\[JX/-XXG'4<\C2R;#.5=SKY"WB/9XNI*
M& 6&JXG$0E0E6ISQ&"JX)X><)X:=3%1IX?L****^J/D0I\?^LC_WU_\ 0A3*
M?'_K(_\ ?7_T(4#CNO5?F?Z#'_!'G_E&S^RM_P!B=XE_]6/XUK]+:_-+_@CS
M_P HV?V5O^Q.\2_^K'\:U^EM?XM^)'_)Q./?^RTXI_\ 5YCC_;OPW_Y-WP%_
MV1?"W_JCP(4445\6?:!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% '^5Y_P>.?\I;_#_P#V:%\%_P#U+OBQ11_P>.?\I;_#_P#V:%\%_P#U
M+OBQ10!_?Y_P1+_Y1(?\$Z/^S0O@G_ZB-G7ZCU^7'_!$O_E$A_P3H_[-"^"?
M_J(V=?J/0 4444 (>GXK_,5_FP_MT?\ )ZG[6_\ V<K\;O\ U8OB&O\ 2>/3
M\5_F*_S8?VZ/^3U/VM_^SE?C=_ZL7Q#7]G?0Q_Y*?C3_ +$. _\ 5@S^)_IL
M?\DMP5_V/LP_]5\#Y6HHHK_0H_SG"BBB@ HHHH **** "BBB@ I\?^LC_P!]
M?_0A3*?'_K(_]]?_ $(4#CNO5?F?Z#'_  1Y_P"4;/[*W_8G>)?_ %8_C6OT
MMK\TO^"//_*-G]E;_L3O$O\ ZL?QK7Z6U_BWXD?\G$X]_P"RTXI_]7F./]N_
M#?\ Y-WP%_V1?"W_ *H\"%%%%?%GV@4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!_E>?\ !XY_REO\/_\ 9H7P7_\ 4N^+%%'_  >.?\I;
M_#__ &:%\%__ %+OBQ10!_?Y_P $2_\ E$A_P3H_[-"^"?\ ZB-G7ZCU^7'_
M  1+_P"42'_!.C_LT+X)_P#J(V=?J/0 4444 (>GXK_,5_FP_MT?\GJ?M;_]
MG*_&[_U8OB&O])X]/Q7^8K_-A_;H_P"3U/VM_P#LY7XW?^K%\0U_9WT,?^2G
MXT_[$. _]6#/XG^FQ_R2W!7_ &/LP_\ 5? ^5J***_T*/\YPHHHH **** "B
MBB@ HHHH *?'_K(_]]?_ $(4RGQ_ZR/_ 'U_]"% X[KU7YG^@Q_P1Y_Y1L_L
MK?\ 8G>)?_5C^-:_2VOS2_X(\_\ *-G]E;_L3O$O_JQ_&M?I;7^+?B1_R<3C
MW_LM.*?_ %>8X_V[\-_^3=\!?]D7PM_ZH\"%%%%?%GV@4444 %%%% !1110
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MM^)'_)Q./?\ LM.*?_5YCC_;OPW_ .3=\!?]D7PM_P"J/ A1117Q9]H%%%%
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M_P!3OQ97WQ7_ #K^,.GBUXHI:+_B(G&O_K29D?\ 2?X._P#)HO"S_LW' _\
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MFL9F^ P5;VE*%2C*7[G$5.6U2-I\LG=)I_HU_P 1 /\ P3^_Y_OC3_X::_\
M_EQ1_P 1 /\ P3^_Y_OC3_X::_\ _EQ7\.%%?W-_Q*/X4_\ /WBK_P .^%_^
M=?E^?=G\(?\ $X7BM_T#\+?^&K%>7_4Q\OQ?<_N/_P"(@'_@G]_S_?&G_P -
M-?\ _P N*IWW_!?#_@G?J< M=1/Q?O[87%G=""\^#US<PBYT^\@U"QN!%/JL
MD8GLKZUMKVTFV^9;7=O!<P-'/#'(O\/E%'_$H_A3_P _>*O_  [X7_YU^7Y]
MV'_$X7BM_P! _"W_ (:L5Y?]3'R_%]S^X[_A_P#_ /!/WC_3OC4,'/'PGU <
M\]<:R,@YY!R">2":0_\ !?\ _P""?IY-]\:@?5?A/J"YQTSMUD9'L<BOX:[F
MYBLX)+F99I$C,:K#;1F:ZN9IY8[>UL[.%?FFO+VYEAM+2(??GFC#%8P[KPD/
MB[6_^$6T77)]"LS>7WB0Z'JL<=^\.G:5"GQ$D\$23VYF#W^IW+QIYMI%##':
MS7D4\UU=6%F(HIO$S'Z,_@ME56K0Q>*XP]K0RS$9Q6AA\8L7*E@,+7P^'J5J
MBPV357!.I7BXJ23E2I8JN[4<-B*D/<RSZ4'C7FU&EB,'@N#W1KYIALFHU,1A
M?JD:N88JA6Q%.A3>)S:DIM4L,^=Q;M4K8:@N:OBJ%.I_><?^"_O_  3\/_+]
M\:QQC"_"G4D'Y+K0'Z4X?\%__P#@GZ.E]\:N@'/PGU \#/KK)YYY/4\9)P*_
MACU=-5^QW*:'/H]OJ:F/R+C7X;ZXTF)%D4W$EY%IMW8WA1;<2E'CNH5CD"R2
M[HD=&R_"E[K.I:#9ZCKITAKR^:>ZMGT2UU*RLI=(EE+:1<M:ZM>7][!<7MCY
M5[)%)<NL<=S#'A)5E1>Z7T5?"6&8TLMD^,/;5L+7Q<*BS7!.@Z>&JT*59.:R
MYRC.,\10TE!*:J>Y*3C44>*'TLO%N>6U<S5/@_V%#%T,%4IO+<8JZJXBE5K4
M7&#QW+.$X8:NVXS;A[.7/&//!R_NP'_!P!_P3^&3]N^-7)R<_"?4#[< ZR0!
M[# SSUI?^(@'_@G]_P _WQI_\--?_P#RXK^'"BNW_B4?PI_Y^\5?^'?"_P#S
MK\OS[LX/^)PO%;_H'X6_\-6*\O\ J8^7XON?W'_\1 /_  3^_P"?[XT_^&FO
M_P#Y<4?\1 /_  3^_P"?[XT_^&FO_P#Y<5_#A11_Q*/X4_\ /WBK_P .^%_^
M=?E^?=A_Q.%XK?\ 0/PM_P"&K%>7_4Q\OQ?<_P!$W]D#_@I)^S;^V_XG\8^$
MO@?/X\FU;P-H.F>(]='BWP;/X9MAIVK:G-I-J;.>:_N_M4_VN%_-A")LBVR;
MFR0/ONOY /\ @VU_Y+M^TK_V2+P3_P"IQJ%?U_U_#_C9P7DW 'B%FO#&0O&2
MRW!X7*JM%XZO#$8GGQ>6X;%5N>K3HT(R7M:L^5*FN6-DVVKO^Z_!'C;./$+P
MZRCBG/8X2&98W$9G2K+ T94,/RX3'U\-2Y*<ZE62?LZ<>9N;O*[TN%%%%?DQ
M^M!1110!_E>?\'CG_*6_P_\ ]FA?!?\ ]2[XL44?\'CG_*6_P_\ ]FA?!?\
M]2[XL44 ?W^?\$2_^42'_!.C_LT+X)_^HC9U^H]?EQ_P1+_Y1(?\$Z/^S0O@
MG_ZB-G7ZCT %%%% !7\&/[7W_)U_[3'_ &7KXM?^ISKE?WG5_!C^U]_R=?\
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M+%%'_!XY_P I;_#_ /V:%\%__4N^+%% ']_G_!$O_E$A_P $Z/\ LT+X)_\
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MA>*_^Q9PK_ZS65G^\'T'?^4<^$/^QEQ1_P"M!CPHHHK^3C^N HHHH _RO/\
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MH8Z>(P\L#6QM'#*BZ=)OGSC.N%?K_$6*R?"1E0S+)J6#R_"8O(<FC2PN9?\
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M/_U$;.OU'K\N/^")?_*)#_@G1_V:%\$__41LZ_4>@ HHHH *_@Q_:^_Y.O\
MVF/^R]?%K_U.=<K^\ZOX,?VOO^3K_P!IC_LO7Q:_]3G7*_T2_9W?\EGXC?\
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M^1L\3?\ 8?U?_P!+[BOO6O@KQA_R-GB;_L/ZO_Z7W%?HOAS_ +]F/_8)3_\
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M<92]I4=*4Y>[2IN[=*RBG&ERR=Z3G&G4@E%%%>P>:%%%% X[KU7YGVU\+O\
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MBSX?L5\*?!;Q?^S'X8N_ _B*W\$ZW\8/&_@/Q+XP\<Z-K=MX@N=:^)VF:?\
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M0O@G_P"HC9U^H] !1110 5\%>,/^1L\3?]A_5_\ TON*^]:^"O&'_(V>)O\
ML/ZO_P"E]Q7Z+X<_[]F/_8)3_P#3R/S7Q)_W++/^PJM_Z91SE%%%?K9^0A11
M10 4444 %%%% !1110 4444#CNO5?F?;7PN_Y$+PY_UZW'_I?=UWU<#\+O\
MD0O#G_7K<?\ I?=UWU?SCG/_ ".,U_[&6._]2JI_2F2_\B;*?^Q9@/\ U%I!
M7S3\??\ C]\,_P#7KJG_ *.L:^EJ^:?C[_Q^^&?^O75/_1UC7L\$_P#)1X'_
M  8O_P!0ZYXO''_)-8_UPG_J=A3Y]HHHK]U/P0**** "BBB@ HHHH **** "
MBBB@#WCX"?\ (:\1?]@NR_\ 2N:OJ"OE_P" G_(:\1?]@NR_]*YJ^H*_#>./
M^2CQ?_7G!_\ J+2/WC@3_DF\)_U^Q?\ ZD5 HHHKY$^P"BBB@#_*\_X/'/\
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MTS_H):?_ .!MM_\ ':.:/\T?O7]=5]X6?9_U_P .OO+U%4?[4TS_ *"6G_\
M@;;?_':/[4TS_H):?_X&VW_QVCFC_-'[U_75?>%GV?\ 7_#K[R]15'^U-,_Z
M"6G_ /@;;?\ QVC^T],/_,2T_P#\#;7_ ..T<T?YH_>OZZK[QI.ZTZK\U_FO
MO/NCX7?\B%X<_P"O6X_]+[NN^KS[X521S?#_ ,-20R1RQO:7!22)UDC8?;[L
M95T+*PR",@GD$=17H-?SEG.N;YK;_H98[_U*JG]*9+_R)LI_[%F _P#46D%?
M-/Q]_P"/WPS_ ->NJ?\ HZQKZ6KYI^/O_'[X9_Z]=4_]'6->SP3_ ,E'@?\
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M[K[_ ( _WS,/^P:E_P"G6?GGB%_N>7?]A-7_ --(X78G]U?^^1_A1L3^ZO\
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MVFR[+^O^&7W'X>-V)_=7_OD?X4;$_NK_ -\C_"G44679?U_PR^X!NQ/[J_\
M?(_PHV)_=7_OD?X4ZBBR[+^O^&7W -V)_=7_ +Y'^%&Q/[J_]\C_  IU%%EV
M7]?\,ON ;L3^ZO\ WR/\*-B?W5_[Y'^%.HHLNR_K_AE]P#=B?W5_[Y'^%&Q/
M[J_]\C_"G44679?U_P ,ON ^P/V-P!XL\;8 '_%/:3T '_,4GK]"*_/C]CC_
M )&SQM_V+VD_^G2>OT'K\7XQ_P"1_B_^O>%_]1J1^V\%?\D]A?\ K[BO_4BH
M%%%%?+GU84444 ?Y7G_!XY_REO\ #_\ V:%\%_\ U+OBQ11_P>.?\I;_  __
M -FA?!?_ -2[XL44 ?W^?\$2_P#E$A_P3H_[-"^"?_J(V=?J/7Y<?\$2_P#E
M$A_P3H_[-"^"?_J(V=?J/0 4444 %?C?\3O^2D_$#_L=/$W_ *>+NOV0K\;_
M (G?\E)^('_8Z>)O_3Q=U]_P!_OF8?\ 8-2_].L_//$/_<\N_P"PFM_Z:1P]
M%%%?J)^5!5/4<'3[\-IYU=387P;25%DS:JIM)@VE*NI2P:<S:FN; +J,\.GL
M;D"_FBLS/(MRBAZIKO\ UUNOO!:._;^NEG]Q^9">"?V@/C%=P?$OQ]\!/%/P
M[^)WP[U/X->(?AE\/];\;?!@_"K2/A[\*?C)X4^)6H_ OP]XC\$?$/Q?J6H>
M.?''_"/:=K.K_$?Q1X7\+> K/7O!O@7P]X=TOPWX4\/O=ZSZO??#3XP^)?!O
M[1FI0:/J?@C7/VG_ (M_"FVU'PE/XOT"?Q#X'^#&GZ%\)?@_\3-=UC7/#FK:
MAX<_X3WQ-\,/#'C;5]0TKPQXAUX6,=YX<TG3]8U/7;&?'W!17 LNI)/FJUYN
M49*<I.DI2G*%6FZK<*47SJG7J0BE:G&+BHTUR0Y?0>8U6XN-&A!0E!PC&-5Q
MA"$Z%54DIU9?NW4P]*<G*]64E)RJ/GGS<#K.N>,])F\7:5X*^'VR/P]\,I=<
M^'>M?V]X<L?#>L>.88/$5CX?^%UOH?VF/6-$@T8:1X8EN-=U*WM_"DFBZ[;:
M;977VG2=4C@H_!GP7=?#OX3_  [\&ZE-+=Z[HOA+1CXMU&YN/M=YK/CS5;9=
M=^(>OZA>^9+]NU'Q!X\U7Q)K=]>^;*+JYOY)$D:(QX],HKK5)*HJCE)N,)PB
MGRJ,8SE&3248Q_D@DVV[15[N[?&ZC]FZ:C&,7*$Y6YG*4J<)0BY.4I?SSE96
M7-.5DE9(HHHK0S"BBB@#]8?V>?\ DC'@/_L&77_IVU"O9Z\8_9Y_Y(QX#_[!
MEU_Z=M0KV>OY_P V_P"1KF?_ &,,;_ZDU3^A\G_Y%.5_]B[!?^HU(*^"/VRO
M^0OX _[!WB3_ -*]'K[WKX(_;*_Y"_@#_L'>)/\ TKT>O7X._P"2@P?^#%?^
MHM8\CC+_ ))W'?XL)_ZF4#XNHHHK]I/P\**** "BBB@ HHHH **** "BBB@#
M[!_8X_Y&SQM_V+VD_P#ITGK]!Z_/C]CC_D;/&W_8O:3_ .G2>OT'K\7XQ_Y'
M^+_Z]X7_ -1J1^V\%?\ )/87_K[BO_4BH%%%%?+GU84444 ?Y7G_  >.?\I;
M_#__ &:%\%__ %+OBQ11_P 'CG_*6_P__P!FA?!?_P!2[XL44 ?W^?\ !$O_
M )1(?\$Z/^S0O@G_ .HC9U^H]?EQ_P $2_\ E$A_P3H_[-"^"?\ ZB-G7ZCT
M %%%% !7XW_$[_DI/Q _['3Q-_Z>+NOV0K\;_B=_R4GX@?\ 8Z>)O_3Q=U]_
MP!_OF8?]@U+_ -.L_//$/_<\N_[":W_II'#T445^HGY4%%%% !1110 4444
M%%%% !1110!^L/[//_)&/ ?_ &#+K_T[:A7L]>,?L\_\D8\!_P#8,NO_ $[:
MA7L]?S_FW_(US/\ [&&-_P#4FJ?T/D__ "*<K_[%V"_]1J05\$?ME?\ (7\
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M^7]WU_#S#_B'F#_Z&6*_\$TO_DO7^GI^AW_"8>$O^AH\/?\ @YT[_P"2:/\
MA,/"7_0T>'O_  <Z=_\ )-?GC@>@_(48'H/R%'^O^,_Z%V&_\'5?+^[Z_AYA
M_P 0\P?_ $,L5_X)I?\ R7K_ $]/T._X3#PE_P!#1X>_\'.G?_)- \8>$B0/
M^$H\/<_]1G3O_DFOSQP/0?D*50,C@=1V'K1_K_C/^A=AO_!U7R_N^OX>8?\
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MQ^QQ_P C9XV_[%[2?_3I/7Z#U^+\8_\ (_Q?_7O"_P#J-2/VW@K_ ))["_\
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MU90 5^7O_!0GXD6_@/7?A;#/I%SJ9U+2?%TJM;WEO:B$6M]X?0JPFAE+E_M
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MH_UPXA_Z#8?^$F#_ /E'E^?=A_J9P]_T!2_\*L9Y?]1'D_O\CZC_ .&A]/\
M^A4U'_P;V/\ \BT?\-#Z?_T*FH_^#>Q_^1:^7**/]<.(?^@V'_A)@_\ Y1Y?
MGW8?ZF</?] 4O_"K&>7_ %$>3^_R/J/_ (:'T_\ Z%34?_!O8_\ R+1_PT/I
M_P#T*FH_^#>Q_P#D6OERBC_7#B'_ *#8?^$F#_\ E'E^?=A_J9P]_P! 4O\
MPJQGE_U$>3^_R/J/_AH?3_\ H5-1_P#!O8__ "+1_P -#Z?_ -"IJ/\ X-['
M_P"1:^7**/\ 7#B'_H-A_P"$F#_^4>7Y]V'^IG#W_0%+_P *L9Y?]1'D_O\
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MN(_X6;\-_P#HH'@K_P *?1O_ ),H_P"%F_#?_HH'@K_PI]&_^3* .WHKB/\
MA9OPW_Z*!X*_\*?1O_DRC_A9OPW_ .B@>"O_  I]&_\ DR@#MZ5>H^H_G7#_
M /"S?AO_ -% \%?^%/HW_P F4J_$SX;Y'_%P/!74?\S/HWK_ -?E ']07[$'
M_)J_P>_[ .I_^I/KU?5E?(_[".HZ?JW[)?P7U'2K^SU/3[KP_JCVU]I]S#>6
M=PB^*O$$;/!<V[R0RJLB.C,CL ZLI.5('UQ0 5^,_P#P51_Y&3X+_P#8#\=_
M^G+PM7[,5^,__!5'_D9/@O\ ]@/QW_Z<O"U 'Y/T444 %%%% "@$] 3@,QP"
M<*JEG8XZ*BAG=CPJJS,0H)!@@!B"%(B(8@[2)RHMR&^Z1<%T%O@_ORZ"'>67
M/A?[15@E[\-))[J;2WTC1/%O@KQ%XAT3Q##XC?PGXQ\/:1K\$NI^#O&=SX4T
M;Q%K.E>$M9\VWFU;6#H.LZ%IKZ=:3>+]+OO!YUZW?X)U;1=8OXM)O;O_ (55
MX%^&\WBWXV:S\,HOBE\/OB+\1_V<;/1/$>@_"G0]+\.^'O!MAI_AK74\1CQY
M8>+_ !?\-_&=S8^%=&?PK<^.H/ '@/5]/\5Z7;6 !^M6ULD;6RH8LNT[E" L
MY88RHC56:0L $569L!20F#P<<,JNI[,CJ'1U/1D=&5T<95T974E2"?BC7M8L
M=<_9[\%>'-7&HZ9KG@?PM\ O'7Q$^'_Q2B\<ZG'K/A*2_GTZ/PI\4_%6@>#+
MN]?2?%5SX=OKOQ#JP\-WPT-M*TZY^)_@W3O#%WJ^ER>D?LR0:G'X2\;7;:=I
M>B>#M7^*/B+5OACH.@0ZU!X;T?P1<:#X2AEM_"BZ_INB:C+X4NO&MMXQU+0[
MN/P]X:T?44O;K4_#7A_3O#5]I'G 'T?1110 4444 ?J+_P $MO\ DHWQ5_[$
MCPY_ZD=[7[9U^)G_  2V_P"2C?%7_L2/#G_J1WM?MG0 4444 %%%% '^5Y_P
M>.?\I;_#_P#V:%\%_P#U+OBQ11_P>.?\I;_#_P#V:%\%_P#U+OBQ10!_?Y_P
M1+_Y1(?\$Z/^S0O@G_ZB-G7ZCU^7'_!$O_E$A_P3H_[-"^"?_J(V=?J/0 44
M44 (>GXK_,5_GC_MI ?\-A?M5<#_ ).*^,G8?]#[K=?Z'!Z?BO\ ,5_GD?MI
M?\GA?M5?]G%?&3_U/=;H ^9L#T'Y"C ]!^0I:* $P/0?D*,#T'Y"EHH 3 ]!
M^0HP/0?D*6B@!,#T'Y"C ]!^0I:* $P/0?D*,#T'Y"EHH 3 ]!^0IR ;UX'W
ME[#U%)3D^^O^\O\ ,4 ?W<?\$E_^4=W[,/\ V)^O_P#J?^+Z_1:OSI_X)+_\
MH[OV8?\ L3]?_P#4_P#%]?HM0 5^,_\ P51_Y&3X+_\ 8#\=_P#IR\+5^S%?
MC/\ \%4?^1D^"_\ V _'?_IR\+4 ?D_1110 4444 .5WC97C=XW4Y5T9D=2.
MA5U(92/4$&GK<7"2/*EQ<)+)GS)4GE663)!/F2*X=\D G<QY /45%10 ]994
MV%)94,;%XRDCJ8Y&QND0JPV2-@;G7#MM7<3M&$9F=F=V9W<EG=V9W=CU9G8E
MF8]RQ)]Z;10 4444 %%%% 'ZB_\ !+;_ )*-\5?^Q(\.?^I'>U^V=?B9_P $
MMO\ DHWQ5_[$CPY_ZD=[7[9T %%%% !1110!_E>?\'CG_*6_P_\ ]FA?!?\
M]2[XL44?\'CG_*6_P_\ ]FA?!?\ ]2[XL44 ?W^?\$2_^42'_!.C_LT+X)_^
MHC9U^H]?EQ_P1+_Y1(?\$Z/^S0O@G_ZB-G7ZCT %%%% "'I^*_S%?YY'[:7_
M ">%^U5_V<5\9/\ U/=;K_0W/3\5_F*_SR/VTO\ D\+]JK_LXKXR?^I[K= '
MS/1110 444AZ'D#@\GD#CJ<\8'4YXXYXH =@G  )+<* "2QSMPHQ\WS97C/S
M CJ,4[RY"YC$<AD&08]C>8"!D@IC=P.3QP.>E?-NA>//AHFD_%6'6?BSI^HZ
M3IOC-;_4M57Q[IUSJTVDRZ%\/8#&DVAW<<]KI.KZ]-)X?CT_P_;:99-)>W&@
MZ5]AFG<K#%XG^&5AX5CO_$'B?0[KPYJOC/5$\'^!K/XD:4^F)*NAZ;Y7A'4M
M>@\1'3!+IBP7GB[4+*X\1'PYX'FUW,+7PT_2A, ?2RJSL%16=V.%1%+.Q]%5
M06)]@":5T>-MLB/&P )21&C< ]"5<*V#V.,'M7B4TVA:G\,K;POK'CCPYX@N
M?^$9\,:MK.K-K.I:EI6I>'[CQ7!;)?WFJZ-.-6O?"]_+IM[X8'B%KRW?45LI
M[O6K^RWZI=0=%\+TTVVT34]*T:VT)=(T?7[JTT_5/#":A'X?\0)<Z=I.J76J
MZ='J&J:ZR-%?7]SI%^++7=7TPW^ESFRNXP9K.U /2:*** "G)]]?]Y?YBFTY
M/OK_ +R_S% ']W'_  27_P"4=W[,/_8GZ_\ ^I_XOK]%J_.G_@DO_P H[OV8
M?^Q/U_\ ]3_Q?7Z+4 %?@S_P61^+W@GX9>*_@);>++K4[>76/#OQ&GL1I^DW
M&I*T=CJO@Z.X,K0NHB*M<Q!%;)<%B.%-?O-7\M'_  <1?\CW^RM_V*7Q@_\
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MJ*_>G_B&*^-__25GQ#_XA'\&O_GC4?\ $,5\;_\ I*SXA_\ $(_@U_\ /&H
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7OY/$TL36/]G,ELEI&WVJX:5RI0!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>chart-415206c664c75dff352.jpg
<TEXT>
begin 644 chart-415206c664c75dff352.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "\ 2P# 2(  A$! Q$!_\0
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MX)_^HC9U^H] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPQH.E^'/"L7B7X3?"?QY%I&C_#GQ[)9>(9->AU36],C^(7Q!MO#\'B&7],:
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M_LT+X+_^I=\6* /[_/\ @B7_ ,HD/^"='_9H7P3_ /41LZ_4>ORX_P"")?\
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M4RS&YM&.'H_V>\30:PF78B->>:4,MHX3%3P^%Q=2A6K0B_\ 0%_XB+_V+/\
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M;_#_ /V:%\%__4N^+% ']_G_  1+_P"42'_!.C_LT+X)_P#J(V=?J/7Y<?\
M!$O_ )1(?\$Z/^S0O@G_ .HC9U^H] !1110!R7CW_D2/&'_8K>(O_3+?5_EQ
M)_JXO^N,/_HI*_U'?'O_ ")'C#_L5O$7_IEOJ_RXD_U<7_7&'_T4E?WI]"O_
M '3Q%_[".%O_ $WQ ?P!]-W_ 'GPY_Z]<4_^E</CJ***_N0_@X**** "BBB@
M HHHH **** /JG]A?_D]3]DC_LY7X(_^K%\/5_I/#I^+?S-?YL/["_\ R>I^
MR1_V<K\$?_5B^'J_TGAT_%OYFO\ /;Z9W_)3<%_]B+,/_5A$_P!&/H3_ /)*
M\;?]E!@/_5<+7Y\_\%6/^4=W[6W_ &2'6/\ TX:77Z#5^?/_  58_P"4=W[6
MW_9(=8_].&EU_+O '_)=\%?]E;PY_P"KC!']5\??\D+QI_V2G$/_ *J,6?YX
M$G^LD_WV_P#0C3*?)_K)/]]O_0C3*_VJCLO1?D?X>!61K>BVFOV<5E=W6KV)
MMM1T[5['4=!U2?1]7TW5-*N!<V%]8WL(DC\V&3<KVU]:W^F7D,DMMJ.GWEM(
M\)UZ*PQ6%P^.P];"8NC#$8;$4Y4JU&HN:%2$MTUNFM'&2:E&24HM22:Z<)B\
M3@,30QF#K5,/BL-4C5HUJ4N6=.<'=-/9I[2BTXSBW&2<6T_(]%^$W_"/^&/[
M&T?Q]XZTGQ#=?\(X-7\>6%YHTWB2_@\*Z=-I>C:5!%K&B:IHNFZ#8VD\RVFF
M6FE*\+S3W#W<UW=75Q-B^&O@+I?AKPUH?A>+XA?$R^M?!]Y9:AX U"?5O#UG
MJW@*[L['6],E;P_<Z;X8M;>ZMM5T[Q!J-CK-CXCM-<M+ZT=81'#@N?=J*^9A
MP'PG3AA*4,HC&G@,)5P.$IK&9A[.E0KXFGC:[]E];]G/$5L?1H9C6Q=2,\75
MS/#X;,IUY8[#8?$4_J9>(/%\YXRK+.)NIC\92QV+J/!Y<ZE;$8?#3P.'O4^I
M\\,/0R^K7RRA@Z<HX2EE>)Q660H1P&)KX>IP&B?#VRT"1[RS\1^+[C6]1\7Z
M-XT\4^(]0U>WN-9\9ZAH>BC0++2_$36^G6>GMX<72XK2U&BZ7I^FV\<=C:^6
MPD$TDV+HWP;\.:+)X:MX]=\;:AX9\$ZM9Z[X)\#:MK]O>>$_"NL:<-272[S3
MXDTJ#7;U-&&JW8T*RUK7M3L])!C$,,GDP^7ZS16_^IG#'^S7R?#M8.=2I04I
MUY+FKXFAC<3[92K-8F.,QV&P^/QL,2JL,;F%"ECL7&MBX1K+G_UWXJ7UJV<X
ME?7(4H5W&&'B^7#X:O@L*Z+5%/"SP>!Q.(R_ U,,Z-3 Y?7JX#"2HX2<J+.E
M%%%?3GRH5^O7_!##_E)%\'?^Q1^,G_JMM9K\A:_7K_@AA_RDB^#O_8H_&3_U
M6VLU^>^+7_)KO$3_ +(OB7_U48L_2?!S_DZWAU_V6?#G_JVPA_>=1117^-)_
MM.%%%% !7^5Y_P 'CG_*6_P__P!FA?!?_P!2[XL5_JAU_E>?\'CG_*6_P_\
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M^37>(G_9%\2_^JC%GZ3X.?\ )UO#K_LL^'/_ %;80_O.HHHK_&D_VG"BBB@
MK_*\_P"#QS_E+?X?_P"S0O@O_P"I=\6*_P!4.O\ *\_X/'/^4M_A_P#[-"^"
M_P#ZEWQ8H _O\_X(E_\ *)#_ ()T?]FA?!/_ -1&SK]1Z_+C_@B7_P HD/\
M@G1_V:%\$_\ U$;.OU'H *0D#J0/J0/YTM?&?[6_['!_:R_X0/'[5'[9?[-'
M_""_\))_R:5\<C\&?^$Q_P"$C.B?\CWCPMXE_P"$A_L+^Q?^*<_X\_[+_M;6
M_P#7_;_W(!].^/73_A"/&'S+_P BMXB_B'_0%OO>O\N2/_51?]<8?_125_=;
M/_P1K2YAFMKC_@J9_P %DIK>XBD@GAD_;C)CEAE1HY8W'_"K1E'1F5AW!-?(
M7_$+1^PIP!^TC_P42    '[3VC@  8  _P"%4]   /:OZ-\!?&K)O".CQ12S
M;)\TS5Y]5R>I0>73P<%066QS*-55OK5:DVZGUZ#I\G,E[.?-:\;_ ,W>/W@A
MG'C!5X7J95G>690LAAF\:ZS&EBZCKO,I98Z?LOJM.I94E@:G/SVNYPY;V9_(
MC17]=W_$+1^PI_T<C_P42_\ $GM'_P#G4T?\0M'["G_1R/\ P42_\2>T?_YU
M-?T'_P 3F\'_ /1(<3]/^7V4^5_^8SU^[[_YU_XDGXN_Z+3AGI_S"YMY7_YA
M_7[OO_D1HK^N[_B%H_84_P"CD?\ @HE_XD]H_P#\ZFC_ (A:/V%/^CD?^"B7
M_B3VC_\ SJ:/^)S>#_\ HD.)^G_+[*?*_P#S&>OW?>?\23\7?]%IPST_YA<V
M\K_\P_K]WW_R(T5_7=_Q"T?L*?\ 1R/_  42_P#$GM'_ /G4T?\ $+1^PI_T
M<C_P42_\2>T?_P"=31_Q.;P?_P!$AQ/T_P"7V4^5_P#F,]?N^\_XDGXN_P"B
MTX9Z?\PN;>5_^8?U^[[_ .1&BOZ[O^(6C]A3_HY'_@HE_P")/:/_ /.IH_XA
M:/V%/^CD?^"B7_B3VC__ #J:/^)S>#_^B0XGZ?\ +[*?*_\ S&>OW?>?\23\
M7?\ 1:<,]/\ F%S;RO\ \P_K]WW_ ,B-%?UW?\0M'["G_1R/_!1+_P 2>T?_
M .=31_Q"T?L*?]'(_P#!1+_Q)[1__G4T?\3F\'_]$AQ/T_Y?93Y7_P"8SU^[
M[S_B2?B[_HM.&>G_ #"YMY7_ .8?U^[[_P";G]A@@?MI_LD9('_&2OP1ZG'_
M #47P]7^DZ'3'WEZM_$/4^]?SA>'/^#8O]C/P?X@T3Q7X4_:K_X*1^'/$_AG
M5M.U_P .^(-'_:HTNQU;0]<TB[BO]*U?3+V'X5"6TU#3KV"&ZM+B,AX9XDD7
MYE%?5'_#G%_^DJ'_  64_P#$Y#_\ZVOYF\=O%K*O%G-LAS#*LJS'*J>49=B<
M%5IYC/"SG6G7Q*KJ=/ZK5JQ4(I<KYVFWLK:G]0> GA#FGA#D^?9;FF;Y?F]3
M-\RPV.I5,OIXFG"C&CA?82A46)ITY.3E[R<4U;=W/V6WI_>7_OH?XU^?/_!5
M=E/_  3O_:VPR_\ )(=8[C_H(:7[U\W_ /#G%_\ I*A_P64_\3D/_P ZVN:\
M8?\ !#_PK\0O#&M>"O'?_!2S_@KYXO\ !_B2QDTSQ#X8\0?ML)J.BZWITQ5I
MK'4K&7X6^5=6LI1?,AD!5]H!!&0?R+AO-*62<19!G->E4K4<HSK*\TK4:3BJ
MM6E@,=0Q=2E3<W&"J5(4G&#G)1YFN9I79^P\2974SOA[/<FHU84:V;9-F>64
MJU52=.E4QV"KX6%2HH)S<(2JJ4U%.7*GRINR/X=Y/]8_^^W_ *$:97]=Y_X-
M:/V%"23^TE_P42))R3_PT]H_)/\ W2FD_P"(6C]A3_HY'_@HE_XD]H__ ,ZF
MO[U7TS.#TDO]4.)]+?\ +[*?+_J,]?N^_P#S_P#^))^+O^BTX:_\)<U\O^H?
MU^[[_P"1&BOZ[O\ B%H_84_Z.1_X*)?^)/:/_P#.IH_XA:/V%/\ HY'_ (*)
M?^)/:/\ _.II_P#$YO!__1(<3]/^7V4^5_\ F,]?N^]?\23\7?\ 1:<,]/\
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MV.BR:Q>PEM/TC4;VWURXL9+;5ETS^R;NTOI_YD/V9?A1\;KSX3?\$G/^"?\
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MKS_B,<_X*W_]"_\ LA?^&7\7?_/8H_XC'/\ @K?_ -"_^R%_X9?Q=_\ /8H
M_P!4.BO\KS_B,<_X*W_]"_\ LA?^&7\7?_/8H_XC'/\ @K?_ -"_^R%_X9?Q
M=_\ /8H _P!4.BO\KS_B,<_X*W_]"_\ LA?^&7\7?_/8H_XC'/\ @K?_ -"_
M^R%_X9?Q=_\ /8H _P!4.BO\KS_B,<_X*W_]"_\ LA?^&7\7?_/8H_XC'/\
M@K?_ -"_^R%_X9?Q=_\ /8H _P!4.BO\KS_B,<_X*W_]"_\ LA?^&7\7?_/8
MH_XC'/\ @K?_ -"_^R%_X9?Q=_\ /8H _P!4.BO\KS_B,<_X*W_]"_\ LA?^
M&7\7?_/8H_XC'/\ @K?_ -"_^R%_X9?Q=_\ /8H _P!4.BO\KS_B,<_X*W_]
M"_\ LA?^&7\7?_/8H_XC'/\ @K?_ -"_^R%_X9?Q=_\ /8H _P!4.BO\KS_B
M,<_X*W_]"_\ LA?^&7\7?_/8H_XC'/\ @K?_ -"_^R%_X9?Q=_\ /8H _P!4
M.BO\KS_B,<_X*W_]"_\ LA?^&7\7?_/8H_XC'/\ @K?_ -"_^R%_X9?Q=_\
M/8H _P!4.BO\KS_B,<_X*W_]"_\ LA?^&7\7?_/8H_XC'/\ @K?_ -"_^R%_
MX9?Q=_\ /8H _P!4.BO\KS_B,<_X*W_]"_\ LA?^&7\7?_/8H_XC'/\ @K?_
M -"_^R%_X9?Q=_\ /8H _P!4.BO\KS_B,<_X*W_]"_\ LA?^&7\7?_/8H_XC
M'/\ @K?_ -"_^R%_X9?Q=_\ /8H _P!4.BO\KS_B,<_X*W_]"_\ LA?^&7\7
M?_/8H_XC'/\ @K?_ -"_^R%_X9?Q=_\ /8H _P!4.BO\KS_B,<_X*W_]"_\
MLA?^&7\7?_/8H_XC'/\ @K?_ -"_^R%_X9?Q=_\ /8H _P!4.BO\KS_B,<_X
M*W_]"_\ LA?^&7\7?_/8H_XC'/\ @K?_ -"_^R%_X9?Q=_\ /8H _P!4.BO\
MKS_B,<_X*W_]"_\ LA?^&7\7?_/8H_XC'/\ @K?_ -"_^R%_X9?Q=_\ /8H
M_P!4.BO\KS_B,<_X*W_]"_\ LA?^&7\7?_/8H_XC'/\ @K?_ -"_^R%_X9?Q
M=_\ /8H _P!4.O\ *\_X/'/^4M_A_P#[-"^"_P#ZEWQ8H_XC'/\ @K?_ -"_
M^R%_X9?Q=_\ /8K\-_\ @HA_P40^/W_!3CX^6?[1_P"TA:?#VR^(5C\/O#GP
MT@A^&GAF^\*>'3X<\+ZEX@U737DTW4-=\0W,FIFY\2:B+F[.H;)(5M8D@B6#
$+@'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>chart-1798924266f5ba1ad03.jpg
<TEXT>
begin 644 chart-1798924266f5ba1ad03.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $M 2H# 2(  A$! Q$!_\0
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MR9_P21_Z1T?L@_\ AD?!_P#\A4?\.3/^"2/_ $CH_9!_\,CX/_\ D*OU&HH
M_+G_ (<F?\$D?^D='[(/_AD?!_\ \A4?\.3/^"2/_2.C]D'_ ,,CX/\ _D*O
MU&HH _+G_AR9_P $D?\ I'1^R#_X9'P?_P#(5'_#DS_@DC_TCH_9!_\ #(^#
M_P#Y"K]1J* /RY_X<F?\$D?^D='[(/\ X9'P?_\ (5'_  Y,_P""2/\ TCH_
M9!_\,CX/_P#D*OU&HH _+G_AR9_P21_Z1T?L@_\ AD?!_P#\A4?\.3/^"2/_
M $CH_9!_\,CX/_\ D*OU&HH _+G_ (<F?\$D?^D='[(/_AD?!_\ \A4?\.3/
M^"2/_2.C]D'_ ,,CX/\ _D*OU&HH _+G_AR9_P $D?\ I'1^R#_X9'P?_P#(
M5'_#DS_@DC_TCH_9!_\ #(^#_P#Y"K]1J* /RY_X<F?\$D?^D='[(/\ X9'P
M?_\ (5'_  Y,_P""2/\ TCH_9!_\,CX/_P#D*OU&HH _+G_AR9_P21_Z1T?L
M@_\ AD?!_P#\A4?\.3/^"2/_ $CH_9!_\,CX/_\ D*OU&HH _+G_ (<F?\$D
M?^D='[(/_AD?!_\ \A4?\.3/^"2/_2.C]D'_ ,,CX/\ _D*OU&HH _+G_AR9
M_P $D?\ I'1^R#_X9'P?_P#(5'_#DS_@DC_TCH_9!_\ #(^#_P#Y"K]1J* /
MRY_X<F?\$D?^D='[(/\ X9'P?_\ (5'_  Y,_P""2/\ TCH_9!_\,CX/_P#D
M*OU&HH _+G_AR9_P21_Z1T?L@_\ AD?!_P#\A4?\.3/^"2/_ $CH_9!_\,CX
M/_\ D*OU&HH _+G_ (<F?\$D?^D='[(/_AD?!_\ \A4?\.3/^"2/_2.C]D'_
M ,,CX/\ _D*OU&HH _+G_AR9_P $D?\ I'1^R#_X9'P?_P#(5'_#DS_@DC_T
MCH_9!_\ #(^#_P#Y"K]1J* /RY_X<F?\$D?^D='[(/\ X9'P?_\ (5'_  Y,
M_P""2/\ TCH_9!_\,CX/_P#D*OU&HH _+=_^")O_  21 '_&NC]D'[R#_DB7
MA =74=K,>OT/0@C(K_'M_;<\,>'?!/[9_P"UUX,\'Z'IGAGPEX1_:?\ C[X8
M\+^&]%M4LM&\/^'= ^*WBS2M$T/2;*/*6FF:3IEI:V%A:H2EO:V\42\(*_W5
MY/NC_?C_ /1BU_AB_P#!03_D_3]MS_L[O]I/_P!7+XTH _U]_P#@B9_RB1_X
M)T?]F@_!'_U#[*OU&K\N?^")G_*)'_@G1_V:#\$?_4/LJ_4:@ HHHH ****
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M^VY_V=W^TG_ZN7QI0!_K[_\ !$S_ )1(_P#!.C_LT'X(_P#J'V5?J-7Y<_\
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M'_V%<,?^F<]/\_\ Z;G^]>'G_7GB7_TO(QU%%%?W$?P>%%%% !1110 4444
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MM[8 _?&BOQ ^#_[7?[>7@']M_P#9._9?_:RD_9G\::O^V'\$/C;\9_%GPF^
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M:#\$?_4/LJ_4:@ HHHH X?XF_P#).?'O_8E^*_\ U']1K_+MC_U4'_7O;_\
MHB.O]1+XF_\ ).?'O_8E^*__ %']1K_+MC_U4'_7O;_^B(Z_O;Z%G^Y>(?\
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M \,ZKX:\6?&#X9^%_$GAVZTS]F[XN_$F'Q%KT_BO4_AXVH^#Y'?0I(?!AO\
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M:5_N=2?='^_'_P"C%K_#%_X*"?\ )^G[;G_9W?[2?_JY?&E '^OO_P $3/\
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M&_\ JER(=7XH?\%^?^4?&N?]E?\ A'_Z?+VOVOK\4/\ @OS_ ,H^-<_[*_\
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M444 %%%% 'Z1?\$A_P#E([^RO_V.WB+_ -5IXZK_ $)$^XO^ZO\ (5_GM_\
M!(?_ )2._LK_ /8[>(O_ %6GCJO]"1/N+_NK_(5_G!],C_DX?#G_ &1F%_\
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M^_'_ .C%K_#%_P""@G_)^G[;G_9W?[2?_JY?&E?[G4GW1_OQ_P#HQ:_PQ?\
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M)_\ JY?&E?[G4GW1_OQ_^C%K_#%_X*"?\GZ?MN?]G=_M)_\ JY?&E '^OO\
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MY?&E '^OO_P1,_Y1(_\ !.C_ +-!^"/_ *A]E7ZC5^7/_!$S_E$C_P $Z/\
MLT'X(_\ J'V5?J-0 4444 </\3?^2<^/?^Q+\5_^H_J-?Y=L?^J@_P"O>W_]
M$1U_J)?$W_DG/CW_ +$OQ7_ZC^HU_EVQ_P"J@_Z][?\ ]$1U_>WT+/\ <O$/
M_L*X8_\ 3.>G^?\ ]-S_ 'KP\_Z\\2_^EY&.HHHK^XC^#PHHHH **** "BBB
M@ HHHH _2+_@D/\ \I'?V5_^QV\1?^JT\=5_H2)]Q?\ =7^0K_/;_P""0_\
MRD=_97_[';Q%_P"JT\=5_H2)]Q?]U?Y"O\X/ID?\G#X<_P"R,PO_ *O,\/\
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MO_1+/AM_X0GA7_Y4T?\ "H?A+_T2SX;?^$)X5_\ E33]KQ-_T Y%T_YFN/\
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M3[H_WX__ $8M?X8O_!03_D_3]MS_ +.[_:3_ /5R^-* /]??_@B9_P HD?\
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M&_\ X:<F_P#HB_JS\KG_ !)GXJ_]#?@3_P .^>?_ $-?U9^5_P W_P#@D/\
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MM'_$++\6?^DINN?^(4?"O_YZM?W]_P 3@^%W_0KXW_\ #3DW_P!$7]6?E?\
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M'?//_H:_JS\K_P WM%?TA?\ $++\6?\ I*;KG_B%'PK_ /GJT?\ $++\6?\
MI*;KG_B%'PK_ /GJT?\ $X/A=_T*^-__  TY-_\ 1%_5GY7/^),_%7_H;\"?
M^'?//_H:_JS\K_S>U_4I_P &T?\ R%?VQ/\ L'_ G_TI^*]>6_\ $++\6?\
MI*;KG_B%'PK_ /GJU]9?LN?\$1/VZ/V,Y/&TO[/G_!7L^%7^(B>'D\6-K'_!
M/GX&^*FOE\*G6FT06S:S\3IGL!;GQ!JAF6U9%NS+"9U<VT!3\U\7OI)\!<>>
M'?$7"F2Y?Q31S/-EE2PU3,<ORRA@X_4L[RW,:WMJN'SK%UH7H82K&GR8>IS5
M7",N6,G./Z=X.?1E\0/#_P 1^'.+L[S'A.OEF4O-'BJ66YCFM?&R^NY+F&7T
MO84L3D>#HS:KXNE*ISXFGRTHU)1<I*,)_P!*E%?C?8?L8?\ !7*WOK.>^_X+
M0Z3J%E#=6TMW8C_@FK^SQ:&\MHYXWN+7[5%\1WEMOM,*R0>?&K20F3S45F0
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M ."VW[.?P>_;W\.ZEXH_:&_9_P#V/O!7PN_:,U?]I'P?\8_CAXZ^)M_^S/\
MM":?XU^*OA?7['Q0;CQ[XV^'&KZS:>))_#'PZL=-\-^!TT_3-$\-^%_"6BP:
M?81 ']56@^+_  IXHGUJU\->)?#_ (@N?#>IR:+X@M]#UK3-7FT+6(5#RZ5K
M,6G7=S)I>I1(0TEA?K;W:*=S0@<UT=?QS?\ !,"QM+7]OG_@GWX?_9KTC]@'
M2_#OP[_8I^.?A/\ :Q\3_P#!.SXF7OQ2TCXV> ;#P]\*M-^$/QB_:>U=_A[\
M._\ A$/&GB[XR6;ZE\+/AY\0$\=?&:UU&X^-FI>(/&L]I::C%<_V,T %%%%
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MBO\ ](\?A]_XD;XI_P#G44?\1PWQ7_Z1X_#[_P 2-\4__.HH _T0Z*_SO/\
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I= G^(7C#6/%LVB6VHW$-M/J$&E2:NUA#>SV]O-=QP+/)#$\C1J ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>chart-b81c50169b2ce7059cc.jpg
<TEXT>
begin 644 chart-b81c50169b2ce7059cc.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #0 2P# 2(  A$! Q$!_\0
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MX)_^HC9U^H] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?Y7G_!XY_REO\
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ML?#Z>'=/B:RE\Z_X?[_\$]_^A@^+G_AHO$'_ ,DT?\/]_P#@GO\ ]#!\7/\
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MYUNXU3AOA/\ \$G/@S\)OB5\,]>T[XL_'3Q)\#O@%\6?'GQW_9N_9(\3ZSX
MG^ /P(^+WQ&'CH:WXO\ "4>E_#W2_B?XAA\.CXD^.6^&7AGX@?$7Q7X:^&<W
MBG5+CPQIL,UMH+Z* ?J:I+*K$8+*"1G."1G&>^/7O3J0    8   'H!P!2T
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MU_FP_L+_ /)ZG[)'_9ROP1_]6+X>K_2>'3\6_F:_SV^F=_R4W!?_ &(LP_\
M5A$_T8^A/_R2O&W_ &4& _\ 5<+7DGQW^-'A#]G?X0^/_C9X^BUJ?P=\-_#]
MQXE\0Q>';"+5-;?3K::W@D73=/FN["*ZN2]Q'MBDO+=2H9C(-N#ZW7Y\_P#!
M5C_E'=^UM_V2'6/_ $X:77\G<*Y=ALXXHX;RG&>T^J9IGV3Y=BO92Y*OU;'9
MAA\-7]G.TN2I[*K+DERRY96=G:Q_77%68XC)^&.(LVPGL_K>5Y%FV8X7VL>>
ME]8P6 Q&)H^T@G'GA[2G'GCS+FC=75[GQF?^#A7]@X$C^Q/VA>"1Q\,M%QP<
M?]#T*3_B(6_8-_Z G[0O_ALM$_\ F[K^(V3_ %DG^^W_ *$:97^CZ^B7X3-)
M\O$NJO\ \CF'_P PG^:7_$WWBU_U3?\ X:)^7_47Y?CZW_MU_P"(A;]@W_H"
M?M"_^&RT3_YNZ/\ B(6_8-_Z G[0O_ALM$_^;NOXBJ*/^)2_";^7B7_P\P_^
M8@_XF^\6O^J;_P##1/R_ZB_+\?6_]NO_ !$+?L&_] 3]H7_PV6B?_-W1_P 1
M"W[!O_0$_:%_\-EHG_S=U_$511_Q*7X3?R\2_P#AYA_\Q!_Q-]XM?]4W_P"&
MB?E_U%^7X^M_[=?^(A;]@W_H"?M"_P#ALM$_^;NC_B(6_8-_Z G[0O\ X;+1
M/_F[K^(JBC_B4OPF_EXE_P##S#_YB#_B;[Q:_P"J;_\ #1/R_P"HOR_'UO\
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MZQ_Z<-+K^7> /^2[X*_[*WAS_P!7&"/ZKX^_Y(7C3_LE.(?_ %48L_SP)/\
M62?[[?\ H1IE/D_UDG^^W_H1IE?[51V7HOR/\/ HHHI@%%%% !1110 4444
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MN.8\4\197D4LPK\.RP4<QQ,,.\5'#0SJ.(=%2^-47B**J6^'VL+[H_B[Z6O
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M_P#DE^(?\0(\8?\ HWG$W3_F EUM_>_O+\3S.BO3/^&:_P!N[_I&A_P44_\
M$8M9_P#E]1_PS7^W=_TC0_X**?\ B,6L_P#R^H_XC=X2_P#1P>&.G_,RI=;?
M_)+\0_X@1XP_]&\XFZ?\P$NMO[W]Y?B>9T5Z9_PS7^W=_P!(T/\ @HI_XC%K
M/_R^H_X9K_;N_P"D:'_!13_Q&+6?_E]1_P 1N\)?^C@\,=/^9E2ZV_\ DE^(
M?\0(\8?^C><3=/\ F EUM_>_O+\3S.OUZ_X(8?\ *2+X._\ 8H_&3_U6VLU^
M:/\ PS7^W=_TC0_X**?^(Q:S_P#+ZOO+_@FK+^U9^R)^UWX ^.OQ1_X)C_\
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M7^5Y_P 'CG_*6_P__P!FA?!?_P!2[XL5_JAU_E>?\'CG_*6_P_\ ]FA?!?\
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M ?J/17Y<?\/M/^"2'_21?]D+_P /9X1_^3*/^'VG_!)#_I(O^R%_X>SPC_\
M)E 'ZCT5^7'_  ^T_P""2'_21?\ 9"_\/9X1_P#DRC_A]I_P20_Z2+_LA?\
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M ?J/17Y<?\/M/^"2'_21?]D+_P /9X1_^3*/^'VG_!)#_I(O^R%_X>SPC_\
M)E 'ZCT5^7'_  ^T_P""2'_21?\ 9"_\/9X1_P#DRC_A]I_P20_Z2+_LA?\
MA[/"/_R90!^H]%?EQ_P^T_X)(?\ 21?]D+_P]GA'_P"3*/\ A]I_P20_Z2+_
M +(7_A[/"/\ \F4 ?J/17Y<?\/M/^"2'_21?]D+_ ,/9X1_^3*/^'VG_  20
M_P"DB_[(7_A[/"/_ ,F4 ?J/7^5Y_P 'CG_*6_P__P!FA?!?_P!2[XL5_?Y_
MP^T_X)(?])%_V0O_  ]GA'_Y,K_.6_X.GOVD_@#^U3_P4TT/XG_LW_&'X>_&
M_P"'L/[+_P */"\_C+X:>)+'Q5X=@\1Z1XI^)EQJ6B2:II[/;#4[*VU'3KFY
..M0S/##?6K/AI-J@'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>chart-e1643913cacfb05a2b5.jpg
<TEXT>
begin 644 chart-e1643913cacfb05a2b5.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %I 2H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]HO\ @DI_
MP23_ ."97Q>_X)F?L*?$[XF_L)?LO>.?B%X[_9>^$/BCQGXR\3_"3PSK'B+Q
M/XCU;PK9W.JZWK>J7EM+<W^IZC=,]S>74SEYII'8X7:J_HA_PY,_X)(_](Z/
MV0?_  R/@_\ ^0J/^")G_*)'_@G1_P!F@_!'_P!0^RK]1J /RY_X<F?\$D?^
MD='[(/\ X9'P?_\ (5'_  Y,_P""2/\ TCH_9!_\,CX/_P#D*OU&HH _+G_A
MR9_P21_Z1T?L@_\ AD?!_P#\A4?\.3/^"2/_ $CH_9!_\,CX/_\ D*OU&HH
M_+G_ (<F?\$D?^D='[(/_AD?!_\ \A4?\.3/^"2/_2.C]D'_ ,,CX/\ _D*O
MU&HH _+G_AR9_P $D?\ I'1^R#_X9'P?_P#(5'_#DS_@DC_TCH_9!_\ #(^#
M_P#Y"K]1J* /RY_X<F?\$D?^D='[(/\ X9'P?_\ (5'_  Y,_P""2/\ TCH_
M9!_\,CX/_P#D*OU&HH _+G_AR9_P21_Z1T?L@_\ AD?!_P#\A4?\.3/^"2/_
M $CH_9!_\,CX/_\ D*OU&HH _+G_ (<F?\$D?^D='[(/_AD?!_\ \A4?\.3/
M^"2/_2.C]D'_ ,,CX/\ _D*OU&HH _+G_AR9_P $D?\ I'1^R#_X9'P?_P#(
M5'_#DS_@DC_TCH_9!_\ #(^#_P#Y"K]1J* /RY_X<F?\$D?^D='[(/\ X9'P
M?_\ (5'_  Y,_P""2/\ TCH_9!_\,CX/_P#D*OU&HH _+G_AR9_P21_Z1T?L
M@_\ AD?!_P#\A4?\.3/^"2/_ $CH_9!_\,CX/_\ D*OU&HH _+G_ (<F?\$D
M?^D='[(/_AD?!_\ \A4?\.3/^"2/_2.C]D'_ ,,CX/\ _D*OU&HH _+G_AR9
M_P $D?\ I'1^R#_X9'P?_P#(5'_#DS_@DC_TCH_9!_\ #(^#_P#Y"K]1J* /
MRY_X<F?\$D?^D='[(/\ X9'P?_\ (5'_  Y,_P""2/\ TCH_9!_\,CX/_P#D
M*OU&HH _+G_AR9_P21_Z1T?L@_\ AD?!_P#\A4?\.3/^"2/_ $CH_9!_\,CX
M/_\ D*OU&HH _+G_ (<F?\$D?^D='[(/_AD?!_\ \A4?\.3/^"2/_2.C]D'_
M ,,CX/\ _D*OU&HH _+G_AR9_P $D?\ I'1^R#_X9'P?_P#(5'_#DS_@DC_T
MCH_9!_\ #(^#_P#Y"K]1J* /RY_X<F?\$D?^D='[(/\ X9'P?_\ (5'_  Y,
M_P""2/\ TCH_9!_\,CX/_P#D*OU&HH _+=_^")O_  21 '_&NC]D'[R#_DB7
MA =74=K,>OT/0@C(K_'M_;<\,>'?!/[9_P"UUX,\'Z'IGAGPEX1_:?\ C[X8
M\+^&]%M4LM&\/^'= ^*WBS2M$T/2;*/*6FF:3IEI:V%A:H2EO:V\42\(*_W5
MY/NC_?C_ /1BU_AB_P#!03_D_3]MS_L[O]I/_P!7+XTH _U]_P#@B9_RB1_X
M)T?]F@_!'_U#[*OU&K\N?^")G_*)'_@G1_V:#\$?_4/LJ_4:@ HHHH ****
M"BBB@ HHHH **** $.<' R<' Z9/89K^7G]N/]O3]JW]G?\ X*.:5H7Q?^-'
MQ*_8^_9LT#Q/>O\ !WQ7?_LKWGQA_8O^,/PK7X8?"#4]<U[]H+XM>"]0N_B#
MX9\5CXJ:W\2O VN7+W/PV\._ ;P[I_@#XA7$^NZ;K/B&]U'^H<@$$'H1@_0U
M^3G[1'_!(_X1?M$?&^_^)FL_&7]H;PG\-OB'_P )NW[0W[._A/XGZM9_"KXY
M?\)YX,\&_#_Q-9W\5TMYX@^'^A>-O!_@;0?#?Q3\-_#C6O#>B?$71[)5O[+3
MM5O_ !!J^N ''_&S]IW]L;P9_P %5OV#?@/<3_##P1^R5\>]>_:GT:WT?0)U
M\9_$SXO0_"/]ER'XEV'B_P <:WJNAV>G_"[0]'\>:O\ V9X;\#^"I]5UK7H_
M#_\ PE'BGQDFF:S:^"K'[#_;DT_XE6_P:UGXB^!_VQ]4_8M\,?![1_&'Q.^*
M_P 3-.^$'PJ^+\$OP[\)>%=0UG71JNE_%31];L-)T[0;.PNM?FOM%M1JUR;5
M;-6>*3R9/FS]H'_@E1'^T!^T7X(_:6O/V\?VYOAIXP^$>I>-M1^!OASX8Z[^
MS/8>"O@FGQ(\%V?@#QSIO@+3?%?[,WB[5I].\1>&K0V=U'XUUOQ?<6CW-Q+I
M=S8.83#[S\9?V$/"_P >OV;/VJ/V7_B;\=?VC/$G@C]K#5];N_%.OW_C7PS=
M^,?ASX;\1:+X(T35?AU\(KR\\%7&B>%?A[/%X-N;Z/P]J.@Z\(-1\:>-9X;E
M8M4L[?3@#(_X)D:M^TYXM_9&\!?$K]JWXE:M\2?'WQ>N=1^*WA%_$OPX^'_P
MP\9^#/@UXVCLM3^$'@GX@>'/AE;67A$?$:T\$'3?$/Q!_LVU$.C>,/$NL^$+
M6ZU2P\,V>K7_ .@-4=,TZTT?3K#2K"%+>QTVRM-/LX(U1$AM;*WBM;:)$C5(
MT2."&-%5$5%"@*JJ !>H **** "BBB@ HHHH **** "BBB@#^??_ (*E?\%3
M/B]^R)^T_P#"'X ^$/&O[,_[.7A[Q%8_"?QC;_%G]L"R^)5A\,/CC+XR\6?%
M#PYXR^%WA[XF>&M.A\ _"2P^%EIX)\):O\3_ !IXGUS5O%UA9_%7PCJ7AGP3
M=Z1HVNW.H?0W[7__  4(_:#^ _BW]A?0?!'[.V@W7@K]I+]HK]C/X2_%;XW>
M(?'>D>)_AEX?A_::\8W^AZMX#^"1\+ZCI7B7XH^.]"TW1=0U6?Q_JNB>%?AK
MHV@ZGX7URUA\8:IK<OA71^K_ &\OV$/VA/VG?&?@OQ!\(/VJ(/A_X//B3X=3
M_$/X/_%WX2>#/CO\*;>U\"#Q[ OQ ^&?A3Q1':Q:-\1]2TWQY>Z1XGT;Q+-X
MB^'OCFSTGPK-JVB:;=^'9I==\*^/W_!)SX^^,OAS^Q?\ _V>OVR? ?P9_9\_
M85U;]E3QI\&O"WQ$_98N_C=\1K_XB_LF6CV/@G7?&_Q*L_V@/A=8:UX>UN&.
MR?7O"FF^!M#83170TW7+*VNH[:U /MK_ (*-_ME#]A[]FZ?XK:=9>"[[QKXM
M^)7PJ^"7PU'Q-\27/@WX6:7X]^,?C73O!VD^+/BIXLLK>[OM ^&G@'3[K5_'
MWCF[T^W?4[GP[X8OM+TM[?4=0M;NWX3_ ()N?MB>,/VL_#GQA'C/XF?LN?%O
M4/A?XWT3P]:^,?V;;3XM?#RZFL]<\,6^LFP^*'[/'QS34?B7\&?$-G>QW;^'
M+J]\7^+O#?Q.\(W.F^,O#5[IB'4-'M:OQH_80^+W[4?PD\6_#']I/]J'3/%%
MQ)9_LP^._@]XB^''[/\ X3\"#X*?M/?L[>*]2\?7OQMTC1?$WBKXCP>-O#GC
M_P 96W@J:Z^$/CN^UC1M"\,Z!K_AF#Q#J"^,+G4M,]%_9-_8Y\8? [XK?M _
MM&?&WXX0?'_]HG]HW3_A+X4\9^,/#WPKTOX(^ -&^'OP-T_Q;;?#?PGX3^'%
MAXK\?:C#=6NH?$#QKK7B/Q1XF\>>)]9UR\UBUL;5M&T#1-*TB  ^\J*** "B
MBB@!DGW1_OQ_^C%K_#%_X*"?\GZ?MN?]G=_M)_\ JY?&E?[G4GW1_OQ_^C%K
M_#%_X*"?\GZ?MN?]G=_M)_\ JY?&E '^OO\ \$3/^42/_!.C_LT'X(_^H?95
M^HU?ES_P1,_Y1(_\$Z/^S0?@C_ZA]E7ZC4 %%%% !1110 4444 %%%% !7/>
M)_$EEX4TF36=0BN9K:*:W@:.T2)YB]S*L2$+-+"FT,P+$R @9P">*Z&O*/C1
M_P B)=_]A'2O_2V.O1RC#4L9FF7X2NI.CB<9AZ-51ERR<*E2,9)26J=F[-;'
MG9OB:N#RO,,70<56PV#Q%:DY1YHJ=.G*46XO1JZ5T]S+_P"%Z^%?^@;K_P#X
M#Z?_ /+*C_A>OA7_ *!NO_\ @/I__P LJ^4J*_7O]1.'_P#GUBO_  IG_E_5
MWY6_'/\ 7[B'_G[A?_"6'^9]6_\ "]?"O_0-U_\ \!]/_P#EE1_PO7PK_P!
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M?@#_ *#C?^"S5O\ Y!KXOHH_XA[DO_03F?\ X.PW_P Q^O\ 2U/^(C9W_P!
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M1_\ 4/LJ_4:@ I&Z'Z'^5+2-T/T/\J<=UZK\P/X /^"T7_*2O]I7_K\^&/\
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M>?\ 8E?_ *EX4_8OH_\ _)XN O\ L=1_]1ZY_9S1117^09_L<%%%% !1110
M4444 %%%% #)/NC_ 'X__1BU_AB_\%!/^3]/VW/^SN_VD_\ U<OC2O\ <ZD^
MZ/\ ?C_]&+7^&+_P4$_Y/T_;<_[.[_:3_P#5R^-* /\ 7W_X(F?\HD?^"='_
M &:#\$?_ %#[*OU&K\N?^")G_*)'_@G1_P!F@_!'_P!0^RK]1J "D;H?H?Y4
MM(W0_0_RIQW7JOS _@ _X+1?\I*_VE?^OSX8_P#JF_A_7Y;U^I'_  6B_P"4
ME?[2O_7Y\,?_ %3?P_K\MZ_V>\,/^3:^'O\ V1'"G_JBP!_B9XJ?\G.\1?\
MLN>+/_5[CPHHHK[D^""BBB@#^K__ (-HO^1=_;%_[#OP,_\ 33\3J_J)K^7;
M_@VB_P"1=_;%_P"P[\#/_33\3J_J)K_)GZ2?_)Z^-O\ KYD/_K+Y(?Z]_1H_
MY,AP+_UXSS_UILZ"BBBOPT_=0HHHH **** "OXV?^#C_ /Y.J^!G_9O)_P#5
MF^+:_LFK^-O_ (./E9OVJO@9M5C_ ,8\D< GG_A9OBWC@5_1OT5O^3PY5_V*
M,]_]0)G\V_2OU\&\XM_T-,D_]3Z9_.W13_+D_P">;_\ ?+?X4>7)_P \W_[Y
M;_"O]2[KNOZ_X=?>?Y0V?9_U_P .OO&44_RY/^>;_P#?+?X4>7)_SS?_ +Y;
M_"BZ[K^O^'7WA9]G_7_#K[QE?T'_ /!N+_R>'\8/^S:M<_\ 5H_#2OY\_+D_
MYYO_ -\M_A7]!W_!N.K+^V'\8-RL/^,:M<Z@C_FJ/PU]:_(_'EK_ (A!QYK_
M ,R5_P#J7A?\T?L7T?T_^(Q<!:?\SJ/_ *C5W^6I_9O1117^09_L<%%%% !1
M110 4444 %%%% #)/NC_ 'X__1BU_AB_\%!/^3]/VW/^SN_VD_\ U<OC2O\
M<ZD^Z/\ ?C_]&+7^&+_P4$_Y/T_;<_[.[_:3_P#5R^-* /\ 7W_X(F?\HD?^
M"='_ &:#\$?_ %#[*OU&K\N?^")G_*)'_@G1_P!F@_!'_P!0^RK]1J "D;H?
MH?Y4M(W0_0_RIQW7JOS _@ _X+1?\I*_VE?^OSX8_P#JF_A_7Y;U^I'_  6B
M_P"4E?[2O_7Y\,?_ %3?P_K\MZ_V>\,/^3:^'O\ V1'"G_JBP!_B9XJ?\G.\
M1?\ LN>+/_5[CPHHHK[D^""BBB@#^K__ (-HO^1=_;%_[#OP,_\ 33\3J_J)
MK^7;_@VB_P"1=_;%_P"P[\#/_33\3J_J)K_)GZ2?_)Z^-O\ KYD/_K+Y(?Z]
M_1H_Y,AP+_UXSS_UILZ"BBBOPT_=0HHHH **** "OE+X]_L/?LI_M0>)M&\8
M_'KX,>&?B3XE\/Z%_P (SHVKZW=>(+>YL-"_M"[U7^S8ETC6M,@:#^T+Z[N@
M98I)1).X$FS:H^K:*[\MS7-,FQ4,=D^98_*L=",X0QF6XS$8'%0A4CRU(1Q&
M&J4JL85(MQG%349Q;4DUH<&997EF<X66!S?+L!FN"G.%2>#S'"8?'86<Z;YJ
M<Y8?$TZM*4H2UA)P;B]4TS\WO^'1/_!.$=?V5/  [?\ (2\;=?3_ )&RC_AT
M1_P3A_Z-3\ ?^#+QO_\ -97PI_P6*_;V_:6_9*^*'P>\+>%O&=U^S#^SSKMM
M\*?$FL_M6W7[+?C_ /::\&ZOX_N_VB?#/A7Q=\&?'UUX.UG3;#X0>$] ^$37
M_P 1]7O-2MV\3?&"RO)_ ?P[\0>$]:TR]O[KV[QW_P %#?C=/\/_ !]XK^ 7
MA?X5_M#:]\!?^"9^F?ML^-+7X-7NO>-?!?QO^*/Q=T3Q[;? /P%\%M29[+Q3
M<?#K6KSX._%;QMJ=\=+OO&^M:&? 'AW1;>+6K[5UG^C_ .(B^(/_ $77&/\
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M:^'O_9$<*?\ JBP!_B9XJ?\ )SO$7_LN>+/_ %>X\****^Y/@@HHHH _J_\
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M_P"3(<"_]>,\_P#6FSH****_#3]U"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH 9)]T?[\?_ *,6O\,7_@H)_P GZ?MN?]G=
M_M)_^KE\:5_N=2?='^_'_P"C%K_#%_X*"?\ )^G[;G_9W?[2?_JY?&E '^OO
M_P $3/\ E$C_ ,$Z/^S0?@C_ .H?95^HU?ES_P $3/\ E$C_ ,$Z/^S0?@C_
M .H?95^HU !2-T/T/\J6D;H?H?Y4X[KU7Y@?P ?\%HO^4E?[2O\ U^?#'_U3
M?P_K\MZ_4C_@M%_RDK_:5_Z_/AC_ .J;^']?EO7^SWAA_P FU\/?^R(X4_\
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M?\GZ?MN?]G=_M)_^KE\:4 ?Z^_\ P1,_Y1(_\$Z/^S0?@C_ZA]E7ZC5^7/\
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M_;%_[#OP,_\ 33\3J_J)K_)GZ2?_ ">OC;_KYD/_ *R^2'^O?T:/^3(<"_\
M7C//_6FSH****_#3]U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH 9)]T?[\?_HQ:_PQ?^"@G_)^G[;G_9W?[2?_ *N7QI7^
MYU)]T?[\?_HQ:_PQ?^"@G_)^G[;G_9W?[2?_ *N7QI0!_K[_ /!$S_E$C_P3
MH_[-!^"/_J'V5?J-7Y<_\$3/^42/_!.C_LT'X(_^H?95^HU !2-T/T/\J6D;
MH?H?Y4X[KU7Y@?P ?\%HO^4E?[2O_7Y\,?\ U3?P_K\MZ_4C_@M%_P I*_VE
M?^OSX8_^J;^']?EO7^SWAA_R;7P]_P"R(X4_]46 /\3/%3_DYWB+_P!ESQ9_
MZO<>%%%%?<GP04444 ?U?_\ !M%_R+O[8O\ V'?@9_Z:?B=7]1-?R[?\&T7_
M "+O[8O_ &'?@9_Z:?B=7]1-?Y,_23_Y/7QM_P!?,A_]9?)#_7OZ-'_)D.!?
M^O&>?^M-G04445^&G[J%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 R3[H_WX_\ T8M?X8O_  4$_P"3]/VW/^SN_P!I/_U<
MOC2O]SJ3[H_WX_\ T8M?X8O_  4$_P"3]/VW/^SN_P!I/_U<OC2@#_7W_P""
M)G_*)'_@G1_V:#\$?_4/LJ_4:ORY_P"")G_*)'_@G1_V:#\$?_4/LJ_4:@ I
M&Z'Z'^5+2-T/T/\ *G'=>J_,#^ #_@M%_P I*_VE?^OSX8_^J;^']?EO7ZD?
M\%HO^4E?[2O_ %^?#'_U3?P_K\MZ_P!GO##_ )-KX>_]D1PI_P"J+ '^)GBI
M_P G.\1?^RYXL_\ 5[CPHHHK[D^""BBB@#^K_P#X-HO^1=_;%_[#OP,_]-/Q
M.K^HFOY=O^#:+_D7?VQ?^P[\#/\ TT_$ZOZB:_R9^DG_ ,GKXV_Z^9#_ .LO
MDA_KW]&C_DR' O\ UXSS_P!:;.@HHHK\-/W4**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@!DGW1_OQ_^C%K_  Q?^"@G_)^G
M[;G_ &=W^TG_ .KE\:5_N=2?='^_'_Z,6O\ #%_X*"?\GZ?MN?\ 9W?[2?\
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M\9Y_ZTV=!1117X:?NH4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3]MS_L[O]I/_ -7+XTK_ '.I/NC_ 'X__1BU_AB_\%!/^3]/VW/^SN_VD_\
MU<OC2@#_ %]_^")G_*)'_@G1_P!F@_!'_P!0^RK]1J_+G_@B9_RB1_X)T?\
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M_9^T^TGT.3XWVG@F"XEUJ=_^$;^$?A1OAWX?MI;:^L+C1/ZUMH]6_P"^W_\
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M ()"_P#1X6E?^&<_:,_^<[1_Q$%_\$A?^CPM*_\ #.?M&?\ SG:_9?:/5O\
MOM__ (JC:/5O^^W_ /BJ /QH_P"(@O\ X)"_]'A:5_X9S]HS_P"<[1_Q$%_\
M$A?^CPM*_P##.?M&?_.=K]E]H]6_[[?_ .*HVCU;_OM__BJ /QH_XB"_^"0O
M_1X6E?\ AG/VC/\ YSM'_$07_P $A?\ H\+2O_#.?M&?_.=K]E]H]6_[[?\
M^*HVCU;_ +[?_P"*H _&C_B(+_X)"_\ 1X6E?^&<_:,_^<[1_P 1!?\ P2%_
MZ/"TK_PSG[1G_P YVOV7VCU;_OM__BJ-H]6_[[?_ .*H _&C_B(+_P""0O\
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MK=QX"\9W_@_2O"WQ8L?$^CV\/A?P+X@O[RZN-+U70M6 .Q^-G_!5AO"_B_\
M8!LO@U\ ?'WCSX4_MM?%G]EGPH/V@?&-L? _PL\->$?VI?!_C'Q_X*M?"-T\
M]UK7Q)^*9\*>#KO5=9\-:#IA\*^!;*YL)O&?BRSU'6?#VBZMX?\ MI?\%B/B
M'^S?^TE\>?@EX+^%W[/TB_LT?#/X:?%"[\&?'WX]^+/A!\=_VS+?XC:%>ZRO
M@W]@CX?Z+\)_&^G_ !?\2Z/J5O:?#:'[1JTMQK?QEU.W^'G]AZ,FSQ#+N?M=
M_P#!/C]M?QQ#^Q9\)OV3O&W['_@#]G#]@;XC?LV_%GX$Z/\ &3PM\=?$WQ*U
M'Q'^SG\-O$?PST'PKXXU?P5XHTCPU=>#+K1?$<C>;HFFZ9K_ )]C:RRW>'N(
MI?+/VE/^"0O[37[3FK?''4/B'\0OV(_&=W^US\/_ (::+\3O%7Q;_9P^*7Q5
M^(/[(OC3PC\)M/\ AYJ^J_L$>+;OXQ^'KCP+X5T_Q3;ZE\7OAEH/B*'2-5\(
M_%'7M<\5:]KGC"35;NSD /Z%]!U236]$TC6)=+U/1)-5TS3]2DT?6H(K;6-*
M>_LX+M]-U6VAFN(;?4]/:8V>H017$\<-Y!/''-*BAVUJXSX<^#S\/?A_X'\!
MGQ#X@\6GP5X0\,>$CXJ\6WPU/Q5XE_X1K0[#1/\ A(/$NI!(QJ'B#6OL/]IZ
MU?".,7>IW5U<!$\S:.SH **** "BBB@ HHHH 9)]T?[\?_HQ:_PQ?^"@G_)^
MG[;G_9W?[2?_ *N7QI7^YU)]T?[\?_HQ:_PQ?^"@G_)^G[;G_9W?[2?_ *N7
MQI0!_K[_ /!$S_E$C_P3H_[-!^"/_J'V5?J-7Y<_\$3/^42/_!.C_LT'X(_^
MH?95^HU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 ,D^Z/]^/_ -&+7^&+_P %
M!/\ D_3]MS_L[O\ :3_]7+XTK_<ZD^Z/]^/_ -&+7^&+_P %!/\ D_3]MS_L
M[O\ :3_]7+XTH _UO?\ @B[\3_AMI'_!)[_@GCINJ?$#P-I^H67[(WP4M[RQ
MO/&'AJVO+2X3P?8^9!=6LVJ)/;SQD[)89XXY8I T<B+(C*/TY_X7#\*/^BF?
M#[_PMO"W_P MJ_P3J* /]['_ (7#\*/^BF?#[_PMO"W_ ,MJ/^%P_"C_ **9
M\/O_  MO"W_RVK_!.HH _P!['_A</PH_Z*9\/O\ PMO"W_RVH_X7#\*/^BF?
M#[_PMO"W_P MJ_P3J* /]['_ (7#\*/^BF?#[_PMO"W_ ,MJ/^%P_"C_ **9
M\/O_  MO"W_RVK_!.HH _P!['_A</PH_Z*9\/O\ PMO"W_RVH_X7#\*/^BF?
M#[_PMO"W_P MJ_P3J* /]['_ (7#\*/^BF?#[_PMO"W_ ,MJ/^%P_"C_ **9
M\/O_  MO"W_RVK_!.HH _P!['_A</PH_Z*9\/O\ PMO"W_RVH_X7#\*/^BF?
M#[_PMO"W_P MJ_P3J* /]['_ (7#\*/^BF?#[_PMO"W_ ,MJ/^%P_"C_ **9
M\/O_  MO"W_RVK_!.HH _P!['_A</PH_Z*9\/O\ PMO"W_RVH_X7#\*/^BF?
M#[_PMO"W_P MJ_P3J* /]['_ (7#\*/^BF?#[_PMO"W_ ,MJ/^%P_"C_ **9
M\/O_  MO"W_RVK_!.HH _P!['_A</PH_Z*9\/O\ PMO"W_RVH_X7#\*/^BF?
M#[_PMO"W_P MJ_P3J* /]['_ (7#\*/^BF?#[_PMO"W_ ,MJ/^%P_"C_ **9
M\/O_  MO"W_RVK_!.HH _P!['_A</PH_Z*9\/O\ PMO"W_RVH_X7#\*/^BF?
M#[_PMO"W_P MJ_P3J* /]['_ (7#\*/^BF?#[_PMO"W_ ,MJ/^%P_"C_ **9
M\/O_  MO"W_RVK_!.HH _P!['_A</PH_Z*9\/O\ PMO"W_RVH_X7#\*/^BF?
M#[_PMO"W_P MJ_P3J* /]['_ (7#\*/^BF?#[_PMO"W_ ,MJ/^%P_"C_ **9
M\/O_  MO"W_RVK_!.HH _P!['_A</PH_Z*9\/O\ PMO"W_RVH_X7#\*/^BF?
M#[_PMO"W_P MJ_P3J* /]['_ (7#\*/^BF?#[_PMO"W_ ,MJ/^%P_"C_ **9
M\/O_  MO"W_RVK_!.HH _P!ZY_C!\*"!_P 7,^'WWXSSXW\+#I(I[ZO^0ZD\
M#FO\0?\ ;\G@NOV[OVUKFUG@NK6Y_:V_:/GMKJUGANK6Y@F^,?C*2&>VN;=Y
8(+B":-EDAG@DDAEC99(W=&5C\DT4 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>ebs20191231exhibit1039001.jpg
<TEXT>
begin 644 ebs20191231exhibit1039001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6Z "BBB@ HIK,$0L<X49. 2?R%5-)U:SUO3TO["4RV[LZJQ0J258J>" >H-
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M/U+4;72-/FO[UVCMX%+R.J,^T#J<*": +5%4QJEJ9+) 9";Y2T)$3$$!=W)
MPO'KC--TS5[+6$N'LI&=;:=K>7=&R%9%QN&& /&: +U%%41J]D=;_L;S&^V_
M9S<;#&P'EA@N=V,'EAT- %ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\R!G:,EB%V#=\G0*<<8]>O-*_A"R)U"*.YNHK+4I#)=6:,OER,WW\$C<N[N
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M2#P[HMOI5M---#;KM1IB"V/P H YK1HKV'6_&,T6H2&6*=-IEC1E8_9T()
M/'3@BH;+Q!KHT70+RZU**237S;PH@M@HMRREG?.?F) P 1@$^G%=';>&8K6?
M59DU&]+ZJ=TV[R_E.T*"OR<?* .<]*B'@^P/ANTT-[FZDCL61[6X+*)H&3[A
M4A0,CIR#[YH RM2UW6-*O]:TD72SR0:2VI6=U+""RA259'"X!Y (.!P><XJ.
M'5/$1O?#:G5(637+5O,4VH_<N(A)N7!R2>1@\=\=JWIO#-O<PWXN;RYEN+^V
M^RRW/R!UBY^51MV@?,QZ9R?888OA6W2;1I1J%[G1D*6XS'A@5V'=\G/R\<8H
M 9X2U&_O8M4M=1G6YFT[4)+43B,(9%"JP) X!^?''I5+3Q=/\1M=5[^=H8;.
MV*PD)M ;S>.F<9YZY]2:V='T*+1I[^:*[N9C?W!N)5FV8#D '&U1V4>O2F2^
M'8'UR?5XKR[MY[B!8)4B9=CA=VUB"I.1N/?'J#0!Q?A2_P!5TGPQX-F6\C>R
MOI5LWM?)' 99&#;^N05^G/3O6PNL^(M6MVU'1HG817SQ>1)Y(A>))"C98G>'
M(4L#TZ#!ZF_%X)LX=+TG3H]1OQ#I$XGMCF+=N (&X[.0 S?G2IX*LH=6N;RW
MO]0@M[N4S7%A',!;RN>I(QGGN 0#WXXH N^)M7?1-#EOHT#R;XXD!Z!G=4!/
M(X!;/4=.HJA;IXGDO[NV,\D-G);;K:YN4@,L4X.-I5.&0C!['J,]ZV=6TNTU
MO2[C3;^/S+:X3:ZYP?4$'L0<$?2LNT\)BUL)K9M=U:>22(PI<RS*TL2'&0IV
MX&<#)()X'/ H I>#-;U+7FE-]<JDNG#[-=VZ!#YDP)S("!PA&-OKSZ<X&@7V
MJZ3X8TB]M[R/[++K3VLEJ80=Z273J26Z@@G(Q@>N:[(>&+:/7(]7MKJYM9DM
M1:M'#Y8CD0?=W+MZCMTQTZ533P/9QZ);:2NIZ@(+6[%W&^Z+?Y@<R#)V8(W$
MGI0!2U#4K^XG\:Z;<S(]M9Z:CVZK'M*^9'*6R>_W1_A573K_ %S1+?PK++?0
MW6G:DL-FUL+<*8&:+*,K9RWW><_ACMT8\,6O]H:K>275U*=6@6"XB8H$VJI4
M8PH(X9N_>BP\,P69L?.O+F]73EVVBS[,1?+M!^51E@N1DYX)[DF@#D]7U75K
M_P #ZY)/J#)-::S]D#P1J@>(3(FT@YXPQ[Y]\<5WY1H[)D>5IF"'+N "WUP
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M8G\/^&KW5K>WCN'M8R_ER.4!'U /Y?K7"*K6VGZ<\S#['9>+3#93R'[EL"P
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M:KQ7]M/?W%C'*&GMD1Y5'\ ?=MS[_*>/IZUP_BES#?:AK*16>MZ6D<2W=ON
MN+4 95X6Z$'=G'<C@]:CO?+L_$/C:>PA@35!80R6>$42ES%(24[D\<X].: /
M1 020#TZU!>O=+93-8I%)<A"8DE<JA;MD@$@5QN@VWAS4]0T[4M.U6"1Y;5X
MY+:U55,L97)\X D_*>Y[G'>L&UT;3/\ A24VJB!6O'TMT:X+DL0&) Z]B* /
M5E)V*7P&(Y /&:R(M:G;QE-H3V\:Q)8K=I,KDLV7*X(P,=#ZUS7BB"?<;Z"*
MSU2W@TE?MNF7!VNL)+'S8FY 8X8'UVCOBL_Q!?7!\4&\L[:26S?P_ ]Y#TG^
MRF5]^T?W@#R/3.,'!H ]-) ZT5Q.JVL5TFDW'A==+NX8[622/3)U BNH3L!9
M#T5Q@#)'\1!QS6_X<NX;OPCI]SI]L\,1M$\F&4\J N ">_3KWZT )XEUN?0[
M6TFAMXYQ/>0V[[Y"I02.%W  <]?45L9 (!/)Z5Y,]QIE]X$T35+EX&U7^UK<
MW<LA F67SQY@;N !V/  '8"M&Z;2M:O=?L=<U:&PO(;S="[*HG2$*IB:%B<_
M@O<GUY /2"0.I%!( R3@5YQ/I&G7^M>-4O8!/Y=A;28E_A?RI#NQT#9YSVR<
M=:GT>Z.HZQX:M=8VW%G<^'4F@$_S)-<_+O)!X+!.?H6]: .XO=0MM.CB>ZE$
M8FFC@CSU9W8*H'XG\LU8) ZG&:\JN;9%TF**Z2.33K3Q;'%9M, RI;[P&4$_
MP!MR_ACM6C?OHVI:_K6D:O?V5G;_ &>'[ TRH +<QCYH6)P"'W<CT'I0!Z+2
M9&<9YK*)NK?PB38R375U'8$P/,O[R5PGREAZDXS]:XR-(9/"_A+5](Q_:LMU
M;I),O^LF+?\ 'PLAZMT<MGIMSVH ](R/6C(SC/2O*-1TS3SX.\:7?DJ9['59
MWMI=Q+0.!&05/\)SZ?2ND33[+3OB/91V<*Q+?Z5.;H G]^5=,,W]YN6Y//)H
M ZNQ>[:T#:A'#%/N;<L+ED W';R0.V,^^:L9&,YKS71+2>Z\ :+#I]U:I=1Z
MC=/#;W@+0W1$L^8V[]"6!YY4&IXA/JFD::-*LK2SO+.YN]^CWIWP3L'(E"L.
M."QVG'&2.F: .[N'O!<VPMXX6@9V%PSN0RC:<;1CDYQUQQ5C(SC/->>6L]I>
M7_@2\MK)K$&>ZC$#MGR]L4@*@C@@,#@^F/6H)!%J'@WQ1>7XVZY975P5EZ30
MR*<P!#U QL QUR>N30!Z42!U.*"0.M<#;:3;:MXZGM]:M8YGET&W>ZA<Y4R%
MW#$CIQ@8].*H:0FHZEX0\+7%G)9W]Y#8REM.O^4NHP54D-SAUP "?[Q]30!Z
M;2UA^&-6TZZT#2([;%IYUHIM[260>8$0!3@=6 XY^GK6Y0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 56GTZQN;F*YN+.WFGA_U4LD2LR?0D9'X59HH
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M\MX_[.M-DAW.OD+ACZD8YI?[*T[S$D^P6V]%VJWDKE1TP#C@5;HH I'1]+,
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M%WQRQ;23E0.&#=.Q'&.E '2T444 %%%% !1110 4444 %%%% !1110 4444
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M X_^+H ]@HKQ_P#X2;XQ?]"[#_X#C_XNC_A)OC%_T+L/_@./_BZ /8**\?\
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MZLQP!7EMIJ$^K?$7P)J%R/W]SHSR2<8RQC<D_B:W?C'_ ,DUU#_?A_\ 1BT
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MJDD_G4T<T4P8Q2)(%.T[6!P?2O*/AOX0T"YUSQ!/-IJ/)I>LNEFQ=OW(1B5
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M![=ZN0W=M<2S107$4LENVR5$<$QMC.&'8X.>:X_Q-/HLW@")-&DMV8^4-)6
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M5K.2\!(,"SJ7R.HQGJ/2JS^,O"\4C1R>(]+1T)#*UY&"".QYK,M[KPLG@[2
MPAEM=UN+6*+F3SLKMV@<[PW7OUSWJU<JO_"QM.^4?\@JZ[?]-8* -V2[MH8H
MY9;B)(Y65(V9P S,<* >Y)( ]<U0E\4>'X+QK*;7-.CN5;8T+W2!PWH03G-4
MO&G_ "#]-_[#%C_Z/2J&CW&D16?B1=7EM5M_[4N/-6=EP5PN<@T =C6=;^(=
M%N]0;3[;5K.:[4D&!)U+Y'48![=_2N=MH]6_X4]Y<0F&H?V2PB!SY@^0[1Z[
MMN/QJY]K\*C0=&""&6V,T T^.#EA)D;=H'((ZM[9SWH U;[Q%HNF72VM_JUE
M:SO@B.:=5;GIP33]0UW2-),8U+5+.S,H)C^T3K'O ZXR>>HKG_"\VFPZ9J\>
MJR6R7@O;DZD+@J"07;86S_!Y>S';%9'A1Q!J7A\W;>7$=*O?(\\X(A^T1^4.
M?^F>W\* .X?6])CTT:F^IV:V)P!<F=?*/./O9QUIFG^(-%U>9H--U>RO957>
MR6]PLC!<XR0#TY%<#JSHUUJTND26ZV9UG3/+DQF#[0'7S#P1D?ZO=@]0>]=Q
MH\NI//(M_?:5<#;E%LHF1ASR3EVXH UZ*** "BBB@ K \<_\B7J?_7'^HK?K
M \<_\B7J?_7'^HH WZ*** ,EO%7AU+QK)M=TY;E9#&T)ND#AP<%<9SG/&*OW
M%Y:VC0I<W,4+3R".(2.%,CGHJYZGCH*X/3],UK6M'UW3((]+2QNM3OXC-/O>
M1 9G!(3&"1V^;TIOB"TOM9U.XL-.L;F^71K-8+>=98U\J\.R0.=S#)4+'T_O
M-0!WE]J-EI=L;G4+N&U@!P9)I BY],GO4$>OZ--IKZE'JMFUE$<27 G7RT/3
M!;. >1U]:Y>TUFTU;Q)H&KZALAMY].D%L)3A8[O>HD3GHX ('T;%9/B*_>6+
M7X'M-,BO#%9R2W%I<M*K8N $$@*KAAR?7!'/2@#N[#Q)H6J7/V;3]9L+N;:6
M\N"Y1VP.IP#5G4-3L-*M_M&HWD%I%G:'FD" GT&>]9^D2ZHUV1?W^D3QE#M2
MSB9'W9'.2[<8SV]*HWCP1?$:U?4&18SIQ6Q:4@+YWF?O N?XMNSWQGWH V5U
MW2&TLZHNIVAL%^]<^>OECG'+9P.2!2:=X@T;5YFATW5K*]D1=S);W"R$#ID@
M'I7">*"DMYXA?26B,!&G+.RC,9NOM0ZXZG9LW8]J[O3(]6C\W^U);&3./+^R
MPM'CKG.YCGM^M $=YXFT#3KMK2^UO3[6X7&Z*:Y1&&1D9!/I5RXU"RM++[;<
M7<$-K@'SY) J8. #N/'.1CZUR4*ZS)XP\2IID&FRQL]N)#>.XP?)7H%4Y'XB
MJ-]I4EO!HO@]+276(;*!KF^2)DCW [EC'SL %W,Q S_ * ._FGAMH7GGE2**
M,;GD=@JJ/4D]*I6/B'1=329['5K.Y6!=TIBG5MB^IYX'O7%#4)+GP]H4.N*4
MCTO55M=6$I! *(WE-(1D;2QB8GIDBK7B?45_M@1/:Z;*9K*Z2WN(+MC.D?DL
MQW)M VDJ!U(SB@#I;;Q9X<O;F.VM=>TV>>0[4CCND9F/H #S4K>(M$34QIC:
MM9"]+;?LYG7?N],9SGVK#\*3:M_9VDB?4=&:V^S1CRHH7$V-@P,F0C/3/%8=
MQ-%I_AZ_N;2YL-5T47<DT^GW2&*ZCD\TLRJX/+AONAEST&: /2J*0'(S2T %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q^B?#?1[%;R768+76
M[V\N7N)+FYM5R-W\(!)P.O?O7844 < WPM5=&U'1[?6#%8W6H+>P1?9L_9\'
M)0?-R"-H[8QWS5F7X:6K^)->UI;XJVL64EL(O)R(&D4*SYW?-T)QQU/-=M10
M!PE[\.+N6V\.C3_$+6-SH,#11W M!)O) &=I; X'3GK5^U\+>(C!?6VK>,'U
M*WN[22W$9L(XMC,,!\J<G SQ[UUE% '$ZG\-+/5? ECX:GO#YM@!Y%Z(>5.>
M?EST(XQGT/:DU7X>W=XOAZ2P\0-I]UH-KY$<XM!)O^55W8+8' Z<]:[>B@#E
M- \$/INNOKVL:S/K.J>5Y,<TL:QK$G<*HZ=_S/K6'/\ !ZUNO#NFZ1-JI;[#
M=R3^=]GQO5R"R8W<=!SD].E>CT4 <C+X#61_%+#4=H\11QI@0?\ 'OM5E_O?
M-][VZ51LO _B[3K&"RM/B#)%;V\:QQ)_941VJ!@#);/2N\HH YZU\)Q0>*=:
MUJ:X$\>KPQPO:M%PJJH4Y.?FS]!53P1X#@\$2:G]FO6N(;Z572-H]IB5=V%S
MD[OO=>.E=910!@>'O"XT'5M;OQ>>?_:UU]HV>7M\KKQG)SUZ\5>U_0[+Q)HM
MQI.H(6@N%P2IPRD'(8'U!%:-% 'GK?#35[ZUBTK6/&=W?:+$5_T06ZQNX7HK
M29)(X'7]*WY?"$3>,].\0PW(ACT^S-HEHL7!7YL'=GC&[ICM71T4 %<?K7@B
M]N/$<GB'P_K\FC7]Q$(KG_1UF28# !*L>#@#UZ=J["B@#CM-^'&GP:#JNG:I
M=S:E/K$GF7ETP",SCE2HYVX/(Z_EQ6<WPTU>\LXM(U3QI>7>B1%?]$%LJ.ZC
MHK29)(&!U_2O0J* .-\0> [C4=:TS5=&UO\ L:73+8V\ 2T64!>1QE@.AQTJ
M*_\  NMZSX;U#1M9\7/?"[,1BE-@B>3L;<>%8;L\=^,5V]% '):]X'?4=1M-
M8TG5Y=(U>UA$'VF.(2+*GHR$X/\ GK@8CTGP!]BM]9FO]7EU'5M9@:":^DB"
M[%*X 5 > ..,]ATKL:* .=L_"8M/ +>%/MN\-9R6WVGRL??##=MSVW=,U#-X
M.F;X>KX2@U4PD0"!KOR,DKGYOEW<9''7O7444 <A>_#'PS<^''TJ+3;2WF-N
M(DO5MU\U6 &')ZDY&3SSS5C5O!\VL> !X6N=5)D\J*-KSR,EMC*02N[J0H'7
MWKIZ* .<\5>$AXF\)#0#>FV \O\ ?>5O^YC^'(ZX]:K^(_ YU;4[76=+U:;2
M-7M8_*%U%&'61/1D)P?\]>,=710!R?A[P1)INN2>(-:UB76=6:/RDF>(1)$G
MHJ#@?_7/J:JQ?#2S_P"%>?\ "(W5X9PC-)%=^3M,;EBP8+D],XZ\C/3-=M10
M!R?A_P #G1+G1WDU#[5'I-E+;Q+Y.S+R/N9^IQ\HVX_6LS5/A7#JFEZQ9R:J
M5;4M4.HI)]GSY!.?EQN^;AB,\?2N_HH Y;3O UMI_B'^TA<"2W_LE-,^RM%Q
ML7;R6SW"XQCOUK'3X:ZOI]O-IFB^,[NPT:8MFT-NLC1ANH60D$?AC\:]!HH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6J!=CGLA&,G."6;/ R1@"MVL,:=K":A<7HFLI97++"\J/^YCSPH /T)/4GV
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M?_0P6'_?X5T%% '/_P#">^$_^A@L/^_PH_X3WPG_ -#!8?\ ?X5T%% '/_\
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M'_">^$_^A@L/^_PKH** .?\ ^$]\)_\ 0P6'_?X4?\)[X3_Z&"P_[_"N@HH
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MW^%=!10!S_\ PGOA/_H8+#_O\*/^$]\)_P#0P6'_ '^%=!10!S__  GOA/\
MZ&"P_P"_PH_X3WPG_P!#!8?]_A7044 <_P#\)[X3_P"A@L/^_P */^$]\)_]
M#!8?]_A7044 <_\ \)[X3_Z&"P_[_"C_ (3WPG_T,%A_W^%=!10!#:7=O?6L
M=U:3)-!*NY)$.0P]14U%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW;I7554T[3+32K=H+2-E5W,CL[L[R.>K,S$EC[D]JMT %%%% !1110 4444
M%%%% '/^.?\ D4KK_KK!_P"CDKH*Y_QS_P BE=?]=8/_ $<E=!0!QNCZ)IGB
M9]4OM;M4O;I=0GMU$V2;9$;:BI_<^4!LC!);-9,%O=:[IFF1EK7618S7B"PO
MIROVV%)?+27."&*@ 98$'=G.:["^\*Z3J%Y)=RQW$4LP"SFVNI81, ,#>$8!
MN..>W%/O/#.D7MM:P-:F!;(8M6M9&@> 8P0K(00, <=#0!S=E'H9T*]MM0%[
MI=IIU\)+K3IY59$)0%8EVYW1MN#!0>6XZ<5"E_)X?T@VSEM'36+QVLTD!/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4"7S",A/FYR,@@CWI+CQ%J^FZ-JE[?:?:R?8[,W4$]K,6AGP#\O(R",>XP:
M)_["U_\ Z'"\_P# .W_^(H_L+7_^APO/_ .W_P#B*MZOK#Z:NF%85D^W7D=L
MV3C:&!.?TK(TK7_$6L6R7D%OHT<#RNBK+=2"3"N5Y 3&?E]: +G]A:__ -#A
M>?\ @';_ /Q%']A:_P#]#A>?^ =O_P#$5"-:\0WFIZI!IFGZ=+#IUP(<3W+Q
MO(?+1^,(0/OXK1L]=CU#PS_;4$3*/)=S%)U5DR&4X]&4C\* *G]A:_\ ]#A>
M?^ =O_\ $4?V%K__ $.%Y_X!V_\ \15+3?%6JR3:/]OL]/\ )U? B^R7+/)$
M3&7!9"HR,#!(/'%2GQ?)'8W%O+9+_;D-R+1+%7XED;)1@<?<*C<3C@!NXH L
M?V%K_P#T.%Y_X!V__P 11_86O_\ 0X7G_@';_P#Q%;R;_+7S-N_ W;>F>^*=
M0!S_ /86O_\ 0X7G_@';_P#Q%']A:_\ ]#A>?^ =O_\ $5T%% '/_P!A:_\
M]#A>?^ =O_\ $4?V%K__ $.%Y_X!V_\ \17044 <_P#V%K__ $.%Y_X!V_\
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M'?>(=1;Q%/HVEPV FMH4E(O;AHVGW9P(P <@8Y;U.,4 2_V%K_\ T.%Y_P"
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ML>/]Q<Y]6 J-]9U^ZUO5++2['3I(M.DC0FXN'C:0M&K\81@/O8H E_L+7_\
MH<+S_P  [?\ ^(H_L+7_ /H<+S_P#M__ (BLY?'OF:EHD*V!2#4/-6Y+O\UK
M(DBQ;>.#^\8+GWS5R[\6/#XNDT.*U5XXK&2X><MTD7:=F/\ ==#G_:% $O\
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MLY)U6UN'=F91D Y48'!Y^E #O["U_P#Z'"\_\ [?_P"(H_L+7_\ H<+S_P
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M/L<S2#WSN48[51\<_P#(EZG_ -<?ZB@!/["U_P#Z'"\_\ [?_P"(H_L+7_\
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M&S49&BC:TN'9T94+9*LHRN%(R#QD4 /_ +"U_P#Z'"\_\ [?_P"(H_L+7_\
MH<+S_P  [?\ ^(K-M_%>O'0/^$BFTJR?355I)4AN7\](U)#,%*;20 3C(J_K
MOBQ-)OK&** 7$$JB:ZFW8\B%G5%?WRSY^BL>U #_ .PM?_Z'"\_\ [?_ .(H
M_L+7_P#H<+S_ , [?_XBI-3UG4$U5],TBQ@NIX+874WGS&,;2S!%7"GYF*MU
MX&/>JLGB;4+O34U/2=-A>Q%BMXTUW.8@P8%MBX4\@#DG@9'7L 3?V%K_ /T.
M%Y_X!V__ ,11_86O_P#0X7G_ (!V_P#\16Q87::AIUM>QJR)<Q+*JN,$!@"
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MP%"LW?))[8K-M](\1WOA"R\*W6F06<"6\-M<W9NPY*(%#;$ ZD#')&,UW5%
M'"R>')4UK5[BZ\&Z=K(N[SSH;BX>+<$\M%V_,I(Y5C^-=I:;OL<.^W6V;8,P
MJ01'Q]T$<<=*FHH **** .?\<?\ (L/_ -?=I_Z4QUT%8'C:.:3PQ*(+>:X=
M;BV?RX8R[D+/&QPHY. "?PI/^$PMO^@/KO\ X*YO\* ,>3P1>:CH^H37=_=6
M^J7T[W0CCF!BCE4_N>W.T)&.O:K&IZ?JVH'_ (FWAJPUF"6%&2-I$1[23: Z
M[B.5W<A@<^W2M#_A,+;_ * ^N_\ @KF_PH_X3"V_Z ^N_P#@KF_PH R;#P3+
M)>:9_;BI>Q6FFO S&5CB0R!@ >"0%XR>N*OZMX0L;K^Q;*WTNT.FVEXTUQ;L
MB["IBD&=IZG<RG]:G_X3"V_Z ^N_^"N;_"C_ (3"V_Z ^N_^"N;_  H J:?X
M3.CZA?V.G)]DT>_43!K5A'+;3 \J#C)5AS[<CH:IZIX7F'B"*Y?0H?$5LE@(
M VH2QLZOYC,3EU.>& K7_P"$PMO^@/KO_@KF_P */^$PMO\ H#Z[_P""N;_"
M@#&M/".J2P:=87DGV2Q@NIKWR[6?/V<Y_<PH2.0NYCG  ( ':B\\'7RVVJZ5
M"3>Z??W%K=YNI S;UF0S*W'(*(#]<BMG_A,+;_H#Z[_X*YO\*/\ A,+;_H#Z
M[_X*YO\ "@"I#X3CT+Q!]LT"PM8;.^A:&\A15380,I(GMV*CCH<9%9]OH_B.
M\\'6GA2YTR"S@%M%;7-V;L.3&H ;:@'4@$#)&,UM_P#"86W_ $!]=_\ !7-_
MA1_PF%M_T!]=_P#!7-_A0!FR^"9M9BUB?4[ZZMKC4Y6Q%!,-BQK\L.1CD@ -
M]2:Z;23?'2+3^TT5+T1*)PC97>!R0?0GFLO_ (3"V_Z ^N_^"N;_  H_X3"V
M_P"@/KO_ (*YO\* .@HKG_\ A,+;_H#Z[_X*YO\ "C_A,+;_ * ^N_\ @KF_
MPH Z"BN?_P"$PMO^@/KO_@KF_P */^$PMO\ H#Z[_P""N;_"@#H**Y__ (3"
MV_Z ^N_^"N;_  H_X3"V_P"@/KO_ (*YO\* .@HKG_\ A,+;_H#Z[_X*YO\
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MB@#B]5\/RR^*[_4)O"MCK<%Q#"D37+19B*;MV X/7<.GI4TOA:'6-1T>74=
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MKF_PH_X3"V_Z ^N_^"N;_"@#%U3P=J*Q:U964CWEIJT$;N;J4%A.C@'L.&C
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>7;J&!5U60RE#_LM\Z]>AJ1;B/0]42;4+E9[M+.YGNVB0C<Q:': /]U  /\
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MMY('V^7L&[I@9_C;J3UJI+X=:X,'GZQJ$@MI%EAR8_E8="3L^;C(^;/7UYH
MJS^)G-S<K;262);2-'LN&8-,R\-R!\@SD9P>G2IY-9OI[G3H["UBV:A:M.&G
M8J8<;,[E'7AP, ]?;FK4FD.)Y9;34;FS$S;I(XA&REN[#>IP3WQQWQDDU0U.
MPEEUG3%6*_9+>"11>0NNZ-V:, G)YX5LY!'/2@"6XUZ73;:\&H0Q&XM?*QY;
MD)()6V(<D97Y@0>N ,\TFGZ\\^HQ6DTEK<"<':]MN^0@9PP/; /S9Z\8YJXN
MBVOV6>&9YIWN"&EGD?\ >%EQM((P%P0",  'FGVUA<0SK)-JMU<A00$D6-5/
MN=J@D_I[4 9R:QJOV>>^DMK5;6VN'B=0[%Y%60J6!Z#&.ASG'45=N+R^FOY+
M/3T@'D(K2RSY(RV<* /89)[9'!YPS^P5.DW.G'4+LK<2M(9<1[TW-N('R8QG
M/4$\U+<Z6TMS]IM[ZXM)F01R-$$/F 9QD,I&1D\C'7O0!BV&K?V3H"%[:*WE
MFU&>W2-G_=QL'D)^8#[H",1QSP.,\:.EZU)>W<MF[V\TBQ^9'-!N"'G!# _=
M/([G//I3K?PY;VUB;5+N[.+AKB*5G4R12,26*G;SDLV=V<[B.G%6K>QN(B[2
MZG=3LR;5++&H3W 50"?KF@#.L-8U.:UL+Z[MK:.WO"B^7&[,Z;A\K9Z')QQC
M@'J<8JW+>7]S>W%OIZ6ZK:D+))/N.YRH;: /]EE.??I2)H2QZ996 O[HI92(
MZ2'R]SA>BM\F,=.@!XZU)<:4TEV]U:W]Q9R2@"41!&5\< D,IP0.,CVSG P
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MBX:=MY!P6QP..    /:DTK3#I<,T9OKR\\Z=YMUU+O*;OX%XX4=A0!>HHHH
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MRV6"-@CC;DXYXZXJI86-_IVOZ?;/,)X(;6=6E6R=069D;+/N(W,5))]<^HH
MT+O5[N.>[%E8K<16(!G9I=K%MNXJ@VG)VD'D@<@>I&G%*D\*2QL&210RL.X/
M(-8MQ-<Z=<ZHB6<]P]ZPEMC'&2K-Y:Q[6;HN"@.6P,-[&K+:''+IUE:27=W'
M]EB$8:VN'AW8 '.TC/3O0!=N[N&QM9+FX8K'&,G ))[  #DDG@ =2:J1:M,U
MU;P3Z1>VXN&*I(WELJD*6^;:QV\*?;.!4%UI#6VD/%:/=73K<17 6XN&D9MD
MBN54N>,A>.<9-1G4+B[U>S%E)>K"TA%Q%+8M&J($8YW,HY+!!C/>@#=HHHH
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M+<6L(B%J%:U)\R/!+,I(ZDL1Q_=4^E &U?Z@EB(E\J2>:9ML4,0&YSC)ZD
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M'#%'.W/GA2Y#?7#*#[Y[8IVC3^;J.JEK:YC$URLT;30.@91#$G4CKE3QUXH
M?=Z^+9;J6/3;RZ@M,B:6$(<$#)"J6!;'? ]ADUK5S%W,I:\D@M-5L=2WN(Q!
M'(T<Q!VH_0Q_, N2V"!U.,&NDCW^4GFA1)M&X+TSWQ0 ^BBB@ HHHH ****
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M\[%W:21G9F]222>P_*K%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MLH;:"1W:,>9YDTFQ$V9W9R#QC^F0";_A O"/_0N:=_X#K1_P@7A'_H7-._\
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MD;MF-F# $C!VG/78:L7GB*\U36-)N;*XEM[3[/()HE8@-,]M)(5;W3:A^K4
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M:1&/%JS1*5D'HI9B&^JGL: -+_A O"/_ $+FG?\ @.M'_"!>$?\ H7-._P#
M=:Q_#DU[XB@L;:[U*[ACM]&LIW\F79)<22JV79^I V?B2<YXK>\,WES<VEY!
M=3FX>QO)+99V !E5<$$XXR,[3CNIH A_X0+PC_T+FG?^ ZT?\(%X1_Z%S3O_
M  '6N@HH Y__ (0+PC_T+FG?^ ZT?\(%X1_Z%S3O_ =:Z"B@#G_^$"\(_P#0
MN:=_X#K1_P (%X1_Z%S3O_ =:Z"B@#G_ /A O"/_ $+FG?\ @.M'_"!>$?\
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M/@N*&5IUO2LK36\O[NW1$'E%B%"@=/F)]<\YJ?3/"-KIFHBZ2;>D;R/%'Y*
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M=-D6P5[1#_9Q!M"<YBPNT8/TXJ]10!CVOA71;*XCGALSNA8O$'F=UC;U56)
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M@FNHV0D,C;7*QYW,H.??@X!K&U7PYJ=M-I$^F6Y>"ZNK%M2MP<>4\3H?.'_
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!6)/XGMX/%4.A- Y\Q!FXS\B2,&98S[E8V/Y>M;5<#+X4UR^T:]U(WTUMJ=S
M='4([(I$565#^Y0OC=]U$4X;')H Z&]\9Z+827\<]RH?3VC25=ZY)? &.>V1
MGTJ])K^C17,=M)JUBD\K!4B:X0,Q(!  SDDAE/XCUKD=4T^_NUUY_P"Q9_,O
M$L[J-0JG.S9O3.?OC!X[U9O]#N;S3?%4D6G$3:C+ ]LK!0S*L$('TVL&Z]"#
M0!V,5Q!.\J131R-"VR148$HV <'T."#CW%9NOZS+HT-G]GLOMDUY=+;1Q^:(
MQDJS9)(/]VKUL^^6Y'V1X-LN-[!<3?*/F&#T[<X/%8_BV&[==(N;2QFO39ZB
MD\D4&W?L"2 D;B!U8=Z &CQ5);_;8-3TN2RO+6S>\2+S5D2>->NUQW!P""!C
M(ZTNL>+[?1]+T^^DM9)1>@2-&C<Q1!-[R'U"C^8K-U"RU7Q#<7>H/I<]C'!I
M5S:VL,[Q^;-)*!DD*Q  V #)ZGM3+?PUJFJ7F^[N9M.AM=.CL(E5(I/-#*#,
M2&#8!.U>WW#0!LZWXJM-"U72K.ZC8Q:D7'VA3\D.W8 6]B749[9JY%K$3ZMJ
M-BZ>6+"&*5Y6;@A]_P"6-GZUR^G>']0N7TFPUFS,]M8VM[832N01-&3$(FZY
M^9%^N0:HKX>\38UK2IP\L=]]DL8]0#KN:U!DWNPS]X(VT^K'- '7>&?$<7B2
MQDN$MI+5XW :&4_,%90Z-]&5E/YCM6S7+6&B:GHWBR*[6ZEU"UOK8P7+-'''
MY)CYB;" 9&"Z],\CM74T %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S^E
M CQIX@..#%:8_P"^7KH*Y_2?^1U\0_\ 7*T_]!>@#H**** "N;\<31VVD65Q
M,X2*'4[221ST51,I)_(5TE<_XQ_X\=-_["]E_P"CTH /^$\\+?\ 0;MOS/\
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M=: ,+_A//"W_ $&[;\S_ (4?\)YX6_Z#=M^9_P *WRP! ) )Z#/6@D#J<9H
MP/\ A//"W_0;MOS/^%'_  GGA;_H-VWYG_"M_(! R,GM0K*ZAE(92,@@\$4
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MI3OKGQ &K.2;>WL&-HG81NX5'^K^7(?]W;Z5H:G9BY\<:,3<3OY,<USY)?\
M=J%41@[1U),N<G)^7C'-=$L:(<JBJ2 ,@8X'04;%W[]HW8QNQSB@#G;2T4^/
MKZ[:XFE^S6"+^]DRL9D<DJHZ# B7W.1DFK7A L?"E@QR%:,M%G_GF22G_CNV
MM&]L8;ZUFMI-RI. LI0X+KW4GT(X]<'C%3JJHH1%"JHP !@ 4 .HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KG_\ A(KV+5+6"[TG[/:WMR]M;R&?,Q90
MQW-'MX0A#@AB>1D#/'05R%SI^K:CKEC<2Z/':WMG=Y?58I$"R6P)/E@;BYW
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M:/50?L\EM>&8@A"^&4HI P#R,\X]:LSP:AJ/@>XM9K%+6_GL)(3;(Z[5<H5
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ&@#NJ*Y_P#M/Q7_ -"S9_\ @U_^U4?VGXK_ .A9L_\ P:__ &J@#H**Y_\
MM/Q7_P!"S9_^#7_[51_:?BO_ *%FS_\ !K_]JH Z"BN?_M/Q7_T+-G_X-?\
M[51_:?BO_H6;/_P:_P#VJ@#H**Y_^T_%?_0LV?\ X-?_ +51_:?BO_H6;/\
M\&O_ -JH Z"BN?\ [3\5_P#0LV?_ (-?_M5']I^*_P#H6;/_ ,&O_P!JH Z"
MBN?_ +3\5_\ 0LV?_@U_^U4?VGXK_P"A9L__  :__:J .@HKG_[3\5_]"S9_
M^#7_ .U4?VGXK_Z%FS_\&O\ ]JH Z"BN?_M/Q7_T+-G_ .#7_P"U4?VGXK_Z
M%FS_ /!K_P#:J .@HKG_ .T_%?\ T+-G_P"#7_[51_:?BO\ Z%FS_P#!K_\
M:J .@HKG_P"T_%?_ $+-G_X-?_M5']I^*_\ H6;/_P &O_VJ@#H**Y_^T_%?
M_0LV?_@U_P#M5']I^*_^A9L__!K_ /:J .@HKG_[3\5_]"S9_P#@U_\ M5']
MI^*_^A9L_P#P:_\ VJ@#H**Y_P#M/Q7_ -"S9_\ @U_^U4?VGXK_ .A9L_\
MP:__ &J@#H**Y_\ M/Q7_P!"S9_^#7_[51_:?BO_ *%FS_\ !K_]JH Z"BN?
M_M/Q7_T+-G_X-?\ [51_:?BO_H6;/_P:_P#VJ@#H**Y_^T_%?_0LV?\ X-?_
M +51_:?BO_H6;/\ \&O_ -JH Z"BN?\ [3\5_P#0LV?_ (-?_M5']I^*_P#H
M6;/_ ,&O_P!JH Z"BN?_ +3\5_\ 0LV?_@U_^U4?VGXK_P"A9L__  :__:J
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M83L,^#L('7:,IYF./NYZ-0!WU<_XQ_X\=-_["]E_Z/2N@KG_ !C_ ,>.F_\
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MT1#<@@*[C@@#.1TSTQ@B@#5HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y_2B/^$T\0?]
M<K3_ -!>N@KG])_Y'7Q#_P!<K3_T%Z .@HHHH *YOQQ&TND644<SPN^IVBK*
M@!:,F90&&01D=>1BNDKG_&/_ !XZ;_V%[+_T>E !_P (]K'_ $..J?\ ?BU_
M^-4?\(]K'_0XZI_WXM?_ (U705S,_BF\M9-=:YTX1)IMO%+;QF0%YBYD W$9
M"@E!@<D Y//  )O^$>UC_H<=4_[\6O\ \:H_X1[6/^AQU3_OQ:__ !JL[5?%
M&J:.TME=RZ='<I);'[48G$(BF+KDIOSE3&W\7/'3I6GX8UV76A?+)-:7*VDP
MC6YM 5CERH8_*22",XZD4 -_X1[6/^AQU3_OQ:__ !JC_A'M8_Z''5/^_%K_
M /&JFUF_U.+5M.T[37M(FNTF=Y+F%I -FW  5EZ[O6JA\27L&F:C'<00'5+*
MY2T18\^7-)($,3 =0#O&1GC#<]Z )?\ A'M8_P"AQU3_ +\6O_QJC_A'M8_Z
M''5/^_%K_P#&JAGUS59O"#ZQ9M9P7-G#,;N">%I!YD0(=%PZD?,IY.>,5!J6
MO:OI5GI;7E_I4+:A.5-P]M((XE\IG *^9DG*XSD=>E %W_A'M8_Z''5/^_%K
M_P#&J/\ A'M8_P"AQU3_ +\6O_QJJBZYJMPVG6]CJ6DW4E[-*IN4M9#&JH@;
M&WS<YSGG/<<5JZ+J=U=7%]8:@D*W=C(JN\&=DBLH96 /([@C)Y'6@"K_ ,(]
MK'_0XZI_WXM?_C5'_"/:Q_T..J?]^+7_ .-4S4?$-['::A=V%NDD%I.EL)&1
MGPVX"60JO)1,]!R2K<@<U3NO%-]9:&+Q[W29UGNH8;6_B#>0RL?G+)O)!4!N
M-W/'3F@"_P#\(]K'_0XZI_WXM?\ XU1_PCVL?]#CJG_?BU_^-5G7/BJZM-&>
M]&LZ/=^9=0VT<L5NZQQ%F&XO^\.<)DX!'2MCP_J$^I+-*^JZ=J$:D*#90,FT
M]\DNV>WI0!!_PCVL?]#CJG_?BU_^-4?\(]K'_0XZI_WXM?\ XU5*_P#$.L_V
M#>ZK8&Q1;>\EMXDFA=_.VR")>0XP2X;GGJ./5FI>(M3TK58-+O-6T:WE>![A
MYY;60)C<JHH7S<Y/SDG/8<4 :'_"/:Q_T..J?]^+7_XU1_PCVL?]#CJG_?BU
M_P#C553XFO(-9T+3VDL[R/4%D>XN8(V157'[K:"QZGCDGI5O1?$,VL^(=5M8
MHHQI]BL:QS<[I7)<,?3:"N!QSUS@T )_PCVL?]#CJG_?BU_^-4?\(]K'_0XZ
MI_WXM?\ XU4\6LWDWBJ32OL!BMHK5IC,[@M(=P5=H!X4_/R>3CH.IR'\5:G;
M1ZL9TL9GTVR-W,MON(MV')A=L_,Q4$@C'3ITR :'_"/:Q_T..J?]^+7_ .-4
M?\(]K'_0XZI_WXM?_C5;_6EH Y__ (1[6/\ H<=4_P"_%K_\:H_X1[6/^AQU
M3_OQ:_\ QJN@HH Y_P#X1[6/^AQU3_OQ:_\ QJC_ (1[6/\ H<=4_P"_%K_\
M:KH** .?_P"$>UC_ *''5/\ OQ:__&J/^$>UC_H<=4_[\6O_ ,:KH** .?\
M^$>UC_H<=4_[\6O_ ,:H_P"$>UC_ *''5/\ OQ:__&JZ"B@#G_\ A'M8_P"A
MQU3_ +\6O_QJC_A'M8_Z''5/^_%K_P#&JZ"B@#G_ /A'M8_Z''5/^_%K_P#&
MJ/\ A'M8_P"AQU3_ +\6O_QJN@HH Y__ (1[6/\ H<=4_P"_%K_\:H_X1[6/
M^AQU3_OQ:_\ QJN@HH Y_P#X1[6/^AQU3_OQ:_\ QJC_ (1[6/\ H<=4_P"_
M%K_\:KH** .?_P"$>UC_ *''5/\ OQ:__&J/^$>UC_H<=4_[\6O_ ,:KH**
M(;2&2WM8X9KF2YD1<--(%#.?4A0!^0J:BB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHJ&[N?LEK)<&&6;RQGRX4W.WT'>@":BN?\ ^$M7_H :[_X '_&C
M_A+5_P"@!KO_ ( '_&@#H**Y_P#X2U?^@!KO_@ ?\:/^$M7_ * &N_\ @ ?\
M: .@HKG_ /A+5_Z &N_^ !_QH_X2U?\ H :[_P" !_QH Z"BN?\ ^$M7_H :
M[_X '_&C_A+5_P"@!KO_ ( '_&@#H**Y_P#X2U?^@!KO_@ ?\:/^$M7_ * &
MN_\ @ ?\: .@HKG_ /A+5_Z &N_^ !_QH_X2U?\ H :[_P" !_QH Z"BN?\
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MHKG_ /A+5_Z &N_^ !_QH_X2U?\ H :[_P" !_QH Z"BN?\ ^$M7_H :[_X
M'_&C_A+5_P"@!KO_ ( '_&@#H**Y_P#X2U?^@!KO_@ ?\:/^$M7_ * &N_\
M@ ?\: .@HKG_ /A+5_Z &N_^ !_QH_X2U?\ H :[_P" !_QH Z"BN?\ ^$M7
M_H :[_X '_&C_A+5_P"@!KO_ ( '_&@#H**Y_P#X2U?^@!KO_@ ?\:/^$M7_
M * &N_\ @ ?\: .@HKG_ /A+5_Z &N_^ !_QH_X2U?\ H :[_P" !_QH Z"B
MN?\ ^$M7_H :[_X '_&C_A+5_P"@!KO_ ( '_&@#H**Y_P#X2U?^@!KO_@ ?
M\:/^$M7_ * &N_\ @ ?\: .@HKG_ /A+5_Z &N_^ !_QH_X2U?\ H :[_P"
M!_QH Z"BN?\ ^$M7_H :[_X '_&C_A+5_P"@!KO_ ( '_&@#H*Y_2?\ D=?$
M/_7*T_\ 07H_X2U?^@!KO_@ ?\:J^&;T:AXJU^Y%M<6V4M1Y=S'L<85^<>E
M'54444 %<_XQ_P"/'3?^PO9?^CTKH*Y_Q@,V.G=/^0M9?^CUH Z"LB]\/07\
MNJ--,X74K6.W8* #'LWD,#ZY?]*UZ* .:N/"MU=,]W/JJG43+ XG6VPBK$6*
MKLW>KL2<]^U7+#0[JTNKJ^DU+S;V[:$2R" *GEQD_*%SP2&8;B2>1Z 5LT4
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MO9-%MC6"T$31N&#"3=N.XY&>>IY-:6EZ-/::A<:EJ%\+V]GB2'>D/E(D:DD
M+D\DL23GTZ8H YH^)=6M/";RWEV#?R:Q)8>?!!NV#SF7Y$YR0JD*#GG&<UN>
M%KV6Y^W037MU</;RJ/+O8%BN(05!PVT!6!Z@@=..U#^%8VTJ>S6[=)6U!]0A
MG"#,4AE,@X/! )Q[C/2K>D:1+87-Y>WEX+N]O"GFR+%Y:!4&%55R< 9)Y)Y)
MH U**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBJ>K:?_:NEW%@;F>U\]-OG6[;9$]U/8T 7*HW6B:1?7:7EWI=G<7,>-DTM
MNCNN.F&(R*X__A5*?]#AXD_\#?\ ZU'_  JE/^AP\2?^!O\ ]:@#M+_3-/U2
M$0ZC8VUY$#D)<1+(H/K@BDDTG39;!;"33[5[1<;;=H5,8QTPN,5QG_"J4_Z'
M#Q)_X&__ %J/^%4I_P!#AXD_\#?_ *U '9VFE:=80O#9V%K;12??2&%45OJ
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M>\<?\BP__7W:?^E,==!7GTGPE@E39+XL\12+D':]V",@Y!Z=C@T\_"I"<_\
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MI3_H</$G_@;_ /6H_P"%4I_T.'B3_P #?_K4 =]17 _\*I3_ *'#Q)_X&_\
MUJ/^%4I_T.'B3_P-_P#K4 =]17 _\*I3_H</$G_@;_\ 6H_X52G_ $.'B3_P
M-_\ K4 =]17 _P#"J4_Z'#Q)_P"!O_UJ/^%4I_T.'B3_ ,#?_K4 =]17 _\
M"J4_Z'#Q)_X&_P#UJ/\ A5*?]#AXD_\  W_ZU '?45P/_"J4_P"AP\2?^!O_
M -:C_A5*?]#AXD_\#?\ ZU '?45P/_"J4_Z'#Q)_X&__ %J/^%4I_P!#AXD_
M\#?_ *U '?45P/\ PJE/^AP\2?\ @;_]:C_A5*?]#AXD_P# W_ZU '?45P/_
M  JE/^AP\2?^!O\ ]:C_ (52G_0X>)/_  -_^M0!WU<_I/\ R.OB'_KE:?\
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M10 4444 %%%% !1110 4444 %%%% !6;KVM0Z#IC7LL$]PV=D<,$9=Y'(.%
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M/ACI&@K%']NM98&E7S!@!7R>>_% $^J>,?$6E7FE:=/H^G+?Z@)F(>^*Q($
M(^?;W!/:F:[XZUGP_P"%H]5NM*L9KF6^6V2&VO#(A4H6SNV]<KC%.\=>'-0U
M?Q!HNH6VB6NL6UE'.LUK<S+&K%PH7J#TQGIVJ";PUJ.H:5I-JGAFRT:.SUR"
M[EMH+E71HE!WMP!SR!B@">\^(ZQ^)-!TNSLEGAU:*&1YS)CRA+G:,8Y.%)K;
M\4>)O^$?6S@M[%]0U'4)?*M+5'";R!DDL>B@=3[UPVA?#G7--N+.:XV2O;:S
M"X8R@XM(D94/U^<\5UOC'1=3N[[1M=T:**XOM'F=A;2OL$R2*%<!N@. ,9H
M@C\<7MM-J%AK6B_V?J5M827L"+<"6*X1 <X8 8.1TQ[U5T[XF1:GX<TK4X+-
M1/=ZG#87-NTG,!<GY@<<C&"/7/M4,^@^(O$VJWNL:GIL>E^5I4]E96AN%E=Y
M)%(+,R\ <XQ6?<?#C5(YO"M[8[(Y+4V0U:#S %<P[<2#U(&X?3'O0!VWAWQ
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MG Z\UN3>'O$7B#5+S6=6L[:P>/2YK.SM(KCS2SR Y9GP !VQ_D@%/_A;#_\
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M_P#@IG_^)H_X3&T_Z!.N_P#@IG_^)KH** .?_P"$QM/^@3KO_@IG_P#B:/\
MA,;3_H$Z[_X*9_\ XFN@HH Y_P#X3&T_Z!.N_P#@IG_^)H_X3&T_Z!.N_P#@
MIG_^)KH** .?_P"$QM/^@3KO_@IG_P#B:/\ A,;3_H$Z[_X*9_\ XFN@HH Y
M_P#X3&T_Z!.N_P#@IG_^)H_X3&T_Z!.N_P#@IG_^)KH** .?_P"$QM/^@3KO
M_@IG_P#B:/\ A,;3_H$Z[_X*9_\ XFN@HH Y_P#X3&T_Z!.N_P#@IG_^)H_X
M3&T_Z!.N_P#@IG_^)KH** .?_P"$QM/^@3KO_@IG_P#B:/\ A,;3_H$Z[_X*
M9_\ XFN@HH Y_P#X3&T_Z!.N_P#@IG_^)H_X3&T_Z!.N_P#@IG_^)KH** .?
M_P"$QM/^@3KO_@IG_P#B:/\ A,;3_H$Z[_X*9_\ XFN@HH Y_P#X3&T_Z!.N
M_P#@IG_^)H_X3&T_Z!.N_P#@IG_^)KH** .?_P"$QM/^@3KO_@IG_P#B:/\
MA,;3_H$Z[_X*9_\ XFN@HH Y_P#X3&T_Z!.N_P#@IG_^)H_X3&T_Z!.N_P#@
MIG_^)KH** .?_P"$QM/^@3KO_@IG_P#B:/\ A,;3_H$Z[_X*9_\ XFN@HH Y
M_P#X3&T_Z!.N_P#@IG_^)H_X3&T_Z!.N_P#@IG_^)KH** .?_P"$QM/^@3KO
M_@IG_P#B:/\ A,;3_H$Z[_X*9_\ XFN@HH Y_P#X3&T_Z!.N_P#@IG_^)H_X
M3&T_Z!.N_P#@IG_^)KH** .?_P"$QM/^@3KO_@IG_P#B:/\ A,;3_H$Z[_X*
M9_\ XFN@HH Y_P#X3&T_Z!.N_P#@IG_^)H_X3&T_Z!.N_P#@IG_^)KH** .?
M_P"$QM/^@3KO_@IG_P#B:/\ A,;3_H$Z[_X*9_\ XFN@HH Y_P#X3&T_Z!.N
M_P#@IG_^)H_X3&T_Z!.N_P#@IG_^)KH** .?_P"$QM/^@3KO_@IG_P#B:/\
MA,;3_H$Z[_X*9_\ XFN@HH Y_P#X3&T_Z!.N_P#@IG_^)H_X3&T_Z!.N_P#@
MIG_^)KH** .?_P"$QM/^@3KO_@IG_P#B:/\ A,;3_H$Z[_X*9_\ XFN@HH Y
M_P#X3&T_Z!.N_P#@IG_^)H_X3&T_Z!.N_P#@IG_^)KH** .?_P"$QM/^@3KO
M_@IG_P#B:/\ A,;3_H$Z[_X*9_\ XFN@HH Y_P#X3&T_Z!.N_P#@IG_^)H_X
M3&T_Z!.N_P#@IG_^)KH** .?_P"$QM/^@3KO_@IG_P#B:/\ A,;3_H$Z[_X*
M9_\ XFN@HH Y_P#X3&T_Z!.N_P#@IG_^)H_X3&T_Z!.N_P#@IG_^)KH** .?
M_P"$QM/^@3KO_@IG_P#B:/\ A,;3_H$Z[_X*9_\ XFN@HH Y_P#X3&T_Z!.N
M_P#@IG_^)H_X3&T_Z!.N_P#@IG_^)KH** .?_P"$QM/^@3KO_@IG_P#B:/\
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M=_\ !3/_ /$U-I_BBTU#4TT[['J%K<21-*@N[5H@RJ5#8)ZXW+^=;5 '/_\
M"8VG_0)UW_P4S_\ Q-'_  F-I_T"==_\%,__ ,37044 <_\ \)C:?] G7?\
MP4S_ /Q-'_"8VG_0)UW_ ,%,_P#\37044 <__P )C:?] G7?_!3/_P#$T?\
M"8VG_0)UW_P4S_\ Q-=!10!S_P#PF-I_T"==_P#!3/\ _$T?\)C:?] G7?\
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MI%?ZAJ4\D*R7I2\LKM9HGN)'=7 RBLNU5B?J J]1GKUH ]'BN8)G9(IHY&0
ML%8$@'D$_6I:\\M;NX2WM8Q=W<>D_P"BK<SHS[HX_)DS\WWE'F! 2.@/:K%E
M_:.IWL=L]_J26"P7C02K(T;RJLD8B9FZG +8)^\ "<Y.0#MYIX;:/S)Y4B3(
M7<[ #)( &3ZD@?C4E<S/>7\O@/3KMFD%[*EDTI5<-EGCW\=NIS5+P_?7A\5S
M6\US<W2N9]Q\QP(L/\HDB9<)@<*4;##G!Z@ [.BN"\7ZK?6^JW0M);J*6U2%
MHE\]U#<Y8I$J$2#'#%S@8Z"IH[?4;G4+9Y-2U)4N=8N[:5$E*JL"K*R@8^[R
MBX8<X.,]* .WHKS>YU'6A:6*W-Y-# +27;,\TD;/,LC*,E$)9MH4A3PV3P>U
MYGUEEN[^>\O!<VMU8JD2%EB.Y8?-^3N#N;@].V#F@#MGGABDCCDE1'F)6-68
M N0"2 ._ )_"I*\[$UY-JFGS+/>3:S'/>&6VEW>5&PBE$?!^51]T C[P.>>M
M0V6HZVUC*\=]<2*;>$WI1I998B94$C#<@$;B,RG8O3 ( QR >C)/#+))''*C
MO"0LBJP)0D @$=N"#^-25S/A!8?MVN/:SW%Q;O=QF*:<LQ<>2@X9N6 ((SST
MZUSL6KZG-J):WNKZ(SQ7BR9=[B2)@K%-T6P(C CY57E@.] 'I%%<OX+O)[A+
MV*626=8F0K/]H>>)R0<A&=0P(QRI)QD8/:L4:EK4-]JJ64US>WGD7;0@.^(W
M4DQAX77"XX"E6PW<'.0 >@/(D8#.ZJ"0H+''). /Q)Q4-Y?6FGQ"6]NHK>-F
M"!I7"@L>@&>]>=S/<WFF3>;>SSV,%Q83.T<\\AC87"[VWLJD$+R5'W=H.!75
M>)[1KJ_\//'YI,>H,1LD91_Q[3$$X/J%&?<CN: .BJ&:ZM[?/G3QQXV@[W Q
MN.U?S/ ]37GLFI:FFB226-]J$U^=(GDU!9-Q^SW 4%< C"-NW *O!'.#C-2:
M]I/V75+VV2[U"26>VT_RY9)6D9B+QBY&?ERN5.,<9]S0!Z)4<,\5Q'YD$J2I
MDC<C C(."/P((_"LGP^MQ!>:O923W$T%M=*+=KAR[!6AC8C<>2-Q;K]*Y<G5
MKJSU24WVH0M::?--;K$Y4&43W&TD?Q<*HQT(QD'B@#OIIX;=5:>5(E9U12[
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MY9TGNWLI;AB[J!"T:AV& =HW<$J,J,],9'3^&9[R70[MYKAI0LT@MI%WRG8
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MIW&G+<6+R&\\UBLHG&['F<CY>6 X''3F@#NK>XANH5FMY%DC;.UE.0><5+7
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M[W;?(\U=^<9QC.<XYJ]7 VOVC_A(-.TF***6.SU>YN7DVR"9599CEU*@ 9D
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MU8MH?L]M% #D1H%SSS@8[URFI>'=:O=8>8/ ;8:C;W:8N#&-D;1D@QJGS/\
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M?->-6)!0-N4$*Q!(&0.V1F*W\;SVXGEU6R\F".RM)4*N@+RS%AC); !(')P
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M31V>GW,\$,GDO=IMV*^T-]W.X@9 )QP3[$U4T[Q8A\._;;R.22:VTVVN[@H
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MYKN0232R*BEB %'"*JC@>G-4])\(6FD7-I-#>W<BV4;QP12&,*JMC(.U06/
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M:2W4<DFP[Q&5#K@,2""P SP:MV7A6UL[];XW=W/.+@W):0I@N8O*Z*H &W'
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M;F.4I+=QV)V1R'J'F"[5//.6[\T 8GAK31/<->2:3I$N-4NC]JEN6%P-MS(
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M /O=/RKM8X8H=_E1(GF,7?:H&YCU)]31%#% I6*-(U+%R$4 %B<D_4DDGZT
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MVEE>WF8Y^T6_DN%)/=E/RG_@)_BKJ[;1]+L[:6VM=-M(()P1+%% JK(",'<
M,'CUJR]O#)+'*\,;219\MRH)3(P<'MD4 <S+:6&K>+]2MM;2.=+>")K.WG/R
M!"#OD53P3NX+=1M'3-<_'%/JL^C6Z6UOJMNLFH+;"_G95DA61 C;@K%L#@$C
MD<Y]>\O[+2]2GBM=1L8+M@K21B>W$BK@@$@D$ \CW/X&GQR6,E^UM&L9N;.-
M3C9S$CYQ@XX!V'@>E %&308[GPVNF+%'ILB /%]D8LMO*#N#*2!G#<\@9Y'>
MN:>:^N_"D_B*]G\JXNY(;>9K=B%M+43!)2AZC(WL6ZCC^Z*[ZJNGRV5UIL,U
M@(S:3)NCV)M4J>>F.^: .2U6QL=,U*SM_#\21/>6MS]IAMC\LD0B8K(0._F;
M &ZG<1FK O8KJS\%BWN%D:6='PCY+*+67<3[ D9]\5TECI6G:9O^P:?:VGF'
M+^1"L>X^^!S26VD:9974EU::=:V\\O\ K)8H55W^I R: /.-!M98K/PO++IM
MGIRW$D3#58;AFDE(Y\MUV+@R#(Y+#MUQ7J=4H1IMTDVG1PPO'9NL<D'E#9&V
MU748QC@,I&.E7: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X
MI5O++PS?>&SH]U<7DOVB.)UCS!,)68AVDZ*/FRP//!P#QGM:PX/%FG?88KB]
MD%LTOF'RP&DV(CE2[$#Y5XZG 'K0!GZ+X?O8-8U&274;Z!%EMPOE[ EQL@C4
ML=RDG)!!P1TJ?1=&NTU34[N6]OK9'U%Y$MUV".5=J\\J3@X/0]J?/XSL8-0F
MLS!<,T5[%:;EB<J2Z!]P('09_'Z&KZ>(](DFEB6\7,*NS':P4A/O[6QAMO?:
M3B@#FO#R3V$BPW#Z_&XO9V\A;7-OAIG(^;9G:002=W>H/[ U6/0Q-)+?7%NN
MHSRW.D80"6$W#L"A"ALXP^"Q##([BNP@UO3;G3'U..Z7['&"6G<%%P._(&1[
M]#4!\4:,MH]T]YL2.18V5XG5PS#*C81NR>W'/:@#1@G$YE BE3RWV?O$*[N
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MHGPFYT4R?=!?: ,G@;L$^E6=2UK3])*"]N/+9U9@JHSG:N-S$*"0HR,D\#-
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M?J=GJD4DEG*7$3F.0,C(R-@'!5@"."#R.A% '*2Z!-<:F;F6WNBTFM,';S'
M-L8CQ@'&PMC(Z$UG7&EZM'#;Q3P7#647VR.&+[-+<%#]H?RCA)%(/E[=K'(
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MG9BR"7*W08;[C<,$;C\Q W98<'(Y.*:UJZ^)KB2[L+ZXNFO8VM+B)F$<<&Q
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MB7433VT<K;9-RQEHU+,N_:1D8Y R1SQQ34\5Z=]IOX9S)";*9(23$[>:S(&
M0 98\]!D\9Z4 4?L^KR_#BS@9;DZ@+6W%PH8K,P!3S5SG.XJ&'7J:S#HOV^Y
M'DZ9<)I:ZA;O!#.C*5PK>:P1N54_+Z<@GOD[=UXRTZ.2)+<F836MQ<+(RNJ)
MY) 97.TE>20<C(QR,D WW\0:7%>)9RW:K.Q12 K%59ONJ6Q@$Y& 2"<CUH X
M?^P;VQMK6/[%(ECYEZ7A%I)/^\,Y\MBB.IR8P-K<@>V<UT'A[2+I=8^V:HMQ
M+/!86J1RS,1\^UQ(< E=W3/7ZUKVGB+2;Z\%G;7@DF.\*-C ,5.& 8C!(/4
MY%.OM?TO3;C[/=W7ER;0S81F$:DX!<@$("0>6P.#0!R?B:WU.?79Y+:QG\R&
M:V-O*D,DA9 5+E) P2,#Y@5P2V/>I[70KR>_A,L$J"%M4FB+%E196O T+$#K
M\I+#/:ND7Q#I3:B-/6[!N#(8=NQL>8!DINQC=CG&<XJM!XIL;W7+?3+)O/\
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M@,%0[&8_-C:Q&!E0<C- &#%!J9U'2M/E,VS5;:WN;S>Q#Q- %\S/?YR85/\
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MG4]-6[-RD!6U6YF5\@(I')#$ , >,CC-:-AJEGJ:2-:2EC$VUU=&1T.,C*L
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MUA#>VTY2+=(6!C=9& Y+<E20.>],LM(N-6U*(ZG97:VC?VC(8Y2RX+S1&+<
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MCFN"ZDRQE512%['*QKC.,$D\TX^&9S!!&+B/,6J7%Z3@\K()@%^H\T?D:?\
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MI_Z%>V_\&@_^-T?VKXI_Z%>V_P#!H/\ XW0!7L/"EU:VCPRW44COI\MJ65"
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M9OG-U:1W-N+&]N8KF9F4^:A01@JO8Y\L<GID\'BI_P"U?%/_ $*]M_X-!_\
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MWDB7R%EC=9,\K(N,C'<$"JW]J^*?^A7MO_!H/_C=']J^*?\ H5[;_P &@_\
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MVJWVE6]P&O+ KY\1!!7<,@CU&#VK/NO&FDVEDE\Z7SVKJ6\^*RE=!ABF"P&
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MA%Y<F[A::)+>TDE8HK!22%!(&2!SZUI:7J]EK-LT]E*SB-S'(CHR/&XZJRL
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_@%'_A1_PB?AO_H7M+_\ H_\* +O]IZ?_P _UM_W]7_&C^T]/_Y_K;_OZO\
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M]_5_QH_M/3_^?ZV_[^K_ (U2_P"$3\-_]"]I?_@%'_A1_P (GX;_ .A>TO\
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MZO\ C5+_ (1/PW_T+VE_^ 4?^%'_  B?AO\ Z%[2_P#P"C_PH N_VGI__/\
M6W_?U?\ &C^T]/\ ^?ZV_P"_J_XU2_X1/PW_ -"]I?\ X!1_X4?\(GX;_P"A
M>TO_ , H_P#"@"[_ &GI_P#S_6W_ ']7_&C^T]/_ .?ZV_[^K_C5+_A$_#?_
M $+VE_\ @%'_ (4?\(GX;_Z%[2__  "C_P * +O]IZ?_ ,_UM_W]7_&C^T]/
M_P"?ZV_[^K_C5+_A$_#?_0O:7_X!1_X4?\(GX;_Z%[2__ */_"@"[_:>G_\
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M_K;_ +^K_C5+_A$_#?\ T+VE_P#@%'_A1_PB?AO_ *%[2_\ P"C_ ,* +O\
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M_M/3_P#G^MO^_J_XU2_X1/PW_P!"]I?_ (!1_P"%'_")^&_^A>TO_P  H_\
M"@"[_:>G_P#/];?]_5_QH_M/3_\ G^MO^_J_XU2_X1/PW_T+VE_^ 4?^%'_"
M)^&_^A>TO_P"C_PH N_VGI__ #_6W_?U?\:/[3T__G^MO^_J_P"-4O\ A$_#
M?_0O:7_X!1_X4?\ ")^&_P#H7M+_ / */_"@"[_:>G_\_P!;?]_5_P :/[3T
M_P#Y_K;_ +^K_C5+_A$_#?\ T+VE_P#@%'_A1_PB?AO_ *%[2_\ P"C_ ,*
M+O\ :>G_ //];?\ ?U?\:/[3T_\ Y_K;_OZO^-4O^$3\-_\ 0O:7_P" 4?\
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M5_QH_M/3_P#G^MO^_J_XU2_X1/PW_P!"]I?_ (!1_P"%'_")^&_^A>TO_P
MH_\ "@"[_:>G_P#/];?]_5_QH_M/3_\ G^MO^_J_XU2_X1/PW_T+VE_^ 4?^
M%'_")^&_^A>TO_P"C_PH N_VGI__ #_6W_?U?\:/[3T__G^MO^_J_P"-4O\
MA$_#?_0O:7_X!1_X4?\ ")^&_P#H7M+_ / */_"@"[_:>G_\_P!;?]_5_P :
M/[3T_P#Y_K;_ +^K_C5+_A$_#?\ T+VE_P#@%'_A1_PB?AO_ *%[2_\ P"C_
M ,* +O\ :>G_ //];?\ ?U?\:/[3T_\ Y_K;_OZO^-4O^$3\-_\ 0O:7_P"
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MWMN.#C'4^E1Z7X-?3)X6'B76[F&%"@MIYT,9&TJ 0$'3/'/84 >7:1XMU_\
MX0RYTF75KM]3U&>W>SN7F8RK$^=Y!SG"^4W_ 'U[UZKX'O9;GP'I5[?7+RR-
M:AY9I7R3UR235*U^&FAVD^F3K+=/)IEK):PLS+\ROOY;Y>2-[8Z5JIX7M8O!
M_P#PC$5U<QVOV8VWG*R^;L/!YQC)&1TH X'PEXVNKOQO%=7>K+-I^OR3QVUG
MYP)M"A CRF?EW 'L,DUF7NJZK/?>(Q9ZKXF?5K?598K""SWR6P4,,*PP5 Z\
M9Z8XKT2[^'OAZ?3+6S@M%LI+1HGAN[6-$G5DQ@EMIR3CG/6M/1= M=#DU%[:
M25SJ-X]Y+YA!VNV,A< <<=\T >9ZSJE^WBW6+74-4\0P3P6=LT%OHY=T69H@
M6!4 C!;Z9YK=T34_$/\ PDGA2SUF>:.>?2YGNX"<!G!^4LO][&/QS77V>@6M
MEX@U'6XY)3<:BD22HQ&Q1&,#;QGOSDFJ6O\ @^#7=5M=3_M34-/NK2-HHWLI
M%0[6ZYRIH SO%NH7EKXS\,VUO=310W$-^98T<A9"L(*Y'?!Y'I7*>!9[S4X-
M(NKR;QO--)(K/.)P;)L-WRV2G&#QZUW*>"[<W.G7-UJNI7L^G?:!%)<2(S,)
MD"L&PHZ <8Q^-5-)^'RZ*EM#9^)]>6VMF!2W-Q'Y9 .=I&SH>_UH Y'7;W7-
M-UG4;O5]3U^PC%X39:A98GL(H<C:LD0(YQD'/.?U[7Q[K]UHG@BYU+39$^T/
MY<<4V,JF]@-_Y'(_"JUY\-=.NI;M$U35+?3[Z8SW.GPS@0R.3D]L@$CD UT>
MHZ-8:KHTND7=NKV4L8C,8XP!TQZ8P,?2@#B=4M-2\#W>AWT/B+4]26]U"*RN
M[>^F\Q)!)GYD&/D((S@?_KYM/&>M:;;>*;?4+V?[/=R7J:9=F0[H)HL_NP?X
M>,%?<<=:[W3_  !9VFH6=Y>:MJFJ?8#FSBO9PZ0GLV !DCL33KKX?:->^'[[
M1;AKAX+R\>],A9=\4C')*'&!W'(/!- &=X9U2_N?&T-I/>320'P[;SF-W)!D
M+#+_ %/K1XWU/5_!^IQ>)+1IKVPGC-K/8M(=J2D?NI%!Z9.%./YFKUS\/[:7
M4(;ZUUO5K">&SCL]UK*B[HTZ9RAYJ_?^%+?5/#L.BWU_>W"12))]H=U,KE6W
M#)VX]NG2@!?#FD:A9^&A:ZOJ-S<:A<JSW$_FDF-WZB,_PA>@QQQFN3T31KI_
MB%JVF2>)=>DMM+2VFB5[XG>6&XA^.1QTXXKTBLNTT"UL_$.H:W')*;C4$C25
M&(V*$&!CC/?G)- '":3!J_BSPU?>*Y?$VIV%R7G:UM[>;9! L9(563'S=.<U
MT5KKUYJWPHDUMV,-Y)I<LA>/Y2'5&^8>G(R*9=?#?3YYKM;;5=5L;*^<R7-C
M;7 6&0G[W!!(SW -=#+HUF^@2:'$A@LWMC:A8^J(5V\9SSCUH \7;Q=KW_"!
MKH_]K78U@2?:C<^<WF?9OLWVC[V<]3BNML9M3\6:[::++K5_86EGH]O<RM9S
M>7-<RNHY+]<#^=;9^&>AF4R^;=;SI(TK.Y?]6%";_N_?VC&>GM5B^\"6-RUC
M/:7]_IU[8VRVJ7=I*%>2(#A7R"&'?IUH XC5=9UJSTS6M .LWDCZ9JMI#%?K
M)MG:*7G:S#J1CK6EJ\NJ>$-9ETN'7-0O[74-)NY4^V2[Y;>6.,L&5P 0/ZUO
MO\.=(?P_+I NKX&>Z6[FO/-#7$LH.0Q8@C]*EMO 5A$]Y/=ZCJ6HW5U:O:?:
M;R8.\4; @A,* .OI0!P<NK:C=7WAN"YOO$DL4_A^.>5-(D8S/+NQO8=_<_2M
MR75+O1==T5(KK59;9=(N[IX-0D)ED898"0?WAT'H*ZG2_!VGZ3J-A?03W+26
M&G#3XP[*0T8.<G ^]Q]/:K5WX>L[SQ#::W,\AGM8)(%CR/+97ZY&,G\Z .0\
M/:1K6JZ)I?B9_&%]#?73+/)'(X:T*,?]6(N .,#.<YK/^('B^^M/%173=62V
MBT"*.XN+8SA#>.[KF+&?FQ'D]^M=%%\,]*CEAB.H:G)IEO-Y\6EO.#;HV<CC
M&2H/.":T+7P-H,+7\EU9QZC-?W#SRS7D:2."W\*G'"CL.U '.?$!))-+L?$&
MEZ_JUNM[<6T2I;792(QN?O!1W(/6G:E/>>%?%6EVD.IZC>V\>G7MRZ75P9#,
MRKN&[UQV]*WAX&T__A%[+P\]Y>/;6,Z312,Z^9\K%E4G;C'..G2M"\\/6=[X
M@L]:F>0S6<,D*1Y'ELK]=PQD_G0!Y^(-<_X5]_PFY\5:E_:?D_;/)\T?9<9S
MY?E8QC''UIK>-=5L?'1U6>24Z$UI9_;("Y*VOG)D2 =L,,$^]='_ ,*PTKR_
ML7]IZK_9'F>9_9?VG]QUSMZ;MN><9ZULGPGICW^IW4JO(NJ6R6T\#8\L(@(&
MT 9'!]: . BO?$NI^"=+N;6ZU*\B_M"Y^VK97.V[DC#L$V,>2!Z#MBNJ^'>H
MK>V%]#_:NH7C6]SCR-3AV75J".$<Y.[OS]:(OAKI5MHNGZ?:7VH6\NF2R26M
M['*HF0N?F&=N"#Z8[5K>'?#%KX<6Z>*XN;NZO9!)<W5TX:20@8&< # [#% '
M+Z=::EXWU?7[B?Q#J>FQ:=J$EC:P6$_E*OEX^=ACYLD]_?\ #FKCQ1J^JZ=X
M5%U>ZL6DN+RWNSH[%9KKRP-K*HX/J?\ @5=[J/@*TN]3NK^RU;4])>^Q]K2Q
MG"),<8R00<-CN*LV_@G2+.70WM!+ FA^;]FC1AM8R+AB^1DGOP1R: )?",0C
MT,,'UEO,D9L:R<W"]L>PXR/K7'^'[/6?&'A[_A*F\5W^FWEQ.[01)(/LL"+(
M5"M%T;@=SW'X^F5QUS\--*N))XEU#4X--N9O.GTR*<"W=LY/&,@$\X!_*@"D
M8]1\6^.-9TN;6[_3K+1HH%5-/E\AII)$W%V/)P,8 Z=/?/-:IKWB<Z#_ &59
MZK+)J5AXF73X;O=L-PFQRJR8X/.,YX.!FN^U7P19W^IC5+*_OM(O/*$+RV$@
M3S4'0,""#CL?\*2#P%H]MIVGV4+W*K8Z@NH^89 TD\PSS(2.<YYQCH* .9TG
M7I?'/BLVB:A?Z?#)H2M<06TYC>WN5N</CT;C&<9*GWIGA:TOGT[Q+J4WB'6I
MY-*O+VU@CEO"R%43"EAW89SGCD"NRL?"&F:=XLO?$MKYL=U?1>7-&"/+/()8
M#&<G:,\^M/T_PO9:=8:M9PS3M'JUS-<3%V&5:488+QT&.,YH \LT'6-4N9/#
M\.FZMXCDUFZ>.6:/4)?]$EA'^L*[^6&/3/>M?QWXQO;/Q<[Z?JJV]MX?2&2Y
MM//"&]9W&Y N?FPG/?'-=A/X$TR?1-*TP3W43:.RO:7<;*)D*^^W'/<8P<4Z
MT\!Z!!%>BZLTU"6^GDFFN+N-'DR_4 [1@#L!TH R=6O;GQ-XVL?#]IJUU8Z:
MVE_VD\UE)Y<D^Y]J@/U [\5+=^'=0@\+7T4_BS4YVL3--;S03>7*%"Y$<K#.
M_!'7CK5@_#RP73]-@M]3U*VNM+C:*WOHI5$WEDYV-\N&7T&.U:&D^$M/T?1;
MS3(9;B7[<7:ZN9GW32NXP6)QC/X4 <=8V/B!OAA'JFEZWJ=WJFH00LRW%X"0
M-WS"(M]UB,^OYT_PQXA73)M9-QJ.MH;2P-T=,UQ"TJ[>KI*3\RGIC'4UU<W@
MS3+CPE;^&Y9+@VUJJ"&8.%FC9>5<,!@,/I6>/AS92"[DOM5U+4+J[A6W:XN9
M%9EA#ARB@*  <<_4T 86G1:SK>MV7AF]US4;.*QTB*ZNGMYRD]Q,YYR_7:,X
MQ[?EF:WKFM:7H_B/0SK%].VD7UFL%ZCD7#1R\E"PZD8QGOFO0-=\(6FM:C!J
MD5[>:;J,$9B6ZLI C,A.=K @@C/-5!\.](&AS:69[QS<7275Q=O*&FFD4Y!9
MB,8XZ8H Y30M2U"77]1BTG4M=EL+.PE^W)K,@\V&7:3'L!^8'\*KVT^L:+X"
MTCQG'XBU6YN'DB^TVEU<>;#*K/M( (R#[YKT'4/"5A?:\-:$UQ;736SVLWDL
MH6>-AC#@@YQU!XZ#TK*T_P"&>F62V4,^JZM?V=BXD@L[F=3"K#D$JJC.#0!R
M2WE]>^(O$"7$OC2Y6WU*2*(:-,/*C08PI!88/T[8J7Q-JALO&5U;W^J>)X=/
MM--AD']FRMN0]"TG8>Y/>NM;X?QIJ%]>6?B/6[ WUPUQ+';3QJF\]< H:T[3
MPM9VVKSZG)//=37%DEG,)RK+(B]R,<D]^WM0!Q'F>,KGX=Z;*+B\GDDO-\GV
M>X1;R:TY*[7&1NZ'CG&/>MSX=ZB+HZI:'4]4G:WD0_8M7B*W5H"#PSDG>"1Q
MZ8]ZG'PYTN/1H=,AOM0B6TNFN;*9)0)+0GJJ';]WKP<]>M3V7@:WLK74 NL:
MHU_J31F?43.!/A""JJ0N ,<=.A/M0!T]%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 445#=W*V=K)</'+(L8R4AC,CGZ*.3^% $U%<__ ,)C
M:?\ 0)UW_P %,_\ \31_PF-I_P! G7?_  4S_P#Q- '045S_ /PF-I_T"==_
M\%,__P 31_PF-I_T"==_\%,__P 30!T%%<__ ,)C:?\ 0)UW_P %,_\ \31_
MPF-I_P! G7?_  4S_P#Q- '045S_ /PF-I_T"==_\%,__P 31_PF-I_T"==_
M\%,__P 30!T%%<__ ,)C:?\ 0)UW_P %,_\ \31_PF-I_P! G7?_  4S_P#Q
M- '045S:>.-.DEDA33]9>2+'F(NF3%DSR,C;QD<\U)_PF-I_T"==_P#!3/\
M_$T =!17/_\ "8VG_0)UW_P4S_\ Q-'_  F-I_T"==_\%,__ ,30!T%%<_\
M\)C:?] G7?\ P4S_ /Q-'_"8VG_0)UW_ ,%,_P#\30!T%%<__P )C:?] G7?
M_!3/_P#$T?\ "8VG_0)UW_P4S_\ Q- '045S_P#PF-I_T"==_P#!3/\ _$T?
M\)C:?] G7?\ P4S_ /Q- '045S__  F-I_T"==_\%,__ ,31_P )C:?] G7?
M_!3/_P#$T =!17/_ /"8VG_0)UW_ ,%,_P#\31_PF-I_T"==_P#!3/\ _$T
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M+Q;J\\2+ILUZ\I:2%/+3<$8G@YSC\:Z+4-.\,:H9S=:3XE;S]06_<?V9-_K
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M#.:Z6/\ L&/0M3T9=,\2_9M3FEFG)TR;<&D^]M.S@<<=:I3Z=HLE_P#;K?\
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M6.#3IE$$HSS'^[^4<]/88Q0 W4WOO"NM:GHMKJ^H7=I=:#<72"ZN#));RH"
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M<PVUI/'')A=N" F2,>_<T^^L?#]U)8/:V?BS3#IT!M[?[!83Q%4/4$["3^=
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M$QM/^@3KO_@IG_\ B:/^$QM/^@3KO_@IG_\ B: .@HKG_P#A,;3_ *!.N_\
M@IG_ /B:/^$QM/\ H$Z[_P""F?\ ^)H Z"BN?_X3&T_Z!.N_^"F?_P")H_X3
M&T_Z!.N_^"F?_P")H Z"BN?_ .$QM/\ H$Z[_P""F?\ ^)H_X3&T_P"@3KO_
M (*9_P#XF@#H**Y__A,;3_H$Z[_X*9__ (FC_A,;3_H$Z[_X*9__ (F@#H**
MY_\ X3&T_P"@3KO_ (*9_P#XFC_A,;3_ *!.N_\ @IG_ /B: .@HKG_^$QM/
M^@3KO_@IG_\ B:/^$QM/^@3KO_@IG_\ B: .@HKG_P#A,;3_ *!.N_\ @IG_
M /B:/^$QM/\ H$Z[_P""F?\ ^)H Z"BN?_X3&T_Z!.N_^"F?_P")H_X3&T_Z
M!.N_^"F?_P")H Z"BH;2Y6\M8[A(Y8UD7<$FC,;CZJ>0?K4U !1110 4444
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M_>MO_15=!7/Z-_R-_B3_ 'K;_P!%5M7=U!8V<UW<R".""-I)'/\ "H&2?RH
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M]X^Q=J%L'!/.!P..IXH EHJGI>J6NL62WMD9&@<_([Q,F\=F&X#(/8]#5R@
MHHJE+J]A#.8'N!Y@G2W*A22)&7<J\#TY^E %VBBH[B=+:WDGD#E(U+,$0NQ
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M$+R#(*K(1M)R".O4$58U+6;/2FACN#,\L^[RX8('ED8+C<=J@G R,GIR/44
M7Z*QI/%>D)%:2))<3B\61H5M[265R$(#Y55)7!(!R!@\4EUXKTRRM([JYCU&
M.*3@,=-N.#NV@,-F5R<8SC.>* -JBJ#:S9QZ/-JTQG@M((VDD,]O)&ZJN<G8
MP#=O3FHH?$6GRQ3S.+NVBMXS)))=V4UNBJ.O+J ?H* -2BLFV\3:9<R/'NN(
M'6)I@MS:R0ET'5E#J-V.^.1D5':^+-)NWMUC:[3[4,P--8S1K+\N["LR $D
MD ')[4 ;5%8MMXLTN[NWM8DU 2QX\P2:=<((\C(W%D 7@=ZN#6+ VEC=B?\
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MJIINI6^JVYN+9+A4SC]_;20D\ Y < D<]1Q5N@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "HKBW@NX'M[F&.:&08>.10RL/0@\&I:* ,C_A$_
M#?\ T+VE_P#@%'_A1_PB?AO_ *%[2_\ P"C_ ,*UZ* ,C_A$_#?_ $+VE_\
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M%T0/PX1MP*E2.!P1TZ4T>+[QT:&+3+62]74%L2JWI,!+1^9N$@C)X'!&W(-
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M B BC*Y5L_-N.,8['G&*[6B@#@;?PYJ=KH^G3S->W<,-WYESI3, NWS2590
M"2IVOM)((![XJ:XM=1AU&;^SK#4K2\DO=[1JRRV,ZF3)D;=G;E>3MVMN]>I[
MBB@#A[ZUU%=&UWP]'I=U)-J5Q.8)U4&'9,<[BV?EV[CD'GCC.:=JNB:]J=UJ
MFK6[P0RQ2Q_889K=FD80'<N'#@*'<N/NGY2*[:B@#A[S1]2F.LZY8VCQ7[7
M>*&3Y3<P-:P*\1]]RG'HR>A-:7]GW?\ 9WA*/R'W6<T37 _YY@6TBG/_  (@
M?C7344 5M2C>72[N.-2SO"ZJ!W)4XKGYM/O8=%\-W*VCSR:28Y)[52-[#R&C
M.,G!92^<>Q[XKJ:* .6,<FJZY)JT^E72645F+98I$VRSLTJMG;G(5=HZXZGC
MUO>( 9;[0K=_]1+J.9!V.R*21 ?^!HI_ 5MTR2*.7;YD:OL8,NY0=I'0CWH
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MED>Y0(S,T+QB-1DYR7R3T^4<U5T[0-0T]O#D]S)>ZA;PQQI+:RN/]#E\O D
M4#(&2I!SC((Z&NWHH PH+.Y76=?F:%A'<QQ")NSD1D''XUAVGAB\MM)\+MYN
MH236TMLUQ;RS%DA C(;Y>V#Q7<T4 <GXPTR]OYKHVML\H?0-0MUV]Y'\K8OU
M.T_E3%T2_P!.\7::MK"7TCSIKG@_\>LC1L&7']UF8,/0EO:NOHH QX[6<>,[
MB\,3>0VG11B3L6$DA(_(C\ZP+G2K\> K&T^S7(GAOXI72 ?O507.\E?<+S7;
MT4 <=<VDNHZ)+9I!J\^;VS=EU%1RBW$;/M]@H)-5+'1-6_M+2);NVD(TJ]%I
M$Y.<P)%,/._X'NC!]UKO** ,7Q'IYNX[*6"V62>*^MF+A1N6,2JS<^G&?PK)
MU'1=<;Q38ZDOV6XC&H!@VUMT$(AE4+Z8RQY[LP[ 8["B@# \06.HZIJFG6MI
MY45O;EKJ66XA,L;.!M1"H92?O,W7C8*P[+0=7,VD:=<2W5NNE-<P"]M@%WQ%
M4,1&[=@8^7!SRAKNZ* //9]'U&VMK:&>WU"6XMM:,]S?6IW2W*&WD191GH<%
M$*C@8XXQ77: Y-I(I&I</G=J  <\=O:M2B@#S:T\-ZO'I(TPV4@M;NW^U7 .
M.)XU90GU8B C_<:KDOAW7=6AGE22&R>VM8+>T6XMR[[HPLF]6#@+F3 Y!_U8
MKO:* .0L=1U"TU/4;V70-0DDOXK>2.*-%P&$0#(6) &#QDUEVNB7VC7EI'<K
MJVV/2+> R:6 5\Q7E+*<]AN&/:O0Z* ,#78)]0\#W-O;0W+S26VU(YAB5CQ]
M[WXK"U/P_J?E:]J>GVQ^WM<S*D1./M=N\,:E?J""5]UQT)KO** *>FQ21:-:
M0R*5D2W164]00H!%<Q'HE[-X1\(V#QW$$MHUO]I\IMKP[8&4\]N2!^-=G10!
MP.L>'KZ"XU,P#4;J.1],=9?,\R4B.X=I-A/=5P?QKI/#[G]^A&KGH=VHJ!Z_
M=_K6U10!R=M+J&B6VHZ:NBW%]/-=SS6[J!Y,PE<N-[$_+C=M.1T7C-30/=Z#
MJVJ/-IEU=IJ$R7$4MH@?!$2(8SDC;@ID$\8;KQ7344 <)9^$K]UMTG M;J*U
M>:"=/F6VN&G:15'J &VD="N1WJ:WT_5I_ =U#=6#0W\^H23M;J=V-UUOX/<8
MYSZ5VM% '-ZMHUYJ/BF.:"\N[&-=/>/[1;%?OEU(!W Y]?PK)L](UBXAT[3!
M;)9FRN)KF\N+F-IXKF8'"L/G!8.7,G)^4J!VKNJ* .(L;#5M*CTMKBSEO%T.
M::V_<IS+ ZCRY$4DYVC"D9)^]U[ZMX]]J_A[70NEO;>?;216RR ":<^61EE[
M<G !Y^E=%10!!9(T=C;HXPRQ*"#V.*GHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHJ&[NH[*UDN95D9(QEA%&TC'Z*H)/X"@":BN?_P"$
MUTO_ )]=7_\ !1<__&Z/^$UTO_GUU?\ \%%S_P#&Z .@K \:?\B\O_7_ &7_
M *514G_":Z7_ ,^NK_\ @HN?_C=97B7Q%::OHKVEG#J4=P)H)D:;2+K9F.5)
M,'$>>=N* .UHKS__ (37Q!_SZP_^"B__ /C='_":^(/^?6'_ ,%%_P#_ !N@
M#H/#7_(6\3?]A0?^D\%=!7"^'/$,>GG4I]3AOGN+^[^T$6VD7>Q1Y:)CYH\_
MP9_&MK_A-=+_ .?75_\ P47/_P ;H Z"BN?_ .$UTO\ Y]=7_P#!1<__ !NC
M_A-=+_Y]=7_\%%S_ /&Z #1O^1O\2?[UM_Z*KH*X72_%6GP^)M<N&M]3*3M
M4"Z9<%AB/!W )E?QZUM?\)KI?_/KJ_\ X*+G_P"-T =!6-?:9?QZS_:VE26_
MG20+;SPW(8+(JLS(0R\@@NW8Y![8J#_A-=+_ .?75_\ P47/_P ;H_X372_^
M?75__!1<_P#QN@"LG@X37=O=:FUM>NUW+=7:/#E'9HQ&H53GA0JCGTSWIA\*
MWUE#';:7-:BUM-06[LXI@P$:E6#1DCMELKZ X["KG_":Z7_SZZO_ ."BY_\
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M /":Z7_SZZO_ ."BY_\ C='_  FNE_\ /KJ__@HN?_C= '045S__  FNE_\
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M+G_XW1_PFNE_\^NK_P#@HN?_ (W0!T%%<_\ \)KI?_/KJ_\ X*+G_P"-T?\
M":Z7_P ^NK_^"BY_^-T =!17/_\ ":Z7_P ^NK_^"BY_^-T?\)KI?_/KJ_\
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MKI?_ #ZZO_X*+G_XW1_PFNE_\^NK_P#@HN?_ (W0!T%%<_\ \)KI?_/KJ_\
MX*+G_P"-T?\ ":Z7_P ^NK_^"BY_^-T =!17/_\ ":Z7_P ^NK_^"BY_^-T?
M\)KI?_/KJ_\ X*+G_P"-T =!14-I<QWMK'<Q+(J2+N42QM&P^JL 1^(J:@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J6L:O8Z#IDNI:E,8;6
M';O<(SXW,%'"@GJ15VL#QJ ?#H!&0;^RX_[>HJ &CQOHS $1ZH0>A&DW7_QN
ME_X3;1_^>6J?^"FZ_P#C=2?-X:;NVC$_4V1_^-?^@?[OW5FN)=?F>SL)6CL(
MV*W-W&V#(1UCC(_)F'3H.<E0"SHGB#3?$5O-/IDSRI!,89-\+QE7 !((8 ]Q
M6E7-^$H(;6_\16]O$L44>IJJ(@P% MH, "NDH **** .?T;_ )&_Q)_O6W_H
MJMF[OK2PB$U[=0VT9.T/-($!/ID]^*QM&_Y&_P 2?[UM_P"BJK>.Y%B@T:1[
MJVM574U)FNDWQ)^YEY89&?3J.M '26]S!=PK-;3QSQ-T>-PRG\14%YJ^F:?(
ML=[J-K:NPW!9IE0D>N":YSP==P0'5"]S;S1W&H+Y5W;Q^5#<.T:C;&N3C&W!
MP3DY.<Y O^-+>*70U=H4=Q>68!*@G'VF//\ 6@#8MK^SO%5K6[@G#+N4Q2!L
MC)&>.V01]145QK&EVBJUSJ5I"KLRJ9)U4,5.& R>H/!]*PKJTOCXW*:7<V]D
M%TQ=V^U\Q3^];@ ,N*YB*5K.YTAKO4].LW$NL*]Q?6^Z)V^UIT7>N">2/F/
M/7K0!Z7;75M>P+/:7$5Q$V<21.&4XZ\BE%U;LLK+/$1 2)2''[L@9(;TX.>:
MRK;5[2T\+RZG]LM+Z*VC=WDL4V1N1DX5=S8/08R>:Y"&#5=!M[E=4LTA&L:?
M.)G2;S-]V%DER1@;<AG'4_<4=J ._L]4T_4"PL;^VNBGWO)F5\?7!HBU/3Y[
MQ[.&^MI+F/[\*3*77ZJ#D5YWIKSW5Q8C2]0L-0N_[*GA0V$'E&U<QJ5,C;FS
M\RA<';R<X/;0-SHUSH6CZ;HRQC5K>>VV0*N)[4JZ^:9!U4;0X8G[V<<YH [C
M[7;&U%T+B+[.0&$N\;"#T.>E5O[=T?[3]E_M:R\_?Y?E?:$W[LXVXSG.>,5S
M,5M)_;"^$RC?98+PZAG'RFVSO1/^_P <8_NI5+PY?VT%P\,VNZ' PU2ZS:36
MV;GFYDP-_FCDY!!V]".M '?--$DJ1/*BR29V(6 +8ZX'?%-^U6WF>7]HBW^9
MY6W>,[]N[;CUV\X].:YKQ7IDFJ>(-&2WF,%U#%<RVTXZ1RCR]I/J#R".X)%8
M=CJ3/.^L7]N]DEOXEW7@D'$'^@"(DG^[O8#=TP0: /0);ZT@+":ZAC*%0P>0
M#!;[H.?7MZTLMU;P2)'-<11O(&**[@%@HR< ]<#DUY_K,-KXEEU)H)!-87M]
M8VR7,1RK$9W%&'!QN'([_2J]S<76LWUCJEY$R2V\5Q8E2, 2K;2&8CV+D+_V
MSH ]"M=6TV^W_9-0M;CRQE_*F5]H]3@\4RWUW1[N40VVK64TA!(2.X1B0!D\
M ^E>?:3,DTNE-#?6&HLFF31.EC;^6UJ#$#F5@S;N5"X.WDYP>U_PM?VS:)9V
M_P#;FASR_P!G!1:P6VRX!$7(+>:<D8.?E['I0!VEKK.E7TOE6>I6ES)C.R&=
M7./H#38]=T>6Y%M'JMD\Y;:(EN$+$^F,YS7$Z7:WL$/A&356LQI^R%H9K6U,
M<B3&+")(Q9OE8$C( RV <9J7PA?VT8M+>37-##^<Z_8S;8N<EVPN_P WKG'\
M- ':6^KZ9=W!M[;4;2:89S''.K,,=> <U8GGAM86GN)4AB099Y&"JH]R>E>=
MP7.EW?A>RT^Q:";7$O%,20@&6%A/DLV.5 7.2>V1WKI?%!AAU#1KO4 /[,@N
M'-PSC,<;E"(W?T .1D\ D&@#;AO[*YM/MD%W!+; $^<D@9,#K\PXID.K:;<V
MCW<&H6LMO'G?,DRLBXZY8' KDM3GTB^0WFGVQETQ-2@EU*>)=T-PH0_,,9#A
M6\LL0,8'?!Q3\2S6&K'4;K1&AN+0:1-'>SV^&BD8NGE+D<,P D^@/O0!WT]Y
M:VJ[KBYBA&TMF1PO ZGGL*J1^(-%F+"+6+"0HI=MMRAPHZD\]!7,6L%Q8>,=
M*T*ZC>:VMH;EK2=QN#PD* C'^\F-ON-IZDU%?VD2>#_&C1VZ*XEN0I"#./*7
M@4 =E9ZKIVH,RV5_:W3*,L(9E<@>^#4\<\,SR)%*CM$VV158$H<9P?0X(KBK
MJ2;0_$L-_P"('M!%;6<[VDMC:F(2L%R\;Y9CG:,J,X//<57T>#6]&OHWO+1+
M676X)$DD6??F[.^5"1M&WAG7O]U1VH [=-3T^2\>S2^MFN8QEX1,I=1[KG(J
M&'7]%N9DA@U>QEE<X5$N49F/H #S7-:)>^'/[+T331;B;4X&C#6J+_I%O,!B
M1Y!D$ ?-N8_>SWSS=MULM/\ %&OWDL$216UG;2E@@&T 2DD?E0!O7&J:?9P&
M>ZO[:"(.4,DLRJNX<$9)Z^U)<:KIUK!'<7-_;0PR_P"KDDF55?OP2<&N2LUM
MM#UFUNO$3Q6\<FG*8I[@@11W#R.]P-QX5F+)C/4#V-48+6YGU2R;2Q!;VDVJ
M74EB+FW9XQ%Y W$(&4[6<2$<CKGO0!W3:OIB68O&U&T6V9MHF,ZA"?3=G&:=
M_:FG_8C??;K;[*O!G\Y?+'./O9QU.*\_#063!]9:WM[I=>C>_38([=!Y+*CH
M"3\K* <DYSD'I3M;EM)UU>_TE[>+2VDTP-<&/-NTRW0+/C(# (4W$$9QC/'
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MWOK.\"FUNX)PZ[U,4@;*YQD8[9!%<?,DNJ:SH!T[4=*N&%K>[KA+,R0-\\/
M02<'_@1Z'UXM27]EH7B^+^U;^SMLZ4J[SB&-V\TD[5)./7&30!OW.N:19SM;
MW6JV4$RXW1RW"*PR,C()STJ6YU33[(Q"[O[:W\[_ %?FS*N_Z9/-<*VHVL?B
MK7G_ +>T.R26>!XQ?VWFM(IMXL,I\U?E_ _6M);[1+#6M;?7I;9?MAC:U><
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MF0$A2 F-G4@Y(X( .J:[MDG6![B)97.%C+@,3UX%"7=M).8$N(FE ),:N"P
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M'XPTJ6PU:[0S$:1-)%<Q[1ORC$$@9Y!(.#['T-+JVF75WI.F6\* R6]W:RR
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MOQ@GH,UJ3H9()$ R2I ^N*XK4_".KWGA&UMH;M$N;;1OL@M'C#KYACVL0VX
M$_=SS@9QU- '<USS>,;9#/(^FZ@MG;W+6TEYLC,2LK["<!]V,]]M:MG<3FYD
MLYXV9H(HR;G;M25FW9P.V-N<9_B%86E^$(6-Y)JHN7\W49KA;<W;^2RF4NA,
M8;:>QP1UZT :DOB&SBT?4=49)O(TUIEF 4;CY6=VT9YZ<=*@NO$ZV]S?Q)I.
MH7,>G,%N)X1$54^6LG +ACA7'05DW^DZRVFZUH,.GB2'5)IF2]\]0D:2_>W*
M?FR,M@ $'CD4[4O!TVIS:_<>=-!/=7*26N+J00RJL$2[9(U;:5+*RG(SC\*
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MANV3P>.F9K?Q"CW-K;W>GWE@]X66 W(CP[* VW*.V"1D@'KM:LZYT6_E\/\
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MT&>-PYY.1GUYK/TK1]<T+^UFC%M=I)-#Y$"((0\:QQHVWYCM.%( /&5SGG@
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M_0$MOR/^-'_"!^%O^@);?D?\:/\ A O"?_0OV'_?D4?\(%X3_P"A?L/^_(H
M/^$#\+?] 2V_(_XT?\('X6_Z EM^1_QJ#P;96NG77B*SLH$@MXM4PD:#"KFW
MA/ ^I-=/0!S_ /P@?A;_ * EM^1_QH_X0/PM_P! 2V_(_P"-=!10!PNE^#_#
MT_B;7;:72H&AMV@$2'.$W1Y..>YK:_X0/PM_T!+;\C_C1HW_ "-_B3_>MO\
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M %)&>>QK7U!M:M;728]+;4;:ZFU!SY.I3I(TRK!(_EDJS *Q0#KP>: -?_A
M_"W_ $!+;\C_ (T?\('X6_Z EM^1_P :S[2__P"$G?59(;Z]MX(HH9(TBE,;
MQ/M<.C8Z$,,$>JU72]ETKP!97;:E>27NKPV\:RS2-(8WD4%G48XVJ7; _NT
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MJZ8)(7;GG.">G0U<U%K[3O#6M7D<>OV<T5C(8Y+^[CD4-URH21L-QUH V?\
MA _"W_0$MOR/^-'_  @?A;_H"6WY'_&HQ'<:)XCTNUBU&[NK?4/-22*ZD\PJ
M53<'4XR.F",X^85G>,+_ %**^N[6QU"6T9K:S\MUY\MGNPA;'?Y3CZ4 :O\
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M:&UO(O,B)#<,5*L#D$,,%2#T(.:X[2_%^A0^)M<N9+[;%<- 8F\ISNVQX/\
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MEO=2P,H;&X9C920=HZ^E4/\ A.O#7_02_P#($G_Q-'_"=>&O^@E_Y D_^)H
MGD\*:5).)]VH)-Y2Q-)'J=RC.JDE0Q60%L;FY.3S3Y_#&CW5O-!<VK7"7$44
M4OG32.SK&Q9,L6R2"Q.<Y.><U5_X3KPU_P!!+_R!)_\ $T?\)UX:_P"@E_Y
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M!17/_P#"=>&O^@E_Y D_^)H_X3KPU_T$O_($G_Q- '045S__  G7AK_H)?\
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M_($G_P 30!T%%<__ ,)UX:_Z"7_D"3_XFC_A.O#7_02_\@2?_$T =!17/_\
M"=>&O^@E_P"0)/\ XFC_ (3KPU_T$O\ R!)_\30!T%%<_P#\)UX:_P"@E_Y
MD_\ B:/^$Z\-?]!+_P @2?\ Q- '045S_P#PG7AK_H)?^0)/_B:/^$Z\-?\
M02_\@2?_ !- '045#:74%]:QW5L^^&5=R-@C(^AYJ:@ HHHH **** "BBB@
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M5PU]8SAU6XD6W1_]&VPR3$%@V&QL0=NO(P15G0KG4].N;?P[(XGO/+BNIYY
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M'M\N!P,5N:+=W]UK=RUVOE[K.&1H><0[I)2JG_;VXW>X';% '04444 %%%%
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M*F=JA<G)P,9/K0(T!8A%!8Y)QU-87]MZ]_T*5U_X&6__ ,71_;>O?]"E=?\
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M12W3..:3RH\$>6N#U&.M8?\ ;>O?]"E=?^!EO_\ %T?VWKW_ $*5U_X&6_\
M\70!N[%'11QQTH6-$4*J*H P !T%87]MZ]_T*5U_X&6__P 71_;>O?\ 0I77
M_@9;_P#Q= &I>:;;7PC6="4C=7V*Q4.5.5# =0#S@\5+;VL-LTS1J=T\ADD8
MG)9NGZ  #V K&_MO7O\ H4KK_P #+?\ ^+H_MO7O^A2NO_ RW_\ BZ -^BL#
M^V]>_P"A2NO_  ,M_P#XNC^V]>_Z%*Z_\#+?_P"+H WZ*P/[;U[_ *%*Z_\
M RW_ /BZ/[;U[_H4KK_P,M__ (N@#?HK _MO7O\ H4KK_P #+?\ ^+H_MO7O
M^A2NO_ RW_\ BZ -^BL#^V]>_P"A2NO_  ,M_P#XNC^V]>_Z%*Z_\#+?_P"+
MH WZ*P/[;U[_ *%*Z_\  RW_ /BZ/[;U[_H4KK_P,M__ (N@#?HK _MO7O\
MH4KK_P #+?\ ^+H_MO7O^A2NO_ RW_\ BZ -^BL#^V]>_P"A2NO_  ,M_P#X
MNC^V]>_Z%*Z_\#+?_P"+H WZ*P/[;U[_ *%*Z_\  RW_ /BZ/[;U[_H4KK_P
M,M__ (N@#?HK _MO7O\ H4KK_P #+?\ ^+H_MO7O^A2NO_ RW_\ BZ -^BL#
M^V]>_P"A2NO_  ,M_P#XNC^V]>_Z%*Z_\#+?_P"+H WZ*P/[;U[_ *%*Z_\
M RW_ /BZ/[;U[_H4KK_P,M__ (N@#?HK _MO7O\ H4KK_P #+?\ ^+H_MO7O
M^A2NO_ RW_\ BZ -^BL#^V]>_P"A2NO_  ,M_P#XNC^V]>_Z%*Z_\#+?_P"+
MH WZ*P/[;U[_ *%*Z_\  RW_ /BZ/[;U[_H4KK_P,M__ (N@#?HK _MO7O\
MH4KK_P #+?\ ^+H_MO7O^A2NO_ RW_\ BZ -^BL#^V]>_P"A2NO_  ,M_P#X
MNC^V]>_Z%*Z_\#+?_P"+H WZ*P/[;U[_ *%*Z_\  RW_ /BZ/[;U[_H4KK_P
M,M__ (N@#?HK _MO7O\ H4KK_P #+?\ ^+H_MO7O^A2NO_ RW_\ BZ -^BL#
M^V]>_P"A2NO_  ,M_P#XNC^V]>_Z%*Z_\#+?_P"+H WZ*P/[;U[_ *%*Z_\
M RW_ /BZ/[;U[_H4KK_P,M__ (N@#?HK _MO7O\ H4KK_P #+?\ ^+H_MO7O
M^A2NO_ RW_\ BZ -^BL#^V]>_P"A2NO_  ,M_P#XNC^V]>_Z%*Z_\#+?_P"+
MH WZ*P/[;U[_ *%*Z_\  RW_ /BZ/[;U[_H4KK_P,M__ (N@#?HK _MO7O\
MH4KK_P #+?\ ^+H_MO7O^A2NO_ RW_\ BZ -^BL#^V]>_P"A2NO_  ,M_P#X
MNC^V]>_Z%*Z_\#+?_P"+H WZ*P/[;U[_ *%*Z_\  RW_ /BZ/[;U[_H4KK_P
M,M__ (N@#?HK _MO7O\ H4KK_P #+?\ ^+H_MO7O^A2NO_ RW_\ BZ -^BL#
M^V]>_P"A2NO_  ,M_P#XNC^V]>_Z%*Z_\#+?_P"+H WZ*P/[;U[_ *%*Z_\
M RW_ /BZ/[;U[_H4KK_P,M__ (N@#?HK _MO7O\ H4KK_P #+?\ ^+H_MO7O
M^A2NO_ RW_\ BZ -^BL#^V]>_P"A2NO_  ,M_P#XNC^V]>_Z%*Z_\#+?_P"+
MH WZ*P/[;U[_ *%*Z_\  RW_ /BZ/[;U[_H4KK_P,M__ (N@#?HK _MO7O\
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M MNW28R (?\ @6<4 6**:K*ZAT8,K#((.013J "BBB@ HHHH **** "BBB@
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M.H^)/#%F)#A#<6LD>[Z;IQFEN;WQ'96J7=WXB\,V]O(0$FEM9%1B1D8)GP>
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MQ$MLP6<O:R 1$] V9_E)]Z ,_0/#<IUG3IM0TH):117TMO#*@86N^>-HD(Y
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MY%066I:_J4LD5AXF\+W<D7WT@MI'*?4"?B@#-U+PS=7&E>))8;#_ $RYU19
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M?H [BBN'_P"$+UC_ )Z:#_X!W/\ \?H_X0O6/^>F@_\ @'<__'Z .XHKA_\
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M2KII"[ES@2P850> !DX ]3ZUU58;>)O"?VI;AM=T?[1&K1B0W<6Y5)!*YSD
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M6%M,LD2PNKQ*P9%.0IR.0"20*K6GA;P]83>=9Z'IUO+M*[XK5%;!&",@="*
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MF6.%&D;"@K(X=CMPRE(B0RD@GCC!-:VB:#::%!-'; $SR>9(1&B G 4 *@
MP!T'J>IIZZ!HZV[6ZZ59B%V#-&(%VDCH<8[=O2@#FI?%L\ES'*VZ.*)=DJ0M
MD.PEE+,I(Y&RV<CIP_XU/J/B?4+6Q$LT%M'+Y9N D-QO**L+R%7&WU5!QUW\
M=*Z1--L(V1DLK=2F I$2C;A2HQQQ\I(^A(J*/0M(B@:"/2[-8F5E9! H4A@
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M5DMT"0N(5!C49P <<#D_F: ,^'7KQO#-UKLMI$L2PM<01K(27C )!;CC*@'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **C6X@>>2!)HVEC +QA@64'ID=LT1SQ3/*D<J.T+[) IR4;
M;!]#A@?H10!)15>[O[.P56O+N"V#G"F:0("?;-227$,*HTDJ()&"(68#<QZ
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MHKE P^:15.0>HP>Q!]Q6@JJBA5 50,  8 %0W=E;7\'D7<*31[@VUQD9'(-
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MXUG&;@D$R8Y..E.O-)T_4)%>[M8YF4  L.F#D?K0!'J<\XGL[2";R#=2,K3
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MN.3Q[T 4D-W9ZG#92:A+=)=12$-(B"2(KCYAM4#;\W<'DCUJG'<W\L=OIO\
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M"R0R^2YZ/M#8_ T 4?#G_(LZ5_UY0_\ H K2JO86BV&GVUFC%EMXEB5FZD*
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+9KJ+Q)
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M=IUA?6EW>37-Y;S)=2"3;';M&58(J=2[9&$].IH H:?K-Q%#(MU;W4\45[)
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M2*GJM:)?)N-Y<02YQM$,)C ]<Y9L_I5F@ HHHH **** "BBB@ HHHH ****
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M0*#]":QKB&V?Q4;FXTV>4) D:2>0S)OW-D^F0".>V3[U)JGFQ7L<2K<06T<
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MKABK8_V<C)P* +,^J0C2Y[^R>&\6&-G_ '<HPV.3\PSZ&IK:^M;LLL-Q$\B
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M#,D7FN9$C5"VT%G<*,G!P,M3IKR*SM5GO72!<#>2V50^[8Z>YQ5;7"!81DG
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
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MC=D9T5C&VY"1G:<$9'H<$C\33Z* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@!DL,5Q$T4T:21MPR.H(/U!I41(T6.-0B*,*JC
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MWCY?PIO]CZ8+K[4-.M?/W;_-\E=V[USCK[U<HH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<:MFU8D"9+98X_E*XRB@D<]%]L]*3[+<KHVH;=+E$\E^9@@\L-)^\#!\[L<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,N+*WF?&-TD2L<?4B@"Q6;K[!-.21B%2.ZMW=CT51,A)/H .36D %4*H  &
M!VH90RE6 ((P0>AH RWFC'B)WW@K;V1,I'.S+9&?J%/Y5GVABMK;1@DMIJ-B
M75;)U4K*GR$!QR0YVDYX7C)]JW[:SM;.'R;6VB@C)SLB0*N?H*;#I]E;W#W$
M-G!%-)]^1(E#-]2!DT 6**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N:
M-RYU^ZLI+W4QNN52(0QCRXP8@_+;<#G/4YY%=+5"VTU[;4;B[%],ZW#[VA94
MV@[0HP0N> !WH IVT-[>2O:3ZC,HL8XXI'APC32E S.>.G(P!QG.<\8J7=]=
M+:P)+>7*O!?FVFDMHPS3+M)!VA3SC;G ZY[5KW.FO)=F[M;R2UF= DA5597
MSC((ZC)P1Z\YXQ#+H2FVMH8+VX@-O,9O, 1FD<YR6W*1R6)XQUH CT*^DN+F
M]MVEN7CA*&/[7%Y<N"#D[< [,C@D9R&]!5S3KRZNVNQ=:=)9B&X:.(NZMYZ#
MI(,= ?0\T6>G&VN9+F:[FNIW0)OE"C:H). % '4_7\J-.L)+%KMI+^YN_M%P
MTRB=@1"#CY%P.%':@"[60L=QJEW>'[=/;16\ODQ+!M!R%!+-D')R< 'C ''-
M:]9\^ER&ZEGM+Z:T,^/."*K!B!C<-P.&P ,].!Q0!4.LW4&B1WKVHN9$N?LT
MRQMM+$2^4608.<MS@D=>M7[>;4)+>5I[*&&4#,2"X+!N. QV_*?7 ;V)J&XT
M5)-/@L;>ZFM8H'1P4"LS%6# DL#D[ADGOS5D6\XLC ;V4R_\]]B;NOIC;[=*
M *NE7"Q:,\TP:,0R3^;NE,NTK(X;#$ D<'''3 JL^M:G']C:32(UCO95CC/V
MKYH\@G+C9QP#T+<\>]6]/TI[&.6*2^FNXI&=BDR(!EV+-]U1W)K+.DSMJ5C"
MAU![:QGWH;AX_*10I VX^=SS@;L\9.<]0#2NI)5UZQ5XOW3"0(ZSD'=MR=R;
M<$<<'/X4NH:A>6U_;6=I91W#7".VYY_+";=O7Y3Q\W;)SCC'(2\TF>[OH[I=
M4N8?*),:(D9"Y7!ZJ2:GET\RZE;7OVJ4&WC=/+ 7:^[&2>,_PCH10 [3KQKV
MV,DD0BE21HY$#;@&4D'!P,CC(X'7H*M54L+'["LZ^?)-YTSS?.%^7<<X& ./
MK5N@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *R9-6O&6>:RTW[3;P,R,?.VR2%20P1<8."".2N2#VP3K5C
MP-J&F)+:1Z=)=J99'AE25%3#L6P^X@C!.,@-P,]>* +<VJV=K%"]W,MNTR[A
M&Y^;MGCKQGD]J=/JFGVUM%<S7L$<$W^KD:0!7XSP>AX&:J2+>66J27JV#W@N
M((XV\AT#1LI8X^=E!4[O7.<\56%A=Q6E@CV?FM]O:YD2-D*PAF=A]XC."PZ=
MP<4 :L6I64UJ]U'<QF&,D.V<;".Q]#R/SJ'2=;L=9M8IK296:2)93'NRR C.
M#^=+9QS)JVH.]NZ12&,I(2N'PN#@ Y].H%0:&;RVL+/3I].FB-M L3S,\91B
MJ@97#%N2.,@4 68K]9M6EM(YK=UBB!95?]XK9/4>F,?C27.MZ79SM!<7T$<J
M#+(7^91ZD=A[]*J&6]_X2 3_ -D7?DB(P^9OAQ]_.['F9QCVS[5-'',FN7]R
M;&0QM;1(DF4_>E2Y*CYL_P ?? ZT 76N[=9XH&F02S F--W+@=<>M,74K%[:
M6Y6[A\F E99-X"H1UR>W6LF"UOK72=#<V4LLUBBK/ CIO_U10D$L%/.._3\J
M@ETW4K^TOFDMGM96OX[J*,3*=ZJJ#&1D!OE/48# <D<T ;MGJ-G?[Q:W"2F/
M&]0>5STR.HS5"Z\0VB20QVEQ;SNUPD3IYG.&<(2OK@D9J"TT^XN+F:66/48'
M:U>%9;J:)BNXC[HC)],Y)&.W4U!=PZE/9:?:)H14V5Q!(Q$L>P!&&?*^;/3/
MW@O&>_% '34452U:XO[3399M,L!?W2XV6YF$6_D _,>!@9/X4 7:*0D[<XYQ
MTS532;B^N]-BGU*P%A=-GS+<3"79R0/F'!R,'\: +E%4K*YOYKR]CN]/%M!#
M(!;3"8/YZXY;:/NX/&#0;J^\EF_LT[Q<>6$\Y>8]V/,S].=O7M0!=HJ"*6=[
MJ>.2V,<2;?+EW@^9D<\=1CWZU/0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG1_^>NJ?^#:Z_P#CE96F:9X7U:_U&QMKC5Q<:;+Y<\;ZK= _[P_><KP1GVH
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MD4J[70]"*K3Z+IUS>_;9;8-/C&[<1G (!(!P2 3@]1GBLW_A"='_ .>NJ?\
M@VNO_CE'_"$Z/_SUU3_P;77_ ,<H T;G1;&ZL(K,P^7' A2 QG:T(*%/E/;Y
M6(J2[TNSOTB6YB+^2<H0[*1Q@\@@X(ZCH:Y/Q3X9L-+\/3W=G<:I',CQ*&.J
M7+8#2*IX,GH36O\ \(3H_P#SUU3_ ,&UU_\ '* +L'AW2+6:&6"R2,P*JQA6
M.T;1M4[<X) X!(R!5F73;.9Y'D@5FE>.1R<\M&P9#^! -<L=)\*_\) FA)>:
MI)?-$TK(FK71$8&/O'S."=PP*ABL?#<U^MM&FOF%YVMEO!J-UY+2KG*@^;GJ
M",XQD8S0!TT7AW2(9&DCLD#%E8<DA2KAQM&<*-P#8&!D4]M!TMKQ[MK-&EDW
M;LDE<LNUCMS@$C@G&2*YO^RO#'_"2?V!YVL?:_)\W/\ :EUL_P!W/F?>Q\V/
M3FM3_A"='_YZZI_X-KK_ ..4 7HO#^E03Q3QV@#Q;=I+L1E1M5B"<%@. QY
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M+%3>R:A<&)<-MR2LQ(&1UQQ6Y?\ A;2;&T\^.#7;PY \NVU6X+G/?F4#'XT
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MBM8%*Q0HL:*6+84# Y/)X]:@;2K)]575'A+7:1F-'9V(0'KM4G:">Y R: .
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MR#4X)]4N].4.);-(WD) VD/NQ@_\!.:+S5+:RCMY)"72YG2!#'@C<QP">>E
M')_V-?\ VK6=8L(&34K/57FM@X*BZB,,(>//=6VD ]F4'M6?H.GZWJ=MH=O%
M ME'I=FTT@U"T=E:64LH7;N7E4W9YXWUZ,KJZAD8,IZ$'(-8-WXSTNR\/C6I
MTN!!Y[P&,(#(KHS*^1GML8GGH,T <M'HE_>VFE>&M2@F9=/NKFT:Y6)@AA:V
MD\J0$YP &5>IPRXSFIK*WU;4]5T36M2L)XKD7Z02*T9_=I';3!F/H&E=\'N-
MM=N-4@;6/[*4.TWV;[26 &T*6VC)SU)SCZ&GZAJ%KI5A-?7DHB@A7<[8)_
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MJ6+VUY-=."@4[9"+>-"R>JDJ<5VE% '$WNFW=QX%\+V:QW,4J2V E\I2)(0
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M%8Y4\N1HSYL93)4XR,]1Z'H:QO\ A'M8_P"AQU3_ +\6O_QJJQTZ]&I+IO\
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MCG6GEDSM#:=$@.!D\M !T% ';T5S_P#PCVL?]#CJG_?BU_\ C5'_  CVL?\
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M*WAUVM+"-4)%Q'*9!D#N%5K?)[>6WI6O/J$-M=26TGCW6/-BP)%33XGVDJ&
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MAQU3_OQ:_P#QJC_A'M8_Z''5/^_%K_\ &J .@HKG_P#A'M8_Z''5/^_%K_\
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MK**XN\<V$4LMSX]U15AN1:OBT@8B4J&"X$)).T@\5"M[&]I<7?\ PGFL+#;
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MO;W6GV-FEE8W+W93RY?DE\Q?D;=@B$=ONGUKT<*H&  !Z 4B(D:[44*/0#%
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M6.)HBH5F'&6<J0/]G/:N>@@U.+P%X>?5-027P])#;?;$@MPDD"?*4)8DY0,
M&( ..?6O3XX8H5V11I&I.<*H I=B[-FT;<8VXXQ0 H((R#D&EI ,# I: "BB
MB@ HHHH **** "BBB@ HHHH *RO%/_(I:Q_UX3_^BVK5K*\4_P#(I:Q_UX3_
M /HMJ +>F?\ (*M/^N"?^@BL+Q'I]HOB#P_J @3[6^I+&9B,ML$$QV@]AGG
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MG43#_P )EINKLR';;6_E!\\'=\K$G S^==$8T*;"BE?[N.*:L$2-N2)%/J%
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M!F\N,&0G:^<#;M+EMG?\,9--237MJDO=,-REL1$ 0?+NQE03(#O XR0,XY%
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MUQ'&3C>Y(5%_%B!^-<YK#:A8RHUUJ.H/I]O;XN;G3RI>"?)9GD3!.S:5( !
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MXVFQC3;L3/%-]H^<1QHSEV3;P"%XP3U&<=* -;^W#_T"-3_[\#_&C^W#_P!
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MKX,_Y]KK_P "6H_X4KX,_P"?:Z_\"6H >E_\.DA:(^(+5_EC5)'U%F>)4.Y
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M:Z_\"6H WO\ A/?"/_0QZ=_X$+1_PGOA'_H8]._\"%K!_P"%*^#/^?:Z_P#
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MC_T,>G?^!"T?\)[X1_Z&/3O_  (6L'_A2O@S_GVNO_ EJ/\ A2O@S_GVNO\
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MIW_@0M'_  GOA'_H8]._\"%K!_X4KX,_Y]KK_P "6H_X4KX,_P"?:Z_\"6H
MWO\ A/?"/_0QZ=_X$+1_PGOA'_H8]._\"%K!_P"%*^#/^?:Z_P# EJ/^%*^#
M/^?:Z_\  EJ .XM+NWO[6.ZM)DG@E7<DD9RK#U!J:J>E:9;:-I=OIMFK+;VR
M!(PS9('UJY0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
F4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>ebs20191231exhibit1039002.jpg
<TEXT>
begin 644 ebs20191231exhibit1039002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V:BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9(6:,G]8Y%_ >M7I?"4>GZTE[H5M;6EO=Q-;:A!$@C!0@[9$P,!@>H[@^H%
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MD0:>_FS.NUXVD.\?(<K\XXXSZC'(!JIXKMEO]1,\L7V"V@M98)8U9FE,V_
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MHHH 3 SG'/K2T44 %%%% !1110 4444 %%%% "4  # & *6B@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHE#%97;<05.T#[HP6 !.*Z>N7?1=;O\ 4+#^T7L3%I]V;A;V(GSY5 8*FS:
MG#88ACD#ISQU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
..4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>ebs20191231exhibit1039003.jpg
<TEXT>
begin 644 ebs20191231exhibit1039003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:*RO[0U?_H!'_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z
M1_\  I* -6BLK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'_P "
MDH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BLK^T-
M7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'_P "DH_M#5_^@$?_  *2
M@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BLK^T-7_Z 1_\  I*/[0U?
M_H!'_P "DH U:*RO[0U?_H!'_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_
M  *2C^T-7_Z 1_\  I* -6BLK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO
M[0U?_H!'_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\
M I* -6BLK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'_P "DH_M
M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BLK^T-7_Z
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M5HK*_M#5_P#H!'_P*2C^T-7_ .@$?_ I* -6BLK^T-7_ .@$?_ I*/[0U?\
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,KPY_R#)O^O\
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MG,C!>5.$;I0!WMYX]T:QAL))X[\-J"NT$*V<AD(0X;*8R/\ "F2_$#1X-/\
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MD6878S3D>82H;D;?E'/7FHQK,TNGZ;+#:(USJ*ADB>;:B?)O.7VYZ>B\_3)
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MU"?9C*LOEY8$QL02OKG;T_"@#2HK/T^74;AS+=-:QIC'V:,%GB;C 9\X)QU
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M4 %93?\ (VQ_]>#?^C%K5K*;_D;8_P#KP;_T8M &G(Q2-F5&D*@D(N,M[#)
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M0 4444 %%%% !4<\$=S \,H)1Q@A6*G\QR*DHH RO^$:TO\ YYS_ /@7+_\
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M#)LP/3D\5UWCG6]0TJRT^STETBOM5OH[.*>1=RP[LY?'<C'2@#3_ .$:TO\
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MF,.8HXUW-M!XR:Q;[6O$'A>]U?1;K5SJ.=$GO[&[>%%EA= ?E8 88<9R1[4
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M7_SSG_\  N7_ .*K5HH RO\ A&M+_P"><_\ X%R__%4?\(UI?_/.?_P+E_\
MBJU:* ,K_A&M+_YYS_\ @7+_ /%4?\(UI?\ SSG_ / N7_XJM6B@#*_X1K2_
M^><__@7+_P#%4?\ "-:7_P \Y_\ P+E_^*K5HH RO^$:TO\ YYS_ /@7+_\
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M02.%+'T&>M $U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?D &>G..IK,NX-+DT2YAL[!V6/4K;=:W$>T*Y>(;5#< %2.!Q\QK=DT:U>.
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MDR6Z7#K&V>O / /.0, Y/K0!IJ=RA@",C.",&LKQ1;6]SX?N_/@CE\N,LF]
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MK5HH ROMNN?] :#_ ,#?_L*/MNN?] :#_P #?_L*U:* ,K[;KG_0&@_\#?\
M["C[;KG_ $!H/_ W_P"PK5HH ROMNN?] :#_ ,#?_L*/MNN?] :#_P #?_L*
MU:* ,K[;KG_0&@_\#?\ ["C[;KG_ $!H/_ W_P"PK5HH ROMNN?] :#_ ,#?
M_L*/MNN?] :#_P #?_L*U:* ,K[;KG_0&@_\#?\ ["H#K&K"^%E_8T/FF(R_
M\?G&T$#KL]36Y64W_(VQ_P#7@W_HQ: #[;KG_0&@_P# W_["C[;KG_0&@_\
M W_["M6B@#*^VZY_T!H/_ W_ .PH^VZY_P! :#_P-_\ L*U:* ,K[;KG_0&@
M_P# W_["C[;KG_0&@_\  W_["M6B@#*^VZY_T!H/_ W_ .PH^VZY_P! :#_P
M-_\ L*U:* ,K[;KG_0&@_P# W_["C[;KG_0&@_\  W_["M6B@#*^VZY_T!H/
M_ W_ .PH^VZY_P! :#_P-_\ L*U:* ,K[;KG_0&@_P# W_["C[;KG_0&@_\
M W_["M6B@#*^VZY_T!H/_ W_ .PH^VZY_P! :#_P-_\ L*U:* ,K[;KG_0&@
M_P# W_["C[;KG_0&@_\  W_["M6B@#*^VZY_T!H/_ W_ .PH^VZY_P! :#_P
M-_\ L*U:* ,K[;KG_0&@_P# W_["C[;KG_0&@_\  W_["M6B@#*^VZY_T!H/
M_ W_ .PH^VZY_P! :#_P-_\ L*U:* ,K[;KG_0&@_P# W_["C[;KG_0&@_\
M W_["M6B@#*^VZY_T!H/_ W_ .PH^VZY_P! :#_P-_\ L*U:* ,K[;KG_0&@
M_P# W_["C[;KG_0&@_\  W_["M6B@#*^VZY_T!H/_ W_ .PH^VZY_P! :#_P
M-_\ L*U:* ,K[;KG_0&@_P# W_["C[;KG_0&@_\  W_["M6B@#*^VZY_T!H/
M_ W_ .PH^VZY_P! :#_P-_\ L*U:* ,K[;KG_0&@_P# W_["C[;KG_0&@_\
M W_["M6B@#*^VZY_T!H/_ W_ .PH^VZY_P! :#_P-_\ L*U:* ,K[;KG_0&@
M_P# W_["C[;KG_0&@_\  W_["M6B@#*^VZY_T!H/_ W_ .PH^VZY_P! :#_P
M-_\ L*U:* ,K[;KG_0&@_P# W_["C[;KG_0&@_\  W_["M6B@#*^VZY_T!H/
M_ W_ .PH^VZY_P! :#_P-_\ L*U:* ,K[;KG_0&@_P# W_["C[;KG_0&@_\
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MM! /.SU85MUE2?\ (VVW_7A+_P"C(Z #[;KG_0&@_P# W_["C[;KG_0&@_\
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M:U71H?,@56?-YQALXQ\GL:VZRK+_ )&75/\ KC;_ /L] !]MUS_H#0?^!O\
M]A1]MUS_ * T'_@;_P#85JT4 97VW7/^@-!_X&__ &%'VW7/^@-!_P"!O_V%
M:M% &5]MUS_H#0?^!O\ ]A1]MUS_ * T'_@;_P#85JT4 97VW7/^@-!_X&__
M &%'VW7/^@-!_P"!O_V%:M% &5]MUS_H#0?^!O\ ]A1]MUS_ * T'_@;_P#8
M5JT4 97VW7/^@-!_X&__ &%'VW7/^@-!_P"!O_V%:M% &5]MUS_H#0?^!O\
M]A1]MUS_ * T'_@;_P#85JT4 97VW7/^@-!_X&__ &%'VW7/^@-!_P"!O_V%
M:M% $<#2O C3Q"*0CYD#;@I^N!FI*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *RF_Y&V/_ *\&
M_P#1BUJUE-_R-L?_ %X-_P"C%H U:*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R/#O_'M>
M_P#80N/_ $8:UZR/#O\ Q[7O_80N/_1AK7H **** "BBB@ HHHH **** "LJ
M3_D;;;_KPE_]&1UJUE2?\C;;?]>$O_HR.@#5HHHH **** "BBB@#*\.?\@R;
M_K_O/_2F2M6LKPY_R#)O^O\ O/\ TIDK5H *IZM8_P!IZ->Z>'"&ZMY(=Q[;
ME(S^M7** /-+30O%E_:^&="U#1H+*TT*[@GDOA=K()Q""%"H/F&<]Z@U3X=Z
MM>Z-KDUNBV^K/J]W<63"1?WUO,H5D)[!ESP>A';->I44 <3X<\.:II_BC2[Z
MY@5(+?PS#I\C"13B=7!*X!]._2M'P=HU]I$_B![V(1B^U>:Y@PX;=&P7!XZ=
M#P:Z6B@ HHHH *RK+_D9=4_ZXV__ +/6K659?\C+JG_7&W_]GH U:*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH \B2P75/ OBG4KFZO/M.FW]^ULZ74B;<!
M2 0#R!@<&G:_IBZ5\.-%GLGOY9]2NK)IU^V/NE+(<JK%OESD],#IZ5Z##X3T
MN#1]2TE$E^S:G)+)< OR6D^]@]J34_">F:MH5IHUQYZVUF8S"8I2KJ4&%.X=
MZ .#U2QGTKP+XBNDT;5-&E%N@22YU/[1O^<9VX8[2/7WKF-=US5)O"]OHB7U
MPMUH#RF\D60AI )TCBR>^1)^E>KCP#I9L;RRGO=5NH+R+RI$N+YY !N#9&>A
MR!S3KOP!H%Y)JDDL$@;51$+DK(1GRRI7'IRHSZT 5?BD\Z> ;W[-.\$K2P*L
MD;$%<RH.H^M<O8>*[Q_%NAV>L221W^CP7T>I1*3B79&I63'<,!D>^:](UG1[
M37M-?3[Y7,#NCD(VTY5@PY^H%5KCPMI-SXDB\026_P#I\4+0[@?E=2",,._!
M(H YS2_&^M2S:)=ZGIUE%IFO2>7:^1*S30D@E-^1@Y [8Q7=US>F> M#TG4(
M+RW6Z?[*6-K!-<O)%;%NOEH3@9K8TK38='TV*PMY)I(X<[6GD,CG))Y8\GK0
M!<HHHH *RF_Y&V/_ *\&_P#1BUJUE-_R-L?_ %X-_P"C%H U:*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH \;UR*^LM2U75]1.I7-J+TO;Z
MUI6H;Q9QAAB-H<X^7H<^M=CH%X]S\2]? N'DMS96CQ L=N"I.0.V:L7OPX\/
MWUY<3R"\CANY?.N;.*Z=()GSDLR XR35G6/ ^D:S>K>LUW97(A\AI;&X:$O'
MV5L=10!Y?%>2W'AOP>MV=3O8I[V^$T5G*WG3 ,< 88$X^O05;U*/6].\#:H]
MPNK6NGRZI!]@M[J8FZ6,G#C.<C/89_Q/I<'@_1K4:0MO;M$FC%S:*KG +C#$
M^N>3]:N:UHEEK]BMG?*[1+*DH"-M.Y3D?K0!Y@\&KV-CXEO-/M]<TS15TA@D
M>IS'S/M&?O("Q(&W/.?Z8[B\FE'PLGG\U_-_L1G\S<=V[R,YSZY[UN:IIMOK
M&EW.G788P7,9CD"G!P>N#6%:^ -+M(I(5OM5EADMWMS#-?.Z;&4J0%/'0\>E
M 'GD:WFJ:UHT#6.I:NO_  C5K*T-MJ!MR&)P7)+#/I^-;^NZ3J)T30;.QL[A
M422:2ZT.75MEQ<+VQ+NRP7EL ]QZ5T4_P[T6::VF2?4;:2UM$LT>VNVB)B3H
M"1UJ:Y\":3=Z?:VLT^H-)92-);WGVM_M$1;KB3K@^E '(:=?I<>%9]!MI]3A
MN+C6(K-K6_;,MFK,'9%;.678CX/7K5#Q!#?6NJ:OJU__ &E=VBW9:WU?2=0W
M?8$!'[LPYQ\O0Y]:]!TOP1HVD36T]LL[303O<&264NTLC*4+.3R3@G'U-5K_
M .'.@:A>W-Q)]MCCO)/-NK6&Z=()W_O,@/)- '&:DLVM?$#51%IVI:U;K:VL
MD8M-0^RA T>=V"PSNIWB:$V^M^'+"33-8DMQITSR:?:WC&<$'/+AAN(^IKM;
M[P#I%[JDNHK/J%G/*B1O]CNVA4J@PHPOH*N6GA73[2]L+T274UQI\+PPR3SF
M1BKG)W$]30!YK9C59? %[XCT^\N6M[#45OM/MY;LRR)"AQ)'(<GC&3M/3'O5
MKQ#JTOB)/$^O6%W,NGZ;I<=O:F.0JK2OB1FX[@$+^->AV/AC2].EU-K:)ECU
M5B]S 6S&6(PQ"]LYY]:JV?@?1+#PM<>&[>&1;"Y+&4>9\[$XR=WX#\J .7M+
M5O%_BR32=4O+M;'3=+MGBMX;AHO->103(Q4@G'2J7BBVDM=.\-:9:ZI>>((_
M[0EB/DW8264!3^[,@/5?<]J[75/!&D:J]M,QNK6YMH1 ES:7#12&,?PDCJ/K
M45Q\/]!FTJPTV*.XM8=/<R0-;3LCASU8MU)/K0!S-SI&H0^#KZ"PM;O0KRZN
M(46*^U8.UT ?]6DFX["V2/>K7@&:.T\27VE26VJZ5<FV6?\ LR\G^T1 !MID
MCD))/)P?_K<;H\!Z0^F76GW4VH7L%R48_:KQY&C9,E60DY4\]NM6-"\(:9H-
MY-?0R7=U>S((WN;RX::38#D*">@S0!NT444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!D>'?^/:]_["%Q_P"C#6)\0;J[:;0M%@O)K*#5K\0W
M,\+;'V 9V!NQ;I6WX=_X]KW_ +"%Q_Z,-3:WH6G>(M/-CJ<'FQ;@ZD,59&'1
ME(Y!% '!7,<?A?Q7!IFAZC<36.I6%V)[9[EIA#)$A(<$DE3G@U#/>W7_  J7
MPM.+J7S9+VU5Y!(=S9<Y!/>NGT?X<:1H>N+K%E=7QN2'6<SRB7[0K#HVX9Z@
M'(QTYI;3X;>'K*]@GC%XT-K-Y]O9R73M;PR9R&5"<9S0!Q7Q$\6/'XOD-IJZ
MVI\.QQ2I;>9M^V3,ZET]P(Q^?'>KWB[7=3_X2_1M;\/RO/;PZ2;][8,<7$.\
M;ACIG:V?PKO=/\,:5IT=XD=L)?MT[SW#3?.SL_7D]O:J^D>#=)T2>TFM!.6L
MK9[:'S)2V(V;<1[\_I0!QFC)9>,-)\47[7=W+;Q7\L]HT=R\>T>2I X(X]JS
M9K$:?\%/[;@NKT7UY';F65KJ1O\ ELO0$\?A7I.D>$M(T*RO[+3X6BM[^1Y)
M4W9 +#!"^@QVILWA#29_"L?AETE_L^,(%42?-A6##GZB@#DO%OANR_X3OP_$
ML]\D>KW%P;M4O95#;4W# #?+SZ5'XEM]9\&:G%#X=F>2WU]$L(TN)V;[+<#A
M903D\KDGW&37>WVB66HZIIVI7"N;C36=H"K8 +KM.1WXHU31++5YK&6[5RUA
M<K<P[6QAQD#/J.: %T32DT31K;3HYI)O(0*TLK%FD;NQ)]3FH9/^1MMO^O"7
M_P!&1UJUE2?\C;;?]>$O_HR.@"UJA9=)O"I(80/@CKG::\UEO;K_ (5!X:G%
MU-YTEY;*TGF'<V9#D$]37JA 8$$ @\$'O7*6OPV\/6E[!/&MXT-M-Y\%F]T[
M6\4F<[E0G'6@#BY?$&IZ#XL\37=S/(^BW%T]DY+$_993'F-QZ DD'_\ 55CP
M[YNK:GX8L;NZN6@NO#KF8+,RECNZY!SGWZUWTGA+2)K75K::!I(M8D\RZ5FS
MEL 9'IC (]Q2:?X2TK3+NPNK9)1)I]H;2#=)D",G//J?>@#DO!7AZS_X2[7B
MT]\XTF]1+57O)&504S@@GYOQKTBL_3M$LM+OM0O+97$NHRB6<LV06 QQZ<5H
M4 97AS_D&3?]?]Y_Z4R5JUE>'/\ D&3?]?\ >?\ I3)6K0 5Y#XD#7?Q \1V
M[V>O7SQV]O\ 91I<K*(',?5L,  3CL>AKUZL^UT2RL]:OM7B5Q=7ZQK,2V00
M@PN!VXH \OUM-6CF\'V.O0ZG?W)L;@W=M8W!661@ 1DAAD@8SSS@]:JVEW?M
MX62^M[ZZ73;CQ#;+9PS79EFA0$AU<YXR<?*?Z\^M7.B65WK=EK$JN;JQ21(2
M&P '&&R.]9<O@/0Y;FXF\N:,7-W'>R1)*0GG)T8#MG//K0!S5EI:^--1\3WN
MKZK>VQTZ_EM+00W+1+:I&!B3 (!)SG)]*S_$<5Q=^+]&L8S?>(HO[&WDV=\+
M<S$.1YI8, ?S[UV>K^ -#UF_GO9?M=N]T MTMK<M$ER!P ZC@\4[4? >BZA<
M6DZF[LGL[86T/V*X:';&#G;Q0!:\)V9L=!CB-A=6#%V8V]U<_:'7G^_DYSC/
M6MJJ&CZ1#HMD;6&XNKA2Y??=3M*^3CC<><<=*OT %95E_P C+JG_ %QM_P#V
M>M6LJR_Y&75/^N-O_P"ST :M%%% !1110!X[X]\7M%XTEN+75A /#GD[+/S,
M?;)&<&5<=\)Q]:L>*-=EM_B5I>N6M](-,@LK6>8!R(S#+(T98CIT=37H5AX6
MTC3[.[MDMA*M[+)-<--\[2,_WB36:GPZ\/K9O:,EQ)$]D+$[YB2(@^\#/J&Z
M'V% 'F^G>(]9L[7Q7K\=S.9KJQ6[MT=BP@62=E4J#P,+@UT6M:0/!NCZ1X@T
MO5K^:^>Z@2<RW3R+?!_O J3CGJ,=/UKM;7PAHMHTFRV+I+91V+QR-N5H4& ,
M?CUJCI_PZT#3KVVN5%Y<"S;=:07-T\D5N>Q12<#'XT 8>G7=P=$^(;-<2%H+
MJ[$9+G,8$61CTKG)-7URPU'PSJ=C+-<+9>&X;R\MBY/GQ;@LG'=L-NR?[M>@
M:I\/-"U;4+F\E-[ ;S'VN*VNFCCN,?WU'6M2'P[IL&K0ZE%"4E@LOL,: _(L
M.0=NW\!0!Y_I45IXK\,^*M3:\NI8[?4KN>SDBN73"^4C+T(X]C72_#;2;>U\
M*V.IK+<R7-_:QO.TUP\@)QG@,2!U[5J:3X0T?1-)OM+L(7BM+YY'E3>3@NH4
MA?08 Q6AI>FV^CZ7;:=:!A!;1B.,,<G Z9- %NBBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"KJ-_#IED]U.&*
MJ554099V8A551ZDD ?6JNH>(;#3=6L-,N6<3WY(CVKE5Q@#<>V20!ZDU4\4Y
M$VA2-_J4U:/S?3E)%3/_ &T9/QQ6!J&A:[XEN-<O;>6WM$E=;:T%S;N9%$#;
ME=#N 7,NX@X/ !YH [0ZA"NJ#3F#+,\)FC)'RNH.&Q[C*Y_WA^%JN2^W3:KJ
M'A&[:WDMKJ0S2W$+J5:-1"RN"#S@2,@_*NMH **** "BBB@ K*;_ )&V/_KP
M;_T8M:M93?\ (VQ_]>#?^C%H U:*** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *;)(D,32R.$1 69F.  .I-.K#\;)+)
MX*U=80S,;1\A>I7'S ?\!S0!%)XPMQ/!!!I>IW,L]JMT$AA4E8V) )!88SCI
M5RV\1V%W:V5U$91#>S- K.FWRY!D%'!Y4Y4K]>.XKF->^S#QG'=RW6K6MI)I
M2+%-ID$KASYC'!,:-V(/:HH[>Z@^'1M7AFC<ZDBV!N$V3R W*E'<==Y.6)(!
M[GO0!Z#1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=:M_"^EP/##?:GJEW/':F2=L85W9WD8C.%P< 9R,4 ==Y/B+_G^TS_P#D_\
MCM'D^(O^?[3/_ .3_P".U7T;6[Z?5[O1-7M88+ZWB2=7MW+1S1,2 PR 005(
M(-9NI6</B'QZVE:BK36%EIJSK;[RJO*\C+N(!&<!,#/3)H VO)\1?\_VF?\
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MIK"UDM8)[=D)<VI<LKA,G@';D<\$DB@#H_)\1?\ /]IG_@')_P#':/)\1?\
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M^?[3/_ .3_X[1Y/B+_G^TS_P#D_^.UJT4 97D^(O^?[3/_ .3_X[6;)%KO\
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MJR,"Q/()R0?2H&\-ZXUGK-VFIV\&MZJL<8FB1O*MHTX 7/)."QSZGIQ7644
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MQX!.XCN!UKSZSU?4K;5= GBO==N(K^Z6"XEU")([><-&S9C3AEY7(P,8ZGU
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9'AW_CVO?\
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MSR0,U<^'\X=-8MT$]M!!>D0:?<EO.M$*C 8'H&.6 !(P>#0!V%%%% !1110
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MFC\Q8%*Q1I&"$5<\GJ22>N>E;E% !1110 4444 %%%% !1110 4444 %%%%
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MNX4'/..N, <9R3V- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5E-_R-
ML?\ UX-_Z,6M6LIO^1MC_P"O!O\ T8M !XI_Y%+6/^O"?_T6U/\ #G_(LZ5_
MUY0_^@"I]4^Q_P!DWG]H_P#'EY#_ &C.?]7M.[ISTSTYK(T;5/#6F:-:IIUV
M\=G*X2 3M*S<\#_6?,%]_NB@#HJYC0/^1W\5_P#76U_]$"ME]:TR.]BLVO8O
M.F4LBALC V]3T&=ZX!ZYXK,\+KX=%QJ1T-I6G,J_;#,TS/NQ\N?-YZ=,<8H
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MZ@]*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% &1X=_X]KW_L(7'_ *,-:]9'AW_CVO?^PA<?^C#6
MO0 4444 %%%% !1110 4444 %94G_(VVW_7A+_Z,CK5K*D_Y&VV_Z\)?_1D=
M &K1110 4444 %%%% &5X<_Y!DW_ %_WG_I3)6K65X<_Y!DW_7_>?^E,E:M
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M?,OE99MR(0<L3P-N!@'&.A &03S67J7A;3?"WP^\1P::K!9K"9F+X))$1!Y
M!Y()QTR3C XKM*Q/&,-]=^%=0L=.L6O+B\@DMPBR(FS<A&XEB!@''OS0!H:3
M_P @>R_Z]X__ $$5;JMI\3P:;:PR##QPHK#.<$  U9H **** "BBB@ HHHH
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M*+DY#%?O;0#MQ_$.: .PHJMIUW_:&FVMZ$\O[1"DNS.=NX XS^-6: "BBB@
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ME[<^1)&J6]Q;8_>VSA<$-'][ (QP#V[5VM5WL+.2Y6ZDM('G7[LK1@N/QZT
M>:Z(18Q>#]3O&2VM[O4[VX4NP"Q":.4QJ3T!.1QZFG:KJ^FR7'C2<QQZA:23
M6$!Q.4B)(VY=UZ(#][Z$5Z&-&TL6;V0TVU^RR.7>#R5V,QY)*XQFI8M/LH8F
MBBLX(XW4(R)$ &4< $8Z4 >9V[QQ^-'2.71M[Z)<K(FD1%4&"A 9LD,>IZ#
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M=*I\J,+D+&0HX[ <#TK<K(\40&[T"YM?[4ATU+A3#)/-&'&U@5(P6')SP<T
M2^'/^19TK_KRA_\ 0!6E5;3;46&F6MFLGF"WA2(/C&[:H&?TJQD;MN1G&<4
M+12 @D@$$CK[4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!D>'
M?^/:]_["%Q_Z,-:]9'AW_CVO?^PA<?\ HPUKT %%%% !1110 4444 %%%% !
M65)_R-MM_P!>$O\ Z,CK5K*D_P"1MMO^O"7_ -&1T :M%%% !1110 4444 9
M7AS_ )!DW_7_ 'G_ *4R5JUE>'/^09-_U_WG_I3)6K0 4444 %%%% !1110
M4444 %95E_R,NJ?]<;?_ -GK5K*LO^1EU3_KC;_^ST :M%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5E-_R-L?_ %X-
M_P"C%K5K*;_D;8_^O!O_ $8M #_$?_(LZK_UYS?^@&LG3_\ DE%M_P!@)/\
MT0*Z2>&.YMY()5W1RH4=?4$8-<<GA/Q-%HO_  CD6OV@TCRC;K*UH?M2PXQL
M!W;<[>-V/>@"OHNMZQ%IWAC0M)M;1WGT&*Y,URS!8]JHO(7D]0,<=>M2_P#"
M0R:E#I']I:;;F\@\0&QD"NQ2.1$D_>)T/3L?4UNVOAQ++7[*_MY MO9Z8;!(
M2,G&]"#GV"8_&J"^#Y5FCD^V)\FNMJN-AY4HR[.O7YNM #/ $^K7$&L-J<T,
MNW5;E$*%B05D(8?-_", *.PK UQ/#;_$G4O^$BTY[U18V_DA;22?:<OG[@..
MW6NQ\/Z+=Z+<ZFLEU#-:7=W)=0J(RLD;2,6<,<D$9/& *DM=%>W\57^M&<,M
MW;0PB+;RNPL<Y]]WZ4 <7IVH7GA?3=;U/2=*N8])DN[6/3;*]WQDEB$E*JW*
MJ2PQGTZ5KS:Q<Z5KT5QX@L[+[5;Z1=7+SV;.=L:.AV+NQG/'4=0*W_$6CMKF
MF+9I,(2MS#-N*Y_U<BOC\=N*KZMX9CU?6?M=Q+_HSZ;/8R1 ?,PD*DD'M@*?
MSH JZ=K'B1UL[[4=.LETZZC,D@@E8R6B[=P+[N']#MQ@GO6%;_$[?#;ZG+<Z
M)]BN)E0V4=Z#>Q(S;0Y7."1D$J!P,\\5N6/A[7?]"M-3UJ*;3[%=H2WA:*2Z
M&TJ!*=Q& #D@#DXJM8>$-7L;>UTI-6M1IEK(I21;3%TT:G(C+YV^@+ 9(H Z
M>W:_-[=BY2 6H*?96C8EV&WYMX/ ^;ICM7#?$;39VU&+5;G2SJFFI;I"(UVN
M;>3SE)?8?O;EPO'/'O7<V\=ZM[=O<7$<ELY3[-&L>&C 7YMQS\V3S[5SWBW0
M-:O9C?:+>KN>..*6SN 6C<+*'#K\PVL.<^H]\4 8-U::!J&D^%[*Q#W>EMK3
M(;>[4DQ?NY28BK#("G@ ] !70#POJ*^,QK"ZG(+$#8+82MG;C/7'3=QLZ8YS
MVK&U734\+Q:%<7]WYSR:ZUY>W"Q$+O>*3)"C.%' '6O000RAAR",B@#D='\%
MSP7NI'6;S^TK*_Y-M,Y=<@A1OR/G.R.+YCR"&]<U8^&__)/-%_Z]A_,UOWM[
M;:=9R7=W*(H(P"[D$XR<=OK6%\.D:/X?Z,CJ586PR&&".30!TM%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% &1X=_X]KW_ +"%Q_Z,-:]9'AW_ (]K
MW_L(7'_HPUKT %%%% !1110 4444 %%%% !65)_R-MM_UX2_^C(ZU:RI/^1M
MMO\ KPE_]&1T :M%%% !1110 4444 97AS_D&3?]?]Y_Z4R5JUE>'/\ D&3?
M]?\ >?\ I3)6K0 4444 %%%% !1110 4444 %95E_P C+JG_ %QM_P#V>M6L
MJR_Y&75/^N-O_P"ST :M%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5E-_R-L?\ UX-_Z,6M6LIO^1MC_P"O!O\ T8M
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MRO#G_(,F_P"O^\_]*9*U: "BBB@ HHHH **** "BBB@ K*LO^1EU3_KC;_\
ML]:M95E_R,NJ?]<;?_V>@#5HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO^1EU3_KC;_^SUJUE67_ ",NJ?\ 7&W_ /9Z -6BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *RF_P"1MC_Z\&_]&+6K
M64W_ "-L?_7@W_HQ: +M]#<7%E+#:W;6DSC"3JBN4/KAL@_C7%V,/BF[\4:M
MH[>,+A8["*W=9!8V^6\P-G/R]MM=Y7/:7I]W!XYU^^EA9;:Y@M%AD/1RHDW
M?3(_.@!;[QEINGW5S;F&^NQ98^V3VULTD=OQGYB.^.2!G%5_^$L:3QK:Z5!"
M\MA<:>;E;A(\JQ++M?=G&S:3SZD51A_M;P[)KMC%H5SJ/]H7<MU:30%/+8R
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MIQVFIVMA=LD3H'$\!0"1<9![+@CH?6@#67QEHAT9M5:>5($G%O(AMW,L<I(
M0Q@;MV2.W<58?Q-H\4UM#+?1Q27*!U64[&0$ C>&P4)!'#8-<7J&J37FG&QO
MK&VMM1L=;T];AK8YCFW.C(X) .=O&#TQ78:CX6TS5-8MM6N4<W5KM\H@C"X.
M3QCG/0Y[#C% $G_"3:/]JN+5;Z.2:VCWLD9WLWW\A0N2S#RVRHR1CI5C2=7L
MM<L1>Z?(TD.]DR\;1D,IPP*L 001Z53M/"VF66OS:Y"CB\GW>8Q(P0=N!C'&
M-O&/[S9SFJ7@+_D"WG_85O/_ $>] '34444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !574=.M=6L);&]C
M,EO+@.H=D)P0>JD$<CUJU10!#:VL%C:16EK$L,$*!(XT& JC@ 5-110!D>'?
M^/:]_P"PA<?^C#6O61X=_P"/:]_["%Q_Z,-:] !1110 4444 %%%% !1110
M5E2?\C;;?]>$O_HR.M6LJ3_D;;;_ *\)?_1D= &K1110 4444 %%%% &5X<_
MY!DW_7_>?^E,E:M97AS_ )!DW_7_ 'G_ *4R5JT %%%% !1110 4444 %%%%
M !659?\ (RZI_P!<;?\ ]GK5K*LO^1EU3_KC;_\ L] &K1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M9'AW_CVO?^PA<?\ HPUKUD>'?^/:]_["%Q_Z,-:] !1110 4444 %%%% !11
M10 5E2?\C;;?]>$O_HR.M6LJ3_D;;;_KPE_]&1T :M%%% !1110 4444 97A
MS_D&3?\ 7_>?^E,E:M97AS_D&3?]?]Y_Z4R5JT %%%% !1110 4444 %%%%
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MEKNH^%+<.L7BB:.:)E_Y9J>+K_QU,_5Z]&CC2&)8HU"(BA54= !T% #J***
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "LIO\ D;8_^O!O_1BUJUE-_P C;'_UX-_Z
M,6@#490RE6 *D8((X-0Q65I ^^&UAC8?Q)& :GHH CGMX+J(Q7$,<T9ZI(H8
M'\#0((51$$2!8SE%"C"_3TJ2B@!GDQ;&3RTVODLNT8;/7/UI3&AC\LHI0C;M
MQQCTQ3J* ((K.U@@,$-M#'"V<QH@"G\!6?XAT:YUS3_[/AU$V5M+E+I4A#-+
M$1@H"3\N1QGGK6O10 R*-(8DBB4(B*%51T '04J1I'NV(J[B6.T8R3U-.HH
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M="F/B5M9OK_[5Y4;164 A"+;JQ!;G)W,=H&>.!6S110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% &1X=_X]KW_ +"%Q_Z,-:]9'AW_ (]KW_L(
M7'_HPUKT %%%% !1110 4444 %%%% !65)_R-MM_UX2_^C(ZU:RI/^1MMO\
MKPE_]&1T :M%%% !1110 4444 97AS_D&3?]?]Y_Z4R5JUE>'/\ D&3?]?\
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MS>)=4UN_U&PFL;*_L$L(H9P!*Z@N6D*@G;R^!SGC/%1_#J*^O;>YUS52&NI
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M.,'<NWJ*N-?ZS!XKT&*XOAY&I03&:T6$!$9(P<@D;^IZ$UU=<QKG_(^^%O\
M=O/_ $6M '3T444 %%%% !1110 4444 %%%% !1110 4444 9'AW_CVO?^PA
M<?\ HPUKUD>'?^/:]_["%Q_Z,-:] !1110 4444 %%%% !1110 5E2?\C;;?
M]>$O_HR.M6LJ3_D;;;_KPE_]&1T :M%%% !1110 4444 97AS_D&3?\ 7_>?
M^E,E:M97AS_D&3?]?]Y_Z4R5JT %%%% !1110 4444 %%%% !659?\C+JG_7
M&W_]GK5K*LO^1EU3_KC;_P#L] &K1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %93?\ (VQ_]>#?^C%K5K*;_D;8_P#K
MP;_T8M &K1110 4444 %%%% !5#5-#TW6A NHVPN%MY!(BL[!=WN <,/8Y%7
MZ* "BBF2RQPQ/+*ZQQHI9W<X"@=23V% #Z*2EH **** "BBB@ HHHH ****
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M;?\ ]GK5K*LO^1EU3_KC;_\ L] &K1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %93?\C;'_ ->#?^C%K5K*;_D;8_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 9'AW_ (]KW_L(7'_HPUKUD>'?^/:]_P"PA<?^C#6O0 4444 %%%%
M!1110 4444 %94G_ "-MM_UX2_\ HR.M6LJ3_D;;;_KPE_\ 1D= &K1110 4
M444 %%%% &5X<_Y!DW_7_>?^E,E:M97AS_D&3?\ 7_>?^E,E:M !1110 444
M4 %%%% !1110 5E67_(RZI_UQM__ &>M6LJR_P"1EU3_ *XV_P#[/0!JT444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW&V*RMSG?&VW CA .=S-SD<\^@H [.BO+IO[2FU#0O#FMZ?/K4\&CBYELQ*
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ML$)C/^M=N?[@(^I%4]"U"W_X1#Q+H$-U%<+H\<\<#QR!PUNZ,T7(ZX!*_P#
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M0N/_ $8:UZ "BBB@ HHHH **** "BBB@ K*D_P"1MMO^O"7_ -&1UJUE2?\
M(VVW_7A+_P"C(Z -6BBB@ HHHH **** ,KPY_P @R;_K_O/_ $IDK5K*\.?\
M@R;_ *_[S_TIDK5H **** "BBB@ HHHH **** "LJR_Y&75/^N-O_P"SUJUE
M67_(RZI_UQM__9Z -6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*** "BBB@ HHHH RO#G_ "#)O^O^\_\ 2F2M6LKPY_R#)O\ K_O/_2F2M6@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPVG( R*MZ1J]IKFGK?632&%G9/WD91@RL58%3R""#0!>HHHH **** "BBB@
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MHH **** "BBB@ HHHH **** "LIO^1MC_P"O!O\ T8M:M93?\C;'_P!>#?\
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MA"X_]&&M>LCP[_Q[7O\ V$+C_P!&&M>@ HHHH **** "BBB@ HHHH *RI/\
MD;;;_KPE_P#1D=:M94G_ "-MM_UX2_\ HR.@#5HHHH **** "BBB@#*\.?\
M(,F_Z_[S_P!*9*U:RO#G_(,F_P"O^\_]*9*U: "BBB@ HHHH **** "BBB@
MK*LO^1EU3_KC;_\ L]:M95E_R,NJ?]<;?_V>@#5HHHH **** "BBB@ HHHH
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MFJ?B%TD\5>$!;%2YN9G4K_SR\AMQ^G*_I7-$@? 58A_Q\;1%M[^?]HQCZ[Z
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MW3C S73ZYJL.AZ)>:I/_ *NUA:3']X@<#\3@?C0!!8^)-,U'7+[1K:5FN[
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M"27#A@NP,1P #N('-3>"]7EU&'5+.:\^VG2[][5+DXW2H ""V."PR5)'7&:
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MVL!R/YU%!X1U/2['3M1M8K:35+6_EO9;6-MD3+*I1HD..-J[0">/E[9KNJ*
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M **** "BBB@ HHHH **** "LJR_Y&75/^N-O_P"SUJUE67_(RZI_UQM__9Z
M-6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT;EE7*.JL.H; )'4-6=+IEB?"WA37#?7$NH7VHV,D\KW+,+AVD4LI4G'RG.
M!QMQZUZ#I7AK1=$E>;3=.AMY'7874$MM_N@GD#V'%0KX/\.I>_;%T>V$_F"4
M.$^ZX8-N Z Y /'6@"]:65M;7MY<0N[2W+JTH:4L%(7 P#]WCTKC_%]G;7>M
M/+I>K266LPO8I/$8MT<L;7*^6S*0-VULG*GV/6NTM["TM;FYN8($CFNF#3NH
MYD(& 3^'%9VO>%-'\2"(ZC:*\L+(5E'#A0X8KD<[3C!'OZT <Q9:S<ZYJWA2
MYO$B6XBO[ZWD:'/ER&.*1=R9_A.*["+1-.AU9]5CM\7LF0\V]LL"%&#ST^1<
M#H.W4UEZKX?NDNM"FT&&QACTF20B"4M&FUHRF!M4_P![-=)0!C?V'IVD:;J+
MV%OY+3PL93O9MYPQW')Y;YCD]3QGH*C\#_\ (BZ%_P!@^#_T 5H:Q%?3Z5<0
MZ<MNUQ(A11<.RI@\') )Z>U1>'=.ET?PWINF3NCRVEK'"[)G:2J@$C/;B@#2
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,CP[_Q[7O_ &$+
MC_T8:UZR/#O_ ![7O_80N/\ T8:UZ "BBB@ HHHH **** "BBB@ K*D_Y&VV
M_P"O"7_T9'6K65)_R-MM_P!>$O\ Z,CH U:*** "BBB@ HHHH RO#G_(,F_Z
M_P"\_P#2F2M6LKPY_P @R;_K_O/_ $IDK5H **** "BBB@ HHHH **** "LJ
MR_Y&75/^N-O_ .SUJUE67_(RZI_UQM__ &>@#5HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LIO^1MC_P"O!O\ T8M:
MM93?\C;'_P!>#?\ HQ: -6BBN3LO&,USXSETI[>-=->66UMKD9W/<1*K.I[8
M^9@/=#0!UE%9.I^*-#T:5H=1U."VE158H[?-@YP<#G'RG\J2#Q7H%UJ$6GV^
MKVLMS,H:-$DSOXW<'H3CG'7% &O161+XKT"#4_[-EU:V2ZWB,QE^CGHI/0-[
M9S6A'>6TUW/:1S*T]N%:6,'E V=N?K@_E0!/163-XJT&VM(+N;5;=(+E6>%R
MW$@4@';Z\L!CWK/U?QWH]AH4.K6MU#=PSW*6ZE7P 2P#9XR"H).#Z4 =-152
MVU2QN[DVUO=1R3+$DQ0'D(WW6^AKGO&WB74='"V6E);K=2V=S=>=<9*HL2@D
M*H^\QR/88R<T =917)7^O^(].T:(W-C9PZC)J<5BCDLT$JNP42@ [@.>A.>#
M2R^*]1MO%UIH4NFK()(U66>-P$\QL$$$GY>%F.P@D[1@T =917(V7BO5-1\2
M:AHL.FI T*,(9Y6!CW+]XG#9<9:,$#!7)S6IX3U>[UO0Q=WR0I<+<30N(00A
MV2,F1DD\[: -JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R
M/#O_ ![7O_80N/\ T8:UZR/#O_'M>_\ 80N/_1AK7H **** "BBB@ HHHH *
M*** "LJ3_D;;;_KPE_\ 1D=:M94G_(VVW_7A+_Z,CH U:*** "BBB@ HHHH
MRO#G_(,F_P"O^\_]*9*U:RO#G_(,F_Z_[S_TIDK5H **** "BBB@ HHHH **
M** "LJR_Y&75/^N-O_[/6K659?\ (RZI_P!<;?\ ]GH U:*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MANK:VOMKH3%(]O(I>%L?CA@"#R/2H-#T6#0-,6PMIIID$CR&2=@79G8LQ)
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M_P#HR.M6LJ3_ )&VV_Z\)?\ T9'0!JT444 %%%% !1110!E>'/\ D&3?]?\
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MHH **** "BBB@ HHHH **** "BBB@ K*;_D;8_\ KP;_ -&+6K64W_(VQ_\
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M)='8W[LA0Y'3GY2#QFJ%UXST*T:!'NY'EN;=;F&*&VDD>2)LX8*JD]C].^*
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MK\$<%\UQY4;A_+BG:-7(((W 'YL$ \T :=%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 9'AW_CVO?\ L(7'_HPUKUD>'?\ CVO?^PA<
M?^C#6O0 4444 %%%% !1110 4444 %94G_(VVW_7A+_Z,CK5K*D_Y&VV_P"O
M"7_T9'0!JT444 %%%% !1110!E>'/^09-_U_WG_I3)6K65X<_P"09-_U_P!Y
M_P"E,E:M !1110 4444 %%%% !1110 5E67_ ",NJ?\ 7&W_ /9ZU:RK+_D9
M=4_ZXV__ +/0!JT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,CER%69P!D\G  H Z:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 5E67_(RZI_UQM__ &>M6LJR_P"1EU3_ *XV_P#[/0!JT444 %%%% !1110
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M HHHH **** "LJ3_ )&VV_Z\)?\ T9'6K65)_P C;;?]>$O_ *,CH U:***
M"BBB@ HHHH RO#G_ "#)O^O^\_\ 2F2M6LKPY_R#)O\ K_O/_2F2M6@ HHHH
M **** "BBB@ HHHH *RK+_D9=4_ZXV__ +/6K659?\C+JG_7&W_]GH U:***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
M*;_D;8_^O!O_ $8M:M93?\C;'_UX-_Z,6@"[?0SW-A<06UR;6>6)DCG"[C&Q
M& V.^.M<2NE6FD^+-&T[09KB34(COU64SNX:#8<F7)(W,VTKWZ]J[34X[V73
M+F/3I8X;QXRL,D@RJ,1P2.^.M<SX8T'Q+H"Q6SMHSP/)ONYE68W$['[SEB>6
M/OQ0!S[1/-X N?'!N)QK2R27<<WG, BK*0(@N<;-@VD8YR:VOB FJ2Z=;WD6
MH"WT^.XM";>-/GF=IE!WMG[H!& !R>I[4LG@W56TV;PXE[:#09K@R$[&^T+$
MS^8T0_AQDD;O0]*WO$NCR:WH_P!AAD2)OM$$NY@<8217(X]EQ0!@>*Y+%_&&
MG6GB*Z^S:(UI(\?F3&*&6Y##AV!'1.0"?6K/P_U-;VVU:U@GEN+.QOVBLY)6
M+$PE591N/+ ;C@GMBM37+'5[BXMY],GM'1%9)K.]0F*3."&! )##'T(-5]-T
M35-)TJ?[-=VTNJ7MW]INII8V$1)(#*J@Y "*%'/;)H R_B'#JILX;F/41!80
MW5KFWB3YYG,Z@[VS]T C  Y/4]J3Q7)8OXQTZT\177V;1&LY'C\R8Q0RW(8<
M.P('"<@$^M=!XFT>77-'^Q0RI&_VB"7<^<8217(X]0M1ZY8ZQ<7%O/ID]HZ(
MK)-9WJ$Q29P0X(!(88^A!H X/^VC/X=N;5;^Z_L2UU]+:6Z$C;EL64, 7^]L
MW%1NS]TCFMKP[J%A#XVN]'\-W:W&G/IOV@ 3-+ DZN%(5LGJ'7< ?US6K!X;
MU2RT2=;74XAJMU>?;+B5HOW,K' ,97J$V@+USQFI]$T*\M]6GUC5'M1<O MM
M#!9J1%!$"6(!/))8Y)P.@H R_"L6I6_CG7XM4U$WLYM;1RRILC3)E^5%R<*/
MS/4]:P@C+\/(_'7GS_VT76\,WG-@J9<>5MSC9L.W&/>NZL]&EMO%6IZNTJ&.
M]@@B5!G<ICWY)^NX5@CP;JO]F+X;:]M/[ 6X$@(1OM!B$GF"+^[C/&[T[4 2
M>)](TFW_ +0UOQ%>W%Q&X6.R@CD=#"=N L05OF=FYSC/X"L5S(+KP[8^.KUH
M;0Z66<S3F*.6[!'$C @%@GJ>N:V;_P />)IO%LFM0SZ1<)&H2QBO%E;[,,?,
M5"D#<QZMU[=*T;ZP\1SI9SQSZ;),D;)=6DT;?9Y"2"'4\L",=\YR: *?P_U-
M;ZTU6VAGEN+2QU!X;225BQ,)564;CR0-QP3VQ4?B?2-)M_[0UOQ#>W%PCA8[
M*".1XS"=N L05OF=FYSC/X"M'3-$U/2--<6]W;2ZA>7OVJ]EEC8(VX@,$ .1
MA0%7)[<UFW_A[Q--XMEUJ&?2+A(U"6,=XLK?9ACYBH4@;F[MU[=* ,*:ZU.>
M]T+P_KMI?:G<1Z0+J>RMI AGE+;096+*,* <Y/+$=:V='UVVTSPQ)'IWVR>[
M-Z]K:Z=>M^]AF//DDY/R*/FW9.%[UH76BZVVH66NVTU@NK16S6US&ZN()HRP
M88/+*01D=>IJ*S\"6$\$DNOQQW]]/=274DD9>-$9PJ[4P<X"HHYZXH P+&^U
M+P_X'\9W#WSW-_:ZA*!<-_?,47S =@"V0.U:DNE0^$M>\//I\L_^G3M:7HDG
M=_M&8V8.VXGY@RYS[D5)I_PZTVTL=?LV5535GD5&1F)BB95 'S'DAE)S]*LV
MN@ZY=:GIUWKEW92KI2N8%ME8&>4KL\Q\], G@9Y/6@##US1(](BLXK6_N;SQ
M;=W2O#<K(X9AY@+EDW$+$$R,=.G>O0W=8T9W8*J@EF)P *XC1_#OC#2;JYO&
MN-#NKR[?=/=3),9&7/"#G 4#@ <5TGB73;O6/#UYIME<+;2W2>496S\J$X?&
M.^W('UH X70=::+Q'9>))KX-!XCN9;9[<RY,*\"V.W/&0A!_ZZ5T\_B#7KGQ
M!JFE:1I5I*--$;-+<W#()-Z;@H 4\]>3P./6C6/ .AWN@SV-AIME8W/E@6]U
M';JKQ.N"K;@,]0,^O-9&G1^)CXO\1"PN=.$VRT6X\]'*K)Y(^=,=><\'KQR*
M +T?C6]U2;2(=$TR*1]4M))R;F8H+<HRJP; )."2..^*;<>.+Z"P"?V2CZJF
MJ+ILML)_DWLI975\?=(VGD9 )]*SO[%O] \3^'M,T2Y@>:UTJYWM=J=L^9(R
MV=O*Y8[N_3%:L?@Z\98+FYO(9+Y]8CU*[=4*IA5VB-!UP!@ GWH Z;3VOGL8
MFU**&*[(/F) Y= <]B0">,=JR/%NDWMY:0:EI#%=5TQS-;+G"S#'S1-[,./8
MXK69;_\ M1&5[?[!Y)#(5/F^9D8(/3;C/OFK5 '&:#=2>-]6@\0M'-!I-BNV
MS@DRIEG(Q([#T0Y0>X8U>\'>(-7\2V,>IW6F6]G8SQYA*SEY&8'!R-N O!QS
MGCWJ[X4T67P_X>@TR>5)9(I)G+IG!WRLXZ^S8JOH^C:IH7@JWTFRN+5M0MHM
MB2RJQB)W9Y P<8- &MYE[_:AB^SQ_8?(#";S/G\S=]W;CICG.:S]?T2'5Y+:
M2_O6CTVU#R7%L&*+,<?*78$?*O)QT/?I6AMO_P"U2V^#[!Y  3:?-\W=USTV
M[<<=<U@^,=!UC7WLH;*>R^PPN9+FUN@^VX;^$-MZJ.N,X)QF@#F8KJZ3P]>Q
MZ5<74&D:GK%O9Z;*TC;TA=D61D)Y"D[MOIG(K>M+.'PUXZL].TXR1V6I6,KO
M;M*SJLD;)AQN)P2'(/K@5:NM#UK6=!FL=4GT^WN(Y(Y;*6QC?;$\;!E)#'GD
M 8';-2Z9HVJ2>(!KFN36AGAMC;6\-H&V(&8,[DMR2< 8[ =Z ,S18=5M_B1<
MKJNHB[EETE9=D:;(H<S$;4&2>W4\G]*Y>\O].AT/6M4O]3EB\6VMS.T<?VAA
M+$48F-4CS@Q[ ">"""2:]&&CRCQ@^M^:GE-IZVOE\[MPD+9^F#6/J7AK7M3^
MV:=-J%DVG7CL'N3$?M20,<F$8^7'50WH>A- &W=:LUOX6FUGRP6CL6N=GJ0F
M[%<WHW@K3M9\.VFHZM)<W6JWUNL[WWVAUDC=UW#R\'"A<X  QQ79/;0R6C6C
M1J8&3RRG8KC&/RKE+70O%^DZ<-&TS5=.:QC7R[>YN87-Q!'T P#M8J. >.@R
M* #Q3-=:;X1L]$GU/S;_ %)X[ WA C)!_P!9(1GC"!N_4BJFC7X3PCXCT/[2
M)I=&2>*.0/N+0,A:)L_[IV_\!J_;^!K<:AIXOVCU#3M-L3!!#=+YK-*S O*V
M[C.  /3FB]\%)'JLEUHB6FGP7>G365U D6Q7R,QN HQD$G)]#0!@^%]4O--\
M+MH&JSM(T^D&\TVY8\RQF+<T>?[R$_\ ?./2NG\+37Y\,^&!%!'+;R:;$;J9
MY,.A\I2N!CYLGKZ5!JO@S^U/!-EHK7 BOK"WC6WNT!^214"Y]=I&01Z&M'2=
M.U/2M.T/3HYK9K>RM%@O"5;<Y6,*I0]N0<Y[4 :&H)>O8RIITL,5TPQ'),A9
M5YY) (SQGC/6N#L'UBQ\!^+?LEY<7FI6]_<JEP1F1B N6 '0XR0!TXQ7HM8.
MGZ!=V5AK5NE]Y$VHWD]Q#/$N3#O VG!ZD$4 <I8ZCX?TSQ#X=7POJ372W[M#
M>JMRTPD4QDJTF2=LFY<]C]X=*QIM5L+'PE<ZW/J4H\8V]PSRQ&X;S5=9.8_*
MSCRM@],8YZUW5CX?U:?5K*^UJ73U33RTD45C&P$TS+M,CYZ8!. .YZU7O/"^
MN:FLNFW]]92Z=--F6Y$1%U+#OW"(_P /HN[T'3- $7CV/5'ALKM-0$&GI>VG
M^C1IAYF:90=[9^Z > !UZ]*LZU NN>-[/0[QI#I\6GR7DD*2%!,^]47=@@D
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M]C]X?3TFN7L/#^K3ZO97VM2:>JZ?O>**QC8"69EVF1\_[). /7K744 %%%%
M&1X=_P"/:]_["%Q_Z,-:]9'AW_CVO?\ L(7'_HPUKT %%%% !1110 4444 %
M%%% !65)_P C;;?]>$O_ *,CK5K*D_Y&VV_Z\)?_ $9'0!JT444 %%%% !11
M10!E>'/^09-_U_WG_I3)6K65X<_Y!DW_ %_WG_I3)6K0 4444 %%%% !1110
M 4444 %95E_R,NJ?]<;?_P!GK5K*LO\ D9=4_P"N-O\ ^ST :M%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K*;_D;8_\
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M?6GT4 00V5I;O))!:PQ/*<R,D84N??'6H?[&TK_H&6G_ 'X7_"KM% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 9'AW_CVO?\ L(7'_HPUKUD>'?\ CVO?^PA<
M?^C#6O0 4444 %%%% !1110 4444 %94G_(VVW_7A+_Z,CK5K*D_Y&VV_P"O
M"7_T9'0!JT444 %%%% !1110!E>'/^09-_U_WG_I3)6K65X<_P"09-_U_P!Y
M_P"E,E:M !1110 4444 %%%% !1110 5E67_ ",NJ?\ 7&W_ /9ZU:RK+_D9
M=4_ZXV__ +/0!JT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9(P!GW) JGX'_P"1%T+_ +!\'_H K=HH **** "BBB@ HHHH **** "BBB@
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MHH **** "BBB@ K*;_D;8_\ KP;_ -&+6K64W_(VQ_\ 7@W_ *,6@#5HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH R/#O_ ![7O_80N/\ T8:UZR/#O_'M>_\ 80N/_1AK7H ****
M"BBB@ HHHH **** "LJ3_D;;;_KPE_\ 1D=:M94G_(VVW_7A+_Z,CH U:***
M "BBB@ HHHH RO#G_(,F_P"O^\_]*9*U:RO#G_(,F_Z_[S_TIDK5H **** "
MBBB@ HHHH **** "LJR_Y&75/^N-O_[/6K659?\ (RZI_P!<;?\ ]GH U:**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M R/)\2?]!#2__ *3_P".T>3XD_Z"&E_^ 4G_ ,=K7HH R/)\2?\ 00TO_P
MI/\ X[1Y/B3_ *"&E_\ @%)_\=K7HH R/)\2?]!#2_\ P"D_^.T>3XD_Z"&E
M_P#@%)_\=K7HH R/)\2?]!#2_P#P"D_^.T>3XD_Z"&E_^ 4G_P =K7HH R/)
M\2?]!#2__ *3_P".T>3XD_Z"&E_^ 4G_ ,=K7HH R/)\2?\ 00TO_P  I/\
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M;.';Z#SLUO'...M<1X=TW0[[P"UWK,%N\LR22:E<2J/,28$[\L>05/ ],#%
M&K>:GJ&G3+#?>(O#]K(R[@D\+(Q'3.#-TX--N-6OK1(GN?$GAZ%9EW1M)$RA
MQZC,W(KF=%?6KS5M/E?3+/4+R3P[:M/]OG,>"9).>$?)/?I6CJ?A_P#LCX9Z
M['>1VKSM!=W 6%/W<&\,VR/(R /P^@H U[;4M0O%#6OB+P_.&<1@Q0LV7()"
M\3=< G'M4DMSK$%REM-K>B1SR?<B>V<,WT'G9-5-<MX;=O"XAACB#:K&3L4#
M/[B7TJIX:TW1M1\(W%SK-M;37$TDYU.6=1O20.P8,3RNT  =, #% &UNU[[3
M]F_M;1_/*;_*^R/NVYQNQYN<9XS4$%IK2ZA>746KZ4\K!(YU^R.1&5!(!_>\
M'#YY]JX[3;75=3N='U&&1SJ]GH:3VYE;'GCS6&Q_]]._8D'M4RZ__:.C^(6T
MR.=KC6=4CM8H5 $JDVT0E&"0 RJLG4@97K0!UXN-8:R%Z-:T0VI&X3BV?9CU
MW>=BI_)\2?\ 00TO_P  I/\ X[7#7=P;+PMXGT!["?3XHT%W907&S<(78;@-
MC,,"0-WZ,*]/#*>A!^AH YJYUF[LKAK>[\3>';>9,;HY8BK+D9&09L]"*GFN
MM7MH$N)]<T.*&3&R1[9U5L],$S8-8MO::G<>,/$S6-MI4J"Z@#&]5BP/V:+I
M@=*O6-I9WWCC6DU&WAFEMHH%LXYD#!("F6* ^K[@2/[H% %RYN]6LK9;FZUS
M0[>!R LLMLZJ2>1@F;%,M]1U&[@EGMO$.@30PC=+)' S*@ZY)$W'3O7)7<;Q
MW#V.D1V[V4'B6)+..4GR58P$R(, X4.6X X)(I]_'.\WBA]3AM+"_MM!N(X[
M>T0[+B)E)\W><;L%=N,#;D^HH Z\SZT++[:=9T46NS?Y_P!E?9M]=WG8Q[U)
MCQ!Y/G?VGI'E[=V_[')MQUSGS>E<+>9'A2[\'9.+=9;HC_IT$?G)^'F,L?T4
MUVY737\'6R:N4^Q-;P++O)"G.T '';./;UXH 9!=:O<VK7<&N:'+;IG=+';.
MR#'7)$V*6*YUBXM#>0ZWHDEL 29DMG* #K\PFQ6);Q6,'B'6['Q MKLN#9R_
MN,K!C>5B5E[/N7G)(8;>@&*R-12]BOK_ $Z1;/SYM8L7N"BG[+L=2$#)UR&C
M4L"?FRO(SP =I:RZW?0">TUC1KB)NDD5J[J?Q$M/"^(3(8AJ>D[P Q7[')D
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J.*"&"(0
MPQ)'&,X1%  SUX%244 1);01VPMD@C6 +L$00!0O3&.F/:B"UM[;/V>WBBW
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C 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>ebs20191231exhibit1040001.jpg
<TEXT>
begin 644 ebs20191231exhibit1040001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6Z "BBB@ HIK,$0L<X49. 2?R%5-)U:SUO3TO["4RV[LZJQ0J258J>" >H-
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M/U+4;72-/FO[UVCMX%+R.J,^T#J<*": +5%4QJEJ9+) 9";Y2T)$3$$!=W)
MPO'KC--TS5[+6$N'LI&=;:=K>7=&R%9%QN&& /&: +U%%41J]D=;_L;S&^V_
M9S<;#&P'EA@N=V,'EAT- %ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\R!G:,EB%V#=\G0*<<8]>O-*_A"R)U"*.YNHK+4I#)=6:,OER,WW\$C<N[N
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M2#P[HMOI5M---#;KM1IB"V/P H YK1HKV'6_&,T6H2&6*=-IEC1E8_9T()
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M_P #ZY)/J#)-::S]D#P1J@>(3(FT@YXPQ[Y]\<5WY1H[)D>5IF"'+N "WUP
M/TK$/@NQ;1]3TN2\O9(=2N3=2.S('20L&RI"C'S*#@@]*W((/*M5@>62?"X:
M20C<_J3@ ?D /2@#SC0+_7-"\&^%]32]AFT^4V]M+9>0 0DAVAP^<E@2#CI6
MT-9\1:M;R:AHL3D0WSPB"3R1"\4<A1MS$[PQ"E@>@X&#U.II_A&TL+>RM#=W
M5S9Z>XDM;>8IMC89VG(4%MN3C)/KR0#4:^"K*+5KF]@O]0@@O)3-<V$<P%O*
MYZDC&>>X!&>_'% $,=_K.NKJDVD7L-K)87[6L,,R QR>7MW^8<%N<G&W&..M
M4O$WB+4]*&HW=O>QR"RN+<);PQAT$;% WG,1PQW' 5LXVG'6M23P99MK-SJ,
M%]?VJ7I#7=I!,%AN& QEAC()'!VD9J.]\"V%\-3C:_U"*WU.59YK>*10BRC;
M\ZY4G/RC@DCVZ8  :I?MXDU[3?M1$-I90SP$(NY&;?GMR/E'6LG_ (2W4(O#
MV@ZIJ+7$%E>67F7=]:6XD\F4A=N]2#A,%N0.N.E;]UX5@N-3-^FHWT$DEL+:
MX6-UQ<(,XW$J2"-QY4@\TVQ\*)IEE:6EGJM\D=K;FV ;RV#IVW IC(['W/6@
M"C_;=_?7<&E6=S)+(NF174EW9+"WFLY*A@)"!LRA/ _B'([[FA2:I+HELVLP
MQ0ZCM(G6)MR;@2,CZC!QVSBLJ?P)IQ73FL+N^TN?3H/L\4]I* [1?W&W AAG
MGD=:W[.TCL;1+:(N50'YG;<S$G)))ZDDDGZT >?ZQJFK7W@_5&GU!DEM==6T
MW01J@>(3(NT@Y]<]?KD<5Z$D<B6_E^<7D"X$DBCD^I P/RQ6"W@JQ?2=1TV2
M]O7CU"[^V.Y9 \<NX/E"% '*C@@UO10F*V6'SY'8+@RN06)]3QC/X8]J .*M
M?$^L?\(;IVJW2SSJUY/'?SV4"M)%&LDJJRH0> 57/!.,_6NH\/7R:CHD%W'J
M$>H)*7*7,:A0Z[CMR,#! P",=0:I:?X3CTNRM;:SU6_06LLLB,QC);S"696^
M3!&23ZY[UI:3I5MHUD;6UW%6D>5V;&6=V+,3@ <DG@ "@#@H)==L=+\5ZMI.
MH00+8:M=SM;R6X<3A0K,"V<C@<8[]_3?L-;O/$VIWUI973:<ME:V\@(C5V:2
M9"XW;@?E P,#!)SR*N'PC:$W\7VR[%EJ4QGNK/*;)&;&X9V[@&P,@'\N:GG\
M.0'5VU6SNKBPN9(1!,;?9ME0?=RK*1E>Q'TY% ')V^LZCXCO/!]U)=2V4DT]
MW%<10!2GF11R*6&X'.<'&<X!]>:AFN]6TN#QIJNFWL<'V'43,8VA#^=B*,E2
M3T&/3GWKK9?".G&WTN&VEN;/^RG9[=X'&[YE*N&+ YW!CD]<G.14,O@NTFL=
M8LWU&_,>LR&2Y^:/() !"G9P, #OTH U-3OVLM O-21<M!:O.JGN0I;'Z5S,
M=W?:1\'X]3L;A5O5TT7C2R)OWR,OF.<>I+'FNM6S0Z?]BF9KB,Q>4YDQEQC!
MS@ =/05A6GAYI_"#^%+^6XCBBB^S">' ,L'12"00#MP",9!![8) (/&-W+9Z
M3HVKQG]_;W]N21U99#L=?H0Q_(>E:'C/4+W2?".I:CITJ17%M"9%9TWCCVIF
MI:,^I/I>G,TCVMA/'<S32@9D,8^1>  ?FP20,87'>K^N:/#K^CW&EW,TT,-R
MNR1H2H;;W&2"/TH P7UO4]'\1F'4;M+NSETN6]\M(0AB:,KD*>I!#=^XJO)X
MAU:TT#1/$DERLT.H20"YLQ&H6-)L8\L@;MREAU)SSTK=;PU#)JUKJ4U]=RRV
MULUML?R]DB-C=N 3OM'3'2H;+PA964%K:?:KJ:QLIA-;6DK*4B8$E><;B%)R
M 2<<=<# !2\%"Z>_\2/<7\]P$U>2(+(%Q@1Q8/ '0<8Z>V>:FU&]U=O&MOH]
MK?1V]K<:=+-GR SHZN@SDGG[WICV-:6G:#;Z7J5_>V]Q<8OY?.D@9@8UD(4%
M@,9R0HZD^V*)]"BG\0PZW]LN4GAMVMUC4IY>UB">"I.<J._:@#D5\0^(XO#*
M:U-J,#FQU+['/$ML +E1<>46)S\IP0>...^>+OB;Q#JFDC4;NWO$?[%<0!+:
M&,.@C8H&$S$?*Q+' 4YQM..M:#>"+-]#FT<ZE?\ V>:[^ULV8M^_S/,Z[,8W
M<]*;=^!+&\34HGU'44@U*19IH4D0+YHV_O!\N<_*./N^W3 !2FO+C3_&VOWL
MM[<2V]CI,5R+?";<#S25'RY'W<YZ^^,"K.G7?B:YNM-NE!:RNX"USYZPA8F*
MY1HMC;B,\$,2<=ZTF\,VC:N=2:XN6>2U%K/$7!CN$&<;QC.?F/0@<]*K:+X.
MM]#*I!JFI36\.?LMO/,'CML@CY1C)P"0-Q.* ,/3]7\3W/@2[\2/J]OYD-I=
MLL'V,8+QN^UL[O1",=.0>2.=2ZU349(-/"7XA:XTXS%+>,/<22X7!VE2HC&3
MDG') R*MVOA*VM/"UQX=2_O6M+A9$+L8_,59"2X!"8Y+-U!ZTA\(6HN[.Z34
M+^.6VL_L3%'0>?#G(5_EXY[KM/O0!A2:I-K>E^!-3N559KJ^CDD"# W&"7.*
MZOQ!=7%GH\LUM<V]M(&0>;<9VJ"P!P #EL$[1W.!6;!X)L[:QTBSCU&_$>D3
M>;;DO&23@J V4Z $C QU]>:T]=T2WU_3OL5Q+-#ME26.6!@'C=&#*PR".H[B
M@#E;GQ)K$&F^+1%<-YFD1)/:RW5NHD*M&6PRC ZCC(!P>15N+6]5T[7["/4;
MU+FTO]-EN3&D 0PM&$)VGJ00QZ]QVZ5;F\$6=PNJ"74M18ZM L-TQD3+!01N
M VX!()' QZ 5:_X1>!M1TZ]DO[N1]/@>W17\O;(C !MP"<YVCICI0!RNJ75_
MJ^A^%=:GN\)>ZO9R_951=D:L^5 .-V0,9))!YX'&.@^(-[-9^#[D0.T<ES)%
M;;U."HD=58Y[?*34,?@"TBM;>QCU;4EL;2Z6ZM;8/&5@96W  E-Q&3T)-:_B
M+1DU_0+K2VD\LS*/+DQG8ZD,K?@P!H I>);Z\T==$33GBA@FU&"UEC\O.8V.
M, ]NGI^5.TG4[^X\8Z_IMS,CVUG';/;JL>TKY@D+9/<_*/\ "I+S2O\ A([2
MP:^>ZL9K*Y2X,<)7'FITY93N7)XQU_02PZ-#INL:AKBW%W-->I&LL.%9<)D+
MM 4'^(]^_- &;X+N'%QKVF'_ %5AJDBP>BHX#[1]"Q_# J'4M6U.PU[5=/EO
MRB2Z?]JTQO*4X=3M=#Q\QR4P.N&]>:U_#NDOI=M=2SX^U7]U)=S@'(5FZ*#W
MVJ%&>^">]3ZCHEEJE]I]Y<H6ETZ4RPD'N1C!]LX/U44 <[IGB>YN]"L]2DGD
MW6=E-<:I$$7.^/*E.GR_,KXQV7\:;)K^K66C:#K\MRMQ#J<L"7-J(U"QK-C:
M8R!NRI(ZDYYZ5T5AH&GZ?)J3PP@_VG,9KA6Y!)4 CZ'DX]6/K5.R\(V=E#:6
MOVJZGLK"42VMK,RE8F&=O.-Q"YX!)QQUP, &%>>)-7M_"GBN^2['VC1[^2*W
M<Q+RBK&0&&,'[YYXJ_=3I;_$F"XDSMCT"=VP.PFB)J;4/ UEJ']JQ-J%_#:Z
MLV^XMHG4)YF "X^7.2%'&<>U7QX=A_MR'5WO;J2:*T-IL<H4>,D$[AMSDD ]
M>U '):I=W^L^'_#.MS7>$O-8LI?LH1=D:M*"H!QNW 8R2<'G@<8ZCQK_ ,B-
MKW_8.G_]%M5"/P!9Q6D-C%JVI)8VUTMU;6P>,K ZMN 4E-Q&>Q)K>U;3(]8T
MBYTR>:6**ZB,4CQ$!MI&#C((Y'M0!@)J=_::IX1L89D%G?6[B:/R\L2D.X?-
MV&?;M61X;U1VU[5M"MKHV=S/K-U<&5D!#QKL#(F1AFY_ <\]*ZAO#$#7>D7)
MO[S?I",D',>'W+M.[Y.?EXXQ5.3P'8R0RI_:.H+*^H'4%G5HQ)%,>NT[. >A
M'- $%[JNN:A<ZO:Z)YPGTR188OEA*2R>6KGS-Q#!3NQ\H&,$Y/0(AN)_B/9-
M,/L]Q)X=D+A"&\MS-'G!Z'!J[=>#;>?6&U6'5=2L[B9%2Z^S3*@N@HP"XV\'
M'&5P<=,5:;0+:WUJ/7(IKD26UF;5+>/84,>0VT#;G.5'?M0!BZ9K>JW%E)I-
MU>8UV'4OLLKK$H'EYWAPN/NF$$C/\7%=B.G7-<YHEM%JFO3^*&TRXL9);9+6
M-;J/RY6 )9F9<\=0!GGY3V(KI* "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ I"0,9/6EK@9I]$U'7?$NF>*
M+B&"5'C^S&9PC);^6I5HB>AW[B2.<X]J .]) QD]:6O,O&%QIUQ!XC1"JW=G
MID1+W[Y=#L9T$*\%6Y!+9^]C@XK3M[JQ_P"$[M+NYGMQ#=^'F#RNR[96$B[L
MD\$@=?:@#N20!DG%!( R2,#O7F&@PSW_ (,T--*N+&6[M[B\=;"\&8KE1*X*
MG^ZP# CZ^E2Q:O8ROX?CO(8])TFX@ND6"[59(4N5E V$G"X #[2>QH ]+I,C
M.,\UB>$K.TT_13:V%^][:),_E2$@JH)SM0CJJG('I@CM7,Z//H>JP7(UN=8]
M=M-6D+ 2!;@.)3Y2I_$5*;5 '!&?>@#T'('4]:,@=37!)'::J_C*/753[5:3
M-Y32?>@MQ$#$Z'^'D,V1WJGH.G_VMXGTY/$%L)[BX\,H]U%-D[V\T#+KTSC'
M7N/:@#TG(SC/6@D#J:\HLK*T@\%>'-6C7_38-9C@CN2Y+K%]I:/8"3PNP8V]
M*UCH.B:OXK\8V^K(K0QI;2?/(0(LQ$F0#/!')SVY]30!Z"2 ,DXJO+?VT-]!
M8O*!<7"LT<?<JO4_3D?G7FFCWC7']E:=XNN8(5N-$B:W^WQADD;<X?EB!OV^
M7[_K5ZVL-)LO$GA1)+E+Z!;&[2.\O I:8*T>P[N^!G:?3D=: .UGU)],M=0O
MM6,%O9VQ+1R(Y),84<L"!ALY  SVJQ,]X+VV6&.%K9MWGL[D.O'R[1C!YZY(
MKS36K:W_ .$8^(">4C+%?AU##=M/EQ\C/3J:Z+4(M.7QMX3:Q$ B9;Q%$&-A
M CY  XZD_F: .RI"0,9/7I7!1Z?'IOB'5?":6J_9-<=;R$A/E6,\3J3VQM&W
MT,@JO?C2=1UGQ!HVNZA:Z<\31_9/-15:.W\M=K0L3QAPQXZ&@#O[V:2WL9YX
M8UDDCC+*COM#$#."<''Y54\.ZJVM^'M/U.2-8GN[=9C&IR%R,XIS_)X=;?+(
M^VTYDF&';Y.K>A]:\_T2RM+*P^'VHV\2I=W!$,LV?FD0P.=I/< @8'0=J /3
M\C.,\^E&1ZUY=+?Z:UUH^J6<\,&[Q ZO)/(#=,I,BOO;C:G0!3GC9R.E:WAG
M0=(O=2\237-LDKVNKRB(LY_=@PH#CGC.3GZ#T% '=Y'K0"#T->3Z9IEB/"/@
M;4!'MNYKV*![A7(D:-EDW)N!SM..E=7X4MK?3O%WBC3;*)+>TB>VD2",81&>
M,[B!T&<"@#I3J%LNIIIOFC[4\+3B,=0@(4D^G+#'X^E6,C.,\UQMY#8I\6(9
M9X;82/HY,;2JH+2B90N"?XN@'>N?&Z[^&4>L1+CQ/%> >;C$XNO/VF,]\$'&
MWIMQQ@4 >FWEW;V%G-=W4JQ00(7D=C@*HY)K*GUZ:/Q)I6FK;(;;4;>699BY
MW#8%.-N,?QCG-0^/H8YO 6MB2-9 ME*P#+G!"D@_45A3VNDWWB3PC:1QVTEJ
MUE>%HHL;&RL.00."#SD'K0!WN01D'B@$$9!R#7EL%ZFEZ+%;22K!HT'B6ZM9
MBR[HXH@9/+5A_<WE>O'2NQ\*66G6<VI'2]16[@GE61HX-OD0N1R$V\ G@D9[
M@]Z +-YK[+KBZ'IULMU?"+SYB\FR."/. 68 G)/10.<=AS4MMJ&H?VNNGWEA
M'&K0-,MQ%*71BK*-N" 0?FS_ (\XYW3&&C?%375OV$8UN&WDL9'.!)Y:E70'
M^]D@XZXYK8\7:A<V_AS5DTIF;48K-Y$$8RT?'7V/4CUQ[4 ;N0<\]*,CUKA)
M8+-+OPA?>'E17NWV3&+_ );VQB+.7Q][!"\GHQ]36!<Z;8IX#U;4(X@+JQUZ
M06UP&.^$?:U7Y6SD?*>W6@#UK(/?I1D9QFN%GTVQT_QKJEE9PK!#=:"9IXD)
M D<2$!SZM@GGJ:QM.TBUAT#P-K&F KJTL]M')*KDM+"5/FHW/*A0>.V* /4\
MC.,\^E&1ZUY:-0TTW?A_5+*:"!9=;E5Y)I ;IU/F[_,;C:N0 %.> O/:H]3T
MRP/AKQS=^4IGL=2DDMI-QS XCB(9?[ISW'TH ]7HKB?$'E^&_$%CXNBM?.CN
M8OL=XL298LW,3CW+ (3_ +0]*WM*CL?#]C9:=<3VL%W=,S;-P3SYC\S[1WY/
MX# H OW[WB6,K:?'#)<@?NTG<HA.>Y )'&>U4]5U9[._L-,MD1KO4#)Y9DSL
M0(NYB<<GJHQ[^U97Q,CC?P!J9D_@5&4YQ@[U_P :A\0V.GW'Q"\-?:+2WE::
M*[W>9&K%]J)C.>N.<>E '3:=+>S:?%)J-M';71!\V*.3>H(..&XR#U_&K.0>
M_2N6^):(W@'4F?CRU1@V<8^=>?YUEZAH-G8>,[9=(@'E7^FW)U*(,764#;Y;
MMG.6+$\GD\^] '>G...M9'AS6I]9@O7N;>.WDM;Z:TVQN7!V'&<D#K]*XC3K
MZP;3/AX_VF SHRH[;QN4>0X()[?,,8/<5#=:1IMWX8\5ZA(A.I6NK79LY4<^
M9'-O'EA,'@LV!@=<T =XFM3GQF^A-;QK"+ 7:S!R6;Y]F",<=^YK0L7O'MR;
MZ.&.;>XQ"Y9=NX[3D@<XQGWKF+02O\2(DN\&=O#J^:!_>\[YOUKG--O8-.\.
MZ&EXX31WUR[CO"QRF-\OEAS_ '=^TG/' S0!W7BC6I]!T-M2M[>.XV2Q(RO(
M5P'=4R, YQNZ<5LUY_XEAT:U\$ZQ_8\RO;R7]O(_ER!H4<S195,<#L2!W-7/
M$BIX7\3VOBF&S\V.[C-E=I&F6+GF)A[EAL)_VE]* .TK&\5ZU/X?\/W&IV]O
M'</!M)CDD*\%@N> <XSTX^M6=#TQ-(TF&T"QB0 O,8UP&D;ESCW)/X8KS74[
MBPU+X<:Y>:GY!UF&^<3F0CS8F$^$49Y"A,  <8S[T >HA[S^TF0QP_8_)!5]
MY\PR9.1MQC;C'.>M6,@]ZXJ8VR_$+594N?)CD\/)(\\;9*_O)!O'N !^0K#N
M)M4T32]2LQ8V_P#:46CM);:GIO"W, 906*]5D .0>0<G% 'I\C/Y;F%5>0#Y
M59MH)]"<''Y5E^%M9?Q#X:LM6EA6![I"QC5LA?F(QG\*H:$/"UQJD&H:#/$T
MLMGL,=K(-ICR"&D4?Q \ GGDCUQR>@W)7PSX#M[G!TJYEE2ZW?<:3#^4K>H+
M=CW H ]1!!&1R* 01D'->?7%A(M_XHTRQO(]/TXM9F$NN88KEF&8]O3:_P @
M8?[?O5.ZU62PT^:WO]-ATGR=9@75VMQYELR/%\KCIA21'N4^O.<T >F@@C(.
M1[5CKK<Y\9G0C;QB#[ ;M9A(2Q(D";2,8'4]S7&ZL;'1M*U&ZTC5!/8W=[:'
M4!:;1!;1%L2%-G"EEQNY[@\9K4LUT>T^*BFP-I"DNADD0E55CYJX.!Q]W]!0
M!V]9?B/6'T#0KK55MA<K:H9'C\S82HZX.#S5^VNK>]MH[FUGCG@D&Y)(V#*P
M]01UK ^(9 ^'^MY./]$>@ N_%-WI>EQZMJ6CE;!E5Y9;6?SF@4_Q,I53@9YV
MYQ700SPW%O'<0R*\,JAT=3D,I&00:YK7M1M=.^';_:2&:XT_R(81RTTCQ[51
M1U))/:L+PY836FL:)X>\01))%'H0,$,P#1F??^\&#P65=H]AG'4T >C5D>*M
M8G\/^&KW5K>WCN'M8R_ER.4!'U /Y?K7"*K6VGZ<\S#['9>+3#93R'[EL"P
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M:KQ7]M/?W%C'*&GMD1Y5'\ ?=MS[_*>/IZUP_BES#?:AK*16>MZ6D<2W=ON
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M !1110 4444 %%%% !1110 56GTZQN;F*YN+.WFGA_U4LD2LR?0D9'X59HH
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M\MX_[.M-DAW.OD+ACZD8YI?[*T[S$D^P6V]%VJWDKE1TP#C@5;HH I'1]+,
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M%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\
MX#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H
M ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__
M (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]
M"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X
M_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\
MA)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+
ML/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_
M .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@H
MKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;
MXQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_
M . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#B
MZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC
M%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\
MX#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H
M ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__
M (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]
M"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X
M_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\
MA)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+
ML/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_
M .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@H
MKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;
MXQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_
M . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#B
MZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC
M%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\
MX#C_ .+H ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H
M ]@HKQ__ (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__
M (2;XQ?]"[#_ . X_P#BZ/\ A)OC%_T+L/\ X#C_ .+H ]@HKQ__ (2;XQ?]
M"[#_ . X_P#BZCA\8_%F:[FM5T.W,L"@R((.5W E<_/WQ0![)17C_P#PDWQB
M_P"A=A_\!Q_\71_PDWQB_P"A=A_\!Q_\70![!17C_P#PDWQB_P"A=A_\!Q_\
M71_PDWQB_P"A=A_\!Q_\70![!17C_P#PDWQB_P"A=A_\!Q_\71_PDWQB_P"A
M=A_\!Q_\70![!17C_P#PDWQB_P"A=A_\!Q_\71_PDWQB_P"A=A_\!Q_\70![
M!17C_P#PDWQB_P"A=A_\!Q_\71_PDWQB_P"A=A_\!Q_\70![!17C_P#PDWQB
M_P"A=A_\!Q_\71_PDWQB_P"A=A_\!Q_\70![!17C_P#PDWQB_P"A=A_\!Q_\
M71_PDWQB_P"A=A_\!Q_\70![!17C_P#PDWQB_P"A=A_\!Q_\71_PDWQB_P"A
M=A_\!Q_\70![!17C_P#PDWQB_P"A=A_\!Q_\71_PDWQB_P"A=A_\!Q_\70![
M!17C_P#PDWQB_P"A=A_\!Q_\71_PDWQB_P"A=A_\!Q_\70![!17C_P#PDWQB
M_P"A=A_\!Q_\71_PDWQB_P"A=A_\!Q_\70![!17C_P#PDWQB_P"A=A_\!Q_\
M71_PDWQB_P"A=A_\!Q_\70![!17C_P#PDWQB_P"A=A_\!Q_\745SXP^+5E;2
M7-UH5O%#&,N[0# _\?H ]EHKR%O$WQAPN/#L.2.?W ZY_P!^F_\ "3?&+_H7
M8?\ P''_ ,70![!17C__  DWQB_Z%V'_ ,!Q_P#%T?\ "3?&+_H78?\ P''_
M ,70!UDL;+\2[O4+G2KJ6R_LU+99OLK2*9!(6( P3T/7I5Z2=6T>ZL+70IDM
M)I/L\44MNP4^827=DZB,;O8G!''!KA?^$F^,7_0NP_\ @./_ (NC_A)OC%_T
M+L/_ (#C_P"+H Z73K6_T;PYKGAA[*[N8[:"5;"Z6$G[2KJ<*2!]\$[<]#QZ
M&EMK6\2?P(38W0&GV[)=GR&_<DP>6 >/[W^/3FN9_P"$F^,7_0NP_P#@./\
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MC_XNLW^T?C5_S[W7_?B'_"@#W*BLGPNVJ/X:L&UK?_:+19N-X (;/3 XK6H
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MSR:266.%#)+(L:#JS' %>6VFH3ZM\1? FH7(_?W.C/))QC+&-R3^)K=^,?\
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M/X@4 =U;WEK=[OLUS#-M^]Y;AL?7%))?6<,ACENH8W'56D (_"O,/'?AO2O
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M6%CXUU7Q+]LWG488X_L_EX\O8JC.[/.=OH.M=!110 4444 %<_I/_(Z^(?\
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MT(('!J1]$TF34!J#Z79M> Y%P;=#(#_O8S5ZB@ HHHH **** "BBB@ HHHH
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M_P )[X3_ .A@L/\ O\*/^$]\)_\ 0P6'_?X5T%% '/\ _">^$_\ H8+#_O\
M"C_A/?"?_0P6'_?X5T%% '/_ /">^$_^A@L/^_PH_P"$]\)_]#!8?]_A7044
M <__ ,)[X3_Z&"P_[_"C_A/?"?\ T,%A_P!_A7044 <__P )[X3_ .A@L/\
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M)_\ 0P6'_?X4?\)[X3_Z&"P_[_"N@HH Y_\ X3WPG_T,%A_W^%'_  GOA/\
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M^A@L/^_PKH** .?_ .$]\)_]#!8?]_A1_P )[X3_ .A@L/\ O\*Z"B@#G_\
MA/?"?_0P6'_?X5BZ;XQ\-Q>*]:NI-;LU@G2V$4AE&'*JV['TR/SKNJ* .?\
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M5=3_ .05=_\ 7!__ $$T 9)\>>$P<'Q!8_\ ?X4?\)[X3_Z&"P_[_"K/A/\
MY$[1?^P?!_Z+6M>@#G_^$]\)_P#0P6'_ '^%'_">^$_^A@L/^_PKH** .?\
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M2_ECEN 7;YV0*%/7CA0..OXF@#S=H[J33]9:[A:>:]U739Y+9WQ_K71O*SV
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M8?M%_/<3AI6<A[7;(RA(SG,>T*.F.>>]9FA6\/BG4]'.N1+?_P#$FE8-*/\
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MX:Y<%VR)6;<65LY4YY&",=J;9>&M-L7FE59YYYHC$\]U<232;/[H9R2![#%
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M#]AA6-4CWMP$8,O.<\%1WJ2[T:POM1LM0N;<27-B6,#[B-NX8/'0]!UZ$9H
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MCTM-,RY8VZ2!P#ZY'KBM.J>FZ;!I=NT$$ES(K.7)N;F2=LX ^\Y)QQTZ5<H
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MBB@ HHHH **** "BBB@ HHHH *JZG_R"KO\ ZX/_ .@FK55=3_Y!5W_UP?\
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M#A>?^ =O_P#$58T?4-6N+IX-0M+4Q&(2PWEE*7B?G!4Y (;OW!'I6Q0!S_\
M86O_ /0X7G_@';__ !%']A:__P!#A>?^ =O_ /$5T%% '/\ ]A:__P!#A>?^
M =O_ /$4?V%K_P#T.%Y_X!V__P 17044 <__ &%K_P#T.%Y_X!V__P 11_86
MO_\ 0X7G_@';_P#Q%=!10!S_ /86O_\ 0X7G_@';_P#Q%']A:_\ ]#A>?^ =
MO_\ $5T%% '/_P!A:_\ ]#A>?^ =O_\ $4?V%K__ $.%Y_X!V_\ \17044 <
M_P#V%K__ $.%Y_X!V_\ \11_86O_ /0X7G_@';__ !%=!10!POB[2-9@\-W$
MEQXGNKF,/$#$UK H.95 .0F>#@_A6U_86O\ _0X7G_@';_\ Q%'CG_D4KK_K
MK!_Z.2N@H Y_^PM?_P"APO/_  #M_P#XBC^PM?\ ^APO/_ .W_\ B*AO=:\0
MV6MV=@=.TV5;V=EC$=W)Y@B7EI&!CP,#'?J0.]=-0!S_ /86O_\ 0X7G_@';
M_P#Q%']A:_\ ]#A>?^ =O_\ $4DOBGRO%R:,;8&U.V%[K=]VX96=8\?[BYSZ
MLHJ-]9U^ZUO5++2['3I(M.DC0FXN'C:0M&K\81@/O8H E_L+7_\ H<+S_P
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M<@9Y_"A]7TR)I%DU&U1HE+2!IE!0 [23SP >/K0!E_V%K_\ T.%Y_P" =O\
M_$4V3P]KDT312>+KQD=2K#[';C(/7^"MFZU"UL].DU":91;1Q^89%^8%<9XQ
MUSVQUJA#XB1Q&;C3KVR,EPD %PBCEP2IRK$$$C'7()Y H HVGAC6+&SAM+;Q
M;>1P6\:QQI]D@.U5& ,E,G@=ZF_L+7_^APO/_ .W_P#B*Z"L_7-731-,>\:%
MIWWI%%"A :61V"HH)Z9)'/:@#/\ ["U__H<+S_P#M_\ XBC^PM?_ .APO/\
MP#M__B*DMM0UZWO(DU?3[1;:5&8SVDS.+<J,X?<HX(S\P[]N:H+XDUZ?2?[?
MM](MGTLQ^>D+3L+F2'KO V[02.0N?QS0!;_L+7_^APO/_ .W_P#B*/["U_\
MZ'"\_P# .W_^(J >(=6U/5I[;0K;3YK>&U@N!+=3.A<2ABN-JGLOZU _C"^N
M$T^&SL;:&^N+N:TN(KN<A()(E+,-R@Y!QP<<@B@"]_86O_\ 0X7G_@';_P#Q
M%9VOVWB'1M#N]1C\5W4K6Z;@C6=N W('9*Z#29M4F24ZFM@I!&S[',T@]\[E
M&.U4?'/_ ")>I_\ 7'^HH 3^PM?_ .APO/\ P#M__B*/["U__H<+S_P#M_\
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M.UD7=YYT-Q</%N">6B[?F4D<JQ_&NTM-WV.'?;K;-L&85((CX^Z"...E344
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M7-_A0!T%%<__ ,)A;?\ 0'UW_P %<W^%'_"86W_0'UW_ ,%<W^% '045S_\
MPF%M_P! ?7?_  5S?X4?\)A;?] ?7?\ P5S?X4 =!17/_P#"86W_ $!]=_\
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M8)QCTK<L))Y=.MI+J$0SO$C2QCHC$#(_ \58HH **** "BBB@ HHHH ****
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M0)LBA0(B^B@8 _*@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGG!XIOB13)H<\2Q32F0JNV%6+?>&<;>1P.M2Z1:V]M:R/;?:MD\AD(NBY<'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%<;K+6B^(+G4H+*4WFG(FR2WLG
M<ROPSJSJI',851D\;S0!V5%<UXFTO3[_ $?4=5DBANB=.(@9XPVS =@RD]"=
MPZ>@JY)H&FVMAJ,26=O]GN!O-N(5$:E5QG;C&>,T ;-%9>C+9V&C:;!''';B
M>-0B(@4,Y0L>G? 8US]O-8VFO2:O;6DD)EO#;2-'9NL;PGY2Q<+L)\WYMV?N
MT =I17+WL2V'BB]U.*,>4MG!]MC"\21EI0SD=V4*#GKM!'<4[2-!TV]TZ(/:
MV[6]O?WC+ 85,;?OI%''3@8Q]* .FHKG/#.CV%II>FZE###;EM-19MD:J)-R
MHQ9B.I&#U]36?X<EL[+4()K6TFM4U4OYL?V.2&-3RT/)4*/D!4X/)(H [.BH
MWGACE2)Y4623.Q"P!;'7 [U)0 45G:\[KI95)6B\V>&%G0X8*\J(V".APQY[
M=:I&RT33M9LDATQK6<R%8I;>#8CL8VR&(^]\NX\]Q0!O45Q;S6-IK]SK4%I)
M$\=T()'BLW"21#*RLSA=O#LS$D_\LA7:4 -=UC1G=@JJ,EF. !4=M=VU[#YU
MI<17$><;XG#+GZBGS0Q7$9CFC21"02KJ",@Y'!]Q6/I@N$\1:A]MBBBFFAC,
M:P$LK1J6&XD@'?EL'C&-N">< &JEY:R73VJ7,37$8R\0<%U'J1U%-N+ZSM'C
M2YNX('E.(UDD"ESZ#/6N?M(XT\.:!=* +EI8)"^/F9Y/]:3[D,Y/_P!:M;6+
M6>2SG:PL[.>ZF3RV^T\!DYX. =W7H<#D\B@#2ID4L<R;XI%D0DC<IR..#6#<
M7VSPSIT=HUXR7<<<?VA8FDDCCV9+MM!PV!@'^\1VJ3PJMI+H4T$$!6V6[N8Q
M$\10;?-?C:P'&#C]* -M)$DW;'5MIVM@YP?0TZLG1+>&UN=6@MX8X8DO%"QQ
MJ%5?W$70"M:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y_QS_R*5U_UU@_]')705S_
M (Y_Y%*Z_P"NL'_HY*Z"@ HKCM;-I_PD%SJ$%E*U[IT:%)+>S=VED.&9&=5(
M_P!6%49/ D-7O$NFV&IZ-=ZK(D-R$TV7R"\88#*[@ZD]#P* .CHK+@\/:9;R
M72QV5LMM=(BO;"!1&2I8YVXP2<C\A4/AL6>G^&=(1$B@^TP18"(%WR&,$DX[
MG!.: -JBN+>:QM-?N=:@M9(GCNA!(\5FX22(965F<+MX=BQ)/_+(5>O83:>*
M+S5+>/+06D!N$1>9HRTH;CNP"J1W^7;WH Z:BN:TK1-+O]-11;6K6D6HSSB)
M8E,<G,B#CIC# CZ"G>%]%L;:VM-1MK>&"00RQ/Y<2KY@9P021UQLX^M '1T5
MQ>AS6-GJ<5]9VDEM%J4[I($LWBBV' @;=M"\[1WY,QKL'GABD2.25$>0X168
M L?8=Z )***SM>EDBTF3RI&B,DD<32*<&-7D568'L0K$Y[8H T:*Y^6PT/3=
M4L1'IC03^:!%/!#@.Q5AAV'WN,DYSTS67>S6-MK]WK,-I(DMG,D9DALW*RH,
M^<S2*N#@.1R>#$* .TI&8*I9B  ,DGM1UILL,5Q$T4T:21M]Y'7(/U% $=K>
MVM]&9+2YAN$!P6BD#@'TR*47EJUV;07,1N%7<80XW@>NWKBLJR%Q'XHN3>10
MPM-;C[.("6$D:-R7) ^8%UXQ@ \$\XI11Q+X;T^[  N6OX9&DQ\WF/.%D_,,
MRGVX[4 =!<WUG9;/M=U#;^8<)YL@7<?09ZU8JCJ4$[6\LMC:6DUX\?E_Z3D*
MR\\$@$D<]/>LO[:UIX1L([/[26DCCMA*L+2/#A<,[!0>0%/J-V!G!H WXY8Y
ME+12*X!*DJ<X(ZBE21'+!'5BAVL <[3Z'\ZQ/"XM#8WEO:Q.EO'=/&J21,G&
M%XPP!-3:);6]G=ZM!:P1P1+=+M2- JC]S'V% &O1110 4444 %%%% !1110
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M#N?4TZZTBVNY6D>2Y0R##B*YDC5Q[A2!^(YJ]10 R.&.&%88D$<:*%54& H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ&'3/_!2_P#\?H WZ*P/L'BW_H8=,_\ !2__ ,?H^P>+?^AATS_P4O\ _'Z
M-^BL#[!XM_Z&'3/_  4O_P#'Z/L'BW_H8=,_\%+_ /Q^@#?HK ^P>+?^AATS
M_P %+_\ Q^C[!XM_Z&'3/_!2_P#\?H WZ*P/L'BW_H8=,_\ !2__ ,?H^P>+
M?^AATS_P4O\ _'Z -^BL#[!XM_Z&'3/_  4O_P#'Z/L'BW_H8=,_\%+_ /Q^
M@#?HK ^P>+?^AATS_P %+_\ Q^C[!XM_Z&'3/_!2_P#\?H WZ*P/L'BW_H8=
M,_\ !2__ ,?H^P>+?^AATS_P4O\ _'Z -^BL#[!XM_Z&'3/_  4O_P#'Z/L'
MBW_H8=,_\%+_ /Q^@#?HK ^P>+?^AATS_P %+_\ Q^C[!XM_Z&'3/_!2_P#\
M?H WZ*P/L'BW_H8=,_\ !2__ ,?H^P>+?^AATS_P4O\ _'Z -^BL#[!XM_Z&
M'3/_  4O_P#'Z/L'BW_H8=,_\%+_ /Q^@#?HK ^P>+?^AATS_P %+_\ Q^C[
M!XM_Z&'3/_!2_P#\?H WZ*P/L'BW_H8=,_\ !2__ ,?H^P>+?^AATS_P4O\
M_'Z -^BL#[!XM_Z&'3/_  4O_P#'Z/L'BW_H8=,_\%+_ /Q^@#?HK ^P>+?^
MAATS_P %+_\ Q^C[!XM_Z&'3/_!2_P#\?H WZ*P/L'BW_H8=,_\ !2__ ,?H
M^P>+?^AATS_P4O\ _'Z -^BL#[!XM_Z&'3/_  4O_P#'Z/L'BW_H8=,_\%+_
M /Q^@#?HK ^P>+?^AATS_P %+_\ Q^C[!XM_Z&'3/_!2_P#\?H WZ*P/L'BW
M_H8=,_\ !2__ ,?H^P>+?^AATS_P4O\ _'Z -^BL#[!XM_Z&'3/_  4O_P#'
MZ/L'BW_H8=,_\%+_ /Q^@#?HK ^P>+?^AATS_P %+_\ Q^C[!XM_Z&'3/_!2
M_P#\?H WZ*P/L'BW_H8=,_\ !2__ ,?H^P>+?^AATS_P4O\ _'Z -^BL#[!X
MM_Z&'3/_  4O_P#'Z/L'BW_H8=,_\%+_ /Q^@#?HK ^P>+?^AATS_P %+_\
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M"E__ (_1]@\6_P#0PZ9_X*7_ /C] &_16!]@\6_]##IG_@I?_P"/T?8/%O\
MT,.F?^"E_P#X_0!OT5@?8/%O_0PZ9_X*7_\ C]'V#Q;_ -##IG_@I?\ ^/T
M;]%8'V#Q;_T,.F?^"E__ (_1]@\6_P#0PZ9_X*7_ /C] &_16!]@\6_]##IG
M_@I?_P"/T?8/%O\ T,.F?^"E_P#X_0!OT5@?8/%O_0PZ9_X*7_\ C]'V#Q;_
M -##IG_@I?\ ^/T ;]%8'V#Q;_T,.F?^"E__ (_1]@\6_P#0PZ9_X*7_ /C]
M &_16!]@\6_]##IG_@I?_P"/T?8/%O\ T,.F?^"E_P#X_0!OT5@?8/%O_0PZ
M9_X*7_\ C]'V#Q;_ -##IG_@I?\ ^/T ;]%8'V#Q;_T,.F?^"E__ (_1]@\6
M_P#0PZ9_X*7_ /C] &_16!]@\6_]##IG_@I?_P"/T?8/%O\ T,.F?^"E_P#X
M_0!OT5@?8/%O_0PZ9_X*7_\ C]'V#Q;_ -##IG_@I?\ ^/T ;]%8'V#Q;_T,
M.F?^"E__ (_1]@\6_P#0PZ9_X*7_ /C] &_16!]@\6_]##IG_@I?_P"/T?8/
M%O\ T,.F?^"E_P#X_0!OT5@?8/%O_0PZ9_X*7_\ C]'V#Q;_ -##IG_@I?\
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M8R+B:,8.-V=NY&R0<]"P[T =7K7BB+1M8L;!K9I5N,&XF#X%LC.L:,1CG<[
M=NA/:DNO%"6GC.T\.R6AVW5OYJW6_@.=^$*X[B-CG/;&*RKGP=>:_<:W<ZCJ
M-[IXOV^SQP0&%E,"#"$DJQ!+%FX((W=C5671/$6H8U&ZL@FI6^FVQC_>H0]U
M#,[D @\!QCD\8?'K0!HZCXZ2QO\ 7;9-/:9=&L_M)D\W:)6 !*#@XQD<\\Y&
M.*U;"]\03W4:WVBV=M;L#NECU RLO''R^6N><=ZY2]\*:Q)IFHJMJ)+F]T22
M.3$BC==22-(RY)Z M@'I@"M70=/@L]4B>'P3<Z:Q!4W33P,$&.X64GGIP.]
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M6#+!LP2W"LJD$ #:>O% '8B:([\2H=AP^&'RGW]*&DC4D,ZC'7)KA9_#]Y)
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M*LZ?K<-_>2V36US:W,<8D,5Q'M)0DC<""01D8ZUS]]H&I:KJD\DL,MO#=:E
MS.LJ!XX(8MRG@GGSL\#ZUT6G:+:Z;/+<H\\]S,JJ\]Q*9'*C.%&>@Y)P,=:
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MXF"P"=)+I4W*90O(4$'*_.%.<]!0!D7OC&YL_"IU0Z8&O8;K[+<68E^XX;!
M;'/&"/4$59U/Q8MIK.GV%K;K<QW=O).\V_ 0"-WC[<[O+?Z8J)O!JPW[O971
MCM);BWN9(96>5C)$W)W,2?F4*/;:*BM?!+VPA'VX/Y$TAC)3[L)A:&.,<_PA
MLY[G/K0!)HWBB\U.VANG.C[)+;SS#!?%YE^3=C;M'L#SQ3M*\9#4])TZZ^R>
M3<7-S';W%NS\PED+ YQR"N"#W!I=(\/ZII]E!8ROI1ABMO(,L5JRRL FT'.[
M&<X)_&FGP=B?0[F*[\N734BCN,)\MTL:D+D=B"3@^C$4 -M?%.J'3;;5[S3;
M5=-GE6-FAN6:6(,^P,5* $9(S@\ YYQ4MGXO68:]]HM/*.DN^Q5?)G0%E!''
M4LC#'T]:AM?"VJ?V;;:/>:A:G38)5D988&$LH5]ZJ6+8 R!G Y QQFI/^$/8
MZC!=&\ 1;R:>= G^M1I1*B]?X753GTW#O0!3M_&UY=BR40:9:/<62W+_ &R]
M,8!+LNU3M.<;?UJ__P )6UOKUCIEY!%Y5W;))]K@EWQ+([,$7.!PVTX;UP.X
MJI;>$;^PDM9+:?3YS#9BV87=LSCAV;<,,,?>Q^%:+>&_MLL[:F8'2XL4M)(H
M$**I5V8,O)(QN&/0C- %2[\3:JFD'4[2PLWA6\>T99;AE;<+DP C"GC@$_C6
MM=:G+I.@S:CJL48D@0L\=LQ<-S\H4D#D\#GN:SK;PO<0^$DT6?4!/.+O[2]R
MT>-Y^T^><CU/2MC5M-BU?2[C3YF9$G0KO3[RGLP]P<'\* ,U-8U6SO+./6+"
MVAAOI/*C>WG:0Q2$%@KY49!P1N'?''.:K^&_$E]KOV>9ETJ.*92S11WC/.@&
M?X-OKC/-6$T?5KV\LI-8OK66&QD\Y$MH&0RR!2H9LL< 9)VCOCGC%6/#V@P:
M'I5M:[(7GA3:TZQA2W/YT 4M8\2W%EK?]EVL=BLH@69?MUT8?M!)8;(_E.2-
MO)[;AQ4KZUJ5W??8-,L(1/%;QSW1NYBHA+YVQ_*#EOE.>PXZYI=9T?4KZ>40
MSV,]I<1A7M=0MC*D;#/S+@CJ#R#Z=14%KX;O]&,#Z/?Q,XM(K6X%Y&S"7RP0
MK@J00W)!'((QTQ0!+8>)FO;VRLWL_)FE>XBN$,F[R9(MN0#CY@=P(/'!'':G
M:MXE72;V[@>V,H@M894VM\TDDDIC5/;+!>?>JB^%]0LY;.[LKZW>\BEN);B2
MXA;;*\N,D*K?*!M  R> .O6I;SPS<:I)<3WMY&DTUI%$&@C($<D<K2(X!)Z$
MKP?2@"2?5];TZTO+C4=,MBD%G+<I);7!90R#/EMN4'GL0#T/ XS#=ZWKL>I6
M%K;V&GNFH*S0M)<NI7:@8[@$/Z9J2XT?6]3M;N'4=3MU66SEMDBM865"SC'F
M/N8DX[ =,GD]KDFCL]_I%SYP TY75EV_?W)M_"@"M>>)#9^(+32WM@T<@1;F
M=7XADDW>6N,<[BA'ME?6H[S5]?A\0PZ5#8Z<ZW,4TT4CW,@.R-D'S (<$^8.
MF>AJ&\\$P:A#J<MS<R_;[V5I8YXY7582N/)^0-M.S:IY')!K5;2YI=<T_5)9
MDW6MI- Z*IPS2&,Y'H!Y9_.@"A)XFN'N#8VEE')>R7LMM$KRE4"QJ&:1C@D
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MB@ HHK+F\3^'[>9X9M=TV*6-BKH]W&&5AP003P: -2BH([RUFN9+6*YA>>(
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M$U.[6[O](LKJX7 $LT"LW'3DBB_\.:'JDXGU#1[&[E50@DGMT=@HZ#)'3DT
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M[5/[+Q<C,<TRHWF@#J">H QSTQ3M7N?#,"VTVL-IN",V[W 1N!SE<]AQR.*
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MY-16VF:?9.7M+&VMW(P6BB521^ H Y[P5J%@FB-:27ENLYU"\7R6E4,2;F3
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M/2N@KG_&/_'CIO\ V%[+_P!'I0!T%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7)
M^#=4TZ#3KFVFO[:.?^U+P>4\RALFX?'&<\UUE4SI&F-*9FTZT,A;<7,"Y)ZY
MSCK0!YXUYJ/F'QLNF.;=;[[1]J$R\V(7R\;.N-O[SZ\U;CAFL_$'B#Q/IJM-
M+::@JW,,?/VFV-O"2!ZLOWE_$?Q5Z!Y,0@\CRD\G;L\O:-NW&,8],=J(H(8
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MR* ,C_A-?"G_ $,ND_\ @;'_ (T?\)KX4_Z&72?_  -C_P :U_)B_P">2?\
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M?R8O^>2?]\BCR8?^>:?]\B@#(_X37PI_T,ND_P#@;'_C1_PFOA3_ *&72?\
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M/)B_YY)_WR* $MKJWO;:.YM9XYX)!N22-@RL/4$=:EI  HP  !V%+0 4444
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MIMA<VZ6]Q8V\L,?W(Y(E95^@(P*+?3+"T"BVL;: *Q=1'$JX8C&1@=<<9]*
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MD$  #.<XH ZVBN.7Q#J,$=MJ\T_F6MY>7-O]C\M0(UC$I1@V-Q8^3SDD?,<
M8I]E?Z\[VEJ=0BDN-4TUKM'DA 6V=6B#!0O5<2\;LG*\GF@#KJ*XV'6-4G=+
M.VU%I[>[U(6MOJ31)N91"\DA4 ;&P8RH;;CD]<<NN]<UR+PW<3026[3V5Z]O
M/<R#EE60*"$ QN((ST .>.U '845S6OG5EU>RMM-UF6"2]DX@\B-DCC0 R.2
M5R>P'/5QVJC_ ,)+>PZVL4MX/-?4VM#IQA $</S".7=C=SA6R3M^; &: .SH
MKB;S7]6T5;]GODU$VMD7NF$ $5M<ED"(NT D89B5.6 4<C<*N6%YJUU#>VG]
MHW,=Q;F.1_M%F@N$B8$DHJY1MVTA>"1@@@D4 =517#S>+KZ/PA*\<L9U?%SL
M\Y C1)$6^>1.@;;M^7NS#MG&G%>:CK>J-8VVI-8PVMG!-)+!'&[RO)NX^<,H
M4;/3))ZC% '2T56T];Q;&-;^6*:Y7*O)$,*^"0#CL<8R.QS5F@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQR+E6'H10!-17/\ _"!>$?\ H7-._P# =:/^$"\(_P#0N:=_X#K0!T%%<_\
M\(%X1_Z%S3O_  '6C_A O"/_ $+FG?\ @.M '045S_\ P@7A'_H7-._\!UH_
MX0+PC_T+FG?^ ZT =!17/_\ "!>$?^A<T[_P'6C_ (0+PC_T+FG?^ ZT =!1
M7/\ _"!>$?\ H7-._P# =:/^$"\(_P#0N:=_X#K0!T%%<_\ \(%X1_Z%S3O_
M  '6C_A O"/_ $+FG?\ @.M '045S_\ P@7A'_H7-._\!UH_X0+PC_T+FG?^
M ZT =!17/_\ "!>$?^A<T[_P'6C_ (0+PC_T+FG?^ ZT =!17/\ _"!>$?\
MH7-._P# =:/^$"\(_P#0N:=_X#K0!T%%<_\ \(%X1_Z%S3O_  '6C_A O"/_
M $+FG?\ @.M '045S_\ P@7A'_H7-._\!UH_X0+PC_T+FG?^ ZT =!17/_\
M"!>$?^A<T[_P'6C_ (0+PC_T+FG?^ ZT =!17/\ _"!>$?\ H7-._P# =:/^
M$"\(_P#0N:=_X#K0!T%%<_\ \(%X1_Z%S3O_  '6C_A O"/_ $+FG?\ @.M
M'045S_\ P@7A'_H7-._\!UH_X0+PC_T+FG?^ ZT =!17/_\ "!>$?^A<T[_P
M'6C_ (0+PC_T+FG?^ ZT =!17"^+?!OAJQT!KBUT*PAE%U;*'2!0<-/&I'X@
MD?C6U_P@7A'_ *%S3O\ P'6@#H**Y_\ X0+PC_T+FG?^ ZT?\(%X1_Z%S3O_
M  '6@#H**Y__ (0+PC_T+FG?^ ZT?\(%X1_Z%S3O_ =: .@HKG_^$"\(_P#0
MN:=_X#K1_P (%X1_Z%S3O_ =: .@HKG_ /A O"/_ $+FG?\ @.M'_"!>$?\
MH7-._P# =: .@HKG_P#A O"/_0N:=_X#K1_P@7A'_H7-._\  =: .@HKG_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUT%<_I/_ ".OB'_KE:?^@O0!T%%%% !7/^,?^/'3?^PO9?\ H]*Z"N?\8_\
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M^A&L_P#P81__ !=>@44 >?\ _"1?%#_H1K/_ ,&$?_Q='_"1?%#_ *$:S_\
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M (,(_P#XNO0** //_P#A(OBA_P!"-9_^#"/_ .+H_P"$B^*'_0C6?_@PC_\
MBZ] HH \_P#^$B^*'_0C6?\ X,(__BZ/^$B^*'_0C6?_ (,(_P#XNO0** //
M_P#A(OBA_P!"-9_^#"/_ .+H_P"$B^*'_0C6?_@PC_\ BZ] HH \_P#^$B^*
M'_0C6?\ X,(__BZ/^$B^*'_0C6?_ (,(_P#XNO0** *>DS7UQI=O-J=JMI>.
M@,T"N&$;>F02#5RBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#&_EU#PY<RR6]L@6^E1+BV@\E+P#'[[;ZDY_*NQI  H"J  . !VI: "BBB@
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M^@/#_P!]-_C1_P ()X7_ .@/#_WTW^-=!10!S_\ P@GA?_H#P_\ ?3?XT?\
M"">%_P#H#P_]]-_C7044 <__ ,()X7_Z \/_ 'TW^-'_  @GA?\ Z \/_?3?
MXUT%% '/_P#"">%_^@/#_P!]-_C1_P ()X7_ .@/#_WTW^-=!10!S_\ P@GA
M?_H#P_\ ?3?XT?\ "">%_P#H#P_]]-_C7044 <__ ,()X7_Z \/_ 'TW^-'_
M  @GA?\ Z \/_?3?XUT%% '/_P#"">%_^@/#_P!]-_C1_P ()X7_ .@/#_WT
MW^-=!10!S_\ P@GA?_H#P_\ ?3?XT?\ "">%_P#H#P_]]-_C7044 <__ ,()
MX7_Z \/_ 'TW^-'_  @GA?\ Z \/_?3?XUT%% '/_P#"">%_^@/#_P!]-_C1
M_P ()X7_ .@/#_WTW^-=!10!S_\ P@GA?_H#P_\ ?3?XT?\ "">%_P#H#P_]
M]-_C7044 <__ ,()X7_Z \/_ 'TW^-'_  @GA?\ Z \/_?3?XUT%% '/_P#"
M">%_^@/#_P!]-_C1_P ()X7_ .@/#_WTW^-=!10!S_\ P@GA?_H#P_\ ?3?X
MT?\ "">%_P#H#P_]]-_C7044 <__ ,()X7_Z \/_ 'TW^-'_  @GA?\ Z \/
M_?3?XUT%% '/_P#"">%_^@/#_P!]-_C1_P ()X7_ .@/#_WTW^-=!10!S_\
MP@GA?_H#P_\ ?3?XT?\ "">%_P#H#P_]]-_C7044 <__ ,()X7_Z \/_ 'TW
M^-'_  @GA?\ Z \/_?3?XUT%% '/_P#"">%_^@/#_P!]-_C1_P ()X7_ .@/
M#_WTW^-=!10!S_\ P@GA?_H#P_\ ?3?XT?\ "">%_P#H#P_]]-_C7044 <__
M ,()X7_Z \/_ 'TW^-'_  @GA?\ Z \/_?3?XUT%% '/_P#"">%_^@/#_P!]
M-_C1_P ()X7_ .@/#_WTW^-=!10!S_\ P@GA?_H#P_\ ?3?XT?\ "">%_P#H
M#P_]]-_C7044 <__ ,()X7_Z \/_ 'TW^-'_  @GA?\ Z \/_?3?XUT%% '/
M_P#"">%_^@/#_P!]-_C1_P ()X7_ .@/#_WTW^-=!10!S_\ P@GA?_H#P_\
M?3?XT?\ "">%_P#H#P_]]-_C7044 <__ ,()X7_Z \/_ 'TW^-'_  @GA?\
MZ \/_?3?XUT%% '/_P#"">%_^@/#_P!]-_C1_P ()X7_ .@/#_WTW^-=!10!
MS_\ P@GA?_H#P_\ ?3?XT?\ "">%_P#H#P_]]-_C7044 <__ ,()X7_Z \/_
M 'TW^-'_  @GA?\ Z \/_?3?XUT%% '/_P#"">%_^@/#_P!]-_C1_P ()X7_
M .@/#_WTW^-=!10!S_\ P@GA?_H#P_\ ?3?XT?\ "">%_P#H#P_]]-_C7044
M <__ ,()X7_Z \/_ 'TW^-'_  @GA?\ Z \/_?3?XUT%% '/_P#"">%_^@/#
M_P!]-_C1_P ()X7_ .@/#_WTW^-=!10!S_\ P@GA?_H#P_\ ?3?XT?\ "">%
M_P#H#P_]]-_C7044 <__ ,()X7_Z \/_ 'TW^-'_  @GA?\ Z \/_?3?XUT%
M% '/_P#"">%_^@/#_P!]-_C1_P ()X7_ .@/#_WTW^-=!10!S_\ P@GA?_H#
MP_\ ?3?XT?\ "">%_P#H#P_]]-_C7044 <__ ,()X7_Z \/_ 'TW^-'_  @G
MA?\ Z \/_?3?XUT%5[__ )!US_UQ?^1H Q_^$$\+_P#0'A_[Z;_&C_A!/"__
M $!X?^^F_P :SO#7@WPU=>%M)N)]%M))9;*%W=H\EF* DG\:TO\ A!O"O_0!
MLO\ OT* $_X03PO_ - >'_OIO\:/^$$\+_\ 0'A_[Z;_ !JEI^CZ=HWQ 6+3
M;.*TCDTIV=8EP&/FKS76T <__P ()X7_ .@/#_WTW^-'_"">%_\ H#P_]]-_
MC7044 <__P ()X7_ .@/#_WTW^-'_"">%_\ H#P_]]-_C7044 <__P ()X7_
M .@/#_WTW^-'_"">%_\ H#P_]]-_C7044 <__P ()X7_ .@/#_WTW^-'_"">
M%_\ H#P_]]-_C7044 <__P ()X7_ .@/#_WTW^-'_"">%_\ H#P_]]-_C6-X
M-\(>';[P=I5U=:/:S3S6R-)(\>2Q(ZDUM?\ "#>%?^@#9?\ ?H4 )_P@GA?_
M * \/_?3?XT?\()X7_Z \/\ WTW^-4(M$TO1?'VEKIEC#:";3[LR")<;L/!C
M/TR?SKKZ .?_ .$$\+_] >'_ +Z;_&C_ (03PO\ ] >'_OIO\:Z"B@#G_P#A
M!/"__0'A_P"^F_QH_P"$$\+_ /0'A_[Z;_&N@HH Y_\ X03PO_T!X?\ OIO\
M:/\ A!/"_P#T!X?^^F_QKH** .?_ .$$\+_] >'_ +Z;_&C_ (03PO\ ] >'
M_OIO\:Z"B@#G_P#A!/"__0'A_P"^F_QH_P"$$\+_ /0'A_[Z;_&N@HH Y_\
MX03PO_T!X?\ OIO\:/\ A!/"_P#T!X?^^F_QKH** .?_ .$$\+_] >'_ +Z;
M_&C_ (03PO\ ] >'_OIO\:Z"B@#G_P#A!/"__0'A_P"^F_QH_P"$$\+_ /0'
MA_[Z;_&N@HH AM+2"QM8[6VC$4,2[40= *FHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "N?\'?\ 'CJ7_87O?_1[UT%<GI]OXIT9KV"VTK3KJ&:^
MN+B.1]0>-BLDA8 KY1P>?6@#K*Y_Q+_R%O#/_84/_I//1]O\7_\ 0OZ7_P"#
M5_\ XS5:6V\2:KJ^DRWVFV%I;V-V;AWBOFE9OW4B8"F->[^O:@"3QA#.D-I=
M6^I7MJSWMK;,L$NU2KSJK'&.N&//TJI?ZKJ?A[4M3$"G4++3M*ANYOM-R0X&
M^X+E<*=S%5'7 ^05U%Y8VVH11Q74>](YHYE&XC#HP93QZ, :ANM'L;W[;]HA
MW_;[86MQ\[#?$-^%X/'^L?D<\^PH Q5\8O)KC645@SVZ7GV-G42%]V<%\!-N
MT,<'YLXR?:KOB'7I='>"*"*WDDE1W EE8$[<<*J*S-G/7&!WZ@58/AW36U'[
M=Y4@D,HG*"9Q$9 ,!S'G;NQWQVSUI^H:'8ZG<1W%PLHECC:+=%.\99&P2IVD
M9!('!H YF'Q9J!-[K*6BR:8EE:W;QR3X>)70LP0!2&('/)&<8[\:<WB:[266
M:/3XFL([X6'F-.1(9"P0-MVXV[V ZYQD^U3KX/T1/+"6TJI'%%%Y8N)-CI&,
M(K+NPP'OFK#>'=,?4?MQAD\SS1.4\Y_*,H& YCSMW<#G'8'K0!C3>.E2Q2XC
ML"[>1"94+G]U/))Y:QG"D\%7W$ D;1@'(K7T#6)-7@G,UJ8)()?+) <)(, A
MEWJIQS@\=0>O6G?\(YI/V>\@%H%2^G^T3[78$R9!W @Y4@@$8Q@\]:LZ?IEM
MID<B6XD)E?S)'ED:1W; &2S$D\ #\* .;3QI>KIRW]SI4*0S6%Q=P!+DLQ,(
M!*M\H !SP1FKNJ>*)K&\^RP6"SRM':LFZ;8"9Y6C )P< ;<YYZ]*T!X?TL6\
M%O\ 908K>&2&-&=B CC# \\Y [U!;^%-(MG\Q89I),Q'?-<R2-^Z8M&,LQX!
M)XH S[?Q1J,EQ%%=:;;PH]Y+8M)%<ER)51W# %!E2$QR0<GIQS0L/&5]IGAK
M3KC6;-9'N-,2XA>.8NTS#RU(<;?E),BGC/?TYZG^Q-/W*WD<K<M=#YV_UK*5
M+=?1CQTYJG;^$-$MK9K9;5WA-O\ 9E26>201Q<?*FYCM&0#QCH/08 ,Y?%]_
M)$(H]*1[I[J.WC+221PMO5B&W-&&XVD$;?3UQ20^-W:_:.73C]FCN)+:1XO,
M=D:/<&;[@79N4C[V>AQV&S!X=TVW97$<TLBS+/YLT[R.752JY9B20 3QTYH'
MAS3%OS>B&3>93-Y9F<Q>81@OY>=NX@GG'<GK0!F:5K&JZAX@L#=6\=K:W6F2
MW,<<<YDS\\.W=\HPP#'ID?,?2IKCQ+-;>)UTJ6TCAA>1(TEFD9#-N7.4^78V
M#\NW=NX/'3-W3O#FF:5=+<VD4JR1PF"/?.[B.,D'8H8D 948 Z8I9O#VG3ZC
M]NDCE,AD29D\]Q&TB@!7*9VEA@<X[#T% '.:KXNOSX8GOEM4M(K_ $ZYFT^>
M.8M(C)$SJ74J "57/!.",5?C\07;:G/IME;+/=-=2*IN;@K&J)%$S'(4D<R*
M N#U)SVJZ?".BE)HVMI'BEBDA\IIY"D:2##A%SA,Y_AQ[8J:?PYID[,YBECE
M:8S^;#.\;ARH0X92" 54 CIQZT 8=SKVJ_VI;PPP"!WO+:.XBDG#JH>-F*J0
MI[KU[X[9IDOC2ZE:YMX+>V#M:W$EO)',T@5HQT8[-AR.?E)QC'O6XOA?1TB2
M**U,*QM$Z>5*ZE3&,+@@^A(/KDYS3+;PEHUJ\;1P2D11O%$CW$C+&CC#*JEL
M 'T]AZ"@#*LO$E^'@M3;K/J%T+>- \Y$6YH7D9L[<CY4)Z')P..M2KXKU*XN
MA86NEVYO(TN#.)+HB-#$R#"L$)(;S 1P,=ZTE\+:2MN(1%,-OEE9/M$GF*4!
M"D/NR" 2.O0X/%36F@:;8NCP0$.D<D>]I&9F$C!G+$G+$E0<GF@"K>:T)?"E
MKJ\22(MU]E=55]K*)'08S@_WN?6HM*\2S7^NS:;<6D=JR>9MC>1A+A6P#M90
M&5ASE2P'%:ATBQ.E0Z68?]$@$:QQ[SP(R"G.<\%1^50VGA[3K*^^V0QR^8I<
MQJ\[LD1<Y;8I.%R?04 9FO\ BU]%OGA6V@FCA6-I!YS&4AFP2%53MP.<L0#^
MM,_X2C59;V.&WTFV,<]]/8PN]V02\8<[F 0X4B-NY.<?6M*_\+Z5J<\\UU%,
M3<A1,B7$B))M^Z2JL 2/7V'H*LQZ-81/$Z08:&YDND.]N)7#!FZ]P[<=.: .
M<D\=2^3:K!IRM<R6[3RHSR%5VN4VJ4C8DDJV"0!@58/BZ[9Y9H]+464$UM'*
MTLQ24><(R,)MZJ9!D$CI6C+X6TF6*.(0S1")'0&&XDC8HYW,I*L"03S@].U3
M_P!@Z9Y,T(M0(YWBD=59@"8]H3'/&-B\#TH Y^;Q/?O=Z9?M L&E/-<DE)2T
MDB1Q2'YEV@#)3<,$]!FBW\=7$L!=]*.^5(C;A6D"%Y)$C5'9HP <R*<C=QN]
M.=J/PQI,=ZMVMNY='D=(VF<QH7!#X0G:,[CGCO3(O">CQP20^1+(CQ"$"6YD
M?RT!#!4);*8(!&,=!Z"@!GA^[U&YU+68M1"(T%S&B)'(715,*'@D \DD\CJ:
MSU\:3MJ#VR:?'<ADN#"MM,SLS1 D(3MV9;'0,<'BM_3=(L]*\\VJR[[AQ),\
MLSR,[ !<DL2>@ _"J*>#]$4KFVE=$61$C>XD9(UD!#JJEL $$\#V]!0 [PYK
MS:W%<&1($D@8!EBD8D9&?F5U5E/7J.<5FMXV-M/J(O[);=+*&>;RC(PG98SP
M0K* P8<@J2!D9K>T[1[/2VE>W\YI)@HDEGF>5V"YVC<Q)P,GCW/K59?"^D+-
M)(UN\@D$B^5+,[QH)/O[4)PN[)S@=SZT 8%UXMU:>TV6]E'!<"ZLP)"9/+9)
M)U1DR\8^;G!P.C9'(Q6IXKN;Z&71H+67RHKF^*7#+*48HL,DF 0I_N9_ #N2
M+(\*:3]FF@9+F02^6"\EW*TBB-MR!7+;EVMR,'K6C<6-O=26TDT>]K27S826
M/RML9,^_RNPY]: .9E\:7=II0U*[TN-8;G3Y;ZT5+C<Q"*'V/\HVDJP.1D=1
MZ$U-7UOQ+;SWL<D5M T4-A(D4%P6PTETR$;B@^\JX/ICC.36^OA'15AEA-M(
M\4D#VXC>>1ECB;[R("?D!P/NXZ#T%6;S0M/O[S[7<1.TI2-&Q*RJP1_,3(!P
M<-R/J>QH ;HVIW-])?6UY;107-C.(G$,A=&RBN""0#T<#IU%8"^+;^*UNVMM
M.2X2RMY;N9I[HABJS2J57"')Q$<9P.WO75P65O;7%S/$FV2Z<23').Y@H4'V
MX4#CTJFGA[2TBN8EMB$NH6@F'F-\R,SL1UXYD<Y'K["@"'Q%>S0:;936TC1F
M6_M$)'4H\R!A^()%8D/B_4;6UABNK>&:\N;R^6,AG*+%#,4YV1DY&54<<@9)
MSQ75W.GVUY!%!/'OCADCE0;B,,C!E/'H0*HOX8TMLE4N(F\^2=7BN9$9'D.7
MVD-E0QY*CC/.,T 8\_C6]6WDN8-&!CM[*&[N%GG,<BAWD0HJ[.2/+)!.,^U;
M>D:G<WMQ?6M[;107%E*J,(93(C!D# @E5/?'3M0/#>DK;2VRVF(IK>.V=0[<
MQH6*CKZNQSU.>35V&RM[>YN+F)-LMR5:5LD[B %'TX':@#!_M2ZTWQ'J\FK7
MT?V"VL$N41$PL2;Y 2>I9B%&?R ]:_@_Q"VM:MJHDU*VN.(I8;>"9'$"$'*Y
M4G)'&X],D]L5THLK<7[WPC_TB2)86?)Y122!CIU8_G43:39M+<RA'22ZV>:\
M<C(6V?=Y!X_#KWH NURNGV$X\87MHVKZE)!:6UK.D;SY!9WF# \<C]VO'UKJ
MJKQV5O'?S7R1XN)XTBD?<>50L5&.G!=OSH X_1?&%]9^&[&YUJU5P^BM?K-%
M,7DE\M8]VX%0 6\Q2,$]\UN:!K\^K7,]O<V7D-$BR+(@D*,#D%<NBG<,>F,$
M?2K2>'M*2VMK;[(&AM;-[*)&8L!"P4,AR><A%Y//'N:?IVBV6EO));B9I)%5
M&DGG>5MJYVJ"Y) &3Q[T <[9^)M0L7E?4+=);!M3N[=9A,3*NPR,OR;<;0$*
M_>STJ:7Q?>V=HD]]ID4?VFS-W;+'<%LJ&0%7^48.)%/&1U].=S^Q-.VHOV?*
MI<O=*"Q(\U]VX]><[VXZ<U5B\):-%#+#]FDDCE@-MMEGD<1Q'JB9/R#@?=QT
M'H, %?4O$ES:WT]E:6,<\R36\,?F3%%8RACDD*< ;?>K6LZQ-I-C;2&.V\^=
MQ&1),0BG:2<84L_3@!<]^ #3K?PUI=LYD6*:25I4E:2:XDD=G0$*26))P":L
M:CI-IJA@:X$H>W<O%)#*T;H2"#AE(/()&* .?M_&-_?P6YL=*A:62VN)Y!-<
M-&J&&7RV4?)DY/3(&._I4&H^*M0O]+FN=+M5BMX7M%EF:;$BF7RG(5=N" LB
M@\CJ<=.>ALO#NE:>JK;6Q0+'+$,RLV%D?>XY/=N:@D\(Z+($4V\JHBQ+Y:7$
MBH_EX\LLH;#$8')R>!Z"@";5=3N;2ZL[&RMHY[J\+E?.D*(JH,L20">X &._
MM7-P^+[^P\/VTLT,$]T8[B:199VWD)*PVJ$1B>!C<0!P*ZS4-*M=36+[2L@>
M%]\4D4K1NAP0<,I!&02#6>?!VB>2D*V\T<:0M 5CN9%#QEBQ5L-\PRQ//J?6
M@#(;QA>6TU_/+ DL#36T5G'N.5,D8?YMJ$XP23C)XP*W=%UF75=.GN)+-XI8
M)&C* ,!(0 04WJI(((Z@<Y';-(WA;265U\B50Z1*=L\@P8\;&&#PPP/F'/'6
MK=GI5G8VDEK#&S1S,S2F5VD:0MU+%B2?3Z<4 <[;>-+F;3+NX;3X/M4'D8M!
M.RR R.$VN'12I!/7!![4MYXSN;&].ESV$0U 28^221XMFP-NRJ%L\XQMZ\YQ
M5N\\&V$NF36EL90TWDH7GN))"L22!]BDDE1P>GK5K_A%M+\L#9<>:)?.^T_:
MI/.W[=N?,W;ON\8SC':@"A;>*=1U(!=/T=3-%;+<7$5Q.8B,NZ!4RO))B<@M
MM&-OKQFZCJ^HS7=LL$DL=LEQ?-,!<E7?R2<#(7[OM^!SBN@E\)Z-+#'";:18
MTB,)5)Y%\V,DDJ^#\X))/S9ZGU.9_P"P-,_Y]N\QX=O^6O\ K._?].V* ,&'
MQLYN4@BT^2:*%H(IFS(TA9T1B1A-I"AQG+ G!XZ9D@U[4M1UC195@2WTZ\GG
M"%9BSR*J/MWKM &2NX8)QCFM4^%])-PLPAD7:8R8UG<1N8P A9,X8C:.2.P]
M!3H/#6EVVH1WT4,HEB=Y(E,[E(V?._:A.T9R>@H Q];U>_T[Q1)*09+.TL4D
MCMTF*>;+)(8UW#;CK@<GCK4MSXGU.UNQIC:9;-J+311JJW3>44D65E;=LR,&
M%@1CW[UM7>CV%]),]U;B1IX!;R98\H"2!UXY).1S4-OX<TRWD641RR3+,LWG
M33O(Y<*57+,22 K, .G)[T ,UC5;ZP;3K>TLX+BZOYC$%DG*1H1&SDE@I)'R
M$=*R(O'0>Y=FT]_L2R3)YB"1G7RPV68; NTE"!AB>5]3CIY[*WN;BVGE3=):
MN9(3DC:Q4J3[\,1SZU13PWI4=X;H0.27>01-,[1*[@AV$9.T$Y.>.Y]30!F7
M/BG4=/TZ*[OM*A3[68EMA%<-(,ODX?";AM SE0V>E5V\82B!KN2QE1[:VO)&
MCWLD<IB5&!&Y 2"&ZX&#D<UJIX1T9(FC\B9LA%1VN9&>((<H$8ME #Z$4V]\
M*6,NDW5K;*R7$UO<1+/+([G=,H#,Q));HO7L,"@#,U;Q)K5NJ6JV=M;7C363
MKB<NIBEG6-E)V<'/!XZ-D'(Q6[JNIW%I<6=E9VT<UU>,P7S9"B(JKEB2 3Z
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M*:3_ ,)?I>CV6G_V)I<OV2WCAW_VFXW;5"YQY/&<5;^W^+_^A?TO_P &K_\
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MN!&-V<<Y[51D\4:K%<6.K74$2VLVD7%W#;0S'YB6@V!\C&0'^\/[S<<<]/\
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M"W:!HK<*;=I&B.X_*9"2_?N2:J-X4T1EA7[%A(8TB"+*X5T0Y574'#@=MV:
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M2-469PC*G*!U!P^.VX&M>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[VZ^W1ZV +/GRU@&=C;<8P1@[_4D9[5U-KXCT>[TU-174+>.VDD,:R2RJH+
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MBMIKN"*>;_51/( S_0'D_A0!QL.I72Z_IT<^HWJWTVJSPW%H01$(0LICP,8
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M9+'4KZ_TT7.G.TS2,2LINE# -P?NX8K_  D X%>A@8 &2<>M,::)51FE0*Y
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M,QLC'<8PX(8$8^\1W]@^+Q!>"TMIEU'3]1\_4(K8O;VCPJBMUX,C9/3G/X4
M9</A;5;C49+B[AWPR26+;;B2-F(ADD9LA%"CAA@#/3\*GO?#^LSZWYD<$:6R
M:G!<KY;1I&8EV D@+O:3 (Y.,#CTK1A\17LNDV:^5 -5FOOL4D>T[%=&/F,!
MG./+5G'/=>>:H:+XHO=4NT676=)A+7<D1LQ82F3:LC+C?YN,D+G.W STH J_
M\(QK$*V<BP,?LJ74!C@FB!822!E<;U(P0,$<'IUZ5NR:)<KX9TG38]K264UF
MSYDR L4B,V"0,\*<<#-9Z^(->BT:77YWT^2QAN)5DMDMW258DF:,L)#(02 N
M[&T9Z<5M^(=1NM/L(UT](I+^ZF6"U28$H6/))P0<!0S'_=H YFQ\(ZG%.D$^
M]D@>Z99VF38_FAP,*$W9._+!CC([\4V?PQK%S:E/LJ0LUI8@A9EY>WD8LG0C
MY@00<$9'(K4U/7]3?PBGB'29;.$+;^9+;W5L\IWYP5RLB[2IR#P>E;20ZN--
M>-[ZR:^)^686;B(#/>/S<GC/\8H YVP\,71OK6ZO+?<@U&2ZECN)$D;!MS&&
M(50N[..!GL<YK5UFQNVUFQU2WLTOEMX9H6MV<*09"A#C/'&P@^S''H<E/$.N
MVWAV\UJ^N=-DCM[I[81Q6<B8V7/DER3*V<J"<8ZD<G'+M3\<QK+>+I$D%PMK
MH]W?$O&XQ)%LV ]/E.XY[\#D4 6/"WAJ?1[QI[R.!G%E!!&Z<^65:4LJY&0H
M#J!TR!5/7?#&I7NM7\L7F20:@L(!69$$6S@ALH6P/O#:>I/3K6GH&KSZC>,D
MFN:;?*L>XQ6MC)"P.1SN:5ACVQWZUD:KXQO+*^UE$U71H6TZ;9!I\\3&XNAY
M2/\ *1*#EBY480].] #;CPOJT=X+N-7E'F7H\J&6-2!+-O4_.K#!'##KTZ]*
MLV/AW4-,_P!&_L^UODF2T7SIY=P@\I54@Y +8VEE(ZD\XZUN:)JD^I3ZHD\2
MQ?8[M844 YP88I/FYZYD(XQT%4K7Q'/-XIDL7BC&GN\EO;3#.YYXU5G!YQC!
M8#CK$WM0!2LO#5VTEDEU;Q1K9F^59 P;F5P4=1V.,^XQ5&?PKJMYI"6/V"VM
M#::3+8924$7+-L Q@<)\A/S<Y;IU-;-CJ6OZK;)JUD+'[')*1':21MYKQ!]N
M[S-V Q W ;2.V>XH6_BB]NM6N[5M:TFS\F^>V2WDL)9)&4-@?,)0,GZ4 6;W
MPY=2:^UU:QQQ6YFM7&PA2/+64,<>OSICZ>U3^&=,O=/2SMKG3+2 6-E]F-RC
M!GF(*\KCD*=I8[N<D>Y,^M7^J1:QIFFZ9-:0&\69GDN;=I@-@4@ *Z==WK6/
MJ'BS4K%$L[B;3[2[BU,6=Q<O \D.QH&F5U0.""<*,%C@YZ\4 33Z#J$CW]BM
MG;%;NZEG747;+1!T*C"]=ZYVCMM'7M52X\,ZEJ,42/IMK9I!:PVK0K(&6?;/
M$Y/ ^ZJQMC//SG@5>G\0:A#H2WD%]97^^[$4EW;V$OEVR;<EFC$C,V#@<$#Y
M@3P#3[3Q)=R6ME(+G3KY;C4EM?M-KG8Z%"Q.W<2C@C!!)Z9[\ #3X:F6]N;B
M*W@4R:U#>*PP#Y2QQJWXY#\>Y]:CTWPH]L=*::TMR;6*[64X!^:5@1]<C.:0
M>)-2DTZ+6_MND6EG<.3;6EV2CS1@]?-+@!B.<;2!G!]:G'BJXB\0:OIUS!$D
M,#;+&<9Q)(L"2LC<]</D8QD!O3D RO\ A&]=M]$DTZ*UAF:ZTNTMWD,X4121
M*0X/'.<\$?CBM)?#5RACD6&$2C6IKQW!&3&PD .?7#*,4E[XMN[:STJX2"%P
M]HE[J1P<0P$J"5YX.69AG/$;5:UJ\UZUUC3K>QO=.2WU&X,*":Q>1HL0O(26
M$RALF,CH,9[XY ,S2_#NIZ9;0V\FFVEZTMI91/),X*V[0J P(ZD @LN.Y/3K
M59/"^NW%Q']HBCC5([N-L/&L0,JL%,:JH.W)!.XDY]>M6KCQ/J$.MW^G3:WI
M%C]B,2#SM/ED,I:)69N)A@98X'/'<U?^W>([S5-4M]/N-,5-/:-%CFM9"9BT
M2N?G$@"\MC[IQ[T 9T?A[5=T5X]E$6@EM93:&4?O/+B=&&>F06##/=1TJSI?
MAJY778=1O;2W6$_;7^SY#B RF#:!Q@DB-R<<98]>M6-1\4.O@NSUZS,-O]K:
MVYN4+I"LLB*Q8 KG:&/<=*B3Q!?O;VT5KJ.FZE=7]W]F@EAM7BBAPAD<N#(Q
M;"KT!7D@>] $T6AWJ^ +'2B$_M&RM(#'EOE\^(*R\^FY0,^E8/\ PA&J_P!G
MZE;.T4@GT^4Q#?UNYHU64^PRA(/_ $T:M/5_$>KZ!%>V]X]C+<);+<V]RL+)
M&5\Q4<.F\G*[U.0W.>V*L:'XANM0UPV*WUAJML(&>2YL;=XU@<%0$8EW!+!B
M1@@C:>* &WGARX/B W5I##':^99,%4A?]4TN[CZ.@'T]JSV\,ZE+H,>C2:79
M'[/#Y37;N"UQ^]1B1Z!@I9MW?'7K6KJ%UXCB\1VNG6U_IB0WD<TJ&33Y':,1
ME."1, Q._K@=.E4K_P =PZ?IFNF6:!;_ $\SK;Q&-]KE$RF['J>O(_"@#<TS
M39++6-5N/+1(+IXFC"=]L84DC\*YR'PA>?V??Q3V\#RS:0]G$20<.TDK8]A\
MZ<_X5+<>*KP:S?VAUC2M.2U:((EQ8R3.^Z)')RLJCJQ'3M6KXHUFXT6VTXQW
M5G;&ZNQ!+<743-'&/+=L[0Z]T Z]Z *,.BZC;W-Q"VG6MRMS=+<_;)7!,8$:
MKC'7>"I /3!_"L]_#>N0:++IT%I#*UWI-K:M(9PHBDB5@P(QR#G@C\<=:?+X
MRU%-+N[B.ZTZXBBN[:&+4DMI!;L)'"O\F_+%/9\<CIS5Y/$EU'ITDJ:CIVJS
MRW$-M;BWM7MU1W;&7W2/D=^,?=/KP 0_\(_J(U"WB^Q0-'#J\M^;[S!N*/O(
M &,[AO"^F%'T&?8^#=3CL$L[J S_ &6PDMLR72JDY;;]W8@8 [=Q+'(..O)K
M;U74O$.A:/J-Y=/I]RL%OYD,Z0/&%?."K)O)(P<@AAZ>]5)?$U[;Z'JVH1:Q
MI>I/96C2I'!8R188="Q,K9'L,?6@#4\+V&H6,5X;\8$TP>/S/+,Q&T ^8T8
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MO7C$VGVMM(LT*,<,Q;S&&$ZG*C..QKO* "BBB@ HHHH **** "BBB@ HHHH
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M^ME.$ACNI)+=&4)"7"2=6.2H.X-W / H U+S1;AM2DU'3=1:QFG14G4PB5)
MN=K8.,,,D9STQD' IECX:M["XL9XIY7>T6?<TF"TSS,K.['URN>..:Q;GQ7<
M13-?BV1XOLEW):CS'4.J30QHS#.,,6+;L9"XQU.8KC7=9TC7+Z"X>&ZN)FM(
M(?)BD,<>X3,6\K<3G"8P&YPO([ '<UCIX;MO^$<&BR32-&&+K*N%='W^8K#T
M*M@CZ5F6GB'6+^>VTZ*&VM[Q_M#/+<0N$98C&.$W!E+>:O4G;@]>*-/UN?3?
MAI9ZO*&NKA;.,_,Y;>[8 )/4C)Y/I0!?C\/2W%W'<ZQJ+:@88WCA01")%WC:
MS$#JQ7(ST )P.:CL/#$]M-IXN]6EO+;2^;2)HE4@["@+L/O$*Q'0=<U1'B?4
MX[>>*X2&.X6:*.*5[.9?,#AB0L )=F&P\9 (YR,&FZ=XFU?5GBL;=+2"\'VD
MRRSPN$(A=5 $>[*D[QG+';@]: -./PM##I>DVL-RZ7&DE/(N0HW$#AE([JR\
M$?0]0*W:XBUUS5X;W4[X26DUB-2LXGC#M)_KH;=3Y3Y "@R;NGS9/2NWH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K(71= U*X_M-;*VG=WW
M&0#(=U.,D="01C)Y&*UZ\TE_M6WL[2)WNK6T$-RR>7YZDS>>Y_Y9<D[<%0W!
MR>#0!Z!&=/M[FX='@CFFE43'< 6DV@*#[[0N!Z8J6"U@MC*88EC,TADDQ_$Q
MP"3^0KSPV$BWTDVH#4#/_:5E<3LK3*I4P(K. IP/GW#CIC'0"ELI]?+3M+<W
M8O?L]U]JC G(4A6V8W?(GS;=I3J/7DT =DGA;1([G[2FGQK+YAEW!F'S$[B<
M9]>:M/I5A)I\FGO:1M:REF>(CY268L3^+$GZUD7%M?6'@AULIKV6[:)7>1Y&
MEFYV^85W9.[&[ '0]!6.5N;J>2UTZYU;^R9+JU596FF$F3O\X*[?/MQY?.>"
M3C!Z ';06T-L93#&$,K^8Y'\38 R?P J*1;&XU!(Y/+>Z@0NJG[R*V5)^AP1
M^%8/BW[=;Q:9%;2S)8B1EN9!)-NP$.S<\?S@9ZG/7&3S6 W]O+8S7,1NGN3I
M\"F8Q.LGE?:GW8_BW"(_[W?J: .];3;)M,&F-;1FR$0A$!'R[ ,!<>F*R[SP
M[I\^FW6B6+06B70!O%";W>)@5[G() (#'.,' XXYVVDOMD8NKN_.C?;2))(6
MN RKY1P!(3YI3?CG/7C.*AN8;A;F\GM'UJ.:YTVS2"69I!*0+F0/G' (0H>>
M<,2>2V0#T1$6-%1%"JH 50. *IKI.F6UNB):0QQ0RM<* N KG=N;Z_,WYUR=
M\EW8WE[;Q3ZL;V&>$:4@FFDC>+:F[><E7^8R;B^2 !TXJ2*#4HI(;X7.HM-+
MJU["Z--(4$'[_8-F=H&5C(;&>@!QQ0!TL6EZ3<P6$T-O&\5K#MM"A.T1,H&.
M."I '!R.!4</AC0[>"6"+3+<1S((Y%*YW*#D#GL#T].U<SI\UT9+9M6FUK[5
MY5G]C2W:3#@HGF%A]QCOW[]_(7!XXK3\2N5U6(7LNI1:?]DD,9L&D5FGR, F
M/DG;]T'@G/!H W['3K/3(##9P+"C,7;')9CU))Y)X')]*K)X>TB.>:9-/A#S
MJZN=O9_O@#MN[XZ]ZY=9]0^W@M)JHU7^T(1%"Y<1?924W%E7]U]S>2>N_@'H
M*BL=-U">#3C<7VL;KG3;F6Y_TN9?WJM'Y8X/RD!FX&-V.<XH [:YT^TN]/:P
MGA#VS($,>2!@=.G(Z4Q=*L$CV"V3;YRSG.23(N,,2>I^4<^U<88=8O;)[R6[
MU2.Y1-.V".5T +[!,=@X/!.<@XQGBKD<]WH^K*)I=0;3;?4I8]SF6<[&MT9<
MGEF7>6 )S@\4 ;[>&M%=X6;3H"8%"IQQM!R 1W )R,YP:ENK/3-98Q7$<=P]
MG)@\D-$Y4'&1R,JP^H-<9!%JNHV4DEQ<:M$8]+FEC59I8F\[S9-F<$$L !\I
MXQC@\58:XU&2Y+:G+J$>G->IY[0F1"H-G$0,I\RIYA;.W W=>IH ZJ+0=)AM
MI+6+3X(X)(6@:-5PIC8DLN/0EFX]ZCN;71+R1[>X2VEDN66)E)R6:,%@/8KD
MGU%<3K-]J(@8V7]MI);VL3VS7+S"23YB2?+C4*QQC<9"3C&0.<VTCU*RU.]B
MTL7BW+7UW)M=I#&Q,!,1^;Y<;L?C]* .RM=(TZR\G[-:1Q&#>8RHY!?[QSW)
MQR3UJO<>&-#NHDBGTR!TCC\I5*\;,YVGU&3D9Z'FN1E>^DMQ'I-UK)B>&W%W
M),TV])C<1 [2_*G89=P7@ #@5U.@0SVMYJ]HTER]O#=K]F-Q*\AVF&-B [DD
MC<6[G'(H T/[-LMX?[,FX3_:,X_Y:8QN^N.*KW'A[2+J)8Y[")U1I&7C&#(Q
M9^1V8G)'0UQEEIVIR:79M->ZR9)M">XFS=S _:5V;._RD;F^48SCD'%&HZAJ
MSWT<J#4([F&2SXWS8=3Y9D(C0"/9AG#%R3D$<?+0!VL5CI-W!.(8()(I3Y,H
M0?*3&2NW_@)!&/:I[:PM;2XN9[>+8]TX>;#'#,!C.,X!QZ=:X>U_M^S.JB-9
M]TO]HG2EC#!!-YTK?O!T);*E">, ]SDPPR:FVGWGE:A?K;[("[%+I]K[_F!9
MB)%R.&"?=X/'.0#L=/T&&WCU#[;Y-W+J<A>Z/DA4<;0@7;D\;5'4G))/>G#P
MWHPLWM/[/B,4CB1LY+%AT;=UR.QSQ6/:W%^_P\U)T2[CNH[>Y$#&621V(#;&
M1F <CIMR,].3U.5KD&IZ?<1V\=[J(MA8!X93+<R.UR68O]P_,V-F$;Y>3@8S
M0!V%@-(LY9-&L!!&\2F22VC'W QSDCMG/ZU'#X8T.!)4CTRW"S1^4ZE<@IG.
MWGL#T'0=JY"]M=4M)KZYC:ZC\_48/ML@DF \O[,I) 0Y4>9M!*]!QG XM:=;
MZM>W6EQRW=^8(XKV5"))HA(5DA\D.2=S#EL;N6'7.3D Z;_A&]&^R_9OL$?E
M^;YV<G=OQC=NSNSCC.>G'2I8]$TN+9Y=C"GEK&J[5Q@1L63\BS'\37 6L_B#
M^QKUUN[\WG]E2M<+B<LEQ\N"-_RHX.["Q\$>P%;&H0WNGZC<VB7&IG2O,M9+
MB032R2*C>:)-KY+ ;EBSM/ )/&: .G;0]+?4?[1:RB-UN#^9C^(# ;'3<!QG
MKBGW]G83O;W-ZJ;K=_W3N^W#-\N.O.<@8/7BN%U*:_\ ,1;:YU:/31;2&TDG
M-QYKR^8W_//YF^7;L$G4>M=!XHMYKGP?;?:Q.\L<]E+/Y&]6^6:,R'"'/ W'
MCIC(Y - &QI^BZ;I3.UC9QP%P%)4<[1T4>@&3@#@5!>6>A1ZC_:%W';+=1[&
M+N0".=J,1ZYX!/X5SVE37IU6Q_>ZD^H->3#4(Y3+Y"P8DVD _(!_JMI7DYYS
M\U1>+K!IM;OBBW>^YL;5(VC,A7*W!+8 ^7(!4_CGUH ZM]"TJ2UBM7L(6AAM
MS;1H5R$B.W*CV^1?^^126^@:3:,7@L8T<NCLW)9F7.UB3R2,GDUR.J)JMA=3
MV=O/??V6E^A>26:=V5&@SCS%)DV>9C.#P3C@9K:L&U!O MP9+F[^TF*<0S+"
MQF"Y;80K?,Q QC/+8'<T 3ZSX834?+^S-:08DDD=9[03*[/C+?>4@\>N#DY!
MXQ&VB>&K&TLK&^2"0V-HD2-.?F:)2%&[^\-Q'!XR:YZSN;UH$CN'U :8MZOV
MFY@GN6WH8FQM+CS47>%W8) )ZXW ,)U?+7$8O\+!(EK,X?S3%]KCV[B?FSLS
MUY*\GO0!W.K6NG7-BSZHD9M[;]^7<X\K:#\P(Y&!GD=LU'8:9I%I(/L%M;QO
M;[E BQ^[\S:S#';=A3^1KD;V:\6PU5O.UO\ ML)??)"TGDH@63R2 ?E P(]I
M3YBQ_P!ZFWOF6.HZL FH!KN_MV9UGG2,1_9Q\S,H)"[U*_)@YV@D"@#LIX=)
ML]+_ +.N$MX[)+=AY$F-OE*!NX/\(!&?J*2UT32[>%5M[.,+YHG!Y)+@<,2>
M20/6N  U$VT-Y,=2^TPV>JPV\F9PP;<IA')SRH)!;D[1GD#&M=S:@+^XS+J7
M]IB[MQ8Q(9?(: B/=D#Y"/\ 6[BW(]OEH Z>X\/Z3=0I#-81,D;.R#D$%R2_
M(YPQ/(Z&K5O8VMH[/;V\<19$0[%Q\JC"CZ 'BN5T:'4(;S2;N6?4'>YN;N.Y
M6::1D$8,AC^0G:N-JX( )SWS53QM>:C'>W@LA?I-;VJ26YCDFVNV6)V)&-K8
MP-V\GC'&.H!U=YX>TC4+A[B[L(9I)%"N6'WL=,CH2.QZCM4D=KIEI?1*D445
MRZS&,#[Q#.'EQ]6()]S7."'4%U$7ZW%^TG]M&$(9I/*^SE2,;,[=N>=V,CUJ
MKX<6677='FN&U)[];*<:C]I\PQQS$QY"[OE7D-@)P0![4 ;_ /8WAFT$UL;2
MS3[1MMWC.#PQRJ ?P@GD 8Z9IYT+P_$QLC9P"2Z D*DG?)Y9X;/7*[ASG/(K
MFM6TPS>)[R,"]4W&H64FZ-Y0/+"X8J<X7D$9&"/:G'^UX9+BSBN=36"*+44B
MD&^9P!Y)C/)RY&7VY.3R : .BF\,VC-80P)#!865Q]J^S)#]^49*MNSQ@DD\
M9)QR.<Z5[8VNHVS6UY LT3$':WJ#D$>A![UA>#)[B2"]CE$[QI*OES/--(DF
M5&=OG#>,'J"6 )X/4#EI;[67:XFM3J<<DMG?"1&DG=T<(QC!R B-D<!!^)ZD
M [I_#6BR0PPOIL#) 6* K_>Y;)[[CUSG/>@>&M$$\<XTV#S(@@4[>R !,^NW
M QGI7+WEAJ%J^I/!>:LYMK>TGM\W4K RL["3C/S A5RGW1D\#-)!+K9\3.);
MBY687\P,0$Y0VWS;./\ 5!=NT[ASNXZY% '9IIME&T;);(IBE>9"!]UWW;V'
MN=S?F:IG1]#NA/8"VA8I'''+&A(95#%T&0<CYB6'O7(QQ:Y::/I\D%QJLL]W
MHHEO2\LDCB0/!N*@YVOL>7 7!)'<BEM[5I]<>/3YM66PN-0@5Y6EF5GC%O+N
M&]OG*[@!G/!Z'I0!V$GAW295E5[-6$LWGMEFXDQC<.?E.,Y(QG)I)_#.B7,$
M,$NF6[10QF-$V8 0]5XZC/.#WYKE(H==M+&*:RGU&:^>/4(56XF=U.PN(,JQ
MQGY5^;J<G).:@MVU>2PN$MKW4#&[609A]HWHYN$#D-+R#LSN4< >E '<V]I:
M:?=2NL@1[UU 1F R53 51_NJ3W[]JC3P_I"7<MTNGP>;-OWDKD'=][CH"W?U
M[URTEE+!XBM%F;49+.QUS$#O--(51[//+9)*^:<9)(&2O0D5T>IZFL_A6[U#
M3A<3@P.8OLX*2D\CY<J2#G_9)]C0 Z'PQHD%O-!'IL"QSJJR#&=P4Y7)//!Z
M>G;I5FTTG3[%HVM;2.)HE=48#D!RK/SWR54DGTKAK%M3N+N:T2XOULWNK,AH
MYK@_*WF"0+))\Q'RKDC !Z8/-6Q]J@N(K74;C55TJ&YNT$D4DQD+ H80SK\Y
M7!DQDG)"@YXH Z@#1CX?BB MVTIHDAC4X,90X55'MT J2TT73;%D>VLXXWC+
M$/R6RP 8DGDDA0.?05SMDM];?#73$A6YBN5%J" "L@'G)NR!R/ESGVS3-(GO
MD\92Q.][<I)+<!R[3((5R2H:-LQE>@5D()R,@\T ;LWA?0[A5673('58O*VE
M>"F20I'< DD9Z$U;&E6 0H+6/:TRSD8ZR+C:WU&U?RKE==@U=KC7[NSGOQ)!
M]G6VC2238(R%\XJB_>;;NQP2"..:J6\M]Y:B>[OVT;[<!-)"UQN5?*;@2,?-
M*;]F2.AR,XS0!MV/@Z*WUK^T;F6VGV^;L5+18V;S.OF$$AN,]%4'))R:T])T
M[2+![A=,@AC=&$4VSDJ0,A"3T #9 Z#-<7JD^J;D$-QJT-H++-BTPG\YI?,D
MSD1_>; CVK)U!Y&=U7Y[O7M/^V:HJ7=U);WK0_91N*R*]O$%*KTP)L<]@7]Z
M .M_LVRWA_LR;A/]HSC_ ):8QN^N.*HWFB:!N@%W9VX,DCI&&X\QI"792/XL
MG<Q!XZUR=]'KUCJ1M&U"\>6".W6SE'GOYQP-[$+\C$ONW!^BXZ"K#++-X@LC
M=-J37\>M2EXSYI@6W D$1 ^X!L*<CG)/O0!TT6@Q)K%K?%H_*L+8V]G L6/)
M#;0Q+9.>$ '3 SUS4FKZ?I%VL4VJPQ,(F$<4DAP5+LJX!'3<=H]\XK!\3W*)
MKYMY[O4XD_LUGACLFE&9=^%/[OJWH#P>^:J)#K;)=WMW/J O4OM.B$<<SB(*
M?LIFVH#M(),F3Z;O4T =3<^'='NQ"L^G0,L$8BC79@!!T3 X*_[)XJU>1VAB
M6:\$8CMF\X/(<+&5!^;/; S7$1SZF/*\J;5&U0FZ_M%',OE(@2385!^1?G\O
M:4Y()Z\UI:AI<S?"^_M0U[<W5QICNPEF=Y7E,><#)R,G^$<<D8YQ0!T)TK3V
M4(UI$RK))(%*Y&Y]V\_CO;/U-4AX?\/6:M$;*V3SXC$0_)>,8.WDY(& ?;MB
MN=O)[G[1=-;3ZJ;H26_]CHK3&.2'8F2X/#?-YF\R<@8/'%:OB6V#:]I%RRW!
M54N(\QE]H9D&T,%XYP>O% %^WT'0IM.V6]E ]M<,MP&7/SM@8D#=<XQSG-7H
M-/L[:P^P06T<=MM*^4HPN#U_/)S]:X1+76M)T*WCTN34&EET-7E61Y)-DBM$
M#L4YV-L9\*H'0<9%;W@][IFO]]Q+-:AD\GS/.8!L'=M>4[F'W?8'/X %\^';
M.TL+F#1X;>PEN(Q'YIA\P*OIMR.,$X&< G.#T-W3]/M]-TRWTZV3$%O$L2 _
MW0,<UPOVK4HK'S$N-3&I"UNFU02M*(XB(V*E0?E7#[=NS&5R>>M-EN=3:P=]
M%N-4EMFM[8WDEP9BZN9!OV9^8'9NW!.@QC!H [-_#>C2& OIT!^SQI%&-O 1
M/N*1W [ YQ36TC1I=3?,2_:Q*EZP61@0X!17P#QD;@?7G.:YC38=1OKFSMI;
MS4&T][R;YHY9X\H(00/,8^85WY()/7('%0+)KLEAY+7&HJWDV<>\,X?_ (_6
M5SG^]Y8&3W'7B@#KX_#6BQ"<)IL"BXC:.0;>"C')4#L">2!@5;U V8TZX.H^
M5]C\L^=YP!39CG.>V*X^9+JTU.:RN9M5_L:+4"-T<L[RX-O&RC>I,A3S&?H>
MN >.*>&N=1^$U_\ /=7$\MO=*AE!:5OG<*".N<8&* .FMM"TNT15@LHUVRB8
M'DMO P&)/)(''/:I[[3[34H!!>0+-&&#@-U5AT(/4'W%<C?PWNG:E<6B7.J-
MI0DM9+B3SI9)%1A,'VODL!N6+.T\ D\9I;#4;NQO;6XG?46TD3W4<#2)+([(
M1&8]PP6/S"0*6YQCGGD Z9-"TJ.#R%T^ 1>2T!38""C'+*1WR>3ZFF+X<T=+
M1[46$7E2.)&SDL6' ;=UR .#GBN?\)0ZC>7T-SJ<^HC[/IMLRQRS2*AE8S!R
MRYPS8"]<XX]JJ^)KS45UV?[)]OCDMY;?RMLDQ5TRI<K&@"%<%@Q<GD$8'% '
M5?\ ".:/^Z L(U$49B55R!M+;L$ X////?)[T7FF:+>ZK$;NV@EO?+WJ&^\R
MHPP2/X@K,,9Z$USI@U:.9;^WN+][I]6N8A'),YB\G$NP%"=NW(0AL9Z<XXIO
MAA _B.SG5]3DD&DNMVU[YI"S%XBP&_@'@Y5>.!@4 =1/9Z7;1Q>?%#&INO,C
MW<?OG)&1[DL?SJ-] T53#/)8P+]DC18V(P$5.5SV(7J,].U<MJ2S3ZT%NFU)
MKQ-:@,42^:8!;AE(; ^3'4ENN[(SVK.:74]0N9(E34@MW;WD<\,DL[$':Q0-
MD*B-D<!!T[G/(!Z#>:?8:O!&+J%+B,'?&V>F1U4CD9![=C4+>'=&>6&4Z;;[
MH%18P$P $^X,#@[>V>G:N&GEU95B2TN+V&-;*W_L[BY8E\'=E1P[;N").BXZ
M#)KIO&9N!!9F*YFA3S&WA#,B/\IP&>$[T]C@C/4=* -M--LHVC9+9%:*5YD(
M'W7?.]OJ=S?G47]AZ6()8/L47E2P^0ZXX:/).T^V6;\ZX:74+ZX^U#S=8AU1
M=/M6L+8R2$+.5;[^T!220-VX 8R<#G%Q)=</BF0-/<+.-08)%B<QFVYV_+_J
MMNW'S==W'7B@#JM2T[2)(I9-1@AVSO$'=^,N&VQ\]CE@!CUJOI@\.17WV/3?
MLJW-N)D\N+JF60RC_OH)GWQ7,VT]T-+M3#-KC:FWV7^T!(TGE))]HB$@PWW3
M@R#"?+LSGC;445MK.FV<\>D"^$K+K#JKO(X+BY7RCAB1N*Y*^N2><DD [3_A
M'](^R_9?L$(AVQH% Q@1C"8/4;1T(JNN@>';U!&MA;2+;;H&51P.=Q1AWY.<
M'/)S7*6\NI>5)MN[]]+\ZW^TM&;DNB_/OVN_[SKY>X+]T9Z9-;WA&2*V@NH1
M]KVW.H3&W:XCD+.H .2S#.,="W)]S0!K+H.EK=I=+:*)8U15.3@!,A>,XR 2
M,]:CC\-:+$MPJ:; JW,;12#;P4;JH'8'T&!6I10!1N](M+R7SG0K*7A=I$X9
MO*?>@/L"3^9J'5]"MM:N+&2Z^:.SD:3R\?>)0J.0<C&<Y'I6I10!4@TK3[8
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MTES=SQP01C+R2L%51ZDGI4M(RAE*L 0>H(H Q?\ A-?"G_0RZ3_X&Q_XT?\
M":^%/^AETG_P-C_QK6^S6_\ SPC_ .^!1]FM_P#GA'_WP* ,G_A-?"G_ $,N
MD_\ @;'_ (T?\)KX4_Z&72?_  -C_P :UOLUO_SPC_[X%'V:W_YX1_\ ? H
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MW_YX1_\ ? H R?\ A-?"G_0RZ3_X&Q_XT?\ ":^%/^AETG_P-C_QK6^S6_\
MSPC_ .^!1]FM_P#GA'_WP* ,G_A-?"G_ $,ND_\ @;'_ (T?\)KX4_Z&72?_
M  -C_P :UOLUO_SPC_[X%'V:W_YX1_\ ? H R?\ A-?"G_0RZ3_X&Q_XT?\
M":^%/^AETG_P-C_QK6^S6_\ SPC_ .^!1]FM_P#GA'_WP* ,G_A-?"G_ $,N
MD_\ @;'_ (T?\)KX4_Z&72?_  -C_P :UOLUO_SPC_[X%'V:W_YX1_\ ? H
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MW_YX1_\ ? H R?\ A-?"G_0RZ3_X&Q_XT?\ ":^%/^AETG_P-C_QK6^S6_\
MSPC_ .^!1]FM_P#GA'_WP* ,G_A-?"G_ $,ND_\ @;'_ (T?\)KX4_Z&72?_
M  -C_P :UOLUO_SPC_[X%'V:W_YX1_\ ? H R?\ A-?"G_0RZ3_X&Q_XT?\
M":^%/^AETG_P-C_QK6^S6_\ SPC_ .^!1]FM_P#GA'_WP* ,G_A-?"G_ $,N
MD_\ @;'_ (T?\)KX4_Z&72?_  -C_P :UOLUO_SPC_[X%'V:W_YX1_\ ? H
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MW_YX1_\ ? H R?\ A-?"G_0RZ3_X&Q_XT?\ ":^%/^AETG_P-C_QK6^S6_\
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MEO-XBTEXI4*.IO8^5(P1UI8_&/A**-8T\1Z2J( JC[;'P!^-;/V:W_YX1_\
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M(*%AGG& .>H ST%6=)T][);B>X97N[R4S3LOW0<!54>RJ /?!/&: -"BBB@
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MEN=0G!D25))KV1WB=<X9&)RIY[=>] $'A;-O=ZWID;NUK8WP2WW,6V*T,;E
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M (!0?_$UT%% '/\ ]A^(/^AON?\ P"@_^)H_L/Q!_P!#?<_^ 4'_ ,37044
M<_\ V'X@_P"AON?_  "@_P#B:/[#\0?]#?<_^ 4'_P 37044 <__ &'X@_Z&
M^Y_\ H/_ (FC^P_$'_0WW/\ X!0?_$UT%% '/_V'X@_Z&^Y_\ H/_B:/[#\0
M?]#?<_\ @%!_\37044 <_P#V'X@_Z&^Y_P# *#_XFC^P_$'_ $-]S_X!0?\
MQ-=!10!S_P#8?B#_ *&^Y_\  *#_ .)H_L/Q!_T-]S_X!0?_ !-=!10!S_\
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MJ.A006)CBU>SDN2SO\T10X*XQSSGGB@"]_8?B#_H;[G_ , H/_B:/[#\0?\
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M+EN(+AUNRS>9$N< ;>03@9]Z -G^P_$'_0WW/_@%!_\ $T?V'X@_Z&^Y_P#
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MO-&/MOV<0']!G/2M^+P_XB\.ZI9ZSI%E;Z@TFF0V=[927 B8/&H 9'P1[?\
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MX/\ ^!,O_P 50!T%%<__ ,(+X<_Y\'_\"9?_ (JC_A!?#G_/@_\ X$R__%4
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MPM[6Q=$?4UEWF6!?X1$5X8C SFMW_A!?#G_/@_\ X$R__%4?\(+X<_Y\'_\
M F7_ .*H Q8M+\5>%]5U@Z%86>IV6JW37B>=<^4UO*X^;<,'<N0.!S52P^'=
MU:2>&H+OR;V&V:^?4V)PK-/'MPH/)&3C\,UTO_""^'/^?!__  )E_P#BJ/\
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M&TP_Y9@;P3VQ@_6EL?!VL-KT5_!H6G>';>*UGBFBL[G>;LNF%5@% P#SS_\
MJZK_ (07PY_SX/\ ^!,O_P 51_P@OAS_ )\'_P# F7_XJ@#DO"7A?5="338;
MCP-I#SVS*)-1%VGFCGE\;,Y /3/:GPZ!XRM=/\0:)::;8BWUB^N91>RW?^KC
MEX^X%))V^_>NJ_X07PY_SX/_ .!,O_Q5'_""^'/^?!__  )E_P#BJ &:EX=E
M7X=S^&[ B65=.^RQ%SMWD)M!/IFN='P]N]0>\BOPD*R:5:0V\Z/EH;B)?O#'
M/![]QFNE_P"$%\.?\^#_ /@3+_\ %4?\(+X<_P"?!_\ P)E_^*H @^'NBZEH
M'A9++5]GVPSRR2%&# [F)SD?6L2+P=K"?"2]\-F.+^T)FD*+Y@V\R[AS]*Z+
M_A!?#G_/@_\ X$R__%4?\(+X<_Y\'_\  F7_ .*H QO&GAG4=5_X1Z2VTNUU
M-=.9C<6MQ*$1P4"@9(/<>G:JTWAO5+WP[)I\'A?3]$87UM.([6X5EE"N"Y.%
M&" !]:Z+_A!?#G_/@_\ X$R__%4?\(+X<_Y\'_\  F7_ .*H X>V^&NLVM[/
M(/*DCBU:![(&0?N[1)7D8?7+]/:O4KN-IK.:)/O/&RCZD5B_\(+X<_Y\'_\
M F7_ .*H_P"$%\.?\^#_ /@3+_\ %4 8=GX#U";PMX<LYM5DTV[T<,^(4293
M(>C8;@D#.#VS5GP-HOB+PQH6F:7=B.YC:69KDEU'V5225"8'SY/)STW'TK3_
M .$%\.?\^#_^!,O_ ,51_P (+X<_Y\'_ / F7_XJ@#H**Y__ (07PY_SX/\
M^!,O_P 51_P@OAS_ )\'_P# F7_XJ@#H**Y__A!?#G_/@_\ X$R__%4?\(+X
M<_Y\'_\  F7_ .*H Z"BN?\ ^$%\.?\ /@__ ($R_P#Q5'_""^'/^?!__ F7
M_P"*H Z"BN?_ .$%\.?\^#_^!,O_ ,51_P (+X<_Y\'_ / F7_XJ@#H**Y__
M (07PY_SX/\ ^!,O_P 51_P@OAS_ )\'_P# F7_XJ@#H**Y__A!?#G_/@_\
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M+X<_Y\'_ / F7_XJ@#H**Y__ (07PY_SX/\ ^!,O_P 51_P@OAS_ )\'_P#
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M$0>XR^TGH0.V:2RU1-=N+>(7LPTS4-5GRRR,A<+$K)%D$%<G)(&/ND>HH ]
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M]#M/K5R?2;6YOO#3RM<DWRG[1BZE428MR1P&XY /% ';45B^)=.MY_#EUO\
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M6#7TBM JP29A>0_-E64MCIT R,&NXT*S:RL&C>S^R,TA8Q_:FN.P&=S<]NE
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MFTMH8+:WF8R?9HU #'(!?:/H!G\*+2]T7^UKJVM)K87TC;IT3&YV4 '/J0,
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MRV<6F6R6\V/,C$8PV.F?IV].U.30]*CB$2:?;J@79M$8QC=NQ_WUS]>:OT4
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MRUQNQG&?S-7:* ,Z;0-'N;\7\VFVTET"&\UHP22.A/J1V/:EO]!TC5)UGO\
M3K:YD5=H:2,$E?0^H]CQ6A10!"EK;QW'VA(464QB+>%P=@)(7Z D_G42:5I\
M=BMA'90):J_F"%4 0-OWYQZ[N?K5NB@"+[-#]J^U>4OG[/+\S'S;<YQGTS4-
MMI=A9W,ES;6D,4TN=[H@!;)W'\SR?>K=% %"XT32[N&2*XT^WD267SG#(.9,
M ;_][ '/6GQZ3IT.FOIL=E EFZLCP*@",&^]D=\Y.?6KE% "    # %+110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !114-W:0WUK):W 8Q2
MC:P5V0X^JD$?@: )J*Y__A!] _YXWG_@QN/_ (NC_A!] _YXWG_@QN/_ (N@
M#H*P/&Q*^&6DV.XCN[21A&A<[5N8V8X ). ">/2D_P"$'T#_ )XWG_@QN/\
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MS_P8W'_Q= '045S_ /P@^@?\\;S_ ,&-Q_\ %T?\(/H'_/&\_P#!C<?_ !=
M'045S_\ P@^@?\\;S_P8W'_Q='_"#Z!_SQO/_!C<?_%T =!17/\ _"#Z!_SQ
MO/\ P8W'_P 71_P@^@?\\;S_ ,&-Q_\ %T =!17/_P#"#Z!_SQO/_!C<?_%T
M?\(/H'_/&\_\&-Q_\70!T%%<_P#\(/H'_/&\_P#!C<?_ !='_"#Z!_SQO/\
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MSQO/_!C<?_%T =!17/\ _"#Z!_SQO/\ P8W'_P 71_P@^@?\\;S_ ,&-Q_\
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MS_\ P@^@?\\;S_P8W'_Q='_"#Z!_SQO/_!C<?_%T =!17/\ _"#Z!_SQO/\
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ML6CT\%64Z80UO('PR +M()[@KP1WJKI_A>UTKR1;:AJ2PV_W(6NF,8 [8]*
M,&RO=6M?#.F^(9-9N;EII8%GM9DB\MUDE$9V[4# C=D<]L'K6]K=S=OJNF:1
M:W+V@O/->6>-5+A8P/E7<" 26'.#P#]1%:>%M'T];>1KFYEM[5P\$=Q=LT,;
M#H0N<9';.<=JN:E;Z7JT,9GNE1K>0/%/#/L>)\$<,#W&1CH1F@#+O9=4TYK7
M24U@S/?WPA2Z=$,UO'Y32$'C:6/ED*2O\7(..:&O7VK:$+W3K?5IIFEL#<V]
MQ.B-);NLJ(1PH# ^8",C/RGGTVX?#VC3V4]NKO<M+*LTEQ]H+3>8/NMO!R"
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M"[79@H0Y8=SG/KQ18^,5N'"SVT486]%K++%.7B3,)E#!BJD] ",#&[.35O\
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M[Q=_T,FG?^"AO_C] #O#%IJ,$FKW6I6BVDE]?>>D2RB3:OE1IR1[H:WJY_\
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M;5;A;B]$!>ZMD\XYD7I]WKG/RCG!QBNM&D>*1,9AK^EB0C!?^QSN(^OG4O\
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MVV%O8#T%;:Z3XJ0*%\0Z6H3[H&CD;?I^^IW]F>+ 2?\ A(M-^;K_ ,2AN?\
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MSO%W_0R:=_X*&_\ C]']G>+O^ADT[_P4-_\ 'Z .@HKG_P"SO%W_ $,FG?\
M@H;_ ./T?V=XN_Z&33O_  4-_P#'Z .@HKG_ .SO%W_0R:=_X*&_^/T?V=XN
M_P"ADT[_ ,%#?_'Z .@HKG_[.\7?]#)IW_@H;_X_1_9WB[_H9-._\%#?_'Z
M.@HKG_[.\7?]#)IW_@H;_P"/T?V=XN_Z&33O_!0W_P ?H Z"BN?_ +.\7?\
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M=7=8U5M.%K#;V_VF\O9O)MXB^Q2=I8EFP<*%4DG!^G-4M#_Y&7Q+_P!?4/\
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M1]]X4TV_U+3I)["REL;&VGB6UD@5D#.T1!5<8&!&P_X%27^C7L.I:==Z&EA
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M$,NG_9'@M@552'+ KZ8XQZ$4 0WGBG4HM*GU*TTNUEAM[N6U<2WC(V5F,0(
MC88/7J,>]:EYJ5YIOAN]U.^M(!/:6\LY@@G+HVQ2P&\J#SC^[Q[UEVOA:]B\
M(2Z-<7Z7%S)=-.UP5P'S/YN2/7^M;6MV#ZKH.H:=&ZH]W:R0J[=%+*5!/YT
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M0C^>9D)!Z@$@$=^: )K;6-0BU2WT_5[""V:[5C;R6UP949E&2C912#C)'!!
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MMJL0/XMO)% &G1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7D0L6D\Y@?+&,?+CHW/2MGQ3<RWGPW:ZG1$EFAMY'6-PZABZ$@,"01D]0>:
M.KR"2,C(ZBEKSV_OM1T;4_$<]G=7$LMQJ=I;JI6+]T)(X_F7<%&0#M&XXZ9R
M<YD.L>(H_-T]KJ:W?[?:PI-=?99+A4EW;@RQ$J,8!4D#.>^* .^HK@S?Z]:)
M>W#ZY-.FF:Q!9"-X(AY\<C0Y,A"CY@)L KM^Z,@YKO* "BBB@ HHHH ****
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MGRNN>:NVXURT %OX-TZ("$0#9J0&(QG"_P"JZ#)X]ZZNB@#C+G3M0O$MTN?
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MM8WNH%@G9<O$LF\*?3=@9_*IJ** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445#=FZ%
MK(;)8FN,?NUF8JA/N0"1^5 $U%<_YOC3_GRT+_P+F_\ C='F^-/^?+0O_ N;
M_P"-T =!4%Y96FHVKVE];17-O)C?%,@=&P<C(/!Y /X5C>;XT_Y\M"_\"YO_
M (W1YOC3_GRT+_P+F_\ C= $O_"%>%/^A:TG_P  H_\ "C_A"O"G_0M:3_X!
M1_X5%YOC3_GRT+_P+F_^-T>;XT_Y\M"_\"YO_C= &KI^EZ?I,#0:;8V]G$S;
MV2WB6-2V ,X ZX _*K=<_P";XT_Y\M"_\"YO_C='F^-/^?+0O_ N;_XW0!T%
M%<_YOC3_ )\M"_\  N;_ .-T>;XT_P"?+0O_  +F_P#C= "Z'_R,OB7_ *^H
M?_2>.M^N2L['QA9W^H7BV^B,]_*DCJ;J7";45 !^[]%S5WS?&G_/EH7_ (%S
M?_&Z .@HKG_-\:?\^6A?^!<W_P ;H\WQI_SY:%_X%S?_ !N@#H**Y_S?&G_/
MEH7_ (%S?_&Z/-\:?\^6A?\ @7-_\;H Z"BN?\WQI_SY:%_X%S?_ !NCS?&G
M_/EH7_@7-_\ &Z .@HKG_-\:?\^6A?\ @7-_\;H\WQI_SY:%_P"!<W_QN@#H
M**Y_S?&G_/EH7_@7-_\ &Z/-\:?\^6A?^!<W_P ;H Z"BN?\WQI_SY:%_P"!
M<W_QNCS?&G_/EH7_ (%S?_&Z .@HKG_-\:?\^6A?^!<W_P ;H\WQI_SY:%_X
M%S?_ !N@#H**Y_S?&G_/EH7_ (%S?_&Z/-\:?\^6A?\ @7-_\;H Z"BN?\WQ
MI_SY:%_X%S?_ !NCS?&G_/EH7_@7-_\ &Z .@HKG_-\:?\^6A?\ @7-_\;H\
MWQI_SY:%_P"!<W_QN@#H**Y_S?&G_/EH7_@7-_\ &Z/-\:?\^6A?^!<W_P ;
MH Z"BN?\WQI_SY:%_P"!<W_QNCS?&G_/EH7_ (%S?_&Z .@HKG_-\:?\^6A?
M^!<W_P ;H\WQI_SY:%_X%S?_ !N@#H**Y_S?&G_/EH7_ (%S?_&Z/-\:?\^6
MA?\ @7-_\;H Z"BN?\WQI_SY:%_X%S?_ !NCS?&G_/EH7_@7-_\ &Z .@HKG
M_-\:?\^6A?\ @7-_\;H\WQI_SY:%_P"!<W_QN@#H**Y_S?&G_/EH7_@7-_\
M&Z/-\:?\^6A?^!<W_P ;H Z"BN?\WQI_SY:%_P"!<W_QNCS?&G_/EH7_ (%S
M?_&Z .@HKG_-\:?\^6A?^!<W_P ;H\WQI_SY:%_X%S?_ !N@#H**Y_S?&G_/
MEH7_ (%S?_&Z/-\:?\^6A?\ @7-_\;H Z"BN?\WQI_SY:%_X%S?_ !NCS?&G
M_/EH7_@7-_\ &Z .@HKG_-\:?\^6A?\ @7-_\;H\WQI_SY:%_P"!<W_QN@#H
M**Y_S?&G_/EH7_@7-_\ &Z/-\:?\^6A?^!<W_P ;H Z"BN?\WQI_SY:%_P"!
M<W_QNCS?&G_/EH7_ (%S?_&Z .@HKG_-\:?\^6A?^!<W_P ;H\WQI_SY:%_X
M%S?_ !N@#H**Y_S?&G_/EH7_ (%S?_&Z/-\:?\^6A?\ @7-_\;H Z"BN?\WQ
MI_SY:%_X%S?_ !NCS?&G_/EH7_@7-_\ &Z .@HKG_-\:?\^6A?\ @7-_\;H\
MWQI_SY:%_P"!<W_QN@#H**Y_S?&G_/EH7_@7-_\ &Z/-\:?\^6A?^!<W_P ;
MH Z"BN?\WQI_SY:%_P"!<W_QNCS?&G_/EH7_ (%S?_&Z .@HKG_-\:?\^6A?
M^!<W_P ;H\WQI_SY:%_X%S?_ !N@#H**Y_S?&G_/EH7_ (%S?_&Z/-\:?\^6
MA?\ @7-_\;H Z"BN?\WQI_SY:%_X%S?_ !NCS?&G_/EH7_@7-_\ &Z .@HKG
M_-\:?\^6A?\ @7-_\;H\WQI_SY:%_P"!<W_QN@#H**Y_S?&G_/EH7_@7-_\
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M*SF3! .  3P3SZ<YZ&M>@##UO5-4MM8T[3-+AM'DO(II&:Z9@JB/9TVCOO\
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M8G9M2F:(,JL0F$+9X![@#MU)Z U1T'QIIVL6]NDDR0WT_F 0[6VDH3D!L8)
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M?9TUQ=027S =T9C*D;<<$''US5+7O#OB'4I=2B"&59;E);9EO3%"(QM.UHU
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MA/LL233F1+=!&C E2VZ$8X!^F.:KZ>]OJEVEK:^.==,TBEXEEMHHO-4=2A>
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M[G2;C58?'FKO9VOF>=*$M_W>S._(\G/&/2KZ>'+^1%=?&&M%6&0=MMR/^_-
M%CPO87MA8W7V^**&:XO9KC9$^Y5#MD#.!G\JPM(T77=%.G78T^&YEL[66RDA
M%P 64NKK(I(QSC!!P>GI6O\ \(UJ/_0WZU_WS;?_ !FC_A&M1_Z&_6O^^;;_
M .,T +I6BW5GX2GTZ=;62ZN?M$C1-DP!I7=]G8E!OQVR*P%\,Z])8W-LJ26]
MJPMO+M;F]^T%72978HY&0@52 ">?05O?\(UJ/_0WZU_WS;?_ !FC_A&M1_Z&
M_6O^^;;_ .,T <G=W,D0'AZW>RN0?$*2!A.?M'-R)6!B*YRO.6S@J,YYK?B\
M.7Z:3:V^R,21ZX]\^&_Y9FX=\_7:PXJU_P (I>>;YW_"5ZOYA&-^RUSCTSY-
M/_X1K4?^AOUK_OFV_P#C- $VN6%Y<:GHM]:1),+&Z9Y49]IV/$Z$CUQN!QWK
M+M/#=_#H>@6C)&)=/OGGFPW 4I,./4YD7]:O?\(UJ/\ T-^M?]\VW_QFC_A&
MM1_Z&_6O^^;;_P",T <Z_A77(-+L(;2W$5]#I<%J+NWO3'LD12")4(*RH"<C
M@GJ.^:ZCQ!IMY?:=9M;>7+=65U%<B-SL68H>5SSC()QUP<5#_P (UJ/_ $-^
MM?\ ?-M_\9H_X1K4?^AOUK_OFV_^,T 9,FAZY<:E/K+6-M',NH07<5J9\^8J
M0M$0S 8#8;([9 &>].;0-9?5O^$C-K +H7RSC3_.ZQB!H>7QC?\ ,6]. ,]Z
MU/\ A&M1_P"AOUK_ +YMO_C-'_"-:C_T-^M?]\VW_P 9H IRV6OC4[#6O[-L
MWFA-S&]I%-L*I+Y>TER,,P\OGI][C..8M \-:G8RQRWB0AQ87,+>6^1ODG,@
M ]L$5H_\(UJ/_0WZU_WS;?\ QFC_ (1K4?\ H;]:_P"^;;_XS0!CS^#M0O-"
MT?36>. V^@SZ?.X;.R5TA4?491L__7JI<^$=5U&RN%DL3%,+)K=#<:G)<;F9
MD+!=QPJ83N,GC@8KH_\ A&M1_P"AOUK_ +YMO_C-'_"-:C_T-^M?]\VW_P 9
MH I^)?#NH:G>:G-:K&1/IL,,09]NZ1)F<@^@P1S[UIZ_!JM_X>V6"+#>,T3O
M&77( 8%U5R" V,@-CKS4'_"-:C_T-^M?]\VW_P 9H_X1K4?^AOUK_OFV_P#C
M- &%;^%=6:_N;B6 K'/=Z?.JSWK3N%AD9GW,W?!! '%7]1\/ZD^N7&K6T<4I
MBOH+J&%Y-OG!86B89QP?G)&>X%7O^$:U'_H;]:_[YMO_ (S1_P (UJ/_ $-^
MM?\ ?-M_\9H D\.66H6]SK%WJ%O%;M?W@GCCCDWX411IR<#G*'-9-[X6OY]!
M$* ?:(=:FU!8TG:(RHTTC ;UY5MK@@^H%:7_  C6H_\ 0WZU_P!\VW_QFC_A
M&M1_Z&_6O^^;;_XS0!CIX;U2.%KZ*Q N?[1@N?(FOGED>.-=OS2,2-W)P!Q@
M#DTY]"UU7&GI9VYM4US^T?M1GY:,S^:5"8SN&2/3CWK6_P"$:U'_ *&_6O\
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M0")HGR) ,<'DXX)'6MS_ (1K4?\ H;]:_P"^;;_XS1_PC6H_]#?K7_?-M_\
M&: )_$UC>7MC;-81)--:WD-QY3OLWA&!(!['%8@\/ZS]@70/LT M%U+[7]O\
M[YO+\_S\;,9WY^7/3OGM6I_PC6H_]#?K7_?-M_\ &:/^$:U'_H;]:_[YMO\
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ML,PW%W):75C*UG!J'B=IK*1HL_)]ED!<*>S,KD?7/>O2'1)!AU5@#G!&:7%
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MX4\MO/E*/?R\,W^\OK6YM!(.!D=#5>QL+?3K?R+=6"EB[,[EV=B<DECR3]:
M.5N=2\^#6-/2\(U&_P!2^S1VZR?O8H\(A8+U4;%:3/OGO3-.U#2_LT&H7NH7
M#:P&DFN8XIR6AV!B\;IG"QJ!MY YP?O'-=KM7=NVC=C&<<TFU<D[1ENIQUH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S[(
M_P#PL6.3:=G]D,-V.,^<O%=!6<FNZ=)KYT.*X62^2!IWC3GRU!4?,>Q.X<4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M DHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ KF+/1O!L&N_9K-;1=3@;SC"EP=ZG).
M=N[UY/'\ZZ>O-=-6WTKQ$CA+35=/GNX_(N5RD\$LDUP 2/XR&+J3D<8X.#0!
MWEC)I<%N8[&>W$7G,#LE!'F,=Q'7J2>GO2RKIL-_)?S- ES# $>1W *1%B1G
M)X!*GGOCVKE-&\+V.O\ A/3OM#21&"XFDS#@%SYK<-QR.!QWP*W(_"NGP:W=
M:QF1Y+B,HT+X,8&!T&/7<?\ @9]L %F?1=&U02W,MK#.+I8V:53]\)DHP(/4
M9.".>::_AG19+**T-A'Y4+F2/:2&5CU;<#NR<\G//>N;",_P+PDKQ$>']VY,
M9P(<D<@\'&#WP>"#S4K76K2OJ5O%KLEHFCV44BLT,3&=F0L7DROW>,87;T/-
M &Y>>&] DM8A=6%ND%I$44@^6$CZE201\OJ#Q18W?AR2WFU*RNK V[(EM)-'
M*OE[4R%0\X &XX'O5+5'AU[P%%+?SKIPOH+>0LZ[EC=F1E5AW7<0I'H:Y.*5
M3'_9][I]K'>G4K&26>W)*7$9O&4;E(^4@AA@YX(YH [6W\,>&T:6.WL;8L]L
MT3JK$GR9.-O7A#M. ..#CO4[VVA2Q2VSFU9-54!D\P?Z0 H7CGGY0!Q54^#]
M/.J7VH"2427L1B9,@I&"!@J,<$'<??<<]L9=[H%GX?A\.VEKOD5-84B24[GP
M8Y.-WL !^ H EUGP4^L:K--,]CY$\L;M*;8^>JKCY 0=IZ$!B,@,1Z5H:SX:
MCU.U_L^(6\-C<W0N+Y&C+-,0RMA3G R5P3@\=*WJ* *CZ="^KQ:F2WFQ0/ H
M'0JS*QS_ -\#\S23Z587-\E]-:H]PD;1!SW1NJD="/8U<HH R(/"NA6T,\,6
MFP^7<1>3(K9;,?\ <&3POL,"F3>$/#]QN\[3(Y \:Q.K,Q#JHPNX9PQ Z$Y(
MP.:VJ* (+:RMK1YG@B"-.P:0CJQ"A 3_ ,!51^%5(O#VD0ZD=1CL8EN2S/OY
MP&(P6"] Q&<D#)R:TJ* ,JU\,:)92226^G11LZ-'QG"JWWE4=%![@8JR=)T]
MA &M(R+:%H(@1D+&P 9?H0H_*KE% &?::#I=C&8[:SC13 +<@Y;,0+$(<YXR
M[?G4-GX6T.PF2:WTZ-9(T,:LQ+%4(P5&2?E_V>E:U% &1%X4T*&VGMDTV'RK
MB,1R*<GY <A1D_* >0!@"M);>%+46H0&$)Y>QN?EQC!SUXJ6B@#+D\-Z/+86
MMB;%%M[/_CW5"4,7&/E8$$<$]^:?:>'](L2GV73X8?+9V4*, %P QQ[@#-:-
M% &19^%-!L)-]MID"-Y;1<@L C=4P?X?]GI4VFZ!I6D2/)86:0NZA"V2Q"CH
MH))POL.*T:* *%WHFF7WGFZLXY3<;#(3G)*9V'/8C)P14NGZ;9Z7;FWLH%AC
M+%V R2S'J23R3[FK5% %*/2-/BAM84M46.SD,L"C/[MR&&1^#M^=5[;PSHMI
M=-<V^G11R$, 1G";OO;1T7/?&,UJT4 9USH.EW=E;6<UFC0V@ MP"5,6!@;6
M!R...#4,OA70IH;:%M-B"6JLD&S*F,,06P001DCD]3SZFM>B@##O_#B7DNEV
MR+:PZ7ITJSBW6'YBZ9V '.%4$YZ9X]ZU;NSM[^V:VNHEEA?!9&Z'!!'Z@5/1
M0!2;2-/>"6!K5#'-.+B1><-(&#!OKE0?PJ)?#VDKJ9U);&,71?S-_.-^,;MO
M3=CC=C-:5% &=+H&E3Z;!ITEE&;6VQY" D&+ P"I!R#CN#43^%]$>VM[?^SX
MU2V9FBV$JREOO?,#D[N^3SWK6HH QW\)Z"UO%;C38HXX2YC6(E-F\Y8 J1@$
M]1TI]WX8T2]2%)]-A*P1>3&$!0"/^Y\N,K_LGBM6B@#*OO#.B:DRM=Z;#)MB
M$0&"H*#HI X('8'IVJ[-86MQ9"RF@5[<!1Y9Z84@C\L"K%% %5],L9$NTDM8
MW2^.;E67(E^4)R#_ +*@?A52#PSHUM;RP16$>R9D:3<2S-L(*98G. 1P,X%:
MM% %.?2;"Y6[6:U1Q>J$N,Y_> # !_"GW^G6FJ6IM;Z!9X20VUNQ!R"#U!![
MBK-% '-2^$(K33M,M=$,-LUA=I<EID+^<1&R98@@DD,.?:NEHHH R;S2KF[\
M2:=J/GQ+;6*2?N]AWLSC!YSC&,=O6I=1\/Z5JTR3WUFDTJ*45\D,%/49!'![
M^M:-% &)<^'Q=:OIDA%M'IVE?O+>W2'#"3:4'.<!0#P .H'I6W110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'8 ] $JQF*.:6/S7& /N[R!DX&?Q[UG:OI,^IWVF2K=QPP6-R+AXS"6>1@I
M ;< H^8]CVZ5R^G27MWJWA#4KS6#>-?QRSF QHJQDP$G9M .T9P=Q)Z<]:[P
ML 0"0">@]: %HIN],9W#&<=>_I3J "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYJ'^R/$W_0U)_P""U/\ XJHC8Z^+I;4^,(1.Z&18O[/CW%00"V-W0%@,^XH
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MQ\N>L8(R3U/MB*U\(Z?9ZFE]#)*"C!_+*QX+A-F2VW=T .-V,\XIO]D>)O\
MH:D_\%J?_%4?V1XF_P"AJ3_P6I_\50!8NO#EO=7[7)N[F-))X[B6W0IY<DB
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M[QBI8 ?-SPI/X4 :=EH\MA<-+'J,\WGSF>Y,RH3*?+5 /E4!0-JGCT]Z9?\
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M(NF189!IZ%9"_P!W!W<YR,54U#4+O2[HVU[X]M89E 9T.GH2@/0MAOE'N<4
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MF5I)0"TDA.XN?]HGGV[5=H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#M4K'&0?]D' H Y&>.ZU_2M!T2\8QZI8W=Q:2$D$K-';2&)\]\_NVS5B*_\
M^$C\2>'O$#1E%%XMI$A'W&%M*\W_ (^P0^\5=/#XM\*3WRK%?VSW3.N,1G=N
M(VCG'IQ2KXM\*^8L27]MN24[0L9^5\D'''7)//N: .=\#:A/%X=TE&\4Z/%"
MJ*#:/ /- SRN[S>OOM_"M_QQ<3OH\>CV<9ENM6E%LL:OM)CP6E.>WR*PSZD5
M>U"+P_I%L;V^M;*WB5E'F- O#$X'0=<TNGZ]H>L7GE6=[!/<Q(6"8PZJ>"0#
MSCITH XB]EGLM%\2Z#>V*V:2H+ZT@\P2+Y;N!(H(XP),G'_305:G2;1/$?A_
MPW('>T34S<:=*<G$/D3!HB?5"R@>JL/0UV^H/86UK)>Z@(5AA0[Y95!"KQG\
M.E)<7NG1ZE:6-Q-"+R;<]M&_WFVCYBOT!H X*#5-'/PGGTZXNK:6ZE@GBBM!
M(K2O*7?8%7KNW$8].M>A6*SI86Z7+;IUB42'.<M@9_6LB;5O"^DW!>22SMYA
M*T)9(OFW@!F' ZX8$_6K4'B71;JSFO(=2@>&W95E8-_JRQ  8=1G(H Y&3_D
MCVO?74?_ $?+6_XG_P"/SPQ_V%U_])YJNZEK&A:0!9W\\$1F4M]GV;BRD\DH
M >,YYQBITU/2KM+&5+JWG2[<_9'4A@[!6)VGU #?D: ,0:C8Z?\ $34C>WEO
M;!],M=OG2JF[$D^<9/-9LM^Z>.=6EM/$.F:='+9V;!KJ,2B8?O<%3YB<#/OU
M%=+JMWH%O,YU06IEBB61C+$'94+;0>AXW9%5++5_".MW:6MHUC=3!2BKY&<!
M1TY'&/2@"^SW-YX:F-I>P7=T]LZQW%O\J/)@@$<G'/N:Y4ZGX?/PL_L\20E_
ML'V8661YWVC;C9L^]YF_\<\^]=S##%;Q"*")(HUZ(BA0/P%1_8;/[7]K^R0?
M:,8\[RQO_P"^NM '':5:>('\1ZDEMJ=K:SI9V0N?/M#.7?8V2")%QSGUK:\9
MP74_@G488@TLI@^=8@09%!!< >Z[ACWK=$:*[.J*'?&Y@.3CIFG4 <[+K?AF
MZ.D10/;WS2SJ;*.V*NT9"GY\ _*JKG)[=/:LSPUJFC:;X1GL]:N;:&Y@>8:E
M#.P#O(SL6)4\MN!!'7((Q76PV-G;3//!:012R??=(PK-]2.M$EC9S7"7,MK#
M)/']R5HP67Z'J* /-M,T/4;J?2\,UOK&GZ'#-:-+G*,)7Q&_L4.QA[^HK9\,
M:B-6TCQ9>B"2!I+MP\,@PT;BVB5E/T8$?A7;>6GF>;L7?C;NQSCTS2+#$H<+
M$@\PY?"CYCTR?6@#A;Y9V^'WA);62..<S:=Y;R(756PN"0",CVR*<U[<:5XK
MFO?%=U!YMAI\TMBUK"8HIHOE,OWF8EQM7Y<XP01[=OY$.Q(_*39&047:,+CI
MCTQ236MO<[?/@CEV_=WH&Q^= 'GFCC5M!U/2=6U/3?LHU!W@U"?SPVYYGWQD
MKVVN=@] U:.@ZGHNF>$[^TUN>WCN(9[G^T8)F&^1F=CG:>6W*1CU! %=I)%'
M,A25%=20=K#(XY%12V-G-<)<RVD$D\?W)6C!9?H>HH YW73&UKX6:*![>,ZE
M 4AD&&C'E/A2.Q'2L[QE_P A'7_^Q5N/YO7<O&DFW>BML.Y=PS@^H]Z:\$,A
M8R1(Y9-C%E!ROH?;VH \VO8I?#QT31MC-IM[J=I/8OC(@?S%,D)]!R67VW#L
M*U-'U.+2],U6TDN].M=874)Y+H:C)Y:NK2$H_J5,>P ].,=J[9X8G"AXT8(0
MR@J#M(Z$>E17%A9W;H]S:03LGW&DC#%?IGI0!SVC37.H_#8MI]M'9W$EG,EK
M' 2$4C<J%<\X. 1]:R[O4] E^%QT^WEA:1K$6\%DI'G"XVX5-G4.'QVR",UW
ME0"QLQ=F[%K"+@C!F$8WG_@76@#C],M=?D\4:T+35+2UD2.T$_GV9GWOY7)!
M$BX[^M3&WU>;Q]JPTW4;6T9;"S\TSV9FW_--C&)%V]_7K[5V"QHKLZHH9\;F
M Y;'3- C02-($4.P 9@.2!TR?Q/YT <'XIM[^?4=9M[=C+>-X:"YB7:9#YC[
MMHR<9YP,GK6P^M^%KBRTB*!H+Q9)XA8V]OM9XV'1MN<J$&<^@!^E=)Y:>;YN
MQ?,*[=V.<>F?2H8K&S@N'N(K2".:3[\B1@,WU/4T <+X:O[BWM;E%\4Z/8QK
MJ5WFVN( TBC[0^<MYJ]>H^7OWJP1XB_X2/Q3-X?N+#<LD!$-S SF5O(3&U@X
M X]0>:ZY](TR1V=].M69CDL85))_*K*11QLS)&JL^-Q P3@8&?PH Y_PDUM#
MX(@;2Y))P(Y7_>J%?S2S,ZLH^Z0Y(QVJ#3;]-(^%D&IJ^YHM*%R7/5Y#'O)^
MI8G\373QQ1Q;O+C5-S%FVC&2>I/O52PTJWL+%[%1YEL9&9(W (16.[;] 2<>
M@P.U '/79;PCX+T-WG:"'39+9+Q@>"A^1]WJ,OGZBJ#WMW-J^FV^KZO/I@OX
M[B^GA$_E>5& BQ0[NQP2QQSE6KK-5T==7EMEN+F46D,@DDM5"[)V4@KN)&<
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M'GMP>* .7L+]4T31].6YEA"6,LY7^T/L,0'FD!C(H+$C!^4 C!R>U7-#FO\
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M_P )$HC$LGA@ ?O(]RR=_P"(<]\GFGR6OBBXMT62/PW+"F"@:*5E7'0CG H
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MZ%_WQ-_C1CQI_?T+_OB;_&@#H**Y_'C3^_H7_?$W^-&/&G]_0O\ OB;_ !H
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M^GI;1BTD#AX2,JV\DMGZEC^=)::386-M+;6]LJQ38$B-E@P"! #G/&U5'T%
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M9I: "BBB@ HHHH **** "BBB@ K \<_\B7J?_7'^HK?K \<_\B7J?_7'^HH
MWZY;6+$)XX\/WS7,\C//-&D3/^[B'V>3.U1W)&23D_A74U#-:6\\\$\L0>6V
M8M$QZH2I4D?@2/QH \ZL%E#+KE_I]E+G7FB>7+"[5C<&)"&'15^5?+[J#ZXK
M5T'2-'U?0-2OM=MK>>[ENKE;V:=07AV2, H8\H%0+C'3KWKI/^$=T@ZG_:7V
M&/[5O\S?DXWXQOVYQNQ_%C/O45[X4T+4;Q[N[TV*263'F')"RXZ;U!PWX@T
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M8QB4&158#:0 =F1E@<-QFKFG^*I[RX2U-A^]*!3)N8)YODB7&2F N#C.2?\
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M%0S$E)>^UEQ@#'>NIHHH **** "L#QS_ ,B7J?\ UQ_J*WZP/'/_ ")>I_\
M7'^HH WZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG_D4KK_KK!_Z.2N@H **R3X:L"23<:ISZ:M=?_'*3_A&K#_GXU3_ ,&UU_\
M'* ->BLC_A&K#_GXU3_P;77_ ,<H_P"$:L/^?C5/_!M=?_'* ->BLC_A&K#_
M )^-4_\ !M=?_'*/^$:L/^?C5/\ P;77_P <H UZ*R/^$:L/^?C5/_!M=?\
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M ->BLC_A%/#_ /T![/\ []"C_A%/#_\ T![/_OT* ->LKQ3_ ,BEK'_7A/\
M^BVI]OX<T6TG2>WTNVBEC.5=8P"#3/%/_(I:Q_UX3_\ HMJ +>F?\@JT_P"N
M"?\ H(JU573/^05:?]<$_P#015J@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH Y_QS_R*5U_UU@_]')705S_ (Y_Y%*Z_P"NL'_HY*Z"@ HHHH ****
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MMCC<79>F>$'-:6JVM_#K]GK%E:"]6*WEMI(!(J. [(P92V >4P02.H]*W**
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M* "BBB@ HHHH **** "BBB@ HHKG_&GA5/&.A#2WO&M )EE\Q4W'C/&,CUH
MZ"BO(?\ A0-O_P!#+/\ ^ P_^*H_X4#;_P#0RS_^ P_^*H ]>HKR'_A0-O\
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M)'(")@GCK4E]X0F$8@L8H/L]K9VL$,+':)@DWF2HV!P&55'?J<UR7_"@;?\
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MFGV4-L[65E=RI>@MN::4;%9PR@HQ#NQ4Y.5.<8&<W_A0-O\ ]#+/_P" P_\
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M (4#;_\ 0RS_ /@,/_BJ/^% V_\ T,L__@,/_BJ /7J*\A_X4#;_ /0RS_\
M@,/_ (JC_A0-O_T,L_\ X##_ .*H ]>HKR'_ (4#;_\ 0RS_ /@,/_BJ/^%
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M (4#;_\ 0RS_ /@,/_BJ/^% V_\ T,L__@,/_BJ /7J*\A_X4#;_ /0RS_\
M@,/_ (JC_A0-O_T,L_\ X##_ .*H ]>HKR'_ (4#;_\ 0RS_ /@,/_BJ/^%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KB[U2GB76)M)U2PBNC'$M]9:G#\DBA/E97!!"X.#PPR#[UVE4[
MW1]+U)TDO]-M+MX_N-/ KE?ID<4 <CJ$]O>?"NRN+:S^R0L]F(X=Q<(HN(P
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
A10 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>ebs20191231exhibit1040002.jpg
<TEXT>
begin 644 ebs20191231exhibit1040002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MJ.>);B"2%\[9%*G'7!&*DHH K:=8Q:9IMKI\!8PVL*0QESD[5  S[X%9[^&+
M%M*CT]9+B,0W+W4,R.!)%*SLY8'&.KL,$$8.#FMFB@#%?PO:3Z/>:;=75Y<_
M;6WS7$LH\W<,;64@ +C:,8  QTI\_AC2[F.VAEA)@MK*2R2'.%,3A 0>_2-<
M'ZUKT4 <^/!UA+'.E_=7NH^;:M:!KJ4$QQ-C<J[0.3@?,<MP.:1?!UJ7EFGU
M/4[BYEB2+[1).!(@1]Z[=J@ @^W/.<YKH:* ,[2M%ATI[F87$]U<W;AY[B<K
MO<@;5X4!0 !V JHOA6T2\,T=Y>QV[7/VIK))0(3+G<6Z;L%N2N[:3VK<HH P
M%\'V*74,JW=ZL%O=&[AM!*/)CD))) QG!+'@G SQBD/@S3A''&EQ=QJEO/;,
M%=?WD<I)8-D=B<C&/QKH** .?N/!MC/YBI=WMO#<0I#=0PR@+<JJ[1NXR#M&
M"5*DBK$OAC3Y;75+;]ZD6J%?.",!MVQK& O''RH/6MBB@"CJ^E0:S8_99WEB
MVR)+'+"VUXW4AE8'GD$=P15"V\)64$WVA[J\N)S=I=O+-("SR*A09P ,8/08
MZ#&*W:* ,2[\+65T\TRW%U;W$EZ+U9X7 :*41"+Y<@C!08((/4U%%X0MK:/_
M $34]2MY_.DF:X296=F<*'R&4J0=H/(X/3%=!10!SL?@K3[8PFRN[ZS\NV^S
M/Y,HS-'N+88D$@[F8Y7:>3S3$\#V,"PBUU#4;7RK)+',4RC="I8A3E3S\YY&
M#P,$<YZ6B@#"?P?I+1RQQK+"KQVZ1^4^TP>1GRRAZ@C/?.:O:9I*Z:9Y#>75
MY/<,#)-<N"QP,  * J@>P%7Z* "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *IVNF06FHWM_&7,M\4,H)X&Q=HQ^%7*\_OK?[;XUUM9
M="U#5EB%N$^S7JPK%F/)&&E3K[9H [-M+MGU8ZFVXS&V^S%21M*;MW3US6=9
M^$K.S\J/[;?S6L$;1V]K)/\ NX58;2!@!C@<#<3CMBN>\9WZQ366B6EY+8-8
MVAO%P7<^8HVP1L5R2"0Q.3SM[TFLZG#K]YX6O(]/O;^VO+2YE:TM9A&P8>5U
MRZ#Y22.M &^/!>GR+*+Z[O;\O;?94:XE&Z*/<&PI4#G<JG<<G*CFI8_"MKYJ
MSW-[>WEPLT4OG3NN[]V247"J %RQZ#)SR:S? CO.=4N8%N+?3FF6."RNIS)+
M;N@(DW9)V9./ESVSWHN/$,.G7&OZS>R#R[&>/3[:-Y BEMB,>3PNYI "3T"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
DB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>ebs20191231exhibit1040003.jpg
<TEXT>
begin 644 ebs20191231exhibit1040003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBHYWDC@=X8O.D ^5-P7=^)H DHK*_M#5_^@$?_  *2C^T-
M7_Z 1_\  I* -6BLK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'
M_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BL
MK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'_P "DH_M#5_^@$?_
M  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BLK^T-7_Z 1_\  I*A
M.MZD+X6?]AOYQC,N/M*8V@@=?J: -NBLK^T-7_Z 1_\  I*/[0U?_H!'_P "
MDH U:*RO[0U?_H!'_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-
M7_Z 1_\  I* -6BLK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'
M_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BL
MK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'_P "DH_M#5_^@$?_
M  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BLK^T-7_Z 1_\  I*/
M[0U?_H!'_P "DH U:*RO[0U?_H!'_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^
M@$?_  *2C^T-7_Z 1_\  I* -6BLK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U
M:*RO[0U?_H!'_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z
M1_\  I* -6BLK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'_P "
MDH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BLK^T-
M7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'_P "DH_M#5_^@$?_  *2
M@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BLK^T-7_Z 1_\  I*/[0U?
M_H!'_P "DH U:*RO[0U?_H!'_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_
M  *2C^T-7_Z 1_\  I* -6BLK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO
M[0U?_H!'_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\
M I* -6BLK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'_P "DH_M
M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BLK^T-7_Z
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M5HK*_M#5_P#H!'_P*2C^T-7_ .@$?_ I* -6BLK^T-7_ .@$?_ I*/[0U?\
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,KPY_R#)O^O\
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MG,C!>5.$;I0!WMYX]T:QAL))X[\-J"NT$*V<AD(0X;*8R/\ "F2_$#1X-/\
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MD6878S3D>82H;D;?E'/7FHQK,TNGZ;+#:(USJ*ADB>;:B?)O.7VYZ>B\_3)
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MU"?9C*LOEY8$QL02OKG;T_"@#2HK/T^74;AS+=-:QIC'V:,%GB;C 9\X)QU
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVAM]2G@ABM-)6=!&K87YA&>?J>U 'H__  C6E_\ /.?_ ,"Y?_BJ/^$:TO\
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MN[(*CE3TP>E8WP_\27^OOIAO?%NH/>3,S26?]FJ(6"ECCS0F.57UZ\4 =_\
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M#P[XIU>]\1:1;:;XDN==689U.WFTX1+;(5SNW[5[]/6@#O\ _A&M+_YYS_\
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MIK,6Y2?<,QCY1N^7D\<<?B =5_PC6E_\\Y__  +E_P#BJ/\ A&M+_P"><_\
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MR<=,G=6M10!E?\(UI?\ SSG_ / N7_XJC_A&M+_YYS_^!<O_ ,56K10!E?\
M"-:7_P \Y_\ P+E_^*H_X1K2_P#GG/\ ^!<O_P 56K10!E?\(UI?_/.?_P "
MY?\ XJC_ (1K2_\ GG/_ .!<O_Q5:M% &5_PC6E_\\Y__ N7_P"*H_X1K2_^
M><__ (%R_P#Q5:M% &5_PC6E_P#/.?\ \"Y?_BJ/^$:TO_GG/_X%R_\ Q5:M
M% &5_P (UI?_ #SG_P# N7_XJC_A&M+_ .><_P#X%R__ !5:M% &5_PC6E_\
M\Y__  +E_P#BJ/\ A&M+_P"><_\ X%R__%5JT4 97_"-:7_SSG_\"Y?_ (JC
M_A&M+_YYS_\ @7+_ /%5JT4 1P01VT"0Q A$&%!8L?S/)J2BB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *Y.]^']CJ-CKUI=7#.NL7(N5;8 ;=PH"
ME>><8]NI%=910!Q5M\,M,:6P&K3?VG;:?8"T@MY8]J@[LF3@]3TI8_AM:6KR
M165\UM8G4H-0BM%BRL3Q]5!ST;CZ8KM** .&LOA?96$N^"^<8UF/4P/*' 3=
MMBZ]/G//Z5-:>"M;TN>^;2O%KV<%[>27;1?V?')M9SD\L<]@/PKLZ* ,W6-#
MMM?T&?1]2+2Q7$821UPK9&"&'H00#6!;>!KV:_L)M>\2W.KV^F2"6UMWMTB
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M1U7W '0FMV;0;&>20L)A',VZ:!)F6*0]]R@XY[CH>^:G;3;=M234,RB=(_+
M$K!-ONN<'\J ,*QM;>YTG4X],:WACGO0T90^6DJXC;;E>@89&1_>JWI=M9VF
ML;$TQM-N'MV(CB*^3*H9=S +_$"5&2 <'OCBU_PCVE_8I+,6Y6&2?[0521E(
MDSG<"#E<$#&.E36FEP6DYG#S33%=GF3RER%ZX&>@X&<=<#.<"@"[6+<V%D_B
MVRG>T@:4VL[F0Q@L65H0ISZ@$X/;-;59UUH=K>7PO));M9@I0&*[D0 '&0 &
M &=H_*@"EXFFLKO13;O$+GS[@6RA83*R-DAV50"=RJ'(P.U4O-@F\)ZWIQB?
MR[.*7RDGA9#Y94M&0K@'"G*@_P#3.MB+P_8PRV\J&YWVSNZ$W,ARS'+%LGYL
M^].N="LKN>ZFF\\M=P>1*!<.JE/0 ' ZGIZGU- &*T427^EZ;>1I--:70:VE
MD4,S0F-RO)[J5 /^ZI/45+J>EQS37\]WIHU**8_)/!(OGVP"A2J;L;<$$Y4Y
MR>F>NP=(LV>RDD1Y)+%BT$CR,S*2"#DDY((/0YZ#T%0R>'[%Y)F#7,:7#%IH
MX[EU20GJ2,\9]L9H J^(K>QOO!UY<&**Y6.PDDMY)$#%?W9(8$C@].:77]*L
M?[ %G':Q0PFY@VK"H386E4$KCH<$\CUJ_J&DVFIV?V.?S5@V%#'#,T0*D8(.
MTC(QVI)='MI]/%C+)<O$'#[C<R;\@[A\V<\$#O0!D6I6;Q+8+>11-J-I#-%+
M+L 9P-FUQ[$,3[$L.QJO]DTA_"L.IZK:2SS75J)Y[R*,M,A9-S$..5 R< <
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG_0&@_\  W_["M6B@#*^VZY_T!H/_ W_ .PJ ZQJPOA9?V-#YIB,O_'YQM!
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M_P"@-!_X&_\ V%:M% &5]MUS_H#0?^!O_P!A1]MUS_H#0?\ @;_]A6K10!'
MTKP(T\0BD(^9 VX*?K@9J2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LIO^1MC_P"O!O\ T8M:
MM93?\C;'_P!>#?\ HQ: -6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,CP[_Q[7O\ V$+C
M_P!&&M>LCP[_ ,>U[_V$+C_T8:UZ "BBB@ HHHH **** "BBB@ K*D_Y&VV_
MZ\)?_1D=:M94G_(VVW_7A+_Z,CH U:*** "BBB@ HHHH RO#G_(,F_Z_[S_T
MIDK5K*\.?\@R;_K_ +S_ -*9*U: "J>K6/\ :>C7NGAPANK>2'<>VY2,_K5R
MB@#S2TT+Q9?VOAG0M0T:"RM-"NX)Y+X7:R"<0@A0J#YAG/>H-4^'>K7NC:Y-
M;HMOJSZO=W%DPD7]];S*%9">P9<\'H1VS7J5% '$^'/#FJ:?XHTN^N8%2"W\
M,PZ?(PD4XG5P2N ?3OTK1\':-?:1/X@>]B$8OM7FN8,.&W1L%P>.G0\&NEHH
M **** "LJR_Y&75/^N-O_P"SUJUE67_(RZI_UQM__9Z -6BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MREC:P37+R16Q;KY:$X&:V-*TV'1]-BL+>2:2.'.UIY#(YR2>6/)ZT 7****
M"LIO^1MC_P"O!O\ T8M:M93?\C;'_P!>#?\ HQ: -6BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** /&]<BOK+4M5U?43J5S:B]+V^M:5J&\6
M<888C:'./EZ'/K78Z!>/<_$O7P+AY+<V5H\0+';@J3D#MFK%[\./#]]>7$\@
MO(X;N7SKFSBNG2"9\Y+,@.,DU9UCP/I&LWJWK-=V5R(?(:6QN&A+Q]E;'44
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M6U"YO)3>P&\Q]KBMKIHX[C']]1UK4A\.Z;!JT.I10E)8++[#&@/R+#D';M_
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MS3Q+;^,?[3MS_:>H/8RVXG7<EJ<)"Q7.1AXPQ]I#0!Z'Y/B+_G^TS_P#D_\
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M7;*TBM8+W35BA0(@-K*Q"C@#)ES6W10!AW.FZU=M T]WIC_9Y!+&#:28# $
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M287<,$X\W&<<9]"?4U/Y/B+_ )_M,_\  .3_ ..UJT4 97D^(O\ G^TS_P
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M2ZNY+(6+S!0DL>?,W. ?E4*3D YXXJ6/Q=)%8:L;_2Y$U'22@EM+9_-\W?\
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MC;;?]>$O_HR.M6LJ3_D;;;_KPE_]&1T :M%%% !1110 4444 97AS_D&3?\
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M5TFEZ;:2^(_&-[/;0R74<L:K*R E,6R'Y2>G7M7;>5'YOF^6OF8QNQSCZT[
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M5TL=6TO3S$7.I/(BN#PFR,OD^N<8IFB:Y#K.AQZL4^S1.S@B1Q\NUV3D_P#
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M]<;?_P!GK5K*LO\ D9=4_P"N-O\ ^ST :M%%% !1110 4444 %%%% !1110
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M(TPVC69TZU-L[;FA\E=C-ZE<8S4BV%FELEJEI L$9!2(1@(I!R"!T'/-6**
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M,\;17JEY9VVH6KVMY;QW$$F-\4BAE;G/(/N*DDCCFB:*1%>-U*LK#((/4$4
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M5J2TMYKF&YD@C>:#=Y4C+EDW##8/;(H \\LK"X>[\7R3>(;O2Y+._DG1('5
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M<_"KPQ;6S*;B:6P@B4=1*CIO_$;&SZ8-=E8>%O#^E70N]/T:RM9U! EA@56
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M)A:Q"2V0QPN$&8U.,A?0<#\JIVOAK0[+46U&UTBSANV))F2%0V3U(/;/?UH
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MG,K94J,?GG]:6_\ "&H7-WJE[!<6\=P^IV^H6.\L5W1QJFV3C@'##C/4'VH
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M0!%;'Q:?&5RLK1+I)0I%)Y''RY8<>9P3Y@&[OY1X7K533X_%ES9:P-:N9+)
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M>?*9/W\LQE4RK)SD@$'@\# JY>VDFK:]XGDU*WT:9[6?8KZE<O'):P!%*-&
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M\5[V$6^F2%=CLQVL0H 82*"3DD@8/% '4>(?$]CX<^Q)=!Y)KZX2"&*/J=S
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M.:?:>*[=OM\>J6DVE7&GP"XGBN"K?NCGYU9"0P^4CCD$8KB[F5'U2YUL,O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6@*+N(D! XQG!'<5+I?B37M4AL]5AT6%M)O90J!9R;A(R<"5EQMQW(!R >]
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M0 4444 %%%% !1110!D>'?\ CVO?^PA<?^C#6O61X=_X]KW_ +"%Q_Z,-:]
M!1110 4444 %%%% !1110 5E2?\ (VVW_7A+_P"C(ZU:RI/^1MMO^O"7_P!&
M1T :M%%% !1110 4444 97AS_D&3?]?]Y_Z4R5JUE>'/^09-_P!?]Y_Z4R5J
MT %%%% !1110 4444 %%%% !659?\C+JG_7&W_\ 9ZU:RK+_ )&75/\ KC;_
M /L] &K1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6M-+M[1GRT,"QEU]0H&17)KX-U6ZU73;G4Y],=].N5G_ +0@MREW<A<X5ST
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MV_\ [/6K659?\C+JG_7&W_\ 9Z -6BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &1X=_X]KW_ +"%Q_Z,
M-:]9'AW_ (]KW_L(7'_HPUKT %%%% !1110 4444 %%%% !65)_R-MM_UX2_
M^C(ZU:RI/^1MMO\ KPE_]&1T :M%%% !1110 4444 97AS_D&3?]?]Y_Z4R5
MJUE>'/\ D&3?]?\ >?\ I3)6K0 4444 %%%% !1110 4444 %95E_P C+JG_
M %QM_P#V>M6LJR_Y&75/^N-O_P"ST :M%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5E-_R-L?\ UX-_Z,6M6LIO^1MC
M_P"O!O\ T8M &K1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M HHHH *RI/\ D;;;_KPE_P#1D=:M94G_ "-MM_UX2_\ HR.@#5HHHH ****
M"BBB@#*\.?\ (,F_Z_[S_P!*9*U:RO#G_(,F_P"O^\_]*9*U: "BBB@ HHHH
M **** "BBB@ K*LO^1EU3_KC;_\ L]:M95E_R,NJ?]<;?_V>@#5HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LIO^1M
MC_Z\&_\ 1BUJUE-_R-L?_7@W_HQ: --T61&1U#(PPRL,@CT--AABMH$@@B2*
M*-0J1HH554<  #H*DHH IZCI&FZO$L6I:?;7B*<JMQ$KA3[9'%/@TZQMK+[#
M;V=O%:E2I@2)5CP>HV@8P:LT4 9=OX8\/VDZSVVA:;!*ARLD=I&K*?8@5?\
MLMN+LW8@C^T%!&9M@WE <A=W7&23BI:* (YX(;F%X+B))HG&'210RL/0@]:J
M:=H6D:.7;3-+L[(R??-O J%OK@5?HH @%E:+'/&MK"$N6+3J(QB4D8)8=R0
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M 4444 %94G_(VVW_ %X2_P#HR.M6LJ3_ )&VV_Z\)?\ T9'0!JT444 %%%%
M!1110!E>'/\ D&3?]?\ >?\ I3)6K65X<_Y!DW_7_>?^E,E:M !1110 4444
M %%%% !1110 5E67_(RZI_UQM_\ V>M6LJR_Y&75/^N-O_[/0!JT444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]ZLT %%1S31V\$D\K;8XU+NWH ,DTRRO(=0L+>]MF+07,2RQL1C*L 0<?0T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5E-_R-
ML?\ UX-_Z,6M6LIO^1MC_P"O!O\ T8M %S4;Z#3--N;^Y;;#;1-+(?91DUY6
M/^$@T[0;+Q'/X?E2XMKU]5NKH7$9+12_ZQ=F<@>65&.VP5ZK?V%KJ=E)97L"
MSV\H >-NC#.>?RJ26&*>!X)8U>*12CH1PRD8(_*@#B4L=/\ $GCO5DO+N::U
M2PM98($N71&W;\R *1R!CGMN^E8^G22:]+X1M-2U&YDMY3J,>X3LAO$C=1'N
M(()R #[X/J:Z5/ &E2:Y=W%Y8VTMBUM;P6D66W1",.&'^Z0R\9YQSTJSK/A"
MTU;5=&>2VMCIVG13QM;D;<;@@38 .,;/48XQ0!R6HF>%=3T*ROKI+&WURQ@M
MY%F8O")=OF1JY.< GIVSBO1=-T^ST>SCT^SW+$FXHLDK2-R<GEB2>M0P^'](
MM[&*QAT^%+:&99TC5>!(#N#^YSSDU9DT^TEOX;^2!&NH$9(I3U56QN ^N!0!
MQ&OZ#')X\L].CG>+3M?5Y]1M5'RS-!M(^F[< V.H7WJ[XATR+6/'6E:9<37"
M61TZX>2&"=HA)M>, ':0>,Y_"NKEL+6:^@O9(%:YME=8I#U0-C<!]<#\J&LK
M9[Z.^:%3<Q1M&DO=58@D?B0/RH CO;6UO-.GL)I&6%H]DA24JRC']X'(/O4X
MCB6V$38:()M.\Y!7'?/7BJLVB:9<"^$MG&XU$ 7>1_K@%VC/X#%67M8);-K1
MXP8&C,93L5(QC\J .2B4^,[FS2QA6V\-:;.DL<@7;]L>,_((U[1*1U[XP..:
MKZ;-!:^&_&PNV53%?WKS!NNUD!7/U4C%;,'@#PG:SQSP:';1R1,'1@#E2#D'
MK5V^\+Z'J5^+^]TR">X&W+LOWL=-PZ-CMG- '*ZMI4!^$*75[:H]_:Z (UDD
M7+QDQ#< 3T/'-:6O6TYN_#=_I\]K_:-MO6"UNG*+<JT?SJ& .& 7(..QKI[N
MTM[^SEM+J)98)D*21MT93U!J#4-'T[5K-;._M(YX$(9%;^ CH0>H/N* .9\(
M_P!H3>-O$US?& .4M8W2W8O'&X5SLW$#<0I4DX'+=*F#I:_%AVNV"F\TE4LV
M8X#%9"9$'ORIQZ5T6G:98Z1:"TT^UCMH02VQ!C)/4GU/N:9JNC:;K=L+;4[*
M&ZB5MRB1<[3Z@]0?<4 4K[7M%L=;D@G53>6UB]S+*L8)AA!&=S=1GL.^*\]_
MXJ"#P]#XE;P]*+F.^.LR70N8\F)AADVYW8\G"X]J]%MO">@VFG7&GV^EP1VU
MWQ.@!S+_ +QZG\36JT,3P&!HU,3+L*8X*XQC'I0!P.L:9:^+/&K)%/L\S08K
MBSNDZQ2"<M'(O^>A(IGAK6)M:^(#QZA%]GU&ST9K:^B' 603#)4_W6!# ^AK
MM;+1--TZ2.2SLXX7B@%LC+G*Q Y"_3)I_P#9.G_VE+J7V2(7<T/D23 ?,R9S
MM- #M.M(+#3X+6U=WAB3:C/(7)'NQY-<UKNGV=GXP\-SV]M%%-<ZA,\TBJ T
MA^SR<D]ZZBRLK;3K.*SLX5AMX5VQQKT4>E)/96US<6]Q/"KRVKEX6/5&(*DC
M\"1^- '+S1:EI_C'5;K1'TZZ:[@A:\@NYVB:V*AE1\A3E2 >..1UKG/#%G?P
M:=X=U*QN;.?4,WRQ6URQB%U \I8LA ;:1A6Z'AJ[_5/#6C:U,D^I:?%<2(NP
M.V02N<[3CJ/8\5)J&A:5JEI%:7MC%+# 08EQM\O P-I&"O''% 'GZ"WN'\4O
MXFG\J"[U*T@-Q8L=EM.J+@AS_<.P%B!R.G:MBYDUSP[J.D)J>I6FO6-W>I!%
MYULL=S"[ A74K\K8&<G .*ZJ'1=,@THZ5%86ZV)4J;?RP48'KD=\^]4]+\'>
M'=&NQ=Z?I-O!. 0L@!)0'KMSG;^% '&VNEW7G:YXATB/=JFF:Y<D1CC[5"5C
MWPGZCD>C >M6?">OZ+)HGB#7[G;)9-K;3PAXMS[S'%M"KUWY.!CG-=W:V-K9
M&<VT*Q&XE,TNW^-SC+'WX%9\_A+P_<V<MG-I5NUO-<F[>+;A6F(P7X[XH Y;
M6M*U;4?#_B'Q%J,)MKN?2I;:TLE.6@@^\P<CJ[8&0.F .:O:Y-!=+X+6R96:
M74(I8=A_Y9+"Y8CVP1^=;>E>$] T2Y:YTS2X+69T,;.@.2I()'Z"GZ=X8T32
M+MKO3],@MYF!7>B_=!.2%_N@GL,4 ::NKYVL&P<'!S@^E<GH3I;?$3Q+;W3!
M+JZ%O-;[N#)"(]OR^H#!L^YK?TG28M)6[$1!-W=R73X7 #.<]/R^IR?:DU;0
M=)UV-$U2PANA&<QLX^9#[,.1^!H Y3Q!)'=>.F%F0SV6AW0OF7^%7QY:,?7(
M8X].:RM-L+?1O"7A+6--O+AM0N9K.%B;AV$ZO@/$5)VX5<XX^79]:] T_0=*
MTJQDLK"PAM[>7/F(BXWYX.X]2?<U4M_">B:7+]LTO2+2.\BC(@)R%4XQQUVY
MZ$@9^M '#7E_J4EL+")I98;WQ/=P2K]J,&]%+%8O,Y*@D8XZXQWIU[<ZQX?T
M_P 0Q6Q338EM8'6V6_-R]H6DV/(I(RBE"3CL5R*Z[1O"ZKH-U8Z_!:W;WUY-
M=S1("T:L[E@%) /''. :T[#P_I&F6L]M9Z?#'%<_Z]2N[S>,?,3DMQQS0!S.
MJ>']#TR">VM[^Z1[S3I\VC7,D@N=BAO,))."#CD$9W8YK9\#VL-KX(T98%($
MEE#(V6+99D4GJ?7MTJSIOAC1-'>1[#38(6E3RW(&24_N\YPOL.*LZ9I-AHMF
M+/3;9+:W#%A&F< GK0!SWP^=(K/5K&5@+^WU2X:Z4GYB6<LKGV*E<'VJCK>I
MZ7J<-C)I4:A(O$UM'-*D8599 PW,"/O=AGVKI-5\*:#K=R+G4=+@GG"[?-(*
ML5]"1@D>QJR-%TQ;.VLTL84M[219((D3:L;*<@@#N#0!YIXDD^V:5K^MV5K>
MS?9II?+U2YU(P>0Z'&V*->P88 (&[N:T=;MKW4=3GO3#_;,,=C"7M[?46MI[
M!BI8NJ\*2W4$G/&.E==-X.\.W%S/<3:1;227!9I=RY5F(P6V]-Q]<9IU]X3T
M'4GB>\TR&5HHQ$K'(.P=%)!Y'L<T <?>B7Q!)I5WIX?7+3^RD<Z=<7YMKD9/
M$YVX5F.,'.!D<=:ZWP=?0:AX5L;BVEO)8]K1[KU@TV58J0Q'!(((SWQ4VH>&
M-$U18%O--A<6R>7#M&PHG]T%<?+[=*OVEI;V-K':VD$<$$2[4CC4*JCT % $
MU%%% !1110 4444 %%%% !1110!D>'?^/:]_["%Q_P"C#6O61X=_X]KW_L(7
M'_HPUKT %%%% !1110 4444 %%%% !65)_R-MM_UX2_^C(ZU:RI/^1MMO^O"
M7_T9'0!JT444 %%%% !1110!E>'/^09-_P!?]Y_Z4R5JUE>'/^09-_U_WG_I
M3)6K0 4444 %%%% !1110 4444 %95E_R,NJ?]<;?_V>M6LJR_Y&75/^N-O_
M .ST :M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5E-_P C;'_UX-_Z,6M6LIO^1MC_ .O!O_1BT 6-:U$:1HE]J3)O
M%G;R3;?[VU2<?I7,:?X7O]5T.#4KSQ%JL>K74(F$D%RR0PLPR%6(?*5&0.0<
MXKK;ZSAU&PN+&X&Z&YB:*0#NK @_H:Y2TA\;Z7I*:);VFG7)AC$-OJ;W+( @
M&%9XMI)8#'0X)H OSZ_J&GR6.C?8AJNMR6WG3K XBB51A2Y9N@+< 8/?TJ+_
M (3B Z>K)IUR=2:\-C_9Q90XG W$%L[=NWYMW3'Y5!_8.M:+J5CJE@ZZQ/'I
MXL;M;J<QR2X;>) V#SDMD'L1SQ51?"6LH5UW-JVM#4VOS;>8?*V&/RO*WXSG
M9_%CKVQ0 6OBJXM/$>OW>M0W-C;Z?I]N[6ID$BABTG*8.#N^49XYX/2MJR\3
M73:G:6&K:+-ICWRL;5FF20.5&XHVW[K8R<<C@\UAWOA36_$DFO/JL=K8C4K*
M"&V1)?-\MHW9QO.!GD@G'8X[5-H?A>>'6[.\D\,Z+I"6JL9)+<^;),Y&!L.T
M;%ZGG)[>] &Q>PZQKVFP11M+HN;DBY D!E,*D_<9<[2WRG/4#/>N5NM=N_#L
M7B<Z;J,][8:?!"D<]Y*9A!=.VTJ';E@ 4)!)P>*WO$47B[4?#Z6UA!;V]U+.
M5N/+NBA$ )^X^TX9ACG''-55\/:CJGA.\\,W6BV6C6C0;;=K>Z,^'!# L"@[
M@$G))YH K:%?VUOK=N(M;UIM]M)(\6JQ2;+X  ^9#NP%(ZX Z'IWJJESJEKX
M/L/&TFK7KW4TL,]Q;&8FW,,L@4QK'T&%88/7(ZUMIIFNZWK6F76MV5I90:8)
M&(@N#*;B1T*<?*-J8)///050B\,Z^^B6?A.YCM?[+M)XR]\)B7F@C<.B>7MX
M8X4$YQP>M &;XKUO[+KFO)?ZSJ5K+:6\;Z9'82-Y:Y3K)MX!+Y_UF!MQBKVO
M:K/'>Z#%KNI75I9W-@TDPTN1O,>Y 4_\L\N8P-V"O&<9[5?;2M?TF\UI--L+
M+4(-7F,ZRW%P8S"S(%*N-IW*,9&/<5#9>&-6\,76G7FFQPZJ8-+33YHY9O)8
M;6+!T)!&"205/H* -3P)?76H^%;>YNK@W.Z200S.P+O$'(0OCC=MQGOGKSFN
MBK#\*:/=Z38W;7QB%S?WDMW)'"28XB^/E4D#. !DX&236Y0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% &1X=_X]KW_ +"%Q_Z,-:]9'AW_
M (]KW_L(7'_HPUKT %%%% !1110 4444 %%%% !65)_R-MM_UX2_^C(ZU:RI
M/^1MMO\ KPE_]&1T :M%%% !1110 4444 97AS_D&3?]?]Y_Z4R5JUE>'/\
MD&3?]?\ >?\ I3)6K0 4444 %%%% !1110 4444 %95E_P C+JG_ %QM_P#V
M>M6LJR_Y&75/^N-O_P"ST :M%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5E-_R-L?\ UX-_Z,6M6LIO^1MC_P"O!O\
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M!ECO*9' ].PKF;_QE<WMWX>6UL-1T^"_U&/9-.B!+F$HY(X8E<_*<, 2/QH
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MBD@X8DEMQ8<?=ZX/%7]5U[^SKR*QMM-O-1NY8S((K8* J @99G95')Z9S[4
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M 5E67_(RZI_UQM__ &>M6LJR_P"1EU3_ *XV_P#[/0!JT444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !64W_(VQ_]>#?^
MC%K5K*;_ )&V/_KP;_T8M !XI_Y%+6/^O"?_ -%M3_#G_(LZ5_UY0_\ H J]
M/!%<P203QK)%*I1T89#*1@@_A4.G:98Z1:"TTZUBM8 2PCB7"@GKQ0!:KF-
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M<[L\$YQBJ?B?3M6N_$%O(;.^U#2!:E3:V5\+8B?=]Y_G3<NW ZG&#QS7744
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M0 4444 %94G_ "-MM_UX2_\ HR.M6LJ3_D;;;_KPE_\ 1D= &K1110 4444
M%%%% &5X<_Y!DW_7_>?^E,E:M97AS_D&3?\ 7_>?^E,E:M !1110 4444 %%
M%% !1110 5E67_(RZI_UQM__ &>M6LJR_P"1EU3_ *XV_P#[/0!JT444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !64W_(
MVQ_]>#?^C%K5K*;_ )&V/_KP;_T8M &K1110 4444 %%%% !5#5=#TW6UA34
MK;[0D$@D1"[!=WN <,/8Y%7Z* "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH H:;H>FZ3-=3V5MY<MX_
MF3N79V<\XY8G &3@#@9XJ_110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% &1X=_P"/:]_["%Q_Z,-:]9'AW_CVO?\ L(7'_HPUKT %%%% !111
M0 4444 %%%% !65)_P C;;?]>$O_ *,CK5K*D_Y&VV_Z\)?_ $9'0!JT444
M%%%% !1110!E>'/^09-_U_WG_I3)6K65X<_Y!DW_ %_WG_I3)6K0 4444 %%
M%% !1110 4444 %95E_R,NJ?]<;?_P!GK5K*LO\ D9=4_P"N-O\ ^ST :M%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@#*\.?\@R;_K_O/_2F2M6LKPY_R#)O^O\ O/\ TIDK5H ****
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M!X*MK^-!'<Z(L5[&#QCRQ\Z_BFY?QKK*SM7T*PUV.*+4$DDBB??Y2RLJ/[.
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MT#1'3D_>1L@(,<J8)!YR#TY-.LM(O=#7P]K']D7S0VK7?VBT$@N)XO/((?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *RF_Y&V/_KP;_P!&+6K64W_(VQ_]
M>#?^C%H U:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH R/#O_'M>_\ 80N/_1AK7K(\._\
M'M>_]A"X_P#1AK7H **** "BBB@ HHHH **** "LJ3_D;;;_ *\)?_1D=:M9
M4G_(VVW_ %X2_P#HR.@#5HHHH **** "BBB@#*\.?\@R;_K_ +S_ -*9*U:R
MO#G_ "#)O^O^\_\ 2F2M6@ HHHH **** "BBB@ HHHH *RK+_D9=4_ZXV_\
M[/6K659?\C+JG_7&W_\ 9Z -6BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?RH M#Q?X?.I?V<-4A^T>;Y.,'9YG]S?C;N]LYIT_BO0K;5#I<NHQK>ABIA
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M12LGF; K.53^\=H.U?<X%<YXBUQ?%VB3>']#L[Z2YOP(II)[.2%+5"1N9RX
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M /9Z -6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKIJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#(\._\>U[_P!A"X_]&&M>LCP[_P >U[_V$+C_ -&&M>@ HHHH **** "B
MBB@ HHHH *RI/^1MMO\ KPE_]&1UJUE2?\C;;?\ 7A+_ .C(Z -6BBB@ HHH
MH **** ,KPY_R#)O^O\ O/\ TIDK5K*\.?\ (,F_Z_[S_P!*9*U: "BBB@ H
MHHH **** "BBB@ K*LO^1EU3_KC;_P#L]:M95E_R,NJ?]<;?_P!GH U:***
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M %%%% &1X=_X]KW_ +"%Q_Z,-:]9'AW_ (]KW_L(7'_HPUKT %%%% !1110
M4444 %%%% !65)_R-MM_UX2_^C(ZU:RI/^1MMO\ KPE_]&1T :M%%% !1110
M 4444 97AS_D&3?]?]Y_Z4R5JUE>'/\ D&3?]?\ >?\ I3)6K0 4444 %%%%
M !1110 4444 %95E_P C+JG_ %QM_P#V>M6LJR_Y&75/^N-O_P"ST :M%%%
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M@,.]9;[,LDSY(VK&KJ<#')YZ]*3PV[W7C'Q)>BUNH8)5M4C>XMWBWE%<-MW
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MG8W4XU5HY+5HK9Y1<*(@GE94$ @@\''#9H W_"FK3Z[X6T[5;I(TFNH1(ZQ
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MSWKJ: "BBB@ HHHH **** "BBB@ HHHH R/#O_'M>_\ 80N/_1AK7K(\._\
M'M>_]A"X_P#1AK7H **** "BBB@ HHHH **** "LJ3_D;;;_ *\)?_1D=:M9
M4G_(VVW_ %X2_P#HR.@#5HHHH **** "BBB@#*\.?\@R;_K_ +S_ -*9*U:R
MO#G_ "#)O^O^\_\ 2F2M6@ HHHH **** "BBB@ HHHH *RK+_D9=4_ZXV_\
M[/6K659?\C+JG_7&W_\ 9Z -6BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<5K6-E;:;8P65G$(K>W01QH.BJ!@"IZ* "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M,CP[_P >U[_V$+C_ -&&M>LCP[_Q[7O_ &$+C_T8:UZ "BBB@ HHHH ****
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M9 70>XZB@">BHTFB>62))4:2/&]0P)7(R,CM4E !1110 44A.!DTM !1110
M445!=WMI80^=>74-M%G&^:0(N?3)H GHI 01D'(-+0 444F<=: %HHHH **C
MBFBG4M#*DBABI*," 1P1QWI%N;=XGF2>-HT)#.'!"D=<GMB@"6BJMGJ5AJ(8
MV-];W03AO)E5]OUP:+S4]/T[;]NOK:UW_=\Z54S],F@"U138Y$EC62-U=&&5
M93D$>QIU !129I: "BBB@ HHHH R/#O_ ![7O_80N/\ T8:UZR/#O_'M>_\
M80N/_1AK7H **** "BBB@ HHHH **** "LJ3_D;;;_KPE_\ 1D=:M94G_(VV
MW_7A+_Z,CH U:*** "BBB@ HHHH RO#G_(,F_P"O^\_]*9*U:RO#G_(,F_Z_
M[S_TIDK5H **** "BBB@ HHHH **** "LJR_Y&75/^N-O_[/6K659?\ (RZI
M_P!<;?\ ]GH U:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K*;_ )&V/_KP;_T8M:M93?\ (VQ_]>#?^C%H T+BV@O+
M=[>Z@CGAD&'CE0,K#W!X-<1I'AS0I/B!XBMWT73VABM[,QQM:H50D29(&,#.
M!GZ5WE9EGHJ6GB'4M8$Y9M0CAC,97 3RPW.>^=WZ4 </XBN;NZ@U.*T^R6?V
M?Q%:1%DMR3+GR2K-AAD@D?4 #CK4UYK\WAG5/%5W^ZFNWN+"W1G4B/S'A4;B
M!D[1R<#GC%;]]X-2[MM4C34)(9;Z_CODD$8/DR($V\'[P_=C\Z+CP7%>KJ3W
M5_*UQ?O;RB>) C0S0J KKU'49Q[XH I>'?%=S=>(4TF>_M]4BG@:5+FWM)(/
M*=2,HP8D$$'((/8U)XO2_?Q1X6%I>10*UY*,/"7^80N<GYAGC(QZG/M6KIFB
MZE;ZC]OU379K]UB,4<21"")03DL4!.YN!R>G8"G:]H4FKRZ?<6U\UE=:?.9H
MI!$) <J58%3ZAC0!@G7_ !)?Z7J/B'3I+&.QLI)A#9RPLSW"1$AB9-PVDE6P
M-IQQFNF74Q<^'AJUL,"6T^T1A_=-PS6)<>"KAH[ZPL]=FM-)U"1Y)[18%9EW
MG,BI(?NALGC!QDXK=O+5(-!GM+6+"1VK1Q1J,X 7  H Y.S\1>)+?1M%\0:G
M)8O9ZB\"36L,#*T*RX"N'+')R02,=#CMFF_\)9KT%GKNN7/V,Z;I-U<VT=LD
M3>;.4;:A+YPO)4'@]SZ4_P ,>$[Z?P]X?75M4N)+2SB@N%L)+<(R2JH(5VZD
M*>BX'09SBMR+PI9_V-JNE74C3V^J7$\\G&TKYIS@?3L: ,]M4\1:%?:6=<N+
M&ZMM2F^SNMO T;6TI5F7!+'>ORD'.#T/M7/:[J/B#7O ?]MO+9IIUY/ RV8A
M;S(XO/38WF;L%N!D;<8)]*ZFV\*WCW]C<:SKDFIQZ<Q>VB,"Q_/M*AW()WL
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MR.M6LJ3_ )&VV_Z\)?\ T9'0!JT444 %%%% !1110!E>'/\ D&3?]?\ >?\
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M +3MO[/(XN?,&P\XQGUSQCKFN:\3:A)8^+K:,30Z1$;$[=2-D9WD)?F%>R]
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M.^ /:L2WL]8\4ZSKNKV,NG?89PVEQ"\A>0M"F0Y4JR\,[-Z_=%>A 8Z4  #
M&* /+;5S?VGAG0=75)[K1];-E<*XR) D,AC;!Z@KM//7!J^-(TTZMX_S86Y
MAC"CRQA<VVXX],GDXZFO04>*0ML9&*MAMI!P?0^]"/&Y;8RMM.UL'.#Z&@#S
MC2;K3[+6-&OO$<L,=M+X>MDL[B[($0DQF4;FX#D%?<BJEG-!80Z=JS#[-H:^
M)9Y+:1EVQQP/$RJW^RA<MCH.17J;QI(NUT5E]",BE9592K*"IX((XH \I\07
M]IJ]OX[N+*83VSV]@JS)]U\,P)4]QG(R/0UU%]IUE8^/_#D=I:0P))97D3K'
M&%#(HBPIQU R:ZT*H& H Z8Q445Y:3S-%#<PR2Q_>1'!9?J.U '%>![W08?"
M&GV]ZUIY\6H-!Y;Q@M'<F5]@QCAL=#73>*+FVM/#EY->Z>VH6@4">!5W$QD@
M,<>P)/X5H3S6UI&9;B2*%,\O(P49^IJ2.1)8UDC=71AD,IR#^- 'E_A:[@@\
M0&R\.ZI+>Z;-]K:YM_.,T=O&/]4X8Y*ECQ@GGKVKK? <4<O@'0?,C5]MG&5W
M*#@[<9'X$C\:V+2UL$@N(K'RE65V:7RVS\[=2?>J7AK2U\/:1%I+:I]L6WPD
M)=51D4  +QU^IYYH U#9VK*JFVB(10B@H/E4$$ >V0/R%<]%_P E3NO^P)#_
M .CY:Z5G5,;F"Y.!DXR:QK?1Q8^([K7KS5#*UQ"MM''(BHL2!V8*".IRQZ\T
M ;=%,>1(P"[JH/3<<4)+'(2$D5L==IS0 ^BHXIXI@3%*DFTX.U@<&I* "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#(\._\ 'M>_]A"X_P#1AK7K(\._\>U[_P!A"X_]&&M>@ HHHH ****
M"BBB@ HHHH *RI/^1MMO^O"7_P!&1UJUE2?\C;;?]>$O_HR.@#5HHHH ****
M "BBB@#*\.?\@R;_ *_[S_TIDK5K*\.?\@R;_K_O/_2F2M6@ HHHH **** "
MBBB@ HHHH *RK+_D9=4_ZXV__L]:M95E_P C+JG_ %QM_P#V>@#5HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LIO\
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MR9(9X3/$1G(<+N7#C)Y[C&>E ',^&8M)U7P;>-K]@LUCI%[="!+V/<T$*$D
MYY!5>/PQ3O"W@RTNO"][<M!_9<NOA9'2T 0P09RD0^J_>/4EC[5M3>#XW\&7
M'AR&]D0W08SW3KN>1G?=(Q (Y;)'MGVJ_P"(-)N=7T"XTNQU Z:\R!//2/<4
M7N ,CJ..O>@#FM)LM-D\=Q2^%[*&UL-.MY(-0GMD"13R'&R/CAF7!)/;.,UW
M-<[X?T#6-%^SV[ZU:RZ? A1;6'3A#VX^;>>_/3FNBH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,CP[_P >
MU[_V$+C_ -&&M>LCP[_Q[7O_ &$+C_T8:UZ "BBB@ HHHH **** "BBB@ K*
MD_Y&VV_Z\)?_ $9'6K65)_R-MM_UX2_^C(Z -6BBB@ HHHH **** ,KPY_R#
M)O\ K_O/_2F2M6LKPY_R#)O^O^\_]*9*U: "BBB@ HHHH **** "BBB@ K*L
MO^1EU3_KC;_^SUJUE67_ ",NJ?\ 7&W_ /9Z -6BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *RF_P"1MC_Z\&_]&+6K
M64W_ "-L?_7@W_HQ: -6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,CP[_ ,>U[_V$+C_T
M8:UZR/#O_'M>_P#80N/_ $8:UZ "BBB@ HHHH **** "BBB@ K*D_P"1MMO^
MO"7_ -&1UJUE2?\ (VVW_7A+_P"C(Z -6BBB@ HHHH **** ,KPY_P @R;_K
M_O/_ $IDK5K*\.?\@R;_ *_[S_TIDK5H **** "BBB@ HHHH **** "LJR_Y
M&75/^N-O_P"SUJUE67_(RZI_UQM__9Z -6BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *RF_Y&V/_KP;_P!&+6K64W_(
MVQ_]>#?^C%H U:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH R/#O_'M>_\ 80N/_1AK7K(\
M._\ 'M>_]A"X_P#1AK7H **** "BBB@ HHHH **** "LJ3_D;;;_ *\)?_1D
M=:M94G_(VVW_ %X2_P#HR.@#5HHHH **** "BBB@#*\.?\@R;_K_ +S_ -*9
M*U:RO#G_ "#)O^O^\_\ 2F2M6@ HHHH **** "BBB@ HHHH *RK+_D9=4_ZX
MV_\ [/6K659?\C+JG_7&W_\ 9Z -6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *RF_Y&V/_ *\&_P#1BUJUE-_R-L?_
M %X-_P"C%H U:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH *RF_Y&V/_KP;_P!&+6K64W_(VQ_]>#?^C%H U:*** "BBB@
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M6@ HHHH **** "BBB@ HHHH *RK+_D9=4_ZXV_\ [/6K659?\C+JG_7&W_\
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M **** "BBB@#*\.?\@R;_K_O/_2F2M6LKPY_R#)O^O\ O/\ TIDK5H ****
M"BBB@ HHHH **** "LJR_P"1EU3_ *XV_P#[/6K659?\C+JG_7&W_P#9Z -6
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *RF_Y&V/\ Z\&_]&+6K64W_(VQ_P#7@W_HQ: -6BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** ,CP[_P >U[_V$+C_ -&&M>LCP[_Q[7O_ &$+C_T8:UZ "BBB@ HHHH *
M*** "BBB@ K*D_Y&VV_Z\)?_ $9'6K65)_R-MM_UX2_^C(Z -6BBB@ HHHH
M**** ,KPY_R#)O\ K_O/_2F2M6LKPY_R#)O^O^\_]*9*U: "BBB@ HHHH **
M** "BBB@ K*LO^1EU3_KC;_^SUJUE67_ ",NJ?\ 7&W_ /9Z -6BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M U:*RO[?B_Z!^I_^ 4G^%']OQ?\ 0/U/_P  I/\ "@#5K*LO^1EU3_KC;_\
ML]']OQ?] _4__ *3_"J-MJGE:U?73:=J7E3QQ*A^QOG*[L\8]Q0!T=%97]OQ
M?] _4_\ P"D_PH_M^+_H'ZG_ . 4G^% &K165_;\7_0/U/\ \ I/\*/[?B_Z
M!^I_^ 4G^% &K165_;\7_0/U/_P"D_PH_M^+_H'ZG_X!2?X4 :M%97]OQ?\
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M):W$:Q*^Y$!52I/W6"DC/(Z<<5>MM"M[75H+Z)R%MK$6<,..$7<"3GWVJ/\
M@- &F!@ 9)QW/>EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
80 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>ebs20191231exhibit1041001.jpg
<TEXT>
begin 644 ebs20191231exhibit1041001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMJCJ< $T 6**AL[J&^LH+RW8M#<1K)&2,95AD<?0U-0 4444 %%%% !1110
M451M=8LKW4[W3H)&:YL0AG1HV7;OSMY(YSM/2KU !15'5]8LM#L&OM0D:.!2
M%++&SX).!T!QDD#/3FKU !14<TR6\+S2;MB*6;:I8X^@Y-0Z;J-KJ^G0:A92
M&2VN%WQN5*[AZX/- %JBLN_\1:9ILYBN9G!5T21DB9UB+G"[V (7/'7U'K6I
M0 4444 %%%,DD6)&=LD(-Q"J6./H.30 ^BJFEZI::SIL.HV$IEMIP3&Y4KN
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M^WWA;1HS' ,QX<%=IW_)S\O'&* (_".I7U]!J=MJ,ZW,VG:A):>>(PAE4*K
MD#@'#XX]*IZ2+I_B1KX>_G>*&VM"D)";0&\WCIG //7/J36QH^A1:++?R17=
MS/\ ;[DW,HFV8#D $C:HXPHXYZ4T^'X1KT^LPW=U!/<0K#*D;+L?;NVL05)R
M-Q[X]0: .*\,W^JZ3X8\*W$=Y&;.[O?L;VGDC[KM)\V_KN!'L,=NYV(]9\1:
MM;_VEH\3LJ7SQ>1)Y(A>%)"C98G>'PI.>G;!ZF]%X'LX='TW2TU+4!#IER+F
M!BT1;>"2-QV<CYC^=.C\%64&JW%Y;W^H0V]W*9I[!)@+>1SU)&,\]P#@]^.*
M +OB75WT31)+R) \IDBAC!Z!I'5 3DCINSU'3J*H6Z>)Y+Z\MC/)#:26P>UN
M;E(3+%,#@J53ADQ@YX/49Z&MG5M*M-;TJXTR_C\RWN%VNH.#Z@@]B" 1]*R[
M7PF+;3YK5]=U:XDDC\E;J696EB0]54[<#.!DX)X'/ H I^#-;U'7O-:]N527
M3P+:ZMU"'?.,DR @?<(QMQUY].>?\.WVJZ3X6T*[@O(_LL^L/:26IA!W+)=2
M*6+=<@G(Q@?6NR'AFVBUQ-7MKNYM9EM5M6CA\L1R(OW=R[>HSP>W3I5./P/9
MQ:)9Z2FIZ@(+.[%W$^Z(OY@<R#)V<C<2>E %'4M3O[EO&^FW,R/;V>G*UNJQ
M[2H>*0G)[G@?X57L+_7=$3PO)-?0W6G:FL5H;86X4P,8BR,K9RWW><_ACMT0
M\+VAO]6NY;FYE_M>%8+F)B@3:JE1MPH(X8]^]%CX:@M&LC->7-Z-/4K:"?9B
M+Y=N?E49;;QDYX)]30!R6LZKJU_X$UJ6?4&2:TUG[)N@C5 \8G2/:0<\88GK
M^)'%=_(C1Z?(CRM*PC(+L "W'?  _2L4^"[%M%U+2I+R]DAU&Z-U([,@=)2X
M?*D* /F ."#TK<AM_+M5MWEDF^7:TDA&Y_4G&!^0 ]* /.=!O]<T/PCX5U%;
MV&;3IS;6LMEY !59"%#A\Y+ D<=*V5UGQ#JUNVI:-$[+'?/%Y$GDB%XDD*-E
MB=X<A2V>G08/4ZNG^$K2P@LK5KNZN;33W#VEO,4VQD9VG(4%MN3C)/KR0#44
M?@JRAU:YO+>_U""WNY3-<6$<P%O*YZDC&>>X! /?CB@"&*_UG74U.XTF]AMI
M+"_:UB@F0&.01D!_,."W/S8VXQQUJEXD\0ZII0U"[M[V.06=U;JMO#&'01N4
M#"9B,AR7. ISC:<8)K4?P99G6+G4(+Z_MH[U@]W9PRA89VQC+#&1D=<$9J.]
M\"V%Z-2C:_U"*WU*9;B6WBD4(LHV_.N5)S\@X)(]NF  &IZ@WB+Q!IWVHB*T
MLX9[=MB[HV?S,]N1\@ZUE-XMOX= T'4]1>XM[&]L1)=7]K;B00S$*5WK@[4Y
M;D#KCD5O77A2"XU-K]-0OH'EMEMKE8I%Q<(N=I8E201N/*D'FFV7A2/3K.UM
M+35;Y([:V^R@-Y;!T[;@4QD=C[]Z *)UK4+^[BTNRN9))$TR*Z>[LEA;S7<L
M 0)"!L^0G@<[AR,<[NAR:I-HEL^LPQ0ZCL(G6)MR;@2,CZX!Q[XK)N/ NG-_
M9SV%W?:7/IT MHIK24!VB_N-N!##//(ZUOV=I'96B6T)<J@/S.VYF).223U)
M)))]Z //M5U75[_PEJ+7&H,DMKX@6SW01J@>,3(H!!SZYZ_7(XKT-8Y$M_+\
MXO(%P))%')]2!@?EBL$^"K%M(U#37O;UX[^\^V-(60/'+O#Y4A0/O*."#6]%
M"8K80^=([!<>:Y!8GUZ8S^&/:@#BK7Q1K'_"':9JUVL\R/=3I?W%E K/%&KR
M*K*A!XRJYX) S]:ZCP_>KJ.BP7::A'J"2[BES&H4.NXXXP,$# (]0:I:?X3C
MTJRM+6RU6_06DDKHS&,EO,)9E;Y,$9.?7WK2TG2K;1K$6EKNV>8\C,V,L[L6
M8G&!R2>@ H X&WEUVPTCQ3J^E:A!"FGZM=SM;26X83A<,P+9R.!QCOWYXZ&Q
MUJ\\2ZGJ%I8W3:<MC;V[@B-79I)4\P;MP/R@8&!@DYYJV?"%H?MT/VRZ^Q:C
M.T]S9Y39(S8W#.W<%..1G],U/-X<@.L/JMG=W%A<S0B&<P;-LJK]W(92,KDX
M([<4 <G:ZUJ'B.]\'7CW4MD]Q+=I/#"%*>9$CJ6&X'.<'&<X!]>:@EO-6TJT
M\9ZMIM['#]AU-IC$T(?SL1194D]!CTY]ZZZ7PCIQ@TN*VDN;/^RF8V[0.-V&
M4JX8L#G<"<GKGG(J&7P59S:?K%B^HWYBUF4RW/S1Y!( (4[.!A0._2@#4U>_
M:PT"^U&-<M;VLDZJ>Y5"V/TKF?M=[HWP@BU*PN%6\CTU;MI9$W[Y&7>YQGJ6
M8G)]:ZW[&CZ>;*=FN(VB,3F3&7!&#G  Y'H*PK7P\USX/;PIJ$MQ'%##]E\^
M' ,L(X4@D$ [0 1C((/;!(!7\87<MGI>B:O&?W\&H6^2.K+(=CK]"&_,#TK0
M\:ZC>Z1X0U'4=/E2*XMH3(K/'O''M2:EH[ZE)I>GL9'M+"=+F:60 &4H/D7@
M 'YL,2!CY<=ZO:[H\.OZ-<:5<S3107*[)&A*AL>F2"/TH P7US4]'\1M#J-V
MEW:2:5+?>6D(0Q-&5R%/4@AN_<5!)X@U:ST'0_$<ERL\.HR0"YM!&H6-)L8\
ML@;LJ6'4G//2MQO#4,FKVVIS7UU++;VS6NQQ'LD1L;MP"=\#ICI4-EX0L[*"
MUM/M5U-8V4PFMK25E*1,"2O.-Q"DY )...N!@ J>"Q=-?>(GN-0GN=FK21!9
M F,".+!X Z#C'3VSS4FI7NL-XUM]'M;^.WM;C3I9L^0&='5T&<D\_>],>QK3
MT[0H-+U*_O;>XN,7\IFD@9@8UD( +*,9R0HZD^V*2?0HIO$,.M_;+E)X;=K=
M8UV>7M8@G@J3G*COVH Y"/Q#XC3PS%K4NHP.;/4OL<\*VP N5^T>46)S\IP0
M>...^>+WB;Q#JFDC4;N"]1_L5Q $MH8PZ"-B@83,1D.2QP%.<;3CDUH-X(M&
MT.71_P"TK_R);O[6S Q;]_F>9UV8QNYZ4V[\"6-XFI1/J.HI!J4BS30I(@7S
M1M_>#Y<Y.T<9V^W3 !0FO;C3_&_B&]EO;B6WL-*BN!;X3;@>:2H^7(^[G/7W
MQ@5;TZ[\37-WIUTH+V-W 6N3.L(6)BN4:+8VXC/!#$G'>M)O#-HVKMJ37%RS
MRVJVMQ$7!CN$&<%QC.?F/0@<]*KZ+X.M]#*I!JFI36\.?LMO/,'2VR"/E&,G
M ) W9Q0!AV&K>)[CP+=^)'U:W\R&SNF6#[&,%XW;:V<^B$8Z<CJ1SIW6J:C)
M!IX2_$+7&G&8I;QA[B27"X.TJ5$8R<DXY(&15RU\)6UIX6N/#JW]Z]I<+(A=
MC'YBK(26 (3'.X]0>M-/A"U%W9W2:A?QRVUG]B8HZ#SX<Y"O\O'/==I]Z ,*
M35)M;TOP)J=RJK-=7T<D@08&XP2YQ75^(+JXL]'EFMKFWMI R#S;C.U06 .
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M%% !2$@8R>M+7 S3Z)J.N^)=,\47$,$J/']F,SA&2W\M2K1$]#OW$D<YQ[4
M=Z2!C)ZTM>9>,+C3KB#Q&B%5N[/3(B7OWRZ'8SH(5X*MR"6S]['!Q6G;W5C_
M ,)W:7=S/;B&[\/,'E=EVRL)%W9)X) Z^U '<D@#).*"0!DD8'>O,-!AGO\
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MZBMW!/*LC1P;?(A<CD)MX!/!(SW![T 6;S7V77%T/3K9;J^$7GS%Y-D<$><
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MQ( 7F,:X#2-RYQ[DG\,5YKJ=Q8:E\.-<O-3\@ZS#?.)S(1YL3"?"*,\A0F
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M =-M,2G,@\A?G/OQS5RB@#%?2]0GU2.)Y+*/1;=DDAMH82)"Z\@,<[=H;##
MSD#WS=O]+M]1FM9+B.-OLLHE0E 6# @C#=5&0,XZX';(-VB@"*YM;>\B\JZ@
MBGCSG9*@89^AJ)M+T]Y(Y'L+9GB ",85)0#H <<5:HH Q/%^D7>O>&KK2[)X
M4EN-HWS$A5 8,>@.>F/QK2LK&VLXR8+.WM7DP9! @ )^H S^56:* *<6DZ;
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MYH Z]]-L))VN'L;=IG&UI&B4L1C&"<>E1G1-):-(SI=F40DJIMTPI/7 QQG
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MA_\  <?_ !='_"3?&+_H78?_  ''_P 70![!17C_ /PDWQB_Z%V'_P !Q_\
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M  ''_P 70![!17C_ /PDWQB_Z%V'_P !Q_\ %T?\)-\8O^A=A_\  <?_ !=
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M&+_H78?_  ''_P 70![!17C_ /PDWQB_Z%V'_P !Q_\ %T?\)-\8O^A=A_\
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MA_\  <?_ != 'L%%>/\ _"3?&+_H78?_  ''_P 71_PDWQB_Z%V'_P !Q_\
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MIRRP[[%G\R(JJ@\ XS@\''6N;_X2;XQ?]"[#_P" X_\ BZ/^$F^,7_0NP_\
M@./_ (N@#M-7M)/%&CVVC36%S8K<YD$[1G=:!#^[.>TAP#UX&?;.7?RZMJ?@
M.VL;C1KF._MKNW1XXK=@CI'*I\Q!CA2JYQU'3'2N?_X2;XQ?]"[#_P" X_\
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MX JQX+AGMTUD7%M/ 9M6N+B/S8RN^-V!5AGU].M<+_PDWQB_Z%V'_P !Q_\
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M)+(L:#JS' %>6VFH3ZM\1? FH7(_?W.C/))QC+&-R3^)K=^,?_)-=0_WX?\
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MI][IEYI32Z3=6<H(EAE.Z<8Y1MV0<XY]LT =C+-% F^:5(USC+L ,_C1+-%
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M,W/Q5\0Z1-I4;V-I;0O#"7?"%E0DYSGJ37KRJ$4*HP , 4 +1110 5S^D_\
M(Z^(?^N5I_Z"]=!7/Z3_ ,CKXA_ZY6G_ *"] '05%;W,%W L]M,DT39VO&P9
M3@XX(]ZCO[&'4K*2SN?,\F7 <1R,A89!QD$'!Q@^H)%8G@5H;;P7IJ%DB7+H
M@) !/F-@#_"@#H+BXAM('N+F:.&&,;GDD8*JCU)/2JVFZSI>L([Z9J%M>+&<
M.8)0^T]LXZ5C>,?*6YT&2^V_V8FH@W6_[@/EOY9;MM\S9UXSBJOBV:RFBU2+
M25,NO'2)</;Y++%D<$CN3]W//!Q0!O6_B/1+N_-A;:O9378)'DI.K/D=1@'M
MWJY#=VUQ+-%!<12R6[;)41P3&V,X8=C@YYKC_$T^BS> (DT:2W9CY0TE8"-P
MFW#R]@'((/7VSGO5*%)M(US7_$]JKNL&IF+4(5Y,EOY,1W ?WD)+>X+#TH Z
MVX\5>';0QBYUW3H3(F]/,ND7<N2,C)Y&0>?:D;Q9X<2VCN6U_35@D9D24W:;
M688R <X)&1GZBN24I)\'+%UPP9K<@^WVE*V/$BWW_"8^'QIAMEG\B\Q]H5BF
M,19^Z0<T =%8:GI^JP&?3KZWO(@=I>WE610?3(/6GVMY:WT1FM+F*XC#%"\3
MA@&!P1D=P:X"#4KS3[7Q+>S>6OB6XDALQ9P)L02'*P,F22P;>6W''W2,#;3;
M)-0T*/5="M=.N=/-]I3R:<LDB,S7,401L%&/)'EM]0QH [>+Q#HL^I'38=6L
MY+P$@P+.I?(ZC&>H]*K/XR\+Q2-')XCTM'0D,K7D8((['FLRWNO"R>#M(#"&
M6UW6XM8HN9/.RNW:!SO#=>_7/>K5RJ_\+&T[Y1_R"KKM_P!-8* -V2[MH8HY
M9;B)(Y65(V9P S,<* >Y)( ]<U0E\4>'X+QK*;7-.CN5;8T+W2!PWH03G-4O
M&G_(/TW_ +#%C_Z/2J&CW&D16?B1=7EM5M_[4N/-6=EP5PN<@T =C6=;^(=%
MN]0;3[;5K.:[4D&!)U+Y'48![=_2N=MH]6_X4]Y<0F&H?V2PB!SY@^0[1Z[M
MN/QJY]K\*C0=&""&6V,T T^.#EA)D;=H'((ZM[9SWH U;[Q%HNF72VM_JUE:
MSO@B.:=5;GIP33]0UW2-),8U+5+.S,H)C^T3K'O ZXR>>HKG_"\VFPZ9J\>J
MR6R7@O;DZD+@J"07;86S_!Y>S';%9'A1Q!J7A\W;>7$=*O?(\\X(A^T1^4.?
M^F>W\* .X?6])CTT:F^IV:V)P!<F=?*/./O9QUIFG^(-%U>9H--U>RO957>R
M6]PLC!<XR0#TY%<#JSHUUJTND26ZV9UG3/+DQF#[0'7S#P1D?ZO=@]0>]=QH
M\NI//(M_?:5<#;E%LHF1ASR3EVXH UZ*** "BBB@ K \<_\ (EZG_P!<?ZBM
M^L#QS_R)>I_]<?ZB@#?HHHH R6\5>'4O&LFUW3EN5D,;0FZ0.'!P5QG.<\8J
M_<7EK:-"ES<Q0M/((XA(X4R.>BKGJ>.@K@]/TS6M:T?7=,@CTM+&ZU._B,T^
M]Y$!F<$A,8)';YO2F^(+2^UG4[BPTZQN;Y=&LU@MYUEC7RKP[) YW,,E0L?3
M^\U '>7VHV6EVQN=0NX;6 '!DFD"+GTR>]01Z_HTVFOJ4>JV;641Q)<"=?+0
M],%LX!Y'7UKE[36;35O$F@:OJ&R&WGTZ06PE.%CN]ZB1.>C@ @?1L5D^(K]Y
M8M?@>TTR*\,5G)+<6ERTJMBX 02 JN&')]<$<]* .[L/$FA:I<_9M/UFPNYM
MI;RX+E'; ZG -6=0U.PTJW^T:C>06D6=H>:0("?09[UGZ1+JC79%_?Z1/&4.
MU+.)D?=D<Y+MQC/;TJC>/!%\1K5]09%C.G%;%I2 OG>9^\"Y_BV[/?&?>@#9
M77=(;2SJBZG:&P7[USYZ^6.<<MG Y(%)IWB#1M7F:'3=6LKV1%W,EO<+(0.F
M2 >E<)XH*2WGB%]):(P$:<L[*,QFZ^U#KCJ=FS=CVKN],CU:/S?[4EL9,X\O
M[+"T>.N<[F.>WZT 1WGB;0-.NVM+[6]/M;A<;HIKE$89&1D$^E7+C4+*TLOM
MMQ=P0VN ?/DD"I@X .X\<Y&/K7)0KK,GC#Q*FF0:;+&SVXD-X[C!\E>@53D?
MB*HWVE26\&B^#TM)=8ALH&N;Y(F2/<#N6,?.P 7<S$#/\ H [^:>&VA>>>5(
MHHQN>1V"JH]23TJE8^(=%U-)GL=6L[E8%W2F*=6V+ZGG@>]<4-0DN?#VA0ZX
MI2/2]56UU82D$ HC>4TA&1M+&)B>F2*M>)]17^V!$]KILIFLKI+>X@NV,Z1^
M2S'<FT#:2H'4C.* .EMO%GAR]N8[:UU[39YY#M2..Z1F8^@ /-2MXBT1-3&F
M-JUD+TMM^SF==^[TQG.?:L/PI-JW]G:2)]1T9K;[-&/*BA<38V# R9",],\5
MAW$T6G^'K^YM+FPU711=R33Z?=(8KJ.3S2S*K@\N&^Z&7/09H ]*HI <C-+0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7'Z)\-]'L5O)=9@M
M=;O;RY>XDN;FU7(W?P@$G Z]^]=A10!P#?"U5T;4='M]8,5C=:@M[!%]FS]G
MP<E!\W((VCMC'?-69?AI:OXDU[6EOBK:Q926PB\G(@:10K/G=\W0G''4\UVU
M% '"7OPXNY;;PZ-/\0M8W.@P-%'<"T$F\D 9VEL#@=.>M7[7PMXB,%];:MXP
M?4K>[M)+<1FPCBV,PP'RIR<#/'O7644 <3J?PTL]5\"6/AJ>\/FV 'D7HAY4
MYY^7/0CC&?0]J35?A[=WB^'I+#Q VGW6@VOD1SBT$F_Y57=@M@<#ISUKMZ*
M.4T#P0^FZZ^O:QK,^LZIY7DQS2QK&L2=PJCIW_,^M8<_P>M;KP[IND3:J6^P
MW<D_G?9\;U<@LF-W'0<Y/3I7H]% '(R^ UD?Q2PU':/$4<:8$'_'OM5E_O?-
M][VZ51LO _B[3K&"RM/B#)%;V\:QQ)_941VJ!@#);/2N\HH YZU\)Q0>*=:U
MJ:X$\>KPQPO:M%PJJH4Y.?FS]!53P1X#@\$2:G]FO6N(;Z572-H]IB5=V%SD
M[OO=>.E=910!@>'O"XT'5M;OQ>>?_:UU]HV>7M\KKQG)SUZ\5>U_0[+Q)HMQ
MI.H(6@N%P2IPRD'(8'U!%:-% 'GK?#35[ZUBTK6/&=W?:+$5_P!$%NL;N%Z*
MTF22.!U_2M^7PA$WC/3O$,-R(8]/LS:):+%P5^;!W9XQNZ8[5T=% !7'ZUX(
MO;CQ')XA\/Z_)HU_<1"*Y_T=9DF P 2K'@X ]>G:NPHH X[3?AQI\&@ZKIVJ
M7<VI3ZQ)YEY=, C,XY4J.=N#R.OY<5G-\--7O+.+2-4\:7EWHD17_1!;*CNH
MZ*TF22!@=?TKT*B@#C?$'@.XU'6M,U71M;_L:73+8V\ 2T64!>1QE@.AQTJ*
M_P# NMZSX;U#1M9\7/?"[,1BE-@B>3L;<>%8;L\=^,5V]% '):]X'?4=1M-8
MTG5Y=(U>UA$'VF.(2+*GHR$X/^>N!B/2? 'V*WUF:_U>74=6UF!H)KZ2(+L4
MK@!4!X XXSV'2NQHH YVS\)BT\ MX4^V[PUG);?:?*Q]\,-VW/;=TS4,W@Z9
MOAZOA*#53"1 (&N_(R2N?F^7=QD<=>]=110!R%[\,?#-SX<?2HM-M+>8VXB2
M]6W7S58 8<GJ3D9///-6-6\'S:QX 'A:YU4F3RHHVO/(R6V,I!*[NI"@=?>N
MGHH YSQ5X2'B;PD- -Z;8#R_WWE;_N8_AR.N/6J_B/P.=6U.UUG2]6FTC5[6
M/RA=11AUD3T9"<'_ #UXQU=% ')^'O!$FFZY)X@UK6)=9U9H_*29XA$D2>BH
M.!_]<^IJK%\-+/\ X5Y_PB-U>&<(S217?D[3&Y8L&"Y/3..O(STS7;44 <GX
M?\#G1+G1WDU#[5'I-E+;Q+Y.S+R/N9^IQ\HVX_6LS5/A7#JFEZQ9R:J5;4M4
M.HI)]GSY!.?EQN^;AB,\?2N_HH Y;3O UMI_B'^TA<"2W_LE-,^RM%QL7;R6
MSW"XQCOUK'3X:ZOI]O-IFB^,[NPT:8MFT-NLC1ANH60D$?AC\:]!HH XG5?A
MK;7/AC2M#TG4&TU=+N1<QS&$2LSC/)&0,Y.?TQ4FG^ [HZ[::QXB\17&MSV.
M3:HT"PQQL?XMJYR>GY#TKLJ* .(NOAN+G3/$UE_:I7_A(+I;@O\ 9\^1A]V,
M;OF],\5V%G;_ &2Q@MMV_P F-8]V,9P,9J>B@#B[7X:V*^%M3T"^NWNHK^]>
M\65(_+:%CMQCD\C;U[YZ5!!\.]2NM1L)O$?BJXUBTTZ026]LUNL0+#H78$EL
M>_/OR:[NB@#D;#X=Z6NK:KJFM1VVLW.HS^8#<6JX@4<!%!)Z#C/? ]*L^&_!
MT7A?6=5NK"Z"V&HLKK8K#M6!@.2IST.3Q@=O2NEHH Y_PQX6'ANZUB<7GVC^
MU+U[O'E[/+W$G;U.>O7BLZQ^'-C%X?UG1;^Z:[@U6\>Z++'Y;1%L8QR>05SG
M]*[&B@#SYOAKJ]]:Q:7K/C.[OM&B93]D%LL;N%Z*TF22.!U_2NA7PI%'XSM_
M$,5P(X[?318):"+@*'+ [L^^,8_&N@HH Y#PS\/;/PMXIU+6+&Z/D7R%5M/*
MP(<L&.&SR,@X&!@5I>+/"EIXLTV.VN)I;:>WD$UM<PG#PN.A'^%;M% '#0?#
M[4;W4[*Z\4>*)M:AL'$EO;?9EA3>.C-@G=^/YXR*VM.\+BP\9ZOXC^V>8=3C
MB3R/+QY>Q0N=V><X]!6_10 5QFI^ [X:[=ZQX:\13:)-?X^UQBW6:.4C^( D
M8/7GW/3-=G10!R%E\-](M_"%UX>NI9KL7LAFN;ISB1Y>#O'7&,#U]\Y-9K_#
M75K^WATS6O&5W?Z-"RD6@MUC:0+T#2 DD<=_TKT&B@#GV\*1CQG9^(8KD1):
M6!LTM5BXQDD'=GC&<8QVJAX>^'MGX:\8ZCKUC=8AOHV06?E8$1+*Q(;/3*GC
M'&?:NOHH P+3PN+7QQ?>)OMFXWEJEO\ 9_+QLV[>=V>?N],4ECX56S\::KXC
M-WYG]I0QQ&W,6 FU5&=V><[?0=:Z"B@#@)/AA+#IVM:3IFO-9:7JT@D%M]EW
M_9^06"G>.#C'3IC\=#5?ACX9U#P_+I=MIMI93-&J1WD=NIE0C&&SP3TYYYR:
MZ^B@#CM4\!W%]_9E_:Z[+9:[IUN(/[1CA!$Z@?QQDX/<]>YZU8\+^#'T/5+S
M6M2U675M7O%"27+QB,*@Q\JJ.@X'Y#I74T4 <_8>%A8^-=5\2_;-YU&&./[/
MY>/+V*HSNSSG;Z#K70444 %%%% !7/Z3_P CKXA_ZY6G_H+UT%<_I)/_  FO
MB 9_Y96G_H+T =!4 L;011Q"UA$<+AXT\L81NN0.QY/-3T4 ,FABN(7AFC26
M-QAD=058>A!ZU7L-+T[2XVCTZPMK-'.66WA6,$^I  JW10!2AT72K:^:^@TR
MSBNWSNG2!5D;/7+ 9-64@AB,ACB1/-;=)M4#>V ,GU. !^%244 5Q8V:VBV8
MM(!;+C;"(QL&#D87IP>:D:"%YDF:)&EC!".5!90>N#VS@?E4E% %>33[*:Z6
MZELX'N$QME:,%UQG&#C(QD_F:DDMX998Y9(4>2$DQNR@E"1@D'MP<5)10!2C
MT72H;]M0BTRSCO&SNN%@42'/7+8S5DP0F=9S$AF52BR%1N"G!(!]#@?D*DHH
M CE@AG55FB20*P=0Z@X8'((SW!Y!JH^@Z/)=F[?2;%K@MN,QMT+EO7=C.:OT
M4 %4H-%TJUO7OK?3+.&Z?.Z>.!5D;/7+ 9-7:* *5WHNE7]PES>Z99W,\?W)
M9H%=E^A(R*=>Z3INI%#?Z?:W9C!"&>%7VYZXR.*MT4 57TO3Y+$6,EA;/:#&
M(&A4QCO]W&*99Z+I6G3&:QTRSM92NTO! J,1Z9 Z<"KM% !1110 4444 %8'
MCG_D2]3_ .N/]16_6#XX./!FID?\\?ZB@#>HHHH CB@A@5EAB2,,Q=@B@98G
M))QW)Y)HB@A@W^3$D?F.7?8H&YCU)]3[U)10!5DTO3YK5[26QMI+>1B[PM"I
M1F)R21C!)/-,CT;2H;%K"+3+..T?[UNL"B-OJN,5=HH H6FA:/83B>STJRMI
M@"!)#;HC 'W J>\L;/4;<V]]:074).3'/&'4_@>*3469--NF5BK+"Y!!P0<&
MJGAB62?PII$TTC2226,+.[G)8E 22>YH MQZ;80V:V45E;I:J05@6)0@(.1A
M<8Z@'ZU9HHH C2"&.625(D624@R.J@%\# R>_'%"P0I,\ZQ(LL@ =PH#,!G
M)[XR?SJ2B@"'[);9F/V>+-Q_KCL'[SC'S>O''-5[30](T]95LM+LK99@1((;
M=$#CT.!S5ZB@#-A\.:%;S)-!HNGQ2QD,CI:HK*1T(('!J1]$TF34!J#Z79M>
M Y%P;=#(#_O8S5ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "N?TG_D=?$/_ %RM/_07KH*Y_2?^1U\0_P#7*T_]!>@#H***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *P/'/\ R)>I_P#7'^HK?K \<_\ (EZG_P!<?ZB@#?HHHH *R[ W4>MWMM/>
MR7*"WAE0.BJ$+-*"!M X^4=<GWK4K*@M-4369;V22T,4L<<3*JMN"H7((/K\
M_P"E &K1110!5U/_ )!5W_UP?_T$U2\)_P#(G:+_ -@^#_T6M7=3_P"05=_]
M<'_]!-4O"?\ R)VB_P#8/@_]%K0!KT444 %%%% &%JRWEHKW:ZE*;IY-MI:H
M%V.>R$8R<X)9L\#)& *W:PQIVL)J%Q>B:REE<LL+RH_[F//"@ _0D]2?8 #<
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AN[NWL+62
MZNYDA@B&YY'. H]34U% '/\ _">^$_\ H8+#_O\ "C_A/?"?_0P6'_?X5T%%
M '/_ /">^$_^A@L/^_PH_P"$]\)_]#!8?]_A7044 <__ ,)[X3_Z&"P_[_"C
M_A/?"?\ T,%A_P!_A7044 <__P )[X3_ .A@L/\ O\*/^$]\)_\ 0P6'_?X5
MT%% '/\ _">^$_\ H8+#_O\ "C_A/?"?_0P6'_?X5T%% '/_ /">^$_^A@L/
M^_PH_P"$]\)_]#!8?]_A7044 <__ ,)[X3_Z&"P_[_"C_A/?"?\ T,%A_P!_
MA7044 <__P )[X3_ .A@L/\ O\*/^$]\)_\ 0P6'_?X5T%% '/\ _">^$_\
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M_P"A@L/^_P *Z"B@#G_^$]\)_P#0P6'_ '^%'_">^$_^A@L/^_PKH** .?\
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M&N644T-E#'(C2C*L$ (/XUV5% '/_P#">^$_^A@L/^_PH_X3WPG_ -#!8?\
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M[I(Y%35!':1174]RID\R<*'#2,5^48&%)P.O;K4] '/^./\ D6'_ .ONT_\
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M4 <)+I<=]XO\0E_"\6KB.YA59'N%3RQ]FB^4 _G^-$FD0W7C#78_^$9AU6.
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MY62'4[B--S,68A5< 9))XH S;33=-\0ZOKEQKT<=R;.\%M!#.?D@C$:$$*>
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M10 4444 %%%% !1110 4444 <_XX_P"18?\ Z^[3_P!*8ZZ"N?\ ''_(L/\
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M!- %+PG_ ,B=HO\ V#X/_1:UKUD>$_\ D3M%_P"P?!_Z+6M>@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *AN[N"QM9+JY<I#$-SL%+8'T'-344
M <__ ,)UX<_Y_P!__ :7_P")H_X3KPY_S_O_ . TO_Q-=!4?GP^=Y'FIYH&[
MR]PW8]<4 8?_  G7AS_G_?\ \!I?_B:/^$Z\.?\ /^__ (#2_P#Q-=!4+W=M
M% ;B2XB2$'!D9P%'..O3K0!B_P#"=>'/^?\ ?_P&E_\ B:/^$Z\.?\_[_P#@
M-+_\36XL\+0>>LJ&'&[S PVX]<TR*]M9K<W$5S#)"N<R+("HQUYZ4 8W_"=>
M'/\ G_?_ ,!I?_B:/^$Z\.?\_P"__@-+_P#$UO-(B;=[JNX[5R<9/H*K_P!J
M:>&V&_MMV<8\Y<Y_.@#)_P"$Z\.?\_[_ /@-+_\ $T?\)UX<_P"?]_\ P&E_
M^)K8:_LTF\A[N!9<X\LR -GZ5.2%4LQ  &23VH P/^$Z\.?\_P"__@-+_P#$
MT?\ "=>'/^?]_P#P&E_^)K9@O;2Y8K;W4,I R1'(&Q^5/6:)H?.65#%C=O##
M;CUS0!A_\)UX<_Y_W_\  :7_ .)H_P"$Z\.?\_[_ /@-+_\ $UOJRNH92&4C
M((.012T <_\ \)UX<_Y_W_\  :7_ .)H_P"$Z\.?\_[_ /@-+_\ $UT%% '/
M_P#"=>'/^?\ ?_P&E_\ B:/^$Z\.?\_[_P#@-+_\37044 <__P )UX<_Y_W_
M / :7_XFC_A.O#G_ #_O_P" TO\ \37044 <_P#\)UX<_P"?]_\ P&E_^)H_
MX3KPY_S_ +_^ TO_ ,37044 <_\ \)UX<_Y_W_\  :7_ .)H_P"$Z\.?\_[_
M /@-+_\ $UT%% '/_P#"=>'/^?\ ?_P&E_\ B:/^$Z\.?\_[_P#@-+_\36W/
M<06L1EN)HX8QU>1@H'XFG++&\0E616C(W!P<C'KF@#"_X3KPY_S_ +_^ TO_
M ,31_P )UX<_Y_W_ / :7_XFMJWO+6[C,EM<Q3(IP6C<, ?J*2&^M+E]D%U#
M*P&=J2!C^E &-_PG7AS_ )_W_P# :7_XFC_A.O#G_/\ O_X#2_\ Q-:\FHV,
M,ACEO;>-UZJTJ@C\,U.K*Z!T8,K#((.010!@_P#"=>'/^?\ ?_P&E_\ B:/^
M$Z\.?\_[_P#@-+_\37044 <-XL\7:'?: UO;WI:0W-LP#02*,+/&QY*@= :V
M?^$Z\.?\_P"__@-+_P#$T>./^18?_K[M/_2F.N@H Y__ (3KPY_S_O\ ^ TO
M_P 31_PG7AS_ )_W_P# :7_XFMTR1B01EU#L"0N>2!WQ4<]Y:VI07-S#"7.$
M$CA=Q]L]: ,;_A.O#G_/^_\ X#2__$T?\)UX<_Y_W_\  :7_ .)K9GO+6V(6
MXN882PR!)(%S^=+)>6L42S27,21O]UV< 'Z&@#%_X3KPY_S_ +_^ TO_ ,31
M_P )UX<_Y_W_ / :7_XFMR&X@N4WP31RKG&Y&##]*CDU"RAC226\@C20X1FD
M #'V.>: ,?\ X3KPY_S_ +_^ TO_ ,31_P )UX<_Y_W_ / :7_XFMTR1AU0N
MH9P2JYY('7'YT&:(%P9$'EC+Y8?*/4^E &%_PG7AS_G_ '_\!I?_ (FC_A.O
M#G_/^_\ X#2__$UMV]U;W<?F6T\4Z9QNC<,,_45+0!S_ /PG7AS_ )_W_P#
M:7_XFC_A.O#G_/\ O_X#2_\ Q-=!10!S_P#PG7AS_G_?_P !I?\ XFC_ (3K
MPY_S_O\ ^ TO_P 37044 <__ ,)UX<_Y_P!__ :7_P")H_X3KPY_S_O_ . T
MO_Q-=!10!S__  G7AS_G_?\ \!I?_B:/^$Z\.?\ /^__ (#2_P#Q-=!10!S_
M /PG7AS_ )_W_P# :7_XFC_A.O#G_/\ O_X#2_\ Q-=!10!S_P#PG7AS_G_?
M_P !I?\ XFC_ (3KPY_S_O\ ^ TO_P 37044 </XL\7:%?\ AB]M;:]+2R(
MH:"10?F!ZE0!6Q_PG7AS_G_?_P !I?\ XFE\<?\ (FZC_N+_ .A"M^@#G_\
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M_P#X#2__ !-;+WEK'<K;/<PK._W8F<!F^@ZTV74;&&0QRWMO&Z]5:501^&:
M,C_A.O#G_/\ O_X#2_\ Q-'_  G7AS_G_?\ \!I?_B:UFU.P0*6OK9=PRN95
M&1ZCFG-J%DD22M>0+')G8QE4!L=<'/- &/\ \)UX<_Y_W_\  :7_ .)H_P"$
MZ\.?\_[_ /@-+_\ $UM?:[;[.;C[1%Y(ZR;QM_/I3(]0LIB1%>02%06(653@
M#OUZ4 9'_"=>'/\ G_?_ ,!I?_B:/^$Z\.?\_P"__@-+_P#$ULP7MK<L5M[F
M&8@9(CD#8_*G3W$%L@>XFCB4G :1@HSZ<T 8G_"=>'/^?]__  &E_P#B:/\
MA.O#G_/^_P#X#2__ !-;2W5N\:2+<1,CMM5@X(8^@/<T]I$1U1G56<X4$\MW
MX]: ,+_A.O#G_/\ O_X#2_\ Q-'_  G7AS_G_?\ \!I?_B:WI)$BC:21U1%&
M69C@ ?6G4 <__P )UX<_Y_W_ / :7_XFC_A.O#G_ #_O_P" TO\ \37044 <
M_P#\)UX<_P"?]_\ P&E_^)H_X3KPY_S_ +_^ TO_ ,37044 <_\ \)UX<_Y_
MW_\  :7_ .)H_P"$Z\.?\_[_ /@-+_\ $UT%% '/_P#"=>'/^?\ ?_P&E_\
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M7_XFMWSHOW?[U/WGW/F'S<9X]>*7S$\SR]Z[\;MN><>N* ,'_A.O#G_/^_\
MX#2__$T?\)UX<_Y_W_\  :7_ .)K:M[RUNRXMKF&8H<-Y;AMI]\=*FH Y_\
MX3KPY_S_ +_^ TO_ ,31_P )UX<_Y_W_ / :7_XFN@HH Y__ (3KPY_S_O\
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MW=QID3SS-ND?+ L< 9.#Z 5JV]O%:6T=O @2*)0B*.P' % $M%%% '/^./\
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M9!X)YXKKJSM,T#2M&:1]/LHX'E #N,LS = 6.3CVK1H **** "BBB@ HHHH
M**** "BBB@ HHHH P/''_(FZC_N+_P"A"M^L#QQ_R)NH_P"XO_H0K?H X^^T
M+2=5\;P6R:79*+%!?WDRVZ!Y968B)2V,]5=SZX6NPJ&.TMX;J:ZCB59IPHE<
M=7"YVY^F31;VEO:>;]GB$?G2&63'\3GJ: /-]3U:0Z]=>*H[*]DCTV[6".:.
M+,1M8]R3G.?[SR-T_P"6:UOV.EZ5JWB_Q$][86EZN+7:TT2R?*8NQ(Z5TL.F
MV5OIW]G16R+:;"GDX^7:>H_')K.F\&>'+AP\VDP2,(UC^;)RJC"@C/( &.:
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M##N/$5^L\ES#';?88M1CL/+8,9I69U1F4@X&UF/&#D*3D5AV^J:]<7<=PM_
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M$*IJ%W;0^4J_=624JJGGL"X//XUF0R7.GI+;F:Y6ZM]4LHF5KY[E&#LNXAG
M8$H[%EZ# ( S78R6-I+8&PDMXWM3'Y?E$97;C&,52A\/6=O=6SPHL<%LS2I"
M!]Z9AM,C,3EB%) SZGKQ@ U:Y[QU+)%X4N"LC11-+"EQ(AP4A:51(<]OD+<^
MF:Z&F21QS1/%*BR1NI5D89# ]01W% &#<Z7X>TJ]TV:VMK>SO<O%9+;IL\WY
M"2AVCE<#// (!K%T?2M!O?AP-0U*&!YI;5I[V\D4>:L^"78OU#*V0/3 %=-I
MWAG1=)N?M-CIT,,P78K@$E%]%S]T>PQ39O"F@W%\U[+I5N\[N)')7Y7<?Q%>
MA/N1F@#F/#EG'K6N++KUC!=71T"P:07,*N0Y,N[@C@GO66]NTK66GV-K:W=I
M!XDN(K*"[8^1Y8MG)7.&^57+@<'& *[W4?#&BZM=_:[_ $^*>?8(][9R5!)
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M^KW(C528IY4*/\PX(" _K7<5@>./^1-U'_<7_P!"%;] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 53U;3(=9TJXTZX>1(KA=K-&0& ]L@U<HH
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M^EI=ZE>S%KN1)9+:,[Y$*2,H*H.2-J]!V-:4^G7"W<ES87@MGGQYR/%YB.0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"3N.#U!QB@#K**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#UXVF@"W!IZ0ZC/?>?,\DZ*A5R-JJI)   _VF_.H&T2)Y5,EW=R6ZR"46SR
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M  XJW<Z2DUR]Q#=W-G)* )3 R@2 <#(8'!QQN&#C'/ JM8:U<W&KS:?=V44
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,D";<G>ISR21D=<&F^'(+VSTJ=;R*Z,IN9Y528Q%V5G+#&P[><]^^>V*V:*
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M>.&.>1W@*[54!L8<GMQQ7144 <H^E:I=Z9?W;&_M[R:X,Z68-L5+J1Y1SSP
MB9^<?=/K5R6TN=2U-OM6G7$$-Q9(AE\R,F"0,S#HQ.0<$$ C.*WZ* ,C18]0
MM--N'O[;==&>1RD++^\YX*Y.!G&0"1C/-&CO>6^DS";3+B.:.25TB9XB9-SL
MP (<@<$=2*UZ* .332M5MM)LKL&_FO8K@7#V6;<*'8GS>>."&<#YSC</2M*]
MUB\3Q+IND6=LCB>*2>[>0_ZB-< 8QU+,<?@:VJ3:-V[ R1C- "U4U2T:_P!+
MN;6-PCRQE49AD!NQ/MFK=% &#<OJ5]/;>79ZA9RI+'YI$T?D[ P+]&RV1D#C
M/(R!VJ/I.H:A:ZG<3MJ%G-<2DI;)]F;(7 C*DYQ]T-]X8)./6NIHH KV,MQ/
M8PRW5L;:=D!DA+!MC=QD$@_G3[B26*!I(8&G=>D:L%+>N">,_7%2T4 8NGVS
MMK3WL6FMIT+0L)@^P&XD+*0Q"$CY0&&3R=WI5<6FH?94TC[&X1+P2?:BR^7Y
M0E\P<9W;L +C'7GI7144 9NJ/YBM:SZ+)J-LZYPHB92?0J[#\^GTJ"/1I[G1
M+2SN[N>"2&02YB97(P240EU.X+\O..2H-;-% &+X>MKVV;4FO%NLS77F1FX,
M.YEV(N?W? Y4]?:ETV6].K7CS:3=6\5PRE9)'A(7" <A7)ZCL*V:* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,#QQ_R)NH_[B_^A"M^
ML#QQ_P B;J/^XO\ Z$*WZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH_X3OPS_ -!5/^_;_P"% '045S__  G?AG_H*I_W[?\ PH_X3OPS_P!!5/\
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MW_PH_P"$[\,_]!5/^_;_ .% '045#:7<%]:QW5M()(95W(P!&1^-34 %%%%
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M9],+#RX\%@)%3JN>AQP=O3-<OI]E:Z+\.=0UO3K9+?44>[B%THRT:?:73/\
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M[E58A<@#.,#<,D"L23Q3JJ7\LXLX9+=+>T1+:.X#%YYWQPX7! 7G.<8(/?@
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M9[.*.>.2(R%');_5Y=%YRN#@8(84 =A1110 4444 %<_I/\ R.OB'_KE:?\
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M?=:MSQ;?30>'WBL0TEW?D6UL(B-Q9^I4D@9"[FY./EH V]R[0VX8/0YI2P!
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M.6))Y))QD\#MT%3444 %9-QX7T:[T&#0Y[,26%N$$49=LIL^[ALYR/7-:U%
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MCM$=(C!<21L%<Y92P;)!.#R>H!JR-&MXHXHK5Y;:*-XF$<<K!0L8^5%&<*O
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M=7DTJM;LN"J[RV""$( P/EK2LM+GMO$NJZD[QF&]BMTC4$[@8]^<\8_B&.:
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M0_\ 7*T_]!>N@KG])_Y'7Q#_ -<K3_T%Z .@HHHH *Y_QC_QXZ;_ -A>R_\
M1Z5T%<_XQ_X\=-_["]E_Z/2@#H**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9NO
M%%Q!XN33Q#$=,62.UGG.=ZW,BLZ+UQC 0'CK(M=+7&-\/TNM"NEO+F4:Q=.]
MRT\5W,(5G+;D8)D*0I" 97HHH GU3QNVGS:Q$-.G<Z=)!&I$3D/O(!)('^UQ
MZ_C5^X\9:1;7,MO*;I3;O&EP_P!ED*0%U5EWMC"Y#CZ=ZS;WPYK=XFJ[FL ^
MH1VT@/F/A9XMN5QM^X=I^;K[58N_#E_>:;X@B9K:.?5Y(Y$ =BJ8AB0@G;G[
MR-CCH1TZ4 =%!=)<23QHDBF"38Q>,J"< Y4G[PYZCC.1VK*\3:EJ.GQZ=%IA
MMEGOKY;;?<QM(J@H[9PK*<_*.]:L!NC)/]H6(()/W)C8DE,#[V1P<YZ9XQ65
MXFTS4-1CTZ33!;&>QOEN=MS(R*P".N,JK'/S#M0!0FU[6=(FNK+55LII_P"S
MYKRTGMT=$<QXW(R%B01N4\-R">E-UCQ7J%EI&ESV-K#<7=S;F\N(B#A8$0-(
M5 .<Y957.>3WI\V@:OJTUW>ZK)91W!T^:SM(+=G:./S,;G9R 23M4<#@ ]<T
MRS\%^==FXUF5W\FS@L[9;2[FBVHJ_/G85SN<GKGA5H =XB\7R:->:--;P)=:
M9>1RSW4J@EXX5"8D7GH-^3P> :OQ^(%75M7CG>);'3[."Z$R]2KB0L2<X(P@
MQCWK.TCPI>:?<Z;'-+;RV6FK=P0J69F,$A3RU.1C*A2IYZ =:ST\ 7T)U.P2
M]B?2;Z2UB5&=A)':QL[/%D#_ &M@Y^[].0#;\)Z]?:Q#<1:K;1VM]#Y<OE1Y
MQY4BAD/)/(^93[H:Z&N<M_"RZ7XDM=4TN601F%X+U+FZEF9T^\A4N6P58'C(
M&&-='0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/Z4/^*T\0'(YBM/\
MT%ZZ"N?TG_D=?$/_ %RM/_07H Z"BBB@ KF_'$C0Z192K$\QCU.T<1QXW/B9
M3M&2!D]!DBNDKG_&/_'CIO\ V%[+_P!'I0 ?\)1=_P#0IZ[_ -\0?_':/^$H
MN_\ H4]=_P"^(/\ X[705DCQ/HK17,HOT\NUB>61MK8V+PS*<?, >"5S0!5_
MX2B[_P"A3UW_ +X@_P#CM'_"47?_ $*>N_\ ?$'_ ,=K0T_7=-U2=X+6X)F1
M=[121/&^W.,[6 )&>]2ZCJ=II-J+F]E,<9=4!",Y+$X  4$DDT 97_"47?\
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M$HN_^A3UW_OB#_X[7044 0VD[75K'.]O+;LZY,4P =/8X)&?H:FHHH ****
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M2]!1+*"<+>(LA=W+A@"77(&T=/6M#4]'U^X-]:13Z;>Z?>,65=0C9FM\C!4
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MN+"2W%SQ\MS%$ZOM/N&7(/N1WIFJ>'->U*PN]&GNM.N["Y9]ES=1LUQ K$G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8-+_ /!4_P#\>H^P>+_^A@TO_P %3_\ QZ@#H**Y_P"P>+_^A@TO_P %3_\
MQZC[!XO_ .A@TO\ \%3_ /QZ@#H**Y_[!XO_ .A@TO\ \%3_ /QZC[!XO_Z&
M#2__  5/_P#'J .@HKG_ +!XO_Z&#2__  5/_P#'J/L'B_\ Z&#2_P#P5/\
M_'J .@HKG_L'B_\ Z&#2_P#P5/\ _'J/L'B__H8-+_\ !4__ ,>H Z"BN?\
ML'B__H8-+_\ !4__ ,>H^P>+_P#H8-+_ /!4_P#\>H Z"BN?^P>+_P#H8-+_
M /!4_P#\>H^P>+_^A@TO_P %3_\ QZ@#H**Y_P"P>+_^A@TO_P %3_\ QZC[
M!XO_ .A@TO\ \%3_ /QZ@#H**Y_[!XO_ .A@TO\ \%3_ /QZC[!XO_Z&#2__
M  5/_P#'J .@HKG_ +!XO_Z&#2__  5/_P#'J/L'B_\ Z&#2_P#P5/\ _'J
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *Y_2?\ D=?$/_7*T_\ 07KH*Y_2?^1U\0_]<K3_ -!>@#H****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#G_^$%\-?] W_P CR?\ Q5'_  @OAK_H&_\ D>3_ .*KH** .?\ ^$%\-?\
M0-_\CR?_ !5'_""^&O\ H&_^1Y/_ (JN@HH Y_\ X07PU_T#?_(\G_Q5'_""
M^&O^@;_Y'D_^*KH** .?_P"$%\-?] W_ ,CR?_%4?\(+X:_Z!O\ Y'D_^*KH
M** .?_X07PU_T#?_ "/)_P#%4?\ ""^&O^@;_P"1Y/\ XJN@HH AM+6"QM8[
M6V39#$NU%R3@?4\U-110 4444 %%%% !1110 4444 %%%% !1110 445#=M<
MI:R-:11S3@?)'+(45C[L <?D: )J*P/MOB[_ * 6D_\ @UD_^,4?;?%W_0"T
MG_P:R?\ QB@#?HK ^V^+O^@%I/\ X-9/_C%'VWQ=_P! +2?_  :R?_&* -^B
ML#[;XN_Z 6D_^#63_P",4?;?%W_0"TG_ ,&LG_QB@#?HK ^V^+O^@%I/_@UD
M_P#C%'VWQ=_T M)_\&LG_P 8H WZ*P/MOB[_ * 6D_\ @UD_^,4?;?%W_0"T
MG_P:R?\ QB@#?HK ^V^+O^@%I/\ X-9/_C%'VWQ=_P! +2?_  :R?_&* -^B
ML#[;XN_Z 6D_^#63_P",4?;?%W_0"TG_ ,&LG_QB@#?HK ^V^+O^@%I/_@UD
M_P#C%'VWQ=_T M)_\&LG_P 8H WZ*P/MOB[_ * 6D_\ @UD_^,4?;?%W_0"T
MG_P:R?\ QB@#?HK ^V^+O^@%I/\ X-9/_C%'VWQ=_P! +2?_  :R?_&* -^B
ML#[;XN_Z 6D_^#63_P",4?;?%W_0"TG_ ,&LG_QB@#?HK ^V^+O^@%I/_@UD
M_P#C%'VWQ=_T M)_\&LG_P 8H WZ*P/MOB[_ * 6D_\ @UD_^,4?;?%W_0"T
MG_P:R?\ QB@#?HK ^V^+O^@%I/\ X-9/_C%'VWQ=_P! +2?_  :R?_&* -^B
ML#[;XN_Z 6D_^#63_P",4?;?%W_0"TG_ ,&LG_QB@#?HK ^V^+O^@%I/_@UD
M_P#C%'VWQ=_T M)_\&LG_P 8H WZ*Y;4M?\ $VDV9N[K0M-\H21QG9J;DY=U
M0<>2.["K7VWQ=_T M)_\&LG_ ,8H WZ*P/MOB[_H!:3_ .#63_XQ1]M\7?\
M0"TG_P &LG_QB@#?HK ^V^+O^@%I/_@UD_\ C%'VWQ=_T M)_P#!K)_\8H W
MZ*P/MOB[_H!:3_X-9/\ XQ1]M\7?] +2?_!K)_\ &* -^BL#[;XN_P"@%I/_
M (-9/_C%'VWQ=_T M)_\&LG_ ,8H WZ*P/MOB[_H!:3_ .#63_XQ1]M\7?\
M0"TG_P &LG_QB@#?HK ^V^+O^@%I/_@UD_\ C%'VWQ=_T M)_P#!K)_\8H W
MZ*P/MOB[_H!:3_X-9/\ XQ1]M\7?] +2?_!K)_\ &* -^BL#[;XN_P"@%I/_
M (-9/_C%'VWQ=_T M)_\&LG_ ,8H WZ*P/MOB[_H!:3_ .#63_XQ1]M\7?\
M0"TG_P &LG_QB@#?HK ^V^+O^@%I/_@UD_\ C%'VWQ=_T M)_P#!K)_\8H W
MZ*P/MOB[_H!:3_X-9/\ XQ1]M\7?] +2?_!K)_\ &* -^BL#[;XN_P"@%I/_
M (-9/_C%'VWQ=_T M)_\&LG_ ,8H WZ*P/MOB[_H!:3_ .#63_XQ1]M\7?\
M0"TG_P &LG_QB@#?HK ^V^+O^@%I/_@UD_\ C%'VWQ=_T M)_P#!K)_\8H W
MZ*P/MOB[_H!:3_X-9/\ XQ1]M\7?] +2?_!K)_\ &* -^BL#[;XN_P"@%I/_
M (-9/_C%'VWQ=_T M)_\&LG_ ,8H WZ*P/MOB[_H!:3_ .#63_XQ1]M\7?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[L;F(B.T3RV!8$C <L% ()W!CVJI?>9XBU5)=,COO/N-/N;>ZM[N(JECNBP
MI( 5RX4'!.1D] * .GM/%NE7>YBT]M&+=KI)+F%HUEA7&Z12>H&0?7!!QS2V
MWBO3)TG>4SV8@M_M3?:H6CS#_?&>H_4<9'-8-K?/?7FBSV6GW4C:1I\S74+0
MM&5<HBB$%@ 6)!]OE^E9VK03:[<:I/HR7MXMUI;B9;J%D\EPZLD,>X#!;YP5
MYZ+F@#KHO%NEM!=37'VBS^RQ"=TN8&1S&>%91U.2,8'.>,9JUIFM6VJ2SP1Q
MW$%Q;A3)!<1%'56SM;'<'!_(USYU47?B&77K&QO+JULM,,4BB!D=W:16VJ&
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MN[-F(WC*O',%9BKJ>5("']/6L*PUE++6I->U"UN8+76;"W*2>0[>1(F_=$X
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MUIQMW2-#*;1_,+C>%&0&!&3C *X/K0!K'Q?IB:9>7TB7,36+*MQ;20E9HRQ
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M  (3_&N>_P"%3^!O^@"G_@1+_P#%4?\ "I_ W_0!3_P(E_\ BJ .A_MS2/\
MH*V7_@0G^-']N:1_T%;+_P "$_QKGO\ A4_@;_H I_X$2_\ Q5'_  J?P-_T
M 4_\")?_ (J@#H?[<TC_ *"ME_X$)_C1_;FD?]!6R_\  A/\:Y[_ (5/X&_Z
M *?^!$O_ ,51_P *G\#?] %/_ B7_P"*H Z'^W-(_P"@K9?^!"?XT?VYI'_0
M5LO_  (3_&N>_P"%3^!O^@"G_@1+_P#%4?\ "I_ W_0!3_P(E_\ BJ .A_MS
M2/\ H*V7_@0G^-']N:1_T%;+_P "$_QKGO\ A4_@;_H I_X$2_\ Q5'_  J?
MP-_T 4_\")?_ (J@#H?[<TC_ *"ME_X$)_C1_;FD?]!6R_\  A/\:Y[_ (5/
MX&_Z *?^!$O_ ,51_P *G\#?] %/_ B7_P"*H Z'^W-(_P"@K9?^!"?XT?VY
MI'_05LO_  (3_&N>_P"%3^!O^@"G_@1+_P#%4?\ "I_ W_0!3_P(E_\ BJ .
MA_MS2/\ H*V7_@0G^-']N:1_T%;+_P "$_QKGO\ A4_@;_H I_X$2_\ Q5'_
M  J?P-_T 4_\")?_ (J@"3QGJ^F3>&W2+4;21OM5J=JSJ3@7$9)Z^@)K=_MS
M2/\ H*V7_@0G^-<\/A1X''_,!3_P(E_^*H/PH\#DY.@I_P"!$O\ \50!T/\
M;FD?]!6R_P# A/\ &C^W-(_Z"ME_X$)_C7/?\*G\#?\ 0!3_ ,")?_BJ/^%3
M^!O^@"G_ ($2_P#Q5 '0_P!N:1_T%;+_ ,"$_P :/[<TC_H*V7_@0G^-<]_P
MJ?P-_P! %/\ P(E_^*H_X5/X&_Z *?\ @1+_ /%4 =#_ &YI'_05LO\ P(3_
M !H_MS2/^@K9?^!"?XUSW_"I_ W_ $ 4_P# B7_XJC_A4_@;_H I_P"!$O\
M\50!T/\ ;FD?]!6R_P# A/\ &C^W-(_Z"ME_X$)_C7/?\*G\#?\ 0!3_ ,")
M?_BJ/^%3^!O^@"G_ ($2_P#Q5 '0_P!N:1_T%;+_ ,"$_P :/[<TC_H*V7_@
M0G^-<]_PJ?P-_P! %/\ P(E_^*H_X5/X&_Z *?\ @1+_ /%4 =#_ &YI'_05
MLO\ P(3_ !H_MS2/^@K9?^!"?XUSW_"I_ W_ $ 4_P# B7_XJC_A4_@;_H I
M_P"!$O\ \50!T/\ ;FD?]!6R_P# A/\ &C^W-(_Z"ME_X$)_C7/?\*G\#?\
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M /%4 =#_ &YI'_05LO\ P(3_ !H_MS2/^@K9?^!"?XUSW_"I_ W_ $ 4_P#
MB7_XJC_A4_@;_H I_P"!$O\ \50!T/\ ;FD?]!6R_P# A/\ &C^W-(_Z"ME_
MX$)_C7/?\*G\#?\ 0!3_ ,")?_BJ/^%3^!O^@"G_ ($2_P#Q5 '0_P!N:1_T
M%;+_ ,"$_P :/[<TC_H*V7_@0G^-<]_PJ?P-_P! %/\ P(E_^*H_X5/X&_Z
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MW_"I_ W_ $ 4_P# B7_XJC_A4_@;_H I_P"!$O\ \50!T/\ ;FD?]!6R_P#
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M!$O_ ,50!T/]N:1_T%;+_P "$_QH_MS2/^@K9?\ @0G^-<]_PJ?P-_T 4_\
M B7_ .*H_P"%3^!O^@"G_@1+_P#%4 =#_;FD?]!6R_\  A/\:/[<TC_H*V7_
M ($)_C7/?\*G\#?] %/_  (E_P#BJ/\ A4_@;_H I_X$2_\ Q5 '0_VYI'_0
M5LO_  (3_&C^W-(_Z"ME_P"!"?XUSW_"I_ W_0!3_P ")?\ XJC_ (5/X&_Z
M *?^!$O_ ,50!T/]N:1_T%;+_P "$_QH_MS2/^@K9?\ @0G^-<]_PJ?P-_T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ\.];N[IHDU[17D@N,(-N]6^5@/0J1^1KG];^)?B"U\&Z?+;20KK"2SK?DQ
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M:OBG_H5[;_P:#_XW7044 <__ &KXI_Z%>V_\&@_^-T?VKXI_Z%>V_P#!H/\
MXW7044 <_P#VKXI_Z%>V_P#!H/\ XW1_:OBG_H5[;_P:#_XW7044 <__ &KX
MI_Z%>V_\&@_^-T?VKXI_Z%>V_P#!H/\ XW7044 <_P#VKXI_Z%>V_P#!H/\
MXW1_:OBG_H5[;_P:#_XW7044 <__ &KXI_Z%>V_\&@_^-T?VKXI_Z%>V_P#!
MH/\ XW7044 <_P#VKXI_Z%>V_P#!H/\ XW1_:OBG_H5[;_P:#_XW7044 <__
M &KXI_Z%>V_\&@_^-T?VKXI_Z%>V_P#!H/\ XW7044 <_P#VKXI_Z%>V_P#!
MH/\ XW1_:OBG_H5[;_P:#_XW7044 <__ &KXI_Z%>V_\&@_^-T?VKXI_Z%>V
M_P#!H/\ XW7044 <_P#VKXI_Z%>V_P#!H/\ XW1_:OBG_H5[;_P:#_XW7044
M <__ &KXI_Z%>V_\&@_^-T?VKXI_Z%>V_P#!H/\ XW7044 <_P#VKXI_Z%>V
M_P#!H/\ XW1_:OBG_H5[;_P:#_XW7044 <__ &KXI_Z%>V_\&@_^-T?VKXI_
MZ%>V_P#!H/\ XW7044 <_P#VKXI_Z%>V_P#!H/\ XW1_:OBG_H5[;_P:#_XW
M7044 <__ &KXI_Z%>V_\&@_^-T?VKXI_Z%>V_P#!H/\ XW7044 <_P#VKXI_
MZ%>V_P#!H/\ XW1_:OBG_H5[;_P:#_XW7044 <__ &KXI_Z%>V_\&@_^-T?V
MKXI_Z%>V_P#!H/\ XW7044 <_P#VKXI_Z%>V_P#!H/\ XW1_:OBG_H5[;_P:
M#_XW7044 <__ &KXI_Z%>V_\&@_^-T?VKXI_Z%>V_P#!H/\ XW7044 <_P#V
MKXI_Z%>V_P#!H/\ XW1_:OBG_H5[;_P:#_XW7044 <__ &KXI_Z%>V_\&@_^
M-T?VKXI_Z%>V_P#!H/\ XW7044 <_P#VKXI_Z%>V_P#!H/\ XW1_:OBG_H5[
M;_P:#_XW705'<2^1;2S;=WEH6QG&<#- &'_:OBG_ *%>V_\ !H/_ (W1_:OB
MG_H5[;_P:#_XW5>PU[Q3J.G6U]!X;T\17,23)NU9@=K $9_<]<&K']H^+O\
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M\2R;PI]-V!G\JFHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N?\
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MIJ-M>W%U! Q9K5U20]LLH<8/?AA4XEC:1HUD4NOWE!Y'U%87AC3Y+.ZU:?\
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MM<EIY&BD5?,1@KQ, )5<L5+*?E SCM0!U%WK-C:VKW/G+.B31PN(6#%6=U0
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MD@9;!X R,^@YJ/5];329;2#[%=7DUX[+%%;!,_*NXYW,HZ#UKD)-(U"TT[Q
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MK:GI\.JZ7=:?.6$5S$T3%3R 1C(]Z ,+5O&'D:;(UC9W OA+;QK#<V[ A9I
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M';T !R>IZ$ LKXTTR1U2*WOY#()#%LM6/F[#A]OK@_\ ULU*_BW2E1)$>:6
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M,R1@X+..HP01CKP< XI3XLTL79MU,[JLT4+SI"3$K2A3'ENF&WJ/QYQ67<>
M8)$@*S6DDL<#0,]W8+<#:79P5!/RL"QYY![@UH?\(K$MK=6Z7)5+B[M;@8C
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M\/V&ULXYT!B)8;UQG.2508Q_#[T[6M/\(07SW.M26D$]Y\S"YNBBS;0%Y0L
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MC98;0K9ZEL8P<YQBLVVE\%6NI"&'4-/^W"Y'RM>AY6F :,9RQ);#,O//;L*
M(X/$>JZ@4L;:WM$O46Z,[.S>6?)E\K"=QN/.3]WWJ>QU>>T^'NEZC)*LMP]E
M;9>X9CO=U09. 68DGH!DGCO5VXT30YYH[2:"+SF,LZ()"KL&8&4\')4LPW#I
MR,]J+J+0%T%K2YDMH]-LML1W3;5@*8VC=G*L"%QSG.* ,6T\5ZK>SI80VUN+
MHWSVIDFBEB7:(!,&\MOF!P<8/US4:^-M0MM.CU"^L+<QSZ?-=110.Q8-$R*5
M)(Z,9 >!QCO6MIL'A:.$:EI\UHT:W&3<+<;QYS 1\L2<N00O/)R.]3W%GX>L
MXE@NEM(H[>TE79,X 6!BOF9!/W20N2: ,E/%6K$FW-@GGM/!''++!-!&1)N!
M^5P&RNW/'!!'3G$MMXBU6\NHM,A@LUO@]R)9'+>45A9%^4=<MYB]^.>M6-'B
M\)W,K1:5=6=W,C),WEW?G2#;PI)+$X&2 .@S5J]TK0FEAM[M(8YKB=Y(1YQ2
M21R,OM(()R!R!QCK0!R]AXKUF#08Y4@M[D6>FVMU<-/*Q>4R,ZE0W_ ,[CGZ
M>FC=>+-0L9I-/FMH7O?MHMUD@BED0*8?-W;%!8D#(P/KD#-:\&DZ#BXTVWAM
M\I!%#/ C\I&NXQ@C.0.6Q5/4KOP<3G4-1TZ)KS9=([W@C9\#:DB-N!' P"OO
M0!33Q3K-V%BM["""9+6>>3[2LB@^6^T84@, P.>>1[U<\.:I?:KJVH32N@M#
M#;2018.8]\>XC/?K5Z/3M#T^Q^U)';PVL=NZF8OA!$QWL2Q/0GDL?KFHM%E\
M-W%R\NB7EG/*D*0N+:Y#X1>%R 3TZ9/- %&W\2:D]Y"TMM;"SGU&YL$VLWF
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M4H0\8&YL@ X(7ISTJ2\G\':?K;SWM_I]M?JXD:.:["8?;@.8RV-VW^+&<=Z
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M1+,5D.S*+)@$'C)7/X=J=IJ:%I5G-<V5U$MN9/+EE:[,BAP=NW+,<')QCUH
MP4CEU#P[J/B"XU6\MKV%[EHRERZQ6PB=U53'G8V HSN!)R?;%:SDOM:UJ\DN
M;/5I05MB5M=4>WCMRT*,PV"1<\DGH:Z6ZT+P_/J@:YMX3=W'[TQ&0@3;<?,T
M></CY>2#VH.M>&M/U*Y1]5T^WO)G43H]RJN6   ()X.,4 'B47=OIXU.QF=9
M=.)G:'>0EQ&!\Z,.F2N<$]"![UC/)J4T.E&ZOIX/[?O<S>7*1]GB$3ND*$?=
M)VJ"PP22V.V-S4]>\/6S3:=JFKV$#NFV2">Y5&VL.X)SR#46I7?AE;.#2]2O
M+!8940PPS3*,J,;67)SUQ@COTH Y_7)KC0;B\T^QO[LV[6L5S^]N'D>W87"*
M<.Q+;64MP3_ <=ZM^-;^[M9;E;6ZFAV>']1FQ&Y7#KY6Q^.XRV#VR:V[31]$
MACO+"""&3SE"W:2.97<$<!RQ)(QG&:K6&C^&GAN+>S6"X6]M0)/](,K/;OD#
M!+$A#\V,''!H R-'DN5\5VEI'%J=@JV[RSQ:CJ#7 N4Q@>6"[C(8@D@@@8R.
M14GC;5KN*[MM/TZ:[CN(8FO6^S022;RO$4;[ <*[;LYXPAK2O=<\)"_A6\UC
M3$N["1O+#W:*\38*L.N>AP0:TG_LZPO9;F1X8+BY3+L[X+I&/<]%#$^V: ,&
M*\C\5:U#$+NYBTYM,BO(H[>=X&E:1W!W,A#?*%48SU;GM6=J6JZKI5_:6^C7
M$^MNEC?*<N&VE)8N7&1O9!N4=R3CC)-= ^C^'+BTLAL@$4CL;.2*<H6,F78(
MRD$AL%L XP.G%++-X7\.W%LD]SI^G2P0-' DDRQD1LP+8!/(+(#GU% &!=7%
M_!=:#<:'J=SJ48LKJ]D1Y2WV\!H 1CH#AV*@ !3@<#--MM9DUJ:.&WU&86&H
MZP\?GQR%6$0MA((U;JF6';!'S=#6Z+CPGHIMKXWNGVBSB9K:1KE55P[*TA3)
MP02$)QW^M/BLO#%QH5S-"+&32YY'NII4D!BW@Y:3<#@$%<Y!&,4 8>K276AW
MUW:V-]=O:VEM%J3)+</*T02;YUW,2Q5T#\$GE3BJUSJVI"74)$O9PFO!X-.
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M96<7)D6 G)+8+$+W.>.]6;S1?#FI7$5U<102/?X"E9BJW7READ*0)/E!/(/
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MV%=)I>K:'/:F'3-1LYH;., B&=6$: <$\],#K[5/%_9UO(;B-X4;4I%.[?\
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M84A>75+.-9PIB+7" 2 ]-O/.>V*5-8TN2VFN4U*T:"W;;-*)U*QGT8YP#]:
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M5:CI^L:/J#:9:R7$T=B5:]2$@1CS$(CY +$X)P.FWG&>35+]M0\+:Y;)K/\
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M5)9"T,RM,S!6!R =I&"!E6 /KGH5U^$:"VLW-G=6L( 98Y54R.#C;@*QY;(
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M3#"DLVLPWWWLD(HC!YQU^5A_^NII_&ME%\\=A?7$"K SS1(FU1-CR^"P)))
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M9 ,MO#>IM"]U]GD%R]Z)P5OL3H!%Y>\-MV%NQ4@@KWS1%X5U1WMFO%M)"B6
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MPE5T%K<BZ#1B.U#1.\OF$A<%7*C[ISDC&.>V;?A[5;G54OWN8&MS;WCPK$X
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MLT\TD,LLLI@.W:#)&8W&0,X(.>M-^Q^,?^@WI'_@LD_^/4?8_&/_ $&](_\
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MIK&D?VM;QQ"Z> (3E0B2)(",89&!!'\C5#['XQ_Z#>D?^"R3_P"/4?8_&/\
MT&](_P#!9)_\>H HP^"BDUS8B^N8M*DLH+1HP4)G1=^X-D97(8#Y<<$XZ#&B
MGA2VCU1KR*YE2)[C[2UN$3!D[_-MW;2>2,]?;BF?8_&/_0;TC_P62?\ QZC[
M'XQ_Z#>D?^"R3_X]0 U/"$:VD=DVJ7KVENL:6\!90L2I(CJ#@?-C8J@MD@9[
MDFGR^$-/N$>.>2:2.078=<@9%PX9^<=B.*3['XQ_Z#>D?^"R3_X]1]C\8_\
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M2A"(01DOY8&/3K45[)J/B.;3K9=$O;"VM;N*ZGGNS&,B,[E5%5V))8#T &:
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MFZ)]M%EY>^4W2Q@[UW# (]*EN?$%U%/;:?!I33ZI-#Y\EL)U"0)G&6D]SP,
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M',!@2(&QZ9&:R_%:*O@_6RJ@$Z?/D@?[#?XFM#3_ /D'6W_7%/Y"@"Q1110
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M "2(X(PBY/? JS10!7O;"SU*V-M?VD-U Q!,4T8=21TX/%3JJHH50%51@ =
M*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHJ&[@>YM9(8[F6V=Q@31;=Z>XW C\P: )J*Y__ (1K4?\
MH;]:_P"^;;_XS1_PC6H_]#?K7_?-M_\ &: .@HKG_P#A&M1_Z&_6O^^;;_XS
M1_PC6H_]#?K7_?-M_P#&: .@HKG_ /A&M1_Z&_6O^^;;_P",T?\ "-:C_P!#
M?K7_ 'S;?_&: .@HKG_^$:U'_H;]:_[YMO\ XS1_PC6H_P#0WZU_WS;?_&:
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M?^AOUK_OFV_^,T?\(UJ/_0WZU_WS;?\ QF@#H**Y_P#X1K4?^AOUK_OFV_\
MC-'_  C6H_\ 0WZU_P!\VW_QF@#H**Y__A&M1_Z&_6O^^;;_ .,T?\(UJ/\
MT-^M?]\VW_QF@#H**Y__ (1K4?\ H;]:_P"^;;_XS1_PC6H_]#?K7_?-M_\
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M/_0WZU_WS;?_ !F@#H**Y_\ X1K4?^AOUK_OFV_^,T?\(UJ/_0WZU_WS;?\
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M;[S*ZDG)7TY'>L;3?#WBAO$L>N:A#I=O<VEI+"6M&;_B82,/E,G PHP#W.:
M.RU WPL93IBV[7>/W0N681DY_B*@GIGI7(>'_$WBO5;S4A<V>CQVVE7$EO<F
M.64NS*N<H",$9QUQWKL+%KMK&!K](DNB@\Y822@;O@GG%8&@>'KW3&\2&<Q'
M^U+Z6>#:Q.%90!NXX- &,?B:A\#V.LHU@VI7,D:/9";)0,^T_+G=TYI^K?$.
M[TV'7F%C QTV_BLXG=F" .,[Y",X ]O:J1^&;+X!T_38[#3%UJ"6-Y;H( 6
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M"B9&3@'C- &F?%U[JFN)IWAZ.RG6XT==1MYKEG523,$*MMR1\N>V<\54\/\
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MV5.QQ[<'J2:?X7\,Z[X<MM<OK:TTVVNM0DC>VTV*1OL\&T8.6QU.23@=A]
M=U12#.T;L9QSBEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#AI/%7B2[CUZ32[;2]NBWDL3_:3("\:(&!&W/S
M=?05J^"]5U_7-*BU35XM.BM[J%);=;0R%QGKOW<>G0U6T[PQ?VEMXKCD:$G6
M+B:2WPQX#)M&[CCGZUK^%M,GT7PMINF710SVMNL;F,Y7('8T <Q;_$29/%^N
M:5J%M#%9Z=#-)#,N=TAB"LRG)QG:V:I:3\3M3N_"IOKC2H6U6?4UTZTM8V*J
MSLBL"Q). -QS^'UJ+Q#\--5UB>^F@N;>%[C56F5MY!^S/$$D4\=3@<=/>KLG
MP_U(V5\UK<6UM>QZ\VJZ<3EHP,* CC&0#@YQGM0!HVWB;7],U^UT?Q-9V"MJ
M$4CVEQ8.Y0NB[F1@W(.._P#D8UE\0/$T?AFT\5ZGIFF-HLS@3?9I)!/"I?9N
M(88//8&M6+P_XCUSQ'9:QXB%A:QZ9%*+6VM)&??(Z[2S,0,#'05BV?@CQ;<>
M#[3P=J#:5;Z4CC[1/#*[S2()/,VJ"H .<<T 7]:^(&HZ=#XB:"UM&.DWEO;P
MF3=M828R6P>V>U+J'C'Q%I/AO4-7N)/#M[]F,2HNGSR28+R!3OSC'!./I46L
M^ M4U!/$:1-:;=4OK6>%7<XV1XW!N/;WK6\5>"K:^\(WND^'M/T^PFNGB8^7
M$L*ML<-SM'/ ./K0!FZAXWUE?%>K:1:7/ARRATYH@K:I</$TN] W&.N/\*=K
M?CC5=/U/3M)BET.WGN;%;I[V\G<6LK$XV1,.OKDGH1^,=[X2UQ/%^M:K;Z-H
M.IV^HM$8_P"T&):/8@4X&PXR?Y"K6KZ'XFNQ:G^SM#O[3[*(I=*N1B*WD'1H
MFV9QC P<=./8 Z/2+[4M2\.17EQ916>H21$^2TH>,-SM.Y<Y4\'CG!KF=+\0
M>-;SQ7=Z'-;Z"IT_R7N71IN4?GY,CDX!ZX&:V_ _A^Y\,>%[?2[N=)9D9W;R
ML[$W,3M7/.!FDTS0KNS\<:WK4C1&VOX;=(@K'<"BD'(QQU]: ,,?$A%\-:[?
M3S:?%J&G7,\-O:M+@RA#A25)R<\]*K7'C[6GULZ?;3>'K)4LH+@OJ<[Q;C(@
M)"X/.*>/AP7\+Z_:7%EILNJ7]U<2VMRR!BBN05RY7(QSTJ&3P7KMMKSW\6E:
M%J<;V-O;[+]B=C1H 2/D/4T =M9:E(GAP:GJ<UFYCA:::6Q<O"5&3E">2,"N
M;TOQ-XQU*"QUB/0;*32;V0;8(YV^U1Q$\2$G"'CG%=#::=+=>&#INIVMK:--
M \$L%D?W2*<C"Y _A([=:YK2]$\=6%II^A)?:=!I]C(H-_%DS2PKT38P*@D8
M!.?_ *X!.WB;Q-K.K:G!X8T_3FM=*F-O++?2.#-*OWE0+TQTR:R[[XL?9;#P
M_J(T[$%_+-'?Q'+26_E%0^W'7&2>G0=JT5T+Q7X=U75I/#G]FW5GJMPUUMO'
M=&MYF'S'Y0=RD@''7^M?3_AW-8R^&XY98;R&Q-Z^HM)D><T\>T[5QR,G'..*
M - >(]=U76]:TW08]+?^S_LCQ2W3/MDCEC9B<KGG(7'MFLG3?&_BBY\#W?BR
MYM-)6T2WD>".,R^89%DV_,#QMX;H<]*T/ 7@J]\(:KKC37*W%G=&%;,[R76-
M X"MD=@R@?3M45EX,U2W^$DOA5WM_M[QRJ&#GR\M(S#G&>A]* (M.\<:VFM:
M-9:G'HMS%JQ*I_9MP[2PG;NRZMV]?QJS>^/I+3Q_%H8M$;3!)':SWASE+F16
M9$';' 'XTR#P/<:!KFEZQX=@LH76 6^I6I^1)EQ]]"%.&!^F?SSDM\*K^\\/
M7CWFMW::S=S/>-'#./LOVC<2AQMW<# SV[4 =%J?B/7+KQ-<Z!X9M+%YK&%)
M;N>_=PBE^50!><D<YZ52USQ/XQTSPK_;QTC3K3[-&3=VUU*[/NW;04V\%2"#
MR0:<VA^*],UN37]*739[K4K2&/4;:XD95$R+@.C <CKP0/\ "SJ?AS7M4^'%
MWHE]J$-YJURGS3$;(P=X;:,#. !C)&30!(VM^(K'1+:;4H=,-]?WL%O;+;&1
MH]KD9+;L'(7>>/2L^/Q;XIUF._U+P]I>G2:793/$HNI7$UUL^\4P,+[9K=NM
M'NKG5M D;9]ETU9))1NZR^7L3 [X#.<_2N>@\.>,/#]OJ&CZ"^F3:==S226\
M]R[K):[^H( (;';]?2@".7XAZCJ5]I46A)I<$6H:<;POJ<CH$(<HR97N"/3L
M:C_X6-J\OA_SX+&P-^NM+I9<2,]M(6'WU8<XSCUJ6U^%]K%J6EP7D5M?:79:
M2UHXE'SM*TA8NHQQU.#G(S4$O@CQ+#X9M]$MY+&X72]5CNK"260H7A7<0LF%
M^\"1R,YS[4 :1\8ZWI=UJ.F:]864=_!ILM_:RVDC-#,$!RI# ,#D?E^L7A;Q
M=KNNSZ>\U]X6\J[02/;073FZ4%<D;#_$.X]C2R^%/$&MWNHZKK;V$5T^E2V%
ME;VKNR*7!R[LP!SDXX'2F^%?#FOZ(VFP3^'_  XJVJ+')>PL?M! 7!8'8/F(
M]^] &3_PLOQ"FB7&N/#H!M+>=HS:FX=+EPK[?E!R,UVGBKQ!/H?@RZUVV@5I
M88DD6*8$#YBHP<?6N1@^%UQ!X>66 64'B.UOGNK:Z495P6R$<XY&/;BNK\6Z
M/J'B/P/=Z7&L$5]=0H""Y\M6#*2-V,XX/.* ,W3_ !]_:C^&S;P1HNJ23PWB
M29WVTD4>YE_,=^Q%4HO&GBK4M'N/$VE:1I[Z)"9&2*:9Q<SQH2&=<#:.AX/I
MW[S3^ )X_B)I_B&REB6Q^>2]MF8C]Z8RF]1C'S9&>G3/-58/"WC+2= N/">F
M3:7)I<OF1P7DSN)H8G)+ J!@L-QP<T =UI6I0:QI-IJ5MGR;J%94W=0",X/O
M7.^/?&%WX6MK1-,LDO;ZX,C^2^<"&-"TC<>@Q6KHNFW>BK::3"L#:5:6*1K*
M2?.:4'!R.FTCGZFL+5/!%YX@\7W>JZAJ=S96T=NMM9"PF"N5.3)ORI')/;J*
M )?$_C@Z7H>D:AIJVQCU:1%CNKQF6"!67<"^WGVQ]?2M+PGJ^IZO9SOJ<%D#
M%)MBN;"<2P7*X^\O)(],&N;L_"7BG2/#L6DV=Q87=M97DOEVMX-R7=JW*K(=
MORLIR>..?:M/P+X6O?#]QJUY=Q6=F-1E1X["R),-N%!'&0.3GG QQ^  *\_B
M3Q;>>)M<TW1+'2IH=(,65N9)$DEWINPI&1G@CG':LZX^)EY>C0WTD:59IJEM
M)*[ZK,R)$Z-M*[A[@XXYJ])HGC#3?%6OZCHL>E/#JYA*/=3.&B*1[<[54YY)
M[]JS&^'.I:6=!&G6^EZJFFVLL<R:@2$DDD;<6 VGH2<4 :6I>-M5TCPM!J$[
MZ)=3W-^MJES:3N]I I'WI&QG@@Y ]14L'CB]L/#&K:SK5M8SQ6&WR+G3+@20
MW9;  7DE2&(!SZ^U.ET?Q0_A](;6ST/3YHKK>]A$NZUNHL#*ME,J2?0=A63:
M?#6[O=.\117R6.DC5TB$-IIY+10-&=P<\#DL.@'3- '0Z3J7C,:I:QZUHUC]
MCNT+&2RE8M:$#($@;[V>GR]ZY.+XG>(4\.KXBG@T%[3S=ALX[AUNF'F;.%.1
MGO\ 2NJTNW\<7&KV<FL7&GVEE:(PF2S)=KQB, G<OR =>.?Z<Y9_"^ZL/#.G
M36:V,'B;3KEIDN ,QS N3L<XR1M(YQD8XH T/$GQ O\ 1F\2B"SMW&CPVDD(
MD#9<S,H8-@]L]J?I7C75WU_^RKT:-?;[22X$^DW#2K"4[29Z9Z"JOB3P-K6N
M#Q/)$;2-]8M[)(5:4X1HF4N"=O3@X/?VI;/P7K4WB*TU.73]#T6*UAF1DTO<
M&N2Z[0'^4#:#SW_P $\,>-]?\0+I\[WOA2&.Z==]J;J07(7=@@)_>P#@?2IF
M\7>+9Y]>N-.TW2I[+1;J2%XY))$GD5!D[>JYQ5?PMX4\1:!;:?:R^'_#4IM6
M&Z]W,9\;LE@=GW@#QSVJ4>&_&5G/XAMM-&DBUUJ[EE%Q/-)OB5QM^Z%P3CWZ
MT ;U_P"*POP_D\4Z?$K_ .ABXCCEZ9_NG'ITK(B^(K1>-+'1+^VBBM;VTA=+
MA<_+-(N0I[8."![UIW_A-T^&\GA;3Y%:06?V>.24[0S=R<9QDY-9<GP_DU&Z
MOTU%HA;W6EV]K&\;$O%-'_&..QP1SS0!O^$==G\0Z3->7$4<3QW<T $><81B
MH//?BN5F\<^)W\&S>)K2STGR+625)XY3+O.V3:-H''3KDUT/@#0-0\-^&1I^
MJ2Q371GDE=XF+!MS9SD@<UDQ>"M43X9:EX;+VWVVZDE9&WG9AI-PR<9Z>U $
M>J^+O%.C6.E->IH$4^IW&Q)'EE6&--F[+L<$'/U%+?\ C/7M-\*7NJF3P_J,
M\<\,4*Z=.\J9=L$.>,'D8JYXM\+ZGJMOH!LK>PNGTR3?+!>L1')\FW'W3GGV
MJI=^%]=U/P[<:<^DZ'I;&ZMYHQ8L0KA7R^[Y!S@#% %6_P#BA=)%X9-C9V\K
MZK&DEX'W?N 9%C^7!_O%QSZ5VVO:NVB:8]VEC<7TN=L<%NF69B#C)_A'')/2
MN 3X8:G#>7\J3V[(VIPS6:LY_=6RRO*R].#E^GM7IMQ&9;:6-<9="HS[B@#F
M=,\9K)\/[;Q/J,*K)/'E;>#),DA8JJ(#DDDX%7/!.O7/B;PI::O=P1P33M(&
MCCSM7;(R]_\ =K$L/A[-)X5T#3K[5+BSN]'WNK6+J5+DG!^93D@'@XXR:G\%
M>'=?\*:-8:;)/;W*&>5[O?(3Y*$DJ(L 9R>3GN30!V5%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %0W=I;W]K):W<*302C:\;C(8>A
MJ:B@#G_^$"\)_P#0OV'_ 'Y%'_"!>$_^A?L/^_(KH*Y/5Y=,_MV^3Q!>M;0I
M;1FS!N&B&/FWLF",OG XR1\N.O(!<_X0+PG_ -"_8?\ ?D4?\(%X3_Z%^P_[
M\BN?U2[UC^Q/%LEG*!!':[MURSK/'_H:$X & W?MSFI+.YLSXLOEN[O31*NI
M;8TN-09)APFT+'T//0=Z -S_ (0+PG_T+]A_WY%'_"!>$_\ H7[#_OR*R-+N
M--,%K)<WTY\0,[BYB2=C('PVY73/$8[< #"D=1E_@RYNW;3_ .VY#]HFTZ)[
M#;(3&T>Q=_7K+G!8GL1C^*@#4_X0+PG_ -"_8?\ ?D4?\(%X3_Z%^P_[\BL7
M4[BT":V]]>RQ:W'*XL(EF99 -H\D1)GY@3C. 026!Z8%2^O-4T^VU>YEFF>W
MNKT0.%8G[++^[VE?1&R5/H=OJ: .E_X0+PG_ -"_8?\ ?D4?\(%X3_Z%^P_[
M\BL/0;FS?7YQ<7>FFX&IW2JDFH,+CB5PH$73IC ]*[R@#A=+\'>&Y_$VN6TN
MBV;PV[0")#$,)NCR<?4\UM?\(%X3_P"A?L/^_(HT;_D;_$G^];?^BJZ"@#G_
M /A O"?_ $+]A_WY%'_"!>$_^A?L/^_(KH** .?_ .$"\)_]"_8?]^11_P (
M%X3_ .A?L/\ OR*Z"B@#G_\ A O"?_0OV'_?D4?\(%X3_P"A?L/^_(KH** .
M?_X0+PG_ -"_8?\ ?D4?\(%X3_Z%^P_[\BN@HH Y_P#X0+PG_P!"_8?]^11_
MP@7A/_H7[#_OR*Z"B@#G_P#A O"?_0OV'_?D4?\ "!>$_P#H7[#_ +\BN@HH
M Y__ (0+PG_T+]A_WY%'_"!>$_\ H7[#_OR*Z"B@#G_^$"\)_P#0OV'_ 'Y%
M'_"!>$_^A?L/^_(KH** .?\ ^$"\)_\ 0OV'_?D4?\(%X3_Z%^P_[\BN@HH
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M:SO<VT(F158H'GC1B P(SACU% $O]FZKG/\ ;LF?7[-'_A2_V=JW_0>D_P#
M:/\ PJI_PCVL?]#CJG_?BU_^-4?\(]K'_0XZI_WXM?\ XU0!:_LS520?[=DR
M.A^S1_X4O]G:M_T'I/\ P&C_ ,*J>%I[YI=9L[[4);\V5_Y,4LJ(K;##$^#L
M4#JY[5T% &5_9VK?]!Z3_P !H_\ "C^SM6_Z#TG_ (#1_P"%:M% '->'(I8?
M$_B%)[AKB0/;YD*A<_N_0<5-XQO)(-%%E;K*]QJ,HM46'_6;3DR%>1R(PY'N
M!2:-_P C?XD_WK;_ -%5N/!#)-',\2-)%GRW*@LF>#@]LT 8'@^_8Z?-IERD
ML$VG3F!4N,!S$?FB)Y.?D('7JIJ+QSI=C=:4EW-;(\ZW5K$)#U"-<1@CZ$,1
M^-= ]A9R7'VB2T@>;*GS&C!;*YV\]>-QQZ9/K575]3TNS$4&H_O6E.^.!;=I
MW;:0=P103\IP<XX.* ,-H;S3/%XL]"L[,PIIBGRIIVB5<RN<C:C9.2?2LBPN
M9E2UDO+EK1@-:,TD):3RB)^J\9;;VXSQTKK'\0:%&EOJ(E$C7>8HI(;=Y)&V
MY)7"J6&#G(/0YJ)=<\-PVRWJ;%"7#0 ):/YJ2O\ .R[ NX%OO'CGK0!C>'8$
MTG6M/@EMK=7N[9_*N["Z+QW8 4EY489SW#9;J1GFKTMI9:OXMU*UUE5FCMK>
M%[6"5L($.[?(!T)W#&[M@=,U-8WOA+3K6ZU33[>UM LBQ7+061CEW,P"JR!0
M^26&!CG-+?ZCX7U2S>ZU2R6XAM&09O--D)5G8*H4.F22<#Y<]J ,NQN;HZ]:
M_P#"/R1ZC;_V4 LE]<NA91*P#9"$MTZD<C!R:S6N+G4-$BT.6*Y>6\U._EO%
ML7W-'%'<2?=8[>/,,8!XR >*[/3=3T>_O62S 6[BA *R6S0R"//& Z@[<^G&
M:6VN=$2_U".U%LEW9 &[$<85T#YDYXYSN+?4GOF@#CWO=5UNY\.W5J[0ZM96
MMX9K=CM62>)H4>-QZ-EL>FX'M3+35(=9G)EEEBTJ]UQDN [%""+5"L3^@WC!
M'<C'?GJY=6\/64L-VJ(T]U&;A&MK1Y961@N7(12P!"KDG^Z/2KMM#I.HZ<[V
MT%I<6=\3(^V-2DQ/4L,<G@9SZ4 <-K?V>T@UC2;/3C:9-FXM_M0,# W*J#A0
M3'N'7V XSUZOPWIIL7N&?2=,L&<*!]ANFFWCG.[=&F,<8Z]3TIEV/"6B6%Y8
M7-IIUI9QQQS74'V51%M=RJ,P"X.64_3&:MV%CH&E:@+;3K"RL[J>$R8MK=8R
M\:D G*CD L/SH Q(++3-6O==GUYE:>TN613)*4-K"$4HR<C9D9;<.I)YXXP+
M;^T=3G2ZN=$BUN=-"M9&CN9S#(29)\%1M/S, ">G:NRU>7PTUTTNJ64%U<69
M12QL3.\6X%EZ*2!P3GI34\4^'C$NIH\F+@I"DPL9=TP(9T5?DRPQO(QD#)]:
M .=T>QL-2N]$AOYX]1M_[)FE5W9MH/FI@?,<Y4';SSQS50I)?W&G6D,-OJ5G
M%?7L=JM[=,L;Q*%Q\X5BVUMP'!X'6NEN)O!MQ!!-?:=:>7)=>1";O32F9I#N
MP Z#[QR2>F>IJ_?0^'+N^M=#OK.QN)Q$TMO:S6ZN%08!(!&%["@#G=1TUU?0
MK)-$TURTMPS627;& _)UWF/.>_W:T_ P;[%J!91;-]L8'3PY<61"J"F3USC?
MQQ\_%:4<.@:-=6=A!;6-G/<.YMH8H50EMN7( ''RKR?H/2EM]3T8ZS-:P/$+
MZ1MLC+$1YC(/N[\89E';)(% ''6UJVIVFF1![2]E3[8_]FWTCHDP\\C>K $;
MEQCD' ;M70:9<QW'@*9X!.BQP7$6)I?,92A=2 X^\ 1@'N *N>1X<UF2XTAK
M.QNS8.#+;26ZLL3/ELX(QD\\COGO6HEM!';"V2&-8 NP1!0%"],8Z8]J //Y
M+/[=%'/BUU/[/I5OYMK<7+P2VOR$^9$^"N6SUXY7[W&!)=QQ:U(M_ (=4C73
M()#:7]PUO<6RLI82HV"NY@>3QROWNP[*ZT+1[[R?MFE65Q]G 6'S;='\L#H%
MR.!]*6^T72M3>-[_ $RSNVB_U;3P*Y3Z9'% &%X;U&&XUJYG\^417&D6-Q%]
MI8!RG[W+'WZ9([USFGVTVI-HX^P66H Z6TH6_NGB4 RG# A&R2".PXKT&^T;
M2]4$8U#3;2[\K_5^? LFSZ9'%-O="T?4C&;_ $JRNS$NU#/;H^P>@R.!0!S?
M]DZ?<>)+.SU"RM4ABTIF$$<I:*-O-&=K$+GOS@5=\.S/+X7OPLSS6T,]S':2
MNY8M$K,%^8\L!R >X K3D\-:#+%#%)HFG/' "(D:U0B,$Y(48XYYXK06&)(1
M"L:+$%VA HV@>F/2@#@/#>AWTNGZ-?6VFPZ<$M \\Z71=[L-"0%* 8Y8ALDY
M&WBKEI=K+X3\%*D^^222U4@-DL5A.\'Z8.?I79Q11P1)#%&L<<:A41!@*!P
M!V%5;?1=*M+Z2^MM,LX;N7.^>.!5D;/7+ 9- 'G>GV\J6FDSOI]O9"XU#']L
M)<L9 1,2$9 HQOP4Y)'//4"K]Q'%;7UQK+B*_@&I[3?0W#17ELWFA?**,,,H
M/R[01E>QSFNZ:PLVLS9M:0&V/6$QC8><_=Z=>:A;1=)?41J3Z99M>KTN3 ID
M'_ L9H Y*\N=G@7Q9&9\3K=7D:C=\P9V.P?4[EQ]13/$&K70\13:M;VUY+;:
M"Z(6A ,1!&;G=SSB-EQP?F2NQET72I]034)M,M)+Q,;;AX%,BXZ8;&:L):V\
M<4D201+'*69T" !RW+$CN3DY]: .%N[VXTS5/$FLK.\NFR7"V]R@.1"#:0F.
M5?0;G(;V8'^&I+C1].N[+PA<7%HDDMU+#'.[9S(OV60X/J,J#^%=FEA91026
M\=I D,HQ)&L8"N-H7!'0_* OT ':G?9+;;"GV>+;;D&$;!B,@%1M]."1QV)H
M SM;TG3Y_#\MO+:1M%:P,84(XC(0@8^E<XMC9V?A[PW"JBULM1DA&H2(Q7S/
MW+%0S>C2!0?7..]=PZ+(C(ZAE88*D9!%1O:6TEI]C>WB:V*;/)9 4V^FWICV
MH YFWMX]-\53Z;HLT=I;&Q$UQ'C=%!+Y@"$+D!2Z[^!C.T&M3Q#+(RV&FQ.R
M'4KH0.ZG!6,(TCX/8E4*Y[;LU;M]'TNTLVL[;3;2&V9MS0QP*J$]<E0,9X'Y
M4Z\L([R:SF9BKV<_G1D>NQD(/L5<T <9?067]H-J3A+NQNKZ.V@NX)3'=:?(
M&6(1HI&"@=22!@\G(8<U:7Q5J">3J+36]Q9SW=W&EK%%^\\F$2'?NSUS&!TQ
M\X[UTW]BZ6+]M173;1;X_P#+T(%\S.,9W8S46C^']-T6VBCM;6+SD@2%[DQJ
M)90H RS 9/2@#F(/%FO) 9+BWAWSVT3H'\L+#)+*D<?W9&9H_G8Y(7[A]<"3
M5]9O;-7BDO[.]>S6ZNO.CA(,?DQ#Y2N<;@\J_@<8S74PZ+I5O;36L&F6<4$_
M^NB2!523_> &#^-*FD:9'"L*:=:K$J&,((5"A2<E<8Z$@''J* .3TB6]\/-'
MX6A,4E_)'!*LI3DAM_G2OSR1Y9Y[EE'>M7Q/K=SI\BP64A1H[=[FX98E<QQC
M@'YW50,Y[D\<#O6G:Z2D&K7.IRS//<S*(D+J (H@20BX'3)))/)X]!4MYI6G
M:A)')>V%M<O&"$::%7*YZX)'% ',+XLU%M(NKB1;>&Y%O9Q0QX)'VN902.N2
M!O3CV-5-VJ:EK*I%J (N=9F>/>A*Q0VR&,@#//[S;[9Y[XKL#H^EM<K='3;0
MSJ%593 NX!3E0#C/! (],5)#IMA;S--!96\4KL[,Z1*K,7QN)(').U<^NT>E
M ''V_BC5KO29K@7EI;?8=/%Y),\)(N-S2;,+N^52L8)P2<M@=.9;W6-5U".Z
M4K!%:M<V]B+9XBS2-*L?F9;(P%$A[<[373OHVE2-;L^FVC-:*%MR8%)A Z!>
M/E P.GI4WV.UX_T:'B3S1\@X?^]_O<GGK0!QECX@OM*M8M0NYOMD.ISW9AC"
MX9G#A8$4Y_B53Q[^U;6EM=CQ1<174B23#3+8W)C&$\W?+T';C/O@"K8\/68U
M&VN458X+0M)#:1Q(D:RMD&7@9+88C\2>M6K*PCLFN) QDFN93++(W5CT ]@
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M]^M:5UIFGWJRK=V-M<+,%642Q*XD"DE0V1S@DD9Z9IEAHNE:4SMIVF6=FT@
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M@J8(XE6,@]1M QS0!!H>GVFG:7"EG;I"LB*[A1]YBHR:T:155%"J J@8  X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$$\+_P#0'A_[Z;_&C_A _"G_ $ ;/_OBC_A _"G_ $ ;/_OB@ _X03PO_P!
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MGI6)'JVJW\VF(XU=O.DU0R6]G+$LJ^7<JJ!B6"X525X)_'K0!TG_  @GA?\
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M"_O?,_&(JN?[S56T&:_OKDSSKKTH&HW">='/$+;:D[JHVEMVT!0#QV- &O\
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M;931^*M0@EUC49+>RAMY426XRI+>9NW<<CY10!:_X03PO_T!X?\ OIO\:/\
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M:N@VA6-PPT^:-/WC^;N9M[+DG:.GH: .C_X03PO_ - >'_OIO\:/^$$\+_\
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M^U>=/#T4T^I70NK6[G(T^>(2.@DB\HLV0I(1\'!ZGO0!T/\ P@GA?_H#P_\
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MM5NA96NJ6Z![JQ-Z)!,6=07&%9=H X?C!/W30!9_X03PO_T!X?\ OIO\:/\
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MQ+'YVQ'>:1@<\'E4C+9]#TJ]I>L/=6%Y<7L4<!LII8I#&Y=#LZD$@'VZ=0:
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MQK2T>_DU/2X;N6V>VD?<&B8'@JQ7(R <'&02!D$<5>H Y_\ X03PO_T!X?\
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M#?B/_2#$(2^X_<!) QTZDUGS>%=)F,3!+F%H7F='M[N6%@9G#R<HP)!8 X/
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MO_RGQ_XT?V/XE_Z&O_RGQ_XUT%% '/\ ]C^)?^AK_P#*?'_C1_8_B7_H:_\
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MJY?[N5ZC8>OK5?\ X2C4O[&_X2/[!;_V-M\W;YK>?Y'_ #UQC;T^;;Z=\\4
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MB@#G_P"Q_$O_ $-?_E/C_P :/['\2_\ 0U_^4^/_ !KH** .?_L?Q+_T-?\
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MH NT52_MG2O^@G9_]_U_QH_MG2O^@G9_]_U_QH NT52_MG2O^@G9_P#?]?\
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M1NYKZ^O=&N+*Z2VCN(V?RY82Y!*9Y^8>O2MG9<_9-GGQ_:-N/-\H[<^NW/\
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M#?\ /+P__P!\P4>3X&_YY>'_ /OF"M3^P](_Z!5E_P" Z?X4?V'I'_0*LO\
MP'3_  H J6NB^%KV,R6FF:1<(#M+101. ?3(%3_\(SH'_0#T[_P$C_PK/\*0
MQ6^H^)(H(DBC75!M1%"@?Z/#T KHZ ,S_A&= _Z >G?^ D?^%'_",Z!_T ].
M_P# 2/\ PK3HH Y#2=!T:3Q3K\+Z18O'$UOY:-;(53,>3@8XR:W/^$9T#_H!
MZ=_X"1_X52T;_D;_ !)_O6W_ **H\5Q"X;1K9VD$4^I*D@CD9"R^5(<94@XR
M!^5 %W_A&= _Z >G?^ D?^%'_",Z!_T ]._\!(_\*H:(OV'Q-JFDVT\TME#;
MP3!996E\F5S(&4,Q)P55&QGC/O3]?:2XUG2-*:XEM[2[:9IFAD,;2%%!6,,,
M$9R3P02$],T 7/\ A&= _P"@'IW_ ("1_P"%'_",Z!_T ]._\!(_\*Q[>PAD
MUO4M!DFN;FP@MX;I ]U(7@D8R*4W[MQ!"A@">,^F*Q]/2>Q\'^%;ZP$L][?2
MVS3":[<"8F%R<D[L#)SP* .P_P"$9T#_ * >G?\ @)'_ (4?\(SH'_0#T[_P
M$C_PKC]:O-7GN-:CN[?[/)C252WAO6*L'NW5OG"KMW#Y3@=!5K5[&XL/#%T1
MIKV<DMW9(%34I)3*#<("NXXV9!(X]: .F_X1G0/^@'IW_@)'_A1_PC.@?] /
M3O\ P$C_ ,*P_#(F3Q1?P&&73D@MT#6,MV\YD).5F7.0%P"O!Y.<XP*NZE?Z
MA<2ZE%I]S';R6Q2U@60@>;,RK(V"01G8P"\8R3D&@"__ ,(SH'_0#T[_ ,!(
M_P#"C_A&= _Z >G?^ D?^%8MCKUY&YLX6DN[EI)=\6I.L+V@C1&8,Z*0XS(A
M! Z/U-.MO''VJ6%TTV9;9O+$CLLFY"\8D.,)MPH89RP/!XX&0#8_X1G0/^@'
MIW_@)'_A1_PC.@?] /3O_ 2/_"LBX\3WBV<$TUI%;BX"31!+H%E3RY)2) 4.
MWY8L'&?O'!R,T:'K>H1BVTO44-QJDWER/F08$;+N=^%&%7!4#!Y*C/.: -?_
M (1G0/\ H!Z=_P" D?\ A1_PC.@?] /3O_ 2/_"L^^\0W&GZ]<"=81I5NL,<
MLI?!C=]Q+'CH $[_ ,6?I&GBR[+[Y-+2*!)K>&;?<'S$,Q&T;-O55=&89XR<
M9Q0!J?\ ",Z!_P! /3O_  $C_P */^$9T#_H!Z=_X"1_X53\/^)9-<F -A)!
M%+;BXB=E<':3P&W(HR0<_*6'7GC)I:AXNNX;"6Y@L8@LT%P]D3,2[F,X!9=N
M &)&.3U4'&> #9_X1G0/^@'IW_@)'_A1_P (SH'_ $ ]._\  2/_  JE<ZE?
M:'86-JX2_O7BDDGEGFV*JHNYG)5.1DJ.%'45!;^*;^XN([0Z5%'=7 B,2&Y)
M5=Z.Y#G9P55.@!SN7W- &I_PC.@?] /3O_ 2/_"C_A&= _Z >G?^ D?^%85W
MXLO[O2;@Z=:113*JPM*T^=DTDAB3RQM^<!@&YQD$>^*\FOZE<ZBK0SRQV:L!
MA)4WOYMPT,;<QGY0L;/CKSR3@4 =+_PC.@?] /3O_ 2/_"C_ (1G0/\ H!Z=
M_P" D?\ A6:OBFZ:RBNC80 7B1O:1B=GD97R1N14+ [%+?*&Z$9XS5!O%U[=
MJD\<0@MC;() DGSB26X,2,NY.@".W(Z'D<4 =#_PC.@?] /3O_ 2/_"C_A&=
M _Z >G?^ D?^%97_  EUTL<#-IB%[V**6UC6XRQ6214 ?Y<*<.&XR.&],F_#
MKS_V'=:A<V\<<EO-+"(TE++(ZN4 #;<\L,=,YXP: )O^$9T#_H!Z=_X"1_X4
M?\(SH'_0#T[_ ,!(_P#"LF#Q==W!:"/3HOM"32HYDE>.-4CC1V<[HPW!D5<;
M>M1OXGU#4(+7[%:+;+/<VT#N\N9$9U25PJ[<$",D9R.<\<<@&U_PC.@?] /3
MO_ 2/_"C_A&= _Z >G?^ D?^%4]5\3-I^JQV<5J)T\V&&5@7RK2.% X0J" 0
MV&89!JGJ'BRZ?2T.GV\:W5W [P,\F0F9DBB)&WG=YF['^R1[T ;'_",Z!_T
M]._\!(_\*/\ A&= _P"@'IW_ ("1_P"%8:>*KZSEN9[RU2:U>>X$'ER_./)"
MH0!M VF0$9)SEAQBKA\1Z@+X:8--MWO_ #@A"W1\I5,1?<6V9XP!C'\2GO0!
MH?\ ",Z!_P! /3O_  $C_P */^$9T#_H!Z=_X"1_X5A:=XHO9#)?2HAT[%M@
MO*-R&>7@DA ,*CH<>G4DDFM31]7N-2U:;=&8[=[.*>*,GE5:24*QXR"RJIQV
MQ]: +/\ PC.@?] /3O\ P$C_ ,*/^$9T#_H!Z=_X"1_X5IT4 9G_  C.@?\
M0#T[_P !(_\ "C_A&= _Z >G?^ D?^%:=% &9_PC.@?] /3O_ 2/_"C_ (1G
M0/\ H!Z=_P" D?\ A6G10!F?\(SH'_0#T[_P$C_PH_X1G0/^@'IW_@)'_A6G
M10!F?\(SH'_0#T[_ ,!(_P#"C_A&= _Z >G?^ D?^%:=% &9_P (SH'_ $ ]
M._\  2/_  H_X1G0/^@'IW_@)'_A6G10!F?\(SH'_0#T[_P$C_PH_P"$9T#_
M * >G?\ @)'_ (5IT4 9G_",Z!_T ]._\!(_\*/^$9T#_H!Z=_X"1_X5IT4
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M  H_X1G0/^@'IW_@)'_A6G10!F?\(SH'_0#T[_P$C_PH_P"$9T#_ * >G?\
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M&= _Z >G?^ D?^%:=% &9_PC.@?] /3O_ 2/_"C_ (1G0/\ H!Z=_P" D?\
MA6G10!F?\(SH'_0#T[_P$C_PH_X1G0/^@'IW_@)'_A6G10!F?\(SH'_0#T[_
M ,!(_P#"C_A&= _Z >G?^ D?^%:=% &9_P (SH'_ $ ]._\  2/_  H_X1G0
M/^@'IW_@)'_A6G10!F?\(SH'_0#T[_P$C_PH_P"$9T#_ * >G?\ @)'_ (5I
MT4 9G_",Z!_T ]._\!(_\*/^$9T#_H!Z=_X"1_X5IT4 9G_",Z!_T ]._P#
M2/\ PH_X1G0/^@'IW_@)'_A6G10!F?\ ",Z!_P! /3O_  $C_P */^$9T#_H
M!Z=_X"1_X5IT4 9G_",Z!_T ]._\!(_\*/\ A&= _P"@'IW_ ("1_P"%:=%
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MQ)_O6W_HJM;4-,L=5@6#4+6*YB5PX25<@,,C/UY-9.C?\C?XD_WK;_T5704
M48-%TNUL_L=OI]O%;F02F)(P%+@A@Q'<Y .?85+?Z=9ZI;?9[ZW2>+<& 8?=
M8="#U!'J*LT4 5+#2[+3(6ALK=(5=MSXY+MZL3R3[FG)IUE';VUNEK$L5H5,
M"!1B+ P-H[8!(JS10!3N])TZ_6<7=E#.+A467>@.\(Q9 ?7!)(]S4%OX<T6T
M1TM],MHU=D9@L8Y*,&4_@P!'N*TZ* (6M+=KM+QH4-Q&AC67'S!202,^F0./
M:JK:+9S&]6YB6XBO9EFDCD4$!E15!'X(I]C6A10!C-X4T9[A)'LH6BCC9$A*
M H"QRS>Y. #GKBKO]DZ?]O\ MWV*'[3C'F[!NZ8_/'&?3BKE% &='X?T>*%H
M8]-MEC8,K*(Q@@KM(^FWC'IQ3[;2XX-5N=3D<S7,Z+$&90/+B4DA!CMEB<GK
M^ J]10!EZAH%GJ,V^155))(Y+E @_P!(,9!C#$]@0#[XQTIUMH-A!J$VH- D
MMW+,9?.=064[0H /LHP/Q]:TJ* *ECI=AIN_[%9PV_F8W>6@&<=!]!DX';-1
MIHFEQR2R)I]N&E.YSL')W;O_ $(9^O-7Z* (+BRM;LDW%O'+NB>$[USE'QN7
MZ':,_05%<:3I]V'%Q9Q2;W$C$KR6 V@Y]<<?3BKE% %!M#TIIH9CIUMYD"HL
M1$8&P(<ICTP>GIFI(]*T^'9Y=G"GE[=F$'R[00OY G'UJW10!FKX>T9(3$NF
MVRH7#X$8'(! _($C'H2.]21:)I<+QO%86Z-$JHFV,#:%)*@?0DX],U>HH HV
MVB:7:8-O80188.-J 8(SMQ],G [9-2OI]G)9O9O;1FW<DM'MX)+;B?KDYSZ\
MU9HH HQ:+I<",D5A BNKHP5 ,A\;P?KM7/K@4HT?31?+?"Q@%RI!64(-P.W;
MG/KMX^G%7:* *4ND:=/>B]ELH7N%*L)&0$@KT/U'K42>'=&CC>--,ME63;N
MC SM;<OY-R/2M*B@"HVE:>T?EM9PLFQX]I0$;7(+CZ$@$^N*2WTG3[0 06<4
M> PR%Y^;&[GOG:/R%7** ,B]\-Z?=V[6RQ)!!*8Q<1QQKB=$^ZAXZ< <<XXJ
M[:V*6T]Q/N+RW+[G<]@!A5'H /U)/>K5% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO"7_ $,FF?\ @4G^-)_PGGA3_H/6?_?=;5K=07MK%=6LJRP3('CD4Y#*>A%
M&-_PG7A+_H9-,_\  I/\:/\ A.O"7_0R:9_X%)_C6_10!@?\)UX2_P"ADTS_
M ,"D_P :/^$Z\)?]#)IG_@4G^-;]% &!_P )UX2_Z&33/_ I/\:/^$Z\)?\
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M'_"=>$O^ADTS_P "D_QK?HH P/\ A.O"7_0R:9_X%)_C1_PG7A+_ *&33/\
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M/K%Q:64EE-,SI<!6DF5U'E[^P4$MM'KZ"@#TJHKFZ@LX3-<S)%&"JEW.!DD
M#\20/QKGM'U.[NO D][+? 2QI<K%?.F0R(SK',5 YRJJW Y_&N:76=0M+"[M
MI+RZ^U;+.56^UI=1,K7"(SHX 9=P/W2 ,=.] 'I=%>=7>KW&PWDFO3V^HG74
MM#8"50HB^T!0FS'>/#[NISUP<5/:76I)%::LVK7DCR:_+9F%G'E>3Y[Q[=N.
MP (/7\* .[>6*-XT>15:4[44L 6."<#UX!/X4RWN[>[MEN;>9)86SB1#D'!P
M>?PKG?%$*-XG\+227$D*K>RCY9-H)\AR!^)&/<$CO6#X?6[TW2/#MY%J5TPO
M+R:WEMV8>5L*S,,+C@@H#GKUH ]!M[B&[MHKFWE66&9 \<B'(92,@@^F*EKR
MZ36M3&BZ?J$FJ3O'#HUM<S+;72130L5):4HXVS!L=,_PD8R:[+Q3?S0:/:/!
M<O:175W!%/<CY6AB=N3D_=)X7)Z;J -J.Y@EGE@CE1I8"!(@/*9&1GZBI:\V
M%RUCK&I6MMK4QMKC5;6VN+TR!GB0P,=N_'4L%3<>1N]>:LMJEVNJ-HRZQ.=+
M_M1+<Z@9 9%!@:0Q>9Z[PHSU^;&<T >@45QMIJR6OB#3+5=>>[L=M]&\LY"@
MNAB*H6X#E07&?KW!K,TN]U#7S IUJ\C@:PNK@-;R!2[+<,J'..@7\\"@#T6B
MO-UUC6]/TG3]4BO[F]NM2\/7%\\4N"@F1(F4HH'&/,88'7COS5:ZUC6K/3KI
MK;52?,TTS[FO5N'W[T"RKA0%!W,".AXP.#0!Z=++'!$TLTBQQJ,L[L !]2:?
M7G'BN&XM(-:TJ35+VXMA8VUWNGERR.9V5L$ 84A0<=!CC%=5XDOETSPP9([N
M=-YBACFB*L[%V51\S?*,Y^\>F<T ;M%>:1ZKJIFU'3(]2G@\N_T^-6%T+B2$
M2N5<;R/0#@YQFKMU>7UA?W&CG5KI;+^U+>%[J60&6&.2$N5WD<9=54$\C?UZ
M4 =S%<P3R3112H[P.$E53DHQ ;!]#A@?QJ6N6\%B-;[Q&D5Z]ZBZF%$SL&)Q
M;Q#!(ZX^[GKQSS6'>7VKVVES:@FJ73FZUN:Q8-,L:6\ GD4;25(4G:J[CG&[
MZ4 >A22QQ;?,D5-S!5W'&2>@'O3Z\TGDN;D0P7^H.(+36[=8V6]\QXMR$E6D
M  .#@C.2-V#6B?$,Z64<+:EB[;Q,;787&_ROM) 3'IY>/PH [JBO.X'U2?2]
M/O#KM^LNH:T]JX#C;'$LDR[5&.#A1R<G\A72^%Y;A9]9T^:ZFNDL+[RH9)VW
M.$,4;X)[X+GD\XH WZ*** "BBB@"&.[MY;F:VCF1YH IEC5LE-W3([9Q4U<K
MX9TZUTOQ7X@MK2,HFRU8EG+L[%7RS,222?4UU5 !1110 445Q<%\9]0O+R]U
M^>SGM]6^RQ6BD,A3<H1#&!EBX.=W4;LY % ':4A(52S'  R37 :;JUX\&B:D
M=8FFU#4+[R+JP+@HJDMO01XRIC SGK\O.<U#H6K7;:;X=O8]=GO[O4&>.[@>
M0,H01N2=H^Z495&>^><Y% 'H5O<0W=M%<V\BRPS('CD0Y#*1D$'T(J2O+XM;
MUB\M+1);Z2!8="M;I9/MJVY9W0EY6RIW@$ 8Z#N.:L7^N:G"T>I7>HNT<%K:
MR3I87*HUNS %B874"56SQSGL!D4 >BR2QP@&614#,%!8XR2< ?4FGUS'CJ&.
M6QTPRW,ENBZI;[G239@%\9S6,-6O/LJZK_:\QU,ZQ]D.F[QLV>?Y?E^7CKY?
MS[NO?.* .]>6.-D5Y%5I&VH&."QP3@>IP"?P--M[F"[A$]M*DL9) =#D$@D'
M]017.^+(HWUOPO)+<20*NHNN5DV DP2D9_$ ?B1WK"T47FF:=H=]#J%T_P!J
MU2:W>U9AY)C+3' 7'!!4'/7KVXH ]$J(W,"W26IE03NC2+'GYBH(!./0%E_,
M5Y]X9UG6;NZT6[N+P&34'<7,,EX'##:Q95B"Y0H0._0$')-;/BO4+RUU4PVV
MHK8JVCW4@ED^XCB6 *QX.,!B,X.,YH ZVBO.1JNH?8[S3UOY[:[CN;<F.YOU
M=75]WR1W*J2I;8?O $<=-U6M)U^;[5I$4UY=1QK?W-K<B[E1OF$194\Q>' S
MP>O&#R* .W>Z@CN8K9YD6:8,8XR>7"XS@>V1^=2UYQ_PD-].'F@U!Y(R=7,;
MJV05C(\L@^@'2IY[W6=$@CGMM0NK^>ZT&XNS'.0X\^,1%650./\ 6-\HX/%
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M,.WRXZ9YSD4R#4KG4HM"TBUUV6>*]:Y::^2/RIS'$1B,@CY7^90QP#\IZ9H
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MYN21C'Y6H-6LKF:.&&4M)(90J[3_ ,LGV/GT ;C/?M0!A2:G'*8#)X"U1S;
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MOFXQ[5H0^)M*N&@\F>1UG$95Q"^U3( 4#-C"DY'!P>1ZC)_PDVECS=TLR&,
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MK?,!D':<?0U GBC2I$9DEF8;@B8MY,RDDCY./GY5NF<8R>.: .?_ +5\2_\
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M84-C(S_(9H HQZE%%9O9Q^ =32VD.7A6"T",?=?-P:5M41[);)O 6J-:K]V
MP6IC'T7S<5L1:_I\UE=7J22?9K4L))3"X7Y20VTD?, 0>1FJFH^+M,L[&^F@
ME^T36AEC\H!ANDC4$KG' RRC/3+ =>* *HUD@!1X&U8 !@ (K7^+[W_+7OW]
M:2?6[B>%HQX0UZ)C$T22Q"V5XU(P=I\WCH/R%:)\4:6(RV^X+JSJT0M9/,7:
M 6)3;N  93G'\0]10?%&D^<\*32RLC*G[J!W#,RAPJD##':P; Z#). #0!S.
MCF[TS43?S>'->NIQ"84(@LXE56(9B0LHRS%5R3Z#I6K<:Q]KFCFN? NK320G
M,;R0VK,A]B9>*T=2\00VGAY]7MHWN@<+%&$8%Y"VQ5(P2OS'!XR/2BV\26,J
M$2R,LB1.[E89"C%,!PC%?GP3C Y]J *+:[*^_?X)UAO,(+YCM3N(Z9_?<XP*
M;-K)N(I8IO VK2QS-ND1XK4ASP,D&7D\#\JT&\3Z6D6]FN PE,)A^S2>8'"!
MR-F,_<(;IT(JK=>+[2UOQ"R-)#^\+20I(Y141&8E0O\ TT7V]\\4 5IM42XM
M4M9_ >J2P1XV1/!:LBXZ8!EP*F'B"=71QX+UD/&NQ&"6V57C@?ON!P./:K)\
M4V,=Q=QS;]D$A5&A1I2ZB-'=\*#A1Y@&?6KUWJ*VTM@%421WD_E;P?NYC9@?
M?[H'XT 9G_"3WO\ T*.N_E;?_'J/^$GO?^A1UW\K;_X]7044 <__ ,)/>_\
M0HZ[^5M_\>H_X2>]_P"A1UW\K;_X]7044 <__P )/>_]"CKOY6W_ ,>H_P"$
MGO?^A1UW\K;_ ./5T%% '/\ _"3WO_0HZ[^5M_\ 'J/^$GO?^A1UW\K;_P"/
M5T%% '/_ /"3WO\ T*.N_E;?_'J/^$GO?^A1UW\K;_X]7044 <__ ,)/>_\
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MSQV[5LR()(V0G 8$5QD?B75FU/4[VPL1>626-M=^7-<^645D9B$&T@L1ZX'
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MGYY[B0'[^YAF0E9022!U+3R-QW-.G\)I>69MKS5+N?\ <R0J3L&P-'Y>0 ,
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MPE8W-E';[MOE73W*%HD=06#+@JP(("M@<<8%;U% &:-#M4TVST]"RP6DD<@
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MV\-S$D5W!#*H2Y55"C=E20=H )4KD"DO_!FGWWVE!<WEM;7A5KBUMY%6.1E
M ;&TD'"KT(!P,@US>C^,[NVT32K!#%)=+ID5S/->-(V\L6 7*J3D[3ECTXX/
M;>TOQ+J.M:M#!:6$4%J+.WNK@W+L)4\W>-@4#J"AY.* -$>'+(72W.Z;>M^;
M\?,,>88C%CITVGIZ]ZK?\(C:1I!]CO;ZRE@C>+SH)%#NC,6*MN4C&22#C([&
MH_$GB*XTF[CMK=K%&>$RC[3(S.Y!QM6- 6_X%T'O5%/%^JZC&DNEZ?:!/[(@
MU-_M,K#&_?\ NQ@?['WOTH N2^!=-:.X@AN[ZVM;NW2WN+>&4;955=@R2I8'
M;P<$9[YJP?"5B997^T76V8VS21[UVLT#(R-]W.?D4'L1V[TW5]723P6-76)]
MD\4,HC$I0@.R\;EY[U2G\4:K%-=7(L;7^S[/4DL9"96\U]SHF]1C'!D'!ZX/
M2@"\OA&Q6Z#_ &F[-HMS]K6Q,@\@2[MV[&-WWOFV[MN>U3Q>&[&*SL[16F\N
MRNVNX\L,ERSL<\=,N?TJKIVM:OJEQ]JMK"V;2_M<EMDRD381F0R8(QC<I^7K
MCGVK&A\<ZF=)TR\NK.RMWU?YK8;Y'$2*I+L^%R?X< ?WN3Q0!U.IZ)::M-%+
M<F4&**6(>6^WY9  W(Y!X&"#Q4>F:!%IU[)?27MW?7<D2P^==,I98P20HVJH
MZDG)!/O6(/&EQ)I<,WEV5K,US);O)<R.(SM&0T:8#ON!' ''.>G-5_'MX=+L
M[S[+;6JR^>LMQ<>;Y DBD*;<A<INP3E\8'')H Z&?PS;23W%Q#>7EI<3W0NC
M-!(H*OY8CP 05(*J.&!YYJ!?"%M!"B6FI:A:R#S#+-%(I:<R-N<N&4KDGG(
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MQK7Q3JD]MINHO8VJ6.KOY=K^]8R1EE8QLXQ@AL#('3/>@#K:*X[PE]K_ .$
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M=_[HR[Q)NZ9QO&[;G&>:M>%[*]TZSN[6\@6/_3;B:)UD#;UDE=P<=N&%;=%
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MQ%M.5SP#*,X!)QQ[NC\6ZE':W_VB*$&!8FAO)[.XM(6+MM*E9!N++P0%)W9
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMS$#J"I.[!  -2Q^+=8"O:&T#W$MS!!:W<VGW%K"QDW;LQR?,2@0GAN<KR*
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MQJ%O=F?4K]Y"0D9R?);'!)! " ?* #QQD Z9]%L7>]8Q$?;H%MY@&(!10P
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M>=@Y=1]U<!L#&%Y'OC&30!UU%<YH-O':^*O$,4*[4+6[D9SEF1BQ^I/-='0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#9;VQZX$_2KWV#Q?_P!#!I?_ (*G_P#CU '045S_ -@\7_\ 0P:7_P""I_\
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M6T$=Q+<)"BS3!1)(% 9PN<9/?&3^= MH!=-="%!.Z"-I=HW%020,^@+$_B:
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MAC&W BC7)VCURS,2>.P[4 7Z*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***ANWN8[61[.&.:<#]W')(45CZ%@#C\C0!-7EVE7DV@_VF;8
M[9-<N+N.V]!=K=O&I_%9$/TB-=C]O\7_ /0OZ7_X-7_^,U6">(1Y>/"6ACRI
M6FC_ .)@?DD;.YQ^XX8[FR>O)]: .:TNYE\-6,5MIR!X[2?5]D14$OY1)09Z
M]NW6KFN-<KX2G\WQ(U])?:<)Q#)$A^;?'^\0J!A/FQ@YSD<\'.T@\11R+*GA
M30T=6=U9=0((9^7(/D=6[GOWJO!IVK6J3I!X)\.Q+<?ZY4O<"3G/S?N.>>:
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M?TO_ ,&K_P#QF@#H**Y_[?XO_P"A?TO_ ,&K_P#QFC[?XO\ ^A?TO_P:O_\
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M8,^.F3Y'.,\4 ,L[6W'Q#U0>1'@:;:D#8.#YD]9'A.'5FTK=!_8WV;[==?\
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M?(SC/.*(9O%-OYGD>&='B\US(^S4V7<QZL<0<GWH Z2BN?\ M_B__H7]+_\
M!J__ ,9H^W^+_P#H7]+_ /!J_P#\9H Z"BN?^W^+_P#H7]+_ /!J_P#\9H^W
M^+_^A?TO_P &K_\ QF@#H**Y_P"W^+_^A?TO_P &K_\ QFC[?XO_ .A?TO\
M\&K_ /QF@#H**Y_[?XO_ .A?TO\ \&K_ /QFC[?XO_Z%_2__  :O_P#&: .@
MHKG_ +?XO_Z%_2__  :O_P#&:/M_B_\ Z%_2_P#P:O\ _&: .@HKG_M_B_\
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M?_T+^E_^#5__ (S1]O\ %_\ T+^E_P#@U?\ ^,T =!17/_;_ !?_ -"_I?\
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M=4C.3RV.]:>C:)I_B32;K5=9#27TMS<*9C*5:S"2,BK&<_)M"@\=3R<UO?\
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M86]]:OOM[F)98FP1N5AD'!Y'!H L4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %97BG_D4M8_Z\)__1;5JUE>*?\ D4M8_P"O"?\
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ML#QQ_P B;J/^XO\ Z$*WZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3'5@0,CW!K;_ .$<L?\ GOJ?_@UN?_CE'_".6/\ SWU/_P &MS_\<H N6]U
M\TEDD@:>V1#*F#\H8''YX-<%J$T^B>*M:\1P6TDS07BV\D:*29$DM(=O_D5(
MQ[9-=C_PCEC_ ,]]3_\ !K<__'*/^$<L?^>^I_\ @UN?_CE '&Z?I\^CWTUF
MKN775; 32+D>:QB4R,?JQ)/UIEC)8OHG[Z>^D\1/:7(U")9&.U_+?=YJDX5
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M+BU=Q#%Y(/VB0%X^NQR&RZ^S9%-NO"6BWE])>RVTJSRJJNT5U+%D*,*,*P&
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M^$CEN+4W,,,L4"-.LD8B15:3S-P)SG:PQQUQ[U,=1O[:TU\O<1SW5O,ZV2;
MN2+=)%0#.6.2Q[D\]!P,*Z\17]O*RVVJ?:[&(R.EUYD2M.52%A&I"$.V7?"@
M#.,9&TT ;-E/K5_X4FN58&^O!L@*D;8@<)Y@/=>#)ZD'%48M)\06-I+IUHS0
MPVD%R]HULRA7<[&B0AB3@,9!@\8 K>U.:\AU321!.JP37#QRQ;.9/W,C#YNP
MRH[?CV.+X<\07]Q8RS79^U3"&.9HHY%8[F1V,2@*N) 4Y0YP#G<: %O+7Q.H
M=K>XN&$LTQD&4)6,3_NP@R,?NCZ@X'KBJOV'Q()XIC+=-<C8P9@@0'R9E&X
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M#1(9[?1K6&X@2"1$VF).BCL,9..,< D#H":OT4 %%%% !6!XY_Y$O4_^N/\
M45OU@>.?^1+U/_KC_44 ;]%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!B^+@6\,W2<[)&CCE_P"N32*)/_'"U9?B*SU.XO;A[32;G[9'&%T[
M4+*=(]H*CY9@S#*A\G&UA@\#-=8Z+(C(ZAE88*L,@BG4 <%J=M-;:N+W688;
MB.6ZW-:F:-!-'' H#X=@I"R,[;2<C(.,BJND^')[O16OCH\;@Z;/-96S[2GG
M7$C.$ ;IM585!('!]CCT.:W@N4"3PQRJ#D!U# 'UYJ2@#S_4O#6J3W:6XL'=
M8)+.&&Z40D>0A0NQ9R7# ^8<*%Z Y)JQ9:5J6GWEM>KH3O(+J^FD2-XES([X
MA8G=]WRV89ZCTYKN** .!3PCJ4ND3>;;H+^+24BM69E.VY8N\SJ>=K;F #=L
M9K7\):++IUQ=7+6DUG')''$D4@A4L%R=Q6(;0?FQDL20.W%=/10!Q"Z)J!N5
M=M&W7L-]/=2W[M&?M"?/LC4YW8*E$P0  #[9FU#3&T;X:1Z-#;K]IN88;-T3
M">9)(51SD?5CGVKL::R*^-RAL'(R,X/K0!P5[X<OIG>YM-)DL;&2Y@,FGQ"
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M/=(^HS@D9Q3Y_!\MC$\&F6"BWAL;6W81,J/>*)MTRDY')10 6Q]\C(YKNJ*
M.*B\-2WNJHTNDI9Z5)>"=[,[,82$H"ZJ2,LS X&>$&>N*I3:!=S6]EIU[X9>
M>T:26ZNGA\@MEY680 LXVJ!C)7J  .]>A44 <,/#=_)XF>6:VFV_;TG2Z7R
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M9O-&4Q,IW\XXYYYX^M %K ]* JJ,  #.>!WI:* $  Z"C SG'-(DB2*61U<
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M[!17C_\ ;/QI_P"@/#_W[B_^*H_MGXT_] >'_OW%_P#%4 >P45X__;/QI_Z
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M_P#%4 >P45X__;/QI_Z \/\ W[B_^*H_MGXT_P#0'A_[]Q?_ !5 'L%%>/\
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M@OG'0/VS38K7^S]:EDLB]QB\6TBC:.,YAMX#*0,+Q^]RO'<UB#6/C0H 71H
M!T CB_\ BJ7^V?C3_P! >'_OW%_\50!OOXAO$T9+NS\0_:YIEMUNW946"T:1
MN2K[2$( *[6W8RI/O:TZ_P!7U)K*QCU5ECN+N>1;F(K([6T<84@,8PK?O7&&
M (QCDURO]K_&?!']BP8/4>7%S_X]39=5^-,D+Q_V3&FY2NY$B!7W'S=: /1_
M"^3%J4BLS0OJ,WE,?X@,*Q_%U>MRO&K;4/C'9VL5M;Z'!'#$H1$$<6 !_P "
MJ7^V?C3_ - >'_OW%_\ %4 >P45X_P#VS\:?^@/#_P!^XO\ XJC^V?C3_P!
M>'_OW%_\50![!17C_P#;/QI_Z \/_?N+_P"*H_MGXT_] >'_ +]Q?_%4 >P4
M5X__ &S\:?\ H#P_]^XO_BJ/[9^-/_0'A_[]Q?\ Q5 'L%8'CG_D2]3_ .N/
M]17GW]L_&G_H#P_]^XO_ (JJVHW/QAU73YK&[T:,PSKM<*L0/Y[J /::*\A;
M6?C/A<:/#G'/[N+KG_>IO]L_&G_H#P_]^XO_ (J@#V"BO'_[9^-/_0'A_P"_
M<7_Q5']L_&G_ * \/_?N+_XJ@#V"BO'_ .V?C3_T!X?^_<7_ ,51_;/QI_Z
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MIS:!92:S&(M0:(&X0  *W?IQ6E0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>ebs20191231exhibit1041002.jpg
<TEXT>
begin 644 ebs20191231exhibit1041002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNRL&8] ,GL3UK#U6\N[03:(]SJ%Y!9:S;1(T4["XDBDCWF(N&!)!/4G.,9-
M'I-%>;QW4Y;Q ^E?VK8VMEI4ZW$&H7C/()RNZ-T5G9E&T-\V0#QC.,TC:MJ*
M_#^31_ML_P#:B2-!]IWGS?*$?G^9NZY\K"Y_O&@#TFBLBSAN-1\(VD2WLUO-
M/9Q9N$.7!*C)!/?KS^-<E+?7MA-J>DQ2W]@L]S8PP1W5P9IHXY9?+DE60LV
MW0#<2I&<#- 'HE%<[H8>P\2ZKH\<\\MI%;V]Q$)YFE:,N9%9=S$MC]V#@GN:
MQO$=_=3Z1XHOHYYXQ9S164"PR%& !C9R,$89C(1GT44 =W17 V%P$\6VL&FP
M:SIZVT;SW\>IWCNLL.T@;$>1RQWX^9<8Q@GG%3:=X]N]2-LUM96\GV^-S;1*
MTF^)MA=/,)7;AL8)!X)'7K0!W%%86D^)%UJ]MH[2$&%[!;N=R>8F<X1,>ORR
M9]-OO6S<"8VTHMF19RA\MI%+*&QP2 02,^XH DHKE_"_]J/INLPR:C]IO8]0
MFC2XG3*@[5Q\@(PHS]T'\:9X>U>/2- NIM<U5G\K4KF W,_5B)& X'3@=!P*
M .KHKB_$VR:%KRSU:]GO]0B4:-;6D[QA6VYWE0<,N2&9G& ./K4U&XO3INOZ
M\]_<K>:3=".WCBG=80L:QDJ8P=K;R6SN!/(QC H [^BN:U'^THO'&CL^H'[%
M,9E2UC7:.(LEG.?F.>G0 >_-8%EJEU<7@UF\75(HO[7:V^TI=8A11,8DC\G.
M"A^4%L9W$GMF@#T2BL31KB2/7=9TIW9TMWCN(2QR524$E?H'1\>@(':MN@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *CN(5N;:6!\[)4*-CK@C%256
MU(E=,NBI((A<@CM\IH S;[PEI6HZ3IVFW"2&/36B:VD# .ICP!SCN!@^M1W/
MA&VGN;J2#4M1LHKQB]S;VTP6.5B,$\J2I/?:1FN1\/VD]SIOA^?2-,UBWOO]
M&ENKV>X8021X!E)#.=P89P O4@\8K6D\9:M!IRWTUM:+%=W\EC:!$ED92CR!
MG<+DD8C/RJ,^X[ '36>AV-A=RW%O&4$EM%:^5_ L<>[: /\ @9_2FZ#X?L/#
M=E)9:<KI \S3!&;.PMV'L,<5B6'BZ]E>#[7:*(/MZVDMP()8E<.F8W57 (^?
M"$'/)X-5;GQ>8?L^M3V0>$V5_<6VR1@7BC>()D9V_."#D@X!&.^0#K++3(+&
MYOKB(NTE],)I2YSR$5 ![80?K6;9^$+"TFMRUQ=W%O:%C:VD[JT4!8$' QD\
M,0-Q. >*S-7\4:UX>@G&I6]C+,UA+=VY@WA0T>W<C G)^^,,,=#P*O:[XAO]
M.O;JUL;$73Q627"JJLS9:783M')"KEL#DXP* +X\.:4-3.H+:1K(;<VY4(H7
M:3D\8Z]OI46E^&+32KF*=;J[N3;PF"U6XD#"WC.,JN #_"HRV3@#FF^&-:?6
MK2>22XM)VAFV;K8.G& ?FC?YD;D\'/KWK$3QU=3:BQ@M/,M%OC:>2EK.TI42
M>69?,"[, @G;Z#KGB@#H]4T.+4KF&Z6[NK*ZA1HUGM64,4;&Y3N!!!*@],@C
MC%))X>T]_#RZ$JO%9JBH C?, I!')SDY')KFKC6-7U4:-J 6WATZXU=8XT1F
M$P56=06/0AMOW<<9')JE;ZM?OF1#&M@NC7LSVIDE.XK*1G=NSG..>P) QQ@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.4A;JJGMG YZ\#GBF+X-TW,KS7%]<3RQI&9Y;EC(H1MZ;3V(89X_'.37044
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M2)(YHQ T:RQP1@1N5\KR<^64(Y4KGK5O3-'@TLSNDL\\UPP:6:XD+N^!@#T
M [ "K]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#V_V93<SEC%%D':IX(Y53GK\HYXJ2+PIIZ2B>:6ZNK@2Q2>?/,6<^6247/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
L% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>ebs20191231exhibit1041003.jpg
<TEXT>
begin 644 ebs20191231exhibit1041003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:*RO[0U?_H!'_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z
M1_\  I* -6BLK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'_P "
MDH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BLK^T-
M7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'_P "DH_M#5_^@$?_  *2
M@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BLK^T-7_Z 1_\  I*/[0U?
M_H!'_P "DH U:*RO[0U?_H!'_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_
M  *2C^T-7_Z 1_\  I* -6BLK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO
M[0U?_H!'_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\
M I* -6BLK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'_P "DH_M
M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BLK^T-7_Z
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M]H:O_P! (_\ @4E']H:O_P! (_\ @4E &K165_:&K_\ 0"/_ (%)1_:&K_\
M0"/_ (%)0!JT5E?VAJ__ $ C_P"!24?VAJ__ $ C_P"!24 :M%97]H:O_P!
M(_\ @4E']H:O_P! (_\ @4E &K165_:&K_\ 0"/_ (%)1_:&K_\ 0"/_ (%)
M0!JT5E?VAJ__ $ C_P"!24?VAJ__ $ C_P"!24 :M%97]H:O_P! (_\ @4E'
M]H:O_P! (_\ @4E &K165_:&K_\ 0"/_ (%)1_:&K_\ 0"/_ (%)0!JT5E?V
MAJ__ $ C_P"!24?VAJ__ $ C_P"!24 :M%97]H:O_P! (_\ @4E']H:O_P!
M(_\ @4E &K145M)++;J\\/D2'[T>X-M_$5+0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %<[K/CO0-#OI+*[N)GGA4/.L$#R^0IZ%RH.VNBKS6TUJU\
M%:WXHAURTN6DU"[:YM"ENTBW:,O$8(!&1TP?6@#K]2\8:%I6G6E]/>AXK['V
M58$,CSY&?E51D]15>+QYX>FT:]U47;K#8$"Z1X666$DX&4(SR3_G%<SJ%PVD
M^(_#?BF_T::QTQ;!X)(8HM_V!VY!95'&0<<"L'Q09/$</BWQ!IMK<#39-/M[
M6*1H60W4@E0EE4C)  QG% 'J$WBC2(!IQ-R7&IQO+:F-"WF*B;R>!_=K+M?B
M1X=O+];&%KXW#,JE#8R@KN.!GY>![FN2MM'U'P_\4- T41/)H\$UU<V$N"1$
MDD3;HB?]EAQ_O5T^C12+\5/$DAC8(UI:A6(X/!Z&@"^?'?AY8;69[TI'=W;6
M<3M&P'FJ<$'C@9[GBK.H>+-'TN74(KNX=&TZ%)[D"-CM1CA2,#G\*\MAT$:U
MI6BZ7>P2B&XUR]60A2"H*MAOSP11%IWB*^B\8Z;J%M)-J-OID-LLBJ3]J$;$
MJP]2RX]\T >M7&O:?:W.FVTTK"35"1:C83O(7<<^G'K44GB?2(O$L7AQ[H#4
MI8O-6+:>1@GKTS@$X]*X9==L_$WB/PD--2X<:2LLU^SV[H+8"+&&) &<C'&:
MP)[/Q/>VUSXW@T>/S#J U&*5IB)Q!'E!%Y>WIMSGGF@#T?5/B#H&CZBVGWCW
MB3J^P!;.5@[8SA2%PWX5=L_%FCWL\D*7#QO%:"\D\^-H]D1_B.X#'2L+Q1+_
M &EK'@F]MD=H9+WS<[3\JF/(SZ=:Q_%FD7^K^*?%-K8Q.99]"B6+ P'(DR5!
M]2!C\: .HT_XB>&M2OH+2&[F0W+;+>6:W>..=O168 $UH6_BC2+J[U.TBNLS
MZ2,W494@H,$Y'J..U<!K6N6OBSPQI7AG1K&[75!-;AX7M73[#Y>-S,Q  Q@C
M@]ZIZKHVHP7_ (H\3:5#(UW:W\L4T.#_ *3:O$H8#UVGYA]#UH ]9T[4+;5=
M.M]0M'+V]S&)(V*D$J1D<&J;?\C;'_UX-_Z,6JO@5&C\"Z(CJ59;*,%6&"/E
M%6F_Y&V/_KP;_P!&+0!>O;R'3["XO;EBL%M$TLC 9PJ@DG'T%<]8?$7PUJ-W
M:VT5U/&]XP6W:>UDC25CT 8KCGMS6CXM5G\&ZVB*69M/G  &23Y;5YM::;J=
MA%X+N=?O;O4-!VV[QPK$L?V&X"#R]^U<L@SC)(]_< [>;XC>'H;RYM=U[+):
MS/!+Y5C*ZJZG!&0N*DU#Q]H6FZE)IT[W;7,2([I#:22;0PR,[0>U<#IM[:Z?
MJWB*.]\3ZQHSOK=U(L%K9M(CJ6X?(C;K@CKV%;<6E:AK'Q*U^XT_6+S2XFM;
M1A)#"I\X%./OCM_6@#HKSX@:#8W$-O,]X9IK=+E8X[.5V$;="0%X^AI;OQ]H
M-E:6%S.]VHU'S/LZ?9)#(WED!OEQD=>XKC_$LB:?\3'EO-;U'2XSI,48NK2V
M,AE8.?E.$;'KT%2:LD^MZYX';1M:O6(^W*-3EM?WBD(O+(Z@<X(Y ]J .K7X
MA>&FTF[U,7D@ALI$CN$:W=9(V8X7*$9YI]GXZT6]6Z>/[:BVEN]S*TUE+& B
MC+8+*,GVZUYGJMK=0^&?%%MJJW4OB$WMLUU<E<K<1*X$;QA5   ZCG'&?0=(
MFIV-YH>OVUKXHU;69I-)N-L%W9M&H^0\@^6O/;&>] '8Q^+M%ETS3=2BN]]M
MJEPEM;.J$[I&) 4C''(.<],54U3X@>'=(OY;*YNI6DMR!<-#;O(D&>F]E! K
MS:+1-3T.3P=;6\,DFDZC>V%\PP2;:X"@2#V#;MW/H?2M[3-<M?!D7B+2=:TZ
MYN+ZZU">XMX5MFD74$DQM 8*1ST.>GOTH ZW4O'>@Z7>Q6<T\\LLUNMR@MK=
MY@T;$@-E0>.*U]*U2VUFP2]M!*(G) \V)HVX./NL :\QUV=+7X@VUU=WE_X<
MB?0HE_T*W,I1O,)\H[48<#V[5Z'X8O+>]T*&2VU&YU%%+*;FYB,<CG)Z@JO3
M..G:@"K!XY\/7'ARY\00WI>PM'V3.(VW(V0,%<9_B'YT_6O&FBZ#?+8W4TTM
MV4\PP6T#S.J?WF"@X'UKQFXT/5-*^&2:CI]O*\&KH]OJ5OM.5=;AC%*!]!M_
M$>M>@)JEMX,\?^(;O78IX[?51!):7B0/(K!$VF/*@D$'M_\ 6H [?2=7L-<T
MZ+4-,N5N+:7[KKD?4$'D'V-1ZWKVF^';#[;JER((2P1?E+,['HJJ.2?I7)^
M[@Z9;7=S?6UQ9IK^LS36-NT+95& (+ ?<S@]?;UJ?Q_%-:ZMX;UYK66ZL-+N
MG:Z2%"[(&4!9-HZA2,T :MAXYT'4;>^ECN)8GT^%I[F">!XY4C R6VD9(^E)
MH_CG1==O(;6P^V,TZEHW>SD1" ,YW%<=!7%ZY>)XNUK4-7T6"=["QT"[AENF
M@>,3.Z-MC4, 3CKT_I73?#_1M2LM!TJZNM<N[B%]/B"V,L2*L.54@ @;N.G)
MH U-<\7Z1X>O(;._>?SYT,D:0V[RDJ#@GY0:6'QCX?G\/RZ\FI1C3X25EE8%
M2C#^$J1G=R.,9Y%<[XGU.UT3XEZ1J-^94M5T^9#(D+R88L,#"@FN8O-,U'4;
M'5/$=MI=RVGOK]O?K:&(K)/!&"'8(>?F+ _A0!Z)HWC;0]=O_L%K--%=%/,2
M&Y@>)I$_O+N R/I5>X^(WABVOWM)+Y\1R^3)<"!S!')_=,F-H/XXK!O=6M_&
M_C'P\WA]+ATTV26:ZO'MWC6$%<;,L!DD]A_C5#PYK]KX:\'Q>%-0T.YO=:@G
M:-M.-LQ%R3*6$@<J5*X(.3Z?C0!Z-:ZU8WFJW^EP2EKK3A&;A=I 4.NY<'H>
M!VK(/Q!\-K:Z3<M>NL6L2-':,86^<JX0YX^7DCK7/OK5KX0^('B2ZUB*X@@U
M.WM6M&C@>19#'&59 5!YSZUR=QX9OY_"7@_2YK66.Y2PU.4*4(*/Q)'GT).V
M@#U:?QCHEOKUQHDETWVZV@,\L8C8A4"[CSC&<<XJIIOQ!T'5KFW@LS>N;E@L
M;FRE"'/0[BN,>]>=:-!?W^ICQ!>VLB7.KV6I3."A^0!51%_)./K6I\/]3L;:
MVT6UF\4ZP+@*D9TUK)O)#'@)N\KID]=WXT =W!XRT*YT[4[^&\+0Z4[)=_(V
MZ,KUXQDCKR.N#5*]^(_AW3[A(+B2\#R;=FVRE8/N 8!2%YX/:O,[_1-3T_PS
MK.NZ9!*_VNZO++4+?:?GC:0^7(!ZJ3^1^M=OKL,K+X"VQ.?+O(2^%/R_NN_I
M0!UQUVQ70'UQVECLDA:9F>)E8*.N5(SVZ8K,TSQ_X>U6^M[*"XGCFNAFW%Q:
MR1++QGY68 'BI_'"-)X&UM$4LS6,H"@9).TUYGI$[3ZIX16RU+4=:GM98EFL
MKJS=(K-"FUW#;5&4[9S_ (@'?-\2?#HFFB1KZ4P2-$YBL974,IP1D+BKE]XV
MT+3H]2DNKIT72Y(X[H^4QV-)]WH.?PKSCP_?V>FS:FE]XHUC27_M2=_LMO9,
M\;+OX;(B;K]:D\16LEU_PFH%O))'<:CIY4;#\Z_+F@#U$Z]IPU&QL!<;YM0B
M::VV@E710"3GIT(K%D^)7A:*[:%KV0Q)+Y+7:V[FW5^F#)C'X]*XRTT/5]-\
M?6OAL^8;*ULKP:;=G)VQ2I\JD^J,"/R]JK_V]<Z9X$L_#=J)K+6K$-%-I<ND
MFY%VV[(()&T#/S9YZ_2@#V&XN8+2UDNKB5(H(D+O(QPJJ!DDFL'2?'OA_6=1
MBL+6YF6:X4M;^=;O&LX'4H6 !JMXRTW4]:^&5W8V\1_M"6TC8Q*,$LI5F4#W
MP1BJVF>,-+US4-*T[3=&GN)D0^<\EL8_[-PO<LO7M\IH N7?Q'\,V5[-;2WD
MK"WD\J>>.W=X8G_NLX& :U&\3:0FO6VB&\7[;=V_VB!0"5D3GD-T/W2<>@KS
MC1]:MO#?@"]\(:GI]V=;5;B$6RVKO]K9RVUU8#!!##DGM5=O!NIW6LZ78EW@
MU73?#,4MM/GB*X2?(4GIT)7Z4 =_>>/M L8IY9I;EDM[F6VE:.UD<(\6-^<#
M@#<.>G7TI+7X@>'[NVCN8Y;E8I9XK>-Y+61 [RYV8R.0=IYZ=*Y/PP][>_#'
MQK<7=G);W5W<7\K0%2"&:$$@ \GG(JSK$$S?#SP,@B<O'=Z:74*<KA.<^E '
M86_BS1KIM66&[W/HQ87B["#'M!)('<?*>GI3['Q-I6I7]M96L[-/=6*W\2F,
MC,+' ;)Z')Z=:\JU#1=2MH_%?B32X9&N$U.\M;F#!_TBUD11D#OM8[A^/I6K
MIE['X8UCPQK6K1SPV$OAB*R,ZPNXCE!5]K!02./:@#M+OQWH%G9S74MQ+Y<&
MHMIK[('9OM &2H &3TZCBFQ>/="DT^\ORUY%;V2!YFFLY$P"<#&1SSZ5YM?1
M3MX5CU1UN[*WOO&AOXYEA/FQ0$-B0+@GC!(X/XUKZQ?VFH> ?$=M9>(-4UR8
MV\;;+NT:,Q@./N_NUSG//7I0!VVC^.-!UO4%T^TN94NW0ND-Q \32*.I7<!G
M\*Z"O-I-2A\6^)/"L>BPW,HTJ0S7=T]M)$D2[ -F6 R6/&!7I- !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %9GB#_ )!T7_7]:?\ I1'6G69X@_Y!T7_7]:?^E$= &G7!W?Q%U*WD
MUB:#PNUSI^C7+P7-RM\JM\N,L$*Y/!SC-=Y7GVF?#FUO]6UZZ\164S1W6I/+
M;QB[81RQ'!!*HV.N>O- &IXI\?VOAW1-.U*"RDOSJ(\R*!6V-Y03>S]#]U<9
M^M7==\76VE:987-I;R:C<:HRI8V\3!3,6&0=QX5<<D]LU@ZMX0UO7O%\]RET
M-'T^RLQ9V1$$4XF5P?,PA/R]EY .!6=:>$_%%CHVD[;>.XOO#-_*+-9)E5;V
MU;C@@G8V. &QC% '36OBO5HQJ*:QX9GT^6SLVNT=)A-!,%!^7S H"MQT(]ZB
MT#Q7XAUQ+&Z_X12."PNPK_:/[31BJ'G.S:"?I6##X?\ $VI:SJNI/IMUIMM<
M6%Q']DN-2$_G32 X*J#M0#..U1^#?#-QHL^E&X^'GDWD 5)=2&H1':<89]H8
MYX)X% '9^)_$X\/BSMX+&34-1U"4Q6EI&X0R$#+$L>% &,GWK,C\=W%NVI6F
MLZ&^GZE8V$E]'!]H$B7$:@YVR <'(QC'%2^,=&U2?5-%\0:-!'=WFCRRDVCR
M!/.CD7:P#'@,,<9K%O-#\1>)[_4]9OM*&G%=&GL;&S-PCR2R2*?F9@=H'..M
M &[X<\2:_KOV.YG\,+9Z==Q"5;K^T$D(4KN7Y H// ]LUU%<KX+\%Z;X>TRP
MNO[-6VU86:1W+B4L=^T;QU*]1VKJJ "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M 9--';P23S.L<4:EW=C@* ,DFN=TKQ]H.KZA!96\ES&]T";5Y[9XTN .3L9A
M@\5LZLN_1[Q?LGVW= X^S!MOG?*?DSVST_&O*O#5U)!KVA6F@76JW4'F8O-+
MU*U+C3DQSME91MQT&.OZ4 >C)XMTA]!O-;663['9.\<S>6<@H<-@=^:J7WC_
M $2QOA9,M[-.84GVV]H\N$894G:.*\['AW4IOAWXANUU34H5%W<D:>BKY<GS
M^A7=S[&K%V\=EXT>6\U75M(C;2;55EL+=G,C!>5.$;I0!WMYX]T:QAL))X[\
M-J"NT$*V<AD(0X;*8R/\*9+\0-'@T_[=+;:HD.]E):PE!7: 22,<#!Z_7TKC
M/$EU;S:EX1OTUC6$LXX+M6U)+9OM&>%Y79QDC'W>E=);7=O?_#W7H[+5-1U4
MK:S@RWT+))DQ'"@%5R/P[T ;WA[Q3IWB:.233TNA&BJV^>W:-7#9P5)'S=.U
M;-87@A'C\#Z(DBLCK8Q JPP0=HK=H **** "LIO^1LC_ .O!O_1BUJUE-_R-
ML?\ UX-_Z,6@#5HI&W!3M +8X!. 3]:R(=9NI=.TJ[^Q0K_:#)N7[03Y:L-P
M(.SYCCMQSW[T ;%%9JZC=276HPI:PD6878S3D>82H;D;?E'/7FHQK,TNGZ;+
M#:(USJ*ADB>;:B?)O.7VYZ>B\_3) !K45E'4[Z+3-0N;G3EBFL@Q">?E)@$#
M95MN<<D<KU!I8M3O(YH$U"RBACN#MCE@G,JAB,@-E5QGL>>>.,C(!J45CWM]
MJ=FLEZ\=LEI%($\DY,LB[@NX,#@$YX7!SP,@GB>^N[O[?#86/DK*\;2O+,I9
M44$ #:""22?48P?8$ T:*R?[9D&A_;?LZFY$OV;RM_R^=YOE8W8^[O[XZ<XJ
M6RN[L7\MA?\ DM*L:RQRPJ45U)((VDG!!'KSD4 :-%8YOM4MYK:6\CMEANIA
M$+=,^;%G.#NSACQR !@9.3CF2ZO-0EOYK335MP;:)7D:<$AV;.$&"-O"Y+<X
MR.#S0!J45G'4+BZT6'4-.@B<SQ+*%N)"FU2N>P.2.../K4EO<W%YHD5W D8N
M9K82(KD[-Y7(![XS0!=HK(CN=5AU>VL[I[.59DD=O*B9"JK@9R6/=E&/?VIE
M[JM[$VH3P)!]FTS_ %RR9WRX19&VG("X5AC(.3GIUH VJ*HW,M].(!IOD!)5
M+M<3 NJCC "@@DG/J,8J.VU9?['FO[M0GV8RK+Y>6!,;$$KZYV]/PH TJ*S]
M/EU&X<RW36L:8Q]FC!9XFXP&?."<=0%_$]X+N_O[&[B:=[,PS7"PI;H&\TAF
MP&#9P<?>(V\ 'GCD UZ*R]>U232[$M;1K+=.&,<;'C"C<S''8 ?F0.]27&I/
M%!:B&#SKJ[P(XMVU?NY)9L'"@=\'J!CF@#0HJA9WE_)>/;7NGB#;&'6:*;S(
MVYQMR54Y]L>G6EFNY6UBWLH",*AFN21G"<JB^Q+9.?1&H O45E3:AJ?]JW%E
M:V%K*L,4<N^2[9"P8L,8$9YRA[^GX(^KRW4%B+"-5GO2W^O&1"%!WE@#\Q!P
MN >2>N* -:BLI-7>'2[^XO(@9].+K,L71R%#C;G^\K+QV)QDXS2VMWJ$6H16
MFHK;DW$321M & 0J5W(<GG[P(;C.#P* -2BL.35[T)/J"1P?V?;SF%U(/F,J
MML=P<X&TAOEP<A>HSBM"];46E2*Q$$:E2SSSJ7 /&%"@@DGGG(QCOF@"Y161
M_;,IT,7@@1KAIOLRQA_D,GF^5G.,[<\YQG':I[&[NOML]A?>4TT<:2I+"I57
M5B1]TDX(*GN>H^@ -"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "LSQ!_R#HO^OVT_]*(ZTZS/$'_(.B_Z_K3_ -*(Z -.BBLZ[UJ"
MUFE3[/<S+;@&XDBCW+#QGGG).,'"@D CCF@#1HI%974,I#*PR"#P12T %%%%
M !1110!&\\44D<;R*KRL5C!/+$ G _ $_A4E96J_\A?1/^OJ3_T1)6K0 45F
MMKENLY7R;@P++Y+703]TKYVXSG/7@G& >IXK2H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *RF_Y&V/_ *\&_P#1BUJUE-_R-L?_
M %X-_P"C%H TY&*1LRHTA4$A%QEO89('YUREEHK6FG:$Z:)*EY T?VC#QYCP
MA5B3OP02<\9-=;10!SLFE+<ZGJUQ=Z/)+NV^0Y>/]Z @&!\_'/\ >Q1'%=QZ
M)I5I=Z&;N%+8+<Q,8V>)U"A2 6P?XNAST^E=%10!SRVE[_8FKQ1VMPJ3QLMK
M:RS!Y!E,=2Q"@GH-W'MG L$7NIFUMY-.FLX89$EE>=XR6V'*JH1F_B R3C@>
M];-% '/-)J,^I-<7FB7DJ6\A%K$DD&P8X$AS("6(Z<?*#Z\U=O5N;758K^&U
MDNHS"T,J1%=ZG(*D;B!C[P//<>]:E% &'_9U[_PCQC,:_:S=?;/)W#KY_G>7
MGIG'RYZ9YJ>S6YN=5EU&:TDMHT@$,4<A7>QR68\$@#[H'/8^U:M% '/Z>^HS
M7J7FHZ+=K<,=J#S(3%:H>N,29)QU;&3T  XJS.;S3]4N;BWL);R.ZB3:(W0;
M9%R,-N(P"-O(ST/MG7HH RHH+C2_#EM9I;R7DT5NL+" H,D+@M\[ 8S[]ZDT
M+[0FCVL%U9RVLL$*1LLC(<D* 2-K$8K1HH HV]M+_;%W>3+A2B0P\YRHRQ;V
MRS8_X *S=;TX:A/-##I<S3RH%-PTNVWZ<,Z!_P!YM[ J>1V'-=!10!B:DE_!
M%:Z;8V=T]F(@LL]O)&) HP B[F7!/=AT[<G(DGL#J7AFXTZ.T?3=\+0PQLR@
MQ\84_(2 .AX.:UZ* ,'2K(QZG#-!I!TN&*V:*4$I^\8E2H&TG=C#?,?[W'4T
M7\4^HW,&W1I(;R&9-EZQCQ&@8%B&#;B",C;CG." ,FMZB@#!\0Z/<W4=U>6=
MS>&X>T-NEO#Y."#GH9!QG(SR,A1Z"I3;7D-KIEVD,DT]I%LE@9D#NK* V"#M
MW @'KC@ULT4 4[6\N+AW:2PEM8%7AIF7>Q[X52>/J<^W>H=%BD:"2_N$9)[Y
M_-96&"B8PB$=B% R/[Q;UK2HH Y^YL)+KQ-/)/8ZA]F>WAB6>"\\I,JTA;(6
M0,1\X'(/>K=[:O9R6%Q8VADCM T36\6T$1L /E!('!5>,],]\"M6B@##&FW=
MYI6KB1!;3ZD[/'&Y!\O]VJ+NQD?P G'KBI;<WE_JUO=36,MG%;0N"LK(2\C%
M>FTG@!3SWR,=ZUZ* .=FM;_['=:,EF[)<W$C"ZW+L6.1R[$\YW#<P QSQVSB
MSK3ZC+/':6]C<R6;KF>:VDC5VY_U8W.I7/=ASC@<\C9HH R+B">XT2(6VGM:
MR6TL;QVC% =L;@[1M)494<<\9&<4^P6YN=5N-0FMI+6,PI#%'*5WG!8LQVD@
M#D <YX/M6I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5F>(/\ D'1?]?UI_P"E$=:=9GB#_D'1?]?UI_Z41T :=<]J>N6-Q=S:
M2-2MK1(_ENYI)E1E!'W$R?O$'EN@SZ].AII12<E0?PH ;;^5]GB^S[?)V#R]
MO3;CC'MBI*** "BBB@ HHHH RM5_Y"^B?]?4G_HB2M6LK5?^0OHG_7U)_P"B
M)*U: .:GUS3-6NFMFU*TAL8)<2;IE#W#JWW0,Y"@CD_Q=!QR>EINQ<YVC\J=
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M([<%;Z:S%N4GW#,8^4;OEY/'''X@'5?\(UI?_/.?_P "Y?\ XJC_ (1K2_\
MGG/_ .!<O_Q5:M% &5_PC6E_\\Y__ N7_P"*H_X1K2_^><__ (%R_P#Q5:M%
M &5_PC6E_P#/.?\ \"Y?_BJ/^$:TO_GG/_X%R_\ Q5:M% &5_P (UI?_ #SG
M_P# N7_XJC_A&M+_ .><_P#X%R__ !5:M% &5_PC6E_\\Y__  +E_P#BJ/\
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MK2_^><__ (%R_P#Q5:M% &5_PC6E_P#/.?\ \"Y?_BJ/^$:TO_GG/_X%R_\
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M  +E_P#BJU:* ,D^&-)8J6@F)4Y4FYE)!Z<?-QUI?^$:TO\ YYS_ /@7+_\
M%5JT4 97_"-:7_SSG_\  N7_ .*H_P"$:TO_ )YS_P#@7+_\56K10!E?\(UI
M?_/.?_P+E_\ BJ/^$:TO_GG/_P"!<O\ \56K10!E?\(UI?\ SSG_ / N7_XJ
MC_A&M+_YYS_^!<O_ ,56K10!E?\ "-:7_P \Y_\ P+E_^*H_X1K2_P#GG/\
M^!<O_P 56K10!E?\(UI?_/.?_P "Y?\ XJC_ (1K2_\ GG/_ .!<O_Q5:M%
M&5_PC6E_\\Y__ N7_P"*H_X1K2_^><__ (%R_P#Q5:M% &5_PC6E_P#/.?\
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M;UXYR?6MZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBH;>\M;O?]FN89_+.U_+<-M/H<=* )J*@:\M5NEM6N81<,,K
M$7&\CUQUIUQ<V]I%YMS/'#'G&Z1PHS]30!+132ZJA=F 4#)8G@#UIEO=6]Y%
MYMK/%/'G&^)PPS]10!+142W5N]R]LL\33H,M$'!91ZD=123WEK:O&EQ<PPM*
M<()'"ECZ#/6@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KE9K"WD\1WO\ Q(+2]5Y81)+(B'RPP^8X(R?6NJK,DT"T
MDNYKKSKU))R"_EWDJ@XX' ; H Q[ZT2SOM(ETTM,=.LIBFP[FE1&B5DX^\=I
M? _O8JG/;F>#Q)=WD.9;K24G"2KS$,S[%P>A 1,_[0S730:'96\]K-%YX>U1
MHX_](<C#'+9&<-D@'G/04ESH%C=R7CS?:";Z(0S 7,@!0$D  'CJ>GJ?6@"E
MI^FV:7RSR:-;:3+!/BW,0C!GS&<@D#D<DX_V0>U8MQ!;PI?K!H@@E:]>.+5%
M6-$MV)X8E3OP#_LX/<@$FNGCT*TCN8;@RWDKP/OC$MW(ZAL$9P6QT)J2VT>S
MM8[F)1+)'=DF5)I6D#9Z\,3C.>U %.YMK?4==N8K^%;F"TM8WCMW7>I9FDRV
MWH3\@ STYQU-9EW!I<FB7,-G8.RQZE;;K6XCVA7+Q#:H;@ J1P./F-;LFC6K
MQP!7N(Y($V1S).WF;?0MG+#_ 'LTR30+&6S:V<W)5YEG=Q<N':1<8)8'/&U>
M.G ]* *NEZ98B7S9=)MM.G=)H3:QJF)H]R\L /FX ^FX^M8%G%''X7TK3[V-
M9XIUL[BU:90V"SQB1.?]XD?[+$=%-=7!HEK!<_:!+=R2"-HP9;J1]H;&<9/!
MX'--3P_IR:=;6!BD>"TD26 23.S1LA!7#$YP,8QTQD=#0!GZMH6GM>I=7%K!
M<27=_&6:2%6(41A=N3U'RY_&MG3K"/3;/[+#@1B21U4+M"AG+;0!V&['X5'J
M&D6VIO$UP]PIB.Y/*N'C /KA2.:NJ-JA1G &.3DT 5-7CCFT>\25%=# ^589
M!X-<Y8Q-8W&DW"Z-'IL!*I-<0.O[TLNU%95QP793DYP0/7(ZFZMH[RUDMI=_
MERJ5;8Y4X/N.15*WT"QMWB;=<R^208UFNI)%4CH=K,1D=N.* *NIZ3IMQK]B
M\^GVLKRB3S&>%6+X48SD<XJ6XMH-3UZ2TOHUFMK>UCDC@D&49G9P25/#8"+C
MTW'UJ:ZT.TO+P7<LMX)5^[Y=W(@7C!P V!TJ>\TV"]:.1S)'-%D)+%(4=0>H
MR.H.!P<C@>@H P;^"*+2M?TU%#VD$(>-&&5B8J24&>@& P';=QQBKTMA::5J
M>GFP@CMENIFAFBB7:DB^6[9*CC(*#GKC([U;;1;%M,FTXK)Y,^3*1,P>0GJ2
M^=Q/&.O3CI3K72+2TF,R^?)+M*"2>=Y64'J%+$[<X&<8S@>E '-Z;I5C*L\<
M^B6MM:I+>-_: 6,-'LG(4 XRN%S] M6_$5JC:U#-'H=OJ<WV&=O+D5/F*M'M
M^\.>I'XFKW_"+:=]GDMS+?&&7?OC-]-AMQ);(W=R3GZU;N-(MKG4([]WN5FB
M78OEW#HN,@D;0<') SZXH QM:T6PL[:!;?3H9DEU&-Q;%$"#*A2%&, ';D^I
M)I\>F6,>EWTC:=;V,]Q:NLEFBIMVHS[6P!R?F'/TK8U'2[?4TB6X:8>4^]#%
M,\9#>ORD9J!- LE,Q9[J1IH3"S274CD(>H!)X_"@#!2*..WTS3;R-9G@F@DM
M)95#,8B1D GNIPI]MA/)J_J&F+->WEQ<::FJ1R$"-HY%\ZVPH!5 V O.6R&!
MRW3@5I_V+8F*SC>-Y/L+B2!GE9F4\_Q$Y(YZ'C@>@J.30+-YYYE>ZA-RVZ=8
M;ET60X R0#P< #(P>* ,G4+>SNAH4L&GQZI&T)\L3A<NGEY!)8?0UK:):6UG
M;MY-O':2SA)IK6,*!"Q0#  Z?=/U.:==:)9736Y/GP_95V0BWG>((,8QA2!T
MXJ6QTRWT]Y7B:9WFQO>:9I"<9P,L3ZF@"Y7-6NFV5YX<35KG:E_-;_:'OC_K
M(7*[CANH53QMZ8&".M=+6;)H%C)(Y83>5(Y>2W$S")V)R24SCD\D="<Y!S0!
MDWR17MYHUS>Z*M[--9R&2'RXV*G]V?XR!@$GOWIE_I[)X>87&GJR'4;=K:SF
M97,2&6-2F>0,_/P"0 V.E;MYI%M?7<5U*]RLL*E4,5P\8 )!/"D#L/RI^HZ;
M;ZI L-R9@B2+(/*F:,[E.1RI'0@'\* ,_2M-LD)E?3+?3YYTEB>T14VR1A\!
MB /FXV_]]8[UA:&D:V^A+!I!TZ:1(V-^=BB<!067Y"2Q89X?'<]1BNG@T2U@
MG,PENWD,31!I+J1RJL03C)X/RCD<\4L6B6,.DKI:K*;9-NP-,[,FT@KAB<C!
M Q@\8H P?$'V>37))H+25KRP@$D<L%H\ADF)#*C.BG "K@@GI+6EJEE8ZUIZ
M:HZ1W$*V4K0K)&&'SA6#<]" OZFK]KI5M:/=O"T^Z\??*6G=N<8R,GY>,#CT
M'I4::'9QZ4=,1KD6Y)SBYDW<G)&[.<<],T 5]$T>SM;83PP11I=VD*21)$%5
MB Q+''4G?@_2FZ)IFGVNIZK);V-M"\=T$1HXE4JIAB) (' R2<>]:5K80V=D
M+.)IO*"[07F9F ]F)S4%CHMKI]S)<0R73/*<OYMU)(&. ,D,2,X4#\* ,ZQT
MJQU33/[0O4!O)M[M<DXDMSD_*C=4V8QQZ'/).:*/<S7>G:W'&3>?V6DUQ'&N
M#.IQO7'<CJON .A-;LV@V,\DA83".9MTT"3,L4A[[E!QSW'0]\U.VFV[:DFH
M9E$Z1^6 )6";?=<X/Y4 85C:V]SI.IQZ8UO#'/>AHRA\M)5Q&VW*] PR,C^]
M5O2[:SM-8V)IC:;</;L1'$5\F50R[F 7^($J,D X/?'%K_A'M+^Q268MRL,D
M_P!H*I(RD29SN!!RN"!C'2IK32X+2<SAYIIBNSS)Y2Y"]<#/0<#..N!G.!0!
M=K%N;"R?Q;93O:0-*;6=S(8P6+*T(4Y]0"<'MFMJLZZT.UO+X7DDMVLP4H#%
M=R( #C( # #.T?E0!2\3365WHIMWB%SY]P+90L)E9&R0[*H!.Y5#D8':J7FP
M3>$];TXQ/Y=G%+Y23PLA\LJ6C(5P#A3E0?\ IG6Q%X?L89;>5#<[[9W=";F0
MY9CEBV3\V?>G7.A65W/=33>>6NX/(E N'52GH #@=3T]3ZF@#%:*)+_2]-O(
MTFFM+H-;2R*&9H3&Y7D]U*@'_=4GJ*EU/2XYIK^>[TT:E%,?DG@D7S[8!0I5
M-V-N""<J<Y/3/78.D6;/922(\DEBQ:"1Y&9E)!!R2<D$'H<]!Z"H9/#]B\DS
M!KF-+ABTT<=RZI(3U)&>,^V,T 5?$5O8WW@Z\N#%%<K'8226\DB!BO[LD,"1
MP>G-+K^E6/\ 8 LX[6*&$W,&U85";"TJ@E<=#@GD>M7]0TFTU.S^QS^:L&PH
M8X9FB!4C!!VD9&.U)+H]M/IXL99+EX@X?<;F3?D'</FSG@@=Z ,BU*S>);!;
MR*)M1M(9HI9=@#.!LVN/8AB?8EAV-5_LFD/X5AU/5;26>:ZM1//>11EID+)N
M8AQRH&3@#@ 8KH_[,M/[0AOS&3<PPF!9"Q)*$@X///(ZGU/J:K2^'K&421[K
ME+>;)DMTN'6-L]> > ><@8!R?6@#34[E# $9&<$8-97BBVM[GP_=^?!'+Y<9
M9-Z!MK8ZC/0UK54U'3;?5+4VUR9A$>HBF:,GV)4C(]J 'JMG!Y>GI'$BM&Q2
M!4 78, \=,?,/SK+T*'3]+TV[N%@@MD%U.)'2,+\JRN%!P.@' ]*N6^BVMO<
M&X62ZDE\IH@TMU(^U6()QD\?='(]*K#POIPB:'S+XQ.Q9D:]E*L2<G(W<Y)H
M CL]-LM6:[NM1MX[J<7,L0\U=WDJC%5"Y^[D -D<Y;/I6K8VBV%C#:)))(L*
M! \K;G8#N3W-07.CVUQ</.'N()) !(8)VC\S''.#UQQGK@#FK<$$5K D$"".
M*-0JJ.@% #I(TEC:*1 Z."K*PR"#U!K$2.6#Q5"9;:"W@-M)#;& Y,G*L0_
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MIW49$:D M[9) _.I:* ,C^UM4_Z%R\_[_P '_P 71_:VJ?\ 0N7G_?\ @_\
MBZUZ* ,C^UM4_P"A<O/^_P#!_P#%T?VMJG_0N7G_ '_@_P#BZUZ* ,C^UM4_
MZ%R\_P"_\'_Q=']K:I_T+EY_W_@_^+K7HH YC67U74[6(1:!=1W%M.EQ [3P
M$!U.<'Y^A&5/LQJ>SEN=/BEBMO"UVBS2O-(#<PMN=SEB29.Y-=!10!R%M97=
MG?:>;?PW=166F0.EM +F%MKN<$Y,AX"@@#_:/M6Q_:VJ?]"Y>?\ ?^#_ .+K
M7HH R/[6U3_H7+S_ +_P?_%T?VMJG_0N7G_?^#_XNM>B@#(_M;5/^A<O/^_\
M'_Q=']K:I_T+EY_W_@_^+K7HH R/[6U3_H7+S_O_  ?_ !=9S:GJ/_"3(_\
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MHH Y9AJ3ZU:7G_".W*V]C T=O"DT "LV 3]_LJ@#_>;VK2_M;5/^A<O/^_\
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M_%UGZWJ>HO81A]!NHP+NV()FA.2)XR!P_<\?C73UF>(/^0=%_P!?UI_Z41T
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MOS$#BJ.H^&M5N)-9,=NI%WK-G=1?O%&Z./RMQZ\8V-QUXKN** .8M=%OHO\
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M/,[+R/9A5SQ!_P BYJ?_ %Z2_P#H!K0K/\0?\BYJ?_7I+_Z : +-E_QXP?\
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M&P0/$&(4W,H#,".Y10!ST+&NP!R,BL7POH!T/1&M9O)-S=327-T8EPADD))
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M0W.H.UXZ.Q/E"0Y5!GH%7:,>QJ#Q-H%SK5E:Z%;V]G'H[-']I+$AT1&#!(T
MQSMQG(P*Z,    8 Z 4 +6?X@_Y%S4_^O27_ - -:%9_B#_D7-3_ .O27_T
MT 6;+_CQ@_ZY+_*IZ@LO^/&#_KDO\JGH **** "BBB@ HHHH **** "LK1?^
M/K5_^O\ /_HJ.M6LK1?^/K5_^O\ /_HJ.@#5HHHH **** "LSQ!_R#HO^OZT
M_P#2B.M.LSQ!_P @Z+_K^M/_ $HCH TZ*** "BBB@ HHHH **** ,K5?^0OH
MG_7U)_Z(DK5K*U7_ )"^B?\ 7U)_Z(DK5H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCH TZ*** "BBB@ HHHH **** ,K5?^0OHG_7U)_Z(DK5K*U7_D+Z)_U]2?\
MHB2M6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH **** "L_Q!_P BYJ?_ %Z2_P#H!K0K/\0?\BYJ?_7I+_Z : +-E_QXP?\
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M]B;4XQ+YODD[&,8DSC:7QM!SQC-9^BXO?'NHZK';S""?3+80RRPLF?FD)'S
M$'ID?2N*U6;5-0\)7-JXU&&[$^Y]%LM+$<$ $VXDOLRPP-V0W)/3K0!Z7JGB
MG1-%N!;ZA?K%-L\PH$9RB?WFV@[1[G JFGB^SE\8QZ!&RNLEF+A)E#,'9CP
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M)GE!1E(C'\8!&67W&17#:CI\EYX?\1WUO%K&J?:I+)-]W;I&;L1RJ3LC5$.
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M -:%9_B#_D7-3_Z])?\ T T 6;+_ (\8/^N2_P JGJ"R_P"/&#_KDO\ *IZ
M"BBB@ HHHH **** "BBB@ K*T7_CZU?_ *_S_P"BHZU:RM%_X^M7_P"O\_\
MHJ.@#5HHHH **** "LSQ!_R#HO\ K^M/_2B.M.LSQ!_R#HO^OZT_]*(Z -.B
MBB@ HHHH **** "BBB@#*U7_ )"^B?\ 7U)_Z(DK5K*U7_D+Z)_U]2?^B)*U
M: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK*;_ )&V/_KP;_T8M:M93?\ (VQ_]>#?^C%H U"0!DG %4M,UG3-:BDETR^@
MO(XGV.\+A@&],BH_$4<LOAW4$@N&MY/L[D2*H8C R>#QR./QKAM&?7XM-\(:
M+IVM"VCO]+:>29K6-VB54B*JHQ@XW$9.?O$G)Q0!Z717%6UQXDUUM6GL];6Q
M33+A[2&/[-&XG>-1N>0D9 9CT7&!5:PU_7?%6IZ=#8:@-*@N]%2]E*0)(RR%
MRI"[@1CZYX'OF@#OJCGN(;6WDN+B5(88E+/([!54#J23T%>>V>N^)SX?T[Q#
M<ZO$ZG4$LY;1+5 DJ>?Y+,6^\&)!;@@=L5UOBS2AK?AJZTXW,=LTVS9)(,KN
M5U901W!( (]#0 [1_%6AZ\9AINHPSM!DR*#@A0<;L'^'WZ5-;>(='O;&2^M=
M3MKBVC<1O+%(&56., D=_F'YUQNA7Y35);76M(B@U*4WJVM[!)OCDPVZ6,=&
M&.",CD"IM&\+6?BCX:^'K:Y=H?+MD821J-X^7H&[<[2?7;B@#MYKJ""6&*65
M4>X<QQ*3]]@I; _!6/X&H+36-,OKRXL[2_MY[FU.)XHY S1G.,,.W-8&H_#W
M3-2.G%RL?V")8PL<*A9<$9W#NI!<;>G[PFI;8!?BA>@  ?V-!T_Z[2T ="UW
M;K=I9M/&+B1#(D1;YF4$ D#T!(_.JNL:-;:W:QP7#S1-#*)H9H)"DD3C.&4_
M0D?B:YSQ!;7]W\1-)BT^^^PN=.N3),(U=@F^/[H;(SG'4'C-53XEUK3X+@WE
MTDZZ+JT=O?3")5\^VD5<.0/NLI=2<8'RF@#J=(T"UT>6XN$FN;JZNMOG7-U)
MOD<+G:.P &3P .M++H-K/KT6L337$LL"D0PO+F*)B,%U7^\02,^YJMHNI76J
M:WK#^8/[.M)EM(%"CYI%&96SUZL%]/E-33>)M-@UH:0_VK[4651MM)3'E@"/
MG"[>_KQ0!8U&?3=.7^U=1EAMQ;H4$\K8V!B,@'W('UP*KZ=XIT/5=+EU*TU*
M!K6 9F=FV^4,9^8'[O'K5?Q9I4^J6M@;2XMH[RSO4NK=+DGRYG4-\AQST).1
MG! -<)%?V\G@+6;2YTK[#JO]A;_-#AUNH &"L"/0DC!&1GO0!Z9!K.F75K;W
M5O?03074GEPR1N&61N> 1_NG\JG:Z@6[2T,JB>1&D6/N54J"?P++^8KG-9\&
M6/B:+3IYY#"]M",%$!W]" V>J_>&WH=U27'@;39_$T&N<(\!3$ C78=HZGWR
M(R#V\L4 ;&FZSIFLQO)IE_;WB1MM=H) X4^AQ5H21F4Q!U\P ,4SR >AQ^!K
MF?#  \6>+0!C_38?_1"5DW-S<Z-XU\4:P;N2:.RTF*X-OY:@. )2JYQD $'G
MWYH [^H+R\M=/M)+N\N([>WB&7ED8*JCW)KCS?>(M&MM&U:_U=+Z+4+B""YM
M/LZ(D7FG ,;#YOE)'WB<C/2MOQ;I3ZOI,4$%S!!<1744\'VCF.21&#!&'4@X
MQQ0!+I?BG1-9M+BZL=1ADBM<F<D[3$!GE@>0."<^U6+?7-*N[..\MM0MY[>2
M40I+&X96<G 7([Y(%>?V6H1MH^M6NHZ2MIJS:9?&.Y23>D\0DDW@'@C:[=",
MXYK=F\(6?BCPMH8GE:![>SC*R1H"Q)C& 2?X0V&([X% '6/=017$5N\JK+,&
M,:'JVWKCZ9%06&L:9JLD\>GW]O=/;-MF6&0,8SSP<=.A_*L2^\!:7>ZS9ZCA
M8OL:QHL"1+Y;A>,,._ 4#^[M&*71 !X_\48'_+.R_P#0'H Z>BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ IDL?FPO'O9-ZE=R'##/<'L:?10!G:+HMMH
M=H]O;O-*TLAEFFGDWR2N>K,>YP /H!6C110 4444 %%%% !1110 4444 %%%
M% !1110 5G^(/^1<U/\ Z])?_0#6A6?X@_Y%S4_^O27_ - - %FR_P"/&#_K
MDO\ *IZ@LO\ CQ@_ZY+_ "J>@ HHHH **** "BBB@ HHHH *RM%_X^M7_P"O
M\_\ HJ.M6LK1?^/K5_\ K_/_ **CH U:*** "BBB@ K,\0?\@Z+_ *_K3_TH
MCK3K,\0?\@Z+_K^M/_2B.@#3HHHH **** "BBB@ HHHH RM5_P"0OHG_ %]2
M?^B)*U:RM5_Y"^B?]?4G_HB2M6@ HHHH **** "BBB@ HHHH **** "BBB@
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MM%_X^M7_ .O\_P#HJ.M6LK1?^/K5_P#K_/\ Z*CH U:*** "BBB@ K,\0?\
M(.B_Z_K3_P!*(ZTZS/$'_(.B_P"OZT_]*(Z -.BBB@ HHHH **** "BBB@#*
MU7_D+Z)_U]2?^B)*U:RM5_Y"^B?]?4G_ *(DK5H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR7^53U!9?\>,'_7)?Y5/0 4444 %%%% !1110 4444 %96B_\?6K_P#7^?\
MT5'6K65HO_'UJ_\ U_G_ -%1T :M%%% !1110 5F>(/^0=%_U_6G_I1'6G69
MX@_Y!T7_ %_6G_I1'0!IT444 %%%% !1110 4444 96J_P#(7T3_ *^I/_1$
ME:M96J_\A?1/^OJ3_P!$25JT %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !64W_(VQ_]>#?^C%K5K*;_ )&V/_KP;_T8M #_
M !'_ ,BSJO\ UY3?^@&N6TWQGX>L/A[I\1U6SN+I-,BB%G#,LDSR>4!LV DY
MSQTKNF574JP#*1@@C((J"+3[*WD$D-G!$X_B2, _F!0!Y:--O=+OO#.GZI+I
MD,<&C;8AJT9> 7&[YU'S ;PNT<]LXJQIT:QVNC"&\M[FU/BK,/V6%HX(_P!S
M)N6/<3E-V2"#C).*],NH+6XA,=Y%%+%G)650RY_&G"W@"1H(8]L1!C 483TQ
MZ4 >;A#9V^H^(HP=^C>)+B63'4P-M24?]\G=_P  JMJT5S/X1@UR;RHXM;UF
M.ZO#<H6C2UP5A60 C* +%GGO7J/D0['3RDVR$EUVC#9ZY]:4QQF+RBBF/&W;
MCC'IB@#RJ[B18?%+V]_I4@.@RBX@TFW9(=W.QF.XKOQN&.N#[5N:EHMCX>\.
M:3KVEV44$FDO%<7#1( TL3*$F+'^([26R?[M=K%8VEO;M;PVL,<+9W1I& IS
MUR!Q6=X@TBXUW3/L%MJ7V*VF!2YV1!VEB(P54Y^4D<9YZ]* *?@J-[C3KG7I
ME(FUJX:Z&>JP_=A7_O@*?^!&LRQUK2M(^(?B@:GJ=G9&5+/9]IG6/?B-LXW$
M9QD?G7:111P0I#$@2.-0J*.@ X J*73[*XD,DUG!*YZL\8)/XD4 <;J5YHNH
M>.M-NM2N;*YT>33I/L,LCJ]NUP),/@_=+;<#\ZP#]D,3;=@\)?\ "2+_ -</
M+\OGV\KSO^ YKU%["SDMA:R6D#P Y$31@H/PZ5)Y$/D>1Y2>5MV^7M&W'ICT
MH \]UZ\\*6UGJT>F6,5RD\UI%=>7-Y=EO9\+O9> !P7P.1M!ZU2L(X)O'%Y:
M_P#$FF$NA3"6'2X<1$AT*AN2&89]!@$>M>F)8VD5J;6.UA2W.08EC 0Y]NE$
M-G:VX006T,0C!"!$"[0>N,=* /./#K6C0> /[-:W+"VN!)Y6,"7[,-V['\6>
MN>:S_P#B3#X:1>5Y!\5><N.GVS[;YG.?XLYS[;?:O6([.UA(,5M%&0Q8;4 P
M3U/U-)]BM!=?:Q:P_:",>=Y8WX^O6@#S]=#TS4+/QY=7EC!<3BYF19)$#% L
M",-I/3DYX]O2NR\/M)<^$M,9Y&,DMA$6<G)R8QS6D(8@' B0"0Y<;1\QZ<^M
M*JJBA$4*JC  & !0!Q'@KQ#I&A^%(='U>_MM.OM)#0W,%Q((V!!.& /W@PP0
M1US5;4=7MM=U#POJ6L6AM-$FEN2J7F/+:3 $#N#P-PWE0?6NZGT^RNI5EN+.
M":1/NO)&&*_0D<5)-#%<1-%/$DL;<,CJ&!^H- 'E6J"U+^(!I07_ (1L7MA]
MM^S?ZG&[_2-NWC&W9NQ[Y[UHR_V0/'<I\*?9/M7_  C]S_QY;=GF;D\O[O&[
M]<8]J]$BMX8(1!##''$!@1HH"@?04RWL;2UQ]FM88<9QY<87&>O3Z"@#R71H
M8'T[PX8-1T.&[%S"4^S6KF^,F?WBR'>3S\P<D8_2O4]/_LO[3??V?]G\_P [
M_2_*QN\S ^]COC%3I96D=RUS':PI._WI5C 9OJ>M2)%'&S,D:J7.6(&-Q]3Z
MT <7KC:KK7CRVMM'6S==!B\^;[66">=*"J#Y1U" D?[U9NG7<WA[3?$?A[7-
M.COE@!OH[2UR4>VF;]X$SSA&W'UKT98HT=W2-59SEB!@M]?6CRHS*)O+7S N
MT/CG'IGTH \TEO;#1(K*X\'^+Y;\S3Q1Q:/)<BZ65&8 JH/SQX!)SGC'-:%I
MINIW_C_Q4;#7I],5)+4.L5O%)O\ W Y^=3C'M7:PZ=8V\[3P6=O%,_WI$B56
M/U(%3+'&CNZHJN^-S <MCIGUH X'Q-X:ATCP_:6T5[=R7%]KMK)<7KLIF:1I
M%&X<8& !@8P,=*9JVER:!XCTJ[UW5+_5]$:=51KN48L[G_EF[A0 RD\9(^4U
MZ"\<<H D17"D,-PS@CH:)8HYXS'-&LB-U5U!!_"@#@==_P!,\)^-M7/(G62V
MB/\ TSA79_Z,\T_C6+J\FD6VE:?=Z5XOFUK4[>>![;2Y+U+I)I,@;3&HR,9)
M![8KU9;:W6 VZP1B$YS&$&WGD\=*9#86=N^^"T@B?IN2,*?TH XJ==8\0>-=
M1O=+CTZ:TTR(Z:!>E]K.V&E*A1U^ZI^E8,KW2^"X_"U_.8K_ $;6;2U,D+<B
M)I 8G4D?W3@9'\->L1Q1Q B.-4#,6.T8R3U/UIK6MN[EV@C9R02Q0$DCI^5
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M;7$UG \-M':PM&BE\;W.6/S$*!@<#F@#+2SO[?XHV4U_J371GL+HQQ*FR.!
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M **** "BBB@#*U7_ )"^B?\ 7U)_Z(DK5K*U7_D+Z)_U]2?^B)*U: "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *S_ !!_R+FI_P#7I+_Z :T*
MS_$'_(N:G_UZ2_\ H!H LV7_ !XP?]<E_E4]067_ !XP?]<E_E4] !1110 4
M444 %%%% !1110 5E:+_ ,?6K_\ 7^?_ $5'6K65HO\ Q]:O_P!?Y_\ 14=
M&K1110 4444 %9GB#_D'1?\ 7]:?^E$=:=9GB#_D'1?]?UI_Z41T :=%%% !
M1110 4444 %%%% &5JO_ "%]$_Z^I/\ T1)6K65JO_(7T3_KZD_]$25JT %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !64W_
M "-L?_7@W_HQ:U:RF_Y&V/\ Z\&_]&+0!J,RHI9B% [DTC,JXW,!DX&3U-9_
MB/2QK?AS4-,(!-U;O&N>S$?*?P.#7 :O+<>-]'T>"!V%Q::0^J/CM<J D8_[
M[$GY4 >GG8'&=H8\#U-*5!QD XY'M7$VNI#Q'XHL]6MHUEBT[1?M4:%]H\ZX
MZ*3V^6,CVW56L?&U]_;6E6\VKZ/J2ZA/Y$]O81/_ *,Q4D8EWLKX(P>!GM0!
MZ!3?D<_PL5/UP:X2P\9:G=:\+2:]TNTF^V&%M)NH7BF\K<0'24MM=B,, %P<
MXS45O<^(+76?%]QI":?Y5M=B5_M0=C*1 AV+M(V\#J<]>E 'H.X;MN1NQG&>
M:1E5QAE##T(S7#W'B@F6?6+6PMUG_P"$6_M**20$L.K",X(RN?H?>K5KKOB&
MVU31#JIL'M-9##RH(G5[9A&9!\Q8AQ@$'@>U '7]:*X"?Q7XH/A7_A++9=-%
MC,ZF*SDA<R)$T@57+AL%N<D8 YZTC:O?Z!XB\::M=2PW%M90P,($B968E#Y:
MABQ ZX/').>.E '?[5W;MHW'C..:=7)_VKXCT:_TK^W'T^XMM3G%LRVL+1M;
M2LI91DL=Z_*03@&LM?%?B?\ X1\>)9!IHL8[LPO:B)_,D3S_ "BP?=A3GM@]
M.O:@#OR0H)8@ =2::DT4APDB,?0,#6+XX_Y$77?^P?/_ .@&N?O/!>@1^"3J
M-E80Z?J%O8?:8;RV'ER)(L>X-D=>1SF@#NI)8X8VDE=8T499F. ![FF6UW;7
MD7FVMQ%/'G&^)PPS]17"V\@\8>(]"M]8B66T&A1ZF;5A^[DG=@N67HP4= ?[
MU=+:^&=)TW7UU/3U6PEDA:*2WMPJ1SC((9D Y*^HYYH V))(X8VDE=411DLQ
MP!^-$4L<T8DBD61&Y#*<@_C65X@TC2]06VO-9E LM.9IWBE*^0YVX!D!'.WD
MCWKA)HF_L35;G3[=].T77=3L[>VA53%F)F5)9 O\(D'';(Y[T >GPW$-PI:"
M:.50<$HP8 ^G%(MS;O.T"3QM*G+1AP6'U%<C-IMIHGCS3+72(4L(M3L+F*=+
M9 @S'L*/@#&X;F&<5GW.A:3;:KHNA>'K9'U33[F*XO+]5'F11#ES+(.K2<C;
MWSG  H []KB!)EA>:-97^ZA8!F^@[TYW6-&=V"HHRS,< #U-><#2K+6/"GBK
M6;V!'U$75XT5TP_>6_DDB(*W5=NP'CW]:M>-+>[UOX9G49M1F@B&EBXEMH@%
M$TA0$;FZ[0?X1C/>@#O@<C(Z4!E;."#@X.#T-1VW_'K#_N+_ "KFO!'_ !\^
M*!_U'9O_ $7%0!U =2"0P^7KSTJ&VO[*]++:W<%P4^\(I VWZX/%<#'I=UK6
MC>,;"SDC6:7720DCE5E 6$F,D<@, 1^-/M#I%OX@TG[?X7N/"VH)-L@FMDC,
M%P2I'DM(G!!Z@$ Y P: /0Z*** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S_$'_ "+FI_\ 7I+_
M .@&M"L_Q!_R+FI_]>DO_H!H LV7_'C!_P!<E_E4]067_'C!_P!<E_E4] !1
M110 4444 %%%% !1110 5E:+_P ?6K_]?Y_]%1UJUE:+_P ?6K_]?Y_]%1T
M:M%%% !1110 5F>(/^0=%_U_6G_I1'6G69X@_P"0=%_U_6G_ *41T :=%%%
M!1110 4444 %%%% &5JO_(7T3_KZD_\ 1$E:M96J_P#(7T3_ *^I/_1$E:M
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MHH **** "BBB@ HHHH **** "BBB@ HHHH *S_$'_(N:G_UZ2_\ H!K0K/\
M$'_(N:G_ ->DO_H!H LV7_'C!_UR7^53U!9?\>,'_7)?Y5/0 4444 %%%% !
M1110 4444 %96B_\?6K_ /7^?_14=:M96B_\?6K_ /7^?_14= &K1110 444
M4 %9GB#_ )!T7_7]:?\ I1'6G69X@_Y!T7_7]:?^E$= &G1110 4444 %%%%
M !1110!E:K_R%]$_Z^I/_1$E:M96J_\ (7T3_KZD_P#1$E:M !1110 4444
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M8\H%VY.">NT<>PH ] HKF/ >HSZEI5Y(UY)>VD=[)'97$Q'FO$,??[Y#;AR
M< 9%=/0 4444 %%%% !6?X@_Y%S4_P#KTE_] -:%9_B#_D7-3_Z])?\ T T
M6;+_ (\8/^N2_P JGJ"R_P"/&#_KDO\ *IZ "BBB@ HHHH **** "BBB@ K*
MT7_CZU?_ *_S_P"BHZU:RM%_X^M7_P"O\_\ HJ.@#5HHHH **** "LSQ!_R#
MHO\ K^M/_2B.M.LSQ!_R#HO^OZT_]*(Z -.BBB@ HHHH **** "BBB@#*U7_
M )"^B?\ 7U)_Z(DK5K*U7_D+Z)_U]2?^B)*U: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ K*;_ )&V/_KP;_T8M:M93?\
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M;Q+D-O2(A@BKC(8E0"3QP3S74GQ+I?\ PDD?AY)_-OVB:5D3!$2C'WCG@G/
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M@ HHHH RM5_Y"^B?]?4G_HB2M6LK5?\ D+Z)_P!?4G_HB2M6@ HHHH ****
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MVXN+29)H6+*'0Y!*DJ?R((_"IZ "BBB@ HJ&XN[>U,(GE5#/((HP>KL<G _
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M\V-)=7@PP^8A"@W<<\,>F.:FU72+?6(;>*Y:15M[F*Y7RR 2T;!E!R#QD<T
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MA5 R<\#DUKT %%%% !6?X@_Y%S4_^O27_P! -:%9_B#_ )%S4_\ KTE_] -
M%FR_X\8/^N2_RJ>H++_CQ@_ZY+_*IZ "BBB@ HHHH **** "BBB@ K*T7_CZ
MU?\ Z_S_ .BHZU:RM%_X^M7_ .O\_P#HJ.@#5HHHH **** "LSQ!_P @Z+_K
M^M/_ $HCK3K,\0?\@Z+_ *_K3_THCH TZ*** "BBB@ HHHH **** ,K5?^0O
MHG_7U)_Z(DK5K*U7_D+Z)_U]2?\ HB2M6@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M110 4444 %%%% !1110 5E:+_P ?6K_]?Y_]%1UJUE:+_P ?6K_]?Y_]%1T
M:M%%% !1110 5F>(/^0=%_U_6G_I1'6G69X@_P"0=%_U_6G_ *41T :=%%%
M!1110 4444 %%%% &5JO_(7T3_KZD_\ 1$E:M96J_P#(7T3_ *^I/_1$E:M
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5E
M-_R-L?\ UX-_Z,6M6LIO^1MC_P"O!O\ T8M &K1110 4444 85_X.T?4;R>Y
MF6Z3[5C[3%#=R1QW&!CYT5@&X&/<=:VHXTAB2*)%2-%"JJC 4#H!3Z* "BBB
M@ HHHH **** "BBB@ HHHH *JR:?;RZE#J$BEIX(VCB)/"!L;B!ZG &?2K5%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5G^(/^1<U/_KTE_\
M0#6A6?X@_P"1<U/_ *])?_0#0!9LO^/&#_KDO\JGJ"R_X\8/^N2_RJ>@ HHH
MH **** "BBB@ HHHH *RM%_X^M7_ .O\_P#HJ.M6LK1?^/K5_P#K_/\ Z*CH
M U:*** "BBB@ K,\0?\ (.B_Z_K3_P!*(ZTZS/$'_(.B_P"OZT_]*(Z -.BB
MB@ HHHH **** "BBB@#*U7_D+Z)_U]2?^B)*U:RM5_Y"^B?]?4G_ *(DK5H
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MYJ?_ %Z2_P#H!H LV?\ QXP?]<U_E61<^(KF+Q3)HT&F&>."S6[FF6;# $N
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MUBS=Y'8*JJ)0223T %4/%^N:7XDLK;0-$U"WU&]N[R _Z)()1"B2*[2,5R
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MU1)(%..<\ \5FZI\0Y(M5U.WM-0T2S339#%Y6H2,);EP 6VX("#)V@D-D@T
M=Z$0.7"@,1@MCDTM<#=_$*>:6Q-I/IVE6]Y8I=13:HKE)G;.8PRE54KCDDGK
MTJQ=7>M77C7PJX>U@CGLII)H0S2+G]WOPP(#<'Y3CCGKF@#L/L=K_P ^T/\
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MQ%>]T:\A>$O(MF6CFMG&/E9'8DCDC.!R.E '84444 %%%% !1110 5G^(/\
MD7-3_P"O27_T UH5G^(/^1<U/_KTE_\ 0#0!9LO^/&#_ *Y+_*LM]!N!XO\
M[>@U 1H]LEM-;&#=O569@0V>.6].U:EE_P >,'_7)?Y5/0 5B^)="N/$%O;V
MJ:@+6W29)9E\C>9=CJZ@'(V\K[]:VJ* "BBB@ HHHH **** "LK1?^/K5_\
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M[.U+8=%22)S-#O\ /CD*EQP1M/R\=<9[ULGQ%H8NY+,ZQ8"XB($D1N4W(20
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MP<\\CM4TVJ:?;V\=Q-?VT<,H)CD>90K@ L2"3@\ GZ#- &?X8T&?0+:]2YU
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MYYXQ^.?:EO?!@O)=3G%^T,]W>PWMM*L63;2QHJKP3\P^4Y''!(]ZG\*^*?\
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M]?UI_P"E$= &G1110 4444 %%%% !1110!E:K_R%]$_Z^I/_ $1)6K65JO\
MR%]$_P"OJ3_T1)6K0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M10 4444 %%%% !1110 5E:+_ ,?6K_\ 7^?_ $5'6K65HO\ Q]:O_P!?Y_\
M14= &K1110 4444 %9GB#_D'1?\ 7]:?^E$=:=9GB#_D'1?]?UI_Z41T :=%
M%% !1110 4444 %%%% &5JO_ "%]$_Z^I/\ T1)6K65JO_(7T3_KZD_]$25J
MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M64W_ "-L?_7@W_HQ:U:RF_Y&V/\ Z\&_]&+0 _Q'?3:9X9U2_MAF:VLY98^,
M_,J$C]16%HO@KP_=^$;:.[L(+N6]MEEGNY$#322.H)?>><Y.1SQ762Q)-$\4
MJ!XW4JRL,@@]17*1^#M7M;$Z38>*I[?2L%$B-JKS11G^!92> !P"5)% #GO=
M3CU*Q\+:)?1,T.GBXFU&]3SV*;MB8"E0S$@Y.>@[FJ,_C#78[:*R2WLO[636
METR<D-Y+!HRZR 9R.-IQD]"/>M63P>+.2QG\/WO]ESV5K]D&Z'SDDASD*RD@
MD@\Y!!Y/7--@\%1Q1VK2:A)-=1ZH-3N;AXQF>3:5Q@'"K@C YQB@#$U_5-?&
MB^*M%OKJS:>TTS[3'=00,@>-PX92N\X;Y" <GKG!JU%J7BC^T=,T"QGTWS&T
ML7<MS+;OM&'V@! _H5'7L3[5LZEX5BU*\U:>6Z=5U33A8LJKS&!O^8'N?GZ8
M[4:3X<N+'4[;4;O4A=W$%@;(D0",./,W!L9.,  8_&@#G?$?C34M(DU&5=5T
M:.2Q9C'IGEM--*@[NZM^[)&3C;QQFM=]9UK6=;NM.T.6SLX[&"&2:6ZA:4R2
M2*65  RX  Y//7@57F\!W;Z=J>DPZ\8--U&265D6T4S!I"209"WS+D_W<XXS
M5V7PO?07QOM(UH6-Q/;QP76^U$J2[ 0KA2PVL 2.I'3CB@#&>YUL>/M+N=0D
MM[0QZ--+<VZQF0* Z;PK;@,G@@XX'!!J0>)_$<'AZW\6W(L/[,F,<CV*Q-YL
M<#L K"3=AF 8$C:!UK4C\'?9[S2KFVU.4FQMWMI_M""4W4;L&8$DC!)'7WZ5
M63P-<?88-&GUR2;0K>162S-N!(R*VY8VESRH('\(.!UH B677?%=YK^DO+96
M^DPRRV#MY3-,X:$=/F !&\?7/;'-;5_$-]X=U"/1$U"QTFVM+2(6MQJ%J[QW
MC@$%?,#!8P, '.3SFNJTC1QI5QJ<PG,O]H7ANB"N-F45=O7G[F<^]4M7\/ZG
M>W=S+9:Z;>"\B$<UM<6PN(Q@$90%AL)!YZ@]<4 ;-C-)<6%O/*(A))$K-Y3[
MTR1D[6[CT/>O,/!\%G)X>A,OP_&JL9Y\WIAMF\S]\_=V#<=.1VKTG1]+@T31
M[32[9G:&TB6)&<Y8@#J:@\.:*OA[1(=,6<SB)Y7\PKMSOD9^F3TW8_"@#%\0
MZW<Z3J":?!JVD:-;) IA$\1FEF/(VK$K*54  9Y]NE5=/\8:MKVGZ#!81VMO
M?ZI'-+/-)&SQPI$VQBJ9!)+$8!/'>M6Y\,WH\0WFKZ9JZV37\<<=PKVHE8;
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M_P"OZT_]*(ZTZS/$'_(.B_Z_K3_THCH TZ*** "BBB@ HHHH **** ,K5?\
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M110 4444 %%%% !1110 5E:+_P ?6K_]?Y_]%1UJUE:+_P ?6K_]?Y_]%1T
M:M%%% !1110 5F>(/^0=%_U_6G_I1'6G69X@_P"0=%_U_6G_ *41T :=%%%
M!1110 4444 %%%% &5JO_(7T3_KZD_\ 1$E:M96J_P#(7T3_ *^I/_1$E:M
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5E
M-_R-L?\ UX-_Z,6M6LIO^1MC_P"O!O\ T8M %G5G>/1[V2-BCK;R%64X(.T\
MBO.O"]QX?U+3])2X\5>('U.XBB\R/[?=!3*0,CTQGWQ7I&HP/=:;=6\>-\L+
MHN>F2"!5;PY83:5X9TO3KG;YUK:10R;3D;E0 X/ID4 <_##/XO\ $.KK<ZA>
M6^F:7.+2*WM)VA,L@4,[NRX8_>  SCBJMQ<W_AZ\UG0/[1NKJW?1IKZRFGD+
M30,N59-_4C)4@GD5IS:7K>AZ[?:EH4%M?6VHLLEQ93S&%DE "[T?:1@@#((Z
MCK4*^'-7U%M7U75C;)J-YI[V-K;0.6CMXR"<%R!N8L1DX'2@#C%UNQ@\/Z9<
MZ9XIUI]>E%N!%=W,S6[R-MWA_,&S;RW?Z5ZR+BX.J-;&S86PA$@NMXVE]Q!3
M;UR  <].:XJ31O&&H>$$\+SZ=I-M ;5+5[IKII2%50I8)L'S<9'/!KL+9+RW
MNTM?+C:PBME"S,Y,K2 X((QC&T Y]2: ,;Q/=WMUK>D^'+*[ELA?B6:YN(3B
M18HP/E0]BQ8#/8 U0U>RF\%O9:MI^I7\UHUU%;WEK=W+SJZ2,%WJ7)*L"0>#
M@UL>(]$O+V[L-6TF6&/4M-9_+6?/ES(XPZ,1R,X!!YP1TJA<:;X@\37=DFLV
MEIING6EPMP\,-R9Y+ET.5!.U0J9Y/4G':@ NO%EQ=OK-K!H]U]DTX3175]'<
MK'L*Q[AL[[NG3ID&G6_BF9H[*PTC2[C4[@6$-S/YMRJ^4CCY0SM]YS@_EG(J
M:#0+V/2O$]LWE^9JMQ/);X;C#Q*@W>G*FL2!+KPQK*)9W.F/=RZ3;1WEK>W+
M0!3$&594?:0R_>!'7@>M &C;>*8-:;0;L6]]:?:=0GMUB\[9RBR ^8H^\/E/
M'8X]*8GC^9K%=4.@7"Z4+G[/+=F=,H?,\O<$ZLN[ )X[\'%9OA#2;_4=&\/Z
MB7B<0:K=W<LG*B17,JAE'H2P(]C6DWA;43\.GT$&'[8;@R#Y_EP;KS>N/[OZ
MT =E1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5G^(/\ D7-3_P"O27_T UH5G^(/^1<U/_KTE_\ 0#0!9LO^/&#_ *Y+_*IZ
M@LO^/&#_ *Y+_*IZ "BBB@ HHHH **** "BBB@ K*T7_ (^M7_Z_S_Z*CK5K
M*T7_ (^M7_Z_S_Z*CH U:*** "BBB@ K,\0?\@Z+_K^M/_2B.M.LSQ!_R#HO
M^OZT_P#2B.@#3HHHH **** "BBB@ HHHH RM5_Y"^B?]?4G_ *(DK5K*U7_D
M+Z)_U]2?^B)*U: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ K*;_D;8_P#KP;_T8M:M93?\C;'_ ->#?^C%H U:Q(/%>GW'
MBN?PXBRBYA0MYI4>6[ *60'/+ .I(QWK1U34(-)TNZU&Y.(;6)I7^@&<?6O+
MC!XETWPW9Z]-H4:W%G>-J]Q<K> R.LF3*OE[>/W9VXSQM% 'K=%<#'9:'XC\
M>:L=1=+JW_LZUFMX7D(1E8/F0#/4#;SVW>]8^G"'6I?!UMJ]S)-:2G48XO-E
M(^UQHZB(-_>^4 \]<#KF@#U:FN2J,RJ6(&0H[^U>6:A"JIJFBV,\J:5%KUC!
M!Y<A_<E]OFHC9R ">@Z$UZ/IMCINB6T.EV*QV\8W-'#O))YR2,G)Y- %72_$
MVG:GHDVK;FM8;8NMTEP KV[)]Y7 S@CK^56M'U(:QI4&HK;3VR7"[TCG #[>
MQ(!.,CG\:X_Q!H-O-\0=.M!(Z66M(\VH6J_<N&M]I3/UW#/J%%6O$>D6FM^/
MM*L+]7DM/[.N'>%9&59"'CP#@C(&<_4"@#M*IZAIVF7R!]2LK6Y6$%@;B)7"
M>I&1Q3;Z+3+O3KFPNWC-LL>R=/-V;%(Z$@@KQ]*L@016H&5$")C+'(V@=R>V
M* .<L_&]E+]C?^R]0MM.O9%AM+Z2)!#(3PG ;<H;L2H'2I=1\:6EA<WB+I]_
M=V^GD"]NK>-6CMS@$@Y8%L @G:#@5EP747C2^M'CDBM?#]A.LENI8*]](A^0
MA?X8P1D=VP.@J*PNK>P\.^-DO)$1X+Z\DE5S@[74%/S! 'K0!T>O^*M)\-Z,
M=4OKE?*9-T*(07GXR @[_P AU-.U;Q';:3!9DV]Q=7%\VRVM;=0TDAQD]2
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LIO^1MC_Z\&_\
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MR>XCV',04?.6';'>MGQII]W?:1;R6<!N9+&]@O#;@@&98W!*C/&<=/<5T-%
M'#&YU+5O&#ZG8Z'=PI%HEQ#%)?0&(2S%T94(/(''?&><=*Q5M-7OO^$>>2#Q
M!<7%MJ%M+>K<P"&WMP#AMB* " 3P1D  \UZG10!YIJ6C:I=6>O6$=A>B6/6T
MU.,Q@*+B(%.(W/&_@G![@5J>'[%KKQ3#J M]>>.UMG7[3JTGE[6<CY%C*Y;I
MDG.!@=:[>B@#E_$D-U:>)-&UZ.RGO;:S2>&>.W3?)'Y@7#JO5ONX..<&L#5=
M-U/6+'Q1JD.F74*ZB;..VMY(\32")QN<IU'7C/.%YKT>B@#.\0Z?+JWAS4M.
M@<)+=VLD*,>@+*0,^W-<A+<7^J?\(M8KX=U"V?3KV%[MY8,1P[8V4A6_B&3U
M'&!SUKT"B@#RMM$OK"UU;2;FU\17,US<SM%'9R 6MTDK$C<^TA.&PV[TXS5O
M6] U$6'BJVM[&>3SM(LH+<+E_,9 X90<#<1D9X[UZ310!PWB_0]3GUSR],A=
MK77X4L]1D3_EBJ.#O/UC:1/RJ+6M)N-/\8SZALUE;"ZLXHHGT<;C&T9;Y&4
MG!!!!''6N^HH X#1]#NK>[\-3'3;N%%O[RYF6XE$KQ;XGPSD !2Q(..Q.,T>
M-=/N_P#A(X+:PX3Q-"+"[VG!4(VXO[_NC*OY5W]9R:%8+KKZT4D>\:/RU9Y6
M98UP =BDX7.T9P.<4 2I<K!J$>F1V5PL8M_,6=8QY*@$*$SG[W?&.@K&\0?\
MCCX4_P"OBY_])WKI:SM5T*PUI[:2\6;S+1R\+PSO$R$C!Y4@\CB@#1JKJ?\
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M6N[93,&N(@8 #*"X_=@C(+>G'K0!-156#5-/NK1[NWO[::WCSOFCF5D7'7+
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M)]-DU^^T<SQI+90I+([RJ 0=V0.?X0N3Z9%71JVFF.:4:A:E+<XF;SEQ&?\
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M 4444 %9GB#_ )!T7_7]:?\ I1'6G69X@_Y!T7_7]:?^E$= &G1110 4444
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M^O27_P! - %FR_X\8/\ KDO\JGJ"R_X\8/\ KDO\JGH **** "BBB@ HHHH
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M:VTZ&221[N,R6\RQ,89E R=LGW3@>AH UZ*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K/\ $'_(N:G_ ->DO_H!K0K/\0?\BYJ?_7I+_P"@&@"S
M9?\ 'C!_UR7^53U!9?\ 'C!_UR7^53T %%%% !1110 4444 %%%% !65HO\
MQ]:O_P!?Y_\ 14=:M96B_P#'UJ__ %_G_P!%1T :M%%% !1110 5F>(/^0=%
M_P!?UI_Z41UIUF>(/^0=%_U_6G_I1'0!IT444 %%%% !1110 4444 96J_\
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M@ K,\0?\@Z+_ *_K3_THCK3K,\0?\@Z+_K^M/_2B.@#3HHHH **** "BBB@
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MTK2;/3HW9TM($A5FZL%4*"?RH XF]\3W]MK$VA#5_L/]EVT*RW TZ6[:YF9
MQSM&%7&/<DT]/$_B+6?^$=MK$P:;<:G'=?:GFMF;RS"4 948@X.3@'LP]*W[
M_P -3R:O-JNE:O/IEQ=1K'<A(DD27;G:V&'# '&?3M3[7PM;VEUI%PMW<RMI
M<4T:M.^]I?-V[F9CWRO;CF@#GY?$6HZ?+JUM!%9M?R:K;6$,WD[%9Y(D)DD
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MS(U[;VVLW=KINH3--<V<:I\S,<N%<C<@;N!ZG&,U)<>$I5O;N?2-:N=+CO\
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MZK8AU6_\F/,BO]Y70 *1P.F.0#0!F^'+-V?Q1HME=26-O#J.('@ S"'C1W5
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *S_ !!_R+FI_P#7I+_Z :T*
MS_$'_(N:G_UZ2_\ H!H LV7_ !XP?]<E_E4]067_ !XP?]<E_E4] !1110 4
M444 %%%% !1110 5E:+_ ,?6K_\ 7^?_ $5'6K65HO\ Q]:O_P!?Y_\ 14=
M&K1110 4444 %9GB#_D'1?\ 7]:?^E$=:=9GB#_D'1?]?UI_Z41T :=%%% !
M1110 4444 %%%% &5JO_ "%]$_Z^I/\ T1)6K65JO_(7T3_KZD_]$25JT %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !64W_
M "-L?_7@W_HQ:U:RF_Y&V/\ Z\&_]&+0!JT444 %%%% !1110 4444 %%%%
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MO^OZT_\ 2B.@#3HHHH **** "BBB@ HHHH RM5_Y"^B?]?4G_HB2M6LK5?\
MD+Z)_P!?4G_HB2M6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6)I;E?L$GB^(23H^!Y>(0Q##MC/(H ]91TD&48,,XR#FJ=SJUM::M8Z9)O\
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M!AF) .X]3[]S6#<>-]96RU;5(-#MWT_1[N:"X+W96658W(+(NW'3GDCN.V:
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M *^I/_1$E:M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5E-_R-L?\ UX-_Z,6M6LIO^1MC_P"O!O\ T8M %C6=+AUO1KS2
M[@E8KN%HF9>JY&,CW'6N=70/$]YJ&BR:I>Z<8-)G\P^0K[[C]VR;CGA3ST&1
MR>>E=?10!P</@74;*W?2[+^QA9&9FCO9;0/=11EMQ7!!5B,D!B>G:KVJ>#KJ
M^&O"*XA0:I-9R19!^00[,@X'?8<8KKJ* .8UKPBVJ^*;#54N5CMDV?;8"/\
MCX\MB\/Y,3G/:H-3\*7G_"0WFKZ;!I-W]O1!-%J41;RW0;0R, >", K[=:ZZ
MB@#F;'PO=6E_H-S)=PRG3(+E)RD*Q>8TNPY55& !M/OTZG-9&L65IKOQ)L(+
M*Z$@MX]^KPIR (G#P!O?>QX[@&N]IH158L% +=2!UH J:Q8R:GHU[80W+6TE
MS \2S)UC+ @'\*Y&R\$ZG%-HK&#1+&/2[A)72RB;=<84J6+$ @X)XYR3R:[N
MB@#DIO"%W)X&U3P^+F$3WTMPZ2<[5$DI<9XSP#4T^AZW9:SJ-WH=U9)#JA5Y
MENE8M!(%";TV_>R /E..1UKIZ* ,KPOI,NA>&;#2IY$EDM81&SIG#$>F:XVY
M^'>K3:+?Z2C:.&NI)'.IO$S74V7+ .<<=@2">.@KT>B@#F)]%UZQUC4+[0KB
MP"ZH$::.[#_N954)O3;]X$ <''(Z\U&OAW7-*U!=0TJ_MKRXFLXK:\_M#<OF
MM'G;*"N<'YCD8].:ZNB@#C+GP=J7VBPU/[38ZIJ,-N]O=#48?W4RL^\%< E"
MI) X/%9VNZ1JFF:9HR"YLDOY]?BE3R+8)!%\CX3 P67 P23GD^U>B4A .,@'
M'(H Y.7PKJ6K_P!KW6L7-K'>7^G-IT"6H9HX(SDDDM@L2Q!Z#@ 54E\):U->
MZ=J%W%HM_-;67V5K>Y#M#$0Q(ECR#\Q& <@=.M=Q10!Q=AX*O[6SM89KRVD>
M'73J;/&A164@Y4+S@Y;@9QCO5O6O!S:UJ.K2RW*Q0ZAI\5JA49>-T=G#8Z$9
M(X]JZFB@#EWT/Q!K226NOWUI'9-:RV[Q6 ;]^77;O;=]W R0!GD]:J:7X3U:
MVN-/CN1HL4%BZLUQ:V8\^Y"C"@[AA,\$D$G(XQ79T4 87B[0I_$&DQ6MO)#N
MBN8YVAN 3%<!3DQOCG:?QZ#BLFR\'7XU>ZO;@Z;:0W.ER6(MK&(JL.6!# X&
M[OG@=N*[.B@#*\-6-_IGA^ST_46MWFM(EA#6^[:RJ %//? YK+;PI=-X4U_2
M/M$7FZK<7<L;\[4$K$@'Z9YKJ:* .8ET+6M.UB;4]#FL7:\MXHKJ"\WA=T8(
M5U9<GH<$8YP.:T?#6B-H.D_9I;C[3<2S27%Q-MVAY78LQ [#)P/I6M10!R%O
MX;\1:=:R:-INI6D&EO<-)'<;6^TPHSEV11]TG)(#$]#TJ[!X<N(M-\26IGC+
M:Q<32Q'G"!XE0!OQ7/%=%10!P[>"]1AU"SNTCTK4/)TZ&T"Z@C,+=D'+Q@ _
M>[C@\=:FT7P9?:8VB^?>03?V9>W=P[*I7S%E5P,#L<OR*[*B@#S_ %;4H_#_
M (FUDVNO:?IINTCFN(M0C;<&V;1)!R/,R  5_O+46B^#[Z7PQX:ODAM/[0LK
M-HY+748BT<B2$-@\$JP(!!QZ@UZ$T:.RLZ*Q4Y4D9Q]*?0!C>'-(N]+BN7O6
MLQ+<R[Q#9P".*%0,!0< MW.3Z]!5#4/"US?:YJLC30'3=9L%M;E3N$L94. 4
M['[_ ']*ZBB@#D4\.^(+\Z7::U>6#66F3QS[[97\VY:/[FX'A!G!."<D=JU?
M%6CW&N:&]G:3117"S131-*"4W1R*X!QS@[<<5LT4 8FC:1>6>M:IJ=Y) 7U!
M+?*0YPC(FUNO;)X]JYZW\!7EA8:*\!TZ[O=.M&M)HKR,M#,A;=D'!*D$<'!Z
MFN\HH Q_#FDW6E6L_P!L>T,UQ*9#':0+%%$N,!%P 6QZMSSVJGJ.@ZK;Z[-K
MGAZ[MHI[J-([NVO$8Q3[>%?*\JP!QW!'TKI** .4M_#&J:GJDVH^)+NU9GLI
M+)+:Q1@BQR$;B6;DG@=@*KIX7U^ZT_3]#U.^L7TNQDB8RPHXGN5B(**P/RKR
MJY()SCM79T4 <Q=^$6N?&T&MBY468"2S6N/]9<(K)&_X*_YJM4[SPA?PZMJ-
MUID.CW$6I/YS?VA 6>WDVA25(!W X!VG'/>NSHH Y[3/#<^GZ[9W[74<R6^E
MFS8B,1EW,@<MM4!0.#P*A'A>Y'ASQ'IGGQ>9J\UU)$_.$$HP-WT[XKIZ* ,+
M2-!GT[7;C4))HW2:QMK8*N<AH]^3]#N%9]IX0N[?PQX=TEKF$RZ1=PSRN,[7
M"%L@<=>>]=;10!PTG@K4K62_M]-71FMKV=YDN;NUWSVI<Y8 8(?!)*Y(QWS6
M[8Z!+9^)Y-4\Y&A;3H;-5VA6RC,<X   (8<"MRB@#C%\(:I::=I8L[FT:\T[
M4I[L"8-Y;K*9.,CD$"3\Q74VHOQ/=?;&MS$9/]&$08,$P/OYZG.>G;%6J* "
ML_Q!_P BYJ?_ %Z2_P#H!K0K/\0?\BYJ?_7I+_Z : +-E_QXP?\ 7)?Y5/4%
ME_QXP?\ 7)?Y5/0 4444 %%%% !1110 4444 %96B_\ 'UJ__7^?_14=:M96
MB_\ 'UJ__7^?_14= &K1110 4444 %9GB#_D'1?]?UI_Z41UIUF>(/\ D'1?
M]?UI_P"E$= &G1110 4444 %%%% !1110!E:K_R%]$_Z^I/_ $1)6K65JO\
MR%]$_P"OJ3_T1)6K0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZMXXH[Q8+N0Q6UV]NRP3L,\*WO@XSC..* .AHK \::]/X<\.O?VL#32^?%$
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M10 5E:+_ ,?6K_\ 7^?_ $5'6K65HO\ Q]:O_P!?Y_\ 14= &K1110 4444
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MYJ?_ %Z2_P#H!K0K/\0?\BYJ?_7I+_Z : +-E_QXP?\ 7)?Y5/4%E_QXP?\
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M.NAV$EJLQF#W,T^XKC'F.7Q^&<4 97BG7+K3+VWMTU;3-)@DC+&>[4RR2/G
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MIPT?1+'3%E,HL[=(!(1C=M4#..W2@"[1110 4444 %9_B#_D7-3_ .O27_T
MUH5G^(/^1<U/_KTE_P#0#0!9LO\ CQ@_ZY+_ "J>H++_ (\8/^N2_P JGH *
M*** "BBB@ HHHH **** "LK1?^/K5_\ K_/_ **CK5K*T7_CZU?_ *_S_P"B
MHZ -6BBB@ HHHH *S/$'_(.B_P"OZT_]*(ZTZS/$'_(.B_Z_K3_THCH TZ**
M* "BBB@ HHHH **** ,K5?\ D+Z)_P!?4G_HB2M6LK5?^0OHG_7U)_Z(DK5H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVWNUM)M:LHYVD,7EM, 0P)4@^AR".>XJ+P5=P7?@W2C"Q/DVD4,@*E2KJ@#
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MHW]G:VT @:VE:3!F$B;B?<#CD>M;5]KNDZ;917MYJ-O#;S8\J1I!B3(R-O\
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MNHG3K;5[2:[!(\I)022.H'J1W KB].-]J>J7T6@:OK.HZ<VE3Q_:;XD1BY;
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M_P"0=%_U_6G_ *41UIUF>(/^0=%_U_6G_I1'0!IT444 %%%% !1110 4444
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M7_QRM>B@#(_X1JP_Y^-4_P#!M=?_ !RC_A&K#_GXU3_P;77_ ,<K7HH R/\
MA&K#_GXU3_P;77_QRC_A&K#_ )^-4_\ !M=?_'*UZ* ,C_A&K#_GXU3_ ,&U
MU_\ '*/^$:L/^?C5/_!M=?\ QRM>B@#(_P"$:L/^?C5/_!M=?_'*/^$:L/\
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M_A&K#_GXU3_P;77_ ,<K7HH R/\ A&K#_GXU3_P;77_QRC_A&K#_ )^-4_\
M!M=?_'*UZ* ,C_A&K#_GXU3_ ,&UU_\ '*/^$:L/^?C5/_!M=?\ QRM>B@#(
M_P"$:L/^?C5/_!M=?_'*/^$:L/\ GXU3_P &UU_\<K7HH R/^$:L/^?C5/\
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M R/^$:L/^?C5/_!M=?\ QRFIX5TR,N4DU)"[;G*ZI<C<< 9/[SDX Y]JV:*
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M"O\ ,JEN@..<G'-9D6F7^I:9J^F6T\$4PUJ5KM;A6(EA;YU0X(."K1CW (H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNO2SS2"+$@C,THW$]=I0K^&*J:1I.I07OV:PLIX?]&N8_,O+01R6;,,KMG7
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *B@MH;8R&&,)YKF1\=V
M/4_CBI:* "BBB@ HHHH *B>VADN(KAXPTL(81L?X=V,X_*I:* "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>ebs20191231exhibit1042001.jpg
<TEXT>
begin 644 ebs20191231exhibit1042001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(/0T .HHHH **** "BJUS?P6LELDA<FZD\N+9&S M@GD@<# /)XJS0 4444
M%%4=,UBRUA;EK*1G%K.UO+NC9"LB@$C# 'C<*O4 %%%07MY!I]G->7+,L,"%
MY&5"Q"CJ< $T 3T5!97D.H6%O>VS%H+F)98V(QE6&0<'V-3T %%%% !1110
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MYIDM8UDDQ"Y&ULXP<?-T/ R: +E%,BECGA2:&19(Y%#(Z'(8'H0:?0 4444
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M2&/S9"_W]YV8(.>>!FFS>#;.36;C4H+^_M!>8-W;6\P6*X(&,L,9!(X)4C-
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M,FJRZ+;MK4446H $3+$P*Y!(!&/48..V:RI_ FFF/3OL%W>Z9/IL/D0W%I*
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M#R2//&V2O[R0;Q[@ ?D*P[B;5-$TO4K,6-O_ &E%H[26VIZ;PMS &4%BO59
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M-<;JQL=&TK4;K2-4$]C=WMH=0%IM$%M$6Q(4V<*67&[GN#QFM2S71[3XJ*;
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M/)AE/*@+@ GOTZ]^M ">)=;GT.UM)H;>.<3WD-N^^0J4$CA=P '/7U%;&0"
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MZ* *ITS3VM$LVL;8VT?W(3"NQ?HN,"J,NFZE<ZNHGFM%T>W9)(+>*)A*SJ.
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MXS3M&?6=.\8W&BWFIR:I9-8BZ2::-%DA??MV$H "&Y(X_A- '54444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !116;XBGU*VT"\GT>$3WZ1Y@C(R&
M;TQD4 :5%>/_ /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_
M /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V
M'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3
M?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P'
M'_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_
M /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V
M'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3
M?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P'
M'_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_
M /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V
M'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3
M?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P'
M'_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_
M /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V
M'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3
M?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P'
M'_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_
M /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V
M'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3
M?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P'
M'_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_
M /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V
M'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3
M?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P'
M'_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_
M /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V
M'_P''_Q='_"3?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3
M?&+_ *%V'_P''_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q='_"3?&+_ *%V'_P'
M'_Q= 'L%%>/_ /"3?&+_ *%V'_P''_Q=1P^,?BS-=S6JZ';F6!09$$'*[@2N
M?G[XH ]DHKQ__A)OC%_T+L/_ (#C_P"+H_X2;XQ?]"[#_P" X_\ BZ /8**\
M?_X2;XQ?]"[#_P" X_\ BZ/^$F^,7_0NP_\ @./_ (N@#V"BO'_^$F^,7_0N
MP_\ @./_ (NC_A)OC%_T+L/_ (#C_P"+H ]@HKQ__A)OC%_T+L/_ (#C_P"+
MH_X2;XQ?]"[#_P" X_\ BZ /8**\?_X2;XQ?]"[#_P" X_\ BZ/^$F^,7_0N
MP_\ @./_ (N@#V"BO'_^$F^,7_0NP_\ @./_ (NC_A)OC%_T+L/_ (#C_P"+
MH ]@HKQ__A)OC%_T+L/_ (#C_P"+H_X2;XQ?]"[#_P" X_\ BZ /8**\?_X2
M;XQ?]"[#_P" X_\ BZ/^$F^,7_0NP_\ @./_ (N@#V"BO'_^$F^,7_0NP_\
M@./_ (NC_A)OC%_T+L/_ (#C_P"+H ]@HKQ__A)OC%_T+L/_ (#C_P"+H_X2
M;XQ?]"[#_P" X_\ BZ /8**\?_X2;XQ?]"[#_P" X_\ BZ/^$F^,7_0NP_\
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M5(]QPNY@,GT%25XO\3;J#Q+XKN]-_M6"R30+!IHO,G6/S;HX;8N3R=H ]B*
M/999HH$WS2)&O3<[ #]::US D(F::-8CT<L I_&O+?&6MQ^*O@U8:B2-UQ/
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M3);ZT@<QRW4,;CJKR &O!],\01VGB:S\?3:G!YFHZE+!=67G*9(K5@%0E<Y
M7:?R7UKM?C!X9T5O"6I^(/L*'4QY(%SN;./,1>F<?=..E 'H0O[)D9Q=P%5Q
MN82# STS4DL\4$1EFE2.,=7=@ /Q->4>/?#.C>'_ (57$NE6*6KW9M3,59CO
M(/'4G^\?SJ[?6,/C'XKG1-9+2Z9I>G+/%:;RJR2-M^8XZ_>_0>] 'I4,\-S&
M)8)4EC/1D8,#^(H2>&6(RQRH\8ZNK C\Z\VM].MO!?Q;TO3=##06&LVLAN+0
M.61616(< ]/NC]:XSP'K%WX:\.R07[?\2C7[:X%O(>D-PH9=I]-P _3T- 'O
M375NEO\ :&N(EA_YZ%P%ZXZ].M*ES!+*T4<\;R)]Y%<$CZBO+-)_T[P!X&T(
M<_VA>AY5_O10LTC_ ,EK"T:_7PY\4M2UV=RMG-JM]97![ ??3\V'Z4 >X)<P
M22M$D\;2)]Y%<$CZBFR7MI%.MO)=0I,WW8VD 8_0=:\+\#7-[IFN:YK[#-[<
M^'[G4L$9&XR[E_#@'\:ZKP?\//#_ (B\$P:GJ\3WFHZFC32WK2MYBL2<8YQQ
M_/K0!Z;-<0VZAIYDB4G +L%!/XT0SPW"EH9DE ZE&!_E7A4]]/K_ ,./#4&J
M.;H1>(%M#(Y),L8!QD_1L?A73>(-!T[P)XN\,7_AR%K(WU\+.Z@21F69&('(
M)/3/YXH ]--U;!9&-Q$!$<.2X^0^A]*:E_92N$CNX'=NBK("37B^J_\ (L_$
MW_L*Q_\ HX5T'@?2=$?4M/EC\!7^G7$<0D74)BWE[@O7[W?MQWH ]-CFBF!,
M4B2 '!*L#@^E1PWEK<2/%!<PRNGWE1P2OU Z5X?'J%W9_#?4K:UG:W_M'Q0]
MI+*AP51E!//OMQ]":]"_X5CX<T^]TR\TII=)NK.4$2PRG=.,<HV[(.<<^V:
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M%>8>._#>E> [;3/$?AJ Z?>07L<+)'(Q$Z,#E6!)ST_G69K5M87/Q;\1B_\
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MH **** "BBB@ KC]$^&^CV*WDNLP6NMWMY<O<27-S:KD;OX0"3@=>_>NPHH
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M&1U4 O@8&3WXXH6"%)GG6)%ED #N% 9@,X!/?&3^=244 0_9+;,Q^SQ9N/\
M7'8/WG&/F]>..:KVFAZ1IZRK9:796RS B00VZ(''H<#FKU% &;#X<T*WF2:#
M1=/BEC(9'2U164CH00.#4CZ)I,FH#4'TNS:\!R+@VZ&0'_>QFKU% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<_I/_(Z^(?^
MN5I_Z"]=!7/Z3_R.OB'_ *Y6G_H+T =!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !6!XY_P"1+U/_ *X_U%;]8'CG
M_D2]3_ZX_P!10!OT444 %9=@;J/6[VVGO9+E!;PRH'15"%FE! V@<?*.N3[U
MJ5E06FJ)K,M[)):&*6..)E56W!4+D$'U^?\ 2@#5HHHH JZG_P @J[_ZX/\
M^@FJ7A/_ )$[1?\ L'P?^BUJ[J?_ ""KO_K@_P#Z":I>$_\ D3M%_P"P?!_Z
M+6@#7HHHH **** ,+5EO+17NUU*4W3R;;2U0+L<]D(QDYP2S9X&2, 5NUAC3
MM834+B]$UE+*Y987E1_W,>>% !^A)ZD^P &Y0 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5#=W=O86LEU=S)#!$-SR.<!1ZFIJ* .?\
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M,%A_W^%=!10!SX\=^$V.!X@L2?\ KJ*/^$]\)_\ 0P6'_?X4OCC_ )$W4?\
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MTP8E3[HJ=/\ ;KLX]#L$MK.W,;,ME-Y\)9SD2?-ECCJ3O;\ZCA\,Z1;+MAM
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MHKJ>Y4R>9.%#AI&*_*,#"DX'7MUJ>@#G_''_ "+#_P#7W:?^E,==!7/^./\
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MS0IM>ZE$LS$D[F"J@^GRJHQ[5@WW@C39;!K>T$D;&(VZ>;/(ZQPNR^8BJ20
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M7<7/E7=P\Q26':<AF)(#!N1G&155$OM&TCP]XB;5;ZXN[ZXMEOTFN&:*19\
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MF('IECCVK5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M++G'EF0!L_2IR0JEF(  R2>U &!_PG7AS_G_ '_\!I?_ (FC_A.O#G_/^_\
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M0/Q-.66-XA*LBM&1N#@Y&/7- &%_PG7AS_G_ '_\!I?_ (FC_A.O#G_/^_\
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M . TO_Q-;D-Q!<IO@FCE7.-R,&'Z5')J%E#&DDMY!&DAPC-( &/L<\T 8_\
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MS_O_ . TO_Q-'_"=>'/^?]__  &E_P#B:Z"B@#G_ /A.O#G_ #_O_P" TO\
M\31_PG7AS_G_ '_\!I?_ (FN@HH Y_\ X3KPY_S_ +_^ TO_ ,31_P )UX<_
MY_W_ / :7_XFN@HH Y__ (3KPY_S_O\ ^ TO_P 31_PG7AS_ )_W_P# :7_X
MFN@HH Y__A.O#G_/^_\ X#2__$T?\)UX<_Y_W_\  :7_ .)KH** .?\ ^$Z\
M.?\ /^__ (#2_P#Q-07WC7P_/87$,=Z[/)$RJ/LTHR2"!_#73T4 <=X>\7Z'
M8>&],L[F\>.>WLXHI4^SR':RH 1D+@\BM'_A.O#G_/\ O_X#2_\ Q-=!10!S
M_P#PG7AS_G_?_P !I?\ XFC_ (3KPY_S_O\ ^ TO_P 36U#>6MR[I!<PRM&<
M.J.&*_7'2D:\M4N5M6N85G89$1D <_AUH QO^$Z\.?\ /^__ (#2_P#Q-'_"
M=>'/^?\ ?_P&E_\ B:V9KZTMY!'/=0Q.1D*\@4X^AITUU;VZ"2>>.)&. SN%
M!_.@#$_X3KPY_P _[_\ @-+_ /$TC>//#2*6?42JCJ6MY0!_X[6W!=VUUN^S
MW$4VW[WEN&Q]<5C>.?\ D2]3_P"N/]10 G_"=>'/^?\ ?_P&E_\ B:/^$Z\.
M?\_[_P#@-+_\3704QI(U=8V=0[YVJ3RV.N* ,+_A.O#G_/\ O_X#2_\ Q-'_
M  G7AS_G_?\ \!I?_B:VKB[MK15:YN(H QPID<+D^@S1->6ML%,]S%$'^[O<
M+N^F: ,7_A.O#G_/^_\ X#2__$T?\)UX<_Y_W_\  :7_ .)K::\M4@$[7,2P
MMTD+@*?QI8+FWN5+6\\<P'!,;AL?E0!B?\)UX<_Y_P!__ :7_P")H_X3KPY_
MS_O_ . TO_Q-;SR)'MWNJ[CM7)QD^@J.XNK>TC\RYN(H$)QND<*,_4T 8O\
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M=0WUK'=6[EXI5W(Q4C(^AYJ:BB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *\TT19DCTS6;^QL)#<:O)&TB[A=K*TCIN+@X('W=F,!1UXQ7I=9J>']
M(CU,ZFEA"+LL7\P#^(C!;'0,1QG&: -*O-M/L/[1TO14@FL7O8+K4)8;*_1F
MAN!Y[JQR.C+D8.#U/%>AVMI;V4)AMHA%&79RH_O,2S'\22:I7'AO1KJQCLI]
M.A>"*1I8U(Y1V))93U!))Z>M ''-;V=WI=[HSP6^B7BZK"6M78SV<LQ575
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MT:[_ -_X_P#XW7044 <__P (K/\ ]#1KO_?^/_XW1_PBL_\ T-&N_P#?^/\
M^-UT%% '/_\ "*S_ /0T:[_W_C_^-T?\(K/_ -#1KO\ W_C_ /C==!10!S__
M  BL_P#T-&N_]_X__C='_"*S_P#0T:[_ -_X_P#XW7044 <__P (K/\ ]#1K
MO_?^/_XW1_PBL_\ T-&N_P#?^/\ ^-UT%% '/_\ "*S_ /0T:[_W_C_^-T?\
M(K/_ -#1KO\ W_C_ /C==!10!S__  BL_P#T-&N_]_X__C='_"*S_P#0T:[_
M -_X_P#XW7044 <__P (K/\ ]#1KO_?^/_XW1_PBL_\ T-&N_P#?^/\ ^-UT
M%% '/_\ "*S_ /0T:[_W_C_^-T?\(K/_ -#1KO\ W_C_ /C==!10!S__  BL
M_P#T-&N_]_X__C='_"*S_P#0T:[_ -_X_P#XW7044 </XK\/2V?AF]N&U_5[
MD1JI,4\J%'^8<$! ?UKN*P/''_(FZC_N+_Z$*WZ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ JGJVF0ZSI5QIUP\B17"[6:,@,![9!JY10!S_\
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M*** "BBB@ HHHH **** "BBB@ HHHH *Y36M533]>DG&K>3'91I)<6TDR[9
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MUY#_ &@0;NX6<MY0^3&W@?\ ?*T -T=?M%TUU!=7Y@C#PO#>!@6;Y"& 8 C
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M">WS#/R^E;5B;EM/MC>JJW1B4S!>@? W8_'- %BBBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@# \<?\B;J/^XO_H0K?K \<?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?O<\99,_[%9]A;)9^%=*U6"29+KR+9G)F8B;=M#!E)P2=QP>H.,4 =91110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %9)T!!/<RQ:A?0M=.7D\N1<D].I7/ X'/':M:L>\UJYLM:B
MLWLHFM7"E[A9SNCW,$7<FW'+G ^;H">V* -"[MI+F()'>3VI!R7AVY(]/F4_
MXTMG9P6%N(+=2%R6)9BS,QY))/))]36;K&L7NG?:FMM/BN([2U^T2-+<-'D?
M-\JX1LGY/4=13TU'4C;WI?3[=;BU(P@NF,;@J#G?Y>0>O&TT 6X-/2'49[[S
MYGDG14*N1M55)(  '^TWYU VB1/*IDN[N2W602BV>0%-P.0<XW$ \@%L=.*L
M:;<SWFGPW-Q!'"\J!]D<ID !&1R57^54;?6KEM=DTZYLHHX@Q2.XCG+AI-N\
M(05&#L^;J10!L54U'3TU*V6"2:6)5D24&(@'<K!EZ@]P#^%5/[9D3Q#)I$MJ
MJ9A66WF$N5D)W?(PV_*WR,>,Y )[8J&'6M2N((#%IEN9Y;B:$J;MMB^6S*3N
M\O/)4X&* -9(&2U\@SRLVTCS6(W_ %Z8S^%9B>&X4B$)U"]>'SO.,;.N&8OY
MAS\N>6YHTC6+[4#;&XT^&!+NT^TQ-'<-)C[ORME%P?G'3/0TNDZU<7U[/:7=
MG';LF[RGBG,JS;&VR8RJD;6(!X[T 3SZ-'+/++%=W5J)SF=('"B4XQGD$J<#
M&5(/O3GT:Q>>PE$6S^S@1;JAPJ@KMQCN,8Q]!5^B@#+;P]9&PU"RC::*+497
MEN-C\DN &QD< @?J:?'I 6Z@N)K^[N#;N7C65EVABI7/"CLQJQ?WJ:?9O<NC
MR;2JJB#YG9B%51[DD#GUJM#=ZL+J".ZTR!8I20TD%T9/*^4GY@47C( XSR:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN,@D'\Z?<22Q0-)# T[KTC5@I;UP3QGZXJ6B@#%T^V=M:>]BTUM.A:%A,'V
MW$A92&(0D?* PR>3N]*KBTU#[*FD?8W")>"3[467R_*$OF#C.[=@!<8Z\]*Z
M*B@#-U1_,5K6?19-1MG7.%$3*3Z%78?GT^E01Z-/<Z):6=W=SP20R"7,3*Y&
M"2B$NIW!?EYQR5!K9HH Q?#UM>VS:DUXMUF:Z\R,W!AW,NQ%S^[X'*GK[4NF
MRWIU:\>;2;JWBN&4K)(\)"X0#D*Y/4=A6S10 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!@>./^1-U'_<7_T(5OU@>./^1-U'_<7_ -"%
M;] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !114-W=P6%K)=7,@CAB&YW()P/PH FHKG_P#A._#/_053
M_OV_^%'_  G?AG_H*I_W[?\ PH Z"BN?_P"$[\,_]!5/^_;_ .%'_"=^&?\
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MAG_H*I_W[?\ PH Z"BN?_P"$[\,_]!5/^_;_ .%'_"=^&?\ H*I_W[?_  H
MZ"BN?_X3OPS_ -!5/^_;_P"%'_"=^&?^@JG_ '[?_"@#H**Y_P#X3OPS_P!!
M5/\ OV_^%'_"=^&?^@JG_?M_\* .@HKG_P#A._#/_053_OV_^%'_  G?AG_H
M*I_W[?\ PH Z"BN?_P"$[\,_]!5/^_;_ .%'_"=^&?\ H*I_W[?_  H Z"BN
M?_X3OPS_ -!5/^_;_P"%'_"=^&?^@JG_ '[?_"@#H**Y_P#X3OPS_P!!5/\
MOV_^%'_"=^&?^@JG_?M_\* .@HKG_P#A._#/_053_OV_^%'_  G?AG_H*I_W
M[?\ PH Z"BN?_P"$[\,_]!5/^_;_ .%'_"=^&?\ H*I_W[?_  H Z"BN?_X3
MOPS_ -!5/^_;_P"%'_"=^&?^@JG_ '[?_"@#H**Y_P#X3OPS_P!!5/\ OV_^
M%'_"=^&?^@JG_?M_\* .@HKG_P#A._#/_053_OV_^%'_  G?AG_H*I_W[?\
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M._#/_053_OV_^%)_PG?A@_\ ,6CR.H\M_P#"@#H:*Y__ (3OPS_T%4_[]O\
MX4?\)WX9_P"@JG_?M_\ "@#H**Y__A._#/\ T%4_[]O_ (4?\)WX8 R=6C'U
MC?\ PH Z"BN?_P"$[\,_]!5/^_;_ .%'_"=^&?\ H*I_W[?_  H Z"BN?_X3
MOPS_ -!5/^_;_P"%'_"=^&?^@JG_ '[?_"@#H**Y_P#X3OPS_P!!5/\ OV_^
M%'_"=^&?^@JG_?M_\* .@HKG_P#A._#/_053_OV_^%'_  G?AG_H*I_W[?\
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MN?W<KN[JSLO1MH50,YQN/K0!U5%>9>(X5T^T\0:'9(TNGQ/ILL=L9#MB>2X
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MVXVA\C[V< GMR ='17$WGBZ^1].OY[3[-I[V\VH!8I=\LL*IM5'7:-I9I8R
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M&QPIYB%:=]H>AW7CO3';2K"9;FQNYI&-NC"5M\&&/')^8\^Y]: .O+* 26
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MF*'*>8@;:?;/2BXM;>[0)<V\4R@Y"R(& /KS4U% $,UI;7"JL]O%*J_=#H&
M^F:=';P0@"*&.,!=HVJ!@>GTY-244 0165I;HZ0VL,22??5(P WUQUJ7RT+*
MVQ<I]TX^[]*=10 P11JA01J$;.5 X.>OYT"*-2I$:@HNU2!]T<<#T' _*GT4
M 1M;PO&\;PHR2??4J"&^H[TD=K;Q0K#'!&D2$%45 %4@Y&!]:EHH ;Y:>9YF
MQ=^-N['./3-'EH"Q"+E_O<?>[<TZB@""6RM9X%@FMH9(DQMC>,%5QTP#4GEQ
MY4[%RGW3C[OT]*?10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.YTJZATF]AE9_L^I7#,)[96)(P@3!9<\$,N<#- &]XEU2;1M#DOK=$>1)84
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M%% !7/\ C'_CQTW_ +"]E_Z/2N@KG_&/_'CIO_87LO\ T>E '04444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %<S=>*+B#Q<FGB&(Z8LD=K/.<[UN9%9T7KC& @/'6
M1:Z6N,;X?I=:%=+>7,HUBZ=[EIXKN80K.6W(P3(4A2$ RO110!/JGC=M/FUB
M(:=.YTZ2"-2(G(?>0"20/]KCU_&K]QXRTBVN9;>4W2FW>-+A_LLA2 NJLN]L
M87(<?3O6;>^'-;O$U7<U@'U".VD!\Q\+/%MRN-OW#M/S=?:K%WX<O[S3?$$3
M-;1SZO)'(@#L53$,2$$[<_>1L<=".G2@#HH+I+B2>-$D4P2;&+QE03@'*D_>
M'/4<9R.U97B;4M1T^/3HM,-LL]]?+;;[F-I%4%';.%93GY1WK5@-T9)_M"Q!
M!)^Y,;$DI@?>R.#G/3/&*RO$VF:AJ,>G2:8+8SV-\MSMN9&16 1UQE58Y^8=
MJ *$VO:SI$UU9:JME-/_ &?->6D]NCHCF/&Y&0L2"-RGAN03TINL>*]0LM(T
MN>QM8;B[N;<WEQ$0<+ B!I"H!SG+*JYSR>]/FT#5]6FN[W59+*.X.GS6=I!;
ML[1Q^9C<[.0"2=JC@< 'KFF6?@OSKLW&LRN_DV<%G;+:7<T6U%7Y\["N=SD]
M<\*M #O$7B^31KS1IK>!+K3+R.6>ZE4$O'"H3$B\]!OR>#P#5^/Q JZMJ\<[
MQ+8Z?9P70F7J5<2%B3G!&$&,>]9VD>%+S3[G38YI;>6RTU;N"%2S,Q@D*>6I
MR,94*5//0#K6>G@"^A.IV"7L3Z3?26L2HSL)([6-G9XL@?[6P<_=^G(!M^$]
M>OM8AN(M5MH[6^A\N7RH\X\J10R'DGD?,I]T-=#7.6_A9=+\26NJ:7+((S"\
M%ZES=2S,Z?>0J7+8*L#QD##&NCH **** "BBB@ HHHH **** "BBB@ HHHH
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M[6M+J5G#J,&G23J+NX1GCBY)95QD^PY[TZXOK6UGMX)YTCEN7*0H3\TA )(
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M2CG.2<8'O5-O'<]ZENL=W!ID@L%N9R;5[G]X69=H5>0BE&+,?5>E:MMX5O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4 =!14-HES':QK=S1S3A?WDD<916/J%)./S-34 %%%% !1110 4444 %%%%
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MTBF1CSN!=,*R^X//X5DKX,O+E&>^O(A<3VQ\Z:($[;CSA*K $<JI50 >R@4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX&&#=/2K?AC5K[6]?U>Z>5AIR)"MI#C& 0S;S[LI1OHP% %G_A!?#7_0-_\
M(\G_ ,51_P (+X:_Z!O_ )'D_P#BJ6&ZU23QI<6TUS"ME;V7F"&-#P7?",['
MJ<1OP, >]8EYJ&K:8NNQMJ-U))I^F?:2UPBH)9@25:(+T0[2I!)[>Y(!M?\
M""^&O^@;_P"1Y/\ XJC_ (07PU_T#?\ R/)_\56_2T <_P#\(+X:_P"@;_Y'
MD_\ BJ/^$%\-?] W_P CR?\ Q5=!10!S_P#P@OAK_H&_^1Y/_BJ/^$%\-?\
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M_P"@;_Y'D_\ BJ/^$%\-?] W_P CR?\ Q5=!10!#:6L%C:QVMLFR&)=J+DG
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MF*K_ "H ZFBBB@ KG_&/_'CIO_87LO\ T>E=!7/^,/\ CQT[/_06LO\ T>M
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M1P?6I;'Q-9WE^EA);WMC<RJ6BCO+=H_- ^]M/0D=<9SBN1\1>;K":UK=I:W
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MX$2__%4'X4>!R<G04_\  B7_ .*H Z'^W-(_Z"ME_P"!"?XT?VYI'_05LO\
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M)?\ XJ@#H?[<TC_H*V7_ ($)_C1_;FD?]!6R_P# A/\ &N>_X5/X&_Z *?\
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M5'_"I_ W_0!3_P ")?\ XJ@#H?[<TC_H*V7_ ($)_C1_;FD?]!6R_P# A/\
M&N>_X5/X&_Z *?\ @1+_ /%4?\*G\#?] %/_  (E_P#BJ .A_MS2/^@K9?\
M@0G^-']N:1_T%;+_ ,"$_P :Y[_A4_@;_H I_P"!$O\ \51_PJ?P-_T 4_\
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M  (3_&N>_P"%3^!O^@"G_@1+_P#%4?\ "I_ W_0!3_P(E_\ BJ .A_MS2/\
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MT?VYI'_05LO_  (3_&N>_P"%3^!O^@"G_@1+_P#%4?\ "I_ W_0!3_P(E_\
MBJ .A_MS2/\ H*V7_@0G^-']N:1_T%;+_P "$_QKGO\ A4_@;_H I_X$2_\
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M=/=3ND8C0.V,A5'0# KH* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"O;?^#0?_&Z/[5\4_P#0KVW_ (-!_P#&ZZ"B@#G_ .U?%/\ T*]M_P"#0?\
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M"O;?^#0?_&Z/[5\4_P#0KVW_ (-!_P#&ZZ"B@#G_ .U?%/\ T*]M_P"#0?\
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M44 <_P#VKXI_Z%>V_P#!H/\ XW1_:OBG_H5[;_P:#_XW7044 0VDD\MK&]U
MMO,RY>)9-X4^F[ S^53444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@R2S^4Q&]]P\N1"'<$\XD7(]?4 ZYI8T=4:159_N@G!/TH,T2D@RH" 206'
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M%)BW#&0"V#Q\J9IGPKJ$<5NC:3*T$"W41@A2V8,SR;ED D)7#+A<\,-N,8H
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M>&Y8=;@DT;1D"((1'A(3;@+(6.0</$1N)RF<YY&:[>@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N=N= \%W%Q/<76F:+),29)Y)(HBV2?O,3
MZGN:Z*N.TSPEY-SI4MUIUL?(-X;@E58DR/E<^O'Y4 :!\'^#5#$Z!HX" ,Q-
MM'P#T)XI8=%\(:/=/=6^FZ5:W-FAE9HH462)<<G@9'!_6N?7P_K]MX>?35T\
M3RW6CVEJS^>@$4D2L'#9.3]X8(SD]<=:M-X=U%M>N6BL@EM,]RTC3M%)&1(C
M -&<>8K$E=RGY<9QVH ZVVU"UNM.CU".9/LTD8D$C$ !2,\GM2G4+(6HNS>0
M"W;I-Y@V'\<XKG[C3M1?P386,6GJ+B$0"6 ^6S*$(W%-QV%N,C=QZUEZ?X>U
M2RN1>76F->Q)>3R"U=X=Y62.,+)@;8]P*N"!C[QQGN =?%JMK-=W5MOV-:M&
MK,Y 5BX!7!SSUJ>.[MIIFABN(GD4;BBN"P'KBN-LO#&J6FN0ZM]EA5(6@46$
M<@,2KY81F3/\2=B>JA@,9I)O!UX^CP6]M#%:W;)?)+.I *^:'VDD<GDK],>U
M '917MI.,PW4,@W[,I(#\W7'U]J@U#5[/3K![V60/&AQB,@ECG! YYP>M<M<
M:%J5R\NH66CQ:;-:P0?9[;S$_?2Q2;NJG 7;E 3SASP*JP^"]5@L[RT(26.*
M!19DN,O)(8VG)]/GC)!_VS0!WGVFW^T_9O/C\_;N\K>-V/7'7%5?[9LCJL>F
MI*))GBED)1@0@C*!@W/!_>+Q]:Y5?"^I_P!O2.WVDJVHO=K=+) J*I!P/N&4
ML =FW.".X'%4I_#M[#I:K-IT&GI8Z)/:7%WYBE9VS$<G;EMA".22,_,>/4 [
MY-0LI86FCO('C0;F=9 54<C).>.A_(U(D\,D G25&B*[A(&!4CUSZ5YP+*7Q
M%J.I7.E6D5O%$]B[QVDL+^<4\[(R08RP#H0#D<+G&>.FTW1KN#PIJ=FT<JSW
MGGM''-)&6!=<#/EJJ+D\D#(R3R: -S^T;':K?;+?#OY:GS5Y;^Z.>OM4C7-N
MMPMLT\8G<;EB+C<1Z@=:X;4_"%VI@%I9NT#:6MH;>V^SJ$D&=Q;S4;Y6R 67
MGY!P>,:%KH=[9W\D4FF1WK374,ZZA+*I,2I&BD'HQ8%6Q@8.[G'(H Z.?4K:
M&"YD219VM5+211.I<>V"1@_7%2&]M%F\AKJ$2X)V&0;L#D\5Y[!X-UA='ELF
MAG:XBTR:U\QY;=8YG8#[NQ [ D;B9""#Z\FK\>G3ZEK.JPP:8@*ZW#,VH%E^
M18UA9EQ][) *@ 8PYR>N0#K]-U.TU;3X[^SE$EO("5;_ #TJKJ7B/3M-TY;W
MS5N4DE6&-8)$)=R<8!+!?KDC%94&A7S?#Y]$-ND%RL;1["XV2X;/5<X5AQZX
M/2J[:!>7NI-??V3'8P-/9G[*S1D_NF<O(=I*\AE48.2$&>PH W]2U^PTEA'=
MR%9FMY;A8A@L4C +8YQGGCUY]*F&K6LELL\#B<-)'&RQLI*%R -W/&,Y(Z^F
M:QO%>CWFHW,4UI:+.?L%Y:D[E4HTBKL/)Z94CCU^M4[CPM<QWD!L;.&*%8]/
M#B,JH)AN-[\=\+0!UL5U;SRR10SQ221'$BHX)0^X[4C7=LERMJUQ$L[C*Q%P
M'(]0.M<OX:T34--UQI&L_(M%BE0^:T4A#,X8")U <H<$D2<YQBJVI:%K%UX@
M:=+/$8U.WN0\9A5'B0IDL2/,,@ (QD+@=^A .N;4;%-^Z]MU\L;GS*HVC.,G
MGCGBGO=VT<D4;W$2O-_JU+@%_H.]<KI_A/RKK3)KG3K8F&>]DN&(5B1([%,^
MO!'TK&B\&ZREI%;S1W#F6RM8,PRVX6 QC!#,Z,X /S QYY/0=: /0UN[9I_L
MZW$1FP3Y8<;L X/'7K55M;L%U./3Q.C2O%+(65E*QB,H&#'/!_>+Q]:P5\,W
M*R13QV\<5S_;,]TTZ[=XB<2 '/T9>*R9/"FIS6$5HNBPV[V^BS6$DPE3_29"
MT1!&#G:=CG+8.2<CU .\34+*1D5+R!C(Q5 L@.YAU YY(IPN[8S20BXB,L2[
MG3>-R#U(["N6N_"K?:]1FM-/MXS+>V,T#(%4A8GC+D>G"M]:S[;PGJL=PT<B
M7#M$]VXG,ENL<GF*X7&$\QB=XR'( (SDX% '87>MZ;96DEU->0^5%(L;E7!V
MLQ  ..G)JS-=6]O&))[B*)",AG<*/S-<?>^%+E(%6RTZ'"6%M&T:E5\R2*97
M*^F=H8 GCFKWB;)U?PZ_]F_;"L\K?9\H&'[ENFXA<CW/XT ;MUJ5K:0-*\R,
M?++HBNNZ08)&W)&<X.*D%Y;^;'"TT:32KN2)G <CV'>N*A\'W@LKX364#32:
M5-#;+N4^2\DLSB-2>@571<].*GN/#VH&6ZMUT]))+NZM[B/4"Z?Z.J",%3SN
MR-C;=H(.[DCF@#KEO+5A*5N8F\D9DPX.P>_IT/Y5!9ZUIU[I]G?Q7<0@O45H
M"[A2^1D#![^U4_#>C#3-'>":VBBGFFF>8J 2X:1RN2.ORL/Y5S5KX<U*VTB"
M"?0H[MVT6+3O+:6/$$B;PSY)^X^Y3E<M\HR/0 [2^U.STY[5+J81M=S"&+/\
M38)Q^0-,TS6++5H%DMI1N(),3,-Z@$C) /'(K.U+2KMK/0P(Q?2Z?<QO,20"
MX$;(S#=[L#^%8;^#;TZ+:VUK#%:79@O8YIU(!!E#;22.3R1]* .V@N;>Z5FM
MYXYE5MI,;A@#Z<=ZK:?K%EJ32)!*!+'++$8G8!\QN48XSTRIP:Q?"NCW=C?W
M%U<6]Q;J]O'"%F>WY*ENBPHHP,X!)R<G@8JHWA.Z,,30016]VVK7MQ)<H1O6
M.59U1LCD_?CX]O:@#K$O;202%+J%A$=LA60'8?0^E++=VT 8S7$487[Q=P,<
M9YS[ G\*XF3PUJ=S9>7!I,.G-;:8;4H)4Q=2!XV7!7/RCRVP6P?WAX'-6I-#
MU#5]:6]OM+2.V:_AF,,TB.0B02)E@"1G>R\ F@#K)[NVMH?.N+B*&(X^>1PJ
M\].32/>VD3(LEU"A?&P-(!NSTQZYP<?2L7Q-87UU<:>;.U,L,/F;VA6$RQD@
M!=OF@J%^\"<$],=ZY^W\&Z@= O[>ZL8&NSH"6-L2RMMF5IS@'L/FC.>.WI0!
MV=_K%EITD44TH,LLL<2Q*P+_ #L%!QGIDCFI;[4+73K=IKJ9$ !(4L 7P,X7
M/4^U<K=:#?MJ3#^RHYV?5X+X7YD0%(U*9')W;@%(P!C'?/%6_$ND7=W?SSQZ
M9'J4=QISVB([HODN23N.[^%LC)&3\@X- &[#JEG-':M]HCC:[C62*.1P'8$9
MZ9Y_"H[?6],NK:6YCO81##,T#N[A0'4D$9/N/QKC;[PWKDP$267*+9E'B, 5
MA$$+;V8%]P(;;MP.G/6I;GPUJ@NHY4M)A%;WEX^RV-N6E69@R.!*"ORC*G.#
M\QQQU .Y>6..(RR.J1J,EF. !ZYJ$ZC8K MPUY;B%QE9#*NTC.,@Y]2/SK#D
MT.<>!(=(:W>:6-(OW0N%#+M<-A7VA25QP"H4X /%84-E?6.KZ2M[HZWK_P"F
MR1PX@27:?)&YPI$>_).<'H?7B@#O)+JWB>-)+B)'F.(U9P"Y]O6DEO;>*1H3
M-&9@A?R0XWD#N!FO/Y/!>L1P?9W6:<3V,5N!;RP*D!4ME2TB,ZJ-PPR<\=!P
M:V)-$O5NKV'^R(;I[B[>X34)'4;5,>T#^]O'W0,;<=^U &I%XILY]4&GPV\\
MDH2)Y&5H\1>8?E5OGR3W.T$>_(K62YMY)G@2>-I8_OHK@LOU':N.M/#&H0M
MYMHU9&TXL0RYQ$/WGY?K5"'P9K#6TEDS7"3);W48NWD@6.1I 0"-B>:<D@G<
M1@C^+ H [>VUBRO-1EL;:43/%"DS.A#)AF90,@]<H<_A3DU2T,/FS2I;#>R
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MP112SZAI2"T6?[CE#(&0^P,B'_@= &Q-K-C%:-=K.D\"2+'(\+JXCR0,M@\
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MX8UBWBTI8['-Q#:VD4CN\4D&8FSAU8;E*\E3&>O6O0: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *Y72/%EQJ/B-M-=;8C?<*T,8;S;?RGV@N
M3PP;@\ 8SWY-=57/Z?X8>RN[,O?"6TT^262UB$.UP7# [WR=P =L8 [$Y(H
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MP0I"@PL:A5  ' &.@XKF;[P9]NUEM0>]B/\ ID-VADM0\T?EE3Y:R%N$.WH
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M;R30LL4ZKP2K=QDCTR#D9'-17'@O[1K8U%[V)BMZEVC/:AIEVD?N_,+<)QP
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M:TDEC@:!GN[!;@;2[."H)^5@6//(/<&M#_A%8EM;JW2Y*I<7=K<#$8&SR1"
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MV_49&0,BK5_?V^F64EY=.4BCQDA2Q))   ')))  '4FLCP]X5CT&Y,X:R+"
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M48VLN3GKC!'?I0!S^N37&@W%YI]C?W9MVM8KG][</(]NPN$4X=B6VLI;@G^
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M2X24:D/$#R7QV?)O-K*H=,#_ %94)CW//.:["37]&ADECEU>Q1X03*K7* H
MVTDC/&&XY[\57U#Q/INF*);J>-;=A 4F$R$-YKE%P-V<#&2W3&<$X. #E?,B
M;P#'X:2WE&O+&L7DF%MRW(()FW8QMW9??G&.^:DU"QUN2W\4-9S?Z))>L)K4
M6X,LT1AB#F-B<;L9P"I!(QWXZFW\3:+<6EQ=C4;:."VG:"262954.#CKG'/;
MUIVJ>(=+TC3VO+F]MPIA:6%/.4-.%7.$R?F)]O6@"#5!%+X'O%L@SQ-IKB$8
M.XCRSMX/.>E9^HC[+)X<U&[BD:QLT;SMJ%_)D:,!'( S@?,,]MU=/%()84D
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MNTMI(HQ&S@E4(:-2 <LIXQUY%9WARXC\.7UE'J^^U?\ X1^SB(:-CAU>7<O
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M7S4AOGF(\N.0D_,F,EEW$#!P<#)%=97(P>.K>WL(C?1O-<F.2>80E%$<8D=
M<.PR3L/"Y/!XH L:;X/L[?5KVZNK=91YD/V5RYW!8X43G'?*FI=,\,6T.IW^
MHWEM&UQ+?-/#('.0N% XZ9R#51O%]XU_)#;Z8\L U&&VCE4IAXWB63=RX.><
MCCH1WR*GB\=Z5*SE4F\H1RR12!HSYPC!+!5#;AP"1N"YQ0!0T;P_=:;=!I?#
M]O+*+R67[6+T@[6E9@=N.H##CVIH\$O#8)=Q0Q/JL%_+=*DLA:&96F9@K Y
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M6*;P=V_9MV\YW>W7BKL/B&QG\/3:XHD^S0)(\J@!G4QY#KP2"05/0X/8XYH
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MW$;X5O+9(A$.&!!!7(.?4].*FLO#EO:36\S3RSO#%/&V\* _FLC-P  ,>6
M.,57^Q^,?^@WI'_@LD_^/4?8_&/_ $&](_\ !9)_\>H AB\$6L=A-8&^N&MW
MM&M(UVQJ8T; R2%!9@  "V?S)-7;_P .07M_+?BYF@N6\DQR)M/E-'YF" 00
M<B5@0>Q[5!]C\8_]!O2/_!9)_P#'J/L?C'_H-Z1_X+)/_CU #)_!T<[B<ZI=
MFZ:-HIKAQ'(SJ6+<!E(3:6.W:!@'O6GJ.D1:AI"Z<)I(%1HGCD3!96C=70\@
M@\H.O6L_['XQ_P"@WI'_ (+)/_CU'V/QC_T&](_\%DG_ ,>H DM?#$5M=6[F
M^N);:TF>>WM6"[(Y&#9.0,D#>V 3QGV&'ZIX<AU2]>Y>ZFB\R&.*1$"X8))Y
MBGD9!SG\Z@^Q^,?^@WI'_@LD_P#CU'V/QC_T&](_\%DG_P >H ??^%+6^O9;
MW[1)'<M.LZ/M5@A$?EXVL"""O7/?D8Q5VVTA;;1FTU;NX^=7!N P60%B26&!
M@8)X &!@5G_8_&/_ $&](_\ !9)_\>H^Q^,?^@WI'_@LD_\ CU $<'@R"V=K
MF*^FCOC.LXN(XHT 8(4^X%VG*L<Y&3ZC PX^#+,QL&NKAY)%;S96V[I&:592
MQP,#E0, 8 IWV/QC_P!!O2/_  62?_'J/L?C'_H-Z1_X+)/_ (]0 D_A*.>W
MNK/^T[V.QN!/BV1E"HTP8.<XRPR[$*20"?882_\ !\%[<RS_ &V9-]Q'<^68
MT=!(D?EY(93D%<<'H0",4[['XQ_Z#>D?^"R3_P"/4?8_&/\ T&](_P#!9)_\
M>H @'@>U%KY"ZA=<I=([$)EUN,%P?EP.5!& ,8QTJS+X4@DED47UREI/+'-/
M:C;ME= H!SC< =BY /./<Y;]C\8_]!O2/_!9)_\ 'J/L?C'_ *#>D?\ @LD_
M^/4 6K;P];VOV#;-*?L,TTR9Q\QDWY!XZ#><?052UOP;:ZW=7<\EY/";RW6"
M4(D;$ 9QM9E)7[QR!UI_V/QC_P!!O2/_  62?_'J/L?C'_H-Z1_X+)/_ (]0
M!:/AZW.,S2'%_P#;NWW_ $^E0:;X7CTV\LY5U"YEAL(7@M;=]FV*-MO&0 3@
M* "3T'U)9]C\8_\ 0;TC_P %DG_QZC['XQ_Z#>D?^"R3_P"/4 3W'AR&XU9K
M\W4R[YH9FB 7;OC! .<9Y'!&>U,/A:W^URW*7=S%))]H^:-@I0S;,D''4>6,
M?4YS4?V/QC_T&](_\%DG_P >H^Q^,?\ H-Z1_P""R3_X]0!:T30(=%>ZE28R
MS7;JTK>6D8) P,*@ SZGJ?RK*3P#9HAC^W7!C$<\:@)&#B52K%B%RS<]2>WU
MJW]C\8_]!O2/_!9)_P#'J/L?C'_H-Z1_X+)/_CU %BZ\.6UV;TO-*/MEO#;O
MC'RB)G8$<=3O.?I44'A6WMM4-Y%=3+$;A[G[.$3'F-DM\VW=MR2V,]?;BF?8
M_&/_ $&](_\ !9)_\>H^Q^,?^@WI'_@LD_\ CU "OX0LI;"RLWGGVV5A]BB9
M2 V,Q,'Z?>!A4CMUXI8/"ZIJ"W]SJ-S=7 N$N"SJB@E8WC PH&!AS^(IOV/Q
MC_T&](_\%DG_ ,>H^Q^,?^@WI'_@LD_^/4 22>%+&:U2UF>62%6NBRD@;Q.6
M+@_]]G%11>$85@:.:_N)B6@*DI&F!%(L@X50"25&2?PQ2_8_&/\ T&](_P#!
M9)_\>H^Q^,?^@WI'_@LD_P#CU %B;P[%)J/V]+J:*87RWGRA2,B'R2N".A3/
MOD\&IGTR:^\.RZ7J=T\DEQ \4TT6%;Y@1Q@ < ^G;I5'['XQ_P"@WI'_ (+)
M/_CU'V/QC_T&](_\%DG_ ,>H CM/!EM;7JWC7DKR*83M6*.-!Y1<J JJ !\[
M9JPWAB-;K[7:W]Q:W7G32>:@0G;+M+IA@1C**1WR![BH_L?C'_H-Z1_X+)/_
M (]1]C\8_P#0;TC_ ,%DG_QZ@"U'X>MX_#MOH@GE,-OY6V0D;SL<,,_4K44/
MAB&/7DU>2[FFDB:0Q*ZIE-^<J7 W,HSP"<#CT&(OL?C'_H-Z1_X+)/\ X]1]
MC\8_]!O2/_!9)_\ 'J +-[X;M+]-22:27&H&-FVXS&T>-I7([%0><CBJZ>%5
M15E&HSB\CG$T=PL<:A#L*;0@7;M*DYXSDYSTPGV/QC_T&](_\%DG_P >H^Q^
M,?\ H-Z1_P""R3_X]0 R?P;#,PE&IW@G:'R)YW"2/*NYF!RRG:07;!7& <8X
M&)+WPA87UA>6<DLZI=7*W!9& 9"$6,J#Z%%*GOAC2?8_&/\ T&](_P#!9)_\
M>H^Q^,?^@WI'_@LD_P#CU #KWPI;76HRWD=S+;B?R_/CC1#OV<#!*DKD  X/
M0=CS2CPO&M_'.FH7*V\5XUZEKA-@E;=N.<;L$NQQGJ3[89]C\8_]!O2/_!9)
M_P#'J/L?C'_H-Z1_X+)/_CU "ZIH=YJ.O_:(KZ:SMVL3;NT.PELMDC# XXZ'
MM4B^%;&.UGMHGDCBEN;:X"@CY#!Y011[?N5S]347V/QC_P!!O2/_  62?_'J
M/L?C'_H-Z1_X+)/_ (]0 J>$H%>-&OKE[2!Y9+:V.W;"SA@3G&3@.V 3QGO@
M8OR:1!-X>?1'=S;O:&U9@1NVE-N?KBL_['XQ_P"@WI'_ (+)/_CU'V/QC_T&
M](_\%DG_ ,>H +GPFEVDT<FIW0BO(DBOD54 N0HQD_+\I*_*=N./3K6AJ.DI
MJ%S9W'GR0O:,Q&P AU9=K*<CT]*S_L?C'_H-Z1_X+)/_ (]1]C\8_P#0;TC_
M ,%DG_QZ@!9?"%A/8VUG++,T=MIQL%((!VYC(?I]X&-3Z>U7=(T<:69W:ZDN
M))]NXLB(H"C@!4  ZDD]\_2J/V/QC_T&](_\%DG_ ,>H^Q^,?^@WI'_@LD_^
M/4 1R>$ECMC'%>7$T5M'-]AMGVA(6=&7J!DX#,HR> >]1Q>#([FPC34[^YN+
ME+>***1@F8-C!QC"X8[E&2P.0 /7-C['XQ_Z#>D?^"R3_P"/4?8_&/\ T&](
M_P#!9)_\>H ELO#4-K=6]T]W+--#,\N2J*I+)LP%4   >G?.:B'@^S$;)]HG
MPVST_AG,X[?WCCZ4?8_&/_0;TC_P62?_ !ZC['XQ_P"@WI'_ (+)/_CU $6L
M:#.EZ=3TY;A[J2Z$K-#+&KQCRA&0H<%6!"C(/U!XQ4NF>'9/^$)ET+496WW<
M5PDSJP9E\YG)YQ@D;^N,9%'V/QC_ -!O2/\ P62?_'J/L?C'_H-Z1_X+)/\
MX]0!8U#PY!?:A+?BYF@N66 1R1[?W31&0J0""#GS6!![5 /"BHT=Q%J=U'?"
M=YY+H+&6D+J$8%2NT#:J@<<;1UYRGV/QC_T&](_\%DG_ ,>H^Q^,?^@WI'_@
MLD_^/4 6=%\.V^B/O@GFD/V2*U_>$'Y8VD8'IU)E.?H*IZIX-MM4O[JZ:\FB
M-UY9D"I&2"F-H#%2P7@9 ///J<O^Q^,?^@WI'_@LD_\ CU'V/QC_ -!O2/\
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M$QEN'N)_,5/WI90N.%X P",8Z54^Q^,?^@WI'_@LD_\ CU'V/QC_ -!O2/\
MP62?_'J .@HKG_L?C'_H-Z1_X+)/_CU'V/QC_P!!O2/_  62?_'J .@HKG_L
M?C'_ *#>D?\ @LD_^/4?8_&/_0;TC_P62?\ QZ@#H**Y_P"Q^,?^@WI'_@LD
M_P#CU'V/QC_T&](_\%DG_P >H Z"BN?^Q^,?^@WI'_@LD_\ CU'V/QC_ -!O
M2/\ P62?_'J .@HKG_L?C'_H-Z1_X+)/_CU'V/QC_P!!O2/_  62?_'J .@H
MKG_L?C'_ *#>D?\ @LD_^/4?8_&/_0;TC_P62?\ QZ@#H**Y_P"Q^,?^@WI'
M_@LD_P#CU'V/QC_T&](_\%DG_P >H Z"BH;1;E+6-;R6.6X"_O'B0HK'U"DG
M'YFIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'A\26ESXG;0H(Y7
MDCMY)7GVD1@HR*4!/WC\XSCI_+8K'FL[AO&EE?+$3;QZ=<1-)V#M)"5'XA6_
M*@"O!XH=[NT6XTFYMK2^G:"VN)&7+. Q&Y.JA@AQ^&0,UT%<9I,^I:EXACO]
M;T+4XI(W9;-"L?D6BG(WDA\LY'4XXS@#J3U4%W)-8&Y:SGB?#'R)-N_@GT)'
M...>XH S8_$]M)XKDT$0N&1#BXR-C2 *S1_[P1U;Z9]*CF\1W<UW=Q:1HTFH
MQV3F*>7SUB!D R40'[Q&>>@SQFN=_P"$6U^'1(-6%Y))JL5U_:9L!'& 96/S
MQ[\9^XS)UQT[5J6,VH^&Y=1MAH=Y?Q75W+=VLEL4P?,.XH^YAM(8D9Z8Q]*
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M92&)!##+$D#+#'8''4Z(OGZOJ^H1C%O))';PD='$2D,P]MS,O_ : -NBBB@
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M8],C-9?BM%7P?K950"=/GR0/]AO\36AI_P#R#K;_ *XI_(4 6**** "BBB@
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M( ^I(%5]6U>UT:"*>[$Q2:9(%\J)G.YC@9 Z#WJS<W4%G"9KB58HP<%F.!0
MRPNTU#3[:]C1T2XB655?&Y0P! .,C/-4[77([F6#_1)X[>Z)%O</MV2\$C@'
M(! )!(Y]B0"SPM=07'AVPCBE5WAM8DD4=4;8.#^59*VL5U=V%EIVIRWEM9W"
MR!(\>7;*ASM9P/F/\ 4G.#D@XR #;N]8%M<2PQ65Q=>0@>=H=N(P<XX)!8X&
M<#)Q]0#-<:I;V\4#KOG-S_J4A7<TG&<CMC'<X'3U%9>LM;P7DWD:E-%=7$8$
MEG;!6EFQD J,94GH6Z >F,U&Z6NDZ?HMAJ$TUI+;VNU;Z+B.)D5%(9B" &SQ
MN&#M]0* +[^(K&/3KF^=+E4M)/+N$,#;XVP#RN,GA@<C(.>,U8;5;=;JU@42
M2?:UW12(NY",9^]]!FL6YO7D\/:DTMQ]HMTE58+HH%,R_+SP &P<C<  <>V:
M="C6VO:?:1(SV3&2XM95&5560Y3/;!((]F 'W: -&36O*E9FL+D6B2^4UT=H
M4-NVYVYW;<\9Q[].:FO=2-K<16T-K+=W$BLXCC*C:HQDDL0!R0!Z_@2,B76;
M'4[TQW%TD-G;RX$)SYEQ(K<$CJ$!' ZL1Z?>NWES#INO+=7CK#;SVWEB9^%5
MU8G:3V)#<>NTT :-E=Q7UI'<P[@KC[K##*0<%2.Q!!!]Q4]9F@J\>D^9)&\?
MFSSSA64A@KRNZY'4'##BI-*UFTUC24U.U\U;=]V/-B9&^4D'Y3SVH B@UKS9
M8/,L+F"WN6VPSR;<,<$C(!W+D#C(]C@X%3WNI"UGCMHK>6ZN9%+"*+ PHXW,
M20 ,^^3V!P:R;+5K+6+^"YGND55?_1+0'+;B"-[@=\$X'\(.3S]UNIPPP^(Y
M;G4;^>TM)K2-(C%(T0:16<D%U.<@.,+WRW!QP ;%UJ/V2V@>2VE,]PPCCMU*
MEBY!)&<XX 8DYZ TEMJL,UI<3S(]L;0LMPDN,QD*&Z@D$;2#QV/X5FO//'8Z
M)J.H!E\ELW+NN#'NC9=S#MR1GTR>@%/MY)+FWUN]LX%N%F)%LKCY;C;$!GW4
MMD9[@9Z8- %RTU8W%S'!/8W%H9D+PF7;\X&,CY2<'D'!_H<1W&NI;RSD6<\E
MM:MMN+E=NV,X!)P3D@ @D@?G@XRM%BMH]5LOL.H7.HA+=HYOM!+?9QP1V&QB
M0!M/./\ =JMJD49N-3+W4\=\\P:#3D/[NZV@;,K_ !AL ,1P ,'&W- '9T44
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% #(HHX8DBB18XT4*B*,!0.
M@ ["GT44 %,$4:R-*$4.X 9@.2!G )]LG\Z?10 4444 )38XXX8EBB18XT 5
M448"@= !3Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** $(!!!&0:KV.GV6F6PMM/M(+2 $D1
MP1A%R>^!5FB@"O>V%GJ5L;:_M(;J!B"8IHPZDCIP>*G5510J@*JC  Z 4M%
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M5S__  C6H_\ 0WZU_P!\VW_QFC_A&M1_Z&_6O^^;;_XS0!T%%<__ ,(UJ/\
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M /PC6H_]#?K7_?-M_P#&:/\ A&M1_P"AOUK_ +YMO_C- '045S__  C6H_\
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M]\VW_P 9H_X1K4?^AOUK_OFV_P#C- '045S_ /PC6H_]#?K7_?-M_P#&:/\
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MD9QOE4J6=B!QCC '_P!< KOX_P!9N)]&M[.+1[=]1TM;YWOYWCC4DX*@C/\
MG-:J>+;^SU?2;#5$T\K=VEQ<SSV<C/&HCY&PG&1MZ\=:SM,^'TAU/0Y-9M+"
M\M-/T86<L<H$@\X-G(!&,8SS6IJ7A#[5XGTN>WA@@TJUL+BTDBC^0J)!@!5
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 <-)XJ\27<>O2:7;:7MT6\EB
M?[29 7C1 P(VY^;KZ"M7P7JNOZYI46J:O%IT5O=0I+;K:&0N,]=^[CTZ&JVG
M>&+^TMO%<<C0DZQ<326^&/ 9-HW<<<_6M?PMID^B^%M-TRZ*&>UMUC<QG*Y
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M>$_^A?L/^_(H_P"$"\)_]"_8?]^17044 <__ ,(%X3_Z%^P_[\BC_A O"?\
MT+]A_P!^17044 <__P (%X3_ .A?L/\ OR*/^$"\)_\ 0OV'_?D5T%% '/\
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M%^P_[\BC_A O"?\ T+]A_P!^17044 <__P (%X3_ .A?L/\ OR*/^$"\)_\
M0OV'_?D5T%% '/\ _"!>$_\ H7[#_OR*/^$"\)_]"_8?]^17044 <_\ \(%X
M3_Z%^P_[\BC_ (0+PG_T+]A_WY%=!10!S_\ P@7A/_H7[#_OR*/^$"\)_P#0
MOV'_ 'Y%=!10!S__  @7A/\ Z%^P_P"_(H_X0+PG_P!"_8?]^17044 <_P#\
M(%X3_P"A?L/^_(H_X0+PG_T+]A_WY%=!10!S_P#P@7A/_H7[#_OR*/\ A O"
M?_0OV'_?D5T%% '/_P#"!>$_^A?L/^_(H_X0+PG_ -"_8?\ ?D5T%% '/_\
M"!>$_P#H7[#_ +\BC_A O"?_ $+]A_WY%=!10!S_ /P@7A/_ *%^P_[\BC_A
M O"?_0OV'_?D5T%% '/_ /"!>$_^A?L/^_(H_P"$"\)_]"_8?]^17044 <__
M ,(%X3_Z%^P_[\BC_A O"?\ T+]A_P!^17044 <__P (%X3_ .A?L/\ OR*/
M^$"\)_\ 0OV'_?D5T%% '/\ _"!>$_\ H7[#_OR*/^$"\)_]"_8?]^17044
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MC_A'M8_Z''5/^_%K_P#&J +7]F:J2#_;LF1T/V:/_"E_L[5O^@])_P" T?\
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MRF21D$S?9Y"2S $]R>AKT)$2.-8T5511@*!@ >F*B6RM$B@A6UA6.VQY"",
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MI:M"NGB3:LL18,96^9C(Z9XXXSTK$CU;5;^;3$<:NWG2:H9+>SEB65?+N55
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M;7-RFO.6E<M,T\7V8@,P'R[MV.,=* -;_A!/"_\ T!X?^^F_QH_X03PO_P!
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MCP2>"#DYP.AYQ5?P[XMFN+VZ:>X>X6]MI+VT@92OE;&/[KIU*&,_7?0!M?\
M"">%_P#H#P_]]-_C1_P@GA?_ * \/_?3?XU7TJVNI=.TO69_$,RS7:QR3*[+
MY$OF#_5HO&WD@*1SP,YYRW3;*:/Q5J$$NL:C);V4-O*B2W&5);S-V[CD?**
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M5_XCBT^VN]2NH4BT:TNI#"^R2XEE#98MUP-G08R6Y[4 :_\ P@GA?_H#P_\
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MX^8DO@ \?+TY- $W_"">%_\ H#P_]]-_C1_P@GA?_H#P_P#?3?XU1U:"X?\
ML.:/7KI_MMS'!-):2A(I1Y3DLH&<9*@]37076G>=IR6HOKR/R@/WT<N)&P.Y
MQS0!F_\ "">%_P#H#P_]]-_C1_P@GA?_ * \/_?3?XUAV5[J-EX6\-:FMUJ&
MH7.I26S3Q&5"7W0NS*NXJH!//)'04W5M>U:6?65^SZC8>4-+6.W\R+S?WERR
M.4*NR@LOR\D=.U &]_P@GA?_ * \/_?3?XT?\()X7_Z \/\ WTW^-3>'HYE\
M\S1:O%G: -2FC?/7[NQFQ[Y]JP[KQ4T/C//VTBPAN$T^2#:=I9@29<X[.8TZ
M\8:@#6_X03PO_P! >'_OIO\ &C_A!/"__0'A_P"^F_QK'D?4#I/B#6DUJ\AG
MTZYN3"A<&';'R%*D=#C![\\4VV\3WEEXDUN:^DD>Q,:FVMS_ ,LI$MXI"B^[
M^8W_ 'Q0!M?\()X7_P"@/#_WTW^-'_"">%_^@/#_ -]-_C7,P:MK=OI*)=:C
M))=1V^K>;(,<O$P"$?3G%7]/U[4OM6@Z3?W!%\+H"=P,"[@-M,R28^JC([,I
M[8H U_\ A!/"_P#T!X?^^F_QH_X03PO_ - >'_OIO\:P;:[UG4-*TBX>;4+N
M V"O<)IT\:7"R$G$C!B"RX!  /4'@]K-ZTUWH^BW]OKU^YN;B"WDDC_<B0%M
MK$ICY6ZY]"* -7_A!/"__0'A_P"^F_QH_P"$$\+_ /0'A_[Z;_&L35KR;3M;
MOX)IM>N+2QL()-UE(I*$M+N9\D9R%'/L:35-;U:WT#1[)M26+5)X'NI)TPX9
M47**2HQ\S-&"1P0&Q0!N?\()X7_Z \/_ 'TW^-'_  @GA?\ Z \/_?3?XU0U
MFZ.K:/I.M:?J5[:I>SVL1CAEV@+)*H8$8^]AB/PI-4?5+._O+6PO+F5K'3H;
MN-'?<TS+,Y92>^Y5V_E0!H?\()X7_P"@/#_WTW^-'_"">%_^@/#_ -]-_C63
MK^MW5W::E?:7=S+:6=M"D;0$ R2RLCD@GN(RF/\ KH:V?#\<ZS3--#K47R@
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MF_QH_P"$$\+_ /0'A_[Z;_&J-PNJKH@2S_M2&>6Z4-#>W4(N)HP,LL3!BH)
M/4@X5NG6M#PO=&5;VV>XOF>"5?\ 1]00":W!48!8$AP2"0<GN,G% #?^$$\+
M_P#0'A_[Z;_&C_A!/"__ $!X?^^F_P :KS:[>16U]J\4+3P)=&TAB&[;&B,4
MDE8*"3\X;H#@*.F2:>GB[%E<W,MM#LM=-^W2/#<"1&!9P@5@.0PC8@]>G% $
MO_"">%_^@/#_ -]-_C1_P@GA?_H#P_\ ?3?XT6^OW]S*\JZ="ME;R^3<R-<8
M=6"Y<JNW!53QU!.#QP,UO">M:K="RM=4MT#W5B;T2"8LZ@N,*R[0!P_&"?NF
M@"S_ ,()X7_Z \/_ 'TW^-'_  @GA?\ Z \/_?3?XU%?^+'M-:6RBM8IH/M4
M5J[K(Q?<Y )X4J-N[)#,"<'VS/I/B&YU'6[G3Y;.. 0[_E:4B4 -A6*E0"K#
MD,I('0T -_X03PO_ - >'_OIO\:/^$$\+_\ 0'A_[Z;_ !J:/6KVYU&9;6QA
M>QM[G[--,]QM?( +,JXP0I..N3@X' SB:1XKU"#3X9M2MXFCN[.?4(7:XP^W
MS%V(P*@*")5"\D\4 :O_  @GA?\ Z \/_?3?XT?\()X7_P"@/#_WTW^-4X?&
M5U(LT/\ 9J27:W4$$:)(Z(YDY/+H"-J@L>"",?A+;^)]0O)S8V^GVS7T;S^8
M6N&6%4C8*2&V9)+'&,<8;T&0"?\ X03PO_T!X?\ OIO\:/\ A!/"_P#T!X?^
M^F_QK+7Q]//:1SVVD,["T2ZEBR[,0^2J)M0@L5 /.!R!ZD:J^(;AO$_]DFSC
MCC+81I92DDJ[ Q= 5VL ?E(#;A@DB@!/^$$\+_\ 0'A_[Z;_ !H_X03PO_T!
MX?\ OIO\:9JWB"6RUIK>VMGN9$6WB6/SMB.\TC YX/*I&6SZ'I5[2]8>ZL+R
MXO8HX#932Q2&-RZ'9U() /MTZ@T 5/\ A!/"_P#T!X?^^F_QH_X03PO_ - >
M'_OIO\:JP>+[Q+=)M1TV"V,^G?;84%WGG*KL<E0 29%QC/?TY=9^+YI1*+FR
M1/(O(+:1U9U4"7&#\Z*<@LO;&"#F@"Q_P@GA?_H#P_\ ?3?XT?\ "">%_P#H
M#P_]]-_C6>_C":6X\^WL'D79$+:+S]HG6>?RXV(V\9$;N.>%/OQ;B\2W\]R=
M.CT^W.H_:98@/M#>3LC1&9]VW/!D5<8Z^U $O_"">%_^@/#_ -]-_C1_P@GA
M?_H#P_\ ?3?XTZW\2N_A7^VY[+8[2&..W23=O8R^6@#8'WCMYQWK+UG6]:F1
M]%BB@M=1DN;>+S(+EB/+DW,=K%,AML3CIP,'VH TO^$$\+_] >'_ +Z;_&C_
M (03PO\ ] >'_OIO\:YZQUZ^LIWO;Y[BX5GN&@ACNB5,<++;HI!49+NX.2>>
MIZ8K;O?$NI:;)%:7FFP"[N)"(3%,\D>P*"S-A-PP2!C;SD<CG !-_P ()X7_
M .@/#_WTW^-'_"">%_\ H#P_]]-_C6EH]_)J>EPW<ML]M(^X-$P/!5BN1D X
M.,@D#((XJ]0!S_\ P@GA?_H#P_\ ?3?XT?\ "">%_P#H#P_]]-_C7044 0VE
MI!8VL=K;1B*&)=J(.@%3444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5@>-/^1>7_K_LO_2J*M^LCQ387>I:$]O8)&]PL]O,B2OL5O+F20@M
M@XR%/8T :]%<_P#VCXN_Z%O3O_!NW_QBC^T?%W_0MZ=_X-V_^,4 'AK_ )"W
MB;_L*#_TG@KH*P_#-CJ5J^JW6IP06\U_>^>L4,QE"KY4:?>*KDY0]JW* "BB
MB@#G]&_Y&_Q)_O6W_HJM/5-(M-8BBCNQ+B&42QM#.\3(X!&0R$'HQ'7O69HW
M_(W^)/\ >MO_ $5704 9UGH.GV*%;=9PS3"9Y&N9'DD<# W.S%F&.,$D>U6;
MVRM]0M_L]U'YD?F))C)'S(P=3QZ,H-6*XKQQX@FTZ::&"]:U:UL6N=OG+$9F
M.[;LRC%RNPY4  ;AD^@!UHLK<:@;\1_Z08A"7W'[@)(&.G4FL^;PKI,QB8)<
MPM"\SH]O=RPL#,X>3E&!(+ '!X&.*YHZW?SZG<1+K#C4(;ZVMX;",+MD4"/S
MW((R4YE&<X&SUJ"R\47#V\>K0ZM+>'9=W5U:84I;VX#M$" ,@Y\L#)RP)ZCH
M =J=%LVTF72I?M$]K.K)()KF21F5NHWLQ;'XT[4-'L-36%;N#>(-WE[6*[=R
M%&'!'!5B,?X"N/N;J_TLM9:MXBNH9H].CGC91&'NK@[E9(QM^8*47Y1DDR<Y
MXIC:[J5Q>W$1U1X=3AFM8(=.B"XE<JC3,0024!=@2#A=A/I0!U%IX=T?29XK
ME?.+QCR86N[R681[L#:@D8A2>!QR>E%MX6TBSGBFBAEVP-OAA>XD:&$^J1EM
MJ]3C X[8KFVU2^6.TU2XN[BXBFEN[T6RQJP%M$',848R6),1SGVK+N=8O+O2
M]7M9]8$MK)9VZRW"722*K3S>7N#!%51C=N ) ]1S0!Z#'I^FMK3ZI&D;7_D"
M%W5\D1D[AQG SCKC)P/2JL7A;3;><RP2:A%F9IC''J-PL>]F+-\@?;@L22,8
MYKFTU-H;]H;O5FT[399[A%NB41G\@1Q+'O(QDL)7]3C XS4<NJ:[<:1=SR7]
MU;26.E)(%1%1Y;B1G\O<"O!PJ9  Y?\ "@#NI+*WEO8+QTS/;JZQMD_*&QNX
MZ?PBLQ?#6@O!>6D-LJ++>?:IA#,RLEP0OS@J<HV-IXQU]ZB\1W\EDNFP37XL
M(+F?R[F\!"[0$9@H+<*68 9/N!R17(IK$MEI@?\ M&:-KM[J^:625;=[A%?R
MX@#L8L^Q%.U5'49]" =Q!X>TNVC$2Q.[&=;EGEG=Y'D7&UBS$DXP!@G%(GAC
M1XTV)9A5\Z6; =OOR*5<]>ZL1CH.V,"N,35;F.6YU"[U)H]0^QV%F[>8B)$T
MB^8\AW A%). V",YP#TKH_!^KR75M/'>7JRLUY+':9EWL\:*N[#;5W#=N.<=
M".O6@"[:>%-(LV1DCN93'&8HOM%Y-,(E(VD('8A>.,C'%%EX7TRP*1V\M_LB
MCV+"^HSO&$(*XV,Y&,=..,<=*PO%NLZE;ZV]E;WB64:6BR6X,VQ[B9F8?*OE
MN9-NU?D'][G/&*IO9H-4U&[FU3[*T^HP6-W,'7;:Q+!O)^8?+ND+*"?[X/6@
M#KY=(TQ+&SBEB"0:84DMV,A7R=BX!W9SC;D')Y&<U5@\.:3IF+J*XO8(H6,N
MTZE.(5YW'*E]N/;&*AM]3LH_#=PT^I/>1K;2SAKA DC098 D8&1@8!QR,&JF
MI6R1_#_3[?5I)X3%':^=,D8D$4BE3N=3P4##YO;\Z )[32/"L$*:E%=K+:6\
MN^-I-1>6WB?.<A6<H#D\<<$\5;U"Z\.:O98NM2LWBAD5A+'>!#$_.TAU8%3U
MZ'U]ZXN_OHIM-U%UN-)F1+W3G?5;5#]ED_T@<2)OQE ,MAN0PR176>'IK#44
MN(O[2T+52I5BNG6X0)UQN'F/GVZ=Z )+'2_#=[8W5G:2PWR2NLEPXNC-(6_A
M8ON+ C;P<\8XQBHHK'PKNN; WT-S<78^SS">_,LS '[F68L,'/ QS3_ L$4/
M@K1VCA1'>RB+E5 +':.OK6;X2TZ_:&>Z673O(_M"]*HUB3/G[1* ?-\S'7G[
MG3CWH W)(M"G\20W+2VK:Q;Q-&@$P\T(W)!4'D=^1QSZU%,GAMTOM(ENK7-^
M[?:;<W0#NS  C&<@D <#%<D)=,/@6#2(?+_X2550?9\#[2MYD;I"/O8WY8OT
MV]\4:K97\VF>(9-EF^G/?RK=XM"]S'$0H=T;=@D#D#'&"1DX% '4ZU_PB^H3
M>5JM]:+-"DD1!O!$ZJZ[74X8'!'8^@/4"M":WTRZ$%PYB(TZ0R1NLFT0D(0<
MD'IM8Y!XP:Q[VUL;CQ7H,J0PS1RVURWF;0WF#$>"3W^M8UW;ZLVB^,&M;ZUA
MM1-=;H7M&=V_<KG#"0 9'^R<>] '2P^'-#L9X+I594CDW6\4ETYAC=N 4C+;
M0>>,#OQ5F6TTJ9-0N6DCVW4?V>[E$V %7<,$Y^4C<WH:R]>!_L'1?^PA8_\
MHU*Y#48KG2O#.O7T"22V>I7M]#=QCGRI?M$BQR@>A&$;_@)[&@#T'4])TNZ-
MO)=%K>2+,<,T-PT#@$<J&4@D<=.G'M52Q_X16.6SBLKVQ:2V=V@5+L,Q9P=Q
M/S$L3DY)R>].\3#-QH8(R/[43/\ W[DJG8V5JGBCQ$4M8EV0VY0B,#;\C]*
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M2VF:W,GVJ2TP5CM_+8!'(Z9?RR%//RGC@T ;=Q=:'8ZLUS=7UI;WK0K$WFW
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MEO5V_:A"L4C;^B E@",X'+$YK \'74$,-Y"UU!,)]2D^SW$0"Q71*!SY:Y/
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M-,PPDNP/L/K@\&IJ* .?_L?Q+_T-?_E/C_QH_L?Q+_T-?_E/C_QKH** .?\
M['\2_P#0U_\ E/C_ ,:/['\2_P#0U_\ E/C_ ,:Z"L/QC>:A8^&Y9=+N%M[Q
MI[>**5D#A2\R(20>O#&@"/\ L?Q+_P!#7_Y3X_\ &C^Q_$O_ $-?_E/C_P :
MHZ9!X@OTDCD\4SV]W 0MQ;M90DQGL0<<J>S=_8@@2:C:ZWIEMYTWBVX8LP2.
M)+"$O*YZ*HQR3_B3@ F@"U_8_B7_ *&O_P I\?\ C1_8_B7_ *&O_P I\?\
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M0@\Y)"<<;AC ]Q5N\\7W&G6%E=R1V6H1SWC0RMITQD6.)8V=FZ<E0I)'I[T
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MO%5U<:I=6J7&BP""[:W6*XNRLSX.,[<=^U3V?BY7U#7K>\MQ!'I.7216SYJ
M?,<>H../]H4 2?V/XE_Z&O\ \I\?^-']C^)?^AK_ /*?'_C63!XWOIX[ 2QZ
M7I\MQ;RRR"]NBBJR2F/:IQR>,U?D\6O9ZGIEK>16\EO>PEY+RUEWQ1,7"IR>
MJDD#/8D=J )_['\2_P#0U_\ E/C_ ,:/['\2_P#0U_\ E/C_ ,:JW_B758M)
MO=2M+2S:.RNI8'661@6VOL!&!WZUKSWM]I^@7E]>Q6YN+:&279"S%&VJ2!DC
M/:@"E_8_B7_H:_\ RGQ_XT?V/XE_Z&O_ ,I\?^-4[SQ;=IJ'V.WBL(Y1;1S)
M%>7)B:[+#.V(XQQTSSR>@ZUI^(M:ET71H[U(H5>2>&(BYDVI'YCA2689X&<G
MZ4 0?V/XE_Z&O_RGQ_XT?V/XE_Z&O_RGQ_XU3N/%5]:Z-/?1KIFJ2)/!#'#I
M]T7+%W"D$D<'GBKRZ_+J-Q%#HZV\HGLA=123,RK]\*00!D<9_$8H ;_8_B7_
M *&O_P I\?\ C1_8_B7_ *&O_P I\?\ C5%?%&L1^&+C7+FUT](TD,2*)GQN
M$WE$L2.%ZFEN/%=W:Z1=7WVC1+HPR01C[+=EU0R2JF7..  Q/X4 65T#Q D[
MSKXH ED 5W_LZ/) S@=>@R?S-2?V/XE_Z&O_ ,I\?^-9TWC2YM8=3W)I]XUE
M8-=K)9W)>,8.-C\?*3U'J ?2I9?%5U;Z3J5_]HT6]^Q6KS".RNS(Q(Z9XX'7
MF@"Y_8WB3_H:_P#RG1_XT?V/XE_Z&O\ \I\?^-2P:KJ=MJ]KI^K6MJHO0_D3
M6LK,-ZC<58,HQE<D$9Z&JOB/Q1<Z+-=16U@MU)#!;R1H9-ID:2?RMN>WKF@"
M7^QO$G_0U_\ E.C_ ,:/[&\2?]#7_P"4Z/\ QHC\1R:E<6L.D1PR?:[&2YC:
MX++M9)$4HP )!&]L^A7%5;;Q/JB:3=ZG?V5H8X;B2TBBMY6+RS+/Y*CYA@!F
M[]LT 6O['\2_]#7_ .4^/_&C^Q_$O_0U_P#E/C_QJ2'5=4M-4M++6+:U5;\L
MD$MK(S!9%4OL8,!U56(8?W>@J'4=>U"'7+K3[0::B6MK%.TE[.T>[>9!@8!X
M'E]?>@!W]C^)?^AK_P#*?'_C1_8_B7_H:_\ RGQ_XT_0/$9UV90+4P(^G6UX
M S9(,K2@K]!Y8P>^:S%\974\EG&@TZU^T0S2E[R<HOR2^7@<<D]: -#^Q_$O
M_0U_^4^/_&C^Q_$G_0U_^4Z/_&L]O&LQTNSN#%96QN;F6W-W/.?LB["0&#X&
M0^/ESCOSQSIVFNW<ESIEM=6D,;WOGY>*82(1'C#(1U# YYP10 S^Q_$O_0U_
M^4^/_&C^Q_$O_0U_^4^/_&G7/B1K>+6V^SJSZ=<1V\"!O]?(\<;(/;+2A:J7
MOC&6TT'3M273S-)-=&VN[=&RT)17,NW^\5\ML#O^- %G^Q_$O_0U_P#E/C_Q
MH_L?Q+_T-?\ Y3X_\:D_MF\O[ZXMM(6TE$4%O<1RRR-LD23S.FT'^X,?6G^%
M]3U'6=&M]3OH+6&.[@CFA2!V8@,,D-D#U'3WH @_L?Q+_P!#7_Y3X_\ &C^Q
MO$G_ $-?_E.C_P :;8ZIK\^O7&G7%OIJ):I%)*Z2R$E7+_=RO4;#U]:K_P#"
M4:E_8W_"1_8+?^QMOF[?-;S_ "/^>N,;>GS;?3OGB@"U_8_B7_H:_P#RGQ_X
MT?V/XE_Z&O\ \I\?^-:.M:D=+TN2YCC$TQ*QP1DX$DCL%09],D9]LU1MO$9N
M;31)EMPK:E<M;3(6Y@=8I6<>Y#1%: &?V/XD_P"AK_\ *='_ (T?V/XE_P"A
MK_\ *?'_ (U)<ZMJ+W^HV>GP6I>Q6)RT[L RNK$] >05'YFL^#Q;=P:1HVJ:
MNEA:VVJRQ .)R!"CPO)EBP SE0/QH N?V/XE_P"AK_\ *?'_ (T?V/XE_P"A
MK_\ *?'_ (U7E\:VSW%[%IWV?4/*:VBMS!."LLLS,-I89"@;<D\\9XI=0\1Z
MGH<5R-4M+5I!93W5L]O(VQVB7<T; C(.,$'G(STQR 3_ -C^)?\ H:__ "GQ
M_P"-']C^)/\ H:__ "G1_P"-0:=XHN+C6+*PE;3+D7BN<V-R9&AVKNRZX^Z>
MF<]2/6H?^$DUN;3-#U"VL[#R]76$!9)7!C=XRYZ#H,8H N_V/XE_Z&O_ ,I\
M?^-']C^)?^AK_P#*?'_C3+KQ/-H]Q+:ZM:H)VA62S%NQ(NW.%,:Y'W@Q'X,#
MV.+VHZK/I6BQ7-Q;)+>RM'"MO&^%:9R%"[B.%R>N.@)QVH J?V/XE_Z&O_RG
MQ_XT?V/XE_Z&O_RGQ_XTV77=3TRX^SZM:VNZ:WEEMY+:1BK-&NXHP89!QR#W
MP>G=FB>)9K^W-W<7&ER0+;^=)'83//,G ."@&?;CG- $O]C^)?\ H:__ "GQ
M_P"-']C^)?\ H:__ "G1_P"-=!10!S_]C^)?^AK_ /*='_C1_8_B7_H:_P#R
MGQ_XUT%% '/_ -C>),8_X2O_ ,IT?^-0S^'->N9())?%&Y[>3S(F^P1@JV"N
M>#Z,1^-=-10!S=QH'B&ZMI;>7Q43'*A1P+!%)!&#R#D?A3H]#\111K''XI"(
M@"JJZ=&  .@'-=%10!S_ /8_B7_H:_\ RGQ_XT?V/XE_Z&O_ ,I\?^-=!10!
MS_\ 8_B7_H:__*?'_C1_8_B7_H:__*?'_C7044 <_P#V/XE_Z&O_ ,I\?^-'
M]C^)?^AK_P#*?'_C7044 <__ &/XE_Z&O_RGQ_XT?V/XE_Z&O_RGQ_XUT%%
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MBVACBFDCB@DB+!_+8H=S9XR5.,#@8SGI2:AJMZ=&L-2TQ8LW+P?N;@$9$C*
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MH25([W8LH&<;@&YZGZC@Y%-V>'UMK6"+58X19Q^5"\=]AU0XRN<\CY5Z^@H
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M'7.>#O3:II,\+Q-JEL%<$$I<JI'T(.14&GW&AZ9:K;6VJ0F)0 HEO?,V@#
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M:!9W;7,6L9D=MS[]19@QQCD%L'C%*R>'6MK^W;4HFCU DW -\?FR,'!W?+P
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MDHH S/\ A&= _P"@'IW_ ("1_P"%'_",Z!_T ]._\!(_\*TZ* ,S_A&= _Z
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M\,V^X/F(9B-HV;>JJZ,PSQDXSB@#4_X1G0/^@'IW_@)'_A1_PC.@?] /3O\
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M"1_X4?\ ",Z!_P! /3O_  $C_P *TZ* ,S_A&= _Z >G?^ D?^%'_",Z!_T
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M _Z >G?^ D?^%'_",Z!_T ]._P# 2/\ PK3HH S/^$9T#_H!Z=_X"1_X4?\
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M $ ]._\  2/_  K3HH S/^$9T#_H!Z=_X"1_X4?\(SH'_0#T[_P$C_PK3HH
MS/\ A&= _P"@'IW_ ("1_P"%'_",Z!_T ]._\!(_\*TZ* ,S_A&= _Z >G?^
M D?^%'_",Z!_T ]._P# 2/\ PK3HH S/^$9T#_H!Z=_X"1_X4?\ ",Z!_P!
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M;0;"#4)M0:!);N68R^<Z@LIVA0 ?91@?CZUI44 5+'2[#3=_V*SAM_,QN\M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2_Z&33/_  *3_&M^B@# _P"$Z\)?]#)IG_@4G^-'_"=>$O\ H9-,_P# I/\
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M'_"=>$O^ADTS_P "D_QH_P"$Z\)?]#)IG_@4G^-;]% &!_PG7A+_ *&33/\
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MGL!FNQ\5O=9T>VM;R:T^U:BL4KPD!BGER$CD=]HH WZ8\L<;QH\BJTA*HI8
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M-U;(*QD>60?0#I4\][K.B01SVVH75_/=:#<79CG(<>?&(BK*H''^L;Y1P>*
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MS\QI'*283(0$D#Z5K:5:7VJ6VI"34=:CT^"4-83S,T$\@V?.#D!BH;IN&>M
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MD.?-D<%R?4[6C_,^M-UOQ->ZA9>'I=/G>U:2:VN+T(<$!IDB,1^K,_\ W[-
M&O9ZW-86_D6_@[750N\A&+;[SL68_P"N]6-<KI-GXET19%LK76AO/WI-.M78
M+DD*";GA1D\>Y/4FNEL+:Y\3SZE>7&JW]K'!>S6MM#9S>4(Q&VPL<?>8D$_-
MD8QQ67;7NHZY?Z-IUWJ5U"T<FH6]S+:2>3]H:!U57X]>N/4F@ _M'QK_ ,\=
M7_\ !7:?_)-5M-M]9M?$Z:Y=Z5KERRHX,,=G:Q*S, "_%P?FPHR<<X%6]6U#
M4]%AUO2EU*YN!;16ES;7$C#S8UDF*,A8 9^X<$\X;%)>7;S>+M<@N9_$31V\
ML*PIIGF&- 848@[>AR2?QH VW\03R-ND\%ZT[%"F62V)VGJ/]=T.!Q3+36FL
M(C#9^!]7MHR=VR&*U09]<"6L[4]8U'2KK7H+6Z=FA73[>V:8[Q$TK&,N<]3R
M"?4BMRUT&ZT^_MKB#7+Z9,E;F*\D\T3#!P5Z;&!P?EXQD8H KCQ!.%D4>"]9
M"RDF0;+;#DC!S^^YXJ*'5A;6SVL'@358H'SNB2&U5&SUR!+@UE6'BX2^-!,V
MKPO8WMW+IT5F)E)C* ;)-N<C<ZRC/HR5;U+295\8Z;9)K>KI!>P74TJ+>,,,
MABVX]!\[<?2@!MI)':7%^R>"=8,%\(U>V,-IY2A!C 7S<<YS5V+6# JK#X&U
M:-4(90D5J I P"/WO7''TK/O-6U&UNM6T^VO9%>35K2PMYI/G-NKP1%F /!/
MWCS_ !&KMY!<^&-0TN>WU.^NH+R[6TN(+N;S=V\'#J3RI! X'!!/% $DFLM+
M:?9)/ VKO;8QY+16I3'^[YN*1M7WV8LG\"ZJUJ!@0&&U* ?[OFXKG;3Q+JUI
MX3U:'4;MS//97MSIEYG#93?NCS_>7 8>JG_9KN;C4#9Z7;R[?.GGV1Q(3C?(
MW3)].I)[ $T 9D/B">W3RX/!>M1)G.U$ME'Z35!)J,4L#02> -3>)I/,:-H+
M0J7_ +V/-Z^]69/$EV+>74H[")M+AG,32M.1*P#[&=4VXP#G +9(&?0&P?%F
MD88B6=@I?++;2$$(<.P(7E5/!8<<CF@"NOB2[5 B^#]<"@8"A;; 'I_KJK0Z
MG';1O%!X!U2))&#.J06BAF!R"0)>3FM=/$6FR30Q"24>>!L=H'5"2F\#<1@'
M;SC/ZU#%XITZ[B1K.1V9S 466&2/>DI.UERN3D*^.WR\D=: .8GBN[K51=W&
M@>(I81<K<B%H;/=N5@RJ9/-W; P!"^PYQQ6X-=E"!!X)UC:K^8!Y=K@-G.[_
M %W7)SFKD?BK2Y3*J&Y,D<HA,7V63>7*[MH7;DD*,G'0=:CO_%NGVUH);8O=
M22)&T2K&^W,AVQAFQA"QXP>?:@"O/KTURJK<>"M9F",'421VS;6'0C,W7WH&
MNRJD:#P3K 6)MR*([7"GGD?O>#R?S-7M0\16VFZO'8W".$,'FR3*C,(\N%7=
M@' /S<DC&/RM0:M97,T<,,I:20RA5VG_ )9/L?/H W&>_:@#"DU..4P&3P%J
MCFV $):"T/E8Z;?WO'X5/+XBN9XFBE\&ZW)&XPR.EL0P]"/.JS<^(##8ZO=)
M;!_L$_D0C?CSWVI@=./G?;WZ46.L:AJ'E7D&G1MILTA5)//Q+LY EVD8VG&<
M;LX.>O% &>FJK';-;)X#U18'&UHEAM0K#T(\W!I1JP%E]A'@35?LN,>1Y-KY
M>/\ =\W%6/#?B8^(=DD;Z;Y<D?F^7#>^9,BGIN3:,=1GGBKC>)=+22=&FD'D
M$JS>0Y5F#!"JG&&;<P&!DDGB@#*DU1);6.UE\!:H]O$04B:"U*(1TP/-P*E3
M798SE/!.L*<%<K':C@G)'^M[GFKTGB?2XX@[23[OGW1"VD,B!,;RR 9 &1R1
MW'J*KIXMLFGE616ACBFECW2(^9 FU24 7YOWCJF.^>,DXH A37IH_*V>"M97
MR4V1XCMAL7C@?ON!P./85#%J<<"2I#X!U.-9CF54@M '/OB7G\:TY/%6E0Q[
MGDG#_O 8A;2&1=@!;*!<C 93]"/6I-3UR'3X;"54>=;Z81Q^6K,2"C/D  D\
M*: ,Z37I9BYE\$ZRYD3RWW1VIW+_ '3^^Y')X]Z1M<D>T^R/X)UAK?:$\DQV
MI3:.VWS<8]JT(?$VE7#0>3/(ZSB,JXA?:ID *!FQA2<C@X/(]1D_X2;2QYNZ
M69#& 0'MY 9 6V#8"/GRV ,9ZCU% &9%JJP(J0^ ]5C5=NT)#:@#:25QB7L2
M2/3-/DUR29)4E\$:Q(LP E#1VI$GU_>\_C4D7C&R:69I08;>.5T#.C[V"^4I
M.S;D'S)=F#SQD9YQ9?Q7I$<!E>68!?,WK]FDW1A#AV9=N5 R.3QS0!3M]=EM
M$*6W@G6(%.,K'':J.  .DOH /PH;796@>!O!.L&*0DO&8[7:V3DY'G<Y)R:U
M+77M/O+W[) \K2<9/DN%!VA]I;& =K X_P#KTNJZO;:1''+<R(D9WLY;=\J(
MC.Q& >@7V_/ (!BC5$6R^Q#P'J@M>OD""UV=<_=\W'6E.K*;IKH^ ]5-PV-T
MIAM=YQR.?-SQ@?E6E_PD^F;6(:X+K+Y7DBUD\PML#\)MR1M.<XQ3;;Q-8W%W
M=1%ML<*&1),'YT6.-W;&. !*@_'VH IC790B(/!.L!4?>H$=KA6Y.1^^X/)Y
M]Z</$5TAD:/P=K:-(<LRI;98XQD_ON3@#\JFNO%EA%+!%!YDK2S+&6,;JB_+
MO;YL8W*@+;>O'UPZV\5Z9*8HY9C'*V%<B.3RD<Q"7:7*@?<YYQ^!XH P_P"U
M?$O_ #X>(/\ P#LO_CM']J^)?^?#Q!_X!V7_ ,=KI].UNQU2>2"V:;S(XUD9
M98'C.QL[6^8#(.TX^AJ!/%&E2(S)+,PW!$Q;R9E))'R<?/RK=,XQD\<T <__
M &KXE_Y\/$'_ (!V7_QVAM3\2LI7[%XB3/\ $EI8Y'TS*1^AK:D\4VK7,,=O
MM:.1 6DE+)L8R^7M*[<@_+)G.,%,'')!-XMTU+87$;2%<AAYD$B%TV.^Y,K\
MWRQN1VXZT <^EQK\4S3);^*C(V-Q>TTW#XZ9VD$_G4W]J^)?^?#Q!_X!V7_Q
MVM^V\2V<L=H)XKBWFN40E&@<A'9=P0MMQNQV^GJ*K6/C"RO((9VCDC$\221Q
M"-VE?>7V84+SE8V;CH!GIR0#)_M7Q+_SX>(/_ .R_P#CM+_:OB7_ )\/$'_@
M'9?_ !VMX>*M(:6*-)Y&,OE8*P.0GF,40,<84E@1@X(-(/$UFMW+#('"K)L1
MHXWDR =I=MH.U=^5R>NTGH* ,FSUO78)]]SHNOW4>,>6;>T3GUR)JG;62UXM
MZW@;5C<J-JSF*UW@>F[S<UH'Q3I"I([7#K'&AD#F%PLBA@I*''S@,RCC/4>H
MJ"?QCIL,ZH5G"*D\D[O Z>0L2@L6!7/\2_\ ?0]10!636/*NWO(_ NK)<R##
MS+#:AV'NWFY-4]#F70K"&VM_!>LM)'$(FN#%:B211_>(EYKH%\1:>9HHC]I0
MS,%5I+61%#,2%!)7"DXX!]1ZBJTOB[3PD)MDN+@SS11Q[8' =7)&]25PR@*Q
MR.N/<&@"E-J:7"0I/X"U258,>4KP6C"/_=S+QT[4Z;5_M%S'<S^!=5EGA_U<
MKPVK,GT)ER*V;K6;*SOH[*5Y/.D"G"1,X4,VU2Q PH)XR:IZAXIL;33!=PDS
MM)%YL*!6'F#>J#MW9UQW/;- %:XU^:[A:"Y\%:S-$WWHY([9E/U!FJ,:OB\^
MVCP+JPNL;?/\FUWX]-WFYJ^WB?3@8V\TJK"3>KQR+(I5E3:$VY+%G4 =3D8S
M3I/$^EQQ*[239._=&MO(9$"$!RR@94#(Y/J/6@"C/KTUT@2X\%:S,JL& DCM
MF (Z'F;K0->E"(@\$ZR%C;>@$=KA6YY'[[@\G\ZOP>(K22PU&_F62"UT^61'
MD=&^<)]Y@,<\AAQGI20^*-*GNA;+).LAD:(^9;2(%<(9"I)4 '8"V/2@#.BU
M?R;J2[B\"ZM'<2_?F6&U#M]3YN34C^()Y&WR>"]:=MA3+);$[3C(_P!=T.!Q
M[5/-XLL4$0AANI99+B*'RC;R(X#Y(;!7.-JL?^ D46'B[3KRU@G=9X?/ 8 P
MN0B,Y6-F.,*&QD9_D,T 48]2BBLWLX_ .II;2'+PK!:!&/NOFX-*VJ(]DMDW
M@+5&M5^[ 8+4QCZ+YN*V(M?T^:RNKU))/LUJ6$DIA<+\I(;:2/F (/(S534?
M%VF6=C?302_:)K0RQ^4 PW21J"5SC@991GIE@.O% %4:R0 H\#:L  P $5K_
M !?>_P"6O?OZTD^MW$\+1CPAKT3&)HDEB%LKQJ1@[3YO'0?D*T3XHTL1EM]P
M75G5HA:R>8NT L2FW<  RG./XAZB@^*-)\YX4FEE9&5/W4#N&9E#A5(&&.U@
MV!T&2< &@#F='-WIFHF_F\.:]=3B$PH1!9Q*JL0S$A91EF*KDGT'2M6XUC[7
M-'-<^!=6FDA.8WDAM69#[$R\5HZEX@AM/#SZO;1O= X6*,(P+R%MBJ1@E?F.
M#QD>E%MXDL94(ED99$B=W*PR%&*8#A&*_/@G&!S[4 46UV5]^_P3K#>807S'
M:G<1TS^^YQ@4V;63<12Q3>!M6ECF;=(CQ6I#G@9(,O)X'Y5H-XGTM(M[-<!A
M*83#]FD\P.$#D;,9^X0W3H156Z\7VEK?B%D:2']X6DA21RBHB,Q*A?\ IHOM
M[YXH K3:HEQ:I:S^ ]4E@CQLB>"U9%QTP#+@5,/$$ZNCCP7K(>-=B,$MLJO'
M _?<#@<>U63XIL8[B[CFW[()"J-"C2EU$:.[X4'"CS ,^M7KO45MI; *HDCO
M)_*W@_=S&S ^_P!T#\: ,S_A)[W_ *%'7?RMO_CU'_"3WO\ T*.N_E;?_'JZ
M"B@#G_\ A)[W_H4==_*V_P#CU'_"3WO_ $*.N_E;?_'JZ"B@#G_^$GO?^A1U
MW\K;_P"/4?\ "3WO_0HZ[^5M_P#'JZ"B@#G_ /A)[W_H4==_*V_^/4?\)/>_
M]"CKOY6W_P >KH** .?_ .$GO?\ H4==_*V_^/4?\)/>_P#0HZ[^5M_\>KH*
M* .?_P"$GO?^A1UW\K;_ ./4?\)/>_\ 0HZ[^5M_\>KH** .?_X2>]_Z%'7?
MRMO_ (]1_P )/>_]"CKOY6W_ ,>KH** .?\ ^$GO?^A1UW\K;_X]1_PD][_T
M*.N_E;?_ !ZN@HH AM)VN;6.=[>6V9UR89MN]/8[21GZ$U-110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %49=+AFUF'4W9B\5M);>6<;65V1B3_W[
M'YFKU<4^BN?&BZ9_;>LBV;3VN"HOWSO\P+U],'I0!LQ^#]"@UJUU6VTVTMI;
M6.1%6&W1%)8J=QP.HV\'_:/K6K:02V]LL4US)<N"<RR!0S9)/\( XZ=.U<U>
M^-6L-<2QFM[)8WO$M0GV]3<_.P42>4%.%R1U8''..U6[+Q//>:^^B?V8T=W;
MNQNB9<I%%_RSD5MOS;\C"\8PV>G(!6M? PBTV#2;G7=0NM+@"@6;+$B.H.0K
M,J!B/;//>K4WAFZ&K7VH6&OWE@;YTDEBCAA==RHJ C>A/11WIFNWES!XFTV"
M*>1(I+"]=T5L!F7RMI/N-QQ]:P(EOM+\ Z?XIBUG49;I;2WN9XKBX,L4P8*7
M7:W3.3@C!!Q0!T<_AJX:ZCOK;7+RVO\ R%@GN%CB(N%4DKN0KMR"QP0!U-)_
MPB%HMA!##>745Y;W#W*7X*F;S7SO8Y&TALD%<8QCC@5'XXDU!-'M8]+O6L[J
M>_@B28=!N?'([CU'>LQ_%L\MYI]R4>*6VM+XW]COP!-$L9VGVY)!]&![T :<
MG@V&[@O#J&HW5Y=WB1QO<N$4HB-N"(H  &>3W-:=_HL-]J=AJ0DD@NK%CMDC
MQ\Z,,-&V>JG@^Q (K-U+Q;_9]G%<?8?,\S2+C4MOFXQY2QG9T[^9U[8Z'-5)
M?%FMI<3V_P#8%N)8[,7RAK\X\GD;2?+XDR.@RO\ M<<@&G8^%[6PETV2.>9C
MIWVCR]V/F\UMS9X[=JV9$$D;(3@,"*XR/Q+JS:GJ=[86(O+)+&VN_+FN?+**
MR,Q"#:06(]<#@<TE_P#$JRMYIS;):206L4<L@GO!%-('0/B*/:=Q"L.I&3P*
M -QO#-JWA2#P[Y\OV>"**)9.-Y$94CMCG:*;=>')#J%Q>Z9J]UICW9!N4A2-
MTD8#&_#J=K8 &1UP,@U%;>(=2U'4-1AT[289;>Q.Q9I+O89G,22* -AP/G )
M/3@\]*?XRGN(/"TSPS26\K36Z%XG*LH:9%;!'/0D4 2V?ABQL6TXV[RC[ \L
M@+MN:9Y 0[.3U)))I=-\,V.E:_J.L6ID634502Q9^12"22H[9+$GW)/>JATK
MQ#'K<\L.K$:?]E\N&)V#.'"_*22I'4G).3\HR2#@9LMMK>E66A_VGJLLUW_:
MJ1.T,K!'C;^%AQN^[_%G&3SCB@#;O?#SR:G+J.FZI<Z9<7"JMQY2HZ3;1A25
M=2-P'&1VX.:2#PK96\5BB33L]I>F]:5V#//*4="SG'<.>F.@ XXK;HH *Q8?
M"NG)H5QI,R?:$NA+Y\TBCS)&D)+,3CKECCTXK:HH YFX\#V=WIUW:7%]=N]V
MT+O.& D#1HJ9! ZLJG/^\:FO_"%K>"],=W/:M=RVTH:(*?*: @IM!!'\(ZYK
MH** ,%O#M[<6=Y9ZAXAO+RWN[:2W9'A@3;O&-P*H#D GVIVJ>%+#59]*N)FD
M2?2I4DBD0@%PI!V-ZJ2JGZBMRB@#FCX0EWWJ1>(=1M[2^GDFFMX5A'+GY@'*
M%@/H<U+<>#M.FANH8GEMXY[."UC6(@>0(69HV7W!;//H*Z"B@#F[OP387%I)
M;1W$\"/8P62[-IV)$Y=2,CKD\YJU#H>H@R+>>([R\ADC9&BD@@4'(QG*H#QG
MUK:HH Y[4?!NG:EI&EZ?,\H.E&(P3*0'^3'!XY!VC(^GH*T[C2XKC6;+5&D<
M2V<4L2*,;6$FS.?IL'YFKU% &/)X<MYK?RI)Y"3J*W[.,99UD#JOT 55^@JJ
MO@O3T^V;)IQ]KO8KL\CY"DOFA%XX4N6/_ S7144 84_AJ1;VYN=,UB\TP7C;
M[B*%8W1GQ@NH=3M8@#)'!ZXS44O@^&---&F:C<Z<^FK*L<D821G\P@N6WJV2
M2,Y]2:Z*B@#GCX/M9-/O;>YO;JYN+]XVN+N4KYC>6P*J  %"C'0#N:T[/2XK
M+4=0ODD=GU"1))%;&%*HJ#'X**O44 8]SX9L;V;5'N3)(NJ1Q1RIG&WR\[2I
M'(.3G/J!54>%9IIH9=0UV^OC:AOLHD6-1$Y4J)#M4;G )P3QR>*Z*B@#"E\)
M::_AN+1(U,*0QQK%.@'FHR$%7SC[V5!J_/I45QK-EJCR.);.*6)5&-K"39DG
M_O@?F:O44 8USX7L;L:F)WF/]I3QSL5;:T+HB*K(1T(\L'/K[4RV\-R"_M[S
M4]7NM3>T):V29(T2-B"-Y"*-S8)&3TR< 5N44 <[?^"M-U'PH?#UQ),80S,D
MRD"1&9F)(./]HCW!(K0O-.>2726B(*V%SYC!CR5\J2/_ -G!_"M*B@#$'AF/
M/D&^N&L!/]H%F0NS=NWX+8W%=W.W/MTXK,U7PM?-:VUAI4SQ1BQ-E)<^:H8H
M2-Q92AR>"<J0<D_4==10!S5QX(LKB\DN?M,J,QE*%43<F^-H_O;=Q"ACM&<"
MK=QX:@ENQ=17,L$J!1$4"D1[8Y(UP".WFLPSWQ6U10!S)\%6[Z?;6DEX\IM7
M9HY)((G/S#YLAE(9B?FW'G/XYL)X4MHI8Q#=316RR0RM;*$VN\0 4DXS_"IP
M.ZYK>HH Q[[P['?:A+<R7LZQW"Q)/ H7;(D;%E7.,@99LX/(.*30-'>PDO+Z
MY4+<WLS.8P^\0IN)" X'=F8^['J *V:* ,7_ (1N/[42U[.;0W7VPVF%VF7=
MN&6QN(# -C/4>G%,C\,>7;BT75+P6D2NMO""H$6X%1R!E@H8[0>.F<D UNT4
M 16MO':6L-M$,1PHL:#T &!6!/X+M+E[EY[N61YRART<9Y5PZ[QMQ)C&/FS\
MO'O7244 8$'A."T\DV=[/;,JLDK0I&AE#,&/1<+R,97''X$(?"-N02;VX\Q9
M&DA?"YC9IQ.3TP?G Z]A7044 8)\*6[+=-)=W#SW<$T,LQVALR[0S# P#A$
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M\%O<,I0?:RSB/YMS$;,9R!@9Y![8Q2^(3*^L>'[5;B>&*>\D$HAE:,N%@D<
MD'D94'% &Y$[20H[QM$S*"8V()4^AP2,CV)K&\26MY>W&CQ6MH\R17\<\TH=
M L2)ZY()SGC /0].*SAH?BMM+U.V?7R)[J3_ $>4$?ND/RMT0$';S\NT9Z;>
M29 M_:>*- CNKV:2:XM)Q=()3Y3.H0@A0 O!8\X!QC- '4T444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*SH'V1[5(R 1R>Y''>@#N**X3Q)XEU2_\.:[/H]ND5K90;'F>9HY][1+(2H
MXVAUZGDYZ5N>+[O4;/3K-]-DC2634;:)BY(!5I5!''8YP?8F@#?HKE)_%>H1
M17>IK86YTJRNS:S$RD3-M<([J,8P&SP3D@'ITKI;<W),WVE(E D/E>6Q.4P,
M%L@8.<\#(Z<T 34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<. ..^#@\@T :LGA"REGD+7=Y]EFG%Q-9"1?)EE!!W$;=W) ) (!/:MFWMS
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<9HFC67B;39=5U
M=YI;VXN9T5UN'0VP21D5(\$;2 H]R<DT =G17)>#_$-]J*:?:7;),7L))6GQ
M\TA2;RPWI\P&[\:I'QIJ4^DZ?<PO8PSW%@+IXOLTUR[,<_*$C.47C[Y)^G!H
M [JBN+'BK7-0AEGTV"PACATBWU%A<*[EC(KMY8P1C[GWNWH<\4[O6+^:;6KR
M5HY;(V-A+':MO&PR.W\08>^< 9^7TY /0**XNSUG5M/O]2GNYH;BQ&N+:O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:7Y?V6-U\NU%JN7)_=@D@?7)/-5&\%Z.8(H$%S#$EJEHZ17#()X4&%5\'YL
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ME@A\QB0"RD#)ZXR:R[;5_$MW=VVG!]+ANIK4WKRF"1TCC) 6/;O!9L[LMD#
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M>XU"WNS/J5^\A(2,Y/DMC@D@@! /E !XXR =,^BV+O>L8B/MT"V\P#$ HH8
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M_AG2;5&2WMO*1K3[&55SCRLL<?7+$YZG-02W>IV'@M;V/R;N]M[596 C95D
M + #<3DKD#D\_E5&Z\63.E_<V$UDEE"]O!!<3*[^9(X#-A5Y?"LF%&"3GD4
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ML*I+X-T>&**.V2YM3"TA22"ZD1QYA!<;LY() .#WYK=HH Q_^$4T7[)+:"R
M@EM4M&0,V/+0LR@<\$%V.[KGG-7+[2[34M/-A=HTL/R\ER'!4@JP8'(8$ Y!
MSFKE% &1!X7TN#YBDTTIG2X:::=WD=T^YEB<X'8=/:F:GX2TC5IKB2ZBGQ=
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M8_,VU5R.>.$7IC&,]:J+X/T?9=K+'/<->1I'/)/<R.[!"2F&)R""<@C%;E%
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M )K>5HV9 ZOM.TC(RO'H>16S10!@6>@RZ9XEBN;""VCTQ=/CM-GF,'CV,[#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$J7%\D,MNL$$SSI!*902QA8J^Y<?+T)')X'.#Q0!N45E:!KB:[:23BW>W='
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MWQQ42SZ\]Y]C3QAH+7.XKY(L"7R.HV^?G-3"'Q0;EK4>)M',ZJ':(::VX*>
M<>?G'O0 S3O"MREO83WFH%KVUC@1"(AM18P<J0#R3N()XZ# ZYLZYX6&MWOG
MR7A2/9&!&T>_848MN3)PI.0"<$D 8(I/L'B__H8-+_\ !4__ ,>J**'Q1.9!
M#XFT>0Q.4DV:8QV,.H.)^#STH MZ7X>&F:M<7XNMWGALQI$(PQ9MVYP.&8=
MV <$YSG-9Z>$Y[RWGCU"](0SW;01H@_=B65FR3_%\IX'&-QSGC#F_P"$C6U2
M[;Q7H@MY-NR8Z<VQMW3!\_!SVI\T?B>WDBCF\3Z-$\S;8E?36!<^@!GY/TH
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M.\CEC94D64AK9"Y<($X<\A>,XZY[XXJ3[!XO_P"A@TO_ ,%3_P#QZC[!XO\
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M*2)/,2FT!YY)<$'D!?.<97).<8'!JVW@:R>>Z)E413M,XVVZ"5&E)+'S#DD
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M&RLT9R"R$CIR%R/84 <7I8?1)=+OA>:9J,&IZA,C-':[907:1RXD)R=I!!!
MXSTQ6=;:I<Q:K!XQ?2KV."ZO666\8Q^3]AD"QQ\!]_!6-_N]V^M=M;6'AB6[
M:[M;?3'N+SS$,D00M+VD&1U_VOUJ_=0:?'I;VUW%;I8"/RVCE"B()TVD'C':
M@"RKJQ8*P)4X(!Z&O/+(R:#J6L^(XBS6;ZG-!J<8R=L8(V3 >J$G/^R3_=KO
MX+2VM6E:W@CB,S;Y"B@;VP!D^IP /P%(EG:QQS1I;Q*D[,TJA!B0MU)'?- '
MF,&=:\-^&]"73KS4+:WTA;BZ2T,>Y'>,QQ9WNHX_>-USE5-3ZE<7OB72?#SL
MA36+-[C?&>JW<"9P<>K(/P:O0;>TTS2 !;P6MF)2D0"*J;\#"*/7 & *8\&C
MV=_$\B6<%W<2LT1;:KR2%0&*]RVT ''.* .)^VQ>(/&6C^(("6M6:2VM3ZJ+
M5W<_BSA3_P!<ZM>!+/5?^$<T*5H-%^S?9HFW>6WG[=HYSTW5UBVNC6<UG9K#
M902J9'M8<*K9(.\HOT8YQZ\U5B\&>%X)DFA\/:;')&P9'6U0%2.00<=: *?C
MFZD_LB+2;:":XGU686YB@*[S%]Z4C<0/N!AR1RPKE[F7=X2USPY>6$UFD%U!
M+!;7!3=]FEG4@?(S# ;>O!X %>DO:V\ES'<O#&T\2LL<A4%D#8R >V<#/TJ*
MXTRPNY?.N;.":0H$WO&"=H8,!GTW 'ZB@#B(KBXL/%OAWPW?N\DUE=RO:SOR
M;BV-M,%)/]Y3\K?@>]55M]-3X,PSR10K>"SW6LBJ!+]HS^[VGKNW8Z5Z'/:V
MDD\-W<01-+:[FBF=1F+(PQ!/3(X-8NBZ?X)EO&GT.VT.6Y@.6DLUB9XS]5Y%
M &WY*W%M&EW%'(V 65E!&['->??9H(_@[>2I!&LA$X+A "1]H;C/X5Z16?)#
MH\44>C2I9HESN,=FVT>;SN;"=^3D\4 8_B*SM7\5>&2UM"QDO)]Y*#YO]&EZ
M^M2:2L</CK7D4*BBTL@%' '^NK:F;3Y-0MXIFMVO(@TL".5\Q1@J64=>A()'
MK574/#.A:K<_:=1T>QNY]H7S)X%=L#H,D4 <V;?4;CQQKQL8M+D4+;;C?(S'
M[A^[BNGF6]A\.S+ D(O5M6V+ ,)YFTXV@]LU#<^$O#EY(LESH6GS.B+&K26R
M,0JC '(Z <5H6=G:Z?:I:V=O';V\8PD42A57G/ % '%-!H'_  J7S@L/EBQW
MB7CS/M.WKGKYOF?CNJ+2K;7+GQ!K#);:7+.$M/M'VY&+"3[.F<8'3.:Z_P#X
M1S1!J7]I?V19?;=V[[1Y"[]W][..OOUJ[';013RSQPHDLY!E=5 +D# R>^!Q
M0!D>+(+*3PC>6U_<_8K62-8GF1-PCRP ./[N2,]L9S@5A$SV6M6\.JV6FRW$
M]C<):WNG%H_D"AF#QG/RG P<D ^F:[:6..6)XYD5XW4AU<9!'<$>E8>A0>#T
MN+B+0%T?SBNV=;(QEMOHVWG'MTH YSPTMO)?>%4U$(T0\.0FQ67[IFPOF;<\
M;MNSWP3[U5UR2"YMO$&EW.CVMG-*;"2Z^RWAF20-<!<$;5VMA>>,D$>@KO[C
M1M+N].CTZYTZVFLXE"QP21*R( ,# (P,#IBFV^A:19V)LK;3+2&U+!VB2%54
ML"""1CD@@'/M0!QT-Q<V/B[P]X<OW>6:RN9GM;A^3<6YMY0I)_O+]UOH#WI_
M@*SU0^&M#E,&B_9?L\3;O+;S]N!SGINKMGM;2YGM[MX8I98,F"8J"4W#!*GM
MD>G6LN+P9X7@E2:+P]IB21L&1UM4!4CD$'% ''2MJL&D^))X-.TZZLAJ=R)F
ME1I)43=AF"8 8*.<9'0UV,$\&@^!DN+:?[;!I^FAXY2<^<J1Y!_$#]:U([>U
MM(Y3'%%"CLTLI "@L?O,??U-0R:39'1I=)C@C@LY(7A\N)0JJK @X X'4T <
MSK%I_9WPSF1PDU]<VX1I74$M<3D*6_[Z?CT  [59UF_A\'RZ4T2B.P,<L#Q1
MQKNFD6,-$!QG=\C #N6K0TV[T34;:#2QJ>GZK<6:QEUCD1R'3&'V@G:=PS[&
MI+[16U+6;.[N[E7M+)O.AM?*_P"6V" [-GG 8X&!SSDT <W]MUF2\N[2_P#$
M)L#I^F+=WC01Q?)+(SL%!93\B*@'J<C)YJDWB;Q#>VTTLGVFR^PZ?;R3- ;=
M%$\D8<F3SCG:"0 !_M<YQCK%\+:;+J5Y?ZA;P7TUQ<+-&9H0?)"HBA1G/]S/
MU/M5ZYT;2[R]CO;K3K6:YBQY<TD2LZX.1@D=CT]* ,_6M4O[#PU;S@1P7]R]
MO;EB-R022NJ%O<*6)]\"L+4=5U?3;V^T>QU62\F/V-(;BXCC+032RE64[5 (
MV#?C&1^(KM;FV@O+=[:ZACGAD&UXY%#*P]"#UJO;:-IEG#'#;:?;0QQ2>:BI
M$ %?!&[ZX)YZT 9FO7=SX<\%W]S_ &A)/=10MY=S<! 1(QPA(50N S#MT'>L
M/5-3US2;VYTRUUA[ZYFM[8))+#'B">68(,!0/E*[FVG) 7KS76:SI*ZQ;V]O
M))MBBN8IW0KN$@1@P4^V0/RI;70])LHEBM=-M8(TE$JK'"J@.!@-P.N.,T <
MC?7VL6FI7MG:ZHTURLUG907$\$9*R2N9)3\JC@1[?E]O7FH=6_M"_DNM!DUB
MZF@DUBUM5E9(@Y_=B:5>$Q@*,CCJ.<CBNZ_LZR\[SOLD/F>=Y^_8,^9MV;\_
MWMORY].*BN-'TZX0A[&U<^=]H!>$,!,!@2?[WOUH S=%W?\ "5>( K%XT-LC
M,>\@CRW3OM,==!5+2M-32[/R1(999':6>9A@RR,<LQ]/8=@ .U7: "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@# \<?\B;J/^XO_ *$*WZP/''_(FZC_
M +B_^A"M^@#E=1TZ&#XAZ+?!Y7FN$N5.^0E44(N%5>BCJ>.I-<_I9NX;>WU&
M\2PG#^('BD@,)^T"4SL@?S-W51CY=N-@KT"<V'V^U$[6XO,/]F#D>81@;]F>
M>F,XJL--T)M;>Y%I8G5%0,[A%\X*> Q[\@$9_"@#@KK4[DZM-XQCTJ^>"WO@
MJ7BF,P_84#1OQOW]2\GW>R_6O34ECD^XZM@ _*<]>E4D;1X[1--1K);=B;5+
M8%0I(',87UQG*^E*O]D:2TQ4V=FPB5Y3E4(C4;5+?[( P">* .+"SZ3XJ\1>
M);4/(EM?)%?P+D^9;_9XCN _O(26'J"P[BJ%K<KJOAW0-%BT^XU2UD,][=PV
MI3+1"1Q'G>RC!<@]<_)7=6NM^&6FG-IJNE-+-F6;RKB,E]J\LV#SA5ZGH!5?
M3]4\&V4BQZ;J.BPNZK$JP3Q D DJH /JQP/4F@#C+X7/B/PWH&D77F0ZG9ZD
M]I)YI&])H[:4QN<$C./+;@D<U;DU$>)M>\/:T%*QVMY#;*G]R9X7DF'X8C7Z
MAJZE=6\'2WPN%U+17NGD5PXN(BY<*4!SG.=I*_0XI?[4\'V[B#^T-%B>*X:;
M9Y\2E)CG<V,\-R<GKR: .?\ !5GJCZ)92)!HK6OFN2TL;&;;YK9YZ9ZX_"MW
MQM?3VOAV2ULTDDO-1<6END6-Y+YW%<D#(0,>2!Q2W?A?P=91O?7NC:/;HC!G
MGF@C0 D\$L1ZD5>MK_0]9NHY+2\L+Z>URR&&5)&BR,$C!.,@X_&@#@;J<V/A
M;Q7X??3KC3H!:/>6-O<E"PB88D V,PP),GK_ !BK=XTVBZOH?ABY+O#'JD<V
MFS-D[H K@QD_WHR0/=2OO7;ZE9Z5-$]SJD%JT<<3H\EPJX6-L;@2>BG S]*=
M=KILMW9QWGV9KG>9+19=N_<HY9 ><@'DCL: .(M[?1S\+K^;4(K<$->D2,H#
MAQ/+MVGKNSC&.<XKM=.BEN-$LUU*-9)S;QF=9%S\^T9R/KFLJ6P\$:5>M>3V
M^AVETDO,TBQ(ZR$;NIY#8(/KSFM:#6-+N;5[NWU*TEMXSAYHYU9%^I!P* .,
MCM;>/X>>+Y$@B5UDU90P0 @;Y1C/I6EXBM+9T\-.]O$SOJ4 9B@)8>4_!]>E
M;6H3Z!I-E)!J4VGV5M>%_,2X=(TF+Y+Y!P&SDY]<U.SZ7<Q6;L]K+&T@:T8L
MI!<*<%#W.W=T[9H Q[9(H/B+=(BI&@T>#"J  /WTU9UY!?W'Q!U+[!%ILF-.
MM=WVY&8#YYL;<?K^%;>MZ=X5NI_M&O6VE22Q1 ^9>K&2D>[ Y;HNYL>F35)+
M/P#K-Q!;1Q:!?3)&(H8E\F1@B@G:H&3@#)P* -F)+R'1&54MENUB;:ML,1[^
M<8!]ZY*T@T!OA-YMPL)3[$7N)' \S[3M^8D]?,\S/OFNTL;"STRU6TL+6&UM
MTR5BA0(HR<G 'O55O#FB/J7]I-I%D;W=N\\P+OW>N<=??K0!QVF6^N77B*Y8
M6^G2W8TG3S=?;U8D2$2YQ@>N<_A72>+!=P>!-2%HOEW"6;<6XQMX^;9^&<5M
M);01W,ERD*+-*JK)(%&YPN=H)[XW''U-2T <[-%X6M[+176.!8?/C&FFW!R7
M/"[=O)&"<]L9SQ5#PO!I4_AK4'U>.V>X:YN/[5-P!D-O;A\] %VX[8QBM^T\
M.Z)I]ZU[9Z396]RV<RQ0*K<]>0.,]Z+SP[HFH7JWM[I%E<7*XQ++ K-QTY(Y
MQ0!Y]8:=J&JMX;>*>2+4;71[FXL992?X9HA&'[D-&=I]F/>M_P (7MMXAUKQ
M!=RV@4F2W62"= 3#(L6UU.>X((S77FV@-RMT84,Z(8UDVC<%)!*@^A*CCV%-
MAL[6WGGGAMXHY;A@TSH@!D(& 6/?CB@#SN&V5?A7X9>UMX/M$EQI^"ZX#MYR
M8W$#.,]:T;>26W\;"XU]+'39-/L998/LB';=1'&\ES@_)M'R8[@Y(KL%TVQ6
MTAM%LX!;V[*T,0C&V,J<J0.V" 1Z4E]I>GZFJK?V4%T$W!1-&&QN&&QGU!P:
M //M#O;VPUK3]=O=(OK1=8E>.]N)C%Y9\U@;?&URPVX5.0/O&MGP[#I,OA[6
M)-:2W>8W=T-4:<#( D;:&)Z+Y>W'MC%=;<VEM>6YMKF".:$X)C=05X((X]B
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M4:Y.T>N69B3QV':@"_1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPMOX*\/0K= K.$OB!*#U#?N.1R>#ZU;MYO%%K;);6_AG1X8(U")$FILJJH[
M"#@4 5O%*::FF:.^EK;B\^W6XTTV^WD;UW[<?P>7OSVQ5.+5=3CC_M+^V9)V
M_M^2P%ELCV>5]I:/;PN[<$^?.>@&>]6K+3M6TVZ>ZL/!7AZUGDX:6&^*,?7D
M057TO1M=TRXDO!X5T.6]>XGF%T;\B1?,D9]N[R,\;L?2@!=!U?4QKUJFIW]Q
M)'?-.('C,,EI<;<L-A7#QE54\-G.#SFNU1UD0.C!E89!!R"*Y."RUFVO);R#
MP9H$5S-D22I?D,^>N3Y'?OZU:@N/%5K!';V_AK1X88E"I''J;*J*.@ $& *
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M;_%__0OZ7_X-7_\ C- '045S_P!O\7_]"_I?_@U?_P",T?;_ !?_ -"_I?\
MX-7_ /C- '045S_V_P 7_P#0OZ7_ .#5_P#XS1]O\7_]"_I?_@U?_P",T =!
M17/_ &_Q?_T+^E_^#5__ (S1]O\ %_\ T+^E_P#@U?\ ^,T =!17/_;_ !?_
M -"_I?\ X-7_ /C-'V_Q?_T+^E_^#5__ (S0!T%%<_\ ;_%__0OZ7_X-7_\
MC-'V_P 7_P#0OZ7_ .#5_P#XS0!T%%<_]O\ %_\ T+^E_P#@U?\ ^,T?;_%_
M_0OZ7_X-7_\ C- '045S_P!O\7_]"_I?_@U?_P",T?;_ !?_ -"_I?\ X-7_
M /C- '045S_V_P 7_P#0OZ7_ .#5_P#XS1]O\7_]"_I?_@U?_P",T =!17/_
M &_Q?_T+^E_^#5__ (S574M?\4:3I\U_=:!IWD0+N?9J;EL>P\F@#JJ*Y_[?
MXO\ ^A?TO_P:O_\ &:/M_B__ *%_2_\ P:O_ /&: .@HKG_M_B__ *%_2_\
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M!D8^0.Q ..,]<<4 ><B*(>&I)G\/LD]U>7$$6M-="-89#.ZH[%274*<#.,<
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MBBB@ HHHH **** "LKQ3_P BEK'_ %X3_P#HMJU:RO%/_(I:Q_UX3_\ HMJ
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M6C/.* %HHI 01D'(H 6BBB@ HI"0.IQ1D>HZXH 6BDSF@'(R* %HI&954LQ
M ZDFEH **** "L#QS_R)>I_]<?ZBM^L#QS_R)>I_]<?ZB@#?HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** $KSW4PLVAV>I37D5LFHWLMVPNMZVTJ,I$2R.A!7]V$
MP3D9'3I7H1&01Z^E9?\ PCEC_P ]]3_\&MS_ /'* ,'PI<-JMQIQ:&:*/3K-
MVVRRM+EI)&1&#L 6&R-R"1G:XI_CS7+5-&U;0725;VZL2MHNPD7+/N7:F.K
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M8C)-(BQ>7$^%QEBSG8,-@CH1@;&K:O-%K,<=O?JB@P"&%2A%RS3F.9>02=@
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M%;]8'CG_ )$O4_\ KC_44 ;]%%% !1110 4444 %%%% !1110 4444 %%%%
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M1696*@LOW21R*=0 4444 %%%% !65XI_Y%+6/^O"?_T6U:M97BG_ )%+6/\
MKPG_ /1;4 6],_Y!5I_UP3_T$5:JKIG_ ""K3_K@G_H(JU0 4444 %%%% !1
M110 4444 %%%% !1110 4444 8'CC_D3=1_W%_\ 0A6_6!XX_P"1-U'_ '%_
M]"%;] '&7M[J22ZAJFF(9'FOUL\QHKR""%6W%$8@,PE,G'IDX.*?8ZD^OMH]
MI+<+<21W,T]R?(:%@(>%5T;E6#O$2.F5..*EN?#>KW%DMB9-(^S1RF6(?9YP
MZ.23N#B4,&^8\@]S1I_AW6M+?S+*71HG*%"WV6=BP+%B23*<DDY)/)XR>!0
MWQS<PW)T_0)8+BXAO93+=QVT32/Y$>">%YP7,:_0FJ&G>(=5E\/Z+96\PAU
M:E_9EV]U 2P"Q2,'*D@ABJHW/K6R-+\1C4&U 7.C?:FB$)D^R39V DX_UN!R
M35=O#NM/J!OVDT7[295F,GV6;[ZHR*V/-QD*Q'_ZA0!437-?EO+;2%O+<3G4
MY[.2Z-OG<B0^:&V9P&YQZ=\=J@;Q7K.^UTH$O=-=7<4MU;VN]F6!E *QEL G
M>N>2!@\<\:BZ!KB7:W:RZ*)UG:X#_9)N)&38S?ZWNO%0W'A75;F,I(^CC]^U
MP'CM[A'61OO,&68,,]\&@"E:WNM:KKFAM/<&SF5+V-U\D8?84 <KDX)!'&>#
MFJ6BZYK$&C:#I<$T\DD^GM=R7$=H)I,;@JJ 6 ZDDL<]O7-;<?A?5HELEB;1
M(Q8.SVY2UG4H6^\<B7G/4YSGO4/_  AFH?9HK=6TB-(&9HC'%<HT>[[P5A,"
M%.!\H./:@#4MUN/%7@>6#485@N+VWE@D4# #99 P&3CH&QDXKE%U"75YK+Q4
MQ8'0UM(Y1_=>48N0?HDB'_@-=1;6/B#2[&.VM[O0K:VA 1$%G*JJ.@'^M]:H
M0:5>K%?:+!>>',7;2275JMO*68O]\D>=D9S0!3TVYU5Y=/&FW4-J?$$]Y?2S
M20^:1&"GE8&1_P L]@J?1]4U*_F@TJPEMM.RU]<22BW#;MEVT8 7('.=S'U/
M;-7X-)UO-G-!<Z&?L4;0VS):RD1J<*5'[W_9 _"J-YX3UR=(41M">.%Y76-K
M>=,-(VYR&$A;DDY7.#GV% %'2+O6M?US3[I+ZVM;N32[@2S)!YBG;<;1M4D<
M<#D]OKD7/#FHZAK/B?3M0N+A46?1!+) B?)N,F#C)XY&?TJ?1?"VN:';V\=M
M=:.9+>%H5D-G+G8S[R,"0#&[VJWI7AR\M-1L+F8Z7Y5E$T47V:&9'"$'Y<F0
M@C.#\P/M@\T =-1110 4F,\&FRRQPQ-++(L<:#+.YP%'J333<VZVWVDSQB#;
MO\TN-NWUSTQ0!)@8Q@<48'H*9!<074*S6\T<T3?=>-@RGZ$5)0 T(H& H SG
M&.]+M'H/3I1D9QGGTI: $VJ.@'Y48'H.*6F++&[%5=690"0#DC/2@!V!1@>@
MI:0D*"20 .I- !2%5)!*C(.1QT-16U[:7D;26MU#.BG#-%(& /N14:ZIIS^7
MLO[9O-&4Q,IW\XXYYYX^M %K ]* JJ,  #.>!WI:* $  Z"C SG'-(DB2*61
MU< E25.>0<$?@013J $P,8P,>E&!G..:6B@ HHHH **** "L#QS_ ,B7J?\
MUQ_J*WZP/'/_ ")>I_\ 7'^HH WZ*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN?\:W
M'B.UT(2>%K=;B_\ .4;&"D;,')Y('I0!T%%>/_VS\:?^@/#_ -^XO_BJ/[9^
M-/\ T!X?^_<7_P 50![!17C_ /;/QI_Z \/_ '[B_P#BJ/[9^-/_ $!X?^_<
M7_Q5 'L%%>/_ -L_&G_H#P_]^XO_ (JC^V?C3_T!X?\ OW%_\50![!17C_\
M;/QI_P"@/#_W[B_^*H_MGXT_] >'_OW%_P#%4 >P45X__;/QI_Z \/\ W[B_
M^*H_MGXT_P#0'A_[]Q?_ !5 'L%%>/\ ]L_&G_H#P_\ ?N+_ .*H_MGXT_\
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M9^-/_0'A_P"_<7_Q5 'L%97BG_D4M8_Z\)__ $6U>:?VS\:?^@/#_P!^XO\
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M*\?_ +9^-/\ T!X?^_<7_P 51_;/QI_Z \/_ '[B_P#BJ /8**\?_MGXT_\
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M]3_ZX_U%>??VS\:?^@/#_P!^XO\ XJJVHW/QAU73YK&[T:,PSKM<*L0/Y[J
M/::*\A;6?C/A<:/#G'/[N+KG_>IO]L_&G_H#P_\ ?N+_ .*H ]@HKQ_^V?C3
M_P! >'_OW%_\51_;/QI_Z \/_?N+_P"*H ]@HKQ_^V?C3_T!X?\ OW%_\51_
M;/QI_P"@/#_W[B_^*H ]@HKQ_P#MGXT_] >'_OW%_P#%4?VS\:?^@/#_ -^X
MO_BJ /8**\?_ +9^-/\ T!X?^_<7_P 51_;/QI_Z \/_ '[B_P#BJ /8**\?
M_MGXT_\ 0'A_[]Q?_%4?VS\:?^@/#_W[B_\ BJ /8**\?_MGXT_] >'_ +]Q
M?_%4?VS\:?\ H#P_]^XO_BJ /8**\?\ [9^-/_0'A_[]Q?\ Q5']L_&G_H#P
M_P#?N+_XJ@#V"BO'_P"V?C3_ - >'_OW%_\ %4?VS\:?^@/#_P!^XO\ XJ@#
MV"BLWP_)J<V@64FLQB+4&B!N$  "MWZ<5I4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
8 !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>ebs20191231exhibit1042002.jpg
<TEXT>
begin 644 ebs20191231exhibit1042002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M  +'C^Z.YJCI5Q=:)>VU_P")HM2M3=33D3RZJ\D*,0[A6A#;54(#C&?NCH:
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M3M&3BNE\,Z[<ZO)>074/S6I3;<);RPI,K ]%D&0000>3V]: -ZBBB@ HHHH
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MRQ[BV&/4_,S'((/S'FF#P1I:+$()KZW\JT2R!AN67="I8A#C_>//7T(KHJ*
M,63PGI$D<T8@:-98X(P(W*^5Y.?+*$<J5SUJWIFCP:69W26>>:X8-+-<2%W?
M P!Z  =@!5^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>ebs20191231exhibit1042003.jpg
<TEXT>
begin 644 ebs20191231exhibit1042003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:*RO[0U?_H!'_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z
M1_\  I* -6BLK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'_P "
MDH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BLK^T-
M7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'_P "DH_M#5_^@$?_  *2
M@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BLK^T-7_Z 1_\  I*/[0U?
M_H!'_P "DH U:*RO[0U?_H!'_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_
M  *2C^T-7_Z 1_\  I* -6BLK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO
M[0U?_H!'_P "DH_M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\
M I* -6BLK^T-7_Z 1_\  I*/[0U?_H!'_P "DH U:*RO[0U?_H!'_P "DH_M
M#5_^@$?_  *2@#5HK*_M#5_^@$?_  *2C^T-7_Z 1_\  I* -6BLK^T-7_Z
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M]H:O_P! (_\ @4E']H:O_P! (_\ @4E &K165_:&K_\ 0"/_ (%)1_:&K_\
M0"/_ (%)0!JT5E?VAJ__ $ C_P"!24?VAJ__ $ C_P"!24 :M%97]H:O_P!
M(_\ @4E']H:O_P! (_\ @4E &K165_:&K_\ 0"/_ (%)1_:&K_\ 0"/_ (%)
M0!JT5E?VAJ__ $ C_P"!24?VAJ__ $ C_P"!24 :M%97]H:O_P! (_\ @4E'
M]H:O_P! (_\ @4E &K165_:&K_\ 0"/_ (%)1_:&K_\ 0"/_ (%)0!JT5E?V
MAJ__ $ C_P"!24?VAJ__ $ C_P"!24 :M%97]H:O_P! (_\ @4E']H:O_P!
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MZ+4-,N5N+:7[KKD?4$'D'V-1ZWKVF^';#[;JER((2P1?E+,['HJJ.2?I7)^
M[@Z9;7=S?6UQ9IK^LS36-NT+95& (+ ?<S@]?;UJ?Q_%-:ZMX;UYK66ZL-+N
MG:Z2%"[(&4!9-HZA2,T :MAXYT'4;>^ECN)8GT^%I[F">!XY4C R6VD9(^E)
MH_CG1==O(;6P^V,TZEHW>SD1" ,YW%<=!7%ZY>)XNUK4-7T6"=["QT"[AENF
M@>,3.Z-MC4, 3CKT_I73?#_1M2LM!TJZNM<N[B%]/B"V,L2*L.54@ @;N.G)
MH U-<\7Z1X>O(;._>?SYT,D:0V[RDJ#@GY0:6'QCX?G\/RZ\FI1C3X25EE8%
M2C#^$J1G=R.,9Y%<[XGU.UT3XEZ1J-^94M5T^9#(D+R88L,#"@FN8O-,U'4;
M'5/$=MI=RVGOK]O?K:&(K)/!&"'8(>?F+ _A0!Z)HWC;0]=O_L%K--%=%/,2
M&Y@>)I$_O+N R/I5>X^(WABVOWM)+Y\1R^3)<"!S!')_=,F-H/XXK!O=6M_&
M_C'P\WA]+ATTV26:ZO'MWC6$%<;,L!DD]A_C5#PYK]KX:\'Q>%-0T.YO=:@G
M:-M.-LQ%R3*6$@<J5*X(.3Z?C0!Z-:ZU8WFJW^EP2EKK3A&;A=I 4.NY<'H>
M!VK(/Q!\-K:Z3<M>NL6L2-':,86^<JX0YX^7DCK7/OK5KX0^('B2ZUB*X@@U
M.WM6M&C@>19#'&59 5!YSZUR=QX9OY_"7@_2YK66.Y2PU.4*4(*/Q)'GT).V
M@#U:?QCHEOKUQHDETWVZV@,\L8C8A4"[CSC&<<XJIIOQ!T'5KFW@LS>N;E@L
M;FRE"'/0[BN,>]>=:-!?W^ICQ!>VLB7.KV6I3."A^0!51%_)./K6I\/]3L;:
MVT6UF\4ZP+@*D9TUK)O)#'@)N\KID]=WXT =W!XRT*YT[4[^&\+0Z4[)=_(V
MZ,KUXQDCKR.N#5*]^(_AW3[A(+B2\#R;=FVRE8/N 8!2%YX/:O,[_1-3T_PS
MK.NZ9!*_VNZO++4+?:?GC:0^7(!ZJ3^1^M=OKL,K+X"VQ.?+O(2^%/R_NN_I
M0!UQUVQ70'UQVECLDA:9F>)E8*.N5(SVZ8K,TSQ_X>U6^M[*"XGCFNAFW%Q:
MR1++QGY68 'BI_'"-)X&UM$4LS6,H"@9).TUYGI$[3ZIX16RU+4=:GM98EFL
MKJS=(K-"FUW#;5&4[9S_ (@'?-\2?#HFFB1KZ4P2-$YBL974,IP1D+BKE]XV
MT+3H]2DNKIT72Y(X[H^4QV-)]WH.?PKSCP_?V>FS:FE]XHUC27_M2=_LMO9,
M\;+OX;(B;K]:D\16LEU_PFH%O))'<:CIY4;#\Z_+F@#U$Z]IPU&QL!<;YM0B
M::VV@E710"3GIT(K%D^)7A:*[:%KV0Q)+Y+7:V[FW5^F#)C'X]*XRTT/5]-\
M?6OAL^8;*ULKP:;=G)VQ2I\JD^J,"/R]JK_V]<Z9X$L_#=J)K+6K$-%-I<ND
MFY%VV[(()&T#/S9YZ_2@#V&XN8+2UDNKB5(H(D+O(QPJJ!DDFL'2?'OA_6=1
MBL+6YF6:X4M;^=;O&LX'4H6 !JMXRTW4]:^&5W8V\1_M"6TC8Q*,$LI5F4#W
MP1BJVF>,-+US4-*T[3=&GN)D0^<\EL8_[-PO<LO7M\IH N7?Q'\,V5[-;2WD
MK"WD\J>>.W=X8G_NLX& :U&\3:0FO6VB&\7[;=V_VB!0"5D3GD-T/W2<>@KS
MC1]:MO#?@"]\(:GI]V=;5;B$6RVKO]K9RVUU8#!!##DGM5=O!NIW6LZ78EW@
MU73?#,4MM/GB*X2?(4GIT)7Z4 =_>>/M L8IY9I;EDM[F6VE:.UD<(\6-^<#
M@#<.>G7TI+7X@>'[NVCN8Y;E8I9XK>-Y+61 [RYV8R.0=IYZ=*Y/PP][>_#'
MQK<7=G);W5W<7\K0%2"&:$$@ \GG(JSK$$S?#SP,@B<O'=Z:74*<KA.<^E '
M86_BS1KIM66&[W/HQ87B["#'M!)('<?*>GI3['Q-I6I7]M96L[-/=6*W\2F,
MC,+' ;)Z')Z=:\JU#1=2MH_%?B32X9&N$U.\M;F#!_TBUD11D#OM8[A^/I6K
MIE['X8UCPQK6K1SPV$OAB*R,ZPNXCE!5]K!02./:@#M+OQWH%G9S74MQ+Y<&
MHMIK[('9OM &2H &3TZCBFQ>/="DT^\ORUY%;V2!YFFLY$P"<#&1SSZ5YM?1
M3MX5CU1UN[*WOO&AOXYEA/FQ0$-B0+@GC!(X/XUKZQ?VFH> ?$=M9>(-4UR8
MV\;;+NT:,Q@./N_NUSG//7I0!VVC^.-!UO4%T^TN94NW0ND-Q \32*.I7<!G
M\*Z"O-I-2A\6^)/"L>BPW,HTJ0S7=T]M)$D2[ -F6 R6/&!7I- !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %9GB#_ )!T7_7]:?\ I1'6G69X@_Y!T7_7]:?^E$= &G7!W?Q%U*WD
MUB:#PNUSI^C7+P7-RM\JM\N,L$*Y/!SC-=Y7GVF?#FUO]6UZZ\164S1W6I/+
M;QB[81RQ'!!*HV.N>O- &IXI\?VOAW1-.U*"RDOSJ(\R*!6V-Y03>S]#]U<9
M^M7==\76VE:987-I;R:C<:HRI8V\3!3,6&0=QX5<<D]LU@ZMX0UO7O%\]RET
M-'T^RLQ9V1$$4XF5P?,PA/R]EY .!6=:>$_%%CHVD[;>.XOO#-_*+-9)E5;V
MU;C@@G8V. &QC% '36OBO5HQJ*:QX9GT^6SLVNT=)A-!,%!^7S H"MQT(]ZB
MT#Q7XAUQ+&Z_X12."PNPK_:/[31BJ'G.S:"?I6##X?\ $VI:SJNI/IMUIMM<
M6%Q']DN-2$_G32 X*J#M0#..U1^#?#-QHL^E&X^'GDWD 5)=2&H1':<89]H8
MYX)X% '9^)_$X\/BSMX+&34-1U"4Q6EI&X0R$#+$L>% &,GWK,C\=W%NVI6F
MLZ&^GZE8V$E]'!]H$B7$:@YVR <'(QC'%2^,=&U2?5-%\0:-!'=WFCRRDVCR
M!/.CD7:P#'@,,<9K%O-#\1>)[_4]9OM*&G%=&GL;&S-PCR2R2*?F9@=H'..M
M &[X<\2:_KOV.YG\,+9Z==Q"5;K^T$D(4KN7Y H// ]LUU%<KX+\%Z;X>TRP
MNO[-6VU86:1W+B4L=^T;QU*]1VKJJ "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M 9--';P23S.L<4:EW=C@* ,DFN=TKQ]H.KZA!96\ES&]T";5Y[9XTN .3L9A
M@\5LZLN_1[Q?LGVW= X^S!MOG?*?DSVST_&O*O#5U)!KVA6F@76JW4'F8O-+
MU*U+C3DQSME91MQT&.OZ4 >C)XMTA]!O-;663['9.\<S>6<@H<-@=^:J7WC_
M $2QOA9,M[-.84GVV]H\N$894G:.*\['AW4IOAWXANUU34H5%W<D:>BKY<GS
M^A7=S[&K%V\=EXT>6\U75M(C;2;55EL+=G,C!>5.$;I0!WMYX]T:QAL))X[\
M-J"NT$*V<AD(0X;*8R/\*9+\0-'@T_[=+;:HD.]E):PE!7: 22,<#!Z_7TKC
M/$EU;S:EX1OTUC6$LXX+M6U)+9OM&>%Y79QDC'W>E=);7=O?_#W7H[+5-1U4
MK:S@RWT+))DQ'"@%5R/P[T ;WA[Q3IWB:.233TNA&BJV^>W:-7#9P5)'S=.U
M;-87@A'C\#Z(DBLCK8Q JPP0=HK=H **** "LIO^1LC_ .O!O_1BUJUE-_R-
ML?\ UX-_Z,6@#5HI&W!3M +8X!. 3]:R(=9NI=.TJ[^Q0K_:#)N7[03Y:L-P
M(.SYCCMQSW[T ;%%9JZC=276HPI:PD6878S3D>82H;D;?E'/7FHQK,TNGZ;+
M#:(USJ*ADB>;:B?)O.7VYZ>B\_3) !K45E'4[Z+3-0N;G3EBFL@Q">?E)@$#
M95MN<<D<KU!I8M3O(YH$U"RBACN#MCE@G,JAB,@-E5QGL>>>.,C(!J45CWM]
MJ=FLEZ\=LEI%($\DY,LB[@NX,#@$YX7!SP,@GB>^N[O[?#86/DK*\;2O+,I9
M44$ #:""22?48P?8$ T:*R?[9D&A_;?LZFY$OV;RM_R^=YOE8W8^[O[XZ<XJ
M6RN[L7\MA?\ DM*L:RQRPJ45U)((VDG!!'KSD4 :-%8YOM4MYK:6\CMEANIA
M$+=,^;%G.#NSACQR !@9.3CF2ZO-0EOYK335MP;:)7D:<$AV;.$&"-O"Y+<X
MR.#S0!J45G'4+BZT6'4-.@B<SQ+*%N)"FU2N>P.2.../K4EO<W%YHD5W D8N
M9K82(KD[-Y7(![XS0!=HK(CN=5AU>VL[I[.59DD=O*B9"JK@9R6/=E&/?VIE
M[JM[$VH3P)!]FTS_ %RR9WRX19&VG("X5AC(.3GIUH VJ*HW,M].(!IOD!)5
M+M<3 NJCC "@@DG/J,8J.VU9?['FO[M0GV8RK+Y>6!,;$$KZYV]/PH TJ*S]
M/EU&X<RW36L:8Q]FC!9XFXP&?."<=0%_$]X+N_O[&[B:=[,PS7"PI;H&\TAF
MP&#9P<?>(V\ 'GCD UZ*R]>U232[$M;1K+=.&,<;'C"C<S''8 ?F0.]27&I/
M%!:B&#SKJ[P(XMVU?NY)9L'"@=\'J!CF@#0HJA9WE_)>/;7NGB#;&'6:*;S(
MVYQMR54Y]L>G6EFNY6UBWLH",*AFN21G"<JB^Q+9.?1&H O45E3:AJ?]JW%E
M:V%K*L,4<N^2[9"P8L,8$9YRA[^GX(^KRW4%B+"-5GO2W^O&1"%!WE@#\Q!P
MN >2>N* -:BLI-7>'2[^XO(@9].+K,L71R%#C;G^\K+QV)QDXS2VMWJ$6H16
MFHK;DW$321M & 0J5W(<GG[P(;C.#P* -2BL.35[T)/J"1P?V?;SF%U(/F,J
MML=P<X&TAOEP<A>HSBM"];46E2*Q$$:E2SSSJ7 /&%"@@DGGG(QCOF@"Y161
M_;,IT,7@@1KAIOLRQA_D,GF^5G.,[<\YQG':I[&[NOML]A?>4TT<:2I+"I57
M5B1]TDX(*GN>H^@ -"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "LSQ!_R#HO^OVT_]*(ZTZS/$'_(.B_Z_K3_ -*(Z -.BBLZ[UJ"
MUFE3[/<S+;@&XDBCW+#QGGG).,'"@D CCF@#1HI%974,I#*PR"#P12T %%%%
M !1110!&\\44D<;R*KRL5C!/+$ G _ $_A4E96J_\A?1/^OJ3_T1)6K0 45F
MMKENLY7R;@P++Y+703]TKYVXSG/7@G& >IXK2H **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %1SP1W,#PR@E'&"%8J?S'(J2B@#*_X1K2_P#GG/\ ^!<O_P 5
M1_PC6E_\\Y__  +E_P#BJU:\QC\=:K8^,->T[493_9[220:?.44"&=8]P0G'
M\0/&<\CZT =S_P (UI?_ #SG_P# N7_XJC_A&M+_ .><_P#X%R__ !5<;=^*
M=;E\!>&X;"]5=>US8JW#JOR@#=(^,8X  Z=ZBU3QCK-_\,]*U+2;HVVK7%Y%
M93D(I(ER588((&2 ?H10!V__  C6E_\ /.?_ ,"Y?_BJ/^$:TO\ YYS_ /@7
M+_\ %5YU+\0-8U+6O"@TZ\\NTG^R)J2JBG?+*S97)''$;=,=:;:^*-3O-2U9
M+OQ3J]H;?4IX(8K325G01JV%^81GGZGM0!Z/_P (UI?_ #SG_P# N7_XJC_A
M&M+_ .><_P#X%R__ !54_&VO7'A?P?=ZE;JLUU&$CBWC@NS!03],YK OYO$W
M@VXTB^U#Q"=7M[V\CM+NWDMT0*7S\\94 C!'3O0!U?\ PC6E_P#/.?\ \"Y?
M_BJ/^$:TO_GG/_X%R_\ Q5>?:!XEU#5=:GMKSQ=J%M.-3DMXK6+35>,H'PH,
MFS ].3Q77>.=;U#2K+3[/272*^U6^CLXIY%W+#NSE\=R,=* -/\ X1K2_P#G
MG/\ ^!<O_P 51_PC6E_\\Y__  +E_P#BJYG[9KWA7Q5I>F7^M/J]GJZ3*K30
MHDD$B+NR"HY4],'I6-\/_$E_K[Z8;WQ;J#WDS,TEG_9JB%@I8X\T)CE5]>O%
M '?_ /"-:7_SSG_\"Y?_ (JC_A&M+_YYS_\ @7+_ /%5Y[X%\2ZAKTUA]N\7
M:A]KDG;?9KIJ^4ZJQ^7S F!E1USW]:ATCQ/JFI37(N_%>KVTHO9(4CMM)66,
M*&POSB,C]: /2/\ A&M+_P"><_\ X%R__%4G_",:3OW^1-O QN^U2YQZ9W5Y
M]KWBZZM?%_B"SN_&%SH\%FT(LXHM/6<.6C!()V'OCJ>]7XM>\6ZK'X:T&6;^
MR-3U"WDN+ZY\@%T1"0H5#P&88)XXS^% '9_\(UI?_/.?_P "Y?\ XJC_ (1K
M2_\ GG/_ .!<O_Q5</JGB'Q#X;/B#0[C5C>SVVE?VA97S0HLB#>$*L -I.3Q
MQ_\ 6@\.^*=7O?$6D6VF^)+G75F&=3MYM.$2VR%<[M^U>_3UH [_ /X1K2_^
M><__ (%R_P#Q5'_"-:7_ ,\Y_P#P+E_^*K'\8:MJJ:SHGAS1[I;*XU9Y2]V8
MPYBCC7<VT'C)K%OM:\0>%[W5]%NM7.HYT2>_L;MX466%T!^5@!AAQG)'M0!V
M7_"-:7_SSG_\"Y?_ (JC_A&M+_YYS_\ @7+_ /%5YOH'B[6KW4- CT_Q+<ZS
M=7+1-J5A)IPC2WB909'\P(.%)P"#SQ^/:^-]9U'3X]+T[294M[S5KU;9;AT#
MB!<99@IX)] : -/_ (1K2_\ GG/_ .!<O_Q5'_"-:7_SSG_\"Y?_ (JL"[F\
M1^#-)UC4K_5DUFQ@M?,M_/C"3+-G&#M !3D'/6LG4+WQ9X7\.VGBN]\0_;T+
M0M>6#6R+'LD(&(R!D$;ASWZ^U ':_P#"-:7_ ,\Y_P#P+E_^*H_X1K2_^><_
M_@7+_P#%5Q">.=5L/&FN:?J,N=->5[>PF*J!!.L88(3C^+/&<\CZU6U#5?%'
M_"":-XBA\33Q2WGV>*6(6T)4EVP6R5Z^W2@#T#_A&M+_ .><_P#X%R__ !5'
M_"-:7_SSG_\  N7_ .*KB/%>JZMX:U71--O/%]U!;W$=Q)<7HLHW<[<%1M5#
MP,XX'?FKGA?Q;J$7AO7=9U6[DU#3+$E["^EMQ UTH7D;<#^+ !QR30!U?_"-
M:7_SSG_\"Y?_ (JC_A&M+_YYS_\ @7+_ /%5R/@KQ;JZ6^JVGB>9;B^M;1=2
MB**J[H63)7 '\+<'W-2:#%XUUK2]/\21^(80]VRS/ITENHMQ"3]T, 6W8[^M
M '5?\(UI?_/.?_P+E_\ BJ/^$:TO_GG/_P"!<O\ \57):RGB6#QUINCP>+;J
M.WU-;B7BUA)A"#(497D<XYJ;S_$'B+Q7J6B6>O2:;:Z)% DLT<"-+<RNN[<<
MC  P>!_^H Z?_A&M+_YYS_\ @7+_ /%4?\(UI?\ SSG_ / N7_XJO/-2\::[
M!H"6UUJOV6\LO$2Z9=W]O;JWF0[6)<)@C/&< =O>MGP+KVJ:KXBO8(M8FUS1
M([<%;Z:S%N4GW#,8^4;OEY/'''X@'5?\(UI?_/.?_P "Y?\ XJC_ (1K2_\
MGG/_ .!<O_Q5:M% &5_PC6E_\\Y__ N7_P"*H_X1K2_^><__ (%R_P#Q5:M%
M &5_PC6E_P#/.?\ \"Y?_BJ/^$:TO_GG/_X%R_\ Q5:M% &5_P (UI?_ #SG
M_P# N7_XJC_A&M+_ .><_P#X%R__ !5:M% &5_PC6E_\\Y__  +E_P#BJ/\
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MK2_^><__ (%R_P#Q5:M% &5_PC6E_P#/.?\ \"Y?_BJ/^$:TO_GG/_X%R_\
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M  +E_P#BJU:* ,D^&-)8J6@F)4Y4FYE)!Z<?-QUI?^$:TO\ YYS_ /@7+_\
M%5JT4 97_"-:7_SSG_\  N7_ .*H_P"$:TO_ )YS_P#@7+_\56K10!E?\(UI
M?_/.?_P+E_\ BJ/^$:TO_GG/_P"!<O\ \56K10!E?\(UI?\ SSG_ / N7_XJ
MC_A&M+_YYS_^!<O_ ,56K10!E?\ "-:7_P \Y_\ P+E_^*H_X1K2_P#GG/\
M^!<O_P 56K10!E?\(UI?_/.?_P "Y?\ XJC_ (1K2_\ GG/_ .!<O_Q5:M%
M&5_PC6E_\\Y__ N7_P"*H_X1K2_^><__ (%R_P#Q5:M% &5_PC6E_P#/.?\
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M;UXYR?6MZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBH;>\M;O?]FN89_+.U_+<-M/H<=* )J*@:\M5NEM6N81<,,K
M$7&\CUQUIUQ<V]I%YMS/'#'G&Z1PHS]30!+132ZJA=F 4#)8G@#UIEO=6]Y%
MYMK/%/'G&^)PPS]10!+142W5N]R]LL\33H,M$'!91ZD=123WEK:O&EQ<PPM*
M<()'"ECZ#/6@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*-0JJ.@% #I(TEC:*1 Z."K*PR"#U!K$2.6#Q5"9;:"W@-M)#;& Y,G*L0_
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MIW49$:D M[9) _.I:* ,C^UM4_Z%R\_[_P '_P 71_:VJ?\ 0N7G_?\ @_\
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M'_Q=']K:I_T+EY_W_@_^+K7HH R/[6U3_H7+S_O_  ?_ !=9S:GJ/_"3(_\
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M5">:CLZ8!.2I0AAD@]"<4 :O]K:I_P!"Y>?]_P"#_P"+H_M;5/\ H7+S_O\
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M5M!)//(L<42EW=C@*H&23^%8=AXSTR_N[6 0WMNM[G[)-<VS1QW'&?E8^HY
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M?^B)*U:RM5_Y"^B?]?4G_HB2M6@ HHHH **** "BBB@ HHHH **** "BBB@
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M&.=N,Y&!71@   # '0"@!:S_ !!_R+FI_P#7I+_Z :T*S_$'_(N:G_UZ2_\
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MC@LOE5PT9(DW$G"A2#DY]/6F77C865C'+=:)?QW;WPL?L@"EC(R%E*MG:RG
M&<]^<8K-L?#&M:3;Z3?0007%YIUS>E[4R[1+%/(6^5L8##"GGW%7;G3/$6L2
M:==7\=O#Y&KQW2VJ.&\B!8V4Y;'S,6;/MF@"T_BN\-Q'86_A^ZGU(0">YM1/
M$!;*20H9R=I)P< =O2GKXM2ZTVSN=-TN\O)[N1XA;!0AA=,AQ(Q.U,$$=>3T
MS63K_A-Y?%,^LKHEMK4-W!'&\,L_E/"Z9PRD\%2#R.O%5YO"FK0Z;I,*V%M+
M;12S27VF6-RUNCL^-AW$_-M[Y(R3G% &L?',$&GWTM[IUQ;7EC<QVLEF70DR
M28\O#YV[3N')(QS5I?%7V6QU"ZUK2[K3%L(Q(Y?$B2J<XV.O#'(QCKDCUKG;
M#PEJUE::ZL>CZ2L5_/!+'I[-OA>-1AXR<<-QG=@C<<U%'X$O[W3-:L8[<:-8
M7MO&EO8-=-<(LR/OWGLJG"C"]LT =+9^*9&U&WLM5T>YTIKQ&>V>:1'5]HW,
MIVD[6"\X/H>>*P=;\9WM]I-E=:?IM]:V-WJ%NEO?[U D4RJ#E0=RJPS@D<^V
M:?I?A*235+>6;PQINDQ0QR":5)S-)(S*5'EXQM').3SVQWJ-M#\4GP_IOAO[
M#:&#3KBW)O1<?ZZ**12,)C*M@#.3C@XSF@#I?&.H7FE^$=4O;"-GN(;61D96
M4&/"GY^>N.N*P-(\17>D6MAI"Z3JVI:E=6OVQEFNTD8+NVEB[-@#H0,_Q 5T
M_B6QGU3PQJFGVP4SW5G+#&&.!N9"!D_4U0L=%O+?Q3::A(J>1%HXM&(;GS X
M;IZ8'6@""X\;^6MY=VVBWEWI=A(T=S>QL@ *??*H3N=5[D>AQG%/O/&134IK
M#2]'NM4EAMH[HM"Z*AC?.#EB.>.!W_"LS^QO$FG:/J7ANPLK6:UO))_L]\]Q
MM\E)F).],9++N.,=>.E:>B>'+C2-9O7!#6K:=:VD#D_,QB#@Y';[PH BL/'<
M5\^F3C2+R'3=4D$-M>R% #(02%* [@/E(SZCTP:N^-)-2B\-3-IGV@2>9'YK
M6HS,L.\>84'][;G%95KX8U*+PKX5TYDC\_2[N"6Y ?@*@8-@]^HKH=>BU:33
M=VB3QQWD4B2!90-DR@Y:,G!QN&1D<B@#B?"LULNC:W=Z1XCGGCCBO"UE-*SR
M0N)9#'+ESN0E<9!')Y/.:LFU\5/X0T*?0[Z>YFFBBNKDW,FYF.U7P&+ X)&T
M+]T[CDBJEGI&JW":EK=_IZ::EO::E$$\P-).9)G?YL#&U<<>N<CBNR\(2))X
M.T8HZMBP@!P<X/EKQ0!E:M:^+SKFFM878:SC1?M3F-0=Q^5B%W@-W8@].V3Q
M4N@FX@\;^(+%KVZN+>.&VEC2>4N(RYEW;<]!P./:NHKE]&D23XB>(RCJP%I9
M E3G!_>T 5]3UO4[+XA?8;.SN=15])61;:.5416\U@7)8@#C ]3Q5ZR\96=Y
M)IJ?99X?MT\UJWF@ V\\8),;\]3AL8ZX]ZAU.TURT\9'6M.T^&^MFTY;9XFN
M!$^X2,V02",<CKZ^U8^K:3)HW@._N]1N;>'53>MJT85LJMP'#+&F>6X 3ISD
MT =AIVKQ:G?:C;P1/LL)A TIQM=]H9@/IN /O7!>,;C'BXQ:[J6H:;8^=!]@
MFAE>*!5\MM[%EXWA\?>[8[$UVOA32Y=)\.VT%SS=R SW3?WII"7?]21] *PO
M$J>)HM73RK&+5]/FNHWMXV=8S 1&RLC_ "\H2<[N<<CTH =(M[)XE\,V$NMW
M%Q']AFGEFMG\I;ID,6UF )!!R>,XYJ71[7Q@NJ:H=1NP+:56-JXB5B&'R [=
MY"_=#X'!W')!XK.TC2F\.>(O"FEW5Q&TL.F7:LP.%W%XSM7/89P/85W] '!1
MVGBB/P;K4FNWT]O<0QRW5LUM)M93M:3&X,3@%MFWH @P2.:ZK2KFX;PM976Q
M[JX-E')MW -*VP'J>,D]S4?BR1(_".KEW50;&8#)QD[&XJ7PY_R+.E?]>4/_
M * * .8\.^-+V3PEHTU]8W%YJVIEEMXHVC!N !N:3.0$49QSSTXYKHM$U]=6
MFN[2:SFL;^R91/;2E6(##*L&4D,IP>?8URVD^'/$6E:;H,HL;>2\T'SK?R/M
M(VW4,@&75L?*V5'!]#S6_H&F:B-;U/7=5ACMIKU(H8K6.3S/*CCW?>;@%B6)
MXZ<4 <QX[N&C\0JFM7M_9:5_HOV26WD>.'=YW[TNZ]'"X*Y.!U'-:%PMV]YX
M1TT^(;B[BN/M!DO+63R_M*JFY"2I(/;)[\GO4_BM/$D-Z'M;5-4TV:>U9(-Z
MQO!(DH)[?,K<9)/'TK-LM*D\.ZKX/M+V2%)//OY76,XCB+J6V+GL-V* -BRM
M?%O_  EM[)<7872Y$*0GRP<%0=IV[\#)DZ@9;RAG'>A:67BHZ)K3:[?3V^$:
MXMFMGV.#@D#<'8KC;RH^7G@GFNZK/U^1(_#VHL[JH^RR#+''.TT <C:Z?XHU
M;3=)U"UU:9(IM-T]G!F(+/O#3,?<H?QZ5WU8_A#_ )$O0_\ L'6__HM:V* "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K/\0?\
M(N:G_P!>DO\ Z :T*S_$'_(N:G_UZ2_^@&@"S9?\>,'_ %R7^53U!9?\>,'_
M %R7^53T %%%% !1110 4444 %%%% !65HO_ !]:O_U_G_T5'6K65HO_ !]:
MO_U_G_T5'0!JT444 %%%% !69X@_Y!T7_7]:?^E$=:=9GB#_ )!T7_7]:?\
MI1'0!IT444 %%%% !1110 4444 96J_\A?1/^OJ3_P!$25JUE:K_ ,A?1/\
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MZU?_ *_S_P"BHZU:RM%_X^M7_P"O\_\ HJ.@#5HHHH **** "LSQ!_R#HO\
MK^M/_2B.M.LSQ!_R#HO^OZT_]*(Z -.BBB@ HHHH **** "BBB@#*U7_ )"^
MB?\ 7U)_Z(DK5K*U7_D+Z)_U]2?^B)*U: "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[1U/OD1D'MY8H V--UG3-9C>33+^WO$C;:[02!PI]#BK0DC,IB#KY@ 8IGD
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M ,[1=%MM#M'M[=YI6ED,LTT\F^25SU9CW. !] *T:** "BBB@ HHHH ****
M"BBB@ HHHH **** "L_Q!_R+FI_]>DO_ * :T*S_ !!_R+FI_P#7I+_Z : +
M-E_QXP?]<E_E4]067_'C!_UR7^53T %%%% !1110 4444 %%%% !65HO_'UJ
M_P#U_G_T5'6K65HO_'UJ_P#U_G_T5'0!JT444 %%%% !69X@_P"0=%_U_6G_
M *41UIUF>(/^0=%_U_6G_I1'0!IT444 %%%% !1110 4444 96J_\A?1/^OJ
M3_T1)6K65JO_ "%]$_Z^I/\ T1)6K0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %93?\C;'_P!>#?\ HQ:U:RF_Y&V/_KP;
M_P!&+0!H75NMW:36SDA)D9&*]0",<5EV?AFSLIM(ECEG)TBS-G!N(^9"$&6X
MY/R#ICO6S10!SE[X.BN+N]EM-6U#3XM1.;RWMF39*<8+#<I*$@ $J1FKMEX<
ML-.U.&^M \7D6*V,<((V+&K;AVSG\:UJ* ,%?"-@N@0Z*)KC[/#="Z5]R[RW
MG&;!XQC<<=.GYUH:SI%KKNE3:=>A_)F R4;:RD$%64]B" 1]*O44 <GI7@Q]
M/EGOK[4;G4[M!.+7S2H6,2').%4?.W&3^56? 2W,'@[3[*\L;BSGLX5A=)U
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M/^0=%_U_6G_I1'6G69X@_P"0=%_U_6G_ *41T :=%%% !1110 4444 %%%%
M&5JO_(7T3_KZD_\ 1$E:M96J_P#(7T3_ *^I/_1$E:M !1110 4444 %%%%
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M*U[=;T9MQ0^>_P N?;I744 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9_B#_D7-3_Z])?\
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M#*1@@C((H R_"W_(I:/_ ->$'_HM:U::JJBA$4*JC  & !3J "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K/\0?\BYJ?_7I+_Z :T*S_$'_ "+FI_\
M7I+_ .@&@"S9?\>,'_7)?Y5/4%E_QXP?]<E_E4] !1110 4444 %%%% !111
M0 5E:+_Q]:O_ -?Y_P#14=:M96B_\?6K_P#7^?\ T5'0!JT444 %%%% !69X
M@_Y!T7_7]:?^E$=:=9GB#_D'1?\ 7]:?^E$= &G1110 4444 %%%% !1110!
ME:K_ ,A?1/\ KZD_]$25JUE:K_R%]$_Z^I/_ $1)6K0 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^O27_P! - %FR_X\8/\ KDO\JGJ"R_X\8/\ KDO\JGH **** "BBB@ HHHH
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MSRR+N W$':H7'3DD]: .LHKC5NM2\.:\-$N=2GU"SO[.::SFN,&:&2, LI8
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M9?\ 'C!_UR7^53U!9?\ 'C!_UR7^53T %%%% !1110 4444 %%%% !65HO\
MQ]:O_P!?Y_\ 14=:M96B_P#'UJ__ %_G_P!%1T :M%%% !1110 5F>(/^0=%
M_P!?UI_Z41UIUF>(/^0=%_U_6G_I1'0!IT444 %%%% !1110 4444 96J_\
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M?_0#6A6?X@_Y%S4_^O27_P! - %FR_X\8/\ KDO\JGJ"R_X\8/\ KDO\JGH
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MJ >4K8!"XZ [1^5 'GNH7$]K)K%A'=SV]G)KMG9S2K*0T,#0QA@&SE<\#/\
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M<@D$@_D01^%3T %%%% !14-Q=V]J85GE5#/((HP>KL03@?@"?H#4U !1110
M4444 %%%1RS10*&FE2-2P4%V !8G 'U)(% $E%%,DD2&)Y9&"HBEF8] !U-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR7#'3+5[6'>P.48J26P.3\HZ8IEUX.T^ZL[ZV-Q=Q&]OQ?F6-U#Q3#9@H<8
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M?]?4G_HB2M6LK5?^0OHG_7U)_P"B)*U: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ K*;_D;8_^O!O_ $8M:M93?\C;'_UX
M-_Z,6@#2EEC@A>:5UCCC4L[L<!0.22?2L73O&.BZG>0VL$TZ-<@FV>>VDB2X
M Y/ELR@-QSQ4_BK3)]9\*ZGIMJP6>YMGCCR< L1P"?0]*YR>>\\1R>'[&#0[
M^Q:PO(KFZDN8#'' L:G*JW1R2<#;GCK0!+H/Q LIK,C5II$F6\EMY)EM7\B(
MB5EC5I -JDKMZGO[U/=^(KJ&]\1Q2WT5G#ITUHD,S0&3:) F00.3DMCVSGM7
M/HFI-X(U#PL/#]^+Z^N+E(I&@(A*R3,1(S]%P#T/)P,#D59UK1=2>+Q5'%:3
MS?:+C3C"P0GS@GE;R/7&#GZ4 =1J/C#1=+O9K2YGF+VX#7+Q6\DB6X(R/,90
M0N1ZFB?Q?I$-O9RH]Q<M?0"XMX;:UDED>(@'?L4$@<CKBN=EGN_#\7BFU;2+
MF_%]/-<PSP!6B(>, I(2?DVXYSVZ9JA8/J::=X=1AJEOIIT*WQ-I5J))9)<#
M*.VUBBXP1T&2>: .AU?QW9VVF:7J&G"2ZAOKY+=BMM*Q0;L."H&0XZ!3R3T!
MQ5^_\8Z-IMU);SR7#O"BO<&&UDD%NI&09"JD)QSS7'6FFZK:>%89)=*U R6O
MB3[;) 1YLYB\PMNX^^<-R1G/-/FTZ[T_5=;:XA\2,NH7!NK8::,QRAD4;'X.
MQ@1@[L#&* .TU#Q1I6G&V5YI;B2ZC\V&.T@>=VC_ +^$!.WD<U7\'ZY)XATV
M\O6D26-=0N(H'1< Q*Y"'\L5@:;8W/A'5;*]ETF]FM)-(BL]EMFZDM71F;8=
MH!*D-]X#&5K8\"6]W!I-\]Y826,EQJ5S.L$@P55G)'3COVXH LZEXQT?2[J>
MWF>YD:U -RUO:2S);@C(WLJD+QS]*=?^,-%T^6"&2XEFEN8!<016T#S-+&?X
ME"@Y'?Z5RFL)K-W>Z[:SPZTC2.RV-OIT"I;SH4 #238ZD]<L, 8 -7O"FF7M
MOK&ASW%G-$L'AF*VD:1"-DH9,H??CI0!JV_CWP[=26RP7<LD=TZQI.+:3RED
M;HC/MPK'^Z3FI]1\8Z-I=Y-:SRSN]L URT%M)*MN",@R,JD+QSSVKF5T;4%^
M&Z60L9A=?VMYQBV'=M^V[MV/39SGTJW;3W?AFZU^UFT2_OVO[R2ZM9+: R),
M'50$9A]P@C'S8&* .JAUBPN-02QAN!)-);"Z0*"5:(G 8-TZU1N/&&AVMN+B
M:\98VNY+-2(7):9-VY  ,D_*0/4XQG(KE](T_4?!]]HLM[87EY&FBBRD:RB,
MQCE$@?! YQ@X!Z<4W3-*U21=(EN=,GA8>)+F[EC=<F)&$I5B1QC+#GI0!L:O
MX]LH/"^JZGIJ3276GJ%>VN+:1&C<C*[U(!"GKGI[U=FUV2'4M'G.\:=JF;?;
M+"8WBFP60D, P#!67![[?4U@^(M%U&]D\;BWLY7^VZ=;);D+Q*RB3<%]2,C\
MQ5[Q#<_VM;>&(XH)X)KC5H)A#/&4D18MSN64].%Q^(]: .FLM0M]0-R+<N3;
M3M!)NC9<. "<9'(Y'(XJU56RO3>&Y!M+FW\B=H<SIM\W 'SISRISP?8U:H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *S_$'_(N:G_UZ2_\ H!K0K/\
M$'_(N:G_ ->DO_H!H LV7_'C!_UR7^53U!9?\>,'_7)?Y5/0 4444 %%%% !
M1110 4444 %96B_\?6K_ /7^?_14=:M96B_\?6K_ /7^?_14= &K1110 444
M4 %9GB#_ )!T7_7]:?\ I1'6G69X@_Y!T7_7]:?^E$= &G1110 4444 %%%%
M !1110!E:K_R%]$_Z^I/_1$E:M96J_\ (7T3_KZD_P#1$E:M !1110 4444
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M-O\ %)GBMM2EO=%-K<3*K:='*QNXHV;:&)S@L,@E=HXSS0!Z0D:1($C145>
MJC %(OE[WV;=V?FQUS[U%?7D&G6%Q?7+;(;>)I9&]%49/\J\Q\'ZU967B/3K
MXZM9W%QXF23[?!%<J[0SEB\.5!R,*QC^H% 'J,<5N)7FCCC\QN&=0,GV)IS"
M.3=&VUL?>4\_I7+:64T#QKK&GR,([34H_P"TX">%5QA9Q^>QOQ-9UCJO]C>"
MM9\:W*A;G5':YA$G'R?<MT/MC:?^!&@#NE\MFWKM+#Y=PZ_2@PQ&(Q&-#&>J
M%1@_A7G?@&[T[1=??P]::Q:ZC'?6B7>^"X64"Y4!9AP3][ ?\ZZOQCIE]J_A
MFZLM.(\]RA,;2%!,@8%HRPZ;@",^] &M;RVKH8[62)ECX*Q$$+[8'2B*&V0$
M0Q1* 2"$4#!/6N TY=!MO$6EA_#UWX3U)92D92%!!=Y4@Q&1,J^>HS@Y Q5/
M0KNX\-:[K&MR2LVCWFMW%M?*>EL^_P#=S?0D[6_ ]J /3D6+(**GR?*, ?+[
M5$C6=U$\,9@FC'#(N& ^HK@X=,OM8\->*[+3F4S/KLQ,9D*"9 T9:/<.FX C
M/O2:<-!MO$6EA_#UWX3U)9"B%(46"[RI!B,B95\]1G!R!B@#T"2& P&.6.,P
M@<JRC: /;I1%]GDC$D/ENC+M#)@@CTR.U<M\3UNW\$W*6[PK&\L*3"16.Y3*
M@P,$=R,^V:N>'[N6#6+OP\;6RMX=/M()%%G$8TW2%]V%SP,K^IH WTABCQLC
M1<# VJ!@>E)'!#$SM'$B,YRQ50"Q]_6N+M_&&MZA;>'TLK6R%SK!N@[2[]D7
ME-PV <G@'C/)QR*>?&.K6MI>6=U:6<NL0ZE%IT/E%E@D:10RN<Y8 *22,GIU
MYH ['9%CR=J8Z[,#U]/K4E>?M=ZYI_CFZN=1MK:\N;;P_++"MDK*)\2J=NUB
M2#D8ZG.1]*T/"?BJ]UV\17O=&O(7A+R+9EHYK9QCY61V)(Y(S@<CI0!V%%%%
M !1110 4444 %9_B#_D7-3_Z])?_ $ UH5G^(/\ D7-3_P"O27_T T 6;+_C
MQ@_ZY+_*LM]!N!XO_MZ#4!&CVR6TUL8-V]59F!#9XY;T[5J67_'C!_UR7^53
MT %8OB70KCQ!;V]JFH"UMTF269?(WF78ZNH!R-O*^_6MJB@ HHHH **** "B
MBB@ K*T7_CZU?_K_ #_Z*CK5K*T7_CZU?_K_ #_Z*CH T9H(;B/RYXDE3KM=
M0P_(TD%K;VP(MX(H0>OEH%S^52T4 0S6=K<21RSVT4KQ'*,Z!BI]B>E3444
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M=13VR"TQ(P20,$=MV" ,C( ['M@WYO#6KVM[J$FAZU%96^IR&6:.:U\UHI"
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M2=-6ZN+A7D::=VC@A5<?>8*222< #W/:LL>-I4TV<3:8!JT-^NG"T2;*23,
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M)HFO:;%97<\32VTMO/YL4X7&X D AAD'!'2M--=T>74FTR/5+-[Y<@VRSJ9
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MR7^53U!9?\>,'_7)?Y5/0 4444 %%%% !1110 4444 %96B_\?6K_P#7^?\
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MEM"NGS^(KF>R@E3 6 I(T?RGH,C('H17J1 (P0#]:IG6-+4D'4K0$<$&=?\
M&@#S[Q/:*%^($=O;@ V=G+L1.IP^6P.^!^E;5DFE:U\1CJ$"6]W!_8<)MY-H
M91F>7)'Y5V:LKJ&5@RL,@@Y!%% 'B^O:JEWX0U>..XT^QD-Q*YTB&U:2[#"7
M)>1RV0>-V[: !T-=8U_HND>*_$DGB1X4%\D)M6G7(GMQ& 43U^;=E1R217=,
M\43+O=$:0[5R0"Q]!Z]Z8+BVD* 31,68J@# Y8=0/<8- '$Z5/8VGCG2MUJ^
MFQW>A)%:6]Q]\,LF=F>?F"XXSFM;QKXOB\+6EM&K0B\OG,=N9V(BCQ]YW(YV
MC(X')R!72TM 'F<J:5=>$[RYT?4CKFH6][;7^I3QJ2\NV0$X7L JMM4= M:%
M_<VOC3Q-:C1+E+JWL]-NUFN(SE%>955$S_>X)QU&*[RD  Z#% 'FBZI;:OX3
M\.^&;5LZM%/:175IC]Y;" J9&<?P@;.">N1BNVL+?Q#'J<DE_J-E-9'=LBBM
M61UY^7+%R#@>U:N!G..3WJ(W5L+D6QN(A.1D1;QN(^G6@#F/&OC*/P_+:Z7#
M<V]M>WP)%Q<Y\NVC'5R!]X]@O<]>!6)*=%@\/:9?Z->G4K?3=:CN]2NQEW8L
MK*\C<=MX/'0#VKT1)HI$9TE1E0E68," 0<$'Z$<TQKZS00EKJ%1. 8LR >9G
MIM]>HZ>M '+Z5>6^O?$&?5M-F6YL+73!:FXC.8WE:3>55NAP%&<=,U9LQ_Q<
MS5#V_LNV_P#1DM=*  , 8'M5?^T;'[7]C^VV_P!I_P">/FKO_P"^<YH Y^T7
M^U?B1?W$O,>B6L=O IZ"24;W8>^T(/Q-:$UGKTNJNS7UB^E-D-:FU;S67;@C
M?OQU]JUC+&LBQ&10[ E5)Y('7 _&AY8XMOF2*FY@J[CC)/0#WH \E:*#5-+T
M[P_IFOWMT!>0B'2I846:R1) 6\\CG:B@@9QSCKQ6KKOC#1]>UB[T*^UB'3='
MM)#%=Y8B6]8?>C7'W8\\$]6Z#CFO18WBD+-&Z,0VUBI!P1V/O3Z /-]6M/#@
M\9K?ZZT7]AW^EQ?9&E8K;,Z$X![9"L"N?4XYJUH.M1:-X7B74DNUT:[O;B&U
MNY&8&WMB3Y1=OO*#T#=AMY'%=Z0",$ CWHX(QU% 'F6GZ=>W]OK^F^#IXGT>
M>>$K<7$S@2%@?/5)@&9L@(-QSC)P:TO"L>M0>/M6@N;/3;>%+*T21+69V$:@
M2",)E!GOG.,<8S7=@ # & *:TL:.B-(JO)D(I."V.3CUH YCQFDMG?:'X@$,
MD\&E73FY2-"S+%)&4+X')VY!X[9IW_"<Z=J&H6-CX>9-7FN)1YYA8[+:+^)W
M;& ?13R3Q745'!+#-'YD#QR(2?FC(()[\B@#@O#/BS0-#N/$%IJ>J0VLYUNZ
M<))G.TL,'I[&I]3FCNO&UQ<P.)(I?"TCHXZ,#("#^5=U10!YG+87.E^"-&\4
M:7"TDD>B0P:C;IUGMS$/FQ_>0G(]LBNO\$<>!="S_P! ^'_T 5NT4 >5O?0V
M_P .+OP86SKIDELDLL'S'+RDJX'=-K;MW3K6W:ZQI_@_Q#XABUBX%N+EXKJU
M9Q_Q\*(E0JGJP9,;1SR*[C SG'/K00"1D#CI0!YGX=C/@^X\/WNND65O-H[V
MSRR_*D,QE$H1ST7(8CGNN*E@TO6?$-CJ=WI:VIL-3UAIVCNW>(75NB*JX*J3
MM9ER>.5'O7HY (P1D>]+0!Q/@@ZQ_P )+XE&H6]C$GVI/,^SRNV)/*CP%RHR
MNWOP<\8[TOBC5;#1?'^@7FI7*6UN+.[4R/TR3'@5U$&LZ7<ZC+IT&H6TEW$,
MO DH+KU[?A^%3+>6KR21K<PL\7,BB0$I]1VH XR:_7Q?XNTRZT!FEMM)@N7>
M\,;+&99$V(BDCYCU8XXX%<IID:2^'=+T>76XH]0BN8LZ?#I>;V&<."S$F0'K
MDES@$9]<5[ UQ L N&FC$) (D+#:0>ASTI#<VRW0MS/$+AAD1[QO(^G7UH \
MWU$'?KW!_P"1HL?_ &A4^O07%MK][X4@5Q;^*)HYT9>D:]+KGW5 ?K)7H](5
M!(8@9'0^E 'E]Z4TKQ5XA34M8L-*2Y\OR%O-/\X7%N(P L9W#.#N!0#K]:L^
M']'@;Q!X:MKV*2Z2WT*9H_ML 5Q^]0+N3+8(5L8R:]'(!QD9QTI: .9^(L1E
M\ ZL%C+E80V ,G 8$G\@:QXM8T&U\9WNK:I=6PL+ZPA&F7<H'DE%+^:BL> <
MD''4UWU(0",$ B@#F/A]$\7AV5A"\%I+?7$MC$ZE2ENTA*<'H,<@>AK8\0?\
MBYJ?_7I+_P"@&M"L_P 0?\BYJ?\ UZ2_^@&@"S9?\>,'_7)?Y5/4%E_QXP?]
M<E_E4] !1110 4444 %%%% !1110 5E:+_Q]:O\ ]?Y_]%1UJUE:+_Q]:O\
M]?Y_]%1T :M%%% !1110 5F>(/\ D'1?]?UI_P"E$=:=9GB#_D'1?]?UI_Z4
M1T :=%%% !1110 4444 %%%% &5JO_(7T3_KZD_]$25JUE:K_P A?1/^OJ3_
M -$25JT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(<Y"LI()(/.00>3US38/!4<4=JTFH2374>J#4[FX>,9GDVE<8!PJX(P.<8H
MQ-?U37QHOBK1;ZZLVGM-,^TQW4$#('C<.&4KO.&^0@')ZYP:M1:EXH_M'3-
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M%E.+:%@#N>15S*2<] 2%''537/ZMHZ^'_!6IZ//+=:E!?/*MA!!:$R1R.6<
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M@#*U7_D+Z)_U]2?^B)*U:RM5_P"0OHG_ %]2?^B)*U: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K*;_D;8_\ KP;_ -&+
M6K64W_(VQ_\ 7@W_ *,6@#5HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S_$'_(N
M:G_UZ2_^@&M"L_Q!_P BYJ?_ %Z2_P#H!H LV7_'C!_UR7^53U!9?\>,'_7)
M?Y5/0 4444 %%%% !1110 4444 %96B_\?6K_P#7^?\ T5'6K65HO_'UJ_\
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M[P^4\=CCTIB>/YFL5U0Z!<+I0N?L\MV9TRA\SR]P3JR[L GCOP<5F^$-)O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "LIO^1MC_Z\&_\ 1BUJUE-_R-L?_7@W_HQ: -6L
M2#Q7I]QXKG\.(LHN84+>:5'ENP"ED!SRP#J2,=ZT=4U"#2=+NM1N3B&UB:5_
MH!G'UKRXP>)=-\-V>O3:%&MQ9WC:O<7*W@,CK)DRKY>WC]V=N,\;10!ZW17
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MQ2))L8HVU@=K#J#[UR>C3Q:?\0_$5M>NL5Q?_9Y[4N<>=$L>TA?7:P.1[YH
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M;"%5M_),G&W%7==OW:_\/PZS<W=U:3Z<TDT.D2N7DGPI\PB(AVCQNP1QG&:
M.]N;:"\MI+:YA2:&52KQR*&5@>H(/45#?:78:G9_8[^S@N;?@^5*@901T(!Z
M8K&\ W=Q?>%()[FY>XS+*(FED#RB,.0BR$?QA< ]_7FNDH KV-A9Z9:):6%K
M%:P)]V.) JC\!3=0TRPU:V-KJ-E!=PDY\N:,.,^O/>K5% &9;>&]$L].ETZW
MTFSBM)_];"L*A9/]X8Y_&M%HT:,QLBE"-I4C@CTQ3J* *EKI6GV+H]I8V\#1
MQ"%#'&%*Q@Y"#';)SBG?V?9&]>]^R0_:I(O*>;8-[)G.TGJ1[59HH AM;6WL
MK:.VM8(X((AM2.-0JJ/0 =*);6WGFAFF@CDDMV+1.R@F,D$$@]C@D?C4U% &
M=J7A_1]9ECEU/2[6\>+A&FB#%1Z<]O:I-0T?3=5M%M-0L;>Y@0@K'+&&"D="
M/3\*NT4 58=-L+?3QI\-E!'9A2GV=8P(]IZC;TJIIOA?0='N6N=-T>SM)V&/
M,BA56QZ ]A6K10!#;VEM:F4V\$<7G2&638H&]SU8^IX'-4Y_#FAW-M);3Z19
M20RSFX>-H%*M*1@N1CEL=^M:5% &9IWAO0](N&N--TBRLYF4H9((%1BI(.,@
M=.!^5.L/#VC:7=2W6GZ7:6L\O#R0PJK$9R1D=LUHT4 4=,TN#2UNA#UNKF2Y
MDX &YSSP/P^O7O2ZGHVF:U (-3L+>\C4Y59HPVT^HSTJ[10!3LM(TW3K(V5E
M86]M;,#NBBC"JV>N0.N:J0^&M(TZ9[W2]'T^WOA$4BE$(7'& ,@9 Z X[5KT
M4 <_HGAE;?0[JQUI+6^:^NI;JYC\O,6Z1RV &[#CK6E8:+I>E6KVMAI]M;02
M9WQQ1!0^>.?7\:O44 9VG>'M&T=I6TW2[2T,PQ(8857</0X[>U3Z?IMCI5M]
MFT^TAM(-Q;RX4"KD]3@5:HH R]3\-:%K,RS:GI%G=RH,"2:%6;'IGT]JMG3K
M$P00&S@\JV97@C\L;8F7H5'8CMBK-% &3)X5\/RW<UW)HMB\\X82R-;J2^X8
M;/'<=?6G7WAG0M3EBEOM'L[EX5"1M+"K%5'1>1T]JU** ,W4O#VBZN(AJ.EV
MET(1B/S8@VP>@]![5>AABMX4@@B2**-0J(BA54#H !T%244 %%%% !1110 4
M444 %%%% !1110 4444 %9_B#_D7-3_Z])?_ $ UH5G^(/\ D7-3_P"O27_T
M T 6;+_CQ@_ZY+_*IZ@LO^/&#_KDO\JGH **** "BBB@ HHHH **** "LK1?
M^/K5_P#K_/\ Z*CK5K*T7_CZU?\ Z_S_ .BHZ -6BBB@ HHHH *S/$'_ "#H
MO^OZT_\ 2B.M.LSQ!_R#HO\ K^M/_2B.@#3HHHH **** "BBB@ HHHH RM5_
MY"^B?]?4G_HB2M6LK5?^0OHG_7U)_P"B)*U: "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ K*;_D;8_^O!O_ $8M:M93?\C;
M'_UX-_Z,6@"_>6L-]93V=PN^&XC:*1?56&"/R-<I;:=XWTS2ET6SFTJ:&)/)
MM]1F=UE2,#"EHPI#,!_M8..:[&B@#DO^$;U;1KZPU'2+B/49X+ 6-RNH3,K3
MJ&W!PX#$-N+<$$8/M59?!VK(HU<7-HVNC4FORIW" @Q^68LXSC9_%C.>U=M1
M0!PUUX/UCQ ^N2:U+96XU.SA@ACMV:7R&C=G&[<HW#)![=2,=S8T;PQ>P:Q:
M7=QHOAW3$M5;>VGP!I)W(P""8U,8&2>"2>F:[&B@#EO$.G^+=6T!+*UETZWN
M))S]I*3R(&@R<*K!202,9/;G%0CPWJFI>&+OPYJ-GI.G63V_EVW]GR/)Y; Y
M!(9%X! /7FNOHH Y6+1]>U;6=-N]?2PAATP2,JVDKN;B1D*;CN4;%P3QSR>M
M48?">N-I-GX8N9+(Z-:3H_VE9&,TT*/O2,IMP#D*"VX\#I7<44 <D^C>(=+O
M-771TTZXMM6F,^^[E='MY&0*V0%(=?E! R/2H;3PIJGANYL+O16MKYK?34T^
M:*[D:+<%8L'5@K8Y)RN.F.:[.B@#%\+Z-<Z/971O98I+N^NY+N<0@^6C/CY5
MSS@ #D]3DUM444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %9_B#_D7-3_Z])?\ T UH5G^(/^1<U/\ Z])?_0#0!9LO^/&#_KDO
M\JGJ"R_X\8/^N2_RJ>@ HHHH **** "BBB@ HHHH *RM%_X^M7_Z_P _^BHZ
MU:RM%_X^M7_Z_P _^BHZ -6BBB@ HHHH *S/$'_(.B_Z_K3_ -*(ZTZS/$'_
M "#HO^OZT_\ 2B.@#3HHHH **** "BBB@ HHHH RM5_Y"^B?]?4G_HB2M6LK
M5?\ D+Z)_P!?4G_HB2M6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *RF_Y&V/_ *\&_P#1BUJUE-_R-L?_ %X-_P"C%H U
M:*H:[=RV&@:C>0$"6WM998R1D!E0D?J*Y6[UWQ58:%H]S!"FJR7:K/.Z1LA1
M,!F!"HPVX.,CYCV!H [FBN3OM:\2V_BFQL8M,A>SD11/,K2%%9\=3Y?8I(!@
MXY7=MXS:\.W^I2Z[KNFZA=I="PDA$4BPB,X>/>00/KB@#HJ*J)J5K)JLVEK(
M3=0PI,Z;3PC$@'/3JIK,F\::'!:VMRUS(R7DLD,"I [-(\;%64*!G.00/6@#
M>HK&B\6:-)I=UJ+W36\-DVRY6>)HY(6XPK(1NR<C''.>,T:?XJTO499H$-Q;
MSP1><T%U;/#(8_[X5@,CZ4 ;-%<]9>.M!U"YM(;>>?;>D+;SO:R+#*^,[ Y7
M:6Z\9ZC'6M?4M2L](L);^_G6"WA&7<@GO@  <DDD  =: +5%<I8^+UU+QE'I
ML!E@METZ6XGBNK9H9$8.@4D. =NUC[?E5NT\;:+>7=M!&]TJ7C[+:XDM)$AG
M;DX1RH!S@X]>U '045RNC^-[6[AUNYU%9+*VTR[:,22V\B#8 N,EARY)/RCG
MD<<\ZFE>)-.U>ZDM(/M$-S&@D,%U;O"Y0G 8!P,C/&10!K45GZOKEAHD437D
MC[YW\N&&*-I))6QG"JH)/%<_XB\=06_A"]U+1S*UW#(+?RY+63=;R$C_ %B8
MRO!R,\$X'.: .PHK/TB61=$AGO;R29@A>2>XM_L[8R3\R'&W ]?2N=O?'=K<
MWNBV^DO,!?7Z1EYK1T2>$JVYHV8 ,,A>1Z^] '945@W?C31+*[FMY9IRMLXC
MN+A+:1X8'/\ "\@&U3R,Y/'?%9^I^([JVOO$D37\=G;:=96TT,Y@\WRR^_<2
MHY;[HXH ZZBJ$6LV$S:@JS[3IK;;H.I7R_E#9YZC:<Y'%49_&.D0Q6CJ;JX>
M\@%S%#;VLDLOE'^,HH)4?7% &[16%=>,]"M=.L[]KPR07Q(MC%$[M(PZJ% S
MN[8QG-6M/\0Z;J<-U+!,Z"S"F=9HFC:,% X)# '[IS0!IT5FV.O6&HRVT5LT
MI:ZM1=Q%H64&(D ')& >1P>:H>([[4HM8T/3M/NUM?M\TJRR-").$C+X /TQ
M0!T-%<I8:UXDN/%MY83:;$EBBD13%I I*YS@^6.N^,')Q\K;2W.*NF:SXIU2
MSU;[1 FEM #+;S-&SY7L K(H*G8_).X9&0.,@':T5E^&+^?5/"VEZA=$&>ZM
M(I9"HP"S*">/QJDOCC0WN8XUEN?)EF\B.[^RR?9VDSMVB7;M//&<X]Z .AHK
MGM$\3MJWB?6M)-M-&FGNBQNUO(H8;5+98C&<MP.ZC(R.:NZKXAL-'GBMI_M$
MUS,I>.WM;=YI&4=6VJ#@<CDT :E%4M)U>RUNQ6]L)3)$69#N0HRLIP592 00
M>QIJ:U82+J#+*2--<I<_(?D(0.?K\I'2@"_16%<>,M%MEL\RSRR7UL+FVB@M
MI)))8SCD*H)Z'..U1OXFLKZTTJ\T_41%#=7XMRKVS%I&"OF(@X*-E<Y/I[T
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M7,#;B-I9=K<=#QZT <'?Z1JNKW.I^(8-,N$C^VV,\-E,HCEN4MR2Y*GH3N.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJT444 %%%% !69X@_P"0=%_U_6G_ *41UIUF>(/^0=%_U_6G_I1'0!IT444
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MPQ&)9!(PRAS\K*#AA\QX(/6@#CI(;C0],\/ZW!K5_=W=]=6T5PL]RTD5T)B
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M)?\ T UH5G^(/^1<U/\ Z])?_0#0!9LO^/&#_KDO\JGJ"R_X\8/^N2_RJ>@
MHHHH **** "BBB@ HHHH *RM%_X^M7_Z_P _^BHZU:RM%_X^M7_Z_P _^BHZ
M -6BBB@ HHHH *S/$'_(.B_Z_K3_ -*(ZTZS/$'_ "#HO^OZT_\ 2B.@#3HH
MHH **** "BBB@ HHHH RM5_Y"^B?]?4G_HB2M6LK5?\ D+Z)_P!?4G_HB2M6
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MRF_Y&V/_ *\&_P#1BUJUE-_R-L?_ %X-_P"C%H ?XC_Y%G5?^O*;_P! ->=P
M6Z:U\/K72K+P+<O>7&G11QWLT,$<8?8 )=^[=P?F'&37IU_:+?Z?<V;L46XB
M:(L.H# C/ZTS2[!-*TFSTZ-V=+2!(59NK!5"@G\J .)O?$]_;:Q-H0U?[#_9
M=M"LMP-.ENVN9F0,<[1A5QCW)-/3Q/XBUG_A';:Q,&FW&IQW7VIYK9F\LPE
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MFLY($N$E<+@HV""/F!(]C3M2TS61XW\-+JFL6UXRQ7<FX6 50%\O<,;CR0<
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M(MPVEF*@;VV\9/J>.:JP^"7MH5T^#7;Z+1TE\Q;) JE1NW;!*!N"9[=<<9H
M-.OM>U3Q=JL"WMM!IFF721^5]GW23!HE8C=GY<$YS@YS[5KZSI%KJ)@NI[3[
M9+8%Y;>W=\(\A4@9!XSZ$],YIVG:/'IU_J5XDK.VHSK,ZD#"$(J8'X+46MZ%
M_:TMG=V][+8WUBS-!<1J&P&&&5E/# C'Y#F@#SZ1Y(M \0:;/!_9UQ<ZS;+=
M6,9'EP0S/&ORL.&#J#D\<DC KJ;JTMM)^(>A#3K>*V%[9W,,Z0H%5ECV,F0/
M0D@?6K2>"[273M3M]0N[B\N=5*M<W9PCY3_5[ !A0N 1UYZYJ?3/#DMKJO\
M:NI:I-J=XD!@A>2-8UB0D$X51]XD#)]NU &[16=H,.H6^BVT6J3M/>!3YCMM
MR>21G;QD# ...*T: "L_Q!_R+FI_]>DO_H!K0K/\0?\ (N:G_P!>DO\ Z :
M+-E_QXP?]<E_E4]067_'C!_UR7^53T %%%% !1110 4444 %%%% !65HO_'U
MJ_\ U_G_ -%1UJUE:+_Q]:O_ -?Y_P#14= &K1110 4444 %9GB#_D'1?]?U
MI_Z41UIUF>(/^0=%_P!?UI_Z41T :=%%% !1110 4444 %%%% &5JO\ R%]$
M_P"OJ3_T1)6K65JO_(7T3_KZD_\ 1$E:M !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K/\0?\
MBYJ?_7I+_P"@&M"L_P 0?\BYJ?\ UZ2_^@&@"S9?\>,'_7)?Y5/4%E_QXP?]
M<E_E4] !1110 4444 %%%% !1110 5E:+_Q]:O\ ]?Y_]%1UJUE:+_Q]:O\
M]?Y_]%1T :M%%% !1110 5F>(/\ D'1?]?UI_P"E$=:=9GB#_D'1?]?UI_Z4
M1T :=%%% !1110 4444 %%%% &5JO_(7T3_KZD_]$25JUE:K_P A?1/^OJ3_
M -$25JT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !64W_(VQ_\ 7@W_ *,6M6LIO^1MC_Z\&_\ 1BT :M%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !6?X@_Y%S4_P#KTE_] -:%9_B#_D7-3_Z])?\ T T 6;+_
M (\8/^N2_P JGJ"R_P"/&#_KDO\ *IZ "BBB@ HHHH **** "BBB@ K*T7_C
MZU?_ *_S_P"BHZU:RM%_X^M7_P"O\_\ HJ.@#5HHHH **** "LSQ!_R#HO\
MK^M/_2B.M.LSQ!_R#HO^OZT_]*(Z -.BBB@ HHHH **** "BBB@#*U7_ )"^
MB?\ 7U)_Z(DK5K*U7_D+Z)_U]2?^B)*U: "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIA(C.4#J67J >17FF@RR!O",3S2LD%WJ<*DL68(@D51ZG   ^E5- BL]'O=
MN/(TS4HKJZ\JVU6PD:*[D+ALF=",N.N[)XQTXH ]7SBD61'!975@."0<UR?Q
M*%L?#MH+V4Q6IU.U$T@;;M3S!N.>W&>:P=;M]-T_4-;M?#T<$-H_ANY>]BM0
M!$'QB)B%X#$;_<B@#TK>F&.Y?E^]STH5U=0R,&4]"#D&O-KC1-(TVS\*6\L$
M<.EZC*K:F[G N91"6C$K'J"^>#P3BJ^MR)H\GBFW\+M]GL(["W>X%GPEO*TI
M$A0#A3Y7)QZ T >AWFKPV>KZ=ICQR-+J'F^6RXVKL7<<_G5_(QG(Q7 ?V1H&
MD^/_  NNBB*(S0W+M'#)N5U\OASSU//S=_?%95OJ%F/A5X>LS<Q?:#?VT?E;
MQO#+< L".O&* /4V=%959U!;H">35.#5K:XUF[TJ/?\ :+...20D?+A]V /?
MY#G\*X9;7P[?2>*[OQ483=VUY(HDE8":V@"J8C%GE<CD%>I]:O\ AZUTM?B-
MJUPL$0N)+"TDA>5 LS;A)O;GG) 7=^M ';YYQ1D>H]*Y;5IX;7XCZ))<2I$D
MEA=1HSL "VZ(XR>^ :XZ_N=/O=#UB:6Y46$GB^,23H^!Y>(@Q##MC/(H ]91
MTD&48,,XR#FJ=UJUM::M8Z9)O\^^61HL#@! "V3_ ,"%<SI5OIMA\1/LGA^.
M"&S?3"][%:X$2OO41,0O 8C?[D4[Q+9:;)\1?"]Q>6]LSF.Y"R2JN2R[&C&3
MW#$D>Y.* .P,B!Q&77>1D+GG%0:A>IIVFW5]*K-';0O,RKU(4$D#WXKR\V^C
M2^ -5U?46B_X26.:X+7!;%S%<J[")%/W@.$ 4<8KO=<:=_ FHM<C;.=,E,@]
M&\HY_6@"C<>/;2RT[3[R^TZ]M1J#H(D>(OE6Z',>X$XY"9W'TJS>^,]/L=9L
MM+E@O/.O%+(/LLN>@( &WYNO./NX.<5)I6EV&I^&-)%]9PW.VQC5?-0-@,BY
MQ]<"M*;2M/N;M;N>SADN$V;960%EVDE<'M@D_G0!3TC7QJFI:CI[V%Q9SZ>8
M]XF*'<'W%2"K'LO?UK5>1(EW2.J#IECBN:T3_D?_ !1_URLO_0'K)\1"SU3Q
MA<VK:9IMW+962&6369\01*Q8YCCVG)XY;C& ,T =+XAU\Z(EFD-D]]=7TX@@
M@1U3)VEB2QX  4U8TG6(-7%T(4='L[@V\RMCB0*I.#W W8S[5YEHVGZ?JVA>
M"FO+6VO =2N;?=)'O!B7SRJ?-D[1A< ^@IUW!;Z;X<\7?V9%;6L_]M>5<-'\
MC):EH\Y*_,$Y;IV+4 >LK(C@E'5@#@X.<&@,K$@,"1U /2O-+6Q&GZX%M'T.
MR673+@S6NE&1A/&%^5V&W:"#T8D$Y(YKHOAWHFGZ;X2TR\MK95NKVQ@>XFZO
M(=N1DGL,X'M0!U=%%% !1110 5G^(/\ D7-3_P"O27_T UH5G^(/^1<U/_KT
ME_\ 0#0!9LO^/&#_ *Y+_*IZ@LO^/&#_ *Y+_*IZ "BBB@ HHHH **** "BB
MB@ K*T7_ (^M7_Z_S_Z*CK5K*T7_ (^M7_Z_S_Z*CH U:*** "BBB@ K,\0?
M\@Z+_K^M/_2B.M.LSQ!_R#HO^OZT_P#2B.@#3HHHH **** "BBB@ HHHH RM
M5_Y"^B?]?4G_ *(DK5K*U7_D+Z)_U]2?^B)*U: "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ K*;_D;8_P#KP;_T8M:M93?\
MC;'_ ->#?^C%H U:@6QM%OFOEM81=N@C:<(-[*.0I;KCVJ+5M2@T?2;O4KK/
MDVL32N%ZD 9P/>N.OM3U^ZUKPJVI:;#907-]YB&"Y,A7]S)\D@*CGG/&1P:
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MR<GW-(-.L5N9KD65N)[A=DTHB7=(OHQQDCV-<N?&U[J5WIUMX>TJ.[.H:?\
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MIZ->V$-RUM)<P/$LR=8RP(!_"N1LO!.IQ3:*Q@T2QCTNX25TLHFW7&%*EBQ
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M **** "BBB@#*U7_ )"^B?\ 7U)_Z(DK5K*U7_D+Z)_U]2?^B)*U: "BBB@
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M7!0!2J,H2,@G=DMUZ8'X5CRV.N0>!H?"":!<RW-K+$AN5*>0\:3!O,4[LDD
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LIO^1M
MC_Z\&_\ 1BUJUE-_R-L?_7@W_HQ: -6BF2S101F6:1(T7JSL !^)IQ(52S$
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MT![GVJ1IHDE2)I$623)1"PRV.N!WQ0 ^BH8+JVN2X@N(I2APXC<-M/OCI4U
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?_14= &K1110 4444 %9GB#_ )!T7_7]:?\ I1'6G69X@_Y!T7_7]:?^E$=
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MO#MO=K:3:U91SM(8O+:8 A@2I!]#D$<]Q47@J[@N_!NE&%B?)M(H9 5*E75
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5E-_R-L?_7@W_HQ:U:RF_P"1MC_Z\&_]&+0!JT444 %%%% !1110 5E0Z#$G
MB"36IKNYN9O+,<$<I7R[96P6"  =2HR3D\8K5HH **** "BBB@ HHHH ****
M "J&J:1!JS6+3O(IL;I+J/80,LH( .1T^8U?HH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#"U'PRU[?3W5MK>I:?]K55N([9T*R8& 1O5BAQQ
ME<=*U-/L+;2]/M["SC\NWMHQ'&F<X4# JS10 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %9_B#_ )%S4_\ KTE_] -:%9_B#_D7
M-3_Z])?_ $ T 6;+_CQ@_P"N2_RJ>H++_CQ@_P"N2_RJ>@ HHHH **** "BB
MB@ HHHH *RM%_P"/K5_^O\_^BHZU:RM%_P"/K5_^O\_^BHZ -6BBB@ HHHH
M*S/$'_(.B_Z_K3_THCK3K,\0?\@Z+_K^M/\ THCH TZ*** "BBB@ HHHH **
M** ,K5?^0OHG_7U)_P"B)*U:RM5_Y"^B?]?4G_HB2M6@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MJ>JPP2Z?*URUP(XE,A^SSO"YP"?O(P/X9Q5RJNIHTFE7<:*6=H'"J!R25/%
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M_P (U8?\_&J?^#:Z_P#CE'_"-6'_ #\:I_X-KK_XY6O10!D?\(U8?\_&J?\
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M?\_&J?\ @VNO_CE:]% &1_PC5A_S\:I_X-KK_P".4?\ "-6'_/QJG_@VNO\
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MGVT4I[&3?*P'U"L#_P "% &U;6Z6END$;2LB=#+*TC?BS$D_B:EHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7=PLI6%. ?\ >7%7--:XU;Q8-7^PW5G;6^GFWQ=1^6SR.ZL0!W"A!ST.>,T
M=)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %106T-L9##&$\US(^.['J?QQ4M% !1110 4444 %1/;0
MR7$5P\8:6$,(V/\ #NQG'Y5+10 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
>444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>ebs20191231exhibit1048001.jpg
<TEXT>
begin 644 ebs20191231exhibit1048001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKK%E/;QP_P!G3I$I1RV\,@<'D#LPX_G7(C[!I-UX<TH:@;O0)KVY#22D>29
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M@J,')SC@XJ[D9QGDUYZ8]/"> Y;(0 _:55C"0!DV[$Y []*KR"'4?!_BF[U
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M_/(&%QGH< =J;X=.F:S:Z3>7>K1V^NVM[_I$4:*MTTVXAXVR=Q0\Y'0*.P%
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MTUB5((E^[$I2-MJCL,ECCW-5[*+3H/B;KKRQVT<S6=L\195#$XEW%>^<=2*
M-[PQK+Z_X;L=5DB6%[N+S#&IR%Y]:U<C.,\^E>4Z'96EGX:\ ZI!$J7LM]'
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M:<=5TNRMO-N4U*)YHYX87="@QT(!R<D9].^.* -0Z5IQ,S'3[4F<$2GR5_>
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MX5!%IUC;W3W4-E;Q3R9+RI$H=L]<D#)I]G=P7]G%=VS[X9D#HV",@].#S4U
M%272M.GGDGFT^UDEE39)(\*EG7T)(Y'M3_L%E]I6Y^R0>>@VK+Y8W >@/6K%
M% %+^QM+-P]Q_9MIYTC!GD\A=S,.A)QDFK,]O#=1&&XACFC;JDBA@?P-244
M5?[+T_=$WV"VS ,1'R5_=C_9XX_"F?V/I?EO'_9MIL=MS+Y"X8^I&.35VB@"
MI)I>G3/ \MA;2/;_ .I9H5)B_P!WCC\*=-8V[S&[2VM_M@4A)GB!8'''/7'X
MU9HH RM%L-0A,E[K$]M-J$RK&QMD98D1<X"AB3U8DGW]A6K110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3#='L$:A@"V2<G&1\O7D5A06.JV_A6PNH]+O97T[69[J>S5'BEDA=I1E.A)
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M RJ<<XW*/?\ "J>@6VH:1=>&M2N;*\:V31!IUQ&MN[26TH*MDH!NP=NW(!'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K#UKQ!/I6L:9IL5BEP
MVINZ1.T^P*RKN.[Y3QCTS6Y7&>,T,OC'P?$EP\#M<W&'CVEA^Z/0,"/T[T =
M):7=^]XUO>:>D"^7O26*?S%8YP5Y5<'H:O'.#@9/8&L1+*VMY+VSU34GOEO4
M,I6YV@I&H ;[H4!02#GU-<[X*1+/6SI>I&1IK>!GTB2=<&:U9R2Q]9!D YY
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M_3 QQFF0_#_5?^$8\1F]N[>YU[7QF5URL4>/NJ#C.!D\X]/2L/\ X5C\1/\
MH>YO_ VXH_X5C\1/^A[F_P# VXH T_&OPQN_$'A_2?L$D$6JV5K':SEG(2:,
M*."0.<,,CCN?:NF\<^'KWQ'X'N=&L3$+F41;3(Q"_*ZD\X/8&N&_X5C\1/\
MH>YO_ VXH_X5C\1/^A[F_P# VXH [#QSX6U#Q%X,MM(LFA%Q%)"S&1R%PHP>
M<&H_$WA"_/B.P\3>&&@M]1@;9=12,4CNHNX; //;IZ>@KD_^%8_$3_H>YO\
MP-N*/^%8_$3_ *'N;_P-N* -Z/X;MKGB75];\32.'N90MFEI<LOEPJ, ,0!R
M<#CU!J/3OAI-:V7B/PW),O\ 8.I%9;-MY:6&08.2".>0._.WWK%_X5C\1/\
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MN;_P-N* /8**\?\ ^%8_$3_H>YO_  -N*/\ A6/Q$_Z'N;_P-N* /8**\?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !116?_ &K_ ,5'_8_D_P#+I]I\W=_M[=N,
M?CG- &A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7&?%W_DF&K_\ ;'_T='79UQGQ=_Y)AJ__
M &Q_]'1T >)> _'^H>"M0^7=<:=,W^D6I/\ X\OHW\^A[8^D=&UK3_$&F1:E
MIEPL]O*.".JGN".Q'I7R%72>"_&^I>"]4^T6I,MK(0+BU8_+(/7V8=C_ $H
M^J*Y_2?^1U\0_P#7*T_]!>M?3;Z/4],M=0A5TCNH5E19!A@& (!'KS61I/\
MR.OB'_KE:?\ H+T =!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD<MFMW=Q2PV&?)"1%6<[2@+G..%8\ <DYXZ5KT %%%% !1110 4444 %%%%
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MS!5!)Y#9(& ,4S3_ !G97-O)<2EGCENI8K)+:&262:./ 9]J@GAMV3@ <=Z
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M3_\ 0KZ[_P!^(_\ XY1_PE4__0KZ[_WXC_\ CE=!10!S_P#PE4__ $*^N_\
M?B/_ ..4?\)5/_T*^N_]^(__ (Y7044 <_\ \)5/_P!"OKO_ 'XC_P#CE'_"
M53_]"OKO_?B/_P".5T%% '/_ /"53_\ 0KZ[_P!^(_\ XY1_PE4__0KZ[_WX
MC_\ CE=!10!S_P#PE4__ $*^N_\ ?B/_ ..4R7Q>T$+S3>&M<2.-2SL8(\*!
MR3_K*Z.L_P 0?\BYJ?\ UZ2_^@&@#,B\7O/$DT7AK7'CD4,K""/!!Y!_UE/_
M .$JG_Z%?7?^_$?_ ,<K1T/_ ) &G?\ 7K%_Z *SO$NL:GI$<MS MC#:00>8
MTUY(1YTG.(D .0<#KSU& >: #_A*I_\ H5]=_P"_$?\ \<H_X2J?_H5]=_[\
M1_\ QRMJUF:YM(9WB>%I8U<QO]Y"1G!]Q7-7WB'41XDOM,M[S2+.*TCB8-?;
MMTA<,3C##IC]: +?_"53_P#0KZ[_ -^(_P#XY1_PE4__ $*^N_\ ?B/_ ..5
M2OO$.J6^HZ?IZ7NC1M<6<ES)=3;O*8JZ* GSCJ'SU/2C4/$.K6<VDVHO=%#W
MZSNUTX;R<)MP%^?J=Q[]J +O_"53_P#0KZ[_ -^(_P#XY1_PE4__ $*^N_\
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M,"1U5=K-GT%6;?5=2UGP[::EI1M()9$S-'=(S!&&0R?*1R&!'X4 ,_X2J?\
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MY.<YCDEW"(#MU4 _]=%H 7_A*I_^A7UW_OQ'_P#'*/\ A*I_^A7UW_OQ'_\
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M<TR\\0SZ_=V-U=::T-EY9D,5I(K2!P3P3*0,8]#0 _\ X2J?_H5]=_[\1_\
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M22XQTP:=JOA_4+N]U2Z$%E=QWAMXOLUPS 201JQ*[@#L;>Y8$9^Z.F>.H!R
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M(?"/]B^6-,2XOEC\M2$\[8<XS[^9TX]*RO%)SKGB7'_'J+C2/M7I_K.<_P#
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M6VN$V2)]K5=P],A@10!KI_JU^@IU9PU_10,#5['C_IY3_&E_X2#1?^@O8_\
M@2G^- &A16?_ ,)!HO\ T%['_P "4_QH_P"$@T7_ *"]C_X$I_C0!H45G_\
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M+/""J36^H>3(%/5=R,"0?2@#C;4373:?8Z:ZP74OB*_FT^Z?YHXHT9M_R_Q
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ML%"YP6P. !Q6?IVG^"M+O([JUOK3?!N%NLFH&1+?=U\M&<JF?8"@#JZ*S_\
MA(-%_P"@O8_^!*?XT?\ "0:+_P!!>Q_\"4_QH T**S_^$@T7_H+V/_@2G^-'
M_"0:+_T%['_P)3_&@#0HK/\ ^$@T7_H+V/\ X$I_C1_PD&B_]!>Q_P# E/\
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M9Y6A?>S_ +L8&,XQG&%'2O0O^$@T7_H+V/\ X$I_C2'Q!H@Y.L6 _P"WE/\
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M'_"0:+_T%['_ ,"4_P : -"BL_\ X2#1?^@O8_\ @2G^-'_"0:+_ -!>Q_\
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M^Q1]CM?^?:'_ +]BIZ* (/L=K_S[0_\ ?L4?8[7_ )]H?^_8J>B@"#[':_\
M/M#_ -^Q1]CM?^?:'_OV*GHH @^QVO\ S[0_]^Q1]CM?^?:'_OV*GHH @^QV
MO_/M#_W[%'V.U_Y]H?\ OV*GHH @^QVO_/M#_P!^Q69?VML-=TE1;Q ,9LC8
M.?DK:K*U#_D/Z1]9O_0* +WV.U_Y]H?^_8H^QVO_ #[0_P#?L5/10!!]CM?^
M?:'_ +]BC[':_P#/M#_W[%3T4 0?8[7_ )]H?^_8H^QVO_/M#_W[%3T4 0?8
M[7_GVA_[]BC[':_\^T/_ '[%3T4 0?8[7_GVA_[]BC[':_\ /M#_ -^Q4]%
M$'V.U_Y]H?\ OV*/L=K_ ,^T/_?L5/10!!]CM?\ GVA_[]BC[':_\^T/_?L5
M/10!!]CM?^?:'_OV*/L=K_S[0_\ ?L5/10!!]CM?^?:'_OV*/L=K_P ^T/\
MW[%3T4 0?8[7_GVA_P"_8H^QVO\ S[0_]^Q4]% $'V.U_P"?:'_OV*/L=K_S
M[0_]^Q4]% $'V.U_Y]H?^_8H^QVO_/M#_P!^Q4]% $'V.U_Y]H?^_8H^QVO_
M #[0_P#?L5/10!!]CM?^?:'_ +]BC[':_P#/M#_W[%3T4 0?8[7_ )]H?^_8
MH^QVO_/M#_W[%3T4 0?8[7_GVA_[]BC[':_\^T/_ '[%3T4 0?8[7_GVA_[]
MBC[':_\ /M#_ -^Q4]% $'V.U_Y]H?\ OV*/L=K_ ,^T/_?L5/10!!]CM?\
MGVA_[]BC[':_\^T/_?L5/10!!]CM?^?:'_OV*/L=K_S[0_\ ?L5/10!!]CM?
M^?:'_OV*/L=K_P ^T/\ W[%3T4 0?8[7_GVA_P"_8KE_B5:6R^ M0(MX@=T/
M\ _Y[)77UROQ+_Y$'4/]Z#_T<E %_P#X0KPI_P!"UI/_ (!1_P"%'_"%>%/^
MA:TG_P  H_\ "MNB@#$_X0KPI_T+6D_^ 4?^%'_"%>%/^A:TG_P"C_PK;HH
MQ/\ A"O"G_0M:3_X!1_X4?\ "%>%/^A:TG_P"C_PK;HH Q/^$*\*?]"UI/\
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M.X@8,A!_X :S8ISKWAG1[&^NH[;5[&_\CR;Z$O'/-$C860 X^9"''/7&,XH
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MP@4'_0R>)O\ P;25U5<%X]>'6]7M?#3:E'8K%;27TDKS"/$F"D SG^\2V/\
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M*"XE14>7'S,JY(&?0;C^=5KK0M*O5N5NM/MYENV5IP\8/F,HPI/N !@U?HH
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M1110 4444 %%%% !7F7CZ_TO5O$<FCWFKV]A_9=DT\+2RA,WC_ZH\_W0,_\
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M?!-U'XDA\276NR3ZFO[N5DMDCBDAQ_J]O)'/.[)-;.NZ*NMQV*-.8?L=]#>
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M0MKD7%K?P6ZQ-"P&!\N2&')!!Z@T 8NE/I,?BW3S<^';KPQJFR2.-8TC%O>
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MQ%K&I:E%H,&EI!IMP;9_MLC^9*X )("_=7G )SG&:Z+3-2M-8T^*_L9#);S
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M0A?NAW8(QVKMJ "J%]I$%_J6G7TKR+)ITCR1!2,,60H=W'HQZ8J_10 4444
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M<-S^=>FY\BRS' %\N/Y8EQQ@?=&/RH KWFMZ3ITZP7VJ6=K*_P!V.>X1&;Z
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MK#' AD4Y5FV#+8/.,@>U=/6'-XCM+K28-0TG4;%XI+J. R3[MO+@,F!R'YP
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MI?)4#.TR=-H;&W=GC&<T 8\'PWLK/PWJ&AVE_<10W=ZMTCE0S0E2A51GJ!L
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M4 %<_K'_ "./AS_MZ_\ 18KH*Y_6/^1Q\.?]O7_HL4 =!1110 4444 %%%%
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M#;LY]L8Q6C0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$VB7-W 9KAI);:2/ RLA.[!WCJ3@KQUK4\,0Q-=K*(/$<3K%G=J-U(\39P.
M7()YSTH M^3XT_Z"&A?^ 4W_ ,=H\GQI_P!!#0O_  "F_P#CM0WXFUGQ>VC2
M7=S;65K8I<NEM,T+S.[LHRZD-M4(> 1DMSTJMJ,=_I<=EHD&M7$B:CJ0A6=V
MW3VT/EM(R;R22QV$!CR W? - %_R?&G_ $$-"_\  *;_ ..T>3XT_P"@AH7_
M (!3?_':SM2AF\,:E8+97][+;ZB98)8+FY><JPB>19$9R64@H00#CGIQ6'9^
M(-5M? \5CJ-],;^2VM;NTO-Y#W$3O'N!;NREBI]05/<T =;Y/C3_ *"&A?\
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MI1XVALS%:ZC#MNX4A%]MEC A=P. I;+=03C. 1U/% %KR?&G_00T+_P"F_\
MCM'D^-/^@AH7_@%-_P#':O:UK4>C0Q.\1D,K%5S*D:C SDLY '\ZRY/&]K]B
M6[MK"ZN$_L_^T)-I0>5%SU);&?E;&,YQQQS0!-Y/C3_H(:%_X!3?_':/)\:?
M]!#0O_ *;_X[4&J^*9A&\6F6<[DW45FMV0OEK*[*"-I.3@-R<8SQZXO^);N2
MPTX7,=_);,&V)'%"LCW#GA44-W)_^OP* *_D^-/^@AH7_@%-_P#':/)\:?\
M00T+_P  IO\ X[67>:[KFAV"KJ$\,UW!I=S>W.R,8W@J(HQCKRQ&>^VK.BZK
MJ%QK%M;IJ+:G;M"[7<AL_*2%AC;M? !).1MY..>,<@%OR?&G_00T+_P"F_\
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M_':/)\:?]!#0O_ *;_X[7044 <_Y/C3_ *"&A?\ @%-_\=H\GQI_T$-"_P#
M*;_X[7044 <_Y/C3_H(:%_X!3?\ QVCR?&G_ $$-"_\  *;_ ..UT%% '/\
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M8*AB50%B 2 6)Z^O-7-7T2#5_(D::>UN;5BT%U;L%DC)&#C((((Z@@@UI44
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M !-K+_T>E=!7/^,?^/'3O^PO9?\ H]* .@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH :Q*H2J[B!P/6O,H9M!72KC5M$\53^&;A2[S:;-.C1Q2Y.
MY6@?H2?[N,]J]/JI+I.FSW8NYM/M9+A<$3/"I<?\"QF@#B;;5I+7Q+H/B3Q
MBV,>IZ-]E=W^5(9]XDPQ/W=PSC/IBNFA\56%YXBBT;3F6^8PM+<3V\@9+8#&
MT,1QECT'7C-:\T$-S"T,\22QN,,CJ&4_4&F6EC9V$1BLK6&VC)R4AC"#/T%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M76_L\%C#.I%RN[<SR*<G;TPHK2/@_P KQW!XBM;D1V^V1I[4CAI64+YB^A(
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M8>&N2GF,WU5=@^I-0Z%=Z3=7EB(_%.OW%PQ5O)E601NW4@DQ@8_&M@>&)O\
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MTY-.T=KF:_CGD"-<+'L6*0(>2.<EA0!I?V?K?_0=3_P"7_XJC^S];_Z#J?\
M@$O_ ,55:\\0ZC865M)<Z)LNKJ\6UBMQ=*0<J2&+ 8'W2,5-I^O7$VM?V1J.
MF/8W36YN(B)EE21 P5N1@@@LO!'>@!_]GZW_ -!U/_ )?_BJ/[/UO_H.I_X!
M+_\ %59U#4EL9+6W6,S7-W+Y<40.,@<LQ/8*,DGZ#J16./%MS*)[JVT2>XTV
MWN6MI)XY09<J^QF$6,E0<]\X&<4 7_[/UO\ Z#J?^ 2__%4?V?K?_0=3_P
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5^[P6'0YYP:]%HH \[F\*:L=/EMX[>5C%II55>9"9'GN/,GC#*%7[J!>@'S
M=*LZQI>H:N+S4+/2);1+:P2"UMGV)).ZRI(. 2%"[ !D_P 1[=>[HH X'2O#
M.HV_B$RZDJBS=(M1O9BPVR72ESL_W5+!L]MB5T/A*-VL+O474H-3O)+J-6&"
M(SA4)';*(I_&MF>"*Y@>">-98I!M='&0P]"*?0 M%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"1-\L]P!AIB.PVD;1V+-[4 =G17EWA.\NH/ Z>'S<2&ZOX[<VDA8EA'<K\[
M^J%9V_ 5!I-NU\^@Q/I#:PHT(-Y37 CVGS<;LL>3VH ]8HK@-:TR[*>'+33(
M#H=T;N>6.(2AU5UB=E#$'!5MHR/0FI],N[3Q;XEG2[MSM_LN-+FSD)_<S+,^
MY3CN".O<8/>@#N**X_P/HFFP"_O([51<0ZG=PQR9)*H)64*.>@'%=A0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"KIT%Y;6BQWU[]MF!),WE"/([#:*M444 %%%% !1110 4444 %%%% !1110
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M@C>662PG5$12S,2AP !U-:[.B;=[JNXX&3C)]*@;4+)'*/>0*RG!!E4$'\Z
M.<U,2Z;JOA_69+>>2VMK66VN?)A:1HMZQE6*J"V,QX.!QD5D0VE[!=1>*9+&
MZ\@ZY-=- (6,RV[P>0',>-V<@,1C.#TKO'O;2(*9+J% XRI:0#</4>M21RQS
M('B=74]&4Y!H Y[PRLMWK6N:T8)H;:]DA2V$T9C=UC3!?:P! ))QD9P,UTE0
MPW=M<.Z07$4K)PZHX8K]<=*07MHTODK=0F3.-@D&<^F* )Z*;O3S/+WKOQG;
MGG'KBFM-$F_=*B^6,OEA\H]3Z4 245!%>6L[[(;F&1O1) 3^E.N+JWM$#W,\
M4*DX#2.%!/XT 2T4BLKJ&5@RD9!!R#35EC:1HUD4NF-R@\KGID4 /HJ,SPJS
MJTJ HNYP6&5'J?04V&[MKABL%Q%*1R0C@_RH FHHJ.*:*=2T4J2 '!*,#@T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5C=)(I(VVR1.IRK*>Q%5;_PK:WE^VH07U]IUY(@2:>RF"&8#@;U(*DCL<9H
MJ>"Y=/4:G8:?8W^GK;7(9[.[" 0%T#;8PI.%/WL9X+&L&W8Z9\5M4U,MM@NK
MJ+3Y\G@%K:)XS_WTK+_P.NST;0K/0XYA;-/++</YD]Q<2F225L8!8GV &!@5
M5U#PEIFIP:K#<&?&JR1RS%'P4:-5"E#CC[@H X)R]U)XMU=R<ZKX<FN4![19
MD2+\XT4_4FM?7M!TC2_A^NMZ?I]K8ZE96L5Q!=6\*QR>8 O!*@;@V<$'KFNJ
MNO"^FW7VD,)$6YT[^S65& "P_-TXX/S'FJ<'@BQ1K<7>H:GJ$-LRM%;W5SNB
M!7[I*@ '&!C.: -;5;"'5M&GL[N66WAGCQ*T;[6"]2,]@1D'V)K@KSRH;/7_
M !#X7M$T_3;?2);>.6",1K=2@Y$B@=0@! ?ODXX%=YKFCP:_H]QI=U+-%!<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S_C'_ (\=-_["]E_Z
M/2N@KG_&/_'CIO\ V%[+_P!'I0!T%<_-J>KIXULK!XH8=-FAF*X;=)*R!/F/
M'R@;L =3SGM705GW6F&XURPU+SMHLXYD\O;G?OV\Y[8V_K0!SMOKNK-%9:V]
MVALKS4OLGV+R@ D9E:)&#?>W9"D]N2,=Z[*N9A\*7$<\%LU_&VDVMZU[#;B
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M-6_Y'#P_]+G_ - %;] &!_PE$O\ T+6M_P#?B/\ ^+H_X2B7_H6M;_[\1_\
MQ=;]% &!_P )1+_T+6M_]^(__BZ/^$HE_P"A:UO_ +\1_P#Q=;]% &!_PE$O
M_0M:W_WXC_\ BZ/^$HE_Z%K6_P#OQ'_\76_10!@?\)1+_P!"UK?_ 'XC_P#B
MZ/\ A*)?^A:UO_OQ'_\ %UOT4 8'_"42_P#0M:W_ -^(_P#XNC_A*)?^A:UO
M_OQ'_P#%UOT4 8'_  E$O_0M:W_WXC_^+H_X2B7_ *%K6_\ OQ'_ /%UOT4
M8'_"42_]"UK?_?B/_P"+H_X2B7_H6M;_ ._$?_Q=;]% &!_PE$O_ $+6M_\
M?B/_ .+H_P"$HE_Z%K6_^_$?_P 76_10!@?\)1+_ -"UK?\ WXC_ /BZ/^$H
ME_Z%K6_^_$?_ ,76_10!@?\ "42_]"UK?_?B/_XNC_A*)?\ H6M;_P"_$?\
M\76_10!@?\)1+_T+6M_]^(__ (NC_A*)?^A:UO\ [\1__%UOT4 8'_"42_\
M0M:W_P!^(_\ XNC_ (2B7_H6M;_[\1__ !=;]% &!_PE$O\ T+6M_P#?B/\
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M0.J'_?".OT)K1\,Z9>6NN7M]=V[1O?64$DA/:4RW#LG_  !71?H!0!U%%%%
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MVX @;@,\8XI^J::(Y-5U2[L&U6V:>66/5].NQ]ILE4XVA6QCRRI&%)SCD=:
M/1Z*Q/$0.H^$Y8[34H[5KM$6&XE<QARQ&%R.1OSMXY^;BN9MXK?2KJYMY-%G
MT*YN-.N D4%PLMK=;0"6R.0Z]B0IP3UH ]!HKS>YU'6W^'^E1S:0(;8_V>#=
M"\#,1YL6#MQGGCOWK7TK1[#Q-=:O>:U!]KFBU":VB21CBWC0X4( ?E)'S9')
MW=>E '710Q01^7#&D:9)VHH R3DG ]22:?7G%EJ\FD"TUF[N)+BUM7U#3C/(
MV3-'&6DB8GN<0LN>Y/O45M;WEA:-X4NY9&N-6GLYR2Q)Q(-UR![?N)#CMO%
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M_A6>J_\ 10?$?_@4W_Q5 'H%%>?_ /"L]5_Z*#XC_P# IO\ XJC_ (5GJO\
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MZ*#XC_\  IO_ (JC_A6>J_\ 10?$?_@4W_Q5 'H%%>?_ /"L]5_Z*#XC_P#
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M45G90+!;Q#"(O0=_Q.><]ZX?_A6>J_\ 10?$?_@4W_Q5'_"L]5_Z*#XC_P#
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MD9CDYC#!3GTQBN>_X5GJO_10?$?_ (%-_P#%4?\ "L]5_P"B@^(__ IO_BJ
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MXGE=+E$NG+W%O%=RQPSL>I:-6"G/?CGOFN<_X5GJO_10?$?_ (%-_P#%4?\
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M]+--<Z?:^(8H(R\K%O+:V:0QELY(4GN<XP.U6=?MU\.SW]AI<LZ6MYH5[-)
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M:(M)^!E*_P# #57PKXJ>_P#$0$^I13V^LI)+9VXD4M;>6Q 4@<C=&5;GNK4
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M*1[ $4D'&2XR>N!QUJIJG]K>&=*NC;ZH]TMS-;V]FUV-[V\DD@C)+?Q*-P8
M]P1G% '645R>HP7OA=K'4(M8OKV.2[AMKJ&[=7$BR.$W+@#:P+ \8& 1BJ=A
M:ZIJ&BZCJL7B"_@NX;N\$*EU:$".5PJE"O*X4 \T =Q17G/]OS:MJ\4T\^MP
MP3Z1:720Z7$[A&D\PMNVJ<= !GTKN-&Q_94&V2\D!!(:]4K-U/W@0"/RZ8H
MR?$NA:MJ.L:1JFD75I!/IOG<74;.K>8JKT4CL#^E0_9OB#_T$O#_ /X"3?\
MQ==510!ROV;X@_\ 02\/_P#@)-_\71]F^(/_ $$O#_\ X"3?_%UU5% '*_9O
MB#_T$O#_ /X"3?\ Q='V;X@_]!+P_P#^ DW_ ,77544 <K]F^(/_ $$O#_\
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MOK.U1J%N-0TY0@7; 7(V'U(&P^OS4 6?LWQ!_P"@EX?_ / 2;_XNC[-\0?\
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MT2:3.<L!SSW^O>M*BB@ HHHH **** "BBB@ HHHH **** .5^)G_ "3W5?\
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M8C)7/4FKC>&K*6TU:TN"TT.JSF:53P4)1%^4]L; 0>QK8HH P8_"MO'X6M-
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M%!=K$X;[';8"D%NA.Q2#CNU6-7\)W>CRZ7K6E7FIZE<:7.H%M-*KYMV^215
M YQ@_P# :[JB@#S^:VUC3M&UWPS;:/<W$FH3W!LKI ODA)R3EVS\I3<V1CG
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M;7=EOGR5_>(TRDL<_P .1GKD]Z *U[JMM:26C^&/&5[K.HM<QJ+$W"7*3(6
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9X@X+*#T)'4 X/Y5+7,^$E^UZAK^MGG[9?F"(]C% /+&/^!!S^-=-0 4444
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M##%6(RH;J1WYZ9KH;RZDMX8Y(+62[+R(A6(CA2<%N3T YJP652 6 )X&3UH
MYZ?PHR7<5[I>K7&G72VR6LKI&DBSHOW=RL"-PR<$>M96L>%KE+CPS96-WJ!^
MS7<TLM^3YDB,8G.YB1C!8@8QC!Q7;%E7&X@9.!DU3OM5MM/N[&UFWF2_F,,.
MT9&X*S'/H,*: ,<>"K2XLM1BU*\N;VZU(QM-=G;&ZF/F/8%&%VGD>^<YJ:U\
M-7(N6N=3UR\U"00/!$&5(T0-U;:H 9N.I_*MTLH8*6 )Z#/6E9E1=S$*!W)H
M PQX6MAHNC:7]HE\O2)8)(WP,N8A@ _6J6H>!Q=KJ-M;:S>66GZHSR7-I$J$
M%V'S%6(RH;J1WYZ9KJJY4>,;ZXO+^'3_  Q?7T5A<O;23130J"ZX)P&8$\$4
M 6)_";)=Q7NE:M<:==+;):RND:2+,B?=+*P(W#)P1ZU+;^%+>W;2&^V74KZ7
M+),))GWM,\BLK%C_ ,")XQ3[3Q9I-UX?GUMI7MK:UWK<K.FV2!U^\C+_ 'AZ
M=\C'6LZ3QM<6ENFHZCX;U"RTER,W<C1EHU)P&>,,64<\^GI0!<OO"-CJ,NKO
M<33?\300;MA"F%HON,A]0<'GTJ'_ (0U+W[2VNZG<:LT]JUH/,1(UCC8@G 0
M#YB0#N]AC%;E]J%MINFSZA=2A+:WB,KN.<*!GCUK%LO%S37UE;7^BWNFIJ.?
ML<LYC(D(7=M8*Q*,0"0#Z>M $EAX:NK>^M;B_P!?OM06R!%O%($0<C&7V@;S
MCU^N,U<U+18M4U+3+N>9]FG2M,D(QM=RI56/^[DD?6LO_A.+??\ :/[-N_[)
M^T_9?[3^3RM^[9G&[=LW?+NQC-3WWBEX=3NK#3M&O-4DL55KMH&C41[AN"C<
MPW-CG ]10!<UC0X=7GTZX:9X)].NA<121XR>"&0Y_A8'!J"W\+65MXLN/$:/
M(;B>+R_*)^120H9P/[Q"(#]*@D\8VDMMIKZ5:3ZG/JD1FMX(=J$1C&YG+$!0
M"0.>_ JYIWB2POM'FU*5C8QVSO'=+=$(;=U.&5CG'IWYR* ,Z;P8^^\ALM<O
MK'3[Z5I;BTA"?>;E]CD;D#=P/4XQ6W%920WZSI=R_9UMQ"MJ<% 0<[\]<XXZ
MU4\.>(K3Q/837UBDBP1W#PJ9!@OMQ\V.P.>_-:] &1KWAZ'7!;2BZGLKVR<O
M;7=N1OC)&",$$$$=01S5?3?#,MOJJ:KJNL7.K7D,;1P-+&D:0JV-VU4 &3@9
M)[5OT4 8]SH!OO#$NBWVH3W+2H5-TP429W95N!C*G&/H*@NO"-E<^#8_# EE
MC@CBCC29<;U*$$/]<C-;]% &>-*,.GV%C97<MI%9-$!Y8!\R-!C8<CH1UQS6
MA110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 <K\3/^2>ZK_NQ_^C%KJJY7XF?\D]U7
M_=C_ /1BUU5 '*77@_4I/$MUKMIXC>VGG18U5K..7R8Q_"I;H">3CJ:M7?AN
M\N'L+Z/6GBU:SC>(WGV=2LR,02K1\#&0",$8(JY9^(+:ZEU:.1'MSI,I2??C
ME=@<./8@_I5#3/&UCJ7A&[\1FWFMXK-9&E@DQO&U=V/3)!4CZB@!/^$+M_[%
M^QB^G%[]L^W_ &_:N_[3G[^WIC'R[>FWCWJYHV@R:??W6IWU\U_J%TJ1O,8Q
M&J1KG:BJ,X&22>3DFM&VNA/96]Q(A@,T:MY;D94D9VGW%3,RH,LP4>I.* ,G
M7?#T6M26UREW/8W]FQ-O=VY&Y,\,I!!#*<#(([5#IGAAK;5AJ^IZI<:K?I&8
MH9)41$A4]=B*  3CD]:NWVL16&JZ9I[QNSZE)(B,,839&7.?P7%6+VZDMK%[
MBWMGO&&-L41&6R0."3CC.?PH IZ]H%OKUM"DD\UK<6THFMKFW8"2%P,9&<@@
M@D$'@BJ=AX7N$U6WU/5];N=6GM WV99(HXDB+#!;:@&6QD9/J:Z!F5<;F R<
M#)[T,RJ,L0!ZDT 97A_0O^$?MIK2.]EN+5IGDABD51Y 9BQ4$#)&6/6J=[X4
MF.K7&J:-K=UI,]WM^TK'&DL<I P&VN#AL8&1Z5JZEJMMI?V3[1OS=W*6T049
M^=LXSZ#@U;+*I + $\#)ZT 8]AX7M++1[[3I)IKMM1WM>7$Y!>9G7:2<  <8
M  & !45GX1LK3P=)X9,LLL$T4J23/C>Q<DEC[Y;/X"MXD*"6( '4F@'(R.E
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M%G^"_P#H.Q_]^9/_ (FC_A9_@O\ Z#L?_?F3_P")H ZNBN4_X6?X+_Z#L?\
MWYD_^)H_X6?X+_Z#L?\ WYD_^)H ZNBN4_X6?X+_ .@['_WYD_\ B:/^%G^"
M_P#H.Q_]^9/_ (F@#JZ*Y3_A9_@O_H.Q_P#?F3_XFC_A9_@O_H.Q_P#?F3_X
MF@#JZ*Y3_A9_@O\ Z#L?_?F3_P")H_X6?X+_ .@['_WYD_\ B: .KHKE/^%G
M^"_^@['_ -^9/_B:/^%G^"_^@['_ -^9/_B: .KHKE/^%G^"_P#H.Q_]^9/_
M (FC_A9_@O\ Z#L?_?F3_P")H ZNBN4_X6?X+_Z#L?\ WYD_^)H_X6?X+_Z#
ML?\ WYD_^)H ZNBN4_X6?X+_ .@['_WYD_\ B:/^%G^"_P#H.Q_]^9/_ (F@
M#JZ*Y3_A9_@O_H.Q_P#?F3_XFC_A9_@O_H.Q_P#?F3_XF@#JZ*Y3_A9_@O\
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MM,[W%SYMDWEO(S;CA"I  X 'M5Z[\9?#._EBEO)].N9(0!$\UDSE .@!*<4
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M $'8_P#OS)_\31_PL_P7_P!!V/\ [\R?_$T =717*?\ "S_!?_0=C_[\R?\
MQ-'_  L_P7_T'8_^_,G_ ,30!U=%<I_PL_P7_P!!V/\ [\R?_$T?\+/\%_\
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M&5MH4Y8(PPIQ@L<\XQO'XF>#1C.NP\\_ZM__ (FD_P"%F^#/^@[#_P!^W_\
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M49RS-D]?0#&]J]F3XHT"XAMNES,T\B)_T[NH+$?@!GV%5?\ A9O@S_H.P_\
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M@[#_ -^W_P#B:/\ A9O@S_H.P_\ ?M__ (F@#JJ*Y7_A9O@S_H.P_P#?M_\
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M *#L/_?M_P#XF@#JJ*Y7_A9O@S_H.P_]^W_^)H_X6;X,_P"@[#_W[?\ ^)H
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MF^#/^@[#_P!^W_\ B: .JHKE?^%F^#/^@[#_ -^W_P#B:/\ A9O@S_H.P_\
M?M__ (F@#JJ*Y7_A9O@S_H.P_P#?M_\ XFC_ (6;X,_Z#L/_ '[?_P")H ZJ
MBN5_X6;X,_Z#L/\ W[?_ .)H_P"%F^#/^@[#_P!^W_\ B: .JHKE?^%F^#/^
M@[#_ -^W_P#B:/\ A9O@S_H.P_\ ?M__ (F@#JJ*Y7_A9O@S_H.P_P#?M_\
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MPN;>;+YQB.9)"/Q"D4 8/B#Q5<V/B*73H-2L;""WMHY99;JSEG^9V<<E'4(
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M$7#+XCT_653:/]#B"^4>>N';K^'2IO$^IW&D:&]Y:[/-6>",;QD8>9$/Z,:
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MR&L?+\G:?^/KRO)\WZ>7\N*T+[0)KOP5_8*S(LOV1(/,(.W*@#/Z5L?:;?\
MY[Q_]]BC[3;_ //>/_OL4 8&K>%#>^*-.UNUN! 8)E>[BQQ<;58(?]Y=[#/H
M?85';Z)XATFUDTO2+ZQ6P+,8))XV,MLK$G: #A\9.,X[9SBNC^TV_P#SWC_[
M[%'VFW_Y[Q_]]B@"#2-,@T;2;73;8L8K6(1J6.2V.Y]SUJY47VFW_P">\?\
MWV*/M-O_ ,]X_P#OL4 <SX"Z>(_^P_=_S6NHE0R0N@."RD5RG@:2.(>(?,=4
MWZ[=,NXXR"5P1[5U/VFW_P">\?\ WV* ,2UTC6=*T'1K+3KRW,NG6Z0SQS*1
M'< (%^\ 64@C(_(CTST\*ZO9W5EJ%I=64E['-=3W E5Q&6FV\*!R -N.>O7O
M75_:;?\ Y[Q_]]BC[3;_ //>/_OL4 8FDZ+JFG2W]\\]FU[J-S')*D<3+"B*
M I"C.2Q4'YCWQQ@5?UFTU&Z@A?2[U;6Y@E$@$BEHY1@@HX!!P<]NA -7/M-O
M_P ]X_\ OL4?:;?_ )[Q_P#?8H Y9O!]SJAU:;59+2VFU*S%IML$.U<$D2,6
MP7;)]!@#'>K4>D:[J&I:=/K=S8>3ILIF1;1'S-)L9 6W?= #,<#//>M_[3;_
M //>/_OL4?:;?_GO'_WV* ,KP]X<MM%T^**2"VDND>1C.L0#'<[,.<9Z'%)I
M?ANWL[W4KNY@MIY;N]:XC<Q LBE5 &2/52?QK6^TV_\ SWC_ .^Q1]IM_P#G
MO'_WV* ,.ZTK6H?$MUJVER6!2YMHH&2Y#Y!1G.1M]=_Z54U7PKJ&IKJDIN;9
M+C4+6TCQAMBO"[.Q]=IW8'>NG^TV_P#SWC_[[%'VFW_Y[Q_]]B@#*AM_$$_F
M0WSZ?##)&R&2SWB5"1@%2>.*S'\/:]?S:<NJW&FRC3IDF2ZBB<3S%.@.>$S_
M !8)R,CO74?:;?\ Y[Q_]]BC[3;_ //>/_OL4 88T35['2=,CTS4(EN[-3YZ
M3*3#=%A\Y;'(.[+ ]LGCFLR7P=J4T=W=^;I\-_<WMK<^5%&P@7R'W#/=F;NV
M!V]*Z_[3;_\ />/_ +[%'VFW_P">\?\ WV* ,*[TW7]5TC4]-OFTR-+RRE@1
M[<295V4J"<]N34M[X>?[3IVH:;)';7UF521MN%N(3P\;8Z^H/8CW-;'VFW_Y
M[Q_]]BC[3;_\]X_^^Q0!AW/AEY_%D>JBX46>4FFMMO+SHK(CY]-K#\46F7OA
M1[Z?6)3=B%[V>WN+615R8)(57:2._P R]/2M_P"TV_\ SWC_ .^Q1]IM_P#G
MO'_WV* ,:"Q\17=]!-JE[:0P6ZM^XLM^)W*D N6Z*,DA1GG'/%5=!TKQ+HVF
M6&FEM(D@M(TB+@2;V50!GTSBNC^TV_\ SWC_ .^Q1]IM_P#GO'_WV* .8U3P
M_KU]:7VE-=Z?=Z?>,Y62\B9YK=7SP!T;;GY22,<>E=/;0"VM8K=69Q$@0,QR
M3@8R?>C[3;_\]X_^^Q1]IM_^>\?_ 'V* ):*B^TV_P#SWC_[[%'VFW_Y[Q_]
M]B@"6BHOM-O_ ,]X_P#OL4?:;?\ Y[Q_]]B@"6BHOM-O_P ]X_\ OL4?:;?_
M )[Q_P#?8H EHJ+[3;_\]X_^^Q1]IM_^>\?_ 'V* ):*B^TV_P#SWC_[[%'V
MFW_Y[Q_]]B@"6BHOM-O_ ,]X_P#OL4?:;?\ Y[Q_]]B@"6BHOM-O_P ]X_\
MOL4?:;?_ )[Q_P#?8H EHJ+[3;_\]X_^^Q1]IM_^>\?_ 'V* ):*B^TV_P#S
MWC_[[%'VFW_Y[Q_]]B@"6BHOM-O_ ,]X_P#OL4?:;?\ Y[Q_]]B@"6BHOM-O
M_P ]X_\ OL4?:;?_ )[Q_P#?8H EHJ+[3;_\]X_^^Q1]IM_^>\?_ 'V* .<\
M>?\ 'AI'_8:LO_1HKJ*Y3QS+'+8Z4(W5RNLV;':<X E&3]*Z;[3;_P#/>/\
M[[% $M<W]MUK6]3U"'2KNVL+73YOLYDEMS,\TNT,W&Y0JC<!W).>E;_VFW_Y
M[Q_]]BN9O=-U6SN]0E\.ZI8PIJ+B61;@\PR[0I=#@@@A1E2/7!&: $LO%-_<
M7VEV4\,,=PVHSV-\$!*[HX7D#)DY .$//8X]ZU&U>6/Q7-ITIC2TBTY;HL1@
MAM[*<GTPM8-KX>OX;&*=K^Q&L6VIR7PG+DQ7!=2A!7@H-C;<#.-HY-/NM!U#
M5AJ%Q?ZE80W-_!%9%+9F*16X<M)@GEF8,PZ #B@"UX8\2WVJO=1ZA#'"\D*W
MUDJJ06MG)"[LG[PV\]/O#BLO3?'6H77@B>^NH88-8@MXKCR\'RY(I"-DBC/3
M!(//#*:TV\+Z=9:I8:AHTT-K)!OBG5YV820LN"HR3@A@I'TK/U'P6EYX3TG3
MHM3@@U'3K>.W-PI^66,!0Z$==IV@CT(% &AJMQXDMO$5A86^K62PZ@\VS=8%
MC$J+N )\P;O3/%6(+S6+S5-4TF.\MHIK**U*7!MBP+.&+DIO'!V\#/'O5J_M
M$N]=TK4%NX%2Q,V]2W+;TVC%%E:):^(=4U)KN!DO4@54#<KL# Y^NZ@#$TV\
M\77^F7]W#J&GS36EU<01VYLR@F,4A7[WF';N"^G!/M5_2O$S^(]1MUTE MG#
M%YE^\J'='(1@0#T<');T 'K5S0;1-)MKJ*6[@D,]]<7(*MT$DC.!]0#2:'9Q
MZ4-0$EU _P!KOI;E=K= ^.#[\4 ;-<KH?_)1O%7_ %PL?_09:Z7[3;_\]X_^
M^Q7,:++&OQ"\42,ZA'AL=K$\-A9,X/>@#?UF[DL-$O[R';YMO;22IN&1E5)&
M?RK,U#6[NU\.Z7?QB/SKN>SCDRO&)716QSZ,<5J7HM+ZQN+.6=/+N(FB?#C.
M&&#_ #KFHM(U>X@TS3=2U'3#8Z=-#+YL&[S;CRB"@*GA>0"<$].,4 .T?Q==
MW.HZM8:A#'$\4US_ &?*H(69(F*LI_VUP"?4-[&GZ7KNK:N]C;1S6]O+=Z)#
M?&0PEPLK,,_+N&1C/&?QIMSX8BNM#O;,ZA#%=O?3WMI<HW,#NY9?KP2I'<$U
M8T/1?[*O-/GDOK=Q::/%8,%;[S(02P]N* &^'+GQ!?WUZ;W4[-X+&]>V:..R
M*-+A5(.[S#MY;I@]*ZBL?1;1-,DU-I+N!_MM\]RNUON@JHP??Y:T_M-O_P ]
MX_\ OL4 <U\.?^14/_7]=_\ H]ZZJN3^'LL</A?9*ZHWVVZ.&.#@S/BNG^TV
M_P#SWC_[[% &'::+JVE^'[2ST^^@6YMIWE82)F.=&=R4)ZK]X<CNO<51F\*Z
ML[)J"W-D=2;5!?R*RMY( @:$(.YX(.>YS75?:;?_ )[Q_P#?8H^TV_\ SWC_
M .^Q0!FVZ^(A!/Y_]EK+M'DF,2;<YYW9[8]*FU_2?[;T6XT\3>0\FUDEV[MC
MJP93COAE'%7/M-O_ ,]X_P#OL4?:;?\ Y[Q_]]B@##M])UJ\UNQU'6I[%5T]
M9##%9J_SNZ[2S%N@"YP!Z]:R]3\ R7_@FVT>.]2#4+6)XX[I5.TJ^0Z$=U*G
M\P#VKL/M-O\ \]X_^^Q1]IM_^>\?_?8H HZ7I4EAJ>K7;R*ZW\\<J*!RH6%(
M\'\4)_&CPWI4FB>'[/399%E>W3:74<'DG^M7OM-O_P ]X_\ OL4?:;?_ )[Q
M_P#?8H R;'PW;P:OJM_=06UP][<K-$6B!:,")$QDCU4GCUJ230UG\2RZG.(9
M8)+%;4PNF[D.S$\\8PV*TOM-O_SWC_[[%'VFW_Y[Q_\ ?8H YN+PK>0P6UB+
MU'LK'4TNK0/DND(!_=$]\$D*?3 [4]-%U_2_M=IHMY8K97,TDT9N8W,EJTA+
M/M X<;B2 <8SCFNA^TV__/>/_OL4?:;?_GO'_P!]B@#G#H.M6.KI>Z==VMU_
MQ+X;.1K\NTCM&SMO)7N=];]@+T6JC4!;B?)S]GW;,=NO-2?:;?\ Y[Q_]]BC
M[3;_ //>/_OL4 <S\1/^0)8?]A:T_P#1HKJZY'X@21RZ-8K$ZN1JEH2%.< 2
MC)KJ?M-O_P ]X_\ OL4 2T5%]IM_^>\?_?8H^TV__/>/_OL4 4O$.F/K/A^^
MTV*18WN86C5V' )J/4X-=^VK/I5U:F)HC&UO=*=JMG(D!7DGL5/!P.1SG1^T
MV_\ SWC_ .^Q1]IM_P#GO'_WV* ,'0O"G]B7UO(MP)H8--2S^9<,S*[,6] #
MNZ=JW&%T+R/881:[&W@@[]V1MQVQC.?PIWVFW_Y[Q_\ ?8H^TV__ #WC_P"^
MQ0!BWGA>WU7Q!+J6J 3Q) D-K$K,OE\DN201RQV_@HJC9^"FMI;>V::)],M;
MBY:& YR(9D(\OGT9F_#%=1]IM_\ GO'_ -]BC[3;_P#/>/\ [[% '+Z3X.NK
M(Z7)=WJ74]K<R2W$A4_O5,!@0?@NS/OGUIT.@>(K#2SH5AJ-DNG*ABAN)(V-
MQ!$> N,[6(' ;(Z#(-=-]IM_^>\?_?8H^TV__/>/_OL4 <\?#E]I%[;W7AV2
MU"QV,=B\%WNP4C)*,&7G(W,#QSGM26'A6YM9]-N9KN.6XAU">^NF5"JNTL;I
MM0<X WCJ>@KHOM-O_P ]X_\ OL4?:;?_ )[Q_P#?8H P-(\*?V/XJO=3M[@?
M8KB';':X_P!2Q?<^W_9)R<=B36CHFE2:4M\))%D^U7TMRNT?=#G(!]ZO?:;?
M_GO'_P!]BC[3;_\ />/_ +[% $M%1?:;?_GO'_WV*/M-O_SWC_[[% $M%1?:
M;?\ Y[Q_]]BGHZ2#*,&'J#F@!U%%% !1110 4444 %%%% !1110 4444 %17
M5K;WMM);7<$<\$@P\<JAE8>A!ZU+10!B?\(5X4_Z%K2?_ */_"L.YL?!L&O7
M&D1^$],F>TLFO+F1;2(+&/X5Z?>/)^E=O7G6A9?7?B))-_K]ZKSUV")MGZ4
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MZ51\!=/$?_8?N_YK5;XIZO-I_A%]/L@7O]7D6RMT4\MO^]^F1]6% &?X-N?
M/C62]CL?"FGPO:%<K-919=3G## Z<?RIFMS^#M.UE]&TWP);ZS?PH'GBM+"(
MB$'IN8CKR./>N;L)-4\'^+O#^I7_ (<?1+!X$TJX<W22B8]G.WH<@$^RUO>&
MM6L/"WQ \6VNO7<5C+>W"7-O+<,$66+YB &/'&X#'U]* -?PM:>!O%EA)<VG
MA?3X);>0Q7%M/81K)"X[$8K/\.WGP_\ $GB2_P!#M/"VG)+9[BLCV<6V8*VT
ME>/7%2:E\1;!_ VN:QI-K+!Y<S6MM,4"BYE;@.G<XSNY':N'6#7?!:>&]8NO
M"\NG0Z,QBO+O[4DGVA)6^;*KR/O-CKU% '97M[X$L/'4/A2;PA8">9D47'V.
M+8"RY4=,^U$EYX$7Q\GA!?"%@]RQVF<6<7E@^7OQTSTKF?&\#7/C+Q%J=F0\
MVFVEG?V[#D91DY_[Y)--\-![WQEX6\0S(5EUK4M1N0#U5 BJJ_A@T =UXLL/
M!OA+1&U6Y\):=<()%CV16<6XEOJ*R+'4?!KZO:Z9J_P^719;QMEO)>:;$(Y&
M_N[@.O(_.M#XS$#P$Q)P!=P_SK+^(VNZ5XG30]%T&_@U"_DU2*1?LSB3RU4-
MEB1TZC\CZ4 =H?!GA-<;O#FD#)P,V<?/Z4I\%^$U!)\-Z2 .I-G'_A7GEW!X
M?UCQMXI7QS>")K,*NGI-.8Q'%@G=&,C+?=..>3T.:SI3?ZQ\//"O]J:G;)<&
M>4PVVJ&18;Y <+O8="!TR1D'K0!ZH/!?A-@"/#>DD'H19Q_X4+X,\)L,KX;T
M@CVLX_\ "O)VU>:V^&WB2QTJQ?3I;2[B6Z-K=F>$*Y.[RVR=HXP0">#6EX;M
M8M/\0W2:9J.EZ;9R:1(US#IMY-=$#!VS\IC<..,Y_/D ]%'@SPD6*CPYI!(Z
MC[''Q^E._P"$*\*?]"UI/_@%'_A7D?A1K70O$.@22VVGW_VJX\F#4=+O76:0
MN<9FC8Y(YYR!7N] &)_PA7A3_H6M)_\  */_  H_X0KPI_T+6D_^ 4?^%;=%
M &)_PA7A3_H6M)_\ H_\*/\ A"O"G_0M:3_X!1_X5MT4 8G_  A7A3_H6M)_
M\ H_\*/^$*\*?]"UI/\ X!1_X5MT4 8G_"%>%/\ H6M)_P# */\ PH_X0KPI
M_P!"UI/_ (!1_P"%;=% &)_PA7A3_H6M)_\  */_  H_X0KPI_T+6D_^ 4?^
M%;=% &)_PA7A3_H6M)_\ H_\*/\ A"O"G_0M:3_X!1_X5MT4 8G_  A7A3_H
M6M)_\ H_\*/^$*\*?]"UI/\ X!1_X5MT4 8G_"%>%/\ H6M)_P# */\ PH_X
M0KPI_P!"UI/_ (!1_P"%;=% &)_PA7A3_H6M)_\  */_  H_X0KPI_T+6D_^
M 4?^%;=% &)_PA7A3_H6M)_\ H_\*/\ A"O"G_0M:3_X!1_X5MT4 8G_  A7
MA3_H6M)_\ H_\*/^$*\*?]"UI/\ X!1_X5MT4 8G_"%>%/\ H6M)_P# */\
MPH_X0KPI_P!"UI/_ (!1_P"%;=% &)_PA7A3_H6M)_\  */_  H_X0KPI_T+
M6D_^ 4?^%;=% &)_PA7A3_H6M)_\ H_\*/\ A"O"G_0M:3_X!1_X5MT4 8G_
M  A7A3_H6M)_\ H_\*/^$*\*?]"UI/\ X!1_X5MT4 8G_"%>%/\ H6M)_P#
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MB'=ALJI#'Y1\H.?F'%<Q+K>I:A\*/$VFWMY%J%OIJ62V]Y$@4,&9"8SC@E.
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M#VB6-X;VTTBQM[ELYFBMT5^>O(&:T:** "BBB@ HHHH **** "BBB@ HHHH
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M HHHH Y7X<_\BH?^OZ[_ /1[UU5<K\.?^14/_7]=_P#H]ZZJ@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH Y3XB?\@2P_P"PM:?^C175URGQ$_Y EA_V
M%K3_ -&BNKH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&7_0BC_P;Q?_ !- '5T5RG_"0>,O^A%'_@WB_P#B:/\ A(/&7_0BC_P;Q?\
MQ- '5T5RG_"0>,O^A%'_ (-XO_B:/^$@\9?]"*/_  ;Q?_$T =717*?\)!XR
M_P"A%'_@WB_^)H_X2#QE_P!"*/\ P;Q?_$T =717*?\ "0>,O^A%'_@WB_\
MB:/^$@\9?]"*/_!O%_\ $T =717*?\)!XR_Z$4?^#>+_ .)H_P"$@\9?]"*/
M_!O%_P#$T =717*?\)!XR_Z$4?\ @WB_^)H_X2#QE_T(H_\ !O%_\30!U=%<
MI_PD'C+_ *$4?^#>+_XFC_A(/&7_ $(H_P#!O%_\30!U=%<I_P )!XR_Z$4?
M^#>+_P")H_X2#QE_T(H_\&\7_P 30!U=%<I_PD'C+_H11_X-XO\ XF@>(/&6
M1GP, /\ L+Q?_$T =717*'Q!XR!./ P(]?[7B_\ B:/^$@\9?]"*/_!O%_\
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M_P"$@\9?]"*/_!O%_P#$T =717*?\)!XR_Z$4?\ @WB_^)H_X2#QE_T(H_\
M!O%_\30!U=<KH?\ R4;Q5_UPL?\ T&6D_P"$@\9?]"*/_!O%_P#$UE6,OC*R
M\1ZKK'_"'*_]I1P)Y7]J1#R_+##KCG.[T&,4 >@45RG_  D'C+_H11_X-XO_
M (FC_A(/&7_0BC_P;Q?_ !- '5T5RG_"0>,O^A%'_@WB_P#B:/\ A(/&7_0B
MC_P;Q?\ Q- '5T5RG_"0>,O^A%'_ (-XO_B:/^$@\9?]"*/_  ;Q?_$T +\.
M?^14/_7]=_\ H]ZZJN \.R^,O#^D_8!X.6Y_?RR[_P"TXD^_(SXQ@],UJ?\
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M2,,=RNX [1D!@#^)R^[\,0SW\U[9ZC?Z9+<X-Q]CD4+*0, E65@#@ 9&#P*
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MM&5,9U*^>5&R>@4RN,^^*E;P?8365]!=W-Y=S:A&(I[J:13*4!R%& %4 DG
M ZUOT <O<PMK_B^\TR[N;F*QT^UAD$$$[P^<\A?+,R$,0 @ &<9)JM>Q75G+
MIOAR+6KF2&]OI%>;S/W\,2Q&3R?,SNR2!\Q^;:?QK<U/0(=1O8[^*\N["\CC
M,7VBT=0S)G.U@RLK#/(R..<=:@'A'3!I9L2UP7-Q]J-V93Y_G_\ /3?_ 'L<
M>F.,8XH R-2A?PSJMM;Z?=W9MM1M[E)()KEYO+=(BZR(SDLO0@\XY'>L.WUW
M5+3P1#IVHWLQOI(;.ZM+S>0]Q"\L6X%NI92Q4^JE3W-=I;>%[:.:6XN[V]U"
MY>!H%GNG4M$C?>"A551G R<9.!S3;[PAI6HZ/IVEW"R&+33$;:0,!(OE@ <X
M[@<\<_E0!DZKHD'_  F>EVPO=56&]ANI9HTU2X4%E,>W #_*!N;@8'-9%W>6
MEGJ7B&348O$5Q!9721QRV=_,L<*>3$<'$J@<DDDCODFN^GTR"XU6TU)R_G6<
M<L<8!^4B3;NR/^ "FVVD6MK+J#@-(-1E\V=9,%2=BI@#'3"CCZT <=JNHWEG
MX5T+1M7UK[#?:B?](O5GPT<2#<2''5C\B9'7<34L/B*X\0:#X=@BO&@DU&Z:
MUOKBW?# QQNSA6_AW&/@CG#<5T.C^%['1)TFMYKF4Q6_V6$3R!A%%O+;5XSW
M YSPJCM3;GPIIMR;TLTZ&\N$NLQR;3#,JA1)&0/E; &>N?Q- #M.T6+1]4)M
M=1N?L\T)!LKBX>;+ CYU9V+#@X('!R.G?9K(TWP]#87[:A->WFH7AC\I9[MU
M)C3.2JA551D@9XR<#FM>@#R_X]NR^$; !B ;]<@'K\CUSWP\^,,EEY6D>)Y6
MEM^%BOCRT?L_J/?J.^>V_P#'S_D4M/\ ^O\ '_HMZ\%H ^R8I8YX4FAD62.1
M0R.AR&!Z$'N*?7S5X ^)>I>$)TLYP][I3M\UOG+1Y[Q^GTZ'VZU])HP=%< @
M,,X(P: '4A(! )&3T'K2UY/K2Q+XLF'B34-0TNX>YG^Q:AYDBP11;5\G80=@
MP<[@>I//6@#UBBN:U?2&N9WO]7UV>#2K:U&U;:X>V&_DM*[(1GC&!G YXJ;P
M1<7]UX4M9]1>:21RYBDG&)'BWGRV?W*;30!OT5YW*+_5?#^N^*%U6^@N[*>Y
M-E''.RPQI 2 K1_=;=L.<@]?:K\$DOC'Q!+#->7EI96FG6TZQ6EPT):68,VX
MLI!.T* !TH [6BN)TI9=<\++<:IKNH6;Z3+<P7%Q:SB+S1&Y7>_!S\J@_B?6
MK?@"VU#^RI=4OK^^N(]0826L-Y+O:&'G9D_WF!W'Z@=J .KHKCO'VL7J:3J&
MF:-,8KN&PEN[JX0\VT2JQ ![.Y&!Z#<>PJEKVMR1P>%]+EN;Y8]0MS+<?8MQ
MN)]B)B-2.1N+9)!'"GD4 =]17G4NI36W@G7WTO5[Y'M94'D:B=ES8J2N]-[D
M[B5R4)[D $U;\(:A'-XLNK33+O47TY;%))(=3DD,HF+<,@E^?;MSD_=SC% '
M=45C>(M/DOH87?4KFTL+??+=QVF\2SJ%X4,GS 9Y(7D]*XE/%%Q:>#]1>#4[
ME+=]76RM;BY)DN;:%BNXL#ELCYRH;YNGM0!Z?17GMGJ\&BMJUQ;7>LQM:Z7)
M<_V;K D9I2O(E1W8D#^$@>HX&*A\/WT+7^BW#ZQKD=U=L/,N;Q'-GJ#%23&B
MDA4YY4@#@<9S0!Z117/^-+ZZL]&A@LIFMY]0O8+-9E^]$)'"LP]\9Q[UAZC=
MS^"=4N8[:[N[NTETBYNTBO+AIBDT.#D,Q) 8-R,XR* .\HK@EAO?#\/AS5O[
M5OKJ?4+J&WOTN+AGCE\Y3RJ'A-K8QM XXYKO: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***0G R: %HIN]/[P_.C>G]X?G0 ZBF[T_O#\Z-
MZ?WA^= #J*;O3^\/SHWI_>'YT .HIN]/[P_.C>G]X?G0 ZBF[T_O#\Z-Z?WA
M^= #J*;O3^\/SHWI_>'YT .HIN]/[P_.C>G]X?G0 ZBF[T_O#\Z-Z?WA^= #
MJ*;O3^\/SHWI_>'YT .HIN]/[P_.C>G]X?G0 ZBF[T_O#\Z-Z?WA^= #J*;O
M3^\/SHWI_>'YT .HIN]/[P_.C>G]X?G0 ZBF[T_O#\Z-Z?WA^= #J*;O3^\/
MSHWI_>'YT .HIN]/[P_.C>G]X?G0 ZBF[T_O#\Z-Z?WA^= #J*;O3^\/SHWI
M_>'YT .HIN]/[P_.C>G]X?G0 ZBF[T_O#\Z-Z?WA^= #J*;O3^\/SHWI_>'Y
MT .HIN]/[P_.C>G]X?G0 ZBF[T_O#\Z-Z?WA^= #J*;O3^\/SHWI_>'YT .H
MIN]/[P_.C>G]X?G0 ZBF[T_O#\Z-Z?WA^= #J*;O3^\/SHWI_>'YT .HIN]/
M[P_.C>G]X?G0 ZBF[T_O#\Z-Z?WA^= #J*;O3^\/SHWI_>'YT .HIN]/[P_.
MC>G]X?G0 ZBF[T_O#\Z-Z?WA^= #J*;O3^\/SHWI_>'YT .HIN]/[P_.C>G]
MX?G0 ZBF[T_O#\Z-Z?WA^= #J*;O3^\/SHWI_>'YT .HIN]/[P_.C>G]X?G0
M ZBF[T_O#\Z-Z?WA^= #J*;O3^\/SHWI_>'YT .HIN]/[P_.C>G]X?G0 ZBF
M[T_O#\Z-Z?WA^= #J*;O3^\/SHWI_>'YT .HIN]/[P_.C>G]X?G0 ZBF[T_O
M#\Z-Z?WA^= #J*;O3^\/SHWI_>'YT >7_'S_ )%+3_\ K_'_ *+>O#;#3[O5
M+V*RL+>2XN)FVI'&,DG_ #WKZ1^)?A&Z\::%;6-A=6\$L-TLI,Y(4KM8'H#S
MS5KP7X&T?P79;+7;/>2+B>[<#<_L/[J^WYYH P?A[\*+3PT(]3U@1W>J_>5>
ML=N?;U;W_+U/H]-WI_>'YT;T_O#\Z '5P&N:1XMN-1EL$2TO[2Z^TB"ZG=A]
MGCE4 HZA2#MYV\\]\5WN]/[P_.C>G]X?G0!PFJ>&?$3WFFVL,%AJ.CZ7;1QP
MV]U=/&)95 'F2 (=V,< G'>NA_M#784TQ;NPM5GN;HQ7"02O(L<>UCN!VCT'
M7 K:WI_>'YT;T_O#\Z .+NO#?B"*QU?0; 6?]FZK-*XNY)6$ELDIS(OE[<,>
M6VG<.O/2KLVBZKHNM'4?#]O:W,4]G%:S6]Q.8MICSY;A@K9X8@C [8KI]Z?W
MA^=&]/[P_.@#D+CPE?I\/I- AGCEO+R7==R@[5;S)=\V/;:6 _"M_7+JYTK0
M+BXTVVCFG@0>3 0<.<@!1CG/8>^*T-Z?WA^=&]/[P_.@#E/$?@&QU6VU>XM9
M+N+4-0@<<7LJ1/)LVKN4'!'0$8/%,;PG>:=:Z#=:44GOM'5U,5W.Y699% D4
M2$$CD KQ@8QC%==O3^\/SHWI_>'YT <5<>$-6U.+4=2N9+2WU2ZN[:YAMU9I
M($$!RB.V 6SSD@=QCI6A:Z;K5[XDBUW5;>TLOL5I)!!!!.93(SE26=MJ_*-H
MP,'J372[T_O#\Z-Z?WA^= '."?Q-?Z7I&K6:6\=P%+7>G2L8TF5AQARI92.H
MR.YS6;-X-U/4X-5U"[DM;;5;VZM[JWB0F2&%H,; QP"V>0QQWXZ5VN]/[P_.
MC>G]X?G0!R4GAW5/$>HR77B""VLH5T^:RC@MIS*6\W =RQ5<# &!CWJ.#0?$
M-Y'HNF:I'816>CSQ3&Y@E9GN3$,( A4;.Q/)]J['>G]X?G1O3^\/SH P-:TG
M5-=TFY@D-K;75O>I<:=(K,R_NV5D+\<$D$''0&J?_"/:EK^HW%[X@AM[1&TZ
M2PBM[>8RX$G^L<L57L  ,>M=7O3^\/SHWI_>'YT <?;:#X@O3HMCK"V26>C2
MI,9X)69[MXU*QG:5&P<Y/)Y'%=E3=Z?WA^=&]/[P_.@!U%-WI_>'YT;T_O#\
MZ '44W>G]X?G2@@\@@T +1110 4444 %%%% !1110 4444 %%%% !5>^L;74
MK*6RO85FMYEVR1MT8>E6** .7_X5IX,_Z%ZU_P#'O\:/^%:>#/\ H7K7_P >
M_P :ZBB@#E_^%:>#/^A>M?\ Q[_&C_A6G@S_ *%ZU_\ 'O\ &NHHH Y?_A6G
M@S_H7K7_ ,>_QH_X5IX,_P"A>M?_ ![_ !KJ** .7_X5IX,_Z%ZU_P#'O\:/
M^%:>#/\ H7K7_P >_P :ZBB@#E_^%:>#/^A>M?\ Q[_&C_A6G@S_ *%ZU_\
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M%ZU_\>_QKJ** .7_ .%:>#/^A>M?_'O\:/\ A6G@S_H7K7_Q[_&NHHH Y?\
MX5IX,_Z%ZU_\>_QH_P"%:>#/^A>M?_'O\:ZBB@#E_P#A6G@S_H7K7_Q[_&C_
M (5IX,_Z%ZU_\>_QKJ** .7_ .%:>#/^A>M?_'O\:/\ A6G@S_H7K7_Q[_&N
MHHH Y?\ X5IX,_Z%ZU_\>_QH_P"%:>#/^A>M?_'O\:ZBB@#E_P#A6G@S_H7K
M7_Q[_&C_ (5IX,_Z%ZU_\>_QKJ** .7_ .%:>#/^A>M?_'O\:/\ A6G@S_H7
MK7_Q[_&NHHH Y?\ X5IX,_Z%ZU_\>_QH_P"%:>#/^A>M?_'O\:ZBB@#E_P#A
M6G@S_H7K7_Q[_&C_ (5IX,_Z%ZU_\>_QKJ** .7_ .%:>#/^A>M?_'O\:/\
MA6G@S_H7K7_Q[_&NHHH Y?\ X5IX,_Z%ZU_\>_QH_P"%:>#/^A>M?_'O\:ZB
MB@#E_P#A6G@S_H7K7_Q[_&D/PV\%JI9O#]H !DD[N/UKJ:0@,"K $'@@]Z /
M-='T[X9ZW>:M%9Z';-;:2BO+=\^6X(8DKSR!M//?M3O#VA^"/$-P(T\$3VD4
ML/VBWN+B(B.:/.,@AC@]\'!QS6@?#EW<:YXTMXK;[/;:EIL-M:R;=L9/E.I
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M7_X5IX,_Z%ZU_P#'O\:/^%:>#/\ H7K7_P >_P :ZBB@#E_^%:>#/^A>M?\
MQ[_&C_A6G@S_ *%ZU_\ 'O\ &NHHH Y?_A6G@S_H7K7_ ,>_QH_X5IX,_P"A
M>M?_ ![_ !KJ** .7_X5IX,_Z%ZU_P#'O\:/^%:>#/\ H7K7_P >_P :ZBB@
M#E_^%:>#/^A>M?\ Q[_&C_A6G@S_ *%ZU_\ 'O\ &NHHH Y?_A6G@S_H7K7_
M ,>_QH_X5IX,_P"A>M?_ ![_ !KJ** .7_X5IX,_Z%ZU_P#'O\:/^%:>#/\
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MXT?\*T\&?]"]:_\ CW^-=110!R__  K3P9_T+UK_ ./?XT?\*T\&?]"]:_\
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MT.GB#_O[%_\ &Z/^$,OO^AT\0?\ ?V+_ .-UU5% '*_\(9??]#IX@_[^Q?\
MQNC_ (0R^_Z'3Q!_W]B_^-UU5% '*_\ "&7W_0Z>(/\ O[%_\;H_X0R^_P"A
MT\0?]_8O_C==510!RO\ PAE]_P!#IX@_[^Q?_&Z/^$,OO^AT\0?]_8O_ (W7
M544 <K_PAE]_T.GB#_O[%_\ &Z/^$,OO^AT\0?\ ?V+_ .-UU5% '*_\(9??
M]#IX@_[^Q?\ QNC_ (0R^_Z'3Q!_W]B_^-UU5% '*_\ "&7W_0Z>(/\ O[%_
M\;H_X0R^_P"AT\0?]_8O_C==510!RO\ PAE]_P!#IX@_[^Q?_&Z/^$,OO^AT
M\0?]_8O_ (W7544 >>:-H^JZIK.MV4OB[6T33;E(8V22/+ QJV3E.N35[4]
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M,T/VVV,T5W8R8,UQ(S,3A#R^_.1C(.ZNVM2#:0E8# #&N(F !CX^Z<<<=.*
M.$TC2-4U/5]:T^3Q;K4::9<I%&Z21[G#1*WS93U)Z5;U/0#H]I]KO_'7B"&'
M>J;MT;$LQP  (R3DU;\+?\C7XM_Z_H?_ $0E2^.9X;;2]/GN)4BABU:S=Y)&
M"JBB9222>@% &-8V-KJ7GBU^(.O,UNGF2QLR(ZK_ 'MK1 X]\5!9K8:A-#%:
M^/O$LC3D",^5A6STY,.,>]7=8U*PUW7K671;J&]%E979NY[9PZ(C1@*A8<9+
M8.,_PDU#X-UFW&F:) _C?2Y";>&/[ /)$F2@ C^]G=GCIG- $<L%A!?-9R?$
M/7ED201.V4\M'Z;3)Y6T'/&":FU+38-)G6WO/'OB%9F7>(H]DKA?[Q5(B0/<
M\5GWVHV=A8ZH=.U>#'VB5IO#FJ0H[RRER61 #O\ G/*_>'(_#=L-3L=%\4ZZ
M=:N8;"6]>&>"2YD""2$1*NU6/!VL'R/?/>@#.N+6RM8+2=_B%KSQWJLUNT)2
M7S N,D;8CTR*6&SLY[&>]C^(6NF&V=4F)=%:-F("AE,61G([4LLO]JZYX=FT
M #2HY5U!XGEM01(-R9<)D<.?F!.#SGO6?>^<FD^)DU:8OKGFV@GPH6-X1*/*
M>,#^$Y;.<D'()X% %J[33[&[GM;GXA>(4DMFVS?*"L9P#RPBP."#U[T7J:?I
MTB)<_$+Q"OF!2C(H=7W#*X98B#G/8U>TVUURZU?Q/'INHV5I ^I;7\ZS::0'
MR(LD'S%'3'!!JQK>F0Z-X=\/:9 S-%::E8Q*S]2%D49- %2STB._DABMO'GB
M%I)XWEC1BB%D1@K'#1#&"P_.JL,>G3W:6T?Q%UTM))Y<;[D$3OTVK(8MA.>P
M-:'BRWNKSQ$UM8DBZF\/7Z0X./G+0@<]N:JZMK>A:A\/GTC3Y8I+V>T%K;:<
MA GCFQA5,?52K $DCC&: +-OH'VK4+O3X/'NNO=66S[1$)8MT>X;ES^[[BGV
M?AF74+9;FT\<Z_+"S,H821#)4E3UC]016>+"\@\1:]KM@AFU+3KJ$2QI_P O
M<)M8?,C^O&Y?]H#U-;OP^G2Y\%V=Q$24EDG=<C!P9G(H A_X0R^_Z'3Q!_W]
MB_\ C='_  AE]_T.GB#_ +^Q?_&ZZJB@#E?^$,OO^AT\0?\ ?V+_ .-T?\(9
M??\ 0Z>(/^_L7_QNNJHH Y7_ (0R^_Z'3Q!_W]B_^-T?\(9??]#IX@_[^Q?_
M !NNJHH Y7_A#+[_ *'3Q!_W]B_^-T?\(9??]#IX@_[^Q?\ QNNJHH Y7_A#
M+[_H=/$'_?V+_P"-T?\ "&7W_0Z>(/\ O[%_\;KJJ* .5_X0R^_Z'3Q!_P!_
M8O\ XW1_PAE]_P!#IX@_[^Q?_&ZZJB@#E?\ A#+[_H=/$'_?V+_XW1_PAE]_
MT.GB#_O[%_\ &ZZJB@#E?^$,OO\ H=/$'_?V+_XW1_PAE]_T.GB#_O[%_P#&
MZZJB@#E?^$,OO^AT\0?]_8O_ (W1_P (9??]#IX@_P"_L7_QNNJHH Y7_A#+
M[_H=/$'_ ']B_P#C='_"&7W_ $.GB#_O[%_\;KJJ* .5_P"$,OO^AT\0?]_8
MO_C='_"&7W_0Z>(/^_L7_P ;KJJ* .5_X0R^_P"AT\0?]_8O_C=8U_HVJVGB
MW2='3Q?KC0W\,\CN98]RF/;C'R8_B->AURFL_P#)2_#7_7K>_P HZ !_!UY&
MC.WC7Q %49)\V+@?]^ZQ+/\ LR_F@BM_B)KY:Y($)DVQK(3T"EH@"3V]:[^]
M_P"/&?\ ZY-_*N*\-Z%JVL>#_#T5]J=H--C@M9UA@LV65@@5T5I#(1U R0HS
M[4 3R:"(M5ATN3Q[KJWL\9DCA,L664=3_J_K^1]*AU+2XM(ECAO/'OB!9I5+
M)#&4ED*CJ=J1$X]\8K.O3K&H?;_%MCIT,\<%VL]I-]I(D,%ON0JJ;#D.#,?O
M#/F#TK6M]9LK'Q%J][<7UK:'5K:";3+N[.(9(Q']W=D=')8KD'#9H JRVUE#
MID&I-\0]>:UN)?)C>-D<L^"2NT1$@C:V01QBI=/TN+4TG>U\=^(BMNH:1I L
M04<\Y>(>AK)NM7>YM[.[DOM,L8D\1#;JEO#LMYLVCYD^=L-R2F<XXK7U34XK
MSPIJ,4?B>QUK<\"3?93&/*A:55DR$8\%2W7TH @N[6TLA 9_'_B(-<1":-$5
M7?RST8JL1*CW(%7(=!%R+0P>/M<D6]0O;LLL160 9.#Y>,X.<=>#Z&G:Y<6-
MKXIEDCU__A'M0-K&IDNTC-M=Q@L0!N(R5).<%3SW%0+>/=^#M%O$M8+:==7A
M$(MD*1R9N"C.@/(5T9V^C&@#0_X0R^_Z'3Q!_P!_8O\ XW6WI&FRZ79FWEU*
M[U!BY;SKME+\XX^4 8X_6K]% !1110 4444 %%%% !1110 4444 %%%% !5>
M_N9+.QEN(K66[>-<K!%C>_L,D"K%% '*_P#"7ZK_ -"3K7YP_P#Q=5(M=OH=
M2N+Y/!.MA[D)YB9@VEE! ?[_ -[&!GT ]*[6B@#D9_%6JS0N@\&:W&Y4A9%\
MC<A(QD9?K3+'Q%?:=8P65KX&UI(8$"(N83P!Z[^378T4 <K_ ,)?JO\ T).M
M?G#_ /%UDZKJFM:EKFB7Z>$-6C339Y)'5_*RP:-D&,/ZFO0** .5_P"$OU7_
M *$G6OSA_P#BZ8OBG4$D:1? NKJ[?>8" $_4[ZZVO+--UF]N-"MKJPUK6KO7
M'D&+4P,]NY\S!#$Q[0NW.3NX]: .E/B>^))/@/5B3U)$'_Q=+)XIU"8 2^!=
M7< Y 80'!_[[JEXF\52:?XD+Q:C%#::,(C>6Y=0;CS3AA@\G8F'X]:=XBU5(
M/%TT-WJ6KVUC%ID,X_LZ)W4$R2AF8HC8&%7DXZ4 7O\ A+]5_P"A)UK\X?\
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M44"6\BA$!@C8\,IS\S$T .'BW5 21X(UD$\G_4\_^/TO_"7ZK_T).M?G#_\
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M2&#,BX;=M  )SDTW1/%;W7BP22:E%+8:K+-!:VXD4F$Q8"-CJ/,"R'G_ &:
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M!/K>D6LS0W&J64,J<,DEPBL/J":I^)-9>P\+SZEILD4LC;$@DSN3<[J@;CJ
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M$:SD#&?W/_Q=-'BK41*91X%U@2$8+X@R1]=]4O"?BB6_U[%SJ,<\&LQ27%G
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MW?E.R,2&E!/W21C/%71X2\%1:-=ZKJ'@Q]/BM4,A2=E+2 #/R[)&'/3!(YH
MV[CP=_:%O?\ ]J:K/=W-[:-9B;RU00QMR0B@8R3@DG/05KZEI,>I?8=\K)]B
MNDN5VC[Q4$8/MS7'0^$/!5WH4.JV'@Y[SS3@VT;!94()#!MT@7*D$'GK6;!I
M?@:72+G5Y/ =U!8VZ.S32&/YBC[&4 2DYR#U&..M '6VGA?4].A:WL/$MQ!;
MF6258_LL3;2[LY&2,GEC4DWAJ]_M2_O++Q!<V2:@Z/+'%!$Q!6-4R&93CA!7
M/7_A/P5;ZB^G6/@UM3NXD$DR6S!1"ISMW,[J,G!P,Y_"J=UIOPSLM,MM0N?#
MOE137OV&575@]M+AB?,&[@ +DD9X((R.: .ND\)6\5KIT>EWDVGSZ8KK!.H$
MA*OC>'###;B 3WR,U#+X-$UA<))JEP]]<W<-W)>LB;M\14H N-H4;1Q]>M9Q
M\#^ QK<>D_\ ".PF:2U:Y#@MLVAE7&=V<Y8=JS!X?\"SI:K8>#GOKFZ@^T);
MPD K$20KLS.% ;''.3Z<&@#J+KPWJ-]9B&[\0SRR1W$5Q!+]FB4Q,A)Z 8.>
M.OI5_3=/U.TG9[W6Y+^,K@1O;QQA3D<Y4 __ *ZXO_A'_AX-,%VWA=EG-Q]D
M%D4;SS-UV8W8SCG.=N.<XIUOX9\#FXEM;_P<^G720-<)%.0WG(OWBC([*2,C
M(SD9]* /1:*\WM="^&][X7C\0V_AY'MG=(S'R)$9G5-K#=P06&>>G(SQ4,^@
M>$H-5733\.+Y[B1'DC"O#AT0@%@3-TRR]<'F@#TZBO-3X<\(/>7EM:_#Z[N_
ML4@CF>)X@%8HKX :8$X##H*DN?#_ ,.;?PQ%X@3PX)[>;:(XHU;S78G&T*6'
M(.<\]C0!Z-17!WOA'X>V6EV^H?V!%/'=E%MD@#,\[.,J%&[J1SS@  DU4B\+
M^#WDFM9? =Q#?1Q><EHS(6G3< 2C"79P2,@L"* /1Z*\VT?PUX/UF\DMT\ 7
M-ND,S0S33/'LB=1D@[923U X!ZU+J7A7P98ZP-+M_!$VH7'V<7#?9F0!5+%1
MDO(O.0>E 'HE%>=W'A;P5;QVD;>"I6U"\#-'IZE3*%4X+,?,V*O(YW=QWXJ"
M30_ %OI]_<77A%[>YTX(T]D_^MPQPI4A]K G/(;'!H ]+HKSF'PQX+_M"ULM
M0\#3Z:UXQ2"2X9&1W"EMN8Y6P< GG&<4W1]"^'&L^&9]?B\.K#:VX<RI-D.F
MT;N@8CE2".>A% 'I%%</HO@?P+KFCVVIV_AN.**Y3>J2[@Z^Q 8\U>_X5EX+
M_P"A?MOS;_&@#JJ*Y7_A67@O_H7[;\V_QH_X5EX+_P"A?MOS;_&@#JJ*Y7_A
M67@O_H7[;\V_QH_X5EX+_P"A?MOS;_&@#JJ*Y7_A67@O_H7[;\V_QH_X5EX+
M_P"A?MOS;_&@#JJ*Y;_A6G@S;M_L"WQZ9;_'WJO>_#_P#IUG)>7FC6<$$0R\
MCNP _7UXH [&BN'T;P1X#US2H=2M?#D20S[MHEW*W#%>1NXZ5>_X5EX+_P"A
M?MOS;_&@#JJ*Y7_A67@O_H7[;\V_QH_X5EX+_P"A?MOS;_&@#JJ*Y7_A67@O
M_H7[;\V_QH_X5EX+_P"A?MOS;_&@#JJ*Y7_A67@O_H7[;\V_QH_X5EX+_P"A
M?MOS;_&@!&_Y*]'_ -@!O_2A:ZNO-&\"^%_^%D)I/]C0?8CI#7'DY;'F><J[
MNN>G%=#_ ,*R\%_]"_;?FW^- '545RI^&7@O'_(OVW_?3?XUA)X?^'DEE',O
MAD?:7NC:"QY\\3 \J1OQP/F)SC;SF@#T>BN5_P"%9>"_^A?MOS;_ !H_X5EX
M+_Z%^V_-O\: .JJCK6EQZWHMYI<LC1I=PM$SJ.5!&,BN#L? OAB7Q]JNF/H\
M!LX+&WDCBRV%9F?)ZY["N@_X5EX+_P"A?MOS;_&@#HKVV>ZT^>UCG:!I8FC$
MJ#YDR,;A[BLFX\(:9)H]MI]M$EHUH8FM[B*-?,1HR"ISWZ8/KDU3_P"%9>"_
M^A?MOS;_ !JE:^!O EWJ=]IZ>'(A+8^7YC,6VG>NX8^;TH WX_#5E_9.HZ9<
M;KBWU&>::4-Q@R,6('T)X/M2RZ";G2M.LKJ^EG>QGAF\]@-TIC8$;OKCDUF?
M\*R\%_\ 0OVWYM_C1_PK+P7_ -"_;?FW^- '3RQB6%XR<!U*Y^M9&C^&H-'G
MM98KB20VVFQ:>H8#E4)(;ZG-<CH'@;PQ>Z_XBL[G1X)(+*[C6W0EL1@PH2!S
MZUIZIX%\ Z/8/>W>@P"-2%"H'9G9CA54 \DD@ 4 =<]G:R.7DMH78]6:,$FH
M[_3+34M+FTVXB'V:9"C*ORX'MCH1U!KA[/PKX*EOULK_ ,%OI<LL;20FZ8%9
M%7[WS)(P! .2#BJG]C> Q;#46\$W"Z0W(U$@>7M_O[?,WA.^[;TYZ<T =?!X
M:N6O+2;4];NM1CL7\RWBDC1!OP0&<J!N(!..@SSBHCX2FBBFLK'7+RSTR9F+
M6D:(3&&.66-R,J#D\<XSQBL.V\+_  ZN?$MSX?70(5O+>)91NW;95(!^4[N<
M9&?J*HWNC>!K32IM43P/<7-G;M.LTL13]WY3LC$AI03RI(QGC\J .YM/#]E9
M7YN(%VQ?88[%;?&46-"Q'_H>/PJII/A"ST;0]2T>VGF-O?O(PWG)B5T"!1[*
M ,9KE)O#OA"W2U$WP]NTN+R<PP6Y>+>Y"%R<^=M PIZG/M5O3/"/@C4-0FTZ
M?P@^GWD40F\FZQED)(W*4=@1D8ZYH ZJ;0(9K'2[0S.%TR6*5& &7,8P ?K5
M;6?"D6JW<]S#>S63W=HUI=>2!^^C/3.>C#+ 'T8USVA^%?A[K[7BVGAZ-39S
M&-O,W#>.0'7#<J2&P?8U2_L;P&8/MR>"YWTD-M.HJ!Y6,XWA=^\I_M!<=^G-
M ':WGAC3YQ9-;0QV4MC<)-#)!&H(V\%3Z@J2#]:I2^$)/)N+&TUN[M-,NG=I
M+2-$.T.275'(RH))XYQDXQ7,7WA[PA8ZI'IY^'EY+).[K T;Q;9@@R2,S @8
MYYQ6M<^!? =CH[:G?^'H;2*.(22K(6+1\?=.UB"<\8!.3TS0!TEUHEO<G2@C
M&%-+G$L2*.#B-HPI]L/^E6K^QMM3T^>QNXQ);W$9CD7U!&*X*U\+^#);ZVMK
MWP//IPO"1;2W."LC %MIV2,4; )PP'0]^*O:/X&\":UI-OJ5OX<B2*X7<JR%
M@P&<<X8^E &M#X8N&N+0ZEKEWJ%O8R"6"&1$7+K]UG90"Y'7MSR<TS3_  QJ
M6EPBVM/$<Z6JN[+$;:(XW,6/S8SU8UAVGA7X>WGB&[T2+P]&+BT7)=MVQ^%+
M!3NY*[TSQ_$*FLO!?@.^MKVXC\.1JMG/+!(&+9+1G!(^;IZ4 ;,G@O2V\-QZ
M-$@B:*-%CNU1?.5T((DSC[VX9HN?#%R;R\FT_7+G3TOR'NHXXHV!?:%+H6!*
M$@#UZ9KE%T+P-=):#3?!4U_+<V4=Z8HBJF**0?+N+R 9.#P">AI9="\!^3IK
MV?@V:]DU$2>7#$ CH8^'#;Y% (/'7M0!U;^%%MOL;Z+J,^F26EJMHNU5D62)
M>@96')!R01@\FH&\&%%MI;;5[B*^ANI;I[LQHS2R2)L8E2-H&W@ #C K E\,
M>#+73_M5[X&GM9'G6""V<HTD[MT"[9"H[]2.AJQI7@WP5J-U/9W'@\Z?>0*K
MM#<'.4;(#*R.RD9!'7(Q0!T$GAV[O;"6UU+7+FX8O')!,D4<3V[H<AEVC!YQ
MP01Q[U)I^@3P:HNIZEJDNHW,4+0PEHDC6-6(+8"CDG:O)].,5G_\*R\%_P#0
MOVWYM_C1_P *R\%_]"_;?FW^- '545RO_"LO!?\ T+]M^;?XT?\ "LO!?_0O
MVWYM_C0!U5%<K_PK+P7_ -"_;?FW^-'_  K+P7_T+]M^;?XT =517*_\*R\%
M_P#0OVWYM_C1_P *R\%_]"_;?FW^- '545RO_"LO!?\ T+]M^;?XT?\ "LO!
M?_0OVWYM_C0!U5%<K_PK+P7_ -"_;?FW^-'_  K+P7_T+]M^;?XT =517*_\
M*R\%_P#0OVWYM_C1_P *R\%_]"_;?FW^- '545RO_"LO!?\ T+]M^;?XT?\
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MV. LF!R91@%A_=.WJM:?G?$+_GQ\.?\ @5/_ /$4>=\0O^?'PY_X%3__ !%
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M17*^=\0O^?'PY_X%3_\ Q%;>D-J[69.M16<=UO.%LW9TV\8Y8 YZT 7Z***
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M%0WFCV-]I8TV>#-JNS:BL5V[""N".1@J/RH \SNH[>.QUV[N?#*7(.J74?\
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M+_ON@#I:*YK_ (6+X._Z&*R_[[H_X6+X._Z&*R_[[H Z6N4/_)7A_P!@ _\
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M2V^*2.=HY(FQC*NI##\#2Z7XL\ :.DJV>O6NZ9MTLLMP\LDAQ@%G8DGCWXH
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MJ7-Q/9S%WN\H5V$;%^7)#?-D\#'K6Q:6E_<:VFHZA#%#Y-H8HTCDW@,[Y?G
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MIZ* (/L=K_S[0_\ ?L5EZ_<QZ7;6PM=/MI;F\N4MH1*H5%9LG<Q S@!3P.O
M[UMUE>(]/EU+26MX;6VNCYB.8;AF0, <G:Z\HW<-V- %?1;E+VYO["]LK1;S
M3Y524PKE'#('5AGD<'&#Z=36M]CM?^?:'_OV*QO"V@OHYO[F6&.WDOI5?R8Y
M6E\M54*,NW+,>22?7';-=!0!!]CM?^?:'_OV*/L=K_S[0_\ ?L5/10!!]CM?
M^?:'_OV*/L=K_P ^T/\ W[%3T4 0?8[7_GVA_P"_8H^QVO\ S[0_]^Q4]% '
M'M;P?\+9CB\F/R_["9MNT8SYZ\X]:ZG[':_\^T/_ '[%<VW_ "5Z/_L -_Z4
M+75T 0&RM<<6T.?^N8KE8M>DEN1HG]DVPUY9RDL?E_N5A!SY^>NPJ1@9SN.W
ML377N6",57<P' SC)KD5\,:M%+'X@6XC;Q"9=TZER(7A. ;<<<*H (./O#/<
MT =3]CM?^?:'_OV*/L=K_P ^T/\ W[%34M ''Z=;P'XFZU&88RBZ?;$+M& =
MS]JZG[':_P#/M#_W[%<WIO\ R5'6_P#L'6O_ *%)75T 0?8[7_GVA_[]BLR\
MN(;;Q'IFEK96YCO(;B1W*#*F/9C'UWG\JVJY?3M-\07&O6-[K2VBC3;>:$30
M2%C=-(4^;;M&P83ID\F@#H?L=K_S[0_]^Q1]CM?^?:'_ +]BIZ* .1\,6\#^
M*?%:-#&RI>Q!05!"_N$Z5J:[<0Z5#9/%96[FXOH+9MR#A7<*2/?FL_PM_P C
M7XM_Z_H?_1"5?\4Z??:C86HT^.*6>VO8+D1RR&-7".&(W8.,X]* %UVXATJ.
MQ:*RMW^TWT-LVY!PKM@D>]8;:Y>76I:C!IUEH[/I\S1C3IVVW5P% .Y>RAOX
M<@@^H[:-[::YK<-HMYI]K9-:ZA;W&([LS;T1LM_ N#TQZ^U4-<T'6M5BN["Z
MTO2M3$K/]DU&>3RY;56)*Y4(3E,\%2,X&<')H FUVXUG3KZR2UL]',%_=+;1
M":%]Z$HS9;!P?N$<>M:M[/!HOAV;4M5M;9Y+:(O*MM%PQ[!0>>>!SW--U+1[
MJZ70E282G3KQ)II)#AG58G0GZDL#^=7-=TI-<T2[TR20Q"XC*B11DHW4-^!
M- &!<WNKZ/;1:EK&EZ5]A+HMQ';AC+;!B!NW'AP"1G '<C-0IJE_>ZGJ5O:C
MP_;1V=V;9$NE;S'PJG/!']['X5:O;#Q)K]BFD:I:V-K;,Z?:[F&X9S,BL"0B
M%1MW8P<DX!/6K.E^%K6*_P!4N]1T^RN);F_:>&1HE=E38@ R1D'*F@#1OC8:
M;IL]]=P0+%;1-+*1&.BC)Q^58VA7UWK.CW*R:;8V>LVSA)()$)C7<%=3ZXVL
M/Q!K0\3:3<:[80::CA+6:X0WC!RK&)?F*KCN6"CMP35:Q\-RZ1XG&H65Q--:
MW5N8KP75R\C[E.8V4MG/5P1GN* ,_29_$.IR7R_9M!065R]LW[B3YF"@YZ]/
MF%2Z'/K6H:M>V]U:Z*L&GW(@F,4+[GS&KY7)P/O@<^E:^A:9<:;+JK3E"+S4
M'N(]IS\A5 ,^_P IJO:Z;J6GGQ%<6XA:XOK@SV89N,^2B#=QQ\R'UXH IZ9K
MD%]XFN=.DTZW2S)D2RG"#,S1%5F![<,V!_NM38[S5=6%W=:)INE_8[::2&,7
M2G?=-&2K$$<(-P(!.[IGBJX\"/ING:9)IEY<R:CILL<J_:+IS$Y)Q-\IR%W*
MS]!U-6X+'Q%H27=AI-K975K-/+-:S3W#1FW,C%V5E"G< S$C!Y'''6@!\6MV
M2Z]_9^H6MGIZG3H;O;.45U=W=60G.#C8.E8NI^,UL[;[5;Z;8W$":O):.R+G
M]PD9D=P1U8*#[<5N6OAF1M?^W:M]GU(#3(+4RS1+N>57D9VVXP =XZ51B\'S
MI>1 Q6PM%UB>[:)3@>2\#1@8QURW3TH M:QK,5AXFT;2;;3[69+YR+B0H/W2
ME6*8Q_>V/_WR:S]#U;4M9M+6[W>'(4G;_4,K>:!NQCKUXI^F^$M4MQITEY/#
M/<6NH1NTFX\VT4+Q1CIRQ+;C[LU1Z#H.JZ/96MM)X4T6XEMVS]K-V Y.XD-_
MJ2<CZ]J +NC>(+>_\3:EHMWIL$!@G=+.4(,7 0*7'^\NX''H?8UG2ZYJ[>$[
M'Q#;6&CB*Y2 /%)$Y8/)(J<$'H-P/X&M-_"MQ-9ZJ#,D%Y)J;7^GW"G)A?:H
M4GV."".X)ID?AG4%^'FGZ"QA^V6YM2Y#'9^[F1VP<>BG% $6IZG>Z7<:?IUW
M'H=M<W@E;[7,C+;@+MP@!.2YW9QD< ]:W-&26ZLBVI:9:P3I(R9APT<JCHZ]
MP".QY'/UJ'7K;5I9XGM+6SU*Q,92XT^[(0,<Y#JVUN>H(/%-\)Z+/HMC=)-%
M!;+<W+3QV=NY:*U4A1L4D#N"QP ,L<"@#7^QVO\ S[0_]^Q1]CM?^?:'_OV*
MGHH @^QVO_/M#_W[%'V.U_Y]H?\ OV*GHH @^QVO_/M#_P!^Q1]CM?\ GVA_
M[]BIZ* (/L=K_P ^T/\ W[%'V.U_Y]H?^_8J>B@"#[':_P#/M#_W[%'V.U_Y
M]H?^_8J>B@"#[':_\^T/_?L4?8[7_GVA_P"_8J>B@"#[':_\^T/_ '[%'V.U
M_P"?:'_OV*GHH @^QVO_ #[0_P#?L5RVL6T"_$CPW&(8PC6MX64*,' CQFNP
MKE-9_P"2E^&O^O6]_E'0!T4MK;1PNZV4<C*I(147+'T&:Y:379](E0Z]I=A&
MDMC->>7;?-) (@&96R,-P<;ACGC'-==<&9;:5K=%>8(3&KG"LV. 3V&:XRQ\
M/:U>66HVFN6-M]IU2V>&YU)+TR.,J0JI'Y8"H">%!]SD\T 7O#NJ'5KUX9H=
M&E58M\@LIED>V?(_=R#J3R?F  RI&.E=%]CM?^?:'_OV*Y_1]'U,:O87E]:6
M=DFG6+VBK:RE_/+%.?NC:@V<#DY;VYZ>@"#[':_\^T/_ '[%'V.U_P"?:'_O
MV*GHH @^QVO_ #[0_P#?L4?8[7_GVA_[]BIZ* (/L=K_ ,^T/_?L5)'''$NV
M-%0=<*,"GT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN@ HHHH **** .4TW_DJ.M_]@ZU_]"DKJZY33?\ DJ.M_P#8.M?_ $*2NKH
M**** "BBB@#E?"W_ "-?BW_K^A_]$)755ROA;_D:_%O_ %_0_P#HA*ZJ@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "N4UG_DI?AK_ *];W^4==77*:S_R4OPU
M_P!>M[_*.@#JZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLETQ6%?)@^<A2QQ\GH"?PK"O))X=!UOP[J=DEM_IEO=V]N9!(I@EN4W*#@9
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M?^AXU3_OQ!_\17544 <K_P (IKO_ $/&J?\ ?B#_ .(H_P"$4UW_ *'C5/\
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MZUM(U"PTGQ#X@BU:Z@M+R>[$Z/<2!/-M_+0(5)ZA2&!'8Y]: *ATZY"V;_\
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M@_\ B*V](L+K3K,P7>ISZE)O+>=.JJV..,* ,?XU?HH **** "BBB@ HHHH
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M 4O^$XN?^A,\2?\ @-'_ /'*/^$XN?\ H3/$G_@-'_\ '*ZNB@#E/^$XN?\
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MSPIJ?]HP:3-/KOB.6ZGBBDDCDL"MNSE06&_R -N<\[NG>@#0_P"$TF\SS/\
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M&/RBO*J.@9L<=ZK-#KR^%_\ A(_[>G-^+7[8;78GV4C;O\K;MW8QQNW9[^U
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M^#M5NQ:3&&22&=MF\ $@9F![CM6Z/ACX.(!_LAA_V]3?_%T =97*'_DKP_[
M!_\ 2@4?\*Q\'?\ 0(/_ (%3?_%USY\"^&_^%BC2/[./V+^R#<^5]HE_UGG!
M=V=V>G&,XH ]"U&S&HZ9=6+.46YA>(L!DKN4C/ZU1L_#T%M=/,\GGH^GPV+Q
MN@VLL9<Y/U\PC'M6%J7P_P#!&EZ7=ZC<:/(8;2%YI EU,6*JI8X^?K@5E6WA
MSP-+<VT%UX7U+3Q=L$@ENI9!'(Q&0NY96 )'3.,T ;UCX%32M.%MIVK75O+#
M>/=6\Q ?8&4)Y; \.NT8YYZ=*EE\'O>PWKZCJCW-Y>"!&G6%8U1(I-ZJJ ^I
M.223S[5S2^'/!LUQ<Q6G@W5KM;:=X'EAG;:74X.,S _I6G9>!? ]]>WEG'HL
MR2V102A[F4<N@88^?T- '8:A:"_TZYLF<H+B%XBP&<;@1G]:RM,T76=/6UA;
M7UFMK=53RC9*I95&,;L\<#K7,S^&/A_;7TMI)HUP&ANX;1W%Q+M5Y5#(<^9T
MY SZD4_6/"7@'1&*W.C3NRVLUVPBN)3MCB +$YD'J /4F@#:?PG=QPW-C8:[
M-9Z9<N[-;K"K/&')+K&Y^Z"2>H.,\8K3N]#@N1I*)(T4>EW"S1J.=VV-XPI)
M]GZ^U<?8>#_"=]<11_\ "&:K;I*,B::=@BC&><3$_I5!-*\!MIPU1_"6K1Z=
MU-V97**H."Q"REL#Z4 =U>^&[34=1OKF[)DBOK!+*2'&!M5G;(/K\_X8JI_P
MB][=+!;:KKTU_802+((&@5&E*D%1(X^\ 0#P!DCFN=O_  UX T\7^_0[J5K!
MH$D6*XE)<S,%0+F09Y(ZXI]OX0\'2+/)=^$]1T^""%I7GNKAP@"]?NRDYQD]
M.QH Z>7PQ:W&G:G8SR.Z:A<M<;Q\K0N=NTJ?52H(/K2)X:$?@M/#4=[(B+:B
MU-P%&XIC!X[$C(]LUR5CX<\#7EU:0R^%]1LEOO\ CTFN9I%28[2V!B4E25!(
M# =*O:MX*\"Z0D(ET6>>>Y?9!;V]Q,TDK8R<#>!@ 9)) 'K0!T%SX4TUY;&>
MQMX;">QN%FCE@A4$@ JR'&,AE)!JE?\ @:RU'P>GAZ:YD'E;C%=*,.A8MG'L
M0Q4CN":YY?#W@);;4'N_#M[93Z=;-=36MQ/()#$ 3N7$A5AP1PW7KBB+PYX(
M,UHEWX4U.QCO)%CAFN)GV%V^Z"5E;&>V: .G?PWJ$6J7=[IVN-9_;%B61/LJ
MR$;%V@@D_P!*T=.T>/2=&.G6<T@;#L;B3#.TC$EI&Z9)8DUR.L>#?!.CR6D3
M>';N[FO)&CABMKB0L2JEC]Z0#H#5)]$\ 16=Y--X;U"&>S>%9;22643'S7"1
MD?O-I!)QG/8T =._@;2?^$>BTN"*.&>%(_+OEB7SA(A#"3/4G<,GGG)J6;PY
M?0WEU/I&M-IZ7K>9/$;=91YF "Z9/RD@#.<C/.*YM/"?@_R;F>Y\'ZI9PVT#
MSO)/.V"%&2!MF/./Y57BT#P.WV1[GPIJ=G;WCHD5Q/,_EEG^X"5E)&20.1WH
M ZL^$Q:I8R:1J$UG=64!MQ-(HF\Z,G)$@.,_-SD$8)/8XJ&;P?--:EGUB5M0
M:]CO'NWB!&Y!A5"9P% [?F37.)X<\&SW%Q%:>#=6NEMIWMWEBG;874X.,S X
M_"I+KPQX(AO9[6T\+:CJ3VI N&LYI"L3$9VDM*N6P0<+D\B@#IKGP_J6HZ;=
MV&I:W]HBN8]@V6BH4.0<\'GI705YM+X?\ >7ISV6@7FH?VDLC0+;7$F<)C=N
M#R+@@G&.N0:AN-(^'MGINH7=WX=U"!].\KS[5Y9?-Q(VU" ),,"<]#V- '=I
MHQAO-7NX+MHYM25 &VY\DJFP$>OK6?+X(TG^PH-.M88K:>V$1AO4A7S5>,@A
M\]225YYYR:P-5\,?#S2-*M-2GTN62"]DCC@\JYF8N7&0?O\ 3'/T%2:AX2^'
M^FZO8:7<:5+Y]^2(RMS,53& -QW\9) 'J: .BE\*6MQI.HZ=/*[+?7+W0D4;
M6AD8@J5/JI (-5X?"+V%MIITS5'M;RPLULS.T(=9XEQ@.A(Z$9!!&,GUK%?P
ME\/H_$R>'I-+D2]DMA<Q@W,VUURPP#O^]\I./05%-X9^'L%O<2MH]P6@O#9"
M))YF>:; .U 'YX/MT.< 4 ;LO@^:2&*4:S*=12_%\]V\*L&81M&%"9 50K<#
MV[UKZ;::G;.YO]56]5@-H%LL6T_@3FN"DT/P#:V]Z]_X:U"QFLK<W+V\\\F]
MX\XW(5E*MS@'GC(SUJ[8^"_"EY=+ _@S5+56S^]GN&"# [XF)_2@#T"BN4_X
M5CX._P"@0?\ P*F_^+H_X5CX._Z!!_\  J;_ .+H ZNBN4_X5CX._P"@0?\
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M_H$'_P "IO\ XNC_ (5CX._Z!!_\"IO_ (N@#JZ*Y3_A6/@[_H$'_P "IO\
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M38D<V'(!92O#8X(&.0>!0!U5YH\5[J]IJ$KY%M;SP&(KE7$NS.?^_?ZUD?\
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MR1O)*2,(B,H9N,DG'H.:N:%/8#58UAOO$D\C@@+?VUPL73.27C"CIQDUU=%
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M\-SIDJNKI_RU0$'8WJ,@'V/UJE=1WOAG4=,E35KR^M;VZ6TGANV5SE@=KH0
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MH_X5EX,_Z 4/_?Q__BJP-=\"^&+/Q+X<M+?28HX;VYF2= ['>!"S =>.1VH
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M /Q5'_"LO!G_ $ H?^_C_P#Q5 '545RO_"LO!G_0"A_[^/\ _%4?\*R\&?\
M0"A_[^/_ /%4 =517+?\*T\&[=O]APX_ZZ/_ /%>]5[[P!X"TVSDO+S2+>""
M(9=VDDP.<#^+DDD #N30!V-%><)X?\ RZ#9ZM%X8DD%]-Y%O;AF$KON8 <N
MOW23DC %7M(\$^!]7MY9$\.""2"9H)X99&W1NN,@X<@\$'()X- '<T5RO_"L
MO!G_ $ H?^_C_P#Q5'_"LO!G_0"A_P"_C_\ Q5 '545RO_"LO!G_ $ H?^_C
M_P#Q5'_"LO!G_0"A_P"_C_\ Q5 '545RO_"LO!G_ $ H?^_C_P#Q5'_"LO!G
M_0"A_P"_C_\ Q5 "-_R5Z/\ [ #?^E"UU=>:MX&\,_\ "QTTG^R8OL1TAKCR
M=[8\SS@N[.<].*Z#_A67@S_H!0_]_'_^*H ZJBN5_P"%9>#/^@%#_P!_'_\
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M+:0&191*V_:2/N,"2/FP, '-6-<@U34/#&G_ &FS OC>V<L\,&7$>)T9N>X
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MII-UICW9(MGE>-TD8#.S*,=K8!.#UP<$U#IWB>]U01RVOAN^:TDE*"X,\ 7
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M;$N?W97802<<-M.<GN,UJ>&IK^S2]::/5I].:>)+);U"UP,\.3GYM@)'+<@
M]L5U5% %:TOXKR6[BC616M)_)DWKC+;5;(]1AQS7#W'AWQ!JVGZGJ\=REK=7
M-U]KMK66U/F*83B!=VX;<A 2,?QMZUWZHJ9VJ%R<G ZGUIU '%'1KO7KS4=0
M6"73[QH[2YL99D(,4RHV5/J.=K#T)K-TP:I9-H^J7^BWR.NH:C-<000F5HO-
M9BO3J.>#WKT>B@#G-'CNM1\47FNRV4]E;FTCM(([A0LDF&9V<KGY1E@!GGK5
M&[\/7E]J^N7=NIMKV*Y@N-.N77Y2ZPJI&>ZGE6'H?:NQHH \]T.TU;3;/1M=
MN=(N=\37\=W9(NZ6%9K@R*ZK_%C:,XY(;(K=L1<ZSXMCUG[%<6EE9V<EO&;F
M,QR3.[HQ.P\A0$'7&2?:NEHH Y6PL+N/PYXC@>VD66XN[UHD*\N&)VD>N>U5
M=.BN_#M[::C/IUW<6]UI-M;3?9X3));RQ;C@H/FP0YZ X*\]:[2B@#A?$3ZE
MK=AI]U=:3J$%K%JZND=KO%T(!$XWML.5)8] <@$9J=%A?1-0M[/1M9U!7"&:
MUU=YF\U-WS",RL<-C) &.0*[.B@#C?#L5Q%K\8TJ/6H-)$#_ &F'5-^U'RNP
M1>9E\_>S@[<>]:OB^UN+S18HK:%Y7%]:.509.U9T9C]  3^%;M% '.:RESIW
MB:SUZ.SFO+86LEI.ENN^2/<RLKA>K#*D$#GD'FDTM;G5?%<FN-9SV=I%9?9(
M1<ILDF)<.S;3R , #."<GBNDHH **** "BBB@ KE-9_Y*7X:_P"O6]_E'75U
MRFL_\E+\-?\ 7K>_RCH ZNBBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ***KW_VW[#-_9WD?:]O[K[1N\O/^UMYQ]* +%%<I
MGXC?W?#'YW'^%&?B-_=\,?G<?X4 =717*9^(W]WPQ^=Q_A1GXC?W?#'YW'^%
M '5UROB?_D</"/\ U]S_ /HAZ3/Q&_N^&/SN/\*P-=/C7_A)/#GVP:%]I^TS
M?9/*,VS=Y+;M^><8SC'>@#TJBN4S\1O[OAC\[C_"C/Q&_N^&/SN/\* .KHKE
M,_$;^[X8_.X_PHS\1O[OAC\[C_"@#JZY0_\ )7A_V #_ .E HS\1O[OAC\[C
M_"N?)\:?\+%'&A?VG_9![S>1Y/G?]];]WX8H ]+HKE,_$;^[X8_.X_PIH?XB
M,2!_PBY(X.&N.* .MHKE,_$;^[X8_.X_PHS\1O[OAC\[C_"@#JZ*Y-G^(B+N
M;_A%U'J6N!2Y^(WIX8_.X_PH ZNBN4S\1O[OAC\[C_"C/Q&_N^&/SN/\* .K
MHKE,_$;^[X8_.X_PIJO\1'&5_P"$78=.&N* .MHKDM_Q$+%?^*7W#DC=<9IV
M?B-_=\,?G<?X4 =717*9^(W]WPQ^=Q_A1GXC?W?#'YW'^% '5T5RF?B-_=\,
M?G<?X49^(W]WPQ^=Q_A0!U=%<EO^(F[;_P 4ONQG&ZXS3L_$;^[X8_.X_P *
M .KHKE,_$;^[X8_.X_PHS\1O[OAC\[C_  H ZNBN4S\1O[OAC\[C_"FE_B(I
M"G_A%P6Z M<<T =;17*9^(W]WPQ^=Q_A1GXC?W?#'YW'^% '5T5RF?B-_=\,
M?G<?X49^(W]WPQ^=Q_A0!U=%<IGXC?W?#'YW'^%&?B-_=\,?G<?X4 =717*9
M^(W]WPQ^=Q_A1GXC?W?#'YW'^% '5T5RF?B-_=\,?G<?X4UG^(B#<W_"+J/4
MM<"@#K:*Y3/Q&_N^&/SN/\*,_$;^[X8_.X_PH ZNBN4S\1O[OAC\[C_"C/Q&
M_N^&/SN/\* .KHKE<_$7;]WPSGZW'^?2DS\1O[OAC\[C_"@#JZ*Y//Q&]/#'
MYW'^%+GXC?W?#'YW'^% '5T5RF?B-_=\,?G<?X49^(W]WPQ^=Q_A0!U=%<IG
MXC?W?#'YW'^%&?B-_=\,?G<?X4 =717*9^(W]WPQ^=Q_A1GXC?W?#'YW'^%
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MNKKS:Q\<^&(O'^JZD^LVZVD]C;QQRG.&96?(Z>]=#_PLOP9_T,-K_P"/?X4
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M-K4! (P77&T@K@@9&"!C'I2P^-OA];ZG<:G%K-FMW=(B32Y;+A?NCICO_G%
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M3]>OXUL5RR_$GP4BA5U^T50, #< !^5+_P ++\&?]##:_P#CW^% '445R_\
MPLOP9_T,-K_X]_A1_P ++\&?]##:_P#CW^% '45RFL_\E+\-?]>M[_*.G_\
M"R_!G_0PVO\ X]_A7.ZIXZ\+S^/-"OXM:MVMK:WNEFD&<(6";0>.^#0!Z517
M+_\ "R_!G_0PVO\ X]_A1_PLOP9_T,-K_P"/?X4 =117+_\ "R_!G_0PVO\
MX]_A1_PLOP9_T,-K_P"/?X4 =117+_\ "R_!G_0PVO\ X]_A1_PLOP9_T,-K
M_P"/?X4 =117+_\ "R_!G_0PVO\ X]_A1_PLOP9_T,-K_P"/?X4 =117+_\
M"R_!G_0PVO\ X]_A6UI.M:;KMF;S2[N.Z@#E#(F<;AU'/U% %ZBBB@ HHHH
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M\4:W#8:TMII7]EWSY-KM830PG.'WYPS<#(P.M;>JZ99:KJ&F7DMXJG3IFE5
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M^CE1(WVM,,,N&R, 9[4 9FH^-KW2=,TF^ L=6BNKN1;AK:S>(B%$W,55CG<
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M:KXUU;2;6\LKN/2XM1L-1MK::Z\EC 89E+"3;G(( .1GM6UX*\07>OW>HPW
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MNO!W_0NV7_?%'_"NO!W_ $+ME_WQ7.65T)%TT>)=4N1I[6,C6LZS31"63S6
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M12P%T<=&4KD'\JS-%UW1TT+3T?5K)66VC!!N$!!VCWH Q-/\$^'9-4N+"_\
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MRV$N([B5''$;D<*Q9VXY^4CUH [BZU"SLB!=7,<.4>0;VQ\J#+'Z =:G5E=
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M(9;>UD>XN"K-;;[CRY)%XP!M.<= 1F@#N9KF"V:)9I4C,TGEQACC>V"<#U.
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M+;N)=>0<Y^8$<"@#T:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!VD6FV$%Q+<0V-O'-/\ ZV1(E#2?[Q R?QJ5;:!/*VP1KY*[8L(!L&,8'H,
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M,SHMC/%/.%/#P@XD!]0$+-]5%<EI>K:Q?7JZ9=7,^ZZW:QDD@I:/&=L7T$A
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M$2]L[C4K6QN/$5X-'$$[0W3730&>19<%?.!!<(O3GYNISB@#NTBCC)*1JI(
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MU]:SV4$4\"Q3-& ZVX;YU'#= "&R* /1, KM(&.F*BBM+:"%H(;>*.)LY1$
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M/4D9()Z"@#9MIM)*QVUL;91YKK'$JA?GC.&POJ".HJU):V\RR)+!%(LF-X9
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MRJZ2@88H !L8XQB@#T8M:/=-;DPM.L66CX+",DCD?W20?8X]J1+&SCC$<=I
MB 8"K&  ,YQCZ\UYQ?:C+%>7^LZ?<7:WTWANUF@6XE(<Y:0.QC'RDJOS$!2
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M9)A"CH0C$A2&./E SGG-6M";3'\:Z2^G:Q-J6_2)WE,MTT^UB\//).TGG*C
M&.@H [HQ1D,#&I#_ 'AC[WUJNKV%U?3Q!8I+FV"K+E,L@89 SCH>M<EKUY!_
M;6LIJNM7&FBTM(Y-/2*Z:#=E6+. "/,.X;<'(X QSSBR7BEM:O=3U6XT[61I
MUK-%!%<-$3/Y&>$!'F'?A=I!'.,<T >@O>:1_:$D+&$W1D6!_P!WEBQ7>JDX
M_NC-71!")3*(D\PG);:,DXQU^E<']KOXO$C-N:*XGU.T6>-6*AB;)B5/J-P'
MY"J>FZO$MQX:G&NWL^I7+2MJEI]I9\.+>5F4Q$X3:XP%  ..^,@ ]'$%O$TD
MHBB0OS(^T#=]3WJ&"\L+B2!+>2.0O )H2@R#&< $'I@\5YOINI27M_I\,5]-
M)%JEC<&5?[7DN)9/W>Y2Z !86R#@(?4=J6TU*XL_"E@-*OYO+30(7D9)C+Y1
M\U%E89)P44OQ_#C&!C% 'ITEO!,Z/+#'(T9RC,H)4^WI2F*-@X**0_#9'WOK
MZUYSJU\;?^T+7P_KEW/9^1:L\ZWC7!@E:Y1?ED8D@LA)*YQQTYYGU4SZ;>:M
MI<&M3V]LAL94-Y>3$$R-*'0S9+QJWEKSG /UH [YK>%IEF:&,RH,*Y4;@/8T
M&WA,XG,,9E P)-HW >F:P?!-[]LTB=<W!-O=/$3+=_:EXP<)+C+H,XR><@@]
M*YJQOFN(M*E_M>[DUN\OS!?V0NW^1"6$B^4#B,(HR& !X!SSR =K97FD:S%<
MM:B*YB$A29C%\KLON1AL>HR*FMM1T^9X+>UN(G,T'GPB/E6B! W CC'(_.L+
MP58Q+X!MX%:<B>*3=FXD+#)(^5B<KT_A(P>>M<UX3TZTU0>'($OKH1KH#&3[
M->.K!]\0*E@VX '/R@@# &,#% 'I,EK;RQK%)!&\:8*JR @8Z8%/V+NW[1NQ
MC..<5Y<FLZG=1:;'J%^B6_\ 9*RK+/JTEAYL@=E=MZ(V]@%3Y3Q\V<'/'3W]
M]J"?"FXOY+PF^72FD^TPAD);9D.,A6![]!]* .I>&*4J9(T<KG:64'%*(T!4
MA%RHPO'0>U>>7FL6^G&\;2]:OKZQ.E^;<S1W7FM%,9$6-@SY$98,Y(X "YP,
M50?4[U?[8L;34WA3RK%D-OJDEX8G>YV,1*XR"5(RHR.GJ: /1I+O3-,%R6>"
M Q()YU1?F"DD!B!SR0>?8U>KS37K>'0-1\0_9=1O4NUT.%X&EOY7D;]Y,&(W
M-SCY?IGMDY;JNJZK_;&JL=0@M;NVODCM$EU.:,JAV[ +9(V$H?)YY/)Z;> #
MTVHGN(8YXX'E19903'&6^9@.I [XR/S%<'9ZD\/C&/S-1EO1/J,T*B"_<-&/
MFQ'+:N,!5Q]]<'@-T/.EXI58O&&B72R.LXM;M8%,[(KR@(47 (!).>.^.<X&
M #KZ*X'0+]&OO#K6.LW-_=WT;G5(9+EI0H$1)8QDXB*R;5P O4BN^H ****
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M0_#-9K M<7"0W+0%EYD</(5R/4G% '6HB1C"*JCK@#%,2UMXV9T@B5F;>Q"
M$MZGWKSV34K>U\/FYT?Q#?W=[+8+)=?OVN!&-\8DE(.?*907PHP.#Q\O":I>
MFW-_:^']<NI[,V]L[SK>-<&"5KA%&V1B2"R%B5SC@<<\@'HD=O!"[O%#'&TA
MRY50"Q]3ZTIBC:02&-2ZC 8CD#ZUP>J>=I=QK6FP:U<6UNBV,L;WEU,P5I))
M%=#+DO&K>6HW9^7/;-1Z=KI@_LQI;RXM[6#69(+F26_^T0X-LY51,<;TW%?O
M<AN.PH [^&"&W0I!"D2DY(10HSZ\4-!"TGF-$A? &XJ,X!R.?KS7G]E>RZ]K
ML-NNK7C6,^I7RYM[ET\R-4C*@,IR%R<C!'7C@T:-)>0IX>O7U._GFN[NZM9O
M.N69'C1)MGRYVY'E*=V,DYR3F@#T$Q1MNW(IWC#9'WA[T10Q01B.&-(T7HJ*
M !^ KSS0[*XO(_"WVC6-6D&JZ8\MX#?2#S&58RN"#E,;CRN">^><UQK#W-AI
MEK>:A.94L9)&DGU1[)& E*!RZ O(X"].G.3R: /1B;-KD6I\DSH/.\OC<N21
MOQVYSS]:>MM DCR+!&KR??8* 6^I[UY7;ZE>"V;6([J9]8E\+Q21EIF)>0,X
M=@F<,0!G&TX/.,DYNQ7]TL.HI;Z_;06QTX2-+'J=QJ'EN74+(7,8\L$;@<'C
M[P VDT >E"- 00B@@;0<=!Z51ENM(\R!)&MF9+C[/$-H;9+MW;1Z' K$\$7O
MGMJ5H7E=K>1"3_:!O8?F7_EG*PW=LE6Z9'K7.BRMI+V6RCO+A)6\4_O0MTYD
M1#$Y!&22FX9^88)]>!@ ]+95< ,H;!!&1WJ.2UMID"2V\3J&W!60$ ^OUKSR
M^O=1L6ETQ+Z4V$6MM;M+=ZA)"1&;9)%C:X 9U!=C@]3PN>:Z;P7<W4^CW1EN
MHKM8[N1+=H[B2<! !\OFNBF3#;ANP>,#)(- '0&*-I%D**74$*Q'(!]Z;%;P
M0*RPPQQJQR0B@ G\*\\M-4=?#J7]IK-[<^))K&X>:R\YI5$RH20T1R(]C# P
M%R<#G-1ZKJ26>GW)\/:]=WRR:)<SW,AO'F,3JJ^7("2?+8DL,# XZ<4 >B/]
MBTVVDG80VL$2%G? 1549/)[#K3VM;=Y6E:")I&7:7* DCTSZ5YYXJLI+*QUK
M3Q?7]Q#-H3W,BS74C_O4<?,,GY00>5&%]L5=N)HHKG7-2CU;4I++2["-[5;:
M[:08:)LOR2)#T(+9&1GUH [;[/ )1-Y,?F#.'VC(SUYIDYLK:5;J?R8I'98E
ME< ,2Q 5<^Y(&*\Q;6;^SFOX;"_;8=,$S^5JCWYC_?1JTFYAA6$;L<+D=#Z5
M?UU=%:S"6NN7EU9P:A823.VH2/'!NEP3YV[()')&[Y?E88SF@#T4(H8L% 9N
MIQR:@F:RTV"YOY5C@C1#+/*$Q\JC))QR<#-8OB_49-$L;/74ED-M8S W,:,<
M21.I3D=\,R'/L:XZ2XUJ31-6T34KNXDFTG3+NXNY&<_O3+ #&I]5!>4 'IY8
M]* /2;N:PCM/[1NA&88$\T2LFXH,9R.,_E5A8HT^[&J\8X&./2O.M7-WH-G=
M16>IWY\[P[-<L9+IW*RHT8#ID_(<.>%P.G'%:$M[;-K6IR:IK=Y9WMMJ$<5I
M:PW##,1";0(0<2!R6R2#WZ;> #K+5].U*VCN+=89XE+QHVS[N"58#(XY!'X5
M;*@KM(!4C&,<5YWH=O)8Z?HNHP7UX)+C69X)(C<,83&TLPV^7G;U .<9SWKT
M6@"*.V@BB$4<,:1J<A54  ^N*>%4,6"@%NI ZTZB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "L^34M+2Y5FEB,WV@688+EA(1NV9 XXY]*T*
M\SDLK.34KVP6>9)G\31-,BW#B18S%E2.<J#\PR,?7@8 /0Y7M;6XC9T"RW+^
M4K+&26.TM@D#@84\GC\Q4XC0!0$4;/N\=/I7"1//I^L+IT%S=?9H/$/E1JTK
M2$1M8-(4R221O)(!SSBHO!%[MUR&U%[_ &B\MH[27,%Y(_(*\W$+Y\J0Y.,'
M^\,<< '>K;P('"PQJ)#E\*!N^OK2M#$[AWB1F P&*@G'I7&:_<6 \0ZA'KVI
M75E#'9Q-IPAN6A+-\^]HP"-\F0HQSVXYYS-4O@(]9EN-1O(O$,4RC2K8SLCL
MNU/+"Q A7#'.[@_Q XQP >CF&(RB8QH9%& Y49 ^M10RV=[%*L1BFC61HY
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M2EY7D+S P_.JDD!@)'P /08XH ]("(""% (& <=O2J\YL;"!YYQ#!%N!9BH
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M:CIVCVJW%](D,>_;& A9F<]E4 DD\\ 9ZUY]I%[J$NM6;3ZC#'JS:DR7-O\
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MPVC_ /'NU^Y;T+B"0IG\<GZ@5QM]JP;7UN(+DPW$>N10R))?2-<"/SE1@80
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M!'YRHP,( 5(BI.,YR"#G)J[91216VGZN+J[:[E\02V[,UPY7R3/(FS:3MVX
M[=: .\NK^VLI+9+B38UU-Y,(VD[GVEL<=.%/7TI;J\@LEC,[[?-E6*, $EF8
MX  'Y^P!/05YQ8RVD][X;:>]GDU[^TV.H0/.[&-O+E!W(3A #@+P.#QWKK]6
M)/C+P^K_ .IV73+Z>:%4+^.PR?K0!O,VU2V"<#. ,FHK2[@OK2*[MI!)#,@=
M&'<&N*\+7-C)<Z>US?WK^(7DE%];K.S;3AMPEC)PB#C:0!_#CJ<[GA'/V/45
M7_4+JET(?3;YASCVW[J -^BBB@ HHHH ***CGA6X@DA<L%D4J2IP0",<'M0
M_ &<#K0 !T&*\X%[KUWI.H".6Z%UH%D]F[1YW33EL-(!_$PB16'O+3;Z[MHU
MU ^%[^XNK!-,,MR\5S).(Y1(FTAB20Y3S-P'. ,B@#TJJ][>VNEV,MY=2>5;
MP+N=@I.T?0<UP/B#6TU:[U1M)U21[;[-IR+-:S':&:[(8JPXSM(!(^AZ5O\
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MZH65TT?IYNZ(?GL+?F:Y'P=+:)!X832;V>;4&R-1@,[L$A\MS\Z$X0!O+VG
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M2-7_ ._D/_Q='_"6ZQ_T)&K_ /?R'_XNNJHH Y7_ (2W6/\ H2-7_P"_D/\
M\71_PENL_P#0D:O_ -_(?_BZZJB@#E?^$MUC_H2-7_[^0_\ Q='_  ENL_\
M0D:O_P!_(?\ XNNJHH Y7_A+-8_Z$C5_^_D'_P 71_PENL_]"1J__?R'_P"+
MKJJ* .5_X2W6?^A(U?\ [^0__%T?\);K/_0D:O\ ]_(?_BZZJB@#E?\ A+=9
M_P"A(U?_ +^0_P#Q='_"6ZQ_T)&K_P#?R'_XNNJHH Y7_A+=9_Z$C5_^_D/_
M ,74<WB75+C8)? NKN(W#J#)#C<.A^_SCK]:ZZB@#C-0U[4M2M#;S^"-9 W*
MZNDL 9'4AE8'?U! -6?^$MUG_H2-7_[^0_\ Q==510!QEKKVI6EQ=7">"-9:
M6[D#RNTL!)P H ^?@ #@?7N35G_A+=9_Z$C5_P#OY#_\77544 <K_P );K/_
M $)&K_\ ?R'_ .+H_P"$MUG_ *$C5_\ OY#_ /%UU5% '*_\);K'_0D:O_W\
MA_\ BZ/^$MUG_H2-7_[^0_\ Q==510!RO_"6ZS_T)&K_ /?R'_XNC_A+=9_Z
M$C5_^_D/_P 77544 <K_ ,);K'_0D:O_ -_(?_BZ/^$MUG_H2-7_ ._D/_Q=
M=510!RO_  ENL_\ 0D:O_P!_(?\ XNC_ (2W6?\ H2-7_P"_D/\ \77544 <
MC#XEU2W#B+P+JZ[W+M^\A.6)R3]^I/\ A+=9_P"A(U?_ +^0_P#Q==510!RO
M_"6ZQ_T)&K_]_(?_ (NC_A+=9_Z$C5_^_D/_ ,77544 </\ VOJ3:T-5D\&Z
M[),D9CB1YX#'$#C<5&_J<#)_Q-6HO$NJ0/*\?@75U:9]\A\R'YFP!G[_ * #
M\*ZZB@#E?^$MUC_H2-7_ ._D/_Q='_"6ZS_T)&K_ /?R'_XNNJHH Y7_ (2W
M6?\ H2-7_P"_D/\ \75:]U[4K[R#+X(UE7MIEFB=)8 589']_H02I]B:[.B@
M#E&\6:RRD#P5K"DC&X209'_C]06&OZEIMC#96W@?6!%"NT9EA)/J2=_))R2?
M4UV5% '*_P#"6ZS_ -"1J_\ W\A_^+H_X2W6?^A(U?\ [^0__%UU5% '*_\
M"6ZS_P!"1J__ '\A_P#BZ/\ A+=9_P"A(U?_ +^0_P#Q==510!RO_"7:SNQ_
MPA&K],_ZR'_XND;Q7K+(5_X0K6%R,9$D&1_X_75T4 <1I6LZEI%JT$/@O7)3
M)(TLLLTT#/(YZLQW]>@^@%7?^$MUG_H2-7_[^0__ !==510!RO\ PENL_P#0
MD:O_ -_(?_BZ/^$MUG_H2-7_ ._D/_Q==510!RO_  ENL_\ 0D:O_P!_(?\
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M *$C5_\ OY#_ /%UU5% '*_\);K/_0D:O_W\A_\ BZ/^$MUG_H2-7_[^0_\
MQ==510!RO_"6ZS_T)&K_ /?R'_XNC_A+=9_Z$C5_^_D/_P 77544 <K_ ,);
MK/\ T)&K_P#?R'_XNC_A+=9_Z$C5_P#OY#_\77544 <K_P );K/_ $)&K_\
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MR'_XNMO2+^YU*S,]UIEQIT@<KY-P5+8XY^4D8_PJ_10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>ebs20191231exhibit1048002.jpg
<TEXT>
begin 644 ebs20191231exhibit1048002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLES$%6>,8&\8;. 64D'#8/2M"_\ %4.G1R23:7J3);PB>Z9(E(MU()^8[N2
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M_P"%D:!_<U/_ ,%L_P#\35;1?%<T-A'=:W=S/(]A#<F 6BJ=TDA10FUCG<<
M#Z$GD@;(\3Q>0[-IFI)<K,L/V0P R,S#(P0=F, \[L#'.#0!G_\ "R- _N:G
M_P""V?\ ^)H_X61H']S4_P#P6S__ !-/F\8EY],CM-.N2;C47LKJ.1%#P,L3
M/C[V,\*<@D;<]\5):>*X?LENBQW>IW<YG81V\"JX2.4H6(+8 !P.N6[#L "#
M_A9&@?W-3_\ !;/_ /$T?\+(T#^YJ?\ X+9__B:LGQII\A@6RM+Z_DGMC<K'
M;PC<$#%6SN(P0PP0><^M+_PFFG2&,V=M>WL;V\5R[VT(;RHY,[25)#'H>%!(
MH J_\+(T#^YJ?_@MG_\ B:/^%D:!_<U/_P %L_\ \375UB7?BBVLKMHI;*^^
MSQSI;R7@B B21B !R0Q&6 R 1SUH S_^%D:!_<U/_P %L_\ \31_PLC0/[FI
M_P#@MG_^)K2M?$UM>:D;2"SO6C$\EO\ :A$#%YB9W*2#D<@C) !/0]*LZGJP
MTZ2&%+&[O9Y@Q6*V0$@+C))8A1U'4Y/;- &)_P +(T#^YJ?_ (+9_P#XFC_A
M9&@?W-3_ /!;/_\ $U;C\9Z?<2V,5K:WMS)?1&5$CA&8U#[&+Y(V[6X/]:DL
M?%=C?W-M&D%U'!>EEM+J2,"*X(!.%.<\@$C(&0.,T 4/^%D:!_<U/_P6S_\
MQ-'_  LC0/[FI_\ @MG_ /B:ZNB@#E!\1] (^YJ?_@MF_P#B:/\ A9&@?W-3
M_P#!;/\ _$UU=% '*?\ "R- _N:G_P""V?\ ^)H_X61H']S4_P#P6S__ !-9
M6F>.-3N/ MQ=WBQ0ZS!:QW*X7Y)HI"-LBC\2I'8CW%='=>+K"TN9T:"[>WM9
M1#<WB1@PP.<<,<YXW#) (&>2* */_"R- _N:G_X+9_\ XFC_ (61H']S4_\
MP6S_ /Q-6_&.KWVDZ;;?V=$[3W5W%;B1$5_+#, 3AF )QD#MGK5B+Q%:+8">
M0S/Y=ZNGNQ0 F8R"/. <8W'\J ,S_A9&@?W-3_\ !;/_ /$T?\+(T#^YJ?\
MX+9__B:9?^.=L8;3=*O9U74$LWE:)0A/F^6X4EAD\'';)&>^'V7C'9=WD-_:
MW1BCU-K-;I(1Y4>6"HK'.<DL!D CD9Q0 ?\ "R- _N:G_P""V?\ ^)H_X61H
M']S4_P#P6S__ !-7QXLL6NQ$(+K[,;G[(+WRQY!FW;=F<Y^]\N<8SQFI]%\0
M6^NM,;6UNTAA9D\^6,*CLK%6"G.3@@]J ,G_ (61H']S4_\ P6S_ /Q-'_"R
M- _N:G_X+9__ (FM"+Q59S7ODI;79M_.> 7OE#R#(N=PSG/!4C=C;D=:CMO&
M.GW+0DVUY#!=(TEI<2Q!4N0JECMYR/E!(W 9 XH I_\ "R- _N:G_P""V?\
M^)H_X61H']S4_P#P6S__ !-2+XWM;BS,UOI]\IELGN[,S1!5N54 G;\W^T.N
M..1FG:?XP2X73;>?3[W[;=VD=S(L40*Q(Q*ER=W"Y&>YP1QUP 0_\+(T#^YJ
M?_@MG_\ B:/^%D:!_<U/_P %L_\ \35VW\6V4LR)<6E[8QRPO/#-=1!$E1 "
MQ')*X!SA@#BJ&J>.#;Z)<7EII-\LHA6:W^TPA4E0LJ[AAN,;AP<-R.* '?\
M"R- _N:G_P""V?\ ^)H_X61H']S4_P#P6S__ !-:<OB:R@M-3N9HKB,:4BO<
MH5&X9C#X&#@G##OUIE_XHMM.N)4ELKYK>"1(Y[M(AY43-C&22"?O#)4$#- &
M?_PLC0/[FI_^"V?_ .)H_P"%D:!_<U/_ ,%L_P#\36OHE_/?-J0G*G[-?201
MX&/E 7'\S61<>,1/?Z3'86]PMK>7YA-U+$/*F14D+;#G(^91@D#(SC(H /\
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M%,R$[2W.",<$DXSCM0!'_P +(T#^YJ?_ (+9_P#XFC_A9&@?W-3_ /!;/_\
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M=H^4<#WK6;QA9H[%K*^%O#(D5Q<^6OEV\C8^5OFSD;@"5! /4\41^,;*2\$
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M% '.^'?#;Z3?S7LMOIENSQ")8["VV#KDL6/S'/''08[UT5%% !1110 4444
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M]F.=I SPO4GGCBM;3]&UA==M=3U2_M9A:V<EJJ00LFXLT9WG)/)\OIVKH:*
M.=U#1-8?6KV_TV_M85OK2.V=9H6<IL,AWC!'/[SI67+X>A/B;1-.LQ<?9=,M
M$2\+Q,$E2(JT WD89@^3@9_BSBNVHH SM6TQM2DT]ED"?8[Q;@Y&=P"L,?\
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ME_M:6Y0Q_;$N/*VG.U(&C1<^S.[?B*Z.B@#G$\,2^1#')<HQ_M=M1G(4_/\
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M!4,.@YY/%=510!C:GI5^^KP:MI=Q;QW$<#V\D=RA9'0L&!X((((_')^M4/\
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M+PQHE]=K:+JGB:&X:#[1Y4]_-&P3>4Y!/'(_*@#O**\]U#0=#T_4_P"S6O\
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M8 $Y<+D]3R.]<W?PPLM[%X629+*XL5LI9D#[9)Y9416!/WF5"Y9O<9->DT4
M<WK\,'AKP1JO]FQLLC0N$^8L[S. BDD\DEBM<M<6\2072^&1=>0VE_89YV$F
M9;B61$C)W<ET!<D]L@'V]$OK"WU&%(;I"\:2QS!02/F1@RY]>0#CVJS0!YUK
M.CFVNM1L-,CN(T>UM[(299F>2XE E<D]2$1234?B'2K:*76;=;:1+"233[:4
MG>X9C*6EE;KD[& S^=>DT4 <[:PI;^.Y(+1 D$6D1)(J]%Q(_EC\A)7157M[
M&"VN+FXC4^;=.'E8G). % ]@ .GU]35B@ HHHH **** "BBB@ HHHH ****
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M_8V#-\OE%BQ&/<GG\*S+?P-I<+6)>YU"X&G2K):+-<EEAVC 4#H1CCG)XZT
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M $6M=57*Z]_R4+PG_NWO_HM:ZJ@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *YCQG_I<^@Z2.?MFJ1NZ^L<0,K?JB_G73US>I6FHR^/-)O5T]Y["UM9
M4\Y9$ CED*@D@L"0%4] ?O?6@":Z\':3=^)8O$$L>;R$KM^1-O 8<_+R3D')
MY&T8(JO'X8T;PU?ZCXGBCQ,8I99LH@4 #/&%^7 !''7)SD\UTU<[XV@U34/#
M\^DZ78R3OJ"&&299$18$) 8G<P)RI;H#TH =X$M'L_!6EK+_ *V:'[1+Z[Y"
M9&_5JZ"F1QI#$D4:A410J@=@*?0 4444 %%%% !1110 4444 %%%% !1110
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M$DBJ9UBE1%D)8@$X'7N<UT7@)-[ZM<PP"PM6G6)=-\PLUK(@(?<.BELJ<#C
M!SS0!-GXB?W/#/\ WW<?X49^(G]SPS_WW<?X5U5% '*Y^(G]SPS_ -]W'^%&
M?B)_<\,_]]W'^%=510!RN?B)_<\,_P#?=Q_A1GXB?W/#/_?=Q_A7544 <KGX
MB?W/#/\ WW<?X49^(G]SPS_WW<?X5U5% '*Y^(G]SPS_ -]W'^%&?B)_<\,_
M]]W'^%=510!RN?B)_<\,_P#?=Q_A1GXB?W/#/_?=Q_A7544 <KGXB?W/#/\
MWW<?X50N=:\=VNMV.D/#X>-Q>QRR1L&GV 1[<Y/7/S#M7<URNK_\E*\.?]>E
MY_[3H ,_$3^YX9_[[N/\*,_$3^YX9_[[N/\ "NJKAH;+58E\86EMJ<UQJ+01
MF*XE8(0YB.-N,!!GIZ?K0!?S\1/[GAG_ +[N/\*,_$3^YX9_[[N/\*YF]U27
M0GNVT/3KS2X_[%FE=;I2,2H\8$FTDY*ASENC>IQ76)X9TG2I+*]AOIK6X25
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MW<?X49^(G]SPS_WW<?X5U5% '*Y^(G]SPS_WW<?X49^(G]SPS_WW<?X5U5%
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M@ [?ZXY&[KZ'&.GM50>"M)1I#%+J<"R2-(4AU.XC3<S%F(57 &22>/6N@HH
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M_HM:NGP=I7V^>]1]0BFN9O.E\G49XU=_4JK@= !TZ#%4M>_Y*%X3_P!V]_\
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M\SN[RK]UG9B2V/<GH/2KMQIMK=7UI?2QDW%F7\EPQ&W<,,..H(QP?0>E6J*
M*<6EV<+WS)$0;]]]Q\Q^<[ GX?*H'%9MEX.TO3V@^S3:FB6Q7RX_[3N#&H7H
M-I?!''3&,5O44 9^K:+9ZS%$MT)5D@?S(9H9&CDB;&,JPY'!((Z&JL7A32TM
M+FWE6>Z-VR-/-<3L\DA0@IELY !' &!U]36U10!D:AX:L=0O3?"6[L[ID"/-
M9W#1-(HZ!L'#8SP2,BG6?AG2;#[*8+=@]I*\\;M*S,9'4JS,2<L2">N:U:*
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M%;N\DOEM&TC*H*J5.Y<D\\=*ZR@ HHHH **** "BBB@ HHHH **** "BBB@
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MJMQZC#"C3-4MM6@EFM2Q2*>2!MPQ\R,5;\,@T 7**** "BBB@ HHHH ****
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MWH S-+57^(?B-64,K6=D"",@C]]6\NF6"0M"MC;K&^W<@B7#;0 N1CL%&/3
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M+@^^>*FLO"USI]E!96GB?5HK>WC6.)!%:850, <P4 =!16+_ &%J/_0V:O\
M]^K3_P",4?V%J/\ T-FK_P#?JT_^,4 ;5%8O]A:C_P!#9J__ 'ZM/_C%']A:
MC_T-FK_]^K3_ .,4 ;5%8O\ 86H_]#9J_P#WZM/_ (Q1_86H_P#0V:O_ -^K
M3_XQ0!M45B_V%J/_ $-FK_\ ?JT_^,4?V%J/_0V:O_WZM/\ XQ0!M45B_P!A
M:C_T-FK_ /?JT_\ C%']A:C_ -#9J_\ WZM/_C% &U16+_86H_\ 0V:O_P!^
MK3_XQ1_86H_]#9J__?JT_P#C% &U16+_ &%J/_0V:O\ ]^K3_P",4?V%J/\
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M-%=77*?$3_D"6'_86M/_ $:*ZN@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *Y75_P#DI7AS_KTO/_:==57*ZO\ \E*\.?\ 7I>?^TZ .JHHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#E=>_Y*%X3_ -V]_P#1
M:UU5<KKW_)0O"?\ NWO_ *+6NJH **** "BBB@ HHHH **** "BBB@ HHHH
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M6A9UR@6>-W&<X. IZ'G'% $?B+7]4T*.2XBT:*ZM4VJC_;-CR.Q "*FPY))
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M-%M]1N;$V37"[UA+[R%/W3G ZC!QCO698^+)+NXLI)-.\K3M1F:&SNO.W,[
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MR@ME8L(8UC!/? Q0!S7Q$_Y EA_V%K3_ -&BNKKE/B)_R!+#_L+6G_HT5U=
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MD=G,8I)%(;*A@R]?J* &?V_XT_Z$:/\ \'$?_P 31_;_ (T_Z$:/_P '$?\
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MNG1+0!F"J(P0I"@#.X'/.:J>--?>*\MK.VUE+>:PM/[0++)L%U*"/+C..JL
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MV8J0<8QBNF\-WDUYJ^OF5Y-JW,!2-V)$8-M$Q ';DD_4F@"K_;_C3_H1H_\
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M1H__  <1_P#Q-=710!RG]O\ C3_H1H__  <1_P#Q-']O^-/^A&C_ /!Q'_\
M$UU=% '*?V_XT_Z$:/\ \'$?_P 31_;_ (T_Z$:/_P '$?\ \375T4 <I_;_
M (T_Z$:/_P '$?\ \31_;_C3_H1H_P#P<1__ !-=710!RG]O^-/^A&C_ /!Q
M'_\ $T?V_P"-/^A&C_\ !Q'_ /$UU=% ' 7S^,[[7]*U<^$(XSI@F A_M2,^
M;YBA>NWC&,]#GVK4_M_QI_T(T?\ X.(__B:ZNB@#E/[?\:?]"-'_ .#B/_XF
MC^W_ !I_T(T?_@XC_P#B:ZNB@#E/[?\ &G_0C1_^#B/_ .)JNVH^+6U!+_\
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M_P"-/^A&C_\ !Q'_ /$UU=% '*?V_P"-/^A&C_\ !Q'_ /$T?V_XT_Z$:/\
M\'$?_P 375T4 <I_;_C3_H1H_P#P<1__ !-']O\ C3_H1H__  <1_P#Q-=71
M0!Y[?V_B+4KN2XN? SD3!1/"OB +%,%Z;T"X/]1P<UK_ -O^-/\ H1H__!Q'
M_P#$UU=% '*?V_XT_P"A&C_\'$?_ ,31_;_C3_H1H_\ P<1__$UU=% '*?V_
MXT_Z$:/_ ,'$?_Q-']O^-/\ H1H__!Q'_P#$UU=% ''W.L>,KJUEMW\$*JRH
M48IK,:L 1C@[>#2P:SXOMH(X(/ <,<42A$1=7C 50, #Y*Z^B@#E/[?\:?\
M0C1_^#B/_P")H_M_QI_T(T?_ (.(_P#XFNKHH Y3^W_&G_0C1_\ @XC_ /B:
M/[?\:?\ 0C1_^#B/_P")KJZ* .4_M_QI_P!"-'_X.(__ (FC^W_&G_0C1_\
M@XC_ /B:ZNB@#S_Q"_C/7[.WMCX0CMA#=PW&[^U(WSL<-C&T=<=:U?[?\:?]
M"-'_ .#B/_XFNKHH Y3^W_&G_0C1_P#@XC_^)H_M_P :?]"-'_X.(_\ XFNK
MHH Y3^W_ !I_T(T?_@XC_P#B:/[?\:?]"-'_ .#B/_XFNKHH Y3^W_&G_0C1
M_P#@XC_^)H_M_P :?]"-'_X.(_\ XFNKHH Y3^W_ !I_T(T?_@XC_P#B:/[?
M\:?]"-'_ .#B/_XFNKHH Y3^W_&G_0C1_P#@XC_^)H_M_P :?]"-'_X.(_\
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MNC'<-S$JRE<Y!!QFH=*\/6 \::K;F2_:&RAM)8$;4;@A68R;B<OSG:O!R.*
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M/:I(20H)P "< <D_C71>&M<EUJ"Z$\*K):S>7YD:N(Y@5#!EW $=<$=B#R:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %1S1+/!)"^=LBE3CT(Q4E% %?3[*'3=.MK"WW>3:PI#'N.3
MM4 #/O@5GR>&+!]*CT\-/&L-RUU#*DF)(I6=G+*<>KL.1C!P<UL44 8K^%[*
M;2+S3;F>ZN1?-OFGEES*6&,$$ !<;5Q@ #'2I)_#6EW,=O%+!N@MK.2R2'/R
M^4X0,#^$:XK6HH P%\'Z>\<Z7UQ>:AYUJUH&NIMQCB;&Y5P!C.!\QR>!S2+X
M.LRTLL]_J-Q<2Q)%]HDN/WB!&WIM(  (;GISSG.:Z"B@#.TK1H-*>YE6:>YN
M+IPT\\[ NY VCH   !V JJ/"MDMZ9DN;Q(&N?M36:S8A,N=Q;&,\MR1G:3VK
M;HH P5\(6"7<,RW%X(8+HW<-J)?W,<I))(&,X)8\9P,G&*0^#=-V1(DMU&J6
M\]LP60?O(Y22P;CL3D=*WZ* ,"X\':?<>8JW%Y!%/"D-U##-M6Y55VC?QG.W
M@E2"1Q5B7PSITUMJ=L5D6/4RIG56 QM14 7CCY4%:]% %2_TZ#4DA2?=B">.
M=-IQ\R-N'X9%4++PM9V=]!=?:KR<6A<VL,TNY+?<,';QD\$CYB< \5M44 4S
MIENVL)JIW_:$MVMQS\NPL&/'KE16;%X,T2&#4H$MF$.ISB>9 Y 208(9".5.
M1GCH>E;U% &-9>&K>UOXKZXO;[4)X 1 UY*'$.1@[0 !DCC)R<=ZNP:9;V^J
M7>I)O\^[2-),GC";MN!_P,U<HH SM5T6'5GMI6N+BUN+5RT,]NX5UR,,.000
M1ZBL^+P;96MO'%97^HVA0RYDCGRSB1][!MP(/)ZXR/6NAHH YT^"-+5&BMIK
MRTMY+5+2:"";"RQH"%#$@L#@D9!!/>D?P3I[!E6\OXTEMX[:=(Y]JSQ(NT*W
M'IG)&#R>:Z.B@#%N/"FFS^<R^=!))/'.DD+[6A=$$:E../E&,'(.35S3-+BT
MN*55GN+B2>3S)9KA]SNV /8 8 &  *O44 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 444C,J*68A5 R23P!0!GW&N6-KKMGHLLF+N\C>2)>V%QP?<C)'^Z:=JFL6V
MDB!91)+/=2>5;V\0!DF;&< $@< $DD@ =37&:[#J&IZ%/XHL8K5WMYUU&SF\
M\[_*B!PF-N,,F\XSUD/TJQJ>I6TWB?PKXI\T'1Y8)HO/)^2!Y%&TL?X<XVY[
M'@T =1'JS_;X+*YTZYMWN Q1V*,GRC)&5)P?;Z^E+-KEC!X@MM#DDQ>7,#S1
MKVVJ0,?4\D?[IJP]]9B54,T;,%,F00=B@?>)[#WKA-<CU"ZT-O%UI#;.]K<#
M4[>03G>8$7'EXVX :/.1GJQH ZO6O$UGH%[86]]!<"._F$*7"!3&CDX ?YLC
MMS@CFI/$GB*R\+Z-+JM^)6BC(&R%0SN3V ) Z9/7H#63KL6F^+K73;83J]KJ
M=O,8G!&>4!##W!P?J*Y77;R^UGX;:I<ZO$T4^E6S6;[^DER'"NX]1@+@_P"V
MPH ]1AD,L*2-&T189V/C*^QP2/UJEIVLP:E?ZA9Q0S1R:?(L<OFKMW%E# CG
MI@CKBKT1#1(RD$%001WKFM%'F^*/%T<;A7,\ !!^Z3;)S0!>MO%%E=2VQ6.5
M;:\F>"VNFQY<LBYR!SD9VM@D8./<9TKZY:SLY;E+6:Z,:EO)@"EV]@&(!/XU
MY]90R2^#O!NDQJ5O;?4X1-%_%'Y#,92?0#&/^!#UKM]/N-;EO)4U'3[.WM@#
MY<D-VTC,<\94HN./<T 5;7Q7:7GA5?$5O:W4ENZY2 !/-8[MNT#=C=GC&<YX
MZUL0R-+"DCPO"S#)C<@LOL<$C\B:XW3+*"T^)6HZ9#*?L?D)J:VN1M2X<LC,
M!]!G'3+9]*GU"S@U#XC+9W-S<^4VE>;Y*73Q@L)A@@*1Z=NO>@#H=6U/^R[9
M9ELKN]=W"+!:(&<GDYY(   ZDU3TWQ-#?Q:A)/IU]IPT\ S"[5 >5W<;&;M@
M_B*V'=8HVD=@J*"68] !7.65OIUQX4EGUWRDM]7D-Q.+A]@Q(1Y:$Y'(41K^
M% &GI&KRZJ)3)H^H:=Y>,?;41=^<_=VNW3'?'6EBURQF\03Z&DF;R"W6=U[;
M22/S'RD_[PK#T(6_AHZT$OGDT"S1)8&DE,@@;#>9&K$Y( "$#/!;%9&L1ZAH
MD.F^+KJ&V0VER9+V2.<NSPSD*RXV@';E,<GA!0!V6KZR-)$2I87E_-+DK!9H
MK/M&,L=S*, D#KW%-FUQ(FLH/L=P;V]C,J6GR"1%4 L6.[:,9 ZGDBLOQ+IW
MAO62);K48[;4((/,MKJ"ZV30J2<.H!Y!(]"#BJ6G"_A\7:)J.L@1RW.@&"0M
MP%N R.Z^Q(R<?[)]* -NZ\4V%MX7D\0K'/-:QHSND:9D7:2&!!. 000>>U:%
M]?QV&F37\D<KQPQ&1EC7<Q &3@5P;1/'\(_$=S)E8[UKVY@!X_=N[%#^(P1]
M:[/5F4>%KU]PV_8I#G/&-AH 1M?M$T6SU0I)MOA%Y$( WNTF-J]<9Y]<#!.<
M4V+Q%8[-0-V6LGTP!KI9B/D4C<&R"05(SCZ$=:R8-(_MGP'H'EW8M9[."UNX
M)V7<JNB#[PR,J02#R.M<SKFE:OKNB^)]911<+<"VCMTAC*?:8H'WNRJ22026
MV_W@OH10!W#^(FCTXZD^CWPM-H<-A-VT]&*;L@=_4=P*+OQ196DMV&CE>"Q=
M([NX4#9 S8.#SDX#*3@' (]\68-;TN]TV.]@NXI[><#9M(8N3_#CKGMCK7%7
MD;VOA?QQITJDWEU?3&&+^*7SU01;?7)^7ZJ?2@#K[_Q':V-Q=0B&:X^PPB>[
M:$ B!#G!.2"3A2<#)P/<96Z\16L,_DVT4M[(MM]K<6^T[8CT;DC.<' '7!KE
MX$.BR>,(]0?YY+2&6-CUE7R/+^7U^=2,>I'K3/"4$GAB]O!K+>4?[#L7!D/&
M(499%_X"2,_[PH Z6Z\41QK;/8:5J.K1W$*SK)8QH5"-]W)=EY/H*;+XMM(?
M"0\2265ZML5W>244R@;L9(#$8[YST-96BQWVB_"S3K-]T6H26T=O$&^]')*<
M+D?[.X$_[IJSXXMX-/\ AMJ-K"!'!;VBQH/100 * .JHI 01D<BEH **** "
MBBB@ HHHH **** "BBB@ HHHH *9*KO$RQR&-R.' !P?H:?2$A022 !U)H \
MXM?%_B9/ 4GBR2>QG^S3.)K0VY0.BR;#M<-PW?D&NV_M_2TL;:[NKV"T6YA6
M9%N)50A2 <G)[9&:XGX>:#I7B#P/$M]YEU +R9FM_M#^4Q$I*[D!P>QP>.]6
M_$.HZ>->UNP5H+&Z7252264Y>Y0A]L<2$XP"3DX))8#'>@#MIKVUMH%GGN8H
MXG("N[@!B>@![YIEMJFGWJ%[6^MIU4;F,4JM@>IP:\YMM3LK70_ &J/J5L!:
M0F)HYI@B-F *QWG@,O0 _P!XCBGWL$<7@[Q)JNFW=K>O>7ZW<\>GRI,8X-Z;
MUR,@DJK$@\<GKW /0K/5M.U&22.QO[:Y>+&]895<KGIG!J'5UU>:..WTB6"V
MDD),EU-'Y@B4>B9&6.>YQP?:L'19?#VL>([;5].UN75;X6K1ED:/$<1.<2!%
M7'S8P&YSVX.-K7_$6G^'K5);VY@B>9MD"32B,.WN3T [GM[G (!G^%-7U>YO
M]7T;6_(EN]*DC'VF!"B3I(NY3MR<,!U'O6_<W=M90^==3QP1@@;Y'"C)Z#)K
M$\+W^BSM<Q:=JEOJ5Y*WVB]GMV# L>!R,@   *,YPO?DU1\17#6?C_PW->$+
MIS)/$CM]Q+AE&W)[$KD#ZF@#HQJ^FMISZBE];O:)G,RRJ4';&<XSGBL#POJ^
MI>(XK#6(-2M&M9T9KNQV@M!G/E[6'(/ SNZ\D8Z55TV#;XM\77$&!ISPQ>9C
M[AN AWD=L@;=WOC-7OAP%_X5]HI4#FU7)'?K0!-XH?Q#!87=]I5]9VD=G"TH
M2: R&<J,D$[AL'&. 3WJVLVL:CH-E+;B+3KRYA1YC-&9/LY*Y("Y&3GCDCUY
MZ&MXC3P]K5G=Z3J>IQQ&%0\J1W?EO%QE6(!'L1D$5#X>O&M?!^DP>);]8+VY
MA\O,\WE22'G'.0=VW&>^: )?"=_K%W'J-MK'E2RV-XT"74*;%N% !SMR<$$X
M..,C'8UT%<CX,T[^R]8UVUL;F6;11+&UKOD,@24@F558DDC.WOU)'7-==0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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..BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>ebs20191231exhibit1048003.jpg
<TEXT>
begin 644 ebs20191231exhibit1048003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "HYYTMH'FEW;$&3M4L?R&2:DHH RO^$D
MTWUNO_ *;_XBC_A)--];K_P"F_\ B*U:X_6=5UO4O&(\,:'?1::(+,75S>/
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M$#P2 9 4#(9?K_\ KY7PAXRO];ETPW?CB!;FXD7S-.&C\M\W*>8#@9 Z]LT
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M%AX-ECE0/J\\"79V#Y@T>XX].?2@#>_X233?6Z_\ IO_ (BC_A)--];K_P
MIO\ XBO.[+XD:U%'XH6_DCDEMD=M,VQ@<B8P@''WOF:/_)J*3QYKZ:+X=DO=
M;@TY[VXO(KN[^QB8+Y1 7"#\N/6@#TG_ (233?6Z_P# *;_XBC_A)--];K_P
M"F_^(KB+[Q7K-MX)EU+1_$4.N7;:A%;12#3_ +. 6QE-I/.<CGWJ]:>,+[Q/
MK&G6NCWJV,=[I<LK[X!(UO.CA2"#C..1CC/!H ZG_A)--];K_P  IO\ XBC_
M (233?6Z_P# *;_XBN8\(W7BK4]>U**_\10S6VDWIMI(ET]5-P-N<[@WR]??
MI2>//%%]HOB32K"+7(]'M+J"5Y;A[3[1AEQ@;>M '4?\))IOK=?^ 4W_ ,11
M_P ))IOK=?\ @%-_\17GLGC[6_\ A [W5(M2MI6M]46UAU!+< 2Q'&6,1Z'G
MI_\ KJU'XMOET#6[^S\9P:S+961D2-=*^S^6V1AB2>>XQ[T =Q_PDFF^MU_X
M!3?_ !%'_"2:;ZW7_@%-_P#$5Q9^(&HZ=XULK34=K:1/96YFE" >1+*/E8G^
MZ2,>@S1#XUUZ[TRPL;62#^U=4U2YM8IY(_DABB8Y;:.I QB@#M/^$DTWUNO_
M  "F_P#B*/\ A)--];K_ , IO_B*Q/#>J:E'XDNM'U#Q-I6LJD9(\H+%<QR*
M<,K1J2,#UZT[7M6UF]\80>%M#O(M/<61O;F\DA$Q5=VQ5520,YZY[4 ;/_"2
M:;ZW7_@%-_\ $4?\))IOK=?^ 4W_ ,17-:IKGBO0-#M;*\-C<:Q?ZBMC9W*J
M0A1NDKIV(P> <=*>FJ>(_#?B?3M*UK4X-6MM6240SK;"!X947=@@$@J?S_+D
M Z+_ (233?6Z_P# *;_XBC_A)--];K_P"F_^(KS;3?B?K%SX%NY;ITAUJ!H9
M8G,8VSP/,J;@O3@DJ?P[UO:S/XPM?&FG:-;^)X4AU7[1)&3IJ$VZH-P7[WS<
M'&>.E '5_P#"2:;ZW7_@%-_\11_PDFF^MU_X!3?_ !%<1KOB_P 0Z5!XRBCO
M(Y)M%73EMI/(4?-*%\PD>Y)X/2KNG^.KS5=5\-6\>VW>Z%[%J=LR#='/#&IV
M\\CDY^A% '5?\))IOK=?^ 4W_P 11_PDFF^MU_X!3?\ Q%<:?&6M?\*<MO$O
MGQ_VE(ZAI/*7&#/L^[T^[535_&=_#XRUK39_%T.B6]F\2VZ-I?VDR!D!/(Z8
M/KZT =[_ ,))IOK=?^ 4W_Q%'_"2:;ZW7_@%-_\ $5RMQJ?B2_\ %.FZ'IGB
M*&&.715O7NSIZOY[;]N=A(V@@@XSQ6UX+UZ_U>#4;/5A$;_2KQK6:2$$)*!R
M' [9':@#0_X233?6Z_\  *;_ .(H_P"$DTWUNO\ P"F_^(K5HH RO^$DTWUN
MO_ *;_XBC_A)--];K_P"F_\ B*U:* ,K_A)--];K_P  IO\ XBC_ (233?6Z
M_P# *;_XBM6B@#*_X233?6Z_\ IO_B*/^$DTWUNO_ *;_P"(K5HH RO^$DTW
MUNO_  "F_P#B*/\ A)--];K_ , IO_B*U:* ,K_A)--];K_P"F_^(H_X233?
M6Z_\ IO_ (BM6B@#*_X233?6Z_\  *;_ .(H_P"$DTWUNO\ P"F_^(K5HH R
MO^$DTWUNO_ *;_XBC_A)--];K_P"F_\ B*U:* ,K_A)--];K_P  IO\ XBC_
M (233?6Z_P# *;_XBM6B@#*_X233?6Z_\ IO_B*/^$DTWUNO_ *;_P"(K5HH
M R$\3Z5(-R27#@$C*V<QY!P1]WL013O^$DTWUNO_  "F_P#B*/#G_(,F_P"O
M^\_]*9*POB#K]_HLFC16>JP:7'>W313W4\2R+&H7.2&(_F* -W_A)--];K_P
M"F_^(H_X233?6Z_\ IO_ (BN7\*>-+F:W\1RZI?V^I6.C;7CU*WB\M9P4+,H
M&<9& ./7Z4>!O&&K7@U"V\3*B745LFHP"- NZV=<XQZJ>#[F@#J/^$DTWUNO
M_ *;_P"(H_X233?6Z_\  *;_ .(KAD\1^*+G0[;Q/+XET?2X[URUKIEY&JQO
M&&Q@RD[MV.>!_P#6/$'C6]@\7S6'_"4V^C60LX9XG^P?:Q(S#G!&#COF@#N?
M^$DTWUNO_ *;_P"(H_X233?6Z_\  *;_ .(J+3=4\GP@-6N-1&J+%;O.UTD'
MD^:HR>$[<#'X5Q_]M^-E\(CQJ=2LC!Y?VG^R?LHV^3GIYN=V[;S0!VO_  DF
MF^MU_P" 4W_Q%'_"2:;ZW7_@%-_\17 ZMX[NF\4W%M_PE=OH-A]DMY[?SK 7
M!D\Q Q'48QG]:]*TXR'3;8S70NY#$I:=8]@E./O!>V>N* *?_"2:;ZW7_@%-
M_P#$4?\ "2:;ZW7_ (!3?_$5JT4 97_"2:;ZW7_@%-_\11_PDFF^MU_X!3?_
M !%:M% &5_PDFF^MU_X!3?\ Q%'_  DFF^MU_P" 4W_Q%:M% &5_PDFF^MU_
MX!3?_$4?\))IOK=?^ 4W_P 16K10!E?\))IOK=?^ 4W_ ,11_P ))IOK=?\
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M;W BQ&ZSVVS(D=D*[P<\'&,\<XKK:* //8OAOJ::?;^'Y/$"/X?M[D3)!]E
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M]DEC@:RW(C2KD-&S[M@/8\J!_P #6G:UJ<UE?6D"745LDT4KL\D#2DLI0!0
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 97AT$:;-D?\O\ >?\
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M$@(&YL<GDX [\\C!- %^BHX//$"BX,9E_B,8(4_0&I* "BBB@ HHHH ****
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M<H =X;_Y%ZR_ZY"M&0N(V,:AG .T$X!/:L6QT_7K"RBM([W3F2)=H+6SY/\
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M$C@FH!I5U-HMU'*T:7MS,;@#)*(X8% 3W VJ">^#4OE^(O\ G[TS_P !I/\
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M@R:HV.G:]80-#'>Z<P::68EK9\Y=V<C[_3+&K'E^(O\ G[TS_P !I/\ XY0
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M?_'*/+\1?\_>F?\ @-)_\<H U:*RO+\1?\_>F?\ @-)_\<H\OQ%_S]Z9_P"
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M=NY2I(//%<//X1UN^TRVN+NRGMY]4\4QW\\%O)\]I 58;BR]&&<Y'3([UO\
MA30+OPUXUU*"YM[F_ANH@UKJ\[M+(J \P.Q/&#R, 9QSVP =W1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI'4#+:FY#.J!H\,HY* ##;P1QGY3U[;= !1110 4444 %%%% !1110 4444
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M_F-*UQ,T9D=\EC@(PY))_&KNFQ7T;2?:H[>"$*B006\A=4 SGDJOMQCM3/\
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MY+; ?7C%,.D7#:Y:ZDKQQ)@O<P E@9-A4,IP.QP<@9"KTQ4W_"1Z%_T&M/\
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M\,G[L?/^Z!Y]:[A$6-%1%"JHPJJ, "@!ODQ?\\D_[Y%'DQ?\\D_[Y%244 (
M%&   .PI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@ HHHH R/#O_'M>_P#80N/_ $8:U)(HYHVBE19$<896&01[BLOP[_Q[7O\
MV$+C_P!&&M>@#-B\.Z)!=074&DV4,]N6,4D4"H4)&#C [BIX])TV*\:]CT^U
M2Z;.9UA4.<]?FQFK=% $4%M;VJ,EO!'"K,6*QH%!)ZGCO4<&FV-JRM;V5O"R
M*54QQ*I4$Y(&!P">:;JFHPZ3I=SJ%QDQ6T;2,%ZM@=![GH/K61)K&LSW\>D6
M5O9B_CM4N+V69F,4.XD*B@<L25;N.!GOB@#<CL[6$2B*VB03L6E"H!YA/4MZ
MD^]-:PLFLQ9M:0&V&,0F,;!@Y'R].M9#ZWJ=CI?VO5;".W-O=K#<E'W(T3$*
M)4/7 +*2",@!O8UOT 126T$LL4TD,;R0DF-V4$IG@X/:B6V@N&C::&.0Q-OC
M+J#L;U&>A]ZEHH *RI/^1MMO^O"7_P!&1UJUE2?\C;;?]>$O_HR.@#5JHFDZ
M;%>F]CT^U2Z;),ZPJ'.>OS8S5NJ>K:E%I&E7.H2J76!"P1>KGH%'N3@?C0!,
M+.U F MH@+C)F 0?O,C!W>O'K38["SA>-XK2"-HD\N-EC *+_='H/:L!]6\1
MS:W)I5G#IGF6UG!/.TS2 %W+@A<9X&SOZT^'Q3*VFK>7-HD#6M^++48P^[RF
M)"AE;C*Y=#R/NL?2@#?BMH(9))(H8XWE.Z1E4 N?4GO4M%% &5X<_P"09-_U
M_P!Y_P"E,E:M97AS_D&3?]?]Y_Z4R5JT ,FABN(FAFC26-QAD=00P]P:KV^E
MZ=:6TEK;6%M#!*"'BCA55?(P<@#!JW10! UE:.L*O:PL+<@P@Q@^61T*^F/:
MA;*T2&6%;6%8IRQE01@+(6^\6'?/?/6IZ* &1QQPQ)%$BQQHH5448"@= !V%
M-AMH+<R&&&.(RN7D**!O8]2<=3[UG:AK$EOJ?V&WC1VBM'NYRW\*CA /=FS^
M"'VK*T'7-<U:#3[N270UANXXY6B25S*JL 2 .FX T =,MM MPUPL,8F=0K2!
M1N8#H">N*BCTS3XIA-'8VR2AV<.L2A@S<,V<=3W/>H-,U)KNZO[.=%2XLI]C
M!>C(PW(P^H.#[J:T: *K:9I[WHOGL;9KI>DYB4R#_@6,TRXT72KN=I[G3+.>
M5L;I)(%9CCCDD5=HH C@@AMH5AMXDBB085(U"JOT J2BB@#(O?\ D:-*_P"N
M%S_[3K7K(O?^1HTK_KA<_P#M.M>@ J*:VM[GR_/@CE\IQ(F] VUAT89Z'WJ6
MB@"&>TMKEHVN+>*4QG*&1 Q4^HSTJ-=-L$V;+&W7RT,:8B4;5/51QP#Z5:HH
M K2Z=8S6:V<ME;R6R@ 0M$I08Z?+C%/@M;:VMQ;6]O%%"!@1QH%4#Z#BJESJ
M3)KEII<"*SRQO/,S?P1+@#'N688]@WI6)X9U[7==L]/OY#HT<%VBR-"DCF55
M(R0!TS0!T-GI>G:>SM96%M:M)]\PPJA;ZX'-..FV!LQ9FRMS;*<B#REV#G/W
M<8Z\U7TC4FOTNHIT5+FRN&@F5>F0 RL/9D96_'':M&@"*2V@EFBFDAC>6'/E
MNR@LF>#@]LU+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M14<\(G@>(O)&&&-T;;6'T/:@"2BLK^P4_P"@EJ?_ (%M1_8*?]!+4_\ P+:@
M#5HK*_L%/^@EJ?\ X%M1_8*?]!+4_P#P+:@#5HK*_L%/^@EJ?_@6U']@I_T$
MM3_\"VH K>*D,<>EZB?]5IVH1SS?[*%7C+?1?,W'V!K.D\$C6#K$^KW-S'+J
M4K+LM[EE185&V,%1P3@;OJQK9.@1L"#J.I$'@@W;4O\ 8*?]!+4__ MJ ,B&
M+4;G4_#-IJ&QK[3XY+F\>-LK_JVA4Y_VRY('^R?2NLK)_P"$?C!)_M'4LGJ?
MM;4O]@I_T$M3_P# MJ -6BLK^P4_Z"6I_P#@6U']@I_T$M3_ / MJ -6BLK^
MP4_Z"6I_^!;4?V"G_02U/_P+:@#5K*F_Y&VT_P"O"?\ ]&14?V"G_02U/_P+
M:LV714'B>UB^WZAS93-N^U-N&'BXSZ<_RH Z>BL.]TZTTZREO+K5=42&%=SL
M+EV('T&2?PKGAXK\(,[1CQ+JY=0"R@7.1GI_!0!WM%9*Z%&RAAJ6IX(R/]+:
ME_L%/^@EJ?\ X%M0!JT5E?V"G_02U/\ \"VK(N;S0;2PN;Z?Q!J2V]K<FUF<
M3RG;*#@K@#)Y(Z<4 =917'Z;JOAO5[U;*S\2:@URX)2*2>6)GQUP' S^%:E]
MI]GIMC/?7FKZE%;VZ&21S=.=JCJ<#F@#<HKG3#I@T4ZS_;FH&P$'V@SK=.1Y
M>,[N.>E6HM&AGA2:/5-39)%#*?M;<@\B@#8HK*_L%/\ H):G_P"!;4?V"G_0
M2U/_ ,"VH U:*P18V3:F^FC5]2^UI"L[1_:GX0L5!STZJ?RJS_8*?]!+4_\
MP+:@#5HK*_L%/^@EJ?\ X%M1_8*?]!+4_P#P+:@#5HKG=6ATW0[5;K4=9U2*
M)Y%B4B>1RS'H %!/--"Z2;N&T_MZ_$T\9D1&NW!Q\@P<]#^\3Y3@G=TH Z2B
MN89]&5[A/[>U!FMEW2*ET[G&"?E SNZ'A<XJ?2[73]:T^._T_6-3FMY"P5_M
M$BY*L5/# $8((H Z"BLK^P4_Z"6I_P#@6U']@I_T$M3_ / MJ -6BLK^P4_Z
M"6I_^!;4?V"G_02U/_P+:@#5K(\56$VJ>%M2L[8;IY;=O+7^\PY _$C'XT[^
MP4_Z"6I_^!;4?V"G_02U/_P+:@# OK";6-;M]?M=#L=8LKG34C5+N54,;;V;
MH4;LP%1S:-=6'A%-#F\I;C4M17R;>!BT=LAE$A520/E1%8]!ST XKHAX?C48
M&HZD![7;4?\ "/QD@G4=2R.A^UMQ0!K45E?V"G_02U/_ ,"VH_L%/^@EJ?\
MX%M0!JT5E?V"G_02U/\ \"VH_L%/^@EJ?_@6U &K165_8*?]!+4__ MJ/[!3
M_H):G_X%M0!JT5E?V"G_ $$M3_\  MJ/[!3_ *"6I_\ @6U &K165_8*?]!+
M4_\ P+:C^P4_Z"6I_P#@6U &K165_8*?]!+4_P#P+:C^P4_Z"6I_^!;4 :M%
M97]@I_T$M3_\"VH_L%/^@EJ?_@6U &K165_8*?\ 02U/_P "VH_L%/\ H):G
M_P"!;4 :M%97]@I_T$M3_P# MJ/[!3_H):G_ .!;4 :M%97]@I_T$M3_ / M
MJ/[!3_H):G_X%M0!JT5E?V"G_02U/_P+:C^P4_Z"6I_^!;4 :M%97]@I_P!!
M+4__  +:C^P4_P"@EJ?_ (%M0!JT5E?V"G_02U/_ ,"VH_L%/^@EJ?\ X%M0
M WP[_P >U[_V$+C_ -&&M>N7T+14EM[L_;]07;?3K\MTPSB0\GWK3_L%/^@E
MJ?\ X%M0!JT5E?V"G_02U/\ \"VH_L%/^@EJ?_@6U $?BVRGO_"]]!;(9)@@
MDCC'5RC!POX[<?C5.2*^75E\2:%#!?P:C:1I- \WE$A2S1NK8(Z.P(..U:']
M@I_T$M3_ / MJ0>'XU&%U'4@/07;4 8VM0ZQ<>$[ZSU22(WFKSBWMK:#E;=7
MP-H; +;5#.2?0XX%=?62?#\9()U'4B1T_P!+;BE_L%/^@EJ?_@6U &K165_8
M*?\ 02U/_P "VH_L%/\ H):G_P"!;4 :M94G_(VVW_7A+_Z,CH_L%/\ H):G
M_P"!;5FR:*@\3V\7V_4.;*5MWVIMWWX^,^G- '3UB^+[6:[\,72V\;22Q&.X
M6->K^7(LFT>YV8_&I?[!3_H):G_X%M1_8*?]!+4__ MJ ,MUU=/$<^MZ18VN
MH6FH6-ND;O=^5C:9&S]UL@B053O]'NK;PO=6%R\<FIZ]J"LXASL5F9<[<\D)
M''G)Z[:WQX?C4 +J.I #H!=M0?#\9()U'4LCH?M;<4 :U%97]@I_T$M3_P#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %94W_ "-MI_UX3_\
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ME)I5II:V@%G9O&\$6]OD9&W*<YR<$=S5?4?!^AZI>2W=U:/YLZA9_*N)(EG
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M<_\ M.M>LB]_Y&C2O^N%S_[3K7H **** "BBB@ HHHH **** "BBB@ HHHH
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MG_I3)6K65X<_Y!DW_7_>?^E,E:M !1110 4444 %%%% !1110 4444 %%%%
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M$5W]I6URL:/+M("@G)Z')_'C- $B>*;73FUFYN4U!I8KJ"$6C,KGS9(T*QQ
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MU)=Y;B7YG*D^I[T[5M2N#?\ B2*&^DBMI=:L+2>>.0@P1,B+)@_P\Y!/;)H
M]$U"_MM+T^XO[R3R[>VC,DC8)PH&3P.34\;K+&LB_=< CZ&O//%VAZ'IFA:]
M96=S.DC:4UP=/\YV0;2<2\YP<\=><=#BC5-&DDU"R@L+:'5K:VTY,Z2VH/!)
M$68GSE/1L].3QMX- 'HM%8O@^^M]1\*:?<VLEW)$8R@:\8-+E6*G<1P3D'GO
MUK:H R/#O_'M>_\ 80N/_1AK7K(\._\ 'M>_]A"X_P#1AK7H **** "BBB@
MHHHH **** "LJ3_D;;;_ *\)?_1D=:M94G_(VVW_ %X2_P#HR.@#5HHHH **
M** "BBB@#*\.?\@R;_K_ +S_ -*9*U:RO#G_ "#)O^O^\_\ 2F2M6@ HHHH
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MO"A651T"[B0V/[P/-:$GB4Z)K'BZ]NY)KBVLWLQ##YGRJ7C48&3A068$G\:
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M% !1110 4444 %%%% !1110 5E3?\C;:?]>$_P#Z,BK5K*F_Y&VT_P"O"?\
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M;_KPE_\ 1D= &K1110 4444 %%%% &5X<_Y!DW_7_>?^E,E:M97AS_D&3?\
M7_>?^E,E:M !1110 4444 %%%% !1110 4444 %%%% &1>_\C1I7_7"Y_P#:
M=:]9%[_R-&E?]<+G_P!IUKT %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %94W_(VVG_7A/_Z,BK5K*F_Y&VT_Z\)__1D5 &K1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% &1X=_X]KW_ +"%Q_Z,-:]9'AW_ (]KW_L(7'_HPUKT
M %%%% !1110 4444 %%%% !65)_R-MM_UX2_^C(ZU:RI/^1MMO\ KPE_]&1T
M :M%%% !1110 4444 97AS_D&3?]?]Y_Z4R5JUE>'/\ D&3?]?\ >?\ I3)6
MK0 4444 %%%% !1110 4444 %%%% !1110!D7O\ R-&E?]<+G_VG6O61>_\
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MBB@ HHHH **** "BBB@#(O?^1HTK_KA<_P#M.M>LB]_Y&C2O^N%S_P"TZUZ
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MOAW6%U_P_9:LL1A%U$',9.=A[C/?G->8P0:$[>(9[_PMJ^I7:ZK>;;FSA<@
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M.)LA!EAE?F!!STZT:7XVDEUF#3+V?1[E[N&1X7TR\\T(R+N*.#STR0W?!XH
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M%% !1110!D7O_(T:5_UPN?\ VG6O61>_\C1I7_7"Y_\ :=:] !1110 4444
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M_!*1?#&K([.OBB=79MS,+"V!+>I^3KS0 GCV[N$\/?V78L%OM8E6Q@/]W?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K*F_Y&VT_Z\)__1D5
M:M94W_(VVG_7A/\ ^C(J -6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZAK-WI?AVSM'^P%5NKN\D81B0C/EJ%!+$ @D\ 9J]H.J:A?BZM]5TUK*[LY
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MB@ HHHH **** "BBB@ HHHH *888B<F-"3_LBGT4 (  , 8 [4M%% !1110
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M &G6O0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME?\ 7"Y_]IUKUD7O_(T:5_UPN?\ VG6O0 4444 %%%% !1110 4444 %%%%
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MY!\T -^'7_)/=$_Z]5KI:YKX>QW-OX(TVTO+*XLY[:(1/'.FTDCN!GIS72T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9'AW_CVO
M?^PA<?\ HPUKUD>'?^/:]_["%Q_Z,-:] !1110 4444 %%%% !1110 5E2?\
MC;;?]>$O_HR.M6LJ3_D;;;_KPE_]&1T :M%%% !1110 4444 97AS_D&3?\
M7_>?^E,E:M97AS_D&3?]?]Y_Z4R5JT %%%% !1110 4444 %%%% !1110 44
M44 9%[_R-&E?]<+G_P!IUKUD7O\ R-&E?]<+G_VG6O0 4444 %%%% !1110
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MO%&@WFHG3K;5[26[R5$2R@DD=0/4CT%6;2REATM;.\O9;U]A5YW 1W!S_=
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M#<'H*Z?7I#9^+/#5]%PUS++92@?QHT9<9^C1@_B?6@#IZ*** "BBB@ HHHH
M**** ,CP[_Q[7O\ V$+C_P!&&M>LCP[_ ,>U[_V$+C_T8:UZ "BBB@ HHHH
M**** "BBB@ K*D_Y&VV_Z\)?_1D=:M94G_(VVW_7A+_Z,CH U:*** "BBB@
MHHHH RO#G_(,F_Z_[S_TIDK5K*\.?\@R;_K_ +S_ -*9*U: "BBB@ HHHH *
M*** "BBB@ HHHH **** ,B]_Y&C2O^N%S_[3K7K(O?\ D:-*_P"N%S_[3K7H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/4/^/1+>%Y))^,G:@&>._''>@"/_ (1#3IOM'VZ6YOS=62V4YN'!+HK,P)(
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M]JNSZ9/>^*]/ED1A9Z1 SI(V/WTSC9_XZF[/NX]*WJ* "BBB@ HHHH ****
M"BBB@#(\._\ 'M>_]A"X_P#1AK7K(\._\>U[_P!A"X_]&&M>@ HHHH ****
M"BBB@ HHHH *RI/^1MMO^O"7_P!&1UJUE2?\C;;?]>$O_HR.@#5HHHH ****
M "BBB@#*\.?\@R;_ *_[S_TIDK5K*\.?\@R;_K_O/_2F2M6@ HHHH **** "
MBBB@ HHHH **** "BBB@#(O?^1HTK_KA<_\ M.M>LB]_Y&C2O^N%S_[3K7H
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MG_I3)6K65X<_Y!DW_7_>?^E,E:M !1110 4444 %%%% !1110 4444 %%%%
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M_K_O/_2F2M6@ HHHH **** "BBB@ HHHH **** "BBB@#(O?^1HTK_KA<_\
MM.M>LB]_Y&C2O^N%S_[3K7H **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%% !1110 4444 %%%% !1110!D>'?^/:]_["%Q_Z,-:]9'AW_CVO?^PA<?\
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M(7'_ *,-:] !1110 4444 %%%% !1110 5E2?\C;;?\ 7A+_ .C(ZU:RI/\
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M,;W+/<7#KU6&/&1_P)F5<^FZH?#.IW9N-8TO5;CS;G3+HD2N -UNXWQL<8'
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M?B@]: -RBBB@ HHHH **** "BBB@#(\._P#'M>_]A"X_]&&M>LCP[_Q[7O\
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M')Z>M $]%%% !1110 4444 %%%% &1X=_P"/:]_["%Q_Z,-:]9'AW_CVO?\
ML(7'_HPUKT %%%% !1110 4444 %%%% !65)_P C;;?]>$O_ *,CK5K*D_Y&
MVV_Z\)?_ $9'0!JT444 %%%% !1110!E>'/^09-_U_WG_I3)6K65X<_Y!DW_
M %_WG_I3)6K0 4444 %%%% !1110 4444 %%%% !1110!D7O_(T:5_UPN?\
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M **** "BBB@ HHHH **** "BBB@ HHHH R/#O_'M>_\ 80N/_1AK7K(\._\
M'M>_]A"X_P#1AK7H **** "BBB@ HHHH **** "LJ3_D;;;_ *\)?_1D=:M9
M4G_(VVW_ %X2_P#HR.@#5HHHH **** "BBB@#*\.?\@R;_K_ +S_ -*9*U:R
MO#G_ "#)O^O^\_\ 2F2M6@ HHHH **** "BBB@ HHHH **** "BBB@#(O?\
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M "BBB@ HHHH **** "BBB@ K*D_Y&VV_Z\)?_1D=:M94G_(VVW_7A+_Z,CH
MU:*** "BBB@ HHHH RO#G_(,F_Z_[S_TIDK5K*\.?\@R;_K_ +S_ -*9*U:
M"BBB@ HHHH **** "BBB@ HHHH **** ,B]_Y&C2O^N%S_[3K7K(O?\ D:-*
M_P"N%S_[3K7H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R/#O_ ![7O_80N/\
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M2^FM@AF-G;B14W#(!.1SB@#H**C@E\^".7RWC\Q0VR089<C.".QJ2@ HHHH
M**** "BBB@ HHHH **** "LJ;_D;;3_KPG_]&15JUE3?\C;:?]>$_P#Z,BH
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MB]_Y&C2O^N%S_P"TZUZR+W_D:-*_ZX7/_M.M>@ HHHH **** "BBB@ HHHH
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MT@DOKI-@-N TEP6C/FB;NR]=V[H<5DZ'#80^&/"RVD=O'+_PD1%P(E4-N!G
MW8[[0 ,]L4 >IF:(2B$RH)",A-PR1]*22>&(9DE1 "!\S <GI7E30Z&_@#5M
M0U(P?\),DUP6F8C[5'="1A$JG[PZ)@#C%;>E:#8Z[XPUYM>L(;N5;6S4I,@9
M8V:([R!V.0.1SQ0!WU<DGC+5+F2^:Q\*W5Y;6-U+;/+'=1 L8V(8A"03TZ59
M^'DLDW@#1GE=G;[,%W,<G ) _0"N.TVUL)T\0BY\;W.BEM7O0;>.[AC4#S#\
MV&&[GZT >CZ9?V.O:99ZK;*)(9D$T+.OS)D$?@>2/SJ'2-=M]5-TH7R6M[R6
MT"NXS(8S@D50^']R]WX'TR1[=( L9C18T*JR*Q56 /(W  _C7%&U\+MHGC.Z
MOOLQU./4;LQR.1Y\3@GRO+[C+=,=3F@#U62:*$ RR)&"< LP&35&]UA++6=,
MTQH69M1,H5P>$V)N.?K7G<L-[J'BF>/7(]&DFCTRU,46L@[0"G[UD'3._(8]
M1@5/I7VA5\'B"\2]9?[0%M*JN%*B-M@&\ D#@ ]P!0!Z6)HC,81*AD R4W#<
M!]*7S$V[MZ[<XSGBO)A%HL?P\T[4;'R3XG::$K,"/M;W9D D5C]X_P 0(/&*
MEUS3KF\U'4O ]L73S;J75867C$9B+*![?:#0!ZKN&[;D9QG'>L*YUX6OBJ'0
M['31/-/&+FZE$JQB-"VS<>[MQT] *S/ M\?$EQ?>*F4A;E(;6 $?=5$W/C_M
MH[C_ (#535=.A7XA:E=65A;G4%T SP2"%2_G[W56!Q][  SUQQ0!W*S1-*T2
MRH9%Y9 PR/J*/-CWA/,7><X7//'6O+EAT"#PEX<OM%^SG7I+FVV2QD&XEE9A
MYPD/WB,;]P/ K?\ !6BZ>^JZYJ\EK')?)K-TD<[C+1KG&U?0?,W3UH V=>\1
MOI%]I^GVMB;Z\OV?RX_.6)55 "Q+'ZC [UM>8FS?O7;ZYXKD?$6F:?=?$/PS
M)<6-M,[1W6YI(E8G8J%,DCL22/0DUS,VI64/PBN+"2ZB6[&H21&W+CS WVPM
MC;U^[S]* /4FFB1MK2HISC!8#MG^584/C*QN8-)GMXI'BU2Z>V0L0"A4.22/
M3Y#^8K)TS0-*U7Q]XINM1L8;MX9[98A,N\)FW3. >.>,_05R^DZ9I%YX>\(V
M7V>V99=8F%W'& "Q FP'QUX &#VXZ4 >N1RQS('BD613T93D4D<T4H8QRH^T
MX;:P.#7E_B"W.CQ^-;318ELK<16$CQP*42-79A*P"],HO..P-6M+LXK3Q18&
MSGT&V$EG-YD&D*Y^T1!/E+X&T8;&&;&<D F@#T=98W8JDBL0 2 <X!Z4/+'&
MRJ\BJ7.%!.-Q]JY/X::-I]CX.TR^M[5%NKJT0S3XR\G< GT'0#L *H30:%=^
M+O$I\4BV+0QP_93=$#R[?R\EHL]#OW9*\Y ]J .JT/7(-:\/6FL[?LT5S&)-
MLC#Y!GN:DU?6K31=.%_<EFB,D<:^7@DEV"COTRP_"O+-/26XL/!MK,-/:Q.G
M2O#'J>?(DG# <@<%@I. ?>K%Y96@\&:JLTFFW-G;ZS;F-+>-C!:$R1B149QC
M;R<[3@;F% 'JTEQ!$%:2:- _W2S 9^E075[+;74<8M&DA:*21Y@Z@(5QA<=3
MG)Y'3%<#JO\ 9%]KVJQPZ=H9@L+:&-[C59-R1QE-RB"(#A<'J",GITJOX9FD
MG@\'/*Y=_P"Q+U<L<G@Q@?H* /0-)UJWU30K+5FQ;1WD2R*LCCY=PSC/K6C7
MDMG90W>F>&66?2+BYCT1,:?K,3>2Z$C+H_0/Q@\$XQTKM?!6K:=+X4TP1HM@
MDI>"WMY;GS"Q1F!",>7'RDC';Z4 =-1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 9'AW_CVO?^PA<?\ HPUKUD>'?^/:]_["%Q_Z,-:] !1110 4
M444 %%%% !1110 5E2?\C;;?]>$O_HR.M6LJ3_D;;;_KPE_]&1T :M%%% !1
M110 4444 97AS_D&3?\ 7_>?^E,E:M97AS_D&3?]?]Y_Z4R5JT %%%% !111
M0 4444 %%%% !1110 4444 9%[_R-&E?]<+G_P!IUKUD7O\ R-&E?]<+G_VG
M6O0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5E3?
M\C;:?]>$_P#Z,BK5K*F_Y&VT_P"O"?\ ]&14 :M45T325OOMRZ79B[SGSQ;I
MYF?7=C-,\1$KX:U0@D$6<V"/]PUPOAC4KS2_"QT#5)VD-SI!O-,N6/,B&+<\
M9/\ >0G_ +Y(]* /0;W3-/U((+^QMKORSE//A5]I]LCBGW-C9WEM]ENK6&>#
MC]U+&&3CIP>*\^U'P_I=]\)X-9N;=GO[?P]&T<_FN"I6'(. <'DTGB#P_I>B
M_"S4+[3K9H+BXL8?,D$KL6RR$]2<<^E 'HEO;6]G L%K!'!$GW8XD"J/H!4=
M[IMAJ48CO[*WNT4Y"SQ*X'X$5PVF:=X1;4[7[/X2URWF$JF.6:UN51&!X)).
M  ?6NXMY+UKRZ2X@BCMT9?L[I)N:08^8L,<8/'>@!1#8V-F(!';V]KQ&(PJH
MGS' 7'3DG&.^:2RTRPTU76PL;:T#G+"")4W'WP.:X/XA6#'6X;_5-+FU+2<6
ML4?ECS!;O]H4R9CSDET(4$ GMWI9+31[]?!ME9W<NI:5)=W 4SN2Q BD(0\
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M/?CBH8],T^*4RQV-LDAD\TNL2@E\8W9QUP3S5JB@",6\(DDE$,8>4 2-M&7
MS@$]\9/YU!9Z5IVG^9]BT^UMO-^_Y,*IO^N!S5NB@!D4,5O$L,,:11H,*B*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R/#O_ ![7O_80N/\
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M_P#Z,BH U:**:9$#A"ZACT4GDT .HHHH **3/.*6@ HHI"0.IQ0 M%)TZT4
M+1110 4444 %%%)D>M "T4UW6-=SL% [DX%+U&10 M%)D>M&03C/2@!:*3(S
MC/-&><4 +1244 +1124 +1133(@<(74.1D+GDT .HHHH ***3('>@!:*2EH
M**** "BD9@HRQ 'J: 01D'- "T4F12T %%%% !129SR*,XH 6BBD# D@$$CJ
M/2@!:*** "BBB@ HHHH **** ,CP[_Q[7O\ V$+C_P!&&M>LCP[_ ,>U[_V$
M+C_T8:UZ "BBB@ HHHH **** "BBB@ K*D_Y&VV_Z\)?_1D=:M94G_(VVW_7
MA+_Z,CH U:*** "BBB@ HHHH RO#G_(,F_Z_[S_TIDK5K*\.?\@R;_K_ +S_
M -*9*U: "BBB@ HHHH **** "BBB@ HHHH **** ,B]_Y&C2O^N%S_[3K7K(
MO?\ D:-*_P"N%S_[3K7H **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRN\N(];OO$5W?:-JFI"QNY+
M=;BUE""PCC  ,0+#=)G+G /4?2O5*Y2Y\-ZU;7&JQZ)J%G!9ZO(99A<0LSP2
M,H5V3! .0 <'H: .@TJ>*YTBSG@N6NHI($9)VZR@J,,?<]:MU4TO3X=)TJTT
MVWR8;2%(4+=2%&!GWXJW0 4444 %%%% !1110 4444 %%%% !65-_P C;:?]
M>$__ *,BK5K*F_Y&VT_Z\)__ $9%0!)X@U"32?#NI:C$H:2TM99D!Z$JI(_E
M7.Z/X%T*_P##]M<ZI:+?ZA>0)-/?2L3,78 DJ_5<$\ 8Q@5U\\$5S;R6\Z"2
M*5"CH>C*1@C\JY:V\.^)]+LAI6E^(+5=/0;(9+FS,EQ G900X5L#@$B@#*TG
MQ1KD&E:9IL"1:A>OJ=SIOVBY<C<L6\B0D=<!1GUP>YIOBO7];_X1KQ!I=Q]F
MM]1L8XI#-;LX26"0XRO.5;((()/ZU/J_A^71Y/"6F:'.89(+R5A<3(9=S&*1
MF+X(SN)(/(^]Q5^X\%W6IZ=K7]I:C&VHZO$D1EAA*Q0*G**JDDD9))R><]J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#(\._\>U[_P!A"X_]&&M>LCP[_P >U[_V$+C_ -&&M>@
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M<]5/H?TZ4 7Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#(\._\
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M>V$R.$&$8 D$,!QU(( XILWA*98M-FL]:N8]2T]71;VY'GF97.75U)&1D @
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M\C1I7_7"Y_\ :=:] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_'BNVM+RRGO[VWMQBXMV47'[HKDE<CYB,-QZ9Q69_P (L_\ T,>M_P#@2O\
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M^PA<?^C#6O61X=_X]KW_ +"%Q_Z,-:] !1110 4444 %%%% !1110 5E2?\
M(VVW_7A+_P"C(ZU:RI/^1MMO^O"7_P!&1T :M%%% !1110 4444 97AS_D&3
M?]?]Y_Z4R5JUE>'/^09-_P!?]Y_Z4R5JT %%%% !1110 4444 %%%% !1110
M 4444 9%[_R-&E?]<+G_ -IUKUD7O_(T:5_UPN?_ &G6O0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5E3?\C;:?]>$__HR*M6LJ
M;_D;;3_KPG_]&14 :M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJT:M&T9E"SNS)A@#DJ",'UK5FOX?$OB7P\VD6MRHT^62:YFEM7A$"&,KY9W
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M.>!R:W/^$ATK^QFUC[6/L*N4,VQNH?RR,8S][CI0!I45B77C#0;+5)-+GO\
M%Y$0'B6%W*94,"<*0!@CGIVZUST?Q'BN-,T74LQ6\%W?R6]V&5F\M0LA4 X&
M2=J] >N,4 =Y1639>*-%U"SNKN"^58K+_CY,R-"T/&?F5P"./44FF>*M&U>9
MX+.[8RI'YOERPR1,R?WE#J-R^XR* ->BLG1O%&C>(7==*O/M/EHKLRQ.%PW3
MYB "?4=1WI-2\4Z+I%X+.]O?+FV!V58G?RU_O.5!"#W; H UZ*Y;1?&5L?"&
MDZMK<Z17.H1Y6.")W:1N<A$4%C@>G2G:SXYTRP\.)K-G*EU')<I;@892K%PK
M!AC*E02<$ \>] '3T5B7OC'0M/95GNW+-"LQ6&WEE*1MR&8(IVC_ 'L43:Y'
M)>6)LK^V>"[LYKB--C,TP4*0RL. !NY!Y.1Z&@#;HKEM,\:V2^'=(O-7GVWE
M_:+<-%;6\DIQ@9;:@8A<GJ>*Z&QOK74K**]LITGMYEW1R(<AA0!8HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** ,CP[_Q[7O_ &$+C_T8:UZR/#O_
M ![7O_80N/\ T8:UZ "BBB@ HHHH **** "BBB@ K*D_Y&VV_P"O"7_T9'6K
M65)_R-MM_P!>$O\ Z,CH U:*** "BBB@ HHHH RO#G_(,F_Z_P"\_P#2F2M6
MLKPY_P @R;_K_O/_ $IDK5H **** "BBB@ HHHH **** "BBB@ HHHH R+W_
M )&C2O\ KA<_^TZUZR+W_D:-*_ZX7/\ [3K7H **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *RIO\ D;;3_KPG_P#1D5:M94W_ "-M
MI_UX3_\ HR*@"[?F[&GW!T\1-=B)C )L["^/E#8P<9Q7FFJQZ;JED\EIX3U7
M3?%;)^[>TM'@V3_WC*,(R9[DG(]Z]/GFCMH))YG"11*7=CT4 9)J"VU2QO-,
M74[:ZCELVC,@F4Y4J.I_0T <)>V5_I?BW4+W4;[6[=+ZWM_+GTFV697=$VLC
M#RW*G=DCH#N-4QH-YI<7AZ_(URRLX(KE9?(6.>YM6E<."RB,C!&<A5RO KM+
MSQMX:T\0F[U>&(7$*SQ$AOFC;E6Z=#1;^-_#5U;7%S#J\+PVJ"29P&PBDX!/
M'J10!3\%61BEU6_QJA6\G4B74@J23;4"[Q&J*4';D9. >*@\33VYU62T\2^&
MSJ6CM&K6ES;V;7#1/T=7QDJ>F" *T(/'OA:ZN([>#68'EE<(B@-\S$X Z5T-
M 'E;Z#J5UX;U-=+M=4ATB._MKBQLI_\ CX\M"#+L63) )P55NZ].:N#2I=?O
M+EK.Y\07,@TNYMTN]3B6WCC>5=H3;Y2,QR <]!CWKL-<\5:/X=:*/4;DK+*5
MVQ11M(^"P7=M4$XR>OX#)XIT_BG0[>PM+Z34H1;7IQ;R#+"0]<# ^M &)HNK
M>?;Z'I*>'+K[3:!%N/M5JT<=ELC*EE<KM8]EVGD$\BL728;B30?#M@MG="XT
MWQ 3=(UNX\M29R&R1@KAEY''(KT$:C9M>O9"X3ST0.R9Z E@.>G5&XZ\5#)K
MVEQ6US</>((K5MDS8)VGY?;D?.O(XYH X0?:;+P+J/@Z31[Z?59C<0QE;9FB
MG\QV*S>;C:  P)R00170>&M-N+/Q5KKW,3D-;V42SLAVR[8V#8)Z\]?K71V-
M[;:E917MG,LUO,NZ.1>C#UJQ0!SO@"VGL_ NDV]U#)!-'#AHY5*LO)X(/(KB
MK;3/#RW6MKKO@_4KZ[FU2Z=)8],E??&TA*E7  Z=#FO5Z* ,+P5;ZI:^$K&'
M6/,%VJME97W.J;CL5CW(7:#]*Y-;F6TT?Q3HSZ%J$EYJ5]>?90MHYCN!(2JL
M7QM4#N6(X (S7I-% 'F9TF]T#7YI;Z_UR"*>PM8H[G2K<3AWB3:R,/+=@<\C
MH#N-3Z?H5W#_ ,(O%#:W]NN;]W-R0[VYD1BI<HH5<DYQCC.*]%HH \R(NKKP
M!9^#(M'OH=6C\F!]ULXAB*.I:;S<;"/E)&"22>E3:MX7N]4\57^@O:R#1[OS
M-2\\J?+$S0F';NZ;MY\S'XUZ/10!R/P_AU*>RNM:UFUEMK^^:.-HI5*LJ1($
M'!YY;S&_X%1JFF7E]XQU(0QR1I<>'S;QW!4A!(9'P-W3(R#BNNHH \Y:2?5/
M"VB^&+?1[ZVU&UEM1-YEJR1VHB92SB0C:00IQM))S71>#;.6T&NM-;O"T^LW
M$JET*[U)&&&>HP.#7244 <[K%M/)XX\.7$<$CPPQW8DD5"53*IC)Z#.#BN.N
M'O8O 5UX6&CZE)J,=XY(2T<QE#=&3>'QM(VGH#G/:O4Z* .;T&SEA\8>*;J2
MW>-;B>V\N5D($BK HX/< Y''?-<MHEO/-I_A:R-C=>=IFL3?:U>W<"+(F(8D
MC&.5Y''(KTVB@#SOQ1H6I:G=>+DM+:<^?!I[Q[5QY_EN[.JDC!; ]^2,]:?I
MUM_:?B*RNXYO$E[]C@G+2:E EO'"73;LQY2ER?0' V@\UZ#10!@>!+62R\#:
M/;30/;RQVJ!XG0JRMWR#T.:RQ</X=\4Z]+>:9>W::J8I+5[:V:82[8PAB8J"
M%((/WL##=>M=G10!Y/8Z1J.GV7A?4+K^U[&"#39+:8V$ >:V<N&&Y&1SM(&,
MA<\#M5NYTV9/"&KW\5OK$HN-3MK@F]13-,D<D>Z01(BE1A>A&2%S7IM% 'G]
M[J-[<^(+YMVK65I/%"]D--TW+WP*9^>5HSL()VX;;M%5/#6F:C!;^%5FL;F-
MK;2;V*8/$P\MRR84\<$X./7'%>ET4 >7V]DUCI/AZ6YBUS2;N+24B%_8P-*0
MP.?)EAV,>O(R/7TKJ_#.HZC!H&EQZOI\R7=U(Z?N;78$&6*O(HXCRH!/N<5T
MM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9'AW_CVO?^PA<?
M^C#6O61X=_X]KW_L(7'_ *,-:] !1110 4444 %%%% !1110 5E2?\C;;?\
M7A+_ .C(ZU:RI/\ D;;;_KPE_P#1D= &K1110 4444 %%%% &5X<_P"09-_U
M_P!Y_P"E,E:M97AS_D&3?]?]Y_Z4R5JT %%%% !1110 4444 %%%% !1110
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M'GT.X\'ZN+1XEB)2[M V%QCGS?84 :5I/XQ:[B%YI^BI;EAYK17DK.%[X!C
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M=_X]KW_L(7'_ *,-:]9'AW_CVO?^PA<?^C#6O0 4444 %%%% !1110 4444
M%94G_(VVW_7A+_Z,CK5K*D_Y&VV_Z\)?_1D= &K1110 4444 %%%% &5X<_Y
M!DW_ %_WG_I3)6K65X<_Y!DW_7_>?^E,E:M !1110 4444 %%%% !1110 44
M44 %%%% &1>_\C1I7_7"Y_\ :=:]9%[_ ,C1I7_7"Y_]IUKT %%%% !1110
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MFL0107JL\44Z3A Q 9D.5SZC.#CVHU?2;/7-+FTV_C,EO,!N 8J>"""".A!
M-43J-Q>>,?[,MY"EOI]L)[K 'SO(2(T]@ K,?^ ^]8.J^*=2MO%K3PS :#IU
MQ#97PV YDE!R^[&0$+1 C_:- &]J?A/3M3O$OC+>6EZL8C-U9W+0R.@[,5^]
M^(IL7@W18=.2P6WD,0NENY"\K,\\JG(:1B<MR!U]!5?7=2U*X\16?AO2+E;.
M6:W>[N;LQAVBB5@H"*>"Q8XR>@'0U-IMCXATS6%BGU,ZKI<L3%I+A$2:"08Q
M]P ,IY[9&* -+5])L]<TN;3;^,O;S ;@K%3P0001T((!JG-X5TJYLM3LYHG>
M+5'$ESESEF 4 @]C\HZ=Q7/ZKXIU*V\6M/#,!H.G7$-E?+L!S)*#E]V,@(6B
M!'^T:/&?B35=#\6:0+:X"::L1FOXBBG='YB1ELD9&WS-W![4 =+_ ,(]IPEL
MI4C>-K"V>UM]CD;(V"@C\E'-9=C\/]*TV.**SOM8@BB.4B34I@@YS]T-CK5+
MQ[XCU/2[[2K+29Q"S3QRWC;%;]R94C"\@XW%S[_(:VDU&XM/&+Z5<R%X+ZV-
MQ:$@#8R$+(GN/F5A]6]J &:CX.TG4[V>YF^TI]K"BZAAN&CCN0O WJ#@\<>X
MX-3ZGX:L-4F@N"UQ:7%O&8HYK.9H7$9ZIE>J\#CMVK7HH QY?"ND2:'!HZV[
M0VMJP> Q2,KQ."2'5P<[LDG/?)SUJ%O"UO;:)J5E82S"ZU!&\R[FG=I6?;A6
M+]>., 8K>HH C@C\F".(N7V*%W'J<#K7.2?#_16:58I-0MK6=BTME;WLD<#D
M]?D!P >X&!73T4 9\&B6%MJ$-]! (I8+3[)&J'"K%D':!TZ@5 ?#&EG1VTDQ
M/]E>X^TE=YSO\WS<Y_WJUZ* .?N?!6D75Q=N[7BPWSF2YM8[ITAE<C!8J#U.
M!GL<<U+_ ,(EI/DB(QR%1IITSF0Y\@]OKQUZUMT4 <?<^#?M7C!;S?=6UI!I
M,5I!/;71CD#+(Y*\')&TKUX_$5JR^$-&?2K73HX)+>.S?S+>6&5DEB<YRP<'
M.3DYSG.>:VZ* , >#-'^P7%G*MQ.MW*DMU)+.S27)7H'8\E> -O2M"+1[.#6
M9=6A1H[F>%89=K8615/RDKT)'0'KCBK]% &+K&FW#ZSI6L64?F36CM#-'N"E
MX),!N3W4A6_X"1U-3ZOX>TW79;.34(#*UE,)H<,1\P(.#ZC(!P?05IT4 9NL
M:%9ZV+<W#3136LGF03V\ICDC8C!P1Z@D$=*IV_@S18!?AH);C^THEBO#<3-(
M9@N<$DG.?F/(Z<8Q@5O44 8=EX1TNSEDEE-S?/) ;?=?3M-MB/5!NZ ]^YIE
MAX-TJPN(YE:[G^SQM';)<7+RK;JPP0@)XXXSUQQ6_10!E:=X<TW2YK26UC=6
ML[/['%ER<19!P?4Y4<TW_A&-+P!Y3\:A_:/WS_K_ %^GM6O10!S,_@#0[BWN
M+24WALKAF<V8NW$*LQR2%!XY)..@/.*M2Z5/=^*;*ZE0K9:5;MY#%@3+,XVD
MX]%0$<XR7/I6Y10 4444 %%%% !1110 4444 9'AW_CVO?\ L(7'_HPUKUD>
M'?\ CVO?^PA<?^C#6O0 4444 %%%% !1110 4444 %94G_(VVW_7A+_Z,CK5
MK*D_Y&VV_P"O"7_T9'0!JT444 %%%% !1110!E>'/^09-_U_WG_I3)6K65X<
M_P"09-_U_P!Y_P"E,E:M !1110 4444 %%%% !1110 4444 %%%% &1>_P#(
MT:5_UPN?_:=:]9%[_P C1I7_ %PN?_:=:] !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !65-_R-MI_P!>$_\ Z,BK5K*F_P"1MM/^
MO"?_ -&14 :M</:>&]1C\7BT>#&@VMY)JD#[A@RNH CQU 5VD?TY%=NS*BEF
M(50,DDX %<W'X_\ #TDJ 3W*V\KB..\>TE6W=B< "0KMZ]\XH SM;MM9G\37
M8NK36+O3VBC%A'IMV+>,G!WB5@ZL#N[\C'O6?H.BZUX>LO#VHRZ5+<R6-O<V
MEW:PNID0/)N5TR0&^Z,\YP?K7HU% '%7D?B&\NM,\12Z/@Z?>RLFGHR^>;=X
M]FXDMM\P'G:#TXSFGZ@NO:^EO*^D&TMXM7LY8(I"HG\M'!D=\,0!Z <X'O79
M5CZOXGTS1;J.TN#<37<B>8MM:V[S2;,XW%5!P,]S0!@C0]2'@[Q?9?9&^T:A
M=7SVR9&90X^0]>_O5&[\.W=CK\VH3Z?J]Y;WMI;K_P 2N^:%XI(TVE742+N!
MZ@\X.?6NUTC6M/UVS-UIT_FQJYC<%2C1N.JLI *D>AJ_0!RVB&3PQHNE64VE
MM#)?W;(\27)E\AGW/EF8DL>.<=R>W-3^/;"\U+P==VMA;-<W#20.L2$ L%F1
MCC) Z UT#(C,K,H)0Y4D=#TXJB-;T]X+6XBG\Z*[N#;Q/$I8%P6!Y X&5;D\
M<4 9L>LZCJB3V<GAG4K(20N!+.T.T':<#Y7)YZ=*Y^\\/Z_:^$?#L^DVVW6;
M*Q%E-&7 VI)$%8DYYV.$;\#7H5% '!ZYX2:QN="GLK6^NK+3;1K.6&PNC!.J
MG;AU(9=W*\C/?/.*U_!VE/8_VC>2:=<61O)E*K=W;7$[JJX#2$LP!]@> !72
MUS,WQ \/P3W,4DEYBTE>&:5;&9HT9"0V6"D<$4 16[2:9XY\0'R6FDO;&"ZM
MHU(!E\L,C*">^=G_ 'T*S+#X=?;?"[PZOJ.HQWNHJT]Y%'=$1><_S'*#@X.!
M_P !KLDCL-4^Q:G'LG\M3);3HW\+K@X(Z@CMTX'H*6PU*UU-;@VDA<6T[V\F
M5(PZ'##GK]: ..MK3Q):_P!C>(Y-,:YU&VLVL-2M!*HDE3<")$).TG*[L$C(
M;'%:D.J>(]1U+[9%I-SI^F6EO(S6]SY?GWLN/E4 $[ ,=<C)/I7454N-3M;7
M4+.QFD*SWI<0+M)W;%W-SVX]: .,L/AU]M\+O#J^HZC'>ZBK3WL4=T1%YS_,
M<H.#@X'_  &BRT/6-:N=-_M^Q>,'1;BPO7+*<N60 \'^(*6KOJ* /-HO#OB&
M[\.O/J=INU5[RRBV!P?W%NZ_-G/<^8^/]JNCOT-[\1M(2+_F&V5Q/,?3S2J(
M/QVN?^ UTU8DVIZ1I/B$6*Q3/J6I[99!#"\IVC"!G(R$0=.PZ^] &W1110 4
M5F:QX@L-#:VCNO/DFNV*P0V\#2R28&6PJ@G ')-:= !116;_ ,)!I96Q9+I9
M$U"9H+=D!8.Z[LC/_ &YZ<4 :5%%% !1110 454TO4K76--@U&QD,EM<+OC8
MJ5R/H>:DO+VVT^W-Q=S+#$&5=S'C+$*!]22!0!/1156XU&VMKR*TE+B26-Y%
MPA(VIC=DXP.HX[T 6J*K:=?VVJZ=;ZA9N7M[F,21L5(RIY!P>15F@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** ,CP[_P >U[_V$+C_ -&&M>LC
MP[_Q[7O_ &$+C_T8:UZ "BBB@ HHHH **** "BBB@ K*D_Y&VV_Z\)?_ $9'
M6K65)_R-MM_UX2_^C(Z -6BBB@ HHHH **** ,KPY_R#)O\ K_O/_2F2M6LK
MPY_R#)O^O^\_]*9*U: "BBB@ HHHH **** "BBB@ HHHH **** ,B]_Y&C2O
M^N%S_P"TZUZR+W_D:-*_ZX7/_M.M>@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ K*F_Y&VT_Z\)__1D5:M94W_(VVG_7A/\ ^C(J
M +.KO:1Z/>OJ#%+,0/Y[ $D1[3N/'/3/2N'NK?6]!\(EC-IGB3PU!:AC%<1F
M&8VZ@$ ,,JV% Z@$X]:]"95="CJ&5A@@C((KFT^'GAM' %K.;8/O%F;N4VX.
M<_ZO=MZ]L8]J ,"]U/4M=\47]K;VVMRV5E;VY@CTR[CMB#(F_>^YU+'L!R/E
M-5FUKQ'>QZ!I-W%?222Q7$EU_9]U#'-.(W"I^\#A1P06"MG/XUVVI^%]+U:\
M6\F2>&Y$?E&:UN9(&=/[K%",CZTEQX3T6XT^TL1:&"*QYM6MY&B> ]RKJ01G
MOSSWH H^#)M5W:E9ZBERL5O,OV7[9<12SJC*"5<HS=#T)Y((J#4+&>Z\6W=W
MX;UJ&VU:"WBBO+2ZMS)%(F6:,YX(ZMRI-;^DZ-8:);O#8Q,HE<R2N\C2/*YZ
MLS,26/U-5M7\*Z3K=U'>744L=W$NQ+FVG>&0+_=W(02/8T <;J/B/4[+3M8M
M1IT-CKOVZUM[J>P8,LHEP%D4OC#;1CYNAP2:E34->T"YNYH[35$M%TRXG,.J
MWT4[>;&NY63$C-@\@CIR*ZVW\)Z';Z/<:4MBKVMT=UP)79VE;^\S$[B>!@YX
MQQ1IOA;2M+N'N8HYIYWC\DRW=P\["/\ N N3A?84 8NF:5)'9:1J-QXKO1+?
MHHG6>XS'=&2,G;&N0(V!Y4IS@=#6'X=\_3/"?A@VUY= 7>NM'*&F8@ING!7'
MH=H)'<\UV6G^#M%TR\ANK:";-OG[/')<R21V^>#Y:,Q5?P%.M_".C6NP0V\@
M2.\^VQH9W*QR_-RH)P!\[<#CGI0!R*RZC>^"+_QDVNWUOJ$7VB>*%9B+>(1N
MP6(Q_=;(4 DC.3UJ[9P7OBCQ+K$=QJ^I65O#;6CQ06EP8O+>2,DG(YXQTZ'G
M(-;D_@G0;B\DN)+:7;-+YTML+B002R9SN:(':3GVY[UJ6^FVEMJ%W?PQ[;B\
M""9MQ.[8"%XZ# )Z4 9O@G4;K5?!FEWU[)YEQ+ /,?&-Q!(S^.*Y;08/%D]O
MX@31+S2886UB]"_:H)&D#>8<G(;'_CI_&N[TS3;31].AT^QC,5M NV-"Q; Z
M]3S6-+X \/37%Q,\-V#=2O-,B7\Z([L<L=H<#DF@ ^'T]M/X'TP6D+PQ11F'
M8[[SN1BK'<,9!()S[URUKITXTCQ9K,.N7MI-9ZE>RP)#-MBC*$M\Z='R>N[/
M&,8KT:RLK73K.*SLH$@MX5VQQH,!16)+X%\/S7$\SVTV+F8SW$0NI!%.Y.[+
MH&VMSZCVZ4 <N^KZQXBUR6%K36&@MK&UD$.EW<=N5DE3>S.6=2WH!R/E.:?;
MW^J/=>$[G5$\R]@.H X=',@2-@I)0E=Q &<'KFNPU/POI>K7:7<R3PW*Q^5Y
MUK<20.R==A*$9'L:DM_#NDVIT[[/:+$-,#BU5&($>\8;C/.1W.?6@#B&FU&T
M\"6GC0:Y?3:A((;B2$S$V\@D=08A%]T##8!'.1UIFN:KKL4.I>'+"_G&J1:A
M+/#*7);[,(C.HSUQNQ'771>"=!@NTN$MI=D4OGQVQN)#;QR9SO6(G8#GGIQ6
MA_8FG'7?[<^S#[?]G^S>;D_ZO=NQCIU[]: ,;PMJ\GB/5M0U:&=SIRQ006\8
M;Y"Y3S)&QZ_O%7/^R:RM4@-C\1-1U2*:Z>6VT$W21>>VQF#N NW/W>.G3/-=
M=HVBZ?X?TY-/TNW%O;(S,$#$\DY/)YJ3^S+0ZJVJ&+-TUN+<N6.#&&+8QTZD
MT <,YO\ 2?#.C^)UUV^N[VYDM6GBDGW0W F90R+']U<!N"H!X[UI^$[:\O\
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M_O/_ $IDK5K*\.?\@R;_ *_[S_TIDK5H **** "BBB@ HHHH **** "BBB@
MHHHH R+W_D:-*_ZX7/\ [3K7K(O?^1HTK_KA<_\ M.M>@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M10 4444 %%%% !1110!D>'?^/:]_["%Q_P"C#6O61X=_X]KW_L(7'_HPUKT
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M.& L,A5B'RD#('S9SB@#LJ*XG3O'-U%H]@E[827VJ2WTVG.MMM4/-%N^;D@
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MY+><LK<!=V'"D^6Q'(S].O% '245QNG>+RECHUC8:=J&IW-]IPNHO-F3>5&
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MBB@#(O?^1HTK_KA<_P#M.M>LB]_Y&C2O^N%S_P"TZUZ "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ "BBB@ HHHH **** "BBB@ K*D_Y&VV_P"O"7_T9'6K65)_R-MM_P!>$O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[UO?_!A/_P#%UILZHNYV"CU)Q2)+')G8ZOCKM.<4 9O_  C>G>M[_P"#"?\
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MO3O6]_\ !A/_ /%T?\(WIWK>_P#@PG_^+K5HH RO^$;T[UO?_!A/_P#%T?\
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MXP1&MV@)+';?3C)/4_?ZT[_A&].];W_P83__ !=:M% &5_PC>G>M[_X,)_\
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M>9PN]@P()/&">3SCKS59O"5N^E:=:/?W9N-+(-G?9431X&W&=N&!'!!'(ZT
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M]R2;M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
-110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>ebs20191231exhibit1048004.jpg
<TEXT>
begin 644 ebs20191231exhibit1048004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHH RO^$DTWUNO_ *;_XBC_A)--];K_P"F_\ B*U:* ,K_A)--];K_P  IO\
MXBD_X2?2@X0R7&\@D+]CFR0.IQMZ<C\ZUJRIO^1MM/\ KPG_ /1D5 !_PDFF
M^MU_X!3?_$4?\))IOK=?^ 4W_P 15^\N19V4]TR,XAC:0JHR6P,X'OQ7&V.O
M>+KW18/$-K'I-_:RJLAT^U#F94.,J)-V"X!Y!4#((H Z/_A)--];K_P"F_\
MB*/^$DTWUNO_  "F_P#B*-4\2Z-HLJ1:C?)!+(F\1X+-M_O$ $@>YXI]YX@T
MBPL(;^YU"%;:XQY+J=WFY&1M R6X]* &?\))IOK=?^ 4W_Q%'_"2:;ZW7_@%
M-_\ $5:TW5+'6+07>GW*7$)8KN0]".H(Z@CT-8.JZYJTOBG_ (1[2)=/M)4M
M5N'FO59S)N8@+&@9<XV\G/?I0!J?\))IOK=?^ 4W_P 11_PDFF^MU_X!3?\
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M% &5_P ))IOK=?\ @%-_\11_PDFF^MU_X!3?_$5JT4 97_"2:;ZW7_@%-_\
M$4?\))IOK=?^ 4W_ ,16K10!E?\ "2:;ZW7_ (!3?_$4?\))IOK=?^ 4W_Q%
M:M% &5_PDFF^MU_X!3?_ !%'_"2:;ZW7_@%-_P#$5JT4 97_  DFF^MU_P"
M4W_Q%'_"2:;ZW7_@%-_\16K10!E?\))IOK=?^ 4W_P 11_PDFF^MU_X!3?\
MQ%:M% &0OB?2G!*27# $@[;.8X(ZC[O6G?\ "2:;ZW7_ (!3?_$4WP[_ ,>U
M[_V$+C_T8:UZ ,K_ (233?6Z_P# *;_XBC_A)--];K_P"F_^(K5HH RO^$DT
MWUNO_ *;_P"(H_X233?6Z_\  *;_ .(K5HH RO\ A)--];K_ , IO_B*/^$D
MTWUNO_ *;_XBM6B@#*_X233?6Z_\ IO_ (BC_A)--];K_P  IO\ XBM6B@#*
M_P"$DTWUNO\ P"F_^(I/^$GTH.$\RXWD9"_8YLD>N-O3D5K5E2?\C;;?]>$O
M_HR.@ _X233?6Z_\ IO_ (BC_A)--];K_P  IO\ XBM6B@#*_P"$DTWUNO\
MP"F_^(H_X233?6Z_\ IO_B*U:* ,K_A)--];K_P"F_\ B*/^$DTWUNO_  "F
M_P#B*U:* ,A/$^E2#<DEPX!(RMG,>0<$?=[$$4[_ (233?6Z_P# *;_XBCPY
M_P @R;_K_O/_ $IDK5H RO\ A)--];K_ , IO_B*/^$DTWUNO_ *;_XBM6B@
M#*_X233?6Z_\ IO_ (BC_A)--];K_P  IO\ XBM6B@#*_P"$DTWUNO\ P"F_
M^(H_X233?6Z_\ IO_B*U:* ,K_A)--];K_P"F_\ B*/^$DTWUNO_  "F_P#B
M*U:* ,K_ (233?6Z_P# *;_XBC_A)--];K_P"F_^(K5HH RO^$DTWUNO_ *;
M_P"(H_X233?6Z_\  *;_ .(K5HH R#XGTH.$,EP'8$JILYLG'7 V\]:=_P )
M)IOK=?\ @%-_\13;W_D:-*_ZX7/_ +3K7H RO^$DTWUNO_ *;_XBC_A)--];
MK_P"F_\ B*U:* ,K_A)--];K_P  IO\ XBC_ (233?6Z_P# *;_XBM6B@#*_
MX233?6Z_\ IO_B*/^$DTWUNO_ *;_P"(K5HH RO^$DTWUNO_  "F_P#B*/\
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MR1[3SW'3J>:Z[PMJ=Q#X=TJ/4[ VMS=2/&B06IC4 %B&9!_J]RC.#W-=-10
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &1X=_X]KW_ +"%Q_Z,
M-:]9'AW_ (]KW_L(7'_HPUKT %%%% !1110 4444 %%%% !65)_R-MM_UX2_
M^C(ZU:RI/^1MMO\ KPE_]&1T :M%%% !1110 4444 97AS_D&3?]?]Y_Z4R5
MJUE>'/\ D&3?]?\ >?\ I3)6K0 4444 %%%% !1110 4444 %%%% !1110!D
M7O\ R-&E?]<+G_VG6O61>_\ (T:5_P!<+G_VG6O0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5E3?\C;:?\ 7A/_ .C(JU:RIO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &1X=_X]KW_ +"%Q_Z,
M-:]9'AW_ (]KW_L(7'_HPUKT %%%% !1110 4444 %%%% !65)_R-MM_UX2_
M^C(ZU:RI/^1MMO\ KPE_]&1T :M%%% !1110 4444 97AS_D&3?]?]Y_Z4R5
MJUE>'/\ D&3?]?\ >?\ I3)6K0 4444 %%%% !1110 4444 %%%% !1110!D
M7O\ R-&E?]<+G_VG6O61>_\ (T:5_P!<+G_VG6O0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5E3?\C;:?\ 7A/_ .C(JU:RIO\
MD;;3_KPG_P#1D5 &K1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% &1X=_P"/:]_["%Q_Z,-:
M]9'AW_CVO?\ L(7'_HPUKT %%%% !1110 4444 %%%% !65)_P C;;?]>$O_
M *,CK5K*D_Y&VV_Z\)?_ $9'0!JT444 %%%% !1110!E>'/^09-_U_WG_I3)
M6K65X<_Y!DW_ %_WG_I3)6K0 4444 %%%% !1110 4444 %%%% !1110!D7O
M_(T:5_UPN?\ VG6O61>_\C1I7_7"Y_\ :=:] !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5KS4+2P
M\G[7<)#]HE6&(,?ONQP%'O5FN*\:Z-:#5=%U=_-DNCJ]I&A>0E8EW<A%Z#.
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MA#86$"P6T"[8XUZ*/\]ZQ)O >BS37+L;P17D[3W5NMTXBN')R=Z@X(_I@'-
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M^C#6O61X=_X]KW_L(7'_ *,-:] !1110 4444 %%%% !1110 5E2?\C;;?\
M7A+_ .C(ZU:RI/\ D;;;_KPE_P#1D= &K1110 4444 %%%% &5X<_P"09-_U
M_P!Y_P"E,E:M97AS_D&3?]?]Y_Z4R5JT %%%% !1110 4444 %%%% !1110
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M4VG\QS70T4 4M*T?3]#LA9:9:):VX);RTZ9]?TJ[110 4444 %%%% !1110
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MN2<XSCL#S3M.\;^']4TJ]U*UOMT.GH7NE:-EDB !/*$9Z ]!VH M?\)!;_\
M/CJ?_@!+_P#$T?\ "06__/CJ?_@!+_\ $UFV7Q%\+:AJ-K86VI%Y;P#R"875
M'8C.T,1C=ST]>.O%9NC?$RPU'Q'KEA<?N+;3DWPN(G+2*@8RLW'&,# ZGGK0
M!TG_  D%O_SXZG_X 2__ !-'_"06_P#SXZG_ . $O_Q-9=M\2O"=W!=7$6J9
MAM(EEFE,+A5#$ #..6R0,#G\C5K0_&V@^(;B>VL;MA/;Q^9)%/$T3!/[WS <
M<C\Z +7_  D%O_SXZG_X 2__ !-'_"06_P#SXZG_ . $O_Q-9NG_ !%\+:IJ
ML>FVFI;IIF*0LT3JDK#J%8C!/\^U4_!?Q!M_%VLZK8H@C%K(QM@(W!DA! WL
M2, DD?+P1^&: -[_ (2"W_Y\=3_\ )?_ (FJ,FJJVOV]Z+#4O)CM98F/V&7.
MYGC(XQZ*:M:_XLT;PTT":E<LLMQGRH8HFD=P.IVJ"<>]06GCCP[>P:?-;W^]
M-1G-O;GRG&91U0\?*>>^,T 6_P#A(+?_ )\=3_\  "7_ .)H_P"$@M_^?'4_
M_ "7_P")J >,] 8ZN!?C.B_\?OR-^[Z]./F^Z1QFJFH?$3PSIBVYN+V0M<6Z
MW*I';R.RQ-R&8 ?*/KB@#2_X2"W_ .?'4_\ P E_^)H_X2"W_P"?'4__   E
M_P#B:I7WCWPSIUC87USJ:K;:BCO;2"-V#A0"W0<'D#!YSQUJ&Y^(OABUALI9
M;Z0?;H_-AC6WD9]F2-Q4#('!Z^G% &G_ ,)!;_\ /CJ?_@!+_P#$T?\ "06_
M_/CJ?_@!+_\ $UC_  [\2W?BG2]2O+J6*58-2E@@:-< Q!4*_7[W6KFL>.?#
MVAZG_9M]?;+K9O=$B=Q$IZ%RH(4?7ZT 7/\ A(+?_GQU/_P E_\ B:/^$@M_
M^?'4_P#P E_^)KF_"?CV*3X?0>(_$][# 7E>,LJ$;B&( 51DDX':M[0_&&A>
M(HKA]/O@3:C,\<J&-XQZD,!Q[]* )O\ A(+?_GQU/_P E_\ B:/^$@M_^?'4
M_P#P E_^)K.TSXB>%]7U2/3K/42TTQ*PEH71)2.H5B,&KB>+M$DTK4=36[)M
M=,F>&Z?RG^1UQN&,9/4=* )?^$@M_P#GQU/_ , )?_B:/^$@M_\ GQU/_P
M)?\ XFJ=_P".O#NF?9!=WS(U[;BYMU$+L9$/3  ZG/3K5'_A:G@WR89O[5.R
M4[3^XD_='./GX^7\: -K_A(+?_GQU/\ \ )?_B:/^$@M_P#GQU/_ , )?_B:
MK:[XUT#P[/%!J%Z1-*GF+'#$TK;/[Q"@X'O1>^-O#NGV-C?W.IHMKJ&?LTRJ
MS*^!D]!Q^/?CK0!9_P"$@M_^?'4__ "7_P")H_X2"W_Y\=3_ / "7_XFLB3X
MCZ#)X?U;5+&=YVTM,RP/$\;[CP@((R 6P,XX[U<\$^)D\6>&H-3PHFSLG149
M51\ D#=U&".>: +?_"06_P#SXZG_ . $O_Q-'_"06_\ SXZG_P" $O\ \37!
MI\0;[5?&VJV-IJT-E86,+F%'L7<S%8V9BS8RNTJ3[@8 -='8^.M*L?#^CW.N
M:O$\VI1R-'/%;R*DNP\X&W(Z@ 'DGI0!L_\ "06__/CJ?_@!+_\ $T?\)!;_
M //CJ?\ X 2__$U7TGQIH&LV%[>VE\!#89^U><C1F'@G+!@#V/Y5!HWC_P .
M:]J2:=87DAN94+Q++ \?FJ!DE2P&>.: +_\ PD%O_P ^.I_^ $O_ ,31_P )
M!;_\^.I_^ $O_P 37$Z/XXU6^\):5J5WJ5I:3W6L?9'+V[,)4R?D 4'#'U/%
M;VH?$_PEI=Y/:7FH2Q2V\C12#[+*0&!P1D+@].U &Q_PD%O_ ,^.I_\ @!+_
M /$T?\)!;_\ /CJ?_@!+_P#$U1U?Q]X;T2XCM[V^82O$)BD<+R&.,]&;:#M'
MUJ;4_&>@Z5!:33WIE%\GF6R6\;3-*N,[@%!XQWH L?\ "06__/CJ?_@!+_\
M$T?\)!;_ //CJ?\ X 2__$U+HFNZ;XBTY;_2[D7$!8H3M*E6'4$'D'ZUSEE\
M0K:[^(MUX7V!(X5V1R>6Y:28<L#QA0 #SWQUH WO^$@M_P#GQU/_ , )?_B:
M/^$@M_\ GQU/_P  )?\ XFN-\'_%;3;K0K-_$6H)'?W$K1LR0,(T^8A0S 84
MD>I]^E=1KOC?P_X<O%L]1O66X*>8T<43R%$_O-M!P/K0!:_X2"W_ .?'4_\
MP E_^)H_X2"W_P"?'4__   E_P#B:OVEW;W]I%=VDR303('CD0Y# ]#7GWAG
MXBW5U\0M5\-ZOY:PB[FAL)53;RC'Y">Y*X_R10!V7_"06_\ SXZG_P" $O\
M\31_PD%O_P ^.I_^ $O_ ,36!X4\:?:/#.IZSXBNX8(;+4)8/,V[0$7;M&!U
M//;DUH:9\0/#6KQ7;VE^Q:SA:XEB>%U<1@9+!2,L,>F>U %__A(+?_GQU/\
M\ )?_B:/^$@M_P#GQU/_ , )?_B:XBU^)KZSX&U#5HKJVTJ]M9T#&6"26.)&
M?"YP#N) /3I[5U>M^.- \.316VIWI%Q)'YGE11-(P3^\0H.!]: +G_"06_\
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MC<BW,'F#)Q\AY7C _"N(UOXCZCI_C[[-"D9\/V5S#9WTQ7)660,<[NP&.?\
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M&VD!@&[ 1N/F.>XR*T-*\<>'M:U=M*L+[S+H(716B=1(HZE"1AA]/PH M_\
M"06__/CJ?_@!+_\ $T?\)!;_ //CJ?\ X 2__$UDW'Q-\(VMQ<PRZH1]E8I)
M(L$C)N'50P&"?85T3W]NFFMJ+/\ Z,L/G%\?P8W9Q]* *?\ PD%O_P ^.I_^
M $O_ ,31_P )!;_\^.I_^ $O_P 37%Z5J_Q!\7:<^OZ1<:;I]D[-]DLYXB[2
MJI(^9NV2".,?A535?BU,/ $.HVT26FL37+6KQM&SI$Z;=Y_)E(!]>^* ._\
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M@OE5<;60YSCZ8_$&@#5_X2"W_P"?'4__   E_P#B:/\ A(+?_GQU/_P E_\
MB:K-XTT!?#UMKYO&_L^ZE\J*7R7RS;BN-N,CE3VINK^./#VAZHNFW]]LN2H=
MT2)G$2G^)RH(4?7ZT 6_^$@M_P#GQU/_ , )?_B:/^$@M_\ GQU/_P  )?\
MXFJD/CCP]/8V%]'?%H-1NOLEL_DO\\N<8QCCGN>*MOXETB+5;O3);L1W-E;?
M:IPZD+'%_>+8QW]: #_A(+?_ )\=3_\  "7_ .)H_P"$@M_^?'4__ "7_P")
MJAI?Q \-ZOJ$=C:WD@FG4O!YMO)&)@!DE"P /%4?!/Q @\7ZGJMHJ",VLS?9
MU"/\\((&]B1@$D_=X(_6@#=_X2"W_P"?'4__   E_P#B:/\ A(+?_GQU/_P
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M_LZXNFN@\)'DY<,I;TSC(K=U2/4O#GQ/F\0KHE[JME?V"VZFRC#O"X(X()&
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M)2S'#@GBN9\9Z3=IXEN+ZSTOQ#:7,EJBQWND'SH[DA<;98\#;C@=<$"O5Z*
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M"<'[5<*;FY+=3(_S'/N!@?A6%J5OJ_A#X@WWB.TT:ZU?3=6@1)DLUW2PR(
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M/XXH Z73GEDTRU>?/G-"ADS_ 'L#/ZURWC+Q!=^%_$6B:C+=,NC3F6WNXL#
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M'VN7[*S/:V\]P7BMF;J47M^.:V]/T.UTW4]0U"!YFEU%D:8/)N4%00-H[=:
M-&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+XM/@AU74K8:9O\ *27SF#&4_,Q=AGCC.>F!717NC6M[#90MOBCL9XYXEC(
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M%CUC13I=S=7"J?+)GC*B3<C*P;E2N<J,\8H J^++ZZL]+@BLYC!/?7D-H)P
M3$)' + 'C.,X]\5GW]I)X8O=+NK+4;^:.YO8[2X@N[IYUD$F1N&\G:P.#\N!
MC/%:1\-K<65Q9ZEJM_J4,X7 N#$IB(.0RF-%(8'!S["FVOAD1WUO=W^JWVJ/
M:$FV6Z,86)B,;L(J[FP2,MGK0!D:1I]UXET'^W)]:U"UO;HR/ 8;AEBM0&(5
M?*!"L  ,[@2>>153QOXD>RO+:RAURWL[BRM3J#[IQ"+MP0$BP3R'Q)D<_P -
M;<_@V&07-O#JNHVNGW;L\]C"Z"-BQRP!*ET#$G(5AU/2M/3-%M-)GNYK;?NN
MG0L&QA%1 BHH &% ' ]S0!E6NK_VCXNTN2TN':QN]&EN50-\K'S(=K$>H#$?
MB:T_$<TEOX8U6:&1HY8[*9D=3@J0A((/K67'X(MK66"2PU?4K%K=9HXO),1V
MQR2"0I\\;?*"!CN ,9K7?2A/H<VE7=[<W2SPO#)<2;!(P8$$_*H7(!P..PZT
M <-87DLE]H=MILFO1:A,T4TW]H7#F"6 8\T@2,=W!XVC()!X%.LIFN[S5&NH
MO%%RR:E<1J]E=2+$J+(0J@!P!@>U=C>^'K2^LK&V:2:)]/>.2VGC8"1&08ZD
M$<C((Q@@FJ<?A.2VFN7LO$6K6B7-Q)<-%%]G*J[MN;&Z(G&3ZT 8%Y<Q-XKU
MNUO+CQ&XMS MNNFFY94!B4G.SY02>?FJJ+O4UO\ 3K?Q =;DD72/-EAT^217
M#^:0&<1$9;;@'WKN['28;"^O+Q)99)KTQF4R$8RB! 1@#J!D^_I3O[+@_MO^
MU]\GG_9OLVW(V[=V[.,9SGWH Q_ \]U=Z1/=///-8S7#/I[7,HDE\G ^\P)_
MB#8!.0.#72UGZ9HUMI$UZ]H\HCO)C.T!(V1N1\Q08R-QY(R>>F,UH4 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@C(.".02""""#5'_ (1&P6WC6.>[CNHYVN!>K+^^,C#:Q)(P<K@8QC '' H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1GC)XKJ%8,H92"",@CO0 M%%% !1110 45F:-K]AKXO&T]VD2SN6MG<C"LP
M)*^H^8<UIT %%)6+9>)X-0N[2.WL;U[6]#FWO1&#"^W.<D'*YQP6 S0!MT5B
M:YXIL]!#M/:WURD*[YWM;<R+ OJYZ#CG')QSBK5QK=G#ID&H1"6[CN55K=+:
M,N\P(R-H^G.3@"@#1HK+T'Q#9>(K:::T6:)[>4PSP7$922)QV9?QK4H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
*HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>ebs20191231exhibit1048005.jpg
<TEXT>
begin 644 ebs20191231exhibit1048005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO-&\7P:)8ZE%K>A2VSW%O+UDL@?X6[H2>"O0]< Y% 'K%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJQU"R&H+IYNX1>-'Y@M_,'F%.F[;UQ[U9H **** "BF2RQPQ-+*ZQQH,L['
M ]2:S8/$^@7.[R-;L)-H).VY0\#J>O04 :M%%% !15:]U"RTZ)9;V[AMD9MJ
MM*X7<?09ZGVHM-1L=0#&RO(+G: 6\J0-@$D#./<'\C0!9JI%I.FP79O(=/M8
M[EB29DA4.<]?F S5JEH K7FGV6H(J7MG!=*IRJS1*X!]LBIHH8K>)8H8TCC0
M85$4 */8"G4M !1110 4444 %%%)0 M%%1S3Q6T+SSRI%%&-SN[!54>I)Z4
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M#(OO&5[/XHU70]'CM@=(LC<SRW",XD? (C4*1C@\MS]*Y;Q]XG?Q5\'H=7M
MMO#<3JES"Q)8,&Z ],9&>1Z=*Z>^\&ZA;^)]7UK1GM7_ +8LC;S17,C)Y4F
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M_P 4CQ-:73:O;'2DL]EQ;B+#23X/SCC@9P>O;&.] '0T5Q/]C?$'_A%?LO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1110 44W<NX)N&XC(&><4V2>&$J)94C+G"AF W'T'K0!)1110 4444 %%%%
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M7C"L_#>M6?@NZ\%_9UDA8206^H>8NP0NQ.77.[> Q& "#@<BK'B#PM_:-O\
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M>@#6HK/^T:K]IU%?L$7E0HILG\_FX8J20PQ\F&P,\]<TQ;K62FF%M-A#3?\
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MM/MR&B$FH"'?(.=S#8V<=AZ\]<8 -#PA;ZA:>$=+M]5=FO4MD$N\Y8''0GU
MP#]*V:IZ7)J$U@DFJ6\5O=,26AA?>J#/ W<9.,<X%7* "BBB@ HHHH ****
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MS?T36+3Q!HUMJMBS-;W*;DW#!'."#[@@C\*Y%-&U?PGK?F:?HPUW3KFSMX&
MD1)89(DV _.<%6 &??\ 7M-.6X6QC%U'%%,<LT<7*IDD[0>^,XSWQF@#'NO%
MT<-I>ZA;V$]WI^GR-'<3QLN?D^^54_>"\Y/'0XS69XJU:6ZO_#,5G;F[L+^Z
M$N5==MPHB9E7!/3HW/' J+3M)UG1="UCPXNG/=+/).;&Z5T$927)Q)DY4J6.
M>#D=,U)=:#J&G'PA9V-C->P:,P^T3+)&O'E%,X9@3R<X':@#H[#0M,LM.FLX
M+%(;:Z=I9;<G<@9OO #H![#BN TRRMT\$>)_"UXI:[TJXD2&0?ZU_,^:W?/7
M<20!^72O4 <@'&/:N4O_  O<3_$.TUF%MME);8O4[221,#"3[Y.?^ 4 9NCW
M,&O_  WTG3G@59[F1+&:/&#&\9/FM[-M1VSZD5TTNK1VU\=&TNQ^TW%M )7B
M1EC2)"2%!)[G!P/;G'&<O0O"]QI?C36+\MC3YV\^UC["64#SC]<QC\&-.^P:
MCHWCF_UB"SDO;'5;>))1"R[X98P0O#$94@GD=_SH =+X]L$T:UU..SNY4FO!
M92QJJ[[>4MM*N,YR#_=SG\:RM2NS=>-O"=_>Z;)IDJ3WT;"X9-VQ8&(8LI(V
M]^OK4-WX9U>WT7=;Z<]S=WGB%=6F@CEC'DH) VW+, 3M4=.^>W-:'C/P_<>)
M-8T)'TR>6PB%Q]K=)8U:(21%5QELD@D'C/3O0!TFE:E)J<33_8I+>#<1$\C#
M]ZH/# #D*>HS@^U7ZYWPU<>(;?3)[37-/EEN++<L-T)(R+U!]UL!B58CKGCW
MJ\FJ7S6^FR'1KA7O& G0NN;0;2<MSSSQQ0!J45FMJ5X!J>-(N#]C&;?YU_TO
MY<X7GCGCFE&HW9FTU/[*G"WB%IWWKBT(4$!^><GCC/2@#1HK*DU6^2RU&==$
MN6DM)&2"$.F;H ##+SP#D]?2IS?7(U&UMAILQAFB9Y+C<NV%AC"D9R2<]O2@
M"]160^KZ@NE75VN@W33PSF*.U$B;YE# ;P<X P2>?2K;WEPNKQ68L)6MWA:1
MKL,NQ&! "$=<G.: +E%9"ZOJ!TJ.[.@W0G>X\IK7S$WHN_;O)SC&.?\ .:M+
M>W)U2:T.GS"".%9%NMR[9&).4 SG(Q0!=HK)CU:_?3M/N6T.Y2:ZF6.:W,B;
MK93G+L<X(&!TYYJ?[?=_:[^'^RY]EK&K0R[UQ<DJ257G@@C'/K0!?HK,35+U
MHM,<Z-<*UX1YZEUS:?+GYN>>>.*&U.]5-38:/<,;/_CW&]?]+^7/R\\<\<T
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MHHH **** "BBB@ HHHH ***2@!:*** "BBDZ4 +1110 4444 %%%% !1110
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M9&WMUF&UWD=LNV.P  '/4D]L$@!X^T*;7/"UVMDTD>H0(9;9XF*L67G;QU#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKF2:X\A/-DC^Z[[1DCV)S5JLCPKI4^A^%M.TRYD$DUM J.0<C/H#Z#I^%:]
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVD1O(;:@4 X<_P )YZ&H)/$=M'IM_?FTOC'83M#(@MF+N00,HO\ $O/4<=:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5.2N,@8!;&. P]:]25E= ZD,K#(([B@#A[(ZK?\ C/Q/IG_"0WMM!IZ6[6Q
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MFNGTVU:^14NVA0SJGW0^!N ]LYJS6/X2L;W3?">F66HN6NH+=5DR<D''3/?
MP/PK8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWD2*4PR,I"R  E#C@X/!Q4E% &7HFD7&FQR2W^HR:E?3!5ENGC6/*KG:H5>
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MZK8MJLFEB<?;(H1.\6T\(20#G&.H-58_$^BRZ;8ZBE\IM=1G6WM9-C?O)&)
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M3C@@\XH OT5E2>)]&BL+^_>]46VFS-!=2;&_=.N,C&,GJ.F:LG5K%=3ATPW
M^USPF>./:?F0$ G.,=Q0!<HK);Q1HJZ7+JAOE%G#.;=Y=C?+)NV;<8S]XXST
MJV-4LCK!TCSQ]M$'V@P[3GR]VW=G&.O'7- %NBLE?%&BMI\-^M\IMI[G[+')
ML;YI=Q7;C&>H(STJR-8L&U&YT\7 ^TVD2S31[3\B-G!SC'8]* +M%92>)='D
MLM/O$O5,&IR"*T?8W[USG QC(Z'KBI3KNF";483=#?I:![P;6_=*5+ ].?E!
M/&: -"BLU?$&E,--*W8(U49L_D;]Z-N[TXXYYQ2/XBTE(-2F:\ CTHE;P[&_
M=$#=Z<\'MF@#3HJA_;6G"[L;3[2/.U"-I;5-I_>*H!)Z<<$=:@D\3Z+%IU]J
M+WRBUTZ=H+J38W[N12 5QC)Y(Z9ZT :U%4VU6Q758M+-P/MDT)G2+:>4! )S
MC'4BJI\4:*-+?5#?+]C2?[.TNQN)-VS;C&?O<9Z4 :U%5!JED=7;21./MJP"
MX,6TY$9;;NSC'7WS52/Q1HLNF6FII?*;2]G%O;R[&^>0L5"XQD<@CF@#6HJB
M-8T\W]W8BY'VFSB66=-I^1&S@YQ@]#TJ%/$FCR6FG727H,.J.([1MC?O6()
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MU/Z5NT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(0#U /&*6B@!JHJ*
M%10JCH , 4ZBB@!, ]A2!$5RX10S=2!R:=10 4444 (RAE*L 0>H-   P!@"
MEHH 1551A0 .O H  Z"EHH *1E# JP!!Z@TM% "    # ':EHHH :%4,6"@$
M]3BE(!ZC-+10 F!G..:,# &!@=*6B@!,#.<<T8'' XZ>U+10 F!SP.>OO1@<
M<=.E+10 F!@C YZ^]&!G..:6B@!,#&,#%&!G..:6B@!,#&,#'6C SG'-+10
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M]?>EHH 3 SG'-&!C&!BEHH 3 SG'-&!C&!CK2T4 )@9SCFC P!@8'2EHH 3
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MNW@4-Y47FRA6P01@,4/3L*VKNV\,ZC!K%[;>()I6O888[J_ADC:.)@ZB(MM
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M?S?Z@;=V6]..: +M%4AK&FE[%!>PEM14M:#=_KP%W$KZ\$&F-KNE);WMPU_
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MDX%6:Q?!]M>6?A+3;:_:1IXX0I\W[X7/RAO<+@'WK:H **** "BBB@ HHHH
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M<\Y]:FHH 8(8A,9A&GFE0I?:-Q'IGTI@M+98HXA;Q".)@T:!!A".A [&IJ*
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MYNW;OVC=MZXSZ4^B@"#[':B;SOLT/FYSOV#=GUS0UE:/=+=/:PM<*,+*8P7
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M>: /3;;4;&]D>.UO;>X>/[ZQ2JQ7Z@'BD&I6!F6$7MN96<QJ@E7<6 R5 SU
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M>ZLI-6E@NM-O)UMVGCB,;V\C?=+#)#(<8SP1[UOC4+(B8B\@(@_UI\U?W?\
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M/? YJU10!6LM.L=-B:*PLK>TC8[BD$2H"?7 %.^Q6N^=_LT.ZY $Y\L9E &
M&]>..:GHH KBQLP+<"UA'V7B#]V/W7&/E_N\<<=J#863)<(;2 K=',ZF,8EX
MQ\W][CCFK%% $/V2V,L,OV>+S(%*Q/L&8P>"%/8' Z>E,;3K%H)K=K*W,-PY
M>:,Q+MD8]2PQ@G@<FK-% $1MK<W*W)@C,ZH4678-P4\D ]<<#BH_[-L/LYMO
ML5OY!?S#%Y2[2V=V[&,9SSGUJS10!%]F@%T;H01_:"GEF78-Y7.=N>N,\XJ,
M:;8+;Q6ZV5N(87$D<8B7:C Y# 8P#DYS5FB@"$6EL)I)Q;Q>;*H61]@W.HZ
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MGM4M% %8:;8+:QVHLK<6\3!XXA$NQ&!R"!C .>:>+2V$TLPMXO,F4+*^P;G
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M-Q;&.'4]0>]LTD7!5#(NUL=L\_A]: /1M2UF^LO&&B:4JP&TU%+@R,5.\&-
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M451MF(D3!8?Q'D\GDYI_POCL[;P1;RJD$4IDN#*P 5B%GDQN/H!Z]* .SHJ
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M45$+B RR0B:,R1J&=-PRH/0D=AP?RIHO;1HX9!=0E+@@0L)!B0D9 4]^!VH
MGHJ'[7; S#[1%FW&9AO'[L8S\WIQSS0+NV/DXN(O](&8?G'[SC/R^O'/% $U
M%0&]M%29S=0A+<XF8R#$9QGYO3CUIWVF 2QQ&>/S)5+1IN&7 ZD#N.1^= $M
M%5VOK-899VNX!%"Q21S(-J,#@@GL<]JD,\(N!;F5/.*EQ'N&XKG&<=<>] $E
M%5_MUGY'G_:X/*W[/,\P;=V<8SZYXQZU()X3<&W$J&8*',>X;@N<9QUQ[T 2
M457%]9FW2X%W 89&"I()!M8DX !Z$YXI_P!I@,LD0GC\R)0TB;QE >A([#@_
ME0!+14 O;1DA<74)2X.(6$@Q(<9^7UX]*4W=L/.!N(O]'&9OG'[OC/S>G'/-
M $U%0_:[8F$?:(LW S"-X_>#&?E]>.>*0WMHL<TANH0EN2)F,@Q&0,D,>W![
MT 3T5$;B 2QPF:/S)%+(FX98#J0.XY'YTPWUFL$DYNX!%$Q220R#:C X()['
M/&* +%%1^?"+@6_FIYQ7>(]PW;<XSCKC/>H_MUGY G^UP>47V"3S!M+9QC/K
MGC'K0!8HJ,3PF=K<3(9E4.8]PW!3P#CKCBHQ?6;0Q3+=P&*9@D3B0;9&/0 ]
MS]* +%%1?:8#)+'Y\>^$!I%WC* ]"1VZ&FB]M62%Q<PE;CB$B08DXS\OKQSQ
M0!/14)N[8>=FXB'V?F;YQ^[XS\WIQSS1]JM]T*_:(MTX)B&\9D &3M]>.>*
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MP*LT4 4%T32DU$ZDNG6PO3P;@1CS"/\ >ZT_^R=._M(ZE]AM_MI4*;CRQYA
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M3[?[3"@2.;RQO11V!Z@>U+;Z-I=JETEOI]M"MX2;@)$H\XGKNQUZGKZFKM%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIOF)C=O7!.,Y[],4NY=Q7(R!DC/(H 6BFB1"%(=<-]TYZ_2C>N2-PRO7GI0
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M4=E9JZ01#"*\K2;1V +$G'M1J6F6>L6$EC?PB:WD*ET+$9VL&'((/4 U:HH
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MH^T^7YK_ .LW[\YSG[W.,XJV-*LEU=]6$)^V20"W:3>W,8)(&,XZGKC-7**
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MTY+0BVTZ=9[9/-?Y)%)(.<Y/)/!R*UJ* * T73Q>7UWY!\[4(UBN6WM\ZJ"
M,9P.">F*B3PYI4<&FP+;$1Z4P:S'F/\ NR%*COSP3US6I10!FMX?TMAJ8-L3
M_:PQ>?O&_>#;L]?E^7CC%.&A::)M-F%N=^E(R6A\QOW:E0I'7YOE '.:T**
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MCG\J^V-,A=<^6O4 @_K2> %2[U+6-2U(L/$AE$&H0GA857[@C']PC!!.<^M
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MNP#Y'S, %&2.V:L:?I;W'B[7]!DU75#I\<-O/&GVZ3>CN&!Q)G?CY<XSCVH
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M1[]G?G.>U:6GW]S=7%Q!=:?)9O"%8%G5UD#9Y!'NIX-<K=QW4OQGQ:7*0/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#(A\013>*IO#_ -DGCEBM?M/FO@(Z[MHV\YZYZXZ4ESKK_P!HW5AIUDU]
M<64:R7"B0(%W E5!/5R!G' QC)&:S%_Y*])_V %_]*&ID]GJ'AGQ%K6OQ?99
MM,OXDFN!/.8FMWB3;D?*<J0/KF@#H=(U:TUS2K?4K%RT%PNY=PP0<X(([$$$
M'W%7:Y7X;65U9^"[9KV,Q37<DET8C_ )'+ ?D0?QKJJ "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *PX?"=A97,TVFW%YIZ3N7E@MIML3,>I"D$*3_ +.*W**
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M6E%NIZB,-D+^6:K7WAY=$\"WVCZ):37L;Q,B6LD_.USAPK$CL6(&>OUKJ**
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** ,J'Q!:3^))=!6*X%U#;_:&9
MXBJ%=VW@GKSGD#''6B[UZ."]GLK6SN;^XM8UEG2WV?NPV=H.YAEC@D <\=LC
M.2O_ "5Z3_L +_Z4-3#;:EX;\4ZWK MDNM+U&..:23SE0VK1IM.[=U4@9R,D
M8Z4 =)IFI6FKZ=!J%C*);:X3<C@8R/<=B#P15JN2^&5O<0>"+:6YC,374LMR
MD1_@1W+*/R.?QKK: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDY)))))]R23^-9VE::^AZWJ2QQLUEJD_VM&49\N8J!(K>@.T,#TR2..,[M%
M'.Q>#XX=)&D)K.I_V>8_+: O&=R'JN_9N /L1CMBKTNA0O/I\D%S/:QZ<,00
MP[ @&W;@@J3]TXZUJ44 9^K:)8ZTMK]MBW-:7,=S XX9'1@1@^AQ@^QJ"?0-
M^K3ZG;:G>VEQ.B(XB*%"%SCY64C/)YZUKT4 9-IIT'A^SN9+:.>\NKF0RRNY
M!DN)2,#)  48 '0*!533O"OV7PJND/?W$$\DAGN+JSD\MVE9][8/H3Q]*Z&B
M@"G_ &?_ ,3C^TOM=U_Q[^1]F\S]S][=OV_W^V?2JB^'PNE06']K:H?)N!/]
MH-S^]?#EMC-CE><8].*UZ* *0TW&IW%]]MNSY\*Q>09?W4>,_,J]F.>3["JT
M>@B.PTZT_M74V^P2K+YK7&9+C&?EE./F4YY'L*UJ* ,_^R?])U&;[???Z>BI
ML\[Y;?"E<Q#'RDYR3Z@&F+HH5-,3^TM0/]G=S/S<_+M_>\?/Z]N:TZ* ,Q]$
M#Q:G'_:6H#^T<_,)^;;Y=O[KCY/7OS3_ .RO]*T^?[?>_P"@QLGE^=\D^5 S
M*,?,1C(/J36A10!DR: )-/U"S_M74U^W3-+YRW&)(,X^6-L?*HQP/<U9;3LZ
MI!?_ &R['DPM%Y E_=/D@[F7NPQP?<U=HH R&\/AM*EL/[6U0>;<&?[0+G]Z
MOS[MBMCA>V/3BK8T_&L'4OM=US;^1]F\S]S][=OV_P!_MGTJY10!D+X?"Z?#
M9_VMJA\JZ^T><;G]X_S%MC-CE.<8]*M#3<:C<WOVV\/VB)8O),O[N/&?F1>S
M'/)]A5VB@#*CT(1V6G6O]JZDWV"19/-:XR]Q@'Y93CYE.>1["I#I&9M2E_M"
M^_XF"*FWSOEM\*5S$,?(3G)///-:-% &:NC!1I@_M+4#_9PQS/\ \?/R[?WO
M'S^O;GFFOH@>#4XO[3U%?[1).\3_ #6V5 Q$<?)TSWYK4HH H'2LWEC<_;[W
M_0HVC\OSODGR ,R#'S$8R#ZDU!)H DTV_LO[6U-?MT[3><MSB6#)!VQMCY5&
M.![FM:B@"FVG;M6BU#[9=#RH3#]G$O[ELD'<5[MQUJH?#X.E/8?VMJ@W7'G_
M &@7/[T?/NV!L?=[8].*UZ* *8T_&L-J7VNZ.Z 0_9C)^Y&&SO"_WNV?2JD?
MA\1Z79V']K:HWV6<3>>USF67#%MCMCYEYQCT K7HH HC3,:A=WGVV\/VJ)8_
M),O[N+&?F1<?*QSR?85 FA!+33;?^U-2;^SW#^8UQE[C (Q*<?,.>G'05JT4
M 9QTC,FIO_:%^/[10+@3\6V%VYBX^0]^_/-(NCA3IA_M&_/]G+MYG_X^?EVY
MEX^<]^W/-:5% &6^AA[;4H/[4U%?[08MO%Q\UOD 8B./E'&>_)J4Z7F^LKK[
M=>?Z)$T?E>=\DV0!ND&/F(QP?<U?HH R)/#XDTR^L?[6U-?MD[3>>MSB6'+
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %8\/B2"]DE&F65WJ,4+F-Y[<((]PZ@,[+NQ_LY%'BZ6Y
MA\'ZQ+9EA<)92F,KU!V'D>]5O *P)X!T,6^-GV*,G']XC+?^/9H T]*U:VUB
M"6:U$JK%,T+B6,HP=>HP>>]9NJ^,+32M1>Q_L[5;V6-5,C6-DTRH3R 2.AQ@
MX]"*W(XHHGE:-0K2/ND([M@#)_ "J'B"_;2="O+R! ;C;MA7'WYF(5!^+%10
M _1-9M]?TM-1M8IXHI&90L\>Q\JQ4Y';D&M"J>D:<FDZ1::?&=RVT*Q[CU8@
M<D^Y.3^-375R+2'S6BEE&<;8HR[?D* )JKW]X+"QFNVADE2%"[+$ 6P.21DB
MJG]N1_\ /AJ/_@(_^%2ZP<Z%?'UMI/\ T$T 94'C:QGTA-7_ +/U)-/=-XN/
ML^X!?[Q526Q[XK;LKZUU*RBO+*=+BWF7=')&<AA6%\.AGX>Z(#_SZK7&^$=7
MGTG2[ZTT\/\ 9+WQ-+:6+1A3LC(+'9N.WHN!GC)[]* /3=2ODTS3;B^DBEE2
MWC,CI$ 6( R<9([>]58-;%UI.EZE;V-U-'J0B8*BJ3"LB[MS\\ =\9K#F&OQ
M:?XBCU#S)--:PD>U>Y,7G(VP[E/E\%>X/6J"WU]I_@_P$]G>/"EQ)86T\852
M)$:,$@DC(^[V(H [^BN2GU2ZT/QT\.I:A*VEWUD\]J'"[8I(^9%X&3\OS#)[
M&FR:CJEE)HVD2RW<EWJ2S7$K+Y7FQJH4^6N["\;P,\G"GN<@ Z^BO/M<O?%N
MD^%K^:XO7@DAOH5LYF$1DDA>15VR!1@$9/*XS5SQ%%K7AJSAUC^W[V[M+>]6
M2^B:.,?Z.Q ;&%S\IYX[$^E ':UC:SXGL- N[2+4TF@ANY1#'=%080Y&0&.<
MKT[C^5+IL\U_K=_=1W;O81!((HQ@HT@&YW!QD_>5>O56JMXMTRSUEM'TZ_A$
MUM<7KHZ'_KVGY'H1U!]: -/5M432+/[7+;SSQAE4B$*2"Q"C@D=R!5Q&+(K%
M"A(R5;&1[<<5YL-3O- A;P;KLS2NLL+:7>O_ ,O4(E3Y"?[ZCKZC\ST@O[C6
MO&.J:*MW-:6^F6\+'R"%>623)W9(/"@#CU)SGB@#I))$B3?(ZHN0,L<#).!^
MM027CQZE!9BSG=98V<W"@>7'C'#'.<G/'':O-]2U/4M8\/V\%]>S+<Z;XGBT
M^6:'""X"R+AR,8S@@XZ9&<=,=3<76H6?C[2--&HS2V=Q93N\4BIRZ;0&R #_
M !?2@"_J7B6*QFNHK>PN]0>R5'NEM%5FB#9QP2"QP,X&>/PJ_IMZVH6*73V=
MQ9ERP\FY4*XP2,D GKC(]C7*>'+"4>./%F-1N\I+;C)*'=FW&"?E[9X^G.:J
M:/XFU.3PEH2W-ZSWNJZG+:/=E%!51))R!C;G"!1QCGVH ]!HKF+^'6-(L-9E
M'B&&.!HU:REO%W-:GH^3CYADC:"#R<<U2L;Z^F\5:CHWVJ_2SDTI+J)KC:LR
M,79"RG&5! Z, 0>PH ZB]U 6NFS7MO;S7WE9Q#:@,[D'! R0,@Y[]JMCD9QB
MO,+.YU+2_@6FJV.JW,5TEL)58A&V_/@@97OGKUSWKJI]2GU'QI_PCR7$MM!!
MIXNY6B(5Y69]H&>P&,\=21V&" =-17FNI^(M=MO#7B" :DZWNB:A# ET(TS/
M%(Z !QC&X*YR5QT%;L%QJNG>/O[,DU26^@O--DN1'.J 12JZCY=H&%(;H<_4
MT =;17$>%]>GO-7M]/U6ZO;+6(H6^UV%TH"7#<?O(B!@J,' !Z'OC-=O0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4A( R3@"EIK*KH4=0RL,$$
M9!% '-Q^/-);4[:SEM[^WCO)/+M;R>V*07#'H%8^O;(&:T[W7(+2^^P1P7%Y
M="'SWAMU!9(\XW') Y.<#J<' .*HZ_9)K][8Z4B@Q6=U'=W3CH@3E$'^TQQ]
M%SZC-#PQO;XA^,FE^^&LU7/9/*.,>V<_C0!U%A?6VIV,-]9S+-;SH'C=>A!J
MQ7'_  Q+GPO.#_J1J-T(/39YAZ?CFNPH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@!" 001D'J#7/V'A/^QFDBT;5KNQLI'+_8PJ21Q$G)\O<I*C/.,D>U=#10
M!FW&C^;9);PW]W;,)UFDGB<>9*002&)'0XP1Z8 P.*FU#38]1>S,KL$M;A;C
M8.CLH.T'V!(;ZJ*N44 4[^Q>^-J4O;FU^SW"S,(& \T#/R-D<J<\CVJY110
M56U"T^WV$UIY\D F0HSQXW $8.,@C]*LT4 <W:>#A9Z)%HL>NZH+&)/+$:F)
M&*?W=ZQAA]00?>IM1\':3>^'(="AC:QM[9EDM7MFVO!(IR'4^N2>3UR:WJ*
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M N;J="GF32!E8$Y4@<JO  X %3S^&4N-<AU>34;LSQ6K6NW$>QD;!;/RYR2
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MT&GV47EV]NFQ%SG\2>Y)Y)JU110 4444 %%%% !1110 4444 %%%% !1110
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M:7\FIZ[OL[POIT-JCN%52LLDG*X.,C"8)Y_B7WSC?%7_ )$B7_KZM_\ T:M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M +!>_:=1D_M679=(JV\?EKBT(4@LIQ\V20>?2F+IU^J:8IUB9C:?\?)\I/\
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MDCALYP2.F>1UJ]=>-=;U'4/$::*)C+HTZ06MI%9F47+!B)/,8*=H."!@K^-
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M,3S3?#JU64DB*:5(\_W=V?YDUWE !1110 4444 %%%% !1110 4444 %%%%
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M5^[:M@#S%YQD8R.!U/)KHZ* ./3P3JBZ5HEF?%NH>9IEP99I@#FZ!;.UOFZ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYP03R,D^G!(]*[^B@#E+#POJUSX:FT/Q)JT5[ ]L;9?L\&QL8X=F).6&!C
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MQ8:!"?%<OG:?,7OI/+S]K4MD*>>PRO/7.>U2/X=\1F3Q R^)Y NHC_0!Y?\
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M>03^..@K/7PMXJ&A:79_\)=+]KM;KS;FX\O)FCSD)UR<>_7\*[*B@#F7T#Q
MVJZW<KXDD6WOK?R[*'R\BT?&-X^G/3KGVJNGAKQ,MIX?B/BJ0R:?*6OW\O\
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M74*DQG.X%67<>05[-S[52T#Q)?6W@O0Y[UUNKS5=JPE8G8Y*L[LP7); 4G
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M*;XR0/DV_-CKG'9:W7NVTSXDPV2<6^L632,@Z>=$1\WXH0#_ +JT =11110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-==Z
M,NXKN&,J>1]* *,.O:/<:D^FPZK9R7J9#6Z3J9!CK\N<\5->ZG8:<%-[>06P
M?.WS9 N<=>OI7+^)/#>GRSZ#8:79PV]Y;WT<\<D2 -##&<R,3UP>%YZEA3M
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MR?FYZ<=,"I;;3[Z[O[;4M76U2>TC=88;9V=%9@ S%F4$\# &.,GKGC8HH Y
M6/CI+VXNT?P^TLN5C:7SF\I.R#&..Y]3^ &[+H&E7C1S:CIME>W2HJM/-;(S
M-CODCBM*B@#EK^R\82:X]Y:G1&MX\K:I<F4F,="QP -Q]>PX'4YW].2]2PB&
MI2Q2W>,RM"I"9)SA0><#H,\\5:HH Y<>'M2T7Q#>ZKH#6LL&I,)+NQNG:,>8
M/^6B.JM@GN".?6MJ!=3;?/<B!) A6.VBE9DSZLY4$]/[HQSUJ]10!PEIX.UV
MR\,:%IT=Q823:1=&5XI'?R+E<L1GY<@@MD<$9 -2R^"]5O-.\3V-U>V>S6F\
MV)HXV!1]BCD$\ %?<G.>.E=M10!R::)XCNO$.B:OJ$VFQFPBFCFB@WL#O"C*
MD@9SM[XQ[TR'PK?7.LZ3JVH1V,%_8$^?>VCMYEVNPKM8%0,'()R3TXZ\=?10
M!QNB>'/$^A Z-;:C8G0UD8PRLK_:H8R<E!_#QD@,3QZ=J?K/A6^UV9?MD=BL
MMO>B:TU&-V%Q#&'W;<;>3C*_>QSG&1SU]% #)3((F,**\F/E5VV@GW.#C\JX
M.+P3K<?PYE\+-+8&9Y_,$XE?;CSA*>-F>V/UKOZ* .;N-$U*Z\7V6L2I:"WB
MLGM9HO.8L=Y!)'R8(&W';.>U4_#OA[Q-H4,>B_VC92:-;N?)F"O]J\O.1&1]
MT>F[/3MTQV%% '*6?AW5]%EUBWTN2TDLM3F>Y0SNRO:R.,/@!2'7/(&5]/>H
MX_"%UIVH^&3IIMVL]"AEB832,KR^8H4MPI /&??..*Z^B@#BU>]7XJZD;&*W
MF(TJ .LTICQ\[XP0K?ECO^:R>!KB*SL[JTNHAK-KJ,FHF1P1%+)(3YB''(4C
M !Z\"NFCTC3HM2?4H[*%;R08>X"_.P]">XJ[0!S4N@7UYJ5YK-RMLE[)IYL;
M>%)6:-%)+,Q<J"23CHO 7WJHWA;5V^'$/AQ;FVAO+>..,2*S-%*J$'#< @,
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MW AO.\W=QCMMVY]\U4 \2?V4H+Z9_:'VCYCMD\KR=_;ONV?AFM>B@"FHU/\
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MU:E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSNGV8R_O[;"EE+COD+[8)[U#/XMUT_V^+31[,MHC_/YETV)$V!_EPF=Q![@
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MNX1C:#@XQS[C@\X .DHJCHNI'6-&M=0:UFM&GC#-!,I#QGH0<^]7J "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH ***:ZED90Q0D$!AU'O0!$E]:2736B74+7"#+1+("Z_4=14D
MDL<*AI9%0$A06.!DG 'YUQ/B'PGI=O=Z"NBV45MJB:A'(MQ$N)3$O,K2-U8$
M<$MU+ =ZL_$2V@DMM$N'B4RQ:U:!'(Y7,G.* .PHHHH **** "BBB@ HHHH
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MX&['3M6C10!FJVN8TS=%8Y8?\3'#O\IV_P#++CGYO7M37?7O(U,I%8>:I/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW?-D 8(VD8_4U8MM<U&2_P!/BGT.2.UU"-G2>.0R>00NX"4;0$R.!@GGCWH
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M.:N44 9'VO7_ .RO-_LJV^W?:-OD?:?E\K?C=NQUV\X__55L3:@=7DA-I&+
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MIIT-A;><UOJ$%U(2ZJ D;;B!D]3VKHZ* &J2R E2I(R5.,CVXIU%% !1110
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MXRGUY//?' QS7-_')%3P9!<H LZWJ*)5X8*5?(SUQ[4 >E45Y/;>>?B3HO\
MPB!D^P?9D.J&W)^R]\Y_AW8QT[X]ZZB;XB6,:SWJVKOI5M?BPFO=X&)#U8+C
ME 2 3GOP#0!V%%<=?_$$67B>^\/)HEW=WMM;^?$MNP;SQ@$ >G!SSZ8&3C/-
M>.-7U+4O$'@ZTFTN6*VO7\Z2PFE"^:_R_(X[;<GKZT >K45Q%MX@T_PR+SPW
MH5C->Q:!:FXNC)<8\M>6V*2#N;!/' '3-2ZO\2=-TS0=*UV*VDNK#4Y/+5U8
M*T;<YW#VPP..XH [*BN.U#Q]/I>BZEJUYX;OK:WL9DC G(1IE?@,H^I&1GOZ
MY%1I\1O^)U8:9+H%XCZI;">R(D0F7(S@C/R]#R3]0* .UHKD]&^(%GJ6DZS?
M75G-9/HCNEW#D2$;<_=(Z]"/PING>/X+S7=+TN>P:#^V+3[592K+O!7!.'&!
MM.%/3(]Z .NHKAKKXE&"ZURUBT&XGET,;[@K.@38,Y;)YZ=L$UI2>.M.'A_2
M=4BAEDDUF1(;.VR S2,<8)Z  ]30!T]%<C_PL*RM=(UB^U2RN+-](N/L\T7W
M_-<G"^6W&X'\..36CI7B47NN7.AWEH;/4+>!+CRQ)YBM&W<' Y!X(Q]": -V
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBFN&*,$8*Q!P2,X/TH =17DOB+PE)H7CSPW
M=Z%J%]+J=]='[6TTV\R1J5+NWHN"<CITQBMCXH^%+._T'4==O-0NEN+.+?:*
MLFV.(C&%"]RS=^O(]* /0J*Q?!Z:E'X1TM=79VOA;+YQ?[V>P;WQC/O6U0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !65X@;5H["*31H!/=)<1DQ-($#IN^<$GI\N?QQ6K10!P&N^
M$E\2>)=&U2UT632[JTNUGN[N0QJ613G9A&.YB0,-T SSVJC:>%M4T3QMK;R^
M&;;7=,UB8W$<TC1?N'))(8/R!EN< ]!C/2O3:* /.;O0/$/AWXB)XDT?2X]1
ML[RT2VN;:"1(O*VJH&T,0 /D4C\1QUJSXST+7M7U7PIK-MIRS2:7=M+<VT<Z
MAE5F0C#-M!P$Y]Z[VB@#@9M!UJX^+-OKLFF,NG_V?]FEE6>,[6(;.!N#$ G&
M<?A7/_\ "!>((? ]QX*CL]YEU,2I?[T\KR.#N(SNW<8VXKUZB@#S^[\-:M%\
M4M#U:VT^2;2]-T[[*\_FQ@D[9 #M+ _Q+V]:G^%V@ZOX?T_5(-7L&M7N+YKB
M/,J.&5@!_"QP1BNYHH \\^*_AW6_$L.EPZ/IK7/V6X,LC>=&@Q@<#<P.:[JV
MMXQ-)>"!H9KA5$JMC/RYQG!(SSZ^E6:* ,?Q#X6TKQ1%#%JL4LBP,63RYFCP
M3U^Z1FK.BZ+9:!ID>G:>CI;QDE0[ESR<GD\]35^B@#S:'0]?M?B_?>*?["N)
M=/F@$2;)X-Y(C1<X,@XRIJYH_@F^O/&>I^+=="6\UU&8;6UC?>84*A,LPXW;
M1T&1R:[VB@#S'P-X7U70HVT+5?"UC=K!<F2#57\IEVYSG!^?(YQ]<''6GV'A
MS7[;6O&]T^D2>7K$+K9D3Q?.<, #\_&=P/->ET4 <%X:\'7<OPF/A36[7[+<
M%)4^9U<!B[.C J3T)'Y58T;PC?GX92Z'J4^-1O+,Q2.QR(SMVHO'90%!_'UK
MM:* //\ P%HVIV%E9V&K^$K.WN=.RHU$F)RZ\X*8^;<>!DX'?/:IOAQH.KZ'
M>:^VJ:<]LM]>FXA<RQN&4D\':Q(/-=U10!YM9>$-8N?$OC-KNR>UL]=MVAM[
M@RQMC@@$J&)[YZ5-X!T/4]-L[33-8\)V45QI[G;J;&)]ZY)!7'S;NW;CGKQ7
MH=% 'F6B^#M1M?'&FZ[8Z9/HHDC<ZM#YJ&!R1P(PK$\L<X/ P/QZ_P 9^&(O
M%WAFXTEY/*D?#PRD9V..A/MU!]B:WJ* .-TJY\2Z5X.BTE]!FEU6TMQ;0R1R
MQ^1)M&U'W%@0, $@C/7BL.'X=7VA_"G4M"LXQ?:MJ)5I?+=57=E> 6(X 'XD
MFO3J* ,?PC:76G^$M+L;VW:WN+:UCADC9E;#*H!Y4D8X]:Y[XL:#J_B7PS#I
MNCV#7,WVI96/FHBJH5A_$PYY%=S10!5TSS?[-MA/ \$JQJK1N5)4@8ZJ2/UK
MS?PQX1U3P_?:CHU[X7LM5LI[IIK74)S$RH#Q\X;YN, X ZY]<UZE10!PMGH6
MKP_&&^U^337&FSV0MXY_-C^\-G.W=NQ\I'2CQGH>L:EXW\,ZE8Z=)<6NF2L]
MPXEC7@E>@9@3T-=U10!YS=>%]7TGQ!XKNK*Q>_AU^S*P-&Z Q2D$;7W$8&23
MD9XK-U?P!K=OX$\-Z'8VGVZXL+S[3=%)451DL2!O(S]['X5ZQ10!R?Q(TK4O
M$'@:YTW3+)IKJY:(B,R(NP!PQR2<=L<$UA/X<UY_&7A#4QI,OV;2[%8+IC-%
ME&V,IP-_.,CI7I-% 'FGAO0?%>C1>,KB#31!>:E.T]AYLL3*Q+.<'#'!PPZ\
M51TSPEXJ3Q7X8UR]TD>9:QNE_(UZDDA<AAO8^GS<*N[ &..*]9HH \M;PMXB
M_M+QS,-(D*:U;F.S/GQ?.>1S\_'7//IZU%>^"O$C>!O##V=H$UGP].9/LLDJ
M8D^;/# X_A7J1QFO5Z* .#\8:-KOCKP--;/I@TV\5TF@MI+A79V7.X$CY1D'
MCGZXK5\)6]RZI=WWA6TT6Z6'RY9$$9>5N,[2G1.,X)]/3-=/10!AW5WXC3QA
M96MMI]N^A/ S7-TSXD23G  S_N]CU//%8W]J_$/_ (1FYN/[ L/[76\V0VXE
MRC0?WOO]?Q'KCU[6B@#GOMOBO_A)Q;_V7:?V1]CW^?YOS>?C[O7IGC[O3G/:
MLO\ M7XA_P#",6]Q_8%A_:[7FR6W,N$6#^]]_KGCJ>.<>G:T4 <X]]XL'B+5
M((]*M&TN*S+V,QDPTL^!A6YX&<CH,8'-45U/Q\='T:4Z'8_;IKDKJ,?FX$,6
M>&'S=<<]6QZ<\=C10!S#ZAXR%]KJ)I%F;>"'.E.9>9WQT;YO_B?3/>HDU'QP
M8_#Q;1;(-<.1JX\S_CW7(P5^;TR?XN>*ZRB@#DGU'QP(?$)71;(O;N!I \W_
M (^%R<EOF_NX/\//%3)?^,CJ.A(^D68M9X-VJ.).8),=%^;IG_>^O>NGHH X
MUM3\?#1=7E&A6/V^&Y"Z?%YN5EBSRQ^;KCW7/IZZ$=[XL/B/38)-*M%TJ2SW
MWLXDRT4^#E5YY&<#H>"3FNBHH XK^U?B)_PB\UQ_8%A_; O=D=OYOR&#^]]_
MKGCJ..<5J?;?%7_"3O;_ -EVG]D"SWK/YOSF?'W>O3/'W>G.>U=#10!Q8U7X
MA?\ "-6EQ_8-A_:SWFRX@,N$6#^]]_K^)]<>FB]]XM&OZM#'I5HVFPV9?3YC
M)AII\#"MSP"<CH,8'-='10!QZZGX].E:)(VAV/VR>X*ZE'YN!#%NX9?FZ[>>
MK8]*L/J'C,7>O*FCV9AMX\Z4QDYN&QT;YO\ XGT]ZZBB@#E$U'QN?^$>W:-9
M#[03_:_[S_CW&1]WYO3)_BYX]Z:^I>.1:^(&71;+SK>4#25\WBX3<<EOFZ[<
M'^'GBNMHH YE+_QB=4T2-](LQ9SV^[5)!)S!+CE5^;IG'9L^O>JHU/QY_8.K
MS-H=B-1AN-NGPB7*RQ9&6/S=<9[KGT'?L** .;M[[Q<WB#3H)])M$TV2R#WL
MRRY:*XP<HO/(S@=#P2<UF_VK\1/^$6>X_L"P_MD7NQ;?S1L,'][[_7/'7ISB
MNVHH YXWOBO_ (2>>W&EVATA;/?%/YOS-/C[IYZ9R/N].<]JS!JGQ"_X1VQG
M_L&P_M22[V74'FX5(<_>'S]?Q/T].THH YM[[Q<-;UB&/2;1M/AM"^G2F3#3
M38&%;YN!G/88P.><U434_'ATW0I&T2R^U3SE=43S>((]W!7YNI7)ZM@]JZ^B
M@#EGU#QH)]?5-'LS%;IG26,O-P?]KYO_ (GT]Z1-1\;%_#X;1K,+< _VL1)_
MQ[_[OS>F3_%SQ[UU5% '(OJ7CH6.ONNB67VBWF TI?-XG3=R6^;J%P?X<GBK
M*7_C ZQHL3Z3:+8SVV[4Y1+EH)<'*K\W3..QSD\\9KI:* .,.J?$#_A']2F&
M@V/]I1W>RSA\W*R0YY8_/U_$?3UTEO?%9\36ENVEV@TE[/?<3B7YDGP?E'/3
M.!TZ'.>U=#10!Q/]J_$3_A%?M/\ 8%A_;/VW9]G\T;/L^/O??ZYXZ].<5JM>
M^*QXFNK==+M#I*6>^WG,OS//@?*>>F<C[O09SVKH:* .,75/B!_PC^G3G0K#
M^TY+O9>0^;A8X<_>'S]?Q/T]+SW_ (O&L:U$FDVC6,-KNTR4R8:>; PK?-TS
MGL,8'/.:Z6B@#D4U+QV;'0';1++[1<3$:JGF<01[N"OS=2N3_%@C%2/J/C42
M>( FC696W _LDF7_ (^/][YO3!_AYX]ZZJB@#E4U#QJ9] #Z/9B.X7.K$2<V
MY_V?F_\ BO3WJ)]2\=C3M=D71++[5!.%TM/-XGCW<EOFZA<'JN3VKKZ* .;:
M^\7_ -J:'&-)M/L<\&[5)/,Y@DQR%^;D9]CGVZUGG5/B#_PCM_/_ &#8?VI'
M=[+6#S<J\.?O'Y^OXCZ>O:44 <\M[XK_ .$G@MVTNT&D-9[Y9Q+\RSX^Z.>F
M<#[O3G/:LK^U?B)_PBR7/]@6']LF]V-;^:-@@Q][[_7/'7ISBNVHH YU[WQ6
M/$M];II=H=)CL]]K.9<-)/@?*>>!G(Z= #GM6>NJ?$ Z%I<QT*Q_M&6ZVWT7
MFX6.'/##Y^N/=L>GIV5% ',O?^,1JNMQII%F;."WW:9(9.9Y<<*WS=,Y[+C'
M7O5=-2\=&T\/LVBV7G7$I&K+YO%NFX8*_-UVY/\ %SQ7744 <H^H^-A_PD.W
M1K(_9R/[(_>?\? R?O?-Z8/\//'O3DU#QH;K05?1[,0W$>=582<V[>B_-_\
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MM8/LUI#;[VD\J-4WMU; QDUR]HKP_%B]B$\[QOI$<OER2LRJQE8':"<*/E'
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M?U%;5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF:X#!=O[JYDC&/HK =^M6Z* *5MI5K:3"6)KDL./WEW*X_)F(KGO'EI?WSZ
M+'3Y[K[%J\%Y,8]N%C3=GJ1D\]*ZZB@"EJ=E_:NAWEB&,7VRV>+<1@IO4C./
M;-<MX8_M:.&TTV_\)QVMU9!5FO\ ]V8G5?XDQ\Q9L=,<9SGC%=M10!RO@R"]
ML$UP7NGW%OY^J7%W#O"GS(W.5Q@GGCH:Y^S\.ZVO@O1REA(FH:-JK7IM)&4&
M=#(Y*J<XSM?C)ZBO2J* .-U/0[GQ5K7V[R9K""+2[BT1IEVNTDPQ]W.<*/S)
MXK(DA\0W'@_2-$D\.78O-*NK42,KQ^5(D3#YD8L,Y"YY QS7I-% &7XATM]>
M\,W^F*_D27ELT:EOX6(XSCWZUS<^GZIXA\/:/HMWILUG<6MQ ]Y*^W8HBY)1
M@?FW8&,=,\XQ7<44 <M;07J_$J]OVL+A;.73X[9+@@;2ZNQ/&<XPW7%3^/;2
M[U#P9J5A8VLES<W,7EQQQXZY'4D@ 5T5% %'1M_]CV@E@D@D6%%>.0 ,I  /
M2N-TNRU;0[J\T>7PM'J2274LMEJ&8_+V2.6Q*3\PVECT!)["O0** .5TNUO8
M/B%JEU)8S+:7%I!#'<84(6CW9XSD#YN.*CMK"\E\;Z_+-97,5G?V<-O%<X&"
M5#AN^1][@D=JZZB@#SV+1M9F^';>"KC3Y$O%46HNN# 8@^1*&S_=_AQG/;O6
MO86=W;?$*YN/L-Q]A;38K6.Y;;M+(S$YYST(YQ75T4 <-;V.I);^-%;3+D'4
MI)&M!A?WH,00=^.1WQQ4<^GZF=#\%0+I=TTNES6[W:@+F,)$4;OSR>U=[10!
MYKX@T[Q'J^F:S;76BW-U>)?K):2^:GE?9UE5E$8+</M!SP"><GH*WXX[_P#X
M6*VJ2:9<I:-I"VYD^4A9!(SE>#SP<9'&:ZNB@#S.UT;Q#::#IE];:5*;_2-5
MN+DV<CJIGAE9\[3DC=M?O[_CN:Y;ZWXJ\,SM!IAL9XI89[2UO&4M*\;AR'P2
M #@ #/UQ7844 <YX=N+J^F$TOA?^Q5C0B0RB/>[^B;?X>O)QGC ZXUEO+DZK
M-:'3Y1!'"LB76Y=LC$G* 9SD8J[10!DQZMJ#Z=I]RVAW*374RQSVYD3=;*<Y
M=CG! P.!SS4_V^[^UW\/]ES>7:QJT,N]<71*DE5YX(( Y]:OT4 9B:G?-%IC
MG1KA6O"/M"^8N;3Y<_-SSSQQ0VI7JIJ9&CSL;/\ X]QO7_2_ES\O/'/'-:=%
M &?_ &A>?:-.C_LJ?9=HS3R;UQ:$*"%;GDDG''I4,FJWZ6&HW"Z'<-+:2LD$
M D3==*,8=3G@')Z\\5K44 4C>W(U.WM1ITIAEA:1[G>NV)AC"$9R2<]O2JKZ
MOJ*Z5<78T&Y:>*X,26HD3=*F\+O!S@#'.#Z5KT4 4_M=Q_;'V+[!+]F^S^;]
MLW+LW[L>7CKG'.>E5%U?46TJ"[.@W*SR7 B>U,B;HTWE=Y.<8QSCWK7HH I"
M]N3J=Q:G3I1!%"LB7.Y=LK'.4 SD$8[^M5H]6U![#3KAM#N5ENY52> R)NM5
M.<NQS@@8'3GFM:B@#/\ [0N_M.HQ?V7-LM$5H)-ZXNB5)*KSP01CGUIBZG>L
MFF,='G4WG_'P-Z_Z)\N?FYYYXXK3HH S'U.^6+4W&CSLUGG[.OF+_I?RY^7G
MCGCFG_;[O[5I\7]ES;+J-FGEWKBU(4$*W/)))''I6A10!DR:MJ":?J%PNAW+
MS6LS1P0"1-UTHQAU.< ')X//%66O+D:I!:#3Y3!)"TCW.Y=L; C"$9SDY[>E
M7:* ,AM7U$:5+=C0;DSI<&);7S$W.F_;O!SC&.:MB[N/[8-E]@E^S"W\W[9N
M787W8\O'7..<]*N44 9"ZOJ)T^&Y.@W(FDNO):W\Q-R)N(\PG.,8YQUY_&K(
MO;HZC<VQTZ80PQ*\=QO7;,QSE ,Y!&._K5ZB@#*CU6_>RTZ=M$N%DNY%2>$R
M)FU4@Y9CGD# Z>M2'4+SSM23^RIRMHBM ^]<79*DD+SQ@\<^M:-% &:NI7I&
MF$Z1./M@S<?.O^B?+G#<\\\<4U]4OE@U.0:-<,UF2+=!(N;L;0<KSQSQS6I1
M0!0-_=_;+&'^S)O+N8V>:;>N+8@ A6&>222./2H)-6U!--O[E="N7FM9VCAM
MQ(FZY4$ .IS@ Y)P>>*UJ* *;7ER-6BM!I\I@>$R-=;EVHP( 0C.<G.:J'5]
M1&E/=_V#<F=;CRA:^8FYDW[=^<XQCG'_ .NM>B@"F+RX.L-9&PE%N(!*+O<N
MPMNQLQUSCG/2JD>KZB^EV=VV@W*3SSB.6U,B;H%+$%R<X(  .!ZUKT4 41?7
M1U"[MSILPB@B5XI]Z[9V.<J!G((P.OK4":K?M::;,VBW"R7;A9XC(F;4$$EF
MYY QV]:U:* ,XZC>"34U_LF<BS0-;MO7_2SMSA>>.?EY]:1=2O2=,!TB<?;%
MS<'>O^B';G#<\\\<5I44 9;ZI?K;:E*NBW#/9L1!'YBYNP #E>>.3CGTJ4WU
MT+ZR@_LR;RKB)GEFWKBW8 85AGDG)''I5^B@#(DU?4$TR^NET*Y>>VG:.&V$
MB;KA00 ZG. ""3@\\5;:\N1J\=F+"4V[0&0W>Y=BL"!L(SG..:N44 9']KZC
M_97VO^P;GS_M'E?9?,3=LW[=^<XQCG'_ .NK8O+@ZN]F;"46ZP"07>Y=C,21
MLQG.<<U<HH R$U?4&T>UO3H5RMQ-*J26AD3?"I;!8G." .>/6K(OKHWU[!_9
MDWE6\2O%-O7%PQ!RJC/!& .?6KU% &6FJ7S6VFRMHMPKWCA9XS(N;0$$Y;GG
MICCUIS:C>@ZF!I$Y^QJ#;G>O^EG;G"\\<\<UI44 9PU&\,FF*=)G O%+7#;U
M_P!$.W.&YYY^7BHWU6_6TU*9=%N&DM'*P1"1,W0 !#+SP#GOZ5JT4 43?70O
M[2W_ +-F\J>)GEGWKM@88PI&<DG)Z>E5I-7U%-+O+M=!N7G@G,<5J)$W3J&
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M,,T3/)<;UVPL,84C.23GMZ5>HH R'U?45TJZNUT&Y:>&<Q1VHD3=,H8#>#G
M&"3@^E69;ZYBU-K8:;/);K;&;[2C+M+@X\L G.XCGTJ]10!Q-OK.OO?O>3^#
M;]KILQ0%YH1' A/J&)YP"QQDX ["K6O:EJLFJ_9!X8O[[3H=K%HGB"W#]0#N
M<':...Y]ASUE% %/2KJ[O;!+B]L6L97)_P!'=PS(,X&2.,D<\>M7*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **9+$LT31L6"L,$HY4_@1@C\*\T\&W^DW
M_A2WCU?Q%>MJ=Q<O;A1K$PGRTI1,*'[ @].@S0!Z=15>*&:#3TA$WFS1Q!1+
M)GYF QN/U/-<9J^C7V@ZIHM_IVM:E<7EUJ$<%U%<7!>.XC8$R'9T7:H)&T
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MQB0*N[:K<@8(P !ST% '1T5CQ>)+5M2@TZZMKJRN+J-I+9;A //"C+!=I/S
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&,@;B2?X<C //3.)+9WTG@;QA9+IM[]HOM1N9+:(VS@RK(PVD<>Q^G>O2Z*
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MU)/.!TX'J: .\HK&\(7]]JGA+3+_ %)-MW<6ZO)QC.>AQVR,'\:V: "BBB@
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MD[#Y;4X)V/QU&.<D=172T4 <8WCV_'A_4M4_X1/4O,LKO[.EL0=TPSC>/EX
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M[5[>\*BW9 6,I;D!5 R3[8['TI-/U_3-4NIK2TN"]Q 2)8FC9&C([$,!CJ*
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MA+#A?O$CH#VK"O;&6R\.7<\L4B0ZAXF2]MH3&=PA\U27V]0"%+=.A'K7J=%
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M44 9PURS,FF(%GSJBEX/W#< +N^?CY./7%1OXBL8[34KIEN?+TQRD^+=\D@
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M#C]VX^8E?<\]>.E:7BU->BTV\U#3=:6P%I"9(H5MTD\]@,X<L">3\H"_KG
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MGC-"Z_I;'3 +H$ZLNZS^1OWHV[_3CY>><5H8'IUHP/3I0!F/XDTB.VU*X:\
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MS3AKNF&;381=#?JJ%[,;&_>J%#$]./E(/.*OX'/'7K1@4 9;^)='CLM1O'O
M(-,D:*[?RV_=,,9&,9/4=,U8.L6"ZC;:>;@?:;N)IH8]I^=%QDYQ@=1UJY@<
M\=>M&.<T 9+^*=%CTNYU-[T"TM)S;S2>6WR2!@I&,9/) R.*LRZSI\&IMILM
MTJ72VQNF1@0!$#@L6Z8S[U=P,8Q1CG- '"CQUX7U/4X[NXU)66UD(LK58G9Y
M)#E?,(QU()"CL"2>3A=3Q+/X2UJ.ZT+6KJW::)06MR^)5)&5*#JQZ8QGTKIZ
M3:-V[ SZT 9'A*#4+7PGID&JL[7J6ZB4N<L#CH3Z@8!]ZV*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **BNKF&RM)KJX<1PP(TDCGHJ@9)_(5S^A7NK^)M
M.36/M/\ 9MI<Y:T@CB5I#'_"TC-D9/7"@8!')H Z6BL[1SJNV[35C"[QW!6&
M2%"BO'L4@X)/.2P//4&H]9@UNY39I-_;6 5-QFF@\XLW9<9  ]3SU]J -6BL
MCPIJ5[K'ABPU#4;=8+J>/=(B9VGD@,,]B "/K6O0 444V21(HVDD8*B LS'H
M .] #J*Y?0-4U/Q;9'5X+G^SM.E=A:(D2M+*BDC>Y;(&2#A0.!W-:>FW&HP+
MJ!UR6W5()LPSHOEHT.Q3DY)P0V[/- &K152VU73KU)7M;^VF6'_6F.56\OO\
MV#QQZU$FOZ-+-;P1ZM9/+=9,"+<(3+@D':,\\@]/2@#0HK&'BK23XBFT3[9"
MMQ!$))-T@ !).%&>IP"3Z<5:AUW1[F18X-5LY7:-I55)U)**2&;@] 003[&@
M"_152SU73M0=TLKZWN6C ++%*K%0>A.#T/K2+K&F/>_84U"U:ZY_<B92_'7C
M.>._I0!<HK"T_P 5Z3K2ZE'9:C;QFRD:(RF13T529 #_  AFQGH<=:M66HVL
M&FV N]9M;J6>-0ESN1!=-C[RJ#CGK@4 :=%5;#5-/U2)Y=/OK>[C1MC-!*KA
M6]"0>M1)KFD22B)-4LV<]%$ZY/...>>>* +]%9VOZU:^'=#N]7O,^3:IN(7J
MQS@*/<D@?C5&TC\1WNE1W[W\%I>31B1;3R T,>1D(Q^\3V)!'L* -^BN._X6
M#:_\()=>('CC@N[820O:2R#BX3K&#WYP>.<&JFH^)KC1XK>Z'B:RO8-1D@MT
M5O*!MW9P)) 5P"BJ3PV<'&3B@#O**YS2WO5UM5F\66M_:RH\EO:B*(2RH0,,
M67&0ISR!SGFM>35],AO5LI=0MDN78*L+3*')(R!C.<X[4 7**IWNKZ9IKJE]
MJ%M:LV,":54)R<#J?7BDN]9TJQ=TN]2M+=DC\UEEF52J9 W')Z9(&?<4 7:*
M;'(DL:R1NKHX#*RG((/0@TZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH ***:[%49@I8@$[1U/M0 ZBN*U+4_%N@7>GZA?7%C=65Y>1VTUE
M# 5>W\PX4J^?G(/7(&?0=M+Q5+XBM=/O-0TN^L[6.RA:4130&0W&T;B"VX;1
MV& 3[T ='15;3YYKK3;6XN8#;SRPH\D)ZQL0"5_ \59H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%!'8D#./>NC\:W,"Z1X;E:9 C:S8L&W#!&X'.?3'-=?-;PW"A9X4E4'(#J&
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MF",2RQ;OF1#T8^W%0)K^DO:6=VNH0&"_D$5K)NXE<YPH]^#5X0Q"5I1&GF,
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M+[5-$98XMWS,@ZL/;FI3:V[1R1F"(I*2TBE!AR>I([TXQ1F42F-3(H*A]HR
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M4?)QCCTXXH-M 5E4P1E9O]8-@P_&.?7CB@"#^UM/^TVEM]LB\Z]0R6R;N95
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M]I+( 1.G6//?G'3L<U4O_$]YH\<%RVN:=>P:C)!!$/E#02.X#MP<%%!)YY!
MR: .XHKG],;55UA1<^(;&\L9%=[>)8E$TRD#!)!Q\ISRHYSS6N^I6$=XME)>
MVZ73_=@:50[?1<YH LT55NM2L+%T2\OK>W:3A%FE5"WTR>:6XU&QLRPNKRW@
M*H9")957"@@%N3TR1S[T 6:*Q6O-5/BN""%K2;29;4NVT-YL;=F+?=VGH!U/
M/H:T!J5@;S[&+ZW-SDCR?-7?G&?NYSTH M45E^)KV[TSPWJ.HV+0B>SMI)P)
MD+JVQ2V" 1UQUS7,7/B[7-'T#0]?O_L%W9ZD8%GAA@>*2+S5R"I+L&QZ8&:
M.[HJ&ZN[:RA,]W<16\0X+RN$4?B::+^S:"*<7<!BG(6*02#;(3T"GN3[4 6*
M*K6VI6%XDLEK>V\Z0DB1HI58(1V.#Q1!J5A=2>7;WMO,_EB3;'*K'8>C8!Z>
M] %FBJUIJ5A?F06=[;W)C.'\F57V_7!XI+;4K"\E:*UOK>>11DI%*K$#UP#[
MB@"U156+4K"XNWM(;ZWDN(^7A252Z_50<BFMJ^F(R*VHVBF20Q(#,OS..JCG
MD\]* +E%9,OB72H?$4>A/=PB\>$RE3(!M^9553_M-NX'7BKG]I6!O/L0OK?[
M5_SP\U=_K]W.: +5%9-IXETJ^UR[TBWO(7N;0+O D'+'<2H'<J%R<=,TMCJ,
M-KIJ/J6M65PSR.!<*RQHV&/R@;B,@<'GM0!JT5 ;RU6>.!KF$2RC='&7&YQZ
M@=Z9'J5A+>-91WUN]TG+0+*I=?JN<T 6J*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIKML1FVEMHSA>I^E #J*XS4
M-:\6:%=V%]J,>G3:=>7<=M+;0(XEMO,.%(<G#X/7@>U;/BK7)-#T2XN+6)9[
MT0R/#$>GR*69F_V0.OO@=2* -JBJ.AW<NH:#I][/CS;BUBE?:,#<R@G'XFKU
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 9?B739=8\,:GIL#!9;JUDB0DX&XJ
M0,^V:ROA]J,5]X/L]/D!AO=.A6TN[9CMDB9!MY'49 R#[UU-4[O1],OY1+>:
M=:7,@& \T"N0/3)% '*>"M16&+Q->ZEJDK6UEJ\\$<MU<LR10KMV@%CCOUZU
MHZC;^)I==74-+BTBYM%A"VWVFYD4H3RS85""3P,YZ#W.=[[!9_8S9?9(/LI7
M:8/+&PCTV],5. %4*H  X ':@#A?AI?R:?\ #JUNM8ELK2QC+"*;SB.#(P._
M<  =QP,$UV\XF:%A;NB2D?*TBEE!]P",_G4;6%FUG]C:T@-M_P \3&-G7/W>
MG7FK% &9Y.O_ /00T[_P"D_^.U-?6<]]HES922IYUQ;O$9$4JNYE(R!DD=?4
MU=HH XWX97L2^%+?19\0:EI>Z"ZM7.'0AC@X[@@@@]*;XZU)&L=,F1O,TR'6
M+==0D',?E@G.3T*AMN>V>.Q%=/>:-I6HRK+?:99W4B?=>>!7*_0D59,$+0>0
M8D,)7;Y94;=OICTH Y.^M5E^)UD]LB/%-IDHU)< HZ;AY6X="<EL9[ ]JY*Q
MM+"+X5^&[Z.&%;A-4@(G &\'[01][KTX^E>IV^F:?:6[VUM8VT$,GWXXXE56
M^H P:C_L72?)$/\ 9EGY0;<$\A=N?7&.M '-PO:+\4]5@NFA'VC3+=423'[S
MYW! !ZUSV@P:#9?!R35;W38[D+%<QR-%A92K3,NT..5'W<^W:O2WL+*1U>2T
M@=D0QJS1@E5/51Z#VI(=-L+>"2"&RMXHI>)(TB4*_;D <T >?_;G_P"$\F:U
MO[*6[D\-R);BU(V"02 H@.3N(S^1S@5=\+7WA?5_#OAM7DCEU&R*>7 LF)TN
M-N)"R@@GG<S9X(Y-=G#IUC;&(P65O$85*Q%(E78IZ@8' /M20Z;86]W)>065
MO%<S?ZR9(E5W^K 9- '%:$UE)I_C6QN# SMJ=XY@?!)3RTYV^GO6:EM:3^%?
MAT9XHG+7,$9+ <J87RI]03CBO27T^R=IG>S@9K@ 3$Q@F0#H&XY_&HFT;2FC
M2-M,LRD>=BF!<+]!CB@#C8[:VBU_Q]9P3IIT3V%NQDC&!"3%+N? ]."<5!HL
M-EXAG\).TFFK_8]L0\8N(I3*3&%"HH).,C=R 1@<=QU^L:&MWIUZNF+;6.H7
M,91;L0C=SUR1@\],Y]ZQ;;PI+=20C4- \/6/DR))]HL5+2DJP(VYC79TZY/&
M: +/Q'T:ZU[P)J5A9(7N"JR1H.KE&#8'N0#CWQ6GIFNZ?>>'(=8^T1QVWDAY
M6=L"(@?,K>A!R"/:M6J3Z/I<EW]KDTVT>XSN\YH%+Y]=V,T >:?V=/:?"+Q3
M?W<30G5;F>]BBD&&1'90N1V) S^(KI?&GD+I/AQCY84ZS8X/&"-X/\JZVYM+
M:\C\JZMXITSG;*@89^AJ%](TR6)(I-.M'CC^XC0*0OT&.* .;U&&"/XJZ&Z1
MQI(^GW(8@ %@"F,^O>LGPW?Z#J7A7^SO$$D;:K;Z@[W-JTFV=[D2DJ5 (8D\
M 8XQQT%=[_9M@9TG^Q6_G1@!)/*7<H'3!QQ2?V;8?;_M_P!BM_M>,?:/*7S,
M>F[&: .$>XTRZUSQ5HWB+6CIS7$@PDK0HLML8E"[6=2>#NZ'@G/7-.ATC2)/
M'>BVDEN+F%M =0+Q 7E = I<$<G;GJ/Y5W-SIMA>S1375C;W$L)S&\L2LR'V
M)'%*^G6,EV+M[*W:X7!$S1*7&.GS8S0!-'''#$D42*D:*%55& H'0 >E<!I\
MMYH^I:4I:WUG0[W4)/L4ZC;<V<SB0L&'1@,N">HYSTQ7H55(-*TZUN#<6]A;
M0S'.9(X55CGKR!F@#/\ &A"^!]>)('_$MN!S_P!<VKAH;9=%T_PGXDOS)J&B
MI8VZ31S,76PD*+MG5>F >#W':O3[BUM[R+RKJ"*>/.=DB!AGZ&F1V%G%:M:Q
MVD"6[9W1+& ASUR.E '(^(=5@M?&VCRWFJ&RTZXLI5MKM#&8_.+*>6=2HR@X
M/U&>36)K&DZ!;:5I0L;@WMG+XGB9IY60IE\^8L;*  F>H'&<^E>BOI&F26?V
M*33K5[7.[R&A4IGUVXQ6+XK\/W>JV^D6NFVUD+>QOXKF2.9BBE$S\B@*1SGZ
M4 8MYHUE:^.]1&GVD,5F^A/]OAC0"+?O_=DKTW8#?@*SHK2VL_@S9ZG96:>?
M]D@%U/#&IF:#S%,JY(.1M!R#Q@=*]'ATVQAM6MH[&VCADYDB2)0C'W&,&I+>
MSM;2$PVUM#!$3DI&@52?H* .*>/PSJ-S/J\7B.>\E;2IHI7MWB_=V^TDLX10
M00>F><]N#BI'-KVG_:=(N([>^O1HEP=)U2R&UI$ 7"NG0'.P@CCTZFN[MM*T
MZSAEAM=/M8(Y\^:D4*JLF>NX <_C3K73K&PW&SLK>VW_ 'O)B5,_7 H X70O
M^$:UVW\.W4>N33W5H%%O9(80\9*XD1E5 VT#.<\8'TK%NK#3A\,O%TZ6T D@
MU2Z$4@49CVS#:%/;&>,>OO7J<.EZ?;W$MS!86T4T_P#K9$A56D_WB!D_C3!H
MNE"-XQIEF$<@LOD+AB.A(QSU- '-2W%O#\6+:2>6-!-H16-G8#>QG7 'J:YB
MYU73KC2]!N;*>VM+0>)$D%N\FZ=?WS;WD8GY<Y/&. PY->HBPL@8"+2 &WR(
M2(Q^ZSUV^GX4S^RM-_>?\2^U_>N))/W*_.X.0QXY(]: .7T.6S;XA>*[>5X2
M;D6?EQL1^]7R3G [C&:S/#FA1>(/A)+I<.Q',URULPQB.19W*$>G('X5W[V=
MK).9WMH6E9/+,A0%BG]W/I[46ME:V2%+2VAMU)R5BC"@G\* .4T?4KWQ-H4^
MO10-%>Q6#VUNC+@K<;<RD>V\*O\ P ^M97AYO#VMZ9X;E.NW#WUC)&8K)&A6
M6.4##JRA Y7[Q;)Y SFO1(XHX5VQ(J+DMA1@9)R3^))/XU!#IEA;WDEY#8VT
M5S+_ *R9(E#O]6 R: &MJ^FJEV[7]N%L?^/H^8/W/&?F]./6G?VG8>=:P_;(
M/,O%+VR>8,S*!DE?4 $'BGFQLV6=3:PE;G_7@QC$O&/F_O<<<TOV2V\R&3[/
M%O@!6%M@S&",$*>W '2@"NVM:6EK=73:C;""SD,5Q(91MA<8RK'L>1P?6IC?
MV8O([,W4/VF6,R1Q;QN9!U8#N.:1M/LFAF@:S@,5PQ>9#$NV1CU+#')X')]*
MD-M ;A;@P1F9%*+)L&Y5/4 ]0.!Q0!5.N:2MD]Z=2M1;1R^4\WFKL5\[=I.<
M9SQBK'VZT-^;#[3%]K$7G&#>-^S.-V.N,\9IITZQ-NUN;.W,+/YC1^4NTMG.
MXC&,YYSZU)]G@^T_:O)C\_9Y?F[1OVYSMSUQGG% %4:YI+6J70U*U,$DWD)+
MYJ[6DSC:#GKD8Q4PU"R-W-:"[A^T0())8MXW(IZ$CL.*!IUB(5A%G;B))/-5
M/*7:KYSN QUSSGUJ06MN)WG$$8ED4(\FP;F4= 3W')_.@"NNLZ6]O:7"ZA;&
M&]<);.)1B9CG 4]SP>*=_:E@)+N,WL&^Q4-=+Y@S "-P+_W1@$\]J>-/LEB@
MB6S@$=LP:%!&,1$="HQP>3TIWV.UWSO]FBW7  F.P9E & &]>..: (1JVG,+
M,B^MS]N&;7]X/W_&[Y?7CGBAM7TU8[N1K^W"6)Q=-Y@Q"<9^;TX]:E%E: 0
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MCM[>-I)'/90,FL?2M0UW6].BU2%+.QM[A1)!;SQ-)(R'E2S!@%)'. &QGJ:
M.@HK.T>^N[O2_M&IVR6=PLLJ21J^Y5"NR@[B!D%0#G Z]JO1RQRQB2.170]&
M4Y!_&@!]%1K/"[*JRHS,N]0&!)7U'M2QRQR@F.17 ."5.<'TH ?14:SPLRJL
MJ%G7<H##)'J/:A9X75F25&53M8A@0#Z&@"2BF[TR!O7YNG/6FO/#'G?*B[<
M[F QGI0!)152\-Z)[3[++;)$9<7 F!+,F#PF#][..O;-3O-%&Z))*B,YPH9@
M"Q]O6@"2BHY9X8=OFRI'N.%W,!D^U5;O5[*QU"RL)YE6XOF98DR,D*I8D^W&
M,^I% %ZBJD1O?[4N!++;&T\M##&@/FJ>=Q8YQCIC ]:G6>)I6A65#(HRR!AD
M?44 245&\\,08R2H@7&[<P&,],TLDL<*;Y9$C7.-S, * 'T52U2_^Q:5/=Q!
M975<1+GAY"<*OXL0/QK+DUZ[N=>;P_I:PR7=I"DE]=2J3'!N^ZH0$%F;DXR
M!W[4 =#161'=:S;ZS;6=W%;3VD\;G[5"K(5<8(0H2<9&XYW'..@[Z8GB,QA$
MJ&4#)3<-P'KB@"2BHWFBC.'E12,<%@.IP/UI?.B#[/,3=NV[=PSG&<?7'- #
MZ*C$\33&$2H95&2@8;@/I1Y\/F^3YJ>8/X-PS^5 $E%1M/"A :5%);8 6 ^;
MT^M+++'#&9)9%C0=6<X _&@!]%-,B+'YA=0F,[B>,?6D66-W9%=69/O*#DK]
M: 'T5SWC+7KG0M'-U8/;-.DT2O'-DG8\BID $?WJW99XH=OFRI'N.%W,!D^E
M $E%-9T0@,ZJ3G )ZT1R)*@DC=71NC*<@T .HID4T4ZEHI4D ."48'!]*1)X
MI)'C25&=/O*K E?J.U $E%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 444UV"(SD$A03A1DGZ"@!U%<=>^)/$NC7EC=:KI=BNE7MREN5@E9K
MBV+G"E\C:W/7;^M;7B?7/[ T2XO(X?M%RL;M##G[Y52Q)]% !)/MZD4 :]%4
MM&O9-1T2POI559+FVCE95Z LH)Q[<U=H **** "BBB@ HHHH **** "BBB@
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MN\T^RU"T-I>6L,]N<?NI$!7CIQ[5&NCZ:EE+9"Q@^SS?ZV,H").WS?WN@ZT
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MM[>[MVT^W,-ZYDN4,8Q,QQDL.YX%2G3K(W<-W]DA^T6Z&.*38-T:GJ >PXH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:5%(Z@L!3RR@@%@"QP,GK0 M%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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,H **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>ebs20191231exhibit1048006.jpg
<TEXT>
begin 644 ebs20191231exhibit1048006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2T4 )@>G6BEHH 3 ]**6B@!,#THI:* $P/2BEHH 3 ].E%+10 F*,#TZTM%
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M^C9;9HWE8',F7,A'S98GCDU-XGO])UN7P;J>Z"6SNK\'=)@C#1-\K?C@$>M
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MD(& 69 3Q]35^L+P3]N_X0[2_MWV??\ 98O+\C=CR]B[<Y_BQU[5NT %%%%
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M #719$9'4,K##*1D$>E9^G:1'862Z>P2>TM^+82+EHT[(<]<= ?3&>F3I44
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MP/VRU:[LC'_$[RLWEX'?<)%(]<T =/XM\17>E^#FUW1Q;RJ5B<-,"04=E (
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MVVT(644T>JAHXYPWE+F--W"\\\_C4'Q%.JK\+=2_MM[+[09H=IM-P3;YL?\
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MG[V)Q;Y&T GJN=V#W&#6=\/KN#3? \M[?7$=M9+>W+1RRL%18S*0.3VSG\Z
M.VHJN;^S%\EB;J+[5)&94AWC<R X+ >E0'7=)%DU\=2M?LJR^29O-&P/NV[<
M^N>* +]%5Q?6AOSIXN8OM:Q>:8-XWA,XW8ZXSQFH%US27LH+U=2M6MKF410S
M"4;9')("J>YR",>U %^BJPU&R-U/:_:X?/MD$DT>\;HU/0L.PXJ)=9TMX+2=
M=0MS%?,$MG\P8F8] OJ>#0!>HJH=5T\->*;V#=8*&NAY@_< KN!;TXYYI!JV
MG$V8%] 3?C-K^\'[\8W97UXYXH N452;6=,6&[F:_MQ'8L5NF\P8A(&<-Z=:
M?_:5C]IM[;[7#YUTAD@CWC,J@ DJ.XP10!:HJ@VN:2EG<WC:C;+;6DIBGE,H
MVQ." 58]CD@8]ZG-_:"^6P-S$+IXS*L.\;R@.-V/3/>@"Q15#^W=)^P_;O[2
MM?LOF^3YWFC9OW;=N?7/%3B_M#?M8"YB^U)&)6AWC>$)QNQZ9[T 6**H+KFD
MM80WZZE;&TN'$<4XE&QV)V@ ]SD$?A4O]I6/VFXMOM</G6J"2>/>,Q*02"P[
M# - %JBJ2ZSIC0VDRW]N8[Y@MLWF#$Q(SA?7I2G5M.!O ;Z &P&;K]X/W QN
MRWIQSS0!<HJH-5T\M9J+V M?J6M1Y@_?@#<2OKQSQ3&UG2T@NYVU"W$5BQ2Y
M?S!B%AU#>AY% %ZBJQU&R%U!:_:X?/N4,D,>\;I%'4J.XY%0MKFDI97%ZVI6
MRVUM*8IIC*-L;@@%6/8Y(&/>@"_15<WUH+]; W,7VMHO-$&\;RF<;L=<9XS4
M']NZ2;);X:E:_96E\D3>:-A?=MVY]<\4 7Z*KB_LS?/8BZB^U1QB5X=XWJA.
M Q'I4"ZYI3VEK>+J-L;>\D$5O*)1ME<D@*I[G(/'M0!?HJK_ &G8_:+FW^V0
M^;:('N$WC,2D9!8=A@$\TQ=8TQHK.5;^W*7QQ:MY@Q,<9POKQ0!=HJF=6TY1
M>$WT ^P#-U^\'[@8W?-Z<<\TO]J:>9+.,7L&^^4M:KY@S. -Q*^HP0>* +=%
M46UK2TM[NX;4+80V3E+ES(,0L,9#'L>14IU&R%W#:?:X?M%PADBBWC=(HZD#
MN.: +--=MB,VTMM!.%ZGZ52;7=)2RFOFU*U%K;RF*68RC8C@A2I/8Y('XU.V
MH6:WWV!KJ(77E>=Y)<;_ "\XW8],\9H Y/4-9\6:%=V%]J*Z=-I][=QVTMK
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M15BB@""VLK2R#"UM88 WWO*C"Y^N*(+&TM99);>UAADE.9'CC"ES[D=:GHH
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M\3_NQ^]XQ\WKQQSVI?LEMNA;[/%NMP1"=@S&",$+Z<<<5-10!7-A9M%-$UI
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MGSR76EVUP^!)+"CG XR5!Z5YOOM=7^&_BZYU)(I-3CEN_M/F@;XG4GREYY
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M,\U=N[.-N<XSGC'K4@N(#<FV$T9G5 YBW#<%SC..N,]Z ):*K#4+)K:.Y%Y
M8)6"QRB5=KL3@ '."<\5(+JW,LL(GB\R%0TB;QE >A([#@_E0!+15<7]FT<$
MBW<!2Y.(&$@Q*<9^4]^!VI3>VH,X-S"/LPS/^\'[H8S\WIQSSVH GHJ#[9:D
MP 7,.;D9A&\?O1C/R^O'/':D-_9K'/(UW $MB1,QD&(B!DACVX(ZT 6**B-U
M;B:.$SQ^;*I:--XW.!U('<<C\ZC.H6*P27#7EN(87*22&5=J,#@@G. <\8H
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M V-N?MXQ=?NQ^_&-OS>O''-+_9>GB2TD%E!OL5*VK>6,P C:0G]T8 '%6Z*
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M%M,%U'PV]UP=Q']X_P![!ZBJ7PLMK6'X?Z7+#!%'+-#F5T0!G(9@"Q'7OUH
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MQP!MJH@ZR.V#M4=.A)/ !JM?K!K=W#),Z+I>F3_:))6.%EF3. #_ '4/)/\
M> '8UA6>E1ZI\2/%*W\UU$PM[5;7R+AX6\HH<D%2"1O!]LT =Q )A$/M#(9.
M_E@@?K4E<UX!O-0O?#"G4IFN98+B:!+A^LR(Y56/KTZ]\5TM !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 ,EC66-HVW;6&#M8J?S'-4M-T/3=(M&M-.M_LL#DD
MQQR, ">I'/!^E:%% &1%X5T2#3+G3([!%L[K/G0;VVN3U.,]??K6K'&D4:QQ
MJ%1 %51T %.HH S7\.Z1)HG]B/81'3O^??G;][=_Z%S6E110 4UT$B%&+ ,,
M':Q!_,<BG44 8<'@SP];*ZV^FK")#EQ'(Z[CZG!YJP_AO1Y+:SMC9*(;%@]L
MBLRB)AT88/7D\]>:U** ,>Y\):!>75U=7&E6\LUXFR=F'WQC&2/7'&>OO4DG
MAK1Y/LQ%DL3VJ>7#) [1.B=U#*0<>V:U** ,ZYT'2KO2AI4UE&UB,?Z.,A#S
MGD#KSSSWYITFB:=->VM[) 7N;-2L$K2.6C!ZX.>_?U[U?HH SX-#TRVFNY8K
M50]]_P ?.YBPFXQ\P)P>./I6?<6MYH%K;:;X6T*W:"7>'D:X$:VQP K%2"7'
ML.<*!7044 5-+T^#2=+MM/MAB*VB6->,9P.OU/6HM3T/3=9,)U"V%QY#B2(,
M[ (PZ, #P??K6A10 PQ*8?*RVW;MSO.['UZY]ZIV&AZ9IE@]A9V:1VDF=T'+
M(<]>#D<]_6K]% &=I^@:7I;HUI;;#$I2+=(SB)3U5 Q.P<#A<#@4L6@Z3!=W
M=W'I\ FO01<-MSYH(P<CIS@9]>]:%% &1HWA70O#\LLNDZ9#:R2\.R DXSG
MST&>PXI-/\)>']*U.34K'2K>"ZD))D1>A/7 Z+GV K8HH S/^$=T@3WLZV$:
MR7X(N77*F0'KG'K@9QU[T/X=TB32HM+:R0VD!#0Q[C^Z(Z%#G*D=L$8K3HH
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M;&@NR)O+[,5V;>G) 8D#U/%/U_QBGAG6;"VU.T5+"^9E6]6;/E$8'SKMX&6
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M(D8?9YLC.5!MP< L2<9)XIUQI0T5O".L:9/="]O+FWMKE6G=UGB="7RI.!M
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MJVTOV2,@K:FYE,''(_=EMI&><8Q5Z;2+.XU*'49%E-S "L;"=U"@XR-H.,'
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M)IS</'YC\R;]^[.<_>&<=*MC2[(:P=7\C_33;_9S+N/^KW;MN,XZ\YQFKE%
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M5I*LT,7F/\CAMP.<Y/))Y-6!HVGB]O+T6X\^^B6*X?<WSJH( QG X)Z5>HH
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M+$QB17<#Y59MH/XX-8OACQ))XHT9M3@T]K=-[1QI-*,N5.#T!P,C'>MVO/\
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MOUU%(RSW3E71KDHRLN<-D'J<GWQ@4 >KT5Q5PU[XCU_Q!I:2^6;#RHH-MY)
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M*[=NT.#G&!C%1OX&T)[&_LO)G6WU&3S;F,7#X9N,]^,X!..3@9KHJ* ,J_\
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M$#:,_*<'J*B3P_9)!ID(>YVZ8P:#,[9)"E?FY^;@]ZU** ,UM!LV&I@M<?\
M$T&)_P!^W'R[?DY^7CTI1HEH)M-EW3[M,1D@_?-@@J%._GYS@=3GFM&B@#*D
M\.6,EEJ-HSW/EZE(TDY%P^X$@ [3GY1P.!4YTFV.HVM^6F\VUB:*,>:VTJ<9
MR,X)XZFKU% &0_AFPDTJZTTO=>1=3FXD(N7#ABP;ALY R.@JS+I-O+JAU$O.
MLYMC;?),P4(3G(7.-V>_6KU% '+Q_#S0HP$#ZBT8;<8GU&9D;G)RI;!!/7UK
M>O-/@OI+5YPQ^RS>=&H. 6"D#/KC<3]0/2K5% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% #)7:.)G6-I2!PB8R?ID@?K63H'B6V\2:8^HV%K=>2KLB^:
MJJ78'! &[UXYQ6S7G_PR_M?_ (0J#[+]B\K[1/CS=^[_ %K9Z4 =3X>\26OB
M6VFN+.WN8XH9FA9IU5<NO4#!/3/7I3-:\36^BW45J=/U*^FD0R%+"U:8HN<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !2$A5+,0 !DD]J6D90RE6 ((P0>]
M ',#QW9IJ-K;W6F:E:6U]*(K6^GA"PRN?NCKN7=VR!FK.J>+K?3-1>Q72M6O
MY(U4R-8V33(A/(4D=#C!QZ$4FMV:>(+^STU0#;V5S'=73]@4^9(Q[DX)]%'^
MT*N^(+]M)T&\N[=0;C9MA7^_*Q"H/Q8J* 'Z'K,&O:6FHVT,\,3LRA;A-CY5
MBIR.W(-:%4](TZ/2=(M-.B.Y;:%8]QZL0.2?<GG\:N4 %%%% !1110 4444
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MM;$/&&'&[:,9]LXS52UMO$D.M6-S'<A[!XV6\6YN%?>V,H\851M.>H'&#TH
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M<[B!N7) XS['&==W5]HGC+2--6]GN;'68YHV29@SPR1IN#JV,X(R".@[5#X
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M.K( ,@YXY)S0!V+3ILF,?[UH>&1""V< X^N"/S%,L;E[RQ@N9+:6U>5 QAF
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MC.Y;:%8]QZL0.2?<GG\:N4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 R5&DB9
M%D:(D<.@&5^F01^E9'AWPU#X:T@Z99W]Y)#N9D:<QED+$DXP@[DGD&MJB@#G
M=-\()H^B7FEV&L:@@NG>03N8R\3L<DJ0@[U>N=#CGO[748[J:&^MH3#YZ[29
M$."5<$8(R >,8/XUJ44 4]-TR#3$F\IGDDN93-/*^-TCD 9. !T ' Z 5<HH
MH *S/$.AP^(]'GTJYN;B""X&V0VY4,PSG&64^E:=% %$:3 ^BG2;MGO+=H3"
M_G;<NF,8.T =/05E:+X-AT;:AU;4KV"%2MM!=3!D@!!'& ,D D#.<#I71T4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%-=!(C(WW6&#@XH Q+?QKX<NM772H=4C:[=BJ*48+(1U"N1M8_0FKM]KFG
MZ=*T5Q*_F+'YKI%"\I1/[S! =HX/)]#Z5D>)=+AU:?1]&MHE4VEW%=LR# MX
MHR<8]"Q&T#_>/\)JK;276A>.-=GOK.ZEL]32"2VN886D5=B;61\9V<\@G Y/
M- '6V]Q#=6\=Q;RI+#*H=)$.58'H0:DKD/A:9&\#6TC*R0R33/;JW58C(VT?
MY[5U] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 -<.481LJOC@L,@'Z9%<QH_A
M75=$T/4+"TUV);B[N'N([D67^J9V!;Y2Y##J/QKJ:* ,7Q3H4WB3P_-I*7J6
MGG[=\IA\P_*P;@;AW%:\0D$2B9U>3'S,B[03[#)Q^=/HH A>UMI)/,DMXG?^
M\R G\Z+JU@O;2:TN8UE@G0QR(W1E(P1^5344 <WI&@:UH-JNG6.L03:?%\MN
M+NU9Y84[+N5U# =L@&I-=\-3ZOIUI:1ZEY36]Y'=O++#YID9&W 8#+@9].W
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M?3KV&W%K*TL(G2XC!R-X)'S DG-=310!4L;.:TL?)DNWN+ALL]PZ@%G/?:.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^/$_9_\ CW^7'S<_-SS3_(U7[5I[_;H?)BC87B>3S.VT;2IS\H!R<<]:T**
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M.D(.7?[TC$DLQ]R236C110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW<^+(;2V.DV^H"U%L5;SGCX^??NP#\P^7;^->C6\\=S;QW$3;HY4#H?4$9%
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MX/'0]?2N9UCQI=#7M!T'1XH%O-8B^T-+<JSI#%M+?=4@L?E;N.GO6+\-//\
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MC% '4$A022 !U)JC8:[I.J3O!I^I6UU+&NYEBE#';G&>.HSQFN$U'Q=>>(/
M?BRUQ!;W^D&6VNB@8I(GS#<G.5)P>I.,=ZU_AAI\2>#=+U"6WM3=O:B-9XXL
M2>5G(5FZGG)].G% '99&<9JK9:MINI2S16&H6MU);G$RP3*YC//# 'CH>OH:
MX./5-=N_C9<Z8MU;BWLK F.-HV*A&:,MT8?.>.>G'2N<TO5]6T+7OB)J>E16
M;FUNEEE^T[B" \G "D<G)YSQCH<\ 'M5%<1??$(1:-X;FCC@@NM?VX:=B8K=
M<#>QY!.,@ 9&?45J^$O$DVOC48;F.,36%TT/G0J1%.G\,BY)ZCMD].M &Y=7
M=M8V[W-W<16\*#+22N%5?J3Q5&V\2Z%>;?L^KV<A;&T"9<MDX&!WR2!7GGB&
MY;Q%\<-+\.W_ ,^FV*><+=ON2R>67W$=^P^@/J:])U32+/5X(8KJ)6\B>.>)
ML<HZ,&!'ITQ]": +U%<+>>.-0N-5\1VVCQ6HA\.VQEF:X1G,[@$E%PPVCY2,
MG//:JFH_$J\_L[POJ.DV=M)'KLWD/#<%@8W#!2 P[9)&<=L^U 'HM)D'\*XG
M0?%VLZAK'B/1+R*Q6\TE0T,T*OY; @XW*3DXXZ$5@^"/$?B#_A76L>)9KBUN
M)$DGN-LL3%F=0I()# !<#  '''IB@#U6BN)\,^)_%6O6-CK#:19#3)K61Y!'
M(WGM(N=H4$X )&!G/KD=*H1_$+5K?6O#MKJ%I;1_VT[1S66QDN+)MP"[B6.<
M[@>57B@#T6DR!^-<1>^,=:OM2UZT\,V5M</H7E*\<RLS7+L3N5<,-N K=<Y(
MK+US6?$-Q\4_#.EQR06B26KW:V\J%PDABD#!\,-Q&& P0.: /3*JW.J:?9^:
M;J^MX!"H:4RRJH0'H3D\9P>OI5;Q!JC:'X;O]4*J[VEL\@7LS <#Z9Q7+Z+&
MQ^#EU=SN9;F_TZXNKB5OO2.Z,<G\,#Z 4 =C8:GI^JPM/IU];7L2MM:2WE61
M0W7&5)YY'YU#/K^C6U_]@GU>QBO./]'DN463D9'RDYZ5YCX>NHOAS\3-8T*Z
M)BTK4(C=VOH, L /P#K[E14(M);7X\Z$;D 74]H\]QSG#LDQ(SW"\*/910![
M)17GWBGQYK6A0:M=BQM[6+3[B.."&\C;=?H2 SQL&& ,Y^Z<?H+'B;QWJ&D3
M>&)+&RAN(-=9 8GSYB[MG"MG&3OQR.HH [FL[4/$&C:3<16^HZK:6DTWW$FF
M5"WO@GI4>@2Z_+;7!\06UE!.L["$6;LRM%@8))YSG/I]!7)_$WPSHUQX<O)Q
MIZSZS>S1QVLF,S/*2 %4_P!T*#QTP"?>@#NKJ]M;&V-S=W$4$*XS)(X5>>G)
M]:+.]M=0MQ<6=Q%<1$D;XV##(ZCZCTKR_P 317>E:I\./#T\QE6&>,S'.0[I
MY:@_AEL?6L>_UJ\TRX^)=O;.RQDJZ[3]QG<1L1Z$AOTH ]BLM9TS49GALM0M
MKB1!EDBE#$#.,\=L\9]:)]9TNUO5LI]0MHKEMH$3R@-S]WCW[>O:O)S<R:;J
M7PNEMCM::U6%P/XE<1@Y_P"^B:SOM4NH^ ?B#J%P2TTNI1G<>HQ*NT?@.!0!
M[DMQ"T[VZRH9D4,T>X;@#T./2I*\R\1ZU=V7P]\,>,%9OMUK]G>5N\J.F)$/
MLW!^H!KTM'61%=3E6&0?:@!U%%% !1110 4444 %%%% !1110 4444 %%%%
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M;LS&=P  [94;1P#@9Y[U1'P]UH1^+U^TV.?$;AD^=_W&'8X/R\\.?Q%>CT4
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M12P0:M-!+>$DR&W4K&.> H/. ,=:N444 %%%% !1110 4444 %%%% !1110
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M[&(!*_@>*L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(PRI
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MD!G)"%0WS XYP1D?C6K10!QNM^%KCQ3K&CW=[I]O8MIMRL\DZ2^9)(%Y$:X
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M:* //?AYX6\2^"-'NK"6UTZ[,T_G*R7CICY0,']V?2H_%G@[Q1XH\+0V4SV
MOVU,WDI\Y_+10K*B*=N3\I'8=*]&HH X#QOX+O\ Q<LR26%D)P8_L5Z)RLEL
M,+O5@%^=<[B.^3VJSJ/A'5QX^TCQ)83VUPEI9?9)A<NRL>'&_@'/W\XXZ=><
MCMJ* *FJ:;;:QI=SIMXA:WNHS&X!P<'N/>N7\+Z/XB\':(^B106VIP0.YLY_
M/\HA6).V12#CDGD9ZUV=% '$^&_ L_A_1=8DDFBO-:U@.T\N2L89LX4'!.,L
M3G'/I5WX=^'M0\+>%8M(U+R#+%([!X)"RL&)/<#%=310!@WNEW6I^(HWO[.V
METNWA(A!F)?S&(RY7;CH,#GNWK7,S^!M6TWXD0>)?#L-E!9^4([FWDF93+G(
M; "G'&T_5:]$HH XRU\*ZM8?$^_\2P-:266HVZ12!W821%0@.!C#9V>HZ^V#
M7T#PCX@T"]\3BVN+-8]5EDGM;G<Q>-V#;04VXX+ DY/3ISQW=% 'E-M\._%*
MR>'+NYFTR2ZTN\DGN&\R0O/N96WLY!W-A0,8[#GTV?\ A%?$>A>/K_7= -E<
MV6J@?:;>ZE:,QO\ W@0#GG)_$C'>N]HH XG5O"VMWWQ T+Q K6;P:;"4GR[(
MSLP8$JN#@?-P":H:)X(UW3M#\6V4XLC+KGFF I.Q5"X88;Y>V[/&>E>BT4 >
M6R_#SQ$_A/PUI"_8/.T:[:>5C.VUQO+ #Y/?]*VK/PAJ@^).L^(+M;8:?J=E
M]EV),3(HVH,XVXYV'OWKN** .$\#^'/%'A6!M#F.GS:9%.9(;P.WFA"<E=F,
M9/UXR>O2J)\#:_\ ;/&4P%CM\01E+?\ ?ME.2/F^3T.>,]*])HH \VU+X?:S
M??#32/#ZRVB7^F7"S<R,8Y -_&[;D??].U:7C#PQJ7BJQ>VO=,T^XS:_N'6X
M*/:W!+<AMN63&S/3.W[OIV]% ')W>F^*](\':5IOAZYM9]0M?*BGENL[60+A
ML?CCWQ[U:<>+_P#A)-1\LV']D_8_]"W9W^?@8W=\9W9]L=\UT5% '&J/B%_8
MFDY;3?[0^TG[?G[OE9XQCC..N/;'>K;CQI_:6N;&T_[)Y'_$JW=1)CC=[9SG
M/MCBNGHH Y)!X\^S^'MS:=YGF'^V/]S(QL]]N>G\6.U*X\=[/$.QM.R6']C^
MRY.=_OMQU[^U=910!RZ#QM]MT'>VG_9_*_XFV.I?'\/],=\]JK3#X@_8M=\I
MM-\_SU_LK_KEN.[=[[<8SWS[5V-% '.(/&'_  D.E>8;#^R_L8_M#;G=Y^#G
M9WQG;CVSGM6;CXC_ /",W.6TO^V/MG[G'W/(_EG/KSCWKM:* .>QXN_X2<'-
MA_9'V/D<[O/Q^>,_I[UEX^(__",6X#:7_;'VS]Z3]SR/Y9SZ<X]Z[6B@#G''
MB_\ X2+5/+-A_97V,_8-V=_GX&-^.<9W9]L8[U14?$+^Q]&RVF_;OM)_M'/3
MRL\8[9QUQ[8[UV-% ',./&OV[7=C:?\ 9O)_XE.>N_'\7]<]\=JB0>._+\/;
MFT[<'/\ ;'NN1C9[[<]/XL=JZRB@#DG'CSR?$.UM.\PN/[']ER<[_?;CK_%G
MM4R#QK_:.A;VT_[+Y'_$UQU,F/X?;TQWSGBNGHH XYA\0O[%U?#:;_:'VD?V
M?C[OE9YSGC..F??/:K\8\7_\)'IOF&P_LG['_IVW._S\'.W/.,[<>V<]JZ*B
M@#BL?$C_ (1>8%M+_MG[;^[(^YY'\LY]>WO6ICQ=_P ).Y!L/['^Q_*.=WGX
M_/&?T]ZZ&B@#BP/B-_PC5H-VF?VO]L_?D_<\C^6?ISCWK1<>,/[?U;RS8?V9
M]C/]G;L[O/P,;^^,[L^V,=ZZ.B@#CT'Q _LK1-S:;]M^T'^T\]/*W<;??;UQ
MWQCO5AQXW^UZ]L;3_(\O_B4YZAL?Q?\ U^_M7444 <H@\=?\4]O;3N"?[8]Q
MD?=]\9Z=_:FN/'OV7Q!M;3O.\T?V/_N;N=WOMQC/?/:NMHH YE!XT_M31-[:
M?]C^S_\ $TV]3+CG;[9QC'OGM54#X@?V#J^YM-_M+[1_Q+]OW?*R,Y[9QG&?
MQKL** .;MQXQ_P"$@T[[0=/_ +,^Q#[;LSN^T8.=O?&[&/;/?%9N/B1_PBS@
MMI?]M?;?E(_U?V?_ !S^GO7;44 <\1XN_P"$GGVFP_LC['^ZSG=Y^._?&<_A
M[UF ?$7_ (1RQ^;3/[5^U_Z5G[OD9X]L^N.<8[UVE% '-N/&/]MZQY9L/[.^
MR'^S=V=WGX&-_MG.?PQWJH@\?_V;H6YM.^U^>?[5ST\O=QM]]N<X[XQQ77T4
M <LX\<>?K^QM/\K9_P 2C/4'_:_^OW]J1!XYW^'][:?MP?[7QW_W?PST[^U=
M510!R+CQ]]AU_:VG?:/.']D8Z"/=SN]]N,9[Y[590>,_[8T7S#8?8/LW_$TV
MYW>=@YV>V<8_'/:NEHH XPCXB?V!J7S:9_:?VO\ T/'W?)SS[9],\]<]JT5'
MB[_A)K0N;#^R/L?^DA<[O/P?N]\9Q^&>]=%10!Q./B1_PBOWM+_MK[;U_P"6
M?V?'\\_^.^]:K#Q=_P )-=%#8?V1]C_T<-G=Y^!U[XSG\,=ZZ&B@#C%'Q$_X
M1_3OFTS^U/M?^F9^[Y.>.G&?7'/3WJ\X\9?VQK7EM8?8/LO_ !+-V=WG8&-_
MMG.?PQWKI:* .10>/OL.@;FT[[2)C_:WH8]W&WWVYSCOC'%2./'/F>(-C:?L
MP/[(SV_WOP]>_M7544 <L@\<>?H&]M/\L+_Q-\=2?]G\/3O[5"X\?_V=KNUM
M.^U>>/[*QT$>[G=[[<8SWSGBNOHH YMAXR_M30\&P^Q^1_Q-<9R9,<[.^,]/
MUK/(^(O_  CM_P#-IG]J_:_]%(^[Y.>>O&?3/.,]Z[2B@#GE'B[_ (2>#<;#
M^R/L?[[&=WGX[=\9Q^'O65CXD?\ "+)\VE_VU]M^8G_5_9\?SS_X[[UVU% '
M.N/%W_"2WQ0V']D?8_\ 1 V=_GX&-W?&<Y]L=ZSU'Q#_ +"TO+:;_:7VK_3L
M_=\G/&,<9QUQ[8[UV5% ',N/&G]JZWL;3_L7V?\ XE>[.1+CC?[9SG\,=ZKH
M/'OV3P_N;3O/\T_VOZ%-PQM]]N<X[X[5UU% '*./'7_%0;&T[DC^Q_89/WO?
M&.O?VIR#QO\ :M!WMI_DB/\ XFV.I;_9_P#K=_:NIHH X]Q\0/[+UO:VF_;/
MM _LO'3RMW.[WV],]\Y[5<0>,?[>TCS&L/[,^R#^T=N=WGX.=G?&=N/;.>U=
M)10!Q9'Q&_X1N\^;3/[6^V?Z/C[GD?RSZ9YQ[UH2CQD?$'[EM.&F_83]X$G[
M3CCWV[L?A[UTE% '%WF@ZWXNTNRT_P 3V=C;?9KI)YI;:8OYNW/"*1\N<X.3
MP,]<\:,Y\4R:AJ%G+8:9=:9.A6VD,S(R K@B1<'=WZ?_ *NCHH R?"^@0^%_
M#EGHT$AE6V0@R$8WL268X[<D\5K444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $,EY
M:Q.4DN8D8=59P"*([JWF;;%<12-C.%<$UR?C[1--B\(>(]0^QPM=W%N9'F>,
M%P0BJ,'&0 %'ZU?TS3--T_1+'6H=-7[5:Z>&_P!%A'F2@Q@E>!\Q) P/7% '
M1$X&34=O<V]W%YMM/'/'DKOC<,,@X(R/0U@6GB66YURUT74=-C@DOK)KE4$_
MF% ,;DD4J,'#>XZBN4\->([[PSX*^U1Z"USI=M>7'VB=)U5HU\]N4CQ\P'?D
M?ES0!Z4;JW%T+4SQBX92XBWC>5'4XZXY'-2UQ[^1)\5=.NH A$^BRMYBC[X\
MQ,$^O%+-X_@2.UO88(+BPN+@0YBN@UPJDX$AB"_=XSUS@@X[4 =?4,5W;3R/
M'#<12/&<.J."5/N!TJOK5I<7^B7UG:W'V>XGMY(XILXV,5(!_ UP_A;5HM>U
M?1K'[/%I5[HL3--&I&+E"I0>41P\1/SD^RXSU !Z-15.TN;V:\O(KFP^SP0N
MHMYO.#^>I&2<#E<'C!JY0!"EW;22"-+B)G/15<$_E2QW5O,^R*>)V'.U7!->
M8SZU9^'/B=XC?RH8KF\^Q6\$\J$0Q,\9)9V'0< XZDCMR1W^CZ%9:';RFVA5
M[F=C+<7&T!YY#R23]>@Z"@"_#<07(=H)HY0CE&*,&VL."#CH1Z5)7 :AXHNH
M_ .N:GH^EV^FSVU[+;RKOY#;PK2#:N"Y)_KD]#W=NT[0*;F...7G<L<A=1]"
M0,_E0 U;VT=@JW4+$] ) :GKRT7'AO2_%OC9M<L8Y;9I;554VID!9HONYQA2
MQ/<CFNA\)F^\(_#M9?$CN'M%=_++AWC0GY(\YP3R!U[@=J .QJM+J-C!=QVD
MU[;QW$O^KA>50[_12<FL*U\6O-KT.DR6MJ[W4+R036MWYR!E&2DA"C8<<@\Y
MYK"T:\C;3/$FH>(;*VFMK769I"WFEW$L918U4%0., !LCZ 4 >AT5S%OXNDD
MUR/2GL[>5[B!I8)+.[$R;EY*.=HV''(/(-5]+\<W%[H8U^ZT5K32?LTDK3FY
M5F#JVT($P,Y['CGVP2 =?17,6_B]WUR#2I+.WE:[A=X)+.[$RAE&2CG:-AQT
M/(/-4;;Q_=S:-INM2:"8M/N[D6\LAN@7B)D,8(7;\PR!GD'T!ZT =K16%>>(
M+KSM1ATC35OWTQ1YZM,8RSE=WEIA6RVW'7 R0/7#;KQ1'";*!8HX+N\MOM/E
M7\WD"%>.&."=V6Q@#L?2@#?IKR)& 7=5!(49.,D]!63X9U]?$6FR7/V9K:6&
M=X)8RVY0R]U; W*000<<YJEHUZVM>+M9E<Y@TETM+=>P<KND?Z\A?H#ZF@#H
M(KF":26.*:.1X6VR*C E#C.".QP0:EKD8O%"VUKXHOHM!2*72929U210UQMC
M#;V8#KMQZGBIK7Q;=R:KH]M=Z/\ 9K;6(BUO.+@.P<)O*LF. 1G!R?<#L =1
M40NK=KEK43QF=5WM$'&\+ZD=<5@2>*+R2T?4=-T=]0L([DVY:*4^<^'V.Z(%
M(*AL_P 0R 3]:<$?E?%;46MX8_,;1HFP3M#-YK\D@'TZX- '84A(52S$  9)
M/:N33QPTGA/3/$*Z:/+OKE8&B,_S1[I/+!!V_-SSVK1N=8DO;^_TO3M/AOC9
M(OVKSY=B%F&1&/E;)QR<X R/? !IC4;%K>.X%Y;F&5Q''()5VNQ. H.<$YXQ
MZU9KS7PQJD.F?#7PIY^E1WT=S>QP*9"N(':9@KX(/([8_,5TMQXGU(^(;_1+
M#1!<3VMNDZ/)="-) Q(Y.#MZ<=?PZT =+17,0^-;>X\,Z3K"6CB35KA+6&W9
M\8E9BI!;'0;6YQVZ5:TWQ#<WGB.^T2?3UAEL421Y4GWHRN"5(! /8@^F.] &
MU++'!&TLLBQHHRS.< ?4TR*ZMIT#Q7$4B%=P9'!!'K]*YCQW!J:'2M4L=._M
M6WTZX:6ZT\=905(#*.Y7)('J:;X5N_"WB.^N]6T98DFEA$-]:/$$<$'(WKZ]
M1GG/KQ0!U5O<07<*SVTT<T39P\;!E.#@\CW!J6O-/!GB*ZT/P-H!?2M^G2W'
MV5[GSPK(SS,%8)@Y4$@'D'VKI=7\8)8R:A'9Q6MP^G#]]'-=B)W;:'V1C:=Q
MVD>@R<>N #H7NK>.XCMWGC6:7/EQLX#/CDX'4U'>:C8Z>$-[>V]J)#A/.E5-
MQ]!D\UR%W=6VI^-_!6J6\)C^UVUV_P Z;7QY2$!O<9/ZTM@EUJWCKQ-9:E96
MEQ:?9[2&2-YRP2,B1L*"G.2<D<8XY- '9RW$$ !EFCCW=-[ 9I8Y8YDWQ.KJ
M?XE.17&?%BWA3X7ZDBQ(%A6$1C'W,2H./3CBNSBBC@B6*)%CC0855& !0 U;
MF![B2W2:-IHP&>,,"R@]"1U&<'\JC?4K&.]2RDO;=+J092!I5$C?1<Y-8]CJ
MJW'BO6]/BTB&&[M((6^TLX!N0V[8&(4D 8]\9/%<WH%]$/#=]JVOV5M,D&KS
M31.9=S_:/.V(!E0!@X4-GH.@% 'H<DB1(7D=41>K,< 4ZN<T_P 4"^U]M$N;
M:W;S+<S1SVMQ]HB89PR,=HVMWQW%-\*WSIJNN>'G8L-)N$\@DYQ#*F]%_P"
M_,H]@* .EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBD/(ZXH C6YMWN&MUGC,R#+1AQN ]2.M$US;VY03SQQ&0X0
M.X7<?09ZUPNLVGA[3/&WAV**V;3;I;EB;X6[*+@E2/*:7'SLQ()))Z'N:O?$
M*PT5?#NHWFH:6U[/+ 8XY1;M*T'& P8 ^6H/S'IWZT =C16?H+PR:!I[6UX;
MV'[-&$N3UE 4#<?<]:T* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@##\96%YJWA34-,
ML(1+<7<)B7<X55SW)/\ 2C['JK^"C86S"QU-;+R8W+ A) F 01VSWZ^U;E%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)8S*8A(ID R4SR!ZXH\V/S?*\Q?,QNV9YQZXH ?14;3PHQ5I44CJ"P%/+*"
M6 +' R>M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%9NO:Y;>'=+
MDU.\BF>VAP96B4,4!.,D9!ZGM0!I45B6WBS3I]1MM/G2YLKF\0O;)=1%!, ,
MG:W() [9S6W0 4444 %%%4]1U2TTJ!9;N4KYCB.-%4L\CGHJJ.2?I0!<HJ*W
ME>>$.]O) 3_!(5W#_ODD?K4M !1574M1MM)T^6^NWV0Q 9P,DDD  >Y) 'UJ
M#3=6:_NKJUETZ\LI;4KG[0@VR!LX*LI(/0YYR* -&BN?F\9Z;;ZK;V,T-[''
M=3"""\:W(MY)#T4/[GH<8/8U8UOQ);:&K&2TOKLHGF2BTMS)Y2?WF[ <'WX/
M% &Q15?3[^VU33X+^SE$MO<1B2-QW4]*L4 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<RP"UN8[E?+"_,Z'*@Y!XS0!EZL)8?&5I<WEG-=:6UC)"OEP-,(IBP)+*H)
M91C..Q'>N2T:\GU./PEHMP7.E7EQ>R!'/^OAA),*-ZK@@XZ$**]&U'3SJ5N;
M62YDCMW&V58OE:0=QNZ@'VP?<56U/PY8ZC9VENH>S:Q97LYK;"M;D# V\$8Q
MP0001VH BURPMK6SDUFWMD2\TZWFDA9$ )_=L-I]1TX]JYFV)TW3? MY;9:X
MNV6.X<?>G$L#2.6/?+@-]1796^GS AKZ^>\*@@*R*B\C!) ')P3UX]JJ6'AB
MUL9K(^=--%IJLME$^,0!ACTR2%^49Z#WYH XZRN94\$>&M=!SJ-UJL4DLH^]
M(9I2KJ3Z;6QCMM'H*0W4O_"O)/$I_P"0I_;'GB3^($7?D[/IY?RX]*[&#PM9
MP26ZB65K2UN6NK>U.-D<C$G/3) +,0,\$^PP'PM9F4KYLOV,WGVW[)QL\[.[
M/3.-WSX_O>W% &7XC\*Z#<SV\1TFTEOM3O5WW$D0>3:#YDAW'D?*I4>FX58U
M^&/_ (33PK/L7S1/<)OQSC[.YQ6Z]@DFJQ:@SL6AA>)$[#<5+'Z_*H_/UJOJ
M&C+J&J:=J#74L3Z<[O&B!=K%E*'=D9Z$],4 :5%%% !1110 4444 %%%% !1
M110 4444 %%%% !7*_$W_DG.M?\ 7 ?^A"NJK+\1Z%'XDT6?29[F:W@N !(8
M=NXC(.,D''2@#"F\.ZGK^I>'KV]-K:V6DXN%6&5I))GVC .54*!CWS5'5-<U
M2QD@NHM3>Z<ZVEM)Y"+]F2%I-OE$D9+@=2N2&R">U=Q96[6EG%;M,\WE*%\Q
MP 2!ZX %<P?A[:_86L5UC44M5O!>6\2F/%O)OW\97+#.>&R.?7F@"+5=9NAK
MNNV5UJ+:7'9V,<VGL-H\XD,7?Y@=V&"KMZ>W-1VFLZVUKX<T^]>X^WZK;R7-
MR<1QR+L5?W:\ #E\],@ CWJCJ,B_\)5?M-KFLZ).OEPPJ+7SDN45>)%)1AR6
M88!SQD]>-<^&;CQ%HUHVJ:C=QZA93O)9:A'&()U4\ LF,#(ZC XQD Y% &GX
M;CUR!;R#69!*BSDVDC,IE,1Z!]H R#W[U@217^L?%'4!%=I;#2+"-+8O#YFU
MI<EG49 S\NTGTXKJ])TO^R[=EDO+B^N)#F6YN""[^@P   .P ]>Y)J*[T-)M
M835[6X>TO1"8'=5#++'G(# ]P>0>V3U'% %3P=KEYK>E7!U&*..]L;R6SN#$
M"$=XSC<H/8@BJMM>W?B+7M<LHM0GL8M,=((O("[BY7<7;<#GDX Z<'.<\;NE
MZ7;:19_9K;<0SM+)(YRTCL2S,Q]2235"7PVJZY<:QI]]-8W%W&L=T$572;;P
MK88'# < _F#0!Q6LZI>^(OAC#>7LSPW4&H1VTXA"A)76X5=W(/ID8[YZUZ7;
MQ-! L3SR3LO623&YOK@ ?I6'?>#;&[\.0:##<7%I:0R+)F(J7=@V_)+ \EN3
MZFM^-66-5=R[ <L0!G\J .0\>7%_8+IVHM8VUWI%A>137,>YA,#G:KJ,8PI8
M''? [9K?U^/59=&N8M&^S"\D0JC7)(49'L.M5HO#LSH(=2UB[U&V642K#,D:
M@D'<H8JH+ $ X]N<U8NM+OI]1-S#K=W;0M&$:W2.-E!_O*64D'\Z *?@:\AO
M?!VGO#8_85B0P&VSGRVC8HPSWY4\UOU7L+&WTVRBL[5-D,0PHSD^I))ZDDDD
M]R:L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
J1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>ebs20191231exhibit1048007.jpg
<TEXT>
begin 644 ebs20191231exhibit1048007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#&U*UUB?4GE@U22RL(K;.R*.-FD
MERV>75L  #MSGVKB? .M>*_&/A2]U(ZXZ7UO=&.*,6\/EN JM@_)G)R1G/'%
M>C:A/%;:?/-/*D4:QG<[M@#CUKS;X"RQKX7O[9G43_;2_EDX;;L09QZ9'6@#
MO-2\4:+I#RI>WHC,&WSRL;N(=WW=Y4$)GMNQFN:\>>*;W0[_ ,-3Z=J21V.H
M7:QW!*HT;Q$J=P8C(X)Y!Z5R7C*_M[C4_&>GV5A-9SFVC:=DB>1KTKCYCU6-
M%&3P 3USVI=8D$OA?X;SJ':.VEB>9MIPBH$WL?88.3TXH ]1L/$.E:\+NWTO
M40UQ;@K*JJ5DB/8[7'ZXQ7.?#;Q9=ZSX(GUKQ#>Q9AN)%>9E6-50!3SC [FL
M[2T%[\8-:\06DJ'2[?3Q#-=JW[IWVKP&Z' '/IBN(TVVO+SX#WUO8JTDD&I^
M;<0H,MY>%Y*]<9P?^ GTH ]LA\3:-/;75P+Y$CLT$EQYRM&8U(R&(8 X(Z''
M/:IM.UK3]5EEBLYF:2%4>1'B>-E5\[20P!YVG'TKSV6'PIXGTK4=<;5=2N1>
MV,=M=R[%"VX,B%<A44%E;GC/ /J,W/AC-J\&I:KHU]>0:M:V$<26^IQ'=O4Y
M*Q[N^ 2<9.W)[$4 >BT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+10
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M>PH DHK(;Q3HJ:9::DU\HM;YU2WDV-^\+'  &,]?:M61UCC9VSA1DX!)_(4
M.HK%B\8^')B-FLVF"_E[FDVC?_=R>,^U;5 !154:C:'5&TP2_P"EK")S'M/W
M"2H.<8Z@\9S5J@ HHHH **QV\6:"A^;4HE0ML60@B-VSC:KXVL<]@2:V* "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBJ&JZWI>AP)/JM]#9QR-L5I6P&.,X'Y4 7Z*KV-]:ZE9QWEE
M.D]O*,I(AR&'3BK% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ+^T-=&VXG*'8B[-BJJYR0J^_))/M0 U-<D@72M'M6\N9]-6XDE^S//M4;5
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MQ:.@1K615_U#H04(^A _"@"E>^([NQ@N+A_)DBFU!;&P"PN23G:S-@DMA@_
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MI/!PU,061O(-2^P7((;8V)?+W(,Y&<@\YJ^=7\2)XM?P^SZ:3<61NX)Q"^(
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M'4%E4W$PMSL=-V2%7/!VX&<U9$.J?;KUS=P?9GB46L?E'=&^#N+'/S#...*
M+U%9:6^N"VTU7O[4S1.#?,(#B9<'(09^4YQ_GBG-!K.=3VWML!*H^P?N3^X.
MW&7Y^;YN>W% &E16<(-8\S3";VWVQ*1?CR3F9MN 4Y^4;N>_%1O;ZZ;34E2_
MM1/(Y-BY@.(5P,!QGYCG//\ ^J@#5HJB8M3^WVCBZ@^RI$PN8_*.Z1^,%3G@
M=>*K26WB Z7>1QZC:+?/.6MI3;DI'%N&%9<\G;D9]Z ->BJ9BU#^V%E%S#_9
MX@*M#Y9WF7=PV[/3'&,54%MX@_LI8SJ-I]N%QN:;[.=ABWYV[<]=O&?_ -=
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 17%K;W2HMS!%,$8.HD0-M8=",]#[U+110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4451U0ZGY<":7]G65Y@LDEPA=8TP23M#*2<@#KWH O45Q^GZQXFU'7]=TB.
MZTI'TDPA9&LI,3&1-W(\WY<=.]=$FI0V]K:G4[BWM+F:-2T;RA?GP,@9//-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#C/"S
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MQ)<G3K0SRJ5DE\A=S@\$$XR0: %TN>PN=+MI]+:(V3Q@P>2 $V]L =/I7/\
MC9@+[PL"0,ZW%_Z+DKH[.PL]/B,5C:06L9.2D,80$_04V[TO3[]TDO+"VN7C
M^XTT*N5^F1Q0!:K%MF\5'62+J+2!IF]L-%)*9]G.W@KMSTSSZUL@ # & .U+
M0!0UO4?[+TJ6X0*TYQ';HQP))7(5%_%B*X?Q1H^K:!H>F:VDUK/)X=E$[&.)
MEDF1CB;)+$?-DL:[Z\TZQU!46]L[>Z$9R@FB5]I]1D<4ZYLK2\M_LUU:PSP<
M?NI8PR\=.#Q0!P_BRXBA\3>$?& D$FD0F2.6<?=B$R81SZ+SR>W%=O->V\%N
ML[2J4? CVG/F$] OJ31#I]E;6AM(+."*W((,*1A4.>OR@8J"RT+2-,E,MAI5
MG:2'(W06ZH?S H S=4-SJGB&WLK&6 #3 +J?SE++O8,L:X!'0;V_[Y-8OAEI
MO#?CO4_#UY)#Y>JC^TK3RP57>3B50"3Z;L>@-=C#IMA;W<EW!96\5Q+_ *R9
M(E5W^K 9--FTC3+F[%Y/IUI+<KC$SP*SC'3YB,T <9XDTJ?4;?Q#=Z=_R$])
MU.*]M".3N2VA)7_@2Y&._%9?C"[_ +;^&>I^)I8FA%_]E6VCDZQPK*A_,L6;
M/<;?2O2;;3;"SFDGM;&W@EE^^\42JS_4@<TESI6G7D$<%U86T\40Q''+"K*G
MT!'% %37-?M-(6*![JVBN[G(@6XE"+QU9B3]T?KT')KD?$UMI[>!BNCWD>H#
M3+Z&]O)86#F0^9OD9BO&>2Q'88[8KLYO#VB7&SS]'L)?+78F^V1MJ^@R.!R>
M*LVFGV6GP-!96<%M$Q+&.&((I/3. /84 <KXCMSJ_COPS#;.&6VANKF9U.=B
M,@1#^+'CZ&L"%9(/@9-I#1G[?'OT\VX^\9S,5"@>IR#]#FO2+/3['3U9;*SM
M[8.<L(8E3=]<"@Z=8F]^W&RM_M7_ #W\I?,Z8^]C/2@#DO#5B^B>/M8M[EO^
M/S3K.2%ST80J8WQ]#@_\"%6?AS;R+HNH7S B/4]5N;R'/>-FPI^AVY'L:Z6[
MT^RU!52]LX+E4.5$T8< ^V14ZJ%4*H  & !VH YCX@Z5<7_APWM@/^)CI,JW
MUH0.2R<E??*Y&._%6/"EU_;=O)XD,31C4%06Z/U2%0< _5B[?0CTK?IL,,5O
M"D,,:QQ1J%1$& H'  '84 >6:KJ%A<:.MS9206T \2))LEDW7#RB<!W))^0=
M<#!^7'(Z5LVFH:->>(/%>F^(;FV7[0$$9GD"+)9F(8V,3TR6)QT)S77MHFDN
MT[-I=FQN6#3DVZ'S2#D%N/F.>>:==Z1IE_/#/>:=:W,L'^JDFA5VC_W21Q^%
M '(6NHZ=I_CBVL[YQ;V+:+&NEF[; P&(<9;^,J$SGG YJOK=AHMII/A-=(B7
M[+!K\"6TA;?\I=RVUCDE2>G;@8XQ7<7^EZ=JL:QZC86UXB-N5;B)9 I]0"*+
MG2].O$B2ZL+:=8?]4)858)],CC\* .2LM(TJ\^(_B:*ZL;:9&M;5F1XP5)82
M;F(Z9QWZ\^]8&DZD+3PEX#EO[Q[;3F,B2W'RE8Y &$6[<" /O#D<<'C%>E'1
MM*-Q)<'3+/SI05DD\A=S@]03C)H71M*6Q>P73+1;20Y>W$"B-C[KC!Z"@#*\
M,6&E6=_JTVEZE+??:I4EN#OC:)),'.W8H 8C!;_@)[TNO6%MJVNVNFW8#0W6
MFWD;KWP6@''N*VK2SM=/MEMK*VAMH$^[%"@15^@'%,DTVPFO$O);&W>YC^Y,
MT2EU^C8R* .*\&R:CJ$<>CZK&X/AAWAFE8?+<2 8A8>H$9+'/<J:RO#5Y8V_
MPJ\*+=QB1I=0"6^^7RXUE$LC*7/]T8)QW./J/3I;6VFCECEMXI$F.9%9 0_
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M>M@J&_XE\Y (SSY;5R%^+&[T'P);J898WO;99$0@@G[.V0<?49^M>CLH92K
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M@*H&  . *6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "HYIX;=/,GE2),XW.P4?K4E5;[3;34A MY DR02B54
M< KN (!(/7&[/UQ0 G]K:;_T$+7_ +_+_C5I6#*&4@@C(([UPGAW2].N/'WC
M2WFL+:2$-9J(WB4J 83D8QWK5U37+GP[97B6VFC['I%HCB:ZF,8N/E/R1G:0
M6 7\R!CO0!T#7MJEVEFUS$MS(I9(2XWL!U(7KBG7-S;V<#W%U/'!"@RTDKA5
M4>Y-</JM[)<>-O#&IZ98K//=Z;<2)&[B/((C(W-@X ![ _2DUC7WU[P-XJLM
M1TX66HZ9;R)<6Y<2*,H61U; R".1QF@#O(W26-9(V#HX#*P.00>AIU<ROB&+
M3K/2M.C:W%S+8K-FXE\M$0!1R0"223P/8\\<WO#.O'Q#ICW+VC6LT,[P2QD[
MEW+W5L#<I!!!Q0!HSWMI:R1QW%U#"\IQ&LD@4N?0 ]:GKBOB-8Z,GAO4+B\T
MI[F>YCV?:4MC*UMQ@/N_A5?O8!&>?4UOQWEP-*TJ32(AJD$QB5YWF"$0E>9>
M1\QZ''4YH UJAGN[:UV_:+B*'=]WS'"Y^F:FJG<Z38WM[#=W5M'/+ C)'YB!
M@H8@G&>YVB@!RZII[L$2_MF9C@ 3*23^=6JX#X>:-IU_X9NA<6<+LNJSLC^6
M-R%9,J0<<8(%:NI>,+G3&6>YTP0VK:B+)1+-LFD!8+YJJ1@KD],\CG/:@#JJ
M@2]M9+N2TCN8GN(E#21*X+H#T)'45B7/B>4ZOJ.F:?;6\]UIP0O;R3E)90RA
MMR+M.0 ?Q((XX)R'OH=)^)&M2K$KSRZ;;B&!>&N)2TF%''4XY/8 D\"@#N:K
MS7UG;31P3W<$4LO^K1Y K/\ 0'K1927<MJCWUO%;SD9:.*8RA?\ @15<_E7-
M>+_#6A3:#JUW?6$=U=SQMLF= TWF$;8U0]1SM  _'J<@'6T51T.VNK/0=/MK
MZ7S;J&VC29R<[G"@,<]^<U<$B%MH=2WIGF@!D]U;VH!N)XX0W ,CA<_G38;V
MTN6*P74,I'4)(&_E7,_%)5;X<:QN4'$2D9'0[UJQJWA72]6\,B(6L5O<1VX:
MWN85"20.%R&5AR.: -^>ZMK4Q"XN(H3-((X_,<+O<]%&>I.#Q2)>6KW;VB7,
M37$:AGA#@NH/0D=0*X30O&%Q?>$/"E]J.G17LM_?+:-/(P!BE#.HD P<G"D\
M8Y-:D*&+XI:FUO%&9&T>%L$[0S>:_4@'\\&@#KJ*Y&/QS++X3TGQ NEILU&Y
M2!X3<G,6Z38"#L^;UQQ4^K^,/L<VHQ6,5M/)IH'FQS7!C:5]H?8@"G)VD<GN
M<>M '3T5RB^,;NZU/3[*PT??_:-@;N)IY_*V$%05<;25QNY(S]*S=9\8ZI-\
M/M3U*UM8[*_L[EK*Y4REA&PD"$HP'/W@0>,>^.0#O.G)JJNJ:<S!5O[8D] )
ME_QJ:W:=H%-S'''+SN6.0NHYXP2!GCVKS-+_ $#2O$?C5M:LA/!)<P($^REU
M8M']W=C:I)/<B@#U&BN.\+"]\&?#B)_$3L9;1&8QAP[(I;Y(]W0GD#K@9QT%
M6(/%UP^M)IC6,$YG@:6&6TN#(@=>3&Y*C;QT/?TH ZFH%O+5[M[-+F)KE%WM
M"'!=5]2.H%<4GQ%OUT&P\1W'A_RM&N&59YQ=!GA#-M#;=O*@X&<@^V.MZW5(
M?BOJ#I'UT6)F"#ECYK_F: .NHKEK;Q=<G5M'LK[34M&UA9&CB,W[ZW*J6 D0
MJ,9 /3H>.>M2/XGOY[-]2TO2#?V,=T8/W<I\Z4*^QW1=N" P/4\@$\4 =+17
M+ZMXQ^QR:BEC#;7#Z;Q+'+<&-Y7VARB *<G!')[G'O35\87=UJ]A86.D;_[0
MT\WD+SS^7MP5!5QM)7&[DC/TH ZJBN)/CG5?[ U#5%T&'.D3R0Z@AO,#,9^;
MRCL^;@@_-M_&M:_\4PQ7<=G:-;>>]JMT3=3&)%1B0HX!))(/TQ] 0#H**XV/
MQY<36>C3Q:')NU.Z:U>)Y@K12*&/&1\P.W(/'!_"GR>+-5.F^)8FT^VMM4T2
M'S<>>9(G5HRZL#M!)PIX('3J* .OHK*\,7%Y=>&]/GOE3SI+:-MRRERX* [B
M2HP3SD<_6LK7O&%SH=M?7TVF!;.QG2+,TOER7(.W<T0Q@@;O7G!Z8H ZJBN<
MO?$>I1^*9- LM)BGE^P_:XI9+G8A&_;AOE)'?IGMTY(AL_&JW7A^SO6L2E]>
M7;626?F\><K,K?/C[HVEB<=.V>* .B6]M6O&LUN8FN53>T(<%POJ5ZXI9[RU
MM2!<7,4);IYCA<_G7'Z;]J_X6W>?:[:""3^Q8\&%]PD'G-\W(!![?A2_%=(V
M\%[I$#;;RW(RN<?O #^A- '8PW$%RF^":.5>F48,/TJ2N"^Q33?$NPU#0-.F
MM;2&TE7496MVMXYR0?+3# ;F#8.0#C\,5=TWQM>W>GRZO=Z.EII=J;A;J?[4
M&:,Q$CY5VC=G&.W)_, ["BN9E\575A_9=QJ>G)!9:I*D*21S%W@=QE XV@8/
M0D'@^O6IK#Q+-/K&LZ;?64-D^EHLH<W)831L"0_W!@<$'K@T ;4UU;6\L,4U
MQ%').VV)'< R-C.%!ZG )XJ:N6N=?N$O/#:W^A0K+J4I 9IM[6C;"W&4!SC@
MXQW'-3KXGEN]5O+'3[>WFDL;J.">%YRLP1MN90NT_* Q[\[3R* -Q;JV>Z>T
M6XB:XC4.\0<;U4]"1U .#^535SD6O01^*]7M+JPAM18V4=P][N!:2/+=>,@#
M!XR:KS>,;BTTFQUV[TU8](O6C!D$V98$D/R.Z[<8.1D Y&>] '5T5RLOBG5Y
M-8UK2[#1(9IM*2*0/)=[%D5PS?W20?EX'3KDCC.UH.KQZ]H-EJT49C2[A638
MQR5)ZC/?!H T**X_3/$6H)K?B>751;I8:4RY9)6)C01;^%V_,3GDY'IS@58E
M\6W-C;Z9J&HZ<D.G:E(D8D2;=);E_N%UVXP> <'@GOUH ZBH)[VUM9(H[BYB
MA>=MD2NX4R-Z*#U/TJGXCO;O3?#FHWUBL37%M;/*@E)"_*I/;KTZ?RKC-5N+
MR?0O ]]=VR2W;:A:E2DNYI08&.2S!<$GJ.1[F@#T:BN7MO&#P'78];LDLY=%
MC2:3R)C*LD;J2NTE5.?E(P1UIUIXMDDU^STR>U@9+Z-V2:TG,PA=1DK)\HQD
M=#W(Q0!TCNL:,[L%51DL3@ 57@U/3[I/,M[ZVF09^:.56'')Z'M6-XZT[4]1
M\/J-*ACN9K>YBN&M)#A;I$;)C/UXZ^E9OAW7/#_B?Q!#<I:MIFOV,;QSV=Q%
MLFV$#([;@" 1Z>@S0!V$%S!<H7MYHYE!P3&P8 _A31>VK7'V<7,)FSCRQ(-W
MY=:\[NH[WPGXCUCQ3ID;2Z:+P1:I8QKTC\J-O.0#^(%F)]0?J:ZJQEM=2\2W
M%_8RQNMSI4!BN$ .07EP?\^E &LVJ:<EP]NU_;+-&I9XS,H90.22,Y JW7E-
MI>V%AHW_  A'CC35T^9]R0:DR;X+AR21*'[/D@G/XXZ5ZK0 M%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %03WUI;.$N+J&)B,A9) IQZ\U/7.Z_H'AL17VNZQI=O>O%"9'>X0
M.0J+PJYZ#CH.YH WH9X;B/S()4E0\;D8,/S%25C>$M)&B>&+&Q,212+'OE1%
MPJR,=S #T!) ]A6S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#4<\"7,#PRABD@VL%8J<?4<T ><>%]+OO$?PHTO0WMTBM;A5\ZY\S/[H2[B
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M^SSYIS*VWD2<?*-V!QGBD676<Z9NM;4"13_:&)3^Z.W_ )9\?-\W'..*TJ*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 0!D\@'\OU%<?+;KK7B#P:E\\L@N-'F:8K(5,A*1$Y((/)Z\\U4EMWTSP_\
M$#18)99-,L8/]$$CE_*+P[GC#'L"1QVS0!Z/87#7>GVURRA6FB5R!T!(!JQ7
M"O.UYKFAZ'<2VZVTNC^='%<Q&2.>7Y01MW+DJO(!SU)Q6_X5TM]&T^XT]]4.
MH"&Y?9\A7R%(#"+EF) SQST(':@!_BCQ!%X:T*XU%H6N)(T8Q0*<&0@%CSV
M ))[ 5HV5P;NPM[DKM,T2R;<YQD XKS_ ,97FK_V7XCDNO#=XT9M9K>"Z$T/
MEQ0XY;&_=\Q&X\9P%&..>FTBUCUSPYH\FHV=Q:/:M%-%&TV#N084G8<$$<X/
MXB@#H:S=1O-4AO;>VTW38+I9$=Y99[DPK'@J .$;).3Z?=K2HH Y'1O%NM:S
MI[7\&@6OD17;6\JKJ#&0!7VLP7R@#CKC(SBNNKC?AA_R+=Y_V$[K_P!#-86M
M31FQ?5]-:24IKR :A-)B7/G!&BC '^J RN"1G!X/6@#T^L.SURYN/&&H:'+;
M11Q6MM'/'*LA9G#EAR,#'W>G/UKFO%3SZ;JFI7^I6 U+19#&&N;=O](TPA%S
M\IZKD[^/[QSD53\1ZG+I_C?59UC9K"73[5+Z>(;G@@9I SJO?MD]@<X.* /3
M:YKQ+XCU;0;>?4(-#6ZT^S&ZXD:Y\N0K_$43:<@>Y&<''K6WIMO96UA"FGJ@
MMB@:,HVX,".#GOD=^]9'C;3;S4?#MR;+4VLGMT,VTQH\<NSY@KA@?EX]?J#T
MH WHI%FA25<[74,,C!P:?5'0[R?4=!T^^NHO)GN;:.62/&-K,H)'YFJEMJFN
M2ZP;6?PZT%EO9?MGVR-AM&=K;!SS@<=LT 6=4N]1MWMHM-T^*[DF<AS-.84B
M4#.XD(QZX&,=ZY^S\6Z]J U<6OAZSDDTF=H)(_[28&5@N?D_<^_?%=A7&^!/
M^0UXN_[##?\ H"T =B#D ^M+7"1Z)::O\1-?MKU[F2!+>TE6,7,B@/ESD8.1
MC'3ISTK,U.6-K6VU?3GDE!\01K_:,TF)7S-L:-0!_J@,K@D9QT[T >G45P<>
MC6FK>//%%G>M<36QM;5O*-P^T%A)R.?R'0>E4=,?6M2\#>%[ZVB@U>6&!VN-
M/NI,&Z0?*&!/!9>/O<?-ZXH [G7]8BT#1+G4YD,BP 80'&YF(51GMDD#-&GS
M:P;VYAU*UMU@4*T%Q YP^<[E*GD$8Z]#GM7">(7TO4_A%)<VEM+&D-TBB*Y'
M[RW<W2AT/T)(^F*VM5$9\8Z?X=_T6"Q>QEFA@GA+Q32[QD;=PR0N2 <]2<=,
M '945YIJNBOI=MH>GMK4]V!XC2+]V[Q^3$Z,_D_>.<<8.<@'C&*[_2]+M-&L
M$L;%&2!"Q56D9R,DD\L2>IH R+;Q%J6J0W=YI&FV]S:VL\D"K)=%)9F0X; V
MD#D<9//?%;.EWC:AI-G>O%Y37,"2F/.=A90<?AFN*O\ PS>6\USXH\#:G]EG
MF=Y+FQE^:WN74D-Q_"V01GU]*;JMV^L>#]%\<6UHT<]ALN9K92<20CB1<=#@
M992>F/>@#T&JNHO?)82MIL4,UV,>6D[E$/(SD@$CC/:N/U@0:MX4\3>(H)'"
M2V4B6<L3LA*1(WS\$=7W?556J'B31+2P^&%WJ5O)=+=W%K:O-+]JD^<@J.1G
M&,,1@#'3C@4 >DT5QFNV4=W\2-&@EDG\F>QN?-C6=U5L%,# /'7G&,]\UB0"
M]MO!7B*RTZ:016&NO!'%YQW_ &</&3$C$YR=Q &<G..IH ].HKB4T^>#Q-J&
MMZ;:3P:?!IF8K=M\*R70W'(BXS\NT$D<G&.1571-,_M72?#_ (CAURW@F5XI
M)[B.W8R71;Y7AD;S.<L<=.". * .PUS4)M)T2\U&"V2Y:TA>8Q/*8]RJI)P=
MIYX]*YYO'5U9:+I>N:IH\<&FZCY7[VWNS*T'F#*EU*+QSS@FMKQ9_P B=K7_
M &#Y_P#T6U>?10NFD^#3XBF:X\-2VMOA5 18+G8/+,I'+)VZ@9ZT >L45R7B
M&Y:X\9:7HL\MO':W-I-(D=S$9(YY0R *5W#)"EB <CGIG&,'6M&ETC3=.L1K
M<]P!XDMU00EHQ:I(P/E ;FR!D$9SC(H ])D+B-C$JLX'RJS;03[G!Q^59'A+
M6Y?$?AJVU6>!())VD!C1BP7;(R]3U^[6#IVF+X>^):V6EO,+&_TYY[FW>5I%
M617 $F6)()SCWYK+\/2VW_"NO#UM/).7N-1D6*VB( N6$TIV.3QLXR?IWZ$
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M.<9Z="*U:@L;.'3["WLK==L-M$L48]%48'\JGH **** "BBB@ HHHH ****
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M[DMY)X][6LOFQ?,0%?:5SCOPQZ_7K5BB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BDR <9ZTM !12 Y&1TI: "BBB@ HHHH **** "BBDR,XSS0 M%%% !1
M110 4444 %%%% !1110 44F<TM !1110 444G?% "T444 %%)2T %%%)D9QG
MF@!:*** "BBB@ HHHH ***0$'H>E "T44A('4XH 6BD[XI: "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *HZII5OJ\<$-T7,44PE9%8KOP" "0>F2#
M^%7J* //M!T/3[WQMXNL+B%GMK9K58(_-<>4&B);;@\9/-;USXAAT."ZLTM+
MN^&C6<<MW*NT83:>1N(W-A"2!^>:J>&[34+?QSXFOKG3IX+746MS;ROMPWEQ
ME6R 21STR*J>([+7=3OM>L)=+FO;2XL=FF.LJ+#&QC(<N"0=^X\'!Z#&.30
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M/)YHNM5OA?7-@F@74P"CRIRT?D2Y'.XELJ >#P3QP#4=A:S^&-!TC2K2TDU
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M>8B,0P< GG##! YQTS6;JFC.UIXNUF[L XU:"*"WLI7",^Q=JDD'AF=N!G/
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MRBLC^UM2_LK[7_8-Q]H^T>5]E\U-VS?MWYSC&/FQ_P#KJV+NY.KO9FPD%NL
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,G&X%20<'@CL<=B":<7B^QE2&Z$,PTZXN?LT5\=OEL^XJ.,Y"EAM#8QGV(-
M&_163>:_'!J,NG6MI/?74$(GGC@V_NT).W)8CYC@X'MVJ[IVH6NK:=!J%E*)
M;>X0/&X[@_R/M0!9HHHH **** "BBJNG7-Q>6,<]U9264S9W02.K,F"0.5)'
M(&?QH M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&]-O-J5DBR/,P:>)O^>G][.!G-:$,LZ?%*XMOM4[6[:.DPA:0E%<S%20O0<
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MHTA\JV39O90.F%SC)]*Z2S\3:;>W26L;3I++;?:H5D@9?-BX^9>.>HXZ\]*
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M'YAFM@IDS&P4;N1AL8/X4 6Z*** "BBB@ HHHH **** "BBB@ HHHH ****
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M;V[TM],%G.+>)_,MI 00S(,-@X(/T^F>M\-PVD=A++8Z6VG07$[2JDB%'D)
MR[*>021WYP!FM>B@#$\51R7FF1:5$C-_:4Z6\I4$[8C\TA/IE%8?4BK]_J,>
MF_95>WN)1<SK;KY$1?86SAFQ]U1CD]JN44 %<9\3XWN/#UK;1VL]TQOX':.&
M!I?D5LL2%!XQ79T4 <.EL_@WQ']OTRRFET'66'VF"VMV9K2?'$@0#.QAP1C@
M_E56ZFATOQ=JKZOI.H7EAJ_E2VEQ;0R2#B-4:-E7D'Y>,CO7H5% ',_\(W=7
M%I:?8-4OO#\$<(5;&U$15.2>=RGYL$ X...*JR&>+XH23QVT\JKH?DK(8F$;
MRB4MLWXVYQ7844 >707-U=GPK?RZ9J8FM;XBZ@2R>.*U)C<!$3 & 3][GW8=
M*UM.D;3?^$ML;NQN7GO;^::V@%N["Y1XU5=K8VD$@@\\=\5W=% 'F*:9<^#[
MK1)-6L;N_L%TE+*>2S5Y#;S*Y;)"\E3NQG_9%7M<MX8_#FG'3M$N;2&36K>Y
M\A+=S)L#@M(Z@$KG!//.,9YXKT"B@#D7=A\5$NC!<?9_[$:+SO(?9O,H;;NQ
MC.T9Q7,217#?"34;%;&]^U-J#.L'V23>P-T'! VY(V\YKU6B@#@M:U6/2?'!
MU&W6\C-SIB++(-/DN(S\[;/E3#*PPV<]0>Q&:W? XTF'PO;66CW,EQ;VF8F:
M:-HY ^=S;E8 J?FSC'0BG7/AR[&LW.I:;KMU9-=[//A,:2H2HV@J&&5./0X]
MJU+"Q6QB=?-DGEE??+-+C=(V ,G  '  P !Q0!R^ERR^'O%WB!=3BG\C494N
MK6X2%Y%D 0*8_E!PPP,#N.E85SI%[I'PST^PEM+AKA]22Y^S0PM(84\_S,$*
M#C"]??->GT4 ,219(A(N=I&1D$'\J\TMO#5MXEUCQ9%<VL]K<37D<VGWLEJZ
M%&5>&5B!D;AR,\BO3J* //\ 5)]:\5_#[4=(FL)[;7H JRQ-$RQ7#1NK$QN1
MM*N%XY[XZ5=U)SXLU#PW+8V]Q$UG>"[N6FA:,P*$(,;;@/F+$# ]">E=G10!
MY_X9U"XTG3Y/"FI:+>7%_!<R^2QMBT%PK2%UD,F-H +<YY&.YXJAJ]KJ?_":
M:_K.G0W#O8FTN(;>2!_)OA&CAT!Q@L-PVD=&_3T^B@#EM?A;Q;X,:YT^&>WO
MH=MW:+/"T<D4\?S*"".O5?3FI(OM$O@W4-2N[:2.[U&W>9X%4LR93:B8 SD*
M%R/4FNEHH \WG2<>!O!,/V.[,MK?6+3QBVD+1",?.6&,@"M:XCEN?B1=B..X
M2.;0A;I<^2XC$GF,<;L8R 0:[*B@#SCPP;2:QTW0]2\,7O\ :VG-&C":)S A
MCP!,'/RXP,C'.>!79>*&V^%]44))(\EI*B)&A=F8H0  !GK6K10!P>M:1J4W
MB#3=8T$2(FJVYT_4&*E&CCQE9<$9#+A@,]]H[U)%&MI\6XGAM+B.QAT(6:2+
M;OY2N)@0F[&/NBNXHH X3PW?I8>*O%5Q<VM^D5U=1O XL9F$@5,$C"G/-6M)
MTR^UCQY-XKO;22RM8+3['8PS#;)(-V6D9?X>I !YQU KL:* ,/Q1,(H; >7-
M(?M\#D10M)A0X))V@X %8-OX>O[3QK>VT*?\4]?R)JDAP<+,IYC'^\P1S[+C
MO7=44 >=Z5/>6S>.9K?2I[B::=YK6&XMG"7($>,#(&X$CIW_ !I-/G>3Q=X?
MU/[+JTL36,\4TTUHZ*DAV';LP @&#R  <<%C7HM% 'E<D=PWPHU6R%A>FY?4
M7=(/LDF]E-R'! VY(V\YKH9[O^S_ (C_ -HR6MY);7^DQPP/%;.^9%D9BAP/
ME.&!^; ]2*[.B@#ROR[H?!2ZT\Z=?"\:>0+;_97+MFY+@@ <C:<Y'%=/K&J2
M'Q+IR&TO!I\]K(1=VMH[2M)N&(2P7=&I R3QD@<C!KK:* /*-*CU32/#GAS4
M/[)OY!H>H70O;;R6\S9*T@WJ#]_:&!R,]>O7&]XJDD\2^ ==?2]*N%\^%?++
MVYCEN"I!)V$;B   ,\GG';/<T4 <5X@O@VM>%?$(M+W[!;S7"RD6LAD021%5
M)C W 9]JQ;W[3/I?CY1IM^KWQ4VRM:OF7,*J,8!YSVZCOCFO3Z* .'\2)<R:
M!X>U:UL+F]@TZ9)+FTC1DE,9C:-B%X.Y=W2J&MV4>N>&-1O?#>AW,<I,$CM<
M1-'+>".0,4 ;YB !^)X&:]'HH X6YU>/6?&7A6_M+'4/(B6Z$S264J^2610
MV5]>">GO6WXYW/X)U>&.*666>TDBCCBC9V9BI   !-;]% ')Z1XGM;'PK81M
M8ZH]U!:1QFW&G3ABX4#;DI@<]\X]Z@T][G0/&VMS:K%+]GU5()K>XBB9TW(F
MUHS@'!SR >H]Z[.B@#S(Z-?:5X9T>XEL[C8GB0:@]O%$SO;P,SX^103P&!(
MR,U;\20ROJ-_JVB/J&GZS'$@%NUNTD&I+L!",I&"W)3@Y7O7H5% $<#2-!&T
MR!)2H+J#D XY&:\]F\*:E=Q:YX:C5X+""9K_ $Z8':/,D&Y$'^RDF\G_ (#7
MHU% '+6#WD_@N\U74K62*^U"U,DD"H69/W>U4  SVSCU8U@K'<6_A'P-.]E>
M$:=<P_:D2V=I(L1,I)0#=P2.U>CT4 <?IMP5^(>M74MK=10O86ZK(]N^UF7>
M6 .,$C<.E3?#2.6#P%IMM<03030!TDCFB:-E.]CT8#L17544 <QH'_([^*_^
MNMK_ .B!71&V@:Y2Z:&,SHA192HW*I() /7!(''L*S8-!^RZ]>:K!?SH;YHV
MG@VH4.Q HP2,C@>M:] $5Q;07<)AN88YHB02DBAE)!!!P?0@'\*BU/\ Y!5W
M_P!<'_\ 035JJ>I64U_:M!%>/:AP0[(BL6!&,?,#0!G>!_\ D1="_P"P?!_Z
M *Y.S6WL+K5-!U[P]?WTTU[-+;/'$\D-W'(Y=<G.U2">=V ,=:[W2--CT?1[
M/3(79X[2%(49\9(48!.._%7* .$\6Z;+K:JEA;"&[\/Q"XC=X'*3-CF!3CYD
M(7#8SU7WJ/Q)K<>I:?X2U.2SNK8G6H3+;RP.)(V\N3(VD9./4#FN_K%U_0)=
M;N=-F6]%N-.NEND7RM^]P"!GD<8)Z?G0!E1VXN?'-]XB@CD%E%I(M#)Y;#SY
M#(7^48RVT #([G'8US=O'/#\/_!D$EC>^=9ZI;R7$0M)"\2HS%B5"Y &17J7
M;FEH YSQMI\E[X=-]9LJ7VF,+ZT=N/F3DJ?9ERI^M7?#L4PTO[==Q&*ZU!C=
M3(>2A8#:GU5 J_\  :35="DU:^A>74[F.R5-LUC&%$=QSGYCC..Q /(X]<Z]
M &0GB*!]'M=3%CJ CNI5B6(VS>:A+;<LO4#C.?2K(U6(WU[:?9KK=9Q+(S^2
M=D@8$X0_Q'CH*O44 9::]"]MILXL[X#4G"HIMSNBR"<R#^$<=:<VM0J=3'V2
M\/\ 9JAGQ ?WOR[OW?\ ?/;CO6E10!G#68C)IB?9;S.I*60F XBPN[$G]P]N
M>_%1OK\$=IJ5R;.^*Z<Y1U%NVZ7 !S&/XASUK5HH HG58Q?VEG]FNMUW$TJO
MY)V(!CAS_">>AJM)XB@CTN\U V.H%+2<P-$MJQD<A@NY%ZLO.<^F:UZ* *9U
M&,:PNF>1<>8T!G\WRCY0 ;&W?TW=\>E5!XC@.E+J/V'4-C7'D>5]E;S =^S<
M5Z[<\Y]*UZ* *:ZE&VK2Z=Y%R'BA$QE,1\H@DC ;NW'2JD?B*"33;"^%CJ 2
M^G6%(VMF$D9)(W.O\*\=?<5KT4 4!JT1O+ZU^S7>ZQC61W\@[9 P)PA_B/'(
M'>HDUV%X--F%G? :DP"*;<YBRI;]X/X>E:E% &:VMPJ-3/V2]/\ 9HR^+<_O
M?EW?N_[_ *<=Z<-9B,VFQ?9;S.HHSH?(.(L*&Q(?X#SC![\5H44 94GB"".R
MU&Z-E?E=.D:-T%LV^4@ YC'\0YZU8.J1C4;:Q^SW6^YB:59/).Q ,<,W\)YZ
M5=HH R'\1P)I5UJ!L=0*6TY@:(6K&1R&"[E7J5YSGTS5LZC&-8&F>1<>8;?S
M_.\H^5C=MV[^F[OCTJY10!R2LW_"V'G\BX\@Z,L'G>0_E^8)BVW=C&<'/6J_
MB7PQK!T[7KFS\0W6V[@E<V:VD3E_W9 C#%2V,# QZ^IKM:* ,3P=9WECX3TZ
M"^N9)YA;QG$D0C:(;!\F !]WISSZUMT44 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 53U+5+7288Y;KS2)9!$
MBPPM*S,03@*H)Z _E5RFM&CLC,H8H=RDC[IP1D?@2/QH P5\;:.\]U B:@\M
MD%-Q&NG3EHLC(W#9QD<UN6\\=U;17$+;HI4#HV,9!&17(^%_^2C>-?\ ?LO_
M $2:7Q+J>HZ6FJ_9+]+9+&P$UE;6L*R,2JL6,H*G8GR@#!'?G- &_-KMG#K]
MOHCB;[7<Q/*G[L[-JXS\W0]1TS4NL:M;:'I<^I7GF>1;J7?RXRY 'L/Y]*XV
M_FOM6\5>$KFVGCL[F[TNXD,GE[Q'N6(G"D\GGC/Z]*AOM4U67PKXVT/69X[N
MZTJU;;=)&(_.CDB++E1P&&#G% 'H%M.EU:Q7$>=DJ!USUP1D5+7(IJUVTVE:
M'9"X1CI:W4LEL(C(!\J*!YGRXSG/![5K>&9-<?3777X52ZCG=$<%<S1?PN0I
M(4D'D#TH L7.MVEO=R6H6:>:%!),D$32&-3G!..YP<#J?2K5I=07UI%=VLJS
M03('CD4Y#*>0:X/Q%+JVE>*-3U'PP7NV-M&=6M0@8QX&$>/)YDV9.WI@#/45
MT&BPQ7/A?13X8U#[/I\9C?,D7F--",[D.3\K$]3V(- '15EZ[XBTWPY;)<ZG
M)+%"[A Z0O(-QZ#Y0<9K4KC/BD6'ABU* ,W]I6V 3@$[_6@#H+_Q!8Z;+9PW
M(N1+?$B"-+9W9B!D@A0<8'/-6)K](+RTM3!<,UWNVND1*1[5S\[?PYZ#/4US
M7@W5TU34[]=6C:W\1VY*3VTO_+*+/R^5ZH>"3U)Z\;:NZQJ>HV?C7P[80W""
MROS<":+RQN8I$6'S>F<=,=* .B#*20""1U&>E9FM>(M.T#[.=1:9!<RB&(QP
M/(&<]%^4'DXZ5A^#([LZYXE>?4KFX$6I&/9($P1Y4>#PH(P.,# ]JC^)A86&
M@E%#,-=M-JDXR<MQF@#H+'Q%I>H:A)IT,[I>QIYC6T\+PR;?[P5P,CW&16I7
M!Z0)/$GQ&FU.^5=/N=!C:V2P!W.X<?ZTMP"A!. /QJ_>ZKK&J7^LV>CFYB?3
M2L,30K 5>4QA_G\PYV_,!\N.AY] #HK_ %*#3EB\W<\MQ)Y<$2 %Y7P3@9P.
M@)Y(  IFDZK!K%F;F"*>+9(T3QSQE'1U.""/\.*X[5X]6N_$7@I]0GDL+R5I
M_.AA\MUBD$#;BI(.<^Y/'O5ZYU77=5.L1Z*UPLNFS&V@V+ 4EE5%8^;O.0"6
MQ\N,#GGH #L:*XF:_P#%-YXFM-(6^@TM[G1VN9%$"RF"8.BG!)PW)(],'UQ4
MDVJ:_J9U:WTJ2?[1ICBVC>*.#9-,(U8F02'(4EL87& #R>P!V5%<8=2\37'B
M?3=+EN8=/-WI3SSQ)"LAAE5D!PV2#R3CMZ@U!8^*M4314MKJ>.74&UU]'6[,
M84'#']X4'&=JG Z9Q0!W5%<OJ5_K/A?3]9U*\NXM0L8(5>S\P!91(>"K[55=
MN2,'KC-/M'\31>(+0.D]QIDT;BZ:Y$"&%P,J4\LY()X(.<>M '12RQP1/-,Z
MQQQJ6=V. H'4D]A52358XXK23[-=.MW,(DV0DE<@D,P_A7CJ>F16%X[N7_XD
M6F D1:CJL,4X_O1KEROXE0/IFK'BO4]1TR]T'['<)'#>:G':SH8PS,K!CP3T
M^[Z=^M '1T5QC7GB*_\ $7B33+?6(K6.PB@DMW6U5F4NCMCYLYY'.?3C%)I/
MBF]UJV\-VHD6VN=5LWNKB:-02H0 $(&!&2S9Y!P ?J #H]=URS\.Z7)J5^)O
M(C(#>5&7.2<#ITY(Y.!6C7!>-8=7@^&NN1:O<PW3+,OV>:,89H?-3;O  &_K
MG QTK:EU*^3XA1:2+HFSGTR2X\LHN4=7500<9Z$\'- '1UG#7+-O$1T$"7[8
M+8W7,9"; P7ACU.6'3WKE+;Q;J4>D/'+.DM[/X@?2;:9XP BAR-Y P"0JD]L
MG%3PVUW;_%A4DOWNMV@R&-YHU#(?/3@[ H([],^] '5V%\FH6[3)!<0A9'CV
MSQ&-B5)&<'L<<&K5>>2^)O$"?#NYU=;V$WUOJ+6[/Y PR_:!$ !T'!]ZVK._
MU>S\>_V-?7Z7EM=:>UT@$"Q^2ZNJE1CDJ0W<D\=: .II"0!DG %>>CQ-KMWX
M>TS5K>\$5[>ZI]CEL# K"$&1E*XP&W*JACDXZ\8QCO)XDEL9(;EQL:(K(_W>
M",$^U &1)XRTB.U^VL;K[$3M2Z%K(8G.<## ="> >A[&KG]NV?\ PD0T'$WV
MPVYN>8R$V @<,>"<D=,UPINM:\ :;_97B"T&L>%POD)?P#$MO&> )%[@<#(_
M,G K6U);B\^)MA]@O%MS+HDI$X0.0IE3E0>,].N1[4 =M5;4+Z'3+">^N-_D
MP(7?RT+M@=>!S7&V'BS5/[!MX;A_M&H2:Q)I?GQHBEMA<EPI(4,53 '3)'!Z
M5;F?Q"FG^(H-2CDDT[["[VD\_DB4-L.Y&$9P1W!P/?- &^NNV!T"#6WD:.TN
M(8Y4++\Q#@;1@=SN QZFC3M9AU&6[@%M=6\]FP66*>/!Y&0002&!]B:X75X9
M9/AAX1:.[EA7.FJ40*02?+P>03D=NWJ#7H\$;Q0+'),\[*.9'"@M]=H _(4
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M(5"V^!+O7:V?FXXZ8[_E6[10!C:;X?.F:WJ-_%?RF#4)1,]J47"R;0I.[KC
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MD7>KRRS7C*UQ=M$NYMI! 51@*/E''/?N<U+J7ARYO=9L=8MM5-G>VT+6\K)
MKK+&Q!(PQ.TY&0>?QK?HH X\_#V!M&NK!]5NF>746U&WN JA[:8L2"/7KSGK
M[5=M?#%\GB&'7+S7&N+J*T:U*K;)&C L&R1DGJ!W_$=*Z.B@#D6\#2/X7N-!
M.K'RKB[^U-+]G&X'S!)C[V,;@/PJ_<Z+/'XAB\2/=F22ULFMVMXK?/FJ2&;'
MS9W$J,?ES6_10!Y3HUU)Y N=,\8P-J3AI#I\^F)+<AV)8QL1M<\G!/'KP*]-
MEADN]->";$<DT)1]O(4D8./6K-% '-3^%]0N]$&AWFN&?3VC$4K&V N)$'53
M)NV\CC.S/OGFK)\.,OBB#6X+M8UM[,V<=MY.5"$ALYSG.0/P'XUN44 <BW@&
M.71;K3IM2EWRW[:C!<Q1['MIRQ;*\G(R?R)Y]+T/AV_;2KRWU'79;^[NH&MQ
M</;HBQ(1@[47 R>Y)/0=ABN@HH YBZ\(2W/AG3-#&I[$TUH6246^6?RL; 1N
MQV&?7VKI%$GE89E,F/O!<#/TS_6GT4 <OIOA34=)OM1NK370#J-P;B5&LU*A
MC_=^;.,8[T_4/"<^I:*;"YU=WEDNUNI;@P#+,K JH4$  ;5'X>]=+10!B7V@
M7%[XATW6/MZQOIR2(D0@RK^8 'S\V?X1CT]ZI3^#[J/7;K4M'U^ZTN._8->6
M\<22+(P&-RE@=C$=\&NHHH YO5])75KW1]+@4_8],N$NIW)R!Y:D1QY/4DD$
M^R\]1G8O[6ZNFM3;7[V@AG624*BMYR#.8SGH#D<CGBKE% &?]AOOM.HR?VK)
MY=TBK;Q^4N+0A2"P/\620>?2F+IVH*FF*=9E8VG_ !\GR4_TSY<?-_=YYXK3
MHH S'T[46BU-5UF56N\_9F\E/]$^7''][GGFG_8;W[5I\O\ :LGEVT;+<1>4
MN+IBH 8G^'!!/'K6A10!DR:7J;:?J%NNNS)/<S,]O<>0F;5#C" =& P>3SS5
MEK2[.J070U&06\<+(]KY:XD8D8<MU!&.@]:NT4 9#:5JATJ6U&O3"Y>X,B77
MD)N1-^?+VXP1CY<U;%K=?VP;S[>_V4V_E_8]B[0^[/F;NN<<8Z5<HH R%TK5
M!I\-N=>F,Z77G/<>0F9(]Q/E8Q@#'&>O%619W@U&YN#J4A@FB5(K?RUQ"PSE
MP>I)R.#Z5>HH RH],U);+3H6UR9I;657N9O)3-TH!RI'10<CD<\5(;"^\[4G
M_M:4)=(JVR>4O^B$*02O][)^;GTK1HH S5T[4 -,!UB4_9!BZ/E)_IAVXRW]
MWGGBFOINHM!J:+K4JO=DFV?R4_T0;0, ?Q<\\UJ44 4#8WOVRQF_M23RK>-E
MGA\I<7+$ !B?X<$$X'K4$FEZF^FW]LNO3)/<SM);W/D(3;(2"$ Z,  1D\\U
MK44 4VM+HZM%=#4)!;)"8VM?+7:[D@A]W4$ 8Q[U4.E:H=*>U_MZ87+7'F"Z
M\A-RIOW>7MQC&/ES_P#JK7HH IBTNAK#79OW-J8!&+/RUVA]V=^[KG'&.E5(
M]*U1=+L[5M>F>X@G$DUT8$#3H&)*%<8 ((&1SQ6O10!1%E>#4+NX.I2&&:)4
MAM_+7$##.6!ZG.1P?2H$TS4EM--B;6YFEM7#7,ODIF[ !!4C^'.1T]*U:* ,
MXV%^9-38:M*%NT ME\I?]#.W!*_WN?FYI%T^_!TPG5Y2+1<70\I?],.W&6_N
M\_-Q6E10!EOINHM;:E&NM2K)=L3;2>2F;08   _BYYY]:F-E>&^LI_[3D\F"
M)DF@\M<7#$##$]1C!.!ZU>HH R)-*U1M,OK9->F2XN)VD@N?(0M;(6!" =&
M (R>>:MFTNCJ\=V-0<6JP&-K3RUVLY((?=USCC'2KE% &1_96J?V5]E_MZ;[
M3]H\S[5Y";MF_=Y>W&,8^7/_ .JK8M+H:O)=G4'-JT C6T\M=JN"27W=<XXQ
MTJY10!D)I6J+H]K9MKTS74,JO+>>0FZ90V2A7H 1QD>E6197@OKV?^TY/)GB
M5(8/+7%NP!RP/4YR#@^E7J* ,M--U%;;38VUJ5I+1@;F3R4S=C!!!'\/)SQZ
M4YM/OR=3(U>4"[4"U'E+_H9VXRO][GYN:TJ* ,X6%^)-,8ZO*5M%(N5\I?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFI*HZMIIU6R-I]JEME9U9FB"DL 0=IW C!QSZCB@#C_#^J-9^-1]HNFD3Q'
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M.W- &7JQ%WJ7@O4)8E6YDNOF;'(W6TA(^F:L>-H(GCT25HU,D>LVFQB.5S(
M<5J:EHJ:E>Z==&YEA.GS&:)(PN&8J5YR#QACTQ2ZSHR:REJCW,L M;F.Y7RP
MOS.ARH.0>,T 9>K"6'QE:7-Y9S76EM8R0KY<#3"*8L"2RJ"0&48SCL1WKDM&
MO)]3C\):+<%SI5Y<7L@1S_KX823"C>JX(..A"BO1M1T\ZE;FUDN9([=QME6+
MY6D'<;NH!]L'W%5M3\.6.HV=I;J'LVL65[.:VPK6Y P-O!&,<$$$$=J (M<L
M+:ULY-9M[9$O-.MYI(61 "?W;#:?4=./:N9MB=-TWP+>6V6N+MECN''WIQ+
MTCECWRX#?45V5OI\P(:^OGO"H("LBHO(P20!R<$]>/:JEAX8M;&:R/G331::
MK+91/C$ 88],DA?E&>@]^: ..LKF5/!'AK70<ZC=:K%)+*/O2&:4JZD^FUL8
M[;1Z"D-U+_PKR3Q*?^0I_;'GB3^($7?D[/IY?RX]*[&#PM9P26ZB65K2UN6N
MK>U.-D<C$G/3) +,0,\$^PP'PM9F4KYLOV,WGVW[)QL\[.[/3.-WSX_O>W%
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ML?L*Q(8#;9SY;1L489[\J>:WZKV%C;Z;916=JFR&(849R?4DD]2222>Y-6*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>ebs20191231exhibit1048008.jpg
<TEXT>
begin 644 ebs20191231exhibit1048008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(FLV#"32I--DB69#F.601<E3T.,-R/7WK!GF@U+X.>'-"T]A+K$FH%H[>/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3KP:6B@!-J[@
MVT;AP#CF@@$8(!'O2T4 )UH P,"EHH *0@'J :6B@ HHHH **** "BBB@!,"
MA551A0 /0"EHH 3 !)QUKE?$?A&[UOQ5HNMPWL,*Z2Q81/&6,A)&><\=/0UU
M=% %#6["34]"OM.@D2)[NW>$.RY"[@03@=>M4/!GA^;POX9M=&FN([DVN\+*
MB%=P9RW()/K^E;U% !1110 @  P  *  .@QFEHH 2@  8 P*6B@ I,4M% "*
MJJ,* ._ HP,YQSZTM% !2=:6B@ I" >HS2T4 (0",$9!HP.F*6B@! ,# I:*
M* "BBB@!,#.<#-+110 A 8$$ @]0:  H    ["EHH 3 SG SZT8&<X&:6B@
MI  H 4  = *6B@ HHHH *0@'J,TM% "$ C! (]Z6BB@ HHHH **** "BBB@
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M[87+1VNR,JVU>&W')R=X8=N #WK2JO8V<>GV$%G#GRX(UC4L<D@#&2>YJQ0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %0M:6S72W;6\1N$7:LQ
M0;P/0'KBIJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/#]O?^5;'1FNH@8D.R7?L!SC) ZXH W/[</_ $"-3_[\#_&C^W#_ - C4_\
MOP/\:YVQO]<O/&^MZ$NLR"+3X+>2!FABRS, 6#83H?;&*JV/B'5M0\4ZYH9U
M>>"6*Z$%@RVR%5/E/(=YV'(^3U!H ZS^W#_T"-3_ ._ _P :/[</_0(U/_OP
M/\:Y_P 1>(M4\/>,=-:2X#:%<R);7"-&N89'#;&W8SC(YSZ4ND>(=4U#XDWF
MF27 &FKIXNH(5C7G+A02V,G(^;\?:@#?_MP_] C4_P#OP/\ &C^W#_T"-3_[
M\#_&M6B@#*_MP_\ 0(U/_OP/\:/[</\ T"-3_P"_ _QK5HH RO[</_0(U/\
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M,^GKPNH:UJ-FN@VZ7_FOK=]CSE5"(82I?:G&#QM&X@YY/I@ V_[</_0(U/\
M[\#_ !H_MP_] C4_^_ _QK@;?XB:MJ.F0K%(L%U#I5[>3R+&")'A8J@P> #M
MR<>O!%;LOBO4I[OP9+ T45MKB[[B+R\L/W0? 8GID^F>.M '0_VX?^@1J?\
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MZ!&I_P#?@?XT?VX?^@1J?_?@?XUJT4 97]N'_H$:G_WX'^-']N'_ *!&I_\
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M/<>2$4/&D)(<MEL=1@8)S3Y?B!HD,=N\GG*LUO%<G.S]U'*P5"WS<YSG"Y(
MR: -/^W#_P! C4_^_ _QH_MP_P#0(U/_ +\#_&M6B@#&@\1QW5O'<0:9J,D4
MJ!T=8!AE(R".?2I/[</_ $"-3_[\#_&CPM_R*6C_ /7A!_Z+6M6@#*_MP_\
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MSDG))_+G@>E:-% !1110 4444 %96D?\A/7?^O\ 7_TF@K5K*TC_ )">N_\
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MEC!D< %>OW<#ZUU]% &3H&@1>'X[R*"YEEBN;I[@)(!^[+G) (&3SZUK444
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M6IX>U&35OB+INI3!5EN_"44SA.@9I@3CVR: /0:*** ,KPY_R#)O^O\ O/\
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MZ\+7_P!&7% &K1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX0?^BUK5H *BN9Q;6LLY1I!&A8JF,G [9(%2U7OP[:?<+&C2.T3!57JQQP*
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M91QSH%F5D9>07P#SU(R/S%>A)NV+OQNQSCIF@!U%%% &5J__ "$]"_Z_V_\
M2:>M6LK5_P#D)Z%_U_M_Z33UJT 4=8U:TT+2I]3O6*P0 %L8R22 !SQR2!SQ
M26NIB>>6&:VDMC&B.'D92D@;=C:P)S]TYZ=J9XA@^U:)/;G31J23%$DM20-Z
M%P&P20,A<D<CD5Q,7@<1Z5K>AR7<T6A7<4:Z?'J$@+07&2?D[A0=O'4\]>I
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M1?\ /WIG_@-)_P#'*/+\1?\ /WIG_@-)_P#'* -6BLKR_$7_ #]Z9_X#2?\
MQRCR_$7_ #]Z9_X#2?\ QR@#5HK*\OQ%_P _>F?^ TG_ ,<H\OQ%_P _>F?^
M TG_ ,<H U:*RO+\1?\ /WIG_@-)_P#'*/+\1?\ /WIG_@-)_P#'* #5_P#D
M)Z%_U_M_Z33UJUS&J1Z[_:&C>9=:>6^VMY>VW< -]GFZ_/R,9_'%:7E^(O\
MG[TS_P !I/\ XY0!JU!=V5K?PB&\MHKB(,&V2H&&0<@X/<&J/E^(O^?O3/\
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M*\OQ%_S]Z9_X#2?_ !RCR_$7_/WIG_@-)_\ '* -6BLKR_$7_/WIG_@-)_\
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MPQJIFNM/,7V*;>$MW#%=AS@E^M '3T5E>7XB_P"?O3/_  &D_P#CE'E^(O\
MG[TS_P !I/\ XY0!JT5DLOB!!EKW2U&0,FVDZG@?\M*7R_$/_/WIG_@-)_\
M'* -6BLHQ^(1UO-,_P# :3_XY1Y?B'./MFF<?].TG_QR@#5HK*\OQ".MYIG/
M_3M)_P#'*/+\0YQ]LTS/_7M)_P#'* -6BLKR_$.<?;-,S_U[2?\ QRCR_$(_
MY>],_P# :3_XY0!JT5E>7XASC[7IF?\ KVD_^.4>7XASC[7IF?\ KVD_^.4
M:M%97E^(O^?O3/\ P&D_^.4>7XB_Y^],_P# :3_XY0 >'/\ D&3?]?\ >?\
MI3)6K61X8#C1W$I5I/MMWO*C +?:),X'.!FM>@ HHHH **** "BBB@ HHHH
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MLZVTV:+7+S4YKE)/M$$4"1I$5V*C2,,G<<D^9Z#I0!HT444 %93_ /(VP_\
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M<1,98&=08\X.""3MZ<$CUX -/_A)=)_Y[R?^ \G_ ,31_P )+I/_ #WD_P#
M>3_XFK>G&^:T#ZAY2S,2=D2D;!V!Y.3CJ1QFK5 &5_PDND_\]Y/_  'D_P#B
M:S-/\0::FN:M(TT@61HMI\B3G"<_PUU%9&F_\C!K/^]#_P"BZ '?\)+I/_/>
M3_P'D_\ B:/^$ETG_GO)_P" \G_Q-:A(4$DX Y)KF8O$6HW7A:3Q-;16YM!&
M]Q':LC>9)"N?X]V Q49 VD#('O0!I?\ "2Z3_P ]Y/\ P'D_^)H_X272?^>\
MG_@/)_\ $U GC+0F,8-XZ^88ADP2;4,@!3<VW:N01@DX-*GB:TGWA7DMO+OU
MLMTULY$CY P.F,G(![<$]<4 3?\ "2Z3_P ]Y/\ P'D_^)H_X272?^>\G_@/
M)_\ $U)_;VF^>(/M!+L9%0B)RKLF=ZJV,,1@\ D\'T-)IOB#3-7=4L;AI"\"
MW";HG0/&W1E+ ;AZXZ'@XH 9_P )+I/_ #WD_P# >3_XFC_A)=)_Y[R?^ \G
M_P 356^UVXTCQ%';ZD8(]+NH6-O.$;<)5Y,;'.,E02,#G!';FU'JKV.GI-K3
MHD[(TIC@A=BB#DY4;CP",GID_2@ _P"$ETG_ )[R?^ \G_Q-'_"2Z3_SWD_\
M!Y/_ (FGIX@TN2XB@CNM[3,%C9$8HS%/, W 8R4^8#/2GZ9K5CK".]C))(B=
M7:%T4\D<%@ <%2#CIWH A_X272?^>\G_ (#R?_$UFCQ!IG_"3F;SI-GV(+GR
M).N\G^[6GINHW%WJ^K6<R1!+*6-(B@.6#1AN<]^>U(/^1M/_ %X#_P!&&@ _
MX272?^>\G_@/)_\ $T?\)+I/_/>3_P !Y/\ XFM6B@#*_P"$ETG_ )[R?^ \
MG_Q-'_"2Z3_SWD_\!Y/_ (FM6B@#*_X272?^>\G_ (#R?_$T?\)+I/\ SWD_
M\!Y/_B:NZA.]KIMS<Q@%X87=0W3(!/-<]J/B+5--T?3;D6L=Y+>>6SF.-U5=
MS(-N.1D[B!\V<XPK<X -3_A)=)_Y[R?^ \G_ ,31_P )+I/_ #WD_P# >3_X
MFL_4_$M_9ZGI]M%IIDCNE1G;;)D9#$C[F>-N> 3C.X)P3HVM[=MXDOM.F:)X
M8;:&>(I&58;WE4@G)S@1CGCJ: $_X272?^>\G_@/)_\ $T?\)+I/_/>3_P !
MY/\ XFM6B@#*_P"$ETG_ )[R?^ \G_Q-9K^(-,_X2>&;SI-@LI%SY$G7>A_N
MUT]93_\ (VP_]>$G_HQ* #_A)=)_Y[R?^ \G_P 31_PDND_\]Y/_  'D_P#B
M:U:* ,K_ (272?\ GO)_X#R?_$T?\)+I/_/>3_P'D_\ B:U:* ,K_A)=)_Y[
MR?\ @/)_\31_PDND_P#/>3_P'D_^)K5KF)_$&IV_AR_U40Q3O%=7$,4:1L-B
MQRR1AF(SGA 3G:.O(H TO^$ETG_GO)_X#R?_ !-'_"2Z3_SWD_\  >3_ .)K
M,U#Q/J%KHME>QZ83)<3!'0A_D'F!>Z@?,#@9.,D;=XZWO[3O?[4TF-A$L%_$
M[/&8W#QL$#=6P>IZ%0?I0!+_ ,)+I/\ SWD_\!Y/_B:/^$ETG_GO)_X#R?\
MQ-:M% &5_P )+I/_ #WD_P# >3_XFC_A)=)_Y[R?^ \G_P 36K10!E?\)+I/
M_/>3_P !Y/\ XFLW2O$&FI?:Q(TTFR:]#1L()"& @B4_P_WE8?A73UE>'_\
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M\!Y/_B:/^$ETG_GO)_X#R?\ Q-:M% ',>&_$&F0>&-*ADFD#QV4*L/(D."$
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MRK7$K*1D<@@@\>M;-% "$ \$9K&U#=+XIT@)%*PA$QD<1MM7* #+8Q^M;5%
M!1110 4444 %97A__CUN_P#K_N?_ $:U:M97A_\ X];O_K_N?_1K4 :M%%%
M!1110 4444 %%%% !1110!E>%O\ D4M'_P"O"#_T6M:M97A;_D4M'_Z\(/\
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M* "LKQ3_ ,BEK'_7A/\ ^BVK5K*\4_\ (I:Q_P!>$_\ Z+:@#5HHHH ****
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M<HGF97HRD[B<\ <\5:#260N5BFO(9O\ A(H]X+R8:)G7/7@KM)S[8S0!TO\
M80_Z"FI_^!)_PH_L(?\ 04U/_P "3_A7/07>HRFT=[BY2^6\N8]2A:1@D<&)
M"K 9PH&(MK#KGJ<FG>$+FZ^U:4MQ>74S76B1RW*SRL^)P5!X/W6Y;(&,XR>1
MF@#3C@L9=5ETM-:U3[9#&)7C,KC"$X!R5P1GT/:I+*PMM0@\^VU;56CW%<M*
MZ9(.#]X#OWJGXSA$,VE:C;RO;W8NTM6ECZF"5@L@/L!\V>Q4&E\27?\ 9T]A
M8?:VTS3IK>6-;B-&PDHV"-<J1CC>0#P<8]* -/\ L(?]!34__ D_X4?V$/\
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M>@SS6QK/_(#O_P#KVD_]!-9AT"RUW0-*2\\S$,,3J%<@<!2>.F>,9ZC)P10
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M/["'_04U/_P)/^%:M% &5_80_P"@IJ?_ ($G_"C^PA_T%-3_ / D_P"%:M%
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M^&-*E_M'4$WV4+;4N"%7*#@#L*TO["'_ $%-3_\  D_X4>%O^12T?_KP@_\
M1:UJT 97]A#_ *"FI_\ @2?\*/["'_04U/\ \"3_ (5JT4 97]A#_H*:G_X$
MG_"JCVUC'//#)K>I(ULF^9FG8)&N,Y9\;1QSUKH*P[2%;C7-?@<L$D$*,48J
MV#'C@CD'W% %>-=*DMI+A?$5[Y<3^6Y-W@JVXJ!@C.21@>O;.:,:8;:"Y77=
M2:&X=8TD29F4.S!55B!\I+,!@XY-6;;PIIMKI-QID?G>1<.7<"5@/O%@  <
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M1KFK,NCQ,Y:+<OVP#;\G'.WF@#JJ*R/M^N_] .'_ ,#A_P#$T?;]=_Z </\
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M3[?KO_0#A_\  X?_ !-'V_7?^@'#_P"!P_\ B: ->BLC[?KO_0#A_P# X?\
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M:/M^N_\ 0#A_\#A_\30!KT5D?;]=_P"@'#_X'#_XFC[?KO\ T X?_ X?_$T
M.U?_ )">A?\ 7^W_ *33UJUR^J7NLMJ&C%]'B5EO6*#[8#N/D3#'W>."3^'O
M6C]OUW_H!P_^!P_^)H UZ*R/M^N_] .'_P #A_\ $T?;]=_Z </_ ('#_P")
MH UZ*R/M^N_] .'_ ,#A_P#$T?;]=_Z </\ X'#_ .)H UZ*R/M^N_\ 0#A_
M\#A_\31]OUW_ * </_@</_B: ->LBP_Y&;5O^N5O_)Z/M^N_] .'_P #A_\
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M'[?KO_0#A_\  X?_ !- &O161]OUW_H!P_\ @</_ (FC[?KO_0#A_P# X?\
MQ- &O52/3HH=2FOHY) \X42)D;6P, XQGI[U3^WZ[_T X?\ P.'_ ,31]OUW
M_H!P_P#@</\ XF@#7JGJ&FQ:DL*3R2B.*9)MB$ ,R.KKGC/#*#Q53[?KO_0#
MA_\  X?_ !-'V_7?^@'#_P"!P_\ B: ->BLC[?KO_0#A_P# X?\ Q-'V_7?^
M@'#_ .!P_P#B: ->BLC[?KO_ $ X?_ X?_$T?;]=_P"@'#_X'#_XF@#7K*\4
M_P#(I:Q_UX3_ /HMJ;]OUW_H!P_^!P_^)K.\1WNLOX8U59='BCC-E,&<7@;:
M-AR<;>: .HHK(^WZ[_T X?\ P.'_ ,31]OUW_H!P_P#@</\ XF@#7HK(^WZ[
M_P! .'_P.'_Q-'V_7?\ H!P_^!P_^)H UZK:A8PZE8RV=QN\N4#.TX/!R/U%
M4?M^N_\ 0#A_\#A_\31]OUW_ * </_@</_B: -2)#'$J&1I"HQN?&3]<4^LC
M[?KO_0#A_P# X?\ Q-'V_7?^@'#_ .!P_P#B: +=AIL6GM<NDDLDEU*)97D(
M)9@BH.@ 'RHH_"KE9'V_7?\ H!P_^!P_^)H^WZ[_ - .'_P.'_Q- &O161]O
MUW_H!P_^!P_^)H^WZ[_T X?_  .'_P 30!KT5D?;]=_Z </_ ('#_P")H^WZ
M[_T X?\ P.'_ ,30 [PY_P @R;_K_O/_ $IDK5K(\+EVT=FE0)(;V[+(&R%/
MVB3(SWQZUKT %%%% !1110 4444 %%%% !1110 4444 %95O_P C;J'_ %X6
MO_HRXK5K*M_^1MU#_KPM?_1EQ0!=OH/M%I)'OG4$9/D/L=O8-QC/KD?6N0TK
M5+J[AT'3)+J[/GW-TETTQ*3J(MQ6)F'.1E,L#\VWT)KL+NW:YA")<S6[!@P>
M$C=QVY!!'X55;1+0Q0JA>.6"9IXYU(WB1LAFY!!R&8$$8YZ<# !R>F:SJ&KS
M3V4UW-$+"SN66:-MID=+B2)'..N%CS@\$L<@\5+J&L7UKHNB>,$DF<2VJ/>:
M>)&V.KQ[BZJ,X*<D\?=#=P*Z%O#.G&WB@B62%8X7@)C?#/&YRZL>IR><]<Y(
M(R:LQZ5!%>?:5>3 @\B.$X\N-..%&..@^N!Z#  NDP"'3XR+M[OS1YAF:0N&
MW<_+DG"\\#TQUZU=JAHVCP:%IR6%K+,UO'GRUE8-L'H..GH.U7Z "LC3?^1@
MUG_>A_\ 1=:]9&F_\C!K/^]#_P"BZ -9CM4G!.!G [UQEI>7NH?#Z3Q.;Z:+
M4'MI+R/$A\J/;EECV?=*@ *<C)Y.<UVE9!\-V)MI;,-,MA,Y>2S##RF+'+#I
MD*3R5!QR>,$T 9*^-YQ;/=/H[_9[<6[7,@G&8UE56R%QD[=W(XZ=ZE'B"[9)
M7O+1?+76$LH_(N&4J-X4,W R,X)'?)%2PZ"]QKFKRWJ2+97,D#1QAUV2^6H^
M\.H^8=.,CKZ5<D\-63M(1)<*)+Q+TJ).!*I!! (X&0"10!6'BE6%K,MIFUO9
MY;>WE\SEI$#XW+CY0WEM@Y/;(&>':%XE?6);5)+ VPO-/COH3YH?*-C(/ P0
M6'KD>G2IXO#=C P\MI1$DLD\,.X%(9'#!F48X^^W!R!N.!3M.\/6FF2VDEO+
M.?L=H+.)78$"($8!XY(P.?:@#-UJYO- U^VU-7N+JQOL6C6OFG$4[']VR@\
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M1110 4444 97A;_D4M'_ .O"#_T6M:M97A;_ )%+1_\ KP@_]%K6K0 4444
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MN49>ARVX, .AVGD4MSJVEVMYIK2Z79+I>I1[HM0.T*K;=RJP*\;AG!SV]>*
M-W^UM-_Z"%K_ -_E_P :/[6TW_H(6O\ W^7_ !JMIUK!=V@GN='M;8N253:&
M.WL3E1@D<X[5:_LS3_\ GQMO^_2_X4 )_:VF_P#00M?^_P O^-96G:GIZZ]J
M[&^M@K-#M)E7!^3ZUK?V9I__ #XVW_?I?\*RM.T^R.O:PILX"JM#@&)<#Y/I
M0!J?VMIO_00M?^_R_P"-']K:;_T$+7_O\O\ C2_V9I__ #XVW_?I?\*Y\:K8
MR:++KL&AVTNEQAG\P;?->)20TBIMP1P2!N!(]^* -_\ M;3?^@A:_P#?Y?\
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M *"%K_W^7_&E_LS3_P#GQMO^_2_X4?V9I_\ SXVW_?I?\* $_M;3?^@A:_\
M?Y?\:/[6TW_H(6O_ '^7_&E_LS3_ /GQMO\ OTO^%<]/J]C::)=ZK<:):+'#
M<S6\2H5+2,DCQY(*C&2G1=QYZ'% '0?VMIO_ $$+7_O\O^-']K:;_P!!"U_[
M_+_C7.WGB#1+32K._&DQ.MW+Y:J%C)7#A6R!D\#)QC(QAMIJ\L]D]_IL2:19
MFWU&)I(Y0R,RX4-@@ J>O4,10!J?VMIO_00M?^_R_P"-']K:;_T$+7_O\O\
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MBEB*(]:L;CPL^N6^B6C>0 9X795*G:"0"%)_B_B"D]>A&0#HO[6TW_H(6O\
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M_OTO^% "?VMIO_00M?\ O\O^-95EJ>GCQ)JKF^M@K1P8)E7!X?WK6_LS3_\
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ME_QI?[,T_P#Y\;;_ +]+_A1_9FG_ //C;?\ ?I?\* $_M;3?^@A:_P#?Y?\
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M_P#SXVW_ 'Z7_"@"GX:=9-)D=&#*U]=E6!R"#<2<UK5D^&E5-*D10%5;Z[
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M1BMKHPSE8Y3&=\4G!P2"N0?HQ'XFE-O";@7!B3S@I028YVD@XS]0/RJ0 *,
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MJ]XVD3V.C6=U#IZ3VTS1W$SJH,BE<#+*P).YF/<X)SUH O\ ]GZW_P!!U/\
MP"7_ .*H_L_6_P#H.I_X!+_\56'_ ,)+=#5K&+^TH9%>[CMKE$1412UOO.W=
M\Y.[!SP,,!@G-:WA.YOK_21?7U\;EI6=0GEJH3;(Z\8'.0!G/I0 B"_DO'LT
M\46S7*#+0BW0NHXY*[LCJ/SJJ+'6/^$G*_VRF_[$#O\ LB]-YXQFET6T?3O$
M;I!>1ZC:7L$EQY[1Q^;"V]?E+H!N5MQQGD;._;2'_(VG_KP'_HPT -_L_6_^
M@ZG_ (!+_P#%4?V?K?\ T'4_\ E_^*K7HH R/[/UO_H.I_X!+_\ %4?V?K?_
M $'4_P# )?\ XJM>B@#'>RUF-&=]?C55&68V:@ >OWJA07\L"W$?BBU>%V"+
M(MNA5F)  !W=22!^-:.L_P#(#O\ _KVD_P#036+=>'$\0:#I&;EX&@AB.4 R
M5.PGG&>B\#IG!(.* +SVNKQR)&_B&)7D)"*;106(&3@;N>.:CBCU&>:6"'Q-
M;R2PX\Q$MD+)G(&0&XZ'\C46H>$8[[4+&Z^UO&+5$1E6- '"!L<;<'ENA! &
M< 9S5BV_Y'C4O^P;:?\ HRXH ?\ V?K?_0=3_P  E_\ BJ/[/UO_ *#J?^ 2
M_P#Q5:]% &1_9^M_]!U/_ )?_BJSGL=8_P"$GA7^V4\S[%(=_P!D7IO3C&:Z
MBLI_^1MA_P"O"3_T8E #?[/UO_H.I_X!+_\ %4?V?K?_ $'4_P# )?\ XJM>
MB@#(_L_6_P#H.I_X!+_\51_9^M_]!U/_  "7_P"*K7HH R/[/UO_ *#J?^ 2
M_P#Q50)]ND2=T\46K+;DB8K;H1%C.=WS<8P<Y]#6]7*6^CC7/"=W8F8PEM1O
MBKA0<$74N.HX^HP?0B@#1DMM5BC$LGB*%$8J S6B $L0 ,[NY( ^M,,>HBZ%
MH?$UN+AAD0_9DWD>N-V:KWO@Z.ZTFSL5O94-I+Y@D"J&;+AFY SG@\YY."V[
MO-<6XM-;\.VRMN6&.9 =H7.(P.@  ^@ % %C^S];_P"@ZG_@$O\ \51_9^M_
M]!U/_ )?_BJUZ* ,C^S];_Z#J?\ @$O_ ,51_9^M_P#0=3_P"7_XJM>B@#(_
ML_6_^@ZG_@$O_P 56=HECK#6USY>LH@%[< C[(IR?,;)Z]ZZBLKP_P#\>MW_
M -?]S_Z-:@"":/4K:2..?Q-;Q/*<1J]LBES[ MSU'YT];75WE>)?$,321XWJ
M+125STR-W&:2_P#^1OT?_KVNOYQ5!8>$X['6;O4/M3N+@.!&8TPNXDGC''7M
MC/\ %DT 2.FH1PO,_B>V6*-BKNUL@56!P03NX-21VFKS1)+%X@BDC=0RNMHI
M# ]"#NY%5=(\-+X?LK\BZ><RQD#>JC"C..0,]^@^4=@.:O>%O^12T?\ Z\(/
M_1:T -_L_6_^@ZG_ (!+_P#%4?V?K?\ T'4_\ E_^*K7HH R/[/UO_H.I_X!
M+_\ %4?V?K?_ $'4_P# )?\ XJM>B@#(_L_6_P#H.I_X!+_\51_9^M_]!U/_
M  "7_P"*K7HH Y?PY8ZP_AC2FBUE(XVLH2J?9%.T;!@9SS5LQZB+L6A\36XN
M2NX0_9DWXYYV[LXX/Y&K'A;_ )%+1_\ KP@_]%K56&(3^,-;A;I)IUHIX!ZM
M<#H>#0!-':ZO,"T7B&*0*Q4E;13A@<$?>Z@\5"[7L5K'=2>*K1()0#'*UN@1
MP>1@[L&H=.\&Q6.F7EB][+(MT0-Y1"R*'++@E>O/T!Y %5K[1?[!^'E_9>>9
MF$&7<J!SM4''<CCC))Q@9P!0!K_V?K?_ $'4_P# )?\ XJC^S];_ .@ZG_@$
MO_Q5:]% &1_9^M_]!U/_  "7_P"*H_L_6_\ H.I_X!+_ /%5KT4 9']GZW_T
M'4_\ E_^*H_L_6_^@ZG_ (!+_P#%5KT4 9']GZW_ -!U/_ )?_BJ/[/UO_H.
MI_X!+_\ %5KT4 <MJECK"ZAHP?648M>L$/V11M/V>8YZ\\ C\:TO[/UO_H.I
M_P" 2_\ Q5.U?_D)Z%_U_M_Z33UJT 9']GZW_P!!U/\ P"7_ .*H_L_6_P#H
M.I_X!+_\56O10!@*UZ\$TZ>*K1H8 3+(+="L>.NX[N,8/7TJ:6UU>%0TOB&*
M,,P4%K11EB< ?>ZDG%9-KH@U_P #1V7GF%_-G9'V@X;?(!GOCGG!!QD9YJWJ
M7@Z*^T^RM%O94%HQP^Q SJ75CDA1S\OT)P6!Q0!/Y>HF[^R#Q-;_ &C;N\G[
M,F_''.W=G'(_,5-_9^M_]!U/_ )?_BJKSQ"#Q;H<(.1'872YP!G!@'0<#\*W
MZ ,C^S];_P"@ZG_@$O\ \5699V.L'Q#J:KK**XC@W-]D4[N'QQGBNJK(L/\
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M-,TZR33=-M;&-F9+:%(59NI"@ $_E5/^WXO^@?J?_@%)_A1_;\7_ $#]3_\
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M?X4 :M%97]OQ?] _4_\ P"D_PH_M^+_H'ZG_ . 4G^% &K165_;\7_0/U/\
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M<GV+4#OC@^46CDC ?J,<4 =1165_;\7_ $#]3_\  *3_  H_M^+_ *!^I_\
M@%)_A0!JU1T?3?[(TV*P6X>:.%0L9=0"%';CK4']OQ?] _4__ *3_"C^WXO^
M@?J?_@%)_A0!JU033-NMOJCW#NY@\A8]H"JN[=]2<U#_ &_%_P! _4__  "D
M_P */[?B_P"@?J?_ (!2?X4 :M%97]OQ?] _4_\ P"D_PH_M^+_H'ZG_ . 4
MG^% &K165_;\7_0/U/\ \ I/\*/[?B_Z!^I_^ 4G^% !X6_Y%+1_^O"#_P!%
MK6K7,>'-;BA\,:5$;+4'*64*[DM'93A!R#CD5I?V_%_T#]3_ / *3_"@#5HK
M*_M^+_H'ZG_X!2?X4?V_%_T#]3_\ I/\* -6BLK^WXO^@?J?_@%)_A1_;\7_
M $#]3_\  *3_  H U:*RO[?B_P"@?J?_ (!2?X4?V_%_T#]3_P# *3_"@#5H
MK*_M^+_H'ZG_ . 4G^%']OQ?] _4_P#P"D_PH U:*RO[?B_Z!^I_^ 4G^%']
MOQ?] _4__ *3_"@#5K*\4_\ (I:Q_P!>$_\ Z+:C^WXO^@?J?_@%)_A6;XDU
MN*;PQJL0L=00O93+N>T<*,H>2<<"@#IZ*RO[?B_Z!^I_^ 4G^%']OQ?] _4_
M_ *3_"@#5HK*_M^+_H'ZG_X!2?X4?V_%_P! _4__  "D_P * -6J>JZ>FJZ;
M-922-&LH'SKC(P0>_P!*K?V_%_T#]3_\ I/\*/[?B_Z!^I_^ 4G^% &E$KI$
MJR2>8P'+8QG\*?65_;\7_0/U/_P"D_PH_M^+_H'ZG_X!2?X4 3Z;IOV"6]F:
MX>>6]G$TC,H&"(T0  =L(/UJ]65_;\7_ $#]3_\  *3_  H_M^+_ *!^I_\
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M ,71_P (WIOI=?\ @;-_\70!JT5E?\(WIOI=?^!LW_Q='_"-Z;Z77_@;-_\
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M-M?VMEY%_+-=!V79>RX55V[B<R#^\.E0VT7AR[O[BRA>]::W!+C[5/QC(/\
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M?\(WIOI=?^!LW_Q='_"-Z;Z77_@;-_\ %T :M%97_"-Z;Z77_@;-_P#%T?\
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MM %.?PWI-S90V<EG'Y,#AXU X4[@Q_/&#Z@D=ZK7L,=OXAT"&) D<:SJBCH
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MZA:640CC6#GU8@ 9/J3@9/>NEJO>V%MJ,'D7<?FQ9R4+$ _7'4>QH L4444
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M:;-A;;_/G:/'[R?&,(V>_I6_65;_ /(VZA_UX6O_ *,N* #S_$7_ $#M,_\
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MF6TRL(TW'C))7G_9!QSZ\=* +_G^(O\ H':9_P"!\G_QFCS_ !%_T#M,_P#
M^3_XS67I.AZA9Z;J,>LW"7J2!F57&1D9.['3G@^O%:OAAF?PII#,2S&QA)).
M23L% ">?XB_Z!VF?^!\G_P 9H\_Q%_T#M,_\#Y/_ (S6K10!E>?XB_Z!VF?^
M!\G_ ,9H\_Q%_P! [3/_  /D_P#C-:M% &5Y_B+_ *!VF?\ @?)_\9H\_P 1
M?] [3/\ P/D_^,UJT4 <QX<FUT>&-*$-AI[1"RAV,]ZZL5V#!($1P?;)K2\_
MQ%_T#M,_\#Y/_C-'A;_D4M'_ .O"#_T6M4T@%QXSU?Y5,L>G6PA<]8RS7 )!
MZC.!G'I0!<\_Q%_T#M,_\#Y/_C-'G^(O^@=IG_@?)_\ &:S-)T/7;72KZWN-
M3S<3.3#-S\AWL2V <'.<X_ \54NM+N]/^'5Q#J;)-<P0!HV/S&$A5  /8C!&
M1UZ]2: -[S_$7_0.TS_P/D_^,T>?XB_Z!VF?^!\G_P 9K5HH RO/\1?] [3/
M_ ^3_P",T>?XB_Z!VF?^!\G_ ,9K5HH RO/\1?\ 0.TS_P #Y/\ XS1Y_B+_
M *!VF?\ @?)_\9K5HH RO/\ $7_0.TS_ ,#Y/_C-'G^(O^@=IG_@?)_\9K5H
MH YC5)M=.H:-YEAIX87K>6%O7(+?9YN#^ZX&,\\\@>N1I>?XB_Z!VF?^!\G_
M ,9HU?\ Y">A?]?[?^DT]:M &5Y_B+_H':9_X'R?_&://\1?] [3/_ ^3_XS
M6K10!E>?XB_Z!VF?^!\G_P 9H\_Q%_T#M,_\#Y/_ (S6!#I5WJ/@22/376&Z
MG>X,C [3,-TB[2??(&3TZ]A5W5]#UVZTVQ@M]3Q/#(#-+S^\_>*0V">, $X_
MX".#0!I>?XB_Z!VF?^!\G_QFCS_$7_0.TS_P/D_^,U3D@$'C#1R502R6%R)G
M7K(5, &3U.,G&?6NAH RO/\ $7_0.TS_ ,#Y/_C-9EG-KO\ PD.IE;#3S(8X
M-X-ZX X?&#Y7/Y"NHK(L/^1FU;_KE;_R>@!WG^(O^@=IG_@?)_\ &://\1?]
M [3/_ ^3_P",UJT4 97G^(O^@=IG_@?)_P#&://\1?\ 0.TS_P #Y/\ XS6K
M7$VFD7VH>!](_LN9;:5A'+.P',O3D^IXSD^GO0!T/G^(O^@=IG_@?)_\9H\_
MQ%_T#M,_\#Y/_C-9FK:'KETVEFVU$(;90)CN8AFV,-_)SWQQS\V?X15I(TB\
M=MY:*GF:<7?:,;F\P#)]3[T 6?/\1?\ 0.TS_P #Y/\ XS1Y_B+_ *!VF?\
M@?)_\9K5HH RO/\ $7_0.TS_ ,#Y/_C-'G^(O^@=IG_@?)_\9K5HH YCPY-K
MH\,:4(+#3VB%E#L9[UU8KL&"0(C@^V36EY_B+_H':9_X'R?_ !FCPM_R*6C_
M /7A!_Z+6M6@#*\_Q%_T#M,_\#Y/_C-'G^(O^@=IG_@?)_\ &:U:* ,KS_$7
M_0.TS_P/D_\ C-'G^(O^@=IG_@?)_P#&:U:YZ.U-UK>O^5M6Y\J..&8\-'F,
M]".1SSQ0!<\_Q%_T#M,_\#Y/_C-'G^(O^@=IG_@?)_\ &:RK+0M=AT"\M)=1
MS<RS%XI,XVKYA)X!Q\PYQ_M8/ J*ZTVYL/"NFKJ#I/>0:A9!9NK(&N805![<
M?*<<$4 ;7G^(O^@=IG_@?)_\9H\_Q%_T#M,_\#Y/_C-:M% &5Y_B+_H':9_X
M'R?_ !FCS_$7_0.TS_P/D_\ C-:M% &5Y_B+_H':9_X'R?\ QFLWQ)-KI\,:
MJ)K#3UB-E-O9+UV8+L.2 8AD^V173UE>*?\ D4M8_P"O"?\ ]%M0 >?XB_Z!
MVF?^!\G_ ,9H\_Q%_P! [3/_  /D_P#C-:M% &5Y_B+_ *!VF?\ @?)_\9H\
M_P 1?] [3/\ P/D_^,UJT4 97G^(O^@=IG_@?)_\9H\_Q%_T#M,_\#Y/_C-:
MM8OBXX\,7GN$'_CZT 2^?XB_Z!VF?^!\G_QFCS_$7_0.TS_P/D_^,U0UG0]3
MN-3T^32[E+6TMR,PK\JC"ODX&,9#!>/[V?X13I-(U=O%R:@M[BQ .8BQZ80;
M?S!;TX]S0!=\_P 1?] [3/\ P/D_^,T>?XB_Z!VF?^!\G_QFH/#T4<&IZ_!#
M&L<4=^@1$&%7-M"3@#IR2?QK<H RO/\ $7_0.TS_ ,#Y/_C-'G^(O^@=IG_@
M?)_\9K5HH RO/\1?] [3/_ ^3_XS1Y_B+_H':9_X'R?_ !FM6B@#(\,&0Z.Y
ME55D-[=[U5MP#?:),@' R,]\"M>LKPY_R#)O^O\ O/\ TIDK5H **** "BBB
M@ HHHH **** "BBB@ HHHH *RK?_ )&W4/\ KPM?_1EQ6K6!+J=CIOBV]-[=
MQ6_F6%ML\Q@-V))\_P Q0!LW5I!>P^3<1[TW!AR00P.001R"" <BH&TBQ>(1
MF$\2^<'#L'#XQNWYW9P<9STXZ57_ .$GT+_H+6O_ '\%'_"3Z%_T%K7_ +^"
M@"670M,EMXK=K11%#&T2*K%?D;&Y3@\J<#(.0<<U,FG6L=Z]XB,)GC$1/F-@
M*.P7.!^ JI_PD^A?]!:U_P"_@H_X2?0O^@M:_P#?P4 6=+TFRT:T^R:?$88
MQ81^8S $G)QN)QSSQ5RLK_A)]"_Z"UK_ -_!1_PD^A?]!:U_[^"@#5K(TW_D
M8-9_WH?_ $73O^$GT+_H+6O_ '\%9FG^(M&37-6D;4[8)(T6QC(,'"<T =16
M<V@Z8Q?-M\DDGFO$)&$3-G))3.TDGD\<GFH_^$GT+_H+6O\ W\%'_"3Z%_T%
MK7_OX* *]OX?W:[J=]>I')#=20O$BROC]VH W+PI.1D=:M-X>TQI)7,#YEN5
MNF'G/CS5Z,!G Y /'4TW_A)]"_Z"UK_W\%'_  D^A?\ 06M?^_@H DCT+38I
M7ECMRI=WDP)&VJ[@AF5<X5CDY( /)]32V>A:=I\EO):P-&UM;_9HOWKD)%G.
MW!/3@?D*B_X2?0O^@M:_]_!1_P )/H7_ $%K7_OX* +5_IEIJB1)>1M(L,JS
M(!(R[74Y4\$=#S4>I:+I^KF!KV N]NQ:*1)&C="1@X92#@]QG!J'_A)]"_Z"
MUK_W\%'_  D^A?\ 06M?^_@H #X9T<W/V@6>V3S5E&R1U4.J[ P4' .T8Z<C
M@U<L-/MM,M1:V<9CA5BP4NS8).3R23U)-4_^$GT+_H+6O_?P4?\ "3Z%_P!!
M:U_[^"@"S:Z596<BO;P;"@94&XD1AB"0H)PH.!P,=*K#_D;3_P!> _\ 1AH_
MX2?0O^@M:_\ ?P5FCQ%HW_"3F;^T[;R_L07=Y@QG>3B@#IZ*RO\ A)]"_P"@
MM:_]_!1_PD^A?]!:U_[^"@#5HK*_X2?0O^@M:_\ ?P4?\)/H7_06M?\ OX*
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M$GT+_H+6O_?P5F6?B+1D\0ZG*VIVP22.#:QD&#@/F@#J**RO^$GT+_H+6O\
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M\EL[?Q9J,EQ"BO)&!!E5894_ZKH:M_V)=_\ 0Q:I^4'_ ,:H UZ*R/[$N_\
MH8M4_*#_ .-4?V)=_P#0Q:I^4'_QJ@#7HK(_L2[_ .ABU3\H/_C5']B7?_0Q
M:I^4'_QJ@#7K*'_(VG_KP'_HPTW^Q+O_ *&+5/R@_P#C59PTBY_X28Q_V]J.
M?L0;S,0[OOGC_5XQ^% '445D?V)=_P#0Q:I^4'_QJC^Q+O\ Z&+5/R@_^-4
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MW<-J/%&JF2==\1"0[9!C/RMY6T\>AH Z&BLC^Q+O_H8M4_*#_P"-4?V)=_\
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MC$?7C'.>"?K6C_8EW_T,6J?E!_\ &J ->BLC^Q+O_H8M4_*#_P"-4?V)=_\
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M_P :H UZ*R/[$N_^ABU3\H/_ (U1_8EW_P!#%JGY0?\ QJ@!WA;_ )%+1_\
MKP@_]%K6K7+^'-(N9?#.E2+KVHQ![*%A&@AVIE!P,QDX'N36C_8EW_T,6J?E
M!_\ &J ->BLC^Q+O_H8M4_*#_P"-4?V)=_\ 0Q:I^4'_ ,:H UZ*R/[$N_\
MH8M4_*#_ .-55-N!=36Q\3ZJ)(%WRDI#MC&,\MY6T<<]: .AHKGD@CD@>=?%
MNH&.-BC', PP8KC'E>H(]^U1L(EA@G_X2K5&BN'5(Y%2)EW,0J@D184DLH&<
M=: .EHK(_L2[_P"ABU3\H/\ XU1_8EW_ -#%JGY0?_&J ->BLC^Q+O\ Z&+5
M/R@_^-4?V)=_]#%JGY0?_&J ->LKQ3_R*6L?]>$__HMJ;_8EW_T,6J?E!_\
M&JSO$>D7,7AG59&U[490EE,QC<0[7PAX.(P<'V- '445D?V)=_\ 0Q:I^4'_
M ,:IDVE36\+S3^)]2BBC4L[N;<*H'4DF/@4 ;5%<JUSIZ65Q>OXUO$@M3B=V
M:W'EG) R#%D9(('KVJUI]JNK6,=[I_BO4+FVE&4DC,!!['_EE0!T%%<U;_9[
MIIEA\87S>2I=SF  *"06R8L%05()'&014,EYI\.GRW\OC2^CMH659)', VE@
M"N08L\@@CU!!H ZNBN:TG[/KML]SI7B_4+N%'V,\7D$!L X_U7H1^=3BR)U
MZ>/%.HFZ$7G&+]QN"9QN_P!5TS0!O45S;BWCAGG;Q??B&W;;++F#8K9QMW>5
MC=GC'7-2V=F;^-WM?%&IR"-S&X @!1AU5@8L@^QH WZ*YBPELM4OKBRL?&=[
M<7-M_K8XVMR5_P#(56+>S^U-*+?Q3J4HA)61D\@JI'4;O*QD=QVH WZ*P;2Q
M:_B\ZT\4:G-%G D00%6^A\K!'N*G_L2[_P"ABU3\H/\ XU0 [PY_R#)O^O\
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M6-)T!8Y) C Y/K6]5.73HYM2@OI)9&>W#").-J[A@GID\>IH N4444 %%%%
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M=_S/8_[!A_\ 1HK;JFFFQ+JKZDTDCS-%Y(#$;53.<# ]?7- %RBBB@ HHHH
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M'AW$>=&"H&3MR3G)&3GK7LM% ',>#+R^N#JMM-,+JPM+KRK"Y"*OF1[0<#8
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ME?VO??\ 0MZG_P!_+;_X]1_:]]_T+>I_]_+;_P"/5JT4 97]KWW_ $+>I_\
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M>I_]_+;_ ./5JT4 97]KWW_0MZG_ -_+;_X]1_:]]_T+>I_]_+;_ ./5JT4
M97]KWW_0MZG_ -_+;_X]1_:]]_T+>I_]_+;_ ./5JT4 97]KWW_0MZG_ -_+
M;_X]5)KK4CK<=_\ \([J'EK;/"5\VVW9+*<_ZW&.#WKHJ* ,K^U[[_H6]3_[
M^6W_ ,>H_M>^_P"A;U/_ +^6W_QZM6B@#*_M>^_Z%O4_^_EM_P#'J/[7OO\
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MHH RO[7OO^A;U/\ [^6W_P >H_M>^_Z%O4_^_EM_\>K5HH RO[7OO^A;U/\
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M>^_Z%O4_^_EM_P#'JU:* ,K^U[[_ *%O4_\ OY;?_'J/[7OO^A;U/_OY;?\
MQZM6B@#*_M>^_P"A;U/_ +^6W_QZC^U[[_H6]3_[^6W_ ,>K5HH RO[7OO\
MH6]3_P"_EM_\>H_M>^_Z%O4_^_EM_P#'JU:* ,K^U[[_ *%O4_\ OY;?_'JI
M:S=ZEJ6AW]C#X=U!9+FVDA1GEM@H+*0"<2GCFNBHH RO[7OO^A;U/_OY;?\
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M2LOVE87MI50(2=W52%'3G^I=:;K^G>+K7Q%!:)J?GV(L[ZWAE6-HR'+ADWD
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MB\DEE)CGB *D$$C[R]?0TNI^'-0U+P1)8">.+5Y62Z,G\ N XDQW^4$!1UP
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*JNC[1AB,[2 I/I[UUM+10 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW/:R6-RMS%)!MW;P",'<#Q@G([T <KK0'A_QRWB>(!+93#::B ,#RI.%D/\
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M$'^61W!K4L='2UOY=0FGDNKR6)83-( -L:DD*   .22?4^P &@02I .#Z^E
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M*@@*R*B\C!) ')P3UX]JJ6'ABUL9K(^=--%IJLME$^,0!ACTR2%^49Z#WYH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
7 **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>ebs20191231exhibit1048009.jpg
<TEXT>
begin 644 ebs20191231exhibit1048009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'7TGUVUO;:WD7R;5(C&]H.<A\@>GOT[=*T+/Q9H5_=BTM=0669HC+&@1OWJ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+MXW;!E;C@?F/S'K5V@ HJE#K&G7&JW&E0WD3WUL@>:!6^9 >A/YC\QZU=H
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M[Z#4M-N]Q\ORRA3<,,.IX(_(_6@!OP@LK>W^'ME=1@&:]>26>3JSMO9>3[
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MDE\N6)T9HS\[*2/F!'W<]36QK?@B_P!6\7-K$>MB&VDL7M# T'F&,,,,4).
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M)X8HRIMLMA"&R=WOD?3%7;?QCJEEX^U+P]KDEI#;16C75G-'"P,B@9YRQR0
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M)"DR$KD $YQCOP*T?$FN#0M-CE1%DN;JXCM;6-CPTLC87/L.2?84 ._MP_\
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M_P!,T&XFMA>Z7<)<0R([&-V1RPSE01D,1T..O--F^'LL]K=W+30KJ4^LIJJ
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M>7YCSI"O(C4D!>3R>.<GT&-K=XB_YY:9_P!_)/\ XFC=XB_YY:9_W\D_^)H
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M:#X-U/0]5T34+RXL1;Z5I;VDQ65LD[B=PRH&,8ZD=ZZC=XB_YY:9_P!_)/\
MXFC=XB_YY:9_W\D_^)H SO!&ESV5OJM]<1M$VK:E->)&XPR1L<)D=B0,X[9Q
M735E;O$7_/+3/^_DG_Q-&[Q%_P \M,_[^2?_ !- &K165N\1?\\M,_[^2?\
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M?&V1_O>:N.W3-:6[Q%_SRTS_ +^2?_$T :M%96[Q%_SRTS_OY)_\31N\1?\
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M4V[^'VIW6K:CJ!N+16DU>WU*U3S&P?*R-C_+QD'J,X-==N\1?\\M,_[^2?\
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MY#)-+(<O*YXRQ^@  '     % '-R7T7B+7]1BAO1)8VNEI+;26\ORF21I 9
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MG.6/>@#0HHHH RK?_D;=0_Z\+7_T9<5JUE6__(VZA_UX6O\ Z,N*U: "N?\
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M")XU\0ZK*#$T<?F&']V3_& L8RWNV>IJ_9::MK/)=2SR75U(BQM-*%!VKD@
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M !%4O#VDSR^&],D&M:A&'LXB$0Q;5R@X&4Z5T,W^HD_W3_*J'AG_ )%72?\
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M_P#OJ+_XBC^Q;C_H.ZG_ -]1?_$5JT4 97]BW'_0=U/_ +ZB_P#B*/[%N/\
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M%:M% &5_8MQ_T'=3_P"^HO\ XBC^Q;C_ *#NI_\ ?47_ ,16K10!E?V+<?\
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M_P"NTO\ Z*:@#5HHHH **** "BBB@ HHHH J:9IMOI-A%8VF\00J$C5W+;5
MP ">W%6Z** *JZ= NI-J'SM<&/RLLY(5<@X Z#D"K5%% !1110 4444 %%%%
M $<W^HD_W3_*J'AG_D5=)_Z\8?\ T 5?F_U$G^Z?Y50\,_\ (JZ3_P!>,/\
MZ * -.BBB@ HHHH **** "JITZ ZG_:(WK<>6(B0Y 9020".G5C5JB@ JIJ6
MFV^K63V=UO,$@(=4<KN'H<=JMT4 %%%% !1110 4444 %%%% &5;_P#(VZA_
MUX6O_HRXK5K*M_\ D;=0_P"O"U_]&7%:M !1110 4444 %%%% !52+3H(+^>
M]CWK+<8,HWG:Q "@XZ= *MT4 %5+W3K?4/)^T;RL,J2JJN0"RL&4D#K@J#5N
MB@ HHHH **** "BBB@ HHHH RO$/_'E;?]?]K_Z.2M6LKQ#_ ,>5M_U_VO\
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M?20[H?&CAHWV.OVV#*MZ'Y>#[4 32>#=/"6L5G-<6,%M:R6@B@*D/'(06!W
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MI_\ ?<?_ ,11_8DO_0;U/_ON/_XB@#5HK*_L27_H-ZG_ -]Q_P#Q%']B2_\
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M$ $DY"<#Y3R>.* .BHK!2UCDU!K!=>U47"IYFU@H!7(&03'@\D=#5G^Q)?\
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M$E_Z#>I_]]Q__$4 :M%97]B2_P#0;U/_ +[C_P#B*/[$E_Z#>I_]]Q__ !%
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M5#PS_P BKI/_ %XP_P#H J_-_J)/]T_RJAX9_P"15TG_ *\8?_0!0!IT444
M%%%% !1110 5BQC/C:['KID/_HR6MJJATZ$ZI_:(:19_*$38;Y64$D CZL:
M,[3_  EIVG6][!$]QLO1MD_?,#C&.N>O7YNO/6L_6=%MM"^'VK6ELTC(;9V.
MYB1G'8=!]!7654U/38-6L9+*Y:00R@K(J-MW ]B: +=%%% !1110 4444 %%
M%% &5;_\C;J'_7A:_P#HRXK5K*M_^1MU#_KPM?\ T9<5JT %%%% !1110 44
M44 %8-C;I=ZOXDMI"P262)&*,5.# HX(Z5O54ATZ&#4+B]C:027.#*N[Y6(
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M22.3713?ZB3_ '3_ "JAX9_Y%72?^O&'_P! % #?^$6\._\ 0!TS_P  X_\
M"C_A%O#O_0!TS_P#C_PK5HH RO\ A%O#O_0!TS_P#C_PH_X1;P[_ - '3/\
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M6\._] '3/_ ./_"C_A%O#O\ T =,_P# ./\ PK5HH RO^$6\._\ 0!TS_P
MX_\ "C_A%O#O_0!TS_P#C_PK5HH RO\ A%O#O_0!TS_P#C_PH_X1;P[_ - '
M3/\ P#C_ ,*U:* ,K_A%O#O_ $ =,_\  ./_  H_X1;P[_T =,_\ X_\*U:*
M .8USPYH4-I;M%HNGQEKVW0E;5!E3*H(Z=".*TO^$6\._P#0!TS_ , X_P#"
MCQ#_ ,>5M_U_VO\ Z.2M6@#*_P"$6\._] '3/_ ./_"C_A%O#O\ T =,_P#
M./\ PK5HH RO^$6\._\ 0!TS_P  X_\ "C_A%O#O_0!TS_P#C_PK5HH RO\
MA%O#O_0!TS_P#C_PH_X1;P[_ - '3/\ P#C_ ,*U:* ,K_A%O#O_ $ =,_\
M ./_  K%\CPW'9WU[<>&-+CM;.X:#<MO&S,0VTDC:,#)[$GVKKZP_#L<<UOJ
M4<BJX_M*X)4\_P ?% &&]WX/3P[#K)\-Z?LF;8$^RQ'#XR1P,]B.G;ICFKK6
M7ATG2Y8O#.EO;:E((TD\B/<I*,X.T*01A/7O70'2[%K);(VL?V=5"JF.  ,#
M]!BL_70J7N@(H"@:EP!Q_P L)J )O^$6\._] '3/_ ./_"C_ (1;P[_T =,_
M\ X_\*U:* ,K_A%O#O\ T =,_P# ./\ PH_X1;P[_P! '3/_  #C_P *U:*
M,K_A%O#O_0!TS_P#C_PH_P"$6\._] '3/_ ./_"M6B@#*_X1;P[_ - '3/\
MP#C_ ,*/^$6\._\ 0!TS_P  X_\ "M6B@#(\,1QPZ.\,2+'''>W:(BC 51<2
M  #L *UZRO#G_(,F_P"O^\_]*9*U: "BBB@ HHHH **** "BBB@ HHHH ***
M* "LCQ1(L.CI*P8JE[:,0BEB0+B,\ <D^PY-:]97B/\ Y!D/_7_9_P#I3'0
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M/^$CL?\ GAJ?_@JN?_C=:M% &5_PD=C_ ,\-3_\ !5<__&Z/^$CL?^>&I_\
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M)'8_\\-3_P#!5<__ !NM6B@#*_X2.Q_YX:G_ ."JY_\ C='_  D=C_SPU/\
M\%5S_P#&ZU:* ,K_ (2.Q_YX:G_X*KG_ .-T?\)'8_\ /#4__!5<_P#QNM6B
M@#F(->LQXGOI3#J&UK*V4 :;<;LAY\Y&S('(Y/!YQT.-+_A(['_GAJ?_ (*K
MG_XW1;_\C;J'_7A:_P#HRXK5H RO^$CL?^>&I_\ @JN?_C='_"1V/_/#4_\
MP57/_P ;K5HH RO^$CL?^>&I_P#@JN?_ (W1_P )'8_\\-3_ /!5<_\ QNM6
MB@#*_P"$CL?^>&I_^"JY_P#C='_"1V/_ #PU/_P57/\ \;K5HH RO^$CL?\
MGAJ?_@JN?_C=1C6]*$YN!97_ )Q&#)_9%SN(],^7FMFL(7U^U_KAB=I/L(5;
M>W" AR8@W.!N)R>QH L?\)'8_P#/#4__  57/_QNHI=9TF:2.26QOI'B.49]
M(N"4/L?+XK.MM=UV3PW=WCZ?BZBE*QKC(9=Q!.1QQS_WSGO4K:KJAT+3M0F+
M6MQ)=P0RP[%*NKS(A)R,_=.001UH T?^$CL?^>&I_P#@JN?_ (W1_P )'8_\
M\-3_ /!5<_\ QNM6B@#*_P"$CL?^>&I_^"JY_P#C='_"1V/_ #PU/_P57/\
M\;K5HH RO^$CL?\ GAJ?_@JN?_C='_"1V/\ SPU/_P %5S_\;K5HH RO^$CL
M?^>&I_\ @JN?_C='_"1V/_/#4_\ P57/_P ;K5HH YC7=>LY;2W"PZ@"M[;L
M=VFW"\"53W3D^W4]JTO^$CL?^>&I_P#@JN?_ (W1XA_X\K;_ *_[7_T<E:M
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ML0;Q\!QMP NW(?TYX_/'45HSW]^CZ',[- UY<"&XMB@VC]W(QZC.05'.<>U
M%C_A(['_ )X:G_X*KG_XW1_PD=C_ ,\-3_\ !5<__&ZU:* ,K_A(['_GAJ?_
M (*KG_XW1_PD=C_SPU/_ ,%5S_\ &ZU:* ,K_A(['_GAJ?\ X*KG_P"-T?\
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M_P# ]O\ XU1]JU__ *!%E_X'M_\ &J -6BLK[5K_ /T"++_P/;_XU1]JU_\
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M_P#C5 &K165]JU__ *!%E_X'M_\ &J/M6O\ _0(LO_ ]O_C5 &K165]JU_\
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M - BR_\  ]O_ (U0!JT5E?:M?_Z!%E_X'M_\:H^U:_\ ] BR_P# ]O\ XU0
M>'/^09-_U_WG_I3)6K61X8+G1W,JJDAO;LNJMN"G[1)D X&>>^!6O0 4444
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M4_\ D-Z-_P!=I?\ T4U:M96I_P#(;T;_ *[2_P#HIJ -6BBB@ HHHH ****
M"BBB@#B;+3M0O_AKI:Z7,8KF:TCEF8-AI28N<D]23CG(]<]C=U31_$5PNF"W
MU(AX,B=@X^=L-ASQQUQQG&[IQFM7PW876E>'[+3;L1&2TA2'=$Y8.%4#/(&/
MIS]:U* ,-4$7C90@V^;I[/( >&82*,GWQ6Y68MC=-XD.HR")8$M3 @5R68E@
MV2, #IZFM.@ HHHH **** "BBB@".;_42?[I_E5#PS_R*ND_]>,/_H J_-_J
M)/\ =/\ *J'AG_D5=)_Z\8?_ $ 4 :=%%% !1110 4444 %81C$WC6<,-QBT
MZ)H\G[C&24$CT. *W:S/L-TGB5M101-!+:I X+D.I5G;(&"#]X=Q0!DZ3H_B
M*VM-2CNM1+33C$$A<?(^!\WW3^H[=!FJ=[IVH6'P]U(:I,9;B&)Y(7+?-%\O
M&,=".>A/6NUK+\1V%UJNA76G6@B#W49C+2N5" CKP#GZ<4 :E%%% !1110 4
M444 %%%% &5;_P#(VZA_UX6O_HRXK5K*M_\ D;=0_P"O"U_]&7%:M !1110
M4444 %%%% !7.0V\MSJ_B/R'VW0V1P2EL>7F%3P<' SSTKHZS+*QNK76]1N6
M$36]XR.I#G>I5%7&W&.W7- &/;:-XA3PW=VCW[&ZDE+1/N *KN)(Q@CD>_\
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M+CR92>PX) .*Z.LS4[&ZO=0TQXQ$L%I<^>[,YW']VZ8"XQ_&#G/:@#3HHHH
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MX9_Y%72?^O&'_P! % #?[,U3_H/S_P#@/%_\31_9FJ?]!^?_ ,!XO_B:U:*
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M:M &5_9FJ?\ 0?G_ / >+_XFC^S-4_Z#\_\ X#Q?_$UJT4 97]F:I_T'Y_\
MP'B_^)H_LS5/^@_/_P" \7_Q-:M% &5_9FJ?]!^?_P !XO\ XFC^S-4_Z#\_
M_@/%_P#$UJT4 97]F:I_T'Y__ >+_P")JM$MQ,TRQ^)Y&,#%9,0184@X()V]
M:WJYK3M-AU;2=5LK@D1R:G,3@ ]),CJ/;MSZ$'F@"P4N!9K>'Q0XMV4,)?)A
MVD$9!SM]*)([J&XA@D\32K).<1*8(OG."<#Y>N ?RJL_@FT?PY!HYN'Q WF+
M)L'WRN">.1G)/WL\\DCBI=1M([ ^&[2$DQPZ@$7( X$$V.@ _2@"Y_9FJ?\
M0?G_ / >+_XFC^S-4_Z#\_\ X#Q?_$UJT4 97]F:I_T'Y_\ P'B_^)H_LS5/
M^@_/_P" \7_Q-:M% &5_9FJ?]!^?_P !XO\ XFC^S-4_Z#\__@/%_P#$UJT4
M 97]F:I_T'Y__ >+_P")H_LS5/\ H/S_ /@/%_\ $UJT4 9'AA631W1W,C+>
MW89R "Q^T29.!QS6O65X<_Y!DW_7_>?^E,E:M !1110 4444 %%%% !1110
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M2D7E,8RBD8*@J00, <=.!Z5:AABMX4AAC6.*-0J(@P% X  ["LO_ (1;1?\
MGS_\BO\ XT?\(MHO_/G_ .17_P : ->BLC_A%M%_Y\__ "*_^-'_  BVB_\
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M_P#(K_XT?\(MHO\ SY_^17_QH UZ*R/^$6T7_GS_ /(K_P"-'_"+:+_SY_\
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M ->BLC_A*M"_Z"4/Z_X4?\)5H7_02A_7_"@#7HK(_P"$JT+_ *"4/Z_X4?\
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M@XR.I_,T ;M%9'_"5:%_T$H?U_PH_P"$JT+_ *"4/Z_X4 :]%9'_  E6A?\
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MBB@ HHHH **** ,KQ#_QY6W_ %_VO_HY*U:RO$/_ !Y6W_7_ &O_ *.2M6@
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MHHH **** "BBB@ HHHH *Q_%#,FC*Z1F5UO;0J@(!8_:(^ 3QS[UL5E>(_\
MD&0_]?\ 9_\ I3'0 W^UM4_Z%R\_[_P?_%T?VMJG_0N7G_?^#_XNM>N8T^YU
M.32-5O+:66YO%OKB*&-@'4*DS*H"EE'08SD>O- &A_:VJ?\ 0N7G_?\ @_\
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M(8@?,0#N(QG)XYK9L[HW<3.;>6 JY4I*!GCOP2,'MS0!0_M;5/\ H7+S_O\
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M /3;SNX.0:N^%9I9_#EI)-*\KD,"\C%F.'(Y)Y- !_:VJ?\ 0N7G_?\ @_\
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M8_#>F(F@74JK9Q .L\(##8.1E\_G71S?ZB3_ '3_ "JAX9_Y%72?^O&'_P!
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M]% &/X79GT9G>,Q.U[=ED)!*G[1)P2../:MBLKPY_P @R;_K_O/_ $IDK5H
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M+N+6-9#9W9F=&?;E3#+'P?7+C]:U*Q+A]9M$5[G7-'@5FVJ9+%U!."<#,_7
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M/XB_Z"FF?^"Z3_X_1]G\1?\ 04TS_P %TG_Q^@#5HK*^S^(O^@IIG_@ND_\
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M $%-,_\ !=)_\?H U:*ROL_B+_H*:9_X+I/_ (_1]G\1?]!33/\ P72?_'Z
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MC@C:,'UKHJR--\,Z;I-W)<68G0,[.L#3NT,3-]XHA.%)R>@[G&,UKT %%%%
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M]]3_ /!K<_\ QRC_ (1RQ_Y[ZG_X-;G_ ..5JT4 97_".6/_ #WU/_P:W/\
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M(*M*^5*DX&<#MW]ZT[3Q%KSWUC<-<3M>3^)9+&>T+'8EL!R-G0;1AMW7WYH
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M'.& [' QQU[T =Q;Z)I=W;QW%O>:A+%(H9'35KDAAZ@^94G_  CEC_SWU/\
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MXUH[$_NC\JQ[76)-4FNO[+L89[>UF:!IYIO+#R+]X( K9 /&3CD'&>M $_\
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M:LW\PLM/N+I;?SC#&S^6N 6P,XR:SFU^$:-I5ZMJ#/JOE+;P%L?.Z[\%L=
M23CMT[4 *VM>%GN5NFU/2&G4864SQ%P/8YS3I-=\,RRQRR:MI3R1'*.UQ&2G
MT.>*6WUN";3[^X:W"3Z?(\4\(.?G4 @*<#.X%2./XAQFJJ>)H2XD>T06?VX6
M#7 ?_EMG;PN/N;_DSG.>V.: ++Z[X9EFCFDU;2GDCSL=KB,LN?0YXI'UKPM)
M+YKZGI#2#^-IXB?SS4J:HK>)9-&-F5V6HN1,6&&!;;@#\.])>:A=)//!I^F+
M>21;%YD$:AB"2&;!Q@;.@).\<=30!!J.K>%M5L)K&\UC398)UVNOVM!^(.>"
M.H/8TO\ ;7AR2S6VO-<TR\4 !C-<1'?CN1G&?PIMCK=SJFC?:[/2/],6:2"6
MUFF"+&Z,58%P#D9'! .<CISB[HM^NL:/;:@;1K8S+DQ/@E2"0>1U''![C!H
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M% X.7.UL X'')% %>YN_"=TUNKZOIBP6\PG$"7,2J\@^ZS8/..H'J!Z5H?\
M"3:!_P!!S3O_  +C_P :1]6@DM;*YL8#=I>1F:-8Q\S1[-P(SZDH.<?>JKI^
MO/)?WEAJVFKIT]I MSN$PEC:(EANW8&""IR"/SH M_\ "3:!_P!!S3O_  +C
M_P :/^$FT#_H.:=_X%Q_XU!X?UB778GNOL$$5FP!@FCNDF\P>X4?*<8R,UL;
M$_NC\J ,N7Q+H)A<#6].)*G %TG^-4?#WB'1(?#6EQ2ZS81R)9Q*Z-<H"I"#
M((SP:WYD3R)/E'W3V]JS_#2*?"VDDJ/^/*'M_L"@!W_"3:!_T'-._P# N/\
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M\#(3'S %@"<@]< XK2EU-&U5M+L[=;BXBC$DY+;4A4YV[C@_,<'  Z DXXR
M'_"3:!_T'-._\"X_\:/^$FT#_H.:=_X%Q_XUH[$_NC\J-B?W1^5 '-P>(=$'
MBB^F.L6 C>RME5S<IM)#SD@'/49'YCUK3_X2;0/^@YIW_@7'_C3+=%_X2S4!
MM&/L%KV_Z:7%:FQ/[H_*@#._X2;0/^@YIW_@7'_C1_PDV@?]!S3O_ N/_&M'
M8G]T?E6;J6J+IVH:9:FS,BZA<&#S0P C(1GZ=3PAH 7_ (2;0/\ H.:=_P"!
M<?\ C4,.M^%K9W>#5-(B:0Y<I<1*6/O@\U%J/B**RGU!(K,3QZ5 L]ZX;:44
M@G"C!W,%4L1QV]>)M6UZSTFU%VZ"2 0-.S(,DJ-H4#U+,Z@?C0 1:[X9@:1H
M=6TJ-I&W.4N(P6/J>>31'KGAB'S/+U724\TYDVW$8WGU//-/LM4\[4+C3;JS
M2"]@A2?RTDWJZ,2 0Q YW*0>/3UI=$U6/6-&34GMA; O*K([ [=CLAR>G\.:
M (H=<\+VY)@U328B>I2XB7/Y&H+C4O#,VIV^I+KNGQW4"F/>MW'\\;$$HW/(
MR 1Z$?4&&_\ $MWI]E'J,FA,U@!&UQ+YH#QA\<JA'S8##/(YSC.*TYM33^U?
M[+L[=;BZ6,2S9;:D*$D+N.#R<'  ['H* *\NK^%)YUGFU'1Y)4^[(\\19?H2
M:R-<'A_6]<TC4G\3:6BZ6TA\EI8W$N\!6!.\<8'I78;%_N+^58-SXFM[>2\E
M%J'L;"Y2VNKC?@H[;<X7'(7>N3D=^#B@"?\ MSPO]G%M_:ND^0  (OM$6T#Z
M9Q0-;\+J[N-4TD-("'87$66!ZYYYJO)XGACWW/V13I\=]]ADN-_S+)O$>=F/
MN[SMSG/?&*T+F\F6YFM[.R2XDBC5L,X1=S$X!.#@ *2>">1P<T 55UCPHEO]
MG74M'6$'/EB>(+GZ9Q45SJ7A>:VEABUK3+8S)Y;R0W$2OM/4 YXX_*FP^)@V
ME0W$^FF&\FO6L$MBX*M,&*G#XY4;6.<= >,\5:@UN&6QU"1K8+<Z=(T4T ;.
M7P&4*<#(8,N..] "6NN>&;&TBM+75],B@A0)'&MU'A5 P!UJ;_A)M _Z#FG?
M^!<?^-4KC7KJRU.U@N]&,=E=7'V9+I906$G.,QXR%)!P<^F0,TVYUO5+;4(8
MF\/+]EGNEMXYFNU#,"?O;-I., MC.<"@"_\ \)-H'_0<T[_P+C_QH_X2;0/^
M@YIW_@7'_C6CL3^Z/RHV)_='Y4 <WKOB'1)K2W6+6+!RM[;,0MRAP!*I)Z]
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M]<BQ;:U!>Z2E[! /,:?[,T+=4E$FQ@?H03]!F@!Z>(_#L:*B:UIBJHPJBZC
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M_%T?VU<?] +4_P#OF+_XN@#*TZQO+W6-"NIK62V72;"2.82+C,SA%VK_ '@
MC'<..1CV?I*WMO!XA,5M-'/<:@[VQ>(@,&1%5^1T!!)]A6E_;5Q_T M3_P"^
M8O\ XNC^VKC_ * 6I_\ ?,7_ ,70!0UNY^R00Z)%I6HW%D80DSVL._\ =CCR
MP<CDCJ>P]SD)K<-GK6F#3[K0+B22XM=T.Z ?N6.<+O'$;+P>O'8FM#^VKC_H
M!:G_ -\Q?_%T?VU<?] +4_\ OF+_ .+H ?!I]^EM"DFKS%TC56(C0[B  3RN
M>3S7/WVEZA9W/B,1Q37KZS9(EO(%&/-"-&0^.%'*G)XQGN*W?[:N/^@%J?\
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M0VLP$#" "-I#\OF,Q/W1DX_$\\8TKJ"6[U^TRC"WLXGFWXX,K?(N/7"F3/\
MO"F_VU<?] +4_P#OF+_XNC^VKC_H!:G_ -\Q?_%T 3BRO,_\A:<_]LH__B:Y
M6UT*]33=*T P2#^S]7-T\Y7Y#"LCRH0W<G*KCJ#GL*Z/^VKC_H!:G_WS%_\
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MB,F,KG'7YA@=3VJAK/AS5]3U*6<7-H\*7=K<VOG;MT(B969 !P-Q4G=UYP>
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M HHHH R-<DE^V:-;QSR1)<WS1R^6VTLHMYGQG_>13^%5(9/$/_"72I(@_LO
MVG8!Q\V#G.,YQGOC;QWJ[K-O<RW>D7%O;M.+2\:65490=I@E3(W$#JZ]ZU:
M.;T3_A(;B_OXM7#);%B(V0;"/E3&"">,9Z9&[=R.!5[PQ<377AZUFN)6EE8,
M&=NIPQ'\A6G([1QLRQM(0.$7&3^9 _6L_P .6<]AH-M;7,?ES(&W+D'&6)ZC
MCO0!IT444 %%%% !1110 5E:G_R&]&_Z[2_^BFK5K*U/_D-Z-_UVE_\ 134
M:M%%% !1110 4444 %%%% '&PW&NS?#W3KW3YI9[ZYMDFF=_G;F/)V^GS8P
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CF_P!1)_NG^54/#/\
MR*ND_P#7C#_Z *OS?ZB3_=/\JH>&?^15TG_KQA_] % &G1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% &5;_ /(VZA_UX6O_ *,N*U:RK?\
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M))!B(XG"?>"'H2/U'(XYJ;0M576]$L]32)X1=0I*$<8(W*#^/7K0!%_;C_\
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M?^R=0&R63Y3&N6_=MT^:NGK*U/\ Y#>C?]=I?_134 ']N/\ ] ;4_P#OTO\
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MDAW7UQ-'(60JZO*S+C#$C@CJ!0!FZ1I?B&+PO):O<F&[9HS [2@&)01D%=K
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M:1!+%;Y/GS-/(Q &YVZG   _ 4 7J*** "BBB@ HHHH **** ,K0^NI?]?\
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M?_Q%']B2_P#0;U/_ +[C_P#B*U:* ,K^Q)?^@WJ?_?<?_P 11_8DO_0;U/\
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M\;Q#_J&O_P"C%K:H RO[$E_Z#>I_]]Q__$4?V)+_ -!O4_\ ON/_ .(K5HH
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M_P#Q%']B2_\ 0;U/_ON/_P"(K5HH RO[$E_Z#>I_]]Q__$4?V)+_ -!O4_\
MON/_ .(K5HH RO[$E_Z#>I_]]Q__ !%']B2_]!O4_P#ON/\ ^(K5HH RO[$E
M_P"@WJ?_ 'W'_P#$4?V)+_T&]3_[[C_^(K5HH YB#2)3XGOH_P"U]0!6RMFW
MATW'+S\'Y>@QQ]36E_8DO_0;U/\ [[C_ /B*+?\ Y&W4/^O"U_\ 1EQ6K0!E
M?V)+_P!!O4_^^X__ (BC^Q)?^@WJ?_?<?_Q%:M% &5_8DO\ T&]3_P"^X_\
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MDL@=1;H V(V(SQS0!T'G1?\ /5/^^A1YT7_/5/\ OH51_P"$<T+_ * NG_\
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M  CFA?\ 0%T__P !4_PK.?3]'&NMIJ>'=,9([9;B25HD! 9F  7;S]WN1UH
MW_.B_P">J?\ ?0JKJ5I8ZK9O9W<FZ"08=4E*[AZ'!Z5S&G:EX3U"TOKE=!L4
M2R3S6S#!DIC.><#UYR5XX8TBWN@S^&KK6K7PSIL@LP3-$Z(IX&>/D)SR.&"_
ME@D [+SHO^>J?]]"CSHO^>J?]]"J/_".:%_T!=/_ / 5/\*/^$<T+_H"Z?\
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MYT7_ #U3_OH4>=%_SU3_ +Z%4?\ A'-"_P"@+I__ ("I_A1_PCFA?] 73_\
MP%3_  H O>=%_P ]4_[Z%'G1?\]4_P"^A5'_ (1S0O\ H"Z?_P" J?X4?\(Y
MH7_0%T__ ,!4_P * +WG1?\ /5/^^A1YT7_/5/\ OH51_P"$<T+_ * NG_\
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M51W=]/D1$12S,QC(  '))-<_K$4VO> [/PY8VMPUS=0V\4DCP.B6P4J69F8
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M\-3_ /!5<_\ QN@#5HK*_P"$CL?^>&I_^"JY_P#C='_"1V/_ #PU/_P57/\
M\;H BUYTCU/P\SL%4:B^2QP/^/6XK5%K +DW(A03,H4OCG )./U/YUFR:]IL
MJ[9+347 .<-I-R?_ &G3O^$CL?\ GAJ?_@JN?_C= %Y+>VM6EF2..(R'=(^
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MGHK*_P"$CL?^>&I_^"JY_P#C='_"1V/_ #PU/_P57/\ \;H U:*RO^$CL?\
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M%+XBL3"X$&I<J>NEW(_]IU1\/:_9P^&]+B:'42R6<2DIIMPPR$'0A,$>XXH
MZ:BLK_A(['_GAJ?_ (*KG_XW1_PD=C_SPU/_ ,%5S_\ &Z -6BLK_A(['_GA
MJ?\ X*KG_P"-T?\ "1V/_/#4_P#P57/_ ,;H U:*RO\ A(['_GAJ?_@JN?\
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MPD=C_P \-3_\%5S_ /&Z/^$CL?\ GAJ?_@JN?_C= &K165_PD=C_ ,\-3_\
M!5<__&Z/^$CL?^>&I_\ @JN?_C= &K165_PD=C_SPU/_ ,%5S_\ &Z/^$CL?
M^>&I_P#@JN?_ (W0!JUAZ4T9\1Z_$Q4EIH?E)ZCR4[5/_P )'8_\\-3_ /!5
M<_\ QNF_V]IOF>9]DU'>1C=_9-SG\_+H T%L;5+9K9;>,0MG*!>#DDG]2?SK
M(\2K#;Z98P1A(P-1L@B#C@7$?059_P"$CL?^>&I_^"JY_P#C=-;7M-=E9[34
M69>5)TFY)'T_=T :]%97_"1V/_/#4_\ P57/_P ;H_X2.Q_YX:G_ ."JY_\
MC= &K165_P )'8_\\-3_ /!5<_\ QNC_ (2.Q_YX:G_X*KG_ .-T :M%97_"
M1V/_ #PU/_P57/\ \;H_X2.Q_P">&I_^"JY_^-T :M%97_"1V/\ SPU/_P %
M5S_\;H_X2.Q_YX:G_P""JY_^-T 'B'_CRMO^O^U_]')6K7,:[KUG+:6X6'4
M5O;=CNTVX7@2J>Z<GVZGM6E_PD=C_P \-3_\%5S_ /&Z -6BLK_A(['_ )X:
MG_X*KG_XW1_PD=C_ ,\-3_\ !5<__&Z -6BLK_A(['_GAJ?_ (*KG_XW1_PD
M=C_SPU/_ ,%5S_\ &Z -6BLK_A(['_GAJ?\ X*KG_P"-T?\ "1V/_/#4_P#P
M57/_ ,;H U:PO#GE2Q:G$Q5C_:5QN0\_Q^E6/^$CL?\ GAJ?_@JN?_C=-77M
M-1V=;3459OO$:3<@G_R'0!>.GV;62V1MHS;JH41;?E  P!^0K,U]D74= C#*
M&_M'(7/./)F[5/\ \)'8_P#/#4__  57/_QNFG7M-:02&TU$NO1CI-SD?CY=
M &O165_PD=C_ ,\-3_\ !5<__&Z/^$CL?^>&I_\ @JN?_C= &K165_PD=C_S
MPU/_ ,%5S_\ &Z/^$CL?^>&I_P#@JN?_ (W0!JT5E?\ "1V/_/#4_P#P57/_
M ,;H_P"$CL?^>&I_^"JY_P#C= &K165_PD=C_P \-3_\%5S_ /&Z/^$CL?\
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M@X_\?:@"7[1XB_Z!>F?^#&3_ .,4?:/$7_0+TS_P8R?_ !BM6B@#*^T>(O\
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M (Q6K10!E?:/$7_0+TS_ ,&,G_QBC[1XB_Z!>F?^#&3_ .,5JT4 <Q!/KO\
MPD]\1INGF4V5MN4W[[0N^?!!\GD]<C Q@<G/&E]H\1?] O3/_!C)_P#&*+?_
M )&W4/\ KPM?_1EQ6K0!E?:/$7_0+TS_ ,&,G_QBC[1XB_Z!>F?^#&3_ .,5
MJT4 97VCQ%_T"],_\&,G_P 8H^T>(O\ H%Z9_P"#&3_XQ6K10!E?:/$7_0+T
MS_P8R?\ QBC[1XB_Z!>F?^#&3_XQ6K10!E?:/$7_ $"],_\ !C)_\8H^T>(O
M^@7IG_@QD_\ C%:M<W#:M=:OXD\DJEUF..&8\-'F%>A'(&>>* +_ -H\1?\
M0+TS_P &,G_QBC[1XB_Z!>F?^#&3_P",5DVVA:['X;N[)]0S=2REXWSC:NXD
MK@''(_\ 0L'I3;S3[BQ\.Z6+]TGO(=0M%$V/F4-<1@@'MQP<<&@#8^T>(O\
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MCQ%_T"],_P#!C)_\8H^T>(O^@7IG_@QD_P#C%:M% &5]H\1?] O3/_!C)_\
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M] O3/_!C)_\ &*/M'B+_ *!>F?\ @QD_^,5JT4 9'A@R'1W,JJDAO;LNJMN
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M&.!CT]*DMK6:\5VM?%=W.L;F-S&MLP5AU!Q'U'I4CZ9>QHSOXEOU51EF:.V
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MLK^R=0_Z&/4/^_5O_P#&J/[)U#_H8]0_[]6__P :H U:*RO[)U#_ *&/4/\
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M /QJ@#1F_P!1)_NG^54/#/\ R*ND_P#7C#_Z *BETJ_$+D^(K\_*>#%;\_\
MD*J/A[3+Z3PWICIKU]$K6<1"+' 0HV#@9C)P/<T =-165_9.H?\ 0QZA_P!^
MK?\ ^-4?V3J'_0QZA_WZM_\ XU0!JT5E?V3J'_0QZA_WZM__ (U1_9.H?]#'
MJ'_?JW_^-4 :M%97]DZA_P!#'J'_ 'ZM_P#XU1_9.H?]#'J'_?JW_P#C5 &K
M6;]@N$\1MJ*>6T,MJD# L0R[6=LCCG.[U'2F?V3J'_0QZA_WZM__ (U59X)D
MOA9'Q/J/V@IYFP6\!PO(R2(L <'KZ4 ;U9GB*PN=5T.ZTZV\H-=1F,O(Q 0$
M=> <_3CZU5AA><2&+Q9=L(CAR$MN.G_3+W%0RR+#8_;G\67WV8?>D6"!@OUQ
M%P/K0!T=%97]DZA_T,>H?]^K?_XU1_9.H?\ 0QZA_P!^K?\ ^-4 :M%97]DZ
MA_T,>H?]^K?_ .-4?V3J'_0QZA_WZM__ (U0!JT5E?V3J'_0QZA_WZM__C5'
M]DZA_P!#'J'_ 'ZM_P#XU0!JT5E?V3J'_0QZA_WZM_\ XU1_9.H?]#'J'_?J
MW_\ C5 !;_\ (VZA_P!>%K_Z,N*U:YB#3+T^)[Y!KU\&%E;$R>7!E@7GP#^[
MQ@8/;/)SGC&E_9.H?]#'J'_?JW_^-4 :M%97]DZA_P!#'J'_ 'ZM_P#XU1_9
M.H?]#'J'_?JW_P#C5 &K165_9.H?]#'J'_?JW_\ C5']DZA_T,>H?]^K?_XU
M0!JT5E?V3J'_ $,>H?\ ?JW_ /C5']DZA_T,>H?]^K?_ .-4 :M9MG87%KK.
MH7)\MH+QD<'<0RE4"XQC!Z9SFF?V3J'_ $,>H?\ ?JW_ /C551'(;J:U_P"$
MHU#S(!F7]Q!M3C/+>5@<$'K0!OUF:U8W.HQVT$/E+&EU#/([N00(Y%?  '.=
MN.HQ518W>V>Y7Q9>&)"0S>7;<$$@C_5>H-,DS&D#MXJO]EPRI&ZP0%2S$  D
M18!)('/K0!T-%97]DZA_T,>H?]^K?_XU1_9.H?\ 0QZA_P!^K?\ ^-4 :M%9
M7]DZA_T,>H?]^K?_ .-4?V3J'_0QZA_WZM__ (U0!JT5E?V3J'_0QZA_WZM_
M_C5']DZA_P!#'J'_ 'ZM_P#XU0!JT5E?V3J'_0QZA_WZM_\ XU1_9.H?]#'J
M'_?JW_\ C5 !XA_X\K;_ *_[7_T<E:M<QKFF7J6EN7UZ^D!O;< -' ,$RK@\
M1CD=?2M+^R=0_P"ACU#_ +]6_P#\:H U:*RO[)U#_H8]0_[]6_\ \:H_LG4/
M^ACU#_OU;_\ QJ@#5HK*_LG4/^ACU#_OU;__ !JC^R=0_P"ACU#_ +]6_P#\
M:H U:*RO[)U#_H8]0_[]6_\ \:H_LG4/^ACU#_OU;_\ QJ@#5K-TBPN-/:\2
M3RVCFN9)T96.?G.<$8XQ]:9_9.H?]#'J'_?JW_\ C55(D>9IE3Q3J!\A]DC&
M" *&SC&3%@G/&!0!T%9NI6-S>W^FNGE+#9W'GNQ8[B=CIM QC^/.<]NE42I%
MDMZ?%MW]G90RR;+;!!&?^>7IS2R1217$$#^*-0#W)VQ$00%7."<!O*QG"DXS
MVH WZ*RO[)U#_H8]0_[]6_\ \:H_LG4/^ACU#_OU;_\ QJ@#5HK*_LG4/^AC
MU#_OU;__ !JC^R=0_P"ACU#_ +]6_P#\:H U:*RO[)U#_H8]0_[]6_\ \:H_
MLG4/^ACU#_OU;_\ QJ@#5HK*_LG4/^ACU#_OU;__ !JC^R=0_P"ACU#_ +]6
M_P#\:H /#G_(,F_Z_P"\_P#2F2M6LCPPK)H[HTC2,M[=@NV,L1<2<G  R>O
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MTD3(LK1,1PZ 97Z9!'Z5!IUA%IEA%90,[1Q X+D$G)).<>YH M4444 %%%%
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MAE# '(QP<FKW_",:%_T";7_OV*B88\;Q <#^S7_]&+6U0!E?\(QH7_0)M?\
MOV*/^$8T+_H$VO\ W[%:M% &5_PC&A?] FU_[]BC_A&-"_Z!-K_W[%:M% &5
M_P (QH7_ $";7_OV*/\ A&-"_P"@3:_]^Q6K10!CR^&=#6%R-*M00IQ^[%4O
M#WAW19_#>F32Z9;/))9Q,S&,9)* DUT,W^HD_P!T_P JH>&?^15TG_KQA_\
M0!0 W_A&-"_Z!-K_ -^Q1_PC&A?] FU_[]BM6B@#*_X1C0O^@3:_]^Q1_P (
MQH7_ $";7_OV*U:* ,K_ (1C0O\ H$VO_?L4?\(QH7_0)M?^_8K5HH RO^$8
MT+_H$VO_ '[%4&TK0QK1TU-"MFV6ZSR2;1PK%@ !CDY4UTE8L8!\;78(R#IL
M.1_VTEH R-/F\(ZC;WL\6CKLLAND_P!%.<8STQG/7CKQ48F\-3>')M;MM AE
MAM\F52@4@ 9.#C#5U$.CZ;;I*D5C $EX=2@((XXP>W XZ5D^*+&UL/ ^KQ6L
M*Q+]E?..2>.Y/)_&@"]_PC&A?] FU_[]BC_A&-"_Z!-K_P!^Q6K10!E?\(QH
M7_0)M?\ OV*/^$8T+_H$VO\ W[%:M% &5_PC&A?] FU_[]BC_A&-"_Z!-K_W
M[%:M% &5_P (QH7_ $";7_OV*/\ A&-"_P"@3:_]^Q6K10!S$'AW1F\3WT)T
MRV,:65LRKY8P"7G!/X[1^5:7_",:%_T";7_OV*+?_D;=0_Z\+7_T9<5JT 97
M_",:%_T";7_OV*/^$8T+_H$VO_?L5JT4 97_  C&A?\ 0)M?^_8H_P"$8T+_
M *!-K_W[%:M% &5_PC&A?] FU_[]BC_A&-"_Z!-K_P!^Q6K10!E?\(QH7_0)
MM?\ OV*S#8Z +O48SH,'E:<H,LBQAB24#X50,G@UU%8>FQ1SZYXABFC62-Y8
ME9'&0P,*9!!ZT 9,$_A&?1+C5ET>/R;=S&^+?/.<#MTZ<]L\]#3PGAR33;+4
M8-!@DMKJ:.'<4"LA=U0'!'(RW7T'>NB71M.6V>V%G'Y<C%G!&23DG.>N02<'
MMVK-\06L%GH]G#;Q+%&NI6>%4?\ 3Q'S[GWH M?\(QH7_0)M?^_8H_X1C0O^
M@3:_]^Q6K10!E?\ ",:%_P! FU_[]BC_ (1C0O\ H$VO_?L5JT4 97_",:%_
MT";7_OV*/^$8T+_H$VO_ '[%:M% &5_PC&A?] FU_P"_8H_X1C0O^@3:_P#?
ML5JT4 <QKGAW1H;2W:+3+9"U[;H2(QR#*H(_*M+_ (1C0O\ H$VO_?L4>(?^
M/*V_Z_[7_P!')6K0!E?\(QH7_0)M?^_8H_X1C0O^@3:_]^Q6K10!E?\ ",:%
M_P! FU_[]BC_ (1C0O\ H$VO_?L5JT4 97_",:%_T";7_OV*/^$8T+_H$VO_
M '[%:M% &5_PC&A?] FU_P"_8K($/AU;6^O)M"@CMK.=H2XCWEBK;2=H' ]_
M2NLK"T""*YM=2BGC61#J<YVL,C(?(/U! - &1)<^$8_#T.M-HT?DS':!]GZ-
MC)!/0#@C/0]NM7'LO#ZOIK)H4#0:BXCCD,84J2C.,J1G&$/YULG1-,-BEE]B
MB\A -J@<CC;G/7..,YR:I:W%'#=:!'%&L:+J7"H, ?N)NU $_P#PC&A?] FU
M_P"_8H_X1C0O^@3:_P#?L5JT4 97_",:%_T";7_OV*/^$8T+_H$VO_?L5JT4
M 97_  C&A?\ 0)M?^_8H_P"$8T+_ *!-K_W[%:M% &5_PC&A?] FU_[]BC_A
M&-"_Z!-K_P!^Q6K10!D>&(TAT=XHT"1QWMVB*HP% N) !^5:]97AS_D&3?\
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M%I?W-W-;)';WTEM&\9.'"@8ZDY;D\#TK0DUC3Q8I=)?VWESJ3#(7!5L#KQU
M[^E %8>)]&'2Y<?]N\G_ ,31_P )1H__ #]/_P!^)/\ XFE\.:I<:WX8L=3D
M6**>Z@$A"@E%)_'./QK"TOQK>3V^AW=_:6ZV^LR/"IA<[H67<02#]Y2%.3QC
MWH W/^$HT?\ Y^G_ ._$G_Q-'_"4:/\ \_3_ /?B3_XFFR^)-+FB L-:TTR^
M9$OSS!@0SXP,'J0&"^]7Y-3L8;M+22[A2=V"+&S@$L1D#ZD<XH I?\)1H_\
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M&C_\_3_]^)/_ (FC_A*-'_Y^G_[\2?\ Q-:]% &1_P )1H__ #]/_P!^)/\
MXFC_ (2C1_\ GZ?_ +\2?_$UKT4 9'_"4:/_ ,_3_P#?B3_XFL[4/$>E/J^E
M2+<.5CED+'R9.,QL/[M=165J?_(;T;_KM+_Z*:@!O_"4:/\ \_3_ /?B3_XF
MC_A*-'_Y^G_[\2?_ !-:]% &1_PE&C_\_3_]^)/_ (FC_A*-'_Y^G_[\2?\
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M?_GZ?_OQ)_\ $T?\)1H__/T__?B3_P")K7HH R/^$HT?_GZ?_OQ)_P#$T?\
M"4:/_P _3_\ ?B3_ .)K7HH R/\ A*-'_P"?I_\ OQ)_\31_PE&C_P#/T_\
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M/AZR%_I<<6I6RR*6.QW +$_*P)QD$=Q6C_:6L?\ 0 ?_ ,"HZ/[2UC_H /\
M^!4= &!'HFJ)X#M=-&FLMY%?12M$)(_NK<B4G.['W0>^<U?T^SU2TU:]M)]*
MCN;2>_\ MD-\\B%8P<9!4G=O7!"D#'3D8K0_M+6/^@ __@5'1_:6L?\ 0 ?_
M ,"HZ ,CPSI%_:2VEMJ>DYDTS>L6H/=^8LBD$91-V58C&00!UZ\5UU9']I:Q
M_P! !_\ P*CH_M+6/^@ _P#X%1T :]%9']I:Q_T '_\  J.C^TM8_P"@ _\
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M^P'&X$9^U1U6TJ;6M.TBSL6T-G:VMTB+"ZCPQ50,_I0!T-%9']I:Q_T '_\
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M_P "HZ/[2UC_ * #_P#@5'0!K5C>)@\MM96\4,TLC7]J_P"[B9@JK.C,20,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#:9@TZY.H6SQN-LJ[@(^'! (5L]^GK4.C>*;^2QT?0]!LK*&Z.A+?I',7,9
M(18E.[([_,2>G>@#K/L6O?\ 0;MO_ #_ .SH^Q:]_P!!NV_\ /\ [.L-_&6I
MS:[?:=9:8)FTV2V2YA1&=G\P9<JXPJA1TR/FP>E2>'/&%SJWBF_T6^CBLY[0
MR_Z*\3+(R!@$=7W$.I4DG@=L9'- &Q]BU[_H-VW_ ( ?_9T?8M>_Z#=M_P"
M'_V=7=3N9K/2[JZMHDFFAA9TCDD$:L0,@%CP![FN+M/'NHSP^(AY5J\FE::E
M]!(L;JDF8RY4@L<C(P&!P1R* .G^Q:]_T&[;_P  /_LZ/L6O?]!NV_\  #_[
M.N3L/B)J*2,VJ6EJT3>'1K*"V#*PYP4)).<^N!CWZU3TN[O-3^(_AC5;Y;59
M;_1GG MXRNU6&0IR3D@'KQ]!0!W'V+7O^@W;?^ '_P!G1]BU[_H-VW_@!_\
M9UR7Q0AB;6O"$C6JW#'544IM4EUR/EYP.?<XJEX4UJ*R_P"$Q\46\9MM.MVP
MNC?=>&1%Y++T0L?3/?TH [K[%KW_ $&[;_P _P#LZ/L6O?\ 0;MO_ #_ .SK
MF;KQ[JFG:#+J-SIJR"6.V-E*L;Q1/)+U4[B20IYR.H/:I+OQGJUG-XKM6BLY
M)= M8IXY!&P68LI<@KN....OO[4 =%]BU[_H-VW_ ( ?_9T"RUXC(UNV(/\
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MVJ;6/&&O:590R-I\ >75X[&-YH7C2>)QD.%)RI!!!SGIF@#HOL6O?]!NV_\
M #_[.C[%KW_0;MO_   _^SKA]>\::Y)X(\0R+);VU[INJ'3VF@C8!TW!=R@L
M2K?-ZGV]1NWOBZ_TSQA:Z!?_ &>!+D1>1<O;N([IBV'56WG8P&, [LGJ1D4
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MFVL+EDBWB'<4 N=N>4.[H<<$X!SGI0!I45"ES&TH@+!9S&)#$2"RCISCWX_
MT&63[8(?L[^48RQGRNT'(&W&<Y[],<=: )J**H:WJL>AZ1<:E+#)-';KN9(\
M;L9QW(H OT450UO58]#TBXU*6&2:.W7<R1XW8SCN10!?HHHH **H7>K066J6
M&GR1RF2_=TC=5^12J%SDY]%-7Z "BJ%CK5EJ.H7]A;2;I]/=4F&.[+D$>HZC
MZJ149UN.6_N+.RM9[V2U(6=H=@6-B,A2689;!!P,XR,XS0!IT51AU:"329-2
MD26WAB$AD65<,FPD-D#_ '33(-;MKKP\FMVJ23V\EN)U5-N\KC..2!D>F>U
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MR)5DBMEN/,.-C*S%<#G.<J>H%7B< GGCTH 6BJ.D:K!K-B;NWCEC02R1%95
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M(?\ K_L__2F.@#5KYP\4?#OQ=>^+-8N[;0[B2">_GDC<%<,K2,0>OH:^CZ*
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MD;IG8,P )"[2#G'3IR10L5MYV@ZI9&:6TLK^=KN:2%HR7FC?=*58 [=[XST
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M!(C] 5(R#S[5'!=6FHQS+;7"3+&YBD,4GW6'5<CH1FIXXTBC6.-0B( JJHP
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M97AS_D&3?]?]Y_Z4R5JT %%%% !1110 4444 %%%% !1110 4444 %97B/\
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M(&0<\_>'\J2;1-+N-,&F26,/V(8_T=5VQ\'(^4<=>?K5U%"(%&< 8&22?S-
M'+:IKM];:RHMKD2P+J5O9R1K&NQ!(%R&8_,7^8,-O &,U5@UO6EN8IYKZ.2'
M^W'T]H1 %#1Y8 YZY&!^N<UT5QX<T6ZNI+JXTRWEFE='=V0$LRXVGZC Y]J4
M>'M* P+-<"X^T_>;_6_W^OWO>@#EO[1N=;'A75Y+C$=QK$@%L%&(\13JHSUR
M O.3U)X%;FNW>I)KFDZ=8WB6J7HF$CF$.PVJ"",G'^>_2K8\-:(+K[4-,@\W
MS_M .W@2X(W@= 3DY/>H-8T6;4]=TF\_=_9[$RE_WC))EU !4J.,?4=: ,;1
MO$.J:E>6FC7<X@N";U9;R*-1YQ@E$8V!L@9SD]?N\=>(9/%.L#1(KV=9(XH?
MM4-W=6D2OY;QR%$E,9R3$=K$[>1]*ZR31M.E@MX6M$5;4[H"F4:(]"5(P1G)
MSCKFDET33)DC1[1 D<9B55)4;#U0@=5.!D'@T <O-K5SIU_XBOQ?/-%'<6<,
M(E*^5$DHC&[(7.%WD_SSUJY-JFM:?J%MIMY<VY&H7RQ03J0TD49C=R&&T+N+
M(54X[\Y(YW9=$TN>:XEFT^WD>YB$,Q:,'S$_NGU'_P!:H$\,:)'IG]F)ID"V
MF\2>6%_C'1L]<C P<YXH H>#4>/^W$DE,K+J\P+D $_*G7'&:I6_B/49[#2M
M820-%?ZB;22S*#$:%V0$'KN7:"<G!^;@<8Z:PTNQTP2BQM8X/.?S)"@Y=NF2
M>YIL6CZ=!=M=16B)*TAE)&<;R,%P.@8C(+ 9.: .7TS7-::?2YKJ]CEBNM5N
MK"2$0!1M0S;6SUS^Z ],'UYK0\6_\A+PQ_V&%_\ 1,M:<?A[2HA"L=FJB"8W
M$0#-\DASEQSU.3S[GU-37VDV.I/"]Y;B9H&WQ$DC8W3(P>#CO0!RNNS+I_Q
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M;2[RY6Y2WBMYXG$00KYGF KQV!CXSSSU-4?#DC2^,_$_VS_C\BEA2$-_#;;
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M!.,$].*UI/#6BRW3W4FFP-*\JS,2O!D'1\=-WOUI1X;T47UQ?#3+<7-R")I
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M:ZD@^P7*W,815.YP"!G(Z88]*77M$37K*.UDN9;=8YXYMT04DLC!EZ@\9 H
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M9<A6(X(5EP?<]<<:#^$+(&[CM9I;6UOK=+>ZMX\;755V#!(RIV?*2.P'<9H
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M8R:;*XA7&0)0 '\N3<2=AVY! R0PR5PJXS5V9!#X\L!&643Z?=-*H8X9E>W
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M?MV'&S(7.[&#R>F:X:W\1:A)H+:Y::O%/?II\SW&E@%V$RKGE<_)L8$< 9!
M/)!K2TF:S?QU:26^I&\%QHI8,\V_>?,4[AZ9ZX''' % '945Q6N27DNN:[ N
MN75E'::7%=PB-E 1\RY/(Y7Y5R._Y5)HLNIZIX@=+_4+JW>/3;*Y:VC*J%E?
MS XQCID#C_ZU '5VMREW;I/&LBJ^<"2-D;KCE6 (J:N TG7I)K/1+;5M5D@@
MO;6Y8W;2^699ED 4;^,84L<=\>V*DN]5FFNY=-;Q*MC)#8P2VEW,-IN"=VZ4
M*" ^2 "O(]!S0!V&I:E:Z39F[O'9(0RH65"W+$ =!ZD<]*E2Y22ZEMPL@>(*
M6+1L%.[.,,1@].<=.,UA^-V_XHZX9R ?,@R<8_Y;)6/XBU/4+4^+?)U*:/[)
M:6LL&"O[DMOSCCO@>] '=45PVHZO>Z)=:[$-0FE@@^PRF68AS DLC+*PP!@!
M5SQTY(K?\.LS?;-NL1ZG;F4-"8R7$(*C*>9D[N?FY.0&';% &G%=Q3&7 =/*
ME\IC(A0%N.F1R.1R.*GKSR^N)+@G[;J$YBMO%"P[S.8PD?EJ=I*X& 3Q5ZRU
M2;4M8=?[>CL[JUU*2![/EFDAR0@"$X^9=K[\''/. 10!VM%>?:5<ZC<1^'7D
MUJ]<ZA=W=M.=ZX9$$S+CC@YC R.<$^V.@\)ZD9-*$%[?"6=;VZMH6F<>9*L<
MK@?[Q"J,_3- '0T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!E>
M'/\ D&3?]?\ >?\ I3)6K65X<_Y!DW_7_>?^E,E:M !1110 4444 %%%% !1
M110 4444 %%%% !65XC_ .09#_U_V?\ Z4QUJUE>(_\ D&0_]?\ 9_\ I3'0
M!JT45YMJOQMT32=7O--ETR_>2SG>!V0)ABK%21\W3B@#TFBJFE:A'JVD6>I1
M(R1WD"3HK]5#*& /OS5N@ J&.SM82YBMHD,GWRJ ;OKZTV]-VMJQL5B:<LH7
MS2=H!89)QZ#)_"L+2]7UO4KS4(52QQI]\+63Y7!==J,7'S<8#]/;K0!N+I]D
MNS;9P#8<KB)?E^G'%(VF6#(J-8VQ522JF)< GJ1Q65X9\30:S8VZW-S:KJ4B
MR,UO$V" KE<@$D],?G6K!J=C=736L%W%),B[S&K G;G&1ZC/&1WH GEABGC,
M<L:2(>JNH(/X5$+&S699EM(!*@PKB,;E&,<'Z5'/JVGVS7*SWD,9M(Q).&8#
MRD.<,WH.#S[&H9_$>BVTC1SZK:1NA0,K3*"N_P"[GTSB@"])!#,4,L22&-MR
M%E!VGU'H:%@B2'R5B18L8V!0%QZ8K+U#Q!::6VHSW5[;F"PMEEEACRTT9.[[
MW/0@# QZU=?4[*+3CJ,UU%#:A=S32.%51[DT /%A9*J*MI  C;E C'RGU'H:
M!I]D(FB%G!Y;'<R^4,$^N,547Q)H;Q74JZM9E++_ (^&\Y<1?[W/%(FMV=WJ
M%M!9:G8R!VD5X@^Z1RHYVX/;OP>HH N'3[)MVZS@.\ -F,?-]>.:E\J/RO*\
MM?+V[=F.,>F/2JT>K:=+.\$=[ TL:%V7>,A0<$_0'@GL:?::C9W[2K:W,<S0
MD"15;E<C(R/<=/6@!1I]D%119P (<J!&/E/J..*465H!&!:PCRCF/]V/D/7C
MTK%?7IX[GQ!%<7%C:QZ:(_)GGR$&]-P,GS<\X'&*UFU.RBF6"6ZB$K8&,]R,
M@?4C)QZ4 31VMO#-)-%!$DDO,CJ@#/\ 4]Z9!8V=JVZWM((3SS'&%//)Z52T
M_P 2:7J6G?;X;@"'S7C!88)*LPX'7G:3CKBI9]9L%L$NH[^VV31EX9"VY6 '
M+<'E1W/:@"NN@(?$MSK-P\,XF@BB2)X 3%L+$,&)ZY<]O2M+[+;^<TWV>+S7
M&&?8-Q'H36=H>M"^\)V.MZ@\-L)[1)YFSMC3*Y/)/ ^IJS::WI=^\J6FH6\S
M0H'D"2 [5/0GVX- $K:?9/ +=K.!H5;<(S$NT'UQC&:DEM;>>2.2:WBD>(YC
M9T!*'U![52?Q#HT4$T\FI6R1P,JRLT@ 0M]W/IGL>],U#Q'I>FVKW$URK+'.
MENP3DK(Y  /IU!^E &C-!#<1^7/$DJ9SM=0P_(U&UA9.6+6D#%P V8P=V.F>
M*KZKK5EH^G+?W4F(7=$0@9W%R O\Z?+K&G02(DM["C2;=H9P/O?=SZ9/3/7M
M0!,ME:(S,EK"I9=C$1@97T/M[4^"WAM85AMX8X8U^ZD:A5'X"EEEC@B:65UC
MC499F. !]:IC7-+,!F%]"5$ABX;G>!DKCKD#G'IS0!8%E:!746L.'8,P\L?,
M1R"?4TIM+8W!N3;Q&<KL,NP;BOIGKBH)=8TV"TCNY+Z!;>5/,27>-K)C)8'^
M[@CGH,UF/XH@L_$-[9:A=VD%G%;6\T$K-M+&1I 023@CY >/6@#873[)=FVS
M@&PY7$8^4^HXXI8[*TA*F*UA0JQ92L8&"1@D>^.*DEEC@B>::18XT!9G<X"@
M=R:HC7]);?\ \3" &-T1P7P49SA 0>A;MGK0!HT53;5M/7S]UY"/L\@BE&\9
M1SC:I'J<C [Y%1-K^CI%#*VIVJI.7$9:4#<5SN ]Q@Y],4 :-%9,GB?2%?30
MEVDJZFS+;O&=RG:I).?PQ]?QJ ^*+"UBB>YO[:<7-Z]M UMDJ,$G#')Y ')]
M: -VBJ*:SIDD$LZ7T+10R^3(X;A),@;3Z') Q[TNH7JVC6J_:[:!I[A8P)SS
M)GJJ#(^;TZ_2@"[15:/4;.6[-K'<QM,-WR \G:0&QZX) /H33;K5;"QE6*ZO
M(H7;!"NV, G )] 3P">] %NBJ]Y?6FGQ"6\N8K>-F"!I7"@L3@#GN:J1>)-#
MFM3=1ZM9M LHA,@F7 D/1>O4YZ4 :=%9EIK-G?WZK9ZE8SP&W,NR-]TG#;=V
M0<;>HZ=>]30ZQILXE,5] PA4-)AQ\JG[I^A['H: +M%5[2^M;^)I;6X294<H
MY4_=8=0?0^QJK#XCT2XO([.#5K.2XFW".-)E)<J2#CGG!!_(T :5%4FUG3$N
M&@>_MTD169E:0# 7[QY]._IWIUAJNGZHK-I][!=! I8Q.&P&&5SCU'- %NBL
M&_\ $2PZ_I&G6DUO*MY<RPSCDLNR)V^4@XX90#UQGM6G%JMA/=_9(KR%Y_FP
M@89;:<-CUP>#CIWH MT53BU;3YA(8[R$B)!(YW<!3G#9]#@X/0XJ2TOK6_C=
M[2=)E1RC[3RK#J".Q]C0!8HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** ,KPY_P @R;_K_O/_ $IDK5K*\.?\@R;_ *_[S_TIDK5H ***
M* "BBB@ HHHH **** "BBB@ HHHH *RO$?\ R#(?^O\ L_\ TICK5K*\1_\
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M/A_[-YUP6NU-RCW(_=[0WF$D ?PG:=VT<=<#KZ* .#T71]>T2+33)I"7L?\
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MRWDZ"X1KI9)  N/,=LD-C   ).,?0;M% !1110 4444 %%%% !1110 4444
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MTGCAN/*#E@6"L2H"D'"NI.6'?\;MCI"6.J:A?K<S2-J#J\D;[=JE5"C;@ ]
M.I-5I?#2-K<VI0:C>6HN@OVNVB9?+G*C )RI*G  )4C( H @?Q3]GUJ.PN[1
M88Y'G4.)][*(U+;F4#"AE!(YSC''/%/6]4O-2\&ZG<?V>T%I/H\MU!<I<?,I
MV956 P0V"#P2.",^MR+P=;17<,QU"\=(+J:XCA8QE1YN[>I^7)!WGJ<CUIL'
M@V*'1KG1SJVH26<MN]M#&[(?L\3#!53MR>. 6R0.E $VAZQ<3WITJ[LU@>.R
MAN8G6;?O1LK\W VL"O09'/6JD,SZWXWU73[IG^QZ3! $MPQ"RO*&8NP'WL
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M])*H3,L@3RP#E3\H7@ 8^N>:OZQI<.LZ7-83R21I+M.^,C<I5@P(R"."!U%
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M,USVE27XUF3P_<W%T[V5R;O[2TC9EMF!\M2?7<2N.XB/K6AJO_(W:#_NW/\
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MN .?3\* .EHHHH RO#G_ "#)O^O^\_\ 2F2M6LKPY_R#)O\ K_O/_2F2M6@
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MEMQC(R.34+^+]3CM;]_+LY'@T=M1B9$<1EESE 2?G7@8<8!ZT =8;&S.[-I
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M%8A,1.X/!']SIW]NM58-;UF[NO\ 1+*&:"WO1:W1X7@8#NI+Y&"<A2IR._-
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MNK.TAMQ-!=V\"6\J,TDT<FW,JX8?*NYNQ_U;9([ '2O;022"22&-W48#,H)
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M4&WL;D\PV\QBS'RJMLXY7VX[5QUK<C4/^$-OGM;:WE;4+E=MNFU5_<S@X^N
M3[UL>$(T1-:C5%5/[6N/E P/X: -Y3#<0D*4EC.5.,%3C@C^8IC6-HY)>UA8
MD!23&#P.U<1X<U'4=&TS3@D5HVEW.K7-IY:JPEC+7,NU@<XQD8VXZ<Y[5N:+
MKFJZO)87JV,8TN^B9]Y*J\7=/XSNR,@C:,&@#:^P6><_9(.FW_5CIZ4[[':Y
MB/V:+]R<Q_(/D^GI4U% $*6MO'.TZ6\2RMPT@0!C]32R6T$LBR20QNZ_=9E!
M(^AJ6B@"(6MNL[3B",3.,-($&YAZ$]Z6&WAMU*P0I$I.2$4*"?PJ2B@ HHHH
M RO#G_(,F_Z_[S_TIDK5K*\.?\@R;_K_ +S_ -*9*U: "BBB@ HHHH ****
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M,V\L[O%&C?>5%)P@/MBMNB@#%C\*:4FEOIS"YEA<H2TMU(\@V,&3#DY 4C(
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M)),Z+&TTTA=RJYVKD]AD_F3UJ[10!DW_ (:TS4I+R2XCES?0"WN D[H)$&<
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M3?#6F:3=R7%G',F]F=83.[11LWWBB$[5)R>@[GUK6HH **** "BBB@ HHHH
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MM-TR1Y;*RA@DD55=T7YF Z GJ: ,8ZS>P>+$LKQIH;6>X*6LB(CP3 1$F-F
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MR-=\,0YSY<DRY"A<X@8=!P/H*Z&LN\TVXN]<TZ\\R-8+%G?;@EG+(5^@ZYH
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M&B*KG /4GM6;K.G:AJFIZAK8TEI;>WTN2SMK24[7NV=@6) .0N   2">>G%
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MX1E)Z\^AH [22YMX3&)9XXS*<)N<#>?0>M0ZCJ=GI-K]IOITAC+J@+'&68X
M'ODUQ<NC-;3'3+G1-2N-)N["*WMXX) YAVEOW<C$_+]Y3NS@8Z\ UT'BRRN+
MKPQY,%N\\L<]K(8T^=B$FC9L9ZG:I^M $]EK\=SK&H6$HAA6U>)8I/.SY_F+
MN&!@<^PS6FUS;I<+;M/&LSC*QEQN(]AUK@M:TR>\?Q-<+I-P9IQ:&T)MR6RH
M7=M(Z$$=CVJQK,-_<ZP\D&D72B+5+.X#Q1@B>,! SEF.00,KM&, $G.> #K]
M/U2QU5)7L;F.=8I&C8HP(# X/Z@_E6;>>*;6-(FL##>*=1BL9BLN/++L%)&
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MFL:2S_\ "00VNDRF&>6QDMT2U(5BC+O(&." .: .Z^W6F ?M4/,GE#]X/O\
M]WZ^U.:Y@6X6W::,3.,K&6&XCU ZUP6MZ)YB>*OLFCN6GA@-ELM2,R!>2G'!
MR%YXZ#TJY%9RW&N3V^I:5J$^=16^M+E?EAV8&TL>JLHRI4CD#'>@#L%N[9I!
M&MQ$7()"AQG ."<>QXJ+3M4LM6M3<V-S'/"'9-Z,",JQ4_AD&N)TK27M1H<D
M>DS0S0ZU=R3,+8J4@?S]N3C[IWQ_Y!QT7@ZWGLM%:SN;22WEANI\EU #AIG8
M$>HP1S[T ;"WUHVP+=0G><)B0?,?0>M1M=EKB!+<V\L;EU=C-A@0,@* #NYZ
M\C%<=>Z%J]E<7+:=:!XM+OO[1T]5P#+YG^MA'H.9O^^T]*TY]+>UU_PY(MLT
MC0?:#<W$<1(#.F220.-SDF@"6V\533V>EW#6"+]OU&6Q=1.3Y11I5W#Y?FSY
M1].M=!)/#$ZI)*B,_P!T,P!;Z>M<19V=XFE:'&UC=*\&O7%Q*IA;*1L\Y#'C
MIB1/S]C70>*K&>XTZ&]L8?.OM-G2ZMT'5]O#H/\ >0LOU(H U4O+60*4N86#
M-M4AP<MZ?6ECN;>5Y(XYXW>(XD57!*?7TKDM-T#5[:;4+)BB0KOO+.8<*EQ,
MI#!<=D;S#])%]*ALM-GGCT%GTZ:V;3;&6#4$>$X<&,+Y8_YZ N-PQD<=B: .
MAU#74M+O3(8%BN4OKH6[.LW,68V<-@ Y!"'N.HK3CGAF4M%*DB@X)5@0#7GH
MT&\7P;X7M+"TET_48Y(_M,R6IW1,L$B;GXYPS ?CD>M=CX<G>;185ETU].EC
M&R2W*$*&[E2?O ]<]>>>: )[/6=-OK)[RWO87MT=D:3>-H*L5//ID''K5Q'2
M1%>-@Z,,AE.017"Z?9:EI[:6TNG7'V:PU.]:Y18]Q82/(8I54<L &'09&[V-
M=!X7T^:PLKX2H8X)[Z::W@88\N)CP,=LG+8[;OPH U1>6I;:+F$M@MCS!G .
M"?P/6@WEJMJ+HW,(MR,B4N-F/KTK@]/T,1VF@J^C.KPZQ=23YM2-L+&?;GC[
MIWQ\?X'!;VNH:>T,ZZ7?/80ZC?![>WBPZ)*^8I%0]5QN&!R Y]Z .^DNK>%4
M:6>)%D("%G #$],>M00:K8W.HW&GPW,;W-L%,L:L"5SG ^O'ZCUKC)-(-E+'
M8RZ)J4VC7>G"UC@A<2/ =\A*OD_*&5TY!P"H&> :V]#LI['Q-J?F6<J13PVQ
MCFSN7Y4VL"QY)S^?6@"UK'B:UTZTU8V[17-YI=J;F6V,NT[<,V,X.#A3V]/6
MM.UNX;J+<DB%@!YBJP)0D9P?2N0\06%X;CQ8L6G3S?VEI"Q6[Q)N#/LE4K]<
MNOYYZ56O]*OOM.HKI&G21B;2+90HB,2S2)*S/&21C<4;;SZ^QH [J"X@N8_,
MMYHYDSC=&P89],BL[6==32I[*%%BFDNKJ*!D,VUT5SC=MP<_I5?PW#"\MYJ,
M>G7UF]YY?F_;?E=V4$?<!P,# SW_  %<Z]IJ(CAL[G2KJ:\M_$ NVN%BRLD1
ME)#ANG"$+CJ-N,8H [DWEJ))(S<PAXEW2+O&4'J1V%06NLZ;>Z:FHPWD)M'^
M[*S@+[<UREC;7[^)--N'TBYMHXKJ]69!&OEH)"2&W$Y;=]XGIDX &,54TZTU
M+3M*\/BZTB_>WM;26SNH8$4NDAV8?;GYE(5ES[^AH ]#R-N[(QC.:A2\M9(&
MN([F%X5SND60%1CKD]*QKFQ-EX#FL+/2GG$=FT<=C+*69EQ@(6SR<=@?8'O6
M&MC>32ZT9H-4@CNYK2:"YC@4.C*%^;8 <X*C*D9P.><4 =S%+'/&)(9%D1NC
M(P(/XU0U;6(]/T;4;^V\JZDT^!Y7A$N/NJ202 <' /:J6EP:M+X3N;:816]^
MXN%BECC,0<EFVRE3RA8G<1V)K%,,M]X/OXU\.75GJ":-)8MOC&6?:0L:8)W+
MN).[IR/4X .P2^@$%O)/+'"UPH**[@9)'09Z]:D>YMXIEADGC21_NHS@,WT%
M<=+9W1FU-+W3I[JWU'2HH;4"(ML958-$W]PEF!R<#WXI$TW5[.]T_8TUU<(M
MG#?13PEX9]@&Z9)/X'7YCR><=,F@#L3<Q-))!%+$]PB[C%Y@!'IGJ0/?%4-!
MUR+6M'L+YA';RWL*RBW\P,P!_+/UQ7/^';*9+RU&J:7J O\ 3'GS=D_N7#[L
MNI'+[L@[<9!]P*K6VG7VG>#?#NHP6FS5M*5(#!.-AD60B-XR?J58>ZB@#NXY
M8YEW12+(N<94Y&:9'>6LJ2/'<Q.L61(RN"$^OI5069T_0'MH(?M4D<#?(3M\
M]R"3D]BS$Y/O7&6^GW<KW)FT_4[>WN-+LX@T,*HT+QROG:O).S<I .20#U%
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MU1)KF)H;;SF16^1BT2S[F(+!=P&>,8Z-6B-7NC\/;C5=-AN'NH[65XH[GYY
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MLVUQ=1OI@DX?:7"(8^P"A"&&,^O.* .EL-&LM-;=;I*6QM#33R3%1Z*78X'
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MG5[Z#4K:&Q:YAU,@))'&& *R]N>H;C.T_@ =:2 ,DX K*/B72_LQNA),UKG
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M3;"W"?:-1F:-7D!*H%1G8X!&3A< 9'7/:N9T#4;G31<:=#%$UW>:Q> %(P$
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MQ;2-'((R7$R#<4)S@Y4,1Q_"15237/$#&>UM+&WGO[&*%KB/A4=W&XJ"9!M
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M*[E4Y/;(R/Q%4O#6O:I?Z?HUB;B![Z[TO[=)<2PL1CY5 VAADDL23D#CISP
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MXDQNSRH(SG ;BNEH **** "BBB@#*\.?\@R;_K_O/_2F2M6LKPY_R#)O^O\
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MA2&)W9VG>O(!QW XS(?%UFDM\LEG>I'83&&>9HUV!]J%0/FR2V]0,#KUQQ0
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M[_ZY<%6Z\8VKQTX%)K'BG3M%:5;C?(T$:RS"(KF-"2 <$@MT)PN3QTY&6_\
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M/.:K#P=HRQP)''/$(+7[(ICN9%+0]D8@_,!VSTK0U'4UTX1YM;BX:0,0(5'
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M:A,\;.K*-@6-G[D<_+^0/?%,C\3V,DMK^[G6WO)VM[>Z(7RI)!G@<Y&=K8)
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MGM;;;;[9%0KM7>=Q#%1P, 9ZFJFH^#-2U+3VLYM7MRCZ;]B.;0D1MS\Z#?\
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MHY]2N;Z"[FM9+RW%O=",*1(HSM/(X8;B ??H>*+;PU:6NH/<1NWD/8QV'V7
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M:[C-NT)?$4EO/YJ2+M!SG QR2,$=JQM*@O9] U&;3Y674)-2NU65Y<8"W<@
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M\MVW0W$:R1L1C*L,@X^AJ:O.+2\U71='TRXTR\GOQ-X?DG>UDVNL31Q(8V4
M#')*X[_49KH_#=T+R]>YMM>BU"TGMD<0HQD,;9^^6S\NX<;>.5.,<T =)52W
MU*UNK^ZL8G8SV>SSE*,NW<"5P2,'H>E<9KEUJ@E\4SVNM744VE-#):0+M*EC
M&K!"N,L&;*@>_<U/=WZV.K^))Y;E[1BNGH7BP6#,2NW)X&<XW'IG/:@#MZ*X
M"U\2RQ2FTO-05+,:V]I+.+C?Y49AWHOF'!P7XW'GMGO5F[U/R[JTTEO$&VVG
MM[AH;^639YDBN %#C 8HI]?FP<YQ0!UU_?6^F6$]]=LR6]O&9)&5"Q50,DX
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M: -0:K:'5!IF^0731M*JM"X5E4J&(8C:<%UZ'O5BXGCM;>2XE)$<2EF*J6(
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M4I)QN*@C[V-PZTXZ[+J<LL,6NC39(K>UN+)K@$/-&R!BQCR-Y8Y4KSC'&#U
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M\ME9F!!&.3G!SVQ]: /0:*XW0M4GU74;>X;6HHYTN9X;K3B2S-@L NS/R;<
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M '1+IE@FW;8VR[&WKB)1M;U''7@5+<6MO=Q>5<P1SQY!VR(&&?7!K(M]7O\
M4KF=]/CMOLUK>_995FW!R !N<'H""W"D<@=1GBE:>)KZ>'27>&WS>ZG<6,@
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M+8"&,I(JG+NR[SWZ;2AZ?Q>U $-CH<,.O:EJ<LL%S)=2(RKY(W0%4"@;LGJ
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M74QI(#@DD'#X//:N5U.XO[V&[:ZE@N#:>)[2*V4QE-F'@P,Y.!\QSQW)[XH
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MGHK$$C]/U/K5"X\4V-MYLCQ3FU@N%MIKH*/+BD.!@Y.[ +*"0, GGH<.3Q'
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M\66T%K910V6IWKRZ8M[&0(R[Q@+G<2P&[Y@3^G85:E\56"VT<\$<]R)+'^T
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M44 8P\+6 14\RXPMZ;X?O/\ EL226Z=,D\=/:D_X1;3_ )?WEQ\MZ;X?O?\
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M21Q%D2,,7) W<DD^O&!]3H?9/$/_ $&+'_P7-_\ ':/LGB'_ *#%C_X+F_\
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M>HW::FL$]S+;SV[I!GR)(A@9RWS \Y''6MO3XKV"V+:E=Q3SDY9HHC'&HQT
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M61]D\0_]!BQ_\%S?_':/LGB'_H,6/_@N;_X[0!KT5D?9/$/_ $&+'_P7-_\
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M.<#)QRV.M7: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW/:R6-RMS%)!MW;P",'<#Q@G([T <KK0'A_QRWB>(!+93#::B ,#RI.%D/\
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M$'^61W!K4L='2UOY=0FGDNKR6)83-( -L:DD*   .22?4^P &@02I .#Z^E
M')^')W\6K;W^JV,<<FDR/ 8B P^U+\LCC_9'1?\ >/H#5S0]8UC5M1O5DMK*
M*TLKV6V<K(QD;:JE2.,=^<X_3FYH.A1Z##=1174UP+JYDN6,H7(=SEL8 XS3
MM(T9=(DOG2ZFG^W7+7+B0+A'( ., <<#KF@"IXETK1);2XU?5M+M]0>UMSY:
M3QA^F2%4'@$DX]^*S+[PI?IX1TS1].CTR5;0!KBUO(B8;AL$D87H-Q+#@\@>
ME=/J%@FHQ112NRQI-',5'\>Q@P!]MP!_"F7UE=74\,EOJEQ9K'N#I$D;"0''
M7<IP1CC'KWH Q])UBRL_ XU"VTQ-.2 21_85 41S*Y0QC'',@(SWSFL[P7=_
MV=KVI^'I;XW@D U"WF;.7W\3#\).<>CUT4FA1%+&.&YF@BLYO/\ +4*PF?G)
M<D$G)8MVYYIFI^'X]2UC3M4%Y/;3Z<7\OR@N'#@!@V0<@@"@#GM8L+C3_%46
MLZMI>FZI8374444_E'[18$D+&1G(*[R"<8(+$U3NW:]T'QUJ<Y(NK.YECMY/
MXH1!$K1[3V^8EOJ:[!=&D>Y9[S4KB\@$_G1V\BQA4(.Y1E5!(4X(R>PSG%07
MOA>TO9;P-++';ZBR->6Z8VS%0!UQD9  ;'4#MS0!EZL1=ZEX+U"6)5N9+KYF
MQR-UM(2/IFK'C:")X]$E:-3)'K-IL8CE<R '%:FI:*FI7NG71N983I\QFB2,
M+AF*E><@\88],4NLZ,FLI:H]S+ +6YCN5\L+\SH<J#D'C- &7JPEA\96ES>6
M<UUI;6,D*^7 TPBF+ DLJ@D!E&,X[$=ZY+1KR?4X_"6BW!<Z5>7%[($<_P"O
MAA),*-ZK@@XZ$**]&U'3SJ5N;62YDCMW&V58OE:0=QNZ@'VP?<56U/PY8ZC9
MVENH>S:Q97LYK;"M;D# V\$8QP0001VH BURPMK6SDUFWMD2\TZWFDA9$ )_
M=L-I]1TX]JYFV)TW3? MY;9:XNV6.X<?>G$L#2.6/?+@-]1796^GS AKZ^>\
M*@@*R*B\C!) ')P3UX]JJ6'ABUL9K(^=--%IJLME$^,0!ACTR2%^49Z#WYH
MXZRN94\$>&M=!SJ-UJL4DLH^](9I2KJ3Z;6QCMM'H*0W4O\ PKR3Q*?^0I_;
M'GB3^($7?D[/IY?RX]*[&#PM9P26ZB65K2UN6NK>U.-D<C$G/3) +,0,\$^P
MP'PM9F4KYLOV,WGVW[)QL\[.[/3.-WSX_O>W% &7XC\*Z#<SV\1TFTEOM3O5
MWW$D0>3:#YDAW'D?*I4>FX58U^&/_A-/"L^Q?-$]PF_'./L[G%;KV"2:K%J#
M.Q:&%XD3L-Q4L?K\JC\_6J^H:,NH:IIVH-=2Q/ISN\:(%VL64H=V1GH3TQ0!
MI4444 %%%% !1110 4444 %%%% !1110 4444 %<K\3?^2<ZU_UP'_H0KJJR
M_$>A1^)-%GTF>YFMX+@ 2&';N(R#C)!QTH PIO#NIZ_J7AZ]O3:VMEI.+A5A
ME:229]HP#E5"@8]\U1U37-4L9(+J+4WNG.MI;2>0B_9DA:3;Y1)&2X'4KDAL
M@GM7<65NUI9Q6[3/-Y2A?,< $@>N !7,'X>VOV%K%=8U%+5;P7EO$ICQ;R;]
M_&5RPSGALCGUYH BU76;H:[KME=:BVEQV=C'-I[#:/.)#%W^8'=A@J[>GMS4
M=IK.MM:^'-/O7N/M^JV\ES<G$<<B[%7]VO  Y?/3( (]ZHZC(O\ PE5^TVN:
MSHDZ^7#"HM?.2Y15XD4E&')9A@'/&3UXUSX9N/$6C6C:IJ-W'J%E.\EEJ$<8
M@G53P"R8P,CJ,#C&0#D4 :?AN/7(%O(-9D$J+.3:2,RF4Q'H'V@#(/?O6<;7
M4]#\;ZEJZ6,E]IVIV\(=XI(U:W>($<AV7Y2"3D'KVK=TG2_[+MV62\N+ZXD.
M9;FX(+OZ#    [ #U[DFFZGI(U>,VUU<R"R<8D@B^7S1W5FZ[3Z#&>AR.* ,
M#X8B5_#$]ZZ&.*_U"XNK=#_#&S\?AP3^-3VU[=^(M>URRBU">QBTQT@B\@+N
M+E=Q=MP.>3@#IP<YSQTT<<<,211(J1HH5548"@= !6/+X;5=<N-8T^^FL;B[
MC6.Z"*KI-MX5L,#A@. ?S!H XK6=4O?$7PQAO+V9X;J#4([:<0A0DKK<*N[D
M'TR,=\]:]+MXF@@6)YY)V7K))C<WUP /TK#OO!MC=^'(-!AN+BTM(9%DS$5+
MNP;?DE@>2W)]36_&K+&JNY=@.6( S^5 '(>/+B_L%T[46L;:[TBPO(IKF/<P
MF!SM5U&,84L#CO@=LUOZ_'JLNC7,6C?9A>2(51KDD*,CV'6JT7AV9T$.I:Q=
MZC;+*)5AF2-02#N4,54%@" <>W.:L76EWT^HFYAUN[MH6C"-;I'&R@_WE+*2
M#^= %/P->0WO@[3WAL?L*Q(8#;9SY;1L489[\J>:WZKV%C;Z;916=JFR&(84
M9R?4DD]2222>Y-6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
%HHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>ebs20191231exhibit1048010.jpg
<TEXT>
begin 644 ebs20191231exhibit1048010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "JVH"Z.FW0L2!=^2_D$XQOP=O7CKBK-% 'F7BS6_$OAOQ%X8TF/7YIAJ
MDRQ74C6T(Q\Z*2@V<?>/7-=G ]UHGV^XUK6!-IZ;'AGG6.,QCD,K;0 3G&..
M^*X#XIW, ^(/@X^<F+:Z5YOF'[I?-C.6]!@'KZ5U/Q-O;"W\"7-Q=Z;_ &K
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4FT9!P,CI[4M% !28!(.!D=#2T4 %(%"] !GTI
M:* $I:** "BBB@ I" >H!I:* "BBB@ HHHH **** "BBB@ I, D''2EHH *0
M  8  'M2T4 %%%% !1110 5D>*=%EU_PU>:/!,EN;I/+\QEW!1GG@8K7HH R
MO#.DRZ%X>LM+FECF>TB$0E12NX#H<'I6K110 4A /49Q2T4 (0#P0#]:6BB@
M HHHH 0  8  'M2T44 %%%% !1110 A (P1D&BEHH **** "D(!&" ?K2T4
M%)TI:* $(!ZB@# P*6B@!" 1@@$>]+110 4444 %(  ,  #VI:* "BBB@ I
M ,X &>M+10 F*%55X50,G/ I:* "DP#U'6EHH 3:N[=M&[&,XYI:** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH ***R?$NXZ0J+++%YEW:QLT,K1MM:>-
M6 92",@D<'O0!K45D?\ "-6'_/QJG_@VNO\ XY1_PC5A_P _&J?^#:Z_^.4
M:]%9'_"-6'_/QJG_ (-KK_XY1_PC5A_S\:I_X-KK_P".4 :]%9'_  C5A_S\
M:I_X-KK_ ..4?\(U8?\ /QJG_@VNO_CE &O161_PC5A_S\:I_P"#:Z_^.4?\
M(U8?\_&J?^#:Z_\ CE &O161_P (U8?\_&J?^#:Z_P#CE'_"-6'_ #\:I_X-
MKK_XY0!KT5D?\(U8?\_&J?\ @VNO_CE'_"-6'_/QJG_@VNO_ (Y0!KT5D?\
M"-6'_/QJG_@VNO\ XY1_PC5A_P _&J?^#:Z_^.4 :]%9'_"-6'_/QJG_ (-K
MK_XY1_PC5A_S\:I_X-KK_P".4 :]%9'_  C5A_S\:I_X-KK_ ..4?\(U8?\
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MMZ,K."/;(YH Z.BLC_A&K#_GXU3_ ,&UU_\ '*HW=IX>LC:"XU+4E^V7'V:
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M6!JLM\GB/Q]KVE3RPVD-E'$+B%BH:X4)T(ZE<,#]?>O0WU[PQ<6JP7FMZ3=
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M]![3/_ R/_&@#5K*\-?\@1/^NTW_ *->C_A*?#O_ $'M,_\  R/_ !K-\/\
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MG_7U)_Z(DK5KF-2\1Z%)J>D.FM:>R17+EV6Z0A 89 ">>.2!^-:7_"4^'?\
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MS1QQQJ69F9"  ![FLZ]M)_MGAK5UAF:.Q#I/&L;%T62+;NVXR<, ",9P2>U
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M)=M/<2",[62-9 NT]&+[E( YZYQBM2ZTNYMKSP]J;Q/(;.28WBQ*7(,R'<P
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M_P!G_P"E,= &K1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6R2\LI?-@<L%?:5R02#P0#P015JJFEV(TW2[:SW[S#&%9^[M_$Q]R<G\:MT
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M3/\ P,C_ ,:T4GAD;;'*CG&<*P/'K2)=6\D?F)/&R;MNY7!&<XQGUS0!G_\
M"4^'?^@]IG_@9'_C1_PE/AW_ *#VF?\ @9'_ (UH?:K?$9\^/]Z<1_./G^GK
M4:73"6Z^T"&*&$C:_G9)7:"2PP-O.1U/ S0!3_X2GP[_ -![3/\ P,C_ ,:/
M^$I\._\ 0>TS_P #(_\ &K[7=LD(F:XB6)C@.7&TGZU*V=IV@%L< G - &7_
M ,)3X=_Z#VF?^!D?^-'_  E/AW_H/:9_X&1_XUEQ^-'&@C7;K3?*L%G:&5HY
M][QXE,18J5&1N'8YQVKI/M,&7'GQYC^^-X^7Z^E &?\ \)3X=_Z#VF?^!D?^
M-'_"4^'?^@]IG_@9'_C6HK!E#*05(R".AI: ,K_A*?#O_0>TS_P,C_QK-T'Q
M)H4-C,LNMZ?&3>W3 -=("09W(/7H00:Z>LKP[_R#Y_\ K_N__1\E !_PE/AW
M_H/:9_X&1_XT?\)3X=_Z#VF?^!D?^-:M% &5_P )3X=_Z#VF?^!D?^-'_"4^
M'?\ H/:9_P"!D?\ C6K10!CCQ'X9$QF&M:5YA&TO]JCW$>F<T)XC\,1JRIK6
ME*&)+!;J,9)ZYYK8HH Q9-?\*S1K'+J^D.B8VJUS$0N.F!FGR>)?#,L9CDUO
M2G1A@JUU&0?PS54^(YXM*O\ 49+972WNY+:.*,_,VV0IDY/.>#@?K4$_C(Q>
M'[34UT^1I+B3R_)!!*D=>.O]>1F@#1'B7PTK!EUO2@0NT$74? ].O2HTUWPG
M$X>/5M'1AT9;B($?K3AK,SW.D%(H_(U/(P3EXR(V?J#@_=Q6S0!C1>(?"T!8
MPZQI$9<Y;9<Q#<?4X/-2?\)3X=_Z#VF?^!D?^-:M% &5_P )3X=_Z#VF?^!D
M?^-'_"4^'?\ H/:9_P"!D?\ C6K10!E?\)3X=_Z#VF?^!D?^-9NJ^)-"DOM'
M:/6]/<1WI9RMTA"CR)1D\\#) _$5T]96L?\ (0T3_K_/_HB:@ _X2GP[_P!!
M[3/_  ,C_P :/^$I\._]![3/_ R/_&M6B@#*_P"$I\._]![3/_ R/_&C_A*?
M#O\ T'M,_P# R/\ QK5HH R)/$OAJ:-HY=;TIT88*M=1D'\,TA\1^&&V;M:T
MD^7RF;J/Y?ISQ6Q10!D?\)-X;WA_[<TO<!@-]KCSCTZTV+Q#X6@+F'6-(C+G
M+%+F(;CZG!YJQJM_/9W&FV]NL9>^NC!NDR0@$4DF<#K_ *O'XU1B\3^9XH?1
MOL;A5.T3[AM+8)_D.G7.: )CXA\+EI&.L:06E&UR;F++CT//(HE\0>%IL>;K
M&D2;>F^YB./UJOH_B>36KZ\LX[0V[0D^7)(0RL %ST//+9X[%?6M+1-0?5-)
MAO)45'D+ JIXX8K_ $H KIXE\-1($CUS2D4=%6[C 'ZTJ^)_#:*%37=+50,
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MRKB)=Q]3@\FMRB@#*_X2GP[_ -![3/\ P,C_ ,:/^$I\._\ 0>TS_P #(_\
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M52..Z1F8^@ /-=-65XG_ .1:O_\ KB: -6BBB@ HHHH **** "BBB@ HHHH
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M%%% !1110!E:O_R$]"_Z_P!O_2:>M6LK5_\ D)Z%_P!?[?\ I-/6K0 4444
M%%%% !6'KLL<&M:#+-(L<:W4N7=@ ,PN!R?>MRB@!@BC$S3"-1(RA6?'S$#)
M SZ#)_,TQS;6:2SN8H%8[Y9#A03@#+'Z #GT%344 8O@_CPEIO\ UP%;5%%
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M'_"3:!_T'-._\"X_\: -.BLS_A)M _Z#FG?^!<?^-'_"3:!_T'-._P# N/\
MQH TZ*S/^$FT#_H.:=_X%Q_XT?\ "3:!_P!!S3O_  +C_P : -.BLS_A)M _
MZ#FG?^!<?^-'_"3:!_T'-._\"X_\: -.BLS_ (2;0/\ H.:=_P"!<?\ C1_P
MDV@?]!S3O_ N/_&@#3HK,_X2;0/^@YIW_@7'_C1_PDV@?]!S3O\ P+C_ ,:
M-.LKPU_R!$_Z[3?^C7IW_"3:!_T'-._\"X_\:S/#_B'1(=(2.76+"-Q+,2KW
M* \R,1QGTH Z:BLS_A)M _Z#FG?^!<?^-'_"3:!_T'-._P# N/\ QH TZ*S/
M^$FT#_H.:=_X%Q_XT?\ "3:!_P!!S3O_  +C_P : -.BLS_A)M _Z#FG?^!<
M?^-'_"3:!_T'-._\"X_\: -.BLS_ (2;0/\ H.:=_P"!<?\ C1_PDV@?]!S3
MO_ N/_&@#3HK,_X2;0/^@YIW_@7'_C1_PDV@?]!S3O\ P+C_ ,: -.BLS_A)
MM _Z#FG?^!<?^-'_  DV@?\ 0<T[_P "X_\ &@#3HK,_X2;0/^@YIW_@7'_C
M1_PDV@?]!S3O_ N/_&@!NJ_\A?1/^OJ3_P!$25JUS.I>(=$DU32'36+!ECN7
M+L+E"%'DR#)YXY('XUI_\)-H'_0<T[_P+C_QH TZ*S/^$FT#_H.:=_X%Q_XT
M?\)-H'_0<T[_ ,"X_P#&@#3HK,_X2;0/^@YIW_@7'_C1_P )-H'_ $'-._\
M N/_ !H TZ*S/^$FT#_H.:=_X%Q_XT?\)-H'_0<T[_P+C_QH TZ*S/\ A)M
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MG44 -V)_='Y4;$_NC\J=10 W8G]T?E1L3^Z/RIU% #=B?W1^5&Q/[H_*G44
M-V)_='Y4;$_NC\J=10 W8G]T?E1L3^Z/RIU% #=B?W1^5&Q/[H_*G44 -V)_
M='Y4;$_NC\J=10 W8G]T?E1L3^Z/RIU% #=B?W1^5&Q/[H_*G44 -V)_='Y4
M;$_NC\J=10 W8G]T?E1L3^Z/RIU% #=B?W1^5&Q/[H_*G44 -V)_='Y4;$_N
MC\J=10 W8G]T?E1L3^Z/RIU% #=B?W1^5&Q/[H_*G44 -V)_='Y4;$_NC\J=
M10 W8G]T?E1L3^Z/RIU% #=B?W1^59?B95'AN_(4 ^2>U:U97B?_ )%J_P#^
MN)H U:*** "BBB@ HHHH **** "BBB@ HHHH **** "LCQ.YCT='"-(4O;1@
MBXRV+B,X&>,FM>LKQ'_R#(?^O^S_ /2F.@ _MJX_Z 6I_P#?,7_Q=']M7'_0
M"U/_ +YB_P#BZU:YJRU+5&TG5-021[N>&]GA@MC&-NU)BJ@;5W9P.I)]: -#
M^VKC_H!:G_WS%_\ %T?VU<?] +4_^^8O_BZR-(U[6KKPQ)>M9^?=HT8B3RSB
M<$C)W+QW/(&%QSWJ"WUK5[OX=76KO<26UW;633QRI$N)L0A@QW*5(8\_*!CI
MV- &]_;5Q_T M3_[YB_^+H_MJX_Z 6I_]\Q?_%U/>K?7.C2?8+@07K0YBD*A
MAOQQD'MGK6+8:U=ZQX5TJ:VN6AU"[D2*4F-24=2?.!&,# 5\>X'K0!>N=2>[
MM9;:?0-3:*9"C@>6,@C!Y$F13;*]&GVD=I:>'=1BAC&%4"+UR3GS.22223U)
MIZ:W:07.I"2\N)?LT\,#1-!C8[A0JK@ MN+ YY'/4"JFI:^TT6FS:;</$&U9
M+.YC>,9ZD,AR..1U'YT 7_[:N/\ H!:G_P!\Q?\ Q=']M7'_ $ M3_[YB_\
MBZGM=7MKRZ,$ D89D42[/D)C;8XSZAN.>N#C-7J ,K^VKC_H!:G_ -\Q?_%U
MF6=M96$HDMO#6K( VY8C*&B0]<K&9=JGZ 5U%% &5_;5Q_T M3_[YB_^+H_M
MJX_Z 6I_]\Q?_%UJT4 97]M7'_0"U/\ [YB_^+H_MJX_Z 6I_P#?,7_Q=:M%
M &5_;5Q_T M3_P"^8O\ XNC^VKC_ * 6I_\ ?,7_ ,76K10!E?VU<?\ 0"U/
M_OF+_P"+K-T+5IX[&8#1M0DS>W+901X&9G..7ZCH?I73UE>'?^0?/_U_W?\
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MS%_\71_;5Q_T M3_ .^8O_BZU:* ,K^VKC_H!:G_ -\Q?_%T?VU<?] +4_\
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M]\Q?_%T?VU<?] +4_P#OF+_XNM6L?69)O[5T:V2>2*.XN)!*(VVE@(G8#/U
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M7_Q=)X6N9[SPS87%S*TLTD67=NK')K6H RO[:N/^@%J?_?,7_P 71_;5Q_T
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M@NV\R*#'$4C >:?^!%$/Y^M3[?$7_/73/^_<G_Q5&WQ%_P ]=,_[]R?_ !5
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M[]R?_%4;?$7_ #UTS_OW)_\ %4 :M%96WQ%_SUTS_OW)_P#%4;?$7_/73/\
MOW)_\50!JT5E;?$7_/73/^_<G_Q5&WQ%_P ]=,_[]R?_ !5 !J__ "$]"_Z_
MV_\ 2:>M6N8U1==_M#1M\FG[OMK;-L;XS]GFZ\],9_'%:6WQ%_SUTS_OW)_\
M50!JT5E;?$7_ #UTS_OW)_\ %4;?$7_/73/^_<G_ ,50!JT5E;?$7_/73/\
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MDZQ;W,FHZ1=6]L\ZVMR[RJC*"%,3H#\Q&>6%+M\1?\]=,_[]R?\ Q5-=]>B
M,EQI2 G +(XS_P"/4 :],E=HXF=(GE8=$0@$_3) _6LW'B'_ )ZZ9_W[D_\
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M<2:B=1>Q5$E+1_+$)B^[ . AZ8Z\>]3GPI%)9PP3ZKJ-P\,\4XGED1I"8SE
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M!AY6.5W94 AAZ$X/'/6M^L;2?#-MHUPS6UY>M;AV>&TDE!A@+9SL&,XY/!)
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M!(EB*E0&+9+;CD\^@H T**** "BBB@ K*\3_ /(M7_\ UQ-:M97B?_D6K_\
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M/[!;_H,ZI_W_ !_\36O10!D?V"W_ $&=4_[_ (_^)H_L%O\ H,ZI_P!_Q_\
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M/^_X_P#B:/[!;_H,ZI_W_'_Q-:]% &1_8+?]!G5/^_X_^)H_L%O^@SJG_?\
M'_Q-:]% '+ZEHK)J>D)_:VHMON7&6F&5_<R'CY?;%:/]@M_T&=4_[_C_ .)I
MVJ_\A?1/^OJ3_P!$25JT 9']@M_T&=4_[_C_ .)H_L%O^@SJG_?\?_$UKT4
M9']@M_T&=4_[_C_XFC^P6_Z#.J?]_P ?_$UKT4 9#:$54L=:U3 &3^_'_P 3
M68)=,-A;7S>(]4CANMOD&238TH;&"JE02/F!SC@?2NFF_P!1)_NG^5<YI>B6
M>N>!M!@O Y2.SMG 5C@D(IY'0],<@XSQ@T $_P#9=LUNLOBF]7[2H>,_:U(*
ME2P;..%PI^;IG [U/'902:C)8#6]7%Q&GF%6? *YQD$K@\^E6;[PSIVH/9//
M]H)LL",_:')P%(ZDY!Y!W ALJ.:8/^1W?_L&K_Z,- #_ .P6_P"@SJG_ '_'
M_P 31_8+?]!G5/\ O^/_ (FM>B@#(_L%O^@SJG_?\?\ Q-']@M_T&=4_[_C_
M .)K7HH R/[!;_H,ZI_W_'_Q-9^OZ,T&@WDO]JZC+LC)V23 JWL1BNGK*\3_
M /(M7_\ UQ- &K1110 4444 %%%% !1110 4444 %%%% !1110 5D^)"%TN)
MB< 7UF23V'VB.M:LCQ-&DND)'(BNCWMHK*PR&!N(P01Z4 :'VRU_Y^8?^_@K
M-T>WCTK[4C:G;313W,MPH"[60R.7()W'.,XZ"K/_  C^B_\ 0(L?_ 9/\*P[
M>32KMM16V\(PRMIT[02@10 LP56^7/7(8=<4 =+]LM?^?F'_ +^"L_7HTU?1
M;O38-1M;?[7"\+R.-^%92IP PYYJ9=!T5E#?V/8C(S@VR?X5$FE>'I;J6U33
M-/::%5:1!;IE0V<9X[X- %V*YM8XD3[5"=J@9WBD6>P65Y5EMQ)( '<,N6 S
MC)]LG\ZA_L#1?^@18?\ @,G^%']@:+_T"+#_ ,!D_P * (YK+0+@7 FMM.D%
MT09]\<9\TCH6_O8[9H%AX>  %IIN!()0/+CX<# ;Z@<9ZU2TBVT351>$:!9P
M&TNGMF#P1G)7'/ ]ZOOH.C*C,NBV+$#(46Z<^W(H =!#HUK.T]NEE#*Y8LZ!
M5)W'+<CU/)]:L_;+7_GYA_[^"L71K71-:T&UU6'0+-!<Q"18F@CR,]B<5EZ;
MJ_AK4$TR23PU':PZJS1VLLMM"59US\IVDD$[3CC!QUH Z[[9:_\ /S#_ -_!
M1]LM?^?F'_OX*H7.B:7%#N@T"QG?>HV"&->"P!.2.PR<=\5-_8&B_P#0(L/_
M  &3_"@"S]LM?^?F'_OX*/MEK_S\P_\ ?P56_L#1?^@18?\ @,G^%'_"/Z+_
M - BQ_\  9/\* +/VRU_Y^8?^_@H^V6O_/S#_P!_!5;_ (1_1?\ H$6/_@,G
M^%'_  C^B_\ 0(L?_ 9/\* +/VRU_P"?F'_OX*/MEK_S\P_]_!5;_A']%_Z!
M%C_X#)_A1_PC^B_] BQ_\!D_PH L_;+7_GYA_P"_@K,\/W5LMA.&N(@?MUT>
M7'0SO5K_ (1_1?\ H$6/_@,G^%9F@Z)I,MC.TFEV3D7MTH+6Z' $[@#IT &*
M -S[9:_\_,/_ '\%'VRU_P"?F'_OX*K?\(_HO_0(L?\ P&3_  H_X1_1?^@1
M8_\ @,G^% %G[9:_\_,/_?P4?;+7_GYA_P"_@JM_PC^B_P#0(L?_  &3_"C_
M (1_1?\ H$6/_@,G^% %G[9:_P#/S#_W\%'VRU_Y^8?^_@JM_P (_HO_ $"+
M'_P&3_"C_A']%_Z!%C_X#)_A0 EE#I>GO.UM<*OGR-*ZFX++N8EF(!.!DD]*
MM?;+7_GYA_[^"N9>?1(=,O=1F\.V"P6UR]LH6.,L[+(8\X*C'/8$D]@3Q5>;
M5O#46@VNJ#P_:-]ID\L1B&(D,/O<#+=CQC/'(7L =)-%ID]_!?2W"M-;9,7^
MD':I(*D[<XS@D=*M?;+7_GYA_P"_@K 1-%DGTOR] T]K?4P?+D"1L5(1GY"@
MJ1A>H8UK?\(_HO\ T"+'_P !D_PH L_;+7_GYA_[^"C[9:_\_,/_ '\%5O\
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M_P !D_PH_P"$?T7_ *!%C_X#)_A0!9^V6O\ S\P_]_!1]LM?^?F'_OX*K?\
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M!N?;+7_GYA_[^"C[9:_\_,/_ '\%5O\ A']%_P"@18_^ R?X4?\ "/Z+_P!
MBQ_\!D_PH L_;+7_ )^8?^_@H^V6O_/S#_W\%5O^$?T7_H$6/_@,G^%'_"/Z
M+_T"+'_P&3_"@"S]LM?^?F'_ +^"JM[%IE^]O)/<+OMI#)$R7!0JQ4J>5([,
M1^-+_P (_HO_ $"+'_P&3_"J&HV.D65U8VT6@Z?+)>S-$NZ)$"X1G)/RGLM
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MO:K:O;QM H $94;0!C''M@5EQZWIL4CR1Z;J"/(<NRZ5,"WU.SFI/^$DM/\
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M?#-L1_>E_P#1C4LGB"QEC,<EAJ3HPP5;3)R#^&RB/7[&&,1Q6&I(B\!5TN<
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M6=H&OVT.DI&UKJ+$2RG*:?,PYD8]0M '445D?\)):?\ /GJG_@MG_P#B*/\
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MU_7;:YT*\@2UU!&>,@-)83(H^K%<#\: .GHHHH **** "BBB@ HHHH ****
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MKP[_ ,@^?_K_ +O_ -'R5JUE>'?^0?/_ -?]W_Z/DH U:*** "BBB@ HHHH
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MOFM:L>**9_%TMSY$BP+9"'S&& S;R<#UXH V**** "BBB@ K*\3_ /(M7_\
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MI]2N9'>4ZD]S+(\+Q L!RYQNR%QM]\\4 =E]JU__ *!%E_X'M_\ &J/M6O\
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M%IEHZ_;;DDM>E<-YSY'^K/ .1GOUP.E=/65X=_Y!\_\ U_W?_H^2@ ^U:_\
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M_@>W_P :H^U:_P#] BR_\#V_^-5JT4 97VK7_P#H$67_ ('M_P#&J/M6O_\
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MH-SK2Z?*(M+M'7[;=$EKTJ=WGR9&/+/ .0#WQGCI6E]JU_\ Z!%E_P"![?\
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MJU__ *!%E_X'M_\ &J-7_P"0GH7_ %_M_P"DT]:M &5]JU__ *!%E_X'M_\
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M\:H^U:__ - BR_\  ]O_ (U6K10!E?:M?_Z!%E_X'M_\:H^U:_\ ] BR_P#
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M /ZXF@#5HHHH **** "BBB@ HHHH **** "BBB@ HHHH *RO$?\ R#(?^O\
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M%]_T,FI_]^[;_P",T?V1??\ 0R:G_P!^[;_XS0!JT5E?V1??]#)J?_?NV_\
MC-']D7W_ $,FI_\ ?NV_^,T :M%97]D7W_0R:G_W[MO_ (S1_9%]_P!#)J?_
M '[MO_C- &K65X=_Y!\__7_=_P#H^2C^R+[_ *&34_\ OW;?_&:S="TN\DL9
MBNOZA&!>W(PL=O@D3.">8CR>I[<\8'% '3T5E?V1??\ 0R:G_P!^[;_XS1_9
M%]_T,FI_]^[;_P",T :M%97]D7W_ $,FI_\ ?NV_^,T?V1??]#)J?_?NV_\
MC- &K165_9%]_P!#)J?_ '[MO_C-']D7W_0R:G_W[MO_ (S0 [1M/N--%W%*
MT3QRW4L\;*3GYW+8(QVSBM.N>0>8L[KXKU+9;N8Y':&W"A@2"H)AP3D8P,TK
M(%M4NCXOOO)?&UMEMSG'_3'W% %Z]L+B[UC3KD-&L%D[R'D[F+(R8QC&/FSU
MK2K ,3BY@M_^$JU,O< F$B&W*R8!/#>3@G )QFK7]D7W_0R:G_W[MO\ XS0!
MJT5E?V1??]#)J?\ W[MO_C-']D7W_0R:G_W[MO\ XS0!JT5E?V1??]#)J?\
MW[MO_C-']D7W_0R:G_W[MO\ XS0!JUE:Q_R$-$_Z_P _^B)J/[(OO^ADU/\
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M7'I@8JE)%Y4*3/XNO@DC!%.VU.26"X_U/J0/:@0N;J&V'BG4S).I>+$-OMD
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MF-2TN\74](4Z_J#E[EP&:.WRG[F0Y&(L>W.>OXUI?V1??]#)J?\ W[MO_C-
M&K165_9%]_T,FI_]^[;_ .,T?V1??]#)J?\ W[MO_C- &K165_9%]_T,FI_]
M^[;_ .,T?V1??]#)J?\ W[MO_C- &G(N^-EZ;@15'0;*XTS0[/3[DQL]I D(
M:,DA@J@9Y'&<=*A.DWJ@D^)-3 ')_=VW_P 9JE&Z26<5X/%FI""8J(G>"W7S
M-Q !4&')!W#D<<T ='6;%87'_"0RZE(T8C-L($522Q^8MD\<=:I2Q^281)XO
MO5\__5G%KAAM9L_ZKIA6.>G%.CMII+U[)?$^J">-=Y1H+=?ESC()AP1GTH W
M:*RO[(OO^ADU/_OW;?\ QFC^R+[_ *&34_\ OW;?_&: -6BLK^R+[_H9-3_[
M]VW_ ,9H_LB^_P"ADU/_ +]VW_QF@#5K*\3_ /(M7_\ UQ-']D7W_0R:G_W[
MMO\ XS6=X@TR[AT&\D?7;^=5C),<B6X5O8[8@?R(H Z:BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ K*\1_\ (,A_Z_[/_P!*8ZU:RO$?_(,A_P"O^S_]
M*8Z -6N6TC3UU7P]JMBS^6)M3NQOV!BO^D,<@'C/''H:ZFLK0]/NM,%W#-Y+
M12W<UQ&Z,=W[R0O@@CC&<=30!F:=X/>W\/3:9<7N7N'1VE5 S(5(/#$9)^48
M)'R_A5:;0Y= ^&>LVD\RS2G39FD*KP&$&T@' + 8X)Y P.U=C6;XALKK4]"O
M=.M/*#WD$D!>5R @92N[@'.,]./K0!8-M#>Z5]DN$$D,\'ER(>C*5P1^5<IX
M;FENH(?"EX?,GT6?9=%A]^*/!@;_ (%F,^^QZ[*)#'"B$Y*J!3$M;>*YEN4A
M19IPHD<#EPN=N?IDT <Y+K=['?:W;O=PQ?9[RVAMSY.6(D5"5 YW.=Q )XSC
M/&:SIM1NM1M+$7F3):^)%MP6"ABJDXW;>,X.#CCBNHN/#^E71N3/9)(;ITDF
M+$Y9DQM/7@C P1TI%\-Z/&,1Z?%&!.+CY,K^\ P&X[__ %Z ,W3-;NY/$LFG
M:@TL#MYY@C,:F&XC5QM:.0=POWE8YR?05TM4K?2;&UN//A@VR9<@EF(4N<MM
M!.%R>3C&:NT %%%% !1110 4444 %%%% !65X=_Y!\__ %_W?_H^2M6LKP[_
M ,@^?_K_ +O_ -'R4 :M%%% !1110 4444 <QI6F0ZOH.IV5P6$<FIW6=OM.
MQ'ZBIIO!MA/H5MI+22^5;N'4DYY[_@<GOQFM6PTV/3C.(992D\SS%'P0K,Q9
ML<9Y)[DU<H P+ZW2TU3PU;1EBD4TB*6.3@02 5OU3GTZ.YU"VO))9"UJ2T48
MQM#%2I/3)X8]\5<H **** "BBB@ K*UC_D(:)_U_G_T1-6K65K'_ "$-$_Z_
MS_Z(FH U:*** "BBB@ HHHH Q==_Y"_AS_L)/_Z27%+'X9LX_$3ZVKR>>XY&
M>,X(/X8(X]JNW^G1W[VLC2R126DQFB>/&0Q1D/4$'Y7;M5R@#&TCPQ9Z-J%U
M>6[R%[DDD,>,';G/KR">WWB*3PC_ ,BU;?[TO_HQJUY$9XV59&C)'#KC(_,$
M?I4.G6$.F6,=G 6,<><%SDG))/ZDT 6:*** "BBB@ HHHH RO#G_ "#)O^O^
M\_\ 2F2M6LKPY_R#)O\ K_O/_2F2M6@ HHHH **** "N6T[2(-<\*7EA<,RI
M)J5\<KV(NYL'\ZZFJ>GZ='IJ31PRR-'+-)-L?!",[L[8P,\LQZDT 9EYX/T^
M\TFUTYWD\JUD#IEL_P 0)'KR,CKQGVI;N%;;7O#\"LS+$DR L<D@1@<UO53E
MTZ.;4H+Z260O;AA&G&U=PP3TR>/>@"Y1110 4444 %%%% &5J_\ R$]"_P"O
M]O\ TFGK5K*U?_D)Z%_U_M_Z33UJT %%%% !1110 5BZQ_R'] _Z^9?_ $1)
M6U5.]TZ.]FM9VEDBEM)"\;1XX)4J<Y!'0F@"E;^&;.V\0S:TCR>?*.1GC/S9
M_ @KQVV#U-&B^&+/0[NZN+9Y"UP>0QXQA>OJ<ACGC[Q'0"MFF2HTD;(LK1$]
M'0#(_,$?I0!D>#_^12TW_K@*VJK:?8PZ9I\-E;[O*@0*NXY./>K- !1110 4
M444 %97AK_D")_UVF_\ 1KUJUE>&O^0(G_7:;_T:] &K1110 4444 %8NL_\
MAWP__P!?<O\ Z3RUM53O=.COIK69I9(I;20R1/'C@E2ISD$'AC0!2M_#%G;^
M(I=;1Y//E'(SQGY@?P(*\?[(]31HOAFST.\NKFV>0M<'D,> ,+U]3N#'/'WB
M.@%;-,E1I(V196B)Z.@&1^8(_2@#'\&?\BAIO_7'^IK;JKIUA#I>GPV-ON\J
M!=J[CDX]ZM4 %%%% !1110!E:K_R%]$_Z^I/_1$E:M96J_\ (7T3_KZD_P#1
M$E:M !1110 4444 1S?ZB3_=/\JYBQ\/VOB#P/X?ANF8"&SMI%QT^XN<_49'
MXUU3*&4J>A&#573-/32]/AL8I9)(H$6./S,955  ' &>!WYH S-0\)6.HRV#
MRRS9L5"(=W)4*0.?7)4Y_P!GW-2#_D=W_P"P:O\ Z,-;54X].C35)-1,LCS/
M$(@&QM5<YP, =_7- %RBBB@ HHHH *RO$_\ R+5__P!<36K65XG_ .1:O_\
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M@'\*Z>LK6/\ D(:)_P!?Y_\ 1$U !_PB^@?] :R_[\+_ (4?\(OH'_0&LO\
MOPO^%:M% &5_PB^@?] :R_[\+_A1_P (OH'_ $!K+_OPO^%:M% &5_PB^@?]
M :R_[\+_ (4?\(OH'_0&LO\ OPO^%:M% '.:EI&A6,MC#'H%E++?7!@0&-5
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M3R'+%5Q_"JX'H,(O XXH R-(TCP]JVE6]^FA6<:SIN"-"I(_2KG_  B^@?\
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MVB>*GU#Q#K&A7MJD%QI6QFFBDW1R(R[@>0-I /(Y[\T 7O\ A)=+_P">D_\
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M1MS)+MV*) 2VXX7\R#CUP?2@"'_A)=+_ .>D_P#X"2__ !-'_"2Z7_STG_\
M 27_ .)J[;7]G>R3QVMU%.]M(8IEC<,8W'\)QT-6* ,K_A)=+_YZ3_\ @)+_
M /$UGZGKEC/>:4\1N&6"\,DA^RR_*ODRKG[OJP'XUTM% &5_PDNE_P#/2?\
M\!)?_B:/^$ETO_GI/_X"2_\ Q-:M% &5_P )+I?_ #TG_P# 27_XFC_A)=+_
M .>D_P#X"2__ !-:M% &5_PDNE_\])__  $E_P#B:/\ A)=+_P">D_\ X"2_
M_$UJT4 8MQK6A7:*ERC3JK;E$EC(P!QC(RG7!/YU+_PDNE_\])__  $E_P#B
M:U:* ,B3Q!H\T;1RF61&&&5K.4@_AMI(=>T:WB6*#S(HUX5$LY5 ^@"UL44
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M7_XFM6B@#FM2URQFO](DC-PRP7C22$6LORKY$JY^[ZLH_&M#_A)=+_YZ3_\
M@)+_ /$UJT4 97_"2Z7_ ,])_P#P$E_^)H_X272_^>D__@)+_P#$UJT4 97_
M  DNE_\ /2?_ ,!)?_B:/^$ETO\ YZ3_ /@)+_\ $UJT4 97_"2Z7_STG_\
M 27_ .)J*?6M"N@HN$:8(=R^98R-M/J,I6U10!E?\)+I?_/2?_P$E_\ B:9+
MK^CSQM%-YLB-U5[.4@_AMK8HH QXM?T>")8H?-CC085$LY0 /8!:?_PDNE_\
M])__  $E_P#B:U:* ,K_ (272_\ GI/_ . DO_Q-'_"2Z7_STG_\!)?_ (FM
M6B@#*_X272_^>D__ ("2_P#Q-'_"2Z7_ ,])_P#P$E_^)K5HH RO^$ETO_GI
M/_X"2_\ Q-9^AZY8VNE)#.;A)!+*2IM9>AD8C^'T(KI:* ,K_A)=+_YZ3_\
M@)+_ /$T?\)+I?\ STG_ / 27_XFM6B@#*_X272_^>D__@)+_P#$T?\ "2Z7
M_P ])_\ P$E_^)K5HH RO^$ETO\ YZ3_ /@)+_\ $U%<:UH5T%%RC3!#N426
M,C;3ZC*=:VJ* ,K_ (272_\ GI/_ . DO_Q-,EU_1YXVBE,LB-P5>SE(/X;:
MV** ,>+7]&@B6*'S8XT&%1+.4 #V 6G_ /"2Z7_STG_\!)?_ (FM6B@#*_X2
M72_^>D__ ("2_P#Q-'_"2Z7_ ,])_P#P$E_^)K5HH RO^$ETO_GI/_X"2_\
MQ-'_  DNE_\ /2?_ ,!)?_B:U:* .:U#7+&;4M*EC-PR07#M(?LLOR@Q.H/W
M?4@?C6A_PDNE_P#/2?\ \!)?_B:U:* ,K_A)=+_YZ3_^ DO_ ,31_P )+I?_
M #TG_P# 27_XFM6B@#*_X272_P#GI/\ ^ DO_P 31_PDNE_\])__  $E_P#B
M:U:* ,H^)-+(P9)__ 27_P")J*WUK0[.+RK5'@CSG9%92*/R"5M44 97_"2Z
M7_STG_\  27_ .)J)-:T**=YXT9)I/OR+8R!F^IV<UM44 97_"2Z7_STG_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ K*\3_\BU?_ /7$UJUE>)_^1:O_ /KB: -6BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ K*\1_\ (,A_Z_[/_P!*8ZU:RO$?_(,A_P"O
M^S_]*8Z +FHRO!IMU-&VUXX793C." 2*^=].^+'CB?4K6&36]R23(K#[+",@
MD _P5]'31)/"\,B[DD4JPSC(/!KD8?A/X'@F2:/1-KQL&4_:IC@CD?QT =C1
M110!D^*1_P 4IJS!F5DLIG5E8@JP0D$$="#7,:R9="\!6?B/3[FX2[M(;>5T
M:=V2Y#%0R.I)!)W'!Z@XP:[/4[!-4TNYT^262*.ZB:)WBQN"L,'&01T/I6<O
MA>V>"RM[N\N[RVL=AB@F*!"R?=+!57=C'0\9YQ0!A>)[M)]&\6Q+;&WFM/*W
M2I.Q\W**5..-N 0,5J:GXLETY==/]GI)_8\<4G^OQYJN"?[ORD8]ZGO?"=K?
M)JZ27MXJZN4\_84^3:H4;<KQP!US3-4\(6^JR7S/J%Y"FH6Z0W*1% )-N=K9
M*D@\GI@'CB@!UUXDE2]F@LM-FO$MKE+><QA]P+!22H"E2%#@G+ \'VS5@\6W
M<EU$)=+CCMGU.33FD6YW,'7< P7:,J2OJ",]#5W_ (1B--7EU"'4KZ%;G:;J
MW1D\NX90%#$;<J2  =I&<"HQX2ME55_M"]PNHG41S'_K"22/N?=Y/'7WH D\
M,:G?ZI;WTE_'"AAOIX$\IR>$<KCD#T'/?/;I51/%EUMO9I],2.VM;PV0=;@N
MTDI=$0!0G0E^O48Z&M;2](BTEKOR9YG2ZN'N#'(5*QL[%FVX ."23R35)O"=
ME)INHV$US=21:A<&Y9BRJT4F0P*%5&,%01G/2@"K/XJU"W9(WT-P\M\MI&6E
M9$D#(65U+(#@8((QQVS6??:U-JIL8[JU-E>V&O0V\\23%T.5W AL#<I5@>0/
MI5G6=%O8H-(B2\U#4)TU**66Z=4+1QJK#.%4+@;AVR<GK6G)X7M9=CM<W*S"
M^6^DE79F610% .5(VA0!@8X'6@"%_%1M]9CL;NT2&.1IP'$V]D$8W;F4# #*
M"0,YQCCGA?\ A)9X]-&JW&F%+"2T6XBE28,Q+$;8V7 PQW#ID=>>F4A\'6L5
MU#-]OO72"YFN(X7*%!YN[S%/RY()8]23[TEMX,LX=*FTF>^OKNP:$P0P32+B
MW0]E( )(P,%B2,<=\@$=UXJOK..9YM$<".YMX4<R,J2B5PF5+(#E2>1CTY](
MY_%U_:B^-QI$(&FW<<%T4NRWR2!"K)\@W$!QD';TX)JV?"HFTY;2\UG4;MEF
MBE$TC1[QY3AT7A,8R 2<9/<TMWX2MKQ-462^O%&J2QRS;3'\I0*%VY3@81<Y
MS0 A\2S27XBL],EN8!>&TDE3?E"."_W=NT-P?FSWQ5;3O%MW>S:=YNE1PPZA
M/<6R.+K<5EB\SJ-@^4B)N<YSV[U=@\,QVNJS7D&I7L<-Q*)Y;,,GE/+Q\_W=
MPR0"0" 3U':F6OA*VM$T]4O[UAI]U+=1;C'\SR;]P;"=/WC],'GK0!)X3U*^
MU?0H[V_2)9))90/*8D8$C #D#&,8[]*P;34&6_O=0U&UCENX]9^QV12Y8$,R
M*H0G:/D )8]><G&<5U&CZ1%HMHUK!/-+$9'=%E*GRPS%BHP!QDGKD^]47\(V
M<EM=PO=W;-<7HOED)0-!,",,F%[;1P<]_6@"M=^+Y[-KJW?3%:[M+RVMY(UN
M/E99V"HZL5YY)R"!R#SWKH;1[F2U1[R&."<CYXXY#(J_1B!G\A61=>%;:\CE
M\Z\N1<37$-Q)<)L#,T1!08*D!05SC'<^M:FH6?V_3Y[/[3-;B9"AEA*AU!&#
M@D$ _A0!R>F>(2WC5&?4(Y[+68F2VA60-Y#Q$E>.WF(2W/<8JYH[GQ#K^NO?
MEG@T^Z%G;VQ8A% 169R.A8EN">@ QWSIZMX?@U>QM+62ZN(#9S1SQ2P;%<.G
M0\J1]0 .N.E(WA]$U674K*]N+.XN%5;GRPC+/M& S*RG# <9&/?/% #+HKX=
MT2X*7;%GE(@:ZD+;'<X4%F.2H)S[*/:J'@R]%]I-YHUW=_;9M,F:V><29,T1
MYC?([E2!]5-;+:0'N[2X:]N2;5F?82A61F4KN;*YS@D#:0!FHFT"/_A()=;B
MO;J&>:V6WDC39Y;*I)5B"I.X%CSF@#F/"6LWFF:+/I%[,]U>P113V+3.2UQ'
M/C8"3R=LA*D]@!5CPEIPO_#5U#J5]=3A-2NEFE,[(TJI(R@%@00O&< @<>F:
MW(/#%A#<:9<L99KG2[=K>":0KNVD ?-@ $@#CCN:K)X0CBTN73X-9U*&.6Z>
MZ=U\DLS,Q9E.8R-N3G&/TH Q;7[;;_V%HTMQ</97^HW+(97)D-LB.\:,QY(.
M%//.W@]Q4=IJ=U<ZY;^'I)9#9IK%U"Q+'+Q1PB18R>I :0#W"8]:Z<>'@UO$
MMQJ=[=7,%P+B&ZF,?F1MMVX 50NTJ2",<[C0OAJSC@A$<DJ7$-RUVMSD&0RM
MD.3Q@@AB",8QTQ@8 .8L=3NKS6[30)I9&M(]4O8F)8YDCB161">I ,@^NP9S
MS70>$[RXN+#4()&,IL=0N+:)I&.616^4$\DX!"Y]JG7PU9Q0VXADECN+>X>Y
M2YR#(9'SO+9&#NW$$8QTQC Q=TW38-*LQ;6^X@NTCNYRTCLQ9F)]2230!F:3
MXBN-3A@!L(XKDW,T-S!]H+& 1D@MG:-W.ST^^.:J+XU6(W(OK(1&"R6ZVQ3B
M0Y+;#&3@ ,&P."1DGGCG8AT.S@U#4+Z,.)=0"B;#< A=N5]"0!D]]H]*R8O
ME@MNMO<7U[=0BP-ALD9 /)R-H^51RN.#U]<T 79];O;)_+O=-2-YIXH+5DN
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M0O(RHS;5'). ":JVNN6%ZUN(#<$70S"SVLJ*XV[OO,H'0$]:B\5LJ>$-99B
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MW.GF+$QC#J,LI;H",]_<=017*Z5JE_=VWAR_CNII+R^N'AU*V9R50!'+_)_
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MS:R5[B%CQ"X(^=F9SY9Y(*X XX'!H Z^BDZTM !1110 4444 %%%% !1110
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M21QRH4D174]589%1K96J'*6T*DC&1&!Q27IO/LQ%CY7GEE ,P)51N&XD @G
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^1:O_P#KB:U:RO$__(M7_P#UQ- &K1110 4444 %%%% !1110 4444 %%%%
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MWOXIWN$:0EE:,A2 <<@$DCIGCI4B>,V^R+J3Z7/_ &9)9-=K<(&RH #*K!E
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MUFLB^2\@Q\^,;@3@$@$ XY%6M5TB/5C:&2YGA^R7"W">3M^9ESC.Y3QR>F*
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M3_\ (M7_ /UQ- &K1110 4444 %%%% !1110 4444 %%%% !1110 5E>(_\
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M<9649Y;)R6P"3SGI7,7EW91ZOKL^FZNS_P#%.K+%,MV9&4JTIRK$D^A_'WH
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M$IB\_9)'LP<DG 9ANS\P'?)SK>*))!K'A^W&H3VD-U=R0S>5+LWCR)"!GUW
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M* "BBB@ K*\3_P#(M7__ %Q-:M97B?\ Y%J__P"N)H U:*** "BBB@ HHHH
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M\._]![3/_ R/_&C_ (2GP[_T'M,_\#(_\:U:* ,K_A*?#O\ T'M,_P# R/\
MQH_X2GP[_P!![3/_  ,C_P :U:* ,K_A*?#O_0>TS_P,C_QH_P"$I\._]![3
M/_ R/_&M6B@#*_X2GP[_ -![3/\ P,C_ ,:/^$I\._\ 0>TS_P #(_\ &M6B
M@#*_X2GP[_T'M,_\#(_\:/\ A*?#O_0>TS_P,C_QK5HH RO^$I\._P#0>TS_
M ,#(_P#&C_A*?#O_ $'M,_\  R/_ !K5HH RO^$I\._]![3/_ R/_&C_ (2G
MP[_T'M,_\#(_\:U:* ,K_A*?#O\ T'M,_P# R/\ QH_X2GP[_P!![3/_  ,C
M_P :U:* ,K_A*?#O_0>TS_P,C_QH_P"$I\._]![3/_ R/_&M6B@#*_X2GP[_
M -![3/\ P,C_ ,:/^$I\._\ 0>TS_P #(_\ &M6B@#*_X2GP[_T'M,_\#(_\
M:/\ A*?#O_0>TS_P,C_QK5HH RO^$I\._P#0>TS_ ,#(_P#&C_A*?#O_ $'M
M,_\  R/_ !K5HH RO^$I\._]![3/_ R/_&C_ (2GP[_T'M,_\#(_\:U:* ,K
M_A*?#O\ T'M,_P# R/\ QH_X2GP[_P!![3/_  ,C_P :U:* ,K_A*?#O_0>T
MS_P,C_QH_P"$I\._]![3/_ R/_&M6B@#*_X2GP[_ -![3/\ P,C_ ,:SO$/B
M+0[G0+R"#6M/EE>(A$2Z1F8^@ /-=-10 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %5M0%T=-NA8D"[,+^03C ?!V]>.N*LT4 >8^+=:\2^&_$?AC28_$,\PU29
M8KJ1K: ?QHI*#9Q]X]<UVD#W6A?;[G6]9$^GKL>&>X6-#&.0RG8 #SC''?%<
M!\4IX?\ A8/@\^:N+:Z5YSG_ %2^;&<MZ< ]?2NJ^)MY90>!+F>ZTS^UH&:/
M;$'8+DG*L64YVCVZ].] &W8^(-+U>ZN=/L[QEO+=<RPO$T4L8/1MKJ#CD<X(
MY%<5X&^(T4FC7DOBK6$$T>HM;QR-#M"IM7;NV+A<G=R<=_2L[PG<O)\9);J:
M6>47FD+Y<LEJT(D/[O[JD A1M(&?3J>M8>E2Q1?"GQ+I4RG[??:@6M;4K^\G
M#&,*R+U895N1Z&@#OO%WB+5-+\:^%;.POL66J3%)X_+1@R@K@AL9&0W8^E='
M>^)M&TZ[>UN[Y(Y(MGF_*Q6'><+O8#"9/3<1FO,];MY-)UKX:V5](!/8JJW.
M6R(_]6.3Z<$9]JBMH[-/%OBWP[XJO+VSCU:Z\Z!8HP?M2;B5 .QCD#;@#W':
M@#V:N#\2^,KVW\;>']%TWY+2YO#'<SX!\TK@-&N>PW#)'?CL:ZN:TNAX;>ST
MV9K>Z%IY5O+/R8WVX4MC.2#C->1^(=)\7V'BKPC:W-SIC2Q2NMDUO$^R,Y3)
MDSR<\<_6@#UQM>TI-=30VO8QJ+Q>:MOSN*^OIV/'6M&N8EU30U^(\&F/I+MK
M#69=+[R!A8^?EW=?7VYQWKIZ .9\1+KEM!K&J0ZO+:VUI9-):P111-ND5&8E
MBRDXS@8XZ&L+P+J/B?Q/X5LM:?7)#<?;0L\!@A$<D(<!QP@(.W/.:ZGQC-%#
MX-U@RR*@:QF1=QQN8HV /4GTKF/@K(G_  @4=OO'G1W$A>//S+D\9% '47WB
M[0=-E>.[U!8Q'*(9)/+=HXY#R%9P-JGV)%6+_7],TVX2WNKG$LD9E"1QM(PC
M'5R%!PHS]X\5XOXNO8+[3?%]K8:=/8"*_226%87<SOOPTKN00@]%&.O>MOQ?
M&CKINOZ1K9TS6]/TB*1!,=B747S?(N>K9#?*0=V1]: .B\3^*-0M/%OA&+2[
M_P#XEVLO^]3RE(=,H002-PR']?2NOL]8L;^\N;2VE9YK1MDZ^4P"-Z$D8SSG
MZ<UY3XLN+N[U3X>NPBTN]\O<Z^7E;4MY8!*GH.#@'TQVKI?AKXBG<7OAG6BJ
MZQI\\@>0=+H;CEP>[9Z^V#ZX .IUZVUF\M1!H^I1:8Q!+W3PB9E] JD@<\Y)
MZ8Z<Y&'\,M9US6_#T\VMNEP\5T\4-TBA1.B\;@!@$9R,XYK1\1Z_X=LYX=$\
M02)'%J,; &=2(6 /0OT!_P ^E8?PT\//H-YX@%J[G1IKI?[/#,2" #N9?4<A
M0W?;0!WE5M1%VVF70L&"W9A<0,V,"3!V]>.N*QO$&D>*-0OTET3Q2NDVXB"M
M ;".?<^3EMS<C@@8]O>MRTCGBLX8[F?SYTC59)=H7S& Y; X&3SB@#SGQ5K/
MB3P]XI\,:/%XAGF35)ECNI&MH >7524^3C[QZYKK?MDWAF.^N_$&L--IP=/(
MN)85!CSP5;RU ZXYQW KAOB9<0CXD^#V\U<6UTC3G/$0\U#EO3@'K72_%>1&
M^&>I[7#>:(A'@YW_ +Q3QZ\ G\* -JU\7^'KV[DM;;5K>26*V%W(,D!(B =Q
M)X'# ]<C-.LO%.BW^HII]O>_Z5+%YT4<D3QF5/[R;@ P]QFN;MHM(M/A%#>M
MI4=\BZ,B31PC#R?*-Z%AR/FR3Z')ZBN+T:]\_P =>![_ &RI;_9'A1!;.D</
MRNHB0L,N!E06).2>O8 'IUSX\\+V;W4=QJT<<EFVV>,QOO0YQRN,U>F\1:3#
M:V=R;P21WW_'J(4:5IN,_*J@D\<GCBO)C+ -7^)C,Z?OK9EB)_C/(POKR0..
M^*E&G6NJ_#[PF$UD:1JUG#/)9W3R;(U967<CM_"3E<'V/7.* .L^(/CW^QO!
MB:EH4Z//=RF*"4Q$A<$AS@C&01C!_6M;3=3_ +'@+:OKS:@M],S:>OV0B?RP
M,E=B+EL=2=O%><>,-2O]6^"FF3:E L5]<7V_8B;3,,R9DVCUSDGISGN*V?&.
MH?V7\3M$U^YO9H-&FL3 E];JKK&Q+'NK#G*\XZ?2@#NKGQ;H%G86E_/J<2VE
MZ<6\P!9'/ID#@^Q]#Z&I]+\0:3K5Q=P:;?174EDX2<1Y(0G..>AZ'IZ5Y3X_
MTS2M-^'FDV&E27,MI)JPFC-Q]YD*ON91@$+D]<#KGH17K]G;64,?FV,,"),J
MG?"H < 84Y'7CI[4 <;KWC)++X@1>']0U-]'L3:"5+A54>=*6P 68$*H /IR
M.3VK:@U.70;.^O/$.J++8K.IMKOR@!Y11<;M@QG=GG@'(Z9Q63XF@\+^)M4N
M]"\2Q) ]JJ-:W;-Y9PRY(60\;@1G:>H(X.*S/AUX>G&E>(]!NKI[_P /O+Y%
MC,W212&WE/;E>1QD$B@#N(O$&ES6]C<17#/%J#;+5UB<B4X)XXXX!//8$]!6
M?-X^\*V\=Q)-K,,8M91#,KJP9'.<+MQG/RGMQCFN;^%MGJL$-SI6JIF+P]<R
MVUNY_P"6C-@Y_!2<>TGM5+X=VVGWWCGQN;F&"X\V]S$)5#!T\R0DJ#U&=G(]
MJ .HT[69I?'&L0/KL$]G;VRLNG);L)H"-NYB=N2#GC!.=PQ[SK\0_"3I"ZZY
M;E9Y/*1L-C=Z$X^7ZG Z^E<IHUU;Q_''Q1.\R+$;!0')PI*I%N&?;:<_0UP'
MRCX'_9@!]H.M;O+Q\^/+ZXZX]Z /?=0U_3-+NH;2[N<7,ZEHX(XVDD91R3M4
M$XX/.*AMO%>@WFF3ZG!JD#65N,RSDD(OXG\JXKQ!>Z9I7Q-TW6H]5LTN)=+.
MY+V4Q0F,DA660!N2<\8Z G([X.LZ"=/^#T,6AZG'K*V^IK=WDEFP9 ,'*@#/
M .P\_7% 'KFG:S8:JTR6<Y:2W($L3QM&\>1D95@",CD<<UQOQ8\1:SX8T_3[
MS2-0:W:>X\F1#%&ZD8)S\RDYX]:T/"']AZKJUSXCTK4+Z_GO+=$N)9E547&-
MJD!5&\8[9QWZC/-_':1'T;2K=6#2B\WF->6"[2,XZXH T_$_B36O!_BW0;1=
M0;5+/5I3%)!/%&)(_F4;E**O]_H1V/X=AJ6OZ7I$BQ7MULD:-I?+1&D8(OWG
M(4$A1ZGBO,-6B_X0;XAV?B@!M5T+41Y8F<FX:T)Z[&.2,<D8/(W#M4NLWT%A
M\5KB]U34)K71]9TU8+:]@571AA<IDJP )#=.>10!Z'>^+= TY[1;O4X8OMJ;
M[=SG9*OJK8P>H[]Q44?B73=;TC4I-%U(--:1N'*IAX7 .,JX]NXQP:\[\46F
MGZ%J_P .[>W-P+"VN92ANE)?9YD9R1C..XXR!C-6M(=+WX@^-=?LI5;1SI_D
M_:%/[N24(F<'H<;7Z>OO0!T7@'Q;-J'@.#6?$-\AE>=XO,*!=QW850JCDGH
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ML=Q[JPYRO..A]C6=XXTW2])\(^'+'2GN'LAJGFQ_:?O%#DLP&!\N3W Z^AH
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MK&\98R$E21D$8^Z*ZH=*6B@ HHHH 2COFEHH **** $ZTM%% !1110 4444
M%)BEHH **** "BBB@!.^:6BB@ I,4M% !2>]+10 4444 %)UI:* "BBB@ I*
M6B@ I" 000"#2T4 %%%% "8%  '0 ?2EHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7_G\U/\ \&,W_P 50!JT5AW&E:=:R0I/J&I1F=]D9;4)\%NPSNP">V>M3_\
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M .*H U:*YO0=(COO#VFWEQ?:D\UQ:122,+^899D!)P&P.35__A'K7_G\U/\
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M5DEEC\Q7V*&7<G!.=H )/2K_ (GL[VXG\<7T 9[(7U@69>58(!O/_ <J3_\
M6KT\>)/#*[MNMZ4-YRV+J/YOKS21^(?"\,/DQ:SI,<0R-BW,07\LT <OX?N8
MK'Q?XON[J]AM+>\OH+>SFE(VF<1-D#/!."/Y5H?#>VOK'3M5LKSRI1!J<P2[
MB3;]JS@LY'KDD<>F.U:K:WX2:V%JVJ:,8!TB-Q%L'X9Q4R^)_#:($37=+55&
M !=Q@ ?G0!PLEMJ>K^$OB#%;AWU&359HE4?>:)!'M4?5 0!WS2Z]=V=Y\"K2
MUM<2S7%K;6L,"<NTRL@* ==P*G/T-==#JWA:VU2XU"#7].C>Z51.@O(]LA48
M5NO# <9[C&>@J5=<\)I<FY75=&6=NLHN(@Q_'.: . O;K4;'4M0TS4-=N[5[
M+PQ'.%CNV0?:54 L.>>1T'!JPES<7_BCP)>:U/-#)<Z;*TA\]H@TFP8/!&"<
MC('7./:MX+X9;QA<>()_$NDS+/;+;FV>6(@!2&!R6ZY'I6Z_B3PS(5+ZWI3%
M#E2UU&<'VYH \]T37M8NH]'M9-0N7L[G7;JWN;CSFW;5 ,<>_.0#ST.3BDBU
M[6KO1O"YFU&[B^TZZUIYR2E6N+?<0"?[WIGV]Z[\ZYX2,+0G5=&,3_>3[1%M
M;ZC-.;7_  JX0-J^D,(QA ;F+Y?ISQ0!P::C<WWPD\3FZO9;AK&]GC@FED+.
M CJR?,>20<8->G:?)-+IUM)<KMG>%&D&,88@9_6L*]O_  C?0I;RZUI2VPD6
M22%+J(+*5(*AN>0" <=\#MD'0_X2GP[_ -![3/\ P,C_ ,: -6LK6/\ D(:)
M_P!?Y_\ 1$U'_"4^'?\ H/:9_P"!D?\ C6;JOB/0I;[2&CUK3W6.]+.5ND(5
M?)E&3SP,D#\10!T]%97_  E/AW_H/:9_X&1_XT?\)3X=_P"@]IG_ (&1_P"-
M ''^*(+VWUC4]8\.>+6_M.U,;3:,[*\<F% ";.N6'0\Y)ZCMSOBJTOG/CBT:
M-OMM[=Z<UL@/+@G"[?7&"/P->F_V_P"%3<_:3J^C^>!CS?M,6['IG.:5O$7A
M=YDF?6=):6/(1S=1%ESUP<\4 >8>);*_/_"8V/S&^N]4L3; =7#?<*^O0_D?
M2NJ\63-J.L:%?:->V=\FGZLL,U@%#$2$D,V0<AE&X]./O=JZ5O$7A=YEG;6=
M):5 0KFZBW*#UP<\4U->\*13O/'J^CI+)]^1;F(,WU.>: ,SXAR2BST.%2?(
MN-=M([D=C'N)P?;<%K-ACEL/CA<W.H?+!?Z8(["1_NDJ4+(#ZY#''O[UT.I:
MQX4U:PDLKO6]->*3&<7D8*D'(8'/!! (/J*>VO>&9[58+O7-)N@ -WFW$1W$
M=R,XS0!Y[JSWH\2^/->TN>6&T@T](A<0N5#7"JG0CJ5PP/U]ZM6.I:A-J)L[
M75+R^M[OPO\ :KG-RSF*XP0&4@_(3Z#'TKJ]=OO#.L>';K18O$6E6D5S$8MR
M7$9"*>N!N%3:/JOAG2=-@M$U[2&>*)(WE6XC0R;1@$_-UP/6@#A-#OVLM"\
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MSR0"<?7/7& #I**RO^$I\._]![3/_ R/_&C_ (2GP[_T'M,_\#(_\: &Q?\
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MPM=1+'=ZQH]P!SB2XB89]<$UE>*Y?#7B?PU-H?\ PDVF6<4Q3+I<1MM"L&
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M0"HX!^8X]Z@N?%:0>%KO6X[-I7LFDCGM_, *.C%7&[T!'7'(QQ5>;2KFVO\
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M!/L\J1#D.&Q@CVYSGTYKA=!M;O2-$T_Q)YD85+>XB:VFW O%).9(MF 26QM
M7'.0.*V/"VGW%CI>DZ=?[4DL+9KFX7/$;R%@JY] ID'X"@#:T_7M-U.[FM+2
MX9IX5#O&\3QDJ>C+N W*<?>&1[T^RUG3]0E\JUN/,8H9%RC*)$!QN4D89<XY
M&1R/45S>HQZA<:[J/V.:WO%O]%E%O)$N'MRIPB[@2"'+DYXR4/856M+B)9O!
M]Q"<0V.DS2W.T<QQ")%P1V^8#CU4^E '2ZCXGTC2O,^VW+1^4Q5]L+R;< $D
M[0<*-P^8\5<FU*S@M([I[A/)FV^4R_-YA;[H4#EB>P%8MW>6VEZ0EE=7-I;:
MCJ$;EO/D50I8DNQR>54N<#OTK*%C&_B/2;2QU-[?3[/16&G7$>QP7#!&8%@5
M)"!?P)[$T =NCB1 ZA@",C<I4_D>13JR_#-]>:EX:T^]OXPES/ KR!1@$^H'
M8'K^-:E !1110 5E>&O^0(G_ %VF_P#1KUJUE>&O^0(G_7:;_P!&O0!JT444
M %5[R_MK!$:YD*^8X2-54LSMR<!0"2< G@= 3VJQ7.:XCKXP\-7#9%NKW,9/
M82-'\GZ!Q^- &H=:T\6T%PLY=+@D1".-G=R,Y 4 MD8.1CC'-21ZG9S:<FH1
M3"2W?&QE!.XDX QUSGC'7/%<7I=E<1A_$D=Q!%!::G?R(MPQ6.6WD< L" <?
M,FX'!SGWK0\+V=VMC:6][&8I+J[N-3E@(QY:M(61".QRZMCU4B@#>M=?TR\U
M)].@N";E4,@1HG4.H."R,0 X!(Y4FGV^LZ?=77V:&XW2$N%^1@KE#A@K$88@
M\'!..?2L:X:XD\9:;<VUQ:W=K-;3Q($3+6PP"7# D$%E53QQQCO6#I8=-"\$
MV^?+N;.YD>ZR>8UCBE68MZ?,P!]R* .SU#Q!INF"3[7,Z^6VUA'"\C9VACPH
M)P 02<8&14=SXHT:TL[6\DO0T%XNZ!H8WE\Q>,D!03CD?G58ZG;:/I<-S>20
M0WM^S/&MQ($.YOFVDGH%&T$^BCJ<"FV3V6A>#0^F317JVL+)%)&05FER1@$<
M<R'&!T)Q0!KZ;J5IJUBE[8R&2!RP5BC)RI*GA@#P015JJFEV(TW2[:R#;S#&
M%9SU=N['W)R?QJW0 4444 96J_\ (7T3_KZD_P#1$E:M96J_\A?1/^OJ3_T1
M)6K0 4444 ,DDCAB>65U2-%+,S' 4#J2:I0ZYIL\$TZW(1+>,2RF5&C*H02&
MPP!VG!YZ<'TJAX[@N+GP/J\-LK/(ULWRIU91RP'U7(K'UG3/^$F\27-M97(C
M@DT15,Z#<JNTP>+([\(QQZ'WH ZRSU.TOY98H)&\V':9(Y(VC=0>AVL <'!Y
MZ<'TJI<>)](M'B6XN6C$SA%?R7* EMHW.!M7)'!8C/:N?MYM2N-?U+6"($\J
MRCTV)X&+1RW!D/() R%+ 'TRPYP:N^+8F@\,/;:9-:LVGB*0V<J[S<!""D?!
M!!8J /4X% &W>:SI]A/Y-S<;'"!VPC,(U)P&8@84$YY.!P?0U+>:A:V"AKF4
M1@AFSC. !DG^0^I [UQVK9@F\<_:AS<Z?$8%/)=#"R!5]?WFX8'=AZULZ<Z6
MUL;O5I41--M(H)))3PKA5>1L_79^*T 7;/Q)I%]:75U#> 1V9Q<"6-HVBXS\
MRL PXZ<<]JMVNH6UY))%"[>9$ 7C>-D90<X.& .#@\^Q]*Y*]GT>[TGQ#J4D
ML-V][;H)8+><;HXERJ%F7.TY9F)[>^VKWA6&_L=6U*PU647UVD4#KJ(&#-$=
MX167HK*0_3KNSW- '44444 %96K_ /(3T+_K_;_TFGK5K*U?_D)Z%_U_M_Z3
M3T :M%%% !1110 4444 %%%% !1110 4444 %%%% !61XGD2+2$ED=4C2]M&
M9F. H%Q&22>PK7K*\1\Z9$#T-]9C_P F8Z '_P#"1Z%_T&M/_P# I/\ &C_A
M(]"_Z#6G_P#@4G^-7O)B_P">2?\ ?(KGGUN_35+/3FT*U2>]@EGC#W1&U4VY
M#?N^#\XX&>_- &G_ ,)'H7_0:T__ ,"D_P :/^$CT+_H-:?_ .!2?XU+!/;O
M';K<1PV]S/&'^SNR[U.,D>^.1^%2AK-I#&# 7&<J",C&,\?B/SH J_\ "1Z%
M_P!!K3__  *3_&C_ (2/0O\ H-:?_P"!2?XU:B:SFC,D1@D09RRD$#\:K7&I
MZ1:Q02RW%L$N)1%$0RD.Q[#Z<Y^E "?\)'H7_0:T_P#\"D_QH_X2/0O^@UI_
M_@4G^-0^(M230=(;45LH[A4DC0INV??=4!!P>[#\*FBFF2X9+ZRM((A'N\U)
M]X!R!@Y5<9SQ]#0 ?\)'H7_0:T__ ,"D_P :/^$CT+_H-:?_ .!2?XU;0VDC
M;8S"YQG"X/'K34EL9(_-CDMW3=LW*5(W9QC/KGM0!6_X2/0O^@UI_P#X%)_C
M1_PD>A?]!K3_ /P*3_&K/FV($1\RW_?'$?*_/]/6HTDC66Z^T1VL4,+#:_F
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MC0Z#9QRZM8HZQ@%6N4!'X9K?\F+_ )Y)_P!\BLWPY%&?#]D3&I)CZE: )/\
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MG_\ @4G^-'_"1Z%_T&M/_P# I/\ &KWDQ?\ /)/^^11Y,7_/)/\ OD4 4?\
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M.W$ %OM,>2!T[^Y_.K_DQ?\ /)/^^16;<WS1Z_:Z5!8P2>= \[RO)LV*K(I
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M_GDG_?(H Y_4M>T9]4T=TU:Q98[ER["X0A1Y,@R>>.2!^-:7_"1Z%_T&M/\
M_ I/\:AU2*,:MHH$:X-T^>.O[B2M3R8O^>2?]\B@"C_PD>A?]!K3_P#P*3_&
MC_A(]"_Z#6G_ /@4G^-7O)B_YY)_WR*/)B_YY)_WR* */_"1Z%_T&M/_ / I
M/\:A35_#,<+0IJ.E+$Y)9%FC"L3ZC/-:GDQ?\\D_[Y%'DQ?\\D_[Y% &<->\
M/!40:MIH5,;1]HCPN.F.>*8=6\,-="Z.HZ2;@# E,T>\#TSG-2:U>KI5G%-%
M9Q3O-<Q6ZHS;!F1P@).#TSGI6?K'B>ST.]M+.\LAYTX#/L(*@%6^Z3C/S*J\
M[1\X.>#@ O2:WX<EDCDEU32W>(Y1FN(R4/L<\4/K7AN2)HI-3TMXV.61IXR"
M<YR1GUJGJWB?3](U>WTZ:T)>;'/RC.0=N.W48Y(Z]ZN+?,/$8TF6Q@5'MGN(
MYEDW$A65<%=HQ][U/2@!L.K^&+<,(-1TJ(/]X)-&N[ZX-.@UOPY;1^7;ZII<
M29SMCN(U'Y UI>3%_P \D_[Y%'DQ?\\D_P"^10!1_P"$CT+_ *#6G_\ @4G^
M-'_"1Z%_T&M/_P# I/\ &KWDQ?\ /)/^^11Y,7_/)/\ OD4 4?\ A(]"_P"@
MUI__ (%)_C5&]U73;_5]$BL]0M;F1;UV*PS*Y ^SS#. >G(_.MSR8O\ GDG_
M 'R*S-5C1-3T,JBJ3?,.!C_EVFH UZ*** "BBB@ HHHH **** "BBB@ HHHH
M **** "LKQ'_ ,@R'_K_ +/_ -*8ZU:RO$?_ "#(?^O^S_\ 2F.@#5KG-0CF
M;Q_H]PMM.T$-I<QR3+$Q16<QE03C'\)KHZQ_^$JT?_2CYT^VSD,=P_V2;;$P
M )#-MP, @_0T <]X@M[^?69C!I-SB'4;&<20QAA<1HR%V+$\;1N7:,'@DY!X
M@DTB%?#WBEVTZ6WN9KJ;R'%N%D='V[53.,AF&"H//U(KO(9XKF!)X)4EBD4,
MCHP*L#T((ZBH;^RL]3MGL;V-98Y,,4)P>""",<@@X.1T- '#S0R7JZM>VEA=
M+JMRUM-):O:- 98873>J,_#%@.?JH([FS<:<LT5MJ=EHVH*'U6&YN([A?WKX
M0HS>7GC^$'IG!/N>ML=+M=.#>0)69A@O-.\SX]-SDG'MG%7* .;\>P3WGA*:
MVM[6>>66: B.%"S865&;ITP%-*/[/@:^:'3-2NX[BV_TA9HIF#A<A442#))W
MG@<<$G'?HZ* . M])U6PT#6-"AM))KE(XVMKD!@MQ" /W&]NA504&>""#U+4
MFH:=!J%D+Z'0M25Y]1LI9UNH27(CD&\[!G&$R,_Q=.<"O0** ..GLOLFN7]C
M-H$EY87L<'V/R(P(HMG)1NGE@/\ /GW/<8J&;3)'U#Q$%AO;1+C4;>:"XMK<
ML0RQI^\"D8<!U.1WZ^AKMZ* . \C55:SDU?29[BTE@N;:5=/AQAFER)&C/*B
M1>3Z'KBNFL+'4K);18[N*#3H(%3[&]NTLR@+C'F[^3_P$_CUK9HH \P&BW4_
M@LVT&GZF-:2^EGMHY%D6%&,[,C,'_=XVD$\$_C71ZKI5ROB*+[.D9BUR 6^I
M <<1\[P.O*%X_P#@2>E=95.#2K*VU&?4(H,75P ))"Q8D#' R<*.!P,9P* +
M8 4    < "EHHH *S/#?_(O67_7(5IUF>&_^1>LO^N0H TZ*** "BBB@ JEK
M/_(#O_\ KVD_]!-7:9+$D\+PRKN212K*>X/!% &3IVGVFI^$K"UO8%FBDL40
M@\$!H]IP1R#@D9'/-7;C2-/NH!!+:1E Q8;1M();<2".1DC)]>]265C!I]LM
MM;!Q$G"J\K/M&,8!8D@<=*L4 <_XCBC@CT:*&-8T75(<*B@ ?>[5T%5+K3+6
M\N()[A'=[=@\8\U@H8=#M!P3SU(JW0 4444 %%%% !65K'_(0T3_ *_S_P"B
M)JU:RM8_Y"&B?]?Y_P#1$U &K1110 4444 %%%% &%'_ ,C]<?\ 8+B_]&R5
MHP:3I]K=/<P6D:2MCY@.F 1P.B]3G&,]Z633+2745U!D<7*H$WI*RY4$D @'
M!&2>N:MT 4[72=/LIY)[:TCBDD.25'3Y57"C^$81>!CI69X2_P"/74_^PM=_
M^C36[(@EC:-BP#@@E6*GGT(Y'U%06.GVNFP-#:1E$9VD;<[,69CDDDDDDF@"
MS1110 4444 %%%% &5X6_P"12T?_ *\(/_1:UJUE>%O^12T?_KP@_P#1:UJT
M %%%% !1110!B>,O^14O?HG_ *&M:-YIME?LC75NDC1LK*QX(P00,CJ,@<=#
M3[RSM]0M)+6ZC\R&089<D9[]1S3X85MX5B0N57H7=G;\2Q)- %:XT?3KKR?.
MLXF\C 0!<8 ! 7CJN&/RGCGI6=J:JGBS0%4!5"7(  P -BUO54;3+5]134'1
MVN(P0C-*Q5 1@X7.T9QV% %NBBB@ HHHH **** ,B+_D<+K_ +!\/_HR6M>L
MB+_D<+K_ +!\/_HR6M>@ HHHH **** "L*Q_Y'C6?^O&S_\ 0IZW:J?V9:_V
MD=1".MRR*C,LK .JYP&4'!QN;&1WH ;;:/IUG+++;V<4;2GYL+P/E5, ?PC:
MBC P.*=::78V$DDEK:QQ/(<D@=.%&!Z#"KP..*MTR6)9HFB<N%88)1RI_ @@
MC\* ,7P;_P BZ/\ K[N__2B2MVJ]E8VVG6JVMI'Y<2EF"EBQRQ+$DG))))/X
MU8H **** "BBB@ K*\-?\@1/^NTW_HUZU:RO#7_($3_KM-_Z->@#5HHHH **
M** "L*;_ )'ZR_[!=Q_Z-AK=JI/IEK<WL-[(CBX@4JDB2LAVD@D'!&02HX.1
MQ0 D.DZ?;WC7<5I&DS #<!TQNZ#H#\[9(ZYYHM])T^TN7N+>TCCE?'('W>,?
M*.B\#MC-7*:Z"1&0D@,,':2#^!'(H Q/"_\ S&/^PI/_ .RUNU6L=/MM.B>*
MU1E620R.6=G+,>I)8DDU9H **** "BBB@#*U7_D+Z)_U]2?^B)*U:RM5_P"0
MOHG_ %]2?^B)*U: "BBB@ HHHH PO%O_ !XV'_84L_\ T>E:-WI-A?31S75K
M'*\9R"PZ_*RX/]X8D<8.1\QI]]86VHVX@NHRZ!UD&'*D,IRI!!!!! -31QB*
M-8U+$*  68L?Q)Y/U- %:XTC3[NX2>>TBDD3H2.O!7D=&X)ZYQ6=+_R/UK_V
M"YO_ $;%6[51-,M8]1;4 CFY9#'O>5FPI() !. ,@=!VH MT444 %%%% !65
MJ_\ R$]"_P"O]O\ TFGK5K*U?_D)Z%_U_M_Z33T :M%%% !1110 4444 %%%
M% !1110 4444 %%%% !65XC_ .09#_U_V?\ Z4QUJUD>*)8X-'2:5UCCCO;1
MG=S@*HN(R23V % &O7(>&M0LK&Y\5S7=U##$FKN7:1P !Y,7^%;7_"4^'?\
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M3/\ P,C_ ,:/^$I\._\ 0>TS_P #(_\ &@#5HK*_X2GP[_T'M,_\#(_\:/\
MA*?#O_0>TS_P,C_QH U:*RO^$I\._P#0>TS_ ,#(_P#&C_A*?#O_ $'M,_\
M R/_ !H U:*RO^$I\._]![3/_ R/_&C_ (2GP[_T'M,_\#(_\: &Q?\ (X77
M_8/A_P#1DM:]<O'XCT(>*KF<ZUI_E&QA02?:DVE@\A(SGK@C\ZT_^$I\._\
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MO^$I\._]![3/_ R/_&C_ (2GP[_T'M,_\#(_\: -6BLK_A*?#O\ T'M,_P#
MR/\ QH_X2GP[_P!![3/_  ,C_P : -6BLK_A*?#O_0>TS_P,C_QH_P"$I\._
M]![3/_ R/_&@#5HK*_X2GP[_ -![3/\ P,C_ ,:/^$I\._\ 0>TS_P #(_\
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MHH ;L3^Z/RHV)_='Y4ZB@!NQ/[H_*LWPZH;P_9%@"3'R36I69X;_ .1>LO\
MKD* -'8G]T?E1L3^Z/RIU% #=B?W1^5&Q/[H_*G44 -V)_='Y4;$_NC\J=10
M W8G]T?E1L3^Z/RIU% #=B?W1^5&Q/[H_*G44 -V)_='Y4;$_NC\J=10 W8G
M]T?E1L3^Z/RIU% #=B?W1^5&Q/[H_*G44 -V)_='Y4;$_NC\J=10 W8G]T?E
M1L3^Z/RIU% #=B?W1^5&Q/[H_*G44 -V)_='Y4;$_NC\J=10 W8G]T?E1L3^
MZ/RIU% #=B?W1^5&Q/[H_*G44 -V)_='Y4;$_NC\J=10 W8G]T?E1L3^Z/RI
MU% #=B?W1^5&Q/[H_*G44 -V)_='Y4;$_NC\J=10 W8G]T?E1L3^Z/RIU% #
M=B?W1^5&Q/[H_*G44 -V)_='Y4;$_NC\J=10 W8G]T?E1L3^Z/RIU% #=B?W
M1^50WLJ6EC/<^4'\F)I-O3.!G&:L52UG_D!W_P#U[2?^@F@#'O?%']F^&H-7
MO-/C5KE T4<<V]<E-RAF*@\].%/Y=':CXNL+'1[74Q;EXKML19*XX/?!)Y&2
M, ].<5:TW3[34O"FGV]Y LL;V4:D'@@&, X(Y'!(XJ]<Z787=N()K6,Q@Y 4
M;<$G<<$<C)&3ZT 9MQKQCATNZ@L8Y+749HX@S3 .F_.#@!@1Q_>K;V)_='Y5
M@>)HHX8M&CB18T758,*HP!R>U=#0 W8G]T?E1L3^Z/RIU% #=B?W1^5&Q/[H
M_*G44 -V)_='Y4;$_NC\J=10 W8G]T?E1L3^Z/RIU% #=B?W1^5&Q/[H_*G4
M4 -V)_='Y4;$_NC\J=10 W8G]T?E1L3^Z/RIU% #=B?W1^5&Q/[H_*G44 -V
M)_='Y4;$_NC\J=10 W8G]T?E1L3^Z/RIU% #=B?W1^5&Q/[H_*G44 -V)_='
MY4;$_NC\J=10 W8G]T?E1L3^Z/RIU% #=B?W1^5&Q/[H_*G44 -V)_='Y4;$
M_NC\J=10 W8G]T?E1L3^Z/RIU% #=B?W1^5&Q/[H_*G44 -V)_='Y4;$_NC\
MJ=10 W8G]T?E1L3^Z/RIU% #=B?W1^5&Q/[H_*G44 -V)_='Y4;$_NC\J=10
M W8G]T?E1L3^Z/RIU% #=B?W1^59FK +J6A[>,WS X[_ .CS5JUE:O\ \A/0
MO^O]O_2:>@#5HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q_%#F/1ED6
M-I2E[:,$3&YL7$? R0,_C6Q65XC_ .09#_U_V?\ Z4QT -_MRY_Z%_5/RA_^
M.4?VY<_]"_JGY0__ !RM>N:LM1U5M)U2_25[N>*]GA@MC$NT*DQ50-H#=!C)
M)]: +W]N7/\ T+^J?E#_ /'*/[<N?^A?U3\H?_CE96D:]K=UX7DO6M//NT9!
M$GEG]\"1D[EX[GD#"XYJ"WUK6+OX=76KO<R6UW;633Q2I$F)L0[@QW J0QY^
M4#'3L: -S^W+G_H7]4_*'_XY1_;ES_T+^J?E#_\ '*N3)=76G(+:Y^SS/L)E
M"!B!D%L C&2,CIWK!T*YU6^GU.2759733M2>W\LPQD21*JGG:H.[YCT]!Q0!
M>N=3DN[66VG\.ZHT4R%'7]T,@C!Y$F13;.__ +/M([6T\-:G%#&,*BB+CN?^
M6G))YSWI;/Q;IM_;17%K'>2)<,JP$VS*)F(8X4M@<!&)YX[TO_"6Z64LS%]I
MF:^CDD@2*V=F;8<,.G!!XQ0!)_;ES_T+^J?E#_\ '*/[<N?^A?U3\H?_ (Y2
M+XGTV6S@NK<RW"3VYN56-,L(Q@%BIYX)QCK[5GW>LW$OB+4++[5-I]MIEO!<
M-,(E97!:0ONR"=I6, 8P<D^U &C_ &Y<_P#0OZI^4/\ \<K-LX+.PF$EMX6U
M:,!MRQ^8AC0]<K&9=JGZ 5<G\8:3:K<?:6GB>V:)9(S"Q8"1MJ-QG@GC/8\'
M!K6L[I;VU6X2*:(-GY)HS&XP2.5/(Z4 9_\ ;ES_ -"_JGY0_P#QRC^W+G_H
M7]4_*'_XY6O10!D?VY<_]"_JGY0__'*/[<N?^A?U3\H?_CE:]% &1_;ES_T+
M^J?E#_\ '*/[<N?^A?U3\H?_ (Y6O10!D?VY<_\ 0OZI^4/_ ,<K/T#6+B+0
MK1!H>I2 1CYD$6#],R5T]9GAO_D7K+_KD* (_P"W+G_H7]4_*'_XY1_;ES_T
M+^J?E#_\<K7HH R/[<N?^A?U3\H?_CE']N7/_0OZI^4/_P <K7HH R/[<N?^
MA?U3\H?_ (Y1_;ES_P!"_JGY0_\ QRM>B@#(_MRY_P"A?U3\H?\ XY1_;ES_
M -"_JGY0_P#QRL@SZU-X/N[K3I99KY[BY7)^8A%DD4!1G@@ 8P#SC@U-JDGB
MD:18FU5!=F8"XPF5QYJ[<8.=N.O'W=V=IH T?[<N?^A?U3\H?_CE']N7/_0O
MZI^4/_QRHGFNXM>T=))95-S;RFXB+?*654[#(!!)Z5N4 9']N7/_ $+^J?E#
M_P#'*/[<N?\ H7]4_*'_ ..5KT4 9']N7/\ T+^J?E#_ /'*/[<N?^A?U3\H
M?_CE:]% &1_;ES_T+^J?E#_\<J.7Q&\+Q)+H>IJTS[(P5B^9MI;'^L]%)_"M
MNLK6/^0AHG_7^?\ T1-0 W^W+G_H7]4_*'_XY1_;ES_T+^J?E#_\<K7HH R/
M[<N?^A?U3\H?_CE']N7/_0OZI^4/_P <K7HH R/[<N?^A?U3\H?_ (Y1_;ES
M_P!"_JGY0_\ QRM>B@#(_MRY_P"A?U3\H?\ XY1_;ES_ -"_JGY0_P#QRDU:
M67^V](M5FDCBG>7S C;=VU,CGZU5LI/$1\57*W*C^S=H\O" 8&Z3;SG&>!G'
M.-G YH M_P!N7/\ T+^J?E#_ /'*/[<N?^A?U3\H?_CE4M 'B"XFOH];W)$6
M'EM&-A!VKG!!Z?3(SNYZ5?\ "]S->^%M+NKF0RS36D;R.>K,5!)H ;_;ES_T
M+^J?E#_\<H_MRY_Z%_5/RA_^.5KT4 9']N7/_0OZI^4/_P <H_MRY_Z%_5/R
MA_\ CE:]% &1_;ES_P!"_JGY0_\ QRC^W+G_ *%_5/RA_P#CE:]% &);^(WN
M[:*YM]#U.2&9 \;A8L,I&0?]9Z5)_;ES_P!"_JGY0_\ QRG>%O\ D4M'_P"O
M"#_T6M:M &1_;ES_ -"_JGY0_P#QRC^W+G_H7]4_*'_XY6O10!D?VY<_]"_J
MGY0__'*/[<N?^A?U3\H?_CE:]% &1_;ES_T+^J?E#_\ '*/[<N?^A?U3\H?_
M (Y6E=,R6DSJ<,L;$'T.*Y667Q WA71KC2I&FGN$@DN7ERY)8QGUR!DG.!C;
MNZ<4 ;']N7/_ $+^J?E#_P#'*/[<N?\ H7]4_*'_ ..5GZK+XG%UI?V)/W95
M?M(**3OV/N!(.,=.N!NV<GD5>@FF3QA=6GG2- ;&.81LV0KF1P2/3@#B@!W]
MN7/_ $+^J?E#_P#'*/[<N?\ H7]4_*'_ ..5KT4 9']N7/\ T+^J?E#_ /'*
M;+J\LT3Q2>'=49'4JRD0\@]1_K*V:* ,&SOVL+9;>W\/:NL2<*K/&^T8Q@;I
M3@<=*G_MRY_Z%_5/RA_^.5KT4 <U<:E;WVHQI/H&JR7-J%G2,L@"\D*^WS-I
M.0>>M7O[<N?^A?U3\H?_ (Y1%_R.%U_V#X?_ $9+6O0!D?VY<_\ 0OZI^4/_
M ,<H_MRY_P"A?U3\H?\ XY6O10!D?VY<_P#0OZI^4/\ \<H_MRY_Z%_5/RA_
M^.5KT4 9']N7/_0OZI^4/_QRC^W+G_H7]4_*'_XY6O6/?RRMXHTNT$TB0O;7
M$KHC8W,C0A<_]]-Q[T +_;ES_P!"_JGY0_\ QRC^W+G_ *%_5/RA_P#CE4=-
MD\2G6+\7B?Z*%;R,(!S_  =\=.N">>N*9I+:_+I6H?VT6C=-[1-'E"""V>^<
M=,=L8Y- &C_;ES_T+^J?E#_\<H_MRY_Z%_5/RA_^.59T.>6YT'3[B9R\LMK$
M[L?XF*@DU>H R/[<N?\ H7]4_*'_ ..4?VY<_P#0OZI^4/\ \<K7HH R/[<N
M?^A?U3\H?_CE']N7/_0OZI^4/_QRM>B@#(_MRY_Z%_5/RA_^.5'!XC>ZB\V#
M0]3DC)(#!8NH)!_Y:>H-;=97AK_D")_UVF_]&O0 W^W+G_H7]4_*'_XY1_;E
MS_T+^J?E#_\ '*UZ* ,C^W+G_H7]4_*'_P".4?VY<_\ 0OZI^4/_ ,<K7HH
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M_CE']N7/_0OZI^4/_P <K7HH R/[<N?^A?U3\H?_ (Y1_;ES_P!"_JGY0_\
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M?Q+I\ZV[BWM8Y@\I9<$L%P ,Y['M6M110 4444 %%%% !65K'_(0T3_K_/\
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M'1$(!/TR0/UI]% &7X9LKC3O#EC:72>7-%%AUR#@Y]1Q6I110 4444 %%%%
M&5JO_(7T3_KZD_\ 1$E:M96J_P#(7T3_ *^I/_1$E:M !1110 4444 9OB*S
MFU#PUJEE;*&GN;.:*-2<99D( S]35VV=Y+=&DA>%L<HY4D?]\DC]:EHH *R-
M,MKI=>U6]FMVABN!"L6]E);8&!/RDX'(ZUKT4 %%%% !1110 5E:O_R$]"_Z
M_P!O_2:>M6LK5_\ D)Z%_P!?[?\ I-/0!JT444 %%%% !1110 4444 %%%%
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M_P#QVC^V+S_H7=3_ .^K?_X[0!JUF>&_^1>LO^N0IO\ ;%Y_T+NI_P#?5O\
M_':S] U6ZCT*T1="U"4",8=&@P?IF0&@#I:*RO[8O/\ H7=3_P"^K?\ ^.T?
MVQ>?]"[J?_?5O_\ ': -6BLK^V+S_H7=3_[ZM_\ X[1_;%Y_T+NI_P#?5O\
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M8O/^A=U/_OJW_P#CM']L7G_0NZG_ -]6_P#\=H U:*RO[8O/^A=U/_OJW_\
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M#5HK*_MB\_Z%W4_^^K?_ ..T?VQ>?]"[J?\ WU;_ /QV@#5K*U?_ )">A?\
M7^W_ *33T?VQ>?\ 0NZG_P!]6_\ \=JE=7\]UK&B)+I5W9J+UVWSF(@G[/-P
M-CL<\^G:@#HJ*** "BBB@ HHHH **** "BBB@ HHHH **** "LKQ'_R#(?\
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M1LT+)(@5D;O[@CN.E7AH>JP:Q:ZO;SV;3_9VMKF$H4CVEMP*8R<J>.?O9[4
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M9TB>5AT1",G\R!^M9_ARRGT[PUIMC<J%FM[6..0 Y 8* >: -.BBB@ HHHH
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M7_/WIG_@-)_\<H\OQ%_S]Z9_X#2?_'*U:Y/2+.:XT;6'L"D.H2ZC=(MQD*P
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M1^6-H>W<G\</72UF>&_^1>LO^N0H ;Y?B+_G[TS_ ,!I/_CE'E^(O^?O3/\
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MG_QRM6B@#*\OQ%_S]Z9_X#2?_'*/+\1?\_>F?^ TG_QRM6B@#EXX]<_X2FY
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M.4:K_P A?1/^OJ3_ -$25JT 97E^(O\ G[TS_P !I/\ XY1Y?B+_ )^],_\
M :3_ ..5JT4 97E^(O\ G[TS_P !I/\ XY1Y?B+_ )^],_\  :3_ ..5JT4
M91C\0@9-YI@ _P"G:3_XY2!=?(!%[I9!X!^S2<_^1*;XO_Y$O7/^P=<?^BVJ
MGKOAJXU0V)L;L6<=OG*)N4<_Q84@9^@#<G##N 7MGB'./MFF9/;[-)_\<H5?
M$#9VWNEG'7%M)_\ '*IWOAV]N?$MKJB:@4AB0!H\OV*$C&[^+:<X(Z#(?I4F
MDQ1Q>*]=6-%0%;8D*,9.UN: +/E^(O\ G[TS_P !I/\ XY1Y?B+_ )^],_\
M :3_ ..5JT4 97E^(O\ G[TS_P !I/\ XY1Y?B+_ )^],_\  :3_ ..5JT4
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MJT5E;?$7_/73/^_<G_Q5&WQ%_P ]=,_[]R?_ !5 &K165M\1?\]=,_[]R?\
MQ5&WQ%_SUTS_ +]R?_%4 :M%96WQ%_SUTS_OW)_\51M\1?\ /73/^_<G_P 5
M0!JT5E;?$7_/73/^_<G_ ,51M\1?\]=,_P"_<G_Q5 &K165M\1?\]=,_[]R?
M_%4;?$7_ #UTS_OW)_\ %4 :M9GAO_D7K+_KD*;M\1?\]=,_[]R?_%5GZ NN
M_P!A6?DR:?Y?EC;OC?/\Z .EHK*V^(O^>NF?]^Y/_BJ-OB+_ )ZZ9_W[D_\
MBJ -6BLK;XB_YZZ9_P!^Y/\ XJC;XB_YZZ9_W[D_^*H U:*RMOB+_GKIG_?N
M3_XJC;XB_P">NF?]^Y/_ (J@#5HK'5]=<L$N-*;;PV$<X^OS4_'B$?\ +73/
M^_<G_P 50!JT5D;]>\SR_M&E;\9V['S^6ZG;?$7_ #UTS_OW)_\ %4 :M%96
MWQ%_SUTS_OW)_P#%4;?$7_/73/\ OW)_\50!JT5E;?$7_/73/^_<G_Q5&WQ%
M_P ]=,_[]R?_ !5 &K65K'_(0T3_ *_S_P"B)J-OB+_GKIG_ '[D_P#BJS=5
M77?MVD>9)I^[[:=FV-\;O)EZ\],9_2@#IZ*RMOB+_GKIG_?N3_XJC;XB_P">
MNF?]^Y/_ (J@#5HK*V^(O^>NF?\ ?N3_ .*HV^(O^>NF?]^Y/_BJ -6BLK;X
MB_YZZ9_W[D_^*HV^(O\ GKIG_?N3_P"*H U:*R'?7H\>9<:4F3@;D<9_\>IV
M/$/_ #UTS_OW)_\ %4 :M%9#'7T4L\^EJHZDI( /_'J5?^$@90RS:60>01')
MS_X]0!K45E;?$7_/73/^_<G_ ,51M\1?\]=,_P"_<G_Q5 &K165M\1?\]=,_
M[]R?_%4;?$7_ #UTS_OW)_\ %4 :M%96WQ%_SUTS_OW)_P#%4;?$7_/73/\
MOW)_\50 >%O^12T?_KP@_P#1:UJUS'AM==_X1C2O)DT_ROL4.S?&^[&P8S@]
M:TMOB+_GKIG_ '[D_P#BJ -6BLK;XB_YZZ9_W[D_^*HV^(O^>NF?]^Y/_BJ
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M\F._7.:T]OB+_GKIG_?N3_XJ@#5HK*V^(O\ GKIG_?N3_P"*HV^(O^>NF?\
M?N3_ .*H U:*RMOB+_GKIG_?N3_XJC;XB_YZZ9_W[D_^*H U:*RMOB+_ )ZZ
M9_W[D_\ BJ:[Z]&5#W&E*6.%!1QGZ?-0!KT5E8\0_P#/73/^_<G_ ,537;7H
MUW/<:4JCNR.!_P"A4 :]%9('B%@")M,(/0B.3_XJEV^(O^>NF?\ ?N3_ .*H
M U:*RMOB+_GKIG_?N3_XJC;XB_YZZ9_W[D_^*H U:*RMOB+_ )ZZ9_W[D_\
MBJ-OB+_GKIG_ '[D_P#BJ -6LKPU_P @1/\ KM-_Z->C;XB_YZZ9_P!^Y/\
MXJLWP^NN_P!D)Y,FG[/-EQOC?/\ K&SW]: .GHK*V^(O^>NF?]^Y/_BJ-OB+
M_GKIG_?N3_XJ@#5HK*V^(O\ GKIG_?N3_P"*HV^(O^>NF?\ ?N3_ .*H U:*
MRMOB+_GKIG_?N3_XJFN^O1 &2XTI 3@%D<9_\>H UZ*RL>(?^>NF?]^Y/_BJ
M:QU]%+-/I:J.I*2 #_QZ@#7HK)7_ (2!U#+-I;*>A"2$'_QZEV^(O^>NF?\
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MF6VG1Y #ER%0=22?S)/N:Z&L^?39I]<M=0:X016J2*L0B.XEP,DMN]O2M"@
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M4]S+<*!$59#(Y<@G<<XSCH*TZX":3^R=8,7B*S<PSZB)K37(#N S*&2&7'*
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M<<X':K=%% !1110 4444 %96L?\ (0T3_K_/_HB:M6LK6/\ D(:)_P!?Y_\
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MU)10 54M=-M;.YN+F%7\ZY*F5WD9R<9QU)P!D]*MT4 %%%% !1110 5E:O\
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M&AJ0"-5U(@_]/)_PH_L)<X_M74L_]?)_PH @?PK;.\K&]O,RV L&Y3_5#/\
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M7-K'JFK":U*^:KS,N-V<$9'.<&@#H**RO["'_04U/_P)/^%']A#_ *"FI_\
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MQGS).<8K5_L;2O\ H&6?_?A?\*JQ?\CA=?\ 8/A_]&2UKT 4O[&TK_H&6?\
MWX7_  H_L;2O^@99_P#?A?\ "KM% %+^QM*_Z!EG_P!^%_PH_L;2O^@99_\
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MU?\ &LE7L'U*PMQHUD8+^%I8Y1L9AM"G! 4@_>ZAB*U?[)TW_H'VO_?E?\*
M%_M/3_\ G^MO^_J_XT?VGI__ #_6W_?U?\:3^R=-_P"@?:_]^5_PH_LG3?\
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M7]E6L/VJ!)?+\M6V[@#C.!GKZ4 7O[3T_P#Y_K;_ +^K_C1_:>G_ //];?\
M?U?\:3^R=-_Z!]K_ -^5_P */[)TW_H'VO\ WY7_  H 7^T]/_Y_K;_OZO\
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M:_\ ?E?\*/[)TW_H'VO_ 'Y7_"@!?[3T_P#Y_K;_ +^K_C1_:>G_ //];?\
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M*_X5E^'=,T^31D9[&V9O-FY,2D_ZUO:@#5_M/3_^?ZV_[^K_ (T?VGI__/\
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M8/'O0!I?VGI__/\ 6W_?U?\ &C^T]/\ ^?ZV_P"_J_XTG]DZ;_T#[7_ORO\
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M &I;A]4\Z(Q13@2(J1\A5&&!*D=#FNH_X2*S_P"?;4__  67'_Q%'_"16?\
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MX_\ B*HZ+K$-EH]K;3VFI++&F& TZ<X/U"4 ='165_PD5G_S[:G_ ."RX_\
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MMJ?_ (++C_XBC_A(K/\ Y]M3_P#!9<?_ !% &K165_PD5G_S[:G_ ."RX_\
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M++C_ .(H_P"$BL_^?;4__!9<?_$4 :M8=_(D?C/2-[JNZSNU&XXR=\'%3_\
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M,L<ZH0\;<, 1QD?K5$^(;)@0;74B#U!TRX_^(H7Q!8HH5;34E [#3+@?^R4
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M;N-CMM1B5!"@GCG%<-IW@'Q!IFF>'I%6VFN]'N;DRVXN619HYNNUP,@CZ?\
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M89TW1+(R]"I!XSV(/O7)67@GQ! FOM.+1I-6T=;-=MRS;90A0DY4?+SGC@=
M* .NT_Q?H.J3/%::@K,EL+L[XWC!A/\ &"P *^I'3O61;^-CJ'C?3M+T]XYM
M,O;.2?S'MY(WRO0J6P"I]0/QK'M_ 6L231QW!@AB_P"$8_L9Y$D+$2YSNQCE
M?UJUH7A;Q!;:]X=O;R"RCATC338R;+@LSX& P&WO@<&@#4\8^(M3T/5- MK
MVWEZI>K:R>=$S% 2/F&&'KTHT'Q9<7GB#7]*U'[*8='V,;Z %(BI7<0V6."O
M.>>QZ8J/QOX;O_$.H:"]M;P36^GWJW%PLSX#H",J!@YX!Z\5F6O@35=.M-?\
M/6<T(T'5(G:UW.?,M)&'*XQRF??^M '5IXJT-[*YO#?JD%JB23-*C(55QE&P
MP!(;MCKT'--;Q;HB)?,]XR?V=&LEVC02!X5;H64KGWZ=.>E<C=>!M6U+P?\
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M@EL[JP^VK;W$T893"C;1N9"<J0YP0>@(-2WWB#4X9K-;2UM94OK^2TA:1V7
M5'.XX!XW1M^&#WX .DR,XSR*6N.O/$%WI;:_<?V79?:[**U,CI(?WV\$<G;G
MCG _6K,_BF\L!JZ7MG"9=/:W*M"Y*;)FVAF)&<+R2?0=J .HHKF!XINXY;R&
M6UBD,5]'96\T3$K,S('SCMM!((R>1C(K6TB[U"ZMIO[0LA;2Q3,B'/RS)P5<
M#)*YSC!Z$&@#1HKD[+Q5J4VGQ7EQ96R+=7DEE D4C.WF++(I)R!QMC)]2?3/
M#W\0:\ES8V3Z3;Q7%W<S0*\LI565(RZR!1D@''()SD$=\T =02!C)QFEKAWU
M236;OP[/=VD<%[::Y-:3!#N7<L$V=I/.TX4__JJ\_C"2SO76^@B, MKNX/D$
ML8Q PR-WW7)4YXQM(P: .JJ".RM(;A[B*UA2:3[\BQ@,WU/4UC7&N:C867VV
M\M(&@F6 0&*0Y$LKA ASU +*=PQGGBJ]SXAUNR\M)M*B'F:A%:QRO(465''W
M@HW$$'((/U&>E '445R*^*=5C#/<6=GLMM533K@I(V6WL@5D!'&/,7(/7GIW
MN6VOZC?W,4MCIHGL7N);=W)VF/867S"<\@LN, 9&0>>10!T5%<EHWBG5-2;2
MO/M+6%-5MYFB*.SF-TQ]X8&0<]N>/?C2\(7U[J?A.PO[Z1'N+F$2%E4@<\],
MT ;6X;MN1G&<=Z6N$TFZ,4RW=U#;3ZG=:U=V=M.4(,8#R!LG.2H2(87V SW%
M^?Q9J$,KV2V5NUY!J<=C*3(RH1(@=''!/((R.W/6@#K**KQS20:>)]0:*-XX
MMTYC)**0,L03SCZUR?AO69E\5W%K=W1E36(1>VZ,?]0Z_*T/U">6?J&- ':4
M5R?AE8_$3:KJ&J1K<.FHS6T,4HRMO'&=H"J> QP23U.?85>U-8](T%--CO)8
MVNI&@CG=RSH'+,S;CDDJN[!/4@9ZT ;U%<7I=_\ VK\.=1M;UEN+K3H)K2X8
MC.]HU.U^?[R[6S[TFB7US8Z=<^%&G?\ M"TF6VM92<LUNX+1R9[E4#CZQX[T
M =K17#>$]*TJ[^'6G_VI$);:-96=')*N=[ %AU9N,#Z^N*+2SNK:?PKH.HL\
ML#QW<TL4QWYV8\J-\_>VK)[\H#VH [FBO/-&NIM0URPT6[_>V%O=:DJI)\RR
MB&14C4YZA0YZ_P!T'J*3P[<RZOKMKH]_^_L;--0,:2C<LOEW"Q1DYZ[4) H
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M@X\IC@A#S\V0<[ACIT[UE7NH)IOQ&N(8%B%W?Z?:QP^9\J,_F3D[C_NK]3@
M4 =CD9QGGTI:Y36M5NK'4-7$%M:+>6NB_:8[LJ2S8+_*1V *D@9/6AO$MS8?
MV9:WCP1O=6\3)<3(PCG=C@QA\X5P,'G[Q;C% '5T444 %%%% !1110 4444
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M">2ZN()=/F\Z%X2H.[:5.<J>""01WS61>>(WU)M 738KH6NK[W,L>Q'V"-B
M-QX.<$^P_"KMCXBLXECM+N6Y#):R3?:KJ-4\Y(B%D<@=.2#R!P>* )QX?B@U
M&XO;&]NK%KIM]Q' 4,<KXQO*NK8; &2,9QSFITTF--1@O%N;C]Q$\:Q$J4.X
M@LQR-V20.<_UK,U7Q8+#2[NZCTR\:2"%)D61 JNKG"G=G'7JIPWM5BY\46EG
M'J37%M=1MI=NES<)M4D1MNP1AL'&QL\]J "3PQ;27VJ78O+M#JL0BN8U9 A
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M.SI I[(#T'YX'%1ZGX5L-6NKFXNI+C?<0QQ'8P&P1L70J<9#!B3GKS]*VZ*
M,F3P[:SW4]Q<S7$[7%G]BE#L 'CY] .?F//O4;>%K.2U6TEN;N6V\J.)XI)
MRR*C%ESD9!R>Q'&/2MJB@""WMA;M,1--)YTIDQ(^X)D ;5]%XZ>YJ>BB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:.:&0;DDC8,K#U!'!% '.R^']:U#PW<Z5J>J6TDC0B*&6& J"000[@L<DX'
MP!SUSQ%J_A?4]1;5#'?6J?VMIJVEQNA;Y67S,,OS=#YAZYZ5U=% '/IX=GEO
MM5>]GB>#4[&.T<1*59=H<$C.>OF'CM@=:=IMAXDM--:"XU.QN)X8?*MG^S,J
ML1C#R#=R>.BXZG\-ZB@!*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD%NOR\FI(]:A?Q99^7J$RQ/J-W:W,<MPVX81]H91@(N5&P=2.<\FN^P/2EH
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M6*>%)8)$DB< HZ,"K#U!'6J=CI?V2[N+J6\N+N68G:9BN(DR2$4*!@<]3DG
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MA_,B=)&C>-NF592&''H:CE\.Z7*\3_9FC>*$P!HI7C)C/)5BI&X9YYSSD]Z
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MC0Z6^FK;2&W<H2'N)&<;"&3#EMPVD C!X[5?MK&WM)9985<-,%#YD9A\HVC
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC.  K!5W9!;(Y ]CC-[0O!RZ(\2'6=1O;2V_X];6X=2D/&!T +8' R<#TZ4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
C "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>ebs20191231exhibit1048011.jpg
<TEXT>
begin 644 ebs20191231exhibit1048011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V:BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "JVH"Z.FW0L2!=^2_D$XQOP=O7CKBK-% 'F7BS6_$OAOQ%X8TF/7YIAJ
MDRQ74C6T(Q\Z*2@V<?>/7-=G ]UHGV^XUK6!-IZ;'AGG6.,QCD,K;0 3G&..
M^*X#XIW, ^(/@X^<F+:Z5YOF'[I?-C.6]!@'KZ5U/Q-O;"W\"7-Q=Z;_ &K
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M Q(?.S./F.<MCC/I7H-CH_BRTU9;O4/&$=SIZ,S26W]G1QY7!P-X.1CCGVH
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MX=4MM(\F>"^E,400*1_K,'#9<C&#G;V[I=Z?8Z5\&->CMM:M-3DN[CSI&M9
MT:2,Z?(O?H,\\^U 'HMGXLT#4+[[%::K;RW'V<7113TB(!#$]!P0<=<'-%KX
MKT.\OX;&"_4SW"&2!61E$ZCNC$ ./]TFL#08-(MOA3;7O]FQ7@31MLZ0J/,D
M&S,D>X<C+9R.QKSZPU".YUWP)?)')!:1RR1) D$GEV_S<(KL"9#C!)R>O04
M>M77CCPU92W4-SJT4<MG_KXRK;T_X#C)_#MS0/&_AEI[.%=9MV>^P(-I)#$]
M 3C //0X->=1W%L/&WQ$D:6,;].D5&)'S$)@@'OS@5@SSP)\*?"$0D031ZL[
MR*#\R@.Y)([<%?S% 'T#12*RNH92&4C((/!%+0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2;1D' R.GM2T4
M%)@$@X&1T-+10 4@4#. !GKCO2T4 )2T44 %%%% "4  # &*6B@ HHHH ***
M* "BBB@!.@P*6BB@!" 1@C(HI:* $  & , 4M%% !28 )( R>M+10 4444 %
M%%% !1110 4@ !) &3UI:* $P,YP,TM%% !1110 F!G.!GUI:** "BBB@ I-
MHR#@<=/:EHH 0@$8(R/>EHHH **** .=\3>%5\0WMC<RM;3168?-I=P^9%(6
MQ\W!!!&/<<].]-\.^#++0-6NM3@BM[>6YB6+R+2(QQ* 2<X).6)/7C@#CJ3T
ME% !1110 4F 2#@9'0TM% ',^(?"$>NZU;ZC.+2[CA@,(L[V O&"6R74@C#=
M!R#QZ5-X8\(V?AJXU"YMDAC>_9"\5O&8XHP@( 523SR23W]!7044 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%9/B7<=(5%EEB\R[M8V:&5HVVM/&K ,I!&02.#WH UJ*R/^$:L/\
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M (Y0!KT5D?\ "-6'_/QJG_@VNO\ XY5+5K'0-"L'OM2U#4[>W0X+'5;MB3Z
M"0DGZ"@#I**Y*W?PK=:-%K$&KZC)93.(XY%U2\)9R=H4+OW;L\8QFI/+\-?V
M<E^-4U,P/-Y"XU2\W&7=MV;-^[=GC&,T =317/V&EZ)J=F+NSOM3EA)(W?VM
M=C!!P009,@@@@@TW3-.T/6;%;[3K_4[BV=F59%U6[ 8JQ4XS)TR#SWH Z*BN
M=DT[081=-+J6H(EF,W#MJ]T%BXS\S>9@'&#CK@CU%58/^$9GDM$74=60WO\
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M '?3%=&GB;PU'&L<>N:6B*,*JW<8 'IC-)'XD\,PQB.+6]*C0=%6ZC 'X9H
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M3G"DMG\:[H:]X46V^S#5M'$ &/*%S%M_+.*4:_X564RC5]($C#!<7,63^.:
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M)MK'D8.><8.#G!Z5YC?Z;K%IH?B[1KB3^U;JWT^U:/48\Y-NKJWED?[NX^I
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M ,: &Z?_ ,C)J_\ NP?^@M6O6%HEY:W^NZM/9W,-S"1 !)#('7(5LC(XK=H
M**** "BBB@ HHHH **** "BBB@ HHHH *RO$1(TV+!QF^M!_Y,1UJUE>(_\
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M_.I/$\%RNE:?+IMI--#9W4<LMK;C:[1!6&%!QRI*L!_LT ;#7E@ELMR]S;K
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MQ'P,D#-;%97B/_D&0_\ 7_9_^E,= !_;5Q_T M3_ .^8O_BZ/[:N/^@%J?\
MWS%_\76K7*3R:S!XETS27UJ7%Y:3S2LD,7RNACP%RG3YSUR>!S0!K?VU<?\
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M_?,7_P 71_;5Q_T M3_[YB_^+K5HH RO[:N/^@%J?_?,7_Q=']M7'_0"U/\
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M+_XNC^VKC_H!:G_WS%_\76K10!E?VU<?] +4_P#OF+_XNLV#5IQXGOI/[%U
MEK*V&P"+<,//R?GZ'/Z&NGK*M_\ D;=0_P"O"U_]&7% !_;5Q_T M3_[YB_^
M+H_MJX_Z 6I_]\Q?_%UJT4 97]M7'_0"U/\ [YB_^+H_MJX_Z 6I_P#?,7_Q
M=:M% &5_;5Q_T M3_P"^8O\ XNC^VKC_ * 6I_\ ?,7_ ,76K10!E?VU<?\
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MN/\ H!:G_P!\Q?\ Q=:M% &5_;5Q_P! +4_^^8O_ (NC^VKC_H!:G_WS%_\
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MC_H!:G_WS%_\76K10!E?VU<?] +4_P#OF+_XNC^VKC_H!:G_ -\Q?_%UJT4
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M=NHJQ?ZCJBZ1INH-))9SR7UO#-;>4NTJ\ZHP.X$_=)P01GJ.M &A_;5Q_P!
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M6O\ Z,N*U:RK?_D;=0_Z\+7_ -&7% &K1110 4444 %%%% !6%XU&?!^I?\
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MSQ+/!;^&]0,TL<0>VD1-[!=S%#@#/?VK4HH I:."-$L01@BVC_\ 015VBB@
MHHHH **** "BBB@#*'_(VG_KP'_HPUJUE#_D;3_UX#_T8:U: "BBB@ HHHH
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M>?\ 0NZG_P!]6_\ \=H U:*RO[8O/^A=U/\ [ZM__CM']L7G_0NZG_WU;_\
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MY_T+NI_]]6__ ,=H_MB\_P"A=U/_ +ZM_P#X[0!JT5E?VQ>?]"[J?_?5O_\
M':/[8O/^A=U/_OJW_P#CM #=/_Y&35_]V#_T%JUZPM%GDN==U:62UFM6(@'E
MS%2P^5N?E8C]:W: "BBB@ HHHH **** "BBB@ HHHH **** "LKQ'_R#(?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB>#4;';(024S=0Y ))^G&!CL*Z^@#*SXB_NZ9^<G^%&?$7]W3/SD_P *U:*
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M7]W3/SD_PH'_ "-I_P"O ?\ HPUJT 96?$7]W3/SD_PHSXB_NZ9^<G^%:M%
M&5GQ%_=TS\Y/\*,^(O[NF?G)_A6K10!E9\1?W=,_.3_"C/B+^[IGYR?X5JT4
M 96?$7]W3/SD_P *02:^<@'2_EZ_-)Q6M7)V6E-J7A_5(+:06\\VI7695R"<
M3OP2"/ISD<\@C@@&MN\0 9_XEF/7=)1O\0;MO_$KW>FZ3-95SX5U";PW9Z:N
MI$36\@9GW/\ ,,].21QVRN.!@+VL75F+75O#*2%99XY)(VFP<OB!^[$G\R:
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M?0U9_L27_H-ZG_WW'_\ $4 :M%97]B2_]!O4_P#ON/\ ^(H_L27_ *#>I_\
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MGHK*_L27_H-ZG_WW'_\ $4?V)+_T&]3_ .^X_P#XB@#5HK*_L27_ *#>I_\
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M3_[[C_\ B* -6L[2=-FTP7,;W*3137,LZ 1%63>[.03N.<9QT'2H_P"Q)?\
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MH4>=%_SU3_OH4 25E:]_J['_ *_X?_0JT?.B_P">J?\ ?0K+UV6,QV.)%/\
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M5QQ*V.WOTP/N_=Y)QGFBQ\/6.GZK<ZE 9O.N?O[I6(/<YY^;VSG'08%:(FB
MQYJ?]]"DDDADC9#, &&,J^"/H: ,KPG_ ,@1O^OZ\_\ 2F2MJJ=C;V6FVHMK
M9PL8=W^:3<2S,68Y)SR6)JQYT7_/5/\ OH4 245'YT7_ #U3_OH4>=%_SU3_
M +Z% $E%1^=%_P ]4_[Z%'G1?\]4_P"^A0!)14?G1?\ /5/^^A1YT7_/5/\
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M )ZI_P!]"@"2BH_.B_YZI_WT*/.B_P">J?\ ?0H DHJ/SHO^>J?]]"CSHO\
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M/2KLK0R:M-:ZOI]Y<Q7-O;MIKQ0R$ J/F4.H_=MOY))'&,G H Z;_A'-"_Z
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MZ?\ ^ J?X5I44 9O_".:%_T!=/\ _ 5/\*/^$<T+_H"Z?_X"I_A6E10!F_\
M".:%_P! 73__  %3_"L)WT*#3+W4;CPWIJ06UR]NFV.,L[+(8\D%1C) X!8\
M\ FNOK!\-"&?3[^!]D@_M&[#H>>#._44 8\VI>%H=#M=4_X1^R*W,GEJ@@B)
M##[W !/&#QC/'(7M>6#1)+G2A'X=TQK;4P=DH2,LI$;/T52I&%QD-WKH'L;6
M2V6V>WC,*XVQE>!C&/Y"LO5V0>(= C#+N%Q*=H/('D2=J +7_".:%_T!=/\
M_ 5/\*/^$<T+_H"Z?_X"I_A6E10!F_\ ".:%_P! 73__  %3_"C_ (1S0O\
MH"Z?_P" J?X5I44 9O\ PCFA?] 73_\ P%3_  H_X1S0O^@+I_\ X"I_A6E1
M0!F_\(YH7_0%T_\ \!4_PH_X1S0O^@+I_P#X"I_A6E10!AZ-:VUEKVKPVMO%
M;Q 0$)$@5<[6["MRLC3_ /D9-7_W8/\ T%JUZ "BBB@ HHHH **** "BBB@
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M42M [J=TFW;VY8@KUXSFM"76M.@NTM9;E5E>40CY3M\PC(0MC 8CG!.>1ZT
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M57/_ ,;K5HH RO\ A(['_GAJ?_@JN?\ XW1_PD=C_P \-3_\%5S_ /&ZU:*
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M4_\ P57/_P ;H_X2.Q_YX:G_ ."JY_\ C=:M% &5_P )'8_\\-3_ /!5<_\
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MJ?\ X*KG_P"-T?\ "1V/_/#4_P#P57/_ ,;K5HH RO\ A(['_GAJ?_@JN?\
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M3<Y_/RZUZQ#=WKZ]JD,<[%+2TB>* (I#.WF=>,G[HX!% $W_  D=C_SPU/\
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M-(<Y\GG/F=,=O?@ WZ*ROM'B+_H%Z9_X,9/_ (Q1]H\1?] O3/\ P8R?_&*
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MQ%_T"],_\&,G_P 8H U:*ROM'B+_ *!>F?\ @QD_^,4?:/$7_0+TS_P8R?\
MQB@#5HK*^T>(O^@7IG_@QD_^,4?:/$7_ $"],_\ !C)_\8H U:*ROM'B+_H%
MZ9_X,9/_ (Q1]H\1?] O3/\ P8R?_&* &Z?_ ,C)J_\ NP?^@M6O6%HC73Z[
MJS7D,,,V(,I#*9%QM;'S%5/Z5NT %%%% !1110 4444 %%%% !1110 4444
M%97B/_D&0_\ 7_9_^E,=:M97B/\ Y!D/_7_9_P#I3'0!JUYC_P )+/IWB*?2
M?%,FHZ=<3W^^QU".9_LLL6\%4P#M VX4\'J2<'FO3JYNX\(_;M*72+_4&NK
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MA$:/?W\WVF2T$$UU$V'W%<%@?7W[UBVGPZM[.'48TU6Y<ZCIJZ?*7CCX15V
M@*!SMX'ZYH 33_B-;W$K"^TZ2RC_ +'&KH_FB3=#G!& !@YZ>OMTK/L/$&HZ
MK\0= F*S6=GJ.EO<BV%T71P>49EX ;'M^)K3M_AY:1SQM/>R3Q+H_P#8[1[
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R-/
M_P"1DU?_ '8/_06K7K(T_P#Y&35_]V#_ -!:M>@ HHHH **** "BBB@ HHHH
M **** "BBB@ K*\1_P#(,A_Z_P"S_P#2F.M6LKQ'_P @R'_K_L__ $ICH U"
M0 23@#O4 O[,D 7<!)[>8*9JH)TB] &2;>3_ -!-?)^E6=T-8LB;:8 7$?\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9&G_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH R-/_P"1DU?_ '8/_06K7K(T_P#Y&35_]V#_ -!:
MM>@ HHHH **** "BBB@ HHHH **** "BBB@ K*\1_P#(,A_Z_P"S_P#2F.M6
MLKQ'_P @R'_K_L__ $ICH TY(TEB:.10R."K ]P>M<Y'\._"$4JR1Z!:*Z$,
MI"G@CIWK>O9VMK&XN% +11,X!Z$@9KQ6R^.VMW5];V[:38!9950D%\@$X]:
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M];MI^5MIHKEA(B$ %,_W< <>WKS4WA*[N;S1I)+NX>XE2]NHO,< $JD[JO0
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MVGCF4D?*6*.,=QN;([YZBI?L_B+_ *"FF?\ @ND_^/T?9_$7_04TS_P72?\
MQ^@"A9>&9=,O]"^QM&;/2;*2U/F,?,??Y?S<#'_+/]>V*OZCI=Q=ZYI5_%)$
ML=BTA=&!R^]=O'ICK1]G\1?]!33/_!=)_P#'Z/L_B+_H*:9_X+I/_C] %6PT
MC5-*O[H)J<']DRW,EWL>$^;&78NZA]VW:6).2,X)'N,;P?ILVI>&]#EG>+RM
M.GEN(D7(9Y/WBJ&_N@!R>^>.G0]']G\1?]!33/\ P72?_'Z/L_B+_H*:9_X+
MI/\ X_0!E1>%=1M_#NF6EOJ$$6H:5<&:"?RBT;Y#@JRYS@J[#@^]2ZQX;O=<
ML(X+^6SFEVN1*L;1FVE.-KQ$$L-N#QGYO4=*T/L_B+_H*:9_X+I/_C]'V?Q%
M_P!!33/_  72?_'Z *5KH6KZ=JMP]IJL1L;QUEG2:$M*L@558HP( W!1U!P<
MXJO!X7OXH[)&N;<_9=7FU$D!OF$AD.S\/-//L..:U?L_B+_H*:9_X+I/_C]'
MV?Q%_P!!33/_  72?_'Z ,N/POJ<$,5O%J-LUO%?SW/DRV[%9$D9VVOAOF*E
M\CH/E'X&E^%+W3&T9UO[=VTQ+B%AY! DCD9&X^;AAL STYZ<<ZGV?Q%_T%-,
M_P#!=)_\?H^S^(O^@IIG_@ND_P#C] &='X5G/A)]'DND2Y6X>YM[F-3^ZD,Q
ME1L'T8X]Q]:GU'0;T3Z;=Z+>16]SI\3P;;F,R)-$^W<&P0<Y13D=Q[U:^S^(
MO^@IIG_@ND_^/T?9_$7_ $%-,_\ !=)_\?H LR6UQ)I,EL\RRW$D3*9"NU2Q
M!YQS@<],GCOWK#TWPQ?Z2]M-:7=N91IL5A<"1#M;R\[)%]_F.5[YZC&3I_9_
M$7_04TS_ ,%TG_Q^C[/XB_Z"FF?^"Z3_ ./T 9MMX3FTN2V_LN\B2.WTO[ !
M/#O)(Y5^H'4\C%7/#WA]=#DO#$(X(;EU9;2 GRH2!\Q4'IN/) &!@5-]G\1?
M]!33/_!=)_\ 'Z/L_B+_ *"FF?\ @ND_^/T 4)/#=Q+)J_GK974&IW:3/;SH
M2I18UCVGT/R!@PZ'M6EH>F2:-HL5AY[7#1;]AD8G:"Q*IDY)"@A03S@4S[/X
MB_Z"FF?^"Z3_ ./T?9_$7_04TS_P72?_ !^@#*TGPOJ&F2:*QN;:7^RK2>W(
M 8>:9"AS[8V#UZFHM.\)ZOHZ:;)8:E:"XMK3[%<>= S1RQABRL &!# D\9P<
MUM?9_$7_ $%-,_\ !=)_\?H^S^(O^@IIG_@ND_\ C] &?<>&+HS:LL%\IAUF
MW6*Y,J9=&$?EEUQP<J!P<8(S[5#>:,^DVGB"[$D0M)]-6"*,9W)Y<;*,GOG=
M_+K6M]G\1?\ 04TS_P %TG_Q^C[/XB_Z"FF?^"Z3_P"/T 8%GX9'B3PYIQU*
M9!&ND-:1^1G(\Q$#.<]"-@&WGODGM>NO#5]J,)DOKJW:[33I;&)T4A29-H:1
MAZ_*/E[<\\\:/V?Q%_T%-,_\%TG_ ,?H^S^(O^@IIG_@ND_^/T 4+SPYJ%W;
M:=;_ &VW$5M:O;S120ET=BJA9%&1\PVG&<_>-5XO!MP;>*VN;Z)HFT;^RKD)
M"067! 9#NX//?/3\M?[/XB_Z"FF?^"Z3_P"/T?9_$7_04TS_ ,%TG_Q^@#,G
M\.ZYJ6B&RU/6+=[B%HWMIX+8K\\;JZO("QR25&0,#D^V+VDZ5?VNM7^IWUQ;
M.U[%"ACAC8!"F[G)/(.[TJ7[/XB_Z"FF?^"Z3_X_1]G\1?\ 04TS_P %TG_Q
M^@#,U3PO>WYUOR[F!!JA@V%E8^6(\=?7./;'O1J/A>]U"36'-U!$=16V,>%+
M>6T+;AGID$_3%:?V?Q%_T%-,_P#!=)_\?H^S^(O^@IIG_@ND_P#C] &9/X5N
MY4UBU^V0_9=; -T/+(:-R@1RG)X95& 3\IYYZ5J:[I!U70I-.MY5@;,;1LR[
M@I1U< C/3Y0*3[/XB_Z"FF?^"Z3_ ./T?9_$7_04TS_P72?_ !^@#)O_  MJ
M-]%K:-=VH?5?(PP1@(_+ !XR<YQZ\9[U;LM&U>PU6Y:#48!IMU/]I>%H298W
M.-ZJV<;21GD9&3]:M_9_$7_04TS_ ,%TG_Q^C[/XB_Z"FF?^"Z3_ ./T )KF
ME7.HOIUQ9S117%A=>>GFJ65@4="#@@]')^HK*L?"VHV=]9W#WMM,+;4+N[($
M;(6$Q;Y>IQC>3^GO6M]G\1?]!33/_!=)_P#'Z/L_B+_H*:9_X+I/_C] &78^
M%[ZU32%>YMV_LZ_N+MB PWB7S/E'ICS3SWVCUK4T'2YM%LY[66YCEA^T331$
M(5*K)(TA#')S@MCMTH^S^(O^@IIG_@ND_P#C]'V?Q%_T%-,_\%TG_P ?H YW
MPQITFKZ+:B62'[-::M<W:A<[V83RL@/H,L&SW&!CO5[_ (1>^/A";1#<V_FR
M733B7:VT!IS-C'U./U]JU/L_B+_H*:9_X+I/_C]'V?Q%_P!!33/_  72?_'Z
M *MMHNJ66LW<UKJ$":??3+<30M$6D23:JL$;(&&"CJ..<4:)HNJZ1*;0ZC!+
MI<<CO GDD3 ,2=C-G! )ZXR<"K7V?Q%_T%-,_P#!=)_\?H^S^(O^@IIG_@ND
M_P#C] #=3TV[N]=TF^@,/E6+2-(KL0S;T*\8!Z9S6?:>$Y8+6UTV2YCDT^QO
MOMD'RD2<,75#VX8_>[@8QWK2^S^(O^@IIG_@ND_^/T?9_$7_ $%-,_\ !=)_
M\?H /#VEW&D6$MM<2QR%[J:=3&","21GQSZ%B,U&NA1W5W?7&K6ME>&=@L.^
M+=Y<87 0DY[[CQW8U)]G\1?]!33/_!=)_P#'Z/L_B+_H*:9_X+I/_C] &-:>
M#[Z'1-,M7U&+[=HLI>PNA&2 F"OENI/(V';P0> :W3'K$EM(3-:Q7'EE8U0,
MR!C_ !,3R0/08^OI']G\1?\ 04TS_P %TG_Q^C[/XB_Z"FF?^"Z3_P"/T 9F
MH>#TFT:RBL$L[34[.6*9+SRLG>A!)/=MW(.3_$:L:KX>GUN#48+N6*);NWB2
M)XLEH98RS*XSUPS9[=/>K?V?Q%_T%-,_\%TG_P ?H^S^(O\ H*:9_P""Z3_X
M_0!33P[<6VNZ??VTT1AL;.2VVR9WR%RK%R1WRN3ZY-%AI.N^?*NJWFFW%O<A
MA<"*V=9) 00%R7("C/0#]235S[/XB_Z"FF?^"Z3_ ./T?9_$7_04TS_P72?_
M !^@"A:^$\K80:A.MQ;:;:26ENH4@NKJ$W/[[!MX]2>X 8G@\7,%K:ZI<+<6
M]E826,(1=K.KJ$9V_P!K8H''')/< :7V?Q%_T%-,_P#!=)_\?H^S^(O^@IIG
M_@ND_P#C] $&G:%/#J%I>W]PD\MC9FT@V*1D$KN<Y[G8O';!Y.>)=<T%-9EL
M9?.,+VLI+$#/F1,I62,^S#'Y"G?9_$7_ $%-,_\ !=)_\?H^S^(O^@IIG_@N
MD_\ C] &;XE\+WVO2W:I?P);W%H(42:$N8'#$ETPP W9 /&?E%3V&B:MIVJ7
M+1:E;_8+N?[3+'Y!\Q9"!O53NP%8C/()&2/>K?V?Q%_T%-,_\%TG_P ?H^S^
M(O\ H*:9_P""Z3_X_0!4T+1-6T6$6/\ :$$VGVQ;[(GE%9"#G:KMD@A<]ADX
M'T-31_"VH:4VDG[3;2_V;ILECT8>86*$-[?ZL<>YK6^S^(O^@IIG_@ND_P#C
M]'V?Q%_T%-,_\%TG_P ?H QK#PKK&D0:4VG:E:K<6=DMC.)H&>.:-3E6 # A
MASWP<UTEK'>QRNMQ/'-"$01D(5?< =Q8YP<G&, 8YJI]G\1?]!33/_!=)_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *:Y*HS!2Y R%&,GVYIU175K!
M>VTEM=0I-#(,/&XRK#T(H Q-*TLW_AV[TO6M,:.*XGN"\4K(P=))7=<%6."
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M1,&1T@4%2.A!H MZ;<WMU!(]]8?8I%F=$3SA)O0'Y7R.F1SCM5RBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ_\ HQ:ZJ@ HHHH ***BNKF&SM)KJX<)#"C22,?X5 R3^5 &=_PDEA_PE?\
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M' S6I:6\UC\0KG28]1OI+6\TG[2ZS7#.4E$NS<A/W<@]!@4 =C17E%J^H?\
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MY)4@E5 Z=,MST%<K8WT^BV-YI]O<S(E_XO:RDN2Y,BQL%)^8\[B!MW=><]:
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MY/+2.,'&YFP3R3@  ]#TQ58^,-/'A\ZJ8Y=XG^R&UX\W[1OV>5UQG=^&.>E
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M:7S6A6ZD"AMVX!?F^4;B3@8&:O'P_8-K,.KMY[7D$7DI(9WQL[@C.#DC/(H
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MN;OINXSZUZ;-HEK<K:M,\QN;6/RTN4D*2$$ -DCJ#@$CU /44_\ L/3#H_\
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MV@9U* ^<[^6IY(3<3M&?3%:.Z_\ [5V>5!]@\C/F;SYGF[NFW&-NWOG.:M4
M8 \$Z&NAKH@AN!8+)YHA^U2<-NW9SNS][GKUK=5 L8CY8 8^8Y)^OK3J* ,B
MS\+:/8O&;>V98XI3+% 9G:*)SGYEC)VJ>3C XSQBL.QT:6Z\>^(+R[M;V"VN
MHK>.WGCE>(2;%8./E8'J1C/IQ79T4 9=WX:T>]LK2SFLE$%BP>V6-FC\H@8&
M"I!Z'\:=#H&GV^M/K$4<BW;PB GS6V^6.B[<X 'TK2HH Q[;PKHUI(#!:LD:
MS>>EOYSF%),YW"/.T'// X/(YJ5?#VFIJ=SJ21S+=W:!)I%N91O4=!C=@8[8
MZ=JTZ* *6DZ18Z'IZ6&G1-#;1D[(S(SA<]AN)('M648[[7=<B6^T<VEEI5TT
MT4TLB.;AP"J,H'*C#%N<'(4>N.BHH S-<\.:3XCMHX-5M!.L3[XV#,CQMZJR
MD$?G4$O@_09M,M].>QQ!;2^=$4E=763^]O!W9YZYYK:HH PF\%>'7CO8_P"S
M@J7X N52:11)@ <X;O@9QUQSFC6_"]IJVC6VE['V6TJR0R-<2;H67(#@YRQ&
M3@$XZ>E;M% #702(R$L PQE3@CZ&L6/P=HB>'SH'V>5M-))\AKF3')W$9W9Q
MGG&:W** (K>WCM8$@BW[$&!OD9SCZL236->>"O#M_K!U:YTY6NWQYC"1U67'
M3>H.UOQ!K>HH HG1[$W%Y.8Y#)?1B*<F9R&4 @ #.%^\>F.IJB_@W0)- &A2
M6'F:<K;DA>5V\L^JL6RO?H1U-;E% &&/!N@_V))HQLF:RF8-*AGDW2D8QN;=
MN;H.I[59U+P[I6L:2NEZC;&YMD(*B21BZD="'SNS[YS6G10!C?\ ")Z,-"FT
M5;9Q9W'^N43/OE]=SYW'H!R>@Q4A\.:>9(9!]I62& 6ZR)=2JQCSG:2&Y^IY
MK5HH QM2\(Z#JNFVNG7>GH;>SQ]F$;-&T./[K*01^?-)<>$=#N=$31WL@+2-
MQ)&%=@Z2 Y#A\[MWOG-;5% &+9^$]+L]1;45^U2W;V_V=Y9KN1RZ<\'+<]?P
MXQBM#3=.M=(TZ#3[&,Q6UNNR-"Q; ^I))JU10!G:SH6G>(+46NIP// &#>6)
MG0$CH3M(SBG:CHUEJND2:5>++):R+M=?.<,P]"V=Q_.K]% &2_AK39+O3KMQ
M<&;3%*VK?:'^0$8.>><@ <YJN/!/AT:TVL#3E%V[B1R)&",X.0Q3.TMGG..O
M/6MZB@ K(7PQI<,\TUJD]FUPQ:5;6XDB5V/4E5(&?<#-:]% &9%X;T>+1YM(
M6PB-E<%C-$^6\PGDLQ)R6SW)SQ3[#0['3I1-"DKRK'Y2R3SO*RIUV@N20.!T
MZX&>E:%% %4Z=:'5%U,P+]L6$P"7OY9(;;^8S5#6O"6A^(+J&ZU*R\RX@&U)
MHY7C<+_=RI!(Z\'U-;-% &5+X9TB6YL+@VK))IRE;3RIGC$((P0 K <@8/J*
MD;0=.;6&U?RY1>O%Y)E6XD'R?W<!L8R2>G7GK6C10!A+X+T%+**R6TF%O#<?
M:8T^US867.=P^;KGGZ\U<&@Z<-6;5A'+]M:'R#+]HD_U><[<;L8SSTZ\UHT4
M 8J^$-!71KC1S8>98W+EY(997<%B<D@LQ*G/.1CFFV_@W0;72+C2H[-_LMT
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MP&^\ 2Q*YR>F.IK5HH XKQ%X;CBM-'TZ'0KC4]&L2Q:*"Z*W$1"[8]I9E)4
MMD!L].PYDTCPK;RI=1&TU2QTR[MVAFL[R^:1I22/F&';8,9'#9.[D# SV-%
M&,WA32F735*W&-*Q]D_TF0>7@8]>>..<\59AT+3;?6)]6BMMEY< >;(';#$#
M .W.W..,XSBM"B@"AJFB:=K7V?\ M"W\TVTGF0L'9&1L8X*D'IU'0U#<^&M*
MN;Y[TP213R1B*5[>=X?-0= VPC=CMGI6K10!'!!%:P1V\$2111*%1$&%4#@
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M%YCF*-SG++&3M4\GD =3ZTK>'-*>XEF:V8F:432H9G\MW!!#%,[2>!V[#TH
MY3[&_B_4/$MC<7MM!<VMT88O,@9YK6/8I22,AUVY.6SCD]<C J+6TOK:-;^:
M&/Q/IBZ;%%=%#LN(< DSQJ>/F!R<'/RCGBNJU3P=X>UG44U'4-+BGND 7S"6
M&X>C $!A['-3W/A[2[NYEN)8'$DT0AE\N>1!(@SA656 (Y/!'<T 6-.EM[S1
M[6:V=GMY[=&C?E6*%00?4'!KR^/1+>Y^&^JZP]W=KJ&FW%W+:7'VE\PF.1B
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M"%KZYEM_M(6-E55B)P&+$]SP/7![#- &M17+W'CNQ@\/2ZTME>216MP;>\A
M026L@8*0X+8X)'()X.:V9M56#4+>S:WD/FPO,\H9=D2KC.[G/\0QC/?TH OT
M5SG_  FEDMSIHEMIHK759!%:7)9"&=AE R@[EW#ID?7%='0 4F0<X/3K7.7_
M (AO[?QQ9:)#I[R6\MK).[JZ9<AE'&2, 9.>YSTXYYW0]<3PQ'XKG32KNZMK
M;69I)F@"XACV1Y/S,,]^!D^N.* /1J*R;K7X(I8H+2(W=Q+!]H5%=4 C[$EB
M,9/ ^A]#4F@:[9^(])34;(.J,S(T<@P\;J<%3CN#0!I45RMUXZ2*?4[>WT'5
M+N72W N%B1.%*[MP.[!XQ@=3Z5))XZL"-':TL[R\364=K5H57!*J6*'+##<8
MYX'<\&@#I<C.,\TM<Q;:O8WOBG38[K1+NTU26QDEBDG"CRTRNY.&/.<=JGE\
M70)'%=1V%U/I\EU]E%W$H8;MVW=MSN*;AC./H".: -_(SC/-+7.6^J:</%.M
M)#I5R-1M;:)IY!MS.GS; OS8]>N*K6?CZVNX-)N_[*OXK'595@BNG"!5D8D*
MI&[=R1U Q[F@#K**P[WQ1#;7&I0V]I-=G28EEO/+*C8&4L N2-S;1G'TYSQ5
M_1]4CUG2X-1@AEBAN$#QB7;N*D9!X)ZB@"[17.WGC&VLUN)WLKEK*UO%LY[G
M"@+(2JY"DY*@L 3^0-7+[7A;W5Q:6EE-?W%K")ITA*C8ISM&21ECM. /3G&1
MD UJ*Q8O$]M=PV!L;:>>XOX#<16[ (R1C&6?)^4 D#ODGC/6HH?%UI-IL%R;
M2ZCN)[HVD=FZ 2M,"<CKC  )W9Q@?A0!OT5@KXJB$VH6<]C/#?Z?!]H>U+*3
M+%_?1LX(X(YQ@\4W_A+[3[#H=[]DN3!K<D<4#?+^[9U+*&&?0'IF@#H**Y>Y
M\;K%)JT4.AZC<2:0P^TJ@C&%*[MP);!&WG Y/I4>H>+;C^UO#46F6,ES::PC
MS[PR*SH(2P4!B,'E6)..F.: .LHK%/B1'N9H[6RFN8[>\2SGDC9<QNQ49VDY
MVC>,GV/!'-:TSO'"[QQ-,RC(C4@%O89(% #]PW;<C.,X[TM><^'KBPN?#Z>)
M]?L)1=6U]-+'>*P\R1S,T:Q+M;<1T7:?EX':NLC\2*FL1:3?6,]G=W$32VRL
MR,LX7EE4@XW#N#^9H VJ0D#&3UKGM$\7C7KB-;71M02!I989+B14"1/&2,-A
MB><=LCD<]<9OC1DM?%GA2]%O+-*MS,H2)<N_[EL #IU[G@=R!0!VE%<W8^-K
M">+5#J-O<:5/I*B2Z@N@-RH1D,I4D,#CMW_"K \3I%J%C9ZAI]S8_P!HY%J\
MI4JS 9V-@G:^.@/!]<T ;E("" 0<@]ZX2;6KOQ#X<\807^G/#%9FYAC.]"$V
M0J0#@Y+9);.,#.,\5<\-^)DM[+PYI5QIUW"E[91QV]VX41R.L0)7&=PX!P2!
MG'''- '8452U?5(-&TN?4+E)'CA )6)=S,20  /4D@50B\2J;^^T^?3[B.\L
MK=;DQ*4;S8VR 5.<9RI!!Q^- &Y17*6GCVVNH](N3I5_%9:M(L,-U($VK(V=
MJD;MW.,9QCW-2W/C0176K6MOHFHW,^D[#.J",95EW;@2V",=NISTX- '345@
MQ^+;*:YT..*"=XM<C9[:8!=JX3>0PSD''L>::?&%G''K3SVEU$=%95G4*KER
MRAEV8)SG(ZXZT =!2 @]#FLBTUN.^U>YT*[LI;:Z2V6<H[*RR1,2N00?4$$?
MSK*^&*A/ EHJ]%GN0/\ O_)0!UM%8VI^(XK"6ZA@M9+R6SB$LZQNB[ 02 -Q
M&6(&<?3.,C,-MXNLM26S_LN)[Q[NU-VD894/E@[?XC][.1CV.2* -^BLC_A(
M(WCT](;29[S4+?[1':G"M&F 27).% + =^3QFJT/BZWFL8)A87BW$]X;);9X
MP&649SDYQM 4G=GI[\4 =!2 @C(.0:X_Q!JUMK_@/Q.C6TD,VGPW$,T4A'RR
M+'N!!!P1R"#5_3]8%GIFAZ=#:RW-U<V"R(JX555$7)9CP.6 'UH Z*DR,XSS
M7':EXWD?0=&U/2;&9UU'48K5Q(45HOWNUTP3@L=K*.<=\UHMJ%@_C2QM;C2I
MX]3:QDDBN'*E4CRNY,ACDYQV[=: .AHKG+GQE:V]A+JJV5S-I4$IBEO(]I P
MVUG"YR4#9!(]"0".:DN_%<5OK<>D0:==WEQ-:&ZA:'9LE7('#%@!UZM@<=\B
M@#?HK+\/Z[!XATTWD,,MNR2O#-!,!OBD0X93@D=:KZIXGCTZ:_BCL+FZ_LVV
M%S=&/:H5#N("[B-S85CCVZT ;E%<]<^,+6&\TJVAL;RY.KP-/:M$JX<!0V.6
M&#AEZX'/7BBS\8V,^CW^H7<$]BVG3FWN;>4 NLG&%&TD-G<N,=<T =!D @$]
M>E+7"WDTL_Q1\.O-ILMG(UI=$L[JP<;5P/E)Y'.1[CDUM>.-<N_#OA2\U*RM
M_-FC 526 $>XA0QSUP2.* -_(SC/6EKG+O4K)O$^@V]_H]Q'?S^>;25RA6'"
M'>"58\E<=CUHU3QI9:7;W%Z]M--86DWDW%Q&R?(0VUB%SN8*W!P.QQG% '1T
M5S5SXS2/5KK3+71M0O;BVCCE/D!"'C<D!E);IQ]?;J0NI^-;+3+>:]>WFET^
MVG\B>YC9/D8-M8A<[F"MP2!V.,T =)2 @]#FL:\UJ"XGNM.M;&74F@B5[E8F
M4!5895<DC+$<X],9(R,YOPO.?ASI!Y_U;]?^NC4 =917+77CE8KG4[6VT'5+
MN;2V47"1(G"E=VX'=SQC ZGTX-.D\=Z>8]'EM+.\O(]95C;-"J\LJDE#EAAL
MC'IZG - '39&<9YI:Y>#6;&]\4:5'=Z)=VNIS6<LD,DX4>4F1O7ACSG':K%S
MXN@@A:\CL+JYT^.Y^S/=0@, V[82%SN90W!('8XS0!OY&<9YI:YZ+4=//C+4
M+>/2[C^TX+%&>;Y?WT6X[57YO7/7%4[7X@VMU8Z;J(TG4([#4)Q +EU0+$Y<
MJH8;L\D=0"!GKF@#K:*Q;SQ)%!>WUG:VDUY-IT"SW2QE1L# E5&3RQ"DXZ>_
M-6M$U>'7M*AU*WAFB@G7='YP4%E/0\$_XT :%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %-=MJ%MI; S@=33JBN;:
M&\MWM[A \4@PRD]10!QGA)-6T2RUA+OP[?.]WJ=Q=1(CP$,CD8!)D !X[T_P
MGI.K^$/"=Z[Z?]JNI[Q[F+3;>5<0J[*/+5CQP,GTK;_X1#0/^@<G_?;?XT'P
MCH &3IR #_;;_&@"CXDO=7DOEL(/#=Y?Z;M#3O%-"@G/]SYG!V^O'/3IG.SH
M]W?7MF9K_36TYRY"0/(KL%'0DKD9// /3%4U\)>'G4,NGQLK#((D8@C\ZNZ;
MI>G:894L(4B+$>8%8GITSD^] %ZBBFJZN,HP89(R#GD<&@!U9OB"XU"WT:X.
MEVLES>.I2(1E1L)XW'<0,#KCOBM*FJZNNY&##U!S0!R'B#P5877@RXL;*UN_
M/6W'V5/M#%ED493@MMSD#/XTVZ@NO$'A[3+7Q+X;GE8C_2_+=?,MY5 Q*A5N
MA.>G//3@UV=-WKOV;ANQG;GG'K0!B>$+/5+#16MM4N)IRD\@MVN&#3>1GY-Y
M'5L?S%8'B'0KR_U2ZU'2K"ZT[78ID6UOH' BNH_E_P!:,X('(((SP,9Z5WE%
M '*V5OJ%OXWU^_DTV?[+<VT$<$H9#YA0-G W9'WN,XZ5S^C^'M<TS2?"6H'3
MI3<Z'YT-W9[TWO')P60[L$C@XR,UZ510!S>FZ5-<^+[_ ,0W%N]O%+9QV<,4
MN-SJ&+,S 9QR0 #SP:YQO!>K)X>O;9<&?1IV?0><G <2C/N>(^>FT^M>BLZI
MC<P7)P,G&3Z4Z@#C_%&C:C-\/Y-,M+5KS4)Y(I95C90#)YRR2'+$#&=V/P%6
M)K>_E^(.G:FNFSBS33I())24^1W96 (W9_AYQFNHHH YKX@6-]JG@^ZL-.M'
MNKF9XMJ(RCA9%8DEB!T4U&]O?GXC6^J#3;@V0TE[9I<I\LC2*^"-V>BXZ=:Z
MFD9@JEF("@9))X% '-^"+.^L;'48K^QEM6EU*XN(P[*=R.Y93\I/;UILEIJ-
MI\1'U./3Y+BSN=-2 S(Z 1NLC,=P)!Z-Q@'GTZCI@00"#D'H12T >:RZ'KDO
MPTU32?['G%]<W[S1P[X^5:<29SNQT%:5Y;:KI?BV[U6/PXVL6.K11%D4QB6U
ME1=N"&.,$8Y!ZC\^XHH JZ<DR6$0N(8H)2"6BA^['DD[0>^,XSWZUR/AU/$G
MAV.?PX-&:XB6XE:SU$2IY0C=RV9 3NR"QX Y_6NXHH Y.QM=1MO&?B2_DTV?
M[-=P6Z6\@9#YIC5@W&[(Y88SBL;2;'Q)IOA_PSI\VD7<EI;+)'J-K#-&LC-_
MRS.=X!3DY&?KZ5Z+10!YB^@:['X1U72TT*199-;^U0I%+'M,7G*_RY(P HQS
MCZ5TWBFTU"YN_#^IV>GS7/V&]\V:W1D60*T;+_$P'!(SS73,ZHNYV"CIDG%.
MH IZB;\Z-='3U1=0-N_D!CE1+M.W)],XKB;'3=9DU_PQJLF@W226T4\5_-<7
M$;2,[HHWD[C\F0<8]>%'&?0J* ."M-+UB#PSKGAW^RY?M&H7%T(IRR^1Y<S'
M#ELYX#=,9R.E6K;1+WPQXI@OK:WFO].ETR*QE\K!DB>+[K;2>5(].AKLZ:[I
M&A=V"JHR68X H YG1O#.^QUX:I#L77;F21X,@F.-E"@'&1NP,G&<$^U,\-Z#
MJ?\ PC%S9ZW*/MDL#6(D7G$*!D1OJ<EO^!#TKJ5974,C!E(R"#D$4,ZKC<P&
MXX&3U- '%>%X];MH+/1[_P +PP3V6R.34MT9BD1,?,N/F+,!TQP3D^E=%I&L
M3ZC=ZA:W.FRV3V<VQ=[JPE0YVN,=,X/';CUK5J.*"* ,(D"[V+,1U8GN3W-
M'.:M9:C'X[TK5K:Q>[MUM)K64HZKY3,RL&;<1\O!Z9/M6.NE:P?#GC2T.DW"
MS:K=7#VBEX_WBO&J*?O<<C/-=_29&<9YH X":PUC2]2TS64\/MJ<#Z9%97EF
M3'YT#H20ZY."/F(X/O79:0)_L(>XLX[)Y&+"VCP?+'8$C@MW...<<XR;U% '
M#Z-?36GC/Q@(]/N+HFX@*>3MPS>0ORG)&/J>*K6'AK4]!;P9;1V4EVFE-</>
M20L@6,RHPP-Q!(#.>G85UNF:!;Z7J5]?PW%P\NH.'G$C*59@, C &,#CBM2@
M#F;ZTOG^(>F7\=C*]G!930R3AEPK.5(XSG^'TK-\*IXD\/V2^%WT9Y4MI&6W
MU/S4\DPEB0S#.[< <;0.<=1UKN** .4M[34(/&^N:@VG3FUN+*&*&0%/WC)N
MR -V1]X8SBL.WT;6H? ?AC3CH]P;O3=1MYKB(/'PD;[B0=V#QTYKT>B@#SW5
M/M8\3:ZUGH^J36M[#%;W,FG20GS&"<[@YRKA6"_+V]\8Z[PY<6D^AVZ6-I-9
M0VZ^0+:==KP[/EVGD],=<G-57\(6'V^>\MKK4+)KJ0R3QVMV\<<KGJQ4'@GU
M&*V+:VAL[=8($V1KG R222<DDGDDG))/))H \[U_2_$>KZ9K-M<Z+-=WBWZR
M6D_G1^5]G65658P6X;:#G(&><GH*U777M"\7WNJV^B3:C9:S#"9(X94$EM*B
M[<'<0"I'4@]?U[6B@#B]4M_$&G>(].\30:;_ &@6LWM+ZSMY%#QJ7WJ4+8#8
M/!Z9QGZ/UNPUS4'T;7TL,7.FWC2G3Q(I<PNNQANSM+@<XSCG&3C)[&B@#DWT
M:YUGQ-=ZTT$EI$=):P@6; =V=BS,0"< < 9YZ\=,X4-CX@D\/^$]//AZZ231
M;^W-SNEB^98T=2R?-R.>I(Z@#/;TFB@#BX;+5$U#QC*VE7 34E4VAW1_O2(1
M'C[W'/KCBJEOI6LVMKX(NAI$\DFCPO!=VZR1AU+0>6&!+8*Y'KG':N^I$=9$
M#HP96&00<@B@#A-5T*]NM8?5-+T^ZTO7%NU7[3"X%O=P!ADRC." F>H#9 QV
MKNY&*1LP1G(&=J]33J* /.;?PUK=U\.4TW[$]IJ=C?->PQ3.FV4B=I%7<I(Y
M#8Y[UN7%I=:_XAT34WT^XLH=*$TTBS[0[R.FT(H!.<<DGIP,9[=510!S'@2S
MOM/TFZM]0L9;20WT\RB1D.Y7<L"-I/8\YIWBFQO9-7T#4[6TDNHM.NG>=(BN
M\*T97(!(S@GIUKI:* .#UWPA>^*5\0794V4E]916MG'*0&/EOYFY\9QN; ]0
M!SZ5=O+74?%+: MWILU@VGWL=[=M*5P'C5@$0@G=EFZ],#UXKKZ* .&33M8M
M+'QCIXTF67^T9KB>UE22/;+YD2HJC+9!R#G( QWHDT[53;^"@-*N"VEE#=@-
M'^ZQ"8S_ !<\GMGBNYHH QO%?]L?\(Y<_P!A*6OOEVJK!6*[AO"D\!MN<&N=
MLM.U&W\67>I0^'[B"TN]($(WS1M)Y@9C\_S'+'(YR?<CH.[HH \YCT?6H_!/
MA33SH]P;K3-0MY;F,/'\J1DEB#NP>O'-:MK::E%K_BRZ;2[CR=0BA^RMN3]X
M4BV$8W<<GO78T4 >>6^E:S8:1X,NSH]Q+-HFZ.ZM8VC,F&B*;E^;:0#CO3FM
M/%<+>+KO3],DM[J^DMY+0^=&2RJB*Z@YX?;GG&,]"<<^@T4 <1I.GW]OXY_M
M:/0;BULI]*$+&69&D$BR%B9/F)+$$ <GMDCMI> +&^TSPK%9:C9R6MQ'-,Q1
MV4Y#2LXP5)'1A72T4 <1?6FJZ-XQU"_C\/\ ]MV&JB)OW;1B2WE1 F"'(^4@
M YSQ3];T3^UOLT.I:-/%)#;^9;7VEN%DM)BS90'()&-O.,$Y)QD5VE% ' M8
M^*M(N]"\02VAU:[BT\V6IP0NHDP6#!UR0"01S_DC1UF?Q+<6FGW":9.+>2[S
M>65M,@N!!MPHW[@,[N2 >AQG&376T4 >>0Z)J\&B^,[&/0FA_M/S&M$CDCVM
MOA"!>O!!SGMZ$U?>+7$DT&WETFYN=,2Q\NYMHI8U*W "@&3+ ,F W )'/(/%
M=I10!YK;>']=MO!6GV9T=Q<:5KBWA@26/,T8G9SLY Z,,9QT/'3/03VVHS^/
M]*U,Z;,EK%82Q2R;T(C=V4@'G)QMY(R/K7544 >?Z?HVLZ?X$O\ P6VGR32E
M)K>UN]R^2\4A;#L<Y4KN.1C/'&:T+?2+S3?&>DO%93S6%CHYLC<@IC=N0C@M
MGHGIU-=A10!S/@FROK"WU:.^LI;4SZI<7,6]E.]';*GY2?Q!K.\0V6N:CJ>M
M64NERWME<6.S36$J+#$Y0AS(I.2VXC!P<8&,<FNWHH X*QT[6%O_  3-+H]Q
M&FEV<D%T=\9\LM$B _>YY4GC/&._%5+[PYKE_9^(Q;V#PW$NJQZA9"9T"SA
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M/<VDD488X!8J0.?K7.W%EKMTWA.5M#EC_LV;?<K]HB)0"(I_>P>23QG@>O
M-6T\86[V^K/J5I+ITNCL!<Q.RN<,NY"I4X.X'IZTMGXOMY_$$.BW$*PSW,+2
MV[).DJN%^\IV_=8#G'(]#6%J'AG5]6O?%\8M7M$U1;9K*XD>,J7A4=0&) +
M=NF?I6WH%WKU[+%_:?AV+2?)!\Z3SDD\UL8P@7H.^3Z8YSD %;QWJ]W:+I.C
MV,[6UQK5ZML;A.&BC_C*GLV, ?6I]7T+PMINAS?;;.*TMPA5[M(SYL>1]\R
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MOG%5+NVU[2_$\FLV6A?VG::G;1)<6K31I+;2)D Y)VD$'!P?_KSW]CK,VO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%-<L$8HH9@. 3C)^M #J*YC3/&%QJ
MUK>7%IH%W(ME<R6TJ++%O+I]X*"P!_.M?1-:LO$&E1:EI[LT$N1AUVLK X*L
M.Q!% &A16/KFN76E([6>BW>I^4GF3>2R*$7ZL1N;@\#/X9&;FDZG;:UI-KJ=
MH6,%U$)$W#! /8CUH N4444 %%%9^N:H=$T:ZU,VS7$=K&TLB(P#;%&21GKT
MH T**YK_ (2^6/18M:GT&_6PDA68R1-'(T<9&=S*&SC!R< XK=L;ZUU.QAOK
M*=9[>= \<B]&!H L45F^(-8&@:'=:JUK+<I:QF1HXBH.!U/)''^<4\ZA.T.G
MRV]A).EV5\PJZCR%*YW'/7G X]: +]%%% !1110 4444 %%07MW!I]C/>W+[
M(+>-I9&]%49)_(5G:7K%_?W42S:0T%I<6PN(;E9@XYQ\CC VM@@\;AUYXH V
M**** "BBB@ HK(37E;Q:WAXVDJ.MG]K$[,NUEWA<  YZD]<=*UZ "BBHFN(4
MN8[9I%$TJLR)W8+C)_#</SH EHHK+\2:VOAS0;G5GM9;I+9=S1QLH./7D]/S
M/M0!J44R-_,B1\8W*#BGT %%8UIXA^UZ[JNDK83K+IL<;DED_?;]V-O.!]WN
M1U[5+X;UR/Q'H-OJT4#P)<%\1N067:Y7G'^[0!J45D6NO+<^)[S0C:2Q/:P)
M/YKLN) Q(& "?0]<?2M>@ HHK"U?Q*VE:YIVDC3I+B74_,%NZ2*!E%W,&STX
MH W:*RH=:E6XGCU'3Y-/BA@,_P!HDD1HRH^]R#QC@G/K5>V\175_8#4M/T:>
MXL67?&QD5)9D[,B'L>VXJ3Z4 ;M%8-UXMLH_";^);*-KVSCC,CA"%< ?>&#W
M!Z@U!<>,5T_2[?5M2TFZM].F",URK)((0^,%P#D#D<@&@#I:*;NW)N0ALC(Y
MX-<Y8>+;G4KS4;6UT&YD?39O)FQ/$,MC/RY89X]<4 =+163H?B2QUYKF&!9K
M>[LWV7-I<)LEA)Z9&2"#V()!K6H ***KF\1XKDVP^T2VQ*M$A )<*&VY/&<$
M?G0!8HJ"SFEN+*&:>W:VEDC5GA9@QC)'*DC@XZ<5/0 4451N=1/]ES7NG6YU
M%XRRI#$X4R,K%6 )XX(/Y4 7J*0'(!(Q[>E+0 4444 %%0W=U#96<UW<.$A@
MC:21CV4#)-5=!UFV\0Z'::M:9$-U&'"GJIZ%3[@@C\* -"BBB@ HHHH ***R
M1KRGQ;_PCQM)5?[$;L3EEV,H=5P #GJW?'2@#6HHJ**XAG>9(I%=H'\N0#^%
MMH;!_!@?QH EHHK(\1:^OAZSANGM);A);B. E&4!"[!03DYQD]@: ->BBB@
MHHIKDJA8*6(&0HQD^W- #J*RO#FNIXBTLWR6TEL!/)"8Y""P*,5.<<=JTI7:
M.)G6-I649"*1EO89('YF@!]%9?AS6X_$>@VVK10/ EQNQ&Y!9<,5YQ]*OW-Q
M#:6TES<2+'#$I9W;HH'4T 2T455U"YN+6W62VLGO',B*8T=5(4D MDGL.?PH
M M45DMKRKXL3P^;24.]HUTLY9=C ,JX !SU;OCI6M0 455U.]_LW3+F^\B2<
M6\;2&.,@,P R<9(%,T?45U?1;+4TC,2WENDX0G)4,H.,_C0!=HK/US51H>BW
M>J-;27"6L32O'&5!V@9)Y(JS97(O;&WN@I03Q+(%)SC(SC]: )Z*R=>UY=".
MGA[26=;Z]BM Z,H$;.V 3DY_(=NU7/M-Q_:OV7[$_P!G\CS/M>]=N_=C9MSG
M..<]* +5%%% !1110 4444 %%%9/]O*/%J^'S:2J[6;78G++M8!E7  .>K=\
M=* -:BBB@ HK)O\ 7EL/$.E:.UI*QU,RA)PR[$V(7((SG/'ICGK6M0 45D7F
MO+9^)=.T1[24MJ"2ND^Y=@\L D8SG/([#K6O0 4444 %%17,DD-K-+%"T\B(
MS)$I ,A X4$\#/3FLG4/$;:8=&6YTV=7U6=("-ZX@=E)VL<\D8/08XZT ;=%
M9%KKRW/B>\T(VDL3VMND_FNR[9 Q(& "?0]<?2C6]>71+C38GM)9AJ%XEHLB
MLH6-FSC/.>@/04 :]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%07CS):2M!$\LH7Y41E#$^Q;C\Z ."\&6VMSZ=
MXE72M2M+1FUN\"&:T,I5LCG.\#T['\:T?A9/;MX6ELHK=X9["\EM[HM)YGF3
M Y9PV!D'/IQ4-EHEUI\-Q#::+K,*74K33!-4B&YV^\V=V03[8J<:8\7A]M"M
M/"E[9V;$$_9[^-'SN#9W[]Q)(Y)/- '0Z[9ZC?Z1<6NEWT=E<2H5$TD1DQD=
MN1CZ\X]*H^![V6_\(6,DUI%:21!K=H81\BF-C'\OM\M4;J+5;K43>_V3K,):
M,1O#%JD2QL!_L[N#SU7!K;T5I5M?LS:0VF0P*%BC,B,"/;:3T]_6@#2HHHH
M*Q/&O_(C:]_V#I__ $6U;=4]6TR#6=-FT^Y>06]PI241MM+*1@C/H?:@"CX:
MDBA\#Z3+.RK$FFPL[/T"B,9)]L5Y]X)O;VT\-:#IL>8K75M1NFA#S-"3$H+*
M@< E<MD\=<8[UWO_  AVF/I\6G7$EY<64*JBVTMR_EE5Z @$;@,#@Y%6=9\-
MZ5KNEIIMY;8@A96A\D^6T++]TH1]TB@#EM;T_4]-\'>+8;V^2:VDM&EM;<SO
M-);@HP8%W )4D<>G(JYJEQ>6K^#3;WLT45Q<QPS0H0%D7R6;GC)Y4=\5J_\
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MG\Z ,._DENM$\1:Y8ZC=1*;>06CQS$H/*0Y=5.5!+@C('101U-9VI32W.A>
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M>6]J\"32A&N)/*B!ZNV"<#\ 3^%,66].J/$UM&+(0AEG$GSF3)RNW'3&#G-
M%?5-!T_69[2>\CD,MF[-"\<K1LNX8894C((X([U GA73(Y-2D3[0&U48NSY[
M_/QCUXXXXQQ523Q%J=V]VVAZ5%?165Z;.97N/*=F &YER,84MW.3@^V=VR>Y
MDL8'O84@N60&6)'WJC8Y />@#%N_ ^A7FDV6FRP3>5I__'I(L[B6#MA7SG&
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M 5%TRS35I-56%1>20+ TO<H"2!^9_E63=^!M!O9-0:>VF*:D=US$+B01L_\
M?V X#<#G%;&H27D-A-)I]O'<72KF**238KGT+8.*L+DJ"P ..0#G% &2GAC3
M8]5M]33[2+JVA\F-C<N?DSD@@GYLGDDY)/-,NO">E7>KR:H5N(;F=!'<&WN'
MB$ZC@!PI ;%;507MY;Z?9RW=U*(H8EW.Q[4 9MGX4TJPM-.M;9)TATV3S+=?
MM#G!P1SD\CD\=*T[JW2[MI+>1G5)%VL48J<?4=*FHH S]$T2R\/Z<FGZ<LB6
ML>=D;R,^S)R<$G/4U%=>';"YU,ZDIGMKMX_*DEMYFC,J=@V.N.QZCL:;JNNI
M9:-JU_9)'>2:4KF:(R;!E4#E<X/.TBKFE7AU'2+.^9 C7,"2E0<A=R@X_6@"
MG=^%])O+"RL'@>*VL)%EMXX9&C".OW3P>2#SS4HT&R&NC6_WQO1!]GWF5L>7
MG.W;G'7GI6E10!B1>$M(@+I'%*MJ\WGFS\UO(\S.[.SIUYQTSSBM"_TNRU,V
MQO(%E^R3K<0Y_AD7.#^&35#Q!KD^B3:6L=HD\=_?QVC.92ICWY^8#'/0]QVK
M:H J0Z99P:G<ZE%"%NKI$2:3NP3.W_T(_IZ53_X1C3A=ZE=#[0)=40)=,)V^
M< 8&!GC )'&*9-KL\/C&UT%K1/*N+22X6X$I)^4J-NW''7KDUH6<M[(]R+RV
MCA5)BL!23?YD>!ACP,'.>/:@#,/@[2#8:?8XN?(TV19;51<O^Z91A3G.3@$@
M9]:YB?2//U[4IM0T7Q!!=W%R2DVE796&:, *AR' #849W <UZ)10!GZ':W5E
MH\%O>3RSS)N^>9][[2Q*AF_B(4@$]R,UG7/@?1+F:_D,=S$FI _:H8;ETBE8
MC!8H#C=[UT-% '/ZAX)T/4K>QAEAG1M/7;;3Q7,BRQKZ;\[B/J:GN/"NDW-C
M96312I!8S">!4F=2) <AR<Y8Y).3G).:T-0N);33KBYAA6:2&-G6-GV!L#.,
MX./RJOX>U1M;\/6&J-$(6NX%E,8.0N1G&>] "+H-DNO?VW^^-[Y'V<N96P8\
MYV[<XZ\]*F_LNR_MC^U_(7[;Y'V?S>_E[MV/SJCI&NS:CK^M:7-:) =+>)0Z
MRE_,#IN!Z#'&.*VJ ,+5_!VC:UJ4>I7,4T=VB>69K:X>%G3^ZQ4C(J=_#.F/
MJ-C?B.6.;3X_+MA'*R)&G *[0<$' Z^E7XKRWGN9[>*4/+;E1*H_@)&0#[XP
M?Q%0:9J2ZK$UU;J/LA8K#+G_ %N#@L!_=R.#WZ],9 ,G4DG\0:H-'N-%F2QM
M+F.X>\GV^7+LPRB,9R26P#QTW>N*N>(=$&M"R :2.2UN5G25)2FS!Y.!]XXR
M #Q_(W[Z>:UM7GAMS<&/YFB4X9E'7;ZGT'&?44ZSO+?4+.&\M)5E@G0/&Z]&
M4C(- !>VD-_8W%E<*6AN(FBD .,JPP>?H:S!X4TTQPP2/=S6D#*T=K-<N\0*
MG*Y!.6 (& 21P..*VJ* *)TFW;5UU0O/]H6/RA^];9MSG&WIU%27&FV=W?6E
M[- K7%DS-!)W3<I5OP(/3Z>E)#/=_:KP74$4-K$5\B82Y,B[<L6&/EP<CJ:R
MM5\3_8H]#N+2W2ZM-8NH8%E,A4H) 6#!<<\ ]QVH L'PS9+<W-Q;SWMK+=R&
M2<P7+J)"1C.,X!P ,@ \=:OZ?I]II5C'96,(A@B!VH"3U.223R22223R2:L'
M.#@9/8$U7T^2\FL(9-0MX[:Z9<RQ1R;U4^@; S0 V^TNSU&6TENX%E:RG$\!
M/\+@$ _J?T]*+?3+.UU&[U"&%4N;T()Y!U?8"%_(&K=8^O:U<:5<:9;6MI'<
M3:C<F!?-F,:IA&?)(5O[N.G>@!T/AO3[>ZU&YB-PLNI@"Z;SV^? P,<\8''&
M*@/@[1VT:UTC9<?8[.198(Q<."C*<KSG/!Z4S7_$YT"P5I[3==O%O4 MY&X$
M J92N <$D9 SBK2^([1M'DU5;>]-M')LP+5][#<!O5,;BO.<XZ T 7[I_(L9
M6VR2;(S\J*69N/0=37(^!/#:)X0TJ#4X+Q);0[VM+@L$24,2&VGKV(Z@'GJ*
MU=!\4KKHEBBMF%Q'YIRNYH,+(44&3&,L &P,D U-HVMW5_J^J:9>6<-O+IWE
M9:&<R*^]2W=5QC% $]MH%C::W<ZQ%YXN[M568F9BKA?NC;G'&>.*@?PGI+SW
M;B.5(KY]]U;I*RQ3MW++TY[X^]WS6U3)94@A>61MJ1J68^@'6@"MJ>E66KZ9
M+IM] LMK,H5X^@(!!'Z@4S6-&LM=TN33+Y':UEP'C1RFX#D#(YQP*H:/K>IZ
MLUC>)I<8TJ_@,J3B?]Y#W7>I SN']TG!_.MZ@#&U#PMIFI36=S-]H2ZLEVPW
M4-P\<H4]5+ Y(/O42>"M!33;_3FM'EMM1E,MS'+.[AW/\7)X/ Y'/ YK>HH
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ML"S%W';8,D?F[&P6"\<'/)]J )[/0+&QUB[U:#SQ=7NWSRTS%7VC"_*3@8'
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M2HZR$&$YS\F,+L],<9- '>T5Q%E;VOBVZ\3VFJ2NEU:7A@A96P]I$$4H\?\
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MN+/-V$\MI4E=/,7^ZX4@./9LU9TG2-/T+3X[#3+9;>VC^Z@)./Q))-7:* *
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M #Z*C:>%&*M*BD=06 IY900"P!8X&3UH 6BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBLYO/\M0K"9^<ER02<EBW;GFF:GX?CU+6-.U07D]M/IQ?R_*"X<. &#9!R"
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MA0509(50  !DD^I[YP, '/\ B^XO['6]$OI[&VNM'@O45@KMYL4K_NTDQC!
MW$8]_P NQK%MO#TNV!=3U>ZU-+:02Q+,D:C</NEMJC<1U';/.,@5M4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
B%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>ebs20191231exhibit1048012.jpg
<TEXT>
begin 644 ebs20191231exhibit1048012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&((?!]@>,'W'K4WP]_L;6;+0$N+_ %#^U]"9U6R"*H@SPQ;Y =I &<M[=>*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4E+10 @55)(4 GK@=:, D' R.AI:* $(!
MZC-+110 4F!G.!GUI:* "BBB@ IJHJDE5 SR<#K3J* "BBB@!" <Y .>#0 %
M    '0"EHH **** "D  )( YZTM% !1110 F 2"0,CI2T44 %%%% "$ ]0#2
MT44 %)C/6EHH 3%+110 @  P !]*6BB@ HHHH S9]&A?6X=8@?R+Q(_)E8+D
M319SM8>QY!['U&16AL7(.T97IQTIU% !30J@DA0">I ZTZB@ I,8Z4M% "8P
M.,"L[2]&ATV>[O"YFO;YP]S<,,%L#"J!V51P!^9))-:5% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ,<\'\C^1H NT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ&T4B^JL,'^=<_I'@>STWP$WA5V$B30NDTH7&YVSEOP.,?04 3Z!J4/B2?\
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M56/5-/E65H[ZV<0#,I693Y?^]SQT/6HQK6DL\*#5+,M<-MA47"YD/HO/)^E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "N.^*NCWFM^ KRWL$:2:)DF$2C)<*>0!W.,G'M78T4
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M@+?XN:';ZI=_:K6+10MI/<+M$IVD%L'HQP<]^E>EW>C:7?W,5S>Z;:7,\/\
MJY9H%=D^A(R*=?:5IVI^7_:%A;7?E-NC\^%9-A]1D<4 >>?!J2V,OB>.V:/R
MQJ):-4(QLYP1[5Z=5:UTVPL6=K.RM[=I"2YBB5"Q/))P.:LT %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 W>GF>7N&_&=N><>N*=7G-_J%Q8^+-.\9-<$Z;>7#:8\>?E2 G$<G
MT,BLV?[K+77:]K\.B26$4AA1KZ<PI)/)LC0[2W+8/)Q@#N30!L454TVXN[FT
M\R]M5MIA(ZE$DWJ0&(# X&00 >G>L+Q!XLN]#@U*[;3%^R:<4R\\WEFYR 6\
MKY2#@'UY((XQF@#J*@N[RUL(#/>7,5O$.#)*X11^)J2.19(EE'"LH89]*\\\
M;ZQ/KWP[N]1MK"%M-DE012O+^]*B90) NW !(X&<X.?:@#T W5LMVMH;B(7#
MH9%A+C>5!P6 ZXR1S4U8$VK;/',.DG2XC(UA)/%>%QOP&4%,8R!D@]>PK/T[
MQI?WEO<:A<:-';:;8RW,=Y.;H,T?E \JNT;LD8[=: .OHKE;;QD[ZOI]I+:0
MM!J ;;);3F5K=@,@2#: ,],@\'CWJ:#Q-?WEM9:E8Z.;K3;RX$2M'*?.6,D@
M3%=N-O&<9S@@^HH Z2BN6\.ZKJ]_XJU^VO$M_L]G/'$FR5OD'E[A@;>2=W)R
M/QQ5OQ'XAN=#N]+@@TX7?]HW(MP?.V;&*DCC!XXZ]J -ZBN9?Q1=0-!8WEM9
M6>J/ T\L4UW^ZC7>57#!<L6QGIQ@Y]#7MO'D5Q8Z;)+:I8W%]<26Y%W*5CC=
M!GA\?-NXV\#.?;% '74UY$BC:21U1%&69C@ ?6N?NO$=_8'2%O=*C1M1OC9N
M%N2?*.7VL/D^8%4SVZBGQZRVHZMKFAW-C&BV$,;B3S=XE60,1E2HVD;?4]:
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M*O#84XQOZ<Y([8%3:GXZ%I#=W-G;0W<-E.89(A/B>7:VURB;2#@YZGG!Z<9
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MB04!.-RXZL,\=/7VK+\0M=Q^./"=Q]@A:]*WJ^7'-\I_=KC+E0<=SQQS@'N
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M5D^4 9'0]R,5@^--6N=<\$1:E%I\(T^>[MS#(\A\T)YR[7V[<#=CIG."/<
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M<,TUM@31QN&,9.<!@.G0]?2K- 'G-WH^IZ;X8U72KQ--DFU?5R]FC2L!*9)
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M$V1%)&R[60D=.,8/M576=#\0^)= +736EAJ,%Q#<V<"2&2.-XR2-[X!.[)'
MP,#KS7844 <E'8>(K[Q;I.LW>GV=K%:VTT,T8NR[9<KR,)S]WI^M:'C'2+S6
MO#[6MAY7VE)X9XUE8JK%)%;!(!QG'I6[10!S!TW69?&ECK4MK;K!#826\BI.
M20[L&XR!D#:!GC//%8EQX4U^7PUJ^FK;6PFOM9-_$3<?*$,JR8/R]?EQ^->A
M57GO[*UF2&XNX(99/N))(%9OH#UH P/$FE:U<7FE:[HHMQJ-@'22UG<A)HY
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MDCIU$TGB6]TZSN&U;31#.EXEK;%7_=W1?&U@<$J.3G@XP<9Z5C)X0UZT\/\
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MTGPM,]FYCNKF2.UAD'5&D8+N'N 21[@4 :ESK6E6:;[O4K2W7>4W33*@+#J
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MQAXTGTJVM9)8TM)'-PY5?E@)P !DD_@!6Q'XP%[9Z.;2+R[C5+/[7AHWE$"
M+G*IRWS. .G<Y[$ ZBBL;PUK%[J]I<'4-/DLY[:X:$EHW5)@.DB;@#M(_*CQ
M1?+;:8MJ+E;>74)!;)*S!=@8$NV3W5 Q'N .] &K#-%<PI/!(LL4BAD=#D,#
MT(-0ZCIEAJ]H;34;.&[@)R8YD##/KSW]ZY+X<W<=H-4\*_:%G_L>X/V9U<-O
MMG^9.>Y&2#Z<"M"V\3SZAK-W86;V@FLKP0364N1/Y60#*.>1@D@8Z=\\4 ;&
MF:'I>C!AIUA#;%QAF1?F8=@3U-3QW]I-?3V,=Q&]S;JK2Q _,@;.TD>^#6!;
M^)Y[_6KO3[-[0365XL$MG-D3F+*[I5YP1@D@8/ Z]J6/Q'<)KOB*UETZ/&E6
ML<Z&!BTEP"KL >!@_+@#GKU- '345S.D^(;W6; WVGSZ;>6\EJTBR1%AY,W&
M(W&2>A/H3CH*I>&M<URX\$:7J$EO%=7%ZZ[YBYVQ(Q8O(X..%QT!]!D4 =G1
M7%OXWNTT+Q#=Q06=W/HCXWQRE8IT*!@PZX.#TSVZU;@\2:LGB#2K&^L;5+?5
MX)'MS%*Q>-T4,0^1C!![9Q[]P#J:KWE_9Z=")KVZAMHRP4-*X4$GH!GO[5S_
M (+U+5M2;5WU(P,(=2G@4QLWR["J@ $?=P.N>IJ'QC;:W:ZKI?B+1[)=3_LY
M94FL2V'97QED_P!H;<>O- '266IV&HAC8WMO=!0"WDRA\9SC./H?R-6JX[1/
M%?AN[MM9\26@DMYH8%.HVLD>R:,QAR-R]R02,^P':K$'B;4QJ^GPW&G-):7J
MMYDD-O,OV-@,C>S##*>F[Y>>U '4T5S-IK^L:C9Z?J^GZ=%<:?>SA?*W;9DA
M)($Q)./0E<=#UJ*S\1:]?ZWJ-E#IUA'#IEY'%<227#<Q,H8E?EY8 YP<#MSU
M !U=%<<OC._FBT_4;33)+JQO9E4Q16TQEBB;[LN[&TC&"1VSU-+HVLZY-JWB
M=IX(KI=/FV0V\+D,<1!E1<C&23R3CDT =A17+6/B>]?Q%;Z-=)9R37-D]QM@
M<@V\B[<Q/R<_>^]QT^[5;1_$7BG7;![VTTO342.2XB99+ARS/&Q"A>.A(QDX
M]<<<@'945R^G^)[K5?#>DWUK' +W4)Q"T+!L1$;O,!YSE K'WQVS71W'G^0W
MV8QB7^'S =OXXH JC7-+.I)IWV^'[6Y8)%NY8K]X#U([CJ*OUYOX4U5[#X>:
M+>WUO;7EQ<70BT]6&&-Q)*XR6.<=6)(YQFNF_MZ_L?$D.A:A#;R27T#RV4\6
MZ-)&3EHV!W$$ @Y&>.U '153OM8TO3&5=0U*TM&<943SK&6'MDUA>$O$&N>(
M[2UU&;3[*WL9?.60K,S2!TD91M&,8X[\YS53XCNL;>%I&5F"^(+8D*I8]'Z
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MAZ>Y$MPT.F7'F&&(NS$ 9( Y]:G\ 6KW6IZUXFME2WTK69(WM+96!/R@JTC
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M;6:8HS,"Q4J,G [9X'U_!LGBK4+C1+[7],M;>:PLI)0(G)$EPD9(=U;HO1L
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M-%% !115:RU&TU%9FLYUF6"9H)"O\+J<,OU% %FBBB@ HHHH **** "BBB@
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M D8L57G   QQSUSQ4\/:'XITJ*WTN\U:RGTNSP(94C=;F1%^ZC'.T#@ D9)
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M7%XC&.1P0/+!#* >_)[C JUI&BR6NK:CK-V8_MFH>6K)$24B1!A5!(!/4DG
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M]: .ZHID1D,2F5563 W!&R >^#@9_*GT %%%% !1110 4444 %%%% !1110
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M"PU"SU2SCO+"YCN;>3.R6)MRM@X//U!J.XUG3K748=.GO(DO)UW1V^<NZ^H
MYQP?RKAO DJ^%M3;09W$=CJ-DFIV+,<*IV#SDS['YL=A3+)'G^*>D:M,K++J
M5C<3*K=4B^41KCM\N"1ZLU '977BOP_9:JNE7.KVD5ZQ $+R ,">@/H3Z&K]
MY?VNGQK)=3+&';8@/)=O10.2>#P/2N=\9:-9W/A2YT:WM(WN=2D*P*1DF9FW
M&0G_ &>6)]!]!58!S\5]/T^61I8M/T%IHBW4R-*(V;Z[1^M '5PWUI<60O8;
MF)[8J6\T,-H ZY/;&#GTQ4=CJUAJ19;.Y25D 8J,@[3T;!ZJ<'!Z'%>6Z[=S
M1R>*-&C)%G<:[9HX'0"8!I!]"5Y^I]:ZOQ1<R:=X^\,36P^>>&]AD4?\M$6,
M. ?HR@T =*=9TT7WV(WD7G[_ "]N?X\9V9Z;L<[>N.U7J\MCRWP!DO6D)N7C
M:\:;/S&;S]X;/KG'Y5Z58S/<:?;SR##RQ*[#T) )H 6\O;;3[9KF\GC@A3&Y
MY&P!G@#ZD\5F-=^&_$=PEA.MG?3Q@S+;7,(+H 0-VQQD=1SBJ_C31]3U;3+6
M31Y8EO\ 3[M+N%)O]7*5!&UOKN_,#IUK.\/^*+76_$"VVJ:9+I'B2UMI$%M.
M/ED1BI)1_P")<H#^?7K0!V2JJ*%50JJ,  8 %+7G\GC#Q*OA?4]=$6F :5>2
MPRP[)#YR(^T[3N^4XYR0<^@K976]8MO%>FZ??)9M9ZM#,\(A5A) T8#89B<,
M"#V H Z>J$6N:9-?W=C'>(UQ9('N$&?W8.<9/3L:YRY\5ZK87NG)>)9HUYJ8
MLY;) 7D@1BP1S(K%<D '! R&]JGTO_DI^O\ _7A:?SDH Z#3-4LM9T^._P!.
MG%Q;2%@DB@@-M8J>ON#5NO-M#UN_T#X;Z//8003&;5)+=EF)'#W4B\8[^Y_6
MM@>*=6T7Q%+IWB6.R^S264MY;W%F'&!'RZ,&/) YR,?KP =C17&W7BO5=/\
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MY@\UFX2==I&QBH8#GKP1TKEY[G6W^(>EVAO((HFTN29X# 6 ;=&'Y#C)]#T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP\K.Z$JH5>O7[H/;I76T4 <UIFC^)3:&VUO6X)5BA:*&2SA:.1R5*B20DGD
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MS%25"[2_*5.2",9W$Y]:MVFAWMKXIU36A=0,E_#'&L)C(*>6&VDMGG.XYXH
MY2^\0:UK'P[T?5#<PVUQ=:G'%.L41VL/M)0 9.0/E&>Y]1717.KZOIGB[3-/
MOI;1]-U&-T29(&1Q<*,["2Y !&2..V*I0^![N/P1;^'SJ4/GVET+F"Y$!V[A
M*9 &7=R,DC@T_P 6-9:KIZ>&Y-2C?73+#)"+?Y9(I-P/FJN2551N/4\=R3R
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M)G:%0GD<MG)R<^P DM/#^LGQ5;:_J&I6;21636KPP6S*K L&R"7.#D#G].]
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MDTF0R13QVY2:3Y2H5FW'CG)]2!TJ[XGT*37]-BMX+W['/!<Q7,4AC\Q=Z-N
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K-\0:Y:>'-#NM6O2?)MDR57JQ)P%
M'N20*TJY'XH:%>>(/ UY:6"-)<1LLR1+UDVGD#WQG'N!0 GAB\\3^)=)CUN>
M\MM-BNAOMK1+?S,)_"78D$D]>,<?IN:%-JLUI-_;$<,=U'.Z?N00C(#\K#//
M(Y_&L+X>>(=-N_ VG(UW##-8VZV]Q%(X5HF0;?F!Z=,_C6CJGC71-(L[*[NY
MI1!?3^3 ZQ$[SG[W^[[]QR,T 87CS6_&NBVUQJ^DPZ>FEV)&])\M-,,@%L=
MN3TSGC/M76:#J9UK0+#5#"83=VZ3&,G.W< <5Q/Q!\8^'#?+X7U343#;$K)J
M!B1G9E!!6(;1P2<$GL.._';:#J-KJVB6M]8Q&*TE7]PI7;\@)"G'8$ $#WH
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MM!Q[E<?A5#P8=0T#Q+I&C0W,&LZ)?1S7&EW(_P!9:_(2V<?=^]A@>,G(Y!%
M'J(UK2SJ']GC4+;[7NV^3YHW;L9QCUQSCKBKU>)^"8K36-#_ +(UC6WL-4L-
M8-T;;8OVB2<'AAGECDD''3%>V4 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4!0/3%/HH @MK&TL@PM+6&W#G+"*,+N/J<4D&GV5K*TMM9P0R, K-'&%) Z
MD"K%% $ LK1;LW8M81<D8,PC&\CTW=:GHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB^FQWD+WD:>8\"N"ZKD#)';J.M %JBBJL.IV%S?36,%Y#+<VX!FB1P6CSTW
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M)()$,[;LN5.1\F"!M]LYH SX/&;0>'-3U2ZL8+4V>J/92"-BT:8D5&D8@ D
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MOW-K#>0^3<1B2/<K%3T)5@P_4"@##T[5_!6D0M;:;JFAV<;$R,D%S$@)/\1
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M^4,Y"(OH/04 9?@WPJOA33Y[7SS/OG<Q,Q),<.X^7'D^@)/U8UE:MX/UN_\
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M#)B )VJ@)//8#G)YU]2BN)]-N(;41F:6-D7S&*J"1C)P#4J7,,EQ);K(#-$
M70\$ ]#]#SSTX/I3I)$AB>61MJ(I9CZ =: .4\/:3XJ\/^&K;1XAI$S6L92.
M9I90#R2"5V\]?459GT#4Y?$.@:B9X)4TN&6.=I'8/,TBJ&8#;@8*YQGOCBMZ
MQO;;4K&&]LY1+;SH'C< C<IZ'FIZ .?U'PP+WQ98:VD_EI#$8KJ+_GN%8/%_
MWRXS5?6]!UH>(XO$'AV[M([DVXMKFWO0WE3(&+*<KR&!)_SUZBB@#)CM]=BB
MLO\ 2[2:4S[[YGC8#80?EB /&. ,^A)YK6HHH YH:'J?_"PCXC_T3[*=/^P^
M7YC;\>9OW_=QGMC]:EU+1M0N_&&D:Q$;;[-I\4R,CNP=O, !(^4CC:/K[5T%
M% '$/X)U*ZL-:MY;N"VFO-3&I64\+,Y@E&W:""HR/D'/N>*WM$@\1[_.\07-
MB71-B16"N$8G&78MWXX &!D]<\7M3U2QT:QDOM1N4MK>/[TC]!_C5E'61%=3
ME6&0?44 96KV.H7U_IPA6V:QMYQ-<))(P:0@':  I& V&]RHZ51\8^'KW7+>
MP;2GMK>]L;M+F*>8D;2O; !R#G!'%=+10!S6K>'+ZZU:Q\1:=-;VFL6T1AE1
M\O#<1$Y*,0 1@\@X_ UIVXUFX9#?):VB(<E+:=I3(>P+%%VCVP<^OKI44 9&
MC6%]!<ZA<ZFMLTUU.'1H79MJ!0JIRHZ 9]RQ/%9NDZ!JVD>*]9U"#['_ &=J
M;+)]F\U@R2!<;_NX^;N/UXYZFB@#D;WPC>:OX1;2;V:&VO([HW5M=6[LWE2>
M87##(&"-Q'ZT_6?"]Y/<^'AI8M8[;1)A(%FD8-( NW;PIQQWYKH=0U&TTJU^
MU7TPAAWJF\@GYF(51QZDBK+,%4LQ  &23VH YC4['Q?/K0N[)]%^S0C_ $>*
MZ$K%&Q@N=N!N.<>PZ=3F6ZT'4]0M-,O+RYMFUK3K@W"/&I6$YR&C[D*4.,\G
M(!YZ5KZ;JUAK$#SZ?<K<11R-$SIG 9>HJY0!SB^%4OY]8NM8\MY=6@%JT<+$
MK#" 0%5B 2226S@<XXXYCB\-W]U_8MOJTUO);:*ZRHT1):YD12J.P( 3 ).
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ML\:PLH1AN P<G@;L^IQVJ,^$M4_L+PYIHN+3=H=S%,7.[$WEJ5 QCC(;WZ4
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M;MUS*JE49@1\F,DD G)QR*BMO#.I:2=6M-+N;;[!JDKSKYV[?:.XP^T#AQW
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MOYB]8]I8Y!'(/;H<U!::SKYUC3D>S-S97:L+EEM)(?LK8RI#,?G4G@\9[^U
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MB'H7_7A#_P"@BN;T;5I(/$OB/2=.DMQJMWJI>);A246-8X][D @G@\ '))]
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M!^% '4)J-E)I_P#:"741M-A<S[P$"CJ2>V,'/I3+'5;+46=;6;<\8!9&5D8
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MT$<#6DD@N&3&\%P0%YR!Z8R>N!=M]=OM9UB?3+%4L7L[6&:Z,\9D9))02L>
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MCM+Q+^Z;LJQ@[%/NS$<>BFNDJO=75KIUM)=7#K#$I!9L=22 .!R23@ =3P*
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MVT.:;71K6J20RW$5L;:"*)2$12<NW/)+8 ]@,<]:VZ9)(L4;2,&(49(52Q_
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M]U$D=[');>;'-MX5P-P(8#CK_P#7 *5WXOOK%-)77D_L$7ENQFG:/S(X[@$
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M%:UQX=OKK7]'U634H =-BDC:-;5AYOF!0Q!\SY?NC'7\:QX/ 6I0Z5IFG?\
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MFWO95>6T=<>7;MGY@^<EP,$CH>1CO5R/0;B[U2SU'6KB"YEL8I$@2"$HFYP
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 445G:_K=IX<T2ZU:^)$%LFXA>K'H
M%'N20* -&BN1\,WWB?Q+I,>MS75IIL-T"]K:+;F7"=B[%@3GKQCC%;>A3ZI/
M:3?VQ%%%=1SNF(00C*#\K#//(Y_&@#3HKB?'NL^+M#TZXU?2ETZ.QLBN]+@,
M\LP) R,< 9/3.?Y5U>DW<U_I%G>7%NUM-<0)))"W6-F4$K^!.* +=%%% !17
M$Z+XLN/$NMZQ8VFIVMA<:==/!!9RP[VE5>#(W()!.>%QC'/6NBL-1F@T&.]U
M]X+*901<%FV1HVXC@GMZ>O% &I15.VU;3KVS>\MK^WFMHR0\R2@JA'7)[8[Y
MI+/6M+U".22SU&UN$A&Z0QRJP08R">>!CG- %VBLC_A+/#F(S_;^FD2OY:$7
M:$,W' YZ\C\Q5^\U"STZ(2WMU#;HS!5:5PH8GH!GJ?:@"Q145O<P7=NEQ;31
MSPR#<DD;!E8>H(ZU6OM:TK3)5BO]1M;61QN59IE4D9QGD],]Z +U%<?\1/&O
M_"(Z+!)9O;/>W<RQQ+*V=J'),FW() QCTR16SH1U:73YWO[ZRNA)*S65S:C(
M:$CY"W8M].* ->BO/_!_B[7=7\3:YX<UF2TM[ZP'[@PP$!P&P7(+<CE"!QPU
M.^'WC/5?$&MZUI&MM:I=Z:^Q4MXR P#%6;))S@@?G0!WU%8VDZE*-%?4]7O;
M9+=G=XYB/*00[B$8DD]5P>W6KEOK&F75K+=0:A;2009\V195VQX&3N.>./6@
M"[16;'XAT6<VZPZQ8R&Z<QP;+A&\QAU"X/)%<UX,\:7&IC7GUVXLK:'2[TVZ
MS?ZI<9(RQ9B,G H [>BHX+B&Z@2>VFCFBD&4DC8,K#U!'6I* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *Y#XHZ'>:_X%O+6P1I+B-EF6)>LF
MT\@>^,X'J*Z^B@#D/AWK^GWO@73E^U11RV-NMO<1NX5HF0;3N!Z=,_C6AJ?C
M70](L[.[N[B007T_DP.L3$.<_>_W??N.1FM*;1M*N+D74^F6DLX.?->!6?\
M,C-6)K:"Y"">".41L'3>@;:PZ$9Z'WH XGQLOAWQCH6JV(UCR[S20[,J3LGE
MR*,C<AP&&1C.#WP<UO>"EU-/!NE+K!D-]]G'F^9]_P!MWOC&<]ZTCI>G->?;
M386QNNOGF%=__?6,U;H P/)\8_\ /]HG_@'-_P#':U-.745ML:G+;23[C\UM
M&R)CMPS$Y_&K=% 'EFM>$/#OCJ*]U[2[Y=)UFSED6X=),*LD;$9<=5SMSN&.
MN>:QM3UO6_\ A$/ VMZZLSVT&H>;=NRG+JKCRG8=SM#8]>O>O8)M(TRX9&GT
MZTE:/[A>!6*\YXR..:L300W$+0SQ)+$XPR.H92/<&@#RCXA6FE'P'K%YX3E6
MX2\OH[G4GMI3(A!R3R"0/FVD@=,\\8K2S)-\;]+?2VW6D>B 731GY=A\PIG'
MN8R*]$AM;>WMQ;P0110@8$:(%4#Z#BH[>QM=/BD6PL[> MSMC01AF]\#]<4
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M <C##^ [,^O(]\[']MW]]J=]INEQ6K3::D?VAYF;8TK+N"+CD#&,L>F1P>:
M-^BN+?Q[//I.CWUCI:LVH7XL)H99]K03?-E?NX(^4\Y]..U=1I<FHR6"-JL$
M$%WE@Z6\A=,9.""0#R,=J +E%4M7O+JQTV2>RL6O;@%52%6QDLP&2>P&<GV!
MK!A\9,DVOP310W;:-:BY#V;9$RE6.W'.U@5(ZGK0!U=%8NA:Q/JY2>.6RNK"
M6'>ES:N3A\\H0>A /UZ\#%3ZMJ%Y9S6L5M;IY<Q<S7<QQ%;*JYRW(SDX Y'U
MH TZ*XF3QY=#PF^LQ:?!-)!J!L9E6<[2?,";T./F!R#@D=>M:NGZ]J+>+)M!
MU.RMX6:S^V6\EO,7R@<(5;*CYLD=.* -J\OK73X//O+B.WBW*N^1@HR3@#/N
M34]8/C#6)=$T=+M+&"\0W$4;K,^ NYPH8#!R02/2H+SQ!JZ^+9?#]CIUH[?8
M/M<4TUPP7[^WY@%R._ SGCD4 =+55=2L7U%M.2[A:\1/,:!7!=5R!DCJ!R*Y
MZS\:F?PU9W\EDJZA=WAL$M1)\IG#LI^;'W?E+9QT'<U16YN++XH7%SJH@5(/
M#[2&6'."@F!.0>01SW/]* .YHKDH?%]_)=:6XTSSK74F"D1)(7M=PRI<[=I7
ML2,8]ZHOXU\1/I6IZG;:!:/!I%W-#=(;L[G6(X8Q_+S@9.3CV!H [NBN9?Q<
MMZ\<6D^66>RBO#).CE0LF?+7" G)VG)[<=<U23QMJ<L6@LN@F&7599(9(;F5
MHVB=%8]"O*G&=WIV)H [.JLVI6-O?06,UW"EU<9\F!G =\ DX7J1@&N<A\:2
M65IK[:[:Q0SZ&Z!Q:N7642*#'MR <G('/>JFKMJ;>.?![:A!;(&EN2/)8DQM
MY#90Y^]_O#'3I0!W%%<=>>-KE;-M3T_3S>VD=P8C!%'(T\B!]C2+A=O4$[>X
M'4'@32>)-=N-9UO2]/TNS:338X9(Y)KE@L@<,><+D'Y0,=.O/3(!U=%<)>^*
M-4U2V\(WNFK#;PZM.#+'(Q)W!&;;D?PY'U/'2NQOKZ+3-+GO[U@L5M"TLI7G
M 49./RH M45RL_BJ^TZSTS5=1LH4T[49(XV\MR9+7S/N%NS#H#C&,\9H@\1Z
M[>^(]2TJUTJSVZ;<0)-(]TW,;KN)7Y>6P>G3CJ: .JHKC+SQQ=Q:!=>(+6R@
MELK:]-J89)&21@)!'OW ''S'[NT\<Y[5I:MK>J6'F?Z):VZ068G>XGF)B>4D
M_N4. 2>#\Q'<?+S0!T-,FFCMX7FF=8XXU+.[' 4 9))KE&\97DR>&I;/2XI$
MUZ,L!)<;3$WEE\?=Z<?>ZXS\M/M_$^HO8>(8KS3;5K_1?OQ).?*F0Q^8N&*Y
M'RGIB@#IK>XAN[:*YMY5EAF0/'(AR&4C((/IBI:YZSU:_N/#VE:E;6UE;V\^
MGK<W#32%4@^1&"C Z8+<]@M5-)\4:UJFB+J::,FRYNEBM6#D PD\SN",A<#(
M'4\=,YH ZRH+J^M;(PBZN(X?M$HABWL!O<]%'J3@\5QU[XPOY_#OBAK)K3[9
MHJG;<Q,6BD4Q[PRCLV,C&2,CJ>E6IM:O]-TOPU]KLK6Z^WW4%N93(Q,19<AP
M"O)P#SD?C0!UU%8#:W?:AJ&I6>BP6\ATPJDC7#$"64KNV+CI@$98YY/3BLL>
M/)KNQT&\T[3%D35KAK9TEFVO!(H;*D;>F5//IV- '9T5@^']=OM0U35M*U.U
M@@N]->/+6\A='212RD9 .>"#5G5M1O;2Z@@MX8DA>-Y)KVX;$4&W& >1DL3Z
MCH>M &K17%?\)W=R>&=(UB#2XI#?:@ME+']H^XQE,>5XPP.TXR1C(K0LO$UW
M#K&J:?KEM;6OV&T6]66WE:13"=P.<J#D;3VYH W+O4K'3VA6\NX;=KB01PK(
MX4R.3@*H/4Y(Z59KSWQ-J&HZKI/AO49+6"*SN]7LI8TW$RQ*7!0D]"2#R!C&
M>IKM]5NYK#2KJ\@A2>2")I!&[[ V!G&<''Y4 6Z*XVS\8ZJZ>';R\TRVBL-;
MV1!DG)ECD="X.,8VG!'7/0^U77\1ZA>PZK=:-:03PZ7,\+)*Y#7+H,N%(&%Q
MT!.<D'H.: .EHKB)_$U_JVM>%9='>$6&J13S;)=P8LL?1L=AN/ [BNMU.ZFL
M=,N;JWM)+R:*,LEO&<-(1T44 6J*YFR\43GQ'/HMU';S216!O-UHY8J0VUHB
M#_$"1@]_04_PWXCG\0I;7ENUG-93PEY/)<E[:3Y<1N#U/+<X'3I0!T=%9^KW
MMY916_V.T\]YIQ&[L<) F"3(WL .GJ1R*YX>-[@^'=>U"*UM;F;1971C'.1%
M,H4,'4X..#T]NM '8T5R]MXFU,:]I%E?Z?;Q6VL0N]N\4Q:1&1 Y#C&.1Z$_
M6MK5[R[LK(265D;N=Y4C";L! S %V/\ =4')^E %ZBN6L_&:8\0BZ6&9="C6
M9IK1MRS(4+\#G!&T@C)IG_"4ZK'?:! UA9RKKL9>/$[)Y&$#D$[6W_+T.%Y'
M:@#K**X^_P#&ETEK<:AIMA]MM[:Y:$P(DAFG"OL=D(&W@@X'.0.HZ5,WB/6[
MK7]2T?3=,M#):V\4\4L]PRJP?=C< N0>,8^O/8@'545P5YXKU35=%\*:EIR0
MVT>JWR1S1NQ)W ,=N1_#E#[GCWKM;F[2PTZ6\O&5$MX3+,R\A0HRQ'Y&@"Q5
M6_U.QTN'SKZZBMX^3F1L9QR?RKG9_%U[8Z3I^O7ME"NE7K1APCDRVR2?<=NS
M=5R!C&>,XJ"5M2D^*XAQ;-$NCDA6+8"-, QQC[QVCVX% '7P3Q7,"3P2I+%(
MH9)$8,K ]"".HJ&74K&&_AL);N%+NX!,4!<;W !)(7KC -<_XYGN?#_@*\?0
MT@M!!&J*%7:(T+!3L Z'GCTJIXC:^3Q=X0D,$$MZ)+P!$<JG,)_B(R!T)X/3
M@&@#M:*Y.V\930Z?JS:K:1)>Z9>):&.WD+),S[?+P2,C.\9X.,$^U6M,\0WT
M_B)M*NK+="]OYT5Y!%(L8(.#&VX<'N#GGT% '0]*SQXAT1G*+K%@67.0+E,C
M'7OVKG/B!>227WA_P\':.VUB]V73*<%XDP3'GL&R!]*V?$SZ1I_A:Y74[$R:
M4D6R6.*,$1ITR%XZ<=.E &T"",@Y!I:YU?$!>?2]*TZ+-S>6AN USQY4*X =
M@.I)(P,COG&,50N/&.I1:=KBQZ;#)JN@D-<6_F'9+$5W!T.,\J"<$=L4 =C1
M6/%K,MU)I1M#;RPWEN;F63) 6,!3N'U+ 8/N>U8P\;74L5AJ%KIQNK"]F5#'
M%'(9HXV/RRGY=I'0D=L]30!V-%<I9^(_$&HZSJ%A::19;=.O$AF>2[891E#9
M7Y.3SG! Q[]L]?'>L?\ ".KX@DTBT2RAO#;W2_:6,@'F^7E/EP<$CKC// ZD
M [NBN:N/$&KMXLN= L]/M"T=DMU%-+<,%(+E?F 7(Y!X&?J*RO\ A.M6_P"$
M7C\1'2+9+6WG\F]C-P2^1+Y;&/"X(!YY(SS]2 =U17.ZIXDFCU"\T_3HXFGL
MHE>0S*Y#,P)5!M!QP,DGID<'G%%?&>IW%QH$,&A^4^LQ3-Y=U*T;PO&N2K K
MTSWY)':@#L**X'5_%FM/X)\1R+#;6>IZ3(UO*T;LZ8V@ATX!SAN,]#S[5VM@
M;DV<9N_+\W'/E$D?K0!9JO>W]GIMJUU?74-K GWI)G"J/Q-5/$6L)H&AW&IR
M1[U@VY'.!N8+N. 3@9R?8&N=\4WUQJ'@#Q \C6EQ:FQ+V]U:ME)00<]S@@@=
MS_0 '9HZR1K(C!E8 J1W%.KE-.U_4K75]&TJ^L8([;4K5C;/',6D5HT5B'&,
M<@]B<>]-N?%U[8W>G_;+."!+_4/L:VKR8N$4L564CH02,XQT(Y- '1)JNG27
M-Q;)?6[36J[IT$@)B'JWIT/6GV5]::E:K=6-S%<P.2%EB8,K8)!P1UY!%<WI
MH ^*6N8'73K7/_?3TOPT 7P3;*!@"YN@/^_\E '5T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,B[=RG:V5(Z@\CWK=U'4K'2;-[S4+J*UMT^])*P4?3Z^U6$97174Y5AD'U%
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MXD4=VT8,B)G:K$=!ZXZ9[UQ>B^*+_3O#NMZSK$L5UY&I30)'$I0NX<1HHR2
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M6+_7_ 7B"^L/LJ:>D=Q BR(Q>94RKN&# +R#@8/0=,\=CHW_ " [#_KVC_\
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M7&KZ;:72VL][#%,VWY&8 C<<+GTR>!GKVK"N])@N_B#I5Y90I$VE02_:Y8U
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M!F3=L7;&1CA222?3 /.-#P[J5[JVAV]YJ.GR:?=N");>0$%2"1D9YP<9'UH
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M)]G03A!)M <(25S[9KF=(\/:MX6>:TT62TN=)DE:6*UNG:-K8L<E5=5;*YY
M(!'K6WINM:?JTES%9S,TMJX2>*2)XWC)&1E6 /(Z''-7Z ,RXM]9_LRY:UN[
M8:E(!Y1E1C!'@]-H.3QGGJ3[8 J^+]%N_$7AFXTBVEABDN=@:63.%VL&X ZY
MQCK6[10!D:[HK:_I$<$KK;W<,L=Q!*OSB*9#E3VR.QZ<$U'::+/+XB_M[4C"
M+B.V^S00PL62-2=S-N(!))QV& .^:VZ* *>EIJ*:=&NK2V\MX-WF/;H50\G&
M 23TQ^-7**I)K&GOK+:.ER#?)#Y[0@'(3(&<XQU([T 7:*** "BBB@ HHHH
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MQND)8Y..P &>><4 <[X;\2:CIW@&SO[N>*\N]1U![6V#1E,S27,BY<Y.5ZG
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M\P-%YFT@,.>V>V.ASQ7N=9U35]2\$7=I<Q6L6II),\+0EU#_ &=FY(8$@;B
M..>>>E:L?AS48M2\1W8N;8C6D0*NUOW16/RP2>_'/;FJ\7@_4K?3_#:0:A;)
M=Z#E%=H&9)4,9C.5W @X.>O6@#KAG'/6N.\7_:O^$S\(_8A%]H,MV$\[.P?N
M#R<<G'7'?ID=:V=/DU<^(]0BN+B&XTX(A@V1;6B;H5+=&)Y)]./6F:[HESJ&
MJ:3JME<11W&ER2.L<RDI*'0HP)!R#@\'GZ4 9%OXFUZW'B#3=1BL6U/2;874
M,T2N(9XRI(RI.005(/-4O$U[J.K>!O#FH>=;Q->SZ?+,GDL07=D88^884'MS
MGU%;S^&YY8M9N9)XCJ6K0>07VGRX4"E54#J<;B2>,D]JJ7?A34I_">C:)'>6
MR/ICV[&9D8B3R<;>,\9P,\T 68=4U*'QLFB3FRD2;3&NC-';LC;UD5 #ESD8
M;I^M8T_C/6XO"EWJB0V+W%KJS6+#8ZJZB41@@;C@\YZD5MZEH6J3>([+7=.N
MK6"XBMGM9TGC:1"C,&RN"IR"._6LA_ NJ'PY>Z2-4MG-UJ9OA*\!RO[P28.#
M@DD#H!CF@#3_ +5UN#5+;1;J2P-]>M-,DL4;[(K= O52V6<LV.H&.>V"]K_Q
M+:Z7(UW;6"31WWE?:C(%B%MG_7E2W!QQMW=?:CQ#X=O]3N=-U;3;Z*RU?3MV
MUGC+Q2*X =&&0<''!ZC]:AU/PWK.I:?9O)JT!U*VO8[LY@;[.VT$"/9NSM&<
MYR3GGTP 95]XHU2Z\.>+HX+F*.XT=,Q74<#+YB-%O'RL>&ZC=TZ$"M&+6[NP
ML]$TOS$>ZN[0R^;':2.(XD5!]Q6)))8#.0.I]BW_ (0V^F;Q(+O5(737H%1O
M+MRIC<1[,CYC\H].OOZEYX3UF:TTBZM]7MX-9TE2D<RVY\F2,J%9&4DG!V@Y
MSUZ8[ #(_%FKVUB(-0T]8[^XU);&RD:)HXYU;D2E"=P 4,2N>HQD9X2T2^C^
M+3+>S0S?\2,^6\493CSQP02>^>?>K&J>%-3UG283>:LBZQ;727=O<10D0Q.G
M 4(225P3G)R<^P%366@ZU_PED6OW]]9%A8FT>""!\$;]V02WJ.OX8[T =+11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !117/\ CC5[_0/"5YJNG&#S[8*<3(6!!8+V(P><]^G2
M@#H**Y==8U?3_&4.F:G-:2VE[9RW$?DQ,K0-&5R"23O&&ZX'(Z#I5.W\1^(+
M^TTS5M.L6N+:\E0RVOD;=D#?Q"0MRP&">,'GI0!VE-DD6*-I'SM49. 2?R%<
M==>(]=O;:^O-!MO.:TNG@AMC;Y6X\MMKY?<-I)#8QTXSG-:$&LWVM:U?Z=8.
MEB-.BB,S2Q^8QED7<%QD#:HQGN2>",<@%A?&&AMI%KJJW;&SO)O(@D\E_G?>
M4QC&1\P/7%;=>3V>_P#X4_HOF8W_ -L)NV],_;6Z5V.H:YJ-SJFI:;I68Y-/
MC3YOLQEWRNNX \C"XV^YR>F.0#IZ*XJZ\87MDFDKKJ#0/MMNQEGEC\R-+@$
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MZ? -+6)X9'MV8L&0OM(W=>V[/;ISP =E4-W=V]C;/<W4HBB3&6/N< >Y)(
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M"8RBJS*R$%CGID&DM-:\1SW.DW,=F;BTO<?:XQ!L%LK#(=7+?,!T/'/48Z4
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ME4R6GD;=D#?Q"0MRP&">,'F@#M*S;[Q!IFFW8M+JX99_+\WRTB=R$R1N.T'
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M$L^KZ)J,5NE]%''>6]S"TJL4&U74A@0V..>M=/2$@8R>O2@#BX_ M_'X0M-
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M?59;V&:+4S&3"L)5HRB!!\VXYR.O'6M>SNHKZR@NX"3%/&LB$C!VL,C]#4U
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M;4+UG2W@4O(R1LY '?"@F@##M_#VMGQ+#KUYJEFT\=BUHT45HRHP+!L\N3U
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M 1P?7I3[_P )R.-!ATRZAM;71)%>..2$R%]JE "0PQP3SZUTU% #&3?$4?\
MB7!Q7&CP-J2^%++0!K4#1V-S'+%(;0\I&^Y5(W\DGJ?0=.I/:T4 <Y<>&)[S
MQ1+JUU=0/;3Z:=/EMA"060L6)#;O4XZ=*AT#PSK>D+!8W/B'[7I5H1]GB^SA
M9BJ_=5WSR!QT'./3BNIHH S=?T^\U71Y["SNX[5IQL>1XR_R'[P ##DCC.>]
M-UK2#K'ANZTAFA0W-N82QC)1<C&0N1TZCGL*U** .6;P=+?>$[31M6U'SKJP
M*-:W\$?ER1NGW'P2<D=#ZUHVUIX@:$6]_J5FR@8::VMV21Q[98A3[\^V*V**
M ,G^R[P^(XM1>ZA:T@MVABM_*.Y2Q!+;MV"3M Z=/J:I:YX;O=1\2Z5K=A?P
MVDNG!U8/ 7\Y'P"I(8<<<>A.:Z.B@#&BT6XDO-4:_FM[BTU) C0+$5( 7:03
MN.<CV%8\_@+;\/V\)6-^(UE4++=31%V;Y@>FX=@%'/  ]*[&B@#FM5T/Q!?V
M]C!;:S9VR6P!E5K(R+,XZ$@N.!P<<\\^E/'AR^U+1M0TWQ)JB:BEZ@C'D6XA
M$0'<#)^;/.3Z"NBHH PH- N9M5L-1U:\CNI=-B=+<1Q% 78 -(V2><# '09/
M7/%27P<S6%]H\-XL6D7]PTTL0C/F(&(9XU;. K'/;C)'ICJ** ,6ZT%DUF'6
M-,DBM[F.V-HZ21EHY(LY48!&"IZ'T)'N+&@Z+%H>GM;I(9I9IGN+B8C!EE<Y
M9L=O8=@!6E10!B^)_#</B2TMH7F>"2VN4F25/O ='7/^TA8?B#VIFOZ!=:G<
MZ5=Z=>QVD^F3-)&LL/F1.&0H05#+R >#GBMVB@#C)/ $EQ8:Q:7.L,PU"\%]
M#+' %>WG 7YLYY&5&!QP3R>HT(_#FHZCI=U9^)=52_\ M%NUOBW@\E54]6QD
MY?@'/08X')ST=% '.:!H6NZ<L,.J:\E_;V:[;=4M_+9^, R'<=V!V&.>3DUG
M3>!K^;POK6BMJMN#JUZ]T9A;']WO<,RXW\\C@YKM** .?N=!O[OQ+INL2WMM
MBR@DADA%NW[S?C<0=W'W1CK5'1?".KZ*1IL/B#=H22%HK8V_[Y$SGR_,S]WW
MQG' Q7744 4[2&_CO+Q[J\2>"1P;:-8MIA7'()S\V3S4M[%-/930V[I'(Z%5
M9U+ 9[X!&?SJ>B@##\)Z%<^&O#=OH\EW%=&U4K'*L13())Y&X^M8S>!;]_!E
M_P"'6U6WS>7+3FX%L?EW2>81MW^HQUKM:* .6U'PQJS:XFN:-K$5C>RP+!>(
M]MYD,X7.&V[@01DXYZ?CGH;"V>TLTAEN'N91DO*XP78G).!T&3P.PP*L44 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %9'B367T;3X'A5#<7=U%:0>9]
MU7D8*&;'8#)QWQBM>LKQ)H$'B31I-.FED@)99(IX_O12*<JP^AH SM1U+5_#
M%OJNI:A+%?:9;6GG0M@)-YN<%" ,;3Q@]1GO5:_UK5]!CT;4;RXBN[;4+B*W
MNHEB"^2TGW6C(YP#P0V2?45=@\-7EYIMS:>)-6.J_:(&M_W< @54/4X!.6.
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M=1M1Y"6;. >@P,\^U5-,TBV\07_C'SB)M-U66**.6-@0X6!0S*>AP3U]1[4
M65U/Q%8:K#+=6LT^E&WD>\DDCBC-LRKN!0*Y+*>1@Y(XYJ33+OQ%JECH^M6T
MUL8+[9+<VCK@10.N048<EQQG/!YX%/T;PWJMHB0:QX@?5;6!"D,1MEC)!!7]
MXP)+G:2.WJ<G&(="\(:CH@CL?^$@EGT:WDWV]HT"B10#E4:7.2H/; STZ<4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M #J*YS1-?U/7_!ZZM:6%NM]))(BV\DQ$8VRE#E\9Z*3TZUT= !1110 4444
M%%%9GB/5)]%\/7VJ6]NEP]I"TQC>0H"%&3R ?2@#3HJMI]RUYIMK=,H5IX4D
M*CH"0#_6K- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7E?QP'B$V&G?V9]I-AN?[3]FS]_C;NQVZX[9_"O5** .+^% UP>"(1KO
MG^;YK?9_M&?,\G VYSSUW8SVQ7:444 %<CJ[N_Q1\.PR9\I+.ZDC]"^%!_\
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MUB_] %7Z@L[.WL+2*TM8A%!"H5$'114] !1110 4444 %%%% !1110 4444
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M"2S\,Z5I332)I\OB*6PD8N>(%D<K&6ZX) 'TR* .WCUR[/CF30)+>%;<:?\
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M^*YGX@R0S>"M<@$K":WLS*0CE2N<[<X_W3Q5+[3#=^+])T74U22R?1O.@AE
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 52N-)LKK4(+^:)FN;;(A<2,-F>N
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M7MV]*K?\(GH?]E+I7V$?85?S%M_-?8&SG.,^O/UYK8W#U'7%([;4)XX]3@4
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M&?P=X=DT;^QVTFW-CO\ ,$.",-_>!Z@^X/3BGGPKH9TA=(_L^,6*MO\ (#,
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M.:5(]D[VS,VGC%J3,^8OISZ<?3CI5ZY>1+=V@$9EVG8)&PI/;-9GA/69M?\
M"MAJ]TD<4MU%O=8\A5Y/3)]J )&\,Z,]U-<&R :X?S)D5V$<K?WGC!VL?<@T
MFN>%]&\1^2=5LA,]N<Q2*[1NF>N&4@X]LUJY&-V1CKFC()(SR.M &5)X8T:6
M"S@:R CL3NME1V41-_>&#][KSUYK6I,C.W(SUQ06 (!(!/0>M "T444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9/./;I3KG1M.N[A[B:V4R2*$D925\U1T5\'YAR>#D<T ,\/ZG_;7AZPU,P&
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M'"DC@^XJ,^%M#-A#8'3HOLMN_F109.R-O4#. ?\ $^M:A13'Y9 92,$'G(H
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M=K7]H:G9V=Y::A-YT[0?Z3:!)#Y95RXVJ% Q@8Z]3FNW?PWH\B6B/8HRV/\
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MRQ+0%;@ ;3GCCKCKWKTFW\)>'K3[/]GTBUC-JS- RI\T9/4@]<\#Z8'I2_\
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MP'_H2UTCSPVUL)9Y4BC  +NP4#/ Y/O0!-1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,4C?)8%6Y;!!7J,_04 =117GX\=Z]%X<T[Q1=:59+H\Y07(25C-&&;;O QC
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M\IY;)]NGT J=X='U-;;5I([.Z%N#)!=,JMY7J58].G/TJ6RU6PU(N+.ZCF*
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MFR$GA8YVD@$J0>0<'Z5&/#ER(-=N2\!U+6U"2')\N)0FQ%!QEL DYP,DGI0
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M !@<<UZE )5@03NKRX^=D7:I/? R<#\:XF3P1J__  A%UX7CO[,PO.6@E,;
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M#6EM##9F6W:53*]S*,DH$5@P4 #)Q_%[&LK5=1.KQ^!-3:,1M>7D4Y0'(4M
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MA9V 86=I!;!SEA#&$W'WQ0!B1>'+FU\7V^KVTMO'9V^GBP6W*L6V;@V0V>O
M&,=*2W\/:AI&K:G<Z/=VZV^J2>=)%<(3Y$V,%UP?F!X)4XY'6NDHH XY_ KZ
M:FB3>'KQ+>[T>-X0;E"Z7$;\N'P002V6R.YI3X-U"Y3Q,M]J5NPUZ)5Q%;LO
ME,(P@/+'(XZ>W6NPHH Y"'PYXAFU30+^^OM/5M)65'CAB<APR!,@D@Y.,]@/
M>C2O">LZ-+-IUEK,*Z%+,TJPF F>$,<M&CYP 23S@D9XYYKKZ* ,*UT&[L_%
M^H:Q#>1?9=12+SH&B)<-&I4;6S@ YR>#TK=HHH **** "BBB@ HHHH ****
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M1X0O9I]7"0ZTK7,JA(V2,D#:"V,_(%0'G^&L:2>Y^('PF6&UD6;6M.9&DAW
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M/I>H"^U#4;65KJX6)E4,R[%Y(X R HYX7ZDYMW_Q/? >@^&8AC43);07=O\
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MAU1U?6+'0[-;O4)A%"TJ1!C_ 'G8*/YY/L#4]FDT=G$MQ*TLH4;W8 $G_@(
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M3+M<PW5Y)&WJ,VEQR/<=?PK$T'6+O4?#*>%KJ0KK$%P=-NR#\PB09:4=^8^
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M;LS3/,TDJJ&+,<G[H''8>@ %:-% &%I7A=-)US4M4BOYW&IN'GMV5/+W 8!
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M=YF<8W;L$<8& ,8XJ>RT18-4;5+JY>[O3"(%E=0H2/.2 !ZGDGO@= ,5J44
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MZ^LHC )X\.98B<E7# [N<G/7))JSH'AU- >_=+^YNC?W+7,@FV8#D $C:H[
M>WH!6S10!B:GX;^W:Y;:Q;:E<V%U#"UN[0JC>;$2&VD,#CD9!%9P\ VZZ,^E
MKJMZ(6OOMN3L9E??O !*DXSCKDGUKK** ,.7PQ%<>(&UBXNY96DLC8R0%%\M
MXB<G/&<DGUK+7X?*-,M]*_M_4?L%I<)/:Q8C+1;6W*-Q7) /3/Z\5V%% ',W
M?@L2:Y+JVGZUJ&F2W2JMXMN4VW&T8#$%2%;'&15I?#$,?B"TU>"\GB-I:_9$
M@ 4H8\@D$D%B<@<Y[5N44 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %<;XJMWF\=^$E%W<Q+))=#;&^ "(&.0,=>2,^E=E63K/A^
M#6;FPNFNKFUN-/E:2&6W90WS*593D$8(./7WH Y0V=W=>+/&WV74[BQ:*.U<
M- %W,P@)&2P/'J!C/K4KZ[JMQHO@G41?/&VI7-O%=QHJ[9=T;,3TR.5Z XYK
M?A\*PP7VKWB:E?>9JZ*L^3&0@5=J[?DXP..<U7'@BU73='L!JFH>5HTRS6QS
M%N)4$+N_=\@ D4 9>JZ]<6'B*:TUBXO=,BFNHO[.OHQFU=/ES$^!PQ(8$MZ\
M$ 5TOB75FT+PUJ&JI&)'M;=I$0]"P'&?;-5KSPM#?QW5M<W]U+8WDXFEM6V%
M<@@[5.W(4E1D9]<$9K7N[6"^LYK2ZC$L$Z-'(AZ,I&"/RH PX+74;:6QU4:W
M)/:_9V:]AE4,)R5RK1XQL.>PX(_.N??6=7F^'0\:0:BZWBJ;K[/P8#&'P8BN
M/[O\7WL]^U=#H/A"'0FB U74;V"V!%K!=2AD@&,<8 S@$@9S@=*9#X)L8+*7
M3$NKD:1+*93I^5\L9;<4!QN"$\[<^O8XH S1<:GJ_C:;3DUF\M+*?1XKM8XE
MC#Q,SD8!*^W<$^XK$GO;_6?!WA6XO;^<W']OQ6TLD9">;MG90Q &"?D!],\U
MW/\ PCL0\22:\E_=I<26PMC&/+\L("2, IG())Z_I5"/P)8QZ!%HZZC?E+>[
M%Y!.6C\R&4.7R"$P>2>H/6@"A>QZO=^.I=!A\0WMM:G2%N R)&75_-*Y!V]\
M#.<GK@C-5/$FL:GIUAJM];:K-<W%C>Q*A@4""",M&ICDSPSG<Q.,D9'W:Z>'
MPU%#XC371J-\]PMJ+0QNT91XP=W/R9SN.<Y_3BLZ[^']A=P:I:G4M1CM-3G-
MS);QRJ$24L&+K\N>H!P21[=, #S=7.O>)-;TB._FLDTR*%8_((#&21"V\GN!
MP .G!SGC&5J-I?GQAX.AOM5EEN3!=K/);D(C.D:Y8+C )R0?Z5LW_@N"ZU2+
M5+;5=1L+T0B&:>VE4&X0?WP5()]P!C\L6+WPK9W<FERQW-W:RZ67\F2&0;F#
MC#ABP.=W<]<\YS0!N44E+0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7/^+/&NC>#+:&;57E+3DB*&%-SOCJ<$@8&1U/>N@KBOB)\
M/$\<PVCQWOV.ZM-P5F3<KJV,@C/'3K]: .B\/^(=.\3Z3'J>ERF2!R5(889&
M'52.QK3KGO!'A*'P7X>72XKAKAVD:::4KM#.0!P.PP /PKH: "L'7M3D&L:3
MH-N[1R:B[O+(IPR0QKEL'L6)5<]LDCD5O5R>MV[V_P 1?#NI,/W$L5Q9LW97
M*[U_/:P_"@"/Q?HR6?AS7M5BN[U)TM&>W$5W+&D&R, !55@.H)Z=ZGT+3K:T
MT72]=DOKQ#'8K+<F6[EE20&/+$JS$9!YR!ZU<\:Q37/@[5;2V@EGGN;62**.
M)"Q9F4@=.GU--L&U"'P#"MG:L-1@TX)'!<(5_?+'@*0<<;ACT]Z )+#Q59WU
M]96GV:ZMVU"W-Q:/,JA9D&"<88D'# X8 \T^U\0V]_):K#:W36]Z[QPW0"^6
MQ4,3T;<,[3C(%<I8PZE-XB\+ZH^C:J6BAGBO9;D*"LCH@^[NPJ AN@ ]!3](
MTRZLM;L+W1+?4=.AN96;5=,GC;[/&-I)>,D8#;L8"DYST&"* )_".J)I>EZD
MLB7-V[Z]=6\,2-YDK8? ^\<D #DYX')KMT8N@8H4)&=K8R/RXKS#2]/UK1-0
MNO$5GI]]+(VJ7"SV#Q-F:UEDW+)'G@,.O;.,'M7IL<PEMQ,J2 ,N0K*5;Z8.
M,&@#B-0M[73_ !MHL5EX@F&JS3EKV&>]++-#L)/[LG:ISMVA0.YQQFMK6+\Z
M!KVES;C]CU6Y^QS(3PLK*3&X]"2I4^N0>U4-6C7QE;:?''I-]9W%O>Q7'FWE
MOY36P1@S8/0D@%1M)ZY/2I/'%L^HW?AO3X1F5M8BN3CM'$&9S_(?4B@#H=5B
M6;2KI&+J/*8Y1RC XZ@@@BO*H=0E3X:Z5?Z7K-]+XGE*&*!+V29IV\S#!XBQ
M!7;GDCC _'U74W*:9<D1R2$Q, D:%F8D<  5Y[I/AG4H?!&C:A86<EIXCT1&
M_=2H4^T(6):)CT(8=#V/I0!W]QJ2V4=ND\;/=7 PEO",L[ 9;&2  /4D#ISR
M*R9O'FBP:<U[)]I58[L6<T?DG?!+D##]AU'.<'MFL?7[BZN+W1/$9\/7MW;6
M\<L%[8-;[IH?,V$,JGAL%.<=JJ^)_LX\*"^L]!;38YM5M'$1@6*:<B1?F9>Q
M/0 \\>] '4:=XKT_5]6GT5K>^LKM8O-6.[A,)FCSC>ASG'Y$?A6+X,U>#2/!
M:S7;S2E]3FMXER7DD=IV5%!)Z^Y/U-7Y+5]6\;:?K,=O/#:Z9:3*TDL+1M*\
MFT!0K ,0 "<XZD 9YQA:<-=TSP5%%;Z;>K+_ &N[W<:0_OA;/*S%HP>K8*].
M1D]#S0!U]KXFL)UU/SQ)9/I1'VQ+@ &,%=P;*D@@KSP:;;^)K:;5K?39K2[M
M)KJ%IK8W"*!,JXSC!)! (.& /-<;/X>U/4O^$QL;;3+NS75(+=[26X8$,R)T
M9BQ.21SG/7FNDT[5]4\1V+6<VAWNE2F!TN9;I JJQ4C$9!RWS<YQC ]<4 7/
M^$LTU;BR1UGC@U"3RK2[:/\ <S.>@!SGG!P2 #V)K4O+R"PM)+JYD\N*,99L
M$^P  Y))X ')-<)X753::?HNH^"Y$U/3S&CW,MHIMQLP/.64]3@9&.<GTYKH
M?'&G7NI^%YHM.A6>YAEBN$@8\3>7(K[#]=M %B+Q-;2:A-IIM+N._B@^T+:R
M(H>6/.-R'=M//;((]*ATOQA8ZQ'9O96MW(;MY4V%%#0^60&,@+94 D?IZC-#
M1K^RNI#J=OX/N]/EMH6\R2>Q$<V?^><?=LGOTX]^*%C:ZCH/B:+6XM/FE@U]
M=VI6\-N<VCCE&'&3P<-W)RP'8 &M=^/=-M9=0A2PU2ZDTU@+E(+4DH"-V[DC
MC'KU[9P:=>Z]H-^WAZX;[1<)?7"O82PAE0/M;&\Y Z;OE.>G2LS1M16R\9>,
M0UI=3EIX"@A@:3>?(7Y>!P>GWL#GKUJE#X?OM$T'P;IIM9IY+"_%Q=&",NL*
ML)">1UP9 ./2@#I)O&=C%JUWI<=AJ5S<V;1"58+4M@2$X;_=&.3[\9YJO:^(
M=#LH_$.I0P7R_8I]U]N1R2P0<JI/ V@=@*31XKB+XA^(+B2TN$M[J&V6&=HB
M$<QJP89_X$/KVK)>TOFL/'D8T^[WZEY@M!Y#?OLP",8X_O>OUH Z&S\8V%YJ
M=C8BVO8?[1B,EK--#MCEPNXJ#G.0.>F#C@FB^\8Z;86]]=-%<S6FG3>1=7,2
M!DB?C(QG<<;AG .,^QQBS17;7/@F0:?>$6.[[5^X;]SF$Q\\?WO3MSTK)N2O
MG>(-*?2-<?2]0U!WE^Q6@G5S\N\K(&R-S*<C!(Y P<X /2;>Y%S:)<I%* Z[
M@CKM;Z8/2N5T[QUNT+5-9U/3;NWMK*YECQ&J2$!#MQ\K'G@DD_+[UT^G7=M?
M:=!=6F?(D0% 5*D#T(/((Z8KS^33]4C\$>*M%.DWAN)[JZ:!E3*S"1\IMP>>
M#R>V.: .I7QC9,H)L=03S9XX+;S+?8+IG4L/+).", Y)(QCZ4DWC73;?1]1U
M*>"\C&ERF&Z@\H-(C  ]B1C!!SG'O576KO5$T;17LK&]:!I46^2"/%Q''M(.
MT'D?-@$CG'3UKF[K3-3&A>-+&+0[Y#J#J]J" ^_,:#&03D\$D]!W.: .SM/%
M=E=ZU#I1MKR"2YA::VDGAV1SJN-VTYSD9'4"I;3Q';WLUH(+6Z:WO)'CAN@$
M,;%0Q/1MP!V'&16+>)<S^+/"5W'979@M8;A;AS P$1=%50W'J#]*H:/I=W::
MYI][H<&H:='=3,VJZ9<1L+:,%22Z%A@-NQC:><]  10 Z%E\4^(O$%GJ]E>0
MP6CPK!-YJ(;+$>\L&#_*Q)SE<\8!X%=''XJT_P"V6=K(ES"+Y2;.:6+"7&!G
M [@XY 8 GM6!!IMYJ%YXVM1;W-L-70):32PLJM^X\LG...?7%'AN>*\6QMKO
MP7-::E9;?.N)[-1%$5'+QO\ Q$XXV\\^G- &UI?C*RUB\6VL['46!GEMY)C;
M$1PN@Y#G/RYQ@?AG&16G?ZI#83VUL8Y)[BZ+"&&+;N;:,L?F(& /?O6'X%BN
M+>UU6.YL[BV:35+BXC$T17=&[DJ1GV[=14GB_3K/56L;:^L[YHP7>.^L0_FV
M<@V[2-H)&<GL>@X[@ FG\7VEM%8236%\@O[HVD>Z-1LE#E-K?-QDJ<=C5N]U
MZWL;JY@DM[E_LML+F1XT#@(20. <Y.UNW8UB6^AZGK?@"?2M<N&-T6D^S74B
M[) %<F&1@.C<*3W]><T[1A?W7@FYU7482VHZI:F1XX5+<>7M15 [$?-CL6-
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M.<CCD;@,]JB\*^(;K7UOWGTZ6U6WO)8%W,A V$+M.UB=V<D\8]": .@HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *R=>\/PZ^MFL]Y=6XL[I+J/[.4&9$.5SN4Y /:M:B@"O=VOVN
MQEM3/+%YJ%#+'MWC(P2,@C/X57T+1XM T>WTNWGGGAMEV1M.5+!>P^4 ?I6A
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %<AXD:_T;Q?IOB*'3[K4+(6LEG<Q
MVL9DDBW,K!P@Y(RN#CM77T4 <3KZ:GJ$6CZ];:5<)'I^HB=[,IB=X2NUGV#^
M,9)"]<>_%2SVTFI>+I/$$-O<I:6NDO;9>W='F=VW;0A 8@ >G4^QQV-% 'F4
M5M>Q^ _!]JVFW_GV&I6SW,0M)"T:HQ+$C;T /X]JZ"Q6[T[QKXBN)M.NFM;^
M.WEBN(X]RX2(JP('.[/& ,\^E=;10!Y_I+:QIOP?@AL]+N#J5K$L;VTML=X^
M?YBJ,,,0I)'49'X57ETN\U/Q%J:VUCJD4.J>'VM8[J\5AB4L_P![)RO4?+@>
MPQ7I%% ')>%M;O[NSL-,NO#U]:7MHBQW,MQ#MA3:,%D?^+/;;Z\\#F7P9!>V
M$NLV5W83PYU.YN$F8#RY$=]R[3G)X/IQBNHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBJFH:A#IT"22Y9Y9!%%&OWI'/11^I]@"3P* +=%<[JGB>ZTN'4;A]$F
MEM]-CWSS),@4G8'8*#@G /7 J;3/$%U?O8M)H\]O;WT7F13F5& ^7< 0#D$C
M/Y4 ;E%%(20"0"2.P[T +161X<UTZ_:W<S6AM6M;R6U9#(')*'!.0/6M>@ H
MK&UCQ-::/JNF::\;RW&HSB)0G2,$'#,??:<#O@^AJX-21=5_LZ=/*ED0R0$G
M*S*,;L?[0R,CT((SS@ NT57OKB2TLIKB*'SFB0MY>[:6 YX/K7+Q_$*%?#]K
MXAN](N[?2K@@&Y#(_E MM#.H.0,^@- '844BLKJ&4AE89!'0BLCQ3KS>&M G
MU86;78@V[HUD"<%@,Y/N1V- &Q116/J>O-INO:3IALVD74W=!/Y@ C*H6Z=3
MT]NM &Q112,2%)"EB!P!WH 6BLCPWKI\0Z=+=FT-J8KF6W,9<.<HVTG('M6O
M0 4444 %%%% !156TGNYI[I+FR^SQQ2[8'\T/YRX!W8'W>21@^E6J "BBB@
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MBK=K.-R;20&9"!A6*G!!)Y&0,T ;]%%% !1110 4444 %%%% !1110 4444
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MAQDD D#)(&>,4 </X=OQ+J]UH-U+<V-M=:W>RI=0RM']HD67_4AE(*\<GU'
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M/3;&&RA>1HH$"1^8VXJH& ,]_P :K7>AVE[K-GJTK3"YL0RP%7PJAN&XZ'(
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^GC/36UBVTV2"]A^V,5M;F6W*PSL!G"L?4=..>V:Z"@ HHHH **** "BBB@
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M4?GZU7U#1EU#5-.U!KJ6)].=WC1 NUBRE#NR,]">F* -*BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KS;0K;5M0M?&VGZ;'9_P"E:Q=1&:XE8>7N503M
M"'=P?45Z0P)4@':2.#Z5C:!X;CT"XU"6*^N;C^T+EKF59@F!(V,D;5&!P.*
M,F'3I?#MMHOA^'5)#!#:.IAMU_TFXD&,,,@A4&3DD@ E02:S[7Q1K#^ -%U*
MXG*R7&HBUO[S8H,,(F="Y_A!^503T&[-=-J/AM+[7K?68=0N[*YA@:W<P;,2
MQ$[MIW*<<CJ,&N9UK0X/#>AZ?I,=]K"6!OVG:]A7S39@%G ("G(+MU(//)/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>ebs20191231exhibit1048013.jpg
<TEXT>
begin 644 ebs20191231exhibit1048013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;U 49]@.* /2RRA@I8 GH">M*6"]2!]37GFG06NO^&O%%QK$:&_AO+I7E?\
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MT/[#'%!XJ475D%BQMC)VR@^A"8DQT!.*W%L;2U^*UO#! D4;:!(FQ>!@2H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M""\L[?4+62UNXEF@E&UXVZ,/0^HJ)-(TZ/2_[+6SA^PE-GV=ERFWTP>U7**
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M8Z39V\=S_KECA51(/0\<CVH YOX<:;I-CX*TO6WA@AN39;9;MS@[-V2"Q[#
M^F*[96#J&4@J1D$'@U1CT/28=-DTR+3;6.RE!#VZ0JL;9ZY4#%78XTBC6.-%
M1$ 5548  Z 4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHKEOB/XBN/#'@N[U"SXNF*PPL1G8S'&[\!D_7% '2/<V\<JPO
M/&LC?=1G )^@J0$'."#C@^U<9X"\,:6/!]E>7MI#?7FI0+<W5Q=()7E+C=@E
ML\ $#%=%H>BP:#9RV=LS&%IWE0,22@8YVY/8=O;% &B2%!)( '))[4BLKH'1
M@RL,@@Y!%<%\4]3NW\'ZQ!ITIBBM8T%W,O\ $691Y0_!LM[8'\1QU'A/_D3M
M%_[!\'_HM: ->BBB@!GG1#_EHG_?0I5D1SA75C['->0?&+P_IFA^!;%;*SAC
ME.HKYDPC DD)20DLW4Y->@QZ1I&A[_$-O8K#)#8,LRVL0!E48?H.K#:<?6@#
MH**XFR^(C3:QH=G=:6((==B,ELZS%GC([.I48SZ@G\>M3Z9X[.LZQ>6-A8Q2
M"SOOLLRM<D3JH8*9?+V\IG(ZY&,G% '6JZ,2%8$CJ :=7E6A7D6C_$_QM<JD
M8V1QE(RVP2.=N%& >68XX!))KTO3IKRXLHY;^T2TG<9:%)O-V>Q; Y^GYF@"
MRS*BEF8*!U).*6O,/B_#Y=YX<F6:<>;J**\?G-Y9 *D?)G;GWQFNT\5Z[?>'
M],BN[#1+C5Y7G6(PVY.54Y^;@'TQT[T ;=-9U099@OU.*4'(!QCVK&\765MJ
M'ANYM[J%98W* AAGJZCCTH V58,,J01Z@TTR1AMI=0?3->4?#C5&\':GXA\(
M:F[$:>SW5MZR+@9 'JP*$#W-5/#^GF'X]7,=ZJ2W'V3SI2?F E:-&;'L"Q ]
MJ /9:*X36?B4=+MM0ODTAI++3K\64YDE,<KGNR*5P1_P+)]JO:_XXDT;7-'T
MR#2C>C6!^Y=9PA!XZ@KC'(YSZT =;17':-X\EU33_$+RZ4L%[H#NLT N-R/M
MW='V_P"PW;T]:HM\4L>'M"UG^QOW>L7+6_E_:N8B'*Y^Y\PXSVH [N6:*",R
M32I&@_B=@!^9IX(8 @@@\@CO7EWC W>H_&+0=(N;6&XLFM9MEN]P0L@:.0.Q
MPORL #C&?NCD9XTKOQM!X5TK4(=,T1CIOAZ6*TD6:=D=@QP/+RIW >[<C\*
M/0**YN^\81)>Z-IVG6XN;W68C- DLGEK'&$W%G(!/3H .37*>,/'VM+\/8M1
MMM+DTJXN[HV4PG8AX3@\IP,@@$;N,>G< 'I]%<GJOC*\T36M!TN_TB(2:S*T
M6Z&[+B$A@.Z#=PRGMW'N5T;QK+K%_P"(K%=,6*?0VV\W.5F/S]]GR_<]#UH
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M1MSC/!(XYQQGVIE5U*LH92,$$9!H :)8V.!(I)[ T^O'?ACH>E:KKWC6TO\
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MH(?$4"I?PC8\B2!Q,!T;CH?7WK:HH X3XC^'M9\1S:.-+LQ(MA="XD>254#
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MXXSLRB!3L7:O [#L/:I** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5!>W<.GV,]Y<-MA@C:1S[ 9-3U3U
M/2K/6+0VE]&\D)8,465TR0<C.TC//- 'G_B*QURST*U\0MI:)J&EW;:E-(MQ
MN9E;_61XQTV87KT05<\<W<4]QX-UY9-VE)J$<DDO\*AP-CGT YY]Z[>ZL+>\
MT]["X5WMY(_+=?-8%EQ@@L#GGOSS56T\.Z39:,VCQ6:MI[ J;>5VD3![88G
M]J -"22..)I)&58U4EF8X '<FL+Q#+->2V.DV<"S^<PN)XV?8/)C(."<'&7*
M#&.1NJS9>&-+L B0I<F*,@I#+>2R1)CIA&8KQVXX[5932+*/5I-55)/M<B"-
MG,[D%1G VYVX&3V[F@#DO#DMQH/C_4M'N[=;6WUH'4+1%DWJ)1Q*H.!R>&QV
M IGBW2KB];6-0T\?\3+2)X+VU(ZDI'EE]PRY&._%=5J/AS2]5U"UO[V"22YL
MR3;R+/(AB)ZXVL ,X&?6I[;2+.TOI[V%91/<X\UFGD8-@8'RDD<#VH \\\6:
MC%XJ\ :OXCA5A:+9)#:!A_$S(TK?F%3ZHWK7H#7T=AI5N[*TDCHJ11)]Z5\<
M*/\ .  2< &H[KPUH]YHRZ--9C^SU&/L\;LB$9S@[2,\\\U6O_!F@ZHELE]:
M2W"VJ;(=]U+\@_[Z_7V'I0!S'C31GL?ASJX+)+>3W$=_?B/G.95)P.NU57 S
MU"9]:U/%P:Z\4^#XK<[G^VR3Y7_GFL9W'Z<C\Q6WI7AG1M$MKBWT^Q2**Y_U
MRLS2>9QC!W$\8[5+8:'IVFS":V@82+'Y2-)*\AC3KM7<3M7IP,#@>@H X'2/
M]"^!VL6USQ<6\=]!.#U$I=Q@^_S"KWA"SN-.\;"WO5*S-X=M N[OL^5Q^#?S
MKKI?#^ESW;W,EKEY)%ED3S&$;NN,,R9VLPP.2,\#T%37VE6>HO%)<1OYL.?+
MEBE:-U!Z@,I!P<#(SC@>E '-^ 5;SO$UT>()]<G,1[-C:I(_$$?A77.@D1D)
M(# @[6(/X$<BL/6_"NGZKX=31$M8X[=&!BVNR>2PSAQMY)!.<'J>M;A0,A0D
MX(P2"0?S% 'E3>:?A+'(+NZ$L>KE!()VW$&[V_,<_-Q_>S6W*K>'O'E^FF><
MRRZ!+>/#),\@DF20!6^8GD@XKH/^$-T'^RO[+^QR?8_-\[R?M,N-^<Y^]GKS
M]>:M#0-.75H]5\N4WL4/DK*;B0G9_=(+8(SSSU//6@#GO#]CI^I:%X>\0_VC
M,EV5CDFN4D^:YD<;6CD]1O.,?PXXQ69<*#:?$A^0\>Z1&!P59;4$$'L0175:
M=X-\/:3J3:C8Z:D-PS%@0[%48\$JA.U3CC( JS;>'M+M9;Z6*V.[4,_:@\KN
M)<C'(8D=./IQ0!S$\I&I^ I1*P>=&61@Q_>+]F)Y]>>>>YK-F\GQ)\/O%.JW
MX,E]$UX@.XAK81@A8U_NC:!D?Q;CG.:ZVV\$>';3[+Y6G\V;[X"\TCF,XQ@%
MF/ &<#H,]*==>"_#]Y=7EQ-8'??*5N52>1$FR,99%8*3[XSGGK0!@N"GB/P"
MZ2R@2VTRN@E;8V+;(.W.,\GG%9<VE0W6C^.I)I[QWL+F>2U)NI/W3+ K@CGD
M@^N>.!U-=R/#&CB:PF6U97TU2MH5FD41 C!P V.1P<]131X4T98K^(6\NS4B
M3=K]IEQ-D8.?F[CCZ<4 8,]Q=7-[X4FO@]W87%DS7$*(9"TIC4AVC&2RC)&<
M$ L,]16AX)TN\T^ROI+PW*B>]E:UCGF=S';[OW:[6)"\9X&#C&>E9GB#PW'_
M &CI\,GANXU31[*U,<'V2\*SP.6&<EG4E=H4##<<\=,;/A71CI0N7C@N[.UG
M">59W5T9VC(W;FSN8+G(& Q'RY[T 9WB%+?4-<O[9 ][/!IF7@E?;#:@EB)
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M3Z@5NP>#?#UMK+ZO#IJ)=O)YK,';9O\ [VS.W=[XS4]SX:TF[O9KR2W=9KE
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M7EG;:A9RV=Y"D]O,I62-QD,#63:>"] LI[.>*R<R6.[[,TMQ+(8@0 0-S'C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBX::.4L[J0Q^[M&"-A[U3C\0:W)H]IK$>EVDMI=^4PC2Z)DBC<C#'Y<-@')
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ME"R7<PAA3N['GCZ $GZ5F6&N7EQXPU71[B*!+>R@AEB="2S;RWWL\?P]A^-
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M;-%L5=KJC\]"<,,8)]36OX0UJZU_0_MUY%#%,+B:(K#G: CE1U^E;9('4@4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM0QPZE91721N)$$BYVL.X]*JOX4T"2.XC.D6H2ZV^>JIM$FT84$#J!@<=.*
M.>FTNRTSXCZ-]D@$?]HV-TMYDD_:-NP@OG[QY/)JA;VD>CWVJ^!%MP(]5F$]
MDP7_ )=Y/]<,^L85L9]5KM6T'3/M-O=BS5KFT7;;NSMF,>@.>!5/1H-4OK\:
MOKFGP6%Q%"8(+>.83% Q!=BV /FVI@=MO7G@ V,06-GA56&""/@*,!% [ >U
M>:V:VT-WX,O[$"*"XN90D\SAKFYC:-R6E88')P<<]N0>*]/(!!!&0>U8T7@[
MPW!&B1:)9JL<HF51$.'&<$?F>.G- '&6?AC1]7L_&*WZ%OLVI3F%VE;_ $<B
M)"'7G@Y[^@QTJ/3K,ZUJW@[^VUDEDN]&F-PKNP\[ 3&X9YR#DCOWKH/#WAMG
MO]>EUG26C6^U!YX]TRLLL1"A5=5;!Y4G# @9J76=%NM0\=:3>'3I)+"SMY8V
MG294*.^W!7#!AC:>1SS0!Q>M::FF^%?'.E6V_P#LNQN8&LEWDB)W"-(BGT&X
M<>]=-KFG6.C>(= L(;<1:=JU_(VH$L2)Y1%^Z#Y/.YN2.Y'.:ZB;P_I-QIAT
MV:QB>S9M[PMG:[9SEO[QSSDYYYJ6XTC3[O3AI]S:1S6J@;8Y!N QT(SR".Q[
M4 <K#I4 \?:KH4=NIT:]TE)[FV4?NXYS(4! Z*64$\=US57PK$EY:V_A&]@C
MDET"[;[5N08=$YA;ZON5L]]C>M=Q9:=::>KBUA"&0[G<DLSG&,LQR3QQR:?'
M:6\-S-<QPHDUQM\UP.7VC S]!0!Y^MG%XKE\2VFH7UE;7-M?2(7E@S/;1+CR
MW1RXVC R"!C.?4U=TAX-8\::CINKLM\EGIUK]C6YC&)5=299=A[D[03VZ5T5
M_P"%= U34H]2OM)M;B[CQMEDC!/'3/KCWJ74?#VD:O<PW-_I\,\T Q'(P^8#
MTR.H]CQ0!A_#&-(O!_E1_<2]N57G/ F;%9?BZ.>SO]6U.XL(-:T9D1+Q%(%U
MI^U 2R9X(PP?'7)S7;:;I&G:/ T.FV4-K&[%V6) NXGN?6HI_#^E7-U-<S6:
MM)<;?/\ F8+-M  WKG#8 '4&@#G;%;1_B5JQV1B"YT>"5E90 X+OEB#UXQG-
M<I96T-SX!\%;F<!M>\K='(5.TRS< @\=!SUXKTV^T#2-2OH+Z]T^">YMQB.1
MUR0,YQ[C/.#7.>)?"J&VT:PT70XVM+?5([NY6(H@*@,#]X@LQW?IUH R;O1+
M;1/%&MZ?I41@TVZT"2YN+=&(1)@Q",.>"0#]<&J;:';6?@[PAK^FJZ:SOL46
M82$M,KA0T9Y^[C/'8#ZUWNH:4EOH.IQZ;9-)=7<#J09,O(Q4JNYW/.,]SP.E
M5/"/AZ'3=!TI;O3S!?6=NL95Y X1PH#,@#%1NYY&"<G/6@#%NKJZLM>\?W5C
MG[5#IML\6!DAA%*0<4_2=(T^\;0M=MM5M(P5V+]DMRCW8=?F20[R6(P2<\@@
MGUKKH='T^WU&?48;94N[@ 32@G,@'0'GG';TJKI_A30-)O9;W3])MK6XF!#R
M1)M.#U _N_AB@#S>?2;$?#+Q%?>3FZL=2N6M9BQ+P%9N"A_A_#KWKJ)]/M=*
M^(OAN6QA$,FH6UV+MU)W3[5C92Y_B()/)YKH1X7T06$UA_9\?V2X?S)8,G9(
MW7)&>3G^0]*E;0=,>ZM;I[4//9C%O(S,6B'HISQ_6@#@M'M(_$OAF#5KO5;6
MSU"UNC+<7"6Q^U0S!SF,MOR<_="XY& !TJ9M"TW4-<\>0W=L)XXA"\:.Q(1C
M;[MP&>N23GJ.<=:['_A%= &M?VS_ &3:_P!H9W?:/+&[=_>],^_6I1X>TD37
M<PLU$E\-MRX9LS#T8YYXX^G% '!V\%OJ4WPWGU""&Y>>UD65YD#&0"V)&XGK
MSSSWJSXB,FE:CJ&JWEA;ZQH;SQ-+-%@76G,H0<9ZH" V!C[Q]>>P;PSH<EC;
MV+Z9;O;6K[X(G7*QGVST^G2GOX?TJ2YEN&LU+S.LDHW';(RXVEESAB,#&1Q@
M4 5_&5Y>Z?X.U:[T[/VJ&U=HRHY4XY8?09/X5S&JVMK9:5X5U?045+N6\MHQ
M+']ZYBD'SJY_BR,L2<X(S7H! (((R#U!K.LO#^DZ=*LEG8QPE"QC SMBSUV*
M>%SWP!0!RWAW0-+O/%GB*2YM_-:RU2*6WW.W[I_*0[ASUS7=U1L]%T[3[R>\
MM+58KBY.9I 3F0^K>IJ]0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2$X&3TI
M:Y_QK/8Q: (]0$KQW%S#"D<;A/,<N-JLQX"$CYO;- &['+',F^*177IE3D4+
M-$S*JR(2R[E 8<CU'M7G<<,1UOQO97/V3;)I\#O#",('\N3L3RP '/'0' JH
M=)T]/#'@"]2W5+J>XLX9+A21(Z/ VY"PYQP!C/ &* /4$D20$QNK@'!VG.#Z
M4BRQN[(DBLR?>4,"5^M><WL;:#JWC2+0($M"NCQ3QQ6Z!0LF)!N51P#@=O2M
M#3--T._NM#UBSU2W_P!6T<4-K$JFX1E^9)!DD@8).>A!H [;SH@0OF)EB5 W
M#DCJ*2>411$F2.-CPID.!N[5Y&VE:?#\++O4H[:-;RSU-S;7'\<.+O "G^$8
M/0>M=?9RP:G\1]?T_58XYOLUK;BRAF4$&)E)E90?5B 3[ 4 :?@_6[G7?#<6
MHZ@((YWGEC81 A/EE9!C))["MKSHMKMYJ8CX<[A\OU]*\DL[2UD\ ^%P$!$?
MB58T96(*J;EQ@$<CC'Z5T<&@:0/B;?:>--MA92Z3%/):^6/*>02NH8I]TG'<
MB@#NMRE-^X;<9SGC%(DL<D?F)(K)_>5@1^=>66%\+'PEX>MYYUATO^V;BWF>
M4;XT4-+Y2MD_=W!>O P/2M#Q!HFFV?AOQ=)!>I=&YLQ<26T2*(87"D*Z@=&;
M&3ZXS0!Z&LL;/L612V < \X]:JZ=J]EJJ3R64ZRI!,T+.I!!9>N/8'C\*XLZ
M98V'BSP9-:VT<4E[;W$=TX'S3KY 8!SU;D=\U7T72[6X\(Z];6TUKI]U+K%Q
M#',8QVN%VHP'5"2JD=,-0!Z-'+'*,QR*X]58&JMSJ]E::G::=+,HNKL,8X\C
M.U1DL?;H/J:P/"%W*VL:K9ZCH\.G:M$D+7)MFW07"G<$D7N.A&#SP*K^(;2R
MD^)7AQ[FW@8/:WA=I$4YVA",Y].?I0!J:!KMU?:EK=KJ!MHQI]XL$31Y7<"@
M89R>3S6])(D2%Y'5%'5F. *\TN-)T_4H_B#+>6L=P\,CM$9!N\MA;@[EST;(
MZCGBK%OJ)N=5\,VNIW4,<-UH22P-=1ATEG.W?U(&[;C!]"?6@#T/>@4-N7:V
M,'/!STIIGA6(RF5!&.KEAC\Z\TU70M-L=,T*RM[LWL*>)8D5^ (E<$M$A'10
M>P/!XZBM*[MM.TGQK8Z&JVFGZ=)8R26D4L(:)IS)^\ !(&[;C'L2!UH Z_4=
M8LM+6V-U,JF[G2"%<C+LQP,?3J?85;DFBB4-)*B*3@%F !KS74]#TO3].\/6
M<,Z:A!'XECC5Y$4K&K!BT2]M@/;UX[5LZ6MKJ7CW7]/U"W@FAM[2V6PA= R?
M9V4[R@Z8+<$CT [4 =I17(^ +A[;PY)#=W'^C1:C/;6$DS\R1!RJ $]>A ^E
M=:S!5+,0 !DD]J .>U_Q9#H6N:1ITD19+^;RYI>T 8$1Y]-SC'T5JZ%F5%+,
M0J@9))X%<)J&BZEXM\/:I*D-ILU?$MK+),RR1HG^I( 7CIOZ_P 9JGKFKQ^*
M/@E=W]RBFYCM]LZL.8YT8*WT.>?H: /1A(C.45U++@E0>1GI2&6,2B(R*)",
MA,\D?2N*DTZSTGXB^'7L+=+=[VSNEN60<S;1&P+GJQR3R>:I^&QHNO>$HKO6
M9535;>_:2Z=7VW"7*RG:N>O(PH4=L 4 =N#J']H7(,MI]F\I3;IM;S _.XOS
M@KTQCWKD6\9ZP/AD?$PBLQ>),R.A1O+P)S%P,YSC!ZU<T:&*'XH>(O*14\RS
MM7?'=B7R:Y=B/^%"W)SQ]I?_ -+: /5))HH0#+(B G +,!DTK,JXW,!DX&3U
MKC=?-A>^)-0M@D<EU!I.)VO#F&&)BQ^5.['')R  %^E<]:V]MJ>E_#HW:K.S
MDPRECDLOD,=C>HZ<'L?>@#U))HI,;)$;/3# YI0RL2%8$CK@]*X77M(TSP7J
M6D^)]/L8K:SLR;2^6-/NP2'A_7Y7Q[X)%=)X;LA!8/?/;K#<ZE*;J<;0&&[[
MJGW5=H^H/K0!JR2QQ &214!. 6.,FEDD2)"\CJBCJS' %<8LFGZGXY\1:3KH
MB8"VA6T2? !@9#YA3/\ MDY(]!Z5!;&T'C70M(+O<:.FD2-8&X;>)IE<*6R?
MO$1C(/HQ(ZT =UYB>7YF]=F,[L\8]<T@DC+L@=2RC+#/(%>3^(;,0>'/'U@D
M8.EV<T,EFN/EAE95:14] "PX'3)K?U;0]+A^('AR..RB5;ZVO%NP!_Q\A5C8
M"3^_R<_-G/>@#N5EC>+S5D5H\9W@\8^M*)$9V174LOWE!Y'UKR;6+.V@\%^/
M;&&!$MK2_#V\2C"Q$K&3M';DG@>IK?U30[32/&_AN]T.$17-W),EUL8_Z1%Y
M98LY_B(..3W(]J .Y,L8E$1D02$9";ADCZ4K2(F=[JN 6Y..!U->7VZP:G\'
M[[5;L!=9A,\\MQC$T5TDAVC/4$850/3 K3M]+M]2^(<"ZO90R33^'8Y+J%T!
M5Y/- .Y>AP?7T'H* .]#J4WA@5(SNSQBD2:*2+S4D1H^NX,"/SKRNSO1IWA3
M1[:6=8-*77KBVF:0;XT0-+Y:L"?N[MO7C@5=\3Z)IMIX:\6307L=RUS:+/);
MQ(HBA<#"N .C-@_7% 'HZRQLY174L "0#R :JZ=J]EJHN39S+*MM,T+L"""R
M@9Q[ G'U!KCWTVRTWQMX2DL[:.&2^M;I+IU'S3@1*PWGJW/<YJEHNEVD_ACQ
M):P36VG7,NLW,$<QC''[]0J$#JA)52.F&H ]'CECE&8I%<>JL#5>Z-Z+NS^S
M26RVY=A<"4'>PVG 3!QG/7/;-<[X1O)CK6IV.IZ/#IVK1Q0M.UJV8+E/F"R+
MW!^\,'G@>E-\501?\)OX0N-B^=]JG3=WV^2QQ^= '6--$F=\B+@@'+ 8STI7
MD2)"\CJBCJS' %>:MH6DW;>/EN+*&187+Q!ER(F^SAMRCLV>XYJQIFI1S:QX
M3MM:D5[6YT!9;?SR"DET0FXG/!;9G'^\?6@#I?%VMWFB:5;WM@+=Q)=0POYH
M)^5W"Y7!'/-;N],D;URO7GI7 >)++3--\%BTTF1GM8]9@(!?<J,9U+*IZ;03
MC Z$$=<UH+';1?%B^$B1(DVA(\FX !_WS@D^O&,T =@&5EW!@1Z@US]OKUU-
MXZET7-L]D-.%W')'DON,FS!.<=CT'>N&TV]CMO WARW=E32[K798KM@?D,?F
MR%5;MM)"Y[8&.AK9U&(:9\0-9ETB"..[/AAI42)0-THD;:<#OPH_*@#OA+&T
MC1K(I=>64,,CZBGUY]H=GH^J6GAS6K?6(4FA*[!;QJ)9688>.0Y);N6SZ$UK
M?$6^DL/#D+;VCM9KZWBO9%.-D#.-_/8$<?C0!:FUZZ7QO9:/$;:2RN;6:4NN
M3('0J,9SC'S>E&M:GK&C^%]8U(M82W%GYLL*JK[?*494.,YW8ZX(%95Q9:?;
M?%/1S:001>=I=P&$2@!E!3;P/;-9%K''!\-O',,2JD<=]J*(HZ*!P!0!Z'I]
MT;K3[6:0J)9H4=E'J5!/%6%97&58,/8UPTJ1IXN\"S;45I+&Y0O@ M^ZC(&>
M_?\ 6L::]CT_1O%DUFR):#7XA<M",A8#Y0DX'8C(/U- 'J,<L<H)CD5P#@[6
M!P?2A9HF9561"6&X ,,D>M<5+HND-<WE_!J-O.;O2I$>UM8T6&6->1(P!/()
M #>^*P[/3K.S\-> -4M[=([Z2]M8GN0/WC(T;AE+=2O XZ"@#T>UU:RO-1N[
M&WF62:S*B8 C"LP)V_4 <_45=KBO#-M86_C?Q9(8;:)XKF#8Q55* P G![9Y
M)_&NQ@GANH4GMY4FB<962-@RL/4$=: %::)9!&TB!SR%+#)_"E$B,2 ZDCJ
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M12RQ7?D!)0/W=KL'E[<_=!^9LCOS7/:?;OJUA\/Y-93[1/-+<1N\OWI80C[
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M$\FT/L5P3M/0X]/>@"K_ &%I/VBWN/[.MO.M1B"3RQNB'HI[?A3!X=T4:O\
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MI%,B,,XXP1Z]>:WU.5!/<4 <IXO\+I=>%M5L]"TNW6^U)0KNH6/<=P)9V[\
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MB]UG3[V6_,)FM]0GM@84*J51MH."2?UIC:Y=P>/)-(N9;9-/72S>!BI5E;S
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M\H^E &;XST/^W_#%W:1(IND7SK5B,E94^9<?4C'T)KC3KY_M;2O'L-E_H=W
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MH6OM+L[IK?\ U1F@5_+^F1Q0!Q]S8Z9/XM\'V42&XL$L+H1+,2^] (]I.?O
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MU)ZC'![FO4(8(;="D,21JS,Y"C +,26/U)))^M48_#NAPJ%BT:P11,)P%MD
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M<ASM!YXP?;);:6S1_%34?LJC['-I4;WJ@?*;CS"$)_VM@/X8H^& C_X0BV=
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M#!XVB63!'R[% #$8+?\  3WJG%.W_"UKFWO\;7TM/[/W]"-Q\W;_ +6=N>^
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M?:&\YG 3!Z'=TQ7/^'M=N-5\5Z_9_;K>[L;1+9K9H ,#>)-V6!.3E0.O;H*
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MX@N)[&VEFMO]1(\2EHO]TD9'X4C:IIRW8M&O[87);:(3,N\GTVYSFK1.!DT
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MQPQ+]U(U"J/P%2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM \,%PFIAU3$9B;Y]B^F)QP.X!KT!XTD 5T5@"& 89Y!R#^!&:!&@D,@1=Y
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MX 9XQUKS*TU33&D\$7-M=6EM:1W$GE6J2[FMD:)^)')R6)Z].<CG&:]5  &
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MK#((JM_9.FF,1_V?:[ <A?)7&?7&* .:M(K6T^+-Q#;1Q0B30XV:.,!0Q$S
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M["5O3J=N/PQ7;57M]/LK0@VUG! 0FP&.,+A<DXX'3))Q[U8H **** "BBB@
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M8BKN.YL#&3ZTP6UN+@W(@C$Q&TR;!N(],]:EHH ADM+::42RV\4D@4J'9 2
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>YR]NH(;8H!P@) R1G. <4 =;=>.%=?#EO80+]L\0HLL2S'*P)L#,6Q]XC.
M!C//(KF_&OBKQ/'\-[RYGL?[(NQ=FRF)!S(A_CC)Z \C//MZU7U'0]^D^&+K
M3_$FAQ:WX?C6,!KL&&50 ,9Z]O0?>-:_BF*/QCX,ETV^\0Z':WSR)*BPW0:)
M-O\ "6)R<\\X]..,D L:SXJUGPR_AFUECL;@:K<);R%$==@)0 CYCSAOTJYH
M/BO4-5\8Z]H$T-LJZ8!Y4J*P+9Z;@3_*L3Q/9+KUCH,\?B+05U+2+I9]C76(
M7 QQGD_PCG'KTJ3PW;1Z/XPUG7KSQ#H4XU-!\D5V%*,.@YSQVSGWQVH ?X:\
M=^)?%$'F6'A^V9;?4!;W;FXVJL?&67/4C)S^'!SPV3XJP".?4HUM3IT&HBS,
M1D_TAT[S 9^Z">F.1GD4[X<PV_A/3;^TU/7-#D-S=M<H]M?!L;@ 00P'3;^M
M4O"UM<^$;Z_T^P\0Z!)HMW<&>.62['G09X.%Z,< #KCC/M0!Z%K.JV^AZ/=Z
MI=9\FUB,C!>IQV'N>E<C:?$&ZC;P[/JEG!':>(BRP>2S%K=L@(&)X;.X<@#'
MO6SK]WX=U_0;W29M=L$2[B,>\7*$J>QZ]C@UQEOHEO=MX6M=4UW18[7PX2Q>
M&^5FN6!79P0-H^49R3Z>] #=-LI=5^-GB.QU2.SN[<V<8FBDB+(4 B90H)X(
M.TG/&<UU/Q14+\-=84  ")  .W[Q:S-+@MK+XDZIXHEUW1#;:A L(B6^&] H
M0 ],'.SI[^U:/C6XT_Q'X6N]'LM<TB.2Z"J9)KQ0$ 8'H,YZ>U 'FFNR?;_A
M]X/L;FUDTN%&4_VQ.H:-.#\J["S<]>0OW1]1Z3J?BZ\TWQMH6@0BWN;35(=W
MV@YWC /((.#G -<S>:$VJ^#=,\*7?B;P_;6EF5,MQ#=>9)*%SC"G:%Z^I_I5
M_6M)L#K7AO4M#\0:,/[#B^S^5>7@P\87:#E<Y.,^E #E\5WOB7PAXXM[V""-
MM+AN+=6A! ?".,D$G'2N1UG_ )(OX._["*_SEKHM)T5-.TGQ792^)-!GDUXR
M&.5;L($+[@21SC[V>"?3WJKJ'AI+WP%HOAO_ (2'P^)--N3,\C7N5D'S8&,?
M[9S]/?@ ]!TC6+C6M4NY+*YL9M(MW\I9(P6D>0#YAG=C ..<<^F.2[Q?H$?B
M?PO?:2X&^:,F%C_#(.5/Y@?AFN2T.QMO#GC*]U#3->T2+1M0PTUC]M&8WQRR
M<8'.>.X/;C':_P#"1Z%_T&M/_P# I/\ &@#@OASXEN+[P(=#9C'JUG-_9Z!O
MO*&SM;'^PH?C_IG76ZIJ$OAQ='TC2M-8PSDP"?RRT-FB*.7QCC\1T)SQ6-H^
ME>&-)\<:MXDCUO33]O5?+C%RG[MC_K#U[D Y]VIGC5O[=N](;2_$FBK:6L_F
MW=K=70\N?!!7(7[P&#P<#F@!^C?$J*Y\,ZYJVHV\:G19FB<V[Y2?G"E<]-QX
M[U=TWQ3K/VF*75M*2/3)],^W_;;?<4@XW&-R>I [C'T].4T_PQ9_V3XITK4O
M$VBF#6I_/AF@N1N5@VY2RD\#..,GZUK^&YKA/#G_  CWB+7M :SCMFM1);7@
M:26,J5&<X"X!Z\YQVH NZ-XQUS6#H^H0:()-*U:25-T>3):*K$*TAZ$'!X&,
M>IK'\.^(C:6_CF^MM)L(+K2[AWE:(.!=,I?);).,[3C'0DU)X'-]X6M1HEQX
MB\/3Z7!*SPSB[_>["<E=O09.><G&3UJG8Z.+.P\80MK^@/)XA,C18O\  B+E
M^&^7D /U'I[\ %VT^)FJN?#%S=Z5:1V6OS& >7,S2(V\)NZ8 RPXYZ=JT-<^
M(8LM6UBQLA9YT:V$TWVF7:;AR-WE1C/7'?GGC%<L?#LO]F>$+4:]X=+^'[EI
MIB=2.)?WBN OR>@[UJO!)H_CZ]\0:#KN@SVNJ(JW5O=WH0HPQ\P*YSTS^)'O
M0!Z!I&I0ZSI%IJ=N&6*ZA655;JN1G!]QTJY5>PG2YLHI4NXKL$<S0D;'(X.,
M$\9SW-6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>^#_ /H7;#_OU1_PKWP?_P!"[8?]^JZ.B@#G/^%>^#_^A=L/^_5'_"O?!_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !115'59=2CB@72X89)I)@K&<D)&F"2QQSV
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M(H=&#*>A4Y!IOG1;7;S4VQYWG<,+CKGTH DHJIIFI6VKZ?%?V;[[>;/EO_>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;*X>>UTVUAEDB$+/'$H)0=%^GM3-+\.:+HDLLNEZ7:V<DW^L:&,*6]OI[=*
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M[?0#/!%)C7+1"70'Y6?YASV/<5!/IFFW_P 45LY[6":T30!B J#'@3D %>A
M]#QQ[5U]_IUEJMHUIJ%K%=0,03'*@921R.#4":#I,=X+R.PA2X$7DB5%VL$Z
M!01T'MTH \YL+[[!X3T&UGG2'2_[;N+:9YEWQJ@:7RE89'R[@O4XX%=GX>TB
MTTO6M3DM=024W8CEEM8(PD,1P0& !."V.?7&:T$\.:+'ITVG)I=J+.X.Z6#R
MQL<^I'K[U-I>D:=HEI]DTRRAM(,[BD2!03ZGU- '.WMU;3?$M-+U81-;MIGF
M64<X!1Y"Y$A /!;:%]P,^IK,U Z=HO\ PC>DVMX!HC7<\32W7[V+S "40DD
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M88K>%88(TBC085$4!5'H *?340(@1> HP.<TZ@ HHHH **** "BBB@ HHHH
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MQZCI0!Z1%-%.F^&5)%SC<C C/X4D5S!.SK#-'(8SAPC [3Z''2O,]0W:(OQ
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M#$DY^[V J>;61HFE3WFMWMJVVX9(_(&W.6PB8).6Z9K+M K_ !3U9& 93I,
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M'?I0!Z/%-%."894D"DJ2C X([?6DCN8)I'CBFC=XSAU5@2OU':O.=01]%O\
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M@YI^J:?SJ\1ADAG7_7&[,H5^>I+,6!!ZYK5TO0M*O_B+XH6\T^WE$:V,JJR
MJLFUR6 ]<CKUY/J: .[9E12S,%51DDG  ID-Q#<)O@FCE7^\C!A^E9'BVS>_
MT3[+#?1V5P\\1@DE7=&TBN&56'<$C'X_A7%:GK5S!HFK1ZCI2:=<V^H6?]LF
MU;=%- Q4%U/7#*N"#SCKUH ]+AN(+@,8)HY0IPQ1@V#Z<4D=S!<%U@GBD=.&
M"L&VGWQ7*ZL?"MI#JFKQ2DF7266?^SY1S".C +P&^;"L??L#6;IKQ6WCW0@K
M6=NDFC2(L-NV=J;H]BLW\?L<#OC- '2>$]7O=7MM2:_\GS;/4I[0&%"JE8R
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MUH)L6L?[%T_[*[B1H!;($+?WMN,9]Z<_A_19!,'TBQ83JJRAK=") HPH/'(
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M>Z39W$-MQ#') K+&/11C@<=*EN=(TR]$(NM.M)Q;D&'S8%;R\=-N1Q^%7**
M*BZ3IJWSWRZ?:B[D7:\XA7S&'H6QDBHTT'1XK.:RCTFR2VN#F:%;= DA]64#
M!_&K]% '/ZCIVIW4ZZ-;VEC;Z T2K*ZL1)M!^:)4 P 0 ,YX!-;]+10!2GT;
M2[J^2_N-.M9KM%V+/)"K.%] 2,XY/YFF'0=':TM[,Z59FWMFWP0F!=D3>JC&
M ?<5H44 (RJZE6 92,$$<$5FCPWH*P0P#1=/\J!R\2?94VQL>I48X/N*TZ*
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MWX]:=:Z;86-F;.TL;>WMCG,,42HASU^4#'-6J* ,^PT'1]*BFBT_2[2U2?\
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MXVE;;&KL 7/H/4U+0 44E5_[1L1:&[^V6_V9209O-78"#@_-G'7B@"S1110
M4444 %%17%S!:0-/<S1PQ)]Z21@JCZDTL%Q#=0)/;S1S1.,K)&P96'L1UH D
MHHHH **** "BBHEN;=Y985GC:2$ R('!* YQD=LX/Y4 2T5'!<0W4*S6\R31
MMG#QL&4X.#R/>D-S;A]AGC#YQMWC.: ):*** "BBB@ HJ(7,!N#;":,SA=YB
MW#<%]<=<407$%RA>WFCF56*EHV# $=1QWH EHHJ.:XAMU5IYHX@[!%+L%RQX
M &>Y]* )**** "BBB@ HJ&&[MKAV2"XBE9/O*C@E?KCI4U !112,RHI9F"JH
MR23@ 4 +14'VZS\B*X^U0^3,0L<GF#:Y/  /0Y[4MU=VUE 9[NXBMXEZR2N%
M4?B: )J*@M[VTN]WV:ZAGV %O+D#8!&1G'J.14] !112$@#)X% "T5'!/#<P
MI/;RI-$XRKQL&5AZ@CK4E !1110 45$]Q!&2'FC4KC(+ 8ST_E3HY(Y5W1NK
MCIE3D4 /HJ&&[MKAW2&XBE9/O*C@E?KCI4@=&=D#J67&Y0>1GIF@!U%%% !1
M4,5W;3RM%#<122)]Y4<$K]1VJ:@ HHHH **** "BHYKB&V0//-'$A8*&=@H)
M)P!SW)J2@ HHHH ***BBN()VD6&:.0Q-LD",#L;K@XZ'D<4 2T4A( R3@"HH
M+JWN@QM[B*8*<-Y;AL?E0!-1110 44R::*WB::>1(HT&6=V "CW)IK75NIA#
M3Q SG$0+C]X<9^7UXYXH EHJO=W]GI\8EO;N"V0G ::0("?3)I\%S;W(<V\\
M<P1BC&-PVUAU!QT//2@"6BBB@ HIDLL<$3RRR+'&BEG=S@*!U)/84J.LB*Z,
M&1AE64Y!'J* '4444 %%%-5T<L%=6*G#8.<'T/YT .HJ&*[MII6BBN(I)$^\
MB."5^H[5*2 ,DX H 6BHH+JWN@QMYXI@IP3&X;!_"GK(C[MCJVT[6P<X/H:
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M1+,8D122%!8*QR2#QCH#[9J1>*GFM]*C_LN>#4M3W[+*Z/EF()]]G.#@#C!
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M_P#A/_%\7D1F.6.R+IL&UB4?.1WS63#X<\4-9Z0;G3[.2_L-36YN;IKO+78
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M1$N 1LAQDY..6QP/S- &_-KL\VJWFFZ391W<]A&C7!EG\I59P2J A6RQ ST
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MEDUO&5>YCG\W[2VT@$+@;1GYCDYXQCF@!L'C"8WND17FE-:1ZP[I"))L31D
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M@\Y[=!6SXHUD>'_#.H:MM#-:P,Z*>A;HH/MDBN8.@ZV/#?A.P&G@SZ-=P2W
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MY^K,H'UH ZFBLG2M2U"ZU?5+*]L8[>.T=#;RQR[_ #4;=C/]UOER1Z,/QUJ
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MC-9FYFDOG,4=N1@>6S 'YLGVX!/M6'>^+]1U'0O#.IZ7;Q01ZKJ$<,L<LQ#
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M^T^AP>*<^H645VEG)>0)<R#*0M( [?1<Y/0T 8-IINKP^-;O69K6 P3V$=N
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M>RMWN+N>."%!EI)7"JH]R>*=!-%<P1SP2+)%*H='4Y#*1D$4 24444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %9NNZS%H6F&[DC,KM(D,,2G!ED=@JKGMR>O89K2K"\8:!
M/XAT06UI<+;WEO/'<VTCC*B1#D;L=NHH Q+EKY?BAHS:A';(!I]RPDA8X/*9
M!R.WKWST%6IO&=TGAP>*8[".31]^2H<^?Y.[;YH&,>^WT[YXI/[(\0ZGXGTO
M5M1M-/@BM[6:WN(H[EW+!]N2#L'IT_7TKVWA/6(?"$W@YWMWL6W11WWF'S!
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M]:S;'Q3<MXAM-(U""VCDN[-KDB*;<ULR[=T;@^S=>.AXHT_P]JMIX'GTMM2
MUB>W9&O5R,2; B'UX55&>O&>M4+'PUKJZIH5W/;Z7;PV-M+;7$,,CMD.%RX.
MT9)VG@XQG.6H T;;Q'JE_:V&J6&E+<Z=>SB,!9,3)$20)B",8XSMZX/7M3KG
MQ#J4\6I3Z)IT=ZFFSF!HVD*O<.N"ZIQ@8SC)ZD$8'4T?#>B>*="MX]!,]B^D
MV[D0WFYOM'DYR$V8QN[;L\#L:6VT3Q-H>MZD-'?3YM-U.Y:ZS=,X>UD;&\@
M?.#C(&1]1UH OMK4O_"9VFE/ID2^?8/<)<,^9%P5!0C'')'0G.*QYO'.LIHN
MJZLNBVODZ1>RV]RINSEE0@$I\G)Y)YQVZUJS:+J?_":V&K)Y$MI:V+VKM)*1
M*[,5.[ 7'\/KWK(?PIKLGA7Q+I)2Q$VKWDUQ"WVARJ+(0<-\G48[=?:@#;U#
MQ(5U!]/L!"9X[=)W>??M ?.Q<*"<G:<GMQUS5WP[J\FNZ';ZA-8S6,L@(DMY
M@0R,"0>H&1QD'T-8-QHOB:QUJ'6]&%@\L]I';7]E<2L$8IG:Z.%SD9(Y'2NH
MT^.[CLT%_*DMRV6D,8(0$G[JYYP.G/7&: ,"'Q#<_P!J>)H5TJV6?28XG#";
M'VD,C,-S;>, 8Q@U5L_&>IR1>'KZ[TJWBL-;9(0R7!:2.1T+*=NW&T[2.N>_
M'2IDT+6$UGQ1>".S,>KP11VX\]LJ4C*?-\G&<YXS5,^&-='AWPMIXBL3-HEU
M#-,3<OMD$:,ORGR^IW9Y'&.] ':7%O%=6\EO/&LD4J%'1AD,I&"#7$>"M07P
MWI6L>'K]CN\.R.R''S2V[9>,CU)R1^5=W7,:OX2_M'QCINN1S>5'%&8[V,?\
MMU5@\0_!P"?88H <EPGA/P_;M<0H;Z_N<R*IPKW$I+-D@$X'S=B<+527QCJ%
MM#K7F:6DS:9:&[CG1GCAG0 EER5.'&.G.?:M/Q;H=WKFEPC3KE+:_LKE+NUD
MD!*>8N1AL=B"1^-4KJQ\4ZSX;U.UU%-.@N+NSDMHH()7,8+J079BN?H /7DY
MX &IXLU.'3K:]OM+@C743;Q:=&ER2TLLHZ/\OR@=<C/'J:O0:_<P>)X] U2"
M));F!I[2>%B4E"GYT(/(8<'N"/3I5#4/#&HZCX3TBT\RWMM5TB2">!@[/$TD
M0Q@G .UAGMQGOBKL6D7FH>)+/7-2ABMC86\D4$$<ID.^3&YBV!QA< >Y/'2@
M"[J^K_V=+96L48FO-0F\FWC9MJ\*69B>> JD^_ [U0E\1WNF6>I3:QIOE?8Y
M8XX)8GREV9" NW/*_,P!ZX]Z7Q;H5_JJZ??://##J>EW'GP>?GRY 059&QR
M0>M5]1T/6O$GAR[MM4GM[&\E\MK9;5BZ6[HV]6+$ L2P&>. ./4@$^G>(KNX
M\0_V3=6*O%) 9H[NW5S&"#@QMN48/<'OZ"N)"J/@%'\H^6Y&..G^G5W6C?\
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MJY7Z@&N.\(3QW/Q#\17"1MIF^*(-ILR[)7(ZSE1Q@YQD$YSS5OX?*!>>+"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)R>"+E;/Q"NG0V6G_P!LVH@%I'*QA1L,&D^Z,$AL8 [>_'<44 <K+H&KO?\
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MVMRQ2-,[LLY +$G_ &1CWJMH&C>)M!NM7D6#2KB/4K^2\ -U(ACW8&W/EG/
M'I7844 <W=:;X@O;*"&Z-A)YEX)KN,3.$\M2"L:?(<CY5)SC/S#&#3?&7AB7
M7=%2WTI;6VOH;B.>WN),KY3HV<_*ISQD8]ZZ:B@"&U-R;6,WB1)<;?W@A8LF
M?8D X_"N3M/"NK:;H>I>&[.6T;3+MI1;W#NPEMHY<[EV;<,1N.#N&<\UV5%
M'+P>&KNP\4Z=>V2VW]GV&F?V>B/,PDQE2#PI'&T#KWS5GPGH]_HL.HQWWV<_
M:K^:[0P2,V!(V=IRHZ>O?VK?HH Y[4]'U.Z\8Z5K%N+4VUA%-&RR2L'?S O(
M 4@8V^O/M2:?H^IV7BO7-79;1X=1C@6%!,P93$K#YOE[[NV<8[UT5% '!VW@
MG6;7PAH]E;WEI!K&B3M-;3 L\4F2VY6& 0"&(.,]*ZC1H];V//KDEH)F 58+
M/<8T SDY;DDY]!C ]R=2B@#$\5:#-KVGP):7/V6]M;J.XM[C&?+(.&^N5+#%
M5;;PA%9>+8]5M9!'9K:)&UL/XI8P41SZXC9A^5=+10!@+HVH#QZ^NG[-]D;3
MQ9A1(WF9$A?=C;COC&:Y\^#=?/@&Z\*A]/'^D%H)S*_S(9S+EAMX/; SZY]>
M_HH YV?2-3G\9Z?K>RT6"VM)()$\YB^7*DD?)@XV^V<]JE\8:-=ZYH8MK!HA
M<Q7$-Q&)F(1BCAL$@$C./2MVB@#FAH^LR>,[7795L1%'I[6KQ+,^X,SAB0=G
M(& .V>O'2LG_ (0G6'T>ZB6[M;74$UA]5L9HV9T5V).QP5'&&(XSUZ=CW=%
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M[0><4 6**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT'Q]KG@F&)CI5_MN@W:.#/(_X$#Y9^F>U=3\3+O3;/3]*>^FN$D748GMHHI
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MEN285SQ&2<G;QQSSQ0!6MA!??%OQ4FNI%(L&G 6ZW !5(L*25SP.N2?<U?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFN-F69=S)&P4K(5Z$Y )XJ_)K_GWD%EIENMS<S6HNR)9?*2.(G"EF"L<DYP
M#T/X@&S17%ZEXHUI[?P_);:7]A;4-0%O/!>2,DBE=QVC"GY3L^]W&..>-E]>
MNIM0N]/TVPBNKFPC1KH/<^6BNPR$4[3DXYY '(YYX -NBN2D\?0-I>D:A9Z;
M<7":G>"S*%U1X9?FRI![@J?;WKH=+N;V[L$FU"P^P7!+!H/.$N "0#N'!R,'
M\: +E1Q7$-QO\F9)-C%&V,#M8=0<=#[5AZ7XD?6F@DM+**:QFGD@DD6XS)#M
M#<NFWC)4#&?XA7*:)KLWA?2/$=U;Z,;BQM-<NC.R2K'Y:;P/D7!W$#G' QWH
M ]+J.6XA@*":9(S(P1-[ ;F/0#U-9>HZW<VUV;>ST[[0%M#=-/-*880 <!=^
MUOF/)QQ@5S.NZE:^(+#P5KD$&PW.L0%=X&] 4DRN?J/TH [H3PF=K<2H9E7<
M8PPW >N.N*DKD=/BCB^*VKF.-4WZ7 S;1C<=[\GWK4\2>(6\/KI[#3Y+L7M[
M%:91U787. >>OT_44 ;5%<PGBG4WUB\T7^P,:A#"MQ"OVM?+DB8D;F?;\IR,
M8 ;GVYJ2P\6OJ6@Z?J-II4[SWMR;8P;N('4L&+N <*-AYQSD<<T =!))'#$T
MLKK'&@+,[' 4#J2>PI4=9$5T8,K#(8'((KEI/%<5WX<U^>YTE;@Z2TL-W:K*
MLD<JJFXD,0,J5/0C/48I\WBHV">'K>VT9W35XP(EBD55AQ'O"@'&>!CL,?E0
M!U%%<;>>,M1_X1[Q%*FF16FJ:(I\R&2?>F"F]7#!>>.<8'ID5HVNL:G'8:1"
M^G">ZO8LF03,8D54#%I'V<$YP!@\]Z -V:>&VB::>5(HU^\[L% ^I-25QFH>
M,+2[\!W>L7.B+>PP3M;W-F\BNFY9 N=Q&&7."#C\*U-4\27%AXBM=%@TJ2YE
MNX))8I/.5%RF,@^@^89/Y T ;]%8_AK7FU^RN9);,V=S:74EK<0&02!9$QG#
M #(P0<XJ'6?$=SIC7_D:69HM/M1<RS32F%'!W?*AVD,V%/IU'K0!O456TZ^C
MU/3+74( 1'=0I,@;@X901G\ZQ[#Q2]R-<2ZLDM)M&8B5&G+;QMW!\[>%(Z'&
M>O% '0U'+<0V^PS3)'O8(N]@-S'@ 9ZD^E8T^NZC$R0KHV)OL1NIC-.4ACYQ
MY?F;""_7C  QUKGO$.I6OB'0_"&MPP;/M&LV;IO +)ECD9^H_2@#NO/A^T&W
M\U/."[_+W#=MSC..N,]Z)IX;:/S)Y4B3(&YV"C)Z<FL--6M?^$ZN-.DTM(;F
M+3A/]O8KN>+S,;>.0N<GD]NE<UXTU637/!]OJ,.F1FPEO;<V]R\O[U5\Y0'V
M;> V,?>SAAD=< 'HM%<[K?BBXTE-3F32FDMM+B66:664Q"7()(B^4AR .>1R
M0*K7FOZI)XMT2SL8;=K&^M);D>9,R,^ O7"G& _ YR?3% '5TG3DUR>J>/;>
MPANKJ&""ZMK.<PS*MT%G)5MKE(L'< <]2,X..V="76_[0O+K3=,L8M0^SPH]
MSYTOEI\XRJ#Y6RQ7G!  !'/- &S#/#<Q"6"5)8R2 Z,&!P<'D>X(IEU>6MC%
MYUY<PV\><;Y7"#/IDUS/PMQ_PKK2\+M'[[Y?3]Z_%07,E]=?%'[#-:6LUJNC
ML1').2NQY@K-C8?F(4#;TQWH ZZ.\M94DDCN8G2+B1E<$)QGGTX(/XTGVRU\
MJ&7[3#Y<Y41/O&),]-I[Y[8KC;0Z5<>$O%.G6F@PZ=#8>=;O%\K>8RQ ASCO
MC'<GCK5"YBC/A'X<S&-3(MWIZA\<@&$Y&?3@?E0!Z()X3.;<2H9@H<Q[AN"D
MX!QUQP>:DKGH]5A;QI?:>NC 7D-@DHNMR;YD+D!!Z#(/4_A69:_$">XTC3=8
M?09(M/O;D6\DIN5+1,9"BG;CYAD#/3';/6@#M**PKKQ'(-3U'3].LENYM,MT
MFN-\WECYPQ55^4Y)"D\X'3GTM>'M97Q!HMOJL=N\$5RN^-78$E?7CI_]:@#2
M)"J68@ #))[4V&:*XB6:&1)8W&5=&!!'L15?58HY])NXIHUD1H6RKC(/'I7&
M>']?E\/_  _\+2&R$UM=+#;R3&;8("YPK,,'Y<]_I0!WU%8]]X@CTZ\O5N8U
M6SL+07-Q<^9RN2V%VXY/RD]?3U%5'\536<NF/J>F?9;35)%BAF6?>T<C#*+(
MNT;<],@L,_G0!T=1O<0QS1PO,BRRYV(6 9L<G [UR4WCC46&K&Q\,3W)TF<Q
MW -RB?*%#$C@Y.#]T9Z=>0*H:EJEOJ7BSP9KFEVAN&O+:[9 -J,P\M,!B>F"
M3GKCG&>X!WLLL<$3RRR+'&@+,[G 4#J2>U-:YMT,0:>-3,<19<#><9X]>/2N
M6D\6+=^%-<NK_0][Z6\L%[8F571@JAC\Q !4J?3/M5?6Q;W&J>"+V.UCA9[K
MY0H'R(8'.T''04 =DL\+S/ LJ-+& 70,"R@]"1VS@_E4E<W;:Q$WB/Q!;P:)
MMO;"WB=I5*[[L$.47@>V!D]^@I6\2WT?B2ST)],@DN+A#++Y%V7^S1#^-\QC
MJ> ,\F@#HZ*YAO&$L4VFM=:4]O;:E>M9PF27;.&!8!FC*\*=O]X\$>M,T?6M
M9O/%/B"TGM8&@T]HHXTCG.[F,N,94 D[AG)&/?&2 =-#/#<Q"6"5)8VSAT8,
M#@X/(]ZDKDM&\4V"^$--OK32EL_M]RUM:6$14#S/,<=0  /E9B<<<]3UO1^)
M98]8N-&O=.\J_2V^U0)%,'2XCS@[6(7!!Z@CWYH WZ*XVS\>SW-CHNI2:&\.
MGZM.EN)C<*6C=R0ORXY7(QGCZ$8)[*@".6XA@V>=,D?F,$3>P&YCT SU/M4E
M<CX\AB-UX7F,:F1==MU#XY *OD9].!^56=<\6S:-#J=T=*=[32RGFRR2^49=
MP!/E J0^ 1W'.10!T/VB'[0+?SD\XH7$>X;MH."<=<9(Y]ZDKA+^>6V^*4=W
MIFFB\N)]!<A ZQ;_ -\F"S'H,#'0GI6C9>.K6?2)+FZM6LKV*]^P2VDTJC9/
MUQOZ;<?-N] < ]* .H9E1"[L%51DDG  J/[9:^5%-]IB\N<J(GWC$A/3:>^>
MV*Y2Y\1P:Y8>(-&NK2#S;:Q>4-%,+B&5"IP0VT<@]01QQUJO8ZG;Z=X+\%)=
M:4M\ET;*&-W*X@D*#:XSDY'.,?F* .YHKF9O%5^VMZGI%AH+W-Q811RJ6N5C
M64-N[X./N\=<]\4Z#QG:W>C:+?VULS2ZTXCMX7;;M;!+;FP< ;3R <\<4 =)
M16'H_B&;4]:U+2IM.-O-IK*LSK,'0[@&3' )RISTXQBK6I:G<VM[:V=I8-<2
M7"R.978QPQ! /O.%;!)(P,>OI0!I45R)\>H?#NGZQ%I4LHO+T63QK*O[I_,*
M$Y_B&0<8'/M5VR\5,=7U'3M6L/[->RM1>!S.)%> D@L< ;2"IR.?K0!NS7$-
MN$,TR1!W"+O8#<Q. !GJ2>U25YYXJU"XU:#PKJ#:5'%;3ZU9R6\S2@RJK/D;
MEV_+N'HQ[9KMM8U Z3I%WJ MWN/LL+2F-& +!1D\GZ4 7:*X^+QY.LFCSWV@
MS6FFZN8XX;LSJVV1URJL@&0"> WXX%6=2\82Z8DMU-I3I8PWZV;22R[)')(7
M>B%<,N6Z[N0": .GJ-IX4F2!I4660$HA8!FQUP.]9%[K]P+J_M=*T\7\VG1J
M]PK3>7\S+N"+A6W,1SC@<CGGC U&]M?^$U\+ZS<0-8B;3[MYA<)LD0;8R%?O
MD9(Q0!W5%8CZWJ$.C'4)]%E$CR*D-M&Y=VW,%!;Y1L'()ZD#J,\5%:^*XC=:
MW;7\"V[Z+$LT[12^:C1LK-D' .1M.01^= '05&D\,DLD*2HTD6/,0,"4SR,C
MMFN:_P"$PN%ET42:0?+UM=UL4N067Y=^'!  .WT)Y!'U6#7X8]3\3F+0_+NM
M,2)YW5D#W0*%ER?91QDGK0!U%%<E9^-IY_["GN-%>WL=:V)%.;A6*2,A8*5Q
MT.",Y[=*L7WBXP1ZU/9Z?]J@T3BZ8S;&)"[W"#:<X4]R,GB@#I:*J:7?'4M,
MM[[R6A%P@D5&8,=IY!R/48/XUBW'BZ4:=?:K8Z9]KTZPD=)I!/MD<1G$C1IM
M(8#!ZL,X..V0#HI9HH(FEFD2.-!EG=@ H]R:;;W,%W L]M/'/$_W9(W#*?H1
M7'>)=5N;W5/";Z<L$]C>W7GQEYF02XB9EW#8< 9!'7D#@8S75Z=IUKIL,BVM
MK%;>?(9I4B^Z9&QN/Z>@H MT444 %%%% !1110 4444 %%%% !1110 4444
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M5UYJA8EESD2 G=\I)^Z#GVI]KX<O-)\1>'S:VS3V&EZ<]F\Q=0S%MOS;2?\
M9Y^O%=A)(D2&21U1!U9C@"HGOK2.V^TO=0K /^6K2 +^?2@#AIO#&MW7A;Q-
MIXM$BN-0U0WUJ'E7#KYB,%)!.#\GTY'-:US9ZS=>+]#U9],"16L$\=P%G4[#
M)MQC.,XV\_IFNHCD26-9(W5T895E.01[&F0W5O<,ZP3QRF-MKA'#;3Z''0T
M<7KV@^(-2N_$,!L[>[AOK0QZ?<2W&!; QE64)@X)8DY'7N>,4@TCQ-I.I:;K
MEAI]O=2_V<EC?6!N@F-IRKJY&"1DY'Y9ZUVK75NEPMLT\2SN,K$7 9AZ@=31
M<7,%K%YMS-'#&#C?(P4?F: .9US3-=U"UT:\$%O+>V6HK=RVRR[55-K+M5R.
M2-PY(YYZ<"BTTS5=#\4:GJ4-G]NM=76*22.&50T$R+M/WR,H1WZC'2NJ!! (
M.0>A%+0!P,OA/5+'2M%@MK9;JXM]9_M2\*2*J@G?N5=V,XW@#IG':N]!R <8
M]J6FNZ1QM)(P1%!+,QP !W)H XFW\-7C^(-/UJ+3#I.HI*3J4T$R^5>1[3QL
M!Y8G:<D#'/)P*KMX=UN3P=XGTPZ?MN=6OIYX!YR;0LA!&XYX(QS^%=Y#-%<P
M)/!*DL4BADD1@RL#T((ZBI* .0N-.UZ;7;2=]/AN; 6"Q+#/<!1:S@\N5 (;
M(P 1R/;)K+M/#>OV_ACPKITNGQF71]02XF\NX4YC0..,XY._I[=:] DDCA0R
M2NJ(.K,< 4V&ZM[C/D3Q2[>NQPV/RH P+73M0C^(-[JKVA6RGL8[=)/,7.Y6
M9B2,YQ\V*7QCIM_J<6DK86WGFUU2"[E^=5PD;9(&3R3VK=AN[:X8K!<12L!D
MA'#$#\*9#J-C<.R0WMO*R-M8)*I*GT.#UH PH['45^(%QK)L7^QOIBVJD2)N
M+J[/TW=#G'U]N:PK/0?$UGX=L+(6"2+!J4LUW:&Y51<PNSL!N'H6&5/!QWKT
M.J-QK>DVEPUO<ZI9P3(I=HY+A%8*!DD@G.,<YH Y&/P]KD6F^+K3^SK91K"O
M]F$,XP"\(CQR!@+CD\>PJS-I&KM)X0==/8_V0/\ 2AYJ<?NO+^7GGGGZ>_%=
M8][:1R01/=0J]Q_J5,@!DXS\H[\<\4L5W;37$MO%<12308\V-7!:/.<;AVS@
M]?2@#CKCP[JM]<>-$-L(4UN!4M9'D4C<L/E_, 21D\]^*?-I_B6:/03+IEO-
M;6T;1WFGFZ 4MM4(['&& (8[>>H/)Z=I10!YW/X8\0MX'UW118VYN+V_DFMS
M'<#:5:4/DY P !@=3["MZ^LM2N/&NCZK'I[_ &6VMIHIB94W*9-N.,\XV\_I
MFNFJ&XN[:T5&N;B* .X1#(X7<Q. !GJ3Z4 8/A'3M0TV;6_MUH85O=3ENX6\
MQ6RCA0 <'@_+].>M4-;T;7;_ %K5E^R6]Y9W=D(K&2:?:+-MK!_DP<LQ.=P]
M ,@5V=4KC6M*L[AK>ZU.S@F52YCEG56"@9)P3G '.: *WA>UO+'PQIME?PI#
M<6UK'"Z))O'RJ%SG'M6=J?AJXN?&-KJMM(J6DT/E:C&?^6@C8/%CWW9!_P!G
M(KI4=9$5T8,K#*L#D$>M)--%;PO//(D44:EG=V"JH')))Z"@#FM6T[6I_%D=
MPEI!?:8;39&DTVQ;>;<29"N#NR, $<C';)SB6_AO7X/!WAK2Y-/C:XTK489Y
M1'<*08XV))R<?,<\#\R*]!CD26-9(W5T<!E93D$'H0:CDN[:&XBMY;B))IR1
M%&S@-)@9.T=3P">/2@#F[C1KZ]\<W-]+:LFGW&C_ & RB1=P8N6)QGI@X^OM
MS6%)H/BP^!H_"S:9;RR64L(BNQ=!4FCCE5@=N,@X'(/IQGI7H],FFBMXFFGD
M2*-!EG=@H ]R: .(UK0_$6I7.OQ2V5K=17UEY=C-)<_+:$Q%60*5ZEB3NXR,
M9/&*L+H^NQZCX9U%;*W9[&SDM;F+[1_J]P0!LX^;[G('KQGK75VE[::A;BXL
MKJ&YA)($D,@=21UY'%3T <7IMEXK\/7U[IMC8VE[IMS=27%M=R7&PVOF,697
M3!+X))&.OJ,\2VVEZYH/BW4KVSM$U*QU<1.[-.L3P2HNTD@CE3UXY'I753W5
MO:JC7$\<(D<1H9'"[F/ 49ZD]A2"[MC=FT%Q$;D)O,.\;PO3.WKCD<T 8?@/
M2]1T3PE:Z;J<,<4\+2<1R;\AG9AGCC[WO4?V#41\1CK'V%C8G319^9YB9W^9
MOW;<YVX_'VKH8+JWN@YMYXYA&YC<QN&VL.JG'0CN*EH XRST?5H;+Q;&]@0^
MJS2R6H\U.0T80!N>.1D^U17&AZPWAKPC8I8$SZ/<VLER/-3&V*,HVTYY)SD?
MKBNXHH YF.PU&/Q_=:P;%VLY-.2V1A(FXNKLW3/0[L?7\ZP(O#6O)\.;#0CI
MP-[;7JS,!.FPJ)O-X.?0XZ=:]%HH X'5%U2Z\5:C<Z3I'VN,VT=I=&WOU@?=
M@L4DR""0&7!4@@'KSQHV^MWEAH^GQV'AT6T4%TEE<VK7"YMUX *$9$GWA^N>
M^+VH>'?#<NKK<W*+;W]V<#RKMX&N"!W",-Y '<'@5L065K;111P6\<:0Y\L*
MH^3/7'U[^M ":@LC:?<)#&99&B950$#)(QU/%<WI?A__ (MHGA_7HUMQ'9F&
M=BZL%P/O@@]N#SZ5T]S<V]G ]Q=3QP0H,M)*X55'N35'4] T?7I+.XU&SCNS
M:L7@+,=HSC/ .&!P.#D4 8.G>&[K6/AU-8ZK<DZAJUN&GGV\AMH"$CV"ID>N
M?6EDTC6-=TW1M-U6R%J=/N89[J<2JZ3>5T$8!W?,<$[@,#/6NPJ!;RU:Y>U6
MYB,\:AWB#C<J^I'4"@#B]!GOTU;QA#9Z>;EI-1(C?S%55<Q(/GR<XZ<@$]>/
M62T\*WVCZGX2AM8#<6FBV\\=Q/O52S2*!D*3G&03]#WKH=$TS1K5KJ]TA@_V
MR5GGD2Z>57D!P3RQ&>,<>F*UJ .%?0]:?2/&%K_9Q#ZS+(UKF9,8:,)\W/&,
M9[U:O=*U:8>%&CL&/]ER*]T#*F5Q&4P.>>3GZ5V%% '*P66L67BWQ!JT.G>;
M'=VT*6H,R#>\8;[W/ );K[5#X:T[5]*C>:ZTUYM5U&X634+V26/;C/*J Q.U
M5R%%=>2 ,G@56L]3L-0,@LKZWNC$0)!#*K[#Z'!XH X(>'/%,MEIANM.M)M0
ML=62ZN+MKKYKM07P1\ORJ W3MC@5T.FZ;JNF^+]<OC:1RV6H^3*LB3 .&2((
M4VGN2.I(&*Z:B@#SRR\(ZU%X/T6(0QQ:KHE^UTD3R@QSJ7=BFX9QE7QDCJ/3
MFMUM,O-0\1KX@N+&2W^R6+V]O:M(AD=W.6)()4#  '/<]._344 >>Q>'-=B\
M#^'M)_L[-WI=]!-,!.FTI&^XX.>IS@?C^/5V>J:A+XCN]-N=.6&VCA66"=9@
MQ<'@AE'W3G./7::UZKF>RMKM+<RP17%R2RQ[@KRD#D@=3@#]* ,3Q?IU_J4F
MB&QM3,++4XKN8[U7"(&! R>3\WZ=:Q->\/>(M4_X2.V>RM[H7L>+"ZEN /(3
M8!Y83!P<YYX!SR> *[B*[MKB:6&&XBDDA($J(X)C)Z @=/QHFN[:W($]Q%$3
MR [A<_G0!RXT[6;7Q/I^O-IRSJNEM93V\$Z[XV+JX(+[0P^7!Y_.J=[X/U9K
M"XU*SE@36GU9=4CB9B8OE4H(BW^X3D^I].:[;SHO)\[S4\K&[?N&W'KFF6M[
M:7J%[2ZAN%4X)BD# '\* ,+=XCU70]0%_I<5C)):O##:1W*RL[L,;F?   [
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M*,_\(AK&X '[!/G!_P"F9K6JCK,>FS:7-;ZM*D=G,ICEWS&(,#QMW CKTZT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-Q\_O3M?TG7-5TS2U,=O)=PZE#>S(LFV.-$;.Q21DG&!D@9.3QP*L?V;J/\
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M,4:2BYFE!CDW@AW9QV'(SB@"/7_%-WHL6IW(TL&UTQ$=I9YC%]HR,D1?*0Q
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M"6TWL69=@&'P22.1[FNSHH Y.#1M?T;Q1J%SI?V.YT[56227[3(RR6\BJ%+
M '>" #C(Y[CK6%X>TB]U?X3^'CIQB-W8W27D:3,520QS,=I(!QD9YQ7HTT23
MPO%)G8XP=K%3CZCFJVF:58Z-9+9:=!Y%NA)6(,2JYY.,GC\* ,"STO7U\67>
MN7$%B$N=/2 0I.Q*.K,0,[?F'/)P.O0XYRX?"6O6_@[P[I"Q637.D7\5S(3<
M,$=48M@'9G)SZ<5W]% '+Z_I&N#7K/Q#H!M7NH[<VUS:7+E4EC)W## <$-[?
MX&#6- \07Z:7K"36?]LZ;<M.L&YA 49=K1!L9Z#[Q'4G@#IU]% '+Z3I>MKX
MRN];OK>S@@NK.*'RX[AI'1E+'^X >OM^-3>(]+U>\U?2;RP6UN;:T:0SV=U*
MT:.Q "/D*V2N#C([\5T5% '!-X/UY_#.KZ:TEB9Y]5-_;,&<*_[X28;CY>F.
M]=Q;&X:W0W21I,1EUB8LJGT!(&?K@9]!4M% '!S>$]?'A/7]!B%BRWUQ-);2
MM,P)61]WS#;\N!D<9R?3'.I=:/J]QXC\.:B(+98M,BF2X!G.XF157Y?EYQMS
MSC.:ZBB@#SV/PGXH_LW3[>8:;+<V&K)>R733OOO<,W+?)\I ;&/FZ<8 YZ#3
M-'U/3_&.KZ@?LKV.I^2Y;>PD1HX]FW;C&"0#G/M@]NBHH Y[QMI&H:[X?.GZ
M<D!E>:*0M/*44!'5^RG.=N*AOM,UV7Q7::K%'936JVAB\BXF;_19=Q)E4!<,
M2,#L>.HS73T4 >>VG@OQ#I_AO01:S6(U;0)9#""[&*>)\AE8X!!(/IQC\MG5
MM,\0ZWX1U.SNELXKV_A,,<"2L8H1@\E]N6/// ' 'N>IHH Y:^T;5[B_\,W,
M<-J!I3,URK3GDF,IA?EYZYYQ3K30M17Q+XCO)U@2UU:&&.)DD+.FQ&7++@#G
M=GKVKIZ* .7T72WT_P $QZ%XE-DD,=L;5O+F)61 I!8E@,$CG';&<^DO@339
M]/\ #-N]W</<7%PJN99%PQC"A8P1V^15R/4GUK5U+1=,U@P?VE8P7?V=_,B$
MJ!@K>M7J .=\3:7JU]J.D76GK;7-O9RNUQ9W,IC27*@(V0K<H<D COZBL"Z\
M(>(IO#>N:4/[/=]1U3[9'()748,B2$$;3C[F._7VY]!HH Y:^T/4M0\6PZA-
M!;K9-IDEE.!.=X,A!)4;<$#&.HK$D\+^*SX-C\+F/3I5LYHO(O&N&7S(TD#*
M"FPX( P>3T[UZ)10!3U""[N]'NK>WF%K>36[I'*I)$4A4@,#CG!YZ=JY+3_#
M7B"*_P##5U+;Z9!_9*313I',[&3S$"F7.T98E<X/KRW/'<T4 <9#X6O;C7=+
MUBXM+6QU*UD)O+RUE/\ I<>TC:5 &23M)STQQFB/PM?76N:7J]Q:6MCJ5I*3
M=WMK*?\ 2X]I&TJ ,DG;G/3'&:[.B@#BK/PQK&F>'-2\+6WV:2PN3,MK=-(0
MT$4N=P9,<LNYL8.#QG%.D\,ZQX?UJWU#PP+6X@^PQ6-Q:7<K1Y$?".& /('!
M&/Y\=G10!RVN:+K>HPZ$0UK-/8ZDE[<LTA1< ,-B#!Z;\#/ISUK-UGPKXAU$
M>)+9382IJB8MKJ:5O,A3:/W.T+@+D$Y![YP37=T4 <L=&UM?$VEZRBV),=@U
MG=1F5@(\NK;D^7Y\;<8.W/MVJZ3HOBO0GGT>REL)-(>9Y+>ZD9O.MD=BQ79C
M#$$G'./7TKLZ* .0@T/7=&U[5Y--CM+K3]7?SR)IFC>WEVX8\*=P. >W]:T_
M!FE7VA^$[#2]0$/GVL>PF%RRD=NH'/-;E% '#:#+J:^(_%ZZ?;03%[Y0CR2[
M0C^2OWA@_+TZ<^U26_@^^TF[\*1Z<L$UKH<<RS-+*4>0R+M)4!3WR<$^WO73
M6&B:=IES<7-G 8I;IMT[>8S>8WJ<DY/O5^@#FCHVHZ7XPO=<TV.*Y@U.&-+J
M"23RV62,81U."",'!''KSTK+N? ^H1:1'<:?=0)K<6JR:KE\^2\CD[H_7;M(
M7.,\=L\=S10!RNHZ)KOB7P[=VVIRVVGW<GEM:I;.9%AD1@X9F(&22!QC@>N:
MFLAXRN+&<Z@--M;F.!U@%N[.LLVW"LV1\J@]N3^6#TE% '&VOA:]M-9N=9TR
MTM=(N)K&2*2"&4M%/<'!1R,  *0><9.>GK/H_A>2T\4C6XK*#2A);-'>06TI
M9+F0D$-C  QAN<9.>GKU=% '-^*M#U"_O=)UC2'A^WZ3,[I%.Q5)D==KKD X
M)'0XK,E\*ZMK.IZ[+J<=I:VVL:?';8AG:1XF7=@\J W+9[?CUKMZ* .;T"/Q
M>#!;ZZVGK%;##3VSLSW6!@9! "^I]2.@%*/#$B>-Y-:CF"V4\2/-;_W[A 51
M_IL8_BJGM71T4 <G?Z3XBT[Q5<:SX?\ L5S#J,<:7=K=R-'M=!A75@#V.",?
M_6?JNBZU>7OA^YW6T[Z=<M<7+,YC!W*PVH,'@;N,GH!74T4 <O9:-JV@:WJ\
M^FQ6]W9ZK+]I"2S&-H)L8;/RG*G /'(]#6$^C2^&-9\$:9:;+J6#[:7W-L\Q
MF3<Y'7'+' ^@SWKT6J%UHFG7NHV^HW$!>ZM<^1+YC QYZXP>,]_7O0!S>J>%
M=2U&P\27 6W2_P!;A2WCC:4[(8U4@98#DDDDX'H.V:LW6BZO/K'AB]6"V":2
MLGVA3.<DO%Y?R_+SCKSBNJHH X>Z\'ZGJ;^*(YW@M4U:2&>TFCE+M%)$%V[A
MM'= >":UM,_X2Z:%O[9BTZ)HHRJI:RL?M#XQDDK\B]\<G/IC!Z*B@#@8O">O
M1>"] T8161N=*O89Y&^T,$=8WW<'9G)SCIQ6Y8Z1JECXSU34U%JUEJ<<!<F1
MO,C:-2NT+C!!R.<C'H:Z*B@"II;:B^G0MJT=O'>D'S5MF+1CDXP3STQ5NBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S]=OYM*T2
M\U&"%)VM(7F,;N4#!5)(R >>/2M"LCQ9_P B=K7_ &#Y_P#T6U '+VGQ%U2Y
M\$GQ:N@V[6<;$2Q+>GS54-M)&8\'UQD5V&B:Q:Z_HMKJUF6\BZCWJ'&".Q!]
MP01^%>%1MKD'P=L)896ET-[IUU&")0LH3S,\/@X!/'3@XZ@UUOC#5;"S\)>$
M8-#94\/W5Y&LVYB%:,$$I(>3@_-N'JIH ]6!!&0<@]Z P/0C@XKRCQ=%K/@_
MPGXBGM+Z".*_GA>*WM"1]C5R0Y4\8#$8X YS3=1M+73/'?@6#3E6&">$-(L7
M"S%5^5F ^\?F/)YY- 'K59/B74M4TK2OM.D:2VJW/F*OV=9-GRD\MGV_K7FD
MD<*>.?B)"ZHL0TIG"$ *#Y:MG'KDYSZUD:J W[/&BS'F5;QPKG[PS++GF@#W
M=22H)&"1R/2C<,9R,>M>6>+;&*[^+GA>W+/$MS:,)FB8HSJ%?@D<\C(SUP>*
M;XDL[?PQXB\(^&;1%71GFED,-U*3'+*3\H<G.0&88'J: /5:,C.,\CM7C_CG
M1+G0OACJ%I=7<%QY6IB2V2+/^B(YSY0ST S^1IS:/8P?%O0+".-EM[_1PUV@
MD;_2#MD/SG.6R57.>N.: /7@01D'(]J 0<X.<5XEH>HWVC?#7QLNF2O&;._,
M=OL)_=*SJK%?3"Y/ZUU7A/1&D;2=:MY["'3KO2A;3VD1+?:SM)W-D %P<YSD
M]>: /0R0,9/7I5"_UNQT[4+#3YY1]JU"0QP1#J<*6+?0 =?<5\^I;1Q_!V+6
M%+B_AUK;%/O.Z,;,_+SQS@\>@]!7?^,+"RO?B_X56ZM(94N;=_.5T!$F V,Y
MZXH ]2R <$B@G R:\=\3"?PYXLNM4O[&+5/#]]/%&+B$#SK!DP%53_#@]NC#
MZFO7;RW@N[26WN8DFAD4AXW7*L/<4 <IX7\::EXKGBN['15_L>2>:%K@S@21
M; "K,IZ[B<8&<>M=@"#T(.*\%T.>XTKX$ZGJ&F+Y-U->>3-<1C#B/*CJ.>Y'
M_ C746^=%^)?A:RTB)8;:^TD"[BB&%E 5R'8#J01][KVH ]2) ZG%0WLLT%E
M--;HDDJ(6578J#CMD X_*O)/ _A73?$6K^++74/.-K::MF"&*5HU0AWP<#V
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:S_U#2:Q&63VSU(X[]:])HH \TEC\2SW;7,GPRB9WE69U.MIL>1<;69/NDC
MQD<8K3EU_P >S1-$_P /TVN,'&LQ*<?4<UW%% 'FM@GB73-/GTZS^%]M'9W&
M?-MSK$;1MD8/RG(Y%.TX^*=*N#<6?PTB2;RA")'UM)&6,=$4MDJOL,"O2**
M/.-+;Q3HL]Q/IWPTAMY+D[IF76D/F'.<G/4\GGKR:NW.M^.KNW>WF^'Z&.0;
M6"ZU&N1Z9'-=U10!YQH[>*?#\;Q:3\-(;2.0[FCCUJ/:3QS@\9X'-)?CQ)JN
MHP:C?_"VRN;JW&(I9=5A8J,Y';!P3D9Z5Z110!YG:P>(++3KG3K?X5626EV2
M9X?[5A*N??(_+T[4RQLM>TS3KG3[/X66T-M=+LG5=9CS(O\ =+'G')XSCD^M
M>GT4 >6R:;KDVFP:;)\*[9[.V<R0PG6DVQL>I [?_7/K4L]KK]UJ U"Y^%5E
M/="(1>;-JL3L5 QSGJ<<9//O7IM% 'CNM>'?$^I:+::/:?#Y--M+:Y^T?Z+J
M\0DW8(^5CT//4@]*BT3P_P".M%O963PYJ%W87$#0SV5[KL+A\XYRH&.XZ=SS
M7L]% 'ES:=KC:4NE-\++<V*2>:MN=:38&]<9^OYU/&GB:+58]53X9Q"^B01I
M.=;0L% P!DGIBO2J* /!CX$\9;[B:+P]J5K<32O*/LFNPQPHS$D80@MQQ_%S
M[5W>G:W\1;/3;:VN/!*W<T,2H\[:M"#*P&"Q'J>M=]10!Y0-"U,:B^H#X1V/
MGN<M_P 3>/8?JGW?TJQ:V.N66M-K-K\*+*&^.3YJ:M$,$]2!T!/J!FO3Z* .
M#O=7\<:A:26EU\/4>&52KH-:C7<#P0<=O:LFWTS6K:$01?"BT\@/O$+:Q&T>
M[UV'(S[XKU*B@#@-0U#QCJFGOI]]\-;:XM9  T3ZM#MP.G;C%4+2U\0V.DS:
M5;?"ZWCL[@8EC&M)^\'H3U(]LUZ=10!Y:VG:Z]O:V[?"V PV3%K9/[<7$))R
M2O/'//%:MSJOC6\-N;GX<P2FVE$T)?5XCL< @,/?!-=[10!YWK,_BOQ!9?8]
M6^&=M=P;MP5]7B^4^H(Y!^E5VM_$3Z,-&;X76QL P8P?VS'AB.A;NW;KGH/2
MO3** . CU?Q_9:<EGIW@""!8E"Q"35HY%4#MC(/3@<\4W3+[QK8WMY<+\/X4
M:_N!-,ZZK",?*J_CPN?J3ZUZ#10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !112;ANVY&<9QWH 6BBB@ HHHH **** "BD+ 8
MR0,G SWI: "BBB@ HHHH ***0,&&5((]10 M%%(6 (!(!/0>M "T4@8$D @D
M=1Z4%@" 2 3T'K0 M%%% !112;@6*Y&1R10 M%%-WH QW#"]3GI0 ZBBB@ H
MHHH ***0L%QD@9.!F@!:*** "BBB@ HIJNCYV,&P<'!S@TI( R3@"@!:*;O7
M .X8;ISUIU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1129&<4 +1110 4444 %%(6 (!(!)P,]Z-P+%<C(ZB@!:*** "BBB@ HHI <
MC(H 6BBB@ HHHH **0L%ZD#)QS2T %%(6"]2!SCFEH **3-+0 4444 %%%%
M!112;AN*Y&0,XH 6BBB@ HHHH ***3<-VW(SC.* %HHHH **3(_*EH ****
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M)&#%&CH1N)8#<0A)P3R<>] '3+XG8/%;SZ3=VU[<W#PVUM*R;I550QDR"0$
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M$4,D<GG0@X)5MP&0>H./;-%GXUBN=.349M*O+:SF@AD@FD*8F>0@"-1NSG)
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M$XYZ]';7&IPW%C97-GYX:UW7-\CJ$648&-O7DY- &E7!7&MW]IX[L=5EF/\
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M6A-:O9?%.VU!_P#4:CI;6BMZ2H^_'XJ6/_ 36IXIT-/$?AN]TIR%:>/]T_\
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MH3NO(7 CCE"LQ0)][&%//N/6HO'-G>ZEX.U'3]/M'NKFZA,:(C*O)[DL0,4
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M>,2!USC(96'52.AX[\4 ;5%<YJ'BN:VU^;0[30[N\O$M1<H%DC19%+%?O$X
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M/Y,[K<*)00VUBL?5@#P>0>#@$<UTKW4$=HUV\JK L9D:0G@+C.?IB@"1Y$C
M,CJ@)"@L<9). *=7GGBS4'U>+PKJ']E;+:;6[-[:X=@9%4OD;EQ\H8<\$]LX
M-=//XBD:>_CTS3VOQII"W)64(2^W<43@[F (R#@<@9SG !N45S\7B^QOTTK^
MS-D[ZM"\UN)I/*!5,;@3@_,"V, 'H?2GS>)DM[>R6>W6WO;P.4M[B98P@0X8
ML_H,@< YR,>M &[3&EC1@K2*K'H"<&LGPWXEMO$=O=-%&8IK.X:WGBWAPK#N
MK#AE(Z&LQ+.UNOBA>FXMHIC'I5NR&1 VT^;+R,]#0!U1=5959@&;[H)Y/TH=
MUC1G=@JJ,EF. !7G7B:T\02>*(S:I=#?-)]BW7";L^00_E-M(B!' WYRW]WK
M5_QU;ZH_AB,01WGDI83"]WS(R[?+&5D4 F1SS@J0 <DG% ';,Z(NYV"CU)Q0
MK*ZAE8,#T(.:P/#NGW4VE7$&O6[3LUP65;ATFC9<#:8P%&U/16&0<YSUJ'X<
M@+X'LE4  23@ =OWST =/13)H8KB)HIHTEC<89'4$$>X->6^"G\-VO@ 3ZIH
MRW4B23AG;3FDW?O&"CS-A'H,YX_"@#U6BL9KIM':PT+3[*2Y<6QV-(Y2-$C"
MK\SX/S'(P,>O2J]EXPM-0T73;^WMY3-J<K0V]JQ 8NI8/D] J[&)/H.Y(% &
M_)(D4;22.J(HRS,< #W-.KS_ ,=WYU?P!XCM[[2Y+:XT_:/W@W(QRI5XWP,C
M!] 1TKH[;Q*\GB--&NM,GLS<0-/:RR.I$JJ0&! .5/(.#V]#Q0!NT5D>)]>/
MAO1WU1K)[J&$CS0C@%%) W<]0,\U/+J4J:C;6<=J)O.@:9G24?(%P._7)8 =
M,\^E %Y)$D7<CJP!(RISR."*=7*:/XAL(_"\NHV&BS6Z?;GA%I$H+M*9=A)Q
MP,L<DY.!ZUHV&KQ:S?ZIH=]9*D]D(Q/'N$L<B2 E2"0,]"""!0!L1R)*@>-U
M=3T*G(IU<I\+_P#DG&C?]<6_]#:KT_B1OME_;V-F+MM-=$N4$P60%E#95<'*
M@,.<CH<9Q0!MB1#(8PZ[P,E<\@>N*=7!QSRZ7\1_$3Z;I+7D\EE;2&*)EC#'
MY\DL>,GCU)_,C<M?%<6I:9I%YIUE-.VK@^4K?*L6%+-YC ';C!'0Y/2@#>=T
MC1GD9411EF8X %1SK;R^7'/Y;;FRBN1\Q'/ [XQG\,UPWB_5K;Q)\+]>F:T\
MN6R=X)(Y,/Y<L;@$J>_L>.M7=;AB'C_P9.(U$I%VI?')'D=,T =E4"6D,=W)
M<QILDE $FTX#XZ$CUQQGKCCL*CU34[;1]-FO[LL(H0,A1EF)( 4#N22 /<U0
MC\02PZE+9ZGILEDB6INA<AO,A" _,K, -K#KCD8Z&@#:HKFF\8+!;:?J%WI\
MD&F:BZ)#<F0%DW_<,B?PAN.03C(SBF7'C&X6_P!8L;30+NYGTD1M(/-C0.K*
M6R#GT' ZGT% '445R%]XQN))?#$FEV+S6VLL7)+*K;?+9MF">#T)/3CC.:MZ
MMXN.E0ZC=-I<SVNEF,74C.$)W $^6",/@,,\CVS0!T1D175"ZAV!*J3R<=<5
M!J-C'J>GSV,SR+%<1F.3RS@E2,$9[<5D7FI6(\8Z59RZ6TEU-;S26UZ=N$4!
M=ZCG.3\O4"LZ;Q^Z:=J6H)X?O'@TN[>WNR9(P4"8W,.?F//0=AUH Z;3-/BT
MK3;?3[=Y&AMHQ'%YAR54# &>^ *L++&[%5D5F'4 \TL<BRQ+(ARKJ&4^H-<C
MX'LX!H5_=1VJ?:FOKU?-C55E;]\^ &/T'7B@#K@ZEV0,"RXR >10SJK*K, 6
M.%!/4]>/RKSCP]9^(4\4'[0EW^[: WN+E/,QL;R_-?:%E '!"8YQ][K4OBNU
MUZ3Q/"UHEP$>Y/V(O.A^?[,^XQ84^4,9'SYRV#@#)H [N\BM+F(0W13&0RY;
M:00>"#U!![BK & !G/N:XOQO8Q'X<O-=6N;N&"!?,N=LDR'>F07'4]<D<'FN
MUH **XSXMPQ/\.-3E>-6DA$;1N1RA\Q 2#VXXJ=;?PO-J.GVL&C"WNVE$L4H
MTYK<J8_GSN9!G.,8SR": .LHKF]5\8#2X;^\?39FL=.G2"XF9MC$MMRR*1\R
MC>,G([XSBK]YK3IJ,FFZ?:?;+N& 3RH9!&J*20H+8/S-M.!CMR1QD TVD1&5
M6=5+G"@G&X]<"G5Y_K.HQ:AKO@K6X],N4GEEN ()(@DX_<M\ASC'/J<=^E=1
MH&OG69+^VGLI+*\T^813P.X?&5#*0PX((- &Q16-JGB!M+US3-.DLRT>I2&*
M.Y\P!4<*6VL,9R0#CU/I27OB%K)-2E;3YIH[!HXQY!WM+(^W"A>V-ZY/09^M
M &H;6%KM;IEW2HI5"3G8#UP.V?6IJPH/%$*7^IV6IPK9R:9;K<RNLGF1F(@G
M<#@'(VG((^F:6V\0W$M_803Z/<0P:C&SP3@[_+PN[$H ^0D=.3Z4 ;E-$B,[
M('4LN-R@\C/3-<^OBMI8[.]M]+GN--O+D6\=S$=S#)($A0#B,D=<YQ@XJ.VU
MNS37?$GDZ+*EYI\4#W,B[-]T"KE,<XP #C)[]* .FHKD[3QS]H71;B71[F"Q
MUAEBBN6D0A9&4LJE<YP<$9]O3!,FL>.+32TO9DB2XATY]ESBX5),C&[8A^]M
MSSR.A SB@#J*;'(DJ;XW5U/=3D5#&]KJFGI( D]K=1!@&7*NC#(R#Z@UYSX.
M\6-X<\ :+)=:/='2ES'-J"LFV(M(P!V9W%<D G'YT >G45C3Z](]_>6.EV/V
MZ:P16N 91& 6&5120<L1SC@<CGFLZZ\=VT7ANU\0VME+<:=,X29RP1K4[MI,
MB\X /!QF@#IO)B\_SS&IE"[ ^.0,YQ_GVJ2L_2]3;5#<2);[+:.4QPS^8&$^
M.K*/3/&?8XXYJ/4=:6SU.TTN)(Y+R[222))9?+4JFW/.#D_,, #L3QB@#2:1
M$*J[JI<X4$XW'T%.K@_$5SYWB#P=JCZ9(EV;B=#" IE'[IODSTZ^^.];-IXO
M22QUB6\TVYM[G1VQ<6J$2NV5#*5*\'(- '1U'Y\(C>7SDV)G<VX87'7)[8K(
MM-=-UKLF@W]@(+AK,70 D$B/&6VD'@8(/48(YZUP$]K;_P#"D=;C\F/9#=W)
MB&T80B<@8].* /5/LL+78NF7=*J[48G.P'KCTSW]>/2G+!$DSS+&HDDP&?')
M Z#/I_B:<G^K7Z"G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !67XA@>ZTLVXTM-4B
ME=5GM7*C?'GDC<0,CJ.>H[=:U** /-[WPCK,?@WQ!HVF6]R]K>-$NFV5S<(S
M6XX+_,6("Y' R3Q[UOZA9ZI=>-=%U2+3I5M[:UGCE=I(_P!VTFW&1NR0-O./
MPS74T4 >;)H?B>>#1+B\T59-3L-36:\N9+M"TZX<;E/9!N'R\8[*:Z+2K+4K
M/QEXBU*;3I?LUZEN+=EDC.\QHP(QNR,D\9_'%=/10!SG@'3;[1_!MAINHVQM
M[FV#*Z[U8'+$Y!4GUJ&.TU/2O&FKZFFF2WMMJ,%NL;02Q@HT88$,'9<9W=1F
MNIIAFB$P@,B>:5+"/<-Q7IG'IS0!P3>%-<T.STC4M,BAO]1LI[F:[M/,"+,+
M@@NJ,>!M(7!.,XS[5U^CS:E<PO<:C8IIY? 2U$@D9 .I9EXR<]!G  YYXT:*
M .,N+B:V^+DC16<MT#H*!A$R!E_?O@_,0,?C5&]\+ZLFBLT%@9KN]UY=5FA2
M5 (4#@[<L0"=JCIQDGMS74V^EZ5)XBDUJ"Y,E^T/DN5N-P\L'(7;G&,UJI+'
M([HDBLT9PX!R5.,X/IP0?QH YK6=,U%/%.E>);"U:Y\F![:ZM ZK)Y;X(922
M%)##D9Y[5/HNC3+K^LZY>0>2=2$426[E6*QQJ1EL$C))/ )X ]ZWFEC61(VD
M4.^=JD\MCK@=Z9)=VT4HBDN(DD;HK. 3^% '.^#_  [>:$;F"[</;VLCP::,
MY*V[-OY/KDA?^V8K%NO"FL:IHOBNR-N;.;4=0%Y9O)(C*VW85#;2<9*?K7H5
M% '%2IXBU?Q#X;U*;P^]F-/>?[4)+J(@%X]F5VDY7)^O'2F:%:>*M 23P^FD
M07-HDSFTU0W"A4C9BWSH?F++GH.#TR.M=MO7^\/SI00>A!^E '&6NGZYH.M:
M[#!I;:A8:O,;J&>.=$,,C* RN&(..!@J#]*UO ]A?:7X.TW3]1MQ;W-M"(W0
M.'Z>XXK>HH Y"/3=5C\0>++PZ;(8=1MX4M2)8_G*1LIR-W'+<9[50_L;6U\+
M^$;+^R93/I%W;R72B:+A8T920=^#G(Q_2NZCFBFW^5*DFQMC[6!VMZ'T/-24
M 97B:+5I_#=]'H;B/46BQ 20.<C."> <9 /8XKGM(TC5(/&MKJXT);&TDTQK
M:4-=(\B/YBMN<C.XG!YR<]R*[:B@#F_&FGW^I6VEI86;7+6^IV]S*%=%VI&V
M3]XC)]*8MEJ(^(DNL'3Y?L3:4MJ)/,CR9!(S]-V<8./K^==/10!YS'X<UU/!
MD5L-,;[;8ZR-02W::/\ ?H)C)@,&(!P>^.16SI]KK3^/)];N=)-O:3:8D(!G
M1G5U=FVD XSSV..1S76T4 >=?\(YKG_"M9M+.FL+Z._^TK#YL9\Q?M'FX!#8
MSM]<<UMZA::I?>+O#>J+I<J06:7/VC=+'F/S%4*,;N2,<XS[$UTR3Q2NZ1RH
M[1G#JK E3Z'TIY&01G% 'G^@27SVWC"RL]-DN'GU>Z2.3S$6,,R(/FR<@#@G
M /'3FKJ^&[[3-4\'16EL]U:Z+!+%<3AT7EH@@(!8$\@D^WK6_IND:;X=^U20
MRO$M[<&:8SS$AY7P">>A/' K1,T0G$!E02E2XCW#<5'!./3D4 <9I=MXH\/7
M=YI-OH\%_8S74D]I?-<J@A$C%BLB'YC@D].M=/K.F'5O#]]I9FVM=VKP>9CH
M64C./QK0HH \\FL?%-YH&@Z9/H!6XTB_M9)91=1>7,D1^\G.>0!P0,9[UK:7
M8:MX;UG6O*TZ2_L]3N#>PM#*@,<K* Z/N(XR!@C/%=;10!P<?@Q+7PUI/A[4
M-(.JV\,<KRW%O(J26\[/N!0LRG&6;D>@R*8-$\5Z7;:%JL2#5]0L(YK>ZMII
MU5Y878%?G/&]0JY/?'Y]_10!GZ1+J-Q;M/J-FED\A^2V60.8UQ_$PX))STX
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M;V,R6ES%<(#M+1.& /ID4 34444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4=7U6#1['[3
M,K.6D2**),;I)'8*JC/J2*O5@^,M%O-;T14TV5([^TN(KNU,GW#)&V0#['D4
M *?$<MC/?IK.G/90V5K]J-U&YEA=.<@-M7YQC[N*B?Q5+9RZ8VIZ:;2TU218
MH)A-O,<C#*+(N!M)Z<%AGCWJM<V.N>+?#]_I^L6,6CK<6S1+&LXG8R'!#D@
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MS('4&->^,GN1TKFM<\.>)=4T_7K273[>ZN)[L2V=Y)<@8@$BLL2J1\A 7!Z
MDD\UNO8ZJ_CRTUA]/_T:/3'MY"DR'$C.K<9() VXS@<]J *;?$&==&DUAM F
M6QMKMK>Z<W"[HL2;-P7^+GJ/U/..TKSN7P[KLOP^UC11II%Y=WLDT0,\>TJ\
MWF<G/&!Q]<5Z#$[21([QM$S#)1B"5/H<$B@#C? ]L#\-(WMK<FYEBN%!A<12
M.?,? #_PGI@]JH^%=.UV'Q-+)=BY:..X NB+@*"_V=-I?Y!YX PN1MPP)P<Y
MK;^&W_(AZ=]9O_1KUU% 'F_B'3?$$WB?=;K=CS'G-H/M8+XV+O\ +DV$0!AP
M =W(.-O6MCQW;QCPU9RO"!,M[9+N?#./WR<%N]=A7+_$+_D7(?\ L(VG_H]*
M .HHJG'/?MJT\$EFB62Q*T5R)06=R3N7;CC''-7* /.[JWTF+XO7?VW35N(Y
M-'1RJ633Y?S3\Q"J><#K6Y87NEZ=I&IZWI6CSHOF;&M(+8QO*Z':#Y9 *DYY
MR.@!JO\ 8M9@^(UUKJZ2\UD^GK:(4GC#DA]V[!8<<GOFIM:C\3ZEI&IQZ;:#
M3I2L?V=#.HDF.X&3++G82HV@Y[D^F "Y:^)A_;5]I6HP1VLUE:K=L\<_F(8S
MD$D[5((QTQTIMOXBN[F339#HLQT_5/\ 53HQ=H@5W*94VX0$=]QQWQ6+%X8U
M&Z\074LFE6^GZ?J&C&QD6*<,T)+,3D ?,QW?3WJ[X87Q;:6=IHVI:?;116*K
M&VH1W ?[1&G"A8\9!( !)QW/6@#"T37)?"^E^);JWT9KBRM-<N6G,<BQB-,J
M/D7^(@<XX&.]>D+(KQB13\K#<#[5P1\/ZV_A'Q5IITTK<ZM>W$UN/.CQMDQC
M<<\$8Y_3-=I9Q.^DPPW,+1,80DD98$CC!Y!(H R(_%-Q<16-]:Z1-<Z9>W A
M2>)RTBJ20)6C"\1Y'7=D @XJ/5O%\FDP7M[)I<GV&QN4MY99)-CN6VY:-"N&
M4;QSD9P?2J/A:S\5Z)9P^')K*V:TM&V1:H+@?-#G('E8SOQQSQWYQSGZ[X<\
M2ZI9>(;233[>ZFN;CS+&\DN0-L(92L2KCY2-O/0').30!TNH>)7AU"^T_3[.
M.\N[&V6=X&N/+>0$$@(-IW=.O R0*-6\4PV%[/8VXM)+FWA$LB7-V(!\V=JJ
M2#EC@]@!QD\UD>)O#]YXA$YGT39?QQ@Z=J%K<JCV\FWHS9#;0W/ .03QTR^7
M3_$^@^(GU/3K2'68M0MH8[R-IQ ZRQKM\Q21C:0>1UH Z+0-:MO$6AVNK6BN
MD5RFX+(,,I!((/T((JC9>)9-2F+6-G'/;1WKVDS+<?O82K%2S1[>!D<<YP0?
MIKV(NQ9Q_;C&;@Y9Q']U<G.T'C( XS@9QFN/?PU>W6OV>KPZ:=+U.*]S=7D,
MRB*ZMPQR&4'+,RX'*\'OQ0!1T[4Y_#NH>,KC3]&^U0VUZ)Y5218E1!"I;''+
M=3@#\>F>L?7Y9FLETVP:X%Y:&[$LSF*)$PN 7"M\QW#C'0$UAQZ/K @\8*VG
M,&U<N;3]['SF(1C=\W'(S]*;;Z5XABET))M,CNK&UTU;>6TEN558KA<#S3C(
M<8&!U(SG - $'B/5+7Q-X*T36X[;R_,U.U*"0 M&?/"L ?J#TZUHO#$GQ@AD
M2-5>30Y"[ 8+8F0#/K63%X;\00^ ]/T5M/C:YM-168^7.N&C6<R9YQC(. .?
M?%;[V&H/\0[?5Q9-]B73&M6<R)D.SJ_3.< #'UH UM7U6+2;:*1T:66XF2""
M)3@R2,>!D].Y)[ &LZ3Q0VG)JCZWITEE%IL2S&>-C+%,K= C%5RV>-N.I%)X
MRT?4-6TRUETEXQ?Z=>1WENDIPDC+D%">P(8U2U72M;\9>%M0T_4[2+1S<1!8
M81.)CYBL&#,RC &5 P.Q)/8  OOXEGL=2T^TU;3?LB:D?+MY4G\P+)C(C<8&
MUB,XP6&1UK,E\>W2Z=JU]%X=G>+1[MX+K-R@(5 I9AUR?F^[Z#KSBI[C3M5\
M1OH:ZI8?8?[,NTO+AO-1Q+(BD*(]I)P2V26 X&,<\9PT+6CX<\7V!TUA+K%U
M/-:_OH\;9$51N^;@C;D_6@#2N]?U-_&NE:=90P/8W-E)<Y:8JS\J.?E.,!N!
MWSVQ4E[XODL2)YM+DCLCJ(L/,DDVR%BVWS%0KRF[ONSCG%51I.LQ:WX>U2&Q
M1OLU@]G<QR3JIB)V8;(SN'RGISTK)U#P]XGO;&[CGTVWN;U-32XCO'NAF6%9
M0RHHQ\@"C&.!QGDF@#I5U6W_ .$YN-.&CXO8]-$RW>4WRQ^9@(/;=GJ1SV[U
MF0?$":71K+6GT&:/3[BY^SS2M<+F$^:8P0N/F&0,],9XSBKJ6.J+\0&UF2P/
MV4Z2MJ2DJ',@D+G )!QS@$XY["L)?#NO#X;1:"=,_P!-2]\XCSX]A7[1YV<Y
M]./K0!Z!-_J)/]T_RKC_  G:,?A39?8K=S=3:< OV>402.V.,28^4^YKKW8O
M:,S(4)CR5;&5XZ''%8/P\_Y)_HG_ %Z)0!A^#]/UJ'Q!<2W7VAK=+B59RLPC
M3SO+3+.FT>;G@!Q@9!.T53U;2_$4OB=O)2]!D6Y:!1>@2>5YD6X)-LQ$&X(4
MY( (W+FO2Z* .4\;00@:%-Y2>;_;5H-^T;L;^F:ZNN8\;_ZG0_\ L-VG_H=;
M=O/?OJ5W#/9I%:1A/L\XEW&8D'=E<?+@X'O0!<KSKQ_X<T?3M LV@T^V\V75
MX#+,8E,DA>0EMS8R<YKT6N6\>Z7J6L:99VNFV9G>*^AN')D5 %1LD<GK0!E_
M$/PWH]AX&UZ[M-.MK=Y;>/<(HE491_E; '7YB,^E;]OXDF;Q+'HU[I<EF+F!
MY[69I5;S I 8,H^Z?F!ZFHO&^GW^N>"K[3M/M"]U=HJ+&[JNSY@3DYQP >F:
MAU#3]1O?&6C:F-.D%K;VT\4Y,J94R;<<!N<;><?AF@""7XAV,?V.Y5();"[N
M! LD=TK3)DX5VBQPA^N0"..U=A7%^&K3Q=HEK%X<EL;:2SM3Y<.J_:!GR<\
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M)>B5)+D+)Y1N 7W2J'_AW$MSV!K%?PAJ6H7FO0OI]KIUEJ^G1PIY4P/D.F_
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M*^CGE431[=JS&3@Y[@X^M '1ZUXHGTE-3F32GEMM+B22>623RA(",D1_*0Y
MZ\CDXJAK!M[GQWX-OXHU#3)=$.5PQ4PY /YU5UW0_$.J7'B"%["&ZAOK39I\
MTUP +7,9#)LP<,6)^8=>YP*M'3-:?5?"5U)IP"Z9%*MWLG4["\008R1GID_I
MF@!_AR&*'XB>+Q%&L89;)B%&,DQOD_6HO&06'Q;X3NX[7SK@74R*$ #L/);Y
M<GMG\*OZ/IVH6WC77]0GM"EI?K;B"3S%.?+5@<@'(SGC]<4>(M/U"[\2>'KN
MTLS-;Z?/)+.PD52 R%  "1GKF@!+7Q?(]EK+7>D7$=[H[A9;2!A,TFY0R%2
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MA5& /]'C[5HW^O?9]:CT>VBAEO9+<W"I-/Y090<87Y3D]>.U4/#/_(T^+/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 1SP17,#P3Q)+%(I5XY%#*P/4$'J*R_P#A$/#'_0N:3_X!1_\
MQ-;%% &4_AC166W6/3X[86I<P_9"8-A;&['ED=<#-::((T5%SA1@9))_,]:=
M10 4R6-9H7B<L%=2IVL5.#Z$<@^XI]% %'3M'L=*,[6<3JURX>9WE>1G8  $
MEB3T 'X5>HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKG_'.E7NN>$;W2]/C5[BY"JN]PJKA@Q)/X5T%% ',>)=+UF^_LK6=(2&/4]-
MD9_LL[_)*CKM=-P[],'VJIXAT[Q+XD\&:A9SV=M;7=Z(TBM5N-ZPA6#%FDP,
MDXZ 8&![UV5% '-WVGZE=>,M&U5+/;;6<$T<VZ1=P,FW&!GD#;S6-)X?\2K8
M:\MI%'%)?:JMXB&XV^=#\@:)F'W20O49ZXS7>T4 <AI6D:QI_B74-2.F6D-K
M=644:06\PS&R;\(!M .=PYX ]ZSK7PWKD7@SPSIGV%!=:3?Q3SJTRA2D;$_*
M1G).1C\:] HH YJWT_4K?QQJ&LFRW6EQ91P(!*N\LA8],XP=V.M85GX9UV'P
M/X>THV*"[TS48KF8-.NTJDA?Y2,\G('Y_CZ%10!REQ;W5CXMU'Q#>0PPZ9_9
M8@:260?*4+.2RC/R_-CCGVK TF+6-%TW3KG4O"JS6NGKYR/%J@=8-P^9DB*C
MH"<+DXZ"O1IX(;J"2WN(DEBE4J\;J"K ]00>HK*L/"6A:9,DMI8!#&<QJTKN
MJ'L55B0OX"@";Q):ZE?>';ZUTBY%M?2PE8)2<;6^O;TSVKG],T368/%.G:K_
M &78V-LE@]K-!'<%S&2ZMNSM&XG:?YD]J[.B@#G/!.E:GH6B?V5?Q0!+>:4Q
M2QREC*'D9\D8&W[P&.?PHO=*U-/'=KKEG##-;M8-9S!Y=C1_O ^X#!W=",<<
M]Q71T4 >?MX>UN3P;XHTPZ<5NM5OKB>W'G)MVR$$9.>",<_UJ[/IWB33-<BU
MS1K&"Z6[LX[>^L+BX$3*R9VNK@,/XB/\\=G10!6T];P6:'4&C-RV6<1?<3)X
M4$\D <9/7KQTK"TO2]5TKQ!KUQ]FBFL]0E6XB=9<2$B,+LVD8'(ZYKIJ* //
MK7PSKD?@GPUI362BZTK4(;B<&9=I2-RWRD$Y)R,=._X[L>G:@OCZ?6S:?Z(^
MFK:KB1=Y=79^F>ASCKUKI** //+;PGXBM?#UBUJMO#JVE:C-=P*\FZ*=)"^Y
M"1R"5?'X>_'7Z-+K5RCW&L6L%B6 6.UAF\[;URS/@<GC@=,=3GC4HH YF_TC
M4+/QI%XDT^(74<MI]DN[;>$? ;<KH3P3U!!(XJI/X9OSH'B8K$C:CX@\P>6)
M $A4Q[$!;O@<G'<X'K78T4 4-$AN+;1+*VNHO*F@@2-U#!AE5 )!';BN;M=,
MUW0M:UR.TT];^PU>9KF*47"QF"1E 97!Y(X&"N?I79T4 >>6/AOQ/I>C>'+Z
MRM[7^T](MWMI[.2?Y9XFQD;P,!@5![CW/2M/Q+IWB+7O!-[:26<*WUV\?EVL
M4P*0JKJQW2$#<?E/0>@QU)["B@#F=2L-1N_&F@ZI'8N+6SAN%G9I$RID"@<;
MN<;><?AFC4?#,]SXRM=6MY52UEA$>H1?\]?+8/"1[[L@^W'>NFHH Y36=.U^
MP\5+X@T&WM[Y)[9;:[LIIO*)VL2CJV",C<0?\X;J^F:]?7.@W;V\$LUE>&YN
M$24*B*590B$C+$ ]2!GVS@=;10!SGCJR6\\,RF.417MK)'/8N.HN P\L#_>)
MV_\  JN+;:AH_AZ*#388KV]3:7\V3RUD9FS(Y.#R26:IIO#^DW&MQ:U-8Q2:
MA#'Y<<[ DJO/0=.YYZ\UHT %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+@F>Z@:>.:2[**%4X(($9P?SJGX 1S-XFN<8AGURX,1[-MVJ2/Q!'X4S4O\
MDKNC?]@RX_\ 0A0!I1^*OL^O0:)K-@VGW-V";642"2"<CJJO@$-[$#^5:8EU
M+[3>K]DM_)14-JWG$&4X.X-\IVX.,8S7(_$?_3M4\*Z7:?-J#:M'<J%^\D2
M[V/H.1^57_#H9/B!XLA\Z9XU6S95DE9PFY') R3@9[#B@#4\*:V_B/PS9:P\
M @:Z0MY:MN"_,1C/?I6Q7E.DEHOAQX&FC9HW_M:WC+(Q!*-*V5..H/'%;&J7
M]SI7BGQ3<6+,7M]"6YCCR2HE!D^;;TSP,^N* .^HKB--T9YWT77;;6H8HG0"
M4Q*^Z^5UZ.2YRV><]0<US=Q:&/X=ZSJXN[PWVFZG.;69KJ0F/;. ._.1P2<G
M\A0!ZF;VW74$L#*/M+Q-,(^^P$ G\V'Z^E6*XLV%J_QB:1H07.BK*3D_?$^
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MSZC/9[9;7/E)&V[]SWWJ?TQ5[5/+L="L-+O]3N)[K[;%&RP8#WCEBP1N@4,
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MP   =]1532_,_LFT\V[6\?R$W7"KM$QVCYP.V>OXU;H **** "BBB@ HHHH
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M:.+F=/+G:*>2,3+C #JK /QZ@U?TS2[+1M/BL-/A\FVA&$3<6P/J235NB@#
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M]J +]QX9TFYO;B\>"1);I0MQY5Q)&LX P-ZJP#<<<CIQTJ:_T+3=2@MX;BV
M6T8-;M$QC:$@8&QE(*\<<5H44 9C^'=+DT^>Q>"0PW+;YSY\@>4\#+.&W'@
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M%YO]FV30&1"F?/D8HIY*H2Q*#/\ =QT'I4'B3Q._AZS3S+5FG=%(F92+8-N
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M?@<9S0!JT50TF759(9EU:W@BECF*QO Y*2IQA\'E>I&#GI5^@ HHHH ****
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MA(T+%MJCH!D]!5!?#&CI%?1+:L$U DW2^<^)B>N[YNXX^E '/1R0:S=Z+;W
M.H7KZ,L\EK<,!;JK[09FX)+Y! Q[].M8MM:7.I_"+2=87==:AI)-RF]B3,D<
MK;HV]04&,>PKN&\(Z#(]H[Z<CM91^5 6=CM3^X<GYE]CD5<TS1M.T:T:UTZT
MCMX68L44<$DY/6@#FKK45N]#UGQAI2*[KI[+8R!<DA4+%_KN.W'_ $S]ZCTO
M1H)9]#\06>L6T2,H4FWMV#7P=?NR$N=S#!.2"003ZUUUG8VNGV$5C:0)%;0H
M$2)1P%]*S=*\'^'M$OGO=-TN&VG?.67)"YZ[03A<^V* (?%TMJ+;3[:X><M<
M7T:16\3 "Y89.QR>-G&3]._0Y_@GS(-=\3V!6.**"\B,<$+$QQ%HE9@N0.,^
MPY[5T6K:-IVN6JVVI6JW$:2"1 205<=&!!!!^E,L/#^DZ7>S7EC816]Q.JK(
MZ#E@!@?R'U[T 9>K_P#)0O#G_7K??^T:M:QX4T[6+M+R5 ER&B#R8W>9&C[O
M+(/ 5CUQUJ'6[2_'BC1M5M;&2\AM(;F.58G16!D\O;]]@#]T]ZZ!22H)4J2.
MA[4 9;>&='?2[73#9*;.TD$D$+,65&&<'!/(&3P<CVXIGA_PU8^'K8+;@O<-
M%''/<'AI]@P&8=,X[]:V*CF=HH7=(FF91D1H0"WL,D#\S0!SOA/_ )#7BG_L
M*C_T1%57Q;%J*ZM'?6NG0:W:06I6YTUFQ*@9CB6//!;Y2/7Y>*T/"]C?6UYK
M=W>6C6HO[[SXHW=6;;Y:+SM)'53WK0N]$L+V\%Y-'(+CRO*\R*>2,E,D[3M(
MR,DT <7"FF:WX@\)+;M-)I\FC3A%=BKN@\H8?'TYYYQW%4X=0DT;PGJEK%<-
M;V-MXE-D9&9F%O;&1,C.0=O)'4'!ZUWJ^'-)2]MKR.S$<]I%Y,#1NRB-/[H
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ML['7?B<Z7 ,UI+X>B?9N*K(#.^,@8R.>AKIKGP]I=W<W%Q/;LSW0"S@3.$F
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MV[[X9%=D>-O574AA^!IO]BZ?_9TVG_9S]GGW&9?,;=*6^\6;.YB>Y)YH SO
MMI;VW@G1F@@2(S6%N\A1<;V,:Y)]37.>)7FTK5-0U'5+!-3T62:,F\MV_P!(
MTTJ$&"#U3(W<?WCG.:[K3]/M=+LX[.SC,<$0VHA=F"CL!DG ]JJR^'=*FN9Y
MY+9F:X=9)D\Y_+E9<8+)G:?NCJ.PH Y@Z19:U\0?$EM?QM+!]AM<QARJDXDY
M.#SCM65HVJW%WH7@>RO;N/R;^&<2-=(9$ED0 1HPW#.06P">2!U-=\N@::FH
M75^D#K=7:A9Y5F<%P. #SV[>G:JTG@_P_-H8T2738WT]6WI S,0A]5.<KWZ$
M=3ZF@#D?$^CG0_A]XJM!J2W$;A9DMDB*):;F'RKEFP#C..WXUJ>-["SN=2\+
M//;12,^J)$Q902R>7(=OTS6Z/"NAKHC:*NGHNGN=SPAF <^K'.6Z#J3T'I4M
MWX?TR^^R&Y@>4V3!K<F>3,;#HP.[K[]: -".-(8EBC4(B*%50,  =!3J0#
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M-Q<1+EO,A?B0X/=<[AZ8.*Z#P[%!>27FOI&F=1D_<N%P3 HVH<^C8+_1AZ4
M;E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2.YV#' Z_=]1WKB++P0LT AO/!D$&HE?WFHQ7P2,R=Y $(8<\A=H].*]*HH
MA6V4V0M9S]H4Q^6YD&?,&,'/KFLRV\(>';,VQM]'M4-JYDA.S)1CW!-;-% %
M*TT?3;&]N;VULH8;BZ;=-(BX+GU/]?6B_P!'TW5)+>2_LH;E[9R\)D7)0GKC
MZU=HH RU\-Z0HO MF +_ #]JP[?OL]=W//I].*CN_">@W^E0Z7=Z9#-9V_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-O;I!*"A$AC#;N-V1]X8R* &Z)XAT2U\'Z=>:=:-9VEW,\5I:R,%._>^<DG
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M"\^Q20*0Y>;*A50\9W;UQG'7G&*AU'4Y+^VU;1M0TN:W==/:=9 =\3J01@.
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MV#(R0!@]>>>E<GI]Z?\ A'-8UW6-(@O1I^K3W0?[01(KQOA0OR_P@ #GD#%
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M*CI+&LD;*Z, 593D$'H0: //)?#FNR_#O5M#&F,+RZO7FB!FCVE6F$G)W<8
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MQ2QSQ++#(LD;#*NAR"/8T /HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M207'F_:6QCA<?(O?DD\ >M,\9:9J&J0:6NGVZS-::G!=R!I @VQMDC)[GM0
MC>*;F!HK.^L+6QU&422>3<7ZB-8U8 ,9 IY;(P-N>#Z5'IWC:+4K&W,5DRZA
M<7CV:VID^7S$!9F\S'*!1G<!SD<9INOZ=KL'B&R\1Z%;PW4J6[6MU93R^7YD
M98,"K<@,#4.M:1XDOXM,UN!+5=7TZY:9+(RDQ^4Z;&B\S RV.=V,9)[8H O2
M>*I;"ROY=6TJ:UEM)T@B5&WI=L^ GEL0N<DX/'%2?\)'<6NNVVCZIIZ037T3
MO:20S^8DK(,LA)5=K8Y]#ZUGZSHVN^*?#L@NDM]-OHYHKBSMQ+YJQO&<C>X
MSNZ<#C Z\U8DTV_UO7-(U2_L39+I*RR>295=I977;A2#C:!DY."3C@4 9_\
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M_)/=$_Z]5H Z6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY[RPB60V\LYCDG#+N^0;3D =_7CCK4R>(+E?&1\/W-A'#&]L;BWN?M!/G $
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M)]AW9&>,#IB@#KJ*P=$\1S:_"UW86<4EB84:.X^T']Y(1ED *=%Z%L]>,9!
MP%^(NHCPY:^)9?#NS2'?;<R"Z#21#>4W*NWY@.,\@YSQCF@#M_M=M]L^Q_:(
MOM/E^;Y.\;]F<;MO7&>,U-7/+K&[QO-I2Z7#YRZ9]IBO/,&Z1-^T)]W(&<GJ
M?I6?I?B[Q!K.D_VG9>&8GA G!5K_ &L7C8@*OR'.<=?7VY(!V-%<[9>*9-1T
M'1M2L[.&27575! ;@@1\,7^;9R5"MG@<C%:FM:O;:%I%QJ=WN,4"Y*H,LQ)
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M2ZU?QAXKL]5L+.>U9[>*:-IRX1!#N55!0;ADD\[<$G&:T?&2J)_#*@ *-;A
M'_;.6@#H#?V8L3?&[@%H%WF?S!Y87UW=,>]3]>17'?$/3=1O=-+V,,KQ16LX
MF6*1F,@*@",0@8<GU/*XR.:G@T;68_"6HV,H>:_FG+))_:$B&3)7#A@,Q=/N
M*,<8[T =+%=6\\;R13Q2)&S([*X(5E.&!/8@CGTJ.SU/3]1W_8;ZVNO+QO\
M(E5]N>F<'CH:Y'P7I&K6FJSW-[YKPB2YC+.[1#S/-)+^5C#A_O!SSVQ6CI
M^(OB( 8_T2R_]JT =+)(D4;22.J(@RS,< #U)J"RU&QU*-I+&\@ND1BC-#('
M"MZ''0US7Q$GOH]+T^*VCB:*;4[5)-\Q0M^]4A<!3P2.3V]#276KWNE^)?[/
MLO#EH^HZC:-<O+'=;5D:/"@,Q0'@'KCT&.X .OHKGHO$&HW\UY;:=IT$EQIZ
M(+E9;G:OG,NXQ*P4YP",L<#D<=<43X\%Q8Z'>Z?ICSQ:O<&V(>4(\$@#94C'
M."I'44 =?17*6_B;7;G4-3TF/0[7^T=/$;_\?I\EXW!*X;9NW<$8VX]Q6QX<
MUJ/Q%X?LM7BB,2W48?RV.2IZ$9[\@\T :+ND2-)(ZHBC+,QP *9;7-O>6Z7%
MK/'/"XRDD;!E;Z$=:Y;3=2U34?%GB33KV&V>SLUAC51*3M5HV<':5PQ.1GD8
MP.N*Q?!OB&^T?P=X6273$;3[R2.S\_S_ -XKNQ"MLQC;GC[V?;U /2**Y75O
M&?V/^T38P6UR=-;;)%)<%))F"AF6-0IR0#@9ZG(]ZZ&SO8KW38+]0T<4\*R@
M2#:5!&>1V([T .N[VUL(?.O+F&WBSC?*X49],FJ[Z)ISZF=2,!%VVW=(LC+N
MV_=R <'&3U]:X?QOJ]QKOP_?4H+"'^SIKB$PRO(?-">>@$FW;@!L8QG.&!]1
M72:]XEO-(34ITTU?LVFP+,TMS,8EN"024C.T@D!?S(&.] '1T5R-[K^J3>)_
M#D-A%!]BU&UEN=DDK(S$(IPQ"G  ?ISD^F*-4\<BTBO+BRMH+N*QG,,D/GXG
ME*G:Y1-IS@YZGG!Z<9 .FO;&WU"$0W*NR!MP"R,ASTZJ0>]%C96VFV45E9PK
M#;PKMCC7HH]*DAE6>".9,[)%#+D8.",]*DH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *SM;
MBNY[ 1VEK;W>Z11-;W! 26/^(<@\XZ>]:-% ',>%_#J^'VU,!!::;>2JUO8/
M)O6'Y</[#<Q^Z"1P/7 A\"Z/_9EG>2I.;JW6:2#3\_PVR.Q50>_S,W/<!>V*
MZ#5='T[7++['J=I'=6^X/Y<G3(Z&K444<$*0PQK''&H5$08"@= !V% '.^$=
M,U31-'O+>\MH?.:ZFN(A'-N#!W+ $D#&,XK$MO"NNVW@SP[I M[9KG2M0BN)
MCY^$9$<M\IVYR<XZ5Z!10!R=S;W>G>*-4\1WL=M#IITQ86>23)4H68EE Y!W
M8X.:P])M]9T/3].NM0\,6]Q;V*[TDAU0MY.X?,T<3+C/) 4'C.%ZUZ)-#%<P
M/!/$DL4BE71U!5@>H(/45EV'A/0=+G6:STV*-T.4Y+",^J@DA?PQ0!C6^E^*
M=!UK44TF*PN]-U*Y:Z5KF5D>UD?[^0 =ZYY &/J*/$OAFZUZ">TN;""ZD2)1
MI^HB41302[>6) R!N&[C.>1CI78T4 55M[E-*%L+HM<B#9]H9>K[<;\?7FN)
MLO#/B6-?#\DUKIRW&EW+/<R?:6=KHM&R&4G;G/.<')/J*] HH XD>'M;.B^+
M;(VUN'UJ::2V/G\*)(PGS<<8VYXSUI8]!U[3-9TS7+*WMIY5TU-/OK-Y]HPI
MRKH^WU[$=*[6B@#F_"&DZII3ZPVI16R"^U&2[C\F8N0&"C!RH_N]??H*8?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M 44QY8X\;Y%7/3<<4>9'Y?F;UV?WL\?G0 ^BFJZNNY&##U!S2A@PR"",XXH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
:4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>ebs20191231exhibit1048014.jpg
<TEXT>
begin 644 ebs20191231exhibit1048014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0$L<#E2* ([7Q3H5Z9!;:K;2>5 MQ)\^-L;#(8Y[<C\Z<GB31GCNG.H11"S
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M$;J/N_-UXZGU[5H1ZMJ&M:MJ]EI5Q!:KI;+"'EB,GFS%=QR,C"C('').>1W
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M^7CIUJ32="NM.\1ZSJLMW%*FJ-$WE+$5,>Q-@YW'.0/05N4C,%4L<X SP,T
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M26#,&)W9]5':L!_ &IIX9O?"UMK<":1,Q-OYEJ6FA4ONV;MP! .>V?I7=T4
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M\4Y$C^&^L%V"YC51D]277 K1719[[4;'4K^^@N38JYM1#"54NR[3(WS'/&0
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M%;);67GVD<<?G23. Q;S%P2L8PHR,=>O:J5SX O9]%U#1(]>$6GW5T;B%!:
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M&+S" &#<#</2JUGX:NM.\1W.K6>HQ0PWJ*;NS%L=DDHZRK\_RL1@'KGOD\T
M<MK>M:SJ'PV\333WJ17%E?S6A>WBVAXU<(0 22,Y/<FO1+>.:*W"3S^?(,YD
MV!<_@*Y@>!WD\-:WHMSJ8<:O<RW/FQV^TQ.[!CP6.0"!Z5TME%<PV:1W=T+F
M<#YY1&$#'V7)P/Q/UH Y#2];\07)U>_N[^S6RT74+B*:..U.Z:*- < EOE/.
M>^<^U3V>J^)[F31[Z&T>>UO2AO(2D:I!&XR'1MVX[>,YSGL!TK1T7PU)IBZO
M%=WD5Y;ZK<R7#QB Q[2X 9<[CD8 _6JF@^$]4T;R;*3Q'+=:3:L#;VK6ZK(
M#E5:3.2HXX &< =.* *-YXDU:Z\%ZCXJTZZB@B@\YK6W:$.KI&Q7+GKD[21@
M@#C.:T+;6=0?QA9:8\RFVN](-V1Y8W)(&1>#Z?,>#7/^)?#5WX;\%^(8X-;Q
MHTD4LL5F\ W1LYSL$F?NECTQGGKZ[[:#<WUSHVN:7J<=I/!9?9WWP><LL3;3
MQ\PP01P>: ,F[\5Z[#X#U[58I[8WFEW\]NCO!D,B.%' (PW.<\CVK4UC4M?_
M .$ML]&TZ\M+>*\L991));EVC=2HS][#?>Z<?CC%0/X#N'\+ZQH1UK*:K=R7
M#3/; M&'?<1@,,G@<\=^*U)?#][-XFT_6CJ,(-G;M T(M3B0,06.=_'W1CKC
MWH RY=8U^]74K?327NM+VP!XX$*7%P(U=MP9LJI+  #D<G)Z4IUKQ)-XCTK3
M'%K8&]TUYYHFB\QH)5*AAD-AAR<=/?/2K-WX4U&/Q#<ZOH>O-IHO@OVR![99
ME=E& ZY(VMCCO5C_ (1J9/$=AJT>H#996K6PBEA+M(&(+,7W#G(';UH YW^W
M_%#>&-=OEO[-9] N9XF;[+G[6(P&Y&[Y,J<<9Y_7:G\07=_J46G6*RPL;".\
MEDA1'=3(2%4!R!CY3G@]NE,7P==#1=?TTZK$1K<\LSR"T/[KS%"L -_/ XIM
MWX.U W&G:CINN"QU2SM1:23"UWQ7$0.0&C+<8/.<_P#U@"G-K_BVVM= 2]@M
M+.[O;\VDZ/'N#C#%9!M<X!"C*]<]Q22ZOKHM?&&EW&HQFYTFV6>WO(8 C;7C
M9MNW)&04(S[UJWWA6\O/[*<ZP&GT^[^UO+-;;O.DP5Z!E"K@X 'H/Q=_PBLK
MZKKUW-?HT.MVRV\D20%6C"HR@AMQSPQSQZ=* ,=-;NO#W@_P[->7,PL9X8Q<
MWL5N&-JGE#:",'@MU8@_3G-:EYOU?X>WS2WT%XTEO.\-U;8"G:6,3C'0C"'V
M(J6P\/ZQI]AIULFMQ3?8H3 ZR6?[N:/:H4%0_!&WKD]3VXJM+H@T'PA>:+II
M62\U$S")%78BO*3DA>=J)NS[ =R: -;POJ<FL^%M,U*8?O;FUC>3']X@9_7-
M:M4])TZ+2-(L]-@),=I D*D]2% &?TJY0 4444 %%%% !1110 4444 %%%%
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M9-<V=X8D\R)E;#*P "L.00<#T]ZKZ)KFJ:GX?BMI[OR];74&L[DK&N$9&)?
MQC'EC(/J1S0!U$=_')J4U@(IP\,:R&1HB(R&)& W0GCD5!K.N66A6\4][YH2
M:9(4,<1;YF( R1P.3WQ61%KM[:^+-<M;Z='L+"PCNHU2+:R@[]V3GD_+[#VK
MG_$-QJ6K^!M+UN>]"I>7EI,UHL:[$1I5*@-C=N'RY).#SP., 'I%(Q"J2<X
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M[OT_.MF:40PO*RNP09(12S'Z <FJ>AZS:^(-'M]5LA(+>X!*>8N&P"1R/PH
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MZ=!J.IIJ.G:JLP*"V6,VSHA?Y<<E2 1@DD>M5)/$.MR^ O\ A-+>]PR@W/V
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ME$D'D(HA=8MX92!D^AR2/8=!=?PG=W>AWMAJ6NW%]/>PFW>Y>%%\N,]0B+@
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MI89[Q8#+#.O;;'PRD>O(-7+KP9I]_I.HV5[)++-J4@FN+I2%D\Q<;"O]T+M
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M ,*YTC/7RW_]&-5IO"LT/B"?6-.U>6RDO41;Z)(E=)BHP'4-G:V/K]*M^%]
M7PSH-OI*7DMTD&=KR*H(R2<  =,D]<T 8%WXDN8?$\NE7^H3Z1*UY']A\R%#
M;7<.5W*'*D[S\PZC!(Q5E=9O-&\7ZC9:UJ+O8269O+!C&BA53/FJ2%!++P1[
M&KM_X7?5(9[*]O\ SK":Z%QY+0C?&0P;:KYX&1Z9Y.".U#53I/B_7K+3H4EF
MFT:],MU)Y3HL052-FX@!MQ*C SD GM0!6O;WQ-:7'ABT;5?+FU.21;H26\9*
M'RV<#@ ?+TZ<D<\<5:6ZUS3O%VB:/=:LM[%<6=PTSFV6,R.FW#''3[W08Z5J
MZSH#ZKJFF7ZWIMVTV1I8U$08.S*5.[)Z8/:EO-!:[\2V.MB\V-9121)#Y>58
M/C=DYSG@8_K0!Q]QK7B<>&?$.K)K:I)HVH3QQH+5,3)&1\K9' QZ8/N>W17F
ML7<OBJPTG[0VGVESI[W(G4*6DE#*/+!8$<*2QXST[9J,^"F;1-9TIM48Q:Q<
M23RMY(W(7.6"\].!C.<5B^)'2+7K6SOO$$ND?9+)4CN)[-)(+HLW. X*AEVK
MGG)SQC'(!-IOB?6O^$;L;B[F,]SJ>I&R@DCA1/D!?]XH)"DLJ<9XR0>1Q5Z6
MY\86,&LLEM->0K"LEB9O)\_=GYUVQ_*W&2O';!S38=$N?%&A3V.J:I)=113I
M-8:E#;_9I5=1D,J], \ @#()^M:,/AJ_&GRI>>(KJZOFV".\,2)Y05PV%11C
MDJ,DYSQZ4 1^$M<AUR6\FMM7EO(D6-3:W,2QSVLGS;@ZA5Z_+CKT/-=+6$GA
MQQ=ZAJ+7PCU*]M1;?:;>$((PN=K!23ELMU)[ <8K8M8I(+2&&69IY(T56E8
M&0@8+$#C)ZT 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 445C>+;JZT_PIJ=_97#
M07%I;23(P56R54G!# \4 ;-%<OIZZM=Z+I-\OB&875W'#,T,L,/ER94.ZC"!
MA\N[!SQ56RNM9O\ QUK>CG6[B*UL88)(=D,.[+@D@DH<@8H [*BN4L=?U+3O
M&*^&-;:*X^UPM-87D2;#(%^\CKDC< "<CC':E\=>);WP]80RZ=!Y\D;BXNE
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MRE:2>)@R%Y<*J C@G:"WL,>HJ'XO3PQ_#C48GD59)6A$:%L%\3(3@=^!FNU
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M#J!SBNJ\(7UQJ7ABTN[NTCM)I-^^.+.PD.1N7/\ "WWA[&MEE5AAE!'H12T
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MIW<EPFEVPN8;R: L# [GY&..<<,,_P"U[U[ 5!() )'0XZ4;5V[<#;C&,<4
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MJ+7=,GTY=0ANUDMW?RU95)8OG&W;C=NSQC&:FL=1M=225[60N(9#%(&1D*.
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M(1C.0K $CWKD-1%G-\&;-Q,8UM[2T.Z*,OLD0IPRCG ;[W<#/>I]$U?2-?\
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M]DQ6XD\IP(B/O \=1W].]97CB*6TAT[Q%:PO+<:/=!V2,9:2!_DE4#UP0?\
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MSC"J,[;,@<  Y.3T'/7C@U1U#QOIEOI.FZE9&2]@U&[BMXGBA=@-SA6S@9!
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MJUYG[-(\+K'/@9^1R,'CD<\CIFN7L+G3=?OM=>TU-CK&IV!MXH7M9;<1JJL
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M>MW$K&.5A_OIMQG^X3WK9\:V,UM\-I;+8\]W)+"\@A0N7D,Z22$ #.,[C]*
M-#4)[F+XCZ/ EW.+>XL[EG@W_NR5V8./7YCUI/!\]S)J?B6&XNY[A;?4RD7G
M/NV+Y:' ]!DG@5%J4H?XCZ!,B2-$MG<*THC8HI?9M!., G!ZTO@TD:WXGW1R
M()=2\R,O&5#KY:+N4D<C(/2@#?O-5M;*=()#*\SH9!'#$TC; 0"V%!XY'U[5
MS&LZXD?BKPI?Q:A<+IM_!<2-&-P64>4I3Y ,EOFX&,Y(XS4OBVT@N=7MY8M3
MNM&U.WMRUM?1J6B8$\QR C:W(! /)[=*S8[G4+K7? USJ=B]O<1V]R;E8X6"
M0EHPJ9X^3..AZ=* .AF\2Z+J7AG4+[[?<6UI")(+B5(Y(YK=@.?EV[E89!Z4
M^3Q1HFE0Z?;W-_)NNK??;F1'=Y5"@Y) Y8C''4DCCFN5D+MI/Q!B6&<M=-*;
M=1"W[[= $&WCYLL,<5)<W<%MK7P_FN-R(EK<*Q9#E#Y"#YAC(P>N>G>@#L-$
M\0Z7XBMY9M,N#*(9#'*CHR/&P[,K $54U+Q3#I_B>QT1K:X9KF-Y6D2W=P N
M, ;0<\D9/0=^M5/#ED7\7^(=<A0I9WOV>.)BI43-&I#. >HY ![X-1Z\9+3Q
M_H%^]O<26_V:Y@+PPM)AVV%0<#C.#R>.* *.D>*;;1;WQ(-8U"[FBMM2*H2C
MS&&/RT.2%!V)DGG@5UMUJ]G:K$2[S-.A>*."-I6=1C+ *#QR.>G(]17$1DMI
M/Q 3R)MUU)/Y ,+9F!@"#;Q\V6&.*A^TMI-YH.K:A::A)I<NC16<LELLH>VF
M4Y.]5PV#G'3J* ._TO5++6;!+[3YQ-!)D!@"""#@@@\@@]C5RLCPW#9Q::[V
M&G/86\\S2JDJE7DSC+LK<@DCH><8)P3BM>@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBH;N[M[&
MUDNKJ58H8QEG;H/\^E $U%8Q\5Z2/MBM).DMC#Y\\+V[K(L?]\*0"1QVJ0^)
M-, TMC+)LU<+]D?RFP^Y=P!..#CGG% $7B/09=>2P5+T6HLKR.\'[G?O:,Y4
M'D<9ZULC.T;B"<<D#%81\:Z +MK07CM,EP+9U6WD.V0C(!PO ]^E%GXU\/W\
MB);7Y8.LK!S"ZHHCSOW,1A<8)YQQSW% &]16/'XHTU[^*QD,\$T\336XF@9!
M.BC+%<CD@<XZX[56B\>>')DMI([]FBNIO)27[/)L#[BH5FVX4DCC=C/7I0!T
M-%8,?B82>,9M %I< 06ZRF7RB0Q9B!]%&#R>I^E5_B)<7%EX'U*^L[F:VN;:
M,/%)#(5(.X#MUX/>@#IJ*X*^O[_0/$7A>"RU&YNUU9O+NK.XD\T[=H)E4GE<
M9)/.*ET:"?4/'7BG3I]3U'[+8&U^S1K=N/+\R,LW?GGUH [BBN-L-4U'2?'!
M\*ZG>/?6M]:M<6-RX"RKC.Z-BN,\ D-U_IF^';^TEC\1-K6O7:&QU>YMX VH
M.C+$NW: -WS')..I- 'HE%5=/MY;'3HK>>YDNWB7!FDY>3'0GU.*I67B?3+^
MPOKZ!IO)T]WCN=\+*49!EA@C/ H UZ:RJZ%'4,K#!!&016=/KUI!&A$5U+(\
M/G^1% S2*GJR]N^ >3@X!P:JGQKX>$%A/_: :/459K4K$[>8%!)' Z\$8ZYX
MQF@#3T^Q33K5;2%V,$?$*-R8U[+GN!V]JM5BKXMT=[+[9'-/)"(/M#E+:1C'
M'DC<P"Y7[K=?0^E)-J&F2>*=/MFNKM;UK>1X85WK#(AQEFXVL1QCN,T ;=%9
M%UXITBR:4SW++%#+Y,TXB=HHGX^5G VCJ <GCOBB]\4:/8:C_9UQ<M]K\DSB
M%(7=F3('RA0=QYZ#)Z^E &O3)%=HV5'V,1@-C./>JNDZO8ZYIZ7^G3^= Y*Y
M*E2"#@@@@$$'L:A'B"Q.KW.D@3F\MH1.\8@;E"< J<8;GCCTH MV-C!I]L+>
MW4A=Q9B3EG8G+,3W))))JQ6-;>*M+N]$BUBW:>2SFE$,;+ ^YF+;!\N,_>XZ
M57AUC3(]8UV2"6_N+JRBB-U;%7*IPVWRU; R0#DC@\'- '0T5YYK7B.75?!V
MAZXLESIYDU"U:4*S1H49QD$\!EQ^%==I?B+3]6OKFQM_/CN;4*SQ7$#Q,5;.
M& 8#(.#S0!JT56O;^"PC1IV;,KB.-$4LTC8)P .IP"?8 D\"L^+Q7H\EI>7$
MEPUO]AD$5S'-&RR1.<;1MQD[LC&,YSQ0!LT5G6>NZ??2W<,<S1RV.#<QS1M&
MT0(R"=P'! //3@U#!XCTF^O(M.2XE2:[B:2#?$\7G(.I1B!G .>.W/2@#7HK
M@?!WBVTT_P .V\6JW=Y-))?30&YD2254)F94#R8(!/'4^G:N]H 6BN$\8^(8
MKFTTB33KB]1)=6MXTN(@Z0SKY@#+D<,..,\''&:Z?4O$-CI?GF83R"U027!@
MA:00KURV/;G'7'.,4 :E%<AJ=[YWCCPE/97TKVE]%=.524^5*HB!1MO0_>//
MO5VUUO2(+G7KN*YOI39NAO8W21A"0G\"$9 P,G YZT =%168GB"PETRRU&,S
M/;WY06Y6%B6W?=XQD CGFH=0\4Z7I@DDN7E%O#*(I[E8F:*%S@89ATY(!/09
MYQ0!LUDZ[HLFK_9);?49["YLI3+#+&JLN2I4AE;AAAC^=07WC30-/NY[2XO&
M$]N%:5$@D<J&. >%.1[CI5C3O$6GZJ+[[*9B=/<QW"O"R%& R1@@9X]* %L-
M*NHITN=2U)K^>($1?N5B2//!(4<Y(XR2?;&3G4JO87T.I6$-[;[_ "9T#QET
M*$J>AP>15"Y\4Z/9M)Y]RRQ12^3+<")S#&_3:T@&T<G!R>#P<4 :]%8NI^+]
M$TB]>RO+MDN(X#<&-87<E 0,C .>O;T)[&HM7U^P;3[R&&2Z=DMO-E>U1]T"
MLN5)(Y!QSCKCG&* -^BN6\(:N(O NA37LLUQ<W5NH4<R2S-@D^YX&23^-6SX
MUT%-/DO9KMH8XKC[-*LD3AXI<@;67&1U'/3GK0!O451TO6++68II;&1W6"4P
MN7B9,, #_$!D8(Y'%7J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *Q=2T&:_\2:7K"WRQ#3!*$A,.X/YBA6R=P[#C
M^M;5% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!\[6QQGG^>;4_AD/K&CZA#>-&-)21(XV3?YGF !BS$Y)XSGUR3FMVB@#%L-
MEL?$FHZS]N$AU%8UEA\G 41@A=ISGN<YSGVI?$OAR'Q'90Q&YEL[FUF6>UNH
M<;X9!T//4<\CO6S30Z&0QAU+J 2N>0#G!Q^!_*@#F[OPA+J>@75AJ>M7-U=W
M)C)O!&B;"C!D"H!MQD9/<YZ],26OABZM_$ UR36II[IK,6T@>% CX8L#@8P
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M-$\PR+IA1"%R<[/,QNV9_A_/J<VCX5=+_6;FVU:XMUU9,M&J*?*DV;-X/7H
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M7+(RS18+(58,,9X[=ZS'\*V]V^IS7\QFN-3L_L<TD2","+##@<_-\QY)/0=
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MW1L]6N56&14VR.=BJS;5!SDC."!CM6YJM_JOAN[T*XDU*34+?4+R.RNHI(T
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M-4NS!JL[S2%PK-'O.6VG'<]SF@#H[0$V$(!P?*7!].*\^6^\6WGAG6=7M_$
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MY=O-$LIA!_A1SSCT#;L59N=!,\M@T=]+&EG-YY0J'\^3!&7)Z_>)&,8./08
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MSJ@82(#E3@_Q+DX/N<@U$WA33ET2RTNW#P+82+-:RJ<O'(I)W\]223G/7<:
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MR5CC,*I&69(SCC)QUR0,\YYJI?:IXC\-V-XMY,CI=WMO;Z9+,RO)")3AM^
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M$MYA<6\4Z@A9$#@'J,C-25Q]Y<W>8+:'4954:4KQ6MF!YPD_YZ,QX"    D
MG/6LQ=<US4-,\%7":H]M)JQ\N[\N)"'_ ';'<,C@\?3/8]* /0B<*3@G Z#O
M6;H6NP:_;7$]O!-"+>YDMG28 -O0X;H3WK$LIKZ?Q&_AF75KF1-.LEFFN<*D
MMP[L=N2!@!5';&21GW3X<1O%I>KQRRM-(FM7:M(P +D/R2!QS[4 =-J.H6VE
M:?/?WD@CM[="[M[>@]2>@'<U3'B.Q;1+'5@)?+U!8OLT6T>9(T@RJXSC./?
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MAM85ACW')VJ !GWXH LT5P$"^)-9D\2PP>);BV?3;UDM"L,7)$:L%?Y>5Y[
M'DY)J?3->O=?TW0KJ:\>$WMB\DEG9KB>64$+O!/"QCDY) R0"30!TFO:]!X?
MMX)[BWGE2>X2 &( [6=@H)R1QDT?V[!_PDX\/F"<7!M#="4@>64#*N <YSEO
M3M7#W6J7FM?"W1;^_D\RY?4X%D?:!N*W.W) XSA1TKH;A@OQ6M6/0:',>/\
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MI;CXKV;B]N41M%>41JR[5_>QY4 CH>,]^.M=K0 4444 %%%% !1110 4444
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M:PW@O+6)7CQ;N'W_ "_+R,D\-GK76U#=W'V2TEN/)DF\I"WEQXW-CTR0/UH
MS(/#B6_B*?6TO[DS36RVQC;:4"KDJ>F<Y).2:?X=T&/P[I[V4-W/<1M*\H,P
M7(+,6;[H'<FIM"U>+7M$M-5AC>*.ZC$BH^-P!]<5H4 8UWX>$VN_VU:W\]G=
MM;BVDV*CJ\88L.&!P02>1^.:K7W@G2KW0DTO=<0F*?[5'=Q28G6<DDR[L?>)
M)SQW[<8Z*B@#,T;1CI4;M/J%UJ-S( 'N+E@6P,X4   #D]N_-5]8\,1:GJMI
MJ]O>W&GZC:J8UN+?:=\9Y*,K @C//L:VZ* .7'@+3GTW5;"[O+RZBU2?[1*9
M&4,DO&'4JHP?E'MQTQQ5O3/#,EA;RK/K>H7]P\1A2XN64M$AZA0!C)P,DY)P
M*W:* .8/@>V_X1FQT :G>"VL94EB<"/>=C;E!^7& ?:M/7/#]EXAT^*RU ,Z
M131S!AP=RG/ZC(/LQI+W7H['Q#INC/:S%]2$ICF&W8-B[B#SG/3MWK2FFCMX
M7FF=8XXU+.[' 4#DDT 9?B+PY:>)+&.WN)9[>2"436]S;OMDAD'1E-4;GP7'
M?>'[O2K[5[^Y>]"K<73E/,95.0H^7:HSGH.YKI:* ,/6O"]OKVE6UI>7ERMQ
M:.LL%[$P2:.0=&! Q]1C%0R^#+.]T.YTW5+V\U![G:7NY7 E4J<H5P %VG)&
M!W.<YKHJ* .=M_"3IJ^GZK=ZY?WES81O&AD$2AE;&0P"<].O7WK1UW0[3Q!I
MWV*\\Q0KK+%+$VUXI%.5=3V(J?4KT:;IMQ?-#),MO&9&CBQN( R<9('3WK(D
M\7V\>EZ%J!LK@QZW)!'$05Q$THR-W.>F>@/2@"W;Z%LO?[0N;Z6ZOE@,$4[H
MB^4I.3M4#&20,DYZ#H.*RD\!VZ>&;70%U6^%M:SB>-\1;P0^\#.S&-W/2NKI
MC2QI(D3.H=\[5)Y..M $-[9B^TR>QDFD03PM$TJ$!QN7!8=@><U0@\/1C45U
M"]NI+VYCMFM4=U5<(Q!;.T#).!S^0&36NS!5+,0 !DD]JQK#Q+%J-W:QPZ?>
M_9;V-I+>]\L&)P/4@DKD<C<!F@#.3P#;1:586,6KZBC:9.);.?=&7A !&T#;
MM(PQZ@D^N.*=-X#M9H-8A.JZALU@+]IRZ'D* 2,KP3@>P[ 5U-% &#)X7$NI
M:1?OJ=T9=)1TB^6/#A@%;=\O< #C%49O %L;?4[*VU:^M=.U,NTUG'L**[?>
M*DJ64'K@''X<5UE% '.#P9 FHI>Q:KJ$;&T6TN%5T'VB-<[=QVY!Y(RN#4$'
M@."VM-(MHM8U +H\ADMRWEDYQMP<ITVG&!C\ZZ#4M0MM)T^>_O)/+@@7<[8S
M^ '<D\8J#3]6>]O;FSFTV\LI+<*V9T79(K9P5920>AR,Y% %/4_"\=[KD.MV
ME_<Z=?QQ>0\MN$(ECSG:RL"#@]#VJ;P_X>B\/17<<-Y<W N[F2Y?SRIVNYR<
M8 _7-:],$L9F:$.ID10S+GD Y /X[3^1H CO+5+VQGM)"RI/&T;%>H##!Q^=
M9C>%[,Z%INE+-.O]E^4;6X!'F(T:[5;I@\9!&,$$UM44 9]II*0:C)J4\S7%
MY)$(?,8!0B D[5 Z<G)ZG\A6A110!FZ[H<&O6<4$TTL#6]PES#+"1NCD0Y4\
M@@\]B*A&GP:3)=:[>S3WMU';%6D\L%EB7YBJ(H[GGN2<>@ V** .9T"UM-3U
M^\\5PV<MO]J@CMXFFC,;R*N2SE3R,Y51GLF>A%=-13)I8[>%YIG6..-2SNQP
M% Y)- %&YT6WNM>LM8>203V44L2("-I#XSGC/\([U4O/"UM<RWYCNKBVAU,
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M\=5E,DZPJIDC,F%=T"@$@+SCG./?-=E10!P>BM=R7EM_8_BG5=1C$BB:&\L
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MS!/.0= P((./7K^0J:[\*6%U)IDB3W=M)IF_R9(9<,P<8<,2"3NQR>N><YH
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MZB^TLKR1OO9=R[MQ ( ^5NA'05TFNZ+:^(='GTN\,BPS;26B;:ZE6#*0>Q!
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MM OE2>2$_9W.Z/&>%/'(-<5I%_=:;X1\':?#>S*=8\F)I6V_N8Q'N*IQP3@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!U.%!-54U_39-,M=22:1[6\95@=8)"7+?=XVY /J10!I45D3^*='MYVBDNF
M2X%J\HB<QI*<81G V@\COQGFI=1U_3M*,BW,LA:&+SI1%"\IBCY^9MH.T<'K
MUP?0T :5%9TFNZ<D%M,DYG%W'YD"VZ-*TB8!W *"<<CGIR/6LV^\0Z%?Z7IU
MVNLSP6]W>1I;R6VY6ED#X\MN,@$\$''>@#HZ*Q;OQ=HME>W-E-=.;FV0220Q
MP2.^T^@53NZ'IG&.:LQ:_ID^E6VIPW0EM;O'D-&C,TI.> H&XG@\8R,'/0T
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MA5K:UG3[_4888[#6)M,9)-TCQ1(YD7!!7Y@<?6K5I9Q65C%9VX*10QA$YR0
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M_9WV.4#[@#C!(W"N8T^"]L/"'A'4)M*OKB'2C-%?VB1.LR!Q@.%X)V\=.QH
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MV]R$M7+Q2&!4 9<9'S C.,>^*[*QUVVOM7O=+2&YBGLMI<S1%5D![H?X@.E
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MH= ^RW!#6C7#RK"S#.]%4#';DY/0<>]4/ K2&[\1F2UNH!/JTD\1F@>,.A1
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MG5;C4=+EMB%B^U-.%<,#E2Q)R1V)XQVS4P\8:0VB6FLJ\QLKN40QR>4>&+[
M".H^;B@#<HK#N/%NFP:E=Z:L=Y/>6D:R20PVKLQ!SC;QR..HX]\U73QYH<EM
M97<;W+VEXZQK<BW?RHW8X"NV,*<\>W>@#I**Q+GQ9IMOJESI8CO)KRVB$KPP
MVKLS*3@;>.?J./>JR^/=">SM+U'N7M+EUC^T"V?RX6+;0LC8PISQ[<9ZB@#I
M**R-1\26.FW$]NR3SRVMO]IN%@3<8HN?F/3T/ R>.E17GC#1[-]/5I)Y3J<1
MEM/)MW<2J$W<8')(Q@=>1Q0!N45B:5XKT_6-0^P017<5S]G%P8[BW:,B,G /
M/OQQ6AI^HPZE'+) L@6*9X6+KC+*2K8]0"",^U %NBH;JZ@LK2:[N9!%! C2
M2.W15 R3^59-WJD=_9WEEY-[:2FS:=&.8SM[%64\'..,Y'<4 ;E%<3X,\66:
M>'O#UC>/=-/>6Z1K<R1,8WEVYV>8>"W!_$$=:VKOQ=I5DUP9#,T%I.MO<W*1
MYC@D;&%8]?XER0"!GG% &Y17*7#RI\5+.)9Y_*ETF9VB,K%-PD0 A<X!QW%'
M@5Y2WB..2>:80ZY-'&9I6D*J$CPN6).!0!U=%<7KFI#2?B-ITLDMX\,NG3DV
MT.^7>X9 -L8SSC/0>YK:T_Q9I&IZ3+J4$[K'#+Y,L<D3++'+D#84QG<20 .^
M: -JBLS3]?L[_4KC3=DUO?6Z"1[>=-K%#T88R",\<'@]:CU;Q-IFBWUK97KS
M">[#F%4@=]^T9(! Y/8 <DD<4 :]%<Y!XZT2;2;_ %$M=1+IK;;N&2V<30GJ
M-R8R![]*GA\7Z5-#--BZCCC,2HTELZB<R?<$?'SYZ<9_+F@#<HK)M_$5G/<W
M5F8KB*]M8Q+):21_O"AZ,H!(8=N">>.M-M?%&G7N@1ZY;">2SE<)&1$=S$OL
M&%Z_>XH NVVGQ6EU/-;DHMPV^2(?=+]V'H3CGL>O7.;=8EG?:9/XMOH(I;O[
M?%:Q^=')O6)4R<%0>">3R/3K7.^,M?BO-.TJ;3WODBDU2W2*ZB+)#./, 8<'
MD$ X)&#C@F@#O:*R=3\1V6EBY:6.XF2S4/=/!$7$"D9RWX<X&2!SC!%.EUZQ
M(MX[=GO)+R'SX8[899HN/GSD #D<DC)/'- &I17(_#JZ>\TO59&FN)4&KW*Q
M&Y9F<(&&T'=R,#L:W;S6K>TNS9I%/=72Q><T-NFYD3.-QY &2#@=3@X!P: -
M&BL5O%NC_P!FV6I).\EI>SK!%(D9.)&;:%8=5.>.1QCFII/$%I'JESI@CN'O
M+>V^TF)8\EX\X!4]#D@CK0!>N;:.[MV@EW>6XPZJ<;AZ$^E2@!5"J  !@ =J
M\[U_Q#/K_P );G6HQ=6,Q"2(T;M'P90, @_,-O![5U5]?:8OBS3+.:6[6_:*
M9H(T#B)UP-Q;^%B,#'4C/O0!MT5S,WC_ $.&VNKC%Z\5E<&"Y=;.0^21C)?C
MY1SW]#QQ5J]U#2SXGT>VEGNA>RI,]JL>\0R+LRQ8_=;  QU(S[T ;E%<S-X_
MT2&&\FVWSQV$YAN62SD/DD $LPQD*,]3Z'&<5K7.M6EO/:VZ%KBXNT9X(8<%
MG0 $MDD #D<DCJ* -"BLW1M?L-?AEEL&F80MLD\VW>/:X)!7+  D$$'&<51G
M\2E/&L?AX65P4-DT[RJG4EU48YZ#+9/TH Z"H8[6**XEN "990 SL<G S@#T
M R?S-<)X>\56FA6FM_VG-?310:W<1F8K).+>,,%7>YS@=N3FNQOM8@LI?)6*
M>ZG\OS3#;)O8)TW'MUSCN<'&<&@#0HJGI6J66M:;#J.GS":VG7*. 1WP00>A
M!!&*Q+KX@Z%:B[)%]*+&4QW/EV4A\G !+-Q\J\]3UYQG% '3T5A7?C+1K.6R
MC\R>=K^%I[7R+=W\Y0N[Y2!\QP1P.>><5(/$UG(D?V>WN[B9[=;EK>.$^9%&
MW0LIQ@G!P.IP< XH V:*RD\2Z3+I%OJD-UYUM=,(X/+4EI')P$"]=V0<CM@Y
MQ@US>G:SY7CSQ!-*+]8+73X9)+>8LQC.6+%5R1C&#\O'XT =S16.?%&F"WTJ
MXW2^3J[(MI)Y9PS,NY0?3(!/--U+Q5INEK<R3^>\%FRK=SQ1ED@)Q@,?H02!
MG (SB@#:HKGE\4>;XQ_L*.SF:);-;CSPF0^Y]JD?[(PW/^'-RV\0VEW/;)#%
M<&*\9EM[CR_W<A4$G!SQPIQD#/;(H U:*Q_%=YIUCX;O)M5ENHK/9MD>U#^8
MH/H5Y'UZ>M-O/%&F:;?VVF2FY:YN(3+"B0.Y=0!T./F//09]\4 ;5%9VB:Y9
MZ_9-=67F 1RM#+'-&4>*1>JLIZ$?UI;_ %B"QE, AN+J=8_-:&WCWLJ9(W'Z
MD' ZG!P#@T :%%8L7BO2KFVT^:RE>\.I*[VL<*_-($^^>< 8Z')'/'6I+?Q-
MI=SH\6J13.8)I/)1/+/F-)N*[-O7=D$8]L].: -:BN+\6Z];ZCX.\1PVDMW9
MW^F0YECW-%)$2,J<J>01GH2#6KI/BC3[F[M-)_TA;B6V\R%Y865)PH&[8Q^]
MC(_GS0!OT57OKZVTRRDO+R4101#+,03WP  .222  .237)_VB]Q\4-/A OK=
M6TV9Y+>=F"'YDVL%R5SU''/K0!VE%8K^+-,CGM5D,R07DWD6]V8_W,LG.%#>
M^#@D8/8FLG1;DVOBWQBL\]U);6S6S*I:24Q@P[F"CD]23@4 =A17,6'B71=,
M\-Z1-"][+97K+!:RRJTCLS$A0S'D9/<UM2ZK;07S6DN]&2 SO(1B-$'<MT'0
M_D?2@"[16-'XIT]K^WLI4N8)+N-I+4RPD"X51D[>^<<[2 ?:J4/C[1KF,RVT
M6H3Q+YNZ2.RD*IY?W@3C@X!.#S[<B@#IJ*R4\1V,NC6FK1":2VO&18=L>6;>
M<+Q[G'T[U:MM2ANM1O+&-)A+9[/,9XBJ-N&1M8\-[XZ4 7**Y3QT\L1\/RPW
M$\1;6[6-Q'*RJZ%N58 X(X'6MB]UZUM+F:V2*XNYK>,2SI;1[S$IS@GW.#@#
M)..E &G17,:KXTMK>WT6?3HWOH-7N4CCGB7*A>2??=A2,=N<],5TJ-O16P5W
M#.&&"/K0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L3Q;;VEYHAM;^R
MN;NVFE17%JK-)%SD2+M&?E(!X_\ K5MT4 <EX:T^_GM-8TC5YY]2TIL16MS=
MQ%)IHV3YU;(!;&<!L<\U'X(M-1BCE.K-YO\ 8X?3K64?,945LF3CN0(UQUS&
M?6NCUC3I=4L?L\&HW6GOO5O.M2H?@].01@U-864.G64=I;AO+C!Y9LLQ)R6)
M[DDDD^IH YGP$TEIH%\+JSO('2^N)MDMK(K,C2,RE05RV1Z9KF[*VO;?X>>$
M;633-0%Q9ZK!)<1"RE+Q(DC,S$;<XP1]>U>I44 <:R>=X^U=Y[&[:SGTA(3(
M;=U1R&<LN\@ '##O7/Z)J5C]A\/1:RNK6]MI162W\[2Y$13M*IOF&595#?>
M4'@G'2O2-2T^#5=,N=/N=_DW,312;&*G:1@X-9=IX;NHT%O?>(+_ %"T4!1!
M,L2AP.SLJ!F'X\]\T <S$JZ3K6L:9K/A>[U1+Z\DN+2X@M1-'*DG/EL3PI!R
M/FXQ[==+QI9//HWA_2888XII=2ME6*'[L:H"S;?]E54UV55OL,1O_MTF9)E0
MI'NZ1J<9V_7 R?:@"6:98(6E<.549(1"[?@ "3^%>565I?Q_!:TTI]*U%;Z&
M[4O;_8I=X'VKS,XV\C;S7K-% '(NTDGQ0L[Q;2\^S-I#P^<;60(':16"EBN
M< ]>G3K4>GZ+?67C&_L%A/\ 8D\RZHK]A,<AH_\ OL+)[8]Z[*B@#@+D?V-X
MMU=-6\.W>J6>J.DUM<6UKY^#Y:HT;C^'[O&>,58%N]KXWT!DTF:UMH-/FB9;
M>V=HH&<J53<HVC@'VXKMZ* /+[JQO[KP7XNMH=-OC/+K1NX8FM71I8O-B;*
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MQUHJ?V?Y)NKK^TX7EM?(MV;S0HR0/]KMCJ.^*P9K*3PWXGN6O?#MQKFG7UO
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M;+ WF@1KM?:IY;&>W6K^E37;^/=3U.32;Z"SGTZ$1RR0XR59R1CKGGIU]0*
M.;66>3X(Z7=M=7'GK/%F03,"^;G:=W/S<'OFO5"0H))P!R37F*:?J*_!NQTH
MZ9>_;HYX]]O]G?>NVX#D].FT9S7I,LDAM'DMTW2&,M&K@KDXX!STH R+/Q?I
MU[<6$<<=RD6I[_L5PZ )/M!)QSD< D;@,U4F\?Z3#;WTXMM1ECTZ<PW12T;]
MU@ ECG&%&?KP>.*YJW75KNX\+:C<Z+JS75K=-]MWQ[5C8QLN$3("H#CY@ ,8
MR2:M+;7AT#QU;_V?>^;J$]PUJIMG_?!X@BD<>H- '97.MVL,EM!"LEW<7<9E
MAAM\;FC&,ODD #D<DCD@"L'X=W!N+?7VW7)5=:G55N69I$ 6/Y3N)/'3K6;:
M#4-&\0Z1K4FFWUQ8S:-'83+#;LTMM*C;LLF-VT\C('Z8K6\#I=QRZ^;K3[JT
M6XU:6XB,Z!=Z,J 8Y_V30!>U'Q=I^G:L^E-!>SWJV_GB&"V9S(N<?+Z]_;@\
MTVU\::/>Z-!J=N\K+/<BT2 QXE\\G'EE3T;ZG&.<UF7=XEE\64>2*=T;0\$P
MPM(5/G]PH)Q^%9PL]9TBRN;^VL+GRM5UTW,\4$6ZXAMR,;@O9B5!..0&['H
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MRNH[>32(X!*T1V"02,Q7<.. 1SG'O4_CFSNKK2+-[2VDN3:ZC;7,D<0RVQ)
M6('<X[#F@"QI?BW3M3U2XTSRKNRNX(_.\J]@,1>/.-ZYZC-(/%^G8M)I([B*
MROI!%;7KH!#(Q^[WW 'L6 !['D5D:KH\_BO6VN[9)K2WBTJXM5GGA:)GDF&!
MA6 ;"@9R1U/&>:SYK'4-;^'EEX3ETZZM=1C^SVTS/"PCB6)US(),;6!5.,$G
M)QCK0!TUSXNT^SU.\TZXAN8KBSMC=,&10)(P<90Y^;Z?AUJ]+J\<,-L6MKC[
M1=Y\FUVKYK8&3GG P.I) &0.IQ7,>+M/O-;N)-0L+62.[\/D369DMF/VN3()
M0<<IA<<?Q'/  )CUZ6\N[C0O$W_".W5[;P1RPWNFO;[IXO,"'<J-]X@IVZB@
M#?MO%VFW5JTD8F$Z7?V-K1U"RB?KLP3CIDYSC ZUH:?J*Z@L^+>>W>WE,4D<
MR@$-M#=B01AAR#7*WMCINI:*!-X4N+.RO+M,BWMO+NHB%8B<K'R"&  [X//7
M%.TO4]5\,>'[^XU2+4M7M;>ZVVLOD?Z2\&T9>13@X4[N3R0,],4 =F2 "2<
M=2:PT\7:<UQ8H8[A(-1D,=G=L@\J9L9 '.1D X) ![&M+4+<ZEI%S;12;#=6
M[QJ_]W<I /ZUS'A'5=633-/T&\\/7MO>6")!-<2Q@6^Q!MWJ^?F)4< =SZ<T
M :C>,--65/DN#;R7OV$700>7Y^=NWKN^]QG&,]ZL7'B&V@FN$2VN;A+658;B
M2%5*Q.P4@')!/#J20"!GV-<-J::UJ>GJ]YHNIM?6FM1S.D<>(%A6;(,8!P^5
MY+8)SG) Q5W7-/O)-4O-6T&WU+3==$L:>6(F:VOUPO\ K."G )&<@C:>O% '
M5ZGXCM=,%TQM[FY2Q4/=M;H&$ QGG)!)V\X7) P<<BAO$MDX4V4<U_NM5N_]
M& )$39VM@D9S@X R>.E<O+$^B^*=7CU+PK/K-GJDRW%M<V]JDY4E%1HWW?='
MR\$G'-.UW1DFFB>"SOM&U2SL%-I=Z5"S1@DL3 0H*E00.#@'=VH [BVG2ZM8
MKB/.R5 ZYZX(R*QD\8::\MMA+C[-=79LX;O8/*>8$C;UW=58 XQD=:TM(-Z=
M'LCJ2(EZ8$^T*GW1)M&X#\<UYW<+K>HV>EW%[HFIG4++6XYKI$CQ#'&)&_U2
MYPPP0=V">N3TH ZVY\;Z;;SZE;I::C<3:9M^T1PVK$@$;L\XXQSGOVS5]O$5
M@;2PN(&>Y.I*&M(HE^>8;=V0#@  <DD@"N>LQ<)XA\83R6%XL=Y##Y!-NY$I
M6':P&!R0QQ[]1D5D:9;:IH\?A'5WTN^FAL;![&]MXX&,T#$+\X3JPRN"1V]:
M -KP7<M<>*?%>1=(B7, 6*Z<LT9\KYAR3QNSC!QZ<5L:KXJT_2-3ATV>.[DN
MKB-I(HX;=G\S;C(7U/(X'3O@5F>%1=MXN\37<NG7=M;WDMN\$D\>P.%B53C/
M/^'0X/%1^(+E;3XD>')7CE=?LEV#Y4;2$?ZOG:H)/X"@#0M/&^C76C7.I[IX
M5M)A;SV\T16:.4D (4]22,=OR-68=7M=7?4M+,=S:W5HB^=$[;'57!*LK(QX
M.#R#QBN6N[76;,^(?$&FV$__ !,[VU"PK#F<01@*\JQM_&>2 1G@$BI]%BN+
M3Q?K5Y_96IQVEY8P&*692[,5WYSDEMW(^7K["@#($LTGPA\.W37-QYWVFVW.
M)F!?=, =W/S?CFN^U#7(;"2:-+:YO)+>(33);*I,:'."<D9S@\#)XZ5PRV&H
M)\*-%TTZ;>_;+>Y@\V 6[[D"2AF)&.F.]:&H))I/C*^OKWPU<:SIVJQPM%+;
MVHF>W=5VE64\@$8.?_KX -*X\:QRZIH,&F6DMY:ZLDLRSQ[?F5$SM )!!!(S
MG&,8Y/34;Q#;"=DCMKF:)+I;1YXU4HDI(7!YSP6 )QBN>OK*ZL]:\*7]OH3Q
M6UI]K22ULHU_T?S5&P$ X'3DCC.>:K7FG7::[)JF@0ZCI^I/J 2ZM6B<VEY&
M'P922-H.SG((.1C&2#0!VEOJ,=QJ=W8+!<(]H$+2/$5C?<"1L;HV,<^E-U+5
M[;2VMHY1))-=R^5;PQ@%I&P2<9( P 3DD#BHK;6TN-?NM':RNX7MXQ(D\L>(
MIUXSL.><%@#[UG^++G4;>XTH6UI=36+W#"]>SCWS1KM.W;CD DX+#D#H1F@!
MT_C;2;;0[O5YDNDBLK@VUS'Y.7BD! *G&1W'.<<CFK-GXGL;W6VT@0W<%QY)
MFB,\)19T! )0GK@D=<=:X.YTW4T\'>+M-31-06:\U,SVR&/>9%;RL<@G)PK9
M.<<=<UTFJ)/>^.=)N8;:\6#^S[B)KC[,X$32;-N<C@\'Z=\4 4/B#KT5YX-N
M9;%+TQ+<1QQWL+;8F82JK#ALE?O#)&TGOTKNYI&B@>18GE95)$:8W-[#) S]
M37ETT>KI\+9/"DN@ZB=3LFBB_=6Y:*55G5@Z/T(('U'.1C)KU*-S)&KE&0L,
M[6ZCV- 'G&M>(I_$'PQ36WBN+%C=Q,I67:I0W 7'RM\P"\'<.O-=EI_B:RU#
M5Y]*$-U;7,4(G47,)C$L6<;USVSQS@^U<*MEJB?">#0GT:_%[:W,:L@@)W;;
MC>2N.HVC.>ASQFM_4[2XO_'H>."Z2VN-#FM/M/V=PJ2.X8 G'' )_3K0!K_\
M);IXN+%)([B*WU&3R[.[=!Y4[$9 !SD9 XR #VS3_%NMR^'/#%[JL-LUQ)!&
M2JJ1@'L3D] >N.:YCPNK?9M/T?4/!)BU*P,:27DMHGV?Y,#S5D[L0,C'.3Z<
MUT/CFPN=3\$ZM96<1FN);=A'&O5CUP/?B@"T^NQ0QVB2VMQ]LN\^3: +YC[1
MEC][: /4D#D#J0*S=3\:V]OX:U74[.UFEN=,#)/:2 (\+XR-^3C;T.03D=,U
M0N?MR^)M$\3KIMZ;(6DEG<P&$M-!N(97\L9)&1@X&1Z54U30+_4[7QIJ5M:R
M@ZM:QPVL#J4>7RT(+%3R,DX .#Q[T =.OB*.*WTY)[6X^VWX/DVP";WVKN8_
M>V@ >I'45S_C36+?6?AW<ZE82W,+0W443+N:-D<3HCHP!P>I&.14][J.IO\
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M<E"^2 V?F!&  ??'-+X?UK1H_"EE=Z7!<I:7$SQ6MO(2TLC^8^1\S'J0QY/
MZX X .DHK 7QCIP&H)<Q7%I<Z<T:SVTP7?\ O"!&5*L5(8D '/'?%:-CJ1O+
MJXMGLKFUDMPC$3!<,&S@J58@_=- %ZBL^^UB&RO(;%(9;J\G1I$MX-N[8N,L
M2Q  R0.3R3Q69=>*H[CPQJNH:;!.;JP25)8'55DMY%4GYP6Q@<'@G(Z9H Z.
MBN5\'Z7;RV&FZX]K<V]\]BB32-(,7>Y58R,%8[CG."V#R:T-3\3VVF1WDWV.
M[NH=/&;N6W5"(. QSE@3A2&.T' - &U16%<>+;"-BMI#<:@19"^;[,%XA.=K
M?,RYS@X YXJ?_A([&2RT^YMA+<G4T#VD,:C?(-NXGYB  !U)(].I% &M17G_
M (NURUU?0(+J);JVDT_6X+>XADRK(PD7<"%)##!!&,CGBNHTSQ);:GJUSI9M
M+RSNK>-9=EU&%\R-B0'7!/&1CG!]J -BBL+Q7>Z79VED-5M[F:.6]A6+R-PV
MR[QL+$$8&<=3SZ&HD\17<GCB;0O[-F$$-HLWFAH_FW.1N^]D*-I'KUXZ4 =%
M16!-XPL+<VLLMO<K8WDXMX;[:ODLY) _BW $@@,5Q[X(-03>.;*/^TQ%IFIW
M#:4^VY6.  J-NXL-S#C'/J>P- '35%!;0V_F&),&1M[L226/3))]@!] !6''
MXSTZ6ZTZ-;:]%MJA"VMZT0$+L5W!>3NR0#CY<'UJR?$<!G=(;.ZGBCNUM))X
MPA1)"0O(+;L L 3B@#8HJMJ,\-KIMS/<)))$D;%UB4EBN.< <US]MXIT72/#
M>A2V]K>K8WYB@M%$9D9-P^4,<DYP#W)X[T =3161H_B.WUB^O; 6MW9W5EM,
MD-T@5BK9VL,$@@X-.U;7[?1[ZPM;BVN&_M"800RQA=@<\A6)88. >U &K161
MJ.L6L0U&VN;2ZDAM;7S9WB4$,K _*N#NW8![#'7N*JZ?KVEVNBZ%%86URR:C
M OV&V&#)L6/=\Q9L#"XSEOSH Z&BN"\;ZQ;:[\+M8O;7[1"UNQB>-F*/'(D@
M5E;:<'\R*ZR\UF*UOQ816T]W=&$SF*#9D(#C/S,.IXX]* -&BH+&[2_L+>\C
M1T2XB655D&&4, 0".QYK&N?&.GVUK)?M;W3Z;#,89+]$4Q(0VTG&[<5#<%@I
M'% '045SVH^,K+3]5?3%L=0O+H6GVM$M(-_F)N ^7D9//TXZYP#LSWL%KI[W
MUR_D01QF61I!C8H&3D4 6**Q8_$]M_;%OI=W:7=C/=Q-+;&X5-LP498#:QP0
M.2#@U%9>,;"^N--1+>ZCBU7?]CN)$4)-M!)Z,67(!(W 9H WZ*P+_P 86&GQ
M37+V]U+96TXMY[N)%,<3[@IR-VX@$@$J#@_0XPTU#^Q_B)XA=+6^OBUE;2""
MW!D;J^<;B ![9'M0!W=%4])U2UUO2K;4[)BUO<QB1"PP<'L1ZCI5R@ HHHH
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M0I:VJH2Y"P^6I(_A+$D\]!C..E=Q10!E>%Q(GA?3(9H98)H+6**2.5"I5E0
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MZVDNHQ"28UC#!C[]1TZUZ-10!RVG17(^(^JWC6EPMK/9011SM$0C,A8L,_\
M A5_Q=HSZ[X;N;2W;9=H!-:2#JDR'<A'IR,?0FMJB@#G(H+W_A#;VXO+9O[1
MU"!Y9H(U+$.R;50#V 5?PS6):_VU8Z%X3LCIM^UG%;>3J,=L-LR2*BA!DD$)
MG.2#V'..#WU% 'EUQH^K#X>>*-'71;J.XNM0F>VC4!@ZO(&&,$\ #J<#TS6_
MXGTZVUJ^AEDM-4L[B&V$EGJ=E&XEB<ELQL!SCA3@C')Y%=E10!G:!_:8T"Q_
MMG;_ &AY"_:-N,;\<].,_3CTKC+#3-4L?A]?>"YM.GDO0DUM;SA"89DD9BLA
M?HN V2#SQP#7HE% '&6&G7&F^/K#%M<RVEMH2V!NO*.PR!U(R?HO7IS6WXMT
MJ?7/"NHZ;:N$GGA(B+="PY /L2,?C6Q10!QNB7-U>[&3P4NE7]O&QEFN(8UC
M#[2 (F4Y;+8YP!C//2L>W@UNZN?#&I76AZD][:7+_;WE*##-&R_(N["Q@D=
M!C'4YKTJB@#A?#\^N^'&O/#SZ%=71-W++97J;?(9)'+YD8D%2"QR,$^GO>L%
MN;?X@:W?36=T+:2T@CCF$+%9&3<6 Q_O?CVKK** .-\$/?Z)X*T/3[G2+TW
MD^SSH$ \C)9M[9/*].1GK79444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW"%HL*TGWRO[OY<CCTJR_A.%Y='E;4[[?HP(MSF+YLKM.[Y.?EXXQ^?-;U%
M')_\*]T\69LDU/4TMENQ=V\2S+MMY-^_Y?EY&<\-GKQSS6C_ &';Z=K5QXC^
MU7TLHM!"\(VN&C3+  ;=Q;.>^236W4<LT4"JTLBH&8(N3U8G 'YT <[H<%MK
M/B&;Q4FGSVV^U2UA-Q$8Y'&2S,5/0<JH/7@]L5:O_#$6HG4(YM0N_LNI%?M%
MKE-G"JI"DKN7(49Y^F#6Y6-K?B2WT>QM[Q8)+N*>Z2V#Q,NU&9]F3D],^@-
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M*._;BMFD9E12S$*JC))/ % '/Q^#K>*PUBR74[_RM9DDEN<F+(9UVMM^3C(
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MG/E,Q).,]1TSCVJA(NJ7VH>,K=M?U&)--\M[;RG5"A,._' Z9[#&>^:ZS5=
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M3?:[[K_5K@KL& /EP<>OO0!4LC?^+-/U2ZMM7GT^\M]0EM[8QDE(!$P&&CR
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M.!(21QT(%=#XL>\'B?PU!;:E=6L5W<2QS)"X 8")CSQR?K0!UM-=BD;,J%R
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M0_9]V<8ZY)^G48(JO-KVH>&](\46T=_/.;+4(;>UGNG,KPK,$R2S=0NXD9H
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MO)M,6<)I_GR%E9=H+D%N6 ;(#9/&: -^_P!0ATZ%'ERS2R"**-?O2.>BC_.
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MY@#T!./7/;0M=1GU6Q\,M<7]S)<7>FB>6QM&,3SL43]XSAEV*I)[\EAC)&*
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M!LL9W&R1DY$;==I&1['@T 2:7K=YJ-S;[](DBL[NV%S!="4,,'&%<8&UL$'
MR.O/%;-<#;7+65OX+T.">YB@U>(R7$OVARV(X%8(K$DH&)'W<< XQFK<4]]8
M^+=6\/+>W3V;Z8+Z"1Y2\ELVXH5#MDD'&1G..U '9T5R'P^M;JY\/Z;KE[J^
MH7=Q<V05XIIMT77.[;_>XQG/<_AU] !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7*?$N&>[\
M#7UG;6MS=33M$$CMXFD8XD4G[HXX!KJZBNKJ"RM);JYD6*"%"\CMT50,DT 9
M]KH\!N8]1DN;JYG2(QP27( :!6QG"[1@G R6!/%-TKPW8:1IUQIT1EGM;EG:
M2*X8."7SO[=#DY%-OM>:R\4:7HILRRZBDS+<>8 %\M02-N,GJ/2MF@#$L?"E
MC8K:1":ZGMK%M]I;SR!D@."!CC)P"0-Q..U7;[1K'4KVPO+J$/-I\IE@;^Z2
MI4_S!^H'I5ZB@#,U/0K;5;ZQO)YITDL)#)!Y;  ,1@DC'/!Q5*Y\&:;/J-[>
MQ3WMH=07;=Q6TY2.<XQN(]<=QC/?/-2V&OS7VL:UIJZ>4ETH1[<RC]^74L.W
MR]!Z]:CU/Q'=:3::-+=:45EU*[AM98Q.I%N\AQU ^;'/3KB@"&Y\!Z-<Z5I]
M@&O(3I@Q:7,5RRSP\8(#^F ..E;.F:9!I-F+:!I7YW/+-(9))&/5F8\D\#\@
M.@JY10!DZKX;L=5O(+]FFMK^W!6*[MI-DBJ>JGLR^Q!%6;/3%M9/.EN;B\G"
M[1+<,,@>@"@*/P&3WJ[10!S=EX$T?3]2>[M7O(X7E\\V(N6^S>9G.[R^F<\^
MG XX%:&E:!;:/=WMS;SW#O?2F:<2N"I?@;@,#'  XXJ_;W4%W&9+>19$5VC)
M7IN5BK#\""/PJ6@#GAX)TI=%O-'22[6RO&8O%YY(0,Q8JF?N@DD\<^]6+WPS
M;7_]G&>[N\Z:XDMRKJ,.!@,?EY.#CGBMFJM[/=PM;"ULA<B28),?-">3'@Y?
MG[V"!P/6@"J-!M_^$A&NF>X-V+?[-RPVF/.[&,?WN<]?PXJCIW@?2-*OS<VC
MWB0>;YRV/VEOLR29SN$?3.>1V!Z=!7144 <Q/X T6>&\@9[U8+R?[284NF"1
MR;@Q9!T!)'O[8K1_X1NP&MQ:NK7"W,<"P'$[;9%4Y7>,_,02>3^.:UJB@N8+
MH2&"19!'(8V*]F'!'X4 8%IX%T>QU-[RV>\CBDE\]K%;EA;>9G.[R^F<\XZ<
M#CBK3>%[.0NDUS=36KW7VLVLC@Q^9OWYZ;L;N=N<>U;5% $-W:6]_:2VEU$L
MT$Z%)(V'#*1@BLRP\,6=BUINN+JZ2PS]DCN7#"#C'' )(' +$D#I2^*M>;PU
MX>N=66S-V+< M&) G!(&<\^OI6Q0!E6?A^WLM;O-7BN;DW%Z$$X9@4<*"%&,
M<8!/2IM4TB+5A;B:XN(A;S+,HA8 %U.5)R#G!YQTJ6PGN[B*5KRR^R.LSHB^
M:)-Z _*^1TR.<=JM4 9^N:+:^(-)ETN^:3[-/@2",@%@#G&<<<@=/2J<GA6U
ME;3'DO+UGTHDVS&0$@XV\G'S<<<UN44 <]=>"M+O3JOVJ2YE&K[#= R 9*8V
M,N!P5VC&/3G-26OA*PM=4CU1;F^>]2W-N9I;EG+KG(+ \'!Y'&/:MVB@#G8X
MK?P/I$5M86&JZE#).0L5NBRO&6)8L<D84G/)/&:L:%H$.G>'GT]X$@:[,LMP
MD1X5Y"2P!]!G:#Z 5JRW,$,T,,D@62X8I$IZL0I8X_ $U+0!DVOAZWM[BWN)
M+JZNI;2)HK9YV5C"K8!Q@#)(4<MD\>YS7MO"%E9V"6=M=WL2QW1NXW64;TD.
M<G..0=QR#D5O44 4M/TJWTZ2YFC9Y;B[D$D\\A&Z0A0HS@       50O/"6F
M7NK7&I2-=))=PB&YCBN&2.=0"!O ZX!(K2U&>[MK"6:QL_MMRH'EV_FB/><_
MWCP..:LT <_;^#-.M3I)AN+T'1P1:YFW;<KM.<CGY>,= .F*>W@_2Y1JJ7/G
M7,>KD&[CE<%6(  (P!M( &,>@K5U&>ZMK"::QL_MERBYCM_-$?F'TW'@58&2
M 2,'TH YZV\%6$%YI]W+?:E=3:;O%LT]VQVA@ 0<8SP/Q[YXKHJ** *)T:Q;
M75ULPC[<MN;82?[!;=C\_P"9J'7_  [I_B2R2UU!)/W4@EAEB<I)$XZ,K#H:
MU*9++'!"\TSJD<:EG9C@*!R2: ,*7P9IUQH<VD7%S?3Q7#*T\TUP7FF*D%<N
M>< @<# _,U:;P];R:S:ZO)=73W5K"84)9<%#C<" .<X%:<4B31)+&<HZAE..
MH/2J=_JL=K9W\T"?:9K&/?)"K '[N[&3P..: ,1_AWHK6%QIRSW\6GSRB7['
M'<E8HV#A_E'4#(Z9QSQ@X-:4_AJTDU)-3M[BZL[P0B!YH9 3*@Z!]X8-CUZ^
M]6=#U+^V="L=4\KR?MENDWE[MVS<H.,X&>M7Z ,.Z\(Z9<V%C8J9[>"PG%Q"
M(9,'S020Y)!).23SU)YS6V!@ $DX[GO0S!%+,0% R2>U<RWC"X;0GUZVT2>X
MTS8TD;I,HE=!_'L/1>_7..W:@"[<^%[.75I-5M+BZTZ]F4+-+:. )@.F]6!5
MB/4C-6O[%LY+*XM+I6NUNTV7#3MN:5<8P?0<G@8 R<5G:WXOMO#NKV%GJENT
M-M?N8XKP."BL,<..J]1SR.:T=7U.73([>2.T-PLTZ0<2!=I=@H)SVR>?Y&@"
MAHO@^PT+_CUN]0EV(4@%S<F5;93VC5N!^1]*L:7X9L-*T2;1HFFELI@X:.9]
MV ^=P!X/))/XTV779I-6GTO3K$7=Q:1H]T6F$:1[\E5!P26(!/0#&.:LZ-JI
MU>TDG>SFLWCF>%H9L;@5.#T)'TP3Q0!GGP9IS:19Z6;F],%E,DT):?<P9,;.
M2#PN!@#CZU:G\/V]QKMOK+W5R+JVC,4>UE"A3C<,8YSBI-4UA=/NK&RBB$UY
MJ$C)!&S[%.U"[%FP<  >AY(J72;N\O;$2W^GM87 =D>$R"0<'&0PZ@]1P/I0
M!5A\,V$5[JETYEG.K*%NXY2"D@"[0,8X^7CC\:K:-X,TS1/EAFO;B)5*0PW5
MRTL<"D8(13P..,]<<9Y-=!56]GNX&MA:67VD23JDQ\T)Y49!R_/WL<<#UH P
MH/ &C0064"S:@R6$WFVP:\?]T,$;%YX7!/O[U?3POIB7^H7>R5QJ0_TF!I"8
M7)7:3LZ9*\&BVUYI_%EWH+69C^SVJ7 F,@.\,Q7[HZ=#WJS!J$L>G2W>JVZZ
M?Y3OE3*)!L#$*V1ZC!QUYQ0!G:'X,TWP_,KVL]],D61;PW-TTD=N#P=BG@<'
M&>N"?4UI:QHUEKM@;*^C+Q[@ZLK%6C<'*LK#D$'O5ZB@#-L]%AM;E[Q[B>YO
M'B$/VF<J75 <[0 H4<\].>,YP*;HF@6V@I/':3W#I<3/.ZS.&S(QRS=,\^G2
MM2B@"A=Z4EWJ-K?-<W$<EKN\M4*A?F&#D$<Y'_UJ(M'L[:]OKVVC\BZO]GGS
M)C<VT87J".![5?HH YN+P+I$7AZ;0M]TUE+)YH#3?-&^[=N5@,@[AFI8_!VG
MQWSWXN;\W4EK]FDE:Y9BZ\\G/!/)]AV%;]% '/?\(7IPTK3],%S>"WTR99[4
M"091U^[SCG&3P?6GWG@_3KS4[N_>:\C:^B$5U%%.5CGPNU2R]R!QZ>H-;U%
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MD5L550()#&RA2" ".1T% %ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+RY("@YSR00&QM/K0!N45Q.B:DFD:MXLEN9+F>*"_B2./>TKG=&N%4,<GEN
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M_<_N2GS<<?-_CTYJ=;.XN_&?B:/R+J"+4-/BMX+EK=PF\*X;#8QQN'UKM:*
M/.'L=0U7X:0^#I=-NH-318;1R\#>4@1U_>B3&TC:N1@YSQBMRT29/B;>SM:W
M0MY--B@2X,#^6SJ[L1NQCH1STKJZ* //8;>[_P"$;\=0&PO1+?W%TUJAMGS,
M'A"*1QW(-3W$=SCP0PL+UOL3*;G%K)^Y'DE/FXX^8_UZ5W=% 'F'B%=9U72M
M8@N-&U-[N#4D>"."(B P+*A#+@@2,5!)ZL#Z"NCB^UP?$:2^?3;O[/>Z9%&D
MBQ@K&RNY97(. 0&!]^V:ZRB@#S)M&U:^\+ZZEK97"72>('U&"":-H_M,8D#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=M]HA5-.BNI#:M&KEI"P'+]EV]NYY]]?PW_;(T:)-?,37\;,KO$1AQGY6('
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M-10!SE[X02^TJ&QEU2[9TNDNY;E@K232*05)XP!P. !P!5K_ (1]O^$G&O\
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M.][=B#6(1%=6ZLNTD1^6&!QNSM]\9YJ&U\%^3>:3>3:W?W$VE(\<3,(P&C8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 445SGC_6[[P[X,O]3TY-US$%"L5W!-S
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ09T4,&"'N?IZU:^'5IJ.B^*KC1K:_.JZ#':&6"X="&M69A^Z)/W6.,E/8'
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ML\(MK^6.WG5HR7_U188.<#[OI^- '5T5RMOKU[9>)-:TW6+E/*MK1;RS:.(
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M-3\(6=OH'C2Q%QHZE(;?6+8?(H4C9YB_PD8'/MWZT >DY&<9YI:Y O?O\6#
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MH K:78)I>EV]BCM((8PID;[SMW8^Y.2?<U0U/0KB_P#$NDZQ'?1Q+IHE'DF
ML9/,4*?FW#& ..*M0:W97&N7&C1F7[7;Q+-(&B95VDX&">O3MQ2ZKK-GHXMO
MM7FEKN800I%&79WP6Q@>RF@#&B\(W-C'JECIVI)!IVIR/(\3P;I(&<8?RVW
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MT_37C:-([<H\WE_<#DL1@$ G &2!T&04F\)ZG;:_=ZCH>OG3H-08/=VSVRS
MN!C>A)&TD#T(^O2NJHH B@@%O:QP1LQ$:!%9SN)P,9)[FN2E\"W<WAG6=%;6
M(A_:UX]TTPLSF,NX9E \SGD<&NRK.UG7++0H(IKXRA)IEA0I$S?,Q &2.!R>
M^* *4^@7USXETW6I-1@!L89(FB6U($F_&X@[_E^Z,=<>]2>)M"FUVULQ;7WV
M.XLKM+J*1HO,0LN>&7(R.?4=JVJJZ??QZE:_:(HYHUWLFV:(QME6(/![<<4
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M O)?%5EKLFH0YMK5K9H5MB ^X@L0=_'(&!@_C52/P4AMM=T^ZOS-IVL32SF
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M;#16AUFXUJ]F2>^FA6W!CC*)'$I+;0"2>6)))/ITQ4>E>&K?2M=U35(I&/\
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M! Y)Y(/ QWR,+5?%NN:?H?BFW$\']I: \96Y,.1-%( 4.W. V,Y[<=*Z2_\
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M!<F\T6"X.HQZB)-Q6ZC  D7<=O   ., CU!K(M=0U+Q)>ZY'8:BVGKIMP;2
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M:3;:G9A_(N4WQ[QAL>XK"34;[Q!=:]%9W[64.F2&UC"1HQDD"!F9]P/RY(
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M3N&, 4ZU\0V=SJ:::T5U;WDD;2K%/ R91< D-]T]1T.:P)M#D\0>#;:"UO\
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M-6!5OO'T.2?P[5YO$.O1:#XQN/M\1N-(N'%N_P!G&%01JV,>O/4YH [P #H
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M.EP:)/J+W.CV\JR1V[Q#S"%;<J,^?F0$#C:#P!G%=/10!A0^'I[?7M4U:+4
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M/;GH*F\1Z&GB+1WT][F2V8NDD<T8!*.C!E.#P>1TK31Q)&KKG# $9&#^1IU
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MNR-&6 )1L97V."13JX[Q1?W\$NL&WU.4/:Z?YUM;V:C= X#DR2EAC!P,*3R
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M;2DN5$21[XV,C*=I*G^Z.H)ZXQ0!U]%>?VWB76!X!TN]GN"9&U(6E_>A #'
MLS(TG3 .%4$XXR36KH%SJ%SXMU:%-3FNM'M5B^SGY&0NRDNN_;N;;P>O&<&@
M#JZR]6UZ#2+W3K6>WG<ZC<"WCD0#:K$$_-DYZ ] :S_%^I7^E"RN8K:\FTT.
MWVXV0S,BX^5@.I4')..>!VR#@ZK=#4](\)7%EJXOA-K@,5X4!)!6;&5P/F P
M",#D=* /0J1CM4G!.!G ZFN*L]0U2ROO%FEOK0D&GV\,]K=Z@%Q"9$<G>5 !
M4%<]*?HVJWP\;6^FFYNY[*XTHW&;I I>175=ZCAE!#'@@>PH O\ _";67_",
MWVO_ &*\\BQFDBEBVKY@*'#'&[&,^]=!#*)X(YE! D4, ?<9KS7_ )I3XN_Z
M_;__ -&&O1M/_P"0=;?]<4_D* +%%<%#J^JZSX&OO%EIJ,EM<1&XFM[?:IB6
M.)F C=2.=P3DYSEN,8J_8:]-XFU:ULDFEL87TB'4'6(@2,TIX&2. N.W4D=A
M@@'745R(O-7M+[0_#6H:HLMU="X>XO(4",Z1X*J!T#$,N2!V.,9S5;Q#)KOA
M_0))3K;32+J<(MW"+O$$DBKL?(^8C+#/6@#MZ*YA[R^_X6.^E+?3):2Z.UP(
MP$/ER>:J[ER/3L<BJG@!M8U;1+#7-1UN>X,B3(]OY:*C$2L QP,Y&/IC''J
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M@-1:=<2ZCKE[=0W;OI\*)#'&I!1Y,;F<'&2,,@ZXR&K.\9_\A/PM_P!AE/\
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MM5268K ^U$\J3DMC;CYAW[UO6EB]K>7EPU[<3K=.K+%*P*0X&,(,< ]:N44
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M&R&X;N6&,@GO@C-6+GPG:R:Z=9L[V\TZYEC6*X%JR!)U7[H8,IY X!&"!WH
MH?"X,/A[IH9MS!I\G&,GSI*2SNKR77O%U@][.8;1(&MQOYA+1%C@]>H[UM>'
MM MO#6DIIEI-<2PQLS*9WW$;B6/8=R:JW?A*UN=:N=32^O;9KV)8KJ&"0+'.
M%!"D\9! .."/YT <O;ZIK=]9>!BNLW$+ZK&XNF5$.\B$MNY'WO3MG!P:BO\
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M571'F8L439'A0![G@ <D^];L.N6$OVO=(\'V-!)/]HB:(1J<D-E@./E/(]*
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MT5II6 ZM@ G R.3QR!W% &A17GFC:Y:OX-U^ZU?7=0ALUU6>*.]5G$T<8*[
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M$TRO/XD\;110R,UUID4<)$9Q*ZQR A3C!(+ 8KO:* ./\/\ BC3M-\%^'_M
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MX2UM(-[@D$?=]C]<<9J!/$&C:IJ^BE;K4(;B<S_9K=HI85EVJ0_F*0 =NTD
M\@X/>L_Q9:)81^%;2UMKB6&QU.%V\J%Y2D:HZ[FV@]R/SJQXBWGQWX4E2"=X
MH&N3+(D+,L>Z+:NX@8&3QS0!9G\>Z!!'=R-+=,MC+Y5SLLY3Y) !)8;?E7GJ
M>.N,UJ7.LV5N]K'YAFEO 6MXHAN:10,DCV (Y/'(]17$IYATGQ_']DN]]V\Y
MMU-K)^^#0!!M^7YLL,<4EW>)IK>$=26"^CN(;!XI"+*24*@1 RO&,,#NQ@].
M#UR* .NL_%.CWUG/=PW$GE6S;)2]O(FU\[=G*\MNXVC)S@=Q3H-8L-8NKG25
MDN+>\BC#O$ZM%($)X=?49[COP:XF2*WO/"=VV@M<:E>V^K)JE]:O ]O)*6?<
MRJC<@8''7[O4FND\-S:5JFH_VEI^B7=LZP&*2ZO(7C<9((C&[DC.2<< @>M
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M/V@-:2#RAY3+EN. 21S6YITAB\8^+IY+>Y6*:*V\N0V[[9=L;!MIQ\V"0.*
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M['#-"DZ;A'/&4=?8J>AJU0 4444 %%%% !1110 4444 %%%% !1110 4444
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MJPU74QIT,-W%<FV6ZV3P&/$9X!Y]^/K5_3]2AU))GA255AF>%C(N,LIPV/4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.2,<@<@ UD0V6H0^$;>*32;^(V'B1;J57A9F\H3LQ8 9+@*0<C(/8GFO4Z*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0D?C7HSJS(55RC$<,!G%8UIX6LK?PJ/#DLLUS:",QAI" X&<@Y '(/(..PH
MS);RVT+Q\\9>.TT]]&\Z?HJ(8Y0JMZ#AR/H!Z59UBQT?X@>')H[*[@G*/FWN
MH\-Y$RX(/\LCN#6I8Z.EK?RZA-/)=7DL2PF:0 ;8U)(4   <DD^I]@ - @E2
M <'U]* .3\.3OXM6WO\ 5;&..329'@,1 8?:E^61Q_LCHO\ O'T!JYH>L:QJ
MVHWJR6UE%:65[+;.5D8R-M52I'&._.<?IS<T'0H]!ANHHKJ:X%U<R7+&4+D.
MYRV, <9IVD:,ND27SI=33_;KEKEQ(%PCD '& ..!US0!4\2Z5HDMI<:OJVEV
M^H/:VY\M)XP_3)"J#P"2<>_%9E]X4OT\(Z9H^G1Z9*MH UQ:WD1,-PV"2,+T
M&XEAP>0/2NGU"P348HHI798TFCF*C^/8P8 ^VX _A3+ZRNKJ>&2WU2XLUCW!
MTB2-A(#CKN4X(QQCU[T 8^DZQ96?@<:A;:8FG) )(_L*@*(YE<H8QCCF0$9[
MYS6=X+N_[.U[4_#TM\;P2 :A;S-G+[^)A^$G./1ZZ*30HBEC'#<S016<WG^6
MH5A,_.2Y().2Q;MSS3-3\/QZEK&G:H+R>VGTXOY?E!<.' #!L@Y! % '/:Q8
M7&G^*HM9U;2]-U2PFNHHHI_*/VBP)(6,C.05WD$XP06)JG=NU[H/CK4YR1=6
M=S+';R?Q0B")6CVGM\Q+?4UV"Z-(]RSWFI7%Y )_.CMY%C"H0=RC*J"0IP1D
M]AG.*@O?"]I>RW@:66.WU%D:\MTQMF*@#KC(R  V.H';F@#+U8B[U+P7J$L2
MK<R77S-CD;K:0D?3-6/&T$3QZ)*T:F2/6;38Q'*YD .*U-2T5-2O=.NC<RPG
M3YC-$D87#,5*\Y!XPQZ8I=9T9-92U1[F6 6MS'<KY87YG0Y4'(/&: ,O5A+#
MXRM+F\LYKK2VL9(5\N!IA%,6!)95!(#*,9QV([UR6C7D^IQ^$M%N"YTJ\N+V
M0(Y_U\,))A1O5<$''0A17HVHZ>=2MS:R7,D=NXVRK%\K2#N-W4 ^V#[BJVI^
M'+'4;.TMU#V;6+*]G-;85K<@8&W@C&."""".U $6N6%M:V<FLV]LB7FG6\TD
M+(@!/[MAM/J.G'M7,VQ.FZ;X%O+;+7%VRQW#C[TXE@:1RQ[Y<!OJ*[*WT^8$
M-?7SWA4$!6147D8)( Y.">O'M52P\,6MC-9'SIIHM-5ELHGQB ,,>F20ORC/
M0>_- ''65S*G@CPUKH.=1NM5BDEE'WI#-*5=2?3:V,=MH]!2&ZE_X5Y)XE/_
M "%/[8\\2?Q B[\G9]/+^7'I78P>%K."2W42RM:6MRUU;VIQLCD8DYZ9(!9B
M!G@GV& ^%K,RE?-E^QF\^V_9.-GG9W9Z9QN^?'][VXH R_$?A70;F>WB.DVD
MM]J=ZN^XDB#R;0?,D.X\CY5*CTW"K&OPQ_\ ":>%9]B^:)[A-^.<?9W.*W7L
M$DU6+4&=BT,+Q(G8;BI8_7Y5'Y^M5]0T9=0U33M0:ZEB?3G=XT0+M8LI0[LC
M/0GIB@#2HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\VT*VU;4+7QMI^
MFQV?^E:Q=1&:XE8>7N503M"'=P?45Z0P)4@':2.#Z5C:!X;CT"XU"6*^N;C^
MT+EKF59@F!(V,D;5&!P.* ,F'3I?#MMHOA^'5)#!#:.IAMU_TFXD&,,,@A4&
M3DD@ E02:S[7Q1K#^ -%U*XG*R7&HBUO[S8H,,(F="Y_A!^503T&[-=-J/AM
M+[7K?68=0N[*YA@:W<P;,2Q$[MIW*<<CJ,&N9UK0X/#>AZ?I,=]K"6!OVG:]
MA7S39@%G ("G(+MU(//)/ H E_M[4M-N_%%ZM]+?:7I%LLEJK!"CR%"S(7 R
MV"!WXW<UH6:>)/[4TR[CN'EL94(OEN)(]K9 VO&%&0<]LX(]^:@T*"XU"66U
M;6KK6]'GMWCG6[LA"HS@ *P5=V06R.0/8XS>T+P<NB/$AUG4;VTMO^/6UN'4
MI#Q@= "V!P,G ].E '25QW@F\CT[P3>WLJNT=O=WLC+&NYB%E<X [FNO<%D(
M5MI(X8#.*S/#V@Q^';%[.&[GN(WE>7,P7(9F+-]T#N: //-1\3Z*^N>'M0EN
MY'NC?M-=L+68"-?*<*BY0$A<XXZDEL<FO2-<U0:/H%]JOE^8+2W>8)TW;5)
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M.&$T*JQX[$,""#45GI"V]Q+>37,MS>2QB(W#A0509(50  !DD^I[YP, '/\
MB^XO['6]$OI[&VNM'@O45@KMYL4K_NTDQC! W$8]_P NQK%MO#TNV!=3U>ZU
M-+:02Q+,D:C</NEMJC<1U';/.,@5M4 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
00 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>ebs20191231exhibit1048015.jpg
<TEXT>
begin 644 ebs20191231exhibit1048015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1M]:TW0_$GB+2/$P,8U*59;<RQM(MU"8E3RUP#N(P1COF@#I)_%>GP^)+71
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M$ CD4 7:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQP< XKH['6]!T?1;M[0-'I.G.%\R*)F7<[9*HJC) WKTXYQV-=)10 E+110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQTS3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFK^'=;O/#UY-XYT]9M%E\[BS?;*VY3C&?E'R =2>3S7J7]DZ;_T#[7_ORO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'R=?O<CCKR*JWGB?2;'7;?1I[R%+N>-I-K2 ; ,8SGN2>!WP:X%]/TQO!GQ
M?[+;EHM0NPAV#*81"N/3YJVVO(8O''AFXN;A$671I0)'< .Q,9P#W- '80:I
MI]U'+);W]M,D(S(T<RL$'N0>*F@N(;J%9K>9)HG^Z\;!E/T(KAM0CNO#WBJ\
MTZPC98/%*[H'C7B"Y&%E;_OV?,YZE#7<6UO%:6L5M;H(X84"1H.BJ!@#\J (
M1J=@]T;.._MC=9($/FJ7R!S\N<\8K!\,>)6N(+Y=;U&T2>/5KBR@R5B$@1@
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MVY XD8.5/=2V2*W: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG.<<XH DCT^RBF>>.S@25P0SK& S9ZY..:JWFA6-W%:VYMH(X+:594185RK
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M!P5YQP>OL*?HGAT6>H_VG-INEZ?<"%H1'IR<,&*DEGVKN^Z,#:,9/7/'0T4
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MI%YQS_N'\J]7AL;2VB>*"UABC?.]$C"AOJ!UIO\ 9UCMV_8[?;G./*7&?RH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !117/>+O&^C^"[:&;5&F=[
M@D10P*&=L=3R0,#(ZGO0!T-%9?AWQ%IWBC2(]4TR5G@<E2'&&1AU4CL:U* "
MBBN.^)%G<IHL>N6,ER)=*F2XFAAG=!<0*?G1@" >.?P- '8T5SNN2P:UHNGV
MME/(!JLD9AEAD9&6/&]G!!R/D!'U85/>^(;/2)9[&*TN[I[&U%S,L&TF./D
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MU\396SB"W!D;J^<;B ![9'M0!W5%8B>+--GTO3+^V$TZZJP2UB11O=L$D')
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M9U*V@B^T%LA95^;8$#-CUYX'/6@#?HKSW0IK75K.YU_6[:ZAGLM3F>*[5U#
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MM;O3D*3P2-LDB?J,[6(((Y&"0:U[J^TN/6O#EI>6]R][,'-G*FX1H1$=VXY
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MIK?6FVW20MI\,@YS"A95D^K9S[@+67X6AN[:ULM#O_!BI?V.R-M0:&,V[(F
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MPZ/=6\6KZ=&MJ\[J<L(I%(9MQ.XEAZ^^*ZGPDUQ_PB^GPW5E/9RV]M'"T<X
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MKH;:U8-:&TN+>*-7DA(?<KJK=>I!KM** .$UNVNIK#1);7P_+:K'K4-XUK!
M-\<2@@L^WY=WL"3C [&M?QS9/=>&GO[5Q'>Z6POK5V&,.G.T^S+E<>]=)65?
M>'[?4=7@U"XNKTK"H'V1;@BW<AMRLR="0<?D/2@"30[.:STN,70 NYR9[G!S
M^\<[F&?09VCV K1HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(V-Q=EA?S7,,LL\C#S?*+A$9ASS@?7;CG)SW">'=-CU>?5D29+R>(122+<2
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MH **** "BBB@ HHI"P'4@?4T +130ZDX##\Z;%-%.&,4J2;&*ML8'!'4'WH
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M1>?Y'FIYNW=Y>X;MO3./2I* "BBB@ HIB3122/&DB,\9 =58$J2,C([<4^@
MHHHH **** "BH'O+6.Z2U>YA6>092)I '8>PZFIZ "BHXYHI6=8Y4<QMM<*P
M.T]<'T/(IY( R>!0 M%0_;+4P+.+F+R7(59-XVL2<  _7BIJ "BBB@ HHHH
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MK)HK?4)XY8)/,0\*@0@@'(/&1_2@#2US6H-#M8)9MF;BX2WC,C[$#-G&YL'
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M<56\;6.KS:G;/9K,EMYMJD9:0/%YWFC:PCVDH5ZE\XQQM;MH7EU#>^./#-Q
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MGVK-&4*,F[L2#P3577[7Q)XC\&:G:S:7':W-Y&L4%HMRK[.<L[OP/; ST]^
M"QJ/B[4M+B6ZO/#KP63W4<"SR72C"O@"1@ 2H!.#GD<=:V_[1D;7CIJ6ZLB6
MXFDF\S[F20HVX[[6[]C^++ZRAUGP[/9:I 8(KFW*3([*?+XY.0<<=0?:LSP7
M:W]MX7CO+V07>HW48D9S\N\!0L8YZ955)]V:@#I:*K:=+=SZ?!+?VJVMTZ R
MPK)O"-Z;N]6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$?@:DHH IZ;I-EI$4L=E$T8GE,TI:1G9W( +$L22< ?E5RBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *PCX-T(7<MU':S0M,
MY>5(+J6*.1CU+(K!3GOQS6[10 R**.&)(HD6.- %5%& H'0 4^BB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S=7\/:5KQMCJE
MH+G[*Y>(,S  D8.0#AA['(K1  &!P*6B@ HHHH **** "BBB@ HHHH ****
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MCS[<KY,4"QK*S%</&^!N(ZEL^A/O6Q\0KPV.@VLTN18G4+=;\CI]G+_-GV/
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MO$]ZBN$C!55W'A<DG)JYKO'A_4?^O67_ - ->=&VM[CX=^ FEC5F&HV2!^C
M$D$ CD4 >H13PS;O*E238VUMK [3Z'WJIJ6M6.E2VD-W.J2WDPBA0D L>I/T
M ZG_ !KG-$L[73/B9J]I86\5K!)IMO*T4*!%+[W&<#C.*?XXAMGU;PL\\43
MZJJ,74'(,4G'/;- %VSUZY/B[5M-O9;5+*TMH)H9 -APY;.XDD'H/2M]I(UB
M,K.HC R6)XQZYKB[?3M+U;XC:S%=6UO=P+IUKMC<!TP?,YQTZ'@]@>.M<]I6
MI&#P=X'^W7?D:?)++'-/(H9%=0XA#9XQD<9X! /:@#U6&:*XB$L,J2QMT9&!
M!_$4V>X@M8_,N)HX4SC=(P49^IK!\,:9I^GZEJTEAJ1N_M4D<LT:!1%$^"/E
M"\!B "1]#WK+U&ZAE^(=UIVJ7L5JDFGQ_8A<1HR2*6?S0-W&3\N1U( ]* .S
M:XA1@K31J6&0"P!-*)8S(8Q(I<#)4'D?A7GNHZ#:Z7X)T_4M(FDU)O#EP;B"
M:4!FEA5CYB @<KMW8_W1BK7B"Y,G@O6?$]FC;KU8MDB)A_L:NH)]<%3(_P!&
M'I0!VT-S;W!<03QRF,X<(X;:?0XZ4BW5LSHBW$1:3)10XRV.N/7%<C9Z7H-]
MK-KJ5OJT-XT]F\/V>W2,1S0XS\ZJ.@.,9Z$@5RNG:?9P?#OP=J<=M&MZ-3M1
M]IQ^\P92"N[KMQQCI0!Z?;ZU876KW>E0W"/<V:QM*H8?*7W87ZX7)'N*NLRH
MI9V"JHR23@ 5R&B16<7Q*\3[HX$EV69CR &R4DSCW/>I/&UPT.J>&HKC_D&3
MZCMNL_=+;3Y0;VWX//<"@#J([F":'SHIXY(O[ZN"OYUSFDZUJOB!H]0TV:Q%
MDMY)#+;2J?,,*,4WA@?O9&0,8P<9[U7@M!!\4;N"TB465UI*RWT04;#+YA5&
M(Z;BH8>X%'PR@@3PKYL<4:N;NY4LJ@$@3/@9H ZN:Y@M]OGS1Q;SA=[!<GT&
M:5;B%VVK,C'&[ 8'CUKD/%<&HQZU-J.F)9ZF(M/5+[2KK@O"6<AD;H"<,"#P
M=H]!52QN;*;QKX:OH(S!;W6@R>4)L!B,QD*3W(% '=">$Q-*)D\M?O/N&!^-
M"3PR2O$DJ-)'C>@8$K]1VKR6_6SN?A?XU,:PR)'K-P\14 A?WB8*^G![5T6K
M:!I]AXU\-W&CVL4<MTT\=V$&1<0>7EFD_O<XY.<EA[4 =M]JMMZ)]HBW.2$7
M>,L1U ]<5C'6+]/B FB,8#92::]TN$(D#B15P3G!')["O/8= TF7X0W>H+;1
MKJ%K-.;6X3_6Q.MPVQ4/49.!M'<YZFNOB\UOB?IXNL><?#S^:/\ :\U,_KF@
M#IM/-V3="[N+:;%PPB\A2-D?&U6R3\WJ>.HXJ>&YM[D,T$\<H4X8HX;!]#BO
M+Q*-*\'>)S;+Y-I%XE=;@1)G9!YD7F #TVY!'H36XVDZ'<WMUJ,.JQ7SW6EO
M&]O"L?DR1#D.P4=02 "?I0!VD=Q!*VV*:-VVAL*P)P>A^E$]S;VJAKB>.%2<
M R.%!/XUR_P[TC3K?PGI&I0VD2WDVGQI)<!?G<8!P3U(R!], =JCUN:PG\67
M-L!"+N+23YTMXV8HX68\*G&6)')R  !UZ4 =<TD:;=SJN\X7)QN/H*2*>*X0
MO#*DJ@D91@1GTXKRJPAM-1T#X>-.L<[^?Y+DG+;?*?Y">N.!Q4VK--H,7Q#C
MT*(6HACM)$CMUVB/>F)&4#H=N3D>F: .PU?7[BU\3:)86<]K);WEQ)#<KC=(
MA6-F'(.!TZ$5JM=ROKB646/+CMS+.<<@LV(Q^.V0_P# 17(ZM'HJ>(/ ]UIR
MVRQ--(L#QX&8C"V![C./Q-6-?N+]? GB'6M-+BZNE=H63[RPKA RG_<#./\
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M '>.*M"X@,DD8FCWQ#+KN&4'J1VJO>SRS:3--IEW;+*8R8IY?GB!]3@]/QH
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MO;+;J(V/J5 QFKDD\,/^ME2/@GYF X'4_A39+RUA6-Y;F)%E^X6< /\ 3UH
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MYANR>N."* .KHK+\,:C/J_AC3-2N=HGNK6.638,#<R@G K4H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *Y#7+Q1\1M!L;\@6,EO,\ ?[CW(( SV)"YQ
M_O5U]5-1TO3]7MQ;ZE907<(;<$GC#@'U&>] 'FE[-'I<'CHV $<,>HVK3K
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M\,AB;4/[!6:2:]?="D+%=Q"<;F)7GD8'4]JZD>'M$5)T&CV 6Y.9U%LF)?\
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MUMK>6MZC26ES%.B.8V:)PP5@<%3CN/2@">BBB@ HHHH **** "BBB@ HHHH
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MCI;-"IC'_ <8JY10!3;2=->R2Q?3[5K6/[D!A4QK]%Q@4ITK3C/%.=/M3+"
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MR>]344 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF<!I, D[1U/ )_"IZ "BBH1=VQNVLQ<1&Y5!(8=XWA2<!MO7&01F@":BBB@
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MI9(2XWL!U(7KB@">BBB@ HHIJNCE@K*Q4X;!S@^AH =137=(D:21U1%&2S'
M JO;:GI]Z";6^MK@ A28I5;!/0<&@"U137=(T+R,J*O)9C@"E)"@DD #DDT
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M5LK68)JUQ.DC2%V6993@@%1C&, YZ <"MC5=6%IXMT/39--BF^VF?R[MF&Z
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M>6T+..LB2KB4$]]Q.3[@&MD^%?[7OM8O]718VU*S%C'$C;C#",DDGIN+'/'
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M+9(!Z=>H["@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBLW7M9BT+3#=R1F5
MVD2&&('!ED=@JKGMR>O89H LMJ-DNH+IYNX1>.I=8-XWE1U.WKCWJS7$7#7R
M_%'1CJ"6R@:?<E9(6.#RF0<^GKWST%3CQO<21Z??VVG_ &FPO9E39$KF:*-O
MNRGY<$="1VSU- '36^I6-W<7%O;7D$TMK@3I'(&,1.<!L=#P:?9WEKJ%I'=V
M=Q'<6\HRDL3!E8=."*Y;13)'X\\9-;Q))*%LBJ,VP,?*;@G!Q^1J"/QG<P^
M]+\1V^EVL5I/(JW$0<JMM&TFS>,#D#C/3K0!V]%8]_KAT^[NWF6/[!8V1NKF
M4$[U^]A0.AR%)Z^GK6;#XJOSJFGV[Z<LL&H*WS0>8?LK@9 D)7!!Z;AT/8T
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M[>\O[9)8YF(96$P!0X'3<I!^E=O:VHA\VZ-K;1WLX'GO$,>85&%RV,G ]>E
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MB_L((H-1M7>UDCF+NIC"DAQ@ 9# \$_CUK:U>\N[&R$EE9->3O*D:Q@X"[F
M+,?[J@Y/TH O45@>'_$3:MJVK:9(+=WTUHOW]L^Y)5=21QV(P01DUOT %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %87B_0)O$6B?9K2X6WO()X[FVD<942(<C=CMVK=HH Y
M:1XAU'Q/I>KZC:Z=!%;6TT$\4=R\A;?MY4[!Z=/U]&^'M%\6:)#'H37-A)I-
MNVV&\RWV@0YR$VXV[L<9SP/6NQJ&ZNH+&TEN[J588(4+R2,<!5 R2: ,+3=(
MU:Q\4Z_JK)9M#J*P^0HG;<#&A7YODXSGMG'O4?AOPO+9^ 8O#.LB"3$#P2&!
MRRLK$\@E00>?3M7212QSPI-$X>.10RLIR&!Y!%-N;F&SM9;JYE6*&%"\DC'
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MZ$@8[XKM** .*ETCQ;J,V@RWT6F))I-SYDLB7+MYXV%2P&P;>O3G\.^[XKT
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MJ78L5M]1A@'EP,Q,31JR[1D $<_>XZ=!VZ:BB@ HHHH **** "BBB@ HHHH
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M0JK*V%X)8\'DXZ^U6M0T?5+WQ7H>KA;1(=.CF65/.8L3*%!V_)@XV]\9SVH
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MZ9KE[#8VM]:QNMW/92,3>DKM^8%5XS\W.3D >] &IXFUZ/P]807,K)''-<I
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M*=9DCE:)V7LZG##\#7-:?=ZQ-\1=:MFNX'MK:UMS'"8F&%;><9W<'/5L'/'
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M'P3<77AK6M#U2: )J=W+=I-;LQ,3.X<#! SM8#G//M5_^Q-4U2?2I-<>T/\
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MT:X+ADA<^<I5E+MSRYW9QZY.:UM%T'4;"?73// BZK<-/&\#,7A)4+CD#.,
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M\<5@>*X=-\1RV.BQZC&VKV]TA<6S@20IM_>D@$E5,98<]RHKKT18T5$4*JC
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M-\Z"W!PN7..O(.<\],U9M?$VM7$ND7,-B;FTOV03PI93(UJCC(?S6^5P.,X
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M,Y(PG S_ !#FK#^(]4LM9U#1+I;66ZCL#?6<ZHR)(@.UE=<D@@^AY![53M?
ME[;Z%IUL+^!=0TF]>[M+A8V*-O9F9'7.<'<1P?2M5_#]W=7UYJUT]N+^:Q-E
M B%C'"A)+$DC+$D@]!P /4T 9%GXLU\V7AG5+N/3_L>M2Q6\D,2/YB/(A(<,
M3C&1]W'XGMTZ>(M#DU$Z;'K%BUZ'*?9EN$,FX=1MSG(P>*Y__A$-4'A_P]I@
MNK3?HES%/YA5L2B,$ 8[9W=<GI74KI]DMQ]I%G;B?.[S!&-V3U.<9H LT444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;:<VHV]Q$FPR1J=K(PR1NSC!'!!K-\0/JUU%X1O;V:W*7&KVTCP1Q$>4Q5B
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MU"WSH2.A'V=OWVZ/R_[WR_+]>:ZBB@#CM0BT?Q7XLTQK&[6XFTN20WA@?*A
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M3A+23<[8'1#R>U '&GQ-XHLM"T+Q-=S64VGWOV=+JTC@*N@D 'F!\\G)^[@
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M.UD"X(/!_BY&:R=$U/Q9J6G7^IB]MIS87%Y"MDMKC[4R9$8W;LK\P''/N>>
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M %)@#.!UI:* $(!ZCI2T44 %%%% !1110 4444 %%%% !2$9&#2T4 1Q00P
MB&)(P3DA% S^52444 %%%% !1110 4444 %%%% !1110 5"UI;/,)FMXFE!!
MWE 6R.G-344 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2,X/7]*Z&VM;R'4;N>;4&GMI1&(+<Q*OD8&&.X<MN///2KE% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;^7,Z_,L4C*%)..X'/\ P$T >M0Z]I%QI@U.+4;9[,MM$PD&W=G&WZYXQUJ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7<4MU; --$C9,8/3/ITZ5<H **** "BJ>HZKI^DQ)+J%W%;)(X1#(V-S$X
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M6-&=V"JHRS$X 'K5?3M3LM6M!=Z?<QW,!9E$D9RI(.#@]^10!:HHHH ****
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M.TG1-9A\6WFN7\UBJ7=K%"T, =BI0L?O''][KC\!4WB'1M3O]5TC4-.GMO\
MB7R2,]O=!BDFY0 W'\2\X^IZ4 8LOCK44\'WFKQ6=K+/8ZB;*7YF5'Q(J!U'
M7G<#@GCUK3M_$.HVOBJ;2=9ALXX#8-?12V[,=BJP5E?/4\YR .G2LF?P3K4F
M@:QI?VVQ?^T-3^W+)M=-O[Q9"".>ZXQVSU-:]YX?O;_Q5%JEPML+4Z;)8S1"
M5BQ#D%B#M[8Q^O'2@#G?%FIZEK7@6UU81VT=C=W=LZ0E6\U(S,NQBV<$GC*X
MXW=3CGT&[NH;*SFN[AMD,$;22-Z*HR3^0KAG\&^)CX33PS]NTV2VM9HFMKEP
M_F-&D@8*R@8! &,@G.,<=:[:\LDU'2Y["[.Y+F%H92@QD,N#CKCK0!PGB>_U
M35?#V@:G(EM%:7FIV<JP!6\V-6<%"6S@G&,C QGJ<<]&FNW8\7ZCI4EG$8K:
MP2ZB:(EI)<LPP<X ^Z>.>O6L-O"/BA_#VGZ')?:8\.F7,$D%R1)ODCB;*AEZ
M @ #@G/MUK9;0]5_X2J]UA)K95N-.%I'M9@R,I9@^,8ZMTSQ[T 1>'?$EYXD
M@BN;*ZTZ6*2W8RHJ-YEI-\NU'4MDCELG"YV\=:PM-\4:]IWPJ?Q)*;6]F#2/
MB0,AYG93G!.>2, ;< 5O67ABX/B:TU^[ALK2[A@>.Y>R9O\ 3"P !<%1@#!/
M\1Y'/%9A\%:Q_P *_N_"@N[)E9RMO-AP0AE,F6ZY/.,#ZY- %[5=<\0Z0UBU
M[8Z88KW5H+5-DKLT<<A R01@L.>0<=.*I%M97X@^(QHD5DUP;2S):\9@@P),
M#"\DG]*V?$>C:GK=II2Q_98IK._AO)0TC%28SG:IVYY]3T]Z0Z1JMGXHOM9L
M/L<R7]O%%)%/(T9B:/=@@A6W [NG'UH S+3QQ>7EGH=S]CBA:]U$Z=>6[Y+0
MR+NW%6!P1\O3'>K%YXAU7[3XIL(#;1RZ3:1SV\WEDYWJ[89=W)&W_P"MVJ.Z
M\%W,&AZ;#IEU"^H6&H_VBTERI5+B0[M^=N2H.\XQG&!]:EMO"^JOJVNWE]>6
MFS6+..!EAC;,95&7C)Z#>?KCMTH @T?7KVR\*^&X;B1+B]U.VC,3K!(^Q!"&
M9G522Y^F,ENU/7QC?V=G?#4M,<7$5U%;64GDR017K2G"8#@E<'.[KC'>H6\(
M:Z/#^B)#J-G!J^A;5M)%1C"Z! A5\\_,!R1T[>M6=4\,ZUXAT%X]4U&VAU-9
MHI[4VJ-Y,#QDE3ACELY.3QVXXY *\JZ@OQ1T<7[VT@_LZY*/ C)_$F006/3C
MG/.>G'.QXPUV[\.Z*-0M+:*X(GBC99'(X=PO'J>>Y%4H=%\177B?2]:U&738
MOL=O+#+%;^8^[>5Y!./[OX>_:/XG;O\ A#'",JN;NVVENF?.2@!8_$6OV?BF
M'1=6L+!?[1ADDL)+>5]NY!ED<D>ASD#\/2OHWBCQ)JOA?_A(3I^F+:FSFE$1
MF<.9$8X[$;< ^_TS@:SZ1?WVNVFL7R6J2:=#*EK!%*S O( &9F*C' P  >I-
M5=#\.:EI7@%O#LLEK)<+!+#'*K,$(?/)XR,;NG.<=J "U\4SW5CX;@AB@34-
M;M1/@@^5 @C#.<9R>H &1UZ\5#<>+M1L5U^RN+6VDU'1[7[9&REDBN(=I.X#
MDJ0001D\]Z:GA#4+>Q\-SV\]LNJ:!%Y W,WE7$90(RDXRN0 0<'!]:GO/"][
M?QZ[>2M;+J&K67V)%#L8[>/:P^]M!8Y8D\#L/<@&AX=O=:U&W2]U*"RAMKBW
MBE@6!V,@++E@^>/3&#^?6LPWFKM\4'L/M< LHM+6=8S$> TNUN=WWODZ] .W
M4G?T2UN;'1+.SN_*,UO"L3&)B5;: ,C('7'2LZXT.^/C:/7;:>W$#V(L[B*5
M26VB0N"N..<D<].O/2@#-D\7:C)X7D\66=O;RZ9&SN+8AO.>!6*EP^< X!;;
MMZ=ZZJ&:*_L8YX7/E7$0='7@[6&01^!KD[7P?J=GX:N_"<5S;'29BZ17#,WG
M0PN2639MPQ&2 VX=>G&#UD< M+%;>T10(8@D2,2 ,# !/ITH Y7Q)X=L)YM!
MT[3;2*"ZMKV.XCDB0!H(8SESGT/"^Y8>E+X?D:^^(GBN2X^;[(MK:PAN=D90
MNP_%CG\J+73/',,LSM>Z%YER_P"]N!#*T@7/ 7)Q\H)P,8[G)))TI=%O++Q!
M>:QI)MV?4($CN8KAF4;TR$D! .>"05XS@<B@#&\#$7G@*[LKE%F@M+BYMHQ(
M-P,:L=HY]!P/I5GP9:K>_"G3[1IC"L^G&,RCJ@8$9_#.:U-*T'^PO"ZZ39,L
MTJHVZ24[1)(Q)9C@'&22<?A5?1O#<]KX%7PU?RID6CVK36['E6!&X9 P>: .
M5\.ZK+J.HZ!H6L^7:/IQ\^QN8@0FIJB-&IC) P-K$D=^,<&NO\<?\B)KO_8/
MF_\ 0#58>';V\M]%MM1%H%TB:.59X2Q:4QJ0N%(&P'@GD],>XTO$NG7&L>'+
M_3+5HDEO(&A#RD[5##!/ ]Z ,'2M<U:QOO#FG7EM:"RU2U*0F-F,L;)$'^8G
M@Y / '![FG7_ (MU'3;JT-W!:1+<:FMG]C))G6)GV+-N#8YZXV]#UJ>7P]JD
MEYX9N ;0?V*K"5?,;]YNC\OY?EXXYY^GO66W@OQ =+%B;_3W\C55OXYW1S).
M1)O_ 'A]0..,\ #C% &U-K-]JMQK%KI(MECTS]S(\ZLWG2E=Q08(V@ @;N>3
MTXYC^&__ "3S1?\ KV'\S4,/AS6]*UO4[G2[FQDL]6(DGCN ZM#-MVED SN!
MZX)'UK3\(:/=^'_"]CI5[-#-+:ILW0@A<?CU^O'TH R-,ED@\>>,YH(#/*EM
M9,D2D R,(Y,+D],]*GT_Q/?-XDL-(O?L<C7EH\KBVSNM94V[HV.XAOO=>.G3
MFDE\,ZI+JGB:Y2[AMEUJUC@ADB=O,@*(RAN@SG=G@\8J&Q\,:[%J>@7L]QID
M0TN"2W>*")]I1@HRN2.3M]@,]Z ,#0M8U_0O!=QJEC865QI]G>W4EPCR,)G0
M3-N*8&T8'KG.#^/47/BF:\N)[?1@I:"VCFWR6DLP=I%+*F(_N_+@DDG[PX.#
M56V\)ZK#H%[X;:XM?L%Y-*S7:,PF$<CEF7R\8S@D;MW?..U2W?AK6M-U\ZIX
M7NK&*.X@C@NK2]5RA$8PCJ5YR%XQ_D %*_U"?5I_!-_=V$UA<2W[^9;3*0T;
M>5(".<''&1[8JYJ/BO4FCU&;1K/[3_9\[0BW-I-(URRXWA77Y4.<@9#=.V:L
MZEH&JW=SH4XNH)WTVY:XG>4LGFLRL"% !V@;CC).  />JR>'O$FDZW?R:%J%
M@--U*<W$L=Y$[/;R-]]DVD!LXS@D?X@%V'7[O5M4ET[3(X[:2UM8I[EKN-F,
M;2@E(]@*G. 23GCC@YXI?#(R'PAF5563[;<[E4Y /G-D U(?#FKZ9XHEUG1K
MJWF2]MXH;V*]9@6:,860,H.3CJ"!]?2WX.T.^\/Z.]E?7%O,YN)95,"L  [E
MN<GW_P#UT 0:GXCO?MVHV6DQ*TVG(N[?:2S"61EWA 4^[P5Y.?O=..:FH>+=
M5TW3M)UN[TX6FF7#*NH)-$_G61/&2,\KNXSCC(.#FIKW0/$%EXGNM8\.WEB(
M]15!>6U\CE0Z#:'0KSG&!CCI^5ZYT2YU$P66IO#>Z:L3?:%<D-/*>Y7& @R<
M+G@X/\(H HZQXAUS1?!LNMSV=H]PKH1!\R;$9PJYY.6^8$C( Z9..1?$6MV/
MBRRTG6;&S2WU1)#9R6TC,4=!N*2$CGCN!6%XCTW5M%^$^H:;J-W!.L#PI:S!
MV9A'YR;5?(&2HP,CKZ5U3:/>ZCKNGZIJ2VT8TQ9#!%!(S[Y'7:68E1@ 9P,'
MKG/% &)/XTU2W\':]K"V%D+G2K^:W,8=MA",%W9QECD^U6=:UWQ/H=E_:=W;
M:8M@+J)9"AD=X('(!=N0"5)Y X(],57G\&ZM/X5\0:.9K-9-8OI;E9 [XC#L
M&((V\D8_'/;'/0ZI<Z=%HC6OB*XL[=+F!HY4:8!7&WY@N<$\>V: )8[ZYF\0
MR6<)A-I!;K)*VT[M[$[5!SCH,GCT]:H>)]>U#1;K28;*S@N/[0NA;'S)2I!*
ML1VZ?+R>?H:=X*TF;2/#%K%=22RW4JB25Y1A_N@*&]U157_@-9WCPS#4/"WV
M?RS-_:ZE5D)"G]V_!(Z?7!QGO0!$/&VH:1>:MI_B.RMQ<V5JMY;M9,VRXC9M
M@'S<@[R!^/YWK?7=;_MV&Q?3_M-O<PNRW*6DT"02*,['+@Y![,,<]JCU+P<W
MB"35+G59$AGO;);*$6[%Q BL7#;B!N)?!Z#A0/>K.BVGBV((-;OM/G%LI$?V
M571KAL8!D)X'KA1UP>V* ,W1?$OB75O#@U[^S],6V-M,_E&9PYD1B!V(VX!]
M^.V<"U:>*I[K3O#<,,,":AKEN)@"#Y4*K&'<XSDXR !D9SUXI^@^']3TGP.^
M@S/:R7"QRQQRH[!#O+')XR,;O?.*J1^#]0@T[PY+!<6RZIX?3RD)+>5<1E C
M*3C*Y !!P<'UH EE\:_V-+K5KKL48FTJW6Z62W!"W,3<#"DDJV[Y<$GKUJCK
MIU9O$WA!]0%H%>]=BD*L&B;RF^7))W#WPO3ISQ>U'P7_ ,) FL3:K)'%<ZG:
MI:H("76W1#N') W$OR>!T ]S$^@>*K^XT*74+K2P^DW'F/)&)&,XV%=V#C!Y
MZ?KVH LV?BF?4M9NK"UELTGL[WR)K&966?R@V#*IW $$?,,#&#US6OXAUJ#P
M[H5WJUPC.ELF0BG!=B0JK[9) _&L34?"U[K%];37R6*S6=_]HM]0B9A.L(D+
M"/&WTPI^;'?%;/B30X?$OAZ\T>XD:-+E,!U&2C AE/O@@&@#.NM=U/1=5TJ#
M5X[62VU27[.LENK*8)B,JIR3O!P1GY>G2L[0XKZY\?\ BF&[DM)H-EHDT;0$
MAD,;D*,L0.ISG.<]JTO[#U359=).NM:;=+F%QFW=F-Q,JE58@J-@&XG&6YQS
MQS)I.C:C9>*]9U6<VQ@U/R=JH[%X_+4J,Y7!SG/;'O0!2^(RJOA2-54 +?6@
M  Z?ODJUJ7B&[_M*]T[2T7SK&)&=I+26=7=@2$_=_=X .23][H<5-XOT6\U[
M1TL;-X$87$4S-,Q PCAL< ]<8JC?Z#X@M?$DNN>'[NQ1KZ)([ZUO0[1ED&%=
M2O.0#C'&?Y $)\:RA='COX4T*;48'<G48VVK*K!?*ZK@G)()(XQQS5B^\43Z
M;/I-EJ4MGIMQ?V[.]Q.K- )1M_=J=PZY)R3V[YJ>]T;4KN%;2\2PU>SD@*W$
M5V6CS+N)W+A6P.< =0 .>.:MMX6O;/0K+1)4LM7T^*U\F:*\9ER^<AE.UL
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M[6<J7-G';[0[*=R9.[H< ECQDX]ZF\&Z+=^'O#5OI5X\,CV[/B2$DA@SENA
MQ]['?I0!GZ)=ZO<^/_$-M<74#VMHMLJQB(@A61V&#NZY/)(.?:N>\'ZYJNB>
M!?"\WV:T;3;B=+20%F\[]Y(RAQV ![<Y'<5UD.B:G8^+-5U:TGM7M]2BBW1R
MA@ZO&I4 $<8.02>O&,=ZR(O!FKP^"='T!9K)I=-NXYS*7<*X1]X&-O!.<>U
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MM8WB[0I]<LH5M_*#VSM*"4_>Y"G C;("$G@DYX-4?#WA6ZT_PW?6DR6;3:A
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MM2+:O']E##*L'8X<#H>.>HQTH Z#5M7L=#TZ34-2G\BVB^^^TMC\ ":MJP=
MZG(89%>=>*=7O_$?PQU?6+66WBL)%D6*%HB7>)7V%BV>&)4D#& ..>H] BD6
M*P21SA4B#,?0 4 3T5QEOXFUV]M]+U2QL3<VM[(AEM1:NK10/T<2DX+ 8)&,
M'MZTMYXB\0V/B:309DL/-OE5M)G\APCX/[T2?O.JKS@$9X]<4 =E4%[>0:=8
MSWMTY2"W0R2,%+84#).!R?PKG=8UC7K;Q/IFBV)L#]NMI7,LL;_(R;<G ;D?
M-]W]:S!XNUZWT3Q-%=Q67]K^'@'9U1O)FC9"Z-MSD$@'C- '<Q2I-"DL9RCJ
M&4XQD'IP:?7(:AK^NKJGAVQL38C^V+:5V>:-CY;I&&SPW(RW3VZU-:ZQKMCX
MKLM'UR33VAO;-GAFMX74O.F-Z9+GM\PXY'TH ZFHYYH[:!YI6VQQC<QQG JA
MH-Y=ZC8&\N6A,<TKFV\J,KF'<0C'+')8 -VZBL\:O?ZQJ>K6>ERV\$>F%8B\
MT1?S9BNXC@C"@$#U))Z8Y +\?]B^+-'AN3!!J-A/\\?GP[E;!QG:P]1Z5HQQ
MI#&L<:*B*,*JC  K@O!M[>V?P]\-"W:W@MI$87-U.0?*&6VA5R-S,V!W^AJO
MK'B35M3^']]<I/';SVNJ_8)F2!E\Y!,J?=8Y3(;D=>HXH ](JM=:=8WTD,EW
M9P7#V[[X6EC#&-O5<]#]*Q;[6KV+5H]$CE7[4+3[3-/'9O( "Q50J!CC)#9)
M)Z>_&9+XPU33M(L)]>M!I9ENGM[F[,+-&@ .Q]N<J'..N<<T =M5#4M/TJY"
M76IV=M-]F^9))X@QC]P2.*-%N+BZTN*>YGMKAW9RLUK_ *N1-YV,.3U7;W/.
M:OT 9">*O#\EO]HCUBS>'!/F+*"O'7GI6I#+'<0I-"ZR1R*&1U.0P/((->=?
M#[5;^P^&5J;71;BZ\LSE90\83_7/DD%]V!W&,\<5T&JZEJ6E>)-"T+3$LH[2
M]AF5?,1B8O*08Z'D<CCC..HH ZBBN%77_%,FGZ^JSZ8MSH4K[IC;N5N5"!P-
MF_Y#@X)RWT[UH+XJFO\ ^RK>T0PS7VG+?R,(&G,:MM 4*,=V/)Z;>G/ !U5%
M<-<^*/%%II6GR7&GVT%U-K":>XEC91/&S?+*@W93(['..:T9]6UK3]0T;1KZ
M6S:[U.:?-U#$P1$C7< %+??(([XX/6@#J**XJ#Q?J5O8ZU/?1VTITZ_%A!Y,
M3+YTC,@5CR?[XR!Z&KD>J^(TU.>W-ND]H;1I8KM[1X1%*/X&4MEE(Y!'3IS0
M!U-%<%8^+/$+Z7X:UFZ^P&UU:XBMIK>.)PZF3.'#%L<$?=Q^)[7_  _/JDWC
M[Q+%<7L4L%LULBIY)!"F,L IW<8+'.0<^U '745S_BO6-0T*.PO;<VWV%KN.
M&],L3,T<;MMW@A@!@D#D'K[53A\57,7BG7-*OYK40V%H+FW>.!]S+C+[LOAB
MN5X&,[NU '17.HVMI=VEI-(5FO&9(5",=Q52QY P.!WQ4-OKFFW5W?6L%SOF
MT[;]I78P\O<"1VYX!Z9K&GUK7;'5O#-C>BR)U,R+>".)@4=8R^%RQXSQSGI[
MTWP__P E#\7?2R_]%-0!OZ5JMEK>G1:CITWGVLI8))M*[MK%3P0#U!JY7*?#
M'_D0-/\ ]^X_]'R5/+JVK:I<:Q#H;6J/I;"%!/&6\^;8'*D[AM7Y@,]<Y/;D
M Z2BN;76]1O=<BT.)8;.[CL%N[QV'FB-F.!&O(SR"2?0#CGC-3QS=1V<]G<V
M\ UB+54TI=N1"[ORLF,Y"[<G;G/&,\YH [:BN9;6M3T[Q5;:%>O;SKJ5O))9
M7"Q%-LD8!9'7<<C!!!!'I[UD:=XPUM?")\6:J+ 6$,4_F6\*.)'D64HFUB2
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M*2W\2Z]>P:5J=E8FYM;Z1#-:BU=3# XR'$A.&*C&1C![8ZT =E1110 4444
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M8V\KRP"5$.\*ISQR3]<UTWAS08?#NE?886#*9I)B%7:BEV+;57G:HS@"J/\
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M1[517P#>0Z'HT%MKGE:GHA;[)>"V&W81AD9,\@@#//\ A0!!XNE\26W@V_\
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M?O\ 3_$6I:S=ZE#<-J,<*R116QC53&" 02Q./F/'/UH J>-/^0MX4_[#"_\
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M49_>1ONRLH] I!8GT!J]K-G?6'A=;/0+O['<6Z(D#& 3%@O\.#W..IZ<GWH
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M7#@ DC/W<#TH V8X9GTU8;V56F:$+-)$-H+8PQ7T&<XKSI;[4_ VE?\ "/\
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MJ+6:&;(5E#%E8,.A!9NQSGMBJ$OAG4K;1)K'2-1M[6>\NY+FZE:!BK;VRRJ
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M"JJC)P !ZGDD]ZT: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,]<T :I 8$$ @\$&HH+.UM2QM[:*$MU\M N?RKEKW6-=U.36$T*.42:;,;>
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M\P!_,8?+@KTYZ\UT&BSZC<Z-:RZO:+:7[1CSX5<,%;O@@D8/7J>M %ZBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ K%\7:(_B#PY<V,#*MR"LMNS=!(C!ES[$C!]C6U10
M!S=_IDGB5])U:ROFTZ\TZ1FV20B0*67:Z.N1R >N?<9S7,^,]"/AWP-XA:35
MWG74KZ*X421HI61I8MW(Z_<ST '/%>DTCQI( '16 _O#- &/'I#W&JVFL:E>
MPW+643BV$,7EHI< ,YRS9.!@=  3ZUR7@C2Y/$/P_6Q?4HCIUQ<S^=%'%^\V
M><Q*;]V &_W<X8^Q'HNQ=FS:-N,;<<4B1QQY"(JYZ[1B@#%A\/3P^+Y-=6]B
M$;VBVAMA;D8126&&W=<GTQCMWJ"/PK<6-QJ@TO4UM;359&FFA>W\QHY&&'>-
MMPQGK@AAG\JZ2B@##U'PK97?@Y_#4&8+=8!% XY,3+@HWN0P!]Z?J'AFSU+P
MLWA^=Y/):)4\U3APP((?/][<-WUK89E12S,%51DDG  JM=7R6MS:P-!<2&ZD
M**T4194P"<N1]T<=?6@##MO"E]<Z=/8^(]=DUB&2!H%46ZP;0PP6."=SXZ'M
MSQS50>"M5DL])L[KQ)YT6D7<<]NPL@'8(K*%<[CDX.,X'?().1V-% "5BZ+H
M-QI6K:I?2WT=P-2E65D6 IL8*%&#N/&!Z5MUG0:Y9W&O7&BH)OM5M"LS[HRJ
M[2<#!/7D'IQ0!4DT34[PW5KJ6LI=:;<.W[A;01R>63_JRX;!7'!^4$CO6WC
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M&)K_ $B\L?$.J/JCW<)A9TA6!8U_V5&<'.#DD]!Z5T-)N4L5W#< "1GD _\
MZC0!SFC^&M3M$6#6?$$FKVT*%(8FMUBX(*_.P)+G:2.W7)R<8AT/PAJ&C&*S
M/B.>XT>W<-;V;0*'4 Y56ESDJ#CC Z8Z<5U59^N:U:>'])GU.^$IMX!E_*C+
MG\AT^IXH YV3P'=QV&KZ38:Y]GTK5/,;[.]J)&@9Q\VQ]P^7/8CZ$=:FN_!E
MY]HT_4-+UZ2QU*TM1:23FW61+B('(#)D#@]#FNJ1Q)&KCHP!&:R+_P 3V.GS
M2(T5S.EO(D5S+!%O6W9L%0V.>A!X!QD9QF@"CJ/@^6\73KN#5Y8M8TZ5Y4OI
M(@_F%QAU9 0-I  P", "K&C>';O3=?U+6+G5!=2:BD0DC2W$:J8U(!')..3Q
MG\36_10!C:]H$FKW>F7EO?&SN=-G,L;^4) P92K @D=CU[57MO#5Y:ZQK6I+
MJD;MJT<:%'MO]5Y:E5.0XSP3GISZ=*Z&B@#C!X!GBT71[>TUMK;4=%W+:7T=
MN.4;@JZ%B&!P.XKI-)L+FQMV^W7[W]W(<R3M&(P<< *HX4#TYY).:OT4 <_=
M^'+JY\86GB%=1C06L#0+;FV)W*QR<MOZ].U7O$&ER:WH5WI<=RML+N)H7D:/
M?A6!!P,CGFM*B@#FU\-:H^A0Z)-KHCM(X%@9[2U\J9T VXWL[ 9 Z@9],5-/
MX9$>FZ=IFE30V-C8RI)Y#0&02;#N4$[A_%ACW) ]\[U% &)XM\.GQ1H4FEBZ
M%H7='$_E[V0JP8%>1@\=?<UJ6<=Q%:1QW<ZW$ZKAY4CV!SZ[<G'YU/10!Q=U
MX N;C3]2TY->>.TO+W[;&GV96:.0R!R&8GYER..A]S5?23=O\2/$D-GJENLR
M6MFDGG0^9O8(W.%9<$9^GS5WE,6&)7WK&@;U"C- ' >(=-M]!?PCI=I>K%*N
MJ-)YTX#%W*.6=AD9RS=B.N!BNAN/#$MV-4N)[Z,W^HVOV/SE@(2&'!^55W9S
MEF.2>N/3%;SPQ2'+QHQ]64&GT <Y/X06]\(6F@WEZ6DLEB^SW<,>QHWCQL?!
M)YXY]<GI5JWT.>35K;5=6NXKNZLX7BM_)@,2)OQO;!9B6(4#K@#/%;-% &(O
MAJW3Q>_B%96#26ZQO /NM(N0)#_M!&*_0U3U#PG?'Q#-K6B:Z^ERWB*EY$;=
M9DFVC"L 2-K <9Y_QZ>B@#F;SPC-_:MCJ^E:JUIJ%K ;:66>+SEN8R=Q#C*\
M[LMD$<FK7ASP]-H,FI/+J+7?]H7;73 PA C, #TZ_=%;E% '):G>VEA\2[&>
M]N8;:(Z1.HDFD"*6\V,XR>_!_*NMHHH *BN+F"T@:>YGC@A3[TDCA57MR34M
M% '+> Y$FL=7EB=7CDUF[9'4Y#*9,@@]Q4FK^%;RYUY=<T76GTJ\:(07&8!-
M'.@.1E21@C)YKI:* ,4Z%<,]C%-?+<6=N6DN(YHLO<RG)#$@@  G(7;CIZ#'
M*>(-#G\+_#7Q#9RZE%-8,DC6</E%#;AFR(PQ8[@,\<9KT6FO&D@PZ*PZX89H
M P+'1I-1.DWU_?PW<5B@DMEAAV!G*;0['<<D G&,#))],5IO!UU-#XBB.K1@
M:]P_^BG]T-FSCY^?E'Y_E74JJHH55"@= !BEH Q9;[3_  SH5K;Z]J5LJ;1;
MB5TV++A>FW)YP/7_  JKX-T-=#\,>5$9HGG+S+YPW/$A_P!6I!_NH%&/4&NA
MDBCEV^9&K[6#+N&<'U'O3Z ,GPU'JD6C(FL79N[E7<"=H1$TB9.TE!]TX[>F
M,\YJ$>'KB#Q->ZU9ZEY(OH8TF@: ."T88(<Y! ^8Y'?U%;E% '')X%N8_"%E
MX>&L1E;.Y6=9S:<L5D\P C?CJ?RJQ=>$M137I]7T;Q ^F/>J@O8?LJRI*RC
M=0Q^1L?7\:ZFB@#C_%7]DW6D_P#"))>EM5<1&U0/F=7W K,3[$%F/H#ZUU-E
M:16%E!9P B*"-8T!ZX P*D\J/SO.\M?,V[=^T;L>F?2GT 8WB3PY!XCALTEE
M:%K6Y64.G5EP5=,]@RL126OAJWM/%EYK\;D-=0)&8?X0Z\%_J5"#\#ZUM44
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M(6YTS7M/NM19XM;E,SE(@IB<A1QR<CY5X/YU:N_#=W>W&D7,^K&2;2Y3-O:
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MX ^ZK2 Y8#CC Z#MQ523X?2+I6I:)9ZY+;Z1?%V6U-NKF L<L%8G[N>V/QH
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M] $E%4;+6M-U&<P6E[%+*(Q+L!Y*'HP'=3ZCBLGQ_?W^E>$;F_TZ[:VGADB
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M*I;@R?W,]-W^SUH T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\LSQIIUYXD2:S60C:T?FIN9<_P )(8^F.>AKUAXHY$V21JZ_W6&13BH/4 T
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MCL1CY0.>3UX'7%=P%5<84# P,#H*%C179U10S?>(')^M '(> [J!;SQ'IYD
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M*]3@CJ3SR:U=+TJ/3K66(^6[W$AEG*1!$9B #A><#  QS[DG)H \]\5'P\?
MVOW^E3F:.^GM3+<R2DI/()5SMSP<+U(X_(XW)[NP7XJZ2(+BW DTB5%V.OS
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MH-IK^EWMTMM!>*TTB>9&K*5\U/[R9 WK[KD53TKQAI&K/J0BNHT33YFC=W;
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MINP52-Q/VH,#CK]T9'L*ZO[?:0_%@227$82]T2);9MV1,?.8X4]^"#QVYZ4
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MZS:6-G=0MJ!MKA(#)OC3>81SAFX(49'5N.#7GMM<V<7PV\%#SH4,.K6C2#<
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M"0NX"CJ 2#CT'M3KF6VU;Q]HFJZ5=0S6UE9W)OKF)P4\M@OEJS#C.[+8]B:
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M'?:H/'J16/XEN=2LO$WAK3[/5KF"WU"66*<!8V+!4W @LI(.: .O  S@=:,
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M0GEAB(G(!?.P9V]3@_B,=: .@I" >HS5:34;6*\M[-W83W*LT2>6WS 8SSC
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3[2+U28/+;S /M>_.W&?N\_2@#T.P\2:5J>H3:?:W+-<PQ^:R/$Z;DSC>I8
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MD=MZEL=!@!,]!B@#MF\5Z(FDW&J/>A+:U<I.6C</$PZJR8W ^Q%+9^*-&O\
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MDM5>"_D0>;$V['DNX^^<9/J.^,BI/'DL:7/AD,X!36X9&_V4"."Q]!DCGWH
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M5!.3^/O4U%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<3!4!ASMW1J<$DC&<#!&*]#HH \H6*ZC^%:Z<VGWRW,6J\Q-;N6P+K>2.#N
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MDM]>^T&-X79S']H5LCJ7^49)&?K7J-M<+<VR7"+(B.-P$B%&Q[J>1]#S4M%
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MJ:9J=GK&FP:C83":VN$WQN!U'T['MBLJU\::;?7[6=M;W\CQW9M96%HX6)@
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MG8S6U[!/?IYEL&@+>8O&3\N=N,C.[&,\UH:IJEKHVGO?7KE8D*K\JDEF8A5
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M,\K[-QY) Z DDD4NL^-XK7PG?ZQ86D\LUG,UK)$Z@&"4$+\_." 6'0G.1]:
M.EFM8IY8I)5+&$[D!)P#ZX[GTSTJ:LR;7(8&MX#;7#7ER&:.T4+YA5?O,?FV
M@<CDGN!U.*HS^-M'MM"N]7E-P(K*0PW,0@8RPR XVLO;J.<XYZT =#17.3>-
MM/@FC26QU)%FNEM8I7MBB2NWW=I8C@]CTK7_ +1C_M?^S!%*9?)\XN -BKG
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M C:><@8ZUZ#2'IP<4 >>Z+=@6/C.Q6RNKF6?5KM8TC@9ED+(JA2P&U>>NXC
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M'IP..,XK&\0Z)?W.A>,[^WLKEFUN2!;2U6%C(PC55+E<97<0QYQP!GK7IE%
M&1KFF0^*/#-Q9'S(?M,>Z)W0H\3CE&P>00P!JIX*-]>:,NLZJJK?:@B%PAR
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M,<<>W&:MT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 56U#4+;2[*2\O)/+ACQDX))).  !R220
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!DW/A^&Z\1VNN->72SVD311Q*4\O:V-V05SS@=^U:U%% !1110 44
M44 %%%% !1110 4444 9.K^'X=8OM/NY;RZ@?3Y?.A6$H%+8(R=RG/!(_&M:
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,,/)9PH))]N >M %VBJ5GJ^GZA=W=I:72336;*LZKG]V3D@$].U7: "BBB@
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M%^'NMDD ?96'/U%.BT>]U271[G4FMQ%IH$T20ECYTNS:K-D?* "3@9Y(YXY
M,_3O%&NW$6HZC>1Z;#IND7EU#>;0YD=(@>4YQG([]<]L<ONO%6JZ;H>G>([V
M*T;3KMHC/!&C"2W27&UMY;#$;ER-HSVJYHWAF>WT_6]/U1X)K?5KF><B'(*B
M7[R\]<>OZ56A\)ZC-H-GX<U.ZMY].LY(_P!\@82SQQL"B,O1?NKD@G('09S0
M!9EUK6=2&KMH$5HYTR8VZQ7"DFYE559E#!E"#Y@H)SSSTHNO$-[+J$VFVB);
M75M;1RSE[66Z"O)NPG[LC&-IR<\Y&!UJ#_A&]=TS7[^[T'4[.&RU2037$-U
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M.I9NQ!R#[8K$M/&?B&3PYI'B">VTY;2ZNUM[B% _F8:4QAE.<#''!!SZC.
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ME<(B#+,QP *HP3:1XGTA)T6#4+"?)7S(]R/@D9PP]0:SXM:OM7U;4+'2?L\
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M+7?JUU-.)1NQ&)&W$8QSC\,Y]N>THH YNZT'4KK6_#^H^9:H-)602)ECYN]
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M,@W-^])C,?'''!SW].V3T]% ''7W@_4K^3Q1_IT-LNNQQJC1[BT)10H!Z9#
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M+X@BTQX95B>X!4M$^0=N&X)(XQZ&@#<HK%O_ !1I]CXAM-#DDQ<7$;R$X.$
MQC\23T_^M6-X?\606G]KQ^(=;B#1:S-:VS7!1#L4)@8  XSU]Z .SHIK,J*6
M8@*HR2>PKB=9\9#4O!&MZEH5Z]K/8&01OL!8A#@DAAP"<^_2@#N**R]-U_3+
MZX&GPZC!-?11!Y85<%AT!./8]?2I)-=TJ*]2RDOX5GDD\I5+<%_[F>F[VZT
M:%%(2%!)( '))[51M-<TN_NOLMK?0RS;/,"*W+)TW+_>7W&10!?HK/&O:4;Q
M;3[?#YSN8T&[AG'5 >A8>@.:BN_$^A6+W"76K6D36N//4RC,><X!'KP>.O%
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M[I7E6<O]H0>7?,%M7WC$Q/0*>Y-%]KFEZ8Y2]OH8" "V]ON G +'^$$]S@4
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M!4DA5"&52>/E8DD?[6:Y?R8M-\,^&H;]HX;>3Q-Y]M%.0NRV)DVG!Z+@@_\
M A7K3QI)C>BM@Y&1G!IU '':-=VA^*7B"&.>$R26=J2BN,L5WYX[D C\Q2_$
M>\MK73-*^T7$<7_$WM&^=@.!("3] *["B@#C/MT=A\39KC4)DCM+_342QN'8
M",E6)= W3)R&]P*Y;58X;7P?K,L[QQZ=>^(DFLUD("O'YJ;F7/\ "2&/'&.>
MAKUIXTD7;(BNOHPR*=0!% (#&)+?RRDOSAH\8?(ZY'7C'-<-IDVBQ>)_&R:J
M]JJ/+$)!-@%H_)7(YZC/ZXKOJY_1-!N[#7-8U"\:VE349UF14R6B*J% Y'/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EHH 2BEHH *0@$8(R/>EHH
M *2EHH S=9M]8N(85T>_M[-Q)^]>:#S<I@]!D<YQ5FPLH]/L(;.$L5B3:&8Y
M9CW8^I)R3[FK-% %>SLX[.-U0LS2.9)'?[SL>YQ[ #Z "K%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
$0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>ebs20191231exhibit1048016.jpg
<TEXT>
begin 644 ebs20191231exhibit1048016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V:BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&9@R9_ND=NE:WV:#Q1>^)].U.]L[>X@NF3]_!NF@A"J8WC8L-HZL"!UR3UH
M]%IN]22-PR.HS533\+HEMF[DG MD_P!)=<-)\H^<CU/6N(\/1/INLZ5I.MZ9
M:W)G@E2PU>U *WB;-S+*IYW%1N).03^- '<Z;J=IJUH;JRE$L/F/&''1BC%3
MCU&0>:LJRMG:P.#@X->36DD6D_"Z*>VCCMQ/JC0WTT2A'%O]J8-DCG&,+[!J
MZ;5K3^Q_'6@R:%;QPF\@N4NH(5"I+&B HS <<,0 ?]K% '9[EW;=PW8SC/.*
MP_#^M7NIZMK=E>10(-.NEAC,6?F4H&R2>_/H*YWPO#HFN>%-'UB]GVZE!=++
M-<(P6=KG<08V/4@DXV^F.V*RKJ\6V\4Z_'J< ?P_/JD2:A(.J'RD\O?Z1[NI
M'MVSD ]4) ZG%07;7+6$S:>T!N3&?(,V3'NQQNQSC/7%<=K^CZ9<>//#5HUN
M@MI[2[5HHSM1U 0A<#MR>._>L6?2XM.T?XA:3;*PTFTA66TCW$K#*T)=U7Z'
M:<>] '9ZKK6HZ;JGA^U$=J\>HSF&X<;B01&S?)[97OFMXLJD L 6Z GK7$ZB
M1N\!?]?"_P#I.U4%M8/%,WB:RU._L[:XM[UT+30YGMXEP8G1RPVC'((&,Y/>
M@#T>FAE)P&!/UJM9QK+I-O%+*UTK0*&DD7:91M')'8GTKS'2+"#3OA$WB&S@
M;^TX8;B-;E68O'$;A@^.>,+D^QR>YH ]7#*Q(5@2#@X/2@,I8J&!8=1GD5QM
MEINEV^K:?X@MM6LXXS;2*(["W\M;F+:6RV&.=N,@^O'>L.R%M!?>"KVR"P6]
MQ/,(Y97#7,\;1.Q:5A@<G!(YYQSGB@#TXLH8*6 )Z#/6L*QUR\F\8ZIH]S';
MI;6=M%-$ZYW'>6'S$\?P^E<YI4.C^)-$UE]=E\J_MM2E^T3APL]MLDS&$;JH
M"@ 8Z\]R:M#2M/UKXDZU!J-JES#_ &;;9AEY7)+]5Z9';T[4 =N2 ,DX [T@
M92NX,"N,Y!XKRO1]3D_X1CP/;7MU$EG<^?'))=)YD1=,B)6&1GC.,GJ!Z"MF
M;PXUK9:A8:5K-K]HGOHKF.TDAVVJR#+&+:"<!MN2,^AQS0!WBLK#*D$>H-5'
MU.U75ETH2 WCV[7 CST165<GTR6&/H?2L/P5>1S?VK;2:1_9-_#=!KVV1@T>
M]HU 9".,,J@_7-4[BRL7^+\<D]K;L?[$,NYXU^^)U ;)[@<9ZT :WA;7+K68
M-1-^D$4EIJ4UFHBSA@A !Y/)/-;C,J#<S!1ZDXKR:]TRRN/!/C349(0]W:ZO
M>/;S$G="RNI!3^Z<]2.O>NAN)QJOC:72M1ELPK:9#):0WEOYJR;B_FE1N W?
M=!ZG [<T =U63=:Y&UKJPTUHI[K3$/F!S\@?;NVDCG..OUIGA.QCTSP]!80Z
MB^HQ6S/&D[CD@,?ESW"_=_"N7TBRL+>^\<2);6\4B3LL;"-05!MP2 >V>3^=
M '6^&]4DUCPYINHW C2>[M4F=(^ "P!. 23CFM(LH."PSZ9KRZRTZTL=#^'V
MJ6T(COIKFWADN,G>\;0OE"?[O P.@[5K^'] TN]\9^)7N;5939ZC!-;AF.(G
M$2MN'/7- '=;EW[-PW8SC/.*"RA@I8 GH,\FO,M%M(/$GABUU2\U:VL]0MKK
MS;B:.W_TJ*<.<H6W9.?NA<<C  Z5'XM>TGT+Q+J-B!OMM3C5[RY8&99D:,;(
ML8**O8D]VXP<T >D?VG:?VL-+$H:Z\@SE!_"F0N3Z9)X^AJU7&?8]/;XNR2/
M;6Q;^QDE#,BY\P3LN[/][H,]>E:GC.:R32;:&]\YQ<WT$44,;A!-(7RJ.2"-
MAQ\WMGO0!OJRNNY6# ]P<TBNK?=8'Z&O.[2V9]2\;Z4+VWTXS):JI@!$4,DD
M9!X]\ $\9Z\4ZU,LHUS1-2L8- UB;3XU:\M.;>:/<R+( ,$?,Q!!YQ]* /0E
M=6^ZP/T- 968J&!*]0#TKS=M2U'2['Q%;RZ+#IOB"#2?-6:QP8+B-=P$BC&0
MP+'@\\"M/2]+TR:^T37K+5K2,;&2);.WV&Z5ER5D^8EMN"W/((.: .UWJ6*A
MAD=1FC>N[;N&1VSS7GOAWSM(UK1K'5K&WNO/63^S=;M.MR"A8B4'G<5^;/<C
MZTFE"32M9TJWU:QM[ZVNYY#IVM6W#R&1'.R8'G)4MR#C@>E 'H>]<XW#KCKW
MI0P+%002.HSTKQ^?2K%?A9KM^+=?M5CJ%PUK.22\!6?C8>J_AU[UU<^G6FD_
M$GP^]A L#WUI=BZ9?O3[0A!<]6.2>3S0!VFY=^S<-V,XSSB@NJYRP&.N3TKS
M+1;6#Q)X8M-5O-6MK34+:Z\VXFCM_P#2HYPY!0MNR<_="XY& !TJTNA:9J/B
M?QQ#>6B3Q)';NJ/DJK& G<!_>SWZC)QU- '=7>IVEE=6=K/*%FO9#' G=B%+
M'\ !U^GK4UP95MY# $,H4[ Y(7/OBO-;6"WU&U^',U_#%<O*C)(\R!BX%NV
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M-!TF;['YVGP2?83FV+H&,7^[GIT'Y"B+0M+@:Z:*S1&O?^/@J3F7_>]:T**
M*UAI]GI=HMI8VZ6]NGW8TX5?H.U03:#I-Q>RWTNGP-=31^5)-L^=DZ8)^G'T
MXK0HH RCX7T,V4%D=-A-M;OYD,.#MC;U4=C_ /7I+_PMH.JWT5]?Z3:W-S"
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M[:VD<5Q<?ZZ5?O2?[Q[U>HH RAX7T$:S_;(TFU&H9W?:/+&[/K]??K23^%=
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !115&_UK2M*>--1U*UM&D^X)
MYE0M],GF@"]15.SU?3-1D>.QU&UNG09=(9E<K]0#Q5R@ HHHH ***IV>JV&H
M7%S!9W<5Q):,$G$;9\MCV)]: +E%%% !1110 453.JZ>-572OM<7VYHS(+<-
ME]H[D=ASWJY0 4454NM5L+*\MK.YNXH[B[;;!$S?-(>O _"@"W1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI^JZ@DDDL-TC8MDC.&8KP6R2-HXZ]>*@\'?:AXO\7"\\HSBYMPQA!"D>2,$
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M]1:W+B)1ILD4C+Y$@Y\WI\K;@IX)X&/4D FU[6=2T6'1?,M[.=[W4(+6X;+
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M?(#<Y)"@L6"C/.!G SV% &M1110 4444 %%%% !1110 4444 %%%% !1110
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M'94V$D@ D '/U]J .YHKF+36];.OV=I-9FYLKJ-_-GCL9H/LK@9&XR<,IZ9
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MV%X&9)(F4@$@X#*#S@C!YK,N-8O]8_MR'2FM8X=-+6[-/&SF:4)N8###: &
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MY],<9.X=?NSXKTW346$VFH6,ERI*'S$*[>,YP0=WI0!T).!DUG6?B'2K^_\
ML-M=A[@Q><BE&421YQO0D .ONI(KFKO6=5U7P5XK+26L,VG27=MO2%L.B1YR
M!O\ E8YZY('H:GTR?4['PSH$G_$O*-;QK)>RQ[%M(?*! (+Y8E@HX('(XXH
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MU=ZV8]\]B]C'#;L2L*/R[;B 2Q..<#&._-=)10!S/A_2/$]B(+35M9M;JRM
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MQV;VDEO/N4,K.'W!@#@@J.,&MZB@#D;WP,]UI,_EZAY.KRWXU);Q8_E2=>%
M4G[@7Y<$^I]JU]%M==3,^O7MK--MV)%9QLD2CNQW$DL<#T [=36O10!@ZMHM
M[?>*-&U:"2!8M,\[<CYW2>8H4XP., >^?:LF?P-<:C;:_;WEU%$-5NENX)(<
MEK>10H7KC=]T>G>NTHH Y]-%O]1U/3+_ %I[;?I@=HTMBQ$DC+MWG<!M &<+
MSR>O%2^+]%NO$/AZ;2[66*%IGC8R2Y(4(ZOT'7.W'XUMT4 8%QH^H3^+K#6]
MULL=K:R0-%N8EBY4D@X[;1]?:LEO MW=:9JMK<WD,4UUJAU2TGA!8V\O& 0<
M;@-OMG)Z5VM% & NC7U[K%EJ^J?9?M&FPR+;0P,Q0R. &<L1D<# &#C)Y-4]
M+\(2IX-O?#6JSQ2Q7)FQ+ ""/,8MT/<$\?2NKHH YS0=,\3VS0Q:WK%K=6]J
M,1M;PLDD_& 923CCK@#DXYXYL^*M$FU[2%MK:=(+B&XBN(FD4LNY'# $#G!Q
M6U10!SBZ)JG_  F$&O2SVLBQZ>UHT:AD+%G#EAUP,@#'/'.:RAX+UE--$,=_
M9B:/6&U-%9&:*3<S$QN.#P3D'U XKN** .+N/!^L3IXE5M1LW&O1(I_<LOEL
M(PA/4\8' _7UN2^'=3EU#PW=F6T!T57$BY;][NC\OCCCCGOSQ7444 <U\1?^
M2>ZW_P!>K5T,$L<L0:-U< 8RIS2RQ1SQ-%-&LD;##(XR"/<4RVM+:SC,=K;Q
M0(3N*Q(%!/K@4 34444 <MK<L;^/?"ZJZLR_:]P!R1^Z'6MK7;*XU+0[VPMF
MC22Z@>$/)G"[E(SQUQGI4Z:?91W1NDLX%G)),HC <YZ\XS5B@#D;KPQJUQHO
MAZQ6>S671;B"8R$L1-Y2%0,8XSD^N/>KVIZ#=OXDM/$>FRQ)>0VYM9X9B0D\
M).[&X E2&Y!P?I7044 <=JG@NYU#0M;@6Y@74-<E1[B8@[(U7:%51U. N,G&
M22?:M&\T;4;SQ1I&L%K9$L(I8WB#,2_F!02#CC&T?7VKH** ,'P[HM[I-]J\
M]S) Z:C=FZ58R<QDJ%VG(YX4<\4:EH=[/XIL-;LKN&+R+>2VF26,MN1BK97!
M&#E>_%;U% ''#PGJAT3Q)ISW%INURXFF5P6Q")%"X(Q\V HYXS[4MQX7URWO
M-/U;1]0LX-1@LULKJ*>-G@N(U.5/&""#D_CC/KV%% %33K>ZM[0+>W0N;EB6
MED5=JY/95R<*.@&?KDDFN>'AC5].UC5IM(O;06.KL99H;F-BT,I7!9,'D'N#
MBNLHH XC3/!NN:5_83PZI92OIEJ]JZRV[E K$'>HW??&,9XR/2B/P-J47AE-
M+74K9IK34Q?VLC0MM)$IDP_/.<]L8KMZ* .3OO#NOP:\-<T34[..ZN8$AOH;
MJ!C#,5SM=0IR",D8ST[UTEC!-;6<<5Q<FYF&3)*1C<Q.3@=ASP.PQ5BB@#D[
M;POJ6EPZMIVFW5N-/U.225#*&\RT:0?.% X<=P"5Q[U)J7A2=K3P_9:6\$5M
MHEQ%,HF)+2;%*A>!QD,3GU[5U%% #',ODDHJ>;MX!8[<_7'3\*XN/P5J<?@;
M3_#8NK0R6=PDIG.[#A9/, VXX)/'6NWHH YJ\\/:C>>*7U<7,-O')I;V!",Q
MD0LV[>IP.0>WXUFV7@[7(!X=,FHZ>#H3,J".W8"1&C*%C\WWR#GL,Y//2NWH
MH XW_A$=4.@^(],:XM,ZW<RSJXW?N?, !!X^;  ]*LW7AW5_MNB:E97-FEYI
MUN]M,LRLT<B,%&1C!!&T''OUKJ:* .0M_">JV^A>(M.:_M9GUJ:>17,;+Y?F
MKM).#SP,XP/J:=-X9U@V_AUH+RS6XT0;&256>&8>6$WXX(8<D?4\UUM% '#O
MX"OIM-U.VDU:))I]3_M.SN(H"&AGX.2"2".,8]#U-;$.D:WJ&EWMOK^H6K2W
M-L]LJV43+&@88+G<26;IZ 8]S7044 <?-X5UF7PWHUK]OLSJ&C7$4L#>4PB<
M1H4VMSGD$DD=^U*OA;63?:]>2W]F[ZQ9I;E!$RB-E5ER#D\#<>.2<=177T4
M<M+X2N+SP):^'KF\6&ZLHH5M[N $['BQL?!_W>1]:M:;:^)8K>6?6M3L&FCA
M9(1;PLD6<?ZR3)Y/'08 Y]>-^B@#+\.3:G/HD+ZN8FO,N&>)"BR ,0K 'D9&
M#^-:E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,^8#&@(PV<8.[T[5P^V.'X#ZHB!4C2>=5 X 'VDX%=9KY'_"QO"//_+.^_\
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MAOH3UKEOB#' W_"./,D9 UVV5F<#[IW9'/:F:3+!>?$37;2\2*6,65M_9R,
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MI&!3O[4T[?$GV^VW3.4C'G+EV!P0.>2/2G7.HV-DRI=WMO;LPRHEE521^)H
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M = &QD5:FGAMH6FGE2*)!EG=@JCZDTR*^LY[F6VANH9)X?\ 61)("R?4#D4
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M=+U/2+G48YX[1[:[OY[I)4G8N [9 *% ,^OS5K6^H65V2+:\@GP<'RY5;!_
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M.22UO;>=(O\ 6-%*K!/J0>* (O[%TDW$UQ_9=GYUP,32>0NZ0>C'&3^-1_\
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MCKAN/F_&G-H>DO8I8'3+3[)&VY(/(4(K>H&, ^XI=)U2VUG3+>_M75HYHU?
M8,4) .TX[C-37M[:Z;9RWE[.D%O"I:21S@** $CL+.*S-E':0K;,"IA$8"$'
MJ"O3G/-.M;6WLK9+:T@BMX(QA(HD"JH]@.!7+ZEXLEFM/#>H:1<0&VU2_@@G
M0J'=5D4MC(.%( P1COVKI[:]M+U7:TNH;A4;:QBD#!6]#CH: ()-$TJ:]^VR
M:;:/<D@F9H5+DCH2<=NWI3]1TK3M7@$&I6-O>1*=P2>(. ?49IT&HV-U/)!;
M7MO--%_K(XY59D^H!XJ6:>&W0/-*D2E@H+L "3P!SWH 6&&*WA2&"-(HHP%1
M$4*J@=  .@JI<:+I5W>K?7&FVLUTJ%!.\*EPI[;B,XY/YFIK>_L[MI5MKN"8
MPG;*(Y VP^AQT_&DAU"RN)5B@O()9&0N$256)4'!. >F>,^M $#:!HS1PQG2
MK/9;@B$>0O[L'J%XXS[5)<Z3IMY8"PNK"VFM% "P21*R#'3"XP,4^VU&QO9'
MCM;VWG>/[ZQ2JQ7Z@'BL;QGKYT3P]?36=]9PZA# TL<4Q#,P )X7(/8\\].E
M &O_ &5IPTW^S?L%M]AV[?LWE+Y>/3;C%166@Z/ITB266EV=L\:;$:*!5*KD
MG ('3)-/L=1MYX(E>ZA-SY"R21AQN (!)([#FIXKRUG@,\-S%)"N<R(X*C'7
MD4 )>6-IJ-N;:^M8;J%B"8YHPZDCIP>*BN](TV_\K[9I]M<>3Q'YD2ML'3 S
MT%13Z_I$&F3ZFVI6S6EN"9)4E5E7';@]?;K4VF:E;ZMI\-[:R(Z2HK85@VTD
M X..XS0!9CC2*-8XD5$0!551@*!T %5&T72WNVO&TZU:X9@S2F%=S$="3CDC
M''I3Y]3L+82FXOK:$0X\SS)579GIG)XS@XIQU"R%S';&\@$\R[HXO,&YU]0,
MY(H BN-'TN[OH[ZYTZUFNHEVI/)"K.H] Q&1U/YUS^N^&#<:IH"V&E6G]FZ;
M-))-#A44AD*@*N,'&<\XZ"NDGU&QMITM[B]MX9I,;(Y)55FSTP">:BN'G&KV
MBI?P10E)/,MF4&28\8*G/ '.>#UH S_$.B&?PCJ6DZ/9P1R7D+QJHQ&NYA@L
M?\YJQH6C6VG6-LQTZWMKQ(%CD:-5SG SAAV)&:MOJNG1D"2_MD)D\H;IE&7_
M +O7[W(XZ\U5N?$>EVNNP:++=Q+=S1-+L9P-H! &?<EN!WP: +$VC:7<7OVV
M;3K62YX_?-"I<XZ<X[=O2EETG3)[Y+^;3K62[CQLN'A4R+CIAB,BGG4;%;P6
M9O;<7)Z0F5=Y[_=SFHE>?^VY%-_;FW%N"+0*/,5MQRY.?ND8&,4 3-863WR7
M[6D#7<:%$N#&#(J^@;J![4E]IUCJEO\ 9]0LX+N'<&\N>,.N1T.#WI%U33WD
MAC6_MF>?(B43+F3!P=HSS@@]/2ENM1L;$H+R\M[8R'"":54W'VR>: (9-"T>
M83++I-DXGVB4-;H?,VC"[N.<#IGI1_86CB2"4:38^9;#$#?9TS%Z;3CY?PJQ
M=7=M90&:ZN8;>/IOF<*N?J36+X/UB\UFWU1[V:&8VNI36T3P)M4QJ%VD<GUS
MU/6@"71[/6)[S^TM?2SBN8HVA@AM&9U16(+,2P')VKQV"^_&V0""",@]JI2O
M.-9MT6_@2$PN6M64>9(<C# YZ#G/'>GMJFG(R*U_;*7D,2@S*-S_ -T<\GD<
M4 )::/I>GO))9:;:6SR_ZQH8%0O]<#FH8/#FAVJJMOH]C$J2>:H2W0 /C&X<
M=<=ZT'=8T9W8*BC+,QP /4UQVO>-5E\#ZAK?AR]MFDM6(&\>9E1)LR!D8SU!
M.>.U '3VFD:987$EQ9Z=:VTTW^LDAA5&?OR0,FHY- T66.:.32+%TN)/-F5K
M9")'_O,,<GW-68KVTGN);:&ZADGA_P!9$D@+)]1U%-_M&Q^V_8?MMO\ :L9\
MCS5\S'^[G- $?]BZ5]JBNO[,L_/@ $4OD+OC Z!3C(_"DCT328M3;4X],M$O
MG^]<K"HD/K\V,TSQ!JHT+0+[53"9OLD#2^6#C=@=,]OK65!>Z_+9:=J-M?:=
MJ%M=2Q><(8&&U&8 E&WG.,]QZGMB@#:MM)TVSNI+NUTZU@N)?]9-%"JN_P!2
M!DU<KC=4\8WGAWQ?%8:NENVCW$:8O(HF0VSNS!1(2Q!!V'G Q6YJ%WJ,.MZ;
M;VTMJ+:Z+B020LS_ "KGY2' _0T :U%<KI^N:EX@OM7CTV]L;9M,NGMA;30M
M([%?XW(8$*QSC [=^E;NC3WESH]I/J$:Q7;Q*9T0<*^.0/;- %VBBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"L\232Z=;>2KD#>VYQQZ\XKGX#%?_!6Z-QG^U(7D,O\ SV6]$IQ[[RVW'?!
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MHDF@GTR!9(F[CS)O\Y[&N=T(:MHOBW3O"VI^9<V]JLTNGWS?\M8-F-C?[2Y
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MM;_P+\\GEEO10V#SQD"@#L]-\037_CZ[TV'4+:[TY-/6XC$ 4[7,A4@L"<G
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M.\9Z<C- ':7.J:?9VR75U?6T$#C*2RRJJL,9X).#Q4\,T5Q"DT,B2QN-RNC
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M7RV).  V<'F@"1]-L)%*/96[*7+D&)2"QZGIU]Z%TZQ299ELK=9$ "N(E##
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MP-;@&823J#'G@9YXSVJMJWBS1])AL)9KV!EU&5(X&$@VLK'E]W3:!SG_ !H
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M5ZZ\0Z+9&<76K6<)ML><'G4&//3=SQG!Q0!/)I>GRS//)8VSRR !W:%2S =
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M>!R: (_[.L=A3[%;[2@C(\I<%1R%Z=!V%206T%K'Y=O#'"F<[8U"C/T%4_\
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M,CTXJC<^)="LQ*;G6+&(0N(Y"]PHV,>BGG@\'BK5QJ5C:11RW%W#&DHRC,X
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M4+E96BLYUE$"A0HR1W;&3_7K5O7-%U&YN[.YTJ6R5+<.'L[N$F&4M@;LKR&
M! .#PQJ72-$>UO3J-W#8Q71B,06RAV*%)!.2>6.0/3'IR: ,S7]5L+3QGIUM
M.\%C<M9RLE_<-P$+*#'&"=I<X!R<X Z'-<59SV$G@#PS;SRPOY'B14E67 V
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M-ND9&^':,2@@<@*H8-7H*P0HY=(D5SU8* 321VMO%,\T<$:22??=4 9OJ>]
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MC[3$S Q%/E+,=H4  Y^45Z/]DMB #;Q8'0;!2O;023),\,;2Q_<=E!9?H>U
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MMC#L4*Q4G<QY;E1C@8YZYH I>/(7M]-M?$-NA:XT.X6ZPHY:'[LJ_BA)_P"
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ML+VV#.I4$9A8/D_7&?>KMQ/<Z3J<MWIUW!JVDW.L!+G3IAB>VN#* 6C(Z_,
MVT]OSKOOLEL0 ;>+ Z#8*!:6RW'V@6\0FY_>!!N_/K0!P-P)Y/$GC^#2647\
MFFVXB6,C<7\N3I[\C\2*COI;75_ GAB/1V3[?'<V@MHT^_"Z8$@(ZC: VZO1
M%@A20R+$BN>K!0"?QI$M;>*9YXX(TED^^ZH S?4]Z .!@73G\1?$'>+8D0Q
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M?0PN$4,H,$;+R)%51CG  /?IWKLZBAMH+<N888XBYW/L4#<?4XZU+0 4444
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MPM/$3:\MM$K2/>63HAB6(LP09X*D8!W9.>>.P7PM?62>+/&+&Z@54NXG8[P
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MK$,S)L6$>3-F8HO#<@%2N#GOWJWHGB1?$WARXN(&DL-0M@T=U 0"]M,HY!#
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M7$ZR?%:XBMIHTNW\.E$!89#^<2 ?<=?I6'YL-_\ !Q=$48UJ+;;BT)Q.MT)
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M#6VK@#:,#H,=*7ITK-D\1:1$;(-?Q_\ $P -IMRPGS_=('-6A?VIU!M/$O\
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M;C>^!;@,57^+##!]^#BI-!UO1]=\0Z#<3:[IHN]/M7ACM[>1MT[NJ@YWJN
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M!E7=@12D<$XR0>O!)ZU@Z1,]IX2\":FYW:=IT[B^QR(2RLJNP[!2W)[9KU8
M#H*6@#@K[RKKQ9K&M64\;:<N@M;W$Z.#'),6)49Z$A?RW =ZREN[*+P9\/\
M$\"&&_MC)A@-F(W#Y].2,Y[GFO40 !@# I: .=\?V=_J'@75K73%9[F2#Y43
MJX!!91ZY4$8]ZQ]6O+3Q1/X5ET.5)+B#4([F01GYK> (WF*X_ASPN#CGBNZI
M  ,X'7K0!R&@7MJ_Q(\41K<1EGCLP@##YBJ/NQZXR,^E=A110 4444 %%%%
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M[:^(=*O+N.UANCYTR&2%9(GC\Y1U*%@ X[_+GBJV@^*+;7[W4K>"&>,65R8
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M?H?V"]OS=2BWL)3%=.;64>4XZ@C;GCC/ID4 ;=%4#K5@K6:F20&]4M#F!\$
M9))Q\O'/S8K NO%=AHGA/4-:M;^XUF-+B0(VTN$<MPF0  BD@9_#).!0!UU%
M<=K&O-:>,/#\IO[BWTVZANS-#-$8AE%7:=K*&SEN >O&!72:5K&GZW9F[TVY
M6>$.8V(!4JPZJ00"#[$4 7:*P;SQ1!:^++;0#;W)>6W:9I5MW8#!4* 0#G[Q
MR>@P,FL70/%EKIG]NKX@UEF\C698(7F&2D86/;G:,*N2>2 ,F@#N**I7NK6E
M@569I'D=2ZQP1/*Y4=3M0$XY'/N*?IVHV>K6$5_87"7%M,,I(O0]C]#GC!H
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M"DT,BR12*&1U.0P/((/I6?%XBTV:>&**65S/O\EA;R;)-H).UMN#P#T//;-
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MB!R7+#(X R.!GG% &A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK$IYHNHY!';,HP7#L=O.#MQR<CMDT =Q>7EOI]J]U=2B*%,98\]3@  <DDD
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M"(O]$99;E@ZDMLQNP%'4^A[8R =/8^)=+U'59-,MY91<I%YP62%T$D><;T+
M!ESW'%,M?%>D7EQ:0PSN1>LZVLIB81SE<[@K8P>A^N.,UCZC.Q^(VEW4%O-+
M&NF3IN$3!-[%2JEL8!.#UKG8;JXO!X5OI-.U%);6_(NK:.Q>.*TRC@(B  $9
M_BY]R,XH [&?QWX?MX[MVN+AELI?*N=EI*QA. 26 7A>>IX]*GO]1TMM<T6&
M34+F.XN"[VD<)<17 V$G>0-I '(!/7%<L"QTOQ_&+:YW7;S&W'V=_P!\# $&
MWCYLL".*>6=KCP PM[G%LC>>?L[_ +G]QL^;CY?FXYH ZY_$%@EQY69F'V@6
MWFI"S1B4G&TL!@<G&>F>,YXJE/XWT.#[=F:XD.GMMN5BM)7,7&22 O"@?Q=/
M>N<E@N+/7GO?#TMW')/JFR^TBYB9HI1YF&G0D?)P-^X'';KP;%JY%]XZ8P7"
MK<;3"3 _[W$ 0[>/F^;CB@#H(_%^BS7MG:QW+M]NXMIQ _DRMC=M$F-I;';/
MMUXK8FFBMX7GFD6.*-2SNYP% Y))["O.9?,7P=X%B-M=>;9WMHUP@MW+1!(V
M5RPQD $BNJ\<Z7>:WX*U33M//^DSP_NQG&[!!V_B 1^- %FW\3:9<7EO:;YH
MI+M"]MYT#QB< 9.PD<G'..N.<4T>*]'.G7^H>?+]GTZ5HKH_9Y,Q,H!;*[<X
M (.0,5@:G(?%H\-+96\\-Q:ZC#>7(DA:,VJHK;U;(&"20H'?KT&:RKR26RTK
MQWH[V-Z]W>S7%Q;K';.RR1O"H#!\;>H/&<]AD\4 =5=>+K>'7],TR*WN)$OH
M'N/.6!V&T 8 P,Y^8$^G?K5]O$%@+A8@9F#7'V82K"QC\W."NX# P<C/3(QG
M/%<OOFM]<\(7[V-Z85TZ:W?;:N6CD*QX5AC*YVGDX''7%5_(N+/Q!]K\/37:
M_:=5*7^D7,3-$P\PAKA"1\G3?N!P>._% '4Z9?Z9/K>L_9[^YDF@,0NHIRPC
MM_E.-@8 #(&21P>M8'B/Q EUJGA@Z==7L<=UJ<:Y"O'%<1;6)YP PSMQGJ.1
MD<U3OK"]U/4/']I913)+?6T"6SM&R+,5A*L%8C!Y^7KWIE]K*ZM8^$A#INHI
M-9:G ;N$V,N8-L;A@?EYP?3/% '8ZCXGTO2_-:ZEE$4#A)YDA9HX2<8#,!@=
M1],C.*UE8,H92"",@CH:\XMS;6&HZQHFOZ'J-X]U>S3VK0Q22174<C;@IP=H
M(S@[L 8ZUZ%:Q>3:0Q>6L6R-5V(<JN!T!]!0!-1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M5>^OK;3;*2\O)1%!$,LY!/L  .22<  <DF@"Q167;>(+.XU(Z:Z3VUYY7G)#
M/'M,B>J]C[C.1W%<SILS>+M7UF*YDU2T:SOECM9(&:+R%1%)![98EL@@Y! ]
M* .ZHKCOB/<366FZ9<P7MQ:%M3@AE:*X:,&-B=P."!T[]1ZU?M4TE];M4TW6
MKB6:)7FD@&H27"R1XVX8,S8^9U(_W: .BHKFI/'VAQVEW= WCPV4[07++9R'
MR2N,EAC*@9[^A]*N0^*M+GU>WTQ&G$ETK-;2M RQ3[1DA'(PV!SQQB@#9HK%
MOO%>EZ<&DN&F%K',();L1$PQ/G&&;Z\$] >"0:BNO&>D6NHW.GD7DES:F,2Q
MQ6DC%0Y(#<#E>/O=.1SS0!OT5B7WB[2M/BN[B9YFM;&40W5S'$72%^/E..3U
M&< XSSBK,NNVJ)%Y<-U/++&95@2W82A!QDJP!7Z'!/;- &E618Z'+;ZM-J%Y
MJES?DLYMHI554ME8\A< 9/ &3SCZG-;_ (3?03;:?<+=2/%J3%+=E@<Y89RI
MXX88(V]<]!37\::>='U:_@M[MY-)4FXM7@:.5?EW D-T!'.?2@#HJ*Y:X-_X
MK\$V\MI/?:=?2QQR*]NWD_/M!YSUCR><<D#O74*"% )R<<GUH 6BLJW\0V=U
M<6T<4<[1W;ND$_E_NY"H8G![?=.,XSVS5#XAO+%X$U::">:"6* NDD,K(P(]
MP1Q[4 =)17/W%]IR:OX?M+JXNTO9E=K9(]XCD(C.[>1\IP.<$YSBIM1\5Z7I
M:SRW#3&WM9%CN;B.(M' QQ@,1]1G&<9YQ0!M45FW^NVE@9%\N>Y>*(32I;1E
MS&ASAC]<' ZG!P.*IOXTT-7T]4N)9O[2B:6U,4#L)549.,#D]MHYR>E &]16
M+9^*]*O=+FOT>:-(+C[-+%+$R2K,2 $*GG)++CZU837;3RKN2X6:U^QE1,)H
M\$$CC&,[LY &,Y/'6@#2HK+LO$%E>:K)I96:WO8XA-Y$\>QGC)QO7L1GCU'>
MIM0U:UTZ:V@EWO<7;%+>"-<O(0-QQV  &220* *=UH$UQXKM-=%\JBUA>!8#
M#D%6(+'=NZ\#''X&MJL"7QIHL&C?VM+-,MNLYMWS VZ.4-M*MQ\N#QD\>]6=
M/\2Z?J6K3Z7$+B.ZAC$VR>!XO,C)QO7<!E<\9H UJ*X/Q[X@AG\+M+ITMZN+
MN**.[MRRQ.WFJKKN!Y&-PR?E)& <UV]S.+6VDG9)'6-2Q6-=S$#T'>@"6BL
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MM958IB-?,3"Y.UEW<<\5!<:9XCF\/ZM9Q2SZQ!8W%K<:?)=Q^7-=*C!WB8D
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM[6807%VJ@Q0R''RL<Y[C) (&>2*LW^L6]C=0V8CEN;N=6>.W@ +E5QN8Y(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,ER\FHI(DZQ,RV\G_/4JF"[8Z ]<>V*[NB@#R7P?%.?$_CJW9+N26[A#0M/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*VZ##+',6("L"1D#GGKC% &U]A7_ )_-1_\ !A/_ /%T?85_Y_-1_P#!A/\
M_%UFC6[F#7I=,NX;?RX;7[6UPLC+^[R1]S!Y!'][IS[5!-XEN;?1[?79;6,:
M;,5+ ,?-BC8X5SV/49';/4T ;/V%?^?S4?\ P83_ /Q='V%?^?S4?_!A/_\
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M% %;["O_ #^:C_X,)_\ XNC["O\ S^:C_P"#"?\ ^+JS10!7^Q#_ )_-1_\
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M(KEO,YPPY Y'\N:MZ7=S7UD+F5$179O*V$G<F<*WXCGZ$4 /^PK_ ,_FH_\
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M_P#BZLT4 5OL*_\ /YJ/_@PG_P#BZ/L*_P#/YJ/_ (,)_P#XNK-% %;["O\
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M2VR0 "5MXVDG.-N.^.M5;^PM]2\56,]M<J2L3"\2,@AXT8,@;T._\QN%=O\
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M (%-1_PAMA_S^ZC_ .!34 9=%:G_  AMA_S^ZC_X%-1_PAMA_P _NH_^!34
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M8+)ITS-(P=V,VY2I<G ^;G.._J*LMX;NYX]<L9I819ZG*TR2*29$8JHP1C&
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M?\_NH_\ @4U &716I_PAMA_S^ZC_ .!34U/".FR%@FH7[%#M8"[)VGK@_F*
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MOLUTDPDV\LA/ 5\<^G7FL>Y\-ZYK5QXK\VT&G+JT5LUI)),K%9(ER P7./F
MSU[XS6[HVH^*+L+_ &MH*6'D*3+LN4E-RV, ( ?E&><L1T YY- ">&?%4_B6
M*VNH=$N;>QN(W87,DB8#*^W;MSGGUZ=?K53Q9#%_PF'A&?RU\W[;*F_'S;?)
M8XSZ9JUX T^_TCPA::;J5FUM<6Q<,"Z.&R[,""I/8]\4GB6PU"[U_P /75I9
M/<0V-T\L[+(B[5*%> S D\YH GN/$LA_M%]-TYKZ'2W,=RRRA6+A0S+&"/F(
M!&<E>3@$G-9M[XMN;G5_# T:&.XL-6$LN]I-K.%B8[,8XP2"?=<4NEZ?K'AN
M^UR"#3FO[;4;N2]MI4E1=CR#YDD#," ",@@'C/?BJ4/A+4M A\(+80+?_P!B
M^<MP!*(\F5""P+?PAB??':@#?'B1KB\N(K&S%REI>1VEQB8"1&8J"VS'W1NZ
MD@G:<#'-:6J7S:;IEQ?+;2W/V>,R&*+&]@.3C) SBN0U?PY?:CJO]I6>ER:;
MK,5VHCU*"=!'- '&?,4-EODR,%<\#G&<=R1D8- '/#QC;E="D%E,8=< \B7>
MFU&*[@K<]<>F>>*C\0Z_;0Z)KC7FBS7MG8#RYTW)MF!4,<9/0!AGOZ9Q6 _@
MC4_[!U*R4J&TR=I- P>4^<3#]<1\] #V-;FMZ/J$WP]O=+@@^T:C>P/YBJZJ
M#+(27.6(^4$G'MB@!NH:]J-MXFT#3+&RC^R7L$LI'F[2=B#Y>G &X'WQVQSC
M:=J<GAW5O&4]CH[W45O>+-*D++&J((59B,]3U. /RXSK7^FZNVL^&-5MM.\S
M[#!-#<PO,BF,NB '.2" 5.<9/L:KQ:5K"CQENTN4'52QM/WL7S_NA&,_-QR,
M\]J .OL;R+4+"WO8"3%<Q++'D8.U@"/T-947B%]5DFAT.W6X\ES'+/._EQQL
M.HV_?)_  _WJG\,6]S9^%],L[R!H+BVM(X9$9E;#*H4D%21CCBI[[1K'4)!-
M-"4N%&$N(6,<JCT#K@X]NA]* );*&ZAA87EV+F5FW%EB$:K[*.3CZDGGK7.:
M%:VTOCOQ3/);Q/+'/:['9 67_1UZ'M71V-O<6L+1W%Z]V0WR22(JOM]#MP">
MO.!_6L'P_P#\CKXL_P"N]K_Z3K0!S.H67B-_%3>5'?;V2X:)1=QB?R/-BR$E
MV[4!."%/S 9&X9 K5\?V^J221/;I,;$" 3%Y T+/YZ[1Y0&\L#@E@0,>O2NX
MHH YFWT^9_!<T>N6TDMU'',S?;)$N&#?-R&4 8].!@8&*M^"O^1&T'_L'0?^
MBUK0U;_D#WO_ %[R?^@FL_P5_P B-H/_ &#H/_1:T 9VK>/[#2XKF["1SVEG
M/Y,[+<J)<AMK%(^K '@\@\' (YJS>^,[33]6.GW-I/'OM'NK:<E?+N0O\*<Y
M+\CC%9NEV_BOP[=WFDVNDPWUA-=2SVE\URJ" 2,6*R)]XX)/W>OMVE\3Z-J/
MB)9D6&>VETI5GTVY'EYFN1R&Z\*,8P< [B>PH T-6\5-HUKIDUSH]YNU&X2W
M$2E"T3L"0#AN3@'IQ[BH],\6R7NJ7NCWNBW-EJ5M +A+9I(W\^(G&Y6!V]>#
MD]^O6L7Q/?:E<:1X5N;_ $I[6_&N6WFVOF(<L%?.U@Q&#VR1[XK:ATZ[N/%L
MOB2:RDA6"P^R06[.ADE)?>S'#%0. !D^N<<4 4+'Q?I^G>$-#O\ 3]#FBLM1
MN$MH;>#8!#O<@9&><\G '7O5]/%EQ%J6G:?J>A75A+J,LD43O+&Z H">2&ZD
M#('>N<MO#VO6W@3PUI9TF1[O2]1AN)T6:+&R.0L<'=@Y!XKIO&U@-0\)W,HD
M^S7-F!>6TK=8I8_F7IGZ<9ZF@#3M=2^U:E>V:V\BK9E5:8D;69E#;1SG(!!.
M?45>K-T&SGL])B^U[?MDY,]R5Z>:YRP'L,[1[ 5I4 %%%% !1110 5E6?_(S
MZG_U[V_\Y*U:RK/_ )&?4_\ KWM_YR4 :M>?-JE[9>.-/\0S3$Z1K3MIL:'[
ML>TYA?WWL'(/HPKK/$;:B=&FATNUDGN)QY>Z-T0Q*>&<%B.0,D>^*Q/$_@O3
M[WPC<VFEZ0D5X(@;01;4>.1<%?F)P,$ 'GIGK0 OQ"AB>#096C5I(]<M-CD<
MKE^<&G)!%%\7I)(XU1I="RY48+'S\9/J<5!K-MX@UGP_H8FTAQ?VVH6UQ=QB
M:+ $9!8J=V#GL/SQ5\66H'XC#5?L$@L3I?V7SC(G$GF;_N[LXQQG'7\Z *OQ
M2ABE\ 7[21J[1O"R$C)4^:@R/3@FMJ[UHIJW]D6-N+J]$'VB16D\M(TS@9;!
M.20< #L<XJCX]TZ^UCPA=Z=IMJ;BYG:/:N]5 VR*Q)+$=E-02Z?J>G^-#XAM
M;&2ZMK^S6WN;=7C$L+J<JPW,%(P2" ??F@"GK/C>=_"TE]I5J8[J*^2QNHIW
M >V<NJL.,@GG@],'/M6W/X@FCU'^RXK*.34%M?M3V[7 4E"S* AQ\QRI] .,
MGFN<U#PCJ<OAS5Y88%;4=0U1-0%L9 ,*CH0F[INVKR>F3C/>KGB719O$+#[9
MX?F\Z.U#VEY:7,:S6TV6RNXLIZ;#QD9)Z]: .LM)S<V<-PT;1&6-7*-U7(S@
MUACQ6TD5M?6NESW.F7-R+=+B$[GY8KYFP#_5Y'7.<<XK5TJ"\AT6SM]2F$]X
MENB7$J]'?: Q_/-<MX6M/%6@V4?AI],B>UM7*0:K]H7:82Q(S'][> <8Z=.?
M4 T=4\8?V9#>WDFFRFPL+I+:>9FV.2Q4;D4CYE&\<Y'?&<5+>^)Y;?Q(V@V^
MCW%S<_8S=1L)$57&X+C)/ R3R?3@'-<QX@T#Q+J]AX@M)M*CN[B:Y$EA=O<H
M%6 .I6-%/*MA2#T!R22>*W5M-5/Q!AUF32Y!:_V2;5V2:,[9#('Q@L"1@8SC
MK[<T :WAW7(_$.D+?);O;.)'BE@D(+1NC%67(X/(ZURD%U<:1\0/%3:5HDE_
M+)#9R-%"Z1#[KY)+'J?Q)K;\$:??Z9IMY;ZA9O;/)?SSIN=&#*[EA]TGD9YS
M44=GJ>E>--7U2/3)+VVU&"W6-H)8P4:,,"&#LO7=U&: );?QOIEWHEAJ4/R-
M?R-%%#<.(BCKG>')^Z%VG)Y[8SD58\.^*+;Q!/J%HJ+'=:=(J3HDHD0AAE65
MQU! /8'@\5SK^$];T;3-)O\ 2UAO-5L+N>ZN+8R;$F$^?,16/3&1@GTS[5UF
MCW&JWD;W&IV"Z?NP([7S1*RXSEF9>.<C@9QCKS@ %*[\3RP^)7T&WTBXGN19
M_:D?S$5'&X+USP,YY//'0UF-\02N@-K1T*Z%K:RF*_)D0&W97V, ,_/@\\8&
M#ZY N/8Z@OQ'_M86$C6(THVOFB2/F3S-_0MG&.,XZ_G6#)X?UR3X?:_I TJ0
M7E_>3R0H9HL%9)-P).[ P.O]: .JU37YK*YN8+;3GN3:6GVN61W\M-N3A5;!
MRWRDXX'O5.7QK"&T+[-IMU<IKD1D@92@VXCW[2">O3V'KQ5'4K#7]1U>X$VD
MBYL+BP5+5)KA%2TFP=Q=03N8Y&& .,8XR:IZ?HNO6Z>"A-I#C^QD=+K9/&=H
M,7E@\L,\\\9X]^* -NV\8A].U:>ZTJZAN])E$4]G&1*[$@%-I'!!##Z<U:M/
M$0?6KO2+^V6UN+6V6Z+)+YB-&21G. 000<C%<[=:5XG27Q9-IEG);SZC+!):
M2&>-2ZHJJZ@AB48@-@]O4&I;#3+W3_%<VM3:+;Z?IDFD^5-ON4/ELKLQ,F,Y
M)!Y/(QR3VH O-XW"V>EWXTF>2SU>40VC1RIYA8Y*;E8@+N )'S'WQ3]8\;VN
MEB^>.**X333BY4W*1R9P&(C4_?(!&>1Z DYKF-)&H:9I.FSZKX4U!]/TTFZB
M\N\ADBM^"=ZID2$*&. Q)'U%;<$'B?P[K^IQV&D1ZKINI7)NHI?M2Q&WD8 ,
M'!Y*Y&?E!H UAXC@U&6&UTF!;YY[-;M@[^6BQ/\ =W'!Y;G QV.<5F?#(*/#
M5T%@-NHU*ZQ"0!Y8\P_+QQQTXI/[.UW1?&,FL067]JV^HVD4-V(9$C>*6/(#
M .0"IR> <_UN^"-/U/3=.OH=3M%MGEU">= LH?<KN6'3Z_\ UA0!/JWB273I
M-0$.FR7":;:BYN)'?RU*G<=J$@[FPI..!TYYI?\ A)X;B;3[>PB66?4+/[9"
MDTOE9C^7@<'+?-T]CDCOC:_I.O:CJVL0/IR7UC=60CT^1[A5CM7V,'+(>2Q)
MR& /89'-0-X>N-1T#2=,USPW)*+2QC1)K6YC$]K,H"Y#%EZX!X)' SGL =I8
M7+WNG6]S+;O;O-$KM"_+1DC)4^XZ5Y_HNLGPO!XLN+;1I+FTM=9FEF\EDC6*
M/9'G /4]3@?F.*[7PY;:C9>';&VU>X^T7T<0$TF<EC[GN<8&>^,UR@T36V\.
M>,;-M*D6?5[J>2U'G1897147)W<?=R?KWH Z6[UZ1;E+>PL'NF:S-YYCMY<6
MS. N[!^8^GH.2*I?\)O:MIFB:BEC<M;:S(D4<F5 B=N@?)XY!&1FJ!L-?DU'
M3TN-)^TZ<NFI#Y$MPBI;W ."[KD[Q@#!&['H#3=*\*W]S\+5\-ZG MI>10E(
MF64/MD5MR/D=/FP?I0!T-]JPBEO[8Z=-=):VHFDV%,.&S\GS$<X4]>V/45C6
M_BVST[P]X=FL]$F6UU4QPV\,)3$.Y20O4<X![8]2*T-.M=23PI-)?0>9JU[$
M9+B*,J/WC*%"@DXX 4=>U<\FAZW%X:\(67]DRM-I%W%+=*)HN%1&4X._!SNX
MH W[#Q9'*VLQZG8R:=+HR":X5G60&(J6#@K[*>.V*B'C!UGT=)=(G*:TNZT,
M<J$CY=^'#%0IV\\%NA%4KBWNK+7/%6IWVG*-.O+"-$DGE3RW\M'!5@"6 ;?C
MI6;HXU'2AH\FM^&-2\K3D6&"9KR"9+8N A(52&(QQSD@4 =-XZ_Y$/7?^O";
M_P!!-17UA<1>%(8M!MGANG\EE^R21P'/&68LI!'J,$D<8J7QU_R(>N_]>$W_
M *":U]/_ .0=;?\ 7%/Y"@#C_A_;ZE'%))/'.+)HW%N$D"P@^:VX>41N5\Y.
M22"".G2LO2++Q$OBE?.CO=R+:FY'VJ/SA%YDNT22;0L@'.Y5P<%1EL&O3**
M.3UJUMH?'_AB:*WBCDE>[\QU0!G_ '/<]ZW]6U2VT;3I+Z[;$:%5 !&69B%4
M#.!R2!SQ6+KW_(\^%?\ >N__ $35OQ?I%YK7A^2#3I4BOH98[BV:3[OF1N'
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M%G9V^GV4%E:Q^7;V\:Q1)DG:JC &3ST%8USJR1^,]/TV324::>TEEBO&9=Z
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M4&39M/RC)/7D U5U;QQ'8K?O:16MRNG2>7+$]V(YI" "PC3:=V,XY(R01[T
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M^V6%IK%X]PR7"QE$#\[$P=V ,]O;/;J+GQC:,\<6GR6;R26B78:\NA FQ\[
M#@DDX/;@?44 =)167X<UR/Q%H=OJ:6\EMYN0T,OWD8$@CW''![BM2@ HHHH
MR--_Y&#6?]Z'_P!%UKUD:;_R,&L_[T/_ *+K7H **** "BBB@ HHHH ****
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MW8&X]23@#MVR<)M*UK2/&M_K&F6T-]::O'$MQ&\_E-#)&-JL#@Y4CKWKK**
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M"4+FW#YVN!RQV97:01TY'(J6#3O%.@:WJ*:5:V5]INI7+72//<&-K61\;\@
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M6U8,H92"I&00>#0 M%%% &1IO_(P:S_O0_\ HNM>LC3?^1@UG_>A_P#1=:]
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M-7BD=(?.)FMBJ;P)%([@'Z$8YZTNIZ+K-WXLBU6U^SV\:Z9+:"0RDO'(Y!#
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M34+2&VO2&W0QS;T!!./FQT(P>G&:\]OM2U36/ACXHN-56W?9+<HI1R=I1]H
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MK&U$:[?+M)&D\UO[Q) VCK@<]>O% #/%&K'2GT@-IT-Y'=ZE#;;I'P869N'
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MU%%% &1IO_(P:S_O0_\ HNM>LC3?^1@UG_>A_P#1=:] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M9&H_\C%H_P#VW_\ 0!6O61J/_(Q:/_VW_P#0!0!KT444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVX:%R6MI7&45L\,#TW#&#VJM)XMU.&S\1F2RM1>:&P;R3(P$T13<K XX+#(
MYY!% '7T5A6&N3ZD-'>U6WDCO[8W,S G]VF%QCU.6 YQT/IBMV@"&YN[:R@,
M]W<16\0ZR2N%4?B:99ZC8Z@K/97D%TJ'#&&4.%/H<'BN2TZ9]9^+&L1W?S1:
M';0I:1-T5I%W-)C^]VSZ4>.YFT76_#>MV8V7$NHI83[>/.AD!RK>N",CT- '
M;45Q<_B[73'X@:UTFR)T.0[_ #+IL2($#G;A?O$>N ..O;4C\2-J,^GVFF1(
M+B]L1?DSD[88C@#('+$EL8XZ$Y[$ Z"BN9/BB]MK*RCU'319ZE=W$D"Q%BZ
M("3(-HR5P!@8SD@<#FK/AS7;O5;C4+6\L7@DLI%59UC=8KA&&0R[@#D8((YP
M>_- &X3@9/2JUCJ5CJ:226%W#=)%(8G:%PP5P 2,COR*P+K4-7_X63:Z;%)
M++^S9)]C;LD^9&I)]QV^I]:Y[3]9U/0-/\6ZE8V%M/;VFMW$T_FS%&9<)D(
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M6SO4\9V@XR,9P:K>"=#U2QOYKV^7,;?:(U,I>.13Y[$GR\E"K_?W?>Y Y'-
M'4V.KZ;J;R)8:A;7;18,@AE5RF<XS@\9P?RJY7,:3_R47Q%_UZ67_M6NGH B
MN+F"SMWN+F:."&,9>21@JJ/4D\"BUNH+VUBNK659H)E#QR(<AE/0BN-LM0U:
M_N/&$5\\#P6I:%%7=\B^3D 9^O)]:K>&=?U+2O#_ (1BGL8/[-OXX;-9!,3,
MKF,E6*XQM.T\9SW]J /0*:[K&C.[!549+$X 'K7)ZEXRNHH[^?2[(7BV$[0M
M!LD,EP5(#["JD#!R!G.<=JZFWF%S;13JCH)4#A77##(S@CL: &6-_9ZG;"YL
M;F*Y@+%1)$X920<'!'7FK%<!X5UI-#\$QN(A+/=:O/:VT6[:'D>=P 3V Y).
M.@-;O]O7UKXB30;^&W$]Y;O-8W$981R%?O(RG)!&0>"<CTH Z*BN!T'Q;?6?
M@"WUO5Y('^T7;1F<[@L6Z=U+/Z*O8#V&1UKKM(N[J\AFDN?LSH)<6\ULV4GC
MVJ0XZXY+#&3TZT :%%8,^MWL'C"/0Y(($ANK1Y[6X+$EW4@,A'J,YZ]*H:1X
MNO-7\/M>16]I]N%_]B^SB1BH8, 3NQR-IWY Z4 =)_:-D+J:U-W")[>,2RQE
MQE$.<,?0<&JS>(M%32_[4;5;06)8J+@S+L8@D$ ]SD'I5.PU>:X\8ZEI,UC!
M$;6VAE6X1]S2JQ;&>!C&#QS]:X:51_PH741@8$\V!_V]F@#U5W6-&=V"JHRS
M,< #UJ"QU"SU.V%S8W45S 6*B2)@RD@X.".O-6:\PT#7-9\/^#)M1M=)M[K3
M;.]NFN<SE9BGG-N*+C&%'J><'CN0#T^BN8O/%AEN)[?25BD>"WCF+2I(RN7!
M94&P''&"2>F1P><:^@ZH^LZ):ZC)9S64DZ9>WG4AXV!((.0.XX..1B@#0HHH
MH **** "BBB@ HHHH R--_Y&#6?]Z'_T76O61IO_ ",&L_[T/_HNM>@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@#*U#1M2;QE9:Y8O:F-+1[2=)V8$*SJP9< Y/RXP2/K6/_PBFN-X;\3Z8WV
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MJ[0!RB^']9M;_P 1M;-8O;ZO^\B,CNKJ_EA-K *0!D9R,^F.<BHWA;6QX?\
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M1[+51PLZJ8]X]/W>%_$UTE% '/6VD:G!XUU'62MH;6YM(X(U$S;P4+$$C9@
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M4$ 9/0'\OUK$'BK6[+5='_M73K2/3=89889()6:2&5ERH?(QS[=/4XYT/'Q
M\ ZYDX_T*3_T&J]MH]]K-OH#ZDMM';::8[I1#(SM-*(RJ$@J-H&XG&3S@?4
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MUSCB@"Y1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 9&F_P#(P:S_ +T/_HNM>LC3?^1@UG_>A_\ 1=:]
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT1.L5_9+*&Z*4B(?.>."0#Z&M"YU"TM_&'C!Q$E[_P 2F)FM$89G*K)N7\B
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M.UF^4@=3@#CD D\=:GM=5L/#UO/!J&MSW80^?NFB9GMH7^Z)"HX'!PSX/Y4
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MD<GU'K5&X\=^%[56:76K<*DQ@9AE@KC&02!P/F'/3GK0!OX & !CTH  & ,
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MZ,?F", C<HZX)&#CN!R.].G\1:3;726TUV$9Y?)#E&\OS/[GF8VAO;.: -(
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ML+B;1[66"UNKEIP\I?,[,!NDP_S $C\<9[UMT4 %%%% !1110 4444 %%%%
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M *+K7H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K(U'_D8M'_ .V__H K7K(U'_D8M'_[;_\ H H
MUZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM5MKU)K.8@1R1@L78G&T*!DMGC&,U)INLV&K-<)9S%I+9]D\4D;1O&2,C<K
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M1GUFSDV&U<SF*5E;*RAL[ O0Y^N,\9 .P\3:[:6FE:E E[/#<P6[,TEO$SF
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MQX)Z#N:T_!$D9'B=0"'DUBYF7*D;T(7:P]0<'D4 :,/CSPQ/<6D$>JH6O2!
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIW$%SHS1"ZN+9T#/YH8\%0$&/8#TR3SWU1W"226\B0R+'(RD*[+N"GUQD9H
M\KTV./7O@MI_A^TC=[^X")&GED&,B;<9"<<* "=W?IU.*Z+3M0M-/^)'BG[6
MY0-;V6UMA;.$?(X'4YX'4X..E;_A?0V\-Z!;:0;H7*6H*QR>7L)&2>>3SS4>
MG:!/8>)M4UEKY91J2Q*\/D[=@C!"X;=[G.1^5 '$0:9/HND>$X;BUGCV:R]X
MT*PLWV:)O,*[L [<;ESZ$GTKH[QIM'^) U6\20Z;>Z<+9;A4++!(KEMK8^Z"
M#U/?BNOHH X[0O#XOH/$YO(7CL-;NW,43J5)0H%,F#R"QR1GG@&G^#[75[C2
MV_M=6BN[&%]-AD/\>TD-*/9L)_WQ[UUU% 'FGAG[%)IMAX>U7P_J#ZOI[)&8
MI5E, *' F#YV!<<_H >*(;J;2] \7:!J5I=_;YY+R:W9+9W6Z21258, 1['/
M2O2Z* ,GPJ6_X1/25>*6)TLXD=)8V1E8( 000#U%:U%% !1110 4444 9&F_
M\C!K/^]#_P"BZUZR--_Y&#6?]Z'_ -%UKT %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5D:C_R,6C_
M /;?_P! %:]9&H_\C%H__;?_ - % &O1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !659_\C/J?_7O;_P Y*U:RK/\ Y&?4_P#KWM_YR4 6M2U.TTFT^TWD
MA1"ZQJ I9G=CA5 ')))J@?%FE1VVHS3M/ =+Q]LC:!B\0*[@2%!R".<C(J'Q
MG=WMEI$$MG:27 ^V1"=HH/.D@BS\TB)@Y88&.#C.<<5R%U'+#'X^D-EJ*6]Y
MI220374;_.%@<$EFZ')^Z>1Z#' !UUKXXT.[U.UL$FG22\7=;226[K',<9*J
MY&&(]N_'6H;CXA^'K:.YD:2[9+2<P7+)9RGR",9+_+\HYQD]2#C.*R9(?^$B
MTGPA:V<$PDLKBUNYG>%D$*1ID@DC&2<  =<YZ#-0Z->P):>-;)[:>XEGU6Z5
M(HX&<2EHT4*"!C/KGH#D\4 =-?\ C'1M/N(+>26>66Y@-Q L%N\GFH #E"!A
MN#T&?? J5O$UAL5H8[JX?[.MR\4,#,\4;#*EEZ@GGY?O<'BN6T[3+O1O$'@Z
MSGM[J7[!ILL$\\=O(\22,$P"X& ,@C.>W.*T+!Y_#_C77I-0@N&M=4,4]K<Q
M0O*"53:T9V@X(P,#N* -6X\9:#;6MA=M>EK?43BVE2)V5S@G&0, \'@\]L4R
MS\:Z+>6^H2K)<Q-IHW74,UK(LL:XR&V8W8Q[5QAT^?P_I7A;[;#)&9/$#W/D
M*A9H4<2$+@9Y () ]ZU]2LY+[7=>UVUMK@VQT,V*;8'W7$I+-E5QE@!M&<=_
M:@"_?>,?#^HZ!>2RS:C#9&T29[F&WE0A''!5P.HZ'L#P>]:\VN65F]O:+Y]Q
M<2VYGC@B4O(8UQEC^8')R2>,US%Y%<2_!1;&.QO3=C2H[;[-]ED\WS @4C9C
M/4'G&*LW-_=+KFEVTNGZ@MA)IW$]K:N)7FW#]T[ ;HUP >JY/4X% %O4_&]I
M;V&C7FGQ2WD&KW4<,<J1$A022<CKNPK #KGZ5IWOB&SL4=GCN9#%")IDBA+-
M"ASRP[=#QUX/%<#86M_;^ _"JRZ7?J^DZTLEU']F<R*@:7+!0-S ;UY /6M.
M[F&E>+]2GU;0;^\L=72&6VEM[=I3&PC"-$ZKT/&?Q- '<V=[;:A90WMI,LUO
M.@>.1>C*>AK'M/&FCWU\;.V-U)(MTUJY^R2 1R*N3O)'RCMSC.#Z5HZ/;QVN
MDV\,5BEA&JY6V0#$0)) XXSSSCC.:Y?PW:W%S:>+[(P75I+?:C<O!)/;21AD
M>-55@6 SR#TH W5\5:6UW:0,\R+?L5M)WB(BG;&<*WN.1G&>V:;>^+=)L([J
M>:24VME*(;FXCB+I#)Q\IQR>H!P" 3@XKF?#$EO=6VF:5?\ A.[CU;3VC$CW
M%N?)B9,#S5D/'0$C'.3Z<UFW<MFO_"1:'<KJEOIM[J3R2^7IDDY.2ID*2IE0
M&8'@@D<_@ =_#XBL)]4CTU1<+<RVQN8TDMW3=&" 3\P&#D@8.#7.^--<AU/X
M<ZU?:7=74$EFS1%T+PNDB,%93T/<CTHOKZ*'QGHFOP0W-SIEQILL$<UK;O+A
MF9&4$*"1D#N*P[J"_G^'7B^T&E:@+JYU2Y>&'[,[-('E!!&T$$<'D9''6@#O
MKS7;.PN$LV$T]T;<W!A@0NPC! +'VR<>I[9K-U+QI:P1:)-80S7D&KS*L<T<
M1("8+'CKNX(Q]<].:NHW]S)XGM[>2POQ836 ,<UK;.'EEW']V[X!C &#@E1D
M\G'%<_IL-];>#?!KS:5J"G2]0'VJ,6KF1!MD7=L W$98<XH [RZ\06=M*\(C
MN9YHHA--%!"7:)#T+#L3@\=3@X%5[CQCH=M::?=F[:2WU)PEM+%$[JY.>,@<
M'@\'GCI61IDL^A>,-<FU&VNOLVJ^3<VTZ0-)RJ;6B;8#AA@8'?M6&ND7VDZ+
MX;CFL;MF77S?20PVSR_9HF\S .P'&-RY'J3Z4 =C8^,=+O[^UL8X[R*XO%=X
M4GM7CR$)#?>'&".GTK3M=2@O+R[M8EDWV;A)2R$*&*A@ >_!!X]16'XZM)3H
M\6N60'V[19/MD.>-Z@8DC/LR9'UQ6MH=I+::6GVD 74[&>XP<XD<Y(SZ#.T>
MRB@""[\4:99ZNVD2&X>]6W-P(8[9V+)D#Y<#YCD]LXP<XQ5(^/\ 0!IR:AYE
MT;;?LFD%K(1;'=M(EX^3GU_E4$HE7XJQ7)M;HVZZ,\)G6W<Q[S,K!=P&,X!/
M6N>>WNW^'?BVU&FWYN+K4+IX(?L<H>17?*D#;D@COVH [^]U:WLI%AV37$[(
M9!#;QEWVCJWL/Y]LU7@\3Z3=:;:7]K<&XCO6*6Z1H2\C#.5V]01@YSC&.<5R
MVI3-IOBBWUB\T>_O=+OM.B@W0V[M);2(S'#1_> (?TZTV^BET2^T+Q!8>'[B
M+3(&N$GL[>',T2R[<2F,=\KDCJ >><T 3^,/$%MJ'A&:^TZ]N+:2RU&&"<!V
MA:-O-0.CCC(P?<5T=AXFTW4-1N-/C:>*XMXA,5N(&BWQYQO7<!E<\9KF_%US
M-J_A&26ST:^43WUN\<8M'\Z0+(K-(R 948'&>>/<58OI+I?B-]NMM/NID_L&
M2*-FMI!&TID5U0MMP"0#UZ4 ;-GXKTN^N;.")I@-01WLY'B(2X"C+;3].><9
M'(JI+X_T&*WN;@O=M%9W!@N76SD(@88R7^7Y1SC)ZX.,XKEK.6\NM2\'ZE)I
MFK&2VDE2\0V;QQV[M"5")'@ *#P&QC&,MFI#%=-X/\<VPT[4/.O+ZZ>WC-E*
M#,KHH4K\O()!H Z^]O\ 3#XGTFVDNKI;R1)7MHX]XAE7:-Q8_=; QCG(S[U.
MOB&R>>.-%G>.2X-LDZQ$QF0$AESVP5(STR,9KG)3-)XD\%S+8WQC@MIUG<VD
MH$):)5 <E?ER0>M5(+2ZL_$$-YX?-_ MUJ1&HZ5<P,8-N\[YT+#Y>FX$'!R!
M[4 =!-XXT6$7Y'VR4Z<^RY6.SD)BXR21C@ =SQZ9J:+Q?H\U]9VL<LS+?\6U
MQY#B&5L;MH<C!./Y8Z\5@6JSK+XY+6-\!=,3!FTE_?#R0GR_+\WS#'%5)H[E
M?"G@2'^S[\RV5W:/<H+*4M"J1,K%AMR,$B@#T:N5U[6+J?Q?IGA2QG:V-S"U
MU=SI]]85R J>A9A@GJ!TYK>L]16]N;R!;:YB-I((R\T159,@'*'^(<]:Y[Q!
MI=U9^,]+\5VMO)<QP0/9WL42[I!$Q)5U4<MACR!SCH* (_%LT_@W2E\06%S=
M206LL8O+6>X>998F8*<;R2K D$$$>^:U)_&.D07LUBINI[J&%9S##:R.S(>A
M4 ?,/<<>]9?C!7\8:,/#VEQSE;R6/[5<O"R)!$K!B<L!ECM "CGGG IUJIM?
MB5=R"SNUM1I,4"3"UD,99'<E0VW!."._- &U#XDTNYT>UU6"X,EO>$+;A4)>
M1CGY0O7/!SZ8.>!26OB;2[F"]E\YH3I[^7=1RH5>)CT&.^<C&,Y[5P&F1:II
M?AWPWJJZ3?R#1[^[-W9_9G67RY6D =58 M@,#QZ_6N@\0M=^(_"]U=Z3I,P,
M<]O<QQ7$1ADO/+<,PVGG&  ,\DCTP2 =#9>(+*]U232\36]['$)O(GC*,T9.
M-Z]B,\>W>L?Q[K$NC6^FSRM<PZ2]UMU&>UR)(X]IV\CE5+8R1SC@=:?X=N=-
MU;4$O[+P[=64L4122XO;8Q.F<?NUW<GG)..!CWK2UG4VL+JSADL9[JSN1(EP
M88&E\L8&"P )V]1T[T 5-(M(;JZ^W:;K-Q?:1<VQ4)]L:0(^X'*N3NR1GJ>,
M=LU@>'O$6HZ'K;Z7KUQ)/IM_>W$6F7TS[F1TE9/)D;U.W(/OCZ2:!HMMIWCN
M>^\.07%KHTMFQO8_*=(6FW#;Y:D<G&<[1@=.^*T[+2;+Q+X6O])U*TN$CEO;
MIOWT#Q,NZ>1T==P'."""/Q]* 'R?;K6?Q+-I\EQ<W4$(:T@DF=T#F(L %)QR
MV/\ ZU8_AV[M/$VE6DVDZ_J U:WEA>_@GNGWG:ZF56B8X4$!A\@ [>HJ?P\G
MB/0])\1-J<9O;ZS3_1954G[8J1?(?=C@ ^]4?%FFV.NFVU+0K"\L_$ZS1F&4
M6LD++\PW><2 NT+GDGG  )S@@'H4T0GA>)F=0XP2C%6'T(Y%<-X%\7VD?A/0
M8-2N+J6YO#Y7VF2-W0RL[;4:0\;CZ9KNII1#"\K*[! 20BEF/T Y)KR^UMKV
M'X7>&K-],U 75KJ$#S0BRE+QJDQ9B1MSC'.: .YU#Q9I6FO=B=Y62P*"[DCB
M++;[N5W$>Q!XS@'G%6+W7+2REDB*S3O#")Y5@C+F.,YPQQZ[6P!DG!XKAO%4
MFH:I9^*M/;2]1$IC!LX[:V=8[A-B_O&< ;VZC:3T  4G-6M:M_MLR:A8MJVC
MZQ;Z>AM[A+9V2Y'S$0NF""01G:<'YAZ8H [Z&59X(YDSMD4,N?0C-/JII37;
MZ19O?PI!=M AGB3[J/M&X#V!S5N@ HHHH **** "BBB@ HHHH R--_Y&#6?]
MZ'_T76O61IO_ ",&L_[T/_HNM>@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LC4?^1BT?_MO_ .@"
MM>LC4?\ D8M'_P"V_P#Z * ->BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"LJS_P"1GU/_ *][?^<E:M95G_R,^I_]>]O_ #DH U:H:YIAUK1;O3//,"7<
M30NX7<0K#!Q[X-/U35;72+07-VS!6D6)%5<L[L<*H'J2:JVWB33Y_P"T1,SV
M;Z7@WB7  ,0*[@V02"".<@F@"WIMF^GZ9;V1F$IMXEC$A7&0!@$C/7 JCH&@
M-H<NHO\ ;3<#4+M[MPT878[  @<_=PHX/YT1>(+&]U%-(FBN[6>Z@,T E4QF
M6,=2I!RI&1P<,/2N8\$>*[6P\)Z/;ZB][*]Q/) ;MHV=!(TSA0\A[GCU]\4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOK.^AU"=IFM%.0J$(V[>5;:?E' YZCI4-QX]TV"/49%L=3F&F2%+KR[;_5@
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M]VP% 3@AB.A!VT3V?B&WM_#^MZMI3:V]K'/;WMNL*F4QNP*2!#QOPBY'O]:
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ME?VX_P#T!M3_ ._2_P#Q5']N/_T!M3_[]+_\50!JT5E?VX__ $!M3_[]+_\
M%4?VX_\ T!M3_P"_2_\ Q5 &K165_;C_ /0&U/\ []+_ /%4?VX__0&U/_OT
MO_Q5 &K165_;C_\ 0&U/_OTO_P 51_;C_P#0&U/_ +]+_P#%4 :M%97]N/\
M] ;4_P#OTO\ \51_;C_] ;4_^_2__%4 :M%97]N/_P! ;4_^_2__ !5']N/_
M - ;4_\ OTO_ ,50!JT5E?VX_P#T!M3_ ._2_P#Q5']N/_T!M3_[]+_\50!J
MT5E?VX__ $!M3_[]+_\ %4?VX_\ T!M3_P"_2_\ Q5 &K165_;C_ /0&U/\
M[]+_ /%4?VX__0&U/_OTO_Q5 &K165_;C_\ 0&U/_OTO_P 51_;C_P#0&U/_
M +]+_P#%4 :M%97]N/\ ] ;4_P#OTO\ \51_;C_] ;4_^_2__%4 :M%97]N/
M_P! ;4_^_2__ !5']N/_ - ;4_\ OTO_ ,50!JT5E?VX_P#T!M3_ ._2_P#Q
M5']N/_T!M3_[]+_\50!JT5E?VX__ $!M3_[]+_\ %4?VX_\ T!M3_P"_2_\
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M)#X<T:#2K:XGG@MP5C:<J6 SG&54?RK2K*_MQ_\ H#:G_P!^E_\ BJ/[<?\
MZ VI_P#?I?\ XJ@#5HK*_MQ_^@-J?_?I?_BJ/[<?_H#:G_WZ7_XJ@#5HK*_M
MQ_\ H#:G_P!^E_\ BJ/[<?\ Z VI_P#?I?\ XJ@#5HK*_MQ_^@-J?_?I?_BJ
M/[<?_H#:G_WZ7_XJ@#5HK*_MQ_\ H#:G_P!^E_\ BJ/[<?\ Z VI_P#?I?\
MXJ@#5HK*_MQ_^@-J?_?I?_BJ/[<?_H#:G_WZ7_XJ@#5HK*_MQ_\ H#:G_P!^
ME_\ BJ/[<?\ Z VI_P#?I?\ XJ@#5HK*_MQ_^@-J?_?I?_BJ/[<?_H#:G_WZ
M7_XJ@#5HK*_MQ_\ H#:G_P!^E_\ BJ/[<?\ Z VI_P#?I?\ XJ@#5HK*_MQ_
M^@-J?_?I?_BJ/[<?_H#:G_WZ7_XJ@#5HK*_MQ_\ H#:G_P!^E_\ BJ/[<?\
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M2J%N!C';KG\*W*Y3Q5_R-WA#_K]F_P#1#5G:5;6OB>+Q2=90-=V^H36\;O\
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MD<#@^@J])<0PP//)*B11@L[E@ H'4D^U,M+N&^L8+V%B89XEE0D8^5AD?H:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6LI8X]25]/N]8MCJ$,*>7#:1.3O Y.U6(7<,]#_M5WE[HVF:EIHTV\L()K,
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M;:U:PB,%HP>WC.=L3#H5'8CMCI6D!@8]* ,G3?\ D8-9_P!Z'_T76O61IO\
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M@]*22>&*/S))41/[S, /SK@?LR^'_$^K^'+:W6.'Q&HN+,J@PC'Y)Q_P%?G
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M=MY4UL+)HW\Q&!\UFXVE3G&.N>/2N>M/$>K36/BB1UL_/T>>1(,(VQE6,/\
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M[AD'FQQMO0'N 2!D?A7 K9KH6L:KX-@M@EOKS_:+)E3A$?Y;A?0; "RCW H
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MS7*#RUF1EE)C9"5+?="A<>F!5OQK8B#4AK.FPRR36UKLUI8L!IK1B,@_]-,
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M%#&+^(%P HRT+=_<@55G>SN=7^(:Q-#+NT^$X7!RPAES^(/ZUW,VBZ5<:?\
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M&Q.EV9M6?>8/LZ^66]=N,9]ZP9_#+S>.;>_;2[5]*@TTVB(=N4<R!MRKC
MQZ\F@#C-5TR&T^'7C6UCC!TVUU%C8 \B,[DW!/0!B1^?O74:WI6G7_Q1TR.[
MLX)UFTR?S5= 1)ADQN'\6,G&?Z5U4^CZ9=:>NG3Z?;26:XQ;M$#&,=/EZ4?V
M-I7VF*Y.FVAG@ $4IA4N@'3#8R* .)VZ9/XC\1:!JM]%IZ>5%%;PR+&JFT\H
M !"XZ!MW3H33]*:U'C32]%GGDN["#10^G-=X/GMOVE^F"VP#'&=I)[FNRO\
M1=*U26*74--M+MX3F-IX5<I]"1Q1J6B:7K"1+J5A;W0A;='YJ!BA]CVH YSX
M=0V]M'XC@M51(8]>N B)T4;4X'H*CN=-L+CXO()K2&3S-"=Y%9 0Y$Z %AWQ
M[^@]*ZFPTC3=+,AT^PM[4S-ND,,04L??%*^EZ=)>_;7L+9KK;M\\PJ9,>F[&
M<4 >73Z7IR_#+Q5(MI#OL]0NTMGV@F!5FRH0_P (&<X&.M=%J]W8W.MZA"#
MEVFBJ+F:[;*>4VXA43(R2>K9P/EX-=4- T46\EL-(L1!*V^2+[,FUV]2,8)I
MW]B:3Y\$_P#9=GYMLNR!_(7=$OHIQP/84 >>6#V<]A\.IKAH9 JM%*[D'&+=
ML*Q/U'!JV'TO6-2\4Z3KFJQV;R2X"R>4,VIC7RV1G'0<GCH3GJ:[@Z)I)LHK
M(Z79FUA??'!]G78C>H7& >3S1>:)I6HW,5S?:9:7,\/^KDFA5V3OP2.* .)B
MT32KOQ]IEK<0"]@?PZ<M=H"\^)$"M(,#+8]1U^E7+.*RTKX@^('CA$-O'I$$
MCK",' +YP!WP!76OI6G27RW\FGVKW:?=N&A4R#Z-C-(FDZ='J$FH)90+=R+M
M><1C>P]">I% 'G5C=62:GX$N+>6UMK0K/Y,7F;I4C:%C^\?/))QD8X;/)K22
M"&\G\>6LU[]C2>YBB-QC(CW0H 2/3)Y]LUU\/A_1;=46#2+&)8Y?.0);(-LG
M]\8'#>_6A=!TA&N2-,M,W?\ Q\?N5/G?[W'S?C0!@^&+S4$\27NFZYI]M'JB
MVD3F\M#^ZN80S!20>58$MQ]<<"NNJM9Z=9:>&%G:0VX?&[RHPN<=,X]*LT %
M%%% !1110 4444 9&F_\C!K/^]#_ .BZUZR--_Y&#6?]Z'_T76O0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !61J/_(Q:/_VW_P#0!6O61J/_ ",6C_\ ;?\ ] % &K)(D4;22.J(
MHRS,< #U)J :E8-;-<K>VY@4X,HE7:#Z9SBK! (P1D&N!T6U:QU6^\"F$_8T
MNA?0G;\OV1R7*>G^M&S'<,?2@#M9=4T^"6.*:_MHY)<&-'F4%\],#/.:?=WU
MI81"6\NH;:,G >:0(,_4UYKXPOK"XTGQI%;/!;2(RI<"=]TUQ(J+MV*3\J@
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M><2,@\YQ@#V&.U>H6NI6,KP6L=Y \\D F2)9 69.FX#TSQF@"[1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!D:;_ ,C!K/\
MO0_^BZUZR--_Y&#6?]Z'_P!%UKT %%%% !1110 4444 %%%% !1110 4444
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M1GU/_KWM_P"<E:M95G_R,^I_]>]O_.2@#5HHHH **** "BBB@ HHHH ****
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M1GU/_KWM_P"<E:M95G_R,^I_]>]O_.2@#5HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH R--_Y&#6?]Z'_ -%UKUD:;_R,&L_[T/\ Z+K7H **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ K(U'_D8M'_[;_\ H K7K(U'_D8M'_[;_P#H H UZA%I;"1I
M!;Q!V8,S;!DD="3ZU*3@9-9]MK^DWEP(+?4())&0R( WWU'5E/1@/49H NR6
M\$SH\L,;O&<HS*"5/MZ5@7&@7=SXW769H[.6P%@;,PR$ER3('WXVX[ 8_'-6
M9/&/AJ(QB37; >;(8T/GKAF'49]L]:L7OB+1=.EEBO-5M()((_-E1Y0&1,@9
M([<D >N: +S01.@C:)&1>BE00*22UMYHA#+!$\8.0C("!^%41XCT0Z?!J U6
MT^RW#;(9?-&)&SC ]3GM2P^(M&N+1[N#4K>6!)C 7C<,/,_N#'4\]!0!H-&C
MJ%=%8 @@$9Z=*;);P3.CRPQR-&<H64$J?4>E4AK^CG3Y-0.I6RVL3%))7D"A
M&'56ST/L>:9:^)=#O=1.G6VJVLMXJ[S"LH+8QGI]* -":WAN%"SPQRJ#N =0
MP!]>:<D:1@A$5026.T8R3U-9:^*_#[S)"FLV3.\C1*!,IRZ@%A^ (S3=+U.R
MBT5KV778K^V\YP+QB@7ER @*\'!PHQUH LWNF">_M]2@81WELK(&(XDC;&Y&
M]L@$'L0#SR#;-O S.S0QDR##DJ/F'H?6LVY\3Z1;:3>:FUXKP6(/GA02Z,!G
M:5Z@^QI;#Q!87FB6^J-/''',JY&[.'*@[!ZGGM0!H&V@9RY@C+'J2@R:!;0"
M-HQ!&$<89=@PWU%1V&HV6J6_VBQN8[B(,4+(V=K#J#Z$>AJK?>)=#TR:6&]U
M6T@EAC\R1'E 9%R!DCMR0/?- %^*WA@_U4,<>%"_(H' Z#Z<FG]>#6?=>(-(
ML=IN=1@B5@K;F?Y0&^Z2>@![$]:FN]3LK$HMQ<*C.I95&68J.K8'.!D9/09H
M L[$PHV+A/N\?=XQQ^%->"&1@[Q(S#H64$BL]/$VA2)$\6L64J32")&CG5@S
MGHN0>I]*L#4+.XO)]-AO4%Y''N>-2-Z \!L'W_"@"PT,3EBT2,6&&)4'(IOV
M2V( ^SQ8'0;!7.>#==DG\%6^I:W?JTK3S1M-(%3<1,Z* !@9X  %:%[XJT>R
MT2\U8W:R06>Y953EPX'W"O4-['Z]* -BHC:VQ55-O$0O &P<53MM>T^;28-1
M>YC2.4*/O9^<C.T=R?84Y=?T@Z?)J']I6RVL3%9)6D"A&'56ST/L>: +BP0H
MYD6)%<]6"@&B*W@@9VBACC,ARY10-Q]3ZUDGQCX;5V0ZW9AD*JP\T<%AE1]3
MZ5HOJ%I%=P6CSHL]PI:*,_><#J0/:@"S14-U=6]E T]U,D,2XR[M@9)P!]2>
M*JQ:[I4UK<7*7T1BM3BX).##_O \KQSS0!H450&N:6=.CU$7T)LY6"I.&RC$
MG P>^3Q1?:YI>F/LO;Z& C&[>V @)P"Q_A!/0G% %^BLN]\3:%ILLL5YJUI!
M)#'YLB/*,HN0 2.V2PQZYJ237M*BE2-[Z(,[HBD'(W/C:N>F3N&!U.10!H45
MEVMU!/X@O8HM92X:*) ]BNP_9SD_,2.<GT/I1+XFT.!@)]5M802RJ\L@1&*G
M# ,>"0>H!XH U**XZU\3+IOBSQ'#K6L1II]JMH;;SMJA/,5V8# !;I[\"M75
MO%NEZ5-ID4EPC_VFX$3J<KLVEM^1QCCCUS]: -RBL5]6:P\0VEA<2"2VU17:
MUD(P4D4;BA]05Y'?Y2/2MJ@ K*L_^1GU/_KWM_YR5JUE6?\ R,^I_P#7O;_S
MDH U:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,C3?^1@UG_>
MA_\ 1=:]9&F_\C!K/^]#_P"BZUZ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R-1_Y&+1_P#MO_Z
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M%! /49H Y#QD&N]9\(QV^?,;51,."#Y:QL7^G%=+8ZI9:D]RMG<+,;2=K><
M$;)!C*\_44Q=-5]6_M*X8231QF* 8XB0D%L?[38&3Z #US=  S@ 9.3CO0 M
M95G_ ,C/J?\ U[V_\Y*U:RK/_D9]3_Z][?\ G)0!JT444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 9&F_\ (P:S_O0_^BZUZR--_P"1@UG_ 'H?
M_1=:] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %86N7EK8:WI$]Y<16\0,P+RN%7)0=S6[10!E?\
M"4^'_P#H.:?_ .!*?XT?\)3X?_Z#FG_^!*?XUJT4 97_  E/A_\ Z#FG_P#@
M2G^-'_"4^'_^@YI__@2G^-:M% &5_P )3X?_ .@YI_\ X$I_C1_PE/A__H.:
M?_X$I_C6K10!E?\ "4^'_P#H.:?_ .!*?XT?\)3X?_Z#FG_^!*?XUJT4 97_
M  E/A_\ Z#FG_P#@2G^-'_"4^'_^@YI__@2G^-:M% &5_P )3X?_ .@YI_\
MX$I_C1_PE/A__H.:?_X$I_C6K10!E?\ "4^'_P#H.:?_ .!*?XT?\)3X?_Z#
MFG_^!*?XUJT4 97_  E/A_\ Z#FG_P#@2G^-'_"4^'_^@YI__@2G^-:M% &5
M_P )3X?_ .@YI_\ X$I_C1_PE/A__H.:?_X$I_C6K10!E?\ "4^'_P#H.:?_
M .!*?XT?\)3X?_Z#FG_^!*?XUJT4 97_  E/A_\ Z#FG_P#@2G^-'_"4^'_^
M@YI__@2G^-:M% &5_P )3X?_ .@YI_\ X$I_C1_PE/A__H.:?_X$I_C6K10!
ME?\ "4^'_P#H.:?_ .!*?XT?\)3X?_Z#FG_^!*?XUJT4 97_  E/A_\ Z#FG
M_P#@2G^-'_"4^'_^@YI__@2G^-:M% &5_P )3X?_ .@YI_\ X$I_C1_PE/A_
M_H.:?_X$I_C6K10!E?\ "4^'_P#H.:?_ .!*?XT?\)3X?_Z#FG_^!*?XUJT4
M 97_  E/A_\ Z#FG_P#@2G^-'_"4^'_^@YI__@2G^-:M% &5_P )3X?_ .@Y
MI_\ X$I_C1_PE/A__H.:?_X$I_C6K10!E?\ "4^'_P#H.:?_ .!*?XUG6OB+
M1$\0ZA,VKV0CD@@".;A<,09,X.>V1^==-10!E?\ "4^'_P#H.:?_ .!*?XT?
M\)3X?_Z#FG_^!*?XUJT4 97_  E/A_\ Z#FG_P#@2G^-'_"4^'_^@YI__@2G
M^-:M% &5_P )3X?_ .@YI_\ X$I_C1_PE/A__H.:?_X$I_C6K10!E?\ "4^'
M_P#H.:?_ .!*?XT?\)3X?_Z#FG_^!*?XUJT4 97_  E/A_\ Z#FG_P#@2G^-
M'_"4^'_^@YI__@2G^-:M% &5_P )3X?_ .@YI_\ X$I_C1_PE/A__H.:?_X$
MI_C6K10!E?\ "4^'_P#H.:?_ .!*?XT?\)3X?_Z#FG_^!*?XUJT4 97_  E/
MA_\ Z#FG_P#@2G^-'_"4^'_^@YI__@2G^-:M% &5_P )3X?_ .@YI_\ X$I_
MC1_PE/A__H.:?_X$I_C6K10!E?\ "4^'_P#H.:?_ .!*?XT?\)3X?_Z#FG_^
M!*?XUJT4 97_  E/A_\ Z#FG_P#@2G^-'_"4^'_^@YI__@2G^-:M% &5_P )
M3X?_ .@YI_\ X$I_C1_PE/A__H.:?_X$I_C6K10!E?\ "4^'_P#H.:?_ .!*
M?XT?\)3X?_Z#FG_^!*?XUJT4 97_  E/A_\ Z#FG_P#@2G^-'_"4^'_^@YI_
M_@2G^-:M% &5_P )3X?_ .@YI_\ X$I_C1_PE/A__H.:?_X$I_C6K10!E?\
M"4^'_P#H.:?_ .!*?XT?\)3X?_Z#FG_^!*?XUJT4 97_  E/A_\ Z#FG_P#@
M2G^-'_"4^'_^@YI__@2G^-:M% &5_P )3X?_ .@YI_\ X$I_C1_PE/A__H.:
M?_X$I_C6K10!E?\ "4^'_P#H.:?_ .!*?XT?\)3X?_Z#FG_^!*?XUJT4 97_
M  E/A_\ Z#FG_P#@2G^-'_"4^'_^@YI__@2G^-:M% &5_P )3X?_ .@YI_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@K@+D= .><GDTFNZ!'KOV%GNY[62QN5N8I(-N[> 1@[@>,$Y'>@#E=: \/\
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M*ZFN!=7,ERQE"Y#N<MC '&:=I&C+I$E\Z74T_P!NN6N7$@7".0 <8 XX'7-
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MV=Q?6GE6NH3V$H<,)H55CQV(8$$&HK/2%M[B6\FN9;F\EC$1N'"@J@R0J@
M#))]3WS@8 .?\7W%_8ZWHE]/8VUUH\%ZBL%=O-BE?]VDF,8(&XC'O^78UBVW
MAZ7; NIZO=:FEM()8EF2-1N'W2VU1N(ZCMGG&0*VJ "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
8* "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>ebs20191231exhibit1048017.jpg
<TEXT>
begin 644 ebs20191231exhibit1048017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%5=0U*RTJ!9[^Y2WC9PBLYZL>@'O0!:HK$_X3+PX#*#
MJT&80#*.?DXSSQQQZU;M-=TR^U%]/M;M)KE(5G9%!X1NASC'- &A1110 444
M4 %%%% !1110 4444 %%%% !1110 451O-8T_3[RTL[JY6.XO7V01X)+MU[#
MCH>M7J "BFNZQQM([!54$DGL*R&\6Z$NA?VX=04:?O*"?8V"0Q4@#&3R,=*
M-FBBB@ HHHH **I?VQI_]L_V.+E3?^29_) .0@(&<XQU(J[0 4444 %%%% !
M1110 44A( )/057T[4+75K"&_L9?-MYUW1OM*Y'T(!H LT55NM1M+.YM;:XE
MV2WCF.!=I.]@I8C('' /6K5 !1110 445#:W=O>Q&6VF26,.T99#D;E8JP_
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MW*I=WN[R(L$E]H+'H.. >M7: "BH4NH)+B2W60>=$ 70\$ ]#[CKSTX/I4U
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MIGVM9YHI  _F!>5#'CVSQGJ<8,/B7Q3K.@V>HWDBV,?V(1M#;%3(]TF%WO\
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M/@7=N\)?'0D8SCV/-96E#4[CPO86T$L=MJ5AY<-U',I924&&4@=F'(/H0>:
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ML:1E6C&WY@QSSDT 7**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX8@E&SP.!U!Z^W-^#7M=L]1\0:;=);ZC<V%DMY:"VA:+S=P;]V5W-W4 <]Z
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M1E65RWS '@\<]1CI764 %%%% #515+%5 +')P.IIU%% !1110 4444 %%%%
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M^V&/8P8#82=V2.<GGCTKJJJZCJ$.EV+WEPLK1H5!$4;2-R0!A5!)Y- '/_\
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MCD;58HH]KVO^K\M2H.0XSG))X'/I6=_P@5U#HVC06>N&VU+10R6UZEMPT;
MHZ%CN!P.] &SX:N=<FM[J/7+7RGAN&6";Y09XOX6*J3M;L17/SP:I<_$K5XM
M*O8+*4Z9;YFE@\W'SO@!<@?B?RYXZO2;&ZLK=C?W[7UW(<R3>6(U] %4?= ^
MIY)YJC<:!>)XEFUS3K^*&2XMEMYHI[<R+A22K+AE(/)X.<^U &/IGB;5]0T.
M)[E[2RN+;4I+#4IP> 4R,Q*<Y9CM '/4\&F6_BS5?^$<UFZ,,ES)IFI_93)'
M;D2^1E"9#'Q\X5SQ@#C..HJ[-X),46F/IFIFVN["ZENFFFA$HN)) 1(77*\G
M<<$'BGV7A34M.?4)+37R'O+U;P&2U! ;"A@P##<"%QQC /<\T 5T\6+'X=N=
M5LM2AU>&6XB@LG"A65G*IB0#'(9LX^7C'3K5[3+GQ"OB(V]U;RS:5);[Q<S)
M&CQ2@_=PK<J1TXR/4U7F\"6=[:ZU'=2A)=8:-Y&M8_*$31_<91D_-NY)[U>T
M/1]8LW636=>.J-$NV(+;K"!ZLP!.YL=^@R>.: *_C'5-2T."SU.WG1-/CN43
M4 8PS)$S8+J>V"1GKQ]*=?Z[-8RZUJ)D\S3M*M0QB51EYMI<@-Z;2GXL?2I_
M$VKZ+963:=J\@;^T(I(X[4*6>XXP54#N=P ^M,T7PS#9^"XM O=TPDMC%=$M
MDNS#Y^?Q(!] * *=K?>)_P"U=-<VKW%C<J?MFY(XQ;G&5:,AB2N>"#D]ZI0^
M)M5@U70XKJYAF?4+F2WO((8]T,#!6*A)0.6&T!@2>_ J]HWA75M/A2RO_$LU
M]I]NNVWB$"QR 8PN^0$EMO;IR 3Z54M? =_!9:-:MXAW+HUQYEL5LE&4VLN&
M^8Y;#?>Z>JF@"71K_P 2ZMK>IPM?V45OIFI")E6U.9HMBMM'S?*>>O.3Z8P;
MWCG5M0T/PO/J6FR0I+#)&#YL9?*M(J''(P?FSSFIM#T&YTC4M5NY;^.X34KC
MSS&MN4,;8"]=QR,*.U.\5:%)XET&;2DO%M!,R,TAB\P_*X88&X=U% &5XC\3
M2:7KIT^YO?[)AFM@UE>2PAH99B6!21CPH&%...IYZ5U4!<V\9D(+E!N*]"<<
MUBZKH-_JB7EO+?VKVE[;B*2":T+A&P077Y^,Y'!ST'/KJ6=A%8Z5!IL3/Y4$
M"P*Q;YMJKM!SZX% ')+XEU:VU+14NKF"9[^]>UN[>&/=# <,5"2@<L-H!!)[
M\"EFUS6[=O$UA)>1?;]/5)]//D#$T;@[!MZDEQL..^,4MMX"OX-/TBR/B'*:
M/=":V(LU!*X88;YCEL-][@>JFMR^\-VU]XEL-;>1EDLXGC:,=)@2&7=_NL"P
M]^>U %'1-;N==M]#GM;L%)[4W%[F,9XPNW_9._</HC?6L^7Q-JUG?:2+BY@E
MDO-3-E=6T,>Z&$'?MVR@?? 5<@D]3P*WM!\-VV@/J+6[LPOKEI@#QY2GG8OL
M&9S_ ,"-84'@"^ATO3=._P"$A)BTF^6ZM#]C7. 6X<[OF/SGGCW!H FLM1\1
MZAXDUBS&H64%KI5W#N/V4DR1,@=E^]\IP>O//85A^*-1U#Q%\++S75N4AMKD
MJR6GE@CRO. &6Z[^ ?3MCO78:3H%SIVN:MJ,U_'<1ZHR,\7V?:4*H$'S;CG@
M<\=?3I6$_P /KY?#EYX9MM>6/2)FW0(]IOE@&\/MW[P"N<]L\]: -*_UC4KS
M6-1TO2_-B;3XHR9(XD<M*X+ $,1\H&.G)R>1CF&SU_6;Z\TK1+NW73-4GLWN
M[[&US$JL$ 3DC+$YYS@>IZ27_A34CK@UK1]>.GWDT*PW@:U$L=P%^ZVW(PPR
M>_\ 7+K[PC</?:=JFG:LUOJ=BCQO//%YJW*.=S!U!7^+)&",?E@ K>!TN(]8
M\4I=2K-*NI &15V[AY28./7&,^]+JIU!_B7I,$6HM% UC/((O+!4$,@)]R<]
M>W;O6EX?\/W.CZCJEY<:D+MM2F$S(L C",%"\<GCC_\ 7UIVJ:!->^(-/UBU
MU VLMG')"Z^2'$D;X) R1M.5'//TH Y".YUBP@\;ZEI=W;V_V'4);@K)#YAE
MVPH2O4;1@=>3SVQSMZGKNM2:IX:@TZ:U@BUF*5G\V$N8R(=X.=PR!GIQTZ\U
M(O@Z[&G>(;-M6B8:[)([M]D(\G>@0@?/S@ 8J5O"U\;KP_<#580VB(R ?9#B
M;<FPY_>?+\OUYY]J (M.U#6-3U2_T7^THXI](AA6XNHK<?OII%+?=)("@8R.
MI)ZC%9L7C+5+C3M(G(BAN3K@TG4(@F4)!8,R$\CH/SK?E\.W%OXDN-<TF]CM
MI;V)8[N&:$R)*4X1QAE(8#CK@C\ZJ7?@E&T&VL;*^,%W;7XU%;IX@^^XW%F9
MER,@[B,9X&/2@":VUF^7Q9K6G2$3V]G:17$**F'RV_*Y[_=&*Q8_$VNW&E>&
M]2M+NU:37+@0RP/;^8D&0S94*RM\NW#98^O'2M,:/=Z'J&J>)[O4Y+QGL0LL
M$%J 28PQ&P9/KP#GW)KE]#FN+*TM[K2/%6@ZI>,FX6HL5^TSL>64NK[]Q/5B
MON>] %Y7U>+7/'%SI5Y!:O;213%I(?,+E;=2%QD  XZ\GFNUT/4&U?P_I^I,
MHC:\M8YBJ]%+*"0/SK)C\*W<<_B&7^U(B=; R#:G]SA-@_C^;Y?IS6KH.F2:
M-H5EI<EPMQ]CA6%9%CV;E48&1D\X'K0!S]IXAU"RNO$5AK%PKW-@@FL_+B"^
M;"PPA [MO^4]LX]:GFU754U&UT$R.UZMB+J[N+>)"<EMH"JQP!D-USP!ZYJN
MZZ-XN\7:??:?/]H.D^8+F2/(0G(V1MZD.-X]-GN*O^(/#%UJ.K6NLZ1JK:7J
M5M&83(81*DL1.=C*2,\\CG_ZP!4@U3Q(NDV9U>.WTV4W;0W,Y*EGC .QHT!8
M;V.T;><<\5E7'C#6T\$ZWJ4$D)NM*U)K17FMRIE0,@!*Y&UL/Z=NE;=YX4OK
MB72[V/7&&HV$TDK3RVX=)BZ[&'EA@%PN ,'CW))JE<> ;J;1M:TP:Z?+U:\^
MU,[V@+(V4)Z,,Y*#T !/'>@#I=,AU2$7!U.\@N2\FZ$0PF,1K@?*>3GG/-87
MC;_D)>%?^PU'_P"BY*ZF$2K"@G='E ^9D0JI/L"3C\S6/K^@W&M76ES17T=L
M-.NEN@K0&3>P!&"=PP,,: ,K7'>7XG^&+=\^3';W4R#L7VA<_4 G\Z-$D=/B
M?XF@3/DO;VLKCL'VD9^I 'Y"MO5]%&I7%A>Q3""^T^0O!,4W+AEVNK+D94CW
M'(![4ND:*NFW-]>RRB>^U"17N)0FT85=J*HR<* /4\DGO0!7UJ\O8-2MH$NX
M[.TEB<F1$\R>24$;52/!R,$DX!Z=NM<G<ZWJVN^%O"6HM=BTEO-6BAN$BC^5
MRKN <'MF,'%=5J/AZ[N/$]OKEEJOV1TM3:RQM ) R%MV5R1M;/?!' XK,A\"
M3V_ANQTF/6CYFG7XO+6=K8$*0[-M9=PW??()R.W2@#JWBG:S,2W&V8IM\[8#
MAL?>QT]\5Y9YE[<?!."[NKLW,EQ<PN-XP0QNP3D]\GFO5HE=(D220R.J@,Y
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M%MA:S_U@*;,</Q\I]^>?:K$G@^6XE\1FYU%6BU^((ZI;[6AQ'Y8()8YX]NM
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MN?891?>(S<7Y4)#<):B-(@&#$[ ?F)VC.3CL .<@">%=<BUU[B>TUA-0M%1
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M,MH7\ML8+H=_!Z'!S@@'Z@$?]K7FI^);G0[2Y%K]AM(YKB=4#LTCYVJH/&T
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MTOFBZO5=HOW1V$(,M\W3TX'J*T:XGQ#!>+XV\)0Q7FZX*7P^T31@D?(G.U<
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M<X. >GS= 1[DUOJBI]U0OT&*SM:\066@V O;KS9(C*L684WX8MMY/0<G')H
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M;4);NTUF.9$D>.,2V\L:[L@JH!!'8@X(].*N3^%+>]\)1>'KZXDEC@C1(KA
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MGDA'8LNPEVR=W&>@'J<UOT %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAVX .1]X-T]>: .SHKAM+UO5;GPG$]SJT44\&JO9S7+1_O)XTD9<(@4@R,
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MS2W_ (TL=,L;V[NK#48Q91++(C6^&*DD C)P>1SSQ6=\3E5/"MNJJ%']HVW
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M>:MQ>%_)N-:G749MVLX\W*+B,A=@V\?W>.<U>T#6H/$6B6VK6L<D<-RI9%D
M#  D<X)]*;XBUR'PYHEQJUQ;SSPVXRZPA2P'3/)'% &8_@M&T?1M,&IW"QZ-
M-'-;N$3<Q0$+NXP1@GTI)_!0_MNYU+3]:U#35OB&O+>W9=DS8QN&02A(ZD<_
M2MR6^>.[LX$LYY4NMVZ9 -D.%R-_.>>@P#S5N@##3PTD/B,:U;WDD3+9"R2
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MOJ^I)HVDW6I2PRS16L32R)" 6VJ,DC) Z#UJ73[Q-0TZVO8U94N84E56Z@,
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MO(89/+?R"ORMOV'.2.C<'&3[5>LI_P"U-'M[@J\/VJW5R%.&3<H/7U&:\N6
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M@PKRD@[H 3D>Q)QZ5@Z#)?Z5X0\%ZC!JESBXNX+22U^40F*0L"-N,Y[Y)_\
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MS;Z[,T<D;8(),0/L>">M=3J-]=6GQ!TNV2XF^RW%C<22P;LJS)MVD#L>3TH
MZBBN"TV;Q+KNC:7XAL+N"&2619Y_,O&,+0DG='Y>S P.,YSD<DU!,VKW8\9
M^(+^(:5(7M3$44J1"' .%Y7/88SSG/8 ]!>:.-XT=U5I6VH"?O'!.!^ )_"G
MUY[*TNL:]X$OKBYN$EOK":6412E%#>2C9 ' Y8_A79:\=1&A7O\ 9.W[?Y1\
M@,0,MVY/&?3/&<4 2:OJ*Z1I-UJ+P2SI:Q-*Z1;=Q51DXR0.@IVFWJZEI=I?
MHA1;J!)@I.2H90<?K7$Q:S;:GH7B:-)=0MKF+3'$VF:@6,ENP23+@L3E6R.0
M>PZ9ING/?Z4W@F9-4N98M1A2WGMFQY6WR-R[5QP00.<Y- 'H5%<-:7M_XC\/
M:UK$.HW%I=6MQ<)9K&^$A$7"ADZ-NQD[L]>,4FD:_?:KK_AFX:22&+5=*EGN
M+<,=A=0F" >G4T =1X@UE/#^B76JRVTMQ';)O=(BN['KR1Q_G%7H)1/;QS 8
M$B!L>F1FO.KZ\NKKX?>.([JYDG%I>W-O"9&R5C54PN>^,FMV34I;GQ%H_AQ9
MI(('TXWD[1L5:4#:JH&'(&22<<\#GK0!KZ/KT>L7FI6JVLUN^G3B"02E<L2H
M;(VD\8([TC:]&GBJ/P^UI,))+5KE9R5V%0P7 YSG)[@5B^";=K77?%4+3R3[
M-03#RG+$>4F 3WP.,]>.:9K%K)>?$_3X([J6UW:1/NDAP'QYB< D''U__70!
MV=%<%INJ7[>&9H+O6I$>TUN2Q\]DWSW,:2X\M<#.]AQD#/4^]3Z4^J:G<^*M
M%2\O+1K5XC9-+*'EMR\0;!8$[ANYP2>#B@#MJ*X[PYJLWB#3-$B,]Q%=0!SJ
M0$AW!X_D9&_WGP1[*<52AG\2^)-%?6-)NHK:Z%W)Y1EO&6)$24J8WB"$'*KR
M2<Y.00.* .ZFGAMHC+/*D4:XR[L% R<#D^]/Z\BHY3%]F8W'E^5M^?>1MQWS
MGM7+;1G/@[SU/;'_ "#_ /Q[M_UQ_&@#6NM?\GQ"NB0:?/<W'V87+,C(JJA<
MK_$PYR*BU+Q?I.F:@ME+.I=)-ER=P MAY32!GSV(7J.YJA;>=_PL_P#TC9YW
M]@)YGEYV[O.;.,\XJ37/!@UC5X+Y[ZX($VYU:4CR4\ME AVXVG<58DY)QUQP
M0#0U'Q1I>G:9#?/<!UNH6EM$^Z;C";PJY[D= ?6GVFOVVIV4L^F(;R6!@DL$
M;*&C<@$J22!D9YYJKKOAEM8T-+ ZC=%X8&13))A9WV85IMH&X \D# /.0>E6
M]!T4:'8FV6ZGF5B&V2/N2(X *IGD+D$@$G&: 'Z%K,6NZ;]MB@D@'FR1&.7&
MX,CE#T)'4&M&N9^'_P#R+<G_ &$+S_T>]1P7<OB#Q;KFE275Q;6^E1P)&MO(
M8V9Y%+F0D<G'  Z<'(- &_JFI6VCZ9<:C>.5@MTW.0,D^@ ]2< ?6H-/U.YN
MKZYM+K2KFS:%5=)7(:.4-GHP_B&.1].N:X#6;^]UOX5ZF=2G=[K3;_[&\L9V
M+<;)T7<0..GZBO2[:W%M L0EEEQGYI7W,?QH E/3IFLO0=>CUY;\I:S6QL;Q
M[1TF*Y+*%)/RDC'S>M<S8:U<1>);?3M=DOK"_>[D,,A<M:7\1W;$3'RJ0"O&
M <KR2361LOH/#_C75++5;JSEL-7NIHE@*A6950_/D'<#TQTH ]2K)US7H]#E
MTY);2:8:A>1VBNA7;&SG@MDY['H#TK%EU2_UK7O[*A^2./38KIE2Z:W9FD+#
M(95)(7:..!EN<\5G:O%K%OHGABWUVY@N;Z'Q!;*\L+9##+%<\#YL$9XH Z[4
MM9%G>16%O;M=WTT3S) KA?D3 ))/ Y8 >Y^I$5QXA%KX6DUZ;3;Q%B@::2U=
M565 H).02!QCU^F:P[JP$GQ9MC]IN5W:1+)\LI&,31C ]O:MKQG_ ,B/KW_8
M-N/_ $6U %E-4EFM=-N(+":9+[:6*,O[A67=N;)Y'0<>M1ZEKGV.\^P6EI)?
M7WV=KGR$<+^[!QU/<G@#V/2N=NKN]M(?! MKV6*&YDBAGA7&V1?)+<\9ZCUQ
M3EL0?B_,?M-R,:-'+@2G_GN_R_[OM0!UUC=?;;&"Z\B:W\Z,/Y4Z;9$R,X8=
MB*GK@+"X\2^(M#LO$&F74,$TDQF/FWC"'R@Y#1-&$(& ,9ZY&<UW] !1110
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M&EQ;E=S1GJC!@0RYYY'!Z8J.7PO92Z)>Z5Y]PB:@7:[G5E\V8N,,22N!D<<
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M SRK*RKC(BA>5O\ OE02?RJ:B@#G/ D$\'AQEN+>:!GO;F0)-&R-M:9RIVL
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+61XAT2YUNWBBMM
M:O=*:-RQ>T8 OQT.>U '":#;W<?QQUC5)-/ODL;FW\J*X>TD",V(NY7'\)YZ
M<5L^.)[Y/$V@1VVB3W$1=_-U"UMA+- #P41CPF>['MTQBI/^$!U7_H?->_[^
M+_A1_P (#JO_ $/FO?\ ?Q?\* .2\+Z&5\$^(-'U_1=46*;5 2J0N9%5BH$B
M<'?M(R<9X'?/,ECIVOVO@'Q7H\QN]3LXD6#2YOLS^;,#G*A2-VT9'L#NQQ74
M_P#" ZK_ -#YKW_?Q?\ "C_A =5_Z'S7O^_B_P"% ')>&/\ A(O"5_H-[):Z
MI?:=?V*VUW;FT<O8E#Q\H7(4$Y]\MU.#7JFKZF=+T>?44LKF]\I0P@MDW2.,
MCH#Z9S^%<Q_P@.J_]#YKW_?Q?\*/^$!U7_H?->_[^+_A0!GW&B6/B;QEX?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5W%9R74*7,^3%"S@.^!DX'4X -<K:>)O[.\)ZW=6>BVUNF@7,UO]ECG*HZH
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M 4TV]MYPLTI0;(CD*" >3C%;$>AZ7%K$NL)8PC4)D"/<[?G(  QGZ #\*OT
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M"YBA6WU*2)X2DFYALC"?,,#&<9ZFH_%&BZK<:GI>NZ$T#7VG&1&@N&*I/$X
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MU%Y]6MIH(RA$("J;0;>=[9YR03R!BI8=6TVXN([:'4+66:6,2I&DREG0C(8
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M5W"X&"2QST QU]2!0!K45RUIXC>'Q7KEMJFHVD6FVD-M);R-MC5?,W]6)Y/
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MB,_[7I^-11>(-%GNH;2+5K*2XN$WQ1+<*6D7U49Y%<SJ-NMU\0+BYL]DEO\
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MN]N;B)((8G&"BK]_\Y"P]PBFJOC:>&SU;PO>7,B0V\6ID/*YPJ;HG R3TYH
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M:74%]:17=K*LT$R!XY%.0RD9!% $U%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV,!@OQ_:*B.[3/'0=2,Y)[@>E>@:CKG@W6=-DT_4];T>:WF \V(WZ8."#U#
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MLTFE031BXM<^7.C)(%8 DX^X>YZUSOAGQ9JO@WX8>']3:UM)](>XD@E4%O/
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MDXKK: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JEJ6CZ9K
M$:1:GI]M>I&=R+/$'"GU&:NT4 87_"#^$_\ H6]+_P# 1/\ "C_A!_"?_0MZ
M7_X")_A6[10!A?\ "#^$_P#H6]+_ / 1/\*/^$'\)_\ 0MZ7_P" B?X5NT4
M87_"#^$_^A;TO_P$3_"C_A!_"?\ T+>E_P#@(G^%;M% &%_P@_A/_H6]+_\
M 1/\*/\ A!_"?_0MZ7_X")_A6[10!A?\(/X3_P"A;TO_ ,!$_P */^$'\)_]
M"WI?_@(G^%;M% &%_P (/X3_ .A;TO\ \!$_PH_X0?PG_P!"WI?_ (")_A6[
M10!A?\(/X3_Z%O2__ 1/\*/^$'\)_P#0MZ7_ . B?X5NT4 87_"#^$_^A;TO
M_P !$_PH_P"$'\)_]"WI?_@(G^%;M% &%_P@_A/_ *%O2_\ P$3_  H_X0?P
MG_T+>E_^ B?X5NT4 87_  @_A/\ Z%O2_P#P$3_"C_A!_"?_ $+>E_\ @(G^
M%;M% &%_P@_A/_H6]+_\!$_PH_X0?PG_ -"WI?\ X")_A6[10!A?\(/X3_Z%
MO2__  $3_"C_ (0?PG_T+>E_^ B?X5NT4 87_"#^$_\ H6]+_P# 1/\ "C_A
M!_"?_0MZ7_X")_A6[10!A?\ "#^$_P#H6]+_ / 1/\*/^$'\)_\ 0MZ7_P"
MB?X5NT4 87_"#^$_^A;TO_P$3_"C_A!_"?\ T+>E_P#@(G^%;M% &%_P@_A/
M_H6]+_\  1/\*/\ A!_"?_0MZ7_X")_A6[10!A?\(/X3_P"A;TO_ ,!$_P *
M/^$'\)_]"WI?_@(G^%;M% &%_P (/X3_ .A;TO\ \!$_PH_X0?PG_P!"WI?_
M (")_A6[10!A?\(/X3_Z%O2__ 1/\*/^$'\)_P#0MZ7_ . B?X5NT4 87_"#
M^$_^A;TO_P !$_PH_P"$'\)_]"WI?_@(G^%;M% &%_P@_A/_ *%O2_\ P$3_
M  H_X0?PG_T+>E_^ B?X5NT4 87_  @_A/\ Z%O2_P#P$3_"C_A!_"?_ $+>
ME_\ @(G^%;M% &%_P@_A/_H6]+_\!$_PH_X0?PG_ -"WI?\ X")_A6[10!A?
M\(/X3_Z%O2__  $3_"C_ (0?PG_T+>E_^ B?X5NT4 87_"#^$_\ H6]+_P#
M1/\ "C_A!_"?_0MZ7_X")_A6[10!A?\ "#^$_P#H6]+_ / 1/\*/^$'\)_\
M0MZ7_P" B?X5NT4 87_"#^$_^A;TO_P$3_"C_A!_"?\ T+>E_P#@(G^%;M%
M& _@3PDXP?#>F#Z6R#^0IW_"#^$_^A;TO_P$3_"MVB@#"_X0?PG_ -"WI?\
MX")_A1_P@_A/_H6]+_\  1/\*W:* ,+_ (0?PG_T+>E_^ B?X4?\(/X3_P"A
M;TO_ ,!$_P *W:* ,+_A!_"?_0MZ7_X")_A1_P (/X3_ .A;TO\ \!$_PK=H
MH PO^$'\)_\ 0MZ7_P" B?X4?\(/X3_Z%O2__ 1/\*W:* ,+_A!_"?\ T+>E
M_P#@(G^%'_"#^$_^A;TO_P !$_PK=HH I:;HVEZ.CQZ9I]M9)(076WB"!CZG
M%7:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBFJZ."48, <'!SS0'5CA6!XSP>U #J*:KHX)1@P!P<'/-&]-^S<-V,[<\XH
M=132Z+]YU&,#DU6NM3M+2^LK&:4"XOG9(8QU;:A=C] %Z^I'K0!;HHHH **K
M:A]L%A.=/, N]A\HW&?+#=MV.<?2LC5=:U#3_$7A_3U2V:#4GD2=_FW K&6^
M7G&,COF@#H**P='UJ]OO%&NZ5<QP+%IOD>2T>=S"168[L_0=!6Z2!C) SQ0
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M(SVSWJ\/#6B+I<FEC2[7[#*=SV_EC83ZX]?>K&F:3I^BV8L],LX;2 $G9$N
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M%=./#NC#2!I TVW&GC_EV"#8>_([\\\TXZ%I1NH+LV,1GMEV0RD?-&OH#V%
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MOH5GIDFF6^E6T=G*VZ2%4^5SZMZ_C5BXT;3;B\@OIK&*6ZM5Q!*1\Z#T4]J
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MO:XMM.M_$,<<BJI*06[&(R *",+R<@8X8UZ*VB:8UW!>-9QM<6PVPRGEHQZ
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M^UOY[^"TCCNKC'G3*/FDQTW'OCMZ4E_H^FZG+#+?6<5P\!W1-(,F,^H]#[T
M<<;33[7QF?#6RQM;&/3E>PMKF#S(VW._F[06 W?=]3@>F:T-+BU;0M"M=/\
M#\<.NV\#2(9[FZ\G9AN%7"MN Y'7C;BMW5] TC7HXX]6TZWO%B.4\U,E?7![
M5=@@AM8$@MXDBBC4*D:*%50.@ '04 <GJ3S/X_\ "+W,2Q3M:7AEC1]P1MD>
M0#@9 /?%<WJ$EI+9:=JNF@+%)XE3;=3L&N9F,Q5^1C:F,@ Y)4#.*](GTG3[
MF_AOYK2.2Z@&(IF'S(#UP>V:IMX2\.N;@MHEDQNG$DV85^=LYR?Q&: .9M]"
MTGQ!XZ\6Q:K:I=P!+/:KL=HS$WS#!Z^AZCG'6L?1;^Y33_"5CJ=W&+&<W:PS
M7J>8DI5P(-W('W,[<]>.^*]$N?#VD7ES]IGT^!I2GEL^W!=/[K8^\OL<BI=1
MT?3=6L/L.H6,%S;<8BD0%1CICT_"@#@?$VE6VC?#SQ1;VM^+B-Y4E:&- L5L
MS.I*(,G Z';GC/O7I+*KH4=0RL,$$9!%9W_".:+_ &0ND?V9;?V>IS]F\L;"
M<YY'?GGGO6A%$D,2Q1KM11A1Z"@#SRSL(-)U;6? ZVL:P:K,MU:X08\B3_7#
MVV;&"^[+4_B*#3)[GQ#:VT$326.DK'-]IQY5LA5V18DQU/<Y &%ZGBNY:UMV
MNTNS"AN(T:-9,?,%8@D9]"5'Y54N?#^CWFH#4+K3+6:[";!,\0+;?3- '%Z3
MJ45UJ7A"RUB1);6XT%9(A.<K+=;8\YSU8(3C/]X^M2ZN-+T"VTG3[:=O[$EU
MHQWF]]T:%E9A'GH(]Y&1TX(/>NJG\+:!=:5%I4VD6CV4)S' 8AM0^H]#[U8?
M1=+DTG^R7T^W-AMV"V\L>6!]/KS0!S6N:/HEKH7BO[$?GN;%IYX$;]U$RQL%
M95'"DXR?7 -9MQ8VMW=_#SSH]WF6[(V"1N7[*3@XZCV]SZUV5MX<T:STI]*M
MM-MXK&3/F0(F%?/7=ZY]Z4^'='/V3.G0'[$,6WR_ZG_=]/PH \_NI/\ A'M/
M\;V^F+]EM+6]M2(X5($,<BQ^:548Q\I;IBNFTO2=.B\26FKV6IVH:XM3&+>P
MA"1SQCD.P#'[O&&]P.];L.B:7;SW,\5C"LEV-MPVW)F'^UZ_C3-)\.Z-H1E.
ME:9;69F.9#$@!;VSZ>U &E1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/XLU*\T?POJ&IV'DF
M>T@:51,I93@9Q@$5L5S_ (^./ 6N?]>,O_H)H UK6[5M+@N[F1(]\2.[,=J@
MD#UJ/5-8L='TB?5;N=5M88RY<$?-Z >I/0>M<I'.7\;^';*^4-9-HS26JN/E
M:YRN[CN1'G'ID^M<_P"(+3R- ^(%E#$#I=M+"]HFW*Q2LJM*$],%AP.F30!Z
MFUU;I$LKSQHC' 9G !/IFI5974,K!E/((.0:X[7+.Z_M"SNO#8TZZEM+5UDT
MN<!4FC<C)0CA6RH'IR,^^UX2O+2_\*Z=<6-L]K;&$+' _6,+\NWWQCK0!!H.
ML7U_KVO:?>>1LTV>..(Q(5RK1A^<D\\UMI<0RR/''-&[Q\.JL"5^H[5YSJ-S
M?6B?$:?3"PNHS"4*?>4>0NXCW R?PJ[K-O:16W@[4/#\:1S/?011-" #);NI
M,BG'5=HR?IF@#N7N(8Y4B>9%D?[J%@"WT'>DDN((71)9HXV<X0,P!8^WK7 Z
M6VAZYI&O6WB*9([V+4I?M)9]DT81\Q;#]X *%"X]_4U#XLFL;RV\9&!(UF@L
MD6ZDO&W$,(RT:1+QMZYW9^\> : .ZN=9L;75K72Y)U%U=*SI'D9"KU8^@S@>
M_P"%6WN(8Y4A>:-9'^ZA8 M]!WK@L6=QXQ\*7-R()/,TF9I)) IW,JQ\DGN.
M?I52WBTSQ%INN6NMZNEE>0:C,;C*HLT.V3,3(QYP%"@$>XH ]&NIEAB_U\4+
MO\L9E/!;MQD9^E9/@S6+K7_"EEJEZL2W$^_>(@0HP[+QDGL!6+HLMOJ7C3Q'
M9:PJS2P0P)!'<J/^/<QY8@'CEB=V.^ >@JU\+RG_  KS2Q&P*J)0,'/_ "U>
M@#IWN((Y4BDFC21_NHS %OH.]57UFQ36TT<SK]L>!I]F1\JAE7GZEN/H:\Z\
M9SV=QH'C"XLO+1H;E$GFN6W2M,@3"Q#C8H[')R=V!WK>=+"3XLPSR);L&T0N
M'8+@N)U&<^HZ4 =3J^K6>AZ7/J-]*(X(%R23RQ[*/4D\ 5EZCK=Y:>,-$TV)
MK=K'48[AG;:=ZF-0>&SC'S>G:J?Q0CC?X?:FTB*WEJC*6&=I\Q>1Z<9JKX@L
M].N?''A*S$,#VNR^S"@&P_(F00.",]10!VD4L<T8DBD61&Z,IR#^-)%<0S[O
M)FCDVG#;&!P?0XKS&24Z/X8\7Q6:F"SMM;4.D*\10,8O-"J.@P6X'8FNGTG3
M](_X2:WU:PU>.>>>S,?DVBH(Y(@<AF"^A( /OB@#1U[76TR\TS3[=8C=ZI,T
M433L1&FU2Q)QR3T 7C)/44ZSOM635Y++4X+58%M_.CNH68"3!P05/W<<=SU'
M-0^*-*T7Q EOH>KJ=USODMG5MKHZ8Y4]FPV?H#6)X>.MZ-XI?PCJ]Z-:L);)
MKFVN95_>HH8*4D_O#GJ>OZ  ZK3-:L-7T[^T+2X1K;<X$FX8PK%=WT.TD'TJ
MTUS B.[3QJL9P[%P I]#Z5Y.UKI[_ 6Y;R;?SU#N6"KO!%RP!]?45U>JZ=H>
ME:]HUK9V$4=]>3RS1!FVPLRQX:20?QL W ZDDG(Y- '1ZKK5AH^D3:K=SHMM
M$F[<&!W^@7U)/ JT]S!%#YTD\:1_WV8!?SKR6Z\B3X6>*XB]O,+?6)O*\M1M
M1?.3E!D[5Y/?O73:A<6*>/8=,GN;6TLVTW-DK1H8FD\QO- SQNQM]\9]: .V
M:2-8S*SJ(P,EB>,>N:$D2:(202(ZL/E93N!_*O/;FPM-%T?0H+#4C?6-KK'$
M,LB*)N&.Q"<*0AR0"<94C.0*U=$\/6YU+Q'JMQ96JP:DP$4)".RH$ ?)7(&Y
MANQGMD\T =)ISW(TN)]1GMI;@+^^EMP5B)'4C).!5F*:*>,20R)(AZ,C @_B
M*\MTB_CL_"7@%;]E729I76Y+_<W[6\H-VQNYYXR >U=[HMGH]IJ&IMI3@M<2
MK+<K&^Z-7*XX X!( )'N#W% &5XH\777A36+#[9!'-I-UO\ .FC1O,M@"HW-
MR05RZYZ=:U]7U"[@BL9M.DMGCNKB.(M(I<%7_B4AA_\ 7J#5((;OQ1IUM<1I
M+#-87B/&XR&4M ""*Y*.&_\ "6MZ=X7F$MSH]Q?1RZ7<DY,.#EH7/L.5/I^@
M!Z*]Q#$Z1RSQK(_"J6 +'V%59=9L8M:ATAIU^URPM,(\C(12HR?3);CUP?2O
M/_&4UE=:3XSEM1$KPF-+B6Y;<YE5%VK$O&T#J#DY;=@=ZU66RF^)FF7,RV[[
M]%D<R.%.7$B<Y]1^E '7VAO/M=X+F:V>(2#R$B4AT7:.'R>N<].U3QW$,KND
M4T;M&<.JL"5/OZ5YC?-<Z7I'Q$?14\J:.Y0KY(P4!C3>PQT(!8ULZY;VD-SX
M/O\ P]'''))>Q0H8 !YEHR,S@XZJ%4'GH: .T:Y@0X>:-?F"<L!\QZ#Z^U+-
M<0VZ!YYDB4G +L%&?QKRU]$TN7PKX_D>Q@9[6^NF@)0?N2(D8%/[ISZ8Z#TK
M=-S9WVKV4,GE/?C0EDGEO6W0QPN1DA.-S$KR<@ #KVH VO%6LWVCC2'L_(,=
MYJ=O:3"123LD;!*D$8/USUK;N)TMK:6XDSLB0NV!DX R:\NLI_.^&O@<M*'9
M=7LE/S9(Q*<#\A7J%S,EO:S32*62-&9@!G( R: .7A\1Z[=^&4\165I83VTT
M7G+;"1O,C3U+]&8#DK@=",UO2:S8QZW%H[3K]KD@:?9D?*@95Y],EN/7!]*X
M+5M$F\&:=-XL\%ZGY>G[1<SZ9*VZWF0XY3^Z<'M^'I6K(MI-\4[&ZN+:*,RZ
M&\I$JC(?S4QG/\0'% '9M<0I,L+31K*XRJ%@&/T%$T\5O'YDTJ1)TW.P _,U
MYQ8I;ZK\-/$%UJBJ-4AENWN96XDAG0L8\'J-H"8QVJUI&HF;Q39V?BKRQ/)H
M4#P)<@;6D.?/X/&\G (ZX% '1:[K-[IVN:#:V_D-;:C<M#+N4EQA&8%3G';T
MK<$T1+ 2)E>6&X<5YSKULFGVGA2T\+.DOD7LZ637$A=&81R8&[J5SP/8#M4E
MR^D:G\*]=GAM EXMO,;])U!F2Y );><=<\@\#&, #B@#T%+B%Y#&DR,X4,5#
M D ]#CTK.N9]3M[?5IA/9.85WVJ;&R@"9Q)SSD@],<5QMYH=E83>#-4T>!8M
M1GNX4FDC^_/"T1:4N>K8 ZGI5S1(8;;4?'D<")'&)@=JC !, )_4F@#I?#6J
MRZKX5T[5;PQI)<VR32E?E4$C)Z]!6G%+'/&)(9%D1NC(<@_C7FD%\MIX5\!)
M=W"V^G3(JSRR*#&)/*_=[L\8SGKT(![5UGAG3-/T[4M6:PU$W/VJ2.::) HB
MA<@CY0O +  D?0]Z -"]U0IJMOI%KM:[GC:9BPR(HE(!8CODD #ZGL:H1ZY?
MZIK6IV&DBS0:6Z1R_:2Q:1V4-P%^ZO.-QSDYXXJCII<_%C6O.ZC3;?R,_P!S
M<V<?\"S46L^%;/Q#JMSJ^A:E-I.O6;^1)<0G(<A00LB=&&"/PQUQB@"SJ/B'
M7[;P@=:BTZV%Y%*T<M@Q9]Q$QC 5QCGIVY]JT-.\10Z_X8.L:1(@/EL=DRD^
M6ZCE& (((Z?KS6%8:W?ZWX$-QJL<:7=OJ$=M,\7^KD9+A%++['^8-5_%-C=>
M#KZ[\3Z1"TNG7B%=7LH^Q(P)T'J,_-Z]?4@ V9?$MW'!H-MMM?[0UM=R,^5B
MB 0.W&26/( &1G/:KUG=ZR^IW.GWL-K&$@62"ZAW%9"20<H>1C XR<YZUD7.
MD:)XB\.Z'HFK!A--9K-:RQML>-D1,E&]?F!QSP#Z5%X7GU[1O%<WA35K_P#M
M:V%G]KM;QAB55#A=DGJ?0^WX  Z32-5&I+<PR((KNRF,-S$#G:V 01ZJRD,#
MZ'U!JOXBUS^QH[&./R_/O[R.UC+\JF[)+$9&0 I[CG%9.B;Q\4/$^S_5&VM#
M)Z;]K8_'%'CRVMI;SPPTT$3LVMPH2Z DKLDX^F>U &WI\]_:P3?VY=6)'G$6
M\T)*"2,@$;@QX;J."0<5I,Z( 795!( ).,D]!7'Z:L-W\0O$&G:E;Q.D%I;+
M8PR("OV<J?,V@\8W\'Z =JY9;,2^&M&ANAYEO!XK%M8RL?F-L)&4 -UQP1]
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7(Y$EC62)U=&&593D$>QK!M-7OW\>7VC3-"UI#8QW$6R,JP+.RD,23G[O;%
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MLABV8PKF >B<?+^%36U[:7B,]K=0SJAPS12!@#[XI$O[.26.)+N!I)5+1J)
M2X'<#N* 'W%O!=V\EO<PQS0RJ5>.10RL#V(/6J:>']&CDMI4TFS5[1=MNP@4
M&$>BG''X5H5#;WUI>%Q:W4,YC.'$4@;:??'2@"&VT;2[-IVMM.M83<Y\\QPJ
MOF_[V!S^--TS0])T42#2]-M;(2G+^1$$W?7%3C4+(O&@O("TI*QCS!ER."!S
MSBK% %._TC3M4,1O[.&Y,.3&9%R4)QROH>!R.:2QTBPTUY)+2V5))<>9(26=
M\= 6.20/K4RWUH]R]JEU"TZ#+Q"0%U'N.HI@U*P9&<7UN47&YA*N!GIGF@"N
MWAS0W@G@;1[$Q7$GFS1FW3;(_P#>88Y/N:?<Z%I%Y:P6MUI=I/!;$&&*2%66
M,C^Z".*LR7=M$-TEQ$@V&3+.!\HZM].1S[U6U"XDET6:XTZ_M8'*;HKJ7#Q+
M[G!&1^- #ET;2UCNHUTZU"7IS<J(5Q,>GS#'S?C45UX=T2]L(;"YTFSEM8/]
M5"T"E(_]T8X_"KDMW;VX'VBXBC.TM\[A>!U//:DAOK.XD\N"ZAE<#.U) QQ]
M!0!S_B;0KFZ338K+2M-O].M"WF:;<8C5OEVH5.T@;<MP1CGV%-T'PI:VEW+=
MMH=CI230- ]I;/YBR@D'+\!<C&  #]X\\XKI(+B"Y0O!-'*H."8V# 'TXIMQ
M?6EHR+<W4,#2'""20*6/MGK0!6_L'2!I;:6-+M!8MR;80J(_7[N,5/8:=9:7
M:+::?:0VL"?=CA0*H_ 5F^*?$$?A_3HY T7VBXGB@B$C< NX7<1G)"@D_AVJ
MSI U,-<F]O+6\MF<-:30KM8KCD,.G!Z$=: )Y=+T^>]COI;*WDNHO]7.T8+I
M]&ZBIY8(I]GFQ))L<.NX9VL.A'O7/>%]6U75=(FU6[EMW027");QQ;.8Y&49
M<L>H7T[UGZ'XZEU;739"VC*3NHC03Q@P )^\^;<1+\W39G ZXH Z2;P_HUS=
MS7<^E6<MQ/&8Y97@4LZ$8()QR,<5(VC:6[6C-IMH38_\>I,*_N/]SCY>@Z>E
M<QK_ (YET?7%L_LZ".&0B13-&3.K1,4YW 1?. /GQD=,U>\3ZOJVF>'5UJTD
MMXMJP[[:2/S.7=5.'# <;NP/2@#:MM)TVRFFGM;"V@EN/]<\<2J9/]X@<_C3
M;+1-+TV3S+'3[>W;! ,487 )R0/0$]A5ZJ\5]9SSO;PW4,DT?WXTD!9?J!R*
M *H\.:&L=Q&-'L0ET<SK]G7$I_VN.?QI3X>T4R6LG]DV6ZS&+8^0N81G/R\<
M<^E6?M]F;HVOVN#[0/\ EEY@W^O3K4>K:K::)I=QJ5]*(K>W0NY)Z^P]2>@%
M $!\.:&;:.U.CV)@BD,L<7V=-J.>K 8X/O6@\4<D+0N@,;*5*]B,8Q6!J>MW
MEKXLT&RAEMS8:B+CSLI\X,<>X8;.,?AVZUNP7,%U")K>>.:(]'C<,I_$4 9T
M?A;0HC'Y>F0(D;!TB48B5AT8)]W.><XS5RXTVPO+JWNKFRMYI[8EH)9(PS1$
M]U)Y'X41ZE83122Q7UN\<1Q(ZRJ0A]"<\4XWUF(!.;N 0DX$GF#:3Z9H @DT
M/2IKXWLFG6SW+%2TIC&6*_=)]2.Q/2EU/1-*UI(TU33K:]6,[D$\0?:?;/2K
MN<C/:H;>^M+MG6VNH9VC.'$<@8K]<=* ()]%TJY:W:?3;65K4 0%X5/E8Z;>
M/E_"LGQ-X;@N-!U>/2-*MAJ.I0/$TJ(D;.6!&7;J>OO6Y_:%EYD<?VR#?*2(
MU\P9<@X( SS@TL][:6P<W%U#$$4,WF2!=H)P"<]!F@#/T'1K73["U?\ LV*V
MNXX!&^ I*\#< 1V)&>.O>K":%I$9N2FF6BF[&+@B%1YW^]Q\WXU:-S L:2--
M&$D(",6&&)Z 'OFHVU"R6U^UM>0"W!QYQE79G..N<=: (3H>DG3#I9TVT^PG
MK;>2OE_]\XQ4VGZ=8Z5:+::?:0VL"G(CA0*N?7 J5)X9(!.DJ-$1N$BL"I'K
MGTIEM>6MZA>TN8;A5."T3A@#Z<4 4K[2RVK6VL6FT7<$;0NK<":)B"5)[$$
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MR]OIMQBFV.C:7IEDUE8Z?;6UL^=\4<056SP<CO\ C5F6X@@@,\LT<<(&3([
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M)! ^4YY48(/:N9U!HQX&\ EF7!O=,Y)_V16QJL<$?Q1\/.J1K+)9W89@ &8
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M** *ITS3S>_;C8VQN_\ GN8E\S_OK&:4Z=8F[^V&RMS<CGSO*7?Z?>QFK-%
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M@"H=+TXW?VLV%L;C.[SO)7?GUW8S4RV\"3R3I#&LTH >0* S@= 3WQDU+10
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFZ5"A^5B"<'D<CO0!HT5R+?$C2E02?V9K7DLP"S?V>XC;)PI#'C!)&/K774
M%%%9>I:Y'87'V2&TN+Z\$#7!M[?;O\L$#/S$#DG '4T :E%4/[7MQH\6IM'<
M+'*BND1A;S26Z+LZ[O:JVB>)K+79[NUBANK6[LBHGMKN+RY$#<J<=P<=: -B
MBN?3QGIK:Q;:;)!>P_;&*VMS+;E89V SA6/J.G'/;-=!0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5'
M//%:V\EQ,X2*)"[L>BJ!DFI*HZMIIU6R-I]JEME9U9FB"DL 0=IW C!QSZCB
M@#C_  _JC6?C4?:+II$\1P&;RV_Y=[A.1'_WZ('N8ZOZ*W]L>//$$E\HD_LI
MH;>TB<9$*LFYG ]6)Z]< "MG7M CUZ&T22[GMGL[E+F*6#;N#KG'W@1CDY'>
MF7'AU6U;^U[*]FLKYXUBG=%5DN%'3>I&,CG!&#SCI0!.MGIVA_;]21%MXY%\
MVX"C"_*#EL>N.OTKE/#6I/8^,Y+>XNC*OB"#[4%)_P!3<H/FB'MY>T#_ *YU
MU%YHC7MIY,FI7(=I4DDD 3+[&#!<%<!<CH!SSD\FDUW0(]=^PL]W/:R6-RMS
M%)!MW;P",'<#Q@G([T <KK0'A_QRWB>(!+93#::B ,#RI.%D/^ZX7GT)I^L?
M\3+XA>'+Q_GMHKRXMX%/*DI"Y=_^^QM_[9^]=-/X>AO!J4=Y<23PZE"(98F5
M0% !&5P,YY_.H9/"ML9M&>"ZGMUT4'[/&FTALIL.[()/!/IUH VI8HYXFBE1
M7C<896&01Z&O.H[B:U^"FGK;NT9F6&W9U."J/,$;GZ$C\:]&=69"JN48CA@,
MXK&M/"UE;^%1X<EEFN;01F,-(0' SD'( Y!Y!QV% &9+>6VA>/GC+QVFGOHW
MG3]%1#'*%5O0<.1] /2K.L6.C_$#PY-'97<$Y1\V]U'AO(F7!!_ED=P:U+'1
MTM;^74)IY+J\EB6$S2 #;&I)"@  #DDGU/L !H$$J0#@^OI0!R?AR=_%JV]_
MJMC'')I,CP&(@,/M2_+(X_V1T7_>/H#5S0]8UC5M1O5DMK**TLKV6V<K(QD;
M:JE2.,=^<X_3FYH.A1Z##=1174UP+JYDN6,H7(=SEL8 XS3M(T9=(DOG2ZFG
M^W7+7+B0+A'( ., <<#KF@"IXETK1);2XU?5M+M]0>UMSY:3QA^F2%4'@$DX
M]^*S+[PI?IX1TS1].CTR5;0!KBUO(B8;AL$D87H-Q+#@\@>E=/J%@FHQ112N
MRQI-',5'\>Q@P!]MP!_"F7UE=74\,EOJEQ9K'N#I$D;"0''7<IP1CC'KWH Q
M])UBRL_ XU"VTQ-.2 21_85 41S*Y0QC'',@(SWSFL[P7=_V=KVI^'I;XW@D
M U"WF;.7W\3#\).<>CUT4FA1%+&.&YF@BLYO/\M0K"9^<ER02<EBW;GFF:GX
M?CU+6-.U07D]M/IQ?R_*"X<. &#9!R" * .>UBPN-/\ %46LZMI>FZI83744
M44_E'[18$D+&1G(*[R"<8(+$U3NW:]T'QUJ<Y(NK.YECMY/XH1!$K1[3V^8E
MOJ:[!=&D>Y9[S4KB\@$_G1V\BQA4(.Y1E5!(4X(R>PSG%07OA>TO9;P-++';
MZBR->6Z8VS%0!UQD9  ;'4#MS0!EZL1=ZEX+U"6)5N9+KYFQR-UM(2/IFK'C
M:")X]$E:-3)'K-IL8CE<R '%:FI:*FI7NG71N983I\QFB2,+AF*E><@\88],
M4NLZ,FLI:H]S+ +6YCN5\L+\SH<J#D'C- &7JPEA\96ES>6<UUI;6,D*^7 T
MPBF+ DLJ@D!E&,X[$=ZY+1KR?4X_"6BW!<Z5>7%[($<_Z^&$DPHWJN"#CH0H
MKT;4=/.I6YM9+F2.W<;95B^5I!W&[J ?;!]Q5;4_#ECJ-G:6ZA[-K%E>SFML
M*UN0,#;P1C'!!!!':@"+7+"VM;.36;>V1+S3K>:2%D0 G]VPVGU'3CVKF;8G
M3=-\"WEMEKB[98[AQ]Z<2P-(Y8]\N WU%=E;Z?,"&OKY[PJ" K(J+R,$D <G
M!/7CVJI8>&+6QFLCYTTT6FJRV43XQ &&/3)(7Y1GH/?F@#CK*YE3P1X:UT'.
MHW6JQ22RC[TAFE*NI/IM;&.VT>@I#=2_\*\D\2G_ )"G]L>>)/X@1=^3L^GE
M_+CTKL8/"UG!);J)96M+6Y:ZM[4XV1R,2<],D LQ SP3[# ?"UF92OFR_8S>
M?;?LG&SSL[L],XW?/C^][<4 9?B/PKH-S/;Q'2;26^U.]7?<21!Y-H/F2'<>
M1\JE1Z;A5C7X8_\ A-/"L^Q?-$]PF_'./L[G%;KV"2:K%J#.Q:&%XD3L-Q4L
M?K\JC\_6J^H:,NH:IIVH-=2Q/ISN\:(%VL64H=V1GH3TQ0!I4444 %%%% !1
M110 4444 %%%% !1110 4444 %>;:%;:MJ%KXVT_38[/_2M8NHC-<2L/+W*H
M)VA#NX/J*](8$J0#M)'!]*QM \-QZ!<:A+%?7-Q_:%RUS*LP3 D;&2-JC X'
M% &3#ITOAVVT7P_#JDA@AM'4PVZ_Z3<2#&&&00J#)R20 2H)-9]KXHUA_ &B
MZE<3E9+C41:W]YL4&&$3.A<_P@_*H)Z#=FNFU'PVE]KUOK,.H7=E<PP-;N8-
MF)8B=VT[E..1U&#7,ZUH<'AO0]/TF.^UA+ W[3M>PKYILP"S@$!3D%VZD'GD
MG@4 2_V]J6FW?BB]6^EOM+TBV62U5@A1Y"A9D+@9;! [\;N:T+-/$G]J:9=Q
MW#RV,J$7RW$D>UL@;7C"C(.>V<$>_-0:%!<:A++:MK5UK>CSV[QSK=V0A49P
M %8*N[(+9'('L<9O:%X.71'B0ZSJ-[:6W_'K:W#J4AXP.@!; X&3@>G2@#I*
MY3X>*K^%ID90RF_NP01P1YSUU+@LA"MM)'# 9Q69X>T&/P[8O9PW<]Q&\KRY
MF"Y#,Q9ON@=S0!6UO_3]<TC21R@D-]<#_8BQL'XR,A_X :OZ[J8T70;_ %0Q
M^9]DMWF"?WBJDXIT.FI%K%SJ9D9Y9XHX0#TC1"QP/J6)/X>E6+BWAN[:6VN(
MUDAF0I(C=&4C!!_"@#B]1U75M&\.Z/XD_M&2Z,[V_P!MMV5?+D27 .P 94J6
M&.>1US4J6<I^+L[?;[D :/')@;,8\]_D^[]WCZ^]:5GX/AMK6SL)K^YNM/L)
M5DMK:4+\I7E S 98*>@]AG.*M+X?5?%+^(/M]P9GMQ;&$A/+\L,6 Z9SDGG/
M>@#7.<< $CIFN0T*XOK?Q_JUEJ]E;K=7ELES!=6[$JT"'8$.>A!;/ON/M72:
MG9W%]:>5:ZA/82APPFA56/'8A@00:BL](6WN);R:YEN;R6,1&X<*"J#)"J
M ,DGU/?.!@ Y_P 7W%_8ZWHE]/8VUUH\%ZBL%=O-BE?]VDF,8(&XC'O^78UB
MVWAZ7; NIZO=:FEM()8EF2-1N'W2VU1N(ZCMGG&0*VJ "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
:*** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>ebs20191231exhibit1048018.jpg
<TEXT>
begin 644 ebs20191231exhibit1048018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V:BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK2T4 %( %&  !Z"EHH 2EHHH **** $P,YP,^M+110 4444 )M&0<#CI[4$
MC!&1Z&EHH **** "N=\3>%5\0WEC<2M;316>_-I=P^9%(6 &[@@@C'N.>E=%
M10!S?AWP99:!JUUJD$-O;RW,*P^3:1F.)5!)S@DY8GOQP!QU)Z,@$8(R#V-+
M10 4444 83>&O^*V'B>.\VR&S%F\#1Y!3=NR#D8.<5NT44 %9GB+1VU_0KK2
MA<_9TND,;R>7N(4]<<CFM.B@"KI=BNF:39Z>KF1;6!(0Y&"P50,_I5JBB@ H
MHHH **** $(!ZCI2T44 %%%% "8&2<<FEHHH 0 #.!UI:** $(!&",@T=*6B
M@!  .@ ^E+110 4A&1@]*6B@! ,# HP#UI:* $  &!P**6B@!,<YI:** "BB
MB@"*YA%Q;2P$[1(A3/ID8K+\*: ?"^@6^CK=?:8K;<(W,>QL%BQSR<\GVK9H
MH **** ,&Y\,_:_&5EXCDO"#8PO%' L> 0P()+9Z\^E;U%% "  = !2T44 <
MGIO@^ZL?B!J?BB2\ADCU"(1&W$9!0 ( =V>?N#MWKK*** "L76=(U74-2M9K
M/66L[1(Y([FW\K=YH88R#D88=CS_ $.U10 V.-(8UBC4(B *J@< #H*=110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !117.^)U::_P!+M_M%S%'(TI<6
M]P\);"\9*$$T =%17(_V/#_S^:I_X-;G_P".4?V/#_S^:I_X-;G_ ..4 ==1
M7(_V/#_S^:I_X-;G_P".4?V/#_S^:I_X-;G_ ..4 ==17(_V/#_S^:I_X-;G
M_P".4?V/#_S^:I_X-;G_ ..4 ==17(_V/#_S^:I_X-;G_P".4?V/#_S^:I_X
M-;G_ ..4 ==17(_V/#_S^:I_X-;G_P".52T2P%YH.GW5Q?ZH\T]K')(W]IW
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M?(I_]CP_\_FJ?^#6Y_\ CE '745R"Z3;NH9;W5&4C((U6YP1_P!_*7^QX?\
MG\U3_P &MS_\<H ZZBN1_L>'_G\U3_P:W/\ \<H_L>'_ )_-4_\ !K<__'*
M.NHKA=7T\6FE7$\%]JBR(F5/]IW!Q^;U<_L>'_G\U3_P:W/_ ,<H ZZBN1_L
M>'_G\U3_ ,&MS_\ '*/['A_Y_-4_\&MS_P#'* .NHKD?['A_Y_-4_P#!K<__
M !RC^QX?^?S5/_!K<_\ QR@#KJ*Y'^QX?^?S5/\ P:W/_P <H_L>'_G\U3_P
M:W/_ ,<H ZZBN1_L>'_G\U3_ ,&MS_\ '*/['A_Y_-4_\&MS_P#'* .NHKA8
MK -K=U;&^U0Q1VT,BK_:=QPS-*"<[\]%7\JN?V/#_P _FJ?^#6Y_^.4 ==17
M(_V/#_S^:I_X-;G_ ..4?V/#_P _FJ?^#6Y_^.4 ==17(_V/#_S^:I_X-;G_
M ..4?V/#_P _FJ?^#6Y_^.4 ==17(_V/#_S^:I_X-;G_ ..4?V/#_P _FJ?^
M#6Y_^.4 ==17(_V/#_S^:I_X-;G_ ..55U73EM=(O+B&^U198K=W1O[4N#@A
M20<%Z .XHKCXM)B>)&:\U3+*"?\ B:7/_P <IW]CP_\ /YJG_@UN?_CE '74
M5R/]CP_\_FJ?^#6Y_P#CE']CP_\ /YJG_@UN?_CE '745R/]CP_\_FJ?^#6Y
M_P#CE']CP_\ /YJG_@UN?_CE '745R/]CP_\_FJ?^#6Y_P#CE']CP_\ /YJG
M_@UN?_CE '745R/]CP_\_FJ?^#6Y_P#CE4S8#^VTMOMVJ>4;9I"O]IW'WMP&
M<[\]* .ZHKD?['A_Y_-4_P#!K<__ !RC^QX?^?S5/_!K<_\ QR@#KJ*Y'^QX
M?^?S5/\ P:W/_P <H_L>'_G\U3_P:W/_ ,<H ZZBN1_L>'_G\U3_ ,&MS_\
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MTQGUKL3:VKH5,$3*6W$; 06]?K5/3=&BT^XN[ABDTMS<-,',8#)N &T'TXH
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M S;F(ZL?4GJ3P.OI4/V^3_H%ZC_X"M1]OD_Z!>H_^ K4 6Z*J?;Y/^@7J/\
MX"M1]OD_Z!>H_P#@*U $,'_(RWO_ %YV_P#Z'-6C6)#>R#Q%>-_9U^2;2W&T
M6S9'SS<D>G/Z&M#[?)_T"]1_\!6H MUG7WA[1]3N/M%]IT%Q+M"[Y%R<#M4W
MV^3_ *!>H_\ @*U'V^3_ *!>H_\ @*U "RZ78S+$LEI$RQ+L0%> O'R_3@<=
M.!5>]\.:-J5RUS>Z;;W$S  O(F3@=!4_V^3_ *!>H_\ @*U'V^3_ *!>H_\
M@*U #I=/M)I;>62!2]MS">1Y?&./3CCZ59JI]OD_Z!>H_P#@*U'V^3_H%ZC_
M . K4 6ZHZ[_ ,@#4?\ KUE_] -/^WR?] O4?_ 5JI:U>R-H=^ITZ_0&VD&Y
MK9@!\IY)]* -6#_CWC_W!_*GU1AOI!!&/[,U$_*.1;-Z4_[?)_T"]1_\!6H
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M/^@7J/\ X"M1]OD_Z!>H_P#@*U %NBJGV^3_ *!>H_\ @*U'V^3_ *!>H_\
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MGG#5)&,>X;L;(^<>E= J*@PJA1DG &.3R: .7TC6]2U7PY>74VZUGME9DD5
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M)/7+,P&!@<;L#CH .<4 4],T?PUJVEVFHV^BVHANX4FC#VZA@K $9]^:M?\
M"+Z!_P! :R_[\+_A4/@K_D1M!_[!T'_HM:VZ ,K_ (1?0/\ H#67_?A?\*/^
M$7T#_H#67_?A?\*U:* ,K_A%] _Z UE_WX7_  H_X1?0/^@-9?\ ?A?\*U:*
M ,K_ (1?0/\ H#67_?A?\*S?#GAW1;CPQI4TVE6DDDEE"SNT*DL2@))KIZRO
M"W_(I:/_ ->$'_HM: *+:9X=_MHZ4GAZ"2585G>18(]B*S,HSD@]4/0&H-/B
M\':G?36=KI=J\D77_11SP,]LC!./FQS5V'_D?KW_ +!=O_Z-FJ>P\-:9INH2
MWUM$RRR=RQ^7(YYZG.,\D\T 9.GIX0U66YBL='MIY(.=HME&\;5;C/3[VW#8
M.5;T-6M*TOPWJUJ\\6A6\7ESR0.DL";@Z,5;ID=0>]7-+\-:9I%Y-=6<3+)*
M>[?=&U01[_<W?-DY+'/-5O"'_(/O_P#L+7O_ */>@"U_PB^@?] :R_[\+_A1
M_P (OH'_ $!K+_OPO^%:M% &5_PB^@?] :R_[\+_ (4?\(OH'_0&LO\ OPO^
M%:M% &5_PB^@?] :R_[\+_A1_P (OH'_ $!K+_OPO^%:M% ',>(?#FB0:#=R
MQ:5:(ZIPRPJ".16E_P (OH'_ $!K+_OPO^%'B;_D7+W_ '/ZBM6@#*_X1?0/
M^@-9?]^%_P */^$7T#_H#67_ 'X7_"M6B@#EX;7PQ*=08Z!#'!I[M'-.ULA7
M<H!( !+'AO2F6:>#;VQN+V/3+00VS,LK&V!"X8KG*@@@XSQV()QFK&@6\5VO
MB*WF4M%+J<J. Q&08X\\CFKEEX8TNQLKFTCA)BNF8S MMW LS 87  &[''8
M'.* ,JVC\*WNE2ZC::##<)#GS$2"/*XR3R2%/ [$]16C9Z#X<OK&"\BT:T$=
MQ&LB!H%!PPR,_G2+HEEH?A^_ALU8;X)"[,?O':><# ]N!V%6O#G_ "+.E?\
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M@-9?]^%_PK5HH RO^$7T#_H#67_?A?\ "C_A%] _Z UE_P!^%_PK5HH RO\
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M'+RK+F!>C#YA^!S0!HBWU\]-6T\_]P]__CU1W%EXAF@9$UVRASQYD>G$D?\
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M#_H+:?\ ^"]__CU'V;Q!_P!!;3__  7O_P#'JU:* ,K[-X@_Z"VG_P#@O?\
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MV/F?8F.[["^,;UXQYO7WS73UE-_R-L?_ %X-_P"C%H /LWB#_H+:?_X+W_\
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MZ"VG_P#@O?\ ^/4?9O$'_06T_P#\%[__ !ZM6B@#*^S>(/\ H+:?_P""]_\
MX]1]F\0?]!;3_P#P7O\ _'JU:* ,K[-X@_Z"VG_^"]__ (]1]F\0?]!;3_\
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M )&#6?\ >A_]%UKT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO-'(%>*2)B&!=5[X['.1D>A(YH T_P"WXO\ H'ZG_P" 4G^%']OQ?] _4_\
MP"D_PK5HH RO[?B_Z!^I_P#@%)_A6;XDUN*;PQJL0L=00O93+N>T<*,H>2<<
M"NGK*\4_\BEK'_7A/_Z+:@ _M^+_ *!^I_\ @%)_A6/I^J2VOB'59Y-(U0P7
MKQO'*+1L#;&JD$=<Y'I76UA)JE\^I:VJM$8M."^5%Y;$N3$'Y(R>I[*3[&@"
MQ_;\7_0/U/\ \ I/\*BN?$2QP,T>DZK,W0(EFP)_/ K-T7Q/J=]IVI3W%@$E
MM5D>-"DAW$,XV':AZ8 P!O\ 51QF?PYK6IZW8W?G1BUEAE8(YC+ CS'&.@4X
MV[>"3D$D#(% #/#6HG2_#&EZ?<Z=J(GM;.*&0+9N1N5 #@X]16G_ &_%_P!
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M&E1&QU!REE"NY+1RIP@Y!QR*Z>LKPM_R*6C_ /7A!_Z+6@ _M^+_ *!^I_\
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MQ6Q_;\7_ $#]3_\  *3_  K&'B'5D\!6NN;8I[JZ@60JD3 1;D))&-W3K\Q
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M** "BBB@ HHHH *R-1_Y&+1_^V__ * *UZR=0)_X2'1QZ^?_ .@"@#6HHHH
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M&X!02-W&>NTD#KC'%+8P^%]3M)KC3]%BNC"Y1HXXTSPQ7()(7G;N'.<$'N*
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M.16E_P (QH7_ $";7_OV* -6BLK_ (1C0O\ H$VO_?L4?\(QH7_0)M?^_8H
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M@W_HQ:/^$8T+_H$VO_?L5FMX=T;_ (2=(?[,MO+^Q,VWRQC.]1F@#IZ*RO\
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MM>\!>&1'.+=X;*+,F7SM,8X # 'Y@A^8'H<8/- '97-U;V4!GNIDAB!52\C
M $D #/N2!^-,GU"RMKJ"TGNHHI[@D0QNX#2$==H[U@7_ (0>\TG3;2*X6":T
M4[Y0\K9)&XXR_/[P*WS;C@<<\U2UJR&GZEX*M!C,5ZP;#,06\E\D%B3C.>I)
MH [6BBB@ K(\)_\ (G:+_P!@^#_T6M:]9/A/_D3]%Q_T#X/_ $6M &M1110
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M$]8&<?Z#/U_ZYM0!JUS%G9)<^(/$[1QH+HF...4Y5ES O1A\P_"M+_A(+?\
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M_A(+?_GQU/\ \ )?_B: -6BLK_A(+?\ Y\=3_P# "7_XFC_A(+?_ )\=3_\
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M2=)?L>H8^Q,NW[%)N^^O.,=/>@#IZ*RO^$@M_P#GQU/_ , )?_B:/^$@M_\
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MPD%O_P ^.I_^ $O_ ,30!JT5E?\ "06__/CJ?_@!+_\ $T?\)!;_ //CJ?\
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M110 4444 %%%% !1110 4444 %9&H_\ (Q:/_P!M_P#T 5KUD:C_ ,C%H_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO^$:TC_GU/\ W^?_ !H_X1K2/^?4_P#?Y_\ &M6B@#*_X1K2/^?4_P#?Y_\
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MM &O1110 4444 %%%% !1110 5E>*,?\(GK&>GV"?_T6U:M97BG_ )%+6/\
MKPG_ /1;4 'D>(O^@CIG_@!)_P#'JH6^A:_;:M=ZC'K=GF[*F6$V!\LE5"@C
M]YN' ]:Z2N7M+)+GQ#XG>.*,71,<<4Q^5ES O1Q\R\^E &GY/B$]-2TS_P
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M\1?]!'3/_ "3_P"/4>1XB_Z".F?^ $G_ ,>K5HH RO(\1?\ 01TS_P  )/\
MX]1Y'B+_ *".F?\ @!)_\>K5HH RO(\1?]!'3/\ P D_^/5FM#KO_"3H/M^G
M^;]B;YOL3[=N]>,>;U]\UT]93?\ (VQ_]>#?^C%H /(\1?\ 01TS_P  )/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK)U ?\5#HYR.//\ _0!6M61J/_(Q:/\ ]M__ $ 4 :]%%% !1110 4444 %%
M%% !63X4&/"&BC(.-/@Z?]<UK6K(\)_\B=HO_8/@_P#1:T :]%%% !1110 4
M444 %%%% !65XH&?">L#.,V,_7_KFU:M97BG_D4M8_Z\)_\ T6U #?\ A([;
M_GQU3_P7S?\ Q-9&GZP;7Q#JT\FE:L8+UXWCE6PDP-L:J01C.<@]JZZL%-2O
MFU37,2*8=-"^5#L/SDQ!^2 6ZGL"?8T 3_\ "1VW_/CJG_@OF_\ B:CN/$T,
M<#,FEZO,W0(FGR G\P!^M9^B^*=1O]-U*>>P"2VBR/&C+)SAG 4[4/3:!P-_
M7*#C,WA[6M1UZQO!,ALY896"2>63D"1QCD;3C;M."3D'(7@4 1^&M472_#&E
MZ?<V&IB>ULXH9 MA,1N5 #@[?45I?\)';?\ /CJG_@OF_P#B:D\-W\VJ>&=+
MU"YV^==6D4TFT8&YD!.!]36G0!D?\)';?\^.J?\ @OF_^)H_X2.V_P"?'5/_
M  7S?_$UKT4 9'_"1VW_ #XZI_X+YO\ XFC_ (2.V_Y\=4_\%\W_ ,36O10!
MD?\ "1VW_/CJG_@OF_\ B:SO#FO6\'AG2H39ZBQCLH5+)8RLIP@&00N"/>NH
MK*\+?\BEH_\ UX0?^BUH QAK!B\72WXTK5GMY[**#>MA)\C*\C'((!QAQTS6
MO_PD=M_SXZI_X+YO_B:3[9=R^+I-/68);0644Y4("79GD4Y/8805G:#XFU#4
MM<N+*YLA%&N=K!9., <<H#SU^<*?3<.: -&3Q+ D;,NG:LY R%73Y<GV&0!6
M5X;U7[!8W*W6FZI&\U]<W 7[!*2%DE9USA<9P13_  [XDU'6[^]M+BV^R[1F
M-PC_ "'9&<?,H[L6^?:V&7Y2,FM/PW?W.H6%P]VZO)!>W%N&5=NY8Y60''K@
M"@ _X2.V_P"?'5/_  7S?_$T?\)';?\ /CJG_@OF_P#B:UZ* ,C_ (2.V_Y\
M=4_\%\W_ ,31_P )';?\^.J?^"^;_P")K7HH R/^$CMO^?'5/_!?-_\ $T?\
M)';?\^.J?^"^;_XFM>B@#E_$.O6\V@W<8L]14LG5[&50.1U)6M'_ (2.V_Y\
M=4_\%\W_ ,33O$W_ "+E[_N?U%:M &1_PD=M_P ^.J?^"^;_ .)H_P"$CMO^
M?'5/_!?-_P#$UKT4 9'_  D=M_SXZI_X+YO_ (FC_A([;_GQU3_P7S?_ !-:
M]% &1_PD=M_SXZI_X+YO_B:/^$CMO^?'5/\ P7S?_$UKT4 9'_"1VW_/CJG_
M (+YO_B:/^$CMO\ GQU3_P %\W_Q-:]% '+P:];CQ-?2_8]1PUE;+M%C+N&'
MGY(VY YX/?!]*T?^$CMO^?'5/_!?-_\ $TZW_P"1MU#_ *\+7_T9<5JT 9'_
M  D=M_SXZI_X+YO_ (FLOQ'JPO\ 2EBMM-U221+NVFV_8)1E8YXY&QE<9PIQ
M75UE^([VXL-)$UJZI*]U;0AF7=@23I&QQZX8T 11^)8'C5FTW5HR1DJVGRY'
ML< BG?\ "1VW_/CJG_@OF_\ B:S/$7B+4M#O;*UAMOM2N,R2['RQVR?+A5(_
MA#?+N;Y3\O2C7_%&H:7JUI;6]B)(I &9MDASE)"1PF>-H;Y=QP#D+P: (WU<
MS>+[:_\ [*U9+:WL9X"[6$GSL[PL, #.,1MUQVK7_P"$CMO^?'5/_!?-_P#$
MTC7EW#XOM]/:8/:W%E//L* %&1XE&#Z8D;K[5L4 9'_"1VW_ #XZI_X+YO\
MXFJ.NZ_;S>']1B%GJ2E[2507L)5490]25X'O72UF^(_^19U7_KRF_P#0#0!7
MM_$-NMO$OV'4SA .-/F(Z?[M/_X2.V_Y\=4_\%\W_P 36E;?\>L/^XO\JEH
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M !-'_"1VW_/CJG_@OF_^)K7HH R/^$CMO^?'5/\ P7S?_$T?\)';?\^.J?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF0>&-5ECAD#QV4S*?/D."$)'\5 '3US^CRQCQ7XAB,BB1IH"$)Y(\E>U6_\
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M7_X!2?\ QVL[Q'#KX\,ZJ9[[3FB%E-O5+.0,5V'."93@X]C0!U%%9'D^)/\
MH(:7_P" 4G_QVCR?$G_00TO_ , I/_CM &O161Y/B3_H(:7_ . 4G_QVCR?$
MG_00TO\ \ I/_CM &O161Y/B3_H(:7_X!2?_ !VCR?$G_00TO_P"D_\ CM &
MO161Y/B3_H(:7_X!2?\ QVCR?$G_ $$-+_\  *3_ ..T :]%9'D^)/\ H(:7
M_P" 4G_QVCR?$G_00TO_ , I/_CM &O65X6_Y%+1_P#KP@_]%K3?)\2?]!#2
M_P#P"D_^.UG>'(=?/AG2C!?:<L1LH=BO9R,P78, D2#)Q["@#J**R/)\2?\
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M3=3@NKH&6X$@A?S60AR[G?\ *3C=D-G[W8]*F\.:#>VNGWEOK8CNHY979(Y
M"!^\=L[.5&[(?CGYL'[HK0_X26P_Y]]4_P#!3=?_ !NHKKQ59Q6[-'8:Q<-T
M$<>E7 )_[Z0#]: %\%<^!M"_[!T'_HM:VZY7PSK%OIGA?2K"ZM=36>VLXHI%
M&E71 94 //E\\BM/_A);#_GWU3_P4W7_ ,;H UZ*R/\ A);#_GWU3_P4W7_Q
MNC_A);#_ )]]4_\ !3=?_&Z ->BLC_A);#_GWU3_ ,%-U_\ &Z/^$EL/^??5
M/_!3=?\ QN@#7K*\+?\ (I:/_P!>$'_HM:;_ ,)+8?\ /OJG_@INO_C=9WAS
MQ#90>&-*A>#4BT=E"I*:9<NI(0#AA&01[@X- $ZV\$WQ"N))88Y'BTR QLR@
ME"99N0>U5= T/6K#7KJYO;GS;=^@,K'=P,'.<MM V_,/<5&-;BB\82WPT_5Y
M+:>RB@\Q=+N/D97D8Y!0'&''0&MC_A);#_GWU3_P4W7_ ,;H RO#GA_5[+4+
M\ZM,ES;3_*5=RPE)CB&[_:&%*9<9^3/\1JYX,C2+2[V.-%1$U2\5548"@3O@
M =A4\GBBQ2)G6SU:0J"0BZ3<Y;V&4 _,UE>&=9ALM/N5N['587GOKFX"'2[D
MD*\K,N<(1G!'>@#KJ*R/^$EL/^??5/\ P4W7_P ;H_X26P_Y]]4_\%-U_P#&
MZ ->BLC_ (26P_Y]]4_\%-U_\;H_X26P_P"??5/_  4W7_QN@#7HK(_X26P_
MY]]4_P#!3=?_ !NC_A);#_GWU3_P4W7_ ,;H =XF_P"1<O?]S^HK5KE_$/B&
MRFT&[C6#4@63@OIERHZCN8P!6C_PDMA_S[ZI_P""FZ_^-T :]%9'_"2V'_/O
MJG_@INO_ (W1_P )+8?\^^J?^"FZ_P#C= &O161_PDMA_P ^^J?^"FZ_^-T?
M\)+8?\^^J?\ @INO_C= &O161_PDMA_S[ZI_X*;K_P"-T?\ "2V'_/OJG_@I
MNO\ XW0!KT5D?\)+8?\ /OJG_@INO_C='_"2V'_/OJG_ (*;K_XW0 ZW_P"1
MMU#_ *\+7_T9<5JURT'B&R'B>^E,&I;6LK90!IER6R'GSE?+R!R,$C!YQT.-
M+_A);#_GWU3_ ,%-U_\ &Z ->L+QBB2Z"D<BJZ/J%DK*PR&!NHL@CTJ;_A);
M#_GWU3_P4W7_ ,;K+\2:U!?:2L5K9ZK+(EW;3;!I5R"5CGC=L9C SM4T 'B3
MP_JMY?6#:1*MO;0?+Y:L56,[)!NP,;>&VY7YOFS_  BD\0Z%K=_J]E<6-R(X
MH\94RMA&"2 MG.5SN"97GYLG[HK3C\46+QJ[6>K1DC)1M)N<K['"$?D:=_PD
MMA_S[ZI_X*;K_P"-T 59;>"'XAV4L4,:23:7=&1E4 N1+;XR>]=#7(-KD4WC
M&WOO[.U=+:VL9X#*VEW&'9WA88 0GHC=0*V/^$EL/^??5/\ P4W7_P ;H UZ
MS?$?_(LZK_UY3?\ H!J+_A);#_GWU3_P4W7_ ,;JAKWB&RF\/:E$L&I!GM)5
M!?2[E1DH>I,> /<\4 =#;?\ 'K#_ +B_RJ6L2W\26"V\2F#4\A .-*NB.G_7
M.I/^$EL/^??5/_!3=?\ QN@#7HK(_P"$EL/^??5/_!3=?_&Z/^$EL/\ GWU3
M_P %-U_\;H UZ*R/^$EL/^??5/\ P4W7_P ;H_X26P_Y]]4_\%-U_P#&Z ->
MBLC_ (26P_Y]]4_\%-U_\;H_X26P_P"??5/_  4W7_QN@#7K*;_D;8_^O!O_
M $8M-_X26P_Y]]4_\%-U_P#&ZS6\0V7_  D\<OD:EM^Q,N/[,N=V=Z_P^7G'
MOC% '4T5D?\ "2V'_/OJG_@INO\ XW1_PDMA_P ^^J?^"FZ_^-T :]%9'_"2
MV'_/OJG_ (*;K_XW1_PDMA_S[ZI_X*;K_P"-T :]%9'_  DMA_S[ZI_X*;K_
M .-T?\)+8?\ /OJG_@INO_C= &O161_PDMA_S[ZI_P""FZ_^-T?\)+8?\^^J
M?^"FZ_\ C= &O65X6_Y%+1_^O"#_ -%K3?\ A);#_GWU3_P4W7_QNLWPYXAL
MH/#&E1/!J1:.RA4E-,N74D(.C",@CW!Q0!U-%9'_  DMA_S[ZI_X*;K_ .-T
M?\)+8?\ /OJG_@INO_C= &O161_PDMA_S[ZI_P""FZ_^-T?\)+8?\^^J?^"F
MZ_\ C= &O161_P )+8?\^^J?^"FZ_P#C='_"2V'_ #[ZI_X*;K_XW0!KT5D?
M\)+8?\^^J?\ @INO_C='_"2V'_/OJG_@INO_ (W0 7G_ "-6E_\ 7M<_SBK7
MKE;KQ!9-XDTZ40:CM2WN 0=,N0QR8^B[,GIV''&>HK3_ .$EL/\ GWU3_P %
M-U_\;H UZ*R/^$EL/^??5/\ P4W7_P ;H_X26P_Y]]4_\%-U_P#&Z .=TS1Y
M[SX6Z=#I*QP7$UG&\A3Y#-^[Y![,3G'S<<Y[5:U+0=<N/!3:>L_F78$A<"4C
MSD*,/+P3M&<A<9VCJ.@H\)ZW%I_AFPT^\T_5X)K2W2)\Z7<,&(4 D%4/'UQ6
MQ_PDMA_S[ZI_X*;K_P"-T 9&O:=)!X5MCJ'E7-[!?VV+@C+?-=1\@GE<@\@<
M#H.*ZZN/\3:Y%?Z?%9VFFZO*SW5O(T@TNX"HJ3(YSE >BG& :V?^$EL/^??5
M/_!3=?\ QN@#7HK(_P"$EL/^??5/_!3=?_&Z/^$EL/\ GWU3_P %-U_\;H -
M-_Y&#6?]Z'_T76O6%H-W%?:SK$\2S*A>$8F@>)O]6/X7 /Z5NT %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%K_Z,N*U:RK?_D;=0_Z\+7_T9<5JT %%%% !1110 4444 %9OB/_ )%G5?\
MKRF_] -:59OB/_D6=5_Z\IO_ $ T 7;;_CUA_P!Q?Y5+45M_QZP_[B_RJ6@
MK$@U.]EUC6(RT'V?3M@2,H0SDQ!^6R<<GLM;=8.C,/\ A*/$2Y&3/!QG_IBM
M %+1/%UUJ4&HR36*Q&UC:5%?>FX 9VYVGIW/WN1\E3>'?$%]X@@NT,(LYHG.
MQI(F.!YC  J< X"X)W9SG*C'/11Q1Q;O+C5-[%FVJ!N)ZD^](D<-NC;$2)2Q
M9MH"@L3DD^Y)H S_  UJ,^K^'+'4+D()KB(.XC!"Y]@2:U*P/ W_ ").D_\
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M:WDB1X678T;*"I7&,$=,8[4 <_>:[??V!;ZO;K'!NNHH9()8V+8:=8CUVE6
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M<=JM?\(OI'_/";_P*E_^*J/P5_R(V@_]@Z#_ -%K6W0!D?\ "+Z1_P \)O\
MP*E_^*H_X1?2/^>$W_@5+_\ %5KT4 9'_"+Z1_SPF_\  J7_ .*H_P"$7TC_
M )X3?^!4O_Q5:]% &1_PB^D?\\)O_ J7_P"*K.\.^'M,N?#6ESRPRF26SA=B
M+B1024!/ ; _"NHK*\+?\BEH_P#UX0?^BUH RY=!\-/KZ69TN>:\CA67SO-<
M^4C%@/F+YZJW2BQA\)ZE=O:VDK2R)G&V[D(< #)'S<XS@^AXJY#_ ,C]>_\
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M_P"!4O\ \53O$W_(N7O^Y_45JT 9'_"+Z1_SPF_\"I?_ (JC_A%](_YX3?\
M@5+_ /%5KT4 9'_"+Z1_SPF_\"I?_BJ/^$7TC_GA-_X%2_\ Q5:]% &1_P (
MOI'_ #PF_P# J7_XJC_A%](_YX3?^!4O_P 56O10!D?\(OI'_/";_P "I?\
MXJC_ (1?2/\ GA-_X%2__%5KT4 <O!X>TQO$M] 89?+2SMW4?:),Y+S \[L_
MPC_)-:/_  B^D?\ /";_ ,"I?_BJ=;_\C;J'_7A:_P#HRXK5H R/^$7TC_GA
M-_X%2_\ Q5'_  B^D?\ /";_ ,"I?_BJUZ* ,C_A%](_YX3?^!4O_P 51_PB
M^D?\\)O_  *E_P#BJUZ* ,C_ (1?2/\ GA-_X%2__%4?\(OI'_/";_P*E_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K)U'_ )&+1_\ MO\ ^@"M:LC4?^1BT?\ [;_^@"@#7HHHH **
M** "BBB@ HHHH *R/"?_ ")^B_\ 8/@_]%K6O61X3_Y$[1?^P?!_Z+6@#7HH
MHH **** "BBB@ HHHH *RO%/_(I:Q_UX3_\ HMJU:RO%/_(I:Q_UX3_^BVH
M/)\1?\_VF?\ @')_\=JC;Z)KUKJMWJ$>K6>Z\*M+$;-MF54*"/GST'K71US-
MK:_:-?\ $SQHGVM3''!*3M9,P+P&P2HSZ _0T :/D^(O^?[3/_ .3_X[4<]I
MXDFA,:ZI80D_QI9,2/\ OJ0C]*R]#TCQ!;:;J<-U<EIIO,$#F;80Y=SOX4@
MY#;NO;:,5+X<T:_AT^\@UP)=122NT:2X;_EHY)V8P,Y# Y)^;&!M H LZ7I.
MN:3I5IIMOJ&GM#:0I"C26CEBJ@ 9Q(.>/2K7D^(O^?[3/_ .3_X[47@QF?P1
MH;,Q9CI\!))R2?+6MJ@#*\GQ%_S_ &F?^ <G_P =H\GQ%_S_ &F?^ <G_P =
MK5HH RO)\1?\_P!IG_@')_\ ':/)\1?\_P!IG_@')_\ ':U:* ,KR?$7_/\
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M7/)\1?\ /]IG_@')_P#':K>"&+>"]*+$DFW')K>H RO)\1?\_P!IG_@')_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH\3?\BY>_P"Y_45JT 97_"1V/_/#4_\ P57/_P ;H_X2.Q_YX:G_ ."JY_\
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M9OAO7K.'PQI43PZ@62RA4E--N&4D(.A"$$>XXKIZRO"W_(I:/_UX0?\ HM:
M#_A(['_GAJ?_ (*KG_XW1_PD=C_SPU/_ ,%5S_\ &ZU:* ,K_A(['_GAJ?\
MX*KG_P"-T?\ "1V/_/#4_P#P57/_ ,;K5HH RO\ A(['_GAJ?_@JN?\ XW1_
MPD=C_P \-3_\%5S_ /&ZU:* ,K_A(['_ )X:G_X*KG_XW1_PD=C_ ,\-3_\
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MKU]_8-OJ]LD4(:ZBAD@FC9FPTZQ'D[=K $\8//J.3TE &5_PD=C_ ,\-3_\
M!5<__&Z/^$CL?^>&I_\ @JN?_C=:M% &%H5U'>:SK$T2S*I>$8FA>)O]6/X7
M /Z5NUD:;_R,&L_[T/\ Z+K7H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K(U'_D8M'_[;_\ H K7
MK)U$G_A(M''KY_\ Z * -:BBB@ HHHH **** "BBB@ K(\)_\B=HO_8/@_\
M1:UKUD^%"3X/T4GJ=/@_]%K0!K4444 %%%% !1110 4444 %97BG_D4M8_Z\
M)_\ T6U:M97B@D>$]8(ZBPG_ /1;4 :M86C$?\)/XB&>?/@_]$K5C_A&M+_Y
MYS_^!<O_ ,565_97A@:K>DV4RS6*@W-VT[@1C8&Y;?G[M '3Q0Q0AA%&D89B
M[!5 RQ.2?J331%#;P,D4:1)\S84!1DDDGZDDGZFN<M1X4N[:XN8KEO*M@S2L
MU[* J D;_O\ W3M)![BFQV/AC6+*8PV\U\L3E9(!<NQ&&*@D%\8.TD>HP>]
M%_P5_P B-H/_ &#H/_1:UMU@:7HN@W^E6EY90SBUGA22$?:95PA (XW<<=JM
M?\(UI?\ SSG_ / N7_XJ@#5HK*_X1K2_^><__@7+_P#%4?\ "-:7_P \Y_\
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M_P# N7_XJC_A&M+_ .><_P#X%R__ !5 &K165_PC6E_\\Y__  +E_P#BJ/\
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ME_\ BJ/^$:TO_GG/_P"!<O\ \50!JUF^(_\ D6=5_P"O*;_T TS_ (1K2_\
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MLK_A&M+_ .><_P#X%R__ !5'_"-:7_SSG_\  N7_ .*H U:RO"W_ "*6C_\
M7A!_Z+6C_A&M+_YYS_\ @7+_ /%5F^&_#^G3^&-*FD2<O)90LQ%S*.2@)X#8
M% '3T5E?\(UI?_/.?_P+E_\ BJ/^$:TO_GG/_P"!<O\ \50!JT5E?\(UI?\
MSSG_ / N7_XJC_A&M+_YYS_^!<O_ ,50!JT5E?\ "-:7_P \Y_\ P+E_^*H_
MX1K2_P#GG/\ ^!<O_P 50!JT5E?\(UI?_/.?_P "Y?\ XJC_ (1K2_\ GG/_
M .!<O_Q5 #;S_D:M+_Z]KG^<5:]<O=:!IR^)-.A"3;'M[@L/M,O4&/'.[CJ:
MT_\ A&M+_P"><_\ X%R__%4 :M%97_"-:7_SSG_\"Y?_ (JC_A&M+_YYS_\
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MK7K)\*8_X0_1<=/[/@_]%K0!K4444 %%%% !1110 4444 %97BG_ )%+6/\
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MCHK*QXB_O:9^4G^-&/$7][3/RD_QH U:*RL>(O[VF?E)_C1CQ%_>TS\I/\:
M-6BLK'B+^]IGY2?XT8\1?WM,_*3_ !H /$W_ "+E[_N?U%:M<QXB&N_V#=^<
MVG[-G.P/GJ/6M+'B+^]IGY2?XT :M%96/$7][3/RD_QHQXB_O:9^4G^- &K1
M65CQ%_>TS\I/\:,>(O[VF?E)_C0!JT5E8\1?WM,_*3_&C'B+^]IGY2?XT :M
M%96/$7][3/RD_P :,>(O[VF?E)_C0 6__(VZA_UX6O\ Z,N*U:YB :[_ ,)/
M?8.G^;]BMMV0^W&^?&/?K^E:6/$7][3/RD_QH U:*RL>(O[VF?E)_C1CQ%_>
MTS\I/\: -6BLK'B+^]IGY2?XT8\1?WM,_*3_ !H U:*RL>(O[VF?E)_C1CQ%
M_>TS\I/\: -6LWQ'_P BSJO_ %Y3?^@&F8\1?WM,_*3_ !JAKPU[_A'M2\TZ
M=Y?V27?M#YQL.<>] &_;?\>L/^XO\JEK&MQX@^S1;6TW&P8R)/2I,>(O[VF?
ME)_C0!JU@:2@D\1>)$)8!IH02K$$?N%Z$=*M8\1?WM,_*3_&J%OI/B"UU:[U
M".ZL?],*M)$5;;E5"@COT'K0!:TSPM8Z4MVMN]P!=[@V)G4@'Z'[W^W][WJ7
M1/#UGH(F%H9/WSLQ!<[0"Q8<9QD9QNZD 9)HQXB_O:9^4G^-1SQ^)9(62.?3
MH6/1U1R1^>10!#X&_P"1)TG_ *]Q6_7/:1IFNZ-I-MIT$NGR1VR!%:0/N(]\
M5<QXB_O:9^4G^- &K64W_(VQ_P#7@W_HQ:,>(O[VF?E)_C6:PUW_ (2=.=/\
MW[$W9]N-Z_K0!T]%96/$7][3/RD_QHQXB_O:9^4G^- &K165CQ%_>TS\I/\
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M@_\ 1:T :U%%% !1110 4444 %%%% !65XI_Y%+6/^O"?_T6U:M97BGGPEK
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M \U_<SJC:9<$A7E9ESM0CH1WH ZVBLK_ (2.Q_YX:G_X*KG_ .-T?\)'8_\
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MV9 Y')X/..AK2_X2.Q_YX:G_ ."JY_\ C= &K165_P )'8_\\-3_ /!5<_\
MQNC_ (2.Q_YX:G_X*KG_ .-T :M%97_"1V/_ #PU/_P57/\ \;H_X2.Q_P">
M&I_^"JY_^-T :M%97_"1V/\ SPU/_P %5S_\;H_X2.Q_YX:G_P""JY_^-T :
MM9OB/_D6=5_Z\IO_ $ TS_A(['_GAJ?_ (*KG_XW5#7M?LY?#VI1K#J(9[25
M06TVX49*'J2F /<T ;]M_P >L/\ N+_*I:QK?Q#9+;1*8-2R$ XTNY/;_KG4
MG_"1V/\ SPU/_P %5S_\;H U:YNPMUG\2>(Y!&IN$:)(9#PR9@7@-@E1GT_*
MK_\ PD=C_P \-3_\%5S_ /&ZQM.UI+;Q'J\LFFZM]GNY(GBF&FS[?EB52"-N
MX<@]J %T#2?$-K#J:7MR7:97$+&;:?,Q]X80\'^]CM]P5+X8T;4XK>\@UW9=
M0RRN0DN&#'S7);9C&&R&!SWQM&*T_P#A(['_ )X:G_X*KG_XW4<_B>SBA9TL
MM6F8=(X]+N Q_P"^D _6@"+P0S/X+TIF8L3;C))S6]7)^%-5BTWPMIUE>6>I
MQ7$,(61/[,N#M/ID)BM?_A(['_GAJ?\ X*KG_P"-T :M93?\C;'_ ->#?^C%
MH_X2.Q_YX:G_ ."JY_\ C=9K:]9_\)/'+Y.H;?L3+C^S;C=G>O;9G'OTH Z>
MBLK_ (2.Q_YX:G_X*KG_ .-T?\)'8_\ /#4__!5<_P#QN@#5HK*_X2.Q_P">
M&I_^"JY_^-T?\)'8_P#/#4__  57/_QN@#5HK*_X2.Q_YX:G_P""JY_^-T?\
M)'8_\\-3_P#!5<__ !N@#5HK*_X2.Q_YX:G_ ."JY_\ C='_  D=C_SPU/\
M\%5S_P#&Z -6LKPM_P BEH__ %X0?^BUH_X2.Q_YX:G_ ."JY_\ C=9OAO7K
M.'PQI430Z@62RA4E--N&4D(.A"$$>XXH Z>BLK_A(['_ )X:G_X*KG_XW1_P
MD=C_ ,\-3_\ !5<__&Z -6BLK_A(['_GAJ?_ (*KG_XW1_PD=C_SPU/_ ,%5
MS_\ &Z -6BLK_A(['_GAJ?\ X*KG_P"-T?\ "1V/_/#4_P#P57/_ ,;H U:*
MRO\ A(['_GAJ?_@JN?\ XW1_PD=C_P \-3_\%5S_ /&Z &WG_(U:7_U[7/\
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M_P#&Z &Z;_R,&L_[T/\ Z+K7K"T*ZCO=9UB:)9E4O",30O$W^K'\+@']*W:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *R-1_Y&+1_P#MO_Z *UZR-1_Y&+1_^V__ * * ->BBB@
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MZR--_P"1@UG_ 'H?_1=:] !1110 4444 %%%% !1110 4444 %%%% !1110
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M-F_^+H_X1O3?2Z_\#9O_ (NM6B@#*_X1O3?2Z_\  V;_ .+H_P"$;TWTNO\
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MX+B9S.?NL>VU?O>IW!FR,??(QP*3PA_R#[__ +"U[_Z/>@"U_P (WIOI=?\
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MSHT20N>&3,"\!L':,^WX4 7L^(O[NF?G)_A4<Z^)GA987TN*0]'(D8#\*R]
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M&?$7]W3/SD_PK(UNTN8/"UO)J!26_AOK8"X!#-AKJ,<':-N5/(' Z9/6NLH
MRL^(O[NF?G)_A1GQ%_=TS\Y/\*U:* ,+0OM7]LZQ]L$(FWPY\G.W'EC'7FMV
MLC3?^1@UG_>A_P#1=:] !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %9.HC_BHM'/IY_P#Z *UJR-1_
MY&+1_P#MO_Z * ->BBB@ HHHH **** "BBB@ K)\*#'@_10>VGP?^BUK6K(\
M)_\ (G:+_P!@^#_T6M &O1110 4444 %%%% !1110 5E>*!GPGK '>PG_P#1
M;5JUE>*?^12UC_KPG_\ 1;4 '_"1Z?\ \\]0_P#!;<?_ !%8VFZW%;>)-8ED
ML-3%O=R1/%.-/F*G;$JD$;=PY![5UU8@U>[.H:RN+<6^F*N%8$-(3$'Y?) &
M3C[IH F_X2/3_P#GGJ'_ (+;C_XBHKGQ/9QV[-'::G.W0)'ITP)_[Z4#]:S]
M(\7S:AIVHW,UD(FLT>54D+1EE#, #P>@4 GUS\HJ?P_X@O->M+O$4=K/;R,
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M_P"(H_X2/3_^>>H?^"VX_P#B*U:* ,K_ (2/3_\ GGJ'_@MN/_B*/^$CT_\
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M]0_\%MQ_\16;X<UZR@\,:5$\=]NCLH5.W3YV&0@'!"8(]Q73UE>%O^12T?\
MZ\(/_1:T '_"1Z?_ ,\]0_\ !;<?_$4?\)'I_P#SSU#_ ,%MQ_\ $5JT4 97
M_"1Z?_SSU#_P6W'_ ,11_P )'I__ #SU#_P6W'_Q%:M% &5_PD>G_P#//4/_
M  6W'_Q%'_"1Z?\ \\]0_P#!;<?_ !%:M% &5_PD>G_\\]0_\%MQ_P#$4?\
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M(X/]KW.2VW=LQYF=V/X>OM1<1^'[:R6]:^U22W+;#)%J5VX1LA<-AS@Y..:
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M(R<5)HNA^'Y[$G2CJ$-NDTD9C2_NH@KJQ#C;O'.X&@#I**RO^$<L?^>^I_\
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MO^$<L?\ GOJ?_@UN?_CE'_".6/\ SWU/_P &MS_\<H U:*RO^$<L?^>^I_\
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MK<__ !RC_A'+'_GOJ?\ X-;G_P".4 :M%97_  CEC_SWU/\ \&MS_P#'*/\
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MF$W$X8,,'/'3WH T:*** "LKQ3_R*6L?]>$__HMJU:RO%/\ R*6L9_Y\)_\
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M9I;B6X=BTB_-(Y<@#'3)H Z2BLK=XB_YY:9_W\D_^)HW>(O^>6F?]_)/_B:
M-6BLK=XB_P">6F?]_)/_ (FC=XB_YY:9_P!_)/\ XF@#5HK*W>(O^>6F?]_)
M/_B:-WB+_GEIG_?R3_XF@ \3?\BY>_[G]16K7,>(FUW^P+OSH]/V;.=DCYZC
MVK2W>(O^>6F?]_)/_B: -6BLK=XB_P">6F?]_)/_ (FC=XB_YY:9_P!_)/\
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M '\D_P#B: -6BLK=XB_YY:9_W\D_^)HW>(O^>6F?]_)/_B: &WG_ "-6E_\
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MZ7O_ (+Y_P#XB@#5HK*_X233O2]_\%\__P 11_PDFG>E[_X+Y_\ XB@ M_\
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M^1.T7_L'P?\ HM:UZR/"?_(G:+_V#X/_ $6M &O1110 4444 %%%% !1110
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M ,]]3_\ !K<__'*U:* ,K_A'+'_GOJ?_ (-;G_XY1_PCEC_SWU/_ ,&MS_\
M'*U:* .8\0Z#9PZ#=R+-J!*IP'U*X8=1V+X-:7_".6/_ #WU/_P:W/\ \<H\
M3?\ (N7O^Y_45JT 97_".6/_ #WU/_P:W/\ \<H_X1RQ_P">^I_^#6Y_^.5J
MT4 97_".6/\ SWU/_P &MS_\<H_X1RQ_Y[ZG_P"#6Y_^.5JT4 97_".6/_/?
M4_\ P:W/_P <H_X1RQ_Y[ZG_ .#6Y_\ CE:M% &5_P (Y8_\]]3_ /!K<_\
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M:W/_ ,<K5HH RO\ A'+'_GOJ?_@UN?\ XY1_PCEC_P ]]3_\&MS_ /'*U:*
M.7NM!LU\2Z=$)M0VO;W!).HW!;@Q]#OR.O;KQGI6G_PCEC_SWU/_ ,&MS_\
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M;M9&F_\ (P:S_O0_^BZUZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *R=0V_\)#I&2<_OL?\ ? K6
MK(U'_D8M'_[;_P#H H UZ*** "BBB@ HHHH **** "LGPKM_X1'1MN2OV"#&
M>N/+6M:LCPG_ ,B=HO\ V#X/_1:T :]%%% !1110 4444 %%%% !67XGV_\
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MV#&0%QG%=165X6_Y%+1_^O"#_P!%K0!F-IOB@>(#JT3Z4OF6Z021,TARJL[
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M #QTO_O[)_\ $UKT4 9&_P 2?\\=+_[^R?\ Q-&_Q)_SQTO_ +^R?_$UKT4
M9&_Q)_SQTO\ [^R?_$T;_$G_ #QTO_O[)_\ $UKT4 9&_P 2?\\=+_[^R?\
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ME4]\CD'M77UAC6+K^T=9#?9Q:Z6H.TC:SYB#Y+EL*.<=* )_^$GT+_H+6O\
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MZ"UK_P!_!5#7O$>BS>'M2BCU2V9WM)551(,DE#@5TE9OB/\ Y%G5?^O*;_T
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MJX"'KW''(PWW>M:$NJW4>KZ5$K6[VNHA\!5)9<1[\A]V&!^E $G_  D^A?\
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MO_(P:S_O0_\ HNM>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU3_P;77_ ,<H UZ*R/\ A&K#_GXU3_P;77_QRC_A&K#_ )^-4_\ !M=?_'*
M->BLC_A&K#_GXU3_ ,&UU_\ '*/^$:L/^?C5/_!M=?\ QR@#7HK(_P"$:L/^
M?C5/_!M=?_'*/^$:L/\ GXU3_P &UU_\<H =;_\ (VZA_P!>%K_Z,N*U:Y:#
MP]9'Q/?1&?4MJV5LP(U.Y#9+SYRWF9(X& 3@<XZG.E_PC5A_S\:I_P"#:Z_^
M.4 :]%9'_"-6'_/QJG_@VNO_ (Y1_P (U8?\_&J?^#:Z_P#CE &O161_PC5A
M_P _&J?^#:Z_^.4?\(U8?\_&J?\ @VNO_CE &O161_PC5A_S\:I_X-KK_P".
M4?\ "-6'_/QJG_@VNO\ XY0!KUF^(_\ D6=5_P"O*;_T U%_PC5A_P _&J?^
M#:Z_^.50U[P]90^'M2E6?4BR6DK /JERPR$/4&3!'L>* .AMO^/6'_<7^52U
MB6_ANP:WB8SZIDH#QJMT!T_ZZ5)_PC5A_P _&J?^#:Z_^.4 :]%9'_"-6'_/
MQJG_ (-KK_XY1_PC5A_S\:I_X-KK_P".4 :]%9'_  C5A_S\:I_X-KK_ ..4
M?\(U8?\ /QJG_@VNO_CE &O161_PC5A_S\:I_P"#:Z_^.4?\(U8?\_&J?^#:
MZ_\ CE &O64W_(VQ_P#7@W_HQ:;_ ,(U8?\ /QJG_@VNO_CE9K>'K+_A)XXO
M/U+;]B9L_P!IW.[.]?XO,SCVSB@#J:*R/^$:L/\ GXU3_P &UU_\<H_X1JP_
MY^-4_P#!M=?_ !R@"OXY_P"1+U/_ *X_U%;4]O#<HJ3Q)(JNLBAAG#*05/U!
M -8.KZ!H%MI-Q-JDNHO9(F9E?4KJ12ONN\Y_*H1IOAK3+2!/M.HV<<C 10'4
M;N-AEPN=F\$#<PR<8YS0!TDUO#<;/.B23RW$B;AG:PZ$>]8^L?\ (T>'O^NL
M_P#Z*-5[BU\.6HA,NK7P$X#1D:S<G*GH_$GW?]KI[U VA>%O[;MMW]H&_N%/
MV>X^VW9WC;D[9=^/N^] '645D?\ "-6'_/QJG_@VNO\ XY1_PC5A_P _&J?^
M#:Z_^.4 :]97A;_D4M'_ .O"#_T6M-_X1JP_Y^-4_P#!M=?_ !RLWPWX>LI_
M#&E2O/J0:2RA8A-3N44$H.BB0 #V Q0!U-%9'_"-6'_/QJG_ (-KK_XY1_PC
M5A_S\:I_X-KK_P".4 :]%9'_  C5A_S\:I_X-KK_ ..4?\(U8?\ /QJG_@VN
MO_CE &O161_PC5A_S\:I_P"#:Z_^.4?\(U8?\_&J?^#:Z_\ CE &O161_P (
MU8?\_&J?^#:Z_P#CE'_"-6'_ #\:I_X-KK_XY0 7G_(U:7_U[7/\XJUZY6Z\
M/V2^)-.B$^H[7M[@DG4[DL,&/HV_(Z]NO&>@K3_X1JP_Y^-4_P#!M=?_ !R@
M#7HK(_X1JP_Y^-4_\&UU_P#'*/\ A&K#_GXU3_P;77_QR@"MX-BCG\ Z/#,B
MO')I\:NK#(8% "#6U+:6\]F]G+ CV[QF-HF7*E",%<>F.*Y/3=.\'6NC"_L)
M+^RL9 &0B]NX!+\N1M4N-QP., U<GMO#EMI[7\FJW_D*&.1K%T22JEF4 29+
M *?EZ\'B@"SXQX\/@#_G^L__ $IBK=KD=2T;PF5M[F^>^N4$RQQ3?;KJ98Y/
M,"@;@Y"G?@=N1[5K_P#"-6'_ #\:I_X-KK_XY0!KT5D?\(U8?\_&J?\ @VNO
M_CE'_"-6'_/QJG_@VNO_ (Y0 :;_ ,C!K/\ O0_^BZUZPM!M(K'6=8@B:9E#
MPG,T[RM_JQ_$Y)_6MV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "LC4?^1BT?_MO_ .@"M>L+7&ND
MUO2#9PPS39FPDTIC7&P9^8*Q_2@#=HK*^T>(O^@7IG_@QD_^,4?:/$7_ $"]
M,_\ !C)_\8H U:*ROM'B+_H%Z9_X,9/_ (Q1]H\1?] O3/\ P8R?_&* -6BL
MK[1XB_Z!>F?^#&3_ .,4?:/$7_0+TS_P8R?_ !B@#5HK*^T>(O\ H%Z9_P"#
M&3_XQ1]H\1?] O3/_!C)_P#&* -6LCPG_P B=HO_ &#X/_1:T[[1XB_Z!>F?
M^#&3_P",5E^&)]=7PKI ATW3WB%C#L9[]U9EV#!($)P?;)^IH ZFBLK[1XB_
MZ!>F?^#&3_XQ1]H\1?\ 0+TS_P &,G_QB@#5HK*^T>(O^@7IG_@QD_\ C%'V
MCQ%_T"],_P#!C)_\8H U:*ROM'B+_H%Z9_X,9/\ XQ1]H\1?] O3/_!C)_\
M&* -6BLK[1XB_P"@7IG_ (,9/_C%'VCQ%_T"],_\&,G_ ,8H U:RO%/_ "*6
ML?\ 7A/_ .BVH^T>(O\ H%Z9_P"#&3_XQ6;XDGUT^&-5$VFZ>D1LIM[)?NS
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M4D#!)(VC;NRK<"I]1CN(;GPQ+.\BW;WBPW!\W.\?9YB0=H53\P!^Z.G05?\
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MUC_KPG_]%M3?^$IT7_G\_P#(3_X5G>(_$FDS^&-5ACN]SR64RJ/+<9)0@=J
M.HHK(_X2G1?^?S_R$_\ A1_PE.B_\_G_ )"?_"@#7HK(_P"$IT7_ )_/_(3_
M .%'_"4Z+_S^?^0G_P * ->BLC_A*=%_Y_/_ "$_^%'_  E.B_\ /Y_Y"?\
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MSIY/_/08\O)P/N8Z_P /WL8^?M265MXD3QE/+<2.VGD#&9!C9NEVC[F"1D9
MPV"F6;!%:G_"4Z+_ ,_G_D)_\*/^$IT7_G\_\A/_ (4 5_#R^3K.OVR,YBAN
MXA&C.6" P1D@9/J2?QK?KC=!\2:9_:NMW<DDL,5U<QO%YL#J6 AC4G&/536W
M_P )3HO_ #^?^0G_ ,* ->BLC_A*=%_Y_/\ R$_^%'_"4Z+_ ,_G_D)_\* '
M>)O^1<O?]S^HK5KE_$/B329]!NXX[O<S)P/+<=Q[5H_\)3HO_/Y_Y"?_  H
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MD G\S6_7&OXDTR;QO:W*R2B"WT^XB>5H'"EFD@*@''/"-^5;?_"4Z+_S^?\
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M;[7\GV)ESY;]=ZGTH ZBBLC_ (2G1?\ G\_\A/\ X4?\)3HO_/Y_Y"?_  H
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M[9_D@<A52>-F)... 3^%;?\ PE.B_P#/Y_Y"?_"@#7HK(_X2G1?^?S_R$_\
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M]:S-!\8C6M0N+8VHA" O$QE7YE54S@@D-RQ.1P 5SR:N6W_(]ZG_ -@RS_\
M1MS6M';00RRRQQ(DD[!I& Y<@!03^  _"@#G?#_BU_$-S=6L4"6LBIYD+2$.
M"NU.<!OG&6/*G&"O/-:GA_49M4TK[3<+&)5N)X6\L$*?+F>/(!)QG9GKWJ]%
M;00/*\,2(TS^9(5&-[8 R??"@?A6/X._Y +_ /80OO\ TJEH W:*** ,B\_Y
M&K2_^O:Y_G%6O61>?\C5I?\ U[7/\XJUZ "BBB@#E!XJN[?P5;:_=102R7D:
M/%#$-FPLI('S-E\'TP<9P*6]\9^1X6&K16JM*[/$L32+\KJK'Y@#GJO*CY@,
MG'%6O!L,=QX!T>&9%>.33XU=6&0P* $&MJ6TMI[-[*6!'MGC,31,N5*$8(QZ
M8XH P[KQ%<-H=OK%FL*Q/<QPR0RC<WS3K%]Y6PK#))&#R,5T587C$8\/@#_G
M^L__ $IBK=H **** ,C3?^1@UG_>A_\ 1=:]9&F_\C!K/^]#_P"BZUZ "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]]3_ /!K<_\ QRM6B@#*_P"$<L?^>^I_^#6Y_P#CE'_".6/_ #WU/_P:W/\
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M(Y8_\]]3_P#!K<__ !RBW_Y&W4/^O"U_]&7%:M &5_PCEC_SWU/_ ,&MS_\
M'*/^$<L?^>^I_P#@UN?_ (Y6K10!E?\ ".6/_/?4_P#P:W/_ ,<H_P"$<L?^
M>^I_^#6Y_P#CE:M% &5_PCEC_P ]]3_\&MS_ /'*/^$<L?\ GOJ?_@UN?_CE
M:M% &5_PCEC_ ,]]3_\ !K<__'*H:]H%G%X>U*19M1+):2L VI7##(0]07P1
M[&NDK-\1_P#(LZK_ ->4W_H!H @M_#UDUM$QGU+)0'C5+D=O^NE2?\(Y8_\
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MUNUD:;_R,&L_[T/_ *+K7H **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT^)/^@3I?_@SD_\ C%'VGQ)_T"=+_P#!G)_\8K7HH R/M/B3_H$Z7_X,Y/\
MXQ1]I\2?] G2_P#P9R?_ !BM>B@#(^T^)/\ H$Z7_P"#.3_XQ1]I\2?] G2_
M_!G)_P#&*UZ* ,C[3XD_Z!.E_P#@SD_^,4?:?$G_ $"=+_\ !G)_\8K7HH Y
M:"X\0?\ "3WQ&F::9396VY3J$FT+OGP0?)Y/7(P,8')SQI?:?$G_ $"=+_\
M!G)_\8IUO_R-NH?]>%K_ .C+BM6@#(^T^)/^@3I?_@SD_P#C%'VGQ)_T"=+_
M /!G)_\ &*UZ* ,C[3XD_P"@3I?_ (,Y/_C%'VGQ)_T"=+_\&<G_ ,8K7HH
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M),[3%FD!C.[J"23V"[3G'(J?4H/$S^"FC1Y3?;9/,$<@+-'L; 7"AMW3 !#
MXRQYR 6=9M/%&K6\=M]ATB&$312N/MTK,QCD5P ?) '*X/!ZUH?:?$G_ $"=
M+_\ !G)_\8K+UF._A\,6UQ?RNNH17UNI>*8XPUT@(&T*""IQ@C.#@DG)/5T
M9'VGQ)_T"=+_ /!G)_\ &*/M/B3_ *!.E_\ @SD_^,5KT4 86@O=OK.L->P0
MPS;X<I#,95QY8Q\Q53^E;M9&F_\ (P:S_O0_^BZUZ "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R=
M1'_%1:.?^N__ * *UJR-1_Y&+1_^V_\ Z * ->BBB@ HHHH **** "BBB@ K
M)\*#'@_10>VGP?\ HM:UJR/"?_(G:+_V#X/_ $6M &O1110 4444 %%%% !1
M110 5E>*!GPGK _Z<)__ $6U:M97BG_D4M8_Z\)__1;4 '_"3:-_S^C_ +X;
M_"L33/$.FV_B766EE=8[J2)XI/*;:P6)5/...0:["L0:S<_VCK"L(!:Z6H)!
M^5GS$'Y<D*HYQR/QH F_X2;1O^?T?]\-_A4-UXLT:"W:0W3R=ML<+LWY 52T
MGQHFH:?J%U):B(V2/-L>5$+(&8#J<#A>6SMSG!XJ;0O$<_B"TNQ!'':W-LY&
M)EW?+O8+E P(X7&>FX-C(% %;PIKFFV/A'1[2YN?*G@L88Y$9&RK! ".GK6M
M_P )-HW_ #^C_OAO\*ET'47U?P_IVIR1K&]Y:QS,B]%+*#@?G6A0!E?\)-HW
M_/Z/^^&_PH_X2;1O^?T?]\-_A6K10!E?\)-HW_/Z/^^&_P */^$FT;_G]'_?
M#?X5JT4 97_"3:-_S^C_ +X;_"LWPWXATJ#PQI4,MV%>.RA5AL;@A #VKIZR
MO"W_ "*6C_\ 7A!_Z+6@#$'B'38?&TURTKF">PAA658F*[UDE)!XXX8?G6W_
M ,)-HW_/Z/\ OAO\*#J%U)XH?2X_)6"&TCN'9E)9MSNN!R ,;/0]:SM$\8+J
M^KS6)MA$!N,3&52&"@9P02'Y/\/0=<&@"_)XIT:*)I#=E@H)PL3DGZ#'-8_A
M77M-M].NOM$[0F;4+J9%DB8'8\S,IQCC((JQH'B\Z_>7-I% MNX4O SNK@@*
MGHWS_,QY4XP5YR:T] U*?5+*:2Y6-9(+N>W)C!"MY<C)G!)QG;G&: $_X2;1
MO^?T?]\-_A1_PDVC?\_H_P"^&_PK5HH RO\ A)M&_P"?T?\ ?#?X4?\ "3:-
M_P _H_[X;_"M6B@#*_X2;1O^?T?]\-_A1_PDVC?\_H_[X;_"M6B@#F/$7B'2
MIM!NXX[L,S)P-C>H]JTO^$FT;_G]'_?#?X4>)O\ D7+W_<_J*U: ,K_A)M&_
MY_1_WPW^%'_"3:-_S^C_ +X;_"M6B@#*_P"$FT;_ )_1_P!\-_A1_P )-HW_
M #^C_OAO\*U:* ,K_A)M&_Y_1_WPW^%'_"3:-_S^C_OAO\*U:* ,K_A)M&_Y
M_1_WPW^%'_"3:-_S^C_OAO\ "M6B@#F(/$.E#Q/?3&[&QK*V4'8W)#SD]O<5
MI?\ "3:-_P _H_[X;_"BW_Y&W4/^O"U_]&7%:M &5_PDVC?\_H_[X;_"C_A)
MM&_Y_1_WPW^%:M% &5_PDVC?\_H_[X;_  H_X2;1O^?T?]\-_A6K10!E?\)-
MHW_/Z/\ OAO\*/\ A)M&_P"?T?\ ?#?X5JT4 97_  DVC?\ /Z/^^&_PJAKW
MB+29O#VI11W@9WM)54;&Y)0X[5TE9OB/_D6=5_Z\IO\ T T 06_B71UMHE-Z
M 0@!^1O3Z5)_PDVC?\_H_P"^&_PK0MO^/6'_ '%_E4M &5_PDVC?\_H_[X;_
M  H_X2;1O^?T?]\-_A6K10!E?\)-HW_/Z/\ OAO\*/\ A)M&_P"?T?\ ?#?X
M5JT4 97_  DVC?\ /Z/^^&_PH_X2;1O^?T?]\-_A6K10!E?\)-HW_/Z/^^&_
MPK-;Q#I7_"3QS?:QL^Q,N=C==ZGTKIZRF_Y&V/\ Z\&_]&+0 ?\ "3:-_P _
MH_[X;_"C_A)M&_Y_1_WPW^%:M% &5_PDVC?\_H_[X;_"C_A)M&_Y_1_WPW^%
M:M% &5_PDVC?\_H_[X;_  H_X2;1O^?T?]\-_A6K10!E?\)-HW_/Z/\ OAO\
M*/\ A)M&_P"?T?\ ?#?X5JT4 97_  DVC?\ /Z/^^&_PK-\-^(=*@\,:5#)=
MA7CLH58;&X(0 ]JZ>LKPM_R*6C_]>$'_ *+6@ _X2;1O^?T?]\-_A1_PDVC?
M\_H_[X;_  K5HH Y"/Q%ID/C2[N&F<P7%A;1)*L3%=R23E@3CCAU_.MK_A)M
M&_Y_1_WPW^%*M_=2^)YM-C\E8+>TAG<LI+N9&E7 .0!CRQV/6LS0?&2:UJ%Q
M;?9A$$#/$3*AW*JIG!!(;ECRO &W.": +\OBK1HHFD-V6"C.$B<D_08YK)\*
M:]IMMH92XG:%WO+J4(\; [7N)'4D8[JP/XU/H'BUO$-S=6L4"6TJIYD+2,&!
M7:G. WSC+'E3C!7GFM70-1FU72OM-PJ+*MQ/"WE@A3Y<SQY ).,[,_C0 S_A
M)M&_Y_1_WPW^%'_"3:-_S^C_ +X;_"M6B@#E[KQ!I3>)=.F%V"B6]P&.QN"3
M'CM[&M/_ (2;1O\ G]'_ 'PW^%-O/^1JTO\ Z]KG^<5:] &5_P )-HW_ #^C
M_OAO\*/^$FT;_G]'_?#?X5JT4 <?X.\0Z;:^%--LKF5X)[6VCBD22)AA@H!Q
MQS6W_P )-HW_ #^C_OAO\*R1XKN[?P7;:_<PPR27D:/%#%\NPLI('S-E\'^[
MSC.!3KWQH+?PL-7BM0TKL\2Q&1?ED56/S '/5>5'S 9..#0!7\5^(M,N=,BM
M+>62:62[MG^2%R%5)XV8DXP. 3^%;G_"3:-_S^C_ +X;_"J5SXBG;0[?6+-(
MA"]S'#)#)\S?-.L756PI&22.>1BNBH RO^$FT;_G]'_?#?X4?\)-HW_/Z/\
MOAO\*U:* ,+0KN"^UG6)[:021EX0& (Z1CUK=K(TW_D8-9_WH?\ T76O0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !61J/_(Q:/\ ]M__ $ 5KUDZ@?\ BH='&/\ GO\ ^@"@#6HH
MHH **** "BBB@ HHHH *R/"?_(G:+_V#X/\ T6M:]9/A0Y\(:*< 9T^#@?\
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M_C1_8$7_ $$-3_\  V3_ !H U:*RO[ B_P"@AJ?_ (&R?XT?V!%_T$-3_P#
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M ,C%H_\ VW_] %:]9.HX_P"$BT?_ +;_ /H H UJ*** "BBB@ HHHH ****
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M=&MO$.CZ)8Z8-/TV46=O' )#J$@W;5 SCR>.E7?M'B+_ *!>F?\ @QD_^,4
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MT5E?:/$7_0+TS_P8R?\ QBC[1XB_Z!>F?^#&3_XQ0!JT5E?:/$7_ $"],_\
M!C)_\8H^T>(O^@7IG_@QD_\ C% &K165]H\1?] O3/\ P8R?_&*/M'B+_H%Z
M9_X,9/\ XQ0 >)O^1<O?]S^HK5KF/$,^NG0;L3:;IZ)LY9+]V(Y'8PC^=:7V
MCQ%_T"],_P#!C)_\8H U:*ROM'B+_H%Z9_X,9/\ XQ1]H\1?] O3/_!C)_\
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M3/\ P8R?_&*S6GUW_A)T/]FZ?YOV)OE^WOMQO7G/D]?;'XT =/165]H\1?\
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M^1.T7_L'P?\ HM:UZR?"?'@_11_U#X/_ $6M &M1110 4444 %%%% !1110
M5E>*?^12UC_KPG_]%M6K65XIY\):P/\ IPG_ /1;4 :M<W;+<3ZYXD,4TQFA
M\M+8"7A"8%/ .5')SR#5_P#X2;1?^@A'^1_PK$TSQ%I=OXFUDRW)5+J2)XI/
M+;8P6)0><8'((H ?H4/BA=-U-;QW%P?-^S$2+_K-[\C>AXZ8/W<8PHYS-X;M
M=8DT^\BUPR;3*YBQ*5/^L<G' 8#.,98@KMP!R*TO^$FT7_H(1_D?\*BN?%FB
M06[.;T/QC$<;,?R H 7PA-+<>#-%FGD>662P@9W=BS,2@R23U-;-<IX4UW3+
M'PCH]I<WB13P6,,<B,#E6" $=/6M;_A)M%_Z"$?Y'_"@#5HK*_X2;1?^@A'^
M1_PH_P"$FT7_ *"$?Y'_  H U:*RO^$FT7_H(1_D?\*/^$FT7_H(1_D?\* -
M6LKPM_R*6C_]>$'_ *+6C_A)M%_Z"$?Y'_"LWPWXATB#PQI4,M]&KQV4*L.>
M"$ /:@"RH:;QW/&\DICATZ"1(Q(P4,9)03M!P3@#KZ52T"'Q+'KUT=2:1K4]
MRZ\G V_P@'CKMV@'KNZU$/$6EP^-IKEKDF"?3X8DE6-BN]9)202!QPPZ^M;?
M_"3:+_T$(_R/^% &1X;MO$1U&_36FD:W<X)\P<MY<0!&%';/*;1NW\'@U?\
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MO^$FT7_H(1_D?\*/^$FT7_H(1_D?\* -6BLK_A)M%_Z"$?Y'_"C_ (2;1?\
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MC'=6!_&@#KJ*RO\ A)M%_P"@A'^1_P */^$FT7_H(1_D?\* &WG_ "-6E_\
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MC_(_X4?\)-HO_00C_(_X4 -TW_D8-9_WH?\ T76O6%H5Y;WVLZQ/:RK+&7A
M9?41BMV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "LC4?^1BT?_MO_P"@"M>LC4?^1BT?_MO_ .@"
M@#7HHHH **** "BBB@ HHHH *R/"?_(G:+_V#X/_ $6M:]9'A/\ Y$[1?^P?
M!_Z+6@#7HHHH **** "BBB@ HHHH *RO%/\ R*6L?]>$_P#Z+:M6LKQ3_P B
MEK'_ %X3_P#HMJ -6L4:U<?VCJ\9AB^S:6H+'?AY,QA^K84=<<G'N*VJP='
M;Q)XC5@"#- "#W_<+0!7TKQI;:EI]_=_9RHLT:4J98U+(&;:?F88X7[Q^3T8
MX.)=$\3-X@M+IK2&..>V<@K*W!7<P4[0=PRJ@\@#)."<5LP6-K;)(D,"(LKL
M[C'WBQ).?J2?SHAL[>S@>.VB6-6+N0.Y9BQ/XLQ/XT 0:%J+:QH&GZFT8B:\
MMHYR@.0I90<9_&K]8G@K_D1M!_[!T'_HM:VZ "BBB@ HHHH *RO"W_(I:/\
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M?E@LF98SN"JN>C8;YF(RI8  9(R*M6W_ "/>I_\ 8,L__1MS6G#8VMO-+-#
MB23$%V ZD*%'Z*!^% &%H/BY/$%Q=6UM L4L:^9%OD4AEVIR<'+<L1E<KP/F
MYK3T'4I=6TO[5-$D<@GGA94)(_=RO'D9]=F?QJW;V5M:R2R00)&TS[W*CJ<*
MO\E4?@*R?!W_ " 7_P"PA??^E4M &[1110!D7G_(U:7_ ->US_.*M>LB\_Y&
MK2_^O:Y_G%6O0 4444 <N/%LT'@ZW\07=M$#=QHT44<@^4LN0#N(+<\84$^@
M-+>>-(;?PP-8BMM[.SQ)&94_U@5B <'/5<8 +#/*C!Q-X0MX;KP!H\$\:R1R
M:?&K*>X*8/Z&MB;3K.XL'L9;=&MGC,;1D<%2-I'Y$B@#(N?$CG1;?6+*&)[>
M2XCA97D!;YYEBR"I(R-V<'D=#@YKH*P?&"JGAX!0 /MUF<#_ *^HJWJ "BBB
M@#(TW_D8-9_WH?\ T76O61IO_(P:S_O0_P#HNM>@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L+7+
M87>MZ1$99HLF8[H9"C?<'<5NUD:C_P C%H__ &W_ /0!0 [^P4_Z"6I_^!;4
M?V"G_02U/_P+:M6B@#%N=*MK.UFNKC5M2CA@1I)'-V^%4#)/Y"H?LNGBS%V^
MKZI%"Q #2W$D9.2 .& /4C\ZL^+/^1.UK_L'S_\ HMJJZSX<3Q#I5BIF\J2W
M560[1WVY^;&X< _=(SWR.* )9].LK:-9)M9U!%=U12;QN2S!5'XLP'XU'-:6
M$%U;VTNK:JKW1VPGSY"KG!; ;&W.%)QGM4.J^#(-0TW3[07)'V#:J,8HU+)O
M4M]U1CY5( 7 R1D'%.U:V%E)X6M5<N(=15 Q55SBVF&<* !]  * +_\ 8*?]
M!+4__ MJ/[!3_H):G_X%M6K10!E?V"G_ $$M3_\  MJS/#&BI-X5TB7[?J";
M[&%MJ73!5R@X ["NHK(\)_\ (G:+_P!@^#_T6M #O[!3_H):G_X%M1_8*?\
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M,O(PQP<L<F@"6RLK+4&F6WU752]NX25'GD1D) 8 A@#T(/XU:_L%/^@EJ?\
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ML%/^@EJ?_@6U9K:*G_"3QQ_VAJ'_ !Y,V[[4V[[Z\9]*Z>LIO^1MC_Z\&_\
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M#TM]-4Z5J&HK:^9( %N'7#AV#Y!P0=^[.>^:7PYX1B\/7MS<QW)D$@V(OEH
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MMK!'/*#, DLIC7&P=PK?RKH*Y_Q#_P AC2/K-_Z * #^VM<_Z!%A_P"#%_\
MXS1_;6N?] BP_P#!B_\ \9I:* *>JWFMZIH][IYTRPB%W;R0[_M[G;N4KG'D
M\]:DLM5\106D<4^FZ9*Z +N2]D0$#V,1_G6#H%Q_;?A_^WKZ:Z_TDR.L<,SH
M(8PQ 4!2,G R3U))]A3[+Q"?)TRTL;>XU+[39F6*XD81F14**6;=SD[@<]Z
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M!6:^=2P"#!(\HX/MD_6M*L[P[_R+6E_]></_ * * -#^VM<_Z!%A_P"#%_\
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MI\C:99"1;><*HOG(8$QYR?*XZ#L<Y[=]+^VM<_Z!%A_X,7_^,UG77_(QZ?\
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M6M>B@ HHHH *SO#O_(M:7_UYP_\ H K1K.\._P#(M:7_ -></_H H T:***
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MO+_X$R__ !5 %>BK'_"+:/\ \^\O_@3+_P#%4?\ "+:/_P ^\O\ X$R__%4
M5Z*L?\(MH_\ S[R_^!,O_P 51_PBVC_\^\O_ ($R_P#Q5 %>BK'_  BVC_\
M/O+_ .!,O_Q5'_"+:/\ \^\O_@3+_P#%4 5O#O\ R%M8_P"ND7_HL5T%4]/T
MJRTL2"SA,?FD%R79BQ P.235R@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HI P)(!!(.#[4R6:*WC,DTJ1H.K.P _,T 244
MU)$D *.K @$%3G@]Z4,"2 02#@^U "T4U9$9BJNI*]0#TH>1(\;W5<],G&:
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MW*;;<L+K][.TDX&>H!% '3T5%;7,%Y;17-M*LL,R!XY$.0RD9!!J6@ HHHH
M**9)(L4;2,&(49.U2Q_ #DU2T36[/Q!IPU"P,A@,CQ@R(4)*L5/!Y'([T :%
M%8L?BBQDBANA'.+&XF$,5Z5'E.Q;:O?< 6X!(P<CGD5M4 %%%9>I:Y'87'V2
M&TN+Z\$#7!M[?;O\L$#/S$#DG '4T :E%4/[7MQH\6IM'<+'*BND1A;S26Z+
MLZ[O:JVB>)K+79[NUBANK6[LBHGMKN+RY$#<J<=P<=: -BBN?3QGIK:Q;:;)
M!>P_;&*VMS+;E89V SA6/J.G'/;-=!0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5'//%:V\EQ,X2*)"
M[L>BJ!DFI*HZMIIU6R-I]JEME9U9FB"DL 0=IW C!QSZCB@#C_#^J-9^-1]H
MNFD3Q' 9O+;_ )=[A.1'_P!^B![F.K^BM_;'CSQ!)?*)/[*:&WM(G&1"K)N9
MP/5B>O7  K9U[0(]>AM$DNY[9[.Y2YBE@V[@ZYQ]X$8Y.1WIEQX=5M6_M>RO
M9K*^>-8IW159+A1TWJ1C(YP1@\XZ4 3K9Z=H?V_4D1;>.1?-N HPOR@Y;'KC
MK]*Y3PUJ3V/C.2WN+HRKX@@^U!2?]3<H/FB'MY>T#_KG747FB->VGDR:E<AV
ME2220!,OL8,%P5P%R.@'/.3R:37= CUW["SW<]K)8W*W,4D&W=O (P=P/&"<
MCO0!RNM >'_'+>)X@$ME,-IJ( P/*DX60_[KA>?0FGZQ_P 3+XA>'+Q_GMHK
MRXMX%/*DI"Y=_P#OL;?^V?O733^'H;P:E'>7$D\.I0B&6)E4!0 1E<#.>?SJ
M&3PK;&;1G@NI[==%!^SQIM(;*;#NR"3P3Z=: -J6*.>)HI45XW&&5AD$>AKS
MJ.XFM?@IIZV[M&9EAMV=3@JCS!&Y^A(_&O1G5F0JKE&(X8#.*QK3PM96_A4>
M')99KFT$9C#2$!P,Y!R .0>0<=A0!F2WEMH7CYXR\=II[Z-YT_140QRA5;T'
M#D?0#TJSK%CH_P 0/#DT=E=P3E'S;W4>&\B9<$'^61W!K4L='2UOY=0FGDNK
MR6)83-( -L:DD*   .22?4^P &@02I .#Z^E ')^')W\6K;W^JV,<<FDR/ 8
MB P^U+\LCC_9'1?]X^@-7-#UC6-6U&]62VLHK2RO9;9RLC&1MJJ5(XQWYSC]
M.;F@Z%'H,-U%%=37 NKF2Y8RA<AW.6Q@#C-.TC1ETB2^=+J:?[=<M<N) N$<
M@ XP!QP.N: *GB72M$EM+C5]6TNWU![6W/EI/&'Z9(50> 23CWXK,OO"E^GA
M'3-'TZ/3)5M &N+6\B)AN&P21A>@W$L.#R!Z5T^H6":C%%%*[+&DT<Q4?Q[&
M# 'VW '\*9?65U=3PR6^J7%FL>X.D21L) <==RG!&.,>O>@#'TG6+*S\#C4+
M;3$TY(!)']A4!1',KE#&,<<R C/?.:SO!=W_ &=KVI^'I;XW@D U"WF;.7W\
M3#\).<>CUT4FA1%+&.&YF@BLYO/\M0K"9^<ER02<EBW;GFF:GX?CU+6-.U07
MD]M/IQ?R_*"X<. &#9!R" * .>UBPN-/\51:SJVEZ;JEA-=1113^4?M%@20L
M9&<@KO()Q@@L35.[=KW0?'6ISDBZL[F6.WD_BA$$2M'M/;YB6^IKL%T:1[EG
MO-2N+R 3^=';R+&%0@[E&54$A3@C)[#.<5!>^%[2]EO TLL=OJ+(UY;IC;,5
M '7&1D !L=0.W- &7JQ%WJ7@O4)8E6YDNOF;'(W6TA(^F:L>-H(GCT25HU,D
M>LVFQB.5S( <5J:EHJ:E>Z==&YEA.GS&:)(PN&8J5YR#QACTQ2ZSHR:REJCW
M,L M;F.Y7RPOS.ARH.0>,T 9>K"6'QE:7-Y9S76EM8R0KY<#3"*8L"2RJ"0&
M48SCL1WKDM&O)]3C\):+<%SI5Y<7L@1S_KX823"C>JX(..A"BO1M1T\ZE;FU
MDN9([=QME6+Y6D'<;NH!]L'W%5M3\.6.HV=I;J'LVL65[.:VPK6Y P-O!&,<
M$$$$=J (M<L+:ULY-9M[9$O-.MYI(61 "?W;#:?4=./:N9MB=-TWP+>6V6N+
MMECN''WIQ+ TCECWRX#?45V5OI\P(:^OGO"H("LBHO(P20!R<$]>/:JEAX8M
M;&:R/G331::K+91/C$ 88],DA?E&>@]^: ..LKF5/!'AK70<ZC=:K%)+*/O2
M&:4JZD^FUL8[;1Z"D-U+_P *\D\2G_D*?VQYXD_B!%WY.SZ>7\N/2NQ@\+6<
M$ENHEE:TM;EKJWM3C9'(Q)STR0"S$#/!/L,!\+69E*^;+]C-Y]M^R<;/.SNS
MTSC=\^/[WMQ0!E^(_"N@W,]O$=)M);[4[U=]Q)$'DV@^9(=QY'RJ5'IN%6-?
MAC_X33PK/L7S1/<)OQSC[.YQ6Z]@DFJQ:@SL6AA>)$[#<5+'Z_*H_/UJOJ&C
M+J&J:=J#74L3Z<[O&B!=K%E*'=D9Z$],4 :5%%% !1110 4444 %%%% !111
M0 4444 %%%% !7FVA6VK:A:^-M/TV.S_ -*UBZB,UQ*P\O<J@G:$.[@^HKTA
M@2I .TD<'TK&T#PW'H%QJ$L5]<W']H7+7,JS!,"1L9(VJ,#@<4 9,.G2^';;
M1?#\.J2&"&T=3#;K_I-Q(,889!"H,G)) !*@DUGVOBC6'\ :+J5Q.5DN-1%K
M?WFQ0881,Z%S_"#\J@GH-V:Z;4?#:7VO6^LPZA=V5S# UNY@V8EB)W;3N4XY
M'48-<SK6AP>&]#T_28[[6$L#?M.U["OFFS +. 0%.07;J0>>2>!0!+_;VI:;
M=^*+U;Z6^TO2+99+56"%'D*%F0N!EL$#OQNYK0LT\2?VIIEW'</+8RH1?+<2
M1[6R!M>,*,@Y[9P1[\U!H4%QJ$LMJVM76MZ//;O'.MW9"%1G  5@J[L@MD<@
M>QQF]H7@Y=$>)#K.HWMI;?\ 'K:W#J4AXP.@!; X&3@>G2@#I*Y7X=X'A>7.
M !?W><_]=GKJ'!9"%;:2.& SBLOP_H$7A^PDLHKJ:YB>5Y?WX7(+L6;H!P23
M0!Y[9-)I,.G_ &CS;OP/-?![-^/,MSO_ '7F=S#OY7O]W/\ =/I.NZF-%T&_
MU0Q^9]DMWF"?WBJDXK/A\)V\.FQZ0;J9]+BD5TM6"\!6W*A;&2@(''7C!)%;
M5Q;PW=M+;7$:R0S(4D1NC*1@@_A0!Q>HZKJVC>'='\2?VC)=&=[?[;;LJ^7(
MDN =@ RI4L,<\CKFI4LY3\79V^WW( T>.3 V8QY[_)]W[O'U]ZTK/P?#;6MG
M837]S=:?82K);6TH7Y2O*!F RP4]![#.<5:7P^J^*7\0?;[@S/;BV,)">7Y8
M8L!TSG)/.>] &N<XX )'3-<AH5Q?6_C_ %:RU>RMUNKRV2Y@NK=B5:!#L"'/
M0@MGWW'VKI-3L[B^M/*M=0GL)0X830JK'CL0P((-16>D+;W$MY-<RW-Y+&(C
M<.%!5!DA5   &23ZGOG P <_XON+^QUO1+Z>QMKK1X+U%8*[>;%*_P"[23&,
M$#<1CW_+L:Q;;P]+M@74]7NM32VD$L2S)&HW#[I;:HW$=1VSSC(%;5 !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
B1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>ebs20191231exhibit1048019.jpg
<TEXT>
begin 644 ebs20191231exhibit1048019.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH **** "BBB@ HHHH **** "BBB@!I12P8J"PZ''(IU%% "%0W4 XYYI:**
M"BBB@ HHHH 3 )!P,CI7*W7A&[G^(MMXK%["([>W^S_9C&<LIW9.[/7YCV[5
MU=% " 8&!0 !G  S2T4 %%%% !1110!Q][X#@O-;OM1NH=.U$WCAE^W6I=X
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MD$8)Z'(/3M7444 8'A?PI:>&3?26RQ(U]*LCQP(4BCP, *I)QW).>2>W2MX
M 8  'H*6B@ HHHH S=,T:'3KF[O6<SWU\P:XG(QN &%4#LH'0?F23FM*BB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJNH:E9:5 L]_<I;QLX1
M6<]6/0#WH M45B?\)EX<!E!U:#,(!E'/R<9YXXX]:MVFNZ9?:B^GVMVDURD*
MSLB@\(W0YQCF@#0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **HWFL:?
MI]Y:6=U<K'<7K[((\$EVZ]AQT/6KU !137=8XVD=@JJ"23V%9#>+="70O[<.
MH*-/WE!/L;!(8J0!C)Y&.E &S1110 4451BUC3YM7ETF*Y5[V&,2R1 'Y5)Q
MG.,=: +U%%% !1574=1M-)L);^^E\JWA&7?:6P,XZ $]ZLT +1110 45'-/%
M;0O//*D448W.[L%51ZDGI5"#Q%I-S<101WBB2;_4B1602_[A8 -^&: -.BBB
M@ HHHH **** "BJ4^L:?;:K:Z7-<JMY=AC#%@DN%&3VP, =ZNT %%(3@9K&/
MC#PZLDL;ZO;1M VV42-M\L^C9^[^- &U134=)8UDC971@"K*<@@]P:=0 444
M4 %%%% !1110 453U/5K#1K7[5J-REM #@RR9"CZGH*BL_$&D7]T+6UU&"2X
M*[Q#OPY7U"GDCWH T:*** "BBB@ HHHH **** "BJU_?VNEV4M[>S+#;PJ6=
MVS@#\*DM;F*\M(;JW??#.BR1M@C*D9!P?8T 2T55MM1M+N[N[2"7?-9LJ3KM
M(V%E##DC!X(Z58DD2*-I)&"HHR2>PH =15/2]5LM:T^/4-.G$]M*6"2!2 VU
MBIZC/4&KE !14<\\5M \\SA(XQN9CV%0Z=J-IJVGPW]C,)K:<;HY "-PSC.#
MS0!:HHJC)K&GQ:O%I+W(%[,C2)#@DE1U.<8% %ZBJ.G:QI^K2726-RLYM)?*
MFV@@*^,XR1SP>U276HVEE<VMO<2[);R0QP+M)WL 6(R!QP#UH M4444 %%4=
M4UC3]%@2?4;E8(Y'$:D@G+$X P!ZFKU !115)-8T]]9;1TN5:^2'SVA .0F0
M,YQCJ1WH NT444 %%49-8T^+5X=)>Y47LZ,\<."25'4YQ@?C5Z@ HHJK>:C:
M:>]LMU+Y9NIA!"-I.YR"0.!QP#R>* +5%%17-S!9V[W%S*L448RS-T% $M%4
M--UK3]6DN8K.9FEM7"3Q21/&\9(R,JP!Y'0XYJ_0 4444 %%%% !156?4;2V
MO[6QFEVW%YO\A-I._8,MR!@8![U:H **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *CD@BF>)Y$#-"^^,G^%L$9_(D?C4E% '&^& #\1?&P(R"]E_Z)-5W@
MO8OB5=6NC&VMV30X$1YT9UC42OCY003Z=1^/2MC1= O]-\4:SK$]Q;R1ZL8B
M8D5@8O+3:.3UR/84]-$OH_&=SKPFMVBFLEM5A((8;6+!BWU)XQ0!F:=XUN+W
MP_HLTD,<6H:G++"WEQ/*D9B+AV"+\Q'R<#/\7)XK5\/:EJUY=:A;:G:%8[:1
M?LUV('A6Y1AG[C$D%3P?7M6'%X#U&#P[86D&JQ0:GI=W)<V=VD1*_.S%D92>
M0=Q'7TKIM&M=5AC>;6;V&YNI !MMHS'%&!G[H))).3DD^GI0!6N-5O+OQ!/H
MFFR00R6MLL\TTT9D +DA%"AA_=))SZ#OD4U\0:P)=&TB[M;:TUG4%E>< F2.
M%(^K  \ELK@9XR<YQRNL>'-5/B1/$&@:A;VMTT MKF&ZB,D4R Y4_*00PR?\
M]77_ (7NYKC2M4@U%6U;37<F65/W<ZR??0J#\H_N]=N!UH H7?BS5M/B\1V4
MT=H^HZ-:_;(9=C"*XB*D\KG(8$$'G%26WB+7(]7\/I?"Q:TUN%L)"CAX7$7F
M EB<,#@\8&/?J;%[X4N+^VUR:6>%=0UFU^R%@"8X(@I  [L?F))XSQTQ22>&
MM2DG\-R_:;4'1 =_R-^^RGE\?W>.>_- &5I>LZ_!I'B_4Y+NTN9-.O;G8CV[
M*/W4:$ 8?A<#IUR<YK2MM5\4OHL.J2)I?E74=LZ\LOV96YED<LP#  Y !'IS
MC):/"FIQ6OB6PBO+7[)K4DTJ%HVWQM*@5L\XP,<>N>U2WWAC4KKPOI.FQWUO
M'=Z7-!*KF)C#-Y0P ZYS@\'KU H JP^.'M+?Q++?".YCT3RWBEA1HO/61,J,
M,3CGC<.",&MB-O$\>HPQRBPEM9H&,DR1LIMI1C:,%\NI]L'CM66W@FXO;G7_
M .T]0BFM]<@B258H"C(Z+M!4ECP.#@Y.1U];^@Z7XBM?)36]8M[R*T7;%Y$!
MC>7C :4ECDXSP !GGG% '/>'O$VI67@.SU&]GAO+O4=0>UME,93]Z]Q(N6.X
M_*.3@ 8 Q[UN2:WJ>F>*+/1;]K:=-4AE:SN(XFCVRQC<R.NXY&#D$$>GO6=!
MX#NSX4;0;G4(E%K=&YT^YAC.^-_,:16<$X)RQ&!V[^FPFBWMYK%GJ^J/;-<:
M?#(EM%!NV;W #.2>>@P!VR>3V */A#6?$7B"UM]1NQIT5F7GBECC1_,+(Y52
MI)P!Q@@_7O@6O$WB5="O]/MYYXK&VO/,#7T\1>-'&W:AP0%W98Y)_A]\B7PC
MH=WX=T;^SKJXAN-LTDB/$A7[[ER""3T+58U:QO;RX01BTN+)HGCN+.Z4[9<D
M8.<'&,'C!SF@#FO$LM_*W@^63[+)>-J><QL1"Q\N3!!Y.W&#WJY::_X@W^(M
M.>WL[[4M*$36YBS!'*)%+#<&8XQ@YYYJ.+P3=6=AX>L[2\A,>C7+7)\Q6_>%
MMWRKS\JC>0.O04FJ^"]0U.?Q&XU"&!=:C@5=J$F(Q= >?F#<@CT/>@"YH_B.
MXNO%D^BRSVUY"+%+N*YMXF0'+E&7DD,,C((/J.<5R+#_ (L5?_\ 7Q-_Z5FN
MNM/#VL1^*(]>N=0LWD.G_9)8(K=D7A]PVDL2!D\DY^GI1/@G43X N/"YOK;?
M-*S_ &D1M@!I?,/RYZYXZT =K7(>'O%-UX@N(TANK*.='D6]T^2%EGM< [>K
M?,,[02!SGC%=9'YGEKYNW?CYMO3/M7,6_A:[GU32-1U26U>\TL'-Y;J5ENLH
M5PV>@YR>3D],4 9\WC+6(_ %]KX2R^U65X\!0Q/Y;JLWE]-^0><]33K\:HWQ
M1NDTA[6.X.AQ?O+I695'G/\ PJ02?Q'X]*9>>!=7GT+5M!AU6UCL+VZ:XA8P
M,94W2!RK'., YZ#)XY%;,VAZG%XG77K6YM))GL5LYXI8V13ARP=2"<<GH<_6
M@#$;QMK8\,/>&SLTU&RU5=-O8R6,9;>J[DYS@AP><_C6C_:WB5?%DGA]GTTF
M:Q-Y!<"%\0@.$967=^\ZC!RO?Z4V]\%S2>'VTZUO(A<7&H#4+JXDC.)) X<X
M4'@?* .> !UK0;1;]O&46O\ FVXC2P:S,'S9.7#EMWU4#&* ,*Z\9ZS!\/M3
MUE8;(ZCI5U+;3 JWE.4DV%E&<CJ#C-:&I7.K?\+'TVR@O84M&L9I?*: MR&0
M')#C)YX].>#FJDW@C4I_">MZ&U]:@ZK>27/G"-OW8=PY&,\], \=:UK_ $34
MKCQ)IFM6]S;1O;V\EO<(Z,P*N5.4Y'.5[T :6M7%]::3<3Z;;QW%T@'EI*X1
M.H!))(X R>O.*R-"\17%]XFO](EEM[J&&VBN(;F"-D#!BP(Y)##*\$'%7?%6
MBS>(- FTZWNA;2NZ.KLNY"58-M8=U.,$54T_0-5@\5OKEWJ%M)Y]FEO-#%;E
M1E68C:2QP/F[Y/T[ &7XYF>X\5>$=%E_X\KR\DFG4])#$H9%/J,GI["M7Q_:
M17?@76/,X:"U>XB<<%)(QO4@]CD"K?B'P]#K]O;_ +YK:[LYEN+2Y1<F*0>W
M=3T([US6L7FJ:I?GPSXDMDTO3;@#=?P,6CO "/W88X\DMZ')/(!Y!H L>'?$
M^JWMYX?M+H0,FI:/]K=C&1()%"#.=V"#NST%3V'B/6KS2-5E2"R>YL=5>R\P
MYCB2)64-*P9NP). W.*M:KX>O'UG2M5T2XM;9[&%[8Q3Q%HS$VWH%(((VC%9
M1\#:J-,O+==8@:676/[4CWVYV,0P.R0!OF4X!P ,'UH EB\6:B\7B>.(VEP^
MC0)<6\_E.B3*T;/@KGU4C(.""#6;KVL>*Y/A^^LO=:?;0W5O:,JPPN9!YK*K
MC); SO!X''(_VJUG\)ZN]UKUP^IVKMK5FD$BBW91&RHR9'S'Y<-G'4D=14U_
MX6O+[X>IX::[@6YBAAC2<(=A,3*5)&<C.P9^M $U[K=Y#JJZ*DT8NDM?M$UP
MEC+*N&8J@"*Q(^ZV26[>_&7+XI\316&BM-IEM:W5[J/V*9)E< \,1(G.0I"Y
MP<GM5S4_#FN3:I9Z]INIVMMJT<!M[E'A9K>>/=N"XSN&TDX/4^U/U+PWJU_'
MI+-J4$ES8WPO99)(B%D8*5V*H/RKAO4GCG)R: *-\NHKXR\&#5GMGO U]O:U
M5EC(\OC 8DCC&?>K=EXEU""]\066M-:1S:9&)[<P0L/-A*DJ^"YW'(*D#'(Q
MGFKVJZ)>7_B;1M6BFA2/3/.+1L"3)YB[3SVQU[YK+OK?2/%'C#3)]/OH[B33
MO,^VFWD#*4# K')COYBJP![*U '3Z:;YM-MVU+R1>-&#,(5(16[@9)/'3K7"
M:;+.NO\ CJ"#29M1:>>-!$A0*Q,6,,688'/)KT0YQQUKGM T"_TG7M9U&XN+
M>5-5F678BL#$57:!D]>/I0!S^FCQ#X*T/PKX?#6<\UU*\$S2[F\LD.X ((R%
M&![XXQ6U::OK5SJW]@/-8I?VMH+B\N8XF:/+,0BHA8'H,DD^PZ\6O$&B7NJZ
MII%Y:SP1#3;@SE95)\PE2N..G!//--O- NH_%"^(=*FB6=[?[-=6\X.R9 <J
MP(Y5@?8Y'I0!E'QS=1:!?2W%I"NI6.HKITN,^2&9E EZY"8;.,Y[9[U>AU?6
M_P#A,;C0"UE+''9+=K/Y3J?F+*%/S$9W+GW'YUE^(=-AT3PW<6LVH6\-WKVI
M*9KB>+,!9B"58$\)L3;US^)J;09M7LM56UW^'KM;I3YCZ>'65-JG:[Y9LKD!
M?^!#% $6D^+]=E\)+XJU*/3Q8BWD)MX5<2-*)"J8)) 4].Y[]\#3@UG74URW
MMWLS>V4\+M)+'92VYMY%&0#O/S!N@]#UIFE^#6A\!2>%-3N8YHFC>,30J5(#
M,6!P2>03^E2Z3H_B>*$0ZOKL%RD$;) \$!C>1BI4-(<G.,YP!UYSQ0!!X8\4
MS^(!'-%=6<NV%C>6*Q-'<6THQA"&;D9W#.!D@?0'A;Q1/XCD@DCN[-L1M]NL
MO*:.XM).,*0S9(!R"<<G\@^/PM=W&LV>L7LEI'?VEM)"UQ:J5:Y+*%!?T Y(
M&3SW&.7VOABYDU_3=:U%K07MA"\;SVRE6N]R[?GST Y.,GGN.A (/BG_ ,DV
MUG_KFG_HQ:R[UG\6>-](L8X'TV70&6\F:Y*B69& P(PI(*'&&.?:NE\8Z'<^
M)?#5UHUO/%;_ &H -+(I;: P/ '7IZU7UCPU=ZDNFZA;W<5GK6G,/+N50LCJ
M>'1ER"58=L\'H: 'ZCKMP=:N-(L'$4EM;I+)*;.2X&YRP5=J8Q]PDDGN,=\9
M'_"5>)F?P[;OI5M9W>J-/%/#<;QL9$8AAS]TX!P><<>]7M2\.ZX=;BU[1M2M
M;2_> 6]Y#-$TD$Z@DJ>""",G_/7.\007MKXF\&Q?;$N+XW-T[22KM5SY))
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MGAE74+Y[Q1&I!C+ #:<]<;1SQ0!N4444 %%%% !1110 4444 %%%% !1110
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M#>9<2/%$_E/Y;R+G<@?&TL,'C/8CJ*UJ\W\+ZQ=:)\.-)F+PSS7UX+2S1XR
MDLD[C<QSR.IXQTQGG-=$^L:EI?BRQT2]EAN(M5AE:TG$6UHY8QN96 ."N#D=
M#V]Z .BF@AN86AGB26-QAD=0RGZ@U':6-G81F.RM(+9"<E88P@)^@KCM(UOQ
M9JFBW.K_ &C2XTM6NHVB-LY\PQE@I!W\#(QCGUSS@1Q^)O$BZ3X9U9Y+"2/6
M)(;>2V\IE*M(A(??D]QTV]#C)ZT =[17*V&L:Y'K>M:-=&UO[BTM$NK1HHS
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMS1"3=C&<\E<@$CT(T(_#T\7B_\ MV.]B6+[$ME]E%N>$5BP(;=UR?3&/SH
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MFS/[W8I101YG'!.??TI]SX->XN=?QJKQ6FN1XEA6$;HW\O9D/GD8YQC\<<4
M5--\0ZA)XDT_2WOH[N._L))7E6#"1S)MSY;# =/F/<].M9VAZAK5E\/=;UA-
M22>YMI;R13<0[@2CMGH1U X[#TK:M/".HQ:KI&HW.NB:7387@*QV:HLD9V\
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M9(,$&2-F#A\]<KTQCG'O5\^*+S3]5\6?V@8I;31K:&X@2*/8Q#)(Q!))R?E
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M:ZW:?;VZ;@JJ0\K_ ###8SPFT_\  U]Z )-9\0Z9X?CBDU.66))I!'&4MY)
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M8)UN$DU1@L"F%AR1NPQQA3@=#S[5S47B76&\,>*ITN ;G1I91!-/;X9T6,.
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M,<\<GGC=L/$%QXFUF6QL;E["&WL(+F1T16D9Y@64?,"-H4<\9)/;'(!U=(6
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M0RD,I&00>"* .?\ ^$8FBUC5[^UU1X5U5%\R$PA@KA-@;.<XQSCU'7'%5/\
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M%%LQ:<8R4VC.2<X[9S6EX0T0>'_#-GI^&$BINDWMN(8]L]]HPH]E%;./TI:
M,+Q5X<E\2VUK;K?+:);7*7(/D[RSH<@?>'%;.)O(QO3SMOW]AVY]=N>GMG\:
MR?\ A*;$W4,:PW+6T\KPI>K&#!O3(8$@Y&"K#)&.#S6R>!F@#G-+\'0VGA";
MPS?W/VZSE$@W"+RV =BQ[GD,Q(/TI]MX9N&738M5U(7\.ER"6W'D>6S.JE5:
M0[CN(!/0+SS5BP\4Z?J3ZA':I=/)IS;+E#;L&5O0 ]3]*ET;Q#8:_I7]J:;Y
MTUME@K&(J7(.#@'GJ,4 <++=P7?B+4KK_A+;72;L791+/4;".69 F%!3<0VT
MXW +GKZDUTL>C:KK%QH6LWM[%;W>FF4[!:D";>"F2"V5RF#CJ">>F*W-+U&V
MUBPAU"U23R91F-I8RA9?7!YP:NT <SJ7A.[D\02:WHNN2Z3<7,:QW:B!9DG"
M\*<-T8#C/_U\VY-"NT;9;:DK6[VWD30WEOYXE.6)<_,OS'<<]CZ=,;=9JZ[:
M-XD;0 LPNUM3=$F,A-FX+P3U.3V]#0!GVGA:;2[.WL=/U!!9PV8M7@N[?SED
MP2=QPR\_,>.F.W3&GHFD0:#HMII5LSM%:QA%9SR?<_C5^HKFXBL[66ZN'$<,
M*&21ST50,D_E0!B:3X9FT[7M6U2:^CN5U8H9X#;[0-B[1@[CQ@\YSGVJO9^"
M(;;2;_0GO6FT6[W^7:/'\UL&YVH^>@/(R#BNAL;V#4;""^M7\R"XC62-O52,
MBH-8U:VT/2KC4KM96@MT+OY2%VP/84 9>B:!J&D>6VJ^))M2@M%/D++"D6P8
MQEV'+D D9)[DXSR.:\"Z8?$7P\AL9-2B;3IIYC-!'%^\V^>[;-^[@-P?NYPQ
MP>E>A6\T=Y:13H#Y<R!P&'.",\U1UK6K+PY9+=74<OEO*D0\F+=\S$*,]AR1
MUH IGPW+::]=:OI%\EF]]&BW4,D'FQN4&%=0&4JP''<'TJM/X*5;'2+2POOL
MZ:7=_; TD/F--+\V2W(Z[V)QZ\8KJ** ,75/#[W^N:=J\%^]I-9))$P6,,)$
M?&1ST/RC!YK:HJG+JME#JUOI4DZK=W,3RQ1]V52,_P#H7Z'TH IZ'X<M-!N=
M1FMF8_;[@S;3TC!YV+[;B[?\"K*G\#-=:;KEE-JA"ZQ<BZ+QP;3#("I&,L<C
MY%X/OS76T4 <]9^&;N#Q)'KMSK4MQ/\ 8_LLR"!$60!MPQC[HR3QR??M4WB;
MPVOB""V:*]ET^^LI?.M;N(!FC;&#D'@@CJ.];=17,Z6MM).ZNRQJ6(1"S'Z
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M, 1FG4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH:H+2SNG$9?R""V]U3Y=X (XXR1QUIUE;W%M\7)5GO9+L'0@4:54#*//Z?*
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M:V$T80Q==RKCJ@^4 GK@GOD@%6\U6YO/&2^'+:Y>T2*P-Y--&JEVR^Q5&X$
M=23@]NG-<WJGBK7K+PYXCA6[0:CH5W%&+GR5_?QR,NTD= V&.<#' XKK=3\/
M"[UJUUNRNC9ZC;QM#YA3>DL1.=CKD9&>1@C!JEJ'@N&_T*_TUKUTDU.<3W=R
M(P7=@5( '0 ;5 '/ ]>: -?2[34;47']H:G]N,DF^/$"QB%<#Y!CJ,YY///>
MN8N_$ES!XGETK4-0GTB1[N/["9(4-M=P_+N7>5)WGYQU&"5Q79PK(D*++())
M ,,X7;N/KCM6#?\ A9]3AGLKW4/.T^>Y%P86A&^/#!MJOG@9'H3R<$=@"*TU
M#5)?'6KZ2]XIMHK**:W7R1^[9BP.>[?=]:YI/$'B9? -CXF?5U:=+ORY8/LR
M".93<&/#'&0<8QM(Z=SS791:#)#XEO-<2]!DNK=8/*:+*J%R5/7.<DY]?:LP
M>!L>$(_#7]J/]G2?SA-Y(\S/F>;CKC[WMTH 6WO-8LO'/]CW.J?;(+S3GN8]
MT")Y$BNJX7;@E<-T8D\=:Y[5=3O]5^#6N7&I7 GN$DFB+A @(2;:.!["NQET
M":7Q+;Z[]O"S06K6PB$/R,&())YSG('?I^=9Y\#AO"-[X;;4W,%Y*\CS>4-X
MW/O8#G'7]* +&L75^FIQ6T.I&VA>S9HXK6-9+EY<@ D,I C [G')Y-8">)M>
MOM \'WL-[%;RZM<+!<_N P;*N2W/3[N<#'UKHIO"\TNO1ZQ'J\]O,;06MRL4
M:[9D#%AC=G:<D\C]*H6W@-K33-'L8M9F*:/<>? SPJ23R IQCC#'WYZ], '2
M:9;7EII\<%_?F_N%SNN#$L9?DD?*O P,#CTKD_"ME=CQ)XJVZK<%TO$7,D<1
M#GR4PS *.1Z @<5VU8NEZ!/I>H:I>IJ E?4I1*ZO#Q&P4*-N#TP!P?2@#CK_
M %2]UKX,VNHZA*)KJ:YA,CA0H.+L <#CH!727VJ:AJ&OZCI&GO=P"P@B)DM5
M@+%Y Q!/FG&T!1P!SSS48\"A?!D/A@:G)]GAE$BS>4-YQ)Y@!YQ][VZ?G4^J
M^$I[S68M:T[6I]*U'R1#/)!$KI.@.1E'R,CG!YQ0!EWGB+7='T[2)O$L<]A$
M\4BZA=6$:S"&4, A;AL(5R3@'G ^O5Z+,UQHUI,]]'?%XP3<Q8VR_P"T,<#-
M5!H=S;O UGJ; 1Q-'*MS%YJSEFW%VP5^;.>F!R>,4W3?#?\ 8]GI=EI^H306
MM@SF2(*I%QNR3NXX^8D\4 ;+(C[=ZAMIR,C.#ZUQ^D_\E9\0?]>%M_6NRK"L
M_#DEIXJO-?\ MY>2]C2*2'R@%"K]W!SD'\^M &-J-M/+\4+6WL;D61.ARCS$
MC5B@\Y/N@\9Z=01[5#I_BO5#H%I!<2&XU";5Y=,-Q&B*S!"Y+A3A0Q5,>F3G
M!Z5T<N@2/XL3Q M[M=+0VBP&+*["P8G.<YR!^ _&LMO ,$NB7&FS:C.6>^:_
M@N8E"26\Y8MN4^F2?P)Y] "_H1\0)JM]%J2R2:>0KVDUP8A,#_$K"/@CN#CZ
MYI+W4KBZ\6Q^'K>Y:T"V)O)98U4NV7V*J[@0!PQ)P>W2K6BZ1=Z>&EU'5Y]5
MNF4()I8TC"+Z*J@ 9[GDG ]!537_  L=6U*TU:QU.;2]3M%,:W$2*X>,\E&5
MN",\CTH H3:GKFG3:'H%_>P/J&IW,R->PQCB&-2^=I& Y&T=, D\&HKC6=8T
M[6M8T%KWSWCTLZC97<D2[D )5D8* IYQ@X'!YS6G>^$HKRSLPU_<?VC9S_:8
MM0(4R&7H21@ J1QMX& !VJ1O#9F:_NKF[$FH7UJ+1KA8MJQ1<_*BY..6)Y)Y
M]AB@#GK36O$$-OX/U.YU47$6L&*&YM?LZ*N7B+!PP&0V1SSCGH*72%U&/5_&
M<T>KW+26TP\OSDC=?]2&&1M'3.  0/7-:Q\'.=,T.Q&J,%T21)('\@9<HI50
MW/3!/3%3_P#"+&/4M7N[;4IHDU51YL)C5E5]FS<#UZ=LXS^5 &/I=YXEG\%Q
M:_-X@M5DN;")@MS L<4+$C=(6').W/&,9QVI]OXHN[#5M>2XEN;NRL-,74(O
MM,*Q2\;]PP%7@[>,C/X5H/X-27P9#X:?49MMMY?D7*H Z>6P9,CH<$?C^M.A
M\(_\3B;4KW5+B]:ZLOLEU$\:*DRY;L!P/F/ _,T )I\?B"[32-235HY(+F+S
M+V!XU"@.F5,1"YR"?XB<BN:T[6+OPWX6\2ZN]]/>RPZO<6\27.PJ7\U8U=BJ
M@\<9 (&!P!71Z#X0GT7R;=]>O+S3K4YM;.5$ CQ]T,P&YPO8'@<<<# /!%F]
MIK-A=7<\]AJTTD[6Q"@1.Y#,RMC.0P!&>GO0!%J6H:KX=UO14FU![^TU.?[)
M*LL2*8Y2I*NNP#C@Y!S]:@\+W'B'5[Z^FN=;46^G:M<6Q@6U3]_&H  +=5P2
M#Q[YSGC5M_#LS3V$VJ:B;]M-R;8F$)\Q7;O?D[F )'&!R3C/23P_H#Z$VH'[
M:;A;Z[>[96C"['?[V,'IP.#^= %?Q=J]WHMO:7,<=U]A\XB]FM(A))"FTX8*
M0>-V,G!P*YW7;QM2\.^&KFVU:+4O-\00F&[V#!&]]FY5"\@8!''(/2NTU"QN
MKFYMKBTOOLKV^[*M'O24-CAAD'L#P16))X&A-I:P07I@,&I_VHY6$8DFR3C&
M>$YQ@<\#GN0"*RU+6K77=?TB;4HKQ[:R2ZM)KJ-8EC9@XVN4 ^4%0<]<9ZU%
MI6NZA_PE6F:?)?RWUK?6$DKR/ J(94VY:(A5)4[CUR#Q@]:OW_@Y-3U#5+JY
MOWV:I9"SECCC"[4&<%3D\Y8]>/:FVW@^>+4M+U&?7;JXN-.B>$$Q1JLB';Q@
M#C[HR>I]10!ST7_(A_$#_K_U'_T$5W.A_P#( T[_ *]8O_0!61'X.*:+K6EG
M4F9-9FFFE?R1E#+PX7GICIGI[UNZ=:-8Z=;V;2^:8(UC#[=NX 8!(]<4 <,V
MJ>)9]'\5W2ZX(9-%NIO(V6L>'5(U<(V0>.OOSU[5=76-:AU/PQ>2Z@)+;6_D
MFLQ JI%F(NI5OO9!&#DD'T%:$?A%TL-=L_[2)77))))F\D9C+J$;;STVCC.:
M=+X4DDCT)?[1*_V(08B(1^\PNSYN?[OICF@#+?5_$FM:==:AH(G$T5Y)%;PL
M(/L\BQR%"'+'?DA2<C&,CZF>YU;6M7N]7M=+-U;2Z?LBC\@0,IE,8?Y_,.2N
M6 ^4#H3GGB9?!,EMJMW/IVO7MC87\IFNK&-4*NY^\58C*9[[>?0CC#[WP=(=
M=DU?1M:N='EN$2.Z2&-'28*,*=K @,!QG_) ,IEUBY\;>'/[0O)[.YDTV=Y[
M> QM&DBE VW*G@Y[Y/H174>)$U1O#]XVC7)@OXXF> A%?>P&=I# ]>E5;GPM
M')J.EWMM?W%K)IT;Q9&US,CXW;BP/)*YW=>36]0!P8\6SR:IX6NH=1E;3=4B
M5;I/+C_=RNI$>YMN1N=74@=U[5+XAU;6K#P7?ZY9ZF06NE:V#PHVV!I508X'
M4'<"<G!'UK0;P'I9\/:AHR/*D5[<M<!U/S0L7WJ$] IZ?4^M7O$'AV+7?#S:
M(DYL[=O+&8T!*JC!E SP.5'X4 8UU%<R?%JU0:E=1Q#2))1$NPJ/WL8*@%3P
M<#)Z\<$5@QW&L:=H/C#5M,U(6IL-9NIA%Y"N)L;"0Q;/!']W!]Z[6[\.M<Z_
M9ZVFH2P7-O;M;RB-%VS(6#$<Y*\CL<X[]ZHCP4W]B:UI3:FQCUFXDGF?R1N0
MR8W!><8X&,Y_&@#HXG-S9I("8S+&""N"5R.V>*\O\NX/PD\3S7&H7-R3/=+B
M;8>1*1NR%!R<>N/0"O3[*![6RAMY)?-:) A?;MW8XSBN:E\"*^AZIHR:O<)9
MZC,\FPQJ3"';>P4]\GN<X'YT ,@O=7TWQAI%A<ZB+JTU2TF;R?)5! \80@J1
M\Q!#8^8FJMGK'B?6M*L-<TB.9A<3"1K:3R!;M 6((!SY@8#'.>N>,<5N3>'9
M9];TG5)+_P#>:9&\:HL.!(' #9Y]%&,=*HZ?X';2[F2&TUR\CT:24RG2]J%
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M50@KD'^_WXH [3S$\SR]Z[\;MN><>N*=7":9%=V7C_5C=ZO=W7V32[9Y"5C
MEQOR-NWY02"<+CD]33]/OO%&JV.C:U8F3;<M'-=0RO#Y!@8995Q\X9<C!/H<
M^E ';L=JEL$X&< 9-9NA:[;>(+2:YM8IHEAN'MV690K;D.#P">]<_H+Z[JNN
MZLDVO2K;Z9JGEK$MO'^]CV*2C''3GJ.>O7C&=I46LOX,\0R:#>/;:A#J][)%
MMC1_,(D)V$,#U' ]\4 >B4V21(D+R.J(O)9C@"N=TO6F\0W.E3Z;?2BT-G]J
MNAM0[]WRHC?+P<K)G;C[GO57XE+*?#EN8KJ:#_3[96$1 #@RJ.<@YQUQTSUS
M0!UU%<O]ON[WQ=+X=34)XHK*Q6>69502S.[$#G;@  9X R3[<R^$-7OK\:II
M^I.)KG2KUK;[0%"^<F RL0. V#R!Q0!T+ML1GP6V@G"C)/TK&L?%%OJ6@KK%
MG87TT33F$0I$#+D2;"=N>@.2>>@JJFH7.M>+-6TB&\ELX-)BAW&$+ODDE!8$
ME@>  ..Y)SZ5R6F7VI:1\+(+JROC%.FJO'(PC4^8&NBK=0<=3TH ]2HKBO%6
MOW>DZM/!?75WI=A-;JMEJ,,2O#',=V?-RI(YVXSQC/UJ^-0N=<\1:GI-KJ#V
M<6GVT+"2 *6E>4,0V6!^4!1P.I)S0!TU%<@U]KVG^(O"NGWVI),UXERE\L,2
MB.5HX\AAE=P.>N"![5#!JWB!X/%L-I*]]<Z?<K'9HR1A@I16(&% )Y.,YYQU
MH [6BN&M?$5UJ.CZQ=:!>7=Y=P1Q#^SKJ)4N;5MQ\P8*C)*_=SD97'M6IX2U
MJWUJ2]EMM3N+A(]BM:7<82>T?YMRL, \\<G/0\\4 =&TB(R*SJI<[5!/WC@G
M _ $_A6=I.O6VL7FH6L$,\<FG3"&7S4"Y8KNXYZ8(ZXK \40W$OC[PJD>H7-
MNLANOECV$*5B^\ RD9P2.<\=,5DF/4A>^.KK3]5DL'M)A,GE1HQ=EMU(#;@?
MEXZ  ^_:@#TBBN-C\17^JW&DV,*S(]UI":A.;5HU<EMH !?@ $G..?N^^=KP
MQ_;:Z8\6O%&N8YW6.0%=TD752P7@-@X...* )[[6[2QO(K'$EQ>S*72U@7<Y
M4<%CT"KGC+$#/%)8Z[:7M])I[++:WT:>8UK<+M<IG&X8)##/&5)QWKF?"#-+
M\1?&;W))N(Y+:- W58MC;<>QZT>./,C\9^#9;4D737LD>5ZF(J/,_ #F@#N*
M*X&37-:7P7XKO!JDGVK2KZYCMIO*BR$0#:I&W:>O7&:U-2O;][F&)-3>,2:=
MYB6]HBFX:7/^L;<-JH!TR0"21SQ0!U5-,B*ZH74,V=JD\G'6O/H_$.NZAH_@
MRZBU'[/+JTGE76V%"&^1B6&1P<KG'3VQQ4Z6&HV_Q&TJUN=>O+ITTJ9S(4C7
M=^]3C;MP,C )Z\#D4 =Y17"+J?B;7=*?5=$,J3B[=88G:$6YC24H5?/SY*J3
MGKD\<5.\FO:EXUU328-=DLK>&UM[B/9!&Y0LS97)'(.._/3WR =!IFO6VJZC
MJ-C##/'+ILB1S>:@4$LNX8YZ8QUQUK4KB=-@N[GQ-XXAL;QK.Z:6V\J=45MC
M?9UQD,"",]>*?HFN:AK6CZ-:B^FAU3SWCU([(]R>3Q*"-N "Q0# !PX- '5:
MA>IIUC->2QR/' A=Q&,L% R3COQ6-;>.-&N$L99#<VL.HD+:SW$#)'*QZ#=T
M!/;.,UI>(/\ D7-3_P"O27_T UPFG>'M3\5_#OPWI;?9;73T2"::<2L\K*HX
M55V@ GUSQ[T >ET5QL+Z[J?C/7=,CUZ2VMK'[)+$%MXV(#ARR<CH<?7ISUS7
MAUG5]9\&7_BBQU%[:6%IY+:VV(8O+B9AL<$9)8*<G(QGC&* .ZHKC4\2W&IZ
MIH:2RMIFG:GI9NQ*" 7F.TB+<PXPI+>^/3-9$VN>)8_A[)K)U5Q<_;EBBD:W
MC"RQ><(PV-O1E.<_EP: /2:*Y"[N=6TS5[+1&U*YOY-0:>Y,JI%')'&@0"-<
MX7&6)SUP,>]037GB[2M$N'NK>>[6&^4JT'EO=&T.<_*!M+@X' Y&>_- ';45
MQ \0W4_A>75-$O;G6H!?+YHBC47,,&!O0(5&7!]1G!SUYK:\)ZI;ZOI]Q=VN
MK-J,#7!$9D0+) -JYC<8'(.>HS@CK0!)J'B>TT[68-)EMKM[JY1GA6*+<)%7
M[Q!SV]ZGTCQ!IVMO<Q6<K^?:/LN()8VCDB)Z94C//8]#7,>*)+J+XE^&WLK>
M.XG6TO"L4DOEAOE7C=@X_*G_  _C34[W5O%-Q+MU*_E$%S9A=OV,Q#;Y9[EN
MASQGT% ';45P<6J>)M=T=-9T3S1*URQCAD>$6[1+(5*-_'G:.O7=Z"I%/B+6
M?$WB32K?Q%)916)MS;LEM&S*7C+8.1]W/7N>.1SD [BBO/\ 0O&&IZ[#X=TZ
M>3[+=WRW)O)HE&3Y#%<)D8!8\GC@ X]0[4-=UG31XJTK^T'>73;#[?97;1H7
M"E6.QQC:<,O!QG% '>22)%&TDCJB*,EF. !3J\V\26^L-X*M]1N_$%S+]KEL
M&\A(XT5"77=R!E@<@X/<?A7HL,;10JCS/,RCF1PH9OKM 'Y"@"KJ>JPZ6D!D
MAN)FN)?*C2WB+L6VEN@Z#"GFLE/&^GR->K'8ZF[6!Q<JMJ28SC/('MSQ71%5
M)!*@E>A(Z5Q_@WGQ;XR!_P"?^/\ ]%B@#=L_$-I?:Y/I$44ZS06Z7!=T 1D8
MD#'.3T/:M6N)FLKF[^)6HV]I?R:>/[(@!D@C4N/WDF -P('Y'VQ5;1_%>J:E
MHOANWD9WO-3%SYTL C5W$#;3MW?*"V03[ XQU !W]%8?AM==B^VPZR=\2S9L
MY'9#*8R.C[.,@]^]5GO;O6O$NK:/;7\E@FFP0X:)5+/)(&(8[@?E4 <#J2<T
M =+17(KJ6KG6](\,WE\BW;V4ES>W5L@'F%6"A4R,#)))X[<8K)U7Q%K>GZ;X
MNT]=08W6B1QSVU[Y2%GCD4D*PQMR,$9P,T >B4U71RP5@Q0X8 ]#C.#^!'YU
MR"WFL6'B_1+:?5I+JWUBUG,D+1(JPO&JL&3 S_$1AB?\,6QFU/3? _BK4;76
M+H7%I?7IC:18WY1^"<KG) QZ>@% 'I=%<E+_ &S9:3%>S^(U O);8L)(%!B4
M_?2$*I+.W  ()K,;Q;J6E67BDS/)+_9MQ;QVANU4,@F5,;]N,@%\^N.#S0!Z
M!34D21=R.K#)&5.>0<$?@016)_9FL0Z@W_$\EDL);5D=9%03)-V="%  QG(.
M>G%<CX=UB]TSX>^&ECO97N-9NX[59955O(W,Y9AQR< XW9Y(^E 'I=%<H]]J
M6F>-+?0GOY;BTU2TDD@DD5#);R1XSR  5((Z@\^W%1^ I=;U?1=/US4M:><3
M0R*]L($5"WF$!\@9S@=.G3TY .OK+O->MK+7M/T:2&<SZ@)#%($'EC8NYLG/
MICH.]9/BW6[G1+^UEN?ML.C-$XGN[.,.8),C:7!!(3&>@Z]<UEZB9[W7O IA
MU5)I98;K-]&BL)/W RZCID\XXP#V/2@#OJ:[;$9\%MH)PHR3]*XJPU;5X]'\
M2VDFL0_:-+O##!?WJJH5"J-EPHP2-QQQR<<5;T/5;U_&EYI3SW4ME]@BNH?M
M<:K(&+LI(P 0#CHP!![ 4 3OXYTU/"4GB4VMX;2.1HV01CS 5<IR,X R/6NE
MKRI_^2&ZM_U\7'_I4:]5H **X;0O$%U>:W!I>J7]WINKJ\IGL9XD$=PF&PT+
M;>0/E(YZ YSUJG<^(M<C^&NL:LNJ2"^L;Z6*.;R8LE%F" $;<=/0"@#LHM>M
MI?$DN@B&=;F*V%R79 $9"VT8.<GG/;M6G7#ZC:7=[\4YX+/47T]CH,>Z:*-7
M?'GOP-V0/R/X=:S6\1^(T\.LDFI*+[3M?339KA8%VW*%UY(_A.&YQB@#TJJN
MHWIT^QDNA:7%V8\?N;9-\C9(' R.F<_0&N6!UH>.)_#Y\07)MKC3A>"4PQ>;
M"PDV%4.W !R/O!NGKS69<^(==C^&=]J U(B_TZ^>V-P(DS,JSB/)&, X/8=J
M /1#(@=8RZAV!*J3R0.O\Q0[K&C2.P5%!+,QP /4UQ][#<2?%FR5=0N8X_[)
MED$:["H_>Q@@ J>#@9/7CJ*L?$P2?\*]U=HKB6$K#DF,@;AD J?8YYQ0!KW>
MO6UGKNGZ/)%.9M1$AAD51Y8V+N;)SZ>GK6G7$Z_;70\6>$8(]0D,Q-Y_I$B(
M6 \GL  N<=./J#5>+Q-JFDZ;KMM<7;7T]CJD5G;7$J(&VR[,%L *2N\^@.!0
M!WU%<YI:>(H?$1^T-+)I,L'(NWB,L<P/\.P<J1V/0]*Z.@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *KW]A:ZI836-["LUM.A22-NC U8J.XN(
M;6WDN+B5(H8E+O(YPJJ.22: ,73_  ]?:;;I91>(+M[.,;8UECC:5%[+YF.0
M/<$^]6-2\.6&I6UK&?,MY;)Q):W$+?O(6]03G.>X.0>]0'Q7 +'^TO[,U$Z;
MMW_;!$NW9_?V;O,VXYSMZ<]*V+>XAN[:.YMI4EAE4/'(ARK*>A!H RIO#QU&
M:W?6+UKV*UD$L=N(Q'&7'1G R6([#./;I3;WPV;SQ/9Z]_:$T<ME&\<4*HI0
MJWWLY&3^?:MRB@#$'AJ*#Q)+KEC>36DERBK=0(%,5P5Z,P(R&QQD$5/XAT"U
M\2:4UA=/+%AUEBFA;#PR*<JRGU%:E,CD2:)98G5T<!E93D$>HH X:VB;3_B;
MIT%YJTVH7 TN5'FG"K\Q="JX4!02 3ZG\JN/\/(GTN72?[:OTT\W/VB"!!&/
M(/F>80#MRW.<;L@9Z$XKL*RM>UZ'P_;03W%M/,D]Q';@Q!?D9V"@MDCC)[9H
M S;OP1%=76JR?VM?1PZO ([R!-F)&"; V=N1QU P#].*D@\(^1?Z1>?VM=.^
MDP-!&'1,2*P ;=QZ*.F,8KHZ* ,=_#L1\3-KD=Y<1/+ L$\"[?+F"DE<Y&1C
M)Z$9_/.=I/@:/1YQ%;ZQJ!TI)?-CTUF4QHV<XW8W;0>=N<>N>:N7/BN"V\0'
M0AIM_->B#[2%B6,AHMVW<"7'?C'7VJWHNOZ?K\$TEC(^ZWE,4\4J%)(7'564
M]#0!!H_A\Z/?:E=)?RS'49O/D1T4*CX R,#., #!JG;Q6/@/2[B6[O+JX@N[
MUI21;F1EDD))X09QGVKI:* ,'PCHT.DZ=<31VIM6U"ZDNFA;K&&8E5QVP,9'
M8DU;\0:'#XATE["::6#+I(DL6-R.C!E(R"#R.]:=% &%/X8#:I;:O;:A/#J4
M$!MY+AE5A<1DYPZX Z\C&,?3BKVDZ3!I$$J0L\DEQ,T\\KXW2R-U8XX[  #H
M *N22QPJ&D=44L%!8XY)  _$D"GT 8%YX6$OB$ZYI^I7.G74L0AN?*5'6=1T
MR&! 8=C5(> H%\-?V$-6O/(-U]IWE4+!M_F8'R]-W/.:ZRB@##O_  [+?B^B
M?4Y1;:A$(KB$Q*1]W:63/W6(]<C@<55OO!4+ZC;:AI.IW>D7,%NMJS6^UA+$
MO16#@@D=C734A. 3C/L* ,'4?"D=VFF-:ZA<V=UIDC/#<KMD=MX(?=N!#;LD
MGWJ&W\&K:_VHT.L7XDU*:.=I"4)1T*D,/EZG;R.G.,"M'0M>AUZ*\DAMYH/L
M=W):2), &WIC/0D8Y]:U* .?F\*BXGNKV34)4U"Y2%/M,,:IL6)]ZX4Y!R>N
M<Y'' JYI^B)9ZI=:K++YU[=HD<D@0(NU,[0 /J<DD_D,5J5EZCKT.FZSIFF2
MVT[/J3LD4JA=BE5+$'G/0>E #-9\/QZO?:=?"\N+2YTYW:*2':20Z[64A@1R
M._:J<?A$1KK8&ISG^V\^>2B_N\KL^7C^[QSFNCHH Y6Y\"Q2V>E"VU:\M+[2
M8O(M[Z(*',> -KC&&& .U;VF:>--M/)-Q-=2NV^6><@O*W3)P !P      *K
MZYKT.@K9M/;SRK=W4=JK1!<(SL "V2./IFM2@#%U/P^9M0.L:7<?8M5$/E>:
M5W1S+U"R+W /0@@CU[5D^&X+Z35FO?%5JZZU%NA@E1<VHC)_Y9$#"D\9W'=Q
MZ<5MZSKT.B3:?'/;3R#4+M+6-XPNU';INR<XX/0'I6K0!REWX$CN4UBW35[R
M&QU=VEFM4";5D8 ,P;&[!P#C./PXJQ_PAR)JD5_#J]]&_P!D6SN /+_TB-22
M,G;\IY/*X/TZUT=96O>(+;0=%N]5DBENHK3_ %JV^TLOYD>HH R+?P'':V.C
MVD6L7FW1YC+;LR1DYP1@_+TP2/7GK6IJ'AZ.^UVSUA+VXM;BUC>%A%MQ+&Q!
M*G(..0.1@UK1N)(U<# 8 TZ@#ED\#16^I74UGK%_:V%[*9KG3HV7RG8_>P2-
MR@]P"/J*T+?P_P#9O$]SKJWTI>YA6%X-B[-JYVXXSD9/>MFB@#GA8VWA>YUG
MQ%<WEQ+'>%);A!#NV[0%7:%&>F/7UIOAG3[634]4\1P6LD']J.GEB1"C,BJ!
MOVGE=QR?<!2:Z.B@"KJ=D=1TVXLA.T N(VC9U4$@$8.,\9YJOH&CC0-&M]+2
MYDN(K9 D;2* P4= <<&M*HS.F9%0^9)&,LBD;O;\Z ,NRT#[%XDO]:6^E=K]
M8TE@*KL 0$+CC/&3WYS5-?!L,,6H65M?SP:;J3M)<6BA2 7^^$;JH;N.>IQB
MMRPNGO;"&YDM9K5I4#&"8 .GL<$\U8H X'Q.;>'Q);6SZE?:#!:60CMIH[82
MP3;FY4 JR@J$7W.?;FW%H=_XFT.XT_4=;N;BS,T<D%V;18)7VD-C:1C:& P=
MHSSVP3V=% &%K_A>+7H;)WOKBUU"P;?;WUOA71B,-QT(/<4J>')X[6$#6;M[
MV.<3O=R!"TI"E=I7 4)ACP /7KS5S7-7CT+1KG5)H)IXK9#(ZP@%MHZGD@5;
MMIUN;6*X4$+*BN >H!&: ,5/"PA,MQ;W\L%[/>B\FGC1<.VS9MV]-NWMU[YS
MS5W2=&ATN6]N _F7-_-YUQ)M"@L%"C"CH,#W/4DUI44 8=]X:^W>)K+73J$T
M<MBCI%$J*4(<8;.1DY^HI?\ A&HH?$LFNV-Y-:2W"*EU"@4Q7&WHS C[P'&0
M15G6-;M]&TB\U)XY+F.R4M,D&TLN!D]2!TYJY:W"W=I#<J"JS1JX!Z@$9H Y
MN#P+%::A<O::Q?V^FW<IFGTU&7RF8_> )&Y5/< BL[1_,O/B%XL^Q:G]F\S[
M*HPBOOQ%ABN>ZGC/(YY!KNZBN;A+2UFN9 2D*,[!>I &>* ,.;P9IXM-+BL9
M);*?2&+6EPF&8;OOAL_>#?Q>OM3KCPI#=66JQ37<C7.KQ>3=7(10?+VE0JCH
MH )]>234UEXFM;G0QK=U!-IM@T4<R37;1@,C@$'Y7;'4=<=:=IGB;3=4NGM(
MI1'<AY0D+D;I$1MID7!/R$]#WH AO/"T5_X5CT&XO9RL0C$=RH42*8R"AQC'
M&T=N:NQ:9<1WUM<-JMU(L$+1O$VW;,Q(.]L <CVP*HMXTT-+TP->Q^2$;=<[
MQY8<.$,><YWY/3'3FI]0\0)IFIVEE<Z?=A+VX6WAN5\LQLY4MTW[@,*?X>U
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M>ZKO;:N3C)]!0!C:'X<FTDJ;O6KW5/)3RX!=;<1+_P ! W-CC<<G'IDYI0^
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M% !7$?%UI5\"2!2P@:ZA6Y(_YY;QG/MG%=O4%Y9VVH6<MG=PI-;SH4DC<9#
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M9#=NTT:RXS%$Q)1>G]W&<\YS61XB%IXEG_X162QNIVBFAEGGD@*Q(BD.6#X
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MPR0!<&'_ )YLI!!7CCN#T-0WO@VPO]!OM)EN;I5U&7S;NX0IYLS9'4E2 /E
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MO'&/SH P(+WQ+X@T1-;T><17!N7:-)9U$'E+(5,;+M)^Z#D]<]"!Q77ZS_R
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M.?M&J6DL]Q)&PC:3RPH(!Q@9+9./3C%=%;^&(K75]1U.+4;X3:C&D<H9HV5
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M#[2XOYS/<*\L3RL.7V2L@)]\**H:+:?\7-\22&XN#L@M&"F4E>1)QCT'8=J
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q9+
M=VWA35+JQNWM;BWM)9DD158Y5"<?,".U;%8WC _\4=K$:JSO+8S1QHBEF=BC
M   =230!9T":2Y\.:9/,YDEEM(G=VZL2@))K0K"TB_BT[P/97DT<Y6UL(_,C
M2)C("J#(V]<^U;4,JS0I*H8*ZA@&4@@$=P>AH ?1110 4444 %<G#JESXD\8
M:GI$%S):Z=HZQK.86VR7$K@G&[JJJ!VP2>^*ZRN*MH3X0\::UJ%]E-)UD1S"
M[QE+>5 0RR'^$'.0QX[9S0!/>:G<^%?%6E6,MU-=:7J[-"@G;?);S  KANK*
MV<8.2#W[5JGQ9HHTN\U,W,OV6QF:&Y?[-+F)UQN!7;NXR.<8K#OXX_&GB?0[
MC3G\[2M)E:ZEO%_U<L@X1(S_ !8())' Z9SQ6'?2O:>'?'.BO9WC7US>7-Q#
M&ENY#QNJ[6#8VXX/?/;&: .]N_$6FV;I&\LDDKVYN1'#"\C"(?QD 9 Y[]>U
M13^+M"MH+">2^'EZB,VK+&["3C/8<' Z'GMUKG9=1D?5[2SEL;VWAETE!'-#
M9N)KA\D&%GVYC ZX^7KG('7&TMVC\.>!(YK.[1K*\_TA7M7S& CC<1C@9(YZ
M?E0!UD'CJPO-<L;"T@NWAN[>2;SC9RC[KA  -N>I.21@8'/-:-YXHTG3W(N;
MATC640O/Y+F)')P%9P-HYXZ\'@XK*U9GL_B/I-X]O</!)I\]NKQ0LX$A=" 2
M!\O /)P*Y_3FM+>"]\+Z_HNHW=Y]JF:&,+*T%ZKR&16R#L R>2<8QGKF@#K[
MKQGH5G?7%C-=2?:+9HUEC2WD8KO.%/"]/?H,CU%9.CZT-+U#Q9/JM]=2V=A>
M)AG5Y?*0Q*QPJ@X&2>@J312$^).O%HI%66UM4BD,;;&*!]P#8P<9'>CPNBS>
M(_%B30OY5S=H5\R,A94\I5)&1@C((H WCKVG"QLKWS93!?LJV[+;R$N6&5X"
MY&1SD@4SQ,9$\-:E-#/+!-#:R2QR1-M*LJD@^_/8USOA#3K^VU.71[P%K+P[
M*Z64I;/F"108\^Z1L5_X&*Z#Q2X3PMJ@PS,]I*B*BEF9BA   Y)- '$7>LZQ
MI'@SPYKEIJ]S=:E??9]]E,5D6[WJ"P QE2.N0>*]#O=1M[#RQ,7+RDB..-"[
MO@9.% )X]>@KSG3M(FT?P_H/BO1=/<WUA91V^IV2PE9)X\#?A2,^8IY![^]:
MGB+4436]'\2&UO[G2#;RVUQ]G25);9G*,&9!AL?+@_\ ZJ -\^-/#ZV,5X^H
M".&6Y^R@O&ZE)LX*.",H1WW8]:ETGQ5HVMWEQ9V-TQN+8!I(I8GB8*>C ,!E
M?<>WK7'>(?[-CT*POK'39[6UG\06DS&2-_-N3N&7*-\W/09Y./<5>UO2Y?$W
MB2XN]'?:J:)<6ANP"%>23[B ]]O)..F10!T<?BG1Y)K:,7#JEV_EVTS1.L4S
M>BN1M)...>>V:BNO&FA6=]<6,UU)]HMFC66-+>1BN\X4\+TXZ].1ZBN5N%DU
M_P"'NE^'8;::#5X6M89(GB*FU:)EWR$XP%VJ<'OD 9)K9T=@/B9X@9HY0LUM
M;)%(8F".4#[@&QCC([T 6M(\7VFKKK!DBN;6+3[B2'>UO(IVJJ9).,!MS'Y>
MN,'%%EXET'3-%TD-JMQ/!>J$M;BZ#N\W7EFQUX/7%9_AJ4V$WBNTNK>YC=M2
MN+D$P-M:-D3:0V,'.#P#GBL*R#Q>%_ <<EO<*]G>HUPA@?=" C@EAC@9(Z^M
M '>:;XDTK5DO&MKAE^PMBY6>)H6BXSEE< @8YS40\6Z,9[2%IYD:^7=:[K:0
M"=?53MYZ@_0@]*YQXX9_$?CF.Z@N6M;O3X4!BC(,H6*0.$8C!8;@/K5'0M8T
MF\N_#7]J:E)%<:7%Y5O&]A-"))'01C<[#;TXP."3GVH [GQ#Y@\/W\D4TD,L
M5O))')&VUE8*2#_]:N!NM:UC2? >@Z_:ZQ=7.IWA@S93%9%O"_WE"XR#WRIX
MKO?$<@C\.:CD,Q:UD5552Q8E3@ #DFN TO1IM*\-Z#XJT;3V.I:;:+#J%D(2
MCW$6/G&TC/F#J#W]^!0!Z1>:A;V C\YG+RG;''&A=W.,G"C)Z=^@JI;^)=(N
M=,DU&.[Q!#*89 Z,KI(#CRRA&[=D@;<9.1CK7,^(]27^UM%\2"UO[G25AFM[
MD0)(DML7V,&*##8^7!__ %54U9(8K*PU_1]%NQ80:M'=W2F-_.N%V,IFV-\Q
MP6'7DXSTP: .OA\3Z9-?36(:Y2ZA@-P\#VL@<1Y W ;>1D]L]_0T@\5Z*;#3
M[\7;FUU*18K6402$.['"@_+\N3_>Q6!IVHP:O\4#=6JS"%] ^1I8FC+?O^H5
M@#CZBN=M;IU\!^'-*^P7YO-,U2V^UQ"TD)BV2DGM\W'/RYH [Z/4=,_X2:^1
M=0NFNK>U4S6AWF*-=QPX7&"QSCC/04RP\:^']2VFUOBT9@>?S6B=4"(<,2Q
M QUP><8/>LZWF5/B?J%RZ2K =)B02M$P4LKLQ7..H!''6L32;"_O/@H=-L[:
M5-0B5F^SR(T;,5F,FWG!^91C\: .TB\3:7)>/9M)-#<+"9Q'-;R1L\8ZLH8#
M=]!S[53C\>>')8;2X6^?[/>/Y<5P;>01;LD ,Y7"DXZ$@]ZS]"U+1-8O[?4+
M?2=0CNK2-S+-?)*#: K@H"_!8G PN>,GTKG((Y4^$&DVC6MP+F.^B+P>0V]0
M+G>25QD?+S0!Z#IWB/3-4U"?3[:647,""1HY8'B+(3@.NX#<N>XR*8OBC2&N
M[:V^T.INV*VTK0N(IF'97(VD^G//;-<_J<<EY\1'%OYBB?P_+;)<"-MBRM(&
M4%L8!P":H^&;C3[VSTK2-0T'4?[8TUH@\-PLIB@:/ \X,3L P"1CKG ZT =%
M+X]\.0PW$S7LICM9S;SLMM*1"PQG?A?E'(&3QG/I4E[XJ@M/%-EH@MYW^T0/
M,TR0.ZX&T +M!SUY/0?C7)C<WA'Q[ +>?S;J^NG@3R&S,&C15*\?,"0>E:/F
MM!XJ\,:@UM=/;OI<EON2W=MLAV$*P ^7H>N!P: .G_X2#3S<I KRMYDYMUD6
M!S&9 2"N_&."".N,@CKQ1XC\Q?#FH2PSRP2Q6TDD<D3;65E4D'WY[&N.@CN+
M+7H;CP_<7!AN]3*W^C74998\N=\\9(R@XW9Z'(]A78>)G">&=3X9F>TE5512
MS,Q0@  <DT 9'@'6KV_TZZTO6)?,U72IC#<.1@RJ?FCDQZ,O\JS=,UK4=6^*
MDELUW*NDC36N+6!&VARLPCWG'4$AB.Q&VDUC2]3.O:9K/AX,!JMM_9U^P!4Q
M+C*S8[,N&'/L.]2P1Q6?Q;@$$$B64.@BRC=8F\M7$P(3=C&=HH Z$>*M'-S%
M"+EL37)M8Y?*?RGF&?D#XQG@CKU!'6H;KQKH5I->P27,K2V&W[1'';2.R @G
M. O3 R3T&1SS7$75[/?:?IL\VG7UO<66OQ2W%E!9.L5J@F.2 J_O"00Q/S$D
MG %;MC,%\5^,II(9DCN+>W\MFA;$FV)@P!Q@D$@8'>@#I!XCTEKC3H%NBS:H
MF^S98G*2C;NX;&!\O."12+XCTV4:@(7GDDTU@MS$MM+O0D9'R[<G(YR,C'-<
M)9,^GZ!X#U"YM[E8=-=XKO$#EH2T3*-R@9QG SCO6QH5WCQ'XQNI;6[AAF,$
MD32VSJ' @ XXZ]/EZ\]* (_#>K0WFDZ5XEU'5M1@N)/EF@*R^3<O*2$1$(P2
M#C!C].375VFO:;>0WDJ7'EBQ8K="93&82!GY@V,#'.>F*XC3[Z?3?AOX;0V,
MN8IXHKIVM#)+9 ;LR!"I.X< '!QNSS56YL+[4+?QO9:=:WQFNC;7%L;F)QYZ
MJB$C+=VVD;>O.,#' !W<7BC2Y;HVBO<"X\@W"0O;2*\L8[H",M]!S6=I/CO3
M+WP_#K%ZMQ9Q32^6I:UE*C,A5!N"D$G R0<9-3:)XCL_$=S!-;:7<QSQ(1/)
M=6K1FVR.4#,.23CA>,#)[9XZ**Z;X/+8"PO!=:9<1M<0FW<-\MSN;;D?-A1G
MC- 'H;:[IR:M)I33.+R.W-R8S"_,8(!8'&&Y(& 2:S(O&_AW4;9C;W\QB>"2
M3SHX) %5#M8YV\$=<=<8..165!J<5[\3+?4X8+O["VBO&MPUK(JEO.5N<C(&
M%/) Z4G@MO(^%SP30S131)<AXGA97RSN5X(R<@CIZT :]MXET+2]&TCS-4GE
MAO41+6>Y#L\W&06;'4@9YQ5[3/$FE:LEXUM<,IL6Q<K/$T+1<9!97 (!'.:X
M>/?'X7\!1O!.'M+N%KA?(<F$+&RDL,<8)'6M%XX9_$GC>*Z@N6MKO3X4S%&0
M90L<@<(Q&"PW ?6@#H1XNT8S6D1GF5KY=UKNMI )U]5.WGJ#]"#TK3O;VVTZ
MRFO;R98+>!"\DCGA0*\ZT+6-)O+KPT-4U*2*?2XO+MXWL)H1)(Z",;G8;>G'
M'!)S[5V/C&XN+7PGJ$UKIR:C*L8Q;/%YBN"P!)3^+ R<=\4 6+7Q#IUU=36J
MO+'<00B=H98'1S&>C $9(R".._%48/'?AVX6SDBO7:*]E\F*7[/)Y>_<5"LV
MW"DD< X/?I6%I5PO_"Q8]1']I3VMQHNP7=Q;.@9Q+N/!4!!CV ],D\X\:R#X
M1V-I]EN1<QZDK-!]G?> +HOG;C.-O.: ._U?6;*VCN;1I[@31P[Y3;1,[0J<
MX8E0=O0X[\$]JI_#^[N+[P)I-U=SR3SRP;GDD8LS'<>236/IFHG1?$_B&WU.
M"Y(U.5;FRN$MWD6=#&%V J#@KC&#6G\-@Z> -)BEAFADBAVLDT3(0<GL0,CG
MKTH HP+>7?Q(U32VU:_CLX;.*>.*.; 5F)!Y()QQTJ6/5]3\/>-[/0-2O&O[
M#5HW:RN)4598I$&61BH 88Q@XSR*KVM[%:_%+5[R:.X6V>PAB286[LC."20"
M!@XS4DEE=^*O'>FZM]EGM=*T6.4PR7$9C>XF<8)5&PP4  Y(&2.* -Z7Q1I,
M%S%#+<.JS3?9XYS"_DM+G&SS,;<Y!'7J".M96D7D\/CKQ1%<WEQ+:V\%K)'&
M[%EBW+(6VJ.F<=JY[PX;,:7;^&-;T34)]7LWV>5()F@E*M\LP;.P+T.?K@'B
MM_2)!#\1/$TTB2)$\%J$D:-@KE%?=@XP<9'2@"Q8>)=!TOPUI]W_ &I>W5E<
MR&*"[GBEF>1BY #$+D<\#('05MOJ=K%J$=@[.)Y8FF4>4^W8N,DMC:.HZGO7
M&^&=$&N?"1-$N(Y+>9XY5 E0HT4GF,R-@\C!VFKFG6VKZ_X+U&YOH#:ZK?V#
M6B(YP4*HRY]LR%V^A7TH VH_%&DRWEO:^?(CW2LULTD+JDX R=C$8;CGCJ.1
MD543QYX=D<K'=SR$/(A\NTF;:T8RP.%X( /UP:P_#E[IFJKIMO<:'J*ZM8%3
M*EVLWEVC*,,X9CM[' ')R.,9(T?A^<6VM(T4L3/K%S,HDB9-R.^589 R"* -
MB/Q+I,NB0ZU'/*]C.RK'(MO(2Q9MJX7;NY) Z=ZTGECBA::1PD:*69G. H')
M)STKBM"TJ[L?$UQX>,8_L?3YO[1MFST$F[9%CT5_,8?[JUN>---O-8\':II]
M@?\ 29[=EC&<;CUV_B!C\: )K?Q-I5S=VULLTB/=J6MC+"\:S@#)V,P /'..
MN.>E85[J8UKQG>>'Y)]2M;>&R3RWM4FB83,[ N64?= 48)^4\]:KZC+_ ,)7
M8^&X+&":*[MM0@N;A'B9&M%C!WALC@_P@=\\9%7K*4?\+0U-RDHC?3X8ED,;
M!&=7<E0V,$C<* .GM87M[2&&2=YWCC56E?&Z0@8+''&3UKD;7Q/>CX@K:W&!
MH^I1R06#>LT).\^V[+ >H5:WO$NIOIND2- )#<SD0P%(V?8S$#>0!T7.X^PK
ME_%_AF6T\'PSZ=J5[//H[1W&GQ,B-ETQ@?(@8Y7(Z\YYH V/%FNW=C>:3HFF
M.L=_K$YC29E#>1&HS(X!X) Z \?E5C4-"O4TV3^RM6OH[T+D/+/Y@E/]TAN%
MSTRH7%8.OK=:H_AOQIIMC<32:8[&YLO+(F\N10' 4X)9?3O72P>)+&^C']G>
M;=3-]V+RG0J?]O(^0>N?PR>* )M=O9K'2I&M=INYB(;8-T,KG:N?8$Y/L#6;
MX%UJ?6?#,1OB?[1LG:TO5/42QG!)^HP?QIMT3K?BI;5+FZM$TN/S%DCB $DS
MY4X+J5.U<CC_ )Z>U9%BDGA?XDW,&^[NK'6K=9)IVAR(KA<@;BBA0&7]<9H
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M+J5W-:I+'J#3,KQEP6,10)M.PY('&1Q79:==2W,,B7 5;BWD,4P3[I( ((]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>=ZYH=IXB^)
MLT&I:?=26$FBBV%R+>0*DXG+#:^,!@#G/3M[5Z)10!Q/AK7-7TK4I_#>O6U_
M>+;$+:ZLEG(R3IC@.0#AATST..O<UHK6ZND\?P1V=R'O5<6V^!T$W^C[/E)
M!^88KOZ* //I([34_#WAV*XEU+1;RVM]MO?^4T1@D5$5E<,/NMDCYL [>#R,
M]+X0N-3N?#\;ZM&@N1+(OF)'Y8G4.<2[>VX?-^.>];E% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC+LP_BSGH,Y_(=: .QHK!\$ZO=:[X1L-1OBK7,@=9608#,CLF<=L[<_C6]0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVNSSWL5HUJY:! DBE@P^4 8&1DX.3Z@5TE% '(IX%9/"=MX=&JMY-M<"=)3
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M23!!+#&,$,1@8 P,<#%3+X=8>)_[;DO3+FQ%DT#Q ADW;LDY^]D^F,=JVZ*
M.6M_!*0:0V@'4&DT/S-ZVK1?O N[?Y?F9Y3/MG'&:O1Z!-#XGN==COE#W%LM
MOY+0Y554DJ<YSG)/_P!:MNB@#(\,:$?#>B1:4+HW,<+.R.R!6^9BQ!P>>6-:
M]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXYH NZ3XJ:#4]6T;7IHDN-*59?M078DT##(<C^$CHW;/2MLZSI@:S4WT.;X
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MP]A,B[V W,4( 'N?2J/@_1]%OO#V@ZH%%Y/;V<7EO).\HA?8N[:I8A3] "*
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M>!SUXZTM%% !6-K&E:GJEU' FHQ0:2\>RZMQ!F27GD!\_*".#QTSZ\;-% "
M8&!THZ\&EHH 9'%'$NV.-4&<X48I3&C.'**67H2.13J* "DI:* $I'C20 .B
ML <C(S@TZB@ HHHH *1E#*58 @\$'O2T4 -V+LV;1MQC&.,4!550JJ H&  .
M*=10 4444 8.JZ1K$NM)J>F:A:@?9_(>UO(#)'C=N+*58$$\ ]<X'I5O2=*:
MRFGN[EH'O+E465K>'RDVKNV@#)/\3<DGKVZ5IT4 )@9!P,CH:  !@#%+10 4
MU8T3[J*O7H/7K3J* "BBB@!K(C,K,BDK]TD=*7&:6B@!I1696*@LO0D<BG44
M4 (0",$9!JEJEOJ$FFM%H]S!9W(*['EAWH!GD;01VJ]10!3TO3_[.LA"\QGF
M=FDFF*X,CL<DX[#L!V  [5<HHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M81.8L'(C)*AL].H(H M4444 %%16]S#=1EX) X5BK>JL.H(Z@^QJ6@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KFYM9U?49-7308[0MI;^2$N$)-Q,$#E00RA!A
M@,G/.>PYZ2N3D\.:[IWB.^U#0-2LXK75&5[F"[A9_*D VEX]I&20!P>* .GM
M7FEM(9+B'R)G16DBW!MC$<KD=<'C-2UGQVVHP7UJJ74;V$=N4E$JDS22<8;=
MTZ9SQ_\ 6T* "BBB@ HHHH AO)FMK*>=5WM%&SA?4@9Q7*?"P&?P1;ZI,WFW
MFI2RW%S,>LC^8R\_0*!CVKL*XV2RU;P'IEU_PCVFC6-/,K31V(D\N6VW<L$.
M#O7/(7 (SWH S!?W6@>.O%EMIIC6#^S1J8BD4M&LP&&X!&-W4\^];3>*-0%M
MX3N1';;-<,2SIL;*%HB^5.[IQC!!I- TFQU;3-4U(WHNKS7(S'=2JFSR1MVB
M((3E=H/(/)/)JK!X1\0M:^'H+G4M/ T.9#'Y<#GS$5"@+9/WL$<# '/7@  E
MUSQ9JNBB:XGBLXTBODA2S.7FE@9E3S=RMA,DD@%>V.IJ9\_\+<3 &?[ ?&?^
MNZU1O?!&M7.FZMIRZI9^3>7XO8I)(&,I/F*X5SG&!M &.V.E;2Z)J(\9QZ\\
MULZ+IWV)D 92Q+ARXZXY&,<_6@#FM;\2:U>_#OQ-=K);V=S87D]F6A1FRBD*
M<$GACD_-^F>:WM5UC6=$U;1H[N6QDT^^N/L]Q.MNZ-'(02@ \PX#$;<GH?K5
M3_A"[R?POXAT:XNX%;5[N:Z26,$B,NP;:0>H! Y[YZ5-XHDM9_"UQHNMW]H^
MJ74&88+=MCO+G]V8T)+'YP.?4=J -G3KV[O-3U$,8396\HAA*H0[.%!?)S@@
M$XZ#D'TKF_B'HDVN7%A%9L4O[:WN+JS<=5F1H67\^1^-=5H^G_V7I-O9M(99
M(U_>RGK)(>7<^Y8D_C5>[L;Z7Q!97\7V?R+:*6-E9FW-O*<CC QL_'/:@#'A
MUZ/Q=X9TN*V^1]87;<JIYBC3_7CV_N ^K@UE?#^YO;+X1Z7+IUO%+-YLBDRN
M%2)#<.&=N1D*,G&><5T&C>%(O#^HZQ?V+"234)O,BBD)"0Y + 8SC+9)P.RC
MM6-:>!]6M/ UEX?2_M3-I]VMS'(48QS@2-)LD7TR>Q["@"S%XNU!X?$R1"RN
MI-&@2>"=%=(YE:-GP1D]-I&0<'BDM/$^N"X\-S7T-A]CUR-5*PA_,BD,6\')
M."#@\8X]33W\*ZT]UK]P]_9.=;LD@=1"RB-E1DR.3P V?4D=J>WA?5&M?#,(
MFM,Z$RECEL3;8S'QQ\O!SWYH 8/%.J_V#XHO"MG]HT.>9(_W3;)52,/R-V03
MG&<_A53Q+<:C?OX.N8[BWA%S>Q2;&@9@)#"[9/SC*\].O?/:K%YX1UAE\1V=
MG?V:6.N>9)^\C8RQR/&$(SG&TX!SC.,\=ZLW?AK59K?P[$MU:,VC2I*[%643
M%4*8 YV\'KD\]J (M?UW5=!@U2X2/3H%M;<3Q[XRS7[A<R$*KY0  #)W>N<"
MKRZ_<ZEJ5OING>3!-)8+?2R3H9!&KG"J%!7))#<Y&,>_%#4?"6KWEYX@,6HV
MJVVMVPB;S8F>2$B,IM4Y V\D].YX[TR3PGKMK=:9JVEZE9+J=M9"RN4FA;R)
MX@<C@'<"#W[^W2@"OK>H>)S!X:6Z-MIMS<ZHL%S"JF5'QO96R''RG:#MZ\CG
MCG:L=6U.?Q/JFB2M:_Z+:PS0S+"PY?<#N7?R!M[$5%JWAS4]0LM,<:C"VHV-
M\MXTDD1\IR RE0H.57#<<]N<DDTLF@ZQ#XI?5[&^M0EW:1V]V)HF+ H20Z '
M'.X\'I[T 947C36I_#7AS5(K2R,NKWHM94)8!22X!7G@?)U.>O2M$ZSX@L-=
M\/Z7J<>G/_:4EPLTEL'XV(SKM#'C("YSGO6?:^"M8M?#F@Z6+ZSD?2+X7F\H
MP#X+G9_X^?FXZ=*W-7T:]O\ Q%HFIPR0)'ICRNZ.3F3>A0@$#C .??VH PY_
M%'B9[?Q)+;0:6G]ARM_K!(WFHL8<KP1@X)YZ=..]:C^)YKF\T"SM(HX7UFU:
MZ\R92XC545MH (RWS#OP :@7PQJ:V_B:(S6N-=+E#EOW.Z,1\\?-P,]JR-5M
M[N&X\/>'X]0TJ*_TVR,I6\5Q')@"-61@RL&P'X![\]J .B\*:UJ.M#4A?Q6R
M?8+V2SW0!AYC(>6P2< Y'&3CFL[Q4/\ BX7@H_\ 3:[_ /1-7_"5Q>C[5I]U
M#I82VVLDNELWE%F+%E(;HXP">3G<":37]!U+4_$FC:K:36L::2TK!)=Q,ID7
M:>@XQ^- &-\5D73M*L?$EH!'J>G7D?DR+PTBL<-&?4'TK4U+Q)J$EUJEMHZ(
M9=-PFU[.:<3RE ^W*$!!AE&3GDGC YEO/#-UKNI6=SKMW$]I8RB:&QMXR$:0
M=&=B<MCL  /7-077AW7K+Q)=ZKX>U*SBBU$(;NVO86=0ZC:'3:0<X XSCC\@
M!#XEU>+5/#XO+2*RLM74I(DT;>;;SA=PC)W ?-@X..W2EUSQ#J^G>'-;UBV2
MRFCLI&6V61&7<J\.6PW)#;@,8^[GO5[7O#KZQX9.F"\87D926"\<99)D.X/[
M<]AV.!2:]X>DU#P;/X>L94B\V 0"67)P.[''4\?K0 :CJNI136RQ&TM+>6V,
MANK@%PTW&V)8PP8DC)[],5S5_P")-5UKPIX5U2TFALCJ6IV\4\?EEP3O/?<#
MMRG(ZGID<YW)= U@>(K+5K:]M$\NP^QRQ2QM($^;<7CY')X!SV ZUGV_@?4K
M;PCI>D+J-JUSI-\EU;N86V,%=F"MSGG<>1C^M &JFN7\'C)M&O1:_9DTLWAG
MC5@Q8.%/!)P.IQSVYK-F\7:JGA-?%T4%L^G9\UK/8WG>1NV[@^[&['S8VX[9
M[UI#0;Z3Q<NL7,MM+ =--C)& P+9?>6'7 SQMST[UGV_@V_A\,R>$WO(7TAF
M*I/\PG6$MN,>,8)ZKNST_AH FDU_7+SQ3<Z-IBZ<L7]GQWD$\P=N&8@;@",]
M.@QUZGH:D7CR7_A%-'U>]2"R^VW#V]U<&-I(;=E+KD@$'#,@ R>-W)XK6BT*
M]MO&$VM0FV^SO8I9I!E@P"L6!SC'4XQZ53T7PWK.C:%:Z9YMA=1Q2S&>*0,$
MG21BVWH<$%NN#Q]: -[1[BZNM/$UU+:S,SMLEM?]7)'D[6')ZC'<\UBZ-=OJ
MOCO7I)#F/2TAM+<=E++OD/U)VCZ**O\ A;P^GAS39K2,J%FN9)Q%'GRX QSL
M3/8?ASG@=*IZ?9'1O'&J2OQ;ZVD4L+=A-&I5T^I7:P]<-Z4 93^*_$KZ+XAU
M"&'2T.AWDT;*RR-YL<:*Q Y&&P3STZ#'>KZ>(]736=#%Q#9C3];#"-(PQE@8
M1^8N6)PV0,$!1CU-,C\*ZDNB>)=/,UKG7)YY5<%L0^:@0@\?-@#/;/M4T_AS
M4Y7\-NLMJIT4YD!+'S?W9CXXXX.>_P#6@"MKGBS5-%\ZXGBLXTBODA6S.7FE
M@9E3S=RMA,DD@%>V.IK1;Q!<V_C*[TJZCMTL8-,%\)5R7QO*G/;C:3T_&L34
M/!>L2:5K%D=6LEMKJ^^WI-+"WF AU?;(V[&T!<9'8#IBKEM"NI_$">5GBN[:
M3P_%%++%_JW+RR'C!/! )ZGB@".X\7:K;>%8/%S06S::^V22T"-YR0,P 8/N
MP6 ()&W'49XR9YM<\1W7B>_T?2HM,"V]O#<12W!D(978@@[>Y XQT]ZBA\'7
MX\,CPG<W<$NDJP43_,)S"'W",KC&>-N[/3MFM.TT2]M_&5YK)DM_LMS;1VXB
M&=ZA"Q!SC'.X\?K0!5NKMM,^)5A;IQ#K5G*)$'3S8<$/]=K%?P'H*ZFN:>Q;
M5?'UOJ(&;;1[62)7[-/(1N _W57GW8#L:Z6@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** &"*,2F41KYA&"^.2/3-/HHH ****
M"H'LK62[CNWMH6N8E*I,T8+H#U ;J!4]% !1110 4444 %%%% !1110 4444
M %%%% !1110 55OM,T_4T5-0L;:[53E5GB60#Z9%6J* (X+>&UA6"WACAB08
M5(U"JOT J2BB@ HHHH **** "BBB@ HHHH **** "FNB2+M=0PR#@C/(Y%.H
MH **** $95=2K ,I&""."*@L["RTZ'R;&T@M8B<[((PBY]<"K%% !1110 U$
M2- B*%4= HP!3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYM&>;4K>VN8G&YU21P"1AOE/U!ZT =+114,%Y:W3.MO<Q3&,X<1N&VGWQTH
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M$?3K0!-12$@ DG '4FN3U_Q@!X+U+6_#]S;2O9%@#(N]6VMM) !'?.#TX]Z
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M4<KND<1VM*Q9CF0'DGDGGJ>M:M_KUCH?A**ZN94+&U40P@Y>=RO"*.I)/'%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1145Q<V]G T
M]U/'!$OWI)7"J/J30!+14<,T5Q"LT$J2QN,JZ,&5A[$5)0 4444 %%%% !11
M5:[U*PT\H+V]M[;S#A/.E5-Q]LGF@"S13(I8YDWQ2+(N2,JP(R.M/H ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %#4-
M#TO5;FUN-0L8;F6S8O TJ[O+)QDC\A^0J_110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S?B&;61K%JM
MMX?GU.PA03'RKF&,--D[0P=@<*!N';)!_AKI** .'^&-Y=2Z5J2W.G26D2ZA
M</YKRHP+&1BRX!)^7N>A[5W%9QT#2CI=SIGV-/L=VSM-$"<.7.6/7/)J]#%'
M!"D,2A(XU"JH[ < 4 /HHHH **** "N.UWPM#KNLW&JZ%JDNDZ]8E89)XN5D
M^5759$_B&&'/\\5V-9<_AS2Y[V>^,,L5U<8\V:"XDA=\   E&!(  XZ4 <!K
M>I7/B'X9Z@=;LH%U'2]4CM)6C&49UFC!=?3(8@_C]*Z34;+3+CQ)'I$%NEP\
M6GL39RD+:P(SX\S&"=Y((&.P/(SSO-X?TE]&?1FL(C8.,-!CAN<Y/?.><]<\
MU!)X3T&6XMKA],B:6UC\J)CG[F<[3S\PR2?FSR2: ."LB^J^%_A\+R>:1I;L
MJ[B0AR!'(/O#GH,9ZUK6>E1Z1XJU[1-/>=-)ETI;EXEF?$$Q9AA3G*[E7/6N
MF3PCH$>G1Z?'IL<=O%+YT8C+*T;_ -Y6!W*?<&K<6CV$-K/;1PL$N?\ 7,9&
M+R<8^9R=QXXY/3B@#@0S/\+_  @SL68WU@22<D_O!6ZT*'XM-&Q=XYM!<O&[
MEE/[Y1P"<#CTK8;PMHK:;;::;,_9+5Q)!%YSXC8=".>W;TJQ_8NG_P!K+JWD
MM]M6+R1,97SLZ[>N,9YQZ\T <+X8\*V&L_#N^L8H8[:XFN;I8IXQM:-EE?8<
MCG X&/3BM7PS?1^*I=-EEM5BDT:$K=1;<>7=9V;![#8S8_VD/:MBXL$\.V]S
M>>'] 2[N[F8-+"DXBW;C\S9;@>N!C-6M#TY["SD>=(DNKN9[FY$7W=[=@>^
M%7/?&>] &5\2/^2>:U_U['^8IMKX775&T34=3OI+A-.C26VMU0(@?:,,W4L1
MVY ]JW=3TJRUFR>RU"$S6[_?CWLH;ZX(S4MI:0V-K';6ZLL48VHK.6P.PR23
MB@#A-#TBWDN_$U\8Y[JYTS599;-'N)#M<0H1WYSG'.>U4;C:_P )[7Q59RDZ
MW&D=P+U>9))3( R,?XE))7;TZ#'%>@Z?HFGZ7<7%Q90-%)=-OG8RNWF-_>.2
M>?>H8?#.CV]P9HK,)F;S_*$C^4).N\1YV!L\YQG/- '/:A&]QXKU.'5+22^M
MY-,C^RQ0KYGV=R6# @?<9CC#G'W>O%95_HEUIWA[P;:ZE/<?;GU:".[9;IVW
M%D<L,YZ_*.1Z<5?UKP\U_P")KRZU7PF^JQR!$M;FSNUB9$ ^ZX+H<[BQSSQ@
M=JU].\(6)TZ&#4()62"X,]K UW))]E.!@!\Y)')SVW$ XH SYM&T>WUV#0;*
MW:Y\FQDD^Q7,I:WA1Y.93NRQ<G( '09Y6N>LVEO_  9X!N+BZN&EDU&.%W$[
M LF).#@]?E'/48X->AWWAW2-2U"&_O+&.:Y@3RTD8G.W.=IY^89['(JO'X/T
M"&"W@BTY8H[6;SX5CD==DG]X8/7^5 '.Z?X?TV7QOK^C/"[::;:WG-IYK>7Y
MC;P6QGKP/QYZUK?#F>:X\!:6\\KRN$=-[G)(61E'/T %:ZZ%IR:C/J"12+=7
M*;)95G<%E'0=>W;T[4_2M)L=%LA9:=!Y%NI)6,.S!<\G&2<<\\4 9>KR7=]K
MUI965O#<)88NKA99C&NXY6(9"MGD,V,=54UC^!GGT/7M7\)WD20!7-_8QI(7
M40R'YE4D#A6]NYKK+72;*RO;B\MXW6>Z(,S&5VWD=,@G' X'H.*BF\/Z7<:Q
M'K$ML6OXEVI/YK@JOH,'&.3QT.30!QUC)+I/B'3TUJP2XCN;UVL-;M6SYS2!
M]L<PZCAB!VX&.E%G)+I/B&P36K!+B*YOW:PUNU;)D:3?MCF'4<,0.W ]*["U
M\.Z59R1/#;,/)D,D2-,[I&YSEE4D@'D\@=SZT6WAS2K22-X;9AY4AEC1IG9$
M<YRRJ25!Y/('<^M '$V5DWBKP]=:E-J]O8:A:WLK2W8MRUQ9M'*<)NWC"[ !
MMQC!Z$\U+XA>;2M4OM1U6P34]&EN(V^W6Y_TC3F4(-I4\[,C/']XYSFNIE\'
M>'9M;_MF32H&OMP8R\X9AT8KG:3[D9JQ)X=TJ6XFGDMF9KB199D,S^7(PQ@L
MF=I/RCJ.PH X_P 2O-I6J:AJ.J6":GHLDT9-Y W^D::5"C&#U3(W<?WCG.:N
M'2;34/B7JUK=B6>VDTR&1H7F<H27<=,], <=.^,UTDOAW2IKF>>2V9FN'629
M/.?RY67&"R9VG[HZCL*>-#T\:I+J:PNMY-'Y;RK,X)7TZ]!V]* /,EM53X3V
MVNF6=]1L+Q4MKAIF+1*MWY84<]-O'O712VW_  E/B/Q)I-W<6R2VQCC@2: N
M\,;1*1)&=XP=Q8Y SP.>!71?\(EH?]DG2OL1^PE_,,'G/MW9W9QN]>?KS3=3
M\'>'M9N(+C4=,CN9K= B2.[;BH[,0<L/][/4T <P-,CG\7>';2ZU&?4HWTJ=
M)9O,9!<["@#$9[YYQ][OD&L74;6 ?#7Q+9LF^'3==:&T60[O)3SHN%)YZ,P^
MA->ER:#IDFHV^H&VQ<VR>7"Z2,OEK_= !P![8J%?"VBK9WMF;$-;Z@Y>ZC>1
MF$K'DL<G[W YZ\#TH TK:W@M(%@MHDBB3.U$& .?2N5^&+O+X1,\V?M$U]<O
M/GKO,K9S^E=3:6D%C:QVUM&(XHQA5';_ !^M9FGZ.=,O+Z&%2;&_F:X^1RK0
MR,/G'!!VL1GCD$GMT .-\'Z!)XC\%7FGSZC)!83ZC<":.%%#NHD)*[SG /TS
M5[4- T^Z^(=GI$B3?8#H<B&W6=U4JLB*!P>!C'3'05UNDZ'INAPO#IMN;>)V
M+,@D8KN/4X)/)I9=$T^;5X]6>!C>Q)L2;S7!5?[N,XQ[8YH Y;1+.SU_5?$E
MAJL/F&PN$M+:.1B3;P",;&0GE68Y;=U/'/ K%4W]Y\.-&\4W0:ZOM&F,TC'[
MUU;)(RMGU^0;LGN,]Z] N_#^EWUZ;V:W87#1^4\D4KQ&1/[K;2-P]CFK@M;<
M6GV00QBWV>6(@H"A<8VX],<4 <S-#:ZMI&N:Y']R[M7CMYHF*,T2*?FR,'EM
MW/=0M8FG7S2VO@#1[IC]AOK$R3*Q^6=TA4HC>HR2<'J0*[S^S+/^RAI0AVV8
MB$(B5BH" 8VY!SC'%4Y_"NB76DP:5/8*]G;$- A=LQ$="K9W+CV- '#7CGPY
M>_$";2E-OY4%DRB(?ZH,K!BH[8!)XZ5M/IBZ7<P^(],U&T"FSEVVMI;E4O\
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M8YZT =)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %9VIZE=V%Q;I#H]U?Q2[@\ENT>8B,8R&89!YY'3%:-%
M &!9V=UI-MK.KQV!FO;Z7[0+*.10?E145=W3<=N2>F2>N,G<A=Y(4>2,Q.R@
MLA()4XZ9%/HH **** "BBB@ KE8](O/#_C#4-8L[9[NPU=(S<Q1$>9#*@(#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO/O&&H7<%GXCO+'
M4[R:>Q5&B-O(8HK$A02K<XD9B22,' (!QQ0!Z#145O(9;:*1NKH&./<5+0 4
M444 %%%% #6)"DJNX@<#UKG--\82:K]N-GX?U&46%T]K-AX ?,3&X &09ZCF
MNEKC?AUU\5?]C'=_R2@#>T/Q#I_B""9[)W62WD,5Q!,A26%_[K*>G\JTV)"D
M@%B!T'>O+[[59-'\>^,M8TY5>.STJ/SNZ?:.-F<=<#.?H:ZFTL?$$&N:?=QW
MT;:>Z,MY'->-*9B1E'C&P!3GJ!@8[4 6],\22ZMHM_?6FERF>SGFMUM&E4/(
M\9P1G[HR?<UMQLSQJSH48@$J2#M/IQ7G"37-M\//%US9W<UK/!J=_(DD) 8$
M2'OC^7-:NO7%UI9\/>(#>7(L4DCAU"+SF"%9%VK(PS_"Y&?7/- ':45QVJZI
M<V&FW&JV]Q(/[1U&*TMC)*2D,9<1EP#D#.&8'&.5X]5GL?$-E-J4G]H>3ITF
MGN8T-VTTT4Z\[D9D^Z1U&>#TQ0!V%%<!8:'J^K^ 8-2M_$6J_P!JW6F1/%_I
M)$8D"AAQZG[I))SG/6M/0M73Q1+I-Q:2SQ16UKYUU&)F&)"=BQOS\V"DA.>?
ME'K0!O:OJUOHM@;NY#N"ZQ1QQ@%Y'8A550<<DD=>*J1:[.NJ6NG7FD7-J]WN
M\N7>CQ_*I8@D'(;CICZ$XI?$^CV.OZ.=+OIG@$\B^3+&V'24?,I4^HQ7-Z;J
M?B+P]K^GZ#XI$6IVUV[)8:K$-KAPI^61>Q*Y&1Z]3S@ [RBO//MU\/!WC:3[
M?=^9IM_="UD\]M\02-&4!LY(!)X-6Y9+^Y\4^';8ZK>1V]]I<KS1QR!0641\
M],Y.X\]?3% '<45YHJZE)X6\6.=>U,/H-S<BS<7!#X2,2*';J_)QALC%:<UU
MJ%_XC\+*=3NH(=3TZ:2XBA8*I8)&<CCK\YY[=L=: .XHKS=8M1DT'Q9&VO:I
M_P 22>?[&XN"'&V(2*';JX!.,$]/TUQ?3:H=$\V]N9);K2Q.]A9L8G9F"?O6
MD##:HR1CN3P"10!V-%>8PZMK-[X)\(7;:O=17-UJJ6L\B,,R)OD7YN.3A!['
MN#6OK%I<^$KK2-4_MC4[K38KDPWZW5TSX60D)(>G"L0/H1Z4 =O16/H6^ZEO
MM3,TS0W,Y%O&TC%5C3Y<@$X&Y@S<=B*V* "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC%='10!%;6T-G:PVMN@2&%%CC4=%4# 'Y5+110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML)GB!E4*A+*Z@*O4<$=NM8GB=[O4?"GA*\EOIDEN+[3VD\M4 9V*G?RIY!Y
MZ>QKHQX=NI-%OK.]UB6[N[^$P2W;PJNU"",*BX ^\3WY/.>E07GA*6[T/2=+
M_M/8NE20RI(( 6<Q?<SSCMSZ^U "3WVIV7CC2=*-\9K*YLYW=7B0.SIMP2P
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MG3-+TB]FOYKG2YED^UZK80I)LY'EL5VD!2-V<+P0!]>DT*X-WHUO<&_CU 2
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M,DBC\M "=H(*[V&,9(;@]NQ /1:*X+QOJ'B_3=#T^]T2X/VOR=UU:O"C[MJ
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ML-\OC/Q[K,4H_LAK+RC,&_=O*(U'!Z'&&'X^]>J$ @@C(/:A55%"JH4#H ,
M4 >=?!FQTR;P+9W/V>VDNXKB5C(55I(V)(Z]5.W'X5S_ (.NH+'X?>-].NI!
M#=H]VS1.,%08@HSZ9/ ]3TKV:DH \!U>YMV^ GAN'SHRXU)MR;@2,-,3D?1E
M_,>M==8W%I-\>[](KB/9+I0C4QN.3A#@$=\#/X5ZC2$9! )&>X[4 >'Z58Z3
MJ'A6'PTGB?2K>RBU=KA;F:Y$=RZ+E0!$>C$]#NZ8X[5[>\B1QF1W5449+,<
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M7W'K_6N6\0>#;OPQXZT[6M!W1Z5J>H6T=_;H/EC8S(0<=E+ 8]#QT.*]8I"
M>HS0!PWB6R\+>+M6O=#\0*EM=66S[-=;_+8JR!B%8\$@DY4YXP<5#\*;34-+
ML]8L9[UKS2;6ZV:?<M]UU&=Q7_9Z=.,[L5WKQQR*5=%96Z@C(-5M4L7U'3Y+
M%+AK:.8;)'C7YMA&"%/\)/KSB@#B_@M#+'X$,K@B.>]EDAS_ '.!_-6KT"H+
M*SMM.LH;*TA6&W@0)'&O15'05/0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/; Y-<IJZZJOCCP>=0DM)%::Y.((F0HWD-D9+'</?CI[\7/BA_R3G5_]Q/\
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MOH-;O[R8VY@NA&$5&;<FT$<Y&#G/X>]:E% '/6?A&UT[QG<>(;-O*%W;-'/
M/NF0LA\P>A(7GUP#ZU$FE>(TT.32'N-.N4EC>(7$BN#&C9 !3D/@''5<XKIJ
M* *.BZ5#HFBV>EV[,T5I"L2LW5L#J?K6%>>%KS5;VRFU$V9DL+_[3#>Q!A/Y
M8<LL6,=,8!.<$#IGFNKHH Y%/"VJ"Q\3VS3VA.NO(R,"W[G>FS!X^; &>W-$
M7AC6K:^T6\M[^SWZ?8&QDCEB9TQ\O[Q!D88A0#[<9KKJ* .&C\$:K#X9L]&6
M_M)!::D+Q)&C9<J)3(%/7DD]>,8Z&MLZ+?'QO'K^^W$(T\V;0Y8MRX<L#C'4
M8Q^/M6]10!R/Q++?\(W;"-U21M2M0A89&?-&..]:(TB\NM=BUJ]%N)[.W>&T
M@C=BJL^-SLQ /.T#&.!GKGC4O=-L-21$O[*WNU0Y43Q*X4^HR.*G551 B*%5
M1@ #  H Y*P\$N?AZ_A'5;B.1"K*L\ (QE]ZM@]PV/KBKBZ#J6I2Z4==GMI%
MTJ43J8-V;B4*55V!'RXR3@9Y[\8/1T4 8.H>&([[Q78:X)C']GB,5Q$.DX#!
MX\_[KC=2ZKHMY?>*=&U:*2!8=,$P:-R=TGF*%...,8S[^U;M% '$-X-UFUTS
M6]$T_4+/^R]4$S1">-C);M(#N48."N3P>HSWJ:?PIKEK<Z;JFCZK:)J5K9+9
M7*SP-Y%S&IR,@-D$'/.>_;I78T4 5--M[JWM +ZZ%S<N2TLBKM3)[*N3A1T
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M(XM2X#,1[F0!O^ K5^[\/W$G@F?0(;A6N+BU>&2XES\SN#OD..I)8G\:WJ*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC+I,61&'<';CZXKI/!]_/<SZO:ZAI<5AJ=O<J;S[.VZ*9FC7:ZGW4#@\CC-
M'0R7$$)(EFC0A"Y#,!A1U/T&1S2K/"\ G25&B*[A(&!4CUSZ5QUYIFGW?Q;B
M6XM()1)H;LZN@(<B= "P_BQ[^GM7.0W2:7X6@C:7[/I,'B>:&<JH*0PAWV9!
M!&P/L/Y4 >IV]U;W<7FVT\<\><;XW##/U%)!>6MT7%O<Q3&,X?RW#;3Z''2O
M/?$$%EINE^(-5TC59;R:YA@:^2V,918A(H9L(,;C'O\ J :MW*Z8CR^(M#UG
M[9J2:5.+>&V$6V1 A9=ZJN<!MH&>Y H W/%.NW6CG3?L1MG-QJ-O;3I)DLJ2
M.!D $8/UK;FO+:V>-)[F*)Y#A%=PI8^V>M>;7<.E3^"?!NHP"%YFU*Q9KC@N
MTC,/-W-U)+9SGN/:K1.FZOJ?BO2-?U5+*5IRI27RU)MO+78R,XZ#D\="<]30
M!Z#-*L,1=Y$0=F<X&>U8WA+6+S6M.NIKY85FM[Z>V_<@A2$;:#R3Z5@Z.]O<
M>-QI5^[W,-MHT!T\7@!:53D22$$<N<*"<9X/O5SX;1P0:'J$%L%$,6K7:(J]
M HD.!^6* -#7/$ LM9TW1H;F&":^\UGFDPPA5%!Z9')++C/O5S3[JYM+."#7
MKRQ%^[,H,+;%E&3M(5N<D8R.>:PO$%O;2?$?PN)(8F,D%[N#*#NPL>,^O>JN
MB)::K_PF=KKB(TRW\J2B4#*VNP>21GHNW)'ODT =M)/#"5$LJ1EL[=S 9P,G
M] 33HY$FC62)U='&593D$>H->6:=9-J,GP[;7;=9KF>"Z68S+EI$$1*!L]1C
M'!]3ZUZ2+6TT[26MK=!:VL,1"K",>6N.U $L5[:33-#%=0R2H2&19 67'J*(
M[RUEN'MX[F%YH_OQJX++]1U%<)HMQ=>']0TW3]8@MKVV6PF&FZM9##-"JAF5
MT[$J%.0<$X[FL^SNK)+[P+<6LEM;6A:8PQF0-*L;1,29'SR2>HQP>YH ZFZU
MZ]U+6]2T?1+VRM[BPAB=6N!O6:1]QV<'A0%Y(R?F]N>@AO(FD6UEN+?[8$!D
MA20$@XYP.N/PKDM)MXT\?^+VMK>$SQV]FT(V#AS')T],G%9/A^/1=<\.:#<W
M&N2)?V=Q&YBC\M;C[5G#JWR[CN8G.>HY- '<6?B/2KZYO8(;V$FRE\F5C( -
MV 2!SVR!]<BKQO+40K,;F(1L<*Y<;2?8UQOAJPTN[U+Q;IUU!;L)M1:,Q$ $
MH84R .N.M0>&$FN)+?PA?1;SX<G+2NR?++&H_P!&/U(;=]8CZT =Z[K&A=V"
MJHR23@ 5&EU;2;]EQ$WE@%\.#M!&03Z<<UB>/889_ >MB:-) ME*Z[AG#!20
M1[@US>LVVG:%X?T"^BACL[6[N;4:E=1Q@EU$;;&D)!W .5))S0!WT5Y:SVYN
M(;F&2%<YD1P5&.O(XI4NK>69H([B)Y4 9D5P6 /0D5YUXHTK1AX?\57MIJ(U
M":YL5EG1?+:)&7A'^4<.1GGOBK-_HEC8ZQX.O]%MXX;Z:Y"S/$/FG@,1:1G/
M\7;DYY/O0!WCWEK'<K;/<Q+.XRL1<!F^@ZFEFNK>WSYT\<6%+G>X'RCJ>>W(
MKSBQ$&I_"W7Y-55?[3AENWNW;_61W"LQC(/4$ 1A?8 "IK?2H=2\::(FNV4,
MUU<>'";Q)4!\R0-&#N'?!)Z],>U ':6NOZ;>:Q=:5!=1R7%JD;2!7!Y?=A?J
M N3]14ME-<Q63/JMQ:>8LC@O!E4"[CM!W'KC&?>N5T"TTVV^(7B>U,%M&OE6
M2PQE5''EN"%'\\5S,EI;'X0,IB3]SK!$1[I_IF/E/4<<4 >L1W$$TDD<4T<C
MQ'$BJP)0^A':D6[MFN3;+<1&=1DQ!QN ^G6N2M[&TTWXKQQ6-M%:I/HCM(L*
M!0["90&('4X)YKG],TV+7_#6BZ-(UE=/9ZJ9YKQYHW2X19'+$*26)?.,,OK[
M4 >I$X&3TKF[WQ+.?"&J>(;!(O(@MY9+/S%)\W8#ASR/E)' ],'/.!>\4"2+
MP=JXM%VR)I\WE!!C!$9QBN>N=@^!Q\O&W^P%QC_KB* -V35+S2= _M+4 +[[
MC,+6(1;$.,G#.<XSGK^%5?"7BF7Q#$Z26V7A#&2>+"Q$[R%50QW9VX))&*U4
ML+/4=(M(;VVBN8E2-PDJAAN !!P?2HM)\.Z=HZ9AC\V<HT;7,H!E=2Y;:S #
M(!/% &#I_CQ[WQ#_ &=_9\@\P1(L&5\R%RSB0NV[:54!"-N2=WUQIWNI:G8^
M+=)L&FMI;/46G!40%7C")N'S;B#S[5);^#]$M;P7$=G'L181#;[%\N!HV=E9
M!CALR-DU4U[_ )'GPK_O7?\ Z)H U+'5#)JESI-V%2\MT64;>%FB8D!P.W((
M([$>XK3KD-2WCXKZ(8<Y;3;D3X_N;EQG_@6*Z^@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ J&ZM+:]@:"[MXKB)OO1RH&4_@:FH
MH J_V98?8&T\65N+-EV&W$2^65]-N,8JPB)&BQQJ$10 JJ, #T%.HH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJS+C@Y .:E2>&2:2%)4:2+'F(&!9,\C([9H DHJ.2>&*2..25$>8E8U9@"Y
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MDK*P5BZIM.5 ;UY(/MFM%K&M2>/]0TU8+>2UMK*.2-!.RD[F;YC\N"WRXQT
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M\L4\$<RKYKKM#2%@O4D^A/%:=OXEN_\ A);72+_2A:QWT#S6DPN [-LQN5U
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M-\RV>%8X9S-YCL,;R<#:!V')YYZ4 5-)\4SVWA/0I]4-M]LU*&/RFDN=JO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5G
M:=H6G:3<7-Q90O')=OYDY,SOO;^\0Q(S[UHT4 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1
M26\,LL<KQ@R19V/W7/7GT/I4M% %&RT73M.G>:SMA"\A9FVL<$L<L<9QDGFK
MU%% !5#4=$T[5B#?VPG"@#:SMMX.1D X/-7Z* "BBB@ HHHH **** "BBB@
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M 4444 %%%8GB+7;C1)])6*UCFCU"_CLW=I"#'OSR!CG@'N* -NBBB@ HHHH
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M06W9;H.N>@QT% ">$[NROO#%C<:<TYM60A/M&?,7#$%6SW!!!^E<RB-_:GQ
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M/-,/VF7&[.[/WO7GZ\T 9UFB'XDZS:MS!)IL$C1$_*27<,<=,G S7+6K2S^
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M/%$D@^TG,TAF<R2'&.7)W=.!SQVHTG1['0[%;'386AMD^Y&9&<+SGC<3CDT
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M)BT49D=HXB<Y*(3M0\G[H'4^M26NAZ=9:G<:E;P,EW=8\^3S7/F8X&03@X'
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH ***0D#&2!G@4 +129&<9&>N*6@ HHHH **** "BD!!)
M (..#[4M !1110 44A(! ) ST]Z6@ HHI 020"#CK[4 +1110 4444 %%%%
M!1110 4444 %%%% !1110 444@(8 @@@\@CO0 M%%% !1110 44UG5,;F"Y.
M!D]33J "BBD!##(((]10 M%)0"& (.0>A% "T444 %%)WQ10 M%("",@Y!H!
M!S@].M "T4G2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M13&S=-RL& /L2H'XUFWEIJ/BB;0?M>F3:>=.O$O;II64@.BL B%2=P+-G/3
M]>* *,42^)_&?B+3-9TEKBUABMH4#NG^CJ59BPP<@L<'*\\#/2NBU[78_#%G
M:R26=Q/;R31VYD1U/E%B%4N6.<9[\U1T.TU"#QQXAO;C3IHK2_%N()F="&\M
M"K9 8D<GCBMG7-)@UW1+S2KC_5W41C)_NGLWU!P?PH 2;5'CU-K&.QFG9+?S
MV:-EP.2 O)')(..W!YK%T/Q!I-OX.TN\TK3)X;6\F\BTM$4;@S.PYYPHR"2<
M\>]7/"UKJEIH2W.M)YFJRHOGK&03\JA5 )/<#=]6:N:TW3O$VE> -%L(]-N%
MFM[O_B86T,\:RO 7=CL<-CNO<'KTH TM?U:WUSP=XKLYK5X;G3+69)HG(8!O
M*+HRD=1@@CH?:KNEZREII>A:9%$9[RXTY)4CWA!L14!Y/?YA@?7IBL!=#UB*
MV\:6\.@M#'J]OBS2.6+!8P;-IYX.>3VZX)ZU<O=#&IZ1H]AJVA79%M9J%NK:
M11/9SJ%'!#=#CMD<#- '7:?=F^L(;IH)+<RKN,4N-R'T..,U5\2:RGA_P[?Z
MLZA_LL)=5/\ $W11^)(%4=#?7M/TG1K/4[:2^N9 R7=SYJ@P 9*EO[QQ@''?
M)^J^/-)GUSP1JNGVREIY(-T:CJS*0P'X[<?C0!C>*K%H? MHEYB>YN+RS:[=
MQGS7:9-V?;D@#H!@5>\66=Q8Z'%;Z):FW@4R&>.!8T@$>QM_F#&<$9^YSFH/
M%MY'J/@?3KV(@I<7=C(/QE0UV5 '%^%EU<>$;OSQ?%C:)]B$+18\ORAL\G/0
M],[^]4/""Z[_ ,)-<&Z\[RA='[;Y+)CSOL\>/-R.>,?ZOC=GMBO0Z* ./ATV
MPM?B:T-O96\,4VBL94CB55<F8 D@#G\:O>'M1=-<UCP[,[/_ &<\<EN[G),,
MBY"D]]I#+GTQ41_Y*FG_ &!&_P#1XIFA6KW'CWQ%JX!\@+!9QMV=D7<_Y%@/
MJ#Z4 =51110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5GZSHUKKEHEM=R7"
M(DHD!MYVB8D9X)4@XYZ5H44 106\-K;1VUO&L4,2!$1. J@8 %+##%;Q"*&-
M8T7HJC J2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
M,O?#VFW]E)9S1.())EG*1R,FV0-NW#!X.X9.._/<U=M;9;2 0I)+(!GYI9"[
M?F>:FHH **** ,N#P]96^I2:BKW+74D)@\V2X=RJ$[L#)XYJ_;V\-K L$$8C
MC7HH_,GW)/.>]2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-.F:"[E-MN6%U^]G:2<#/4 B@#IZ*BMKF"\MHKFVE66&9 \<B'(92,@@U+0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
H0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>ebs20191231exhibit1048020.jpg
<TEXT>
begin 644 ebs20191231exhibit1048020.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC;P==Z=>1W$0^U@M&"=A:( *V/NG..#S0!UP\0Z2;Q+47L?F22F%#@[&D'5
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M>'HX6.F:PZZCO ^6, @3H?\ >8(,>DAH ZF[UW3;&%9;FY"*T?F\(S$)_>(
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M2!W..*KR>(]%CTZ'4'U.V%K.P2*7S!AV)Q@>ISVKGI+^/3OB5]OO[B--.O\
M3%BL[IG'E!U<LR;N@)!!]\>U<UJ\,=MX3\0W$C(EAJ&O136:/TD02Q[W4=U.
M&/N!GH: /2+#Q!I&J7=Q:6.H07$]L 941LE0>_N/<<4ZUUO3KVY2WM[D/))&
M98QL8"1!@%E)&&7D<C(YKE+^_P!-7XEJ[31/$_AV52$<?O!YBL%!]2H8CVYJ
M+PK/<V&MZ;IMGJD.NZ--;2-;3,!]HL$4+A7(ZJ>%Y .1CM0!W]%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;C4;"Z^"%W'>31?VE',3=QRD"47'GY8D==V/TKUK]Q>6W_+.>"5?9E<']"*
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M.<NZ#[I/ [8[=*T: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*XM;>[C\JY@CG3.=
MLB!AGZ&I::[K&C.[!549+$X % %,:)I*D$:79@CD$6Z?X5*=.L6G:=K*W,S
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M/0D=10 D5C9P3M/#:01RO]Z1(P&;ZD5GZE::O!#;P>&UTRTC9V\\SQ-\@/\
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M"(T@'R*[;5)]R <?E7+>%/%*SZ>R:[JUJ+U]0GMH%=DB,@1RH"KW_6MQY_\
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MD18T5$4*JC 4#  IU% %6/3+"&\:\BL;9+E_O3+$H=OJV,TR^T?2]3DBEO\
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M6&*=-DT22+G.UU!'ZT >8O\ 8I? /@ W'DNIO[-&WX(QL8,#[>HKH-,CL_\
MA97B*S"Q;)]/MO,B&,/]\'([\$?G74_V;88Q]BM\#G'E+_A3TM+:.7SDMXED
M/\80 _G0!Q?A*&YCN6\*W*.T/AZY9UD8<2Q'FW&>^ Q/L8U]:S8KS1[D^(]
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M J&"  /UQGG -='%:6T&[R;>*/<,-L0#(]Z6WM;>TC\NV@C@3.=L:!1GUP*
M):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-;JQ'PB6-9H5,6L@!20"G^EYZ=OEY^E=C>W5O_PM72$\^/<VESX&X<Y="/S
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MA=-=?$\QM+F(J1#)G*$@\;201CH<U=GU.\D\"^,8-82S6YMXI8GO+8XBNV,
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M V[8N[UQS5.QUG3M1GEM[6Z5YH0#)$05=0>A*G!P>QZ5C>,?$#:'+I,+W?\
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M DXBPQ_ X!IFOZBFB_$;2;_59!#I<EA+;Q3R<1PSEU)W'HN57&37:4C*&&&
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M$L4A4*&8Y9O4D]R3R3ZF@!FEZI9:SIT6H:?.)[68$QR!2-V"0>" >H-6Z0
M8%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 445QOQ6U>\T;P#>SV+M
M'-,R0^8IP45CR1Z<9'XT ;;^*]!2ZEMO[4@:6$XE"$N(O]XC(7\2*OV=]::A
M#Y]E<Q7,6XKYD3AE)'H1P:P?ASI]KI_@'1TM451-:I/(0.6=P&8GUY./PK:T
M[3+72HI8;.,112S/,4' #,<G'MG)_&@"*^U[2M-G,%W?11RK'YKIG+(G]Y@/
MNK[GBKL$\5S D\$J2Q2*&21&#*P/0@CJ*\;\6ZAJ7A'QYKVIZ8$U6VO+15U"
M$ DVF5"IO(&!ZCV)!QP:]#^'<-C!X#TJ+3;Q[RV$1*S.NTEBQ+ CMAB1CMB@
M#I:*Q?\ A,_"O_0RZ1_X'1?_ !5:-CJ-CJEO]HT^]M[R'<5\RWE61<CJ,@XS
M0!%?ZSINER117MY'%+-_JHLYDD_W5')_ 4[3]7T_5?,^PW<4[0MME13\T9]&
M7JI^HKS7X9W$NM_$;Q5JU^2]U P@B#]8DWL-H],! /\ ]='C*YET;XU>'+JP
MRDE^D=O<JO21#(5);UP#_P".CTH ]6HKSK_A.M<%WXRMMMCG0(O-MV\E_GQD
MX8;_ $&.,5?MO%NMW?@K1-8AL(7FOY56[E48BM8]Q#28+= !W./Y4 =A=74%
ME:R7-S((H8EW.[=%'J?:J#^*-"CTJ+57U6U%C-)Y<=QY@V.V2, _@?R-<AI/
MB^[\0Z?XRTR[,$W]EPR+#<PH4$R,KX)!)Y^7J.N:Y&+5GT;X':#<BQL+Z-M0
M=&AOH#(N=\I####!&TCOUH ]Q+ $ D#/ ]Z6O-]>OM<E^,NDZ3;:C!% MF]Q
M"LEN716*NI+ ."QPIP<C&>G7-ZV\8ZK:>/=1\.ZX]E!!%:-<V<\<# R*!G)R
MYZ -G']TT =U65%XGT2;4CID>I0M>@X-L"?,'U7J*L:0U_)I-M)JGE"\>,-*
ML2%54GG;@D].G6O-]+_Y.-UC_KS7_P!%0T >JT5YC<^.O%#7WBRUMO[,1- 0
MRI(\#EG49.W&_&2!U]NG/%G4OB1=6?A3PWK,L"V\6JMMN[A8C(MO@<X7(SDY
MQR> >IH ]%HKSOQ/XWUO0_".F:S:2Z7?/>7I@WI&QBDC)<HRX?*G:HR#G!)]
M*O6OBS5M.^(B>%M<-G*EY:FYMIK:-H]F Q*D%CD81N?;WX .VHKS:P^)&HZC
M;V^KVMJLUG-J7V8V<5N[2I!T\TN.-P/)&,8./>KDOB[Q%K%UKP\,6MK-_8ER
MENMO*N6NFW$2'=N 4#!QZX_"@#O"P! ) ).![U4MM7TZ\U"ZL+:\BENK3'GQ
M*V6CSTS7 :G?Z_<_&+3--2^AMXTL&N(XG@,B1EE8,& <;F^7 ;( ].N7Z7XI
M33O%/C6:[T^Q4:7$)6GMH2DMQ@' 8ECD]!VH ](HKSFW^(&JVMKX:U34TMGM
M-?F:)HHHRK6V6PA#%CNZ\Y'TJ*\\;>*#K/BO3[7^S$CT*V:Y25X'+.H7=M(W
MXR1QG]#G@ ]+HKSF^^)-W;>"/#^O26Z0+J4WEW<ZQ&1;< D$A<CJ5.,GIGK7
M8^'-0FU31TO)KFUNA([&*>U!$<B9^4X))!QU!/!!H U:*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445Y7
M\;]7\0:78Z<-+N+BULI&?[1-;L5._C:I8<@=?K^% 'JE%<7\*+_6M2\$0W&N
M-+)+YK""6;.^2+ PQ)Y/.X9[@"NTH *R]5UI=.N[*PAMS<WM^SB"(,$&$&69
MF/0#([$\CBM2N<\6>';;Q$]G$FH2Z=JUKOGL;F'[T>-H?CNOS+D?2@"]INL7
M%WJ=UIUWILMG-;11R%RX>.0,6 V$=<;3U /M4T&HR1Z9]LU:W73F5B&C,HD
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M'97/G&>2=[V0HJJYW1-%C8% &/PSUYKH?B#%=S> =9CL@QF-JW"]2O\ $/\
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M^DZ?!J-O$L[P:H7:[BEF++(S_>..Q/MBHK7P/H]M/I\^^]FFT[=]FDENY&9
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MZGK.L:;+9K;MI<L<>X2[_,WIN!Z#'!''-;5 %34F,6DW)"22D0L J(69CC'
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ML(R>IXIL%W!=/.D$H=K>3RI<?PMM#8_)A1-=P03P02R!9+ABL2]V(4L?T!H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPKX(UM+FZ-_-?VT$DK7#D-'(6#(5SC'X9[^M;VBZ59OXY\8 1LC VQ#1R,C
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M(]S9#9SNW9W;L\[LY]Z?#H5A DZA)7>Y01RRR3NTC*,X7>3N Y/ /<^M:-%
M&)_PAVA_V=::>+:86ME*)K>,7<P\IQT(.[/';T[5._AS2I-3FU,VS+=SQB.2
M5)G4L ,#H<9 )&[K@]:U** ,=/">B1^'WT 61;3'ZV[S.P'.>"22O(SP1S1:
M>%-$LK^._@L?]*CA\D2O*[LR>C;B=Q]SDUL44 8>D^#= T.]:\T[3Q!*22H\
MQV6,GKL4DA<^P'I4A\*:(4U%/L("ZIN^U 2. ^[[Q'/RD\9VXS@5L44 1PPQ
MV\$<$2[8XU"*,YP ,#K4E%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW-IXC,L37'ERN&4-N1-IR,,.XR01]=N]DGBLII+9(WF1"461BJDX[D D?E0
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M07*%[>:.5 Q4M&P8 @X(X[@UBZ+XAN-:CMKJ"RA>RNK9IDF@NO,*,-N(V&T
M,=Q[G!4BN=O?%-S'\/KK5-&TNWTUQ?-;R1[\;"9A&SC:N"Q)S[9SSW /0*CF
MGAMH6FGE2*)!EG=@JJ/<FDA:X:W#3Q1I-@Y1)"R@]OF*@_I7G5[J.HZ[\/\
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MD+R>;YS@G!48QTZG( X% ';T444 %%%% !1110 4444 %%%% !1110 4444
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MS!-)&TJ@($<,1GOTX_I6;K?]IW'C)KG1M-2[EM;%8;CRKX6\T9=BVQR58,,
M$=QDG/(KMW=8T+NP55&2S'  K%F\/^'=?G75UACGDD7;]JM;AD\P#CEHV&[&
M,<YH YV:QOM3T+3=,T[0!IS:-JL#S6K7*LJI'B3Y7_B)##KWSGWU_P"RM1F\
M;7NHM;".SNM,6T5S(I96#,V2H/3YL?A70VEI;V-NMO:PI#$G15&![GZ^]34
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M[2-8\/R:U96=JEY:ZC<R75K*90ODO(/F60'G:#R"NX^U=?10!Q-MX5OM'O\
MPG%90"XM-%AFCN)6D"ES(H!*CZ@G'OWKMJ*J-JVFK=_9&U"U%QG'DF9=^?\
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M>G;'OW (;/Q[?W&CZ1K4NB1Q:=J-RMO(WVK,D;,Y12%VX*Y SR#UX]>MU/\
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MXK2ZEMVN+)DNM\<X7@J6VY4C(SP?\4T_Q?<7WAB?4SID<5]#=&T:P-R21*)
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M*33X[3S#+^\+(S-N*@8YW>M4DT+6A!XLC-K!_P 3DNUL?/Z9B$?S<<=,\9H
MMW'BVX&I:':V6F">/6K9YX9'GV;=J!L,,' ^8<\]^#50>,=:?3]7=-"MC=:+
M(ZW:&](C954/F-MF22IZ$#Z]J2VT'64U#PE/);0!-%M)(+G$^2Q:-4!7CD?+
MGG'6G0Z%K"1^+ UM#G669K;$_3,0C^;CCIGC- &A-XLMVATS[,(EEU*U^UQ_
M:9-BQQX7DD Y.7  'OSQ68WCVY32HKLZ*QE_M1=.F0387)8 21DJ-ZD'CI47
M_".^(]/M?#^HZ8MH=2TNQ%C=6LLI\NXBPOW7 X.4!''\N;6N:3XBUC2;'S8K
M0W<>HPW;0K,1'$D9!V!MN6)QUP.OMR 6;?Q'JDFK:EH]SIMM;WUM:+=VQ%R9
M(Y$8E?F.T$$$<C'^-2^!=1U#5O"5C?ZB(S+<1"3>DA8ODDG((&WZ FHETG4G
M\=3ZN\$26<^F+9Y\W+JP=FSMQT^;'6I_!>F:GHOAJUTK4TMU>S3RD:"0OY@!
M/S'(&,\<<_7T *D.J:M/\1+W2I([=K&&QC<)YK X=F!8C;AF^7&. !WY-<[X
M;U^]\.>#_M::7'+ID.IS1SR&?:ZA[@J"B!2" 6&<D?UKJ7TG5+?QU+K-M';R
MVES8I!)OE*NC(S-P,8.0V.HQ_/!;PIKS_#J[\/FWM1>3WAF#>?\ NPIG$O7;
MG/&.E &SJ'B;5X_$=UH>G:)%=3PVB74;/=^6KJ7*\_+P>#Z_A4DGB:\N+?4[
MO2M.BNH-+E>*0/.4>9T&9 @VD<= 3U((XZTEOIVJ_P#">2:U+:PI:2Z<EJ<3
MY=65V?.,8(^;'6JUAHFLZ"^LV=A#!<VFHW$ES;2/+L-N\@^97&.5!Y!&30!:
MMO&$5[J>A06ML)+36[>6>&X,N&38H)4IM_VL?>[&HF\;+;:-KVHWUCY0T6Z-
MNR13>9YIPFT@E1C)<#VJF_A*_P!%_P"$7DT6.&]_L.*6"2.:7RO-$BJ"X.#C
M!7.,=ZIW>F:GI>@^)TU%=-+:U>?Z*KN2KR2!(PA!''(X.?<@ 4 ;YU^_C\3V
MV@7>G6Y:ZMS.)4N"5"@@.N"O)&1Z9'I7*Z%K]YX:\+W]]%I<<VG6VKW N',^
MQU5I]N44*<XSSDCVK6TK^U=*U:UDU+PW&K2J+-+M-4-PZ+R0H5U!QD9)!SQD
MYQ527PIKTO@#5]"-O;"[OKR29&\_Y KR[^3MSD8QTH Z>?6YYM;N-'TJWAFN
M+2%);AYY"B(7SL7@$DD*3[#'7.*RQX\\S3+*\CTWYY-572[N!Y]K6TQ;:>BD
M.!U[9!%2II.J:=XLN-?L[:.>+4[>..\M3,%:.2,85E8C##!((X]?:J%WX-U!
M/#[FU,$FIOK(UAXRY6-G#AO+#8SC: ,XY(SQF@#9F\0W@UW4=&BL8?-M;%;N
M&5YSM?+,H##;D<J>A--\"ZCJ&K>$K&_U$1F6XB$F]9"Q?)).00-OT!-5;/2-
M<F\87.KWT%I!;W6FK:LD<[.T3!F/]T!NO)^7KWQDW/!>F:GHOAJUTO4TMU>S
M3RD:"0OY@!/S'(&,\<<_7T -^BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHKE?$NI:Q;>+O#=C8- (+N2<NLC,"[)"QP2!]WG/U Z8H Z&VU&QO
M+B>WM;N&>6V($R1N&,9.<!L=#P>*LUY_%=:I8^,?&<VE65O/)&MI(_GRE%P(
M"<# ))/;H/>MI/&$5W9:0UM&L<^J6GVL"7)6% %SG:,DY< =,\G/% '345C>
M&M;N-:M+DW=B]I/:W#0-PVR4#HZ$@$J15"]\1ZT?$UWH.FZ5:RS0VJ7,<LUT
M50AF(^;"Y!^7H,_44 =117'Z=X]6_P!-M=]H+74I;J6TFMY&++!)$,R$D#)
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M1BT6T\O1;R2&=6NVRZ(%)*?)R<$GG Z=><67UC5[CXA65G:F#[!)I37*QNS
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#M]%SDT76IZ?8R)'>7UM;O)]Q9I50M] 3S0!:HJ)KF!+A+9IXUFD4LD9<!F
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MZ?:W,=M<7UM#/*0$BDE56?/3 )R:+C5-/M#(+F_MH#$H>023*NQ3P"<G@>]
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M%9&J^*-(TG2$U.:^@>WF8) R2 B5B< *>_N>P!-6VU?3$C61]1M%1T,BL9U
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M=9TK4[/6GU"Y2WDCC@0Q86%E^82HJ@A1P,'HQ%=E'&D,2Q1(J1H JJHP% Z
M#TJO;Z7I]H)A;6%M#Y_^M\N%5\S_ 'L#G\: ///#>E:3+\*M1NFL;22:.._
ME:-69!NDX![< 4Z*VL[73OAS=6\,,4SR0JTJ !F#6YW GODXKT%-,T^.%X$L
M;98I,;T6%0K?48YIITC3"J*=.M"L?W!Y*X7Z<<4 <%;:?IS6GQ"!M+<B.64
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M KN7L+*6=KB2T@>9T,;2-&"Q4]5)ZX]J;/IFGW5LEK<6-M-!'C9%)$K(N.F
M1@4 <-JR:+I]MX4.E!(=*CUO]W(7S&<K(258G[I8G';TXQ6AH5S%/XZ\36^H
M&-C-#;O:^9@K):[#G;GJNXG/N:ZV:TMKB 036\4L0QB-T!48Z<'TIEWIMAJ!
M0WME;W)C.4\Z)7V_3(XH \MM[*,>&/":WJ*\'_"1>7:&7J;4^;L&3U4\<=",
M=J]5M;.UL8!;V=M%;P@DB.) B@DY)P/4G--N-/LKO;]ILX)]@POF1AMOTR*G
M  &!P* /,;)HKWX/ZS!J0!U6![G[4I_U@N][&,^NXG9C\ *U[LSIXF\!)J+
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MJ<J6Z:9/%;L9OW\DD?F;8]K=!D<[MH_$U6T76;"?3])@P+.XO+-9H;*1OG5
MHR/?&16Q0!Q6E:AXFU75M?TZ/5;2-]+E2*)VLLARR;LL-W'/I4]IXCN;+Q5J
M=MKNHVUM96UE;RKYFV-8W<L""Q//(]:@\&S1/XU\9*DBLWVR$X!R?]7C^?%.
MLX[.X^*FMB=(96CTVW&' .W)?/7V(_.@#JWO[-+-;U[N%;9@&68R#80>A#=.
M:+.^M-1M_M%E=0W,62N^%PZY'49'>O*M&U-;#PGX)O;F]DMM,BEN8I[F(*P@
MD)98BVX, ,;AG'&:[KPK!HXNM4O='OI+\7<JO<7(=6B>3!!V[0%SC&<>W?-
M&M<ZQI=E))'=:C:P/%'YLBR3*I1,@;B">!D@9]ZDCU"REL!?QWD#VA7>+@2
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU*RL$ NKR.V:13LW$9XZD#T'?L.]8_@+5;S6?#(O+ZZ%U*;F=!*%4!E61@N
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M\%C<RX_>^2"& 8$HP&"58#!YZ&J%KX=NKFY@EU2PT6W-O*LRO8PDR,RG(PS
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M'W]SJ7AN"ZO+2*VG9Y XASY;D.V73/.UOO#ZT ;E%%% !1110 4444 %%%%
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M &LJN,,H8>A&:=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM9SF"8%&7:X )'(YZCD<4W2M..FVA22X:YN)7,L\[*%,KGO@=!@  =@ *O4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN^,=*M4 %%%% !16//XFL8%NIBD[VMDYCN;I$!CA8?>SSDX[D @<YZ&M<$,
M000>010 M%%% !1110 4453U'4[?3=/NKV4/(EHA>5(1N< #/3Z<T 7**K:;
M?1:II=IJ$"NL5W"DR!P P5E##..^#5F@ HHHH ***AO+E+*SENG1W6)"Y6-=
MS$#T% $U%4M'U6#6](M=4M5D6&ZC$B"0 , ?7!-7: "BLU]>L$\0Q:#YI:^D
M@:?8HR%0$#D]LYX^E:5 !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7FGQA\9ZYX6@TZ#1W^S?:RYDN?+#'Y<849! ZYKTNJM_IMA
MJMM]FU&R@NX<Y\N>,.N?7![T <S\,/$FI>*?!Z7^JJ#<).\/FA=HF  ^; X[
MD<=Q785%;V\%I;I;VT,<$,8PD<:A54>@ X%2T %9GB#47TO1IYX 6N6Q';J$
M+DR,<+\HY."<G'8&M.LV^TF6]U6QOOMKQI9,SK $!5V*E223SG!(&.F30!Q>
MAO:^%_'T5G:I=1Z=K=JL>;BWDB_TJ(=?G R67KZM6WJ7_)4=$_[!UU_Z%'6A
MXG\-+XEM[2)KV6S:TN5N8Y854N)%^Z03G'4TLOA]YO$5EK<E^YFLX&A$8C 5
MU;&XGOG@=* ,[P7_ ,A;Q7_V&&_]%1U<UNXNUUBUM8]0:""2"0BWM5#7,LF5
M (RI 0 G).!DC)J?1-!_L:[U&X%X\_\ :-P;B160 *Y '&.V .M,U#PW]K\0
MPZW;ZE=65PEN;:41!")8MV['S X.>XYH YJP\4ZS<>&?"6I270\[4=26SNU\
MI<2+F0$].#^['3CDU=OO%-YHVI^*FN)#<VVEV4-S;Q%5!#.'^7( XR!UYJ8>
M HX?#MII-KJUS&UA>"\LYY$5_)8,Q VX&X?.W7GGKVJ>+P7&]_J=UJ.HS7RZ
MI:K;7,3(JJP (R,#C[QQC&/<\T 8^NV]\)_!UW=ZG)<M-JD1EC*($WF)SE<#
M( Y&"3P1GGFKBWVJ7.L>,=.EU*4165O UJT2*C0[XW8X./4#D\U*G@67[/IE
MM/XBOYH=*N4FM08XMRA5(52=OS<'&3V_.M*U\-I!K.K:D]W)+_:R)'-$5 50
MBE5VD<]"<T <SIU]J>C_  Z\.WD)O[RV:*%KS[/&CS0PF,_<&WD!MN<Y.,_4
M=1X7U"+5-'^V6^K#5(9)7,<Y4*P7/"L !@CIT]ZJZ?X4GTO3["TM=;NB=/)$
M+2HC Q[=HC8 #( []<@<UI:-HT&BPW*PL6DN[E[F=\!0TC8R0!T& !^'.3S0
M!AW6JW]AXKU#3KW5&ALY]/-W8R^4G[HH?W@/R_-C*D>Q/4\U!X;UW5-;T73(
MI;N2'5?M<D>H+Y29C$6=XQMP!S&!W&\=:WM9\.VFMW>FW-R65].N/.3;_&"I
M!0_[)."1WVXHT_P[::=KVI:Q"6\W4=A=3]U"HP2/]["Y]<"@#*TG4-0N=9\6
M6-Y=F>*Q:-;<;%78K1;R.!SR>I]*YR+_ ))-X3_Z_;'_ -&BNQM?#;6NH:S>
MIJ$ADU?;Y@,:XC*KL!7_ (#ZYJH?!*?\(SIVA+J<RPZ=-'+%((UWG8=R@]NO
MM0!TDW^HD_W3_*O+-,NM=\/_  QT?Q'::MNMK2.+S=.,";)(BX4C=][=SG.<
M>WKZKM+1['.21@D<9KG++P9%:Z9;:/-J$UUI5I(KQ6TB*"VUMRJ[ ?,H.#C
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MVZ>6"\);>, -N!&?O8/H!Q6QX>O-1B\5:WHE[J$M_%:QP3P2S(BNHD#;E.P
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M+FW95\IQAL-G&=^[;TX 4],C.S0 4444 %%%% !1110 4444 %%%% !1110
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M"<SO*SQ+F)FMR67;P,C) SW'(/2@#T"LC5O$EIHU]9V=S!<M+?,4M_*CW!V
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6X(S\W/IR0,D#GH156\\;:-:7*6RFZN99;3[7$MM;/)YL?'*8'S=<\=,'.*
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M[ ,A&^G!]*HH!I.O:O9ZOX6NM5@U*Y-S:7,-F)E=74 QOG[F"/XL#'I7H=%
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MQ7;T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&PEAFS_JHRX#%=HZ'@''/6@#M**KV%TU[80736TULTT8<PSKM>/(Z,.QJQ0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNE95F@D+%B5*J!U8]1W^E;6C:.=*B<S7]SJ%S+@27%R1N(&<     9/ '<T
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MOM.J6<D]Q)$51G\L*,*2,#);)QZ<8KH/#<6N6Z7D&LRK,JSDVCEPTGE'H'P
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MX&"".",<UMZ3I8TNW9'N[B]GD.Z6XN&!=ST'0  #L ,?B2: +]%%% !1110
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MZNV\$;LDX.T<$\>W2LBTU35M1L?#KV6KW:ZI=W)CU6&/83"@#>83&ZLL>Q@
M.!G/<F@#T>BN':?7_$D.KRZ3=?9KFSOY;6U;[1M2,QD#YTVG=NZG.>&&,5V5
MJTKVD+3^7YS1J9/+.5W8YP>XSTH ?++'"@>5U12RJ"QQRQ  _$D#\:?7'?$2
M!I8- Q<3Q ZW:(1&^T'+]3ZD8R/2HKV#5+OQV^@Q>(+^VM#HXG!CV;U?S=N0
M2OL,YR>O(S0!VU%>>>)]7U'3=-U>_M=5N+JYL+N)8W@ 6"W3,8,<@. ['+$X
M!(R/NUIW8U*\^(5QI UJ\M[)])6X"0A R,92IVG;QP!R<GW% '845Y]9:UKT
MG@C3[PQW6IFWO9H;\6Q"W$T*-(@*XQSD(3C!.#ZFFWNN37&@:1>:#X@N72YU
MR&V9I4!95=^8Y 1NRO3J,CJ3G- 'H=%>?W>JZKX-\0WT$VHW.KV+Z3-?QK=;
M=\<D7494 ;3D=N/YOU'4=3TCPGI'BF+49[F:1K=[R%CF*=)2H(5>BD%AM(].
M<T =[3$ECD:14=6:-MK@'[IP#@_@0?QKC88=6U7QKK^G'Q!?6]M9BSEA6(1@
MKN#DK]W[IQSW/'/'-'04FL-$\6W46LO:2Q:G=1I<7;^8D>-F'(/5NP_ 8H ]
M#JG>:BMMILU[!;S7WE9'E6H#.Y#;2 "0,@Y[]C7,:;=W<GC.?1O/U&.QGTD7
M"BY?]Z'\S874DEDR#T.,$=!7/:?<ZAI/P+_M;3]3N(;M8BX9MK@?O2" &!QG
M/7KF@#U,<CTI:YFYU";4O'+>'O/EM[:WT\73^2Y1Y79]H^8<A5 [8R3STKF=
M4U_7+;PQXAMQJ<RW6B:C#!%=!5S-%(Z8#\=0'Y*XSQ0!Z917)VDFH:=\0UTV
M35+F\M;S37N62?;B.19%7*8 P,-TJUXKU>>PFT?3[:0P-JE\MN\P RB8+-MS
MQN. !]30!T5%<>]UJ&F^,GT&._N'L[[3WN(7<B22UD1@#AF!RI!'WL\T[P F
MI7^A:;KNH:S=74ES:8>W8*(L[LAA@9W8&.O?MP* .NHKG];ED;6[2T%[/Y;V
M\C?8;,[9Y6RH#E\C:BY/4@$D=>E<K!KFN7O@SPI??VK+%<W>JK:7#!$/FIYD
MBY/'7Y!T(!YS0!Z517&Z<FHGQ+K_ (=;6KV2+[+#/;W$A4RP.^X'!  QE0<8
MQVJ#0]5OM5T?3]'FNYX]8@O'AU!U?YU$1R[?[K H!_UT&.E '<T5A^,];E\-
M^$=0U:! \UO&/+##(#,P4$^P+9_"LO6)[_PUJ&@3PZA<7D&H7J6-W',VX.74
MXE7^Z05)PO&#TH Z+4M6M],TV]OG5YTL5+3)" SKA0QX)'.T@_C4NGWL>HZ;
M:WT2LL=S"DJJW4!@" ??FN!TRT,>@>/9&N[F4I=7L>)9=P/[A.3[]OI4^F7&
MJ:3_ ,(6_P#:DLUMJ4*6\MHT:"-5\C<I7C<"".22<^W2@#T"BN$2X\1^)-+N
MM1T>Z6VNX[V6.WWW)$2+'(5V/&%.<JN23SEN"!Q4BIJ^K>--5TW^W[NUMXK2
MVN(Q;^7\C,6R 2O*\=QD\<]B =-KVM0>'M&N-5N89IH;==SK"H+8]>2*NPRB
M>".900)%# 'W&:P/B'_R3_6_^O1ZS[:XU/2_%?A^UDU26ZMM6M)O,@>-%2)H
MT1E*8&1U(Y)H [.BO/9]8U"VFT:ZAU*>\:ZUH6MQ<)Q:R1LSCRT4GDJ !N4=
M0?F-2R#5[_5_%UI_PD%]#'IXB>V\H(K(3#OQG;]W/;J>Y- '>U@_\)=9[-:<
MV=Y_Q),?:%V+N8;=^5&[D;>><5C:9XDOM9/AG36N#!+J&F_;KR:, ,V%4;5R
M,#+$D^@'&.M4+6"2V3XC12W$EPRQ_P"LD W$?9N < =!@9[XH [.+6EGT[3+
MZ"RNIH]1\LJ(U!,*NNX,_/ '0D9ZUIUP;7]_I_AOP(UG>/#%=2V=M/$%4B1&
MA+=2,C[O8]ZD"ZKJ?BGQ3IIUZ^@M[2&V>#R=BM&71S@';TR/J>.?4 [BBN!M
M_$FI7/A?PE?7<YBMK]U74KM/E*_*=N2/N!G !(QCVS6KX3DU&?5=9:74+FZT
MR"X\JP,FPHR[06(;;N;:V5R6(_$4 =337=8T9W8*JC))Z 5SFIZE-<^-K+PX
MLTEO ]E)>3/&VUI<,$5 PY Y)..>![YRH[N^F3Q=X>O+R>9-+B62WN=P$ACD
MC9@C$#G&",]2* -_3O$9U*YM?*TR\%E>PF:WO=H,; <C=@Y3(.1GK['BMNN<
M\ 6_D>!]';SI9/,L86Q(V0OR#@>@K+$.KZSXQ\1:2/$5]:6MM%;/#Y"QAD+A
MS@';]W(Y[GCGCD [>BO,[77?$%_HWALRZI)!=2:N^G7;Q(FV8+Y@W\CK\@]L
M]CTK<ADND\5VWA&75+R:&#3GO9;AW"S3DR[54LH& HSTP3Q[Y .PK,EUVWA\
M1V^A-!/Y]Q \R2;1Y95<9&<YSR.U<>_BS5-)75]&EN//N;;5+:RM+R502$G
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M:>CI$/W85@X ;<-G? Z8Z<50G\"6%Q;ZA#)?WY^WW2WC.'16BF4C#H0@P?E
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MSFMF21(HVDD8(B LS$X  ZFJUS>31_9&M;-[M+B4*[HR@1(03O.>HX' YYH
MPU\"62>'+?05U+4!:6TXGC.Z/>&#;P,[.1NY_P#K5B:FJMXJOY+S4?$FD2XB
MAA>R@:6.Z15SO^6-QG<S#:,?KQZ%10!R4>DZW>6&G;]5U(36U[YL<I*1&2'(
MXG4#GC=@  \C..<=)J-BFI:=/922RQ+.A0R1-M=<]P>QJS10!D1>';?[9)>W
MEQ->W$EJ;3S)MBD1$Y(^10.3C)]N,523P/IRZ%:Z2UW?.ME(DEG<-*/-MF7[
MNPA<<#CD'(ZYKI*JFYN/[4%K]BD^SF R?:MR[0V[&S&<YQSG&* *2^'HMUW/
M->7$UY=P"W>Z;8'2,9^50%V@9)/3J?88J-X,L7\*P^'7O+UK>W*-;S;U$L)0
M@K@A0.,=P:L^(?$D&@Z!=ZPL$E[':$K(D+*""#@Y)/8]<9/M6P#E0?44 <W)
MX<72)[W7K6;4=0U V1C,+S@?:&4,5Z 8/.., =<9KF-'M9H["WM]$\0>)UOH
MHU5;.\LSY,; ?=<O& $'^^3CH2<5Z910!S5QX'LI=:N-3MM1U*P^V$&[M[2X
MV17!'&2,9!(ZD$&K<>DW$7BE+Z"[NTLEM/):U,@\C((V[$[$<Y/T SSC6FGB
MMXQ)-(J*65<L>[$ #\20/QJ2@#-UW0[;7[*.VN)9H3#.EQ%- P#QR(<JPR"/
MS!J"+PU##XACUL7]ZUPEJ+4H[(4:/.[!^7.=W.<_IQ6S10!RUW\/]-O(=4MV
MO]1CM=4F-Q+;QS (DI()=?ESG(!P21[=*OQ>&HH=>_ME=1OC<_9!:$,R,I0$
MMSE<YW$G.?TXK0M[FXFO;N"2RDAB@*B*=F4K."N20 <C!XYJU0!SMCX.ATVT
M@M[/5M1C^SW#W$;%HR=SYW _)@J2Q.#WZ$8K#\8:/!ING:;;VK7+2W6OP7ES
M/&NZ0'=\\IVK@  #MC@5WU% &5;Z%:FZFOKJ5[^>X@^SEYPN!%U* * ,$G)]
M?P %2S\'V=I;VUDUY=W%A9RB6VM)F4I&5.5&=NY@IY )/0=<"N@HH R;/P_%
M9>(+W6DO;IIKY46:)RGEX0$+@!<C&3W[\YJC<>!=,N;?5[:2YO?L^K2&:6%9
M@%CD)4ETXX.54\Y''N:Z 3Q-</;B13*BJ[)GD*Q(!_':WY&H=/N;B[MS)<V4
MEFXD=1'(RL2 2 V0<<CG\: ,NS\)V]KK4&L/J6HW-Y%;&V9YI@1*F[<-P"@<
M$=L#US51O 5A_P (M<^&X]0OUL;@\ R*QB7=NV)E< 9/4Y/OTKJ:* ,:\\.1
M7>H6FIK>7%OJ-K&8A=1;-TD9Y*NI4J1GGIP>F*@O?!NGWVB7&E/<W2)=7 N+
MF9&3S)I P;<Q*D=57@ #  Z5T%<WJWC.+1K*^O[C1M3>RL9#')<H(=K$$*=H
M,@8C)QG'K0!=/AZ-O$%OK;W]VUS;VYMPI\O8Z$@G("=20#P1TJ;6]#L]?LEM
MKOS$,4JS0S1-MDAD7[KJ>Q%9]WXK>RM[F:XT'4XA!:/=C<82'1,;@"LAY&X'
M!_#-:^F7HU+2K2_5#&MU DP0G)7<H./UH IPZ B7$UY->W%Q?2P?9_M3A T<
M><X4!0HYY/!SQZ#$F@:)#X=T>'2[:XGG@@&(S.5+*OIE0,CZ\UI44 8VH>&K
M:_UR#6%O+RTNH83;L;:0*)8B=VUL@]^<C!]ZSXO .GP:;9Z?#J.HQP6-Y]L@
M'F(Q1]S,!RAX!9OKGG-=310!@SZ9;Z-J=_XH:>_GE:W"2P1HKAD3) 50N[(R
M>_>H_#MC!<ZMJ'B46$EI)J(CC03(4D:-%^\RGE23QCT5:V+2YN)YKI)K*2W6
M&79&[LI$RX!W#!X&21SZ5:H KW]A;:I83V-[$)K>X0I(A[@UF67AB&V:Q^T7
MUW?IIW_'HER4(C.-H;Y5!9@I(!.>OKS6W10!STO@ZT8:PL-_?0)K&\SQI(NQ
M690K,H*]2 .N<=L4-X0C:+1(_P"TKL#1"#;D"/+X78-WR\_+QQBNAHH YA_
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MMWHD6CAYX+:.83?NG&YY V_<Q(.3NY/J: *ES=7D7Q,LK47LYM)M,FD-MD;
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MT:YO?MS.KH"LW0D?+T(P"#D<=.M:.G:1!IT]U<J\DUS>.KSSRXW/M4*H^4
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M?NM9ADN%FO OG1"4^4S*NT-M]=O'I[9YI-9\/P:W-92SW5S"UC,)X?)91B0
M@$Y4YX)XZ<T <_MOEU__ (1:*]N;N.UL!<F2YOVAFE+R.,ET3)"@ #IUYSQ5
M*Z'B>Q?PUIM]KY%S-?26\\EJP;>GELRELJ/G QU&.AP:Z;7?"5AKUW;7TEQ>
M65]:@K'=V4WE2!3U4G!!'MBL#Q/IB6NH>%K*T6_\NWO7FEN8D>5TRC#>[X/)
M8]^O/:@!;%]1TKQ%KOAZXU&YU&S.FB]MY+IM\D62RE"W<$C(],4W1IV3P-X1
MA%]+")HHPUM;@^==@1D[%8$;0#@DY P.2*Z>/0+=$OF:XN)+F_0)/=,5\PJ
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M/M7E[2<9^[Z8K7U.'4-1^(DFCKKFH6EG+HYGVVSJI1_-"Y4XX^O)ZC.#5\>
M]+7P]_827-ZEF9_/($H)W;]XZC &[G@"KX\/0_\ "1)KIO;LW:6_V8@E-C1Y
MW8(V_P![G/\ 3B@#G2VM^(SKD&GW?DSV%R;2UE-\\1B944AW14(?<Q).>,<
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MOK-_I\UIJUY+#]GFV(&4 Y<#[P/0@\8Z8K1T35K_ %'Q-X?FGGG0:CH37%Q
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MER^&H)C-F^O@MQ +>=1(,2H 1SQP<$C*X/O6K!!%:V\=O!&(XHD"(B]%4#
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M6M_93=&9)+2;SH9()3&Z-@@\CL02*A@\-6EMJ-]J$-Q<I/J$:QS'>"-JC"@
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M3W%T9=*5EMCO P"-ISQSE0!S_/FKFKZ7!K6ESZ;=-(+>X79*(VVEE[C-7:*
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M@DN;>YP9GN)FDD<CH2Y.<C QZ4 9,UM]A^(NF65O<WBVMSI]PTL+74C*S*4
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MUO;N*6UU>Y,<R3L).&4<MG)R.N>M=Q=>$-+NGL92;J*YL$\J"YAN&24)_<+
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MS70:DL^@>+] CT^XN6MM3:6VNK>2=Y VU-RR#<3AA@Y(ZCK6U;>&=*M_#QT
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MMJADD;JQQC)]^*W:HZ/I%KH>F1:=8B06T(Q&KN7*CTR><5>H **** "BBB@
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MF&-1]Y1DALX!W'J16K<:>NH_$R]T^XNKTV<FCQRM EU(J[C*RG&#E1@#@8%
M';5#>7<%A9S7EU((H($,DCMT50,DUY_H=\USX/T"VO+^[FG;4)H8X%;+WJQO
M( CL2,*% ))/1<<YQ69JXEG^'OC6TN]Q2PU!A!'YS.L(Q&=H)QE06. 1@9H
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M?D*[@NW8 "#P<Y/- '?W#RQV\CPQB615)5&;:&/IG!Q^59_AC63XA\.66KM
M(#=Q[_*#;MO)&,X&>E86FNOB;7/$<-_+)_Q+Y4MK>))&3R5*!O,&#PS,3ANH
M  %6OAI_R3K1?^O?_P!F- '44444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !5;4-/M-5L)K"_MTN+:==LD;]&'^>]6:* ,+3_  ;HFF6%Q96T$XCN$\N1
MFNI"^S^Z'W;E'L"*L7/AG2;N?3YYH)3+IB[;1UN)%:,$ 'D,,Y  .<YK5HH
MXC0-"^V:OXD?4+:^MXKZ]+H"[QI/#L5>0#Z@\<'!]*Z6[\/:7>W%C/-;L'TX
MYM?+F>,1<8X52!TXY'2M*B@#G[CP-X=NS?>=9.RZA)YL\8N) ADR"7"AL*V1
M]X &K<7AK2H-3_M.**9;OR!;^8+J7_5CMC=CJ2<XSGGK6K10!S__  @WA\6,
M%DEK.D5O.;B$K=S!XI#G)5]VX9R<X/>I4\':!'#J$*V \K4ABZ0R.0_ !/7@
MG R1@D@&MNB@#';PKI#BP#PSL=.;?;L;J7<K=-Q.[YCCC)SQQ3KGPSIES?SW
MICFBFND$=R8)WC$ZC@;PI&<#C/7'&:UJ* ,NX\.:5<W5A<O;LDFF@BT\J9XU
MA!&" JD#IQR.G%26&A:?IM_=WUI'*D]ZP:X9IY'#D# .&8@<<<#I6A10!GZE
MH=CJL]O<W$;K<VI)@GBD:.2//! 8'H1U!X--;P_ICZ3<:6T#_9KK<9P)G#2E
MOO%G!W'/0\].*TJ* *VGV%OIEC%96BNL$*A(U>1G*J!@#+$G&*2ZTVSO+NTN
M[B!9)K)V>!SU0E2I_0U:HH JVVFV=I<WES!"(YKUQ).XZNP4*/T _6LT>#M"
M&FWNF_99OLM_*TMS&;N8^8YY))W9Y[XZUN44 <QJUK<:@/\ A%DT>9M,=(Q+
M>SRAT\L'++R2Q; P,],Y[<],    , = *6B@#-.@:<=9?6/+F%])#Y+2BYD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,_$2ZU:R\#ZC<:
M+Y@NT1?FB^^J;AO*^X7//;K735E>(;K4K.PBGTJS>\G6XCW0(0"\9/S\D@#C
M)Y/6@#C_  KKGAOQ5)I[Z'?3Z??6TBR7%A+</^^4 A@021)C.=W7CG&:Z#4O
M'6F:=/J">3<W$.E&,7\\*J4@+G ')!8CJ=H.![\5S6L^#[+6/%>BZKH&EW&F
MWD%XLU],UNT""->2"" &<GCY<YR<G%5+7P_>:3XT\06^J^&[O6--UFX-Q!+
M04!+$[7!8 #YL<]-OO0!V>K>--/TRX>VAAGU">*R:^E2UVGRX!_$2Q Y[ 9)
MK"U_XBO&_AE=&LIYX=<G1EE^0,R!EW1J&88;D DX'/!/44KC2]9\*?$A==M-
M%FO]+OK%+66&R <V^U5  !QP-@Y.!@FK/C;2M6O]6\'ZQ:Z/,8M-NV>XMH2K
M/$I:,C@''1#G!P#W/6@"XFI6D_Q5MH)9-8M;XZ=D64C1FWVG)).US\W;CNO7
M%6F^(VC+#+>^5<MI<-Y]CDU !?*$GTW;BO(^;&.:R)],U*X^,-MJ[:;=1V)T
M[[.\P7(20AN,CTR!D<5S@\':[!\/KGP4NGS/>R:J'2<)^X,/!\POT XZ?>]J
M /0M3\<6.E^)8/#SV%_<7MS!YT'V>-&61<-T.[C[I'( [YQS5KPKXJL?%VF2
M7UC'-#Y4S0RQ3J Z.,$@X)'0BN4N]%U"W^+.@7\=E<S:?I^F_99;I8R0&VR
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M.JVS07-A/I)_TJ.["@JO/S94D8X/>N8\:VVJ:_J7@W4+;1[P"SNUN+R,Q',
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M-FYL&->F<$9&1FN8T/PYKMA\*_$NAW&CW*WEQ=NT"* PE#!!\N#T&PG)P.E
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !6-%X;CM+N\N+#4;RS^VS&>>./RV5I" "WSHQ' ' ./:MFB
M@"GI>EVFC:?'8V,7EPQDD#.222223W)))JY110!G:SHMMK<$$=P\L;6TZW$$
MD3 -'(N<-R"#U/!!%,BT&'^TK?4;NZN+ZYM59;=YP@\K<,,0$51DCCG-:E%
M!1110 4444 %%%% !1110 4444 %%%% !1110!EW^@P7NJP:JES<6E[!$T*R
MPE3E&()4AU8=0.<9]ZDL-&M["\N+[?)<7ET%66XEV[F5<[5PH  &3T'UK0HH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4 %%5;N[DMI[6-+.:X$\NQGCQB$8)W-D].,<>M6J "BF"6,RM"'4R*H9ESR
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MFCZ3=:E)!+-':Q-*Z1;=VU1DD9('0>M2Z?>)J&G6UZBE$N84E56Z@, <'\Z
M+%%%% !156^NY+183'9SW1EF2)A#C]V&."YR1\H[U:H **** "BJFJ:G;:18
M/>71/EJ54!1EF9B%51[DD#\:BTW4YKZXNK>XTVZLI+9E&9@"DH(R"C D-[]Q
M0!H4444 %%5KN^CM8+B0*T[V\?F/#$1OQSC@D#L>I[5#HFJQ:[HMIJL$;QQ7
M<8D5'QN /KB@"_156*[DDU&XM&LYXXX41EN&QLD+9R%YSD8YR.]6J "BBB@
MHHHH **RO$>O1>&](?4KBVGGB1E5A#MRNY@H)R1QDCIFM6@ HHIDLL<$3S2N
MJ1QJ6=F. H'))H ?1110 44P2QF5H0ZF15#%<\@'(!_0_E3Z "BBB@ HHHH
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MVR\)6]K#96TM]=W=IIT@DM()RI$9483)"@MMSQD\<=2 : .=FDUJ\D\8Q_\
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ML=8DU"\:XLHFB1?W85U;&[<-G? Z$>V* .<TZX\3:WI&E:_87*1O.ZSW"2W
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]M6D\R:,P[0I!8C:=W3YCUS7344 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4454U/4K72+"6_O7=+>%2
MTCI$TFT 9)(4$X]Z +=%<Y%X]\.S:6=5BN+N2Q )-PFG7!0 <$DB/ Q700RI
M/"DT;;DD4,IQC(/(H ?165>>)]%L-4M]*N-1A%]<R"..W4[G)/3('W1[G%:M
M !1110 4444 %%%8VO>+=$\,>5_;%V]L)CB-OL\CJQ],JI&: -FBLA?%&EMJ
M%M8,UW#<73%85GL9X@Y )(#,@'0$]:O7VH6FFQ1R7DZPI+*D*%OXG<X4?F:
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M$=E&!M\R,8W2X]&(R/;)[UK:KX/:^\/W6DV>J2V+7\S37ERD89YBWWAU& <
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MHKFT\I%2)"Q"F,@;L@#^(G-7)M;\5WWQ*UKPMIFJ0P0PV8FAEGMU<PDB,\8
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M!\.3>&O#8AO-OVZ[F>ZN@IR%D?\ A!]@ /KF@#IJ*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@!K1HYRR*Q]2*=110 4444 %%%% !1110 4444 %)@#\:6B@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **0,"2
M 02#@^U,EFBMXS)-*D:#JSL /S- $E%-21) "CJP(!!4YX/>E# D@$$@X/M0
M M%-61&8JKJ2O4 ]*'D2/&]U7/3)QF@!U%%(K*XRK!AZ@T +13(Y8YEW12*Z
M@XRIR,T/+''C?(JYZ;CB@!]%,:6-,;I%7=TRP&:?0 44QY8X\;Y%7/3<<4>9
M'Y?F;UV?WL\?G0 ^BFJZNNY&##U!S2A@PR"",XXH 6BF-+&C!6D52>@)QFAI
M8TD6-I%5WSM4G!;'7 [T /HI"RK@,P&3@9/4T,RJ,LP R!R>YZ4 +13)9HH$
MWS2)&N<;G8 9IV0!DGB@!:*BBN;>X&Z&>.09VY1P>?3BG++&[M&LBLZ?>4')
M7Z^E #Z*8)8S*8A(ID R4SR!ZXH\V/S?*\Q?,QNV9YQZXH ?14;3PHQ5I44C
MJ"P%/+*" 6 +' R>M "T444 %%%% !1110 4444 %%%% !1110 4444 %%(Q
M*J2%+$#.!U-<RGCW2S#>SO::@D&G3-!=RFVW+"Z_>SM).!GJ 10!T]%16US!
M>6T5S;2K+#,@>.1#D,I&00:EH **** "BJFIZE;Z59FZN!(PR%6.*,N\C'HJ
MJ.235#0O%6GZ_<7-I#'=6MY:X,UK>0F*50>C8[@^HH VJ*Q8_%6G2R1E1+]E
MFN#;17A4>2\H)&T'.>H(!QM)& >E;5 !1167J6N1V%Q]DAM+B^O! UP;>WV[
M_+! S\Q Y)P!U- &I15#^U[<:/%J;1W"QRHKI$86\TENB[.N[VJMHGB:RUV>
M[M8H;JUN[(J)[:[B\N1 W*G'<''6@#8HKGT\9Z:VL6VFR07L/VQBMK<RVY6&
M=@,X5CZCIQSVS704 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>(!+93#::B ,#RI.%D/^ZX7GT)I^L?\ $R^(7AR\?Y[:*\N+>!3RI*0N7?\
M[[&W_MG[UTT_AZ&\&I1WEQ)/#J4(AEB95 4 $97 SGG\ZAD\*VQFT9X+J>W7
M10?L\:;2&RFP[L@D\$^G6@#:EBCGB:*5%>-QAE89!'H:\ZCN)K7X*:>MN[1F
M98;=G4X*H\P1N?H2/QKT9U9D*JY1B.& SBL:T\+65OX5'AR66:YM!&8PTA <
M#.0<@#D'D''84 9DMY;:%X^>,O'::>^C>=/T5$,<H56]!PY'T ]*LZQ8Z/\
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M$]A*'#":%58\=B&!!!J*STA;>XEO)KF6YO)8Q$;APH*H,D*H   R2?4]\X&
M#G_%]Q?V.MZ)?3V-M=:/!>HK!7;S8I7_ ':28Q@@;B,>_P"78UBVWAZ7; NI
MZO=:FEM()8EF2-1N'W2VU1N(ZCMGG&0*VJ "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
3 HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>ebs20191231exhibit1048021.jpg
<TEXT>
begin 644 ebs20191231exhibit1048021.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKMM?GBM_#^H2S2+&@MI,LQP/NF@#G_#NI2WNFZ?XDN]?>.*2V!O+62,>47<
MJ$X!4@G QG=QWYKH8=>TJ>*YE6]B1;3_ (^!+F-H>XWAL%?QK@4NBG@[P-J2
M.)=/TV2 W^SYO)_=; [ = I//I6M</;W?CFYUJSN8FT^'16AN[E'!B9R^47=
MT) R?8$>M '16GBK0;Z1H[;5;:1DM_M+8?&V+^^2>@Y'YBI[+6M.U"YDMK:Z
M5IXE#O$RE&"GHV& )4^O2O/K<-+\%--ETR$7+68@>Y@A +,J2*\B$#OQDBMN
M^U/2O%^D:G/X947>HR:7+ +M(RK1@C*Q;B/O$\X[8R<<9 .DMM?TJ[O4LH+V
M-IY%+Q*01YJCJ4)&''NN:M7=Y;6%LUS=SI#"F,NYP.3@#ZD\ 5Q'A[4?"_B*
M?26@CO)M6L>?LTDDV;)MN'W G '&.>O K:\=:C#IFAPW%Q:Q31_;8 99D+1V
MWS@^<P')"XSC(YQ0!I+XATAK>ZN&OXHH[,XN?.S&83C(W!L$9'3/6F6OBC0[
MV^AL;;4X);FXB\V*-6Y=<9X]\<XZXKA/M]JNH>.]]\\XNM*A:*:5-HE BE!(
MPH&,D 'OD=:E-[I\>F_#MEN;=1&\>XAU&W]P5;/I\W!]Z .G\8:_!IV@:J+?
M4C:WUM:NZO&@?RWVDH&)!5=QP #@G/%:F@3RW/AW3;B=R\LMI$[L>K,4!)_.
MO/H]7MK+PMXRT35YEAU9GO9/*E^]<*ZDHZ#^(8P..@7L*[OPK*DWA/260DC[
M%$.01R$ - $LWB#2;>\2TFO8TE>3R5SG:9/[F[&W=_LYS6%J>N"^\8'PW'?S
MV48L3*98%PYE,FQ1D@\#!/H<\US>CW&A7.D/X7\1QWKZS!<N'L/-F'VA_,+K
M(FTXP20=W ')/'-= M[:_P#"X9$^TQ;O[$6+&\??\\G;]<$''6@"M9ZC?ZWJ
M>H:$/$,T%UI\,$<%W#;A?.F*EGD="",< ;<@=?7CJ+?7]+ENXK$7\;W,H/E\
M%5F*_>V$\-CN 3BN5L[A;[Q/XZM-/NXS=SP0I;[9!DN+<CCUPW7TJMX;OO#.
MMVVBV<D5Z^LZ:T>;&228-:2( &8@G:% SUX/ ZG% ':W/B#2;.Y%O<7T<;^8
M(B3G:KGHK-T5CD8!(/-5K3Q18WGB:]T./?YMFD99BC ,S;L@<=@HYZ<^U<EH
M&L:5!IE[X5\0VQGU5+Z9C9RPEC>%I3(CKQ@@Y'/;&3@5L:==16GQ0URWG8I+
M>6EHUNNT_O HD#$>PR,F@#I[R^M=/B66ZF6)7<(F>2['HJ@<DGT'-00ZWIEQ
M92WL5Y&8(',<K'(,;@XVL#R&R1P1GD5C>-=4M],.CM=10HCWP O9T+)9G8WS
M_4Y*C/ SD],5RUI)I4]MXLL]0U"[@CDU6&47>WRWB)$7ERD[0 -X!Z#@$].:
M /1K+4K34'F2VE+/ 0LJ,C(R$C(!# $<<U5O;NU'B#3;4ZQ]GN")&%BI4FY&
MT\L,9 7!((Q63X-O-3FO=4L]2GMM0^R>4L>J6R!1<@@G# <;E[X_O"HO$MS;
MQ?$3PBLDT:L#=Y#,!C=$ ,_4\#U- #;C69-=\4:EH5KJL^G?9;>+R)8(\DS.
M6)+9'(&T#' .3[8ZZ!9$@C2:02R*H#N%V[CCDX[9]*Y'1+VU;XG^(XUN8B[V
MUHJJ'&6*A]P'J1D9],UV5 !1110 4444 %%%% !1110 4444 %%%% !1110
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M1R-K$>@)H U*0  8 Q7.:?XPT[5H=8+2S64-A,\)GEB:/ 55RV6& =S' //
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MXWE@TV?JJ$#)8L-W!'&X@C/>M6?Q'I%M=+;S7@1FF$&\HWEB0]$+XVAO8G-
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MG)#); KYD0VNCA@&1@PRIY]B*Z/^U;1=0333(YNS&)-BQ,<*3@$D# &0>IH
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M55R2!EB>23S0!S&L6DMU\/M*U;3@)+[1XH;R#;_%L4"1/Q7<,>M/UZTU"\\
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MVV5P 7^?E5SU;_9)';/9T4 <5X'G.B7=YX2U"427MHP>*[.?]+C*C;DDGYU
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ML<OB3YL=LGK@]L$@%#Q%K>WQ3I>ADWB6UQ'/)<-;Q3!VVJNT*R#.,MDE3Q@
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M-)<Q++,LUK$)I8GMI$D$9SA@I7+#@] :XJ]OFM;[QY<0:>NH[S:M%!)"9$E
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M/836TT"2Z?\ N[BVMB\MT=Q_=>8 =JCKCCKG('4 T-2\8V-D^C_9UENH]6D
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M60;79.&V]P#V/O\ _KJ>B@"*WMX;2VCMK>-8H8D"1HHP%4#  J6BB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7)_%#_ ))SJ_\
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MEQ=)'=1:@;358E@#>6JN1(RCMM&#DY&"*[K3K(V4,H>3S)9IGFD?&,EF) _
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M*** "BBB@ HHHH *C,,32B5HD,B]'*C(_&I** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI_\ ?RV_^/5JT4 97]KWW_0MZG_W\MO_ (]1_:]]_P!"WJ?_ '\MO_CU:M%
M&5_:]]_T+>I_]_+;_P"/4?VO??\ 0MZG_P!_+;_X]6K10!E?VO??]"WJ?_?R
MV_\ CU']KWW_ $+>I_\ ?RV_^/5JT4 97]KWW_0MZG_W\MO_ (]1_:]]_P!"
MWJ?_ '\MO_CU:M% &5_:]]_T+>I_]_+;_P"/4?VO??\ 0MZG_P!_+;_X]6K1
M0!E?VO??]"WJ?_?RV_\ CU']KWW_ $+>I_\ ?RV_^/5JT4 97]KWW_0MZG_W
M\MO_ (]1_:]]_P!"WJ?_ '\MO_CU:M% &5_:]]_T+>I_]_+;_P"/4?VO??\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#(TW_ )&#6?\ >A_]%UKUD:;_ ,C!K/\ O0_^BZUZ "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*PM;M8[S6](AD>5%)F.89FC;[@_B4@UNUD:C_P C%H__ &W_ /0!0 [_ (1V
MS_Y^=3_\&=Q_\74+Z3I4<HA?4KY9#@!&U:<'GIQOK:KSBT@;2O%=M)XO\-6#
MW-_=_P"BZQ;L90)B<QQMN *X&%4^P]S0!ULVE:3;2QQ3ZG>Q22G"(^K3J7^@
M+\U-_P ([9_\_.I_^#.X_P#BZRO%GAK0)]&U6^U*QCNKB6([9G0-*K8Q&D9Z
MKS@ #J3W)-;/AZVO++PYIUKJ$ADNX;6-)F)R2X49Y[\]^] %632M)AN$MY=3
MO4FD^Y&VK3AF^@WY-3?\([9_\_.I_P#@SN/_ (NL'QKX6T6;P[JEQ+8)<:G<
M@FWN"H,YG/$2JW4 ': !Q@?6MB22^CL+'1DN"VHRP*)[@<^4H #R?4GA?<YY
M - #XM#TZ92T5]J$@5BI*:I.<$'!'W^H--;1M,2=(&U"_69QE8SJLX9A[#?S
M7'Z-K)\*?"K4;ZUCWRV][<Q6Z,2V7:<HN<]>2"?I6UX?OH-"OK/1-1L;N#4=
M20R?;K@HWVR51EP65C@CLIX P!Z4 ;?_  CMG_S\ZG_X,[C_ .+IHT&P,AB%
M[J)=0"5_M2?(!Z'&_P!C^5:P92<!@?QKD/#]M#;?$KQ0((UC#V]F[!1U8B3)
M^M &W_PCMG_S\ZG_ .#.X_\ BZ/^$=L_^?G4_P#P9W'_ ,76K10!E?\ ".V?
M_/SJ?_@SN/\ XNC_ (1VS_Y^=3_\&=Q_\76K10!E?\([9_\ /SJ?_@SN/_BZ
M/^$=L_\ GYU/_P &=Q_\76K10!E?\([9_P#/SJ?_ (,[C_XNC_A';/\ Y^=3
M_P#!G<?_ !=:M% &5_PCMG_S\ZG_ .#.X_\ BZ/^$=L_^?G4_P#P9W'_ ,76
MK10!E?\ ".V?_/SJ?_@SN/\ XNC_ (1VS_Y^=3_\&=Q_\76K10!E?\([9_\
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M:WMM)M1)<362WCBY<Q"%&X4-@$[B0>,<;3STR 6?^$=L_P#GYU/_ ,&=Q_\
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MK10!E?\ ".V?_/SJ?_@SN/\ XNC_ (1VS_Y^=3_\&=Q_\76K10!E?\([9_\
M/SJ?_@SN/_BZ/^$=L_\ GYU/_P &=Q_\76K10!E?\([9_P#/SJ?_ (,[C_XN
MC_A';/\ Y^=3_P#!G<?_ !=:M% &5_PCMG_S\ZG_ .#.X_\ BZ/^$=L_^?G4
M_P#P9W'_ ,76K10!E?\ ".V?_/SJ?_@SN/\ XNC_ (1VS_Y^=3_\&=Q_\76K
M10!E?\([9_\ /SJ?_@SN/_BZ/^$=L_\ GYU/_P &=Q_\76K10!A:%:QV>LZQ
M#&\KJ'A.9IFD;_5C^)B36[61IO\ R,&L_P"]#_Z+K7H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
M(U'_ )&+1_\ MO\ ^@"M>L+6YVMM;TB5+:6X(,P\N';N/R#U('ZT ;<A<1L8
MPK/@[0QP">V37/BTU;7DLTUG3[>Q2VN$N'6.X\XR.ARH7Y1@;@#D\\8QSFKO
M]M7'_0"U/_OF+_XNC^VKC_H!:G_WS%_\70!E:G_PE<FMF:WT:PN;.W/^BK+?
M%#N[NP"'GTYXY[FM2*77Q;Z>9K6S::24_;0LI"PIR1LX^8C@<XS_ "7^VKC_
M * 6I_\ ?,7_ ,71_;5Q_P! +4_^^8O_ (N@#'NSXN;6I+J/1-.N(8219B6_
M*[!C!<@1GYCSSG@' ZDF[/X2TW6U@O?$&GPS:B8525HI'51C)VC!&0"3R:M_
MVU<?] +4_P#OF+_XNC^VKC_H!:G_ -\Q?_%T <KIWPVBA\&:GI#B.VO+R=I$
MF1V<+MD+PY!].,_C6Y)I5_K6K:/?:E;1VHTLO*RK)O\ -E9=HVX_@&2<G!/'
M%7O[:N/^@%J?_?,7_P 71_;5Q_T M3_[YB_^+H 9I?A+P_HEX;S3-)M[6<J4
M,D:X.#U'Z"JFF:9J-OXVUC59K=%M+Z&".-A("P,8;)(]]WK5[^VKC_H!:G_W
MS%_\71_;5Q_T M3_ .^8O_BZ -6BLK^VKC_H!:G_ -\Q?_%T?VU<?] +4_\
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MU&Y,]M(L@<K\BH-RXZ_+GO6C_;5Q_P! +4_^^8O_ (NC^VKC_H!:G_WS%_\
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M  (H)'& ,D>I)[U9EU)IFC:3P]J+-$V]&VQ94^H/F<>GT)%2?VU<?] +4_\
MOF+_ .+H P=#T34_#^H>((DM(8M$O7:XMD24;H7*?/\ +C 4D< 'BLOP[I=]
MXD^&&C:++;+#:2I"T]QY@(,2.'PHZ[CM Y  R3DUUMSJ+W=M);S:#JACE4JX
M4QJ2#[B0&H=,FCT:Q2QL/#NJ16T?W(RR,%'H-TAP/:@!FD:9J5IXTUS4I[>-
M;/45@$3"7+ QJ0<KCOGU[5T3$A20-Q X [UE_P!M7'_0"U/_ +YB_P#BZ/[:
MN/\ H!:G_P!\Q?\ Q= %+PAIFH:5%J::A!'&;K49[N,QR;AMD;(!]Q2ZCHDW
MB&_M_M\*6VG6\JS-#D&2Z=?NA\<! ><9.3C.,<W/[:N/^@%J?_?,7_Q=']M7
M'_0"U/\ [YB_^+H JRZ;>6OBFZU5(!?6U[:1V[1;@'B*%CP&X*MOYYSD=#5+
M3? .DKHMM8ZK:1SFWEGDA1)'"P"5]Q12""0/E'/IGBM?^VKC_H!:G_WS%_\
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M :M%97]M7'_0"U/_ +YB_P#BZ/[:N/\ H!:G_P!\Q?\ Q= &K165_;5Q_P!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'5=&EU"*07L)'VG3Y%9%"D'J@91T[$^M=]=-=)"39PQ32Y^[+*8UQ]0K?RH
MFJIJEQ/9Z9<W5ND;R0QM(%D) ; SC(Z57^T:_P#] S3O_!A)_P#&:EUC/]A7
M^>#]FDS_ -\F@##TS7_$&K>&+?7+33+%_/A\Y;?[0X<CT!VXS70(;_\ M.4.
M+?[#Y2^65+>;YF3NR.FW&,=^M<?X"T:>?PEX:O1JMWY<$8E-LVSRR"K+CA0>
M-V>3VJS9VL#?%'6HGC$D<VEP-(C_ #*V7<'@]L <4 =C29KS70[*PTSQ;'I-
MRGF:-+<RW&BR2("K3X =-W4A>=F>O)YPIJV]JGBK6O$VE7]S9QSP2B.)9[<O
M+!"8U*R1MO&WYBS9 Z]3T% '?L2%)&,XXR<"L/PKK=WKEMJ#WD,,4EGJ$UIM
MA)((C.,Y/7OZ5@:6\6H>,8-&U.Y&I6UKHT4MJ;A 5NB6P\VT\$X &?<^IJY\
M.((K;3];MX!MBBUR[1!G. ' 'Z4 6]4\0ZI:>+;+0;6SM)?ML$DR2RS,FW9U
M! 4^M3^'/$W]MW>I:=<VGV/4-+E6.XB$GF(0P)5E; R" >H!K&U^.67XI^'T
MAG,#_8;G#A0WIV-0>*?"UEHW@3Q-=":>YO+V,SW%S*P#.P'RC"@ *,G QWH
M[343?BS)TP6QN=RX^TE@FW<-WW><[<X]\59Z5Y[XNT#3--\$2WMK"T=Q//9R
M2R>:Q,C>8BY/."<,:TB;/6/'^K:-K4<<T<=C"UE;S %61MWFNH/\6=HSU 'U
MH [#I2UY_+]F@UG0/#Z:A'/IILYUMWU)//6XF1U7!Y4,0N[';!X[&NB\)Z2F
MB6EY81:@+N-+MV6-8]J6VX!O*49.%&<@9XS0!>O-3\K4K?2[<*]W.C2D-]V*
M-2 7;\2 !W)]B1!XHUU?#?AZZU3R3.\*_NX5ZR-V'\R?8&L?26=_BIX@\[.8
M[&U6#/\ <.XG'_ LU<OC>:GXD"6EK;75OI:$2+<3F-3/(OLC9*QGV_UM &WI
M]]!J>GV]_:OO@N8EEC;U4C(JQ7#_  ^:33O[5\&ZBB;]-EWP1[O,5K:7YE )
M W $D$X':N=<0K\&5+;!)#J96(G[R'[9C ]/ES^% 'K.<4M<=J<(E\<W,>H6
MAU.SDTL"*W11(86WD-E3TW]F_P!DC(Q6EX)T>[T/PI9V>H'-[MW7!WE_F/;/
M<@8'''% #_$6OW&B7.E1QV2S1:A?1VC2M)M\LOGG&.> ?3M4VKZR;'4-/TNV
MC22]U%G$0<X5%1=SN<<G' QW)'3K63X\^]X:_P"P_;?R>KWB'P_/J6H:9J^G
MW:6M_I;N8S*A:.1'&'1@"#R .>U %9O&4.GPZVNL1"&XT5%DE$1RLT;#*,F?
M4\8/0]^]3-K]]IVIZ9;:Q:P11ZH3'$\+D^3-C<(VR.<@'##'(Z=ZYO3= ?QG
M=>)[[4)5^QZC%'8VLT"%0XCY,B@DY&_H<\X-27=GK.I^)O#VAWEY;7ATF5;Z
M\F@A9-NQ2(]Q+$;G)/RCT)Z4 =1-KCSZU)H^EPK/<6ZJ]W,[8CM@WW0<<LQZ
MA1CCDD<9FN]3?3+RSCO0A@NW$"SH"-LQ' ()/#8P#G@X'.<UPFDZ3Y_ASQ;>
M2WUY::I#J-W*TL5R\?ENHW(2H(!&,=0>#5[Q?>7MY\&%O[M2FH/;VDQP,$2F
M2,@@=CGM[T >@44@S@9Z]Z6@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** ,C3?^1@UG_>A_]%UKUD:;_P C!K/^]#_Z+K7H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P &,W_Q5'_"/6O_ #^:G_X,9O\ XJ@#5HK*_P"$>M?^?S4__!C-_P#%4?\
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MGLU "PL@VIC@;<=,#TIMMX?TBTTAM(@TZW2P<$-;[ 5;/7.>I]S4?_"/6O\
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M_-3_ /!C-_\ %4 :M%97_"/6O_/YJ?\ X,9O_BJ/^$>M?^?S4_\ P8S?_%4
M:M%97_"/6O\ S^:G_P"#&;_XJC_A'K7_ )_-3_\ !C-_\50!JT5E?\(]:_\
M/YJ?_@QF_P#BJ/\ A'K7_G\U/_P8S?\ Q5 &K165_P (]:_\_FI_^#&;_P"*
MH_X1ZU_Y_-3_ /!C-_\ %4 :M%97_"/6O_/YJ?\ X,9O_BJ/^$>M?^?S4_\
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M110 4444 %%%% !1110 4444 9&F_P#(P:S_ +T/_HNM>LC3?^1@UG_>A_\
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MVM)U*#6-)M-2M@PANX5E0,,$!AG!]Z *W]MR_P#0$U/_ +XC_P#BZ/[;E_Z
MFI_]\1__ !=9.O>)/$&E176I6N@Q7&EV18S,]R4G=5^^Z+MQ@8/4Y.,UO?VK
M:?V.FK%R+9X5F4XY(8 @ =R<@ >IQ0!7_MN7_H":G_WQ'_\ %T?VW+_T!-3_
M .^(_P#XNJWAOQ+_ &SX?FU>]A6P2*:975GR(UC8C+'IT'/:K&C:K=:W$E_%
M;+;Z?)\T!ESYLZ=GV\; >HSDD=A0 O\ ;<O_ $!-3_[XC_\ BZ/[;E_Z FI_
M]\1__%UJUAZ7K\]_XGU;1YK(6ZZ?'"ZR>9N,HDW'.,<?=Z<T 3_VW+_T!-3_
M .^(_P#XNC^VY?\ H":G_P!\1_\ Q=-OM<*:O'HVGP"ZOVC\V4,VV.WCS@,Y
MP>2>B@9/L.:U(A((U$K*SX^8HN ?H,F@#-_MN7_H":G_ -\1_P#Q=']MR_\
M0$U/_OB/_P"+K5HH RO[;E_Z FI_]\1__%T?VW+_ - 34_\ OB/_ .+K5HH
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M&M:@UG>36]I_9M[:+.IC+"2!B 0AR2'&#U&.1TK<H RO[;E_Z FI_P#?$?\
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MM0!6_MN7_H":G_WQ'_\ %T?VW+_T!-3_ .^(_P#XNM6B@#*_MN7_ * FI_\
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M_P#XNC^VY?\ H":G_P!\1_\ Q=:M% &5_;<O_0$U/_OB/_XNC^VY?^@)J?\
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M?VW+_P! 34_^^(__ (NC^VY?^@)J?_?$?_Q=:M% &5_;<O\ T!-3_P"^(_\
MXNC^VY?^@)J?_?$?_P 76K10!A:%<-<ZSK$K6\MN2\(V3 !A^[]B:W:R--_Y
M&#6?]Z'_ -%UKT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5D:C_R,6C_ /;?_P! %:]9&H_\C%H_
M_;?_ - % &L>G-<1JGA:PT#6=)UCPU$+"YFO8H)X(#B.ZA8_/E.F57+9'H:[
M:2-)8VCD4.C@JRD9!!ZBL[2_#ND:+C^SK)(-H*J<EB@/4+DG ]AQ0!'K4K7L
M<FBVDH2>XCVS2C_EWB;@M_O$9"CUYZ U<L%L;6PM[:R>(6\2B"%58$?)QM'J
M1M(_ UEWW@7POJ5[+>7NBV]Q<3-N>23)+'\ZO+H&DI#80K81+'IS;[10.(3@
MC(_,T 5=< UB*;089,),NR]E!_U41ZJ/]MAP/0')[ T-4FU/^TK+^R]!_M/2
MK6(/#Y%W%&AE!(&0QY"@<=LG/515BZ\ ^%+VZENKK0[::>5B\DCY)8GJ2<UN
MVUM#9VL5K;1+%#"@2-%& J@8 'X4 >0^?J5S\(=<B>PDM81?.SRB56+(;G,H
MP.1M'4]",XKL+RWFT/Q=X=&DW=T]M?F2"YMI+AY8V18]RNH8D+C Z8'(%=3:
MZ98V=I):6]K&EO(SL\>,JQ8DMD'U)-1V6C:?ISJ]K;[&1/+0L[-Y:?W5R3M7
M@<# X'I0!3TG4O$%U>F+4_#T6GV^TD3+?K,2>PVA1[\UG:-_R4OQ+_UZV7\I
M*ZNJ$&BZ?;:E-J4,!6[G $LOF,2X'0')Y [>G:@#C=%T1-4UWQE]LN[RUO3>
MJJR07+Q-''Y8\IOE(SP3C.1Q]:Z+P+J%_JO@K2[[4R3=30Y=B,;P"0&_$ '\
M:T+O1=.OK@W%Q;!I6C\IV5F7S$_NM@C<O7@Y')JZB+&BHBA548"@8 'I0 ZB
MBB@ HHHH **** "BBB@ HHHH **** ,KQ#_QY6W_ %_VO_HY*U:RO$/_ !Y6
MW_7_ &O_ *.2M6@#S*:VUNY\3>/#H%\T%XC6A6,*O[X>3RN2,J2,@$=ZOKJ6
MGV/P@N+SPM$]K'# =R9)E@?<!+N[[URQS[ ],5UMGH&F:??S7]K;>7<W'^NE
M\QB9?3=D_-CWZ4L&@Z7;7=U=064<<MX2;C;D+,3U++T/XB@#F[71;2#4['7+
M/6;.UBFMI(PMA:E%NE*%@S?.V2N-P/X=ZH^'8GT_7;#1]=TJ)+N2UECM=4LG
M_=WR *6W_P 0? !R3R2<=>>ITOPCX?T5YWTW2K>V:X4K(4!R5/4#T'L.*FMM
M%T_2E6:SLF9X(RD*>86**<95-[80' X&!P/2@#RZ+1;<_!^U\1P/,NLV9,EK
M="5BZMYY78!G&#G&.Y/K77Z8D/B'Q?XCLM=MHYS:+;QP6\HW+'&R9+*#W+9R
MPYX SQ3_  )X6_L[PS8P:OICP7MM(SM&\X>/?O)5PJL5R 1SC-=%>Z'INH7:
M7EQ;?Z2B&,31NT;E#_"64@E?8\4 ><0BXOO#WA;[=<3RF/Q$;2*<RL&E@7S0
M"2#U^4#/7CK6K;Z;%9ZUXRT?3;D:7;S6=N\;*3LAED5U+CTS@9Q7877A_2KV
M*UBGLD,=F0UNBDHL1' *@$8([&FR^&M'GN+NXELEDEO4\NX9G8^:O]T\\CT'
M:@#F?#[ ZI?Z/J^AQZ7JAL 7:R;%O=1!B-ZD8*G+8P><&L.WB%U\// ,4K/B
M75H0Q5RK'*S9Y'(^HKT>'1-/@64)"Y,L8B=WE=GV#.%#$D@<G@''-0CPSHHT
MJ/2O[/C-G$XDBB))$3#H4.<J>O3'4^M '-:;HEKI'Q#O=)TQ'BTN\TKS[JW2
M1MB2^9M5AS\I9=W3K@UBV[%O@=HS,Q)-S;DDGK_I0KTBWTFRM8)HH8F43_ZU
MS(QDDXQ\SD[CQQR:J?\ "*Z)_94>E?8%^PQ/O2WWML5LYR!GUY^O- &1>0QC
MXK:>W)\[2IPZEB0<.G;IWK)\+^&-*U?PSK^GM:P0O+J=Y"DL<85X@'^7:1R
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M<+N\N1,%21W'^-:>HZ99ZO9M9W\/GV[_ 'XRQ"M]0#R/K3A8P+9K:+YJQ*,
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MKP/3KVP0"KX"DGE\!Z(]QDR&RCY/4C''Z8KH*C@@BMK>.W@01Q1($1!T50,
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M!)_PK5HH RO["'_04U/_ ,"3_A1_80_Z"FI_^!)_PK5HH RO["'_ $%-3_\
M D_X4?V$/^@IJ?\ X$G_  K5HH RO["'_04U/_P)/^%']A#_ *"FI_\ @2?\
M*U:* ,K^PA_T%-3_ / D_P"%']A#_H*:G_X$G_"M6B@#*_L(?]!34_\ P)/^
M%']A#_H*:G_X$G_"M6B@#*_L(?\ 04U/_P "3_A1_80_Z"FI_P#@2?\ "M6B
M@#*_L(?]!34__ D_X4?V$/\ H*:G_P"!)_PK5HH QYO#<-PH6;4=1=597 -R
M>&4@@_@0#3_["'_04U/_ ,"3_A6K10!E?V$/^@IJ?_@2?\*/["'_ $%-3_\
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MI_\ @2?\*/["'_04U/\ \"3_ (5JT4 97]A#_H*:G_X$G_"C^PA_T%-3_P#
MD_X5JT4 97]A#_H*:G_X$G_"C^PA_P!!34__  )/^%:M% &5_80_Z"FI_P#@
M2?\ "C^PA_T%-3_\"3_A6K10!E?V$/\ H*:G_P"!)_PH_L(?]!34_P#P)/\
MA6K10!E?V$/^@IJ?_@2?\*/["'_04U/_ ,"3_A6K10!E?V$/^@IJ?_@2?\*/
M["'_ $%-3_\  D_X5JT4 4=.TJ'39)Y(YIYI+@@R/-)O)P,#]*O444 %%%%
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MPN(KZWC\H7%O.T3NG=6*XR.3^=/\.^$](\*Q3QZ3#)$MP^^0-,S GU )P/P
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!Y1GR1MZ[NH(SC&>],NO&FFVVJ76FBWU"XNK3R_-C@M'<@.<!AQRH[GISWH
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M</\  ^QO&N[G[0DZ?O1.P9\W6T[CGYN">N:]1DC66-HV+ ,,$JQ4_@1R/PH
M?17G/@SQG8Z1X.TQ-5:_97FECDOGA=XD8S/M#R'OT]?>NQU+7[;3C< 6]S=&
MUC$MP+= WDH<D$Y(R< G R<=J -6BJ]C?6VI6,%]9RB:WN$$D;KT93TJQ0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5C^+A))X1U:"&&6::>SFBCCBC+LS,A & /4]:V**
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MG&[&!T]?KCH/$BZGK_AQ;^QT:0&UO(;J.QND"272H?F#*>F0> >?E]Q7:44
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M8'@[B!WZ5G6&E:OX&GT"]DL+K4[>+2S87B6:&62!R_F!@HY89^7CL/I7I-%
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MF8QDJLAE5]I(XZ#KT]ZJ/HMS#X]EM;<I_96HA-1NX\\I-$0!@?[;>63Z^6U
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M&HC-H=@_>_N1'@<\?-ZXXYKN** . @LM3LH_ MRVDW<ATNV>VNHHU4O&Y@5
M>N,;E/.<5K:!!>0^,?$MS-8SPP7LD#V\K@;7V1!&[Y'([BNIHH \S>S\17]M
MHEU?Z%>RZI8ZNDUY(TD>TH-XQ$-V G*^G3G)YK5TY]<\,:YJ]F-"N=2M=2O&
MO+6XMW0*C.!N20L1M (ZX/':NWI"0.IQ0!RDMOJ-K\1;/49+*6XAFTG[(\T"
MC8DOFAB6R>%QD_IR:U/%%K!>Z.;2ZTIM3M9I%2>!/O!/[XY'*G!XY].:V**
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MO-9BFTYY&&Y/:GRV^LZ/>Z!K]KI5Q>I#IGV"^LX]HFC'RG<H)PWS+@\UWM%
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M **** "BL&P\22ZE-:2VFERS:9>/(B7B.#M*DC<R=E8J<')[9 S6]0 4444
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M"2?F;.>N3G-;@X&,Y]Z .$TK5KF#Q)9Z?K[7]E?O<2M#.)F>SU!"'VJO.U2
M5(& ?E'<UBO'=V_A7Q?J]IJ=Y:SV&M7<L*P2;4W!P3N'\0/3!X]J[RW\+VD
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MC&2PQS[UG2>%;%[S3;M)[J.32P_V?;(#RXPY;()8MW)/OUK:8$J0"5)'4=J
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M.>>M %6RL-?M?$5M/]K0Z9+$R7,,]VTS-)C*O'E!@\'(! QT'%5?B':I<1Z
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MABNQK-T'0[;P[I<6F64LS6T.1$LK!B@))(!P#U/>M*@ HHHH **** "BBB@
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MF_>/_$O(_ CWH [>BO-]&U_4[KPYX3LYKAII-1FN(III;AHFE$1<*ID4$@G
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M8BZD8G[.&78<-SZ\GDC% 'IB-O16QC< <4R"YAN?,\F19/*<QOCLPZC\,UR
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M&F6Y::XAE97F\O!2,N,'(#9.,$[1GJ<U_&>C_8?"LMO-JES>A=6MY(5DF;=
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M![F@#:HKD?%UWJ-AJ4-Y]CN[_2([=A<Q6$[)/ Q/$NU2"XP".O&":J6E_O\
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MI!8$%3GG&WISS)+J,NL^)$TBVE6XM%TJ*ZBQ>R6QGWLP\P% 20 %[C&[N<8
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M'5[>S3O<75M*972=XRQ^S%B1M(P2>I&,].E>D 8&/2@!:*** "BBB@ HHHH
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M01M.#C)..,L2<9]:J:9X&T72+XW-FMTD8D,L=H;ES;QN?XECSC/IZ=L5T5%
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MV2V47BPQ7(N8(Q=R!;=PV[]V,_+R3TYYZU<C\+V45WJ-U'-=++J:*ER?-X8
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MJW"#('F $!L9/]:WJ* , >"]'6PTZS472KIC;K:1;IQ(GR[2-P.<%>,>E;P
M50H& . *6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y/XH?\DYU?_KFG_HQ:ZRJ&
MM:+8^(--DTW48WDM92"Z+(R;L'(R5(/4"@#G#$VB_$:PBBO;IX;^PG>Y6>X9
MU9D*$/@G"GDCY0!CM61#=SPW/A:]L[R[N8KS4&ADOII2IO497/\ JLD!.!MS
M@C P.]=K+X=T^?4[;4I1/)<VL9BB=IW("G[P(S@YP,YK/B\ ^'H8+>!;:X\N
MUG\ZW4W<I$)YX3YOE7DY X/?- &2UU)X9\6ZK8RRSW$>JVRSZ8DT[L!*#L:%
M<GC+,AXZ ^U33+-#XCT_PK]H::&/3#/_ *1<2*;F3>%)+#EB "<9Q\V>PQU%
MWI=E>WEG=W$"O-8NTENQ_@)4J?T/Z#TJIKWAC2O$:P'4(7,MLQ:">*1HY(B>
MN&4@\T ,\+V-[IFFRV-]J0OWAN&"-N+-$APRHS'EB >I[$5SL6APZ[XW\607
M%W>P(!9X^RW#1'=Y1PV5Y..P/'L:[+3M.M=*LDM+.,I$F3RQ9F)Y)+'))/J:
MIW'AO3[C49[\&Y@GND5+@P7#QB90,#< >H'&1@^] '$Z'KNJ:E:>&M,O[D2F
MZ6\#2R2-']K,+A4R5Y/RDDCO@5=OFU/PQIRV,VK++%>ZO%$F97W6D,F3L,A^
M;!*X!Z@-]*Z?5/"FBZQI=OIMU9*MO:D&W\EC&T!' *%<$4?\(IHS:%+HLMH9
M[.<YF$TC.\C<?,7)W%N!SGC QTH YW5M)U'2=.\0W U5H+>72Y9H;2&XD+12
MQKGS$8G('(R!QG%5K:.;3]0\$WT=]>O+J,?E70EN&9)5\@L/D)VC! Z >^:Z
M6T\&Z/9Z7=:<B7$D5W'Y4S2W+O(T>"-FXG(7!/ QUJ4^%-*9=-4K<XTO_CT_
MTF3]WQCUYXXYSQQ0!G_$J!)_A[K'F G9;EQAB.1TSCK]#56^E:VU3P_H$#E;
M>\MYIBLUQ(/.= F$W9)QAF..G KJ[^QMM3L)[&\B$MO<(8Y$)(W*>O2LJ]\&
MZ)J&D0:9=02R16S!X96G<S(PZ,)"=V>W7L/04 <KK.GZIHVFP6[ZY.<ZY;>2
MD,[EH(I) /+8L?G'&1N!JS<74WA7Q-KZV<US<01Z%_:(@N)WF'G*T@R"Q) (
M49Q70OX.T:338=/>*<PPSBX#?:9-[2CH[/G<Q&!U/8>E61X=T[^V&U9DE>[>
M#[.S/,S*T?/RE2<$9)/2@#B=6M(IO#W@W5FN9[BZN-4L))9FF8B4NP8Y7.,9
MZ #CH*O^7?>+)_$-O%=BWN;.\:VMW%Q(C6H"J4<*O!R<G)Z\CH*U4^'_ (?2
M"*W$=W]F@G%Q#!]ME\N%P<C8-WR\G/%3:AX(T+4]5_M.>WF2Y90DK0W#Q^>H
MZ!PI&[\: ,!["?5?&EMIUYK%Y)#/X?\ -F:UN7C223S$&]0#\N>#Q^.1G+T@
MO?$T_B"PCO##/83_ &6V<W,BR6P$:E) %ZDL6.3UZ=!74?\ "/:=_;<>LJDJ
M7<4/D(4F95$><[-@.W&>>E5=3\%Z'JVK?VI<02I=%0DCP3O%YRCH'VD;A0!D
M:;<S:OXJ_L74[W[3'8Z5#+F%C&MU(Y(:7@\C@8'0%B?3$_PYA%OI.J0!W<1:
MS=IND8LS8DQDD]3[UK:AX5TK4;RUO&BEM[FT3RHIK29H6$?]S*D97VJ;1M!T
M_08[B/3XY(UN)FFD#S,^78Y)^8G'X4 <[KNG6\_Q+T$R>=^]M;LMMG=?NB/&
M,'C\,9[U%IN_Q38^([FZN[B"ZM;^>VMS%,R?91&!L( (Y_B)/7.#QQ7376@6
M%YK-OJ\HF^V6RLD+K.ZA >HV@XY[\5%<>%],GO;JZ"S0M>J%NUAF9%N !CY@
M#UQQD8.* .,M;N^\13^"9KV\O+<ZG9W/VM()VC$NV,8; .%)R3D8//TKT"WM
MXM+TI(!<2>5;0[?.G?>P '5F/6JMQX<TRYO["]:*1)M.4K:^5,T:Q @ @*I
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MY@5K2:(Q-$.!MQC QTQVQTI+[2;#4=*DTN[M8Y;*1!&T)&!M'3&.F,#&.F*
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M\56VK:A+J0-HLB27+,EPDA53&4Z=^N,]R2>:M^,+N4:7XFU#3KVZGGL9$VW
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MXL8W8(S)_=!PWT/2K.IVYT3QIH$6EF2.WU/SH+NW61MKJJ;A)UX8'^+J<]:
M.RK*U76#97]AIEO&DEYJ!D\H2,5151=S,< GN!CWKSJ>V>/X=ZGK(OKXWVG:
MG*;65KJ0^7MN-N,9PV1D'=D_I72^)--M+CXD>&/-C+>=#>[\.PSM2/'0\?A0
M!U&DW%_<Z>DFIV*V5UEE>)91(O!(!##L1@\\\\U=KB-*B3Q5_P ),=1EE2XM
M=1FM+=ED9#:QHHV,F#P2<MGO]!6+8W-[XB/@.;4KF[CDU"&Z6Z6*=XQ*%B.&
MP" "1SD8/S4 >HT5P<6B6\7Q#&B_:;Y[!="#>2]Y*03YVWKNR. .F.E8$\,D
M7PQU/5!>WK7FCWLL=E*UR^8E2?"C&<'CCG)QQV& #U&22]&I0QQV\;6;1L99
MC)AE<8V@+CD'GG/:K5<GJ =?BAI2"><1S:=<%X_.;9D% "%S@'D\BN1N;1O^
M$(\4ZE]NOS=Z7JUU]CD-W(3%LD 7O\W''S9H ]:HKD=3DED\86*ZA%)<:5+I
MCE88HVDVS[URS(H)QM( ;& 2>A-6_ VGZA8>'4&J/=-=22.V+FX>5UCW'8#N
M)"G;C(&/?F@#HZ*X'Q=+=6&HZA>7]E)?Z+)$D;7%I)^_TQ@O)VYZ'<&)'..N
M1BK]BZ3_ !(U"%)&>TN-(AF$>X[&+.X+ =L@"@#KZ*\IMWN;CP/X3?\ M"\2
M277C;M(EPV60SS#!R<'&U<9!QBM*?3GT/Q7JFE6%W>C3[S1)+MXVNI&:&96P
M'5RVX9^O/X4 >B5B:;KL][XHU;1I;1(ET^.%TE64L91)N/(P,?=Z<_6N&:QG
ML/!GACQ/97]Z^JYLT??<NRSI)M4QE,[<<]AGC)R>:Z;2XUF^(WBB-BP5[.S!
M*,5/23H1R/PH Z33I+V:QC?4;>.VN26WQ12>8HY.,-@9XP>G>K5>8:/JMW%X
M%\+6\EXP34-2F@N+B=V.X;YBJLV0?F95'7D9'>MJ70-5T^WUNWLM:MX7OHXV
MM;3YU2W?(4X.XE0YXXQSTH [6BN1\'ZA%-JVHVD^ESZ/J<<41GLF;=%@%\21
M$<$')!QCI3K^Y-_\1K?0KS)L4TMKI8B<+-*9-O/][:O('OGL* .LHKRK6YKV
MV\-^,],2\NOL^E74!LIA.X9!)L9H]V<LJ[L8.>#]*]&TS1[;23<&W>X=KF3S
M)#-.TF6Q@D9/&<=!Q0!?HKAK'1X=4\>>)(+JZOFAM7LIH8Q=R (VUF]>F1TZ
M<GCIBCIUO?>*/#:ZXFKP6%[%<O+)=8<O 4<YB8;@-NT8VXQCGJ<T >CT5B'5
MM8?5S8MX:N19F0I]N%U$%V_WMH;=^F:X6+2/MW@C7]4?5-16]TR\O7M)OMDG
M[KRV) Z_-G&"6R<4 >JT5P-K?7GB+6X--U P(QT6WNA;3A@'=\^8P"D<J0H'
MISC&:K7FF7=G)X4TRZUVZO7%_+;S3Q3/'O0(YVM\QR1]W=U]P: .SU?6!IUS
M8644:R7>HS-% KMA1M0NS$^@"_B2/K4VDW&HW-F6U2Q2SN5D9"D<HD1P#PZG
MK@CG! (KC]:\/:=9>*?!UE&DS1>=<I^\G=F($+,!N)SU-6M)BB\3:QXDM=2,
MF;&Y6UMXUD93!'L!5UP>&8DG=UX'84 =I17EMO>:CK'AWP9<WU[=">;5&M99
M(IF3SXU\T!B <9(0<]>X(K6FT2WL?'6C:1!<WXLGT^Y+Q->RL#AU/4MD?>/3
M!Q@=* .\HKRU=.63P=XP+7=Z?[%O+L:?_I4@^SA(U=<8/.">^>/QST$CQZQJ
M.G6\KR7UU)I*RR6;/Y<";R/WS$<[L@A< D<].M '945Y99W-YJ/A'P'<3W]Y
MYUQ?+#,ZW# R+B3KSR?E'/7WJQ=WMUX6;QS%I4LWEV=M;3VZ22-+Y+R*P=AN
M)/8-^% 'I=%<Y#I5A:75EK&G7T^'MF18A*76^RNY6;.<L "=W7FN>T6TO-?\
M/Z/XCCUJ"VN1(D]Q<J'+2'.'A8;L8R=H&.,# H ]$HKG/'^JW>B^"M0O[)BD
MR*BB11DQAG52P]P"36=K,']@:]X;N-&>0+>W?V2YB$C,MQ&4+;VR3EEVYW=>
M>30!J7VOW[W^H6.B:?%>W&F)$\T<LWE^87!(13@C.T9R>.1^&\A+(I92I(R5
M/;VKC/#.FVD?Q"\5.D9!@DM?+^=CC=#SWYZ]ZL>/4D)\/F*YN("^LV\3&&5E
MW*V[((!P>@ZB@#K:*\ZNKFX\*ZEXO32GF9(-+BO(HI96E"2G>"PW$GL"?7%2
MZHITO0_#FN:3/*UW-<VJ2OYA;[:DN P?GYB<Y![8XQ0!Z!17G$NEI?W'CB.X
MN[YDLV5[<?:Y!Y3>0'!'S9.#T!R!Z5;L-5DU.[\(Z=J<S-#?Z-]J<%B/M,X2
M/AO4 %VQZX]!0!WE%<'JP.@#2]$@U*YEL[_6A%.SR'= C+O6 -U /'?.#CO4
M\L#Z=X[?2+*2:/3M0TN2>6".5E$$B, '0@Y3.<'&,GF@#M:QM2UJXCU<:-ID
M$4U^;1KO$[E$"A@H&0"<DD_3!^E<%I\4D'A+P5K:WEVU_-J%M!)(]PY#1R.5
M92N=N"/;/O71'3;1_BXY:,Y_L=9O]8WW_///7].E '66$UQ<6$$UW:FTN'0-
M) 7#^6V.5W#@X]:L5YM;2R:W\,]0\337,T&LQ"ZN!,LA#6[Q,VV,>B[54%>A
MR2<DU*ML_B+QAIL6I37D27_ASS[FWBN9$42%X\X /R]>V,XYSSD ]$HK@K+1
M8+[Q1XKTVYN;Z2UABM?+C:\D.TF-N<[L]><9QGM63;F8>#O"'B%KR[DU*2]M
M(GF:X<[XV?8R%<XP1UXR>I.: /24DO3J<D36\8LA$I2829=GR<J5QP ,<YJU
M7(6T;-\3=5M6N+DPR:5$^SSWPA,C E>?EZ#IBN5L(9(O /AO7OMMX^H+J$2>
M:]RY!1IRK*5S@@@\Y&3ZT >LT5Q.J">;Q+KMOJ$5S<P-I\1TX6R._DMAPWW?
MN.6 PQQP.#P:WO"EE>Z?X:L8-3DEDOO)4W+2SM*?,P,_,Q/Y#CTH V**\^U.
MYGTK79)];M))]-GU&-[;5[20DVQ#J!#(O4)N7:<<'/3)IRVMWXOD\0P_;XK:
MZM+Y[>&0[_,M%4#8R888!Y;/?D'@< '?T5Y\=,&L>.8]/O=2N[BWF\/)+*8;
MB2-)7\T#>H!^4' .!QZYJ::8>$?&5W$WF3VVL68:QCEE9O\ 2$X,2Y)QOW*?
MKF@#L;N2]CEM1:6\<T;RXN&>3:8TP?F P<G../>K5<1KE@VCW/@^WBNK@LNH
MK#,?.?;-F-R2RYP>1GGITI;*"/Q=)XE@OKN:"ZM+]K:!HI"KVD:JNQT'8D[F
MSWZ=!0!VU%<3)*^M^*I]%DNH9H(=-@E@6XW?OPY8/* I'/"C/;MC)JM<6.NZ
M9IFE1K-'XI73Q.EW;,^R2==P"N,DAFCP5Y]?6@#OZ*QO"=Y97_AJTN-/:=K=
M@P47.?,0AB"K9YR""/PKC/$MR5TO5=5TZ>>XEMM7C7[=)*4,)\V-##$!U09(
M.< Y/WJ /1?MEO\ ;OL/F W'E>:8QU"9QD_C_(U/7&V^GVI^+=])Y7S_ -EP
MRYW'EO,<9Z^@ _"IOB3YB^%A+#<3P2)=VX#0RE>&E53D#@C!Z'(H ZRBN'1&
MT'XA7<%@US+%-H;W;P23O())DE #?,3@D''%94\TK_"F#Q=;7<O]LHBW7VH.
M27<N T9'0IR5V]!Q0!Z;573I+V6S5]0MX[>X+,&CBDWJ!N.TYP.HP?QJ4 SV
MP$JLAD3Y@K%2N1S@CD'W%>7Q/</\*M+F^W7@G75PGG"X;<P-VR_-S\W'][-
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M/9S"" -O\RV0QJ5D3:PP2Q8Y[XQT%==I"RC1K1)[P7L@A57N5&T3$#&_\>M
M#[*2]D^T?;;>.#;.RP^7)OWQ\;6/ P3SQV]:M5Y;=&=/A[XVQ>7>^UU6Y$,G
MVE]ZA=@ W9R1CC!K<^R#2?'OA\VUQ<G^T[.Y%V)9V<2E%C*G!. 06/0#TZ4
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M9 T-M=W/GR0C !RV3C)YP"0/7FMRB@#*NO#>F7EQ=331S'[8 +E!<2".8
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M\C(.#TK0HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445FZWXA
MTCPY:K=:O?1VD3MM4ODEC[ 9)_"@#2HJKIVI66KV,=]I]S'<VTHRDD9R#_\
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MJ5\KRRG35W7%N('65"1E<H0" ?4C&.<UHZ3J"ZIID%XJNAD12P:-DP2 3@,
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M@M&6.R'[P8.%R6)([\Y. *ZFSO+=OBKJ \U1NTR&,9. 7$CDK]0&''6NPHH
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M7EI<7LQ,K->1Q-D@"3D[1CD<'IVK1?7-.U?XC>'[O3YFN86LKE/,CB<@$E,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "H+JSM;^ P7EM#<Q$Y,<R!U/X&IZ* &111P1+%#&L<:#"H@P%'H!3Z*
M* "L7Q!X9A\1/8O/?WEM]@N%N81;^7@2KG:QW(V<9Z=*VJ* ,*7PI;7FI6E]
MJ=]>:B]B_F6\=P8UCC?^_M1%R1V)SBH+SP5;3ZY-JUIJFI:;)=!1=QV<P1+C
M P"00<''&1@_CS5[2->35M0U.R6TFMWTV98G\TK\Q*[@1@GC!%:U &)>>%[>
MZU32[]+V[MFTI66VBA\O8H9=IR&0D\#'6D?PQ$FJWFH6%_=6#WZ@720;"LC
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M\:Z<S&%V,9)#9RK?)@KSZ9Z<\5T-% %#2=(M]'AG2 L[W,[W$\CXS)(W4\
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MGO+H:RNVZ\Z;.?EVY& ,' _#M@<4VV\%6<-]IE[+J6IW5QI@=87FG!RK #!
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M-+<,N%6WW[%;!V9.!P.F<8/(Z:W\+P0:5=6+ZCJ%P]Y'Y<UW/,'F9<$;02,
M<GH.Y/4YJ"Y\%:;>>'+70[B>[>&RV&TG$@6:W*#"E64#D#CD&@#'U"\\0>%=
M,U.2ZOH&MY[FWCL2T[3R6BR,$<NS*-P&25SGT.:U[K1KFVEO776KK[#/9,GV
M9Y6,@E'/F)(3E?ER"HX[C%3)X0TY]%NM+OYKO4DO%"SS7DV^1P/N\C&,'D8
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ[0P%:&I^)[?3KB]@2SNKM["V%S=>2%Q'&=V/O,,G"L<#TKD)M(U:3X6:GI
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MJ%'7N5Z''6L[3?#,\=Y):Z,NH:;I%_93I>V5UGR[:5@ OE9[Y+9VDK@=>@H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN3<S0B!HR5\O8"2 !MSP23UK5HH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME:SI%@+,2QZG.T/G>9CRR%+?=QST]JV: "BBB@ HHHH **** "BBB@ HHHH
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M]E<ZFIM-8M9-WDG> L,J]0H(V^GMGFNCM_!/AVUUA]6@TY4N7D\TXD?R]_\
M?V9V[O?'O5E?#6E+,TGDRL&N#=&)YY&C\TMNW["=N=W/3&>>M "^)KF&S\-:
MC/<7TEA$L#;KF(9>+(P"H]<GCWKF=+BFM_'\5CY$EE:W.B,[P+<$LS+(@#OM
MX$F&()!/UKLK^PM=4L)K&^A6>VG0I)&W1A67;^#M!M;FWN8K-Q/;1F*.9KB1
MG"G'!8MDXP,9SC'&* ."M;=XOAQI.O"]O&U"WU(+'*]RY^4W90J1G!!!.<@D
MUU=C*/$?BSQ#97LLRQ:8888(8YFCV;DW&3Y2/F)Z'L%XZG.B/!F@C1UT@6DO
MV%9?-6'[5+@-G=D?-GKS]>:?=>%-*NM434]MS#=B,1/+!<R1F9!T5R#\WU/-
M &;\+QCX=:4,DX63D_\ 75ZKZUX6DU+6KK7?"VKMIFM0L(;G(W0W!"@A9%_W
M2O/IVKI-$T.P\/::FG:;&\=O&255Y6?!)R<9)QR2<#BH9/#6FO>W-Z@N8+B[
M8-/);W4D1DPH49"L!P /I0!RIDU'QOX#NV:V^PZYIMS)'L@<A&GB.648/*MT
M(.>3[9K3T2\L_&=S#JT D2UM[,1;4D9")GP74E2.4  !_P!LUJ76_P -Z9;V
M^AZ$]ZAEVF&&54*9R2[,YYYZGKSFI=%TA=-T86;JJR2L\MP8"4!D=BS[2,$#
M)('L!0!Q?A;2EF^&ZZW)?:@VH?V?<*)Q>2 @!F(P <9!4'/7KFB3SKK2/AZ[
MWEVK77E),R7#KY@-N2<\]<_Q=?0UV=IX:TNPT231;2&6&QD5E,0GD. W4 DD
MJ#D],=340\):.+;3[<PS&/3,?9/]*E!BP,#!#<\<<]N* .;L8KS3[SQQI6CW
M#Q?9H8I;(3S%A#))"Q)#.3@;@#R<"C3M/GU#4_#-S90ZC:P1VK/JA9Y8/-;8
M-FXY'F-OR<\@C.>"*VM=\.(FG:S=:/8B?4]2@\J9)KE]LZXVX(8E00I..,#Z
M9K%TGPU +JV?2]$US19()$9I+G4"8@JD%DV>:^[(!&,8YZB@"."TNO%UCJ\W
M]J16-[:ZC-$MQA_,LA&_R@8< #: 3Q@Y.<TS7;JYTV\N[_6+9M0T>8Q%=2LV
M(ET\A5!!3.0A;YCCLQ!SP*Z>[\$^';W6&U:?3E:[?'F$2.JRXZ;T!VM^(-69
M_#6EW,]S++#*PNW5[B(SR>7*R@ %DSMZ*!TYQSF@"SJUQ%;:->7$UT;6*.W=
MFN%&3$ I^8#N1UKB=.$MKXL\-1P)-!;7^GSB1GG)EN@JH5DE X#\YSDGGJ.E
M=[<VT-Y:RVMS&LL$R&.1&'#*1@@_A6-;>"?#UJ]G)%8MYECG[.[7$C,@(QC)
M;)'' / [8H Y'2K9[3PQKOB!;B\N-0TFZU#[(9+F1U4+N !4G#>OS9/'7@5L
MZ9I$DD^B:]::U#'$R 2E%=C?JZ\!R7.6SSG&1S71:9H.FZ/%<16,#I'<N9)4
M>9Y S'[QPQ/7OZU3TCP7X?T*]:[TW3Q#*22H\QV6//78I)"Y]@/2@#/^)/F+
MX5$L-S/;R)=VX#PRE>&E53D#@C!Z'(JDVEG0/B'I=OI]S>-:ZQ;7(O8I+F23
ME I$@))*L2P&1CVK1^(=C=:GX8^PV=E+=R2W,+,D?9%D5F))(["MBSTBR@E:
M[1)VGEB$?FSS.\BIUV@L<K^&.>M 'GNF)+IWPZOO$\,]Y/J=E]L2!Y+AW"KY
MK+DJ3AL?>R03Q[#&OJ\0T>U\,ZMHTTIGN+VW@F/F%OMD<H^8OD_,?X@QZ5U>
MF:!IFCV4ME96Y6VE+%XI)7D4EOO<.3UR<^N:BL/#.DZ:T!MH)-ML2;>.2=Y$
M@R,'8K$A>"1QT!('% ',/*?#'BW5=/P9(]9MEETU96+*)<[&B&>@RRM@= 3Z
M59U2T;1_$'@VSM;NZ$0FEAD4S-MFQ"QW.,X)SSGWKJKG3K2[N[2[G@62>S=G
M@<]4+*5./P-07^AV.IW]G?7*RF>Q8M;LDK*$)&"< X.1QS0!R D_X2;0?%UY
M>33B6TGNK6!$F9! L:8& #C)Y)SUSCH,5'I=S)>'PMH4DD*V\GA^.=(IP2D\
MFU!C (R57)Q[DXX!'377@S1KJ_N[PI<0O?)LND@N7C2?C&64'!./_KT77@GP
M_>Z39Z9<6326]CC[,3/)YD.!CY7W;@.!QG' ]* .<;[;H4VC^&9M9>Y@OM4E
M1Y4+(\,0C\Q;?<6+<D@9SG!Q5_1;*&P^)^L10%]C:;;N%=RVWYWX&>@[X]S6
MQ=>$=$N]%BTA[/;:PN)8MDC*\<@.=X?.[=DGG.3FG:?X7TW3=4;5(?M4EX\(
MA>::ZDD+J,GG)P>O?IVQ0!5\2-!+J^D63O+--*TKI8 @1W "8+2D_P *Y![Y
M)'!Q7-:4-:N_"5W;63Q37%GKD\<=I/.=L\4;D^0'/.,9QGC"X/&:[75?#^F:
MU-:S7]NSRVC%H)$E>-DSP<%2#@XY'0U6C\':# CI;V1MP]S]J/DS2(5EP1N7
M##;U/ P.>E %7P7?VE[:WZP6=S83Q76+FQN.MN^Q?E7ML(&1CCGM5=I(=:\=
M:IHNI$F&UL87MH-Q ?>6\R3'<@[ #V[=371V.G6NG"7[-&0T[^9*[L6>1L 9
M+'D\ #V  JCK7A31=?N(+G4;0O/;@B.:.5XG /5=R$$CV]Z .>W&'Q#X>\,3
MZA/?6/V:X9Y9VRUU)&=H1R/O;1NX[X&<XK,U8W5G;>.-(@N;E;&QLTNK0I,Z
MFW=D8E P.=N5SMZ#-=S=>'=*O+2UM9+0(ED0UL86,;0$# VLI!''Y]Z23PYI
M4NFW.GRV[O!>'-QF9]\QQCYGSN/  Z] !TH Y*ZTY8-?\)-%=WB-J4<D-XPN
M7S,H@W@=?EY'\.,9XQ5*]1M/TKQ_IMK<W45OIZQS6H6X?=$S0!V ;.<9[9Q7
M<OX:TJ26PE>&4OIH(M6^TRYCR,'^+GCCG/'%9'BGPW GA_7Y=*LIYM2U:W,3
MA9G;S6QM4D,VT8'?C XH Q[O3I-$U'PIJ^GWEX]S?W,5K>))<,ZSQO&6)*DX
M&W;D8  J.XU*XTBT\?7UJY26.^B <#)0&.-2P^@)/X5UNA:):6]I87+P3BXM
MX B+<2NY@X 8*&)"],9';CI4UMX<TRUEU!TA=_[2)-VLLC2+*2,<JQ(Z<<=J
M ,>V\/;-9M+Y-3@6RNX&AEM80Y6]!4LK9+GY@ 3NZD9YKF-$G72/AGX>:!Q:
MKJ-^EO=3%F 5-\G4@C ) 4D$<$UW6B>$-#\.RM+I=D878%06E>38I.2J[B=H
MSV%$?@_P_%I=UI:Z:ALKLDRPL[,O4GC)^49)("XP3D4 5]%T6?1]?NI/[1B^
MS7<(9=/C1@D;*0#(N6.,Y ( &:Z$@$8(R#6##X.T6QT2\TRTL"T5W'Y<JR7$
MFZ1>@4N26 &3TZ<\5I:/IXTG1[33Q(9!;1+&&))Z#WR<>F>U ' LS+X&\=#S
M9 ;34;O[.?,.8MJ(5VG/ &>,>M7IK;[;XR\/037-WY-SI$C31K<NJN1Y?8'C
MKSC&>];]WX*T"^N;V>XLF8WXQ<H)G"2'&-VP';NQ_%C/O5A/#&D17EI>1V\B
M3647E0,MQ(-B=UQNP1]: .#CU.ZTKPY<Z=%<SI:+XI_LTRF5B\%J7!(#DY'!
M*YSD9KH+RW.D>/M'LM.,D=EJUO<K=V\;L%7RU!61<'Y6RVTD8SD5M1^%-$CL
M[ZS^Q&2WU&0R74<LSR"1SU;YB<'@<C!X'I4UKI%CI3-=11SRS+%Y8DEE>:0(
M.=H+$D#V'7 S0!YE'I\O_"IH_$T>IWXU>Q:62"=KIV VW##85SA@W?())/7'
M%=*5N/%6NZ]I=S-%#+:I"D,3A]T(>(-YB88<[V//7@#-2>!/#*P^%K2#6+&Y
MAN89GE>VFE8Q[O,9D;:&VG VGZC/7FMO5_!^A:[?Q7^H66^ZB78)8Y7C8K_=
M)4C(]C0!S+6,S^*_#5A=ZO<WP>PN4N)8YGC6X*;0#@-P>3D@Y/K5&#4Y]'\.
MZG91W<D5I!XF^P"661F^SVY*$C=G('S$9SD!NM=X_AW2WO[2^^SLD]E'Y=N8
MYG18TX^4*"%QP.,=JB3PIHB6M_:FR,D&I.9+J.69Y%D8]6PQ.#P.1@\#T% '
M-:U%?>#+76=;L[^$*^GEH].CB;8LJL!YPRQQ@,,@#GBFZSIMO;:GX,NH;B>9
MY+Y0\KSLXFS$QWD$XS[^AQTKI=+\(Z%H]E/9VEB/)N4\N432-*73D;<L2=O)
MXZ55A\!:' MH@%ZR6,OFVJ/>RD0G! "_-P.: )?'.J7.C>#=1O[1F2:)% =1
MDH&=5+#W )/X5&=+TO3+I-8M]4EM(6LW5E63?', N_S6SG<P )W=36_<6\-W
M;R6]Q$LL,JE'C<9#*>""*R-)\':#HB3)8V.U9HS$PDE>4!#U0;B=JGT'6@#E
M-->2V\0^#9+7SEM[^*=9+B:4^;?+Y.\/*HXY(##))&>W2I;.YFTSQ%90Z[9N
MPN;YVL=9MI-R7&_?LBE'48#8 Y'RC'3-=%;^!_#EK]D\K3SFR<O;EYY',>1C
M:"6/RX)^7I[5:MO#6E6KQ-'#*5@E,T4<D\CI'(<Y8*Q(!^8_3/% ''6=M=^*
MO#]QJHUB'3[^"\E9[K:YDM/+D/R$;P-NP ;<8(.3D\U)X@N9]*U6\O=9LWO-
M'EGB,>I6CGS-/("C8R=0FX9./[QSG.*Z23P3X=EUIM8;3E^UNP>0B1PDC#HS
M(#M)[Y(]ZLR^&M+GGN)9896%U(LL\1GD\N1AC!*9V_PCMSCG- &K69X@OI['
M29#9@->SD06JGO*W"GZ#[Q]E-3PZ79P:I<:G'$1=W2)'*^]CN5<[1C.!U/04
ME[I%EJ%W:W5RDK2VC%X2L[H$8@@G"D G!(Y[$B@#A;R*?PEXIT+5S8BTL)(U
MTF[;SQ)D'F)VX'(8<L?6M3Q>;^UU7[?_ &=_;&EQVFVXM(9=L]L2S'SD'<D#
M''/R\'K71ZSH>G>(+'[%JD!N+<L&,?F.@)'3.TC-12>&]-EF$Q%T)/(%N66\
ME!>,$D*WS<\L>3SSUH FT*>VNM!L)[.9IK=[:,Q2.,,R[1@GW]:XRRN)=.\0
MV-OK]DS_ &F\D-EK%M)OCNMX?;'*.H^5N!R/E&, 5WUO;PVEM';6\:Q0Q($C
M1!@*H&  *SK;PUI=H\+10RE;>0RPQR3R.D;G.656) /)^F3B@#AYV9?AYXS(
MFD!L]2NQ;MYAS%M(VA3G(QG@5N17$>K^,GT74B7MX=*BG@@9B!*68AW/J1A0
M/3GUK3NO!/A^\GO99[%F^W\W"">0([8P6V [0V/X@,^].U'P;H.JQVB7=D2;
M(;8)(YGC=%]-ZD$CZF@#F]7TU;:;P?IBZI=78AU&6(W3OF4XCDR-V.H^[GJ,
M>M:?A,/9>)_$VD)<7$EI9RV\D"SS-*8_,BW, S$G&1GK6M/X7TF=M/;R'C_L
MPYM%BE9!&<8S@'GCUS45UX4TN7^U9?L\DTNJQA+I7NI%64 8 .#\N!QD#I0!
MN5YU:VMWXKT&[U(:Q#87]O>S%KK:YDL_+E.$QO V[ ,C&"#DY/-=QH^GC2M'
MM-/$AD%M$L88D\X'ODXK.E\$^'9M:;6'TY?M;L'D(D<)(PZ%D!VL?J* .8\9
MQ'1M:74[:XF%M=VYBU9$#,+:)V ^T*,_(V<C\S@[36OJL]O;Z_X:T%7V:7>)
M.V!(2)V15**6SR#N)Y/S$#K6\^A:?(+\/%(XU)=MT&G<AQC&!S\HP<<8JG<>
M#=!NM$AT:>R+V=NP:!6FD+0D=-KEMRX]C0!A:VJ^&+.&QM=4E%O?:Q&DHF<E
M;2.0,WE@@@JA90,9X#=LU)<^']2L!JT=AK=O:MJ%NHM[,*Z1Q2A@NX'<2N[<
M%.W')!'(K?\ ^$7T7^PY-%>P22QEYDCD9F+G^\6)W%N!SG/ ]*AM/!N@V6ES
MZ;!9L(+C;YI:>0NVTY4;RVX 'H >* .:L;F:]@US3(;1_#NO-:Q*8)),P'YF
M"O&R]F+;21@YQU-:7A"_CDUF_L[K29M'U18(C-9[MT+*"X$D1'!!+8/T'4YK
M:?PWI<L-Q'-#)-]J18Y9))W:1E4Y5=Y.0 23P>IS5BSTFSL;B2XB61YY$6-I
MII6D<J,X7+$G')X]\T 7:*** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHKE=8NENO'FEZ%>$?89+.:X\IONW$H90%(_B 4LV.G0]A0!U5%>5
MZE!%;Z+\08+<%8[22-K=58XA/E*?D_NX)/ Z9KH;]E7QWX/9&PT]M=>9M/\
MK (D*Y]<9./J: .SHKS&:2-HM!U;37DDCGU]4&HS2?O[E7D=67 '^K[ $]%'
M JV=&M-3\0^-;>[:XEAB2!XT:X?",82V1SZ\CT[4 =U=W]M9/;I/*$>YE$,2
M]W8@G _ $_A2(]]_:4JR10"Q$2F.0.?,+Y.X$8P!C'>O.VBCU72_AW=7\:W,
MTTB)))*-S./)8D$GKD@'ZUN65I WQ*UFT<&6VETJ M#(Y=.7<$ $X P!P.*
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M09IUN9C;1&Y5%G*#S%0DJ&QR 3U&:\\"J=%^(44<CHEO+,T0BD9/+(@#<8/
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MH_A62WL'B">(O(D@NER\!)E:2(^P;'X 4 >H44V-$BB6.-0J( JJ.@ Z"G4
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M=8&KW&E0R7N03)E@'(Z%E!VMVZ@]*VZ* (YH4N(7ADW;'&UMK%3CZCD5D_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLMM.\B'Y@0,;1SC) R<=>E)'XPU2X^*EQX>CTV0VME9DLJR)EBSQXE.3T /
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M-5O_ !=-X;NM+GL;E;<7$32.K>8G'4+]T\].>AJJ?B+;NT=S;:9/<Z9)J/\
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M'^T+>Z+/']HBP$RYSG=C^,< FO7J* .!AT/66^+0U^32Y(].;3Q;F0S195L
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MY*!/.N'WR/CNS=S0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH5NE=9+>42P31-MDB<=U/].A[UH44 4;#2K?3Y9YU:2:YN=OG7$I!>3:,*.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-<%D90Q0D8##
M&1[\TZD9@JECG &>!D_E0!RW@6:YNK#68KV[FO#!J]U;K).V6**P4#C@<=@
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M;.ZA&M6<2VUSY?[I2(&0Y<< AB..OX<T ;R^*]--Y9V[K<1+?Y^QSR1$1W!
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MDE(MIX@IA E?H  3NR&YSUXH F\#7ER^EZLU]>S71M=5NHA+,V6V(V![#@=
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M?3[IA_!$XW+(?]QES[YQWJOX7T"\TC7;S3&B8:/83-=:>S$G+3+RH_W/WO\
MW\% &E%XUTJ>_DLH(K^66*Y%M+LLY"(F(R"W'RCW/7M67<>*[#1_!NJZSH\=
M[=B.[E0B?=E)BP!R'Y5 Q''X8JSX2\V+7O$S36EW"L]\)HGEMG19$$:KE21@
M\@\=:YV73=1O/AUXJM(=.O!<SZG/<0PO;NC2(9E<%00,Y / H ZJ_P#%<EKX
M@TC3%TR[Q?B9V9HQD!%Z 9ZY*D^WUXMZEXIT_2TGFG6X>VM7"7-Q%'NC@)Q]
M[N<9&< XSSBL;69KF?Q1X6UN+2[][:);N.11;GS(S(J!-R]5!VGDXQWQ67;0
MKI>JZMI.L^$[K5/M=[+<6ES%:B6*9)&W!'8\*03CYN,?J =5=>+]+MM4?3 M
MU/=K;?:5C@MG<R(3@%<#YOJ..#S5[1]7L]=TN'4;%V:"7.-ZE64@D$$'H001
M7.012VWQ)CF:QGCMH]#6V\R&VD,*R"3=L5@N/N]/RZ\58^'R30>'YH+BUN+:
M07MP^R>!HR5:1F4C<!G@B@"W=>,-,M=1O-.$5[/=V<:R20P6CLQ!SRHQR..O
M3ISDU8C\3:7-I-EJ<$S31:@0MJB*2\K'/RA?48.<\#!S@"LBS,D'Q(UBZDM+
ML6\EC B3"UD*.R%RP!"X/4?7M7,Z'I^J6&B>#]3;3KW&C3W,=[:FW<2JLNX!
MPA&6V@@_+GJ?>@#MW\5V2V6IRI!<&ZTM-]Q9,@651C(/7!!'\0)%9C>(K'4/
M">BW^LI>VIOGM2OD*ZAI6VL/F7HA)[D9J&YTJYUCQ#K6LVL$J02Z(=/A$L9C
M,\I+,3M;!P,J,D=SZ5G70NY_AOX>M!I.HBXM)K%)8C:/O'E%-[;0,X&#R>O;
M- &OXBUK_BK=+T-UO1:S13R7'V>.4-(0J[0&3D@;B3@]0,U/X9?2M/O-7M(M
M3U&ZGL!']LEU&1\(N&*8W8& O5@.0 23UJ#5I2?B/H,X@N6ABM+A9)1;N40N
M$V@MC )P:SKO2;[5M4\=V<-O<0G4K6".UFDA=(Y66)E8!B,8R0/Q[T =/;^*
M-/N-1M+$K<0O?QM)9M-$56X51D[>XX.<, <4RV\7:7=36:Q^=Y-_(\5I<E/W
M<SKG(!SD?=.,@ XXS5+P_P"(+W5+>UMY/#U]:7EO'BX:[@\N.-@N"$8_>R<8
MQV.3Z'EP^JWT7AR^N=%U;[9::F&O(A;,D4 VN (TX!7D?.,^[4 =;I?BO^T-
M4UFWDL;J*'391'N$18G"!B<+DY.> !G&*?HVM:-:^%+"[LY[F2SG/E6OG%I)
MIF+$ <\DD@]>@'8"J6@_:-,\4^)5N;"\$=S<I<Q3+ S1NGE*#@CJ<C&T9/M7
M.:5IFJVG@[P?>C3[LR:)<L;RS,+++L;<I94(RQ ;.!UR: .YB\3:>[7L4JW%
MO<6""2XMI(B9%0]& 7.X>ZYJK:>.=&O)-.$8NEBU/"V]P]NPB9R,A-_3=@'C
MV(ZBLVZM9-1\57?B""WN5M(-&>T!:W=7GD9]V A&X@ #MU;V-9"PW:>"O!=N
M=.U#SK#4+9[F,6<I:)4#!B1MZ#(^O:@#K)-1;2/%UIIDCLUKJ\<K0!CGRIH\
M,R@_W64Y [%3CKQOUR7B.!K[QUX5BB!)MFN+J4C^! @49^K,!^==;0 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ >I- #J*SVU_1UTY-2;5+06<C%4G,R['()& <\\@CBKS,J(7=@JJ,DDX %
M#J*KV5_9ZE;BYL;F*YA+%1)$X920<'!'O2F]M1?+8&XC%TT9E$.X;R@."V/3
M)QF@">BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KB?B+\0U\#16D<-D+NZN]Q56?:J*N,D^O7I]?Q[:L#Q7X+T;Q
ME;0PZK%)N@),4L3[73/4 \C!P.H[4 ,\#^+8O&GAY=4CMS;NLC0S1%MP5P >
M#W&&!_&NBK-T#0-.\,Z3'IFEPF*!"6Y.69CU8GN:TJ "N)\5SMJ7COP[X:FY
ML)A+=W,9Z3E 2BGU (R1T/%=M7/>)O#D^JW6GZMIEQ';:MI<C/;O*"8Y%88>
M-\<X([CD4 :6JZ/9ZO:);W,2D12)+"VT9C=2"I'IR/RXK..O7^H7.J1:):V\
MPTN3R7\]ROG2A0S(N!\N 0-QSR>G&:MP2:Y=JJ75I:V X\QXKDS,?4*"B]?4
M]/2LRST75M!UK5KC3$M;FSU27[3LFE:-H)B,-T4[E. >Q'O0!7;QT]U8>'[[
M3-.6>'6IC#B6;8\3@-E2,8X*D$Y[=#5K3O$&JWLVN:;<6EI!J.EF,@QS,T3I
M(I93DJ#D 'MUJA_PAE]I]AX:LM-:UF31[HW,[SRM&968-NP K=2Y/)]JNVVC
M:S:^(_$.IK%8M%J<4*P*;APRF-2OS?N^ =V>,XQWH YK3[^;2OA+IVMW>D6&
MI&TB1X?.8EUWMM9N5//S<@'GGFNGU?Q#K%MXG30M-TRVGDFLGN8I9;DH,JP&
M& 7@<]LYXZ<D9DOA+7)/A<GA7_B7B\2..+S?/?RR%<-G_5YS@=,?C6K+I.KR
M^.++6_*LA:PV3VTJ_:'W@LP8D#9@XVXY(S[4 00>(O$-YJNK:5;Z19+=Z=%
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MBZFWC:PU>WCL_L-I:26Q5IV$AW%3D#81QM]: -*]/]A:'*=)TH3&$9AL[<!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 51O\ 1M/U.:":
M]MQ+);-NA8LP,;>JX/!]^M7J* "BBB@ HHHH *0@$8(R#2T4 4],TC3M%MC;
M:98P6<)8L4A0*"3W.*N444 %%%% !1110 4444 %%%% !1110 4444 %5[ZQ
MMM2M)+2\B$L$HVO&20&'H<=1[58HH @L[.WL+2.UM8_+@B7:B9)"CL!GM[5/
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 55O]2L=*M_M.
MHWD%I#G'F3R!%SZ9/>K5>:?&'P9KGBF#3I]'3[3]D+B2VWA3\V,,,D ],4 >
MC6]Q!=VZ7%M-'/#(,I)&P96'J".#4M<?\,/#>I>%_!Z6&JL!</.\WE!MPA!
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MGW&6-C_JXU)VEMPR3@GH,'MA:3?6R>"? 4\ES&L5KJ:I/(S@+$=DO#'MVZT
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M#?73D)$N%#JHR SGCKT []*XA9M/D^'RP3312>1XC 828!13<D\CC;E<G'%
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M"Y0C VY!Z<9#8JY>ZI9V/CO6+37=6;3(+VUA-I))Y8BFB"D.NYU(!#%CC/\
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M_C20V=K;22206T,3R'+LD84L?<CK5*^NX?[4TV%=:BM7D=F%K\A:[7:>!GD
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M#UQD8R*Z"37-*BNQ:2:A;K.9!$$,@^^1D)_O$=NM %E;.U2)XDMH5CDX= @
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M:%E<VL)9  I\L97'3%+#:6UN28+>*(G@E$"Y_*IJ* (7M+:242R6\3R#&'9
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MB%I (Y/OH(QAOJ.]2)#$C[TB16*A<A0#@=!]*DHH A@M+:V+FWMXH3(=SF-
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MCCB1$)SM50!GZ4 >>>&9K;POXEAM+S9!8:O$\NC%Y01;*6W-#Z#=E6X_W<G
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>ebs20191231exhibit1048022.jpg
<TEXT>
begin 644 ebs20191231exhibit1048022.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V:BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/<7-M;RO)HTDCN\:DLRO'AB?4<X/:@#K[8WYNKH72VXMPX^S&)F+E=HSOR,
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MHX8R.%/?=M7/48Q4/AC5+S3O"FK*[-<_8=3GLM,,K$F90X2)2W4C>=N?0>U
M&UIOBNUU+Q7J6@(A62RC5T<])ADJ^/96PI]\^E;U>:Z]9ZGX6&A^(I;2V2/1
MW\F^FAN6D>:&4@2,RF->=QW=>I-;OBR#4)[ZROM,M;/6([>!S-I=PP'FHQ7$
MD9.1N&W'/9CZT =;16-X2NK*]\+6$^G1S16ICVQQS??3:2I4^X((_"N'UU[=
M]-GUC307,>O)B_G?]^7\Y59(\#(C RHR>0#QWH ]1HK@CH.G:S\2-;MK^.2>
MW-E;2^69G W[G(;@]L<=JIVMDGBO1M3N;O5+6QO[._F\VZ\@FXLC'*=@#[QA
M=@ QC&">IR: /2:*S]5N8;7P_>7-W<RP11VKM)/&,.@VG+*.Q[CWKBM-@CM/
M%WAD06T=K;WNF3JZ;@TEPBK&5:8@89N2>_.>30!Z+17G=G;1Z5JNM>"O*4+J
M<RW%F2/^6$G^M&?^F>UL?5:N:]:Z;=:IJ-C!;I/)9Z2%>*X(%O:(=Q5D7&2Y
MQVQ@*.10!UUX;\/;?85MV4S#[1YS,"(\')7 Y;..O'6LRRUN[N/&6H:)-!"D
M-K;13QR(Q+-O+#GH!]WI^M<BSO=>'/AY>32R23M>6R.S2$[@8F)R,\G(!R>:
MV#/%;?$+Q#<3RM#%%HT+O(G5%!D)(]P* .R;.T[0"<< G%8GA;6[K7+2^DO(
M(H9;6_FM-L1)'[ML9R>OY"N1TU$M/$G@N:SA%O!>V]P#(S@SW4?D[P\Q& 23
MAL<X)/-5ET#3-0\+^+-1N_,2YL]4U"6WN%E93 RL6!7!P#D<^OY4 =M?ZW=V
MGC#2M&$$)MK^*=S*6)<&, XQT'WAZ_A6[7"1S7=QXG\"37X(NY-,N6G!&"',
M41;(^N:S[*R7Q5X?O+^ZU6VL=0M+V5IKL6Y-S9LDIPN[?P-H QC&#ZT >EUS
MFG:YJNLM#?Z;;VKZ8UW);R)(2LH1&*&0'.#RI^7'3'-;\D,5S;M#<1I+&ZX=
M'7*L/0@UY39.FC?"H7MG"ELT^I-!=W4*A'2 W3*WS#D<<>V>* /6J*XO4K&/
M1_''AX:-"MM'J GAO((!L26-4W!R!QE3CYNO.*@\":%I\LE]J,L;R7-CK-ZE
ML[2L?*7<5P!G!X]<_H* .[HKD_%]X4U[P_IT\L$5E>R3"0W$9>)Y%4>6C#(S
MG+8!/4"LR[TNQT"SN=/GU.6:*]U*W\G3[1!%&DCMD0\E@(WVY89X&?49 ._I
MKEQ&QC"L^/E#' )]SSBO,Y;R^T-/'W]GK%;RVT%O+%!;?ZN!FC;<RC YP,DX
M&2,XKJ=.TGP^M[I.LZ;.87E@:.+R7&+Q67=F3C+D8)R3USF@"UX0UNX\0^'H
M]1NX8H9GEEC9(B2HV2,HY/\ NULN7$;&,*SX.T,< GW/.*\BAT^VB^&<&N(K
M"_M=5+03[SF/-YM(7G@$$Y'>O7Z ,7PCK5QX@\.PZE=0QPS22S(R1$E1LD9!
MR?9:V2<#)KRRQOI+7P%X?@WE+.]UY[>\<''[HW$IVDCH"0 ?8D=ZZ"6PAT_X
MB6NGV%M$NGZEI\QOK-4'D_(0%<ITR=VT^M '5:?J%MJMFMY9R"6!V95<=&VL
M5)'MD'%6JX[X5VUM#X TV2*&*.65&,C(H#/B1P,GO^-=C0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 57OK"TU.TDM+ZVBN;>08>.50RG\#5BB@#-L= TW3W1[>&
M0F/_ %?FSR2B/M\H=CMXXXQ1>>']+OKPWD]K^_:/RWD1V0R)_=?:1N7V.16E
M10!GWFA:9?FU-Q:JWV,@VX5BHB(X!4 C!Q3?^$>TO[5=W0MB)[U0EQ()7!E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 4Q+<28:^^4,_ED'Y=H..AR0>E,N=3U67Q_IMI;RPK92Z=)<"-P<D[D!)QW
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M? W $H!SCKD8SWK.U/Q"VM>%/&=A+]GE?3;21!/;MF.97A+J0,G!'0C)Z=:
M.WAFCN(8YHG#QR*&1AT((R#3ZYGPSJEQJ-EI\6G?9Y+&WM8X[BX8DGS0HRB
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MEP-Q Y8DD #([G/'.)>>-KVRTO7Q)I\#:GH.UIH_-(CEC8;E=3@GD?P]L=:
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MLGQ)>:GJ-MX4OKBWMX[:ZUFTE6)23)#G)7)Z-D'G &#Z]: /0**** "BBB@
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MMPMHMQ)*UK).J@DJHVI@\E6Y)&,=\\8-]K_B&^M?#DC6XTJ6YU06]S;S0O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ***J:G<7=O9EK&V%S=,0D2,VU,GNS8.%'4_3
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MZ**C2:*1VC25&=/O*&!*_6@"2BHS-$I :5 2VT L/O>GUHFE2&(N\B1CLSG
MS0!)16%X2UB]UJQO9;Y85EMK^>U_<J0I$;;0>2:V)Y5BB),L<;'A#(<#=VH
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M::? B);Q;(8@, 8' J0VEL6@8P1YMN83M'[O@KQZ<$BIJ /+ L%_\&GU<_\
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MW][\: %T:.VBTJW2U2)$$:DK$ !DJ#V^M<):Z#HFKQ>-9=7MHI!#J,Y$S]8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !3)H8KB%X9HTEC<89'4%6'H0>M/HH Y6Q\&+H/B"35M&E0Q
M3ILDL[G)6,?],GY,8_V<$'VP,;UWI.G:C);S7^GVMS-;G=$TL2N8V_V21Q_]
M:KE% &>^@:-+:/:2:39/;O)YK1-;H59^NXC&">>M.;1=)83!M+LR+A528&!?
MWBJ,*&XY ' !Z5>HH SVT'1GB@B?2+%H[8YA0VR$1?[HQQ^%2SV%O]H?4(;*
MU;45B*1SN@#8[*7QD+FK=% &-HEGJC32:GKBVR7TD:Q+%;$LD2 D\$\DDG)^
MBCMFM2XMH+RW>WNH(YX9!AXY4#*P]P>#4M% $$%E:6MJ+2WM88;<# ACC"H!
MZ8'%5$\-Z%'!+!'HNGI%,09(UM4"O@Y&1CGFM*B@"D=&TLV<EFVG6K6\K!I(
MFA4JY&,$@CD\#KZ"GPZ;8V]O);PV<"12Y\Q%C&'R,'<._''-6J* ,ZW\/:):
M+"MOI%E$+<L8@ENH\LMC<1QQG S]!4MIH^EV"S+9Z;:6RS_ZT0P*@D_WL#GJ
M>M7** ,^'P_HMLL*P:18Q+ S/$$MD C9A@E<#@D=<4T>'-"%O);#1=/$,S!Y
M(_LJ;78="1C!-:5% &?=:!HU]#!!=Z393Q6W^I22W5EC_P!T$<?A4U[IMAJ-
MI]COK*"YM^/W4T89>.G!JU10!3_LC3?L,=C_ &?:_9(2&C@\E=B$'((7&!@\
MU<HHH Q]/T""RLYM)D@@N=++,T,,J!O+#$DQD$8*@DX/H<=LG0L["RTZ#R+&
MT@M8LY\N",(N?H*L44 4ET72DOS?KIEFMX>3<"!?,_[ZQFEDTC3)KPWLNG6L
MET5V&=H5+E?3=C.*N44 5+?2M.L[9[:UL+6""0Y>**%55OJ ,&FWFCZ7J,R3
M7VFVEU)']QYH%=E^A(XJ[10!5N],T^_$8O+&WN!'D()8E;;GKC(XJR    ,
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M6VRJC@E#C.".QP0>: ):*** "BHEN8'N'MEGC:>-0SQ!P64'H2.H!P?RJ6@
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MWG4\R@!3NR  .X]LFETCPX]K\-9/#WB/[/#''!*CR1R;@%R6$G(&".#CG&*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^1YB1Y;3D,<;?O$*,KTX'-;FIW]GX7T>!8+50OF1VMI:Q84,[$*B#T'OV -
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M)\OR\XQGG%5=&T;Q7H/F:):O82:1YKM;WCNPFMXV8L5V8PS#)P<X]?2NTHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:@#T!M0BMI;&UNW1+N\RJ1H<Y94+-CO@8Z^X]:?%J%M/J%Q812AI[5$>51_
M'W;<^_RDX^GK7$7]A977BCP,US:PR^;9W"N9$!W 0J0#GK@DFH3''IGB+Q]J
M-A:0B\M+2&:W81C*R&!R2/<GKZT >C45PNE:+#=#0]?MM9MHE90K-;6[*]Z'
M7!21O,)9LY.2,@@GC%<U=6$,?PXU[5@\YO=.U2=K28SN3"5G &.?3J>I_ 4
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MS&4/L:55Q@J&SQG) )]CE:7IPT[XI_88Y"S)X; :4]7<W!+.?<L23]:S+/\
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MX- 'J+ZA;)J46G&4?:I87F6/OL4J"?S8?K5FN(?2M-3XLV@6QME5=%=P!&N
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M7LUNPN1'Y9FAE>)F3^ZQ0C</8Y%%YH.E:A806%S8Q/;6S*\,8&T1E>%*XQC
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M)M&L=1E6\O+,I=-#Y+E96!*9)V$J1N7)/!]>E1:CHZZDUE9M$D6G6DB3&-0
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MSTFR2RT^V2WMT)*QH, $DD_J30!:HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@]^F/I7-:MX=OK_5SJ5CIDVFZS%=J(]0@F013P!Q_K5#9;Y.,%<Y [=.[HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!0UG1;'7]-DT[4HFEM9<;XUD9-V#D9*D'J!5R*)88EC4L0HP"[%C^)/)I
M]% !1110 4444 %%%% !1110 4444 %%%% %+5M)L];TZ73[^-I+:88D19&3
M</0E2#BK%M;QVEM';Q;O+B4*N]RQP/<\FI:* "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ***S?$.NV?AK1+C5KXMY, 'R
MH,LQ)P /<DB@#2HK#.MZC;7%C'?:.$2]E$:RV]R)5B)!/SY52.G;(SWK<H *
M**IZAJEGI@M_M<P0W,Z6\*]W=C@ #]?H#0!<HK(?6[E/%<>BC2+IK=[8S'4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVSN%#.FX[,[0!G;@4 1^7XB_Y^],_P# :3_XY1Y?B+_G[TS_ ,!I/_CE:M%
M&5Y?B+_G[TS_ ,!I/_CE'E^(O^?O3/\ P&D_^.5JT4 97E^(O^?O3/\ P&D_
M^.4>7XB_Y^],_P# :3_XY6K10!@W]SX@L(8Y&GTU_,GCA %O(,%W"Y^_VSFK
M/E^(O^?O3/\ P&D_^.4>(?\ CRMO^O\ M?\ T<E:M &5Y?B+_G[TS_P&D_\
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MN"1DC..U=5X2FGNO">E7=U<23W%U9Q3RR.1DLR GIP!DT /\OQ%_S]Z9_P"
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M:M% &5Y?B+_G[TS_ ,!I/_CE'E^(O^?O3/\ P&D_^.5JT4 97E^(O^?O3/\
MP&D_^.4>7XB_Y^],_P# :3_XY6K10!E>7XB_Y^],_P# :3_XY1Y?B+_G[TS_
M ,!I/_CE:M% &5Y?B+_G[TS_ ,!I/_CE'E^(O^?O3/\ P&D_^.5JT4 97E^(
MO^?O3/\ P&D_^.4>7XB_Y^],_P# :3_XY6K10!E>7XB_Y^],_P# :3_XY1Y?
MB+_G[TS_ ,!I/_CE:M% &5Y?B+_G[TS_ ,!I/_CE'E^(O^?O3/\ P&D_^.5J
MT4 97E^(O^?O3/\ P&D_^.4>7XB_Y^],_P# :3_XY6K10!E>7XB_Y^],_P#
M:3_XY1Y?B+_G[TS_ ,!I/_CE:M% &5Y?B+_G[TS_ ,!I/_CE'E^(O^?O3/\
MP&D_^.5JT4 97E^(O^?O3/\ P&D_^.4>7XB_Y^],_P# :3_XY6K10!E>7XB_
MY^],_P# :3_XY1Y?B+_G[TS_ ,!I/_CE:M% &5Y?B+_G[TS_ ,!I/_CE'E^(
MO^?O3/\ P&D_^.5JT4 97E^(O^?O3/\ P&D_^.4>7XB_Y^],_P# :3_XY6K1
M0!E>7XB_Y^],_P# :3_XY1Y?B+_G[TS_ ,!I/_CE:M% &5Y?B+_G[TS_ ,!I
M/_CE'E^(O^?O3/\ P&D_^.5JT4 97E^(O^?O3/\ P&D_^.4>7XB_Y^],_P#
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M;;:M9!6NK@26,T\)##YI3OC)QTRI..O>O7/[9TK_ *"=G_W_ %_QH_MG2O\
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MBGL?$C2(R6<*-'*SEAG?'U0CD[^!QU/6O4O[9TK_ *"=G_W_ %_QH_MG2O\
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M_P"_Z_XT 7:*I?VSI7_03L_^_P"O^-']LZ5_T$[/_O\ K_C0!=HJE_;.E?\
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MHHH **** "BBB@ HHHH *QM5CCFU_1TE174^=\K#(^X*V:R-1_Y&+1_^V_\
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M -GV7_/G!_W['^%']GV7_/G!_P!^Q_A5BB@"O_9]E_SYP?\ ?L?X4?V?9?\
M/G!_W['^%6** *_]GV7_ #YP?]^Q_A1_9]E_SYP?]^Q_A5BB@##U^RM$L[8K
M:PJ3?6P.(P.#,E:G]GV7_/G!_P!^Q_A5+Q#_ ,>5M_U_VO\ Z.2M6@#FH_$'
MAV:^N[&*QGDN+(@7$<>F2L8\C(SA.XY'K5[2KO0-;BD?3A:S^4VR5/)VO&WH
MRD J?J*Q/"__ "4;QK_OV7_HDUG:M<IHWQ?2\ME.V7199K]$_B5-Q5C[_*!F
M@#N_[/LO^?.#_OV/\*S--O\ 1M5GU""VL?GTZ7RI@]MM.[&> 1D\>U9-C?\
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M'4+GQ9K^DR7CB"UM[>2 A$W1%PY;G'/W1US6?I&OZKJ/@WP_J5QJ$-N]X_\
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M_?L?X58HH K_ -GV7_/G!_W['^%']GV7_/G!_P!^Q_A5BB@"O_9]E_SYP?\
M?L?X4?V?9?\ /G!_W['^%6** *_]GV7_ #YP?]^Q_A1_9]E_SYP?]^Q_A5BB
M@"O_ &?9?\^<'_?L?X4?V?9?\^<'_?L?X58HH QM)CCAUW64B144/#\JC _U
M=;-9&F_\C!K/^]#_ .BZUZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R-1_Y&+1_^V__ * *UZPM
M;^U?VWI'V,0F;,V/.)VXV#/3F@#;D5GC95<HQ! 8 $J?7GBL>ST2]_T<ZQJS
M:F;5_,B'D+$"PZ,P'WB,\=!GG&0")<^(O[NF?G)_A1GQ%_=TS\Y/\* ,Z^\,
MZW<:S-J-KXKGL_,78D2V4+B-/[H+@GGJ?7 ]!C0BTF_BM]/B_MNX=K:4O<R/
M&I-T#G*G^Z,GMTQBESXB_NZ9^<G^%&?$7]W3/SD_PH S+CPQKLFJ7-];^+[B
MV,YP$6QA<(HZ*"P)P/YY-:-_H<M]X7ET1]0D+3VY@FNI$WNX889L9 !.3[#T
MIV?$7]W3/SD_PHSXB_NZ9^<G^% %K3;.2PTNWLFF65K>)8UDV;<@# )&3Z>O
MY51\/Z#+H<FHLUZ+A;^[>[<>3LV.V 0#D_+\HXZ^]29\1?W=,_.3_"C/B+^[
MIGYR?X4 :M8MCH,MGXFO]:-ZLAOTCC>'R<!0@.W!W=?F.?7VJ7/B+^[IGYR?
MX49\1?W=,_.3_"@">]TP7U_I]S)*1'8R-*(MO#N5*J2?8,WXD>E7JRL^(O[N
MF?G)_A1GQ%_=TS\Y/\* -6BLK/B+^[IGYR?X49\1?W=,_.3_  H U:*RL^(O
M[NF?G)_A1GQ%_=TS\Y/\* -6BLK/B+^[IGYR?X49\1?W=,_.3_"@#5HK*SXB
M_NZ9^<G^%&?$7]W3/SD_PH U:*RL^(O[NF?G)_A1GQ%_=TS\Y/\ "@#5HK*S
MXB_NZ9^<G^%&?$7]W3/SD_PH /$/_'E;?]?]K_Z.2M6N8UPZ[]DM_-&GX^VV
M^-I?[WFKC\,UI9\1?W=,_.3_  H S[/PO?V&MZIJUOK*B;5&C,RFT!5=B[5V
M_-QQZYJWIGA:QL)[V[G>6_O;]=ES<W)!9TQC8   J^P'US4N?$7]W3/SD_PH
MSXB_NZ9^<G^% &7HG@VXT9X[4>(+RXTBW</;V$D:?)@Y4&3&YE!Y XZ#MQ5N
MP\.3V%WK-RFH*SZL_F-F#B)@H48^;D8'?O5G/B+^[IGYR?X49\1?W=,_.3_"
M@"'2O#4-AX37PY<S?:[58&MRQ3:6C((P>3SSUI;;PO8Q>$5\-3E[BU-N8978
MX:0G[S>Q))/M4N?$7]W3/SD_PHSXB_NZ9^<G^% %'1?#.HZ6(UN_$5SJ4=JI
M%HD\*@1\$ N5PTA )')'4]\$+I=I;> O"KIJ&I&6QM&:0S& [D#N2<A<Y^9O
M2KN?$7]W3/SD_P *,^(O[NF?G)_A0!G^%M-LSJ.K>(+2&2./59@T0<%<J% +
MA3RN]@3[@*:U=<T:S\0:/<:5?*Q@N%P2IPRD'(8'U! /X5%GQ%_=TS\Y/\*,
M^(O[NF?G)_A0!#;^'YWO+&ZU;4!?R:<&^SD0^7\Q&TN_)W-C(XP.3QTP:1H$
M^F:UJ>I-?K/_ &G(LDL?D[0A5=HVG=Z =<U-GQ%_=TS\Y/\ "C/B+^[IGYR?
MX4 5_%?AQ_%&F)I_V\VD2RI*Q2(,S%3D#DXQGV[5++I6J73PK=:PI@217DCA
MM@AE .=I)8\$@9QUZ4_/B+^[IGYR?X49\1?W=,_.3_"@#/U/P@=7TV^M[R_W
M7-U<)/'=K#A[?81L"?-QMYQ_O'.<G)JOA.YU*73]0BUF2SUBP0QB]B@4B5#U
M5XR<$=_KFM#/B+^[IGYR?X49\1?W=,_.3_"@#/U+P:FIZ5!!)JETNHV\XN8]
M27:)!+C&=H &W'&WI@"IHO#VHK9?OO$$\^HF2-S=M BC"$D((UP IR<]SD\]
M,6L^(O[NF?G)_A1GQ%_=TS\Y/\* *:^%Y(YK^]AOQ;ZC?S0RR3PP;4_==!L)
M.<C.<G)SVXJWI6AIIVI:AJ;R))=ZB8_.:*/RTP@(7"Y)SR<DDYS[4N?$7]W3
M/SD_PHSXB_NZ9^<G^% #-8\/QZE>VFIV\YM-2L2WD7 7<"K##(Z\;E/ID$=B
M*YZ(ZCJNO);^-+:.TAL)A/9" '[+<N.CLY_B'9#CKGGMTF?$7]W3/SD_PHSX
MB_NZ9^<G^% %6Y\,ROXCEUBSU66S%W D-U"D:MYH7.TAC]T_,1_AUK.M? +6
M.F:);VNMW"7&BNY@G,*,"K@AE*],8/!))%;>?$7]W3/SD_PHSXB_NZ9^<G^%
M &)<> #-I.L::-:N/)U>Z%S*7A0LK?*21C')*#V Z#O6I+H%S/XDL-;DU!/,
MLX&@\M8,+(&QN/WN#P,>GO4^?$7]W3/SD_PHSXB_NZ9^<G^% &;'X.:'2-8T
MN+59?LNJ-,0CQ*?)$N=^#P2>3C/3WJ2?PF\T&A[-3DANM%RL4\<2_.I3805;
M(R5[^O:KV?$7]W3/SD_PHSXB_NZ9^<G^% %9/#(.OZAJ=Q=">+4+9;66V:+C
MRUSCYL]?F.?KVJKH7@^ZT8Q6S^(;R\TNU8&VLI8T&S'W0S@;F"]AP.!Z5IY\
M1?W=,_.3_"C/B+^[IGYR?X4 4H_"TDKZ9_:.H"\32YO.MV\C9+G! #/DY ST
M &<#)/>SXLT1O$'AVYL(G6.X.V2W=NBR(P9<^V1@^Q-29\1?W=,_.3_"C/B+
M^[IGYR?X4 07-O<Z]!I]Y9WCZ;<V<QDDC>(.0VPJ8W&1Q\W8\\$'D&B+0)Y]
M>M]9U6[AN9[.)XK:." Q(F_&]CEF))  ZX SQWJ?/B+^[IGYR?X49\1?W=,_
M.3_"@#)TOP1+I$S6MMKUV-$\PR+IAC0A<G.SS,;MF?X?UY.<KPT9-4U_Q=#I
M^L0Q++?88*@D<#RU4NAW#!SD9(89 X]>KSXB_NZ9^<G^%&?$7]W3/SD_PH I
M7'@^W_XDG]G7<NG_ -BJT<'EJKY1E"L#N'7 '/K70UEY\1?W=,_.3_"C/B+^
M[IGYR?X4 1:/H,VEZOJ>H/>K.=2D621/)V[&50HP=QXP.]2WFB#5+N&34IQ/
M;6\@EBM53:A<?=9^27([#@9YQG&#/B+^[IGYR?X49\1?W=,_.3_"@!;[13/K
M%OK%I<?9[V"%H"63>DD;$$JRY!X(!!!'XTMCI#:=%=O;SH;N]G,\\TD659R
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M*LO_  '3_"C^P](_Z!5E_P" Z?X4 6/MEK_S\P_]_!1]LM?^?F'_ +^"J_\
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M_8>D?] JR_\  =/\*/[#TC_H%67_ (#I_A0!8^V6O_/S#_W\%'VRU_Y^8?\
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M!QWXZ@TQ+/PY)J4VG)8V!NH(TEDB^SKE58D ]/\ 9/Z>HH T?MEK_P _,/\
MW\%'VRU_Y^8?^_@JO_8>D?\ 0*LO_ =/\*/[#TC_ *!5E_X#I_A0!8^V6O\
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MK_S\P_\ ?P4?;+7_ )^8?^_@JO\ V'I'_0*LO_ =/\*/[#TC_H%67_@.G^%
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MQ6T,<,8>$[(U"C_5CL*VZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4>.-[Y+2'V7)8GV]2*S]7U?1=(6Q\+7VK06D,=JGVAYY0C21#Y0@SW?:<GL
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M6]M[BZT6%+BWN&MMH97C9]K*&[;2,Y[_ (5LZSH%YJ]QI-Q_:$,,FFSBX/\
MHQ99'VE>F\8&">,GZU5G\)7<U[X@N%U2)1KENL#K]E)\H*A0$'?R<,?QQ]*
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M5U/5YV\46/AVTE\AY[>2ZFG"AF6-2% 4'(R2>I!P >.>,V'5]2NO^$ET"[N
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MY!KGM4\4ZEX6\9&+4IFNO#\D47F7#1J&LI)&<*6*@90E#R>F1^(!TGG>(O\
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MM8HF5@WFMO)))R">@[>];&@C[=J^KZP>5>86=N?^F<.0?SD,GY"MZD "C
M]J ,&R@UW2WFO=<\0VUU8PQ,SHEAY)7'.[<'/0 \8K%NK;2=7\6:+KGAFZBF
MO3.?MDMK+N5K;8VX28.!\VT 'G)]N.YI%55&%4 >@% 'F_C?2O$MIX3\032:
MCITMM<!Y)1]D?SF7("KNWX&!@#CMZDFN]TE+U-+@74989;H+\[P1E$//& 22
M.,=^M7** "BBB@ HHHH **** "BBB@ HHHH **** ,KQ#_QY6W_7_:_^CDK5
MK*\0_P#'E;?]?]K_ .CDK5H \YT*TT+7O'_C&&\2UO!(]N(PS E@(L-M^A&#
MCI5_Q3I,NF:SX8\06\<D]MHK/!<A5W,L+IL\S ZA>IQZ^U=O10!R/C+5;75?
M"UWI6CW$.H7VIQ>1!#;R!R0W!<XZ* 22QXK!\0V^EZ5KO@/1[^[MS#81RQ3&
M60* !"JJ6R>,D#&:]*5$0DJH4L<G ZTZ@#SF..S@^).FR>#F66&XCD&L&!O,
M@" #82W(#9SP#V%=;XNGB@\(:NTTJ1J;*9078#)*' ^M;-% '%^&/%6C:=X!
MT@-?17%Q%81+]DMF$LS.$ V!%R<YX]N]<U#I>H>%_#>FZMK$,\44NM2:AJ45
MN3NMEEC9%)V\_+P3CUKUFDH \_N4\(ZCI>JZC:WUTL%XULEQJJS/A9%D41$%
MN,H=I)[#]*E]<:O=>$O%VG7SV^IR6MDHCU*T3'VE2K':P'&]1R<=F%>EA550
MJ@ #H *%55&U0 !V H X'7]7TVZM_!EQ%>0M'_:D)#[L J(G!()[9(&?7BEL
M[O3AXT\<&6XM@QMK<99UY41$,/H#@'\*[ZB@#R[0M<L+;1/!<,TL%NS6DD:Z
MB_S&!@%#1+V#MQ][/3H<U32XC'P^O 7D/V'Q&)+@R(5,:?:<Y88&..2.WH*]
M<QFB@#B]5U&QN/B/X4DBN8B'MKO:<XR&5-O7UP<>O:LG3KJWA\">(M!UAE&J
MK)=K);O_ *RX>0LT;(.K;L@ CN*]+II52P8J-PZ''(H \]T_;8>-?"]IJMQ"
M;ZWT%HI3(XW"7Y.,^O#?7FM/X=W-O-%X@C@FC?;KETP5&!PI;@\=CSBNQHH
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M\._] '3/_ ./_"C_ (1;P[_T =,_\ X_\*U:* ,K_A%O#O\ T =,_P# ./\
MPH_X1;P[_P! '3/_  #C_P *U:* ,K_A%O#O_0!TS_P#C_PH_P"$6\._] '3
M/_ ./_"M6B@#*_X1;P[_ - '3/\ P#C_ ,*/^$6\._\ 0!TS_P  X_\ "M6B
M@#*_X1;P[_T =,_\ X_\*/\ A%O#O_0!TS_P#C_PK5HH RO^$6\._P#0!TS_
M , X_P#"C_A%O#O_ $ =,_\  ./_  K5HH RO^$6\._] '3/_ ./_"C_ (1;
MP[_T =,_\ X_\*U:* ,K_A%O#O\ T =,_P# ./\ PH_X1;P[_P! '3/_  #C
M_P *U:* ,H>%_#PZ:#IH_P"W2/\ PH_X1;P[_P! '3/_  #C_P *U:* ,K_A
M%O#O_0!TS_P#C_PH_P"$6\._] '3/_ ./_"M6B@#*_X1;P[_ - '3/\ P#C_
M ,*/^$6\._\ 0!TS_P  X_\ "M6B@#*_X1;P[_T =,_\ X_\*/\ A%O#O_0!
MTS_P#C_PK5HH RO^$6\._P#0!TS_ , X_P#"C_A%O#O_ $ =,_\  ./_  K5
MHH RO^$6\._] '3/_ ./_"C_ (1;P[_T =,_\ X_\*U:* ,K_A%O#O\ T =,
M_P# ./\ PH_X1;P[_P! '3/_  #C_P *U:* ,K_A%O#O_0!TS_P#C_PH_P"$
M6\._] '3/_ ./_"M6B@#*_X1;P[_ - '3/\ P#C_ ,*/^$6\._\ 0!TS_P
MX_\ "M6B@#*_X1;P[_T =,_\ X_\*/\ A%O#O_0!TS_P#C_PK5HH RO^$6\.
M_P#0!TS_ , X_P#"C_A%O#O_ $ =,_\  ./_  K5HH RO^$6\._] '3/_ ./
M_"C_ (1;P[_T =,_\ X_\*U:* ,K_A%O#O\ T =,_P# ./\ PH_X1;P[_P!
M'3/_  #C_P *U:* ,K_A%O#O_0!TS_P#C_PH_P"$6\._] '3/_ ./_"M6B@#
M*_X1;P[_ - '3/\ P#C_ ,*/^$6\._\ 0!TS_P  X_\ "M6B@#*_X1;P[_T
M=,_\ X_\*/\ A%O#O_0!TS_P#C_PK5HH RO^$6\._P#0!TS_ , X_P#"C_A%
MO#O_ $ =,_\  ./_  K5HH RO^$6\._] '3/_ ./_"C_ (1;P[_T =,_\ X_
M\*U:* ,K_A%O#O\ T =,_P# ./\ PH_X1;P[_P! '3/_  #C_P *U:* ,K_A
M%O#O_0!TS_P#C_PH_P"$6\._] '3/_ ./_"M6B@#*_X1;P[_ - '3/\ P#C_
M ,*/^$6\._\ 0!TS_P  X_\ "M6B@#*_X1;P[_T =,_\ X_\*/\ A%O#O_0!
MTS_P#C_PK5HH RO^$6\._P#0!TS_ , X_P#"C_A%O#O_ $ =,_\  ./_  K5
MHH RO^$6\._] '3/_ ./_"C_ (1;P[_T =,_\ X_\*U:* ,K_A%O#O\ T =,
M_P# ./\ PH_X1;P[_P! '3/_  #C_P *U:* ,K_A%O#O_0!TS_P#C_PH_P"$
M6\._] '3/_ ./_"M6B@#*_X1;P[_ - '3/\ P#C_ ,*/^$6\._\ 0!TS_P
MX_\ "M6B@#*_X1;P[_T =,_\ X_\*/\ A%O#O_0!TS_P#C_PK5HH RO^$6\.
M_P#0!TS_ , X_P#"C_A%O#O_ $ =,_\  ./_  K5HH RO^$6\._] '3/_ ./
M_"C_ (1;P[_T =,_\ X_\*U:* ,K_A%O#O\ T =,_P# ./\ PH_X1;P[_P!
M'3/_  #C_P *U:* ,K_A%O#O_0!TS_P#C_PH_P"$6\._] '3/_ ./_"M6B@#
M*_X1;P[_ - '3/\ P#C_ ,*/^$6\._\ 0!TS_P  X_\ "M6B@#*_X1;P[_T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5_9&F?VC_:/]G6GVWI]I\A?-_P"^L9I4TG38[TWJ:?:K=$DF<0J)"3U.[&:
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M9A_,Q([JY?<5Q@ EB.M=-10!Y_:>%O$EGH&F67DV4XL]0EGN+1KEA%=1NSL
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M#G(ZJB@!&)"D@9..!ZUSWA32]2TB+5EO880UWJ,]Y%Y4I8;7.0IR!@BNBHH
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MMK=8M-BF2X4SDG,BJOR_+SC;GG'6NHHH **** "BBB@ HHHH **** "BBB@
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MKM)R5&% SCN2>V.>??P?XGC\$W/@^%M.EM48"TO9)G5_+\P.%= A&1Z@^G%
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M,7!GD<^7 68[8SC)*@JHSQQVKHZ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ JGJ>DV&LVOV74;=;F D$QN3M)'3([U<HH 9'&L
M4:QIG:HP-S$G\SS3Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*N8FMIHK27XAZ4D: 7CRW6DL/W<JHYCWX[3\$Y]3CUW>EV6EV.G;_L=LD)?
M8J.2!T&>N!V':F?V+IGVAI_L46]Y!*PQ\K..CE>A;CKC- $%J?MGB&[NC]RR
MC6UCSV=L/)^GE#ZJ:Q/&-M>PW>E:_IFI3&:&[BA2S.UHIDD8(P QG=@D[L\
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MOI@'\JWK3P;X9L;J.ZM-"L(9XFW1R) H93Z@U>N]'TV^G$]U90S2 !2S+G<
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M56:+:@S]4(^M;]YX.\-:A=R7=YH=E<3RG+RR0AF8^Y-7ETC3ETQ=,6Q@%D@
M6 ( BX.1@=N>?K0!S=FN_P"*FLZ@6"6UGI<-O+(QPH<L9.3[+R?3(J]#-9:G
MK-MK-S<1)%"##I\;. S-)@-(1URPP%'4#)/WL#4.BZ8VG2Z>UE"UK,<RQ,N1
M(<Y);U/ Y-5++P?X;TZ[CN[+0[&WN(CE)8X%#*<8X- &-XT\,:+=Z5>ZU;11
M6FK6BM+#?6H"R^<H^4$C[Q)PN#D\^M=79M.UE UTH6<QJ90.@;'/ZU3A\.:+
M;ZC)J,.F6R74K^8\H09+_P![Z^_6M.@#SOPK976K_!FZLTS]ONX[U'R>3*9)
M!@_7@5T/P_NHKKP+I(C^5[>V6WE0\,DB#:P(['(J_IFEMI-]=K;A397DS7&S
M.#%*WW\>JL>?8D]CP^XT#2KF>2:6RC+S?ZTKE?-_WP/O?CF@#R_5[,7NC?$3
M7%7=97,L26S]G:(;6<>HR<9[\UT6HZ#9Z3XN\,7ND1>7<WLLD5YABWVF'RRS
M,^?O8(')[D>U;WC'1KC4O!5]HVDVT?F31"**,$1H@R/R  [5H:;I-E9+'/%9
M+!-Y83DY*+_=!R<+D=!Q0!PND:=IW_""^+Q]DMUD6YU%050*P522!QS@''';
MBI[2<O=^ ].O%!T^?3-X1^4DG6)-H8=#@9(![GVKLSX>T<M>-_9EL#?_ /'T
M1& 9O7=ZTLFA:5+IT6G/80M:PD&*+;Q&1T*_W2.V.E 'G^MV8MH_'NG6\8&E
MQ6"7*1 82"=HV)VCMG 8CW'K5Y-.L]-\5>";FS@6&>\@GCN95^].HM]P#GJV
M"!C/3%=F=$TQM/DL&LHFM923)$PR)">I;^\?K3#X>T<M:L=/A)LN+8[?]3_N
M^GX4 :5<!%ID-K\79K"%W6RO+(:K-; _(URLFP-C\=WNP!["N_J@=#TMM3&J
M&QB-\!@7&/G ],]<>W2@#!\;WWV6]T&&XGB@T^YO&2XDF3=%N\MO+#C(X+<\
MG&0#VK*U#3M(T2QUB.;49)XM1N;4M9686&))&;  ZA0^WY\]L^HKN;_3[/5+
M-[._M8KFWD^]'*H93^!JI'X9T.+1WT=-)M5L'.6M_*&UCZGU/ YZ\4 <9'"B
M^(/&5E,EJB2:9#(\%OPBOLD_-L <X&<#BMSX?Z-IUKX8TG4X;95O;C384EGR
M2SC:" ?IV]  .U:R^&-"0DII-HA,/D$K$ ?+SG;QV))SZU<L-/L],M5M;&WC
MMX$^['&,*OT% %'6_#F@^(U-OJUA;74@3 9E'FHI[JWWEY]*J>!DNHO#:P7-
MR]TD%Q-%;7$ARTL"N0C$]^!P>XP:T+[P]H^IWL=[?:;;W%Q&FQ9)$R=O7:?4
M>QJ>_BN7L6M[$K#(Z^6LG:$8QN [D=AZXH YOX7;_P#A!;93GRUGN%AS_<$K
M8_K77U5TS3K;2-,M].LTV6]M&(XU[X'K[U:H **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ K*\2:XGA[1I+YHC-(76*"$''FR.0JKGMR>3Z9K5KD?B1 [:)I]X
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M  %2:G74M)U?5;;4Y]0M1:V;$649E7=+*WR^9C.>A*J.^XGN* ))-?U"^O\
M5H-'BMV32 %D,RL?M$NW<8U((VX&!N.>3TXYUM%U:WUW1K35;3/DW40D4'JN
M>H/N#D?A7,>%G71+[QDEZ0ABU%[XENGE.@93]/E8?@:N?#:PN=-^'>D6UPA6
M;R6DVMQC>S. ?P84 =316;NUS_GEI_\ W\?_ .)JY;&X,(^U"(2YY$1)7]:
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M^Z=YTDC4[.FQ5 XZY&[@#FMJXT71]6^*5W#=V=O<P3:)'(Z, 5=O.<;B.YP
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MF6\N!HATJ12R-9W#RR@]E)QMR.^":Z:N/M- M-"\?P/H,:VMO=VDC:A:Q<1
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MS<R21W1C_P"7B$QDNTA_BYQR>Y'M0!U5KK-OK%I?'2+J%Y8&>%)&.Y/,4=2
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M58Y".K;P.>I!SZ5VUQ:V]W 8+F"*>%NL<B!E/X&HX]/LH8A%%:01QAQ($6,
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MQ@@'-?"X./ UMG/EF>X,/^YYK8_K77U7L+&WTVP@L;2,16]O&(XT'90,"K%
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MCX9\G.4M;QI\?W,(!G_@6*Z^@ HHHH **** "BBB@ KG6UB_U3Q%J.DZ5)!
M-+BC,TLT9??*X+*F 1A0HR3UY&,8KHJX_0E71_&WBM;QQ$ESY-[%(YP&C"%6
M/_ 6&#]1ZT )_P )P+K0M$OHQ'9MJEW]DFDF^9+5P&W \C)+)M&<=0?:MC1]
M2NKC5]4TVX*3+8-%MN47:&+J24(SC<N 3CLR\5Q&E6;?\(3HVD:G:A;7Q#J,
MK3M,O^JC8O(@&>C-M4 ]1NXYQ6IHAO\ PH-;T&.;[9;6:1OITS@;UDF9@L3D
M=3NP<]<-GN* .A6YU?4;>Y?3IK>(/=/'#+/&76*-/D)V@@L2ZL1R!@@^QHZ/
MXDOH-!UF\\0QQ!M'FEC:>W4JEPJ*#N4$\'G&,]16PD>GZ9I]II,UVL0:,01!
MI_+DDP.=I!!SWXYKB!H%XWA[QGH.G7,]YI^W_0/-D,A$I4M)&&/7YL#ZDYYS
M0!N)XCU.Q@T/4-4$'V;694A:*-"#:O(I:/YL_,.-IX')R,#BM>_O[J/4EMK*
M/SFBMGGDC&!O/W8TR>FX[CG_ &*Y76W77O#_ (.M+([Y+F]M9RHZI'&I:0GT
MV\ ^Y KI]+GBV:CK5Q(L<4TK;9'. D,>5!SZ$AW_ .!T 8_]K>)]&\1Z9::R
MVGWEEJLC0JUI$\;6\@4L!R3N7 //!_D9SK^IZE-K;Z1Y"PZ,YA"RH6-S,J[G
M7((V@9"]SGGVJ*T\0^'M7UFVU*36;%V0F'3[5+A6DR^ 7* YW-T Q\JYSC)
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MTBSFN+,21?ZM?,C\M,'^[N3;GIR* -:UUZ^74]5T26*.YU"RB2:V9?W:SH_
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M'BBWU&QNY/+MKVWG<(LFV.56.QNC8!Z'L:\^2XMI_$OB^*XO;.[-QI,3'RP
MDC*LF<#)SMQZG%='\/\ 3]/A\':->6]K MQ)I\2R3J@WM\H)!;J>>U %C4=:
MF7Q7::!%/':&XM7N!-(FXRD,!L3) R!DGKQV[TW3M7U/4= FOH8HI+BUN)HU
M"@B.\6-BN5ZE=P'!R<'U%9WBK3;7Q3XDMO#FH*8;=;-[N&X3 D,N[;A&[;1\
MQ ZY7/ YO^"+C4)-$EM=2>.:73[J2T2XC7:LZ)@!P!P/0X[J: -C2]2MM8TR
MVU&S??;W,8DC/?!['WJW7(?"Y77P-;$Y\MIYVA'^P96Q77T %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4A (((R#VI:QO%.NGP_HK7<4:RW,LJ6]M&QP&E=MJ
MY]N<GV% &E:V5I8H8[2UAMT8Y*Q1A 3ZX%-.GV)N_M9L[?[1U\[REW^GWL9K
M'BU:\TWQ1::'J,ZW*ZA;O+;SB,(1)'C>A XQ@@CN,$'/6LF+Q;>7.BW&KPW$
M;7,%^;4Z5L&?];L"'^+S"OS9Z>V : .TCBCB4K&BH"Q8A1C))R3]2235>TTK
M3K"1Y+*PM;9W^^T,*H6^I YJ+4+F9;VPL[9]LD\I>0X!(B09;KZDHO\ P.L2
M]O/%&FZYI3R3VEU::A=?9Y;** A[=2K-O#[OFVA>20![#/ !TEU96E\JK=VL
M-PJ'<HEC#@'U&:D\J/S!+Y:[PNT-CD#TSZ5@2:M>:EXIN]#TZ=;9=/MTEN9S
M&';S),[$ /&, D]SD 8ZTNC>*%O_  K-J]Q"$GL_-CN84.?WL9((7ZD#'U%
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MV*9^T11'$C%NH)PVW' P,YJ[/XD%WXATW2[>\%G;ZA8F[AN"H+3G(PB[L@$
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M;F(&?F; S_= QZYZD6ELML+86\0@ P(@@VC\.E-CL;.&0216D"..C+& 1^-
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MQJ&\IFC98V(((P">I'&?7%9.IS^&+33M6U2"=M8COKJT%S.TX%L)0X",6C
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!=WEK80&>\N8
M;:(<&2:0(H_$U/6+XS /@?7LC_F&W'_HMJ )/^$K\-XS_P )!I>/^OR/_&M1
M'26-9(W5T<!E93D$'H0:\I^&FJ1OX/T'P_<:7+/;ZC<7,<LLD0,&T+(^W/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'\:XW6'M)=.75=- V_\ "1(1=W#!KB23S@K*N -J 9 !))4=!0!ZD65<Y8#
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MUU_A^^L+G0-+>R=EAFM4:WCE($A0*.H[D<9Q0!J4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %5KZPM=3M6M;V!9X'^_&_P!UO8CN*LUE>)M<3PWX?N=5>,2>3M"J6V@L
MS!1D]AEAD^E %ZRLK;3[5+6TB$,$8PD:]%'H/0>U5?\ A'])\V[E^Q1^9?+M
MN6YS,/1O7CCZ<536[U^WO].2;^S[RTNY"LLMO&\9A'ELPP"S!@2H&>.O3GB^
MLUS!>WLEY<VBV,<:/$!E7C&#O+DG&...G0T 0'PSHC6]M;G3H?)M&W6Z<XB/
MJH['Z5(= TEIKR9K&(R7Z>7=,1DS+C&&]1CBI=,U2UU;3(=1M7S;S)O1CQ\O
MJ?2K,4L<\8DBD61#T9#D'\: *,>@Z7%%)$MHI66+R6W,6/E_W,DY"_[(XJ-O
M#.B-:6]H=.A-O:OO@BYVQ-V*CL?I6?XCUW4]*UW1;"T6T:+5)VA+2HQ:(@;L
M\,,\=N*Z1<[1N()QR0,"@#*OO"V@ZGJ,6H7VDVMQ=Q8VRR1@MQTSZX]ZEU'P
M_I&KW$-QJ&GP7$T'$<CK\RCTSZ>W2KOGQ&;R?-3S0,[-PW8]<42310[?-E2/
M<<#<P&3Z4 5]-TG3M'A:'3K*&UC=B[") NXGN?6N<MO#\UQX[UC4;_37%I=0
M0Q03B903L#;@0K;L'(X[XYKJY9XH$WS2I&N<9=@!G\:K:AJ]EICVL=S,JR7D
MPAA3(R['T]@.30!'=:!I-[%;17&GPR1VF#;IMPL1'0J!P,>U2W^DV&IB'[9;
M)*T#;HG.0\9]58<C\#2[KS^UP/.MOL)M\B/!\XR;NN<XVXQVSFIS/$)A"94\
MTC(3<-Q'KB@"N=)TXZ:^FM90M9N"'@9 5;)R<CN2><^O-5+/PIH&GSPSVNDV
MT<UN"(I-F60'T)YK4>:*+/F2(FT;CN8# ]:&EC2+S7D58P,[R<#'UH R7\'^
M')'N7?1K1C=N'GS&")&W!LD?4 GUQS3]2\+:#K$D$FHZ1:7+6P"Q%XA\JCHO
MT]NE:B2)(NZ-U=?53D53@UBRN=7NM+AF5[FTCC>901\N_=@?7Y2<>A'K0 MY
MH^FZ@]L]Y803M:-N@,D8/EGV].@_(5''H&E17)N$LT#M,9R,G:92<E]N<;N>
MN,U=$\)F,(E0R@9*;AN ]<5!JL\]KI-W<6OE^=#"SIYH)7(&><$&@"2\LK;4
M+1[2\@2>"3 >-QD-SGG\154Z!I36T]L]FLD=P LPD8N9%'16))) R<#IS47A
MK5FU?P]IE[<O$MU=VB3O&G'4 G SG&:TGGBC=$DE1&<X168 L?;UH HGP[I#
M?9-UC&?L/_'MG/[G_=]/PJ%_"/AV1KDOHMFQNG\R;,0^=L@Y/X@'WK8J/SX=
MZIYJ;GSM7<,G'7'TH JIHNFQZ@=02T1+HQ^49ER&V?W<^GM3M.TJPTF)XM/M
M4MHY&+LL? +'J<>M67FBC.'E12,?>8#J<#]:1IXDD6)Y45W^ZI8 M]!0!5OM
M&T[4IXI[NT22>$$1S#*N@/4!A@X/IFGR:5ITNF'3)+&!K(KL-N8QLQZ8Z>]6
M2Z!MI=0WIGFJ]^]R;"X%A-;I=*A\MI\F-6]6 .<4 1:3H>EZ#;-;:58PV<3-
MN98EQN/J3WHU31-,UJ.--2LHKD0MOC+CE#Z@]15KS5BMQ)<2QJ H+/G"Y_'M
M6)X6UJ]U>768[W[/FPU!K:-H%(#($4@G)//S4 7K;PYHEG'<QV^E6D:78Q.H
MB&)1TPWJ/;I3=-\,Z)H]M/;Z;IL%K'<?ZT1+@O\ 4]<5H13Q3J6AE20 X)1@
M<'TXK!\0:_<Z;JFC6UF]J\=Y?K:W"MEG0%6;(P>/N]Q0!=/AC1#IT>G'38?L
M<3[TM\?(K=<@=!SS5Z>RMKJV%O<0K+$K*P1_F&5(93SZ$ _A5;7[^72O#NIZ
ME J-+:6DLZ*X)4LJ%@#CMD53_M:^T[PY_:VH+'>DJDA2TB$.Q6QG[\A!QG/4
M9]* -6]L;74K.2SO;>.XMY1AXI%#*P^AK/@\)Z!;:4^E0Z3;1V4C;I( GRR'
MU;^]^-4/"7BJ3Q#YL+P!G@WF2XBPL?\ K&"*%)W9V8).,51L_'LEUXA_L\:>
MPWB.,6^Y/,CD+N)"S;MI4*$. 2>?K@ Z:?1M-N=*_LNXLH9K+:%\B1=RX'3K
MZ=O2F6?A_1]/TM]+M--MHK*3/F0",;7SUW#O^-4+[5-4L/%6DV#26DMGJ4DR
M;1 RR1A(BX^;>0>1_=%;-[]I^PS_ &-XDN?+;RFF!*!L<%L<XSUH SK3PEX>
ML9K>:VTBU22USY+[,F/..A/3H/IVK1O;&TU&T>TO;:*Y@D&'CE4,I_ TL,A$
M$/GR1&5U&2G"LV,G;GMU/TI\<D<R!XG5T/1E.0: *<&F6VEP3/IUHGGLF!N<
MY? .U2YR<?RS5/1+;4;BZDUC6;."SO'A6".WBE\WRD!).7P,EB>@X 5?>M>6
M>*!=\TJ1J3C+L ,_C3F=50NS *!DDG@"@!U8X\)^'Q:BU72+58!+YPC6/"[_
M .]@=_3TJKHVO7-]XHUW3IWMC:V"6S6\D0(+"0.3N))!^Z.F*Z#S$P&WK@]#
MGK0!371M.34AJ0M4^V!/+$Y)+[?[N?3VJO:>%]!L-5DU2TTFUAO9,[IDC ;G
MJ1Z9[XZUI&>$3"$RH)2,A"PW$?2AYHHMWF2HFT;FW,!@>M $E9"^%="2>2:/
M388S*VZ1$RJ.>Y9 =I_$5JEU";RP"@9SGC%)'+'-&)(I%=#T93D'\: *]_I5
MAJ<,<-[:QS)$P>/(P8V'0J1RI]Q4;Z'I<NG/ITEE$]K(VZ2)AD2'N6_O'ZU;
MBFBG4M#*D@!P2C @'TISND:%W8(JC)9C@"@"A_PC^DF:UF-C&9+(8MG.281Z
M+Z4R;PUHD\EW)+I=LSWN!<ML ,H]&]>@_(5H>?%Y'GB13%C.\'(Q]:Y[P_J^
ML:]%IVKPFR&F7BNTL#*PFA7G80V2&)P,C Z\4 :=QX>T>[TR+3+G3X);.$AH
MX77(0CH1Z=33K?0=(M)9Y;?3+6)[F,1S%8@-Z 8"GVQQBK=Q,L,1)ECB9OE0
MR' W=OK6-X-UJZUWPO#J>H"%)GDF5_*!" )(RC&2>RB@"WI'AS1=!,ITG3+>
MS,QS(8DP6]L^GM2P^'=%@LKBQBTNT2VNB3/"(AMD)]11K&H26WAZ]U'3W@ED
MM[=Y8R_S(Q4$X.#[>M5M-O\ 4M2T+0M026TB:[BAENQ(I^8-'DB/G@[B,9SQ
M0!=M=&T^RCD2WM@GFJ$=MQ+,HZ#<3G R<#/&:=INE6&CVWV;3K6.U@SN\N,8
M4'Z5:$B$D!U)'4 TC31)&96D147JQ8 #\: *U_I&G:J83J%E!=&W??%YJ!MC
M>HS45WH&E7UVUW<V,3S.FR1^1YB_W7Q]X>QR*O>;'Y8D\Q=AQAL\'/3FD6>%
MCA94/..&'7TH > %4*H  & !VK(D\(^'96N6DT6S8W;[YR8A\[9!R?Q /O6L
M&4L5##<.HSS3J ,]=!TM+YKY+*-+EX_+,JY#;,8VY';V[5G7-C?:)!!I_A71
M[..WG+^;(TWEK;$XPX3!W]2<#&<>^:Z&B@"MIUC!IFG6]A;+MAMHEC0>P&*3
M4-,LM4A6&^MDG5'#IN'*,.C*>H/N*M44 4'T/3)-/DT][*-K64EI8VY$A/4M
M_>/US3#X>TDR6DAL8R]D,6S'.81_L^E:5% &2WA?07UD:RVDVIU '=]H,8W9
M]?K[]:U2 001D'J#2T4 9UEH&DZ;*LMG8Q0LF[8%'$>>NT=%SWQBG1:+IL.I
M2:E':(MY*,/."=[CT)[CVJ_10!7O]/L]4LY+._MH[FWEQOBD7*G!R/UJLGA_
M28[N*[CL(HYX8Q%'(@VE$_NC'0>U:-% &=#X?TBWM;FTCTZ 6]X2UQ$5RLI/
M4L#U)]:72-!TG0('@TG3X+-)&W.(EQN/N>IK0HH Y_7M/U";7]$U.RMEN$L&
MG,J&0(3O3:,9]ZWHV9HU9TV,0"5SG!],TZB@ IDC.L3LB;W"DJF<;CZ9I]%
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MN_L<(GM(S';N$ ,2D $+Z# %6Z* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K.U^33
M4T>9=7CCDL9F2"59/NXD=4&?098<]JT:@N[.VO[9K:\MX[B%B"T<JAE)!!&0
M?< _A0!P2Z7J7P^US28=)U&6\T/4KQ;4Z=<G>UN6!.Z-NNT8)(_/.<BS9V=M
M_P )?XZA$$922UM'9-H(9C'(<X]<\UU=IH6DV-PMQ:Z?!%*JE4=4&4!ZA?[H
M]ABI(=)TZWOIKZ&Q@CNI_P#6S+& \GU/4T >;V=U:Z?X(\&;W@MK&XDC%]+L
M4KDQOY9D'<;P.3W7VKL?#NEV&GZUJDUEJ(N&O!'+/!$JB&)L$!@%Z,P'/KC-
M:::!HT6G2Z='I5FEG.2TENL"A')[E<8)X'Y5+INE:?H]J+73;.&T@!W>7"@4
M$^O'4T <QXS8#Q=X-R0/]/D_]%FNDU2^-I;F.$AKR9'%M%U+NJ%NGIQ^H]:9
MJ/A_1M7D634M+M+QT&%:>%7*_3(XHLO#^C:==?:K+2K2VGV[/-BA56V^F0.G
M% 'GLR0W7P;M=8M.=8B,<L=RH_??:S*%;GJ26)4CT.*V;:73]5\4>)]*\1^1
MYOE1)$DQ  MVB&XH3_M%B2.^/05U<>A:3%>M>QZ=;I<,_F%Q& 2_][_>]^M-
MU'P_HVKSPSZEI=I=RP?ZMYHE8K[<]O:@#F/^)1+K=EI]H1.\&C<3:@^^)+8L
M!OVGEV;;R<CY>I[5SVFK;7G@[X?O<K%.W]H)$QD 8[=LN%.>W X]J],NM&TN
M^O(+R[T^VGN+;_4RR1*S1_0GI41\.Z(VG_V<=(LC9^9YOV<P+LW_ -[;C&?>
M@#GHH8(?BQ*]E%$#)X?##9@!SYV >/8 ?2N?B6#4/@W<:K-QK$)DF>XQB=+M
M9#CGJ&SA0/0@=*]'&D::NHC45L;<7@38)Q&-X7^[GKCVIG]A:3]N:^_LZW^T
M,X=I/+&68=&/JWOUH X^QTBSU'X@WL>JV%O*\NC6TEQ"Z HTI9PQ*]"?>J>A
M6M[>_#SP\FFWMNM]:W<S6T-X"T5P$>5?+;'HO(/;;[9'>G1=+:_>_.GV_P!K
MD4H\_EC>RGC!;KBH4\-:'';);1Z3:1PQR>:B)"%"/TW#'0^XYH H^"KV.]TJ
MZ TLZ7/!>R175J&#*DW#,5(X*G<#^)K$@BCMO'/C">UMH/ML=E;26N47)E*2
M=/<G&?6NWMK6WLX1#;0I#&"3M08&2<D_4GG-1MIE@VI+J365N;U$\M;DQCS
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MS&5/4!5"E?S]:[A-'TR/4FU)+"W6]<8:X$8\PCT+=:;/H6DW5X;R?3K>2X8
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MP##H1Z$>M '):;9)#XM\4Z=%"C:28(9F@*@QQSLI+8'0$@*Q]\&K?PSMX(O
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ME89!!R"*KOIUG)IO]FR6T;V?E"+R&7*E,8QCTQ4T<:0Q)%$BI&BA551@*!T
M% #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM/,TS3;#[(S&50[';( 0">GSCTZ&IOAGX=U7PW8:G;ZK;K$US>M<1E) X(8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX<M5/]DSZ:)7M@24C; &X#MG.#CKFO.TGNT^$D6O#4+TZA!K&R*4W+G8NS.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *HZIIB:K'!#+/-%%',)'6&5HS( " I92"!D@_A5ZB@#@-
M#TF"_P#&?BS3KBXOVMK-K5;=!?S#RM\1+8._N>:6*=M!^(=S%LO]2==$@_=Q
M9D>1A(P+ ,V%R%'<#\35[PU#=1>._%%W-97,-MJ#6QMI9(BJR>7&5;Z<^N,U
M+%'<1_$N]OWL[D6ATN.!9Q"Q5G5V8@8'H?QH TK3Q1I]_HUEJ=JLTJW[%+>
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MBXMMF)-JS%CM!X;@@\&MZ,73_$E=3DT^[BM3HWD&1HB0LGF[]O&>=OIQGC-
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M,2W.@7>F&-?]*:Z"A2V/NQX)+<\YP!@>IH J>'_&+:AX:M]6O[*:!KNX,4"
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M, 6;=R2!CCJ3BJEGX;&N:IXLMM3L;JV@U&XCEL[EHBI4HF ZG^$@@'G&?SH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7.F746I26LLEO))@+&GR[U.&()^[Z_6@#0T_1DL9/.FO;N_G"E5ENG!*@]0
MH"CIUQFM*N$\?:U#J/@?7!:V=S<6\"O$;J-E""13@X&X%@#P3C&?7!QOV.O0
MKJ=MH)M;@7)T\7:283RW0%5(!W9SDCJ!]: -RBN>A\96,^F&]%K=J?MYT]8&
M5?,:;=MQPQ7&>Y..*BOM8M]:T/Q%8/;S6]SI\+I/$Y ()CWJP93R",&@#I:6
ML3P5_P B-H7_ &#H/_1:URM]JVG:?XTU"T\9PR1PW3K_ &7>REO(6/:,JK#_
M %;;LDMP>>H&* /1:*YN._@\(Z/IEM.;J_BNKP6\5RCK(<RR$H79F!/!&2,U
M)J.L6U[=:KX>DMKF.:&P-P78J$=#D J5;/4'J!0!OTM>?>$O&%MI/A7PY:WN
MGW\=M/!% M^T0\@2$< G.X#/&<8]^]=+J/BFWL$OI(K*ZO8M-P+N2W"D1G 8
M@ L"Q"D$@= ?7B@#<HK)E\00FZ2TL;::^N7MQ<F.+:NR,_=+%R "><#KP>E4
M)?'>EQZ-!JBP7<D4MV+.2-8AO@EW;2KKG@@^F?;- '2T5@VOBE;K4;[3?[*O
M8+ZU@%PD$VQ3/&20&4AB!R,<XQ61IGCXKX,M/$&JZ;=JMS(%#1*C+\[D+C#9
MP.!R 3Z&@#M:*P$\5!IH+5M'U"&[N9I8X8)D52ZQJ&+YW8"_,!USGM3K;Q;I
M]UHT>HK'.IEN3:+;%1YIG#%2F,XSD'G.,#.<4 ;M%<KJOC-[/2=<EBTJY6^T
MB(.\,VT*0RDJX8'#+P<@<\8Q6YHUW/?:3;7%Q!+#*\:EA)LRQP.?E)&#_D4
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MH\2+,)<&)N^W'R[.F,<5UWAZZU@7*VUQX:N+*.0M+<WMS=0NTCX]$)Y/ [
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M<L-5,<D4D*1M)!(J!"K!R/E.T'.<"C71=V.LZ%<VVCS->6]O,94TSRV,2,5
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M^GMVFMO/V,LH'7!1CR.X/:N%TB;1=1L)?#/B*!M*\5%61KJX)62XD.<.LO\
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M\BU<D6KV\8() )VG)&#QC'8]<4V+QI'+?PZ>=$U6.]GM6N4MWB16P&"[<EL
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M$ESX9U%)X@5:TD)1N<':3_.N4\,>+DTKPWX:M;W2[V&SN;:"WCU!@OE>:4
M(SN )X#$ 'Z<UV>H02WFCW5NJJLTUNZ ;N Q4CK]37'P:+J>I^#]%\,W.G36
M9LS;B\FE9"H6$@G858[BQ48] 3G'0@&[JGBRUTR&\N?LES<VM@VVZFAV$1'
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MJ/Q"ME//8WE@+2=(P&DMW5RRMM!Y4Y(XS@T 3W'CO2[?0)]8:WNREK<?9KF
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *CGGBM;>2XF<)%$A=V/15 R34E4=6TTZK9&T^U2VRLZLS
M1!26 (.T[@1@XY]1Q0!Q_A_5&L_&H^T732)XC@,WEM_R[W"<B/\ []$#W,=7
M]%;^V/'GB"2^42?V4T-O:1.,B%63<S@>K$]>N !6SKV@1Z]#:))=SVSV=RES
M%+!MW!USC[P(QR<CO3+CPZK:M_:]E>S65\\:Q3NBJR7"CIO4C&1S@C!YQTH
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M*TN;RSFNM+:QDA7RX&F$4Q8$EE4$@,HQG'8CO7):->3ZG'X2T6X+G2KRXO9
MCG_7PPDF%&]5P0<="%%>C:CIYU*W-K)<R1V[C;*L7RM(.XW=0#[8/N*K:GX<
ML=1L[2W4/9M8LKV<UMA6MR!@;>",8X(((([4 1:Y86UK9R:S;VR)>:=;S20L
MB $_NV&T^HZ<>U<S;$Z;IO@6\MLM<7;+'<./O3B6!I'+'OEP&^HKLK?3Y@0U
M]?/>%00%9%1>1@D@#DX)Z\>U5+#PQ:V,UD?.FFBTU66RB?&( PQZ9)"_*,]!
M[\T <=97,J>"/#6N@YU&ZU6*264?>D,TI5U)]-K8QVVCT%(;J7_A7DGB4_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
)10 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>62
<FILENAME>ebs20191231exhibit1048023.jpg
<TEXT>
begin 644 ebs20191231exhibit1048023.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@L8@!1F<'@8P0<YY&.:W+?Q!I=T\D<-V#)%")V1D96,9Z. 1EE]QD5P<FLV
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M481^<RJI<I'TWL%!PO\ M'BN,T_6M+TW4/$?A[Q/&?/O-0EGAA>%I/MD+@;
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M*?W?7TDV_P#?5'B"XM_#MMX?M[L0J7NSOU*9,K;RE6+28_O.S,!G@;LG.,4
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MZ^] '=V]Q#=V\=Q;2I-#*H9)$8%6!Z$$=:I/XATF.[%J][&)#-]G!P=GF_\
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M#Q_>W#(7#?PG)'0CZT ;-+7EMIXA\01_"Q?%TOB&1KV-G)AG@A\F;;*4"85
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M)O%.B0:5%JCWZ?8I6V+.JLR[LXP<#@YXP>_% &M255FU.TM[F&WFD9))T:1
MT;8VK]XDXP,9&<XZU0T;4],&B37\>M->V:32LUW.PPOS'*@X' Z"@#9Z4  $
MD  GK[UR$.N27?Q-@LK>^N3:G3))7M)8C$$<.@#890QR">3GOBMT>(])-[#9
M_:P)9W*0EHV"2L.JJY&UCP> <\4 :=%9QUW31=);>>Q=YC K")RAD&<J'QMR
M,'(SV/I3M<U>WT'1KK5+E)'BMHR[+&A9CCZ?S/ [T 7@ .@ I:P8?&&CBPL9
M[V\2UEO4!2.1&4D[=QP",XZ\]*E3Q=H4MI%=0WWG12Q-,OE1.[>6IVLY4*2
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M&;3]5D(#1LR+EY21(%!*@H>#@]1QC-=9X-OM'U'6M:U"RU:WNKR_>.26WBW
M0HB!%P& )]VP.H%:VN:-?:A=V5[IVJ&QN+(OM5X1+%(& !W+D'/'!!&,GUJ:
MPTRZCNEO=3O([N[6-HD:*#R416(+ #+'DJO5CT&,<Y ,?Q+JD5EXHTB"=/LJ
M313;=06#S)%/R_NDX(!;KR#G&!R<UQJ3PIX%M+259%>#Q(&D2:-@0OVAF).1
MSA>3Z9YZUZ[10!Y_K3/>>-M9@TR9?M5SX:,-NRMPTV^0@ _WL$'Z<UF7.O:?
M>>$O"=I$LB76GZG8K<VODOOMS&<-E<9'0X]:]3HH KWDL<>GS2R,$01$DMQ@
M8]Z\QMYH%^'_ (&CE908-4MVF5NL87?N+#L!D9)]17JU% 'G][-IS^+_ !4M
M[F6TFT>-)5B/S2 !]X7'5@#VYIVBMJ27=[I*:DGB#3_[,=K:^V@S1$D 0NPX
M8GKZ_+S7?44 >6/?VDOP\\(0OG-K?V*W"21D;=A_>9!'1<<]A70^*[N#3_%W
MA75KE_+L8S=1O.%)16DC79DCUP:[*B@#RFX>ZN].\62V%I<S/%K,-X8/)93-
M$GED@9'7Y2=O7CI776FM:/XG6XN]'M3<S_8GB>Z:W*,@/(BW, 22>=HX&.>H
MSU%% 'EES>P3?!?3K9=XF@-I$Z-&RD.DJ%Q@CG !)QTKH$O4TCXC7]YJ<R1V
M.IV, LKN1@(@4W;H]W0$[MP]:[.B@#RF[M#9>&II9U\NVOO%*W=K$Z](/-7+
M;>RD!F^A'K73Q7-NWQ:D9)4(DT1$# \,PF9MN>YVG./2NOHH Y+XFRHG@FYC
M)_>23V^Q!RS;9D8X'? !-0ZI=K8?$'2];N)5.CSZ?):+<YS%#*7#99NBA@H&
M?:NSHH \L\0VS'1?'FI0<V.IF!+,+TF=4 =D'?)XR.NTFO2["6":P@DMF1H6
MC784Z8Q5BB@#A=-U6+1/&7B.SUHO%)?RI-9R-&S"XC$878N!R5(QMZ\UB>'-
M6BL?"_@V&:%K976=#J#VQ9K=NRID$ OG&<$8!Z]O5:* /)92S> ?$D*0W3-!
MKYG<20N&\O[0C;CD?W>3W%=+J.N6L_BR*$)):QW.G;H;R.U9I;KYS^Z4E3@#
M&[IDY!&.I[6B@#E?AG(&^'^E1E75X8C&X="N&!.1R.:P[R673]:GO= U 3^=
MJ:I>Z%<J&+OY@4RQ=UZ!\]."3TQ7HU% 'GDU_!IGB/QM:W7F+/?0QR6L8C8F
M91;[25P.@((/IWJM8SQ00?#N_NE:&TM+62*>::,JD3F!5&XD8&2, ]*],HH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!P #W''![C%<K!+>:/J5D4>WUG0KW5V$)QMN;&X=WW>SJ&+Y[@9["@#8\/\
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MQ;U&3GO75^+K:.\T(V[ZB=.D>XA\BYVA@DHD4QY!X(+ #'O0!=_MK2?(:?\
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ML<$(:&_N%B<*,QA9_E"GMC/&/7WKK+]8/^%I:#,@C\R73KG<Z@9<?)CGOWH
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MB?\ #/\ *=ZX\]^<_P#3Z:ZGQFG]BW^G^,88R?L#>1?!%R7M7(!/OM;##\:
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M6/,6.0,4R,C('3(JQ63X=L-/M-)MI[*U@B:>WB,DL2 -+A>"S#ENIY/J:UJ
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ J*XMH+N/RKF".9,YVR(&&?H:EJEK.JV^AZ
M1<ZG=Y\FW3<0O5CT"CW)( ^M  ='TLHJ'3;0JI)5?(7 /MQ4L=A9PW#7,5I
MD[9W2K& QSUR>M8>M>(;S0=*LQ+%'<:OJ=PD%M; XC21NQ/7:O<]3[9XEU"V
M\2VND7%Q9:G%=:@L3,L,EL!$S8Z* =P]LLWO0!N+&B.[JBJSG+$#!;C'/KQ4
M$VFV%Q=)=3V-O+<1_<E>)6=?H2,BL6ZU^YO?%0\-Z44BDAMQ<7MS(F[R5)PJ
M*O\ ?.<Y/ '8TV^UJ\\-:QIMOJ5P+O3]3F^S1W#($DAF(RH;'#*V". ",=Z
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M*I+!<CA>3GUH V1I&F!74:=:A9/O@0KAOKQS3I=+T^:T6TEL+:2V4Y6%H5*
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M&70$H?49Z4MQ:V]W%Y5S!'/'G.V1 PS]#0!YMJ5CH%G:>%H[!_-L'U[<DD[
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MWEC_ ,(!XG@^T0;?^$D8(@<8VFXC;IZ8#'\#73WMSI\'Q-A'F1!&\/RJ4C8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAF5B]UY?W\," F3D#ANF>,\6]#\,+HVMZI?+/O@NYC);P]H-X4RX_P!YE!_
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M8731J<K&3G:!T&>3CTZ@ 6[\4:E+H.JZ]I:6GV/3C,$2=6+7(BR'8,& 09#
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MPL19NS-YT4?9&XPV.@.1Q0!J7Z)'$UXM@U[/%&PCC3;O(.,@%B ,X'?M7+^
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M4NH(5B.1GKC\A3J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH ***JZEJ%MI.G7&H7DGEV]O&9)&Z\#T]3[4 6J*J6EQ/]A%SJ
M CMV8;RA./*!_A)[D=S2W4UPUB9].\J=P-R*6^64?W0PZ9]>: +5%5-+U*VU
MC3+?4;1BT-PFY<C!'J".Q!R"/45;H **** "BBL;Q!X@&CO9V=O!]JU'493%
M:6^[:&(&69CSA5').#0!LT5A7TWB6PL6ND_L^^9,%X(X'B(7/S%3O;<0,\8&
M?:MQF51EF 'J30 M%-9U4J&8 L<*">IZ\4D<L<R!XI%D0]&4Y% #Z*0,K9VL
M#@X.#T-,2>&1MJ2HQQNP&!X]: )**A6=+B)S:SQ.PR P.X!O?!K(\&:S=Z_X
M9@U&^6);B269&$*D*-LK*, DGHHH W:*;(',;"-E5\?*67(!]QD9_.N$MO&G
MB!_#6HZ^]EI\T.F7,L4UNA='98SAF5B2,XYP1VZT =[15*SU:SO=*M-3698K
M>[B26,RD+PP! ^O-6FEC0@-(JD] 6 S0 ^BF>9&&*[UW 9(SR!2+/"[A%E1F
M*[PH8$E?7Z4 244R*:*92T4B2*#C*L",^E.#*Q(# D=0#TH 6BH_M$&Y5\Z/
M<Y(4;AEB.N/7%54UFQEUF72$G5KJ&)99$!'RAB0 ?<X)QZ?6@"]13'ECCQO=
M5STW'&:!+&7*"12PZC<,T /HJE>273&U:QN+54^T*)S,"VZ/!RJX/#9QC-9E
MMK&H2^-=1T5_LX@@LH[B!@AW99F'S<\_=[8H Z"BL'P=K-YKN@_;;]85G%S-
M$1"I"X21E& 23T%,BUR[7QO>Z1=-;)906"72. 58%G*X8DX_A]!UH Z&BD#!
ME#*001D$=Z%977<K!@>X- "T5S\^MWEOX[AT>0VXL)=/DNMVTAU965>3G&.3
MVK=66-HA*KJ8R,[P>,>N: 'T5'%-%/'YD,J2)_>1@1^8HBN()P3#-'(!UV,#
MC\J )**0,K$@,"1UP>E<]XPUZYT33DGL)+5IA<0QRQRY9@CR*F0 1C[W>@#H
MJ**C6>%YFA65&E099 PW#ZB@"2BHY+B&(,9)HT"8W;F QGIFI* "BHS/$K[#
M*@;=MP6&<XSCZXI^Y=VW<-V,XSS0 M%1O/#'(D<DJ([\(K, 6^@[T]F51EF
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M)]QBX ;Z>M222)$A>1U1%&2S' % #J*H:EK5AI5E'=W5P@BED2*(A@?,9B
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M41MGKE<8H Y32&^S_%.ZA=K.(RZ-$SQ6O"!A*P /]Y@IZX'!' JS\.KF"U\
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M-.,32)"H:3_>..?QH X+3VM[;Q1X*>#[-;6\MA<!(T<-)Y7EH5\Q^ Q)&>F
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M=QCKS5J**."%(88UCCC4*B(,*H'0 #H* 'T444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=K>V\,4*2XMFCD+&1,#EAC@YS0!<HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH CAMXK<,(8Q&'8N0O R>IQ[]?KD]Z66*.>)HI5W(PPRGH1Z'VI]% "*H
M50J@  8 ':EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBB@ HHJO?WUMIMC->W<HB@@0N['L/\: +%%%5;1[YYKH7<,,<2RXMVC<L73
MY88X.<\4 6J*** "BL2VURXF\8WFA2VL:1V]HERDJR%BX9BO(P,=#Z_6MN@
MHJ.=I5@=H(UDE ^1'?:&/H3@X_(UF>%=:?Q%X9L=7DA6!KI"YC4Y"\D8S^%
M&O1159[Z!;\6 D4W30M,L>?X00,GT&2/U]* +-%8OA?7)]>L;N>XMH[>2WO9
MK4I&Y<?(VW.2!G\A6U0 445@7^N7[ZG>Z7HMK!<7=C;QSRK/(4#ERVU 1T)"
MDY/ R/? !OT5'"\DD$;RQ>5(R@M&6!V''(R.N*QUUVY/C630&M8A&NG_ &Q)
MA*26^?9@C''?U[4 ;E%8OA?7)]>M+R6YMH[>2UOIK4I&Y<?NSC.2!G\A6U0
M444ASCCK0 M%5=.>]DL(7U&&*&[(_>QPN713GL2!GBK5 !1139"XC8Q@,X!V
MAC@$]LF@!U%9Z:BUII]F^K^3;W5PR1&.-RRF5N-JD\G_  !K0H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "N1U=W?XH^'89/\ 5)9W4D?H7PH/_CO\ZZZLG6M):]N+#4;;:+[3
M93)#N. ZLNUT)[!@>O8@'M0!E?$O_D3)?^OJU_\ 1Z5TEY&DMC/'( 4>-E;/
MH1S5;4]'L=?L4M]3MY'BR',1E9,,,$9V-R01[\BDU6UN9]*DTZR+(UQ&83.[
M;O*4C!;DY9L9Q[XSQ0!D?#2:>?X=Z*]P27%OM&?[JL0O_CH%=15>PLK?3;"W
ML;5-D%M&L4:^B@8%6* "BBB@ KG];DNKS6;+3[.W2Y6U(O+E'EV#@D1 G!_B
M!;_MF*Z"J-KH]E9ZA<ZA DHN+K'G,T[L&QT^4D@8[8'% '*>"'FT/Q'J_A:[
MA6W5F.HV,:ON41.<.H.!PK>W<U=^)^Y?A[JLL<LL4D<:LK12,A^\!S@C(P>A
MXK8N?#FE7>LPZS-!(;^!=L<PGD4H/0 -C![C'-9WQ"L;W5/!.HZ?IUH]U=7*
M*D<:$#^($DDD < T 9.HZ0-"\<:#<:;<79;5))H+]'N'?SU$9;><G@@CMC'&
M,5FZ5:_8_">M>(8GNKC4M*N=0^R-)<.X0 LO*YPW'/S9/'7@5W5CH]A"R7:6
M\ZS>48U,\SN\2GJJY8[>@Z>@]!3M+T+3=&BGBL(&CCN',DJM,\@9CU.&)Y/?
MUH XW4XQI_ACP[K^D2.=0DGM0\H<EKU9<!ED_O9SGGICC%%GX=M-?U[Q;9WU
MU>F*&ZC$'^ER#R6,*G<.>2"> <@=A76V7AC1].>)K6U9%A<O#$9G:.%CG)1"
M2JGD] .I]:P='\/O=>)O$ESJ5A=P07TR&%A<,BS1B,*0P1N>0>&'0_6@#$\/
M:MJ&MP>%].U>YBQ=Z;-*/M49D2[D60*N1N7<?+^;G/7.,X(FUG1IM(T>RLCK
MD]SL\16X3RF>/[,DCJ?*^^VX $$9SC(KM-6\,:+KEC#8ZAI\<L%N0854F,Q8
M&!M*D%?PJ.7PCH<VFV^G-9%;6VD\V)$FD3#YSO)# EL\Y))H N:7I-IHUJUK
M9+(L32-)B25I#ECD\L2:XGRV'_"PXA<7.(5#Q-]H?<A^S[N&SD#)Z9QVZ5Z"
MJA$"C.%&!DDG\SUK*_X1?2,Z@?L\F=3&+O\ TF7]\,8Y^;TXX[<=* ..M;5=
M/;P'J4$UQ]IO5CAN':9F$B-;D[2"<8! (XJY]HE\.>*-8TIY99AJL"SZ6)I6
M8!R?+:(9/ #,K<=%)]*Z0^%-&:*QB-O-LTX@V@^U2_NL<#'S>G'TXZ5=N=,L
M[N^M+V>!7N+)F:!SU0LNUL?44 <MY:#QS8>%[MGGTZWT<SQI<,7%Q+Y@4E\_
M?(7G!_O$^E8NH&Z@\-^.]+6XN#9Z6P:RD$S!H]T8<QA@<E5)'!['%=_J.BV&
MJR02W<),MLQ:&:.1HY(R1@X92",CJ,X-1R^'M*GTF72I+8FTG):9/-<&4GJ6
M;.YB>^3S0!SXNH[WQ=I6AZAA[-M&^T1PO]R>7< <C^(JHR ?4GL*KZDJ:&FB
MZ##JCO97&I20S2W9,@7Y&=(205)7)48SVP>,BNBU+PEH>KV5K:7UD9H[/_CW
M8S.)(_HX.[L._85+<^&=%N]#&B3Z=$^GCI <X!SG(/7.23G.>30!3\/:+)HF
MJ:E'_:<<T-QY<T=C'"42UX()7+-@,03C@9!Q69K%FEU\3=-@EEN/(GTV<R1+
M.X1L,@' /'7G&,]\UT>CZ'IN@VIMM,MA!&QW-EF=F/3)9B2?Q-$VAZ?<:O%J
MTD4AO84,<<@F<;5/48!Q@_2@#SL:7"_@KQ>6FNC_ &->W:Z?_I+_ .C!%5UV
M\]B>ISQ7007,\GCG02T\NV[T:229-YV.X\OG;TSR:VU\)Z*MG>V8MI?(U!S)
M=(;F4B5C]XGYN_?UI+KPEI%W'8*\5PATX%;:2.ZE21%/!7>&W$$ #!/:@#E;
M!-4OM!URVL+I9;B#Q#,D$-W,Q2:-"K>3DG(4@'CIZ\$UFZ_/8:A\//$,3:5+
MIM[:WD#W%C,01;R,8E!0CC:5&1CU/K7=0>#M"MH)H(+1XXY[G[4P2>1<2]F7
M##;^&.@JR_AW29;"[L9K0307IS<B5V=I3@ $L3NX &.>,#% %ZWMX;6!88$"
M1KT4=N]>=2*Z^'/B$HN+G-O<3-$WVA]RD0*P&[.<9[9Q7H=G9P6%JEK;1[(H
MQA1DD_B3R3[FLW_A%-%\F_A-M(8]2)-VIN9?WQ/!S\WIQ].* .7AM$TWQ'X+
MNK:6?SM0@DBNF>9F$RBWW $$XX89& ,5)HD-IXH\-3:MJ%[+:ZC!?2O-<Q/B
M2U\N4XC&<X78%!7ODGJ:Z8^%](9[!S#,6TWBT)NI<Q=N/FYXXY[<=*C;P;X>
M;6VUDZ9']M=P[.'8*SCHQ3.TMGG)&<\T 9L"+)\5-21QE6T: $9Q_P M7KG(
MKNZ/PCTZ]:]N?M,>HA1,9WWE?MA7!.<D;>,'M7H$>B:?%K,FL)$XOI$\MY?.
M<@J.@VYQC\*S)/ 7AV6*>%[25H9YO/,/VF38C[MQ*+NPF3UVX].E %'3?)\2
M^)_$EKJ8,GV"6.WMX2Q'DH4W>8OHS$D[ASP.>*YWPW>.?#7@?26GABM;Z*XW
MB9"T<CI]Q& 89!W,<$\D#@UW=UX5T6\U%-1FM&^U)&(C*DTB&1!_"^UAO'LV
M:B?P5X<DT&/0GTN-M/C;>D1=LJWJ&SN!Y/.>] ">&=(DT274+1M46ZC>831V
MRQ%%M P/RKEF^4XR!QC\:R?[/M&^,,DC0*7_ +%2;=_MB<@'ZX %=/I6D6&B
M68M-.MQ!#G<1N+%CZEB22>!R3VIEWH6F7VIP:G<6H>[MTV1RAF!"YS@X.#SR
M,]#R* /,KJR1/ 7B76$EG2]L=7NI+:1)F41,)QR #CGOFNINB=?\9ZEHUW+;
MB."SA>WM[B)G#!MV^1<.O(.T9ZC QC)SLCP=H0TNYTS[')]CNI/-FA-S+AV)
MR2?F[GD^M&J>#M!UD6IU"Q,[VB[893-()%'H7#;B/J30!-X9M)K#0+:RN-4.
MJRV^Z)KMDVE]K$8(R>1C;G/:N:LK2WM?'GBNY@M%DFMK.UFA3GE]LI_4@5VM
MM;06=M';6T20PQ*%2-!@*!T %4K?0-.M=6GU6&*1;RX $LAN)#O Z @MC [<
M<4 <%<.S?"BW\66MPYUM$2Y^V*27DD,@#1MZKR5V=!Q@<5T499OBR&==K'P^
M"5]#Y]:T/A?1K>8R16A53-Y_DB5_)$F<[A'G8#GG..O/6ISH>GMK)UDQ2?;C
M%Y/FB9Q^[SG;C.,9YZ=>: //1J5QIGA'5WAE>%)_%,T$\Z-M,433@.P/;CC/
M;-;^HV@T;QSH4&EH8;75([B&]MHR0C*B;EDP.C G&[J<XK=M_#&C6UA=V,=G
MNM;UF>XBED>19&;J2&)Y/J*FL-#T_39!+;QR&18_*5YIWF9$_NJ7)(' X'H/
M2@#SN\%_%HFL>&;:XNY=9TV]:>T<W,F^2W(\U2S9RP*@QXZ9V]*ZW19K3Q4[
MZQ!).MF]I'!$(YW3YF7>YX(Y&Y5SU!5A6ZNFV::K)JBP*+R2%8&E[E 20/S)
M_3TIEGI%CI^F#3;2'R+4;L)&Q7&XDG!!R.2: /-K/S;GX;^"IFN[E99-5MT=
MTF8%@TK9SS@_CFN@TZT?2_&VO:;I4KQ)+ID5RBRRM(JS%G7=\Q/7 SZUM#P=
MH0TVUTX6DBVMG*)K>-;F4")P<A@=V00>1Z9I-2\/Q)]OU33+</K$UJT,;3SR
M%'X.U64G!7)Z8H Y33--N]6L?"SP0WL-TC;M5N1))$)DVG<3*I'F;FVE2">#
MZ5W>L1B;1KV,M(@,#_-&Y1AP>A!!%<-IOA* Q0Q67AG5M$O8@H^UMJ7[J)AU
M("RG?]-@!Z'%>@W-M%>6TEM,&,4JE7"N5)!Z\@@B@#S)K6&]\)?#R:Y032/>
MVZ,[G)*F-R1GW('Y5L/:_P#"2>(O$&BRW%O%]B2**VBEA9VBC:('S(\.N#N)
M^8<\ 9KHF\*:(^D6^DM9DV=K(LD$9F?,3+T*MG<,9/0]ZCU3P9X>UFX@N+[3
M$>6W01QNCM&0@Z*=I&1['B@#F6L'/BOPM97.K7&HA[&ZCGF65XUN-@4 [0QP
M>3D@\]R15!=)MW\-^-(6DN3'I%Q<FP7[0^+<B(."O/9O7/ZG/?OX?TM]0M+_
M .S%9[)/+MRDKHL2]-H4$+C '&.U0KX5T=(+Z!;>7R]1)-VOVF4^:2,'/S=Q
MP?;B@#F;^75IK+2-56PCUVW73(VO+ OB92X!\Y >"WRL/7CCJ:W]$MM*U?1M
M!U&UEN9(K2$&U9Y&5C\FP[P#AC@=\\U83PMI,7D^5%<1F"#[/&T=Y,I$><A<
MALD#/&>GX5,=!TO?ISBS13I>?L80E1%E=IP <'CUH T:*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;F:YCCBB>U#*KKT5CG.,#D]:VZ* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBT=SYBC&T9Q&0Q&-H]N:Y:RU"7PQX)\1:G:SS-/'K%Q;QM-*TBING"!R">2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !6%%IKZ7XKN]3AC9[;58XUN HR8Y4R%;']TJ<'T*@]"2-VB@##@
M\+6]O_:Q2^O,ZN2UP2R<$C;E?EX^7C_Z]5[W06A\)+X5TZ2=HYH?LOG2X/DP
M'AB2  3MR .I)';)%V[U[[)XGT_1&LY#]OCED2XWC:-@!(QU[CTK7H BMK>*
MTM8K:! D4*"-%'90, ?E4M%% !1110 A&00"1GN.U<T_@6PDT._T=[Z_-MJ%
MP;F?YTW%RVXX.S@$@'\*Z:B@#'?P['+K=EJ\FH7CW-G$8DR8PK*V-VX!.^!T
MQTXQ5AM$L7\0)KIB_P!-CMS;!^VPMN_/KS[FM"B@#(N_#MO/K U>WNKFQO3%
MY,DML4_>IG(#*ZL#CL<9]Z@O/"&G7>B0Z.LEQ;VT4PG/E.-SR!M^YBP.3NY/
MJ:WJ* .?U3P=9:GJD6JK?:A8WR1"%[BRG$33)_=?C!_ #]!1JW@S2]5AL5$E
MW93Z?G[-=6DQ2:,'[PW'.<]\YS^)K6O[BZMH$>TLFO':5%9%D5-JDX+9/H.<
M=ZHVNO\ VGQ3>:$;.2)K6W2?SF<$2!B0, ?0]?RH N:9IL.E6@MX9)I226>6
M>0O)(QZLS'J>!]  !P*SKCPE9RZY-K%O>7MC<7**ETMK*%2X &!N!!Y XRI!
M]ZE\2:__ ,([8179LY+E9)XX3M<*$WL%!.>>I[ UL4 <O;^ -+M+32X+:\U&
M%]*WBWG2X_>;7^\IXQ@X'  ]L5)_P@ND?V5J.F^9>&#4;C[2^;@EHY-P;<A/
M0[@#DY)[YKI*BBN(9I)HXI%=H'\N0#^%MH;!_!@?QH PM4\%V&J26=PU[J-M
M?6:E$OK:XVSLI.2K,0003VQQVQ6SI]A#IMFEK 9&5<DO(Y=W8G)9F/))-6:9
M++'!$\TKA(XU+,S' 4#DDT <U=^ -)O(]3A>YOTM]3E,\UNEQB-9202ZC'4D
M \Y'M5Z+PS##K@UA-0O?M/V46OS.C Q@DC.5))W'.<_IQ2W_ (B6RUK1].6T
MDE356<)<!@%3:A?IU)P/0=>M;- ',?\ "!:4=$&DO<WKQQW)NH)O,59;>4DL
M61@HP<DGG/6K>G^%K:QULZRU_?W5ZUN+=GGE!#*"2,JH SS]/;.2=RB@#+US
M08->CM8[BXN(1:W"7*>05&9%.5)R#T/:HT\.Q1:[<:RE_>+<W,(A<9C*[5SM
MP-G4$DTMCKWVWQ)J.C&SDA:PCBD\UW!$@?=C '0?+W_*M>@#)T3P[::'H@T>
M&2:XM!O 6X*L0&)+#( R"2>OK4FGZ!IVG>'H]!B@WV*0F$QR<[U.<Y]<Y.?K
M5V&XAN/,\F17\MS&^.S#J*EH P['PI:626<+7=W=6VGL'M+>X=62$@$*00H9
MMH) W$X_ 4^+PQ91ZEJE[)+/<?VLBQW4,I4QLJJ5  "@CY21UYSSFMFB@#G]
M"\'66@2(8+[4;F* $6T%U<EX[<$8^08'8D9.2 3ZFH;7P)I=EJ4ES;76H16T
MLOG/IZW)%J7SG.S'KSC./;%6+#Q)/J<UG-9Z7)-IEX\B)>)("4VDC<R8X5BI
MP03VR!FMZ@"MJ-DFI:=<6,DLD27$9C=HR VTC!QD'M6.?!UJ;/2;7^T;X)H[
M*UJ0T>057:N?DYPO%=#10!SEYX)T^\NM3F-Y?PQZK&5NK>*8+&[;-N_&,[L8
M[X..0:E7PC9I/H\J7EZIT9"EJ/,5A@KM.[*DG*\>W;%:EW<74$MJMO9-<K++
MLF<2*ODK@G>0>O( P.>:I66O?:_$NH:*;.2)K**.7S6<$2!RV, =/N]_RH B
MC\+6\4VK3+?WF_5P!<',?&%V@K\G'R\?_7YJ*/P9906^EQP7M[%-I"-':7"N
MF]$8 %""NUA@ <C/'6M?3KBZNK,2WEDUE,68&%I%<@!B <KQR #^-6J ,:3P
MKI5QI-[IUW$UU'J#;[N25OGE;C#$C&",#&, 8&!4&G^#[;3[2:#^U-4NFEA,
M"S75P)7AC/54R,#.!SC/ ]*Z"B@#&M_#4%KX8_X1^&_OTMUC\N.9)0LT2CH%
M90.F*UT78BKDG QDG)-.HH PO#NF/H'VG21&QLS/)/:.!E51SN:,^A#$XSU!
M'<'#;/PE!I<DG]D:G?Z;;RN7-I T;0ACR2H=&*Y]%(%;5Q<0VMN\\\BQQ1C+
M,W0"I: ,G4/#6G:GIB6,ZR@1RB>.9)#YL<H.1(&/.[W_  Z41:!"DEQ<2WES
M/>7$ MS=R;/,6/D[5 4*.23]WGOT&-:B@#FAX(LAHVG:4NH7ZV^F3I/;$-'N
M5EY7)V<@'/7UYS5P^&K5=9N]6ANKR"XO(U281R#8Q52JOM((R <>GMFMFB@#
MG8_!6FKX2/AEY[N2Q&/++2 2188,-K #HPSSG\JDM_!]A#JG]I2W-[=7#6OV
M64W$^Y9DR3\PQ@]3P,#VS6]5>_GN+:QFFM;0W<Z(6C@5PAD/ID\#\: ,71/!
M6GZ#,AMKS49K>$DV]I<7)>&W)S]Q<>YQDG&:DC\':2L6J6\@GFM=5D>2>VDE
M)C5G.6*CL20#GMVQ6Y&S-&K.FQB 2I.<'TIU &/9^&X+6:UEGO;R^>R0I:FY
M9#Y.1@D;5&3CC+9.,^IS'8>%;6PL]3M$O+N6+5'DDG$C)D/(,.RD*,9_+CI6
ME=W%S!-:K;V37*2R[)G$BKY*X)WD'KR ,#GFK5 &5:Z!#!?V]]/=W-[<6L+0
MP/<E"8U;&[[JC).T<G)X]S4VH:6+^XMKA;RYM9;8ML: KR&&"&#*01QZ5?HH
M YZ?P7I\\%O%]INXC!?_ -H;XV0-)<9)WME<'KT  ]JL?\(S:-K-WJDT]Q.]
M[;BVGADV&)XQG"XVY[GOWJ[<ZE'9WUO;W"E$NCLAFS\IDP3L/H2 <>N".N,W
M* ,*Q\)65E':6YNKNYM+"026EM.ZLD)&=N"%#';GC<3CCT&&WGA"QO-5O-0^
MUWT!OXA%=0PS!8YMHVJ6&,Y XX.#W!K?HH YW_A"[!=/TFQCO+Y(M(D66V_>
M*QW*" 3E3G )&.!STI]QX/LI=8N=3M[R^LI+U MW';2A4N,# + @D''=2#6_
M10!GZ%HUMX?T>#2[-YG@MUVH9GW-CZ_X5EW'@C3Y;O49X+V_LX]45A>6]O,%
MCE8C!?!4D-[@C/?-=)10!SD?@C38)M/FM[O4()+"V^R*\=R09(>,(QQTX[8Q
M34\":5%HD>DQSWJ0P78NX'$_SP2!BPVDC &6/;OS72T4 <[J7@JPU#48-1CO
M=1L+V*(0M<6=R4>9!T5R0=WUZ^];EI:PV-K';6ZE8XQA<L6)]R3R2>I)Y-34
M4 <^?!]H8]80WU[C6LBZ^9.Z[3M^3CY>/_K\TK>$K=AI&=1OLZ/_ ,>QW1^F
MWYODY^7C_P"OS6_10!GWFB6-]J]AJL\6ZZT_?Y#>F\8.?7VJ+4O#]MJ.HVVI
M+-/:7]JI2.YMRH8H>J,&!5E[X(X[8K5HH P[KPG876AWFD/+<+'?N9+J967S
M)F.,DDC'8#@#   P*CU3P=9:J;&9[V^MKVP39#>VTHCFVGJI(7!!^G\ZZ"B@
M# U'P;I6IZ1!ITS72&VD\Z&[CG(N$D[OO.3N.>_]!3XO"T$-BL"ZCJ+3K,LQ
MO7G#SLR@@9)!&,$C;C')XY.=RB@"AIVD0:=/=W*O)-<WCJ\\\N-SE5"J/E
M  QP*I7GA.PO=9FU0SWD,ES (+F*&8HDZC.-P'.1D]"*W** ,"Q\)0:9!90V
M.IZC"+*%H4/FH^Y#C@AE(XVC& ,?B:T]+TRUT?3HK"S0K#%G&3DDDEF)]R23
M^-7** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 445@PZBVK>*[S3HW9;724C,VTX
M,LS@L 3_ '54 X[EAZ4 ;U%<W::KHK1>(+B*YU I!*1>[EES$P0 ^6N-P '/
M ]ZA?4M#70O#NZ[U$6]U/;BQD#2;Y6.-@D8=CW#'F@#JJ*P-0U%]$\1Z=&\C
M-9:M(T!5CGRIPNY2/0, P(Z9 (ZG._0 4444 %%,ED2&)Y9&VHBEF/H!UKDO
M"4MQXQTL^(=0N;J.&ZE<6=K!</"L,2L5&[8068D$DDD=, 4 =A16) K>'5U*
M[U+4Y9=/RDD+3L7:$8VE/5N<8ZD[L<FIK?Q%93:@=/E2XMKORC,D,\1#2(.I
M7&=V.X'(]* -6BN97X@:"]O'=*]T;9[C[.T_V60)$^[:-Y(^7)]>>1ZU,WB?
M;XR?0?L5QLBM!.THB+;B7VC&/X1AN>Y_4 Z"BN=M?'.AWC_N7N?+!F$DS6LB
MQQ&,$MO8C"G /!P?S%6[#Q-I]_>P6:">*6ZM_M-MYT9431<?,OYC@X//2@#7
MHK%D\6:5%- KO*(+BY^RQ77EGR6ER1M#?4$9Z9'6HM&\3'5]=U73_L=Q"EA*
ML2L\9&X[=Q)/;.1@>GUH WZ*R]6\1:=HEQ:07TDJ/>/Y<.V%F#-@G&0,9XZ=
M3V%5H?&&E36.I76+J(:7_P ?D4MNR21+MW;BI&<$<T ;M%9;>(=/6XTR$O)G
M55W6K>6=K_+NP3V.WGFL^7QYHD<%[.!>R)I\IBNMEG(3%@ DL,9 &>I]#C.*
M .DHK$B\6Z3/JEK8(\^;T$VTY@80S$#<0KD8)QS7,Z-XJM/#T_B1=2FU"XB@
MU9QO$<MQ]GBV)@LW.U<YQD^N.] 'H-%9TNN6:QV[P%[QKJ+SH4MEWL\?'S#L
M!R.2>XK/;QQH*V-G>?:93%>S_9XR('R)!G*-Q\K#!X/)QQF@#H:*IZ7J4.K6
M*WD$4\2,S+LN(6B<$$@Y5N1TJA=>+-+M%EFE:8VD$WDS7:Q$PQ/G!!;T!."0
M, \$C!H VZ*PM2\8:3I>H-I\WVJ2Y%L;D1PVSN70$#*X'S=>V<8.<8K7%U#]
MC^UN_EP^7YA:0;=JXSDYZ<>M $U%8T/BC39;FT@;SX!?_P#'I+-$42?C.%/8
MD<@'!/:LK_A)#K2^([!;>\M18*T:2J&C;<(]V[<#\O)&!Z?7% '745QGA#Q9
M9?V%X=L+N6Z:YO+6-%N)(G,<DH3)7S#P6X/?J".M;>I>*-.TM9Y+CSV@M7"7
M,\<19("<?>(^HSC.,\XH V**P-0\9Z/IU[)92&ZFN$MQ<^7!;/(7C)QE<#YA
M[CC@UKSWMO:V$E]<2>5;Q1&61W!&U0,DD=>E %BBLBS\2V-Y>"S2.XCN)+;[
M5%')%M,L60-R_F.#@\]*B_X3#1_["AUOS)OL,LODB3R6RK;]F",9'S<4 ;E%
M<\/$GG^,9_#OV.X5(K59&F"$;BS8!!'11@\^OTYP/"/BNTTO0?+U2XO9B=2G
M@:Y='E6+,Q5!)(<X[#D]QZT >@45GWNLVUG="S"37-T8S+Y%NFY@F<;CV SP
M.<GG&<&J,WC70H=.L]0-T[6][.+>)UA<XD)QM;CY"#G(.#P: -ZBN8D\0Z/J
M%_H_F-J=M/+=2+;1/#+"'=58,'! !&.<&KFH>+=,TRUN+N[6ZCMK9RDD_P!G
M;9D-M.#CGGCB@#;HK$NO%>G6BREDN9#;VRW5RJ0DM;Q,"07!Y!X/')X/%5]0
M\6Q6VLZ+96UM-<PZFCS">.,L"@3<-O<GE3["@#HZ*Q-/U#2YO$>LI!<W7VJV
M2'[6DQ=8HAAMI4-@#(!)(X/%+'XKTR26S5C-%#?MLM+B2(K%.W8*W8GMG&>V
M: -JBN>NO&^CVLNH18O99=-*_:8XK21F0$9W$8^[CG/3TS6W:74%]9PWEK()
M()XUDC<=&4C(/Y&@":BN)FNCXC\8:KHEU_:,-M;VL*PFW+Q&.1RY,F1W^5<$
MY''N:UXO%.EVMM;>9<7#VC.+9-0DCS%)(#MY8>I&-V I/0T ;]%8%_XSTC3]
M0N;"07DES;(KR10VDCMM8X#  <CU(X]\UKWU];Z=9O=W3[(DQDX)))(   ZD
MD@ >IH L45C7/BBRLK:]N+R"[MUL$62X#PDE5;.&&,[A\IZ9_G4\FOV$.H6-
MB[2";4$9[;]V2'"KN;GL0.QH TJ*Y:;XC>'H(99VDO&A@G,$\JV<A6!@<'?Q
M\HSQSSP>*N7OC#1[&_%@SW$UTUM]ICB@MGD,J9 &S ^?KVSP"3C% &[17">,
M/$-IKGPNU35M&OKB,PC;NC=X9(W#*&5@,$<'D'UKH;^]TU?%6E6<\]VE\R3-
M;QIO6*0;?F+?PM@ 8')&?>@#:HK%O_%>EZ:'EN6F%K%,()KM8B88G)QAF^I
M)Z \$@U+>^(;.Q>Y#)/,+, W+0Q[A%D9&?PP>,X!R<"@#5HI"0!DG %<)XO\
M017=OHDNGRWR13:O;)'<1[TAG7S &'!^8''&1@XXS0!WE%9.I^)+#2A</,L\
MD=F UT\,1=8 1G+8]N2!D@8)&#6/?77F?$+PY):WDKVMY9W,A59F,4@"H58+
MG'1CS0!UU%<Y8:WI$7]NWMO+?RBTGS>+(DA\M@@R$1AD# SP*T(_$%E-IECJ
M,0FD@OR@@*QDLV[[IQU QS[=Z -.BL6^\5Z7IVZ2X:86L<P@ENQ$3#')G;AF
M^O!/0'@D&HKGQII%MJ5SIQ%Y)<VK1B6.*TD8KO. >G*_[73D<\T ;]%8M[XK
MTO3\R7#3+:K/]G>[$1,,<F=NTM_O<$] >"0:=J^LV<:7=E_I4LD,.^X^R!BT
M"D'!)7D'@D 9; SB@#8HKG/A]/-=> ]'GN)7FEDMP7DD8LS')Y)/6KE]XFT^
MQ:ZW+/,EE@W<D$1=;?(S\V/;D@9(!!.,T :]%8E]XOT>PELHGFEE;4(VDM3!
M \@E4+N^4@8)QC '/(K1LK^&^TZ*_0/'#+'Y@\Y"C*/<'I0!:HK+LM?M;^XM
MXHHKA1=0F>WE>+"2H,<@]OO#@X/M4+>*]+CN+5':9(;R;R+>Z:(^3+)SA0WO
M@X/0]B: -JBN>3QMI$MY):0)>S317/V:14LY#L?&1NX^4'H"<9YQT)JQ:>*=
M,O=#FUF SM:0LRN?)8/E3@C;UR#QC% &S16'%?Z;-XR^RB6\74ET_>8'#K$(
MMX^;!^4MDXR,]Q3F\6:4D]LC/*(;NX^S077EGR9)<D;0WN00#T..#0!M45C:
MCXJTS2UEEN#-]FMY!%<7*1%HX6..&(^HR1G&><5)>>(K*S:X^2>=;15:X>"/
M>(@PR,_ASQG .3@4 :M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %<EX9@>R\;>*[>88,\L%U$3_&C(5R/HRD5
MUM59["*>\AO 3'<0@JLB]2AQE#Z@X'XC(H Y#3?.27QL[V-\HN)2\&;.4></
M)"?)\OS<CM5"6&Z7P-X*@_LZ_,UI?637$0LY2T2Q_?+#;D ?KVKTBB@#DO&D
M#:AJGA6SA!\P:NEV>.D<2,6)_,#\176U62QB6_>^?,D[)Y:LW_+-,YVKZ9."
M>YP/08LT %%%% $<\*7$$D$@RDBE&'L1@UQ?@V>?P?I8\,ZS:W2_8Y'%K>16
MSRQ7$3,6!R@.UAD@J<?C7<44 <CXRM]2UOPWYVG6<K-:7<-U% X*/<K&P9AM
M/(]@><CITI+M?^$A\5>']3LX+F.#2UGFGDEMWC(WH%$8# $L3DD#.-ON*Z^B
M@#RN6"\?X4:M8+IFH_:Y-0=T@^PRAV4W(<$#;R-O.:Z9Y)H/B2FH_8;U[2[T
M=(4E2V<A7$K,0W'R':P/./3KQ7744 <+X<DO[;P?X@^SZ5<->+=7DT-M=VKQ
MB8.S,G# ;@1V'TXJG9?:KKQ1X<U!;+6"K6<\,\\]LT8BD8)QL.!&!@]  <<%
MC7HU% '!^#M0O;#1[3PM?:#>?VC8-Y7F-;DVS*&XE$G3&.?7(XK1T!;BS\:>
M(X9K*Z5;N>*>&?RCY3((E4_/TSD8QU]L9KJZ* .3\9"4ZQX:>.UNITM]1\V5
MH+:241IL9<G:#CDBLRXL[N]UCQ[;Q65V#J.GQQ6KO;NL<K"%U(#D;3RP'6N_
MHH \XBO)[V;P2\6DZF%T]BET9+-T\IO(*$$$9P#_ !=/>I8%N/['\=H=/OP]
MY-.ULILY<S!H0@V_+SEACBO0J* //IQ<?8O G^@7Y-G)&;D"RE)A A*'<-O'
MS''/\JL:>\NER^*[2YTZ[DFOKV2:VB6V=EN$:-5&& V]00<D8[XKN:* /,X]
M)N_!]QHDNHZ9<:K8II2V5P;2,RM;RAR^[:.2IW%<^P^E7-8B1+/09;#P_=6D
M UV.[>&"R=G6,*P:214!VDDC@\XQWR!Z!10 @.0#Z^M><Z=;WMA\/M4\(7=A
M=2ZDJW,$!$#,ESYK,4D#XV@9?DDC&.:]'HH X;3K*XTOQWHT$L%W-':Z"+)[
MI;:1HC*&0\OMP,A2<YKH?%VEW.M>$]3TVS8+<7-NR1Y. 3CIGWZ?C6Q10!PE
MZ)_%.C^'[&*QNK:\M;VWGNA- \8MO*^_\Q&">PP3G.>F:6 7-AJ7C.&73KYO
MM;>? \=LSI(I@"_*0.3N&,#GVQDCNJ* /-C'=)X1\#0G3M0\VQO;9[E!92EH
M52-U8L N0 2*DMPFF:KK&D:UX8O-2%Y>RW%I-#;>;%/'(=VQCT4J3@[L#%>B
MT4 <=;));_$NW)T^XB@71%MA)%;2&!)!)NV!]N,8'T_&M[Q)+>0>&]0ET^S6
M\NEMW\JW==PD..A7O]._2M.B@#S[3#/+XWT;4EL=8DADTZ6&2>ZMV3;(60X*
MG C  /8 ]LUD2K?1?#F;P\-(U*2_M-2W2*EJY4K]KWAE;&&!!_AR>_3FO6**
M .1#3VOQ*EOGL;QK:\TJ*..5+=F5661BP8@?*0"#@]>@R>*YF2"]D^$^I60T
MO4?M<NHM(EN;*7S"IN1(#C;TVC.:]4HH XZ-Y](\?7NJ7$%R^G:O9PB*=(';
MR7CS\C*!N7(;/('/'6L"ZTJ]L=.BN6L+UA>>+$U,016LDC0P!QEF50=IP-V#
MSSCKFO4** .2\5^;)XA\+RQ6EW+'#>M+*\5M(XC4QLH+$#CDCK5*[G.N>*S)
MJECJ,.CZ/)NMH/[/G;[7./\ EJ=J'*K_  ^IYKNJ* //]7O-1U2YU>UFTC4H
MH[G2T:R2WMV7SW:-BPED&,%2<;"0.O!)%,M_MD'_  @E^VE:@8[*TDM[A5MF
M+QN844;EZ@%E(R<#OTYKT.B@#@;G3KS5/$'C6TA@N8#J.GPP6T\D#K&[B.0,
M Y&#RP'7OQ3+F*Y\1>#M'T);"ZMM1@FMA<"2!E%MY1&]]Y&TC"G;@G.1COCT
M&B@#A[9I4U_QM(]C?".YCB\AOL<N)ML&P[3M^;YN./Y5M>!UDC\%:1!-!/!-
M!:1Q21SQ-&RLJ@$88 UO44 <9:QSS^.O$J"WO($O+*"&&Y:UD6,LJN&PY&.-
MP[UD+:7M[\+O^$.ETZXCU9$6T*- WE_*XQ*),;2N!NSGJ,=>*]*HH Y'3EEA
M^)5\6MKPQ/IL$"7+6T@C=T9RPWXV]"._-:_BF&UN/#MS!?64][;2E$EA@5FD
MVEU&Y0O.5^]Q_=K7HH \Z.EZY-X<\3Z/%<W6JV1L0NGSW416=F*MF+) +XXY
MQU;'KB47TVI>(O!MW!I6I+!:).D[R6CIY;&(+@@C.,\9Z>A/./0*0YVG:0#C
M@D9H \WTJY27PYXQTQ;2XN+FYU74(HHD@9A(SD@?-C YZDGCJ:GL$'AWQUHM
ME=EY#;>&1;O)'&SC*R(,G ) XZ^XKJO#V@G0([Q!>-<B\NI+MBZ!2'<Y;&.V
M:1M 9O%J>(1>L'2T-H(/+&TQE@QYZ[L@<^W2@#BM:T>]_P"$(\7SP6%TSZU>
M^9:VL=N[2%<H-Q0#*[MK-R!QC/-=!K,CS^.?"US%9WKP1)=>;*+23;%O10NX
M[?ER0>O3O7744 >;:;&EA]M\.:SX5NM0N#=3/;S"V\R"Z1Y"ZEG^ZN"W.>F/
M6I_$=C.FJ:A?Z$+^QUJ 1QB-+=WM=378N 01MXR4SGY<<UZ%10!GZQ:7.H^'
M+ZSB8175S:21(P/"NR$#GV)K@+B^NKOP;X>TPZ+J<=_I=[9K=0?8I,*(B 6#
M8VL"!D8)X->GT4 >>972?$.L6FL^'+W4;?4[C[3:SP6IF5U9%4Q/V4C;CGC'
MM5^>WE@\:^%@FF3006ME/'(+>W=H;<LJ!4W@;0/E(_"NTHH Y/PFDG_"0>*&
MFM+F*.XO5>)I[=T611&JD@L #R#4/A'1[_3M0N-+NHF&FZ//(=.<_P#+191E
M?^^ SK_P+VKLJ* /-M,B2R2[\-ZSX4N;^Z^TRM;S?9O,M[I'D+JS.?E7&><]
M,=SQ6WHPDB^(^O.]I=)#/;6R13-:R+$Y0/N <C;QD=^>U==10!YKI4264%SX
M9UGPI<W]VMQ*89C;;[>Z1I"ZNSGY5QD9STQW/%:.G3W/A[Q-X@M+^PO98]2F
M%S9W$%L\J2#8%\LE0=I&T#YL#'>NYHH YGX=1SP^ ]*M[FVGMIH8=CQS1E&!
MR>QK.T9I_#UQXCT[4K*ZF^UWTUY:O%;O(MPD@'R J" PQ@@X[=J[>B@#S?3=
M)O= N/ EE=6UW,UA'<?:I8;=Y4A,B84%E!'4X_#/2O0KQMME.WD^=B-CY?\
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MS;6O#5_96TP5KVTDCCDSQ\RD _3F@"JGBW3BUD\D=Q#:Z@XCM+N2,"*9C]T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP(1<1X(?*CYQ]>M>>+<>)KGP7J6OQ^);@76E7%RT<9BC\N5(G.0XV\Y48&,
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M ]N84:.Z,H'RA5^\ZD]#SP>"* -S7M1N=+\4^%C/J$L%K,+@74.X;'*PDC(
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MM)?3W<<.JO'"TXPRH$3Y=N!MP2>,"M;4/%6AZ7>O97E^L=S'#YQA",S;,@<
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MN@(V+11>?(=Q7&<88'\:VHM2@G\:Z[>*DXM9M'B$<SP.JO@OW(XSGC.,]LT
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M(=0Z#&61F7:?O#UZBN:\%^+[-/#>EP:QJDDM_=3RQ"256;<_G.%5G VJ2 ,
MD=L57\,O+I6L6-KI^J'4]!>VD?;=+^^TL* 0K/U /W=K8(Q[&L:*5!\(+"+:
MRSKJ2NT6PB10+HODKU^[S]* ._\ [1TT>*IH?[6F^U0V6Z2RW?ND3=_K#Q][
MG'7IVJNOC_PLYM0NKQD7;E(G\M]A;)7!;&%.0<9(SUZ51CN(9/BUYB.&C;0Q
M&''W2WG%MN>F=O./3FN6T[[+JOP:;0K=5FU&YDECBMP/G+FX8A\?W1U+=!@\
M\4 >@W/BO1+2]N+*6]S<VR!Y88XGD< ^@4'/T&3Q4*^-O#CQVDB:FK17I58I
M5C<IEC@!FQA"3V8@UDV$D5O\3;TS3#":/#$9FX#,KL6&>F0,$BN::2/_ (4O
M+:JI%Q]OR(0AW_\ 'YOSMZ_<Y^E 'I.HZYI^E;Q=2R9CC\V010/*8TY^9@@.
MT<'D^A]#5>;Q9H-O+:QOJ41:\B,T 0%O,3&<C /M@=3D8KE;S4;+2O&6IR:V
MM]_9VKQPR65S:F9HW C"M&1%WSR./XJ>\=E8^+?!L-M9FQMK>&\ @;), D"[
M V?NEN>#WR* -G5/'6EVOA&\\0V+27D5N6C"+"X(E'&UP0"G)&2<=?<9Z&WN
M$NH1-&LBJ<X$L31M_P!\L 1^5>7ZA&]]X4\?VUI&\TDM\TT2(I)D3$>67U'R
MGD>E=Y_PE6E?:=.@+3J=3W?9F:W=5;'J2/ESGC/6@#9HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J<^G1RZA#J$;&*
MYB4QEP,B2,G)5AW&>1Z'V)!N5D:OK-E;I<VC3W FCA\R4VL3.T*G.&)4';T.
M._!(Z4 :]5)=/CN+^&[G/F?9LF"/'",1@M[M@D ]@3ZUQ_AW5[>7P3X6DUC5
MKZ.ZNYX_+D1W+7$NXX1V .5/<'&<>U=1=^(-/LY9HY7E;[.RI,T<+NL;-@J&
M(!P<$'V!!. : -.BLS4O$.G:49A<R2$V\?FS^5"\GDIS\S;0<#@_D?2G2Z[I
MT:6S),;@W<?FVZ6Z&1I$P#N 7^'D<].1ZT :-%8S^+=$321JK7C?9#+Y+.(9
M"8Y-P7:ZA<H<D## =:LOKFGQZNVDO*XO%@-QY?DOS&" 2&Q@\D< YH T**YV
M'QYX<N$M98KV1H;N;R8YOL\GEA]Q4*S;<*21P#CUZ5)%XHBF\7W&@"VN%^SP
M(YD,#D,S$@<@8"@#J< GITH WJ*P_&.M2:!X5U#4(%<W$<#F$B)G"O@X+8!P
M!ZG JGILMGIS0:D^IZH_VV)819W(E<RR@9+HCC<#C.<87'/:@"[J.@7%]XGT
MO6DODC734E58# 6W^8 &^;<,?=&.*?XJT*3Q+X=NM'2\%H+H!7E,7F$ $'@9
M'I1_PE>C#3+O4'NF2&Q8K=*T+B2$CG#)C<..>GO4VE>(-.UJ6>.PE>0P*C.6
MB95(8$J02 &Z'IF@"] LB0(LSJ\@&&9%V@GV&3C\ZDK"O_&6AZ;=W%G<74AN
M;9 \D,=O([8.<8 '/0].F.:5O&?A]=-L=1_M!3:ZA(([>58V(9B<8/'RG@]<
M=#0!N5S6F^&]9TN(6<'B5VL59BHDM%:< DD_O,X)R3R5-78?%.E7-M#-#).Y
MN'=(H?L[B5RGWOD(W8'<D8Y'K3)?%^AP:+/K$EX5M+>0Q3$POOB<'!5DQN4Y
M[$=Q0!JVEK#96D-I;ILA@01HOHH&!4U8;>,-$2_:Q>YE6?RS)&&MI )U!P?+
M.W]YR1PN<]J3_A--"&B7&L/=21VMK(8I]\$@>)QU5DQN!Y'4=Q0!NT5B6GB_
M0[W5WTJ"[8W80NB-"ZB51U,9(P__  '--\,^)H_$D=W(EO/ (+F2%5DA=>$.
MWDD8SG/&<B@#=K$;0+AO&:>(1?1A5LC9_9O(/W2X<G=NZY [=*DU+Q3H^DWP
ML;RY9+EHC*L2PN[,H('& <G)' YIEIXOT*]T9M7AO@;5)?)<E&#K)D#84QNW
M9(XQWH VJIZK;7EYILL&GZ@=/N6QLN1$LNS!!/RMP<C(_&J?_"4Z2L&H2R2S
M1_V9@W<;6\F^$$9!*@9((YR,C@^E3?\ "0::=,L]2$LK6U\R+;LMO(2Y?[OR
MA<C/J10!-I>G#3;/R3,]Q*[&2:>0 -*YZL<<#T '0 #M5RL"?QMH, O<W,SF
MP;;<K%:RN8N,DD!?N@?Q=/>I8_%VB37UI:1W3,;W_CWE$+^3*<9VB3&TMCMG
M/XT ;5%9.H^)M+TKS3=32".W95GE2%W2$G&-[ $#J#[ @G -,N_%>C6>H-I\
MES(UT(/M BB@>1G3(&5V@[NO09Z'TH V:*Y?4?'.GP:-IVIV"RW<.H7D=LC)
M"YV9D"ON&,@@;L+U)[5T?VA#:_:0LFS9OV^4P?&,_=QG/MC- $M%<[X>\7VF
ML^'SJ\R2VL8DD7$D+C@2LB '&&8X'"D\G%6?^$KT<"]$L\L#V$8EN(Y8'5T0
M]'VXR5]QF@#9HKFSX_\ #:VKW37LJP+'')YAMI-I$GW<';@\\'T/!JQ_PF.B
M"^ELC<3"X2/S5C-M+F9<XS$-O[SG^[F@#<HK)M/$^DWNEG4H;AC"LWV=E:)E
MD67<%\LH1NW9(&,=Z<;I=:M;J/3YY[6ZM9-N9(F39)M# ,I W+AAGL0>#GD
M&I5.[TZ.YNH+Q&,5U;Y"2@9RIQN0CNIP./4 ]JK^&]:3Q!H-MJ2Q^4\@*RQY
MSY<BDJZ_@P-:$\0GA>(NZ!AC=&Q5A]"* )*@O;87MC<6C221">)HS)$VUUR,
M94]B,\5Y[X<U"YO/AC'KU]XGNK6_$<[F=Y4*@H[A0488(PHXQDUM1:\EWX&T
MJ_\ $4]UI4]X8<FV#HQ?<-HX!P&P.#V.* +EIX<U6.R73+[7Q=:>(O),:V:Q
MR/'C&UGR1R.#A0?I70LN8RBL4R,!EQE?<9XKF+F>YC^)]C;B[G^S3:9,[0;S
MY>X.@!V^O)YI?!,US*_B&.YNY[G[/K4T4;3.6*H$C(4>@&3Q0!T5K:Q6=NL$
M"[47)Y.223DDGN2223ZFIJIWVJVEA+%#*SM/-DQ0Q(7=P.I '89'/3D>HK-O
MO%5DOA>^UG3W:X^S1RC:(7+)*BD[77&4P1SD#% &]17,>$X&O;:QUK^T=3:2
M6S1;J"X,@BED*JQ=5<<<DX*87GVIMA<SQ?$/6H)KV5K6.P@F6.23Y(B6?<0.
M@Z4 7M'T"XTO6]6U*6^2<:G(DAC$!3RRJA1@[CG@>E;=9%EXGTJ_NK:V@FDW
MWD;2VI>%T6=!C)0D8/!!^ASTK#\?^(H8?".KBQO+N*XME*?:+5'"QR<?*9 ,
M \X//!X.#0!V=%8/V^P.NZ5;3:A=)?FU=TME+"*9=HW,_&"1CCG(R:BE\>^'
M(H9IFO)3%;SFWG<6TI$+#&=_R_*,G&3@=<=* .CHJE=ZO9V=Q#;.[27$ZL\<
M,2%W95QEL#L,CD^H'4TS2-<T[7;=I]-G,T:G!8QLF#SQ\P'(P<^E &A16->>
M*]'L=1ETZ:>4WD4/G&".WD=V7.,J%4[N_3/0^E">+=$DL-/ODNV:WU*98+:0
M0N0TC-M"G ^4Y!'S8Z4 ;-%9C^(=,COKNR>=UN+*$3S(8)!MC)P&!VX8<'IG
MI5&/QWX=E2SE%ZZP7QVPW#P2+$6YPI<KM#<'@G- '0T5A+K^GZU#J-C97-S!
M=6\.YU>%X9%4@[77>!D''45B>#_&VECP_H5GJ6HRM?7<*)YTJ.RR2G^$RD;=
MWMG- '<45E:EXCTS2O.-U)+LM@#</' \BP@\@N5!QQ@_0YZ57OO&>@Z?<FWG
MO&,HMOM06*%Y-\60-R[0=W7MG@$] : -VBJ\E];0V#7\LRQVR1>:TC_*%3&<
MG/3BJ5IXDTR\NC:QR2K-]G^U*DD#H7BZ;U!'(]NO/2@#5HKG8O'GAR:.VECO
M9&ANIO(2;[/)Y8?<5"LVW"DD<;L>O2M#4-7LK61[-Y)VG,1D9+:)I'C3IN.T
M''?'K@XSB@#2HKF/AQ>3W_@6PNKFZENI9&FS-*Q9G F<#)/L!6@/%&DF74HA
M-,9-* :[7[++F,$9!QM^;(!/&>.: ->BLR+Q%IDUE8WL4LSP:BP2V9;:0^82
M"1QMR!@$Y.!@5'>^*-)TYS]JG=(DE$,EQY+F*-R< ,X&T<D#KP>#B@#7HK&A
MO=.E\7SVL=_=-?1V:^9:$L(53=PX!&-Q)QD'H*;-XPT2W2.62YD$$LQ@CG6!
MVCDD!(*JP!R<@CT.#B@#;HKB$U]-+\=ZS]KO+R:U^PV\T-NJ/*5)+[BL:@D<
M 9...]:>I^-+&TM-'NK19;N'5[B..&6*%V4*>2< 9W8!PO7/;@T =)134=9(
MUD&0K ,-RE2![@\C\:R4\5:1)-;(+APEW)Y=O.T3B*9_[JN1M).#CGGMF@#8
MHKCM5UA;_P ;KX=EDU&&T&GO(QM8YXW,ID5 =R#.T#//W<GGH*ZC3[62RT^"
MUENI;MXD"F>;&^3'<X[T 3R!S&PC95?'REER ?ID9_.LCPIH,OAK08=)DO5O
M!"SE91#Y9.YBQR-Q[L:V:* "BBB@ HHHH *@FM([B>&64LPA;<B9^7=T#>Y&
M3[=^N*GHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ KAM/O7T'Q5XCM-4M[H_VE,MQ9SQV[R+,OEA=@*@X*XQ@UW-
M% 'E=F)5^'_@J%[2Z66VU6W>9&MW#(BLQ+$8^[@CGIS6CXACG@U?4]3\/7%S
M!JHDC2;3I8C);ZF-J@$ CK@[2P/&TYQUKT.B@#A(M3;PWXMURWUC3[R:VU9X
MY[6:"V>=9?W81HCM!P1MX![>E2_O]&\=6NJWMHUMIMWI2VB[%W):2*^X(VWA
M00<9Z9&*[:B@#S'5M&O9/#'BS4+>UF,5]J4-U;VZQG>Z1O&7<+U^;:Q]2 #W
MK6CU2*^^)%CJ4%O>&Q.D2QBX:UD5<F16YR,@8!Y( KN** /*%64?"!+/[+<B
MZ74=WD_9WW@?:_,SMQG&SG-=1;R-;_$VZG:WN&AO]-@6"5(6*$J[[@6QA< @
M\XKKZ* .;^(.YO NK0QQR2RS6[1QQQH69F/0 #FLS49)8/$/AKQ (Y9=,BMY
M;:X*QL3;LZKAV7&0,K@G''>NWHH \YUFREN%\:ZQ;Q2FVO\ 3DM;<+&V;F01
ML-RKC)'(4'OSZ5VV@2))X?L"BLH%NB[60J5(4 @@\CI6A10!Q27]K8?%356N
MG\L-I<&'*DC[[\9[$]AWQ6#)ILVFZ'I;26DZ)<>*AJ"6ZP,S06Y=B-R@97 P
M<=L^M=Q;:!-;^++O73?*XNH$@,'DXVJI)7#;NN2<\?E6W0!R&JM-IGQ#L-<G
M21]+GTY[)I50L+>0N'#-CH&  STXYKG]?TZXDT/QSJ4-O,T&KM EG"L3%I2B
MJK.%QG!.>>X7/2O3Z* ..U699_'GA2XB21H8X+L22")MJ;T0*&..,D'K7-:Z
MQ_X1CX@YCE19;E98B\;*'7;&NY21@C(/2O5JR/%.AMXE\/W.CB[^RI<@*\@C
MWD $' &1Z4 8VIQQ^(/%'AN?3T8C3I))[B7RRODH4V^6<@88DCY>N :?X#,E
MLFKZ?/;7$4T>J7,I,D+*A5I,J0Q&&R#GC-=3"LJPHLSK)(!\S*NT$_3)Q^=2
M4 <=K=U!9_$W1);@[4_L^Y7?M)"_,G)/8=LGUK(N$NM-77M<MM.:2SU+5K8I
MNM3(T,:A0]RL>,D[LE>.P/(Z]=<Z#/<>++371?*BVL#P"W,.=RL06.[=UX':
MMJ@#B/# '_";^(-UO?O!?6UJT<UU X$H59 Q)8 #D@;>/88H\*:9?6FL3:)<
M+NT[0)F>RD+9WB5<QJ?=%:1?^!+Z5UNI6UQ>:=-;VMZ]E-(N$N(U#-&?4 \&
MH])TT:9:&)KB2ZGD<R3W$N-TKD ;B  !P  !T  H Y*U<"^\=,8IE6?:8B8F
M_>@0!#MX^;YN.*H2%D\'>!(O(G\RTO;1IT$#EH@D;!RPQD $XY]:]*HH \WB
M>TT[5M:T?Q#I&I71O;V6>U,"2R174<G(3Y3M!'0[L#U-:D 6T^)%GFV:"&+0
M?L^41FCC?S%8)OQCA0:[2B@#RI(YQX323[)=$6GB@7<JBW?<(?/+;PN,D8.>
M!7J,$HG@255=0XW .I5@/<'D?0\U)10!Y9:V^H+\.;:TATV]ENM%U0W%U:B)
MXVE07#L51N-QVL&&TGH/:M=KC1]3TC5]2TO2KT2MI<MNUU<Q2B0DCY8E#Y+<
MY)QP#CUKO** /.]8W2?!6TM8[>=IQ:VD1@6!O,WHT>X;<9XVG\JUK^9)/B1H
MEPB2-$MC<*THC;:I8H5!;& 3@]:ZZB@#S:UALKG3O$=KJ<%\D%SX@:6.:"-T
MDB4A-DR''0,O4?7I71>#7U93J5MJ%V-0MK>5%M=1,01KA2N3G'#;>!N'7GTK
MIZKWMK]MM6MFD>..3Y9-APS+W /;/J.?3!Y !Q_@6[32O"T-S/%.R:MJLIMQ
M%$7VK)(VUFQT7 SGIR*[2::.WA:65MJ(,DX)_04L44<$*0PHL<<:A411@*!P
M !3Z /+?"%IH47PVM[/7-"FFO%6;S(1ITC3DF1RNTA<YP1@YXXY%23VNN6WP
MFTVTUM;B?41=P,4VM+(L8F##=C)R%'/ITKTZB@#D;N3=\4-+F5)#"-,E0RB-
MB@9G0J"V, D T[P.Q^U>) T<J>;K,LT>^-E#H40!AD<C*GD5UE% '(:D9M)^
M(]MK-TDATRYTTV?G*I98)1)O^;'0,.,^H%9[64L6D^.-3$4JV^K*XLX1&VZ0
MB'9N"XS\S9QQSC/2N_HH R?"T@?PMI8PRM':1(ZNI5E8( 00>0:P'FFB\<^(
MIX;*2Y;^R8UA1HSLGD3S"8PV,'J!^-=K10!YE873W6N>#=0^S:@PB6>*X463
MQ16[M#@1JF %4'(SR,#EN*J&XGL_AEK/A6^L[S^V(?/&%MG<7 >0N)%8 @@[
MO7M7K%% '$W$WF^-O"DXAN%CCLKA9&>!U\LLJ;0V1\I.T\&L=@[^"O'-N+><
MS76H73P)Y#YE#A0I48^8'!Z5Z=10!Y[J>IV^DZ]H.KK]J21M+>&5S9R2H4RA
MVE5&Y6#<Y([8[\;G@5])_L:6'3+YKQA</+<L\+0L)')8_(PRHYX^G4U9O_#]
MY+K3:KINM36,TL*PRQM$LT;JI)7 /*GYCT/>M#3]/-EYDDMP]U<S8\V>0 %L
M=     ,G ]SU)H YXR"/XL23ND@A_L40^;Y;;-XE9BN[&,[>:YB".>/P+8S&
MTNL:=XB6[GC\A]ZPBX9MP7&2-I!XKU6B@#A+?4$N/'VI7ZVUXMI+HT:QS/:R
M*KD.Y[CC.> <$]NV<J%9(_AMX2MWMKCSK?4;5IHO(;?&$DRQ(QD #O[UZA10
M!QDI,OQ-NGCCE:.70A"L@C;89!*[;=V,9P0:Q8;5]7^&.E^%X;>9=45H(Y$D
MA9#:%) SNV0,8 .#WSQG->FT4 >=-):Z5XAUS3?$.EZE<Q:C<F>UDMTEDCN$
M=%4QD(<9&,<]O:KUI&EI\1=,06+VT,>A&V"I&S1POYB$1[P,9"@]_P"==O10
M!E>)YKBW\,:C-:V":A,MN^VU=-ZR\="O\0]N_2N1TVZ#>-](U()J4\$NERQ-
M<36KQJ'W(<;=H"  'L![DUZ'10!Y1ME_X5!)9BUN?M0U'<(?L[[\?:]^=N,X
MV<YKH++4#HGCS6I=1AN3:ZNEO+8W,=N\BL%3:8_E!(.>0/?WKMZ* .4^&@=/
M!-I!+;S021RS;DFB9#S*[ C(Y&".147B#3]0M_%]K>:9$Q36+9M/O'7I#CYT
ME^H7S ,]\"NPHH XSP=I-[I]_<Z5<Q,+#1)Y%T]V.?,67#+SZHI*Y_VCZ5C:
M=]DMDOO#.OZ'J-Y>&[F>%565X+U'D+JV0=B\GDG &,]<UZ910!R-N"OQ6D<1
M2"(:)' ) C;-XE9BH;&,X(-<GINH:+%HUAHVHWEW96&G:@;B-9=.FW[4D9D5
MI "F,\EAVX]Z]6N(1<6\D#,ZK(A0LC889&,@]C7/V'AC4;.S339/$5Q/IT<8
MB6+[/&LAC P%,@'IQD 'W!YH IZ?<(OQ)UFY99! UA;JDWEML<J6+!6Q@X!'
M2N:TZ.>#P%X0DDL[H?V;K"O=1BV<O$F9>2F,X^9>@[UZFB+&BHBA548 '0"G
M4 9^KV\VJ>'+ZVM2T,]W:2)$7^4HS(0,^F":X>X277?AQIWAJ*UGM]8B-K \
M3Q,IMFB9=TA.,!=JD@YYR ,DUZ110!R#2@?%I92DOE?V-Y'F^4VSS/.#;=V,
M9QS77T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %9=SX@LK:69"L\HMY%BFDBB++$[
M8(4X]F4GL,C.*U*\]UZUNHM8O]3\.F^M=7$Z)+9/ SVNI+A1NY&T<'!8'C:<
M^M %J+6TT;QWXD6ZFOKB%+>UDCMXQ).4R'+E5&=HZ9Z#I[5K:EKFB7=EHMT]
M]=+!?W<)LWMA(HE<GY5<@8"G/*MCH?2J&GR-#\0/$MQ+:W:P26MLL<IM9"DA
M0/N"G&&QN'2N=M(;N/X?>#K9]/OQ/9ZK;O<1?8Y=T2H[%F(VYP 1S0!V=]XV
MT:PO+RS=KN6YL@K30PVDCN <G( '*X&2W3ISS3V\::"MEIUX+QGM]3<):R)$
MY5FYX)QP>#P>>#Q6-9:C;V/Q+\1-.)0KV=H0R0N_0/Q\H/)SP.^*QX])N]*T
M7PY$]C=!CX@-^\,4#/\ 9H6\S ;:#C 9<CW/I0!UR>-=)D:[B2.^:ZM"/,M!
M92>=@C(8)C.TCO\ XBKL/B'3;G2K34K:8SP7N!;"-"7E."<!>N1@Y],'.,5B
M:>[0_$?7+F2VNE@>RMU24VTFQV3?N .,$C(Z5RNFV]_8^$_#&H2Z/?7,6ESW
M*7UE]G=9E21FPZJ0"V.#QZ_7 !W$OC?1+?3;N^GFGB2RE$-S&T#[X7.,!@!P
M#D8/0YZU8M?%.F7>J3:;%]H%S%"9U5[=T\Z,'!:/(^<9P..N>*Y+Q'';7W@?
M69]'\/W<#7K0!?\ 1'$]RRR DE,%MH'0GW[8SKW<IF^(^C74=K=F#^SYD:;[
M+($5G9"H8[?E. >O2@#1\)^)/^$FTV2\^RS6^)Y4570CY5=E'/0G YQT-6WU
MZR37#HI\[[:(#<!!$V&C!P2&Q@\D#&>M8OP]6>TT6?3;JSN8)[:\N"YEA9%(
M:5F4JQX8$'.1D5)XQL[^.YTG7=)MC<7UA<^48AQYD4OR,#[ E6]L$T 7[?Q5
MI=UI$NJPFX:VBE\EC]G?=OW;2-N,YW''2F6]YIMWXJO+6.YO?MR6:":!C(D:
M(6.&4' W')Y'I6'H_A_4-*\5W&FG?-I,S1ZF\[_Q7 &UU/NSA9/;%7(&=?BA
M?3M;7(@.E1Q";[._ELZR.Q ;&"<$4 <Y+=7O_"GM9N?[0O/M-O<W.R<7#^9A
M9BH!;.2,<5Z7&-]LH)/S( 2#@]/6O,F@NW^$>N60T^^^U37-QY<!M) [[YBR
MD+MR1CG->EVD@EM(I%# ,@X=2I'U!Y% '!>&/&5AHND7*:Q=WLH34[B)KEXY
M)DA7S"JB23!"]N":[*]UNULF*;9KF01><T=M&9&$?]XX['!QW.#C.#7%6D5P
MG@[Q#X>?3[EM1O+F\6&%K=]K"5CL??C;MY!SGC'K2M;/X3\0+_:FF7NIV%SI
M]M EU:0O*8I8E*E65><-G.?7\: .[TW4;/5].@U"PG6>VN%W1R+T(_I]*J_\
M)#9&=8U6=T:X-L)DB)C\T'!7/;!!&>F1C.>*?H-O#:Z/#%;Z:NFP_,R6JJ%\
ML%B1D#@$YR1V)-<:EK=6NOI>^'S?0&YU,KJ&E7,#&!E\P[YT+#"\#>&!P3@=
M>* )=)\2V^@ZCXH_M*XOKB&VU#C"R7!@C\M3DD9VJ"3U]_0UUUSK5E;FV16:
M>6[4O!% N]I% !+#T'(Y.!R!U(KBU$[:9X_7[#>AKQIOLRFTDS-F (-OR\Y8
M=J=IJW>EZYX?UN>UNC82:&FG3?N'W6LJL&RZ8W '&W.,<"@#I9?&6BPZ-+JT
MD\HMK>;R+C]PY>"3."KKC*\D=?4>M6_[>LAKD>BMYRWDL)G53$VTH."=V,<$
M@=:P-,\.C5+CQ9/=1/%8:ZZ1Q1NA5MJQ;#)M/(RV2,\\ UB"P\3_ -D:3XAD
MM7?6-(F6S6V+'$\63%(Q]V)#9]$!H Z^Y\8Z/9I$]S)<1)+=FS1FMG"F4'!&
M[&."#SGL<=*LZ3XBL-9NKNUMO/CN+,KYL-Q \3@-G:V& .#@USWBNR>QTWPU
M:PPW-T;75K::9X;=Y#M7<7D;:#C).3]:LZ<S_P#"S-5E-M<K#+801I,UNXC9
ME9RPW$8SAAWH F\=:S/I&BQBV\Y9;JYA@\R)"=BM(H;!'1B"0._I4EG+8Z)=
M2K!-J=Q)?CSX["0M(T(7AF4-RH)(ZG&>E5OB%YC:-9QPVUS<.-1MI"MO \I"
MI(&8G:#C %13--I?Q".LSPSR:;J&GI LR0LWD2(Q.U@!E002<D=>* -.;QGH
M4&BKK#W3_9#+Y+,(7S')G:5<8^0@\?-BK^EZM;:O%-);)<*L,IB;SX&B)( .
M0& )&".:\]UC2KR/PQK]RME=M_:VLQ7-O;1V[L_EK)'ERH&5R%8X(!QCOQ7I
ML4BRQ+(N[:X!&Y2IQ[@\C\: ,Z3Q#9).8PL\B"Y6U:9(BR+*2!M)^I )Z \9
MSQ7+V/B*'0O$WBP7\]]<06TT#(BK)<&%#"&8X&=J@DGL*ANK6YMM=DU'PZ;Z
MWNY=2"7FF3P,UO=+Y@!F4D87Y1NW@XXQUZS6YE&I^.I&LKP)=*GD$VDG[[$&
MP[?E^;YN.* -[4=6TB6[T,R7ETK7DPDLC;[Q'/E#@,0,$8.<$^E0WGCW0K*2
M]B=[N22P8"X2*SD9HP1G<1MX4#^+IR*YQ!.-%\ 1FQO@]E+%]I7[)+F';"4.
M[Y>/F-7])U*VL?&WC);B.9]TML0L<#2;_P!PORC .3[=_P Z -V;QAHD+:</
MM3R#5%+VC1PNRR *6."!UX^[UR0,57'CG1C;W4BK?-)9N5N+<6<AFBP,[F3&
M0N#G)XKEM,T>]T*/P)97%K<,]G+<2W!BA>18!(KX5F4$#!<+^'I6M8,\?B;Q
MI.]I=B*X2#R6-K)B7;#M;;\OS<\<4 =*=<L&L[2Z@D:X6^0/;+"I9I1C.0.P
MQU)P!WJ@_C?0H].%])<2I$+K[(X:!PT4V0"CC'R'GO@5QEG'=Z9H_A/5+G1[
MZZM+.Q>ROK=;=Q-;LVPAPAP2,I@D=JOZ_%!-X:2?2] NK5+C5+:;8MH_G2A7
M4M(Z $@8'?DX]Q0!U=IXITZ]NKRTA2[^TV<8E:"2V='D0]&0,!N!(Q530?&%
MOJWAVUU:>":$W<FR*+RSERS-M5>S' Y/3@G@551W?XJBY%M=?9WT40B8VT@C
MW^:6VEL8!V\\UAZ/:0S?#G2=%UG3-6MWMIQ%)-%!(DEK(/,(E4@9(& -P!7Y
M^O6@#O\ 3]1AU%9C$DL;02F*1)4*,K  ]#UX8<]#45[K5K9W7V39-<7(C\UH
M;>,NRIG&X^G.<#J<' .#69X-.KK:7L.J3M=I#<E+6\DA\J2XCVK\S#N0<KN[
MX_&J41GT'X@ZO>7L,[6.KV\!@N(XFD6-X@5,;;02"=VX9X/UH U)O&.A0Z=8
MZB;PM:W\RP0RK$Q7>3C#''R8.<[L=#4^E>(]/UB]NK*W^T1W-IM,D5Q \3;6
MSM8!@"0<&N%FTN\T[1;:5[*[/VOQ4NI+!';N[00>;GYE4';\HSCWQUKH[1G;
MXHW<XMKD02:7%$LS6[B,NKNQ&XC&<$=Z .AU#4[73$B:Y<AIY1##&HRTCGHH
M'X$^@ )-4[3Q/I=Y/>6XDEAEL 3=K-"Z"# S\SD;>G/7D<UD^/66"/1KU8KI
MKBVU!7B>W@,Y3Y&W;HP064J".,$=<\5ARP6OB32?%-KIMS<'7-7A65HKBTDM
M05C"JJJ'[=B<GEN<#% '90>)]-GN[6V8SP->J6M&GA9%G &?E)[XYP<'':GZ
M?XAL-3DOHK;SC)I[[+A'A9"K8SCD<\>E<WJ!E\5VGAR"WL[FWN;2_@NKH30/
M']F$8.X$D 9)^4 9SG/05-K6D7\7C)9;")C9Z];_ &7467@1F/D.3ZF,N@]\
M4 ;P\0V3VMM/"EQ,UW$9H84A;S&08^;:>@Y'7'4=S5-O&^@+8V5Y]JD,-[-Y
M$1$#_P"LYRC<?*PP>#SQQFLCQ+OTCQC;:O<Z5=7VE36(M'^R1-(UM(KE@Q5>
M=I#8X]!57688DM/#\EAH-U9P#78[QX8K1V=8PCAI)%4':22.#SC&><@ &^GC
MG17EMX3]M2>Y61HH7LI5=MAPP *\G/89-./C?0TT"76WEG2U@E,$P:W??%(#
M@JRXRIR1UP.15+5R_P#PL?09Q;7+PQ6MPDDJ6[LB,^S:"P&!G!ZUS&H1W4G@
M[QI:IIVH//=ZPTUO&+*7,J$Q89?EY'R-^7TH [=O&.D)J+Z>YNEN!&98E-K)
M_I"@X/E\?/\ A]>G-3V/B;2[_2IM2CE>.&WE,,RRQ,LD<@(&PIC.[)&!U.1B
ML?4I&F^(GA^ZCMKIH$M+A7E%M)L0OLVACMP,X/6N=FLM2N=.\1O9Z==2RQ:^
MFH1V\D#Q_:HD\O(4D#.=IZ<\?2@#MO\ A+-+26\AN#<6\]E#]HFAD@;?Y7]\
M  [E]<9QWQ45IXTT6]N=/@BDN -20-;2O;NL4AV[MH<C&[';/;'7BL>*YTW4
M]/U#4+#PY>V\@T^6%IKBS99B2.(E'+-SDG' P/6L\^<OAGP)&;"^\RQN;8W*
M"SEW0A(61BPVY W$4 =1HOB<:QKNJZ>+2>%;"58E9XB-QV[B2>@SD8!YQ]:S
M_&-Z=-\1^&;EKNXB@:ZD2:.-W*R#RF(!0?>.>G!-/\.K/9^,_$D$]G<J+NYC
MGAF\EO*9/*4$[^F<C&,Y]NN'>+XYDUCPYJ MYI+:SO7:X>*-I#&K1LH)"@G&
M2.<<4 6[7Q;HVJZ?J,B2W4/V%2+N)X)$GA!'79C=TR00.WM6)K5U'_PCOA*Z
MTJ_O3;2ZI9(KO,X::)F'$G/S9P.M3-:27&N:_P"(8[>9+633%M(AY+;[AQN)
M8)C<1RJCCGG'%9,D5RO@'P9 ;"],UI?V3SQ"TD+Q+&?G+#;D 4 = DLT?Q6E
M@^TSFW;11,86E)C5_.QN"DX' '2M:S\06=]/;1PI.4NT,EO,8B(Y5 SD'Z$$
M9QGJ.*Q',G_"T7N1:7+6_P#8GDB4V[^67\TMLW8QG%9WABTNM.UK34T5[[^Q
MKE)'N=.OX6!TYMN1L9@"/F.W;SP2>>H .WO]0M=,M3<W<OEQ[@@P"2S$X"@#
MDDDX %5+7Q!975W<60$T5Y;1^:]M+$1(4/1E'\0SQQGGBLKQU9WTL&DZA902
M7(TO4HKJ>WB&YWC (8J.[#=D"F"'^U_'=EKEJDRV=C82I),\+)YK.1A " 3@
M D\<' ZT 4_#TK>*[J]NKBYU.VN++5I1 T3/&@BC8*(R#\IR,[@1GD^E7O$L
MDT/C#PKY5S/&DUS,DL2RL$D B8C*YP<&F> #(EMK"36US TFK74Z">W>/=&S
MY5AN SD4OBH2'Q7X6D2VN98X+J5Y7B@=UC4Q,H+$ @<D4 :5SXMTFTDF$DDA
MAM[A;6>X6,F.*5L85C_P)>>@SR15C4-7M+>=K$BXGN#$9'BMD+.D?3<<=.^.
MYP<9Q7 >)I-1U31O$-I)I6I"ZAU!&AM[:U<0O"LJ'S<@8E9E4GDDCC &":VK
M2]GT7QYJUW?6-\;+6H;=[2:.U>788T*F-@H)4Y)(R.YH I^'M8LO^%;Z?<:S
MJ6H%9[YU2XC:0R.PN6V!G'(!P!\V..*ZF\\6:79:G-IC_:I+V*'SS!%:R.S+
MG *@#YN<],C@YKA5BO/^%6V]D=,OQ<KJH<P_9)"VW[49-V .FWG/2NF64CXH
MR71MKO[,VC+$)_LLFS>)6<KNVXSM.?TZT :\/BC2)]#@UF.Y+6MRXCB^0[WD
M+;0@7KNW<8I]EXBL+W5)M+07"7MO@S0O _[L$9!+ %<$=.>:X".-HOA];F:Q
MU&*ZM-<-Q"!9OO1C.S*_ED NNUCP/7MU'0>&]3TNY\1ZA?/-=G4[R!1Y4MA+
M;#RXP>$#9W'+$GG/3B@#LZ*JZ;?KJ>G07J03VZS+N$5Q'LD7V9>QJU0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*** "BHKFX2TMI+B0.4C4LP1"S8'H!R:KZ1JEOK>DVVIV@<07*;X]XPV/<4
M7:**:[!$9R"0HR< D_D.M #J*SM#UNT\0:>;ZR$HB\UXL2IM;*L5/'U%)%KM
MG-X@FT-5F%U! )V+1E4V%MHP3UYSTXXH TJ*** "BBB@ HHHH **QE\3V3WL
M$$<%U)#<3O;QW:1[H3(N0RY!R.5(R1C(/-;- !1110 444T.I8J&!9>H!Y%
M#J*** "BBFJRN"58, 2.#GD=: '4444 %%%% !16&GBW3GGA&RX6UN%D:*^,
M8\AQ&"6^8'(X4D%@ 0.,TQ/%]J]];6@TW5-UV$>"06I9'C8XWD@G:HR,[L$9
M'% &_1156>^6"_M;,V]PYN=^)8XBT<>T9^=OX<YX]: +5%%9L6NV<WB&70E6
M87<-N+ABT95-A;:,$]><]..#0!I44UF5!N9@H]2<4Z@ HHHH ***S=*UVSUB
MYOH+59@]A-Y,WFQE/FP#P#SC!H TJ*** "BBB@ HHHH **** "BBB@ HHHH
M**:SJ@RS!1D#)..2<#]:=0 455L+Y=0@>5;>X@"RO'MN(BC':<9 /8XR#W%6
MJ "BFEU#A"PW$$A<\D#K_,?G3J "BFR.(XV<AB%&2%4D_@!R:HZ'K5KX@TJ/
M4K(2""1G5?-7:V58J>.W*F@#0HHHH **** "BBFLZH 68+D@#)QD^E #J***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-:W* $HW0@@]5(X(I;317@O[G59KE)M2N(5@\[RMJ1QJ20JIN)QDDG+<G\*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M YVZ\)"X;2W35+E'TV8W"R,JNTTA!!9R1W!(P,8[8P,="P)4A3@XX)&<4M%
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M*Y$:AU))!P%&W!.>,>^><SOX6^U7"7.H7[W-Q#:2VL,PC5&59  S-C[S<#T
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M",:<]J5QL5U_=NWL)@3G^ZPH V=<\1 :SX<NK+5'CTZ>ZFBN5*A(V"1L226
M/!'KCCVKHM-UW2]7M9KFQO8Y8H&*2MROED#)W X(X]:Y?Q)%9Z=KG@NQ+KY=
MM=-_K#T B(#$^I;'/K65J2S7]Y\0K33")KB5+9XXD;F8+$OF 8Z]"IQW.* .
MZ@\1Z1<7#VZWJ)*D7G;95:/='_?7<!N7W&145GXM\/ZA,D-IJUO*\D3S+AN-
MBG#-GI@8_+GI6!H>I^$]=U2RU.Q%Y->V2.7>YGG_ -!5E(</O.W).!CGU'3-
M9&CP27WP2GMM*C$MX@E+0IP[?ORQ4XYRR#\<B@#OK/7M,OKTV4%SFX$?FB)T
M9&9.FY=P&Y?<9%/U#6=-TDP+J%[#;&XD$<0D;!=CV'^>*YCP_?\ A;Q%K%EJ
M&F)>W-_:HX9IY9R;,,N&5MYVY)P,<^HZ9J3XC/!'::"]SM\E==M3)O&1M^;.
M?:@#9T_Q5H.J174EEJMO*EG_ *\[MOECU.<<>_2HX/&7ARY+"'6+9MEN;EB6
MP%BSC<2?<C\Q6*1:W7Q"GURRFB-E!H[0W=RC QLY?*J6Z$@ D^@V^HK)TB^M
MK'X(VTWV&&^\B)4F@=-PC)E&6=1S\N0Q'4X_&@#O;+6+#4+B:WMYR9X IDBD
MC:-U!Z$JP!P?7I44/B/2)[N.UCO5,LRLT.58+,%^]L8C#X[[2:X.:634?$^L
MQZ=?3WD^H^'"EI<&(HLC[G^Z0H  R.??J36WX7\0Z'KEII%G'9%]5T^-4>WD
MMR&L6"[7))&%X&!ZY ^@!>M/%^F:SI.JSF[DTZ"V>6#[3(AC*!?EW_,, [B<
M \],BM2#4K*UT>QFDOFN$FB00RE2TESE<@A5&22.< >O%<5IMW!!X0\9V$[&
M.X2YU!FC=".'SLYQCYLC'KVID>JQZ&/!FMWI8Z2FE?9)ID4LMM*R1X+8Z9VE
M?;F@#N(_$.DRZ=_:"7T;6WF>5NYSYF<;-O7=GC;C/M63XGUU9_!FM7FC:C)!
M=6$3EBJ;9(W49VLKKD9'L#Z5G:UK&DVVC6^I6.F0I976KQN;V2V.Q'(R;G;@
M$\C 8]3STQG$F8W*?$*VMVNKN2YM(I(6> AIAY&,@!0.O P.>U ';Z/XJT:_
MGATN/5(9=1$(9HMWS,0/FP>A(YSCI@U4\,ZA=/JWB:*_OWFAL;T+&\VU1&GE
MJQ'   &3S65=?8]?D\(QZ+)#//87,<\TD!!%O"L9#JQ'W=QVKM/)Q[&LZY6?
M4++Q];Z;^_N7NTD2)&^:5%1-P&.3D*R\=^* .\MM;TS4;E[""[(N#%Y@C96C
M=D/&]=P&X?[0R*@T75I+C4-1T>[</>:<Z9<#'FQ.,H^/7J#CC*GH"!6)X?O_
M  MXBUBRU'2TO;F_M4<,T\LY-F&7#*V\[<DX&.?4=,TU;F*Q^(WB#5YW,=E8
M:5"MRX4G#99^@Y)"C]: .VKGM/\ %^G:G-JT?F/:Q:=*8FGE0H.%4LV6&!@M
M@9ZXSWK8T_4+75=/@O[*42V\Z!XWP1D?0\CZ5R.@7EO9:KXPM+MC%*UZ]QM=
M2!Y1B0!L],'!H O/XIL-$T313]MN-4%_-'!#=-&29 3R[%1CIG QDX^II5U"
M[;XE06BWLK6$^CO<+;LH55?S4&>@.<'OTR:Y2&:.+X<>"+EV_=66IVS7+ $^
M2 '!+>F"1^==!+=PS?%6U,<P4OH<BJ6&"&:564$'H<#..M '0MXATE+V.T>\
M59)93#&2K!'D'5 ^-I;@_+G-:5>7>')M O-(LO#NM6U_)KMC(JM8--<<RHW$
MHP=H7^+=TZ_CZ!8:[INIZA?6%I<>9<Z>X2XC*,NPGIU'/0\B@!-0\0Z/I=P+
M>^U&"WF*&01N_P VT=3C_.:P/%'B6&_^'NIZQX;UC#6Z$B:#&58$94AAD<'V
M/2D\47%I:_$'PG->/''&([W]Y+@*IVQX.3T^OO7.:_!&FD>/M4MBHL-1$$=L
M4^[/*JX=D]<DXR.I!]* /0;#Q#I-]?'3;>_BEO(X][Q G..A(/0X/!QTI9O$
M6D07'D2WJH?-\DN5;RQ)_<+XVAO8G-<UJ-U:'QWX3-O<0A#9W2!D88&Y4V#\
M2#@>U8UI+&WPIOO"U\H.NQK-;M9,?WLLS2%D=1U8$D-N''4YXH [R\\3:)87
M<MI=:E!'<0Q^;)%G+*N<=!W]NM30ZWIESI4>JP7D<EG*!Y<JG(8DX  ZDYXQ
MUSQ7)V+1VGQ,M8KVYB:XA\.I#)*S#F029;D]\9./3FN>L[I;?POI]_MFGL=.
MUVYDO8[5V#QQ.90LGRD' W@\=J /3]/U>PU7SA9W D>W?9-&RE'C;T96 (_$
M5%>^(='TZ\^QW>H00W!C,GE,WS;1WQ^(QZ]JR_"Q\/WM]>:MH*3S"Y1%GO9)
M)F$Q7.U1YAYVCJ1TR!ZXJ:Q/;)\4= \V2,%+.Y7YB/E9MFT>Q.#C\: -I/%.
MAR:2FJIJ$;6+OY?G@-M#9QAN/E.>.<=:M/J^GQZBVGR7*QW*Q&8QN"O[L=6R
M>"!GK7FEVZ7/@?QLEN1*R:Z;C9'\Q\L2PL7 '485CGV-;JZYIVH?$S3;RTN/
M.M6TF95G5&V$^8AZXZ8!R>@H WU\9^&W2W=-7MV2YD\N)P259MQ7&<8&2" 3
MP<<58M=?TG5+R?3;'4D>ZCCW%8_O!>FY<C##/<9%>;22VK?!34(@T9D>^<A.
M-Q)NMPXZ_=Y^E=7?7=H?B?H9CGB*MITZ JPP=Q0J/QP<4 0^$/&EA'H5E!KN
MN1MJ-Q<3H#,0"V)G5<X&%X QT]JZG4-:T_2@?MDY3:GF.%C9RB?WF"@[5Z\G
MCBO.K86EU\+;_P .&-)-7EGN$6Q(Q,)6G8HQ7J  5;<> !UJ[/=V.@>++^V\
M53W<4%_;VXM;J.698Y=L>QT.P]=V3@_WO?D [&Z\4Z#9>5]HU:V3SH3/'A\[
MHP,[ACMCIZ]JOV=Y;ZA9PWEI*LUO.@>.1>C*1D&N#9-)T[Q3X*MK:#[%;017
MGE0SL2T0<+LW;B2I;L#SV[5V4>N:8VNOH*3XOXH!,8=A V=,@XP>W - %B]U
M"UT^-'NIA&)'$<8P2SL>BJHY)X/ ]*I2>*=#ATJ75)=2ABM(9#%([Y4HXZH5
M/(;VQFLWQEJ<.FW6B_:(XXHY;MA_:$D>\69V-@@=-S9V@G@9R0<5P^HW,(\#
M^.K0O,TTNI&1!-$5>0,(L'&!R<$XP.AXQ0!Z=9^(=(O]3FTVTOXI;N%=[Q*>
M=N<9'8C/'&:Y[XA>)4L/"FIMINJ26U[;X420QY4/D90N5*AL'ID-2:A>63?$
M?P\UO<0%6L+E%9&!7YMFP<>N#@5R4VJV\?P>U/P[?L4URV\Q;BU=29'<S;MX
M&.0<@[NE 'K\DB11M)(ZHB EF8X  [DUC)XS\.2+;.FKV[)=R>7"X)VLVXKC
M.,#)! SUQQ6M'<Q2VJW(;;$R[]SC;@>ISTKREIK0_!*>'='O-\3Y?&X_Z9NZ
M=?N<_2@#TFQ\0Z1J=_+865_%-<PKO>-<YVYQN'9AGN,BD@\1:1<W<-K#>JTD
MY80G:P28K]X(V-K$8.<$]*Y[4;ZV3XF:5)%)')_Q*IU 1A\Y+(54>YP<"N:M
M]7M;J/PC>1EH8X-0*R65O;,([(E' C^[DOGU//4 "@#OK:YM[V\UI+'79)Y4
MV*T4>QA9MM(PORD9."2#GGTK$T36EN?A[HEYK&O265S=M&?/!7?,^_[@!!SG
MH<#I2Z+>6J>-?&CM/&J_Z,VXL "%APQ]\'@^AKG%N(%^#6@1M(@=+JV#*3RI
M68%LCM@<GVH ]#O/%&AV%S-;7.IP)-;H'ECSEE!]AW]NM3)K>F2:5'JJ7L36
M4P'ES Y#DG  [DD\8ZYXKG$N[+_A;4TAGA_Y :*'+#&1*[$9]=N#].:YBVN+
M.+X;:=<FZ$3:=KIG3Y"R*?M#E1(%Y"%6SG'<8H ](M-?TJ]O7L8+Z,WD?W[9
M\I*O&>4;!''/2I[W4;33Q']JFV-,VR)%4L\C8SA5 ))P">!T%<OX2U+1M6\3
MZKJ=IK%I<7EY%$IM+=R?+2,$;CN +$ENN..!5CQ;JD&G:UH27");K-),!J+Q
M;S;'9C:O& SYP"<C@\&@#<@UK3+C3'U**]B-I'N#RL=H0@X(;/0@\8/-<];Z
M[)=_$R.PM[^=K0Z6\KVDL1CV.)$ ;!4-R#U.>^*Y 3S1:%>RQQW4T-AXM-Y>
MHT+!VMP^[<5P,\[6QCMT%;ESJUKK'Q AGT6[6=IM"GB@GB!*^874J-P&.,'Z
M4 7_ !MXE2WTR+^R]4DAG%]#"3%'E)<R*KIO*D9 SD*<\'T-;5[XN\/:=/-!
M=ZM;Q2VY42J6R4+' !QWX_"O/)M;T]_A;8:4Q,6I:?/:QW-HT9\V)TF7<Q7&
M<'DY[YQUKJ-,N;.;XJ:M\\;-+IUNL>>I(+%E&>X&"10!T5WXATFQN/)NKQ8C
MY@B+E6V(YZ*SXVJ3D<$@\BG7>N:;8RO'<7!4QE1(1&S+&6^Z&(!"DY& ?45Y
M]9SZ$8M2\+^*8+^34&O9F%H))]M\KRET9 IV\Y'IC&35G7Y7TS4]4OM#U%#=
MJT4=]H=U\ZWO[M #'_%N*D+D9R5YZ4 =Q>:YIMA(Z7-P5,>WS"(V98]W3<0"
M%SVS6A7G/B2>2PUC5]1T74D^VAHDOM$NP&2^S&F/+'4,5(7(SDKS7:Z[!=WO
MAO4+>R)CO)[21(><%7*$#GZ]Z &Q>(M(FNHK9+U2\[%86*L$F8=0CD;6(P>
M3TK#U371>^,1X;6\N;2$6+2M+;HP<RF0(O.#P.3Z$GGI6%<SPZ]\.M&T73R$
MUF"2TC%MTEM9(F4.S+U4* W)[$>HK;^UVP^,!4SQ@_V((OO#[_GYV_[V.<=:
M .IL(;BVL((+NZ-W/&@62<H$\PCJVT<#-6*** "BBB@ HHHH **** "BBB@
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M*FNBR(R.H96&"",@BN6M_%^FZUX7U"^N+FZTFV5I8OM)B>-XU#%0RDKC=QG
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M#$YC<1R2#.463&TMP1@'.015+3O%]EJ5SJ\3+/:Q:=*8FFE@=!PH+$DC Y/
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M4M$OE-R!C.3C QD=<=:J?\)-H_VB*$WF/.E,,4IC<1/(#C:),;"<@C /4$4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M% AP)"/^68\@H=W]WYN.>]>BT4 <]X^MYKKP)K,-O$TLK6K;409)[\"L2XU
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&:ZAMY(HY'_>3
M-MC0#);UX]!W/:IJY70+I]3\;^))Y#D6!ALK<'^ ;=[G\6(_[Y'I0!U55;C4
M+>VO;2SD\SS;LL(ML;,ORC<<D#"\>O6N:LO$.IQ2^(K#4I8FOM.=3:".+:)8
MY!^Z."3DEOE/;-6KS5-7T_Q+X;TR6>VEAU 3+=,L)5BZ1%LJ=W SVQGCK0!L
MQ:I;337L2>;NL2!-F)AR5W?+Q\W![9IMMK%E<P6<ZNZ)?*&@,L;)NR,XY'!Q
MV/)Y]*P[#6]8N;CQ1;O):>;I<@6V80MLP8PXW#=D]<=:B>ZN/$/PH:_NF5;N
M?33<AXQMV2JN]6'IA@#^% '7T5F>&]2?6/#6FZE( )+JUCE<#H&*@G]<UIT
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M3Q4[:BDLD%\8XQ+!E1B)"O 88 Z8_'.: .LT^_@U.PAOK;?Y,R[DWH4;'N"
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M9Q]LES;?Z_\ T2;]UQGYOE^7CGFKEGKVG7^J3Z;;3,]S;Q++(IC90%;[I!(
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M.0#\Q&3P,9Q[U7N-?GU3P=K^I:1K\5Q#!8-)!*D06:&15<NKKV/"X.!CGZT
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M6W8*Y!P, ^_KVU% ',3^%]1B\01Z[IFJPPWCVZV]XLUL7BN%!X;:'!5A]?\
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M1110 4444 %<S!J>H:_J>LVNG7HL4TN46\;>4K^9+M#,7S_",@8&#P3FNFK
M'ARXLM=OM4TC4([7^T0OVJ&:W,J%U& ZX9=IQUZ@T <_#XQUK5+#PU=6OV:U
M?4+Q[.[B>(N%= ^2#G[N4SCKVR*V_#6I:G)KNN:-J=S'=MISPM%.L0C+)(A;
M!4''!!&>]1/X+$-OHEOIU\MO%H\YG7S8/,:9R&W%B&7KN8\=S^%7]-T*XL/$
MNJZP]]'*FI"(- ("IC\L%5PVXYX)SQ^5 &5XF%\WCCPO#!J$D$4K7),:HI 9
M83\W(Y.&(K.(U5?$_C:72[V*S>$6TF]X?,+$6X(&"< <<GD_2NFUO0)-5U'2
M]0MK]K.YTV1V1A$) RNNUA@]\=#V]#56+PO>17VO77]J1L=:55(:U/[G:FP8
M^?GY?IS^5 %.V\4WNK0Z';VT4B7&HZ;]NN&MQ&60?(,)YAV\L_4YX'3G(U_#
M4VNRV4Z:_:B*>*X=(9 4S/%_"Y"L0I]1[5COX$N4TS1DLM<:TU/1HS#;WL=L
M"'B( */&6(;H._6NCTJQGL;8B[OGOKJ1MTL[($#' &%4<* !T^IY)- &2-4U
M/_A8,VB^?!]D.E?:HAY)RK^9L^8Y^;IVQU_&N;B\3^)E\&V_B6:^M66&^\F>
MW6VP)D-QY7WL_*0",8].2<UUC:#<_P#"7MX@2_C&;'[&(#;DX7=O#;MW7/MT
M_.LG_A!+K_A#F\-G6(_+:Y\_SOLAW?ZWS<8W_P![]/SH OOK&H67CN+2KV6
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MFDQZN\5YI$OFV5_%  R'GAD+$,#D@C(SQ0!9OM3USP_9W7VQX;SSKV&VTV7
M#MYA"_O%&U<J2<8(SCM5C2IO$:>();>]MY9=*>W#QW,_DK)'+G!3$;<J1R#C
MCI3+KPE)JVA7-AK6JRW=U<;"+J*,0^2R'*%%&<8.3U).3STQ/I6BZQ:QNVI^
M(GU"Y$31P2"U2)8L_P 14$[FX')/X<G(!NT56T^&YMM/@@O+O[9<1H%DN#&$
M\QN[;1P,^E6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;V[A -U"JYN3'G$>&Z$9Y&*?XSNM+3X2ZM8Z;<++:V21VJ2!PRLP9/E!S\V
M0"?7/H:[W[':_P#/M#_W[%.-M;E A@C*CH-@P* ,K2-#TR">VU:RW%S:F+<)
MF=65BK=R>ZCIZUA_$>XAAG\*B65$QK]LQW,!A0&R?IR.:[1$2-0J(J*.RC I
MLEO#*VZ2&-SC&64&@!9'C6%G<CRPI+'MBN6^%T4T/PXT=9P0QB=AG^ZSL5_\
M=(K?U*Q.H6+6(D\F"9=DQ3ABAX*KZ9'&>W;GD6HHHX(4AA18XXU"HBC 4#@
M4 >?V*Z)GQO'JR6Q+7S[TD"^8R&)-N!UY.<8[].:BTNZ713X7TS5VBL-3326
M_P!.NF_U:Y4&% 3M,G ZYQMZ'->AO;6\DZSO!&TJ?=D* LOT/:G/%'(RL\:L
M4.5+#)4^H]* /(;.?3Y/A_X;M[B6%O(\1JDJRX&P&XD)# ]/E.2/0UT[SV=M
M\0M?5988PVB1,X# 9(,G)^@Q^&*[4VMNPPT$9&2>4'4]:0VEL22;>(D]24%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO4QJ",'.,'/IVK<1TD0.C!E/0J<@UQ>OV&G3>-/"E@((?LI6]S!& J'Y%)!
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M?#NC$6H.F6Q%G_Q[CRQ^Y_W?3\*T%974.C!E89!!R"*;+<00 F6:./:NX[V
MP/7Z4 9MSIR:7#>W^AZ5:OJ4PR06\OSSG^)L'MGK3M%LKF!;B]U!(DOKUQ),
ML1W+& H54#$#. .N.I-:(EC,7FB13'MW;\\8]<^E,CN[:6 W$=Q$\(R3(K@J
M,=>>E !=6EO?6TEM=0I-!(-KQN,JP]".XJF?#NC,+4'3+8BSXMAY8_<_[O\
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MLY?LH M_,MT;R0.@7(^7H.E '":;X<T#4I?&D6H65N8XKU]I91_HX,2DLO\
M=.<G(QT]JK:)?W"3^%[;Q#>?95FT8FWDN%4JTNX9!W<;O+V\GGDCOSTFA>&"
M-7UNZUC2K9UOKSSX&;;(0FU0%8>ORYQR*Z/4=*T[5[<6^I6-O>0@[@D\8< ^
MHST- 'G>J:'I%EIVA6UE<M>P#Q-&JR-MQ&'W%XXRH&$SV'?([5+J"OH.L>,Q
MH%NEJZZ/#,D=N@4!\2#>%'&0.?PKNYM"T>YMX+>?2;*6&V_U,<ENC+%_N@C
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M> 69^#&C(AB622XM/-V$*Q_T@#DCG/!_(UN75J-(\>ZC'H=K';RR>&WE6*%
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MO\#M/D6.W,T2V;[@%W*QF12?KC</SKH;O2]/O/BX$N;."99-"9Y$= 5D(G4
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M33-*M897;SRR^4(LCAPJ##'V..@^H (/"]W!XCF?Q1'#MCGA2"UWKA@@Y?\
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M 4^6@7('0?09.!VH M4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5GZ[K=EX>TB?4[^58X85)
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M7*?,I(Y&<<BN@O!HNE>+[33K*WL]/N%L)IO-EPD$<;.-VU 0&<E>>1@#OTH
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M< <]:MT4 9XT'1A 8!I-B(6;<8_LR;2?7&.M..B:2TRS-I=F9%"A7-NF0!C
M!QVP,?2KU% !5./2=-AO6O8M/M4NG)+3K"H<D]26QFKE% %1M*TY[P7CV%JU
MR.DQA4N/^!8S5ET21&CD4.C AE89!'H:=10!171-)4PE=+LP;<8AQ;I^[&<_
M+QQSZ4?V)I/[W_B5V?[_ /UO^CI^\[_-QS^-7J* *+Z)I,L<4<FEV;I "(E:
MW0B,'KM&./PJY'&D4:QQHJ(@ 55& !Z 4ZB@"I)I.FS7Z:A+I]K)>1C"7#0J
M9%^C8R*+S2].U%D:^L+:Z,>=AGA5]N>N,CBK=% %6YTO3[U8UN["VN!%]P2P
MJP3Z9'%$>F:?%=M=QV-LERPPTRQ*'/U;&:M44 4&T'1V@2!M)L3$C%EC-NFU
M2>I QP34TVG6-S+!+/96\LEN<PN\2L8C_LDCC\*LT4 5#I6G-9R61L+4VTK%
MI(#"NQR3DDKC!)-.BTZQ@L?L$-E;QVFTK]G2)1'@]1MQC%6:* *R:=8QM;LE
MG;JUJI6 B)0801@A>/E!'I3[FUMKV$PW5O%/$>J2H&4_@:FHH CA@AMH5A@B
M2*)!A410JJ/8"F265I+:-:26L+V[##0M&"A'H5Z5/10!!:6-I81>396L-M&3
MG9#&$&?7 IMWI]E?[/MEG;W/EG*>=$K[3[9'%6:* *9TC3#</<'3K3SI 5>3
MR%W,#U!.,FF'0=&-N+<Z38F$,6$?V=-H8]\8QGBK]% %2XTO3KNV2VN;"VF@
MC.4BDA5E4^H!&!1+I>G36B6DMA;26\?W(7A4HOT7&!5NB@"G+I.FSI"DNG6L
MBP#$2O"I$?\ N\<?A2_V3IOGR7']GVOG2@B23R5W.#U!.,FK=% % Z#HYMA;
M'2;'R _F"+[.FT-_>QC&?>IO[.L=MPOV*WVW7^O'E+B7C'S<?-QQS5FB@"FV
MD:8Q@+:=:$VX"PDP+^Z Z!>./PHN-)TV[NDNKG3[6>=!A99(59U&<\$C/6KE
M% %6?3;"YN8[FXL;>6>/&R62)69?H2,BJUSX?TR6UN((=.L8C<@"4FU1@W.<
MD8PQ!Y&>_-:=% $-G:Q6-E!9P B*WC6- 3G"J,#]!4U%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !12!@20""0<'VIDLT5O&9)I4C0=6=@!^9H DHIJ2)( 4=6! (*G/![
MTH8$D @D'!]J %HIJR(S%5=25Z@'I0\B1XWNJYZ9.,T .HHI%97&58,/4&@!
M:*9'+',NZ*174'&5.1FAY8X\;Y%7/3<<4 /HIC2QIC=(J[NF6 S3Z "BF/+'
M'C?(JYZ;CBCS(_+\S>NS^]GC\Z 'T4U75UW(P8>H.:4,&&001G'% "T4QI8T
M8*TBJ3T!.,T-+&DBQM(JN^=JDX+8ZX'>@!]%(65<!F R<#)ZFAF51EF &0.3
MW/2@!:*9+-% F^:1(USC<[ #-.R ,D\4 +1445S;W W0SQR#.W*.#SZ<4Y98
MW=HUD5G3[R@Y*_7TH ?13!+&93$)%,@&2F>0/7%'FQ^;Y7F+YF-VS/./7% #
MZ*C:>%&*M*BD=06 IY900"P!8X&3UH 6BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HI&)520I8@9P.IKF4\>Z68;V=[34$@TZ9H+N4VVY877[V=I)P,]
M0"* .GHJ*VN8+RVBN;:5989D#QR(<AE(R"#4M !1110 454U/4K?2K,W5P)&
M&0JQQ1EWD8]%51R2:S]#\5Z=KL]U:Q1W-I=VF#-:WD)BD13T;![>XH VZ*P(
M?&6FRZS;Z6\%[;M=[OLL\]N4BN"!DA&/MSR!G\16_0 445EZEKD=A<?9(;2X
MOKP0-<&WM]N_RP0,_,0.2< =30!J450_M>W&CQ:FT=PL<J*Z1&%O-);HNSKN
M]JK:)XFLM=GN[6*&ZM;NR*B>VNXO+D0-RIQW!QUH V**Y]/&>FMK%MILD%[#
M]L8K:W,MN5AG8#.%8^HZ<<]LUT% !1110 4444 %%%% !1110 4444 %%%%
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MYM!&8PTA <#.0<@#D'D''84 9DMY;:%X^>,O'::>^C>=/T5$,<H56]!PY'T
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M/3)5M &N+6\B)AN&P21A>@W$L.#R!Z5T^H6":C%%%*[+&DT<Q4?Q[&# 'VW
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>63
<FILENAME>ebs20191231exhibit1048024.jpg
<TEXT>
begin 644 ebs20191231exhibit1048024.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTD:M%J$+63':)@W!.=NWUSGC'7-<Q=:EIUW\3]$F2XB=?[-G*,W'+,NTC/J
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M+^+;:"RGAU[6D:Z;4Y[>)IL*S*LA5<A0 .F.PKJKW5+/3RBW,VUW!*QJI=V
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M*YC,5XI>($[2R)A3Z'V/(S[TWP[?62Z?XW?[5"$_M.Y?.\8VF- #]"01GUH
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M3@G<4V\'UP<>M8MA<0Q_#76O#FJD'6D-U&]L_P#K;B61F:-D7JVXLN"/3VH
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M:^)=%O=0_L^VU*"2Z\OS!$K<E>^/IW'451T[QMH]_'J<\ERMK;Z?<-$TDX*
MA0N6YZ?,Q '7BN?GO=/77/A\\=S;B-8YERKK@ V^T#\6X^O%55O;:V\,_$'3
MYY!'<M<WT@C<$':\8"'_ ($>GKVH [6'Q7H%P)C#JMN_D>7Y@#<@O]P8[D]
M!SGCK5JTU>POHIY;>Y0K;,5G#90Q$#)#!L%>.>:X^]U33M/\">'+H0VLD)DM
M(_M3+OCLR%_UA _ND$=1@GFL*]:>\7QW;Z=)<7UQ*+.>,-&0UQ$J)OQA0""
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MT^EV(TW3(+,.9#$GSR'K(YY9C[EB3^- %NBBB@ HHHH **** "BBB@ HHHH
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M06.-Q8$X&XYP<8XS6FWB/2%O(K5KP!YI3!&Q1O+>0=4#XVEN",9SD$4 :8
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MZCJ$T#6VIWNGO:0QM\I1U1E)]LREC] M4?#E_P"'M<&DV[6-^^LZ>4+6L[7
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MFM8TV,_V1WD#AG')7< /IT/2@#7\$ZG-J.I^(]U[<74,-^$A\\%3&/+4E=I
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MSLOY[4^;,LIDNV65"Q"O\Q 4=<<X/I0!UT/C/0+BZCM8KUVEEN#;H/L\N&D
M!P#MQT(.<XQS5NVU_3;NYO;:"61YM/\ ^/E/(D!CXR.J\DCD 9SVK-\9VCZI
MX5-[IN)+NQ9+^S([O'\V/Q7<OXU@2V&KGQ!;ZC'#,J>*8#;WL><?90/F0GT8
M0[U_WJ .E;6-)OM8T4QZK<QS7*226ULJLB7*E,DNI7H ,C..W7-7&\0::MRL
M'FR%GG^SJZP.4,F<%=X&W(((Z]01VK"\0M'%X^\) #;'#]J#E5^6,-$%7/89
M/ K)B\ZQUU)] O))8;O52M]HETF[RSYAWSQD\H 1OS]TYZ]!0!V%]XFTC378
M7=RT:1R".27R7:*)CC =P-JGD=2.H]:U*\TM)-.MI=5\.>)-.U2>ZFO9I((H
M_/:*^C=RZD;3L'7!S@#')ZX[>SUJQ_M@^'U$D=Y;VRRE"C;-O PKD8;&1^?U
MH N7FH6UAY0G=MTS%8T1&=G(!)PJ@GH#7*^*M=#6WA_4[#4I[>UDUF.WGSF(
M,@9PX<, PP4((..AJYXRM;.[DTY)[^YTNY1W>UU"$X$#@ $/GC:P/0X!QCO7
M-WM[J%QHGAP:M'&T\/B)&::&(JDT2,_[_;_"ISG/3G/>@#MK'Q-H^HI>O;WF
M!8<W0FC:(Q#!(8AP#C )STXI;+Q#IFI70L[:XD$\D'GQK)"\9>,\;UW* PY'
M3-<E?WAM_%/BV>"Q&H%M)B$=NR%DN&4/N3T;@C('/:H]-O(YO&F@7Z->W$4N
MG31&9K1XXU<F,[57: JCGGVY)(H 6._U/_A ?%T_]J7?VBPOKU()]XWJL9^4
M9QP..V*[C2G>71K-W=F=[="SDY))4<\UY_#(&\ >-HP&\R>_OVB3:=T@<G85
M'4@]B*[W0Y%DT&P9#D?9T'T(4 CZYH Y#0/&5AHZ:Q%K^L2LT6LSPQO*K2>7
M&"H7<5&$7KC.!U]Z["[UBRLPADD>1I$,B);Q-,S*,98*@)QR.>G(KBK&6&TT
MGQAI5W;R->7FH7;P6AB.^X60 (5&/F!]>@ZG%5EA?P?J>E_\) M\UBVC069N
MK-YL0S1ELJPC.<'=P>>GUH ]#T[4;/5K"*^L+A+BVF&4D3H>WX'/&*J:CXDT
MK2FE%Y<LH@"F=DA>180>F\J"%_'''/2F^&K:RMM( TZPDL;621I(XY=P=@3]
MXAN5SUP>?7!XKE['5H-!UGQ!HNO6%S-_:-Z]S:[;1IDNXW51Y8P",C;@@X%
M'7W6MV%H\:/,TLDL9E2.WB:9BG][:@)V\CGI5:;Q9H4&FVVI2:E%]DNY!'#*
M 2&8G&.!QSP<XQWK"MI9-"\>W5UJL0M;+4=/@2WE_P"64#QYW0[N@^\2.@/:
ML"]L9;+PY<S212)%?^)UO;>$H=P@\Q<MMQD A2W3@$>M '?V'B72-3N+JWM;
MS,MFH>99(VCVJ>C?,!E>.HR*?;:_IUU,(8Y)0S0&X4R6\B!HQ@%@64 CYAT]
M:Y?4+BU;XAWTLD;7-L_ATQLJ XE(D9B@(_B*GIUYI/"YN=,UN"RM-4.K:&;-
MW62Y7]]IV"N(V?C@_P!T\C;[4 ;^C:KI,?AO^T8=7FO+$228NKDDL3YA&T<
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M['D?C7%7>EW=IXRGTBVBSI7B$?:[C!XB:,J)ACTD!13[L:[F@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBJ][>V^GV_GW+[4W*@P"2S,0%4 <DDD#% %BBN
M:U_QG;:1X<U/4XK:YDEL?W;0O ZXD(!7=D?=^8$MT].:GOM6TN74]&CFO+^U
MGGF8VT CDB$Y"L") 5Z <X..QH WJ*YR\\>^';(W0ENYBUF^RX6.UD8Q\9)(
M"\* 1STJ^GB/2I+S3[1+DO)J<;26C+&Q250NXD-C'3GDT :E%<SKFMV^H^%/
M$+:;=W$-SIMO,'95>)XI%C+#J ?0Y%3Z9K=O::#HD=W++->7EFC1QJK222D1
MJ6/'UY)]1ZT ;]%<SJGC>PM=%L=3L4EO(KZ[CMT*0N=A,@5MPQD$<C'4GC%6
MFU+39_$]A!]LO8KUK:1X[0K)'&Z'&6=2 ,C'&>1DT ;E%8]UXJTBS,K33N((
M)?)FN1$QAB?(&&<# Y(!/0'@XHO/%.DV.I'39II3=^09UACMY'9TR!\NT'<>
M>@R>#Z4 ;%%4=(U>QUW3DO\ 3Y3+ Y*Y*E65@<$$'D$$=#3;W6K.QN#;/YTU
MP(_-:&WA:5U3.-Q"@X&<X]<'&<4 :%%<IXK\716G@2XUO1IS-YT>+>>*)G52
M6"Y/&%(R>&[C'M6GHVGQ07$]_;WFI-!<*H^S7C2$(RYRP$GS#/IT.* -BBN)
MN_%1USPUXI^RK>V,NFK<)#*(WC;,<0;);& =Q/RYSC'%7_#?BK3KBUT?3);F
M9KVYLD9'DB?9,RH"X60C:S#J<$]Z .GHK!L-7TA;O7+I-2N7%JZF\6<OY=L0
MG1 1P"!DXSDFM"SU:WO;J6U1)XYH461DFA9/E8D C(P?NGITQS0!>HJK>ZC;
M:>(_/=M\S;(HT4N\C8S@*.3P"?8#)JE!XHT>XT^6]6Z(C@G^S2HT;"19LX\O
M9C=NR1@ <YXH UZ*RX/$>FSR74/F2Q3V:"2:"2%UD5#T8+C+#W&:I6WCGP_>
M/8""ZE9-0;9;RFWD$;/V7>1@,<?=)S0!T-%<_9^+(;KQ+JFDFUND73TC_>&V
MD.YF#L>@X& N,XR<XSQ3(/'OANY@%Q'?/Y'E23&9H)%0*C;6RQ7 .?X>O(XY
M% '1T5G66NV-]?36*-+%=0QK,\,\31MY;9 89'(R"/;OBH(_%6D2W=K;K/(#
M>[OLLC0N(Y]HR=C8P>.1Z]LT ;%016D<-S-<C<TTV SL>=HSA1Z 9/YFLCPW
MXGC\127ZI:W$ M;J2!1+ ZY"8!R2,;MQ/R]0.U;U !1110 4444 %%%% !11
M10 4444 %%%% !4 M(_MIO&+-*$,:%CPBG!('U(!/T'H*GHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P R-2L*<_-\H!;.UF&>Q7WSJ>'=0UI_$.H6%Y'>7&FK$DEK>W5MY+%L .A
M50>>1P._6@#J**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/6NELOA[%9^&]8TP:B\EWK;N]Y>M",L6SG:@/ Y..3U-=<8XRVXHI;UQS3Z
M,31O#46F^$D\.74PO+986@+%-A:-L@@\GG!/-9WA3P9>>%XQ9+XAN;K3(G+P
M6C0JA3)S@N.2,G.!@9]LBNLHH Y.W\#DZUI.J:EJ"WDVDQLD,BVWER2Y&!YC
M[CN YQP.O)/.8=*\ 2Z%K%[-I6O7%KIM]*99K!8E.&/7;)U7TX&<=\@&NRHH
M Y&3P-(WBW5/$*:H%EU*S:T:(V^51"J@$'=R?D!_.J\'PTMD\ 3>$)M2DD@>
M3S([A8@K(=P;D9(/(]N/SKMJ* ..U/P%-J<>A,_B"ZCN=&?<DR0IA^% ^4\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=IZH?B3JVIVLJ#3O[.ACNI0PV-<!B1ST)$>,^F11\+)X9OA_IXBE1RC3!@K
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MK7C8R$^4A&;_ &0QS]<4 2Z5KTU_\0;_ $^'45N;"+3TF6((H\J0N00>,YP
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M<;>,8KIJXWX:W%M+IFKI;21L$UBZ.U3]U2^5X[#%=E0 4444 %%%% !1110
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M@';W('.3U';.*T+77M*O;M;2WOHI)G0R(H./,4=64GAA[C- %QX(94"21(Z
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M'+^\34QI<2M+$MS)A3'ABH?##&21D#K6LFLZ;!+96$NH(]U=1@P!N'G&.6
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MPRC?GE#OSTP#TQFMK4]0N;VWO8[>:VEL!I+32N(SN9G5MFT[L $ G!!(X]:
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M!+J/  SP<,,=<'//'-=)10!C>%] 3PYIDMG&5"RW,DXBCSY<.\YV)G^$?XG
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MG;@D8/0]#0!SK^&M<T_Q%>ZAH&J6L%KJ;*]U!=P-)Y<@&TO'AAR0!P>*M?\
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M.6"&W9$QO##:2QQR.I[=N]7?">B76@:7+974T,Q>YEG5X@1]]BQ!!]":W**
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M671O!USHEO=":>9)(UGFS@ C8F1_LH%&.^WWK>O+VWL(//N9-B;@HX)+,3@
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M4 %8'C?6;_P_X6N=4T\0-+ 4^692P(9U7C!'/S9_"M^N1^*3!?AWJ>7"$F$
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M924GCSN'(.58'OSQQ5:X\(R2>'=8T^*[C%YK3R/=7+1$J"XVX5<] H &3[T
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MM?+C*DQJ=N223G)!((QQCUJW?WD6G:?<WTY(AMHFEDQUVJ"3^@K*UZ#4=/\
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MR*[A>2/>A9#T8 @X.3T-5[30-2MO%-UK;WUO,;BS2V\OR2N"I)#9W=R3Q^M
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M&IR,KNR"#GG/M4^H>&=3O)='G&JQ//IUR;J22: GSG*E2  PVJ < <]!UYR
M1MK.L17L>ASS1-J$5K]HN;FVLWD7YG94"IGCA23D_3KQ5F\3>([;1]$N+VQ@
ML[FZU:&QNHY(V^9&?&]/F^7(['.,^U:&N^&]1N==M]>T+4TL;^.'[/,LT/F1
M3Q9W $ @@@DG(I-5\,ZAJ5AIT+:I&]Q:7\5]+-)"<2,AR%50?E7H.IX'<Y-
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M%P9%A61MTJEE!!(   Y[G/48YV_#UUJ=[H=M/K-D++4&4B>!6!"L"1D8)X(
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M28[]H=\9FS@(Y/"C'/;.>HQ0!U-%<U'JU_=ZK9:$ES%%<_V:M[=7,:AP23M
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MYQ!/JLD4I>T3RQ \?W'49.6SDD]_UK2T/2M8M'$NM:V-2D1-D?EVXA4#C+,
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M^SK;3Q-;B:*6-?N?+D8*YX.>GXYZ"PM6L[-()+A[B09+RR8R[$Y)P.!R>@X
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MS <G'3-*&#9P0<'!Q0!S\/AR]@UO6]234H?^)M'&@C-J?W.Q2JG._P";@G/
M_"J-MX&FLM/T,0:H@U'0PR6]S]G(22-AAD=-W.1W!&#S77TBL&4,I!!Z$=Z
M.?D\*)>0:TU]<A[O6;?[-++%'M6*,*54*"3TW$G)Y)[<"M+1+&ZTW28+.[O%
MNY(4">:L7E@@  ?+D^GKUSTZ"_6?+K=E%KL&BL91=SQ-*@\IMI5<9^;&#U'
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M;N,B/<"2V.^%4X'KBJN@^&]4TMH8]0\1SZG;6HQ;1- L97C WL,ER >.GKU
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MYN=5MDVL%CWQ(L(9MNX@$].6SU)YQ@ZUOX2F75K_ %"ZU>6X_M*T6WN8Q"J
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M@ HHHH **** "BBB@ HHKG/'NJ:CHOA&[U'3)TAN(&CP7C#Y#.JGKP/O>AH
MZ.D)P">>/2N.EO\ Q%HOC'3+*]U*&^LM9$J*HM@GV65$W#&#EE/3DY]Z9X5N
M/$VMZ>VH3Z[$HAGNH##]B4B3:Q56)R",8Z#KWH ZS3KU=1L(;Q8)[<2KN$5Q
M&8Y%_P!Y3TJS7"Z+XJU'4/#_ (6BFN M_KC2>9<A%^14#,VU<8W'  R,<YYJ
M_J%_KGAVRN/M=U%??:;Z&WT^78HE42,%.\ *A().,8SQG% '5U7@O(KFXN88
MPV;9Q'(2.-Q4-@?@P_.L*QN=>L=7NI-2\Y]$6U,OGW?D"6*13\RXBX*[><D9
MR*@-]=Z>FAZ6&^S7VNSRRSRE03#\K2N!G@L.$&<C Z'&* .LHKD=6U37/#&F
MW3W=W!>&XO8;?39G0!T\P@$RA0JG:<D8ZXYJ6XU+4M"\6Z3IUQ>O?V6KB2,&
M6-%>"5%W @HH!4C(P1D'O0!U-(&5B0K [3@X/0UQ/A[Q'=:KJD.GWNI3V&JQ
M^9]KTRX@1,C#8:%MOS '!')R.3[V/AW'<G2KV:XU&YNB=1N4Q-LZB4C=D*#D
MX]<>@% '7T4A( )/05PH\0ZS?^!)O&5E>B/8);B.Q:)#$848C:QQNW%5)R&'
M)Z8H [NBN(DU77=9\3PV&F:JFGVE[HJWT3&U61XF+J!UZ\'Z<GC.".IU.2\M
MM$N9+::W%W' Q26Y.R(.!]YO1<\F@"]17':5K6HR^+4TD:A+=6UQI1N4FGME
M3$JNJDIA5)0AL\_@<5C6WB+Q,/!6F^)IM6C<B^\F>W%J@69#<&+D]00,8QCI
MSGK0!Z517+R:I?:5X[%EJ5^3I=_:O)9[D10DB<NA8#)^7YASTSUQ6KX>>\GT
MB.ZO9Y)7N2TJ!T53'&QRBD #D+C/OF@#3I-REBNX;@ 2,\@'_P#4:XN\\2W,
M'B>;2K[4)M(E:ZC^P>9"AMKN'Y=PWE2=Y^<8R,96GZ)%>'XA>)R=2N9%@2UV
M12;-A#(Y"GY<@ DXP0?7- '94T,K%@&!*G# 'H>O]17#V7B'58];\/6\VHB]
M74FFBN_+A7[.KJA<>2^T%@",9RP_&JFDZG=Z%I7C'6)K^YO&M-5FC2.?9M=M
MD2HS$*",9 P"!@=* /1&4,I5@"#U!%9VLZW9Z!:PS7:R^7+,D*>5&6PS$ 9[
M 9/>L;[7XBTS4UNKE;F?1UMI7O#<BW5H65=P,?EG)!P1@YQQS6#X@GU+5_ N
MEZW<7Y"WEY:3-:+&GEHC2J54'&[(^7))YYX'& #T:2011-(P8A1DA5+$_0#D
MUDVOB>SOO#*Z_:6]Y<6S9VQQ0%I6PY0X0<]1GZ5LUYE9:EJ.C?!!-2TNX2WN
M+<R$,T8?@W# X!X[^AH ]-HKE=3OM9/CRUT>VU!+>SN=/EF($"LR,K*,@GJ>
M>.WJ#6&=9\3MX4UZ^&M(L^@75Q$'%JG^E"/#?.,8&0<?*!ZYH [R>^6"_M;0
MV]PYNM^)(XBT<>T9^=OX<]L]35@,I) 8$KU /2N8NM9U(>*?#,,<Z)9:I#,\
MT(C!.5B##YCSC)[8Z5F>'3J<7_"87,6K-+<6]_,D7VXH(<B)-K.0H( X'! P
M.G>@#O*K7M\EEI\]YY4MPL*EC';IYCMCJ%4=3[5RVEZSJ$_BN+2#J4]Q:W6E
M-.MP\"(5E5U4M'\@RI#9&01TP2*QM)O=7TSX07FL6NK2O=QFYE5KB-) I$\F
M2. 23U)8D>@H ])1M\:N 1N .&&"/J*=7,/K-W?>);+P_!<M:LVF?;[B=$4N
MP+!%5=P*CG)/!Z <5@ZMXJUZQT'Q1;+=QC4=!EBV71A4^=%)@KE?NAL$YP,>
MU 'HM-9E12S,%4#)). *YA+W6-/\=6FFWFH+=VFHVDLHB$"IY#QE?ND<D$-_
M$33/B0)QX75H+R>V_P!,MU81;?G#2J,'(/'.>/QR.* -I]=LT\0Q:$5F^URP
M-.I\LA-H(!^8]3R.F:TJXC5;:\/Q$T:W@U!UF_LNY!N9(U9\;TY  "Y_#'L:
MCLO%>J1:&8+F7[5?C7'TA;A8T4OAB=^W(7=M! '3.* .[HKB[V\\6:=8Z].S
MN+2WL7N;.YNTA,JR*I+(5C."#C(../>FC5M=L-)TR]NM2%W)K;VT$,,=O&GV
M=F1G<@D@,2%.-V!GMCB@#MJ*XC4M?\0^%]/UK4M0@>YL((4>SDNC$)!*S!-C
M"+@KE@<X!QFK>IZAJOAK4]$:XU!M0M-2NELIT>)%,<C@E73: 0,J<AL\=Z -
M75/$=II;3H8+FZ:UC66Y6UC#F%&) 9AD'^%N!DX!.*U8Y%EB61#E74,#C'!K
MC?#UI.OQ%\3L=1N7$8M"RLL>) 8WP#A,X';&/?-=I0 4444 %%%% "$9&#0
M% "@ #H!2T4 %%%% !1110 F 2"0,CH:6BB@ HHHH **** "D95888 CT(I:
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0<2AE"DMSZ =._Y56NO \-U'KMNVI7"VFM,9)(%51Y<A4 L&QD_=''2NIHH
MYRU\*W,6MV6L76NW%S<VUNUN_P"YC194)!Q@#CE>>Y]14"^"/+\,7_AY-6F-
MG=M($#1*3"CN78#&,G+'D_E7544 8%SX8:2]T[4[:^^SZG80F#S_ "MR31'J
MKID9&1D8(P:@U#P7%J&B:G8/>LL^KRK)>70C&YL8P%&?E "@ <\9ZDYKIJ*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *RO$]Q<V7AC4K
MVSN&@GM;66>-@JMDJA8 @@\<5JUA^-9X;?P3K332I&&L)T4NP&6,;8 ]SZ4
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M8W"S(CF-\ @HXZJP/*D>AIE]K-AIK,MU.4*1^:^U&?RTY^9MH.T<'DX'!]*
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M&!6?!KVEW"W++>(AM #<+,#$T0/(+*P! /8D<U6@\7^'KJXM+>#58'DO/]0
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M6$:/]V<9R"<=]WO79Z#:VUEHEI;65I):6T:8A@E9BR+G@'<20<=CTZ=JT**
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M$<6MSQVPOFBGM)IV"I-&$VE5)XRI'3KSFN<AMO[)T#PC!J&($&NM<1PS<&&
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M;G4+DD0VL32R$==JC)_E7G%A)I*VU_X6\2V.HSZ@;N9DM0UP8[Y6E,B.NT[
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M\5W<QN#&Q+Y1-PX)')]ACU%<Y;75G%\-O!0\Z%##JUJTHW %-KDN3Z8!Y^M
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M'P@DENFGVL5E="&.=L^3]S:"3T...O4XS0!UMKXET6]TDZK;:E!)9*VPS!N
MV0-N.N<D<=>1ZTZ/Q!I,EO=3F^CC2R.+GSLQF$XR-P;!&1TSUK@;N6#2KG7]
M;CM(9=)OM6LQ#.Z%H874#S+G ^\ _<'DCK4MK?6R:QXW+WDDRW.G0/%/-'M\
MU1%(,C"@8R0 >_&,T =E#XN\/7"R-%JULPBA2=_FQA'QM/XY QUR13Y?$NF1
MV%_=K)++_9ZYN(4A?S4XR,H1N&1SDC'?I7(IJ5E8?"?0KD6MO<1HEG%+(Z;T
MM6!7=(X'/R-DD<<U'93)<^(/&$,%Q/>R7VE0F"1HL&;$<HRN% QD@ ]#QR:
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MH-Z9!;:K;R>5;BY?#8VQGHQS_GFN8CN;>/Q)X\>25%1[6#:S' ;;"P;![X)
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M'^]A=>%;:.2,%B?X1SR!C-7[3Q#IEY<W-JD[13VJ"2:*XB:%E0]'PX&5]^E
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M2R#.563&TG@]^<<52TWQ?9ZH^L+)'<VL.G3-$9'MY%.%12S$XP#EC@=< '%
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M;V%[+=:9KCWD]LD;HTL0GWX1N,DJ=PVGM]*OW\%AXMT+5I?#MA>M?2Z<]O\
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MIO63U!7^(8YQWQ6Q10!Y[I][$/']EJF_4+BUET>2,W4UJZ*6\Q&QMV@* !Z
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MDIC(Y!'/7MFGQ>)=)N-,M=0M[KSX;T[;81(S/*W.5"XSD8.>.,'.,5S6OO\
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M(K8QC+\G/RXYQ5W[#=:'XC\)_:(+FZ2VTN2RDF@A:0>;B,#) ^4':>3@>IH
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MSHI:;[:(#<",0OAHQP2&Q@\D#&>M8O@LLNI^)0\$\0FU1IHS+"R"1"B#<I(
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M$16;S-V55@&SM&00>E,^&XEC\+&&>VN+>1;NX8K-$R$AI68$9'(P1TJ72?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN;*86TL#QX,$A( +^WS Y!.>WL =914=O-Y\*R^7)'N_AD7:P^HJ2@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KF/']CJ%YX>CDTV!KF:RO(+LVZ=9EC<,5'J>^/:NGHH X
MAM0;5O'NA:E;:;J2VJ6=Q'))-921B-F*8!W >G7IZ$\UC75M>R^ ?&-HNF:@
M;B\U2XDMXOL<NZ57=2K ;>F ?I7J%% '&^+EN98M#UVUTNXU&VL9F:YLA"1*
M8W0KN", =R]<=:H:M9/J>A3:KX>\.26LL%W;78CF@$,U[Y3[BI7K@#&,]3G
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MD*.![J>1]#SZU-110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.>*GL]76[O/LK65U;.8?.4S*NUER!P58\\].M<=;V\\7B'7;H^']2N;*]TA
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MGINL/?W=I'P91YTI<)Z\/E?45LBUDUKQQIVM0P7$%KI]G*C//"\+2/(1A=K
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MEVT$)MW#2+(Q*$#'3'Y=ZU-32XFUGP=<1V5VT=JTC7!%N_[H&$H-W''S'^M
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MB$[K=0F/=$<_./;@]<'VI+'Q78W]W8VXAN8?[2@:>RDE0!;A  21@DC@@X8
MX-8U_P#VBOCR]U"PT^>7.@&&W:2!A$\X=G5"2..".OKCK6;8IJ4^N^%-3DTC
M5F>%)X[V2XCV[)&C X3("("#T '3J: )[%7&A>.X_M-R?)O+CRG^T/O3$"$8
M;.>#[UU'A)F?P;HCNQ9FT^ DDY)/EK7-V<-TNE^-D:PO%:\N)WME-N^9@T2H
MNWCG)']:Z3PFDD7A+2()H9(98+*&*2.5"K*RH 1@^XH UZ*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6ZC12BOG:>-VXC<0N0,9_.IKSQ5;6DDL2V5[<306@O)XXT4-%&<XSN8<_*W
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M^> N ?O#G YJ;P_JFCZ1X:U*?2['5)H-/NY([I929)VD55WOAFR1C' QWXH
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M** "BBB@ HHHH **** "BBB@ J+[-#]J^TE,RA=@8DG:.X [9P,XZX'I4M%
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M7CMJ;K_A2>B&4$D:I%Y'F'&4\\[<^W]* /3;;Q/9RZRFC7,%S87\L9DBAN4
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M5-NQ&P3\V3GH#T%:A(4$D@ <DGM7!:[93PZCX.N9M2N+IY-13S=[ H[F)SN
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M U)5N-NY&#.&52JC@A>F.* .@U[7HM!BM))K:>9;JZCM@T6W",[  MD@XY[
MU;6[D;4Y+,V<RQI"L@N3CRV))&T<YR,9Z=ZX#7%NK[PEX:UFYU":2>\U"QGE
MC!'E?.ZL%5>P7( (Y..<YKH8;B^E^(.I:7)J$[6ATR.:.,;5\IF=E.T@9_AZ
MG)H W+R_^SZ;/>6MO)?M%N AMR"SL#@@9(&00?RJV#D D$9['M7ENG37^G?
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M=%T0:0CF34+S4+B0 -<7D@9]HZ*,  #D]N>^:T#-$)U@+J)74NJ9Y*@@$_\
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MC/57!7:1GGH,'IBMJB@#GKWP;87VB76E27-TBWLXN+J=&3S9G!!!)*D#[J\
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M(S7V9/,4.-NS<6!VELL"HQT[8J;7_#W]GZ1KMS:+J&H2ZOM6ZAC9=VTX0N@
M!)5,X7/.*JZ-;3/?VTFDZUXGG"2+Y\6JPLL(CS\P)DC4EL=-I)SC/&: ([>7
MQ%XET/\ MK2[V&UNOM3M&TMXXB2-)2IC>((5^Z.3UR<Y XIVLZS<:;KUQ%K;
MWUE9S7$7V#4K:1C;(ORYBD4< E@PRP/WNHP*UE\!Z7'JMQ>P76H00W4AEN+"
M*Y*VTSGJ63&>>XS@]",5;NO"UM>B[BN+R\DM+R42S6C,AC8C' ^7< =HR ?7
MU- &AJWVS^R+S^SF1+WR'^SM)]T2;3MS[9Q7(:+K,=\]_:3G4K'4H=/?[3IM
M_(S\_P#/5&)(9>V1QTX'?LK^SCU'3[BRE>1([B)HF:-MK ,,$@]CS6:WAF"6
M22>XOKR>Y>U:T6X<QAXXV.6"X4#)P.2">* .*T4W^E>&O!&H0:I=$74]O:2V
MQ8>28G1N-N.HP#G.>OL!<\4ZK?6>GZUJ-EJ=S<7%E>1B-X&V06JYC!B92<2,
M<MG@XW#IBN@/@NS_ +*TO35O[Y8=*F2:U(:/<K+D+D[.0,G\^<U%=^ -*NX]
M3@>ZU!+?4Y3/-;I<;8UE)!+J,=20#@Y'M0 V[_Y*IIO_ &"+C_T9'2>!?]?X
MH_[#\_\ Z!'6F/#=N-<MM7^V7AN+: VZAG5E9"03G*Y)) .<T_1M @T26^D@
MN;F7[=<-<RB8J1YC8!(PHQP!QTXH Y_7[22^^).DV\=Y-:;],N-TL! ?&].
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M5^(7BU_/N&\LVI"M,Q!W1$D$9Y SP.W:N=\/F^TSP-X/U2WU2Z7S+V"V>V#
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MLI&Y\[\;5&,YZ?EB@#F-/U.^AUWPJ$O[RZAU(3I<W$K8BNR(BX>.,GY "."
MN0>XYJYHKWWBCPY:^(8=9EL;I[EI6&XF%(ED8&(QY"_='+'G/.>U7;;P'IUL
M--_T_4Y#I;$VI>Y^XI4KLX ^7!QZ^]/MO VF6FIS7=O=7\5O/-Y\FGI<8MFD
MSDL4QGKVS@^F* ,_0+$'Q]XL*W5TK(UMM/G%L;H2>AR#@G@$8%8RZMK+_#'3
M]0&KW(O#JGE/,2"9%-T4PW'3'88KMT\.VL6O76LPW%U#<7:*LR))^[8JI56V
MD<D _3VK/'@6P7P_'H@O[\6D5Q]H7YTW!]^_KLZ;N: *]@]]IWQ"N=)_M&ZO
M;>?2A>!+IP=DHDV?+@#:"#T'%8EMJ&LZCI6AO!J5ZFMSZCY.IP(P/E1[F$F8
MV!5 H P<>G))KK+K0_L^JR>(H)KNZU"&R:W2#=&JS*/F"?=X);!SD?EQ7':1
M82KIL-OI>J>+K34DC^6TG@86\<G7#&2,KLS_ +9..F: .R\9)='P3K"6A9I_
ML,H4C[Q^4YQCOC--\#&$^!-#-OC9]@A!Q_>VC=^N:W0#M ;!..<5C6_AF&P2
M2'3-0O=/MI&+_9H#&8T).3MWHQ7)YP"!Z 4 <=ID#3W7Q&V/(EEYQ,9C<J/-
M$3>9R/?;FHM7L43X$6\HGN"386CX,S%>3&,8ST]J[Q?#UC#H4NC6GF6MO*K*
M[1,"[;L[B68'+')R3S5.X\'6=UX53PU+?7IL41(QAD#[%QM7=MZ# ]^.M %3
M7&N]-\0^&(+;4+H6]Q=R1S1/)N$@\MF&21N.".F<>U0VIOO%D&N26^K3V%W9
MZC+:6IB8[(/*(&63(#[N2=V>",8K9OO#L6H76FW-Q?WAFTUS)$RF,;F(()8;
M,'@D=JJ7'@C39M9N-3BN]0M#=D&[M[6Y,<5R1QEP!G./0C]: *<UW?:WXAU#
M28+@>796L#*T-V]N6>0,?,!56W#@ #..N<Y&,Z?_ (22/4?"6F:CKK+<W1NH
M;U[(C9)LC8AAE0=V,=> ><<5T&L>#;#5M2@U)+J]TV]@C\D3V$WE,\><[&X(
M(_"GS>$[.2ZTNYCNKN!M*+FWV.IR7&'+%E)8L"<DGN3UYH U-/M&L;"&U>ZG
MNVB4*9[A@9']V( R:\KTV/5-+^$UGXET_6KJ&:P#2+:97[/(GG,&5EQDDY/.
M<^F*]=KGK3P9I]G9QZ>MS=RZ;%+YL=A*ZF)3NW 9V[B W."Q% %"ZU*70/&D
M-QJ-[.ND:G:N8EED.RVG0;F7Z,F2,]P0*W?#T5S'I$<MX\S3W!:9DE<L8@QR
ML?/]T$+^&:R=9$/B?4DT"72+LPV=U%/-=3P[8<+\PV-_$2<*0.Q:NIH X2*S
MU77?$WBC3#XCU&UALY(/LY@*J4+Q!NH'W03T&,]R:S;#6]<UFQ\&R3:I<6TM
M]/<6UWY(4"7RUD&_IU.W/H#SBM72+&>\\=>*Y5N-2L([EK<1ND6Q9@L05B&=
M"."",K@\_2MJ?PAI[G2?L\UQ9II'-K' 5VJ<8).Y23D$@Y]?6@#+L#-<>*+C
MPQ/J5]);Z78QOYC3E)KAY&/S,Z8)"@  #UYSQ6'=:YKO]A3VXU29+C3?$,>G
MBY"KFXB+KC?QU ;!QC/?K7<7_AZVO-6AU:*XN+*_BB,/GVY7+QDYV,&5@1GG
MID5SGC72(K'PU:6%C!=R-+JL,\LD,;22$^8&DE8J.O?/T ]* &RW6I^%/& M
MWU.\U2QO=/GN3'=,&:*2( DJ0!A2#C&,9-2:9'XBU*RT/7;;4($\\QRWOF7C
MM'-$X^95CV;48$C;@]L$GK726FC01WIU*:>:]N7A\E9;@+E(R<E0%50,G!/&
M3@>@K-TKP+IFC70>TN]1^RI)YL6GO<DVT39SE4QV/(!)&>>M &?X7M]2U/4]
M6FN]>U!TTW6I8XH@RA701I\KC;R/FZ#&.3WJAHEEJ5]\.=171[N:UU".^NY+
M=HFQN83,=I]0>GXUUND>'H=&EOY+>]NY#?S-<2B4H0)" "PPHQP!QTXZ54AM
M[7P-H[""+5-1BEN2WEQ1":16<DL<*!QGK]: (=%U=/$]SI=U8S31VT-GY]P@
ME/WV.U8V]2"DF>^0.QJ7QT+^'PW-J.FSSQSV!%PR1.5\Z-2#(A^J@^^15GPO
MI":5I\\GV1;6:_N9+N:(?P,YR%/N%P#CC.<5L.BR(R.H96&""."* .%;Q-':
M>-4NVO+B30[VQ8Q,9"8UG5!*0![Q$$>^0*74X]8LKGPK9G6+V&2^N)%NU#AN
M3&S$ D9^7H.W .":WH_!NBQZ+IVD"W)M=-G2> $Y.]23DGOG)S]:GU;P_#J]
M]87DMW=02:?(9(/)* !B,$G*G/!(H PV2_TGQIX>TK^V;Z[MIK2Z\P7#J2Y7
M;M8D*,GYN_H*PK73U'@SQZ_VJ\S#=WX7_27YVQJ03SR> #ZCCI7=7>@07FOV
M>LO<W"SV2.D2*5V8;&X$%<G.!W[<5!%X2TV)M6 >Y:#5_,-Q;F4^7F1=KE1V
M) ]\=L4 8<5U<6T/A?0[65RNHVC32&2Z>-FV1I\BN 2H^;/&/N]>M5->7Q-H
M7A:_:;6=K)?0&T,4QED6&215*2,R@D#)P>I[FM^Z\#:9=Z-::;+=7^ZQ</;7
M@N,7$)  &UL8'  QC'&>O-/N?!EE=Z*VESWVH2+)*DLMP\P>:5E(*[F(/ ('
M  ''UH IV+WNF_$9M+;4[N\M;O2VNBEPP;9(LBKE< ;00QX'%=;60/#T7_"0
M0ZXU]=M=0VWV;!*;&0D$@@+U) .1C\N*UZ "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBN6^)-Q=V?@/4[NRO)[2>!%99(&VM]X
M#&>HZ]J .IHKBM2MKRT\=Z591ZSJ/D:M;7'VE#/D9CV$%!TC/S$?+CCWYK*.
MOZCHOA_7;5+^XE-MK:V,%U</YDD,4GEY)9LYV[FP3GM0!Z561XIU_P#X1G0+
MC5C9R7:P8W(CA>I R2>V2.@-8VHS7/ASQ=HD5I<W4]GJ?G0W%O/,\V"B;U=2
MQ)!X(('!':N:UR67Q#\'+KQ%<WES]INOWI1)V$2+YP41[,[< #&2,Y&<T >E
MO<7*ZG%;+9,UL\3.]UYB@(P(PNWJ<@DY]JR[[Q)-%=7L&F:8^I/IQC%TD<@5
MQO&<("/F(7!()'48R:J7-Q=Q_$^QMA>3FUFTR:1K??\ NPRN@!QZ\GKFJ/A;
M2H5\4^*A'/>(T=W&B-]JD8C,"\D,2&//!8''X4 =;IMQ<W=A'/>636,[9W6[
M2*Y3!('*\'(P?QJU7G&AZ]?R>$?"MO=7TYDU:^E@N+MY#YA56D(4-U!;:JY'
M0=,<8W-3M)M$TW6&/B>>W@N#$UOYH:>2UR0K!26+-O/ '8GB@#JZHW.H2?V9
M]LTRV_M%BP"1QR*F\;@"0S<<#)]\5R5M+<R>(]=TB9KZ*R?2DN$@GNV>2-B7
M4D.&)7.!P&_G65$)]-^"NG7UA?7EM-MM68I.QSNE1"!DG:,,>%Q0!ZA17*F[
M?6?'6H:+//<06MA9Q2)'!,T1E>0G+EE(.   !G&2?;',W6KZT?#ES;MJETLV
MF>(4L$ND8!IXC(F-YQR0&P?7OF@#U"JEGJ$=_+,+==\,+F,S9X9P<,%]<'()
M]1CL<<?<75]X?\4:U:P:A>747]@MJ")<RF39,K,ORY^Z#QP.*L:-%J"_"33U
MT9E^W26,3INDV[V;#,-W9FRP!]30!UMU-);V[S1P-.4&3&A^8COCU/M26=Y;
MW]G%=VLHE@F4.CCN#7.>#]7MM1O=0C']HVEW$L0N--U"1W: _-\REB<JV1R/
M[OO4?@"5\>(;/GR;36[E(1V520^T?0L?SH ZHW$0N1;>8OG%"X3OM!QG\S4E
M<4EG"GQ5U&XS<L4TF&?:MS)@MYCC&-V,<#Y>GMS6;_:.H7GPQ/C*'4[B/4U1
M[L 3-Y("N<Q&/.TKM&WIG/.<T >CUB:_XFAT31&U6*W:]B6<0MY;@!6,GEG)
M/HW' -:,+#4=+C:5'B%S""RJY1EW#D!A@@\]17E\5JD7P*$L;R[YIHL[Y7=1
MB\ &%)P/?&,]Z /6J*XIKB[T'QS-;K?WM[;S:/+=O#<2EQYJ.!E1T7()&  /
M:HM+BUW5=-T+7[;4HXFE,4UVTE](\4\;CYT$178AR<#'0C&3UH [JBL#QIJ\
MVB>''NH)/)=YHH/.(!\D.ZJ7YXX!.,]\55U>*X\+0:EK=MJ=Q-!%ITC+I]S(
MTH:9 6$@9F) QP5''>@#J:*X'4KF^TCPQHGB2TU&[N+F62V^U)),SQW2RX#
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M1;!"^P,AGVXSGR\_IG/MGBM2RNEO;&WNT!"SQ+(H/8,,_P!:GKDS>#4_&[:
MLTD%A::8EQ&EM,T7FEFV@[D(.U0   <9/TH ZRBO+]1U;68?#.MVO]J70ETC
M5XK:"Z5\/)$[IA7/4D!\$\9XS6_;Q7%G\0Y-(;4K^YL[[27N)$FN&)202*NY
M",;,ACPN/:@#K8+B*YC,D,BR(&9"5Z;E8JP_ @C\*DKRBT2XT[X*I?Z??WEK
M<^<!N6X<CFZ*8P3QPQSMQGOFNKO[(Z7>6-L==U2Y-Y=22FS,N9;C$?W4<%?+
M13ACR!V[@4 =92$A022 !R2>U><67B'4;?0S:3W<JF3Q,VE>>\F^2&'<3C>>
M2<#:&//.:UO$FBM::!XD)U>ZEM9]-DDALY)W9HG1#E@Y;<5/RY7I^>* .NAF
MCN((YX7#QRJ'1AT8$9!J2N#CNGL;7P;H<$]Q#!JZ[KB;SW9\) &V*Q)*AC@?
M*1@9QC-.N[G4--\0ZWH,-_=FT?1CJ%O(\I>2V<,4*AVR2#C/).,'&* .ZHKF
M/!%G<-H6FZO=:K?W<]YIT!DCGFW1@[0=P7LW."<\]ZAUR=]&\9Z=>7-[<)I6
MHPRVDR&X=8X9@NY' SP2JL.._/7F@#K:JI<7+:G);-9,MLL2NMUYBX=B3E=O
M48 !STYKA?#U]>7=I=>';NZOTU'^T$99)+E_-%JX\U6)SP=@9#CC=C-:]J9Y
M?B%J^F37MW)9G3(76+SF41EF8':5P0< <]?>@#2U[Q-#HNC#4XK=KV'SU@)C
M< *QD\ODGT;C@&MNO(X+98_@7:2I)+YDT\&XO*S@$70Z*3@?AC-==8_:=,^)
M#:;_ &C>75M=Z4URR7,I<+*LJKE1T4$,>!@>U '745A^)YO+33XA?S6YFNU'
MD6X/FW8"L?+4@C;V);(P <D52\%7=Y+/KUI=23,MGJ)2%9I3*\:%$;:7/)P2
M>Y^M '4T5S-Q=MJ?CB709KB:&WM].6Y"0S-$TK,Y4G<I#84 # /5N>@K/EGO
MM/U3PYX5N=8FO/M37)N+P'RY91&NY8\@Y!PPR002%]S0!VU%>>:K?:GI=QXK
MT>#4;OR+;2#J-I,TA>2!L-E-[9)!*Y&3D<\TEPNJZ./"VMQ:W?W3:A<VUK>6
MTTNZ)UE7JJ]BOKU/<GG(!Z)17"+J%SX=UG7-'NKJZNFNXEN-),UP[%MQ\OR@
M<\$2,O(YPV>U=EIUHUCI\%J]Q+</%&%::5RSR'NQ)]30!9K.U35TT^XL[-(Q
M+>7\C1V\1;:"54NQ+8.  /0]1Q7%P:A?ZS\-[OQ='J-U;:E&MQ=1JLS".(1,
MV(C'G:1M3!R"23G/2I]2C36?$W@F^N!<0O?03R2)'<R)L)MPV!AAMY/.,9[Y
MH [#2;VYO[$37FGRV$X=D>&1@V"#C(8=5/4&J6K>)HM-72)(K9KN#5;J*WCG
M1P%7S.0WJ> 3P/Q%2^)X$F\)ZI$S2!19R'*2,K<*2.0<]OQ[UQ5W9B+P/X%2
M&:9&FO\ 3V+M(TA0F(_=WD@#T'3VH ]+HKSV?5K[PQ>>+XH+RYO(['3XKNV6
M[E,ICD8.#@GG;D XZ<<8K7L].UB/5M,U*#4D%BZ%;I);^2<709<HR!E 1L\_
M+@$'&* .KHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *S]<T6U\0Z3-I=ZTHMI\>8(VVE
M@#G&<>H'2M"B@#)F\/P7&K6.J2W5R]S8(R0L67&&P&R-O.<#\N,577P?I1M]
M4MKCSKJ#5G\RZCF<$,_'S# &T\#IZ"IKC7FM_%EGH1LSMN[>29;CS!@;,9&W
M_@0]*V* ,NRT""TN8;F:YN;Z>VC,4$ETX8Q*<9Q@#).!ECD\=:R9OAYHLMI>
M6*S7\5A>/YCV<5R5A5L@DJ.V2.F<>W2M+2]>;4=?UC27LS =,,/[PR!O-\Q2
MP. .. ._>MB@#)_X1VU_MJVU?S[K[1;0&"/=+N&PX)!R"3D@').:2P\.P:=>
MW]Y;W=UYVH,'G+,I!8# (&WC ].*UZ* .=_X0;1F\,IX>D$\EE%)YL):7]Y"
M^2VY6'(.23^/I3F\%Z9-HL^F74U[="X*-)<SW+/.2ARA#GIM/0#CD^IK;EN8
M89H89)%62=BL:GJQ +'] :BAGNWU"YAELO*MHPAAN/-#><2#N&WJN..O7- &
M=:>$].M-5_M,2WDUT;?[/(TURSB5<DY8=SR?;VJO_P (/I7_  CW]@B:]^P[
MU8(;@D@*VY5!/0 @' KHZ* ,F\\.VUUJ,&IK<7%MJ$$1A^U0E0[H>2K J589
MYZ<'IBH;KPCIEWI4>FDSQPI<?:28Y,/)+NW;V8@DG=S6Y10!DGPY:/K?]L2S
M7$MR;7[(P9EV/%G.TJ!ZG.?Z<51TO0#!X?/AFZ:=8+5A]FN8GVL8U</'\W9E
MP ?7&1UXZ2B@#+BTV+3)KC4A]HOKZ:-8S(^W>RKG:@P JC+'G Z\FF^'-&.B
MZ8T4K*]U<SR75TZ]&ED;<V/8=![ 5K44 9<WA^RGU^/6R9TNTA$)\N4JDB!M
MP# =<$DU4C\':9$DUM&]PNGSS>=)I^\>07SD\8W $\E0=OM6_10 5S1\!Z1_
M8TFCK+>K923"7RA<$A,/O"KGH QSQ^.:Z6B@#*;P_;OKL.M/<W+W<,!MP2RA
M2A.2" .Y&:H:9X%T?2+[[1:27JP"3S4L3<L;:-\YW+'TSGD9S@].@KI*Q]<U
MYM&N]*A^QF9-1O%M?,\P*(RP)SCDGA30!>U/3;/6-.GTZ_A$UM<+MD0]Q_0]
M\UG:/X4L-'B>,3WE]OC,(-]<&;9&>J*#P%Z9XYP,]!6W10!AV7A+3[%+:!9;
MF6TLY/-M;6:0-'"PZ$<;CC/ 8D#MT%2)X;MH]1U&_CNKI9]314N"'7!"C"X&
M., D?C6Q10!SX\%Z6NEZ?IRRW:QZ9+YEI(LY62+@C 8<XP2*MV?AZUL=;NM7
MAGN//NT1)59P495&%&,=LGGKZYJ'4M>N(=0N-.TJP6_O;:V%S+$T_E#:Q(50
M=IRQVMP<#ISS6M;2M/;13/"\+2(&:)\;D)&<''&1TH YS_A7VBBV-L)+Y8%N
MA=0Q+=,%@D#;LH.W.??DXQFIKWP1I5WJ[:FDU]:3RHL=P+6Z>(7*J, 28.3Q
MQG.:Z*FR2)%&TDC!$0%F9C@ #J30!EW/AO3KG5+/4<2PSV<1A3R)"BM&2#L8
M#JN0.*M66G1V$UW+'-<2&[F\YA+*7"' &%!^Z..E4-1\2"RU'1;:*U,\.KR%
M$GW[0GR%P=N,G@>U;= %>_LUU"RFM'DDC29"CF,@-M(P1D@XJKI.B0:+HZ:5
M9SSBWB79$68,T8] <?SS6E5'6-8LM"TZ2_OY"D2$* HW,[$X"J.Y)Z"@#*7P
M1IB:!;Z&L]X+*VF$T2^:-RL&W#YL9.&YIVH^"M,U'5AJOVB_M+QD$<\MG=-"
M;A1T#[<9_#'\JDN]=U.PTN;4[C0)3!%&9#%%.KS@ 9Y7[OUPQ_&IK_Q#!:WE
MKIUO$]WJ%XADBMXR!MC'5W8\*O;/4G@ T :<$$5M!'! @CBB4(B+T4 8 K+D
M\-68U274[*:XT^[N !/);, )L="R,"I/OC/O2+X@-MJMOIFK6GV*:[R+:19/
M,BE8<E V 0V.<$#/8FJS>*;D^([K0H-'DGN+6!9RRSH%9&.!C..?8T 7+'PY
M865S?73>9=7.H*J74UPP8RJH("E0 H&"> !4-EX2T^Q2V@6:YFM+.3S;6UFD
M#1P,,X(XW'&> Q(';H*F\/>(K/Q)9S3VJ2PR6\S07$$ZA9(9%ZJ0"1^1K6H
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MYO?MEU$=/Q!%&K03"9?W['.Y=O\ #C Y/7-<[)XZ9?A]_P ):NE,P^;=;>>
M5 D,?+8]@>!0!T.D:7#HVF0:=;22O!;H$B\UMQ51P!GT%)JVCV.N6:VFH0B6
M)9DF"_[2,&'\L'V)JY(S+&S(F]@,A0<9/I67X7US_A)/#\&K?9C:^<\B^47W
ME=DC)UP.NW/XT 6!H]DNN-K0B'VUK<6QD_V V['Y_P A446A6T/B";6UFG-U
M/$(7!8;"@.0,8[$D^M:=% '-?\('I T9M'66]6R,PE$0N"0F&W!5ST 8Y_GF
MM#^P+<Z]%K;7-RUW%;_9P2RA3&3D@@#N1FM6B@#+UKP_9ZZMJ;EYXI;27SH)
MK>4QNC8P<'T(."*32?#EAHU[>7=H;CS+U@THDG9QN  S@GJ<#).36K45S*\%
MM)+'$9G121&"!N/IDT 9.N>%-/UZ[MKV66ZM+VU!6.ZLYC%(%/5<CJ*==>%M
M,N;"TM=LT1LI/-MKA)3YT<G=MQR23DYSG.><U-X<U@>(/#]EJX@\@7<?F",M
MNV\],X&:TZ .7\1:2EEX2U]H([J^O]0LI(FD$?F2S,8RJ#"#  ST  &2>YJ3
MP[H<+:5H]Q=/>2M9P(8;>[7;]G?9M)VE0Q(!(!;.,\5;MM>:?Q9=Z"UF8_LU
MLEP)C(#Y@9BOW0..A[ULT <Q"!XE\0VE[/HMW9QZ,\OER7L01I)&^4;!DY3&
M3GUVXZ&NGHJ*>Y@M1&9Y GF2+&F?XF/0"@#&_P"$/TT?:XHWN([*]E,MS8JX
M\F1CU.,9 /< @'N*L7_AZVU#5;'4GN+B*?3]WV;RF4*FX;6XQSD<<TVRUYKK
MQ1J&AM9F+[%#',)C(#Y@<D= ./N^M;% $=Q!%=6\EO,F^*5"CJ>ZD8(K!7P3
MIJV&GV0N;[RM-F2>VW3[BC(,)U!X4< =/:NBHH R!X:L3JMYJ,KS327T @N(
MY"#&\8! 7;CW/YU6T/P9IF@3J]K/?2QQ9^SP7%TTD5OG@[%/ X)&>3@GU-=!
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %<YXXU>?2-#A-O*8'N[R&U,XZPJ[ ,P]
MP,X]R*Z.J>JZ59:WILVG:C L]M.,.A./<$$="#SF@#D[RQBTSXF:/);M<2 Z
M=='RY)WDY&SD;B2">_KBJVDIK.OZ%I'B*WU**VF9UN+B<WLC(Z9.^(Q8V =O
M;'7.371VG@[3;74+._:>_N+FR1DADGO)&(4XR#SR..GYYJ.S\#:'8:H]_;17
M$8>7SC:BX?[.),YW^7G;G/(].U &#<ZE/H^M?$+4K90T]M:6LD>1D!A"V"?8
M=:T;#3=3&I:5JUOJ4<=FZ8N%:]DG%XK+\I 8 *P/((]<=*VH/#MA!J6H7^))
M)=34+=+(^Y) !M VG@  D<53TCP9I/AZ4SZ<ERYC#&W@FNG>.$D'.Q22%SG&
M>N": .69]:O]%V+-J \0KJYCD\F218Q%YI!&1\HC$??U']ZM#Q(7)UV.UU"]
MN9K'35*I'.T2V+!&8.S@Y=VP#C!Z<X!K,TS17:#RVLO%>FZF[,\L5K=LELLK
M,6)5BQ3;D^YQV)KK#X-TZZFDN[\S2W=W;)!?>5.\<=R57;N9 0#WQ0!STD(U
M3Q'X%O+J2<SW>G3O*Z3O&2?*C;C:1CECG'7O4LNKWVCZSX[N8YY[D6%E;SV\
M,KEEC8QR,<#L,C)QZ5T!\':/]GTV'9<#^RP1;.+EPX4@*5+9R00 ,>@ Z59@
M\/6-OJM]J0\QYM054N5D?<DBJ"%&WI@ D?C0!RFIRW6D^&M!\0V%_=3W4LUL
M+@/.SK=K+@,"A.T'+9& ,=N*9)97%_JGC2WEU;4UCLO*>V$=VZ>6Q@#Y!!S@
M$].GMTKJ+'PIIE@+>./SWMK23S+:VEE+QP-S@J#SQDXR3CMBE7PO8+<:G<++
M="355"W1\X_. -HP.WR\<=J '^%+R?4/"6D7ERYDGGLHI)'/\3% 2?SKC&MK
MFYTGQK)+J^I[M-N9GM"MXZ&(K"KKT(R >QX]L\UWNE:9;Z-IL&G6AD^SVZA(
MQ(Y8JHZ#)["J">$].2#4X1)<[-69FNQYQ^<L,''ID<<8H YKS+NVN/!NK_VC
M>27&JND=VKSL8I%>$M_J_NC!'& #ZYHC76/%=CJ=Q9WJV=Y;ZA-#%/\ ;9%^
MS>6^ IB VG*C)SUW?3'2R>$].DATR%I+K9I1!M,3$%"!@<]^..<\5!<^!M#N
M=8EU0QW$4MP0;F*&X=(K@C_GH@.&_D>^: ,F"WFU3QYJ-A=:G>M:OI<$QCM[
MIXTW,S E"I!4< \'GOFL*.;4!\,[7Q$^KZ@^H65VL<;FY8*R"Z\K#J#A\KU+
M GWKT%= M$UJ?6$DG6[GA$+L)/EV#. %Z#!.:I?\(3I']@'0LW7]GF7S?*\\
MYW;M_P![K][GKUH IV\[>(/&>OZ7>37$<&F1VZ010SO%GS$+-)E2"3G 'ICW
M-<V=3UB[T+28YM3NTGMO$PTQKF-]IN(E<C<P'#'@=>X^M=W<>'+.?4(]126X
M@O4A\AKB&3:\J>C]FYYSC([5%=^$M*N[&RL=DT-O8S">!892I$@)(<GJ3DDY
M)Y))- &5/IT5EJUIH\6I:E?'[/-+]A>Y?<=SC]Z\VX$*O*@<GG(SBN>@U#5+
MWP1X/N9-5O$N9]82UFE28YD3S)%^;^]PB]0>E=U?^&M.U'5+?4YOM"74$1A\
MR&X>,R1DYVMM(R,\XJFG@718K&VLHA=106EU]J@1;AOW<F201SP 6.!TY- '
M/W&IW7A/4/%J6MQ=74-IIT5Y!'=3M-Y<C;P<%B3MR 2,]J76;"../P7?B\N;
MB6;5+<R223LRREHG;=M)P#Z8 P"0.*ZO_A&M/.J7>HR"6::]A\BX61\I)'R
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M;3&=)Q.QE:0J5+,QSNR"1SD8P.U7M/TRVTR.5;<,6GE,TTCG+2.<98GZ #T
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M[FC!P3GGGCVKG[_33/XEU.XO].\1VL\\P$,VDW#B*:)5"J6*M@-USD#''UH
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M'C";E!/\1) ZX';(/8^&;#4=,%[:W]^MRAF\VVC\UI7MXVZ(7;EAD'!-0R>
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M7<T>[.2H[ YX/TK<>U;2_'VB1P7=XZ:I9W(NUEN782% A5@"<*?F/W<8[8H
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M*E5/4MC &.3T'-;NB6%P?&6H7D/VV+2%@C$$4KRQQ^<<[]L9P,8V]L9Z<YH
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M^J06;1RO+YS1K,_DF3KO\O.W/?IUYZU>L-!T_3=1N]0M4F6XO2&G9IW<.0,
M[22 0..!TK2HH HZQH]CKVFR:=J,32VLN-\:R,F[!R,E2#U%0OX=TY]5M]49
M;@W=M$8HI#<R<(>H(W8.>^:U** ,[2M#L-%-R;%)4^US-/-OF>3=(>K?,3@G
MVJ;4-,L]4CBCO8%F6&9)XPW\+H<J:MT4 54TVSCU675%A47<T*PO)W**20/S
M8_IZ57M=!T^SUBZU>!)EO+P*)W,[E7"C"_*3MX[<<9K2HH R8/#&DV\>HQK;
MNR:H6-XLDSN)2PP3@GCCCC%1-X0T9K*RLVBN&BL)EFM\W<NY7485L[LG X&>
M@XK;HH RT\.:='J=WJ2+<+=7J!)W%S(-RC@#&[ QDXQTS7-:]X9MK"TTC3;3
M1+V[T:TDDD9;2Z;[1 ^W";2S@[?F;(!]/?/<T4 <OX7TF2RO7N;<:M;63Q%3
M;ZE=&4L^00R@LQ3 !'49STXS6_J.GVNJZ=/I][$);>X0I(A.,@U9HH IOI5C
M)?VE\UNGGV4;QP,!CRU; ('X**BFT.PGUJ'69$D-[;H8XW$S@*IZC:#CGZ5H
MT4 8<G@W0Y8]1C:VE\O4W9[I%N)%5RQ!8@!L+N(&<8SCFIF\,Z6]QIUPR3F7
M3 1:-]ID_=@C!_BYR..<\5K44 4=8T:QU[3VL=1A,L)97&URK*P.0P8$$$'T
MJO8^&-)T[4VU*V@D%V\0B>5YW<N!G!;<3N;DC<><<9K6HH R]=\.Z9XCMXH=
M2@+^2_F0R(Y1XF]592"*:?"^COHC:/):>9:,V]@\C,[/G.\N3NW9 ^;.:UJ*
M ,I=+M=+BN+Q$N+FY,/EF21VFE91G"C/;)Z#OR:P/ OAJ.'PEI4.IV]TD]G\
M[6MP[;$E!)#!3P>H(Z@'GK7:44 <Y=)<Z_K,5E=:+)!9:;=K<?:9RI69E!V>
M6 2?O'))[#'?CHZ** ,>;POI<UY=7.R>-KW'VI(KAT2? Q\R@XZ<<=1P<T:S
MX5T;7K6VM[VTP+0YMGA<Q-#QCY2N"!@#CIP/2MBB@#&F\):-<:/'I,EO(;2.
M02[1/(&9P<AF8'<QSSDDU-_PCVG_ -L_VQMG^V^1]G\W[3)_J^NW&['7GIUY
MK3HH XK7_"]O8Z/;:?IVC75[IS7OVB[BANV,Z=2&C+..=Y!.".,^N1/X:T=K
M?4TN[*/6[.U",)8M2NS()2>FU"S$$=<\>G.>.NHH S]9T.PU^S%GJ,<DD </
ML29X\D'()VD9P0#4.I>&M-U62SEN1<":R+>3-%<R1R*&^\-RD$@X&>:UJ* .
M?;P-X?;3[S3_ +)(MK?3^?/$EQ(JN^0<X##'0=/05<O_  [IVII9K=K<2?89
M!+ WVF0,K@8#$ALDX)Y.>M:E% &4/#>FC4;S4 DXN;Z,1W#BYD&]1P!C=@8R
M<8Z9-1P>%-+M+.RM;5;BWCL"WV;9<R9CSP1DGD>QR*V:* ,6;PEHUQ!;0R6\
MA6VNC=QE;B16\_)/F$@Y9LD]:G7P]IBZK<:GY,CW-U%Y,Q>9V5T[*4)VXY/;
MN:TZ* ,'1?!>A:!<FXTZVD1AGRU>=W2+/78K$A<^U02_#_P[+#=6YMIUM;N3
MS);5+J18=^020@; )('2NEHH 9'&L4:QKNVJ,#<Q8_B3R:QXO!V@PZ5<Z4MC
MNLKEMSPO*[*O);Y<GY,$DC;C!YK;HH S['1;2PN#<J9IK@QB+SKB5I'"9SM!
M)X&>3Z]\T[5]'L=<L39ZA$9(MZR#:[(RLIRK!E(((/I5ZB@#)C\-:7#JJZI'
M',MXMO\ 9A)]ID/[O.=N-V#SSGKGFJY\%Z VC7&D/9M)97,IF>.2>1\.3DL"
M22ISSQBMZB@#-T70-/T&!XK%),R8WR32M*[8Z LQ)P.PZ#)J35M%T_7+46VH
MVPF1'#H=Q5HV'1E88*GW!J]10!G6>B6UI(DC375R\?W#=7#R[.V0"<9Z\]>3
MS4%QX7TNXO+JZ\N:)KU0MTD,SHEP ,?.H."<<9ZD<&MBB@#,NO#VF7E[87DD
M+K-IP(M?*F>-8@1@@*I Y''(Z<5 WA+1774EDMI)%U4?Z8KW$C"3C&<%N#@#
MD8Z5M44 8O\ PB>D^?87!2Y,VG;OLTANY2R[N&).[YLC@YSQQTHO/"6BW^I7
M&H7%L[3740BN LSJDR@8&] 0&P.F1Q6U10!S]SX'T"[TVRL'M9%33_\ CUE2
M=UEBXQP^=W0 8SV'H*LS^%]'N-'ATJ2V86T$BRQ[9G5UD!R'#@[MV<G.<\UK
MT4 95QX;TV>[@O%26WNH(O(6>"9D<Q_W&(/S#OSGGFF7?A;1[W3+?39;9UM;
M:02QI%.\>'!R&)4@DYYR3UYZUL44 4KC2;2ZNK&YF$C2V#%H#YK#!*[3GGYN
M/7-7:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1SVS^?%;NH^*K&QU*QTN&.6^OK]#+!!;E<F, G>68@ <''//:O(/#\6H:O\
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MW5LB,=<9JY0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !45Q#]HMY(?,>/S%*[TQN7/<9!&?PJ6B@#
M#\)^%+/P?ICZ=875U-;M(9 +ED)4GK@JH].];E%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH **9++'#$\LKJD: LS,<  =2:?0 4444 %%,DDCB ,CJ@+!02<9). /SI]
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M/5 'P.H!ZJ1G'6M<ZE?:!XRO;6ZU*YU"S_L:342DP0%'1PI";0, @].:M/\
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MV>H1*GV=0+>",O&IBDS]YCN;.,D$C[M:T7@1%338YM>U2>/2IA+:*[1Y0!2
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M:[-Q- E["^#'*LN 2@ ^4@D8QVZYK<TSPM%9V\L-_J-[K EA,&;YPVV(]5
M'7 R3DG'6F67A&WM8+*TEOKJ[LM/D62UMYBI"%?N9( +!>V3V&<X% &!+)K5
M[?\ C"W'B&\@32_+>V,:1@J3#YF"=O*Y/L3W-02SW6N:M\/[Z:]N(9+ZVEDD
M$+!5#_9\E@,8SR1]*ZA/"<*7.L7"ZE?;M94"X'[K"X78"OR<?+QSFHAX*M%L
MM&MX]1OT?1<BUG5HQ)L*["I^3!!7C.,^] &;8+K&I^,M>L6\07<5MIMQ:O$B
M1QY8,F]D)V_=/(]>G)Q5276=3MKC1KB/4Y;QKG6/LES-&H%H\;%P$0'DE0%^
M9<\@Y)Z5U.G>'8M-US4-6COKN634=GG12%"GR+M7&%!&!QUY[UDQ?#RQAL+6
MQ35M3%O8W:W5FGFIBW().!\O(Y/WLD=L<Y &V\VI^*(M<>QU62PN+&_DL[0(
M 40Q[<LXQ\VXD]> ,8&>3!%;S2?%@%]0G;&B),1&PV$^=@@#!PIVCW]ZT)O!
M%J=9N-1L]4U*P%Y@W=O;3!4G(&,G()!(ZD$'\>:O3>&K5]?MM9AN+BVFM[<6
MQCA91')$&W!6!&< ^A'ITH V**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *RO$FO)X;T>34Y;6
M:XCC9581%1MW,%!.2.,D=,UJUROQ,S_P@&HX.#NAQG_KLE '545Q5RFJ:'XT
MTFV.LWE_9ZT)HIX9RN8G5"P>/:!M'&,57L=1U"WMM7\,W>H7$FL)=K%:7#/\
M[Q2\QR#M\BAR0./D.>M '>U5T^ZFO+8RSV4MFXD=?+E*DD D!N">"!G\:F6+
M9;B%9'&%VAR=S=.N3U/UKS:35]:7X8W&H#6+G[9!JC0^>=N77[2(\'C@8/\
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MJ-Q=_:[N"VO(Y7W).)>-ZKT0@X("X%49CJ]U:^,6/B"_C.E3.]J8RBD%85<
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MP>_'3-9>GW%X/$>N>&;B[N)[6&WCNK:8R'S8E;.4+]3RO!/.,Y)J3X96XA\
MZ3())6\VW4E7<E5Y/0=J .G>>-)?)W!IBA=8P1N8# .,^Y'YUG^'M=C\0Z?)
M>16TMN([B2 QRD;@4;:<X)'7WK!CM-WQ>N6^T7&!I$4NWS3MSYK#&/3@<5S4
M;:AIO@;5M<LM4N8);'6)WC@C($;C[1A@XQEL@GOQQ[Y /6**Y&\NM1UKQ'J^
MD6LC1)I\,(3R[MH&#R*6W_*IW <  \<'(.>-SP^NJ)H=K'K4T$^H(I2>6W.4
M=@2,]!S@#/ YS0!I45Q>F2:CXJT*76+;6)=/NUO9!$,YBACCE*['3(#95<DG
MG+<8'%6;:[E\1^)]>TY[NYMH-+$,4*VTIC;<Z;C(2.O8 'C@\'- '5TE>:VV
MO:[J-GX?$FJ2P7']L2Z==/$B!9P@?Y\8Z_*..F>W:K%RU[':>.M&FU.\N8+&
MS2>WDEE_>IOB=BNX8XRO3T.* /0(9H[B".>%Q)'(H='4Y# C((I]>=S&_L/#
M?@I+#5;NW%[<6T,PR&!5H23C(SQMX'3U!K8GMI[&_LM)?6M1OP+>5_LZ/MN9
M"7&)&D7: B@E1G&3CKTH ZRF331V\+SS.L<<:EG=C@*!R2:X'0_$FHZCH_A*
MRN[MUFU9K@7%RN%=EAW?*".A; R1SP<8)S1XXTN[LO ^MQSZO/<PB:*6V0N0
M\2,ZC8S9RXSNQG]<4 >@URE[X_MK+[3)_8&NS6UL7W7<5F#"RKG+!BPRO!YK
MIK>$6\"Q"220+GYI&+,>>Y-8WB@"ZAL-$0?\A&Y5)%':%/GD_ A=O_ Q0!8U
M'Q!#IVEVUZUC?3O<[?+M+>'?.21N(VY[#KS5G2=2.JV"W9L;RQW$@0WD8CD&
M.Y7)P*SO$?A9=?D@N8]5O].O+566":TFVA=V"<K_ ! X&1[5#X=UN[_X1:XN
M]>9?M&FR3PW,T:X67RF(+J/?'3U_*@#2AUZPG\0W.A1RYO;:!)Y%_P!EB1^8
MX)_WA4^IZA%I6GRWDR2R+'@".)=SR,3A54=R20 />O.=4:[T&XT?Q;<:9=V]
MQ#<-_:TCA=IBF(!&0Q)"':%XZ 5W>OZ#;^)+&*WFO+NV$<@FCELYO+<, 0""
M/K0 FD^($U.UN+J;3=0TN*W&6.H0B+(QDD<G@8Y-1V7BFTO);)6M[BWBU$$V
M4TRJ%GP-V!@D@E?F 8#(]^*Y#5YM<@\#>+M$O[IKZ;380(KS;AI877=AL?Q!
M=P)[U>\7 ?V'X.6T^]_:]CY6WTVG]-N?PH ZB\\06EEKVG:-)%<&XU$R")Q&
M?+&Q"YRQXZ#H,]:?KNMVWA[2)]3NXYY(8%W,((R[8_D/J<"L;Q'_ ,CUX/\
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MP?J=M:S:A=R:IJ$5RZ;0[!S*C.R[%! POT&.*]!HH R;;1H6NTU.2]N;NX6
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MU=S:?;3":"RE=6CC(.5&=NXA3R 6(Z>@JQ#X<BM]7U+5(K^\6?4D1)N8RJA
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M""8FS+X'_;3;^E-TZ[DTSSFA\)ZV\UP^^>>1[9I)6Z98^=V'  P . !7444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ"&)8U9V"C&78L3]2:?4<<J7$ DB<[7'RMC'\ZYO1?"NK:7JD=W=>+M1U&)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&SM.T@''!(R*6B@#E_!?@
M^7PBM^C:DEZM[<&X.+?RRK'K_$<BNHHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *Y:_\ !\][X^L/%8U..,V,)A6V-L3N4AP<MOZ_
M.>W8<5U-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-X=,0U>]%IYW$;/&Y#'T! (S[5/>:S8Z?:Q7-T\L44KA$)@D)W$X ("Y!)(
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MN'A\R24ICDG<!DD9-.U3PK>ZEX2M]#CUV:RF@\L"[M8RC,J#&"-W?V/7'TH
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MOV#R5W*?029R!P!P <#KGF@#&MM;\8ZUXN\2>'M,U6WMQ8E3!<3VZL4R?NX
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M5'"TBM+,=K#+;20!\Y[GH/PN>-? <OBZQT^RCU86<-BP=2]N9G<@8&6+C/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH 0@$8(R#2*BHNU%"CT Q3J* "BBB@ HHH
MH **** "BBB@ HHHH **** &M&C_ 'D5OJ,TH  P!@"EHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=[F1=RVRL3F0CO@#Z9(I]M'K"ZG;;-6^WZ7/ Y,IB3S%?C:0R@*5(S_#V[T
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MX10FP* O3 '% 'F_A71]'\17GC""Y(E:35IE!CF((4@ ' .#SG\JZGQ3=1W
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M&.&59=NT9+*05Y[#(SQU^F00"GXM5G\':VB*69M/G  &23Y;5QE_J&EW^D^
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M?@O0;RZW>5:QL\^QY,DL>=H)/))Z?6N9\0>&M4E\"RNVJVAN+9CJ22+!@_:
M3)D/OQU) ..A%=^\:2##HK#KAAF@QH4V%%V?W<<4 ><>-_$=EXB^"MSJ4,T0
M:ZBAS&'&5D\U-R8]00?RS5FY%KX3\80:_<2_;-&U-%@6]GE,S6$G;#L21&_?
MG /M7=_9H,8\F/'^Z*=Y4?E^7L79_=QQ^5 !'(DT:R1.KHPRK*<@CZT^D551
M0JJ% Z #%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8T]Q:><LA)PJ DA5Z$DD]U]ZN:IJFH:;)H.@K>B?4M4D9'O/*5<)&N^1U3D
MXP #D#/.<<V-:U3PQ?+>:%JMS;32!0);-^9&R,C8O5CSQMR<^]<W_95[HO\
MP@VIZDQ*Z4DEM>.S9\H2Q[5+'IA2 I/3F@#<M-8U)=9U;P]O6YO;:&.>SGF
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MMW$<-[=7,DUN)CC[1;M&%C"9^_C!&!GK0!U'@V]N=2\':3>WDIEN)[5'DD(
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M#ML*,%;.<G*X'8YYJA(;+0/#'A2XAU)M1T;3;AUO+NS8D1ET<!_ER0JLY'J
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M QY_&7AFV7=-KMBJF8PY\X$;P 2,^VX9],UH7FIV5A&DES<*@<$H!EBP')(
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M\6TM[^&2=U+H@;_6*.I4_P 0'J,UPVIN;SQ#XZL=*G0W]QI<"QQQN-[N$D#
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MVOGUG3F0FSEDN ;.11AF.3M"@9QGKP,9XKHO'TL<7@765=U4R6<B(">68J0
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M_P!GZ%.[V4KG/F+*,H,]RBM(I_WAZ4 ='?>)-(TV1EN[LQ!'6.23RG,<;'&
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M.5!/*^X&*XFPDTE;:_\ "WB2PU*?4#=S,EJ&N#'?*TID1UVG8!DC).,8R>]
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M99 @EV-',5E*JA4KW QQ@YYKIO$_B#4-/\%Z?JKQ369G>W_M!HDW/:1-@R$
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M\%Q##Y[QW,+PGRO[XW@97U/;O0!J45GV>MV-]=+;0F82/"9T$EN\89,@;@6
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MGOP*QM0U"#4/$?@NZMEF>W1YV>0PL%0&$J"<C@%C@9Z\UW5% 'F.H6U]>_\
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M(F,_O0( OR\?-\W''>J4C%/"'@*,QR^9:7MHTZ")BT06)E8L,9 !('->E44
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M?QO);G82KA1EN>Q (_.J-GXTTF_OC:6R7KNMT]K(WV1PL3J,G>2/E';G'0T
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MW*;-T6<%P<D8!Z\Y'<5%%XKTV2\M+8K<1_;T9[.1X2%N HR=O?..1D#(Z9H
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M$YF@OB%M@B$O*QS\H7KG@Y],$G % $NCZ4-*M61[J:\N)6WSW,V-\K8 R<
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MR>3<-:A[:Y1G+*[2'A<9&<\\=SQ7I5% &?KHC.@WRS63WT1@</;1@EIEQRH
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M2OH;R)[742L3S;$X*.2 >A_'%,U'2X-9^)\OV_2KF?39M#^QF5[23RQ*9BV
MVW@[3][MZUWU% '*>$YM3T>23PSJT%U.MF0MEJ A9HYX?X0S 85UZ'..E=1+
M(L4;2,&(49(52Q_ #DT^B@#D_AZ)].\ 6D-U9745Q:I*7@>!DD/SLP # 9)!
M'YTZZ:'Q=/I$MO8WD!L;Q;IY;NU>!H@H.4&X#<6. =N1C.3P,]510!FR:TL<
MNI(=.U!O[/5&++;DBXW+G$7]\CH1ZUAM8VVN^*]&US3[*>V:S$K7-Q-:O SJ
MR%1&0P!8Y.>X&#SR*ZZB@#A;:TO/#VF^)-(CLKB>6]N9Y]/,43,D@F7A2P&%
MVMD'<1QS5G3O U[I]E8QVOB.\LI+:RCMG6&*)U)7EB-ZDC+$G\O05V-% '(?
M#32=1TGPP$U&>YWO-*5MYXE3R?WK\C !^;(;G/7CBI_&-E?K<:3KFD6_VB_L
M+GR_*[212_(P/L"5;VVDUU%% '$:/X=O]*\5W&G_ #S:1,8]2:9_XKD JRGW
M9PLOL5J2Q=HO'/BR>2WN5AEMK98Y#;OMD*(^X*<8;&X#BNSHH \JT^VO;#P[
MX2U2;1+N^M].MYK6^LQ;MYT6\J0X0@$X*C/L:TO$,"7?A&>32O#=S:?:;VWD
M$263":8)(K,[HH) P#C=SQ[BO0Z* .,\7K/#K&C:^NE7&J:?#'+#<V\4):6-
M9-A5PAYX*<CJ*VO#BVK03W5GHQTN*X<,%DA$4LIQR[+U'H,\\>XK9HH XL7T
M5C\5=2,R3%6TF#YHH7DP1(_!V@D5FP6NJZ#H\4JZ=<BWU'7)KN=;>W\V>SA?
M.S:@!() &2!E0Q[UUUOH!@\4W.O?;79[F!8&A*#:$4DK@]<Y)K8H \WM;)/)
M\4VFI:#JLMC>7L,@!C=W9"(UWJP)9F4@MQDC;S@\4Z73-=E\*>*-)6>[U6T^
MRA=.FNHBMQ(2I+1DD OCC!QU)'T]&HH HZ-=?;-*MYOL]Q;YC V7$9C<8'=3
MR/QJ]110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !6;KVNV7AS2Y-2O\ S?(C(#&*,N1D@#/8<D<G
M K2KD_B@<?#S4R 3@P\#O^^2@"]8^,--OM=_L;RKNVN7C,D!N;<QK<(.I0GK
M^E++XNTZ"2U:6.X2TO)_L\%Z4'DO(20!G.X D$!B,'UQ5#4K-_$?BG1+JW@N
M8(=-6>26>:!HB"Z;%1=P!)YR<<?+UYK%\,6K6ME:^'M2\$[]1LB(A?/9HULZ
MJ>)?,/?'..N?3L =+'XTT^?49;"VL]2GF@N5MI?+M&(C8C(9L_=7W/\ +FL&
MPGB\27VO3:NE]:)I]]B&Z641_8TC1&(R&X))8G@@@^PQJ>%4GA\1^)GFM+J&
M.YO%FADD@95D41JIP2/4=*QX='O=7T;QII:V]S:RZG>2RVKSPNBR*40#DCH2
MI'K@]* .HB\5637-E%/!=6J:CQ9S3QA4G.,@#!)4D<@, 3]:@3QMITNH364%
MIJ4\MO<K;S>59NPB)&0S=POOBLF\BO/%&DZ!8'3KNSNK2\M[B\\Z!D6#RN6V
MN1ALG@;2>N?6KGA830>(O$TD]I=11W%VLT,CV[A9$$:J<'')R.G4]J '_P#"
MPM&_LU-3\F_%D9C#)<&V(2 []F7ST&?Q'&0,UHV?B:RN];.D>1=V]PT1FA-Q
M"46= 0"5)YXR." >:XB2PU!_A+J>F+IE[]MFO)&2#[,^Y@UQO!Z=-O-=%J1G
MF\?:)>P6=T\$5G<(\IMW"HS[-@8XX^Z?IWH OV_C#3;F6R"1W M]0E>&UNF0
M>7*ZYR!SN&=K8R #BJ]QX\TN :B5M-1G_LQ]MT(K5B8QC<6.<87'//OC.*Y;
M;K5_#X>O;S1-4:_L]55[Q?+"QQC#C$:YQMY'S ?4UI10W0/C@&PO ;[)M?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %97B30(O$NCR:7<74]O
M#*RES!MW':P8#)![@5JT4 ,C5DC57<R,!@L0 3[\4^BB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BD# D@$$@X/M3)9HK>,R32I&@ZL
M[ #\S0!)134D20 HZL" 05.>#WI0P)(!!(.#[4 +135D1F*JZDKU /2AY$CQ
MO=5STR<9H =112*RN,JP8>H- "T4R.6.9=T4BNH.,J<C-#RQQXWR*N>FXXH
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M@#8HKGT\9Z:VL6VFR07L/VQBMK<RVY6&=@,X5CZCIQSVS704 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
%44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>64
<FILENAME>ebs20191231exhibit1048025.jpg
<TEXT>
begin 644 ebs20191231exhibit1048025.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ JCJEO?W,<$=A>FS/G S2JBLWEX.0H8$9)V
M]O6KU% '$Z5+KFI>*/$>D'Q%=QII9MUMY/(MR3YD>X[_ -WS@^F*6+7KC1_&
M-Q;:[JP%K'I,,S*P4*LI=@VW: 3]W/<]:C\)WMI-\1_&(CN8G,SVACVN#OVQ
M$-CUP>#CI4L5U9#XNWQ>>$-'H\:99@-I$C,PS]""?:@#ITU?3I--BU*.[B>T
MF ,<JG(?/0#'4D\8ZTNGZK8ZK'(]C<+,(G,<B@$-&PZJRGD'V(KRW2K^*R\(
M>&]2D:633-.U&[%[]F9MUN':4(YV\@ -^3>]=WX6_L&ZN]0U30A+,MWY?GWC
MR2,L[*" !O/.T8R1ZXZ@X &ZOKEW+XJM/"^E2+#<20-=W=R5#&"$':-H/!8M
MQSD#K@U;GL=9M9[.2TU6:YA$ZBZBN(XR3&>"5*JN"#@GKQTQ6!K"MX;^),/B
M>Y5O[+O;#[%<3A21;.&#*S8Z*< 9Z ]:ZB#7=.O9$CTZ[AOV<C/V:02!!_>8
MC@#Z]>U ',V5SKVH^*O$^EIX@F@32_LYM2UO"1F2,N=_R9(!]".*U? GB*?Q
M3X2M=5NH5BG<LD@3.QBK$97/8XKG=%ATG6OB-XR@GG$T<_V0(D=RR"8"$AQA
M6&\ \'KBN@\17%AI.CV^A6DT&G-?L+2!4(01(?OL!VPN['^T0.] %7PUXKN=
M3\4ZEIMY&(X98UN]+/\ SUM\["WXD;A[/3O%M_J=EK_A^UL=2EMH=1NF@F5(
MXVP N<J64X/'O6/XUM9?"YT;Q-_:!E.DSK$8?+1"]N^%=5"@9(&"!VP33_&V
MHZ5?:YX087T+V[WK2%TFP-A3 .0>!DXS0!J:3K>I0^/[WPQ=7(U"".R6[CN?
M+59(B6 V/M 4YSD<"HK/6YM:\4:OI#ZW)I=W93>7;6:1QYDCV@^:=ZDODD\#
M& !ZYJKH$L'@?7[G0M09$L]0<W.GZC)C,N?O12/W9<\$GD'Z"G:[%X0\6"ZB
MUJ>#3]0T^9XX[HRB&5 IX9&.-PZ>H!SWH ZO11J"Z3"NJR+)>KN$KJH4,0QY
M [ C&*+K6]-LIFBN+D(R%5<A&*H6^Z&(&%)R, ]<BLSP%-JL_A"S?6)));G+
MA995*O+&&(1F!YR5P>>:YO7[F33=7U;4-#U**>;SXTO]"N@#]I;:@#1?Q!BN
MT<9!(]L4 =S;ZQI]WJ-QIUO=))=VW^NB .Z/TSZ9[>M,77=-> 3)<[U:5H5"
M(S,SKG<H4#)(P<X'&#Z5SOBM;W0M>LO$FEVQGDN4_LZYA'\9;_4L?I)@$^C4
MW7]+M;.'1+*+76TG4K9)&M+UPI21\+Y@D!X._.?J#0!J:CXRTJQBTZ1)3.NH
MW(@B9$8J,$AB3CC&T\=21]:OWNO:9IT8DN[M8U\L2$[6.Q#T9L#Y5]S@<5PU
MYJEQ-X?\,ZGJL$-J+?7_ /2)H ?)8?O5\X9Z*Q.<GU]ZEN=6TG3_ !;K5OXE
MFNK:VU58I;*7=*D<T?E!6CPO\0(/!Y^:@#LI_$>BVT\<$VJ6JR2Q><B^8"63
M&=W'8]CW[56;QIX;6Q2];6+86[N4#[NA!P<CJ,9&<],CUKF@FF6/C3P?:6T7
MV2&&RNEB@G<EXPP38#N.02,X!YZCM5.&ZL#H/Q%VSV^99[DKAE^?,  QZY;(
M'O0!Z6'4IO# J1G=GC'K65!XKT"ZO(K2WU:UEGFE:*-$?.YU&2!2^%IXI_"6
ME2QRK(OV.(%@V1D( ?R(.:Y3PP(]0T?QG;Z;+"U]+J5ZT)1AN!9<(V?3.<'Z
MT =A#X@TF>^CLH[V,SRAC$I! EV]=C$8;'?!-,OO$FC::9?ME_'$L)Q*Y!*1
MG&0&8#"D\8!.3D5QWAN_\,ZY!HMJT5[)K&G-'_H4DDP-I(@PS$$[0H&>O!X'
M4XK'?6[6+X5ZWH%^[)KEN+C[5 R'>S&4MYG3E2"#NZ?I0!Z@FKV$E\;%;E3=
M"'S_ "<'<8\@;@.XR0.*SM5UW2;CP[/=)X@33X-_E?;(V7<C@\J P.3QC&,U
MAW-_:Z/\0]*O=0F6WM[C0VMXI'SAY?-1M@]\=JYN[O+>3X3>*$+%7;59\(ZE
M6)-P"!@]^.G;% 'I6H>)M$TJ>2"_U2W@EBB,SQL_S*F0,D?4CZTMSXDT>SA2
M:>_C6)HUE\P LJHWW68@853V)P*YV]O-.E^*NDDW%N^[2YEC.]3EF=-H'N5W
M8]1FLV6_T;3O$7B#1_%,ES;KJ$WF6Q#RB.ZA:)4V*$ZD;2,=>: .YN]:TZQ&
M;BY 'E^:2JEPJ?WSM!PON>*MQ2)-$DL;;D=0RGU!Z5YWJL46F3+-H6IKH^H6
M6EQ*VG7YWQ7-N-Q2-LG.Y?F&021G'>NYTF>2;0[*XDM&M9'MD=K;O$2H.S\.
ME $<7B'29KN.UCO8VDF=DBX.V1E^\JMC:Q&#D Y&#6@[K&C.[!5499F. !ZU
MY,FM6-W8^%[J-Q:QV^M*)-/@A.RRR)!M8XSO)/<C.3@5W/CZWO;SP/J<6GQ-
M+.8U81*.9%#*67'NH88]Z -*SUW3+^[-I;7://Y?FB,@J73.-ZY W+[C(IJ>
M(=)>[CM5OH_,E<QQDY"2..JJV-K,,'@'/%8*:YH_BZVDF\/J)]4%C+''/Y15
MK,LO"LQ'!W8&,]B>@KGYY8=8^%.GZ#9$)KD/V:W2UZ303QNH9BO5< ,Q/H?>
M@#N+OQ9X?LGNDN-6MD>SVB==^3&3G ('?Y3QVQ46J>+M,TUM+ E\X:I(!#)&
M"R;""V[(]AQZY]C6)I]WIZ?$3Q89KBW4_8[89=UZ!7WC\,KG\*Y_2KVW@\&>
M [R691!:7X2XDSD1$I( &].2.OJ* ._N?%WAZTDDCN-8M8WB9%D4ORA?.T'T
M)P>*GE\0Z3#=?9I+V-9/.$&<'8)3T0MC:&Y'RDYYKG-)NK"X^*.MCS(6DDL;
M8(K8W'&\L,'G(^7([<9KFM>UBTN]%U55(L7M=:1I;&*(Y&)US-*<$_-U!&!R
M!R: /2]0UO3=*R+VZ6(JGF.,%MB?WFP#M7W.!5&[\6Z;;:[8:4)/,>\B:82H
MI9 @ P00,'.1T[?45SL6OZ;H_B[7K;Q"QBM]76&6SDEB8I<1>6%,8&.H.?EZ
M_,?6I;V:UTSQGX5F:V-A9FQN((8C&?D)V;(\ <-@?=_"@#J;SQ!I.GRO'=WL
M<1C*B5B"5B+=-[ 83/;<13=0\1Z+I<WDWVIV\$GEF78SC.P=3CT_G7'Z5>6U
MCHWBG1===4OGNKJ0Q2?>NHY!\C(/X\CY0!GH!4%@@TS7O 5CJTT0O+?3IXY%
MD891V2,*I]^H'K@XH ]!CU&RETY-16ZB^QO&)5G+8381D')[8JE9^*="U"?R
M+35;:63R#<$*_2,'!8^@_P#UUH3O#;6CO*R10QH<EB JC'\J\WTF)[SX%1Q:
M5&L]U%;@211??.)0TB<<Y*@\=3D4 =W#XCT>>66);^)'AB\YQ+F/]W_?&[&5
M_P!H<57B\9>&YKNVM(M9M&GNP# @?[^>F/KV]>U8FCW_ (6\1:E;ZEI1NKR^
MMX) 7EDF/V567YE?<=N2<#'/J.F:YBTCL=7^"^F:18-"^JR/$+>*/'F)*)02
M^.HPN26]* /1;GQ9X?L[F6WN-7M4EAD2.1-^2C/G:#COP?IWJ>Z\0:397(M[
MF]CB<R",EL[5<]%+8P&.1@$YYKG-%GLI?BCXEC:2!Y7M[144D$G:&W ?0[<^
MG%8=E=:$]KJ7A?Q0EZVHF]F8V8DF'VT-*9$9 IP<Y'IC&30!Z#=ZYIMC(\=S
M<A#&5#D(S*A;[H8@84GC /7-&H:YINE9^VW2Q;5#O\I;RUZ;FP#M'!Y.!Q7#
M:].^F:EJM]HFHQRSK)%'J&A79WBZ.Q #&?O!BNT9&<D>U/N=2TK3/%FO:?XI
MEN;6/4F22U<22B.XB,2HT8V'!(((QWS0!V5SXDT2TG6"?5+5)&B\X+Y@)*<8
M;CL<C'KGBJ6I^--(L?"LOB&WN%O+8 B,P@G>^<!3Z<]<]*YZ(:98>._#%K$B
MVD4&F3I##.^7B!*;%.XY#8SQUZBLBXEBN? 'CJ*U=9F76)I=D1W'9OC.[ [<
M,<^QH ](EUW388XG>Y_UP8QHL;,[!?O$*!NP.YQQ5#5?&.EZ=9Z;=1S"YCU.
MXCA@>++*0QY;(]!GZD8K)U'Q'ILOBO31',EM'=6,C0ZF(BSS#>/W,601DX#=
M#D8P.<US&GW,4/P[\+22,R1Z=X@4W3.A A'G2\MQQC(SZ9% 'H@U&RF\1(D>
MLEI5LFD;3DP?E)4B0C&X'D #WZ5/;Z_I5WITVHV]['+:6Y(EF4$JF.N3CMW]
M*YYKZTD^+%BRS)F31)% ;Y3DRHRC!Y!P"<=:@CL+FQ\8:AX>CA8Z9K+KJ.\#
MY8P"!.A_WF"#'I(: .IN]=TVQA66YN0BM'YO",Q"?WB ,A?<\5<@N(;JWCN+
M>5)89%#)(C JP/0@]Q7":GJ>GZ+XZU-?$<US:6FHV\/V.X6218V"@AXR4[Y)
M.#_>/KSU?ANTLK'0+6VTVUEM;- WDQ2EBP4L2"=WS#.<X/(SCM0!7T/Q58:[
M<:C%;LRBQN6AW.I7<%52S<C@98C\,U;M=?TJ]NDM;>\1I94,D2D%?-4=60D8
M<>ZY%<!,EU=>'_'VB6._^U)=0FG2!5.YHF6/D?[P# >M:FJWEIXG7PHVARH]
MS!J$-PZ1GY[:%5;S0X_A[+@XY(% &UX^N[W3_!6IWVGW<EI<V\6])$"D]>GS
M ^O;FKFG^)M%U"_;3+;4[>:]B7+PJ^6XZX]<=\=*H_$.&6?P!K,4,;R.UL<*
MBDD\CL*S+X6.NZ[X5DT.2"=[&4RRSVY!6&#RR"I(Z;B5 'L?0T =-+X@TF"\
M2TEO8TEDD\E<@[3)_<W8V[O]G.:O2RQP0O--(L<<:EG=S@*!U)/85YAHMQH5
MUH__  C'B*.]DUJWN&#V'FS SR>8661,'&#G.[H.2>.:[KQ=<I9^$M4N)+#^
MT$2V8M;=I!CD'';U]J +-EK>FZC<FVM;H/,(Q+Y;*59HST< @97W'%%MKFFW
M=S';07(>252\7R,!(HZLI(PPY'()'-<-9:I93>.M.N_MYOH;C19HU>*$I$3O
M0E(\#H!GJ21W-.\-W$NGZEIMA9:E%KNA3VTK0%P/M.GHJ9"L1U4\+S@@X':@
M#MH-=TRXN$@BN@SR*SQDJP615ZLK$88#U!(JOI&I6#:=>WJZXM_:QW$K/<.R
MA(1U*!@ -JCO^M<GX6N9=/U72+'3]3BUK0KB&1H/, ^T::JID!F'\/1?FP0<
M#M5!#97OP\\9HUT4C&KW,P>%?,('FJR':.JD@?AF@#OU\2:*UT+5]2@AN"H9
M89V\IV4]PKX)'!Y'%0+XR\-L8 NLVK?:9/*B(?(9LD8S]00#T..*P-$UO1M<
M\91:L=<TTW4=@ULEK;S$E\MO9B653@;>!@XY.:YJ2ZL?^%/ZRL<\'FG4W;:K
M#<3]J!4X_P!T9'L* /4=0UG3]*!-[<B/";V 4L57^\0 <+[GBG3:M80VT%RU
MTC17./(,?SF;(R-@7);CGC/%<1>ZQI6F>--3.OW4T%CJL$#V%U'+((94"$,F
M4.,Y)(_WO<9CCFL/"WBG0KB6&33_  ^VFS6UHURS;8)6E#Y<MRFY /O=.G8T
M ;O@G5KC5;G7_,U![V&WU$Q6[LJC:FQ3MP .A)[9]:WKW5K'3FVW4^PA#(P"
M,VU!U9L [5]SQ7,>!;NVN=:\4_9WW*^I^8I"D!E,:<@]\D'ZU%XN8V_B"2]T
MO78M.U>WT]6>WN\&"\AW2$*0><@AN1R-P]: .KGUBPMX8)9+@$7*[H512[R#
M&<JH!)XY/'%2V-]::E:)=V5Q'<0/]V2-L@]C^-</8:C)8^,=,U/6+<:;9W^A
MQPP"4[8[>8-N:(D_=)&.N,[0.U:O@JU>.^\0WL7&GWNHF6U ^Z_R@/(OLS9Y
M[XS0!H2^)[)?%*^'MSB<VYE9]API+*J@'&#G)]ABL;PWXLMK2"^AU_6D,ZZO
M<6L+3[5)57VKG:  /? &:DN[N&P^*\#W3F)+G1C#"Q4X=Q-DJ/<#GV'-<I<W
M5C-\-/&ICEA9IM5NF7!&7S*"A]\CD?2@#TR_UO3M,<I=W01UC,K*%+%(QP78
M '"^YXJCJ?BW3=.U#2;0R>;_ &H6:.2,%E$81FW9 P<X 'USVKG-6UNRN-;O
MK-)$MI)](4Q7$4?F2Z@"'PB'!&U<G. 2<]1BLW3[^VATSX=:A+(5M;97AEE*
MG:KFW*@=/[W'UH ](U#4+?3-.FO[EF$$"%W*J6./8#DUR&J^*9KS1O#&L6%Y
M):17NHVL=U%@;=CC<RDD9X]0<=:ZK6E:?P_?I$C,TEI(%4 Y)*' QZUYU/J>
MG7'@7P-";B-A#?V*3*XP%*)AP<\<'@^E 'HFF:[I6L>?_9U]%<&V8+*$/W">
M1GV/8]#26VOZ5>7JV<%ZC3NADC0@CS5'5D)&''NN:XC6"U_XG\86.FSHUY<Z
M)&D2(XW2. ^0/?! ]LBKN@:EX6\1WFE36J7DVJ662())9LV)*X?=DX XV^_'
MX ';7-S!9V[W%S*D,2#+.YP!5:SUK3K_ .T"WND+6O\ KT<%&BXR-RM@@8YR
M:P?B!--96&EZFL4DUII^IQ7%XD:EB(@&!; Z[25/X9[5F>)Y[+Q1X2UVY\*V
MXN[B:WC$MU#&5\]5<$Q D?,=FX8'3('>@#KK37M+O;D6UO>(TS1^:B,"ID3^
M\N0-R^XR*JR^,_#4*&1]:M @F,!829 <8R,CZCGIS6%JUY9^)M2\*W&ASQS3
M6]Z+B1HR,P0;&\P/C[N3M7![\=JPVNM/?P3X_59K<O)J%T0 PR^5781ZY(./
M?- '<WGBFQL_$UMH3EO.FA:9FV':H!4 9QR3G\,<]13X_%OA^:Z2UBU>UDFD
MG-NBI)G=( "5&/8BN:_M"UA\:>&KZ28&WN-(DABE7+"23,9VC'4\'BG>$;NR
M,GC"2-(KN5=4FF$,9!>1!&H&/8G< ?7- '4VOB#2;RZBMK>]1Y)E9H>"!,%^
M\48C#X[[2:6[\0:38S^3=7T<3!UC8G.U&;[JLW12<C )&<UYU8:Q97.H^"+V
M*X401O-&UM;PD16;- P$0XR6SQR23C( !K0T;6-*MK;5?"WB2W,VH-J$S_9)
M(2YO0\A>-EXP<\?3'.!0!U<'BBQN/%%SH*;_ #K:)&9BC8+,3\HX[!>O3GV-
M63XATD7:6QOHP[RF%"<A&D'5 ^-I;_9SFN<\\P?$;6+<OY%U?:7 +3@G<P,@
M)!QV)&3VK!\V+4/A"OAQ5"ZY$$MOL1.)UN%D'S8Z_P"UNZ8R<T =W?>+?#^F
MS30WFKVL,D&WS5:3E"QP <=#[5%XUN;NR\':I>6-T]K<6]L\J2(JDY SCY@:
MQ=/EM#\5K^&::"6<Z3#%R1EF#,6 ]\8)'TK4^(,L<7@'6O,<+OM'1<GJQ& !
M[T 6='\1Z9?-!IRZC%+J MUDDB#?,>!N/H<'KCI5@>(=)-XEK]MC\QY3 AP=
MC2#J@?&TL/[N<UR4]YIZ>)/ 1CN(%403J-KC !A  _%A@>_%8=SK5E>:9I4R
ML+(6OB*)IM.BA.+0><V6D.,[CG/4#YL <4 >F7&MZ;:W!@FN0KB18F(1BJNV
M-JE@,!CN& 3GD5?KS?4[M]/U6]U'0=12Z$M]&+[0;I<O))E5#Q?Q*V I].#G
MIBO2* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBH+V]MM.M'NKR9884QN=O<X ]R20 .]
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MO&A^T()(VC#Q?WU+ !EY'(R.: -.BL$>-_#1$)&KPE9I?)1@&*[\XP3C Y!
M)P#BM"_UBQTPA;J5@Y0R;(XFD8(.K%5!(4>O2@"Z0#C(Z=*6J!UO3?L5O>)=
M":&Z&8# IE,HQGY54$GCT'%2:=J=EJ]H+NPN%GA+%=RY!##@@@\@CT/- %K
M)!(&1T-+6?J.N:=I6[[9.R[$\QPD3R>6G]YMH.U>#R<#@^E-'B'23?6EDMXK
MSWL?F6P1&82IC.Y6 P1COF@#2HK/FUW3;?[7Y]SY0LBHG+HP"EL;1DCDG(P!
MG.13$U6TU6&^M[&\DBN;9=LH\LI+"2,J2KKW[$C!H NW*2-;2I 461U(4L.
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MFJ0S2S^88U4'YMF=W.,<8/Y4 ;5)6;;^(])NKJ&VBNQYEP"T!:-E6<#KY;$
M/QS\I/'-%_XCTG3'=;R\$0B95E?8S)$6QM#L!M3.1]XCJ/6@#2(!ZC-+5#4-
M:L-,!^U3,"$,A$<3R%4'\1"@D+[GBFMKVF"&&9+GSDN(O.C-NC2[DX^;" \<
MCGI0!HT@ !)  SUJ@VNZ<+>WG6=I$NH?/B\J)Y&:/ .[:H) Y')'<5:M+J"^
MLX;NVD$D$\:R1N!]Y6&0?R- $U( !T %4]4M;V[@CBLKY[$^:#)-&JL^P9R
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MAD&48J5W#UP><5/10!YI)<0MH_Q%42*3,\OE#_GIF *-OKEACCO5J2ZM%O\
MX?NLL>V)'#$'A,VY3!]/FXY[\5Z#10!Y?<6UY>^'/'>A623#4IM1FG2(1L"\
M1$9X.,?, P SS6OJMW;>*Y/"[:,P:YM]1BNIU7AK6)5;S%<?PYX7!QD_2NYH
MH Y[Q_!+<^ ]9A@C:21K5\(@R3WX%86HZE97WB+P1/%)NA5YV+.A4 >25!.1
MQEN >YZ5WU% 'E^HBXNV\<)IJ-<2B\M+E((B0TZ1B,R!2.3]TCCOQ70^'KWP
MUK^L0:GI,-Y<7<$+))/<-/\ Z.IZH=YP6)[#/0GTSU]% ''_ !$DABC\.27.
MWR5UVW+EAD ;7Y-9>O:9-K_B#6[[06617\/O9M-"PVS3,V50,."0HP3VW 5U
M'B30;K7)=+:"]BMET^]2\P\!D\QE! 'WA@?,:VQG'/6@#A-!U/PUK]SILT=I
M?-JEAEGCN7G L#MPY8L=H'&,=^/?%KX<W%JGAR\)DC0QZA<R2%OEP&D8JQ]B
M,8-=E10!Y1:+<W/PFMQ8H]Q)8ZD;FYM4'[QXEN6?&WKR,-COBNDO9K;7_&7A
MS4M)N8YH;!+B6[N(V^6.-D ",>Q)_A/(P3CBNSHH X#PE/;+X!UH;T5EGO&<
M'@_,S;3^(QCUK/>2W'@?P%&S)NAU"S:53UCVJP<L.V">2?6O3Z* //\ 4+Z*
MW\9>)Y4MEO\ .BH%MAR+AEWED]S@C(ZX-5=/U*WG\7>%[Y;F::%[&>,LMLT<
M,3$)\BC;P!@YR3C')XKTJB@#R2>6%OA'KT*,IF?4I&6,#YFS<!E('4_*,CV'
MM70S:]:^'O'E]>:LS_V;J]G +.\6-I(\INS'E0>3OW5W5% 'GFK7-IHFJZ)J
MMQIUS8: ;2:VQ;*\7V0LZLK,L>"H8+R,<'KR*Z?PM#I2VEU<Z-:RPVUW<-,9
M93)FX<@;I,/S@GC/?&>F"=RB@#S[4-0T_1O&VL1>(Q>PV>IK"UG/$TWER 1A
M'C(C/7()QC^+W&;.NZ6FG>$=,U;1M/DMGT"3[5!;,27\CD2(<\C*$G'8C':N
MXHH X[7IWTKP?]NNK!)YKJ\BGN?-B,@MMSKAV4<MY:A1Q_=%4M#OK>+QKX@F
M>YN9HKBPMY([F>$J) HDRV=H '( Z ]LUWU% 'E<$JP?#3P;=R;A#INI6\EV
M0I)A4;P2P'(QN'YU=FU>%_$OBN]M["748I-'B,<)A;9< "3(Z=#G\1TS7H]%
M 'G&F:A!<>,_#=XEQ/<QS:?/$'2U9(D8^7\B +P!SU)QCDU%:W,<?PQ\3:;(
MLB7437RO&T;#YG=R@'').1C%>F44 >?I<_V?X@\,:S=/_P 2E])-H9S]RWF.
MTY8_PYV[<GN,&L[7[<MI?CW5(.;'48X([7;TGD5,.R#ODD#(Z[3Z5ZC10!Q%
M]=V;>-?!TD,L9C%M<KN4\+N1 H/ID@@#U%6OBC@?#O5"PR/W.1C/_+9*ZVL7
MQ;H4_B7P_-I,-XEH)V0M*T7F8"L&P!N'=: ,;4%L]7\;>';W2Y(I$TU+A[J>
M(C;%$8]JHQ' ))X4] ":RM$MIM3^&&OV&F$?;99KS:@^5FW.Q7_OI> :]%C$
M@C42LK/CYBHP"?89-/H \^O[F#Q-H/AJTTLXU"WO;:62$#$EF(Q^\+CJN!D<
MXSD8ZTW2]8L-+N=<\-^([.66YN=0FG@@:V:5;Z*0Y3;P0>PYX&!Z''H=% 'G
MU_J%IH/C6]?Q$EW:V6I6T M9X'E\M60,&B/E]\G(X[GUJ.ZT_3K,6 T+4)/"
M]Y:VC-:"Z),4T+2,=DBOSG(W8^\N[IQQZ+10!YU<227]MH]^=0_X1?7H].#(
MLB@6\B$\Q,K=OE! ZC/?''2Z#KP;2M"@U*U-C?ZC ?+MDB;:NQ<D=/D&,$ _
M2N@HH *XCPW=0-\3_%A652+A+3R3GB39&0VT]\9YQTKMZ* ..,]NOQ>D=W10
MFAB/>W #><6*Y]=O./2N5LKAK7PMI6H^5<3V6F:U<R7D5L6$D<;F4+)A2#@;
M\\=C7K=% '-^%VT*^O+S5M#AGD%RL:S7LK2_ORN0%'F<G:._OCUQF:_!+H/Q
M"LO%CPR2Z=-9-8WCQH7-O\VY7('.W. 3VQ7;T4 9EOK^FZ@R+IEU#J#.1G[-
M('"#N6(X7Z'D]*Y'3+;3-6^)?BF*[VS13PVJQC>0LNV,AP,'#8XR.:]!HH Y
M[Q#<6>D:)#I%H\5@;QEM(!& @@1N&<#H-JY([9P.]<]XUTN;P]9:5X@MK^>Y
MFT2X00V[)$"\+81T4(@)^7'X UZ%10!P'C>^T[4KSPG(LT<UNVI+*YSPL>TC
M+?W1DXYQ4NB^7X&\0SZ3<*/[)U1S<65Z5SL?^**1_P <JS=N,UW5% '$Z[_P
MB7B@7ECXC\FUGLIFCAN9&\E\8!#1N>O7D#/(Y'2M'P!_:@\)P+JLLTTBR2+#
M-.I622$,0C,#SDCUYQBNEHH X,:S:>'O&6OVGB&.18-5:*2TE,#2I.@C"-%A
M0>00>.^3Z\N$HT3QU8ZA>6PT[2;G2!:6^X!8[60/N\ML<)E<>V1CG%=U10!Y
M3KUJR>%O&%X@(L]3U*![2/'^MVO'YCJ.X8@G/<+GI727-W:O\4=)DBFC:-]*
ME0.I!!+.A49]P"0*[*B@#R>>=$^%?B32W61;R.ZN0T31L#EIB5 XY)'(QVKJ
M?$>KVEI;^'Y4CB%K-< #4!#Y@M/W9 *C'#'[H)X&3D&NOHH \F<W7]E^(S9V
M]Y=/:Z]#J$D+PL'GA7RF/! &3MSCCITKKDU?2/%%K?7>BVIN9FT^2%KO[.R,
M,C*Q98 DY).!TQSU%=710!Y?;73CPSX(U)$FDLM'>--07RF'E-Y7E[R".0A)
MR1TS6O=>5>^,-0UVRGC?3HM#:WFN$8&.60N650>C$#TZ;@.]=S10!S?P]:(^
M ]'2/:&BM4210,%7 ^8$=CFJ>I36Z_%72/,9,KI\Z G^%V9-HSV) .*["B@#
MSR[OM-TCQ=KEGXF%[%;ZFT<EI-$TWESIY2HT>(^X*GC'.?I2@Z;H_CGPZCP#
M3K6/2)UA2=O]2-ZX#,WW3CCD]3BO0JP[C0;J;QC:Z\M]$L5O;-;_ &<P$E@Q
M!)W;N#D#M0!P>O6:IX7\8WL*8LM4U&W:TC"_Z[:\?F.H[@D,<CJ%STKH_&5Y
M'9W^@:ZZSS:-"TRW,MFSYC$BJ$D^0YVC!!]FKM:* //[JW\+WVE3W=H][8V]
M]>1,NK+)*&\]0Q60>9SM& "W0Y/IFJ=W/KUQX9OC<*NK#2]4MYVN[%3&=0A3
M8S$!3]]0 "5.,K@=*],HH X(7GAG5K/4]9TE+F>9=+E@EO)WFPBGD1?O#R2Q
M)P.F/<9S_M-LGAGX>@2(K6]S;^=V,>(65]WIAC@Y[UZ;10!Y\EZ--O?',,FG
MR7LTC>>EH8F*SQ^0HZXQ@X(_2H=,U""X\9^&[Q+B>YCFT^>(.EJR1(Q\OY$
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M"A3GGGIR3BKW@_6+;^Q--\-7^D3G6--9(VMY;5BL;(<"82$;0,?-G.?3.1D
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MQ=,J6[A)Y5A=HX6.,!W *KU'4C&1GK2WOB;1M/ODL;F]"W$D1E2-49RRC'3
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MC21.%F*J-^UR-KD=\$U;OO%&DZ<S&YFD2%)1#)<"%C%&Y. &<# Y('H#P<4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5R?Q1./AWJ9()QY/ '7]\E=96/XIT%O$NARZ3]K^RQS,I=Q'O.%8,
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MU%4O-(GB+0W7SA3,F1\O W;P<<>U=IK\$MSX=U*"%"\LMI*B(.K,4( K0HH
M\]\@Z]X7\+:1:PS"[LIK22X,D+(;3R5&\G<!AN-H'4Y],FH;5[:PO=7T'Q!H
MFHWDES>S36WE1R20W<<C%@.#M!&<'=@#'6O2** .-O!Y'Q"\/_Z-(D5O83Q2
M-'$[11,VS:N[&/X3UJII$DFBV?B31M5MIWN)[NXGM]L+.+R.497:0,%NQ';Z
M5WM% 'G6G:=<Z+JW@6RO(YI)+"RN(KB1(F=(G=4"J6 ('0C\*FOIX]%\::M_
M;6G:A/8ZJ(I+6>T261<B,(T;!.^1D<=Z[^B@"CHMO%::1;006(L(E7Y+8?\
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MD*6QC.!5CQ&S?\)UX5<0S/'"]RTLB1,R1AHBJ[B!@9)Q7644 >97]IJ%XGC
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M.5EA:,D-(S*?F R""*ZRB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%[*RD;K-&2&#_P#?'EJ/HU86A6\5M8GPSK/A6ZO-0@E98YFMR]M<+O)60O\
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MWVQDDY4L,CL-H)Y["N;\*VK#Q/XGBGTZ^2TOC \;W:,1*GE!3EF/)SGCJ.A
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M"S>TO(EMW,MNS*H#^7C<1E<$@=* -[PC>O=^+O%*^;=F**6V"0W3,3"3&2P
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M*9H8C;O(\BM*&4@C.[CJV2/>NCU>X:R\=Z3K36=[+92V$UMOAM9'9'+HRAE
MW+G!ZB@#73Q9I$FG2WPFD$<5V;(HT3!S/N"^6%QDG)Q45UXNLH-,U:Z2WN7G
MTA2;FT\O$B_+N'M@CG.<8KDK.YU;3]$U-TT>]0R^)9992;3S)(H&DR98UP0Q
M&,9&<=>:EALKN6Y\<00:;J6W4]/3[(]RCYE_<,OWF[[B/E/(ST&. #=FUZPO
M-&T*XU1[ZTDO+FW$0A21 \QP0I(XV$GH3@@>U;%[KMI9W,ML(Y[F>",2S1VT
M1D,:'."<>N#@=3C@5Q^I27%WX2\*"/3-2WVNHV+31FRDWHL>-[%0,@#GD]<<
M9K1T]Y] \::[+?P7+6FJ^3/:W$4#R#*IM:-MH)## P#U% &K/XQT."TT^[-V
M9+?4G"6TL<3,KDYXR!@'@\'G@\4ZS\6:3=PZC(9)K;^S!NNDN8&B>-2"0VTC
M." <5QB:1>Z3HOAR.6QNV?\ X2 W\D4-N\OV:%O,P&V XQN7(]2?2M"X0'Q3
MXM:[TB^N[.ZL;>,(MK)BX"APZHV,$X88P>>U '7V>JQ7=Y):?9[B":.-92LT
M>W*DD @]#T/'4=ZO5Q7AF.^T;4[N".[OM1T&&R\V%[N!O/@<'_5*2 S_ "@G
M&,C@?7K;"\CU"P@O(DD1)XPZK*A1P",\@]#0!8HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *R/$^@_\ "2Z+)I;7;6T4KHSNB!F.U@P STY K7HH
M 9&'$:B1@[@?,RK@$_3FGT44 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -D#F-A&P5R/E+#(
M!^G%97AC0?\ A&M%CTI;MKJ*)G9'= K?,Q8YQP>6-:]% &-8Z ]EXEU#6S>F
M1M02-'A,>%0("%VG.>YSGK[5LT44 %%%% !1110 4444 9&IZ"=5U&&>;4KM
M+1$VR6*%1%.0<@MQGZC/(&.F<Z]%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5C3: \OBR'7_ +:5:&V-LL'E@J4+!B<YSG('
M/MTK9HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJ6IZ
MI;Z5#')<+,_FR")$AB:1F8@G "@GH"?PH NT5SR>-M+DN+NWCM]1>:R"FXC6
MQE+1;AD9 '<<U;L/$MAJ6K-IEL)S,MJEUN>(JK1L< @GK^5 &M1110 4444
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M#JOB"RT@V N!*XU"YCMH6B3<N]S@9/0"@#4HHHH **** "BBB@ HII=595+
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MI%W+:RB*=(69'*[@"!GIWKB[/6O$,>G>$=8N-56>/5I8;>YM?LZ*I\R-CO#
M9# KV..>E=Q?6S7EA/;))Y1FC*;]N[;D8SBN?/@Q_P"Q]%TT:HP319XYH'\D
M;G* A0W.,8)SC% $5KJ&J^(TUV;3]1:Q.G7DMG;1K$C*SQ@9:3<"2"QQ@$8&
M._-8D>K7?BG4? ^II>W-B+Y+EGAAV%4D2)@6 93G/S#G/!XP<FNG'A=[6_U&
MXTO4FLXM4;?=0^4' D(P9(SD;6(ZYW#VHN?!]J4T5=.NIM..B[EMS$JME&7:
MP.X'DCOZ\T :6N37]MH=[-I<(GO8X6:",_Q-CCZ_2N5M?$K:EHFMWFG:[<F:
MSLB_V6ZMXTN+690Y.Y=@!!^4=^AP:Z[4K-[[3I;6*YDMG<#;,F"R$$$$9[\5
MFCPQ%<7UY?:C,L]Q=V7V%VBB\H>422>,G+'/7/88 YR 9+ZYJ@A\%W O#_Q-
M?+6[3RTVR9A+D],@Y'8XK,TZUUV>7Q=-HVKK820:M*ZJ;=9!*PC0[6+9PIX'
M&#[]JV(/ TZ1:/'<>(+N8:-*&ML0QKA I4*>#DX."3GIQCFK@\*RPSZH+359
M(+75I3+<Q^4"ZL5"L8W_ (<@#J&QVH R;7Q3J>I3^#+N.5(+?6!)]JMQ&#EE
MB9N&/(&X?_7ITVK>(M:M=1NM!\])K6\DM[>+$'D/Y;[2)-QW\X)XQC(^I&73
M[_Q-X;L]"*M!H<UQ'<1J"/LX6(Q@$'GDD 'OR1G!JZW@N6#6;N\TS7KW3K74
M)#+=V<2H5=S]YE8@E">Y'/N., !'J&J:]J>KZ?:WITN738HD C5),S/'ORQ9
M3E1D#C&<-STK.U>'5I/%?@Z&\U22&XD2X\\6>WRA*L/+*'4]=Q'S9P.F*U+W
MP:QULZMHNL7&CS2PI#<K#&DB3(HPO#@@,!P#Z58O_"T=W-I,]O?W%I/I3.8Y
M5"NSAUVONW Y)ZY]>: #QP9D\$:S);W,MM)'9RN'B(#<*3C)!QGVY]"*RK;4
M;NT_X1GP_#?2^9J5N9GN72,O'''&IV( H7))')!XS[5U&J:=#JVDW>FSEA%=
MP/"Y4\@,""1[\UBOX.WV6EYU6<ZCI+9M;TQKD#:%*%1@%2H (Z^] !HNJW\?
MBS4_#E_.;L00QW5M<LBJYC8D%7"@#((X( R*I^*(KJ7QYX6BBU*ZMHY3='9%
ML(5EB/S ,IR<,1SGCIBM[3=&6SOKK4IY1<7UX$664)L4*N=JJN3@<D]223UZ
M8BUKP^-7O]-OX[Z:SN=.=VCDC56RKKM888$<COVH Y0QZFWB?QS+INIFP>#[
M-('6%9&9A; @'<"-O'/&?<=]"T\3W^K1:#;1+,D]_I?V^X>U$>\?<&%\P[0,
ML2>IX'KD:47A>2&\URZ7426UI560-"#Y>U-@V\_W?7///M5*7P&/[,TB&UUB
MXM+_ $9/*M;Z*-=WED %74\,, ?YS0!J^&6UW[%/'KR#S8[AU@E.S=+#_"SA
M/E#=B!QQ6-<?\EEL_P#L!2?^CA72:5ISZ=:E)[R6]N)&WS7$H +M@#HH 4
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M7M0NHI+PZ3+:!TB\I2F"W(R26)QW[< =X_"VD?VMX5\./>7Z75K90031PI&
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MEWB6\OO$7PCO/$$E_+$+K$BVJJGEK%YP4(>,DX ).>OMQ7ITJ&6%XUD:(LI
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MZ\EH5@C$=RJW'E$OP3DC^Z0!Z=Z /3**Y.^U+4]4US5]*T][J'^SHXE5K8Q
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MEE*P1L5=50[AD=<M]/:I'O=;OKW4]'M+N[:?2HH81<0>2IDF:(/YCANQR/E
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MDUI\5]/$E]-=(VDSE?."Y4[TSRH'!X_6@#J]1O3I]D]T+2XNRA4>3;)ND;)
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MAG,^H+(T4@0>7\B[FR<_3H.]:E<3XBM;K_A-/"5O'J$OG$7H^TNB%P/+7H
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MWI3:C<6T\\2NB-Y(7*EF"@G)'&2*U: .9;P3;S6>N6ES?7$L6MN9)P%5?+;
M&5P/0#@YZ5NV-L]E8I#/>2W3H/GGFVAF]\* !^ J9Y8XV17=5:1MJ G[QP3@
M?@"?PI] 'GWA2T.L'Q5;1ZH\-O=:O<"2-%7<T9"C<A/(#<C/(XXP>:Z1O"T(
MUO3=2MKJ2V73(#;P6R(NSRS@$'(S_"._:M-KR1=3%F+*X*& R_:0!Y8((&S.
M<[N<],8JKH6O0Z]%>20V\T'V.[DM)$F"[MZ8ST)&.?6@""7PV(]<N-8TZ^DL
M;B\C5+I51727;PK8/1@.,]/4&JM]X&TZXTFPLK2XN+&;39#+:W<+#S4<Y+$Y
M&&W$G([UTM% '/77@ZVU+0IM-U.^N[R:9UD:]9@LJNOW63: %QV &.3ZFDA\
M(1RZ9=66M:G=ZQ]IA,#27&U2B'LH4#!R <\DD#TKHJ* .5B\$R[M+-UXAO[C
M^R9=]L62('&TJ QV_-P<9/Z=:6\\#QW+:S''J]Y;V>L;FGM8PFWS&4*6#8W=
M #C.#CTXK5U+78=,U;3=.EMYW;4I&CCE4+L4A2QW<YZ#TK4H YZ/PF(M3TF^
M&J7+-I4!MXE=(SYB' .["CG"CICI3-4\'B[UTZUIVKWNDW<L8BN3;;2LZCIE
M6!&X#@&NDK+UG78=$DL$GMYY!?W<=HCQA=J.YXW9.<=>@/2@"(Z!)#*K66HR
MPI]G%N\4B"59!ECO.>2^6/.><\@U=TC2[;1-)MM,LPP@M8Q&FXY) [D^M27U
MV+&QGNVBDE6%"Y2( L0.3C) _6J%EKZZAI6E:C:V%U+%J6P@*%S K*3N?GH,
M8XSUH R)? $7V34].M=8O+73-2+O)9HJ,J,WWMI(R >N*GO_  4MQ<V5]9:S
M?6.HV< MOM<>PM-%UVNNW:>>G%=()8S*T0=3(JAF7/(!S@_C@_D:@T^\>^M!
M/)9SVC;V7RIP W#$9X)X.,CV- % :#+;O9R6>J7$<ELDJN9@)/M!D*EF?ISE
M>,8QG'3BLZX\ V#Z986]G=W-C=:=,\UM>PE=ZNY)?(Q@JV?NXQT%=510!SE_
MX074O#TNDW6JW<C7$B2W%TP0R2,K!EP,;5 *C@#^9)M:UX>.MV^GQ3W\L;6-
MS'=!T1<O(ARN01C&>PK9K*N]>AL_$.GZ+);3F74%D:*4!?+^098'G.>1V[T
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MA\$Y ^4 <?2LN[\'6UW9V5N^IZ@KV=VMYYX=&DEF7HSED(/I@ #  Q@5T &
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MZ+H9964@KDE2  5'  Z>YR 5?$=W>+?WL4&HS Q:>9(;6S $D;Y;][(QXV\
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M,ADDM$5'B#GJRAE)4GV./:K.H>'8-2T2ZTJ6[ND2\4K<3(4\R0$8.25('''
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M8O()+LJ94VQO&2J! =I7@X7J,?H,6='T:VT6UDAMVDD>>9IYYI2"\TC=6;
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M'Y8W*8U8JWRX*\] ![YH [>BO+6O]<3X>7FO_P!OWK7FGWTBQYVA)%6?9AU
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MA&2K-DE2".&SS^5 '6T5YSH"^)-1\"IKMOK-Y=ZD8YXX[9W18Y,3$=U^_@$
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@#E(?A[ID%G9VBZAJAAL+D7%HIN1^Y(S\HP.GS'KDCL15Q/"5LC:NRZA??\
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M"+V]!T88M"&3@;=O/R\_+QS_ #YH P+:?4+6T\:Z8NJWKC2QYEK<2R;Y8]T
MDV[F!R >E,DN]3FM/ >S5KN$ZA$BW)1P?,_T<L6.1R<^N1WQ71_\(G:>;J\G
MVV\W:PFVZ^9.0%VC'R\?+Q_]?FF_\(A9^5I$8O;T#1L?9"'3*X7:,_+S\O'-
M &'9W6LV!\9Z9I]U<7TVG*DEA]J?S'5I(=^W)Z@'H#182W=_K7AU]*U/4);2
M6T:74\RE@K!5*;MV=K%BP*C'&>.*OZ[X>-GIVOZA8QWFH7>JPB.XMQ(HWK@)
ME< <JA. ",X]:SM'L)3=VK:1J7BP-%*GF1:HK+ (P1O5O,09.W(&TDYQVYH
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M>:O##MN[U(TF?U" @?H>?H/2@#EI=9O]*U_QG,;F:ZCT_3H;FW@E;*(VR1B
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDL,YP.1CL0<+;Z7K*Z-XETBVN+W4=-ETMTL7OHBDRRLCCR@6 + <<D<9QZT
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MO?C^^!VH -$UO1(/"_\ :5K<7)L3/(JM<;VE9S(1M .6)+' '7I69::A)/\
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M(3"$A9&+#;Q@D5/>/J=OXF\67=AI<]Q++IL*VHEM7\J9T#[ER1@_>'&>>@H
MZ:R\2V5[?I8^5<03RVWVJ%9H\>;%D#<N"?4<'!YZ5SFJWMA>?#SQ+=:/<WZ>
M2]RS/)+)&Z3#E@,D,%!XV\#VJ'3?M3^,M%U,:;K+Q/I\L,T]U RE9"4/*G 0
M<'@  ]LU7CM[QO ?C&V_LZ^$]Y?7CV\1M) TJR'Y"!CD'].] '>Z42VD6;,2
M28$))[_**S3XOTL31C]\8)+S["MT$_=>?G&SKGKQG&,]ZT-'8MHMD2DD9$"
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MDS3V[1AMBOG[V"#\PX(S0!V%%%% !1110 4444 %%%% !1110 4444 %%%%
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MU74M0%[+.VI2++*CJH"L!M&W'.,#'.:BF\7:?;O:O+%<+9W<XMX;[:ODLY)
M'7< 2" Q7!]<5#:ZSH\6L>(9HHKT7-DD+7VY'((VMLV(?8')  /!YH Z.BL7
M0O%%IXA*-9VE\L,ENLZ7$UN5B8$XVANA8=Q5J^U>"UNX[!(9KJ\EC:0008W!
M!P6)8@*,D#D\GI0!H45Q'@?58;;0M7N[A[CR_P"VKB.))BSR\N%1.<DMR!BM
MM?%NG)-J%O>I/83Z=!]IGBN%7/E?WU*E@PXQP<YXH W**RTUM'DFAGL+VW:.
M#S\-&&WKG'R[&;)]NM9^D:[HEEX1TV[L?M LKEEALXY"7ED9F(5?F)Y)SU/
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M*O!>VFH122P>7R%68N3GIT/K0!VMQXC@AFNXX;.ZNA92+%<O"$Q&S!3R"P)
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M,1"K(9 ^TYYZ=^F>*YH:9K,?PJAT!]%O/MMK<QC: I$FVXWDJ0>FT=3C.>*
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MV^E6JSS[V,DBQ11H,M*['"JH]2?7@=3@"@":UM_LMK%;^:\HC4*'DQN('K@
M?I4U8D7BBV674HM1MY]/;38A-,TP!0QD$AE9<@]",=<TU?%,4=Y807UA<V2:
MF=MK--M*L^,A&P258CH#UZ=>* -VBN3G\>PQ0:I-'HFIS)I,QCN]JQCRU"AB
MW+\C!Z#)XZ 5)?\ BBY3Q-HEA963SVFH027'FHR R*%&  Q& -P)[^G>@#J*
M*YRV\8I>:K/I]MHVI2/:W:VUPX1-L6X AS\WW>>V3[=,K:^,K6ZETP_8[J.V
MU5WCM+APH#,H)Y7.5!"DCCZXH Z*BN?O_%UO9075VEC=W5G93>1<SP*K!&R
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M[.NYAIENEQ>[-@\I6!; RWS$ $G''O4%[XGNE\3:-86=C)/::A;R7'FJR N
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M4DG<<8X& 3GG@@$]QXZ,::NT&@W\W]CR%;H!HUVJ%#%A\V#P<@#)]<<4Z_\
M%%W_ &_X>MM/LS-9ZI#)<"3>JM(JQ@@8/0?.#^%4(]+U@1>,T.D3YU4N;0^;
M#^\S"(Q_'QR,\XX_*B+2M;MSX,NTTF1WTJUDMKJ S1AD+1(@;.X@KE.Q)P>G
M:@#5A\7R76L76FVVA7\CV=U'!</F,",. 0Y^;D8.<#)QU I8?&$4DNFO)I]Q
M#::I<-;VTSD!MXW8W)U4-M..O;(%1>'[/4[;Q-XCN+C3I+>&^FCDMIGDC96V
MQJG(5B1R,].E<ZNC^)KF'0[J]T)Y=3L-3$UY<2741,RX<93GA!D?+QCLIY-
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MS++]FF+(RV[!&W<@YR5'ICGKQ5>X\<-&-7\C0;^<Z.^+D!HUPNW<6!W8/'(
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M]-C_ "2 ^VUL_P# :HZ9X2GTKQ=(]NW_ !)I(H[AE8Y8W2*8\GURI#$]V -
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBN=\>:Q?:#X/OM1T^-&GC0
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MHZA_9[13:?.]N]HTH+M(I VY QDY&/7(]:=J7BM+"6:V2*V>[M8%EGBENUB
MR"0BDCYFX] .G(S0!T-,62-V=4=69#A@#DJ>N#Z53T/6+7Q!HMKJUD6\BZ3>
MH88([$'W!!'X5A0>)+.TC\3WT.A2PRZ9)NNU4QAYR(PVX\X^[CN3[9XH ZRH
MIKF"V"F>>.(.=J[W"Y/H,USUIXP>;4M)M[C2)[:WU>(M;7#2*07";RI4<@8S
M@G\A63"&UKQKXEL=:TZ">QBM;:)EEFR(8V$C$CCN<$XP1M'/ H [RBN5_P"$
MPAL=&L]6?3WCT*5DC2Z\W+QH3M21T(X0\<[B<$9%27/BVZ77;W1[+0+J[N+-
M(I&Q-&@9')&X$G'&.AY/H* .CEC6:)XGSM=2IP2#@^XZ51T70K#0+0VUBD@#
M'+O+(TCN>@RS$G@=!T%84GCJ?[#J]W#X?NG31YWCN0TT:D*BAF8<G)P<X&>G
M49 JW'XNWZIID$FF3Q66K _9+MG7YFV;P"@Y4$#C]0* .CHKFKSQ>;+=<2Z9
M*MBFH"P:5WVN7+!=ZH1RFXXSG/?%,MM<U6;Q[J&DFS0V=K:Q.NV7YCN+?-C'
M4XQC/'KS0!TJ21R@F-U<*Q4[3G!'4?6GURFE>)M*MO#]]J4>F/8JNHR6[6R!
M3)-<%PO8XW,Q]<>^*OIXC>#6XM'U*P-O=7,+RVABE$B3[>60$A<.!@X(QCO0
M!N45QB?$)FTB/6&T&Z2P%T;:XE:5,PGS/+!VYRW.,XZ9ZGFNPF=HX7=(FE91
MD(A +>PR0/S- #Z*XZT^('VK3M*U0Z)<Q:=J,ZV_VAI4_=.SE5^7J1D<GM[U
M<UGQG;:8U^(8X;@Z:,W*O=+$Y.T,5C4_>8*0>PYP"3D  Z6BN<D\9V,L=O\
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M[T,C$]V.[:/H"?KV&?X!TZ_T?P=8Z7J5J;>YM5*,-ZLK?,2""I/8CKBNCHH
MY^XT^35_$I.I:67T^U@VVSNR,K2,?G8KG(X"@<=VZ9K,.A7NB^/X=4T32?\
MB77-KY%^L<D: L#E'"E@21T/MTKL=Z[]FX;L9QGFD,L:G!D4?4T <?;:!=7?
MC#Q%-J>DLVE:O;PP@M)&<[%(.0&R,YX(].U2Z/:^)M)T6_T.6%KHVT4B:9J
ME3,B[3Y:N"00P.!G&#C\3UH((R.11F@#BO%.DZAXOT%-,N?#YMK\LA6]::-H
M[9@06=&#;SP#@;1GOCK79L3'$2%:0JO08RWYX%*SJ@RS!1[G%"NK_=8-]#F@
M#A]+\+ZI/\+IO#5W$;"^'F&-V=77<93(ARI/&< _CUK:T*^\47KQ)K.C0Z:(
M1^^D6Y67SVQ@;%7[HSSR<\8YSD;[,%!9B !U)IDL:W$+Q%V =<$HV#@^A'2@
M#S7P[87WB/X26&@)8O''=#8]VSIY:QB4L2!G<6P, 8Z]\<UU%II^H0_$.\U$
MV#BPGL8[=)O,3AD9FY7=G!SCI6OHNC66@:;'IVGJZ6T6?+1Y"^W)S@$\]35^
M@#B='MO%GA^2YT.WTN"[L6N))+346N540H[%L.GWF*ECTZ]..M1^)/#=]J]]
M<75IIDMGK$$J"QU>"=$#)\N?-&[) ^88VG@#'6NZHH XXV_B7P_XFU*;3=*C
MU;3M5D6?_CZ6%K:78%;.[JIV@\9(J>2PUC_A-M+U*6S,\,%A)!<31.@42.RM
M\JE@=HVX]>G6NJHH \]G\-:U>>#O%.F?8?)N=0U&2[M1)*A$BLZL!D$X/R]^
M.1S6G>0>(;[Q!:W%SHZ3Z<]IM^RO=+LMY]Q.^0?Q_+CD!L'./4]?10!YU8^&
M_$%GX2\,6[::C7>B7XDD@6X7,D>'!8'IGY@<9Z?E6_'8:D?B(-7DL2MH=)%J
MTBRH0)/,WGC.2N.,XZ]JZ:B@#ECX;NH_',NH0LHTN\1)[J/^]<Q<)QZ$$-]8
MQ4-Y;>(M#\77NIZ3IB:M8ZJD7G1?:5A>"1%VAANX*D8]_P"O7T4 067VK[)&
M;WR_M!&7$?*J2<[0>X'3/&<9KCFT;6&M_&B?V:^[6 PM/WL?S9A\OGYN.>?I
M^5=Q10!Q<FF:NQ\'L-+E_P")4?\ 2QYL7R_NC'Q\W/)S]/?BIK71[Z;Q1XFD
MN[&6*QUBWA@CF$D9(V(ZL2 V1G?Q].U==10!P2^'];O? D?@R]LO+*".W:_6
M1#$T*.#N SOW;5Q@KU[XK7T[3]0M_'VIW[V#K8W5K##%-YB'F/=G(W9P=W'%
M=-10!P\6C:PNC>,;9M,D$NKS3O:CS8_F#Q!!D[N.1D^U/GTG5VB\'A=,E)TE
ME-T/-C^7$1C./FYY.?I^5=K10!YQJF@^)]0L;Z.XTF.ZO4U))X+M[I/WD"RJ
MRI&#]S"CD' [\DUOP:?JUKX[N-4^PI):WUC#&[K./W+H6)&#RV=W!Q]<5U%%
M 'G@\)ZS=>&+ZW^SBUOXM;?5+,2R*4D_>;U4E2<<9'UQ6Y+I]]K?B+2-7NM.
MEL8])CF?RI)(V>6610N!M8C &>21DXXZUT]1Q3PW"EH94D56*DHP(!!P1QW!
MH \^;P]KK?#>\T0:4XO9;XS(IFBVE3<"7.=WH,?7\Z] \U_LWF^1)OV[O*RN
M[/IUQG\<>]2T4 ><P>'==B^'>C:*=*<WEC>Q2RJ)HL;4EWD@[N<@X^OYUII!
MXF\/^(M1DT[1TU33M5E6Y&;I(7M9=JJP;.<J=H^[G'O78NZ11M)(RHB@EF8X
M  ZDFA'26-9(W5T< JRG((/0@T <?>V?B;1_$B:WIUC%JZWEI';WUNDRPLKH
M6*NA;C;\Q&.M&K:;XB.K:+XEALXKJZM/-CN=/CF5?W4F,!'; ++@9SC/M795
M72^LY+MK-+N!KE!EH1("ZCU*]: .0M]/UU=6\3:A)H,<D6IBU\NVFGC;S550
MKHPZ [2>IQD=^]SPIX>FT/5KYK2&YL='FB0Q6%Q,LGES9.XIAF"KC'&>3GL!
M75T4 <UXDTW4I?$?A_5M/M%NET^2<31F41D"2/:&R>P/7OZ U6TK3]7\-:EK
M<<&G-J%KJ5T]];R1RHOER.!N1PQ! R!@C/'OQ7744 8_A/0O^$:\+V&CF02M
M;1X=QT+$EFQ[9)Q6-9Z?K6F'Q':1:89SJEY+<6UR)D$2AT50'!.X8*Y.%/M7
M8TR::*WA::>1(HT&6=V 51ZDGI0!Q#>'-:\*W&CWN@6RZLMIIXT^ZMFE6%I%
M!W"12W .[/!['\NNTM]0EM/.U*%+>:1MP@1]_E+@84M_$>Y^N.<9JV"",@Y!
MI: .,@M/$GAWQ'JO]G:5'J>G:K.+I'-TL1MY2H5@X/)4[0?E!JT=.U9?'MGJ
M<MHT]M#I;6TMPC(NZ5G5B0I;('R_K^-=310!Y]%I'BBUT:YBM].D!EUV2\FM
MUN41KBU=BQ0.&X/3()&1QFDD\/:V(?%\,.BPPQ:S;(MJD,Z *WD^7M(X P>3
M^F:]"J.6>&#9YLJ1^8P1-[ ;F/0#U/M0!R,VF:M)J'A"X&F2[=+5Q= RQ93=
M%Y8Q\W///';WXK'^S:A=3:PL'AJ?4='O]0>5EM+^%(;C:0"2KX;)9/FP<$CN
M.OHPGA-P;<3)YP7<8]PW!?7'7%8-IX2\/;Y); SI"TC&2"VOY5@+Y^;,:OMZ
M]1C'M0!F73:U_;5EXMT#3#?V][8+;W-A+*L,J ,65@6.W(W,",_3UIVLZ;XB
MGOM#\20V<4U[I\LWFZ<DP'[J50I57. 6&T'G ))[ 5V*(D4:QQJJ(H 55&
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M*&=(?.AE>2(-Y@6$ 9&#D9&?:NJLM6UN:!8KKP[-;W>,,_VB(V^?4,&W[?\
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M#!XCE&N2Z)?6 @OOL_VFW$4WF)<(#@X8A<,#U!'OS639^.[^]\/MKT?AF;[
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M3Q,L)D4+#''M"AFSC.%).,\G'.,T ;UKXDN'\3KHE]I3V?GV[7%K*9E?S I
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M4V>K03*O[H,,B0 Y;C<-N#GCD9-='XFT5?$7AN_T@R>5]JB**^,[6Z@_3(%
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MUA"%\8W'J3^))K3H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***QO%FO2>&?#MSJZ6?VL6X
M!:/S-G!(&<X/<B@#9HKG)O$UW9.L6HZ?!92W,YCLQ->*%= NXNYQ\F.F.>2!
M[U0E\=7::/K%W%HZ7,^C,#,D5T?+EB(SYD<FSYL '(P,8/- '95%!<V]T'-O
M/',(W,;F-PVUAU4XZ$>E9_\ :\TMSIT5K;PW"7D#3O(LY 1 %Y'R_-DL ,X_
M2LC3?%=G%HNHW\FFPZ>T.J269A210)9]X3<S8 Y8Y)[ 9YH ZRBN5C\7W<E_
M>Z?#IMO=W4%I]JMVM;LO#. <&,OL^5_08.<CI48\<LUEX<O5L(/L^NND6\W9
M'D2,"0N-GS=".W/'O0!UU%4+*_N+O4+^!K:-+>UD$:3+*6,C;0Q^7:,8W =3
MSGTJGK&MWEA<S16^G*\<%H;E[FXE,4.<D",-M/S'!/L,=<T ;=%<FWC9Y+?P
M]<6FDO,FNCY,S!3$VPM@\<].O']*?;>-!!:ZX^MV0L9M$9?/2&7SE=74,FTX
M7).<8('- '1RW=M#/%!+<11S3DB*-G :0@9.T=^ 3Q4U<)K+W\OCKP?+?:=;
MVY:6<AXYO,9?W+?(WRCZ\9'7\>MUG58-%TN6_N%9U0JJHGWG=B%51[DD"@"]
M16'_ &[>V5[<1ZOI@MK2&S:[-[#*9(E"GYD8E5PP'/N*IR^+[BSL]-U2_P!-
M6'3-1=$$JS[I(/,_U9D7;C!R,X)QGO0!U%%<L_BK59=2UO3[+0XY)M)$;9EO
M-BRAE+=0IP< 8&,=<D=X8O'%Q+:Z)J?]C[-,U::* 2M<#S8Y). =@7!7/&=P
M/?% '7T5S#>)]5FU?6=+L=#CEGTM8F#2W>Q90ZLW920>.!@]\D=ZL/CJXFT_
M1M7_ +'V:7J<T4!D:Y'FQNYP#L"X*AN,Y![XH [&BN8U;QB+-M16RBM+AM-X
MEBENQ%)*VT.5C7:=QP1Z9/%,'C"ZNM6L[#3]',OV[3OML+S3^5CE1M<;25QN
MY/)]J .JHKA-4\::G+X*DU*SL8[6\BO_ +!=1O.3Y+B41MM(7YNO7C&<\XY[
M>!IF@5KB-(Y<?,J/O4?0D#/Y4 245RDWC25=!?Q'!IHGT:-SF19L3-$&VF4)
MMP1D$XW XY]JEG\57K^(CHVFZ5'=,^GB]@G:Z"(ZEMHS\I('7ID]..I !TU%
M9/AG7/\ A(M$BU!K8VLA=XI82^[8Z,589[C(ZUG7GBC5!X@OM$T[0A=7%M;I
M.CO="-'5B1R<''3CKGVZT =/17*6/CRTOM'L[HP+:WES</:M;7,P1894!+AG
MQT '7'.0,<\5;OX@RV>BZU>'2DFFT=D#B*YS#,C_ '723;S[C'&* .T)"@DD
M #J36-=VF@>+HT1[B._6RG60"VO&'ER#E2?+8<CMFN>\<ZCKK^"M5,NEQ641
MEBC5S=Y=XFD0?="G!.2I!/'/)K8-Z+;Q EI;Z79C7;RV,MPR3'8D*-M4L^P%
MN6P!M]><"@#HE4*H49P!CDY/YTM<=>>/7L] U>]?2LWVC2B*[M//X&<;75]O
M*D$$< ]>*GU#Q5J^E/:_:_#NV.\U".T@*W:EBKC(8C'!X(QG&>_>@#JJ*Y:+
MQ-K4NKWVBC0H!J%M$D\?^F_N7C;(R6V9!R,8"GZXYJ73_%<^JZ!IFHV6DRO+
M?S-"\9?Y+8J6#L[@'Y04(!QSD=,T =)17&S^/GA\+:QK"::D\ND736\T<=SE
M'QM^=7V]/F'&,]:TH/$5X/%,.C7^EBU2[@>:UF6<.6V$;E=<?*<,#P2/>@#H
M**YN/Q1>W5K;:EI^CM>:;<7/DAXY29MFXKYNS;C;D9^]G'/'2H=5\;+9)?R6
M<%M=+ITACEB:["32D %A&FTYQG')&2"/<@'545!;W<5S8Q7B$K%+$)07&TA2
M,\CMQ7+CQY&QTZYCMH)['4)EB4PW.^XB5ONR/&%X7UYR,CZ4 =?17.Z?XGFN
M+[7+.^LH;*72 ';_ $DN)$*E@_W!A<#WQ@U(VN:J%M4;1T@FEM&N9WGN"(+?
M! $9DV<MSTP,8)YQ0!L7-W;6<8DNKB*!"P4-*X4$GH,GO4U>?>)=7@\3?#C3
MM:2V\KSKRV94<AC&?/56 /U!Y[UTT.O7$WB:_P!#^Q1A[6U2XCE\\XD#$@ C
M;\OW?>@#;HKF=+\676KZ!IFHVVCN9=0G>(Q^86CMPC."[N%Z?)QQU('O63K'
MC>^D\"ZYJ6G6\$=WIMR]G(PGWH#\H\Q"%^;AP0#C].0#MY;FW@EBBEGCCDG8
MK$CN 9"!DA1W.!GBI:YS4M7DM=:T"TO]&MWEO9Y$283!Q;,$8Y7*@DE1[=32
MR^);N==3FTC3H[R'2Y6AE+S^6TLB@%U0;3TSCDC)R/>@#HJ*Y1O&_P!HN-!7
M2].-Y#KD4CPR-,$*%$W%6&#WX)SQ@X!X!2+QN8=&U6[U.P2TN=*NUM9XA/OC
MRQ0*^_:,+\X).,@ \4 =916?IE]=WCS"XMH4B4(T,\$WF),K \@X&,8Z<_K6
MA0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 -D021LC%@&&#M8J?P(Y%4=&T/3_#]B+'
M3(7AM@2PC:9Y "3DXW$XR236A10!FPZ!IUOK<VLQ12B^G4))(;B0AE'0;2VW
M [<<5I444 %%%% !1110 4444 9M]X>TG4]3M=2O;))[JS_U#L3A.0>F<'D
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M1P">G;H.LB,AA0RJJR%1O53D ]P#WI]% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ5S<630^;Y4:D;9,X<'=T&/KSTX.,#1K#5-%:?09_"D=\1/(UIJ9$9B:-V+
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M:SLHE;:P8EL$@9Q@#/;GK@;T6IWDD]@AT:ZCCNPYE=W3_1MHRN\ GEO;..]
M&G7!:AK=_9^-[#67F/\ 8=Q.^D%>P?(Q+^,BLF?1?>NLUZZOK31[B33;62ZO
M"A6%$ X8]&.2!@=?PKGM=\%6%UX*N+"VCOVE%M_HZ&ZE8B4#*G:6VYW8S^-
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M#^O+8:9)]KA"QQ200?>*L6#;V5 QQQGUS7165M?0^*O%=Y)IUQ]GO8;=;9P
M?-*1LK8YXY8=<4 =-IFHV^KZ7;:C:,6@NHEEC+#!P1GD>M<NFNW>N2^)]-N]
M-FAM[)3$K"1,+^[W98ALY.1TR ,>]:?@>UNK#P9IEE>VTEM<VT BDC?&01]"
M1BLN&SU2PU;Q8#I<\L6H8FMYHV3:_P"Y";>N=VX>F.^: (/!WB>*Q\.>&-/N
M;"\2*\MX[>*\95$32[,[>N[G!P<8/8UNZIXJM],BO9UL[FZ@TXXNY8=F(^ Q
MP"P+$*03C^?%<S_9>JIX4\&6G]EW+7&EWMO+=Q@+F-41E8YS@\L.E3)9ZCH?
MB+5(9?"W]M6NHW1NK6ZC$68V8#<DF\_* 1UYZT =HNH6SZ8-2CDWVS0^>KK_
M !)MW C\*Y7P; OBS1E\2:Y&MT]^[M!;2_/%;1!BJJJGC/&2V,G-=7%;;M.2
MUN(XN81'(D8PG3! '85ROA.TU'P99/H%Y:3W=A!([65[;KYF8V);8ZCY@P)/
M(!!S[4 6]+O-!TJ[UB:WUF-X(HUEG@:<R?9 H;=P22JXP0OKG%6E\50)=6$5
M[8W5E'J1VVDTP7:[D9"'#$JQ'(!^G7BN:;PIJ6M1^-2\+62:YY(LS,0&.Q,9
M8 DJ"?7G':KUU::CXGL=!L[G39[&:QO(;J]:4#:AB!X0@G=N;&".V<XZ4 ;6
MG>)H-1NM5M1975M-I3 3K/Y8SE=P*X<\$<Y.!2KXB26&T\G3[IKJ[@^T+:N4
M5TCXY<EMHZCC.?;@XR]<\/WLWBVVO;$#[)J,!M-5!/'EJ=ZG'<D;TSZ-4/B:
MQO[/Q7:Z]!HG]M6;VGV2YMD"&2+#EE=0W!ZD$4 6O^%@:6=/L;Q+2]=;R\^P
M[%C4M#-DY1QGKP>F<T\>-46\L[&;0M5AN[U)6B@>--Q\LX(SNQSQSG&#UK-U
MNSU&ZL]"EM]!:#R=8BO)+6 )F&)58$L00I;D' SUQSC-:&K6UY+X]T*^BL9Y
M+6V@N$FF4#"&0+MZG/\ "<XH 23Q[8P^&;S7);"^1;"X:VNK;8IDBD! P?FQ
MCYEY![U8D\7QPZP-+ETC45GFB:6T^1,704@$+\WRGD'Y]N!UQ7*:CH^L7'A7
MQA8Q:3=&?4]3,]JIVCS$)CYSGC[AZX[5T>HP7ESX[T#4(K"X-K;6]PDTA4 1
MF0)M!&<_PG..E %NQ\6V5YI5U>RP7%J]I<_9)K:4+Y@FR $&"022RX(..:8W
MC"VAO;RQN[&[@N[2U^V>3\CF6'."R$,02#P02/QKF;C0-9O;#Q"(-.9+AM93
M4K-+G;Y=RJ;/E//&=AX..HK7MY+O4-)OGC\)-I+&SDCV.D?FRR,,!4VG[OJ3
MCM[T 6K/QQ:74FD%M-OX+;5P!;74J*(RY7<$/S;@< \XP>Q(YI^A>(;W5/$6
ML6$^G2PPV,R1(VZ,A?D#9;#9R<CH"!Q[U@G3=4'AKP7:_P!E71FTJZMWNT 7
M,:I&R,>N#R1TK:T.UU"P\8:^9K"7[+?S1SQ709=F!$JD8SNW9'3'X^H!H:UX
MCM]#NK"WGM;J4W\WDQ-"@8!L$X/.>@/051B\9>=-?V<>@ZFVH6!4RV>(MVQA
ME7#;]F"!TW9SV--\76MY=:GX>DM;.:X2TU$7$[1@81 C+GD\\L.!3-.@O+7Q
MWK^H2V%P+6XM[=(9 H(D,8;< ,Y_B&,T 78?%MA=Z?I-U9Q3W!UC/V6)5 ;A
M2S;B3@8 .>?IFJMQXZLK;P_<:R^GW[16=RUK=QHL9>!U;:=V7 *Y(Y!/6N?T
M6T\1Z5X6\,Z=)I-Z;:!I8]2M[>1%E/4QX.X?)D\X(Z<\9!U_">B3II^OZ5JF
MDFVM;R_G=4W*4>*0# 7![#/8>V>P!T,NJK%J-G8BUG>2[C>0,FPK&J[<EOFS
MU91P#UJ_7)^ ["^@L))=2G6XDMRUA;2C^*"%V4-]6.<^NU:ZR@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>^<L2%'0#KSVS0!W=%8%MXPT^\T33M3@1\ZD2D$#E4;<,[@Q)P NULGVXR2
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M$-E=M+.Z.@"*8V0<,P)Y;M65;V.N:*_B72UTB:^M]5GGN[2ZADC"J95Y1PS
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MMDMUN0C=E\G&[=T?T[5GMHFL:IX M_!M[ISP31B&VENPZF'R8W4[U.<DE5
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M>".1225MMI()('8GK5O5_">IZW+K.K0JME?3_9OL,4S X,#;P7VDCYFXZG
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MLK&;1X[[2VO5N-2AB@D^7;!,2=K\G.1SC _*H/"]EJ-GK&ORWFGR6\5]>^?
MYDC;*[%7D*Q(/RY_&G>,M/O]1_L46%F]Q]DU6"ZFVNB[8TSG[Q&3STH ;:^(
M[Z7QGJVF36+)9V$$+B0.IQNWDN1G.#M  &3QSUJWI'B"35Q93Q60^Q7T)EBN
M$F#[<8PK@#Y6YZ G&",U06SU:R\;ZM?0:<TUOJ%E"L4_F(%C>,/E6!.>=PQ@
M$>XJGH7ARYL?$EKJ5AILVB02Q.=3L_.1H))"!MV*K'!!R<X' ]2: .FU?6+?
M1X(7G(WW$HAA0N%#.03R3P  "2?0=S@5@2?$*UAL]9=[%Y;G1E5YHK:9)%=&
M&0ZN2,CUXR/2KGC'3-4NX=/U'14CFO\ 2[KSTMY6VK.I5D=,] 2&X)JEK$?B
M'Q!X/U6W?1!93W5N8(+3[1&[ECU9FR% Z8 )/7\ "U)XPEAU6RL9=$NU_M&)
MGLG#H3*RJ&*D9^3@YR?QQ4;>.%@T76+VZTBYCN-&DV75JLB,0"H8,&R 5((]
M_:F7FGZI/K_A2]339?*TY9OM69(\H7BV#^+GGT[?E6)XAL-0M='\>W=U8O#;
MW\2R02%T.X+&$.0&)!R,].E '0P^-#_;=CI]]H]W8PZD#]BNI64K*P&=I .4
M)'3/)]!6;X<O;#P\_C*]G"P6EKJ;.P1>G[M. !W)/3U-7'T^\\02^'6FL9+.
MWTV1;N221T.]U0JJIM).,MDDXX'KTS;CPGJFKZ5XMT^:W:R;5+P7-I*[HRG:
M$VYVDD9*>G0T ="?$DEKJ=C8ZII[69U$$6LGFAU+@9\M\#Y6QZ9!P>:9I_BL
M7EIK,T]D;231Y&2:*649.U=V[@<*1T/?FJMS8ZGXFN=";4--?3AIMTMY<%Y$
M8-(JD!4VL202V<G' ]>D6L:')/X[LY+694@U"W_XF<./]8D+*T;?B6V'/52:
M -&X\4" PVQMHH[][87+V]Q=+$(E)( +$?>)!& ,<')'&:]GX[TW4-*L+RUP
MLM^9%CAN)5CV&/A]S<@ ' XSG<.*@UFTUW2_%W]NZ1IJZK;7=JEM=6OG+$Z,
MC,5=2W!'S$$5'K-AXE%UI/B*SL8+B]M/-CN--$P4-#)M^57.!N78#GH3GVH
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M5K-K=>#KQ=*DE.F6<MK=1"6,&-FC10V=V"N4/3)QVSQ0!J6WBZXO=8NM.M=
MO)#9W:6]S(9(P(E8 [_O<CG.!DXZXX!6#Q@))M+,VFS06VK3/#;2.V) R@D;
MT(^4,%.,$]LXJ/P_8:G::_XCGGL7MXK^=9K:5W1@<1A.0K$CD9^E<_#HGB>6
M/0KJ[T19-2L-0$MY<R7D9:<;7&Y3SA!N'R\$= M '47WBEH(;ZYL=,FU"WTZ
M7RKEH6^<L,;A&N/G*YYY'<#.*A3Q%?R^._[&73W%HM@MQOW*"=S[=Q!.0!M(
MQUY/'2J&GVWB?PYJ^J6=II$>H6.H7DEY;W1N5C$#2'+*ZGYB >1M!_PN2:?J
M<'C^/4/L;W5I<:4EG)<(Z)Y;K(S$L"<X(;C //'O0 ^?QI'%I3ZXEA)-HT<I
M1[I'&_:&VF0)CE <\YS@9QBB_P#&$D&M/I-AHMUJ%Q]B%Y$8Y(U65"VW@D\=
M^O/MS6/9:!KEIX&NO!;61DRLEO;ZAYB>4878G<PSN# ,> IY Y[C2L]'O;#Q
MW;W,5C*VFPZ.FGK.9(_O*^X$C=G&.,XZ]N] &YK&JIH^@7>JS1D"UMVF,9/)
M(&=OUSQ6!<7$6F?#F34]8L6U1KBU$]_&NW]X6&2/F(^5<X [ # K9\5:7)K?
MA74],A_UMS;.D>>F['R_KBL6^CNO$'PJ^S6%NTUW=V"P^5N52DF K!MQ&-K
M@_2@"]=^)QI^I:9I4.D7$SW]N\D'EL@7Y%!*\GC&1R<#Z]*;9>,K>?1[J]N[
M.:UN+2\^PR6FY7<SDJ%12#AL[EP>G/M56?3]4E\4>&;\:9*(+"VFCN3YD64:
M14 XW<XVG./UK)G\+Z[=66N&&U^RWAUE-4T\S2(4D*;,*VUB03M/7U'O0!U"
MZC)J%U>Z+J>D/%BV\W>?WL$J'(QNP/F!ZKCWYKGO!VN#1O 7A1)+9I8[]TM
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MR.2%^7&2N1C/'T(P3O\ B*&*X\-ZE%-&LB&UDRKC(/RF@"_%+'/$LL4BR1N
MRNAR&'J#3ZX3PKXDGT_0O"EC<Z7(EG?6T5M%=F5<^9Y60"G7:=IP<_A6KJ?C
M"33(KB\ETN1;"VO4M'EDDV2,25&]$*X9<L.=PS@^E '34A.!D]*PKSQ*\>H:
MA8:?9QWESIT2RRPM<>7(X89&Q=IW<8YXY.*V;F&*XMI(9HUDC=2&1QD,/<4
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M9+ F.:,#:P(/]Y1^%;=AIEIID)CM(BH8Y9G=G=SZLS$D_B:MT <O?>&[_4_
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MB>)E0'#XP&R@([?RKJ-)EU2X@:XU2VCLY'(V6J2"3RP/[SX&23Z<#CW-:%%
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M1L#.>G;DBGP^,)6UN'2VLK>9[J%Y('L[P3+O49*.=HV''0\@\U5U#PA<:_\
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M9I9C2[@7<Q64.)I54A0F/X<L3\V#P!CN,UO#NM2>&?%6FFSC$VKW<\UL?.&
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M;.XNH(!_!<NNV1OR'_CYJ";0;S4/%&NM<VS1Z?J>FK9+,'4G(WY.,Y_CX^E
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MVNMV:Z=)H@62?9-YR-&REE93M!R<$8QUK"L/#'B"UT+PM8RV<#2:+>>;+LN
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M;7==UR_43&SU!["RCD&5@1 ,E1V9MV2>O&.E;MS8Z5H5Y=^)6"6JI:,+HHN
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MX=WESQK(FX8.&&1D=CS4U1P))'!&DLGFR*H#28QN..3CMFI* "BBB@ HHHH
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M]=10!P#>%/$+?#$>%VBL?M,7EQQR"=MC*D@?<3MXR!C&#]>PV9M(U.S\7?\
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MCM0!WM%<'I4%OXH@\4/JP_TNVU">WB<G#VD:*/+,9_A_O9'4DUF:?)=:W=>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MID6F&P3[%"^^.#<VQ&ZY SQSS]:-5\+:%KCP/JFF0W;VXQ&\H)8#T)ZD>QH
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MPMK[QGX0DU+3K9KFZM;EKI7A4[F$4?!R.<$G&>E=3_PCND?;)+H6*"2602R
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MSPRD/<$E2L1+?*%)X/\ LY%1W-U>Z'<^.38+#:SQ:?;SQPVGW(G*ON8# ^;
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MS)!XC2!?-4-MB^TN-N3VP ,>@%;MSH&C:C\3GLI[*&2S?006A481B)\#@>@
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M:Y<+%X5U+Q3 @C74KF#?.L?S"R$BIGC!(9=S?1_:@#OTD23.QU;!P=IS@^E
MD1G9%=2R_>4'D?6N#U&QATU-0UW1-3@:^DT>816]A$JQRA1E9" 3DJ2 #[@4
M_1]/TB]D\/ZY9ZM;HZ#;$MK$%>XW+\R2<DMC!)SR"": .Z)"@EB !R2>U8'C
M'7;O0O#<NJ:<+>5HI(E82Y(P[JG&".?FS3O%UG<W^EP6]E=V\%W]I1X$N5+1
M3LN6\MP.Q"D_@*XK6[R.X^'WB*UETG^R;^+4;;[9;HX*>8TD.&0CLR@'UZT
M>HAU9F56!*]0#TI!(AD,8=2X&2H/(_"N,2SL=#^)\7V*!+:*XT>62Y"#_6%9
M5P[?WFY/)Y.:PK=[2.3P9?V 2&VFOY/*EF<-<S(RN6:1A@<GJ.>V3VH [#3M
M;U.]U[Q%IC1VH.F>3]G(#?-YB%OFY^G3%6?!^LW'B#PI8:M=)&DUU&7=8P0H
M^8CC)/I69H)'_">^,?;['_Z)-/\ AE_R3G1?^N!_]"- %K3M=NY_%NM:5=BW
MCMK"*"2%UR&(DW9W$G'\(Z5OE@JEF(  R2>U<*-)T_6/'_BB'4+6.ZC6RM/W
M<HW*"5DYQTR.QZCM61H5]+<:?\/K._8R6%S%,)/,Y625%Q$K>N.< ]P/2@#T
M?4+F6'2;BZLS$\D<3/'O)*' SSBJOAK5)M8\+Z=JET(TENK9)I @PH)&3C)Z
M5S4,#:?XK\465BNS36TU+B2)>$BG8,#@= 649/KUK,TZ["Z9\.].NR!IMW Q
MF#_<DD6(>4K>OS$D#N0/2@#KM'UR[O\ Q7K6ES+;FWL8[=X'BSEA(')W'./X
M1TI=7UF^L/%&A:=%' UKJ4DR2LP.]2D;.,<X[#UK+\-6MK9_$?Q7%:Q1PJT5
MFY2, #)63)QV]?QI_BZWAN_%WA*VN!NCDN+D,F<;AY#<'U'8COG% '4S/+):
M2M9/$9BC>4S\INQQG';/7%):/-]BMS=O";AHU\PPYV,^.=N><9SCVKS^"PM+
M>S^(.E0P1Q6,'[R*!!M2,M;!B5 X'(SQ3'L[>YMOAN98PQ>)(V.2,K]ES@X[
M4 >C^=$$,AD38#@MN&!3Z\]TWP[HTWB?QAILFG6YL85MY(K78/*C=X3N94Z!
MC@<@9%=!\/YI)_ .BR2N7<VB LQR>./Z4 = TB(RJSJI8X4$X)^E*65<;F S
MTR:X/1[>S\01>+H]<BC>YBOYH6,H^:"!5'E%2?NC&6!'?)K(L;9]:F^'TFN0
M^=<75K=+.9,YF01?+N]<C!.>N3ZF@#U!R[0EH"A8KE"W*^W3M6-X.UV?Q!X7
MLM2O1#%<W)DRD60ORR,O ))Z 5K65E;:;90V5G$L-O H2.->B@=J\FL=/LH?
MAEH.LQP)]OBU.,QW/5U!NF4J#V4@G@<<YH ]>>1(\;W5=QP,G&30SHGWF"\$
M\G%<#+%;>(/$7B?1]5NK6*52J1)<0AF6W,2X:,DC'S%CD=#CVJ Z)IM[XQT"
MTN7.I6\FBS(\TW6Y52@5F]>.?R- 'HAEC4@-(H)&0">HI7D2/&]U7<<#)QDU
MYQKUN=!FU"\:PMM5\/*\*3HG%SIIC1%&S/WE&%8#_:)[DFS)';>(?$/B;2-5
MNK6*52B1)<0AG6W,2D-&21CYBQR.AQ[4 =%J6LWMEXOT72DC@-IJ*3EV(/F*
M8U!&.<8.?TJ.\UC5+S5]2TK0_LB7.FP12N;M&997DW$)\K#:,)UY^]TXYR&1
M(?$W@:)+R2\1+:[5+B3[TRB),,?7(YSWJ30--L%^)7BAELK<-#'9-&1$N4+)
M)N(XX)[^M '91-(84:9523:"X4Y ..<'N*5)$E4/&ZNIZ%3D5ROCBZ:*Y\/V
MTW&G7>II%=Y^ZPVG8K?[);&0>N*HWE@EMX\O+*RMT%C>Z*\M[;*@\LR!]J/M
MZ;B,CWV^U '=53M]4M+O4;NP@E#S680S@<A"^<#ZX&?Q%><0&U/@;X?.QB,P
MU&T"$XW8^8,!WZXS^%;_ (<LK&/XC>*Y!;6Z2I):F)O+4,I:'+;?3/.<=>:
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M=R>62N<[.R@]0!Z#BK44\,ZLT4J2!258HP.".QI%NK=Y%C2>-G9=ZJ'!)7U
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M"DJHZR*&&<,I!4CW! -+/<06T?F7$T<29QND8*,_4TK21H@=G55.,,3QSTH
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M&EVDM[%C9</"I=<=.<9X[>E3QZ?9Q7\U_';1K=3HJ23!?F=5Z GVS0!G^(B
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M>3-A%');U_ >M,OK"SU.V:VO[2&Z@;DQS1AU/X&H['2=.TP'[#90VY88)C0
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M]TK3]2,9O;.&X:$DQM(@)0GK@]J9<Z+I5Y:16EUIEG/;P_ZN&6!61/HI&!0
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M^EZ?)?+?26-NUTL9C6=HE+A#U7=C..3Q0!Y9<6EK_P *?U)1#&!;ZPPAP/\
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MAHV!!;J00 ,>P]*F5M(U:;Q3H_B/66L)3>OYD4C0H6@P/*=2ZD\*!C!X/UY
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M\LAYU!#8SMY/7'.*S;7Q-I^OZ)>W&DZM;6[1^8BW$A5A%@E1(5)'RDC(SU%
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MIL\J10ZA:R2.&942926"G#$#/.#P?2EM=3T^_=TL[ZVN60 NL,JN5!Z9P>*
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M=1E:YM6DVSRS^:6C* $,V1M QV&.E:VDSVR?$CQ/:W$D8>XALPD3D9E&R3.
M>OO73G3[$WHOC9VYNP-HG\I?, ]-V,T][2VDG\][>)I2AC\PH"VW^[GT]J /
M*[>7[+\.].D11_9T/B,F_"CY%MQ.^<C^[G9QZ5U6H6PG^)FE2V:HZ2Z=.-1Q
M@J\65\K=V/S%L>P-=1#86=O$\4%I!%')]]$C"AOJ!UIMOIEA9P/!:V-M!#)]
M^..)55OJ .: /*[6VT^+X2:1>QQ0+-'JD;+, -RD79'7K]W]*];EBCGA>*5
M\<BE64C(8'@BJO\ 8^E^5Y7]FVGEYW;/(7&?7&*MHBQHJ(H55& H& !0!Y3)
M;ZDOA^;1K6(M=^#+LW44CKS+&IW0J#_M1LP./[@]:Z6_^SZKX"U_6YH!MU&Q
MEFB$J#*Q+&1%U_%_8N:[ 11JSL(U!D^^0/O<8Y]>*8]K;26PMI+>)X  !$R
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M#@X].TR6\^((DM;9A&!@% =@-L"2/3D9^H]J9;7D,,GPUN[FX2.,6$H>61P
M&-JO4GOFN^_LG3<R'^S[7,HPY\E?GYSSQSS3AIUB(HX196XCB?>B")<*WJ!C
M@^] ''Z!INE7'C_Q;YME:RF&>TDC5HU;8?)4[E'8[N<CN*Y\ZMID^F>%KJSN
M+:SLUUT.EJ9=TL2DR[FE<G())Y'0;L9/%>HQ:?903M/#9P1S-G=(D8#'/7)
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M(0>@XXH X*^FTW2M:\>">U+V7]G6SS6UN=A?*.IQCID$9-2Z;?6__"R-+?\
MM"QD$FC/$JVK#8O[Q"L8.26/Y>N!7<C3; 2O,+*W$D@(=Q$N6!Z@G'.:(].L
M81&(K*WC$(*QA8E&P'J!QQGO0!YQO4_"SQDP8$?;[[G/K)7H^G$'3;4@Y!A3
M!'T%-&DZ:L3Q+I]J(W(+((5PQ'0D8YJQ%#%!$L4,:1QKPJ(H 'T H \NOS-9
M^'?B$-)38Z7RY6 8(0K'YF,=/EW_ *UJZQJ&AS^*/!%U8W-F81),(F1U&V,P
MD*/89P,>O%=O!86=L[O;VD$+2??:.,*6^N.M1P:1IEJRM;Z=:0LK%P8X%4AC
MU/ Z^] 'G=D-(UWP[?V.NZW+9W\&H2O<PH8EG65924*$J6)(VA<9X^4>E:NG
MZ=IL_P 0/%J7%K;R#[):EA(BGJC[B1ZGC)KKGT?2Y-174GTVT:]086Y:%3(/
MHV,T\Z7I[2O*;"V,DF=[F%<MGKDXYH \TTRZCC\*?#NYN)E2*.[VM([85?W<
M@ )/3IBNDM1;?\+=N'@$8\[08W8H!\Y,S<GUXQ^E=.-,L!;_ &<6-L(=V_RQ
M$NW=ZXQC/O3OL%E]I-S]D@\\\&7RQN/;KC- '+>#8+6_@\56LR1S0RZW=1R(
M>05*H"#^M4_"R7;747A.]1V3PY.7:5AQ-$!_HWXX)/L8AZUU=SI[6=E</H5G
MI\%^R8B:6+;&3_M;.<?2C1K"ZM8I;C498I;^Z</.T*D1K@ !5SSM '?J23QF
M@"GXY!;P)KH R?L$W_H!KF]4FL-2;P+&)8+F%KD*RA@RG%N>#Z]1Q[UZ"RAE
M*L 01@@]ZJG2=-*QJ=/M2L0Q&/)7"<YXXXYH \[U5WT^7XA)IJ%!&+.1HX
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M?EA5N6QV&)D7 ZX<GM6SX;U&?6]#FU_48C;RQV9M2)!C:R ^<P] 7&/^V8H
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MD\;0%=XE5@5*^N>F*XC7O&PO_ NI:OX>U 03VDNT?*K,5\T)DJPX!&2.,]*
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MP9')+,Q]RQ)_&IY(HYHS'*BR(W56&0?PJI9ZSIFH7#6]G?03RJ@<HC@G:>C
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MVL.KV<D]TN^"-9E+2#U [T 6SIUB5"FSMR%Z#REX_2GI:6T<QF2WB60Y)<(
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MZ^]-_L^R^;_0X/F^]^Z7GOSQ69JGBS2=)O=-M9[J+=J+'RVWC:$"EMY/3!P
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M6.,*&^H'6G0VUO;Y\B".+=UV(%S^52T4 %%%% !1110 4444 %%%% !1110
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MZQ8ZG+?W4-JX:1GP+>)AR)!@ <XP#SGD=#4?PYT_2]4^&-C;O%!*)K:2"<J
M6 9CN4GJ#T_2NU2"&,,$B10YRP50,GU-.5%0850H]AB@#C?!/VZY6/3]21M_
MAQGM#(PXFDZ(X^D1'_?RL&\=[C0_'\6EXGF&HK(T,1R7C B\P8'7*AQ^=>HA
M0"2  2<GWI%C1#E44'V% '*1:QH/B8_;/#[Q76J"QD2*:,8:V5AP'_NG=C@\
M]<< UA>&[SP[K6EZ#8W-U=OJNFRQ8TXG;)!-'\K$@ ':.2<\8Z\\5Z/'#%""
M(HT0,<G:H&3ZT+#$LK2K&@D889PHR?J: //;*YGTO5;(Z;>P:OHU]JKI]CE
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M;* ?(&CCYVESQR<XVXP2<5VL<,4,?EQ1HB#^%5 'Y4>5'A1Y:X3[O'W?IZ4
M>2VUW;I\/+#,V%L/$:M<LXV^2OVICE^!MX(/;&:W;S7-/L/'-Y)J^IR65CJ-
ME";"Z! BD5=^]=Q!'5LCU!]Q7?>6A4KL7:W48X-))#%, LL:2 '(#*#@^M '
MG3VVBZ?K'@2TLE\NS2>[:!;ELML,;%6^;G!;!'U%6+*33_\ A(_'Y+VV/+BR
M25Z&W&[\-W7WKOFC1CED4D=R*3RH^?W:\]>!0!Y9IVKPZ;IW@O4+Z]DATO\
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M.J1+=0 $M#BY)^8?P\=,]:ZO3KW3?^%GZ\\ES;#.GVX!=U' WEASZ#;G\,T
M;VIZII\MKITJ:]'9I=W$1MWC9#]J!(^1<YR&R!Q5O4-:TW2\_;;M(2$\Q@<D
MJG]XXZ+[GBO,+&^LU^%WA 274(,6L6^X%QE-LQ)SZ84Y^AKH!KNG:)XS\06G
MB.010:HL,EI+(A:.XB$81HQ@'.#GCON/K0!UUSK>FVB1/+>1XFC,L8CRY=!@
MEP%R2HR.>G(JCJ_B[2]*M=.N!,LZ:E/'% \?S*0Q&6R.P&3[UAS:GIUCXFT[
M3EMUT4/I?[B8PYE>/?Q;QJ00&& Q&">0 .]<YI]W#'\,_!TTC[([#68/M3L"
M!#AY =Q[8R/SH ]%CO[2X\21Q0ZT&D%F7.G*5.5+*1*>-PZ@?C4TGB#28;L6
MTE]$LAE\GD_+YG]S=TW?[.<US<M[;3?%>T,-Q&KRZ%(J;N#N,JLHP><XR<5@
MVTT4_P (KOPY= ?VW$)+=[)C^^:X,A96 ZG)(;<..ISP: ._O/$NAV%Q-;W6
MJ6T4T$?F2QF0;D7..1^/3K5RROK74K.*\LITN+>9=T<D9RK"N,LYH+?XI11W
MMU UU#X=CCD=G&3()"6Z]\9/TJY\,KBWE\)F.WEC<17MR"J,#M!F<CZ9!!%
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M9S(^P,W.,;N^,YH N:GHE[?>*]*U=);<6^GQS(87!+2>8 "<]!C:/6MX
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M6DB]CM#>*))I##&Q5@CR#J@?&TMP> <\&@#3HK%_X3'P[]J6V&KVYE:X^S
MD_O,9VYZ=QSTKG_$6JM'\/=8U/0_$5Q</#.S+<KL.W+@&,';]T X!'/O0!W(
M55S@ 9.3@=:",]:R['Q/H>I:G+IEGJ4,UW$-S1*3DCN1V8?3-.?Q%I,5Y':2
M7@6264PQL481M)_<#XVEN"-N<YH TL"A5"@*H  [ 5A>)]=M;'2=1BCU![>[
MAMF?S(8]_DG!*ECM*KG'\6*G\)W,][X0T>ZN9&EGFL89)';JS% 23^- &MBB
ML.UUK289M8O&U\3PV\B^>LCCR[0A<;00.^,GD\U-:^*M#OK^"PMM2BDN;B/S
M8D&?G7&>#C&0.2.H]* *^AZ'>:=K6KW]W+;RIJ4ZS*J YB*J$ R>O Z\5O,H
M8%6 (/4&L[Q!K=OX=T2ZU6Y21X[="VR-2Q8]AQT^IX%<[J_B&1=7\+WD>H2V
MUC=2RK=1.NQ&Q"S9.X!N#[XH [.EK.T_7]*U2RGO+.^C>"V9EF=LIY1 R=P;
M!''/-+9Z[IM_>O907!^TH@D,,D;1N4)QN 8#*Y[CB@#0HJ"[O;>PA\ZYE$:E
M@J\$EF/0 #DD^@YJK;Z]I5U9W%W'>QB&T8K<&3,9A(ZAPV"I^HH T"JE@Q49
M'0XZ4%5+!BH)'0XZ50M=<TV\N);:*XVSQ)YCQ31M$X3^]M< E??I5+_A-?#6
M(C_;%N5FE\E&&2-V<8)Q@#.1D\'% &[2;5W;MHW$8SCFL)O%EBOBJ302)%>&
MW$TDK1,%!+8 SC&, Y;I[]:?;^,O#EW/'!!J]N[RB0I@G!$>=YSTP,'\C0!M
MTFU=V[ W8QG'-9]EK^F:C="UMKG=,T0G1&C9"\?3>NX#<O(Y&1S36\1:2EY'
M:->*))93#&Q5O+>0=4#XVEN#\N<\4 :=(%5<[0!DY.!6)H_BFSUG6-1T^!)5
M-C*(MSQ.N\[<D\C '.!GKUZ5N4 %)@>E8WBR_OK+0I4TE=^IW68;-?\ IH03
MG\%#-^%2>&-;C\1^&K+58_E-Q$#(H_@<<,/P8&@#6K)\0:5>ZI;VWV#4!9SV
MMPLZ[XO,CD(S\KKD$CG/!&" >U<Q;ZGJS>#O&5P=5N#<Z;>7BV\Y";E6.,%5
MQMQCZ =:Z[0II+CP_IT\SEY)+6)W8]6)0$F@"I9:3?27D%[K$UE+-;$M"MI;
M&,*Q4J269F)X)&.!SSGC&R%4,6 &3U..M9MYXBTFPF,5U>+&5=8W<JQ2-VQA
M6<#:I.1P2.H]:DO];T[37:.ZG(=4\QUCC:0HG]Y@H.U>O)P.#0!?HK,N?$>B
MVD=I)/J=LB7N/L[>8") 1G(([8[]*@7Q=HDFF7^H6]V;B+3\_:%BC8NA SC;
MC//KT]Z -JD95888 CT(K L?&>D3:-IU_>W<=FU^B;8Y<K\[*&(&1R!G[W3W
MJS#XJT2YM8;FWO1.D^_REBC=W?8</A -V >IQZ>M &L0""",@]0:  H 4  =
M *I)K6FR:9%J<=Y&]I-CRI4.[S"3@!0.2<\8'.:R]7\;:5IWAZ^U:&1[C[&3
M&T*QL'67LKJ1E.W) H Z*BHK:YBNX%GA+%&SC<A0_D0#5&Y\1:39W/D7%XJ-
MYHA+E6\M9#T1GQM5CD<$YY% &D1D8-%<9#XD32/&/B2+6-6?[%;Q6KP)(H/E
M[E<L%"C)''7!X')KII-:TZ*UMKHW2O%>8^SF,%S-D;AM"@EN.>!TH NA54D@
M 9.3@=:6LE_%.AQZ8-2DU*%+4R&+>V0=X."NWKNSVQFI+#Q#I&J7\]C97T4]
MS;J&DC7.=IXW#^\/<9% &B55L94'!R,CI0RJPPP!'7D5E3^*=#MB#/J,<49E
M,0F<$1%QU4/C:6&#QG/!]*DOM?TO3D\RYNL((Q*S)&T@1#T=MH.U>#R<#@^E
M &B0&!! (/4&LOQ)I<^L>'+W2K62.%KN%H=[@D(",$X'6II];TZW2-VN=ZR1
M><IA1I<Q_P!_Y0<+SUZ5:@N(KJUCN8'WPRH)$8 _,I&0?RH @TNUDL],M[>?
MRS+%$J.T8X;:,9Y^E6]J[@V!D<9QS6.?%FAC3I]1-\!:6TODS2F)PL;]U;C@
MC@?B*MRZQ80R01S3F-KB-I(]\;+E5&6))'&!USB@"]30JABP4 GJ<=:X?Q#J
MDD'PPN=4T3Q#<W1CDS'>_*6D!FVE<[>@R0",=!S6GJUY>VWQ \/6L=Y*+2\A
MNC+;X7:2BJ5/3/\ %W/:@#IZ0C(P:YGXBWE[IW@;4K[3[R6TN($5EDC"Y^\
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M,S(>;>'80ZO_ '2257!YS]#7;T4 <;X)N;/^T?%+>;$&.K22[B0,Q[$ ;/\
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M.BP %LXQ@$$?7BF^-;E]+\0>&M8N5<Z59W$PNW52PB9X]L;L!V!+<]LUV-%
M'F.H2_VYJOC2+1BUQ)>Z5;B!HT;;-M5\@-C!R"!UYS6IH^I^%_$=Y8WEK;7U
MQJ-DDA9)Y)\V6Y"'#;CMYP%QSG\"1W5% 'F_AYKJUO=/TW1=535=(NK:4P+,
M ;C2L1_*&8<[<D+AL$<#M4_@_6]*N-"TKP[?Z>[ZUICHC64MN2T4B''G;B,
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MHW:Z@OE,3#O:55<C'.W=SCIFM_Q7<:?K?@+Q%>Z'9F1+B*-GN8X"IN64C/4
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MUK?RZY9R[6L6EGQ)(K$K*I!VA3][=T'/X^HT44 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !6;XANK.ST*[EO\ 4)-.MS&5:YB.'CSW7@\_@:TJ
MY[Q\1_P@NLI@EY+1T10,EF(P !W- %F;Q+HNG/:6ESJ($UQ#OA#JQ:10,YX'
M4^G4DX YJ6Q\1Z1J.ES:G;7J&T@9DED=6C\MEZA@P!!Z<$=ZY:XN('\5>!Y
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MN+J.*V"_/)(9FV,!W .,MT&T\\4 >CWNLV.GS"&>1S,8S)Y4,+RN$'&XJ@)
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MR/4#)YK$NM<L=9\=^%+W3_/FA$5X'<6\F$+)'@-QQSU]._6CP]=0Q:9XS9Y
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MO+.]EM9(KB %HV W*TJ*03C.,$],5E76N6.M>.?"=[I_GS0JEV'<6TGR%D0
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M[0]N;6593'TW*A4%AGC(S62?%6FZOX-@U.]O[O1HKEHR)8T9'!+ A5)4[LX
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** &N&*,$(5L?*2,@'Z=ZQO"F@S^&](.GS7R7@\Z259%@\L_.
MQ8@C<<\FMNB@ HHHH **** "BBB@ HHHH H:Q::A>V7E:;JATV?>K>>(%E^4
M=5VMQSZU+IUC'IMC':QN\@7):1SEI&))9C[DDD_6K5% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !11534=4L])@2:]E,:22"--L;.68]  H))X- %N
MBL$>-=!,EQ&+FXWVH!G7[%/F($9&X;/ER.>:MV7B'3=0U-].M9G>X2W6X(,3
M*/+;[K D '/M0!IT444 %%5;_4K/2[<3WMPL*,P1<\EV/15 Y8GT'-55\1:8
M;B"W>6:":X;9"EQ;20F0]<*'49_#I0!J4444 %%(2 ,DX I: "BBB@ HI"0.
MIQ2T %%%% !12$X!)[51TG6;'6X9Y;"1W2WG:WDWQLA#KC<,, >,T 7Z**S]
M1UNQTJYL[>[D=)+Z8008C9@SGH,@8'0]3VH T**H0:U8W.LW&D12.;NVC625
M&C90%)P""1@]#TS5^@ HHHH **** "BBB@ HHK/UK7+#P_ILFHZC(\=M&0&=
M(V?!)P,[0<<\<\4 :%%%% !129&<9YI: "BJ&M:U8Z!ISZAJ,CQVZ$!F2-GP
M2<#.T'') R>.:2?6[&WUJUT>61Q>7:N\2>6VU@HRWS8QQZ9[T :%%%% !161
MJGB;2]':07<L@6#9Y[QQ,ZP!ONER!\H/_P!?I5V^U"#3U@:?S")YD@3RXV?Y
MF.!G X'N>* +5%)D9QGFEH **** "BBB@ HHJAINM6.K3WD-G([/92^3.'C9
M-KXSCY@.QH OT444 %%%% !1110 4444 %%%4)]:L;;6+72)9'6[O%=H5\MM
MK!1EOFQCCTSGD4 7Z*** "BFR.(XV=@Q"C)VJ6/X <FJ>CZQ9:]IL>HZ?(TE
MM(S*CLA4G:Q4\'D<@T 7J*** "BBB@ HI,@]#TI: "BBB@ HI 0>AS2T %%%
M% !1110 444V1Q%&TC!B%&3M4L?P Y- #J*I:1J]EKNF1:EI\ADMIBP1RA4G
M:Q4\'D<@U=H **** "BBB@ HHHH **** "BBJ&G:U8ZI=7EM:2.TEC((YP\;
M)M8C./F SQ0!?HJK=:A!9W%K!+YF^[D,<>R-F&0">2!P,#J:M4 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-1U< 'C<,'CK0!R6NZU=:W\(]9FO0IGM[HVS,J%-^RX4!BIY4D8R/6M_7O\
MDH_A/_KC?_\ H$=5Y? 5U+X9U;0_[<S'J-VUP)7M06CW2!R,!ADY'7@>U:U[
MH%W>^(](UAM0A4Z:DJF(6QQ)Y@ 8YW_+]T8Z_C0!+XIUP^'M$>]2-9)FD2&%
M'.%+NP49]AG)^E4+G5M2T/Q+I5A?7"7MGJQ>(2>4$>&95W#IP589&.H]36IX
MBT*V\2:)/I=T[QK+@K(GWHW!RK#W! JK#H-W<ZCI]]K-[#=2Z<K>0(8#&&=A
MM,C98\XS@# &3UXP 8_A"&]_X2WQ09KT2JEY&L@\D#S#Y*X[\8XX]JU/%NK:
MAI!T=[)X1'=ZI;VDXDC+,4=L':<X!_ ]:ET30+K2M7U6_EOXKA=3F69HUMRA
MC(4* #O.> .U.\2:#/KT>GK#>I:_8KV*\RT!DWM&<A?O# SUH R;)]2?XE:P
MAOR\,%E;LD!C&-I,GR@YXY')[_@*/"OB>;7KN%'OTCNXT;^T-+FA\N6W?'&W
M/)4'C/.<CD=*TW\/7"^*9M:M]2\I+JU2"X@\G)8H6*E6S\OWN1@_45#;>%[A
MM6TO4]3O(+FZTN-T2>*W,;S[EVY<[CQ@DX]3GCI0!:\1:Q)I26,%NFZXO[H6
M\?R[MORLS-C(SPIQSU(K"O\ 6O%6F:5K\[P((K&W^T65W<PJ#( "61D5NH['
MI[5N^)_#R^(].B@2[DLKJVG6XM;J,9,4BYP<=Q@D$>]49_#.KZCX?O[#5->2
MXNKV V_G+:;8XD/7"!N6/J3V'% %*36?$<&JZ!$;JRDBUN)UV&W(^SN(MX;(
M;+]#QQ^%03^)=>L-+\60R7%I/>Z#MDCG-N0LB-$) "H;@C.,Y_"MB;PS>37>
M@7']IPJ=%#<?93B8E-A_C^7Y3[\_E6-XJT2;2]"\9ZO/?Q2)JMIDQ" IY;)'
ML7#;CG(]NM $TFN^(]*U+0KG49K.XTW694MFAAA*O;R.N4(;/S9P<\#Z55AU
MQ/#1\=:Q)'YOV:]0JF<;F,4:J,]N2*VM.T6?4[70[G4;R&>"P1)X(X8BN^39
MM5V.X] QX'?GVIG_  A27$?B"WU&\6XMM<?>Z1PF-HB% !#%CG&T'IU'X4 )
MJ.K:MX=U#1OM]Q%>6NIW*V<P2+889G!V%.>5R",-D].:AM/$6HV=QXBL-7G1
MKK3U$UIY407SH6'R$#/+;_E/;./6KT/AR\N#IBZSJ$5['I4@EA\N QM+(JE5
M=R6/(!)P,<\^U4'71O%OC#3[[3KC[0=*$@NI(B=A(8%(V]2'&\#MLSW% %B3
M5M5_M"/0_-8WD-BEQ=7%O K?.S%0%5C@#*MZ\8Z=:KP>(M>$&E:=J5@;35+Q
MI_,,2J_[N+'SJN[ +;UX)..>#5W7?#%[>ZW;ZYHVK?V9J$4/V>0O")8YHLY"
MLN1T))!S4>J^$+J_MK"X@UN6#6;"5I8[\Q!@Q<8=3'TV$ #'; Z\Y *4_B'Q
M%I6C7D^JV$HCM[U$%Y'"&8VQZR&-2?F7H>W.<<8K>\-ZA_:EC+=1ZG!J5L\W
M^CSP@ [-J\,!T8-NST[<"H8]'UI+6*1M<634!,LDDK6V(F0*P\L1AA@?-G.2
M<\^@$N@^'XM$FU"X4QB34)Q/(D,>R-#M"X5<GKC)/<DT 9_B35M3L)KSRKJ&
MVCALC-:JL?G2SR#<6W(.1&,+DC'WNHJDWB;6KNX\(_9&LX4UZU>697B9O+80
M[^#NY )Z<'CKS5^^\*7=QKFI7UOJ_D0:I:K;W,+6X=AM# %&)^7[QR"#W_""
MT\&7UJ_AMCK,4AT&-HU#6?$H9!'V?CY1[\\].* *:>,-1TK2M=74C!>7NF7J
M6L#HGE+,9 NS<,G&"W..PI^HP7\'Q%\*_;+U+I6BO,8B"%6\M=V,'[O3 /(Q
MU-3W7@/^T(M>AO=1#1ZQ*DZF& H]O(@4*0=YSC:.P[U,GAG6Y]8T?4]2URWF
METL2KB*RV><'4*2<N<'C.1Q[4 :/BG5KC1=%:^MX9) DJ"9HX_,:*(L [A>^
M!G^?.,5S^H>)[R'P9?:]I6L6NH117$8MY1$#NC8QJ5<#&&!9CV[<5U>IVM[<
MPQ?8+Q;2:*42;GC,BN!D%2,C@Y]>*P+CP)#=:5KMLUPEO-K3I([6\6V.)DQM
M(7/)RN2<\Y[4 79]5O8?'=II/F(UG<V,LY4I\RLC*.#Z?-7$Z)?^(M$^'*:W
MIT]F]G8SW#RV4D)+S)Y[[CYF?E(YP,=NIZ5V%OX;U4^(K'7+_68II[:W>"2.
M*UV(X8@\?,2/N]R?PJO;>"YX=#D\.RZDDFD23.[*("LS(SEVC+[L8))&0N<<
M<=: )EUF_P!>OM3M-'N([7[!#$5>2/>9)9$WJ#GHH!7..22>1CD76M4N=:L/
M#TIAL]0;3C>WTD0WA/F"!8\\<MDY.< 8[Y"7OA._C\12ZSH&L+ICW<217<+V
MPF238,*P&1A@./2IKKPM(-4T_5]/OS%J%G"T$DEPGF+<QL<L' (P=WS CH>V
M* ,#5?&.MZ?H'B:,-:C5- DC!E,)*3128*-MW?*V#SU&1[\; U/6[/QG;:5>
M75K+;ZE:2RPB. J;=T*\9+?.,-[=.W2FZGX).IZ)K%FVH)'>:U(KW5U]GR,+
M@*JKN&  H')/4GO5VXT"]N?$NF:U)J,&ZPADB:);4@2;\;B#O^7[HQU_&@#E
M=*U37-/^'>M:TFHQSW-O<73C[1!NR5D8$\$=AQV'I6_)=>([6QCN[K4-.$-S
M-"68Q[/LL14[\$G]XQ.T#@<GIVJ+_A";I?#VKZ''K*BUU"25H]UKDPB1BS G
M<-QYX/'T/:WJGAJ^U"QT@1ZK'#?:5,LR3?9BT4A"E>8]_H?[W% &5!XTN[?3
M=:,X6XGLM0CL[5Y(C$9/,V;"Z\8P7YP!D#M6Q/'XDMYKQ#?0/9FR+QW/E 2P
MS@] O0KCD9Z'KFL^7P#]KAUR"^U:2:+5W2;Y(0C0RJ%PX(/."HP..."3UK3T
MG1=6BC8:YK?]I,(C%'Y=N(5 /!8C)RWOT'/'- '-^']<O[#P7X9A-RL]YK+I
M%$\J<1 @L['GYC@>W)%:YUG5;#Q--H$\\,YGL6N[*Z>'D%3AD=5(![$$8J&+
MP),GANPTN35]UQI,R2Z?=);A?**YP&7<=V02#R >.G?330;F74I=6O+J![\V
MAM82D!$<*DY8[2V22<=QP /4D I^"M0U_6]*L=9U&[M#;75KG[/% 0RR;N&W
M9Z8SQCCCKU-G5M9N1K\>B60D20VINI98XU=@N[:H 8@=<Y)ST [Y%GPMHLWA
MWP_:Z1+=I=BU78DJP^7E>V1N//O53Q!X9N]1U6TUG2-4.F:E:QM#YAB$J31$
MY*,N1WY'^< &/<^(/%EEIFDM>6UM;7,^L)8RB2/_ %T;'Y9%PQV9 P0<]^E6
MH+[Q++XFU'P^VI68*6T=U%=BT.4#%E*;-V#RO4GIZYXM:AX5OM0M=.2760UQ
M:7\=_+-);9$KIT4*& 1<<8YZ=<Y)M1:#=Q>*[K71J$)^T6BVP@^S'Y0I)!W;
M^>6/:@#G1XPUR;PAH&J0BS%U>ZFEC<(R-M?]ZT9*G/RYV^AZ^U:6FZOKECXT
M/A_6I[:\BN[5KJUN((#%M*L R%2Q]<@Y_GQ@Z]HDWAGPMH&EOJ<,KCQ# \,Y
M@V;2TK.<J7.<$D]1P/QKL8-%G;6FUF\N(I+Q;8V]N$B(CB4G<QP6))) [C@8
M]20#E/#&MR:3X"T&UM@GVK4M0EM8FD&5CS-*68CC. #@9ZD5MG5=5M/%)\.3
MW22?;;-KBQO#"-R.IPR.HP&'(((QZ>]00> FC\*V>CR:IFYTZZ-W9WJ6^TQR
M;V?E2QW#YB,9&16FNFBTU%_$FMW<+2VEHT8:.,I'#'G<[<DDDX'/8#'J2 96
ME>(M5O\ PXD<LT4>O#4#8S((LHCJV6P,\CR@7Z\T^\US6[\ZLNAHQETV4P0K
MY*NL\JHK,')8;02VWC&.N3G ?H-IIFJ^+;[Q3ILAEMI8(X5D4GRY91G<ZCU"
M[%S_ +P[&G3^%-3M_$%WJ6A:\=.AU JUW;/;"92X&-Z9(VL0/<?7I0 G]O:K
MJ-ZVG0P2V-S;V4,]R$C29HY9-V$Y(&!M.3WSP1CFG<>+-5TW3='E\26[:,+D
M2I>7,<8E2&12!&#U"JX).3G&,>]7M1\(WHU:WU70=:;3[M+9;6?SH?/2XC7D
M%@2/F&3S5YM&U%!;B/4XYT$4B7<=W!O6Y9R#NP& 7&" ,$8.* +VD333Z5;S
M7%S!<R.N3-;_ .KD&>&7D\$8[UR\VNZW;OXFL)+J$7VGHD]@?L_$T;@[01G)
M)<;..^,=:Z+P[HD/AW0[?2X'WI"6.[&T99BQP.PR3@=A4-_X;M[_ ,2V&MM(
MR/9Q/&T8Z3 D,F[V5AN'O0!GZ/X@N-8L=$NX+M!'-:M<WQ,0X P"O^R=^1WX
M5JH2>*-8?P5_PF5LT)@&9_[/:/@P!L8W]0^WG/3MCO6]H/AFUT&34FA8R+?7
M+2A&'$:G)V >FYG/_ C69!X)FM]#F\-KJ2G1)'.V,PGSDC+;FB#[L8SD9QD
MX]#0!%<:QX@U'Q3)I6DWME;P2:7'?02RVS,R[G*X(W<].O&,]#698ZM):^,_
M$FDVD\4>J:A>Q"W:5?W:A8$+L1WP/X0<G/89(ZB+P]<0^+SKJ7L*PFR6S^RB
MV/"*Q8$/OZY/ITK*O? ,E^^KRRZHBSW]Q'=6\T=L5>SE0!593OYX'MUH NZQ
MJ>J:5K7AZS2XAE@O[EH;@M#ASA&8$$' ''3&?>LR;6?$]S>>*+:VOK&#^QBC
M0N;4MO!B\S:06X]">?8"M:^\.ZEJ-SHMS<:M 9M+F,K,MF0)V*E>GF?+P3Z\
M_E3(_"]Y'>>(+@:G"?[;4#:;0_N2$V#^/YOE^G/Y4 5U\4W=['X4CC5;;^WX
M3++,!GRB(@^Q<\9)/&<\ \5:\*:IJNIW.KQ:A+;R1:?>O:1-% 4:3: =Q;<0
M3S@@*,$?A7-ZS:#2H/#OAFY\06=F;*!G6XO;-3;3[ $12K-C>,D_>]\=*Z#P
MC<7K-/:/>:9J%E$JF*YTZ#RHPQ)W)@$J3T/!XSSU% %B\U>XN?%B>';*86[)
M9&\GGV!F +;%50>,YR23G@#UR.=U+QEK=EX=U\ VHU/0[J.%W,1*3QR,NQ@-
MWRMAN>HR/?CI-2\/2S^(;;7].NDMKZ&$VT@DC+QSPDYVD @@@\@@_G5#4O!#
M:AH6IV(U!([O5KA9[JZ-ON!*E2JJNX8 " <D]_6@"6WU36;3QQ%I&H7%M<6U
M[9O<1"*$H861E!7))W##=>/PKIZPI= O)O%-CKCZA!FUMGMVA6U(WAB"Q!W\
M<J,<'\:W: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&8*I9B  ,DGM2UR?Q.>XB^'
M^IRVUU);LJ*&*8RZE@I7GH"#VH V[C7+*UUNST>4RB[O5=H1Y3;2$&6^;&/3
MCKR*M7MTEC93W<B2.D$9=EB0NQ &< #DFN0\0P7J^-O"4,5X&N"E\//EC!Q\
MB<[1@$XZ4Q?$&NP^%/%#O=P2W^AS3)'<-!Q*BQAQE00 V#CT]J .VAE$\$<J
MA@LBA@'4J1D9Y!Z&GUQNK>*9M,AT:;49Y[+3[RTW3:A# '"3$+M5\@A5.6[=
M<<C!KIM)EEFTBTEFN8KJ1X5+SPXV2''WEQV/6@"Y17)6VHZ]X@TN;5M%NX(F
M2\>*WM9D'ER1I)L;S&P6#'#$8QC@8/6K$.I7VO:SK-C87WV&/2V2%76)7,DI
M7<2VX'Y1D# P3SSTH Z6BO/D\9:WJ&E^'[FW-K:SWFIG3[R-HBZAUWY*G/W?
MESCKSC-3RZIK:P>,-*N-4WSZ7:+<6UY%"L;@/&[;<<C@IC/7F@#N58,H92""
M,@CO2UY^NHZUI'A3P<+*^B?^T);6V?SX 2JO%G@C' V^F3GJ*UYI-<L9K:QO
MM;B;?#*PGMK8?:)I-WR@188;54\D=\<B@#J:0D*I9B  ,DGM7%Z3XNOM5T3P
MPK&.&_UPR"255RL:QJQ<J#_$=H SP,YYQBJWC5?$-GX-U?[5J2F)+F!;::)5
M$DL3R(K+(-H ^\?NXSW[Y .^HJ.WCDBA5)9FF<=9&4 G\!Q7%77B35K&\TTR
MWD4TESK LKBVABW011LS!0),9\P *2,]SP* .YHKCK6]\2:EXNUK3(M4M;>W
MTR:V9?\ 1-Q='7<R<MQQQGZ8Q5<:]XGU;2TUG0K*:<-<$1VK>0L,L*R%3EF<
M.'P"<\#/&.] '<$X!)SQZ#-5].OH]2L(;V*.:-)EW*LT91Q]5/(I]WYWV24V
M[I'-L.QG3<H/N 1G\ZX5/%.O3>#_  KJD5Q;BXU2^A@N-\.0P=FZ8/ X],^X
MH ] K';Q/IRWT-K^_99K@VRW"Q$Q><.J%AWR"/3((SD&L[2;[6#XFU?0+[4$
MG,5O%<6]PEN$:,.6!4CD'!7C/XUSOAS5[KP_\/%OA<>?-<ZA+;01RH-BR/<L
MNXD8)'4D9[8XH ]+HKEKK4]3T/Q/I>G7%W]MM=762-))(E#P3(NX?=P"I&>.
MHQUK/T74?%6J:5=:FVK6<8LYKN$P_8MPEV%@K9W K@CIS[D]@#N:*\^3Q#XD
M30_"^LF^MI/[6F@MIK9K?"YE4_/N!SD$9P,#M[F]_P )'J.A:KKUKJMRFH16
M&G+J$3+"(F ^<%./=1@^_>@#LZH:WK-GX?TJ;4[\R"WA&7,<;.1^ ''U/%85
MG>>*FU/3)OLLL]C<J?MPE\A%AR,JT6URQ&>QW'%8/B34K[Q+\+-5UV*\\FUF
M600VHC4J85D*98XW;C@G@@#@8/< ](1Q(BNO1@"*=5=)DM].6:0X2.'<Q]@,
MFN,F\2ZT/ Z>-(9T9,"X?3S&NPP;L;0V-V\+SG.,]J .NO\ 5+?3C%'())9Y
M]WE01+N>3:,G ]AW/MW(I=*U.VUC3HK^S+F&7.!(A1@02""#R"""/PKD]46X
MO/B1H$L&H211S6%Q)$/+4[!^[R.1W]ZV?',EQ#X)UB:UN9+:6*TD<21XW<*3
MCGIGUZ^E %Z]UVQL-0L+&9I/.U%REOMC)5B 3RW0<#US6C7GVJQ7<8\#HER)
M)VN?DDE083-NW9<9Q^OK5D>*M3T:'Q/!J$T=_-I#P"WE\L1[_.4;0P!QPQZ^
ME '<45S5A-XFC\10QSVT\VE30MYTMQY"-!*.1M$;$E3TP02..:E\6ZU/H5I:
M7.V=+)I]M[<V\0D>WCVG#;<'C=M!.#@9XSB@#H*@O;R'3[*:\N-XBA0NY1&<
M@#KPH)-<E=>(+V'2]#OK+5X;^*^UB.U,R1J5DA=R!T'#@  ].<\>EB\U.];7
M?$&D2S"2UATH7$0* ,I;>",CJ/EH Z+3=0@U;3+;4;4L8+J)98RPP=I&1D5:
MKS+3=2\0>'?!7AO61>6\^E^5;0SV7D898WVJ'#YR6!(XP!S^>U)XGG_X2B72
M+J_;2[L7D8M8)X5$-W;Y7<5<CER-PZC!P,=: .RW#<5R,@9(I:XO13J)\;^+
M"+]YS;?9Q%%*%"',195R!D %CT_'--T_Q%J0\0Z'8R7R7BZG;3&X980(8YD5
M6_=. -ZY)'4]!SF@#MJ*\XN/$GBB/PMK6M_VC:AM'U&:+R1:\3I&X7!.?E&/
M3)]_3I6U.[U?Q!?:/8W9L5L+6*5Y516=I)=VT88$;0%YXR<CD8Y .BHKDWUC
M7$GTO1+J,?VG-:27%W)8;#@(RJ-GFD#DL"<@XP1CG(TO#,VNRV=PFOVOE317
M#)!+E,SQ?PNP1B%;L1[4 ;55=1DLH+&6YU'RA;0*9':5054 =:Q(]3O=<U_6
M--L;TV,>E"./S$C5VDE==V3N!^4# P,$G/(KF?$&LWGB/X3WUW.PM;FVG^S7
M<<2@H[I,JG&>0._Z<T =OI>KV5U=SZ;!;36DUJJN898#&"C9PR]B"0?<'K5J
M_P!0M]-L+B]N6;R;9"\IC0N5 &3PH)Z5);1316X2:X:>09S(RA2?P'%<+I O
M'T'QK)=:A-<[+N\BQ(J\[8E / ] !CI0!W%A>PZEIUM?V^[R;J))H]PP=K $
M9'T-1V=W;S75W:P021-;2 2%H2BN6 ;*GHW7DCO7%Z-J.L:38^"]]Y#)8ZC!
M#:M:B'!3]QN5@^<D_+SVY_&K\.O:]O\ %T2)'>W&E,@LXHHMN=T8?&,DL>?7
MG';- '8T5S?A378==EN)K36#>VZ(@:">)8Y[>3+;@Z@#CICCL>35C4M4G;Q)
M9:!:R_9WGMY+F6<*"RHI50J@@C)+=2#@ \<\ %S6M;LM L?MM^91%O5,QQ,_
MS,0!G XY(Y.!6A7">,$U>+X=ZA'K,L$TR7T BEA&/,B^TQ[2PP &QU XK4\1
MZEJ-I=W*0WZ6T<=B9;=(8Q+-)*"<EE(.(QA>>.3U% '3T5QEIXFU*[N_!DGF
M(L6N02-=0A!@,L&\%3U'S>YXI#XAUJ)/%4<*-?2Z5/$ENJ1 R%&56;@8W$!B
M0.^!0!VE%<5'XQC7P_J.L6&J+JL*>3%!'*BI+#,[["LB@+QEE/.. ?K6CITW
MB6/Q$D5Q;3RZ5+ 2\USY"O#*.@ C;E2/4$CUH Z2L*]\::%IR7$EU<7*16TA
MBFF%C.T:/G;C>$*]2!UZUNUQ?Q5C2+X;ZDL:!0986( QR9T)/XDDT :]QXQT
M>V@N99FO(_LL)GD62PG1M@."P#(,C/?MWK8MKA+NUAN8L^7,BNN1@X(R*Q?'
M,:'P3KDA4%UTZ=0V.0"G(_0?E61IVHZQINJ>%[6>\AFLM6MFC,"P[?(*0AU(
M;.6SC!S^0H [:BN'_MWQ/JVEC6-!LYI_])816K>0(98ED*'+,X</@$YX /&#
MU.[XQO+FP\&:O=V99;B*SD9&'5#M//X=?PH F_X2/3GGEAMS<71@8I*UM;R2
MHC#JI9002.X&2/2K6FZI9ZO;&YL9A-$':,L 1\RG!'/H:S/ UO!;>!M$CMP-
MC643DCNS*&8_B234>MZ@-%N]/T[3U2&YUN^*F0KD1X7<[@=-V%&.V3DYZ$ Z
M*BN2DUG5M.\1WF@2W*7!DT]KVRNI81N4J=K(X7:&[$$8]\UEV7B/Q$-)\*ZU
M<WUO)#JMS#;3VJVX'^L!P^[.<@CI@#GVR0#T#(W%<C(&2*6N)TC^TSXQ\7;=
M4=C:F 1++$K* 8=X&!@X!8]",]\TW0]3\5:AX.C\0MJ6GEYK LEO-#Y<:2;O
M]8TF>F <C '3GO0!W%%<7#XKFL==U*WGN9;ZPM=(_M)998!$YVLP8+@ %2!D
M''XFM#3V\17D>D:FE[;R6]W&)+RW9 %B5DW+Y1 R2#@'<3GVH Z,,"2 02#@
MX[4M><:9KEYX>\.>*=:N;N2^>VU:>"-)@H#OO2-"2 "!T&!Q@<5NZCJ>J^'=
M7T9+J\%]::I.+27=$J&&8J2K)MQ\I(((.2/6@#JJ*X_PU>^(]9O[Z2?4[9+;
M3M6FMGB2TYFC51@9W?+@G/?O6SX@N[NTCM#;W,-K#)<!+B5^9 F#@1K@[G)
M &#U/% &E-:V]P09X(I2O3>@;'YU( % 50 !P .U</#XOU2#PCXEU Q?:[G1
M[N6& O$49T 0JSJ,8(#Y. .!VJX-2UA/%UAI=MJ<5W:7=BUU)+);ABFT@ @H
M5 5MW&<\B@#K:0@,"" 0>"#WK@],\0:^='U'7[_4+=K329[Q);6.UP;A8\A<
M-GY.0/7W/IHVM[XI&IZ;.;66>PN%/V[S?(58,KE6BVN6(SV.XXH ZI$6- B*
M%51@ # %.KA[;7/%&K:?I^MZ393317,JN]J_D+$;<D]&+[PX&#D\9S\M2_\
M"33OXGETBZOVTR]6]46]M/"HBN[?(R4<C)8C/?KQCO0!V=9VH:[8Z;=6-M<-
M)OU"410%(RRLQ&>6Z#@>M0>+GN(?"&KS6MR]M-#9RR)+'C<"J$\9^G6N1U"*
MZ3P_X$"W(EF:^MC&TJ#"9MVP,+C('YGUH ]&HKD+#5]=BO?$VE2W5M>7.FPQ
M36DTR"%#YB,=KXXP"O7T--TO7;Z?Q4FC_P!HO=6]SI;7*W!MPNV4.JDQG: R
M$-D<'IU- '8!@PRI!&<<4A95X)YP3CN1]*Y/X9F[F\'07-U>RW+337!/F!<@
M^?)DY R<GFDG%Z_Q7AB&HS+ ND/*L(52H_?(&'3O@9/7B@#?TC6K+7(;B6R,
MA6VN'MY/,C*$.N-PP>>_>IIK^*'4;>Q:.8R7*NRNL1*+MQG<W0=>,]:\ZCO=
M9TGP_P"*]7TV\AA6QUJZE,+P[_/PRY4DGY1CTY]ZZJ\UG4(O&FA6,<L0L-1M
MIY'C\OYPR*I'S9Z?-V Z=Z .EJ&\NDLK*>[D21T@C:1EC0LQ &< #DGVKDM+
M\33WWB :9=7[6&HQ74@ETVXA55E@&[8T38RW&TDY/1N ,5N>*KV\TWPMJ5_8
M21QW%K;23(9(]X^52<8R/3_ZQH T%$%_:1O)#OCD4.$FCY&1GE3T-2JJHH5%
M"J!@ # %<?JGBF;3;71+C49Y[.PO+0/<:A# '$<Q";0V00JG+<XZXZ<UTVD2
MRSZ1:RS74-W(\2EIX<;)3C[RX[&@"Y17#:UXDU;2W>X-Y$[QZK';FTACWQ+
MSA1O?&5D(.[&[N.,5W- !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9GB/1(O$
M?A^\TB:9H4NDV^8HR5(((.._(%:=% '.R^&[ZXUO1]5N-76673%E!!M0!*9
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M"X>W<2H4.]#AN#SU]: *]AH'V?7Y]<NIH9;V:V6W8P0>4I4$G)!9B6Z#.>
M*A\1^&)-8O+'4K#4GTS4[ L(KA8A(I1OO*R$C<#CUXK?HH YO5/"ESJOAN72
MI]89I[B9)9[MX 2Q1E8!5! 4?(HQSQGN2:2Z\*7-QK=WJ,>L/ M_:+;7<20*
M=VT'!0L3L^\>.>OXUTM% '(KX)N8-+T."VULI>Z&Q^SW+VRLI0IL*E,CJO?.
M:FMO"-[9S:M<0Z]+]HU*:&;>UNI\MH]O8$9!VXQP,&NHHH YBX\$6>I#5VU*
M1))=6ACAF:VB\D+L)*L 2V6R<Y)/0#ZV-$T'5K J=5\13:KY*E8 ;=8MO&-S
M8)+MCC)/<\9YK?HH J:7;7=IIL-O?WQO[E 1)<F(1F0YZ[1P../PK.\7>'9/
M%.A2:0+T6D4S*9'\G>WRL&&.1CD>];E% &7K.E7&L^'+K2I+Q(I+N%H9)TAX
MPPP<*6XX]S6?)X7NI+K0+C^TH@VB!@H^S'$V4V'/S\?+^O/M7244 <E:^"KO
M3[VYCL/$-Q;Z/=2M+)IX@4E2QRP20\HIYX XSP0>:ZJ6*.:%X945XW4JR,,@
M@\$&GU1U#58=/>&$QRW%S.&,5O" 7<*,L1D@8&1U/<#J10!DZ5X:U+P_$;+2
M=9B&FJQ,-O>6IF: $YVJX=?E],@X]:FU?PO'JEG;+]MECOK2Y%U!>$!F64>J
M\ J1P5XXK3TS4H-6TV&_MUE2*4$A9HRCJ02""#T((-5[_7K+3KW3[2;S6?49
M?*@9(R4)P3RW0< ^] %8>'II+RYU*ZO(I=1FM/LD<J6Y6.*/.3A"Q))/)RW8
M?CFCP5<KH&BZ2NK1@:/<QW$4AM#F0QYVAAO]SG'Z5UU% & OANX@U[4]4M=3
M,8U-$\V!H R[T38&SD'&.WJ.O:JB>"F_X0$^$YM39D556*Y2':RA6#KE22#R
M.>F1^==510!S">$)YM;.J:CJ[7C36!L;F+[.J)*A8GC'*CD^IYZ]J- \)W^B
MB&TF\0SWNF6A_P!&M7@564#[H>0<L%[# Z#L,5T]% '+#P/;RVFMZ?=WLD^G
M:O/)<&W\M5,4CD$L&[X*@CT[YJU#X=NIIM.DU?4DO_[,)>WVV_EEI-I4._S'
M<0">FT9)/IC>W*&"[AN() SR1_DBEH Q/#N@SZ%)J327R7*7]X]V5$&PH[XR
M =QR.!_C1K^@3:O=Z;>VFH&RNM-F:2)S$)48,I5@5)'8]<\5MT4 <+J^D2>%
M_#^O3MK%X\>JSAFE2!<VS2;4:1BHY4 9. .,CK@U%X>FN8+^"/1_$^C:Q%(X
M6>"ST](RB8/SLT;87'HP&>@Y-=[N4N4##< "1GD ]/Y'\J%14&$4*/0#% &!
MH_A46&DZEI=]=I>VVHRS2.HA\LCS<[QG<<CGCN/>HM!\+:EI'DV]WXCN-0T^
MTQ]FMG@5"H'"AW'+X[=.0/2NBEG2)'8[F,:[BJ*6;'T')Z&JFB:Q:Z_I$&J6
M6_[/< E/,7:V 2.GX4 8.E^"KO2)6M+7Q#<+H9D,BZ<8%)0$Y*"7J$SVQG'?
MFK5]X6FU1/LVH:A'/:+?"[C4VV)8\/O"+)NX&>,[<XR/IT=% %;4K&/4]+N]
M/F9ECNH7A<KU 92#C\ZYT^#KY[+1+>36Q(=&G2:-FM!A]B[%& PP,$YZG)_"
MMB;7[*._DL(%FN[J$ RQVT9?RL]-QZ*3Z$Y]JDT[6;+5)[B"V:3S;4J)DDB:
M-D+ D A@.PS^5 &'J/@EM3N=>DGU/;%K=O' Z1P8:+8#M(;=SU.1CGVJ:U\+
M7T>OV6LW6N/<7%M:M;2!;9$61"0W YV\KSUSVQ72T4 8OAGP^_ANR>Q6_>YM
M1*[P1M&%\H,Y<@D?>.6//'THO?#\EQXGMM=MM0:VDBMFMI8_*#B6,L'QD_=.
M1UYX]*V-RAPA8;B"0,\D#K_,?G3J .2/@FX?P]K6D/JR,NL7,EQ)+]EP8S(0
M6 &_V&/ZU=?PY=2ZYH^J2:C&6TN%XO+6V($N\ ,<[^/NC'7\:Z"B@#G&\+37
M<NGG4M0CNDTZZ^TP,+;9*",[5+[C\HR.@&=HS6GKNFMK.AWNF+.(/MD+0M(4
MW[588.!D<X-7MRER@8;@ 2,\@'I_(_E3J ,*+0]1@@M(8M3@:.&T%K+%-:%X
MY@.C;=XP<<=2#D^V+F@:-!X?T2UTJV9GBMU(#-U)))/';DGCM6C5>^NUL+&:
M[:&:80H7,<"%W;'95'4T <I-X N)-.NM.37Y4M9;[[; IME8QOY@D(9LY<9Z
M=/QKL8U9(E5G,C* "[  L?7CBB-_,C5PK+N .&&"/J*=0 4444 %%(S*BEF8
M*JC)). !2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %<YX^U/4-&\&WVI:9<+!<6X4AFC#]
M6 Z'COZ&NCK)\3:&/$F@W&D-<FWCN=H>14W, "#QGW H R3J>K:3XV@L;_45
MN[*]LII_+$"IY#1E<[2.2"&Z$DUG2>(M;D\!CQI;W@! -R=/,:>480V-F[&_
M=MYW9QGMBNAG\/S7/B&PUF:_4R64+P^6(,+('QN)^;CH,>GO5*#P0EOI4V@I
MJ#'0Y9"_V0Q?.BEMQC$F?N$Y_AS@D9H K?VGK6J>,9=+L]5%I9RZ3'>1,+96
M>,LY'\6<GCOQUX[AV@>-(8_"%CJ/B&ZVSR2RP-)%;NPD:-V7.$!QD*#Z5JKX
M?DC\4R:[%>*K/:"T$!ARJH"6!SG.<G\N/>I/#.A'PYI7]G"[-R@E>16:,*1O
M8L1P>>2: ,74M=U*^\0:%;Z'J4<5CJT%RV][4EE\L+\V&P<_,< XZ<Y'!SX?
M%>M:0=9TC4IDO[ZQN[6"VNQ$J>8MP<*64$+E>?0']:M^*;A3\1O"T,-_%;W$
M<5X?G 8?,J !AD=<''(/%:=SX,LM1TW5+?4)GFGU5UDN+B,;&5D $>P<[0N!
MCKWSG- %4R^*K6[OCNE.G_86DBGO%@,D,Z]@L1 92/7D&J%CJ7BH^"[?Q&UZ
M^H-<6D#M9V]HF] 67S)$/\3;-WRD8S^1VK'PUJ,5G-%J/B&?4IFA:"&26!%$
M2L,$[5QN;'\1/\SF2S\.7-AX9L]&MM5='LC'Y-QY(SM0C"LN<'(X/3@_C0!B
M/XTCM_"FI:W8:J-559(XK=)XPCP2,0NV155>A.>W''O5[4=0U7P]KNCPRZ@U
M_::I*;5_.B16AEVDJR[ ,J<'(.?K4\W@JPOH-974B)I-:$:W+0IY0'ECY"HR
M<$'G))Y]N*G@\/7#W%C<:IJ(OY-.#?9CY&SYRNW>_P QW-C/3:.3QTP <E-X
M@\3Q>#]1U\ZO&7TO4)8S"+5-LZ)+L*L>HXZ8Y]SVW_$NI:G:W%^MOJ0MQ#8&
M:VAMHEEE:0;B6D#*0J<  Y&>><XIK^!FD\,:CH+ZJQAU"X:=Y! -Z%GWL!SC
M&?Z_A//X0EGU2^O1K,\0U*U2"]BCB3$FU2H92<E.&/ ]: ,N_OY=5A\ ZC.J
MK+=W,4SA>@9K=F./;)KJ]<GO[;0[V?3(!/>QPLT$?]YL<#W^G>L:/P;+'9:#
M;#5Y'_L1E:)GA7Y]J; #@CC:<>OO6]J5G)?Z?+;17+VLC@;9D +(0000#]*
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M*.P_, WJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ***YOX@:CJ&D>#+_4=,NOLUS;A2K[%;JP
M!&"#V- '245R37^J:1XWM[.\U-[RSO;&:=HC"BB%XROW,#."">"2?>LU]>UJ
M;X?_ /":6]\1*JFY^Q%$\DQ!L&,G&[.T?>SG/MQ0!W]%<1+>ZYK'B^73+'6W
ML+6728KV(BVC=HF9R,<CG@<Y_"NEU^;4K;0+N72HC/?)%F) !ECWP#QG&<#U
MQ0!8U*_BTO3;B_G21XK>,R.(EW-@#)P*73;Z+5-+M-0@5UBNX4F0. &"LH(S
MCO@UQ\&N6^M^'/$;V^J7$XCT]E>RO(ECGM)-DFX, HX/R^O(/-5M(N]6TFS\
M$R?VFTMIJ,,-M)9F) BCR-RLIQNW#;SDX/H* /0JRX]?M9/$%QH@BN!<V]L+
MEF,?RLA.T;>Y.0>W:N6U;7M6T^1+E-3^T,-92WDCMXE-ND+2;1&6*@F0 @G!
M)#>U:4/_ "5RZ_[ <7_H]Z -G0];MM?L&O+2.:.-9GA*S*%;<C;3QD]Q5B2]
M\O4H;+[+<MYL;/YZQYB3;CAFSP3G@>QKG_A[_P @.]_["MY_Z.:I;W4-0B^(
M6G::MX18W5C-(T(C7AU*@'=C/\72@#HU='9E5U8H<, <[3@'!_ @_C6=<Z]:
MVOB"RT22*?[1>I(\3A/W>$&6R<]>1TSUK!^'L5P$UQYK^YN-FLW46V78<[6
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M\PJ 6QW('%3T4 8D_AS&O2ZWIUZ]E=7$2Q7(\L.DP7[I(/\ $.@.>G8U7O\
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M8W=HUD5G3[R@Y*_7TH ?13!+&93$)%,@&2F>0/7%'FQ^;Y7F+YF-VS/./7%
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G 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>65
<FILENAME>ebs20191231exhibit1048026.jpg
<TEXT>
begin 644 ebs20191231exhibit1048026.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN9%O8T%I_P ? ES&T/<;PV"OXUYU9WP'@OP9>QEY;+2+F(:D%0XA.UEW-Q_
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M33[UH[BV4B3";9(6QD91QQZC(YKD&UO5V^'7AO51J4JW-S<VJ7#!5_?*\@#
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MDN0',JPY",5$C8PA8# 8Y'&<\US5EXHBTGQ+XE@UW6,6MI-;K;><%&P-$'8
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MKRLKJ&5@RL,@@Y!% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;0RLI$8Z8(P<]?:CPGXKT^ZT?0[*[U(2:I=V4;D/DF1]@+#=C&[OC.: .JI
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M:S;;Q#I5[>1V4%WF>:,R0AHV43*.K(6 #CW7-8OA;67@L_$-QK&I/)%9:Q-
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MHT$AAEB>)RA.-P# $KGN.*@\07EE:Q6:7FKOIK37<:Q&,C=,VX?N\8.0>AH
MUL#(..12UD7GBO0K"YN+:XU&-9K90TL:@LR@Y[ ')X/ YX-6%UO39-+AU..[
M1[2XQY,B9;S">@4#DGV S0!?I" <9 ..E<KXGU^.Z\$ZU>Z+J4D-Q8Q/N*)L
MDB=1G:RNN5_('TK7L]8M ]AI\]P1>W-N)$1E;,@"@L0<8.,\\]Z -2BL^VUW
M3+NVN[F*[0163LERT@,?DLH!(;<!C (KG9M>:Y^(NCV=I?7/V::UG>:UDA,0
MX"[&PR@D')YY''% '94F 2"1R.E9K^(])CO(K5[L*\TIAC8QL(WD'\ DQM+9
M!&,YR"*K>(]<M+'3K^%;Z2"ZBMRY>"(R&'@[2QVD*#CJV.] &V0#U&:" 1@C
M(-8_@^ZGO?!VCW5U*TL\UG$\DC')9BH))J.VUC28;O6;LZZ9H[9D^T1NP\NT
MPN,*<=\9/)YH 7Q1H=UKL-A';7,4'V2^BNR9$+;O+.0O!&,GO6T@PH! ![@=
M,UD6GBW0;Z]M;.VU*.2>\C\V!=K 2+MW<$C&<<XZ^U:=U=6]C:RW5U,D,$*E
MI)'.%4#N30!-28!()'(Z50M=8L=3FGL[6Y=+F.,,R/$T<B*W1@KKR/?!%<))
MK&L?\*<N=4&K7(OH;B1?M V[F N2F#QQQZ8H ]*P"0<=.E8?B70KO6GTO[-<
M0P+I]]'>$.A;S"F<+P1@<]:W:S8]?TV:>.&.=V:7=Y1$+[9-H);:V,-C'8F@
M#1484# 'L.E& "2!UZUDMXIT5-).JM>@62R&)IO+?",#M(;CCGCGO6'>>(DT
M3X@WD6J:JZ:<-+CF2)QD*YD8':JC)X7W/7M0!V=)5"'7M*N-)CU6"^BDLI<!
M)4.0Q)P% ZEL\8ZYXI+77M+NX;J6.\55LCBY$P,30\9^=6 *C'.2* -&D  S
M@8S6?:Z_IEY=&UCN2LXC\T1S1O$S)_>4.!N7W&15)O&_AE51SJ\.QYO)# ,5
M#YQR<8 SQD\>] &]2 !1@  >U8<_BJS@\5IH#1S>9]F,[R>2Y4?,JJ,@8QR<
MGH,#FG0>,?#MS=1VL.JP/++(\: 9P60989Q@8 //3@^E &W1699^(M*O[J*V
MMKO=+/&980T;*)D'5D) #CD<C/6DF\1Z1;W2VTMX$9YO(#E&\OS?[F_&T-[9
MS0!J45@V'BRRO_$&I:4J2Q_V>$#220NJEB&9LDC   &"<9YQD8J_::W87UTM
MM;RN97B,R!X73>F0-P+  CYAR/6@"_156]U&TTY(VNIMGFN(XU"EFD;KA5 )
M)P">!VK'UCQIIFF^&+K6X&>Z2!C%L2-LB4'&UQC*8.,YQC\J .BHJ*VN([N!
M9XM^QLXWHR'KCHP!%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5C^+94B\(ZN78+NLIE7/\3%"
M!ZDGM6Q10!YOJ%W9MX/\#!Y8V$%[8F4=?+V1D,6';:2,YZ5KZI<'2?B19:K>
ML(]*N-,:T2X;_5PS>8'^8]%W* ,GJ178T4 >4^([5_\ A&?'5_"#]BU2>'[$
M@'^N90@=U'<,V>1UVYZ<UTFK7-G)\1?"\D<D3(MM= .I! W!-G/;.#BNRHH
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M++&!#@.0?]6/(*'/I\W'/>HX)[<^'_B$N]-TUQ=&,=Y 80JX]<MD#'>O2:*
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MC\01W<L'DL&E@7RR0 1U^7..O'2MRYUS3]9\?^&[O3)VGB:UNU\V.%B%+!,
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MC#/<0./.(60$_= &20 ,#.>!2">)/#?P_4Y#VMQ;^>-AS$%A96+#^$!B <T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!CZ?HMU!JDU_J&K2Z@VYQ:QO$D:VR,02!M'S'@#<>P[
M9.=BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0V=Q:P2K*7NY#'&4C9@" 3\Q ^48'4T 6J*** "BBB@ HHHH **** "BBB@
MHHHH **** "BL_6M;L= T]K[4'D2!6"EDB9\$G S@<9) R>*T* "BBB@ HHH
MH **** "BBD) &2<"@!:*SQK=B=?_L,/)]N^SFXV&)@OE@A<AB,'D]L]ZT*
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MW$($=W!E=Q5SU<_,!@C' P>33KS7-=U$:NVA1N9-.G:W@C\I&2>1%!8.68$
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M2_BPT8!)6( '(Z< #%7])U/6=,NO"=K/<V\MCJMKY7D+#AH2D.]2'S\V<8/
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M-NT+1#[LAS\C'W4,X_X$/2@#/N=5U2XU2\T>QEE\W3[>(R7$4$;%Y7!(RK$
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MWNI(G6T\L$"+SU"_-UW\ D].HQWKH]0UG4[W5M4TW2O-C?3HXQOCB1]TKKN
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MGMQCG.L652H9@"QPH)ZG&?Y UGZ7KMIJ]W?VULLROI\HBF\V,I\Q&> ><8-
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M@\EXL&^"4?=*B,_,#T(/YU7\ W6NZUHFGZ[J>KK+'<6[!K1;9%&[></N'.<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWDMZT,65"?+M4C.T8');DX[^E=#XA\<Z=H.OZ;HTC;KB[?,IVDB&/!.>.I)
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M?;U 7!(;N  <\&O8J;M4-N"C.,9Q0!ROQ/L;_4?A]JEOIR/).51BB?>=0X+
M?@#QWZ5R-N3J_C/P*VC2+*MAIJM=O$<B%-F-K8Z$X(P><FO6J0*JYVJ!DY.!
MUH \(%S:MIGQ0;S8B9KL&(Y&7!F?[OJ.G2O6/ 4B2^ M#*.' LHE)!S@A0"/
MP(Q7044 >0_VG86_[0=Q=3WMO%;BUV&9Y0$#>4.-Q.,U=TO3;CQ'\89_%D43
MQZ/I\?EQ7,BE5N&\LH=N>HRS'/3@>M>HT4 >&^&;?2=5\&^*;'4K[[+#/JRE
M9T(/E$L CD?W=V,GTSTZU/)_PD^J?#WQ3I4[IJ4VGR01K?VQWF[B4[F7</O;
M1@^O)!KVK&:%4*,*  .PH \^T?6?"^N:!+K-K&@U2/1V@N9-C#R%"\HQ^Z/F
MZ=SVXKA+6"XN/A)H$T.9+:PU<R7R+SY:[CAF'H,_K7O@55^Z ,G/ I: /*98
MX=3^(GBS4M[S:&NBM!=SV[;ED)C4E5(X+  _3'O2^ 5U/3?$5QX<6_@US2HM
M/:6SO(R"UNK, (R?X<[?N'^Z".]>IA55=JJ OH!Q2A0N< #)R<#K0!\W37D"
M?!Z+2F9A>P:T6FAVG=&-C#YO3\>N#Z&O0/B))8W/Q$\%^=+"]OYC.Y+ KM++
MM)[8./H:]1"@9P ,\G'>EH \O^)$2Z!XB\+ZK'&UGI-M<R&XDM(5Q"[X^<C:
M021D\@]#WKK/!MAI5K;W]UH][=7L&H737+SS8V/(WWBF%48^@QV[5T94,"K
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ME[A$^];JK+O+C^'H>O6I)KFU'C3XCNTL7SZ3(B,2.3Y8! _' QZU[,%4$L%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>)QE6"YR#U!&>HZU?AUW6K?Q3I6GZ@EDUKJUO*\0@5@\+QJK$,Q.&!#=@/\
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MU4R!BK' P1@>HK+TV;Q%;S>+9]!CT]C!JTLC)=!R9<1H2J[2-IP.ISR>@ZT
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MTK =3@9P/<]*Y^[\1ZOI%KI.J:BEI)8ZA+%%/'"C![8R?=.XL0X!P#P/4>E
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MUKJ*6@#DM2\'7&HZ9KP:X@34-=5(Y9,$QPHBX55[MCGGC)/;I5FXT'4KC7-
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M$&E:O?'1=8MH=,U&=KB6*XMR\EN[??,9! Y//S<#T/?KJ2@!L:"*)(P6(10
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M!!K=R;F-T4GR6^7"G/4?(.>.]=G10!S5SH6LW>NZ'JT]U9&33%F$JK&RB3S
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MT3 @"3S-IP>23Z8QCO6M/X=NKSQ5+JMR]N;2?33I\MN-VXJ6+%@?QQBNCHH
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M".F:M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO+*%>W):)Y$",2=W( &0,#GO2OX5U!H?#:"^M@=#*DDPM^^PFS^]\O!SWYH
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MJFW(\^*-\$A2<JVWG'J,8].BM]3DU+5[)=/NDDL39BYG;8"7#G$6#VSAR?\
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MI49VESD?-TSQGOC% '845QLNM:_>QZG#IGSW6F$0 I;JR7$XC5VW;F!526
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5E>(]!@\2:/)I\\CPDLLD4T?WHI%.58?0UJT4 8D&AW5
MQJMEJ>L7<-S/I\;K;B"$QJ&< ,YRQYP, =!D]>V1-X%NY/#.J: FMJEK?3/)
M&3:9:)7?>P/S#<<\ \<$\'C'944 8%QX>O+GQ%I6L/J$&=/BDB:(6I_>AP Q
MSO\ E^Z,<'\:H:1X-U+1G-A;>(7_ +"$A=+(VX\Q%)R8Q+G.W/MG'''6NNHH
M Q-'T&ZTS7=6U&6_BG34Y$D,2VY0QE5"CYMYR,#TZUKSPQW,$D$R!XY5*.IZ
M,",$5)10!R ^'MF?#6GZ/)=RR-97*3&X/WY /E*'V,?R?0#TK2UO0+K4=7TO
M5+'45LY]/\Q=LD'FHZN #QN&#QP<UNT4 <K8P6/@2TO7UG7$:UU"_DEC,\03
M#R98J<?>/![ >U6/!&AQ:)H.V))8Q<S/.D<V=T49)\M#GIM3:,=CFN@>-)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%\16?AO2A%]ON(FN)II062VA!QNV@C<2> ,CWJ>>/7K*>S,-Y'>V[SJMR)(
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MWC(,GD>>A<[?0IGJ,&M2:32=:,VK>']<GU36AI<\=MY+Q@QJ4)42*BJ1\^W
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M Z'ZU'>ZG8::JM?7UO:ALD&:54SCKU-5]!M);73%>Y3;=W3-<7 ]'<Y*_P#
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MGI0!7TSP[86%D('M+61M[.=L"JBECDA5YVKST_K6A<V=K>QB.ZMHKA =P65
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M=* '?V=8Y0_8K?\ =@!/W2_*!TQQQ3HK*UMW9X;:&-F&&9(P"?RJ&_U?3=+
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M-=B,%&57T'H*EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<+%H$TUNROIUCXP>6]2/D);"4D$@?P@[3^%=;,JWOQ-TN]TN5)4CTZ87TD3
MJ4)'E*2.,[MQ'L#76+#$@(2-%#=<*!FDAMX;9/+@A2),YVHH49_"@#DOA;=0
M2>![.T25&N+4R)/&#\T3>:_##L?8U%.NG_\ "X&%VMOEM"1D\T#EO.?)&>^,
M_AFNT5%3.U0N3DX&,GUKGF\/W4_C>76KE+.6S>Q6T$+$EAM<N&P5QU)&/UH
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MEC1"N\9#>>#C'KQFN@U?6+'2?';W.L7TUKIVH6$2V=Y'(1%N1G+(6'&3N!H
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M):YB%YYS K\FZ1\9],KM^HQ0!N2>*=/T72]&6?4CJ#Z@Z1176T 2CO(<# &
M?K^=7DU&SD\0,$UV,^79;WL R80;@?-8_>'! Y.,5PD5W;P^!? -[)/&MM;7
MT'GR[AMB_=N/F/;D@<UO"_LC\75;[3$N[0/XF"G_ %V[!!Y!QS@]J -Q/%WA
MV1[9$UJS9KMRD&V4'S&R5P/Q! ]<<5<O=6L-/;9=7*QML,A7!)"#JQ Z*.Y/
M%>5&\TY?@S=F.XMA(-4W?*ZYS]K!!^NSGZ>U=%J^NZ=H?CR:\.I6(%]I<8VW
MLK1QD!FV%'"L&!R<CCL<G- ';6.HV.IPF;3[VWNXE;:7@E610>N,@]>17*V_
MBF+2?%?B.WU[6HX[*V:U%J)]J;=Z,S 8 SS]>!6KX(MK*R\(:?9V&I1:E#;Q
M[/M,3!E8Y)(&#Q@G&.U8MG<:99?$'Q6=5DMH5G@M2GVG \R,1D/C/WAG ./:
M@#J)->TF*2TC?4;<->@&V <'SA_L_P![\*L"^M6OVL!.AND02-%GY@IX!^E<
M%8>&=0_X5A:+#"\.I:?.]_IT<@.Z/$C,D9'7YD.T@_WO:NG\*SMJMD_B&6%H
M7U0*\<;_ 'HX5&$7\<L__ Z )-6\4:?I&LZ=I=Q)B:^+G)!PB*A.2?J ,>_M
M6/9>*(],\2>)(-=UE$M+.:W6V,^U=H>+>0, 9Y/7T%.\6W,-AXT\)7MU((K=
M)+I&D;H&:+"CZDC '>LNVO--D\0?$&1Y[8YAA4LS#.T6X5ASVW<'WH [J?4K
M*VMX[B6Y01RX\L@[O,R,_*!RW'/':EL=0L]3M%N[&YCN('R \;9&1P1]1Z5Y
ME8:O;:?8^#M2U&[ECTDZ0;-KJ!SMMY_W9PY'3(3;^%=QX3@TB.TN[C1!*UK=
MW33M/([,)W(&YUSVSQD<$@T ;U%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !116-XK\0Q>%_#MSJLD1F:,!8H@<&21CA1^9_+- &QM&,8&,YI:Q+7
M2]9:R66[UV9+YEW,(HH_)C;^Z%*Y*@^K9/J*EM-0DT[1K$:Y./M[H(W$:%FF
MD ^;8J@D]">!TH UJ:$169E10S=2!R:S7\3:)'I+ZK)J<"6<;%'E9L;6'52.
MH;_9QFBV\2:->:A+I]OJ$,MU#&9'B4G.T<$CUP>#CI0!J45S>G>.M%O-/O-0
MGN/L=M:SO$7N%9,A3C/(ZDYXZ^U78_%6A3>>(M2AD:WE2&14R6WM]U0 ,L3@
M\#/0^E &O15&UUK3;RSGNX;N/R;9F2=G^3R67[P<-@J1[XJO_P )-I!6Z(N6
MWVD7G2Q&)Q($[,$(RP/J 10!K45B:-XIL-4\/0ZS(_V:&158B0$;2WW5Y'S$
MY XSD]*M0:_I5Q'<NMZB?8_^/A9@8FA'4%E8 J#VR.: +Z(D8PB*HSG &*=6
M5IWB;1=7NQ::?J,-Q.81.$0G/EYQN_4?F*@U#Q39:?XCLM$D60S7,;R,PC8J
MJC&.0.221]._:@#<HKB='\5P:7>Z_'K^M?);ZD8H&G !5-B'&% P 6ZX[\UU
M%YK%A8&-9[CYY$,B)&C2,R#JP503@9'/3D4 70J@   8Z<48K U;QCIFFVVF
M3QR?:8]4G2*"2)2Z%2>6R!Z \=2?QQNK*CPB8-A"N[+<<=>_2@!6174JZAE/
M4$9!I0   !@#H!6=%XATR>3RX[AV;R3.H\E_GC! +KQ\R_,.1GK2?\)'I'V2
MSO!?(;>^<1V\H!*R,3@ ''4GIF@#3HK.U#7M,TIF%[="/RU#R85F$:G@,Y .
MT=>3@<&L&_UUM/\ 'UJ)]5*Z5+I4D_EG;LW!T *D#+$@\#)Z\4 =?2$!@00"
M#V-5M-U.RU>QCOM/N4N+>3.V1.AP<$>QSVJG)>V7_"3K;_VSMN(K1G?3PR[=
MNY?WC<9!'3KWH MZE%>RZ?,FFW$5M>,N(I98]ZJ<]QD9[U%I&G2Z?;.;FX^U
M7=P_FW$P38'; '"]@   /;UJG_PFGAK]T?[9MB)I?*1@V06SC&>@&<C)X.*H
M^)/$2VOB+2=$\^:".[\YKF2*-MX5$!4*0#U+#)'(QVS0!U5-5$3.Q57)R<#&
M36);ZE;>'K+['JVLO>RP N\[PG<D9)VF38"%XXW'&<$^M6[SQ%HU@UNMUJ=M
M$;I"\(,@/F* 6+#'; //2@#0V+OW[1NQC=CG%.K$A\9^&[@*8=8MI"T'GA58
MEMF0N<=>I QU-(WC3PVMK;W1UBW\FX.(WR<==OS<?+SQ\V.: -RBJ%_K6G:8
M_EW5QM<1F4HB,[+&."Y"@D*/4\5GZKXOTW3;C28@YG&J/^ZDB1G3R]I;=D Y
MZ# ]\]J -X*H   &.F!TI/+0L6*+DXR<<G'2LNUO;.Y\27,4&L&::.V3S+ $
M%8>2=YXR&.<8)[=*>OB+26NH[87J;Y9#%&Q5@DCCJJOC:S<'@'/!H T617QN
M4-@Y&1G!IU8]WXMT"QENHKC5;=)+/'GH"6*9S@$#OP>.V*T[6Z@O;6*ZM94F
M@F0/'(AR&4]"* )-J\\#DY/%! /4=*Q[CQ?X>M3="75K?-HP6<*2Q0^^,^G/
MIWJ1?%&AO?6]DFIP-/= &%5;(?(W !NF2.<9S@T :A /4 XYYHP!VZUFW?B+
M2+&=X;F]2,Q,J2MM)2)F^Z'8#"$Y&-Q'45*NM:<^L-I"W(-\J>88-K9"?WNF
M,=L],\4 7J3:O/ YZ\=:KVNH6M[).EO(7:VD\N4;2-K=<<CZ?F/6N5?Q+'HG
MC76H]9U@QZ?%:V\D"2@81F+Y"A1D_=]SB@#L61'(+*K;3D9&<&G5276-.?3H
MM1CNXY+6;'E21G=YA/0*!R3[#FET[5;'5HI)+&X641.8Y%P5:-AU5E."I]B*
M +3(KXW*&VG(R,X-.JG?:E:6.V.>9EDE!*)&ADD('4A5!) R,G&!Q7':+KZ7
M7@S4KK5/$SVR?VE-##J&4#[%<;=HQ@Y Z =S0!W9C0N'*+O P&QR*=5*^U>Q
MTYBMU.5*IYC!49]B?WFV@[5X/)P.#27.L6%I%%)+/Q,F^-41G=U !+!5!.!D
M9..,T 7J:(T4Y"*"3G('?UKE?$>LO)#X<O\ 1M4)M+W58(7,)5DFC;.1G&>J
MXX([YK=O];T[379+JXVLB>8ZHC.8T_O-M!VKP>3@<&@"]2*B)G8H7)R<#&35
M675;&*""?[0)$N1F#R09#*,9RH4$D8YXIJ:SI[Z>E^ERK6\C%$8 Y=LD;0,9
M)R", 9H N*BJ254 L<D@=:=6?:Z[I=Y9SWD-['Y-L2L[.=AA(ZAPV"I'OBN?
M_MY[KXCZ?8VM_.;22QFDEM9(O+ 8%=K8*AB#D\\CCB@#KE1$SL15W')P,9-
MC16+A%#$8) Y-1W5W;V-L]S=3)#"@RSN< 55M]=TRY^T!+M4:U :=)E,3Q ]
M"RL 0#ZXQ0!>V+OW[1NQC=CG%#(C,&95)'0D=*QX/&/AVYFM(8=6MW>].V
MG#G.,9Z G' /7M5"/4[JV^(>HVMQ>RO81:7'<K$5!$9,C D;1D\+WR: .H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?BFT53936^H*6LH8"6F"R1YN)&P>&"Y!&!P.IKHX+ZQE^++W(FC"MH2*KO\
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M,8O?;C<,\%OEYY%6M;UBQN/$G@[7(Y2U@6N5,H0G:SQ852!R&)XQUSQ7<T4
M>:K?:+:ZKKVA>*Q>I+>WDDL$:O/MO(7 VA0AP2 -N.O ].-&Q>RM/B9;Q82V
M$/AY(D223<8R)"=FXGDA??..:[FB@#R998F^%TC1$,EIK?FRA!GRX_M6[<0.
MVTY^E>J6UQ%=VZ7$+%HY!E6P1D>O/:I:* "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAD,N49)!_ 58!@WMC-><Z3<?V=X:\+:E<Q7;:=8S7L-\+8R+);^9(3&Y"8;
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 F*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MD) !). .] "T5DKXHT=T:5+F1X%)W7*6\C0#'4^:%V8'KG%:%I=P7]G#>6LH
ME@G021NO1E(R#0!-1110 44F:6@ HHHH **0$'I2T %%%% !1110 450O=:L
M=.O[.QN962>^<QP*(V(9@"<;@,#@=S5F2ZBCNH;5F/FS!F10,\+C)^G(_,4
M34444 %%%% !1110 44F:6@ HHHH **3/..]+0 4444 %%%% !1110 4444
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MN=S1NP!!WC'"D8Y]><\=1!HES)K"ZS?W$$E[%;&WMQ%$1'$&(+-@L222!W&
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MREF)P2Y(^][]^E+H'AG6M)$%E=^(FO-,M"/L\/V<)*0/NJ[YY"\= ,X&>.*
M*]AXAU40^(;*_EA.J:=.L=LJ1;5D60#R3C)^\QP>>,58N-7U*75+C1K65A/8
MVT3SW$=L'W2/NP-I;A<+GN3GJ,<WKGPU;W/BVT\0>8RO!;M"\0^[*<Y0G_=R
M_P"8]*IZOX8U&7Q NNZ%JZZ==O"(+E)8/.CG0$E21D889/.?_K@&/JMWJ=]:
M>#)]9L18W[:R@GA!! (209')X(P>O&:V(=5U/7KO68])N8;5=,G^RQ^9%O\
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M^YYMK?3Y+J!#T:<EE)]R%&1Z9K6\9:R-&T^V>735OX;B[B@VF;85D+90_=/
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M-N,#!R<X"G5?$EYXMCT=9[?3UFT=;QE,'F/!(7"E<[L,1R,\#V- '8$A1DD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?DV]ZEL"KQX"E7C+<Y '?K7844 <SJ7A"35=&2WNM7G.IQ7"W46H)&%,<JC
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M".W>K.G^';*PT*72"#/%<>8;EGZS-(27)QZY/TK5I"RJ0"P!8X )ZGK_ $H
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MSW<MN<3+;0M((CUP2.,_[.<^U6=.U.SU:V^TV,XEC#%&X*LC#JK*>5(]" :
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MFJ[(G8*4!R??DC/-:6L^%DU7PE_PCD5VUM 42-I2F]R%(.>2.20,DY[T_7=
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MQGWZU=G\.W4^LZ/JDFHH7TJ.1 BVV!*' #9^;@X48]#Z]* .>O?%&MOX=O\
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M&*YQVSB@#9FN(X(Y&.YS$F]DC&YL<XX'/.#^55=$UBVU_1[?5;,2"WN5+()
M V,D<C)]*Y[P_#<'XA^)R^HW,B0_9<1OL*D-&Q"_=R "3C!'OFN;\-WFKZ/X
M%\):A!J1%M-=PVLEGY*;&CDD*DEB-VX=<@@=L=R >J4TNH<(6 9@2%SR0.O\
MQ^=</XNUS5]*MM<N[74QYEB(Y+:WMHE=8TP"WGEEX+$G #9Q@BIIEN;CXJV6
M-0N8HVT9Y1$NPJO[V,$ %3P<#)Z\=10!T/B#7;7PWI,NIWL<[P1$!A"FX\D
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MT[E9+.Y:ZL[R,*LL,C,6/3@@ECQZ5NZ-I4^G1N]YJ4^I7<N!)<3*J<#.%"J
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M(/;M6I0 44V21(8VED=41 69F. H'4DUFW6O6]IXAL=%D@G\^^21XI H\O"
M%@3G.>1V[T :E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;<@9ZG').:UKBZUCQ!=Z];:;</;2:?-]FM2DXC".(U;>XVG<"S8P>,#IG)H
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M:;HMCF2W969?,^4?.,8XX/&<T]Y-0BD\8Z+-JUY<PVMBEQ;S2,HEC+HY8;E
MXR@[<4 =-K/B.VT>RL[PPRW4%Y/%#') 5*CS" K')''/;-:]>;W,/D_"SPQ^
M]DDWRZ8WSMG;DQ\#VK=O[VZT/QU:/>W\IT?4X7CC1V 2"X7YN3CHR@XR>H-
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M4 C;865H]H!4#'0YXZDGF@#M:*X2UU34K!=>\/WE_//JJ3*-/F<@%XIL+$P
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M"6:ZV0W-S;DCR94D908PO\. W!'/R\DYH ]!IDDL<*AI'5 6"@L<9). /Q)
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M<\,6/\/)VXX'6K%U=:I>^--,L8]6N+6UO=*>>2.)4^5@4&5)4X//?..<8ZT
M=G17->!KV\NM-U"WOKI[M]/U*XLTGDQO=$;Y2V, G!KI: "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "J.M:1:Z]H]SI5[O\ (N4VL4.&'<$'U! -7J* .>MO",<.KV6K7&K:
MC=WEG$T0>9TPZMC(("@=NV/?-267A:"V?33<7UU?#2P1:?:-F4)7;DE5!8A<
MCGUYR>:W:* .8L/ ECIEZ[VNH:BE@TIF_LSSQ]G#YSP,9QGG;G'\JWM1T^UU
M73Y["]B$UM<(4D0]P?Y?6K-% &)9>&8K=[)KJ_NK\:=G[(MP4_=G&T,=JC<P
M4D GU]>:DL/#L6GZ[?ZPE]=R3:AL\^.3R]AV A< *", ^OUK7HH R=<\/0:Y
M)93M=7-G<V$IE@GMF4,I(P1\P(((/I69/X TZ>RU6S;4-1$.K2"2X'G*?FP,
MD%E/7:,YS[8%=310!BS>'(Y-7T_5Y=1O7N--B=(QB/#A@-VX!.2<#ICVQ6?I
M:VOB7Q)!XE33;FW6RMF@BDNH3$\C,>?E/.% (SW\QO2NJIDLJ0Q/+*X2-%+,
MS'  '4F@!719$9'4,K##*1D$>E<E_P *[LQI9TE-8U1--699H;42)B$AMP"L
M4W8SV)(_'FNN5@RAE.01D&EH YFZ\#6-W/JC-J&H1Q:M%LNH(Y5".P39O^[D
M''O@]P1Q4Y\(VGG:5.M_?K-ID30I*LJ[I4;&5?Y>G ^[C';%;?G1>>8-Z^:%
MWE,\A<XS4E '*7'P^T^XMK^T.HZE':WMS]J\A)5"PR[PY9?ESU'0DCVS73I$
M4MQ")9,A=HD8Y;Z\]ZDHH Y<> [(>'5T(:EJ'V5+G[2&W1;]^_?UV8QNYZ5>
M?PS;RZ^-9FO+J6;[&;-XG$?ER1$Y((V9Y//!'Y<5M44 <B/AY:+IJ:6NLZH-
M/AG6>WMO,3$)5MP ;9N(SV)./KS5J^\%6MSK3:M:ZIJ6G7,R*ET;.8*+D*,
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MR[/E^3CY>._YT^Y\):?>^%H_#UY-<7%M"B+%,S*LL>S[A#*  1@<X^N:W:*
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M?\27S=HF8+D3@8QG&..1T-<VPOK/PGXLUFRU2ZM9K#6[N6&.)@$8B49WC'S
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MG>3&:4%TW;BVXX.S@%N: &QWDFN>,]7TB2XG@MM*@@PD$IC:224,Q<LN#@
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M-^[?O^]L_O<UH+X>A'B&+7&O;I[J.U^RX)38T>0QR O4L <C'Y<4 8>AB_\
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M6.I7MA>74(>;3Y3+ W]TE2I_F#]0/2KU% &9J>A6VJWUC>3S3I)82&2#RV
M8C!)&.>#BJ5SX,TV?4;V]BGO;0Z@NV[BMIRD<YQC<1ZX[C&>^>:Z"B@#FKGP
M'HUSI6GV :\A.F#%I<Q7++/#Q@@/Z8 XZ5<7PS:Q6UM%!=WL4EM*9A<";?+(
MY7:2Y8'=D=CQP/05LT4 4]-TNVTN*5(-Q:>9IYI'.6DD;JQQQV X & *K3>'
M[>;Q!%KAN;E;N&(PIM8; A.2N,<Y(Z]:U:* ,.3PEI[3WS12W-O!J+%KRVBD
M BG8C!)&,J2."5(SWJ:;PY9RZQ9:HLD\4UC&8H$B8*BH<97;CD' _+C%:U%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:88VF%H[('P3MW*"">W!Z\4 =18^-="O_"[^)$N_+TZ+/F/(I#(0<;2/7D8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS<%X)ZG)[>AJQI]\-0M?M MKBW&]DV7$91_E8C.#V.,@]P10!:HHHH ****
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MT11;@ 9.TGOCG!P2.10!K445G)KVG2Z^VA),S7R6YN&38<! P7.[&#R>WH:
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M&EZP+\P/I9D,$8B#*V]=K;N>>/3%:NH64.I:;<V%QGR;J%X9-IP=K @X_ T
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MW8S6T<PA:5"F_;NV@C!(&>M 'FFE:!JGBSX5Z'HD<<%M9N$>:Z:4EPBL3A%
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M0IK2]E7S8#/>_(A)Q\I1OE^4^9GICA&_#0T'06T2747^UFX&H7;7;@Q[=CL
M"!STPHZ_G3M$\.V>A3ZA+:[LW]R9V!Z)GG:/;<6/_ C0!S]IK?B!](\4/&3?
MWFG:BT-LD42JWEA8R0J]V 9B,YR?RI]EXB;4] UN_P!)UUYVMK;<D5U;JLUI
M(JL65T"KUP,9ST-:%OX4GM8=46'5I(Y-2O%O#(D0!BD!4X'/*X0#!]Z>_A?S
MGU6YFND^VZI;+:RS10[55 ".%R<M\QY)/;L,4 9EGXCO[V'PEIOVDQW6KZ>+
MNZN@B[L+$K$*"-H+,WIP >.F*U_XAUK3!XHTLWHDN-,L/M]G>/"I9D*D[7
M7(9<9QR.U:Y\'(-/T6.*^>.]T-0EG=K&,[-H0JZYPP*@ ]/;%2W/A1;NRU99
M[O-YK$/D7-PL6-L>TJ%1<\  D\D\D]: ,FVU37+76?"[76J"YM]:B99K?R$5
M8V$.\,I W9R.<G'/ '0.^+=Q<6WP[U V[,@D:..5EZB-G ;\^GXUHOX5E>30
MY#J9W:)GRCY _>979\W/]WTQSS6W?V-MJ=C/8WL*S6]PA22-NC T /MHH8+6
M*&W55AC15C"] H&!C\*+>WAM81# @2,$D*.@R23^IK%TW0-3TJV2QM]?E>RC
M&V(36ZO-&O8"3.#CME33M0T^_2^TD:7?3P16\I-Q#L#),AQN+L><]<=R6SV)
MH W:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *:[!$9VSA1DX&3^5.HH SM%URQU^VFN+!I&C@
MG>!C)&4.]<9X//?N!2)KUA)XA;05:7[:MN;D@Q,%V!@N0Q&#RW;/0UC> ?\
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M"XCB^SR,)IBG#$A2,+GCG[Q)_A!H Z9?$-F^A6NKQQW$D5Y&CP11Q%Y7W#<
M%&><<GL,&C0?$5CXA@GDM!-');2F*>"XC,<D3CLRFLSP!?P7W@'2S9,)9+:T
MCA8.K(!(J+D9(Z<CD9%0>#KB[CU_Q!I^JV4,.I>='<R3V[%HYXW!5,9Y&T)C
M\SZT =?39)$BC:21U1$!9F8X  ZDFL'Q!JMS;ZQI6D6OF*U^)G9HB@?;&%RJ
M[^ 27'/H#CU'+^+8_$,/P_UY-4NY52*9#:R*Z>;)"SJ"DFT8XR>G7OWH ](H
MJ*WB>&!8Y+B2X89S)(%#-SWV@#]*XS1/$-U<>(;?3-6O;K3M52:4RV4\:B&Z
MCPVTPMMY ^4]<\'.: .XHKA+74_$VO:-:ZYH[2*\LY<0RO$+=H0Y!0_Q@X'7
MKG/0<5>CU*^UR/7[JWU"6RCTNXEM;=(50Y>- 6=]P.<L<8X&!ZG- '6T5C>$
M+ZYU/PAI5]>2>;<7%JDDCX W,1DG XK9H :TB(R*SJI<X4$_>."<#\ 3^%.K
MC?$,,\GQ(\-K'J%S"DD%V=B;"JE53D!E(R=Q!)S[8I;34-4\26.N7UEJ4ED]
MC=S6UI&B(5S$.KA@2=QSD<8&,8/- '8T5D^%M9;Q#X8T_5GB$3W4(=T'0-T.
M/;(.*UJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D8$J0IP2.#C.*6B
M@#(T#0!H*WBI>2W O+J2Z?S%48=SEL8'3VI'T#=XJ3Q!]NE$J6QM1#L788RP
M8^^<@<YK8HH SM4TG^UXS:W5RXLG&)((AM,H[JS==I]!C/0DCBKT<:0Q)%$B
MI&BA551@*!T %/HH QFT.ZBU2]U"RU>>!KQE9X7C62(%45<@$9!PO7/X<56E
M\%V$WAN^T9[BX)U"8W%Q=9 D>;<&W],#E5XQC Q6Q=7<EO<VL26<\ZW$A1I(
MP-L( )W-D].,<>M+J-ZNFZ=<7KPRS);QF1DB +$ 9.,D#I[T 8[^$V;6+?5E
MUJ_2Z2V^RW#CR_\ 2(]Q;GY<*<D\KCCIBJT7@*U@T"PTF'5+U1IMV+JUG^0M
M$P+8&"N"/F;J#U_"M_2=1CU?2+/4H49([N!)D5^JAE! /OS5N@"C!I\L&I-=
M'4+F6(P+$+=R"@()^?IG<>]5?$.A2Z]#!"FK75@D4GF$6ZH?,(^[G<#P#SCU
M^@K5\V/S3%O7S NXKGG'K^E/H PK'PR\,=W'J>L7VKQW4)@:.Z*A50YW ! .
MOK[4Z#PVJPV%M=7LMU;:<ZO;HZJ&RHPA=A][;VZ<CG-;=% &/JWA_P#M75=-
MU WLL#Z;(TD2(BD,S*5.[/L?:IM1T9+W4+34HIWM[VS#K'(H#!D;&Y&!Z@X!
M[$$=:TJ8TL:2)&SJ'DSM4GEL<G% %33M*BT^6ZN-[2W-[())Y6 &XA0H  Z
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MDJR-D$9Y^M=%10!SESX.CEETVZAU6^@O=/:1A=@H[S>8 'WAE*G.!CC P,#
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M33M,TW5KBS&GHD8D$:.955=N&##^6*N:?I<=C-/<M*]Q=7)7SIY, L%&%4
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MNRTO8I%$R+@ J?EP5P!QC^M;FEZ:FEVGDB>>YD9M\L]P^Z25L 9)X'0 8
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M*3366W@=)40B0QJ_F.-IW EL8Z87I5,V^I3^//#O]I7LB79TR<SK;2#R@ZE
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M)FFFW:3+!@Q7$XDD28'JI"CY2.HSUZ4C>"-.GAUB"[N+N[AUEQ)<1RL@"N
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M6C2^N[J'4HIQ=7$IQ%=%8MX>-"<H,],!00>_6@#OZ8)HS.8 ZF55#E,\@$D
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MEI+0JLA^>3'S$' ^GY^H!W%%><Z7XDUF:VL-$N;@371U6ZL)+HOY)G2!2>&
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M_,2<8/R]1R" =C16)X8MM:L[:ZMM9NHKDK<,ULRRF1UA/W5<E5R1SSCFMN@
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M],T9K.1CJ(E*3[EV+L7<1CKGIV% %2R\&6%E90Z<+J[FTVWD$D5C*R&-2&W
M$[=S -R S'\:KZN(/%&J1:)+I-T8K"\CN)KF>$K%\@W#8Q^\22%(]"WMGJ:*
M "L5_#%K_;%]JD-W>6\U_&J3K%* A*KM#8(/(4X].^,\T^;7A#XJMM!:SDW7
M-N\ZW!9=N%(! '7OWQ^-:] '-#P/9+HFG:0FH7ZV^F3I/;D-'N#(<KD[.0#_
M /7S2WG@BQN=:EU:#4-2L)[@*+I;.Y\I+G P"XQUQQD8-=)10 R&*."%(8D"
M1QJ%11T4#@"L1?"D%KJ-Q>Z5J%[I;7;^9<16QC:*1^[;75@&/<C&>];2SQ-<
M/;K(IEC579,\A6) /X[3^50Z?<W-U:^;=63V4F]E\IW5S@,0#E>.1@_C0!4O
M/#NGZCI%QIM\KW,=U@S22-\[,.C9&,$$#&, =A26OA^.&ZAN[F^N[ZYMXFB@
MFN2A,0;&XC:H!8X&203Q[G.M10!S!\"6+>';G0FU"_-G<S&9_FCW;B^\X.SH
M6YJ_+X;MY=;@U@WEXMY%;"V9TD51,@;<-X"XX8D\8'8Y'%;%% &#9^$+&TT?
M4=)>XNKFTU%I&F69ER#)G>5*J,9)S[=JBM?!5G;7FFWC:CJ=Q/IJ-'$\MQG<
MAQ\K  #'RCI@GOFNCHH YJT\"Z;8ZC+<6UYJ$=K+-Y[Z<MQBV,F<YVXSUYQG
M'MBKT?ANRBUZ\U=9+CS+Y%6X@W_N9"J[02N.3MXZX]L\T:1KXU;5-5L/L<EN
M^F2I$QD93OW+N!&,X&".]:] '/VG@VPM+:&Q%U=RZ=!,)H;&5E,2$-N49V[B
MH;D L15JT\/PV?B"]UJ.\NFFOE19HF*>60H(7 "Y&,GOWYS6M4<D\44D4<DB
MJ\S%8U)Y8@$G'X F@"MJ^E6NN:3<Z9>JS6]S&4?:<$>X/J#S65!X-MHM2LM2
MEU34[F\LHWB26:926#8^\ H'&/3GOFK>CZ\-7U'5++[');/ILRQ-YC*2^5#
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M#;R2I$\S(I(C0@%O89('ZT 245F>'-:3Q%H%IJ\4+0I=(76-CDJ,D<G\*TZ
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MK>Y@8"2/(PPY!!!'4$$4B:!:I97MN)I_,O\ )NKG(\V4E=O7&!\HP   .V*
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MM=!N)Y8[==(%YMCE:-IG+[.64@D*!TS_ !9/04 =917$W<M]I%QH?AO^U'U
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M%@ES<Z?-82,3^XG*EUP<<[21S6;XC\(6/B.2*YEN;RTO;="MO=6MPR-%DYX
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M[>U2^)?$-IX7T2;5;P,T<14!$^\Q)QQ^&3] :TXI8YXDEB</'(H96'0@\@T
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M2YA\VWN!)N1_O84\##'8W'M0 [_A"]+&G6-@);SR=/G2>#-PS,KH,)R<\*.
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M5(6)2%(S\P.<8/3'&,G,ND6>HZIIN@>(+?5XX78Q2W4QGD<72OP\3(?E!+'
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MV\ZE9%CD9"RGJ,J0<&@#SWQ!;:K>>'G\0V^D3KJ$%V-5@F+IQ&HPJ%=V['E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-@$1 $@*&&02,< ^^:<\<C6GQ"TVYB6.VM[-)HK5)2\<3- S';P,9*@XQC-
M'>27MQ<65G=Z5!'<QW#QL3)(8]L+<EQP<D ]*OUY[?6ZV?A'P;):R30EM0T[
M>$F<*X;;N##.".!UK2LC'XB\7^([#4P[QZ?Y$5O#O*A%=-QD&#]XG^+J !B@
M#L**\K2ZU&^T#PT;N_NS+'XB-A]H69E-Q"ID 9@#@GY0,XSQ72^&81IOCCQ#
MI5O+,;-8;:=(Y9FDV.P<,06)/.!WH Z^BN.\70-<>,/"UN+N[@CN9;A)E@N&
M0.HA8] < ]1D<C/!'%8%]:SZ+'XUT>TO+S[!;::M[;9N7+6TA5\J'SG!VYP3
M0!ZA17G=[$-%TK07AN;P?V]=V=O?SO<N<KL)PO/R;C@?+CBM*2W_ +.^(%OI
M5H'_ +-U33Y7N;4,=D;(0!(O]TG=@XQG@]: .RJJLEZ=4>)K:,60A5DF$GSF
M3)RNW' Q@YS7$:!O,%QX*NI99+RSU [YFD;S'M<^8LA;.>1B/VS5J:YFTOQ]
MK<L+32I#H2W*0/*S+O#OPH)XSM' H W?$^N3Z!8V]U#:)<++=16[[I"I0.X7
M<!@YZ].*VJ\OU&W@OOAYH.N23/-?7%W9S3W!D.79I5W*>VT$X"]!M&*UI8;G
MQ5K/B/37NHH9;.1(8 Q??;J8E994VL,$L6.?8#I0!W5%>?ZM_:MBEK=W,?\
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M\_A#?\(/X\>.:6&2+4M0D1XI&1@RJ".00>W2@#T2$R-!&TR*DI4%U5LA3CD
M]ZR?$.NSZ)-I2QVB31ZA?QV;.92ICWYY QSP#W':L=FBO)] LF>6\N#IIE-@
MS[86&$'FR-[$X'!.6SC@FN;CDN+_ ,"^$TNKF9I!XB6'S?,)<*LDRC#'G@
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M=,MGL*M:?:?:W\6^';V]N(]-T^5&M;KSF#VP>+>0'SG"9XR>AQTH [RBN'\
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MJ1/$GB?7K34W:1=/$$,$2LR! T>XR@ \,2>&Z@ 8[YF^%PQ\.M*&2<+)R?\
MKJ] '645Q>DQIXJU'Q-%J;RB2TO3:VZK(5-O&$&UTP>&)+'=U/'85A:;>:AK
MEIX$N=0O+I9KJ6YAG:*=D$RJD@5B <9(4'<.>>".* /4:*Y+P?%]@\1>)])A
MEE:SM+F%H(Y9&?R_,A5F +$G&3TJ?6Q!>>*+6P)DO)A9R2?8&?9"%+*/.=NN
M1@J, GDGCDT =-17,?#FZN+SP'IDUW,\TVV12[L68A9&49)Z\ 5T] !1110
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MQ<>?Y<L3FW6V(@G>)3$I)"[5(&!N..,C-:%O!#:V\=O;QK%#$@2-$& J@8
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M9XD/51N.5Z#..3@<\"ETO0--T:WGM[&!TAN'+R1R3/*&8_>.')QG/..M:5%
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M(R+:1%1)(S[<V[DXR3@9)XK..DII?AKP?KVFRW*:I(UC"W[]V$\;JH:,J3C
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M;N"V1[A<=.*V[F";3/&6HZ3I=S]@L;S1)+AMO$=I,&*+*HZ+P>0,9VYKJ9M
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M4\FN6T#PXT^J>(I-7TVYACOKYI(\W!5)HMJ@!E1\'H>&'0_6@#-T"\O+O5/
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M1D3.U2>PS7-Z'8V,/B_QI(EI;QO')#Y;"-05W6X+8/;)R3Z\U@:;I]M9^$_
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MPW MOM44D3$QR1@X;KR"IQ]00?4#SR[MIGU>YUC!^PQ>,;<NW\("#RV?Z!V
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M2K'6;)K+4;=;BV<@M$Q.UL'(R!UYYJY61XJU2[T7PS?ZG91PR36D+2A9L[2
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MSHS1R(/0.I# >V:>NC6"V4UF("8IQB7,C%I!_M-G<?3D].*O4T.K$A6!*\$
M]* (;6QM[*R2RMD,<$:[$0.WRKZ YR,=O2L^'PGH=O9W%E#8".VNB3/$LCA9
M2>NX9YSW]:UMZERFX;@,XSSB@NJYW,!@9.3T% $ T^U M@80YM6+0M(2[1D@
MKD$\]"1^-5QH&F+JS:L+8B^9=AG\Q]Q7^[U^[[=*OEE! +#+=!GK0SJH)9@
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M7J7WV-/M4<?E)-D[U3^Z#G./:@#S^V26/X<W5K;2JMO9ZZ\0MVDV^;"MQ_J
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M<*/KD_6N>^)\,<OP[U<R*#LA#+['<*T)?"VFM>:7+#96\"Z828#&F&7/\(]
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M1(=$LD6.83(!"/E<9P1],G\ZL0Z!I5O<>?#91H_FF8 9VB0YRX7H&.3SC/-
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MP0,9Z8I&0>&M;UCPW#$NW7@)M-8KD!FPDJ?1,^8!V7-=B?#FCDVA-A$39?\
M'MG/[G_=]/PJEIT.J:IJT>HZSI46G_81)';1B=9F<L0#)D ;1M& .OS'/04
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M7:0IW,!@GH*7SHO.\GS$\S&[9N&['KBO-8]$TJXL_'ZRV,$BPSRM$&0$1'R
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M4TW0I;*.?3%AQ]J4LL[N"Q7*D;0%QS@\GVYH:W:V]KX@\)7F@QQ1O-.83]G
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M!D,Y5@89W0D,LJ],Y!Y_'!J&>]3Q W@/5M2LH8Y;R5S*KH,']R^.O8GD#WH
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MV[>E6YKNVM\^?<1184N=[A?E'4\]N1S39+^SA5VENX(UC"ERT@ 4-T)],]J
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MN6M4NH6G3EHED!=?J.M8/A[Q!/<SZQ%K%U:1FSU-K2!E'E!E"(0,%CD_,>]
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M4GA;09M976)-)M6OU(87!C&[(Z'Z^_6IVT/2FNWNSI]N9W<.[^6,NPZ,?4C
MP3TQ65%K]PGC6\TVZN;5=.BTZ.[CD VXW.5^9B2#TZ\=:Z SPB#[094$.W=Y
MFX;<>N>F* )**BM[F"[A$UM-'-&W1XV#*?Q%2T %%%% !1110 4444 %%%%
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M],[L>U4K;1-)O_B7X@BN["VG4VEK)LDC!!?+Y;'][@<]?SKMXXTAC6.)%1$
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M+<2.TL\BC >1CEB!Z<X'L!65XVT>^US2;>RL8892+N&:03/M78C!B.AR3C%
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M?B=HUO>X^Q/8S&UW?=-SN&?^!"/./J?6NELM.L=-B,5A96]I&QW%((E0$^N
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M=>(['6-/UQKRY:U:)8[<Q!6AZY=44' .,9Z$@4GQ 2'=X;DF6/:-=MPS.!@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %8OB[4KW1O#%_JE@T FM(6E"SQEU8#MP1BMJL/QK:37W@K6;:
MW0R326<@1%&2QVG@>] %O29[V]T"UN9Y81=7$"2%DB(12R@_=W9QSZU7T'4Y
MY]$M+O5KJT6>Z.%\M?*4DG 4!F))_&H_#NL:>W@K3M1-W$MLEG'YDC. $(4
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MVXD+*#D_Q,V>".:M^!9K9;WQ);"2,7']M7#>7D;]N$YQUQ0!V%%%% !1110
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MZ65_;7+1@%UAE5RH/3.#7/>/O$QT7PW>R:9JMI!J4 4K$Y5WY(R I/7!ST-
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MGIP3WJY0!3N-+M9;>YB2UM5-U_KB\"LLA]6'&[\:DL+*'3=/M[&W!$-O&L:
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MS\L2#SGOGT^E>M6UC:6086EK#;ASEA%&%W'U.*:^FV$DSS/96[2R !W:)2S
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M##;)R/\ KHU='_9]EO=_L<&^3.]O+&6SUSQSFGP6T%LI6W@CA4G)$:!03^%
M''6T&ER_$?Q(-3CM7'V*U*BX"GY,2;R-W;IFN;T^63P_IGAF>]N+BPT7[=>>
M5-M!\A7)^SEMZD %2_)' ;M7J5Q8V=VZ/<VD$[1G*&2,,5/MGI4DT,5Q$T,\
M22QN,,CJ&!'N#0!@^%;;1TN=4N]'OY+];N99+BX#HT32XP=I0!<XQG'MWS6)
MXBU+3SKVO66^"RNAI2I-+.V7NE8.52)"<<$G)P22P&.]=S##%;Q+#!$D4:#"
MHBA0![ 4C6T#SK.\$;2J"JR% 6 /4 T 8O@6XBN? VB-%*LNRQA1BK9PP101
M]17,:/J6@W.D:SH/BAXC?C4I6N+25RLMP3)NB* $%N-@&WT':O0XHHX8UBBC
M6-%&%51@#Z"HVL[5[I;MK:%KA!A9C&"X'H#UH Y*QAL[OXH:\+F*&1DT^V!6
M0!MN=^X?D1^=8'AW5;&V\&^"DN3 )WFF%O=W,A$-LRAQE@"-Q*G:%)')Z\5Z
M4=/LFD:1K. N^=S&)<MGKDXH_LZQ\GR?L5OY>[?L\I=N[UQCK[T >37D]G+X
M \;Q/=17#KK+2JQQDAFAPX Z G.".O-=A<QV5I\3M#%JL,/FZ9<+B,!=ZAD*
MCCJ.N*ZJ2QLY=WF6L+[VW-NC!W'&,GWQ36TVT^]';01RJ,1R")<H>Q'':@#S
M*T;3M0T >&Y-:TL>1K#S?:I[M%E95G+D^6?FWDY7G@CG/:M:ZO["S\;:WIVM
MZL=*M[JVA^R%_*6*6 (59 SJ0,,6XR/O5=M/"NK?9!8:C:^'[M0I5K^2W9YI
M,]69",%CU)W=:ZA=*L?LEM:RVT<\=JJK%YR!RN  #D]^.M %?PU:VECX=LK7
M3VG:TBCVP-<'+E,G:?ICI[8KFK:2>3Q+X^CTV0&^$%OY 4\B3[.0O_CV*[FJ
M\=A9PR^=%:01R<_.L8!_.@#SFZ:'4OA%HT>ED#589+6.V5>)([I742<=01^\
M)]LDUKZ58Z9<_$WQ/'/;6LKB"S8(Z*W.&).#WSM.?I77I8V<=TUVEI MPXPT
MRQ@.WU/6E2RM(YS.EM"LI))D6,!CGKS0!7US28==T.]TJXQY=U"T9./NDC@_
M@<'\*\Z.K:D]CH_BZXMY%?0)!8:@@3+R[CY<Q'J%(C88[EO2O5*9Y,1C,?EI
ML8DE=HP23D\?7F@#A/%UJMMX7T:.^5!+=:U;2W*L1@N\FYE]P!D?1:N6T5K#
M\5[ZVCCA2.71(B\8  8B5QR/IC\*ZR>TMKK;]HMXIMOW?,0-C\Z9_9UCO+_8
MK?<1@MY2Y(QC'3TXH \OTV^CT[X>^%+V3G2K;5Y#>%1E47S90C-C^$,5/UQ6
MYXIN/#]SX4\5ZAI$D$\MS9 75U!)OC=@I"+D'&[!Z#GD9ZBNV2RM(X7ACM84
MBD^^BQ@*WU'>D73[);9;5;. 0*<B(1C8/PQB@#BYX[.T\6>!3;I##YMO<J2@
M W@PJ?QYY^IK1^)X)^'>JX&<+&3]!(I-=$-.L0R,+*WRGW#Y2_+SGCCCFIW1
M9$9'4,K#!5AD$4 <7K<^GZI\0/")26"ZA,5ZRD$.K$*F".QY4_B/:N?N9S9Z
M1XJ-MN%K:^(XYKI+< LL.8C(0N".Q)!&.#GO7IQT^R+HYLX"T8 0^6,J!TQQ
MQBEALK2W+&"UAB+##;(PN1[XH YK0SH.H^)O[8TW6I-5O&LO*DDC>,HD>X%0
MX11ALYQGG@^E4_'$;Z;XI\->*9%9K'3I98KM@"?)65=HD('8'J?I796UG:V4
M9CM;:*W0G<5B0*"?7 J4@,"" 0>H- %-]7L!;I-'=13B7_4K"X<RD] N#S_D
MGBN:T2XC3QIXJM-7,:RR^5)%YV LEKLQQGJH.[/N3746NF:?92-):6-M;N_W
MFBB52WU(%.N;&SO"ANK2"<QG*&6,-M/MGI0!Y99V:Q^'_!<>H(K1MK+B 3CG
M[.1)L!SVQMX]"*UITB36/B-:VZHI;3(6$28&6,$F3@=_N_I7?3V5K<D&XMH9
MBHP#)&&Q^="65K%,9H[:%)6SEUC 8YZ\T ><W\^F7WAOP$WFVTZ)?6D4C;@0
M/W#94GZXR/SK;U*ZTC2_&5G80I9Z7/\ 8)9!=2?*@C:0;DC3(4N6&XD],=#F
MNH;3;!D5&LK<JF=JF)<+].*E>V@E>-Y((W>(YC9D!*'V]* /)M U>#3O#G@N
MZNYA_9EI>7,=XQY6"0F01%QVQD]>F0?2MOQDVB3^!?$UWHGERB=X9+FY@??'
M)('3.#DC( &<>OKFN]-I;-;O;FWB,+YW1E!M;/)R.AI4MK>.V^S)!&L 7;Y2
MH N/3'3% '(3ZE"_Q-TJYDGCETVXTV6*RF# QFY\P%P#TR47'X$5S/B2U">'
M/B#+$JG3'N86M>!M\["><5_X$<<=P:]3ELK2XMA;36L,D   B>,%1CIP>*&L
MK1X$@>UA:%/N1F,%5^@[4 ,L;2PMHM]A!!&DH#%H5 W\8!)'7CO7(Z]'-H_C
M(R6UOYL?B6T-FZ[=RBX3[C-_L^6S9]DKM8XXX8Q'$BHB]%48 _"E9%8J64$H
M<J2.AQC(_ G\Z .'\%PW0F'AZ\5V3PS.Z+*X_P!:&'[@_A&S9'8[:E\.?9XM
M5\:I%Y:(EX"0N !^X7/ZY_6NS"*K,RJ 6.6('7MS4"Z?8KOVV=N/,&'Q$OS#
MWXYH \VAEC'PU\"DNH']JV(SGT<Y_E7I.I G2[L 9)@?_P!!-(=,T\H$-C;%
M020OE+@$]>WL*L@!0   !P .U 'E*:=87?PN\-C38;<ZPTML;5X@/,$H<%R2
M.>%#$YZ8YJ\;S2I=2\4:)XFUI].:XNF8PR&)%GMV10A1F4DD 8P#D$<<UZ#%
M8V=O.]Q#:0132??D2,!F^I')I9;*UN)HYIK:&26(YC=XP63Z$]* *UK"\/AV
M&&S\X.EHJP_:/]8"$PN_WZ9]ZX'P[/H.M:#H5I>ZS='4]/GB(TX&-)TN4X8[
M0@<C.XDDXQDD]:].J!;*U2Z:Z2VA6X<8:41@.P]">M 'FWV33FT'XCDP6Y>.
M:YV_*N5Q ",>GS#\Q5Y;Z"#Q#X(N[JYC2.329E\UV #-LBXSW/M7<#3-/ 8"
MQML-]X>4O/UXJ06=JJ1HMM$%B;=& @PA]1Z&@#B+1(AXD^($4"J"8+?Y$'<V
M[=A[UG7E_:3_  B\/^3<Q2>2^G1R;7!V,&3*GT(QR*]'CL[6&5IHK:&.1LY=
M4 )S[TUM/LFB6)K. QJ254Q+@$]3C% '%7VI6=IX\UBRUS5VTN&\M8?LKR>4
ML<T04AUW2*0"&+<9&<U6L9=/T'Q5X<MVGE30QIL\>G37C<><9 <Y.!S'PN>S
M8[UW\UA9W*1QSVD$J1$&-7C#!/IGI3KFUMKR+R;JWBGCSG9*@89^AH Y'P+<
MV4FO^*TM)H7#:EY@6-@<@QKEN.Q.>?6I-8N8+/XG:++<S)"CZ=<HK.V S;D^
M4>I]JZR*"&#=Y,*1[CEMB@9/3G%#PQ2NCR1([1G*%E!*GU'I0!Y[I<MM-X-\
M6V.M;!>I<W1O$D^\V[F-@.XQM"GV&*[#PM'?1>%-*CU(L;Q;2,3;_O;MHSGW
M]?>KTEC9S7*7,MI!)/']R5HP67Z'J*L4 >22ZSIESI?ARYM+BVLK6/Q DGV/
MS,R0 O)N>5F.023G' &['/%;UA;:;/XV\:^9#;N/LMJ<,HZ&)MW],_A7;"QM
M!OQ:PC>XD;]V/F8=&/J?>FG3K$L[FRMRSYWGRERV>N>.: ,/X=2>;\/M$;?N
MQ:JN<YQCC%<O'<Z/>#Q'H/B?6I;*5]0E:2U<QJ9XRP,3)E"S?*%  )/ ]J])
MAMX;9-D$,<29SM10HS^%,DLK66YCN9+:%YX_N2M&"R_0]10!Q>D:O9:9XXUF
MVUJZ%K(UK:BQ-ZX!>$)\P!/!.\MD#J?I6#9/#;_#KPE<.5BM[?Q%O=V^58T^
MT3#)ST'(KU&YM89F29K6":>')A:51\K>S8)'U%8OA+0+K2?"R:-K$=G<;9)&
M/EDNCAY&?D,HZ%L=^E &5I=]IM]\3-;5;BWGBETZW ^8,L@5GW8[,!WQ7/64
ML4?PK\&W#2*L,&L6S22$X5%$[9)/8"O4196JJRBVA 9 C 1CE1T!]AZ4BV-F
ML#6ZVD A<Y:,1C:WU'3M0!PVNZOI5UJFOV\$]M;3-I2"2>1]SWB,KE5B4G&!
MGD@'.X#'>J-C)87TWPV,[P3PK82QMYA#+Y@@B^4YXW CIZCVKTIK6W:99F@C
M,JKM5R@W >@/I3)+"SFM1:RVD#VXZ1-&"@_#I0!Y_+9PVD'Q#GL$2+2Y;(JF
MSB,SB!_-V]NI4''?Z42:G'IEQX/N;_4)+#39=)\F.Z4(4CG*QD;BRD#*@@'Z
M\XS7H1M+9K<6QMXC"  (R@VC'3CI36L+-[4VKVD#6YZQ&,%/RZ4 9'A*TTJV
MM;Y]'NY;NWN+MYGG9E:-Y& W%"H QGTXSFM^FQQI%&L<:*B*,*JC  ] *=0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !45Q<06D#W%S-'
M##&,O)(P55'N34M<YXZOK33_  \LM[;)/$UW N96(CB;S!MD<CG:I )'?&.]
M &S9ZE8ZCYHL[J*<PMMD5&R4/7!'4<>M<UK_ (G":UH-OI6KP,MUJ"P7$,>U
MRZ;6)(/H"H'%<S>WDTVH>-$TO41>7MWI4#0/" /-"B0.8]O4 < Y/.!G-6]4
MU[0+VU\$36-Y:A(M0A&P.H,"^4P*L/X><#GTH [.'4K6&_U2>;7[>6W@$>^
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M/WWAG7X=!*W]Q/J-AM\NQR%>V8+M?<H484 $'/!X'4BL6X.GM\,O&C(;<O\
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M:G=N0'/EYZ%BN_CKZ]14^BWWAGQ%K6EZG8:G<:A?6\3[%# &W1EPPD4 8&<
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MK@5EL;?1_AQ)&]O$?,BRRD#[UN0_YMU]Z9;WFBW$&N>'?%.H7$%RVH3,]F<
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M@U^*"2,K'KEUM1",*I88X'0=: .PHHHH **** "BBB@ HHHH **** "BBB@
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M$LJRR01O(GW7902OT-2T4 %-9%==KJ&'H1FG44 ,$48C,8C78W!7:,'\*<%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD# D@$$@X/
MM3)9HK>,R32I&@ZL[ #\S0!)134D20 HZL" 05.>#WI0P)(!!(.#[4 +135D
M1F*JZDKU /2AY$CQO=5STR<9H =112*RN,JP8>H- "T4R.6.9=T4BNH.,J<C
M-#RQQXWR*N>FXXH ?13&EC3&Z15W=,L!FGT %%,>6./&^15STW'%'F1^7YF]
M=G][/'YT /HIJNKKN1@P]0<TH8,,@@C..* %HIC2QHP5I%4GH"<9H:6-)%C:
M15=\[5)P6QUP.] #Z*0LJX#,!DX&3U-#,JC+, ,@<GN>E "T4R6:*!-\TB1K
MG&YV &:=D 9)XH 6BHHKFWN!NAGCD&=N4<'GTXIRRQN[1K(K.GWE!R5^OI0
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MSVS704 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/ "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>66
<FILENAME>ebs20191231exhibit1048027.jpg
<TEXT>
begin 644 ebs20191231exhibit1048027.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;V'0_'GB&+6)H[2.]6"6REF8)')$B;612>,J<\>^: .DN-?TFV6T>6^B"WI
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MI0K9EMGF9/WLXVXZ[L\8QFEM?$VC7M[<65K?+-<6T?FR1HK$[/[R\?,/]W-
M&K2=*YG3?'NC7>A2ZQ=3-96T<KINGB=<@.57MR3C.!DC.*T(_%>AS>8(M025
MHIQ;E8U9F:0C(50!EN.>,\ T :Q&1@T  =!BJ%OKFF76G2ZA%>1_9H&9)7?*
M>6RG!5@V"I'H1FJTOBO2(K:^F\Z4MI\7FSP?9Y%E5<9!V$ X/KC'O0!L  $D
M#KUI:S?#^L1Z[HEIJ*1O&9X4=D9&7:64,0,@9'/4<5H.I=&4.R$C&Y<9'YT
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M@^N*=10!D:)I-]9F2ZU?45U"_D01F5(1$BH"2 J@GN22>_'H*UZ** "BBB@
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M%MT2VUTKNJG";T0(&],D$ 'TH Z1/$&FR74-LDLC-/(\43""38[(&+ /MVG
M1N_8U5\.^)H?$,M^L5O<1"TNG@7S8'3(4*"22, [B?EZXZBN7T@3:?K6G-H-
MY)<Z?>7;?:=(NDW/8$ABTB,>44'(YX.[C.:U_!,A@OO$-A-#/'/_ &O<3_/$
MP4QL5*L&Q@Y[<]C0!H:MXH@TKQ!IFD-;W#O?>8Q=+=W"JJD\;0<G.WIG ZXX
MK#L/$\&B^(/%":SJ=Q);VUQ%Y09&E,2&(,QVHIVJ">3C'3-6_%#FT\:^%M0D
MAF:WB^UQN\432;6=%"@A0>I!K,MYH3?>/G;@3JOEY4_O0(-AV_WOFXX[GWH
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MO#T^JMK4]S8+<R!KBX#.58MR@ 7.T$X'%4Y;J#_A:EI.) 8CHTD9E'*;C*K
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MX+4RRL^Y?W*L%.P$#)[G QBN/M)!!X&\/VEQ;W"26GB%7FCDA?*H+AV+=.0
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MTJR79)>-#R%)/)Q[\UB'Q5I^B^&-)N+2ZOM7AO;I+>&YEC>1WW2X9F(4=!G
MQDX  -=6\L<432NZK&HR6)X KRVT61/A7X;D\B;_ (E^JP37*")B\2+.225
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MAE'^](%.%4G&,CJ<G'%5M/N8VOOAVS)*HMK&6.4O$R^6Q@1!G(XRP(!/7'%
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MUC5-2\/WTD>I!XTN-*G3S(=3&Q,%%/?:0I*_W><=: /1**0$E02,''(]*6@
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M]NWMAXKC\T26QFV>2X)VJL1^4H!@9QGOG- '6ZQH=Y?:C:ZEI^K26%U;1O$
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MH0F:V58')D3;NXP.N"..O(XJJ?'F@"QFN_.N2ML[)<(MG*9+<KU,B;<H!ZG
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MCD]N/>IKSQ5IED+B20S-;VDGEW-S'$6CA;C(8CTR,XR!WQ6;JHN+7XB:5?\
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M[GC-9,JSW'Q,BN!:WL,,FAO!YYMWV1R-*K!2P&W( )ZUBV]I>M\+YO!L^G7
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M2X<">W>,21.J@,I8#/0].F* .HFU.""\M+1TE\V\#&,!"<;0"=Q[8R.M/O\
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M:RM)ID4L4;[C$"J2*8VSCH01D?C7FZ3:A>IX9OI](U47-IJ6;R!;1XXK?*N
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M6N\R10--,1$B+N<N0 @ R<GIQ0!)16)'XKT]YK)98[FWAU%@MG<31[8YV(R
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MW&;1@J"-6#$,>&7N""1ZXXKTBB@#C;9)XO&GB>Z>RNQ#<64"12?9W*R,BON
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M)0$D#U/Y5W=% " Y&:6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K"\::[/X;\+7FJ6UJ
MUQ+$F%P5 0DX#-D\@$C@9/\ ,;M<[X_TZ[U7P/JEE8PF:XDC!2->K88,0/?
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M7#(RH"P.0,'&#ZUL::MS<ZEJ&KM;2VR301001RC$C",R-O*]LF3 !Y^7G&:
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M'E%IH-VTA]BY)&5P<<@<UI:!I\S>+=<UXQ20V]\L$4*R(4:3RU.7*GD<G R
M>#VQ0!)JWB*ZL?%FEZ-#ITTT=W'+*TB-'\P0#@ L.A8$DX[8SS6!I>O0^'=4
M\6R36^H7D-O?!W\D&4Q1^4I+$L>@YXSGK@<5L>(+>]C\:>']4@L)[NW@CN89
M3" 2C.$VDY(P/E//:LN*VO/L_CD'3[P'4&<VH,#?O@80@QQ_>'?ZT =7+KEL
M%MA:Q2WTMU#Y\,4&W<T?'S98J /F'4CK2Z)K=GK^G_;+(N%61HI(Y%VO$ZG#
M*P[$5PYL;W3F\/ZM<>'9]6M8](CL+RT%N'FMY%P0X1NO.0<=N:[;08U2P:2/
M24TJ.:0NEL(U1P, 9<+QN./RP.M $.I^)K;3$O)?LMU=16 S=R6ZJ1!P&.<L
M"<*0Q"@D BHY/%VG1ZCI]F4F*:G$9;2ZPHAE4+NX8MP<=B*YQK671O$VK17_
M (2EUNUU*X^T6MU!;QRE2RJK1ON(V@%>"3CFK_B#1'\1Z?#X>DM/L*6UN+CS
MX;?,4<P&$2/C! )Y]1P.IP 3Z[XOGLO"L.L66EW1^U31QQB78I0.P <C=WSQ
M^&<#FM>?6Q"RP+I]W/=F+SFM8O++QIG ))<+R00/FYP<=#CEM6EUKQ%\/4-Q
MH]S%JEO/;R3VPCP9-DJEF3/4$ G'7M2:O'<VGBM==N/#$^K:=?V:0O$L"2SV
MLB,Q4[">A#<X/'>@#:3QYH4EKIMPDEPR:FS)!MMW)#+G<IP.&!!&WJ>P-*?&
M-K+H^K7MK97;W&DAC/9S((I%PNX$[CC!'.?3H#TK'U*WE2^\+RPZ')9PPW[S
MR06MJ6$"%&4%_+!&XDC..F>^,T+97EWK?CF*.SN5_M&UC2U>2%D25A 4.&(Q
M]X@4 =-X;U&XU;P]8WUU;O#+/;QNV[;AR4!+#:3@$GC.#[5G7GCO2+.>_MQ#
MJ%Q-IY N(X+-V9 1NW$8X4#G)XYXS5OP@TX\*Z;!<V4]I+;6T<+QSJ Q*H 3
M@$\9!ZUA:5J,5CX]\8B6"ZER]H1Y%N\N[_1UX^4'!^N/YT =$GB.PN;.RN;
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M\U)110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M22V2!CWXXYH Z.BL:+Q)#_:RZ5=V=S97<L+30)+L(G5?O!2K$;AW'7\*R_\
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M_P!HU(!(]B(VY]F[^%L#/;]<5,/%\;*$72-1^U"T-W+:NB))%&&*\Y8#)*G
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M@<FNFMY7F@622WDMV.<QR%2R\]]I(_6@"6BBB@ HHHH **** "BBB@ HHHH
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MMIXYI?+P(VDV[0<\_P )SCI5CQ[I]YJ?A*XM["W:XN%EAE6)2 7"2JQ SQG
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M88(^HKB9]"U*\OO&&EM:2Q0ZRH:WO=R^6/W(3!YW9W#ICI7<4!@P!4@@]"*
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M D7J3ACN^B]?4=:R;*TU'P]XLUJX^PSWMCJS)/%)!M+1R*NUD8$CK@$'IZT
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M)"'CX"2AR<[L=/>N@FL]1B^(L.KQ:?)-9W&EBU:170>2XE+G<"<XP>V>?SH
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M;&^AEFB#Q\(DN\D'=@\'CFNTM=9N)O$5QI4VF36\:0B:&Y9U*S#Y=PP.5(+
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MSZ<]T;5+B(IEGW%,X)'RE@1DG\,<TR[M[^?Q[I&IKIMP+2&RFBFD8H/+9RI
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M:(*=AVGJ2#GMGN>M=987VLZY:3)=Z+)I*&!D*W$JLSR$8^7:3\HYY.">..M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\R\G &>O%5#\0H(M%U:]NM(O(;O1G5;RR+(73=]ULYP5/J/RH Z\ *    .
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M%,-Z\",,!WE)" GC@8&>F<UZ76;K&A6>N+:K>--BTG6XB$<A3$B_=;CKC\J
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M/3)]$DE#'6+83(;>8E#RJJQ^;=@@C'&<\\'K]-N;RZ@D>]L#9.LSHB&59-Z
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MFCLB1 Z?*WE'C+%>OK[<XKMZS+'0;33]7O=4A>8W-_M^T%Y,A]HPO'; XXH
MXZ/PKKGARRT._P!-M8M1N['[0+VR$@02+.P=@C-QE2!UZXJ_XCM-?UOPQM31
M#%</=P2I:)-$6C1'5B78L%R<'@$]O>NUHH YKQ/I<6NK96U]H,UY:LCNTD<B
M+-:2_+L(.X?[6=I/('45=\*VFIV'AVUM=7N'GNX]P+R,&?;N.P,PX+!< GU]
M>M;%% ''PZ?JL7B7Q5>G2YC!J%M!':L)8OWC(CJ>-^1DL,9QTK/&CZXGA/PE
M8_V+.;C2KRWDN4$T/"1JP)!WX.<\#^5>@44 4=9$[Z1<+!8I?.R@&UD*@2J2
M-RG/'(SUKEM(\*W-FVL6FGQW-AH][8F.*RNI0XBG;<"4 9MJX(SSR>G KMZ*
M /.X=.\23:7X2M7T!X6T2XB%P7N8_F"1,F]<$_+]>>>G>K6B75Y#K'C"*VTV
M6[9[_P#=E'0+O\E!AMQ&!TYP>]=U69I>@VFD75Y<VSS&2^D\V?S)-P9^F[';
M@8XXH XM-,E\+:]X&TQ(WO'M+.\23RB 22L98C<1QD_E5C5?!VI:S%KVIQ*M
MI?WUQ;36D$K X%N/EWE20"QW="<?+[UUEUH-I>:U:ZQ*\_VJS5EA*R850WWA
MCH<X[UIT <M<6-]K^MZ+J-SILUA'I1DGD25XRSR,FT(NUB,#)))QT'J<,\*Z
M9J4&@ZM8W]@]G)<W=S+$9)$8,LK,1]QCC&><_K7644 8'@FVU&P\*V.GZE8F
MTFLX5@(,JOOVC&X;<C![<Y]A5.TL-2\/^+-8NXK"6_L-6,<RF!T#PRJNTJP9
MAP>"".G0UU=% 'GU]X5U6T\ )I-K9&\OI[];R98I$5(SYPD(!<C. ,#'4CM7
M?1.TD:NT;1DCE&QD?7!(_6GT4 >>R:'K\?A/Q3HJ:297O;JYDM9%N(P)5E;*
M\$C& 3G..V,]M*ZL-5FU_P )WBZ5/Y.G1S+=$RQ9C+QA!QOYY&3C/'Y5V%%
M'"^'[3Q/H,+>'3HL-Q;Q2.+753.FP1,Q(+H?F++GH.OJ.M=U110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %<O\1-=N] \(S7%@VR\N)$MH9"/
MN,YQN_ 9Q[XKJ*Q?%OAV/Q3X<N=*>4PO)AHI0,^7(IRI_/\ 0F@!UKX5T:VT
MY;-K&*?Y?WDTJ[I9&[NS]=W?.<U7@N5T!-,\,V:F]O!;GRQ))L"Q1X&]VP2.
MJC@')/U(=IVI>(1;);ZCH#_;%&UKB&XB^SN?[V2V\ ]<;"1[U3U'2-5MO%>G
M>)+6,7SI:O9WL$;+&Q1FWADW$#ANQ/3OF@!MUX[BL]$U>\ETV;[9HSA+NS$B
MY7/*L&/5".0<9]JMP^)YV\00:3=:3+:_;+=YK.5Y5/F[,;E('*G# ]_Z5AZU
MX6U/4-*\574-H?MVO"&.*V,B#RDC4*"[9QD_,3@GJ!S6G>6.IW7BWP[J:Z;*
MMO903I<;I8\H9%4#C=SC:<X_#- %*P\9:G!X8UC7=1TU9ELKJ=/+MYQ\H1MN
M/F X&.O4^E:R^)-0VH7\/7,?VF>.*T)D4B0.I8N^W)C50#G(SR.*P9/#^O+X
M0\2:$NG([7EQ</;2K<+B02ON!(/3 )SGVQFM;7+?7;G2M(^QV+.L4RF_L#.J
M-+&%(V[LX(S@D9Y'![B@":W\8VQL-3N+NW:&;3+K[)+#&XD\R0[=@0\9W%@!
MD#GKBI)->U.&XO+2712D\-F;J&42EH),'!0R;1M8>F#QS7,2>#M<N+/Q!;Q6
MMK8//>PWU@Z2AD#H$PF !@?*03QVP#73Z?-XAU>UE35=+BTD&!H]GVA9C(Y&
M,Y4851S[G/;'(!0T/Q5<GPCI%]J4*R7NIF..WCCDYF=@3DY V@ $GK@#OTJ_
M'XG:/4KS2KS3VBU"WMOM4<44H=;B+.,HS;>0>""!^-<[;^&M?7PQX>_T.*+4
M?#TR,L!G!%R@!5P&'"D@\9_'%;$FEWNH>(9/$$UA+!Y&G-:V]J[QF1W=LLQ*
ML5 & !\WKTXR .T?7)?&&E_O= DCTR_LF82S3KMD)^4QD#YAD$_-CL?;+XGM
M?!6BZ7I*E"9YS;VXDE*1JS;Y-NXY(4 %5ZD_**F\$6%[I7A'3]-U"V-O<6D0
MB<;U8-CN"">*D\36/]I6<-G-HZ:K9RR8N82RJRKM.&7<1R&QW!P30!?TZZN+
MN&0W5H;66.5HRF_>"!T8' R#UZ5DZSXHETI=3E32Y)K?2HDEN)7D\O>",D1Y
M!#D#KR.3BG>#M)O=%TF:SNI9FA%R[6D<\@DDA@XVHS G.,$]3@$#/%8?B#1/
M$&J77B&V?3X;V"\M3'IL\EP%6WS&0RA#DABQ)W=^,D 4 ;\WB1'U"#3["&.>
MYFLQ>)'+-Y1>,G "\'+<'C@#N:1_$CM>6NGP6:?;[BR%V;>>?RB%Z;1P=S9S
MV &.2*P[_P /W.KZ99V6K>'FD:WL8Q!<6ES&LUM.,@@.67C 0\9&?6EO_#EY
MJ6F66GZ]ICZI-;V*;=1M9DCFBN1G<0S,IQPISW(Y'H ;=UXGCMULH6CAAO;N
MV^T>3=7 A6)>,AFP><G  !S@^E9:?$2WETNSO8=+N)6GU(:;+&DB'RIL] <_
M,,<@C@Y'2J[Z1XKTB?1M9MDCUF^AT\66HP-,(S*,A@ZNW&0<YSU_'BQK]EX@
MU6RTB9]-4SV^K0WLEO'.A$,2?P[B1N8]>F.<9XR0!+CQ)XA_X2/0[!]&CLA>
M?:6>*2Z#,_EK@<J" /F#>I/ICF]9ZYIL>O\ B/S=.%A)IL4,EW=OMS.A5RI.
MW/"A3C///04FOZ=J<WB;P_K%A:)<+8BXCFC>4(5$JJ V><@%><9/IFJ,WAJ^
MU/6?%L=S;O;V>M6D,$$^]3@HCJ25!SU8$?3M0!?;Q:ULFFW=_IK6VGZG(D<,
M_FAFC9QE/,7'RY]06P>N*@N/&ETL^M06GA^XGDT<J9@TZ(&4IOR#SSCH!GWQ
M55]&UG6O#VEZ#J=A]F-I- ;JZ$J-'*L1!S'@[LM@=0,9/IS)#I>JQZEXNF.F
MR;-51/LI$L?S%8A'@_-QSS]/?B@#I],OX=5TNTU&WW>3=PI,@;J P!&??FL:
MY\5NMIJ&H6.FM>6.FR/'<2+*%=BG^L,:XPP7GJ5S@XSWM^$[2ZT_PIIEA>P&
M"XM+9(9%+*W*J!D$$\'%86G:/K6AZ=K.AP6/VN"[FFELKH2HJH)?X9 3N^4D
M\J&R* $\4ZM/?3>%GTV..YL+^]CE4F7:)OW;NJD8.!P&^H''%=/I^G6NE6LQ
ML[%8&G<W$L,)X:4@9QG YQ[#O7-77AR^T^#PG8Z?:/=PZ+,KSR[T7($;(<!B
M.<MG'ZUV18B,L$8G&=HQD^WI0!P5QXGDM_A\NJ:!I,6GK)?&!HF<*8B9]C,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *SM7T*PUU;=;])7%M,L\029DVR+]UOE(R16C10 BC:H&2<#&2>:6B
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMB2P;/W<XSTZ]/3- &_16/%XHTRXTBPU*W>29-1(6UB1?WDK$$[0#T( .<G
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K#\9QRS^#M6MK>"6>>YM)(8HXD+%F92!TZ?6MRB@#$\)VD-OX
M<T[-C]FNDM(HI@\'EON50"#D9/(Z]*Y^XTB\U/7/&UJL$\":K8PP6L\D3"-V
M6-U;G'3+#Z\XS7=T4 <1X;D-V;2"?P1_9^HVH'GW,UK&L2,!R8W'+$GICIGK
MQSCLFN7]OH-Y>Z'J;:C9ZNLMX-H$:+\XQ$N[&WE?F ^IKT^B@#S^ZTR[776U
M308-1T[4WU +=6S1L;2\B#X,C$C:#L&<@YSVR0:9!:R:1K>K6&I>#Y-82]O)
M+FSNXK:.1&60YV2,WW-IR,GM^OH=% $$(^RV$:O&B>5$ 4@0E5P.BJ.<>@K@
MM+T/4[[X/R:&MK+;:D@<K#<QE S"8R*.>"",#\>:]$HH Y'P[<0W]U#<#P6^
MD3VZL9YI[1$*':05B(^9LGN!C&>Y K*MM'U'5/"'BK3$M9[6ZO=1N;FV%Q$R
M+(I<,G)&.<8P?QKT.B@#C_#]U#>W$%PW@E])N;56-Q/-9HNP[2"(2OS/D]P,
M8SWP*G^',%S9^#;6RO+2>UN())=\<T94_-*S C/7AATKJ:* .7\3PWD?B?PW
MJ<%C<7<%I+<+,(%#,OF1[5."1QGJ>@JKHHO/#6J>(+:\L+NYAO[U[^TE@A:5
M9-Z@&,D [2"H'S8&.]=E10!A>"=$G\.^#].TJZ8&>",F3:<A69BQ /MNQ^%8
MNFHOP^O=:.HAUT2]NVO8;M$+B%GP'1PH)49 P<8]P:[>FLJNA1U#*PP01D$4
M <AI]K_PE/C"S\61@C2[&U:.P9N&N'?(:3'4+MX&<$G-,\/>?X4O];LM0L;Q
MX+O49;VUN;:V>='63!VG8"58$'J!71Z;H=EHY9=-5[6W9BQMD;]UD]2%/W?H
MN!6C0!AV$D\7]IZU<65P@G*^3;A-TQ1%P,J.A)+<=AC..<9]CX;M-6\.2OJH
MU!)M11Y;V+SIH\.X^9=F0#M&%''(4=:ZRB@#@-'EU9_A=?:/J.G7PO[>SFLX
M0;9\W"[2L;#CTP#GICFK_A[6IM*\':=:3:%J[7=G9QQ- MHV6=4 P&Z8R.N:
M["B@#DM4\(W-U!?WRZ[JT%U=PYEMK:2/RF<1[=H!0G;QTSW/K63:^%-2@\!^
M'VW7=Q?Z5<V]\;:<KN4*H#PK@# QG .3GO7H=% ''76AMXI\3S7\T4T&GQZ7
M)91F:(QN[RYWD*P! "X'(&2>.E4)-(U'5/!>E>$+BSFCF@D@AO)2A$2PPL#N
M5^C;@JX Y^;D#!KT"B@#A?%?@JYDT+7)+#6M9EENUEE%DLD9CD=A]S&S<1T
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MS$LX ) S@+G)QVYKI** ,34M0>+5)+*]TN>[TN6U4M)';F90^Y@590"6R,=
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M*TCB=X$,C021DXRHYVD$\@'GK65>Z#J$7@GQ2%LYGO-=NIIH;5!ED#8"AL<
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M=HL;""Y4!7>.02!3V(.,>G-:FDW+7<4EPO@Z32'AA82M) @=W(QLBV<D?[1
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M00X3?,R9W%?FQ@;6.21T^F<OQ1HNHK)H^IZ$ U_I[_9R7Z-#(-C%O7:=K_\
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M;!SDY'3(''O0!T=)D9QGFN>\4:_>Z/?Z-:VED\RW]X(G=64' 4MM 8CDXZG
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M:CC8</NR<#:2 >>I&,YJF_Q TZ/2WO6LKS=#?"QN(556:"4D#G#<KR,%<YH
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MK/+MVLY&55@"2I8= ?T/%7/$FJ3:)X=O]3M[;[3):P/*(]P4?*"<DGL,=N:
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MVRP7!V[6,:MNXSD?>&.*Q]$L-7T43:!-X7BO=LTAM-4/EF(QLQ8&3/S97/0
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M4MQ%9WIFG="N$4QLO<C/+=JZ:B@#@]3T.[GUMM4TBQN]+UH7BJTT; 6]Y '
M+2#.#\F>P;(X[5U/B3^UO^$=OO[#V_VEY)^S[L?>_'C/7&>,XK3I REBH8;@
M,D9Y% '#Z58:@GC6PU9-!N[>VDTU[>:2YF1I0Y=&W2'<2> 0.I]@*R- M;K7
M_A'#X?M[*827;21^>X'E(GGL2^<]AGCKD=,<UZ;*ADB9%D:,L,!TQD>XR"*H
M:!H5MX<TJ/3+*69[:(DQB9@Q7))/( SR2>: .:L;DZ?\2==1;2XG3[!:#,*A
MB" ^ 1GOSSTXYQ5.;PUJEEX6L;>.Q>:ZEUQ-2N(8F7$*^;O*Y) .!@<=3G%=
M=:Z!;VFOW>M)<7#7%XJI*K,I0JN=H QQC)[_ %S6K0!RD]A>7'Q%^VFRG%C)
MHS6C7 VX61I V,9ST'7'6JOA)_$FDZ=;>&KO1'#V1\H:B)$\AX0>& SNW;>-
MN.O7%=K3'DCB ,CJ@)P-QQD^E 'G/B/3?$>L:=K]I<:-/=W7VL/83><@A%NK
MJ5" MP^ <\9.3ST%;GEZA9^.9=:ETJY>VN]-C@'DE':.179MK#=Z,.1D>]=8
M&5L[6!P<'!Z&EH \\U'PUJL7@Z\@BLGFOM3U@:C);Q,O[D&56VY) )"J,XZG
M/UJWJ5KJ6E^+[G5D\.G6K#5(8@R)Y?FVTB CHY VD$9YZC\^XHH J:8DT>GQ
M">WBMI#EC##C;'DDA>."0#R1U.:X^;P[J=[_ ,)AH[VCPQ:O(9K>]+KY?,:J
M 1G=G<O/'3//3/=T4 <3<6.I^)-(T33+O39K*:SNH)KV20KL7RN3L()W;B!C
M'0$YQT/1>)K&?4_"VJV%JH:>YLY8HU)P"S(0!GZFM2B@#AKBWU>ZA\(L=$NH
M_P"S[A7N59XR8U6(IGAN<D]!DX';I5RPM;^W\5^*;U]-N/(O8H/LSC;^]*1E
M2 ,Y')XSBNMHH \]LM :;P;H.BZ[H-TRV\+"66%AYUI*N-C*5;.#ENF>@R*Z
MCPE;:K::!%!K$\D\Z2.$>8@RF+<=F\C@MMQFME65U#*P8'N#FEH XFP&O^&=
M=U>TBT2;4[/4KQKRUN(I441LX&Y9-QRH!'4 \=CTJQ'8ZGHGC6YU=[:2]M-4
MM(HYWMP"T,T8('RDYVD$\C.#U]:ZZB@#SJ[\-ZK;Z)*\6GRS75_XA75)+>-D
MS#&)%."20-VU1G!/)_&MP6M])\19-0^P3K92Z0MJ)VVX$GF,^",YZ'KCK74T
M4 >:)I&NK\-=-T1M#N?MEC=0;E$D9WA)=S,#NQC &,X)/;O72^('U>35M*,.
MG75WI+H_VJ"WD1)/,(&S?EAE>N0#CUSTKIJ1F5%+,0J@9))X% 'F<'A_Q%9Z
M)#+:Z0$N](UN6\BM?-0+<Q,S@JA'3Y6XSCZ5T>J?VQXG\(:Q -)DL&N+-XK>
MWN'7S)'(/)P2%'0#)]<XXKJ:6@#$T^_U&.QTJ)]$N4,N(I@TB9MP$^\V"<@D
M8P#_ (5H:J9/[*NA%"\TC1,JQIC+$@@#GBK=-#*Q(# E3@@'H: .;O?#<7B7
MP?:6%['+97<$4;0R\>9;3*!A@0?7T/(K&E\.^('\'Z1)*B3ZQI6JM?RPA@HN
M3YLA8*>@W!\C./PKOZ* .96PN-8\9:?KC6LUI;Z?:RQJ)P%>223'&,GA0#R>
MYXS7-V_A_7QX!TZP721]OT*^%PL$\B&.\ :3*J03@%7ZMCG\Z]*HH P?#TMQ
M=NUR_AX:+&$V[)0GFR-D9^YT48[\G/08YWJ** "BBB@ HHHH **** "BBB@
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MGEL))$5W1TV. <E=P'3G'O0!5\/EC\4-=,EC]DE-C;EU#!@YW/\ ,".H(QU
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M:&5%,,FT*RN&8'' .1GZ&LK1]+\3:;X<\,V$^D32VML)4U&SBN(U=\\QDG<
M5Y.5S]0: -+6?&UP/"%QJ>FV3I<0WOV&=)77,#B01L1V;D\?7)]*VKSQ"+29
M+/[,IOFA,S023H@1<X&6/&20<8ST/2N0/AC7?^$.U[3$TF.*:35S>VT23IME
M3SD?:IXQ@*1SCZ5J:G!KUGXEA\16FA?;X;NS6VN['SHQ+"59F1@2=IX8@@'\
M3UH TK'QMI^IZ9875E%+)<7\KPPVIP'#IG?N.< *!DGGC&,D@5F^$<GQ[XN+
M67V.0_8R\8(()V/\P(Z@]<]?7FC5M.U[^T="\20::DDU@\RSZ;#(H812J!\K
M'"EAM!/8DX!XS5OP_;:H/&.N:E=Z7+:6M_%;>2TDL98&-6!!"L>?F'3(]Z )
MM?UW4=/\3:%IMI9>;#?/,9&\Q06V1,=HSTYP<^V*L7'B0B2_73]/FOQII NC
M&ZKAMNXHF?O, 02.!R!G/%5O$MCJ+^(/#^JV%D;Q+":;SHUD5& DC*!OF(&
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M:32I2FDP&2YEMY/- ?&?*48&7QV'3O5FT\22RZU'I-UIQM[F>R-Y !-N!4$
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M+A%&L8>.Q9@HQDE),GZT =?167JFM)IU]8V"K&UU?LXA667RT.T GYL'GD8
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MQI@NS:B5)5$A;?Y>X*<#;OXR6SWQ5K4O%D=E++;QPPFZMX%FG@N+M(2NX$A
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MM;VNGK<S2WK3)9"X"K;1._W0YZ[5Y]SG%==110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[NI+*33A*T<]P\HW_)\WS$\\G\Z /2:Y^7Q?;1>-(_"K6EQ]KE@,\<OR^65
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M8 R0,"LOPK<^)/%NC_V[97$::C#JQDFEFNV55A &8-@! 3!'X\]: /7J***
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M4'F7@31W,EEB8?NF+!L].>0.N:ZNB@#'N/"ND7/B"/7I('%^B",R),Z!U!R
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MM44 9VCZ%I^AQ3K8Q%7N93-/*[%GE<]69CU_E2W6DI=ZG;7[7=S'):AA&D;
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *HZIIO]J100M=7-O&DPDD^SS/$T@ /R[E((&2#U[5>HH
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M4LO )(P3QSQ6GX/LM1TZ_O[3[7>W>C(D9LY-0C99D;YMR98!F4#;@D=\#H:
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M0-Q+,H'/ YR>?0X+7Q?I=[IEI>VOG2M>2F"&V" 3&1<[E() !7!)). !UZ4
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MSQWH VJ*SM#URS\0:>;RS\Q0LC121RKM>*13AE8=B*A7Q%"VM7ND+979NK.
M3E<)B5"< I\W/(/ITYH UZ*P[/Q7:7^AV>KVMI=R0WLPAB0!-^22N2-W !!S
MSD8/'%4%U[3K/_A)[_3M.NY;NP*O>([;/,81Y!7<V -H'0#Z$T =717G>M:I
M->Z+X+UB[AN()I=2M3( <B4-$SDA$)R"0, C=QTKK=&\16^LWE[9"UNK.ZL2
M@FAND56PP)5A@D$'![]J ->BL;6?$]EHE_96-S#=R37Q<0^3"7!*J6Q]3C
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M_K0!L456T^]34=/@O(XY(EG0.$E7#KGL1V-6: "BBB@ HHHH **** "BBB@
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MH!:/(A59<0>6<$]/F]?K7<44 >>31:E/X>\&P'1[Z.33;VV>Y5HLE$CB*,V
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !115+5]3CT;2[C49X998;9#
M)*(@"RJ!DG!(S@#ZT 7:*YVP\:V&I^&9_$5K:7C6$"NS,40,53.X@;NV#_2K
M7AKQ-9^*M-_M'3X;A;8L45YE"[B.N "30!L45RWBGXAZ%X0OH;+4_M+331^:
MJPQAL+DCGD=P?RJ[X6\6Z=XOLIKS3([A889/*9IHPN6P#@<GL1^= &Y1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L3QK_ ,B-
MKW_8.G_]%M6W5'6=+36])N=,EN)H(KJ-HY&AV[BI&"/F!'(/I0!Y=X0&K?\
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M:>YBN=.0);I$RB-%YXQM/7)H XK38]<\1>-?%>AIXEU"QM+5U,312%GC))P
M3R%ZYQ@].<9!FN=6UO6_%GB+0[.:_:72[-([$6]PL/[XJ#YLGS+N^;'&",'I
M78Z3X1L='U^_UJVN;IKG43FX61E*-SD8 4$8^M0:EX%TS4/$:Z_%=7^GW^P)
M+)93^7YR],-P<\ #C'0>E '-3:UK^H^.= \+:A<R:>?[/^TW_P!D<*TLNUN
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MU#5X=8CGN++4(HFA%S;%0S1G^$AE8'U'&14-KX-TW3M*L=.TR6YL$L9C-')
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M2K*HP!M92/QQGD\XJ+_A$[)=*U"QCN;J-]3+&\NU9#-,6&#DE2!QP  ,=L4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH ***Q/&+S0>#]5NK:XEMY[:TEFBDB<J595)'U'L: -NBN1T_2
M]6OO"%A?6.OWL.I36<<P>9EEC=V0$AE8'Y23VP12^&O'EGJN@Z;=ZBK6EW>7
M'V,QK&[)]H!(VY (&<9&30!UM%93^)-+CN;^W>:19=-C$MRI@D^1#G##CYAP
M>F>E95UXR\.ZCHUVWV^\AMC9^<UU!!*I2-N-RN%^\/;H>O0T =516)+XGT?3
M6T^SGNIO-NX=]N&B=VE55SU Y;&..I)''-267BC1[[2;G5$NO*MK-F2Y,Z-&
MT++U#*P!!Y'YT :]%9$?B?3'U.+3&:XBO)D$D<4EM("R$XW=, 9ZYQCOBF>+
M/$*^&=#DU V\D[;EC150L S,%!;'09(^O04 ;5%<7JNL_9/'>CS-=7J6=Q97
M#-;%)/F92H7$6,EN3VS6_9>)=*O])?5(;AA;QR&)]\;*Z2 [=A0C=NR0,8R2
M1CK0!JT5FV&NV&HWUQ8Q-)'=VRAI()HFC<*>C $<@^HJGKGB=-&UO2---M/*
M=0D<,Z0LX551FXVCEL@<#.!DGM0!O45DZCXETS2Q,UR\VRV -P\<#NL (R-Y
M XX(..H!!/%07WC/0M/N6MIKJ1IA;?:@L4#R;X\@;EP#NZ]L\ GM0!NT5S[^
M-]"4WBK-<RO9!6GCCM)6= PW [0N<8&2>@R.>:?'XRT*6>QCCNG=+\JMO.('
M\EV89">9C:&/]W.>U &[137=(HVDD=41 69F.  .I)K*@\4:5/=6L EEC-Z"
M;5Y871)\#/RL1@G'('<<C- &O17%7FI?VYXRO=!EFU.VMH;-!&UJLT3+*SL"
MY90. %&"?EZ]:U?$.N'PEX>@ED6>^FW16XD*%BS$A=[[1COG ZG@4 =!17%:
MAK/V+X@Z?*]U>BTGTR9_LFR0[G#H!B(#);&>V:OZGXET*^\'7&IR:E=VNGMF
M.2>W61)HF#8(X&Y3D8Y'?WH Z:BL^[UBSL9?(<S22+%YS)#$TC+'TW$*#Z'W
M.#C.#5NVN([NUBN83F.9 Z$C&01D4 2T5CS^*M(MID26X=8Y+C[,)_*;RO-S
MC9OQC.01Z9&,YJ2^\0Z?I\L\<K32-:H)+CR(7D\E3R"VT'' SCKCG&* -2BL
M>Z\5Z)9FP\V]!741FU=$9UE&,\,!CIVZGBJLWC72QH.IZK;I<S?V9N$]N8'C
ME1@,X*L 0,<Y/&* .BHKGH_&6F0V&FRZA)+;S7Z@1J;64!GV[B!\OY>O;-2I
MXPTB6WCEB>XD+P-<>4ML_F+&K%2S+C(&01SUQQF@#<HK..O::;&TO([CSHKX
M VPB0LTV1GY5 STY/IWQ61JGCK3[70VU&R2:Y9;M;-XQ"P,,I8*0XQD8ST[\
M8ZT =114<,RSPK*BNJL,@.A1A]0>14&HZE::5;"XO)?+1I%C0!2S.['"JH')
M)/84 6Z*QCXJTA+._NI9I8ETTXNT>!]\/&X$J!G&.<CC%-M/%VC7VHV]A#/+
MYUU$9;<M ZI, ,D*Q&&('4 \4 ;=%96G^)-,U2"]GM)962PD:.XW6\B%'49*
MX8 D@>E7K*\AU"RAO+<N89D#H70H2#T." 1^- $]%8T7BO1YKBWB2X<I=3-;
MP3^4WE2R+G*A\8)^5O8X.,U7N?'&@VK7J//<.^GL!<K':2L8\C.2 OW<<[NG
MO0!T-%4)M;L(K>TF$QE%Z ;98E+M,"-V5 YQCG/0=ZP/!5_)?:SXE!NKJ>&&
M]18EN2P:(>6"5VM]W#9XH ZZBJ%]K-G87,=I(9)+F5&D2"&,NY1<9; Z#D=?
M7%<WXLUA+[PWI.K:/J,P@GU&V"O"[()$:0!E8<'U!!H [.BN6>:X3XJPVPNI
MS;2:-)*8#(?+#B5!N"],X[UT5Y>6]A;F>YDV("%& 26).  !R220 !R: )Z*
MQE\5Z44OBSW"2:> US"UM)YD:D9#; ,E<=QD4^R\3:5J)LQ:32S"]A,\)6"3
M!C!P6)Q\O/KB@#6HKF;CXA>&K:.622]EV03&"9EM92(6& =_R_*,G&3U(..A
MJW=ZCI;^(](@;4+E;J5)7MH82WDW"[,DM@;6P!D<\9]Z -NBL&#QGH=U??8H
M)YI)A<FU8"VD^20#.&.WY1[G@X/H:F;Q3I*W5O \TBK=R^3!.T+"*63^ZKXP
M2<''8XXS0!L45RWC'7[:#PYK4=M<W27%K;/NFM4<^1)LR@+J.#G;GT!&< UL
M>'9'F\-:7+*[.[V<+,S')8E!DDT :-%<7X_\0PQ>$=7%C=WD<]LI3[3:JX6.
M7CY2X& ><'G@\'!KH&UBULXK6"5I9KJ6 2"&&-I)"H RQ Z#)ZGOQUH U**R
MX?$>E7&FQ:A;W/FPS2>5&$1M[29QLVXR&X.01Q@YIT>O6#VD]RSRQK;S""19
M(65_,.,*%QDD[AC .<\9H TJ*R(O%&DR"]#SO!)IX#7,4T3(Z _=.TC)![8S
MGIUJU9:K;WUS/;1I/'-;JC2)-"R$!MVTC(P?NGIZ4 7:*S[G7+"TUBUTF:21
M;N[5F@3R7*N%&6PP&W@>]06_BG2;FSU"[BEF,6F.R71:VD4QLHRPP5R<#GC-
M &O16&NI:9<^*;6!;V]2^:R:1+1ED2-HR5^=E( W#@>HYKG;.XO?^$6\<%M1
MO#+9WUV+>8S'?&%A1E /8 ]A0!WU%9GAJ22;POI,LKM)(]E"S.QR6)09)/<U
MR>C>+;+0;CQ$FLZA>3)!JSJC,DD_DQ;$QDJ#L7.<9QW]Z ._HJA/K5E%% Z2
M-<&YC\V%+=#(TB8!W +VY'/3D>HI^E:K9:U8)?:?.)H')&=I4@@X((/((/8T
M 7**X:V\01Z+XR\4KJ%W>SV\*6KQ0JKSF,%'+E54':O0D].GM74G7-/-E:W<
M4QGCO5#6PA0NTH(W9"@9Z<^W>@#0HKB?&.O0ZCX U'4-&U"X@EM9DC<QEHI(
MW$BJR,#@@X/3WKJ+[5;6RF2U=I'N)D9DA@C+N5'5L#H!D<GC) ZT 7J*Y3X>
MWLE_I6I2O=7%RBZK<I"]PS%_+#84?-R.,<5HR7VG?\)<EJ;Z[%_'9._V4;_)
M,>Y<OC&"V< 8.>M &U17.?\ "?>'?)6<7<QA,_V=I?LTFR)]VW#G;A.>/FQ7
M1T %%8ESXOT>U19I)IC;M+Y*W"6[M$TF=NT,!@\\9Z9[U;37+"34KK35>4W=
MI$)98O)?.PD@$<?-G!Z9H T**QX?%.CW&F6FHP7+207TIBM@(FWRN"05"D9X
MVMU';-1S>,=$M]&N=6FN9$MK29H+C,#[HI!@%67&0>1[<CGF@#<HK%3Q=H\C
M,J32EQ<"W1/(<&5RNX; 1\PQSN'&.<XILOC'1(-&GU:6YD2VMIC!/F!]T4@(
M!5EQD')'7CD>M &Y161:^*-*O-3FTZ&68W,4)F"M;NOFQ@X+1DCYQGNN<]JQ
M[?Q?8:SX3U&_OC>Z;:HTT32QQ2*\:!BH8, ?FXSQG!H Z^BL27Q-H^F-I]G/
M=3>9=P[[?=$[M*JKGJ!RV,<=22..:EL/$VDZCIMQJ$-PR0VLC13B:-HWB<8R
MI4C(/(XQSD4 :U%9MEK]A?:E+IJ-+%>11B4P3PM&QC)P' 8#(SQQT/6L3QA?
MMIFO^&[AKZ>"V>[D2>-'.R0>4Q&5'WCD# YYQ0!UM%8%OXVT*YT^^O4N)@FG
M'_2XVMI!+".N63;NQCG..Q]*N_V_I_V"RO@\K07[(MN5@<ERPRO &1D<Y- &
ME161XLO-1T_PKJ-WI41EO88"T2A=QSW('<@9./:L319K37;:QU+PWXAO+E(Y
MD-Y!-<%RZ]PZM]PCKA< X/!XH [*BO/]:UO5/"?C&:[\RXO/#R6\!O8G8R-:
MF1I%$B]]H\OD9/7Z8Z.Y9;GQ%I,MO>S&VN()9"L4Q\N7&PH>#T^8].O?- &[
M17 Z5J\6M:WJVE:GK-YIFMPW<B6T"RF-5B!_=LB'Y9,CD[@3SZ8KLM(BNH-&
ML8;Z0R7<=O&L[DY+.% 8Y^N: +E%8UUXKTBTEE66X?RX)UMYYEB9HXI6QA68
M# /S+],C.*2\\6:18ZC-ITLL[WD$0F:"*VD=RI. 5 7YN_3.,'- &U167#XC
MTF?18-8BN@]G<$+$P1BSL3M"A<9+9R,8SQ6%HVIR7GQ*U2W6XO/(CT^)C;W&
MY1$Y=LX4\<C;R/SH [&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "L+QL2?!>L1)')))/92Q1I
M&A=F9D(  '-;M% '(Z5KYT_P9IL%MIU_=ZA%8Q1K:K:2+^\" 89F4*HSU)/Y
MU@/X;N_"W@W03=(]Q-:ZW%J&H&W0R; =P8@#DA<J./0UZ;10!Y^MV;CQ1XFN
MUL[U;>YTF)89&M9 )" _'3()W# ."?2G*LA^")M!;7 N1I/V<P&!Q)YFS&W;
MC/6N^HH X29RWB/P/*(+@QP6TZS,('Q$6B55#<?+D@CGTK/NX8KG1?'L-U:W
MIBGN3-&(X64R (@#(2,'YE[9Z5Z76=KFCKK>G?9#=3VK+(DL<T! 9'1@RG!!
M!&0."* .4T;6=+U/Q78WM_J$O]HQVS6MO$^G36R,S$%B2XP2=O"Y]>M:OQ%M
MKBZ\$WB6T$D\BR02>7$I9BJS(S8 ZX )_"K]GHUZ)(WU76)-0$3!XX_(2)-P
MZ,0HR2.W..^,@8V* .,NKL7?Q#T&\CM[H6XLK@&1[9U"EBNT-D?*3M/!P:P'
MM]0DTC6Y[2PNIWM?$QU#[,(WC:Y@&W.PX&>A(QZ?2O4J* .8\-SZ3JFI-J>F
MZ3=Q.+?RI+N\CD1_O B,;^2!@DXX!QZU%XM$EOXE\+ZD;>XEMK6YF$S00M*4
MWPLJY"@G!/%=910!YT)8-+UW6M,U_1]2N8M1N6GM7MXY)([A'4 Q$*<9&,<\
M8]JT+.,6GQ&T]1826T,>@_9@$B9HHG\Q2(]X&.%!_*NUHH XO3Y/*\6^,9GA
MG6.:.W\MS"^V7;$5;:<?-@D#BL-$FC^'/A"!K2Z\^UU&T>:,6[EX@CY8D8R
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M9;=FV$/M&&(RF#[5ZK10!YWXDBM9_A]K$ND:/=0B^EB9 8'\ZY8.A+E#\V,
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M+&:082XB4,T9SG@'CV_&FZ5IJZ79^3Y\EQ*[&2:>7&^5SU8X '8  <  #M0
MW6[^;3-*EO(+:2Y>)D_<Q*6=P7 (4#J<$XKB=8TG3;KQ)I6K^%89[;63>)]J
M\J!XE:#.9/.4@ <>N"2>_;T6B@#GX&@N?%^K6\L+/%-8V\)\R%O+D(:?>N2,
M'AQD>]8F@^']3\-^,X-.0M/H"P3RV+MDFV+%-T)/IQD?C[UW=% '":XOA[Q5
MIEQ%X@T^XM[VWEEC@D6UD$WRNP5HF ^?. <#(SU%=#X/BU6'PEIL>MLS:@L
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M,X=&*+_N@'&0,'KQD T=2\2Z!J'AX7<UW>16S7:P,8%D22.97'R-@?+S@'.
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M:SD$<\-Q"T4B$C()5N<$<@UPEKH]]HFE^$+:>RNV>#5)+J9(+=Y1;(_F$ E
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ML9KQH+FTC@>17%U$8SA"06 _NG&0:P_AI9S67@'34G0H\H>?8?X5=V=?T84
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MY[^]6WB7;)91R[89^<_.,9/Y\].F: %\.07":4+N\C\N\OF-S<)G.QF PG_
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MD,211($1%"JJC 4#H!3Z /,[4:G=7_A/4I]'U<W%K-(+[S(=BQ.T3+A$R J
M\!@ ,8R2:DU#1-2UFU\=V=K;7$,NH21/:M+$T:S!$4$!B .2I'X^E>D44 <#
M?:G>:YJ/A:ZCT'587M+PO=I):,@A)B9>K8!&3U''\JZ/Q?/J5MX:N9=)M6N;
MH%,(D8D8+N&XJIX9@,D ]QWZ5MT4 >>P0W">*-4O5TS4TM+O1 BW%VISN4N3
MN+'*GD?+P?8"JUE;OXC^&7A_1+:UN1.PM2TKP,J0HC!F?>1M/RC@ Y.[ZX]#
MO[4WMA/:"5H?.C*&1 "5!&"1GC-5]"TE-"T:VTN.XDGBM4$<;R ;MHZ X %
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MUK(A; *=0K!\_7K76Z'!'!I<8BTR+3(V9G6UC14V GC<%XW'J<=SCGK6A10
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MJ@4/O5O*XR">0$;)Z>Y- '<VGBBSNM<;2&M;RWG\DSQ-/#M6= 0"4YSQD<$
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M\;Z<+JRADL]0C74(R]K*UOE)B%W;!@D[L>V#V)J2W\8Z;)9:I<W,=S8G2/\
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M+[1Q((Y)T!B<] ZD,N?;(P?8T ,M?#CRZ5']NU*_;4GC#274=TZ;9".2J [
M >BXQZYK&T/X@(GAM;G7(Y6N[?4#IEPUO#E6E# !L= ""#]<XK8LO$,T>DQ"
M^TK4%U*.,+);1VKL&D YVR ;"">AW8YYQ7*3^&-0TGP;;P/;27.HW>M1ZE>)
M;(7"'S S#(]% 'N>E '8Z?XHLK[4KS3W@NK*XM(A.RW<8CWQ'(WKR?EX/7!'
MI3(?%EE+>:? UM=Q1ZGG['<21@1S8&[C!W+D<C<!FL75M.NM7\8:DD5O<QV]
M]X>:Q2Z:%@BRLSG!...&!_3K5KPKJ^LR6-EI%YX?N[.ZLT6*YN)@OD848RC
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M3V[=,ZT5G?6'Q#2Z_LYWM;C28K82VZ@11.DC%@<GY1@\?E0!UM%%% !1110
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MD<\T# +$^S.,[@25R"<9Q]>*E\.ZHMIX4\/VD4$MW=RZ7#(L,14'8L: L2Q
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MDS<,UV$"1>I.UCN^@Z^HZU4ELI=8\3R'4+"ZBL[.';:2B4(LCL?WC?(V[H%
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M#RNG[L@@G(ZDY/8UO'5;/P9H.EPQ1W&H6MU=""":!A)Q(Y*DG.6X/4 Y(]Z
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MT.+'AOQ%:^)=.>[MD:-H9WMYXG()CD7J,C@CD$$=C0!KT444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %8WBZUNK_PGJ=C8VS7%Q=6TD,:*RKRRD DL0,5LT4 9?AN&YMO#
M>G6MW;/;SV]M'%)&S*WS*H!P5)&,BLO0M/OXO$GB26\L)8+7498WAE,D9W!8
MPAX#$@\9'%=110!P%IH.N0^ [CP5)8EGVO;0WX=/):%F)#D;MP(!(VXZ@<XY
M&MXE\.WLEEI$^A.J:CI$J+ \G0Q,!'(#[;3N_P" UU#,J*68A5 R23@"DCD2
M6-9(W5T<!E93D$'H0: .7\8Z1<R>#HM)TFRDNGCEM]J*R@A8Y%8DEB.<+^=4
M_%6A3:Y<7$R:-=17\$0.F:G:SI'(C[<['.X' ;V(P3CGKV:2QR,ZI(K-&<.
M<E3C.#Z<&GT <F]AJW_";:'>3VSW$=KI\D%U=(5">:VSD#.<94]N]9UAH6M:
M9X,U'P<+!IU=9X+2]\Q/*,4I8[GR=P*[SD '.!C-=T\L<;(KR*ID.U QP6/7
M ]>AI] '(66B7VE>,=.EAL9IM.LM$_L\7'F1C+!D(.TMG&$].I_&K?@JQO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_-QD\CV]^* .DTK48=7TFTU*W#"*[A29 W4!@#@^_-8E]XP:P#W,VF2)8IJ
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M1O#="2:(L,H9(POR@]_F.,\T =;16!XXU2_T7P=J.H:<L?GPPDAI&(V#IN&
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M-&I9XS,H90.22,Y H X;6O#/B74[#7[.2SM+F:ZNQ+:WDEQAO)$B,L07;\N
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M[/X'\0:0+!1=:EJ,MQ#F9-H1Y _)SP0!CIW'OCT%$$:*BEB%&!N8L?S/)IU
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZUZQ:^!_#%E<6=Q;:-;Q36.?(=005SW//S'W.:3_ (0CP[_I_P#Q+S_Q,O\
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MY?V\;=@&[:'*YW;,\9Q[XQS0!TE%("",@Y!I: "BBB@ HHHH **** "BBB@
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MS&A*[6!.=N_DG&<=LYKL:* .4DL+G4/%+>(?L<\4-MIKVT,3@+),[-D\9X
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M3^WO#_BO4KR+0I]1LM9$4H$$L8>VE5 A5MQ P<#D<#WKM2R@@$@%C@ GK06
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M/US1+CQ'IT>DRW]IJT\UW:W,4L8"-(N&1PS @ @8(!H V_ O_(AZ%_UX0_\
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M, DF3:@8L (]S!=WO@D<5F>&!XEMK:ST;4/#\$+602-]2$R-'+&F,%5'S;F
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM8W8:AY<L4R O XBD+(V>F"!^AH [%G1" S!2QP,G&32@@]#FO.M8U"T\/\
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MZ6JNF?\ (*M/^N"?^@BK5 !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5E>*+>YO/#&I
MV5G;M/<75K+!&@95Y9" 26(&.:U:* .$?1]:_L+P?;#2I3+HTT#72B:+I'$4
M.T[N<DY'TK4TVRU&T\;:]J<FG2_9;R&W6!UDCRQC# C&[(SNXSZ<XKHWN(8Y
MHX7FC667.Q"P#-CDX'>I* //+;PIK5Q\.X-)DMA9ZII]Z;RW\R16CD83-(HR
MI/9L<]ZW)=/OM;\0:/JUUITMC'I*32>5))&SRRNH4*NUB, 9.21DXXZUT]%
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MW3=7LX/$OF:,L_V_4#<0P321E9XF"*RGD@$A6Z\<BNRI&944LS!5 R23@ 4
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M5''/#,\B13([1-MD56!*'T/H:DH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N<\?:M
MJ&B>#;_4--$?G1H!O=R#&&(7<N <D9X!Q_0]'6%XUT>YU_PAJ.EV93[1/&/+
MWG )#!L9]\4 8?B!KB'QYX4NCIT3WSQ7JF."0'=A%VY=@O SGD<<XSWM2^.Y
M+;PQJVJSZ,XN=(N&M[FU6X4@$8.X/@94AAVS[5)>66M7WBKP[JLNF+%%8I<?
M:%2X5BAD4* ,XSC;D_7C-9&H>'==NM#\6V,>G8DUFZ\VV)F3 4JB_-SQ]SMG
MK0!T$OBF>TPNH:8MBUQ.(K+S[M LR[2Q9B/]7@ Y'/. ,YJO:^-OM,&IJNF/
M->:=+%$8;23SDF\P@(RN ,KS\QQ\N#3O$>FZU?0Z1J^DPQQZIIDID^R3R#;*
MK*5=-PR <=#46JQ>+M6\/RNEK#8W+2Q$6*766>-6S(IE &"PXXZ =>> "=O%
M-TS:[9)8VZZAI$"S!?M):*0,I(^8*""-IR,>G/.:N>$+V^U'PKIMYJ"Q^=/:
MQ2;TD+%\H#N/RC!)/09^M8EEX?U9=;U>;^SK.QL]2TY($6.;/DLH<8P%&?O@
MG''UK:\(6NHV'AFPL-3MHX)K.!+?"2^9N"*%W9P,9QTH JZYXLGT:'4[HZ4[
MVFF;/-EEE\HR[@"?*!4A\ CN.<BK%WXDVZL=*L+>&XNQ9K=B*:X\HR*2P 3Y
M3N/RG/0#(YYXY[7_  ]XBU0^([9K.VNUO8R+"ZEN,>0FP#RPF.#G//&<\GC%
M6-;T"ZUVT2WU+05DDCM%^R75K<JLMK/\V?G)4XX0Y&><\&@#7F\2R?VBFF6U
MI$]^UDMX;>>X\HL"2-J_*=Q!4YZ8X]>"\\4+;S0VB1VR7KVJW+Q7=T(%C#<!
M=VTDDD-V_A.<<9R-7\-7>J6%O8:MIO\ :<UO81B'4H)ECFCN@"&;)((4D*>,
M]^#2/I'BK1-3L=7L4AUF9].BL]1ADG\HR.F2)58C'5FSG^O !=LO'=MJ-II;
M06ZPW.I/+&D5U-Y:H\>-R[@#DG(Q@<BK<WB:2V.FV]S9Q6U]J$DL:0SW&U 8
MSC[^TY)X(&.<U6U;3+S6+.VMM<T2#4K:82-<P12+NMF^7R]C,5)P-P)R#SD<
M<51B\-7@\.6.BZUIO]MV8\[S5DF4S0 L##AV(R54D$@CV]P#2OO%5WIL>E?:
M=$E\W4+QK0HDRD1L"V,$@9R$R. .>M1P>*M5N+_4=*C\/9U*Q"/Y?VQ?*>-P
M2IW[<@\$8VGGOWK+'AS7;?2O#MJ4DO3INJ&[<R3J7C@&\)'N)&Y@KCVXZ]*U
M[*RU&V\;:QJKV#FUNK:&*$K(FYC'NSQNXSNX_7% !;^-K*ZT/2M1C1(I-5W"
M**XF$:H5!W[GP< $8R <DCCFJ,WQ#6#1M3O3I9EFTN=(IXX;@/&P<@*Z28&X
M'/\ =R,'BLS3_#'B73/#>@36EM#_ &MH<LP:VDF'EW,4I)8!AT/3&>X/XZGB
M*R\2>(?!]Y;2Z=#!=W31"*T6X5Q$$<,S-)@9)QT .,#U- &E;>)+N3Q(^B7>
MDFTDDM6N;61K@,)54@$, /D.2/[U0^"-7U76M/N[G4HH%Q>31J8I2V-KE=N"
MHX&.N>?043V6I3^.M-U86#+:0V,D$I:5-RL[*W0'D#;@_IFG>#]+U/1H;ZQO
M8(EA-[/-#,DNXR*[EA\N., \T 5=7BC7XH>')5C42/:7@9P.6 "8R>^,FDO_
M (@6MG;M?1PP7%A'<>3(4NA]H #["XBQRH/N#CG&*MZIIVH3^.=%U.&T+VEE
M#/'+)YB@YD"XP"<D#;S]>,UG:+8>+= \[0;>SM;C3C-(UKJ+7&UH(W8MAH\$
MNP)..@/'- &U9^()+CQ1>Z%/9+ ]M MQ'+YVX3QL2-P&T8P1@^A]:A;Q6L=C
M82SPP07&HEC;QRW.U#&HSO9RO (QQ@GYA[XB\4>'+K5=2TR^T^80S0L]O=-G
M!>UD7#CZ@@$>AYH\4Z3JQO-)UG0(X9;K2S(AM)7\M9HI  RANQ&U2.W\J .?
M\5Z];^)?AUXDCEM$CN-.^1P'$L9.05>-\#((SS@'K7H4/^HC_P!T?RKE/$-C
MXB\0^"=3M);"&"\O4$<-HDZN(AG)9I"!DGT'H/<UO1SZD+NRB&GJMJ\+&XD>
M8;XG&-JA1G=GGG- &-\3(8I?AYK!DC5]D&Y=PSM.1R*VM(M;=?#]E;B",0_9
MD'E[1M(VCM2>(-)77?#]]I32>7]K@:,/C.TD<'\#BLO3;GQ':Z-;Z?)H@-[#
M$L/VG[2GV9B!C?UWXXSC;[9[T 9VF:TGAGPIX9AM]):9-0,5N/)94VNRD]#U
M)VGT'J:TK/Q>!)K46LV7]FR:/&LTV)A*K1,"0P( Y^4C&/SJKK.@W\>G^&;+
M3K<W:Z1>0S2N75"R1QLAQD_>.[/I[U5U3POJ.M:IXGBD@-O:ZO90P03EU.UX
M]QRR@YP2P_+M0!!XAN;N]UOPA=W.E1VRRZBK1R^<'D4&-CL<;1@G@X!89!]L
MZ>J^/(-/BN[F"""ZM[*<PS*+L+.Q4[7*1X.[!R.2,X..V:%Q8^*]43P[]JT>
MWBFTJ]22XD-X-L@5&4LN 2 <YP>?;O4^GV7BOP]J-_I]A8VE]IMW=27-O=2W
M/EFU\P[F5DP2P!)(QU]>> "W<>+[UM9N-+TO0);Z6*VCNHR;E(A(CDC.3TZ=
M#R?05H>+M3O='\*:CJ-A'$]Q;0-(OFL0%P.O .2/3C/J*I6>G:G#X^N=2EM6
M:SEL([43F1,ET9F+%0>AW?\ UJTO$^FS:SX8U/3;<JLUU:R11ES@;BI S[9H
M Y/6I+@ZCX*O[BR22],[ >3)O9P8&(^9@N,GD]A6S#XHDNK#7HK[12MUI Q<
M6:S+(LJ,F\$,0 05/0BJ5QINNW5QX6GDTM4_LR0O<JEPK;1Y>P 9QDY)/TQS
M3AI.K+JGB^X_L]C'JT,:VO[U,DK%Y?S<\9)S]!Z\4 6[3Q/:Q:7X=BM;.WM6
MU>U#VMO)-Y44:A%.P,%//S   <X/I6[IUS/=V2375J;68EE>(ONVD,1UP,@X
MS^-<JN@7$_A;1-$U?P^E_:V]GY-U&)4WQR(J*CH2P]'Z$'G\*V_">FWVD>'H
M+'4+AYY8V?:9'WLB%B44MW(7 S[4 <YJ5G:^&/B=IVM);Q):ZVAL9W" >7/U
M1OJV-OX5NK96NJ^,'OY+>)_[)B\B*0H"?-?#-S_LKLQ_OM4GC#0O^$C\,7>G
M(=MP5\RV?."DJ\H<]N1CZ$U:T*PFT[1H(+F027; R7,F/ORL=SGZ;B<>V!0!
MDGQA+%-IK76E/;VVIWC6D)DEQ.K L S1%>%.W^\>"/6IKSQ-<K%J%QI>DOJ4
M.G2^3.(Y2)'<8WB- IW%<]R,D$"N:3P[XIDLM+-UIUI-J%CJJ75Q=O=_-=J"
M_(.WY5 ;IVQP*TK#3_%'A[6-3M]/L+2^L-2NWNX[B2Y\O[*[\N&7!+#/(Q_7
M@ V[C79GOI;#2[$75U;VZSS)-+Y(C#YV+G:QW':>,<8Y/2LZZ\10S?\ ".37
MGAZ4/J-R%C%VJJ]G+M;G!&<X#<C''>H;O3?$6B^*Y=9TBUBU:#4+:*&[ADG$
M#K)'D+(#@C&"<@5+KFF:U>R^'I3;I<2V5\+JZ,;JJJNUAM7=@MC=C)QG';-
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M94R"T7E_+SS@\_3WXJE?6-[8P>,+B\L(!#JQ06BW$BE)'*+$J,%.02V,?S%
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MXY(H KCQZCZ!HNKP:5-+'JMXMIL$J@Q.7*'G^+E3CIGCD5-'XJU.36+S1O[
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MSA)&3;C!R,@,2,CK5>]GU*3XI6MK]FMI8$TJ9D22X8#:TL89B-A^; QCT[T
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MHKF)/%T]M)J]E<Z?&FHZ9:_;!$+@^7<0X/S*VW(Y!!!'![GK4C>*I GAR7[
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M.UU; SR.XX_D =7!/#=0)/;RI-%(H9)(V#*P/0@CJ*DKB_#VNPZ3X*\,6I:
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M[-NUE'F13Q;L,1_=;=@CT[>G>=*@M+^SU!)'LKJ&Y6)S&[1.&"L "02._(H
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M!FCF@82,T4Q7(*L=H(# ^G%:PTF^O/$":_=V\44MK9M;VUL)MV6<@LS-CCH
M, ]S[4 -\)>(M6\2V=IJ4NE06NGW5NSJXN-SAPV,;=HXQGG/;H*N76N36OBR
MPT0VR-'?02RK,)#E2FW(*X[[O6H?!&DW^@^%++2=16 36BE-T,A=7&2<\@8Z
M]*B\0:5JDGB+2-;TJ*VN'LEFAE@GF,099 O(8*W0KZ=Z *__  FY@TC5;V]M
M(X/[.U0:>S>:6CY*#S&.W(4;\GCM[U<F\1RV&FSWE[#;NAFBBLY+>4E+DR8"
MG./E&XG/7 !/-9VFZ%XAT^#5U>'3;H:AJ9NC$[L$DB955T(*G'"\=?>JG_"
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M;7,^B1+-F&XQ',K*S8S@[6&PC'/:F7NA:[/X%T[2H3;1WMG]G6:(S-Y5RD>
MR%MN0& YX]JK_P#".Z_]NUZY$&FHFK:?';I$DSXA95=0N=O(^?.[ Z8V]P 3
MVGB_4GE\/S7FE0PV.N(JI(EP6DCD:/>,KMQM."!R3W..E&@:MKEYJWB19XK:
M9;.Z\J*,3,H&(U(4?*>N>3ZGI4+>'M=_LOPI;""S\S1)(FG_ -(;#A(S'\OR
M=\YY^E7],T?5]*US79XTM);349A<1$RL'W>6%V$;< 9&=V3].> #.MO&<T?A
M3P]J=IHL(BU6ZCMOL\<VWR=S$#:-N#T/<<FKUOXMGM;S6;77;.&T.EVRWF^W
MF,JO$0WJJG<-I'3FLFW\)Z];>$/#FDK%9-<:1?Q7$I-PP1U1B<*=F<G=W'&*
MOW_A>^U;7]9DNE@CL-4TU;(.DI,B$;CNV[<=6]>U $]OXLNCK%A:SV"-;WZM
M^]MV=S:L!D"3*@8/3([_ )U@^-=8N=>^'-WJ5K:0'39I$$3.Y\TH)E DQC R
M1TZX.<YXK>T*U\6^3%I^NMI_V:W78]Q;NQDN@!@94@!>Q)S[ <YK"D\)>*(_
M ]SX/B6PF@1@+6]>=E8Q^8' 9 IY'J#^= 'H4QD6%S"BO(!\JLVT$^YP<?E7
M!I\1-5'ANR\3SZ!&FCR,%N76ZW2Q OMW!=O*@X[@D]@.:[R(R&)3,JK)CY@K
M;@#[' S^5>;^%-+OO$7PIT_16AABL[G(EN?-R?*$Q8@+C[QQCK@9SGM0!T5Y
MXEUK_A([S1--T>VN);>VCN4DDNRBNK,1S\O!X/'(]_59?%=Y-I>H:SIMA%<V
M&GR2(P:4K).(^)&3C Q@X!^]CM4UMI.IP^/+K5S#;"PFLH[9<3'S 49FSMVX
MP=V.M9]EX<UG1],U;0K(6TME>R2O:W#R%6MQ+G<K+CYMI)(P>>^* -*/Q.FI
MW=G9Z,D<TEW9"^,DQ*K'"QPN0.2Q.1CCH>>QY70]=NO#OAWQ%J;6$+NGB*5)
MH%F("EVC3Y6V\X+9Y K63PIJ/A[6M.U'P^L%U%#IR:=<6US*8RRJ<K(K!3SG
MJ,56?P?KESX8\0Z=,;*.XU'4C?VQ65F4'>C!6^48'R=??H* .BF\0/;>+1HL
MT$:P-8/>"Y\PY 5E4@KCWSG/:J]KXAU2]ATS4+?2!-IVHR* 4D_>PQL"5E88
MQC&,@'(R.M4QHFNZCXJ@U?4;>Q@MVTZ2SG@BN&=DWL#D-M&X\>@QGO1X9TKQ
M7H]M;Z'=2V#Z=9$+'>H[>=)$#\J;,8!QP3GITR>: )O">IZQJ&JZ\M^+<Q6V
MH-"GENWR 1IA0".1SDG(Y)XKJ:YK2M)UG2-3UZ2);.2"^G:[MV:1@WF&-5",
MNW@97J">.WIO6)NVL8&OTB2Z,:^<L))0/CG:3SC- $]%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4;
M[1M/U*ZM[J[M_,FM3N@?>P,9]1@\'WJ]110 57OK"UU.RELKZ!+BWF&V2-QD
M,*L44 0VEG;6%I':6<$<$$2[4CC4*JCV J:BB@ HHHH **** "BBB@ HHHH
MBN+6WNXQ'<P13H#D+(@8 ^O-/5510JC"J, >@IU% !1110 4444 %%%% !11
M10 4444 ,FB2>%XI,E'&#AB#CZCFJ^F:79:/9K9Z? +>W3.V)6)5<\\ GC\*
MMT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC1@K2*I/0$XS0TL:2+&TBJ[YVJ3@MCK@=Z 'T4A95P&8#)P,GJ:&95&68 9
MY/<]* %HIDLT4";YI$C7.-SL ,T[( R3Q0 M%117-O<#=#/'(,[<HX//IQ3E
MEC=VC616=/O*#DK]?2@!]%,$L9E,0D4R 9*9Y ]<4>;'YOE>8OF8W;,\X]<4
M /HJ-IX48JTJ*1U!8"GEE! + %C@9/6@!:*** "BBB@ HHHH **** "BBB@
MHHHH **** "BD8E5)"EB!G ZFN93Q[I9AO9WM-02#3IF@NY3;;EA=?O9VDG
MSU (H Z>BHK:Y@O+:*YMI5EAF0/'(AR&4C((-2T %%%% !1534]2M]*LS=7
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *CGGBM;>2XF<)%$A=V/15 R
M34E4=6TTZK9&T^U2VRLZLS1!26 (.T[@1@XY]1Q0!Q_A_5&L_&H^T732)XC@
M,WEM_P N]PG(C_[]$#W,=7]%;^V/'GB"2^42?V4T-O:1.,B%63<S@>K$]>N
M!6SKV@1Z]#:))=SVSV=RES%+!MW!USC[P(QR<CO3+CPZK:M_:]E>S65\\:Q3
MNBJR7"CIO4C&1S@C!YQTH G6ST[0_M^I(BV\<B^;<!1A?E!RV/7'7Z5RGAK4
MGL?&<EO<71E7Q!!]J"D_ZFY0?-$/;R]H'_7.NHO-$:]M/)DU*Y#M*DDD@"9?
M8P8+@K@+D= .><GDTFNZ!'KOV%GNY[62QN5N8I(-N[> 1@[@>,$Y'>@#E=:
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M9UBQT?X@>')H[*[@G*/FWNH\-Y$RX(/\LCN#6I8Z.EK?RZA-/)=7DL2PF:0
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M^%,OK*ZNIX9+?5+BS6/<'2)(V$@..NY3@C'&/7O0!CZ3K%E9^!QJ%MIB:<D
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M7:VV9<#^$[E/![COTZ9JOI7AV?3KX75QK^IZCM0JD5TZ;%)Q\V%5<G''/J:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
/ %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>67
<FILENAME>ebs20191231exhibit1048028.jpg
<TEXT>
begin 644 ebs20191231exhibit1048028.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+J2U\F=V$DSIPV6'$8)Z9#<<\5G>+H7U/QUX4LK7YIK2>2\G*_\ +*( #)]
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M<LK&+XB^*Y!:VZ21R6IB;RU#*6ARV#VSSG'7FNQBECGC66&19$895D.0?QH
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M]ZXO6+&WTWQ5X8FT.&. W<CV\Z6X"K-;^66RV.NW (/O[URUYI%@/A]XKO1
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZF@#F=1MX!\5])D$2;Y=,N1(<<L R8SZ]37(W6CZ:/A[XNNA:1>?9:K=_9I
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M88P3]:5O#^BM<6]PVE69EM5V0.8%S$O8+QP* //;-+2]TSX=27*0SDGRI&D
M;@0-A3G\.*VWC6W^)]]-IL,?G/X<$B! ,2/YK!3QUZ 5TQ\.Z(=/CT\Z19&S
MB?S(X# NQ6]0N, \GGWJ<:5IZZC_ &B+&W%X5V?:!$/,V^F[KCVH \WE2&[^
M#5OJ]M_R&(BDR7*C]_\ :_-"MSUW%B5QZ'%;%OHVG:A\2M8BU"PMYEDTVW>6
M)T#(SEG!)'0GWZUUD>A:3%>M>QZ=;K<,_F&01@$O_>_WO?K3CHVEF]DOCIUK
M]JE7:\_E+O8>A;&2* ,+X9.S_#W2]S%MBR("3G"K(Z@?@ !63K5G;Z-XNOK8
M644MOXIL_+2,QY4W2';@XZ J^XG_ &2:[:PTVQTNW^SZ?9P6D.=WEP1A%SZX
M%2R6\,TL4LD2.\+%HV(R4)!!(]."1^- '#>#(?MB6F@WMNC2>%IG25C& &<9
M6%A]4);Z@&J%DEOJWPNUV\U-5&K0R7<ES*>)(;A&8QX/4%0$  [<5Z1';PPR
MRRQQ(CS,&D8#!<@  GUX 'X55DT+29;XWLFG6[7#%2TAC&6(^Z3ZD=B>E '(
M:49?^$]T:?4T2.\N/#)^TE@ 6DWQE@?<<UA3M ?A%XK^SE/*&JW&S81MV^>N
M,8[8Q7INHZ+I>K/"^HZ?;7;6[;HC-$'V'VS]!^51MX=T1[>:W?2;)H;B0RS(
MT"D2/G.YACDY/4T 84MS'<_%/^SM1"M%'I8DL8Y!E6<N1(P!X+8 'J!GU--^
M'$=O!9:[!:JBPQ:Y=*B)T501@#VQ70WV@:/J4,$-[IEK<1VYS"LD0(C^GI4M
MCI6G:9YOV"QM[7SF+R>3&%WD]SCK0!R=YI6GZO\ %6XM]1M8KJ$:'$WE3#<I
M/G/R5/!_I7.6DYTC2[6TFN/)\/KXDG@BEE&^-8 K>6#G@H)<\GCY17IM[HVF
M:C,D]Y8P3RQ@JDCH"R@]1GKCVZ5)-IMC<Z>=/GLX)+,J$^SM&"FT=!MZ8H Q
M/#NEV&GZWJD]EJ(N'O!'+/!"JB&-L$!@%Z,P'/KC-4?%=OJ*ZV^H:9%9ZKY-
M@$O-)NN"T3,QW1L> 3M8$'@[1[5T^FZ5I^CVHM=-LX;2 '=Y<*!03Z\=33+O
M1=,O[G[3=6,$TWE^5YC(-Q3).TGNO)XZ4 <2!IFM^(_!NVW+6,NDSLD$_/R;
M8\!AT/X\'%5+-]-L?#VLZ?<Q-]E'B@VUK;1.(X\EHV5&."%CSDGCIGBO0GT?
M3)+R*\?3K5KF!=L4QB7?&OH#C('TJ%O#6A-;W%N='L?*NFWSI]G7$K9SEN.3
MGO0!PWEQ/?\ Q!M+HVC@V,+F*)<()/)ES@$GYAM&3UXSQ39[2PT3X?:!JD4$
M=NMVM@FIW03<6AV@G?ZKNV@CTXZ<5W@\.:& P&D6(#PB!@+=>8Q_ >/N^U3Q
MZ5IT.GG3HK&W2S*E3;K$HC(/4;<8Q0!P?B&&/1M-U_6M"U42W\^F#?%:*HC5
M0P'G?+T8*6P?0'TJQJMOHR:IX'NM-2W6-KDK#(F,M&86/7OSC\3[UV.FZ)I6
MCVSVVFZ=;6D,ARZ11A0Y]_6JL'A+PY;,K0Z'8(5D\Q<6Z_*WJ...I^F: )?$
M6BV_B+0+S2KA5*W$3*K,,[&Q\K#W!P:\Z&K,\6@^+I;..+^P66QU9C'\P+'R
MW_[X(5O^!^QKUBJQT^S:VEMC:Q&&9F:2,H,.6.22.Y)YH X3QEI=O%\-+V\F
MLXX[NYN8;M\H R.\Z8!]PI"_A6E=6UC_ ,+;MY)X+?)T61]SHO+B:/!R>X'>
MNIOM.L=4M_L^H6<%W#G/ESQAUSZX-,FTC3;B:VFGL+:66T_X]W>)28O]T]OP
MH \SOM-L+KP9XXOI;>.6YM]4NVAF89:)E*D%3_"<]<8SWKU"U/GZ?"TN'\R)
M2V1G.1S54>'=$6WFMAI%D(;AM\T8MUVR-ZL,8)^M7H+>&U@2"WB2**,;41%
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MSV[2!@J3.KE 5SUW8[=^E=)5272]/GMH+:6R@>"W=7AC,8VQLOW2H[8[5;H
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MFDT^[BN4@E,,C1-D*X )&?Q% %NBBJNHZG8Z19/>ZC=16MNGWI)&P/I[GVH
MM44U'5T5U.589!]13J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BJUOJ%I=W-S;6]PDDUHP2=%/,9(R ?P-6: "BBB@ HHK.GU[2K:_
MCL9KV-)Y9!$BG.#(1D)NZ;L8.W.>: -&BBJ=CJNGZFUPMC=Q7)MI/+E,;;@C
M8SC/K0!<HHHH **** "BBJU[J%IIR1/>7"0K-*L,98_>=CA5^I- %FBBB@ H
MHJ.>>&U@>>XE6*)!EG<X % $E%4M/U>PU7SA97*RM;OLF3!5HV]&4X(_&KM
M!1110 4444 %%%5(]5L)M3ETR*[B>\A3S)(5;+(N<9/I0!;HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X7XE_$.7P/%9Q6=
MG'<W5WN8&4G8BKCTY).?6NZK%\2^$=&\6VL5OJ]J91"Q:)T8JZ$]<$=C@<>U
M %3P%XN'C3PV-3:V^SRI*T,T8.5W  Y!]"&%=+5#1=$T[P]ID>FZ7;B"VCR0
MH)))/4DGDFK] !4(M81>-=B,>>T8C+]]H)('YDU-4<YF$#FW1'EQ\HD8JI/N
M0#_*@#C/A9;0W7POT59XPX1GD7/9EG<@_F*D;QCJ4]G;ZKING/>V<L^PVT=G
M,93%N*^8)/N$_P 6W'3C-:7@;0KWPSX6MM%O7@E:U+A9868APSLW((&,;L=Z
MS]&\-^)=#W:1::G9'0O,9H79'^U0HQ),:_P]R QZ>G:@"PGBF>\U^ZTJTELX
MKFTNXXFLKA6$TL)*[I5.X \%B  ?N\GFH]&O-:G\:^(X);FWEAL_(2*(HR@!
MHV90#DXY;DX.?;@4:UX5O=>D"7B6(:"\6:TU!&87$$8<-M V\G (^]CD'!QS
M=M=%U*Q\6ZKJL$UL]IJ*1,T3AA(KQH5 !'&#P<\GV[T 8J^-=4'@:RUY-/M/
M.GOC;R1!V"J#.8_E]3QW(_I6QINMZH?%UQH.J06BDV8O+>2V9CA=^PJV[J0<
M<C'TK&7P9K2>";;0?-L3-!?"Y\WS'VD><9<8VYSDX_7VK6ETZ^M_&)\37)M8
M[.+3#;2J)&9UPWF%A\O/3&/Q]J ,T^-M2E\/Z;K]M:VKVVHWPM4MY"RO&&D*
M*Q<9R<C)4+WZ\<];>->KILKVB0F\$>41\E"V.F>#@],__JKSK2DUBVTJ/6X4
M\.7UJ9&O8]\\L;%G).0@W(LF#C@=>*],B<R0H[(4+*"5;JOL: .+_P"$YNO[
M'\.:H1:)#JLZV]T&1LV[DD''/0,-I)[D'OBM/5/$TVDPZE=RQ1306\\=K:HN
M5::9]HP6R1@%@"0.S>G--_ 44MMXAMI+C=!J;.UHG:U+A68CZRJ&_P" BK>H
M^$?[2\&)H<MXRW:A91> 9/V@-O,F/=\DCT- "S:YJ.E^(-/TK4Q:R1ZHKK;W
M,$;*(Y5&=CJ6.01T((Z8QWK-F\::C'X%O?$ M[;S[*[>!HL-MD"R^7D<Y!YS
MW]*U5T;4-3U72]0UH6D;:6':..VD9Q+*R[=YW*-H SA>>3UXYP;SP3K\WA[6
M/#\%YIZ65Y=M<02LKF0!I0Y5AT&.>1G/MU !IWX_XNII!_ZA=S_Z&E8GC#6;
M[Q!\,M6U6S6V739%9(T=6,DD:R;?,W9P,D$A<'COD\=+-HVIR^,=/UIGM##;
M6CV\BAF5F+D$L!@]-O3-8+>"-?@\):AX2M+S3VTR7<+2:;?YL2,^[8P P<$G
MYL_AZ '=QL$MD9C@! 23VXKG;/7=;U.RT_6-.L;>>PO)P# 3MFC@)($N\M@G
MH2F.^,\5T,$4@LTBN2COLVN44A3QS@$FN5\/^'/$FA1)HJZG9OHD,A,,FQ_M
M0CSGR_[H]-W7'3'& "9O$FIWVG:IJNCPVLEMITTD:PRAM]UY?WR&!PG.0.&S
MCMGB$^,;Z^U+0X=)M+9[;6;.2XCDG=@R%0I(8 =MW;.<=NM26OAK5=(CU?3]
M,FM&L-2EDFC:9F$EHT@^8!0"'&>0,KZ>]+'X4N;#6?#\NG_9_L.C6LEMMED8
M2.'"@MPI&1MS[Y[4 8VM^*-;N/A]KTV;:TU#3;QK*X>$,RN,H-R9.5)$@ZYQ
M@_AT.I:SJ6FZ[H&GS0VDR:A-)'+,H92A5&8;5.<< <Y/?BLN;P7J=YH7B;39
MI[2(ZQ=F[A=&9O+;Y,*P*CCY!R/4\5HZCHNM:AJ>@7\KV._397EG56=0Q92N
MU>#T!ZGKZ"@"A/XH\1R/XB2TLM-4Z(P.99'82+Y>_' ')'?@#WZB]#XIGN-4
M\-1QP1?9=>M'N.<[XML:OC.<'.['0=*AC\.:NDOB=LV1&MC]U^]?]V?+$?S?
M+SQSQ]/>H1X6UJWM/"\MK+8F^T&%K=DE9_*F1HU0D$+D'Y0<8_&@":/QC/!;
M:RUW!&\NGZBEC (0P\YGV!<CDCE^<9X'&:MZ7K6JR^(7TV\LGDM6M_-BOH[.
M6!%8'!C8/GG'((/X5E-X&U&ZLM>M[O4H$DU&\2\MIH(R&AE4+M.">F4Z<\=Z
MW-#M_$N\2>(+NP8QKM2.Q1P)#_?<MW]@,<GKQ@ ?K&M/9ZIIND6JQF]U)GV-
M)DI&B+N9B!R>H &1DGKQ63/XMU&Q.NV%Q:VTFHZ3:?;(F4LD5S#@G..2I!!!
M&3]:O^(= N-0U+2]8TZ:./4-+D<HLV1'-&XVNC$9(R,8.#@]JJ7GAF]OAK=]
M*;9=1U2Q^PQH)&,<$>&_BV@L26)Z#H![T 0V?BC6C>^'FOK2R6SUR,!?)9C)
M%)Y7F G/&#@\=O4U#IC7L?B?QP^FQQ27:2VS11RYVNWV=3@XZ9]:L-X<U@P^
M%U!LMVB$>;^]?$N(S'Q\G'!SS]/>K6FZ?<:)KFO:SJ4]G#9Z@\4@?SB/*"($
M^8L .<9ZT ,T[Q-<ZMH.BWEH+?[5J4@26-D;$6 QE&,Y^7:1SU..F:U?$-Y?
MZ?H5W>Z;#%/<VT9E6&0'$@ R0,=\=*Q?"NDVB>(-9U>RN/.L9IR+95(,:NP4
MSLA'4,ZJ/JIKJ^HP: .3/B^4:IX;C62T:RUV(L)=C!E?8& QN_BS@9Z$=Z37
MO$NJ:9X9U+6([:RN(K>Z\J%7W+N02",L1SD[B?3@9[XJL/A\T?AJ\TV"^"W
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%5-1U73](MOM.I
M7L%G#G:'GD" GTY[T 6Z*BM;JWO;:.YM)XYX)!E)(F#*P]01UJ6@ HHK+O;;
M5[C41]EU%;.S6(<"%79Y"3GD]  !]<^U &I17$^#=0\2>(O#&EZ[)J<1:>4F
M>V^S*%*"0H<-U!P,]ZZA]:TN*^6QDU"V6Y=MBQ&0!BW7;]<=NM %ZBJ4VL:;
M;70MIK^".9G6,(T@!WMC:OU.1@=>:I6GBO2;W6[_ $J.[A$MB%WEI -S$,6
M!Z[0H)(]?:@#:HK&T[5K*VT>&>\\0VMZLLKI'=ED193O("KMX)'W>.N*N6.L
MZ9J<T\-AJ%M=26YVS+#*',9]\=.A_*@"[16?+KVD0S&*74[2-PQ3#S*HW#JN
M2<9'<=:M3WEK:VC7=Q<PPVRKN::1PJ >I8\8H FHJ@==T<?9LZM9#[6,V_\
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MHKF_"GB:TU'1](@O=4MI-7NK*.9X3(HD<E02=H_/I6DWB+1%N!;G5K+SFF$
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MO;*99K>==T<B]&%2"WA5RZPH&/5@HR:<B)&@1%"JHP%48 % #J*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBLK6/$>G:#);
M)J#3H;N40P^7;O('D/1?E!Y..E &K167;^(],N-233?.D@O)%+1P7,#PM(!U
M*[P-V/;-:E !1110 445G:=KEGJE_?V5L)1+I[JDXDC*<L,C&>3Q0!HT444
M%%%(S*BEF8*H&22< "@!:*S7UVS3Q!%H9$WVN6!IU_=D)M! /S'@GD=,UI4
M%%%9VH:Y9Z9J%A8W E\[4)#'#MC)7(!/+=!P#[T :-%%(652 2 6.!D]30 M
M%%% !12*RNH96#*1D$'(-+0 44C,J*68A5 R23@ 4M !116=;ZY9W.NW.C1B
M;[5:Q++)NC*KM8D#!/7H>G% &C1110 445FZYKMGX>L!>WPF\HNL?[J,ORQ
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M])2X6-5+X)._;D+NV@X'3.*V_P#A'+D^(K+6I-4,LMK;-;[7@&'#$%CP1@Y
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MQEMO)PKQEMQYW9!S^G'O5/0_!UWHS16I\0W=SI-LX:VL9(T!3!RH:3[S*#C
MXZ#MQ0!/X\U34-$\(7FI:9-'%<0;""\>_(+A?H.OH:SY]0\1:+XOTRTOM0@O
M;+6?-C5%M@GV655W#!!RRGIR<T[XJS11?#O4UEE6,R>6JY."3YB]*U8=(>]U
M"SU:[U"*\:TC<69BBVH"XP7/S'<<<<$#!/'/ !S6F^(->3P]?>)=1U..6VTR
M6[1[1+55^T;"53YLY7D#UXZYJ[J&L:QH>GZ-K,]\+R"\FABO+<Q(JH)>C1D#
M=\I(X8MD5IZ1X4CL-$O]'O+D7UK?22NZF+81YA)<<$\<\=Q4=KX3D2TT_3[_
M %(WMCIDJ26\;0[9&*?ZL2-G#;>.@7) SGN 94=SXNU>]\0VECK-O:OIMR$M
MR+16\S,:L$.2<#GD\GGMC!-#\97?B<Z%9PO]BFOK"2\NI8U!(V/Y>U-P(&6R
M>0>![Y$7AUI=1\3^+H]-UB&$27:*P$8D8 1*I=#N&#G(R01D#CUVI/!MK;G2
M9=(G-A<Z1&88'*>8KQD89'7(W ]<Y!SS0!EMXDURU3Q%I@B?4+[1W@>.6&(>
M9-!+@D[.AD50W8 D#BG1^,$_L&\U33M5&J(TT%O DL:I);RNX0B10%Z$YYQG
M&,]ZV!X;D2*]FAU!HM3OIXIIKM8AC]V5VH$S]S"XQDGYCSS5>Y\$66HQ:Q_:
M,@>;5TB69[>/R@OE\HRC)^8$YR2>W:@"M-JNOZ%<7U_?0W%SHL%B\[-<F!94
ME7G:OEGE6'J,@]ZS->&I7-AX2U&[U#S#<ZM9R2VXB41H6R1L(&[CIR3GVK?L
M?"UT;.:UU[6Y]:B>%H%62)8@J,,$G;RS8XW$^OJ:HKX%O?[/T[3I?$D\EKI=
MU%/:_P"C)O41YVJS?Q8X&<#W![ &[XEUI/#OAR^U=X_,^RQ%PF<;FZ*/S(KF
M-<M]1CUOPA->:D;GS+_,D?E(JJ_E.<I@9"]1AB3TYZYZ_5=+MM9TFYTR]!>"
MYC,<F#@X/<>_>N>3P7J#KI*7GB2:==)G$L!%LBLP"E0&)SDX/7'X9YH K2:Q
MXDUBPN[_ $".8RP7<D5O 1!Y$JQR;"'+'>"<$Y&,9'7J;"&1_BON*^7(?#P)
M4_-M/GGCCK4B^"[BUU6[GTSQ!=V.GW\IFNK)(T8%V^\4<\IGOC\,<8T%\/-'
MXK&NQW:KMLA9+;^3\H0-N!SGKG\,?G0!@6VJ>)M2\'ZY<6E\IU33[^YB@*P+
MMD6(X"[2#U ..<Y(YK6L-:;5UTN[LKZ3[(;+[7=?(A+ C"J>."2'Z8^X15OP
M[H3Z#%>1F[^TB[NY+LGR]A5G.6'4\9Z4OA_PW9^';>Z@M2S)<W#S;6Z1AB2$
M'^R,G ]SZT 8%GJ_BC5;#2M:TV":2.ZD22:UD\@0B!NNUL[]X&.3U.>!TI^E
M7/B36->U>V_MJ*WM]-U!$PEFI,D90,4Y/R]>O)S[<5/I/@F?1Y3:V^OW?]B"
M0R)IIC3Y<G.SS/O;,_P_AGDYTM(T*32-4U2_:^$RZC*)I(_)V[&"A1@Y/&!0
M!AV6NZM%8Z[IE]?&36K.Y6&V81(H=9<"!P,8P2?FZXP:[!5FAL]N\W$R)]YL
M+YC8[XX&37+:;_8_BSQ9;>)=,+S0V-LT/VC8R++(QX&& SL&_P#[^"NKN(O/
MMI80Q3S$*[AVR,9H XOP]XM:\=FO=2FBO+.TDDU'2KFW6.1' !W1_*"4&&[G
M@KFM#2IO$.JV&C:W;W\/EWFR:ZLY$ C2%USA&"[MZY'4X)STZ58B\,--J%A?
M:K>)?36$,D,3BW\MI ZA6,AR=W&>!@9).*K:'X-N-$:.T77KJ?2()/,M[!XU
M^3G(4R?>90>0..@ZCB@#G$FUBRLO&^I:7J"6AL=2FN-I@63S2L2$J<]!@=N?
M>NADUZ]U+4X--LUN82VFQWLKVHB+@R$A0/-.,#:<\$\CIW>O@Z4:;KUB=3!7
M7)9))6^S\QEU"L%^;IM QG]:9>>"[B1]-O;#6Y=/U2PMA:_:HX%99HAT5XV.
M#Z]>N?; !7M]<\0HVB:'JJ1VFJZC+.)+A C?N8ANWA02H9LJ,'(')QT%9B-J
M&F:_X\N$U!WN;73[>:*=HTW?+'*P##&T\C' '%=!J'@[[;!831ZK<1:M83--
M%J#(K,S,,.&3@%2 !M&,  4MMX087^KW=_JLMT=7MEM[B-85C7 4KD=2.&..
M?KF@"F^NZFI\'3"ZXU8(MW'Y:[6S"7R.,@Y'8XJF-6&@ZY\0-5\L2&U%K(J$
MX#'[.N 3Z9Q5^#P/=JFC+<^(9YO[&D!M]MNB?($* 'KDX/4YZ=!SFXOA**2]
MUZ6]N1<0:ZJK/#Y>W8%38-ISZ?KSQ0!':OXGCUVRW)/<:=,CB\-P($\EL95H
M]AR03P0<X&.:Z:N<T'PQ?Z284O?$5UJ5K:#%K#)$B[., LPY<@'C/'?&<8M^
M&8-4M].ECU6^DOG\]C#/+$(G:/ QN4=.=V.^,=.E &/;1W;_ !4OE.I7/E1Z
M=#(L.$V@&1P5^[P.,YZ^_2N<L+_6-$\#3:U97\<<%IJLH:U\@,)E:Z*L&8\C
M[W&,=.^>.YF\/N?%']NV^H20.]LMO+#Y:LL@5BRG)Y').<=1Z5EGP*[>$;CP
MXVK$Q7%P9VF^SC>"9/,(^]C[P_*@"2^U75-1UC5M-TMKF%M.2-5>W6!MTKIO
M&_S#]W!48 !Z\],;>BRZG/HMK)J]NEMJ!C_?QHP90W3(P3P>O7O6/?\ A*\E
MUO\ MK2]=ETN]FB6*\,<"R1W 7H=C9PP['GC\<]!9VJV5I';H[R;!R\ARSDG
M)8^Y))_&@#@WUKQ/+X=\3ZBNL11RZ)?7"Q!;1<2)&JMM.<X!R>G.3U[5I+K&
MLV_B#PZ\]]'+::VKA[40!1 1%YBE6^\>F#D\^@JRG@Z1='US33J8*:W/+-*_
MV?F,R *P7YNF ,9_6IIO"\TL^A3?VBH;1<[,0<2Y38<_-Q\OIWY]J ,?5/$.
MKZ?/%-]O25_[82UDMH(@\"0.X4*S[<B3!!(W<$],5+XEUC6O#_B"&,WP>PU5
M&M[0LL:_9;DD;2QQRG/OZ'/&7M\/Y/[.?3TUZY2U6^%[;)Y*$Q/YGF8)ZMSG
M'3KWK3O_  L-5M]2@U&[%TM[ ((R\(S H[C!Y.[#9XY [   %;Q+?ZMHD&@K
M!?B0W&J6]K=/)"NZ57;G&.%Z=A^-0_:]>OO&>KZ+%JR6MO#:PS0NEJK-&6+#
M^+(/3O\ @!UJU=^%KR^TO2K.YUDRR:9=17*W#09:5H_NAOF_,CK[=[,&@SV_
MB6]UM;Y#)=P)"8C!\J!,[3G=GJ3G^E '*1^)?$9\%Z7XGDU"$'[3'#<6J6Z[
M9U,WE,2QY#'J,8 ]#716>H7\_C76-'>\?[-%:0S0D(FZ)G+ X..?NC&<U5'@
M9QX/A\-C53Y,,XF$WV<;SB3S /O8^]^GYU>N/#5R_B+^V;;5GM))K9+>[CCA
M4B4*205)SL/)]>/SH YRU\3^(+GPEX6U%;V 3ZEJ*VMR6MP=P+N,\'CA!P.?
M<5HVT_B*;Q1JOAXZX D5O%<Q77V1/,CW%@4 ^Z1E<Y()QQ[A]MX#>TT/1]*3
M6'9-)O!>1N\ .Y@6(7@CY?F/<GWK5AT&>'Q-=ZXM\A>ZMU@,1@^50I)4YW9S
MDG/]* (_!.KW6N^$K+4+XH;E_,21D7 8I(R9QVSMS^-9NBQW;_$GQ)OU*Y>.
M&*SVQ,$V[6$I"_=R "21@@\\DUL^&-"/AO18]+^U_:HXG=D<Q[#\S%R#SSRQ
MJ,>'I8?$MWK5IJ,D)O88TF@,:LK,@8(V>H W'@=?6@#A_#]_K&B^ ] U*WOT
M6U^W"WDL_(!$B/.RDECR&YR,8'L:WO%FN:MI<6M7-OJ*(UC"DMK;01"7Y0N6
M,^5.T$Y P1P.,FIT\"NGA.S\/+JQ\JSN%G28VXWL5?S #\V/O'\J=>^!WO'U
MI/[:GBMM:3-Q"D*G$FP+N#')V\#Y?UH JW#7EY\1M&9=1N((I=*DG$*!"JG=
M'D#*GKW)YXXQ6]XP_P"1+US_ +!UQ_Z+:JI\*R?;]*OUU:=;G3[=K:1_*3]_
M&V"1C&%Y48(_^O6IK.G'5]&O--$WD"[A>%I-NXJK @X&1S@T <Y8ZO<%_#7A
MZTF-LUQI8N9IPH+*BHH"KN!&23R2#P/?(RM?UG5?[$\8:)<7T@N-+MEFAO(E
M5'FB=2=K#& 1@@E0,]L5T4OA(F/1YX+_ ,G4='C\J&Y$.5DCVA2KIGD$ =",
M'D8J27PG;W=AK$5Y<-)<ZU'Y=S<1KLP NU0JY. !S@D\DY- &7J6LW/AS3M&
M-W=WHTR6$_:=0B@1V@;"[ P"$!.6YVDY KI=$G>YT:VG>^BORZDBYBQME&3@
MC' XQ5&'0]3MX[,)K0E:W@:&43VH9)@=N#M5EQC;Z]S5S0=%M_#^C0:9:DF.
M(L<D 9+,6. .@R3@=J -&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHKF_$>HZAI&MZ)<+=LNEW-U]ENX]BG#,#Y;9(R!NP
M#SW'2@#I**X6Q\1Z@USXCTZ74));JW=1IKF)%WJ[&-3]WG$H*D].^*TX=0OM
M1\27?A^+498!IEI$\]RD<?F32R9QPRE0H SP.I[8Y .GILCB.-G8,0H)(52Q
M_ #DUY^?%NL-I<1>=8[VR\0)I5T4C79<*7 W $$J2I'0\'-=#!J5ZOQ"N=(>
MX,EG_9B72(R*"CF1D(! R1A>_K0!HZ)K5IX@TJ/4K'S/(E9U7S$VM\K%3QVY
M4TU-=LW\1/H0$WVQ+;[2<QD)LW!>&/7D]O0UQ7AK69M*\!Z+;6I5;G4]5FM(
MY&&1'F>4L^.Y !P/4BM.SM[BV^+C+/>R78.A91I4164>>.#M !Y]N] '1ZMK
MEGHSV278FS?7*6T6R,L-[' R>@_&M&N2^((E-GH8A*K+_;EIL+C*@[CC('45
M0O?$FM>$=8OK;5[M-5MCILM];.(5B=&C(!C(7C:<CGK0!WE(S*BEF8*H&22<
M "N7M)O% U?3I=DUQ83J1>B<0*L1QE6BV-NQGC#;N.]1_$O[0OA3?;WDUO\
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M2M-_D7,8DCWC!P?45;9E499@!G&2:X'PS=W<'@_PM#'?+:6TMD?,\I!)<R.
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MR>O:M[^V;YO&6DV:SD6>H:=)</"54[&79C!QG^(]: .FD=(HVDD8(B LS,<
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M7KBQU:"$P272PHZSQD[MK(>."3CT]ZNKHE[ ;5[;5F,L2R"X:YA$@N2Y4DL
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M3'S\S8''0\=>#Q5'4O&%O9ZMHMG!!/<Q:HKRB:*%G4QB,L-N!R2=O3H,Y[4
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M_(\[[+)LC?=M =MN$R?7'KTK4O-;L[*Z-HQDEN5A,[0PQEV6,'&X@>_3N<'
M.* -"BJ.DZS8:[9"]TV9IK=CA9#&R!OIN R/<56'B;3#=:E:AK@S:6H>Z06T
MF54YP1Q\V0">,]* ->BLF'Q+IMQIUEJ$+3R6]^X2W9;=R7)R1QC('!Y/%48[
MNPOH_$0T_4;YIXSB<.SK]G<1\",,!M'&>.YH Z2BO.3>WS> ?!M[]ONA/+>V
M2S.)FS,K.-P<_P 6?>O0KB>.VMWGEW;(U+-M4L<?09)_"@"2BN>M?'.@7C6
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M,\-#3);D7$TDK32NH(4,0!A<]L**Z>BB@ J.>9+>%II-VU!D[5+'\ .34E%
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M =ST!(YZXZZB@#@O#5M/X1\2/ITEH[V.KI]IBEM[=V2SDR282<<)R2N<8)/
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MO3O#WA&TN-/O8(1%+%=7$=B[SP. ,1@;2R!L\L!VX(ZU4GM[L?#/Q1IJZ;J
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M'(7/7&23BI:* .9\4?\ (R>%/^PA)_Z(DK:LM2COI[N%(;B,VDOE,TL10.<
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MEQ#,/+))8CY2-O(!YZ4S_A-M)>]ELX8[Z>>&X%O(L=G(=CD9&[CY0?4X![<
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M&JXX<GE3V (SP:U: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*U2#6+!+VV2589,[#*A0L.F<'F@"[116=J>N66D7-C;W7FA[^=;>';&2I<]
M6Z#H>_:@#1HHHH ***S+[7["PO-/M96D9]2D\NW:.,LC'!/WNG0>M &G13)9
M!%$\A#,$4L0HR3CT'<U%8W:7]C!=QQRQK,@<),A1U![%3T- %BBBB@ HHHH
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MR,L-[G R>@_&M&@ HK,U+7[#2FL1<-(W]H7"6\#1QEE+MTRPX'YUIT %%%%
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MX;N]+T[2[6TU;:=-A: %H,I,AVXWKNZC:.010!=\.W8OM$@N5U)-320N4ND
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MVB)'(Z-$'VMM7'?&0 ?I6WYE[96&A0#6'6&:(^;^[1KF4[!L2-53&!R2<9
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "J]]=&RL9[I;>:Y,2%Q#
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MO-::@8VA\B,).GVGRB'^7.<'C!&,=,\T >G55:]9=42Q^R7!#0F7[0%'E#!
MVDYSN.<XQT%<EXFU^ZTO6;FVU"[N]*LYHD73]1CC5K=9".1*<'!+>O&.F#S6
MC)J5[#\18[)KUFTY](DN?(V+A761!N! R>#Z]Z -/Q#KMOX;T>75+N&>6&(@
M,(5!(R0!U(XR16G7F'B&[O?$7PEN?$$E_+']J(D%JH7RUC\X*$/&2< $G.<^
MW%='?:CJ6J:_JNDV#W,(T^*(!K9XU;S)%+!FWYR ,  <?>SGC !UE%<'/=^*
MAJ7A;3KW4UL[G4([F.]%O&CKNC3(=21U[XZ ]N*L"ZUF[O\ 4-#@O;N672H(
M8S<Q>2CR2NA;S&##&.@ ''#9SQ@ [2LS1]=M]:FOXH(9XFL+C[/*)E RVT'(
MP3Q@BL&RU76[O5]+\.:G,EK>_P!GO>7\ML0?,VN(U521@9)+' [8&*7P+#)!
MJ?BB*:X>X==5QYK@!F'E)C. !G&.U '7&1%=49P&?.U2>3CKBG5QVI03R?%+
M2PM_<QH=-G8(A7:N'CR "IZ]SUX'-,M=1U3Q%I.M:G9:E)926=S/#9Q(B%!Y
M7]\$$G<>O/ (Q@\D [-CM4G!.!T%9NAZ[;Z_;7$]M#-$+>YDMG690&WH<-P"
M>])X9U=M?\-:?JKQ")[J!9&0= W?'MGI7":?;ZTOA_Q+J6E:V]D]CJU],D A
M1DE*N6(<L">0,<8Q[T >GT5Q-IXBO_$ES%;VRW-NO]EVUVXMGC5]\P8]7SPN
MT=.YYKHO#9UG^PX$U\Q'44RLK1$;7P>#QP"1C(]: -2BN(35]5.F>-,ZE*9-
M*DD^R2[(]T86$.!]W!&?44QM4UJYU'P=!'JSPIJ]A))=8AC.76)&W#(X.6/M
MTX[4 =U67<Z];VOB&RT1X9_/O8Y)(Y H\O" %AG.<\CMWKD4\4:II&BZU;SW
MAO+JTU9-/M;F=%!Q)LPSA0 =NXGMG JW?VDUE\2_#;2W]Q=(UK>8$P7*D*F2
M-H'7CCH,<4 =O17"6.I>)]<TG3M=TMG4SRB62&62(6Y@).4QC<"!WSG(/;@6
M-+;7-4\5ZW:-K\T5MIE[ 8T6"/\ >(4#LA..G.,CGWH [.BL#Q;K,^DVNG0V
MKB.?4]0ALDF*@^5O)RP!X)P#C/&2.M4Y;S4-*\:66B/?3W%EJUM*T3.%,EO+
M'@D@XY4@C@@\_E0!U=%>=0^(M:D^&^AZRVI2?;9KZ.*9Q''B56G*$$;<#Y?3
M%:3-KFI>-]7TF'7YK2VMX+>>+9!&Q4L6RO(Y!QWYZ<]<@'3:OJ<6C:5<ZE/%
M+)#:QM+(L2@MM R3@D=A4:ZNLEKIMS%974T>H;,&- ?)#+N#/SP.V1GDBJWC
M/_D1]>_[!MQ_Z+:L.:_O["Q\$K:W;107<D$$\012)%,);J1D?=[4 =M17)17
M.J^)AKIT[5&T^;3[QK.U554H'15):3().XDC'88[TMSJ>I7^O3Z-"\RFTLH9
M97LVC0O))NY&_/RC;QCUYH ZRBN#DO/%EO+X7L]0U&.WO+NXF@O/)C1UD"QN
MROTX; ''3/;'%26VH>(K=/%>EVUU+JEWICQ&SDE5!*RR1ARO "DCG''7'TH
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MY;;P'!/ QTXQ0!V-%9/B2YGM=,5X+^*Q+3Q*\KKN8H6&Y4&#ER.%&#R:Y?\
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MO(TC7#.KO.S#:?,W*01@#@ 8P,8Q0!R&LW<&L>'O#]U8ZW=7<$GB"W3?NVN
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M0AM8K^>W_P") P>:/:92//7H2" 3ZX]>G4=)KNA6^OV<-O///;M;W"7$,T#
M/'(ARI&01^8-5U\,Q)XA37!J-]]I2S^QA69&0QYW<Y3.=PSG/Z<4 <QI?B35
M9-*TO39+EIKJXU2YLGNF94=TBWD<XP&.U1G'KWYKI/#]MKEI?ZA%J4Z2V+,K
MV0>;S)HQCYU8X&1GH>35-OA]ILFC2Z9)?7[AKLWL4^]%EMYB22R,JC')/7-:
M^C:*-(C<R7UW?W$F ]Q=N&<@9PHP  !D]!W- &%XMUFYT?54DOEOXM$:VQ]L
ML1N-M-N.6D49)7;MQP1G.0>U.[22_P#&GAL0:FW[W2)R;N  F0?N_F4G(&>N
M<'^M=/?:(UY?372:E=6XN+86TL2!&1E!8YPRG#?.><XZ<55A\'V5KJ>G7UK=
M7< TRU^RV\"LAC$?&<Y4DDX'.>U '.V?B/5+31)[.2\>XN$\0MI,5U+M#[,@
M@DXQNQE0<=2.#6O#:Z[:7.JB[G5]+ELF:&.6?S98Y0,-@[1E"#W)P?K4A\!Z
M9+IFIZ=<W5Y<PZE=&[D,C(&BF)!WH548/ ZYZ?7-FP\+BSLIX9]8U*]FFB,/
MVFYD5I(T/4+\N!VR2"3@9Z"@#C+V R_!31&\Z5 JV8*H0 V98QSQV[5Z7;PF
M"!8C+)*5_CD(+'ZXKGYO!%I-X6MO#AU/4%M+8H4=3%YA"$%03LQ@$#M]:Z*)
M&CC5&D:0@<NV,GZX 'Z4 <+I\MQ;Z-X[N+2Y>VG@U&YECE15)5E@C(X8$=JA
M\1^?J'@KPG=SW<_FS76G&0AA\S,5)8\=<UT</A"WAL]8M1J5^4UEWDN"QBRK
M.H5MOR<< #G--NO!UO=Z)INDMJ=^D.F/$\+H8M[&/[FXE,'&!V&>] %2>YOK
M[Q#>Z%;W%P(["TB<NEP(Y'>0O\Q.TY "CCIDG.>*V?#BZNFAV\>NRP3:C&"L
MTD!^5\$X/08.,9XZU2UCP?;ZKJ5OJD6I7^GZA#%Y)NK215:6/.=K@J0>>>E;
M-C91:?9QVL)=E3.6D8LSDG)9B>I)))^M '#:_K.I6$-U?VVIS7,MOJT<68 !
M;Q1&15\E@?O-@G)&2">HZ5H2+JFH>.M5TC^W+RVLUL89HQ"L8:-F9P0I*]..
MX)]ZFG^'VGSVM[9_VEJ4=K=W/VH0)*H6&7>'++\N>HZ-D>V>:T(/#,=OKDVL
M1ZG?>?/;K;LK&-EVKG:>4SD$DYSWYH YG1_%&I:AHWA.PGNBMWK$LZ7%TJ@,
M4@W9QV#-M49[9..<5>\/VK6GQ*\01&XEG7[':E#*VYE&7XSU/?KS5A?A]I\>
MA6>EIJ%^#I\YGL[O>@F@<DDX(4 @DG((/7Z5?TSPPFG:W/K#ZE>W=W<PI%*9
MB@5@N<':J@#J>G% &3XRMWF\4^% +NXB5[R12L;X /E.=V,=>V3VSZU42PN;
MWQUXJAM]3N+';:69,D 7>3LDQR0<#UP.?7UZC6] @UMK*22YN+6>QG\Z&:W9
M0RG!!'S @@@GM4%OX7BM=6U+4XM2OA-J,:1R@M&RH$!"[<IG(!/4G.><T <]
MI7B?4M7TOPM;,Y-QJEI+-<2(XB:3RPHP#@XR6W''IQBNB\-0:W:I>6^L7$<Z
M+.6M&\S?((CT5S@9((//>L]OA]IQT'3]*2_U!&TQR]E>)(BSP9Z@%5 (/?(Y
MK<TG2ETJV:,W5Q>32'=+<7+[I'/0=   .P  _,T <ZMLY^+DY^V7(4:/'+LW
M_+_KF&W&.!\HJG9WGB7Q#HEKKVE7*Q323F0++< 0>4'(,;)M/\(Z]<]P.*Z>
MX\/6\_B2'75NKJ&YC@%NZ1. DJ!MP##&>&)/!'H<BLVV\"6-GJ,TUMJ.HPV5
MQ*9I=-28"W9R<GC&0#W4'!Z=.* ,W4-=N++Q))9:S<7NFK+>Q?V?>)S:RQ97
M,38X#'# [N>>"!4V@6DK?$'Q9_I]V/+-J%^<$#=$QZ$$<$D@=/K6O=>%H;U)
M[>ZO[J:RN+@7#VK[-H8,&V@[=P7< 2,^O/-3)X<@A\07>M07EW#->1HLT2.O
MEL54JK8*YR ?7'J#0!Q?]MZXWPSM=2&KS"]_M/R7F*)^\4W)CP1C@8_NXK?L
M)M1T_P ?W&DR:E<7]M/IGVQ5N-F8Y!)LPI51A2#TIX\!60\.)H0U34?LR7/V
MD-F+?OW[^OEXQNYZ5;N="^S:P_B2.ZOKJ]@L6MUM@8@LRCYMOW,@E@.<C\N*
M .5M]9UC4-*T26WU2YCUJZU'R-1M8]A:&/<P?]VRD)L &&QSW)S7;:_JG]A>
M'+[4RIF:SMWD"G^,@<9QZFN"T>*X338H-)\0^)(M15,BPN+(M''*>2K%X\!=
MQZE^G>O2+FUBOK&6TO(UEBGC,<J=F!&"* .$UNVN6M?!VH7&I3W$L^JVKS*2
M/+9F5CE5Q\N.0,=CSD\T[Q3K&I:?8ZQJ%IJ<T]Q8WD8C^S@""WCR@,<F>'8Y
M;.,D9'W:U(_ ,"VEC9OKFJ26VFW*7%I&SQ_NBF=JYV9(&>^>!BG77P_T^[@U
M2V;4=2CM=4F-Q+;QRJ$24D$NORYY(!P21[=, $ MG;XN2G[9<A1HZ2[-_P O
M^N(VXQP.!5!]8U*WN-$N8]3FO3=ZO]EN9T %K(C&3"(IYRH5?F48R#DFNF;P
MS;MKEMK O;U;F"W%L^)!B= VX!^,_>YXQZ=.*S(?AY80V-I8IJNJ?9["Z6YL
MT\Y<0$$G:/EY')^]DCL1S0!T.K><-(NS;SM;S+"Q25 I*D#(.&!'YBN.36]8
M7P7X;U62&]O[>6!9-2-F?WY!3A@!R0#R<8/3MFNUN[47=C+:>=)$)8RADC(W
M*",<;@1GZ@UDV?A5=.L]-MK/5KZ,:;$T43-Y;;T;;\KC9@@;1C&#[T 3^%KV
M#4= @NK;4FU**1I"EPXPQ&]B%88&"HP#P.E<VYUC4-=\6V/]OWL$.GI ]MY2
MQAD+1%\9V_=S^)XYKK=(TFVT:S:VMMQ#RO-([XW.[L69C@ <D]@!5!/"T4>H
MZM?)J=\)-714G7]UM7:NU2OR<8''.>M &%IGB6^UG_A%=.EG:%]3L&N[N:/Y
M6DVJ/E4_PY))..<#C&:HZ]?:@FG>,_#]Q?7$L5C8"ZM;C<!($9&S&[ <@$?4
MCJ:Z./P190:=I=K#?7BSZ03]BN\IYL:D8*G"A64C@@CFKA\,64MGJ<%T\MQ)
MJT?EW<[D!W7;M &    3C ]3R2: )_#T)@T"Q4S22Y@0YD()'RCCITK2JEI.
MG#2=.BLA=7%T(E"B6X8%R , < #H!T'ZY-7: "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *R?$FO)X;T>34Y;2:YCC9581%1MW,%!.3TR1TS6M7*_$S/\ P@&H
MX.#NAQG_ *[)0!U5%<3=OJ?AKQGI0_M>\U&SU83I<6]QM.QTC+AH\ ;1QC'2
MH-,?Q+KFCZ3XALKVWA>5UN+CS+YS$\)SNC\OR]JD#@$'.1R30!V<%U/+?W5N
M]E+%%!L\N=F4K-D9.T Y&.ASBK5<5%=ZDVM>-;4ZI<[;."![5ODS!NB9B%&W
M'7U&?YUFV=YJUMI?@K67UF\GDU*>"VN89&!B=9(F.<8^\"H.<YY/TH ]'HK@
M=8U2_P#.\40S7MQ:7UI&K:1%"Q'F#9E2JCB0LX(((..G%=AHT=Y'HMHM_-+)
M=F)3,TFW<'(R1\H X)QT[4 7J*\W@@UW5M(\2W*^)M0AGTO4;E+39L /EJI
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M37^M1_#O4M?_ +>OFO-,OIA%EE"N%FVX< ?,".,< <8 [@'J=%<B[WVD>/\
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ML+X/.<X'ICWKEFN[RZ^'7C5;V\ENWMKF^MTDEQG8HPHX 'Y 5=U3_CY\!_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRVCIY:RQLY(^\N[:PZ[2/YUU%YX<M;G5(-4MYY["]AA\@36NT;XLYV,K*RD
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MF:)9:0]\]E&8VOKEKF8_[; 9Q[<9_$UH5GZYK-GX>T:YU6_8K;VZY;:,DY.
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M(]TL+!0[>0K9QCKEC].V",UT-YX0TR^U2[U"1[I'OH1#=117#)'. "!N ZD
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MS:ZA=V[&*62U*3'"+&N 5!R!N92V1C@BN@N=$M;S0)-$NC)/;20&!BY&XKC
MY ZCUQVI;_1;2_T-]%;?#9O#Y!6$@'R\8V@D' QQ0!R.HVJ7OBOP1)/+<EI[
M6X\QEN9$)(A4YX88.2<D<GOFI9M8O])U_P :3_:9KJ/3].AN;>"5LI&VR1B
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MI*.4;'LRD$?4&O)X+=4^!5G*CR[YIX,EY&< BZ'12<#\,9KUF-!%&L:EB%&
M68L?Q)Y-<X? 6D?V*='2:]2R\X2K$+@D)AMP5<@X 8Y_GG% &>;J[T#QO>VZ
MWUY>V[:))?M%<R[_ -ZD@'R]E!!Z# ]J;I<.NZC9:#KMOJ4<7FF*6\:2^D>.
MXC<?,@B*[4;)XQT(QS71'P];MK\>MO<W+W4=O]FY*[&C)R00%[D9_P#K<52T
MKP-I&C7GG6<MZ+=9#+'8M=,;:)\YW+'TSGD9S@\T 7?$_P#:?]@S_P!CJ'O
MR%8_,\LR*'!9 W\)9<@'L37%:CKR3^"_$EWIUWJUC?V21L]I=S2":S?V))RK
M#)')'7\/0-3TZ/5+/[-++-$-Z2*\+[75E8,"#]0*I/X8T^XM]1BO/-NVU.,1
M74LI 9T (4?* !C)Q@=3F@#-U"ZN8?'GAR".YF6&\M;DSQ>8=CE%0J=O3(W&
MN5M=/O1X(UK6;+6[ZRN-/O;ZXA2*0+$=DC,0ZX^?.,<^WX]G;>"].M[[3[Y[
MO4+FYTY76&6>Z8DA@!@XQD #ITY.<T]?!^G(MQ;B6Z-C<S&>:Q,@,3N3N/4;
ML$\E=V#Z8H Q([B_U;QAI<<NH7EM;W^A&YEMHI-BH^Z/.,<@_,>>H[$5DR-J
M8\$^(KLZ]J?GZ%>W,=G(+@@E8V!7S#_RTZX.[(QVKNY= MY?$$6M_:+A+F*
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M'"U!%_Q2OCO3+A-,N=/TW58$TV7SVC(,R#]RWR.W) *\XH ]%HIKKO1DR5W
MC*G!'TKS/2YKZR\ WGBEM5U&YO;'[8D2RW!:/'F,H++T;;UR?IT H ].HKE+
M+3-2BUK3=2M]02*R>-DN(GOY+D789<HR[@ K#&<CJ/:N?1]:U'1+15N-07Q
M-6:.[\J614$0E8,./E$83&".X_O9H ]+HK@O%$DHA\1FTU&]N)]/T\.@CG:%
M+!EC9P2P/SNW!Q@\  D TNH->:EK?@^-M3O8(]2LIS=+!,4#D0J01CH<L>>O
M/&* .Z=F6-F5"[ $A0<9/I6#I'B.[UOPS#J]GI!:66=HC:FX4%564HS;B,<
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M/C+@[OUY[YJAHNOZC>:!X1LY[AI9-1:X2:62X:)I?*W!5,B@D$X!XY.W'<T
M>D45@^&]/U'3+G4(+R^6:!Y%EM;<SM,]NI!!4NP!*DCCTY%5/,F'Q/:S^TW'
MV:713*T/GOL#^<%W 9PIQQD8H ZFBO.["XUR;P@SV+S:A-;ZS.LD$MVRRW$"
M.X\M9"<Y  /7D*12KXEB?2K2/3IKV(7VM"TN8;^9XY;4F,L8BYW%<E0 1V;
MP: /0Z*Y[0]-U+3=:O3<7J&RN45X+,W+SM"PX8JS@':<CCL:KZC>R7OQ M?#
MTLLL5F-->\(CD,9FD\P(%)!!P!DX![C/2@#I9YX[:WDN)F"1Q(7=CV &2:R-
M*UR^U.:TE_L@QZ=?6PN(;I9PQ4$ A9$P-I((/!:N9WW,EAXVT&ZN+FXMM+CW
MVLS3OO"R0E_++@Y8+[DY!YS71^"+6.V\&:.4:4^;8P.WF3.^"8UZ;B=H]A@4
M :[W2!Y88L2W$48D,(8 X;(7KTR5;\C5#PQK@\2>'K75Q;FV%SN(B+[BN&*]
M<#TK"T"RB'Q,\4R;YR8X[-E!N)",LDF<C."/0'@=L5R^CQSZ=\._#FLV^H7B
M3IJ$<?EK.1$8VN&5D*#Y3G.<D$^] 'K=%<5</?>(]<\0:9%*8FL#'#!MOI(&
MAW1AA)M0?,=Q/4]%QZYZ?15NX]'M8[^[CN[J--DT\0PLC#@G].?>@"]4<4\4
MS2K%(KF%]D@!^ZV <'\"/SKA=*U&XM?$-E8>(5OK>[EN)3;7L5P[VFH*ROA>
M#A" 00,<;>.M95M>R>&?!7BS5+&2<7$.LW%NCR3/((U,RIO(8D$@'.2,G'-
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MEMI^HV#-<FWU29IKM3,?WCMC<<]LX'3'2K#^&K*2^TZ]>6Z:?3%9;9C,?E#
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MH))YY%CBB4N[L<!5 R2: )*P[SPCI=]J=SJ$AN4DO(A'<QQSLL<X PI=1PQ
M..:DUS79=)TJ'4;739=0A=U\P1N%,<9&2^#U[<#DYK8H Q+;PI8V$-E'8SWE
MK]AB:&%DN"WR'&00V01\H[<=L5'?>"M#O]*M-.>WDB2R<R6TL,K)+$Y.2P<'
M.23D^IYK?HH I:7I5MI%G]FM?,8%MSR32-))(W=F9B23P/R JO=^'K.YU0:I
M&\]K>F+RGFMY-ID3KM8<@X['&1V-:M% &->^%=*OM"31'CDCL$(/E12%=Q#;
M@2>I.[G.>3R:UHHS%$J%WDVC&YSDGZT^B@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD/BI
M!'-\.]3+@DQA&7#$<[U';KU[UU]5=3TVTUC3I].OX1-;7"[)$)(R/J.10!R?
MB'3HF\;>$K));B.(I? E9FWD;$)&\G<,^H.?0BLT&XMO!OC:SBOKQ4TNXG^R
M/]I?S(E$2N%#YR0"3U/>NO7PKI2WMC>;;DW&GJRV\C74C%=WWLY;YB>^<TS_
M (1#1_L^I0%+@QZHQ:[4W,G[TD8/?C(XXQQ0!A:G+JL5EHU]#92:O8Q6 ^V6
M4,Y6<%@N)5&?G(VL,=>3BND\,W5I>^&;">QN);BV:!0DLQ/F-C@[L\[L@Y]Z
M0>'+%&MGADNH7M8/L\;I<OGR_P"Z>?F[<G)':KUE96VF6,5G9PB*W@7:B+DX
M'\R?U- 'GMMHTFKZ5XJ>76=3CET_4[D6;K>N/)*HA4]?F'08.<#I@DFEM6O/
M$.I>%/M][>Q#4]'EDNHX;AXP[!4PP /RD[LY&/3I6CX:T);V;Q$NI6U_;QWN
MJ2RB)R\:7$)"A21[X;(X)'!XKI)_#NG3ZM:ZHR2K<V:%(#',Z*BG&5V@XP<#
MC':@#GM'A36-?UW1[V:Z:'2%@M;:,W#JZJ8\^86!!+L?XCSQQWSD:/X@U+4(
M_#6C:E=2LEW>WD$UT&*-<I;YV L/[QQG'7:1W-=Q=^'K"[U+^TL36]V8_*>:
MWF:,R)_=;!YQV/4=C4=]X5T;4-*M]-EM D%HP>V\ES&\+#HRL#D'W[T <?)9
M1V.N>/$MGGC":7#+&5F;=&PCE(VG.0 1G&:MO=7/V;P!<"[N/,N3$LY\YOWP
M-N6.X9PW//-=)9^%-)LKRYNTCGEGNXA#.\]S))YJ@8PVXD'J>M5;?P'H%NMF
MJPW+BQD\RVWW<K&'C 53NR%&>@X]<T 96G1?\);I>KW,^J7%C>V^HS1)-%*5
M-FL3_* N<<J,MD<[CGMB33[*V;XJ:G.OF$G3K>7/FN-S%G&2,\C ''3VK5G\
M$Z#<ZS)JKVKK/,09T29UCG(Z%T!VM^(Y[U>ET'3IM;367A<7J1B+>LK*K*#D
M!E!PV"<C(./RH S/'=G=S^&9[NPEG2[L,7,:Q3,GFA""R':1D%01CZ5S[>)8
M+7Q=;Z\DMQ)H>HV;1(3,Q3[0$$HVKG +*=G'\2D?7T,@$$$9!ZBLN/PUI$>E
MV6F)9(+6PE2:WC_N.IW!OKDG\Z .:UNSN=(L_":&\NA.^L0)<C[4[+)O#,RG
M)Y4$#&>@%7[?_DK5[_V!8?\ T<];6JZ'8ZTUJUZLK&SF$\.R9DVR#HWRD9(R
M>OK2+H%@FMRZRHF%[+#Y+OYSX*#H-N<<$YZ4 8WPX_Y%J?\ ["-W_P"CFJGJ
M.EPZO\4+BUN)KF.$Z%$6$$S1%OW\G5EP<>P/US73Z/H=CH-L]MIZ2)%)(TA5
MY6?YB<D_,3C)IE[H%C>ZDFI,9X;Q(O)\Z"9HV:/.=IP<$9)/MVH X33]7U*U
MM+?0[B_DEMQXAFTU;N>1@TD2(61&<<Y+X7(ZX(KKM TJ\TG5=0674$DM;D)+
M#9!F;[,>C$%CG:QYQT!!Q5J\\+Z+?:'_ &+<6*-8YR(\D$-G.X-G.[))SG)R
M<]:DT;0;#0;=HK))"9""\DTK2R/CIEF).!V'04 9%W=+J/C\Z#=R.+6+3!<Q
MPJY03.TA4DX(SM &![D^F*TULFGKHVC2:S>ZG*L\P6W+?-= *3B1\CY8PRDY
M)S@<$\5M:YX6TKQ#);S7T,@N+4DPSP2M%(F>H#*0<'TIMSX2T:ZAL(S;R1?V
M<S&V>">2-TW?>^=2&.[OD\T <)<7>H?\()J@-]=0S6/B$VL+1W+L4C\]%V;C
M@NH#$#<.G:MR739=#\?Z9:6U]?3V>M6]RMY#/<O)AD4$2 DY4DMCC ]*9XP\
M*VEGX9NK31=,N))+^^AGEB@+N.)%9R.<+P.V,FNKL=)M(+D:@OGS7#Q"-9;A
MV9U3KM ;[O.,\9.!G.* /-[:'^S_ (*+?64UQ;W"W0"O'<.NT?;"N  < ;20
M?6NNNFD'Q/M;99YU@GTF9I(A,P0L)$ ;&< X)Y'-7T\':$FEWNF"T8V=Z298
M6F<J,G<=@)^3YCGY<<T6O@_2+6^AOT6Z>\@B,2W$EW(\A4]<DM\WX\#M0!QN
ME_:;/P1J?B87U_<7^G/?"W$MR[H &91N4G#8ZY//'L,;D&G75O=:;KMIJB"V
M$+>;$)I)?MX9,K]XXW#&01SU[5O:5X=TW1[.>SM(I#;W#,TD<TK2JQ;.[AB>
MN3GUJKHO@S0] N?/T^WE0C/EI).[I#GKL5B0N?4<T </JX76_@\/$-S<2RWU
MQ)%-(XE;:";A08]N<;5Z8QU&>O->IRQ+-$T3YVL,':Q4_F.17.R_#_P[+!=6
MQM[A;2ZD$LEJEU(L._<&R$#8!) Z5T4<:Q1K&I8JHP-S%C^)/)_&@#S*UOKV
M3X8^%;][ZZ-T^H6Z/-Y[[G5IB&#'/S CCG-:R:8-6\<>)K"ZOM0^RK;6SI$E
MY(H1F#Y(P<@9&<=/;IC5'@#PZ(/L_P!FG, G$\<1NI-D+[MWR#=\G//RXJ_'
MX:TZ'4KO48_M*W-Y&(YG%S)\R@848S@8YP>O- '&Z)KEYJ5AX'TR]NI2FIP3
M27,N\JTYB7Y4+#GG.3ZX]S45Q</X8U'Q_<Z>SJT,%D8RS%S%N5@2,YX7)('0
M8]*ZT^"-!.C6VDBWF6WLY/-M66X?S(&]4?.X?3.*FM/"6CVEQ>7"P2S27\8B
MN3/</+YR@8 8,2#P3U]: ,ZUT.YCUJROXM56*RN(6BF@CN)7^UY4LK!BW##!
M.X<D9JI\.-.-QX?T_6KJ_OKB[VSQ'S;EV0KYK=5)P3QUZ\_3&QH_@S1=!+G3
MX9T)4HF^YD?R5/4)N)V_AS5W1=#L?#]@+'3DECMU8LJ/,TFTDY.-Q..23^-
M&?XB>.35])LS//))(96&GQ':MP N-TC9&%7.>^21P2*K_#ZXN9]#O(KJ5Y#:
MZE<VZ;Y#(517("[CR0.@)[5K:KX>T[6;FTNKN.43V98PRPSO$ZAN&&Y"#@X&
M13M(T#3="^TC3;<P+<RF61=[%=QZX!.%'L,4 85E*/$7B_Q#8WTDHBTSR88(
M4E9-N]-QD^4CYB> >P7C&37+::98/A9X7DAN;B)EU:.-C'*R^8K7+ A@#A@?
M>N_O?"VEWVKKJSI/#>!/+>6WN'A,J?W7VD;A]:KIX(T*/2+?24@G6TMIA/%&
M+J0;9 =P;.[UR<=,T 9>LZ?;S_%#12_F_O;*Y9MLSKR/+ Q@\?AU[TW3;&!/
MB?KL@$S-%9VTBCSWY8F3WY'L>*Z*?P]87.L6^K2_:#>6R&.)Q<. JGJ-H.#G
M'/%+!X?L+;6I]8C$XO+A0DKF=RK*.@VDXP/I0!Q^CPZCXB\.Z7XCAU>*TN?,
M%Q/<>;(P(R=\+)G;M[8[8'>I](TTWOBKQ&T]]J,BZ;?PRVT0O), ^4&VGGE2
M3C!X]*W+?P/H%IJ[ZG!:/'*\OG&(3/Y/F==_EYVY[].#S5[3] L-,U&\U"U$
MPGO6#3EYW8.1P#M)P#@8X[4 <?H\&H^(/#^D^(X=7BM;CS%N+BX\V1@XR=\+
M)G;MSQCM@8JO/8-=P>./.U'43_9\C26NV]D7RF$ <$$')P>QR/:NJM? ^@66
MK/J5O:/'(\OG&(3/Y/F?W_+SMS^'':IAX4TI1J0"W&-5S]K_ -)D_>9&#WXX
MXXQQ0!RCPKJOB+P#>W;2//=Z=,\SK*RECY,;=B,<D].M=EXE5CX9U,I++$ZV
MDC+)%(496"D@@@@]14#^$=&DMM.@:&8KIF1:G[1(&C4C!7=NR5( &#Q@8K2O
MK*'4;&:RN YAG0I($<J2IX(R.10!P \S1_!^A:FNH7?GZNMC;74T]T^Q$902
M1S\F?N[A@\YZ\UL'2-9TJ;5YK#484-SI[FUL2[,J3J.) 7/ Y (Z9P:VO^$9
MTEO#W]@2VQGT[RQ&(9I&?"CH Q.1C QSQCBLNY\+0Z+X7U*VT&R:[NKBW,02
MZN6<NIXV;F/  )P.!G\Z ,C3;:ZU*]\+S67]IQQ?9F?56>2:(2'8-NXDC>V_
MTSD9[8I@FG'A/QX/M=UNLKNZ-LWVA]T.V%&4*<Y !SQTI^DZ GGVW]DV7B72
MY(70DWEZ?)501N4J78," 1@#'N.M=%>>"]$OKJ^GFAF_XF*%;F);AUCD.W;N
M* [=V.^..O7F@#%U!VEU+P#([EV=V+,QR23;'G-9OBF\EBTK6M4TZ\NKB:SU
M*,"\,IC6W(DC0P1J/O 9(;( .X]2*[)_"NE.=-)CG']E_P#'IBYD_=\8_O<\
M<<YXJM<^!?#]W]O$UI*4U"3S9XA<R!#)D$N%#8#9 Y S0!ES64!^+YFV2%QH
MGFX65AN83 #H>G'3I[5DQW5QJ7PLE\7"^GBU=$ENQ,LK (R.?W6W.-F%V[2,
M=^O-=O+X;TN74;34&AD%S9Q^5&XF<93(.UN?G&0#\V>>:A'A+1UDFVPR+!<3
M>?+:B5O(>3.=Q3..H!(Z'N* .::SDU_QNMK>7=_;076@1W,MO#=.@20R8..?
MEZ#@=<<U)-=MX.\57T-Q+<W-KJMKYFGI-<.^)TX:%=Q."VY2/QKJ3H%@=?&N
M8F^W>5Y.\3OM\O.=NW.W&>>G6LXI<^(-=@%YHLEK:Z1=-+'-<%3Y[@%4* $G
M;ABV3CD+[X -;1[!M,TFVLY)Y)Y8XP))9'+%V_B.22>N:X!K)[C0O&\LNHZB
MSZ==W#VA%[(#$5A5UY!R<'L<C\S7IE8J>$])2WU&W5+CR]49FNQ]ID_>%AAN
M_&1QQCB@#F?W]K?>#=66]NWNM398[S?.Q256@+8V9VC!&1@"D@@U'Q;INI74
M.IK8WMOJ$T:7'G.&M/+DP%V A<; ,@]=Q)KIY/"FE21Z=&RW&W2R#:8N9!Y9
M P._/''.>*AN? ^@76LR:K):.)YB#.J3.L<Y'0N@.&_$<]\T 9=F?^$IUGQ#
MIU[>2H]DL,-OY$C1^4'B#><H!ZEB<$] H'KFO?62W/C3PS9RZA/<J-,N4DN$
M?8\^/+!.Y>1DC.5(^M=!JO@[1=8U--2NH)4NE3RVE@G>(R)_=;:1N%3OX<TQ
M]5M=3$4B7%G%Y,'ERLJQI_="@XQP.W:@#C].NO(\.:KI\^J7L45MX@:RM=CF
M2:5-R%8%8G/S9*Y)X'? H66\CD\=61DGM([2RBN+>**Z<F!VBD)*L,$9*J2!
MQG/6NED\$:%+:75L\$[)=W(NY";F3<)A_P M%.[*M[C%._X0S0Q)=R""</>P
M""X;[5(3*H!&6.[EL$C=UP3SR: .7M8Y;!_ VHQWUZ\^H+'#=>9<.R2H;<M@
MH3M&"!@@>YR>:O6RZA)J_CBQL]2DBF40+:27$S,L#/#G@DG:-Q[=*W3X2TEH
M=.A*W.S2R#:#[5)^[(&!SNYXXYSQQ3CX5TDS:G*T<Q;55"WA-P_[P 8'?Y<#
M@8Q0!R]E?B>/6+&[M-0T36(=,9WMQ<N8V"YQ-$X/]X@$]>F<X-4A#/#X=\#Z
MI'J5^MY>SVMM/)]I8AXY(FW#:3M[#G&<\]>:[G_A'+!EG\TW$TD\'V9Y9)V+
M^5G.T-G(![GJ>YX%0MX0TAK'3[(I<>1ILBR6JBYD'ELHPISG)P.F: ,SP_$=
M-\=ZUI<$]P]G]EM[A8YYWEV.Q<,07)/.!GFIO$5_*WBWP]H;R/'9WWGR3;&*
M^:8T!5,CG'.2.^ .F:UH=!L+?6YM9C$WVR>,1R.9W*LHZ#;G''TI^JZ-8ZS%
M$EY$2T$@EAD1RCQ..C*PY!H XC59;O39_&&D07-R;*WT<W]L?.;=:R[7^56S
MD E=P&<#'%7YKB<:EX%E%U.#=*RS@3-ME'V<M\PSAN><FNG@T2PA@NHC$9OM
MHQ<O,Q=IAC;AB>V.,=!6=;>!M"M39,L5R[6#;K9I+N5FBXP%!+9"@<;>GM0!
MSF@:9(+'QFNEW!M;TZI/#;RR3OM5BD>,\]23][KS5S0[Z.\GU73[JRO]&U5;
M)3+:&X8IM!;]["X/<G!(QT'6MZ3PEHTLU_*UO(#J/-P%N)%5CP-P .%; 'S#
M!]ZGCT"R1II&,\LT\(@::29C((P2=H;L,D].3WH XK2=7NIM#\"Z7/=3"/5@
MYNI_,(>38A8(6SGYF(SSDXQWIM[*_AG7O&EYIH?S(-)@EB#,7$9^?IGL.N.G
M6NMD\&:')H5OHK6TGV2U</;?OWWP,.A1\[ACZT^S\)Z19WL]XL4TT]S"()WN
M+B27S4&>&#$@]3UH S+'2;I-6TK5[75HX[5XRLL8FDE%\&7*GYCC<,9R.<9[
M5/XUU*>R71K2.5X(M2U.*UGF1BK*AR2H8<@M@#(YP35G1?!FA^'[CS]/MY4(
MSY:R3O(L(/78K$A<^W-:.J:59:S8/8ZA )H'P2I)!!!R"".00>XH YLI+I?Q
M!M]*M9)FT[4["5YK<R,1"Z$#>ISE<AL'&.>>M,^'5E###K4J>9N&L7D8W2LP
MVB3T)QGCKUKH[/1;2SE>=6FEN)(Q$;B:4O)L'103T&3GCOR:;H^@6&A"=; 3
M*MQ*TT@DG>0,[<LWS$\F@#G/B&KO?^%$CE\ISK,85P =IVMS@UO6UG>VNI32
MW^JFXMYXDBB0H(RKY;.-O4D$?3%+J_AK3-<N;6YOUG:2S?? 8[AX_+;^\-I'
M-.C\/64=Y%=F2\EFA#>49KN60(6!!(#,1G!(SUY- 'G,Z7$?PSU76AJ>HF_T
MZ_F-M,;N3Y=L^ ",X;(X^;-=1+ VC?$72H[:ZNY$U&TN3=)-<-()&3858*3A
M3R?N@#M6F?!6B'1;C1C#.;&YD,LL1N9/F8G<>=V>3SC-6Y/#MA-J=GJ4GVA[
MJR4I YN'^4'&01G!S@9SUH Y#2(M2\2>'-.\11:M'9W0E^T37'FR' #'?"R9
M"[>V.V >M6M&TO\ M'QEXA2YU#43'I]];R6\8O) JGRPQ!YY4DGY3QBMF#P/
MH%MK#ZI#:.DLDOG-$LSB$R9SO\O.W.>>G7GK5RRT&RTS4+W4K19OM5[AIB]P
M[+(P&!P20, 8X'2@#B9(]8U'19XE-_\ \) NKE/.A:18_*\W! D7Y1&(\C&>
M&']ZM>;S=5\5ZAH#2YAL;*#R8I;B168-NW29!RQ&%&3T^I-8VG: 7C*3Z'XC
ML=4D=Y)C9WYCMO,9B2RL)-H7)],^Q/7J[[P;INLQV$VKB274;2%8S>02M#(W
M'S<J1P3DX[9- '/26.HV^J^#M.O=>NKN5I+NWN9X)GC$P2)\9&?O#[I;[V<G
M(/2AJ=OY7A?Q[I#37$UI8.'MEFG=S'NA5\;B<D9.<'-=U+X7TF2?3IA#)&VF
M9^R>5,Z"/(P> ><C@YSFFKX5T@/J;-#+(-67;>+).[+*,8Z$\''&1B@"?2;&
MV31K*/R]ZJB2+YK%\-@<Y8G\/2M!N%/(7CJ>U5M-TZVTJRCL[42>5&, R2-(
MQ[<LQ)/&!] !5IE#*5/0C!H X'PY>W%IKNG:9K]O<V^IE)/)O8YC);:D-N2W
M7AL?-@C@9 P"!7?UDV/AO3M/>T:(32"R4I:K-,T@@!&#MW'TXR<X' XK6H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ K+\1ZO)H/A^\U6.U%T;2(R&+S-F0.O
M.#_*M2N?\>_\B%KG_7C+_P"@F@#06]O9DTZ6WLEDBN0&N',VWR%*9! Q\W.!
MVK0KBK]IHM6\$-%<SHDK-'+$LK!) (&(RN<$@U'I]O#XNM_$'VZ\FMKRUU*6
M".:.3:]FD9&PI_=R!DGOD_@ =S17#MN\2^)=9TB6ZB9+6V@^SK,&W;73)E4*
MR_-N.,]L#I5633YU\0^$=/N]:NKXM!>0W,T<SQB?RPH&0&.",D$@Y//- 'H5
M%>=Z?;:@-&\2:1I-T%:TU@):174S%63$;F'=G(5OF'7^(U!-XB2TT/5#%9W&
MA7D=Y:0ZA;R-E+5'<*7C93C:5!Y7'.3QUH ]+HKFM+T.;3/$OVV/4H8[:ZMB
MAL(48)(RD'S1EC@X(!('.1GFG^)&@EU?2+)WEGFE:5TL 0(K@!<%I2?X5R#T
M/)'!Q0!T5%>43RW9^'M^K75Q%)9>(#;1&.X<[$^T*NS/\2@$@;AZ<5N2'_A&
MO'E]]B-Q)"^@RWLL,D[R"26.0 -\Q."02.* .B\3Z])X>L(+M+,7*RW,4#9D
MV;-[!0>ASUZ5LUY?JT":A\.]$UR:YFGO;FZLYII?.;#,\B[EVYQM!. ,<;?K
M7I-[:17]E-:3;O+F0JQ5BI'N".AH GJ&[>>*TFDMH1/.L;&.(OL#L!PN[MD\
M9KRJ6]N8O#5FNR2?4?"MVQU(!V_>P1O@[A_%O5@XS_=;TKJ-2"7GA?Q)X@M+
MB:,SVLK6LT$S(0D49PPP>,L"<CJ-M &KJGB&ZTJ;1(IM.7=JEPEO(1/_ *AR
MI8CI\W0C/%2V6O277BK4-#>S$0LX(YEF\S=Y@<L.F./N^IKF]3=Y-*\ R2,7
M=KZU+,QR2?(?DUI:;_R5'6_^P=:_^A24 :6NZ[)HUYI4(LQ-'J-XMJ9/,V^6
M6!.<8.>%/I6S7(^/XC.?#40E>+?KD(WQG#+^[EZ'L:P]2GU#P=J^O6NE7=W<
M6W]AO?QQW,S3FWF#[006).",G!/\)H ]*JO>WMOI]J]U=2B.), L?4G 'U)(
M'XUR^GZ,PU'1];L]9ACMW0JZQJ[?;U9<KN)<Y88+;L$]>U)\3K6&X\,0M*FX
MQW]MMY/&95!_0D?C0!L2:])%XP@T!K,;)[1[E;CS/[K*-NW'^UUS6S7$:GID
M$WQ&TJQ#30VXTFX!6&5D8CS$XW [A^!!K*AU>[TWPG<6K7T@@A\1OIWVF:1F
M:*W\W^)\YQCY<YR >HH ],HKG-'T2;2?$DTXU&%;:[MO^0=%&P0.K#,JY8XX
M8 @#G(-4/%UM]I\8^%H#<7,<5S+<QS)%<.@=1"QQ@'@]>1SSUH [*BN$BL8[
MKQ'?^%_-3[-I]E"+6"Z>1V*MNW2 [@20<#/.,#&,G+;JRURPTO2%2:+Q2+!)
MX[RW=O+>X 8 .H)(9DP5Y)R2>] '>T5YJ\MIJTW@LZ=>:E#9W4US$Z-.Z285
M'RC#/W@05W=?0]#575;J_P#!8\76FCW%PUG!:6]Q )':4VCR/L;:6R>F6Y]*
M /5**XK6K=="U?PU=Z*\@%Y>K9W$:R%A<Q,C$NW/S,NW.[KSUKGI[ 3>$_&E
MX]W?&?3=3N6M'^UR9B**A4CGGTYSQ0!ZM56XFO$OK6*"S66VDW^?,90IAP/E
MPN/FR>.HQ7'>()]222WU673O[9TTZ:GVJVADVSVK'<3-&O<D<<8/R<$<T\W2
M2>)O!,MA?7,EE=VDYVM(P655A4HS)TW<F@#H/#NNR:XNI>;:"U>POY+,J)-^
M[:%.[.!UW=*O7$UXE[:1P6BRV\A;[1,9=IA 7*X7'S9/';%>?VFAIJECXNN#
MJ-]9RVVKW+P/;W+1K&XC0[B%QN[=<\#C'-6K+4=0OM2\ WUS<3I+?6\QN8A(
MPCE(MR0Q3IG)ST[T =-I6O2ZCKFLZ6]D(6TMHE#>;N\W>FX'IQQCUJU#J3PZ
M;:W&KPI8W$[I$8!+Y@$C-M"A@!GDC_(KG=)B$WC+QM&7D3=]D&Z-RK#]QU!'
M(-<XL2ZGX#\"W-^SW$[ZI;JTDCDLP9GSDYZG YH ]5HKB=9%OX0\6Z?KDCM'
MI5U$;*X#.Q2WDQF.0 GC(4J3]/6N@\.6;VVEB:9&CN+QVN948DF,N<A/;:"%
MX]* -:L[7=8BT+29+^5#)M9$1 <;W=@JC/;DCGL*Y[3Q%XE\3^);/50SBPDB
M@MX=Y7R49-V]<=&8Y.[KP*YN]EN-7^%EE<:JS7-Q;ZE';I<.3F5!<A-Q]20,
M9]LT >BZ;<:M)=7<.I6,,,<14P3PR[EF!!R-IY4C'?@YXJIKGB:/3/#VI:M9
M0K??V<666,2;!E?O#.#TS_.M:&UAM[86T2;8@" N3T/OUKR^"QMK;X6^+GAB
M",+F]C&">%$AP,4 >HV\OGVT4V-OF(&QZ9&:EKAHX'TCQEX9^SWEVXU.UG2Z
M66=G239&K*0I.U2#G[H'6J.EVUWXG\,P:\NL0V%]%<--+<[':2$JYW1,-X&W
M'&W&,8.* .^U"^@TS3KF_N6*P6L32R$#)"J,G^58G_"0ZNME9:@^B1&UO)(5
M'E7FZ2)9&50S+L X#9.TG\N:VM4-FNE7C:@%:S$#FX#=#'M.[/X9KS^^L=9^
M&<"WVG7IU/PTDJ":PNOFDME9@ 8V[@$CC]#UH Z6_P#&,>D>*[71-5M5MXKY
M?]&O%FW(S9P%8%1M)^I_PTM3U.[L=0T^VALXIDOI3%O><H4(1WZ;3D80]^N/
MK69K>BV/B#6I],U"+S()]-P<=5/F<,#V(/(K TG4]2M?$NC>$]>+2W]C=/);
MW>.+NW^SS /G^\"0#_7F@#IX]?O=0OK^#2-/@N8].F\B9YKHQ%I H8JH"-T#
M#DD<_G6AH^H2:II<-Y+:M:R2;MT#G+1D,003Z\5RNJ>%KFYU2Z\1^#M6.GZF
M9#'=02#=;W+H<8=>QXZ_CQG-;?@[79?$7AR&_N+06EQO>.>)>5$BL5;!]"1G
M_&@#=HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J:IIEKK.G3:?>JSVTZ[9$
M5RFX>F00:MT4 9,OAG39WTYY%G9M,_X]3]H?*<8]>>..<\5!>>#/#]_K!U:X
MT\-=. )&$CJLN.F]0=K?B#6[10!BZSX1T/7[R&\U&R\RY@&U)HY7C?;_ '25
M()'L?6II/#>DR7EC=_9F273E*6OES.BQ*0 0%4@8( !XYQ6I10!B_P#"(Z+B
MZ MYA]KF6>8B[ERTBD$.#NX(('(QT%6!X?TLVUW;RVHG2^ %R9V,AE & "6)
M. .GI6E10!D:'X6T;PX'&EVAB+@*6>5Y"%'106)('L.*EU7P_IFM36LU_;M)
M+:,6@D25XV3/!Y4@X..1T-:5% &"W@CPZ;6>U&G;(+B<7$D<<TB R Y!X88Y
MYP.,U<_X1_3?[6CU4Q2M>1P^0LK7$A_=_P!T@M@C//(Y/-:5% ',_P#"OO#W
MV9K00W2VAF$RVJWDHBC<'=E5#87GT_#%=(JA$"C.%&!DDG\SUIU% %-=(L%E
MOI1:IOU# NCC_6@+M /_  'BF3:-8S:&=%,16Q,'V?RD<K^[QMVY!SC'%7Z*
M ,:7PMI<UOIT#I.4TME:TQ<.#&5& <YYP..<U8AT.Q@UN?68UE%Y<((Y&,S%
M64=!MSCC/I6C10!1U71[+6K>*&]1SY,JS1/'(R/'(,X96!!!&3^=%IH]G:>>
MP1II+D 3RSL9&D & "3V&3QTY/')J]10!AZ-X-T#0+IKG3+ 0R'.W,KNL>>N
MT,2%S[8K1U32[+6M/DL-1@$]M+C<A8KT.0000000.15NB@#(3PQI<>J0:E''
M,MS;PF"-Q.^ A.2",X.3R2<DFFP^$]&AL+^P-JTUMJ,K2W,4\K2!W8Y+?,3@
MD\\8Y K9HH RM#\,Z1X<C=-,M3%O #,\C2,0.@RQ)P,].E27^A:=J=]:7MW%
M(UQ9DM Z3R)Y9/!("L!R./IQ6C10!C:WX3T3Q#<07.I6?F3VXQ'-'*\;@>FY
M2"1[>]32>'M,=K1DAD@:RC,4!MYGBV(<97Y2,@[1USTK3HH XKQ!H(&M>&+:
MQTVX_L^PFFDF>W8KY6Y" =V0Q)8Y)&3U)ZUT\&BZ?!;W, MQ(MYG[09F,AFR
M,?,6R2,<8Z 5>HH R]/\.:9ICPM;Q2DVZE(!+.\HA4\$(&)V\<<=N.E0CPCH
M@M+ZT^S3>1J+F2Z0W4N)6/4GYN_?'7 K:HH R#X8TLLK!+E"+=;4E;R4;H@6
M(4_-SC<W)YYZTZ7PWIDM[I]YY+QR:8A2T$<K(L2D;2 H.,$ #D5JT4 8LGA3
M2GGNWV3K'?/ONK=9W$4['@EESCD  XZ]\U8N]!T^]U&QU":.03Z?N^S%)601
M[A@_*#@Y''/:M*B@#+A\.Z?;WM_>Q"=9]2 %R_VA_GP,#C/&!QQBH5\(Z(NA
M0Z(;5VL;=Q)"AG?=&P.05?.X8/H:VJ* .:U"VNM5NQX?;1/+TB!X9&NY)%*2
M*A#A%3KG<H!SVR?3/2T44 9EWX>TV\U#^T'CEBNC'Y32P3O$SI_=8H1D?7IV
MI+[PWI&HZ;!IMQ:?Z';E3%#%(\2KM^[PA'3'%:E% #(XQ%&J*6(48&YBQ_,\
MFL6?P9H,\%_ UFRQZBY>Z5)W4.2<MC!^7) )QC.!FMVB@#)?PUITEYI]XXN&
MGTU2MLQN'^0$8.>><@ '.:KKX)\.KK3:PNFJMV\@E<B1@C.#D.4SM+9YSCKS
MUK>HH @O+2#4+*>RND\R"XC:*5,D;E88(X]C6<GA;24,(,<\D5NP>*"6ZD>)
M"/ND(S$<=N..V*V** *7]DV?]J_VIME^U;/+W>>^W;G.-N=O7VJ2?3[2YN[6
M[F@5Y[1F:"0]4+*5;'L0>GT]*LT4 8Y\+Z7Y]Q-$+JWDNG,DYM[N6+S&/4D*
MP&??K4LGAW29-/M+ V:K;64J301QL4".IRIX/////7O6G10 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MIL8CE<R '%:FI:*FI7NG71N983I\QFB2,+AF*E><@\88],4NLZ,FLI:H]S+
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
C %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>68
<FILENAME>ebs20191231exhibit1048029.jpg
<TEXT>
begin 644 ebs20191231exhibit1048029.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>)/#5F5L?[26=FBB8*V58%QGMD@9Z5ZM9WD%_:I=6S^9#(,H^" P]1GM[]Z
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M7P=;7>J0)%<N\FYT4*)OF/[S X^8Y.1P>O>NHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6K7ZZ3K,$>CW\QF:&2 M+"3UV'.,XXR<]!P<4 5K[Q;XC;QWK'AVQ?3TAL[
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MUFGEVXA@*NR@8&]B3P!T 'IDF@#I:*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@_Z!NH_]^/\ Z]1T4 2?\)1!_P! W4?^_'_UZ/\ A*(/^@;J/_?C_P"O4=%
M$G_"40?] W4?^_'_ ->C_A*(/^@;J/\ WX_^O4=% $G_  E$'_0-U'_OQ_\
M7H_X2B#_ *!NH_\ ?C_Z]1T4 2?\)1!_T#=1_P"_'_UZ/^$H@_Z!NH_]^/\
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M?_7JEIEV]_I=K>2P&!YX4D:(G.PD E<]\=*LT 2?\)1!_P! W4?^_'_UZ/\
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MDX.#SQ7-VOCN^F\+)XE?0T-AD^:L5WNEC4-M+;2@!''K0!V__"40?] W4?\
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M !% %VBJ7]K0_P#/GJ?_ (++G_XBC^UH?^?/4_\ P67/_P 10!=HJE_:T/\
MSYZG_P""RY_^(H_M:'_GSU/_ ,%ES_\ $4 7:*I?VM#_ ,^>I_\ @LN?_B*/
M[6A_Y\]3_P#!9<__ !% %VBJ7]K0_P#/GJ?_ (++G_XBC^UH?^?/4_\ P67/
M_P 10!=HJE_:T/\ SYZG_P""RY_^(H_M:'_GSU/_ ,%ES_\ $4 7:*I?VM#_
M ,^>I_\ @LN?_B*/[6A_Y\]3_P#!9<__ !% %VBJ7]K0_P#/GJ?_ (++G_XB
MC^UH?^?/4_\ P67/_P 10!=HJE_:T/\ SYZG_P""RY_^(H_M:'_GSU/_ ,%E
MS_\ $4 7:\Y^&7_(T^+_ /K\'_H<M=NVIPNA4VFJ8(QQIMR#^82LW3K'0])N
MI+FPTC4X)9>9&6PN_G_WLKSU/6@#F/B-_P CQX0_Z^U_]&QUUOC3_D2]8_Z\
MY/Y5#J%CH>JWD=W?:1J<\\)!C=K"[S'W^7"\<^E6KV33]1LC97=AJLMNPPR'
M3[KYAZ$A,G\: ,OX8?\ )/-+_P"VO_HUZQ/#?_):?$/_ %ZG^<5=;IHTS1[7
M[+I^FZG!!G(C&GW15?7 *<=>U4ETCP\E])?)H^JI=29WSK97@=L]<L%S0!JZ
MC>PM%?V*MF:.T:5P/X0P8#/UVG\J\]^%VG7ESHMC>0WL@M[;4Y6EML+M;,.
MV<9R"PXSCVKLX++1+9+M8=*U1/MH N&^PW>Z4#(&6VY[G\Z@@T7PY:V[V]OH
MVJ0PR'+QQV5XJM]0%P: .AM+N&]@\^W</&690PZ$JQ4X_$&IJR[*YL=.LX[.
MST[4H8(AM1%TRYPH_P"^*G_M:'_GSU/_ ,%ES_\ $4 7:*I?VM#_ ,^>I_\
M@LN?_B*/[6A_Y\]3_P#!9<__ !% %VBJ7]K0_P#/GJ?_ (++G_XBC^UH?^?/
M4_\ P67/_P 10!=HJE_:T/\ SYZG_P""RY_^(H_M:'_GSU/_ ,%ES_\ $4 7
M:*I?VM#_ ,^>I_\ @LN?_B*/[6A_Y\]3_P#!9<__ !% %VBJ7]K0_P#/GJ?_
M (++G_XBC^UH?^?/4_\ P67/_P 10!=HJE_:T/\ SYZG_P""RY_^(H_M:'_G
MSU/_ ,%ES_\ $4 7:*I?VM#_ ,^>I_\ @LN?_B*/[6A_Y\]3_P#!9<__ !%
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M **** "BBB@ HHHH **** "BBB@ K(U'_D8M'_[;_P#H K7K(U'_ )&+1_\
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MBB@ HHHH **** "BBB@ HHHH RO$/_'E;?\ 7_:_^CDK5K*\0_\ 'E;?]?\
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M45]:744J?:;"]9F:V8KQM))^0XR,<=: .GHHHH **** "BBB@ HHHH ****
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M ,)5H/\ T%;;_ONC_A*M!_Z"MM_WW6O10!D?\)5H/_05MO\ ONC_ (2K0?\
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M_P#05MO^^ZUZ* ,C_A*M!_Z"MM_WW1_PE6@_]!6V_P"^ZUZ* ,C_ (2K0?\
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M'_P)3_&C_A(-%_Z"]C_X$I_C0!H45G_\)!HO_07L?_ E/\:/^$@T7_H+V/\
MX$I_C0!H45G_ /"0:+_T%['_ ,"4_P :/^$@T7_H+V/_ ($I_C0!H45G_P#"
M0:+_ -!>Q_\  E/\:/\ A(-%_P"@O8_^!*?XT :%%9__  D&B_\ 07L?_ E/
M\:/^$@T7_H+V/_@2G^- &A16?_PD&B_]!>Q_\"4_QH_X2#1?^@O8_P#@2G^-
M &A16?\ \)!HO_07L?\ P)3_ !H_X2#1?^@O8_\ @2G^- &A16?_ ,)!HO\
MT%['_P "4_QH_P"$@T7_ *"]C_X$I_C0!H45G_\ "0:+_P!!>Q_\"4_QH_X2
M#1?^@O8_^!*?XT :%%9__"0:+_T%['_P)3_&C_A(-%_Z"]C_ .!*?XT :%%9
M_P#PD&B_]!>Q_P# E/\ &C_A(-%_Z"]C_P"!*?XT :%%9_\ PD&B_P#07L?_
M  )3_&C_ (2#1?\ H+V/_@2G^- &A16?_P )!HO_ $%['_P)3_&C_A(-%_Z"
M]C_X$I_C0!H45G_\)!HO_07L?_ E/\:/^$@T7_H+V/\ X$I_C0!H45G_ /"0
M:+_T%['_ ,"4_P :/^$@T7_H+V/_ ($I_C0!H45G_P#"0:+_ -!>Q_\  E/\
M:/\ A(-%_P"@O8_^!*?XT :%%9__  D&B_\ 07L?_ E/\:/^$@T7_H+V/_@2
MG^- &A16?_PD&B_]!>Q_\"4_QH_X2#1?^@O8_P#@2G^- $7A;_D4M'_Z\(/_
M $6M5_%5PQL8M,BBEEDU"3RG2$9<0CF4CD?P_+GL6%0^&M;TB'POI,4NJ622
M)90JR-<("I"#((SP:?\ :=#.NC5SXCA,BPF%83<P^6JD@G QG)(!SGL/2@#"
M\*W']B>.M4T,VLUG9ZH/[0L8Y5"X?@2J,$CK@X[ 5*L&K:UXP\2:5_PD5_:6
MUK':O#Y 0,A=7. =OW<CGN<#GCF]K,'AS6M4T[49?$<=O<::S-;F"[A&"V V
M<@YR!C'2L73[ZQF^(/B2<:ZUC%+#:I'.C1A)L(V[#.I4D$CIZF@"K8:WX@U.
MU\+QSZM-!/-?W%C=O"B 3>6'&\9'7Y?IGG%;N-1TCQIX>THZS>7EM-:W)E%P
M4)=DVD,2%!)^;OZ"G2:;X5*Z4MOK\5HFDN7MUANXC\QR&9MP)8G)S]35N[/A
MZ[U^RUI_$,*SV2.D4:W46S#XW9!&><#OVH A\)?\C#XL_P"PDO\ Z)2KOCC_
M )$77?\ L'S_ /H!J#2CX?TF^U"\B\0PROJ$OG3++=1%0V ,C !'  J?6+S0
M-:TJXTV?7;:*&YC,<ABNHPQ4C!&3F@"AJ^BW6O\ P[M;*QD2.[6"WFA\S[K,
MFU@#['&*SKRZU#6?B%X8@ETUK*:PBGNKI3,LAC5DV#E<C!;@<Y.#P,5T-MJ.
MC6FF16,/B*WQ$@C29KB$N .!VQT]J;IUSX;TUIY8M7LY+BY8-/<2W2-)*1P,
MG/0#H!@#L* .&O%ET^&]U2UCFO/!<U^[WEGN^="KD22)QGRO,!)7/.WT)KH?
M$/B.R;4+FWO(+\V]G"3"(K&61)I63(?<JD84' YZDGL#5K[)X9%K<V*^((DT
M^ZD9Y;(747EG<<NH.-P5B22 >YQBMB;6="FMW@;5[$(Z%#MN4& 1CCF@#)^&
MM]#>> ]+6)90;>!(G\R)DRP4=,CYASU'%=56'I-YX>T72;73+76;0P6L8CC,
META; ]3FKG_"0:+_ -!>Q_\  E/\: -"BL__ (2#1?\ H+V/_@2G^-'_  D&
MB_\ 07L?_ E/\: -"BL__A(-%_Z"]C_X$I_C1_PD&B_]!>Q_\"4_QH T**S_
M /A(-%_Z"]C_ .!*?XT?\)!HO_07L?\ P)3_ !H @TW_ )&#6?\ >A_]%UKU
MB:+<V]WK>L36T\<\9>$!XW#+GR_45MT %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5CZFJOX@T=74,
MI\_@C(^X*V*R-1_Y&+1_^V__ * * -+[-;_\\(_^^!6'/XI\-6^N#17?=?&1
M8_+CM)' 9L8&X*5[\\\=ZZ"N&2#7_!.I66_4SJ^C7]X(94FB5);>25^'#+]X
M%VYSZT ;&L>*_#6@W1M[]MC)CS6CM7D2'/3>RJ0N?>MJ*.SGA2:%(9(Y%#(Z
MJ"&!Y!!]*S_$ BAT2[M8;=);C4%>**''^ND=2.?8#DGL ?2K.AZ8NBZ%8Z6L
MAD%I;I#O/\6T 9H RM3\7>&-'OC:7THC9&"22BV9HHF/0,X7:IY'4_6M.^O-
M+T^.%YUC)N'"0)''O:5B,X4 9/ )]@,U1\4VT<WAVZT6UA1KC5%DABCQP&?.
MZ0^R[BQ/T'4BL8VWV3XE>'M-W,UO8:-+Y!;NV50GZ[0* .DAU'1Y].EOU,0@
MA9DEWQ;6C8'!5E(R&SVQGD>HJOH^O:'KEU<6EFI6YML&6"XM6AD4'H=K@'!K
M*\.$GXB>,;?&;=7LI0I' D,7)^ORJ?P%)875Q%\3+B/5M,2WN;NP"V-Q#-YB
M/#&V64Y4$-E\GVP/<@'6_9K?_GA'_P!\"L,^*?#0UW^Q ^^^\SRMB6DC+N]-
MX7;QWYXYS4^F>+=$URZ:RTV_\VX"%L>2ZX XS\P [BL"UAU[P5JFGVT^I_VO
MHM_<_9R98E2:VE?)#97[P+9SGUH [3[-;_\ /"/_ +X%'V:W_P">$?\ WP*E
MHH B^S6__/"/_O@4?9K?_GA'_P!\"I:* (OLUO\ \\(_^^!1]FM_^>$?_? J
M6B@"+[-;_P#/"/\ [X%'V:W_ .>$?_? J6B@"+[-;_\ /"/_ +X%'V:W_P">
M$?\ WP*EHH B^S6__/"/_O@4?9K?_GA'_P!\"I:* (OLUO\ \\(_^^!1]FM_
M^>$?_? J6B@#&\06\*V=L1#&/].MAPH_Y[)6I]FM_P#GA'_WP*S_ !#_ ,>5
MM_U_VO\ Z.2M6@#)N]3TFUO?L'E>?=[=Y@MX#(ZKV+8&%'H3C/:G6&HZ3J-Y
M/9P1XN+=%>:*6W,;(&SC(8#^Z:YOX72-=V&MZA<\WMQJ\PN">HVX"K] .@]Z
MW?%&I6_AK1;_ ,1FW$D]M;[1VW_-\JGVW-^IH UOLUO_ ,\(_P#O@4?9K?\
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MPSQDL@')/)PWTYZ&L?5-6U?4_ 8:YU!DNK76EL9Y8$5!<!9PN2,''8X'\N*
M.^FEM(-0MK)K-V>Y5RKI!E$V@9W-C"YSQGK5K[-;_P#/"/\ [X%<[>ZAJFG^
M,M TK[:LUI>PW)EW0J'9HU4@DCC^+H .E8<^M^*&T#Q+J,>JV\;Z)?3K&HM
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M2#P!C'IZU4L[KQ2]_I5RL,MQ9W*_Z<DH@5(@5R'B*MNP#V;=D>] '3_9K?\
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M>$?_ 'P*EHH B^S6_P#SPC_[X%'V:W_YX1_]\"I:* ,;PQ;PMX4TAFAC)-C
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MPT8<*ZX Z\9P#R*M:3KMSKNGZ UG>2)-<JTM[F-,JL8VR*1C@^857C'&3VH
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M_5=#D\3^(K/2[R!TDFB>V2-L[XUB521ZX/4^M '=_9K?_GA'_P!\"C[-;_\
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M1_!TU@U^FEZ3]E0,7E-N@";?O;LC@C!R#TQ5?2;7P+KK3+I=AI-RT! E5;5
MR9Z9!&<>] '2SH\MO)''*879"%D4 E"1P0#P<>]95GHUZ7MI-9U0:B]HV^+;
M;B%=^"-[ $Y8 G'0<],XP[_A$_#G_0!T[_P%3_"JLNC>$(KQ;-M'TUKE@&\E
M+-78+TW$!3@>YXH Z&BLC_A$_#G_ $ =._\  5/\*/\ A$_#G_0!T[_P%3_"
M@#7HK(_X1/PY_P! '3O_  %3_"C_ (1/PY_T =._\!4_PH UZ*R/^$3\.?\
M0!T[_P !4_PH_P"$3\.?] '3O_ 5/\* ->BLC_A$_#G_ $ =._\  5/\*/\
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M*WT3PE=7UW90Z-IS3V903K]B4;=PW+R5P>/3-6?^$3\.?] '3O\ P%3_  H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5D:C_P C%H__ &W_ /0!6O61J/\ R,6C_P#;?_T 4 :U<' NN^#]9M%U9K+5
MM-U&\\O[9';^5/;S2,2NX9.5+'&<\<>P/=R!S&PC8*Y!VL1D ]CCO6);Z5JU
MX+8:_=V<ZVLJS*MK"R"1U^ZS;F.,'G [@<XXH 7Q%:V4/A_4HC:+/)J"L@AQ
MEKB5AM4<_0<]@,\ 5<T#37T?P]I^F22^:]I;1PL_]XJH!Q[5D7^C^*9M;DO[
M36--CB V6\4UD\AB7OSO')[G'M6C%::W';Z>C:G#))'*6O7:WQYRG/RH,_+@
MD8Z\#\P"CXMTZT?PK?Z7#:1RSZIOCAC(R7G?)#G_ '?O9[!?:LLPO!\1?#FD
MRR-+%IVD22(S?QR?+&6^NW^9J_<:-XL;6+B_M]:TQ _R0K+8NYAC_N@^8.N
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M.Y-:&E^&KJUU_7-0O9K6YM]:\L26XC/R!$*8R3\P(Z\"J]KX*FB\/W_AFYU
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M<=P&"< +TQWR-TZUJ=AXJAT&]:WF^WVSRV5RD13#I]Y'7<<C!!!!'I[UGP>
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MHHH **** "BBB@ HHHH **** ,KPM_R*6C_]>$'_ *+6L/Q19>(-.\10^*-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P _^- &K165_P (UI'_ #ZG_O\ /_C1_P (UI'_ #ZG_O\ /_C0!JT5E?\
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M36-YI^H-IVI:=(SVUP(PZX88967N" /RJGJOA75=9\.3:?>:W&UW<2Q/)/\
M9?D01N&540,,#(Y)))R?;%RRTKP[J43RV:"=(Y&B9DF?AU.&'7L:;?V'A;2D
M5]1FMK)7.%:XO#&"?;<PH 76]!OM7N='N%O[>&33;@7#9MF82MM*X'SC:,,?
M6JL_A._EOO$5PNIVZKKMLD!4VI)A"H4!SO\ FX8]AVJ>ZL_"=D(3=W-K;BX_
MU)EO2GF?[N6Y_"I)M+\.075K:RJJS7F[[.AG?,FT;CCGL.: *DOA2_DL_#T
MU.W!T1T?<;4GSBJ%!_'\O!/KS2S^#3?:GKTU]>1RVFMV\<#P)"5>,("%(?<0
M3\Q/3TK3_P"$:TC_ )]3_P!_G_QJI#I_ABXU&;3H"DEW;J&EB2=R8P>F>>*
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M #_XT?\ "-:1_P ^I_[_ #_XT :M%97_  C6D?\ /J?^_P _^-'_  C6D?\
M/J?^_P _^- &K165_P (UI'_ #ZG_O\ /_C1_P (UI'_ #ZG_O\ /_C0!JT5
ME?\ "-:1_P ^I_[_ #_XT?\ "-:1_P ^I_[_ #_XT :M%97_  C6D?\ /J?^
M_P _^-'_  C6D?\ /J?^_P _^- &K165_P (UI'_ #ZG_O\ /_C1_P (UI'_
M #ZG_O\ /_C0!JT5E?\ "-:1_P ^I_[_ #_XT?\ "-:1_P ^I_[_ #_XT :M
M%97_  C6D?\ /J?^_P _^-'_  C6D?\ /J?^_P _^- &K165_P (UI'_ #ZG
M_O\ /_C1_P (UI'_ #ZG_O\ /_C0!JT5E?\ "-:1_P ^I_[_ #_XT?\ "-:1
M_P ^I_[_ #_XT :M%97_  C6D?\ /J?^_P _^-'_  C6D?\ /J?^_P _^- &
MK165_P (UI'_ #ZG_O\ /_C1_P (UI'_ #ZG_O\ /_C0!JT5E?\ "-:1_P ^
MI_[_ #_XT?\ "-:1_P ^I_[_ #_XT :M%97_  C6D?\ /J?^_P _^-'_  C6
MD?\ /J?^_P _^- &K165_P (UI'_ #ZG_O\ /_C1_P (UI'_ #ZG_O\ /_C0
M >%O^12T?_KP@_\ 1:UJUS'AOP]I<WA?2I9+8EY+*%F/FN,DH,]ZG?3_  O'
MJ":<\MNM[(,I;->$2-QGA=V3QS0!T%%9#^'=%CC:22WV(H)9FG<  =R=U06.
ME>&M3@\_3VANXLX\R"Z:1?S#4 ;U%97_  C6D?\ /J?^_P _^-'_  C6D?\
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M110 4444 %%%% !1110 4444 %9&H_\ (Q:/_P!M_P#T 5KUD:C_ ,C%H_\
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M215BD8M'M7:!RH!R/I4OB31M1U/4M&NK+[,%TVZ-PPFD92_RE=HPIQPW7]*
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M?2KI)L,SF&Z4%CM<8R.6![\J/P +=KXHU6_M-?BL(K.\O=(=?*:,,([I60.
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M44 %%%% !6%KEK'>ZSI,$K2JK&8[H9GB880=&0@UNUD:C_R,6C_]M_\ T 4
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M?^#2Y_\ BZ/^$:LO^?K5/_!I<_\ Q=:]% &1_P (U9?\_6J?^#2Y_P#BZ/\
MA&K+_GZU3_P:7/\ \76O10!D?\(U9?\ /UJG_@TN?_BZ/^$:LO\ GZU3_P &
MES_\76O10!D?\(U9?\_6J?\ @TN?_BZ/^$:LO^?K5/\ P:7/_P 76O10!D?\
M(U9?\_6J?^#2Y_\ BZ/^$:LO^?K5/_!I<_\ Q=:]% &1_P (U9?\_6J?^#2Y
M_P#BZ/\ A&K+_GZU3_P:7/\ \76O10!D?\(U9?\ /UJG_@TN?_BZ/^$:LO\
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MRVTHV5!4@X[<@T 6_P#A&K+_ )^M4_\ !I<__%TC^';"-&=[S4U51DLVJW
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M7&M:QXGM]8T^SN+=M05)5:8R;=L:;54%!D#KG(Y)XH W)]'TBU(%QJ=_"6Y
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M[;A( LAR#@=>^1QSUH ZO_A&K+_GZU3_ ,&ES_\ %T?\(U9?\_6J?^#2Y_\
MBZ=I&J7.I.7,5J]H\*R0W5K<&5)"2<K]T8Q@?7/:M6@#(_X1JR_Y^M4_\&ES
M_P#%T?\ "-67_/UJG_@TN?\ XNM>B@#E_#N@6=QX:TN9I]10R6<+%8]2N%49
M0'  ? 'L*N?V+I/VG[-_:5_Y_P#SR_M>XW=,]/,STJ?PM_R*6C_]>$'_ *+6
MN4^(VGW,NJ:?JVFK_P 3#2+6>]B _P"6@22'<A]059^/\: .I/ANQ )-WJ@
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M=]/NS<W3;]@.58;4&#TW<9[ 5U%% '%ZSX8O-9U!+HV,-KJ5O>*]MJT$H5A
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MD46FV5F*1[ &!!_V@3WKK:* "BBB@ HHHH **** "BBB@#(TW_D8-9_WH?\
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M>$=>7X=Z?X<VV!NK2:)VD^T/L94DW\?)G)QCI6Y-I.IR^.K/6Q';"TAL7MI
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MC=L7GDB*R.>K%&*9/N=N?QH O?V&?^@OJ?\ W_'^%']AG_H+ZG_W_'^%:M%
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MU-4TTVD&J.(K>59@Y60C*QR# VL>V"PR.O>@"Y_89_Z"^I_]_P ?X4?V&?\
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M:;.#5'$5O*)@Y20C*I(,#:3VP6&1UH N?V&?^@OJ?_?\?X4?V&?^@OJ?_?\
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M#/\ T%]3_P"_X_PH_L,_]!?4_P#O^/\ "M6B@#*_L,_]!?4_^_X_PH_L,_\
M07U/_O\ C_"M6B@#F/#>C&7POI4G]J:@F^RA;:DP"KE!P..E:7]AG_H+ZG_W
M_'^%'A;_ )%+1_\ KP@_]%K7(_$73YHM;T_7]+B4:AI5M->G:,&=$>$,C'J1
ML9Z .N_L,_\ 07U/_O\ C_"C^PS_ -!?4_\ O^/\*S]:U5-8\-VT>F3'_B<Q
M?)(O5(=NZ1O8A?E]F9:Q_ -VFC_#+0Y;;3VGFNW$06%<99I&&YV X4=SS0!U
M']AG_H+ZG_W_ !_A1_89_P"@OJ?_ '_'^%9W_"73?8];9=*,MWHCXN+>*<,'
M4KORC8&3CL0#P15R+Q ;FRT>XMK=)O[5*E56;[BE"Y;..0 .>G) [T 2_P!A
MG_H+ZG_W_'^%-31ED7='K.HN,XRMP#_2KFI:?%JEFUG<,X@D(\U48J77J5)'
M.#T/J,CO7*:9H=IH7Q N&T.$6NGKINZ^@BSY?FEOW>!T#;0WX8]>0#?_ +&&
M_9_;.H[B,[?M SC\J4Z)M&3J^I #N;@?X5PD#27?PDN?%CD#6)&DOUNL?/&R
MR':H/4*$4+CI@D=ZV_';1ZEX*L-1965S<V<J .0!ND3.1T/![T =#_89_P"@
MOJ?_ '_'^%(-%!8J-8U(E>H%P./TJSJ=\;&V7RHQ+<S-Y=O%G&]SZ^@ !)/8
M US/@BWDM?$7BN&:X>XE6\A+ROU9C"I)QV&3P.PP* -[^PS_ -!?4_\ O^/\
M*/[#/_07U/\ [_C_  K5HH RO[#/_07U/_O^/\*/[#/_ $%]3_[_ (_PK5HH
M RO[#/\ T%]3_P"_X_PH_L,_]!?4_P#O^/\ "M6B@#*_L,_]!?4_^_X_PH_L
M,_\ 07U/_O\ C_"M6B@#"T*V^RZSK$7GS3X>$[YFW-_J_6MVLC3?^1@UG_>A
M_P#1=:] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %9&H_\C%H_P#VW_\ 0!6O61J/_(Q:/_VW_P#0
M!0!JR%UC8QJ'< [5)P">PSVKGF@U/Q''91ZII']F);7,=S('N$E+-&=RA"O;
M<!DG''&.<CHZ* .3U6Y\32:V3%X82]L+9@;<-J"1;W'_ "T88/3^$=NO7&-:
M*\US[/I[3:5#YL\I%VB7(Q:IR00<?.1P#C'-:U% '(7MUXI;6WG7PJEW;6['
M[(&U&./!Q@R%<'YCR!Z ^YJQ=:7J4FK:-XD-JAOK>%X;RTB<<HX!PK,0"58#
MK@$9Z<"NGHH Y>PTW4M*DUO7UT\76I:I/&PLQ.J%8D 1%+'Y=P7+'MDXSWJS
M!IL^H^);77KJR:Q-I:R01Q.ZM(Y<J26*DC V\<G.X].^_10!BZ3X0T+0[TWF
MG6)AG*E"WG2/P>O#,1VJII=AJ$'CK6=2FL72TO88(XI3(AYC#9R V0#NX_I7
M2T4 <JFE:GHE_KATRU%S%JS_ &B$^8JB"<KM;?DYVDA6RH)ZC'3.MX;T6/P[
MX=L=(B?>+6((7QC<W5C^))-:E% !1110 4444 %%%% !1110 4444 %%%% &
M5XA_X\K;_K_M?_1R5JUE>(?^/*V_Z_[7_P!')6K0!RGAS3M3L_&/B+4+O3WA
MM=3>%H',B-CRTVG< Q(SVQG\*F\66.HWM[H<MC8M<K8Z@MS,1(B_*$9<#<1D
M_-^G6ND9E1=S,% [DTM '-ZU8:A<^,?#]_;V;26MA]H\^3S$&/,0*, G)P1S
M^F:S=&L?%/AV>\T:UT^WN=/FNI)K6_:X"_9UD8L0\>,L02>G7U%=M2$@ DG
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *PM<@DN-;TB.*[FM6)F/FPA"P^0<?.K#]*W:R-1_Y&+1_^V__
M * * '?V1??]#)J?_?NV_P#C-']D7W_0R:G_ -^[;_XS6I7FUC]D;QC"WB[0
M;VPU2ZN2]E=->M);RD'*)A&V@A0!@CG'O0!VO]D7W_0R:G_W[MO_ (S1_9%]
M_P!#)J?_ '[MO_C-8WB[PKI5[INI:MJ4UP;J&%Y()UF=#;;5^4( <9R,^I)^
M@&[X>%^/#FG#523??98_M!/7?M&<^^>M $?]D7W_ $,FI_\ ?NV_^,T?V1??
M]#)J?_?NV_\ C-<[XU\+6#Z+J>M2S71U:)&DM+F.9U:-_P#EE&B@X&3M7&.2
M<]33KNXN[_Q5X>\.ZD0ZK8->W\?\,\@ 0 CNH8DXZ'CTH Z#^R+[_H9-3_[]
MVW_QFC^R+[_H9-3_ ._=M_\ &:P]!8RZ[XG\+-+*EG92P20>6Y5DCE3<T:D<
MA<@@8Z!N,8&*WA./1K?QWK%MH5X(K:.VC$U@6?F;<<R*&[8*C(ZD_3(!TO\
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MJT 97]D7W_0R:G_W[MO_ (S2'2;U02WB74@!U)CMO_C-<[X6L[>/XD^+U6%
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M MT\2A(W+%5#?-GDCJ 0,]<YH U_[(OO^ADU/_OW;?\ QFC^R+[_ *&34_\
MOW;?_&:U:* ,K^R+[_H9-3_[]VW_ ,9H_LB^_P"ADU/_ +]VW_QFM6B@#*_L
MB^_Z&34_^_=M_P#&:/[(OO\ H9-3_P"_=M_\9K5HH RO[(OO^ADU/_OW;?\
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M]D7W_0R:G_W[MO\ XS6K10!E?V1??]#)J?\ W[MO_C-']D7W_0R:G_W[MO\
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M5X6_Y%+1_P#KP@_]%K6K65X6_P"12T?_ *\(/_1:UJT %%%% !1110 4444
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M/_Q-']EZK_T,5S_X#P__ !-5;;Q)<7'C6\T/^SYEAM;>-_-^7#%BWS=<[<#
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MR@,H#,O3CCTYH WO[+U7_H8KG_P'A_\ B:/[+U7_ *&*Y_\  >'_ .)K7HH
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MKQ+>XM_-4D1749CD7G&&7MTH I_V7JO_ $,5S_X#P_\ Q-']EZK_ -#%<_\
M@/#_ /$US7B#1;_16T[5K#6M1FU66^ABDCDG8PW(=L.OE_=50,D8Z 'ZUHO<
MOKGCZ\T>665;'3+)'>..1H_,ED)()*D' 4<#U.?3 !J?V7JO_0Q7/_@/#_\
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M%%% !1110 4444 97B'_ (\K;_K_ +7_ -')6K65XA_X\K;_ *_[7_T<E:M
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M?>^"Q9W]GM6>]>&+R?E_C1@=Q8XXP.">3QR =#:>(X+Z:U%O9W3V]W+)%%=
M(8R4#$Y^;<!\C $BKNI:E:Z3827MXY2*/ X&2Q)P% '4DD #WKC-,TFZMM>L
M=0T2VO\ 2VN;@G5M/E4_9=I!S(N> Q;;C:<\\@8-;?CG2;[5M!C_ +-427=E
M=17<4);:)3&V=N??^>* +<'B.!]772;FSN;*\DB,T$<^S]^H^]M96(R.X)![
M].:YK2HQXNUC6TU;3KM3:Z@J6\XD16M B(0H*N2"223MR#GD^FE/;3>(?%.A
M:HEI<VMOI2SR2FXB,;%W0*(P#R>Y)'' P3FE\(17-OJOB%KFSN(%N]1:>!I(
MR!(FQ5S[<J>#@T =51110 4444 %%%% !1110 4444 %%%% !1110!E>%O\
MD4M'_P"O"#_T6M:M97A;_D4M'_Z\(/\ T6M:M !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% &1IO\ R,&L_P"]#_Z+K7K(TW_D8-9_WH?_
M $76O0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !61J/\ R,6C_P#;?_T 5KUD:C_R,6C_ /;?_P!
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MU3P_;:O>V]Q=75Z(X 0UK'<%(9@2#^\0?>Z?XYK5HHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** ,KPM_R*6C_]>$'_ *+6M6LK
MPM_R*6C_ /7A!_Z+6M6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#(TW_D8-9_WH?_1=:]9&F_\ (P:S_O0_^BZUZ "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *R-1_Y&+1_^V_\ Z *UZPM;BGFUO2$M[DV\F9L2; V/D'8T ;M%97]GZO\
M]!T_^ J4?V?J_P#T'3_X"I0!JT5E?V?J_P#T'3_X"I1_9^K_ /0=/_@*E &K
M165_9^K_ /0=/_@*E']GZO\ ]!T_^ J4 :M%97]GZO\ ]!T_^ J4?V?J_P#T
M'3_X"I0!JT5E?V?J_P#T'3_X"I1_9^K_ /0=/_@*E &K165_9^K_ /0=/_@*
ME']GZO\ ]!T_^ J4 :M%97]GZO\ ]!T_^ J4?V?J_P#T'3_X"I0!JT5E?V?J
M_P#T'3_X"I1_9^K_ /0=/_@*E &K165_9^K_ /0=/_@*E']GZO\ ]!T_^ J4
M :M%97]GZO\ ]!T_^ J4?V?J_P#T'3_X"I0!JT5E?V?J_P#T'3_X"I1_9^K_
M /0=/_@*E &K165_9^K_ /0=/_@*E']GZO\ ]!T_^ J4 'B'_CRMO^O^U_\
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MNK*>-TV_O!RC[B"N#WP<@^O%-NO"-Y8> ]*T_3F2?5-%>*XMV)PKR*?G7/\
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MM"W:6Z_LOS5.GPW<F^6)=OS#.3\N>@//%=-65_9^K_\ 0=/_ ("I1_9^K_\
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M_P" J4?V?J__ $'3_P" J4 :M%97]GZO_P!!T_\ @*E']GZO_P!!T_\ @*E
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M]GZO_P!!T_\ @*E']GZO_P!!T_\ @*E &K165_9^K_\ 0=/_ ("I1_9^K_\
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M%%% !1110 4444 %%%% !61J/_(Q:/\ ]M__ $ 5KUD:C_R,6C_]M_\ T 4
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M-@YP,?0FL34?"NM)XP\.NNO:I<PQ?:-UQY$.+8;!@?*@ W=.?3B@#T&BBB@
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M1TH ZFBBB@ HHHH **** "BBB@#(TW_D8-9_WH?_ $76O61IO_(P:S_O0_\
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M*.[EN4>9YMTJJ&#.2S= .YK7HHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?Q%_T%-,_P#!=)_\?H^S^(O^@IIG_@ND_P#C] &K165]G\1?]!33/_!=)_\
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M--R=)\<^)!<6MTQU.UMS:&*W9UE*(ZL-P& 02.I%8]@L]OX3\"W,ME>JEA=
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M110 4444 %%%% !1110!D:;_ ,C!K/\ O0_^BZUZR--_Y&#6?]Z'_P!%UKT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5D:C_ ,C%H_\ VW_] %:]9&H_\C%H_P#VW_\ 0!0!KT44
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!E>(?^/*V_Z_[7_T<E:M97B'_CRMO^O^U_\ 1R5JT %%<!I^L6VI>)=6T?6]
M5OM-U=+IULHUN6A0P_\ +-HP#L<D<G<"23Z<#I+;4ET2TT72]7GEDOKE$MQ,
M5+"64+\V6[$X)YH V9 YC81LJOCY2RY /N,C/YUD>%=!?PUH<>E->?:TB=V2
M0Q;&^9BYSR<\L?2L_P 2:W;WGA[Q/:6<]S!?:39/)(4W1,C&-F0AAC(.W/%-
M\/\ C'2GATC2IYKA;JYM8Q%+- ZQSN$&X+(1AC]#0!U=%8NH>+-*TP327,DH
MM[>40W%RL1:*%R0 &;ZD9QG&><58O==M+.XDM@D]S-#&)98[:(R&-#G!./7!
MP.IP<"@#2HK$G\8:'!::?=F\+V^I.$MI8XF97)SQD# /!X//!XJ-?&.FRV&J
M7,,-XTNE+NN+9[=HY0""5.U@." >?:@#?KG;;PUJ-A<3BQ\1W,5I/,\QAD@C
MD9&<[FVN1TR3U!J*S\<6"^'](U'5%GM7U)8E7_1WV&1T#8!QC')QZXXS5N'Q
M;IUPL2P17CW$RR.MJ;9EE"(VUF*MC R0.>N>* -6SM(K*V6WA!VKDDL<EB22
M23ZDDD_6IZRXO$>ESZ5::E!<&:"](6V"(2\K<_*%ZYX.?3!SC%9&L^.[.Q\.
M:CJ-G#--<6,HMY8&B(:&4D ;Q_=Y!R.O:@#JZ*BMYQ<P+,(Y(PV?EE0JPY[@
MUSGCN_U:#1S:Z"V-2=&N%(ZK'%AF^N3M3'^W0!U%%9FF:Y;:GX<M];A5WAF@
M$VR-2[#CE<#J0<C\*ICQGHYT[3M05KAK;4Y1#:NL#'>Y) !],D'KB@#?HK-N
MM>L+*>\CNI'A6QMQ<3RM&=BH<X.[N?E/ YXJ.U\26%S>26>VYBN4MQ="*2!M
MSQ$XW*!G//&.OM0!K45S^G>-M#U55DMIIO(:&2;[1);ND2JAPV7(P#WP><5D
M:MK0N_&'A46KW\$=Q-*2KAXX[B/RF(.WH<''! /(XH [>BLM?$%E)<1QQK.Z
M2SM;I.L1,9D4D,N>V"I&>F1C-:E !1110 4444 (<XXZUC>'M FT*74F>^6Y
M&H7CWC#R=A1V ! ^8\848[^];5% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!E>%O\ D4M'_P"O"#_T6M:M
M97A;_D4M'_Z\(/\ T6M:M !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% &1IO\ R,&L_P"]#_Z+K7K(TW_D8-9_WH?_ $76O0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !61J/\ R,6C_P#;?_T 5KUA:W]J_MO2/L9A$V9L><#MQL&>G- &[165
MCQ%_>TS\I/\ &C'B+^]IGY2?XT :M%96/$7][3/RD_QHQXB_O:9^4G^- &K1
M65CQ%_>TS\I/\:,>(O[VF?E)_C0!JT5E8\1?WM,_*3_&C'B+^]IGY2?XT :M
M%96/$7][3/RD_P :,>(O[VF?E)_C0!JT5E8\1?WM,_*3_&C'B+^]IGY2?XT
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MK)X]X&0%";3R<*,[?7/K5#39''C^UU5;36)K6;1WA-S<VT@)D\U&.5P-G /
M ![ YYZK'B+^]IGY2?XT8\1?WM,_*3_&@#B;'2-3U'X)3Z+;VES;ZB$D'D7$
M#Q,W[XOM&X#.Y>/3FKU]K)UO6?"MY;Z5J:?9[IVND>RD7R"8F7!)7G!/49%=
M1CQ%_>TS\I/\:,>(O[VF?E)_C0!R5M:W5GK\%YX?-_ EUJ)&HZ3=0,80I8[Y
MT+#Y>FX$'!R![5Z%65CQ%_>TS\I/\:,>(O[VF?E)_C0!JT5E8\1?WM,_*3_&
MC'B+^]IGY2?XT :M%96/$7][3/RD_P :,>(O[VF?E)_C0!JT5E8\1?WM,_*3
M_&C'B+^]IGY2?XT :M%96/$7][3/RD_QHQXB_O:9^4G^- &K165CQ%_>TS\I
M/\:,>(O[VF?E)_C0!JT5E8\1?WM,_*3_ !HQXB_O:9^4G^- &K165CQ%_>TS
M\I/\:,>(O[VF?E)_C0!JT5E8\1?WM,_*3_&C'B+^]IGY2?XT :M%96/$7][3
M/RD_QHQXB_O:9^4G^- &K165CQ%_>TS\I/\ &C'B+^]IGY2?XT :M%96/$7]
M[3/RD_QHQXB_O:9^4G^- &K165CQ%_>TS\I/\:,>(O[VF?E)_C0!JT5E8\1?
MWM,_*3_&C'B+^]IGY2?XT :M%96/$7][3/RD_P :,>(O[VF?E)_C0!JT5E8\
M1?WM,_*3_&C'B+^]IGY2?XT :M%96/$7][3/RD_QHQXB_O:9^4G^- !X6_Y%
M+1_^O"#_ -%K6K7,>&QKO_",:5Y)T_ROL4.S>'W;=@QG'>M+'B+^]IGY2?XT
M :M%96/$7][3/RD_QHQXB_O:9^4G^- &K165CQ%_>TS\I/\ &C'B+^]IGY2?
MXT :M%96/$7][3/RD_QHQXB_O:9^4G^- &K165CQ%_>TS\I/\:,>(O[VF?E)
M_C0!JT5E8\1?WM,_*3_&C'B+^]IGY2?XT :M%96/$7][3/RD_P :,>(O[VF?
ME)_C0!JT5E8\1?WM,_*3_&C'B+^]IGY2?XT :M%96/$7][3/RD_QHQXB_O:9
M^4G^- &K165CQ%_>TS\I/\:,>(O[VF?E)_C0 W3?^1@UG_>A_P#1=:]86A?:
MO[9UC[883-OASY.=N/+&.O-;M !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %9&H_\ (Q:/_P!M_P#T
M 5KUD:C_ ,C%H_\ VW_] % &MTK@=&\03>)/%#I#XKGL&CF+?V-)8*C/$IP,
M.Z[CN R<=,GTS7>R.L4;2-G:@). 2<#V'6N/U&?2?&4VCW.C2"XN;.^CG^T(
MA4P1J<NK$@$;A\NT\DD<<' !9\26/B*2WO=1LO$#:=]E1GM[=(4=&"C),A8$
MG)!Z8 &.IS6QX?OY]5\/:=J%S"(9[JVCEDC'12R@G%<]XA\6:%)?RZ'?7<D5
MM'Q=E;>5_-_Z9 JI&/[Q]..YQN0^(]->VTZ8>=''J4ABM0T# L1G!(Q\H(7(
MSCB@#$\5P>);73=1UZT\0&T-BCS160@1H7C0$X<D;BS >HQG'O4USKU[?:MH
M.C0EK*74+4WEX5 +Q(%'R+D'!+'!/8 ]SD5=9\7^'[K4I-+O[N1+.UD!G5;6
M5Q<.#D+E5(V CGU(QTSEUZZ#Q?H?BS:\6G7%E):RR3+L\D,0\;-_=!P1ST)&
M<9H T- UJ5M3US1]0G$DFCRH?M#X7=#(F]2V,#(^8$\=*JZ1K>I7_CVXMIF,
M>GOI:7-M 5PP!E90[=\D+G'8$#&<UFV_A^_U[5/$6K6=ZMC#J-U;K"\MOYJS
MQ0)@_+N7*LQZYY"]P:73]-\0P_%(O>:Q#<!=*C,DBV'EK(GFO^['SG!SSGGK
MTH [ZN9T;4-2E\<Z_IUW=B:VM8;9[=%C"B/>'S[GH.IJ[I6F:[:7AEU'Q%_:
M$&T@0_8DBP>QW YK)T6XA;XF>(@)%/F6UJJ<_>*A]P'KC(SZ4 .\8QZ_:V,V
MJ:9K;P7$3HMK8K$ACG)8 (VX;BS9[$ ?AFNK0L44N &QR > :X_Q;)X8\2:?
MJ&DS^7<ZG:JRPPB,BX27'RF/(R><<CCUXKIM(ANK;1K&"^D\VZBMXTG?.=SA
M0&.?<YH N4444 %%%% !1110 4444 %%%% !1110!E>(?^/*V_Z_[7_T<E:M
M97B'_CRMO^O^U_\ 1R5JT <1I>M2:_KFL:=-KL^F:G9W4D5O9JJ ")?NOM93
MYF[J>>XQCJ=RVUF/2;#2;/7;LC4[J)(S^Z8^=+@;L;1C.><5S>NIX1\5VURV
MM2QZ;J5E<30PW&3%.ICD959#UD!P#@9Y..M3Q:3K>N_#"Q74"Z:_;HMS;R2#
M#K,C$QEO0E< Y_O&@#JY]8L+:YFMY[@1200^?)O5@J1\_,6QC'![]C56X\3Z
M9;6M[<.UP?L,(FFB^RR+($.<$*5!.=IYZ<&L*"2#6/!=_KFMVTT46KPIYD29
M\R& #:H&/<LX_P!ZJ-BVK-;:[I!OX]?M?[*8VVHQJ#+DA@(7*\,W?U]>M '4
MZ5XDM+_P_9ZK-OA^TQQGRS$^2[*&VH,9?K_"#G%#^+M BTZ74)=2CBMX)?)E
M,BLK))_=*$;@WMC-<2VHI!X;\&ZLT=Y)IFFPBWOS LB/"QA5=_RX)"D$$CU(
MIWB?^P[GP)X@OM$MYF74#;AKF0RDW3JX^Z).3M7N.#S_ ': .U_X2W0?M<UJ
M=2C$T">8R$-\RYQE>/GYX^7//%6]*U>PUNS^UZ=<K/#O*$@$%6'4$$ @CT(K
MFM3N+63XE>')(Y8F06=R-ZD$ MLVC/OSCUI_@2:)[[Q.B.I+:S+*H!^\A1 &
M'J"0>?:@";Q1XA%CK6CZ.'N(TOIG^T20Q.6V+&S84J.I(&=O(&>G6K5MJ5GX
M>M'M=0UBXO6BS,9)(6=X8F)V^85!P!@_,V,X/I6=XJN8(O&_A,R2JHBGN&D)
M/"!H2H)],D@#-0Z/?0Z'XF\26VN2K!]MN1=6TLWW;B(H%VJ?XBNW&WKSTH Z
M*[\2Z+8_9?M.I6Z?;%W6Y#9$BXSD8[8'6K6FZE9ZOI\5_83B>VF!*2 $9P<'
M@\]0:\TLK-]%TSP-:ZF/)>&_EF:.7K!&PD*;O3&Y1ST/':O4V9(T9W8*JC))
M. !ZT <MX\\0:CH>FQOI,7G3Q$7=POI;1LOF?B<@?3<>U=!_:EF=)751+FS:
M$3"15+?(1G.!STYKGM,MU\32ZCJT6J3117+&U6&-(F_<H64;@Z$C<2[=N&6J
M?PXO4M;6^\*3S^<VDW#Q6TC?\MX"25(/0D<@XZ<4 ="?%&C""QG^UDQZ@=MJ
MPA<B8]@./\CFK$^N:;:RW<=Q="$V<8EG:16544]#N(QSSC!['TKSV30]7?1M
M2T"U22/_ (1JZ:\TV7&?-/$D* ]\!G4_5:V]1OI$\ 7>O7&E+<2:@T=PUM-&
M9!%&64(64<D*H#$#OGIUH Z2+Q#I4QNE^U>4UF@>=)XVB:-3T8AP#@XZU7M/
M&'AZ^=EM]5@?9;?:F)RH6+.-Q)& .1^=<I9W]N/'5_=&\N+B&YT-=EU-"45R
M'<G'R@!1D?GU)-4HTGD^"^DFQ@:<V,D$EY;1K\[(D@9U*^O0D4 =#)KK7/Q$
MTFSM+ZY^S36D[RVLD+1#("[6PR@D')YY''%:OC&34(?#=S-I=ZUG>)M$4@56
M&2P'(8'CFL"77--U?X@^&[O3IFN86M;I3)'$Y )\O )QQWSGIWQFM_QC<0P>
M'9C+(J;I(L GDXD4G'KQ0!'X,U]]=\-175YB.]MBUO?(<#9,G#9],]?QK'\)
M:]JVN^,]:6ZNG33X(H9;.U"*!Y<@)5F.-V2 &QGC=BH+W2+Z+QI/!IB[]'\3
MPA[R1#\L+)C>01_?0[?JV>U2:)=P1_$OQ0T6UP]M;"!5(Q*40[E4]"1P..E
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M0J.6"EB2QR<#&0/<V] U/PWK\^FR):7S:K8?,\5P\X%@=N'+%CM XP!WX]\
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M29)!8<;B< +U[]*K6FLV6AZ[XBT7Q'!*W]I7C7%MFV:5;R)T51&  <D;<8H
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MP:S_ +T/_HNM>LC3?^1@UG_>A_\ 1=:] !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %86N-=)K>D&S
MAAFFS-A)I3&N-@S\P5OY5NUD:C_R,6C_ /;?_P! % #OM'B+_H%Z9_X,9/\
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M,9/_ (Q1]H\1?] O3/\ P8R?_&*U:* .8UV?73:6_FZ;IZC[;;X*W[MEO-7
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MA5_*3RY =TF<;..ASU]*FEU"VN=3TT6NO6R+(9#]E0HYO!M/0YR I!.1Z8-
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M^,5JT4 97VCQ%_T"],_\&,G_ ,8H^T>(O^@7IG_@QD_^,5JT4 97VCQ%_P!
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M!^=I#*<8'H5._/3'->FQV\$3;HX8T/3*J :/(B\[S_*3S<;=^T;L>F: ./\
M'BQ:;X*L;6291Y5W9Q@L<9VR)D_D,UT]_JNFZ=#$^H7EO;Q7#B.-IG"J[$$X
MR>.@-69(8IL>;$CXZ;E!Q226T$T/DRPQO$,?(R@K^5 ',^&M,M+3Q/K%WHP1
M-*N8X25A_P!4UP"^\ICC[NS..,Y[@XZND50JA5   P .U+0 4444 %%%% !1
M110 4444 9&F_P#(P:S_ +T/_HNM>LC3?^1@UG_>A_\ 1=:] !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %9&H_P#(Q:/_ -M__0!6O61J/_(Q:/\ ]M__ $ 4 :]%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 97B'_CRMO^
MO^U_]')6K65XA_X\K;_K_M?_ $<E:M '&Z5K5WXBU36+2+7/[/O;"ZDABL1#
M&WR+PLCAAN8-U^4J ,#W.YI^I?9K#2[;6KJ&/5+F% R,0IDEV_,%'USP*Y76
M[3PEXL6[O;B_BTC6--GFA%Y',(IHC&[*&/3<IVY_, @U4GU&_P#^$;\$:QXC
M;R)(M04W4THV!04D5';^[D;2<XY- '5^(M:0>'-=?2=21+_3+625_+VNT3!&
M90RD'&=O<4N@>*-+OX+&P;5K:75&M8WEA$@WEB@)X]>^*Y*>]M]1O_B*MG)Y
MYN=)B\@("3*!;R#*_P!X9(Y'7(QUJ:6*QU?1_!<&D-;RWMM<VTV;<@F")5S*
M6QT'8@]20.M ';76NZ597 M[J_@BDW*A#-@*S?=!/0$]@>M/OM8T[3#MO;N.
M%MI<@GD*.K$#HON>*X;1]7T:.TUCPSXFC$E^VHS.UI)&6:\#/NC9!_%GY0/3
M:.@K1TJ^CTSQWXCBUJ6.V-XD$UJ\[A4DA5,,JD\?*V<CWS0!T\^MZ5;"V,VH
MVJ"[Q]GS*O[W/=?4>]5E\5:')IEYJ4&I03VUEGSWA;?L([8'KV]:\\CABTWP
MUX5AU!HX8&\1F:WBN"!LMSYNW(/0<@_\"%;,DUO+XM\;VMO+&\\VE0@1HP+.
MPCD!X[D97\Q0!TNG^+]&O-(T^_FO[:V-\D92*24!@[*#M]R,\U.GB;1);2.Z
MBU.WEAEW^6T;;]VW[Q '.!W/:N NM4TJX\#> U:[MG2&^L$FWL-JE8R'!SQP
M>#Z=ZZ/5]3TZQ\:V=F3!ITDU@[I?[ 6E#2#,,8^Z6) 8\$GC YH Z8ZI8"P2
M_P#MD)M9 "DP<%7STP>^>V*R]6\9:/IGA^YUA;I+B.%C%LC//F] A'53DC.>
ME>?Z#JT>E^&O!FI7+.=-T^YNHKY@I(MY'WK&S#'&,GZ;O<5N^,)])U#P%XAO
M]$A22*9X9)KJ)3MG99$W$'OM4#)''7N#0!U4^IV4^IZ6D.NQ0M*SE;52A-V-
MI'?D $$Y'I1<>+?#MJDCSZU9(L4GE.3,N%?T^O(SZ=ZP/$.J:==>+O!EQ#>0
M/&]Q<,D@<893$P!![@G ![UFQW.F,OQ%W3VQ9MV<LN2OV<#\MV1]: /0+C4+
M2T2-YIU43'$0'S&0XSA0.6X!/':H[#6-,U3<+#4+:Z*#+K%*&*?4#D?C7 /J
MUAIUIX$UA]1MT\NQ:$B=RL3 PH'RX!VN" ,$<\CC%=)X&%@;/4I[+5+._>\O
MY;N86DN]("^,)GKT&<D#))XH C\3ZGJ>C>)=!D6^:/2;^Z^RW*>6A*R%?W>&
M(R 2,'],4R+6=0M?B@V@W>I>99W%C]JM8O+0'=NP5) R> 2/IWK1\;:*VO>$
MK^RAS]I$?FVY'42H=RX_$8_&N-U%=0N/">F^/OLK'5(+J*^,*]3 RK&8Q[%<
M-^)H [&*[G^V:S=7.K^1IUL1#$TBQJL3;06;<1R 6 &3U!SFH9?%6GZ+I^BQ
MW&I?;Y-0,<<=R0%$HQDR' P!@?C^=3R6PTOP/<QWKH)/LDKW+L<*9'!9S]"S
M&N-6\MH?!OP^O9)XUMK>ZMQ-,6&V,^2X^8]N>.: .@3Q*NG>,M7CU35T32XK
M2WF@\W:JH7+Y (&6X7WKJ[>X@N[:.YMI4FAE4/'(C95@>A!KC=.O=-F^*.M2
MO/!E=,MQF0@%1EBPYY'!&1^=6?A;/#-\/-+$4JR>6KHVUL[2';@^G&* )TUF
M]U[Q1?Z/IEQ]CM-*"+=72HK222L,A$W J  .20>>..M:$$&L6NN0I)?&\TUK
M>3<9(E659=R;<E0 5QO[#WSQCF='FB\(>.->MM6D6VM=9G6[LKJ4[8W8@[XR
MQX# ] >HKI-2O_[3TK4+71)UGNFM91'-"X*1R%2%!8<9R1Q^- %E->TF2\2T
M2_@,TC%$7=]]AU53T)&#D#D8J&Z\4Z!9&Y%QK%G&;0JLX,HS&6S@'W^4\=>*
MX:YFM]8^%>DZ5IS*NLPO:PPVXXE@N(W4.2O5< .23VYK4L+G3?\ A8'C/SI[
M7=]DM5.]ESM$;[QSV^[G\,T ;^J>+-*TN;3(WN$?^TW A=6RNS:6WYZ8P./7
M/UJ:?Q5X?MI'CFUFS1XV1'4S#*L^=H/H3@\>U>?:7?VL/A+X?WLUS&MO;7>R
M:4N-L1\J0 ,>W4=:Z'2)]-N_BAX@0O;R2O9VH5&QN.-Q88//'RY';B@#IFU[
M2EO%M&OX1,TODA=W!DZ[,]-W^SUIU_K>F:6VV^OH8"%#-O;[JDXW-_=&>YXK
MS'4]:L+K2(Y(I8K 6WB&-YK!%^:'%Q\TDQ.2"3R.@YQSBMNUUW2-.\0>)=+\
M2NL0U*59H#.C8NK=HE0(O'.,$;>N2?>@#IY_%6F0>([?0S.IGFMVG+9^4#*A
M1GN3NS]![BK5SKVE6=P8+F_@BD#!&W-@*QZ!CT4G(P#US7+R7%IIGQ T)I8_
ML,$NC26]O$XQAM\9$8']X =!6;IMU;1^!_$FB:RR#4UFNQ- _P#K)VD),;*.
MK;LJ%QZ"@#N+_P 1:+I<SPWVJ6MO+'&97224!E3CDCL.1]<T2>(=(B5';4(=
MCJC!P<KA\;,D<#=D8SUSQ7%62I:^,O"5CK$T#7T6AO%*LK@MYI"#'/4GYA[\
MT:].^DZCJ]_H=]!<HL\2:CH5P!F5MB*IB(Y#%=H'8D>V* /1)4:2)D25HF88
M#H 2ON,@C\Q7%^#[GQ%XB\-MJ$FO&.Z\^6)0;2,Q_(Q49  )Z>HKM))4BB,L
MKK&BC+,Y  ^IKS_X;>(M%L?!A^U:K:1,MW<,4:9=^#(2,+U.1TP.: -[PKXI
MDU6/4[35XH;/4='E\N\"-^Z(P2LBD]%(!//3%:!UBRU*"[M]-U)!=0Q;CMP7
MCR.&VL.0?7&#7GL^G:K+I/BCQ6;&YC74;RVECM-I69[6%QDE>Q9<G![#WKI-
M)NO#6O:J-5T>ZN-1O4LWC:;>Y$49YV,#QDGH#SP3VH E\'^,+"^T31[?4M8M
MGUB[MU=HF=5=V/L.A/I6]=Z]I5C.T-U?PQ.A4/N;B,M]W<>BY[9QFO-X8+/4
M_A+HVD6'D/K'F0B"./'FPS+("[$#E<*&R3_6G>,=5L[K2O&=C$T=C<1N-]JJ
M;IKO"I^];.<)C@;0,;<D\XH ]#OO$FB:9-+#>ZK:02PQ^;(CR@,B9 R1VY8#
MWS49\6>'5D\O^VK(MO2/ G4_,^=H^IP:YM+[2K[XHZ>S7%M,)=!=8]Y!WDRK
M@#/7*[L>HSVJ7P^^G3?$KQ9%NMI)=MGL3*D_+&<X'L=N?0XH Z:?7=*MKQ;2
M>_ACF=Q&%9L#>>0N>@8^G6F:SJUG8V\T4NHI:3^47#<$QC^\000!GN>*X#3K
MK0[O2+OPSXDFN_[4CO)?,L [JURYE,B-'CKG(.<^YXK4TW5[33/$GBNPUVXC
MM[JYF$MOYYQ]H@\L*BIG[V,$8'<GWH Z#P1J%UJO@S2[^^F,US/ 'DD( W')
M[#BMZN'\!^(=)L/ WAJUNKZ.*:\7[/ AS\\@/W?8\CKZCUKN* "BBB@ HHHH
M **** "BBB@#*\+?\BEH_P#UX0?^BUK5K*\+?\BEH_\ UX0?^BUK5H ****
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M<;#CZ5I?;-=_Z ]K_P"!Q_\ C= &K165]LUW_H#VO_@<?_C='VS7?^@/:_\
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MQ1HGB;6GTXW-P6\J0Q(L]NT:A-C,I)( (P#P>G.: /0+S4++3XQ)>W<%LC'
M::0("?;-0KK6DM''(NIV925_+C83KAVX^4'/)Y' ]:X[2M2L-&\;-;:K<M:0
M_P!D6R:8]^X0^6,^8"3QOSMSW^7VK##0Q^ )KA<1VT'BCS&;&U8T%R.3Z 4
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M\@+(O0-DDC'!YQ0!U]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 97A;_D4M'_Z\(/_ $6M7;Z\
MATZPGO9R1%!&TCX&3@#/'O5+PM_R*6C_ /7A!_Z+6J>OR/J6J6>@VES!',"+
MV<2IY@$<;#:"H93R^#UZ(: #P7XAN/$&DS-?P"VU&SN9+>[@'_+-U/'X;2.?
MK6L-5TXK.PU"U*VW$Y$RXB_WN?E_&N+WS^%/B7#-J%W;-;^)8O*<Q1&)5GB
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M9@V[)Y V_=QCG'J<BM"*X@G+B&:.0H<,$8':?0XZ4 9W]KWW_0MZG_W\MO\
MX]1_:]]_T+>I_P#?RV_^/5H&Y@4@-/&"7V %QRWI]?:JKZS8IK<>CF=?MCV[
M7&S(^5 RKS]2W'K@T 0_VO??]"WJ?_?RV_\ CU']KWW_ $+>I_\ ?RV_^/5H
M^?#Y@C\Y-Y8J%W#.0,D8]<<TD=Q!+(\4<T;O']]58$K]1VH S_[7OO\ H6]3
M_P"_EM_\>H_M>^_Z%O4_^_EM_P#'JT3<0K,L#31B5AE8RPW$?2JEMK-C=ZK=
MZ9!.KW%F$,P!'REMV%^N%R?J* (?[7OO^A;U/_OY;?\ QZC^U[[_ *%O4_\
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M3U(YX)SR1UH Z.BLC^W_ /J$:I_X#?\ UZ/[?_ZA&J?^ W_UZ ->BLC^W_\
MJ$:I_P" W_UZ/[?_ .H1JG_@-_\ 7H UZ*R/[?\ ^H1JG_@-_P#7H_M__J$:
MI_X#?_7H UZ*R/[?_P"H1JG_ (#?_7H_M_\ ZA&J?^ W_P!>@#7HK(_M_P#Z
MA&J?^ W_ ->C^W_^H1JG_@-_]>@#7HK(_M__ *A&J?\ @-_]>C^W_P#J$:I_
MX#?_ %Z ->BLC^W_ /J$:I_X#?\ UZ/[?_ZA&J?^ W_UZ '>(?\ CRMO^O\
MM?\ T<E:M<OKFM^;:6X_LO44Q>V[9>WQG$JG'7J:T?[?_P"H1JG_ (#?_7H
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M#MX+<<$]^*P[S^Q]0OHKZ\\*7-Q=0X\N:6P5G7'3D^E:']O_ /4(U3_P&_\
MKT &CS^(Y9Y!K5CI]O$%^1K6X>0EL]P5&!BL3X@$07GA>]D^6WM]9B\V0]$#
M!@"3V&>];?\ ;_\ U"-4_P# ;_Z]1W&K07EN]O=:#J$\,@P\<EH&5AZ$$X-
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M7-]%;W=FLC-%<QN<,=I)PRC+9'8&@#5UWQ+J^F_:9]/\./J%E9@F>;[2L;'
MRWEJ02V!].00,UMZ9J%OJVF6NHVI)@NHEECW#!PPR,^]4];DDNX)-'LGQ=74
M95GZBWC/!D/OUVCN?8$B[IUK:V&GP65F +>V00Q@'. ORX^HQ0!SVN>+-4TE
M;F]@\-RW>E69(N+D7*I)A?OLD9&2!@]2,X/;FM/5M?33_"\NO6UK)>PI;_:
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MS9',TK2$.C#&T!<<YYSS7">+=#LK#0(+1;F6[2/7;=T29]WV822+^[4]@ >
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MYR#(,ZJ Q'8E!G-=/9:$%U;3-7M=8@2UFB:.2*&-R+]63*EB7.6&"V[&>N:
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MS7*6VCVL(GDO'W31E]H,"$%\G!X)*I_P,T 3>%_$=OXIT5=2MXVBS(\;Q/\
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M)(68 -)-,\LC = 7<EB!D\9P,U=HH *SK;0M.M-6GU6&*5;RY 6:0SR,' Z
MJ6QQDXXXK1HH SK[0--U&=YKFW8O+&(I=DKH)4&<*X4@..3P<]3ZFKZJJ($1
M0JJ,  8 %.HH **** "BBB@ HHHH **** "BBB@ HHHH RO$/_'E;?\ 7_:_
M^CDK5K*\0_\ 'E;?]?\ :_\ HY*U: ,NP\.Z7INI7.HVD,J75V09Y&N9'\S
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M9X>L-6?5+73EBN7<R'#ML#GJP3.T'W JR/#NE+J%W?K:E+F\7;/(DKKNXQG
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M6;;K=UGD3RV]1M8<^]1W?A31;[4FU&XM"UP\0BD(E<+(HZ!U!PV,\9!K8HH
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MA1@;F+'\2>33J* "BBB@ HHHH **** "BBB@#(TW_D8-9_WH?_1=:]9&F_\
M(P:S_O0_^BZUZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *R-1_Y&+1_^V_\ Z *UZPM<NH[+6](F
ME69E!F&(87E;[@_A0$_I0!NT5E?\)'8_\\-3_P#!5<__ !NC_A(['_GAJ?\
MX*KG_P"-T :M%97_  D=C_SPU/\ \%5S_P#&Z/\ A(['_GAJ?_@JN?\ XW0!
MJT5E?\)'8_\ /#4__!5<_P#QNC_A(['_ )X:G_X*KG_XW0!JT5E?\)'8_P#/
M#4__  57/_QNC_A(['_GAJ?_ (*KG_XW0!JT5E?\)'8_\\-3_P#!5<__ !NC
M_A(['_GAJ?\ X*KG_P"-T :M%97_  D=C_SPU/\ \%5S_P#&Z/\ A(['_GAJ
M?_@JN?\ XW0!JT5E?\)'8_\ /#4__!5<_P#QNC_A(['_ )X:G_X*KG_XW0!J
MT5E?\)'8_P#/#4__  57/_QNC_A(['_GAJ?_ (*KG_XW0!JT5E?\)'8_\\-3
M_P#!5<__ !NC_A(['_GAJ?\ X*KG_P"-T :M%97_  D=C_SPU/\ \%5S_P#&
MZ/\ A(['_GAJ?_@JN?\ XW0!JT5E?\)'8_\ /#4__!5<_P#QNC_A(['_ )X:
MG_X*KG_XW0!JT5E?\)'8_P#/#4__  57/_QNC_A(['_GAJ?_ (*KG_XW0 >(
M?^/*V_Z_[7_T<E:M<QKNO6<MI;A8=0!6]MV.[3;A>!*I[IR?;J>U:7_"1V/_
M #PU/_P57/\ \;H Y;1[2\O/'7C:&TU V6^2U5G6(.PS#U7/0_@:9K?AFPT&
MW\(Z18/<1VZ:H(FQ,P,@9)&;.,#)/<#([8K;LG\/:=J$]_:V&JQW-S@SR?8+
MPF7'3=E><=L]*=J5QH.KR027UCJDK6S^9"1I]XNQO[PP@Y]Z ,RZTBST3QMX
M1M-/$L5N!>@1&=W7[F[HQ/=C^=0:3;V'BK0]4O-5NGMM0M=1F\VZC<+-9>7)
M\JJ2#M&P#COD]S6W=76A7FHVVH7%CJCW5IGR)/[/O 8\\'&$QR.#ZU4FLO"-
MQK7]LRZ)>M?9#&7^R[O#$="5V;21ZD9H :D2GXL7,>^;RY]"5V4RMP3,1D<_
M+P!TQTKDK>QBA^&6G:VLDYU"UU+]S.TS$H#>%".O0@G/KFNY:?06U5]5^Q:J
M+UXO),PL+P'9UV\)TSS]>>M5!9^%!I?]EC2M4^Q>9YGD?8;W;NSG.-OKS]>:
M (]3B,WC'48=2MI-0LWTU/LL42&3R&RP;('W&8XPQQ]WKQ6OX-TR]TCPM96N
MI.[WWEAK@M*9#O/N2>V!QQG-<5K LKSQ'<W&I>#-7U: I'':7-K;SQND:CE9
M-VPD[B3G)XQZ5TWAN^L](TUK<V^K1QM*7B@>QNYO(4@?)O9,GD$^Q8@9 S0!
M!#_R6BX_[ "?^CS5;Q;_ ,3/XC>%+"R^>YL9);NY*_\ +&+ 'S>FXC%:$T?A
MJ?4GU)[#5_MCKL:=;.^5BO\ =R%Z>W2K6GWF@Z4)/L.F7T!E.Z1UTFYW2'U9
MO+RQ^M '(74L31:+J^FEY(Y_$<:#49G_ '\ZM*RNN .(\94 GHHX%:>FVNF6
M?C?QI>RQQVXMHK>7ST0;HLPN7<<=>I]ZMG2_!A613H-YB283D?V7=X#YSE?D
M^7GL, U;<^&9-1?4&TB\-R\/DL_]DW.&3!&"/+P>"1TZ''2@#GM,46OB7P;+
M:1F""]MK@-(\F9[M!$'#S8X+$_-U.,]1TKTBN.MM.\'6GV8PZ%>J;1R\!.EW
M;%"1CJ4Z<GCI[5N?\)'8_P#/#4__  57/_QN@#5HK*_X2.Q_YX:G_P""JY_^
M-T?\)'8_\\-3_P#!5<__ !N@#5HK*_X2.Q_YX:G_ ."JY_\ C='_  D=C_SP
MU/\ \%5S_P#&Z -6BLK_ (2.Q_YX:G_X*KG_ .-T?\)'8_\ /#4__!5<_P#Q
MN@#5HK*_X2.Q_P">&I_^"JY_^-T?\)'8_P#/#4__  57/_QN@#5HK*_X2.Q_
MYX:G_P""JY_^-T?\)'8_\\-3_P#!5<__ !N@#5HK*_X2.Q_YX:G_ ."JY_\
MC='_  D=C_SPU/\ \%5S_P#&Z -6BLK_ (2.Q_YX:G_X*KG_ .-T?\)'8_\
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M :M%97_"1V/_ #PU/_P57/\ \;H_X2.Q_P">&I_^"JY_^-T :M%97_"1V/\
MSPU/_P %5S_\;H_X2.Q_YX:G_P""JY_^-T :M%97_"1V/_/#4_\ P57/_P ;
MH_X2.Q_YX:G_ ."JY_\ C= &K165_P )'8_\\-3_ /!5<_\ QNC_ (2.Q_YX
M:G_X*KG_ .-T -TW_D8-9_WH?_1=:]86A74=[K.L31+,JEX1B:%XF_U8_A<
M_I6[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !61J/_(Q:/\ ]M__ $ 5KUD:C_R,6C_]M_\ T 4
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M%JGB-K^ZMM3B>YEB,<[*ML8F;9'LSM(PHR"#G)S3K:>[UWQ3H9NKN]MHM1T
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MR6<]RCS)$3$5 0LP4%LGID]@:UZY7XD?\B>__7W:_P#H]*ZJ@ HHHH ****
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MBMC0-<LO$FBV^K:>S-;W ) <892#@@CU!!H 2\T*SOM6LM4F,WVFPW?9RLA
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M* ,KPM_R*6C_ /7A!_Z+6IO[(M_[:_M?S)_M/E>5CS3L"9SC;TZ\^M0^%O\
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MY"?_  H_X2G1?^?S_P A/_A0!KT5D?\ "4Z+_P _G_D)_P#"C_A*=%_Y_/\
MR$_^% &O161_PE.B_P#/Y_Y"?_"C_A*=%_Y_/_(3_P"% &O161_PE.B_\_G_
M )"?_"C_ (2G1?\ G\_\A/\ X4 :]%9'_"4Z+_S^?^0G_P */^$IT7_G\_\
M(3_X4 :]%9'_  E.B_\ /Y_Y"?\ PH_X2G1?^?S_ ,A/_A0!KT5D?\)3HO\
MS^?^0G_PH_X2G1?^?S_R$_\ A0!KT5D?\)3HO_/Y_P"0G_PH_P"$IT7_ )_/
M_(3_ .% &O161_PE.B_\_G_D)_\ "C_A*=%_Y_/_ "$_^% #O$/_ !Y6W_7_
M &O_ *.2M6N7USQ'I,UI;K'=[BM[;L?W;]!*I/;TK1_X2G1?^?S_ ,A/_A0!
MS&CV^H7/CGQM%87T5FS26JF1[<RL,P]5^8 $>^:CU/PW!X:L_">CZ;>7L4/]
MIB&5DG93*&21F+ '&<C@XR.U:^GR^$],U2ZU.UN9UNKP@W#M).XD(&!D'(X'
M3CBGZK=>%=:EM9+ZZF9K202P&-YH]C_WOEQSR: *5QIRZ)XR\)V5G=WAMV%X
M&CFNGD#83<,[B<D%C@^E1:7$OBS0]0O[G4[BQOX-0F4SQ2D&S$4G" 9P!L S
MD<[B36G>7?A:^U6SU.XN96NK'=]G=6F4)N&&X'!R.#D52EL_ TNLR:LVX7$K
M!Y54S+'*PZ,Z#Y6/U% $R!V^*=Q;?:+DV\VAK*8C.^U6,Q4E1GY3@#IBN5MX
MIXOAOIVO_P!HW[ZA;:EMCD>Z<C:;PH5*YPP()SG)]\8%=>USX5;6GUG[5,+Y
MX/LYE#S#]WG.W;T')STZU3%CX(&BC1A+<?81+YHA\^XP&W;LYSG[W/7KS0!)
MJC2R>+M0MM22ZGLFTU&LUM4=_+?+!R0G*N3C:QQT.#UK5\&V>HV/A:RCU>29
M]0:,/<F:=I6#GMEB<<8X'&<UPVKW^B3>)KJ;4=-U>=#''%:7>F3R M&HY$GS
M*=VXGDY&,>Y/4>&]9T[3M-:&?4;DJTI:&.Z9YI(4(&$9\')R">IQG&3C- $4
M/_):+C_L )_Z/-5O& ^V?$7PA:6?S7EM++<3;>L<. "3Z X(JY*OA";6'U=K
MN[6]DC\II8[BY0E,YVX4@8SVJUIU[X4TJ2::S<+-.099G66263'3<[ L?Q-
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MF<7\J>6\ADG(9>R[?NX]L4 <\MS/J'PJ?Q<M[-'K"))=BX61AL97/[O;G&S
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R-1_P"1BT?_ +;_ /H
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M)XNG$2-P\C>P!./4X'K6C8V<.G:?;6-N"(;:)8HP>RJ !^@H L4444 %%%%
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MD]S-);6^F*T,<DA81EX)"V,],D=*A*:GH%EX4U>VUB\G6\EM;2XLI6!A9)%
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M^#9] NM'NO$EO=1W8'GSSZDC3.1@J=V>,8& !CVZUV--=TBC:21U1$!9F8X
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MYZ>M=$9$$@C+J'8%@N>2!C)Q^(_,5!J%_;Z9927ETS+%'C[JEF8DX  ')))
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M4 2T5%]IM_\ GO'_ -]BC[3;_P#/>/\ [[% $M%1?:;?_GO'_P!]BC[3;_\
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M0 4444 %%%% !6)K-M;W>NZ1#<P1SQDS$I(@9<[!V-;=9&H_\C%H_P#VW_\
M0!0!/_PC^B_] BQ_\!D_PK$GU+P+;:V-%D@T_P#M NL?DK8[CN;&!D+CN._%
M=57#1+XB\%:G9K=:@FKZ-J%Z(7+0"*:VEE<X;(^\I=N<\\T 7M7U/P+H5W]E
MU*"PAE&-V+'>(\]-[*I"Y]R*VH]#T*:-98]*T]T<!E9;="&!Z$'%0>($MX-"
MO;:.V6:;4%>)(,<SRNN!GVQU/95/85:T+3/[%T&PTOS#+]DMTA+_ -XJH&:
M,'4M6\!Z1J'V&_BTZ&8,%<FRRD9/(#.%VJ>>Y%:6HVGA;2+![_4++3+>V09,
MCVZ8_#CG\*B\56D,OAJ\T>VMT>?5%DAAB(X,CY)D/LN2Q/MZXJ/Q-9K8?#75
M+)6+K;Z1+$&;J=L1&3^5 &A;Z/H-U;17,.E6+13('1OLJ#((R#TK(TW4O NL
M:FVFZ?!I]Q=+N)1+'@!>IW%<8]\UHV5I+?\ @FUM(;EK62?3XXQ,@RT>4 R/
M>LG0;G7M!UZ#PWK4\.H6MQ SV%[%"(F'EXS&Z#@8!&"/_P!0!T'_  C^B_\
M0(L?_ 9/\*H6<7A/4-0N]/L[/39[FS"F=$ME/E[LX!.,9X/%3:5XO\/:Y>&S
MTS5;>ZN I<QQDYP.I_45F:-_R4SQ-_UZV7\I* -#5;3POHFFS:CJ.GZ?!:P+
MEW-LIQV' &2<]A5M=!T1E##2+'!&1_HR?X5P'C[Q'H>KZ#K<3ZM9[[2-X;6T
M,R[WE!VNY7KGJJ^VX]QCT73+ZTU'38+NRN([FW=?EEB8,K8X."/<$?A0!%_P
MC^B_] BQ_P# 9/\ "JSZ?X:CU&+3GT[3A=31-*D7V9,LJD GIZL/\@ULUY7X
MCU. 7,/C>WED>ZL+T!8PC8:Q^XP!QCYLM(#Z-[4 =IK47A?0-/:^U#2K1(%8
M*62Q#X).!G"\9) R>*O_ -@Z)G']D6&3V^S)_A6'\1I8[CX=WLT3AXY/L[HP
MZ,#-&0:;=F_?XK6L":@Z6XTF258M@*C][&&_$X'/:@#>;0M#12[Z38*JC))M
MT  _*J6EP>%=:AEFTVQTZYBAE,+NELN-X ) ..>HY'%;U<GX"X7Q'_V'[O\
MFM &Y_PC^B_] BQ_\!D_PH_X1_1?^@18_P#@,G^%:%% &?\ \(_HO_0(L?\
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MV+LA9F7&"V&/'7@>W>LX>+=:F\!:1K:-;)<S7J6UT/*)##SS$2O/RYQGH>M
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MG:W0EB4&23CDU8O[+PSID:/>:=81^8VR-1:JSR-_=50I+'V -3>%O^12T?\
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M] R#_OF@#5HK*_X1C0_^@9!_WS1_PC&A_P#0,@_[YH U:*RO^$8T/_H&0?\
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !61J/\ R,6C_P#;?_T
M5KUD:C_R,6C_ /;?_P! % &M7 VRZQX3URU&N6VG:G9:C>>6NH00;)X)I&)7
M>#G*DG (/''L*[V0.8V$;*KX.TL,@'MD=ZPX-,UC4%M1K\MBRVLRS;+-' E=
M3E2=QX .#@9Y YQP0!/$EAIL>@:H)+)+B2_4KY94%YY6&U%&>_0#T SQBKWA
M_3I=)\.Z=IT\OFRVMM'$[^I50#CVK'U#3?%\NN/?6=[HX@0;;:.Y@E<Q#N>&
M W'U[#@=\Z<5OKR6^GK)?6DDJREKYC"0'4Y^6,9XP2 ,YX'Y@&=XNTFPD\*Z
MC8)91S7.I%TA0J"SW#YVMGK\O7/95]!2^*+%;;X9ZE9SD7#6VE2+YCC)++$1
MN^O&:BN=-\9-K,]];7NB;#E(%GMY7,*>@(8#)P"3CGCL *T=5TO4=1\(7&DO
M<PR7EW:M!+.P*H"RD,P '3G@?K0 64%U=>";6WLKD6MS+I\:1SE=WEL4 W8R
M,XK#\,2W^AZ]%X>UK3M/662W9K+4+&+8LRIC<C \A@"#Z&N@BM-6M/#,-G:2
M6B:A;PI&CR!GB)7 R0,'D _3/>BTTV\FOX=2U9[=KFWB:.&.W!V1[L;CD\DG
M:!T&!GUH FLM?T;4K@V]AJ]C=S %C'!<H[8'4X!SBL'0XHXOB5XF$:*@-M9D
MA1C)Q)71VVEZ=9R^;:V%M!(1C?%"JG'ID"LO3M&O[7Q?JFLRM;F"_BBC$:LV
MY/+#8/3!SN_#WH R/%5AX@L]4G\06D&G:O910J'T^XA_>K&N2QC?D;B23TYP
M!S@5UFF7EOJ.E6E]:#%O<PI+$,8PK $#';@UGW%MXAN;F[MS=6$=A-Q%*D;^
M?&I&",$[2>N#V]#TK4L[2&PLH+.V01P6\:QQJ/X548 _(4 34444 %%%% !1
M110 4444 %%%% !1110!E>(?^/*V_P"O^U_]')6K65XA_P"/*V_Z_P"U_P#1
MR5JT >>Z;<F'QGXZC&F3ZAYK6R^3&JD/^YQM.2  <]ZF\-_VCX-\,Z%X<O&#
M:E<B9\^6\ZP(IW$;4Y;&]1P0.3S@<[&AZ%J6F^*-:U:X>U:+5FB;RXV;=%L7
M:.2/FS^%2>*/#]]JLVGZEI%ZEGJ>FN[0-*A:-U< .C <X.!R/2@#&O\ Q?XA
MT[P]J%[-I<(FLKN.%)98I(H[F-W50ZHQR#\W()XQWK3MM=UB#Q=+HNI06CI)
M8M>6YM=VX;6"E&W'YCR,$ ?2H=9\.Z]KGAJ:QO;^S-[<RQ.QC1UAB6-PX55)
M)))'))[^P%6+G0]4N/%D.MK):Q*FGO:,@=BV6(;<#CL0.* (?#'B>Y\1B&>W
MN;"5#$WVJU5&CGM)>,(V6)(SN!.T=,CK5:U\:W2^'9;V[MK?[:VJMIEO#&2$
M:3S-BY)R<=23[5;M?#-T_B"PUR]2RCOK.!XY9K4L#>%E &\8& .3CYN<<\<T
ME\#7=QX<O--N[R&*Y?4FU&UN806\F4OO&5.,X/'N#VH T9-<U+3?$UGHNHBU
MG&IPR-9SPQM$!)&,LCJ6;C'((/MBL-/&OB(>%X_$<MKIHM8KTP7,2[R[)Y_E
M90YP",CKG//3I70KHU]?:Q8ZOJHM1/IL4BV\-N[%&D< ,Y8@$<# &#C)Y-8I
M\%ZLW@6?PV;FSWRW7GB?+X \[S<;<>HQUZ4 =S7G'Q N8-2DO'@U6WMKSP\$
MGLXGG53)<##M\I//R */=V':O06-S]DRJ1?:-GW2QV;OKC./PJEH%A=:;I"6
MUXT,MUN=Y9(R=LKLQ8MR.,DGCG% %*;Q?91>"!XJ5#) UNLJQJ>2S$ )GL=Q
M"UCZNNJCQQX/.H26CJTMR<01LI1O(;(R6.X>_'3ISPEGX"O/^$6U?PS>W4"Z
M?>S/-:>1NW6F7#JO.-RA@#V[^O$UQI&OM=Z+JFM:MI, T>1VDE",!+O3R\G)
M !.>GKZ]* '/XJU5++Q9,8;-)="8F)0K,LBB+S,,<CD],CI[U;E\1WL>H>&(
MQ' 8=:1O-&UMT;"(R94YQCM@BJ.F:2=6G\;VKL8X=1N#;K*!GK;JI(]<9_2E
M@\+>(9)_#TUYJ&GAM%9AMBA<B1?+V9.2.2/H![]@"QIGBJXU;5Y;*">RBGMK
MQX;C3Y8V6X6)20)%);#9 5N%QANO'.?8:IKT-WXPNS<VMT=.E_=Q/"R#"Q!@
M 0QP.3V.3SD5H7/A:\U._P!/N=1^Q^?IU[]HCOH=PG:,,2(B,="" 3D@X/'-
M$GAC4X[KQ$;6[M3;ZTI95D1@\;F,1G)'&!C/3)Z<=: *@\4^(8[;PW?26VG/
M;ZV(HC$N]7CD>(N&W9(VY!R,$@=S5JV\57MA<^(;?75MG_L:W2Z$MHC*)(V5
MCC:Q/S KCKSGM39/#&JMI/AJR66TW:'+#([%FQ-Y<90 ?+\N0<]\>]32^%9[
MW7-=N+UX#8ZQ9K:,B,?,0*&&[.,9.X_3CK0 R'7M>.IV$?V!;FVO$82E+.:+
M[(^W*[G;AU)XR /7':LM/&GB+_A%X?$4MKIHMH[TP7,*[R[+Y_E90YP"..N<
M\].E:^@Z1XJL(X;/4]7L[JSLUQ"T43)-/@842-D@#IG )..3USGGP9JY\"R^
M'#<V7F/=^>)_FP!YWG8VX]>.O2@"W#<ZK)\3[NT:]A-I#IT<B1& \!I"",[O
MO?*/FQZ<4[PUXJN/$4L#PSV7!=;VQ,;)<6A . <MSR "=H]O:V-#U!?&"Z['
M<VZ1S626US"49B"K%LH>.NXCD54M?"UY-K.DZMJ?V-;[3D99;NUW![O*;<."
M!@<YZMR.,4 ;6MW=[96*R6$$4CF5%D>9PJ01D_-(W(R%&3@$9KFQXRU#^SO%
M#QK97,VAH)8YE5TCF0Q>8/ER3G@C@X/6MGQ5HMYK5C:)87,4,UI>1W06=2T4
MVS/R.!SC)!^H%9$_A'69F\2LU_9.=>MDB8")E\MA&8\CD\ 'IU/J* )+7Q)K
M::OH$=_#8_8];B;:(0_F0N(_,Y)."#@\8X]3U-#Q)K%_K_@+Q!?V!M4T]([B
M!%D1F>9$RKN&# +R#@8/0>O&G)X<U62?PU+YEF#H@/F#<W[W,?E\<<<<]^>/
M>J+>"]:M=&UG0-/O[(Z5J'G-!YZ/YMN9,Y3C@KD\'J,]#0!UFC?\@.P_Z]H_
M_017)>/_ +%KOG:#-JMO8M;6QNE,EPL1:<Y$(Y(X&&)^JUU^G6UQ9:3;VLLD
M<TT$*H652BL0,=,DC]:JZ#87MC%=-J#027%S<M,\D).&SPHP1QM4*OX4 4/#
MWBAM8\!QZ]'";BY2U=I8$^\TR [E'U(X^HJ#1_%-QJFGRZG9SV6IVT=D\K16
ML;),DPP1&REB>><<#I3-,\-:UI5WX@-I=VD-OJSO/ B[B;:9EQOZ8.3@D<=*
M>/"UXVL7.M1_8].U&6PDMM]IN*S2-@B1\@?=(X')YZ\"@!-(\7_;M.EUC[=8
MW>G6]D\]R+>-DE@D4 [&5F)Z;NPZ46WB'7)+_2V^P?:+.^XG$=G,C6>1E6+M
M\KKG@D!?6E_X0X7VKSZCJ$-K;/<V$EG=+9$_Z5OQEFR!C !P.3SUX%.\/:)X
MGTU+?3]1UFTN-.L\")XH66XE5?NJYS@ <9P,G&">N0"/P/<ZK=W&OOJ%[%<+
M%JTT("PE""JH!CYB N!TQGOFJ_CQS%K_ (2D6)Y674CA$QN;Y#TR0/UK7T#0
MKW1=1U9FNH9;*^O)+M$$9$BNX7()SC V\<<YJ+Q)H.HZOJ^C7EK);1QZ7<_:
M"LI;,IQC' XXSSS0!C^%E/B'QUJ'BVV7[':);G3FMGXF>56R6D4?=(X &<XQ
MTJW?>*]5E@OKG1+07/V*Y:!;8V<SM<[&VOB1?E0YW8X/3GK@7)O#M[:>*?[>
MT::"'[5&$U"UESLG(^ZX(Z,.1G'([54@\-^(M)U:^.BZM9Q:9J,[7$D=Q SR
M6\C??,>" <GGYN!Z>H!;CU_4$\8VNE7D4,-G?V;7%JQC82EUQNC;YL9 .>E1
MOXENXK>Q#B%IM4N)!:-';R.%A4%A(44DME0#@8^\/0U9\2^&!KMC90Q74EO/
M93I)'<9)?;]V09ZY9"P^N*3Q-X<GU2"PFTF[2PU#2Y?,M)"FY,;=K(P_ND<<
M4 8NJ>+_ !#I?A[7;V3383)IC(T%S+!+#%<QMCD(QW!E/!&:OZMXBU;P_;I<
M:S]@M[:YO%B2XC221;6,H3F49&3N 7(('S9]J;K'AWQ!KWA2_P!.U"_LOME\
MJ1GR4=8(%4YRH))9CW)([>G.Q?6^JW$%IY8LF921=V\I8Q3*5(*@X..<'D'T
MH Q]6\1ZMIOAZWU%/[.N_-OHX1-$6\MXG<*KJ QYP?7@^M7GUF]U#Q#?Z-I3
MVT+Z;#&T\UQ&T@+R E5"AEXP,DY[CBL>3P)<Q>')-*L)+: 3:F+_ ,O+>5
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M'$25AB4EL!B 6)8Y)P.@';)V: "BBB@ HHHH **** "BBB@#(TW_ )&#6?\
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M+*%B$OI54$H#P V /8<5:NM.TBQV_:]7O+?=]WS=5E3/TR]6/"W_ "*6C_\
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M1_Y&+1_^V_\ Z * ->BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** ,KQ#_QY6W_7_:_^CDK5K*\0_P#'E;?]?]K_ .CD
MK5H \T.MZ=H'BOQS/J5I)<6[O9JR+#N0[H<88GY5!)ZL0*V/"\-SX%^')DUE
MA(UL'F$,3[]@9OEC5N_) ],FK&F^&;X>(/$5UJL%C-8:X(PT22LS*J(4P04
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M.#(\:#:K*(T^5CC#=3WR<<X !&?$NM>5XCL9[>S@U'2;=;B*2-F>)T968<$
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MT\6ZLTOAV>]T^UCL=<154QS,98Y&CW@D8QM.",9ST^E=#KH!\/ZB",@VDO\
MZ :YQO#6MG3O"MN%L/,T-XVFS</B0)&8_E_=]P<\].G/6NEUBWN;O2+NVM%B
M,T\+QKYKE5!((R2 3W]* /,H[&YU[X>>%;#1[&X_M*!H95O3"T:6RC.YO,(
M/T4G-=EJOBFYCN=2MM+@2:730 ZO%*_G2%0_EJ4&%X*\G/)Z<9J]X1TN]T3P
MQ8Z5?>09;2(1;X'+*P'?E1CZ5F7&B>)-,\37NI^'Y]/DM=3V-<V]\7'ER*H7
M>A4'.0!D'TH 2+Q;J][J]EI]KH\<#7NFF\47<K(T3!E4JZ[<C!)Z9SQTID?C
MEX_#?V_48(;2>+4FTZY?<S0PNK%3(3P=O'MR0,CK5M=#U=/%]EJ[2VMQ#!8/
M:RL\C)([,P8L%"D 97 &>A]JJZ;H&O:?97L+0Z7.MWJLUW+"\SE)(9=Q:,YC
MX()7L0<=J )->\0ZAI?@[4M7>SL+];=@8]LA$4\1"X<<-GECQGMU]=*ZUJ:3
M7DT+3UB^U?9?M4TLP)2)-VU1M!!))SW& ,^U<]/X$O%\(:YHNG?9;8:I/OAM
MC*YAM5^7(!VY.2I., #..W.K<Z%J</B>V\1V MFN&L_LEY:R2L$=<[E9'VGD
M'U'(]* *%[X[N[7PQK%\-.A_M'1;CR+JW:8[.2 '4XR00P(!QW_'1C\0:G!X
MKCTC4K"!(KNUDN+9H)2[C81E7! &<,.GTYZUG:KX+O[[PWKMM%):C4M<N%EE
M9W81Q!2NU00N6P%ZX&23TZ5?OM'UF[\4Z;K")91I:VLL,B_:'+!I-O*_)R 5
M[XS[4 +X:\2S^(TMKNV>SEM9D8SQQL?-M'[(X)Y/7)P.G .<UTM<E8>%KO\
MX273]>NK>RLKR")TO9+*1B+TLN!N!5> ?FYR<@#WKK: "BBB@ HHHH RO"W_
M "*6C_\ 7A!_Z+6M6LKPM_R*6C_]>$'_ *+6M6@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#(TW_ )&#6?\ >A_]%UKUD:;_ ,C!K/\
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M?SXKB&X\U3R!M/RC!^;W'!YK7H RO[ B_P"@AJ?_ (&R?XT?V!%_T$-3_P#
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M=V2Y4@[EQ@#@D8]3DZ_]DZA_T,>H?]^K?_XU1_9.H?\ 0QZA_P!^K?\ ^-4
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MCZ#Z<XKNT8O&&:,H2.5;&1['&169_9.H?]#'J'_?JW_^-4?V3J'_ $,>H?\
M?JW_ /C5 &3X=TJ_\'0W&E06,FH:9YSRV;021AXE8Y,;!V4<'.""<YY JSHN
MA7"^([_Q+J2K'=W<:V\$"MN\B%><$]V)Y..!T!/6KO\ 9.H?]#'J'_?JW_\
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M9+>)6W(QQN7+#(&/\,T[4_&-EI=O/>26MS+86LWDW%W'L*QMNVGC=N(5C@D
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M(S<(-CG^%P0RD^V0,^U5M(UO4TL8K75M#ODU")0DAA57BE(XW*^< 'K\V,4
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M3.=I!)R,X/7UK.3PPJ:-/!K&D2W46K:O/?2QPG,ECN!V,"ISN&U<[<\L>HH
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M!'?)/7FNCT"]OI;G[)-X;O[87&Z2[O;QHAYC8QT5F]@!T 'M6./#VJ1>!)?
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,KQ#_ ,>5M_U_VO\
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MXT]E>2W21O)N(]P#*R9QT.<@9H [FBN=G\71K#)+;:?<W(@L$OIMN%"QL"0
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M]CC%;U% ')W=I?>)=1T*XGTR>P73)S=7 E*9,@0@1I@G=R<YZ8'O4W@>RO\
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M44 %%%% !61J/_(Q:/\ ]M__ $ 5KUD:C_R,6C_]M_\ T 4 :]%%% !1110
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M4\0ZYIBZ)K*ZG8WLEC9CRKGRA]\%0QVE6R.&&2<8S0!>_LS5/^@_/_X#Q?\
MQ-']F:I_T'Y__ >+_P")ITNL6UH+.VAAFN)[F+?#;18+[% RQ+$  9 R3U(Z
MUA7WCK=::9/IFG7,GVO4Q8S+($5H7!.Y""W+$*0"#CWZ4 ;?]F:I_P!!^?\
M\!XO_B:/[,U3_H/S_P#@/%_\36C@3VX$D;)O7YD8C*Y[$@]?H:X_X9[Y=,U2
M::>>>1-4N(5::9I"J*0 HW$X H W_P"S-4_Z#\__ (#Q?_$T?V9JG_0?G_\
M >+_ .)J74=9@TZ[M+,Q33W5Z7$$,0&6"#+'+$  #'4]Q7(^+M:M-8\+6&J6
MQN8A!K$$4D;95D99@KJRJ2&/'O[4 =3_ &9JG_0?G_\  >+_ .)H_LS5/^@_
M/_X#Q?\ Q-5M-\76.H:O-I4MK>Z?=Q1><J7L0C\V/."ZG)R![X/MUIO_  F.
MGK%:74EO=1:?>2"."^=%\IB3A2?FW*&[$J!T]10!;_LS5/\ H/S_ /@/%_\
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MM% &5_9FJ?\ 0?G_ / >+_XFC^S-4_Z#\_\ X#Q?_$UJT4 97]F:I_T'Y_\
MP'B_^)H_LS5/^@_/_P" \7_Q-:M% &5_9FJ?]!^?_P !XO\ XFC^S-4_Z#\_
M_@/%_P#$UJT4 97]F:I_T'Y__ >+_P")H_LS5/\ H/S_ /@/%_\ $UJT4 <Q
MX<T_47\,:4\>MSQ(UE"5001':-@P,E<G%:7]F:I_T'Y__ >+_P")H\+?\BEH
M_P#UX0?^BUK"^*!DA\*"X@GG@F6Z@420RM&V&< C*D=0: -W^S-4_P"@_/\
M^ \7_P 31_9FJ?\ 0?G_ / >+_XFB/6;6'7?^$?6WG%PEH;I"<%7C#!>#NSG
M)[XK/D\=:7%HYU1[>\6%;PV;KY0+)('V'.#C&>^: -#^S-4_Z#\__@/%_P#$
MT?V9JG_0?G_\!XO_ (FH].\2VVHZS<:0;2\M+J&(3JMS$$\V,G&]<$\9XYP?
M:K.KZ7_:\*6LMU/#;;LS+!(8WE'9=PY [G&"<#MG(!%_9FJ?]!^?_P !XO\
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M RO[,U3_ *#\_P#X#Q?_ !-']F:I_P!!^?\ \!XO_B:U:* ,K^S-4_Z#\_\
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MQK6O:K'96<<6@:HS7<>^X-HJL]NI_AR6 W]N.G7GBM3R?$7_ #_:9_X!R?\
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M)_\ ':/)\1?\_P!IG_@')_\ ': -6BLKR?$7_/\ :9_X!R?_ !VCR?$7_/\
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MEW#WXJ?Q)I=W_P *YU#3XH7N;^Z@?<L*EM\SG+8]!DGKT&*UO)\1?\_VF?\
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MT>3XB_Y_M,_\ Y/_ ([0!JT5E>3XB_Y_M,_\ Y/_ ([1Y/B+_G^TS_P#D_\
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MBK'D^(O^?[3/_ .3_P".T 9&JI>:?\0;/64TVZO;6739+,FV4,8Y#(KC=DC
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!12!@20""0<'VIDLT5O&9)I4C0=6=@!^9H DHIJ2)( 4=6! (*G/![TH8$D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ9*MH UQ:WD1,-PV"2,+T&XEAP>0/2NGU"P348HHI798TFCF*C^/8P8 ^VX
M_A3+ZRNKJ>&2WU2XLUCW!TB2-A(#CKN4X(QQCU[T 8^DZQ96?@<:A;:8FG)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
A10 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>69
<FILENAME>ebs20191231exhibit1048030.jpg
<TEXT>
begin 644 ebs20191231exhibit1048030.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR.E.HH **** "D  & ,"EHH 3 SG S1@9!P,CO2T4 )@9S@4M%% !1110 A
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%<[XG5IK_2[?[1<Q1R-*7%O</"6PO&2A!- '145R#Z5
M;1H7>^U-549+-JMR !_W\JI_Q)?^@]<_^#N?_P".4 =U17'0Z=9W$8D@U'49
M4/1DU>X8?F)*<-*MV+!;[4R5.& U6YX.,\_O/0B@#KZ*XF:#2[:0QSZS>Q..
MJOK,ZG\C)3X+*PN@3;ZI?S =?+UBX;'Y24 =G17'R:9:PQF26_U*-%Y+-JUR
M /Q\RJRC1F.%UVZ)/8:W/_\ '* .YHKC9K"RMXO-GU+48H_[SZO<*/S,E5_^
M)+_T'KG_ ,'<_P#\<H [JBN)EM]+M]OG:Q>Q[QN7?K-P-P]1F2FHFCR.$CUN
M[=F. JZU.2?_ ")0!W%%<+_Q)1_S'KG_ ,'<_P#\<J00:6T#3KK%Z8E.TR#6
M;C:#Z9\R@#MJ*X=$TB1@D>MW;L>@76IR3_Y$J6>QL+50UQJ>H0J3@&35[A0?
MSDH [.BN%_XDI_YCUS_X.Y__ (Y4LEMID4X@DU>^24D 1MK-P&YZ<>90!VM%
M<7<6>GVNW[3JM_#N^[YFL7"Y^F9*?+IUG!"9I=1U&.-1DN^K7 4#Z^90!V-%
M<1;PZ5>(7M=9O)U!"EHM:G8 G@#B2FG^Q02#KMT".H.MS_\ QR@#N:*XRWLK
M"[!:VU2_F"\$QZQ<-C\I*E_L>'_G\U3_ ,&MS_\ '* .NHKA/L _M[[+]NU3
MR?LOF;?[3N/O;L9SOSTJU+IMI;Q&6;4-2CC7J[ZM<@#\3)0!V-%<+_Q)?^@]
M<_\ @[G_ /CE.,>D+&LC:W=A'SM8ZU/@X]#YE '<45Q#1Z2L:R-K5V$?(5CK
M4^&QUP?,]Q3/^)+_ -!ZY_\ !W/_ /'* .ZHKB)(M)A?RY=:O(W'\+:U.#_Z
M,JP-+MC'Y@O]3*$9W?VM<XQZY\R@#KZ*X7_B2_\ 0>N?_!W/_P#'*L06%E=1
M^9;ZEJ$R9QNCU>X89^HDH [*BN1_L>'_ )_-4_\ !K<__'*/['A_Y_-4_P#!
MK<__ !R@#KJ*Y'^QX?\ G\U3_P &MS_\<H_L>'_G\U3_ ,&MS_\ '* .NHKD
M?['A_P"?S5/_  :W/_QRC^QX?^?S5/\ P:W/_P <H ZZBN1_L>'_ )_-4_\
M!K<__'*/['A_Y_-4_P#!K<__ !R@#KJ*Y'^QX?\ G\U3_P &MS_\<H_L>'_G
M\U3_ ,&MS_\ '* .NHKD?['A_P"?S5/_  :W/_QRC^QX?^?S5/\ P:W/_P <
MH ZZBN1_L>'_ )_-4_\ !K<__'*/['A_Y_-4_P#!K<__ !R@#KJ*Y'^QX?\
MG\U3_P &MS_\<H_L>'_G\U3_ ,&MS_\ '* .NHKD?['A_P"?S5/_  :W/_QR
MC^QX?^?S5/\ P:W/_P <H ZZBN1_L>'_ )_-4_\ !K<__'*/['A_Y_-4_P#!
MK<__ !R@#KJ*Y'^QX?\ G\U3_P &MS_\<H_L>'_G\U3_ ,&MS_\ '* .NHKD
M?['A_P"?S5/_  :W/_QRC^QX?^?S5/\ P:W/_P <H ZZBN1_L>'_ )_-4_\
M!K<__'*/['A_Y_-4_P#!K<__ !R@#KJ*Y'^QX?\ G\U3_P &MS_\<H_L>'_G
M\U3_ ,&MS_\ '* .NHKD?['A_P"?S5/_  :W/_QRC^QX?^?S5/\ P:W/_P <
MH ZZBN1_L>'_ )_-4_\ !K<__'*/['A_Y_-4_P#!K<__ !R@#KJ*Y'^QX?\
MG\U3_P &MS_\<H_L>'_G\U3_ ,&MS_\ '* .NHKD?['A_P"?S5/_  :W/_QR
MC^QX?^?S5/\ P:W/_P <H ZZBN1_L>'_ )_-4_\ !K<__'*/['A_Y_-4_P#!
MK<__ !R@#KJ*Y'^QX?\ G\U3_P &MS_\<H_L>'_G\U3_ ,&MS_\ '* .NHKD
M?['A_P"?S5/_  :W/_QRC^QX?^?S5/\ P:W/_P <H ZZBN1_L>'_ )_-4_\
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M444 %%%% !1110 4444 %%%% !7/^(?^0QI'UF_] %=!7/\ B'_D,:1]9O\
MT 4 +7CWA+5+?1KOQA<26+W)%RHC58"Z*=\H&X]%7D=:]@<L$)5=S8X&<9KB
M_!WA+4M%U'6Y-32UDM]6?<5BE9BHRY((*C.=] '2Q6]CX=TRX:&,16R,\YC1
M>!GDA1[GH/>N)\*ZGJ.D?$/4]%UIQYFIXNHB#\H?;G:OMMRO_ !78:U9WNH3
M6ENEO!+8"4/="24JS@ [0  <_-M;J.F*YSQ;X(NK[4--U#PY':VEW92;S)(Y
M4-R"!@ YP1^IH H_%78NL>%G9<XNVSA<DC='V')^E1>9%XA^*%E>>&1LBL$
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6WH_A+5=!\<WFJ:>EHFDW@VR6_G-N'0[@-N,[L\9Z$U/\0_#&J>*K&TM-/\
MLR""7S6>>0KG@C  4^M &Y>Z591"\OXH$CF>T>)RJ@!UZC/KCG\Z\Y^&E[;+
MX?@TR?3S<?;]3>-GD@W1A?*!(+'C/R]*]/NENI]+E188Q<21LNPR?*"1C[V.
MGX5R7@[PWKOA;0Y+"6ST^[D^TFXC?[6R@$J!_P \SZ?K0!V&G6,6FZ?;V,&?
M*MXQ&F?0<"K%4M'BOX=-C75'C>\9G:4Q$E 2Q("YYP 0/PJ[0 4444 %%%%
M!1110 4444 %%%% ">'?^0MK'_72+_T6*Z"N?\._\A;6/^ND7_HL5T% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[_+_ /$T?\(Q%_T%-1_[_+_\36W10!B?\(Q%_P!!34?^_P O_P 31_PC$?\
MT%-1_P"_J_\ Q-;=% '(_P#".Q_\)3Y/]HW^/L6[=YB[OOXQG;TK3_X1B/\
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MP6<^B31?:H'E@D$F]5*@'9*0,1MR/[P]Z %_X1B+_H*:C_W^7_XFC_A&(O\
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MB.Z4@MS&.X K?K(TW_D8-9_WH?\ T76O0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !61J/_(Q:/\
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M3&PST'<UB^%/!PT'Q)K-^5G$4TJ"T+W;R;DV*&+ L<G<#RW/IQ7844 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M /0SZI_W[M?_ (S6O10!D?V-?_\ 0SZI_P!^[7_XS1_8U_\ ]#/JG_?NU_\
MC-:]% '*_P!DWO\ PE7E_P#"1:EN^PY\SR[;=C?T_P!5C'X9]ZT_[&O_ /H9
M]4_[]VO_ ,9H_P"9P_[A_P#[4JSK,$5QHUY',@=3"YP1WP<'ZT 5O[&O_P#H
M9]4_[]VO_P 9H.BWY&/^$GU7G_IG:_\ QFO+X;I(/A[H%UH-X[>*))(]D4$Y
M=YLL=PD3/*XZEAQQ7H=SXP$.LWFDP:+J-W=6:QNXA5"&1R1N!+=!CZ^W!P -
MTKP4-$%P-/\ $.L1"YF::4,T$FYVZM\T1P3[5?\ ['O@0/\ A)]4Y_Z9VO\
M\9JM=^+8(+:]O8;&YNK'3Y&CN;B';A2OWRJDY8+WQZ'&<5BZK>0#XA:!J=C!
M)>_:M-N&C%O@F8?(5P20 ,'J2!0!J:QX,&NV7V34_$.K2VX8/L!@C&0<@G;$
M.A&:NIHE[&BQCQ1JN ,#<EL2?Q,.365J'BG2M1\$:G?ZAI-W+;6SR6U]9';Y
MB,IPP)#8(Y'(/>J6KSI8_$/1+RVL)[B232YPL$ !9^4P.2 ,#N2!0!TAT>_
MR?$^J ?]<[7_ .,T?V-?_P#0SZI_W[M?_C-8UUXOTG5/".KW-_I5XT=ENAU#
M3W51*G'.?F QCG(-37_B.[LM?\/Z78Z:[6M]#)+\KH"0B#Y1D\8W*2?;C/-
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M0[ 'I]FC_P#017GVFS^'[#Q-XN76$0PVUPC0HT;,$7R\L% ''/:@#M_[&O\
M_H9]4_[]VO\ \9H_L:__ .AGU3_OW:__ !FJUK=6^A1V.BZ?:W-S)<)+<0QE
MN$3=N(9V/8N%'4]/K3[3Q=87NBV.I013LVH2F&"V( E:12P9>N!C8Q)SC H
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MY#_X C_XJC[!KO\ T'(?_ $?_%4 :]%9'V#7?^@Y#_X C_XJC[!KO_0<A_\
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MZ=,TZQ\/WVD>(O#,4=I+<6>EZ9):S72E=N]@G8G./E/;N*Z#[!KO_0<A_P#
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MFFOD5@[L06(W';N(X+;=N??/6M>LC[!KO_0<A_\  $?_ !5'V#7?^@Y#_P"
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MV-R+IS=%-Y=58!5"L>[9)..!CG/'25D?8-=_Z#D/_@"/_BJ/L&N_]!R'_P
M1_\ %4 :]%9'V#7?^@Y#_P" (_\ BJ/L&N_]!R'_ , 1_P#%4 :]%9'V#7?^
M@Y#_ . (_P#BJ/L&N_\ 0<A_\ 1_\50!KT5D?8-=_P"@Y#_X C_XJC[!KO\
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M&:))X<\(:;I,Q!EMXOWF#D!V)9@/Q8T ;E%%% !1110 4444 %%%% !1110
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M,7=OJ:/'!;VSB$PK,A$@(&)68#)^\<]@!FNCA:XM_B3->2:?>?9[[3(4CD6
ME5978LK$<*0"#@GZ9/% $MKXHT#3-"U/6%N;^2SAOI5G:6.5V27(W*%(RJ@D
M  X K2M/$^FWNM-I,9G2X\HS1F6!D29 <%D8C# 9'3ZCBN$N[>]E^'WC&U33
M-1-Q>:K<26\7V*7=*KR*58#;R, G/:NCU"9KCX@>';N*SO3;K:W"O+]CE"QE
M]FT,2OR_=/7IWH TKGQAI%K$UQ(TYM%N#;&ZCA9T\W.-HVY8\\9 QGC.:T[A
M7OM+E6VEDMWN("(Y"I5HRR\'!P01GH>:\SBN+!-.NM$OHM6M])75))]BZ7))
M\JS%L"9<@J6&>!D D9[UZE!/%<V\=Q XDBE0.CKT92,@C\* .&U2QDLO''AO
M28M5U4VM[%<FX#7\N9"B J<[N.3VQ6X^I6/A$16>HW][.+VY(M6E629AD9V;
M\'/(.!U/'6LWQ 9C\2O#-PEG>R6]K'=+/-':2.D9= %RP7')'X=ZF\:^8=2\
M-O':7<ZV^IK-*8+:241IL<9.T'')% &A'XOTZ:*,PP7KS20/<&V^SLLJ1JVT
MLRMC'(P!U/8&LWQ9XI5/"-MJ&D23/'J$D*QW$2'A'=0W/56() [Y]Q3M:NKS
M_A+5LY;"^-C)8_NIK*%LS2[C^[>4<H ,$ E1R<GM7-+%>I\)M%T]]*U(74%U
M 'A%G(S@)*&8X ) QW/7M0!IZI,ND:UIEI:MJXM-8N]UQ;N7;:$C<[4S\PW$
M*6&>WH3G6\/Q:38>(KO3[;4-5FNTMQ(T%[)(4AB9B0%W#GDD9Y..,\5#XGE>
M3Q/X6GBL[V6*"YEDE>.SE81JT3*"V%XY(ZU#=6MS?>/]62."ZBCNM#%K'=-;
MR",2;G.-^,9 8'K0!MKXLTI[FTAWRK'?N8[6X,9$4SCLK>^#@]#V)K$\,:LN
MFV_B*2^N+J=(M>DMX0S/-)@K&%11R3UZ"CPCK%T=*TW0;SP_>PZAIR)#*TUN
M1 @0;?,63H<J.,<Y/IS7/VD.K:5J^J>)+73]1G$.LS%[![.3,]O*(U\R(%?O
M@J>G4 @\=0#N;S4--/B71[:XDO8;Z1)FMX0'6-QM^;?CY6( X&203[U6F\?:
M%##>39O7CL9C#<E+.0^20!EF&/E49ZGK@XSBJFK3/>>-O"E[!9WS6\:W1ED-
MG*!%OC 7?E?ER0>M9*I<GP]X]@_L_4/-O;BX:V0V4N9@T2HI7Y><L#_.@#MK
MG6;2WFM;=2UQ<7:L\$,(!9U !+<D  9')(ZBFZ-K^GZ]%+)8-,RPMLD\RW>/
M:P)!7+  D$$'&<5QE[=G3KKPMJ,=IJ*7,6G/%*5L))L( @*O$-KCYL$-TX[Y
MXW_ \NEFQO(;&:X>X:Y>YO!<V[0/YDI+9V,.%."!UZ=2<T 7+F]TT>+K*SDG
MNUU 6\K1Q+O$+IQN)_A8C QU(S5.7Q_H4-O=7!-XT5G<&"Y9;.0^21C)?CY1
MSW]#CI46JB4_$C1)EM+IX8K2X22=+=VC1GV;07 P/NGO6%LN7\)>.;8:=J'G
M7E[=/;1FRES,KHJJ5^7G)!H ]&5ED0,K!E89!!ZBO/+))I]3\8K/KNHVL6F2
MK]FE-XY6 &/<3AB01GUS7;Z,^_1+)C'+&1 @*2QLC*0,$%2 17(^&]-MKWQA
MXGEU'19'2XNHWMI;S3V"NJI@E6=<=10!H>$?%%S?^#=)OM6B=M1O8WVPPQ_/
M,%8C>!T (P<\#YAZBK;^.-"CTZ._DN)5B:Z^QL# ^Z*;."C\?(1GOCVS6;XM
MCFTWQ)I>M-I4^I:;';RVEQ%;1F1X-S*RN$')'RX..@K/U^&*30+6?3?#UW:Q
MRZQ;W)BBLG,KJK O(Z*"5Z'KR<>^* .IM_%%E=A5@M[UIV,F+=[9HY-J$!FV
MMCCYE^N>.:F/B"Q^R64Z^:[7X_T: 1GS9.,GY3TP.N< =ZQ?%=E:ZI?V+,^I
MZ?=Q0O)::G:1.?*)(S&X Z'@[6QG!''?+MQKUMJ'AGQ%K-G))LM9K6]$$)+0
MEVRDAC R,A1NP/ES0!TS>+]'CTJ]U&629$T]BEW$8',D+=<,H&0/?I[TZS\6
M:7>ZK#IL9N$FN8C+;O+ R1SJ,%MC$8; /:N3UK3;JYM_&FKV]I=-'J=G';6L
M26[F2=E0@MLQNQDX!([$],&K]U))+XB\%W"6-^8H(YQ,_P!BEQ#NB"C?\ORY
M;CGZ]* .CA\06=Q<V\44<[1W,KPPSB/]V[H&+#/;[C<D8..,UJ5Y]IEG=6.N
MV-SH']H06]W=M_:&E7<#^5 "&+2QLP&WGI@_-N_"O0: "BBB@ HHHH ****
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MG_>A_P#1=:] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>_\ $M[;W-U%S(J0[0Y8JN!Y?KCBN@E\1:9IUQ'IVH:A$+\0>8\:@DD# )
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M_?TO_OB3_&M>B@#(QXD_OZ7_ -\2?XT8\2?W]+_[XD_QK7HH R,>)/[^E_\
M?$G^-&/$G]_2_P#OB3_&M>B@#(QXD_OZ7_WQ)_C1CQ)_?TO_ +XD_P :UZ*
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M^,4 :M%97VCQ%_T"],_\&,G_ ,8H^T>(O^@7IG_@QD_^,4 :M%97VCQ%_P!
MO3/_  8R?_&*/M'B+_H%Z9_X,9/_ (Q0!JT5E?:/$7_0+TS_ ,&,G_QBC[1X
MB_Z!>F?^#&3_ .,4 :M%97VCQ%_T"],_\&,G_P 8H^T>(O\ H%Z9_P"#&3_X
MQ0!JT5E?:/$7_0+TS_P8R?\ QBC[1XB_Z!>F?^#&3_XQ0!JT5E?:/$7_ $"]
M,_\ !C)_\8H^T>(O^@7IG_@QD_\ C% #?^9P_P"X?_[4JWJ\\5MI%W-,X5%A
M?)/T/ ]ZP_/UW_A*L_V=I_F_8?N_;WV[=_7/D]<]L?C6G]H\1?\ 0+TS_P &
M,G_QB@#B/!L/A.+P)I?]JV]E%?6Z"1V: "='5RP/3=G@?6M>6]CNOB+H-U)&
M82^F3$K)UC+E"JMZ-@'CZUT'VCQ%_P! O3/_  8R?_&*/M'B+_H%Z9_X,9/_
M (Q0!P\<D!\&^/T!7?/?7C1+CF0-&H4J.X)S@CK5N&_LH/%_A:YN9HDC_L21
M1*YPJ-F,<D_=[CGN<=ZZW[1XB_Z!>F?^#&3_ .,5B7&D^+)_&%KKRQ:0L5M;
M/;_9C<RDL&()._R^N5':@#G]4LS'X6\=7\"%;/5)O]#0+_KF"*&=1W#-G![X
MSTK7>Z&F^.-,UF[D TFZT?[)'<D_NX9MX<ACT7< !D]QBND^T>(O^@7IG_@Q
MD_\ C%'VCQ%_T"],_P#!C)_\8H Y_1M!BU:;Q:9T/]DZS.%@&.'Q&%>5?JW(
M/?;GTJ7P6=2NE:?6UVS:.CZ<LC'B5E;YY?HRK'SZAO6KFL)XSO;(1:8-,TV<
M2*QF^U--E1U7:T..?6IM.AU[3;&.UCTW3Y-F2TCZD^Z1B268_N.I))/UH X6
M9XG^#FL0*,RO?2D1!?F;-SN4A>I^7GZ"NFU6X@D^(WA]X)DVFRN4\Q3E06V;
M!GIS@X]<5N_:/$7_ $"],_\ !C)_\8H^T>(O^@7IG_@QD_\ C% '"^')M'N-
M(L_#6M:?J$NMV,BHUD[W&QG5OEE!!V!?XMWUZ\9NQ3VWG?$#+)F893/_ "T'
MV<+Q_>^;(X[GWKK?M'B+_H%Z9_X,9/\ XQ1]H\1?] O3/_!C)_\ &* .,M[E
M+?\ X5Y?R+(8+>SD@F9(V?9(;=%"D $@Y!&/45WVHW$5KIMQ/,X1$C8DGZ?S
MJI]H\1?] O3/_!C)_P#&*/M'B+_H%Z9_X,9/_C% '#>";?PHG@'35U>WLHKZ
M%2\C/ !.C+(2#TW9X&*V-5OTNO&?@R[9&A5ENI&5^L8>(!-W]TGI@]^.:Z'[
M1XB_Z!>F?^#&3_XQ1]H\1?\ 0+TS_P &,G_QB@#F+1;:\U[Q]#*TA@N8HE_<
MC+NHM]K[/4@Y''>LSP_K>BZE-X6BOM:MXIM*C"0Q^5)&T\C1B-0Q90%X[ G)
MZ''%=;K-KXAUC1[K3FL[&W%S&8S+%J3AES]8/\BL^#3?',R+;ZQ-HU[;*5)C
MBD>%I,$$!CY;#&0.@% %2+_2/$'CZ*$&1Y[6%8E49,A$#*0OK@\''>J@2#7/
M!_A32=/*R:A:2V;RJH^:S\H#S&<?P'@C!QDGBNS^T>(O^@7IG_@QD_\ C%'V
MCQ%_T"],_P#!C)_\8H Q-#N8(OB%XMDDE5$,=H0[' .U&#8/?&1GTKEK>14^
M$&@0MD2QZA"7C(.Y<7&XY'48'/TKT3[1XB_Z!>F?^#&3_P",4?:/$7_0+TS_
M ,&,G_QB@#$N9UM?BK:W,BR&&[T8P0R)&S*[^<&QD#TY^E59=,N[+QA<Z%!$
M6TG76%_(1TB*$>>N/1_W8_X&U=(UQXC*D#3-,!(X/]HR<?\ D"LG1-/\76#/
M<ZJ=/U6^=1'YYNVA"H"2%"+!@<GD]^/04 =97#^,;+4].\3Z9K^AQ;[B[5M,
MN1C@!\F.0^RMR?;BNC^T>(O^@7IG_@QD_P#C%'VCQ%_T"],_\&,G_P 8H S?
M%>D7$?P^N=,TB)Y9(((Q%$"=TBHRDKD<DLJD>Y-4M$U3PQK>I6VJ64%Z]U9Q
MOYLUV\X^QJ1\RL7.TDG P,]SVK?^T>(O^@7IG_@QD_\ C%'VCQ%_T"],_P#!
MC)_\8H Y3PA)#%\&C&V$>*SN$D0C#*Q+X!'7)R/KD55U&>-?A?X5C+?/'+8;
MT RR["N_(ZC;@Y]*[7[1XB_Z!>F?^#&3_P",4?:/$7_0+TS_ ,&,G_QB@#$U
MNXAD^(OA5TD5E6&\W.IR!O5 F3[D''K65X>U:SLM.NO">NZ?)<ZI'>3,MM);
M-(MYNE,B2 X*XR1R>F,UV'VCQ%_T"],_\&,G_P 8H^T>(O\ H%Z9_P"#&3_X
MQ0!Q7BN_%R?%^F_9Y;6<6G[N.WMB7OAY7WV<*<J/NX!&,<DYQ5M+Q(O$OA+4
M'CG^SR:7+ K^0_,A\O"XQD9P<9ZUU7VCQ%_T"],_\&,G_P 8H^T>(O\ H%Z9
M_P"#&3_XQ0!Q=_;7.K3?$.RTQLW-TD'D!3CS<0JK!3WY!7ZFK>HW,'BG3_#,
M.E<7MOJ%O/-$!A[-4!\S>.J_W<'J2,9KJ?M'B+_H%Z9_X,9/_C%'VCQ%_P!
MO3/_  8R?_&* .-2:W-C\0UW+NG:7RQWD!@"C;_>^;(X[UV/A219/"6DE6W$
M642M[,$ (/N""*7[1XB_Z!>F?^#&3_XQ1]H\1?\ 0+TS_P &,G_QB@#5HK*^
MT>(O^@7IG_@QD_\ C%'VCQ%_T"],_P#!C)_\8H U:*ROM'B+_H%Z9_X,9/\
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M:RK-9+!CEE,N1+_N;#NW=.".M=Q]H\1?] O3/_!C)_\ &*/M'B+_ *!>F?\
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M[D#O0!<\1+XL$5Y?Z7J-I916B%XK66V\S[0%&27?/RYY  '3J>>-C0=2;6-
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M.%/E2;=I\S;G/1ONY&2,9&>':'<:_!XHOM)U.[CU&UCMH[B.Z2 1&-F8CRV
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MVKF+9M.;Q1X_\PVQ/D0@[BOW?L_S?AG&?>L^PO[:#3_AO?7-U&EO"DD<DSN
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MUQ6CH>I6K_$V]<ZK#=_:-)B*RQ[5C<J[YV8ZJ/7)QR": -WP'J=[K'@VQO\
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M4I!#'$I.<(H4?I4E% !1110 4444 %%%% !1110 4444 %%%% !1110!D?\
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MM35?^A=N?_ B'_XJC^U-5_Z%VY_\"(?_ (J@#7HK(_M35?\ H7;G_P "(?\
MXJC^U-5_Z%VY_P# B'_XJ@#7HK(_M35?^A=N?_ B'_XJC^U-5_Z%VY_\"(?_
M (J@#7HK(_M35?\ H7;G_P "(?\ XJC^U-5_Z%VY_P# B'_XJ@#7HK(_M35?
M^A=N?_ B'_XJC^U-5_Z%VY_\"(?_ (J@#7HK(_M35?\ H7;G_P "(?\ XJC^
MU-5_Z%VY_P# B'_XJ@#7HK(_M35?^A=N?_ B'_XJC^U-5_Z%VY_\"(?_ (J@
M#7HK(_M35?\ H7;G_P "(?\ XJC^U-5_Z%VY_P# B'_XJ@#7HK(_M35?^A=N
M?_ B'_XJC^U-5_Z%VY_\"(?_ (J@#7HK(_M35?\ H7;G_P "(?\ XJC^U-5_
MZ%VY_P# B'_XJ@ _YG#_ +A__M2K6L:BFDZ1=:A(A=+:,R,H&20.N*PO[2U'
M_A*=_P#85QYGV+'E^?%TW]<[JTSJ>J$8/AVX(_Z^(?\ XJ@#A]9TW2-/U&RU
M[P-J$<.I7-U&CV%I(#'=H6^<-&/NX&23P!@]#S3O%FJV<P\9Z>I2QN4M06B5
M-TU]B+ASD'Y ..!QC)(KM!J&HK(9!X:G#MP6$\.3^.ZG?VGJF<_\(Y<9QC_C
MXA_^*H Y35-6T]KWP'+]MA"F8MEG"\>2RYY[9XS3)]2TBQ\3^(=,\3W<]K'J
M+K);/O=8[F Q*A0;>I!!&/>NN_M35?\ H7;G_P "(?\ XJD;4M38@MX;G)4Y
M&;B'C_QZ@#F5-EHOC3PT"DEG9G29;>V2<L6SN0K'SD[L=NO:GZM:7NE>+)[.
MPC?[)XI3:[IQ]GG7 D?VS%D^[**Z3^U-5_Z%VY_\"(?_ (JL;2QXGCU![[6-
M.DO)$WI:K$T,:Q(Q!.?G.6X49[ >YH ZV...WA6.-5CCC4*H' 4 5P/A'7M'
MMO$WBYKC5;*$/J"LADN%7< @!(R>>175?VIJO_0NW/\ X$0__%4?VIJO_0NW
M/_@1#_\ %4 <BXDU?Q3K'C Z=--I5AI#VEM&R%&OCR[%0>=O)4''.1BJNGZM
M97/B;P5=0W\4L)M;B(1V\>(;<F./;$IQDD8P023QG S7<?VIJO\ T+MS_P"!
M$/\ \50-3U08QX<N!C_IXA_^*H X:#5K'3O"'BBWNK5+R2#5YWFM9 V$5IQM
M=\<[1D-[@''?&GHFHVTWQ.F=-2%]]JT>/RYE0!)")7)V8&"H]<GT)KIO[3U3
MG_BG;CGK_I$/_P 50-3U0=/#EQQQ_P ?$/\ \50!KT5D?VIJO_0NW/\ X$0_
M_%4?VIJO_0NW/_@1#_\ %4 :]%9']J:K_P!"[<_^!$/_ ,51_:FJ_P#0NW/_
M ($0_P#Q5 &O161_:FJ_]"[<_P#@1#_\51_:FJ_]"[<_^!$/_P 50!KT5D?V
MIJO_ $+MS_X$0_\ Q5']J:K_ -"[<_\ @1#_ /%4 :]%9']J:K_T+MS_ .!$
M/_Q5']J:K_T+MS_X$0__ !5 &O161_:FJ_\ 0NW/_@1#_P#%4?VIJO\ T+MS
M_P"!$/\ \50!KT5D?VIJO_0NW/\ X$0__%4?VIJO_0NW/_@1#_\ %4 :]%9'
M]J:K_P!"[<_^!$/_ ,51_:FJ_P#0NW/_ ($0_P#Q5 &O161_:FJ_]"[<_P#@
M1#_\51_:FJ_]"[<_^!$/_P 50!KT5D?VIJO_ $+MS_X$0_\ Q5']J:K_ -"[
M<_\ @1#_ /%4 :]%9']J:K_T+MS_ .!$/_Q5']J:K_T+MS_X$0__ !5 &O16
M1_:FJ_\ 0NW/_@1#_P#%4?VIJO\ T+MS_P"!$/\ \50!KT5D?VIJO_0NW/\
MX$0__%4?VIJO_0NW/_@1#_\ %4 :]%9']J:K_P!"[<_^!$/_ ,51_:FJ_P#0
MNW/_ ($0_P#Q5 &O161_:FJ_]"[<_P#@1#_\51_:FJ_]"[<_^!$/_P 50!KT
M5D?VIJO_ $+MS_X$0_\ Q5']J:K_ -"[<_\ @1#_ /%4 :]%9']J:K_T+MS_
M .!$/_Q5']J:K_T+MS_X$0__ !5 &O161_:FJ_\ 0NW/_@1#_P#%4?VIJO\
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M[->R^#+W0=GF&^C\DPXXM-A\T<?P[0H/OBL:>\M+;PK\0K.>>*.X>_NV6%F
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K(U'_D8M'_[;_\
MH K7K"UN>2WUO2)(;66Z<&8>5$5#'Y!S\Q _6@#=HK*_M;4/^A<U#_O[;_\
MQVC^UM0_Z%S4/^_MO_\ ': -6BLK^UM0_P"A<U#_ +^V_P#\=H_M;4/^A<U#
M_O[;_P#QV@#5HK*_M;4/^A<U#_O[;_\ QVC^UM0_Z%S4/^_MO_\ ': -6BLK
M^UM0_P"A<U#_ +^V_P#\=H_M;4/^A<U#_O[;_P#QV@#5HK*_M;4/^A<U#_O[
M;_\ QVC^UM0_Z%S4/^_MO_\ ': -6BLK^UM0_P"A<U#_ +^V_P#\=H_M;4/^
MA<U#_O[;_P#QV@#5HK*_M;4/^A<U#_O[;_\ QVC^UM0_Z%S4/^_MO_\ ': -
M6BLK^UM0_P"A<U#_ +^V_P#\=H_M;4/^A<U#_O[;_P#QV@#5HK*_M;4/^A<U
M#_O[;_\ QVC^UM0_Z%S4/^_MO_\ ': -6BLK^UM0_P"A<U#_ +^V_P#\=H_M
M;4/^A<U#_O[;_P#QV@#5HK*_M;4/^A<U#_O[;_\ QVC^UM0_Z%S4/^_MO_\
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MY:VW?GYE '."UFTWQ7J?AB*)OL.O,+V-E'RQKTN5)[9P,>AD%7=1$$?Q5T4
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M+FH?]_;?_P".T :M%97]K:A_T+FH?]_;?_X[1_:VH?\ 0N:A_P!_;?\ ^.T
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MIUQ-:M&)8XV=?,4LIP,X(!%4O^9P_P"X?_[4J[J?&E79_P"F#_\ H)H XO\
MX3C6K3P/:>,+NUL9K*38UQ;PADDC5GV95B2&.2.,"NZ^T1"W%PSJD14-N8X
M'OGI7D-A:26W@;POK&HM+J6@0*/MUBWW8?F.V8!0-X4]5;=_AU_BS5($UKPR
MTM]'#I=TTQ^TD*T7F[%,1)/'(+X/K@T =<MS UO]H6:,PXSY@8;<>N>E4M3U
M_3=*TF34[BZB-O'@ JX.]CT4>I.17)2:#;1VEY;:)K\?VFXU**YC65%:V%P
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M#W$WDQHA&5R<$ECV '8Y(XR 5H_^$=AT^;3XO#4L=G.<RVZ:0RQN>.2H3!/
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M_B:Y_4?%GBRPLY;]O"4 M%8>7YFHA9&#,%3*;#ACD<9ZG%=FNXH-P ;'(!R
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MBG_I]CI.AVOSZC>:C$T"+]Y%7):3V '?WJ+[&/%U_P");"[N[:&ZM;HQ1&6
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MIIMUX:U*P:[W[))S'M 5<DG:Q/H/Q%7_  YI+:5:7+S[?ME_<O=W(0Y"N_\
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MX'N6Y^@]*M444 %%%% !1110 4444 %%%% &1IO_ ",&L_[T/_HNM>LC3?\
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M 2%Z[ P+_P#CH:E_X2'1_P#A*O._M"#R_L.W=N[[\XK2/B;0F!!U*W(/4$T
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MN-0GGGG77$MS*9G#,HED0$D$?-A1\W7WKJ;63PW#J)U676 ^I2VRP33B9@'
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M6*2Z8+,N-N,$X!"EL=/UK'TJZT-;BU.DWOB#3WB>,D7MZ?)5 1N4J68-E00
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MBLK_ (2?0_\ H)P?]]4?\)/H?_03@_[ZH U:*RO^$GT/_H)P?]]4?\)/H?\
MT$X/^^J -6BLK_A)]#_Z"<'_ 'U1_P )/H?_ $$X/^^J -6BLK_A)]#_ .@G
M!_WU1_PD^A_]!.#_ +ZH U:*RO\ A)]#_P"@G!_WU1_PD^A_]!.#_OJ@#5HK
M*_X2?0_^@G!_WU1_PD^A_P#03@_[ZH U:*RO^$GT/_H)P?\ ?5'_  D^A_\
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M^J -6BLK_A)]#_Z"<'_?5'_"3Z'_ -!.#_OJ@#5HK*_X2?0_^@G!_P!]4?\
M"3Z'_P!!.#_OJ@#5HK*_X2?0_P#H)P?]]4?\)/H?_03@_P"^J -6BLK_ (2?
M0_\ H)P?]]4?\)/H?_03@_[ZH U:*RO^$GT/_H)P?]]4?\)/H?\ T$X/^^J
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MHZK>Z9:JKW-B$,X,)4+NSMP2.>G:@";_ (2#1?\ H+V/_@2G^-'_  D&B_\
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M6_\ SPC_ .^!0!4_X2#1?^@O8_\ @2G^-'_"0:+_ -!>Q_\  E/\:M_9K?\
MYX1_]\"C[-;_ //"/_O@4 5/^$@T7_H+V/\ X$I_C1_PD&B_]!>Q_P# E/\
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M1?\ H+V/_@2G^-6_LUO_ ,\(_P#O@4?9K?\ YX1_]\"@"I_PD&B_]!>Q_P#
ME/\ &C_A(-%_Z"]C_P"!*?XU;^S6_P#SPC_[X%'V:W_YX1_]\"@"I_PD&B_]
M!>Q_\"4_QH_X2#1?^@O8_P#@2G^-6_LUO_SPC_[X%'V:W_YX1_\ ? H J?\
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M&B_]!>Q_\"4_QH_X2#1?^@O8_P#@2G^-6_LUO_SPC_[X%'V:W_YX1_\ ? H
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M "BBB@ HHHH RO"W_(I:/_UX0?\ HM:@\5WGDZ8MDIF\S4)!;YAC:1U0\R,
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MFO4ZS;S18KW7=-U9I7633EF5$ &'\P '/TVUI4 %%%% !1110 4444 %%%%
M&1IO_(P:S_O0_P#HNM>LC3?^1@UG_>A_]%UKT %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A:Y9VM
M_K>D07EM#<PDS$QS('4D(,<'BMVLC4?^1BT?_MO_ .@"@!W_  BWAW_H Z9_
MX!Q_X5B7%Q\/+76QHDUII"ZBSK&+<62EMS8P.%QW%=?7#0_\)%X,U2T2_O(-
M7TC4+SRFE%N(IK:65S@G!(92S8YY&: +>K7'P]T.\6TU*TTBWF."5-DK!,]-
MQ"D+GWQ6PGAGPW(BNFAZ6Z, 59;2,@CU'%,\0PVL&@7\"VJS2Z@&C6'&3<2N
MN #^0Y[*N>@JUH.FG1M T_3&E\UK2W2$O_>*J!GZ4 <_J-U\.])U$:??VVCP
M7&0I5K)2J$\@,P7"G'/)%7-5LO!>B6ZW&H:5I<2-G;BQ5V;'7"JI)Q]*=XKL
MK>3PQ>Z1;VR//J@>*&(C.Z5\DN?92=Y/8+]*T4M9-*T:&.SMQ>W-K;+#'N<(
MTFT 8+'IG% &9!9>";G1AK,.GZ,VGE#)]H^RQA HZYR.,57T8^ O$$LT.EV&
MDSRP#,D9L51U'KM90<>_2H_  LKWPP]I)8/;7%I?2"\MI<$)<!_,.,<%02"O
MT'IFK:Z>FH_$ :Q"H6/3K-[5Y0/]=(S [<]P@'/NV.H- &A_PBWAT?\ ,!TS
M_P  X_\ "LVWMO!5S+"D6DZ:1<,5AD.GA8Y2 3A'*;6X!/!.<&K=MXF\-^(/
M/TZSUBVN':%O,2*3Y@F,$^V,UQ.B7UQ'<>']"UQR=)BG5]'U%(]JWNSB%'_N
M''(_O<?\" .]_P"$6\._] '3/_ ./_"C_A%O#O\ T =,_P# ./\ PK5HH RO
M^$6\._\ 0!TS_P  X_\ "C_A%O#O_0!TS_P#C_PK5HH RO\ A%O#O_0!TS_P
M#C_PH_X1;P[_ - '3/\ P#C_ ,*U:* ,K_A%O#O_ $ =,_\  ./_  H_X1;P
M[_T =,_\ X_\*U:* ,K_ (1;P[_T =,_\ X_\*/^$6\._P#0!TS_ , X_P#"
MM6B@#*_X1;P[_P! '3/_  #C_P */^$6\._] '3/_ ./_"M6B@#*_P"$6\._
M] '3/_ ./_"C_A%O#O\ T =,_P# ./\ PK5HH Y?_A'-"_X2KR?[%T_ROL.[
M9]E3;NWXSC'6KMWH/A>QM9+FXT+3A%&-SE;!7('K@*34G_,X?]P__P!J5=U/
M_D%7?_7!_P#T$T <Q'=_#R6T6\%CIBVK_=N)-.V1'_@;(%_6M&]TKPE8Z6^I
MRZ+IKVJ('+PV*294]" JDGKVJK\.8XYOAMH\4J+)&]J596&0P).017(:-K&I
M>&_!/BW^R9(C#HFJ2Q6?GH741[@"@P1TSGOUH ]$'A?PZ1G^P=,Y_P"G./\
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M>*[M=6WQ)*(=C03*NX< \J>>.HQU- &E_P (MX=_Z .F?^ <?^%'_"+>'?\
MH Z9_P" <?\ A7(2^*?$Z^$]5UW[1IX;2;V:)X1;MB=8W"D9W?+QGU^M;1U?
M6K/Q;IEA=3VDMKK$$[1I'"5-NT:JP^;=\X(;'0=.W2@#5_X1;P[_ - '3/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K(U'_D8M'_ .V__H K7K"URSM[_6](@N8_,C)F)7)'(0>E &W(&:-E
M1]C$$*V,X/KBL6UT?5+@6PU[4;:\%K()46WMC%O=?NL^6;.#S@8Y -2_\(MH
MO_/G_P"17_QK/GM_!=MJ(TZ>ZLHKTLJBV>]Q(2V-HV[LY.1CZT )?Z#XFN-;
MEU&U\1VENA79!$^F^9Y*=P"9!R>YQS@=@*TH;#6(K?3XVUE9)(92]Y(UL/\
M25.?E S\G)&,9X%9NH0>"]*NH[74+FSM)Y>4CFNRK$>N"W2M$>%]%(R+/_R*
M_P#C0!F7'A_Q2^KW&H6_B:TB\WY8T;3-_DQ_W03)^)/<_0 :1LM?A2R6WU>V
MD\N/;=&YM"QF?^^-KC;SGY>16?=P>"[#4(]/O+FSM[N3&V&2[*N<]."W?MZU
M-J6F>%='MOM.I&"SASM#S7#*"?09;DT 2OH%Y!HUY;:9J:VM_?3--/>M!O\
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M0^:EQ".0&7(P0>00?:MG_A%M%_Y\_P#R*_\ C1_PBVB_\^?_ )%?_&@"E?\
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MG(VD;<9(/%+9>$?#"P+-9:9"D<RA@T99=PQD'K[U8_X1;1?^?/\ \BO_ (T
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M!+:1R!Y8X]/"/-SDY<N3DGJ<9/-3W'A:8'5H;"^6UM-88O<H8MS([*%=D.0
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M@^UTBYUUV(EAU:=G$1Z)&P^9<=LLS].Q% $]I<0ZUKT=[ PDM;.T5HG'1GF
M;\P@7\)*P+_Q+K$_A/Q;<0K:V-WI4\L*/&&?*K&IW9./FYX.,#C@UO\ @_PZ
M/"WAZ'3#,9Y$9B\I_CYPOY*%7_@-9D?A*_ETKQ187,]N@UR666-XRS>470*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %86N6L=[K>D0RM,JDS',,SQ-]P?Q(0?UK=K(U'_D8M'_[;_\
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M;]AW9_M*XW9WX^]OSCVSBM"70M,@C,DUYJ$:#JSZM<@#\3)2_P#,X?\ </\
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MK<__ !RC_A'+'_GOJ?\ X-;G_P".5JT4 97_  CEC_SWU/\ \&MS_P#'*/\
MA'+'_GOJ?_@UN?\ XY6K10!E?\(Y8_\ /?4__!K<_P#QRC_A'+'_ )[ZG_X-
M;G_XY6K10!E?\(Y8_P#/?4__  :W/_QRC_A'+'_GOJ?_ (-;G_XY6K10!E?\
M(Y8_\]]3_P#!K<__ !RC_A'+'_GOJ?\ X-;G_P".5JT4 97_  CEC_SWU/\
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M ,]]3_\ !K<__'*/^$<L?^>^I_\ @UN?_CE:M% &5_PCEC_SWU/_ ,&MS_\
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MUJWU^6&&*>S@73S=$!'BPWFJI/&2Q&1WP/2@#>DT'38HFEDN]12-1EF;5KD
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M]]3_ /!K<_\ QRM6B@#*_P"$<L?^>^I_^#6Y_P#CE'_".6/_ #WU/_P:W/\
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MHK*_L6X_Z#NI_P#?47_Q%']BW'_0=U/_ +ZB_P#B* -6BLK^Q;C_ *#NI_\
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MN/\ H.ZG_P!]1?\ Q% &K165_8MQ_P!!W4_^^HO_ (BC^Q;C_H.ZG_WU%_\
M$4 :M%97]BW'_0=U/_OJ+_XBC^Q;C_H.ZG_WU%_\10!JT5E?V+<?]!W4_P#O
MJ+_XBC^Q;C_H.ZG_ -]1?_$4 :M%97]BW'_0=U/_ +ZB_P#B*/[%N/\ H.ZG
M_P!]1?\ Q% &K165_8MQ_P!!W4_^^HO_ (BC^Q;C_H.ZG_WU%_\ $4 :M%97
M]BW'_0=U/_OJ+_XBC^Q;C_H.ZG_WU%_\10!JT5E?V+<?]!W4_P#OJ+_XBC^Q
M;C_H.ZG_ -]1?_$4 :M%97]BW'_0=U/_ +ZB_P#B*/[%N/\ H.ZG_P!]1?\
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M(H U:*RO[%N/^@[J?_?47_Q%']BW'_0=U/\ [ZB_^(H U:*RO[%N/^@[J?\
MWU%_\11_8MQ_T'=3_P"^HO\ XB@#5HK*_L6X_P"@[J?_ 'U%_P#$4?V+<?\
M0=U/_OJ+_P"(H U:*RO[%N/^@[J?_?47_P 11_8MQ_T'=3_[ZB_^(H ;IO\
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M\V/F/XG)J+6[*XU&[TRV6/-HET+BY?(QB,;D7'?,FP_\!-:] !1110 4444
M%%%% !1110 4444 %%%% &1_S.'_ '#_ /VI5[4((;G3[B&>))8VC8%7&0>*
MH_\ ,X?]P_\ ]J5?OFD6QF,,#SR;"%C0J"QQZL0/UH X'P;K<'AKX7Z'>O82
MW'VN40R/"%SN:4J"V3D_@#73V7B6:ZUF\T>;29K2]@MQ<PQRRH1-&25!RI(4
M[A@BN6MO#^O0?#?1M%;1Y3>V5Y%+*@GAQM2;>2#OQT_6NB2SU$_$;^U3ITJV
M+:4+7SC)'\LGF%^5#9Q@XR!U]N: *GAWQC-/X1MM8U>%(Y+NX>. +*N'8R.
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM6B@#*_LS5/^@_/_ . \7_Q-']F:I_T'Y_\ P'B_^)K5HH RO[,U3_H/S_\
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M \7_ ,31_9FJ?]!^?_P'B_\ B:U:* ,K^S-4_P"@_/\ ^ \7_P 31_9FJ?\
M0?G_ / >+_XFM6B@#*_LS5/^@_/_ . \7_Q-']F:I_T'Y_\ P'B_^)K5HH P
MM"AF@UG6$GN6N9 \69&55)_=^@ %;M9&F_\ (P:S_O0_^BZUZ "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOI+FVTZW3+(&"@+@<+G:6/IG'7BG^'M7EFO_ "FT#5X[F[;?=7MW;B*,  X
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MD=B1UZ]J?XYT&]U>RL+W2U5]0TF\2\@B=MHFV]4SVR._M6GY'B+_ *".F?\
M@!)_\>H\CQ%_T$=,_P# "3_X]0!':^(Q>0@1:5J<=T1_J+BTDC"GWD(V8]P3
M[9Z5FWT5T?B+HUR;6=X8K&:*6>.%C&KN5(&<?[)^G>M;R/$7_01TS_P D_\
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MT);I-9U@7DL4LV^'+0QF-<>7QP68_K6[0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !61J/_(Q:/\
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MY/4GZU=ND'B7QEH-Y:+(;/2DFGGD="HWNH5(^?XA\Q([8&>M $[WE_'\38+
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M&P9Y )_2MVLC4?\ D8M'_P"V_P#Z * '>=XB_P"?'3/_  ,D_P#C5'G>(O\
MGQTS_P #)/\ XU6ITKA-%\0W'BCQ')]@\716T4,Q+:0;!?,,:G&=[X)W 9R
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MC5[2\M'N(YC;I%) R,H((3@J=PYZY_4 VO.\1?\ /CIG_@9)_P#&J/.\1?\
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M>WL<)4 N6SB,$X!8CA03W.!5X_.GROC<.&7!_$4 9GG>(O\ GQTS_P #)/\
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M10 4444 9'_,X?\ </\ _:E6=:N(;;1;R6>5(HU@?+.P 'RFJW_,X?\ </\
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M"  RGTSG!K9\77=OIGC+PKJ-]*MO9Q-=QR3R'"(SQC:">V<&NQI" PP0#]:
M/+KC4;27P_\ $3]YM\V5V02*5+9@0+@'U(XK1N+[3EU_P"T-U;*OE3JI5UP
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M '\-9VBW,FGZMI2:1J,6KZ/>W3[;*4 W.G,5<L01_",L#NZ;@!US7=:7I_\
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M[@EF$;;00T9\L]<G(^I]::\.F:?XA\#VUE;&RM(6O&CAF9BT:LAV%MW*[B>
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M(4EMHVX/!.3TK6\.:U'XB\/66KQ(8UNH@Y0G.UNC#/?!!% #?M/B#_H$Z?\
M^#!__C-'VGQ!_P! G3__  8/_P#&:U:* ,K[3X@_Z!.G_P#@P?\ ^,T?:?$'
M_0)T_P#\&#__ !FM6B@#*^T^(/\ H$Z?_P"#!_\ XS1]I\0?] G3_P#P8/\
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MS6QQ-'%*K-&?< \4B:SI<E]]A34+9KHYQ")5WG'7C/;OZ4 5_M/B#_H$Z?\
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M+J,#3V-M+)O3;)L9$+;2.QX[^M %G[3X@_Z!.G_^#!__ (S1]I\0?] G3_\
MP8/_ /&:BT+Q#87]K96KZG:RZF]I'++ )5\S)0$DJ.G7/2G)<2S2ZO\ 9=;@
MN&0+Y<*HC?8SMY#8.2203\W2@!_VGQ!_T"=/_P#!@_\ \9H^T^(/^@3I_P#X
M,'_^,UD:+K%SJ/@?1;^]UN&PN[ORF>:1$_?$MR@4X&6'''(S6D_BO24\1/H;
MWD*7$4'FR%Y H4DX"\]3C)]L>] #Y)_$,D;)_9EBFX$;EU%\CW'[FN<T[1_'
MECI\>EO=Z3-8HGE@DL)RGH7VE2?<IS76PZSI5Q927T&IV<MK%GS)TG5HT^K
MX%6HI8YXDEAD62-P&5T.0P/0@CK0!DV[:Y:V\5O#H^GI%$@1%_M%^% P!_J:
MD^T^(/\ H$Z?_P"#!_\ XS5@:SI;7HLAJ%L;DL5$/FKN)'48SU'I6%K/B6'_
M (2BW\.PZO#8%[:266X5XRZ."JH@#@C)W$X(R<#% &K]I\0?] G3_P#P8/\
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M+57\MIS<)L#?W2V<9]J (?M/B#_H$Z?_ .#!_P#XS1]I\0?] G3_ /P8/_\
M&:CG\4:5!XBAT)[N%;J6!IOFD "\J%7W+;L@=<#W%9/AWQ2J?VK'X@UBU1XM
M8FL[4RLD.Y55,*!W^][]: -K[3X@_P"@3I__ (,'_P#C-'VGQ!_T"=/_ /!@
M_P#\9JY>:A9Z>BO>745NK'"F1PNX]>/7BF/J^F1V4=Z^HVJVLN!',9EV/GI@
MYP?PH K?:?$'_0)T_P#\&#__ !FC[3X@_P"@3I__ (,'_P#C-176L6-Y]G%A
MXBL[<K?+%)M:.3SB#\T/)X8Y'3D5;N->T>TGD@N=6L898O\ 61R7"*R<9Y!/
M'!!H A^T^(/^@3I__@P?_P",T?:?$'_0)T__ ,&#_P#QFIY-;TJ&RCO9-2M5
MMI03'-YR[' ZX.>?PJ5M1L4LEOFO(!:N 5G\P;&!Z8;H<T 4_M/B#_H$Z?\
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MZW-I/'<0OG;)$X96P<'!'7D4 4/M/B#_ *!.G_\ @P?_ .,T?:?$'_0)T_\
M\&#_ /QFM6B@#*^T^(/^@3I__@P?_P",T?:?$'_0)T__ ,&#_P#QFM6B@#*^
MT^(/^@3I_P#X,'_^,T?:?$'_ $"=/_\ !@__ ,9K5HH YCPY<:XOAC2EATVQ
M>(64(1FOG4L-@P2/*.#[9-:7VGQ!_P! G3__  8/_P#&:/"W_(I:/_UX0?\
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M@_\ \9H^T^(/^@3I_P#X,'_^,U2\0ZMJ6FZ]H-M;O +2_NS#,&0F3A&88.<
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M+J9 A1)C #'OR".ISST.#VS5?7XM.T6WN)K+4Y+JQO\ 5[,ZOM*>1%$2=_W
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5D:C_R,6C_ /;?_P!
M%:]9&H_\C%H__;?_ - % &LRAE*L 5(P0>AJEI^B:5I!<Z;IMI9F3[YMX53=
M]<"KU% &7/X7\/74[W%QH.FS32,6>22TC9F/J21DFK(TO3PEM&+&V"69W6RB
M)<0G&,H,?+P>U6Z* ,F7PIX<FE>67P_I<DCL6=VLXR6)ZDG')J:YT#1KW[/]
MJTJRF^RKM@\R!6\I?1<C@>PK0HH JW.F:?>6:V=U8VT]LN,0RQ*R#'3Y2,<5
M!9>'M$TZX%Q8Z/86LP! D@MD1@#U&0,UHT4 %126MO+<17$D$3S0;O*D9 6C
MR,':>HR.N*EHH JW6F:?>RI-=V5O/)']QY8@Q7G/!/OS5JBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#(_YG#_ +A__M2M*XMK>\@:"Z@CGB<8:.5 RM]0
M:S?^9P_[A_\ [4J?7=4&B:#?:H8FF%I \OEJ<;L#.,]OK0!/9:=8Z;#Y-A9V
M]I%G.R")47/T IB:1ID6H-J$>G6J7C9W7"PJ)#GU;&:PX+_7YM/T[4[6]TZ_
MM[J6'SEA@8;(W8!BC;SG&>X]3QC%=!_:%E^^_P!,@_<?Z[]X/W?^]SQ^- $4
MVBZ7<7GVV?3K62YX_?/"I8XZ<X[=O2K,\$5S \$\22Q2*5='&58'J".]<]KV
MN75GJ?A_[#<V[66H7GDS$+N+#8S9#9P!\OI^-;UK>VE]$9;.ZAN8P=I>&0.
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M<:A54>P'2J7_  CVB'SLZ/8'[0XDF_T9/WC@Y#-QR<\Y-:-% &&;/6=0UO\
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MY_T+NI_]]6__ ,=H U:*RO[8O/\ H7=3_P"^K?\ ^.T?VQ>?]"[J?_?5O_\
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M7=3_ .^K?_X[0!JT5E?VQ>?]"[J?_?5O_P#':/[8O/\ H7=3_P"^K?\ ^.T
M:M%97]L7G_0NZG_WU;__ !VC^V+S_H7=3_[ZM_\ X[0!JT5E?VQ>?]"[J?\
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M+S_H7=3_ .^K?_X[0!JT5E?VQ>?]"[J?_?5O_P#':/[8O/\ H7=3_P"^K?\
M^.T :M%97]L7G_0NZG_WU;__ !VC^V+S_H7=3_[ZM_\ X[0!JT5E?VQ>?]"[
MJ?\ WU;_ /QVC^V+S_H7=3_[ZM__ ([0!JT5E?VQ>?\ 0NZG_P!]6_\ \=H_
MMB\_Z%W4_P#OJW_^.T 'A;_D4M'_ .O"#_T6M:M<QX<U6ZB\,:5&NA:A*J64
M($B-!M<!!R,R X/N!6E_;%Y_T+NI_P#?5O\ _': -6BLK^V+S_H7=3_[ZM__
M ([1_;%Y_P!"[J?_ 'U;_P#QV@#5HK*_MB\_Z%W4_P#OJW_^.T?VQ>?]"[J?
M_?5O_P#': -6BLK^V+S_ *%W4_\ OJW_ /CM']L7G_0NZG_WU;__ !V@#5HK
M*_MB\_Z%W4_^^K?_ ..T?VQ>?]"[J?\ WU;_ /QV@#5HK*_MB\_Z%W4_^^K?
M_P".T?VQ>?\ 0NZG_P!]6_\ \=H U:*RO[8O/^A=U/\ [ZM__CM']L7G_0NZ
MG_WU;_\ QV@#5HK*_MB\_P"A=U/_ +ZM_P#X[1_;%Y_T+NI_]]6__P =H U:
M*RO[8O/^A=U/_OJW_P#CM']L7G_0NZG_ -]6_P#\=H U:*RO[8O/^A=U/_OJ
MW_\ CM']L7G_ $+NI_\ ?5O_ /': &Z;_P C!K/^]#_Z+K7K"T*>2YUG6)9+
M66U8O"/+F*EA^['/RDC]:W: "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R-1_Y&+1_P#MO_Z *UZR
M-1_Y&+1_^V__ * * ->N8M-?UK5M5;^RK/39M)CN/*>X:[/F@*<,=@!'4'&3
MR,'O73'&#GIWS7$:MX8T[1]8T?6?#<$=A=RWL4,L5K\L=S Q^<%!QPN6SCM]
M* -+7M8\368NKO2M'M+BRL@6D%Q.R2SX&6\L!2 !TR3R0<#IG:TC4H=9T>TU
M.W5EBNX5E56Z@,,X-4M<N!>)+HEO<+%+/'BXEW#_ $>)N"?]XC(4?CT'-VQ?
M3K>QMK>REA6V0>1 $<8.WC:/7&T_E0!@>(/$'B32X;O5+31;6;2['<95EG9+
MB1%^^ZC;M &#C)R0,]ZU+G4-3O-.MKC0+:WD-S$)EDO)&1%4@$#"@DDY^@YY
MZ PZZ\6KI-H*3JD<B[;Z3<!Y<1ZH/]IAQ[ Y_N@WWB@O]+^SV5XUO%)'MCEM
M&7*J./E)!'XXH S]!U^]UKPS_:/]F>7>K(\+6WF?)YB.4)#X^[D9S@\9X/>+
M1M<U>7Q'=Z%K5C;1316Z744]I(S1NC,5P=P!#9!^N#4/@/[;:Z3>Z=>W/VB/
M3KZ2UMKD@*98UVXSCJ025)]14-I::AI/Q&:--0FOK35+-YITG"EH&C90I! &
M%.X@#_>- '7UA:7KUU?>*=7T>XLXX%T^.%T=9-YD$FXY/ Q]WIS]:DTJ^\17
M%X8]4T.VLK?:2)8K[SB3V&W8/?G-9FC?\E,\3?\ 7K9?RDH ZRBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#(_P"9P_[A_P#[4J]J,T]OIT\]L(S+%&74
M29VG SCCI5'_ )G#_N'_ /M2KNI_\@J[_P"N#_\ H)H YW1O$'B/6/#-MKEM
MI=A,+B/S%M1<LCD9/ 8J1GCOQ[U=TWQ$WB;PQ)J.@B*.[!,?E7P($,JGYED"
M\\>WJ*I?#R>&U^&>D3W$J111VI9W<X50"<DFN&DLC<_##QEK,D+1VVI:A)=V
M2L"I*%P ^/?)H ]CW!0-Q )X^II=PQG(QUZUQ?BNVOUU7^T+2RM-:MX; )=Z
M7.<2*A9CYD9.1DX(([[!6;'9Z/KGBOPX5AD>PN]"<B*9B#(@,>U7 X/'4=#B
M@#T8$, 000>A%%>0ZIIZ:;X5\7:? N=-T[5;8V);YA 6>)I%4GH!NQ^)]ZZV
M[BM7^+5JGEPLTNC3"9< EQYB ;AWXSU[4 =/INI6NK6GVNRD$L!D>,..C%&*
MDCU&5/-6597&58$=.#7E5A+;Z1\,;6XA2"V2;53%?3",<0?:G!WXP2N, C/0
MX[UO3^'[6&;4YK;7K>R;4M,:,I9P".%>0%G(#'D;@,Y&1],T =N&5ONL#]#3
MJXSPI/+;^([C3-5T6WT_5ELU;SK+'V>ZB5L!@, J06Q@\\UV= !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!E>%O^12T?_KP
M@_\ 1:UE>)?%T_AKQ!I=M<6T<FG7[%9+@$AK?E5!;L1N=>>*U?"W_(I:/_UX
M0?\ HM:S?$VCV_B#5$TFY_U=UI5TF?[I\R##?@<'\* -G6M331](N+]D,AB7
MY(QUD<G"J/<L0/QJCX0UNY\1^&K76;F** W2EEBC).P D<D]>GI7->&M1O?$
M6G1VNIQNLWA])([TL.)+E0R)SWPN6/NRGM5/0);(?"WPK;W8ED:YNHT@@1PB
M32!W8+(2#\G&2,'H.M 'IBLK*&4@@]"#2UY[HVC6NL7_ (ST"\6W^SR3Q;8X
M%PD3M""60=F!YSZCMTJ7PLXUP:=I%]:1B?PTS+>+Y8V^<N4B*^S+N?CN%H [
M+4KFXM;-GL[4W5PQ"Q1;MH+$]6;!PHZD^@[GBL/2/$.KCQ*WA_7["V@N7MS<
MV\]G*SQ2(" P^8 @C(_SUZ*YN8;.VDN;F58H8UW.['  K$LXH;K5Y-6NIHXK
MNZA-M9PEAOCBY8\?WF(W'T"@=CD I-XSE.C3^(X[>-M%@N#$3D^;)&K[&F';
M ;/R]2!G(/%:'BG7[C0=+AOK6TCNDDGBB9FEVA [!0P !W=?45Q5J#;? .XL
M'0BYACELWA_B$QF*[<>I)'YUO^-('L_A_9VTIR\,]C&QSU(EC!_E0!V,CI%&
MTDC!$0%F9C@ #J36#X:\2R>(+_5XC:FWAL9D2'=G>ZL@8,1VSG..H!YYI?%(
MU:5;2#3]+&HVS.6NX_M"Q;@,;5)/52>3ZA<=":PO!-YJD_C'Q.+O21:K)<1-
M*?M*OY3")0%X'S9'.1TH [RBBB@ HHHH **** "BBB@#(TW_ )&#6?\ >A_]
M%UKUD:;_ ,C!K/\ O0_^BZUZ "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *PM;NDL];TB:1)74&8;8
M8FD;[@[*":W:R-1_Y&+1_P#MO_Z * !]>LY8VCDL=1=&!#*VFS$$'L?EJAI9
M\/:+_P @W1+VV." 4TV?(!YP"5X'L.*Z:N?'B+4I]7^S67AVXN;$3>4=0^T1
MJ@P<.=I.XA2".G..* ,^\TSP?J%W)=WGAB:>>5MSR2:5,68^YVU<$N@K%91+
MHEX(]/;=:J-+F A.,97Y>.M)KGBF^TLW$MGX=NM1LK,9N;B.9$VX&6V*>7P.
MN,<Y'8UN:=?V^J:=;:A:/O@N8EEC8C!*D9% '+7&D>#+NXDN+CPM++-*Q9Y'
MTF8EB>I)VU9N(_#ERUHTNAWNZRC\NW*Z;.IC3IM&%Z<=*-;\87FD"XNX_#MW
M=Z7:,5N+Q)44KM.&*QGE@IR">.A[<UJ7NL7(LH)]'TU]4:XC$L8$JQ)L(!!+
M-ZY&!B@"E=7&AWNEG2[C1KR2R( \C^RY@@P<C "\8-/L;[2--1EL]+U"+=C<
M1ITY9L=,DKDX]ZDT?Q*FL^'?[6AL;D2!FB>TP#(LJMM*9Z=>^0,<G'-1Z-XE
MN+[7+K1=1TF33;V"%;A%,JRI+$3MW!A[C&* +7_"0VO_ #YZG_X+IO\ XFJ4
M%SHMMJ,NH0Z3J"7<PQ),-/GW..P)V\X_2M^2011/(P8A%+$*"3QZ =:Y^W\4
MW0\1VNCZGH<]A]N1VM)C,D@?8,LK!?NG'/4_6@"]_P )#:_\^>I_^"Z;_P")
MH_X2&U_Y\]3_ /!=-_\ $UJT4 97_"0VO_/GJ?\ X+IO_B:/^$AM?^?/4_\
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MT4 97_"0VO\ SYZG_P""Z;_XFC_A(;7_ )\]3_\ !=-_\36K10!E?\)#:_\
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M #YZG_X+IO\ XFC_ (2&U_Y\]3_\%TW_ ,36K10!E?\ "0VO_/GJ?_@NF_\
MB:/^$AM?^?/4_P#P73?_ !-:M% &5_PD-K_SYZG_ ."Z;_XFC_A(;7_GSU/_
M ,%TW_Q-:M% &5_PD-K_ ,^>I_\ @NF_^)H_X2&U_P"?/4__  73?_$UJT4
M97_"0VO_ #YZG_X+IO\ XFC_ (2&U_Y\]3_\%TW_ ,36K10!E?\ "0VO_/GJ
M?_@NF_\ B:/^$AM?^?/4_P#P73?_ !-:M% &5_PD-K_SYZG_ ."Z;_XFC_A(
M;7_GSU/_ ,%TW_Q-:M% &5_PD-K_ ,^>I_\ @NF_^)H_X2&U_P"?/4__  73
M?_$UJT4 97_"0VO_ #YZG_X+IO\ XFC_ (2&U_Y\]3_\%TW_ ,36K10!E?\
M"0VO_/GJ?_@NF_\ B:/^$AM?^?/4_P#P73?_ !-:M% ',>'-<MX?#&E1-:Z@
MQ2RA4E+&9E.$'0A<$>XJ=[W2)-1347TS43=HNU9?[/GW*O&0/EZ<#BK?A;_D
M4M'_ .O"#_T6M:4DB0Q/+(P1$4LS$X  ZF@#$DU'2I(9XFTS4-ERVZ8+ITX\
MPX ).%YX 'X52-MX8;2QI9\/W1L@X=;<Z9-L5AW V\'D]/6M7PUXAM/%&C)J
M=F&1&=T*/]Y"K$8/IV/XUK4 <C/>6&CQ7%_H'AB9]1=$CV_8)8=Z@@8+",X
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M3:+_ -!"/\C_ (4?\)-HO_00C_(_X4 :M%97_"3:+_T$(_R/^%'_  DVB_\
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MC-,/B76=*T;Q!9WUO$TS)/=>9?.8I(F^_'Y6S:I'0$'.1R3UKK]9_P"0'?\
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M3^$A0_#NQY)F\R;[1N^]YGFMG=[XQ^E &G=>+X;73-5O6TV]#:2,W$#*BO\
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ML_[T/_HNM>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK3__  *3_&J%W=>&;W5]/U276[/S].\WR0MW&%_>*%;(SSP*W?)B_P">2?\
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M $&M/_\  I/\:O>3%_SR3_OD4>3%_P \D_[Y% %'_A(]"_Z#6G_^!2?XT?\
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MIR0,YQ3K2R\+VNJ6>IMXI-Q=VL+0B2;4D/F(2#AL8Z$#IC/?-=;Y,7_/)/\
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M^)89A>7#W,JSW<)'F.<LPP!C..G2I-:E\*:_:I!>ZO99B<20S17J))"XZ,K
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M,RIG&X].I!P.IP< X--_MO1FTB#5(Y$EMKEE2 I'EI')P%"XSNSD8[8.<8-
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M&<'\^>"#S6O$;:"%(8FC2.-0J*I "@< "@":BH_.B_YZI_WT*/.B_P">J?\
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M $E%1^=%_P ]4_[Z%'G1?\]4_P"^A0!)14?G1?\ /5/^^A1YT7_/5/\ OH4
M245'YT7_ #U3_OH4>=%_SU3_ +Z% $E%1^=%_P ]4_[Z%'G1?\]4_P"^A0!)
M14?G1?\ /5/^^A1YT7_/5/\ OH4 245'YT7_ #U3_OH4>=%_SU3_ +Z% $E%
M1^=%_P ]4_[Z%'G1?\]4_P"^A0!)14?G1?\ /5/^^A1YT7_/5/\ OH4 245'
MYT7_ #U3_OH4>=%_SU3_ +Z% $E%1^=%_P ]4_[Z%'G1?\]4_P"^A0!)14?G
M1?\ /5/^^A1YT7_/5/\ OH4 245'YT7_ #U3_OH4>=%_SU3_ +Z% $E%1^=%
M_P ]4_[Z%'G1?\]4_P"^A0!)14?G1?\ /5/^^A1YT7_/5/\ OH4 245'YT7_
M #U3_OH4>=%_SU3_ +Z% $E%1^=%_P ]4_[Z%'G1?\]4_P"^A0!)14?G1?\
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MZ=>./B==IJ>E-9W=Q8!+*990\<T*-ELX P^6'7L!^(!O_P#",Z!_T ]._P#
M2/\ PJC9V?@W4+^ZL+/3])GN+,*9TCM4/E[LX!.,9X/%6=+\6^'];O#9Z9JU
MO=3A2YCC;)P.I_45EZ,/^+F>)O>ULOY24 ;/_",Z!_T ]._\!(_\*/\ A&=
M_P"@'IW_ ("1_P"%:=% &9_PC.@?] /3O_ 2/_"C_A&= _Z >G?^ D?^%:=%
M &9_PC.@?] /3O\ P$C_ ,*/^$9T#_H!Z=_X"1_X5IT4 9G_  C.@?\ 0#T[
M_P !(_\ "C_A&= _Z >G?^ D?^%:=% &9_PC.@?] /3O_ 2/_"C_ (1G0/\
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M'\Q&8*PR< %>N>E)I?B"^N/%0T9;V*[BFTPW27!MR%60.%.TC =#NR,'MUH
MW/\ A&= _P"@'IW_ ("1_P"%'_",Z!_T ]._\!(_\*XZV\5>)CX2TWQ)/<61
MC:]$%Q;);G,BF<Q9#;OE(XP,'IDDYQ6]=ZS?W/B+5-)MYTL1I]BEQ'(Z!O.9
MMW)S_ NT XP<GJ* -/\ X1G0/^@'IW_@)'_A1_PC.@?] /3O_ 2/_"N=T[Q9
MJMYH^@F=(UOM;5YAY%N1Y42J"<*SG<<D8).,'..,%9O$'B/2M(U"?4M/E,=M
M=1K'=I""[6S'YW,:D_,@S[=#C@B@#H?^$9T#_H!Z=_X"1_X4?\(SH'_0#T[_
M ,!(_P#"HO#6I#5;&:[BU2#4K9IO]'FB4 [-J\.!T8-N[#C' HU3Q;X?T2\%
MGJ>K6]K.5#B.1L'!Z']#0 LWA[P]!$TKZ%8%5&2$L58_@ I)_"L:*^\!W%@;
M^'2[:6S )-PFCN8\#@_,(\<8/Y5V%><?#F\U>'P/IT=KID4MLUXZ/,9_F5#<
M,&.S;V!/?WH ZB+3O"LU^EE'HEBTDEL+E6^P+L*$X'S;<9]NM7/^$9T#_H!Z
M=_X"1_X5G1ZC?Q^.V\/J\"6 TG[1"(XL,C>8$&2200![#K6;I^M^(9O$5QX9
MO+BWCOX)OM'VA81LEL\8!5<YWEN#V'/7N ='_P (SH'_ $ ]._\  2/_  H_
MX1G0/^@'IW_@)'_A67J&LZC=ZOJ.F:5OC?3XH\ND*R;I74L <D87&.G)R>1C
MF*S\0:Q?WFEZ+<VRZ9J<]D]W?#A_*56" )R1EF.><X'J>@!:TRS\):O+=Q6>
MCV+M93>3,'L%0J^ <891V-&KV?A#0K(WNIZ3I\%LI :7[ &5<G R54XY('-8
MOAC4H-#NO%=UK=_#&D>JJKW##8IS&@7CG!/'XT?$#6=-USX5:U=:7>17<"A$
M,D1R PD0D?J* -:RC\%:A>"R@T[31=%/,$$MB(I&7U"NH)'N*T_^$9T#_H!Z
M=_X"1_X5S^HZ-JGB#Q1X?OULSI]MI&^5IIG1GE+* $548_+QSDBG>&]1\4:X
MUQ<27VGQ0VE]<VKQBT8^9L)56'S\8..,G//- &IIVD^&=4L8[VVT.R\J3.WS
M+!8VX)!RK*".15K_ (1G0/\ H!Z=_P" D?\ A7.:/XOU"^\,:#+,8!J6LW4D
M&\(?+C"M(2P7/.%3 &>I%7K[5=;\/6>HS7_D7<7G01:=*!M>1I&"$2*,#Y6/
M;&1Z4 :O_",Z!_T ]._\!(_\*/\ A&= _P"@'IW_ ("1_P"%4--N_$(\1&VN
MK:2;2Y+?>+F2-(WBE!^[@,<J1TXR/4UT5 &9_P (SH'_ $ ]._\  2/_  H_
MX1G0/^@'IW_@)'_A6G10!F?\(SH'_0#T[_P$C_PH_P"$9T#_ * >G?\ @)'_
M (5IT4 9G_",Z!_T ]._\!(_\*/^$9T#_H!Z=_X"1_X5IT4 9G_",Z!_T ].
M_P# 2/\ PH_X1G0/^@'IW_@)'_A6G10!F?\ ",Z!_P! /3O_  $C_P */^$9
MT#_H!Z=_X"1_X5IT4 9G_",Z!_T ]._\!(_\*/\ A&= _P"@'IW_ ("1_P"%
M:=% &9_PC.@?] /3O_ 2/_"C_A&= _Z >G?^ D?^%:=% &9_PC.@?] /3O\
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M<GUE<EW_ /'F- #O^$9T#_H!Z=_X"1_X4?\ ",Z!_P! /3O_  $C_P *TZ*
M,S_A&= _Z >G?^ D?^%'_",Z!_T ]._\!(_\*TZ* ,S_ (1G0/\ H!Z=_P"
MD?\ A1_PC.@?] /3O_ 2/_"M.B@#,_X1G0/^@'IW_@)'_A1_PC.@?] /3O\
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M1O#>H0F:SM[>>-7:,O&Q(W*<$9SV(H&C>&S?FP%O;FZ6,2F'<=P0G ;&>F:
M-L*H.0H'X5B6&@W-GXIU'6WOHI$OXXHS +<J4$8.W#;SG[QSQ4__  C.B_\
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M^9_QH_X1G1?^@?'^9_QH U:*RO\ A&=%_P"@?'^9_P :/^$9T7_H'Q_F?\:
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MLRH1]-=FA;=DE>1D.,9/7[P/>@#H:*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#*\+?\BEH__7A!_P"BUK"\2C_BYW@H^U__
M .B5K=\+?\BEH_\ UX0?^BUK.US0M4O_ !9HVLVC6@CTD3!8Y78&7S4"GHO&
M,>] &1\3XUTJ+2_$UD!%J5I?11!TX,T;9#1MZ@_XUI:GXKO5_M-M(M!<G3',
M9B,$KM<N%#,JL@PIYP,YR>P')GNO#5WKFK65YKMS"UK82B:"QMU.PRCH[L>6
MQV  'UJK_87B;2-?O[C0;K3GT_4Y?/EBO0^Z"4@!F3;]X' ."1^'6@"W#X@O
M=8O'LM*BCM)H;.*YG^W1,3&TH)2,H"I!^4Y.>..#VUM(N+^ZTJWGU.R%E>.G
M[Z 2!PC>Q'!'?\:Y^\\-:Y9Z^FM:#J-J9YK5+:]COT8I-L^[)E.0W)XZ5TMC
M!/;V:1W-P;B;DR28VAF)R<#G YP!DX&.M '->(H8A\0/"$PC42&:[!<#DC[.
MW>FZQ<R:7\1=/U&^CE.ER:=);1S*A=89RZL2V =NY5 S[5H:SH]_?>(]%U.W
M:W$6EO*[)([!I-\93C .,9)[Y]JT]0749(C%I[00LXQY\N6,?N$QAOQ(H \R
MG>\O=/\ %ITFWGN+"#6X)C;I&0T@!1IU"D9Z@$CZ^M;MYK-KJ'Q'\,3Z7(["
M2UNQ=MY3)F'8"H.0,X<=.QKJ=+TB/0-(6RTR,2LI+LT\A#2NQRSLP!Y)YZ5'
MIFAFWU2YUB^E6YU&Y01;U7"0Q Y$:#TSR2>IYXX  .)T+Q'J%IH-SX\OM*6[
MAO9B9)!<?OK:V#[55$VX*C&3\P)))KTJ*1)HDEC8,CJ&4CN#TKE(_!]U#X<N
M?"T4\(TF9V"2Y/FQ0LVYH]N,$\D!L\ C@XYZN.-(8DBC4*B*%4#L!TH ?111
M0 4444 %%%% !1110!D:;_R,&L_[T/\ Z+K7K(TW_D8-9_WH?_1=:] !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %86N6L=[K>D0RM,JDS',,SQ-]P?Q(0?UK=K(U'_D8M'_[;_P#H
M H =_P (Y8_\]]3_ /!K<_\ QRJ\FF:)%.+>34[Q)B0!&VLW ;GIQYF:W*\Y
MM(9=&\4VS^+?#FF33:A=XMM9MOWA28DF-&W ,.,*I'' ^M '57&F:):31PW.
MIW<,DO$:2:S<*S_0&3FK'_".6/\ SWU/_P &MS_\<K+\5^'=!FT75;S4;"*Z
MN)XCB5T#2[L;8TC/4<X  [GU)K8\/6EW8^'-.M+^0RW4%K&DSDYRP4 \]^>]
M %.73-$@NH[6;4[N.XE^Y$^LW =_H#)DU8_X1RQ_Y[ZG_P"#6Y_^.5A^-/#&
MBR^&]4EDT^.XU&[W?9YR@,[3MQ$%;J #M '0 ?6M:1KU+&RT1+DMJ$D"BXN5
MZQ(  \G^\3D+[G/(4T .AT/2[A2T%YJ$JJQ0E-7N2 P.".).H-']AZ7]H^S_
M &S4/.V;_+_M:YW;<XSCS,XSWK!\!W,&D>"9FV,RQZA<QQ1*<L[><P51GJ2<
M#G\:71[6>V^*-TUW)YEU/HD<LQ!)56,SC:O^R  !ZXR>2: .A_X1RQ_Y[ZG_
M .#6Y_\ CE13:-I-NR+/?WT32'"!]7N%+'T&9.:N:CJMOIVE7E^SK(MI;O.R
MJPR0JEC_ "KB_#FNOI=EI^M>(-/N//UYT#ZB2C+$7YBCV@DI'C 'ODGK0!UO
M_".6/_/?4_\ P:W/_P <H_X1RQ_Y[ZG_ .#6Y_\ CE:M% &5_P (Y8_\]]3_
M /!K<_\ QRC_ (1RQ_Y[ZG_X-;G_ ..5JT4 97_".6/_ #WU/_P:W/\ \<H_
MX1RQ_P">^I_^#6Y_^.5JT4 97_".6/\ SWU/_P &MS_\<H_X1RQ_Y[ZG_P"#
M6Y_^.5JT4 97_".6/_/?4_\ P:W/_P <H_X1RQ_Y[ZG_ .#6Y_\ CE:M% &5
M_P (Y8_\]]3_ /!K<_\ QRC_ (1RQ_Y[ZG_X-;G_ ..5JT4 97_".6/_ #WU
M/_P:W/\ \<H_X1RQ_P">^I_^#6Y_^.5JT4 <O_8-G_PE7D^=J&W[#NS_ &E<
M;L[\?>WYQ[9Q6G_PCEC_ ,]]3_\ !K<__'*;_P SA_W#_P#VI4WB"QNM3\/:
MA8V4_D7-Q;O'%)G&UB"!R.GUH SXK/P]/*\,.L7$DB,%9$UN<E23@ CS>#GB
MKG_".6/_ #WU/_P:W/\ \<KC=*UO2K^73/#?B/21H6M:?+$]HKQCRW9&!_=.
M.,-@C'OQDUU=KKUU=>(M6T9;*)9+"**6*0SG$H?=@'Y?EQM]Z "?2M&MIH8)
M]1O8I9VVQ1OK%P&D/HH\SG\*G_X1RQ_Y[ZG_ .#6Y_\ CE<=J>MOKUCX*UZ'
M3PMQ<ZAN2 2 D?NY!C>0..,]/P-;$/C>2RFU:U\1Z>MA<Z;;"[Q!+YR3PDX!
M0D YW?+@@<T :=UX1TB^MWM[L7UQ"XPT<NHW#JWU!?!HM?".D6-NMO:"^MX4
M&%CBU&X15^@#X%$>K:M#J,$.H:2D5I- \K7,,Q=;8J,E9,@=0>".X/UK-G\:
M3V^@0^)GTY?[&D92S"4^<D3-M64KC!Z@E<Y /7M0!L?\(Y8_\]]3_P#!K<__
M !RC_A'+'_GOJ?\ X-;G_P".5FS>)=6E\17^BZ=I-O-+;6T=Q'++=[4=6) S
MA20>.@S]169>^+M2U+0?#.IZ9!% FJ:A'#/')*=P(+90$#IF,@GT[<T =+_P
MCEC_ ,]]3_\ !K<__'*/^$<L?^>^I_\ @UN?_CE95UXFUQ=?N=$LM#M[BZ@M
M([D$WFU&#,5(R4X/!QZ^U)JWC"ZTA'NKG34AM4OUM LTVR:92RJ947&"N6Z=
MP,Y% &M_PCEC_P ]]3_\&MS_ /'*/^$<L?\ GOJ?_@UN?_CE5[O7;R2\U&TT
M>RBNYM-C5IA+*4WNR[A&N ><8Y/ W#KSC,N==UN7Q1X>MXK2.V@O;26XDMIY
M"L@=57*OA3TW].Y]* -O_A'+'_GOJ?\ X-;G_P".4?\ ".6/_/?4_P#P:W/_
M ,<JC:>)YM2O[F"P@MY19WWV6XA,Q$\:AMIDVXZ=Q[<Y[5MW\EQ%8S26B1O,
MJY59'*K^) /;VH QTLM DOSIZ:M=-=@$FW&M7!DP.OR^9GBK?_".6/\ SWU/
M_P &MS_\<KD/"^HK9^!O#M]J&GV]S>R.L6FMYF9'EE+;BQ*_)QDDC=QGOBND
MC\0W</B!M"OK*);N6V-Q9O',?+G .&4DKE6''8\<^U %O_A'+'_GOJ?_ (-;
MG_XY2-X>T]%+-<ZDJ@9).JW( '_?RL_PGXEU3Q-:6FHOH\5KI]S"[>9]IW.'
M#X"[=HXP#S[=.F<_Q).VJ_$/1/#,_.GB![ZYB/W9RN0BMZ@$9QT/>@#6M[/P
M_>%A:ZQ<SE2 PBUN=L$G SB7UXJW_P (Y8_\]]3_ /!K<_\ QRI-4T2RU6.V
M$\*![2>.>!PHS&R,&&/0'&#[&LY_$=[=_P!J2:-817<6ERM#)YDQ1II% +HF
M%.,9 R>IR.,9H N_\(Y8_P#/?4__  :W/_QRC_A'+'_GOJ?_ (-;G_XY61_P
MFYNI_#W]EZ>+FWUU)6CD>;88V1"Q5A@]Q@D$]#@'C,:>+=<ECUB!-$M?MVC/
M_I"F\/E.A0.NQMF2Q'8@#W[4 ;?_  CEC_SWU/\ \&MS_P#'*/\ A'+'_GOJ
M?_@UN?\ XY65)XRF=O#C6>EB:+7HRZ%Y]IB/EE]I&/U^O!XS%%XJUV9M8LH]
M$M/[0TA@9@;P^4Z,F]=K;,EB.Q 'OVH VO\ A'+'_GOJ?_@UN?\ XY1_PCEC
M_P ]]3_\&MS_ /'*SE\9VUQI^D30)''-JML;A%N)-JQ( N[) .>6  QS[8JC
M+X]NH?#USJ3:-NEL[U;29!,0CAF55DC8K\RG<..* -__ (1RQ_Y[ZG_X-;G_
M ..5#=:/I%C;/<W=_?6\$?+RRZO<*J\XY)DP*A&OZI'=P:==:9!#J%W+)]GC
M%SO3R4 )D9@N1RP&W')[XY%'6_$M]8^$-3O]3\.1NUE/Y,D$LO[J=-R@2*2I
MRIR#@@=#Z4 ;7_".6/\ SWU/_P &MS_\<J"XTK1K1XDN=1O86G<1Q+)K%PID
M8]  9.3]*=K&LWMC=20V]E'Y45J;A[NYD,<.[.!&#@_,<9]ACKFN<U[5(=?T
M7P9K"0>5]JUBTD"MR4R'R,_6@#:U/P1X:U&,/JUO-=)$,@W5_.X3_OI^*?8:
M%X?,(M].N[GRXA@1V^K3[4'T63BN@KRK2[^\T3X5^(K[2Q%'/'J%U\[9&P;]
MN1CJ1QC_ .MB@#T#_A'+'_GOJ?\ X-;G_P".4?\ ".6/_/?4_P#P:W/_ ,<J
MG=>(I+&2SL)EM4OKB%ICOG;RT12!DG;DDEAQCUYXYS/^$]NAI5M=_P!BGS7U
M5=-F3SL $L 'C)4;U(/!XH W_P#A'+'_ )[ZG_X-;G_XY1_PCEC_ ,]]3_\
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MLR?^> ;Y /89('TH VO^$<L?^>^I_P#@UN?_ (Y1_P (Y8_\]]3_ /!K<_\
MQRM6B@#*_P"$<L?^>^I_^#6Y_P#CE'_".6/_ #WU/_P:W/\ \<K5HH RO^$<
ML?\ GOJ?_@UN?_CE'_".6/\ SWU/_P &MS_\<K5HH RO^$<L?^>^I_\ @UN?
M_CE'_".6/_/?4_\ P:W/_P <K5HH PM"M8[/6=8AB:9E#PG,TSRM_J_[SDG]
M:W:R--_Y&#6?]Z'_ -%UKT %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5D:C_R,6C_ /;?_P! %:]8
M6MV[76MZ1$MQ+;DF8[X2 WW!Z@T ;<F\1MY84O@[0QP">V:P%L]7UQ+1-;L;
M6S2VN$N'6&X,IE=#E<94;1N /<\8[YJY_8DO_0;U/_ON/_XBC^Q)?^@WJ?\
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M29Z*@YVJ"<#/)R2>: ,[QS&QU<WNO^&9=3\/VL:A9K>Z(>W)Y>0QJ06'0=>
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M-8R3Q&*=;B*10#E3@###KC&/0UI^+-$GUKPY=V=@\<%XSQSPNPX,D;*R[O\
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MQ#_\16K10!E?V7J7_0P77_?B'_XBC^R]2_Z&"Z_[\0__ !%:M% &5_9>I?\
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MC_\ 7A!_Z+6N<\9)K>G^(;#4O#TL\LL5M/<7-@TSF.ZC1H@5"DX#8D)! [4
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M^A@NO^_$/_Q%']EZE_T,%U_WXA_^(K%NY3X?\;Z#:64LIM-72>*:&25I!N1
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M_P"@IIG_ (+I/_C] &K165]G\1?]!33/_!=)_P#'Z/L_B+_H*:9_X+I/_C]
M&K165]G\1?\ 04TS_P %TG_Q^C[/XB_Z"FF?^"Z3_P"/T :M%97V?Q%_T%-,
M_P#!=)_\?H^S^(O^@IIG_@ND_P#C] &K165]G\1?]!33/_!=)_\ 'Z/L_B+_
M *"FF?\ @ND_^/T :M%97V?Q%_T%-,_\%TG_ ,?H^S^(O^@IIG_@ND_^/T :
MM%97V?Q%_P!!33/_  72?_'Z/L_B+_H*:9_X+I/_ (_0!JT5E?9_$7_04TS_
M ,%TG_Q^C[/XB_Z"FF?^"Z3_ ./T :M%97V?Q%_T%-,_\%TG_P ?H^S^(O\
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M/T?9_$7_ $%-,_\ !=)_\?H U:*ROL_B+_H*:9_X+I/_ (_1]G\1?]!33/\
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M);RV<<C("=Q)W?=)^7(_V1Z4 4_"DVM:OX+N%.JD:@U[<1?;'0,4 E()5>G
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MNGVC/7=CG/OZ^] &G1110 4444 %%%% !1110 4444 %%%% &1_S.'_</_\
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M(EC=VT4,1\LYG9$(+!<9(Y"@XYYQ5_X?$KX&TF"1)(YH+=4DCD0HR,.Q!YH
MS=8UZ"#QT=(UW4+C3;&2V1K!XY6ACFD)._=(,<CY0 3CUZBH_%L6K:3\/-<D
M;6+MYH7,EM=+($D\L[, E<=,D<8SC/>M/6+K2-2NK[1/$6G%[)-C132P,8FR
MO(#@85P?<'!&.]<?/IM]8_"[Q)I\2WUQ8R7!CTB*6-FF,65Z+C.W.<9'0$]#
M0!Z!8^)M*OM2.F0SR?:5A\Y0\+JLJ X+(Q&'&3U!-4+3Q+H&G:3JFJG5+N:S
MAOI%GDG61_)D^7,:C;D*,@ 8QDU3OYTD^(7AVXC25H5L[A7D$3;4+;-H8XXS
M@]:YO421\._'8>*2/S-3GF3S(V7>C,F&&1R#@\T =W:>+]#O=7;2H;MOM00R
M(K1.HE4=2C$8<?3-5V\?>'5M6N_M<QMTF,$DPM92D3 X^<[?D&3C+8JEJB1:
M]XG\.W%@C[=-DEGN)3&5\E"FWRSD<,21\O7 -<[(LC_#/Q7;+;7!GN-0NFAB
M\A]\@>3*D#&2".<T =Y:^)M*N]7_ +*BFD%RR&2/?"Z),HZE&( <#(Z$TEQX
MHTFUGCCFGD6.2?[.MQY+^3YN<;=^-N<@CKC(QUK"U*=9?&GA">-)GBCAN1(Z
MQ,1&7C0+N..,D$<UC:"+6/31X6US0;^ZU2WE9%1TE:WN/G)67=G8%Y!)/3!Q
MD\4 =;=>-]!M);Z)[B=I-/(^TI':RNT8(SD@+]W'.[IR.>:;J7C"TL]0T.W@
MCFN8M7+.L\4+R+Y8C9P1M!))(7@ X&2<5CVTH3Q'XX=XI@D\4/E,86Q+M@VM
MM./FPQQQ6;8^=:Z9\/[V6TNS'IX>&Y"6TC/$S0% "H&?O<9Q0!Z)>WL&GZ=/
M?W#%(+>)I9#CD*HR?T%<Q?WNI-\.KWQ!]KEM;Z2Q:\C$9!6$;2R)@@@X& 3C
M).?8#3\96<^I^"=7M;=&\Z6S?8G<G;G;]3TK*U>\AG^$,LD; _:M'VQ*O)=F
MBX4#N?:@#-U#6M9T32_#&HP:M/?3ZG+!'-8SI&?.#KEF3:H92/KCD9K6\:WM
M_9:CX?2RU&>U2^U%+:<1[2&0@G^('!XZU@6UBN@6FB>,=(M//C2RBMM5M8X\
MN$VC+J.H=3U'<?G5SQW?Z=J5QX692MU;?VFDTP\LN%C"D$N,<#GN/7TH Z>&
MUDCU:../7+F?9&6FMI2A^5LA6!500<CU]?2N3L[W6[BR\6W/_"1W4+Z/=S);
M%TB*!40, X*<CMG.:Z"RNO#EGK"#1[: 7-VNR4VT6Q%106W.0,<=!W)(^HPO
M"&G:3J^K>*$O[2*Y$NJO+&LR966/ PP!X9<CW% $=UXTN)=$\*ZEJYGTW3=3
M5_M\]ON7:X \L;ARB,<G(YP!SC-=5I%E,+JZGAUB>]TNY@B^RDS"3RV!?=M?
MJP(*\G)]Z-:U"UL[NTTN]T]IM-NX)1*5MC+''M,84. " I#-U&.!7/>$M+M]
M$\5ZG)HLDL7AI[57992PA2YW<^66ZC:.2.,D#/&  7_A[=ZCJOA^ZN=2U&:Z
ME-Y-"KL%78JMM&-H'/&<^]4_"][JNH>'O$-Q=ZM<RS6M[=06\F$!C6,?+P%P
M3]:K?#O3-%NO#UU+J&G6;SK>SN[75NN\(7)4G<,XQWIO@RXM;3PCXEC.V!?M
M]V\41783&P^3:OH>@Q]* (+[6]:A^"\/B./5[@:EY<4AEVIAMTJJ1MVXQ@^E
M;%]J6IZ!XXT321J,NI6FKK*LD,ZIYD!0 [U9%!P<\@^AQ[<QJ,BO^S_#8*&:
M[,4,?V<*3)N6968;>O &:])T[3-'CE&I6%I;^;*FT7"*"Q7TW=0/:@"IINIO
M!XDN_#MS(TC1P+=VLC'+-"Q*E2>Y5AC/4AAG)R3NUR30O<_%M)XQ^[L]&VRL
M.S22_*I_!6/X5UM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!E>%O\ D4M'_P"O"#_T6M8GB*[OXO'GA[3K?5+BVM-12Y,Z1[.L
M: J02IQR>:V_"W_(I:/_ ->$'_HM:YGQ<MC=?$;PM%>113V\*78N!*@>-"T:
M[-V>!DCC- '06;"QGOKR;79+JQA4)()]G[AUY;!51G(8<<\BF76O6-_%?:9#
M/<VM\EHTZH\3PR%.SKN R,\<=.^*I>*O#YA\&W]KH%BJR>?'="UA&P2%'1F5
M0.F0G;N?>JVFW.E:^SW>G:+?+=QVLB/->Q2(T.Y<>6"_4D]AQQR>F0!GA#QK
MI?\ 8.@V6H:A*U]=P(@FE1RDDI'W?-(VEO;.?QKL;Q;E[25;1TCG92(W<9"$
M]R.^.N.]>=16KZQ\-M'\,PV\RZG&UNDJR0LAM#&X9W;(&. 0/7/&:]#O[V+3
MK&:\F61HX5W%8HR[GV"CDF@#DOLNK^'O&.CP1:Y?:G:ZF94N8+TJQ3:F[S$*
MJ-HS@8Z<BDM]0U#Q#;^(]2MKV:V_LVXEMM/2-L(&B4$NPZ/N8XP>@'&#S3M&
M\46E]JT=Q+IVJ-J-T1"BO8R)';1DY(W, /=CW( ["H+.*?PW8>)]+:VFEFN[
MJ>YT\1QEA.)5&%!'&0V0<]!R>.: 'V?BF;Q1J'A^P@=[:*]TYM0O?*8JV 0@
M16'(&\G)&#A1ZFGP^,!H5KXFBU61[C_A'Y5V.3\\L<BAHE)[MD[<_0GO572_
M#LWA'5?#M],#)!#I3:=>2(I81/N$@8X_A+;AGMQGK5+4_#&H:QIOB?5X+9S+
M?WUO/;6[KM::*WP!P>FX!L ^WK0!T_AG48M0D#7FLQ76JF,2R6D$V(X%/\*J
M#\P'3<<\]QP*Z6N1NXEU_P 8^'=4TY) E@D[W,K1LFU73:L9R!\VXYV]L'..
M,]=0 4444 %%%% !1110 4444 9&F_\ (P:S_O0_^BZUZR--_P"1@UG_ 'H?
M_1=:] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %86N&Z&M:0;)(7FS-@3.57&P9Y )K=K(U'_ )&+
M1_\ MO\ ^@"@ \SQ)_S[:7_X$2?_ !%'F>)/^?;2_P#P(D_^(K6Z5P>B^(9_
M$_B6067BY;1(9B3H[6"B1HE./OOR=P&20#C=CM0!TWF>)/\ GVTO_P ")/\
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M ,")/_B*/,\2?\^VE_\ @1)_\16O10!D>9XD_P"?;2__  (D_P#B*/,\2?\
M/MI?_@1)_P#$5KT4 9'F>)/^?;2__ B3_P"(H\SQ)_S[:7_X$2?_ !%:]% &
M1YGB3_GVTO\ \")/_B*/,\2?\^VE_P#@1)_\16O10!D>9XD_Y]M+_P# B3_X
MBCS/$G_/MI?_ ($2?_$5KT4 9'F>)/\ GVTO_P ")/\ XBCS/$G_ #[:7_X$
M2?\ Q%:]% &1YGB3_GVTO_P(D_\ B*/,\2?\^VE_^!$G_P 16O10!RN_7_\
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MTO\ \")/_B*BF\:>&K>-Y)-:M D<WDNP?(#C&1D>FX9/09J]>ZQI^GLBW-P
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MR7$>G7\-R]L0)50\IGI^!['H: ,^RM-?LC-(MMICS7#[YI6N)-SG&!_!P
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M==T2\0R11:E8W4UC-*8]R&2,XW;<CJ"#C/>F>#M6U/6/ -EJDS)<:A/"[#<
MBL^Y@,XZ#@4 7O,\2?\ /MI?_@1)_P#$4>9XD_Y]M+_\")/_ (BL*67Q-X?\
M2:0EUK(U>TU2=K>6!K5(C"VPL&0KSM&TY!SQ]<UVE &1YGB3_GVTO_P(D_\
MB*/,\2?\^VE_^!$G_P 16O10!D>9XD_Y]M+_ / B3_XBCS/$G_/MI?\ X$2?
M_$5KT4 9'F>)/^?;2_\ P(D_^(H\SQ)_S[:7_P"!$G_Q%:]% &1YGB3_ )]M
M+_\  B3_ .(H\SQ)_P ^VE_^!$G_ ,16O10!A:$;HZQK!O4A2;?%D0N67&SC
MD@&MVLC3?^1@UG_>A_\ 1=:] !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %9&H_P#(Q:/_ -M__0!6
MO61J/_(Q:/\ ]M__ $ 4 :LDBQ1M(YPJ L2!G@5QVI3:-XPNM%O-#N8;N]M+
MV.87$'WH8@<R*YZJ&7(VGJ2..M=G28QTH X[Q%XN\/R7TV@WNI+! G%Z0C'S
M!WB!4'K_ !'TX'))7<@\1Z2]KITJS-'%J4ABLPT3#S",XXQP"%R,XXQ6M24
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MO##%<.2R*RC83O.06/0'GMVQ7H9 /49I: /,I+NU.B_$:-9XOWCS%%##YB8
MN0.^6&/K4MSJ=KI5UX9U;4I9UT>32?LINH'<+!,=A^8IR =N/J/:O2*0@$8(
MR* /--:70(-%TZ?34,=E=^)+>Y:2X=R)_F!DE <YV]<GIQGH<FQK9:]\8>([
M33)T-Y=>'1'"$<9>3,G /K@CZ9%>B44 <9X:\0Z!K]MI$$%J)-4L8PIA> AK
M%@FU\DCY1QCWX_# \/W&A7FBVWAK7H[Z37+.;:]@99@7E5B1(N#C:?O;N@Y-
M>HX SQUHP,YQS0!S_CZSO]0\#:M:::&:ZD@(54ZN,@LH]RH(Q[UBZM>6GBA_
M"DFARH]Q!J,5Q(L9^:V@56\U7'\/9<'O@5W=( !G  SUH Y#2;RV;XH:]&)X
MR[6=JJC<.2N_<![C(S]:D^)!V>&(IV!\N"_M996 SL02KDGV%=910!Q,E_87
M/Q6T^99HV7^QI2C-Q@F1<8SW*@D>HYZ5S<5T(?#DM[#YD]II_BB:XO([9CO6
M LX#C;S@%@PQZ9[5ZU10!S'AF3P[J6J7.KZ$9KIY85CGO6DE96P?E3YSR1SG
M'3C/6NGI  !@# I: "BBB@ HHHH **** "BBB@ HHHH **** ,KPM_R*6C_]
M>$'_ *+6J&MW,6JZ]9>'X;]()8_],FQM8_(1Y:8/4[CO_P" >]7_  M_R*6C
M_P#7A!_Z+6M6@#SZZE'A#XE6MW=:@)8->@,-T754\N2/'ENP'8@[<U8L+W2[
M3XD>*FU">VB\RULPK3LH#)L?<,GMTR*[FL'3="N[+Q5J^L2W$$D6I+"HB"$-
M'Y2D#G/.=Q["@#A-.MH](M_!D%\5MXQJES/%%/P8HF#F/(/3JO7N?6O5B8X8
MBQ*QQH"2>@ [FGT4 <))XZ\+ZCJ27-UJ.8;*0FUMUAD9I9.1YA 7W(4>^3SC
M%M!'H7Q$U#4;^1+>TU:RB*3RL%19(L@H3T!VD$>N#Z5V%)0!RG@>V;3M(U75
M+[_1DU/4[B_43?*4C8@+G/3(4'\:@^'-_:6?PPTZ>XN$CCM87,Q)_P!7AF/(
M]?:NSHH XC3?&7AW5=9@O7O#)>.?(L;187+1!R 2>,;FP,G.% QZD]O110 4
M444 %%%% !1110 4444 9&F_\C!K/^]#_P"BZUZR--_Y&#6?]Z'_ -%UKT %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5D:C_R,6C_ /;?_P! %:]9&H_\C%H__;?_ - % &O1110
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M7VU674#J<EO'<V<\40#^:N28RBJ01V!R/Z]AXMECA\(ZL9'"[[*9%!/+,4.
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MYEMI%CFCC9T9TW#(&>1D4 5/M'B+_H%Z9_X,9/\ XQ1]H\1?] O3/_!C)_\
M&*Q/#^H^*M<\)6>M07FF_:;F+S!;R6CA#R?EW"3(Z=<'Z5I>&/%5MXAT274)
MH_L,MI(\-[#*X_<2)]X%O3OF@"S]H\1?] O3/_!C)_\ &*/M'B+_ *!>F?\
M@QD_^,5+%KVD30W$T>I6K1VQ F;S5_=YZ;O3/;/6N<\.Z]<:U867B*3Q#;P6
MS;C>V+B,I&K$B,!N&5N!U)SSQ0!O?:/$7_0+TS_P8R?_ !BC[1XB_P"@7IG_
M (,9/_C%3#7=(-G+>?VG:+;POLEE:956-O1B3P?8U*=3T\74%J;ZV%Q<KN@B
M\U=\JXSE1G)&.>* *GVCQ%_T"],_\&,G_P 8H^T>(O\ H%Z9_P"#&3_XQ6+I
MOB66QN?%,NN7X:TTJY58V\L+M0QAMH Y)R?<UT6CZK;:SI<%_;21NLJ*S!)
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MSW$J111C<\CL%51ZDGI0!G?:/$7_ $"],_\ !C)_\8H^T>(O^@7IG_@QD_\
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M_&*U:* ,K[1XB_Z!>F?^#&3_ .,4?:/$7_0+TS_P8R?_ !BM6B@#*^T>(O\
MH%Z9_P"#&3_XQ1]H\1?] O3/_!C)_P#&*U:* .8\-SZZOAC2A#INGO$+*'8S
MW[JQ&P8) A.#[9/UK2^T>(O^@7IG_@QD_P#C%'A;_D4M'_Z\(/\ T6M7;^]B
MT[3Y[V?/EP1EV &2<#H/4F@"E]H\1?\ 0+TS_P &,G_QBC[1XB_Z!>F?^#&3
M_P",52\%>(+K7M*G&I0K;ZG97,EO=PCHC Y&/;:1SWYK0NO$>AV/G_:M7LH?
MLY59@\ZCRRV=H//!.T\>QH 9]H\1?] O3/\ P8R?_&*/M'B+_H%Z9_X,9/\
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M_8Y-#\5:-=J=1U::*/5;10 EQO.9,)_ T?/X*<\YSW/]J:E_T+]U_P!_X?\
MXNHTN[R.9ID\,S+*_P!YQ+ &;ZG?0!LT5E?VIJ7_ $+]U_W_ (?_ (NC^U-2
M_P"A?NO^_P##_P#%T :M%97]J:E_T+]U_P!_X?\ XNC^U-2_Z%^Z_P"_\/\
M\70!JT5E?VIJ7_0OW7_?^'_XNC^U-2_Z%^Z_[_P__%T :M%97]J:E_T+]U_W
M_A_^+H_M34O^A?NO^_\ #_\ %T :M%97]J:E_P!"_=?]_P"'_P"+H_M34O\
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MU-2_Z%^Z_P"_\/\ \70!JT5E?VIJ7_0OW7_?^'_XNC^U-2_Z%^Z_[_P__%T
M:M%97]J:E_T+]U_W_A_^+H_M34O^A?NO^_\ #_\ %T :M%97]J:E_P!"_=?]
M_P"'_P"+H_M34O\ H7[K_O\ P_\ Q= #=-_Y&#6?]Z'_ -%UKUA:'-+/K.L2
M36SVSEX<QNRL1\GJI(K=H **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ K(U'_D8M'_[;_\ H K7K(U'
M_D8M'_[;_P#H H UZY'3O$.L^(-8=M%N] DTJ&?9(K2.]T$4X8X4[1G!*Y[$
M5UCLJ(S.0J@98DX %<7K.B:2-6T/6?#R6\&H/>1@/9[0MQ;D_O=VWA@%R<^H
M [T 7]?OO%MNEU>:/;:;]ELU+>5=[S+<A1EMI! 7N!G.<9X%;.BZFFM:)9:I
M'&T2W<"3!&ZKN&<5EZ_J^GW$DN@-JEM:M(F+N1YU0Q1MU49/WV&0/0')[ Z5
MGJ&D)96:VEW;+;2GR+0+( LFW(VI_>QM/3TH PO$6K>+=-MKS5K&STTZ?8AG
M>WG+^?-&GWF# [5Z$@8/'/?%6M;\51V6@V-Y;3V=M<ZGL%K_ &A)Y<2[EW$N
M1S@+Z=R!WIFO:KI6I2S:!-J=K!#PM^TDZH=AY,0R>K#KZ*3W(K0G3P]K=K;V
M]PEA>0SQEK>.15;>G0E >W3D>U #--D\1_V1+)J*Z7/>LW[@6;.(=IQ@L6Y[
MD\=AQ531=5UW_A)KS1-:BLY?*MDNHKJS1D7:S,NUE8G#94XYZ"H/!EO#H>GZ
ME;BZ TB&_9=/>:3A8R%RH8]5$A=1]*CL]/N-*^(S"ROKFXL[^S>:]@GE,@A=
M2HC8$\C<"0!Z*?3@ Z^L#2=;O[SQ;K.D74%O'#810/"T3,S,)-V=Q./[HX _
M$U+I+^*FO2-9@TA+7:<&SFE9]W;AE QU[UFZ,1_PLSQ,,_\ +K9?RDH ZRBB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#(_P"9P_[A_P#[4J[J6H6VDZ;<
M:A>2>7;VT9DD;T '\ZI?\SA_W#__ &I5/X@Z5=:UX%U6PLE+W$D(9$7JY5@V
MT>YVX_&@!^DW>OZSIL6IAK.PCN4$D-M) TKA#RN]@Z\D8. ./>KVDWUU)H_V
MK6(X;.=))5E4/\BA9&4$$]B #GCK4'A75[/6/#-E=VLJE1 JR+GF)P &5AV(
M-8WB+45E\4^$V<[M(FN9PSL/W;S!/W)]^=VWU.".QH ZR&ZM[BW^T0W$4L.,
M^8C@K^8XI$O;265(H[J%Y'3S$19 2R_W@.X]ZX'5[%%U[QC#%"C:;)HHFN8R
MH*+=8?!QT#;5!/?H?2JTFEZ<NB?#Z86L*RSRV\<L@7#2*ULVY6/4@X (/&.*
M /2(;RUN8FE@N8I8T)#.CA@I'4$BDCOK2680QW4+RL@<(L@+%3T;'I[UY]>6
M-G#J?CZRBM84M_[*AE\E4 0/Y4OS = >!S["J\NB6,7AOP1J6E6\<>JO<6>V
M>(?O)5*?O QZLNT'.>@&.!0!Z2+VT,1E%U"8U."XD& ?3-4[SQ!IEEJ=EITU
MU&+B]#-&N\<*%)W'VZ >I-<1)-:6^D_$:">2*-VEF81N0"=UNNTX]STIZ/8_
MVO\ #^>9H/*.F7 :1RNWB&+&2?3F@#T"6]M()XX)KJ&.67_5QO( S_0'K1->
M6ML2)[F&(J QWR!< G&>??BO/(_[(UN/Q-I7B'6?L,XU"7SHW,2/Y0(,+J64
MG&T+C']:MPZ)I-_\1Y[:\LX[J-]"@=UNHP3(WF,-[C&-^ .<9% ':ZEJ%MI.
MFW&H7DGEV]M&9)&] /ZUE:5=:_K.GQ:ENL]/CN%$D%M) TKJAY4NP=1DC!P!
MQZFHOB#I%UK?@/5-.L%+3O$K1HO5MC*VT?4+C\:M>&=4M/$'A>TN('(#0K'*
MBL5>)P,,IQRI!H M:1<W\NFM)J\,5O<QRRK((R=FT.=K GL5P:LPWUI<6[7$
M%U#+"N=TB2!E&.N2.*\MM=6NO^$$T[4=3U&ZEMFUSR[VXD;S-D*LZJ2#D;0P
M0GBM/7],T-M&\4W]IJ7]HSW.EL\ZJ8FA4JI\M_D48?K@^@- 'H$=Y:RS>1'<
MQ/+L#[%<%MIZ''I[TCWMI'=+:O=0K<.,K$9 '8>PZUP@L;.Q\0> Y[6WBAEG
MCF661% :4&VS\QZMSSSWJC8KI&O>';ZSUS6Y;34(-0D>YB0Q+.DRRDH4)4L2
M1M"XSQ\H]* /29+RUA<I+<PHP*@JT@!!;[H_'!QZXH-]:+=BT-U"+@C(A,@W
MG_@/6N,TS1-)O?B+XG2ZL+:;9'8RA9(P0'VN2V.F[@<_XUA:M?V,^D175C)!
M;P?\)*C[97W7#RB;#N23\@]!@_+CD=* /18=>TZXUNYT>*YC:ZMD1I%##@MN
MPOUPN2/<5;6]M'NFM%NH6N%&6A$@+@>XZUQEO)#'X\\326OV?[3)I]L]I]WY
MW*R8*^N215#P^F@ZWH7AVYDUR47UE-$RP1F)9A<=)$8;=Y!)8MGJ.2>] '6^
M+=;;1M OKBTNK2.^@MGGBBG^;?M!)PNX$].M:.FSR7>D6EQ(1YLT".QQQDJ#
MTKSE;FUU'X;^,#J7E-J:377VI)<;E=<^5UYP %"_3BO0= =)/#NG.C!E-K'@
MJ<C[HH P=&UKQ!J^HZW:FZTRW72[KR YLY&WC;G)_>C'6M^RNKF#2EGUN2U@
MF0L)71ML6 Q"L-Q. 1@\GO7$Z%HD&N:SXUMY+N[@+WQCS;W+Q@9C R0I /XU
MK:K,T/Q&\/VUY_QY-:3?9]WW3<C'_CVS./J<4 =4MS ]O]I2>-H-N[S0X*X]
M<],4S[?9E787<&(\;SY@^7/3/IGM7G&KV2QVGQ$MXXD.F) DL2%04CN#"6D*
M^ASM)]S4_BK0](MOAQ!=P6%M'<2M8L\ZH [GS$&XMU)PS<YSR: /01?6A,P%
MU#FW_P!</,'[O_>]/QI1=VS6OVI;B(V^W=YH<;,>N>F*XVXT?3$^*5E MA;K
M%+I,K21",!7*RIM++T.,GK6;IECY^A:GI]A?Q:=+!XFG%@'3="'1MZQE?[IP
M>.QQCF@#T6WNK>[C\RVGCG3.-T;AAGKU'U%2US7@Z_GN7U:WOM,BL-2M[L?;
M! VZ*5S&F'4^ZA>#SZ]:Z6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#*\+?\BEH_P#UX0?^BUJAXXUS4O#NAKJ.
MG"U9A/'$R7$;,#O8+D$,,8S5_P +?\BEH_\ UX0?^BUKGOB1<P7^@2:7:S1S
M7L=]:!X$;+J6D&W(]Z .MEO(+&&,ZA>6\3-QN9A&K'V!/]34KSPQE \J*9#A
M S ;CC/'KQ7&Z]=6$OB35;93!%=1Z0%N)KM\IY3%B%1,C))ZMG ^7@U@V4-C
MJ-G\.3,D-PVQH92<,2!;D[&]NG!]?>@#T^WN8+N+S;:>.:/)&Z-PPR/<5F>*
M]5O=$\-7VIV,$$TMK$TNV9B%P!D]!S]./K61X1@@LO&/BZRM(DAMH[FV=8HU
M"JK- I8@#@9-7_'W'@+7/^O&7_T$T /U;Q"=)\,0ZF\2R7$XA2*/.U6ED( &
M>PR<GV%1_P!MWNF>)K+1]5>WF34H9&MIX(FCVO& 71E+-QM.0<]B,=Z=>:%;
M>)/!MOIMS))$KP1.DL9^:-U *L/H16':6.H:UX\L9[F^6^M?#\4JO<I (DDN
M)%VE ,G)"\L0< X&!S0!8;QAJ'_"*CQ='%;MI8D+&U\MO.\C?LW[]V-W\6W;
MC'&>]:?BS7KS1='@U#3H;>>.2XAC=I6;A7<+E0.OWO4?C7*Z[X;N].T,^"]&
MU-IHM3EQ!:M""UI"7W2,SY_U8YQD9R0 36Y\0(H[;P9% G"1W=FBY/83)_A0
M!UU%%% !1110 4444 %%%% !1110!D:;_P C!K/^]#_Z+K7K(TW_ )&#6?\
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M4_[XC_\ BZ/[<G_Z .J?]\1__%UKT4 9']N3_P#0!U3_ +XC_P#BZ/[<G_Z
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MU3_OB/\ ^+H_MR?_ * .J?\ ?$?_ ,76O10!D?VY/_T =4_[XC_^+H_MR?\
MZ .J?]\1_P#Q=:]% &1_;D__ $ =4_[XC_\ BZ/[<G_Z .J?]\1__%UKT4 9
M']N3_P#0!U3_ +XC_P#BZ/[<G_Z .J?]\1__ !=:]% &1_;D_P#T =4_[XC_
M /BZ/[<G_P"@#JG_ 'Q'_P#%UKT4 9']N3_] '5/^^(__BZ/[<G_ .@#JG_?
M$?\ \76O10!D?VY/_P! '5/^^(__ (NC^W)_^@#JG_?$?_Q=:]% &1_;D_\
MT =4_P"^(_\ XNC^W)_^@#JG_?$?_P 76O10!D?VY/\ ] '5/^^(_P#XNC^W
M)_\ H ZI_P!\1_\ Q=:]% &1_;D__0!U3_OB/_XNC^W)_P#H ZI_WQ'_ /%U
MKT4 9']N3_\ 0!U3_OB/_P"+H_MR?_H ZI_WQ'_\76O10!D?VY/_ - '5/\
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M_P#Q=']N3_\ 0!U3_OB/_P"+K7HH R/[<G_Z .J?]\1__%T?VY/_ - '5/\
MOB/_ .+K7HH R/[<G_Z .J?]\1__ !=']N3_ /0!U3_OB/\ ^+K7HH R/[<G
M_P"@#JG_ 'Q'_P#%T?VY/_T =4_[XC_^+K7HH QM%-Q-J>IW<UE/:I.\?EK.
M%#'"8)X)[ULT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIX48JTJ*1U!8"GEE! + %C@9/6@!:*** "BBB@ HHHH **** "BBB@ HHHH
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M#E=: \/^.6\3Q );*8;340!@>5)PLA_W7"\^A-/UC_B9?$+PY>/\]M%>7%O
MIY4E(7+O_P!]C;_VS]ZZ:?P]#>#4H[RXDGAU*$0RQ,J@* ",K@9SS^=0R>%;
M8S:,\%U/;KHH/V>--I#938=V02>"?3K0!M2Q1SQ-%*BO&XPRL,@CT->=1W$U
MK\%-/6W=HS,L-NSJ<%4>8(W/T)'XUZ,ZLR%5<HQ'# 9Q6-:>%K*W\*CPY++-
M<V@C,8:0@.!G(.0!R#R#CL* ,R6\MM"\?/&7CM-/?1O.GZ*B&.4*K>@X<CZ
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M3C!!8FJ=V[7N@^.M3G)%U9W,L=O)_%"((E:/:>WS$M]378+HTCW+/>:E<7D
MG\Z.WD6,*A!W*,JH)"G!&3V&<XJ"]\+VE[+>!I98[?461KRW3&V8J .N,C(
M#8Z@=N: ,O5B+O4O!>H2Q*MS)=?,V.1NMI"1],U8\;01/'HDK1J9(]9M-C$<
MKF0 XK4U+14U*]TZZ-S+"=/F,T21A<,Q4KSD'C#'IBEUG1DUE+5'N98!:W,=
MROEA?F=#E0<@\9H R]6$L/C*TN;RSFNM+:QDA7RX&F$4Q8$EE4$@,HQG'8CO
M7):->3ZG'X2T6X+G2KRXO9 CG_7PPDF%&]5P0<="%%>C:CIYU*W-K)<R1V[C
M;*L7RM(.XW=0#[8/N*K:GX<L=1L[2W4/9M8LKV<UMA6MR!@;>",8X(((([4
M1:Y86UK9R:S;VR)>:=;S20LB $_NV&T^HZ<>U<S;$Z;IO@6\MLM<7;+'<./O
M3B6!I'+'OEP&^HKLK?3Y@0U]?/>%00%9%1>1@D@#DX)Z\>U5+#PQ:V,UD?.F
MFBTU66RB?&( PQZ9)"_*,]![\T <=97,J>"/#6N@YU&ZU6*264?>D,TI5U)]
M-K8QVVCT%(;J7_A7DGB4_P#(4_MCSQ)_$"+OR=GT\OY<>E=C!X6LX)+=1+*U
MI:W+75O:G&R.1B3GID@%F(&>"?88#X6LS*5\V7[&;S[;]DXV>=G=GIG&[Y\?
MWO;B@#+\1^%=!N9[>(Z3:2WVIWJ[[B2(/)M!\R0[CR/E4J/3<*L:_#'_ ,)I
MX5GV+YHGN$WXYQ]G<XK=>P2358M09V+0PO$B=AN*EC]?E4?GZU7U#1EU#5-.
MU!KJ6)].=WC1 NUBRE#NR,]">F* -*BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KS;0K;5M0M?&VGZ;'9_Z5K%U$9KB5AY>Y5!.T(=W!]17I# E2 =I(
MX/I6-H'AN/0+C4)8KZYN/[0N6N95F"8$C8R1M48' XH R8=.E\.VVB^'X=4D
M,$-HZF&W7_2;B08PPR"%09.22 "5!)K/M?%&L/X T74KB<K)<:B+6_O-B@PP
MB9T+G^$'Y5!/0;LUTVH^&TOM>M]9AU"[LKF&!K=S!LQ+$3NVG<IQR.HP:YG6
MM#@\-Z'I^DQWVL)8&_:=KV%?--F 6< @*<@NW4@\\D\"@"7^WM2TV[\47JWT
MM]I>D6RR6JL$*/(4+,A<#+8('?C=S6A9IXD_M33+N.X>6QE0B^6XDCVMD#:\
M849!SVS@CWYJ#0H+C4)9;5M:NM;T>>W>.=;NR$*C.  K!5W9!;(Y ]CC-[0O
M!RZ(\2'6=1O;2V_X];6X=2D/&!T +8' R<#TZ4 =&V=I*@%ATR<<UPEK=:I:
M:[XIM+ZR@34[BQ^UVUS:LQ62)5*(O/(*G\R3[5U^J65Q?6RQVNHSZ?*L@<2P
MJC$X_A(8$$&FV.E):7,MY+/)=7<R+&\\H4'8N2%    R2?QY)H \[U(+'^SU
M;&#[XMK9HRO7S/-0\>^:]#UO4SHWA^^U1X_,-I;/-L'\152<?G6?%X0LXHX+
M3SYFTVWN?M,-D0NQ7W%@,XR5#'(7/7'8 5MW%O#=VTMM<1K)#,A21&Z,I&"#
M^% '%ZCJNK:-X=T?Q)_:,ET9WM_MMNRKY<B2X!V #*E2PQSR.N:E2SE/Q=G;
M[?<@#1XY,#9C'GO\GW?N\?7WK2L_!\-M:V=A-?W-UI]A*LEM;2A?E*\H&8#+
M!3T'L,YQ5I?#ZKXI?Q!]ON#,]N+8PD)Y?EABP'3.<D\Y[T :YSC@ D=,UR&A
M7%];^/\ 5K+5[*W6ZO+9+F"ZMV)5H$.P(<]""V??<?:NDU.SN+ZT\JUU">PE
M#AA-"JL>.Q# @@U%9Z0MO<2WDUS+<WDL8B-PX4%4&2%4   9)/J>^<# !S_B
M^XO['6]$OI[&VNM'@O45@KMYL4K_ +M),8P0-Q&/?\NQK%MO#TNV!=3U>ZU-
M+:02Q+,D:C</NEMJC<1U';/.,@5M4 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
/ 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>70
<FILENAME>ebs20191231exhibit1048031.jpg
<TEXT>
begin 644 ebs20191231exhibit1048031.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V:BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHK+U?6'TR6UABLVNI+DL%"N%Q
MM&3R: -2BL#_ (2#4/\ H!O_ .!*4?\ "0:A_P! -_\ P)2@#?HK _X2#4/^
M@&__ ($I1_PD&H?] -__  )2@#?HK _X2#4/^@&__@2E'_"0:A_T W_\"4H
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MT W_ / E*/\ A(-0_P"@&_\ X$I0!OT5@?\ "0:A_P! -_\ P)2C_A(-0_Z
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/^(?\
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MO_(6UC_KI%_Z+%=!7/\ AW_D+:Q_UTB_]%BN@H **** "BBB@ HHHH ****
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M:03V$/DV7A2ZMH\YV0BV1<^N!)4^F^(=:75;ZUU^QL+2"RLA=2S6UPTFT$G
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M:0.I( 8$D9&#U'K0!QJ:?Y<PF3P=,LH.0X2U# ^N?,I]S:RWK!KKPE<7#*,
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MO:A_WW!_\=KJ:* .6\_4_P#H7M0_[[@_^.T>?J?_ $+VH?\ ?<'_ ,=KJ:*
M.6\_4_\ H7M0_P"^X/\ X[1Y^I_]"]J'_?<'_P =KJ:* .6\_4_^A>U#_ON#
M_P".T>?J?_0O:A_WW!_\=KJ:* .6\_4_^A>U#_ON#_X[1Y^I_P#0O:A_WW!_
M\=KJ:* .6\_4_P#H7M0_[[@_^.T>?J?_ $+VH?\ ?<'_ ,=KJ:* .6\_4_\
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M:C"HC6X ^@$E/\_4_P#H7M0_[[@_^.UI:)K;:JE]!)"L=]IT[03Q!OE+8RK
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M74T4 <YX8,S:EK#3VTMLYDB_=RE2P^0?W21^M='61IO_ ",&L_[T/_HNM>@
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M-QM=,GA^^5KP$7)&G3 S ]=W'S?C2E/#AAMH3H%]Y=F=UNG]G38A/JHQQ^%
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M )\=4_\ !?-_\31_PD=M_P ^.J?^"^;_ .)H UZ*R/\ A([;_GQU3_P7S?\
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M;_>^4_H ?RH ]&HHHH **** "LK6/^0AHG_7^?\ T1-6K65K'_(0T3_K_/\
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M\\NQT,CG+,%=E&3WX KI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3U]O6@#-AU'PY;V<MK')=!)P1*YCN#(^1C)D(W$XXSG(K'M]$^']K+#)%9W
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MV_V/[9YR"W\OS?-)^79C.[/ICF@#&L]9T"P606[SJ97WR.UO,S.V ,LQ4D\
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M]>: ,;3CX3TN0/:F\^1B\:2BYE2(GJ45LA3R>@'4UK?\)1I'_/>;_P !9?\
MXFJ]_P"+%L]6.G0:'J^H%&5'GL[=6B1C@[2Q88(!!/IFM^@#(_X2C2/^>\W_
M ("R_P#Q-'_"4:1_SWF_\!9?_B:UZ* ,C_A*-(_Y[S?^ LO_ ,31_P )1I'_
M #WF_P# 67_XFM>B@#(_X2C2/^>\W_@++_\ $T?\)1I'_/>;_P !9?\ XFM>
MB@#(_P"$HTC_ )[S?^ LO_Q-'_"4:1_SWF_\!9?_ (FM>B@#"T*\@OM8UB>W
M9FC+Q %D93Q&.Q -;M9&F_\ (P:S_O0_^BZUZ "BBB@ HHHH **** "BBB@
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M9FJ^(=$DOM':/6+!Q'>EG*W*$*/(E&3SP,D#\10!T%YYWV*?[/\ Z[RV\O\
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M5"US8QM''_I< 4AL;LC'? ].G&*H2Z5X/GMK^"7Q2C"^NEO&<7\*M',",.A
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M?]!S3O\ P+C_ ,:/^$FT#_H.:=_X%Q_XT :=%9G_  DV@?\ 0<T[_P "X_\
M&C_A)M _Z#FG?^!<?^- &G169_PDV@?]!S3O_ N/_&C_ (2;0/\ H.:=_P"!
M<?\ C0!IT5F?\)-H'_0<T[_P+C_QH_X2;0/^@YIW_@7'_C0!IT5F?\)-H'_0
M<T[_ ,"X_P#&C_A)M _Z#FG?^!<?^- &G169_P )-H'_ $'-._\  N/_ !H_
MX2;0/^@YIW_@7'_C0!IT5F?\)-H'_0<T[_P+C_QH_P"$FT#_ *#FG?\ @7'_
M (T :=%9G_"3:!_T'-._\"X_\:/^$FT#_H.:=_X%Q_XT :=%9G_"3:!_T'-.
M_P# N/\ QH_X2;0/^@YIW_@7'_C0 WPM_P BEH__ %X0?^BUK"\2_P#)3?!7
MTO\ _P!$K5SPWXAT2#PQI4,VL6$<D=E"KH]R@92$ (()X-5]4'AG5=:L]7?Q
M9%!<V <6WDWD&V/>,-PP.<@=\T 4OBR-VC:2D'_(0;5H/L>W[V_)Z?Y]*EDD
MUGQ-)KT>G70MI[&Z:UM6%X\7DLJ*0S(J$."Q/WLC'  ZFY;GPE'JB:K<Z_:W
M]]$I6*>ZOHV\H'KL4$*N?4#-4[[3_"%YK<FKP^*?L$]PH6Y6RU1(EN .!O .
M<XXR"#0!/8W=YKFNW.BZA>M"UCI]N[FQF:,332!MTBL,$JNT8'3GD'C'0Z-!
M=VNDV]O?WZZA<Q*4DN0@3S"">H!.#V/N*YG5+'P=J-[:WT'B2+3+JUA\A)K#
M4(XF:(=$/4%:VK/6_#5A:1VL&MZ>(XQ@;KU&)[DDELDDY))Y)- #/$T']J:=
M+X=M@!)?ILE('$$)/SN?<C(4=S[ D9/D"W^+ME#MVVT?A]DMQV#"900/^ XJ
MO+IGAN6[N+H>/KV*2Y??)Y.L1H">G0#@ <"M.67PJ\-@L?B"TAFTY=MO<I>Q
M&105VMDMD-N'7(.3SU&: *_A+>?&WC)E_P"/?[5;A?3>(AO_ *5-X#_U.O\
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MDDR6UI=1"!-[O=6;0J!]6 JO9^,]!N]5@T[RKFW>ZS]EEN;-XH[G']QF'/\
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M]3AM!X@\57(9X4?[-"%&2T<)*X'UE:3]*Y5_$FA?\)KX:O#J:3SEKIKR98I
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MWG],4ZUU+5O$.F:UJ-AJ3V;V5U-!:1+&A0^5WDW D[CGH1@8QSS0!UWDQ?\
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M42( V#TR.U<_\3?^2<ZU_P!<!_Z$*AU6]U:WU;PK96%^+>"_$D<RF%7SMA+
MY/.>/ID#.>E '6>3#_SS3_OD5C6?B&POKVUA@T^Y:"\5VMKP0J8)-O7D$E>
M2-P&>V:RM*NM4N4\3Z->:K-,^FR@0W8CC60HT8?:1MV\9(SCOVK+T'4KK1_
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M=/FTV_D^PBR%S.-J'S"_$:D[<@_+(3@C&!ZT ;ODQ?\ /)/^^11Y,7_/)/\
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M*** "BBB@ HHHH **** "BBB@ K(U'_D8M'_ .V__H K7K(U'_D8M'_[;_\
MH H U7#%"$8*Q'!(SC\*Q?#GAP^&[&XM(+Z2X6>9Y]TL8RKN<GIC(SVK<HH
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MCJ6F1^5#>PHI+)C!5U.0PX'XUMZ;8?V=:>4UQ+=2LV^6>8C?(Q[G  '
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M_?P?XT 6**K_ -H67_/Y!_W\'^-']H67_/Y!_P!_!_C0!8HJO_:%E_S^0?\
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MD'_?P?XT?VA9?\_D'_?P?XT 6**K_P!H67_/Y!_W\'^-']H67_/Y!_W\'^-
M%BBJ_P#:%E_S^0?]_!_C1_:%E_S^0?\ ?P?XT 6**K_VA9?\_D'_ '\'^-']
MH67_ #^0?]_!_C0!8HJO_:%E_P _D'_?P?XT?VA9?\_D'_?P?XT 6**K_P!H
M67_/Y!_W\'^-']H67_/Y!_W\'^- %BBJ_P#:%E_S^0?]_!_C1_:%E_S^0?\
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MVE?] RS_ ._"_P"%7:* *7]C:5_T#+/_ +\+_A1_8VE?] RS_P"_"_X5=HH
MI?V-I7_0,L_^_"_X4?V-I7_0,L_^_"_X5=HH I?V-I7_ $#+/_OPO^%']C:5
M_P! RS_[\+_A5VB@"E_8VE?] RS_ ._"_P"%']C:5_T#+/\ [\+_ (5=HH I
M?V-I7_0,L_\ OPO^%']C:5_T#+/_ +\+_A5VB@"E_8VE?] RS_[\+_A1_8VE
MC_F&VG_?A?\ "KM% %+^QM*_Z!EG_P!^%_PH_L;2O^@99_\ ?A?\*NT4 4O[
M&TK_ *!EG_WX7_"C^QM*_P"@99_]^%_PJ[10!2_L;2O^@99_]^%_PH_L;2O^
M@99_]^%_PJ[10!2_L;2O^@99_P#?A?\ "C^QM*_Z!EG_ -^%_P *NT4 4O[&
MTK_H&6?_ 'X7_"C^QM*_Z!EG_P!^%_PJ[10!2_L;2O\ H&6?_?A?\*/[&TK_
M *!EG_WX7_"KM% %+^QM*_Z!EG_WX7_"C^QM*_Z!EG_WX7_"KM% %+^QM*_Z
M!EG_ -^%_P */[&TK_H&6?\ WX7_  J[10!2_L;2O^@99_\ ?A?\*/[&TK_H
M&6?_ 'X7_"KM% %+^QM*_P"@99_]^%_PH_L;2O\ H&6?_?A?\*NT4 4O[&TK
M_H&6?_?A?\*/[&TK_H&6?_?A?\*NT4 4O[&TK_H&6?\ WX7_  H_L;2O^@99
M_P#?A?\ "KM% %+^QM*_Z!EG_P!^%_PH_L;2O^@99_\ ?A?\*NT4 4O[&TK_
M *!EG_WX7_"C^QM*_P"@99_]^%_PJ[10!2_L;2O^@99_]^%_PH_L;2O^@99_
M]^%_PJ[10!2_L;2O^@99_P#?A?\ "C^QM*_Z!EG_ -^%_P *NT4 4O[&TK_H
M&6?_ 'X7_"C^QM*_Z!EG_P!^%_PJ[10!2_L;2O\ H&6?_?A?\*/[&TK_ *!E
MG_WX7_"KM% %+^QM*_Z!EG_WX7_"C^QM*_Z!EG_WX7_"KM% %+^QM*_Z!EG_
M -^%_P */[&TK_H&6?\ WX7_  J[10!2_L;2O^@99_\ ?A?\*/[&TK_H&6?_
M 'X7_"KM% %+^QM*_P"@99_]^%_PH_L;2O\ H&6?_?A?\*NT4 4O[&TK_H&6
M?_?A?\*/[&TK_H&6?_?A?\*NT4 4O[&TK_H&6?\ WX7_  H_L;2O^@99_P#?
MA?\ "KM% %+^QM*_Z!EG_P!^%_PH_L;2O^@99_\ ?A?\*NT4 4O[&TK_ *!E
MG_WX7_"C^QM*_P"@99_]^%_PJ[10!2.C:63DZ;:?]^%_PH_L;2O^@99_]^%_
MPJ[10!2_L;2O^@99_P#?A?\ "C^QM*_Z!EG_ -^%_P *NT4 4O[&TK_H&6?_
M 'X7_"C^QM*_Z!EG_P!^%_PJ[10!2_L;2O\ H&6?_?A?\*/[&TK_ *!EG_WX
M7_"KM% %+^QM*_Z!EG_WX7_"C^QM*_Z!EG_WX7_"KM% %+^QM*_Z!EG_ -^%
M_P */[&TK_H&6?\ WX7_  J[10!2_L;2O^@99_\ ?A?\*/[&TK_H&6?_ 'X7
M_"KM% %+^QM*_P"@99_]^%_PH_L;2O\ H&6?_?A?\*NT4 4O[&TK_H&6?_?A
M?\*/[&TK_H&6?_?A?\*NT4 4O[&TK_H&6?\ WX7_  H_L;2O^@99_P#?A?\
M"KM% $-O:6UHI6VMXH0QR1&@7/Y5-110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44@8$D
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M$$'VH*3_ *FY0?-$/;R]H'_7.NHO-$:]M/)DU*Y#M*DDD@"9?8P8+@K@+D=
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MZ-S+"=/F,T21A<,Q4KSD'C#'IBEUG1DUE+5'N98!:W,=ROEA?F=#E0<@\9H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
@ !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>71
<FILENAME>ebs20191231exhibit1048032.jpg
<TEXT>
begin 644 ebs20191231exhibit1048032.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=0'3]6 DWQC9'%(<E002=N#N7!/=31KZV6H_'>VBEO#% UFT+SPSF,QOY;X
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M82R;7WQQ2G&U0W0MU]\'GI5[XQ^&+_7_  _:W>F0M/<:=*9#"@RSH0,X'<C
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M5+3X=:?I3;[VQF,ETB?>ME5EWEQ_#T/7K0!Z[K#31Z/=RV\[P2QPNZ.H4D$
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MXKT*PO?L=UJ,<<HD6)B58HCL,JK.!M4D#."0:XKQ1-"GQO\ "^9$58K=E;G
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M#Q!IV598T5D=\$KPP. V"/4$=:G\&^*]*TWP':1:I=)97>F0>1<6DQV3*R<
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MX45SZD  U9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4 -*J6#%02.AQR*=110 G?-+110 4F!G..:6B@!" 1@C-+110 @ '08K.O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWEM(\L,T*7 1@ LA8DE<]1N/>G/X9U)W\-M]JM0=#^]\C?OOD\OCGY>.>_-
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MEA??8R^I&6.Y@A4L;.14+A?,#%6/&"./7BI;+Q-J,+^(K75S:+=Z5^\@$$+
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MFB9FD16*;F8,,$XW  =.,\\:'A_0_$>G""SU+7(+NPL\"'R[<I-*!PHD;=C
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M#!=R2<MCH  !G//& #$\0W&K7UGX3U"[:U6&ZU>SE-O'&VZ+=DJ-^[YL X/
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MS,B?O"3D8&20,>F3G.* .FADL=<TF"X$<=S9W<23()8\AU(#*2I'T/-6P H
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M[0[F8(Q*E6SQUP<@_P!1=N];L;+5K'2YWD%U?EA HB8JVU2S?-C X'3.:T*
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MD69W%48L!)\W)[<;?QK=MM"NX?&%SKKWD+QW%JEL8!"00%)(.[=ZD\8K=HH
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M=VCVNGM=)+:Q6Y5IBC%4(8M\O( Q@\=SVZ-=%N+O5;35+^\@GDLHW%JL4)1
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M/JUA*L<%\L?VN*)6?[*>LIC4D;AT/;G..,5O>&]0&IV$EW'J<.I6SRG[//$
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MVC9(2L<29W'"EB22W).>P''=GA;09_#NFO8RWR7:M-),&6 QD%V+$?>.>2:
M,CQM_P C)X/_ .PF?_0#78USWB3PU>:[?Z9=VVJ169TV8SQAK7S=S8QS\XXQ
MFK']E:O=74;:CJ\#V\8;]S:VAA+,5*@EC(W3)('K@]J ,*'Q+JL&JZ'#=7,$
M[ZA<R6]Y!#'NA@8*S*$E Y8;<,"3WX%4=.3Q"&\63Z%>6ENUOJ\TGES0&3SV
M$49VDY&T>_)Y[8YT;7P'?P66C6S>(=RZ-/OMBMDHRFUEPWS'+8;[W3U4U?7P
MO>V\VKI9ZJD5KJ\S32AK?=+$S*%;8VX#H!C*G!]: *>E^+9_$MWI5C9G[$]W
MI?\ :-Q(%#L@+; B9X^]NY(/ Z<Y&=JGC'7+#P_XDC#VPU/09HU,IA)6:*3!
M1MN[Y6P>>HXZ<\;TOA"*UOM,O]$G6QN-.MOL:J\9D26#^XPR#P1D'/7KFH-2
M\$G4=#U:R.H+'=ZQ*LEW=>1G[NW:JKNX "@#)/?UH W-,AU6(W!U.\@N-\FZ
M%882GE+C[I))W<]^*N211S)LD0.H8-@^H.0?S JG<VNIS0V8AU*.WEBF1[ED
MM@5G09W( 2=F>.<DC%7Z .-?_DM47_8O-_Z4"F^)H9D\=^%8[ Q0R,M^0[H6
M5240EL C)R2>HK4;PY=-XV7Q*-1B 6S^Q_9OLQ_U>_?G=O\ O9[XQ[5+J6@W
M%_XGTK64ODB735E58#!NW^8 &^;<,< 8XH Q+7Q9J-EHFLF_,5W>Z=J8L(9%
MCV"4N4",RYXQYG(!'2M33;GQ$OB+[/=6\LVE20;OM$R1QO%*#]W"MRI'MD>M
M56\#"YLM=LK_ % 2PZS<?:<PPF-X)!MP5.XYQL4]*T-#T?6+)U?6=>;5&B7;
M"%MEA _VFP3N;''IR>* $UG69H=>TO0;1UBFU 2R/,5W&.., G:#P6)( SD#
MDX-8>H>*-9TM?$FG/+;R7FE67VZUN7AXFB(/#*" &!&,C@]<5OZ[X>.JWNGZ
ME:W7V34=-D9H)2F]65AAT9<C((]P16+XHTE;#PMXHU>]N$EO;W3WB9U38B*J
M,%1023U8D\\D_04 1/KOB72[K0+Z_N+.YT[698K:2"* JUN\BY1@V?FY'/ ]
MA2>&9M8$/BVY_M-9IK?4YT3SH 5RL4>TX!!Q@ 8!K1TC1IM4TS0+C4+V&XMK
M&..X@CBAV[Y!'A68[CG:"> !SS[5/:>&+FQGUHVVJ 6^JRO.(GMP?*D=0K$M
MN&X?+P./J: ,VP\5WU[I?A2V+QIJ&O1-))-LXC5$WN57IDY &>!G/.,4MSXB
MU?3;[7-&EFAEN;/33J-E<O#]^,9!5U! R&&,C'TJ=/!#Q:-HEM%J06_T(_Z)
M>"#@KC:RNF[D,.#@C\*MS>&);O\ M2ZN;R(ZAJ-I]C\Y8#LABYX5=V3RQ))/
M)QZ4 9%IK^OQ-X4O;RZM9;;6U2.6W2#:49H=X</GKD<C&.<>];OC'4KW1O">
MH:EI[Q+<6L)D7S8RZG'; (Y_SBJ#>$+PV/AZV&JP@Z$R,C?9#^]VH4&1YG'R
MG\_RJ7XBND?P^ULNP4&U8#)[G@"@#/FUKQ)I&L:)+J%Q9W.G:Q*+8Q10%6MI
M&4E,-GYP<'.0/H*-&UKQ!>'5+^]O[-+'1]0N89XX[4[IHXU[$M\OKW[\UHV6
MC3ZE'H]WJ%]#<Q6"":W2*$J&DV;0['<<X!. ,<G/M4VA>&Y-*CU6&[NXKR#4
M[J6Y=!;F/:9/O+G<<C H Q+OQ-K%EX-M?&32126[B.>XL!&,+ [ #:W7> P)
M)X.#P*T8];O++QG=Z=JEV@L)++[79/Y87Y5/[P,>Y7@_0U';^"I4T-/#EQJ2
MW&BQR*5B:#$QC5MPC9]V",@#.W)'''6M+7_#5MK\^G332-&]A<>:"O\ &A!#
MQG_988S]* ,K4=7U[3+'P]+)/#OU'4H8+E'@PZI)DA00< @#!X/.<8IFO>)Y
M['7KG2I;\:3(\*G39IX@8+IR#N#.>A!P,9'KSG%;'B+09M=;33%>I;"PO8[P
M;H#)O9,X7[PP.35?6O#5WK4.I65Q?P/8:@ /*EM=[0':%)1MV,\9&1P>>: &
MOK=[;^/9M+N)8?[.323>@+&0ZL) IR<G/&>@'6LJ;Q/K*^"4\9Q/$T.!.^GF
M,;?(W8P'Z[PO.>F>,5M1^&7C\4)K O$:!-/^P?9GA))3=NR7W=<^W2J,'@F2
M'0Y/#9U(/HC296(PGSEC+;C%YF[&,\9VYP<>AH :=5UW4?%MUI-C?VMM;'3H
MKN"9K4NZ;V8<@M@GCKP/;O6GX,UBYU_PI9:C>*@N)/,23RQA2R.R$@=L[<_C
M21^'[F'Q7/KD5]"$EM%M1;FV/RJI+*=V_P!6].GIUJ3PKH4OAO0X]+DO$NUB
MD=DD6'RS\[ER"-QSRQ_"@#+2_P#$6H>*->T>WO[2VCLXH'MY?LI8KO#G!!;D
MY4<^W YXRK?Q9X@F\+Z%XFDGM%AN[B&"XLU@/S!WV%@Y.0<\@8QVYKIK70;N
MT\1ZKK,>H0DZA'%&(FMCB/RP0ISOY^\<]/PK*3P+<Q^#M/\ #B:O%ML9TF6<
MVA);8^]01O\ 7J<]* &^*_$&K:/%K%S%=01?884EM+>./S3*N,N9@!E%)RH.
M5Z=3TJU>ZUJ-EXCT1YID31]57RB/+&Z.<KN12WHW('&<BH;[P1=WCZ[&NN&*
MUUM!YT?V4,R2; N0Q;[O ^7&?0CK47B$6%SHB>#9M0^TZT\<7D^6FQU8,-LH
M ^Z%QD\]!UYY .@T6YNKUKVZEF#VK7+):+L (1?E))[Y8-CVQ7-W\.I7'Q1N
MHM+O(;.9M#BS/+#YNT><_1<@9^I_"NRL[2&QLH+2W7;%!&L:#T &!61=Z#=G
MQ/\ V]I]]%#,]H+26*> R(5#%@1AE(.2?7/M0!A:=XSU.>QAT^ZAC_M?^U)=
M-E>!<J?+0R-(JL1U7& 3U.?:MS0+G7FU#4+;5;9_LD91K.Z<(KR CYE95)&0
M>^!FJ=[X%@N-%2VMM0FMM0CO#?IJ"J"WV@D[F*]""#C;Z #M6MHVG:C9J\NJ
MZI_:-TX"[UA$2(H[*H)Y.>3GGCTH HZGK%W)X@;1+'S4:*T6XEEAC1V&YBJ@
M!R!CY23UZCI67>ZIXQM?!ZZO/;Q6]Y8N6O;8(K>? IY=/F.UMO."3T/M6GKO
MAB[OM:M];T?5SI>HQ1&W=S")HYHLYVLI(Z')!S5G^P[MDLXY]3^T1QS>==B6
M#FY?^'HP"*#@@8/W1G/.0#/7Q)/;^$KWQ1)*EQ:R*9;&$ +A"<(&8=R2,^G3
MJ#3X+GQ0FN6\/DM-87$+^=-/#&GV:4#*D!7RR$\8Y(]:9:^"$AL=8TF:]631
M]3=W2S6':;4MR=C;CQGG&,9Z8Z5/HF@:YIXC74?$C:BELI%LK6HCP<8#2$-E
MR ?4>IR<8 ,/3/%&O)X-;Q=JES:R6T$-QOM(H"K2.LC*AWY^49&,8/'/)KI(
M(O$<6IVK27=K<V<L+?:<Q[##)@;3'CJI.00QS[U5TKP>MIX.F\,:C=K>VTJR
MKO2'RF =BQ_B;D%C@^PI^@^']8TT0QZEXA;48;1=MLGV81GI@&0@DN0#CMZG
M)Q@ R;;Q5K \)ZCJ4\8N)[/5)+:1K6 DI"D@5G5,DDA<GDGWR!5A?%FW0FO[
M'4H=62[OHK6QD5 &4OM&)%&WY@=QQ\N>!QUJUIOA?4M*L)X+;6HQ-+J+WPD^
MR';\Y)9"N_E3GU&*AN/ 5K>VFK+/<>3<:G-'/YMI'Y8@DC V,HR><Y).><]J
M (KCQ!K>@-JEYJ=I+<:1;61N(KB01QR"4''E$*3D'@AL<=\U2\0)JC7O@^YO
MKV.43:I&TD*Q!5C<QN1L/7;C(YR3P>.E;,7A:^OM,NK+Q)K3:H+BW:W'EVZP
M!5.,M@$Y?@<]!C@<G-,>#=9F@TB"\\11S)H]RDT#BRP[JJE0'.\@G!QD =\@
MGH =C1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !4<L$,X FB20#H'4'%25SGCW5-1T3P;?ZGI<
M\<-Q;*&#/'OX+ <#.,\]\_2@#H418T"(H51P !@"G5R%]>^(;/QA8:7_ &G
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M$W.\&/CME1@]>>]6;.Y\5?VKILOV>:>PN%/VT3?9U6$D95HMC%B,\8;<<=Z
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MU+C?EE.>GR9QUYQD=:V_#NHZH?$VMZ)J5XMZ+)8)H9A"(SMD#94@<<%>#[T
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M^<U%J5VU_P"(_ =XZA6N#/*5'0%K8G^M '1:;K&GWNH7VF6:NDNFE%F5H3&
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M-L\L0F\X2 >9N&1R2,Y'3TK7NK];5[5?L]Q.+J41AH(]X3()W,1T7CK[BK=
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M9E<*';SI>!GJ?:NB@OA/?W5H+>XC-KLS+)&5CDW#/R-_%CH?0U6U3Q!9:0;
M3B5Q?W*6T+1)N7>YP,GH!0!IT455TZ^&I6$5VMO<6PE!/E7,9CD7!(Y4].E
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M5L/$&GZB9(X)<3H\RBW<A97$;E&8+G)7<,9HTS7;?4[Z\L5@N+>XLA&TL<Z
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M%SJGVFVU:TG;RA B?9WC"G*'&2#NZ-FK-_X-AU#1]5LY;QA<:PRM>70C&2
M JC.%   '7OU)S5B;P[-<:UI6JR:CF73(WC51" ) X ;//!PHQCI0!R%C=:O
MI?P_\1:K:ZQ<-<VUY=[6GCC<960C/W1R0/IZ 5T-PVNV-G#<W/B"'R[NXAW
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MWT("+:(?-C*!FC)/0<]>O\JGTWP.VDSO;VNN7BZ*TAD&E[4**2<E0^-P3/\
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M(@\2VVLP7C1BVLOL2V_E[@8LAN6)SG('/M0!G6]WK?B"#6!INJBTN--N39P
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MR/AMX0?[9)-++J&GLGGA2(R6''R@$C/J2?>O3IH4GMW@<?NY$*$#C@C%<L/
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MVVJZ=%J^DW>FSLRQ7<+PN4/(# @D>_-8C>$9W71O-UF65](D\R-GA7]X=NP
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&+5]'O;M]MG* ;G3G*N6((_A&6!W=,@#KFO1 BKC:H&.F!TI0JABP4 GJ<4
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M"K#IQGCISVI&\0:M?^!-5\1V5W;1Q?9))['_ $8EU5$))?YR,DA@/3C(/(H
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M0G":MYEC=*.C@%?+/U#.>?3([T =S1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "LW5M5&GM:6L2B2\OY?)MXSTR 69C_LJH)/
MX#O6E7(:OO'Q3\.^9_JC970B]-^%W?\ CN* .FEO+:R2-;V\AB9N TCA-Y]@
M3536=5;1?)O9]IT]I%BG;O"6;:KY[KD@'TSGL:Y?Q'=6$VK>)+>,P17,6DJE
MU+=MD,C!RJ1ID>O+9Z[>#46I3Q7'P(W-*LI&C0ACNR0_EIP??.* /0:*JZ8)
MAI5H+G/G"!/,SUW;1G]:M4 %%%% !7'>*]>\1^'?#VIZZ!IWDVLH$-L\#L[H
M9 @+.)  3G/ Z8KL:XWXMD#X9:OGTA_]')0!;UJ]\3:1I6I7AFTV9+:PEN$D
M6U=,.@SM*F0Y!&><]JUM&U..^TZR,MQ$;R6UCFDC5AN&Y02=O4#)JKXS91X&
MUTY&#IMQ@Y_Z9M7*QV-G8:CX N;6WCAGF5EED48:0&V).X]6YP>: .^>]M([
ME+62YA2=QE(FD =OH.II\\\5M;R7$[B.*)2[NW15 R2?PKS2S72->T'4[+7=
M;DL[Z'4)7N8E,2SI(LI,90E2Q^4*%QGT%=SXETZ?5O"FI:=;L1/<VDD:%CC+
M%2 #]30!2T75=8\26(U6T-M86,Q)M4G@:661,X#MAU"@]0O/&.:TM'GU.5;M
M-5AACDAN#'&T((21-JD,,^Y/TQCG&:R/A]J$.H>"[&TYBN;"!;.Z@.5DB=!M
M((Z@G&?QKC;G4-2;PAXLE>\N[F*TUUK1]TK.8[173<!S_=)!/7&: /4H+ZSN
MA(;>[@F$7#F.0-L^N.E*M[:O&TB7,+(GWF$@(7ZFN4UJ"-?&GA6ZT@1J\HF2
M4PXVR6HC!YQU4';CW(]:HP6QTGQ#JW@^.';:ZU(+RV*K\J1OQ<+GMC;QZ;Q0
M!W$U_9V\*33W<$43G"N\@56^A/6GR7,$6SS)HTWYV[F W8&3CUX!-<3<W%D/
M'FHZ7JM\EA$]A"MDDBQB.2+YA(J[U(ZXR!U 'IQG-H>C1:OX&L8&;4+-7O(D
MFNMK--&(V(!( #)GIV(QZT >B&_LA&)#=P;#'YH;S!C9_>SZ<]:?]IM_)2;S
MX_*?&Q]XVMGI@]\UQ$>@:-'\4OL2:9:+;+H(;R!$NPGSR 2O0\>M<^+:V?X?
MZ7&T2%;;Q*(H/6-/M)&%/4<>E 'JGV^SVS-]K@VVYQ,?,&(S_M>GXU(LT3P"
M=)4:(KN$@8%2/7/I7%+HVEK\5GM5T^V$#Z(LK0B(!&<3%0Q7H2 <9Q6##=)I
MO@BT#2-!I<'B26*Y9%!6& 2R;<@@C:'V=J /4(;ZTN+=KB"ZAEA7.Z1) RC'
M7)'%*EY:RS>3'<Q/+L#[%<%MIZ''I[UP&O:7H;:/XIO[74_[1FN=*>2=5,30
MJRJ?+?Y% #]<'T!IXL+&RUWP)<6MO%#-/'*DLB* TH-L3\QZMS@\T =AI6O:
M=K,UY%8W,<ILYS Y5@=Q"J21[ MC/J#5]YHHW1))41GR$#, 6P,G'KQS7(>
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M^S$_LX<%"NXB7;VSG /L!4OP_BEM[76;=,_V?#JTZ6([+&",JO\ LAMP'T-
M&T=>L'UN31(KJ+[:D/FLI((3)PH(SR3UQZ?45G>$?$,NJ:.)M5N+9+M[N>!%
M3Y ^QRHVJ22>!ZFJ,(M(?BU>F40HSZ5 4WX!+&5QD>_05R4ME9#X5:GJ@@B-
MW%JCO%<X!="+L8VMU Y/3U/K0!ZQ<WEK9JK75S# K'"F5PH)]!FINO(KA+JX
ML[CQSKFEZUJ(LEEM81:K,(]LL!4[PI=3_'NSCV]..G\,6MK8^'+*UL;J>ZM8
M4V0S3D%G0$X.0 ",=#Z8H U:*** "BBB@ HHHH **** "BBB@ HHHH ****
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MW[<-*LA=9W>?]G3S,^N[&:L7=G:W\!@O+:&YB)SY<T8=<_0T >7>([,1Z/\
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M*;%=0U865I<Z+"ME<9C\IV#'S5W.I )^3TS@>U01_P!F:#JWA.TM[N67P_\
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MQI++H BRQ $DOG#*KZGV%8$LAMO!WBM[2/?;V_B1WN8H1U@#Q&08'; .?;-
M'I5GJFG:BSK8W]M=-'C>(95<KGIG!XI+?5]-NKMK2WU"UFN$&6ACF5G S@G
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MY@\*N<DC/4GI5OPG=VUYX6TU[:>.94M8D8HP(#!%R/K6?X=_Y';Q?_U\6O\
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MBC2[;Q%#H,EW"EW+"TI#.!LY4*#GNV[@=>*I^%X-&_M'5;[2-1DU$WCQM<W
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M:VH1G@4*?L> 002O)+$9P>>PJSH.MVGB#2+?4;21"LT:NR*X8QDJ#M;'0C-
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MU"W@<;2PDD V@G )] 3TSUHNM;TJQF>&[U*U@E2,RNDDRJ508^8@G@<CGWH
ML&TMFW[K>([P%;*#Y@.@/J!1;V=K9QF.UMHH$)R5B0*"?H*;8W]IJ=HEW8W,
M5S;R?<EB<,I[=14=_JVGZ6H:_O8;8$%AYC@<#J?H.YH LQ0Q01B*&-(T7HJ*
M !^ K$L='O[#Q/JVHQO;26VIRQ.RL6#Q[(E3CC!SC-:$FMZ3%/;P2:G:)+=@
M&W1IE!F!Z%1GYOPJIJGBO1M+T:]U1KZ&:*S)5UBD#'S!_!Q_%GMVH V:*H)K
M6FMI\=\;ZW$$G"N) 06_N@]SUX]J0:]HYMK>Y&J6AANG$<#^<N)6)QM7GDYX
MP* %UF"^NM/EMK$6^Z9&C8S,P"@@C(P#FDT'3GTCP_IVF22+(]G:QPLZ]&*J
M!D?E3K#6M+U0SC3]1MKHV[;9O)E5_+/OCIT/Y40:UI=S(T<&H6\C+&92!(.$
M_O\ ^[SUZ4 3/8V<MTEU):0/<)]V5HP77Z'J*=<VEM>1>5=6\4\><[)4##/T
M-4=)O(4T);N?6X=0A4R%K_Y$0@.1_#\OR_=S[5/;ZQIMW'/)!?V[K;_ZXB0?
MNN_S>G'K0!/+9VL\:QS6T4B)]U70$+]!VILEA9S6OV66T@>W'_+)HP4_+I52
M+Q+H4]Q;V\6L64DUT"8$6=290"1E1GGH?RK3H @:RM'@2![6%H4^[&8P57Z#
MM3C:VYMC;&",P$8,6P;<>F.E2T4 1P00VL*PV\*0Q+]U(U"J/H!0\$4KH\D2
M.T9)1F4$KGKCTJ2B@"J-,T\*5%C;!6ZCR5P?TITNGV4UL+:6S@D@4Y$31@J#
M],8JQ10 BJ%4*H 4#  ' J&2SM9KB.XEMH9)HO\ 5R,@+)]#U%3T4 075E:7
MJ!+NUAN$4Y"RQAP#Z\TLUG:W"JLUM#*J?=#H"%^F>E344 5TL;..83):0+*.
MCB,!AQCK]*1M.L77:]G;LNXM@Q*1D]3TZFK-% $+VEM(L2O;Q,(2#&"@.PCI
MCTI1;0".2,0QA)23(NT8<GKD=\U+10!%!:V]K (+>"*&(=(XT"K^0IT44<$:
MQ0QK&B]%08 _"GT4 0265K-<1W,MM#)-%]R1HP63Z'J*7[);;Y'^SQ;I1B0[
M!EQZ'UJ:B@#F?$WANXU)=+CTNVL(XK/4([R99"4$@0$;0%4]<]36]#8VD%L;
M>*T@BA;[T21@(<]>,58HH J_V7IY0(;"VV@D@>2N 3U[>PJ2:TMKFW^SSV\4
ML/ \MT#+QTX/%344 02V-G/ MO-:PR0J,+&\8*CZ#I2_9+80I#]GB\J,@HFP
M;5(Z$#MBIJ* "J[:?9/-YS6<#2YSO,8+9]<XJQ10!!+9VL\@EFMH9'48#/&"
M1^)HBL[6WD:2&VAB=N"R1@$_B*GHH @M[.UL]_V6VA@\P[G\N,+N/J<=:Q/%
MFB:AK;Z2+1;0Q65_'=RBXD9=X4,-HPIZ[N]=%10!6BL+.*U-M'9P1PGEHDC
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M&-8T'144 #\* /.KZ:UUGP'X9ATAD_M"*YM!;QH?G@D3 DR.HV@/FM+75O-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)(P50/K26#W4NG6TEY&D=T\*F9$.55R!N ]LYKAH+O5K[PSXY.H74$R0R7D
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MP50J'(SM)))], \XSU\8ZY(OAY3H:VD^JR2PS0W;.C1NBL> 5^Z=H.>3@]*
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M"-H (&XYY/3CG!\):X=/\%>&-.@4FYO+1W#>0\PC1#RQ1.3RRCJ.I.>,$ ]
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M]@TX6,D<N]U0C'[V/@?,0 "#CCC-5H_!FMP^#K+0A=6,CVE^MPLAWJ"BRF0
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M((-[G._=D,0/3T[].]=/10 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!472].6^-^MA;"[(P;@0KYA_P"!8S5N
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ-/)<V+VEY:K;M(PF5QN:4;3@(0>H//?@58EN[:"5(IKB*.20X1'< M] >M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5R&K[_ /A:?AWS,^4;*Z\KTWX7=_X[BNOK.U;2AJ)M;B-A'>6,OG6T
MI&0#@JRG_9920?KGJ* .<^W6+?$36=/UUX55[&$6*W! 5HB&\W;GC);&>Y"C
MTIOB:#3;;X0:A;Z>S-8Q63);L[EMP!PI!/4$XP?3&*Z>]T;3=82$ZKIEI=/%
M\RB:)9-A[X)%1ZKI0U9(;*8*M@CI+*@ZRE#E4QV7(!/KC'>@"SIGG#2[3[3G
MSO(3S,]=VT9_6K5%% !1110 5QOQ;./AEJ_TA_\ 1R5V55;[3;#4XA%J%C;W
M<8.0D\2R 'Z$4 9WC-@/ VNDD8.FW'/_ &S:N5BL+.PU+P#=6MO'#/.C)+*H
MPTH-L2=QZMR!UKNWTVPDL?L$EC;O:8Q]G:)3'CTVXQ4)T'1F^SYTFQ/V7_49
MMD_==_EX^7\* //[1-+U_0M3M=:ULV=]!J$KW**(UGCD64F,H2-WW0H7';Y1
M7H>IQK+HMTDB^8# V0X!R=OI22:'I,VIKJ<FF6CWR?=N6A4R#T^;&:NT >6V
MMS!!X/\  R9B^P2W%NM_MQ@G8=GF>V\=^X%;MW9^5\1KN.TB7[-<Z,TE]&%^
M1I ^(V(_O$!A]![5U,>C:7%8RV$>FVB6DQ)D@6!1&Y/4E<8-26>GV6G1F.RM
M8;=6.6$2!<GWQUH \ZT6ZTF+P%X1@DCBDN9KB$Q*)0B>: Y#2D=0,' [D#ZA
M]E.@TWXB0?:;>0@328A^523;C<P7)QSUYZUW3>'M$>R:R;1[$VKR>:T!MDV%
M_P"\5QC/O3SHFDL)PVEV9%PJI,# O[Q5&%#<<@#@ ]* (/"W_(I:/_UX0?\
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M+Y*[F8="3CDCL>U %ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-_=)79&/J26/T4T =/1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!'%!% '$4:H'8NP48!8]3^-2444 %%%% !
M1110 4444 %%%% !1110 4444 %1QPQ0ES&@4R,7<@<L?4_Y[5)10 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNY3;;EA=?O9VDG SU (H Z>BHK:Y@O+:*YMI5EAF0/'(AR&4C((-2T %%%%
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MU-/]NN6N7$@7".0 <8 XX'7- %3Q+I6B2VEQJ^K:7;Z@]K;GRTGC#],D*H/
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MEC]?E4?GZU7U#1EU#5-.U!KJ6)].=WC1 NUBRE#NR,]">F* -*BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KS;0K;5M0M?&VGZ;'9_Z5K%U$9KB5AY>Y
M5!.T(=W!]17I# E2 =I(X/I6-H'AN/0+C4)8KZYN/[0N6N95F"8$C8R1M48'
M XH R8=.E\.VVB^'X=4D,$-HZF&W7_2;B08PPR"%09.22 "5!)K/M?%&L/X
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M4LKB^MECM=1GT^59 XEA5&)Q_"0P((-16VCB"2XN6NYI;ZXB$1NF"[D49P%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
@@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>72
<FILENAME>ebs20191231exhibit1048033.jpg
<TEXT>
begin 644 ebs20191231exhibit1048033.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB>XT_P NW8-@&0(@X/J#_(T >AV_B71KN^6R@OT>9W=(\*VV1D^\JOC:Q'<
MDBJ4_CWPM:_:1/K$*-:.$G0JVZ-LD8*XSU'IQ7GOP]CTK4]*T?2-1O-1BU?0
M[UI$T](U78V\MN/R9VX/S9;U]16?]HMC_P +08R1YF8>2<CYQO<?+Z\E>GJ*
M /2_%_CG3_#/AZ+4HW6Y>\ %F$RRR$C(8D?PXY]^U:$GBO1(A&6O#F2-I@JP
MN66-3@NP RJ@\;C@5Y9XI1[CX(>&)85,B6UQ"9B@SY8".#GTP2!^-:GQ :)]
M87Q-X?UT6.K6=@L@CE.U+V L^ N?O'*GY<$-E<=C0!ZG!/'<V\=Q"V^*5 Z-
MZ@C(-25GZ!+-/X>TZ6XM1:3/:QL]NHP(CM&5 [8Z8K0H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6B
M@! JJ20H!/7 ZT8!(.!D=#2T4 (0#U&:6BB@ I,#.<#/K2T4 %%%% "%0WW@
M#@YY%+110 4444 %%%% "8&<X%+110 4TJK$$J"1T)'2G44 %%%% !1110 4
M444 %)@$@D=.E+10 4444 %%%% "8 )..3U-+110 4A /4 TM% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !11534=4L=(MQ<:A=1VT3.$#R' +'H/K0!;HK#'C/PX;A[<:O;F:,
M;GC!.Y1ZD8R.HK5LKVUU*SCO+*=)[>4921#D,/:@">BJNHZE9:39M>:A<);V
MZ$!I'X5<],GM4MK<P7MK%=6TJRP3('CD4Y#*1D$4 2T50M=<TR]U*?3;>]BD
MO+89F@!^=!QR1^(_.K] !145S=6]E;27-U/'!!$NYY)&"JH]23TJI8Z[IFHW
M!M[6[1YQ&)?*(*N4/1P" 2ON.* -"BBB@ HK*'B?1#JO]D_VA']OSC[-@^9T
MS]W&>G/TJ:YUO3;/4(M/N+I8[N89BA(.Z0?[(QS^% %^BJ5MK&G7FI7.G6UY
M%+=VF#/"K9://3-7 P;."#@X..U "T5EZEXDT;1[B.WU+4(K667_ %:RY&_I
M]WUZCI3[+Q!H^HW;6=IJ5O+<H,M ' D ]=IYQ0!HT453U'5;#28DEO[I(%D<
M1QAN6D8]%4#EC["@"Y1573M2LM7L([[3[E+FVE!*21G(.#@_J*M4 %%%% !1
M110 4444 %%02WEM#.D$DZ++(K,J$\E1U/T'KTY'K46EZMI^M68O-,NX[JW+
M%?,C.1D=10!<HHHH **H0:YIESJTVDPWL3W\"[I+?/SJO')'IR/S%7Z "BD)
MP,GM6;9^)-%OX[R2UU*"5;$9NB&_U(Y^]Z?=/Y&@#3HJKIVHV>K6$5]I]PEQ
M;3 E)4/#8.#^H-6J "BBB@ HK(D\5Z%"LCR:E"D41*M,V1%N'5=^-I/L#FK%
MQKFEVNIP:9<7L45Y<#,,+'#2?3UH OT44V1UCC:1LA5!)P,\"@!U%9^GZ[I6
MJV$E_8ZA!/:PDK),CC8A !.3VP"#3-+\1Z/K4\D.G7\5Q)&H=E7(.T]&&>H/
MJ.* -.BLF3Q1HD.IC2Y-0C6^)P+;!\P]^%QD\5JLRJI9B H&23Q@4 +16?9:
M]I.HZ6^J6FH02V4>[?.'PB[>N2>F*;I7B#2=;DECTZ^CN'A"M(HR"H894X(Z
M$<@]#0!I45#-=06\L44TJQM.VV,,<;VZX'O[>Q]*FH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH=N&2%+1G^TS'YB@"8VCJ/7)I=6\=:[!KGAFUL;&!4UR ,]O=1LLD+XY!;/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 (0"02 2#D>U+110 4444
M%%%% !1110 4444 4O['TO[5]J_LVT^T9W>;Y"[\^N<9J[110 4444 %%%%
M!1110 4444 %%%% "8&X-@9 P#2T44 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-[4?\)IHHF>)I9D\JZ^R2NT#A(Y>FUFQ@<]Z .B_X2B#_H&ZC_WX_P#KT?\
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M_KUE>'/^18TG_KQ@_P#1:UHT 2?\)1!_T#=1_P"_'_UZ/^$H@_Z!NH_]^/\
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M42:91-<&U61X'5/-'\!8C&30!T7_  E$'_0-U'_OQ_\ 7H_X2B#_ *!NH_\
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MV/C-;?6M7L]7E(AM[Y+:WD6 X7<.-[ 8'/'- ':?\)1!_P! W4?^_'_UZ/\
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M0 ,_-UKL#XFTH7OV7[0=WVG[)YFT[//QGR]W3=C_  Z\4 ;/_"40?] W4?\
MOQ_]>C_A*(/^@;J/_?C_ .O6);^)M.NM1FTZ+SC=02B*2(Q$%202#],*3GIT
M]:N7^J6NFF!;ASYER_EPQJ,M(V"<#\!0!?\ ^$H@_P"@;J/_ 'X_^O1_PE$'
M_0-U'_OQ_P#7K /C#11I]A?BXD>WU"3RK=DB9BSYQM( R#D'\J5/%NCOI1U$
M3N(A<?9=AC;S#-G&S;UW4 ;W_"40?] W4?\ OQ_]>C_A*(/^@;J/_?C_ .O7
M+^%M<O-6U/6[>Y;='8W*QP[H]C!2"<,/6F6NN7NO>*=1TNPF6UL]*VK/,$#2
M22-GY5SP ,'/!/% '5_\)1!_T#=1_P"_'_UZ/^$H@_Z!NH_]^/\ Z]8O]HRZ
M4&35[B.1Y[KRK(11X:4; 0,9^]D-SP/ITID7BO2)[.SNH9VE6^=D@18SO9ES
MN&WKD8/],Y% &[_PE$'_ $#=1_[\?_7H_P"$H@_Z!NH_]^/_ *]8MQXGTJVV
M^;.P!B29SL.(D<@*S_W<D_Y K6H D_X2>#_H&ZC_ -^/_KTR'Q=:7$8DBL-0
M="2,B#N#@]_44E9V@?\ ((3_ *ZR_P#HQJ -7_A*(/\ H&ZC_P!^/_KT?\)1
M!_T#=1_[\?\ UZCKF?'&M7VA6>G3V4RQ_:+^.VDWH& 5@Q)Y[C;0!U7_  E$
M'_0-U'_OQ_\ 7H_X2B#_ *!NH_\ ?C_Z]<=HWB]FEU@:I)$UG87*007L2$+.
M6.-N.06!P...>U'B/Q<8?#-SJ.CRXGM+Q;:9)8^4;< RD'Z]10!V/_"40?\
M0-U'_OQ_]>C_ (2B#_H&ZC_WX_\ KUR=OXE>W\2^(K;4KB./3]+C@D1RN"H=
M<D''7G@=ZEU?QG9:=8F:.&:6<726K0E"&C=L$;O^ G(]?SP =/\ \)1!_P!
MW4?^_'_UZ/\ A*(/^@;J/_?C_P"O4,;^9$L@5EW '##!'U':G4 */%MHTS0K
M8Z@9$ 9E\CD YQW]C3_^$H@_Z!NH_P#?C_Z]95M_R,%__P!<(/YR5HT 2?\
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M6YC8R/A%# X/R]>!^=:OC2"VU/2X=)>X6WU28B>PQDXE0CH<?[6/H<]JZ>C
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M4JL=S$Y<D*%<'<0,D#Z"IJ "LZ^_Y#6E_P"]+_Z!6C6=??\ (:TO_>E_] H
MT:@OXI9]/N(80ADDC95WL0,D8Y(!_E4]% ' VO@/5&T70M*NKBSA72;DSFY@
M=FD?YBVU<J-O7GD]!5EO ]T9&M1<0_8FUK^U3)N/F=/]7MQCK_%GIVKM:* .
M6FT#5O\ A,H/$-LUG$2K07,7F-^]AXV\[/O Y/X**T/$.FZEJ1L183P1QPW
M>X64'YTQT!'(]QQGIG'79HH X2S\$:K::-H5AY]F[:5J7VMVWL Z;B0!\O7D
M_E0O@?5%TUE$]I]JBUO^U8!O;8W3Y&.W(^H!KNZ* .?\.:)?Z9JNLWMZUL1J
M,ZS(L+LVS Q@Y S]:BM_#M[H_BB_U;2C;S0:F%-S;SNT95QG#*P5L]3P1WZU
MTM% &#K6FZWJ5O9K#/:0E+H23QG=@Q@?=# 9S[_+G...^ G@&[_X12+1+@6<
M[PRS213+*\;1LQRC*=IQCG(Z>]=[10!Q@\':A'K(NY6L-3BN;**WO!?*2=Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKG_$/_(8TCZS?^@"N@KG_$/_ "&-(^LW_H H 6BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH SO#G_(L:3_UXP?\ HM:T:SO#G_(L:3_UXP?^BUK1
MH **** "BBB@ HHHH **** "BBB@#-U/_D*:/_U\O_Z)DK2K-U/_ )"FC_\
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M"$_-%G.X>V :U;;2;R3Q;?KJ,&HE7U"*]M+B!5\HJHP S$9&!D%<C()KNJ*
M.-\$:$EO-J=Y?::8[O\ M2>6VDFBPPC<  J3T!Y_K79444 %9U]_R&M+_P!Z
M7_T"M&LZ^_Y#6E_[TO\ Z!0!HT444 %%%% !1110 4444 %%%% !1110 444
M4 %9V@?\@A/^NLO_ *,:M&L[0/\ D$)_UUE_]&-0!HT444 %%%% !1110 44
M44 9UM_R,%__ -<(/YR5HDX&:SK;_D8+_P#ZX0?SDJ_)(L4;2.=J("S'T H
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M:Q_UTB_]%BN@KG_#O_(6UC_KI%_Z+%=!0 4444 %%%% !1110 4444 %%%%
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M ,>$7_7Y:_\ H^.M&L[7?^/"+_K\M?\ T?'6C0 4444 %%%% !1110 4444
M%%%% !6=??\ (:TO_>E_] K1K.OO^0UI?^]+_P"@4 :-%%% !1110 4444 %
M%%% !1110 4444 %%%% !6=H'_((3_KK+_Z,:M&L[0/^00G_ %UE_P#1C4 :
M-%%% !1110 4444 %%%% &=;?\C!?_\ 7"#^<E:#*KHR.H96&"",@BL^V_Y&
M"_\ ^N$'\Y*T: .)N<?\+HLP/^@0?_0WIM[JNI2>*]2TFUO;>P%A';/9K-(8
MT=#S)\H!WY'R^W&.:[$V-F;G[2;2 SC_ ):^6-WY]:62RM)KB.YEM89)HO\
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M/^ND7_HL5T% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDWV"_.YX^!:N2/D'48XJ_P#V@W_0-U'_ , W_P * +=%5/[0;_H&ZC_X!O\
MX4?V@W_0-U'_ , W_P * +=%5/[0;_H&ZC_X!O\ X4?V@W_0-U'_ , W_P *
M +=%5/[0;_H&ZC_X!O\ X4?V@W_0-U'_ , W_P * +=%5/[0;_H&ZC_X!O\
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M0UI?^]+_ .@5-_:#?] W4?\ P#?_  K/O+UFU?3F^P7R[3)\K6K@M\O88YH
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ML/,E6-6"D<C+ ]N*V*YWQ1:V]GX;CAM8(X(AJ-FVR-0HR;N(DX'J23^-=%0
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M6?\ >A_]%UKUD:;_ ,C!K/\ O0_^BZUZ "BBB@ HHHH **** "BBB@ HHHH
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MV,/A.'Q#>:/#'%<0+-%'$OF'#)O4.=@">F3P"1S4U_K6B6.A#5S8;X'#;/\
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M_H)V?_?]?\:H:?96AUO5E-K"0KQ8!C''[L5)K$EKI<-NT>F6T\EQ<I;HK (
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M8;8%VARMMOQG&<$#Y@,\D<#!ST- &M_;.E?]!.S_ ._Z_P"-']LZ5_T$[/\
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M(*W1HR8MI*GL<,1D>M;LD:31/%(-R.I5AZ@U#86%OIMHEK:AUAC "*\K/M
M  +$D# Z4 5KGP]I5S9+:-911Q1LS1^4@4QEB2Q4CH3DYQUR:S_$-K;V6G:5
M;VL$<$*:I:[8XU"JO[T'@"NBJI>:9:7\L,MRCN8)%DC'FN%#*<@E0<$@^HH
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M*-86Q6#/E*85Q'GKMXXS[4 >:VWB?5[K3_"=G/J/DC5+"=WNI9C%YDX&%!<
M].N.YP#1KNJZY'J]Q:MKDJ&'PH]^[6<F(Y+A"1O7(X!P#QC]>?2GTG39+9+5
M]/M6@C;<D30J44^H&, TLNEZ?<2M+-8VTDC+M9WA4DCTR1TH \YBO9]2\5^!
M;N_OI5^U:2TSD2[%:4Q@DX'&23S^5=GKG_(Q>&_^ON;_ -)Y:U5L+)5A5;2
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MC*..X,X6[A 9GW,0$(Y/?'3/MSS0!TW_  C5A_S\:I_X-KK_ ..4?\(U8?\
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MO10!RNJ>'K*/5=&03ZD1)=.K;M3N20/)D/!,F0>.HQQD=":TV\-Z>JEC<:H
M!D_\3:Z_^.4:O_R&-"_Z^Y/_ $1+6G-_J)/]T_RH YF-/#<FDC51J.K)9M'Y
MB22:C>Q^8NW?E0S@M\H)X!Z5/<V7A^TLVNYM3U 0KNR1K%TQ)4$L !)DD8.0
M.1@U5TW1(O$'PRT6PEE:+=IMN491D!O) 4D=P"0<9&<5=O\ PA:WOAY='6YE
M2.(LT3-\P5B#C(X) W<#/89)H BN;/0+40-+?:L4GE6&.2/4KQTWLX0*65R
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M&)'DCU&]?RUV;\L%<E?E(/('6M-?#>GLH87&J$$9'_$VNO\ XY63J.B)X?\
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MW2@"]_PC5A_S\:I_X-KK_P".4?\ "-6'_/QJG_@VNO\ XY6O10!D?\(U8?\
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M HHHH **** "BBB@#(TW_D8-9_WH?_1=:]9&F_\ (P:S_O0_^BZUZ "BBB@
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M]EU__H+V7_@ W_QV@#5HK*^RZ_\ ]!>R_P# !O\ X[1]EU__ *"]E_X -_\
M': -6BLK[+K_ /T%[+_P ;_X[1]EU_\ Z"]E_P" #?\ QV@#5HK*^RZ__P!!
M>R_\ &_^.T?9=?\ ^@O9?^ #?_': &^$_P#D3M%_[!\'_HM:UZY?PU;:R_A;
M2&@U.TCB-C 41K)F*CRUX)\P9_*M!H]:641-K>GB1AD(;$Y/X>;0!L45DBWU
MUBP76;$E3A@+!N#UY_>^]-,6MA78ZU8 )]XFQ/R]^?WO% &Q161'#K<J!X]:
ML'4]&6Q)!_\ (M.^RZ__ -!>R_\  !O_ ([0!JT5E?9=?_Z"]E_X -_\=H^R
MZ_\ ]!>R_P# !O\ X[0!JT5E?9=?_P"@O9?^ #?_ !VC[+K_ /T%[+_P ;_X
M[0!JT5E?9=?_ .@O9?\ @ W_ ,=H^RZ__P!!>R_\ &_^.T -U?\ Y#&A?]?<
MG_HB6M>N7U2VUH:KHP?4[1F-TX0BR8!3Y,G)'F<\9';K6G]EU_\ Z"]E_P"
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MI3;ZZ&"G6;$,<D#[ V3_ .1: -:BL=(]9DD:--<T]G7[RBR)(^H\VG_9=?\
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M.1YG/'TH ZBBLHVNO 9.KV0 _P"G!O\ X[4:KK#Q-*FNZ<T:_><61('U/FT
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M *"]E_X -_\ ': -6BLK[+K_ /T%[+_P ;_X[1]EU_\ Z"]E_P" #?\ QV@
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M\C!K/^]#_P"BZUZPM#2YCUG6%NYHYI=\67CB,8(V<<$G^=;M !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %9&H_P#(Q:/_ -M__0!6O61J/_(Q:/\ ]M__ $ 4 :%[9P:A936=RF^"
M=#'(I_B4C!%><V&B:7>?%WQ'IT^GV[6C:9$OE>4H5<A!P,<'W%>FUDV_AK3;
M7Q!<:]$LHO[E!'+(96(91C VYQQ@=J ,.UU_Q%>^--7T"RCTU;;2I+8F659
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MELW<9S\S,<X///TP.*ZNL?Q#97FHPVEM;1(52]MIY)'DQM6.9'.!CDX4UL4
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MIF ;+?O1SEF9OS)KJ:Q]>LKS4&L8K>)#'#>0W$DC28P$<$@#')P* -BBBB@
MHHHH **** "BBB@ HHHH *RO#7_($3_KM-_Z->M6LKPU_P @1/\ KM-_Z->@
M"K<HC^/K'>BMMTRX(R,X/FP\U5L?#>I6WB^?4WO UL^&"EG.06E.T9?/R[P>
M<K\[85<"M*ZLKS_A*;/4H8DD@2TDMY,R;64L\;9 QSPAK7H Y72?#6HV/B:X
MOY[Q9+9QC86<[@2Y Y<GY=P^]N')V[>E6O"R*EWX@5%"J-5;  P!^YBK?8D*
M2HR0.!G&:R- L+NS?5)KN-(VO;XW"(C[MJ^6B\G YRIH V**** "BBB@#*L_
M^1GU/_KWM_YR56\7J&TRS5@"#JED"#W_ -(CJS9_\C/J?_7O;_SDH\16%SJ&
MGPQVBHTL-Y;W&UVVAA'*KD9]<*: ,OQ+X:U#5-3LKBQNU@BB^4IEP$^20;L!
MA_>"_+M;#'YN *37O#6IZEK5I>6MZ(XX\;@6DPI"N"2 X/.0OR%3@G);@5T\
M;.T2M(FQR 67.<'TS3Z ,"5$7X@6C*B@MI=QN('7][#6_61]BO)?%L>HO$B6
MT-G+ #YF6=F>-@<8X&$-:] !1110 4444 %%%% !1110!D:;_P C!K/^]#_Z
M+K7K(TW_ )&#6?\ >A_]%UKT %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5D:C_P C%H__ &W_ /0!
M6O61J/\ R,6C_P#;?_T 4 7[]KI-.N6LD5[I87,"MT9\':#[9Q7">#_%J:O=
MVMC/?7UMK=LC?;M-O %-PX0Y*9&!S@[1M&.HXS7=:C;27NF75I%.8))X7C24
M#)C)! ;'MG-8L_AMKC6-.UK4IHKB?2D<QM;VVR24E<<_,>.ORCN?PH =HGC"
MWU^VAFL["Z5GN);>2*38'A9!D[QNX'0<9Y(]:R&\?PZQX8OK^QT[5K:W2UG9
MKQ8X_P!RR<$#+8+<Y';CKG.+_A72;8:EJGB*TBN;==69)$@N8RAB;:-YVGH2
MV,^Z\<8J/3O \FG^ [SPM_::R?:5E47/V;&T2'GY=_/4]Q0!$/'=O86NG6QL
M]0OYY](74%DQ&I= F6+?, &XR0./2K+>/=->'3VM;:YN)+^R>^6)0JE(E&3N
M).,]@!W]N:J-\/YC-8R?VNF;/1FTH#[(?F!4KO\ O\'IQ^M8NL>&]5TI-!TF
MP^Q72V-E-$]S>0S11N&(&W?$2P)!/RDX/)YXP ="WQ$TH:=:78M[C==6<EZL
M+-&'6%.K'YL9/0#.2?2NGL[N&_LH+RV??#<1K+&W]Y6&0?R-<99>&]2U-M&\
M0)]GT/4;.![22U^S&2!X=QV@*2I7@!AW&0#TKMHD,<2(7+E5 +$ $^_'% #Z
M*** "BBB@ HHHH **** ,CPG_P B=HO_ &#X/_1:UKUD>$_^1.T7_L'P?^BU
MK7H **** "BBB@ HHHH **** "BBB@#(U?\ Y#&A?]?<G_HB6M>LC5_^0QH7
M_7W)_P"B):UZ "BBB@ HHHH **** "BBB@#*T[_D.ZQ_OQ?^BQ6K65IW_(=U
MC_?B_P#18K5H **** "BBB@ HHHH **** ,KQ'_R#(?^O^S_ /2F.M6LKQ'_
M ,@R'_K_ +/_ -*8ZU: "BBB@ HHHH **** "BBB@ HHHH *R-2_Y&#1O]Z;
M_P!%UKUD:E_R,&C?[TW_ *+H UZ*** "BBB@ HHHH **** "BBB@ HHHH **
M** "LKPU_P @1/\ KM-_Z->M6LKPU_R!$_Z[3?\ HUZ -6BBB@ HHHH ****
M "BBB@#*L_\ D9]3_P"O>W_G)6K659_\C/J?_7O;_P Y*U: "BBB@ HHHH *
M*** "BBB@ HHHH **** ,C3?^1@UG_>A_P#1=:]9&F_\C!K/^]#_ .BZUZ "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *R-1_Y&+1_^V__ * *UZR-1_Y&+1_^V_\ Z * ->BJFJ,5
MTF\9201 Y!'4?*:Y>[L-2F^'UDNCEUFDM%DG"/\ -+F'GMEB3CHR\\YXP0#L
MZ*Y/6K'Q)+X=MXHIV:[1V^T%)0WF#=\N $4GL< KCU;'+]5ANH-/T26\8_;U
MO[>.619-Q8%^1D*H(/\ NB@#J:*** "BBB@ HHHH **** "BBB@ HHHH R/"
M?_(G:+_V#X/_ $6M:]9'A/\ Y$[1?^P?!_Z+6M>@ HHHH **** "BBB@ HHH
MH **** ,C5_^0QH7_7W)_P"B):UZR-7_ .0QH7_7W)_Z(EK7H **** "BBB@
M HHHH **** ,K3O^0[K'^_%_Z+%:M96G?\AW6/\ ?B_]%BM6@ HHHH ****
M"BBB@ HHHH RO$?_ "#(?^O^S_\ 2F.M6LKQ'_R#(?\ K_L__2F.M6@ HHHH
M **** "BBB@ HHHH **** "LC4O^1@T;_>F_]%UKUD:E_P C!HW^]-_Z+H U
MZ*** "BBB@ HHHH **** "BBB@ HHHH **** "LKPU_R!$_Z[3?^C7K5K*\-
M?\@1/^NTW_HUZ -6BBB@ HHHH **** "BBB@#*L_^1GU/_KWM_YR5JUE6?\
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MK$\107-V^G0V]M))Y=]#,[C&U%5LG.34G_%2?]0O_P B4?\ %2?]0O\ \B4
M:]%9'_%2?]0O_P B4?\ %2?]0O\ \B4 :]%9'_%2?]0O_P B4?\ %2?]0O\
M\B4 :]%9'_%2?]0O_P B4?\ %2?]0O\ \B4 :]%9'_%2?]0O_P B4?\ %2?]
M0O\ \B4 :]%9'_%2?]0O_P B4?\ %2?]0O\ \B4 :]%9'_%2?]0O_P B4?\
M%2?]0O\ \B4 'A/_ )$[1?\ L'P?^BUK7K TVQ\0Z9I=II\3Z:Z6L$<*LPD!
M;:H&?TJQ_P 5)_U"_P#R)0!KT5D?\5)_U"__ ")1_P 5)_U"_P#R)0!KT5D?
M\5)_U"__ ")1_P 5)_U"_P#R)0!KT5D?\5)_U"__ ")1_P 5)_U"_P#R)0!K
MT5D?\5)_U"__ ")1_P 5)_U"_P#R)0!KT5D?\5)_U"__ ")1_P 5)_U"_P#R
M)0 :O_R&-"_Z^Y/_ $1+6O7/W5CXBNKNSN&?3%-G*TB@"3YB49,'\&)_"K/_
M !4G_4+_ /(E &O161_Q4G_4+_\ (E'_ !4G_4+_ /(E &O161_Q4G_4+_\
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M,0+-%-D"3K'(K@?B5Q5C_BI/^H7_ .1* ->BLC_BI/\ J%_^1*/^*D_ZA?\
MY$H UZ*R/^*D_P"H7_Y$H_XJ3_J%_P#D2@#7HK(_XJ3_ *A?_D2C_BI/^H7_
M .1* ->BLC_BI/\ J%_^1*/^*D_ZA?\ Y$H UZ*R/^*D_P"H7_Y$H_XJ3_J%
M_P#D2@#7K(U+_D8-&_WIO_1='_%2?]0O_P B57GL?$-Q>VMVSZ:&M2Y50),-
MN&#F@#?HK(_XJ3_J%_\ D2C_ (J3_J%_^1* ->BLC_BI/^H7_P"1*/\ BI/^
MH7_Y$H UZ*R/^*D_ZA?_ )$H_P"*D_ZA?_D2@#7HK(_XJ3_J%_\ D2C_ (J3
M_J%_^1* ->BLC_BI/^H7_P"1*/\ BI/^H7_Y$H UZ*R/^*D_ZA?_ )$H_P"*
MD_ZA?_D2@#7HK(_XJ3_J%_\ D2C_ (J3_J%_^1* ->LKPU_R!$_Z[3?^C7IO
M_%2?]0O_ ,B56T^R\1:?9K;(^F. SMDB3^)BW]: .@HK(_XJ3_J%_P#D2C_B
MI/\ J%_^1* ->BLC_BI/^H7_ .1*/^*D_P"H7_Y$H UZ*R/^*D_ZA?\ Y$H_
MXJ3_ *A?_D2@#7HK(_XJ3_J%_P#D2C_BI/\ J%_^1* '6?\ R,^I_P#7O;_S
MDK5K BLO$,6H7%Z'TPM<1QHRD28&W=C'_?56/^*D_P"H7_Y$H UZ*R/^*D_Z
MA?\ Y$H_XJ3_ *A?_D2@#7HK(_XJ3_J%_P#D2C_BI/\ J%_^1* ->BLC_BI/
M^H7_ .1*/^*D_P"H7_Y$H UZ*R/^*D_ZA?\ Y$H_XJ3_ *A?_D2@#7HK(_XJ
M3_J%_P#D2C_BI/\ J%_^1* ->BLC_BI/^H7_ .1*/^*D_P"H7_Y$H --_P"1
M@UG_ 'H?_1=:]9>DV-];W=]=W[VYDNF0A8 V%"KCO6I0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 44@8$D @D'!]J9+-%;Q
MF2:5(T'5G8 ?F: )**:DB2 %'5@0""ISP>]*&!) ()!P?:@!:*:LB,Q574E>
MH!Z4/(D>-[JN>F3C- #J**165QE6##U!H 6BF1RQS+NBD5U!QE3D9H>6./&^
M15STW'% #Z*8TL:8W2*N[IE@,T^@ HICRQQXWR*N>FXXH\R/R_,WKL_O9X_.
M@!]%-5U==R,&'J#FE#!AD$$9QQ0 M%,:6-&"M(JD] 3C-#2QI(L;2*KOG:I.
M"V.N!WH ?12%E7 9@,G R>IH9E499@!D#D]STH 6BF2S10)OFD2-<XW.P S3
ML@#)/% "T5%%<V]P-T,\<@SMRC@\^G%.66-W:-9%9T^\H.2OU]* 'T4P2QF4
MQ"13(!DIGD#UQ1YL?F^5YB^9C=LSSCUQ0 ^BHVGA1BK2HI'4%@*>64$ L 6.
M!D]: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **1B54D*6(&<#J:YE
M/'NEF&]G>TU!(-.F:"[E-MN6%U^]G:2<#/4 B@#IZ*BMKF"\MHKFVE66&9 \
M<B'(92,@@U+0 4444 %%5KZ^BT^U,\PD?G"QQ(7=V/0*HY)__7TJAH?B:QUU
M[R*&.XM;FQ8+<6]W%Y<D>1E21Z$ X.: -BBL"'QEILNLV^EO!>V[7>[[+//;
ME(K@@9(1C[<\@9_$5OT %%%9>I:Y'87'V2&TN+Z\$#7!M[?;O\L$#/S$#DG
M'4T :E%4/[7MQH\6IM'<+'*BND1A;S26Z+LZ[O:JVB>)K+79[NUBANK6[LBH
MGMKN+RY$#<J<=P<=: -BBN?3QGIK:Q;:;)!>P_;&*VMS+;E89V SA6/J.G'/
M;-=!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5'//%:V\EQ,X2*)"[L>BJ!DFI*HZMIIU6R-I]JEME9
MU9FB"DL 0=IW C!QSZCB@#C_  _JC6?C4?:+II$\1P&;RV_Y=[A.1'_WZ('N
M8ZOZ*W]L>//$$E\HD_LIH;>TB<9$*LFYG ]6)Z]< "MG7M CUZ&T22[GMGL[
ME+F*6#;N#KG'W@1CDY'>F7'AU6U;^U[*]FLKYXUBG=%5DN%'3>I&,CG!&#SC
MI0!.MGIVA_;]21%MXY%\VX"C"_*#EL>N.OTKE/#6I/8^,Y+>XNC*OB"#[4%)
M_P!3<H/FB'MY>T#_ *YUU%YHC7MIY,FI7(=I4DDD 3+[&#!<%<!<CH!SSD\F
MDUW0(]=^PL]W/:R6-RMS%)!MW;P",'<#Q@G([T <KK0'A_QRWB>(!+93#::B
M ,#RI.%D/^ZX7GT)I^L?\3+XA>'+Q_GMHKRXMX%/*DI"Y=_^^QM_[9^]=-/X
M>AO!J4=Y<23PZE"(98F50% !&5P,YY_.H9/"ML9M&>"ZGMUT4'[/&FTALIL.
M[()/!/IUH VI8HYXFBE17C<896&01Z&O.H[B:U^"FGK;NT9F6&W9U."J/,$;
MGZ$C\:]&=69"JN48CA@,XK&M/"UE;^%1X<EEFN;01F,-(0' SD'( Y!Y!QV%
M &9+>6VA>/GC+QVFGOHWG3]%1#'*%5O0<.1] /2K.L6.C_$#PY-'97<$Y1\V
M]U'AO(F7!!_ED=P:U+'1TM;^74)IY+J\EB6$S2 #;&I)"@  #DDGU/L !H$$
MJ0#@^OI0!R?AR=_%JV]_JMC'')I,CP&(@,/M2_+(X_V1T7_>/H#5S0]8UC5M
M1O5DMK**TLKV6V<K(QD;:JE2.,=^<X_3FYH.A1Z##=1174UP+JYDN6,H7(=S
MEL8 XS3M(T9=(DOG2ZFG^W7+7+B0+A'( ., <<#KF@"IXETK1);2XU?5M+M]
M0>UMSY:3QA^F2%4'@$DX]^*S+[PI?IX1TS1].CTR5;0!KBUO(B8;AL$D87H-
MQ+#@\@>E=/J%@FHQ112NRQI-',5'\>Q@P!]MP!_"F7UE=74\,EOJEQ9K'N#I
M$D;"0''7<IP1CC'KWH Q])UBRL_ XU"VTQ-.2 21_85 41S*Y0QC'',@(SWS
MFL[P7=_V=KVI^'I;XW@D U"WF;.7W\3#\).<>CUT4FA1%+&.&YF@BLYO/\M0
MK"9^<ER02<EBW;GFF:GX?CU+6-.U07D]M/IQ?R_*"X<. &#9!R" * .>UBPN
M-/\ %46LZMI>FZI8374444_E'[18$D+&1G(*[R"<8(+$U3NW:]T'QUJ<Y(NK
M.YECMY/XH1!$K1[3V^8EOJ:[!=&D>Y9[S4KB\@$_G1V\BQA4(.Y1E5!(4X(R
M>PSG%07OA>TO9;P-++';ZBR->6Z8VS%0!UQD9  ;'4#MS0!EZL1=ZEX+U"6)
M5N9+KYFQR-UM(2/IFK'C:")X]$E:-3)'K-IL8CE<R '%:FI:*FI7NG71N983
MI\QFB2,+AF*E><@\88],4NLZ,FLI:H]S+ +6YCN5\L+\SH<J#D'C- &7JPEA
M\96ES>6<UUI;6,D*^7 TPBF+ DLJ@D!E&,X[$=ZY+1KR?4X_"6BW!<Z5>7%[
M($<_Z^&$DPHWJN"#CH0HKT;4=/.I6YM9+F2.W<;95B^5I!W&[J ?;!]Q5;4_
M#ECJ-G:6ZA[-K%E>SFML*UN0,#;P1C'!!!!':@"+7+"VM;.36;>V1+S3K>:2
M%D0 G]VPVGU'3CVKF;8G3=-\"WEMEKB[98[AQ]Z<2P-(Y8]\N WU%=E;Z?,"
M&OKY[PJ" K(J+R,$D <G!/7CVJI8>&+6QFLCYTTT6FJRV43XQ &&/3)(7Y1G
MH/?F@#CK*YE3P1X:UT'.HW6JQ22RC[TAFE*NI/IM;&.VT>@I#=2_\*\D\2G_
M )"G]L>>)/X@1=^3L^GE_+CTKL8/"UG!);J)96M+6Y:ZM[4XV1R,2<],D LQ
M SP3[# ?"UF92OFR_8S>?;?LG&SSL[L],XW?/C^][<4 9?B/PKH-S/;Q'2;2
M6^U.]7?<21!Y-H/F2'<>1\JE1Z;A5C7X8_\ A-/"L^Q?-$]PF_'./L[G%;KV
M"2:K%J#.Q:&%XD3L-Q4L?K\JC\_6J^H:,NH:IIVH-=2Q/ISN\:(%VL64H=V1
MGH3TQ0!I4444 %%%% !1110 4444 %%%% !1110 4444 %>;:%;:MJ%KXVT_
M38[/_2M8NHC-<2L/+W*H)VA#NX/J*](8$J0#M)'!]*QM \-QZ!<:A+%?7-Q_
M:%RUS*LP3 D;&2-JC X'% &3#ITOAVVT7P_#JDA@AM'4PVZ_Z3<2#&&&00J#
M)R20 2H)-9]KXHUA_ &BZE<3E9+C41:W]YL4&&$3.A<_P@_*H)Z#=FNFU'PV
ME]KUOK,.H7=E<PP-;N8-F)8B=VT[E..1U&#7,ZUH<'AO0]/TF.^UA+ W[3M>
MPKYILP"S@$!3D%VZD'GDG@4 2_V]J6FW?BB]6^EOM+TBV62U5@A1Y"A9D+@9
M;! [\;N:T+-/$G]J:9=QW#RV,J$7RW$D>UL@;7C"C(.>V<$>_-0:%!<:A++:
MMK5UK>CSV[QSK=V0A49P %8*N[(+9'('L<9O:%X.71'B0ZSJ-[:6W_'K:W#J
M4AXP.@!; X&3@>G2@#HVSM)4 L.F3CFN0\.SWT'CC6K'5[*W2\NHH[J.YMF)
M22!?D5#GH5.?KN/M71ZI97%];+':ZC/I\JR!Q+"J,3C^$A@00:CM=(6WEGNI
M+F:>\GC$37+A0RJ,X"@#  ))Z=3SF@#G_%-Q?V/B?0;VYLK:YTE+Q8%*NWFQ
M32_(LA&,$#)&/?/ICHM=U,:+H-_JAC\S[);O,$_O%5)Q56U\/RC[-_:>JW.I
MBUD$D0F2-1N'W6;:HW$9XSQGG&0#6I<6\-W;2VUQ&LD,R%)$;HRD8(/X4 <7
MJ.JZMHWAW1_$G]HR71G>W^VV[*OER)+@'8 ,J5+#'/(ZYJ5+.4_%V=OM]R -
M'CDP-F,>>_R?=^[Q]?>M*S\'PVUK9V$U_<W6GV$JR6UM*%^4KR@9@,L%/0>P
MSG%6E\/JOBE_$'V^X,SVXMC"0GE^6&+ =,YR3SGO0!KG.. "1TS7(:%<7UOX
M_P!6LM7LK=;J\MDN8+JW8E6@0[ AST(+9]]Q]JZ34[.XOK3RK74)["4.&$T*
MJQX[$,""#45GI"V]Q+>37,MS>2QB(W#A0509(50  !DD^I[YP, '/^+[B_L=
M;T2^GL;:ZT>"]16"NWFQ2O\ NTDQC! W$8]_R[&L6V\/2[8%U/5[K4TMI!+$
MLR1J-P^Z6VJ-Q'4=L\XR!6U0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
+ 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>73
<FILENAME>emergentheaderjuste2.jpg
<TEXT>
begin 644 emergentheaderjuste2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#R17AI9@  34T *@    @ ! $[  (
M   -   (2H=I  0    !   (6)R=  $    :   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $YA9VQE+"!"
M<FEA;@    60 P "    %   $*:0!  "    %   $+J2D0 "     S<Q  "2
MD@ "     S<Q  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M1_\ Q%'_  I#0?\ G_U'_OY'_P#$5Z511[21Q?VSF/\ S]?WGE5[\#;%PO\
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MU#3GMY'W-%(S%'P",D;<@_0]AG.*(V<;#P^(P];)W@W-1FI7UO9GK8(HKEM
MT/Q*FH_VCXDUI97VLJ65HN($SW)/+'ZCBBHLCYVI3C"7*I*7I?\ 4ZRBBBH,
M HHHH **** "BBB@ HHHH **** "BD# T9% "T4FX49H 6@]#1FD)RIH \M^
M-T%X^B:?-$V+2.<^<,\!BORL?888?5A6K\(Y=/;P- EF4%PKN;E< ,'+'&?^
M XQ[ 5V=[96^H6LEK>1+-#(,-&XR"*X"Y^#UM#>-=>'-9O-(D8GE&+!5/\((
M(;'U8UJI*UCZ&CC</6R]8&M)P<7=.UT_6VIZ.2",Y&*XOXGZIIEGX-NX-1*/
M-<Q[;>'/S,^1A@/13@Y]O<50?X>>)VA$1\>WFW_KBP/YB3-2Z=\)M*BO5O-:
MO+O6+K@L;F3Y6(Z''4X]"32BHIWN88>G@L/4C6G6YK.]HIW^]V2,GX(Z7<0:
M?J&I2@"&[>-(>N6V;LL#T*_-@8[J:]6Q4,%NEM$L<,:HB#:JJ, #T%35,G=W
M.+'XN6-Q,\0U;F8M%%&:DX@HI-PSBES0 4444 %%%% !11FB@ HHHH ****
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?*D=$Q:*!_6BD0%%*>AI.U(!:*044 !P:***8K'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6808339696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of the business and organization (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>category </div>
<div>segment </div>
<div>product</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_NumberOfCategoriesOfPublicHealthThreats', window );">Number of categories of public health threats | category</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_NumberOfRevenueGeneratingProducts', window );">Number of revenue generating products | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_NumberOfCategoriesOfPublicHealthThreats">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the number of categories of public health threats.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_NumberOfCategoriesOfPublicHealthThreats</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_NumberOfRevenueGeneratingProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the number of revenue generating products.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_NumberOfRevenueGeneratingProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818293408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of Lease Expense Cost</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Supplemental balance sheet information related to leases was as follows as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:49%;"/><td style="width:27%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-style:italic;">(In millions, except lease term and discount rate)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>24.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease liabilities, current portion</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>22.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>25.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating leases:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted average remaining lease term (years)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>8.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted average discount rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:10px;padding-top:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The components of lease expense were as follows:&#160;</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:81%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease cost:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amortization of right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest on lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total operating lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818673872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits, beginning balance</a></td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increases for tax positions for prior years</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition', window );">Unrecognized tax benefits acquired in business combinations</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decreases for tax positions for prior years</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases for tax positions for current year</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Lapse of statute of limitations</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits, ending balance</a></td>
<td class="nump">$ 10.4<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6827979744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_InventoryValuationReserveMember', window );">Inventory allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning Balance</a></td>
<td class="nump">$ 14.0<span></span>
</td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired', window );">Additions from Acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="nump">23.0<span></span>
</td>
<td class="nump">14.6<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(19.1)<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
<td class="num">(8.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending Balance</a></td>
<td class="nump">17.9<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid expenses and other current assets allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning Balance</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired', window );">Additions from Acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending Balance</a></td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="nump">$ 5.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_InventoryValuationReserveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_InventoryValuationReserveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6825436464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - PaxVax Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 04, 2018 </div>
<div>USD ($) </div>
<div>employee</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets, weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 266.6<span></span>
</td>
<td class="nump">$ 259.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ebs_PaxVaxMember', window );">PaxVax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_NumberOfEmployees', window );">Number of employees | employee</a></td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">$ 273.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Acquired intangible assets</a></td>
<td class="nump">$ 133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets, weighted average useful life</a></td>
<td class="text">19 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired in-process research and development</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 69.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ebs_VivotifMember', window );">Vivotif | PaxVax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_PresentValueDiscountRate', window );">Present value discount rate</a></td>
<td class="nump">14.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ebs_VaxchoraMember', window );">Vaxchora | PaxVax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_PresentValueDiscountRate', window );">Present value discount rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_NumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of persons employed by the entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_NumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_PresentValueDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure present value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_PresentValueDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=84229725&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ebs_PaxVaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ebs_PaxVaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ebs_VivotifMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ebs_VivotifMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ebs_VaxchoraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ebs_VaxchoraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818959456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Acquisition of Raxibacumab Asset (Details) - Raxibacumab - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 02, 2017</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_UpfrontPayments', window );">Upfront payments</a></td>
<td class="nump">$ 76.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_AmountOfPaymentForManufacturingRelatedMilestones', window );">Amount of payment for manufacturing related milestones</a></td>
<td class="nump">20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="nump">$ 77.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Increase to contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_AmountOfPaymentForManufacturingRelatedMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with manufacturing related milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_AmountOfPaymentForManufacturingRelatedMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_UpfrontPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to upfront payments by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_UpfrontPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=84229725&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ebs_RaxibacumabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ebs_RaxibacumabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6732209056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Defined benefit and 401(k) savings plan - Accumulated Other Comprehensive Loss Before Income Tax (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss</a></td>
<td class="nump">$ 5.4<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service cost</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total recognized in accumulated other comprehensive loss</a></td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6814359856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Purchase commitments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationFiscalYearMaturityAbstract', window );"><strong>Purchase Obligation, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Total purchase commitment</a></td>
<td class="nump">$ 59.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermPurchaseCommitmentPeriod', window );">Purchase commitment period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Materials purchased under commitment, amount</a></td>
<td class="nump">$ 51.3<span></span>
</td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermPurchaseCommitmentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermPurchaseCommitmentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6825148112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Components of Lease Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseCostAbstract', window );"><strong>Operating lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">$ 2.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total operating lease cost</a></td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating lease cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6813111536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 752.7<span></span>
</td>
<td class="nump">$ 681.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="num">(210.4)<span></span>
</td>
<td class="num">(171.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property, plant and equipment, net</a></td>
<td class="nump">542.3<span></span>
</td>
<td class="nump">510.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">49.5<span></span>
</td>
<td class="nump">36.3<span></span>
</td>
<td class="nump">$ 32.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember', window );">Land and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">46.5<span></span>
</td>
<td class="nump">44.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings, building improvements and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">234.8<span></span>
</td>
<td class="nump">216.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">334.2<span></span>
</td>
<td class="nump">293.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">55.7<span></span>
</td>
<td class="nump">55.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction-in-progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 81.5<span></span>
</td>
<td class="nump">$ 71.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>85
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( %.36% ?(\\#P    !,"   +    7W)E;',O+G)E;'.MDD^+
MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V
M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F'
M.>RGGD7E2B.5^S3%":4A+<TXP)6E/S/WJVR;A5ND9T*YKCM+1[873T$7LF<;
M!I99-G\LCNVW<+ZT+/0:S>,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C
M-R."?S]PN -02P,$%     @ 4Y-84"?HAPZ"    L0   !    !D;V-0<F]P
M<R]A<' N>&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(?
MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+""
MWTG] E!+ P04    " !3DUA01>VS:^X    K @  $0   &1O8U!R;W!S+V-O
M<F4N>&ULS9+!2L0P$(9?17)O)\VJ2.CFHGA2$%Q0O(5D=C=LDX9DI-VWMXV[
M740?P&-F_GSS#4QKHC1]PI?41TSD,%^-O@M9FKAF>Z(H ;+9H]>YGA)A:F[[
MY#5-S[2#J,U![Q $Y[?@D;35I&$&5G$A,M5:(TU"37TZX:U9\/$S=05F#6"'
M'@-E:.H&F)HGQN/8M7 !S##"Y/-W >U"+-4_L:4#[)0<LUM2PS#4PZKDIAT:
M>']^>BWK5BYDTL'@]"L[2<>(:W:>_+:Z?]@\,B6XX!47E;C>-'=2W,B&?\RN
M/_PNPKZW;NO^L?%94+7PZR[4%U!+ P04    " !3DUA0F5R<(Q &  "<)P
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ME;F5^,YT^*BRW7A0J'W;[4[,?MTOVON#5I^&#Q+1^%5D^1=02P,$%     @
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MY2BB%%POT5454B4LX2.5#K8S)I0"A&++*G6=4-<E&9"L9*A?8T(I0"A'":4
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M-]?3'9\"JX;X?/'\#ZG_ E!+ P04    " !3DUA0G@!(_K$!  #2 P  &
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MX\O&_M?&>$ INQL<H18_V&(HJ'TXWN'93F,V&=[T\P]BRS<N?@-02P,$%
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M=K\QQ@.FDMS@ '7XO59#0>/#\1;/=AZRV?!F6/X/6S]Q^0=02P,$%     @
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M^K,9QVPT'';3#V+S-\[? 5!+ P04    " !3DUA008-!X;4!  #2 P  &0
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MVOKI)S?7TUN>%E;UL4W)_*\H_@)02P,$%     @ 4Y-84,+<9#NT 0  T@,
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M-G'2.64 +L]7]B^Q=E_+65AX0/G2EJ[)Z!TE)52BE^X9AZ\PU7-+R53\-[B
M].%!B<]1H+1Q)45O':J)Q4M1XGW<6QWW8;S976'K #X!^ RXBP V)HK*/PLG
M\M3@0,S8^TZ$)]X>N.]-$9RQ%?'.B[?>>\GY/DG9)1!-,<<QAB]BMG,$\^QS
M"KZ6XLC_@?-U^&Y5X2["=W\HO%TG2%8)DDB0_+?$M9C]7TG8HJ<*3!VGR9("
M>QTG>>&=!_:>QS?Y'3Y.^Y,P=:LM.:/S+QO[7R$Z\%(V-WZ$&O_!9D-"Y<+Q
MDS^;<<Q&PV$W_2 V?^/\%U!+ P04    " !3DUA0@_60$+@!  #2 P  &0
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M]_YLQC$;#8?=](/8_(WSOU!+ P04    " !3DUA0\#PMPK0!  #2 P  &0
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M>$)DAGV2()#$E@3A! ZGX ZI"Z>/X:2$"7*0('<$^7]'G'E'A# %+#(#168
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MX_%E8_\;8SQ@*KLK'*$./]AB2&A\.'["LYW&;#*\Z><?Q)9O7/X%4$L#!!0
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M._^RL?^-U@Y\*KLK/T*=_V"+(:!QX7CCSV8:L\EPNI]_$%F^<?D'4$L#!!0
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MM7'36SM7\X69 R.'Y2T@ZX-4_ 502P,$%     @ 4Y-84"G7&XS% 0  -P0
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M,#_ZL[(1653*5D"G6]DA!56&'_;'4^+P'O"SA5&O]LAU<I'RS05?R@SO7$'
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M"J;<+RI'I05?5$PIG+[/:]>[=5KT[S0_(5P(X8Y 9B-7^2>J:9%),2$YG_U
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M85\/($V?TC5]=SPT5>V#@V5)*RKX#?Y/>[1HL4FE:!1HUQA-+)0IO5WO#]N
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M+6Q94*B5F3[JN9@>\K10?)A[%%H:9?$?4$L#!!0    ( %.36%" +#^6$@(
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M4WL,"%12;Y=JSX?9-022=78LH_&_(?\/4$L#!!0    ( %.36%!099G;@@(
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M2ED)U1GU3F9;>W4*[AY2L:WJVU#=%\U1L'FHY*$]YCK=67OQ#U!+ P04
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M8V9:F)D(V@W=V1O_(HI_4$L#!!0    ( %.36%#3=J,9Y@$  .H$   9
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M->?V\[.%9,/TLJ#Y>2O_ E!+ P04    " !3DUA0]0>FP20#  "B#0  &0
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M*W,:Z_.FWS7T%TK6PXXH&+=EJW]02P,$%     @ 4Y-84/\*X@YB @  50@
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MWGQ828^Q-V4[_@_V;VUG*ANE7TJ5?Y\^BWK\O-CX'VZT [<._.K Q \=P#K
M4@=A'<12!VD=Y%('91V4XQ!/+VM\^P]YEV_7C;D$S51 YWRH4W:G^OW=#P_'
M[1R_ZS>@[9^^;Z6"=?P^!+(VN\F&W]B(6YM[;"-6ZM;F =OP6XO'!5&>L(V2
M5Y.X3_::,2<SYJ,_S+,1C X 9  8 XA9@#1U,IU,Y&A23YDJ%;F9$%8RBU)Z
M+8)<BR"2X70 20:0*!DIG/U_D&B=*LJ<7":;;&:3T,M0Y#(47@:LG!)32R%2
M$B+%$-)3."LRP&IYX61D@(Q(TJF<78:2S&@(EM!\3A (4\PE]&24SE!$Y$F%
M>?H&(PI'N#@,X3!O@3.:KHP3":$.Q3$0BWQOCJ8UP[R6(G4;%.;LER0"#Q#-
M6280$!=HBP3*2*;1R@-$<YMA<J<K%T=BG%FCNH6AN<L(\LY:LGUQ"N^0-QV:
MP PS>,7==%($\P4B#\T9S7.V(BH.E?9DI&Z A >';@>,Z ="N3@92BA-(IG-
M_SSJ1S<(CAN$Y&Y56"/U\U[+Z?; B?8@W=RLT1R%@8=+W"/FN#NX8KSCN#FH
MS%<3G&X.G&@.KD#MK-$<B*?@:ZR<[@[\$Y+.:=YS0M25\_(?.29^W\D\%<QI
MYG."^2)S@2CF^]X)S7Q.:+=R6[,UNF&DCQHT\3DF/AJ&'JW17 %2G])PFOB<
M(+[R]$*@60S))Z98FJ) 4!2-(X IZLD5:((")=^NV %FJ'<> <]03JFWV[0!
M$]0_CP#-3\#JC><1P.K->.1A,= L!LQB/"8 (=_>,0%H%@-F,1H3 ),8O# T
MB6&!?,-GY!MH%L,2^;9&MT#@&WR YC$L$7#  NY7'T&S72S1;($UVT-503<$
ML42SQ2<T6] M02S0;$%H-O-MCZ!;@EBBV8+X$4YH=CP[3QG.W/[(F]>B;H,7
MTW6F&@]0CL9TN@_93V=A<-+YX7I3ZF,W7*;]=3.==4TWG3G;<[SX>IBX_1]0
M2P,$%     @ 4Y-84$0UEP^+ @  /0D  !D   !X;"]W;W)K<VAE971S+W-H
M965T-C,N>&ULC5;MCN(@%'V5I@_0%OJEIIJLFLUNLIN8V>SL;U349MK2!=39
MMU^@V%1Z.YD_%O#<<^X!+E#<&7\3%TJE]UY7C5CZ%RG;11B*PX761 2LI8WZ
MY\1X3:3J\G,H6D[)T03558BC* MK4C;^JC!C.[XJV%5694-WW!/7NB;\WYI6
M[+[TD?\8>"G/%ZD'PE71DC/]1>7O=L=5+^Q9CF5-&U&RQN/TM/2_H,4693K
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MHE[[9T(X%I2!)\A*\>DP#FI\YO(V%?=T.#^' 2>=_C;PQP^4XB]02P,$%
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MJAH:58DFD'#-T5.\.Z16[P2O%71JT@]L)2<AWNS@RR5'D04"#F=M'9AI'G
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M*S7Z-,^JT<^;U;_3W(3($J*.$,*'A-@2XO^$Y"$AL83D64)J">FS!&@)<$0
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M2=<4<JQ;#G2;.<H4Q[KEJ!_;"VY LQH?4R!=T3I>KX%N,[MS<="/11IDKC7
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MUW*44@GM) FT>V>1'^X?I3BJ[G6IWYOATFKX4/)B+N3"^ZW@YG]02P,$%
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M,Y"OF<J,I1),TKT+(@*L)P$(HTQ!"5B<,/ ,RJ\12GF6.1(6>1,@G=!,1[!
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MWC?=9=Q>5\/I\G#3E.?QY-R_'=\O_P=02P,$%     @ 4Y-84%/?CP;7 @
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MLY"TR%W//:W#YR$*YH!GME[PB;K7HLE B4WL4%F?H72HBI%HRNS<RS< .E8
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MW"O521U2<\MUCC+?76]*N>_ZRT1?-^-+]7C3J=/T@X%__=5B_1=02P,$%
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M/Z'H'XP^#Z<O_NT(:/T'4$L#!!0    ( %.36%!$.SB2G@(  (0)   9
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M5264N(^_G:C;[RF(P_%=_:L,G@>S@Q1M</6G/+#STDU=YX".\%*Q5WS[AKJ
MYJ[31?\#75'%X<()WV./*RK_G?V%,EQW*MQ*#3_4M6SD]=;IWVEV0M 1@IX
MXJ>$L".$GX3H*2'J")%&\%0H,C<%9'"5$WQSB'J\+11O$5A$//M[L2B3+>_Q
M]%"^>EVE29![5R'48=8*$PPPH$=X7+W?(K!ML0X,NK;!QD3$\S&D,"$ Q'87
MH3704 J$HT!#NT!D%8BD0#02B+1,*<Q<8AJ%F:7^\ >TT!4C&S"TY!2F)IBE
M=N-SJ_&YQ;B6WK7")(--_)F&V2A,/,1H5I\A1D9CJ]'8-!KH1N,I$YO8""4>
MA#*RD5AM))9\Q9J-9-+&)*)XAAC93*TV4XO-1+.9&KD QF,U,?XLU*S:, ]R
MFEG-9H;9>::7F<S8Y(L_T[ZP33:95JO,@R\=^/:BZ%MRF^I5T9]\!Z8AQ5/(
MV.N# @XL7C/=*S"+B)E;"VJB?!4=Q5Z_E'UO<!35B)SD,4^=/;XT3%3TP6K?
M2KP$XBC3UM>BQ9!'W*>,ZD]^0G(J&^KL,.,'I3S.CA@SQ!WR]]1USKPEZB<5
M.C(Q3/B8J+Y 31ANNY['ZQNOU7]02P,$%     @ 4Y-84-N!/BJ6 P  S1
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MH.XP'6"+(\* 'L$C)^&U_;WQ"$%,)_#)!'Z;P)]4@6E5Z&+B-J:X586 '")
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M8+S?X!!? \_UJ5(F0(J\HR?X#NI']R3TCHPJA[J!5M:\10*.&_P8KG>9P5O
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M+=Q$<AO%NV'8DG'B%W\!4$L#!!0    ( %.36%#HVS-,# (  -D%   9
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MTU_.7+14Z5!<L.P%T)--:ADFJU6*6]ITJ"KLV5Y4!;\JUG2P%X&\MBT5?W?
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M<%9FF^F]<%/$!8KWXX#$TY2N_@%02P,$%     @ 4Y-84)=J<.#P 0  VP0
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M]V(83T.@>#>.7C3-_^P_4$L#!!0    ( %.36%#^;W=!&0(  .8%   9
M>&PO=V]R:W-H965T<R]S:&5E=#DY+GAM;'U4ZVZ;,!1^%<0#Q-P";420FD35
M)FU2U&G=;X><!%0;4]L)W=O/%TH)>/F#[>/O<HZ-3]XQ_B8J .E]4-*(M5])
MV:X0$F4%%(L%:Z%1.R?&*99JR<](M!SPT9 H05$0I(CBNO&+W,3VO,C919*Z
M@3WWQ(52S/]N@+!N[8?^9^"E/E=2!U"1M_@,OT#^;O=<K="@<JPI-*)FC<?A
MM/:?PM4NTW@#>*VA$Z.YIRLY,/:F%]^/:S_0"0&!4FH%K(8K;($0+:32>.\U
M_<%2$\?S3_5G4[NJY8 %;!GY4Q]EM?8??.\()WPA\H5UWZ"O9^E[??$_X I$
MP74FRJ-D1)BO5UZ$9+174:E0_&''NC%C9W>RL*>Y"5%/B 9"F-XEQ#TA_B(D
M=PE)3T@F!&1+,6>SPQ(7.6>=Q^WMMEC_1.$J4:=?ZJ Y;+.GCD>HZ+5XC!YR
M=-5"/69C,=$($PX(I-0'B\AEL8EF].C68#M'I,M;R&X."</4G47L+#0V O%-
MH8]N@<0ID!B!9"P0!Y.3LIBEP32VU$7F-EDZ398.DW!B8C'9R"18_.<H4J=)
MZC"97,DFG542+V*W2>8TR1PF\>3>L[LF]N+GF'!6+1K][13XV702X97LTDC]
MTXRB0[-ZBO1KF<0WJHG9GO,E8SO@3\S/=2.\ Y/J+9H7<V),@DHQ6*CL*M5T
MAP6!D]333,VY;3UV(5G;=U4TM/;B'U!+ P04    " !3DUA008-U.#$"   K
M!P  &@   'AL+W=O<FMS:&5E=',O<VAE970Q,# N>&ULC57MCILP$'P5Q /$
MV'PF(DC-554KM5)T5:^_G<0)Z RFMA.N;U_;<(C"(MT?L,WLS*R7M?-.R%=5
M,J:]MYHW:N^76K<[A-2Y9#55&]&RQGRY"EE3;:;RAE0K&;VXH)HC$@0)JFG5
M^$7NUHZRR,5=\ZIA1^FI>UU3^?? N.CV/O;?%YZK6ZGM BKREM[83Z9_M4=I
M9FADN50U:U0E&D^RZ][_A'<''-L AWBI6*<F8\^F<A+BU4Z^7?9^8!TQSL[:
M4E#S>K GQKEE,C[^#*3^J&D#I^-W]B\N>9/,B2KV)/COZJ++O9_YWH5=Z9WK
M9]%]94-"L>\-V7]G#\8-W#HQ&F?!E7MZY[O2HAY8C)6:OO7OJG'OKO^2DB$,
M#B!# !D#2)]++^2<?Z::%KD4G2?[S6^IK3'>$;,W9[OHML)],^:567T4VS#*
MT<,2#9A#CR$33(S#$8,,_RA"0!'B",*I""$P00@2A(X@^L]E/'/98V*':1R&
MQ)L45HE E6AI,TQ@@A@DB &;Z<SF$I.0#!9)0)$$$,EF(A!F"XNDH$BZ($CQ
MRE9D($'V\9)O08+MPD&4S-/<+DL>K94<!_#_'RQTLC6&E0["'T\5P_V!R;)>
M43#OPAZ43K(--RLUP7 ;X64?I7CEY\-PCV"@25:SA;L$ VT2X7FV\;*V9(-G
M0FARS-EKY >5MZI1WDEH<V*Z<^TJA&:&,=@8KM+<7..$LZNVP]2,97]\]Q,M
MVN%J0N/]6/P#4$L#!!0    ( %.36%!%[\-$_@,  (42   :    >&PO=V]R
M:W-H965T<R]S:&5E=#$P,2YX;6R-F%V3HC@4AO\*Q?T "=]=:E5K]TRWLE5=
ML[6[U[1&I0:("]C._OM-(-)P<FCU0B$^[^%-SB$)S"Z\^E4?&6N,WT5>UG/S
MV#2G!]NNMT=6I+7%3ZP4_^QY5:2-.*T.=GVJ6+IK145N4\<)["+-2G,Q:]O>
MJL6,GYL\*]E;9=3GHDBK_Y8LYY>Y2<QKP\_L<&QD@[V8G=(#^Y,U?YW>*G%F
M]U%V6<'*.N.E4;']W'PD#PGQI: E_L[8I1X<&[(K[YS_DB>ON[GI2$<L9]M&
MADC%SP=;L3R7D82/?U50L[^F% Z/K]&_MYT7G7E/:[;B^3_9KCG.S<@T=FR?
MGO/F)[^\,-4AWS14[Q/VP7*!2R?B&EN>U^VWL3W7#2]4%&&E2']WOUG9_EY4
M_*L,%U EH+V@&YQ)@:L$[J? ^U+@*8%WK\!7 O]>0: $P;V"4 G">P61$D3W
M"F(EB.\5$.>:.>=3$GPMZ9--[K[*-=V$ HG=%59;J4]IDRYF%;\857>SG5)Y
M3Y,'H1+!96M;^^V?HEIKT?JQB#TZLS]D),4L.X8.&,^-QLQ:9TA/V,)"[X.B
M/I94TP,7*YWPHF#,/"',F'C&HH1CYKO.!/X8^8&% 4/R@C'QF'E%F-@!0WMS
M:#:W#2<Z0DB 9\C%*\5M([BC2G'Q"!X>P6LC>$,/+JRUCO%;INP&)+# J*T0
MR+5 I"<=^A9;8%B>$8@&%@$%@5"N!2KKAPY1!SI_T2'?@9=[12[GP4AK))('
MN[?1H8!:H-P3'8JHY<?##YYF'T^SKZ4Y]L!@K3LF&%P35/WF)I%T1#@<<&NB
MI /<:8 X!4.X#FXZO4DD@>;4&61AY#3$G8:(4S#YK<-[*D*'D(K0H<BW8F?P
MF9C<(]Q]A$P=$_V/\0@Q,G7 3,7:*/M$ZS\":3=@HD,>L2+<L%SGT87505*F
MK9H.4AG@3M\@$+%<8!F%)K)$IO8"!+$,YQT%?75#W$82A0SMAH,9=6P7WS(\
M$JK;]>'BJ:!1PBF<NS<812"58)1C3:R!9&(9)2Y2RB";2P7)I X+ ]3I"L<B
MX/L)P[Z)J@?5^#S!^7 YG."<T''P.:);('&W<+?YHK!X6,E@@9SJ$,P]@A'+
M"6#R48S"'12.Q5/3PL0>B&";( ^FWT/3#[./4I$+LX]@:/9Q3L\^SMW,/NK6
M(S#[>-<C6 $3G8(5@&"B K3;'\4HA16 8N'4+#NQ/2+(_@@.\IKHFYMA 707
ML@=/>06K#NW[C-K8\G/9R.5VT-J_,WFD\BD1M"_)PRM!VM?R'4O[5/D9OGM!
M\T=:';*R-MYY(YY.VP?(/><-$]Y%R9C&D:6[_B1G^T8>AN*XZEZ,="<-/ZF7
M/G;_YFGQ/U!+ P04    " !3DUA0#"Q*L1,"  "F!0  &@   'AL+W=O<FMS
M:&5E=',O<VAE970Q,#(N>&UL?53K;ILP%'X5Q /$X9HF(D@ET;1)FQ1U6O?;
M(2<!U<;,-J%[^_E"*06O?V+[^+N<<W!.UC/^(BH Z;U2THB]7TG9[A 29044
MBQ5KH5$W5\8IENK(;TBT'/#%D"A!X7J=(HKKQL\S$SOQ/&.=)'4#)^Z)CE+,
M_Q9 6+_W _\M\%3?*JD#*,]:?(.?('^U)ZY.:%2YU!0:4;/&XW#=^X_![IAJ
MO $\U]"+R=[3E9P9>]&';Y>]O]8) 8%2:@6LECL<@! MI-+X,VCZHZ4F3O=O
MZE],[:J6,Q9P8.1W?9'5WG_PO0M<<4?D$^N_PE!/XGM#\=_A#D3!=2;*HV1$
MF%^O[(1D=%!1J5#\:M>Z,6MO;Y)DH+D)X4 (1T*0?DJ(!D+T3H@_)<0#(9X1
MD"W%].:()<XSSGJ/VZ_;8OV(@EVLNE_JH&FVN5/M$2IZS[=)F*&[%AHPA<6$
M$TPP(I!2'RU"ET41+N@S@\,2D28?(<<E) A2=Q:1L]#("$33+-('MT#L%(B-
M0/RA4]&L4Q:3&$QC,,EVM7&[)$Z7Q.$2SUR6F$WTGUZD3I/483)K>)$N2PE6
MLWH/2U 0KH+9I[.@[004S9)%D]=*@=_,)!!>R;I&ZH\^B8[#YC'4KWT6+]00
MLC/C7<9.L!^8W^I&>&<FU7_)O/@K8Q)4@NN5*J!20W,\$+A*O=VH/;>CPQXD
M:X>IB,;1G/\#4$L#!!0    ( %.36%#KV%EN90(  "<(   :    >&PO=V]R
M:W-H965T<R]S:&5E=#$P,RYX;6R55MN.FS 0_17$!RR86R B2+FH:J56BK;J
M]MDA3D!K,+6=L/W[VH:PA$RBE(=@#^><N<!XDK:,OXN"$&E]5+06"[N0LID[
MCL@+4F'QPAI2JR<'QBLLU98?'=%P@O>&5%''<]W(J7!9VUEJ;%N>I>PD:5F3
M+;?$J:HP_[LBE+4+&]D7PVMY+*0V.%G:X"/Y2>2O9LO5SAE4]F5%:E&RVN+D
ML+"7:+Y!OB88Q%M)6C%:6SJ5'6/O>O-MO[!='1&A))=: JO;F:P)I5I)Q?&G
M%[4'GYHX7E_4OYCD53([+,B:T=_E7A8+.[:M/3G@$Y6OK/U*^H1"V^JS_T[.
MA"JXCD3YR!D5YM?*3T*RJE=1H53XH[N7M;FWO?Z%!A.\GN -!"]^2/![@O])
M0 \)04\(!@(*3+6Z5$QM-ECB+.6LM7CW>ANLOR(T#U3U<VTTQ3;/5'F$LIZS
M)(Q2YZR%>LRJPW@C#!H0CE(?7'B0BY5W0P]F$Q=K !.&UYC-+0:A" [$!W/U
MC8!_E>L,%@A @< (!%<"\:18'28RF/I1L4+010BX2&"!"!2(GD]R!@K,;B((
M$)HD>8M)(G?R2B',1&<#83PXV!@,-@8$?%@@ 062Y\N%7+B#W"<*!H"2*)A4
M# 1-NP $W6D#=*?G$2!Q+VFPIY?(^X^ZP=V(?""*:3?UH'#43HG[$B;C:UK%
M6TKLO23NZ)IVI#,Z+2O"CV82"2MGIUKJ$V=D':;=TM.G[<2^TE/0G,*?,MT(
M_8'YL:R%M6-2G>7FQ#TP)HF*6.5C6X6:VL.&DH/4RYE:\VYT=1O)FGXL.\-_
M@^P?4$L#!!0    ( %.36%#E&(0:<@(  +H(   :    >&PO=V]R:W-H965T
M<R]S:&5E=#$P-"YX;6R55NUNFS 4?17$ ]28+X>*1,J'IDW:I*C3NM\.<0(J
M8&8[H7O[V892"C=5]B?8EW..[SW$ODY;+EYDSIAR7JNREDLW5ZIY1$AF.:NH
M?. -J_6;$Q<557HJSD@V@M&C)54E\CTO1A4M:G>5VMA>K%)^4651L[UPY*6J
MJ/B[825OERYVWP)/Q3E7)H!6:4//["=3OYJ]T#,TJ!R+BM6RX+4CV&GIKO'C
M#H>&8!'/!6OE:.R84@Z<OYC)M^/2]4Q&K&29,A)4/ZYLR\K2*.D\_O2B[K"F
M(8[';^I?;/&ZF .5;,O+W\51Y4MWX3I'=J*74CWQ]BOK"XI<IZ_^.[NR4L--
M)GJ-C)?2_CK912I>]2HZE8J^=L^BML^V>T/BG@83_)[@#P3\.2'H"<$[(?R4
M$/:$<$) 72G6FQU5=)4*WCJB^[P--?\B_!AJ]S,3M&;;=]H>J:/751(G*;H:
MH1ZSZ3#^"(,'!-+JPQ(^M,3&G]']CPMLYX@X^@C9S2$8QW 6 5AH8 7"<:'$
M@P5"4""T L%8("*P0 0*1+,,0HPG5L\Q"9E@MA!FXN@.P,0^G&P,)AO/!")R
MXZL34(#<;]<"%%C<8=<<DY!@8A>$F>CLYA@2W:@V 9--@$5"6 ![\$;T[C<,
MW]C+^ [+ %!")KMM"X+BB6D Z*9K&#P:UMB?2> HN2$![VL<_(=O\,[&X3V^
MS4$+?[HU 5!"R-0W"+289(Q&!WC%Q-DV1^ED_%(K<PZ.HD,#7ONF 4SB&].8
M;6-XE^FZ^@\JSD4MG0-7NKW8)G#B7#&=H_>@#Y!<7R2&2<E.R@R)'HNNFW83
MQ9O^IH"&Z\KJ'U!+ P04    " !3DUA04#,>Z+D#   P$   &@   'AL+W=O
M<FMS:&5E=',O<VAE970Q,#4N>&ULC9C;<ILP$(9?A>$^@ 0(R-B>J>WXD+@S
MF7;:7A-;MID"<D&.V[>O.)C :I/8%S$HW[]:[;\B**.+*'Z71\ZE\3=+\W)L
M'J4\W=MVN3WR+"XM<>*Y^LU>%%DLU6UQL,M3P>-=+<I2FSH.L[,XR<W)J!Y[
M+B8C<99IDO/GPBC/6187_Z8\%9>Q2<SKP+?D<)35@#T9G>(#_\[EC]-SH>[L
M+LHNR7A>)B(W"KX?FU_(_2:L^!KXF?!+V;LVJI6\"/&[NEGOQJ93)<13OI55
MA%A]O?(93],JD$KC3QO3[*:LA/WK:_1%O7:UEI>XY#.1_DIV\C@V0]/8\7U\
M3N4W<5GQ=CV^:;2+W_!7GBJ\RD3-L15I6?\TMN=2BJR-HE+)XK_-=Y+7WY<V
M_E6&"V@KH)U S?V1P&T%[IO ^U#@M0+O5H'?"OQ;!:P5L%L%02L(;A6$K2"\
M51"U@NA6 7&NSCEO$O:QI#.;W#S+U6Y"@<1N&JONU'DLX\FH$!>C:/;:*:ZV
M-+E7*A6\&JU[O_ZEZM92C;Y.HB :V:]5I):9-@SM,9X;#IE'G2$=8:L4NCPH
MFL>4:GHZG&&F$U[(ALP<88;$ Q8E&#(+G6'^$%EB84!)5A@#2KM&F,@!I?VT
M-$^?)[S1$4(8[I"+=XI;1W#[:00^'L'#(WAU!*_?:R%8[+1A_)K):\9EC@5<
MG"$4(18P8*Y3U',M4+P'G2*18X'.6B"Q L<"G;-$8@4NI%9(+.K O-9(+!+
M-3XV5#2@')#\DQXJ""DLZD:G?%7Z"+?8QRWV$8L)L+AA@GXVVKIF"*25>]Y
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M(53,&-Q^>#/XPT_B.,* 4@PS!CQR&:%D,<N+O3/)R46F,>&UYEV_48T(5]#
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M<.%]&^H, H('%6]25;W7&>K3"_KUSC'(2,HF>71IE"YKK3QF! H1U11;4&
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M .O%@-;]!"\+N4:N:"FZKTXW"P!^/#9^%O[D_"SG0YC\ M-DKER22V<<#M-
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MPG'$CRW80_>>OD9]P=[U@^!YF^0I-:V?DMU K'D^R>HT^H3S9@7</'01$4G
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M,M8+QWE1X:[ F@1(]RD0H2BI4I/7P,)^?\PR,A9<T.5-2,O:L=7:=L#-/@A
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MZ(KB2:^Q/&;)!=[BBJE6F,%$3B[.'G]14H60%F; $DJJT31<[0_VB(5ARFT
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M!\H4RU[*_:BV%59XH@J/IG$T)HOER2.3.^$L0+3+0IQB6N^:Z=A]5MR%=;6
M>I\B"YXI#!45W]R\_73C$-$4SM:0'ISH5"?BI(MU>AK?42-$6(@.]/S5]:>6
M<1AC:18[NLT<"0/C<;^(&7A?:+>6I+MVCIW7+4COB95Q(0CDY4)UI?H8#O]:
MNSD:)YNY-K::@#L:F('WJT[WNILJR3P39V&)D(%?PA'D8O@T#W$@K:5P&/4
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M,=<-*BE.%"I <&4R=T>1>/!O_ZLW'OYRL"CGR]]!E+][G*Z6D[OY<N7NM\-
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M"B9:,^8.?<?CLL_"[,V#'+)&\@&$9BR,@-#]?H+>_4(/.-'WW[WA637JR8#
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M28CR/OL]7D<^*Q\PK\)UM?S-GME FLF:(/$D@I5AQ0[Z*?OR.7X!!DS:YI2
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M@XP*+)TB.E;+;W ]/<#F 2N>13F#.$98:O"M<EEX$R:2CL4C;U,1U]BZBO%
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MXL\NBO?DR&%RX.)=4Q9-:!.:-P0/[_T2G=BB&03A9'100).#U;K%DFHKJF<
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MVZ_28.D=)!(R3QD>)5<X 3<RJ6];O..IM;J,=LA/<>MR)J6M,ZR'3HX;+9B
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M&RP,^Q&CKE ?[R<<1LHO#C- J0DXYUI0+)0A/BPFU3XWI*D4+7$^XC-3(20
MLTTG9&PCGDYTP13H6:11S>,C!-\@MT$K_X$EZ2O0690;")\W:]"Z3*:JIOF;
M8[SAFC%)TE'#NNDP$8+X]Q+B.6*$,)_ER^R4L'MR=UI0(JF,L<8TB3N=IFF.
MN"O>;8:@$B7;"6;=XJ]P.OP-\G.=(SR98GX)HDT/;((-BX;I12+36>^I[CXA
MI9**09B(6,S@%_(,4X:K[3: !6_<JB9"7#!0GO55:0!-" L:EA710F]"4^I:
M8?Q<O%!"E?3O*#DP_@RB]'C%P:?Z/&83?9IF5B/^!H+.K5$8JM$) T59LR^$
ME;S)D(H\!9F[5S6GDFT#T1@5<LJXK IM#7$^O9#%1)1$O#=,P(RG9LNMB0Q;
MNX,.=4P=D=XU1XAYX41T/_=Z!)R2W?_H2D9E5RX=UM#,O@;C%EG=HAS><:*=
M6ONH;.A,?Y)\-3$,8;D?<F6S<L0E&D2@D6D=*,BOQ<+UR+B'(AO5H3C.&IG=
M.(:B@7'XQ8HUDE0Y3$0L=MF!?YCJV@6]^*8U$*>IR#2N>N9L9E9X:Q\&A9@,
M&@(J$4\PV.-86(_F*I8Z#6[2H$S[$N^@OC1+H-GA]B?81BHRW@7,=*/87;S\
M]/YU(#)I8Y%F^+,\'*9HFC?KI9.\D08%!EF:B)+'X$*Z>/G^T^OTFD (KIOE
M?+8442Q7 B\HUH:R3DDYAM$(O<+&.B@C_#1)V!<<SQ JOPWWI2@BVV5P(EL_
M&'D3S7WH3?8Z A;&E%S52D%CTY -?1Z1$1_I*JDUH.QA7M;W<-5*04E?=ZIY
M^=JW&QDR5$)P4\!)'R%E:7-.L/S+^.R8PNL^NWO,K<!JRH;!Q.8>U.ZC9-U*
M2S)#83A$CGEDKSH77,-:3X^=XGJSEG8G&&0#U5MX\YI+0S'001B[P"6\LZP@
MK3OG?5E<1@. ^H\V#^QQ9MX'F^J^))4-;(1!0QU(2THM/7C=/WM8SA8$-NBX
M^K/$R.?M,PV"LQ>4Q4+D#:G&5J"[J@PJ8D ,1<NXJ\&H&'95$4L!J4'*6$D.
MN3>8NF6!''. RC&\T)A\.M86O;QA)WIHL[$B98Y3AH0;6YB^G_2A;(G6A&8Z
M*R>@^U"Q #'77#-0%YJRT("EMQCRL0]4NA>'O"K!_\V$K5U]DNIN4<(F$D+&
MX,.QED;H9[.T44[W,N\V&':OV?(XIQYVM._"=<, KC(70O'!2>8@!@.TA08!
MRA-7D\2/\G0=!'P;Z9$T8$)S96\'(#O7'>$0:PRD(_AOP-&M\-#> <R[(Q?Y
M N[RA[7>TF+O <N.9T&KZIK"ALAG=EU.U"*)/S!K(F 84+565&)!,!YI6FDD
M4[-\WO4T%-:@51H+8]:^3Q61<(@_4!5!P]K>ND@HY\A0PJD'APJB>*)SE),^
M&>D45R1@BT8\]=&97"V/6&#*8S\*J&O-<,/92:ZV[&=0XXA--3Y^@@]-$.X6
MG;.&?GWUYP<_3D3JL@C!4+&*(03F#"CQKWB>H-J(QR35R%5) #<SU C5$'W3
M1VI&-TX$^S5;>2&<M#(5&C2@18K/.U&H[*36H(YU9A)*!5,"S1U+MQHXJU4%
MDA;.*XAZHGG=KLI[M=BQ6]Q# FYF0)X*G4Q!S.+A#$XVF[$VB"?.NQ!>FP$R
MEA\4>_"3B<@E;(9)LLH=9!;."U\S"M8);_%PI_*H>5D;<Y-.[:@U=6B"'B67
M71#%1\5HLZ9$W\&62\EBS><M1(PC:"Q1XC.)WXU.^8^P+24,G3C6'DP=O42\
MYZ02Q[YLBF*NZFCC'G;BADUVHW_7(X.1(V%0GS_* <U)=R@U4T1RY9&S$O[\
M-+Z6<J_=!0#=<(XE$&PF"PW2#G)X7<Y11G7,&M-1HBG%;+2)"5,UM;OEMX5@
M()BXF4RQ7V,?VS$>RI((:S=>]]ZU$=K=V6HJ9BT?]%+96)F.-<A/2K6L2^5O
MA,KRCD--Y#?#Z$1C0 RM&3E:@O',%B"$*A0)*;0UD-C<0DWA"&HX8G2W<W]4
MN0>AL'!$(J+$W;NK!G:<+ Y8$9-QL""\8LWUB/P:0IU*=WP M0D\.!,9NGOW
M<?EPIYRZ@R8OMQ".0LI;F2?H/O.*H)-MA05ONZC73D)G[3I<>-:1IYN(+V+"
M!>9EB-&JD[&9;+'A2+:-KWDN*-@H.Z$N;E[D8AOS&& 0GO,ZS.=&1Q7*GZIG
MQ\KZ3N$/$)Z'X.XV"N(.TWCS\0^AYB>.,O[9VP>65-%"\@  (QL>; ^)\-$5
MU0U<#)/'4-?42'>WGS>0DI*P]B1,*6O6L,EL:CO-K6^L[-OUMO$!*,I@N>\T
M1*\AIN^OBCC;'/?'4+8-A?]^;LG3UI*S7+S6@!TN;UX4__:_SDZ&_5]@VC5D
M;,R/)&U07OQ%GX%;A#"PEC>TI1!FQB9@ML&OD-5TX-H&>S^[N"B1QW  MBAV
M,.<:K#<P5%.X6'%8RBGHF;4I81]=,8Y7,#N"BF'$!##F3%B$ =,'Z<W7;VQO
M9+%<'.GWS$3\4DRDV.M3[H6P.[WE*?HJZ4&KH5'T -R]F>$V[7\FM^?><8 [
M,-%^U2R3[)>,3K&:<;7,!2:>^F(VN#]&SH>LRO6CMZ<2X$7%%3/]V^%)]2Y,
MN$]((\#ZF30O+GBAE5U%4W:2#%4G69/B/9O.2JBS^W,^ E(V?;:R%?-(B)FH
MI/JE>]4MILOYG&J$V7*@/-O<.AF7?#+N)>$"/9!%W/N?S#VQ:*H$GFS=9[-"
MX-Q8KBIW)\LLW.2WO/"&7[C0%]0N#-2.L[=K25LI:H&(T^GJR2GG3$:SBAV;
M^QV7=9,-)UN!")0KL06H68\-"8'\R*+VI2='C?.F\F))^ZA+<)WE:.4>?5^!
M.JA*P[F1X7V=(64DZW"9X:LL$?)]+KU[F-L"JX^9=:LS!XC\5Q9 .#V3@0%F
M9PKNV*"O #N CC2Y#P+*(/A.G&F.($R.9;KW7"U$)P4Q0/[E#M(B.(_7)C=T
M._V@3,%ZMFZG#T1GO7FJN:AUA%=" >'[]]M"MZJ@_Y&DFZ=8>_*M!JIFIF W
M P5/TZB9K@YX>(<=IC:RZEO5+J1QYO(Q,WI=KA:8^OL 6L<=]&GO <V-Q#Q(
M2%!-G\>\<B=E2%X6CY!]=5).7==JL<%0"4!<N$,X*[RO[^_! +9>3GZ#V"@,
M3D/9P =>\"*FI6F">HG8!"?Y()+NHLXFR>[X6H+@@_%RYF'&8*C"MT!#)U'\
M-4+&.TI\.5M>+><;XBR.S+K%%<[V$LO,P+'_"*63L9SA,WT+O@/8>K("I*8H
ML 6A8(OF$*AWL7Y\8(JGB[\D,=X[17B1!987:R_,J+([_H+HCZ3L&Z';_,8N
M4;1UL>]PRCG#2;<'$O;*9N:O[+.N)W?5=(/>/8BI1M$NHHM#DR42K$=:ZI?,
M;6;])UAW>5UE?'?72_ Z0VJE8S#LCF2D2Q9J,5 X[K1;O :KDIT=+7R0S1*.
M$R:+Z@$7R/6&.5]4&L)MPH+3U#94.7^8B=BZ6/*&H3'BVD/P3#G=AH-QP-&*
MQ137[C^$8>5O*6;#1"XDWZ-03T/BKQ716#D 6H 8I*(![(@W6ZL!$@- -SB:
M*!T#. (C,L?_*M F0G[4@.RD^@H><N,K\2H^NK28?(2A_I7PJKE[P)4 J'U<
M2KBO;&'R\%5'F61[(3=_1Y"OXP*(M!FTD9NHGGWEI,49V3,.\\&FK .(*U]N
ME##SFZ*"=)O\/FBVL83L*J^AE+TZ'4Q<Q*ZUFG?#R??1V1,G+L/GN*YT;$ZT
MO%LN]$=?FS,AOEA+;N S7,N7 J7=MTD:?\@'K"PA5@E<2S^AY.J)PJ'@<JL\
M>B4?$)Y^D$,=S#8^.JW=?&54R9"#A05&+1J K_]N5DDC"B3?^=X7,;<.TC6<
M7<X!!:P) O$5DQI(+9.2@-^S>=.*'4! [$1$+^>EN_VN)FC'-G5"*,3EQL>9
MYP$&P-(47$'"1B'W#H/9W.%EF.&:$D>B)#Q/.!2_3\4&3)(G=(P^ "_Q*N8&
M:.O>OO):-@8%&+??Q>.LFD\QKJ77_R5TXTEXH%M+]I.M]#W5*8/3@%JD1A4N
MJ"8$1+&5A'VR>#0-*.@>& TJRL'EW)-DN%^7($4B?<A02YM.9%PTCKCX>C/J
MC_A.?%H*B7)\2X.@<S.'@DQ(10?&W>A[/D1/94C<^E)Q(."1]@66YLJLWX<2
M_>".!('UVZ+(]AKD:529]=#+!4%()8E40);X>9%%;447)D>_VI]F]6]'F*ZC
M51M1E;'$L:+RIC>D)GY>X1:(^,^F;)1P\,QA=3+@JE1LL:[NK^=5-+1T2$9E
M(>9FDRSYD9DY1@FUQ+.5@V<GP@L%_4"\, XW.J!)[74JD&/E]0[?;<::&7N?
MC!/8CZ4RH(+7U5WY=<:J+45N"-\4* W>J5BF_\CV'/2/M?X8$!Y,@@HB20T[
M,0C1L\C2^.HE4'^.#D - E4U6((9AVP")=@@)'-)A^TJGM[UHZG1PHKWO.04
M7^_L0Q:*3UOS++K<<1 ;>W]P,1G,H*.RL\PMJ56K/4^6*R@6"*#$OI@POY^:
MQI 630%AG\:V0!G!%F*@4.P)FSI4["'!%'0%7%7REBEAU4XM7SUJ^G^'51':
M/:,UQZZ%K[/J&V%B\I) IK?A_(0PPN6#21 EBS#$E5%:_81GR,M@W];!AY8%
M"M4#_@V%_Z3;Q.!(M3TX<F@/"]""ZH%B,5HV)#$T*;SHQ6@I5"5B=+DFKS,2
M/ N\ EBJE.S5%J" V11R)IA$7BD<61W$JWLNI>FPY/0N^&19"\W:!X3PJO.S
MX33<8B/EX#!G$R4YPM)(ZQ#ZV2(_2Z$U.9U-W8.T=,9C\;7R_A>?2=9D.#%U
MKU+GT?:T_>B=XO?[^8OZH9Q4__L9'I;5U^K93@T5^M"Y8D1\@6R3DZ-^IW@+
M9\5I-81*<#KL'Q8'S_P#SPXA^^1-=;U"5 ;XDE26-^=7+Z57_WC7?#:@/&@
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M@3WFT3T,^EF2MAJ%:/LJ\D8V!CUGS:F0O-!+=4,;O&3==;&*<78<K==V"HB
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M&S/IM\;JBW-V@H!_E0]R-<UDE;JF$"J!PT'#[I_<S(\B\!QA$6D(Z>@3HA@
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MCW&FJ%(4CL3\]B7=@ %#3OAQ[MBU''Q"(315<DLU:/$#89E."RF/J5TW?,I
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MYZOC_OL$!XO18I]WQLD[J3E8#BU&U':*AU+\;T\(T[71PC^T*8CE@>@"$&Z
MP<+BQ6^TH*M)A 1 Z8IN+)4533FXN$6)<1I(C%/O-!ODU)!N^,0!5;[:7W)7
M[SB@AKJ0R8 P.:+ 1+4PD"ZJIOF4#127GU2L2]JNM(ABYA(,4J01)2[">C2H
ME ;<<(."<#4M0B"P3 ?)6K ?_#NZ20TL"&M[TI!5I0#&MD9GVS$HRLWZSNDJ
M?V>U7RV5OGSB@]39;!!(P^:^.GZFX=.,T<HKUM*&3Q7'X#7=4;A+'P*]"FF*
MO=>T_>7:T%RGN&^P(1T?YY2V"W-HI#YJ?N5SL:$\,=ZX#$4TW !AN=QL3=T(
M#6"';6VH.IM:J3++L*U6; -W:J3#X8Y,I<D+F1;'3=C1.#>/018*IZ&$;FIF
M'(V3=Z&V;O(E5-E-OFPP!@VR(#O#[#9@.=^D 2CLFX[@-'UR)VH#]21;J#52
MU(^/3_C'2\R5!7D%$<RM++>OT!(7*6VQ%68CF]IXR%6N9O,N3*?U(5.HM/FA
M8-A!+-(._0.WW..M+16+G[2BZ36\P^*V9EZUK_7VY\-EW_[\EAW8>8!-F[&]
M@<:*NBU#;1E$QKJH>=GYL_,I5Q5YIX/0Q X^77U)'Y:*OGM0J"D\O,^@]R(P
M,ZP=J;F!4>;P=)X<J_'="#V=\#6L5K$]9&!;F=Y4"LH4%]YQT4S8QTYH^OL'
M7H&6'9<J_5BNT"OYGN(=H/)5>\3(]U:2357BYJ+ &6:VK1AP:L0P1<&^*U#5
MZNZ)O=S7-/#%T]SXVBA,_-H3'[K%Q>,2:2;K6![DG2=2$HUK\S$<_XZ/=5I"
MC0THH..Y-9$1:3NX*:__K;Q_^.7CMIX:3D[P6%AV3]T]4XILS%!0FK<V8\"%
M)A*"NI]-.Y(I@YIPR;3 8'K,&TJJ)@N+^#NFUK(6$5Q%4>VLP264D)>!![EO
M&XMO-8+%M+RQ6"X:7MI2_VKG/K:7!,M<A)2UA&>1?*H7+:OOBT &F]047]/X
M>*;D9*K8N#MY>5W:,K=!JN)K6^;V57->]BM')>XT3JCT,!D>4LW.0%S!9MCA
M9NXDH#<,G%].7.=_WJQF]726/6]M[>ZT#G(&6T<?,>[]"G+OCP"2)V/F"-G5
MRIK+I;QJ7IQH."S"P/(O35M_;:XGN^TF1 ](7,*Z.'CK"_7NO8H-1ZX=Q/('
ME'S.*UE68$L7(R[F'#\1U71NO72R2!"VEG.&5MI3:]-*SHD%8&NAY4;.V%:*
M>PO51(69]Z:0+U?)[==>>+CICL[7'<ZSM=:*P\F$6VH.)URCK>!P\\V13YA6
M@:>YEZ#$<,*6XY+!Z?XWUPK.V*)S17V3W<"ZOLGEKZ5],\IW6MEW"\DU5^;=
M/Z$J*2O>V#@@Q E0C:@\'RFF!\.:EN[WDFJ"PVNTMO6V:/MVJ6B'(/P]:JUF
M])>GOKI/Y=2$C[973-U[B=J3#W8MEGID:YB&95'WSV=CC;5!LTD47-=EQ\#$
MFK@)0!^  4D&5"LQ[5,X-6&ZV>*H#4]5[4^U5>U,C <M%5/S(IE6[-QC^J:8
MYKZ;(=\;M,GV7=BSWFIR09GJ?EF!4DJK9E=2ZP8FHPHJI.XWYI;5:RYZF@YO
MYWJG3S_".]9"W?]$!Q5)4]MR6V'2W.G(5B9]^K3;:I4^P:S5!BEVW.VG)@2H
M>M/L^ PKCB:FBJQ;<9=*I/%+O5PT+ZM90=%A"1IX^H(_K;CI_EN1U@--3VY<
M$C2_ ON7!7WZZFPM%+IK1"0$NR;3:8E[W76 WP-.4*XG=QH3I"1U#RFVUX\"
MS)C*/"0L9;M.GW5\ ] O"/+]555/5K.'K2B2"5:\NRNK;QRQM/5A>(@-: U8
M#[TL;\XVU 9STVL(O](5BI)#@YJJ^X/[Y"IE)E?3]L*9C?=!KH)F_@3FBFGN
M,MS&A0J*R8;1M9>VIN!N9VUKF=0M8ZV39=VK?NK6EUN!+H>Y6VF?LK-[O-MH
MKC"E3[-DFHGH2(O*;(_RX*JBC129*2&ZC>"W5 _-W4IQX="4&?N2H:F L:T4
M:(L+?*?*H+NXT+<6"&W+%%FL9U,="&UB]3M# *'KTU:@;6GHH\>:E9S;)TAL
M$0*H;VN'[AJX_3M%F9%FIQRXZ%]M\HCD*IL^(1]"FB&,.(KY]PWNENBQPG?1
MM;V]/IZ LV=+&+R<+3]C$=-_%$\H:#<<=<_&)^,TM.TDZ[,]R0;; =-@JP2B
M0/]:+6]7Y<.=TR.R0W[".,^RCL.SK+OY-!M^A\#MB4V7[1>Y.,XLL01%;H,#
M0=]H>05Y$*@A<TJ#LK.)*)*/'\Q6 NQG@R+3VK2)>I.O-ICM(KOI@VPZ]6ZE
M;'>]AK:82+.8]*UE2YMOC.8*HCZ^J"V\2&"(+B_=I(S/W<GZ;DWFLYM'2@YC
M5/HG*/KB!FIVX[^^4#BD3M'K'QV?=8IW#. $;9NH8VE#@T/1L[1SR8"7>9NF
M!W+CO)E&&+<+MXJW% 6/U[HZTA89!?J5Q%.D,@Z96!N&TP(\+&*6X-LTK>G;
M\KI*7*2OY]FTYVSH7QA"1;C:@!0G%ON/#.<21SLY=H6:BML/NF%(BNHP7#08
M!O.3WM1'MV7Y\']MQ]2M=LI]VBX_+\,.I3_IC3M+$(=:(K6*O[W#E/4,)!9F
M#Y#K<Y>'.AS^V.&";DU3IG?P%7HA_[C)U/WHR.,(BFD02$OC:#ZO$)CO<<N@
MT[).Z9-_JNOU__/_ 5!+ P04    " !3DUA0@-C<E74"   B#@  #0   'AL
M+W-T>6QE<RYX;6S5EVUKVS 0Q[^*4,9H8=1VTB;M:ANV0F&PCD+S8N^*8LNV
M0 ^>+&=)/_TDRT]QEY1F821O8NE.][^?I(MS\0NUIO@IPUB!%:.\"&"F5/[9
M<8HHPPP5%R+'7'L2(1E2>BI3I\@E1G%A@AAUQJX[=1@B'(8^+]D]4P6(1,E5
M &>M"=CX.Q'C #Z???Q5"G7[ =CGZ--HY%ZXS^>W0\]9[3J'P.I\BP/H32^A
M\U?A3FA+X-66P"U$[BXF=R@^?8_X5N&!Z.R=Q+N !]+7NT_1[9_CJ^";MX(W
MHP?A,]>$.W6YA'XB>%<U$V@-6A\Q#):(!O .4;*0Q$0EB!&ZMN:Q,42""@F4
M+E>=WS.6XL6Z/3LSE5SK,,*%K'+;#/9S42\?.)J9 224MH!C: VAGR.EL.3W
M>E(MKHRO7* >S]>Y)DPE6GOC*]@%5 ^=9"%DC&6;QH.-*?0I3@R.)&EFGDKD
MCG$J)9@>Q 2E@J.*H8FH!UHVPI0^F:_YSV1#>Y4 N\9<B0N!H6B&>M?UL+LU
M>V=]-:O=E[W<2Q?D9"G4UU)OAU=S4[?X4>*$K*KY*FD!M#K*<[K^0DG*&;:;
M>3.AMV?"T$=-'I )25ZTGBF52!NPA&")I2)1W_);HGR.5ZHIIU6R+_/X!)D/
M?<XIYE@BVH?6M7_,I_R?B<V/X3\S5Z^5(?$!(2>SXV<TS<$)0$Y/ ?(DKOOZ
M^"$G-\?/:%K!XX><'>#-OA/2J3NA7KNUT6RU5K H"56$U[@9B6-L>4RW&\ ?
MIIFF&RU/UW-I>846^@_;AKZ.C7&"2JH>S18K9P"[\7<#[DW;5?-6(H#=^ ''
MI&157^]T_PK#/U!+ P04    " !3DUA0_1OK;V<'   M1@  #P   'AL+W=O
M<FMB;V]K+GAM;,6<6V_;N!9&_PKAEY,!)B>R;.M2- 4ZS72.@:+-U)V\#FB9
ML8E*I(>DTJ2__E!R+F2B?)B7;3W9NB]3$M?>O/CM#VV^K[7^SFZ;6MGSR<ZY
M_9NS,UOM1,/M?_5>*+_E6IN&.[]HMF=V;P3?V)T0KJG/TB3)SAHNU>3=VX=S
M79JS<$$[43FIE5_9K;B2XH=]VMXM,NYWN!'?^/I\DDP8;YW^*&LGS 5WX@^C
MV[U4V_/)=,*NI;%NU5V[W[.12C;RI]CT2W:G?_Q/&_E3*\?K565T7?='=1OZ
M@_P5[..:*V&<K*(='5]_Y9[U?)(E_H0WTLJUK*6[.Y_TWVLQ\;_B+/@9?3D\
M?!X*\8WY-\6HKZ]E)2YTU39"N4,Y&E%W5U=V)_=VPA1OQ/GD@[X1AEWRK>BP
M_566F\-/<+YPGKB8>2/]!K/<3#M&2AYE=2TW_NH;]ANON:H$ZTO7!H I $Q'
M V0GESR G '(V1$A5QU$=X!E^II]V0L30,X!Y'PTR ^ZV0>0"P"Y& ^2VUT
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M7]0GS;OU_3D>_JGEW?\!4$L#!!0    ( %.36%">K0Q<'P,  &D_   :
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ME^NGNWA9]4^*[CK&^/ ;4$L#!!0    ( %.36% SD(N*>0(  !$]   3
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M4=CE& ^Z&_\5Y><T'5[F)\L_H6]_ U!+ 0(4 Q0    ( %.36% ?(\\#P
M !,"   +              "  0    !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M %.36% GZ(<.@@   +$    0              "  >D   !D;V-0<F]P<R]A
M<' N>&UL4$L! A0#%     @ 4Y-84$7MLVON    *P(  !$
M ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 4Y-84)E<G",0
M!@  G"<  !,              ( !M@(  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " !3DUA0)U3M&G$#   A$0  &               @ 'W"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 4Y-84%:<+:"8
M!   21<  !@              ( !G@P  'AL+W=O<FMS:&5E=',O<VAE970R
M+GAM;%!+ 0(4 Q0    ( %.36%#E=GU:4 (  %,(   8              "
M 6P1  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !3DUA0
MQ;(HNEP$  "O%   &               @ 'R$P  >&PO=V]R:W-H965T<R]S
M:&5E=#0N>&UL4$L! A0#%     @ 4Y-84%8G\]O  @  . H  !@
M     ( !A!@  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    (
M %.36%!M3&T)A 8  " E   8              "  7H;  !X;"]W;W)K<VAE
M971S+W-H965T-BYX;6Q02P$"% ,4    " !3DUA0 !;2V'8$  !=%@  &
M            @ $T(@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#
M%     @ 4Y-84*^BIH;" 0  3P0  !@              ( !X"8  'AL+W=O
M<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( %.36%"> $C^L0$  -(#
M   8              "  =@H  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q0
M2P$"% ,4    " !3DUA0Y%E(1K4!  #2 P  &0              @ &_*@
M>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( %.36%!ACMEK
MLP$  -(#   9              "  :LL  !X;"]W;W)K<VAE971S+W-H965T
M,3$N>&UL4$L! A0#%     @ 4Y-84&>;<@NT 0  T@,  !D
M ( !E2X  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " !3
MDUA0<_J*3[4!  #2 P  &0              @ & ,   >&PO=V]R:W-H965T
M<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( %.36%!B;XA$M0$  - #   9
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M970Q."YX;6Q02P$"% ,4    " !3DUA076W]W+4!  #2 P  &0
M    @ $&/   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (
M %.36% VL-*1M@$  -(#   9              "  ?(]  !X;"]W;W)K<VAE
M971S+W-H965T,C N>&UL4$L! A0#%     @ 4Y-84$&#0>&U 0  T@,  !D
M             ( !WS\  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"
M% ,4    " !3DUA0? 1V ;\!   W!   &0              @ '+00  >&PO
M=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( %.36%#"W&0[M $
M -(#   9              "  <%#  !X;"]W;W)K<VAE971S+W-H965T,C,N
M>&UL4$L! A0#%     @ 4Y-84(/UD!"X 0  T@,  !D              ( !
MK$4  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " !3DUA0
M\#PMPK0!  #2 P  &0              @ &;1P  >&PO=V]R:W-H965T<R]S
M:&5E=#(U+GAM;%!+ 0(4 Q0    ( %.36%">EP(&MP$  -(#   9
M      "  89)  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%
M  @ 4Y-84"(9-KRV 0  T@,  !D              ( !=$L  'AL+W=O<FMS
M:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " !3DUA04$/\M[0!  #2 P
M&0              @ %A30  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+
M 0(4 Q0    ( %.36%!?'KD&R@(  'L+   9              "  4Q/  !X
M;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ 4Y-84%-; *6V
M 0  T@,  !D              ( !35(  'AL+W=O<FMS:&5E=',O<VAE970S
M,"YX;6Q02P$"% ,4    " !3DUA0<CZ?KM(!  "<!   &0
M@ $Z5   >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( %.3
M6%"%72H)Q0$  #<$   9              "  4-6  !X;"]W;W)K<VAE971S
M+W-H965T,S(N>&UL4$L! A0#%     @ 4Y-84*6[$B2R 0  T@,  !D
M         ( !/U@  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
M    " !3DUA06NXAIK<!  #2 P  &0              @ $H6@  >&PO=V]R
M:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( %.36%!U:*33N $  -(#
M   9              "  19<  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL
M4$L! A0#%     @ 4Y-84.[S<AW2 0  G 0  !D              ( !!5X
M 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " !3DUA0*=<;
MC,4!   W!   &0              @ $.8   >&PO=V]R:W-H965T<R]S:&5E
M=#,W+GAM;%!+ 0(4 Q0    ( %.36% VLQJ0S0$  )P$   9
M  "  0IB  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @
M4Y-84*,ZL)WJ 0  9@4  !D              ( !#F0  'AL+W=O<FMS:&5E
M=',O<VAE970S.2YX;6Q02P$"% ,4    " !3DUA0^OZ4V-L!   !!0  &0
M            @ $O9@  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4
M Q0    ( %.36% D?L?@[@$  &8%   9              "  4%H  !X;"]W
M;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ 4Y-84#W'WPRV 0
MT@,  !D              ( !9FH  'AL+W=O<FMS:&5E=',O<VAE970T,BYX
M;6Q02P$"% ,4    " !3DUA02<W"8;<!  #2 P  &0              @ %3
M;   >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( %.36%#N
M ,E+N $  -(#   9              "  4%N  !X;"]W;W)K<VAE971S+W-H
M965T-#0N>&UL4$L! A0#%     @ 4Y-84/7NNY*Y 0  T@,  !D
M     ( !,'   'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %.36%#%R!GR#@(   (&   9              "
M 5E[  !X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ 4Y-8
M4,$""T_D 0  Q00  !D              ( !GGT  'AL+W=O<FMS:&5E=',O
M<VAE970U,2YX;6Q02P$"% ,4    " !3DUA0=(?\&U<#  !W#P  &0
M        @ &Y?P  >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0
M   ( %.36%"VG0&W7 (  .8'   9              "  4>#  !X;"]W;W)K
M<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ 4Y-84!CWKCN@ 0  F0,
M !D              ( !VH4  'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q0
M2P$"% ,4    " !3DUA0N)2B1G\$  #A%@  &0              @ &QAP
M>&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( %.36% NA+=W
M+0(  "X&   9              "  6>,  !X;"]W;W)K<VAE971S+W-H965T
M-38N>&UL4$L! A0#%     @ 4Y-84--VHQGF 0  Z@0  !D
M ( !RXX  'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " !3
MDUA0]0>FP20#  "B#0  &0              @ 'HD   >&PO=V]R:W-H965T
M<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( %.36%#_"N(.8@(  %4(   9
M          "  4.4  !X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#
M%     @ 4Y-84-CW-V+N P  FQ,  !D              ( !W)8  'AL+W=O
M<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " !3DUA0&,9O'I0"  "^
M"0  &0              @ $!FP  >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM
M;%!+ 0(4 Q0    ( %.36% 9CC+T#@0  %@4   9              "  <R=
M  !X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ 4Y-84$0U
MEP^+ @  /0D  !D              ( !$:(  'AL+W=O<FMS:&5E=',O<VAE
M970V,RYX;6Q02P$"% ,4    " !3DUA07<X66'0"  "L"   &0
M    @ '3I   >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    (
M %.36% SQ1&<X $  .<$   9              "  7ZG  !X;"]W;W)K<VAE
M971S+W-H965T-C4N>&UL4$L! A0#%     @ 4Y-84&/0BN9= @  0 <  !D
M             ( !E:D  'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"
M% ,4    " !3DUA0'E[2^+L!   0!   &0              @ $IK   >&PO
M=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( %.36%!7I>]M_P$
M '8%   9              "  1NN  !X;"]W;W)K<VAE971S+W-H965T-C@N
M>&UL4$L! A0#%     @ 4Y-84+Q"WX+^ @  \0L  !D              ( !
M4;   'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    " !3DUA0
M@L7VLN<#   A$P  &0              @ &&LP  >&PO=V]R:W-H965T<R]S
M:&5E=#<P+GAM;%!+ 0(4 Q0    ( %.36%#<PY8$- (  &4&   9
M      "  :2W  !X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%
M  @ 4Y-84*T3-08$ @  TP4  !D              ( !#[H  'AL+W=O<FMS
M:&5E=',O<VAE970W,BYX;6Q02P$"% ,4    " !3DUA0-[;?MR8"   "!@
M&0              @ %*O   >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+
M 0(4 Q0    ( %.36%!B"&!?Q0(  !T+   9              "  :>^  !X
M;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ 4Y-84-G4*!]I
M!   81D  !D              ( !H\$  'AL+W=O<FMS:&5E=',O<VAE970W
M-2YX;6Q02P$"% ,4    " !3DUA0$/JM84L"  !^!P  &0
M@ %#Q@  >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( %.3
M6%"B=CE-!@(  - %   9              "  <7(  !X;"]W;W)K<VAE971S
M+W-H965T-S<N>&UL4$L! A0#%     @ 4Y-84"-!*)BO 0  PP,  !D
M         ( ! LL  'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4
M    " !3DUA0!?PGU<4!   5!   &0              @ 'HS   >&PO=V]R
M:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( %.36% A2Y.(VP$  !0%
M   9              "  >3.  !X;"]W;W)K<VAE971S+W-H965T.# N>&UL
M4$L! A0#%     @ 4Y-84&Z".4L- @  Z04  !D              ( !]M
M 'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4    " !3DUA0O=,/
M>BP#   U#0  &0              @ $ZTP  >&PO=V]R:W-H965T<R]S:&5E
M=#@R+GAM;%!+ 0(4 Q0    ( %.36%#2G=<$> (  $\)   9
M  "  9W6  !X;"]W;W)K<VAE971S+W-H965T.#,N>&UL4$L! A0#%     @
M4Y-84/O_W\_> P  71$  !D              ( !3-D  'AL+W=O<FMS:&5E
M=',O<VAE970X-"YX;6Q02P$"% ,4    " !3DUA0?S-_^74"  !["   &0
M            @ %AW0  >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4
M Q0    ( %.36%#G0>/=# 0  "$4   9              "  0W@  !X;"]W
M;W)K<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @ 4Y-84'['\&*F!
MRA<  !D              ( !4.0  'AL+W=O<FMS:&5E=',O<VAE970X-RYX
M;6Q02P$"% ,4    " !3DUA04]^/!M<"  "9"@  &0              @ $M
MZ0  >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( %.36%#/
M_1"[I0,  ,$0   9              "  3OL  !X;"]W;W)K<VAE971S+W-H
M965T.#DN>&UL4$L! A0#%     @ 4Y-84%/E<][J P  #A(  !D
M     ( !%_   'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %.36% N-/2EW0$  .,$   9              "
M 7+_  !X;"]W;W)K<VAE971S+W-H965T.34N>&UL4$L! A0#%     @ 4Y-8
M4'99S9[X 0  L04  !D              ( !A@$! 'AL+W=O<FMS:&5E=',O
M<VAE970Y-BYX;6Q02P$"% ,4    " !3DUA0EVIPX/ !  #;!   &0
M        @ &U P$ >&PO=V]R:W-H965T<R]S:&5E=#DW+GAM;%!+ 0(4 Q0
M   ( %.36%#QBA\1 @(   L&   9              "  =P% 0!X;"]W;W)K
M<VAE971S+W-H965T.3@N>&UL4$L! A0#%     @ 4Y-84/YO=T$9 @  Y@4
M !D              ( !%0@! 'AL+W=O<FMS:&5E=',O<VAE970Y.2YX;6Q0
M2P$"% ,4    " !3DUA008-U.#$"   K!P  &@              @ %E"@$
M>&PO=V]R:W-H965T<R]S:&5E=#$P,"YX;6Q02P$"% ,4    " !3DUA01>_#
M1/X#  "%$@  &@              @ '.# $ >&PO=V]R:W-H965T<R]S:&5E
M=#$P,2YX;6Q02P$"% ,4    " !3DUA0#"Q*L1,"  "F!0  &@
M    @ $$$0$ >&PO=V]R:W-H965T<R]S:&5E=#$P,BYX;6Q02P$"% ,4
M" !3DUA0Z]A9;F4"   G"   &@              @ %/$P$ >&PO=V]R:W-H
M965T<R]S:&5E=#$P,RYX;6Q02P$"% ,4    " !3DUA0Y1B$&G("  "Z"
M&@              @ 'L%0$ >&PO=V]R:W-H965T<R]S:&5E=#$P-"YX;6Q0
M2P$"% ,4    " !3DUA04#,>Z+D#   P$   &@              @ &6& $
M>&PO=V]R:W-H965T<R]S:&5E=#$P-2YX;6Q02P$"% ,4    " !3DUA0HM(E
MG0 #  #>"P  &@              @ &'' $ >&PO=V]R:W-H965T<R]S:&5E
M=#$P-BYX;6Q02P$"% ,4    " !3DUA0.64RSEP"  #5"   &@
M    @ &_'P$ >&PO=V]R:W-H965T<R]S:&5E=#$P-RYX;6Q02P$"% ,4
M" !3DUA0:#<B6G[E  #JH , %               @ %3(@$ >&PO<VAA<F5D
M4W1R:6YG<RYX;6Q02P$"% ,4    " !3DUA0@-C<E74"   B#@  #0
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4!08     = !T .8?   X& (    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6808512896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Changes in Stockholders' Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828929616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings per share</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Earnings per share</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table presents the calculation of basic and diluted net income per share:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions, except per share data)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Numerator:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>54.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>62.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>82.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest expense, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amortization of debt issuance costs, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income, adjusted</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>54.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>62.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>85.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Denominator:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted-average number of shares-basic</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>51.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>50.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>41.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Dilutive securities-equity awards</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Dilutive securities-convertible debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>7.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted-average number of shares-diluted</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>52.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>51.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>50.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income per share-basic</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.06</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.25</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.98</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income per share-diluted</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.04</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.22</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.71</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the year ending </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>0.9</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">  million shares of common stock are not considered in the diluted earnings per share calculation because the exercise price of these options is greater than the average per share closing price during the year and their effect would be anti-dilutive. For the years ending </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, substantially all of the outstanding stock options to purchase shares of common stock were included in the calculation of diluted earnings per share.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6975668816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 1,106.0<span></span>
</td>
<td class="nump">$ 782.4<span></span>
</td>
<td class="nump">$ 560.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of product sales and contract development and manufacturing services</a></td>
<td class="nump">433.5<span></span>
</td>
<td class="nump">322.3<span></span>
</td>
<td class="nump">187.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">226.2<span></span>
</td>
<td class="nump">142.8<span></span>
</td>
<td class="nump">97.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">273.5<span></span>
</td>
<td class="nump">202.5<span></span>
</td>
<td class="nump">142.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">58.7<span></span>
</td>
<td class="nump">25.0<span></span>
</td>
<td class="nump">8.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">991.9<span></span>
</td>
<td class="nump">692.6<span></span>
</td>
<td class="nump">436.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">114.1<span></span>
</td>
<td class="nump">89.8<span></span>
</td>
<td class="nump">124.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(38.4)<span></span>
</td>
<td class="num">(9.9)<span></span>
</td>
<td class="num">(6.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="num">(36.7)<span></span>
</td>
<td class="num">(8.3)<span></span>
</td>
<td class="num">(5.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before provision for income taxes</a></td>
<td class="nump">77.4<span></span>
</td>
<td class="nump">81.5<span></span>
</td>
<td class="nump">118.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">22.9<span></span>
</td>
<td class="nump">18.8<span></span>
</td>
<td class="nump">36.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 54.5<span></span>
</td>
<td class="nump">$ 62.7<span></span>
</td>
<td class="nump">$ 82.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share-basic (in dollars per share)</a></td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share-diluted (in dollars per share)</a></td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="nump">$ 1.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of shares - basic (in shares)</a></td>
<td class="nump">51.5<span></span>
</td>
<td class="nump">50.1<span></span>
</td>
<td class="nump">41.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of shares - diluted (in shares)</a></td>
<td class="nump">52.4<span></span>
</td>
<td class="nump">51.4<span></span>
</td>
<td class="nump">50.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product sales, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 903.5<span></span>
</td>
<td class="nump">$ 606.5<span></span>
</td>
<td class="nump">$ 421.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingMember', window );">Contract development and manufacturing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">80.0<span></span>
</td>
<td class="nump">98.9<span></span>
</td>
<td class="nump">68.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember', window );">Contracts and grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 122.5<span></span>
</td>
<td class="nump">$ 77.0<span></span>
</td>
<td class="nump">$ 70.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_ContractDevelopmentAndManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828950640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Litigation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Litigation</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Litigation</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">ANDA Litigation</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On September 14, 2018,  Adapt Pharma Inc.,  Adapt Pharma Operations Limited and Adapt Pharma Ltd. (collectively, "Adapt Pharma"), and Opiant Pharmaceuticals, Inc. ("Opiant"), received notice from Perrigo UK FINCO Limited Partnership ("Perrigo"), that Perrigo had filed an Abbreviated New Drug Application ("ANDA"), with the United States Food and Drug Administration seeking regulatory approval to market a generic version of NARCAN&#174;(naloxone hydrochloride) Nasal Spray 4mg/spray before the expiration of U.S. Patent Nos. 9,211,253, (the "&#8216;253 Patent"), 9,468,747 (the "&#8216;747 Patent"), 9,561,177, (the "&#8216;177 Patent"), 9,629,965, (the "&#8216;965 Patent") and 9,775,838 (the "&#8216;838 Patent"). On or about October 25, 2018, Perrigo sent a subsequent notice letter relating to U.S. Patent No. 10,085,937 (the "937 Patent"). Perrigo&#8217;s notice letters assert that its generic product will not infringe any valid and enforceable claim of these patents.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On October 25, 2018, Emergent BioSolutions&#8217; Adapt Pharma subsidiaries and Opiant, (collectively, the "Plaintiffs"), filed a complaint for patent infringement of the &#8216;253, &#8216;747, &#8216;177, &#8216;965, and the &#8216;838 Patents against Perrigo in the United States District Court for the District of New Jersey arising from Perrigo&#8217;s ANDA filing with the FDA. Plaintiffs filed a second complaint against Perrigo on December 7, 2018, for the infringement of the &#8216;937 Patent. On February 12, 2020, Adapt Pharma and Perrigo entered into a settlement agreement to resolve the ongoing litigation.  Under the terms of the settlement, Perrigo has received a non-exclusive license under Adapt&#8217;s patents to make, have made and market its generic naloxone hydrochloride nasal spray under its own ANDA. Perrigo&#8217;s license will be effective as of January 5, 2033 or earlier under certain circumstances including circumstances related to the outcome of the current litigation against Teva (as defined below) or litigation against future ANDA filers.  The Perrigo settlement agreement is subject to review by the U.S. Department of Justice and the Federal Trade Commission, and entry of an order dismissing the litigation by the U.S. District Court for the District of New Jersey. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On or about February 27, 2018, Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant received notice from Teva Pharmaceuticals Industries Ltd. and Teva Pharmaceuticals USA, Inc. (collectively "Teva"), that Teva had filed an ANDA with the FDA seeking regulatory approval to market a generic version of NARCAN&#174; (naloxone hydrochloride) Nasal Spray 2 mg/spray before the expiration of U.S. Patent No. 9,480,644, (the "&#8216;644 Patent"), and U.S. Patent No. 9,707,226, (the "'226 Patent"). Teva's notice letter asserts that the commercial manufacture, use or sale of its generic drug product described in its ANDA will not infringe the '644 Patent or the '226 Patent, or that the '644 Patent and '226 Patent are invalid or unenforceable. Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant filed a complaint for patent infringement against Teva in the United States District Court for the District of New Jersey.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On or about September 13, 2016, Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant received notice from Teva that Teva had filed an ANDA with the FDA seeking regulatory approval to market a generic version of NARCAN&#174; (naloxone hydrochloride) Nasal Spray 4 mg/spray before the expiration of U.S. Patent No. 9,211,253 (the "'253 Patent"). Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant received additional notices from Teva relating to the '747, the '177, the '965, the '838, and the &#8216;937 Patents. Teva's notice letters assert that the commercial manufacture, use or sale of its generic drug product described in its ANDA will not infringe the '253, the '747, the '177, the '965, the '838, or the &#8216;937 Patent, or that the '253, the '747, the '177, the '965, the '838, and the &#8216;937 Patents are invalid or unenforceable. Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant filed a complaint for patent infringement against Teva in the United States District Court for the District of New Jersey with respect to the '253 Patent. Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant also filed complaints for patent infringement against Teva in the United States District Court for the District of New Jersey with respect to the '747, the '177, the '965, and the '838 Patents. All five proceedings have been consolidated. As of the date of this filing, Adapt Pharma Inc., Adapt Pharma Operations Limited, and Opiant, have not filed a complaint related to the &#8216;937 Patent. Closing arguments are scheduled for February 26, 2020. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In the complaints described in the paragraphs above, the Plaintiffs seek, among other relief, orders that the effective date of FDA approvals of the Teva ANDA products and the Perrigo ANDA product be a date not earlier than the expiration of the patents listed for each product, equitable relief enjoining Teva and Perrigo from making, using, offering to sell, selling, or importing the products that are the subject of Teva and Perrigo&#8217;s respective ANDAs, until after the expiration of the patents listed for each product, and monetary relief or other relief as deemed just and proper by the court.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Nalox-1 Pharmaceuticals, a non-practicing entity, filed petitions with the United States Patent and Trademark Office Patent Trial and Appeal Board (the "PTAB") requesting inter parties review ("IPR") of five of the six patents listed in the Orange Book related to NARCAN&#174; Nasal Spray 4mg/spray. In a series of decisions, the PTAB agreed to institute a review </span></div>of the '253 Patent, the '747 Patent and the '965 Patent but denied review of the '177 Patent and the '838 Patent. Nalox-1 did not request review of the '937 Patent.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828877712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue recognition</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Revenue recognition</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company operates in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>one</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> business segment. Therefore, results of the Company's operations are reported on a consolidated basis for purposes of segment reporting, consistent with internal management reporting.&#160;</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> the Company's&#160;revenues disaggregated by the major sources was as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="36"/></tr><tr><td style="width:8%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="35" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">U.S</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Non-U.S.</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">U.S</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Non-U.S.</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">U.S</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Non-U.S.</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">Product sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>568.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>334.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>903.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>526.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>80.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>606.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>374.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>46.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>421.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">Contract development and manufacturing services</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>80.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>80.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>98.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>98.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>68.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>68.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">Contracts and grants</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>105.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>16.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>122.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>71.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>77.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>65.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>5.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>70.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">Total revenues</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>674.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>431.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>1,106.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>597.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>184.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>782.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>439.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>121.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>560.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Contract liabilities</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">When performance obligations are not transferred to a customer at the end of a reporting period, the amount allocated to those performance obligations are reflected as contract liabilities on the consolidated balance sheets and are deferred until control of these performance obligations is transferred to the customer. The following table presents the rollforward of contract liabilities:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>30.5</span></span></div></td><td style="vertical-align:bottom;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adoption of new accounting standard (ASC 606)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>42.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">January 1, 2018</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>72.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferral of revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>29.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue recognized</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(29.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>73.1</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferral of revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>46.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue recognized</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(30.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>88.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Transaction price allocated to remaining performance obligations</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company had expected future revenues of approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$600 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> associated with performance obligations that have not been satisfied. The Company expects to recognize a majority of these revenues within the next </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>24 months</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, with the remainder recognized thereafter. However, the amount and timing of revenue recognition for unsatisfied performance obligations can materially change due to timing of funding appropriations from the USG and the overall success of the Company's development activities associated with its PHT product candidates that are then receiving development funding support from the USG under development contracts. In addition, the amount of future revenues associated with unsatisfied performance obligations excludes the value associated with unexercised option periods in the Company's contracts (which are not performance obligations as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">).</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Contract assets</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company considers unbilled accounts receivables and deferred costs associated with revenue generating contracts, which are not included in inventory or property, plant and equipments, as contract assets. As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company had contract assets associated with deferred costs of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$34.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$1.2 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, which is included in prepaid expenses and other current assets and other assets on the Company's consolidated balance sheets.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Accounts receivable</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Accounts receivable including unbilled accounts receivable contract assets consist of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Billed, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>227.3</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>234.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unbilled</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>43.4</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>28.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>270.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>262.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company's accounts receivable balances were comprised of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>69%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>76%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, from the USG. As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> allowance for doubtful accounts were de minimis.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6824717856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract', window );"><strong>Property Plant and Equipment Income Statement Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, plant and equipment</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Property, plant and equipment</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Property, plant and equipment consist of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #ffffff;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Land and improvements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>46.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>44.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Buildings, building improvements and leasehold improvements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>234.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>216.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Furniture and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>334.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>293.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Software</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>55.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>55.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Construction-in-progress</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>81.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>71.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>752.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>681.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Less: Accumulated depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(210.4</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(171.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total property, plant and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>542.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>510.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, construction-in-progress primarily includes costs related to construction of manufacturing capabilities.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Depreciation and amortization expense associated with property, plant and equipment was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$49.5 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$36.3 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$32.2 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818693888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' equity</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Stockholders' equity</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Preferred stock</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company is authorized to issue up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>15.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares of preferred stock, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$0.001</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> par value per share ("Preferred Stock"). Any Preferred Stock issued may have dividend rights, voting rights, conversion privileges, redemption characteristics, and sinking fund requirements as approved by the Company's board of directors.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Common stock</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company currently has one class of common stock, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$0.001</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> par value per share common stock ("Common Stock"), authorized and outstanding. The Company is authorized to issue up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>200.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares of Common Stock. Holders of Common Stock are entitled to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>one</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> vote for each share of Common Stock held on all matters, except as may be provided by law.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Accounting for stock-based compensation</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has one stock-based employee compensation plan, the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan (the "Emergent Plan"), which includes both stock options and restricted stock units.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, an aggregate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>21.9 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares of common stock were authorized for issuance under the Emergent Plan, of which a total of approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>5.8 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares of common stock remain available for future awards to be made to plan participants. The exercise price of each option must be not less than </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>100%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of the fair market value of the shares underlying such option on the date of grant. Awards granted under the Emergent Plan have a contractual life of no more than </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>10 years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company utilizes the Black-Scholes valuation model for estimating the fair value of all stock options granted. Set forth below are the assumptions used in valuing the stock options granted:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:top;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expected dividend yield</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expected volatility</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37-39%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">38-39%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37-40%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Risk-free interest rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.57-2.48%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.54-3.03%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.66-1.88%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expected average life of options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>4.5 years</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>4.5 years</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>4.3 years</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Stock options, restricted and performance stock units</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following is a summary of stock option award activity under the Emergent Plan:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Emergent Plan</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions, except share and per share data)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Number of Shares</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Weighted-Average Exercise Price</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Aggregate Intrinsic Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Outstanding at December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1,871,468</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>32.59</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>50.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>295,770</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>60.16</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Exercised</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(199,352</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>25.98</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(84,011</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>52.26</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Outstanding at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1,883,875</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>36.74</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>34.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Exercisable at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1,253,658</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>29.46</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>30.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The weighted average remaining contractual term of options outstanding as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was  </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>3.3 years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>4.0 years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively. The weighted average remaining contractual term of options exercisable as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>2.3 years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>3.0 years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The weighted average grant date fair value of options granted during the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$21.13</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$18.48</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$10.53</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> per share, respectively. The total intrinsic value of options exercised during the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$5.3 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$24.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$13.9 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively. The total fair value of awards vested during </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$16.9 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$16.9 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$17.9 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively. As of the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the total compensation cost and weighted average period over which total compensation is expected to be recognized related to unvested equity awards was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$37.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>1.5 years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following is a summary of performance stock and restricted stock unit award activity under the Emergent Plan. Performance stock units of approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>0.1</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million shares were granted and remain outstanding the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and are included in the table below.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions, except share and per share data)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Number of Shares</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Weighted-Average Grant Price</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Aggregate Intrinsic Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Outstanding at December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>921,093</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>42.82</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>54.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>594,752</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>57.94</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Vested</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(434,629</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>38.81</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(128,364</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>53.17</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Outstanding at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>952,852</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>52.77</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>51.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Stock-based compensation expense was recorded in the following financial statement line items:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:61%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cost of product sales</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Selling, general and administrative</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>19.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>18.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>11.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total stock-based compensation expense</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>26.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>23.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>15.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Accumulated Other Comprehensive Loss</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table includes changes in accumulated other comprehensive loss by component, net of tax:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Defined Benefit Pension Plan</span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Derivative Instruments</span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Foreign Currency Translation Losses</span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, January 1, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(3.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(3.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive loss </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(5.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(5.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive (loss) income before reclassifications</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(2.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(5.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net current period other comprehensive loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(4.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(4.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(9.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818734896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's intangible assets were acquired via business combinations or asset acquisitions. Changes in the Company&#8217;s intangible assets, excluding IPR&amp;D and goodwill, consisted of the following:</span></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:32%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Estimated Life</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Cost</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Additions</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Accumulated Amortization</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Net</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">Products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9-22 years</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>778.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>10.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>82.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>705.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate trade name</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>5 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Customer relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>8 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>28.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>23.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contract development and manufacturing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>8 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;&#160;&#160;&#160;Total intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>814.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>10.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>112.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>712.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Summary of Future Amortization Expense</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Future amortization expense as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>58.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>57.3</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>54.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>54.4</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2024 and beyond</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>487.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total remaining amortization</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>712.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Summary of Goodwill</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table is a summary of changes in goodwill:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #ffffff;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at beginning of the year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>259.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>49.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Measurement period adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>210.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at end of the year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>266.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>259.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6975775696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The total purchase price is summarized below:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:85%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Purchase Price</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amount of cash paid</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>117.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of contingent purchase consideration</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase price</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>119.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The total purchase price revised for adjustments is summarized below:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in&#160;millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">October 15, 2018</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>581.5</span></span></div></td><td style="vertical-align:bottom;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Equity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>37.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of contingent purchase consideration</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>48.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Preliminary purchase consideration</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>667.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Final purchase consideration</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>668.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The table below summarizes the final allocation of the purchase consideration based upon the fair values of assets acquired and liabilities assumed at October 4, 2018.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">October 4, 2018</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Measurement Period Adjustments</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Updated October 4, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of tangible assets acquired and liabilities assumed:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts receivable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>4.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>4.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>19.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>19.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prepaid expenses and other assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>12.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>11.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>57.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>57.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts payable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(33.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(34.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total fair value of tangible assets acquired and liabilities assumed</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>69.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>70.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired in-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(9.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>133.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>133.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>61.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>7.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>69.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase consideration</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>273.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>273.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The table below summarizes the allocation of the purchase price based upon the fair values of assets acquired at October 6, 2017. The Company did not assume any liabilities in the acquisition. The Company has finalized the purchase price allocation related to this acquisition.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:85%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Purchase Price</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of tangible assets acquired:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>74.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>20.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total fair value of tangible assets acquired</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>94.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired intangible asset</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>16.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>8.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase price</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>119.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The table below summarizes the final allocation of the purchase price based upon fair values of assets acquired and liabilities assumed at October 15, 2018.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:64%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">October 15, 2018</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Measurement Period Adjustments</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Updated  October 15, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of tangible assets acquired and liabilities assumed:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>17.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>17.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts receivable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>21.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>21.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>41.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>41.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prepaid expenses and other assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>7.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>10.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts payable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(32.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(32.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(50.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(50.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax liability, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(62.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(62.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total fair value of tangible assets acquired and liabilities assumed</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(56.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(54.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired in-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>41.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>41.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired intangible asset</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>534.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>534.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>149.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>148.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase price</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>667.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>668.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>95
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ebs-2019123110k.htm": {
   "axisCustom": 0,
   "axisStandard": 31,
   "contextCount": 312,
   "dts": {
    "calculationLink": {
     "local": [
      "ebs-20191231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ebs-20191231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-eedm-def-2018-01-31.xml",
      "http://xbrl.fasb.org/srt/2018/elts/srt-eedm1-def-2018-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "ebs-2019123110k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ebs-20191231_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2018/elts/srt-doc-2018-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-doc-2018-01-31.xml",
      "http://xbrl.sec.gov/invest/2013/invest-doc-2013-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ebs-20191231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/srt/2018/elts/srt-ref-2018-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-ref-2018-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml",
      "http://xbrl.sec.gov/invest/2013/invest-ref-2013-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "ebs-20191231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2018/elts/srt-types-2018-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2018/elts/us-roles-2018-01-31.xsd",
      "http://xbrl.fasb.org/srt/2018/elts/srt-roles-2018-01-31.xsd",
      "http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd",
      "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2018/elts/us-parts-codification-2018-01-31.xsd"
     ]
    }
   },
   "elementCount": 785,
   "entityCount": 1,
   "hidden": {
    "http://emergentbiosolutions.com/20191231": 2,
    "http://fasb.org/us-gaap/2018-01-31": 50,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 57
   },
   "keyCustom": 76,
   "keyStandard": 513,
   "memberCustom": 23,
   "memberStandard": 59,
   "nsprefix": "ebs",
   "nsuri": "http://emergentbiosolutions.com/20191231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Cover Page",
     "role": "http://emergentbiosolutions.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102100 - Disclosure - Summary of significant accounting policies",
     "role": "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of significant accounting policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414404 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "role": "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415402 - Disclosure - Earnings per share (Details)",
     "role": "http://emergentbiosolutions.com/role/EarningsPerShareDetails",
     "shortName": "Earnings per share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:InterestOnConvertibleDebtNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PurchaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416401 - Disclosure - Purchase commitments (Details)",
     "role": "http://emergentbiosolutions.com/role/PurchaseCommitmentsDetails",
     "shortName": "Purchase commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PurchaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417402 - Disclosure - Segment information - Narrative (Details)",
     "role": "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails",
     "shortName": "Segment information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417403 - Disclosure - Segment information - Product Sales (Details)",
     "role": "http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails",
     "shortName": "Segment information - Product Sales (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418402 - Disclosure - Quarterly financial data (unaudited) (Details)",
     "role": "http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedDetails",
     "shortName": "Quarterly financial data (unaudited) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4QTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420401 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)",
     "role": "http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails",
     "shortName": "Schedule II - Valuation and Qualifying Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103100 - Disclosure - Revenue recognition",
     "role": "http://emergentbiosolutions.com/role/RevenueRecognition",
     "shortName": "Revenue recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104100 - Disclosure - Acquisitions",
     "role": "http://emergentbiosolutions.com/role/Acquisitions",
     "shortName": "Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105100 - Disclosure - Fair value measurements",
     "role": "http://emergentbiosolutions.com/role/FairValueMeasurements",
     "shortName": "Fair value measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106100 - Disclosure - Inventories",
     "role": "http://emergentbiosolutions.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107100 - Disclosure - Property, plant and equipment",
     "role": "http://emergentbiosolutions.com/role/PropertyPlantAndEquipment",
     "shortName": "Property, plant and equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108100 - Disclosure - Intangible assets and goodwill",
     "role": "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwill",
     "shortName": "Intangible assets and goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109100 - Disclosure - Long-term debt",
     "role": "http://emergentbiosolutions.com/role/LongTermDebt",
     "shortName": "Long-term debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110100 - Disclosure - Derivative Instruments",
     "role": "http://emergentbiosolutions.com/role/DerivativeInstruments",
     "shortName": "Derivative Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111100 - Disclosure - Stockholders' equity",
     "role": "http://emergentbiosolutions.com/role/StockholdersEquity",
     "shortName": "Stockholders' equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001000 - Statement - Consolidated Balance Sheets",
     "role": "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:IncomeTaxesReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112100 - Disclosure - Income taxes",
     "role": "http://emergentbiosolutions.com/role/IncomeTaxes",
     "shortName": "Income taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113100 - Disclosure - Defined benefit and 401(k) savings plan",
     "role": "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlan",
     "shortName": "Defined benefit and 401(k) savings plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114100 - Disclosure - Leases",
     "role": "http://emergentbiosolutions.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115100 - Disclosure - Earnings per share",
     "role": "http://emergentbiosolutions.com/role/EarningsPerShare",
     "shortName": "Earnings per share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116100 - Disclosure - Purchase commitments",
     "role": "http://emergentbiosolutions.com/role/PurchaseCommitments",
     "shortName": "Purchase commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117100 - Disclosure - Segment information",
     "role": "http://emergentbiosolutions.com/role/SegmentInformation",
     "shortName": "Segment information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118100 - Disclosure - Quarterly financial data (unaudited)",
     "role": "http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnaudited",
     "shortName": "Quarterly financial data (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119100 - Disclosure - Litigation",
     "role": "http://emergentbiosolutions.com/role/Litigation",
     "shortName": "Litigation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120100 - Disclosure - Schedule II - Valuation and Qualifying Accounts",
     "role": "http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccounts",
     "shortName": "Schedule II - Valuation and Qualifying Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Summary of significant accounting policies (Policies)",
     "role": "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of significant accounting policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001501 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2302302 - Disclosure - Summary of significant accounting policies (Tables)",
     "role": "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of significant accounting policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Revenue recognition (Tables)",
     "role": "http://emergentbiosolutions.com/role/RevenueRecognitionTables",
     "shortName": "Revenue recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Acquisitions (Tables)",
     "role": "http://emergentbiosolutions.com/role/AcquisitionsTables",
     "shortName": "Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Fair value measurements (Tables)",
     "role": "http://emergentbiosolutions.com/role/FairValueMeasurementsTables",
     "shortName": "Fair value measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2306301 - Disclosure - Inventories (Tables)",
     "role": "http://emergentbiosolutions.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307301 - Disclosure - Property, plant and equipment (Tables)",
     "role": "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentTables",
     "shortName": "Property, plant and equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2308301 - Disclosure - Intangible assets and goodwill (Tables)",
     "role": "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillTables",
     "shortName": "Intangible assets and goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309301 - Disclosure - Long-term debt (Tables)",
     "role": "http://emergentbiosolutions.com/role/LongTermDebtTables",
     "shortName": "Long-term debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310301 - Disclosure - Derivative Instruments (Tables)",
     "role": "http://emergentbiosolutions.com/role/DerivativeInstrumentsTables",
     "shortName": "Derivative Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311301 - Disclosure - Stockholders' equity (Tables)",
     "role": "http://emergentbiosolutions.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002000 - Statement - Consolidated Statements of Operations",
     "role": "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312301 - Disclosure - Income taxes (Tables)",
     "role": "http://emergentbiosolutions.com/role/IncomeTaxesTables",
     "shortName": "Income taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313301 - Disclosure - Defined benefit and 401(k) savings plan (Tables)",
     "role": "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanTables",
     "shortName": "Defined benefit and 401(k) savings plan (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314301 - Disclosure - Leases (Tables)",
     "role": "http://emergentbiosolutions.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315301 - Disclosure - Earnings per share (Tables)",
     "role": "http://emergentbiosolutions.com/role/EarningsPerShareTables",
     "shortName": "Earnings per share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317301 - Disclosure - Segment information (Tables)",
     "role": "http://emergentbiosolutions.com/role/SegmentInformationTables",
     "shortName": "Segment information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318301 - Disclosure - Quarterly financial data (unaudited) (Tables)",
     "role": "http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedTables",
     "shortName": "Quarterly financial data (unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ebs:NumberOfCategoriesOfPublicHealthThreats",
      "reportCount": 1,
      "unique": true,
      "unitRef": "category",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401401 - Disclosure - Nature of the business and organization (Details)",
     "role": "http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganizationDetails",
     "shortName": "Nature of the business and organization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ebs:NumberOfCategoriesOfPublicHealthThreats",
      "reportCount": 1,
      "unique": true,
      "unitRef": "category",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ebs:ConcentrationsRiskPolicyTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402403 - Disclosure - Summary of significant accounting policies - Concentration Risk (Details)",
     "role": "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails",
     "shortName": "Summary of significant accounting policies - Concentration Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ebs:ConcentrationsRiskPolicyTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402404 - Disclosure - Summary of significant accounting policies - Estimated Useful Lives (Details)",
     "role": "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails",
     "shortName": "Summary of significant accounting policies - Estimated Useful Lives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402405 - Disclosure - Summary of significant accounting policies - Asset Impairment Analysis (Details)",
     "role": "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails",
     "shortName": "Summary of significant accounting policies - Asset Impairment Analysis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003000 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2017Q4QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402406 - Disclosure - Summary of significant accounting policies - Earnings Per Share (Details)",
     "role": "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails",
     "shortName": "Summary of significant accounting policies - Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2017Q4QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentPlansMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ebs:NumberOfStockbasedEmployeeCompensationPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "plan",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402407 - Disclosure - Summary of significant accounting policies - Accounting for Stock-based Compensation (Details)",
     "role": "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails",
     "shortName": "Summary of significant accounting policies - Accounting for Stock-based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentPlansMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ebs:NumberOfStockbasedEmployeeCompensationPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "plan",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402408 - Disclosure - Summary of significant accounting policies - Recently Issued Accounting Standards (Details)",
     "role": "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails",
     "shortName": "Summary of significant accounting policies - Recently Issued Accounting Standards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "I2018Q1Jan01",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q3YTD",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403402 - Disclosure - Revenue recognition - Narrative (Details)",
     "role": "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails",
     "shortName": "Revenue recognition - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain_2020-01-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403403 - Disclosure - Revenue recognition - Remaining Performance Obligation (Details)",
     "role": "http://emergentbiosolutions.com/role/RevenueRecognitionRemainingPerformanceObligationDetails",
     "shortName": "Revenue recognition - Remaining Performance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain_2020-01-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4QTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403404 - Disclosure - Revenue recognition - Disaggregation of Revenue (Details)",
     "role": "http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails",
     "shortName": "Revenue recognition - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD_srt_StatementGeographicalAxis_country_US",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403405 - Disclosure - Revenue recognition - Contract Liabilities (Details)",
     "role": "http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails",
     "shortName": "Revenue recognition - Contract Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "lang": null,
      "name": "ebs:ContractWithCustomerLiabilityAdditions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ebs:ScheduleofAccountsReceivableNetTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:BilledContractReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403406 - Disclosure - Revenue recognition - Accounts Receivable (Details)",
     "role": "http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails",
     "shortName": "Revenue recognition - Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ebs:ScheduleofAccountsReceivableNetTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:BilledContractReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2018Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueAcquisitions",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404402 - Disclosure - Acquisitions - Adapt Narrative (Details)",
     "role": "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
     "shortName": "Acquisitions - Adapt Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember",
      "decimals": "INF",
      "lang": null,
      "name": "ebs:NumberOfEmployees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "employee",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2018Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueAcquisitions",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404403 - Disclosure - Acquisitions - Adapt Preliminary Purchase Consideration (Details)",
     "role": "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails",
     "shortName": "Acquisitions - Adapt Preliminary Purchase Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004000 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404404 - Disclosure - Acquisitions - Adapt Preliminary Allocation of Purchase Price (Details)",
     "role": "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
     "shortName": "Acquisitions - Adapt Preliminary Allocation of Purchase Price (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404405 - Disclosure - Acquisitions - PaxVax Narrative (Details)",
     "role": "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails",
     "shortName": "Acquisitions - PaxVax Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember",
      "decimals": "-1",
      "lang": null,
      "name": "ebs:NumberOfEmployees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "employee",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404406 - Disclosure - Acquisitions - PaxVax Preliminary Allocation of Purchase Price (Details)",
     "role": "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails",
     "shortName": "Acquisitions - PaxVax Preliminary Allocation of Purchase Price (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404407 - Disclosure - Acquisitions - Acquisition of ACAM2000 Narrative (Details)",
     "role": "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails",
     "shortName": "Acquisitions - Acquisition of ACAM2000 Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member",
      "decimals": null,
      "lang": "en-US",
      "name": "ebs:TermofContractUnderAcquisition",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404408 - Disclosure - Acquisitions - Acquisition of ACAM2000 Business (Details)",
     "role": "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails",
     "shortName": "Acquisitions - Acquisition of ACAM2000 Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "D2017Q4Oct2_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "ebs:UpfrontPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404409 - Disclosure - Acquisitions - Acquisition of Raxibacumab Asset (Details)",
     "role": "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails",
     "shortName": "Acquisitions - Acquisition of Raxibacumab Asset (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "D2017Q4Oct2_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "ebs:UpfrontPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Fair value measurements (Details)",
     "role": "http://emergentbiosolutions.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair value measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2017Q4",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4_us-gaap_CashAndCashEquivalentsAxis_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405403 - Disclosure - Fair value measurements - Narrative (Details)",
     "role": "http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair value measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4_us-gaap_CashAndCashEquivalentsAxis_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Inventories (Details)",
     "role": "http://emergentbiosolutions.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - Property, plant and equipment (Details)",
     "role": "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails",
     "shortName": "Property, plant and equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005000 - Statement - Consolidated Statement of Changes in Stockholders' Equity",
     "role": "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity",
     "shortName": "Consolidated Statement of Changes in Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408402 - Disclosure - Intangible assets and goodwill - Schedule of Finite-lived Intangible Assets (Details)",
     "role": "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails",
     "shortName": "Intangible assets and goodwill - Schedule of Finite-lived Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Intangible assets and goodwill - Narrative (Details)",
     "role": "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails",
     "shortName": "Intangible assets and goodwill - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Intangible assets and goodwill - Future Amortization Expense (Details)",
     "role": "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails",
     "shortName": "Intangible assets and goodwill - Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Intangible assets and goodwill - Summary Changes in Goodwill (Details)",
     "role": "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails",
     "shortName": "Intangible assets and goodwill - Summary Changes in Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2017Q4",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409402 - Disclosure - Long-term debt - Components of Long-term Indebtedness (Details)",
     "role": "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails",
     "shortName": "Long-term debt - Components of Long-term Indebtedness (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409403 - Disclosure - Long-term debt - Senior Secured Credit Agreement (Details)",
     "role": "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails",
     "shortName": "Long-term debt - Senior Secured Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "I2017Q4Nov14_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Long-term debt - Convertible Senior Notes (Details)",
     "role": "http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails",
     "shortName": "Long-term debt - Convertible Senior Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "I2017Q4Nov14_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - Long-term debt - Future Debt Payments of Long-term Indebtedness (Details)",
     "role": "http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails",
     "shortName": "Long-term debt - Future Debt Payments of Long-term Indebtedness (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfInterestRateDerivativesHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "instrument",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410402 - Disclosure - Derivative Instruments - Derivative Designated as Cash Flow Hedges (Details)",
     "role": "http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails",
     "shortName": "Derivative Instruments - Derivative Designated as Cash Flow Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfInterestRateDerivativesHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "instrument",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410403 - Disclosure - Derivative Instruments - Narrative (Details)",
     "role": "http://emergentbiosolutions.com/role/DerivativeInstrumentsNarrativeDetails",
     "shortName": "Derivative Instruments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005501 - Statement - Consolidated Statement of Changes in Stockholders' Equity (Parenthetical)",
     "role": "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquityParenthetical",
     "shortName": "Consolidated Statement of Changes in Stockholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Derivative Instruments - Fair Value by Balance Sheet Location (Details)",
     "role": "http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails",
     "shortName": "Derivative Instruments - Fair Value by Balance Sheet Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410405 - Disclosure - Derivative Instruments - Cash Flow Hedging on AOCI (Details)",
     "role": "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails",
     "shortName": "Derivative Instruments - Cash Flow Hedging on AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411402 - Disclosure - Stockholders' equity - Narrative (Details)",
     "role": "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "INF",
      "lang": null,
      "name": "ebs:CommonStockNumberofVotesPerCommonShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411403 - Disclosure - Stockholders' equity - Stock Options Valuation Assumptions (Details)",
     "role": "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails",
     "shortName": "Stockholders' equity - Stock Options Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2018Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411404 - Disclosure - Stockholders' equity - Stock Options and Restricted Stock Units (Details)",
     "role": "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails",
     "shortName": "Stockholders' equity - Stock Options and Restricted Stock Units (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2018Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Stockholders' equity - Stock-based Compensation Expense (Details)",
     "role": "http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails",
     "shortName": "Stockholders' equity - Stock-based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411406 - Disclosure - Stockholders' equity - Changes in Accumulated Other Comprehensive Loss (Details)",
     "role": "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails",
     "shortName": "Stockholders' equity - Changes in Accumulated Other Comprehensive Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412402 - Disclosure - Income taxes - Narrative (Details)",
     "role": "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412403 - Disclosure - Income taxes - Components of the Provisions for Income Taxes (Details)",
     "role": "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails",
     "shortName": "Income taxes - Components of the Provisions for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412404 - Disclosure - Income taxes - Net Deferred Tax Asset (Liability) (Details)",
     "role": "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails",
     "shortName": "Income taxes - Net Deferred Tax Asset (Liability) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "lang": null,
      "name": "ebs:DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101100 - Disclosure - Nature of the business and organization",
     "role": "http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganization",
     "shortName": "Nature of the business and organization",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Income taxes - Reconciliation (Details)",
     "role": "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails",
     "shortName": "Income taxes - Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2018Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Income taxes - Unrecognized Tax Benefits (Details)",
     "role": "http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "shortName": "Income taxes - Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PensionExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413402 - Disclosure - Defined benefit and 401(k) savings plan - Swiss Plan Funded Status (Details)",
     "role": "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails",
     "shortName": "Defined benefit and 401(k) savings plan - Swiss Plan Funded Status (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PensionExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413403 - Disclosure - Defined benefit and 401(k) savings plan - Components of Net Periodic Pension Cost (Details)",
     "role": "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails",
     "shortName": "Defined benefit and 401(k) savings plan - Components of Net Periodic Pension Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413404 - Disclosure - Defined benefit and 401(k) savings plan - Weighted Average Assumptions (Details)",
     "role": "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails",
     "shortName": "Defined benefit and 401(k) savings plan - Weighted Average Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413405 - Disclosure - Defined benefit and 401(k) savings plan - Accumulated Other Comprehensive Loss Before Income Tax (Details)",
     "role": "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails",
     "shortName": "Defined benefit and 401(k) savings plan - Accumulated Other Comprehensive Loss Before Income Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Defined benefit and 401(k) savings plan - Expected Future Benefits Payments (Details)",
     "role": "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails",
     "shortName": "Defined benefit and 401(k) savings plan - Expected Future Benefits Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Defined benefit and 401(k) savings plan - Narrative (Details)",
     "role": "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanNarrativeDetails",
     "shortName": "Defined benefit and 401(k) savings plan - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414402 - Disclosure - Leases - Narrative (Details)",
     "role": "http://emergentbiosolutions.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FI2019Q4",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414403 - Disclosure - Leases - Components of Lease Expense (Details)",
     "role": "http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails",
     "shortName": "Leases - Components of Lease Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "FD2019Q4YTD",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-2019123110k.htm",
      "contextRef": "I2018Q1Jan01",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - ebs-2019123110k.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - ebs-2019123110k.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 86,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "U.S Government",
        "verboseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2017-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ebs_ACAM2000Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business acquisition in October of 2017.",
        "label": "ACAM2000 [Member]",
        "terseLabel": "ACAM2000"
       }
      }
     },
     "localname": "ACAM2000Member",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_AdaptPharmaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business acquisition on October 15, 2018.",
        "label": "Adapt Pharma [Member]",
        "terseLabel": "Adapt Pharma"
       }
      }
     },
     "localname": "AdaptPharmaMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_AdjustedNetLoss": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes and other adjustments.",
        "label": "Adjusted net loss",
        "totalLabel": "Net income, adjusted"
       }
      }
     },
     "localname": "AdjustedNetLoss",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_AmendedCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amended credit agreement dated October 15, 2018.",
        "label": "Amended Credit Agreement [Member]",
        "terseLabel": "Amended Credit Agreement"
       }
      }
     },
     "localname": "AmendedCreditAgreementMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails": {
       "order": 3.0,
       "parentTag": "ebs_AdjustedNetLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The after-tax amount of amortization of issuance costs recognized in the period associated with any convertible debt.",
        "label": "Amortization of issuance cost on convertible debt net of tax",
        "terseLabel": "Amortization of debt issuance costs, net of tax"
       }
      }
     },
     "localname": "AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_AmountOfPaymentForManufacturingRelatedMilestones": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with manufacturing related milestones.",
        "label": "Amount Of Payment For Manufacturing Related Milestones",
        "terseLabel": "Amount of payment for manufacturing related milestones"
       }
      }
     },
     "localname": "AmountOfPaymentForManufacturingRelatedMilestones",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_AmountOfPaymentForRegulatoryRelatedMilestones": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with regulatory related milestones.",
        "label": "Amount Of Payment For Regulatory Related Milestones",
        "terseLabel": "Amount of payment for regulatory related milestones"
       }
      }
     },
     "localname": "AmountOfPaymentForRegulatoryRelatedMilestones",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_AmountRequiredForNetLeverageRatio": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of leverage ratio required to be maintained under a debt covenant agreement.",
        "label": "Amount Required for Net Leverage Ratio",
        "terseLabel": "Amount required for net leverage ratio"
       }
      }
     },
     "localname": "AmountRequiredForNetLeverageRatio",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_AmountforDeliveriesofProduct": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount for deliveries of product to the Strategic National Stockpile (\"SNS\").",
        "label": "Amount for Deliveries of Product",
        "terseLabel": "Amount for deliveries of product"
       }
      }
     },
     "localname": "AmountforDeliveriesofProduct",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_BasePeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Refers to the base period of contract term.",
        "label": "Base Period",
        "terseLabel": "Base period"
       }
      }
     },
     "localname": "BasePeriod",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ebs_BiothraxMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Refers to NuThrax which is sold by the company.",
        "label": "Biothrax [Member]",
        "terseLabel": "Anthrax Vaccines",
        "verboseLabel": "BioThrax"
       }
      }
     },
     "localname": "BiothraxMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses And Other Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses And Other Liabilities",
        "negatedTerseLabel": "Accrued expenses and other liabilities, measurement period adjustment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets",
        "terseLabel": "Deferred tax assets, measurement period adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities",
        "negatedTerseLabel": "Deferred tax liability, net, measurement period adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Finite-lived Intangible Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Finite-lived Intangible Assets",
        "terseLabel": "Acquired in-process research and development, measurement period adjustment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
       "weight": -1.0
      },
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Expenses and Other Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Expenses and Other Assets",
        "terseLabel": "Prepaid expenses and other assets, measurements period adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      },
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accrued expenses and other liabilities, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Expenses and Other Liabilities",
        "negatedLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_CIADMMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Refers to the Center for Innovation in Advanced Development and Manufacturing contract.",
        "label": "CIADM [Member]",
        "terseLabel": "CIADM"
       }
      }
     },
     "localname": "CIADMMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash proceeds in excess during the term of the Senior Secured Credit Facility from certain dispositions of property or from casualty events involving their property, subject to certain reinvestment rights.",
        "label": "Cash Proceeds Excess Amount from Dispositions of Property or Casualty Events Subject to Certain Reinvestment Right",
        "terseLabel": "Cash proceeds excess amount from dispositions of property or casualty events subject to certain reinvestment right"
       }
      }
     },
     "localname": "CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_ChangeInFairValueOfContingentConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value measurement of contingent value rights and contingent purchase considerations granted under purchase agreements.",
        "label": "Change In Fair Value Of Contingent Consideration",
        "terseLabel": "Change in fair value of contingent consideration, net"
       }
      }
     },
     "localname": "ChangeInFairValueOfContingentConsideration",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_ChangeinContractWithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Change in Contract With Customer, Liability [Roll Forward]",
        "label": "Change in Contract With Customer, Liability [Roll Forward]",
        "terseLabel": "Change in Contract With Customer, Liability [Roll Forward]"
       }
      }
     },
     "localname": "ChangeinContractWithCustomerLiabilityRollForward",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ebs_CommonStockNumberofVotesPerCommonShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock, Number of Votes Per Common Share",
        "label": "Common Stock, Number of Votes Per Common Share",
        "terseLabel": "Common stock, voting rights"
       }
      }
     },
     "localname": "CommonStockNumberofVotesPerCommonShare",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ebs_ConcentrationsRiskPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for concentrations risk.",
        "label": "Concentrations Risk [Policy Text Block]",
        "terseLabel": "Concentration risk"
       }
      }
     },
     "localname": "ConcentrationsRiskPolicyTextBlock",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ebs_ConsolidatedSecuredNetLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum consolidated net leverage ratio required to be maintained under a debt covenant agreement.",
        "label": "Consolidated Secured, Net Leverage Ratio",
        "terseLabel": "Net leverage ratio"
       }
      }
     },
     "localname": "ConsolidatedSecuredNetLeverageRatio",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ebs_ContingentConsiderationCurrentPortion": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the current portion of liabilities incurred and payable to former shareholders and stock option holders for certain developmental, regulatory or commercial milestones.",
        "label": "Contingent Consideration Current Portion",
        "terseLabel": "Contingent consideration, current portion"
       }
      }
     },
     "localname": "ContingentConsiderationCurrentPortion",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_ContingentConsiderationNetOfCurrentPortion": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the noncurrent portion of liabilities incurred and payable to former shareholders and stock option holders for certain developmental, regulatory or commercial milestones.",
        "label": "Contingent Consideration Net Of Current Portion",
        "terseLabel": "Contingent consideration, net of current portion"
       }
      }
     },
     "localname": "ContingentConsiderationNetOfCurrentPortion",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_ContingentConsiderationObligationsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for contingent consideration obligations.",
        "label": "Contingent Consideration Obligations [Policy Text Block]",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationObligationsPolicyTextBlock",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ebs_ContractDevelopmentAndManufacturingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract Development And Manufacturing [Member]",
        "label": "Contract Development And Manufacturing [Member]",
        "terseLabel": "Contract development and manufacturing services"
       }
      }
     },
     "localname": "ContractDevelopmentAndManufacturingMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_ContractManufacturingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue earned during the period arising from manufacturing sale under the terms of a contract.",
        "label": "Contract Manufacturing [Member]",
        "terseLabel": "Contract development and manufacturing services",
        "verboseLabel": "Contract development and manufacturing services"
       }
      }
     },
     "localname": "ContractManufacturingMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails",
      "http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_ContractWithCustomerLiabilityAdditions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable recorded during the current reporting period.",
        "label": "Contract with Customer, Liability, Additions",
        "terseLabel": "Deferral of revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityAdditions",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_ContractsAndGrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue earned from products sold or services provided under the terms of a contract, including, but not limited to, government contracts and grants.",
        "label": "Contracts and Grants [Member]",
        "terseLabel": "Contracts and grants"
       }
      }
     },
     "localname": "ContractsAndGrantsMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations",
      "http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_ConvertibleSeniorNotesDue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Convertible Senior Notes Due 2021 [Member]",
        "label": "Convertible Senior Notes Due 2021 [Member]",
        "terseLabel": "2.875% Convertible Senior Notes Due 2021"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2021Member",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Credit agreement dated September 2017.",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_DebtCovenantNetLeverageRatioFour": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.",
        "label": "Debt Covenant, Net Leverage Ratio, Four",
        "terseLabel": "Net leverage ratio four"
       }
      }
     },
     "localname": "DebtCovenantNetLeverageRatioFour",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ebs_DebtCovenantNetLeverageRatioOne": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.",
        "label": "Debt Covenant, Net Leverage Ratio, One",
        "terseLabel": "Net leverage ratio one"
       }
      }
     },
     "localname": "DebtCovenantNetLeverageRatioOne",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ebs_DebtCovenantNetLeverageRatioThree": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.",
        "label": "Debt Covenant, Net Leverage Ratio, Three",
        "terseLabel": "Net leverage ratio three"
       }
      }
     },
     "localname": "DebtCovenantNetLeverageRatioThree",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ebs_DebtCovenantNetLeverageRatioTwo": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.",
        "label": "Debt Covenant, Net Leverage Ratio, Two",
        "terseLabel": "Debt covenant, leverage ratio from September 30, 2019 to September 29, 2020"
       }
      }
     },
     "localname": "DebtCovenantNetLeverageRatioTwo",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ebs_DebtInstrumentAccruedInterestOnConvertedNotes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount for accrued, but unpaid interest on the converted notes for the period.",
        "label": "Debt Instrument Accrued interest on converted notes",
        "terseLabel": "Accrued interest on converted notes"
       }
      }
     },
     "localname": "DebtInstrumentAccruedInterestOnConvertedNotes",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_DebtInstrumentCovenantDebtServiceCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Debt Service Coverage Ratio",
        "label": "Debt Instrument, Covenant, Debt Service Coverage Ratio",
        "terseLabel": "Debt service coverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantDebtServiceCoverageRatio",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ebs_DebtInstrumentCovenantLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.",
        "label": "Debt Instrument, Covenant, Leverage Ratio",
        "terseLabel": "Covenant, leverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatio",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ebs_DebtInstrumentNumberOfAdditionalEquityInstruments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of additional equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.",
        "label": "Debt Instrument Number Of Additional Equity Instruments",
        "terseLabel": "Additional conversion rate of notes per $1,000 principal amount (in shares)"
       }
      }
     },
     "localname": "DebtInstrumentNumberOfAdditionalEquityInstruments",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ebs_DebtInstrumentNumberOfEquityInstruments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Number Of Equity Instruments",
        "label": "Debt Instrument, Number Of Equity Instruments",
        "terseLabel": "Conversion rate of notes per $1,000 principal amount (in shares)"
       }
      }
     },
     "localname": "DebtInstrumentNumberOfEquityInstruments",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ebs_DebtInstrumentRestrictedPaymentsLimitAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Restricted Payments Limit, Amount",
        "label": "Debt Instrument, Restricted Payments Limit, Amount",
        "terseLabel": "Debt instrument, restricted payments limit, amount"
       }
      }
     },
     "localname": "DebtInstrumentRestrictedPaymentsLimitAmount",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_DebtInstrumentTermOfVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of the interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Debt Instrument Term of Variable Rate",
        "terseLabel": "Debt instrument, term of variable rate"
       }
      }
     },
     "localname": "DebtInstrumentTermOfVariableRate",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to continuing operations before purchase price adjustment.",
        "label": "Deferred Income Tax Expense (Benefit) before purchase price adjustment",
        "totalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_DeferredTaxAssetsOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Lease, Liability",
        "label": "Deferred Tax Assets, Operating Lease, Liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiability",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible scientific research and experimental development tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Scientific Research and Experimental Development",
        "terseLabel": "Scientific research and experimental development credit carryforward"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employee which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employee",
        "terseLabel": "Employee contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByEmployee",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Compensation Limitation, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Compensation Limitation, Amount",
        "terseLabel": "Compensation limitation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Contingent Consideration, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Contingent Consideration, Amount",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 16.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to permanent differences.",
        "label": "Effective Income Tax Rate Reconciliation, Permanent Difference",
        "negatedLabel": "Permanent differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifference",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 15.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) from Gilti (Global Intangible Low-taxed Income) tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act of 2017,Global Intangible Low-taxed Income Tax, net",
        "terseLabel": "GILTI, net"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act of 2017, Transition Tax on Accumulated Foreign Earnings, Amount",
        "terseLabel": "Transition tax"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to transaction costs.",
        "label": "Effective Income Tax Rate Reconciliation,Transaction Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTransactionCosts",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Uncertain Tax Positions, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Uncertain Tax Positions, Amount",
        "terseLabel": "FIN 48"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A share-based compensation plan adopted by the Company in 2006.",
        "label": "Emergent BioSolutions Inc. 2006 Stock Incentive Plan [Member]",
        "terseLabel": "2006 Stock Incentive Plan"
       }
      }
     },
     "localname": "EmergentBiosolutionsInc2006StockIncentivePlanMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_EmergentPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Refers to the Company's two stock-based employee compensation plans, the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan (the \"2006 Plan\") and the Emergent BioSolutions Employee Stock Option Plan (the \"2004 Plan\").",
        "label": "Emergent Plans [Member]",
        "terseLabel": "Emergent Plans"
       }
      }
     },
     "localname": "EmergentPlansMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum exercise price of option as percentage of the fair market value of the shares underlying such option on the date of grant.",
        "label": "Exercise Price Of Option As Percentage Of Fair Market Value At Grant Date, Minimum",
        "terseLabel": "Exercise price of option as percentage of fair market value at grant date, minimum"
       }
      }
     },
     "localname": "ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Measurement Period Adjustment",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Measurement Period Adjustment",
        "terseLabel": "Measurement period adjustment"
       }
      }
     },
     "localname": "FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense expected to be recognized during the fifth fiscal year and after following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite Lived Intangible Assets Amortization Expense Year Five and After",
        "terseLabel": "2024 and beyond"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_InProcessResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount of purchased research and development assets acquired in a business combination that have an indefinite life until completion or abandonment of the associated research and development efforts.",
        "label": "In Process Research And Development",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopment",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_LesseeOperatingLeaseTerminationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Operating Lease, Termination Period",
        "label": "Lessee, Operating Lease, Termination Period",
        "terseLabel": "Operating lease, termination period"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTerminationPeriod",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ebs_LockUpPeriodForAdjustmentOfFairValue": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The lock-up period considered for adjustment of fair value, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Lock-up Period for Adjustment of Fair Value",
        "terseLabel": "Lock-up period for adjustment of fair value"
       }
      }
     },
     "localname": "LockUpPeriodForAdjustmentOfFairValue",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year and thereafter following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Five and Thereafter",
        "terseLabel": "2024 and thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Refers to Manitoba Scientific Research And Experimental Development.",
        "label": "Manitoba Scientific Research And Experimental Development [Member]",
        "terseLabel": "Manitoba Scientific Research and Experimental Development"
       }
      }
     },
     "localname": "ManitobaScientificResearchAndExperimentalDevelopmentMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_NARCANNasalSprayMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "NARCAN Nasal Spray [Member]",
        "label": "NARCAN Nasal Spray [Member]",
        "terseLabel": "NARCAN Nasal Spray"
       }
      }
     },
     "localname": "NARCANNasalSprayMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_NumberOfCategoriesOfPublicHealthThreats": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Refers to the number of categories of public health threats.",
        "label": "Number Of Categories Of Public Health Threats",
        "terseLabel": "Number of categories of public health threats"
       }
      }
     },
     "localname": "NumberOfCategoriesOfPublicHealthThreats",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ebs_NumberOfEmployees": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of persons employed by the entity",
        "label": "Number Of Employees",
        "terseLabel": "Number of employees"
       }
      }
     },
     "localname": "NumberOfEmployees",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ebs_NumberOfLendingInstitutions": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of lending institutions in which the entity has a credit facility.",
        "label": "Number Of Lending Institutions",
        "terseLabel": "Number of lending institutions"
       }
      }
     },
     "localname": "NumberOfLendingInstitutions",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ebs_NumberOfRevenueGeneratingProducts": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Refers to the number of revenue generating products.",
        "label": "Number Of Revenue Generating Products",
        "terseLabel": "Number of revenue generating products"
       }
      }
     },
     "localname": "NumberOfRevenueGeneratingProducts",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ebs_NumberOfStockbasedEmployeeCompensationPlans": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the number of stock-based compensation plans the company maintains.",
        "label": "Number Of Stock-based Employee Compensation Plans",
        "terseLabel": "Number of stock based employee compensation plans"
       }
      }
     },
     "localname": "NumberOfStockbasedEmployeeCompensationPlans",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ebs_NumberofAdditionalOptionPeriods": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Refers to the number of additional option periods.",
        "label": "Number of Additional Option Periods",
        "terseLabel": "Number of additional option periods"
       }
      }
     },
     "localname": "NumberofAdditionalOptionPeriods",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ebs_OperatingLeaseOtherLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Lease, Other Liability, Current",
        "label": "Operating Lease, Other Liability, Current",
        "terseLabel": "Operating lease liabilities, current portion"
       }
      }
     },
     "localname": "OperatingLeaseOtherLiabilityCurrent",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_OtherLongTermDebtFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Long Term Debt Facility [Member]",
        "label": "Other Long Term Debt Facility [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherLongTermDebtFacilityMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Refers to product sales from other products.",
        "label": "Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_PaxVaxMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business acquisition on October 4, 2018.",
        "label": "PaxVax [Member]",
        "terseLabel": "PaxVax"
       }
      }
     },
     "localname": "PaxVaxMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The rate of interest that was being paid on the original debt issue that is to repay in the third year.",
        "label": "Percentage of Original Principal Amount Required to Repay During the Third Year",
        "terseLabel": "Percentage of original principal amount required to repay during the third year"
       }
      }
     },
     "localname": "PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The rate of interest that was being paid on the original debt issue that is to repay in the first two years.",
        "label": "Percentage of Original Principal Amount Required to Repay in First Two Years",
        "terseLabel": "Percentage of original principal amount required to repay in the first two years"
       }
      }
     },
     "localname": "PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The rate of interest that was being paid on the original debt issue that is to repay in remaining years.",
        "label": "Percentage of Original Principal Amount Required to Repay Remaining Years",
        "terseLabel": "Percentage of original principal amount required to repay remaining year"
       }
      }
     },
     "localname": "PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ebs_PresentValueDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure present value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.",
        "label": "Present Value, Discount Rate",
        "terseLabel": "Present value discount rate"
       }
      }
     },
     "localname": "PresentValueDiscountRate",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ebs_RaxibacumabMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Raxibacumab [Member]",
        "label": "Raxibacumab [Member]",
        "terseLabel": "Raxibacumab"
       }
      }
     },
     "localname": "RaxibacumabMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A valuation allowance relating to prepaid expenses and other current assets.",
        "label": "SEC Schedule, 12-09, Allowance, Prepaid Expenses And Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets allowance"
       }
      }
     },
     "localname": "SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_ScheduleofAccountsReceivableNetTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Accounts Receivable, Net [Table Text Block]",
        "label": "Schedule of Accounts Receivable, Net [Table Text Block]",
        "terseLabel": "Schedule of Accounts Receivable, Net"
       }
      }
     },
     "localname": "ScheduleofAccountsReceivableNetTableTextBlock",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of share-based compensation awards vested. Includes options, share units, stock appreciation rights, and restricted stock.",
        "label": "Share based Compensation Arrangement Share based Payment Award, Awards Vested in Period, Fair Value",
        "terseLabel": "Total fair value of awards vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the period over which options can be exercised from the date of grant.",
        "label": "Share Based Compensation Arrangement by Share-based Payment Award, Options, Exercise Period",
        "terseLabel": "Exercise period of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of reasonable estimate for income tax expense (benefit) for remeasurement of deferred tax from change in tax rate pursuant to Tax Cuts and Jobs Act of 2017 for which accounting for tax effect is incomplete.",
        "label": "Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense (Benefit)",
        "terseLabel": "Provisional transition tax amount reduction"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of reasonable estimate for income tax expense (benefit) from effect of Tax Cuts and Jobs Act of 2017 for which accounting for tax effect is incomplete.",
        "label": "Tax Cuts And Jobs Act Of2017 Incomplete Accounting Provisional Income Tax Expense Benefit",
        "negatedTerseLabel": "Provisional tax benefit"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of reasonable estimate for undistributed accumulated earnings of foreign subsidiary intended to be permanently reinvested outside country of domicile for which accounting for tax effect is incomplete pursuant to Tax Cuts and Jobs Act of 2017.",
        "label": "Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Provisional Undistributed Accumulated Earnings of Foreign Subsidiary",
        "terseLabel": "Estimated undistributed foreign E&amp;P"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of reasonable estimate for income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017 for which accounting for tax effect is incomplete.",
        "label": "Tax Cuts And Jobs Act Of 2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense",
        "terseLabel": "Provisional tax expense"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act of 2017.",
        "label": "Tax Cuts and Jobs Act of 2017, Measurement Period Adjustment, Income Tax Expense (Benefit)",
        "terseLabel": "Provisional tax benefit, adjustment"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term loan dated December 2013.",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Term Loan Facility"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_TermofContract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Refers to the term of contract with BARDA.",
        "label": "Term of Contract",
        "terseLabel": "Term of contract"
       }
      }
     },
     "localname": "TermofContract",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ebs_TermofContractUnderAcquisition": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of contract under acquisition.",
        "label": "Term of Contract Under Acquisition",
        "terseLabel": "Term of contract under acquisition"
       }
      }
     },
     "localname": "TermofContractUnderAcquisition",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ebs_UnitedStatesGovernmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "United States Government [Member]",
        "label": "United States Government [Member]",
        "terseLabel": "USG"
       }
      }
     },
     "localname": "UnitedStatesGovernmentMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_UnrecognizedTaxBenefitsCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The gross amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns, and classified as a current liability as of the balance sheet date.",
        "label": "Unrecognized Tax Benefits, Current",
        "terseLabel": "Unrecognized tax benefits, current"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsCurrent",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_UnrecognizedTaxBenefitsNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The gross amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns, and classified as a non-current liability as of the balance sheet date.",
        "label": "Unrecognized Tax Benefits, Noncurrent",
        "terseLabel": "Unrecognized tax benefits, noncurrent"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsNoncurrent",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_UpfrontPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Refers to upfront payments by the entity.",
        "label": "Upfront Payments",
        "terseLabel": "Upfront payments"
       }
      }
     },
     "localname": "UpfrontPayments",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_ValueofContract": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Refers to the value of contract.",
        "label": "Value of Contract",
        "terseLabel": "Value of contract"
       }
      }
     },
     "localname": "ValueofContract",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ebs_VaxchoraMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is a live attenuated cholera vaccine and the first vaccine approved by the FDA for the prevention of cholera infection",
        "label": "Vaxchora [Member]",
        "terseLabel": "Vaxchora"
       }
      }
     },
     "localname": "VaxchoraMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ebs_VivotifMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is a live attenuated vaccine for oral administration to prevent typhoid fever.",
        "label": "Vivotif [Member]",
        "terseLabel": "Vivotif"
       }
      }
     },
     "localname": "VivotifMember",
     "nsuri": "http://emergentbiosolutions.com/20191231",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "invest_DerivativeNotionalAmount": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://xbrl.sec.gov/invest/2013-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r180",
      "r246",
      "r251"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails",
      "http://emergentbiosolutions.com/role/LeasesNarrativeDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails",
      "http://emergentbiosolutions.com/role/LeasesNarrativeDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r177",
      "r246",
      "r249",
      "r500"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]",
        "verboseLabel": "Products and Services [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations",
      "http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations",
      "http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by range, including, but not limited to, upper and lower bounds.",
        "label": "Range [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails",
      "http://emergentbiosolutions.com/role/LeasesNarrativeDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Extent of variation, for example, but not limited to, upper and lower bounds.",
        "label": "Range [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails",
      "http://emergentbiosolutions.com/role/LeasesNarrativeDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by revision of previously issued financial statements.",
        "label": "Restatement [Axis]",
        "terseLabel": "Restatement [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revision of previously issued financial statements.",
        "label": "Restatement [Domain]",
        "terseLabel": "Restatement [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r135",
      "r136",
      "r137"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the amount as previously reported before the correction of an error or other adjustment.",
        "label": "Previously Reported [Member]",
        "terseLabel": "Previously Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r129",
      "r516"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "Schedule II - Valuation and Qualifying Accounts"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r179",
      "r246",
      "r250",
      "r502",
      "r504",
      "r514",
      "r515"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r129",
      "r516"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "Accounting Standards Update 2014-09",
        "verboseLabel": "Accounting Standards Update 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounts Receivable, Net [Abstract]",
        "terseLabel": "Accounts receivable [Abstract]"
       }
      }
     },
     "localname": "AccountsReceivableNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r18",
      "r247"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.",
        "label": "Accounts Receivable, Net, Current",
        "totalLabel": "Total, net",
        "verboseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": {
     "auth_ref": [
      "r62",
      "r68",
      "r70",
      "r284",
      "r412"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]",
        "terseLabel": "Defined Benefit Pension Plan"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r36",
      "r221"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r68",
      "r77",
      "r411"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Derivative Instruments"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r61",
      "r68",
      "r70",
      "r411"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Derivative Instruments"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r65",
      "r67",
      "r68"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss, net"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r64",
      "r68",
      "r70",
      "r412"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity",
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r60",
      "r68",
      "r70",
      "r412"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Losses"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Intangible assets, weighted average useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by new accounting pronouncement.",
        "label": "Adjustments for New Accounting Pronouncements [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r304",
      "r335",
      "r340"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.",
        "label": "Allocated Share-based Compensation Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r81",
      "r108",
      "r460"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of deferred financing costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r108",
      "r202",
      "r211"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive shares excluded from calculation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r174",
      "r480",
      "r492"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r2",
      "r3",
      "r57"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r306",
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by award type pertaining to equity-based compensation.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails",
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r422",
      "r426"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails",
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BilledContractReceivables": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.",
        "label": "Billed Contracts Receivable",
        "terseLabel": "Billed, net"
       }
      }
     },
     "localname": "BilledContractReceivables",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Buildings, building improvements and leasehold improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingImprovementsMember": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Addition, improvement, or renovation to a facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building Improvements [Member]",
        "terseLabel": "Building improvements"
       }
      }
     },
     "localname": "BuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Common stock issued for acquisition (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r398",
      "r399",
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total purchase price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combination, Consideration Transferred [Abstract]",
        "terseLabel": "Business Combination, Consideration Transferred [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r398",
      "r399"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Amount of common stock issued for acquisition including adjustments"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r107",
      "r406"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Increase to contingent consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r397",
      "r400",
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Fair value of contingent purchase consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r397",
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Remaining consideration payable for acquisition cash amount"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/Acquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": {
     "auth_ref": [
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred",
        "terseLabel": "Adjustments",
        "verboseLabel": "Total purchase price"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]",
        "terseLabel": "Measurement Period Adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod": {
     "auth_ref": [
      "r393"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in income that would have been recognized in previous periods if the adjustments to provisional amounts were recognized as of the acquisition date.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period",
        "negatedTotalLabel": "Total fair value of tangible assets acquired and liabilities assumed, measurement period adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r391"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r391"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r391"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r391"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      },
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r352",
      "r391"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "verboseLabel": "Deferred tax assets, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r352",
      "r391"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedLabel": "Deferred tax liability, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r391"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Acquired intangible assets",
        "verboseLabel": "Acquired intangible asset"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r390",
      "r391"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Acquired in-process research and development"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r390",
      "r391"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r390",
      "r391"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Total fair value of tangible assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r390",
      "r391"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "verboseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]",
        "terseLabel": "Fair value of tangible assets acquired and liabilities assumed:",
        "verboseLabel": "Fair value of tangible assets acquired:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r113",
      "r114",
      "r115"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchases of property, plant and equipment unpaid at year end"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r0",
      "r33",
      "r110"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash held in money market accounts"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r8",
      "r111",
      "r117",
      "r182"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r103",
      "r110",
      "r116"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents and restricted cash at end of year",
        "periodStartLabel": "Cash and cash equivalents and restricted cash at beginning of year",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Reconciliation of cash and cash equivalents and restricted cash:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r103",
      "r455"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "terseLabel": "Reclassification of net deferred losses from accumulated other comprehensive loss"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.",
        "label": "Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]",
        "terseLabel": "Summary of Funded Status of the Swiss Plan"
       }
      }
     },
     "localname": "ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "$0.001 Par Value Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquityParenthetical",
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r17",
      "r230"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value; 200.0 shares authorized, 52.9 shares issued and 51.7 shares outstanding at December 31, 2019; 52.4 shares issued and 51.2 shares outstanding at December 31, 2018"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r73",
      "r75",
      "r76"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Software",
        "verboseLabel": "Software product life"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r163",
      "r164",
      "r451",
      "r452"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r163",
      "r164",
      "r451",
      "r452",
      "r501"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r163",
      "r164",
      "r451",
      "r452",
      "r501"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r163",
      "r164",
      "r451",
      "r452"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r159",
      "r163",
      "r164",
      "r165",
      "r451",
      "r453"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r163",
      "r164",
      "r451",
      "r452"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r117",
      "r410",
      "r413",
      "r414"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of presentation and consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction-in-progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of contract balances and changes in contract balances.",
        "label": "Contract with Customer, Asset and Liability [Table Text Block]",
        "terseLabel": "Summary of Deferred Revenue Contract Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r239",
      "r240",
      "r247"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r239",
      "r240",
      "r247"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Contract liabilities, net of current portion"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r248"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of product sales and contract development and manufacturing services"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of product sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.",
        "label": "Cumulative Effect of New Accounting Principle in Period of Adoption",
        "terseLabel": "Adoption of new accounting standard (ASC 606), net of tax"
       }
      }
     },
     "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r377",
      "r382"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r125",
      "r379"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r377",
      "r382"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r377",
      "r382"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r481",
      "r483",
      "r491"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r459",
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]",
        "verboseLabel": "Long-Term Debt [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r46",
      "r122",
      "r231",
      "r232",
      "r233",
      "r234",
      "r458",
      "r459",
      "r461",
      "r489"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet": {
     "auth_ref": [
      "r462"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Line of Credit Arrangements, Net",
        "terseLabel": "Debt issuance capitalized costs"
       }
      }
     },
     "localname": "DebtIssuanceCostsLineOfCreditArrangementsNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsCurrent": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.",
        "label": "Deferred Costs, Current",
        "terseLabel": "Deferred costs, current"
       }
      }
     },
     "localname": "DeferredCostsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r378",
      "r382"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r38",
      "r460"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r38",
      "r460"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "negatedLabel": "Unamortized debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r378",
      "r382"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r108",
      "r121",
      "r378",
      "r382"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r14",
      "r15",
      "r366",
      "r482",
      "r490"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r353",
      "r370"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r378",
      "r382"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r345",
      "r375",
      "r376"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets, Deferred Income",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r367"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r345",
      "r375",
      "r376"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r368"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r344",
      "r375",
      "r376"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Federal losses carryforward"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails",
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "auth_ref": [
      "r344",
      "r375",
      "r376"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "terseLabel": "Foreign NOLs"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails",
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r344",
      "r375",
      "r376"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "State losses carryforward"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails",
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r345",
      "r375",
      "r376"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r372",
      "r375",
      "r376"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development carryforward"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r344",
      "r375",
      "r376"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails",
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r353",
      "r370"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax asset (liability)",
        "terseLabel": "Deferred tax liabilities, net"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails",
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r345",
      "r375",
      "r376"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r345",
      "r375",
      "r376"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Right-of-use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r345",
      "r375",
      "r376"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r345",
      "r375",
      "r376"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Fixed assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "auth_ref": [
      "r63",
      "r68"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "totalLabel": "Total recognized in accumulated other comprehensive loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax": {
     "auth_ref": [
      "r68",
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax",
        "terseLabel": "Accumulated benefit obligation, end of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "auth_ref": [
      "r68",
      "r285"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "negatedLabel": "Net actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r68",
      "r285"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax",
        "terseLabel": "Prior service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r268",
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedLabel": "Actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Expected rate of return"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of future compensation increases"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r256"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Projected benefit obligation, end of year",
        "periodStartLabel": "Projected benefit obligation, beginning of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r263",
      "r298"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Net benefits received (paid)"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "terseLabel": "Employee contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation": {
     "auth_ref": [
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in benefit obligation of defined benefit plan from business combination.",
        "label": "Defined Benefit Plan, Benefit Obligation, Business Combination",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets": {
     "auth_ref": [
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in plan assets of defined benefit plan from business combination.",
        "label": "Defined Benefit Plan, Plan Assets, Business Combination",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r270",
      "r275",
      "r276",
      "r295",
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r277"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r277"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in next fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in remainder of fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Remainder of Fiscal Year",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r277"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in fifth fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r277"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in fourth fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r277"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in third fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r277"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in second fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r278"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of contributions expected to be received by defined benefit plan from employer in next fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Total contributions expected"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r282",
      "r294",
      "r296"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r267",
      "r275",
      "r276",
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Fair value of plan assets, end of year",
        "periodStartLabel": "Fair value of plan assets, beginning of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency impact"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r255",
      "r274"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "terseLabel": "Funded status, end of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r259",
      "r281",
      "r293",
      "r296"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest Cost",
        "verboseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails",
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r279",
      "r291",
      "r296"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAmendments": {
     "auth_ref": [
      "r264"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment",
        "terseLabel": "Plan amendment"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAmendments",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r271",
      "r298"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "terseLabel": "Net benefits received (paid)"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency impact"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r257",
      "r280",
      "r292",
      "r296"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost",
        "verboseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails",
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "negatedLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r273"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Matching contributions made by employer"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r108",
      "r172"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r58",
      "r59",
      "r424",
      "r477"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Asset Derivatives"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r58",
      "r59",
      "r424",
      "r477"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Liability Derivatives"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r423",
      "r425",
      "r429",
      "r432"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r420",
      "r423",
      "r429"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r428",
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effect in current period from application of guidance for revenue from contract with customer compared with guidance for revenue recognition applicable prior to change when using transition method for cumulative effect in period including initial date of application.",
        "label": "Difference between Revenue Guidance in Effect before and after Topic 606 [Member]",
        "terseLabel": "Difference between Revenue Guidance in Effect before and after Topic 606"
       }
      }
     },
     "localname": "DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Summary of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority",
        "verboseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails",
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r80",
      "r132",
      "r140",
      "r143",
      "r144",
      "r145",
      "r149",
      "r487",
      "r499"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income per share-basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations",
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails",
      "http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r80",
      "r132",
      "r140",
      "r143",
      "r144",
      "r145",
      "r149",
      "r487",
      "r499"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income per share-diluted (in dollars per share)",
        "verboseLabel": "Net income (loss) per share-diluted (in dollar per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations",
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails",
      "http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r117",
      "r146",
      "r147",
      "r148"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r455"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r124",
      "r354",
      "r355"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate reconciliation, percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r354",
      "r355",
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal corporate tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average period expected to be recognized related to unvested equity awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r336"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unrecognized cost of unvested options awarded to employees as compensation.",
        "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options",
        "terseLabel": "Compensation cost expected to be recognized related to unvested equity awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An arrangement whereby an employee is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Although there are variations, normally, after vesting, when an option is exercised, the employee-holder pays the strike value in cash to the issuing employer-entity and receives equity shares. The equity shares can be sold into the market for cash at the current market price without restriction. Options may be used to attract, retain and incentivize employees, in addition to their regular salary and other benefits.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity",
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EurodollarMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.",
        "label": "Eurodollar [Member]",
        "terseLabel": "Eurodollar"
       }
      }
     },
     "localname": "EurodollarMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r441",
      "r442",
      "r443",
      "r444",
      "r448",
      "r449"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r275",
      "r276",
      "r296",
      "r443",
      "r475"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair value measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r275",
      "r276",
      "r296",
      "r443",
      "r476"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r445",
      "r449"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Summary of Reconciliation of Contingent Consideration Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair value measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "auth_ref": [
      "r447"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "verboseLabel": "Additions due to acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Expense included in earnings"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Milestone achievement - asset acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r447"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedLabel": "Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r445"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Balance, end of period",
        "periodStartLabel": "Balance, beginning of period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r422",
      "r427",
      "r436"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fixed rate on a U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to the Federal Funds effective rate with no additional spread over the Federal Funds effective rate on that variable-rate leg. Alternate captions include overnight index swap rate (OIS).",
        "label": "Federal Funds Effective Swap Rate [Member]",
        "terseLabel": "Federal Funds Rate"
       }
      }
     },
     "localname": "FederalFundsEffectiveSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Finance Lease, Cost [Abstract]",
        "terseLabel": "Operating lease cost:"
       }
      }
     },
     "localname": "FinanceLeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r466",
      "r469",
      "r473"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r466",
      "r469",
      "r473"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Amortization period of intangible assets",
        "verboseLabel": "Estimated Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r210"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r203",
      "r207",
      "r210",
      "r214",
      "r479"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r210",
      "r479"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r203",
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r204"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r117",
      "r454",
      "r456"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Translation of foreign currencies"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r190",
      "r192"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r194"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible assets and goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r193",
      "r197"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r108",
      "r191",
      "r195",
      "r199"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill, impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r196",
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Measurement period adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r420",
      "r433"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r108",
      "r215"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "terseLabel": "Impairment of IPR&amp;D intangible asset"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Asset impairment analysis"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In Process Research and Development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentPolicy": {
     "auth_ref": [
      "r37",
      "r117",
      "r342"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets.",
        "label": "In Process Research and Development, Policy [Policy Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentPolicy",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossAttributableToParent": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.",
        "label": "Income (Loss) Attributable to Parent, before Tax",
        "totalLabel": "Earnings before taxes on income"
       }
      }
     },
     "localname": "IncomeLossAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "US"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "International"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails",
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails",
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r357",
      "r363",
      "r365",
      "r380"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r173",
      "r383"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Total provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations",
      "http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails",
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r117",
      "r350",
      "r351",
      "r364",
      "r365",
      "r371",
      "r384",
      "r503"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r349",
      "r354",
      "r355"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r348",
      "r354",
      "r355"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Change in U.S. tax rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r119",
      "r354",
      "r355"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Impact of foreign operations"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r120",
      "r354",
      "r355"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Federal tax at statutory rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r354",
      "r355"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible equity-based compensation costs.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Amount",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r354"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other differences"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r354",
      "r355"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount",
        "terseLabel": "Return to provision true-ups"
       }
      }
     },
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r120",
      "r354",
      "r355"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State taxes, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCredits": {
     "auth_ref": [
      "r354",
      "r355"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount",
        "negatedLabel": "Tax credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r105",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid during the year for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r51",
      "r485",
      "r497"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income tax receivable, net"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.",
        "label": "Increase (Decrease) in Income Taxes Receivable",
        "negatedLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "auth_ref": [
      "r142",
      "r147"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "terseLabel": "Dilutive securities-convertible debt (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r141",
      "r147"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive securities-equity awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r206",
      "r213"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r206",
      "r213"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information about effect of transition method for cumulative effect in initial period of application.",
        "label": "Initial Application Period Cumulative Effect Transition [Axis]",
        "terseLabel": "Initial Application Period Cumulative Effect Transition [Axis]"
       }
      }
     },
     "localname": "InitialApplicationPeriodCumulativeEffectTransitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effect of transition method for cumulative effect in initial period of application.",
        "label": "Initial Application Period Cumulative Effect Transition [Domain]",
        "terseLabel": "Initial Application Period Cumulative Effect Transition [Domain]"
       }
      }
     },
     "localname": "InitialApplicationPeriodCumulativeEffectTransitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r201",
      "r208"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r78",
      "r171",
      "r457",
      "r460",
      "r488"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestOnConvertibleDebtNetOfTax": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "ebs_AdjustedNetLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The after-tax amount of interest recognized in the period associated with any convertible debt.",
        "label": "Interest on Convertible Debt, Net of Tax",
        "terseLabel": "Interest expense, net of tax"
       }
      }
     },
     "localname": "InterestOnConvertibleDebtNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r102",
      "r104",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid during the year for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails",
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r24",
      "r188"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r1",
      "r54",
      "r185"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Total inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r7",
      "r55",
      "r117",
      "r151",
      "r186",
      "r187"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r26",
      "r27",
      "r188"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Raw materials and supplies"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserveMember": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reserve to reduce inventory to lower of cost or net realizable value.",
        "label": "SEC Schedule, 12-09, Reserve, Inventory [Member]",
        "terseLabel": "Inventory allowance"
       }
      }
     },
     "localname": "InventoryValuationReserveMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r25",
      "r188"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandAndLandImprovementsMember": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Real estate held and assets that are an addition or improvement to real estate held.",
        "label": "Land and Land Improvements [Member]",
        "terseLabel": "Land and improvements"
       }
      }
     },
     "localname": "LandAndLandImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r472",
      "r473"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total operating lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Operating leases:"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Summary of Lease Expense Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Litigation"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/Litigation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesNarrativeDetails",
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesNarrativeDetails",
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating lease, renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "verboseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r23",
      "r484",
      "r495"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r13",
      "r483",
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Outstanding credit facility"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Current borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r13",
      "r228",
      "r483",
      "r493"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Total debt",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "negatedTerseLabel": "Current portion of debt, net of debt issuance costs"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r127",
      "r227"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r127",
      "r227"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r127",
      "r227"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r127",
      "r227"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Debt, net of current portion",
        "verboseLabel": "Debt, net of current portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.",
        "label": "Long-term Purchase Commitment, Amount",
        "terseLabel": "Materials purchased under commitment, amount"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentAmount",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermPurchaseCommitmentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Long-term Purchase Commitment, Period",
        "terseLabel": "Purchase commitment period"
       }
      }
     },
     "localname": "LongtermPurchaseCommitmentPeriod",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PurchaseCommitmentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MajorCustomersPolicyPolicyTextBlock": {
     "auth_ref": [
      "r159",
      "r163",
      "r164",
      "r180"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.",
        "label": "Major Customers, Policy [Policy Text Block]",
        "terseLabel": "Significant customers and accounting receivable"
       }
      }
     },
     "localname": "MajorCustomersPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r154",
      "r169"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "verboseLabel": "Nature of the business and organization"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r103",
      "r106",
      "r109"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r71",
      "r74",
      "r79",
      "r109",
      "r147",
      "r486",
      "r498"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "ebs_AdjustedNetLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity",
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows",
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome",
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations",
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails",
      "http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r131",
      "r133",
      "r134"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently issued accounting standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Non-U.S. Government",
        "verboseLabel": "Non-US"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r178"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes Payable, Current",
        "terseLabel": "Debt, current portion"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "auth_ref": [
      "r416",
      "r418"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date.",
        "label": "Number of Interest Rate Derivatives Held",
        "terseLabel": "Number of Instruments"
       }
      }
     },
     "localname": "NumberOfInterestRateDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganizationDetails",
      "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r68",
      "r77"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r465"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease, liability",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r465"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r464"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r471",
      "r473"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r470",
      "r473"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r372"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsValuationAllowance": {
     "auth_ref": [
      "r346",
      "r369",
      "r373"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Operating Loss Carryforwards, Valuation Allowance",
        "terseLabel": "Operating loss carryforwards, valuation allowance"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r422",
      "r436"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails",
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r63",
      "r65",
      "r408",
      "r411"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedLabel": "Unrealized losses on pension benefit obligation, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent": {
     "auth_ref": [
      "r408",
      "r409",
      "r411"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r408",
      "r409",
      "r411"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "verboseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r61",
      "r65"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Unrealized losses on hedging activities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "terseLabel": "Amount of Gain/(Loss) Recognized in OCI on Derivative"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r65",
      "r69",
      "r428"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r72",
      "r75",
      "r408",
      "r409",
      "r411"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Total other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity",
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome",
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r61",
      "r65",
      "r438"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax",
        "terseLabel": "Unrealized losses on hedging activities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax": {
     "auth_ref": [
      "r61",
      "r66"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit), before reclassification adjustments, related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax",
        "terseLabel": "Amount of Gain/(Loss) Recognized in OCI on Derivative"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r85",
      "r108",
      "r219"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Other Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r43"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r422",
      "r436"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails",
      "http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental information on non-cash investing and financing activities:"
       }
      }
     },
     "localname": "OtherNoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedLabel": "Contingent consideration payments"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForPreviousAcquisition": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash outflow representing an adjustment to the purchase price of a previous acquisition.",
        "label": "Payments for Previous Acquisition",
        "negatedTerseLabel": "Milestone payment from asset acquisition"
       }
      }
     },
     "localname": "PaymentsForPreviousAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchase of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r97",
      "r302"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy an employee's income tax withholding obligation as part of a net-share settlement of a share-based award.",
        "label": "Payments Related to Tax Withholding for Share-based Compensation",
        "negatedLabel": "Taxes paid on behalf of employees for equity activity"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r91",
      "r403"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Amount of cash paid",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "negatedLabel": "Asset acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment and other"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Disclosure [Text Block]",
        "verboseLabel": "Defined benefit and 401(k) savings plan"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy": {
     "auth_ref": [
      "r117",
      "r290",
      "r297",
      "r299",
      "r300"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension plans. This accounting policy may address (1) the types of plans sponsored by the entity (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]",
        "terseLabel": "Pension plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPensionsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost (reversal of cost) for pension benefits. Excludes other postretirement benefits.",
        "label": "Pension Cost (Reversal of Cost)",
        "terseLabel": "Pension expense"
       }
      }
     },
     "localname": "PensionExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares or units awarded to employees for meeting certain performance targets.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r306",
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by plan name pertaining to equity-based compensation arrangements.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the equity-based compensation arrangement plan.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 15.0 shares authorized, 0 shares issued and outstanding at both December 31, 2019 and 2018"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r2",
      "r31",
      "r32"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfMediumTermNotes": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a debt funding received on a regular basis with maturities ranging from 5-10 years.",
        "label": "Proceeds from Issuance of Medium-term Notes",
        "terseLabel": "Proceeds from term loan facility"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfMediumTermNotes",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "verboseLabel": "Proceeds from revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities": {
     "auth_ref": [
      "r96",
      "r101"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net cash inflow or outflow from cash and cash items that are not available for withdrawal or usage.",
        "label": "Proceeds from (Repayments of) Restricted Cash, Financing Activities",
        "verboseLabel": "Receipts and payments of restricted cash"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfRestrictedCashFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Proceeds from Sale of Productive Assets",
        "terseLabel": "Proceeds from sale of assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r94",
      "r338"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from issuance of common stock upon exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product sales, net",
        "verboseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails",
      "http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r36",
      "r222"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Type [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "verboseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": {
     "auth_ref": [
      "r117",
      "r218"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Property, Plant and Equipment, Estimated Useful Lives",
        "terseLabel": "Estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r35",
      "r220"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Property Plant and Equipment Income Statement Disclosures [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r9",
      "r10",
      "r222",
      "r496"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Total property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r34",
      "r117",
      "r222"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r9",
      "r222"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Summary of Property, Plant and Equipment Useful Lives",
        "verboseLabel": "Schedule of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentTables",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r9",
      "r220"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property, Plant and Equipment, Type [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "terseLabel": "Total purchase commitment"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationFiscalYearMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Purchase Obligation, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "PurchaseObligationFiscalYearMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "verboseLabel": "Quarterly financial data (Unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r68",
      "r77"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-term Lines of Credit",
        "negatedLabel": "Principal payments on revolving credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfMediumTermNotes": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years.",
        "label": "Repayments of Medium-term Notes",
        "negatedTerseLabel": "Principal payments on term loan facility"
       }
      }
     },
     "localname": "RepaymentsOfMediumTermNotes",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Payment of notes payable to Aptevo"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "auth_ref": [
      "r342",
      "r343"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by form of arrangement related to research and development.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "auth_ref": [
      "r342",
      "r343"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r341",
      "r505"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r117",
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research Tax Credit Carryforward"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r0",
      "r8",
      "r116"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r20",
      "r235",
      "r494"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r241",
      "r245",
      "r246"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenues",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations",
      "http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedDetails",
      "http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised good or service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer [Member]",
        "terseLabel": "Revenue from Contract with Customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r118",
      "r254"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r130",
      "r254"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]"
       }
      }
     },
     "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information when using transition method for cumulative effect in initial period of application for revenue from contract with customer.",
        "label": "Revenue, Initial Application Period Cumulative Effect Transition [Table]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Table]"
       }
      }
     },
     "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r243"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, remaining performance obligation, amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails",
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueProductLineMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue during the period derived from a specified product line, after deducting returns, allowances and discounts, when it serves as a benchmark in a concentration of risk calculation.",
        "label": "Sales Revenue, Product Line [Member]",
        "terseLabel": "Sales Revenue, Product Line"
       }
      }
     },
     "localname": "SalesRevenueProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails",
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Loss Before Income Tax"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the assumptions used to determine for pension plans and/or other employee benefit plans the benefit obligation and net benefit cost, including assumed discount rates, rate increase in compensation increase, and expected long-term rates of return on plan assets.",
        "label": "Schedule of Assumptions Used [Table Text Block]",
        "terseLabel": "Schedule of Weighted Average Assumptions"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Summary of Significant Components of the Provisions for Income Taxes Attributable to Operations"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r46",
      "r122",
      "r231",
      "r232",
      "r233",
      "r234",
      "r458",
      "r459",
      "r461",
      "r489"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Summary of Future Debt Payments of Long-Term Indebtedness"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r423",
      "r429",
      "r433"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r126",
      "r415",
      "r417",
      "r418",
      "r420",
      "r421",
      "r427",
      "r429",
      "r434",
      "r435"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DerivativeInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Net Income Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits Activity"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r304",
      "r334",
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that sets forth the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.",
        "label": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r304",
      "r334",
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.",
        "label": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]",
        "terseLabel": "Summary of Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Future Benefits Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r203",
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r198",
      "r200"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "verboseLabel": "Summary of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r213",
      "r216"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r7",
      "r28",
      "r29",
      "r30"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Components of Net Periodic Pension Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Stock Unit Award Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r36",
      "r222"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information [Table Text Block]",
        "terseLabel": "Schedule of Quarterly Financial Information"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
        "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]",
        "terseLabel": "Schedule of Product Sales"
       }
      }
     },
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r170",
      "r174",
      "r175",
      "r176",
      "r198"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r306",
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an equity-based arrangement under which compensation is awarded to employees, typically comprised of compensation expense; changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan; and cash flow effects resulting from the equity-based payment arrangement. Component disclosures are by type of award and plan name.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r311",
      "r324",
      "r327"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Compensation, Stock Options, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Award Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Valuation Assumptions, Stock Options Granted"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r363",
      "r380"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Reconciliation of Income Before the Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Summary of Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails",
      "http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r86",
      "r184"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.",
        "label": "Share-based Compensation",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Restricted stock units granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Restricted stock units grant price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "periodStartLabel": "Outstanding, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding, end of period (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Common stock authorized for issuance under the plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Common stock available for future awards (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "periodEndLabel": "Exercisable, end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "periodEndLabel": "Exercisable, end of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r326"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Stock options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value of options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r313",
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "periodStartLabel": "Outstanding, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, end of period (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r303",
      "r309"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity-based compensation award.",
        "label": "Equity Award [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails",
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Stock options grant price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r117",
      "r306",
      "r310"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.",
        "label": "Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]",
        "terseLabel": "Accounting for stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intrinsic value of equity-based compensation awards outstanding. Excludes stock and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Contractual life of awards"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r330",
      "r339"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected average life of options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term of options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term of options outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "verboseLabel": "Summary of significant accounting policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock": {
     "auth_ref": [
      "r189",
      "r225"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for arrangements in which the entity has agreed to expend funds to procure goods or service from one or more suppliers, or to commit resources to supply goods or services to one or more customers.  May include identification of the goods or services to be purchased, the goods or services to be furnished, identity of the buyer or seller, pricing, effects on pricing (such as penalties) of failing to reach minimum quantities required to be purchased, effects on pricing (such as penalties) of failing to deliver minimum quantities required to be furnished, cancellation rights, and termination provisions.",
        "label": "Purchase and Supply Commitment, Excluding Long-term Commitment [Text Block]",
        "terseLabel": "Purchase commitment"
       }
      }
     },
     "localname": "SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/PurchaseCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails",
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r50",
      "r230"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity",
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity",
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity",
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r113",
      "r114",
      "r115"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "terseLabel": "Issuance of common stock to acquire Adapt Pharma"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r16",
      "r17",
      "r235"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issuance of common stock in acquisitions (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r49",
      "r230",
      "r231",
      "r235"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Shares issued to extinguish convertible notes (in shares)",
        "verboseLabel": "Shares of common stock due to conversions (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r16",
      "r17",
      "r230",
      "r235"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.",
        "label": "Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures",
        "terseLabel": "Employee equity plans activity (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r16",
      "r17",
      "r230",
      "r235",
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r50",
      "r230",
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of common stock in acquisition",
        "verboseLabel": "Equity"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails",
      "http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails",
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r50",
      "r230",
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Shares issued to extinguish convertible notes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r16",
      "r17",
      "r235",
      "r305",
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.",
        "label": "Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures",
        "terseLabel": "Employee equity plans activity"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r17",
      "r21",
      "r22",
      "r183"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets",
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity",
      "http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity including the portion attributable to noncontrolling interests, after the cumulative effect adjustment of a new accounting principle applied in the period of adoption.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance",
        "terseLabel": "Balance, as adjusted"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r372"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforward, amount"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Tax Credit Carryforward [Line Items]",
        "terseLabel": "Tax Credit Carryforward [Line Items]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.",
        "label": "Tax Credit Carryforward [Table]",
        "terseLabel": "Tax Credit Carryforward [Table]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardValuationAllowance": {
     "auth_ref": [
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Tax Credit Carryforward, Valuation Allowance",
        "terseLabel": "Tax credit carryforward, valuation allowance"
       }
      }
     },
     "localname": "TaxCreditCarryforwardValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "verboseLabel": "Corporate trade name"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r48",
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r48",
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r17",
      "r230",
      "r235"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r48",
      "r236",
      "r237"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost, 1.2 common shares at December 31, 2019 and 2018"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "auth_ref": [
      "r230",
      "r235",
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.",
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "negatedLabel": "Treasury stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.",
        "label": "Type of Adoption [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails",
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnbilledContractsReceivable": {
     "auth_ref": [
      "r52",
      "r478"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.",
        "label": "Unbilled Contracts Receivable",
        "terseLabel": "Unbilled"
       }
      }
     },
     "localname": "UnbilledContractsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r347",
      "r358"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Gross unrecognized tax benefits, ending balance",
        "periodStartLabel": "Gross unrecognized tax benefits, beginning balance",
        "terseLabel": "Gross unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails",
      "http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r359"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "terseLabel": "Decreases for tax positions for prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r361"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedLabel": "Settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from acquisitions.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Acquisition",
        "terseLabel": "Unrecognized tax benefits acquired in business combinations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails",
      "http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increases for tax positions for current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increases for tax positions for prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r362"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "terseLabel": "Lapse of statute of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r155",
      "r156",
      "r157",
      "r158",
      "r166",
      "r167",
      "r168"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charged to costs and expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedTerseLabel": "Deductions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from business combination.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired",
        "terseLabel": "Additions from Acquisition"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesReservesOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r139",
      "r145"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average number of shares - diluted (in shares)",
        "totalLabel": "Weighted-average number of shares-diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations",
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r138",
      "r145"
     ],
     "calculation": {
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average number of shares - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations",
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://emergentbiosolutions.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 13
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3367-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3521-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3044-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(ColumnA))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22580-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1448-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1505-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1500-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1930-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=109236672&loc=d3e543-108305"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=109225645&loc=d3e1280-108306"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9054-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "305",
   "URI": "http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=68049868&loc=d3e3927-108312"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=66092785&loc=d3e4492-108314"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=66092785&loc=d3e4556-108314"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=68071081&loc=d3e1205-110223"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130539-203045"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130551-203045"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130556-203045"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130556-203045"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130543-203045"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=108792157&loc=SL49130690-203046-203046"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=108792157&loc=SL49130690-203046-203046"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=108792157&loc=SL49130690-203046-203046"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(b)(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i),(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e2709-114920"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e2709-114920"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e2709-114920"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e2709-114920"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e2709-114920"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=112275985&loc=d3e4179-114921"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6801-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=107668666&loc=SL79513924-113897"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=SL79508275-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=115928272&loc=d3e28680-109314"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=115928272&loc=d3e28680-109314"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109238119&loc=d3e30536-109315"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=SL37586934-109318"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e32059-109318"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e32123-109318"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e32247-109318"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e32280-109318"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e31917-109318"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e31931-109318"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.15)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109238393&loc=d3e36027-109320"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "30",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=84229725&loc=d3e961-128460"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=84229725&loc=d3e1043-128460"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=108330185&loc=d3e2207-128464"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=84161108&loc=SL65897772-128472"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5504-128473"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=109124213&loc=d3e6578-128477"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=109124213&loc=d3e6613-128477"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6812-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3A-02)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3A-03)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=27015204&loc=d3e355100-122828"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109975725&loc=SL5629052-113961"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109976185&loc=SL5864739-113975"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109978405&loc=d3e80720-113993"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80748-113994"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19190-110258"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=SL7498348-110258"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19279-110258"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=109250915&loc=d3e13531-108611"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=109250915&loc=d3e13537-108611"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=109250915&loc=d3e13537-108611"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=68176171&loc=SL68176184-208336"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=113997351&loc=SL77916155-209984"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918638-209977"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109247956&loc=d3e107207-111719"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109247956&loc=d3e107207-111719"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109247956&loc=SL51823488-111719"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=68054760&loc=d3e55302-109406"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6904-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99384497&loc=SL65671331-158438"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r506": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r507": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r508": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r509": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Forms 10-K, 20-F, 40-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-1"
  },
  "r511": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r512": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r513": {
   "Article": "12",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "13",
   "Sentence": "Column B"
  },
  "r514": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r515": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r516": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(c)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6911-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e637-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e640-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e681-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669686-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e689-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL34724394-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e557-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=109228884&loc=d3e1436-108581"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.20)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3179-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3.a.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>312</ContextCount>
  <ElementCount>589</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>86</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001000 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001501 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002000 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003000 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/ConsolidatedStatementsOfComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004000 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005000 - Statement - Consolidated Statement of Changes in Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquity</Role>
      <ShortName>Consolidated Statement of Changes in Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1005501 - Statement - Consolidated Statement of Changes in Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/ConsolidatedStatementOfChangesInStockholdersEquityParenthetical</Role>
      <ShortName>Consolidated Statement of Changes in Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101100 - Disclosure - Nature of the business and organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganization</Role>
      <ShortName>Nature of the business and organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2102100 - Disclosure - Summary of significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2103100 - Disclosure - Revenue recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RevenueRecognition</Role>
      <ShortName>Revenue recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2104100 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2105100 - Disclosure - Fair value measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/FairValueMeasurements</Role>
      <ShortName>Fair value measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2106100 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2107100 - Disclosure - Property, plant and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/PropertyPlantAndEquipment</Role>
      <ShortName>Property, plant and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2108100 - Disclosure - Intangible assets and goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwill</Role>
      <ShortName>Intangible assets and goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2109100 - Disclosure - Long-term debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/LongTermDebt</Role>
      <ShortName>Long-term debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2110100 - Disclosure - Derivative Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DerivativeInstruments</Role>
      <ShortName>Derivative Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2111100 - Disclosure - Stockholders' equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2112100 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IncomeTaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2113100 - Disclosure - Defined benefit and 401(k) savings plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlan</Role>
      <ShortName>Defined benefit and 401(k) savings plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2114100 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2115100 - Disclosure - Earnings per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/EarningsPerShare</Role>
      <ShortName>Earnings per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2116100 - Disclosure - Purchase commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/PurchaseCommitments</Role>
      <ShortName>Purchase commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2117100 - Disclosure - Segment information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SegmentInformation</Role>
      <ShortName>Segment information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2118100 - Disclosure - Quarterly financial data (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnaudited</Role>
      <ShortName>Quarterly financial data (unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2119100 - Disclosure - Litigation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/Litigation</Role>
      <ShortName>Litigation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2120100 - Disclosure - Schedule II - Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccounts</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Summary of significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2302302 - Disclosure - Summary of significant accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of significant accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Revenue recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/RevenueRecognition</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Acquisitions</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Fair value measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair value measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/FairValueMeasurements</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2306301 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Inventories</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Property, plant and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentTables</Role>
      <ShortName>Property, plant and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/PropertyPlantAndEquipment</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2308301 - Disclosure - Intangible assets and goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillTables</Role>
      <ShortName>Intangible assets and goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwill</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2309301 - Disclosure - Long-term debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/LongTermDebtTables</Role>
      <ShortName>Long-term debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/LongTermDebt</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2310301 - Disclosure - Derivative Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DerivativeInstrumentsTables</Role>
      <ShortName>Derivative Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/DerivativeInstruments</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2311301 - Disclosure - Stockholders' equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/StockholdersEquity</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2312301 - Disclosure - Income taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IncomeTaxesTables</Role>
      <ShortName>Income taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/IncomeTaxes</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2313301 - Disclosure - Defined benefit and 401(k) savings plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanTables</Role>
      <ShortName>Defined benefit and 401(k) savings plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlan</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2314301 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/Leases</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2315301 - Disclosure - Earnings per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/EarningsPerShare</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2317301 - Disclosure - Segment information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SegmentInformationTables</Role>
      <ShortName>Segment information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/SegmentInformation</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2318301 - Disclosure - Quarterly financial data (unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedTables</Role>
      <ShortName>Quarterly financial data (unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnaudited</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2401401 - Disclosure - Nature of the business and organization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganizationDetails</Role>
      <ShortName>Nature of the business and organization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/NatureOfBusinessAndOrganization</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2402403 - Disclosure - Summary of significant accounting policies - Concentration Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesConcentrationRiskDetails</Role>
      <ShortName>Summary of significant accounting policies - Concentration Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2402404 - Disclosure - Summary of significant accounting policies - Estimated Useful Lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesDetails</Role>
      <ShortName>Summary of significant accounting policies - Estimated Useful Lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2402405 - Disclosure - Summary of significant accounting policies - Asset Impairment Analysis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAssetImpairmentAnalysisDetails</Role>
      <ShortName>Summary of significant accounting policies - Asset Impairment Analysis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2402406 - Disclosure - Summary of significant accounting policies - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails</Role>
      <ShortName>Summary of significant accounting policies - Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2402407 - Disclosure - Summary of significant accounting policies - Accounting for Stock-based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesAccountingForStockBasedCompensationDetails</Role>
      <ShortName>Summary of significant accounting policies - Accounting for Stock-based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2402408 - Disclosure - Summary of significant accounting policies - Recently Issued Accounting Standards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SummaryOfSignificantAccountingPoliciesRecentlyIssuedAccountingStandardsDetails</Role>
      <ShortName>Summary of significant accounting policies - Recently Issued Accounting Standards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2403402 - Disclosure - Revenue recognition - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RevenueRecognitionNarrativeDetails</Role>
      <ShortName>Revenue recognition - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2403403 - Disclosure - Revenue recognition - Remaining Performance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RevenueRecognitionRemainingPerformanceObligationDetails</Role>
      <ShortName>Revenue recognition - Remaining Performance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2403404 - Disclosure - Revenue recognition - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RevenueRecognitionDisaggregationOfRevenueDetails</Role>
      <ShortName>Revenue recognition - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2403405 - Disclosure - Revenue recognition - Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RevenueRecognitionContractLiabilitiesDetails</Role>
      <ShortName>Revenue recognition - Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2403406 - Disclosure - Revenue recognition - Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/RevenueRecognitionAccountsReceivableDetails</Role>
      <ShortName>Revenue recognition - Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2404402 - Disclosure - Acquisitions - Adapt Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/AcquisitionsAdaptNarrativeDetails</Role>
      <ShortName>Acquisitions - Adapt Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2404403 - Disclosure - Acquisitions - Adapt Preliminary Purchase Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryPurchaseConsiderationDetails</Role>
      <ShortName>Acquisitions - Adapt Preliminary Purchase Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2404404 - Disclosure - Acquisitions - Adapt Preliminary Allocation of Purchase Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/AcquisitionsAdaptPreliminaryAllocationOfPurchasePriceDetails</Role>
      <ShortName>Acquisitions - Adapt Preliminary Allocation of Purchase Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2404405 - Disclosure - Acquisitions - PaxVax Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/AcquisitionsPaxvaxNarrativeDetails</Role>
      <ShortName>Acquisitions - PaxVax Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2404406 - Disclosure - Acquisitions - PaxVax Preliminary Allocation of Purchase Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/AcquisitionsPaxvaxPreliminaryAllocationOfPurchasePriceDetails</Role>
      <ShortName>Acquisitions - PaxVax Preliminary Allocation of Purchase Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2404407 - Disclosure - Acquisitions - Acquisition of ACAM2000 Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000NarrativeDetails</Role>
      <ShortName>Acquisitions - Acquisition of ACAM2000 Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2404408 - Disclosure - Acquisitions - Acquisition of ACAM2000 Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfAcam2000BusinessDetails</Role>
      <ShortName>Acquisitions - Acquisition of ACAM2000 Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2404409 - Disclosure - Acquisitions - Acquisition of Raxibacumab Asset (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/AcquisitionsAcquisitionOfRaxibacumabAssetDetails</Role>
      <ShortName>Acquisitions - Acquisition of Raxibacumab Asset (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Fair value measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair value measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2405403 - Disclosure - Fair value measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair value measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/InventoriesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentDetails</Role>
      <ShortName>Property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/PropertyPlantAndEquipmentTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - Intangible assets and goodwill - Schedule of Finite-lived Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillScheduleOfFiniteLivedIntangibleAssetsDetails</Role>
      <ShortName>Intangible assets and goodwill - Schedule of Finite-lived Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Intangible assets and goodwill - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillNarrativeDetails</Role>
      <ShortName>Intangible assets and goodwill - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Intangible assets and goodwill - Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillFutureAmortizationExpenseDetails</Role>
      <ShortName>Intangible assets and goodwill - Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Intangible assets and goodwill - Summary Changes in Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IntangibleAssetsAndGoodwillSummaryChangesInGoodwillDetails</Role>
      <ShortName>Intangible assets and goodwill - Summary Changes in Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2409402 - Disclosure - Long-term debt - Components of Long-term Indebtedness (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/LongTermDebtComponentsOfLongTermIndebtednessDetails</Role>
      <ShortName>Long-term debt - Components of Long-term Indebtedness (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2409403 - Disclosure - Long-term debt - Senior Secured Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/LongTermDebtSeniorSecuredCreditAgreementDetails</Role>
      <ShortName>Long-term debt - Senior Secured Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Long-term debt - Convertible Senior Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://emergentbiosolutions.com/role/LongTermDebtConvertibleSeniorNotesDetails</Role>
      <ShortName>Long-term debt - Convertible Senior Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - Long-term debt - Future Debt Payments of Long-term Indebtedness (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/LongTermDebtFutureDebtPaymentsOfLongTermIndebtednessDetails</Role>
      <ShortName>Long-term debt - Future Debt Payments of Long-term Indebtedness (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2410402 - Disclosure - Derivative Instruments - Derivative Designated as Cash Flow Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DerivativeInstrumentsDerivativeDesignatedAsCashFlowHedgesDetails</Role>
      <ShortName>Derivative Instruments - Derivative Designated as Cash Flow Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - Derivative Instruments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DerivativeInstrumentsNarrativeDetails</Role>
      <ShortName>Derivative Instruments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Derivative Instruments - Fair Value by Balance Sheet Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DerivativeInstrumentsFairValueByBalanceSheetLocationDetails</Role>
      <ShortName>Derivative Instruments - Fair Value by Balance Sheet Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2410405 - Disclosure - Derivative Instruments - Cash Flow Hedging on AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DerivativeInstrumentsCashFlowHedgingOnAociDetails</Role>
      <ShortName>Derivative Instruments - Cash Flow Hedging on AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2411402 - Disclosure - Stockholders' equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2411403 - Disclosure - Stockholders' equity - Stock Options Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsValuationAssumptionsDetails</Role>
      <ShortName>Stockholders' equity - Stock Options Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2411404 - Disclosure - Stockholders' equity - Stock Options and Restricted Stock Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/StockholdersEquityStockOptionsAndRestrictedStockUnitsDetails</Role>
      <ShortName>Stockholders' equity - Stock Options and Restricted Stock Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Stockholders' equity - Stock-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/StockholdersEquityStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stockholders' equity - Stock-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2411406 - Disclosure - Stockholders' equity - Changes in Accumulated Other Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/StockholdersEquityChangesInAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>Stockholders' equity - Changes in Accumulated Other Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2412402 - Disclosure - Income taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2412403 - Disclosure - Income taxes - Components of the Provisions for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IncomeTaxesComponentsOfProvisionsForIncomeTaxesDetails</Role>
      <ShortName>Income taxes - Components of the Provisions for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2412404 - Disclosure - Income taxes - Net Deferred Tax Asset (Liability) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IncomeTaxesNetDeferredTaxAssetLiabilityDetails</Role>
      <ShortName>Income taxes - Net Deferred Tax Asset (Liability) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Income taxes - Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IncomeTaxesReconciliationDetails</Role>
      <ShortName>Income taxes - Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Income taxes - Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income taxes - Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>2413402 - Disclosure - Defined benefit and 401(k) savings plan - Swiss Plan Funded Status (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanSwissPlanFundedStatusDetails</Role>
      <ShortName>Defined benefit and 401(k) savings plan - Swiss Plan Funded Status (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>2413403 - Disclosure - Defined benefit and 401(k) savings plan - Components of Net Periodic Pension Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanComponentsOfNetPeriodicPensionCostDetails</Role>
      <ShortName>Defined benefit and 401(k) savings plan - Components of Net Periodic Pension Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>2413404 - Disclosure - Defined benefit and 401(k) savings plan - Weighted Average Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanWeightedAverageAssumptionsDetails</Role>
      <ShortName>Defined benefit and 401(k) savings plan - Weighted Average Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>2413405 - Disclosure - Defined benefit and 401(k) savings plan - Accumulated Other Comprehensive Loss Before Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanAccumulatedOtherComprehensiveLossBeforeIncomeTaxDetails</Role>
      <ShortName>Defined benefit and 401(k) savings plan - Accumulated Other Comprehensive Loss Before Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Defined benefit and 401(k) savings plan - Expected Future Benefits Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanExpectedFutureBenefitsPaymentsDetails</Role>
      <ShortName>Defined benefit and 401(k) savings plan - Expected Future Benefits Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Defined benefit and 401(k) savings plan - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/DefinedBenefitAnd401KSavingsPlanNarrativeDetails</Role>
      <ShortName>Defined benefit and 401(k) savings plan - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>2414402 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>2414403 - Disclosure - Leases - Components of Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/LeasesComponentsOfLeaseExpenseDetails</Role>
      <ShortName>Leases - Components of Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>2414404 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>2415402 - Disclosure - Earnings per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/EarningsPerShareTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>2416401 - Disclosure - Purchase commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/PurchaseCommitmentsDetails</Role>
      <ShortName>Purchase commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/PurchaseCommitments</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>2417402 - Disclosure - Segment information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>2417403 - Disclosure - Segment information - Product Sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/SegmentInformationProductSalesDetails</Role>
      <ShortName>Segment information - Product Sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>2418402 - Disclosure - Quarterly financial data (unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedDetails</Role>
      <ShortName>Quarterly financial data (unaudited) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/QuarterlyFinancialDataUnauditedTables</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>2420401 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccountsDetails</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://emergentbiosolutions.com/role/ScheduleIiValuationAndQualifyingAccounts</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="ebs-2019123110k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - ebs-2019123110k.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - ebs-2019123110k.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="ebs-2019123110k.htm">ebs-2019123110k.htm</File>
    <File>ebs-20191231.xsd</File>
    <File>ebs-20191231_cal.xml</File>
    <File>ebs-20191231_def.xml</File>
    <File>ebs-20191231_lab.xml</File>
    <File>ebs-20191231_pre.xml</File>
    <File>ebs-20191231exhibit1010.htm</File>
    <File>ebs-20191231exhibit1011.htm</File>
    <File>ebs-20191231exhibit21.htm</File>
    <File>ebs-20191231exhibit23.htm</File>
    <File>ebs20191231exhibit1039.htm</File>
    <File>ebs20191231exhibit1040.htm</File>
    <File>ebs20191231exhibit1041.htm</File>
    <File>ebs20191231exhibit1042.htm</File>
    <File>ebs20191231exhibit1048.htm</File>
    <File>esb-20191231x10kxex311.htm</File>
    <File>esb-20191231x10kxex312.htm</File>
    <File>esb-20191231x10kxex321.htm</File>
    <File>esb-20191231x10kxex322.htm</File>
    <File>exhibit44descriptionof.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>chart-1798924266f5ba1ad03.jpg</File>
    <File>chart-415206c664c75dff352.jpg</File>
    <File>chart-72427e25e1fe46f7dc1.jpg</File>
    <File>chart-8b39ed0292bc17f2549.jpg</File>
    <File>chart-9deb655d727f202e4f8.jpg</File>
    <File>chart-b81c50169b2ce7059cc.jpg</File>
    <File>chart-e1643913cacfb05a2b5.jpg</File>
    <File>emergentheaderjuste2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/invest/2013-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6809348224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue recognition - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCurrent', window );">Deferred costs, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.0<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.00%<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Accounts Receivable | USG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.00%<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13537-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ebs_UnitedStatesGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ebs_UnitedStatesGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828931968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue recognition - Accounts Receivable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts receivable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BilledContractReceivables', window );">Billed, net</a></td>
<td class="nump">$ 227.3<span></span>
</td>
<td class="nump">$ 234.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled</a></td>
<td class="nump">43.4<span></span>
</td>
<td class="nump">28.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Total, net</a></td>
<td class="nump">$ 270.7<span></span>
</td>
<td class="nump">$ 262.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BilledContractReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BilledContractReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68054760&amp;loc=d3e55302-109406<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818701232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments - Derivative Designated as Cash Flow Hedges (Details) - Interest Rate Swaps - Designated as Hedging Instrument<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>instrument</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of Instruments | instrument</a></td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Notional amount | $</a></td>
<td class="nump">$ 350,000,000.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 12<br> -Section 13<br> -Sentence Column B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>invest_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6809392464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Components of the Provisions for Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="nump">$ 29.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">11.6<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">International</a></td>
<td class="nump">11.0<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">24.0<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">32.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
<td class="num">(6.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">International</a></td>
<td class="num">(4.1)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment', window );">Total deferred</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">8.6<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 22.9<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 36.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to continuing operations before purchase price adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6826568128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' equity - Stock Options and Restricted Stock Units (Details) - 2006 Stock Incentive Plan - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning of period (in shares)</a></td>
<td class="nump">1,871,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options granted (in shares)</a></td>
<td class="nump">295,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(199,352)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(84,011)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, end of period (in shares)</a></td>
<td class="nump">1,883,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, end of period (in shares)</a></td>
<td class="nump">1,253,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning of period (in dollars per share)</a></td>
<td class="nump">$ 32.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Stock options grant price (in dollars per share)</a></td>
<td class="nump">60.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">25.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">52.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, end of period (in dollars per share)</a></td>
<td class="nump">36.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, end of period (in dollars per share)</a></td>
<td class="nump">$ 29.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">$ 34.5<span></span>
</td>
<td class="nump">$ 50.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable</a></td>
<td class="nump">$ 30.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units granted (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, end of period (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning of period (in shares)</a></td>
<td class="nump">921,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units granted (in shares)</a></td>
<td class="nump">594,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(434,629)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(128,364)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, end of period (in shares)</a></td>
<td class="nump">952,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning of period (in dollars per share)</a></td>
<td class="nump">$ 42.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units grant price (in dollars per share)</a></td>
<td class="nump">57.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">38.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">53.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, end of period (in dollars per share)</a></td>
<td class="nump">$ 52.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Outstanding</a></td>
<td class="nump">$ 51.5<span></span>
</td>
<td class="nump">$ 54.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of equity-based compensation awards outstanding. Excludes stock and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6825927408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-term debt - Components of Long-term Indebtedness (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Nov. 14, 2017</div></th>
<th class="th"><div>Jan. 29, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 822.5<span></span>
</td>
<td class="nump">$ 808.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of debt, net of debt issuance costs</a></td>
<td class="num">(12.9)<span></span>
</td>
<td class="num">(10.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Unamortized debt issuance costs</a></td>
<td class="num">(11.2)<span></span>
</td>
<td class="num">(14.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Debt, net of current portion</a></td>
<td class="nump">798.4<span></span>
</td>
<td class="nump">784.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_ConvertibleSeniorNotesDue2021Member', window );">2.875% Convertible Senior Notes Due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 10.6<span></span>
</td>
<td class="nump">10.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_OtherLongTermDebtFacilityMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=ebs_TermLoanFacilityMember', window );">Term Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">435.9<span></span>
</td>
<td class="nump">447.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 373.0<span></span>
</td>
<td class="nump">$ 348.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ebs_ConvertibleSeniorNotesDue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ebs_ConvertibleSeniorNotesDue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ebs_OtherLongTermDebtFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ebs_OtherLongTermDebtFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=ebs_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=ebs_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6825528688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill - Schedule of Finite-lived Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 814.9<span></span>
</td>
<td class="nump">$ 147.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Additions</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="nump">667.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">112.0<span></span>
</td>
<td class="nump">53.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">712.9<span></span>
</td>
<td class="nump">761.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">778.0<span></span>
</td>
<td class="nump">111.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Additions</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="nump">667.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">82.2<span></span>
</td>
<td class="nump">27.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 705.8<span></span>
</td>
<td class="nump">$ 750.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ProductMember', window );">Products | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Life</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ProductMember', window );">Products | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Life</a></td>
<td class="text">22 years<span></span>
</td>
<td class="text">22 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Corporate trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Life</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 28.6<span></span>
</td>
<td class="nump">$ 28.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">23.0<span></span>
</td>
<td class="nump">19.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="nump">$ 9.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ebs_ContractManufacturingMember', window );">Contract development and manufacturing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Life</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 5.5<span></span>
</td>
<td class="nump">$ 5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ebs_ContractManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ebs_ContractManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6982389984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments - Fair Value by Balance Sheet Location (Details) - Interest Rate Swaps - Designated as Hedging Instrument - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Asset Derivatives</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liability Derivatives</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109247956&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109247956&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828883648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Derivative Instruments</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company is exposed to certain risk arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company has entered into interest rate swaps to manage exposures that arise from the Company's senior secured credit agreement's payments of variable interest rate debt. All outstanding cash flow hedges mature in October 2023. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company had the following outstanding interest rate swap derivatives that were designated as cash flow hedges of interest rate risk: </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:61%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:19%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Number of Instruments</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Notional amount                  (in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest Rate Swaps</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#00497f;"><span>350.0</span></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The table below presents the fair value of the Company&#8217;s derivative financial instruments designated as hedges as well as their classification on the balance sheet. If current fair values of designated interest rate swaps remained static over the next twelve months, the Company would reclassify $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>0.5</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million of net deferred losses from accumulated other comprehensive loss to the statement of operations over the next twelve months. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:11%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td colspan="8" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Asset Derivatives</span></div></td><td colspan="8" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Liability Derivatives</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="4" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td><td colspan="4" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Fair Value</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Fair Value</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Fair Value</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest Rate Swaps</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">Other Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">Other Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> The table below presents the effect of cash flow hedge accounting on accumulated other comprehensive income.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:30%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Hedging derivatives</span></div></td><td colspan="5" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Amount of Gain/(Loss) Recognized in OCI on Derivative</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income </span></div></td><td colspan="6" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest Rate Swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818844976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of significant accounting policies</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Summary of significant accounting policies</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Basis of presentation and consolidation</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The accompanying consolidated financial statements include the accounts of Emergent and its wholly owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Use of estimates</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The preparation of financial statements in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) requires management to make estimates, judgments and assumptions that affect the amounts and disclosures reported in the consolidated financial statements and accompanying notes. Management continually re-evaluates its estimates, judgments and assumptions, and management&#8217;s evaluations could change. These estimates are sometimes complex, sensitive to changes in assumptions and require fair value determinations using Level 3 fair value measurements. Actual results may differ materially from those estimates.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Estimates and judgments inherent in the preparation of the consolidated financial statements include accounting for asset impairments, revenue recognition, allowances for doubtful accounts, inventory, depreciation and amortization, business comb</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">inations, contingent consideration, stock-based compensation, income taxes, and other contingencies.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Cash, cash equivalents and restricted cash</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Cash equivalents are highly liquid investments with a maturity of 90 days or less at the date of purchase and consist of time deposits and investments in money market funds with commercial banks and financial institutions. Also, the Company maintains cash balances with financial institutions in excess of insured limits. The Company does not anticipate any losses with such cash balances. Restricted cash includes cash that is not readily available for use in the Company's operating activities. Restricted cash is primarily comprised of cash pledged under letters of credit.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Fair value measurements</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, an exit price, in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value include:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:left;padding-left:24px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"/></tr><tr><td style="width:11%;"/><td style="width:89%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Level 1 &#8212;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Observable inputs for identical assets or liabilities such as quoted prices in active markets;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Level 2 &#8212;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inputs other than quoted prices in active markets that are either directly or indirectly observable; and</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Level 3 &#8212;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unobservable inputs in which little or no market data exists, which are therefore developed by the Company using estimates and assumptions that reflect those that a market participant would use.</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On a recurring basis, the Company measures and records money market funds (level 1), contingent purchase considerations (level 3) and interest-rate swap arrangements (level 2) using fair value measurements in the accompanying financial statements. On a non-recurring basis, the Company measures its IPR&amp;D assets (level 3) using fair value measurements. The carrying amounts of the Company's short-term financial instruments, which include cash and cash equivalents, accounts receivable and accounts payable, approximate their fair values due to their short maturities. The </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">carrying amounts of the Company&#8217;s long-term debt arrangements approximates their fair values due to variable interest rates which fluctuate with changes in market rates.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Significant customers and accounts receivable</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Billed accounts receivable are stated at invoice amounts and consist mostly of amounts due from the USG, as well as amounts due under reimbursement contracts with other government entities and non-government organizations. Our opioid overdose reversal product is sold commercially through physician-directed or standing order prescriptions at retail pharmacies, as well as state health departments, law enforcement agencies, state and local community based organizations, substance abuse centers and federal agencies. If necessary, the Company records a provision for doubtful receivables to allow for amounts which may be unrecoverable. This provision is based upon an analysis of the Company's prior collection experience, customer creditworthiness and current economic trends. Unbilled accounts receivable relates to various service contracts for which work has been performed, though invoicing has not yet occurred.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Concentration Risk</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Customers</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has long-term contracts with the USG that expire at various times from 2020 through 2029. The Company has derived a significant portion of its revenue from sales of ACAM2000 and Anthrax Vaccines under contracts with the USG. The Company's current USG contracts do not necessarily increase the likelihood that it will secure future comparable contracts with the USG. The Company expects that a significant portion of the business will continue to be under government contracts that present a number of risks that are not typically present in the commercial contracting process. USG contracts for ACAM 2000 and Anthrax Vaccines are subject to unilateral termination or modification by the government. The Company may fail to achieve significant sales of ACAM 2000 and Anthrax Vaccines to customers in addition to the USG, which would harm its growth opportunities. The Company may not be able to manufacture Anthrax Vaccines consistently in accordance with FDA specifications. The Company's other product sales are largely sold commercially through physician-directed or standing order prescriptions at retail pharmacies, as well as to state health departments, local law enforcement agencies, community-based organizations, substance abuse centers and other federal agencies. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Although the Company seeks expand its customer base and to renew its agreements with its customers prior to expiration of a contract, a delay in securing a renewal or a failure to secure a renewal or a renewal on less favorable terms may have a material adverse effect on the Company&#8217;s financial condition and results of operations.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company&#8217;s trade receivables do not represent a significant concentration of credit risk. The USG accounted for approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>61%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>76%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>78%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of total revenues for </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, and approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>69%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>76%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of total accounts receivable as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively. Because accounts receivable consists primarily of am</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ounts due from the USG for product sales and from government agencies under government grants and development contracts, management does not deem the credit risk to be significant.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Financial Institutions</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Cash and cash equivalents are maintained with several financial institutions. The Company has deposits held with banks that exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with financial institutions of reputable credit and, therefore, bear minimal credit risk.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Lender Counterparties</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">There is lender counterparty risk associated with the Company's revolving credit facility and derivatives instruments. There is risk that the Company&#8217;s revolving credit facility investors and derivative counterparties will not be available to fund as obligated. If funding under the revolving credit facility is unavailable, the Company may have to acquire a replacement credit facility from different counterparties at a higher cost or may be unable to find a suitable replacement. The Company seeks to manage risks from its revolving credit facility and derivative instruments by contracting with experienced large financial institutions and monitoring the credit quality of its lenders. As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company did not anticipate nonperformance by any of its counterparties.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Inventories</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Inventories are stated at the lower of cost or net realizable value with cost being determined using a standard cost method, which approximates average cost. Average cost consists primarily of material, labor and manufacturing overhead expenses (including fixed production-overhead costs) and includes the services and products of third-party suppliers. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company analyzes its inventory levels quarterly and writes down, in the applicable period, inventory that has become obsolete, inventory that has a cost basis in excess of its expected net realizable value and inventory in excess of expected customer demand. The Company also writes off, in the applicable period, the costs related to expired inventory.&#160;Costs of purchased inventories are recorded using weighted-average costing. The Company determines normal capacity for each production facility and allocates fixed production-overhead costs on that basis.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company records inventory acquired in business acquisitions utilizing the comparative sales method, which estimates the expected sales price reduced for all costs expected to be incurred to complete/dispose of the inventory with a profit on those costs.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Property, plant and equipment</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Property, plant and equipment are stated at cost less accumulated depreciation and impairments. Depreciation is computed using the straight-line method over the following estimated useful lives:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"/></tr><tr><td style="width:52%;"/><td style="width:48%;"/></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Buildings</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">31-39 years</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Building improvements</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10-39 years</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Furniture and equipment</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3-15 years</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Software</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3-7 years or product life</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Leasehold improvements</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lesser of the asset life or lease term</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is credited or charged to operations. Repairs and maintenance costs are expensed as incurred.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company capitalizes internal-use software when both (a) the software is internally developed, acquired, or modified solely to meet the entity&#8217;s internal needs and (b) during the software&#8217;s development or modification, no substantive plan either exists or is being developed to market the software externally. Capitalization of qualifying internal-use software costs begins when the preliminary project stage is completed, management with the relevant authority, implicitly or explicitly, authorizes and commits to the funding of the software project, and it is probable that the project will be completed and the software will be used to perform the function intended.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determines the fair value of the property, plant and equipment acquired in a business combination utilizing either the cost approach or the sales comparison approach. The cost approach is determined by establishing replacement cost of the ass</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">et and then subtracting any value that has been lost due to economic obsolescence, functional obsolescence, or physical deterioration. The sales comparison approach determines an asset is equal to the market price of an asset of comparable features such as design, location, size, construction, materials, use, capacity, specification, operational characteristics and other features or descriptions.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Income taxes</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Income taxes are accounted for using the liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss and research and development tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Deferred income tax effects of transactions reported in different periods for financial reporting and income tax return purposes are recognized under the asset and liability method of accounting for income taxes. This method gives consideration to the future tax consequences of the deferred income tax items and immediately recognizes changes in income tax laws in the year of enactment. On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (the &#8220;Tax Reform Act&#8221;). Further information on the tax impacts of the Tax Reform Act is included in Note </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">12</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of the Company&#8217;s consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's ability to realize deferred tax assets depends upon future taxable income as well as the limitations discussed below. For financial reporting purposes, a deferred tax asset must be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax assets will not be realized prior to expiration. The Company considers future taxable income and ongoing tax planning strategies in assessing the need for valuation allowances. In general, if the Company determines that it is more likely than not to realize more than the recorded amounts of net deferred tax assets in the future, the Company will reverse all or a portion of the valuation allowance </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">established against its deferred tax assets, resulting in a decrease to the provision for income taxes in the period in which the determination is made. Likewise, if the Company determines that it is not more likely than not to realize all or part of the net deferred tax asset in the future, the Company will establish a valuation allowance against deferred tax assets, with an offsetting increase to the provision for income taxes, in the period in which the determination is made.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Under sections 382 and 383 of the Internal Revenue Code, if an ownership change occurs with respect to a "loss corporation", as defined therein, there are annual limitations on the amount of net operating losses and deductions that are available. The Company has recognized the portion of net operating losses and research and development tax credits acquired that will not be limited and are more likely than not to be realized.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Because tax laws are complex and subject to different interpretations, significant judgment is required. As a result, the Company makes certain estimates and assumptions, in (1)&#160;calculating the Company's income tax expense, deferred tax assets and deferred tax liabilities, (2)&#160;determining any valuation allowance recorded against deferred tax assets and (3)&#160;evaluating the amount of u</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">nrecognized tax benefits, as well as the interest and penalties related to such uncertain tax positions. The Company's estimates and assumptions may differ significantly from tax benefits ultimately realized.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Acquisitions</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In determining whether an acquisition is a business combination versus an asset acquisition, the accounting guidance requires an entity to first evaluate whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If that threshold is met, the set of assets and activities is not a business and therefore treated as an asset acquisition. If that threshold is not met, the entity evaluates whether the set meets the definition of a business. If an acquired asset or asset group does not meet the definition of a business, the transaction is accounted for as an asset acquisition. Otherwise, the acquisition is treated as a business combination.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In a business combination, the acquisition method of accounting requires that the assets acquired and liabilities assumed be recorded as of the date of the merger or acquisition at their respective fair values with limited exceptions and generally use Level 3 fair value measurements. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Accordingly, the Company may be required to value assets at fair values that do not reflect the Company's intended use of those assets. Any excess of the purchase price (consideration transferred) over the estimated fair values of net assets acquired is recorded as goodwill. Transaction costs and costs to restructure the acquired company are expensed as incurred. The operating results of the acquired business are reflected in the Company's consolidated financial statements after the date of the merger or acquisition. If the Company determines the assets acquired do not meet the definition of a business under the acquisition method of accounting, the transaction will be accounted for as an asset acquisition and recorded at cost rather than a business combination and, therefore, no goodwill will be recorded.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair values of intangible assets, including acquired in-process research and development ("IPR&amp;D"), are determined utilizing information available at or near the merger or acquisition date based on expectations and assumptions that are deemed reasonable by management. Given the considerable judgment involved in determining fair values, the Company typically obtains assistance from third-party valuation specialists for significant items. Amounts allocated to acquired IPR&amp;D are capitalized and accounted for as indefinite-lived intangible assets. Upon successful completion of each project, the Company will make a separate determination as to the remaining useful life of the asset and begin amortization. The judgments made in determining estimated fair values assigned to assets acquired and liabilities assumed in a business combination, as well as asset lives, can materially affect the Company&#8217;s results of operations.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair values of identifiable intangible assets related to current products and product rights are primarily determined by using an income approach through which fair value is estimated based on each asset&#8217;s discounted projected net cash flows. The Company's estimates of market participant net cash flows consider historical and projected pricing, margins and expense levels, the performance of competing products where applicable, relevant industry and therapeutic area growth drivers and factors, current and expected trends in technology and product life cycles, the time and investment that will be required to develop products and technologies, the ability to obtain marketing and regulatory approvals, the ability to manufacture and commercialize the products, the extent and timing of potential new product introductions by the Company&#8217;s competitors, and the life of each asset&#8217;s underlying patent, if any. The net cash flows are then probability-adjusted where appropriate to consider the uncertainties associated with the underlying assumptions, as well as the </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">risk profile of the net cash flows utilized in the valuation. The probability-adjusted future net cash flows of each product are then discounted to present value utilizing an appropriate discount rate.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair values of identifiable intangible assets related to IPR&amp;D are determined using an income approach, through which fair value is estimated based on each asset&#8217;s probability-adjusted future net cash flows, which reflect the different stages of development of each product and the associated probability of successful completion. The net cash flows are then discounted to present value using an appropriate discount rate. Indefinite-lived intangible assets are tested for impairment annually or whenever events or changes in circumstances indicate that its carrying amount may not be recoverable.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Assets acquired and liabilities assumed in a business combination that arise from contingencies are recognized at fair value if fair value can reasonably be estimated. If the acquisition date fair value of an asset acquired or liability assumed that arises from a contingency cannot be determined, the asset or liability is recognized if probable and reasonably estimable</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">; if these criteria are not met, no asset or liability is recognized.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Asset Impairment Analysis</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Goodwill and Indefinite-lived Intangible Assets</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Goodwill is allocated to the Company's reporting units, which are one level below its operating segment. The Company evaluates goodwill and other indefinite-lived intangible assets for impairment annually as of October&#160;1 and earlier if an event or other circumstance indicates that we may not recover the carrying value of the asset. If the Company believes that as a result of its qualitative assessment it is more likely than not that the fair value of a reporting unit or other indefinite-lived intangible asset is greater than its carrying amount, the quantitative impairment test is not required. If however it is determined that it is not more likely than not that the fair value of a reporting unit or other indefinite-lived intangible asset is greater than its carrying amount, a quantitative test is required.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The quantitative goodwill impairment test is performed using a two-step process. The first step of the process is to compare the fair value of a reporting unit with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is not impaired and the second step of the quantitative impairment test is not necessary. If the carrying amount of a reporting unit exceeds its fair value, the second step of the quantitative goodwill impairment test is required to be performed to measure the amount of impairment loss, if any. The second step of the quantitative goodwill impairment test compares the implied fair value of the reporting unit&#8217;s goodwill with the carrying amount of that goodwill. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination. In other words, the estimated fair value of the reporting unit&#8217;s identifiable net assets excluding goodwill is compared to the fair value of the reporting unit as if the reporting unit had been acquired in a business combination and the fair value of the reporting unit was the purchase price paid. If the carrying amount of the reporting unit&#8217;s goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to that excess. The Company used a qualitative assessment for our goodwill impairment testing for </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The qualitative evaluation completed during the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> indicated </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>no</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> impairment losses. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has mater</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ial indefinite lived intangible assets associated with in-process research and development (IPR&amp;D) which were acquired as part of the acquisitions completed in the fourth quarter of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Following a qualitative assessment indicating that it is not more likely than not that the fair value of the indefinite lived intangible asset exceeds its carrying amount, impairment of other intangible assets not subject to amortization involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. Determining fair value requires the exercise of judgment about appropriate discount rates, perpetual growth rates and the amount and timing of expected future cash flows.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> The Company used a quantitative assessment for our IPR&amp;D impairment testing for </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and determined there was an impairment loss of $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>12.0</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million, which was recorded as a component of R&amp;D expense (see Notes </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">4</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Acquisitions</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">5</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Fair value measurements</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">). </span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Long-lived Assets</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Long-lived assets such as intangible assets and property, plant and equipment are not required to be tested for impairment annually. Instead, long-lived assets are tested for impairment whenever circumstances indicate that the carrying amount of the asset may not be recoverable, such as when the disposal of such assets is likely or there is an adverse change in the market involving the business employing the related assets. If an impairment analysis is required, the impairment test employed is based on whether the Company&#8217;s intent is to hold the asset for continued use or to hold the asset for sale. If the intent is to hold the asset for continued use, the impairment test first requires a comparison </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">of undiscounted future cash flows to the carrying value of the asset. If the carrying value of the asset exceeds the undiscounted cash flows, the asset would not be deemed to be recoverable. Impairment would then be measured as the excess of the asset&#8217;s carrying value over its fair value. Fair value is typically determined by discounting the future cash flows associated with that asset. If the intent is to hold the asset for sale and certain other criteria are met, the impairment test involves comparing the asset&#8217;s carrying value to its fair value less costs to sell. To the extent the carrying value is greater than the asset&#8217;s fair value less costs to sell, an impairment loss is recognized in an amount equal to the difference. Significant judgments used for long-lived asset impairment assessments include identifying the appropriate asset groupings and primary assets within those groupings, determining whether events or circumstances indicate that the carrying amount of the asset may not be recoverable, determining the future cash flows for the assets involved and assumptions applied in determining fair value, which include, reasonable discount rates, growth rates, market risk premiums and other assumptions about the economic environment.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Contingent Consideration</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In connection with the Company's acquisitions accounted for as business combinations, the Company records contingent consideration associated with sales-based royalties, sales-based milestones and development and regulatory milestones at fair value. The fair value model used to calculate these obligations is based on the income approach (a discounted cash flow model) that has been risk adjusted based on the probability of achievement of net sales and achievement of the milestones. The inputs the Company uses for determining the fair value of the contingent consideration associated with sales-based royalties, sales-based milestones and development and regulatory milestones are Level 3 fair value measurements. The Company re-evaluates the fair value on a quarterly basis. Changes in the fair value can result from adjustments to the discount rates and updates in the assumed timing of or achievement of net sales and/or the achievement of development and regulatory milestones. Any future increase in the fair value of the contingent consideration associated with sales-based royalties and sales-based milestones along with development and regulatory milestones are based on an increased likelihood that the underlying net sales or milestones will be achieved.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The associated payments which will become due and payable for sales-based royalties and milestones result in a charge to cost of product sales and contract development and manufacturing in the period in which the increase is determined. Similarly, any future decrease in the fair value of contingent consideration associated with sales-based royalties and sales-based milestones will result in a reduction in cost of product sales and contract development and manufacturing. The changes in fair value for potential future sales-based royalties associated with product candidates in development will result in a charge to cost o</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">f product sales and contract development and manufacturing services </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">expense in the period in which the increase is determined. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The associated payment or payments which will become due and payable for development and regulatory milestones will result in a charge to research and development expense in the period in which the increase is determined. Similarly, any future decrease i</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">n the fair value for development and regulatory milestones will result in a reduction in research and development expense.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Revenue recognition</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On January 1, 2018 the Company adopted ASC topic 606 using the modified retrospective approach applied to those contracts in effect as of January 1, 2018. Under this transition method, results for reporting periods beginning after January 1, 2018 are presented under the new standard, while prior period amounts are not adjusted and continue to be reported in accordance with historical accounting under Topic 605. See further discussion of the adoption of Topic 606, including the impact to our 2018 financial statements within the recently issued accounting standards section below.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company recognizes revenue when the Company's customers obtain control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services by analyzing the following five steps: (1) identify the contract with a customer(s); (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">contract; and (5) recognize revenue when (or as) the entity satisfies a performance obligation. To indicate the transfer of control for the Company&#8217;s product sales and contract development and manufacturing services, it must have a present right to payment, legal title must have passed to the customer, and the customer must have the significant risks and rewards of ownership. Revenue for long-term development contracts is generally recognized based upon the cost-to-cost measure of progress, provided that the Company meets the criteria associated with transferring control of the good or service over time.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Multiple performance obligations</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. Contracts sometimes include options for customers to purchase additional products or services in the future. Customer options that provide a material right to the customer, such as free or discounted products or services, give rise to a separate performance obligation. For contracts with multiple performance obligations, the Company allocates the contract price to each performance obligation on a relative standalone selling price basis using the Company&#8217;s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers, however when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the contracts&#8217; inception.  </span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Transaction price and variable consideration</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Once the performance obligations in the contract have been identified, the Company estimates the transaction price of the contract. The estimate includes amounts that are fixed as well as those that can vary based on expected outcomes of the activities or contractual terms. The Company's variable consideration includes for example consideration transferred under its development contracts with the USG as consideration received can vary based on developmental progression of the product candidate(s). When a contract's transaction price includes variable consideration, the Company evaluates the variable consideration to determine whether the estimate needs to be constrained; therefore, the Company includes the variable consideration in the transaction price only to the extent that it is probable that a significant reversal of the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Variable consideration estimates are updated at each reporting date. There were </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">no</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> significant constraints or material changes to the Company's variable consideration estimates as of or during the twelve months ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Contract financing</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money if the timing of payments agreed to by the parties to the contract (either explicitly or implicitly) provides the customer with a significant benefit of financing the transfer of goods or services to the customer, which is called a significant financing component. The Company does not adjust transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Product sales</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">CBRNE</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The primary customer for the Company's CBRNE&#160;products and the primary source of funding for the development of its CBNRE product candidate portfolio is the USG. The Company's contracts for the sale of CBRNE products generally have a single performance obligation. Certain product sales contracts with the USG include multiple performance obligations, which generally include the marketed product, stability testing associated with that product, expiry extensions and plasma collection. The USG contracts for the sale of the Company's CBRNE&#160;products are normally multi-year contracts. AV7909 and Trobigard are product candidates that are not approved by the FDA or any other health agency, but are procured by certain government agencies under special circumstances. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The transaction price for product sales are based on a cost build-up model with a mark-up. For our product sales, we recognize revenue at a "point in time" when the Company&#8217;s performance obligations have been satisfied and control of the products transfer to the customer. This &#8220;point in time&#8221; depends on several factors, including delivery, transfer of legal title, transition of risk and rewards of the product to the customer and the Company's right to payment. The USG contracts for the sale of the Company's CBRNE products also include certain acceptance criteria before title passes to the USG.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Opioid and travel health products </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Revenues are recognized when control of the goods are transferred to our customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Prior to recognizing revenue, the Company makes estimates of the transaction price, including variable consideration that is subject to a constraint. Allowances for returns, specialty distributor fees, wholesaler fees, prompt payment discounts, government </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">rebates, chargebacks and rebates under managed care plans are considered in determining the variable consideration. Revenues from sales of products is recognized to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with such variable consideration is subsequently resolved. Product sales revenue is recognized when control has transferred to the customer, which occurs at a point in time, which is typically upon delivery to the customer. Provisions for variable consideration revenues from sales of products are recorded at the net sales price, which includes estimates of variable consideration for which provisions are established and which relate to returns, specialty distributor fees, wholesaler fees, prompt payment discounts, government rebates, chargebacks and rebates under managed care plans. Calculating certain of these provisions involves estimates and judgments and the Company determines their expected value based on sales or invoice data, contractual terms, historical utilization rates, new information regarding changes in these programs&#8217; regulations and guidelines that would impact the amount of the actual rebates, the Company's expectations regarding future utilization rates for these programs and channel inventory data. These provisions reflect the Company's best estimate of the amount of consideration to which the Company is entitled based on the terms of the contract. The amount of variable consideration that is included in the transaction price may be constrained and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. The Company reassesses the Company's provisions for variable consideration at each reporting date. Historically, adjustments to estimates for these provisions have not been material.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Provisions for returns, specialty distributor fees, wholesaler fees, government rebates and rebates under managed care plans are included within current liabilities in the Company's consolidated balance sheets. Provisions for chargebacks and prompt payment discounts are shown as a reduction in accounts receivable.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:normal;">Contract development and manufacturing services</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company performs contract development and manufacturing services for third parties. Under these contracts, activities can include pharmaceutical product process development, manufacturing and filling services for injectable and other sterile products, inclusive of process design, technical transfer, manufacturing validations, laboratory analytical development support, aseptic filling, lyophilization, final packaging and accelerated and ongoing stability studies. These contracts, with a duration that is less than one year, generally include a single performance obligation as the customer benefits from our performance upon full completion of our services. The performance obligation is satisfied when the Company must have a present right to payment because legal title has passed to the customer, the goods are in the customer&#8217;s possession with all the risks and rewards of ownership, and the efficacy of the goods has been confirmed. The Company recognizes revenue at a "point in time" based on when the performance obligation to the customer is satisfied.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:normal;">Contracts and grants</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company generates contract and grant revenue primarily from cost-plus-fee contracts associated with development of certain product candidates. Revenues from reimbursable contracts are recognized as costs are incurred, generally based on allowable costs incurred during the period, plus any recognizable earned fee. The Company uses this input method to measure progress as the customer has the benefit of access to the development research under these projects and therefore benefits from the Company's performance incrementally as research and development activities occur under each project. We consider fixed fees under cost-plus-fee contracts to be earned in proportion to the allowable costs incurred in performance of the contract. We analyze costs for contracts and reimbursable grants to ensure reporting of revenues gross versus net is appropriate. Revenue for long-term development contracts is considered variable consideration, because the deliverable is dependent on the successful completion of development and is generally recognized based upon the cost-to-cost measure of progress, provided that the Company meets the criteria associated with satisfying the performance obligation over time. The USG contracts for the development of the Company's CBRNE product candidates are normally multi-year contracts. </span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Research and development</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We expense research and development costs as incurred. The Company's research and development expenses consist primarily of:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">personnel-related expenses;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">fees to professional service providers for, among other things, analytical testing, independent monitoring or other administration of the Company's clinical trials and obtaining and evaluating data from the Company's clinical trials and non-clinical studies;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">costs of contract development and manufacturing services for clinical trial material; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">costs of materials used in clinical trials and research and development.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Comprehensive income</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Comprehensive income is comprised of net income and other changes in equity that are excluded from net income. The Company includes translation gains and losses incurred when converting its subsidiaries' financial statements from their functional currency to the U.S. dollar in accumulated other comprehensive income as well as gains and losses on its pension benefit obligation and derivative instruments.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Translation of Foreign Currencies</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For our non-U.S. subsidiaries that transact in a functional currency other than the U.S. dollar, assets and liabilities are translated at current rates of exchange at the balance sheet date. Income and expense items are translated at the average foreign currency exchange rates for the period. Adjustments resulting from the translation of the financial statements of our foreign operations into U.S.&#160;dollars are excluded from the determination of net income and are recorded in accumulated other comprehensive income, a separate component of equity. For subsidiaries where the functional currency of the assets and liabilities differ from the local currency, non-monetary assets and liabilities are translated at the rate of exchange in effect on the date assets were acquired while monetary assets and liabilities are translated at current rates of exchange as of the balance sheet date. Income and expense items are translated at the average foreign currency rates for the period. Translation adjustments of these subsidiaries are included in other income (expense), net in our consolidated statements of income.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Earnings per share</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company calculates basic earnings per share by dividing net income by the weighted average number of shares of common stock outstanding during the period.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company calculated diluted earnings per share using the treasury method by dividing net income by the weighted average number of shares of common stock outstanding during the period. For the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company calculated diluted earnings per share using the if-converted method by dividing the adjusted net income by the adjusted weighted average number of shares of common stock outstanding during the period. The adjusted net income was adjusted for interest expense and amortization of debt issuance cost, both net of tax, associated with the Company's </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>2.875%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Convertible Senior Notes due 2021 (the "Notes"). The weighted average number of diluted shares was adjusted for the potential dilutive effect of the exercise of stock options and the vesting of restricted stock units along with the assumption of the conversion of the Notes, each at the beginning of the period. During the fourth quarter of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company issued a notice of termination of conversion rights related to the Notes and issued </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>8.5 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares of common stock due to conversions that occurred in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. After the date of conversion and during the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Notes are strictly debt instruments and, therefore, no longer impact the diluted earnings per share calculation. </span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Accounting for stock-based compensation</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>one</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> stock-based employee compensation plan, the Emergent BioSolutions Inc. Stock Incentive Plan (the "Emergent Plan"), under which the Company may grant various types of equity awards including stock options,  restricted stock units and performance stock units.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The terms and conditions of equity awards (such as price, vesting schedule, term and number of shares) under the Emergent Plan is determined by the compensation committee of the Company's board of directors, which administers the Emergent Plan. Each equity award granted under the Emergent Plan vests as specified in the relevant agreement with the award recipient and no option can be exercised after either </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">seven</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> or </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>ten years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> from the date of grant depending on the grant date. The Company charges the estimated fair value of awards against income on a straight-line basis over the requisite service period, which is generally the vesting period. Where awards are made with non-substantive vesting periods (for instance, where a portion of the award vests upon retirement eligibility), the Company estimate and recognize expense based on the period from the grant date to the date the employee becomes retirement eligible.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determines the fair value of restricted stock units using the closing market price of the Company's common stock on the day prior to the date of grant. The Company's performance stock units settle in stock. The fair value is determined on the date of the grant using the number of shares expected to be earned and the ending market value of the stock on the grant date. The number of shares expected to vest is determined by assessing the probability that the performance criteria will be met and the associated targeted payout level that is forecasted will be achieved. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company utilizes the Black-Scholes valuation model for estimating the fair value of all stock options granted. Set forth below is a discussion of the Company's methodology for developing each of the assumptions used:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Expected dividend yield &#8212; the Company does not pay regular dividends on its common stock and does not anticipate paying any dividends in the foreseeable future.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Expected volatility &#8212; a measure of the amount by which a financial variable, such as share price, has fluctuated (historical volatility) or is expected to fluctuate (implied volatility) during a period. The Company analyzed its own historical volatility to estimate expected volatility over the same period as the expected average life of the options.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Risk-free interest rate &#8212; the range of U.S. Treasury rates with a term that most closely resembles the expected life of the option as of the date on which the option is granted.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Expected average life of options &#8212; the period of time that options granted are expected to remain outstanding, based primarily on the Company's expectation of optionee exercise behavior subsequent to vesting of options.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Pension plans</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company maintains defined benefit plans for employees in certain countries outside the U.S., including retirement benefit plans required by applicable local law. The plans are valued by independent actuaries using the projected unit credit method. The liabilities correspond to the projected benefit obligations of which the discounted net present value is calculated based on years of employment, expected salary increase, and pension adjustments. The Company reviews its actuarial assumptions on an annual basis and makes modifications to the assumptions based on current rates and trends. Actuarial gains and losses are deferred in accumulated other comprehensive income, net of tax and are amortized over the remaining service attribution periods of the employees under the corridor method. Differences between the expected long-term return on plan assets and the actual annual return are amortized to net periodic benefit cost over the estimated remaining life as a component of selling, general and administrative expenses in the consolidated statements of operations.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Derivative Instruments and Hedging Activities</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's interest rate swaps qualify for hedge accounting as cash flow hedges. All derivatives are recorded on the balance sheet at fair value.&#160;Hedge accounting provides for the matching of the timing of gain or loss recognition on these interest rate swaps with the recognition of the changes in interest expense on the Company's variable rate debt. For derivatives designated as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt. The cash flows from the designated interest rate swaps are classified as a component of operating cash flows, similar to interest expense.&#160;</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Recently issued accounting standards</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Recently Adopted</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2016-2,&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Leases (Topic 842)</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;("ASU 2016-2")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In February 2016, the FASB issued ASU 2016-2. ASU 2016-2 increased transparency and comparability among organizations by requiring the recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements for both lessees and lessors. The Company adopted the new standard effective January 1, 2019 using the modified retrospective approach. An entity that applies the transition provisions at the beginning of the period of adoption records its cumulative adjustment to the opening balance of retained earnings in the period of adoption rather than in the earliest period presented (i.e., January 1, 2019). In this case, an entity continues to apply the legacy guidance in ASC 840, including its disclosure requirements, in the comparative periods presented in the year it adopts the standard.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company utilized the transition package of certain practical expedients permitted: ASC 842-10-65-1(f) and ASC 842-10-65-1(g). The Company made an accounting policy election that kept leases with an initial term of 12 months or less off of the balance sheet which resulted in recognizing those lease payments in the consolidated statements of operations on a straight-line basis over the lease term. In addition, the Company has made an accounting policy election, by class of underlying asset, to not separate non-lease components from lease components and instead to account </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">for each separate lease component, and the non-lease components associated with that lease component, as a single lease component.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">January&#160;1, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> the total right of use assets increased </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$13.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, while total operating lease liabilities increased </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$14.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. There was no adjustment to the opening balance of retained earnings as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">January&#160;1, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The standard has not materially affect the Company's consolidated net earnings. The Company continues to apply the legacy guidance from the old lease accounting standard, including its disclosure requirements, in the comparative periods presented (see Note </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">14</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">).</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU No. 2014-9, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Revenue from Contracts with Customers (Topic 606)</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> ("ASU 2014-9")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In May 2014, the Financial Accounting Standards Board ("FASB") issued ASU No. 2014-9. ASU No. 2014-9 (known as ASC 606) supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, as well as most industry-specific guidance, and significantly enhances comparability of revenue recognition practices across entities and industries by providing a principles-based, comprehensive framework for addressing revenue recognition issues. The Company adopted ASC 606 as of January 1, 2018 using the modified retrospective method resulting in an adjustment to opening retained earnings of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$32.5 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the cumulative effect of initially applying the new standard.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Under ASC 606, the Company finalized the review of its portfolio of revenue contracts that were not complete as of the adoption date and made its determination of its revenue streams as well as completed extensive contract specific reviews to determine the impact of the new standard on its historical and prospective revenue recognition. Because many of the Company's significant contracts with customers have unique contract terms, the Company reviewed all its non-standard agreements in order to determine the effect of adoption. The Company tested a sample of remaining agreements to verify that there were no changes in accounting based on the assumption that these contracts had similar characteristics and that the effects on the financial statements would not differ materially from applying this guidance to the individual contracts. To estimate the financial impacts of the adoption, the Company did not apply the contract modification practical expedient and retrospectively restated long-term contracts for any contract modifications.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The opening balance sheet adjustment as of January 1, 2018, was the result of the Centers for Innovation in Advanced Development and Manufacturing ("CIADM") contract with the Biomedical Advanced Research and Development Authority ("BARDA"). Under ASC 606 at January 1, 2018, the Company determined that the performance obligation under the arrangement is to provide ongoing manufacturing capability to the USG and would recognize the consideration received in the initial </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>7 years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> year base period on a straight-line basis over a </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>24</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">-year period as the capability being created during the base period of the contract is being provided to the customer over both the base period contract term as well as </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>17</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> additional option periods. As the Company&#8217;s performance obligation is providing the USG with continuous access to its production capabilities throughout the contract duration, a time-based measure resulting in straight-line revenue recognition is proportionate to the Company&#8217;s progress in satisfying the performance obligation when compared to the total progress. This measure of progress is most reflective of the Company satisfying the performance obligation over time. Beginning in June 2013, the Company was expected to be able to stand ready and be available to respond to the USG and importantly to respond to any task orders that may be issued during the base period and additional option periods. Being able to stand ready to perform in the event of an outbreak is of importance to the USG and by entering into this arrangement with the Company, the USG expected to receive the benefit of having access to Company&#8217;s readiness and its capability to immediately respond to public health threats. The Company concluded the identified stand-ready performance obligations represent a series of distinct services that are substantially the same and have the same pattern of transfer to the customer.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition, the Company determined the CIADM contract includes a significant financing component which is included in the transaction price. The Company calculated the financing component using an interest rate the Company had on its other debt obligations at inception of the contract. The difference in revenue recognized under ASC 605 vs. ASC 606, as of the adoption date, was primarily attributable to the difference in the overall consideration or transaction price resulting from different accounting treatment related to options within the contract and the inclusion of a significant financing component under ASC 606.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Prior to the adoption of ASC 606, the Company recognized revenue under the CIADM contract on a straight-line basis, based upon its estimate of the total payments to be received under the contract. The Company analyzes the estimated payments to be received on a quarterly basis to determine if an adjustment to revenue was required. As a result of the adoption of ASC 606, as of January 1, 2018, there was an increase in the deferred revenue liability of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$42.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and an increase in deferred tax assets of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$9.9 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> with an offsetting reduction to retained earnings of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$32.5 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2018-2,&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Income Statement - Reporting Comprehensive Income (Topic 220):&#160;Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> ("ASU 2018-2")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In February 2018, the FASB issued ASU 2018-2. ASU 2018-2 provides the option to reclassify certain income tax effects related to the Tax Cuts and Jobs Act passed in December of 2017 between accumulated other comprehensive income and retained earnings and also requires additional disclosures.&#160;ASU 2018-2 is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted.&#160;Adoption of ASU 2018-2 is to be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the tax laws or rates were recognized.&#160;The adoption of ASU 2018-2 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Not Yet Adopted</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2016-13,&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">("ASU 2016-13")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In June 2016, the FASB issued ASU 2016-13. ASU 2016-13 provides guidance on measurement of credit losses on financial instruments that changes the impairment model for most financial assets and certain other instruments, including trade and other receivables, held-to-maturity debt securities and loans, and that requires entities to use a new, forward-looking &#8220;expected loss&#8221; model that is expected to generally result in the earlier recognition of allowances for losses. The guidance&#160;became effective for annual periods beginning after December 15, 2019, including interim periods within those years, but early adoption is permitted. The Company has evaluated the effects of this standard and determined that the adoption will not have a material impact on the Company's consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2017-4,&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> ("ASU 2017-4")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In January 2017, the FASB issued ASU 2017-4. ASU 2017-4 simplifies the subsequent measurement of goodwill and eliminates Step 2 from the goodwill impairment test. ASU 2017-4 is effective for annual and interim goodwill tests beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates on or after January 1, 2017. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2018-13,</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">&#160;Fair Value Measurement - Disclosure Framework (Topic 820)&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">("ASU 2018-13")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In August 2018, the FASB issued ASU 2018-13. ASU 2018-13 improves the disclosure requirements on fair value measurements. The updated guidance if effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted for any removed or modified disclosures. The Company is currently assessing the timing and impact of adopting the updated provisions.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2018-14,</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">&#160;Compensation -</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Retirement Benefits - Defined Benefit Plans - General (Topic 715-20):&#160;Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;("ASU 2018-14")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In August 2018, the FASB issued ASU 2018-14. ASU 2018-14 modifies the disclosure requirements for defined benefit pension plans and other post-retirement plans. ASU 2018-14 is effective for all entities for fiscal years ending after December 15, 2020, and earlier adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2018-14 on its consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2018-15,&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> ("ASU 2018-15")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In August 2018, the FASB issued ASU 2018-15. ASU 2018-15 clarifies the accounting for implementation costs in cloud computing arrangements. ASU 2018-15 is effective for all entities for fiscal years beginning after December 15, 2019, and earlier adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2018-15 on its consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2019-12, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Simplifications to Accounting for Income Taxes </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">("ASU 2019-12")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In December 2019, the FASB issued ASU 2019-12. ASU 2019-12 removes certain exceptions for recognizing deferred taxes for investments, performing intra-period allocation and calculating income taxes in interim periods. The ASU also adds guidance to reduce complexity in certain areas, including deferred taxes for goodwill and allocating taxes for members of a consolidated group. ASU 2019-12 is effective for all entities for fiscal years beginning after December </span></div>15, 2020, and earlier adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2019-12 on its consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818160224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Inventories</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Inventories consist of the following:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #ffffff;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Raw materials and supplies</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>70.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>51.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Work-in-process</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>89.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>103.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Finished goods</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>62.3</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>50.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total inventories</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>222.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>205.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818795776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The components of debt are as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:top;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Senior secured credit agreement - Term loan due 2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>435.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>447.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Senior secured credit agreement - Revolver loan due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>373.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>348.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.875% Convertible Senior Notes due 2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>10.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>10.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>822.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>808.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current portion of debt, net of debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(12.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(10.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unamortized debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(11.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(14.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Debt, net of current portion</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>798.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>784.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Summary of Future Debt Payments of Long-Term Indebtedness</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Future debt payments of long-term indebtedness are as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:81%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>14.1</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>35.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>33.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>735.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2024 and thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total debt</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>822.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6829039872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summary of Reconciliation of Contingent Consideration Liabilities Measured at Fair Value</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table is a reconciliation of the beginning and ending balance of the contingent consideration liabilities measured at fair value using significant unobservable inputs (Level 3) during the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2017</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>12.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expense included in earnings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(3.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Additions due to acquisition</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>48.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>60.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expense included in earnings</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>24.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Milestone achievement - asset acquisition</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>10.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Measurement period adjustment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(67.1</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>29.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6811025280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Recently Issued Accounting Standards (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>Period</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, liability</a></td>
<td class="nump">$ 25.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Adoption of new accounting standard (ASC 606), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (32.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability</a></td>
<td class="nump">$ 88.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ebs_CIADMMember', window );">CIADM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_BasePeriod', window );">Base period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_TermofContract', window );">Term of contract</a></td>
<td class="text">24 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_NumberofAdditionalOptionPeriods', window );">Number of additional option periods | Period</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member', window );">Accounting Standards Update 2014-09</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member', window );">Difference between Revenue Guidance in Effect before and after Topic 606 | Accounting Standards Update 2014-09</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member', window );">Difference between Revenue Guidance in Effect before and after Topic 606 | Accounting Standards Update 2014-09 | CIADM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Adoption of new accounting standard (ASC 606), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings | Accounting Standards Update 2014-09</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Adoption of new accounting standard (ASC 606), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings | Accounting Standards Update 2014-09 | CIADM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Adoption of new accounting standard (ASC 606), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_BasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the base period of contract term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_BasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_NumberofAdditionalOptionPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the number of additional option periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_NumberofAdditionalOptionPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_TermofContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the term of contract with BARDA.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_TermofContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130531-203044<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130532-203044<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ebs_CIADMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ebs_CIADMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6730959296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue recognition - Contract Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_ChangeinContractWithCustomerLiabilityRollForward', window );"><strong>Change in Contract With Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning balance</a></td>
<td class="nump">$ 73.1<span></span>
</td>
<td class="nump">$ 30.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_ContractWithCustomerLiabilityAdditions', window );">Deferral of revenue</a></td>
<td class="nump">46.7<span></span>
</td>
<td class="nump">29.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="num">(30.9)<span></span>
</td>
<td class="num">(29.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Ending balance</a></td>
<td class="nump">$ 88.9<span></span>
</td>
<td class="nump">$ 73.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ChangeinContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in Contract With Customer, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ChangeinContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ContractWithCustomerLiabilityAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable recorded during the current reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ContractWithCustomerLiabilityAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130531-203044<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130532-203044<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6826946256">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1</td>
<td class="nump">$ 879,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1</td>
<td class="num">$ (3,700,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_CommonStockSharesIssued</td>
<td class="nump">50,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1</td>
<td class="nump">$ 618,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_CommonStockSharesIssued</td>
<td class="nump">1,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1</td>
<td class="num">$ (39,500,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1</td>
<td class="nump">$ 304,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity including the portion attributable to noncontrolling interests, after the cumulative effect adjustment of a new accounting principle applied in the period of adoption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6826874144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' equity - Stock-based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 26.7<span></span>
</td>
<td class="nump">$ 23.2<span></span>
</td>
<td class="nump">$ 15.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 19.6<span></span>
</td>
<td class="nump">$ 18.4<span></span>
</td>
<td class="nump">$ 11.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6836382352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt - Senior Secured Credit Agreement (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 15, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 29, 2017 </div>
<div>USD ($) </div>
<div>lending_institution</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet', window );">Debt issuance capitalized costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_NumberOfLendingInstitutions', window );">Number of lending institutions | lending_institution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Current borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_DebtInstrumentRestrictedPaymentsLimitAmount', window );">Debt instrument, restricted payments limit, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Federal Funds Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_DebtInstrumentTermOfVariableRate', window );">Debt instrument, term of variable rate</a></td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Eurodollar | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Eurodollar | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Base Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Base Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amended Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Current borrowing capacity</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_ConsolidatedSecuredNetLeverageRatio', window );">Net leverage ratio</a></td>
<td class="nump">2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_AmountRequiredForNetLeverageRatio', window );">Amount required for net leverage ratio</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_DebtInstrumentCovenantLeverageRatio', window );">Covenant, leverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Outstanding credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 318,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amended Credit Agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_DebtInstrumentCovenantDebtServiceCoverageRatio', window );">Debt service coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amended Credit Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_DebtCovenantNetLeverageRatioOne', window );">Net leverage ratio one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_DebtCovenantNetLeverageRatioTwo', window );">Debt covenant, leverage ratio from September 30, 2019 to September 29, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_DebtCovenantNetLeverageRatioThree', window );">Net leverage ratio three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_DebtCovenantNetLeverageRatioFour', window );">Net leverage ratio four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=ebs_TermLoanFacilityMember', window );">Term Loan Facility | Amended Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Current borrowing capacity</a></td>
<td class="nump">$ 450,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Outstanding credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears', window );">Percentage of original principal amount required to repay in the first two years</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear', window );">Percentage of original principal amount required to repay during the third year</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears', window );">Percentage of original principal amount required to repay remaining year</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight', window );">Cash proceeds excess amount from dispositions of property or casualty events subject to certain reinvestment right</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_AmountRequiredForNetLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of leverage ratio required to be maintained under a debt covenant agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_AmountRequiredForNetLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash proceeds in excess during the term of the Senior Secured Credit Facility from certain dispositions of property or from casualty events involving their property, subject to certain reinvestment rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ConsolidatedSecuredNetLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum consolidated net leverage ratio required to be maintained under a debt covenant agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ConsolidatedSecuredNetLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtCovenantNetLeverageRatioFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtCovenantNetLeverageRatioFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtCovenantNetLeverageRatioOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtCovenantNetLeverageRatioOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtCovenantNetLeverageRatioThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtCovenantNetLeverageRatioThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtCovenantNetLeverageRatioTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtCovenantNetLeverageRatioTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtInstrumentCovenantDebtServiceCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Debt Service Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtInstrumentCovenantDebtServiceCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtInstrumentCovenantLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum leverage ratio required to be maintained under a debt covenant agreement. A leverage ratio is calculated by dividing the funded debt by earnings before interest, taxes, depreciation and amortization for the most recent four quarters.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtInstrumentCovenantLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtInstrumentRestrictedPaymentsLimitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Restricted Payments Limit, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtInstrumentRestrictedPaymentsLimitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtInstrumentTermOfVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of the interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtInstrumentTermOfVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_NumberOfLendingInstitutions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of lending institutions in which the entity has a credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_NumberOfLendingInstitutions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The rate of interest that was being paid on the original debt issue that is to repay in the third year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The rate of interest that was being paid on the original debt issue that is to repay in the first two years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The rate of interest that was being paid on the original debt issue that is to repay in remaining years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section S45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68176171&amp;loc=SL68176184-208336<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ebs_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ebs_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ebs_AmendedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=ebs_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=ebs_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6835392912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 58,700,000<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="nump">$ 8,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets, weighted average useful life</a></td>
<td class="text">13 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_InProcessResearchAndDevelopment', window );">In-process research and development</a></td>
<td class="nump">$ 29,000,000.0<span></span>
</td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_InProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of purchased research and development assets acquired in a business combination that have an indefinite life until completion or abandonment of the associated research and development efforts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_InProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6731654912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments - Cash Flow Hedging on AOCI (Details) - Interest Rate Swaps - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Amount of Gain/(Loss) Recognized in OCI on Derivative</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax', window );">Amount of Gain/(Loss) Recognized in OCI on Derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), before reclassification adjustments, related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6975626736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Reclassification of net deferred losses from accumulated other comprehensive loss</a></td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=112277219&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6826162640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income taxes - Net Deferred Tax Asset (Liability) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal losses carryforward</a></td>
<td class="nump">$ 8.5<span></span>
</td>
<td class="nump">$ 10.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State losses carryforward</a></td>
<td class="nump">17.4<span></span>
</td>
<td class="nump">18.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment', window );">Scientific research and experimental development credit carryforward</a></td>
<td class="nump">11.0<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Foreign NOLs</a></td>
<td class="nump">36.9<span></span>
</td>
<td class="nump">35.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">18.1<span></span>
</td>
<td class="nump">11.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory reserves</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_DeferredTaxAssetsOperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">7.5<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax asset</a></td>
<td class="nump">128.8<span></span>
</td>
<td class="nump">119.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="num">(51.2)<span></span>
</td>
<td class="num">(46.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(54.5)<span></span>
</td>
<td class="num">(60.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right-of-use asset</a></td>
<td class="num">(5.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">(114.8)<span></span>
</td>
<td class="num">(107.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(64.5)<span></span>
</td>
<td class="num">(66.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax asset (liability)</a></td>
<td class="num">(50.5)<span></span>
</td>
<td class="num">(54.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal losses carryforward</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development carryforward</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(4.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax asset (liability)</a></td>
<td class="num">(7.7)<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State losses carryforward</a></td>
<td class="nump">17.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development carryforward</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">$ (16.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DeferredTaxAssetsOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DeferredTaxAssetsOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible scientific research and experimental development tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31931-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6825081232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Concentration Risk (Details) - Customer Concentration Risk<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">61.00%<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">69.00%<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13537-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818653712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Net Income Per Share, Basic and Diluted</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table presents the calculation of basic and diluted net income per share:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions, except per share data)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Numerator:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>54.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>62.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>82.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest expense, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amortization of debt issuance costs, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income, adjusted</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>54.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>62.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>85.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Denominator:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted-average number of shares-basic</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>51.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>50.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>41.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Dilutive securities-equity awards</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Dilutive securities-convertible debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>7.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted-average number of shares-diluted</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>52.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>51.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>50.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income per share-basic</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.06</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.25</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.98</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income per share-diluted</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.04</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.22</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.71</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6678057312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_LesseeOperatingLeaseTerminationPeriod', window );">Operating lease, termination period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">14 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_LesseeOperatingLeaseTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Termination Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_LesseeOperatingLeaseTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818889504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw materials and supplies</a></td>
<td class="nump">$ 70.5<span></span>
</td>
<td class="nump">$ 51.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">89.7<span></span>
</td>
<td class="nump">103.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">62.3<span></span>
</td>
<td class="nump">50.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 222.5<span></span>
</td>
<td class="nump">$ 205.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6827060432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Reconciliation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">US</a></td>
<td class="nump">$ 63.9<span></span>
</td>
<td class="nump">$ 71.0<span></span>
</td>
<td class="nump">$ 80.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">International</a></td>
<td class="nump">13.5<span></span>
</td>
<td class="nump">10.5<span></span>
</td>
<td class="nump">37.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossAttributableToParent', window );">Earnings before taxes on income</a></td>
<td class="nump">77.4<span></span>
</td>
<td class="nump">81.5<span></span>
</td>
<td class="nump">118.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Federal tax at statutory rates</a></td>
<td class="nump">16.3<span></span>
</td>
<td class="nump">17.1<span></span>
</td>
<td class="nump">41.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal benefit</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Impact of foreign operations</a></td>
<td class="num">(6.9)<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCredits', window );">Tax credits</a></td>
<td class="num">(3.6)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount', window );">Transition tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">13.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Change in U.S. tax rate</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
<td class="num">(13.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other differences</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Return to provision true-ups</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts', window );">Transaction costs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount', window );">Contingent consideration</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount', window );">Compensation limitation</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount', window );">FIN 48</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet', window );">GILTI, net</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference', window );">Permanent differences</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 22.9<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="nump">$ 36.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Compensation Limitation, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Contingent Consideration, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to permanent differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_EffectiveIncomeTaxRateReconciliationPermanentDifference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) from Gilti (Global Intangible Low-taxed Income) tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to transaction costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_EffectiveIncomeTaxRateReconciliationTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Uncertain Tax Positions, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32059-109318<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible equity-based compensation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>ebs-2019123110k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2017-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:ebs="http://emergentbiosolutions.com/20191231"
  xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2018-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ebs-20191231.xsd" xlink:type="simple"/>
    <context id="FD2019Q4YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="I2020Q1Feb14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <instant>2020-02-14</instant>
        </period>
    </context>
    <context id="FI2018Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractDevelopmentAndManufacturingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractDevelopmentAndManufacturingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractDevelopmentAndManufacturingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractDevelopmentAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FI2017Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FI2016Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="I2018Q1Jan01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q3YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">ebs:CIADMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">ebs:CIADMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">ebs:CIADMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentPlansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2017Q4QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentPlansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="I2019Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentPlansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ContractsAndGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain_2020-01-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_MajorCustomersAxis_ebs_UnitedStatesGovernmentMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_MajorCustomersAxis_ebs_UnitedStatesGovernmentMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ebs:UnitedStatesGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="D2018Q4Oct15-Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-15</startDate>
            <endDate>2018-10-15</endDate>
        </period>
    </context>
    <context id="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-15</startDate>
            <endDate>2018-10-15</endDate>
        </period>
    </context>
    <context id="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-15</instant>
        </period>
    </context>
    <context id="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:ACAM2000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-06</startDate>
            <endDate>2017-10-06</endDate>
        </period>
    </context>
    <context id="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:ACAM2000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-06</instant>
        </period>
    </context>
    <context id="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-04</instant>
        </period>
    </context>
    <context id="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-04</instant>
        </period>
    </context>
    <context id="D2019Q3Oct5-Sep30_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-05</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-04</startDate>
            <endDate>2018-10-04</endDate>
        </period>
    </context>
    <context id="D2018Q4Oct04-Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-04</startDate>
            <endDate>2018-10-04</endDate>
        </period>
    </context>
    <context id="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-15</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-15</instant>
        </period>
    </context>
    <context id="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_VivotifMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:VivotifMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-04</startDate>
            <endDate>2018-10-04</endDate>
        </period>
    </context>
    <context id="I2017Q4Oct2_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:RaxibacumabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-02</instant>
        </period>
    </context>
    <context id="I2018Q4Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-15</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:ACAM2000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-15</startDate>
            <endDate>2018-10-15</endDate>
        </period>
    </context>
    <context id="D2017Q4Oct2_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:RaxibacumabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-02</startDate>
            <endDate>2017-10-02</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:ACAM2000Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:AdaptPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_VaxchoraMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:PaxVaxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:VaxchoraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-04</startDate>
            <endDate>2018-10-04</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ebs:RaxibacumabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_CashAndCashEquivalentsAxis_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_CashAndCashEquivalentsAxis_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandAndLandImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandAndLandImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ebs:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-15</startDate>
            <endDate>2018-10-15</endDate>
        </period>
    </context>
    <context id="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ebs:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-15</startDate>
            <endDate>2018-10-15</endDate>
        </period>
    </context>
    <context id="I2017Q4Dec28_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-28</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-15</startDate>
            <endDate>2018-10-15</endDate>
        </period>
    </context>
    <context id="D2017Q4Nov14-Nov14_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-11-14</startDate>
            <endDate>2017-11-14</endDate>
        </period>
    </context>
    <context id="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-15</startDate>
            <endDate>2018-10-15</endDate>
        </period>
    </context>
    <context id="I2018Q4Oct15_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ebs:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-15</instant>
        </period>
    </context>
    <context id="I2018Q4Oct31_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="D2019Q2Jun01-Jun30_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="D2016Q3Aug12-Aug12_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-08-12</startDate>
            <endDate>2016-08-12</endDate>
        </period>
    </context>
    <context id="D2017Q4Nov15-Dec28_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-11-15</startDate>
            <endDate>2017-12-28</endDate>
        </period>
    </context>
    <context id="I2017Q3Sep29_us-gaap_DebtInstrumentAxis_ebs_CreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-29</instant>
        </period>
    </context>
    <context id="I2018Q4Oct15_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-15</instant>
        </period>
    </context>
    <context id="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-15</startDate>
            <endDate>2018-10-15</endDate>
        </period>
    </context>
    <context id="D2019Q2Jun01-Jun30_srt_RangeAxis_srt_MinimumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-15</startDate>
            <endDate>2018-10-15</endDate>
        </period>
    </context>
    <context id="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-15</startDate>
            <endDate>2018-10-15</endDate>
        </period>
    </context>
    <context id="FD2019Q2QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="D2018Q4Oct15-Oct15_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-15</startDate>
            <endDate>2018-10-15</endDate>
        </period>
    </context>
    <context id="D2018Q4Oct15-Oct15_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_FederalFundsEffectiveSwapRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-15</startDate>
            <endDate>2018-10-15</endDate>
        </period>
    </context>
    <context id="FD2019Q4QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="D2017Q3Sep29-Sep29_us-gaap_DebtInstrumentAxis_ebs_CreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-29</startDate>
            <endDate>2017-09-29</endDate>
        </period>
    </context>
    <context id="I2018Q4Oct31_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ebs:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="I2014Q1Jan29_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-01-29</instant>
        </period>
    </context>
    <context id="I2017Q4Nov14_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-14</instant>
        </period>
    </context>
    <context id="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-15</startDate>
            <endDate>2018-10-15</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ebs:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:ConvertibleSeniorNotesDue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_DebtInstrumentAxis_ebs_OtherLongTermDebtFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:OtherLongTermDebtFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ebs:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_ebs_OtherLongTermDebtFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ebs:OtherLongTermDebtFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ebs:EmergentBiosolutionsInc2006StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_TaxCreditCarryforwardAxis_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">ebs:ManitobaScientificResearchAndExperimentalDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_TaxCreditCarryforwardAxis_us-gaap_ResearchMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_RangeAxis_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_RangeAxis_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:BiothraxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_OtherMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_OtherMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ACAM2000Member_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ACAM2000Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ACAM2000Member_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ACAM2000Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:BiothraxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:BiothraxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_NARCANNasalSprayMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:NARCANNasalSprayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ACAM2000Member_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:ACAM2000Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_NARCANNasalSprayMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:NARCANNasalSprayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_NARCANNasalSprayMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:NARCANNasalSprayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_OtherMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:BiothraxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FI2018Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:BiothraxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ebs:BiothraxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2018Q1QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="FD2018Q3QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2018Q2QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="FD2018Q4QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q4QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2019Q2QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ebs:SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ebs:SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ebs:SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ebs:SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ebs:SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ebs:SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ebs:SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:InventoryValuationReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <unit id="category">
        <measure>ebs:category</measure>
    </unit>
    <unit id="segment">
        <measure>ebs:segment</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="employee">
        <measure>ebs:employee</measure>
    </unit>
    <unit id="U004">
        <measure>ebs:Period</measure>
    </unit>
    <unit id="product">
        <measure>ebs:product</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="plan">
        <measure>ebs:plan</measure>
    </unit>
    <unit id="lending_institution">
        <measure>ebs:lending_institution</measure>
    </unit>
    <unit id="vote">
        <measure>ebs:vote</measure>
    </unit>
    <unit id="instrument">
        <measure>ebs:instrument</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="FD2019Q4YTD"
      id="Fact-0BD3C0995FA0484776C2CCD31321C490-wk-Fact-0BD3C0995FA0484776C2CCD31321C490">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="FD2019Q4YTD"
      id="Fact-DCE61C9A1BB8C9987DB2CCD31324739A-wk-Fact-DCE61C9A1BB8C9987DB2CCD31324739A">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="FD2019Q4YTD"
      id="Fact-AE8528EB878831920FF3CCD3131E8F3F-wk-Fact-AE8528EB878831920FF3CCD3131E8F3F">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="FD2019Q4YTD"
      id="Fact-4FCB2F0288357E5449D1CCD313234BD3-wk-Fact-4FCB2F0288357E5449D1CCD313234BD3">2019</dei:DocumentFiscalYearFocus>
    <dei:EntityCentralIndexKey
      contextRef="FD2019Q4YTD"
      id="Fact-5858D59267F6E2794B37CCD31322D850-wk-Fact-5858D59267F6E2794B37CCD31322D850">0001367644</dei:EntityCentralIndexKey>
    <ebs:LockUpPeriodForAdjustmentOfFairValue
      contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      id="Fact-004147C9F8445EB2BEE4CD12CCF57622-wk-Fact-004147C9F8445EB2BEE4CD12CCF57622">P2Y</ebs:LockUpPeriodForAdjustmentOfFairValue>
    <ebs:ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod
      contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentPlansMember"
      id="Fact-1F13E31BA271685985F5ECB9841B3E98-wk-Fact-1F13E31BA271685985F5ECB9841B3E98">P7Y</ebs:ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="FI2017Q4"
      decimals="INF"
      id="Fact-293DD5B35ECCBBAFB261CCD3136283AF-wk-Fact-293DD5B35ECCBBAFB261CCD3136283AF"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-7811F32207A98A796167CCD313702799-wk-Fact-7811F32207A98A796167CCD313702799"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-1D6F086D4D730C48E35CCCD3136D8E7E-wk-Fact-1D6F086D4D730C48E35CCCD3136D8E7E"
      unitRef="shares">200000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-F2905976DA944122F402CCD3136FF2F9-wk-Fact-F2905976DA944122F402CCD3136FF2F9"
      unitRef="shares">200000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-DD95BCD1181424E576E0CCD3136CAA51-wk-Fact-DD95BCD1181424E576E0CCD3136CAA51"
      unitRef="shares">52400000.0</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-7FE9F9723523DC0043F2CCD3136C79D7-wk-Fact-7FE9F9723523DC0043F2CCD3136C79D7"
      unitRef="shares">52900000.0</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-A1C409E685456649E735CCD31370DC0C-wk-Fact-A1C409E685456649E735CCD31370DC0C"
      unitRef="shares">51200000.0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-196B6DE27D4E81101FEACCD31370F3F1-wk-Fact-196B6DE27D4E81101FEACCD31370F3F1"
      unitRef="shares">51700000.0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember"
      decimals="INF"
      id="Fact-347FFE0406F003AB91AEECAB60A9A2D2-wk-Fact-347FFE0406F003AB91AEECAB60A9A2D2"
      unitRef="number">0.459767570558937</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember"
      id="Fact-F4305E1A35255CC0747C1182B2E987E4-wk-Fact-F4305E1A35255CC0747C1182B2E987E4">P22Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember"
      id="Fact-A40FE3312D13E9FBFBED1182CBDE25CF-wk-Fact-A40FE3312D13E9FBFBED1182CBDE25CF">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember"
      id="Fact-E5C82AF26E47037CFB931182A87A8332-wk-Fact-E5C82AF26E47037CFB931182A87A8332">P22Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember"
      id="Fact-0C024E0B0659F69AEB7D1182D657EBE0-wk-Fact-0C024E0B0659F69AEB7D1182D657EBE0">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="FD2018Q4YTD"
      decimals="INF"
      id="Fact-562BAC791DC7B83530F8F202354F7420-wk-Fact-562BAC791DC7B83530F8F202354F7420"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="Fact-4979D8A8D1024B56EFA65F9AA5C02129-wk-Fact-4979D8A8D1024B56EFA65F9AA5C02129"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="Fact-976CFE354E8527CB44CF5DF4CDDEEE88-wk-Fact-976CFE354E8527CB44CF5DF4CDDEEE88"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="Fact-ED9CB847D28D83AA05234AC58FB530C3-wk-Fact-ED9CB847D28D83AA05234AC58FB530C3"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="Fact-936F3640C118636448225F9AA505A598-wk-Fact-936F3640C118636448225F9AA505A598"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="Fact-D250607EE6BEB8FAD0EC5DF4CD029AE5-wk-Fact-D250607EE6BEB8FAD0EC5DF4CD029AE5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="Fact-EA45B2CA5409D6BBA84E4AC417F89181-wk-Fact-EA45B2CA5409D6BBA84E4AC417F89181"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-70FDBD81F69D5ADF0DFACCD3136E5F36-wk-Fact-70FDBD81F69D5ADF0DFACCD3136E5F36"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-A50348F11EEC4D07B433CCD3136CABAF-wk-Fact-A50348F11EEC4D07B433CCD3136CABAF"
      unitRef="shares">15000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-907333815B126E0B2816CCD3136DCBCC-wk-Fact-907333815B126E0B2816CCD3136DCBCC"
      unitRef="shares">15000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-1F31BF76CF678FC6F441CCD3136A4C32-wk-Fact-1F31BF76CF678FC6F441CCD3136A4C32"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-E5D72D4750CCFE6DAB38CCD3136EEB2C-wk-Fact-E5D72D4750CCFE6DAB38CCD3136EEB2C"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-38CC27C3E3DA0E8C180DCCD3136B8AD3-wk-Fact-38CC27C3E3DA0E8C180DCCD3136B8AD3"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-6D312E089507DEFF5DA9CCD3136DCF7C-wk-Fact-6D312E089507DEFF5DA9CCD3136DCF7C"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingImprovementsMember"
      id="Fact-85BBBC89E6799713C2A7F1AB5E070225-wk-Fact-85BBBC89E6799713C2A7F1AB5E070225">P39Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      id="Fact-BA785462645B3804DB7BF1AAAB36A198-wk-Fact-BA785462645B3804DB7BF1AAAB36A198">P39Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember"
      id="Fact-7A7AF3494B045A10B280F1AD41750F97-wk-Fact-7A7AF3494B045A10B280F1AD41750F97">P7Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember"
      id="Fact-7A20C7F94EDA8FC173B8F1ACC3C48B76-wk-Fact-7A20C7F94EDA8FC173B8F1ACC3C48B76">P15Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingImprovementsMember"
      id="Fact-BBADBF699DF252DD9BEBCCD3134D871B-wk-Fact-BBADBF699DF252DD9BEBCCD3134D871B">P10Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      id="Fact-A9FF5A6677376C7180BECCD313524D84-wk-Fact-A9FF5A6677376C7180BECCD313524D84">P31Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember"
      id="Fact-B5B87BA286EB74C576D5CCD313897398-wk-Fact-B5B87BA286EB74C576D5CCD313897398">P3Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember"
      id="Fact-4D9BFC05D89504802A0ACCD3134BBB40-wk-Fact-4D9BFC05D89504802A0ACCD3134BBB40">P3Y</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="-5"
      id="Fact-35C53CD6878F4E0438CFB73D91D6552B-wk-Fact-35C53CD6878F4E0438CFB73D91D6552B"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="Fact-D274CB885E51A5CCA887CCD3139630F8-wk-Fact-D274CB885E51A5CCA887CCD3139630F8"
      unitRef="number">0.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="Fact-D71195EC48BBA45BD22BCCD313A5F092-wk-Fact-D71195EC48BBA45BD22BCCD313A5F092"
      unitRef="number">0.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="Fact-406A455B4715867B9EABCCD313446694-wk-Fact-406A455B4715867B9EABCCD313446694"
      unitRef="number">0.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="Fact-F20A4A37133F9F2454E4CCD3139DEFE0-wk-Fact-F20A4A37133F9F2454E4CCD3139DEFE0"
      unitRef="number">0.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="Fact-7B9B74C9A4D0FF83BAEBCCD313453DA8-wk-Fact-7B9B74C9A4D0FF83BAEBCCD313453DA8"
      unitRef="number">0.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="2"
      id="Fact-64135B4AAD205C77A58FCCD31342922B-wk-Fact-64135B4AAD205C77A58FCCD31342922B"
      unitRef="number">0.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="4"
      id="Fact-16508A648A3DC0310FD3CCD3134485BF-wk-Fact-16508A648A3DC0310FD3CCD3134485BF"
      unitRef="number">0.0188</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="FD2017Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="4"
      id="Fact-629B0FFAB96DFB424D35CCD3131D40A4-wk-Fact-629B0FFAB96DFB424D35CCD3131D40A4"
      unitRef="number">0.0166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="4"
      id="Fact-53883476781D1C65E799CCD31344EC3C-wk-Fact-53883476781D1C65E799CCD31344EC3C"
      unitRef="number">0.0303</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="4"
      id="Fact-173F687093CBB7CC100FCCD313AF8F9B-wk-Fact-173F687093CBB7CC100FCCD313AF8F9B"
      unitRef="number">0.0254</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="4"
      id="Fact-D92536EC643587187093CCD3138C82BD-wk-Fact-D92536EC643587187093CCD3138C82BD"
      unitRef="number">0.0248</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="4"
      id="Fact-6EFB4B82730F48A98309CCD3139B28D9-wk-Fact-6EFB4B82730F48A98309CCD3139B28D9"
      unitRef="number">0.0157</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:TreasuryStockShares
      contextRef="FI2018Q4"
      decimals="INF"
      id="Fact-2FA95B5F2ECE1E31C4E4CCD3136F45A0-wk-Fact-2FA95B5F2ECE1E31C4E4CCD3136F45A0"
      unitRef="shares">1200000.0</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="FI2019Q4"
      decimals="INF"
      id="Fact-BA2EB120ECBC1819D5D5CCD3136A2DC5-wk-Fact-BA2EB120ECBC1819D5D5CCD3136A2DC5"
      unitRef="shares">1200000.0</us-gaap:TreasuryStockShares>
    <dei:DocumentType
      contextRef="FD2019Q4YTD"
      id="d45214558e733-wk-Fact-6915A4AE9C59E1DC5952CCFBC9C49D24">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="FD2019Q4YTD"
      id="d45214558e753-wk-Fact-693BCF7D8D116EBDC427CCE866F62D76">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="FD2019Q4YTD"
      id="d45214558e763-wk-Fact-E300F256C7F110839A82A53BAFD86470">2019-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="FD2019Q4YTD"
      id="d45214558e782-wk-Fact-E636F38F1EE47C855200CCE8E1F0624A">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="FD2019Q4YTD"
      id="d45214558e795-wk-Fact-E899CAA77B9E401E871DCCE92F818FB1">001-33137</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="FD2019Q4YTD"
      id="d45214558e804-wk-Fact-4E795D19D19EAF5C3836CCE98191EB9D">EMERGENT BIOSOLUTIONS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="FD2019Q4YTD"
      id="d45214558e825-wk-Fact-BA59EE6256C07CE71BBDCCEB6EADD9D7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="FD2019Q4YTD"
      id="d45214558e835-wk-Fact-801B622281BE96521169CCEBDE635904">14-1902018</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="FD2019Q4YTD"
      id="d45214558e866-wk-Fact-E0DFB4A0C859EBFB98EDFC9DCFD1C917">400 Professional Drive, Suite 400</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="FD2019Q4YTD"
      id="d45214558e898-wk-Fact-B10D018D7C26FA21BA06FC9E0882CD16">Gaithersburg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="FD2019Q4YTD"
      id="d45214558e903-wk-Fact-98952A7DA5E7C2952664FC9E40640E3B">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="FD2019Q4YTD"
      id="d45214558e908-wk-Fact-328062924879A1689C18FC9E7E79567C">21079</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="FD2019Q4YTD"
      id="d45214558e929-wk-Fact-5F084B75A5C1D344DABCCCEC99888A4B">240</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="FD2019Q4YTD"
      id="d45214558e933-wk-Fact-99B2F5BCF4615D79624BCCECD937CE20">631-3200</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="FD2019Q4YTD"
      id="d45214558e969-wk-Fact-9F258F8E97448394D5ACCCFC47027A3D">Common stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="FD2019Q4YTD"
      id="d45214558e974-wk-Fact-1810D63F51CB0066585C21DCF9C60367">EBS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="FD2019Q4YTD"
      id="d45214558e979-wk-Fact-EF6F148D2B4701E4386BCCFD624727F1">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="FD2019Q4YTD"
      id="d45214558e989-wk-Fact-132B7CCB4887299ADBA7CCFDB5D3069C">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="FD2019Q4YTD"
      id="d45214558e1007-wk-Fact-B8315FECC9EBBB0F0B79CCFE422F5DFA">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="FD2019Q4YTD"
      id="d45214558e1018-wk-Fact-6F3A6897B9FBB6745E71CCFEA0FD7CFB">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="FD2019Q4YTD"
      id="d45214558e1032-wk-Fact-2368A95E242F37E5B3A6CCFF0F27E4BF">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="FD2019Q4YTD"
      id="d45214558e1050-wk-Fact-B7761F48EAAFE4B33171CCFFDCAFD21F">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="FD2019Q4YTD"
      id="d45214558e1067-wk-Fact-44772163A2E0AD6B4352CD00606D9AA8">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="FD2019Q4YTD"
      id="d45214558e1072-wk-Fact-BD2552FE77C2806DEC4ACD00B13D5D12">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="FD2019Q4YTD"
      id="d45214558e1086-wk-Fact-51474DEE08236CC8D367CD0132DDB690">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="FI2019Q2"
      decimals="-8"
      id="d45214558e1096-wk-Fact-9694610AD90073E2173F11766F52FC74"
      unitRef="usd">2500000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="I2020Q1Feb14"
      decimals="-5"
      id="d45214558e1107-wk-Fact-02AF5B97929A8AFC581E5558B0CD6B07"
      unitRef="shares">52000000.0</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-36DE45B87865F1A879C4B216C88C081F-0-wk-Fact-0F6B22398EF1CE50F6ABB219ECE45A82">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Portions of the registrant's definitive proxy statement for its &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; annual meeting of stockholders scheduled to be held in May &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, which is expected to be filed with the Securities and Exchange Commission not later than 120 days after the end of the registrant's fiscal year ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, are incorporated by reference into Part II, Item 5. and Part III of this annual report on Form 10-K. With the exception of the portions of the registrant's definitive proxy statement for its &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; annual meeting of stockholders that are expressly incorporated by reference into this annual report on Form 10-K, such proxy statement shall not be deemed filed as part of this annual report on Form 10-K.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e922-wk-Fact-5336B3A0808E295F0F9ACCD313516FB8"
      unitRef="usd">167800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e941-wk-Fact-C850578AFC61C3CD2C52CCD313602FC1"
      unitRef="usd">112200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e956-wk-Fact-7D6350B9DCF7F0111A28CCD31365A60F"
      unitRef="usd">200000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e975-wk-Fact-E144E7602026284DE3B5CCD3135AA1A0"
      unitRef="usd">200000</us-gaap:RestrictedCashCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e995-wk-Fact-8E63B5B6EE5EB579E66FCCD31378EC92"
      unitRef="usd">270700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1014-wk-Fact-0A8EDAB4A88157AF37E1CCD3136590C8"
      unitRef="usd">262500000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1034-wk-Fact-9E7A6321764CCA011270CCD3135EBFCB"
      unitRef="usd">222500000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1053-wk-Fact-9BE8FA4DD47B7E5F9DB4CCD31363B9B9"
      unitRef="usd">205800000</us-gaap:InventoryNet>
    <us-gaap:IncomeTaxesReceivable
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1073-wk-Fact-7CF3B381E5B3B0C5CE28CCD3135B583C"
      unitRef="usd">4600000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1092-wk-Fact-C35A4CA04DDB71D4CFEFCCD313632F6A"
      unitRef="usd">8600000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1112-wk-Fact-FB52AFB0B296536D08DBCCD313662B20"
      unitRef="usd">20400000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1131-wk-Fact-A1EFFB4329FBD17570DACCD3134EA78B"
      unitRef="usd">31500000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1151-wk-Fact-151DC1949FADB06E4A7BCCD3134BEBC8"
      unitRef="usd">686200000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1170-wk-Fact-3C94BD3322A10D90DDC3CCD3135DAD1B"
      unitRef="usd">620800000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1232-wk-Fact-899C00B0608B636FBD8FCCD3135FCC56"
      unitRef="usd">542300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1251-wk-Fact-B7B7C9765C1C2455B6F1CCD3135E93E8"
      unitRef="usd">510200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1271-wk-Fact-23DCBB460AF8A0ACBBE7CCD3135B1023"
      unitRef="usd">712900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1290-wk-Fact-7B0EEA06D43CF1A4D27DCCD3135E9C23"
      unitRef="usd">761600000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <ebs:InProcessResearchAndDevelopment
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1310-wk-Fact-2B0343D7D345B2E16A1ACCD31364046E"
      unitRef="usd">29000000.0</ebs:InProcessResearchAndDevelopment>
    <ebs:InProcessResearchAndDevelopment
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1329-wk-Fact-2A654F2FE5B913B49F31CCD3135C7D21"
      unitRef="usd">50000000.0</ebs:InProcessResearchAndDevelopment>
    <us-gaap:Goodwill
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1349-wk-Fact-C76E5389C37865AFD040CCD31368C9CE"
      unitRef="usd">266600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1368-wk-Fact-5C9C3DE9C91BA7971D23CCD31385ABAA"
      unitRef="usd">259700000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1388-wk-Fact-B4860D2049F842006F6DCCD31359362A"
      unitRef="usd">13400000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1407-wk-Fact-4810C830DE23A4ABCB7DCCD3138204CB"
      unitRef="usd">13400000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1427-wk-Fact-7FCE1A7F977633CA61C6CCD3135169F2"
      unitRef="usd">76900000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1446-wk-Fact-536D348900D24C3F7762CCD31344BBDF"
      unitRef="usd">13700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1466-wk-Fact-1EA27C25A586FC51A656CCD313530225"
      unitRef="usd">2327300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1485-wk-Fact-85DB590568FD23FC26E9CCD3138391FB"
      unitRef="usd">2229400000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1634-wk-Fact-84D541D5E03415DF4535CCD313518995"
      unitRef="usd">94800000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1653-wk-Fact-4DCDB7EF87AB975796DDCCD3135C1B6D"
      unitRef="usd">80700000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1668-wk-Fact-00378ECED7A8D9C18EC8CCD31358120F"
      unitRef="usd">39500000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1687-wk-Fact-141EE5B8E68DEBB46841CCD3135F9C9D"
      unitRef="usd">30700000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1707-wk-Fact-09D363D31AFF605BE8D7CCD3135550AA"
      unitRef="usd">62400000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1726-wk-Fact-48546A54ACE6E8D86951CCD31367440C"
      unitRef="usd">58200000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1746-wk-Fact-1020D890222BC2C85069CCD3135A4D97"
      unitRef="usd">12900000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1765-wk-Fact-E4FA23442C7530649177CCD31356CD22"
      unitRef="usd">10100000</us-gaap:NotesPayableCurrent>
    <ebs:ContingentConsiderationCurrentPortion
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1785-wk-Fact-D9896AC4336730797F99CCD31363C697"
      unitRef="usd">3200000</ebs:ContingentConsiderationCurrentPortion>
    <ebs:ContingentConsiderationCurrentPortion
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1804-wk-Fact-E38AA87ED30245FFE5A1CCD313542315"
      unitRef="usd">5600000</ebs:ContingentConsiderationCurrentPortion>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1824-wk-Fact-A7ADE41022942BAB2731CCD3135EC5C3"
      unitRef="usd">3500000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1843-wk-Fact-0F08F0A7A07DB94CE8E5CCD3134F3619"
      unitRef="usd">15100000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1863-wk-Fact-03B8082E9C77E15C2DA1CCD313679814"
      unitRef="usd">216300000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1882-wk-Fact-03F6F4EA8F3939850287CCD31383C673"
      unitRef="usd">200400000</us-gaap:LiabilitiesCurrent>
    <ebs:ContingentConsiderationNetOfCurrentPortion
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1943-wk-Fact-A9E3703BEE571B9E45A7CCD31362AEB4"
      unitRef="usd">26000000.0</ebs:ContingentConsiderationNetOfCurrentPortion>
    <ebs:ContingentConsiderationNetOfCurrentPortion
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e1962-wk-Fact-7F9482301B2A33C64259CCD31357772E"
      unitRef="usd">54400000</ebs:ContingentConsiderationNetOfCurrentPortion>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e1982-wk-Fact-0163307C7DD7CD378E59CCD31360AD48"
      unitRef="usd">798400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e2001-wk-Fact-6EFA9A3FEB39B8EF4FC4CCD313587151"
      unitRef="usd">784500000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e2021-wk-Fact-282CAC6196A96CDFDFABCCD313572CE7"
      unitRef="usd">63900000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e2040-wk-Fact-473A3A2E14986DA3749FCCD313847061"
      unitRef="usd">67500000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e2061-wk-Fact-E84BA4D84777937FDC2ACCD31354A380"
      unitRef="usd">85600000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e2080-wk-Fact-FDF258FBD155CE931D7ECCD3135563AE"
      unitRef="usd">62500000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e2100-wk-Fact-55823CB2410564CDB287CCD3136485E8"
      unitRef="usd">48600000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e2119-wk-Fact-AF27DB7F93A5F2DEEFD8CCD3136675D4"
      unitRef="usd">49200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e2139-wk-Fact-2ACA55C535E89FCEEF99CCD3135815A7"
      unitRef="usd">1238800000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e2158-wk-Fact-6B468270AF1582984F05CCD31351A58C"
      unitRef="usd">1218500000</us-gaap:Liabilities>
    <us-gaap:PreferredStockValue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e2260-wk-Fact-424B0C2E8B14A5378EECCCD313544555"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e2279-wk-Fact-76A133ADF7E0A02AE353CCD313811089"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e2299-wk-Fact-2E6F3C493879F596FC67CCD313620373"
      unitRef="usd">100000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e2318-wk-Fact-2916B05A2D4ED2260DFBCCD3135AD4DC"
      unitRef="usd">100000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e2338-wk-Fact-E0263BE513DF033898BACCD31360CF40"
      unitRef="usd">39600000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e2358-wk-Fact-D2DD65E797AD45B1FCFCCCD3135526EA"
      unitRef="usd">39600000</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e2379-wk-Fact-3EA1755D2F188C56A786CCD3134FD3EE"
      unitRef="usd">716100000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e2398-wk-Fact-6AFDEFB0F56B65D8EBB7CCD31361CCB7"
      unitRef="usd">688600000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e2418-wk-Fact-17B79BDB5B7BBBC71297CCD313657C2F"
      unitRef="usd">-9900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e2438-wk-Fact-FCE9974F1DB16F154351CCD3135C560E"
      unitRef="usd">-5500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e2459-wk-Fact-3A03B529B6C6A592A3A6CCD3135EE2E5"
      unitRef="usd">421800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e2478-wk-Fact-A306E97D3D239A3D354FCCD3135C9792"
      unitRef="usd">367300000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e2499-wk-Fact-0B3690615016B293BE9FCCD3135F817C"
      unitRef="usd">1088500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e2518-wk-Fact-AFEDF1DE0BEA35BDB75FCCD313596B2B"
      unitRef="usd">1010900000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45224251e2543-wk-Fact-C0A242398559F24FB376CCD3136399FA"
      unitRef="usd">2327300000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45224251e2562-wk-Fact-08C73019DD676487846ACCD31359BD1C"
      unitRef="usd">2229400000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember"
      decimals="-5"
      id="d45227565e949-wk-Fact-550DB7545370460F2298CCD31390DFC6"
      unitRef="usd">903500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember"
      decimals="-5"
      id="d45227565e968-wk-Fact-3810A958B43C733CFB24CCD3138A0CA4"
      unitRef="usd">606500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember"
      decimals="-5"
      id="d45227565e987-wk-Fact-E3F5520D7C718745B7DFCCD3138C7AFB"
      unitRef="usd">421500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractDevelopmentAndManufacturingMember"
      decimals="-5"
      id="d45227565e1003-wk-Fact-EB42D93755BA6257EE81CCD31389177D"
      unitRef="usd">80000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractDevelopmentAndManufacturingMember"
      decimals="-5"
      id="d45227565e1022-wk-Fact-904BD4C0F92F891BCF1FCCD3137C85C8"
      unitRef="usd">98900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractDevelopmentAndManufacturingMember"
      decimals="-5"
      id="d45227565e1041-wk-Fact-16361A9FD27C7C14B912CCD3137DFB76"
      unitRef="usd">68900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember"
      decimals="-5"
      id="d45227565e1062-wk-Fact-5F00D21AD433133B00D3CCD313757E7C"
      unitRef="usd">122500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember"
      decimals="-5"
      id="d45227565e1081-wk-Fact-B30465A8C2F3A2E082CECCD3138D3955"
      unitRef="usd">77000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember"
      decimals="-5"
      id="d45227565e1100-wk-Fact-9AD0A541FEBE16626E99CCD31378BB04"
      unitRef="usd">70500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45227565e1121-wk-Fact-94CAA3BE61215202AE0CCCD3138C57F6"
      unitRef="usd">1106000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45227565e1140-wk-Fact-E5CE75B1C99F6C4E48F4CCD31371D6BF"
      unitRef="usd">782400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45227565e1159-wk-Fact-85CDAEF339CB7AEE40B1CCD3138717AC"
      unitRef="usd">560900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45227565e1304-wk-Fact-1A17B919655248A478E6CCD3137C25B5"
      unitRef="usd">433500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45227565e1323-wk-Fact-0BD5F5131BBA62715B14CCD3137D83D8"
      unitRef="usd">322300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45227565e1342-wk-Fact-2D01B99AAE4512BE7D14CCD3137863F0"
      unitRef="usd">187700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45227565e1363-wk-Fact-BB99500874D827111E94CCD313734577"
      unitRef="usd">226200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45227565e1382-wk-Fact-192DC0603EFF1E62BD18CCD313791315"
      unitRef="usd">142800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45227565e1401-wk-Fact-55D5D9EE3A86D99320CECCD3137E1784"
      unitRef="usd">97400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45227565e1423-wk-Fact-6DC68E6B8F7ED1B32B53CCD31386366A"
      unitRef="usd">273500000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45227565e1442-wk-Fact-9178D87C78320892421CCCD313853D3A"
      unitRef="usd">202500000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45227565e1461-wk-Fact-606ED401806C2E5BE08DCCD31387060A"
      unitRef="usd">142900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45227565e1482-wk-Fact-6CC25FDAD57AD605F0EFEE0DD6E4C0A9"
      unitRef="usd">58700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45227565e1501-wk-Fact-13AE45AAD591A38D64EBCCD313882444"
      unitRef="usd">25000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45227565e1520-wk-Fact-1225424380838E1DB578CCD31376D614"
      unitRef="usd">8600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingExpenses
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45227565e1541-wk-Fact-9C63E17D0E9E2EB7B07ACCD31374D235"
      unitRef="usd">991900000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45227565e1560-wk-Fact-D862905C5CBC0C43A582CCD313745728"
      unitRef="usd">692600000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45227565e1579-wk-Fact-9B9EEB604312E2E1C251CCD31375F246"
      unitRef="usd">436600000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45227565e1662-wk-Fact-5EAB37A75F982F7A9C3DCCD3137A6859"
      unitRef="usd">114100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45227565e1681-wk-Fact-450A2B99937449611C98CCD31386669F"
      unitRef="usd">89800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45227565e1700-wk-Fact-88A83CAADC155D683453CCD3138500BF"
      unitRef="usd">124300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45227565e1845-wk-Fact-7CBF4D87B27968819869CCD31372F3CF"
      unitRef="usd">38400000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45227565e1865-wk-Fact-242972BC4070FEAC319CCCD31379135C"
      unitRef="usd">9900000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45227565e1885-wk-Fact-877211EB9E49BA449B4ACCD3137E2218"
      unitRef="usd">6600000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45227565e1907-wk-Fact-EFAF683CA24BADEB8065CCD3137AFDE3"
      unitRef="usd">1700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45227565e1926-wk-Fact-6671A1D4F503CBCB1C99CCD313879C25"
      unitRef="usd">1600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45227565e1945-wk-Fact-B20F2D9332F409310848CCD3138412B3"
      unitRef="usd">900000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45227565e1966-wk-Fact-81DAC95D090A7A600B2CCCD31375D9C1"
      unitRef="usd">-36700000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45227565e1986-wk-Fact-30971FC148524C20DFD7CCD3138916B9"
      unitRef="usd">-8300000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45227565e2006-wk-Fact-59B2701692826D03179CCCD3137D7C9F"
      unitRef="usd">-5700000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45227565e2091-wk-Fact-15849D8BF637472B8ADECCD31379DEFF"
      unitRef="usd">77400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45227565e2110-wk-Fact-E99100EAFF39BE9F20A8CCD313844D4A"
      unitRef="usd">81500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45227565e2129-wk-Fact-3C7C65F6526D0FE54F6FCCD31383F49F"
      unitRef="usd">118600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45227565e2150-wk-Fact-815A1535A7EA25FCCD27CCD31380042F"
      unitRef="usd">22900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45227565e2169-wk-Fact-4D13AEFC5D9B488A367CCCD3137B2702"
      unitRef="usd">18800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45227565e2188-wk-Fact-9218D9AEEE0D40961A99CCD313765A05"
      unitRef="usd">36000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45227565e2214-wk-Fact-7DC5791E3DA27455A6AECCD31377CEF0"
      unitRef="usd">54500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45227565e2233-wk-Fact-2233E7AC5FE7EADFA0A9CCD3137B1D77"
      unitRef="usd">62700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45227565e2252-wk-Fact-E93855FEF0C5D1679E3DCCD313722951"
      unitRef="usd">82600000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d45227565e2335-wk-Fact-86DB00C3EBD85B656393CCD3138EDEB2"
      unitRef="usdPerShare">1.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2018Q4YTD"
      decimals="2"
      id="d45227565e2354-wk-Fact-87E66476E07C4C47E84FCCD3138767B9"
      unitRef="usdPerShare">1.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2017Q4YTD"
      decimals="2"
      id="d45227565e2373-wk-Fact-7509B93E651C38CE4A6CCCD3138CB254"
      unitRef="usdPerShare">1.98</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d45227565e2456-wk-Fact-3D47F2A0E1F49321A098CCD313819F36"
      unitRef="usdPerShare">1.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2018Q4YTD"
      decimals="2"
      id="d45227565e2475-wk-Fact-1C4F6F61BDFC84790364CCD3137FF970"
      unitRef="usdPerShare">1.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2017Q4YTD"
      decimals="2"
      id="d45227565e2494-wk-Fact-9E773D140AC5081CC2BDCCD3138E79BE"
      unitRef="usdPerShare">1.71</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45227565e2572-wk-Fact-6C476F7FC811DEF066C8CCD313726405"
      unitRef="shares">51500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45227565e2591-wk-Fact-AA3A26AF9233B4E47F37CCD31384CE40"
      unitRef="shares">50100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45227565e2610-wk-Fact-FC3D132112BD46DA7C18CCD3137FB2FE"
      unitRef="shares">41800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45227565e2631-wk-Fact-26467B8874FB56A63BF6CCD3137FA89C"
      unitRef="shares">52400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45227565e2650-wk-Fact-49D658F4DEFA67C8563CCCD31381661E"
      unitRef="shares">51400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45227565e2669-wk-Fact-888877977CEDD432DA63CCD3136C30C8"
      unitRef="shares">50300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45232163e886-wk-Fact-7DC5791E3DA27455A6AECCD31377CEF0"
      unitRef="usd">54500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45232163e905-wk-Fact-2233E7AC5FE7EADFA0A9CCD3137B1D77"
      unitRef="usd">62700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45232163e924-wk-Fact-E93855FEF0C5D1679E3DCCD313722951"
      unitRef="usd">82600000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45232163e1002-wk-Fact-1491B4B773CC46B33FF6CCD31382A48C"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45232163e1021-wk-Fact-AC5605D73790C0A328EFCCD3138217EE"
      unitRef="usd">-1600000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45232163e1041-wk-Fact-5417BA53613C505A2DE0CCD313821B9D"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45232163e1062-wk-Fact-637E7E91168467F87D0CB2246394E792"
      unitRef="usd">-1600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45232163e1082-wk-Fact-D725BD2999FDA69C0E15B22463741A23"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45232163e1101-wk-Fact-176111CD532B4B190C1CB2246406B555"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45232163e1122-wk-Fact-C297ADD0A24247ED3AD3CCD31384C669"
      unitRef="usd">3200000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45232163e1142-wk-Fact-6F15219A9C09561F63F2CCD31383291F"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45232163e1162-wk-Fact-A37500CD25575D912628CCD313854406"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45232163e1183-wk-Fact-F702E6116BA005717710CCD3137114A2"
      unitRef="usd">-4400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45232163e1203-wk-Fact-85089016933E47A775DDCCD3138523AA"
      unitRef="usd">-1800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45232163e1223-wk-Fact-5B21670B6A453CD2AA06CCD313812342"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45232163e1249-wk-Fact-2167B38B07773525CADFCCD31383D724"
      unitRef="usd">50100000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45232163e1268-wk-Fact-CFBD7BFD40A59A99F3CFCCD313830053"
      unitRef="usd">60900000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45232163e1287-wk-Fact-930FAC0A0BCAA75EE229CCD3136C57D3"
      unitRef="usd">83200000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e949-wk-Fact-7DC5791E3DA27455A6AECCD31377CEF0"
      unitRef="usd">54500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e968-wk-Fact-2233E7AC5FE7EADFA0A9CCD3137B1D77"
      unitRef="usd">62700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e987-wk-Fact-E93855FEF0C5D1679E3DCCD313722951"
      unitRef="usd">82600000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e1065-wk-Fact-94934C6F39F7F4F3628DCCD313748029"
      unitRef="usd">26700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e1084-wk-Fact-3D09F5A8BBC3B6CBDCDCCCD3136A8EA4"
      unitRef="usd">23200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e1103-wk-Fact-B352691FC99E659B929ECCD3136F5CDC"
      unitRef="usd">15200000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e1124-wk-Fact-0BF09E44B53E6659DF58CCD3134374AF"
      unitRef="usd">110700000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e1143-wk-Fact-12BAC36B254B0EFA23CCCCD3137AF674"
      unitRef="usd">62200000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e1162-wk-Fact-982E26B456D9E3F9E885CCD3134A87C4"
      unitRef="usd">42600000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e1183-wk-Fact-58405A0E79843DEA0ECECCD3134923A8"
      unitRef="usd">-1100000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e1203-wk-Fact-96DD44DB927FC4D6C560CCD313826897"
      unitRef="usd">8600000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e1222-wk-Fact-0EDED9EEF79E4387F35FCCD3137C7249"
      unitRef="usd">3300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <ebs:ChangeInFairValueOfContingentConsideration
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e1243-wk-Fact-BF841B970C5DDEBA3D0CCCD3134589B9"
      unitRef="usd">24800000</ebs:ChangeInFairValueOfContingentConsideration>
    <ebs:ChangeInFairValueOfContingentConsideration
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e1262-wk-Fact-75ACA1418E71750AB209CCD31344B66C"
      unitRef="usd">3100000</ebs:ChangeInFairValueOfContingentConsideration>
    <ebs:ChangeInFairValueOfContingentConsideration
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e1281-wk-Fact-D93E9BCECF0813230248CCD31343B354"
      unitRef="usd">7800000</ebs:ChangeInFairValueOfContingentConsideration>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e1302-wk-Fact-410CCC0BC56F753EE8DAEC913479F2C7"
      unitRef="usd">12000000.0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e1321-wk-Fact-0C2E1AC86B7FBF1D0CC8B24403622FB4"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e1340-wk-Fact-4467221FA4513B6B4338B2440382EC05"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e1361-wk-Fact-EF015AB34B024808ED05B236552ABB25"
      unitRef="usd">3000000.0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e1380-wk-Fact-B07CB3D41CB501F0A207B23655780D6C"
      unitRef="usd">900000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e1399-wk-Fact-111076F67CA8D4FE51CCB23654EC43E5"
      unitRef="usd">1700000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e1421-wk-Fact-3B7F821E0291B8CF40C2CCD3136E6122"
      unitRef="usd">200000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e1441-wk-Fact-4C838F6D592AC9EAB240CCD313784045"
      unitRef="usd">-200000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e1460-wk-Fact-22C91D675F8BBC825960CCD3137CD927"
      unitRef="usd">-1200000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e1543-wk-Fact-39F29B2DA439E2657D68CCD31387B4D7"
      unitRef="usd">8200000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e1563-wk-Fact-0C907D58620779ADD5AACCD31351C4C9"
      unitRef="usd">94200000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e1583-wk-Fact-7AF02E2F3D61FF9AF91BCCD31375CDBD"
      unitRef="usd">4800000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e1605-wk-Fact-EF9D01F8B5A0F7566C07CCD3134A2C22"
      unitRef="usd">16700000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e1625-wk-Fact-A8E40C414DA8253E59D0CCD3136DBA7F"
      unitRef="usd">1900000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e1645-wk-Fact-49C9654D515BC588D967CCD3138371A9"
      unitRef="usd">-6100000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e1666-wk-Fact-F06A2049E6AE72AFB485CCD31372D69C"
      unitRef="usd">11700000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e1686-wk-Fact-98C46523DAF37C119CADCCD3136EDF8C"
      unitRef="usd">5100000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e1706-wk-Fact-7925E4CC482FDC4C5E16CCD3136B374B"
      unitRef="usd">-20100000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e1727-wk-Fact-B82096D5D28E0E1DE4BDCCD3137FB99C"
      unitRef="usd">27400000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e1747-wk-Fact-98EF8A1B3A643BFE9843CCD313847B40"
      unitRef="usd">7900000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e1767-wk-Fact-1CA1898DFEA051CCC492CCD3137D6E97"
      unitRef="usd">3700000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e1789-wk-Fact-F0D532250AAE4B7C6A14CCD3134DF5F7"
      unitRef="usd">16500000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e1808-wk-Fact-5A08E62E6E41549A5FC6CCD31380B55A"
      unitRef="usd">-7000000.0</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e1828-wk-Fact-E4535CD1D6175E24CA18CCD31373B402"
      unitRef="usd">16100000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e1849-wk-Fact-4D8D27694AF018AB0990CCD313460D92"
      unitRef="usd">-15100000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e1869-wk-Fact-E3FFECAECD63424330EACCD31369B036"
      unitRef="usd">-11600000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e1889-wk-Fact-52F31EC555CC6927540ECCD31350D9B2"
      unitRef="usd">1600000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e1910-wk-Fact-683ED368AC822C62D4C8CCD313728C4A"
      unitRef="usd">4200000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e1929-wk-Fact-E9DA993C3A24E6CB860ECCD313480ACE"
      unitRef="usd">8400000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e1948-wk-Fact-C101306649B286203633CCD313760C19"
      unitRef="usd">3300000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e1969-wk-Fact-5D9C5E6DB7D689A0579CCCD313819A20"
      unitRef="usd">16000000.0</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e1988-wk-Fact-A82EC91FD22E1BBB3D88CCD3137B3C2B"
      unitRef="usd">200000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e2007-wk-Fact-CF6C24A0DDABE6F1512ECCD313794D26"
      unitRef="usd">15000000.0</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e2028-wk-Fact-53C9BB28553649FC0CD8CCD3134F7B72"
      unitRef="usd">188000000.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e2047-wk-Fact-B038FC8723F050A6992FCCD3134C32D9"
      unitRef="usd">41800000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e2066-wk-Fact-D7AC0456F3EE40DFBFB5CCD3134270BB"
      unitRef="usd">208100000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e2150-wk-Fact-387E17842BFDF7B7716ECCD31376156F"
      unitRef="usd">86900000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e2170-wk-Fact-BE41ABBC9324FF2F9553CCD3137C54B9"
      unitRef="usd">72100000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e2190-wk-Fact-4553EDA6A617050DEF50CCD31345D6C6"
      unitRef="usd">54800000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForPreviousAcquisition
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e2212-wk-Fact-551A63B91C0F4C6524EAB2471762EA05"
      unitRef="usd">10000000.0</us-gaap:PaymentsForPreviousAcquisition>
    <us-gaap:PaymentsForPreviousAcquisition
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e2232-wk-Fact-D1C41757F2969CAEB863B247176621F4"
      unitRef="usd">0</us-gaap:PaymentsForPreviousAcquisition>
    <us-gaap:PaymentsForPreviousAcquisition
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e2251-wk-Fact-E22AD20BC8103B14A1F4B247176E41B2"
      unitRef="usd">0</us-gaap:PaymentsForPreviousAcquisition>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e2272-wk-Fact-E1043AC3A990DF5FD434CCD31368770B"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e2291-wk-Fact-750372074957FF5FEDC4CCD3134C315B"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e2310-wk-Fact-59972506EA00BF28E716CCD31345528D"
      unitRef="usd">77600000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e2332-wk-Fact-55700B24378B27D9E671CCD313474628"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e2351-wk-Fact-FFD96083DB4B1B46ACD4CCD3136B350F"
      unitRef="usd">827700000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e2371-wk-Fact-313B53E38CA2B0CC7E12CCD31377A474"
      unitRef="usd">117500000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e2393-wk-Fact-28FB304AE074BC3C7F9DCCD313736AC6"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e2412-wk-Fact-6D4693CDB7FAE2EA2606CCD3137D23A8"
      unitRef="usd">2600000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e2431-wk-Fact-2A1613503F0E4F0DB0FDCCD31352DA48"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e2452-wk-Fact-4E291D2A5FA2EB763F37CCD31343DC5D"
      unitRef="usd">-96900000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e2472-wk-Fact-0215D706357DC82A6917CCD3136D9A70"
      unitRef="usd">-897200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e2492-wk-Fact-A726DE34176E5E635AFECCD313420215"
      unitRef="usd">-249900000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e2576-wk-Fact-D633A029C3501AD564ACCCD31381B1F2"
      unitRef="usd">130000000.0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e2595-wk-Fact-7A64CE5EAF7E71AC4236CCD31378CEF8"
      unitRef="usd">348000000.0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e2614-wk-Fact-E8C3C906E106EF501852CCD3137B19B9"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfMediumTermNotes
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e2635-wk-Fact-2BE56630115CA57D9FB4B26E441146E9"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfMediumTermNotes>
    <us-gaap:ProceedsFromIssuanceOfMediumTermNotes
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e2654-wk-Fact-D3292182412046937463B26E446FA64B"
      unitRef="usd">450000000.0</us-gaap:ProceedsFromIssuanceOfMediumTermNotes>
    <us-gaap:ProceedsFromIssuanceOfMediumTermNotes
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e2673-wk-Fact-A69CF00FBDFF70980446B26E44024D4B"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfMediumTermNotes>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e2694-wk-Fact-9278D98977991691F95ACCD3136E9345"
      unitRef="usd">105000000.0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e2714-wk-Fact-F47F1BD282674F26494BCCD313562E55"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e2733-wk-Fact-964AEB5817E8AC949B2FCCD31347628D"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfMediumTermNotes
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e2755-wk-Fact-6A5A67159C1899AE4F2CB25B7B750163"
      unitRef="usd">11300000</us-gaap:RepaymentsOfMediumTermNotes>
    <us-gaap:RepaymentsOfMediumTermNotes
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e2775-wk-Fact-F71CF115BBECDCB9C1EBB25B7B84D65B"
      unitRef="usd">2800000</us-gaap:RepaymentsOfMediumTermNotes>
    <us-gaap:RepaymentsOfMediumTermNotes
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e2795-wk-Fact-62AB7ECA474FDCB8913AB25B7B75D72E"
      unitRef="usd">0</us-gaap:RepaymentsOfMediumTermNotes>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e2816-wk-Fact-A12423419BD191002F73CCD3137001D6"
      unitRef="usd">8200000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e2835-wk-Fact-5F8B0E5489921F995B75CCD31348902F"
      unitRef="usd">15900000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e2854-wk-Fact-8B14458631D53DB40A39CCD3137173FE"
      unitRef="usd">19300000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e2875-wk-Fact-A3595B6028B2A42D258CCCD3136CA2EC"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e2894-wk-Fact-B215D15B55351D7CB4C7CCD3137E5096"
      unitRef="usd">13400000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e2914-wk-Fact-C029EE29A4F11E0F17FCCCD31378CB86"
      unitRef="usd">1400000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e2936-wk-Fact-43266921E26168FAA933CCD3134ABB00"
      unitRef="usd">7400000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e2956-wk-Fact-CD6648998DCD8CF30B3FCCD313426C6E"
      unitRef="usd">6600000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e2976-wk-Fact-F23152A6FEF177B6DF20CCD31380FDDB"
      unitRef="usd">4300000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e2998-wk-Fact-E4899C990CADE1FAD58BCCD313736D22"
      unitRef="usd">0</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e3017-wk-Fact-FDC331B7D24198480D7CCCD31384AA43"
      unitRef="usd">0</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e3036-wk-Fact-B11E57073939A46E0D59CCD3137ECBE9"
      unitRef="usd">20000000.0</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e3058-wk-Fact-4219B44957785334849ACCD3136913DE"
      unitRef="usd">50400000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e3078-wk-Fact-146F9646A8DD1AC5981ECCD31370A103"
      unitRef="usd">3400000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e3098-wk-Fact-A88BE54C33F2D133B3B1CCD3136B347E"
      unitRef="usd">10900000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e3120-wk-Fact-C7838F4FB983869D9025CCD313757A3D"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities>
    <us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e3139-wk-Fact-DCEBA7D4764C2E6841AFCCD31377A171"
      unitRef="usd">1100000</us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities>
    <us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e3158-wk-Fact-3C765009B34E95622207CCD313502632"
      unitRef="usd">-1000000.0</us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e3180-wk-Fact-8C54E772E26C005C521FCCD31353787E"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e3199-wk-Fact-4762F6CA7095406D62C2CCD313777C5F"
      unitRef="usd">100000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e3219-wk-Fact-D67BF7D56A8441D196BCCCD31341F595"
      unitRef="usd">33100000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e3241-wk-Fact-D3E1729E330380D2C26CCCD3134E2EEE"
      unitRef="usd">-35900000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e3261-wk-Fact-D7399057B96F67FC7AF3CCD31379CE82"
      unitRef="usd">788700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e3280-wk-Fact-ED3955D537C6C2E45CF7CCD31349A38C"
      unitRef="usd">-51400000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e3302-wk-Fact-450254A0C36445CBE13CCCD31380F855"
      unitRef="usd">400000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e3321-wk-Fact-A97F4C9278A4CFE98AC9CCD313778FF7"
      unitRef="usd">-200000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e3341-wk-Fact-7FD7E93DE538F6EBEB13CCD313837BC0"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e3362-wk-Fact-BB5679B21BAEAF2ED2E2CCD31350EFBE"
      unitRef="usd">55600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e3381-wk-Fact-FDB49301E0EC16DE9256CCD3137AF1DE"
      unitRef="usd">-66900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e3401-wk-Fact-892EF083B175DB87061DCCD313504A09"
      unitRef="usd">-93200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45235985e3424-wk-Fact-7890970BA71EE684CCADCCD313509117"
      unitRef="usd">112400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2017Q4"
      decimals="-5"
      id="d45235985e3443-wk-Fact-3AE99597F8F935C48246CCD3136DD405"
      unitRef="usd">179300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2016Q4"
      decimals="-5"
      id="d45235985e3462-wk-Fact-156823373026275E77CCCCD313554131"
      unitRef="usd">272500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45235985e3488-wk-Fact-DC2EA43DC3E3189D364B5F9B81EFD3C5"
      unitRef="usd">168000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45235985e3507-wk-Fact-7890970BA71EE684CCADCCD313509117"
      unitRef="usd">112400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2017Q4"
      decimals="-5"
      id="d45235985e3526-wk-Fact-3AE99597F8F935C48246CCD3136DD405"
      unitRef="usd">179300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e3609-wk-Fact-113AC9216554653399B4CCD3137A6AD8"
      unitRef="usd">34500000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e3628-wk-Fact-8916F0CB3B55A9D3CFFECCD3137FFC25"
      unitRef="usd">10200000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e3647-wk-Fact-04494E4F1552BB4E6D55CCD3137D7209"
      unitRef="usd">8400000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e3668-wk-Fact-80E364F204890CD01FBFCCD31371AAD0"
      unitRef="usd">30800000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e3687-wk-Fact-4B66BF050AEE45A96CB3CCD313526A6D"
      unitRef="usd">14000000.0</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e3706-wk-Fact-DBDAFE28FF958DFF016ECCD313805D20"
      unitRef="usd">12000000.0</us-gaap:IncomeTaxesPaid>
    <us-gaap:StockIssued1
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e3789-wk-Fact-5AE8431AD2BB023B5A9ACCD3137053EF"
      unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e3808-wk-Fact-AF882D82582536BF3F23CCD3136F53E1"
      unitRef="usd">37700000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e3827-wk-Fact-5D737C3E5E2858EA3903CCD3134CA771"
      unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45235985e3848-wk-Fact-33F140E38FA1A7D9BF9BCCD3134DCE42"
      unitRef="usd">12300000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45235985e3867-wk-Fact-07B63CF9A3E48A65C40ECCD3137EF194"
      unitRef="usd">14700000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45235985e3886-wk-Fact-07AEC17B039D11BE1D85CCD3136DD001"
      unitRef="usd">4600000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45235985e3969-wk-Fact-5336B3A0808E295F0F9ACCD313516FB8"
      unitRef="usd">167800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45235985e3988-wk-Fact-C850578AFC61C3CD2C52CCD313602FC1"
      unitRef="usd">112200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2017Q4"
      decimals="-5"
      id="d45235985e4007-wk-Fact-0375FEEE05AEBD8C47B75F9E0534052E"
      unitRef="usd">178300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45235985e4023-wk-Fact-7D6350B9DCF7F0111A28CCD31365A60F"
      unitRef="usd">200000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45235985e4042-wk-Fact-E144E7602026284DE3B5CCD3135AA1A0"
      unitRef="usd">200000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="FI2017Q4"
      decimals="-5"
      id="d45235985e4061-wk-Fact-E2A1DB7DEA588AAACDCF5F9E962AC974"
      unitRef="usd">1000000.0</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45235985e4088-wk-Fact-DC2EA43DC3E3189D364B5F9B81EFD3C5"
      unitRef="usd">168000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45235985e4107-wk-Fact-7890970BA71EE684CCADCCD313509117"
      unitRef="usd">112400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="FI2017Q4"
      decimals="-5"
      id="d45235985e4126-wk-Fact-3AE99597F8F935C48246CCD3136DD405"
      unitRef="usd">179300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="d45239726e1105-wk-Fact-CCD60CBB29558FA48B74CCD313A25B9E"
      unitRef="shares">41000000.0</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d45239726e1129-wk-Fact-00728D5DE9D4A72A6063CCD313AA3E7F"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d45239726e1148-wk-Fact-3F78537B1F7AD2DDAB80CCD3139CB2AB"
      unitRef="usd">352400000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="INF"
      id="d45239726e1163-wk-Fact-7CA8441C5E731C286468CCD313A5CD6B"
      unitRef="shares">400000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d45239726e1183-wk-Fact-7DC9B1A65457438E80BBCCD3139B924F"
      unitRef="usd">-6400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d45239726e1203-wk-Fact-0046BC6B7B32C6EE7626CCD3138F1BA9"
      unitRef="usd">-4300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d45239726e1224-wk-Fact-5EDD27243B580B362C22CCD3138EA61A"
      unitRef="usd">254500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2016Q4"
      decimals="-5"
      id="d45239726e1243-wk-Fact-F2E7C25177615B0EC7ECCCD3138DDD25"
      unitRef="usd">596200000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="d45239726e1258-wk-Fact-53CC5DEAE9276C242410CCD3138F0304"
      unitRef="shares">1100000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d45239726e1296-wk-Fact-8AFE519BBDF814C323FACCD31399B1D2"
      unitRef="usd">28000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45239726e1388-wk-Fact-6081051CD8ED522120B7CCD31393997D"
      unitRef="usd">28000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="d45239726e1408-wk-Fact-29B4D68DD690658528DF8EAC7608313B"
      unitRef="shares">8500000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d45239726e1427-wk-Fact-074E3FABB56BC63D90E68EAAB7B42AB7"
      unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d45239726e1446-wk-Fact-E3C3276AB6C7A55B4C4C8EAAB7C201C8"
      unitRef="usd">237900000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45239726e1538-wk-Fact-40EF030AC4F137886252CCD313AC18B0"
      unitRef="usd">238000000.0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="INF"
      id="d45239726e1615-wk-Fact-ACCC04DD0642C76F63548EC28880990F"
      unitRef="shares">800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d45239726e1630-wk-Fact-E1579B86D479235412738EC0FE18FCA8"
      unitRef="usd">33100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45239726e1689-wk-Fact-B58D20645014DCA1AA198E7B21C76981"
      unitRef="usd">33100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:NetIncomeLoss
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d45239726e1821-wk-Fact-35FDB15319750DD940D8CCD3139D7749"
      unitRef="usd">82600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45239726e1840-wk-Fact-E93855FEF0C5D1679E3DCCD313722951"
      unitRef="usd">82600000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d45239726e1951-wk-Fact-10F899BE1F10F659984BCCD313A84DD0"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45239726e1990-wk-Fact-5B21670B6A453CD2AA06CCD313812342"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="d45239726e2010-wk-Fact-4A8002F2822CD3C742B1CCD313917AD5"
      unitRef="shares">50600000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d45239726e2034-wk-Fact-6914AF6510155DAC0F38CCD313A52D35"
      unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d45239726e2053-wk-Fact-9F98F15CF0FEBB183283CCD3138BC2CA"
      unitRef="usd">618300000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="INF"
      id="d45239726e2068-wk-Fact-09081519B3BB4F0C9DCBCCD31395847F"
      unitRef="shares">1200000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d45239726e2088-wk-Fact-39CD732B8F388C87FEAFCCD31395427B"
      unitRef="usd">-39500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d45239726e2108-wk-Fact-5FF3FC7F515F0A0BE3F8CCD3139B14AE"
      unitRef="usd">-3700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d45239726e2129-wk-Fact-8529E12375C7DEE4B9FACCD313AEF3FE"
      unitRef="usd">337100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2017Q4"
      decimals="-5"
      id="d45239726e2148-wk-Fact-3691C94D49348CC7919BCCD313A8578F"
      unitRef="usd">912300000</us-gaap:StockholdersEquity>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d45239726e2274-wk-Fact-9DFFDDBD36F0FAE4E7278E7B21E05F55"
      unitRef="usd">-32500000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="I2018Q1Jan01"
      decimals="-5"
      id="d45239726e2294-wk-Fact-0CA92E946AECE131C2378E7B21C4194D"
      unitRef="usd">-32500000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:CommonStockSharesIssued
      contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="d45239726e2315-wk-Fact-787E01F3F8D21F6D91458E7B21CE0332"
      unitRef="shares">50600000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
      contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d45239726e2334-wk-Fact-0BD4462D6C8B5D2F32CD8E7B21BC19FF"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
      contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d45239726e2353-wk-Fact-6C0B336B2ED2308717398E7B21DCD7FD"
      unitRef="usd">618300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:CommonStockSharesIssued
      contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="INF"
      id="d45239726e2373-wk-Fact-DA67CBB2B1FC957BBE228E7B21CAC1E5"
      unitRef="shares">1200000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
      contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d45239726e2388-wk-Fact-5936900494BB07B0189D8E7B21D9266A"
      unitRef="usd">-39500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
      contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d45239726e2408-wk-Fact-E74AF32DC7D0DE3C21708E7B21D5B3E3"
      unitRef="usd">-3700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
      contextRef="I2018Q1Jan01_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d45239726e2429-wk-Fact-4FB41CF48E82EC9B9C318E7B21C08BEF"
      unitRef="usd">304600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
      contextRef="I2018Q1Jan01"
      decimals="-5"
      id="d45239726e2448-wk-Fact-95A219BCBEAEA76AE5648E7B21B4F6A6"
      unitRef="usd">879800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="d45239726e2469-wk-Fact-1D21B0C149F2A18880F0CCD31394E823"
      unitRef="shares">1100000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d45239726e2507-wk-Fact-7453DCADFE19DAC48660CCD3139A2978"
      unitRef="usd">32600000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45239726e2599-wk-Fact-241CD17F4BE6F7BDEC3FCCD3139ADCB5"
      unitRef="usd">32600000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="d45239726e2619-wk-Fact-F666003E41D3CD59DFD6CCD313A1D62B"
      unitRef="shares">700000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d45239726e2657-wk-Fact-B77330C49B5FBED0E54ACCD313A04AD1"
      unitRef="usd">37700000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45239726e2749-wk-Fact-8031858837B14DEF41F5CCD31391F41E"
      unitRef="usd">37700000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d45239726e2841-wk-Fact-F08E9AA8E7AD50C3BE84CCD313A4F689"
      unitRef="usd">100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45239726e2900-wk-Fact-94FB638730F1D282AE87CCD3138A1AAF"
      unitRef="usd">100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d45239726e3032-wk-Fact-DE54BD21E499093EEA13CCD31394DBDE"
      unitRef="usd">62700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45239726e3051-wk-Fact-2233E7AC5FE7EADFA0A9CCD3137B1D77"
      unitRef="usd">62700000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d45239726e3162-wk-Fact-B471399577DB095DFF5BCCD313975DAB"
      unitRef="usd">-1800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45239726e3202-wk-Fact-85089016933E47A775DDCCD3138523AA"
      unitRef="usd">-1800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="d45239726e3223-wk-Fact-DED86EF4F36D82A01FA4CCD313AC3E39"
      unitRef="shares">52400000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d45239726e3247-wk-Fact-FCAC0EC3B7E436D643C1CCD3139E7DC2"
      unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d45239726e3266-wk-Fact-0EB92831F9E22B18DD3DCCD3138727EC"
      unitRef="usd">688600000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="INF"
      id="d45239726e3281-wk-Fact-48FEF34C2C831A416B1CCCD313A7F728"
      unitRef="shares">1200000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d45239726e3301-wk-Fact-1795BAA72F3AB427C7B6CCD313ACE63E"
      unitRef="usd">-39600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d45239726e3321-wk-Fact-BD1E9E43ECA910844A10CCD313A65287"
      unitRef="usd">-5500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d45239726e3342-wk-Fact-6AB7EC4B62E2D8F0CFE3CCD313AB88C4"
      unitRef="usd">367300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45239726e3361-wk-Fact-AFEDF1DE0BEA35BDB75FCCD313596B2B"
      unitRef="usd">1010900000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="d45239726e3376-wk-Fact-93E8AAB64F9FB4A88FBDCCD3139F2CB0"
      unitRef="shares">600000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d45239726e3414-wk-Fact-5520DE461494CBC14C5DCCD313912422"
      unitRef="usd">27500000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45239726e3506-wk-Fact-9B0807055A10FA8AF8C0CCD313AA00FE"
      unitRef="usd">27500000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d45239726e3637-wk-Fact-E2F999AC3F63F0949223CCD3139F87F8"
      unitRef="usd">54500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45239726e3656-wk-Fact-7DC5791E3DA27455A6AECCD31377CEF0"
      unitRef="usd">54500000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d45239726e3767-wk-Fact-A29F6BE908AA44DDFCD6CCD313A0AAD0"
      unitRef="usd">-4400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45239726e3807-wk-Fact-F702E6116BA005717710CCD3137114A2"
      unitRef="usd">-4400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="d45239726e3828-wk-Fact-D225C48870F32709B42FCCD31388821B"
      unitRef="shares">53000000.0</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="d45239726e3852-wk-Fact-21E6102EEEC1D45C8932CCD313910A0B"
      unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-5"
      id="d45239726e3871-wk-Fact-5BD09B64F3308D2DDD59CCD31398B5FA"
      unitRef="usd">716100000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="INF"
      id="d45239726e3886-wk-Fact-AA5DA49F7E8D4B6DC131CCD313A5D3ED"
      unitRef="shares">1200000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d45239726e3906-wk-Fact-8FF657C5FA99D972123ECCD313A95FC5"
      unitRef="usd">-39600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d45239726e3926-wk-Fact-8B694F970B5C4D0AAE3CCCD313AE3FE8"
      unitRef="usd">-9900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d45239726e3947-wk-Fact-F1CF84916BC5E1CB212ECCD3138D3F90"
      unitRef="usd">421800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45239726e3966-wk-Fact-0B3690615016B293BE9FCCD3135F817C"
      unitRef="usd">1088500000</us-gaap:StockholdersEquity>
    <us-gaap:NatureOfOperations
      contextRef="FD2019Q4YTD"
      id="TextSelection-A800F1C4D27C28FCD7F4CCD313BBA2AA-0-wk-Fact-9DB5AD1689EDB6E531CECCD3133173FA">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Nature of the business and organization&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Organization and business&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Emergent BioSolutions Inc. (the "Company" or "Emergent") is a global life sciences company focused on providing specialty products for civilian and military populations that address accidental, deliberate and naturally occurring public health threats ("PHTs," each a &#x201c;PHT&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company is focused on innovative preparedness and response products and solutions addressing the following &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;six&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; distinct PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives ("CBRNE"); emerging infectious diseases ("EID"); travel health; &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;emerging health crises, acute/emergency care, and contract development and manufacturing ("CDMO")&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. The Company has a product portfolio of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;twelve&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; products and product candidates (vaccines, therapeutics, and drug-device combination products) that generate a majority of our revenue. The U.S. government (the "USG') is the Company's largest customer and provides us with substantial funding for the development of a number of it&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;s product candidates.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;The Company's product portfolio includes:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Vaccines&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ACAM2000&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; (Smallpox (Vaccinia) Vaccine, Live), the only single-dose smallpox vaccine licensed by the FDA for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;BioThrax&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; (Anthrax Vaccine Adsorbed), the only vaccine licensed by the U.S. Food and Drug Administration ("FDA"), for the general use prophylaxis and post-exposure prophylaxis of anthrax disease;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Vaxchora&#xae; (Cholera Vaccine, Live, Oral), the only FDA-licensed vaccine for the prevention of cholera, it is orally delivered; and&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Vivotif&#xae; (Typhoid Vaccine Live Oral Ty21a), the only oral vaccine licensed by the FDA for the prevention of typhoid fever.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Devices&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;NARCAN&#xae; (naloxone HCl) Nasal Spray, the first and only needle-free formulation of naloxone approved by the FDA and Health Canada, for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;RSDL&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; (Reactive Skin Decontamination Lotion Kit), the only medical device cleared by the FDA to remove or neutralize the following chemical warfare agents from the skin: tabun, sarin, soman, cyclohexyl sarin, VR, VX, mustard gas and T-2 toxin; and&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Therapeutics&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;raxibacumab (Anthrax Monoclonal), the first fully human monoclonal antibody therapeutic licensed by the FDA for the treatment and prophylaxis of inhalational anthrax;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Anthrasil&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:pt"&gt;&#xae;&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; (Anthrax Immune Globulin Intravenous (Human)), the only polyclonal antibody therapeutic licensed by the FDA and Health Canada for the treatment of inhalational anthrax;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;BAT&#xae; (Botulism Antitoxin Heptavalent (A,B,C,D,E,F,G)-(Equine)), the only heptavalent antibody therapeutic licensed by the FDA and Health Canada for the treatment of botulism; and&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;VIGIV (Vaccinia Immune Globulin Intravenous (Human)), the only polyclonal antibody therapeutic licensed by the FDA and Health Canada to address certain complications from smallpox vaccination.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Product Candidates&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;AV7909&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:pt"&gt;&#xae;  &lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;(Anthrax Vaccine Absorbed with Adjuvant), is a product candidate being developed as a next generation anthrax vaccine for post-exposure prophylaxis of disease resulting from suspected or confirmed Bacillus antracis exposure. The USG has started procuring AV7909 for the SNS prior to its approval by the FDA and has been reducing its purchases of BioThrax as a result; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Trobigard&#xae; is a combination drug-device auto-injector product candidate that contains atropine sulfate and obidoxime chloride. It has not been approved by the FDA or any similar health regulatory body, but is procured by certain authorized government buyers under special circumstances for potential use as a nerve agent countermeasure. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company also generates revenue from contract development and manufacturing services on a clinical and commercial (small and large) scale by providing such services to the pharmaceutical and biotechnology industry.&#160; These services include process development and bulk drug substance and drug product manufacturing of biologics, fill/finish formulation and analytical development services for injectable and other sterile products, inclusive of process design, technical transfer, manufacturing validations, aseptic filling, lyophilization, final packaging and stability studies, as well as manufacturing of vial and pre-filled syringe formats across bacterial, viral and mammalian therapy technology platforms. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;We operate as &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:normal;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; operating segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <ebs:NumberOfCategoriesOfPublicHealthThreats
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d45239790e745-wk-Fact-8C0EA2876B98364DF72C4B70294D8DE7"
      unitRef="category">6</ebs:NumberOfCategoriesOfPublicHealthThreats>
    <ebs:NumberOfRevenueGeneratingProducts
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d45239790e753-wk-Fact-AFC4D7FEC1B69D9268EC53E9045A3EE9"
      unitRef="product">12</ebs:NumberOfRevenueGeneratingProducts>
    <us-gaap:NumberOfOperatingSegments
      contextRef="FD2019Q3YTD"
      decimals="INF"
      id="d45239790e886-wk-Fact-20F8B8EEF5B456B8A214AA36B150B705"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-718444C1A52C3D62A595CCD313BBC6B4-0-wk-Fact-28382D9B1EA77F59D98ACCD31363FF32">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Summary of significant accounting policies&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Basis of presentation and consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The accompanying consolidated financial statements include the accounts of Emergent and its wholly owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The preparation of financial statements in accordance with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) requires management to make estimates, judgments and assumptions that affect the amounts and disclosures reported in the consolidated financial statements and accompanying notes. Management continually re-evaluates its estimates, judgments and assumptions, and management&#x2019;s evaluations could change. These estimates are sometimes complex, sensitive to changes in assumptions and require fair value determinations using Level 3 fair value measurements. Actual results may differ materially from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Estimates and judgments inherent in the preparation of the consolidated financial statements include accounting for asset impairments, revenue recognition, allowances for doubtful accounts, inventory, depreciation and amortization, business comb&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;inations, contingent consideration, stock-based compensation, income taxes, and other contingencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Cash equivalents are highly liquid investments with a maturity of 90 days or less at the date of purchase and consist of time deposits and investments in money market funds with commercial banks and financial institutions. Also, the Company maintains cash balances with financial institutions in excess of insured limits. The Company does not anticipate any losses with such cash balances. Restricted cash includes cash that is not readily available for use in the Company's operating activities. Restricted cash is primarily comprised of cash pledged under letters of credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Fair value measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, an exit price, in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value include:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:left;padding-left:24px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="2"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:89%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Level 1 &#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Observable inputs for identical assets or liabilities such as quoted prices in active markets;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Level 2 &#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Inputs other than quoted prices in active markets that are either directly or indirectly observable; and&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Level 3 &#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Unobservable inputs in which little or no market data exists, which are therefore developed by the Company using estimates and assumptions that reflect those that a market participant would use.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;On a recurring basis, the Company measures and records money market funds (level 1), contingent purchase considerations (level 3) and interest-rate swap arrangements (level 2) using fair value measurements in the accompanying financial statements. On a non-recurring basis, the Company measures its IPR&amp;amp;D assets (level 3) using fair value measurements. The carrying amounts of the Company's short-term financial instruments, which include cash and cash equivalents, accounts receivable and accounts payable, approximate their fair values due to their short maturities. The &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;carrying amounts of the Company&#x2019;s long-term debt arrangements approximates their fair values due to variable interest rates which fluctuate with changes in market rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Significant customers and accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Billed accounts receivable are stated at invoice amounts and consist mostly of amounts due from the USG, as well as amounts due under reimbursement contracts with other government entities and non-government organizations. Our opioid overdose reversal product is sold commercially through physician-directed or standing order prescriptions at retail pharmacies, as well as state health departments, law enforcement agencies, state and local community based organizations, substance abuse centers and federal agencies. If necessary, the Company records a provision for doubtful receivables to allow for amounts which may be unrecoverable. This provision is based upon an analysis of the Company's prior collection experience, customer creditworthiness and current economic trends. Unbilled accounts receivable relates to various service contracts for which work has been performed, though invoicing has not yet occurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Concentration Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company has long-term contracts with the USG that expire at various times from 2020 through 2029. The Company has derived a significant portion of its revenue from sales of ACAM2000 and Anthrax Vaccines under contracts with the USG. The Company's current USG contracts do not necessarily increase the likelihood that it will secure future comparable contracts with the USG. The Company expects that a significant portion of the business will continue to be under government contracts that present a number of risks that are not typically present in the commercial contracting process. USG contracts for ACAM 2000 and Anthrax Vaccines are subject to unilateral termination or modification by the government. The Company may fail to achieve significant sales of ACAM 2000 and Anthrax Vaccines to customers in addition to the USG, which would harm its growth opportunities. The Company may not be able to manufacture Anthrax Vaccines consistently in accordance with FDA specifications. The Company's other product sales are largely sold commercially through physician-directed or standing order prescriptions at retail pharmacies, as well as to state health departments, local law enforcement agencies, community-based organizations, substance abuse centers and other federal agencies. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Although the Company seeks expand its customer base and to renew its agreements with its customers prior to expiration of a contract, a delay in securing a renewal or a failure to secure a renewal or a renewal on less favorable terms may have a material adverse effect on the Company&#x2019;s financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company&#x2019;s trade receivables do not represent a significant concentration of credit risk. The USG accounted for approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;61%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;76%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;78%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of total revenues for &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively, and approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;69%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;76%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of total accounts receivable as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively. Because accounts receivable consists primarily of am&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ounts due from the USG for product sales and from government agencies under government grants and development contracts, management does not deem the credit risk to be significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Financial Institutions&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Cash and cash equivalents are maintained with several financial institutions. The Company has deposits held with banks that exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with financial institutions of reputable credit and, therefore, bear minimal credit risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Lender Counterparties&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;There is lender counterparty risk associated with the Company's revolving credit facility and derivatives instruments. There is risk that the Company&#x2019;s revolving credit facility investors and derivative counterparties will not be available to fund as obligated. If funding under the revolving credit facility is unavailable, the Company may have to acquire a replacement credit facility from different counterparties at a higher cost or may be unable to find a suitable replacement. The Company seeks to manage risks from its revolving credit facility and derivative instruments by contracting with experienced large financial institutions and monitoring the credit quality of its lenders. As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company did not anticipate nonperformance by any of its counterparties.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Inventories are stated at the lower of cost or net realizable value with cost being determined using a standard cost method, which approximates average cost. Average cost consists primarily of material, labor and manufacturing overhead expenses (including fixed production-overhead costs) and includes the services and products of third-party suppliers. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company analyzes its inventory levels quarterly and writes down, in the applicable period, inventory that has become obsolete, inventory that has a cost basis in excess of its expected net realizable value and inventory in excess of expected customer demand. The Company also writes off, in the applicable period, the costs related to expired inventory.&#160;Costs of purchased inventories are recorded using weighted-average costing. The Company determines normal capacity for each production facility and allocates fixed production-overhead costs on that basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company records inventory acquired in business acquisitions utilizing the comparative sales method, which estimates the expected sales price reduced for all costs expected to be incurred to complete/dispose of the inventory with a profit on those costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Property, plant and equipment are stated at cost less accumulated depreciation and impairments. Depreciation is computed using the straight-line method over the following estimated useful lives:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="2"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:48%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Buildings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;31-39 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Building improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;10-39 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Furniture and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3-7 years or product life&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Lesser of the asset life or lease term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is credited or charged to operations. Repairs and maintenance costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company capitalizes internal-use software when both (a) the software is internally developed, acquired, or modified solely to meet the entity&#x2019;s internal needs and (b) during the software&#x2019;s development or modification, no substantive plan either exists or is being developed to market the software externally. Capitalization of qualifying internal-use software costs begins when the preliminary project stage is completed, management with the relevant authority, implicitly or explicitly, authorizes and commits to the funding of the software project, and it is probable that the project will be completed and the software will be used to perform the function intended.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company determines the fair value of the property, plant and equipment acquired in a business combination utilizing either the cost approach or the sales comparison approach. The cost approach is determined by establishing replacement cost of the ass&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;et and then subtracting any value that has been lost due to economic obsolescence, functional obsolescence, or physical deterioration. The sales comparison approach determines an asset is equal to the market price of an asset of comparable features such as design, location, size, construction, materials, use, capacity, specification, operational characteristics and other features or descriptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Income taxes are accounted for using the liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss and research and development tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Deferred income tax effects of transactions reported in different periods for financial reporting and income tax return purposes are recognized under the asset and liability method of accounting for income taxes. This method gives consideration to the future tax consequences of the deferred income tax items and immediately recognizes changes in income tax laws in the year of enactment. On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (the &#x201c;Tax Reform Act&#x201d;). Further information on the tax impacts of the Tax Reform Act is included in Note &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;12&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company's ability to realize deferred tax assets depends upon future taxable income as well as the limitations discussed below. For financial reporting purposes, a deferred tax asset must be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax assets will not be realized prior to expiration. The Company considers future taxable income and ongoing tax planning strategies in assessing the need for valuation allowances. In general, if the Company determines that it is more likely than not to realize more than the recorded amounts of net deferred tax assets in the future, the Company will reverse all or a portion of the valuation allowance &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;established against its deferred tax assets, resulting in a decrease to the provision for income taxes in the period in which the determination is made. Likewise, if the Company determines that it is not more likely than not to realize all or part of the net deferred tax asset in the future, the Company will establish a valuation allowance against deferred tax assets, with an offsetting increase to the provision for income taxes, in the period in which the determination is made.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Under sections 382 and 383 of the Internal Revenue Code, if an ownership change occurs with respect to a "loss corporation", as defined therein, there are annual limitations on the amount of net operating losses and deductions that are available. The Company has recognized the portion of net operating losses and research and development tax credits acquired that will not be limited and are more likely than not to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Because tax laws are complex and subject to different interpretations, significant judgment is required. As a result, the Company makes certain estimates and assumptions, in (1)&#160;calculating the Company's income tax expense, deferred tax assets and deferred tax liabilities, (2)&#160;determining any valuation allowance recorded against deferred tax assets and (3)&#160;evaluating the amount of u&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;nrecognized tax benefits, as well as the interest and penalties related to such uncertain tax positions. The Company's estimates and assumptions may differ significantly from tax benefits ultimately realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In determining whether an acquisition is a business combination versus an asset acquisition, the accounting guidance requires an entity to first evaluate whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If that threshold is met, the set of assets and activities is not a business and therefore treated as an asset acquisition. If that threshold is not met, the entity evaluates whether the set meets the definition of a business. If an acquired asset or asset group does not meet the definition of a business, the transaction is accounted for as an asset acquisition. Otherwise, the acquisition is treated as a business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In a business combination, the acquisition method of accounting requires that the assets acquired and liabilities assumed be recorded as of the date of the merger or acquisition at their respective fair values with limited exceptions and generally use Level 3 fair value measurements. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Accordingly, the Company may be required to value assets at fair values that do not reflect the Company's intended use of those assets. Any excess of the purchase price (consideration transferred) over the estimated fair values of net assets acquired is recorded as goodwill. Transaction costs and costs to restructure the acquired company are expensed as incurred. The operating results of the acquired business are reflected in the Company's consolidated financial statements after the date of the merger or acquisition. If the Company determines the assets acquired do not meet the definition of a business under the acquisition method of accounting, the transaction will be accounted for as an asset acquisition and recorded at cost rather than a business combination and, therefore, no goodwill will be recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The fair values of intangible assets, including acquired in-process research and development ("IPR&amp;amp;D"), are determined utilizing information available at or near the merger or acquisition date based on expectations and assumptions that are deemed reasonable by management. Given the considerable judgment involved in determining fair values, the Company typically obtains assistance from third-party valuation specialists for significant items. Amounts allocated to acquired IPR&amp;amp;D are capitalized and accounted for as indefinite-lived intangible assets. Upon successful completion of each project, the Company will make a separate determination as to the remaining useful life of the asset and begin amortization. The judgments made in determining estimated fair values assigned to assets acquired and liabilities assumed in a business combination, as well as asset lives, can materially affect the Company&#x2019;s results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The fair values of identifiable intangible assets related to current products and product rights are primarily determined by using an income approach through which fair value is estimated based on each asset&#x2019;s discounted projected net cash flows. The Company's estimates of market participant net cash flows consider historical and projected pricing, margins and expense levels, the performance of competing products where applicable, relevant industry and therapeutic area growth drivers and factors, current and expected trends in technology and product life cycles, the time and investment that will be required to develop products and technologies, the ability to obtain marketing and regulatory approvals, the ability to manufacture and commercialize the products, the extent and timing of potential new product introductions by the Company&#x2019;s competitors, and the life of each asset&#x2019;s underlying patent, if any. The net cash flows are then probability-adjusted where appropriate to consider the uncertainties associated with the underlying assumptions, as well as the &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;risk profile of the net cash flows utilized in the valuation. The probability-adjusted future net cash flows of each product are then discounted to present value utilizing an appropriate discount rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The fair values of identifiable intangible assets related to IPR&amp;amp;D are determined using an income approach, through which fair value is estimated based on each asset&#x2019;s probability-adjusted future net cash flows, which reflect the different stages of development of each product and the associated probability of successful completion. The net cash flows are then discounted to present value using an appropriate discount rate. Indefinite-lived intangible assets are tested for impairment annually or whenever events or changes in circumstances indicate that its carrying amount may not be recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Assets acquired and liabilities assumed in a business combination that arise from contingencies are recognized at fair value if fair value can reasonably be estimated. If the acquisition date fair value of an asset acquired or liability assumed that arises from a contingency cannot be determined, the asset or liability is recognized if probable and reasonably estimable&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;; if these criteria are not met, no asset or liability is recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Asset Impairment Analysis&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Goodwill and Indefinite-lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Goodwill is allocated to the Company's reporting units, which are one level below its operating segment. The Company evaluates goodwill and other indefinite-lived intangible assets for impairment annually as of October&#160;1 and earlier if an event or other circumstance indicates that we may not recover the carrying value of the asset. If the Company believes that as a result of its qualitative assessment it is more likely than not that the fair value of a reporting unit or other indefinite-lived intangible asset is greater than its carrying amount, the quantitative impairment test is not required. If however it is determined that it is not more likely than not that the fair value of a reporting unit or other indefinite-lived intangible asset is greater than its carrying amount, a quantitative test is required.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The quantitative goodwill impairment test is performed using a two-step process. The first step of the process is to compare the fair value of a reporting unit with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is not impaired and the second step of the quantitative impairment test is not necessary. If the carrying amount of a reporting unit exceeds its fair value, the second step of the quantitative goodwill impairment test is required to be performed to measure the amount of impairment loss, if any. The second step of the quantitative goodwill impairment test compares the implied fair value of the reporting unit&#x2019;s goodwill with the carrying amount of that goodwill. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination. In other words, the estimated fair value of the reporting unit&#x2019;s identifiable net assets excluding goodwill is compared to the fair value of the reporting unit as if the reporting unit had been acquired in a business combination and the fair value of the reporting unit was the purchase price paid. If the carrying amount of the reporting unit&#x2019;s goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to that excess. The Company used a qualitative assessment for our goodwill impairment testing for &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. The qualitative evaluation completed during the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; indicated &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; impairment losses. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company has mater&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ial indefinite lived intangible assets associated with in-process research and development (IPR&amp;amp;D) which were acquired as part of the acquisitions completed in the fourth quarter of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Following a qualitative assessment indicating that it is not more likely than not that the fair value of the indefinite lived intangible asset exceeds its carrying amount, impairment of other intangible assets not subject to amortization involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. Determining fair value requires the exercise of judgment about appropriate discount rates, perpetual growth rates and the amount and timing of expected future cash flows.&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; The Company used a quantitative assessment for our IPR&amp;amp;D impairment testing for &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and determined there was an impairment loss of $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;12.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million, which was recorded as a component of R&amp;amp;D expense (see Notes &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;4&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Acquisitions&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;5&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Fair value measurements&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;). &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Long-lived assets such as intangible assets and property, plant and equipment are not required to be tested for impairment annually. Instead, long-lived assets are tested for impairment whenever circumstances indicate that the carrying amount of the asset may not be recoverable, such as when the disposal of such assets is likely or there is an adverse change in the market involving the business employing the related assets. If an impairment analysis is required, the impairment test employed is based on whether the Company&#x2019;s intent is to hold the asset for continued use or to hold the asset for sale. If the intent is to hold the asset for continued use, the impairment test first requires a comparison &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;of undiscounted future cash flows to the carrying value of the asset. If the carrying value of the asset exceeds the undiscounted cash flows, the asset would not be deemed to be recoverable. Impairment would then be measured as the excess of the asset&#x2019;s carrying value over its fair value. Fair value is typically determined by discounting the future cash flows associated with that asset. If the intent is to hold the asset for sale and certain other criteria are met, the impairment test involves comparing the asset&#x2019;s carrying value to its fair value less costs to sell. To the extent the carrying value is greater than the asset&#x2019;s fair value less costs to sell, an impairment loss is recognized in an amount equal to the difference. Significant judgments used for long-lived asset impairment assessments include identifying the appropriate asset groupings and primary assets within those groupings, determining whether events or circumstances indicate that the carrying amount of the asset may not be recoverable, determining the future cash flows for the assets involved and assumptions applied in determining fair value, which include, reasonable discount rates, growth rates, market risk premiums and other assumptions about the economic environment.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In connection with the Company's acquisitions accounted for as business combinations, the Company records contingent consideration associated with sales-based royalties, sales-based milestones and development and regulatory milestones at fair value. The fair value model used to calculate these obligations is based on the income approach (a discounted cash flow model) that has been risk adjusted based on the probability of achievement of net sales and achievement of the milestones. The inputs the Company uses for determining the fair value of the contingent consideration associated with sales-based royalties, sales-based milestones and development and regulatory milestones are Level 3 fair value measurements. The Company re-evaluates the fair value on a quarterly basis. Changes in the fair value can result from adjustments to the discount rates and updates in the assumed timing of or achievement of net sales and/or the achievement of development and regulatory milestones. Any future increase in the fair value of the contingent consideration associated with sales-based royalties and sales-based milestones along with development and regulatory milestones are based on an increased likelihood that the underlying net sales or milestones will be achieved.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The associated payments which will become due and payable for sales-based royalties and milestones result in a charge to cost of product sales and contract development and manufacturing in the period in which the increase is determined. Similarly, any future decrease in the fair value of contingent consideration associated with sales-based royalties and sales-based milestones will result in a reduction in cost of product sales and contract development and manufacturing. The changes in fair value for potential future sales-based royalties associated with product candidates in development will result in a charge to cost o&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;f product sales and contract development and manufacturing services &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;expense in the period in which the increase is determined. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The associated payment or payments which will become due and payable for development and regulatory milestones will result in a charge to research and development expense in the period in which the increase is determined. Similarly, any future decrease i&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;n the fair value for development and regulatory milestones will result in a reduction in research and development expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;On January 1, 2018 the Company adopted ASC topic 606 using the modified retrospective approach applied to those contracts in effect as of January 1, 2018. Under this transition method, results for reporting periods beginning after January 1, 2018 are presented under the new standard, while prior period amounts are not adjusted and continue to be reported in accordance with historical accounting under Topic 605. See further discussion of the adoption of Topic 606, including the impact to our 2018 financial statements within the recently issued accounting standards section below.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company recognizes revenue when the Company's customers obtain control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services by analyzing the following five steps: (1) identify the contract with a customer(s); (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;contract; and (5) recognize revenue when (or as) the entity satisfies a performance obligation. To indicate the transfer of control for the Company&#x2019;s product sales and contract development and manufacturing services, it must have a present right to payment, legal title must have passed to the customer, and the customer must have the significant risks and rewards of ownership. Revenue for long-term development contracts is generally recognized based upon the cost-to-cost measure of progress, provided that the Company meets the criteria associated with transferring control of the good or service over time.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Multiple performance obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. Contracts sometimes include options for customers to purchase additional products or services in the future. Customer options that provide a material right to the customer, such as free or discounted products or services, give rise to a separate performance obligation. For contracts with multiple performance obligations, the Company allocates the contract price to each performance obligation on a relative standalone selling price basis using the Company&#x2019;s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers, however when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the contracts&#x2019; inception.  &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Transaction price and variable consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Once the performance obligations in the contract have been identified, the Company estimates the transaction price of the contract. The estimate includes amounts that are fixed as well as those that can vary based on expected outcomes of the activities or contractual terms. The Company's variable consideration includes for example consideration transferred under its development contracts with the USG as consideration received can vary based on developmental progression of the product candidate(s). When a contract's transaction price includes variable consideration, the Company evaluates the variable consideration to determine whether the estimate needs to be constrained; therefore, the Company includes the variable consideration in the transaction price only to the extent that it is probable that a significant reversal of the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Variable consideration estimates are updated at each reporting date. There were &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;no&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; significant constraints or material changes to the Company's variable consideration estimates as of or during the twelve months ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Contract financing&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money if the timing of payments agreed to by the parties to the contract (either explicitly or implicitly) provides the customer with a significant benefit of financing the transfer of goods or services to the customer, which is called a significant financing component. The Company does not adjust transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Product sales&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;CBRNE&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The primary customer for the Company's CBRNE&#160;products and the primary source of funding for the development of its CBNRE product candidate portfolio is the USG. The Company's contracts for the sale of CBRNE products generally have a single performance obligation. Certain product sales contracts with the USG include multiple performance obligations, which generally include the marketed product, stability testing associated with that product, expiry extensions and plasma collection. The USG contracts for the sale of the Company's CBRNE&#160;products are normally multi-year contracts. AV7909 and Trobigard are product candidates that are not approved by the FDA or any other health agency, but are procured by certain government agencies under special circumstances. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The transaction price for product sales are based on a cost build-up model with a mark-up. For our product sales, we recognize revenue at a "point in time" when the Company&#x2019;s performance obligations have been satisfied and control of the products transfer to the customer. This &#x201c;point in time&#x201d; depends on several factors, including delivery, transfer of legal title, transition of risk and rewards of the product to the customer and the Company's right to payment. The USG contracts for the sale of the Company's CBRNE products also include certain acceptance criteria before title passes to the USG.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Opioid and travel health products &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Revenues are recognized when control of the goods are transferred to our customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Prior to recognizing revenue, the Company makes estimates of the transaction price, including variable consideration that is subject to a constraint. Allowances for returns, specialty distributor fees, wholesaler fees, prompt payment discounts, government &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;rebates, chargebacks and rebates under managed care plans are considered in determining the variable consideration. Revenues from sales of products is recognized to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with such variable consideration is subsequently resolved. Product sales revenue is recognized when control has transferred to the customer, which occurs at a point in time, which is typically upon delivery to the customer. Provisions for variable consideration revenues from sales of products are recorded at the net sales price, which includes estimates of variable consideration for which provisions are established and which relate to returns, specialty distributor fees, wholesaler fees, prompt payment discounts, government rebates, chargebacks and rebates under managed care plans. Calculating certain of these provisions involves estimates and judgments and the Company determines their expected value based on sales or invoice data, contractual terms, historical utilization rates, new information regarding changes in these programs&#x2019; regulations and guidelines that would impact the amount of the actual rebates, the Company's expectations regarding future utilization rates for these programs and channel inventory data. These provisions reflect the Company's best estimate of the amount of consideration to which the Company is entitled based on the terms of the contract. The amount of variable consideration that is included in the transaction price may be constrained and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. The Company reassesses the Company's provisions for variable consideration at each reporting date. Historically, adjustments to estimates for these provisions have not been material.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Provisions for returns, specialty distributor fees, wholesaler fees, government rebates and rebates under managed care plans are included within current liabilities in the Company's consolidated balance sheets. Provisions for chargebacks and prompt payment discounts are shown as a reduction in accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:normal;"&gt;Contract development and manufacturing services&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company performs contract development and manufacturing services for third parties. Under these contracts, activities can include pharmaceutical product process development, manufacturing and filling services for injectable and other sterile products, inclusive of process design, technical transfer, manufacturing validations, laboratory analytical development support, aseptic filling, lyophilization, final packaging and accelerated and ongoing stability studies. These contracts, with a duration that is less than one year, generally include a single performance obligation as the customer benefits from our performance upon full completion of our services. The performance obligation is satisfied when the Company must have a present right to payment because legal title has passed to the customer, the goods are in the customer&#x2019;s possession with all the risks and rewards of ownership, and the efficacy of the goods has been confirmed. The Company recognizes revenue at a "point in time" based on when the performance obligation to the customer is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:normal;"&gt;Contracts and grants&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company generates contract and grant revenue primarily from cost-plus-fee contracts associated with development of certain product candidates. Revenues from reimbursable contracts are recognized as costs are incurred, generally based on allowable costs incurred during the period, plus any recognizable earned fee. The Company uses this input method to measure progress as the customer has the benefit of access to the development research under these projects and therefore benefits from the Company's performance incrementally as research and development activities occur under each project. We consider fixed fees under cost-plus-fee contracts to be earned in proportion to the allowable costs incurred in performance of the contract. We analyze costs for contracts and reimbursable grants to ensure reporting of revenues gross versus net is appropriate. Revenue for long-term development contracts is considered variable consideration, because the deliverable is dependent on the successful completion of development and is generally recognized based upon the cost-to-cost measure of progress, provided that the Company meets the criteria associated with satisfying the performance obligation over time. The USG contracts for the development of the Company's CBRNE product candidates are normally multi-year contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Research and development&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;We expense research and development costs as incurred. The Company's research and development expenses consist primarily of:&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;personnel-related expenses;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;fees to professional service providers for, among other things, analytical testing, independent monitoring or other administration of the Company's clinical trials and obtaining and evaluating data from the Company's clinical trials and non-clinical studies;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;costs of contract development and manufacturing services for clinical trial material; and&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;costs of materials used in clinical trials and research and development.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Comprehensive income is comprised of net income and other changes in equity that are excluded from net income. The Company includes translation gains and losses incurred when converting its subsidiaries' financial statements from their functional currency to the U.S. dollar in accumulated other comprehensive income as well as gains and losses on its pension benefit obligation and derivative instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Translation of Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;For our non-U.S. subsidiaries that transact in a functional currency other than the U.S. dollar, assets and liabilities are translated at current rates of exchange at the balance sheet date. Income and expense items are translated at the average foreign currency exchange rates for the period. Adjustments resulting from the translation of the financial statements of our foreign operations into U.S.&#160;dollars are excluded from the determination of net income and are recorded in accumulated other comprehensive income, a separate component of equity. For subsidiaries where the functional currency of the assets and liabilities differ from the local currency, non-monetary assets and liabilities are translated at the rate of exchange in effect on the date assets were acquired while monetary assets and liabilities are translated at current rates of exchange as of the balance sheet date. Income and expense items are translated at the average foreign currency rates for the period. Translation adjustments of these subsidiaries are included in other income (expense), net in our consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Earnings per share&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company calculates basic earnings per share by dividing net income by the weighted average number of shares of common stock outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;For the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company calculated diluted earnings per share using the treasury method by dividing net income by the weighted average number of shares of common stock outstanding during the period. For the year ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company calculated diluted earnings per share using the if-converted method by dividing the adjusted net income by the adjusted weighted average number of shares of common stock outstanding during the period. The adjusted net income was adjusted for interest expense and amortization of debt issuance cost, both net of tax, associated with the Company's &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2.875%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; Convertible Senior Notes due 2021 (the "Notes"). The weighted average number of diluted shares was adjusted for the potential dilutive effect of the exercise of stock options and the vesting of restricted stock units along with the assumption of the conversion of the Notes, each at the beginning of the period. During the fourth quarter of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company issued a notice of termination of conversion rights related to the Notes and issued &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;8.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; shares of common stock due to conversions that occurred in &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. After the date of conversion and during the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Notes are strictly debt instruments and, therefore, no longer impact the diluted earnings per share calculation. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Accounting for stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company has &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; stock-based employee compensation plan, the Emergent BioSolutions Inc. Stock Incentive Plan (the "Emergent Plan"), under which the Company may grant various types of equity awards including stock options,  restricted stock units and performance stock units.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The terms and conditions of equity awards (such as price, vesting schedule, term and number of shares) under the Emergent Plan is determined by the compensation committee of the Company's board of directors, which administers the Emergent Plan. Each equity award granted under the Emergent Plan vests as specified in the relevant agreement with the award recipient and no option can be exercised after either &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;seven&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; or &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; from the date of grant depending on the grant date. The Company charges the estimated fair value of awards against income on a straight-line basis over the requisite service period, which is generally the vesting period. Where awards are made with non-substantive vesting periods (for instance, where a portion of the award vests upon retirement eligibility), the Company estimate and recognize expense based on the period from the grant date to the date the employee becomes retirement eligible.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company determines the fair value of restricted stock units using the closing market price of the Company's common stock on the day prior to the date of grant. The Company's performance stock units settle in stock. The fair value is determined on the date of the grant using the number of shares expected to be earned and the ending market value of the stock on the grant date. The number of shares expected to vest is determined by assessing the probability that the performance criteria will be met and the associated targeted payout level that is forecasted will be achieved. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company utilizes the Black-Scholes valuation model for estimating the fair value of all stock options granted. Set forth below is a discussion of the Company's methodology for developing each of the assumptions used:&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Expected dividend yield &#x2014; the Company does not pay regular dividends on its common stock and does not anticipate paying any dividends in the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Expected volatility &#x2014; a measure of the amount by which a financial variable, such as share price, has fluctuated (historical volatility) or is expected to fluctuate (implied volatility) during a period. The Company analyzed its own historical volatility to estimate expected volatility over the same period as the expected average life of the options.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Risk-free interest rate &#x2014; the range of U.S. Treasury rates with a term that most closely resembles the expected life of the option as of the date on which the option is granted.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Expected average life of options &#x2014; the period of time that options granted are expected to remain outstanding, based primarily on the Company's expectation of optionee exercise behavior subsequent to vesting of options.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Pension plans&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company maintains defined benefit plans for employees in certain countries outside the U.S., including retirement benefit plans required by applicable local law. The plans are valued by independent actuaries using the projected unit credit method. The liabilities correspond to the projected benefit obligations of which the discounted net present value is calculated based on years of employment, expected salary increase, and pension adjustments. The Company reviews its actuarial assumptions on an annual basis and makes modifications to the assumptions based on current rates and trends. Actuarial gains and losses are deferred in accumulated other comprehensive income, net of tax and are amortized over the remaining service attribution periods of the employees under the corridor method. Differences between the expected long-term return on plan assets and the actual annual return are amortized to net periodic benefit cost over the estimated remaining life as a component of selling, general and administrative expenses in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company's interest rate swaps qualify for hedge accounting as cash flow hedges. All derivatives are recorded on the balance sheet at fair value.&#160;Hedge accounting provides for the matching of the timing of gain or loss recognition on these interest rate swaps with the recognition of the changes in interest expense on the Company's variable rate debt. For derivatives designated as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#x2019;s variable-rate debt. The cash flows from the designated interest rate swaps are classified as a component of operating cash flows, similar to interest expense.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Recently issued accounting standards&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2016-2,&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Leases (Topic 842)&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#160;("ASU 2016-2")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In February 2016, the FASB issued ASU 2016-2. ASU 2016-2 increased transparency and comparability among organizations by requiring the recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements for both lessees and lessors. The Company adopted the new standard effective January 1, 2019 using the modified retrospective approach. An entity that applies the transition provisions at the beginning of the period of adoption records its cumulative adjustment to the opening balance of retained earnings in the period of adoption rather than in the earliest period presented (i.e., January 1, 2019). In this case, an entity continues to apply the legacy guidance in ASC 840, including its disclosure requirements, in the comparative periods presented in the year it adopts the standard.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company utilized the transition package of certain practical expedients permitted: ASC 842-10-65-1(f) and ASC 842-10-65-1(g). The Company made an accounting policy election that kept leases with an initial term of 12 months or less off of the balance sheet which resulted in recognizing those lease payments in the consolidated statements of operations on a straight-line basis over the lease term. In addition, the Company has made an accounting policy election, by class of underlying asset, to not separate non-lease components from lease components and instead to account &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;for each separate lease component, and the non-lease components associated with that lease component, as a single lease component.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;January&#160;1, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; the total right of use assets increased &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$13.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, while total operating lease liabilities increased &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$14.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. There was no adjustment to the opening balance of retained earnings as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;January&#160;1, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. The standard has not materially affect the Company's consolidated net earnings. The Company continues to apply the legacy guidance from the old lease accounting standard, including its disclosure requirements, in the comparative periods presented (see Note &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;14&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU No. 2014-9, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Revenue from Contracts with Customers (Topic 606)&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; ("ASU 2014-9")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In May 2014, the Financial Accounting Standards Board ("FASB") issued ASU No. 2014-9. ASU No. 2014-9 (known as ASC 606) supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, as well as most industry-specific guidance, and significantly enhances comparability of revenue recognition practices across entities and industries by providing a principles-based, comprehensive framework for addressing revenue recognition issues. The Company adopted ASC 606 as of January 1, 2018 using the modified retrospective method resulting in an adjustment to opening retained earnings of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$32.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; for the cumulative effect of initially applying the new standard.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Under ASC 606, the Company finalized the review of its portfolio of revenue contracts that were not complete as of the adoption date and made its determination of its revenue streams as well as completed extensive contract specific reviews to determine the impact of the new standard on its historical and prospective revenue recognition. Because many of the Company's significant contracts with customers have unique contract terms, the Company reviewed all its non-standard agreements in order to determine the effect of adoption. The Company tested a sample of remaining agreements to verify that there were no changes in accounting based on the assumption that these contracts had similar characteristics and that the effects on the financial statements would not differ materially from applying this guidance to the individual contracts. To estimate the financial impacts of the adoption, the Company did not apply the contract modification practical expedient and retrospectively restated long-term contracts for any contract modifications.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The opening balance sheet adjustment as of January 1, 2018, was the result of the Centers for Innovation in Advanced Development and Manufacturing ("CIADM") contract with the Biomedical Advanced Research and Development Authority ("BARDA"). Under ASC 606 at January 1, 2018, the Company determined that the performance obligation under the arrangement is to provide ongoing manufacturing capability to the USG and would recognize the consideration received in the initial &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;7 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; year base period on a straight-line basis over a &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;-year period as the capability being created during the base period of the contract is being provided to the customer over both the base period contract term as well as &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; additional option periods. As the Company&#x2019;s performance obligation is providing the USG with continuous access to its production capabilities throughout the contract duration, a time-based measure resulting in straight-line revenue recognition is proportionate to the Company&#x2019;s progress in satisfying the performance obligation when compared to the total progress. This measure of progress is most reflective of the Company satisfying the performance obligation over time. Beginning in June 2013, the Company was expected to be able to stand ready and be available to respond to the USG and importantly to respond to any task orders that may be issued during the base period and additional option periods. Being able to stand ready to perform in the event of an outbreak is of importance to the USG and by entering into this arrangement with the Company, the USG expected to receive the benefit of having access to Company&#x2019;s readiness and its capability to immediately respond to public health threats. The Company concluded the identified stand-ready performance obligations represent a series of distinct services that are substantially the same and have the same pattern of transfer to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In addition, the Company determined the CIADM contract includes a significant financing component which is included in the transaction price. The Company calculated the financing component using an interest rate the Company had on its other debt obligations at inception of the contract. The difference in revenue recognized under ASC 605 vs. ASC 606, as of the adoption date, was primarily attributable to the difference in the overall consideration or transaction price resulting from different accounting treatment related to options within the contract and the inclusion of a significant financing component under ASC 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Prior to the adoption of ASC 606, the Company recognized revenue under the CIADM contract on a straight-line basis, based upon its estimate of the total payments to be received under the contract. The Company analyzes the estimated payments to be received on a quarterly basis to determine if an adjustment to revenue was required. As a result of the adoption of ASC 606, as of January 1, 2018, there was an increase in the deferred revenue liability of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$42.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and an increase in deferred tax assets of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$9.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; with an offsetting reduction to retained earnings of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$32.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2018-2,&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Income Statement - Reporting Comprehensive Income (Topic 220):&#160;Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; ("ASU 2018-2")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In February 2018, the FASB issued ASU 2018-2. ASU 2018-2 provides the option to reclassify certain income tax effects related to the Tax Cuts and Jobs Act passed in December of 2017 between accumulated other comprehensive income and retained earnings and also requires additional disclosures.&#160;ASU 2018-2 is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted.&#160;Adoption of ASU 2018-2 is to be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the tax laws or rates were recognized.&#160;The adoption of ASU 2018-2 did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2016-13,&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;("ASU 2016-13")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In June 2016, the FASB issued ASU 2016-13. ASU 2016-13 provides guidance on measurement of credit losses on financial instruments that changes the impairment model for most financial assets and certain other instruments, including trade and other receivables, held-to-maturity debt securities and loans, and that requires entities to use a new, forward-looking &#x201c;expected loss&#x201d; model that is expected to generally result in the earlier recognition of allowances for losses. The guidance&#160;became effective for annual periods beginning after December 15, 2019, including interim periods within those years, but early adoption is permitted. The Company has evaluated the effects of this standard and determined that the adoption will not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2017-4,&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; ("ASU 2017-4")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In January 2017, the FASB issued ASU 2017-4. ASU 2017-4 simplifies the subsequent measurement of goodwill and eliminates Step 2 from the goodwill impairment test. ASU 2017-4 is effective for annual and interim goodwill tests beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates on or after January 1, 2017. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2018-13,&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;&#160;Fair Value Measurement - Disclosure Framework (Topic 820)&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;("ASU 2018-13")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In August 2018, the FASB issued ASU 2018-13. ASU 2018-13 improves the disclosure requirements on fair value measurements. The updated guidance if effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted for any removed or modified disclosures. The Company is currently assessing the timing and impact of adopting the updated provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2018-14,&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;&#160;Compensation -&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Retirement Benefits - Defined Benefit Plans - General (Topic 715-20):&#160;Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#160;("ASU 2018-14")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In August 2018, the FASB issued ASU 2018-14. ASU 2018-14 modifies the disclosure requirements for defined benefit pension plans and other post-retirement plans. ASU 2018-14 is effective for all entities for fiscal years ending after December 15, 2020, and earlier adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2018-14 on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2018-15,&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; ("ASU 2018-15")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In August 2018, the FASB issued ASU 2018-15. ASU 2018-15 clarifies the accounting for implementation costs in cloud computing arrangements. ASU 2018-15 is effective for all entities for fiscal years beginning after December 15, 2019, and earlier adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2018-15 on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2019-12, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Simplifications to Accounting for Income Taxes &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;("ASU 2019-12")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In December 2019, the FASB issued ASU 2019-12. ASU 2019-12 removes certain exceptions for recognizing deferred taxes for investments, performing intra-period allocation and calculating income taxes in interim periods. The ASU also adds guidance to reduce complexity in certain areas, including deferred taxes for goodwill and allocating taxes for members of a consolidated group. ASU 2019-12 is effective for all entities for fiscal years beginning after December &lt;/span&gt;&lt;/div&gt;15, 2020, and earlier adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2019-12 on its consolidated financial statements.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-A746A1A3ACD1894585E8F18F1CD7BDA1-0-wk-Fact-4E5172CE3A1F196CB33EF18F3B5DDE3B">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Basis of presentation and consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The accompanying consolidated financial statements include the accounts of Emergent and its wholly owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="FD2019Q4YTD"
      id="TextSelection-15F4DECB56F8495F2E72F1903D6CD905-0-wk-Fact-FF7E0328EC6B48BC11A9F1904A956FB5">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The preparation of financial statements in accordance with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) requires management to make estimates, judgments and assumptions that affect the amounts and disclosures reported in the consolidated financial statements and accompanying notes. Management continually re-evaluates its estimates, judgments and assumptions, and management&#x2019;s evaluations could change. These estimates are sometimes complex, sensitive to changes in assumptions and require fair value determinations using Level 3 fair value measurements. Actual results may differ materially from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Estimates and judgments inherent in the preparation of the consolidated financial statements include accounting for asset impairments, revenue recognition, allowances for doubtful accounts, inventory, depreciation and amortization, business comb&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;inations, contingent consideration, stock-based compensation, income taxes, and other contingencies.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-515400D39367EAFE22DFF1909EFB2911-0-wk-Fact-92F0304C327D43E1A838F190B0B2F09D">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Cash equivalents are highly liquid investments with a maturity of 90 days or less at the date of purchase and consist of time deposits and investments in money market funds with commercial banks and financial institutions. Also, the Company maintains cash balances with financial institutions in excess of insured limits. The Company does not anticipate any losses with such cash balances. Restricted cash includes cash that is not readily available for use in the Company's operating activities. Restricted cash is primarily comprised of cash pledged under letters of credit.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-2A185E3F0D0046D625C4F190F09BB031-0-wk-Fact-C9FAA12CB0C3DE3A89B1F190FC81D251">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Fair value measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, an exit price, in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value include:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:left;padding-left:24px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="2"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:89%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Level 1 &#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Observable inputs for identical assets or liabilities such as quoted prices in active markets;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Level 2 &#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Inputs other than quoted prices in active markets that are either directly or indirectly observable; and&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Level 3 &#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Unobservable inputs in which little or no market data exists, which are therefore developed by the Company using estimates and assumptions that reflect those that a market participant would use.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;On a recurring basis, the Company measures and records money market funds (level 1), contingent purchase considerations (level 3) and interest-rate swap arrangements (level 2) using fair value measurements in the accompanying financial statements. On a non-recurring basis, the Company measures its IPR&amp;amp;D assets (level 3) using fair value measurements. The carrying amounts of the Company's short-term financial instruments, which include cash and cash equivalents, accounts receivable and accounts payable, approximate their fair values due to their short maturities. The &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;carrying amounts of the Company&#x2019;s long-term debt arrangements approximates their fair values due to variable interest rates which fluctuate with changes in market rates.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:MajorCustomersPolicyPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-58A3DC8EAEAD0002B27FF191B4D75717-0-wk-Fact-D8345FEA3554FAC2D246F191C17CE1F3">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Significant customers and accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Billed accounts receivable are stated at invoice amounts and consist mostly of amounts due from the USG, as well as amounts due under reimbursement contracts with other government entities and non-government organizations. Our opioid overdose reversal product is sold commercially through physician-directed or standing order prescriptions at retail pharmacies, as well as state health departments, law enforcement agencies, state and local community based organizations, substance abuse centers and federal agencies. If necessary, the Company records a provision for doubtful receivables to allow for amounts which may be unrecoverable. This provision is based upon an analysis of the Company's prior collection experience, customer creditworthiness and current economic trends. Unbilled accounts receivable relates to various service contracts for which work has been performed, though invoicing has not yet occurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:MajorCustomersPolicyPolicyTextBlock>
    <ebs:ConcentrationsRiskPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-200B47B32D34AB251077F192CFDEE5DB-0-wk-Fact-8D99252F6AC97F67A0F1F192E1A5D1D5">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Concentration Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company has long-term contracts with the USG that expire at various times from 2020 through 2029. The Company has derived a significant portion of its revenue from sales of ACAM2000 and Anthrax Vaccines under contracts with the USG. The Company's current USG contracts do not necessarily increase the likelihood that it will secure future comparable contracts with the USG. The Company expects that a significant portion of the business will continue to be under government contracts that present a number of risks that are not typically present in the commercial contracting process. USG contracts for ACAM 2000 and Anthrax Vaccines are subject to unilateral termination or modification by the government. The Company may fail to achieve significant sales of ACAM 2000 and Anthrax Vaccines to customers in addition to the USG, which would harm its growth opportunities. The Company may not be able to manufacture Anthrax Vaccines consistently in accordance with FDA specifications. The Company's other product sales are largely sold commercially through physician-directed or standing order prescriptions at retail pharmacies, as well as to state health departments, local law enforcement agencies, community-based organizations, substance abuse centers and other federal agencies. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Although the Company seeks expand its customer base and to renew its agreements with its customers prior to expiration of a contract, a delay in securing a renewal or a failure to secure a renewal or a renewal on less favorable terms may have a material adverse effect on the Company&#x2019;s financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company&#x2019;s trade receivables do not represent a significant concentration of credit risk. The USG accounted for approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;61%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;76%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;78%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of total revenues for &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively, and approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;69%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;76%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of total accounts receivable as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively. Because accounts receivable consists primarily of am&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ounts due from the USG for product sales and from government agencies under government grants and development contracts, management does not deem the credit risk to be significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Financial Institutions&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Cash and cash equivalents are maintained with several financial institutions. The Company has deposits held with banks that exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with financial institutions of reputable credit and, therefore, bear minimal credit risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Lender Counterparties&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;There is lender counterparty risk associated with the Company's revolving credit facility and derivatives instruments. There is risk that the Company&#x2019;s revolving credit facility investors and derivative counterparties will not be available to fund as obligated. If funding under the revolving credit facility is unavailable, the Company may have to acquire a replacement credit facility from different counterparties at a higher cost or may be unable to find a suitable replacement. The Company seeks to manage risks from its revolving credit facility and derivative instruments by contracting with experienced large financial institutions and monitoring the credit quality of its lenders. As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company did not anticipate nonperformance by any of its counterparties.&lt;/span&gt;&lt;/div&gt;</ebs:ConcentrationsRiskPolicyTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember"
      decimals="2"
      id="d45240615e845-wk-Fact-20E74D71369AB31921ABCCD3133D13DD"
      unitRef="number">0.61</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember"
      decimals="2"
      id="d45240615e849-wk-Fact-4749A820B80A9EA996D8CCD31332D2F3"
      unitRef="number">0.76</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2017Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember"
      decimals="2"
      id="d45240615e853-wk-Fact-D0D72AD2F7EF4FAFD7E1CCD3133E812F"
      unitRef="number">0.78</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember"
      decimals="2"
      id="d45240615e870-wk-Fact-BABCA966275889EC24C2CCD313699766"
      unitRef="number">0.69</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember"
      decimals="2"
      id="d45240615e874-wk-Fact-D099732EAB399864CDB1CCD3136A355C"
      unitRef="number">0.76</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-CC789D15256543043027F19361C748A5-0-wk-Fact-B58488A6BFA5ADEDF047F1936C428DD2">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Inventories are stated at the lower of cost or net realizable value with cost being determined using a standard cost method, which approximates average cost. Average cost consists primarily of material, labor and manufacturing overhead expenses (including fixed production-overhead costs) and includes the services and products of third-party suppliers. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company analyzes its inventory levels quarterly and writes down, in the applicable period, inventory that has become obsolete, inventory that has a cost basis in excess of its expected net realizable value and inventory in excess of expected customer demand. The Company also writes off, in the applicable period, the costs related to expired inventory.&#160;Costs of purchased inventories are recorded using weighted-average costing. The Company determines normal capacity for each production facility and allocates fixed production-overhead costs on that basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company records inventory acquired in business acquisitions utilizing the comparative sales method, which estimates the expected sales price reduced for all costs expected to be incurred to complete/dispose of the inventory with a profit on those costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-323780F717CBF4DF833BF193C3C7D3E4-0-wk-Fact-A9E0C61A8B8C934FC6E4F193D084FB5E">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Property, plant and equipment are stated at cost less accumulated depreciation and impairments. Depreciation is computed using the straight-line method over the following estimated useful lives:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="2"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:48%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Buildings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;31-39 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Building improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;10-39 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Furniture and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3-7 years or product life&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Lesser of the asset life or lease term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is credited or charged to operations. Repairs and maintenance costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company capitalizes internal-use software when both (a) the software is internally developed, acquired, or modified solely to meet the entity&#x2019;s internal needs and (b) during the software&#x2019;s development or modification, no substantive plan either exists or is being developed to market the software externally. Capitalization of qualifying internal-use software costs begins when the preliminary project stage is completed, management with the relevant authority, implicitly or explicitly, authorizes and commits to the funding of the software project, and it is probable that the project will be completed and the software will be used to perform the function intended.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company determines the fair value of the property, plant and equipment acquired in a business combination utilizing either the cost approach or the sales comparison approach. The cost approach is determined by establishing replacement cost of the ass&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;et and then subtracting any value that has been lost due to economic obsolescence, functional obsolescence, or physical deterioration. The sales comparison approach determines an asset is equal to the market price of an asset of comparable features such as design, location, size, construction, materials, use, capacity, specification, operational characteristics and other features or descriptions.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-B0B0A514FF698F398244B1BFD31465F7-0-wk-Fact-006A5E33EE6989AB4A33B1C4F31293B7">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Property, plant and equipment are stated at cost less accumulated depreciation and impairments. Depreciation is computed using the straight-line method over the following estimated useful lives:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="2"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:48%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Buildings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;31-39 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Building improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;10-39 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Furniture and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;3-7 years or product life&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Lesser of the asset life or lease term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Property, plant and equipment consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #ffffff;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Land and improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;46.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;44.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Buildings, building improvements and leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;234.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;216.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Furniture and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;334.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;293.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;55.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;55.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Construction-in-progress&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;81.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;71.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;752.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;681.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(210.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(171.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;542.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;510.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-59F20EBE867EC8FDF910F19430CB454B-0-wk-Fact-E30DB2E59C60ABB56EB7F1943BF47664">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Income taxes are accounted for using the liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss and research and development tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Deferred income tax effects of transactions reported in different periods for financial reporting and income tax return purposes are recognized under the asset and liability method of accounting for income taxes. This method gives consideration to the future tax consequences of the deferred income tax items and immediately recognizes changes in income tax laws in the year of enactment. On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (the &#x201c;Tax Reform Act&#x201d;). Further information on the tax impacts of the Tax Reform Act is included in Note &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;12&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company's ability to realize deferred tax assets depends upon future taxable income as well as the limitations discussed below. For financial reporting purposes, a deferred tax asset must be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax assets will not be realized prior to expiration. The Company considers future taxable income and ongoing tax planning strategies in assessing the need for valuation allowances. In general, if the Company determines that it is more likely than not to realize more than the recorded amounts of net deferred tax assets in the future, the Company will reverse all or a portion of the valuation allowance &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;established against its deferred tax assets, resulting in a decrease to the provision for income taxes in the period in which the determination is made. Likewise, if the Company determines that it is not more likely than not to realize all or part of the net deferred tax asset in the future, the Company will establish a valuation allowance against deferred tax assets, with an offsetting increase to the provision for income taxes, in the period in which the determination is made.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Under sections 382 and 383 of the Internal Revenue Code, if an ownership change occurs with respect to a "loss corporation", as defined therein, there are annual limitations on the amount of net operating losses and deductions that are available. The Company has recognized the portion of net operating losses and research and development tax credits acquired that will not be limited and are more likely than not to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Because tax laws are complex and subject to different interpretations, significant judgment is required. As a result, the Company makes certain estimates and assumptions, in (1)&#160;calculating the Company's income tax expense, deferred tax assets and deferred tax liabilities, (2)&#160;determining any valuation allowance recorded against deferred tax assets and (3)&#160;evaluating the amount of u&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;nrecognized tax benefits, as well as the interest and penalties related to such uncertain tax positions. The Company's estimates and assumptions may differ significantly from tax benefits ultimately realized.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:InProcessResearchAndDevelopmentPolicy
      contextRef="FD2019Q4YTD"
      id="TextSelection-FDF821C3F6296D86BEB7F194A7D69284-0-wk-Fact-E2D5BE550E485113F1A7F194B36C4113">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In determining whether an acquisition is a business combination versus an asset acquisition, the accounting guidance requires an entity to first evaluate whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If that threshold is met, the set of assets and activities is not a business and therefore treated as an asset acquisition. If that threshold is not met, the entity evaluates whether the set meets the definition of a business. If an acquired asset or asset group does not meet the definition of a business, the transaction is accounted for as an asset acquisition. Otherwise, the acquisition is treated as a business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In a business combination, the acquisition method of accounting requires that the assets acquired and liabilities assumed be recorded as of the date of the merger or acquisition at their respective fair values with limited exceptions and generally use Level 3 fair value measurements. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Accordingly, the Company may be required to value assets at fair values that do not reflect the Company's intended use of those assets. Any excess of the purchase price (consideration transferred) over the estimated fair values of net assets acquired is recorded as goodwill. Transaction costs and costs to restructure the acquired company are expensed as incurred. The operating results of the acquired business are reflected in the Company's consolidated financial statements after the date of the merger or acquisition. If the Company determines the assets acquired do not meet the definition of a business under the acquisition method of accounting, the transaction will be accounted for as an asset acquisition and recorded at cost rather than a business combination and, therefore, no goodwill will be recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The fair values of intangible assets, including acquired in-process research and development ("IPR&amp;amp;D"), are determined utilizing information available at or near the merger or acquisition date based on expectations and assumptions that are deemed reasonable by management. Given the considerable judgment involved in determining fair values, the Company typically obtains assistance from third-party valuation specialists for significant items. Amounts allocated to acquired IPR&amp;amp;D are capitalized and accounted for as indefinite-lived intangible assets. Upon successful completion of each project, the Company will make a separate determination as to the remaining useful life of the asset and begin amortization. The judgments made in determining estimated fair values assigned to assets acquired and liabilities assumed in a business combination, as well as asset lives, can materially affect the Company&#x2019;s results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The fair values of identifiable intangible assets related to current products and product rights are primarily determined by using an income approach through which fair value is estimated based on each asset&#x2019;s discounted projected net cash flows. The Company's estimates of market participant net cash flows consider historical and projected pricing, margins and expense levels, the performance of competing products where applicable, relevant industry and therapeutic area growth drivers and factors, current and expected trends in technology and product life cycles, the time and investment that will be required to develop products and technologies, the ability to obtain marketing and regulatory approvals, the ability to manufacture and commercialize the products, the extent and timing of potential new product introductions by the Company&#x2019;s competitors, and the life of each asset&#x2019;s underlying patent, if any. The net cash flows are then probability-adjusted where appropriate to consider the uncertainties associated with the underlying assumptions, as well as the &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;risk profile of the net cash flows utilized in the valuation. The probability-adjusted future net cash flows of each product are then discounted to present value utilizing an appropriate discount rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The fair values of identifiable intangible assets related to IPR&amp;amp;D are determined using an income approach, through which fair value is estimated based on each asset&#x2019;s probability-adjusted future net cash flows, which reflect the different stages of development of each product and the associated probability of successful completion. The net cash flows are then discounted to present value using an appropriate discount rate. Indefinite-lived intangible assets are tested for impairment annually or whenever events or changes in circumstances indicate that its carrying amount may not be recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Assets acquired and liabilities assumed in a business combination that arise from contingencies are recognized at fair value if fair value can reasonably be estimated. If the acquisition date fair value of an asset acquired or liability assumed that arises from a contingency cannot be determined, the asset or liability is recognized if probable and reasonably estimable&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;; if these criteria are not met, no asset or liability is recognized.&lt;/span&gt;&lt;/div&gt;</us-gaap:InProcessResearchAndDevelopmentPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-768B7F1FE0988BB1C632F19631BF40A9-0-wk-Fact-8D5821EC7982CB8B0B34F1965A8163A1">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Asset Impairment Analysis&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Goodwill and Indefinite-lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Goodwill is allocated to the Company's reporting units, which are one level below its operating segment. The Company evaluates goodwill and other indefinite-lived intangible assets for impairment annually as of October&#160;1 and earlier if an event or other circumstance indicates that we may not recover the carrying value of the asset. If the Company believes that as a result of its qualitative assessment it is more likely than not that the fair value of a reporting unit or other indefinite-lived intangible asset is greater than its carrying amount, the quantitative impairment test is not required. If however it is determined that it is not more likely than not that the fair value of a reporting unit or other indefinite-lived intangible asset is greater than its carrying amount, a quantitative test is required.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The quantitative goodwill impairment test is performed using a two-step process. The first step of the process is to compare the fair value of a reporting unit with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is not impaired and the second step of the quantitative impairment test is not necessary. If the carrying amount of a reporting unit exceeds its fair value, the second step of the quantitative goodwill impairment test is required to be performed to measure the amount of impairment loss, if any. The second step of the quantitative goodwill impairment test compares the implied fair value of the reporting unit&#x2019;s goodwill with the carrying amount of that goodwill. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination. In other words, the estimated fair value of the reporting unit&#x2019;s identifiable net assets excluding goodwill is compared to the fair value of the reporting unit as if the reporting unit had been acquired in a business combination and the fair value of the reporting unit was the purchase price paid. If the carrying amount of the reporting unit&#x2019;s goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to that excess. The Company used a qualitative assessment for our goodwill impairment testing for &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. The qualitative evaluation completed during the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; indicated &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; impairment losses. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company has mater&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ial indefinite lived intangible assets associated with in-process research and development (IPR&amp;amp;D) which were acquired as part of the acquisitions completed in the fourth quarter of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Following a qualitative assessment indicating that it is not more likely than not that the fair value of the indefinite lived intangible asset exceeds its carrying amount, impairment of other intangible assets not subject to amortization involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. Determining fair value requires the exercise of judgment about appropriate discount rates, perpetual growth rates and the amount and timing of expected future cash flows.&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; The Company used a quantitative assessment for our IPR&amp;amp;D impairment testing for &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and determined there was an impairment loss of $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;12.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million, which was recorded as a component of R&amp;amp;D expense (see Notes &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;4&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Acquisitions&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;5&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Fair value measurements&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;). &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Long-lived assets such as intangible assets and property, plant and equipment are not required to be tested for impairment annually. Instead, long-lived assets are tested for impairment whenever circumstances indicate that the carrying amount of the asset may not be recoverable, such as when the disposal of such assets is likely or there is an adverse change in the market involving the business employing the related assets. If an impairment analysis is required, the impairment test employed is based on whether the Company&#x2019;s intent is to hold the asset for continued use or to hold the asset for sale. If the intent is to hold the asset for continued use, the impairment test first requires a comparison &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;of undiscounted future cash flows to the carrying value of the asset. If the carrying value of the asset exceeds the undiscounted cash flows, the asset would not be deemed to be recoverable. Impairment would then be measured as the excess of the asset&#x2019;s carrying value over its fair value. Fair value is typically determined by discounting the future cash flows associated with that asset. If the intent is to hold the asset for sale and certain other criteria are met, the impairment test involves comparing the asset&#x2019;s carrying value to its fair value less costs to sell. To the extent the carrying value is greater than the asset&#x2019;s fair value less costs to sell, an impairment loss is recognized in an amount equal to the difference. Significant judgments used for long-lived asset impairment assessments include identifying the appropriate asset groupings and primary assets within those groupings, determining whether events or circumstances indicate that the carrying amount of the asset may not be recoverable, determining the future cash flows for the assets involved and assumptions applied in determining fair value, which include, reasonable discount rates, growth rates, market risk premiums and other assumptions about the economic environment.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d45240615e1099-wk-Fact-AFB6BE6361EF0042208EF200ABD1AEF4"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember"
      decimals="-5"
      id="d45240615e1120-wk-Fact-C32FD711B872DB8478CBB1501BA3B71C"
      unitRef="usd">12000000.0</us-gaap:GoodwillImpairmentLoss>
    <ebs:ContingentConsiderationObligationsPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-D9C7E11492424F7DC88CF196BF73B22D-0-wk-Fact-377C44902BE1BB80C62CF196CC47C085">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In connection with the Company's acquisitions accounted for as business combinations, the Company records contingent consideration associated with sales-based royalties, sales-based milestones and development and regulatory milestones at fair value. The fair value model used to calculate these obligations is based on the income approach (a discounted cash flow model) that has been risk adjusted based on the probability of achievement of net sales and achievement of the milestones. The inputs the Company uses for determining the fair value of the contingent consideration associated with sales-based royalties, sales-based milestones and development and regulatory milestones are Level 3 fair value measurements. The Company re-evaluates the fair value on a quarterly basis. Changes in the fair value can result from adjustments to the discount rates and updates in the assumed timing of or achievement of net sales and/or the achievement of development and regulatory milestones. Any future increase in the fair value of the contingent consideration associated with sales-based royalties and sales-based milestones along with development and regulatory milestones are based on an increased likelihood that the underlying net sales or milestones will be achieved.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The associated payments which will become due and payable for sales-based royalties and milestones result in a charge to cost of product sales and contract development and manufacturing in the period in which the increase is determined. Similarly, any future decrease in the fair value of contingent consideration associated with sales-based royalties and sales-based milestones will result in a reduction in cost of product sales and contract development and manufacturing. The changes in fair value for potential future sales-based royalties associated with product candidates in development will result in a charge to cost o&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;f product sales and contract development and manufacturing services &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;expense in the period in which the increase is determined. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The associated payment or payments which will become due and payable for development and regulatory milestones will result in a charge to research and development expense in the period in which the increase is determined. Similarly, any future decrease i&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;n the fair value for development and regulatory milestones will result in a reduction in research and development expense.&lt;/span&gt;&lt;/div&gt;</ebs:ContingentConsiderationObligationsPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-0110B4198BD9556F81CFF19771237D7F-0-wk-Fact-A256E164467882FF9ED5F1977FD26BEF">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;On January 1, 2018 the Company adopted ASC topic 606 using the modified retrospective approach applied to those contracts in effect as of January 1, 2018. Under this transition method, results for reporting periods beginning after January 1, 2018 are presented under the new standard, while prior period amounts are not adjusted and continue to be reported in accordance with historical accounting under Topic 605. See further discussion of the adoption of Topic 606, including the impact to our 2018 financial statements within the recently issued accounting standards section below.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company recognizes revenue when the Company's customers obtain control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services by analyzing the following five steps: (1) identify the contract with a customer(s); (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;contract; and (5) recognize revenue when (or as) the entity satisfies a performance obligation. To indicate the transfer of control for the Company&#x2019;s product sales and contract development and manufacturing services, it must have a present right to payment, legal title must have passed to the customer, and the customer must have the significant risks and rewards of ownership. Revenue for long-term development contracts is generally recognized based upon the cost-to-cost measure of progress, provided that the Company meets the criteria associated with transferring control of the good or service over time.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Multiple performance obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. Contracts sometimes include options for customers to purchase additional products or services in the future. Customer options that provide a material right to the customer, such as free or discounted products or services, give rise to a separate performance obligation. For contracts with multiple performance obligations, the Company allocates the contract price to each performance obligation on a relative standalone selling price basis using the Company&#x2019;s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers, however when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the contracts&#x2019; inception.  &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Transaction price and variable consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Once the performance obligations in the contract have been identified, the Company estimates the transaction price of the contract. The estimate includes amounts that are fixed as well as those that can vary based on expected outcomes of the activities or contractual terms. The Company's variable consideration includes for example consideration transferred under its development contracts with the USG as consideration received can vary based on developmental progression of the product candidate(s). When a contract's transaction price includes variable consideration, the Company evaluates the variable consideration to determine whether the estimate needs to be constrained; therefore, the Company includes the variable consideration in the transaction price only to the extent that it is probable that a significant reversal of the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Variable consideration estimates are updated at each reporting date. There were &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;no&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; significant constraints or material changes to the Company's variable consideration estimates as of or during the twelve months ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Contract financing&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money if the timing of payments agreed to by the parties to the contract (either explicitly or implicitly) provides the customer with a significant benefit of financing the transfer of goods or services to the customer, which is called a significant financing component. The Company does not adjust transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Product sales&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;CBRNE&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The primary customer for the Company's CBRNE&#160;products and the primary source of funding for the development of its CBNRE product candidate portfolio is the USG. The Company's contracts for the sale of CBRNE products generally have a single performance obligation. Certain product sales contracts with the USG include multiple performance obligations, which generally include the marketed product, stability testing associated with that product, expiry extensions and plasma collection. The USG contracts for the sale of the Company's CBRNE&#160;products are normally multi-year contracts. AV7909 and Trobigard are product candidates that are not approved by the FDA or any other health agency, but are procured by certain government agencies under special circumstances. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The transaction price for product sales are based on a cost build-up model with a mark-up. For our product sales, we recognize revenue at a "point in time" when the Company&#x2019;s performance obligations have been satisfied and control of the products transfer to the customer. This &#x201c;point in time&#x201d; depends on several factors, including delivery, transfer of legal title, transition of risk and rewards of the product to the customer and the Company's right to payment. The USG contracts for the sale of the Company's CBRNE products also include certain acceptance criteria before title passes to the USG.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Opioid and travel health products &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Revenues are recognized when control of the goods are transferred to our customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Prior to recognizing revenue, the Company makes estimates of the transaction price, including variable consideration that is subject to a constraint. Allowances for returns, specialty distributor fees, wholesaler fees, prompt payment discounts, government &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;rebates, chargebacks and rebates under managed care plans are considered in determining the variable consideration. Revenues from sales of products is recognized to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with such variable consideration is subsequently resolved. Product sales revenue is recognized when control has transferred to the customer, which occurs at a point in time, which is typically upon delivery to the customer. Provisions for variable consideration revenues from sales of products are recorded at the net sales price, which includes estimates of variable consideration for which provisions are established and which relate to returns, specialty distributor fees, wholesaler fees, prompt payment discounts, government rebates, chargebacks and rebates under managed care plans. Calculating certain of these provisions involves estimates and judgments and the Company determines their expected value based on sales or invoice data, contractual terms, historical utilization rates, new information regarding changes in these programs&#x2019; regulations and guidelines that would impact the amount of the actual rebates, the Company's expectations regarding future utilization rates for these programs and channel inventory data. These provisions reflect the Company's best estimate of the amount of consideration to which the Company is entitled based on the terms of the contract. The amount of variable consideration that is included in the transaction price may be constrained and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. The Company reassesses the Company's provisions for variable consideration at each reporting date. Historically, adjustments to estimates for these provisions have not been material.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Provisions for returns, specialty distributor fees, wholesaler fees, government rebates and rebates under managed care plans are included within current liabilities in the Company's consolidated balance sheets. Provisions for chargebacks and prompt payment discounts are shown as a reduction in accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:normal;"&gt;Contract development and manufacturing services&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company performs contract development and manufacturing services for third parties. Under these contracts, activities can include pharmaceutical product process development, manufacturing and filling services for injectable and other sterile products, inclusive of process design, technical transfer, manufacturing validations, laboratory analytical development support, aseptic filling, lyophilization, final packaging and accelerated and ongoing stability studies. These contracts, with a duration that is less than one year, generally include a single performance obligation as the customer benefits from our performance upon full completion of our services. The performance obligation is satisfied when the Company must have a present right to payment because legal title has passed to the customer, the goods are in the customer&#x2019;s possession with all the risks and rewards of ownership, and the efficacy of the goods has been confirmed. The Company recognizes revenue at a "point in time" based on when the performance obligation to the customer is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:normal;"&gt;Contracts and grants&lt;/span&gt;&lt;/div&gt;The Company generates contract and grant revenue primarily from cost-plus-fee contracts associated with development of certain product candidates. Revenues from reimbursable contracts are recognized as costs are incurred, generally based on allowable costs incurred during the period, plus any recognizable earned fee. The Company uses this input method to measure progress as the customer has the benefit of access to the development research under these projects and therefore benefits from the Company's performance incrementally as research and development activities occur under each project. We consider fixed fees under cost-plus-fee contracts to be earned in proportion to the allowable costs incurred in performance of the contract. We analyze costs for contracts and reimbursable grants to ensure reporting of revenues gross versus net is appropriate. Revenue for long-term development contracts is considered variable consideration, because the deliverable is dependent on the successful completion of development and is generally recognized based upon the cost-to-cost measure of progress, provided that the Company meets the criteria associated with satisfying the performance obligation over time. The USG contracts for the development of the Company's CBRNE product candidates are normally multi-year contracts.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="FD2019Q4YTD"
      id="TextSelection-FBD13A00EEB20DE07F85F197F2FFCF2C-0-wk-Fact-3D2A1D70C7A71F0E9F1AF19820FF678D">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Research and development&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;We expense research and development costs as incurred. The Company's research and development expenses consist primarily of:&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;personnel-related expenses;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;fees to professional service providers for, among other things, analytical testing, independent monitoring or other administration of the Company's clinical trials and obtaining and evaluating data from the Company's clinical trials and non-clinical studies;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;costs of contract development and manufacturing services for clinical trial material; and&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;costs of materials used in clinical trials and research and development.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-EA765559BFCEAD3EB914F198568C9AB5-0-wk-Fact-6CA20C41BBC439B0EE71F1986B37C57A">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Comprehensive income is comprised of net income and other changes in equity that are excluded from net income. The Company includes translation gains and losses incurred when converting its subsidiaries' financial statements from their functional currency to the U.S. dollar in accumulated other comprehensive income as well as gains and losses on its pension benefit obligation and derivative instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-0262A720728023542CC8F198ABACDF53-0-wk-Fact-FF3664D3AEAA7426C0C3F198B5B1AC21">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Translation of Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;For our non-U.S. subsidiaries that transact in a functional currency other than the U.S. dollar, assets and liabilities are translated at current rates of exchange at the balance sheet date. Income and expense items are translated at the average foreign currency exchange rates for the period. Adjustments resulting from the translation of the financial statements of our foreign operations into U.S.&#160;dollars are excluded from the determination of net income and are recorded in accumulated other comprehensive income, a separate component of equity. For subsidiaries where the functional currency of the assets and liabilities differ from the local currency, non-monetary assets and liabilities are translated at the rate of exchange in effect on the date assets were acquired while monetary assets and liabilities are translated at current rates of exchange as of the balance sheet date. Income and expense items are translated at the average foreign currency rates for the period. Translation adjustments of these subsidiaries are included in other income (expense), net in our consolidated statements of income.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-F52CD9519909335380A3F1996165CB30-0-wk-Fact-082A626E6BC6D6F9FCC9F1996FFBCB5B">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Earnings per share&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company calculates basic earnings per share by dividing net income by the weighted average number of shares of common stock outstanding during the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member"
      decimals="INF"
      id="d45240615e1328-wk-Fact-B6C5D12B6E07FF53C461F1B2EE69E907"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="FD2017Q4QTD"
      decimals="-5"
      id="d45240615e1337-wk-Fact-DF35E9F91486E3617F7D18CF7F2B187C"
      unitRef="shares">8500000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="FD2019Q4YTD"
      id="TextSelection-17E83EAFEBC2D78963C9F199EF33BDF3-0-wk-Fact-35B4737EF649724ADC84F199FAACD799">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Accounting for stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company has &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; stock-based employee compensation plan, the Emergent BioSolutions Inc. Stock Incentive Plan (the "Emergent Plan"), under which the Company may grant various types of equity awards including stock options,  restricted stock units and performance stock units.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The terms and conditions of equity awards (such as price, vesting schedule, term and number of shares) under the Emergent Plan is determined by the compensation committee of the Company's board of directors, which administers the Emergent Plan. Each equity award granted under the Emergent Plan vests as specified in the relevant agreement with the award recipient and no option can be exercised after either &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;seven&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; or &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; from the date of grant depending on the grant date. The Company charges the estimated fair value of awards against income on a straight-line basis over the requisite service period, which is generally the vesting period. Where awards are made with non-substantive vesting periods (for instance, where a portion of the award vests upon retirement eligibility), the Company estimate and recognize expense based on the period from the grant date to the date the employee becomes retirement eligible.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company determines the fair value of restricted stock units using the closing market price of the Company's common stock on the day prior to the date of grant. The Company's performance stock units settle in stock. The fair value is determined on the date of the grant using the number of shares expected to be earned and the ending market value of the stock on the grant date. The number of shares expected to vest is determined by assessing the probability that the performance criteria will be met and the associated targeted payout level that is forecasted will be achieved. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company utilizes the Black-Scholes valuation model for estimating the fair value of all stock options granted. Set forth below is a discussion of the Company's methodology for developing each of the assumptions used:&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Expected dividend yield &#x2014; the Company does not pay regular dividends on its common stock and does not anticipate paying any dividends in the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Expected volatility &#x2014; a measure of the amount by which a financial variable, such as share price, has fluctuated (historical volatility) or is expected to fluctuate (implied volatility) during a period. The Company analyzed its own historical volatility to estimate expected volatility over the same period as the expected average life of the options.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Risk-free interest rate &#x2014; the range of U.S. Treasury rates with a term that most closely resembles the expected life of the option as of the date on which the option is granted.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#x25aa;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Expected average life of options &#x2014; the period of time that options granted are expected to remain outstanding, based primarily on the Company's expectation of optionee exercise behavior subsequent to vesting of options.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <ebs:NumberOfStockbasedEmployeeCompensationPlans
      contextRef="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentPlansMember"
      decimals="INF"
      id="d45240615e1360-wk-Fact-B838AB8DB68657D87615CCD3133826AD"
      unitRef="plan">1</ebs:NumberOfStockbasedEmployeeCompensationPlans>
    <ebs:ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod
      contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentPlansMember"
      id="d45240615e1371-wk-Fact-776E5A2BF027BCC1F056CCD3131E699D">P10Y</ebs:ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod>
    <us-gaap:PensionAndOtherPostretirementPlansPensionsPolicy
      contextRef="FD2019Q4YTD"
      id="TextSelection-77FFA221F131277FCB5EF19A5AE62FC9-0-wk-Fact-5660FC91CA75E642F7E5F19A65E0E7AE">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Pension plans&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company maintains defined benefit plans for employees in certain countries outside the U.S., including retirement benefit plans required by applicable local law. The plans are valued by independent actuaries using the projected unit credit method. The liabilities correspond to the projected benefit obligations of which the discounted net present value is calculated based on years of employment, expected salary increase, and pension adjustments. The Company reviews its actuarial assumptions on an annual basis and makes modifications to the assumptions based on current rates and trends. Actuarial gains and losses are deferred in accumulated other comprehensive income, net of tax and are amortized over the remaining service attribution periods of the employees under the corridor method. Differences between the expected long-term return on plan assets and the actual annual return are amortized to net periodic benefit cost over the estimated remaining life as a component of selling, general and administrative expenses in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementPlansPensionsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-0250C4B1801341933685F19B0C87590E-0-wk-Fact-BF5DF0E44CB8C6F7130CF19B1A0DCF82">&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Recently issued accounting standards&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2016-2,&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Leases (Topic 842)&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#160;("ASU 2016-2")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In February 2016, the FASB issued ASU 2016-2. ASU 2016-2 increased transparency and comparability among organizations by requiring the recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements for both lessees and lessors. The Company adopted the new standard effective January 1, 2019 using the modified retrospective approach. An entity that applies the transition provisions at the beginning of the period of adoption records its cumulative adjustment to the opening balance of retained earnings in the period of adoption rather than in the earliest period presented (i.e., January 1, 2019). In this case, an entity continues to apply the legacy guidance in ASC 840, including its disclosure requirements, in the comparative periods presented in the year it adopts the standard.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company utilized the transition package of certain practical expedients permitted: ASC 842-10-65-1(f) and ASC 842-10-65-1(g). The Company made an accounting policy election that kept leases with an initial term of 12 months or less off of the balance sheet which resulted in recognizing those lease payments in the consolidated statements of operations on a straight-line basis over the lease term. In addition, the Company has made an accounting policy election, by class of underlying asset, to not separate non-lease components from lease components and instead to account &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;for each separate lease component, and the non-lease components associated with that lease component, as a single lease component.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;January&#160;1, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; the total right of use assets increased &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$13.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, while total operating lease liabilities increased &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$14.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. There was no adjustment to the opening balance of retained earnings as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;January&#160;1, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. The standard has not materially affect the Company's consolidated net earnings. The Company continues to apply the legacy guidance from the old lease accounting standard, including its disclosure requirements, in the comparative periods presented (see Note &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;14&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU No. 2014-9, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Revenue from Contracts with Customers (Topic 606)&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; ("ASU 2014-9")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In May 2014, the Financial Accounting Standards Board ("FASB") issued ASU No. 2014-9. ASU No. 2014-9 (known as ASC 606) supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, as well as most industry-specific guidance, and significantly enhances comparability of revenue recognition practices across entities and industries by providing a principles-based, comprehensive framework for addressing revenue recognition issues. The Company adopted ASC 606 as of January 1, 2018 using the modified retrospective method resulting in an adjustment to opening retained earnings of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$32.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; for the cumulative effect of initially applying the new standard.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Under ASC 606, the Company finalized the review of its portfolio of revenue contracts that were not complete as of the adoption date and made its determination of its revenue streams as well as completed extensive contract specific reviews to determine the impact of the new standard on its historical and prospective revenue recognition. Because many of the Company's significant contracts with customers have unique contract terms, the Company reviewed all its non-standard agreements in order to determine the effect of adoption. The Company tested a sample of remaining agreements to verify that there were no changes in accounting based on the assumption that these contracts had similar characteristics and that the effects on the financial statements would not differ materially from applying this guidance to the individual contracts. To estimate the financial impacts of the adoption, the Company did not apply the contract modification practical expedient and retrospectively restated long-term contracts for any contract modifications.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The opening balance sheet adjustment as of January 1, 2018, was the result of the Centers for Innovation in Advanced Development and Manufacturing ("CIADM") contract with the Biomedical Advanced Research and Development Authority ("BARDA"). Under ASC 606 at January 1, 2018, the Company determined that the performance obligation under the arrangement is to provide ongoing manufacturing capability to the USG and would recognize the consideration received in the initial &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;7 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; year base period on a straight-line basis over a &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;-year period as the capability being created during the base period of the contract is being provided to the customer over both the base period contract term as well as &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; additional option periods. As the Company&#x2019;s performance obligation is providing the USG with continuous access to its production capabilities throughout the contract duration, a time-based measure resulting in straight-line revenue recognition is proportionate to the Company&#x2019;s progress in satisfying the performance obligation when compared to the total progress. This measure of progress is most reflective of the Company satisfying the performance obligation over time. Beginning in June 2013, the Company was expected to be able to stand ready and be available to respond to the USG and importantly to respond to any task orders that may be issued during the base period and additional option periods. Being able to stand ready to perform in the event of an outbreak is of importance to the USG and by entering into this arrangement with the Company, the USG expected to receive the benefit of having access to Company&#x2019;s readiness and its capability to immediately respond to public health threats. The Company concluded the identified stand-ready performance obligations represent a series of distinct services that are substantially the same and have the same pattern of transfer to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In addition, the Company determined the CIADM contract includes a significant financing component which is included in the transaction price. The Company calculated the financing component using an interest rate the Company had on its other debt obligations at inception of the contract. The difference in revenue recognized under ASC 605 vs. ASC 606, as of the adoption date, was primarily attributable to the difference in the overall consideration or transaction price resulting from different accounting treatment related to options within the contract and the inclusion of a significant financing component under ASC 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Prior to the adoption of ASC 606, the Company recognized revenue under the CIADM contract on a straight-line basis, based upon its estimate of the total payments to be received under the contract. The Company analyzes the estimated payments to be received on a quarterly basis to determine if an adjustment to revenue was required. As a result of the adoption of ASC 606, as of January 1, 2018, there was an increase in the deferred revenue liability of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$42.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and an increase in deferred tax assets of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$9.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; with an offsetting reduction to retained earnings of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$32.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2018-2,&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Income Statement - Reporting Comprehensive Income (Topic 220):&#160;Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; ("ASU 2018-2")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In February 2018, the FASB issued ASU 2018-2. ASU 2018-2 provides the option to reclassify certain income tax effects related to the Tax Cuts and Jobs Act passed in December of 2017 between accumulated other comprehensive income and retained earnings and also requires additional disclosures.&#160;ASU 2018-2 is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted.&#160;Adoption of ASU 2018-2 is to be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the tax laws or rates were recognized.&#160;The adoption of ASU 2018-2 did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2016-13,&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;("ASU 2016-13")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In June 2016, the FASB issued ASU 2016-13. ASU 2016-13 provides guidance on measurement of credit losses on financial instruments that changes the impairment model for most financial assets and certain other instruments, including trade and other receivables, held-to-maturity debt securities and loans, and that requires entities to use a new, forward-looking &#x201c;expected loss&#x201d; model that is expected to generally result in the earlier recognition of allowances for losses. The guidance&#160;became effective for annual periods beginning after December 15, 2019, including interim periods within those years, but early adoption is permitted. The Company has evaluated the effects of this standard and determined that the adoption will not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2017-4,&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; ("ASU 2017-4")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In January 2017, the FASB issued ASU 2017-4. ASU 2017-4 simplifies the subsequent measurement of goodwill and eliminates Step 2 from the goodwill impairment test. ASU 2017-4 is effective for annual and interim goodwill tests beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates on or after January 1, 2017. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2018-13,&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;&#160;Fair Value Measurement - Disclosure Framework (Topic 820)&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;("ASU 2018-13")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In August 2018, the FASB issued ASU 2018-13. ASU 2018-13 improves the disclosure requirements on fair value measurements. The updated guidance if effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted for any removed or modified disclosures. The Company is currently assessing the timing and impact of adopting the updated provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2018-14,&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;&#160;Compensation -&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Retirement Benefits - Defined Benefit Plans - General (Topic 715-20):&#160;Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#160;("ASU 2018-14")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In August 2018, the FASB issued ASU 2018-14. ASU 2018-14 modifies the disclosure requirements for defined benefit pension plans and other post-retirement plans. ASU 2018-14 is effective for all entities for fiscal years ending after December 15, 2020, and earlier adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2018-14 on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2018-15,&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; ("ASU 2018-15")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In August 2018, the FASB issued ASU 2018-15. ASU 2018-15 clarifies the accounting for implementation costs in cloud computing arrangements. ASU 2018-15 is effective for all entities for fiscal years beginning after December 15, 2019, and earlier adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2018-15 on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ASU 2019-12, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;"&gt;Simplifications to Accounting for Income Taxes &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;("ASU 2019-12")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In December 2019, the FASB issued ASU 2019-12. ASU 2019-12 removes certain exceptions for recognizing deferred taxes for investments, performing intra-period allocation and calculating income taxes in interim periods. The ASU also adds guidance to reduce complexity in certain areas, including deferred taxes for goodwill and allocating taxes for members of a consolidated group. ASU 2019-12 is effective for all entities for fiscal years beginning after December &lt;/span&gt;&lt;/div&gt;15, 2020, and earlier adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2019-12 on its consolidated financial statements.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="I2019Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="-5"
      id="d45240615e1456-wk-Fact-533B1E946F42F1C2DFA99268D858489C"
      unitRef="usd">13400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="I2019Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="-5"
      id="d45240615e1460-wk-Fact-2347D449B77A8E9C11B0926921CB2E33"
      unitRef="usd">14000000.0</us-gaap:OperatingLeaseLiability>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d45240615e1488-wk-Fact-6E4D9BB564ADA5C9B891CCD3136BC891"
      unitRef="usd">32500000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <ebs:BasePeriod
      contextRef="FD2019Q4YTD_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember"
      id="d45240615e1499-wk-Fact-4AE058FD8E574C283C34CCD31367B3CF">P7Y</ebs:BasePeriod>
    <ebs:TermofContract
      contextRef="FD2019Q4YTD_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember"
      id="d45240615e1503-wk-Fact-2A28AB43CD87391F920AF1F66176E3A2">P24Y</ebs:TermofContract>
    <ebs:NumberofAdditionalOptionPeriods
      contextRef="FD2019Q4YTD_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember"
      decimals="INF"
      id="d45240615e1507-wk-Fact-05ED3174192790F5AD0ECCD3133F8AD0"
      unitRef="U004">17</ebs:NumberofAdditionalOptionPeriods>
    <us-gaap:ContractWithCustomerLiability
      contextRef="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember"
      decimals="-5"
      id="d45240615e1520-wk-Fact-C52B0DF8896ACB8EDE95926D9E7AC34A"
      unitRef="usd">42400000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember"
      decimals="-5"
      id="d45240615e1524-wk-Fact-70ED0A7A6B58E29D31C8926D435B3E9C"
      unitRef="usd">9900000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ebs_CIADMMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-5"
      id="d45240615e1528-wk-Fact-C06F1F343DA3910F7C59926EDC4B8A12"
      unitRef="usd">32500000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-644A3C695C3906857B9CCCD313BB17C8-0-wk-Fact-96673CB49BBCB1A2593FCCD31359A038">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Revenue recognition&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company operates in &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; business segment. Therefore, results of the Company's operations are reported on a consolidated basis for purposes of segment reporting, consistent with internal management reporting.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;For the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; the Company's&#160;revenues disaggregated by the major sources was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="36"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:6%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:6%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:6%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="35" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;U.S&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Government&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Government&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;U.S&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Government&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Government&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;U.S&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Government&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Government&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;Product sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;568.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;334.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;903.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;526.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;80.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;606.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;374.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;46.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;421.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;Contract development and manufacturing services&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;80.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;80.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;98.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;98.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;68.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;68.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;Contracts and grants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;105.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;16.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;122.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;71.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;77.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;65.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;5.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;70.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;Total revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;674.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;431.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;1,106.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;597.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;184.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;782.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;439.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;121.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;560.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Contract liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;When performance obligations are not transferred to a customer at the end of a reporting period, the amount allocated to those performance obligations are reflected as contract liabilities on the consolidated balance sheets and are deferred until control of these performance obligations is transferred to the customer. The following table presents the rollforward of contract liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December 31, 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;30.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Adoption of new accounting standard (ASC 606)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;42.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;January 1, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;72.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferral of revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;29.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenue recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(29.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance at December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;73.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferral of revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;46.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenue recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(30.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;88.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Transaction price allocated to remaining performance obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company had expected future revenues of approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$600 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; associated with performance obligations that have not been satisfied. The Company expects to recognize a majority of these revenues within the next &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;24 months&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, with the remainder recognized thereafter. However, the amount and timing of revenue recognition for unsatisfied performance obligations can materially change due to timing of funding appropriations from the USG and the overall success of the Company's development activities associated with its PHT product candidates that are then receiving development funding support from the USG under development contracts. In addition, the amount of future revenues associated with unsatisfied performance obligations excludes the value associated with unexercised option periods in the Company's contracts (which are not performance obligations as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Contract assets&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company considers unbilled accounts receivables and deferred costs associated with revenue generating contracts, which are not included in inventory or property, plant and equipments, as contract assets. As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company had contract assets associated with deferred costs of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$34.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$1.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively, which is included in prepaid expenses and other current assets and other assets on the Company's consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Accounts receivable including unbilled accounts receivable contract assets consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Billed, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;227.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;234.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Unbilled&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;43.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;28.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;270.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;262.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company's accounts receivable balances were comprised of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;69%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;76%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively, from the USG. As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; allowance for doubtful accounts were de minimis.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d45242871e735-wk-Fact-2D4184C2A4BFC1DCCBE4CCD3135C647E"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-F9483EF5767AE9F862EBCCD313BB7640-0-wk-Fact-646987C387ECE45176BBCCD31346D431">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;For the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; the Company's&#160;revenues disaggregated by the major sources was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="36"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:6%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:6%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:6%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="35" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;U.S&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Government&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Government&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;U.S&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Government&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Government&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;U.S&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Government&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Government&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;Product sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;568.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;334.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;903.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;526.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;80.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;606.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;374.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;46.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;421.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;Contract development and manufacturing services&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;80.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;80.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;98.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;98.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;68.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;68.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;Contracts and grants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;105.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;16.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;122.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;71.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;77.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;65.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;5.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;70.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;Total revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;674.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;431.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"&gt;&lt;span&gt;1,106.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;597.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;184.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;782.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;439.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;121.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"&gt;&lt;span&gt;560.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d45242871e1382-wk-Fact-87C800322451665605A8EC944BE6C164"
      unitRef="usd">568800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d45242871e1401-wk-Fact-9B3F3FB68206F1D842DEEC944C03CE60"
      unitRef="usd">334700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember"
      decimals="-5"
      id="d45242871e1420-wk-Fact-550DB7545370460F2298CCD31390DFC6"
      unitRef="usd">903500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d45242871e1440-wk-Fact-ED65F311E8CF9CB97757CDB6789016C4"
      unitRef="usd">526100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d45242871e1459-wk-Fact-D7CC21FD5E6BB5E18120CDB6785E0F1F"
      unitRef="usd">80400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember"
      decimals="-5"
      id="d45242871e1479-wk-Fact-3810A958B43C733CFB24CCD3138A0CA4"
      unitRef="usd">606500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d45242871e1498-wk-Fact-B7CEC24876BFDBAEBB64CDB678D39BA8"
      unitRef="usd">374800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d45242871e1517-wk-Fact-9481E316B235E5CC24EECDB678E226B3"
      unitRef="usd">46700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_us-gaap_ProductMember"
      decimals="-5"
      id="d45242871e1537-wk-Fact-E3F5520D7C718745B7DFCCD3138C7AFB"
      unitRef="usd">421500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d45242871e1552-wk-Fact-BD5F9ED73A8506F29649EC944BEB8C83"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d45242871e1571-wk-Fact-7CFAED2889DB1AB95E9CEC944C088D9B"
      unitRef="usd">80000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember"
      decimals="-5"
      id="d45242871e1590-wk-Fact-338F6F1A2F49501FCC4DEC944BFEC414"
      unitRef="usd">80000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d45242871e1610-wk-Fact-ABB990842A3DDD4AF3DECDB678C31A23"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d45242871e1629-wk-Fact-A580107786B450897E6ACDB6797F63DB"
      unitRef="usd">98900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember"
      decimals="-5"
      id="d45242871e1648-wk-Fact-9B2D5691B6EBA991A1A1CDB6798F69DC"
      unitRef="usd">98900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d45242871e1668-wk-Fact-0E01588E930268065A2FCDB678F21F84"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d45242871e1687-wk-Fact-F1D3A8C00F6C989DDCEACDB6787EC3C9"
      unitRef="usd">68900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractManufacturingMember"
      decimals="-5"
      id="d45242871e1707-wk-Fact-CFD425AFAD9D362B460BCDB679B5F895"
      unitRef="usd">68900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d45242871e1727-wk-Fact-844E01A51EE668409D98EC944BD7BCB9"
      unitRef="usd">105900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d45242871e1746-wk-Fact-E37F1D5FDE82017EFD53EC944BC5992C"
      unitRef="usd">16600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember"
      decimals="-5"
      id="d45242871e1765-wk-Fact-5F00D21AD433133B00D3CCD313757E7C"
      unitRef="usd">122500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d45242871e1785-wk-Fact-9C6C9109F73A5DF2646DCDB679500529"
      unitRef="usd">71500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d45242871e1804-wk-Fact-942B12187A93B792B0D1CDB6792114D6"
      unitRef="usd">5500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember"
      decimals="-5"
      id="d45242871e1823-wk-Fact-B30465A8C2F3A2E082CECCD3138D3955"
      unitRef="usd">77000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d45242871e1843-wk-Fact-B6237A10225D5B82C82ACDB6799F7232"
      unitRef="usd">65100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d45242871e1862-wk-Fact-91C4DA1BFB527AC25B26CDB6793148E3"
      unitRef="usd">5400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ContractsAndGrantsMember"
      decimals="-5"
      id="d45242871e1882-wk-Fact-9AD0A541FEBE16626E99CCD31378BB04"
      unitRef="usd">70500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d45242871e1907-wk-Fact-642376D34BCECBF589F2EC944BDD81B7"
      unitRef="usd">674700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d45242871e1926-wk-Fact-B7858D6709B7236A3EC0EC944BF073CE"
      unitRef="usd">431300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45242871e1945-wk-Fact-94CAA3BE61215202AE0CCCD3138C57F6"
      unitRef="usd">1106000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d45242871e1965-wk-Fact-1FB3253B51EFBB6ACAD3CDB67902BEB1"
      unitRef="usd">597600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d45242871e1984-wk-Fact-A6C1F133EBBF060FD64ACDB679AA3878"
      unitRef="usd">184800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45242871e2004-wk-Fact-E5CE75B1C99F6C4E48F4CCD31371D6BF"
      unitRef="usd">782400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US"
      decimals="-5"
      id="d45242871e2023-wk-Fact-E88DC0919E321E8A0AEDCDB67911E7E7"
      unitRef="usd">439900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d45242871e2042-wk-Fact-E34015F07D6527A22272CDB678A4F540"
      unitRef="usd">121000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45242871e2062-wk-Fact-85CDAEF339CB7AEE40B1CCD3138717AC"
      unitRef="usd">560900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-A21FD06DC624B97C276CCCD313BB4135-0-wk-Fact-B278B9B59075409FFCE9CCD313621BDA">The following table presents the rollforward of contract liabilities:&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;December 31, 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;30.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Adoption of new accounting standard (ASC 606)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;42.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;January 1, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;72.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferral of revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;29.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenue recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(29.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance at December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;73.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferral of revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;46.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenue recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(30.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;88.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="FI2017Q4"
      decimals="-5"
      id="d45242871e2125-wk-Fact-6CFFD3A7DB1D0EDD52BF21E423C263DD"
      unitRef="usd">30500000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member"
      decimals="-5"
      id="d45242871e2140-wk-Fact-995AA6AE591D4B1466C021E6FAE07362"
      unitRef="usd">42400000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member"
      decimals="-5"
      id="d45242871e2160-wk-Fact-A9365FAE5398BA4496CF21E709815361"
      unitRef="usd">72900000</us-gaap:ContractWithCustomerLiability>
    <ebs:ContractWithCustomerLiabilityAdditions
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45242871e2180-wk-Fact-09D2F43329F2B6CB2D1621E3F8C3B6AC"
      unitRef="usd">29300000</ebs:ContractWithCustomerLiabilityAdditions>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45242871e2200-wk-Fact-AEEE3B83D0D8CA173D7421E3FA0C33B4"
      unitRef="usd">-29100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiability
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45242871e2221-wk-Fact-32CD898261F5C2CF1A6ECCD3132C63F1"
      unitRef="usd">73100000</us-gaap:ContractWithCustomerLiability>
    <ebs:ContractWithCustomerLiabilityAdditions
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45242871e2241-wk-Fact-0C52014E1FC2F7A47570CCD31329A808"
      unitRef="usd">46700000</ebs:ContractWithCustomerLiabilityAdditions>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45242871e2261-wk-Fact-AA1E3FF9D22E5B61FEE6CCD3132FEEF2"
      unitRef="usd">-30900000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiability
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45242871e2287-wk-Fact-09F346A22D9AC3BF1CE2CCD3131C94FA"
      unitRef="usd">88900000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="FI2019Q4"
      decimals="-6"
      id="d45242871e2306-wk-Fact-6A4EC8C6FF858B3B897BCCD3134FE850"
      unitRef="usd">600000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="FI2019Q4_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain_2020-01-01"
      id="d45242871e2310-wk-Fact-0BAE98A03B37759EC9FCCCD3135A8FCA">P24M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:DeferredCostsCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45242871e2332-wk-Fact-3DC65CE4DF34CC6AD669CCD313571990"
      unitRef="usd">34000000.0</us-gaap:DeferredCostsCurrent>
    <us-gaap:DeferredCostsCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45242871e2336-wk-Fact-6CB75151180C16AD53DECCD3135B039A"
      unitRef="usd">1200000</us-gaap:DeferredCostsCurrent>
    <ebs:ScheduleofAccountsReceivableNetTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-DEB76CBC7BCB0D6BB962F5602128F79A-0-wk-Fact-376F875BA2C4AD8BD384F5606070CFA4">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Accounts receivable including unbilled accounts receivable contract assets consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Billed, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;227.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;234.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Unbilled&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;43.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;28.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;270.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;262.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</ebs:ScheduleofAccountsReceivableNetTableTextBlock>
    <us-gaap:BilledContractReceivables
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45242871e2459-wk-Fact-3778D939BF3DF4C0867ACCD313561809"
      unitRef="usd">227300000</us-gaap:BilledContractReceivables>
    <us-gaap:BilledContractReceivables
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45242871e2478-wk-Fact-B9E036D8ED63CDFFA725CCD313517506"
      unitRef="usd">234000000.0</us-gaap:BilledContractReceivables>
    <us-gaap:UnbilledContractsReceivable
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45242871e2493-wk-Fact-0D9F1AD3D42755C69BCDCCD31356E645"
      unitRef="usd">43400000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:UnbilledContractsReceivable
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45242871e2512-wk-Fact-4BD74A9A3E8DA3253499CCD313948CB6"
      unitRef="usd">28500000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45242871e2537-wk-Fact-8E63B5B6EE5EB579E66FCCD31378EC92"
      unitRef="usd">270700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45242871e2556-wk-Fact-0A8EDAB4A88157AF37E1CCD3136590C8"
      unitRef="usd">262500000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_srt_MajorCustomersAxis_ebs_UnitedStatesGovernmentMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember"
      decimals="2"
      id="d45242871e2576-wk-Fact-C1FEF904A65ACAE271BACCD3134B769F"
      unitRef="number">0.69</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_srt_MajorCustomersAxis_ebs_UnitedStatesGovernmentMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember"
      decimals="2"
      id="d45242871e2580-wk-Fact-8AA9DD13A06C7A514A52CCD31359B8F8"
      unitRef="number">0.76</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-E3E2DFE157716E4F649ECCD313BCC6C7-0-wk-Fact-2F8BC131A6A64DAC6674CCD313254D85">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Acquisitions&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Adapt&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;On October 15, 2018, the Company acquired Adapt, a company focused on developing new treatment options and commercializing products addressing opioid overdose and addiction. Adapt's NARCAN&#xae; (naloxone HCI) Nasal Spray marketed product is the first needle-free formulation of naloxone approved by the FDA and Health Canada for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. This acquisition included approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;50&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; employees, located in the U.S., Canada, and Ireland, including those responsible for supply chain management, research and development, government affairs, and commercial operations. The products and product candidates within Adapt's portfolio are consistent with the Company's mission and expand the Company's core business of addressing public health threats.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The total purchase price revised for adjustments is summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:79%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in&#160;millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;October 15, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;581.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;37.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of contingent purchase consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;48.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Preliminary purchase consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;667.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Final purchase consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;668.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company issued &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;733,309&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; shares of Common Stock at &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$60.44&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; per share, the closing price of Emergent's share price on October 15, 2018, for a total of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$44.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; (inclusive of adjustments). The &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$44.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; value of the common stock shares issued has been adjusted to a fair value of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$37.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; considering a discount for lack of marketability due to a &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;two&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;-year lock-up period beginning on October 15, 2018. The remaining consideration payable for the acquisition consists of up to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$100 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; in cash based on the achievement of certain sales milestones through 2022 which the Company has determined the fair value of to be &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$48.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; as of the acquisition date. The fair value of the contingent purchase consideration is based on management&#x2019;s assessment of the potential future realization of the contingent purchase consideration payments. This assessment is based on inputs that have no observable market (Level 3). The obligation is measured using a discounted cash flow model.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;This transaction was accounted for by the Company under the acquisition method of accounting, with the Company as the acquirer. Under the acquisition method of accounting, the assets and liabilities of Adapt were recorded as of October 15, 2018, the acquisition date, at their respective fair values, and combined with those of the Company. The &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Company reflects measurement period adjustments in the period in which the adjustments occur. The adjustments during the measurement period resulted from receipt of additional financial information associated with certain acquired contract assets and the value of associated contingent purchase consideration. These adjustments did not impact the Company's statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The table below summarizes the final allocation of the purchase price based upon fair values of assets acquired and liabilities assumed at October 15, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:64%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;October 15, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Measurement Period Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Updated  October 15, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of tangible assets acquired and liabilities assumed:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;17.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;17.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;21.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;21.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Inventory&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;41.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;41.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Prepaid expenses and other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;7.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;10.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(32.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(32.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(50.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(50.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred tax liability, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(62.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(62.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total fair value of tangible assets acquired and liabilities assumed&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(56.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(54.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;41.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;41.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquired intangible asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;534.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;534.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;149.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;148.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total purchase price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;667.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;668.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company determined the fair value of the intangible asset using the income approach, which is based on the present value of future cash flows. The fair value measurements are based on significant unobservable inputs that are developed by the Company using estimates and assumptions of the respective market and market penetration of the Company's products.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The fair value of the intangible asset acquired for Adapt's marketed product NARCAN&#xae; Nasal Spray was valued at &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$534.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. The Company has determined the useful life of the NARCAN&#xae; Nasal Spray intangible asset to be &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;15&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; years. The Company calculated the fair value of the NARCAN&#xae; Nasal Spray intangible asset using the income approach with a present value discount rate of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;10.5%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, which is based on the weighted-average cost of capital for companies with profiles substantially similar to that of Adapt. This is comparable to the internal rate of return for the acquisition and represents the rate that market participants would use to value these intangible assets. The projected cash flows from the NARCAN&#xae; Nasal Spray intangible asset were based on key assumptions including: estimates of revenues and operating profits; and risks related to the viability of and potential alternative treatments in any future target markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The intangible asset associated with IPR&amp;amp;D acquired from Adapt is related to a product candidate. Management determined that the acquisition-date fair value of intangible assets related to IPR&amp;amp;D was &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$41.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. The fair value was determined using the income approach, which discounts expected future cash flows to present value. The Company calculated the fair value using a present value discount rate of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;11%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, which is based on the weighted-average cost of capital for companies with that profiles substantially similar to that of Adapt and IPR&amp;amp;D assets at a similar stage of development as the product candidate. This is comparable to the internal rate of return for the acquisition and represents the rate that market participants would use to value the IPR&amp;amp;D. The projected cash flows for the product candidate&#160; were based on key assumptions including: estimates of revenues and operating profits, considering its stage of development on the acquisition date; the time and resources needed to complete the development and approval of the product candidate; the life of the potential commercialized product and associated risks, including the inherent difficulties and uncertainties in developing a product candidate, such as obtaining marketing approval from the FDA and other regulatory agencies; and risks related to the viability of and potential for alternative treatments in any future target markets. Non-amortizing IPR&amp;amp;D assets are considered to be indefinite-lived until the completion or abandonment of the associated research and development effort and are evaluated for impairment annually. During the year ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company recorded an impairment charge of $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;12.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million to the IPR&amp;amp;D asset. The fair value of the IPR&amp;amp;D intangible asset is $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;29.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million at December 31, 2019 (see Note &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;8&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company determined the fair value of the inventory using the comparative sales method, which estimates the expected sales price reduced for all costs expected to be incurred to complete/dispose of the inventory with a profit on those costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company recorded approximately $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;148.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million in goodwill related to the Adapt acquisition, which is calculated as the purchase price paid in excess of the fair value of the tangible and intangible assets acquired representing the future economic benefits the Company expects to receive as a result of the acquisition. The goodwill created from the Adapt acquisition is associated with early stage pipeline products. The goodwill generated from the Adapt acquisition is not expected to be deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:normal;font-weight:bold;text-decoration:none;"&gt;PaxVax&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;On October 4, 2018, the Company completed the acquisition of PaxVax Holding Company Ltd. ("PaxVax"), a company focused on developing, manufacturing, and commercializing specialty vaccines that protect against existing and emerging infectious diseases. This acquisition includes Vivotif&#xae; (Typhoid Vaccine Live Oral Ty21a), the only oral vaccine licensed by the FDA for the prevention of typhoid fever, Vaxchora&#xae; (Cholera Vaccine, Live, Oral), the only FDA-licensed vaccine for the prevention of cholera, adenovirus 4/7 and additional clinical-stage vaccine candidates targeting chikungunya and other emerging infectious diseases, European-based current good manufacturing practices ("cGMP") biologics manufacturing facilities, and approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;250&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; employees including those in research and development, manufacturing, and commercial operations with a specialty vaccines sales force in the U.S. and in select European countries. The products and product candidates within PaxVax's portfolio are consistent with the Company&#x2019;s mission and will expand the Company&#x2019;s core business of addressing PHTs. In addition, the acquisition expands the Company's manufacturing capabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;At the closing, the Company paid a cash consideration of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$273.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; (inclusive of closing adjustments). This transaction was accounted for by the Company under the acquisition method of accounting, with the Company as the acquirer. Under the acquisition method of accounting, the assets and liabilities of PaxVax were recorded as of October 4, 2018, the acquisition date, at their respective fair values, and combined with those of the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The table below summarizes the final allocation of the purchase consideration based upon the fair values of assets acquired and liabilities assumed at October 4, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;October 4, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Measurement Period Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Updated October 4, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of tangible assets acquired and liabilities assumed:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;4.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;4.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Inventory&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;19.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;19.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Prepaid expenses and other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;12.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;11.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;57.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;57.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred tax assets, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;5.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(33.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(34.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total fair value of tangible assets acquired and liabilities assumed&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;69.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;70.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(9.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquired intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;133.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;133.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;61.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;7.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;69.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total purchase consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;273.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;273.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The fair value of the intangible assets acquired for PaxVax's marketed products are valued at a total of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$133.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. The Company has determined that the weighted average useful lives of the intangible assets to be &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;19&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; years.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company determined the fair value of the intangible assets using the income approach, which is based on the present value of future cash flows. The fair value measurements are based on significant unobservable inputs that are &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;developed by the Company using estimates and assumptions of the respective market and market penetration of the Company's products.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company calculated the fair value of the Vivotif and Vaxchora intangible assets using the income approach with a present value discount rate of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;14.5%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;15%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively, which is based on the weighted-average cost of capital for companies with profiles substantially similar to that of PaxVax. This is comparable to the internal rate of return for the acquisition and represents the rate that market participants would use to value these intangible assets. The projected cash flows from these intangible assets were based on key assumptions including: estimates of revenues and operating profits; and risks related to the viability of and potential alternative treatments in any future target markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The intangible asset associated with IPR&amp;amp;D acquired from PaxVax is related to a product candidate.  The Company has adjusted the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. The Company estimates the fair value based on the income approach. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company determined the fair value of the inventory using the comparative sales method, which estimates the expected sales price reduced for all costs expected to be incurred to complete/dispose of the inventory with a profit on those costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company determined the fair value of the property, plant and equipment utilizing either the cost approach or the sales comparison approach. The cost approach is determined by establishing replacement cost of the asset and then subtracting any value that has been lost due to economic obsolescence, functional obsolescence, or physical deterioration. The sales comparison approach determines an asset is equal to the market price of an asset of comparable features such as design, location, size, construction, materials, use, capacity, specification, operational characteristics and other features or descriptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company recorded approximately $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;69.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million in goodwill related to the PaxVax acquisition, calculated as the purchase price paid in the acquisition that was in excess of the fair value of the tangible and intangible assets acquired representing the future economic benefits the Company expects to receive as a result of the acquisition. The goodwill created from the PaxVax acquisition is associated with early stage pipeline products along with potential contract development and manufacturing services. The majority of the goodwill generated from the PaxVax acquisition is expected to be deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company has incurred transaction costs related to the PaxVax acquisition of approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$4.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; for the year ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, which have been recorded in selling, general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Acquisition of ACAM2000 business&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;On October 6, 2017, the Company completed the acquisition of the ACAM2000&#xae; (Smallpox (Vaccinia) Vaccine, Live) business of Sanofi Pasteur Biologics, LLC ("Sanofi"). This acquisition includes ACAM2000, the only smallpox vaccine licensed by the FDA, a current good manufacturing practices ("cGMP") live viral manufacturing facility and office and warehouse space, both in Canton, Massachusetts, and a cGMP viral fill/finish facility in Rockville, Maryland. With this acquisition, the Company also acquired an existing &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;-year contract with the CDC, which expired in March 2018. This contract had a stated value up to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$425 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, with a remaining contract value of up to approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$160 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; as of the acquisition date, for the delivery of ACAM2000 to the SNS and establishing U.S.-based manufacturing of ACAM2000. This acquisition added to the Company's product portfolio and expanded the Company's manufacturing capabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;At the closing, the Company paid &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$97.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; in an upfront payment and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$20 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; in milestone payments earned as of the closing date tied to the achievement of certain regulatory and manufacturing-related milestones, for a total payment in cash of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$117.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million. The agreement includes an additional milestone payment of up to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$7.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; upon achievement of a regulatory milestone, which was achieved in November 2017. The &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$7.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; milestone payment was made during the fourth quarter of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and is reflected as a component of financing activities in the consolidated statement of cash flows. This transaction was accounted for by the Company under the acquisition method of accounting, with the Company as the acquirer. Under the acquisition method of accounting, the assets and liabilities of the ACAM2000 business were recorded as of October 6, 2017, the acquisition date, at their respective fair values, and combined with those of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The contingent purchase consideration obligation is based on a regulatory milestone. At October 6, 2017, the contingent purchase consideration obligation related to the regulatory milestone was recorded at a fair value of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$2.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million. The Level 3 fair value of this obligation was based on a present value model of management's assessment of &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;the probability of achievement of the regulatory milestone as of the acquisition date. This assessment is based on inputs that have no observable market.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The total purchase price is summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:85%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Purchase Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Amount of cash paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;117.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of contingent purchase consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total purchase price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;119.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The table below summarizes the allocation of the purchase price based upon the fair values of assets acquired at October 6, 2017. The Company did not assume any liabilities in the acquisition. The Company has finalized the purchase price allocation related to this acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:85%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Purchase Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of tangible assets acquired:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;74.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;20.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total fair value of tangible assets acquired&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;94.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquired intangible asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;16.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;8.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total purchase price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;119.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The fair value measurements are based on significant unobservable inputs that are developed by the Company using estimates and assumptions of the respective market and market penetration of the Company's products. The Company determined the fair value of the ACAM2000 intangible asset using the income approach, which is based on the present value of future cash flows, with a present value discount rate of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;15.50%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, based on the weighted-average cost of capital for substantially similar companies. This is comparable to the internal rate of return for the acquisition and represents the rate that market participants would use to value these intangible assets. The projected cash flows from ACAM2000 intangible asset were based on key assumptions, including: estimates of revenues and operating profits, the life of the potential commercialized product and associated risks, and risks related to the viability of and potential alternative treatments in any future target markets. The Company has determined the ACAM2000 intangible asset will be amortized over &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;10 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company determined the fair value of the inventory using the probability adjusted comparative sales method, which estimates the expected sales price reduced for all costs expected to be incurred to complete/dispose of the inventory with a profit on those costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company determined the fair value of the property, plant and equipment utilizing either the cost approach or the sales comparison approach. The cost approach is determined based on the replacement cost of the asset and then subtracting any value that has been lost due to economic obsolescence, functional obsolescence, or physical deterioration. The sales comparison approach&#160;determines an asset is equal to the market price of an asset of comparable features such as design, location, size, construction, materials, use, capacity, specification, operational characteristics and other features or descriptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company recorded approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$8.1&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million in goodwill related to the ACAM2000 acquisition, calculated as the purchase price paid in the acquisition that was in excess of the fair value of the tangible and intangible assets acquired and represents the future economic benefits the Company expects to receive as a result of the acquisition. Goodwill generated from the ACAM2000 acquisition is not expected to be deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;Acquisition of raxibacumab asset&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;On October 2, 2017, the Company completed the acquisition of raxibacumab, a fully human monoclonal antibody therapeutic product approved by the U.S. Food and Drug Administration ("FDA") for the treatment and prophylaxis of inhalational anthrax, from Human Genome Sciences, Inc. and GlaxoSmithKline LLC (collectively referred to as "GSK"). The all-cash transaction consists of a &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$76 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; upfront payment and up to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$20 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; in product sale and &lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;manufacturing-related milestone payments. The Company recorded an asset (including transaction costs) of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$77.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, at date of acquisition, which is recorded within intangible assets, net line item of the consolidated balance sheets. The Company has determined that substantially all of the value of raxibacumab is attributed to the raxibacumab asset and therefore the raxibacumab acquisition is considered an asset acquisition. During the &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;twelve months ended&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, a contingent milestone was achieved which resulted in a payment of $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;10.0&lt;/span&gt;&lt;/span&gt; million with a corresponding increase in intangible assets.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <ebs:NumberOfEmployees
      contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="INF"
      id="d45245159e738-wk-Fact-9FB86D68CCD4C01714DFCCD31381A3AF"
      unitRef="employee">50</ebs:NumberOfEmployees>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e793-wk-Fact-5004B19712F48B301276CCD3136414B4"
      unitRef="usd">581500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e808-wk-Fact-1D3D91B3BB3478A46B5ECCD313628B57"
      unitRef="usd">37700000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e828-wk-Fact-D3BCBE7FDED6ABF702DFCCD3136196BB"
      unitRef="usd">48000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="D2018Q4Oct15-Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e848-wk-Fact-ADC131A3958DC98B5E7D1C7A71E6188E"
      unitRef="usd">667200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
      contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e868-wk-Fact-061F2B0484F1EDF5CED01C7AD060D130"
      unitRef="usd">1500000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e893-wk-Fact-A7EB867C5DB3C46275C3CCD31366C702"
      unitRef="usd">668700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="INF"
      id="d45245159e905-wk-Fact-5B6E4FD29D347BF19B8DCCD313866162"
      unitRef="shares">733309</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="INF"
      id="d45245159e909-wk-Fact-0C09B89C86AEC3BCB728CCD3137BD046"
      unitRef="usdPerShare">60.44</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e913-wk-Fact-587FAD4752FB048CC22ACCD3138B3BAC"
      unitRef="usd">44300000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e917-wk-Fact-587FAD4752FB048CC22ACCD3138B3BAC"
      unitRef="usd">44300000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e921-wk-Fact-1D3D91B3BB3478A46B5ECCD313628B57"
      unitRef="usd">37700000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="I2018Q4Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-6"
      id="d45245159e930-wk-Fact-3A9A4CF685D73E536719CCD3137F1473"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e934-wk-Fact-D3BCBE7FDED6ABF702DFCCD3136196BB"
      unitRef="usd">48000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1082-wk-Fact-1188D993CB232C0AB69DCCD3136BE09C"
      unitRef="usd">17700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1110-wk-Fact-24E2BEE25CECA47251B1B690521C77C7"
      unitRef="usd">17700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1125-wk-Fact-42FA4FC1259B27C255B6CCD3137BF1FE"
      unitRef="usd">21300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1153-wk-Fact-A0643B350B24B6450AC7B690541A874C"
      unitRef="usd">21300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1173-wk-Fact-6870F38100CDFD1C23ACCCD3136D10D8"
      unitRef="usd">41400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1201-wk-Fact-E2AF0D398A450669C9DDB69055DF4D2E"
      unitRef="usd">41400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1221-wk-Fact-9DAF4D95FA6D2C0B2026CCD3137268D5"
      unitRef="usd">7800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets
      contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1235-wk-Fact-AD6A4EB6229D8D4D4CBEB68DF6BBA866"
      unitRef="usd">3000000.0</ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1249-wk-Fact-61DD5595E055E3C0C1AEB690578CB484"
      unitRef="usd">10800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1269-wk-Fact-FA33531313E137C2946CCCD31378B99B"
      unitRef="usd">32200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1298-wk-Fact-4547E2148C27EEB45865B6905917092D"
      unitRef="usd">32200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <ebs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities
      contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1319-wk-Fact-3C08496C4C021A50D0BBCCD31377DD31"
      unitRef="usd">50400000</ebs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities>
    <ebs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1348-wk-Fact-1F22308CABE839BE3088B6905ADCDE5F"
      unitRef="usd">50400000</ebs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1369-wk-Fact-14B0DB4D044CDC4DB85ACCD3136E4114"
      unitRef="usd">62400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities
      contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1384-wk-Fact-38B3E8D05A122D644175B68DFB1DBD87"
      unitRef="usd">500000</ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1399-wk-Fact-E1AE23A4553862A3632AB6905CF0ADB8"
      unitRef="usd">62900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1420-wk-Fact-8D6BF9530C4403298FAECCD31372611D"
      unitRef="usd">-56800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod
      contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1435-wk-Fact-B93153ADD2971620D292B68DFE30AC97"
      unitRef="usd">-2500000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1449-wk-Fact-DD5AA485D2EC7307D198B6905E980161"
      unitRef="usd">-54300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember"
      decimals="-5"
      id="d45245159e1522-wk-Fact-92DBED2BC6CCF7F45E9BCCD31376E43C"
      unitRef="usd">41000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1550-wk-Fact-C5DBCDE47C701BC2A1DEB690608BA3FD"
      unitRef="usd">41000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1570-wk-Fact-D4270AAC9257163A36E8CCD31373ED98"
      unitRef="usd">534000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1598-wk-Fact-9C9B863E98E4D79950BDB690622E0084"
      unitRef="usd">534000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="I2018Q4Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1618-wk-Fact-B23A99E1F28843760122CCD31374CDC5"
      unitRef="usd">149000000.0</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1632-wk-Fact-F3C51CA7E29296147D24B68E01680445"
      unitRef="usd">-1000000.0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1647-wk-Fact-F27A08E197428454F225B69063BD30F9"
      unitRef="usd">148000000.0</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="D2018Q4Oct15-Oct15_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1672-wk-Fact-ADC131A3958DC98B5E7D1C7A71E6188E"
      unitRef="usd">667200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
      contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1686-wk-Fact-043DD5900466FA1A0059B68E02779AFE"
      unitRef="usd">1500000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1700-wk-Fact-A7EB867C5DB3C46275C3CCD31366C702"
      unitRef="usd">668700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1716-wk-Fact-9C9B863E98E4D79950BDB690622E0084"
      unitRef="usd">534000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      id="d45245159e1720-wk-Fact-14BCAD1CF8992B579F91CCD313228019">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <ebs:PresentValueDiscountRate
      contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="3"
      id="d45245159e1724-wk-Fact-7C2F7CD4A245DB20391CCCD31393E600"
      unitRef="number">0.105</ebs:PresentValueDiscountRate>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1731-wk-Fact-C5DBCDE47C701BC2A1DEB690608BA3FD"
      unitRef="usd">41000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <ebs:PresentValueDiscountRate
      contextRef="D2018Q4Oct15-Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember"
      decimals="2"
      id="d45245159e1735-wk-Fact-736E022F1DEB92C9693ECCD3138E54DC"
      unitRef="number">0.11</ebs:PresentValueDiscountRate>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember"
      decimals="-5"
      id="d45245159e1743-wk-Fact-C32FD711B872DB8478CBB1501BA3B71C"
      unitRef="usd">12000000.0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="FI2019Q4_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1747-wk-Fact-CEC5494F14C151866514EC9541C6D101"
      unitRef="usd">29000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="I2018Q4Oct15_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember"
      decimals="-5"
      id="d45245159e1762-wk-Fact-F27A08E197428454F225B69063BD30F9"
      unitRef="usd">148000000.0</us-gaap:Goodwill>
    <ebs:NumberOfEmployees
      contextRef="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-1"
      id="d45245159e1772-wk-Fact-80979D521F8563EB96C8CCD3137CA596"
      unitRef="employee">250</ebs:NumberOfEmployees>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e1779-wk-Fact-E55DCDCAE2272CF5C658B6A0050A1B07"
      unitRef="usd">273100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-A07E8B05B0B320FB3040CCD313BB51AE-0-wk-Fact-0059C8DCC0DB354EA587CCD3137EEF14">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The table below summarizes the final allocation of the purchase consideration based upon the fair values of assets acquired and liabilities assumed at October 4, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;October 4, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Measurement Period Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Updated October 4, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of tangible assets acquired and liabilities assumed:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;4.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;4.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Inventory&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;19.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;19.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Prepaid expenses and other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;12.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;11.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;57.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;57.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred tax assets, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;5.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(33.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(34.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total fair value of tangible assets acquired and liabilities assumed&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;69.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;70.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(9.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquired intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;133.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;133.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;61.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;7.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;69.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total purchase consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;273.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;273.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The table below summarizes the allocation of the purchase price based upon the fair values of assets acquired at October 6, 2017. The Company did not assume any liabilities in the acquisition. The Company has finalized the purchase price allocation related to this acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:85%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Purchase Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of tangible assets acquired:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;74.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;20.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total fair value of tangible assets acquired&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;94.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquired intangible asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;16.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;8.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total purchase price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;119.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The table below summarizes the final allocation of the purchase price based upon fair values of assets acquired and liabilities assumed at October 15, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:64%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;October 15, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Measurement Period Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Updated  October 15, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of tangible assets acquired and liabilities assumed:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;17.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;17.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;21.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;21.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Inventory&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;41.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;41.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Prepaid expenses and other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;7.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;10.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(32.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(32.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(50.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(50.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred tax liability, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(62.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(62.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total fair value of tangible assets acquired and liabilities assumed&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(56.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(54.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;41.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;41.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquired intangible asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;534.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;534.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;149.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;148.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total purchase price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;667.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;668.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e1972-wk-Fact-A482B828B4D74188D94BCCD313316F33"
      unitRef="usd">9000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2000-wk-Fact-35B9407472C378449AFBB6A110B235EF"
      unitRef="usd">9000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2015-wk-Fact-56DAF271A7A1015ED659CCD3135D26FC"
      unitRef="usd">4100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2043-wk-Fact-C1DE7CA91112FD34AC2DB6A113A91927"
      unitRef="usd">4100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2063-wk-Fact-529BA5ADCF122823A776CCD31321637E"
      unitRef="usd">19700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2091-wk-Fact-482B8CE495CFAF06AC71B6A1168B967D"
      unitRef="usd">19700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2111-wk-Fact-20B58D0EFBD9D1E9E331CCD3131E1D6D"
      unitRef="usd">12200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets
      contextRef="D2019Q3Oct5-Sep30_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2125-wk-Fact-93DF9C8D747F2A17EAC6B6A0A1B23514"
      unitRef="usd">-300000</ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2140-wk-Fact-72F26374D84ACE672C06B69FEA330388"
      unitRef="usd">11900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2160-wk-Fact-C92B2275A0BEE063D3DDCCD3133176C4"
      unitRef="usd">57800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2188-wk-Fact-6617F6414A4EFC1215DBB6A11BC357A2"
      unitRef="usd">57800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2208-wk-Fact-1DD0CD03EDF28BB0F14BCCD3131EFA3A"
      unitRef="usd">3800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets
      contextRef="D2019Q3Oct5-Sep30_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2222-wk-Fact-E103B720240114A460F0B6A0A448D4DD"
      unitRef="usd">1800000</ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2236-wk-Fact-C54654F324908C232056B69FF115B71A"
      unitRef="usd">5600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2256-wk-Fact-EC3522B503B4BBA35E28CCD3132AC285"
      unitRef="usd">3500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2285-wk-Fact-154228A3C146A737B022B6A11F4D9147"
      unitRef="usd">3500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <ebs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities
      contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2306-wk-Fact-55A539F8AE85664520D9CCD3135E5AB2"
      unitRef="usd">33600000</ebs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities>
    <ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities
      contextRef="D2019Q3Oct5-Sep30_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2321-wk-Fact-D9EB7599F1E68308E77CB6A0A6C0054C"
      unitRef="usd">400000</ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities>
    <ebs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities
      contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2336-wk-Fact-CEC8B5B9B420C21745F3B69FF8043B4E"
      unitRef="usd">34000000.0</ebs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2358-wk-Fact-BEF3CCE312010817AAABCCD31329E743"
      unitRef="usd">69500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod
      contextRef="D2019Q3Oct5-Sep30_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2372-wk-Fact-DA3E4EF8C80B7180B0AAB6A0A8D5643E"
      unitRef="usd">-1100000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2386-wk-Fact-21693F0FAEBE876F676CB69FFC2C0CB5"
      unitRef="usd">70600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2457-wk-Fact-FE971225ED9252D4E01CCCD313605E61"
      unitRef="usd">9000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets
      contextRef="D2019Q3Oct5-Sep30_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2471-wk-Fact-8C1390A5A7D865FDBF2BB6A0AB766975"
      unitRef="usd">-9000000.0</ebs:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2486-wk-Fact-F80FFC9F8F6510F10776B6A000C300BB"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2506-wk-Fact-9B321BDDC93A5853AB25CCD3135F29FB"
      unitRef="usd">133000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2534-wk-Fact-D302DA4BE0548B477B08B6A1268A2E85"
      unitRef="usd">133000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="I2018Q4Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2554-wk-Fact-BF14365023700C0DD8B0CCD3131F9D9B"
      unitRef="usd">61600000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="D2019Q3Oct5-Sep30_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2568-wk-Fact-7F532CE7ABFD40FF84AFB6A0AD96D48E"
      unitRef="usd">7900000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2582-wk-Fact-63E99590CCA82F9BA027B6A002F29BF7"
      unitRef="usd">69500000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="D2018Q4Oct04-Oct04_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2607-wk-Fact-AB7889E74C10BF182703CCD31335F3FE"
      unitRef="usd">273100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
      contextRef="FD2019Q3YTD"
      decimals="-5"
      id="d45245159e2621-wk-Fact-DA562DA6CBD42C0361B2B6A0AF892920"
      unitRef="usd">0</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2635-wk-Fact-E55DCDCAE2272CF5C658B6A0050A1B07"
      unitRef="usd">273100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2647-wk-Fact-D302DA4BE0548B477B08B6A1268A2E85"
      unitRef="usd">133000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      id="d45245159e2651-wk-Fact-BC4D2DA34F9A22D83BFACCD3138AEFCC">P19Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <ebs:PresentValueDiscountRate
      contextRef="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_VivotifMember"
      decimals="3"
      id="d45245159e2665-wk-Fact-55E22B8FDB34E1E24E07CCD31379F65A"
      unitRef="number">0.145</ebs:PresentValueDiscountRate>
    <ebs:PresentValueDiscountRate
      contextRef="D2018Q4Oct04-Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_VaxchoraMember"
      decimals="2"
      id="d45245159e2669-wk-Fact-9DC3904E192B4C532D47CCD3137C3CE3"
      unitRef="number">0.15</ebs:PresentValueDiscountRate>
    <us-gaap:Goodwill
      contextRef="I2018Q4Oct04_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2685-wk-Fact-63E99590CCA82F9BA027B6A002F29BF7"
      unitRef="usd">69500000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45245159e2692-wk-Fact-C2F0EF7DA1780A73C60ECCD3131D9B4E"
      unitRef="usd">4500000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <ebs:TermofContractUnderAcquisition
      contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      id="d45245159e2711-wk-Fact-1B082A7CF602B3B4CCFCCCD31375671B">P10Y</ebs:TermofContractUnderAcquisition>
    <ebs:ValueofContract
      contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-6"
      id="d45245159e2715-wk-Fact-B7DEF7390453164A905FCCD3131F8FDB"
      unitRef="usd">425000000</ebs:ValueofContract>
    <ebs:AmountforDeliveriesofProduct
      contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-6"
      id="d45245159e2719-wk-Fact-469723C98504D59238ABCCD31388356D"
      unitRef="usd">160000000</ebs:AmountforDeliveriesofProduct>
    <ebs:UpfrontPayments
      contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-5"
      id="d45245159e2726-wk-Fact-580D31E9D62D9130F8A8CCD313220B34"
      unitRef="usd">97500000</ebs:UpfrontPayments>
    <ebs:AmountOfPaymentForManufacturingRelatedMilestones
      contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-6"
      id="d45245159e2730-wk-Fact-B3343B8A93A7892A9A10CCD31379FA2E"
      unitRef="usd">20000000</ebs:AmountOfPaymentForManufacturingRelatedMilestones>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-5"
      id="d45245159e2734-wk-Fact-89FFE5626C5ED5169D02CCD3134EFBAC"
      unitRef="usd">117500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <ebs:AmountOfPaymentForRegulatoryRelatedMilestones
      contextRef="FI2019Q4_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-5"
      id="d45245159e2738-wk-Fact-9D16AC4CDE54C8F2A62DCCD31320E670"
      unitRef="usd">7500000</ebs:AmountOfPaymentForRegulatoryRelatedMilestones>
    <ebs:AmountOfPaymentForRegulatoryRelatedMilestones
      contextRef="FI2018Q4_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-5"
      id="d45245159e2742-wk-Fact-FE07B1AE2B3F1237ADC4CCD3132464B0"
      unitRef="usd">7500000</ebs:AmountOfPaymentForRegulatoryRelatedMilestones>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-5"
      id="d45245159e2754-wk-Fact-E40B3F82DBC0C960D929CCD31357708C"
      unitRef="usd">2200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-54EBA914C2462247E29BCCD313BCA4E8-0-wk-Fact-E8A83525C5587B051AFFCCD3137F0F74">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The total purchase price is summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:85%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Purchase Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Amount of cash paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;117.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of contingent purchase consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total purchase price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;119.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The total purchase price revised for adjustments is summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:79%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in&#160;millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;October 15, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;581.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;37.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of contingent purchase consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;48.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Preliminary purchase consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;667.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Final purchase consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;668.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-5"
      id="d45245159e2813-wk-Fact-89FFE5626C5ED5169D02CCD3134EFBAC"
      unitRef="usd">117500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-5"
      id="d45245159e2828-wk-Fact-E40B3F82DBC0C960D929CCD31357708C"
      unitRef="usd">2200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-5"
      id="d45245159e2853-wk-Fact-7965A2493E578771B8C2CCD3134D5E92"
      unitRef="usd">119700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-5"
      id="d45245159e2934-wk-Fact-1E2B365E3E3EFE3A58EDCCD31359CF76"
      unitRef="usd">74900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-5"
      id="d45245159e2949-wk-Fact-D820D09D9E2E8763BD26CCD3135B81C9"
      unitRef="usd">20000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-5"
      id="d45245159e2969-wk-Fact-0C9DC01E7B64EE0628A4CCD31359B921"
      unitRef="usd">94900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-5"
      id="d45245159e3010-wk-Fact-A8608293A9F966D7A995CCD3135A2E35"
      unitRef="usd">16700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-5"
      id="d45245159e3030-wk-Fact-36B36519B299EB164851CCD31357797C"
      unitRef="usd">8100000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-5"
      id="d45245159e3055-wk-Fact-7965A2493E578771B8C2CCD3134D5E92"
      unitRef="usd">119700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <ebs:PresentValueDiscountRate
      contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="4"
      id="d45245159e3067-wk-Fact-8109781596F9CCE7A3A1CCD313241CF5"
      unitRef="number">0.1550</ebs:PresentValueDiscountRate>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="D2017Q4Oct06-Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      id="d45245159e3071-wk-Fact-67A7940BC42A914C5E07CCD3137CF0A0">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:Goodwill
      contextRef="I2017Q4Oct06_us-gaap_BusinessAcquisitionAxis_ebs_ACAM2000Member"
      decimals="-5"
      id="d45245159e3084-wk-Fact-36B36519B299EB164851CCD31357797C"
      unitRef="usd">8100000</us-gaap:Goodwill>
    <ebs:UpfrontPayments
      contextRef="D2017Q4Oct2_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember"
      decimals="-6"
      id="d45245159e3098-wk-Fact-355023AEF965CC59F8F5CCD3132673D0"
      unitRef="usd">76000000</ebs:UpfrontPayments>
    <ebs:AmountOfPaymentForManufacturingRelatedMilestones
      contextRef="I2017Q4Oct2_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember"
      decimals="-6"
      id="d45245159e3102-wk-Fact-2160EAB50904F32CD233CCD313906EBA"
      unitRef="usd">20000000</ebs:AmountOfPaymentForManufacturingRelatedMilestones>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="D2017Q4Oct2_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember"
      decimals="-5"
      id="d45245159e3110-wk-Fact-DD19AC7C0DB145156A30F5B8B9BB79DA"
      unitRef="usd">77600000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_RaxibacumabMember"
      decimals="-5"
      id="d45245159e3122-wk-Fact-345A1473599D5177CF4DEC99CDB03042"
      unitRef="usd">10000000.0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-52953495809D84304ABECCD313BC05E6-0-wk-Fact-EB235D54A8BAE64EC877CCD31347CC27">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Fair value measurements&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company&#x2019;s recurring fair value measurement items recorded on a recurring basis primarily consist of contingent consideration liabilities, interest rate swaps and investments in money market funds. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Contingent consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The contingent consideration liabilities have been generated from our acquisitions. These liabilities represent an obligation of the Company to transfer additional assets to the selling shareholders if future events occur or conditions are met. The Company&#x2019;s contingent consideration is measured initially and subsequently at each reporting date at fair value.&#160; The changes in the fair value of contingent consideration obligations are primarily due to the expected amount and timing of future net sales and achieving regulatory milestones, which are inputs that have no observable market (Level 3). Any changes in expectations for the Company&#x2019;s products are classified in the Company's statement of operations as cost of product sales and contract development and manufacturing. Any changes in expectations for the Company&#x2019;s product candidates are recorded in research and development expense for regulatory and development milestones.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The following table is a reconciliation of the beginning and ending balance of the contingent consideration liabilities measured at fair value using significant unobservable inputs (Level 3) during the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance at December&#160;31, 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;12.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Expense included in earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Settlements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Additions due to acquisition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;48.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance at December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;60.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Expense included in earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;24.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Milestone achievement - asset acquisition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Measurement period adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Settlements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(67.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;29.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Interest rate swaps&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The valuation of the interest rate swaps is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each interest rate swap. This analysis reflects the contractual terms of the interest rate swaps, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash payments (or receipts) and the discounted expected variable cash receipts (or payments). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. To comply with the provisions of ASC 820, Fair Value Measurement, we incorporate credit valuation adjustments in the fair value measurements to appropriately reflect both our own nonperformance risk and the respective counterparty&#x2019;s nonperformance risk. These credit valuation adjustments were concluded to not be significant inputs for the fair value calculations for the periods presented. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we have considered the impact of netting and any applicable credit enhancements, such as the posting of collateral, thresholds, mutual puts and guarantees. The valuation of interest rate swaps fall into Level 2 in the fair value hierarchy. See note &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;10&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; "&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Derivative Instruments&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; " for further details on the interest rate swaps. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Money market funds&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The fair values of the Company's money market funds are based on quoted prices in active markets for identical assets (level 1). As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company held cash in money market accounts of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$52.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively. These amounts are included in cash and cash equivalents in the consolidated balance sheets.   &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Non-recurring fair value measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Separate disclosure is required for assets and liabilities measured at fair value on a recurring basis from those measured at fair value on a non-recurring basis. As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, there were &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;no&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; assets or liabilities measured at fair value on a non-recurring basis, except for the IPR&amp;amp;D assets acquired with the Adapt acquisition and the assets acquired from PaxVax, Adapt. See Note &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;4&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. "&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Acquisitions&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;" and Note 8. "Intangible assets and goodwill" for further details on the IPR&amp;amp;D assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-B4AB4B5DCB5360B18DE5CCD313BCC824-0-wk-Fact-D416678294825737F290CCD313481072">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The following table is a reconciliation of the beginning and ending balance of the contingent consideration liabilities measured at fair value using significant unobservable inputs (Level 3) during the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance at December&#160;31, 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;12.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Expense included in earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Settlements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Additions due to acquisition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;48.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance at December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;60.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Expense included in earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;24.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Milestone achievement - asset acquisition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Measurement period adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Settlements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(67.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;29.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="FI2017Q4"
      decimals="-5"
      id="d45245832e800-wk-Fact-637AD56D0886D317A68CCCD3139212EA"
      unitRef="usd">12300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45245832e815-wk-Fact-8FB2D740C2EFA786E47BCCD31385EBD4"
      unitRef="usd">3100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45245832e835-wk-Fact-90CA06A26412CE3561F5CCD313997134"
      unitRef="usd">3400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45245832e856-wk-Fact-966220F0626779C6BBE2CCD3138E0C58"
      unitRef="usd">48000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45245832e881-wk-Fact-51E9570A56EF1F947366CCD3139421F0"
      unitRef="usd">60000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45245832e896-wk-Fact-3E612A3313CB77A8D382CCD313807538"
      unitRef="usd">24800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45245832e916-wk-Fact-80277A338CEA1C893A04CCD31386BFF0"
      unitRef="usd">10000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <ebs:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45245832e936-wk-Fact-E71C6A6CCD60FDA28557B2B2DA31E55F"
      unitRef="usd">1500000</ebs:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45245832e956-wk-Fact-D15034ADF973B2CB3434CCD3137E1D23"
      unitRef="usd">67100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45245832e982-wk-Fact-593086BF0DE886F0BF73CCD313919718"
      unitRef="usd">29200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_CashAndCashEquivalentsAxis_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member"
      decimals="-5"
      id="d45245832e1019-wk-Fact-064A3991F63C071F53FF3F438704D5A2"
      unitRef="usd">52200000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2018Q4_us-gaap_CashAndCashEquivalentsAxis_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member"
      decimals="-6"
      id="d45245832e1023-wk-Fact-0998DC6D6C9E04155B852CCDC03C601F"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-63DC0FF3F5C3B60044E2CCD313BC9F03-0-wk-Fact-0C212F8921E7910A8A38CCD31358E0A9">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Inventories&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Inventories consist of the following:&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #ffffff;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Raw materials and supplies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;70.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;51.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Work-in-process&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;89.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;103.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Finished goods&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;62.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;50.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;222.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;205.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-C8ECBBE4ECAC594DD0BCCCD313BC4CBC-0-wk-Fact-A20BDBC3726ECDCE67ACCCD31364A9A9">&lt;div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Inventories consist of the following:&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #ffffff;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Raw materials and supplies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;70.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;51.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Work-in-process&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;89.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;103.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Finished goods&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;62.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;50.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;222.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;205.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45245537e846-wk-Fact-7850538D9C43C5AE003BCCD3137D6445"
      unitRef="usd">70500000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45245537e865-wk-Fact-8ECBA0BF2A49313E94D4CCD3138CDA8D"
      unitRef="usd">51800000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45245537e880-wk-Fact-74F48BDC00BE7E544133CCD3139213C9"
      unitRef="usd">89700000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45245537e899-wk-Fact-9EFA53F48F94481BBAEDCCD3138892E9"
      unitRef="usd">103200000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45245537e919-wk-Fact-18AA258CCCAD4E7D6A7DCCD31399F784"
      unitRef="usd">62300000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45245537e938-wk-Fact-F2E2E060AECFD41D31A5CCD3138C934F"
      unitRef="usd">50800000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45245537e963-wk-Fact-9E7A6321764CCA011270CCD3135EBFCB"
      unitRef="usd">222500000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45245537e982-wk-Fact-9BE8FA4DD47B7E5F9DB4CCD31363B9B9"
      unitRef="usd">205800000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-C0657CF3A369C9F7D157CCD313BC3598-0-wk-Fact-38D8EE95CA4E3D9A96D0CCD31348F6E8">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Property, plant and equipment&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Property, plant and equipment consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #ffffff;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Land and improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;46.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;44.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Buildings, building improvements and leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;234.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;216.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Furniture and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;334.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;293.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;55.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;55.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Construction-in-progress&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;81.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;71.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;752.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;681.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(210.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(171.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;542.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;510.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;For the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, construction-in-progress primarily includes costs related to construction of manufacturing capabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Depreciation and amortization expense associated with property, plant and equipment was &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$49.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$36.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$32.2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; for the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandAndLandImprovementsMember"
      decimals="-5"
      id="d45246361e847-wk-Fact-2CD507A72F402AEEA720CCD3135FC5EA"
      unitRef="usd">46500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandAndLandImprovementsMember"
      decimals="-5"
      id="d45246361e866-wk-Fact-BD39275200601330B022CCD31332F4F4"
      unitRef="usd">44600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember"
      decimals="-5"
      id="d45246361e881-wk-Fact-5952CAB40DC98F2DB65FCCD3133568AB"
      unitRef="usd">234800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember"
      decimals="-5"
      id="d45246361e900-wk-Fact-4607CD7A1242BB13E295CCD3132A9C38"
      unitRef="usd">216200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember"
      decimals="-5"
      id="d45246361e920-wk-Fact-E90F96DB0D54B0B1F03BCCD3132C7EF7"
      unitRef="usd">334200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember"
      decimals="-5"
      id="d45246361e939-wk-Fact-F867F8EF437983321241CCD31323B2AB"
      unitRef="usd">293900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember"
      decimals="-5"
      id="d45246361e959-wk-Fact-3173EA625E51F36F0583CCD313617439"
      unitRef="usd">55700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerSoftwareIntangibleAssetMember"
      decimals="-5"
      id="d45246361e978-wk-Fact-9A0A91C46D340595B450CCD3132B5BA6"
      unitRef="usd">55200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"
      decimals="-5"
      id="d45246361e998-wk-Fact-49EE4615C3951E2EB444CCD3133247E8"
      unitRef="usd">81500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"
      decimals="-5"
      id="d45246361e1017-wk-Fact-25F2414AFA3528F10186CCD31333E7B5"
      unitRef="usd">71800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45246361e1037-wk-Fact-ECA0ED6EA7E0D82DE419CCD3132DD2DB"
      unitRef="usd">752700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45246361e1056-wk-Fact-E0416796D2277F2997D7CCD3133205A5"
      unitRef="usd">681700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45246361e1076-wk-Fact-CF641EBDB256DF126646CCD3132E5F41"
      unitRef="usd">210400000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45246361e1096-wk-Fact-B5EAB04BB3CD63080320CCD3132F2DBB"
      unitRef="usd">171500000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45246361e1122-wk-Fact-899C00B0608B636FBD8FCCD3135FCC56"
      unitRef="usd">542300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45246361e1141-wk-Fact-B7B7C9765C1C2455B6F1CCD3135E93E8"
      unitRef="usd">510200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45246361e1164-wk-Fact-BFF9DD13E5B1758A9F88CCD3134ED24E"
      unitRef="usd">49500000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45246361e1168-wk-Fact-09F0E22509DF348E9361CCD31349261C"
      unitRef="usd">36300000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45246361e1172-wk-Fact-4D19F32ACA591CE6F38FCCD3135A1541"
      unitRef="usd">32200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-4D71F65C18591F6B9305CCD313BD8DED-0-wk-Fact-74AED7C7E71A4A72F0BCCCD3132ABC80">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Intangible assets and goodwill&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company's intangible assets were acquired via business combinations or asset acquisitions. Changes in the Company&#x2019;s intangible assets, excluding IPR&amp;amp;D and goodwill, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;padding-left:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="15"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:32%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="12" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Estimated Life&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Additions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Accumulated Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"&gt;Products&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;9-22 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;778.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;82.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;705.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Corporate trade name&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;8 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;28.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;23.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;5.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Contract development and manufacturing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;8 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;Total intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;814.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;112.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;712.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="15"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:32%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="12" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Estimated Life&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Additions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Accumulated Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"&gt;Products&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;9-22 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;111.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;667.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;27.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;750.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Corporate trade name&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;8 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;28.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;19.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;9.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Contract development and manufacturing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;8 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;Total intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;147.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;667.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;53.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;761.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;For the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company recorded amortization expense for intangible assets of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$58.7&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$25.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$8.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively, which is included in the amortization of intangible assets line item of the consolidated statements of operations. As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the weighted average amortization period remaining for intangible assets is &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;13.6 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Future amortization expense as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;58.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;57.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;54.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;54.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2024 and beyond&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;487.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total remaining amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;712.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;During the year ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company recorded the impact of an impairment charge of $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;12.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million related to our intangible assets associated with the IPR&amp;amp;D acquired as part of our acquisition of Adapt. The $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;12.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million impairment charge is reflected as a component of  research and development expense on the consolidated statement of operations. The IPR&amp;amp;D intangible asset balance on the consolidated balance sheet at &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; was $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;29.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The following table is a summary of changes in goodwill:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Year ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #ffffff;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance at beginning of the year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;259.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;49.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Measurement period adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;6.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Additions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;210.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance at end of the year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;266.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;259.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-99D15BF460908D2FBDF9B2C200C299D7-0-wk-Fact-A6FC41FDF4910D9410EAB2C218584A07">&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company's intangible assets were acquired via business combinations or asset acquisitions. Changes in the Company&#x2019;s intangible assets, excluding IPR&amp;amp;D and goodwill, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="15"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:32%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="12" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Estimated Life&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Additions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Accumulated Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"&gt;Products&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;9-22 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;778.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;82.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;705.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Corporate trade name&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;8 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;28.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;23.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;5.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Contract development and manufacturing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;8 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&#160;&#160;&#160;Total intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;814.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;112.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;712.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember"
      decimals="-5"
      id="d45249685e938-wk-Fact-BFBFDEBCF30B1983CA10B2C592FFBF09"
      unitRef="usd">778000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember"
      decimals="-5"
      id="d45249685e952-wk-Fact-AC36B9A93966685C87AC117D2F3BE9C3"
      unitRef="usd">10000000.0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember"
      decimals="-5"
      id="d45249685e966-wk-Fact-AB69DDDAC11D1E38AC68B2CAD89C81C0"
      unitRef="usd">82200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember"
      decimals="-5"
      id="d45249685e981-wk-Fact-C598645C9A0AB717A024B2CC9010D762"
      unitRef="usd">705800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember"
      id="d45249685e996-wk-Fact-413118B55B2FD4FEEF93B2CE751A5928">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-5"
      id="d45249685e1006-wk-Fact-1DCA591912805E7DBBBCB2C5931E20B0"
      unitRef="usd">2800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-5"
      id="d45249685e1034-wk-Fact-F939615548440E2831F1B2CADAFF0648"
      unitRef="usd">2800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-5"
      id="d45249685e1049-wk-Fact-ECD134AC14121777FA13B2CC951EB39E"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      id="d45249685e1069-wk-Fact-950BCE73811A080E1AF2B2CE75347213">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-5"
      id="d45249685e1079-wk-Fact-7FDCE7981FD591E531E9B2C5930F9F58"
      unitRef="usd">28600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-5"
      id="d45249685e1107-wk-Fact-B89EDD6AE6527A81A627B2CAD42F9F10"
      unitRef="usd">23000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-5"
      id="d45249685e1122-wk-Fact-911B5E4A129494F648DBB2CC984F8233"
      unitRef="usd">5700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="FD2019Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember"
      id="d45249685e1142-wk-Fact-F3041CD0D296821E0C65B2CE7595DB8B">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember"
      decimals="-5"
      id="d45249685e1152-wk-Fact-51C182416B9F0C55288DB2C595111164"
      unitRef="usd">5500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember"
      decimals="-5"
      id="d45249685e1180-wk-Fact-6217D83DC72C03ECF3CDB2CAD4921ECE"
      unitRef="usd">4000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember"
      decimals="-5"
      id="d45249685e1195-wk-Fact-F48D38E4F302593AD2F9B2CC929378AC"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45249685e1230-wk-Fact-A2E8C74583DFEC0018C1B2C592FF1D37"
      unitRef="usd">814900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45249685e1244-wk-Fact-AC975C7B2571E2934370117D2F35EE25"
      unitRef="usd">10000000.0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45249685e1258-wk-Fact-E8601FC07D6276C8611CB2CADB22BA84"
      unitRef="usd">112000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45249685e1273-wk-Fact-27F900C72C5D1EA89EB6CCD3134DEE83"
      unitRef="usd">712900000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember"
      decimals="-5"
      id="d45249685e1481-wk-Fact-EC8A143F235A6F0F7253B2C59B4A30E9"
      unitRef="usd">111000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember"
      decimals="-5"
      id="d45249685e1495-wk-Fact-2FABCFDF5269BB27AC17117E648BF639"
      unitRef="usd">667000000.0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember"
      decimals="-5"
      id="d45249685e1509-wk-Fact-0F0F8EA90A1AF9276F4CB2CAD4489F6F"
      unitRef="usd">27900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ProductMember"
      decimals="-5"
      id="d45249685e1524-wk-Fact-7C125A3865F22BFE55F4B2CC901478EE"
      unitRef="usd">750100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember"
      id="d45249685e1539-wk-Fact-C6E243487BCD0214212E117ED525CA4D">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-5"
      id="d45249685e1549-wk-Fact-CDAF5E2B6DE1E57C5DC3B2C592F04569"
      unitRef="usd">2800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-5"
      id="d45249685e1577-wk-Fact-64D53D2F5AF3FB833119B2CAD9595EF5"
      unitRef="usd">2700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-5"
      id="d45249685e1592-wk-Fact-73703E399EF976D571F5B2CC901ADA02"
      unitRef="usd">100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      id="d45249685e1612-wk-Fact-CD4378D6F7450143246F117ED8D333E4">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-5"
      id="d45249685e1622-wk-Fact-D72E8258418E57FFC1BAB2C597DF63AA"
      unitRef="usd">28600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-5"
      id="d45249685e1650-wk-Fact-305E0617212D1F594E90B2CAD70A5C8D"
      unitRef="usd">19400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-5"
      id="d45249685e1665-wk-Fact-B0C45DAF9D3CB7A9BD6FB2CC99FF8C15"
      unitRef="usd">9200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="FD2018Q4YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember"
      id="d45249685e1685-wk-Fact-64D97DDA4BC4DB90DBF1117EDC446A02">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember"
      decimals="-5"
      id="d45249685e1695-wk-Fact-44E29B67C799D6C0D4B7B2C5930F42ED"
      unitRef="usd">5500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember"
      decimals="-5"
      id="d45249685e1723-wk-Fact-AD66A8592DA8854D0785B2CAD517287C"
      unitRef="usd">3300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ebs_ContractManufacturingMember"
      decimals="-5"
      id="d45249685e1738-wk-Fact-058F5D538EEBEF2E4535B2CC90238CC5"
      unitRef="usd">2200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45249685e1773-wk-Fact-2C732840137CB3B2FF36B2C59CD1B67C"
      unitRef="usd">147900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45249685e1787-wk-Fact-1393705FAE48B2721C12117E690541DA"
      unitRef="usd">667000000.0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45249685e1801-wk-Fact-ADEB9F714F64237D4AA7B2CAD5E2CAEC"
      unitRef="usd">53300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45249685e1816-wk-Fact-FAAFDFA256E7EC5FA786B2CC90A00B07"
      unitRef="usd">761600000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45249685e1837-wk-Fact-6CC25FDAD57AD605F0EFEE0DD6E4C0A9"
      unitRef="usd">58700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45249685e1841-wk-Fact-13AE45AAD591A38D64EBCCD313882444"
      unitRef="usd">25000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45249685e1846-wk-Fact-1225424380838E1DB578CCD31376D614"
      unitRef="usd">8600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="FD2019Q4YTD"
      id="d45249685e1854-wk-Fact-0B32C5E48D3C222BC071CCD3132FC219">P13Y7M6D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-CCAF55F5B6EFD38C048CCCD313BD9EA2-0-wk-Fact-B373E238564E120EBC1FCCD3132D61FB">&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Future amortization expense as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;58.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;57.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;54.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;54.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2024 and beyond&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;487.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total remaining amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;712.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45249685e1913-wk-Fact-6D500E7FD456923A15AECCD31352C727"
      unitRef="usd">58700000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45249685e1928-wk-Fact-F0B99759E42FFC6F5489CCD313515422"
      unitRef="usd">57300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45249685e1948-wk-Fact-EDE1B983CBBB6515BA44CCD3134F85F1"
      unitRef="usd">54600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45249685e1968-wk-Fact-326F2DD95817A1A002FCCCD31350E5BF"
      unitRef="usd">54400000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <ebs:FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45249685e1988-wk-Fact-1DC12762781C2042F850CCD31350630F"
      unitRef="usd">487900000</ebs:FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45249685e2013-wk-Fact-27F900C72C5D1EA89EB6CCD3134DEE83"
      unitRef="usd">712900000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember"
      decimals="-5"
      id="d45249685e2029-wk-Fact-C32FD711B872DB8478CBB1501BA3B71C"
      unitRef="usd">12000000.0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_AdaptPharmaMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember"
      decimals="-5"
      id="d45249685e2033-wk-Fact-C32FD711B872DB8478CBB1501BA3B71C"
      unitRef="usd">12000000.0</us-gaap:GoodwillImpairmentLoss>
    <ebs:InProcessResearchAndDevelopment
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45249685e2041-wk-Fact-2B0343D7D345B2E16A1ACCD31364046E"
      unitRef="usd">29000000.0</ebs:InProcessResearchAndDevelopment>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-FD5A1F6D594701F60B61CCD313BDE017-0-wk-Fact-A448FA4A4935B8A36DD8CCD3132D9F3C">&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The following table is a summary of changes in goodwill:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Year ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #ffffff;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance at beginning of the year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;259.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;49.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Measurement period adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;6.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Additions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;210.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance at end of the year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;266.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;259.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:GoodwillGross
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45249685e2160-wk-Fact-0476B91EA1574A23DB9ACCD313714CA2"
      unitRef="usd">259700000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="FI2017Q4"
      decimals="-5"
      id="d45249685e2179-wk-Fact-CDE103C943F4EE8ED4EFCCD3136D2849"
      unitRef="usd">49100000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45249685e2194-wk-Fact-C19E4A5946048D3A90BE118577654EEA"
      unitRef="usd">6900000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45249685e2213-wk-Fact-89FF224DC8C7EAC96B6E1185775D971A"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45249685e2233-wk-Fact-3473E66A365C19F30831CCD313709C48"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45249685e2252-wk-Fact-E5772E3B577B60892A85CCD3136FA612"
      unitRef="usd">210600000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillGross
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45249685e2277-wk-Fact-9C366BA98887F810A6D5CCD3137087AE"
      unitRef="usd">266600000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45249685e2296-wk-Fact-0476B91EA1574A23DB9ACCD313714CA2"
      unitRef="usd">259700000</us-gaap:GoodwillGross>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-93E28B14392F783DFB4ACCD313BDA4A2-0-wk-Fact-1E2C353D239840263BEECCD3132CA173">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Long-term debt&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;  &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The components of debt are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Senior secured credit agreement - Term loan due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;435.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;447.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Senior secured credit agreement - Revolver loan due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;373.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;348.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2.875% Convertible Senior Notes due 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;10.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;10.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;822.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;808.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current portion of debt, net of debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(12.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(10.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(11.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(14.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Debt, net of current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;798.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;784.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Senior secured credit agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;On September 29, 2017, the Company entered into a senior secured credit agreement (the &#x201c;2017 Credit Agreement&#x201d;) with &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;four&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; lending financial institutions, which replaced the Company's prior senior secured credit agreement (the "2013 Credit Agreement").&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;On October 15, 2018, the Company entered into an Amended and Restated Credit Agreement (the "Amended Credit Agreement"), which modified the &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; Credit Agreement. The Amended Credit Agreement (i) increased the revolving credit facility (the "Revolving Credit Facility") from &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$200 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$600 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, (ii) extended the maturity of the Revolving Credit Facility from &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;September&#160;29, 2022&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;October&#160;13, 2023&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, (iii) provided for a term loan in the original principal amount of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$450 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; (the "Term Loan Facility," and together with the Revolving Credit Facility, the "Senior Secured Credit Facilities"), (iv) added several additional lenders, (v) amended the applicable margin such that borrowings with respect to the Revolving Credit Facility will bear interest at the annual rate described below, (vi) amended the provision relating to incremental credit facilities such that the Company may request one or more incremental term loan facilities, or one or more increases in the commitments under the Revolving Credit Facility (each an "Incremental Loan"), in any amount if, on a pro forma basis, the Company's consolidated secured net leverage ratio does not exceed &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2.50&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;1.00&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; after such incurrence, plus &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$200 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and (vii) amended the maximum consolidated net leverage ratio financial covenant from &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;3.50&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;1.0&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; (subject to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;0.50%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; step up in connection with material acquisitions) to the maximum consolidated net leverage ratio described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In October 2018, the Company borrowed &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$318.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; under the Revolving Credit Facility and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$450 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; under the Term Loan Facility to finance a portion of the consideration for the PaxVax and Adapt acquisitions and related expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;For the year ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, we did &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;t capitalize debt issuance costs. For the year ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; we capitalized &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$13.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, as a direct reduction to the Term Loan and the revolver.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Borrowings under the Revolving Credit Facility and the Term Loan Facility will bear interest at a rate per annum equal to (a) a eurocurrency rate plus a margin ranging from &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;1.25%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2.00%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; per annum, depending on the Company's consolidated net leverage ratio or (b) a base rate (which is the highest of the prime rate, the federal funds rate plus &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;0.50%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and a eurocurrency rate for an interest period of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;one month&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; plus &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;1%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;) plus a margin ranging from &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;0.25%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;1.00%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, depending on the Company's consolidated net leverage ratio. The Company is required to make quarterly payments under the Amended Credit Agreement for accrued and unpaid interest on the outstanding principal balance, based on the above interest rates. In addition, the Company is required to pay commitment fees ranging from &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;0.15%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;0.30%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; per annum, depending on the Company's consolidated net leverage ratio, in respect of the average daily unused commitments under the Revolving Credit Facility. The Company is to repay the outstanding principal amount of the Term Loan Facility in quarterly installments based on an annual percentage equal to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2.5%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of the original principal amount of the Term Loan Facility during each of the first two years of the Term Loan Facility, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;5%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of the original principal amount of the Term Loan Facility during the third year of the Term Loan Facility and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;7.5%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of the original principal amount of the Term Loan Facility during each year of the remainder of the term of the Term Loan Facility until the maturity date of the Term Loan Facility, at which time the entire unpaid principal balance of the Term Loan Facility will be due and payable. The Company has the right to prepay the Term Loan Facility without premium or penalty. The Revolving Credit Facility and the Term Loan Facility mature (unless earlier terminated) on &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;October&#160;13, 2023&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Amended Credit Agreement also requires mandatory prepayments of the Term Loan Facility in the event the Company or its Subsidiaries (a) incur indebtedness not otherwise permitted under the Amended Credit Agreement or (b) receive cash proceeds in excess of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$100 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; during the term of the Amended Credit Agreement from certain dispositions of property or from casualty events involving their property, subject to certain reinvestment rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Amended Credit Agreement contains financial covenants, which were then further amended in &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;June 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. The financial covenants require the quarterly presentation of a minimum consolidated 12-month rolling debt service coverage ratio of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2.50&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;1.00&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and an amended maximum consolidated net leverage ratio of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;4.95&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;1.00&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; for the quarter ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;4.75&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;1.00&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; for the quarter ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and  &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;3.75&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to 1.00, thereafter, which may be adjusted to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;4.00&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;1.00&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; for a four quarter period in connection with a material permitted acquisition. The Amended Credit Agreement also contains affirmative and negative covenants, which were also amended in &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;June 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to limit the amount of restricted payments as defined in the Amended Credit agreement to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$25 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; until the filing of the Company's &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; Form 10-K. Negative covenants in the Amended Credit Agreement, among other things, limit the ability of the Company to incur indebtedness and liens, dispose of assets, make investments and enter into certain merger or consolidation transactions. As of the date of these financial statements, the Company is in compliance with affirmative and negative covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;&lt;span&gt;2.875%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt; Convertible senior notes due 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;On November 14, 2017, the Company issued a notice of termination of conversion rights for its outstanding Notes, of which &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$250.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; was outstanding as of the notice date. In connection with the notice of termination, bondholders were given the option to convert their notes into the Company&#x2019;s stock at a rate of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;32.386&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; per &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;$1,000&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of principal outstanding, plus a make-whole of an additional &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;3.1556&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; shares per &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;$1,000&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; principal outstanding, in accordance with the terms of the indenture. The Company was not obligated to pay accrued or unpaid interest on converted notes, and bondholders who did not convert by the deadline of December 28, 2017 would retain their bonds but lose the conversion rights associated with the Notes and be paid interest of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2.875%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; until the earlier of maturity of the Notes in 2021 or the bonds being called and repaid in full by the Company. Between July 15, 2017 and the notification of termination of conversion rights, the Company accrued interest on the converted Notes of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$2.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; which was recorded as an increase in additional paid-in-capital on the balance sheet. Between November 14, 2017 and December 28, 2017 (the &#x201c;conversion period&#x201d;), approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$239.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of bonds were converted into &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;8.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; shares of the Company&#x2019;s common stock, inclusive of shares issued as part of the make-whole provision. In addition, the Company recorded a reduction in additional paid-in-capital on the Company&#x2019;s balance sheet of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$3.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; associated with debt issuance costs attributable to the converted notes. After giving effect to the converted bonds, the outstanding principal balance of the Notes as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; was &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$10.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Future debt payments of long-term indebtedness are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:81%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;14.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;35.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;33.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;735.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2024 and thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;822.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-7F42964A222271EB3AB1CCD313BD3CA0-0-wk-Fact-F39E4B0B45AAF9D702DACCD31329EBAA">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The components of debt are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Senior secured credit agreement - Term loan due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;435.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;447.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Senior secured credit agreement - Revolver loan due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;373.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;348.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2.875% Convertible Senior Notes due 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;10.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;10.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;822.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;808.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current portion of debt, net of debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(12.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(10.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(11.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(14.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Debt, net of current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;798.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;784.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember"
      decimals="-5"
      id="d45247219e847-wk-Fact-78ABF6E6789609E38069CCD313653515"
      unitRef="usd">435900000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="FI2018Q4_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember"
      decimals="-5"
      id="d45247219e866-wk-Fact-6F80D437FD970B6DA8BCCCD31363457A"
      unitRef="usd">447200000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember"
      decimals="-5"
      id="d45247219e881-wk-Fact-011B577331FA8DD6BF5CCCD3136805F2"
      unitRef="usd">373000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="FI2018Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember"
      decimals="-5"
      id="d45247219e900-wk-Fact-FDEA481EE18755F0B87BCCD31367BB51"
      unitRef="usd">348000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member"
      decimals="-5"
      id="d45247219e920-wk-Fact-B37055ADD09BB78884E8CCD31365468D"
      unitRef="usd">10600000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member"
      decimals="-5"
      id="d45247219e939-wk-Fact-C4CA6435D3985A942597CCD31364A4C7"
      unitRef="usd">10600000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_ebs_OtherLongTermDebtFacilityMember"
      decimals="-5"
      id="d45247219e959-wk-Fact-08B22B915247E4658515CCD313683ABE"
      unitRef="usd">3000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_ebs_OtherLongTermDebtFacilityMember"
      decimals="-5"
      id="d45247219e978-wk-Fact-11F606BB695065012BE5CCD31367F678"
      unitRef="usd">3000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45247219e1003-wk-Fact-5386E050AFE659B4A21ECCD313659993"
      unitRef="usd">822500000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45247219e1022-wk-Fact-8DAE5579866B62C08D91CCD313645010"
      unitRef="usd">808800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45247219e1037-wk-Fact-E4E353421F6CF0F1D415CCD31366C1C9"
      unitRef="usd">12900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45247219e1057-wk-Fact-B88CB1FA3CCB30D69E6FCCD3136804F6"
      unitRef="usd">10100000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45247219e1078-wk-Fact-BF4A209FA00AA7B96FDBCCD31365D653"
      unitRef="usd">11200000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45247219e1098-wk-Fact-4E9AD266589779509EBFCCD31365B621"
      unitRef="usd">14200000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45247219e1124-wk-Fact-0163307C7DD7CD378E59CCD31360AD48"
      unitRef="usd">798400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45247219e1143-wk-Fact-6EFA9A3FEB39B8EF4FC4CCD313587151"
      unitRef="usd">784500000</us-gaap:LongTermDebtNoncurrent>
    <ebs:NumberOfLendingInstitutions
      contextRef="D2017Q3Sep29-Sep29_us-gaap_DebtInstrumentAxis_ebs_CreditAgreementMember"
      decimals="INF"
      id="d45247219e1158-wk-Fact-C0C462B43319DDE848CBCCD3135573B2"
      unitRef="lending_institution">4</ebs:NumberOfLendingInstitutions>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="I2017Q3Sep29_us-gaap_DebtInstrumentAxis_ebs_CreditAgreementMember"
      decimals="INF"
      id="d45247219e1169-wk-Fact-952BBF05FD8612C11E46CCD3134E009C"
      unitRef="usd">200000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="I2018Q4Oct15_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1173-wk-Fact-91E85509F8F2B7B32D82CCD3134DD5EB"
      unitRef="usd">600000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="I2018Q4Oct15_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1186-wk-Fact-89420427D00DC1294C00CCD3134A2401"
      unitRef="usd">450000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <ebs:ConsolidatedSecuredNetLeverageRatio
      contextRef="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1190-wk-Fact-A8A1C0D6F9908651BF2CF713D52FCE59"
      unitRef="number">2.50</ebs:ConsolidatedSecuredNetLeverageRatio>
    <ebs:AmountRequiredForNetLeverageRatio
      contextRef="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="-6"
      id="d45247219e1198-wk-Fact-A3830A92E6BDAA3E7784CCD3134C91E9"
      unitRef="usd">200000000</ebs:AmountRequiredForNetLeverageRatio>
    <ebs:DebtInstrumentCovenantLeverageRatio
      contextRef="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1202-wk-Fact-B2DDC27A29F4A23D9AFCF71F631C3DAA"
      unitRef="number">3.50</ebs:DebtInstrumentCovenantLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="D2018Q4Oct15-Oct15_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_FederalFundsEffectiveSwapRateMember"
      decimals="INF"
      id="d45247219e1211-wk-Fact-ADAFEA9E088E61A8D357CCD31352C005"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCredit
      contextRef="I2018Q4Oct31_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="-5"
      id="d45247219e1218-wk-Fact-5F8728DA86B9DA59CE91CCD313492C1E"
      unitRef="usd">318000000.0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="I2018Q4Oct31_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="-6"
      id="d45247219e1222-wk-Fact-AF553393B9E0D3CAB4C7CCD3134D04A8"
      unitRef="usd">450000000</us-gaap:LineOfCredit>
    <us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet
      contextRef="FI2019Q4"
      decimals="INF"
      id="d45247219e1233-wk-Fact-44B2AC52F1CDE611977CB70C1887C954"
      unitRef="usd">0</us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet>
    <us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45247219e1241-wk-Fact-D1E772395E0853AAB701CCD3134FD89E"
      unitRef="usd">13400000</us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember"
      decimals="INF"
      id="d45247219e1248-wk-Fact-172AF64C2CC8EC189821CCD31353A52D"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember"
      decimals="INF"
      id="d45247219e1252-wk-Fact-BDB64F927918F4D8D10BCCD31353B43A"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="D2018Q4Oct15-Oct15_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_FederalFundsEffectiveSwapRateMember"
      decimals="INF"
      id="d45247219e1256-wk-Fact-ADAFEA9E088E61A8D357CCD31352C005"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <ebs:DebtInstrumentTermOfVariableRate
      contextRef="D2018Q4Oct15-Oct15_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember"
      id="d45247219e1260-wk-Fact-07670D62DC78A408943DCCD313547D84">P1M</ebs:DebtInstrumentTermOfVariableRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="D2018Q4Oct15-Oct15_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember"
      decimals="INF"
      id="d45247219e1264-wk-Fact-FFC42CAC3B9378376DFACCD3134E2268"
      unitRef="number">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember"
      decimals="INF"
      id="d45247219e1269-wk-Fact-5846259A1C5A70FB1025CCD3134FC182"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember"
      decimals="INF"
      id="d45247219e1273-wk-Fact-0117A704357629F217D4CCD3134A1D7F"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1277-wk-Fact-5EA4B9128E15729C9C4FCCD31354CC93"
      unitRef="number">0.0015</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="D2018Q4Oct15-Oct15_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1281-wk-Fact-774D9941A0A53B8EB464CCD3134BC155"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <ebs:PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears
      contextRef="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1285-wk-Fact-690F4CAFD3F12CCE1A5BCCD313489B93"
      unitRef="number">0.025</ebs:PercentageOfOriginalPrincipalAmountRequiredToRepayInFirstTwoYears>
    <ebs:PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear
      contextRef="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1289-wk-Fact-CFEA0A816E9EA107A568CCD3134E0570"
      unitRef="number">0.05</ebs:PercentageOfOriginalPrincipalAmountRequiredToRepayDuringTheThirdYear>
    <ebs:PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears
      contextRef="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1294-wk-Fact-347DA37033EED93BAB8DCCD3134C2EB6"
      unitRef="number">0.075</ebs:PercentageOfOriginalPrincipalAmountRequiredToRepayRemainingYears>
    <ebs:CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight
      contextRef="D2018Q4Oct15-Oct15_us-gaap_CreditFacilityAxis_ebs_TermLoanFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1305-wk-Fact-7F3D506C648ACA981B37CCD313548328"
      unitRef="usd">100000000</ebs:CashProceedsExcessAmountFromDispositionsOfPropertyOrCasualtyEventsSubjectToCertainReinvestmentRight>
    <ebs:DebtInstrumentCovenantDebtServiceCoverageRatio
      contextRef="D2019Q2Jun01-Jun30_srt_RangeAxis_srt_MinimumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1316-wk-Fact-43DEF740AB6C4569CF2EF71E34FF558B"
      unitRef="number">2.50</ebs:DebtInstrumentCovenantDebtServiceCoverageRatio>
    <ebs:DebtCovenantNetLeverageRatioOne
      contextRef="FD2019Q2QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1324-wk-Fact-9C0F97ECDA8A8BBE9E24F71E5E9FAFD1"
      unitRef="number">4.95</ebs:DebtCovenantNetLeverageRatioOne>
    <ebs:DebtCovenantNetLeverageRatioTwo
      contextRef="FD2019Q3QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1337-wk-Fact-666AEACC188D8F7284F3CCD313564179"
      unitRef="number">4.75</ebs:DebtCovenantNetLeverageRatioTwo>
    <ebs:DebtCovenantNetLeverageRatioThree
      contextRef="FD2019Q4QTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1349-wk-Fact-287333B8E8978D1E8C4CF71EB26BE4A4"
      unitRef="number">3.75</ebs:DebtCovenantNetLeverageRatioThree>
    <ebs:DebtCovenantNetLeverageRatioFour
      contextRef="FD2019Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1353-wk-Fact-C344F1401B1D4EFFC78BF71F0D0BBDCC"
      unitRef="number">4.00</ebs:DebtCovenantNetLeverageRatioFour>
    <ebs:DebtInstrumentRestrictedPaymentsLimitAmount
      contextRef="D2019Q2Jun01-Jun30_us-gaap_DebtInstrumentAxis_ebs_AmendedCreditAgreementMember"
      decimals="INF"
      id="d45247219e1366-wk-Fact-1778F1660A70F19662C1936BAEC8FE94"
      unitRef="usd">25000000</ebs:DebtInstrumentRestrictedPaymentsLimitAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="I2014Q1Jan29_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member"
      decimals="INF"
      id="d45247219e1376-wk-Fact-C03F1A46AF219A1B4359F6FFD39DB952"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="I2017Q4Nov14_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member"
      decimals="INF"
      id="d45247219e1383-wk-Fact-07272BB5CC8741E962EECCD313481203"
      unitRef="usd">250000000.0</us-gaap:DebtInstrumentFaceAmount>
    <ebs:DebtInstrumentNumberOfEquityInstruments
      contextRef="D2016Q3Aug12-Aug12_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member"
      decimals="3"
      id="d45247219e1387-wk-Fact-235528EE95CCDD9CED1BCCD313527907"
      unitRef="shares">32.386</ebs:DebtInstrumentNumberOfEquityInstruments>
    <ebs:DebtInstrumentNumberOfAdditionalEquityInstruments
      contextRef="D2017Q4Nov14-Nov14_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member"
      decimals="4"
      id="d45247219e1395-wk-Fact-A85E82461E05E111D969CCD31347E2ED"
      unitRef="shares">3.1556</ebs:DebtInstrumentNumberOfAdditionalEquityInstruments>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="I2017Q4Nov14_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member"
      decimals="INF"
      id="d45247219e1404-wk-Fact-5AD0266C3EE765ADCEABCCD31353BC27"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <ebs:DebtInstrumentAccruedInterestOnConvertedNotes
      contextRef="D2017Q4Nov14-Nov14_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member"
      decimals="-5"
      id="d45247219e1408-wk-Fact-5A30BFE4A5FEAB5585E1CCD3134943B0"
      unitRef="usd">2400000</ebs:DebtInstrumentAccruedInterestOnConvertedNotes>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="I2017Q4Dec28_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member"
      decimals="-5"
      id="d45247219e1412-wk-Fact-79CC0B7784F3EA2DBC61CCD31355D8D8"
      unitRef="usd">239400000</us-gaap:DebtInstrumentFaceAmount>
    <ebs:DebtInstrumentNumberOfEquityInstruments
      contextRef="D2017Q4Nov15-Dec28_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member"
      decimals="-5"
      id="d45247219e1416-wk-Fact-233F839CE7DA44E58868CCD3134A33F7"
      unitRef="shares">8500000</ebs:DebtInstrumentNumberOfEquityInstruments>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="I2017Q4Dec28_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member"
      decimals="-5"
      id="d45247219e1420-wk-Fact-83DA0568A4F540F2D457CCD31354EC57"
      unitRef="usd">3600000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_ebs_ConvertibleSeniorNotesDue2021Member"
      decimals="INF"
      id="d45247219e1429-wk-Fact-E9A3848C2DBAE5012526CCD313561EA7"
      unitRef="usd">10600000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-D14E63530B6D4AAA33C5CCD313BDE974-0-wk-Fact-065EC1BF2EC8B14B5EB0CCD3132A7985">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Future debt payments of long-term indebtedness are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:81%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;14.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;35.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;33.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;735.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2024 and thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;822.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45247219e1484-wk-Fact-92A9D4435C6AFCBCDAE6CCD313932ACB"
      unitRef="usd">14100000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45247219e1499-wk-Fact-5988940D9D52326949D6CCD31388E470"
      unitRef="usd">35900000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45247219e1519-wk-Fact-C7044F22A3673358C39DCCD31392CD98"
      unitRef="usd">33700000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45247219e1539-wk-Fact-CE3D3881B1F49549AC7ACCD313776233"
      unitRef="usd">735800000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <ebs:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45247219e1559-wk-Fact-ABB01064E0CC85BF3207CCD313763D86"
      unitRef="usd">3000000.0</ebs:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter>
    <us-gaap:LongTermDebt
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45247219e1584-wk-Fact-5386E050AFE659B4A21ECCD313659993"
      unitRef="usd">822500000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-72A89327CFC045CFA4A893A69E05A3C1-0-wk-Fact-ABC3EFDD1696ABE21F5893A7C40A28B2">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Derivative Instruments&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company is exposed to certain risk arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company has entered into interest rate swaps to manage exposures that arise from the Company's senior secured credit agreement's payments of variable interest rate debt. All outstanding cash flow hedges mature in October 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company had the following outstanding interest rate swap derivatives that were designated as cash flow hedges of interest rate risk: &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Number of Instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Notional amount                  (in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#00497f;"&gt;&lt;span&gt;350.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The table below presents the fair value of the Company&#x2019;s derivative financial instruments designated as hedges as well as their classification on the balance sheet. If current fair values of designated interest rate swaps remained static over the next twelve months, the Company would reclassify $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million of net deferred losses from accumulated other comprehensive loss to the statement of operations over the next twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="8" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Asset Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Liability Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="4" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="4" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;Other Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;&lt;span&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; The table below presents the effect of cash flow hedge accounting on accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:30%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Hedging derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Amount of Gain/(Loss) Recognized in OCI on Derivative&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Location of Gain or (Loss) Reclassified from Accumulated OCI into Income &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;&lt;span&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-D21F456DA0DB4089511593A97B8A38F2-0-wk-Fact-33D22958724AA0544ECC93AABCB94311">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company had the following outstanding interest rate swap derivatives that were designated as cash flow hedges of interest rate risk: &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Number of Instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Notional amount                  (in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#00497f;"&gt;&lt;span&gt;350.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="INF"
      id="d45249230e791-wk-Fact-782EDDB1DF99CB6212CB93D09787B070"
      unitRef="instrument">7</us-gaap:NumberOfInterestRateDerivativesHeld>
    <invest:DerivativeNotionalAmount
      contextRef="FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="INF"
      id="d45249230e801-wk-Fact-D764E2AF101AFC78C7DB93D09E5F590D"
      unitRef="usd">350000000.0</invest:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-EE4492BC59D9D677EBBE93AAE2DF2EBF-0-wk-Fact-10A65DC92274E6CD752E93AB30F2EF99">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The table below presents the fair value of the Company&#x2019;s derivative financial instruments designated as hedges as well as their classification on the balance sheet. If current fair values of designated interest rate swaps remained static over the next twelve months, the Company would reclassify $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million of net deferred losses from accumulated other comprehensive loss to the statement of operations over the next twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="8" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Asset Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Liability Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="4" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="4" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;Other Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;&lt;span&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember"
      decimals="-5"
      id="d45249230e809-wk-Fact-5C7F0750F05BBE6AADBBECA01244FAF2"
      unitRef="usd">500000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-5"
      id="d45249230e1102-wk-Fact-8D2C8569C2151AD1BA1D93D6CC6F5777"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-5"
      id="d45249230e1116-wk-Fact-0D81E06B4E77BDBCDE0193D6D1CE47F7"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-5"
      id="d45249230e1135-wk-Fact-22342397583B82597F3B93D6D69706ED"
      unitRef="usd">2000000.0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-5"
      id="d45249230e1155-wk-Fact-7FE75A9CC3B05D30BFF293D7E3D658B0"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-5878A207866FB090105C98BA473E6C8F-0-wk-Fact-ACF76D79D163BBBF35A298BACC4626BF">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; The table below presents the effect of cash flow hedge accounting on accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:30%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Hedging derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Amount of Gain/(Loss) Recognized in OCI on Derivative&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Location of Gain or (Loss) Reclassified from Accumulated OCI into Income &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;&lt;span&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember"
      decimals="-5"
      id="d45249230e1334-wk-Fact-71062B02773D93D42D7193D9A212FB8A"
      unitRef="usd">2000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
      contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember"
      decimals="-5"
      id="d45249230e1343-wk-Fact-B9435A39AB4005C3D95293D9A463F7CB"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d45249230e1362-wk-Fact-88E454B848F6750A5B4298AD83E02B28"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="FD2018Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember"
      decimals="-5"
      id="d45249230e1377-wk-Fact-897726E659C1BF7600A793D9A9E88091"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-A102C2AD0293933B3CFACCD313BE0269-0-wk-Fact-7406BA55A8A88BD18BE6CCD313687C45">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Stockholders' equity&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Preferred stock&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company is authorized to issue up to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;15.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; shares of preferred stock, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$0.001&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; par value per share ("Preferred Stock"). Any Preferred Stock issued may have dividend rights, voting rights, conversion privileges, redemption characteristics, and sinking fund requirements as approved by the Company's board of directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Common stock&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company currently has one class of common stock, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$0.001&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; par value per share common stock ("Common Stock"), authorized and outstanding. The Company is authorized to issue up to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;200.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; shares of Common Stock. Holders of Common Stock are entitled to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; vote for each share of Common Stock held on all matters, except as may be provided by law.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Accounting for stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company has one stock-based employee compensation plan, the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan (the "Emergent Plan"), which includes both stock options and restricted stock units.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, an aggregate of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;21.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; shares of common stock were authorized for issuance under the Emergent Plan, of which a total of approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;5.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; shares of common stock remain available for future awards to be made to plan participants. The exercise price of each option must be not less than &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of the fair market value of the shares underlying such option on the date of grant. Awards granted under the Emergent Plan have a contractual life of no more than &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;10 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company utilizes the Black-Scholes valuation model for estimating the fair value of all stock options granted. Set forth below are the assumptions used in valuing the stock options granted:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Expected dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Expected volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;37-39%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;38-39%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;37-40%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.57-2.48%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2.54-3.03%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.66-1.88%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Expected average life of options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;4.5 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;4.5 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;4.3 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Stock options, restricted and performance stock units&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The following is a summary of stock option award activity under the Emergent Plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="10" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Emergent Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions, except share and per share data)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Number of Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Outstanding at December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1,871,468&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;32.59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;50.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;295,770&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;60.16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(199,352&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;25.98&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(84,011&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;52.26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Outstanding at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1,883,875&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;36.74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;34.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Exercisable at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1,253,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;29.46&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;30.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The weighted average remaining contractual term of options outstanding as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; was  &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;3.3 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;4.0 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively. The weighted average remaining contractual term of options exercisable as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; was &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2.3 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;3.0 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The weighted average grant date fair value of options granted during the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; was &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$21.13&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$18.48&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$10.53&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; per share, respectively. The total intrinsic value of options exercised during the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; was &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$5.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$24.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$13.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively. The total fair value of awards vested during &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; was &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$16.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$16.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$17.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively. As of the year ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the total compensation cost and weighted average period over which total compensation is expected to be recognized related to unvested equity awards was &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$37.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;1.5 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The following is a summary of performance stock and restricted stock unit award activity under the Emergent Plan. Performance stock units of approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million shares were granted and remain outstanding the year ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and are included in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions, except share and per share data)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Number of Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Weighted-Average Grant Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Outstanding at December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;921,093&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;42.82&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;54.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;594,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;57.94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(434,629&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;38.81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(128,364&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;53.17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Outstanding at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;952,852&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;52.77&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;51.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Stock-based compensation expense was recorded in the following financial statement line items:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cost of product sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Selling, general and administrative&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;19.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;18.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;11.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;26.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;23.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;15.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The following table includes changes in accumulated other comprehensive loss by component, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:6%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Defined Benefit Pension Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Foreign Currency Translation Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, January 1, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(3.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(3.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other comprehensive loss &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(5.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(5.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net current period other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(4.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(4.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(9.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="FI2019Q4"
      decimals="INF"
      id="d45252404e738-wk-Fact-4C57654DA23897ACB2EAF6BD074F89ED"
      unitRef="shares">15000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="FI2019Q4"
      decimals="INF"
      id="d45252404e742-wk-Fact-1CC3C94A937B33F5EB4CCCD3136F00CF"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="FI2019Q4"
      decimals="INF"
      id="d45252404e752-wk-Fact-1AB42C1C80CE1D400F65CCD3136C58E8"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2019Q4"
      decimals="INF"
      id="d45252404e756-wk-Fact-A4276C7329AF217B728CF6BD407A1630"
      unitRef="shares">200000000.0</us-gaap:CommonStockSharesAuthorized>
    <ebs:CommonStockNumberofVotesPerCommonShare
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d45252404e760-wk-Fact-1057361E2C611395F0CFB1B10865B086"
      unitRef="vote">1</ebs:CommonStockNumberofVotesPerCommonShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="d45252404e777-wk-Fact-01C9452B7F7D346CB788CCD313A97C34"
      unitRef="shares">21900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-5"
      id="d45252404e781-wk-Fact-53FDDCC8B3EF67D272FBCCD313A6F912"
      unitRef="shares">5800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <ebs:ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="d45252404e785-wk-Fact-A8435198BE54DAB7BA3ACCD3137361FB"
      unitRef="number">1</ebs:ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d45252404e789-wk-Fact-4C6BB05A911AA395D7C0CCD3135E5D4E">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-A20CE09B9DE0357A7AA8CCD313BD0429-0-wk-Fact-9B84D274E406DED16713CCD313448E96">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company utilizes the Black-Scholes valuation model for estimating the fair value of all stock options granted. Set forth below are the assumptions used in valuing the stock options granted:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Expected dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Expected volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;37-39%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;38-39%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;37-40%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.57-2.48%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2.54-3.03%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;1.66-1.88%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Expected average life of options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;4.5 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;4.5 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;4.3 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="d45252404e914-wk-Fact-DB83BC4B671746420ADDCCD31335E8DC"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="d45252404e929-wk-Fact-388F3C5582E6EF548814CCD3132FDB9E"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="d45252404e944-wk-Fact-43666FF84299922E8A82CCD3133606EF"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d45252404e1046-wk-Fact-8B8AE862F962FD361602CCD3132B218C">P4Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d45252404e1060-wk-Fact-4B53F2A3A077FE23E44ACCD313371655">P4Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d45252404e1074-wk-Fact-88A7EC2E11F047D31CE6CCD31339A238">P4Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-5A568097EADAA68623F5CCD313BE79C6-0-wk-Fact-D5ADB7DA945DEFDB11D6CCD31367AD98">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The following is a summary of stock option award activity under the Emergent Plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="10" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Emergent Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions, except share and per share data)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Number of Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Outstanding at December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1,871,468&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;32.59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;50.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;295,770&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;60.16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(199,352&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;25.98&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(84,011&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;52.26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Outstanding at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1,883,875&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;36.74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;34.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Exercisable at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1,253,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;29.46&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;30.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="FI2018Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="INF"
      id="d45252404e1230-wk-Fact-AB56AEE6FF4B76D66B19CCD3133B69D0"
      unitRef="shares">1871468</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="FI2018Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="2"
      id="d45252404e1249-wk-Fact-18DC5725006FE2F7481BCCD3133A516B"
      unitRef="usdPerShare">32.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="FI2018Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="-5"
      id="d45252404e1268-wk-Fact-0BDE5FB8A0E5AF4DADFACCD31338F8A2"
      unitRef="usd">50100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="INF"
      id="d45252404e1283-wk-Fact-102EB811C9CBE276EDC6CCD31333A469"
      unitRef="shares">295770</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="2"
      id="d45252404e1297-wk-Fact-CAA6F410AE276A3BBD54CCD313317A72"
      unitRef="usdPerShare">60.16</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="INF"
      id="d45252404e1337-wk-Fact-AA90A95B647FF5DDDDBDCCD31339B91F"
      unitRef="shares">199352</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="2"
      id="d45252404e1352-wk-Fact-8E599FD3095F21CA890DCCD31337BD60"
      unitRef="usdPerShare">25.98</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="INF"
      id="d45252404e1392-wk-Fact-9379DD4743690B40308CCCD313341CC4"
      unitRef="shares">84011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="FD2019Q4YTD_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="2"
      id="d45252404e1407-wk-Fact-4F82DF5D104907ABC4DCCCD31330D7ED"
      unitRef="usdPerShare">52.26</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="INF"
      id="d45252404e1447-wk-Fact-E2EA0CDD4B5BA5D1B5F2CCD313323A89"
      unitRef="shares">1883875</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="2"
      id="d45252404e1466-wk-Fact-3249FED9BCE69D6E38CFCCD3133C3AE4"
      unitRef="usdPerShare">36.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="-5"
      id="d45252404e1485-wk-Fact-5842B74A58212652CCEECCD31332D8E4"
      unitRef="usd">34500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="INF"
      id="d45252404e1500-wk-Fact-43E21B5DC8B32B8F4731CCD313391DE1"
      unitRef="shares">1253658</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="2"
      id="d45252404e1519-wk-Fact-95EBD3F095B9937243EBCCD3132F3B8C"
      unitRef="usdPerShare">29.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="FI2019Q4_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="-5"
      id="d45252404e1538-wk-Fact-7737E6C3D5C1FF3BDE3BCCD313385DC1"
      unitRef="usd">30800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="FD2019Q4YTD"
      id="d45252404e1558-wk-Fact-895D81B3066ABC97C49155720D5969FF">P3Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="FD2018Q4YTD"
      id="d45252404e1562-wk-Fact-2FDB40624AE79D3A6A3B557219A34C3F">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="FD2019Q4YTD"
      id="d45252404e1575-wk-Fact-FCB8D524068A8F0BDF78CCD313AB95BB">P2Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="FD2018Q4YTD"
      id="d45252404e1579-wk-Fact-89FD030CBEC41A7DF091CCD313AE4F44">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d45252404e1598-wk-Fact-848124C7B1EA80D919F2CCD31362CCC1"
      unitRef="usdPerShare">21.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2018Q4YTD"
      decimals="2"
      id="d45252404e1602-wk-Fact-6410F6616A9ED23887EBCCD313ACCCB3"
      unitRef="usdPerShare">18.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2017Q4YTD"
      decimals="2"
      id="d45252404e1607-wk-Fact-8208C7DAF673BB02C9C5CCD3135B4245"
      unitRef="usdPerShare">10.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45252404e1623-wk-Fact-B8AC7865DBA288E7E361CCD3131BAAD6"
      unitRef="usd">5300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45252404e1627-wk-Fact-182CAF4752AEF80BFE35CCD313641A64"
      unitRef="usd">24400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45252404e1632-wk-Fact-404EAD494934D0FE4D85CCD3135DF052"
      unitRef="usd">13900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <ebs:ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-5"
      id="d45252404e1648-wk-Fact-B1F3C1A4C874526DD163CCD313A9927B"
      unitRef="usd">16900000</ebs:ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue>
    <ebs:ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue
      contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-5"
      id="d45252404e1653-wk-Fact-602018009611D15D966ECCD31346AB65"
      unitRef="usd">16900000</ebs:ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue>
    <ebs:ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue
      contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-5"
      id="d45252404e1657-wk-Fact-DC37BA0434D6D600385ACCD3135CAFD6"
      unitRef="usd">17900000</ebs:ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45252404e1665-wk-Fact-C40A3A62D59AEE4AAB98CCD31361C660"
      unitRef="usd">37000000.0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2019Q4YTD"
      id="d45252404e1669-wk-Fact-03A57996C275BB033FB3CCD3135C135C">P1Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-4DC71DE0E89FEEA5A8DACCD313BEB7ED-0-wk-Fact-E911D29B7CA8042BABFFCCD313A795A5">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The following is a summary of performance stock and restricted stock unit award activity under the Emergent Plan. Performance stock units of approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million shares were granted and remain outstanding the year ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and are included in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="11"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions, except share and per share data)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Number of Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Weighted-Average Grant Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Outstanding at December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;921,093&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;42.82&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;54.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;594,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;57.94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(434,629&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;38.81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(128,364&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;53.17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Outstanding at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;952,852&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;52.77&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;51.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="-5"
      id="d45252404e1678-wk-Fact-2005BA463FB5B1598FF8B73652B917CA"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="INF"
      id="d45252404e1769-wk-Fact-07EA5EB4787027E20E4BCCD31395D81E"
      unitRef="shares">921093</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="2"
      id="d45252404e1788-wk-Fact-15B7FE6EB9A2479BA82CCCD3139591EC"
      unitRef="usdPerShare">42.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="-5"
      id="d45252404e1807-wk-Fact-B9C79E611F8A7114FD0ECCD3138B181A"
      unitRef="usd">54600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="INF"
      id="d45252404e1822-wk-Fact-128AA9C7B9C6E9B8CBDDCCD313914AEC"
      unitRef="shares">594752</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="2"
      id="d45252404e1836-wk-Fact-A65C5577BAD207556663CCD313928BF5"
      unitRef="usdPerShare">57.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="INF"
      id="d45252404e1876-wk-Fact-808211C2B87C48C910BBCCD3138F9384"
      unitRef="shares">434629</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="2"
      id="d45252404e1891-wk-Fact-796F4F95268330325FBFCCD31393730F"
      unitRef="usdPerShare">38.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="INF"
      id="d45252404e1931-wk-Fact-C7C99C803C030562A52DCCD3138C2FC7"
      unitRef="shares">128364</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="2"
      id="d45252404e1946-wk-Fact-9DBEFFC55966C5244D5ACCD31392C6C3"
      unitRef="usdPerShare">53.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="INF"
      id="d45252404e1986-wk-Fact-7A9427D0AE39999A98F0CCD31394BDC8"
      unitRef="shares">952852</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="2"
      id="d45252404e2005-wk-Fact-0553EBD0B096778303A5CCD31396B36B"
      unitRef="usdPerShare">52.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_PlanNameAxis_ebs_EmergentBiosolutionsInc2006StockIncentivePlanMember"
      decimals="-5"
      id="d45252404e2024-wk-Fact-D1C1C23FF6C44097BA7FCCD3139310CF"
      unitRef="usd">51500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-81EFEA2E3F9AAA695A69CCD313BD6440-0-wk-Fact-E9E998EDB32DA0F5C4FACCD313866285">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Stock-based compensation expense was recorded in the following financial statement line items:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Cost of product sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Selling, general and administrative&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;19.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;18.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;11.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;26.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;23.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;15.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d45252404e2211-wk-Fact-7A377D174377B3F842F5CCD31360D3EF"
      unitRef="usd">3100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d45252404e2230-wk-Fact-7D3579472B1C9DC7653CCCD313534DF8"
      unitRef="usd">1700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember"
      decimals="-5"
      id="d45252404e2250-wk-Fact-423A62D64E476AAFF73DCCD31352EC1B"
      unitRef="usd">1100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="d45252404e2270-wk-Fact-AF4FB6AFAA07E8CE00E9CCD313594C7E"
      unitRef="usd">4000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="d45252404e2289-wk-Fact-4837F88019812866084DCCD3135B9DD7"
      unitRef="usd">3100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="d45252404e2308-wk-Fact-93BA592857BAB5465F51CCD3135BB115"
      unitRef="usd">2500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="-5"
      id="d45252404e2334-wk-Fact-6F78FBCDDC8DC96ADF11CCD31357763C"
      unitRef="usd">19600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="-5"
      id="d45252404e2353-wk-Fact-16337646A54BC8AD5E3FCCD313583FCC"
      unitRef="usd">18400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="-5"
      id="d45252404e2372-wk-Fact-D4FC9A913C74DDE3D794CCD3134B24DD"
      unitRef="usd">11600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45252404e2403-wk-Fact-47670159802E59A32337CCD3134B196D"
      unitRef="usd">26700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45252404e2422-wk-Fact-8C135B12BD2E7A2C60DACCD31355CE19"
      unitRef="usd">23200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45252404e2442-wk-Fact-3D982D2C34F119DA1DE6CCD31353C607"
      unitRef="usd">15200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-707FBF80FD8D3A1A60495FB4B9F59223-0-wk-Fact-75F991765D18477B10505FB5057A52EF">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The following table includes changes in accumulated other comprehensive loss by component, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:9%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:6%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Defined Benefit Pension Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Foreign Currency Translation Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, January 1, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(3.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(3.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other comprehensive loss &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(5.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(5.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net current period other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(4.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(1.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(4.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(9.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"
      decimals="-5"
      id="d45252404e2676-wk-Fact-1F73B2DA76F484B3F36B5FAC1689E096"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"
      decimals="-5"
      id="d45252404e2695-wk-Fact-2692F63EA36CC9FC0E715FAC164A3FAA"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-5"
      id="d45252404e2715-wk-Fact-5FB2B9E37F1A5AE8ABB65FAC15ED5E0B"
      unitRef="usd">-3700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d45252404e2735-wk-Fact-5FF3FC7F515F0A0BE3F8CCD3139B14AE"
      unitRef="usd">-3700000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"
      decimals="-5"
      id="d45252404e2756-wk-Fact-9AE6EE2A3A935D4FFEC35FAFC07EB649"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"
      decimals="-5"
      id="d45252404e2776-wk-Fact-084B0F138774D7B207465FAFC0B5EFB2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-5"
      id="d45252404e2795-wk-Fact-0B6F258D8003B35248455FAFC0DEF3E6"
      unitRef="usd">-1600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45252404e2816-wk-Fact-85089016933E47A775DDCCD3138523AA"
      unitRef="usd">-1800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"
      decimals="-5"
      id="d45252404e2847-wk-Fact-2EC0C2E5A65D05E873155FAC160C7E56"
      unitRef="usd">-200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"
      decimals="-5"
      id="d45252404e2867-wk-Fact-2C84210288E677071E4F5FAC1570FD05"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-5"
      id="d45252404e2887-wk-Fact-C23550B8EECA0A781E6E5FAC162B2362"
      unitRef="usd">-5300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d45252404e2902-wk-Fact-BD1E9E43ECA910844A10CCD313A65287"
      unitRef="usd">-5500000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"
      decimals="-5"
      id="d45252404e2933-wk-Fact-8C35A1539E2642FC67D45FAFC185A608"
      unitRef="usd">-3200000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"
      decimals="-5"
      id="d45252404e2953-wk-Fact-F1A98F163E3F46077D705FAFC12305F9"
      unitRef="usd">-2200000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-5"
      id="d45252404e2974-wk-Fact-8454309FD6B485D180435FAFC2844354"
      unitRef="usd">400000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45252404e2993-wk-Fact-7A5404A7C44D85C0676A5FAFC0872466"
      unitRef="usd">-5000000.0</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"
      decimals="-5"
      id="d45252404e3014-wk-Fact-0100F3CDF9680847AF9F5FB1FA4278F6"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"
      decimals="-5"
      id="d45252404e3033-wk-Fact-DB2DF6C5D105177F9A615FB1FA1A250A"
      unitRef="usd">-600000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-5"
      id="d45252404e3052-wk-Fact-E387B33DA48FCA40975D5FB1FA25EC53"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45252404e3072-wk-Fact-3C2F102C4495AF9500AF5FB1FA740D27"
      unitRef="usd">-600000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"
      decimals="-5"
      id="d45252404e3102-wk-Fact-D6C9CA23F16885A466015FB24D721FDC"
      unitRef="usd">-3200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"
      decimals="-5"
      id="d45252404e3122-wk-Fact-C76C6CC52546B8B4FD685FB24D1D620B"
      unitRef="usd">-1600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-5"
      id="d45252404e3143-wk-Fact-9DE61487E00899D9BD6D5FB24D13C879"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45252404e3162-wk-Fact-F702E6116BA005717710CCD3137114A2"
      unitRef="usd">-4400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"
      decimals="-5"
      id="d45252404e3188-wk-Fact-844C0A60A87AE6488B275FAC161CA266"
      unitRef="usd">-3400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"
      decimals="-5"
      id="d45252404e3208-wk-Fact-ACE33BC83F7BAD968A595FAC15DDB2F8"
      unitRef="usd">-1600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember"
      decimals="-5"
      id="d45252404e3229-wk-Fact-F90530F0790ECB04F4F55FAC17A3432E"
      unitRef="usd">-4900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-5"
      id="d45252404e3249-wk-Fact-8B694F970B5C4D0AAE3CCCD313AE3FE8"
      unitRef="usd">-9900000</us-gaap:StockholdersEquity>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-2D1B5092F7357C0114EBCCD313BE1C94-0-wk-Fact-F440AD2372EBC655C50FCCD31326CE51">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Income taxes&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to reverse. Valuation allowances are recorded as appropriate to reduce deferred tax assets to the amount considered likely to be realized. As a result of the reduction in the U.S. corporate income tax rate from &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;35%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;21%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; under the Tax Reform Act, the Company revalued its ending net deferred tax liabilities in the United States at &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and recognized a provisional &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$13.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; tax benefit in the Company&#x2019;s consolidated statement of income for the year ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. During &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, we adjusted the provisional estimate by approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$4.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, bringing the total tax benefit recorded to date to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$17.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; related to the revaluation of our deferred tax assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Tax Reform Act provided for a one-time deemed mandatory repatriation of post-1986 undistributed foreign subsidiary earnings and profits (&#x201c;E&amp;amp;P&#x201d;) through the year ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. The Company had an estimated &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$95.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of undistributed foreign E&amp;amp;P subject to the deemed mandatory repatriation and recognized a provisional transition tax of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$13.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of income tax expense in the Company&#x2019;s consolidated statement of income for the year ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. During &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; we reduced the provisional transition tax by &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$0.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, bringing the total transition tax to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$13.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;While the Tax Reform Act provides for a territorial tax system and it includes two new U.S. tax base erosion provisions, the global intangible low-taxed income (&#x201c;GILTI&#x201d;) provisions and the base-erosion and anti-abuse tax (&#x201c;BEAT&#x201d;) provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The GILTI provisions require the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary&#x2019;s tangible assets. The Company is subject to incremental U.S. tax on GILTI income. The Company has elected to account for GILTI tax in the period in which it is incurred, and therefore has not provided any deferred tax impacts of GILTI in its consolidated financial statements for the year ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Significant components of the provisions for income taxes attributable to operations consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;29.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;State&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;11.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;2.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;11.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;24.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;10.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;32.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(6.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;State&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(4.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;9.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total deferred&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;8.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total provision for income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;22.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;18.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;36.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company's net deferred tax asset (liability) consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Federal losses carryforward&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;8.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;10.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;State losses carryforward&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;18.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Research and development carryforward&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;10.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;State research and development carryforward&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Scientific research and experimental development credit carryforward&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;11.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;13.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Stock compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;7.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Foreign NOLs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;36.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;35.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;18.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;11.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Inventory reserves&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Lease liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;4.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred tax asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;128.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;119.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fixed assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(51.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(46.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(54.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(60.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Right-of-use asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(5.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred tax liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(114.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(107.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(64.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(66.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net deferred tax asset (liability)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(50.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(54.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company has a net U.S. deferred tax liability in the amount of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$7.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and a foreign net deferred tax liability in the amount of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$42.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. The Company had a net U.S. deferred tax liability in the amount of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$4.8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and a foreign net deferred tax asset in the amount of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$49.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company currently has approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$40.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; (&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$8.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; tax effected) in U.S. federal net operating loss carryforwards along with &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$14.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; in research and development tax credit carryforwards for U.S. federal and state tax purposes that will begin to expire in &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2027&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2024&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively. The U.S. federal net operating loss carryforwards are recorded with a &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$4.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; valuation allowance. The research and development tax credit carryforwards have a valuation allowance in the amount of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$9.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. The Company has &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$280.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; (&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$17.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; tax effected) in state net operating loss carryforwards, primarily in Maryland and California, that will begin to expire in 2025. The U.S. state tax loss carryforwards are recorded with a valuation allowance of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$245.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; (&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$16.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; tax effected). The Company has approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$199.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; (&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$37.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; tax effected) in net operating losses from foreign jurisdictions, some of which have an indefinite life (unless the foreign entities have a change in the nature or conduct of the business in the three years following a change in ownership), and some of which begin to expire in 2022. A valuation allowance in respect to these foreign losses has been recorded in the tax effected &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;amount of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$34.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. The Company currently has approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$11.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; in Manitoba scientific research and experimental development credit carryforwards that will begin to expire in &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2027&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. The use of any of these net operating losses and research and development tax credit carryforwards may be restricted due to future changes in the Company's ownership.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The provision for income taxes differs from the amount of taxes determined by applying the U.S. federal statutory rate to income before the provision for income taxes as a result of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;US&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;63.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;71.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;80.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;13.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;10.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;37.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Earnings before taxes on income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;77.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;81.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;118.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Federal tax at statutory rates&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;16.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;17.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;41.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;State taxes, net of federal benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;10.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;4.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Impact of foreign operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(6.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Tax credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Transition tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;13.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Change in U.S. tax rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(4.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(13.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Stock compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(2.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(5.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other differences&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Return to provision true-ups&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(2.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Transaction costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;5.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Contingent consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;4.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Compensation limitation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;FIN 48&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;GILTI, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Permanent differences&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Provision for income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;22.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;18.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;36.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The effective annual tax rate for the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; was &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;30%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;23%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;30%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The effective annual tax rate of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;30%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; in &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; is higher than the statutory rate primarily due to the impact of state taxes, GILTI, contingent consideration and other non-deductible items. This is partially offset by stock option deduction benefits, tax credits, and favorable rates in foreign jurisdictions. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The effective annual tax rate of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;23%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; in &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; is higher than the statutory rate primarily due to the impact of state taxes, GILTI, acquisition transaction costs and other non-deductible items, and the jurisdictional mix of earnings. This is partially offset by the impact of the SAB 118 benefit and the stock option deduction benefit.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The effective annual tax rate of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;30%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; in &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; differs from statutory rate primarily due to the jurisdictional mix of earnings. Due to the impact of the Tax Reform Act enacted on December 22, 2017, the Company recognized a $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;13.4&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million tax benefit as a result of revaluing the U.S. ending net deferred tax liabilities from &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;35%&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to the newly enacted U.S. corporate income tax rate of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;21%&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. The tax benefit was fully offset by tax expense of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$13.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; for the transition tax on the deemed mandatory repatriation of undistributed earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company recognizes interest in interest expense and recognizes potential penalties related to unrecognized tax benefits in selling, general and administrative expense. Of the total unrecognized tax benefits recorded at &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$0.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$0.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively, is classified as a current liability and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$10.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$8.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively, is classified as a non-current liability on the balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The table below presents the gross unrecognized tax benefits activity for &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Gross unrecognized tax benefits at December&#160;31, 2016&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Increases for tax positions for prior years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Decreases for tax positions for prior years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Increases for tax positions for current year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Settlements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Gross unrecognized tax benefits at December&#160;31, 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Unrecognized tax benefits acquired in business combinations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;6.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Increases for tax positions for prior years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Decreases for tax positions for prior years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Increases for tax positions for current year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Settlements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Gross unrecognized tax benefits at December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;8.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Increases for tax positions for prior years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Unrecognized tax benefits acquired in business combinations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Decreases for tax positions for prior years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Increases for tax positions for current year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Settlements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Gross unrecognized tax benefits at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;10.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The total gross unrecognized tax benefit of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$10.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of which &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$7.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; relates to the acquisition of PaxVax is entirely offset by a receivable pursuant to a Tax Indemnity Agreement that became effective as at the close of the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;When resolved, substantially all of these reserves would impact the effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company's federal and state income tax returns for the tax years 2016 to 2018 remain open to examination. The Company's tax returns in the United Kingdom remain open to examination for the tax years 2012 to 2018, and tax returns in Germany remain open indefinitely. The Company's tax returns for Canada remain open to examination for the tax years 2012 to 2018. The Company's Swiss tax returns remain open to federal examination for 2018. The Company's Irish tax returns remain open to examination for the tax years 2013 to 2018.  &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company&#x2019;s Canadian &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; Scientific Research and Experimental Development Claim is under audit. As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company's 2017 Canadian and US federal income tax returns for the Adapt entities prior to acquisition are under audit.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="FD2018Q4YTD"
      decimals="INF"
      id="d45257978e735-wk-Fact-A1EC10E2907AED2FE7EB9921AEEBC0DA"
      unitRef="number">0.35</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d45257978e739-wk-Fact-CFC7FB7C1D8E3B59B64C9921FC16FA50"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <ebs:TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e747-wk-Fact-267187EAABD6C9FE84D7CCD3139C845E"
      unitRef="usd">-13400000</ebs:TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit>
    <ebs:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e760-wk-Fact-69171786ACAD119EA1F0CCD3133C6275"
      unitRef="usd">4500000</ebs:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit>
    <ebs:TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e764-wk-Fact-F9B8C5078CE116C0848DCCD31323B73D"
      unitRef="usd">-17900000</ebs:TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit>
    <ebs:TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e775-wk-Fact-A3CAD7910A3246E70476CCD31328619B"
      unitRef="usd">95400000</ebs:TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary>
    <ebs:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e779-wk-Fact-9B177448C7B84FB44AEBCCD3133A7CEB"
      unitRef="usd">13600000</ebs:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense>
    <ebs:TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e792-wk-Fact-EEE56E84815F086A4EFACCD31327D563"
      unitRef="usd">300000</ebs:TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit>
    <ebs:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e796-wk-Fact-AC6D7F703178621A3C97CCD3139BBD6D"
      unitRef="usd">13300000</ebs:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-5EBC093CAFEEC78B9595CCD313BEDA36-0-wk-Fact-184B82A339BC399E8832CCD313306A6A">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Significant components of the provisions for income taxes attributable to operations consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;29.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;State&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;11.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;2.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;11.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;24.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;10.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;32.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(6.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;State&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(4.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;9.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total deferred&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;8.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total provision for income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;22.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;18.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;36.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e1033-wk-Fact-00F7A3527F40BBF0BB72CCD31398E174"
      unitRef="usd">1400000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e1052-wk-Fact-5B048CB8B8391AC79B8ECCD313A083F6"
      unitRef="usd">1800000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e1071-wk-Fact-9DBD1128E19683DD0F9DCCD313A49F1C"
      unitRef="usd">29400000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e1087-wk-Fact-19CA1FE04F0A078DEBDBCCD3139AE1F2"
      unitRef="usd">11600000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e1106-wk-Fact-992EF6A4AB046EE4C28DCCD313A26D95"
      unitRef="usd">2400000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e1125-wk-Fact-E6C5A9017AF74834DD7BCCD31394EF2E"
      unitRef="usd">3000000.0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e1146-wk-Fact-CA2F271EC9908236A23DCCD313A1912A"
      unitRef="usd">11000000.0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e1165-wk-Fact-F62160E90669534F19A8CCD313927EE8"
      unitRef="usd">6000000.0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e1184-wk-Fact-9A6C6628DAE8AF4E627CCCD3139C1255"
      unitRef="usd">300000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e1205-wk-Fact-FFD18DA9C5B6FE90C0D9CCD313A300F6"
      unitRef="usd">24000000.0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e1224-wk-Fact-41B024510CC3E059F5F6CCD3139F8E6C"
      unitRef="usd">10200000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e1243-wk-Fact-6223FFE7E68160BDC2A5CCD3139B0FB4"
      unitRef="usd">32700000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e1326-wk-Fact-82C62F495DDABB2A5751CCD313921B80"
      unitRef="usd">1900000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e1345-wk-Fact-F8238B496476B9A22E53CCD3139D616F"
      unitRef="usd">7500000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e1364-wk-Fact-3E5C45F49D5757076CDCCCD313A4FDA9"
      unitRef="usd">-6000000.0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e1386-wk-Fact-87335E7292EC5F9BE465CCD3139ACB36"
      unitRef="usd">1100000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e1405-wk-Fact-CDABDCD8E21A05A54B86CCD313A1903B"
      unitRef="usd">3000000.0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e1424-wk-Fact-30F425FC1BAEF20D5F78CCD3139A9F62"
      unitRef="usd">-600000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e1446-wk-Fact-59158AF8CED40AFE8829CCD3139D68FD"
      unitRef="usd">-4100000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e1466-wk-Fact-D2710A5A1DCD26632BCBCCD31399FAE5"
      unitRef="usd">-1900000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e1486-wk-Fact-FE315517CCA27794E9D3CCD313997C2A"
      unitRef="usd">9900000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <ebs:DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e1508-wk-Fact-DC0AFF649CFECD224358CCD313A23579"
      unitRef="usd">-1100000</ebs:DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment>
    <ebs:DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e1528-wk-Fact-A52875A8912998262707CCD3139EFCC2"
      unitRef="usd">8600000</ebs:DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment>
    <ebs:DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e1547-wk-Fact-80B4472A1E1F2B6FAED2CCD3139C39E4"
      unitRef="usd">3300000</ebs:DeferredIncomeTaxExpenseBenefitBeforePurchasePriceAdjustment>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e1573-wk-Fact-815A1535A7EA25FCCD27CCD31380042F"
      unitRef="usd">22900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e1592-wk-Fact-4D13AEFC5D9B488A367CCCD3137B2702"
      unitRef="usd">18800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e1611-wk-Fact-9218D9AEEE0D40961A99CCD313765A05"
      unitRef="usd">36000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-E67A5EDD0C208C0D4910CCD313BE4BCB-0-wk-Fact-2D87E2EA331CD9FE767ECCD31325DA37">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company's net deferred tax asset (liability) consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Federal losses carryforward&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;8.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;10.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;State losses carryforward&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;17.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;18.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Research and development carryforward&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;9.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;10.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;State research and development carryforward&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Scientific research and experimental development credit carryforward&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;11.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;13.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Stock compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;7.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Foreign NOLs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;36.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;35.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;18.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;11.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Inventory reserves&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Lease liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;4.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred tax asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;128.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;119.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fixed assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(51.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(46.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(54.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(60.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Right-of-use asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(5.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Deferred tax liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(114.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(107.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(64.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(66.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net deferred tax asset (liability)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(50.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(54.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e1736-wk-Fact-851353CCF69139692574CCD3136E2F79"
      unitRef="usd">8500000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e1755-wk-Fact-A068DFCE49EBF1C3CFC2CCD31371E346"
      unitRef="usd">10700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e1770-wk-Fact-7D1E4E148C950E4B63EFCCD31369BA26"
      unitRef="usd">17400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e1789-wk-Fact-5093F314E6A4C09D608BCCD313712641"
      unitRef="usd">18100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember"
      decimals="-5"
      id="d45257978e1809-wk-Fact-FC0DBC7CBEBA6EF559BECCD3136869E8"
      unitRef="usd">9000000.0</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember"
      decimals="-5"
      id="d45257978e1828-wk-Fact-7BBC9FE4B2D1293F494CCCD31373090B"
      unitRef="usd">10100000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="d45257978e1848-wk-Fact-6CFEDD158E15F68299C5CCD3136A9A49"
      unitRef="usd">5000000.0</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="d45257978e1867-wk-Fact-320FF9ADE0C0874447C6CCD31398CD84"
      unitRef="usd">5000000.0</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <ebs:DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e1887-wk-Fact-7499BC1896851524FF5ECCD313699EE9"
      unitRef="usd">11000000.0</ebs:DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment>
    <ebs:DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e1906-wk-Fact-DA457076BC9D9235A5B3CCD3136AE69E"
      unitRef="usd">13100000</ebs:DeferredTaxAssetsTaxCreditCarryforwardsScientificResearchAndExperimentalDevelopment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e1926-wk-Fact-C7B2F698628DD1FFB7EECCD31370790F"
      unitRef="usd">7600000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e1945-wk-Fact-4118AF55F6E881CD27A4CCD3136B2B62"
      unitRef="usd">7500000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e1965-wk-Fact-8D21E85B3DC0F13517D9CCD3139A4F24"
      unitRef="usd">36900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e1984-wk-Fact-85E97B31A33AF1080A40CCD3139C12F8"
      unitRef="usd">35400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e2004-wk-Fact-070D77321BDCFC931EA8CCD313951447"
      unitRef="usd">18100000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e2023-wk-Fact-A887FDD65D0D0E06F773CCD3137450C1"
      unitRef="usd">11600000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e2043-wk-Fact-03A3149E85F5EA242910CCD3136678AF"
      unitRef="usd">1800000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e2062-wk-Fact-EEEB2B9CDF6D3AA3F9E6CCD31369793F"
      unitRef="usd">3400000</us-gaap:DeferredTaxAssetsInventory>
    <ebs:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e2083-wk-Fact-C313CC873895D8F2F43B3F487C7A4643"
      unitRef="usd">6000000.0</ebs:DeferredTaxAssetsOperatingLeaseLiability>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e2122-wk-Fact-B870DBC5AC3CCDD7F647CCD31397A61F"
      unitRef="usd">7500000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e2141-wk-Fact-C4DFC29EAC573BCCDAAFCCD313651963"
      unitRef="usd">4900000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e2161-wk-Fact-3E4DC24741CB1DE474BACCD313685626"
      unitRef="usd">128800000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e2180-wk-Fact-AFF9BEEA038D11765368CCD3136C6E30"
      unitRef="usd">119800000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e2200-wk-Fact-1FA54F737C6FBF99C12BCCD313945525"
      unitRef="usd">51200000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e2220-wk-Fact-B5F1D0CAD6E61F507B5DCCD31369C885"
      unitRef="usd">46400000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e2241-wk-Fact-C3F961AE004D5B623282CCD313A2C090"
      unitRef="usd">54500000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e2261-wk-Fact-FD2E667512F3FC963DC6CCD31367281E"
      unitRef="usd">60400000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e2282-wk-Fact-C4446092D3585EEE788C3F49F098A0EC"
      unitRef="usd">5900000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e2322-wk-Fact-5692974508F42B4D8C20CCD3138A9D79"
      unitRef="usd">3200000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e2342-wk-Fact-768507A580C073937B0FCCD3138F9BB1"
      unitRef="usd">700000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e2363-wk-Fact-CC27C94ED174E2E4DC5ACCD3136986A6"
      unitRef="usd">114800000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e2383-wk-Fact-C71197419775F35A1062CCD313724B0B"
      unitRef="usd">107500000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e2404-wk-Fact-B13A87F9C0BB60FBB3D0CCD3136F48FA"
      unitRef="usd">64500000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e2424-wk-Fact-2F564953CF3FB7386DB9CCD313965140"
      unitRef="usd">66400000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxLiabilities
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e2450-wk-Fact-56C6CDFC8F78977D7464CCD3139B6462"
      unitRef="usd">50500000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e2470-wk-Fact-0F5D9D1132F9C627A52FCCD3136A413C"
      unitRef="usd">54100000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember"
      decimals="-5"
      id="d45257978e2487-wk-Fact-C051ECDB61F990F2B9A9CCD3132328D8"
      unitRef="usd">7700000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember"
      decimals="-5"
      id="d45257978e2491-wk-Fact-CD135974A43F035BE9CFCCD31331484B"
      unitRef="usd">42800000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember"
      decimals="-5"
      id="d45257978e2495-wk-Fact-CA75286BF1717280D14ECCD3132CA01A"
      unitRef="usd">4800000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember"
      decimals="-5"
      id="d45257978e2499-wk-Fact-01D409166E5877DFFB71CCD3132A6F76"
      unitRef="usd">49300000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember"
      decimals="-5"
      id="d45257978e2515-wk-Fact-ACC06E9C301627AD7D70CCD3138B77B4"
      unitRef="usd">40500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember"
      decimals="-5"
      id="d45257978e2519-wk-Fact-54F39BC07F765FFE7D3ECCD3139E7CDC"
      unitRef="usd">8500000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="FI2019Q4_us-gaap_TaxCreditCarryforwardAxis_us-gaap_ResearchMember"
      decimals="-5"
      id="d45257978e2523-wk-Fact-C5517D7ABC3B74BDFB74CCD313916323"
      unitRef="usd">14000000.0</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember"
      decimals="-5"
      id="d45257978e2536-wk-Fact-C8AD4D60CEAE6D2DEB54CCD3133C0BB2"
      unitRef="usd">4700000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:TaxCreditCarryforwardValuationAllowance
      contextRef="FI2019Q4_us-gaap_TaxCreditCarryforwardAxis_us-gaap_ResearchMember"
      decimals="-5"
      id="d45257978e2540-wk-Fact-317AE198D66BE85EB7E5CCD3132654DA"
      unitRef="usd">9100000</us-gaap:TaxCreditCarryforwardValuationAllowance>
    <us-gaap:OperatingLossCarryforwards
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="d45257978e2544-wk-Fact-E6B9C4F1FAF7BCA1C694CCD3132B643C"
      unitRef="usd">280700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="d45257978e2548-wk-Fact-1A7627ACBB6453DDAEE4CCD3133DA475"
      unitRef="usd">17400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:OperatingLossCarryforwardsValuationAllowance
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="d45257978e2552-wk-Fact-FFBCC395DAD3FBD10D81CCD3133A8AB4"
      unitRef="usd">245000000.0</us-gaap:OperatingLossCarryforwardsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="d45257978e2557-wk-Fact-D819B02072DBED69022ACCD3132F813F"
      unitRef="usd">16400000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember"
      decimals="-5"
      id="d45257978e2561-wk-Fact-6D3BF62DD5BE9CA2D95CCCD31326097A"
      unitRef="usd">199000000.0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember"
      decimals="-5"
      id="d45257978e2565-wk-Fact-3942CAE671EBC2159B4BCCD3139DC6C0"
      unitRef="usd">37000000.0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="FI2019Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember"
      decimals="-5"
      id="d45257978e2573-wk-Fact-3B6F338238C9055419E2CCD31330CAA9"
      unitRef="usd">34300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="FI2019Q4_us-gaap_TaxCreditCarryforwardAxis_ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember"
      decimals="-5"
      id="d45257978e2577-wk-Fact-01F0FFFBBFD157257912CCD31332A857"
      unitRef="usd">11000000.0</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-DE857BDF90656B97A20ECCD313BE6983-0-wk-Fact-71A285AB80CA6F75823ACCD3133ABD8B">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The provision for income taxes differs from the amount of taxes determined by applying the U.S. federal statutory rate to income before the provision for income taxes as a result of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;US&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;63.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;71.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;80.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;13.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;10.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;37.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Earnings before taxes on income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;77.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;81.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;118.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Federal tax at statutory rates&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;16.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;17.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;41.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;State taxes, net of federal benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;10.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;4.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Impact of foreign operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(6.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(2.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Tax credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(1.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Transition tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;13.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Change in U.S. tax rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(4.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(13.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Stock compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(2.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(5.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other differences&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Return to provision true-ups&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(2.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Transaction costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;5.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Contingent consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;4.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Compensation limitation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;FIN 48&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;GILTI, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Permanent differences&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Provision for income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;22.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;18.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;36.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e2747-wk-Fact-F002EB2677DC09B4A877CCD313A4E570"
      unitRef="usd">63900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e2766-wk-Fact-E5B6F15CAA81C428D2FDCCD313A7B326"
      unitRef="usd">71000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e2785-wk-Fact-D234687DBF056F805613CCD3139C7E78"
      unitRef="usd">80700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e2801-wk-Fact-5F83BA5205FB0366F0EDCCD31396DB7B"
      unitRef="usd">13500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e2820-wk-Fact-42F7F2A672FFD5AB79D8CCD313899461"
      unitRef="usd">10500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e2839-wk-Fact-FBD514B7131B7CD9A459CCD313A79C54"
      unitRef="usd">37900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e2860-wk-Fact-DC2754897D980D8CEF7FCCD313A73026"
      unitRef="usd">77400000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e2879-wk-Fact-11988081782A138CBC93CCD3139DC924"
      unitRef="usd">81500000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e2898-wk-Fact-891A803E6264A7918C65CCD3139762AF"
      unitRef="usd">118600000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e2924-wk-Fact-CA3738127F9D52322777CCD3139F7390"
      unitRef="usd">16300000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e2943-wk-Fact-1A8F897FC76D275FA46ECCD313A9EC3B"
      unitRef="usd">17100000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e2962-wk-Fact-E4C56B5B056CDBC43DEDCCD313A28388"
      unitRef="usd">41500000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e2978-wk-Fact-BFB841208CC73C75AB5ECCD313956995"
      unitRef="usd">10300000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e2997-wk-Fact-BEE9AA41337049556771CCD31395BE8A"
      unitRef="usd">4300000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3016-wk-Fact-918D2F850E0B86E07A83CCD313A1D056"
      unitRef="usd">1300000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e3037-wk-Fact-770A2604FEDC68E6250BCCD3138E9352"
      unitRef="usd">-6900000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e3057-wk-Fact-7EC3F2C8BC3A09460302CCD313A9E280"
      unitRef="usd">2800000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3076-wk-Fact-46EF7D2127EDFAE2A26FCCD3139B4695"
      unitRef="usd">-2200000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e3098-wk-Fact-D98281A0796EA07F390FCCD313907546"
      unitRef="usd">-1000000.0</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e3118-wk-Fact-572D3AB2B6F1AA610CE7CCD3138B9CA3"
      unitRef="usd">-100000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3138-wk-Fact-75D674F1C43EA9D8F893CCD313897009"
      unitRef="usd">300000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e3159-wk-Fact-844D8A554B270233C156CCD3139227D9"
      unitRef="usd">3600000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e3179-wk-Fact-07B39085859A7C28960BCCD3139EE901"
      unitRef="usd">1800000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3199-wk-Fact-F08AE17C5D645A3980F1CCD3138FC6C6"
      unitRef="usd">1900000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e3221-wk-Fact-A2F76D95347EAD7DD3DFCCD3138FD584"
      unitRef="usd">0</ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount>
    <ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e3240-wk-Fact-F9012B163A32C77CFD8ACCD31396FFFA"
      unitRef="usd">-200000</ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount>
    <ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3260-wk-Fact-C74D19A637EDF8D8A7A9CCD313A52C61"
      unitRef="usd">13600000</ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e3282-wk-Fact-760DA48B1F2C108BB29CCCD31399FCB1"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e3301-wk-Fact-9C88F7068382292CF34FCCD313A8CF96"
      unitRef="usd">-4500000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3321-wk-Fact-9263566D669B507B67ADCCD31397F03A"
      unitRef="usd">-13400000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e3343-wk-Fact-DA2AB288F37B71351613CCD313A141AE"
      unitRef="usd">-2400000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e3363-wk-Fact-B966B9AD01B5E3F80CD7CCD313A5AC07"
      unitRef="usd">-5800000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3383-wk-Fact-7E6631E5F7508C51860BCCD313A5F60B"
      unitRef="usd">-4000000.0</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e3405-wk-Fact-455F74D526515ECE9076CCD313A07E0F"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e3424-wk-Fact-08BE2D82BE0380B54084CCD313879962"
      unitRef="usd">-1300000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3444-wk-Fact-F661E11B0178E254119ECCD3139AEAA5"
      unitRef="usd">-700000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e3466-wk-Fact-49E108CC1508C9430206CCD3138A6308"
      unitRef="usd">-2300000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e3486-wk-Fact-A14B45A822C3730A5A5ECCD3139EB9E4"
      unitRef="usd">1100000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3505-wk-Fact-CDD68777EA4C4F3A3BBACCD31398664B"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <ebs:EffectiveIncomeTaxRateReconciliationTransactionCosts
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e3526-wk-Fact-7283B32F4C8A049BFCA5CCD31398150B"
      unitRef="usd">0</ebs:EffectiveIncomeTaxRateReconciliationTransactionCosts>
    <ebs:EffectiveIncomeTaxRateReconciliationTransactionCosts
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e3545-wk-Fact-402116147DA7114A143BCCD3139AF2CD"
      unitRef="usd">5400000</ebs:EffectiveIncomeTaxRateReconciliationTransactionCosts>
    <ebs:EffectiveIncomeTaxRateReconciliationTransactionCosts
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3564-wk-Fact-FE484D15E6DDA9CD9F93CCD313A10831"
      unitRef="usd">0</ebs:EffectiveIncomeTaxRateReconciliationTransactionCosts>
    <ebs:EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e3585-wk-Fact-C66CC80F134581326D5C4B4C4CE10ED9"
      unitRef="usd">4700000</ebs:EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount>
    <ebs:EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e3603-wk-Fact-5D6AA9482AEB0A9F36804B4C4B42DB70"
      unitRef="usd">0</ebs:EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount>
    <ebs:EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3621-wk-Fact-88C8A87580EEDBCA542B4B4C4B5A2744"
      unitRef="usd">0</ebs:EffectiveIncomeTaxRateReconciliationContingentConsiderationAmount>
    <ebs:EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e3642-wk-Fact-46BBED23D9C9EFB3D3133F5059077535"
      unitRef="usd">1300000</ebs:EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount>
    <ebs:EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e3661-wk-Fact-AC5402A698B8AB818A6B3F5059585B2B"
      unitRef="usd">1100000</ebs:EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount>
    <ebs:EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3680-wk-Fact-CC147A0E5C3EA046239E3F5058D747F7"
      unitRef="usd">1300000</ebs:EffectiveIncomeTaxRateReconciliationCompensationLimitationAmount>
    <ebs:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e3701-wk-Fact-7D697E7CC25BB55BF8B93F520E5C139B"
      unitRef="usd">1100000</ebs:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount>
    <ebs:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e3720-wk-Fact-DA53DA0D67B14C9EB7F33F520DE2051E"
      unitRef="usd">300000</ebs:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount>
    <ebs:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3739-wk-Fact-0857DBAA367D10490C823F520E07403B"
      unitRef="usd">500000</ebs:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount>
    <ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e3760-wk-Fact-64585C067AE0F4007750CCD313722318"
      unitRef="usd">3600000</ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet>
    <ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e3779-wk-Fact-DF6D5A2058A136B1D07CCCD31391DCD6"
      unitRef="usd">400000</ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet>
    <ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3798-wk-Fact-8AC472AF92540A726C10CCD313A67786"
      unitRef="usd">0</ebs:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncomeTaxNet>
    <ebs:EffectiveIncomeTaxRateReconciliationPermanentDifference
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e3819-wk-Fact-D7537EEF0BA925704662CCD3139838FC"
      unitRef="usd">-1800000</ebs:EffectiveIncomeTaxRateReconciliationPermanentDifference>
    <ebs:EffectiveIncomeTaxRateReconciliationPermanentDifference
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e3838-wk-Fact-FC725F7434F99245F0F9CCD313968484"
      unitRef="usd">0</ebs:EffectiveIncomeTaxRateReconciliationPermanentDifference>
    <ebs:EffectiveIncomeTaxRateReconciliationPermanentDifference
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3857-wk-Fact-C54EF7615B4C72915C32CCD3139921CA"
      unitRef="usd">300000</ebs:EffectiveIncomeTaxRateReconciliationPermanentDifference>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e3884-wk-Fact-815A1535A7EA25FCCD27CCD31380042F"
      unitRef="usd">22900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e3903-wk-Fact-4D13AEFC5D9B488A367CCCD3137B2702"
      unitRef="usd">18800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e3922-wk-Fact-9218D9AEEE0D40961A99CCD313765A05"
      unitRef="usd">36000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d45257978e3947-wk-Fact-9ADCB7CB9269F8543BD0CCD3131ED915"
      unitRef="number">0.30</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2018Q4YTD"
      decimals="INF"
      id="d45257978e3951-wk-Fact-4D53EC28A15236599E99F6A1C2FE5647"
      unitRef="number">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2017Q4YTD"
      decimals="INF"
      id="d45257978e3956-wk-Fact-3E29EF9EAE47CB65E595CCD313A27073"
      unitRef="number">0.30</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d45257978e3963-wk-Fact-9ADCB7CB9269F8543BD0CCD3131ED915"
      unitRef="number">0.30</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2018Q4YTD"
      decimals="INF"
      id="d45257978e3974-wk-Fact-4D53EC28A15236599E99F6A1C2FE5647"
      unitRef="number">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2017Q4YTD"
      decimals="INF"
      id="d45257978e3985-wk-Fact-79513A24644DC8DFAD1A9920961FB0CC"
      unitRef="number">0.30</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <ebs:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e4006-wk-Fact-A03EE79A5129F083A677F6A45AB3E2EE"
      unitRef="usd">13600000</ebs:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense>
    <ebs:UnrecognizedTaxBenefitsCurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e4021-wk-Fact-AB969EA365EC2DE4F6D8CCD3133D50CE"
      unitRef="usd">0.0</ebs:UnrecognizedTaxBenefitsCurrent>
    <ebs:UnrecognizedTaxBenefitsCurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e4025-wk-Fact-B38EE8DB234CDBF8CF3ACCD3133F5CBB"
      unitRef="usd">400000</ebs:UnrecognizedTaxBenefitsCurrent>
    <ebs:UnrecognizedTaxBenefitsNoncurrent
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e4029-wk-Fact-68451D6D6C12A6151B40CCD3138F12D7"
      unitRef="usd">10400000</ebs:UnrecognizedTaxBenefitsNoncurrent>
    <ebs:UnrecognizedTaxBenefitsNoncurrent
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e4034-wk-Fact-89F2669C5A2BA70B8751CCD3132E0A34"
      unitRef="usd">8400000</ebs:UnrecognizedTaxBenefitsNoncurrent>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-65339A9D3D6CDA9485EACCD313BEBC40-0-wk-Fact-949C0A7619FA586E74FECCD31397BF2E">&lt;div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The table below presents the gross unrecognized tax benefits activity for &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:88%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Gross unrecognized tax benefits at December&#160;31, 2016&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Increases for tax positions for prior years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Decreases for tax positions for prior years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Increases for tax positions for current year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Settlements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Gross unrecognized tax benefits at December&#160;31, 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Unrecognized tax benefits acquired in business combinations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;6.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Increases for tax positions for prior years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Decreases for tax positions for prior years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Increases for tax positions for current year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Settlements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Gross unrecognized tax benefits at December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;8.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Increases for tax positions for prior years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Unrecognized tax benefits acquired in business combinations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Decreases for tax positions for prior years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Increases for tax positions for current year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Settlements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Gross unrecognized tax benefits at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;10.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2016Q4"
      decimals="-5"
      id="d45257978e4101-wk-Fact-A325DF1CF1C36155DEA6CCD313AC7239"
      unitRef="usd">1800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e4116-wk-Fact-6F8367DCDDF510CFB02ECCD313AC5878"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e4136-wk-Fact-80C31CAA01C7AB8E3782CCD313AC2382"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e4156-wk-Fact-CC9254AEBB1B18D99E3ACCD313426C69"
      unitRef="usd">500000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e4176-wk-Fact-8D038110126C3F90B731CCD313458A6F"
      unitRef="usd">300000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257978e4197-wk-Fact-F624E910D5425B413F9ECCD313206193"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2017Q4"
      decimals="-5"
      id="d45257978e4222-wk-Fact-13A2639039475E1836AACCD313AC3D4E"
      unitRef="usd">2000000.0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e4237-wk-Fact-BD50A74C4AE98C82EECB3F5307BDE172"
      unitRef="usd">6500000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e4257-wk-Fact-BDB5131E614326517A83CCD313AC2836"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e4277-wk-Fact-D9483685D4FE2A25006DCCD313498207"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e4298-wk-Fact-CCA63EA928EF7BDB5963CCD313461952"
      unitRef="usd">300000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e4318-wk-Fact-5D43332E61CE3B60A3BBCCD313ACF251"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257978e4338-wk-Fact-A2315D70D863BD9A1938CCD31347BD20"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45257978e4363-wk-Fact-77A9B07E18CCB21B24FDCCD3131B1833"
      unitRef="usd">8800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e4378-wk-Fact-51EF1CC11CB11CE425A8CCD3131BE2B1"
      unitRef="usd">500000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e4398-wk-Fact-4146481F1F63C883A91CCCD313AEE415"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e4418-wk-Fact-07F4AB85B6B3A157CED0CCD31345E50E"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e4438-wk-Fact-EF2AA339B5EA43911EC0CCD31348C288"
      unitRef="usd">1500000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e4458-wk-Fact-A619174718DCC6A69548CCD313491F43"
      unitRef="usd">400000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257978e4479-wk-Fact-6C45581688575CC24CA9CCD31346EF56"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e4504-wk-Fact-E5CB52672D78F63A5C2DCCD31346E1C8"
      unitRef="usd">10400000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45257978e4516-wk-Fact-E5CB52672D78F63A5C2DCCD31346E1C8"
      unitRef="usd">10400000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="FD2019Q4YTD_us-gaap_BusinessAcquisitionAxis_ebs_PaxVaxMember"
      decimals="-5"
      id="d45257978e4520-wk-Fact-74642D14BB00D3D40685CCD31327A742"
      unitRef="usd">7000000.0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-54E00AE3322A68B09018CCD313BF8CE7-0-wk-Fact-34F43F72780C1A6C7E5CCCD313AAABF7">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Defined benefit and 401(k) savings plan&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company sponsors a defined benefit pension plan covering eligible employees in Switzerland (the "Swiss Plan"). Under the Swiss Plan, the Company and certain of its employees with annual earnings in excess of government determined amounts are required to make contributions into a fund managed by an independent investment fiduciary. Employer contributions must be in an amount at least equal to the employee&#x2019;s contribution. The Swiss Plan assets are comprised of an insurance contract that has a fair value consistent with its contract value based on the practicability exception using level 3 inputs. The entire liability is listed as non-current, because plan assets are greater than the expected benefit payments over the next year. The Company recognizes pension expense as a component of selling, general and administrative expense. The Company recognized pension expense related to the Swiss Plan of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$1.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; reflected as a component of selling, general and administrative for the year ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The funded status of the Swiss Plan is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;18.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;18.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Employer contributions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Employee contributions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net benefits received (paid)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Actual return on plan assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Settlements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Currency impact&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;20.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;18.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Projected benefit obligation, beginning of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;28.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;28.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Service cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Employee contributions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Actuarial loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;7.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net benefits received (paid)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Plan amendment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Settlements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Currency impact&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Projected benefit obligation, end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;35.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;28.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Funded status, end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(14.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(10.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accumulated benefit obligation, end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;31.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;25.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Since assets exceed the present value of expected benefit payments for the next twelve months, all of the liability is classified as non-current.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Components of net periodic pension cost incurred during the year are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Service cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Expected return on plan assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The weighted average assumptions used to calculate the projected benefit obligations are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Discount rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Expected rate of return&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Rate of future compensation increases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The overall expected long-term rate of return on assets assumption considers historical returns, as well as expected future returns based on the fact that investment returns are insured, and the legal minimum interest crediting rate as applicable. Total contributions expected to be made into the plan for the year-ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; is &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$1.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The following table presents losses recognized in accumulated other comprehensive loss before income tax related to the Company&#x2019;s defined benefit pension plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Year Ended December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Year Ended December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net actuarial loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;5.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Prior service cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total recognized in accumulated other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Actuarial losses in accumulated other comprehensive loss related to the Company&#x2019;s defined benefit pension plans expected to be recognized as components of net periodic benefit cost over the year ending&#160;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&#160;are de minimis.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Future benefits expected to be paid as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:86%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;6.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;12.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;401(k) savings plan&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company has established a defined contribution savings plan under Section 401(k) of the Internal Revenue Code. The 401(k) Plan covers substantially all U.S. employees. Under the 401(k) Plan, employees may make elective salary deferrals. During the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company made matching contributions of approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$5.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$3.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$2.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:PensionExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e735-wk-Fact-018DB323553AB2682FE1CCD313A9E036"
      unitRef="usd">1000000.0</us-gaap:PensionExpense>
    <us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-E2EC471C29C70CEF447BCCD313BFE7EB-0-wk-Fact-B3C7BDC6887772AC652ACCD313AAC347">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The funded status of the Swiss Plan is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December 31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;18.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;18.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Employer contributions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Employee contributions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net benefits received (paid)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Actual return on plan assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Settlements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Currency impact&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;20.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;18.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Projected benefit obligation, beginning of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;28.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;28.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Service cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Employee contributions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Actuarial loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;7.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net benefits received (paid)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Plan amendment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Settlements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Currency impact&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Projected benefit obligation, end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;35.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;28.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Funded status, end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(14.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(10.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Accumulated benefit obligation, end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;31.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;25.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45260012e818-wk-Fact-42EEA5A8E340FED23675B6BF080CE7DC"
      unitRef="usd">18200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="FI2017Q4"
      decimals="-5"
      id="d45260012e837-wk-Fact-A5A44087DDD4252DB503B6BEFB6B5114"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e852-wk-Fact-42E7D2D83EE63404C7BBCCD313285D9C"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e871-wk-Fact-D20F3672E2B1BAFEA7D0B6BEFCF32409"
      unitRef="usd">18200000</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e891-wk-Fact-3AF8A66C4CE05F1DFB50CCD3132970BE"
      unitRef="usd">1000000.0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e910-wk-Fact-7D2B24B494B6FB0AF0F8B6BEFE506F14"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e930-wk-Fact-32032BD991E05F772312CCD3132D8F90"
      unitRef="usd">700000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e949-wk-Fact-C157863D187DB279FBF6B6BF00078F18"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e969-wk-Fact-0B4CABCACAA771DDCC93CCD31329F2B2"
      unitRef="usd">1700000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e988-wk-Fact-928506CF90E3BD3DD830B6BF01B87F2C"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1008-wk-Fact-B2E64195F23691BA4846CCD313354BBD"
      unitRef="usd">1700000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1027-wk-Fact-A7994694BFF16CA0598FB6BF0338191C"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1047-wk-Fact-61F76A421A38F97365FACCD31322D65A"
      unitRef="usd">3000000.0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1067-wk-Fact-D48F8D0612F3C3FBFA94B6BF04F4C991"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1088-wk-Fact-4364FF8DCBC30304FEA8CCD31327CF10"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1107-wk-Fact-17C6F8105BA9D7A83426B6BF067CFAC6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45260012e1132-wk-Fact-BE857D1BCA81C9ED1610CCD313258D26"
      unitRef="usd">20600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45260012e1151-wk-Fact-42EEA5A8E340FED23675B6BF080CE7DC"
      unitRef="usd">18200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45260012e1171-wk-Fact-12C5FC87DA2BF4BA3081CCD31326B381"
      unitRef="usd">28600000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="FI2017Q4"
      decimals="-5"
      id="d45260012e1190-wk-Fact-9B1ACBB09D34968E40D4B6BF09AE29B9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1206-wk-Fact-EAB6481E0F9A625A4407CCD3132886B3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1225-wk-Fact-6EE6963219252B8CC395B6BF0B79B9DC"
      unitRef="usd">28300000</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1245-wk-Fact-775257FF8A3DCC01AAA0CCD3132948D1"
      unitRef="usd">1300000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1264-wk-Fact-9367DB171AA268679EAEB6BF0D199AD8"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1284-wk-Fact-74F51C64095247854CA9CCD3132724F6"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1303-wk-Fact-90D48C0C11968A8F25DEB6BF0E87C8D7"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <ebs:DefinedBenefitPlanPlanAssetsContributionsByEmployee
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1323-wk-Fact-473385EB52085F19D59DCCD3132D5BF4"
      unitRef="usd">700000</ebs:DefinedBenefitPlanPlanAssetsContributionsByEmployee>
    <ebs:DefinedBenefitPlanPlanAssetsContributionsByEmployee
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1342-wk-Fact-D673FE4517B4EDAFF8BBB6BF0FF751F1"
      unitRef="usd">100000</ebs:DefinedBenefitPlanPlanAssetsContributionsByEmployee>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1362-wk-Fact-BED7AC0D8D3763DD2315CCD3132C3044"
      unitRef="usd">-7000000.0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1381-wk-Fact-1FF715C3C70C419FC1FCB6BF1187F761"
      unitRef="usd">-300000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1401-wk-Fact-27E38B37FA17CFD9EFD1CCD3132867DE"
      unitRef="usd">-1700000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1420-wk-Fact-6624CDC69D56C20C898DB6BF13CCD5F0"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1441-wk-Fact-25EFEA5B54E709C2714ACCD3132E0C41"
      unitRef="usd">-1700000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1461-wk-Fact-99CB0A1B5579E2CF0987B6BF1542B4F0"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1481-wk-Fact-C515109E6BE976E21934CCD3132911BE"
      unitRef="usd">3000000.0</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1501-wk-Fact-F574F05071062B4691DCB6BF16BACA7A"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1522-wk-Fact-D2FAC2388B22281FD11ECCD3132D7324"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1541-wk-Fact-E5F117D8E596A15417E9B6BF185EDBB6"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45260012e1566-wk-Fact-DC396EC69515B07DBE5DCCD313258FAA"
      unitRef="usd">35300000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45260012e1585-wk-Fact-12C5FC87DA2BF4BA3081CCD31326B381"
      unitRef="usd">28600000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45260012e1605-wk-Fact-2165BA5D560F311C6E78CCD31327BB27"
      unitRef="usd">-14700000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45260012e1625-wk-Fact-82BD23E44480927CE39BB6BF1B4E0213"
      unitRef="usd">-10400000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45260012e1647-wk-Fact-76FD0799A048E86E0EA3CCD3132EB538"
      unitRef="usd">31000000.0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45260012e1666-wk-Fact-F595BE45A207DB26D1E2B6BF1CE38650"
      unitRef="usd">25600000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-A7B4F4E7C299AAF46696CCD313BF4B80-0-wk-Fact-35F6225893B9CB81DD7DCCD313AAF48B">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Components of net periodic pension cost incurred during the year are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Service cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Expected return on plan assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1753-wk-Fact-775257FF8A3DCC01AAA0CCD3132948D1"
      unitRef="usd">1300000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1772-wk-Fact-9367DB171AA268679EAEB6BF0D199AD8"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1787-wk-Fact-74F51C64095247854CA9CCD3132724F6"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1806-wk-Fact-90D48C0C11968A8F25DEB6BF0E87C8D7"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1826-wk-Fact-61474BABA116F8CF13DE9949A8E10562"
      unitRef="usd">500000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1846-wk-Fact-770B319E37A1FF2C46B3B6C03FB15A58"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e1872-wk-Fact-9B67EA1A8E3447210D789949A8E99C86"
      unitRef="usd">1000000.0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e1891-wk-Fact-1C4686F3FBDF51ED315AB6C0410BB83F"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-4D4CAFE4BF9C3ACE0D14CCD313BFCA1F-0-wk-Fact-18610A76D24E4A19173CCCD313AFCEEB">&lt;div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The weighted average assumptions used to calculate the projected benefit obligations are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Discount rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Expected rate of return&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Rate of future compensation increases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d45260012e1958-wk-Fact-CFC667B12F6C773A3F4C9949B2A9907C"
      unitRef="number">0.002</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d45260012e1973-wk-Fact-9BCEF0748423ED268D13B6C1FBC24C34"
      unitRef="number">0.009</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d45260012e1989-wk-Fact-C615ABFE23A0BD92B26F9949B2B8A032"
      unitRef="number">0.030</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d45260012e2004-wk-Fact-DA0B29B909C898EAB57BB6C1FD959539"
      unitRef="number">0.030</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="FD2019Q4YTD"
      decimals="3"
      id="d45260012e2020-wk-Fact-7E58D527C295C48292819949B2A91900"
      unitRef="number">0.015</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="FD2018Q4YTD"
      decimals="3"
      id="d45260012e2035-wk-Fact-2E29176EE7A999949A16B6C1FEFAE31F"
      unitRef="number">0.015</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45260012e2052-wk-Fact-9F7ADA9E695242747DE2CCD313AC8C0B"
      unitRef="usd">1100000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-DC032CA169DCD9087FF1CCD313BF15EA-0-wk-Fact-01033F2174C6806520ADCCD313AB3B63">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The following table presents losses recognized in accumulated other comprehensive loss before income tax related to the Company&#x2019;s defined benefit pension plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Year Ended December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Year Ended December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net actuarial loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;5.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Prior service cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(1.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total recognized in accumulated other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45260012e2132-wk-Fact-322E530CBC58A5A613789949A3826885"
      unitRef="usd">-5400000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45260012e2151-wk-Fact-96B512CD29B6B9F93D6CB6C2C8A554DF"
      unitRef="usd">-100000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45260012e2166-wk-Fact-8A639732C548D59D59629949A386F41E"
      unitRef="usd">-1700000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45260012e2186-wk-Fact-268740A85C3F32E6B873B6C2CA74B8E9"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45260012e2211-wk-Fact-4E050BB8AFB21D44BB1B9949A37D4372"
      unitRef="usd">3700000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="FI2018Q4"
      decimals="-5"
      id="d45260012e2230-wk-Fact-A05C53568BDE9F5A9DBEB6C2CC1B8672"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-8276738AC5B662A56806CCD313BF0BAE-0-wk-Fact-398F0A2864F3E47BCCD1CCD313AAB3EB">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Future benefits expected to be paid as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:86%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;6.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;12.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45260012e2301-wk-Fact-B3E86B4E3D12A7BAD854CCD313A4AAE8"
      unitRef="usd">1000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45260012e2316-wk-Fact-AC8F3E8B8F9C1CB57285CCD313A9BC1B"
      unitRef="usd">1000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45260012e2336-wk-Fact-71C940229CDF7720BB3ACCD3139F192D"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45260012e2356-wk-Fact-6BF70156D08B3935AA99CCD3139C2628"
      unitRef="usd">1000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45260012e2376-wk-Fact-245BD44631A016A1A484CCD313A3B9B6"
      unitRef="usd">1000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45260012e2396-wk-Fact-6638265978E7E1D905B3CCD31398068A"
      unitRef="usd">6600000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45260012e2421-wk-Fact-4182A9FD34715C2017F1CCD313A98DE5"
      unitRef="usd">12100000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45260012e2448-wk-Fact-C62C7507CA56C406EF51CCD313AC50FB"
      unitRef="usd">5100000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45260012e2452-wk-Fact-9E805C14DE4390A30D4BCCD313AAAE6B"
      unitRef="usd">3100000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45260012e2457-wk-Fact-6E274D4241CFBE8B1685CCD313ABA0BB"
      unitRef="usd">2700000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-92266C75B52E22FAED28CCD313BFBB50-0-wk-Fact-2D9A468682AC41A6E673CCD313A3538A">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Leases&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company has operating leases for corporate offices, research and development facilities and manufacturing facilities. We determine if an arrangement is a lease at inception. Operating leases are included in right-of-use ("ROU") assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;represent the Company's obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company's leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company uses an implicit rate when readily determinable. At the beginning of a lease, the operating lease ROU asset also includes any concentrated lease payments expected to be paid and excludes lease incentives. The Company's lease ROU asset may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise those options.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for separately. The Company's leases have remaining lease terms of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;14 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, some of which include options to extend the leases for up to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and some of which include options to terminate the leases within &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;padding-top:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The components of lease expense were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:81%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Operating lease cost:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;For the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; total lease expense was $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million and $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;1.6&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Supplemental balance sheet information related to leases was as follows as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:49%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-style:italic;"&gt;(In millions, except lease term and discount rate)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;24.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Operating lease liabilities, current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;22.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;25.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Operating leases:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;8.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Weighted average discount rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-83198D0477ADA4677A3BCB3A15E4D048-0-wk-Fact-C3AF9E72431952489EECCB3C04A4B116">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Leases&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company has operating leases for corporate offices, research and development facilities and manufacturing facilities. We determine if an arrangement is a lease at inception. Operating leases are included in right-of-use ("ROU") assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;represent the Company's obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company's leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company uses an implicit rate when readily determinable. At the beginning of a lease, the operating lease ROU asset also includes any concentrated lease payments expected to be paid and excludes lease incentives. The Company's lease ROU asset may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise those options.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for separately. The Company's leases have remaining lease terms of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;14 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, some of which include options to extend the leases for up to &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and some of which include options to terminate the leases within &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;padding-top:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The components of lease expense were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:81%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Operating lease cost:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;For the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; total lease expense was $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million and $&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;1.6&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Supplemental balance sheet information related to leases was as follows as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:49%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-style:italic;"&gt;(In millions, except lease term and discount rate)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;24.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Operating lease liabilities, current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;22.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;25.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Operating leases:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;8.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Weighted average discount rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="FI2019Q4_srt_RangeAxis_srt_MinimumMember"
      id="d45252988e749-wk-Fact-0BDDA559C88E17A93208B1EE93E60E7D">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="FI2019Q4_srt_RangeAxis_srt_MaximumMember"
      id="d45252988e753-wk-Fact-38F72F9446B60A6CA4DDECA6802DDD40">P14Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="FI2019Q4"
      id="d45252988e757-wk-Fact-00DFCA9EF18E080F2121A0D7F594D3CE">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <ebs:LesseeOperatingLeaseTerminationPeriod
      contextRef="FD2019Q4YTD"
      id="d45252988e761-wk-Fact-0844F3121E2333ECB5FFB1EE60BCCDEB">P1Y</ebs:LesseeOperatingLeaseTerminationPeriod>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45252988e837-wk-Fact-3A2099065765BB9F6352997B0050B119"
      unitRef="usd">2700000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45252988e852-wk-Fact-4D09F7680BAC91240F10997E65F28936"
      unitRef="usd">600000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:LeaseCost
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45252988e877-wk-Fact-5090AB901FBE0D366926997F2972F5A7"
      unitRef="usd">3300000</us-gaap:LeaseCost>
    <us-gaap:LeaseAndRentalExpense
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45252988e900-wk-Fact-DBE0084A49F49E706B65B6C48A520E22"
      unitRef="usd">3300000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45252988e904-wk-Fact-17419BA1C24018F1F3F8B6C489B0AB73"
      unitRef="usd">1600000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-1B164940B113E60EEB5E99678C2AF611-0-wk-Fact-FF61C89274D594084B3F996C54FB5941">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Supplemental balance sheet information related to leases was as follows as of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:49%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-style:italic;"&gt;(In millions, except lease term and discount rate)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Balance Sheet Location&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;24.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Operating lease liabilities, current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;22.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;25.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Operating leases:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;8.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Weighted average discount rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;4.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;padding-top:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The components of lease expense were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:81%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Operating lease cost:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Total operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;3.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember"
      decimals="-5"
      id="d45252988e974-wk-Fact-C86A0D4140A5DEE769FB998167312912"
      unitRef="usd">24700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <ebs:OperatingLeaseOtherLiabilityCurrent
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember"
      decimals="-5"
      id="d45252988e1020-wk-Fact-C971CCBCE1C40F02D1169981BE329EF1"
      unitRef="usd">3600000</ebs:OperatingLeaseOtherLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="FI2019Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember"
      decimals="-5"
      id="d45252988e1045-wk-Fact-98C676E70D36951D845A9981FA3D5BCB"
      unitRef="usd">22100000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45252988e1070-wk-Fact-9AD4E61F96FE5F85751F998240B98D1B"
      unitRef="usd">25700000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="FI2019Q4"
      id="d45252988e1147-wk-Fact-4D6760446F002CF79116FCE39D8E5DCB">P8Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="FI2019Q4"
      decimals="3"
      id="d45252988e1172-wk-Fact-B9C97A9AF25494F7CEA8998B0A47C674"
      unitRef="number">0.042</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-C12C729E1D42A21EF832CCD313BF925F-0-wk-Fact-47B993DE30E089BFB515CCD31330D095">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Earnings per share&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The following table presents the calculation of basic and diluted net income per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Numerator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;54.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;62.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;82.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest expense, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Amortization of debt issuance costs, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income, adjusted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;54.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;62.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;85.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Denominator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Weighted-average number of shares-basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;51.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;50.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;41.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Dilutive securities-equity awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Dilutive securities-convertible debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;7.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Weighted-average number of shares-diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;52.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;51.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;50.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income per share-basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.06&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.98&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income per share-diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.04&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.71&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;For the year ending &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;  million shares of common stock are not considered in the diluted earnings per share calculation because the exercise price of these options is greater than the average per share closing price during the year and their effect would be anti-dilutive. For the years ending &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, substantially all of the outstanding stock options to purchase shares of common stock were included in the calculation of diluted earnings per share.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-FE8692B1FA5B9CEDD313CCD313BF311F-0-wk-Fact-EF9F20A2F9EFA3E37C7ACCD31334B37C">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The following table presents the calculation of basic and diluted net income per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Numerator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;54.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;62.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;82.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Interest expense, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Amortization of debt issuance costs, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income, adjusted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;54.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;62.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;85.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Denominator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Weighted-average number of shares-basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;51.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;50.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;41.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Dilutive securities-equity awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Dilutive securities-convertible debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;7.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Weighted-average number of shares-diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;52.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;51.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;50.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income per share-basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.06&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.98&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income per share-diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;1.04&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.71&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257953e956-wk-Fact-7DC5791E3DA27455A6AECCD31377CEF0"
      unitRef="usd">54500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257953e975-wk-Fact-2233E7AC5FE7EADFA0A9CCD3137B1D77"
      unitRef="usd">62700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257953e994-wk-Fact-E93855FEF0C5D1679E3DCCD313722951"
      unitRef="usd">82600000</us-gaap:NetIncomeLoss>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257953e1010-wk-Fact-B5FBD4527A27D849BCB1CCD3133733EC"
      unitRef="usd">0</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257953e1029-wk-Fact-BBD983D8EED01ADD1A66CCD3133D3AF7"
      unitRef="usd">0</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257953e1048-wk-Fact-D8B74E3DCBF9B165C04FCCD31338D4C2"
      unitRef="usd">2600000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <ebs:AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257953e1069-wk-Fact-1AFD3B276107C8238E98CCD3132C70EB"
      unitRef="usd">0</ebs:AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax>
    <ebs:AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257953e1088-wk-Fact-31F3C792CB788650929BCCD3133ADCE8"
      unitRef="usd">0</ebs:AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax>
    <ebs:AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257953e1107-wk-Fact-2E0CE53F008B6536ED3DCCD3132F1611"
      unitRef="usd">700000</ebs:AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax>
    <ebs:AdjustedNetLoss
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257953e1133-wk-Fact-8C8ED074934EFB310BB2CCD3133D08CA"
      unitRef="usd">54500000</ebs:AdjustedNetLoss>
    <ebs:AdjustedNetLoss
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257953e1152-wk-Fact-F3865CD7E3981BEAC3B2CCD3133331D7"
      unitRef="usd">62700000</ebs:AdjustedNetLoss>
    <ebs:AdjustedNetLoss
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257953e1171-wk-Fact-EA5E6B10521F0FF507D7CCD3132A9325"
      unitRef="usd">85900000</ebs:AdjustedNetLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257953e1249-wk-Fact-6C476F7FC811DEF066C8CCD313726405"
      unitRef="shares">51500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257953e1268-wk-Fact-AA3A26AF9233B4E47F37CCD31384CE40"
      unitRef="shares">50100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257953e1287-wk-Fact-FC3D132112BD46DA7C18CCD3137FB2FE"
      unitRef="shares">41800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257953e1308-wk-Fact-EB153DA46E9E3AD647E8CCD313394900"
      unitRef="shares">900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257953e1327-wk-Fact-EA66C4B7F8BCC56DF46ACCD313398692"
      unitRef="shares">1300000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257953e1346-wk-Fact-F61283E14943D6E41F65CCD3133A5118"
      unitRef="shares">1100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257953e1367-wk-Fact-59E7FB21D61CDD267EB7CCD313352CD9"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257953e1386-wk-Fact-883DE3136848682D6F29CCD31330A1F4"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257953e1405-wk-Fact-0889C99C0E0104F75BB0CCD3132E4248"
      unitRef="shares">7400000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257953e1427-wk-Fact-26467B8874FB56A63BF6CCD3137FA89C"
      unitRef="shares">52400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45257953e1446-wk-Fact-49D658F4DEFA67C8563CCCD31381661E"
      unitRef="shares">51400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45257953e1465-wk-Fact-888877977CEDD432DA63CCD3136C30C8"
      unitRef="shares">50300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d45257953e1491-wk-Fact-86DB00C3EBD85B656393CCD3138EDEB2"
      unitRef="usdPerShare">1.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2018Q4YTD"
      decimals="2"
      id="d45257953e1510-wk-Fact-87E66476E07C4C47E84FCCD3138767B9"
      unitRef="usdPerShare">1.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2017Q4YTD"
      decimals="2"
      id="d45257953e1529-wk-Fact-7509B93E651C38CE4A6CCCD3138CB254"
      unitRef="usdPerShare">1.98</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q4YTD"
      decimals="2"
      id="d45257953e1550-wk-Fact-3D47F2A0E1F49321A098CCD313819F36"
      unitRef="usdPerShare">1.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2018Q4YTD"
      decimals="2"
      id="d45257953e1569-wk-Fact-1C4F6F61BDFC84790364CCD3137FF970"
      unitRef="usdPerShare">1.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2017Q4YTD"
      decimals="2"
      id="d45257953e1588-wk-Fact-9E773D140AC5081CC2BDCCD3138E79BE"
      unitRef="usdPerShare">1.71</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45257953e1605-wk-Fact-BF1471644548C124B686ECA862B4EC5D"
      unitRef="shares">900000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-4E76B290A2BD9E00AB6FCCD313C19898-0-wk-Fact-EF5C2A0B99E163E24E62CCD313660590">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Purchase commitments&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; the Company has approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$59.7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of purchase commitments associated with raw materials and contract development and manufacturing services that will be purchased in the next &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;For the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company purchased &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$51.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$12.1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$3.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively, of materials under this commitment.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock>
    <us-gaap:PurchaseObligation
      contextRef="FI2019Q4"
      decimals="-5"
      id="d45258050e739-wk-Fact-50FD17B825DD6E574EF5CCD31361082A"
      unitRef="usd">59700000</us-gaap:PurchaseObligation>
    <us-gaap:LongtermPurchaseCommitmentPeriod
      contextRef="FD2019Q4YTD"
      id="d45258050e743-wk-Fact-4C190CFB2A47BE1B288ECCD31362DB2A">P3Y</us-gaap:LongtermPurchaseCommitmentPeriod>
    <us-gaap:LongTermPurchaseCommitmentAmount
      contextRef="FD2019Q4YTD"
      decimals="-5"
      id="d45258050e762-wk-Fact-AB4B992868B84091A0C0CCD31363D47B"
      unitRef="usd">51300000</us-gaap:LongTermPurchaseCommitmentAmount>
    <us-gaap:LongTermPurchaseCommitmentAmount
      contextRef="FD2018Q4YTD"
      decimals="-5"
      id="d45258050e766-wk-Fact-A9929A0833BB872D6819CCD313641784"
      unitRef="usd">12100000</us-gaap:LongTermPurchaseCommitmentAmount>
    <us-gaap:LongTermPurchaseCommitmentAmount
      contextRef="FD2017Q4YTD"
      decimals="-5"
      id="d45258050e771-wk-Fact-5A49ED9E3A4F29D1C6B4CCD313633B7C"
      unitRef="usd">3000000.0</us-gaap:LongTermPurchaseCommitmentAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-7BD9E46096C5D44DC081CCD313C1B3D3-0-wk-Fact-395012045990372DE1BDCCD313348AA5">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Segment information&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;For financial reporting purposes, the Company reports financial information for &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;one&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; reportable segment. This reportable segment engages in business activities based on financial information that is provided to and resources which are allocated by the Chief Operating Decision Maker. The accounting policies of the reportable segment is the same as those described in the summary of significant accounting policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;For the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company&#x2019;s revenues within the United States comprised &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;90%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;91%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;89%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively, of total revenues. For the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, product sales from ACAM 2000 and Anthrax Vaccines to the USG comprised approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;43%&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;65%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;68%&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively, of total product sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company's product sales from Anthrax Vaccines, ACAM2000, NARCAN Nasal Spray and Other comprised approximately:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"&gt;% of product sales:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Anthrax Vaccines&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;46&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;ACAM2000&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;NARCAN Nasal Spray&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;32&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2017&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, aside from Anthrax Vaccines and ACAM2000, there were &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;no&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; other product sales to an individual customer or for an individual product in excess of &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;10%&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; of total revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;For years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, the Company had long-lived assets outside of the United States of approximately &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$90.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$82.9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;, respectively, which are primarily located within Canada and Switzerland.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="FD2019Q4YTD"
      decimals="INF"
      id="d45260430e735-wk-Fact-64CE13581DD8FCAB6553CCD31340C16D"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_srt_StatementGeographicalAxis_country_US_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember"
      decimals="INF"
      id="d45260430e758-wk-Fact-0E4694001CE2D952FDC4CCD3133C1C05"
      unitRef="number">0.90</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember"
      decimals="INF"
      id="d45260430e762-wk-Fact-9C40FEFFCBC4F633C2C9CCD313346940"
      unitRef="number">0.91</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember"
      decimals="INF"
      id="d45260430e767-wk-Fact-601F771A60C21092D9BACCD3133D9317"
      unitRef="number">0.89</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember"
      decimals="INF"
      id="d45260430e787-wk-Fact-6B7AA742FD7F4E6EB59FECAB78813832"
      unitRef="number">0.65</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember"
      decimals="INF"
      id="d45260430e792-wk-Fact-F75EEA128B55BFFC91C1ECAB8C500909"
      unitRef="number">0.68</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-CC8030FD9F8953221785CCD313C1708D-0-wk-Fact-172CDBAF8AF0929C5AA7CCD3133F6EFF">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;The Company's product sales from Anthrax Vaccines, ACAM2000, NARCAN Nasal Spray and Other comprised approximately:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"&gt;% of product sales:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Anthrax Vaccines&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;46&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;ACAM2000&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;NARCAN Nasal Spray&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;32&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember"
      decimals="INF"
      id="d45260430e917-wk-Fact-F78FCD40361B58612EF1CCD3138B4E07"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember"
      decimals="INF"
      id="d45260430e932-wk-Fact-DDFDF68EA714615CF62DCCD3138C11CE"
      unitRef="number">0.46</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_BiothraxMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember"
      decimals="INF"
      id="d45260430e947-wk-Fact-3A151730FB3AA3A63AADCCD31393CA9B"
      unitRef="number">0.68</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_ACAM2000Member_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember"
      decimals="INF"
      id="d45260430e963-wk-Fact-04E6E4CCDC58C031E9E6CCD3138E3903"
      unitRef="number">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_ACAM2000Member_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember"
      decimals="INF"
      id="d45260430e978-wk-Fact-335D230D9988EE7A55F3CCD313A52932"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_ACAM2000Member_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember"
      decimals="INF"
      id="d45260430e993-wk-Fact-C15B74FD0C24CB8B89FFCCD31390A86E"
      unitRef="number">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_NARCANNasalSprayMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember"
      decimals="INF"
      id="d45260430e1009-wk-Fact-A5E2B3388BCEF47B15E7ECACCCBFF8A8"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_NARCANNasalSprayMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember"
      decimals="INF"
      id="d45260430e1024-wk-Fact-D6189E9FB1FD57A70A41ECACD23DE224"
      unitRef="number">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_NARCANNasalSprayMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember"
      decimals="INF"
      id="d45260430e1039-wk-Fact-5060D9E81275FD82A445ECACD746C8EF"
      unitRef="number">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2019Q4YTD_srt_ProductOrServiceAxis_ebs_OtherMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember"
      decimals="INF"
      id="d45260430e1055-wk-Fact-314C29E4288041BBC712CCD3139203AD"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ebs_OtherMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember"
      decimals="INF"
      id="d45260430e1070-wk-Fact-EEE7C923E77CB2479B07CCD31393A8B0"
      unitRef="number">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ebs_OtherMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueProductLineMember"
      decimals="INF"
      id="d45260430e1085-wk-Fact-0EE0E2F949A83D2450BDCCD31390962B"
      unitRef="number">0.32</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:NoncurrentAssets
      contextRef="FI2019Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d45260430e1129-wk-Fact-D61AB776E16054E971BECCD3132FF0CB"
      unitRef="usd">90600000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="FI2018Q4_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-5"
      id="d45260430e1133-wk-Fact-735C9174412621830998CCD31331932E"
      unitRef="usd">82900000</us-gaap:NoncurrentAssets>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-BB6375B692FEBE28AA4ACCD313C1B0F4-0-wk-Fact-5DC0DF92D65C654CC6CFCCD313A62424">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Quarterly financial data (unaudited)&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Quarterly financial information for the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; is presented in the following tables:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Quarter Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"&gt;2019:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;190.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;243.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;311.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;360.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Income (loss) from operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(27.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(7.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;70.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;77.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(26.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(9.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;43.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;46.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income (loss) per share-basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.91&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income (loss) per share-diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.90&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"&gt;2018:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;117.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;220.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;173.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;270.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Income (loss) from operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(9.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;66.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;21.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;11.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(4.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;50.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;20.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income (loss) per share-basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.42&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.07&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income (loss) per share-diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.98&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.41&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.07&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-D0BC7159C53E2D787ECDCCD313C1E990-0-wk-Fact-9CD774E4B7D73BD90A6CCCD313A53BCA">&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Quarterly financial information for the years ended &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt; is presented in the following tables:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Quarter Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;December&#160;31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"&gt;2019:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;190.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;243.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;311.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;360.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Income (loss) from operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(27.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(7.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;70.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;77.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(26.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(9.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;43.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;46.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income (loss) per share-basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.91&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income (loss) per share-diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;(0.18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"&gt;&lt;span&gt;0.90&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#ededed;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"&gt;2018:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;117.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;220.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;173.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;270.7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Income (loss) from operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(9.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;66.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;21.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;11.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(4.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;50.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;20.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(3.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:5px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income (loss) per share-basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;1.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.42&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.07&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Net income (loss) per share-diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.98&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.41&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.07&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q1QTD"
      decimals="-5"
      id="d45262055e1024-wk-Fact-6EC6F021F61939DDD280CCD3133084AF"
      unitRef="usd">190600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q2QTD"
      decimals="-5"
      id="d45262055e1043-wk-Fact-C1E446403A54C32BAB13CCD313A86BA6"
      unitRef="usd">243200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d45262055e1062-wk-Fact-D3BB37626B5BB17C4AF9CCD313419AFD"
      unitRef="usd">311800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2019Q4QTD"
      decimals="-5"
      id="d45262055e1082-wk-Fact-B5ED9EBA54125765CA8DCCD3133803C7"
      unitRef="usd">360400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="FD2019Q1QTD"
      decimals="-5"
      id="d45262055e1097-wk-Fact-E38C72D31F1F7F54176BCCD3131B1577"
      unitRef="usd">-27400000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2019Q2QTD"
      decimals="-5"
      id="d45262055e1117-wk-Fact-47FE07C6521BCE3F81D3CCD3139F6924"
      unitRef="usd">-7000000.0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d45262055e1137-wk-Fact-86C1256CA35F926D5D58CCD31332EF8B"
      unitRef="usd">70700000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2019Q4QTD"
      decimals="-5"
      id="d45262055e1157-wk-Fact-7B705D380D8C11C3B61DCCD313402DF9"
      unitRef="usd">77800000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q1QTD"
      decimals="-5"
      id="d45262055e1177-wk-Fact-84AEA0A472C2C70E3266CCD31338F70D"
      unitRef="usd">-26100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q2QTD"
      decimals="-5"
      id="d45262055e1197-wk-Fact-32A4DC4298C817BAAFEACCD31332016F"
      unitRef="usd">-9500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3QTD"
      decimals="-5"
      id="d45262055e1217-wk-Fact-1F94CB94F7CA515A1302CCD3133462BD"
      unitRef="usd">43200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q4QTD"
      decimals="-5"
      id="d45262055e1237-wk-Fact-81A3FE19A16184259141CCD3133977C0"
      unitRef="usd">46900000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q1QTD"
      decimals="2"
      id="d45262055e1344-wk-Fact-283574E78E942BAEA00FCCD3133A3E08"
      unitRef="usdPerShare">-0.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q2QTD"
      decimals="2"
      id="d45262055e1364-wk-Fact-66286533481F2F70879CCCD3134144DE"
      unitRef="usdPerShare">-0.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q3QTD"
      decimals="2"
      id="d45262055e1384-wk-Fact-B73A896822ADF730AB9BCCD313A0BADA"
      unitRef="usdPerShare">0.84</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q4QTD"
      decimals="2"
      id="d45262055e1404-wk-Fact-4E5D7A63BAE8C450BB96CCD3138FE7DA"
      unitRef="usdPerShare">0.91</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q1QTD"
      decimals="2"
      id="d45262055e1424-wk-Fact-0D56F29D548E02AFCD40CCD3131C971E"
      unitRef="usdPerShare">-0.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q2QTD"
      decimals="2"
      id="d45262055e1444-wk-Fact-16C39AC10A25AAE86784CCD3131C0482"
      unitRef="usdPerShare">-0.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q3QTD"
      decimals="2"
      id="d45262055e1464-wk-Fact-29CF5B68493400146F77CCD313A48233"
      unitRef="usdPerShare">0.83</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q4QTD"
      decimals="2"
      id="d45262055e1484-wk-Fact-4AE5C4BEF348EC72C8C1CCD3133784BF"
      unitRef="usdPerShare">0.90</us-gaap:EarningsPerShareDiluted>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q1QTD"
      decimals="-5"
      id="d45262055e1669-wk-Fact-227C8B2D8179E780A180CCD313A368B8"
      unitRef="usd">117800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q2QTD"
      decimals="-5"
      id="d45262055e1688-wk-Fact-8E72C67A6CFF4C8E01BACCD313378A78"
      unitRef="usd">220200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q3QTD"
      decimals="-5"
      id="d45262055e1707-wk-Fact-24102AAD8A5998594409CCD3131C90C7"
      unitRef="usd">173700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="FD2018Q4QTD"
      decimals="-5"
      id="d45262055e1727-wk-Fact-3DAB7800EC8B2BE4502CCCD3134301D0"
      unitRef="usd">270700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="FD2018Q1QTD"
      decimals="-5"
      id="d45262055e1742-wk-Fact-D4B19E943CAF3091A7B4CCD313419542"
      unitRef="usd">-9500000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2018Q2QTD"
      decimals="-5"
      id="d45262055e1762-wk-Fact-0D308D9870B18B7FF97FCCD31336FA4C"
      unitRef="usd">66800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2018Q3QTD"
      decimals="-5"
      id="d45262055e1781-wk-Fact-8E97C8E20AA6F7DC7E0BCCD3133B0345"
      unitRef="usd">21300000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2018Q4QTD"
      decimals="-5"
      id="d45262055e1801-wk-Fact-A51ED508838B349F46FACCD3133EDCEA"
      unitRef="usd">11200000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q1QTD"
      decimals="-5"
      id="d45262055e1821-wk-Fact-F80A04A8C4E7AE31BC59CCD31339BEF9"
      unitRef="usd">-4900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q2QTD"
      decimals="-5"
      id="d45262055e1841-wk-Fact-EE6931F40629924BBB3DCCD3133B6536"
      unitRef="usd">50100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q3QTD"
      decimals="-5"
      id="d45262055e1860-wk-Fact-4EB29DA0A6BE67A46E36CCD3133CFFE8"
      unitRef="usd">20900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2018Q4QTD"
      decimals="-5"
      id="d45262055e1880-wk-Fact-7DA4E33EBB93C65184C0CCD313416306"
      unitRef="usd">-3400000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2018Q1QTD"
      decimals="2"
      id="d45262055e1988-wk-Fact-88CDF1A8BF89278B2845CCD31337684B"
      unitRef="usdPerShare">-0.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2018Q2QTD"
      decimals="2"
      id="d45262055e2008-wk-Fact-86DA83AA14CFF7ADD3B2CCD3131FAD0B"
      unitRef="usdPerShare">1.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2018Q3QTD"
      decimals="2"
      id="d45262055e2027-wk-Fact-2297018600F3FAD02532CCD313A0BAA1"
      unitRef="usdPerShare">0.42</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2018Q4QTD"
      decimals="2"
      id="d45262055e2047-wk-Fact-B27D4E90A9323F9AFDE1CCD31340325E"
      unitRef="usdPerShare">-0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2018Q1QTD"
      decimals="2"
      id="d45262055e2068-wk-Fact-24B7D36B1E4ECDD08F94CCD31323E9B5"
      unitRef="usdPerShare">-0.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2018Q2QTD"
      decimals="2"
      id="d45262055e2088-wk-Fact-2C2129A967B423B2EA8CCCD3134000EE"
      unitRef="usdPerShare">0.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2018Q3QTD"
      decimals="2"
      id="d45262055e2107-wk-Fact-8E9E54ECABE5DADE841ACCD3133F7317"
      unitRef="usdPerShare">0.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2018Q4QTD"
      decimals="2"
      id="d45262055e2127-wk-Fact-66A0554F354AAFB66AC7CCD3131F00CB"
      unitRef="usdPerShare">-0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-4718ED41BD42CC7BD561CCD313C1F284-0-wk-Fact-73DCB0E6EB1D965318ACCCD313A2BB17">&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Litigation&lt;/span&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;"&gt;ANDA Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;On September 14, 2018,  Adapt Pharma Inc.,  Adapt Pharma Operations Limited and Adapt Pharma Ltd. (collectively, "Adapt Pharma"), and Opiant Pharmaceuticals, Inc. ("Opiant"), received notice from Perrigo UK FINCO Limited Partnership ("Perrigo"), that Perrigo had filed an Abbreviated New Drug Application ("ANDA"), with the United States Food and Drug Administration seeking regulatory approval to market a generic version of NARCAN&#xae;(naloxone hydrochloride) Nasal Spray 4mg/spray before the expiration of U.S. Patent Nos. 9,211,253, (the "&#x2018;253 Patent"), 9,468,747 (the "&#x2018;747 Patent"), 9,561,177, (the "&#x2018;177 Patent"), 9,629,965, (the "&#x2018;965 Patent") and 9,775,838 (the "&#x2018;838 Patent"). On or about October 25, 2018, Perrigo sent a subsequent notice letter relating to U.S. Patent No. 10,085,937 (the "937 Patent"). Perrigo&#x2019;s notice letters assert that its generic product will not infringe any valid and enforceable claim of these patents.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;On October 25, 2018, Emergent BioSolutions&#x2019; Adapt Pharma subsidiaries and Opiant, (collectively, the "Plaintiffs"), filed a complaint for patent infringement of the &#x2018;253, &#x2018;747, &#x2018;177, &#x2018;965, and the &#x2018;838 Patents against Perrigo in the United States District Court for the District of New Jersey arising from Perrigo&#x2019;s ANDA filing with the FDA. Plaintiffs filed a second complaint against Perrigo on December 7, 2018, for the infringement of the &#x2018;937 Patent. On February 12, 2020, Adapt Pharma and Perrigo entered into a settlement agreement to resolve the ongoing litigation.  Under the terms of the settlement, Perrigo has received a non-exclusive license under Adapt&#x2019;s patents to make, have made and market its generic naloxone hydrochloride nasal spray under its own ANDA. Perrigo&#x2019;s license will be effective as of January 5, 2033 or earlier under certain circumstances including circumstances related to the outcome of the current litigation against Teva (as defined below) or litigation against future ANDA filers.  The Perrigo settlement agreement is subject to review by the U.S. Department of Justice and the Federal Trade Commission, and entry of an order dismissing the litigation by the U.S. District Court for the District of New Jersey. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;On or about February 27, 2018, Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant received notice from Teva Pharmaceuticals Industries Ltd. and Teva Pharmaceuticals USA, Inc. (collectively "Teva"), that Teva had filed an ANDA with the FDA seeking regulatory approval to market a generic version of NARCAN&#xae; (naloxone hydrochloride) Nasal Spray 2 mg/spray before the expiration of U.S. Patent No. 9,480,644, (the "&#x2018;644 Patent"), and U.S. Patent No. 9,707,226, (the "'226 Patent"). Teva's notice letter asserts that the commercial manufacture, use or sale of its generic drug product described in its ANDA will not infringe the '644 Patent or the '226 Patent, or that the '644 Patent and '226 Patent are invalid or unenforceable. Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant filed a complaint for patent infringement against Teva in the United States District Court for the District of New Jersey.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;On or about September 13, 2016, Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant received notice from Teva that Teva had filed an ANDA with the FDA seeking regulatory approval to market a generic version of NARCAN&#xae; (naloxone hydrochloride) Nasal Spray 4 mg/spray before the expiration of U.S. Patent No. 9,211,253 (the "'253 Patent"). Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant received additional notices from Teva relating to the '747, the '177, the '965, the '838, and the &#x2018;937 Patents. Teva's notice letters assert that the commercial manufacture, use or sale of its generic drug product described in its ANDA will not infringe the '253, the '747, the '177, the '965, the '838, or the &#x2018;937 Patent, or that the '253, the '747, the '177, the '965, the '838, and the &#x2018;937 Patents are invalid or unenforceable. Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant filed a complaint for patent infringement against Teva in the United States District Court for the District of New Jersey with respect to the '253 Patent. Adapt Pharma Inc. and Adapt Pharma Operations Limited and Opiant also filed complaints for patent infringement against Teva in the United States District Court for the District of New Jersey with respect to the '747, the '177, the '965, and the '838 Patents. All five proceedings have been consolidated. As of the date of this filing, Adapt Pharma Inc., Adapt Pharma Operations Limited, and Opiant, have not filed a complaint related to the &#x2018;937 Patent. Closing arguments are scheduled for February 26, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;In the complaints described in the paragraphs above, the Plaintiffs seek, among other relief, orders that the effective date of FDA approvals of the Teva ANDA products and the Perrigo ANDA product be a date not earlier than the expiration of the patents listed for each product, equitable relief enjoining Teva and Perrigo from making, using, offering to sell, selling, or importing the products that are the subject of Teva and Perrigo&#x2019;s respective ANDAs, until after the expiration of the patents listed for each product, and monetary relief or other relief as deemed just and proper by the court.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"&gt;Nalox-1 Pharmaceuticals, a non-practicing entity, filed petitions with the United States Patent and Trademark Office Patent Trial and Appeal Board (the "PTAB") requesting inter parties review ("IPR") of five of the six patents listed in the Orange Book related to NARCAN&#xae; Nasal Spray 4mg/spray. In a series of decisions, the PTAB agreed to institute a review &lt;/span&gt;&lt;/div&gt;of the '253 Patent, the '747 Patent and the '965 Patent but denied review of the '177 Patent and the '838 Patent. Nalox-1 did not request review of the '937 Patent.</us-gaap:LegalMattersAndContingenciesTextBlock>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="FD2019Q4YTD"
      id="TextSelection-217D97A19B706B785CBACCD313C111DB-0-wk-Fact-359250E6B5C3D0D968A9CCD313A08F9E">&lt;div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"&gt;SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="21"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:35%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;(in millions)&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Beginning Balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Additions from Acquisition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Charged to costs and expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Deductions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;"&gt;Ending Balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Inventory allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;14.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;23.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(19.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;17.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Prepaid expenses and other current assets allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;4.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(0.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Year Ended December 31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Inventory allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;4.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;14.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(8.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;14.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Prepaid expenses and other current assets allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;5.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(1.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;4.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Year Ended December 31, 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Inventory allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;8.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;(8.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;3.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;Prepaid expenses and other current assets allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;4.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;span&gt;5.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember"
      decimals="-5"
      id="d45264290e1099-wk-Fact-0DD31D376D328B622FAA99D5BAAB56F5"
      unitRef="usd">14000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember"
      decimals="-5"
      id="d45264290e1118-wk-Fact-FC0BF8231D967664280778674C5584C5"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember"
      decimals="-5"
      id="d45264290e1138-wk-Fact-1E7EF2C50762028A6F6699D5BAC64FC5"
      unitRef="usd">23000000.0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember"
      decimals="-5"
      id="d45264290e1157-wk-Fact-656E69047FC941F1F16299D5BAC139D2"
      unitRef="usd">19100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember"
      decimals="-5"
      id="d45264290e1177-wk-Fact-4A326107C44BBDB8117299D5BAB97FF0"
      unitRef="usd">17900000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d45264290e1197-wk-Fact-014106C37CC40BDE49DF99D5BAEB33B7"
      unitRef="usd">4300000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d45264290e1216-wk-Fact-60AC3B69A0751F23684F78674DFB2A7B"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d45264290e1235-wk-Fact-DBC4572D309E689FC1F199D5BACA2517"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2019Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d45264290e1255-wk-Fact-5520D5FE65894D619F7699D5BAD77BB9"
      unitRef="usd">300000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2019Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d45264290e1275-wk-Fact-0D205A4868CDD1184D8C99D5BAB2A642"
      unitRef="usd">4000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember"
      decimals="-5"
      id="d45264290e1515-wk-Fact-E0FEA6FBE506BFA2772099D5BAA7A9C2"
      unitRef="usd">3800000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember"
      decimals="-5"
      id="d45264290e1534-wk-Fact-79D13253727F263C48637846E040041E"
      unitRef="usd">4400000</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember"
      decimals="-5"
      id="d45264290e1554-wk-Fact-97C8301501777EF4AA1A99D5BA820ECB"
      unitRef="usd">14600000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember"
      decimals="-5"
      id="d45264290e1573-wk-Fact-2B45DA06EFCF2B4BD68E99D5BAD3BF65"
      unitRef="usd">8800000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember"
      decimals="-5"
      id="d45264290e1593-wk-Fact-0DD31D376D328B622FAA99D5BAAB56F5"
      unitRef="usd">14000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d45264290e1613-wk-Fact-7F1AE09A558CADE5422B99D5BAF05819"
      unitRef="usd">5300000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d45264290e1632-wk-Fact-CB90DA871E496D90605D786752E0148D"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d45264290e1651-wk-Fact-2FC6EA20944F6F2B895099D5BA9FCF75"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d45264290e1671-wk-Fact-104B2005F5C7EEFD14F799D5BAE4DC40"
      unitRef="usd">1000000.0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d45264290e1691-wk-Fact-014106C37CC40BDE49DF99D5BAEB33B7"
      unitRef="usd">4300000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember"
      decimals="-5"
      id="d45264290e1931-wk-Fact-A03BA5267DE6067FF6D799D5BAA3EB7E"
      unitRef="usd">3500000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired
      contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember"
      decimals="-5"
      id="d45264290e1950-wk-Fact-B13A1D4337235906443878675462A3D9"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember"
      decimals="-5"
      id="d45264290e1970-wk-Fact-46715A333E627DC81B5099D5BA9B4244"
      unitRef="usd">8800000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember"
      decimals="-5"
      id="d45264290e1989-wk-Fact-D158CF9D9C75F1A9EF0199D5BAE04443"
      unitRef="usd">8500000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_InventoryValuationReserveMember"
      decimals="-5"
      id="d45264290e2009-wk-Fact-E0FEA6FBE506BFA2772099D5BAA7A9C2"
      unitRef="usd">3800000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d45264290e2030-wk-Fact-B62AE626319F4831D6CF99D5BAE84C5A"
      unitRef="usd">4900000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired
      contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d45264290e2049-wk-Fact-856BF181CEC1BE6EAE62786755702E01"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesReservesOfBusinessesAcquired>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d45264290e2068-wk-Fact-0DD4B7C61C3B1CA1E6AE99D5BABD05F1"
      unitRef="usd">400000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d45264290e2088-wk-Fact-7D762B82E66A936CCF3699D5BAAE9643"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ebs_SECSchedule1209AllowancePrepaidExpensesAndOtherCurrentAssetsMember"
      decimals="-5"
      id="d45264290e2107-wk-Fact-7F1AE09A558CADE5422B99D5BAF05819"
      unitRef="usd">5300000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6835388736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Adapt Preliminary Allocation of Purchase Price (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 15, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract', window );"><strong>Fair value of tangible assets acquired and liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 266.6<span></span>
</td>
<td class="nump">$ 259.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract', window );"><strong>Measurement Period Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ebs_AdaptPharmaMember', window );">Adapt Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract', window );"><strong>Fair value of tangible assets acquired and liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">$ 17.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">21.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">41.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">10.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(32.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(50.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability, net</a></td>
<td class="num">(62.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total fair value of tangible assets acquired and liabilities assumed</a></td>
<td class="num">(54.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired in-process research and development</a></td>
<td class="nump">41.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Acquired intangible asset</a></td>
<td class="nump">534.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">148.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">668.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract', window );"><strong>Measurement Period Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets', window );">Prepaid expenses and other assets, measurements period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities', window );">Deferred tax liability, net, measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod', window );">Total fair value of tangible assets acquired and liabilities assumed, measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Total purchase price</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | Adapt Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract', window );"><strong>Fair value of tangible assets acquired and liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">17.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">21.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">41.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">7.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(32.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(50.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability, net</a></td>
<td class="num">(62.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total fair value of tangible assets acquired and liabilities assumed</a></td>
<td class="num">(56.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Acquired intangible asset</a></td>
<td class="nump">534.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">149.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">667.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development | Previously Reported | Adapt Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract', window );"><strong>Fair value of tangible assets acquired and liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired in-process research and development</a></td>
<td class="nump">$ 41.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Expenses and Other Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued expenses and other liabilities, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in income that would have been recognized in previous periods if the adjustments to provisional amounts were recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31917-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=84229725&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ebs_AdaptPharmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ebs_AdaptPharmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6982688320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Acquisition of ACAM2000 Business (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 06, 2017</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract', window );"><strong>Fair value of tangible assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 266.6<span></span>
</td>
<td class="nump">$ 259.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ebs_ACAM2000Member', window );">ACAM2000</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Business Combination, Consideration Transferred [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Amount of cash paid</a></td>
<td class="nump">$ 117.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent purchase consideration</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">119.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract', window );"><strong>Fair value of tangible assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">74.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total fair value of tangible assets acquired and liabilities assumed</a></td>
<td class="nump">94.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Acquired intangible assets</a></td>
<td class="nump">16.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">8.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">$ 119.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ebs_ACAM2000Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ebs_ACAM2000Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6817794608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined benefit and 401(k) savings plan - Weighted Average Assumptions (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of future compensation increases</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Total contributions expected</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions expected to be received by defined benefit plan from employer in next fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6819149264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk | BioThrax | Revenue from Contract with Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">45.97676%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">68.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Geographic Concentration Risk | Revenue from Contract with Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="nump">91.00%<span></span>
</td>
<td class="nump">89.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Assets | $</a></td>
<td class="nump">$ 90.6<span></span>
</td>
<td class="nump">$ 82.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13537-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_BiothraxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_BiothraxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818846944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Leases</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has operating leases for corporate offices, research and development facilities and manufacturing facilities. We determine if an arrangement is a lease at inception. Operating leases are included in right-of-use ("ROU") assets and liabilities.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">represent the Company's obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company's leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company uses an implicit rate when readily determinable. At the beginning of a lease, the operating lease ROU asset also includes any concentrated lease payments expected to be paid and excludes lease incentives. The Company's lease ROU asset may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise those options.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for separately. The Company's leases have remaining lease terms of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>1 year</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>14 years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, some of which include options to extend the leases for up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>5 years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and some of which include options to terminate the leases within </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>1 year</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The components of lease expense were as follows:&#160;</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:81%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease cost:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amortization of right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest on lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total operating lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> total lease expense was $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>3.3</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million and $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>1.6</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million, respectively. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Supplemental balance sheet information related to leases was as follows as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:49%;"/><td style="width:27%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-style:italic;">(In millions, except lease term and discount rate)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>24.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease liabilities, current portion</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>22.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>25.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating leases:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted average remaining lease term (years)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>8.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted average discount rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Leases</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has operating leases for corporate offices, research and development facilities and manufacturing facilities. We determine if an arrangement is a lease at inception. Operating leases are included in right-of-use ("ROU") assets and liabilities.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">represent the Company's obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company's leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company uses an implicit rate when readily determinable. At the beginning of a lease, the operating lease ROU asset also includes any concentrated lease payments expected to be paid and excludes lease incentives. The Company's lease ROU asset may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise those options.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for separately. The Company's leases have remaining lease terms of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>1 year</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>14 years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, some of which include options to extend the leases for up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>5 years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and some of which include options to terminate the leases within </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>1 year</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The components of lease expense were as follows:&#160;</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:81%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease cost:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amortization of right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest on lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total operating lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> total lease expense was $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>3.3</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million and $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>1.6</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million, respectively. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:16px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Supplemental balance sheet information related to leases was as follows as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:49%;"/><td style="width:27%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;font-style:italic;">(In millions, except lease term and discount rate)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>24.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease liabilities, current portion</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>22.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total operating lease liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>25.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating leases:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted average remaining lease term (years)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>8.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted average discount rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6809925152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">54.5<span></span>
</td>
<td class="nump">62.7<span></span>
</td>
<td class="nump">82.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized losses on hedging activities, net of tax</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Unrealized losses on hedging activities, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized losses on pension benefit obligation, net of tax</a></td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(4.4)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">50.1<span></span>
</td>
<td class="nump">60.9<span></span>
</td>
<td class="nump">83.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109978405&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6813698016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> shares in Millions, $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Feb. 14, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover page.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EMERGENT BIOSOLUTIONS INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">14-1902018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">400 Professional Drive, Suite 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Gaithersburg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">21079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">631-3200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Portions of the registrant's definitive proxy statement for its </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> annual meeting of stockholders scheduled to be held in May </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, which is expected to be filed with the Securities and Exchange Commission not later than 120 days after the end of the registrant's fiscal year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, are incorporated by reference into Part II, Item 5. and Part III of this annual report on Form 10-K. With the exception of the portions of the registrant's definitive proxy statement for its </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> annual meeting of stockholders that are expressly incorporated by reference into this annual report on Form 10-K, such proxy statement shall not be deemed filed as part of this annual report on Form 10-K.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001367644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EBS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 20-F, 40-F<br> -Number 240<br> -Section 15<br> -Subsection d-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828909536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly financial data (unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Quarterly financial data (Unaudited)</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Quarterly financial data (unaudited)</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Quarterly financial information for the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is presented in the following tables:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Quarter Ended</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions, except per share data)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">March 31,</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">June 30,</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">September 30,</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">2019:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>190.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>243.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>311.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>360.4</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income (loss) from operations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(27.4</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(7.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>70.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>77.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(26.1</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(9.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>43.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>46.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) per share-basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.51</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.18</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.84</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.91</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) per share-diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.51</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.18</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.83</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.90</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">2018:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>117.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>220.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>173.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>270.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income (loss) from operations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(9.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>66.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>21.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>11.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(4.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>50.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>20.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(3.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) per share-basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.10</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.00</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.42</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.07</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) per share-diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.10</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.98</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.41</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.07</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828880864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of the business and organization<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of the business and organization</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Nature of the business and organization</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Organization and business</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Emergent BioSolutions Inc. (the "Company" or "Emergent") is a global life sciences company focused on providing specialty products for civilian and military populations that address accidental, deliberate and naturally occurring public health threats ("PHTs," each a &#8220;PHT&#8221;).</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company is focused on innovative preparedness and response products and solutions addressing the following </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>six</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> distinct PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives ("CBRNE"); emerging infectious diseases ("EID"); travel health; </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">emerging health crises, acute/emergency care, and contract development and manufacturing ("CDMO")</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The Company has a product portfolio of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>twelve</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> products and product candidates (vaccines, therapeutics, and drug-device combination products) that generate a majority of our revenue. The U.S. government (the "USG') is the Company's largest customer and provides us with substantial funding for the development of a number of it</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">s product candidates.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">The Company's product portfolio includes:</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Vaccines</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ACAM2000</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (Smallpox (Vaccinia) Vaccine, Live), the only single-dose smallpox vaccine licensed by the FDA for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">BioThrax</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (Anthrax Vaccine Adsorbed), the only vaccine licensed by the U.S. Food and Drug Administration ("FDA"), for the general use prophylaxis and post-exposure prophylaxis of anthrax disease;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Vaxchora&#174; (Cholera Vaccine, Live, Oral), the only FDA-licensed vaccine for the prevention of cholera, it is orally delivered; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Vivotif&#174; (Typhoid Vaccine Live Oral Ty21a), the only oral vaccine licensed by the FDA for the prevention of typhoid fever.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Devices</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">NARCAN&#174; (naloxone HCl) Nasal Spray, the first and only needle-free formulation of naloxone approved by the FDA and Health Canada, for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">RSDL</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (Reactive Skin Decontamination Lotion Kit), the only medical device cleared by the FDA to remove or neutralize the following chemical warfare agents from the skin: tabun, sarin, soman, cyclohexyl sarin, VR, VX, mustard gas and T-2 toxin; and</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Therapeutics</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">raxibacumab (Anthrax Monoclonal), the first fully human monoclonal antibody therapeutic licensed by the FDA for the treatment and prophylaxis of inhalational anthrax;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Anthrasil</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (Anthrax Immune Globulin Intravenous (Human)), the only polyclonal antibody therapeutic licensed by the FDA and Health Canada for the treatment of inhalational anthrax;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">BAT&#174; (Botulism Antitoxin Heptavalent (A,B,C,D,E,F,G)-(Equine)), the only heptavalent antibody therapeutic licensed by the FDA and Health Canada for the treatment of botulism; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">VIGIV (Vaccinia Immune Globulin Intravenous (Human)), the only polyclonal antibody therapeutic licensed by the FDA and Health Canada to address certain complications from smallpox vaccination.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Product Candidates</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">AV7909</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;  </sup></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">(Anthrax Vaccine Absorbed with Adjuvant), is a product candidate being developed as a next generation anthrax vaccine for post-exposure prophylaxis of disease resulting from suspected or confirmed Bacillus antracis exposure. The USG has started procuring AV7909 for the SNS prior to its approval by the FDA and has been reducing its purchases of BioThrax as a result; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Trobigard&#174; is a combination drug-device auto-injector product candidate that contains atropine sulfate and obidoxime chloride. It has not been approved by the FDA or any similar health regulatory body, but is procured by certain authorized government buyers under special circumstances for potential use as a nerve agent countermeasure. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company also generates revenue from contract development and manufacturing services on a clinical and commercial (small and large) scale by providing such services to the pharmaceutical and biotechnology industry.&#160; These services include process development and bulk drug substance and drug product manufacturing of biologics, fill/finish formulation and analytical development services for injectable and other sterile products, inclusive of process design, technical transfer, manufacturing validations, aseptic filling, lyophilization, final packaging and stability studies, as well as manufacturing of vial and pre-filled syringe formats across bacterial, viral and mammalian therapy technology platforms. </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We operate as </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:normal;"><span>one</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> operating segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6975520192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Valuation Assumptions, Stock Options Granted</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company utilizes the Black-Scholes valuation model for estimating the fair value of all stock options granted. Set forth below are the assumptions used in valuing the stock options granted:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:top;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="8" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expected dividend yield</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expected volatility</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37-39%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">38-39%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37-40%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Risk-free interest rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.57-2.48%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.54-3.03%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.66-1.88%</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expected average life of options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>4.5 years</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>4.5 years</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>4.3 years</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Award Activity</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following is a summary of stock option award activity under the Emergent Plan:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Emergent Plan</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions, except share and per share data)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Number of Shares</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Weighted-Average Exercise Price</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Aggregate Intrinsic Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Outstanding at December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1,871,468</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>32.59</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>50.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>295,770</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>60.16</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Exercised</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(199,352</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>25.98</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(84,011</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>52.26</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Outstanding at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1,883,875</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>36.74</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>34.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Exercisable at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1,253,658</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>29.46</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>30.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Stock Unit Award Activity</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following is a summary of performance stock and restricted stock unit award activity under the Emergent Plan. Performance stock units of approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>0.1</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million shares were granted and remain outstanding the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and are included in the table below.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions, except share and per share data)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Number of Shares</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Weighted-Average Grant Price</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Aggregate Intrinsic Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Outstanding at December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>921,093</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>42.82</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>54.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>594,752</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>57.94</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Vested</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(434,629</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>38.81</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(128,364</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>53.17</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Outstanding at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>952,852</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>52.77</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>51.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Stock-based compensation expense was recorded in the following financial statement line items:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:61%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cost of product sales</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Selling, general and administrative</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>19.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>18.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>11.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total stock-based compensation expense</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>26.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>23.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>15.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table includes changes in accumulated other comprehensive loss by component, net of tax:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:54%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Defined Benefit Pension Plan</span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Derivative Instruments</span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Foreign Currency Translation Losses</span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, January 1, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(3.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(3.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive loss </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(5.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(5.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive (loss) income before reclassifications</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(2.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(5.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net current period other comprehensive loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(4.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(4.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(9.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828908992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract', window );"><strong>Property Plant and Equipment Income Statement Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Property, plant and equipment are stated at cost less accumulated depreciation and impairments. Depreciation is computed using the straight-line method over the following estimated useful lives:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"/></tr><tr><td style="width:52%;"/><td style="width:48%;"/></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Buildings</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">31-39 years</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Building improvements</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10-39 years</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Furniture and equipment</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3-15 years</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Software</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3-7 years or product life</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Leasehold improvements</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lesser of the asset life or lease term</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Property, plant and equipment consist of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #ffffff;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Land and improvements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>46.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>44.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Buildings, building improvements and leasehold improvements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>234.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>216.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Furniture and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>334.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>293.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Software</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>55.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>55.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Construction-in-progress</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>81.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>71.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>752.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>681.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Less: Accumulated depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(210.4</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(171.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total property, plant and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>542.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>510.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentIncomeStatementDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828940128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Summary of Disaggregation of Revenue</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> the Company's&#160;revenues disaggregated by the major sources was as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="36"/></tr><tr><td style="width:8%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="35" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">U.S</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Non-U.S.</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">U.S</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Non-U.S.</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">U.S</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Non-U.S.</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Government</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:8pt;color:#ffffff;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">Product sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>568.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>334.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>903.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>526.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>80.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>606.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>374.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>46.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>421.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">Contract development and manufacturing services</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>80.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>80.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>98.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>98.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>68.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>68.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">Contracts and grants</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>105.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>16.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>122.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>71.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>77.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>65.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>5.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>70.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">Total revenues</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>674.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>431.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#0094ff;"><span>1,106.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>597.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>184.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>782.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>439.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>121.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;"><span>560.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Summary of Deferred Revenue Contract Liabilities</a></td>
<td class="text">The following table presents the rollforward of contract liabilities:<div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>30.5</span></span></div></td><td style="vertical-align:bottom;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adoption of new accounting standard (ASC 606)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>42.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">January 1, 2018</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>72.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferral of revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>29.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue recognized</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(29.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>73.1</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferral of revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>46.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue recognized</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(30.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>88.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_ScheduleofAccountsReceivableNetTableTextBlock', window );">Schedule of Accounts Receivable, Net</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Accounts receivable including unbilled accounts receivable contract assets consist of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Billed, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>227.3</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>234.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unbilled</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>43.4</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>28.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>270.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>262.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ScheduleofAccountsReceivableNetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Accounts Receivable, Net [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ScheduleofAccountsReceivableNetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contract balances and changes in contract balances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818844976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Acquisitions</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:normal;font-weight:bold;text-decoration:none;">Adapt</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On October 15, 2018, the Company acquired Adapt, a company focused on developing new treatment options and commercializing products addressing opioid overdose and addiction. Adapt's NARCAN&#174; (naloxone HCI) Nasal Spray marketed product is the first needle-free formulation of naloxone approved by the FDA and Health Canada for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. This acquisition included approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>50</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> employees, located in the U.S., Canada, and Ireland, including those responsible for supply chain management, research and development, government affairs, and commercial operations. The products and product candidates within Adapt's portfolio are consistent with the Company's mission and expand the Company's core business of addressing public health threats.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The total purchase price revised for adjustments is summarized below:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in&#160;millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">October 15, 2018</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>581.5</span></span></div></td><td style="vertical-align:bottom;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Equity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>37.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of contingent purchase consideration</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>48.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Preliminary purchase consideration</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>667.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Final purchase consideration</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>668.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company issued </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>733,309</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares of Common Stock at </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$60.44</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> per share, the closing price of Emergent's share price on October 15, 2018, for a total of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$44.3 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (inclusive of adjustments). The </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$44.3 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> value of the common stock shares issued has been adjusted to a fair value of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$37.7 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> considering a discount for lack of marketability due to a </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">two</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">-year lock-up period beginning on October 15, 2018. The remaining consideration payable for the acquisition consists of up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$100 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in cash based on the achievement of certain sales milestones through 2022 which the Company has determined the fair value of to be </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$48.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> as of the acquisition date. The fair value of the contingent purchase consideration is based on management&#8217;s assessment of the potential future realization of the contingent purchase consideration payments. This assessment is based on inputs that have no observable market (Level 3). The obligation is measured using a discounted cash flow model.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">This transaction was accounted for by the Company under the acquisition method of accounting, with the Company as the acquirer. Under the acquisition method of accounting, the assets and liabilities of Adapt were recorded as of October 15, 2018, the acquisition date, at their respective fair values, and combined with those of the Company. The </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Company reflects measurement period adjustments in the period in which the adjustments occur. The adjustments during the measurement period resulted from receipt of additional financial information associated with certain acquired contract assets and the value of associated contingent purchase consideration. These adjustments did not impact the Company's statements of operations. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The table below summarizes the final allocation of the purchase price based upon fair values of assets acquired and liabilities assumed at October 15, 2018.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:64%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">October 15, 2018</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Measurement Period Adjustments</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Updated  October 15, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of tangible assets acquired and liabilities assumed:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>17.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>17.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts receivable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>21.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>21.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>41.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>41.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prepaid expenses and other assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>7.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>10.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts payable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(32.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(32.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(50.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(50.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax liability, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(62.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(62.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total fair value of tangible assets acquired and liabilities assumed</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(56.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(54.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired in-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>41.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>41.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired intangible asset</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>534.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>534.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>149.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>148.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase price</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>667.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>668.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determined the fair value of the intangible asset using the income approach, which is based on the present value of future cash flows. The fair value measurements are based on significant unobservable inputs that are developed by the Company using estimates and assumptions of the respective market and market penetration of the Company's products.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair value of the intangible asset acquired for Adapt's marketed product NARCAN&#174; Nasal Spray was valued at </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$534.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The Company has determined the useful life of the NARCAN&#174; Nasal Spray intangible asset to be </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>15</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> years. The Company calculated the fair value of the NARCAN&#174; Nasal Spray intangible asset using the income approach with a present value discount rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>10.5%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, which is based on the weighted-average cost of capital for companies with profiles substantially similar to that of Adapt. This is comparable to the internal rate of return for the acquisition and represents the rate that market participants would use to value these intangible assets. The projected cash flows from the NARCAN&#174; Nasal Spray intangible asset were based on key assumptions including: estimates of revenues and operating profits; and risks related to the viability of and potential alternative treatments in any future target markets.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The intangible asset associated with IPR&amp;D acquired from Adapt is related to a product candidate. Management determined that the acquisition-date fair value of intangible assets related to IPR&amp;D was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$41.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The fair value was determined using the income approach, which discounts expected future cash flows to present value. The Company calculated the fair value using a present value discount rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>11%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, which is based on the weighted-average cost of capital for companies with that profiles substantially similar to that of Adapt and IPR&amp;D assets at a similar stage of development as the product candidate. This is comparable to the internal rate of return for the acquisition and represents the rate that market participants would use to value the IPR&amp;D. The projected cash flows for the product candidate&#160; were based on key assumptions including: estimates of revenues and operating profits, considering its stage of development on the acquisition date; the time and resources needed to complete the development and approval of the product candidate; the life of the potential commercialized product and associated risks, including the inherent difficulties and uncertainties in developing a product candidate, such as obtaining marketing approval from the FDA and other regulatory agencies; and risks related to the viability of and potential for alternative treatments in any future target markets. Non-amortizing IPR&amp;D assets are considered to be indefinite-lived until the completion or abandonment of the associated research and development effort and are evaluated for impairment annually. During the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company recorded an impairment charge of $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>12.0</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million to the IPR&amp;D asset. The fair value of the IPR&amp;D intangible asset is $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>29.0</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million at December 31, 2019 (see Note </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">8</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">).</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determined the fair value of the inventory using the comparative sales method, which estimates the expected sales price reduced for all costs expected to be incurred to complete/dispose of the inventory with a profit on those costs.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company recorded approximately $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>148.0</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million in goodwill related to the Adapt acquisition, which is calculated as the purchase price paid in excess of the fair value of the tangible and intangible assets acquired representing the future economic benefits the Company expects to receive as a result of the acquisition. The goodwill created from the Adapt acquisition is associated with early stage pipeline products. The goodwill generated from the Adapt acquisition is not expected to be deductible for tax purposes.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:normal;font-weight:bold;text-decoration:none;">PaxVax</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On October 4, 2018, the Company completed the acquisition of PaxVax Holding Company Ltd. ("PaxVax"), a company focused on developing, manufacturing, and commercializing specialty vaccines that protect against existing and emerging infectious diseases. This acquisition includes Vivotif&#174; (Typhoid Vaccine Live Oral Ty21a), the only oral vaccine licensed by the FDA for the prevention of typhoid fever, Vaxchora&#174; (Cholera Vaccine, Live, Oral), the only FDA-licensed vaccine for the prevention of cholera, adenovirus 4/7 and additional clinical-stage vaccine candidates targeting chikungunya and other emerging infectious diseases, European-based current good manufacturing practices ("cGMP") biologics manufacturing facilities, and approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>250</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> employees including those in research and development, manufacturing, and commercial operations with a specialty vaccines sales force in the U.S. and in select European countries. The products and product candidates within PaxVax's portfolio are consistent with the Company&#8217;s mission and will expand the Company&#8217;s core business of addressing PHTs. In addition, the acquisition expands the Company's manufacturing capabilities.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">At the closing, the Company paid a cash consideration of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$273.1 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (inclusive of closing adjustments). This transaction was accounted for by the Company under the acquisition method of accounting, with the Company as the acquirer. Under the acquisition method of accounting, the assets and liabilities of PaxVax were recorded as of October 4, 2018, the acquisition date, at their respective fair values, and combined with those of the Company. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The table below summarizes the final allocation of the purchase consideration based upon the fair values of assets acquired and liabilities assumed at October 4, 2018.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">October 4, 2018</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Measurement Period Adjustments</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Updated October 4, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of tangible assets acquired and liabilities assumed:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts receivable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>4.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>4.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>19.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>19.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prepaid expenses and other assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>12.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>11.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>57.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>57.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accounts payable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(33.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(34.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total fair value of tangible assets acquired and liabilities assumed</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>69.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>70.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired in-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(9.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>133.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>133.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>61.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>7.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>69.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase consideration</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>273.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>273.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair value of the intangible assets acquired for PaxVax's marketed products are valued at a total of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$133.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The Company has determined that the weighted average useful lives of the intangible assets to be </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>19</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> years.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determined the fair value of the intangible assets using the income approach, which is based on the present value of future cash flows. The fair value measurements are based on significant unobservable inputs that are </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">developed by the Company using estimates and assumptions of the respective market and market penetration of the Company's products.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company calculated the fair value of the Vivotif and Vaxchora intangible assets using the income approach with a present value discount rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>14.5%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>15%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, which is based on the weighted-average cost of capital for companies with profiles substantially similar to that of PaxVax. This is comparable to the internal rate of return for the acquisition and represents the rate that market participants would use to value these intangible assets. The projected cash flows from these intangible assets were based on key assumptions including: estimates of revenues and operating profits; and risks related to the viability of and potential alternative treatments in any future target markets.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The intangible asset associated with IPR&amp;D acquired from PaxVax is related to a product candidate.  The Company has adjusted the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. The Company estimates the fair value based on the income approach. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determined the fair value of the inventory using the comparative sales method, which estimates the expected sales price reduced for all costs expected to be incurred to complete/dispose of the inventory with a profit on those costs.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determined the fair value of the property, plant and equipment utilizing either the cost approach or the sales comparison approach. The cost approach is determined by establishing replacement cost of the asset and then subtracting any value that has been lost due to economic obsolescence, functional obsolescence, or physical deterioration. The sales comparison approach determines an asset is equal to the market price of an asset of comparable features such as design, location, size, construction, materials, use, capacity, specification, operational characteristics and other features or descriptions.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company recorded approximately $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>69.5</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million in goodwill related to the PaxVax acquisition, calculated as the purchase price paid in the acquisition that was in excess of the fair value of the tangible and intangible assets acquired representing the future economic benefits the Company expects to receive as a result of the acquisition. The goodwill created from the PaxVax acquisition is associated with early stage pipeline products along with potential contract development and manufacturing services. The majority of the goodwill generated from the PaxVax acquisition is expected to be deductible for tax purposes.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has incurred transaction costs related to the PaxVax acquisition of approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$4.5 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, which have been recorded in selling, general and administrative expenses.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Acquisition of ACAM2000 business</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On October 6, 2017, the Company completed the acquisition of the ACAM2000&#174; (Smallpox (Vaccinia) Vaccine, Live) business of Sanofi Pasteur Biologics, LLC ("Sanofi"). This acquisition includes ACAM2000, the only smallpox vaccine licensed by the FDA, a current good manufacturing practices ("cGMP") live viral manufacturing facility and office and warehouse space, both in Canton, Massachusetts, and a cGMP viral fill/finish facility in Rockville, Maryland. With this acquisition, the Company also acquired an existing </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>10</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">-year contract with the CDC, which expired in March 2018. This contract had a stated value up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$425 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, with a remaining contract value of up to approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$160 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> as of the acquisition date, for the delivery of ACAM2000 to the SNS and establishing U.S.-based manufacturing of ACAM2000. This acquisition added to the Company's product portfolio and expanded the Company's manufacturing capabilities.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">At the closing, the Company paid </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$97.5 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in an upfront payment and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$20 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in milestone payments earned as of the closing date tied to the achievement of certain regulatory and manufacturing-related milestones, for a total payment in cash of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$117.5</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million. The agreement includes an additional milestone payment of up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$7.5 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> upon achievement of a regulatory milestone, which was achieved in November 2017. The </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$7.5 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> milestone payment was made during the fourth quarter of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and is reflected as a component of financing activities in the consolidated statement of cash flows. This transaction was accounted for by the Company under the acquisition method of accounting, with the Company as the acquirer. Under the acquisition method of accounting, the assets and liabilities of the ACAM2000 business were recorded as of October 6, 2017, the acquisition date, at their respective fair values, and combined with those of the Company.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The contingent purchase consideration obligation is based on a regulatory milestone. At October 6, 2017, the contingent purchase consideration obligation related to the regulatory milestone was recorded at a fair value of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$2.2</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million. The Level 3 fair value of this obligation was based on a present value model of management's assessment of </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">the probability of achievement of the regulatory milestone as of the acquisition date. This assessment is based on inputs that have no observable market.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The total purchase price is summarized below:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:85%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Purchase Price</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amount of cash paid</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>117.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of contingent purchase consideration</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase price</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>119.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The table below summarizes the allocation of the purchase price based upon the fair values of assets acquired at October 6, 2017. The Company did not assume any liabilities in the acquisition. The Company has finalized the purchase price allocation related to this acquisition.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:85%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Purchase Price</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of tangible assets acquired:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>74.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>20.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total fair value of tangible assets acquired</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>94.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired intangible asset</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>16.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>8.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total purchase price</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>119.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair value measurements are based on significant unobservable inputs that are developed by the Company using estimates and assumptions of the respective market and market penetration of the Company's products. The Company determined the fair value of the ACAM2000 intangible asset using the income approach, which is based on the present value of future cash flows, with a present value discount rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>15.50%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, based on the weighted-average cost of capital for substantially similar companies. This is comparable to the internal rate of return for the acquisition and represents the rate that market participants would use to value these intangible assets. The projected cash flows from ACAM2000 intangible asset were based on key assumptions, including: estimates of revenues and operating profits, the life of the potential commercialized product and associated risks, and risks related to the viability of and potential alternative treatments in any future target markets. The Company has determined the ACAM2000 intangible asset will be amortized over </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>10 years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determined the fair value of the inventory using the probability adjusted comparative sales method, which estimates the expected sales price reduced for all costs expected to be incurred to complete/dispose of the inventory with a profit on those costs.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determined the fair value of the property, plant and equipment utilizing either the cost approach or the sales comparison approach. The cost approach is determined based on the replacement cost of the asset and then subtracting any value that has been lost due to economic obsolescence, functional obsolescence, or physical deterioration. The sales comparison approach&#160;determines an asset is equal to the market price of an asset of comparable features such as design, location, size, construction, materials, use, capacity, specification, operational characteristics and other features or descriptions.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company recorded approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$8.1</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million in goodwill related to the ACAM2000 acquisition, calculated as the purchase price paid in the acquisition that was in excess of the fair value of the tangible and intangible assets acquired and represents the future economic benefits the Company expects to receive as a result of the acquisition. Goodwill generated from the ACAM2000 acquisition is not expected to be deductible for tax purposes.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Acquisition of raxibacumab asset</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On October 2, 2017, the Company completed the acquisition of raxibacumab, a fully human monoclonal antibody therapeutic product approved by the U.S. Food and Drug Administration ("FDA") for the treatment and prophylaxis of inhalational anthrax, from Human Genome Sciences, Inc. and GlaxoSmithKline LLC (collectively referred to as "GSK"). The all-cash transaction consists of a </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$76 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> upfront payment and up to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$20 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in product sale and </span></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">manufacturing-related milestone payments. The Company recorded an asset (including transaction costs) of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$77.6 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, at date of acquisition, which is recorded within intangible assets, net line item of the consolidated balance sheets. The Company has determined that substantially all of the value of raxibacumab is attributed to the raxibacumab asset and therefore the raxibacumab acquisition is considered an asset acquisition. During the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">twelve months ended</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, a contingent milestone was achieved which resulted in a payment of $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>10.0</span></span> million with a corresponding increase in intangible assets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828883648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible assets and goodwill</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Intangible assets and goodwill</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:12px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's intangible assets were acquired via business combinations or asset acquisitions. Changes in the Company&#8217;s intangible assets, excluding IPR&amp;D and goodwill, consisted of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:32%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Estimated Life</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Cost</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Additions</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Accumulated Amortization</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Net</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">Products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9-22 years</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>778.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>10.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>82.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>705.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate trade name</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>5 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Customer relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>8 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>28.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>23.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contract development and manufacturing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>8 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;&#160;&#160;&#160;Total intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>814.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>10.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>112.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>712.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:32%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Estimated Life</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Cost</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Additions</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Accumulated Amortization</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Net</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">Products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9-22 years</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>111.0</span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>667.0</span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>27.9</span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>750.1</span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate trade name</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>5 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Customer relationships</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>8 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>28.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>19.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>9.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contract development and manufacturing</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>8 years</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;&#160;&#160;&#160;Total intangible assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>147.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>667.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>53.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>761.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company recorded amortization expense for intangible assets of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$58.7</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$25.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$8.6 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, which is included in the amortization of intangible assets line item of the consolidated statements of operations. As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the weighted average amortization period remaining for intangible assets is </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>13.6 years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Future amortization expense as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>58.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>57.3</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>54.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>54.4</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2024 and beyond</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>487.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total remaining amortization</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>712.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">During the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company recorded the impact of an impairment charge of $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>12.0</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million related to our intangible assets associated with the IPR&amp;D acquired as part of our acquisition of Adapt. The $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>12.0</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million impairment charge is reflected as a component of  research and development expense on the consolidated statement of operations. The IPR&amp;D intangible asset balance on the consolidated balance sheet at </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>29.0</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million. </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table is a summary of changes in goodwill:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #ffffff;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at beginning of the year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>259.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>49.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Measurement period adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>210.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at end of the year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>266.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>259.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6825394592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal corporate tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit', window );">Provisional tax benefit</a></td>
<td class="nump">$ 17.9<span></span>
</td>
<td class="nump">$ 13.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit', window );">Provisional tax benefit, adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary', window );">Estimated undistributed foreign E&amp;P</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense', window );">Provisional tax expense</a></td>
<td class="nump">13.3<span></span>
</td>
<td class="nump">13.6<span></span>
</td>
<td class="nump">$ 13.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit', window );">Provisional transition tax amount reduction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred tax liabilities, net</a></td>
<td class="nump">50.5<span></span>
</td>
<td class="nump">54.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Foreign NOLs</a></td>
<td class="nump">36.9<span></span>
</td>
<td class="nump">35.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal losses carryforward</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="nump">10.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">64.5<span></span>
</td>
<td class="nump">66.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State losses carryforward</a></td>
<td class="nump">$ 17.4<span></span>
</td>
<td class="nump">$ 18.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate reconciliation, percent</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_UnrecognizedTaxBenefitsCurrent', window );">Unrecognized tax benefits, current</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_UnrecognizedTaxBenefitsNoncurrent', window );">Unrecognized tax benefits, noncurrent</a></td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits</a></td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition', window );">Unrecognized tax benefits acquired in business combinations</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward, amount</a></td>
<td class="nump">14.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardValuationAllowance', window );">Tax credit carryforward, valuation allowance</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember', window );">Manitoba Scientific Research and Experimental Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward, amount</a></td>
<td class="nump">11.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred tax liabilities, net</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">40.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal losses carryforward</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">280.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">16.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State losses carryforward</a></td>
<td class="nump">17.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsValuationAllowance', window );">Operating loss carryforwards, valuation allowance</a></td>
<td class="nump">245.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred tax liabilities, net</a></td>
<td class="nump">42.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">199.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Foreign NOLs</a></td>
<td class="nump">37.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">34.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ebs_PaxVaxMember', window );">PaxVax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition', window );">Unrecognized tax benefits acquired in business combinations</a></td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reasonable estimate for income tax expense (benefit) for remeasurement of deferred tax from change in tax rate pursuant to Tax Cuts and Jobs Act of 2017 for which accounting for tax effect is incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reasonable estimate for income tax expense (benefit) from effect of Tax Cuts and Jobs Act of 2017 for which accounting for tax effect is incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reasonable estimate for undistributed accumulated earnings of foreign subsidiary intended to be permanently reinvested outside country of domicile for which accounting for tax effect is incomplete pursuant to Tax Cuts and Jobs Act of 2017.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalUndistributedAccumulatedEarningsOfForeignSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reasonable estimate for income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017 for which accounting for tax effect is incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act of 2017.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_UnrecognizedTaxBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns, and classified as a current liability as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_UnrecognizedTaxBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_UnrecognizedTaxBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns, and classified as a non-current liability as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_UnrecognizedTaxBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31931-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 30<br> -Paragraph 5<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238119&amp;loc=d3e30536-109315<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=ebs_ManitobaScientificResearchAndExperimentalDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ebs_PaxVaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ebs_PaxVaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6813561088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-term debt - Future Debt Payments of Long-term Indebtedness (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2020</a></td>
<td class="nump">$ 14.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2021</a></td>
<td class="nump">35.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2022</a></td>
<td class="nump">33.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2023</a></td>
<td class="nump">735.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter', window );">2024 and thereafter</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 822.5<span></span>
</td>
<td class="nump">$ 808.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year and thereafter following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6806834800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill - Summary Changes in Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 259.7<span></span>
</td>
<td class="nump">$ 49.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period adjustments</a></td>
<td class="nump">6.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">210.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 266.6<span></span>
</td>
<td class="nump">$ 259.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=84229725&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6813083872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' equity - Stock Options Valuation Assumptions (Details) - Employee Stock Option<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected average life of options</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.57%<span></span>
</td>
<td class="nump">2.54%<span></span>
</td>
<td class="nump">1.66%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.48%<span></span>
</td>
<td class="nump">3.03%<span></span>
</td>
<td class="nump">1.88%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6824169120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Earnings Per Share (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Nov. 14, 2017</div></th>
<th class="th"><div>Jan. 29, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Shares of common stock due to conversions (in shares)</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ebs_ConvertibleSeniorNotesDue2021Member', window );">2.875% Convertible Senior Notes Due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ebs_ConvertibleSeniorNotesDue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ebs_ConvertibleSeniorNotesDue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828985616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue recognition - Remaining Performance Obligation (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">24 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6812343776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Adapt Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 15, 2018 </div>
<div>USD ($) </div>
<div>employee </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266,600,000<span></span>
</td>
<td class="nump">$ 259,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ebs_AdaptPharmaMember', window );">Adapt Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_NumberOfEmployees', window );">Number of employees | employee</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Common stock issued for acquisition (in shares) | shares</a></td>
<td class="nump">733,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 60.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Amount of common stock issued for acquisition including adjustments</a></td>
<td class="nump">$ 44,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock in acquisition</a></td>
<td class="nump">$ 37,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_LockUpPeriodForAdjustmentOfFairValue', window );">Lock-up period for adjustment of fair value</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent purchase consideration</a></td>
<td class="nump">$ 48,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Acquired intangible asset</a></td>
<td class="nump">$ 534,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period of intangible assets</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_PresentValueDiscountRate', window );">Present value discount rate</a></td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired in-process research and development</a></td>
<td class="nump">$ 41,000,000.0<span></span>
</td>
<td class="nump">29,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">148,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Adapt Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Remaining consideration payable for acquisition cash amount</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development | Adapt Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_PresentValueDiscountRate', window );">Present value discount rate</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development | Adapt Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_LockUpPeriodForAdjustmentOfFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The lock-up period considered for adjustment of fair value, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_LockUpPeriodForAdjustmentOfFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_NumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of persons employed by the entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_NumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_PresentValueDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure present value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_PresentValueDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ebs_AdaptPharmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ebs_AdaptPharmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6809965648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly financial data (unaudited) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 360.4<span></span>
</td>
<td class="nump">$ 311.8<span></span>
</td>
<td class="nump">$ 243.2<span></span>
</td>
<td class="nump">$ 190.6<span></span>
</td>
<td class="nump">$ 270.7<span></span>
</td>
<td class="nump">$ 173.7<span></span>
</td>
<td class="nump">$ 220.2<span></span>
</td>
<td class="nump">$ 117.8<span></span>
</td>
<td class="nump">$ 1,106.0<span></span>
</td>
<td class="nump">$ 782.4<span></span>
</td>
<td class="nump">$ 560.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Income (loss) from operations</a></td>
<td class="nump">77.8<span></span>
</td>
<td class="nump">70.7<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
<td class="num">(27.4)<span></span>
</td>
<td class="nump">11.2<span></span>
</td>
<td class="nump">21.3<span></span>
</td>
<td class="nump">66.8<span></span>
</td>
<td class="num">(9.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 46.9<span></span>
</td>
<td class="nump">$ 43.2<span></span>
</td>
<td class="num">$ (9.5)<span></span>
</td>
<td class="num">$ (26.1)<span></span>
</td>
<td class="num">$ (3.4)<span></span>
</td>
<td class="nump">$ 20.9<span></span>
</td>
<td class="nump">$ 50.1<span></span>
</td>
<td class="num">$ (4.9)<span></span>
</td>
<td class="nump">$ 54.5<span></span>
</td>
<td class="nump">$ 62.7<span></span>
</td>
<td class="nump">$ 82.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share-basic (in dollars per share)</a></td>
<td class="nump">$ 0.91<span></span>
</td>
<td class="nump">$ 0.84<span></span>
</td>
<td class="num">$ (0.18)<span></span>
</td>
<td class="num">$ (0.51)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="num">$ (0.10)<span></span>
</td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per share-diluted (in dollar per share)</a></td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="nump">$ 0.83<span></span>
</td>
<td class="num">$ (0.18)<span></span>
</td>
<td class="num">$ (0.51)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.98<span></span>
</td>
<td class="num">$ (0.10)<span></span>
</td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="nump">$ 1.71<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6825932576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined benefit and 401(k) savings plan - Swiss Plan Funded Status (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionExpense', window );">Pension expense</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, beginning of year</a></td>
<td class="nump">18.2<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets', window );">Acquisitions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">18.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Employee contributions</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Net benefits received (paid)</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlements</a></td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Currency impact</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, end of year</a></td>
<td class="nump">20.6<span></span>
</td>
<td class="nump">18.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation, beginning of year</a></td>
<td class="nump">28.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation', window );">Acquisitions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">28.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest Cost</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee', window );">Employee contributions</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial loss</a></td>
<td class="nump">7.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Net benefits received (paid)</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendments', window );">Plan amendment</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Settlements</a></td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Currency impact</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation, end of year</a></td>
<td class="nump">35.3<span></span>
</td>
<td class="nump">28.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status, end of year</a></td>
<td class="num">(14.7)<span></span>
</td>
<td class="num">(10.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax', window );">Accumulated benefit obligation, end of year</a></td>
<td class="nump">$ 31.0<span></span>
</td>
<td class="nump">$ 25.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employee which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DefinedBenefitPlanPlanAssetsContributionsByEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=112275985&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in benefit obligation of defined benefit plan from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in plan assets of defined benefit plan from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=112275985&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e2709-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=112275985&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=112275985&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAmendments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAmendments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=112275985&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost (reversal of cost) for pension benefits. Excludes other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6832000608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - PaxVax Preliminary Allocation of Purchase Price (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 04, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract', window );"><strong>Fair value of tangible assets acquired and liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 266.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 259.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract', window );"><strong>Measurement Period Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ebs_PaxVaxMember', window );">PaxVax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract', window );"><strong>Fair value of tangible assets acquired and liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">$ 9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">19.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">11.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets', window );">Prepaid expenses and other assets, measurements period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">57.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets, net</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets', window );">Deferred tax assets, measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(3.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(34.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total fair value of tangible assets acquired and liabilities assumed</a></td>
<td class="nump">70.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired in-process research and development</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Acquired intangible assets</a></td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">69.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">273.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract', window );"><strong>Measurement Period Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities', window );">Accrued expenses and other liabilities, measurement period adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod', window );">Total fair value of tangible assets acquired and liabilities assumed, measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets', window );">Acquired in-process research and development, measurement period adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | PaxVax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract', window );"><strong>Fair value of tangible assets acquired and liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">19.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">12.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">57.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets, net</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(3.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(33.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total fair value of tangible assets acquired and liabilities assumed</a></td>
<td class="nump">69.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired in-process research and development</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Acquired intangible assets</a></td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">61.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">$ 273.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses And Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Finite-lived Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinitelivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Expenses and Other Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesandOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued expenses and other liabilities, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in income that would have been recognized in previous periods if the adjustments to provisional amounts were recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=84229725&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ebs_PaxVaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ebs_PaxVaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6819032256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value measurements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, beginning of period</a></td>
<td class="nump">$ 60.0<span></span>
</td>
<td class="nump">$ 12.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Expense included in earnings</a></td>
<td class="nump">24.8<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Milestone achievement - asset acquisition</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment', window );">Measurement period adjustment</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlements</a></td>
<td class="num">(67.1)<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Additions due to acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, end of period</a></td>
<td class="nump">$ 29.2<span></span>
</td>
<td class="nump">$ 60.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Measurement Period Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6827273424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 46.9<span></span>
</td>
<td class="nump">$ 43.2<span></span>
</td>
<td class="num">$ (9.5)<span></span>
</td>
<td class="num">$ (26.1)<span></span>
</td>
<td class="num">$ (3.4)<span></span>
</td>
<td class="nump">$ 20.9<span></span>
</td>
<td class="nump">$ 50.1<span></span>
</td>
<td class="num">$ (4.9)<span></span>
</td>
<td class="nump">$ 54.5<span></span>
</td>
<td class="nump">$ 62.7<span></span>
</td>
<td class="nump">$ 82.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestOnConvertibleDebtNetOfTax', window );">Interest expense, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax', window );">Amortization of debt issuance costs, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_AdjustedNetLoss', window );">Net income, adjusted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.5<span></span>
</td>
<td class="nump">$ 62.7<span></span>
</td>
<td class="nump">$ 85.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of shares - basic (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.5<span></span>
</td>
<td class="nump">50.1<span></span>
</td>
<td class="nump">41.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive securities-equity awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Dilutive securities-convertible debt (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of shares-diluted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.4<span></span>
</td>
<td class="nump">51.4<span></span>
</td>
<td class="nump">50.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share-basic (in dollars per share)</a></td>
<td class="nump">$ 0.91<span></span>
</td>
<td class="nump">$ 0.84<span></span>
</td>
<td class="num">$ (0.18)<span></span>
</td>
<td class="num">$ (0.51)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="num">$ (0.10)<span></span>
</td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share-diluted (in dollars per share)</a></td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="nump">$ 0.83<span></span>
</td>
<td class="num">$ (0.18)<span></span>
</td>
<td class="num">$ (0.51)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.98<span></span>
</td>
<td class="num">$ (0.10)<span></span>
</td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="nump">$ 1.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares excluded from calculation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_AdjustedNetLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_AdjustedNetLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The after-tax amount of amortization of issuance costs recognized in the period associated with any convertible debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_AmortizationOfIssuanceCostOnConvertibleDebtNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1930-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1500-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestOnConvertibleDebtNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The after-tax amount of interest recognized in the period associated with any convertible debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestOnConvertibleDebtNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818680256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Defined benefit and 401(k) savings plan - Expected Future Benefits Payments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2020</a></td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2021</a></td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2022</a></td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2023</a></td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2024</a></td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Thereafter</a></td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear', window );">Total</a></td>
<td class="nump">$ 12.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in next fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in remainder of fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in third fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in second fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>152
<FILENAME>0001367644-20-000010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001367644-20-000010-xbrl.zip
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M.,Y7!KR>+%3/X.T3 73U 1& [J=V>&]:-#6$JCP4 8OC1$#F%5(3")\AXD1
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MW,\EH^H]V2) #W(@.8)L70*6IN;+@VG<M9A!<]G\HBF:E@"K!C6;JTU([T7
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M&RV7*XXV'QG$4D@31S>0L\&/>Z':8G\7[F*_)!](2?<_8"MAPO6TKV^Y5)B
M08?S\SO"L6&,>FK0;D/U&!*/Z3[&=69A4WUM1BO^]3;F?^_;F%_5E8D;OZ*S
M=42,ZR;DS<-_XC5=--L&O,I-0H]:1X"\PYXX?N0Q= W&P></^[GG_C[8M7[-
M.;Z]^"5'00Q',+]L=(R!Z!A'YG>>\9S$FX%S>Q!9=(L(XY<GB,-H_J;YN39:
MSWR:'_\,Y0I$PZ%WG$7 "CR\20.A9$]@F^H9*+# <O8;-PMZW?&[+@!$I2'2
M>J@-1LD68QRW:!^,_2_G1B(IP_$;XQ]\\M=]DOKGZB4GZ3<@(YR8Q@R[S)5"
M:U]AI.O(4#8&W--8+0SB_$0KN;IH4EPL!I6""%3J[T^$P$.T?ZY?^GX#,Q^D
MGIHCCTQ4L,37PZAJWCN,3EBB6,F9ND (1UN,_=#<RVL[?UU-?,9^26;5!YC(
M8SR&7>-YS=",4:2@[ YMRIN(E=9"VYU8"AT.Y[S'6+A "8K>]_>'\+^F'Y!V
MP"_I"HMFH3NWO=('5<-(<E>>.AC$QTIU\^0 A>N)14[+D/F,%S;3W';H1<U_
MZ_'^3NAWND5XH/HW0#/IE^8I2(J >/)T'-]S#XC1\J=#@NYPRLQ0)#1=>6?^
M\.JS.>>:W,\:G\7=CH&KG)W[TNZS1T<)^?GY[!7/SJ2R V-7V_IKAL5U*'KL
MM=Q^NV5WRQZS7N7W1C^ZCQ6]8L0%N/M+?BFN</%9.E1V3?VLF=CZO7V#%X\?
M=!0S$X\NL98X%V1?73*X[/F?[<55[I85[3$C#EZ59FKGKNSVW?'^>V3 'F^O
M[TF"C365-;P2EW&7%&G(<\C&;<PB@Y!19R29XN-,(1N[9*M:6G-6%K!\28-O
M>@UHX>>GK^ENJ%;Z%A:32W@[:-EV.L7V=7$U09V[LB#;\D)O:A+K9ZXWJ)[,
MU3Y9MH.?:"17M*F]IJ.>O75-4-UI_R Y!9RLL8EF_D[;*U[/+Y@DKB@3OQT?
MX%/[0G<'(8J@DKW-CL38Q K:]=1F9O1!U.OSS]PWL[;.A9WFP.=3JP(C:^G2
MH5G' _:46.?^J>7XKN#!<&_BLO9:#] A-_;]Y2&7'NT7$[KN\2Y:%2Y-Z:]?
M%]UWV?U )SUJZJUG:65QO.6U]0?*BU[%3/R8Z GI:L^@&YEK;H\E02J$==VV
MOC)##=4K2[OB1\[CS5YQ'6XM>9'T8DRIQR1))SUIC-!F9%;Z]+/5A]'H-6>/
M$6=98;2G3EYNADIAY.L#-[8S!Q6CKU0LK=RO[Z-\M;K;>)]OME>0:IY7[X=G
MA=X^1%[Y^8+#H]U&H=\*^SY[R[S7SVMGCO"M\KBR5NWX@ZV?87^SX,;>_/9A
MOH^;FT]@>7U7] #\0U?IXY=#]V7/H>K=*7JR.EG9Y]IVXPKD7W@;'XUN/'-M
M(RB^8K'>E@_5^/U/7>W9WIL8:QRRC&(IVVM/>WW,L):*:1 $P1Z:K[8HK+MR
M<4;SH.T-@U>.RVXQ_-]5*&]I.''6T70KU7Q[EHJV">'/G-8\,=O$P:TE6EUY
M435_DJBF,H.6:V+IM:7K'AMJ1K]R-;7VSUE,*_#/K#!_%EI9ZC?^6D9]]].L
M2.M/)]8Z)M9WW[.1,3N_]&O?A4J\<\$.HZ;"L-&WDX=O8QRXO>1LYUJR5:O^
M\,RDG+?;YM8K%%F\<],DY*.6GV/)EB0->80C%A.(;L87LS8"U8:6U'4E?^]H
MK\/#O-7OM',_.3.+-]KNBGR19A%UK6'GD>;[&S>_LUG#WKPM:KM D:3"#NJI
MWJUZWYUSC[,3D=/0,'ML[B;_>(4=!^ZQH5KVLCQ-Q1V>*HI-*&CT=368JBH]
M.*).M[ISD>TFGY$PL'7-"_R=7'(+MW/MZJ[<HZ>&S';>V6!L)6&08\]SRCF]
M[5Y:5,-UPS">W$7;-U:INHHJ1[2LA%C>_DFTX1_\W>N%^1L,_X0.7+RQ'?S*
MX@P)XQ[@A6Z>X7S\M"Y6L?WK0-Z)06C&,F[E+YF? /\KQ<G%+<&J]2B,$30/
M-TL1D-MA_:72 QO.EBTEC'_8B*;;@6'>F$K^U(XX2]1W( <SSOW,RA<.YK?W
M6N:49&7%9CUSK<FJT4@PR0_TR>QA6GMFTG><NF$VNM/W2-YZ&XOU=]_%33@^
M) PU\DSD.GRG72P?%)-E?8S.!*K7=2>O+,H9,5J2Z!=P32Q+V%%N]? *GY?O
M<VT#TJ_&B7?=GW]QUB@L/R!S>*IE1P;KDIJ/,.:^M?),I9ID0[ZF3>KV$.[A
M_,/Y#:E*84H[/[^VKSNM>;D]Y-G@RU=$8]4C;IK%6^&@Y_R5:]Z"I3^=_G23
M77/G>(;#\Y$![JK:<KN136]?:$A'WE^^_<K+3T'$&0TE)Q4K#6D#ZV6A&<96
MZ^*#4O^ $P>@%:KZ/DH_&!,Q>PQ\MQ6_5Z]34[>LTCF[?$EZ/,'S4)=[[(=A
MRK1E9._JR85-OLZGY+)VBU45^\AWO!N1#':*.?3ERX7"*.5%YW4E.[O[%,2+
MHG:?9%SBE=S*C\-/:$G'U,X]I63#MGO#:SDC_.XZ24/3X#=N. X:>2/M18F*
MTM.D;+<OKB/5'A\2,EJ>6;,_(7-41XN.B>?%@J89L:GIBJHRAZ[ =<E#=6Y2
MT34DH]+.#*YN)*H\VDU2#S_<OG[+'V>.XHX=\CL5YKJRKWZ[29;GEB#QWJ4I
MQWPZB\I2+(H>MG_GJ-BDV*6>,E=5262SDNRHM^A_/GOKY$W@7ZS='RNU];V:
M286E?AV;99SVG+K<5OEV5G3=QQ@"*R%O>BY\V5=.F*O+@BW<4YIG[5["B(/1
M/?>(W)NYQG9C[MO'<SVF9:\Y*"_;Z:GX_M*Q&O>\4UL[O^UWBCWL:D"+-M[C
M+_EY+.>!>U&[""CY)@@(RWW:O#&V;;W-*.^8]XX=94JQ#XW;#BY6O"]]LE&[
MKJMK4/:+<^..T-*"IZ["FZ975I2GC&X[T6<I]KYJ\&C&#Z6JJOK'==M<G3Y[
M7:@V2Y.<=F!X7>'T'E'XSN[?3*Q5-1(!#6Z;/QJHFCJ][M#_(E7;OZ-MQJ?/
M6FK,;46Q#TW&DF5?'.M4XA(Y28[2OF!LPO^0)GG75X/.KET:4W326Z'9+#8@
M3_4JP]:)6DF1&4]M#CBJ<WW"3&#=@9PP^$!=DN'OHYI?%F9@F6(96:WN/>[[
M?"*\5Q]:>>.>,VS76Y9H&O.S,R+#V,PU-/^>?;VYY J20HB'0Y61EDY^3&-[
M=CA#3V71DZR8:VK+I<+>;X.?NUU:8W5'RRYC2WIV/O[6SANL,5/)!^SA[],O
MJ;*VBZ+K#NN?ZZ0*,\S%DCI2U=5;"L:D6V['7H^I.WVY<HGLL@2K;50C_6>-
MAMGC^L<NI:Z\P;?!Y^'B_B7?_C^1;]^NYUGN'CY:-?/X\<SK/[_W\]MZ>4R"
MPS'T8(?MP4JM<O&>5UKEMQ>]U"YZ^;)]D'!E;+FDT1K<NWA5HX:VVLWK>Q7?
MQ6OM_#/F:^_"N=@LWLV*TIMBS[1 #XL.>]>=U^V>/[ML_GACOL=N?^=>OY)N
MVX/.A=GC]LY1"8%7[GT;[RL/O$C3\LIL+R6[,AZ2]J#MS)6D!2>]E,"(*X_-
MZX+0,D5>A_/*2(6'LLX]&S[''<SW#G2.=#FWX55UR0.G>U'?^5X3ZU]M_*(>
M%3A-"Z$I$)6YE!I>M1$GI# KJ^ZG5U!H:K9J575!YJC#;HT4BXX#Q]\KKXZ?
MTJKP^N-5<AM!5X&MX!A/&)R;Y*4)X]0Q_IP_G*K32K3U89%E1Y+M@B2'.\^_
MF"Q^;'NXK+R\LN!BES:O0FMLE]^+09V7G_<%+JJ-+9URF2L*$ 'BM#.T4,H*
M1-&']06B5RO!H=0]7QHR\N 4-\[$O39&X,6[==KZGRY4=QK<3_ 4J_3RO?"S
M>7W"GLZO]6[#=*E!)Q6_.TRN[$]DA\;Z)@U6YY;U;A91^7?2@A^-;CI5%<**
MI-N\TSOA[KG+73TZ+:IE,#AK->.3W=-4-0*U[Q*L*X8+?01&TH<J3:5D- >5
M&%N++SZX<_X4)IJY<D-A]0XMA0\&TI:>VA!2=\I_V:#FAV.\Z5$#M]7XI]^3
M:W=Z&-IZM;I8)KXRO-S3Z+LMT6%[V9*K3F>W/UM_YNBKIIS(M^FW%G05G[8P
M^AYE\37A^4AFPJA%^?=7JZN7(4JWZN*(F^ KJO[%M!#]73>;-*' /8\*XNWB
MXD/NQ"\U[J3!=N R:/@^<0<FTV5K:4@NM:W3:CUM>\MEB0M=Q-<-)EEM23N*
MKHDI5F;_F"I.N?S]PE'==RH[3[_5U6,K%5@_W'6FY\;ZE&/1Q6"7Q"CRTC+E
M\8Y[[F?2'_9 YX=IT\JM(.?24VC*'M=GI"M<,FV-J'A1D,23?H@F+H0V;6FB
M#+&6L?"H'08'$N$L7:$,(XP)[R<XBH!$?2%5%OJX\F [>O:5","R[%U2]Z0@
MH^=BF5#<4PA^MT^:PZ.>;C3H"]\+XSBY<"1GMA;D'&/VA#MP\752"V!/RY?<
MP(@7DP$X:4)W+5\^)K\ OC3XP,$GNLK%H:@L:I?&F;+0U+T;7Q,FV$SC2&7H
M6HO@).EMC1U$/TP$6'M%0'PKA]&.-B3/OT,82* M)BWW87*.@3T4>O)0#3.$
MWQT^ ZV&HU1M3;M,E CJ]FT&JVDL%[CWH,L70YN/%Y[_.'"Y?@5G[N/K,/;J
M"^MZ]&V::/V743JMX)H]R&G"-+^BIA2" 46MKK5 -@_A\ETKKP_^4+L6LO7>
M&)0+7S@T,-J5?]06[?TP\?YXE9+,O;G75&^;F-?GJ?Y"%;[:EBK"=<KS<L+;
M>TFK3\\-Q629Q9C;"I37?[^4O;^$T*!2>=_J^>,YJJ_T1XA^$GW+G+Y, T#.
M-%%/!'Q_2E.!!LHIQ7[C<X/@)UV7UDH-;M\ +=+ G8MG'6T;2<;5D\/+GS[A
M\7J_M+Y*WJV%D['V7W\QW"$Q?J-TVO9==@X>PHLB($Q%B"'K\/S)FRYB/O]6
M!VET'*0ABGH\&V$244P@[A,T>QLZR^S!K'3^!.=Q7C0'D%<2Y6'W]-%(K\#\
M+]J=E4%A*2P7GU>L5TZ=&C$;[>]O=;^K?_XM\PYL.D%C;[J(ZQ0FY*/%7]'W
M#I?M7J,5EDF/:W;E]'_^G%OAUDLI@ZO&(;8B=[+KQK,T-.\[VOTII[R28I_[
M?KRC-SBQ]+M7(!A%YX*LJ/A\KA[K;6'\\_Q!FL02!W$Q)U7\'\$UXG<)F2(@
M-(-#0Z/\Z&1$UUA#!+0$?;%>07"5MC'695TY8'_@ *<K)"?BIN:ZG/8W]O8+
M[/<NV L 8KM1:>H*$?"QB$5!-/1!U+&;/]1<QYR6CJ/JY@X^+AV;F2&5]^!=
M%<+A,48M<UJ2 H(O!N1Y7<QC5\>RF*Y7MX*L<PC&I]-3.%B=6L[ JN14?XI&
M/3.4=TF?RG5A?97>K!Q%$ %T8.&X-.E0R>6ZHE4[C]\@R'_$_&G HO 5YG<S
MY#M&\=_RXU47T7E36[I0'$=8V1R?X#)L=$!V[1^WCSN=CS_0M,&J:\UQNZ\R
MRX^Q TIUU:/[4D9WSCGS.NO/VGW.KXAZM*ODL$VYES\G#W[Y<+PKIG%LCNA7
M^HBQ)2?CAJ-AT>,28F&KBA/\A0-=:JRGAKL\8CV F?2>&XUWQP/43-4J8J5L
M\2MA)BJQ+8-PO;$;6P/SUBFN]>WIF.-'38;JW.NV.S-]M'ST7/I'@\2*=Q2-
MW&XJ/,RW[3^JY[V#O3G54O[U<JF1/XJ+Q->];9)N6O>V8Y7Y?JG$CJO4R$I?
MP6)D S>;/(E<X'='3FL=];%+<.I"M#.?I@A3 J[[;WO= 19-#D52]:_[FK&R
MDGT(Z>4*D\;I-1/KIMR#?X*R'+<=I[>_>V&B,K1&;,L5?Z/+[Y);AO]\)K2.
MFVJV^\"]5BU#.-<U6W E]WC6G4?V!OLZ@O,MT#36U=UOQDT\DUOJ[E BO <V
M)%KM.GTM5EWYH'M5YJ[V[+B!J3NNQD=RW78>+O'NJ-DG<(RP>YIC3^[AZY1Y
ML%T5#W(5DBYM^)#T8D3I;%$68UWQ98ML[_L7F3UZ9O5W='Q_J#,5K),V?A4K
M>#7RP^_!A9U^5<USKQGOQQC&0ZE!G=HFM2T6[>/Z^3MZM;1W6Q84MU\1[%S@
MY+MEBS:[N*@D8MM9Z;X^4SF+UP^CGFQY5U?P&E]XC#<:*A^5N(N=J.0C;:1Y
M*4-S5-H^Z[#>A4M9FW\:74JY?,S+HLR?>]Z\LW]=16W#\XLO2LS#8@*7.<2L
MO#K<4/SDW@8'_3F[;XO3OZ=$'6Z6LSGH??K_Y/,\F,9[!6L(_D3P"6]\!9IH
MWPZH<''00D(B\9)J]W@S9Y 7B676W,R.CXQP5UQC_P8.EY.$J&NY/\_3N:_3
M4"9\]72Z]DJ%G_ZB$?)O[P^D=8B 4Q18ZSXU&S^"E3>.<\Q&'U6KMY/6E1%0
MC1[-TV"[LUM?LX__:C_XA+@7P2-@Q8(&_^"/Z#$JHM3,/65O!]78!KQ;]TP7
M.65=6RTOITF>TZP< /0Z9JDCS(S&.Y6;65:XJ)%+.HK&=2W&U 2[FDK*LMOU
MF\QUPSR41( 3H;(%&.AK.'ZET\#QX>:?.PWD=;\Q,CUO?S[!_G)!+I>^\UWX
M<I78U$LK3G\H>(!HI;S;<+\<=.3?/_$@-^?Y!KS/A*J&,CW.:NH;ZI=#'5F.
MKO68/W"S.-H-<B5,Y$7 S\Z,7[111W#P(]QRVK!C@PB O9II_'7H<X2*O!<!
M,IYLJE!R_F!OY=R0"##%_^6:5$JO%G^_"(@X0=J"L6#;  :RGQP*(3/G?MT6
M6<.I0$.)&.D.>X35T73=4<;;(<2"$D6;-ARP1G8/4822\U<+4;]S__%%9Z :
MXK63?'DN#56Z[(=&T/) +0IW(TD30WKF+9 SF0I-&PA/S.'GJM)IF;IP:!*;
M(=Q@>%($U&V"L;UE.)!_V?;O'?$"JGL(YV'&DS""0:^^ADW0/7_'\SLO"KU+
M8RO@H\'I>U_\1<"J#!9>!.QQ!G_9=I&H(P+2\,HB@)6-"9/AZ+]>1/NUAPU_
M<S?IF]8  U&.$QPA,42 ;*4Z-YSEA\A''VLE0@,^?>]-Z4%/TP3+B*K=6\9_
M8-S;W/1UO*_6<3A#._&3KZ%]5=2V[;B-)V38VXM,E:G# \(HV@#UICN*.Y%Y
MJ1')T.-A"Q^*PV/<YY"4[$ZH7D?KK5ZU"OW[J_-JXN$YW^S34E@O7YTWK6M_
M5[3E9);5ZB,73![E"+9XK,_2+$A)3N9Y:VY/XDFU3M)7KN5DAQ2=C([<MLM,
M:TTL>X69C]FU'1J*4?1&24>=EHMQH1:#6]?<.-1E?S' Y8Z7E4I\L+WRY3O0
MV5^>+GA#='FH!@^-&"2;HUIZO"O8*A/<U@@.0#4;:0.9N!)K^G5R"%,9&BCH
M0M4YVOU%&3X_1\H]$=F, 5SXA3Z[CSI*8Y:/ _;HLD\&QF7J5>C'J3\[DMFX
MT?VL S)$1S#Q6?O9K_:S^0.ZK.V"^*&'5SWNA,D\-GJ5>XKS(#G@6:.45;ZS
M7+9]@_9^ ZWCP8GWGAWT)B6QE^R+8:<N9:>JM&2'99$_3!TAN83DWGE\V,G)
ML?Y8HN;E.KL,LRJGX\?C_1.-Y,]F!"I=#L(U:,L+UT)U6V@*T,CF\B%TK7DM
M#0TJ_G<M)4(AMK_!K$"A!,P4 9*[L, X\-<088!P B@/#?N]H<"!#)"O])><
M[6_%MRDB^UNXGFA\R@N(+4?$2/E0GOFOFJRD0IG36H,0HO^5*93^Z^7>(X@]
M%J6TA1"+:8P%J<_\Y=Z?UP]"A_#<Y;KU%/[A"UC,1MAP,+F<FH_[9=M.$T7H
M(S4&@\_V!&CZX%]OA$;J<1W1L/D7#.%$;%_3J'^Y$?I^XC_F!JQE '85 ?NK
M,?OI5D=%0*LBEH+^Z'I&/9ZOS-% 57\RT+!Y#,!RI]AQ.A3+O,+YBVZ93\<H
M<"A.0@3,C;;^@\9?^9?Q2^?^@]<B;BZ_&KF["U\XA$C+\H:%=[YRBVE%0XC\
M.&R/KM,(3ZB/>0[5F)"6P+G4I-IL9]]5+CN*N$:>+Q6&ZI32'OJ>4!AO6?;X
M9-]>VY]XQ>IXHEACJBI74>+,:TBN]=U/C\0M!D<:=5LV_3DXLV52^YW/=>]7
MQ#%%9\6TD#PEXH.@1YTGU76<FC^ V81=TQ[<1701( W[1Q=5-H:,?7MH^5Y-
M\[[+@^\EW$+^#\L''M-5H5NLS(,S=N2Q1PYGFVRD:&_JN'<R,P/;JL/W' =O
MA(^?PA+C<EEU4:H 76Z:.:IP[(N+9>!I<""95E2?5ED:2^AG=T_8$,VO^5:W
M2S2+4Y2*[SXT[G X Z!-CIP>X>?_=A+QOVZRO/ YPDT**<GW.<GI)[,A*>_J
MM1RZ2W:D_AY#E[;)&8I45>\:7]F3;?DZWSOTPU[?6:/=;5-:JJ?Q?O4I9Z5O
M78_=,[S+RANR%:*SG+W*9IWO%QB,!YTWL@^MRFQW\SX^NKWPX"DUROGX_CWC
M+^)ZGB_YUN.PC@[/"BD90C*J0>ID+D;F7_7'=]$\*>%=4*%G#;//DL['-_BM
M(IZ$+].*AQ Y^N!DG5](JD9K,5F,P1+C*A']X3X.HP8OZVO>P%3&OAMZ4FFR
MB<L(S\^$+3,9K#%)SX:5"X2D$9(6IZ'LV5BY IFMO=R^JW+;GGQJI'Z,H5.[
MWXRUU.?^&E[*[AO^5L7ER3\/I?Y@SO(^CFYUL3 &*R-=3;PK_/*]%(-2T])[
M1Y,#&@HR>T?*RI\FBLT\[[W_V/.YP=2(86"7]+ON^U=[,[R2HT:Z%;?62W)?
M5BF0#7L\IT3 7?(GA2&>!YFM@:QBGA F&%  9U);&:YHJ%' @#575@Q4".5)
MNJ9/RL8;DB@J);2^^U.+="/;&Y+])AJ,E2^QQBBQVL)\/ZY\P#"B3^O18I^Q
MFN6M[X3.:@A?8L6PE%E$J9GL8]++DZ+ <WZ84.69<!QK)WOU'(691!R7/!@>
M6[V1B;X3 <4;*8/XJ&K%[G'BL0O&UP?]PI6JB[S8%L@VSFCC44SPM%NWZUM+
MPOA:YRU*-T+VXCH=@MDB0(*0?L.[F^ZV@8.!F0[1,+<Y';[--.TJ?N_FN]PI
MU+0ERV>;5W?@=J^@>X=,+4Z12F?/9?OO%S=H[>9B1&GQFX+B$F$U-$ AX83)
MT^1/XI:<23KM4_8@)40$^."P^EZSVV2C&W*\S60'80F=SI0H9H: JVE>$ZZH
M&K(;([&F#:DZ</-9?E(M(YRR2K81OR8_0)D<DYP48>RS)^MIACR#I[?WW]V_
MV1<0X.OA>^G:->,=I??OMO@'!/AON>C2UU>C;&G\DZ&U_AA]Q:$VRRTOXNJ5
MBIK>1AU*I9E  ]G)0^.>+&8/KL&H;(([:,"ACK=FPQ06CSJX1PT3;B]+8<H-
M%E71JUJ3,UFK;4KOU6S))9JWHFN]^7)*9E6<AMW7HZV5ST7G>"47FF=(FGW_
MO.B'MF*#B2P7%^[.#0Q'K%D3_K5%+B?=#K)=<2YM6/RU>)T]HQAH,^:@&*CD
MWN?\X*S@R-B5TV53F3\?+S31'C99]]'8-L.)$$UW[H]CJXK;AT\HG2U)&[UJ
MU)"04_-=WR0@+.LI(\#CFG2BVMH-Q5/9#YX_[,\RYQ[CF]^Z0))$KL*S+$LJ
M%A<#L^-K!(<Q=Q^#!A[Q&1.Z EED#9S&@1JJQ84/,/9/6=Z$+N928VE>CY4'
M_")FF!A>4R%O*=41$X K-;%V8(_2#_R28:8DLN=&)H&&YRIDB,?^:!P&Q]][
M"#3[B6;SOWPX7"TI?%*I+C# )M*=D8K%%3Q76\AM? />0<5A,8Z4/=QO(K4O
M!^VDK:B60XY]I.I3E\'7Z= JA1;6QEO<LU+!O;Q;S_&$9$&C$BF1K2K5L'UL
M]OX37)N^FRXGLU\MI?XEG$2?@IU[E<>BR3+F^5[QYQ1X?(_Z^A=9QOPVU]*'
M*W8H.B0Y=!<V7RGH/>G"$*.;;SF^KN^CL6D:(<^\'3%E/?:QX*X,SMNK4USE
MM[_C>4",^O%2G2:=+09[=ES/4VY:GO'D?B_;:59+9_RV%NP-W^":#YC7^<%_
M&"*RN %RN(DA<6%P0[6*\!DJ]0D./P)'8TD27KU)F(BJC#G@%6CGJ*JPNRGF
MC$B"#6(Z-,(LRHXIAI:/EAHYA@70QM\[-C 5'%F/4Y,"5=(';4K_\A>J),>"
M[#"(%Q/G9"6%H^)>R6&W!$[GE$I+GJ%UY?T4K"@:!?B098G+X:M76J >!56=
MMQ\D%T[1][865]!ZM>BSA:-!];2&+YXG.P(D+61MBUNG[TH-Z_S=_>?_M@O*
M__/9Y^_K>]WWDN<U/\G.K([M?2?[3M:K\&85?C:T6B_F'*;*?7PO6WFY?IW^
M9;-WL<^?[^/BEY/>48K(MRHM3PV"8LA">#,+ISCB9YSL%U6YC9.!"?5PQ"*[
MJO-1;T#+I[%R\_#S,R[FK]I_7-CBZ7/]5;+/KN\E=XMEFI6OQ\@M:/9"%W!,
M$G((V0YMB"K+=[<=MZ51(\9 "[=RN"L0U8G7\MK"AN3<^ISJ ]B*L6TGM&UF
M(OU.:']A'5>_:OL=72U,HIUE+!Y+MHY$5 4FR"H.)5)_S=?RC\@^%C6$)G5%
MTL_\]?TUVM]>M97X:M#O!X4]-KYKN67[44__Q62Y>+-W-CW6Y:U[56CAQM(#
M3''&BY.P;2U)B?.^,7+F1 !3FL&:$+=HW=@]\[JA9R;F@JO.A]897P>/.8^.
M@"6OJ^((UYK6._[J-Z\=-PQ:+R#@V"81J#(</# I 8_1VT[6$/B*=XB[,@@9
M9M<K3OU16NZKZUK0L46)_=ER4]C5LNUU&^Z:C545=;7N57,<(-^BB%6O&4'7
MMI%4$'7XU("J;OU+4Q_V8\,:O!2REF4I)>/B4G/-5ZR:YOGD7&] :='B'?P8
M1-HTMSY [F+_E[J(@B]6A4Z=)LN1/[H027<._01\@C/H"/ME-?OII Q(6K^I
MENLPELUN]M+O5BAT@JTF#Z70>63?2Y>,>9-^V68?W^L7UME_O>IW)/VF<2"=
M4M3XQEI\I%^CS7@#QYJ%"YVF*?7V.L%8F9JD6R\^=U5-J_"E3UA!$5?[?M*3
M7N<Q7JEOX)6NTMYBQ[M]!N\F),S:#[FT&NNQ_"0)NJ;MB!Y+2FHX58'S/6%9
M6=NTU$HOI:NAZ2.EWWI-Q<(2LEQ.C/".)5WU5RTI/G3B8=37!)>._^H_@_(N
MA8<Q[. J=#W:A"NDC@L$.B/0R^Y;E7[9R"+8<H :ZD#:6@E/LEV7_*SK0B5;
M!]K4NWX4GR.I>+_T2AA=)U7<XKXD+5"^,E[_T@=N:-]T&6(NR<6C<8,<+%]E
M#.M!9!2;?M4P]6<E5L99U9@>:#,FX2"V&9PM AX?Q'%5#.LAOCF9/HD<8LJ)
M@)\Y3Z2F3=-I'WZBZF'SIX"'N#"V^DAE-@4-D(/J+C+E1<"(&BA%XZH3;47
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MR=;]69LZ'OA^7INGLF,;E)W\3P#X#M&&B()1* FZ?[!%J*C$[RKFZ3(B]<3
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M0@6VQU0D1E6>[P^#J\2 WX6(?6(@'N2T!-'K=-JAVH-BX*6/2![L=Q4#*\4
M%2^<+43*[HC.T:;+T2B_5/0V_7%*E*WFG+G@!$V8/+$ ==#'IQM9WYV%M@V)
MX*S*'Q GF9HNLO@)0;=$N7]9X5,Q$/NK"RV+VZ"2<E1.#*P&%\:<>3YG?%+F
M0/E15#70JL;E?$Z!OUR I7J*HZW2@7+>GG<>G( D]R']=0&6>+AKL+F('ELZ
MJ&_C]]RP6?6[=<P/KS=%=/(MKQ!FQG5ELGKCY2^_^[CJ<,FV.BL4R_1R5BD&
MNE3IE6QW#-M*P-G4W_=Q.J)[T"['S*_*/W5'M6E#:R/E[I#!^86LI=K9]^ R
MU><>"8^B\F(;O UW(D<,Z [KAAWE3MM=CM[^QMUNW?@)O_X'9G>^13'*Q0 2
MR^#KB(''/H*C$ </8QHN*Q7/DX,F3_^2XOPTC(-!3H,8L-!"9:MDD1YW'HWY
MUJF-?#27U%27YHA =IT:O-RX(I+!";BU*W3 ]<T37LP=A2?&[ANSE@4\(%C1
M#I:U%56ZYI7LB3Q1EM$M.'W1;H!+3?HNRJ+((=-3KYKI2,UT3=F07I=AH(Q-
M-]E1_5X1<>*2O['[,MB669V'I-1)\RO(>UQ6*9:W5S]Y0'!*.-9YKF,#/B:/
M+09NW&G:V5?0:-)XBDQ8Y47*71T33*UM7\QU^]/[S7E]R56!J\[\7'P];E+9
MLKKP4)K>J0L:"CXIM>QQQ] >U@E>PI@$P;#VF[X)^S5WYQ?'&QR;@@5+3=F3
MGC,ZC)V?X#_[V %LSI_M[YUKO$GIA\)VWJKECFC9O_<(_B-?E3J/Y3%R2F@=
M;1:#N%^0< NZ 9IIST8WZXL2P-%[:#L+L1::B(&1'&)-0S51:8C48\U;-E\A
M(-UNLN;E3%-+'C@(K")KA@RN[VYL..J7S6N("F07$W!(M-&.TDT>RS+.WPDI
M]-URI%O/,%/SW8#F'X@FMR<Q+&@]R=&FN])*0Y4>:Q[ ;99T@9\_XEAL;N#<
M(87O#Y(K*FJH"8K?XSM#&JZ-[^[?;'VNHCL_[)F=$1(T&[C:0N=(AA,<_MY,
MV5VA_J@V=\&>.S[#_/99Y;M4?6+^]U.K"@CRKA,3LJ>/*OW9FKK2.VQ&]76E
M3K#RLZUFG;Z-AT+-O1?W.=<'GY<VS9,\5"[I,<8UV.JXI>'028ZC3OWWMF3U
M%/ZUVM8 J73/+>Y7<E:5)<LKF%LJ*3E$^[=B3O,;\3^ -YU1>AO(/4'>+ 8>
MF@O$  Z3O@O.<^'?@IHA[D5S#^SPIT@QL"K4G#$V?4<@3)DR^*O!MZ8T@O!I
M0E\F_STRR&'<8,D*Y7CE!WGA\8:LM>._JU(3A:;L09#9.H"X'JCH*5W^]FV;
M,/PYL4&G+.VVM>]+OPZ=]%5QVDR5W73X*)%.A*UP"S9*U2S!.LIN:+RL.^ K
M23#:P8%PET EG[Z+\J;)'G<N#87<8^>XFA0YW0T^M:&J:G-4@4-H>_YRI_MG
M'O8[.!.L\_I(5V8?\ AQI.DH$\B@[MSMIN*L+1]_?@KU_3KKVY6FM#Z%R9DH
M"#MY:*RY(]_R]),OKK:Z<J(1^X,*:"A^;(W]P77 WRW^0@5J?[T4>UQR'B/L
M94<QY7D8JC8#,5$JA8G2+3[$IW._EM'_LF06P-J2^$B:1P^D*$.]15Q]T6Z6
M\T*PYN)KQD0BN+A#6V1-_I_H3]'8K+88",4*:DPP$K7E20@E9@?%P!5X!'T7
M3$!3F<-/'\>C7\'(B/CM#Y?\7S9< >0!+5@0^K:@GYW9*>@S(LYYD;":E@ 9
M$+\S!9B>_CA.^8CG7V8L@^8\D:N,=E*HT'4A P-/U3W63\=+1%%L,4YTZH 8
M.&09)09^'N&5B^XJXT3.,D0:")],6; .GPH4 ^>HI\1 1TPZ\6'7P@R6!F+_
M[H93NEG\PV$I(A._,.';]_B?;K"S*+42&]+"1#F1<P/KYWY>GNCV?2LQ4)!X
M&B6MA9[=$?'%0&O2;IKFXD>0%21:V:$M*DAN:J-8(R2%6T6C91FB^T[.X2[O
MXLHZ0Z?<&^Q;PVQFKQ-MNPP+;X9X7/>ZMO(VN$?%6'N Z,(:2__CHVY9=MZ0
MZV'XP57M54Y*N&1F=XWG*%,NIM8Q5:O37\_W1%2Y[<6,MGJ;_$,V1W1MME5<
M^K/2;JF\E4IDD2,NGGDBR<4H_VA:Z(AD:$=?7LGCCD3NEW/W70D?9HE1+#@%
M\1*LM^;-)Y?0U@Q"-29&D/HI=]\.TFT4)SW6X7=U3^HRE_JX M^*BY%>?N9-
M?KDN?D?@RHXO%E]ZPIV=Y3V1 +9>.J9F?2E*"5REVJ8)HN30:7]UH%.SJ]+"
MIY D_>-S@VO'UB#<E[$JY=+RBK*NT.DU_GO,FE-BIXR:CDY8GSIPB?UFWE_[
MN\=[LJ:=\I'CC5M42:NVGEF]-J/^O/KG5&DD@]0_W7<]J*]%SA5_*,;+5<G!
MH*[K$XQ<: S[ELSTX*U#<]TW\L@CB84ZW(NYH,I1M82G\)60?%<Y*I.PE/J.
MD#_#Q%GI%Q)U'D7F;>?L\";==SHM+??>,X S?DE5DSF@N\2ZLIB'3_AA],ZZ
M;M$XR=R1:V'E7/ZZF^SSU/?J]E:=$H:<4=4#G[QRJM+1^/9.WPIW6NY @UH2
M/:UFG^$=SU'6"J'IXX^<0M(<:[V_N@IL5^3S'-%\WU_&"+K" :4G5"]UIA^M
M[.#::LG^/F?H43"8)-WDTE.ZUT)#N7;GQZ_,;XO-"HS%>TS\9,]'>.KLB$/.
M\AT]M[_3XQXEU0J\M9H]O1(;/%X@P@N[M)[M>A,M?6KR3( G1[6))@KGYLP5
M^IBDSGUPB Y7]N N7$+\$1WMQUWKX.)J=K!)(F.IXZK1SO??YL;9.V]G1]U_
M6IRSSIYH1W[J/-$C7,-$'0["X6@=/I&V6%2:(8RF]]"1353ADP3VM"@>5 'G
M7 .,%J83B#\#*C'O>:4?!\W9)V Y= AJ5TXE\D]COEOT@CK_X. Z9Z0=*N$<
M7'=<@OCMBAB03(8:786@&#@?#1/%@,-T@@+Z- QUIL&D$6$.@RD&L.QU.9:]
MZB$O?\.S1H1R^JC])HQZ1O^Q)*$I!IXF/:!D]WQK^)N25@FL+<FMPZR%M;\B
M@&=Y+&.VZ3KQ6RUMG"L&GN\4 Z-/Z'-JO&EAG#KVYZ5K+7'1NXK^DTN8"X9Z
ME*%9!^?YO%:ZJ*.6*%C)"1(9UTK"DAWAHA$F;7&N#EQTQB4_CM<6_(&N_A_7
MTRWS_R=B.Q,WJ8\)W7R!!M37*,0T85<"9UP,V' Z>$'? X3\11_HHVTUQ-_\
M"9SSD!<I+\IC[*5=S^(?/PO.G=&ED,5 M1/X38U56BZZK>8E!NQ4W2B1SB,M
M0@4OU'Y0X KU;>H&9SDY/3^G >AC>#61[X1-PO.=UG-$//11II[&/Q*,0PMV
M^2RP;=!7A'DL_]YOV$BF36B(@>N,V2W'Z/R"O?H'%_ <-L;G[__=C8JY"70E
M-I8[-B-[L1%-J2>(G/J;*?M[_@HJ\W7T!:.AS5"?4BUC\6D=[0F"<:*F*Y,N
MT/EUP\"IUTKP&1M H1_8?^EQ_';@[U:=Q, )L[]9JWJ(FYY!5Z:+@>U_8.E%
M*(1%-FRT.@]]9MA/_!S^FY)1X(G&ZB>X_*4+[3WU4"EC\A(4H(_\QA.<H/1!
MQ=;"C0SX-O0QAWP97 %Q=HF!J,11VD^+X9JAK=AOJD!&H(3N:$%FT":TNUL,
M](@8\QOQ=LA<![HF19G<A(4W#&BQ4*NB8(C1=!N<L_\GEEQ!H5R1GD=&_S J
M?0\+'K<SAK@[-F:I@!=W>Z6IV&>G&>/APD/V;?=.A2_K^4#DR5A/[GB/+TD1
MKCL,  "EH]\$D+@!B(%HQU8 X--'61)D_X^56[+KUA5?H!DVNU]WULS?]ZVC
MNOKXZ0LAV[M.5I6ZW+F8U_-P[&?(ULF1YH!Z,= \!)(VW2=5.T>/>Y\>.GU7
M)T:E,N 9EJUF/Y_9X9U,>[589)9V(FU%'FCQ?&2U:Q_M0Y*"*!RJU<6_R!-M
MP'J"A?VUU[#4<L316KB_32 -M7W X'B P=,L@= P(Y&D&)#/K!8#LX>#0<+"
M];L+1-3+@C+-6.A!-6@)C-$23A9M1B;S"A'U$/TZ+/>8\7P:B<[FKQ,#V5CB
M&A$'<0F^8D XCNUB74 /PJ(I'MF>CFKP4\3 Y]P4Y/X0IF >6\4M0DV3>8UB
M8$9E8O[ZB- &5(+:_)@6X'>E/3\90N:BB 7]W'(0<F/]8QS%@/46;,C7BH':
MK#9,&W9BNS4EE!K:[&40MM<7VDQAD'M@B^>95F(_#E#E9\5 >A\A50Q\-^CY
M(6A!;E/TL&8[8JY"G_0"OT$+U#E!%>;BA^+1MPRN8DJO(YILC4IC"(FSR,8Z
ME9^-;O(518.C7R'V8R)RIQ_C.;,,D!M" M&XU9IC8D#_%0T3.Y]\Z(/S-)Z&
MT$T,',Q;A;7ZYYF!7U;A,*O$P']L^ VAVN\P)%J[@="!$KTMG;'*6HAOIT&N
M#?(63;!3P5K=^:;\ETUXS"8QD$GK/7M3X(=^5-D(U1\1RHUCPLY(B=F%WGG4
M@;]RM9R'<YPF?E:B@NQ>1F]+-;JQS=R90^BGH]+6G!9YQ,>IHQ3+:)%(:U&!
MX5LU5ZL>PX37]-DBXK%W5,[QM([C'?2S,>/MW-WJ*EP;I>_VQ!,0\SX1O?T(
MFXB[V$1\!843 0N9#4&*K^B*(1>H.QM?/6O0RKOKW7M?P>5*(ES\P*^GMF \
M%"UT>G9B<[KVB%_YJ[*\.<D;66N^9ZWYNL!WS3B_0 ER-/[THG?\Y.Y%4L:E
M;%43HL?V$Z<R0K]^_3:MN:ZK/!ST+O]O2U#_4'*_.V)Q8EI4] )S5 WJJ1_@
MZ*8<04^S&(!',$W\Y"E4[0WR3#&(F?5_K\28;AD(TVOU5P6X2_-8PG7%J/0"
M%CLDD=OUM@:UELH\R:D7&<D)16,="G[/PK15*(H+SDZO[A)WJT@X]TLL.X?_
M\#K(,.=VL.*^^STY#J4;LLT:9XYT^ID4E/J=W=6Y*VR'8TAP1+[#NOMG1[:J
MGW^3X>PS:6Z3VOD9N6;Q\6E7M&I?F>V];W<+3SJ$CIUH.%O(\7!X'!%R*:H@
MW_:@Z>6\QLQ7(/4*V T*IL3 (U5OR&T$E<50)Z6!MA-A^\TV'T&XHQ_$:'UP
MQY._="?&.^<.@\CVHZ+CW.NZ_\"D_F+B/Y"-J=M_>BQ=N+69S!C_-\S<4M5>
M_/$WKOE7;NR'3?1?@9+X7X3Y_VC_L5U<,QN+-AHFM#QA52.9+@9V93'"AZ#:
M.[QPD>)]@P[4(R3HERN#F"MC[&_H/#?X-^3R=TST5Y2)Q<(X3>[THJZ)3YZP
MYOO0+\L@S#+T0,#<"+KR[&]8+V^1U3XN17?@$Q\<QL_8EF:(PO[2LK=!5!H<
MF#Y)A^_4.5F:(JX"3#54VZ+J2,NQB,4!.QXA"@JP  _UZ!25[CVM$Z:L.SU%
M47CVLNZZCTY:S_;5?1Z7<ZN\DBS3-NC6"K?4"DUC.!<W,3T-OE"-&GVYNQ0N
M-^R//L-<ZBQC5W22H&"6_,"TZWM&E+>F<M6)0?K<&=RL-3=YW;"Z$O<,0?$2
MJHW[8^2->R!1U@IWK_[=U5.KO%>=/'+"VR'*K^!.DNFAU8'6&5^:=0FC"?]\
M\H*][^N&%'MBTE)TY5<VEL7C")CI'^^ON01=W+^OP1/D./W$714=08S@5N$&
MA,AFQ&AR)6M9\3[5&3HN^D(=_<0L;'JB1KA0O# _+U/@6I^E@[:TBX'RL'Q,
M3&EAJ>:DP!9F+J,<__D3BDZ9EN_P_?]T4>:?FQ1P#M;F,J2AZH.0)W$#I36=
M\:HA&L0@2%5E-018!-56*1&7GF:-@SP#'A0QE5O)RXLPM^#&E7P@*W!3U$F[
MV_M_C-2A*V!67%B0(N*^7KO/J%FU]O3@%="O;->'P0\;KT6L!&]6MUSP*86T
M*%+((.S(9XCHH#<441'^OB4)_S)E\I8 CW:7$Y6K)(0:X LQ,&7/H2NCK<32
M9?/X-46A*?'JVWF42-B!Q88F60*P'RGGTI(K Z\%<0FQSED&R,NB@,OC++E
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M"/%^_GKTJP9?"M9"<;=)/=44522X@-(RE8OX."-.YAX\)6Y8\B-ZV;VG_6+
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M&;KD)90SA^^T"38@ /L.#T2 C4ZC^JN7S <B@,S/:*2'$:#="'<&*]QEBD&
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M4YHPB5C[<4_.>$8.;H!_R/K0GKA[\G.CA^82BBJ9'O/Z&;1?$2#"G(US<T6
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MC?]Z-5ATHPNEL</L*YIS3O \EGVH#AY% )::<$NGTZCF)Z=0%@H=*1J[4EZ
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M&=96O^+^,<>@<Y'['=ZPVX[O.1MV>5-*VX#/0ZV69PL=]GM\D'F;XE<6\6Y
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M)H157G%E&EYB%J*6H<U,;FIOZB)TOTI][JD>5L++_RT? *7=_PU02P,$%
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M>IMZYA1%1#Q<F<)_QMM=N9KYT_GF#_K/(11HC2.SXU! = D*W)P5EA,G?J"
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M3:WOF_K4;2_,)9:U3.+S:8U;FC/Q$2I1#3%F)&_/H1"J1?ZX2$-H5,17* Z
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MS$59T-U*1TC@$A2((Z) %]F46+@7\_';F\*+OW8=*6M_P4\UHD"V JM6$9'
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M3.?R3WWR;C*J.WZB[E!!9\K1[.@4;5Q\47C!7/Q/==F!69R\M^[@=MWY2;_
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MF[Q%&[E+@-+X2=E!KB7J(Y7U("JJ- %J-R8"FN-5N!2$JS-_7'H=-YO$KM4
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MNTBM'2)#..]FHIR?Y"#1PLVQPI>F"W:T2+089^ 9]N4P>OWYU;;"L\DE15H
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M7Y'.)!H6TPK+()-X6*#"^F1/1%L1LX$CPLV2025*Y_1PL7OM)%!S+,+%2-5
MVCO0N[A_'-#Q:JYP)7Y$!EFFS1V50;</MTT>(OUQZ.TU96D@4JI+?I8F70(B
MUD8&*02!/.ZVM\*WUTIF([5O@7=V<(7:N0@18("4?D<1J<(22CU!<S.G@HO5
MT%X-P0)K[!41N7<QJ'7K7^;? OR+W/Q#(H.NJ^F(?\B@JT[P48IX"QE;'4>L
M%+%DT(=4%A:2+ *1GSSY4#(<$5! 2N)]X"N\NE,&B5<:L]/PHG<,#BB>B=S
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M-\T^]W'^4JN\I9Y9=C/G[YZ_:DFV.^- V_TCB3,C$R>HIH[VS-B>_GZ8R^)
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ML/P<[@PJCIVD@4R5Y*KDOS7VW2(K*.CS8>$=?\,OHG*Z8;W84?0E8PQL2^Y
M:]@YT<39UT"(;ID$/+3.$JX57(&),Z6[*6C[8&,*6EO1>(8;C=<J:<UR)4U
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M"]&MD"OXZ__LY^LB_Z=K:-"/(?VQ&B$:\S0U9D*C]#4T]37H"H@)KG/T7R9
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M[+1X^PL.EU=:7\B_>K%MS)G:F4>2WCZ[,T/'_O;U5[_I&$R?'@1E6&>*YN
M:&?.EI$G#HM(FS./S+-TUYM>#,37=6\\8V7*S]JZ9OO= [F;%Z1L]LWYL;>Q
M^G*Z8F_[0*G49$6EEW0G9I3KY'9QWN%/SSSWVZTI2*U_^YR&XGOD;-68'AK"
M&3F *IX)<'^Q$0U=V2^AH6,J$+KS\S[,LQ[J'S( 9:BST9J&Q@=1[ 99JL2<
MAMB_\BF>'$'/,S_&@"*CTU0N&=1M @9A@J+\(96)/N*"+RQ_!Y;1& 1XXN/]
M[ =/ZNH!P#NJ2D0.V.*YZN' '4IRD$&0(!O+Y\._J4HH$U$\TF4F F67)013
MYA4'8B*IR?"]GQ:$J!3/HR/#0@S<PW=9^-C^N-8BR/J&LY;N=-NMV^*UXJT@
MXJP?"US8V:3E-'2[[1P-Y>@<?2;1?&_?U7@I9->1S'77.KC?MY3N;'EP[T%^
M##NU.+.:NV+SH\GK"DS.1X:4>Y67.:\+619^_;2:2IPCJO1H/9_+^O353^6)
M<ZZ, F.\[YG,D&MOWNWU'A@Q]MKTJ/*WUEGGGB<L2$-L9Q]A:N*>IH*=H2#Z
MXDO:F:J)CI2. YM:F1]^$AFPP+.HQ\.(:C1W$3NJ_-*"8S4'.)?6V!;87NI2
MQ)SVFI8]9W5U\Y;+[V]NNOE69%EPT>O>Q5#4Q:_2*<'UM#0 /7P@=8;?Q.ZG
MBKF-EWY)=5]9>[BGSMW'ICZJD604P?(P7).*2P91_P(XXN?@/U\ XR\7$$ZM
M$"5UB6[2T,GH%!IZM3&(AN)NRXCJ'M*&YT'-7!P%?-3,IL96(E^"1(/%:E?*
M6'8,[EHBP^<W2$;&"' _'@0DT8&T%WH!_IN"BQ-AQ;3WDD$#0)GMO8XTM$!%
M0^NW?&.IY<1V%-*Z?/ 8E((4.NP_M@?X,_GH_$/S[UR[$37KY-T99:;>FYX=
M6&XQ/2Y68VHE[S#\-GS8;V0*R;@-&-',3C5XCX9JY[*9E:5.QY\$'#L_L6!>
M5N5Z@RG";9?G7KM1%2>P*LQ:UQ09^((7EIH?A!3*)\ZN#OI276VZ7F=#0$!"
M*IRW\I99Y(Y %A+B6]STN>/Y?K_0Z'>^[PP]V88QOSYE==$0#R8G%U.3)>@F
MCQ'8HS6">MFO!,II>-ZQCH8B<O_.%& 9-O+M?E,$L/K;C>BHV /C!DVOGGW
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MEXSX^=>N_@GX%;B<U#V(X.;("-.NYN$22</^:324N1%$!)1&0[/^L968/2Q
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MF6E7QF)^&=.8&D]$X^GM#'[:16UI_WC"H7XP_$3&!(S_^-&6E7B0//"5BT5
MA".?L L)"EQ<$IV_MX\Z>_-MW$ ?OR\'\*TE'HG&R46]S]%%RANHVS$X"$?V
MQC@K+^'RG+=<!GG%MG0'-K&G7&@"+!S"&(_/;.G?2 J+U.Z#3BS'%HZESJG(
M7!FE+SG!,PSG\YCWSK>HRCM64<7W!%XT));14&)6\%"X&K J?A,B@MCX$FMJ
MW'B S&]\/8=@]#IP5%G*$2O-]L].3E8]ZVE(?S1 QQE(%UHD(A8)BX)HR*F%
M3/M7BR3_U4::6!8U$_3(L2L!;LA#V'@0'%Q#110A%2L0="U;Y6(#DN&$SCX
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M201;%1KR]$J5'G[X\.%$O4V*<M=44) =GOS]^NI> 7KT^3< %,!XL:0L *0
MC ?Y5-7D+)!Z?7\\&!Y+S49=XHHZ,% =,"ZO&E"H=(+\@,N_CE,2+P7?(W#2
M0(20'\\@7#87(ULQ$B5^LJTXC/J([T@>16M;@60OVY5 BE8;@6P=N42<8A7Y
MU[&N=RP?'0]/MY,B'>?-I-#U=B'%AQ/(' FU@,T)CM%JZ4," \K6E^+O>I+Y
MC.6H?$F)2!$_2!&';[<045$F:"87B?HB96OM5(X&:M$UMN9OGN?KB)&M>1-5
MW*$T[21I+T86D#?J+[<F')D*DO&;9BPY<E[.Z..)0T,2L+6<F=[5F=),]?0?
MQRF1EL*$C D;JX4TV8K)7UO+XR*L;!V;*+RLDOQQG-9N)P%:.?/*Y:8@0E)+
M_6JSQ.3(8?*(N#(T7C4!)5,M_GV<DF@G"8'8X8U[1UHK^KEUO^#8D>2&3830
M=>2/X[1R2P&")6O>+9):ZI>E6T!":* HR4?ZX7*)B4>C)^*97+4_ZJ7[#GE
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M1C0!)"X05%_\^!WPB#"06;<'T!(ECQS1J:64@KPPO%AN!;BBG)\AC[)XK7F
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M?0RUCO.5=6OJ%?U5UN!(_HS5<0F=V&G*+C[5Q3JWFBJ1#:WHKL2W</5]\_"
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M'OX\J:/K$;@S1POX^;?_ U!+ P04    " !3DUA030R<Z.Y*!  <VC  $P
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MWFV2P2UJ-VU""YK **::\%G>:F:M]KD5-YNX(_12]ZE-^.&].<Y#.P5,#FK
M7S_RVN8+=YHHUO-&48MZR.\U/.2.6B3MJ&EEZ5V#5*6*&>ZTT$22C48MXGQ\
MNTG)9L-FR=1+XX_I\XA\A!$D]KVZ:$KNVNR-_&:3#] BHAN=\H)G6EFRNM_
M4T\@3'^VQV[P;DU6MA!Y>:<EE#';3Z@&-(0TD'T:Y7)QHQT<,S\Z.:8!+)[7
M(-$I37E-XISTV@(O>*=%_O=:Z2*_V:)KDKOVD W>;'ALY+8X1G"C:37HT<Z$
M7WU$LYIJ55$-ZJG@N)E^57Z_4; -F\$!-YH<JFERG_1N\/:=FY!*Y;3IFQ8U
M@$*@10W06RUQQ9G&2[/ITO,';7(5[K3;.JTV3L,C=TG4[S=_A-Z:X8"VBJ/:
M@"9:0)G8Q.^EO&QB^=&H!4UPHX7Y_%G,YS<S']S)O)G>([W=[,:W>O$M%-%J
M4M)[,ZSN/NF%4=H"D*E!K=JQ@:<J3FSBJZ0EDIXTD2[2@S^#"X'34S?T2!WR
M[5HTO]FD"5KFU,A.29,AEC2[VE&X@"$0A6=3Q@ 9M0@XN-$4/B5]@K8T:854
MX1R/!TY(E%E61[MV\9OV3TKMXC=NHI16X]R8=+-+$))TW@)AR(1NFJV76D+M
MXP#HG-!1N_$+<&Z=J8Q8F 1DFW>7WVP6T"WJH[S31.3N?=N>#]R9(2>B-!G,
M%A(XH@G?+8:SUV0QH[2?J0J:U0 9_MD2WL$[#=\9M!E@@T;[JW3K9T9DF@D)
M[A;!R69$E3>;.#IKL2:R5FZ<L=TXOM_L6@*S@E1(VMW+<D#31-MP'#<B>1QT
M&H#'ND!LJAPVBSHC[W$.=<*(5O-_EMG?8.ZWJ<M&#>G%7G+7XJ'F]V8(R;F^
M=YOHN8]:/DEO-5GQ=Q5]$M!#]R#8[OPHB8(L]:,P^5 8R!K'MT2*Y@=YVO>3
M*'VUJ+O\7A/RFWQR2NN-WCAR +EO,?^+FXW119AT+9B+HKRBD#*X^#&-W3#I
M1_'017#A>Z0S5JTOT>\_M.4RX*T9WO#,S?T:4*<W^)]:5.6\:?-GO-S@'\\+
M&=1F,L4P=RWRX:X93VUHC1J'TVVT65ML+?N(+2"%.\VH:$5! ^A+G3 S2-P<
MD,"W]Z8<XK'5D-^LI$3/[_L>15W+%M"+(4WAHW0 DOVI16"4=V=Y_K-WN]N#
MX2#_1NW;9*/&;3) J1?V^FW6>G6_A:%FAI::PTI/03,?4>_C?[_5@EXP@ZC-
M;,_O-=ID;0$\O-.TC 'QVJ(Z>*L1;&W@:AA\G[DMT,4[3=8RN9^S05L8YO?U
M/3DDCG:R:6.-M)$UI)PUTI,O_^<_?AD0MP?__L<O0Y*Z#(X^PSU],!'-"*P8
M(,=;,(]/&"__ZZ\G*7E*/^:)9Q_I@ZF?!N1+F?'VR\?\;WCUQ^+=O]Q%O><O
MO_3\!R9)GP. ;A]>=M9WAW[P_.G6'Y*$N2"/S'4T=,//]%[B_YM\XMA1^ADF
M67\2 #L*W&=T%,G)EU_\IT_X$1+GO_J]'@GIKW#_(G<1\YD_I=?H8C@6JN7?
MQ'_<6B=,Z [QC<3_I,/,>SA[)W#O3Q@?L..X7GK&&I9@LIHF.3HKJJ*BR"9O
MFI; "3QGBAI[]OCS;*&!)TRN-_YZ HKFTUT$&';#OALDL CZSR\?)R;]BC68
MU')('3_QW. ?Q(WML&<!"=668YFVS)F:SAF&:FJ:JEA&.4M1$31]O)QY T^^
MG)UQ/%#;VZ==TDT^[RMX+.HY<"VIS5NW58E7;4-55%7@-)YU'"&?#F>KCN",
MYSUOX,D7YQ^KGC*">GK"HF,:O,/R, M)L251U"RN@)\@ JF,)SQOX,D7G,';
MIVR'P)7/)FZ$N\%YV"-/?R?/M0E+JJ1:DL;+BB/;O**)AJ 4\^ M5:H(?=[
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MMR#&Y@:X>AZU#?'+UW[RTW@V2.@-AF[\DSY;#KPF#R3,B!-'0W0/<:Y_^.G
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M,E$UE)I=.&<@@(Z3UATAVRUI!XZ 98"=K%D.+_&6I8&'E(M_T5(5SJBX=\Y
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M:&J"XS_A;WLBKO%@\S$T3K[@GQ/@6!&A+@#,BF#;H7D,QNL<6O7#-]*JD?D
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MK>?0MLGSX1?@IE<PP_C9W]W8=T&L7</4)^L W81>[)AGC<2[Q*>G$56K6YS
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M8##EQC9O .>]+" <SVKC!ZYB,G)]VN@U3.CC]:9I^]@Y;%':PJ#'VZ%R-($
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M%L&"K0D.X\"FY7LU=^L^R'5W,JF42;QB2:+(V9*A"I)LZKIC\H+ :H+#ZH;
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MR)JC<89DB)K!L8YEZ2OG;^&8^7N3T/Y&[MT SP'S"&W_T;'Y$;.YQNLR+[!
M>:PCJ8JABKJF\8K("ZHLR"RW<C87CYG--PGM[WY(F!NW3])GQO(3+XB2+%Y(
MIQ_W1H@IJ[PCB 8G8?<A^$NV3-56!4G5))#.F]@(Z79"CE@B\YHH*99L"P+&
M[QQ-%2U6 :EAVJRE.*RX<HDL';-$WB2TO^<EFIB3/'$L5G$D@4V+,D_A7D S
M=F^J]%[FNYNFF.6+*=5Y:V;F*HN]@9ODE3OYL[54]TZ"'*\$D5A.T6Q>E@5%
MDDR6UW5%M23)XB2#<PQC]1)$/F8)LDEHWY1M+YQQFPKL=-@Q^_$RN\#RFB-:
MG*SHML2:JJJ 'A-Y338%2V,-9^7,KAPSLV\2VM_=T+VG13=@(Z 'E^7%:F@#
MZ*$;/"<^U?V5+#"CL)?WO,$QUR3)@I0.N1R1//FZLPN.6%2H%B\KK*+H%BM(
MNF'ICH.;AX*I*IIH"<KJ1<519V%L$MR_82\J/W5I$20R/UP(RK]KT1]&OXNR
ME"D\$<S=Z 3"\0H$#?27R?&:99J:A*%(2S),#B[(FB(YVNH%@GK,\F"3T*YL
M@INR<C</'MQDHU% _W;CY\YY.'8!8'(L'JK)&H8F28*EV[+ \0(H*MM4.'WU
M D [:@&P06B;M,=%@NT^D.W!!'#O8U(( MH:0\_[6[IX 3P&O6IWB0_4 @QC
MZZ&3%,<K*50P87G%,6U>U\"&=31=MQRXQ H6*[+."G?%2DEQW+[#!L%MPH4X
M"G+[@*:%]!;<*-Y!-'3<O@KRDT6!PW(!CF-M2==%W>1%3==L769%29/9U7/[
M42=S;Q+<E[1[\GF8-R6L=QGL$D*:$T(TU59TF^? ;I,E2Q5UWE)E7<;^]IJL
MR"LLEFM/".DR0HY8&DN<H\BZ9&N*;4HF*^F:8\H:9VNZZ1B"LOI47(X]9FF\
M27!;?DQHZ=PI8S\1+Z/QVLM^W_?*; ^S;.$&[P28HU?6.6+'+ Q4R[1LD5=5
M69(<B3-4439M1;$LB]-U;O7)'=Q15\IO$MR5!,"#(4B8+&J?[2 6.F9?"?7Q
MK.0XNB!JMB6)CJUQCF.PK&QKDJG+QNJC+MQQ5]EM$-Q%JN8S<_D8@JX?^"-,
MU# !MBZ\Q2 A 2, XZ_Y?6H+5!DA18)':Z)H)S2.5V@HG" IHJ8I@FI*ABGI
MEB/;G,CK6%FFFJO?U.&.NG1OD^ NQ0/E?$SG K&13,B"6WAEDI\CD9P66S^Y
MB\&<ASTRPA[EG0=QU/)!4C5+8579LBU3XM"RM6W%,32>Y63%YM?@01QUS=\F
MP7T5^Z'GC\!JJ'9W&8<4)Q_<D/C!][H2P+D17\7A6$'F3,'B+,G4+-6V!5FS
M#=.V9=Z0^0U$?'_O)/3Q2FA'DV1)$"S-,@R)E5A5,2R)MSC=41U5,XW52^BC
MK@'<)+CMIX%_YQ?)> U9>LQ-<6A/Y\*U"X"Q=N(/5CM5U,E9ALSQNB0JBBQQ
MCJSRMF4)/*>;',<YUDI[==[ JMRTR_[HJ&\L&SG64&1>M!U=EV2+U37!5F59
M4DR9D[754E\A&ZFC^C2+ #_2XQ3&UWL'<9A-[XA./>)7=NJ1X.BLJBJR8BJ.
MQ J&SIHTA*L8BBA9M-5I=^K18N3P^E5LZ,084Z<G'>G7_V N+F]MYMK^JE];
MYQ=?\=2?/^#7LV^7EW_'OV]N]5N;'NJYLO-DDM2-TRVRS.WL(]6H/8DGX_7*
MPT:9QXD3^Z8/@/."K$>P%\6C&_?. I@,IGXG5;4()HG[^3'.0^*&?G[F'/YY
M%?L/^,;:P8K?X)][BBSFFF!J&:-[]"0X3M.D#^L^?D\/@MK,3YF(YKC1HQQK
M"X+9  S3*$9-S?1=+STMX#"U<CQ1/:87<;7]# TBAK@QPB WW$<DIOES"$KL
MOC$D\3T:[X8?W41!EA]5>!YZ'Y@HA@>><5"4Q<Q=T0N=X"0SE'>(FOOGT_(K
MT;A0=WRI/W821E%"JWO'MV+R0,(,7S:*HS_SS@!>E*3YA00/Q<1? P DG79T
MAX/\A[QGR'"\FY0?[]A."Q^8/P@#"X2Y!7BN()(_R,%9U /4AFN]9QZCN)<P
M@?^3,">/?A"<GC G=R3P8>H)_IZ?W4E_Q1)&C%ZE^1T?I%+8H[_2)> O\$7B
MN4D^GH TQJ/GDQ.ZNL0'6L)C./,#$"D.@*2\*/PS"_-SHY&F8;'#"(FY(!)$
MZBG3&]=74]C4@%Y'=5R[X97%UJ?,?1P]IH,:-@'ZO0P8('$#Q X\G2&] ;?
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M@BP#$[2']%$$4,I@8UXE/::..@5-]+&C!8HUS5Q%&8NX8KY52W=V(VS0#*Y
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MI/A(:)#9QZ@5KGSR>^..T:5*I/'F?EX*A7]G(TS2=(<T\[)&XHT;]#0V66
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M/<4O/8DU=H=9X@&/QL6!KC1NCU2#YWR3,]K;$40S[0&;%,5Z&-%Q\?#HLR&
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M!]N$[C(V:YSD74E/3V<;MWZT67UFVH#(#FT[)P?<L83FJEQHL?7$EPLP6^Y
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M Z5U/_'C/WC(MQ.3@#M8(5.>.CKPI0\J' *W@NPH0<L>1QJ=<*RF*MV#4-8
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MF/8&!&2%]+^TE5\$O#"QJ1/42Z9HZIC9X,B%>8VU(<A_HA/K\K#LQ_!5#OR
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M\EE 7&' Y*1*_JC(<3+U+>!OO[G<R1$#3G_1<\]*E @B-V9U'GGRKY%(%)J
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MZ3039MU[%3P_P^06!9;"C@]/?2-]0+(/[7#;E1!K8L#&S3+6];15EY7C$[5
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MY/\.WY$UXL%O N6N^)<!;P5 6I;1AFY_+T>ZR19T-M3H2;<HS9D: %J4+7?
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M6IC<EY74S-1'ZW^&"9"/> [0B)"*V EZ@]%H(W_JRZ:>V*W/KS,S4V;-%#5
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M-*.'W]S+[^-K#_]T;WG?&E-T6A*R$G[[/9:$--<][CB*/KG/3<MUS>.G_#@
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MQ0!]>#@(&'O()=/.#W^]=F&0^<YU?D:J1!+V%4U#)!JU%DB,'Z#JN\X_Q^O
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M.L6M>WUNE_)!?[CK0FO?C!"_A?0GHNT>3>%1)'&7]_U3Z'%I2PN;2V'816M
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M DKH,!PR9B.N%N%*FCMU%9U'0SA&!Y_YF70"611 9CI[[L#S4"14R" S?IK
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MN5(R_HXGJ SWAW.?_$8I-.,NJ];/T=\480?K1D]8Z3,"!MB9!8A8P/^LZN8
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M5]'._F_>V(G!F.5=AZQ=F@ 'U23]RU<FI%SN#2P:C,M>RL]P$%OTZY"S)L*
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MZIA![V5;"3:I?*P^J/C!E^$14? IX\8N)M[@).%6:8"02M'>K>C/'GQ\$^M
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M &\IZX:5H((;GL/&P?$LQ0!I0V"DPOX!?@/B.[)DZUV.0,,B5QH!<3-3_*/
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MO<+TLOQRT+D#&4T*&YET$^AY-8-.X#YP;,,WY*'.GNJB+$9IYC%5O(R^:&&
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MCIW>@R]2C*9KEV/LA>B-D5%#@-APL2H2*7ZD!H79+SZU+'D<7G(+*]RDS8A
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MQ2$:H[M"LAVFS*5(I3Y8SY:$3AH[UXS3"+Y7<'4@E4?CUYKV:R8A1ZQJT3"
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M>2-90IP(*)Y8L"SC%%M"J(49YCZ2PQ8'>1S3U0;6M#3@B:>/-R,J).VD&RN
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M_WC#/KV-PF]$07D4C@#M7__QV^<W9>Y'Z8IO*?0>!7YM*<$H3;!Z"N49%E;
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MP[LJE[UU:W9W%P "C_XLPI2,%7CPIU&>#$'/U57-Q<^C)([)",>#*W=A/E5
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M0"33KW3MG?!'++*XAK9[@*%Y;!\+SI5G*EI'Y$_\$*3?2*[@,9Z3QQ"TQVD
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MY<[5(*-W\#CXHTXZ[G!ZTX9W<(<*99RM+8L  $TRFJX5A&ETWZ+E"U&$(2L
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MIWQ) $K+JV65.6QY09$GX@O6T(1^4ZLTY^T',7@:S#/RD_AC)3WJJIP544X
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M/G*S"R]0]8M%KP7\CVYX*^//V?'=PN#NAO]RXNQ^C!&N1^'+6O@B@B1'VA#
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M*D8)Y00+)X"N9XI*+1%Y*6_LQQSX0X-F'E8VO/9#(F2)"!,1)B),1'B;"!'
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M3^O[K$DF<43BB!T]T=_S[X/+8,A6,,Q^-I?3<9#9VQKU3?8AB'$7)$'0WZX
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M$(2_?F=4SH_*%OGWHD9;%5U;72M:^KO0M2:?7ZK),/X5D[JJ!*[Y!E8MA90
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M8J<DSVML16[W,FMJ:\G2GAHM/KUO\&&&L'[1QN02LI^]H )9PB)8!$F,=ET
MX\V4#NVWG5"C#)%T8H[R:OLM#X\PUYLMXCF"M=K;8L[6OP&WA$(F_&KK+5_O
M#7%TX6ET$@]K.S\.<-S,?S_?;>P0QWGW\=/_*6[F/Z?B]%5CN/>MR,(?L0'A
M^X@<"X]<JYA&>UTWBW/('O1B-<V21Z9I9XA(-L8P,/+4BW,-5?:4'#B)C92?
MSXL[^'!(T.-ON'G@=2K=_V"^XK+D,%+V&;Z?"(]AO 7&=7^0Y)47@OBG0I ?
M+@39 2GS(*"-?;;+6^P0"]O+&CV:3&[10S*'.JW!W !E-"XO%UUUK"F-=K/6
M^%HT%;< 2+L/""1/6FPR74+.<\&SX5J2E9\JS9KTYJHZ^:$H[&_0<B3A74+:
MG>.O;A#9:1)D418Q:3"LV/(AMV3&3NJ[ONEK\=<TL!TWSR+;=9T\2JS4<CRX
M-#'])#-S^Y@"J!KN4K9>:;O'C3J&CBBL&A,F?^U9"[""!2:C(;TQ^UIC-9&&
MKA#9(HB#3C'7)+X=B_J1!=5\=JH$](LH;=&4U<WELFD5I@+PV#P?0UZ>5OT#
M\0,,%6 ?.R;3VG=Z6TFPD);-"C$EI,8;(-(4=1U5"YW:]$H5B,Q>-_7RZGHP
MO[YKF6E=S,[)2:2"5R@1P6H5C*@AS&[45 )4 <;ZHJBFHFRE7R:!LRJJH<:
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M*8(T#"W7RKTH"?W<\R,CATR=E3'+)373HP("=N9R '/Y*KH]24OCB Z_?A]
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M +V>%34B(9[ZBD*; +W6AD_4>!V+61<B)]14NVG.P.">7=5HB+"'@4LX@S\
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MON&<:!S7RE7';-0<>)(%<;'&L?K/Y?@*%P JT4N:=ZPM+KB:[5=U_PGN;MD
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M&N8CP1-G=UK.X;8M.YBG1;/F0FIYQ)$";#"$7<- [9#7<.NP(6H#MJB^4E:
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MF(Q*<I3**1",REY/X?.K5NPKOA,X,PY2T4ZF]>T]\2>D%.L;;[U?2[4TN*Z
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MDW/N<$.'Q-5U0LM"=!-:733YU=Y7[\N&!]]";8KXG'#^S.+%RC9N)*&9>P/
MNW\7"KMVN<"^040;4K>+X8 IR6N\,Y@\Q;?A6@Y0E>T\\#+^-]V=E'W>\+HW
M,%?&CFLYAF>ZI6E;@31&8B]Q4].*/8BW,H<\<3PS-V,KR[PP"PV_;QJE; K>
MR0#$.SYKG]AP/X-Q-F8F$^21V-J==:VM=V1M_<%O]$?W1M&WJOVCO&S_2'C<
MYG):?BYG5=V\K]F9FBY+R[#,WW!?G"%!/=Z5Q.,,NO)5-\6T_9^S=^_SLP$S
MGV!>H1B>JCC_YZSZMOB)73VN%_Q:IODN M\5!Z.8JU_^(L_-PZIV;: #&ND
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M:9Q[[KGY9O(6]UO_XZNWW:V')G QZ_A@:/$-A-E%N^;/<D[;7.;D0! K9#7
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MDTG&5H2_NY;CBMY(.9-RY76$^;J4):=>THYJJN)#$GL-;ZUF$^T([L:N/.+
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M3M.19K'/]D+BQTELI%X<AYZ5NYYAF5:0^V&DT738OI<'OAM'5N)$:1"G=N#
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MN8/ LP>:MPDT?A7R[A'E98@B*D1! L<D0$RQ&$<FYF%DD$44@P0RF&ZQ)N]
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MEV3Y#6!&%EXY?"V]4K[@_&W?BH-%OYW=Z':V!Y,WAE\V%JV69CF'EE+W;T#
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MP>;&17Y?N$H^6S:9>CI?7$_!O*J"_IG=7RCW]%8@[GC#Y$^@)J,L*_?(G%D
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M7#P35A(WKHOLI_Q%1]F?MF"[6*?RT?I>Q"KN[57L4;/I(G7C[R5C-Y!NO5^
MB9FG><$C>';)*UR!13+_EI9C=7+K^^;TV)_3P<@-H!/<CY\^_R.YG?UD:@$S
M.[NYF%H!K8UW4MI!( R3X6@(GU]Z6V&.Q.U>%9;$K-K[\I+;O"''?!6%\HHH
M2%VDATY^IW#4M35DO4EZ!Z^QVC;SIE>+Q'F-R=5TN0!3Q47Q8.('H_E@>6NU
M;Y 6WE@*..:"*RL3</M.<-R%!Y;-GY/IW>2B4) ;T'TON;[.1=^>6/,+5]?:
M\3[%C>#>^>C4!Z<2^ T;:PU^-@RG2^_$1/()_C] PF(ZOZ]9E05:.I7.$@NX
MM^GB9CHLL7Q]B"VKN)O _-#9?#2P3@!(<!$7!I!VZ)Y5A^:1-9B$9=Y\<.J5
MN[(P_MELFNUXOI5M:\$JG\=IEJ\;)X<H!T_?[+&>U=YR :#]O\YK&SFZ]WQV
M8:%=>0S%<I?/73[QH\RN>2O-^+IUSF@MRGKE= [6UE%V8V\%*^4X&>0Z7"[J
M3I%S:)RX5YG8-7SA+!,XQ;YJN4R"4EM\NTKAF+$]?;AT2 7J/YG>PG!.K[(I
M/.P@!02Z@ 5FXJP;NYVP]@6\V.SF/K/;6?G3CJ:YWYF_T8,O7+V:!;SBJ>&-
M853A2L5Z6"[Z3M;=DE@<: V8RM:XAN40X,P:+);[Q Z;C6]=P(L-W+-<>%8.
M+EQVX&*^'.2?6=V:P]J:75@;XL*:1,E@9"?9VE4N.I8?6"SA[NT'-XD=3C@1
M!'A0Y_A?/04,"3S 8#[*S81351J[4LR'=IVP4_J7@RHP$__6"2>FUL?D?/*2
MVW)-BZTF:VQ^*P9GTW(M3*R:17)1C\,D^1JV2M/--7J6C&PQ^)8MX]#I+G'6
M;?J78S8JP&T;F2N3<+*CL+PR!%>.1;GZ%B;S"N^NTDEJS?.U6%R^DF:Y"3=(
M[4IMC4+K>BW'BQUV6(YZJU$:6$N]-$-WCY,%O4U#-DWFUN%:6(=M-IJE%BAJ
MN[SC*;Q#[JJM_ ,KJU8LZK1/141PLK1VY7)NW]S&^6'H"X?HUCK)A;NQJ#_W
M-QB,^2%/OF%J#*T]LG 3X#P\. 'FW!H:)PN#-TY.2PO+YJP4D)3;8GOUQ*UK
M:PC:C<UZ755VA"1&42R-CZ5"OJ2A0$7L'1M=(WE_9+.^AI %FVMHAV=GZA_[
MKZ_F-2!V5_3ON-OLJ["(W2SUTHE=75N^I0%8L^.7\^E1?.'9A:[UV%7NX3C/
MU)F@*V,"KIFE,.23;Q<%"HWS'9 AV(I@<Q7^4MECZ86HLI[9>!P,<?EU^9?V
MHA]L&&XTR-%L:(?!*<R')<S^W+Y$R9Q2P84?^K\2&$GOJE".$X+6WR<>V%A3
MD$A/.%F4%VLK<NG #K>LAF(-*P<'!%JRG[P?OH!NCV?3O[P?_ID,!B!#R8]>
M_AN8_#9X_.-J&.TEOB03<'P!I[-%NIQ[P0B>[QL8^G#L+Z'WP[O\^W<_%D'/
MM>70A0/! 2@?(7_RZ<2NY>53?,]O[<&46P%>[?[%QK\ PV*0-[YS*_'&TCUS
MF&3#03^\&_S\ZZ=W/[K$&N_[R.K(^K'P6QY'=.[)];6UMNRO=\D\O9G:B"E,
MGW7?0 YNK,Z%X-5:F^U7,$7 .X,C%@MX9Z=YGKU;<9MK@,-_N[::>%/=!,[_
M/!W\^1V^2^TEYO?@) \OO?^T)LIB8YC6IQ,0>EKO:)!'N>PK=" ?2.(J'P@'
M2!%?AK% )* !"\.XH(647$@<U+="OH)C.[T."XOL#ZO(-0W>WA"1N5\AW(:(
M.&CI*T5L?[X/>IU\G_=N"5M9I7>Y*,#$FW 5W_IK5M!!69F!#^S*4^C5ZL2;
MQ$J@*V8:%I;_<F:MJ4Y821)7?F8@#1A)=K^,4RR8KQ&/2YX"N^E:EQ"W2U:)
MR+:K68K$LX3A04M('&H)D=>VA"[*..0\O4T ;@ 05B*Q\O]R0>B@\2QQM8?*
MA):$AEIQQ S7A*JRQ8A2E M3%PO?!>%A8HSCM9R/TFQZ_2GW^[HF(V NOK:U
M_/!.R,7*DA[F(WF_9C<5SMB7W[[DD=QZ7/6/RR^7[_--C/4UM7:!'8L_V%65
ME[>5:^/9.LOK*8Q-?L._X.MA8<-4!Z_?SX8CR\SE4W*>_7R;;#">9L[*KYL#
M+B+4#14FM2ZC"H&^1MH(8C2F*%9^V4">H("RN@K_,;N>P_T_)?</\' TL-B_
MG)59OKZKZW:N <+=<,'$WZ\B5MV8?XJJE9U21@/E:^I+I8FO?8Q6B5,^B;8A
M_/?K0@#BZ?S7NE87P8]?;7X%&-R["%5?%];)JZ,ZG'E;#D\I%YD-B4[6-K\+
M_"@VOD<5^(+[,DJ_KS:W!^G<[K&#(?'-!J/M%N=66/1]&:5;W3C+5Y"RA*84
M3[B.2QWI2DF-K/'F*1W'$1=$A#PR' MM$,FEE$5QX&]5+)00]75:U"Z4<I9F
M/\^G64>A"^-=V'7<C9 \>)Y\FZ=I(16%XY\X.V!4;!5N27%ELW9$>%0MTP\+
M/V2AB3@+54Q\6.J*)0Y%0J+'(>[S2K?VX%O\,8_POH[L=&#56\ZLK;B.4$D=
MFU9"4WK)=A^L.,&YRK]-O[OQ<+&Q7!*[(4V,U'IH(!E@/R(!C3&ATC<@6KDT
M,<&"1J5)G;$T;2.,E9;;9 A^3^Y$N)W.Z7(.OO3_+)/Y N2F_;7K"#L(^79O
M5B;6Y99!XJ+#,!RY7EV/)LEDX!)?;)9LWB2UV&ZVF2"V?MJM^BNJG#PQMEY.
M!;>H[^GERNARFXNLJ\WB#1OLVW))\[PNI^LKAHR+6DRL#(9FU9GS='[I_?&$
MJZUR?[*MQK ;D?$JWNW26ZL\#G?DSNC[MG^=)SN.YO4ZE&IWO@@=#]P&8+FK
MG2>2K9>CG))CFV=PN>FPLK2;D\R;7L'C)N7^^2I;<O<B<.F!M[QS1IYTHXU-
MZ%UW<J)=B8*M'E]/MNC&(E/CA8T8^-ZQ(B8(4:@%,IKH@@A?2J2V[-W=?!/%
M(*XQ3Y0EX_?'<LX.IIRX))TP?7^Q.28>W4K' 8&N29V5J)I\KU=+W4Z'J:,F
M $<L^>;0]U]=(@R,90G%?>UIK?:4]K6G[=6>\I?5GHHW5GM:I#1?U:M-UGV2
M!Y>)AV/N95"\4N'Z^E:O*W=I'Y.I5RL[SS-]-ZR!]<W9!S*%-F'^R^ F'2['
MZ>_7.Z Y"^YK?]E9#L;3P9_O=L@,9U'@:\Q"<%D(83(B.B@GW6>1>E_%!R/E
M*\H)#SE7,D <^W&Q\R=C%,O'"YMC16/$1:2P$!$R''RE(FP3!$8J]!Z\I116
MAYE%M?DR;4;47M=*6JR3MN;9H".;OWT+@N"*3ZY2VR^T<>MP^S5K%UW+!D+E
M!6IH5[_KQ"[3XS6Z+XQR)EQ'AN0-TO&X^/;_>P>3:/^V61?EWSN&]NOH%LSU
MW]([[_,4UL7-I[T;#1<W\"N\;L$%!8,[3F99^J'\I?[.COGIW8H%>,5:S=X]
MS!&<WT+QO_]4'K3Y'7[D*WK0:0=3$Z\S8N%+OL5Z=94,_OPV!Q]H^'X]OZK;
MK,8FO1WM5YEK]Q]<]X<\)&[MK^S'ES7YO1T-A^.TPR-;&%I'&]N21=_[9$'H
M643:Q9AV6^3V=V=S<;A5!,3NQ+Z@'V4CC/=MO_)S^!\[S.!_8&V,PK3?,SI5
M4O_3P*)X+:ZP-]3UPBX=&XOAUE+XEKIX'(H!1/5QM':(6[M&S7H&</%UASO9
M%1[L-V7<-$%NW77DXY7U([7@/F&:1EPJ*7&@RM +,SS2I%G&ZFY80OI2'I.S
M^EQIJ??'I*4A4B'*B.2&JSC"@H1EW(^P@-JXWR-A0T%#P7S$&#'(5P&)%$/E
MZ9Q0":>?0J#01=)<++ *#A:[Y..2W6%%TK$>3\Q#SR[A9KUTW$6P-^O#DZU]
MUG6^FR$LZ)/I(N=_2AV51GV+?;N*?9LRV>8CC%UP<\?3UEYG;;=V/<V\^>WR
M/B#:!T1?W\1[24#TN:'0SH_I&PR%GD9/P?7PPT.4(A]>*'AO?) >W(<X%RGY
M6%*F]6'R4PR3ZUII!;:9S()'%/X71]3G*BJRX[D.8RG:[592B%G7@FB2G49#
MYW/!JT^/<1CV(?0GXP.K:KR-(L@@;70$?K@4-#!$%/@0*!SJ-O&AG-9/=E+A
MB*B<TJ[A!4$[VAB=9=3]-/ DC[I?'V0KOQ!>3A$^:C3[*-0F1#B2@6!1A 11
M/BO-BT 3W"9\_)9V#BAT;UB\*2!X649:BV,PA5O92JX/-Z,A:$43<WWV7F\)
M)EM<JSW$;T \1;A*$?>50 I\2E_'6@@C?:UY ?$^B6C7^EV^[@* 1:.;E/T"
MT#(FE'+40\ 6!-189*BP,22L Z)U%&#!%,>K/"LMM_*LNJJ=JM&NU[URGG%R
MU%$ZFK^9S*GGC49'@([S/JWJ>&E51U&<MY!SM540_K;SG9KMW=R!%K/K.53[
MVBRM&$JV6KVUT"W[XNVT<:5(R*IF!R,M%7PL8AV&D?2ICTMR)1S&_'E-.9N$
MT>U^FNSP?IJ7?'N7X&@M-9_>.W-WC\Q51\T3Z(WYL%(^VAWSXIGM,7-ZF_'H
MNFJ^5FMR<WN;S@>C(HVR)-<MX*MLH>-::UX<K<OF5I[G!LP],GZVU<Z5Z[T(
M,V??R$8L.\!\3Y&LF.^%]*5F* @9<7P(O&H;'<;(1YOFW,-M>?_(TNOE^!>8
MVM?FP'<-5K+CH,JI45R]J.=EG75DU5NU;X3Y9N:T"XTPZVOT&^^"F6\G]:TP
MW[C:/- *LPN4>10I=HXAZ);&_)!>F"N#K[O=,'>X$VWUP_SYD9Z2NT;*(I\M
MM#I:9\FWV0-NGOPUNDH&R]OD:M?^^YN&UEH/./+D'G"U@;$-U<#A "2^@3\G
MWBV(]F#LUB[KL5]-ARXL-D]F*5@N@\J?M"C^O0J;V98P7FP[LEF],?/E-\^O
MM2.$^_[P+C;^NQ]7KOO*=\S]2S":;N['\&!.=4>3FV1<+J+P(#?PR!>Y4OR'
M>\Z?TXD-<7T9C*QU 6ORQ\G@TEWI9[C(],LM&%?_U_6$=3WI;*E;'J8;VZ4H
MCY2[SDB9]^[G+_\W;U;G2@S?.^=^O4OI)!M96]D1D7=CQ=(5.07E'!'J1[$6
M/ RYCE5<Y$T0(:E!SVB]0@Y:LSY78M18;PTI7ILP?%>[E>YT)* 851SR!"SC
MR \XTHC%E(2&4)K/O$8B"OPVFJZ\GFATHNU*B7_675GKQ-,3\-JLU)Z ]P$"
MWE;*T!M@]14O8_65[0G3GNY#J[9'Z\'ERLTLG?\?5C'V[=;C/W:%M9WB6B*D
M,5C[H0R1";#]6O@4Q3Q0@0X"J8W?5"_Q-M?[@RODY.5KK_BN4<.PV%]:\T=7
MVZ8KJ;(!S]%DVVV\\"8@:L[>'"W2VU4#KGH+C2NP:,%6];*;=/^>"#S2^K:9
MC=@65UVYLW4'QY)@+!;ST=6RWL5@TP,JPWU@ D_GZ?8QZSYFR2!75Z<UQ]54
M'51:GJ3%73JV>^QPU$V6MWUO>[5_C:[RNGU9KW,%KK>V6+50RN4^#UCD'962
M>G^NOW5ANQ^3R@ZFC/N82<JU-AQ+&<;,1*'6H0D01>S ;*I=]'S^'%XE;[V0
MA3?VUX^3TI+>Q^BWD8A5XV-_-;3%A]07;IFP;4US ^:+K(4;B\TH0&J;E#.=
MN"4?%G^P-]V>_HYM_>V7];9B1/_^?Q+W9)D2V#>2\2#B/D>(*8(1K-(1B:-8
M1,(QY"3/M?>>;Z,>QF "SZOE6CRMX")RG^1I'!^NIN/A5H -1,7&UOA3E?Y(
MSW69X^=JWI[5$,&RF:P2@,93FU26/=[Y@&A.F>8*::,88(P?K 03\4C4.Q\$
MA'+#F:\"'Z0D"I4L<@,8_$ODHP;XWOO@K<X''9N?>'>Z7D>ER:NC8)VL[M V
M*H=,V$OFFS1/6<?4*^T)_N-? $+E3\Z\7LZ=);D[N=/9U#4KO.@%5IYTE60C
ME^1@N>_&]V6\=H,7>;WS5XV8[B+/,@-#*,\7R^Z265;L#GV'3U?Y36!\IO?E
M+O/U<C($([[!?967A2H.59!J6Z6N#N_^/7Q@I%K=,SF^Z!TB$'GS'9?PL+$A
M-UW.ZPY0[L1EZ=K)JSU#ZS/56GVM)P [#ZU(VJ\WQ"UV(0O_+4O!M $)SVZ2
M>7H#$Y7.01)7B;HV2=!N2PQ $VP>P< :/7EZLLUMODT7:U[F2M\>'(115JJ=
M%?Y1Z7J"*EAG-/V?)9QB/UAX:>(\A)G-RBL[3,/'E?Z6Z[(;=&<YKQ@@KQ^B
M+G^H.5_^.I6"%QDH:YE.2=Z;P?FWHUO[3%5"L_7-\_P2EP;IW!Q[Q*[N35GI
M]MM;'M21R?NAZ/7VXZ7GVZVWZFWSIRO>H=SXVIR-,A'<W7$P!@D878_2U3YW
ME3&^UH-SE65BVTFM\GKJX>FLZ"\Y<6D]9:;[:D]C+;[VHB?W!G ]%^3(WV&%
MTZZE>)8F<SN<<,OZ(]@;3+)\IWJC[WC]L&I>FFA\M;+S:A7 OQ8"_[NM'LY7
ME, N*'_4R@8^6CFPQ<63 9R5[&V,%<"ZS0)NPH!3@0*L3,17?HLBK&8>&H:%
MD(IH\">XI#(FNB"I90HC24ZOL]7U=#R>WKFX45Z2D6='U >W!,NK]-MH,LDS
MTH8VZI,O]WD<K8JQ[4?T%:JM8521=+FO6&2EW_6.P2X[-@]$G62D:&USJZ5[
M'*$)<L\&O/:TQV,#5L]C T9ML@&3SO#6G@H7\+F.Z-ESW 3%(@SKZ<[E27:E
M?O[L2N2[6P6O*$D5JDQ?0:5ON#!(*0$&K_2%*MH[:())M+7/O;+>?ZU"0_\Y
M6MQL6>K9NJF>K1OVJPT:=ZV-39HBT:F)O19R2<^GC<@90%Y4>*QY/DGNWH(3
M8-V3;,^B>EZT/D[/<45VH>* &,E02*+8ETI$3!9MHA6/ L.:TO,'U/SG9#3Y
M99IE'XMY^SB)BEG;L4&KBKC!B]6?]A1 ;TFYOZ2+Q7A]:^J,=/F'/<I,*V76
M*/21\(E@F(01Y0*7V>9:2TS;5N;:/+6KO:Q![=V6\RX;KKL\Q'.! 7]8;J 4
M>PRUW9XSQ(4]L,!%!0M"$()B)(B04H<B"**"T$I%*.2J'5APE EE3YY6 8&I
M1IG9^_7\E>,3JBOQB1I-V78P[>R"%\\;C6Z@H:KX8#B.-)?(YR**<:R9I*)H
M=J$9P?$V'\R1(ANJD<B&:+-+Q>-,?NVI2(^DQP][;.\5I$/[OS=E*ZWO<AR(
M%;JRG&@D,/$I8$,82.DK0U5I.2'):4N6T_.B([HI<XJP2]4DA#PD2#TZM(P.
MJX+ALGK$9>V\WRX6ZJ'B>5"A<045"A% "$I5&/DX5)KZJ&B"HT00-V=6/  5
MCSE:C2'#024J/3*\ 62HY6_/+-O7L&"S:Z*7WMFB :W0()(X%+[U*P2*C4\4
MYS(@ 3$^Q1'G<9W]81<2W#T?"6I7^>2FUE_-;*O8<,E[:#@!:&ANL^6$@6#/
MGHRN!5\-YH@RW\1:TH"$ 66TL MDA VAK[HGTYCV"]GHENI>T7D+NS6;HG/.
M>S?[0KZZ,R'?AR2OB[U>-B6LE<CP7EU\:RUAGF7;J8K1@&N*K$^'3*24B%$0
MRY+9"VN)&PL*/36 K!L)(!-]28X:0'Y5A7L+/6+JI<YON(CUXW8A[PEQ?GXM
MN'_62J1VU2ZODX'G14YWHZ'EODP&@W1FZR6K"RW2P<UD]#_+M-Z/8M7CI=[M
MPDLFR?C>%EL7U.*KZLM:0PQX+E<<NOU@1:./U47FZ?4XI\HMRK@L%#@^;WCT
M[)$7K#^G8PG.PPN+J27I7LX=*;>C;<PLO_9FO>;[G!T]+^ZJ7VK]3H"+WXL:
MRM'M;&PK,K]/+2=I7E*65]96M60%;>F.0G+796AC-FITY9;C:9C,AP6A/\SY
M-]=U8P)6=7EH;3**DM;KT5_EL)=$:-X/KI1RD(YFEMFL8'JJG[N:KN_)?)17
M&-D+E.>X"Y17*PA1UX]\Z%;U'B?)6O%HK0IW;7#@$K! W-GWS@?Z1QBDN6V(
M451:;U79[IH=>,:B34'1BZ#@W_\^RLHF3?Z7T%,$77B.B,*M:UYMD;SP[O)^
M2?/9-+_P/!V.%C7UJ()6NPJ8UUI0V7PARXL[FX]R=O-"PCV E!M7/#Z]FWB
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M\^?UQZ^V^,O_1':W ;RV_V*P\0'/"5, =-0MS93GC6: M&D#=EM4K39&0_K
M2![Z@1)*:!W*$!&G:C241ID OE2U4L%><KI\&KTX#3.%<OWGMV#C8[ 35BIR
M(]>2X'=*]=I3E"VNA;4[3#><,_1%)QPX4&]G*Q"@-CN8,:9"&W-#(0)A.!+$
MX"(48@1RN2D"?'L:+T4 ?#$(P#L$.#T$>$&#>S 8<"Y$.[" 5 >@2'",79&,
MD%P$,!0^<81:H49,AT0M5.VOQ()[JV%+T8!<"!K@XZ*!4]>LZB^)LYSS;'!
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MF0</@NO_[\;[N( M*S1HMO]73A?=4F5I>?O]H^\6CVJ:>IN?3\XO9<&A_O(
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MZ&RZ L$:K#::*G_J4@\^C?SR<;.G/:S!W)8>&!V=';@\HHA</:NS*4Z>TYS
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MV>TD]G^.Z\U]_<@EE^V*3_KNGV3VU^)N\J\0\,^_E6]Z^;?7_L0W^MB2K\T
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M>.'/-B$)34GW8'1O=W/9)Y90$%T8A,$UYA&M,X_KU/@M2W-:>BUK<R2D$)*
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MV&=5]H.LZ+>R*.TVU<KPJYU65'"A$."",:.!!!!07PJM",<A\T6]TTKYAK.
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M6F_$N:JSC3CRD<=J++U78Q^97XW&VL3JVE1O$U...GTP>5[?&D8590)('JI
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M32%H:C6Y<U_KJ5=\XUB:.O?UE%"E<U\OI^"^-8/(MYM9WQ*;)"J;Q)4DB =
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M741LX:;O/=C5B)S_;E?O,9HD@]GR/8[3R364@CF/=Y#F*8S\.G9)[-U/;VW
M/'#1NS6Y([LN^=+:+[QS3N][9[L1^"W\7]'#XV^?L]_@;[_8G4K&T^_WEV&L
MZPFK^\AZNJ.98=O[(V\&6+R6"<#6@G$)@<*(L) #PED!6()!J7<'K'_4):EV
M'!<6 O3ISN32]74F7,M'T#9@Y20]ON-KU6RY<A5*XY3L_]I@O$2XUY7VU:AJ
MXDI>!MG['!;:;VZ'^%5Y"JDAYX0(GVM!C"9$E>EKK+@?;BM^WV8/;C]DQ:LF
M=H6PE=+WBF7=I[ME([#%<M##"V(M5QGG#]W%8A<3B[E0+$^5+T9B+Y#CMB41
MF*RQ[H8A9:'UKR$UP 9B)#2J,%P\H QOB1S^?33Z'G\8%4G- R1L7B4PP*T,
MRN:%HRUAF&2U=@,6<,,!=C$Z@M;)D67Z3CN6C):9E;=%:J^;E6-+S(UW1K'5
M_[D?N./;E1%66D18$QMP#JQS-BA2%NES:@UDYIQEZ<W><.K>/'D:>Z/X*3\Q
M+ YG8R].QDY2*OQ-\V.%[\/QK;W>8#2QD#1PQZO#\=.U.\7NET:WC+?^^N'W
M;Q]FT59UH?)8./NBZ_*+W(N1%>CKZ'::YM:_O) .U;<EUSFW>#E;K_HZ)?&_
MIH,DGCO.L;A6[)QSBEQXF^U;_7PWGDR3T:O1L?UD_+,7I]DA?E2>8KO-+#X\
M+NH %JXQ<[UFVY_G,N8#S$%:CQ?LO>4912LW,R&SWY _;W[G+P/4U,N*28H3
M_1SK,K'./^2N4/B$!67O[$#?B;9[PHS2MW]5"EN235#+KCP:UY(1[NOF<C,#
M>PN]O+RAO,%LF>=\S24%$FE;G$VY;RR=5[NMJM.^]NZMCS>,/]U5%;*?[E8X
M,]\RAI#7BM>H*Q"0V%<F#'TNM*22EO5&@<*L5KP&!=$"*6QMKH^E#(7 J(CM
M %-,O5K7M/9[%HO73AJ5OMK;R%C:L[*4<J/*FI,:4KTL:%JH-!I;-<UG%N;U
M+>FL<N5N[,#'+L.O6Y6RYC6P+PU ;15[]I;CY+?=MJ*XR/%V @+T8GFR?^^3
M\KL>H^_Q]6T21W]<1W?V7G^-AD_1<^I*>.^38JT:ED6PSP587MY</L;<OC=0
MSHAV*V?$[S:YBPW0HY$]6ES)VD7G6FM >8':CM:_M2@[K=?G0Y"W%N6:W8N'
MP^*O__L=>)?];C>L5_Z^1 Z^#1XL/GRT#N>7\4.TT(CT-.A/[NV/]G&+FG^K
M"L/H,8U_+7^H/W-6X?]N1BTT&^P!787I*N:A_#L8^O-OY9M>_@V^\B>PW<?.
MYLLVIG):[  I6B7:S?&T68WV7?:?-5UPE3C"=8-FFERKE2M3F+&#K4V=!&L7
M4K#Y9B.T <?:.4K:>_O)(FN2KN@WG0D<?M-@H_:LZ*$E=$MFME8MW[&&9W4R
MMK&,B4[&.AG;LXSQ72QLNPWEVEBQF!RWZ[2_Q99EZO[;K!-VX";Y[5D:5JU&
M:]G!+PGX3EQA#SIOKMOC=NWQ=E8)GMX*%*UIQQNKV"Q@MV.LXKQ)/@$+O$F;
M) 2X&J$"@.$*4\0- 5H;^S]>G%%)$4).7IZF%=Y/(6W-5^&_2B#9*&-PYW(<
MWAPU_GQ'@]MM *;%.+(I<M"J_I!J0(2OA1980N5SJ458\%L!@<T"K_G;D:.Y
M8N,;T2!R= #1 40'$"L @L/:=#8=0(BL&R&9P$$ C"Q: 161!BX,;'X[0/"F
M  +)1GV+HR'$Q40[&55$EX+;-@ 0%=$#E+Z")@3$  6X"$(=% 4G4H70+$S=
M*K0TVP UZO\^[ATZ#&B82+Z+ XZ8EEJGHZ>DBALJ'P15FX:4*#1,$65]:1:&
MQ$=EM[Q"+)"T*>5KS)-&YV$G.Q4[;Q5#57]WR'RJI/45E>%$8!($O+1O)#2+
M//S;JEACOBB^ >>@8A?CBGYPI^^CK!!W5?I]<Y?TS24&E^*R0E)935\A@S@,
M?2F!0)@IA$NK"25$"^2-96"9=Q@=VEEM4INWEH_.TK; TJ[;O5-2XDW5EE66
MV#!D%S&4@#%),3%0*E%88L3#Q8$(;U?;QMQ<=E"M[92S4\ZC**>H>-ND8CYC
M-OQ4H5"&A QQO^3[M.[TJDCT#<K9F(.\C!3B#)7S4NHIOV64&KUFJBH/Z3_7
MYL2\06S:Z%PC4+/2)H 6!:1/-3/66/L@D(5SC0%8>:R[+U;&UW)1I!V^]79R
MT-GVSK;OT;8C5-EV C5 A$+@^S@$5!IJ"HI#:43(5AW$'H'O"8(;= FVO5/.
MRU9.4A5@,H2P<?-'F+"+J0,?*5HR=0&C5Q5@;JZ<S26FT0V_!.6\%,>[G(BT
M:UM<DSYURT#L8D#Z&.TAW5YV>[G-LU[,R>*K+3U=F=M:-PNCZLQ0()\A0R0-
M J6U];$XA>7A ]1B81Y8:1R+/3A">@,V.T.Y.QEL<0QT2JJXJ?*16DY1("PT
MD8QPIJ5"**2X4+Z 068:4[[&$A%\R32@$RS"Z73LM'7L_3HEJTU>PB'U";4F
M+K"VC0/._, OVRU,H&1C2O:VA,(F8Y6:/6Y?%- V]PDM8]>Z& ^W:^/8R;\5
M-?^68TQ#CB0*?6JD#@DKTXC*UWCAV*[4_KDZUZ-XN8M#;3LOM[/ QU;(#560
MU$[.?1M9!GX@0@05H(H2+=BL+!5@W; *-N;KGDG!>:=IIZUIZWQ=4CO1QL 0
M1(T/M0H- @$UO"PE5=*PA:;%'56M>8\7--K#V'F\)^/Q=MTBC7C&:\&BUBY"
M):1"&>&' 0'*A$(@.<L^";,P,&06&.>UK<><-TR:]8YWE9=3P)>7\K*"O;IS
M%<ZX_&8M.K *'0+$(5!40>NZ(\8PTG[9'RJ-"A<*W[=&A[?YZQM-(V_VA&A#
M03@%$.C4_A+5?IW6U])E)L204LA]7R'.)0EE4)Y(2>XOMI!NK?6-5=_)@RI[
M5WQWD*Z7_F8E>%T@L'4@0(&H3+UOW7_#B/1-:(T](IB*DFT%V_?7A^*6"K]"
MTW4VXO'S-.G=1VG\.1GT8M5W0['<>,:#A 8-)\Z[T*#S$3H? 5)4P86ROW"J
MA(1(2H$8XJ"<H1T:WT=[A(O&<ONB6:ZTMGH-G=9>MM:2BL]0 $T(1PHZ\D+-
M; @?E(3FOE5<LD>M;9 "JNMP/SM??S;">&&"\<Y[BNV>]L=3-R5U%RT_;H?S
M,28^K%O%749"G \] .55NZ* 5$&*J>*A<B>P-HXJG"(! $$+I;S'X 5 >TR5
MO$5(.F* (_E*AX?.H]F6O<#>&7B$LAI400*(E8W8:" U$4)A5E(;<6UCNH5B
MD6/P'HA&)U2LW> .?#KPZ<!G7^##8&T(!H(BD"H,0Q 0(!E4LB@^X8PJL'"\
M? Q>AWVR';8)?+)X\R^3R-Y,^7IS@K'D.^V2NET;C*91OJ;Y&G^</MAK]%9[
MP/,2\;5W'_>GP_C379FNL-*ATC2>I*Z2<1#=#H:#R2!.O[D'^V:OJ(?CWA_O
M,JETOWZ-AW&VJ=<AXXJ&00!\!(1O!5(Z3B GC#HDVM?78":W*! \1*'"&/J!
M-"%GO)CNA&B@,'_GQ5:X'MT&)M-X?DOMNL77]W$&QQ"!/[]4X:QLK[;O+J4R
MN'O.7QJ,+$9;Z"/V/?L/@PJ!_'8?>_[XP5[\^=]2;Q1/9B=S+D+W(K?:WOMA
ML=;/O[B]2P?I)/7&=][$?OAN/+06QC[CK_,RT,"J+"Y"[:)SY@*4%RC6T/U>
M_]:1PX#A',!"D,-IIA1>+QX.B[_^[W?@7?:[?9I>^?N2A?\V>(A3[V/\Y'T9
M/T0+QO5IT)_<VQ_MXQ:X8)=^&#VF\:_E#[^]1(!WLZ30+.<IWJU.&>5?P>F?
M?WNW@%#%U[_R)[#=Q_;Y91NGQ8XU<'Q'M^*-X\8W2HKS-S>)[;!4*Q?FT)/8
M@[@7/]S&B8?AU2[YU;9.MC^LH+VWG[37&5I+F:XX&MZ<%*FE*WIH"75>S4'*
M$?:X?&WE\6G5(AU7QL0%GRX5_?O><&R]U-3K14GR;*.]IRA945;6^&)TP\#;
MD9[8ZG"'XUH3.878,;,8)B&63-KWD#SH8R$R?"6%Q"P@_?1H1=$&O-]_M\+H
MUR0Q#<8V3K#K_"*1\2$/>QNI=&F2L:5K)&];YO3L$Z,M!I9-H816S? *,!$8
M/R0RU ;ZV#=^48;#88C)2CZ*W:!$- (E$#1*=-O5UQR"169S_Z=CEEFOR;S*
M!/, AB2$1/B2@I!HAEWU:^842*W0+IH\UXZ_-\\ \D:'EG:N09NK7T])-3=5
M1B&K7G8@L<&0A$P1'\B  :%+LXH8@7M4QH9LJVBT;Z6SK7NVK5_B-(Z2WKT7
MC?IVOW_$P_&C*W_N[&P3=E: 2K6-#P+M<U^'6K'04"IU<>+*!).+XQ$75-O^
MX-O?!Y,YM2XW<+EY_>_B:O\]JSM0T\G]V*K"L_HY2&=_+GUNW^[2)'G^>W;L
MT$A7:Z.E!YUI[DSS(4VSJ+6+<:U]::R#C *(K)4FDI1EAAA(L)+^;7O]%<?7
M7QLJ=^;\A,QY'BHGG5'?IU$G%2@PWX1! *D((35,("G]@I:5*:G(^HSZ/HWZ
MG,?_MVDR2/N#[(D:@P?:F??.O+=0KS?59%;UE6($C)$J"($/!">$<+\<HBC\
M0"S,:3NH>3\U3>[L_+[M?&]@[?G@SKYWSMC'/Q_M!YRMS]AG:I8_$\W. 6C$
M 1 5;' BI?:AD$Q02!$QAI91O91AN)1S9@UD5'M;@H?5_+"VL4&UK_M+JL/.
MM'>FO84:NZ&.2E"C@%0D&YABX_= (DP5U;ATTD,FP\/K:$.Y=MP%YR=EM"?C
MWA]6&!Y<YU?6,M29X"U-L*R-_O.Y1H9)P9"PH;@QFH>%";9*+\'*Z6-U%2]?
M*[KR_-H>6<4NFO32K_=1$NLHC?OU-_CC=']VF#=+\-29X<X,']0,UZ8$$@B%
M,I0:%@H!';&(*JM/-=*KASKL64^;L<5G,E#P4DQQP?/K??ST^PIZILX(KU=N
M5BFW"! ,A76L Q\8B"GD03F$01&#UJ?/5A>N%'NU-Q.+63>)M[.Q+53*3=50
MD%J'1RBYQE!AK P$ B@"2G9$B,SZ(I-MU+ 9"XIIHV6<G0G=LPDM1<=+XA_Q
M:-J-^=S2C"( *OT%' 2<8P1UX!M?8ABJ<O 9A83PM?H[3WFZO_1PLV6>G<WL
M;.8A;28"J**\5$)P$P2,!B  (6#&*F"1/R(4^.MKKM?J7$/I7MAH+J@SD'L?
M!6CMXF2</&='M,F/543 G8E<KZZD4E> %89$VF#3T% A@F8D5XQQH=:G>V?[
MLC_KV"S;8V<<.^-X4./(*G+5, PUTM(/# NP4MC(D)7U#5SBW;2MH<"QBQM/
MR2S^'D=I[,VX]CJ;N*U-%)5-]*T^^K[@6$@:"(,,P1H;(KC/%6$$OUKA4*5\
MW,Z4A)/[LXX-TY%VUK&SC@U!T__Z?P2":!OVDLYJ[-EJ?)K8A>G&*.[)ED!4
M>7Q:<->H2I7OLB !-XR48]&X8G"]QY=MU1X+8AKE@=I6)#KKT@+K<GFCT! D
M%?>\3P+C(QDJGW+L:"*4*IE;*)0,;ZVIS<1EI)MH?$X6.%A@3._,\;[,,:N4
M'(<D\!'A!/H:!J']0:N2-H*R#>B9_IJ,TW1_J4ZTS]$VG4'N#'+;#;*HJ-24
M,5*'H0)8!!!R1JV.%KKJLQ"#K76UJ0-$>5!=[4SROJM8!S^M/<YL<7>VN-+8
MOE^CP0A4&@R-HL1PS'UFM)&N:*[@7Y.$VD^\HL&U23V?D_&C7>7GS\-H-'&-
M8?^:#O;;KDGA#3I$4G51^'<1A\/2A*^8^= 9[Y/,U6ZHVZC2;4T-#("O A8R
M:"C@F@;E4:8OQ!YTNZ$XFC5ZP'E**KQ<:2_%O'\83:+1]X&;W-79^!UM?#UM
MAHV;TQ@"0 *J&<)(%-3E"OE ON:EUW#@K^-Q_VDP'%H(J/:I+'F8_WU_5I\<
M9BC"*4%&9_4[JX]J^3,3H) Q3B$RV/B2X:#D=6(<"1@>0MN;\0,8Z/R B_0#
MOKA;N![?74_3N)G,^P4[ @+5SL\(84"B %-!PS#D0OB.U]4 *10(_<V@P55-
MV251B;W][[&+!/9H\ _3J7I*T-#9^W.V]UU%5FNM4E>1M5=#A6LE691))%TS
MFC $:1(('Q4M+T+)X-6Y?35#M=^Z+-QL GI7P>A,U_F9KG,\75X+ Z2" <X$
M!5Q1 7S L<1<@Z+>2QBI]6N-JAO 0#-!:K.C]3;=\5/0]LN.8>>JQQIK_NG<
MAY6XP6K=03[BOB1A #D)D:LGHV4)F11,K2PAFY&2U]!CCX3#I!V%9*>$*9T'
MT7D0:Y&@WB?((;2!A/T?IP93!0$KI_8BHE?/,-H0"9H:SWO8'H]34OC+=B+^
M&0VG&96G%PTMND2CWLZL4YT'L0HW2(V62D.L!#?2!UHS8+3&0<FY88@P:FUA
MZVSG5+EQ^VLO;OA0O/,C.C^B\R,L'J *#Y"AC$B*?8.-YEBP0)=LKXQ"LK[0
M?2,\:.C8O-GRN<Z;.!=OXF,\L?+TLJG->S_+3FR#@O/B@:UX],=35\&W"S3L
MO>EI1W/QIWTLU%K#^O^S]^[-;2-9ON!707B[=KHC;'>^']5[)R(S@>RHW6J[
MPG;=B?FK B(ABUT4J4N0MC6??C/Q(""2$B$*($$1<V?J6A*)1^8YO_,[)\^C
MAUAZ(-.BH';48Y@)K1&6"^>EA9RPHDF^U(P\V23_&%$:"CHD5X<(P3G [,"N
M3H2;)S,MG0!BCW&O,=+Q"NF I:$,(<3(^94,<451V;U $8@;9E]U1ALI:;?#
M<=/=/0= >X(W_GT9N[<J?]^>>.U(MLGWYL/JUGUE]& AW)63=S=)MI(0@9\V
MEP[ZM:NMUK]7Z7)R?9__:C)S6.AV@+C/=&\2BD)9E0;SZZ!\P8YN$B:C;%QL
M#M(8O@T\+^CXIF^#Y4T2^#D\\>P^N(G3( YFCF;__O[S^X?T>\V[ W<S_Z7X
MUD^S/\+"Y.#UEWW@51O[:0"%D0DU@U9*8)&6JG" ?3E)^-2<A;TTK>E0X-#]
MT<GMR/A56MRW-@J8[SC"#]PR3^L#ZSK=CVR4;>R?,1O2,]MTU'HO*;)6;11"
M3"4GBF +,-61-(69PY (\NB12YN24HSN:%M0"-IQ8GM<27D??'F +N/S11=9
M#5,RBE,DF+:00XX$""$I)AHBHP!\*MR^EQJ=&EUVG?+W"UWR,%!?I416!!J&
M!$C(6$0%YZ$?? D+*5',\OV=@3XDCQ0MGQI7Y'M\<ADY&2$374/F0QH]T.8S
MH,VCE5/<V7):$.B[N\7\A].59>)^TPM<HK"R7LH8P!S-P0!ZMS[D(2^SU37G
M>FL4X.,CQ_K)C\FN&.B1X>FO/=GURAI18K'4!G!G>:BU$0]QP5EDQ$WX5#AG
MW^2Y<B/[*0[B]-+@64MR?9V,ELGX;YZY9/3W.AF[%9UF!&=>+FXP=:L;C.K+
M&\33N?O#]\GRIB=@4AO.9*@?)<J5-EASHD-'<LKS$,B<L[TI5F[[C9.JR;(N
M02HC<7O$9_<WZQ+T*4F3>#&Z:4UT(-G1"O_(LN.^N2C>*R/&X^1;,IUG'6TR
MN1IE:[(A,>X?#V7,?S-=.H.4?>=NM;B;ITGJ;%B\#'S=?'"5?/6,>AXD/^XF
MB\3?MN,W0P#Q8W@2W;\&Z9QK. FX<^@Q<5M_G[O4ST00MZ.+9.1CW.,<2.*>
M0 EF%90(%9*0 1.IB(4HC#0MH 3[O+;]\\>;)K&=VB*1TP?POFUG:N9R]7RL
MN8F_.3=\UQ5[ZJ-34AUR8<A5!*4(&=.1H)'F$2U\=$9)N!7)V6F$GBUW)S!E
M<L=IV6E#@6E?I*%*FXN8EH98:)7EVBAHF"P0"&E&MH\\N_*,/GM+K6;C7^=N
M:__?U6*2CB?9P[<F#DCL*@2\3">)B*J]J.+>)3;:;3?%8:BBJ#1!H2+\J1:$
M^YRD!WO:=_& ?$=.YJF=IIR_[N,Z;X.[A7N)A7L$_Z5_Q8O[:190=O]GXNG$
M?6XVB=\^37T=J:,UGE4QYX;<:I<Q[(WYHU7%LK7:&"QIJ$)L=0A!*(H0-59"
M/2<4U#;W.@($$GIZ[ZXG$$BKDW,G 5(#!#@*=10R"1 JBE&1%;#!0,GSDP2X
M*P/]E&BW397Z&%*N-?%C(=:6H3#,SL\5"J5CT06-!I)OT>BNB%-'!UY0R@$J
MREVO#A*P),@X7YW#2!L$J=2D;,;NFSCNKS)Y7 R*C>RE-&!^>F'8(D?;M"A)
M@^O%_'9]CO[O&G0ZEI2ZE?.<Y+N[_4WAQ+O=GHV3ZXE;(3\!]CH)_KJ:39,T
MS=SX\D+);)GE+Y2>_^C&-]8KG?U9O%PY1C1?^*T;KT:9W^__<+5*)S-_K>*#
MRYM%D@3WSLWU\4IO*_R3UR\W_SY+%NG-Y.YO;_, YH-'WDW;T/M /1:+**)H
M_CON =+JC8KE\D![E22SBLZ5CUI;[37X5EF.7D8GL_R.V8%MF0ZY>8!;.YL=
MN55,%AL)HL\]X"TN<KKS70CPQG)D_[U9E/>ZB[\F[ZX62?SGN_C:/>O/\?1[
M?)^Z)_K[S:)8JY9/N$&7"[ [T[5\C0?[OB$8&9!^<<_Y.9DFF1*^0R'4%$AD
M.:;<  A)5."GCJ"1Y!W.\<]=(AFKY;._3EXF7>7B'DV:^A8GY-4Q%];,8BP0
M%D8"2@F44=&8 0.CU%,=WKIAQ5W9-G+RU)Z'Y+?_F16<US*^++#.I]8VA)3[
M3\!22I 2E!_C,#2Y2O_X5^SD8'X5?QY-O+&^GHS*>+(?B/'#T82)C^G'T[ *
M\+='EN'IZ5$6^,G7P#UTN0@/#S>2VCH\..G8><KQRD]*<Z7S_:L=^GJ]RTE;
MNBO>YIB27[_GGQ3=QO=N]?P7EXM)QJ7&J\2OY/4JXXPY\UL3Q ("_B.MB.!&
M;MR#"I.'"A/F"O/?7\)-I?L\NDG&JVGR\?KWF2=Z7V=N53Q0ZV3FN.\R_>3(
MJ,V?^8LOEO%65T_GHS_?[+#A8>3T6H=6 D:9=JXN E%IA)D4^%UUUL2A0H(J
M+9S%8)939TU4&6S3H=!O@L0IV)WGB8M5TH[M/ATU]/+DP/K;)/6@Z1,2)IE%
M\^+A]G@\<7QZ4;@H#P\)BP\DCB[>NM<>!U?W'OBG]UX EYMGWSXVNUK.%_?!
M(@O2SLO[7"6>WF=?>.(YLGH7)Y&KZ=I163LC/[>>B;F]^K6+/JB@!.4%:JRV
M?M>9!^#I@QHT"/**LZS"*Q@ETVGQU__UQKGB_F?W-J/RYQT[_L6A81I\2+X'
MG^:W\5:]Z??)>'GC_NE>MZB6<WL^C>_2Y.?R'_5WSDK<WJP[%:Q[=T#TYO%&
M!OD]&/KI'^6'-O\&G_@3..QKK^9FC3M#;)=M%\7/_6X9$2:WD_T0=)W]3]-6
M,A ^>QC#"];JT94I7/FCK4V9-!U@^/8E/4:>WW[I-4K:7]TW"X:;/M(]8"UP
MN/669\=9T6-+:#V)O]-^8!TNWZGZ8PTRUEC&Q"!C@XQU+&/\)1:VWX9R;[S\
M]\]'ZJ;S*IMPO9H>6WNBJ)Q4450+ (HT8IR'!DA-E."\F/])(LJWCI7S2+D_
M0K:+^:W)#TS<8A2GRXZ2Z2P4L(ZH)X]5+-6#1B_O:XB/,PRL+?%^]B"E2V^)
M]>H[7O489)K""JO*2R*JF874*"6@(4B$R!;CQ177&&V5X[<+*Z(M6.&[CE<.
MAY4!/0;T&-#C$?005:Y;B#!A@H?: LJL</^!N,AU,SSB6PVEVD4/WA9Z["S[
M.$/TN!3OZ1?OJ\XR@8FGPRR%CKP/ :I49FH%UHHB0*T&F#$+HK!LG1YJOM4/
M[ !%WYW<VJKS 7$_ABP,].((D;A+G(:P3Z-1E7=!D.46*<:1M2%5FLM0%/UN
MI"1L:RQCJQK=&N^'77;VWI:)07$'Q3V)XN*J99'5(85$<XBAYB:4BE!9>NS2
MT*WJQ%85MS7*C7F[<<"^*NZE4/(H7LS<HZ3K!+,LC\Q+<B96K:K\(1,7S@$,
M#F/IK++IH4&<$B%Y* 5PYCQR)KZ$!@R>"N:IY7(QN5IE27)?YK_%/KN\2R;.
M=Y72GV(BQV#1>V?1NQZCT1.3SBN3#J$4 @C(!5*.?QMM)%Z7C$KTA$EOJ+>M
M\6T!CSM)9U#/03U/HYZRZG\C)%0"X(@A1AS'AL*PHAV6Y RIK>8/SU;/UE@U
MA.(]NPC]O!1>;8N"CJS%^S)X6->1#DE$0Q+1/B23M0FH1F&.!43<RI BC! O
MDXBDY5@^DD3T)?[Q*7&@-9I,)UG$8/UK7S4Y2Y.B1DPM"VG]7$II]7TGK9U&
M]MF."MTAK>BL^,B0&-!3V&D*- 376@8**R2WAK,0<6H5844!J)*1P8^<%W8'
M-.T=./!6!^P->#+@R8 GC^ )JUHR1L10IJD&E)E0&X+#,O] (8'%(XE&W>%)
M:QX;:3>@,OAC':OBY[+I:9*^S;M 7*^+[J]R:7IIM.5BCS+<?]8*KZT6!"(@
MC.'8<*HT+0>S4";E5L_A1Q3^09O,V@EGI[X(&'R1<^<.C;7UG)2RJ1K*JNI(
M1Y%4?K UYH!(2ADOI_5)JB.QU<+TY6K8&E/?U;/K# WKH&RO6=G\M+FULDGH
MRV\$!1'0@D6 *U$< RH8.N;;OK*U=_#P.I3M4ECL+[=W<=Z#MFSV.E]G@PWT
M]3'Z^M=]NHPKP\DY4(@!8IV?RD3$$ 5%&U(124RWQC8]HLM%)MX#=S3,FH3Y
M[GU;(S.>SV-3=W7WNZ=K=H]3LKNM'_V-R6P*R"/M;0;+_8HM=VT\!(\,ML@(
M;;!R(L$ !F@=[D:BZ;G: =K>&EU&.R:<GZ$%'Y3NO)5NKXWE%5\F++(\1!#Q
M*+0J0L[@%NFN4A/6.$9T@-8]CS<WL;'H/6I1_<[)E.XVGI?"Q,UZKL..\0P#
M%3^8BM?2]T(ID( *<,DB]U^+)2AA G!*FKK5^4[],GM^$_MN6'F['2\&5CX0
MA%[C0%/-A[#2?,I1B)5&OL6-4@P"$Q7I;D)+H[;&L'>B^<]CZ$TT'[2:@G).
M"CZH]&M4Z7T:C2N-YC1DG%AH"(Z4#'V2&2ZKUKG#_:-H=&M1\W8/BH>H><?8
M\V4]PF,(DA_,S"&MZMX$(:%0E!*-.$ 8&TA9P<P1XF%3;5Z/_>DTK0.W6UDS
M\.W!./=9NQOK<ZV.%7#M?&I!!96*&R0D*P^]9!1)\$A/F>?I<WN9W*T&O,])
M;0=%O4A%E;4>,D"H"'+CV#2A"DL!;)'6):QAIFE([$E%;3&WI,WCY_-7U(NA
MV^X+Z203Y67\8V#<AV558X2J-HX*6<Y"23'AD0IY&.+0EGH?4K%N-)%<I3]'
MV6CGR;?DP<'8-@"LEJF:C?_?^56J1LN/UU[SJYUS'_@X4Z/1ZG8U==\>%V=M
M9;>@G5,]7\;:_R=9S,=Q>N,M@4 0_6-(Q1Z,=N\TN:G11J3J[F0=@T8:,JPP
M,IP;ZWSGL@>KM5;U1GF[B'@/I^.#VK\>M=^G];6>;H:3$$K%L$]R$4[EN2K;
M/5)DJCZM)]?Z]OA^NY&V(2Q^M!26; 2Q[U3CF],,A/U0PBZJNF?.0*B(T- B
M X'0&CGESVV^M$8WC:B5YUW1+/83QKMHR#+P[L$ ]U\AF_)N7)M]((T0E@,F
ML$!((F,Q*;NJ"F/E<_/']NI@^_29M-IC8*#/@_;V7'MK(2^)&*:,A8Q)30'7
MC*MR<@FW #>M8&ZLO>VGACL^W&:OY/-7WTLAUI^7\]&?3L)N?:^:3 H'3GUH
MV@FN-2<+%5(:.:..N1^C0.%Z:IF"!*JH(21\F,_&R7CE;G<U38J&0I]OXD6B
MXS09F]JVF7GZ\B!WLRJ25KNJ#SDJ Q_H,Q0T5GY6*;^6C&FI0@ UC; 5P(3E
M'&6J#.#'4O[V63X=$EH&K;XDK1:X5H#-&(81M9P"82@4Z\PS1:W[][&TNGWV
M3UHM\SI_K;X4\O]QZ? @&!=UR*/'>KT/W']O/)V :F QH0XB2$@1HY!&)I*
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M&9:[:;),U&CDVQ0XR<_&)DR*\BT[7[B_K&Y74[?W8YO[.E$!0NLD/E_,]?
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M+R_GZ[ZF%:K- /V/-+A.QNM)G#XT\7"T<+)<+8ICDF4QFS<[2,TZQ7MA]/F
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M<8IJ22+(*H.P$!HA)* -(8S*5"V.48-SYHU6D-&/T4T\^YI\BI>)R?YU7&8
MWI.A#=H+WNB2*, %-H2EM0A<1"V$/!01E4SYO_!(9@Q!T"C4NDF+PU9TOZ?^
M_-!"[-11]R=;B+VL-^PA2S,T#^L'U!U&>EC5520T6++(,$DAU8"'.J+ANK>K
M50U<HR8-@-KIZXKI4.I\[H3D>'&(H7E8)Z1)T*'Q8*\/.%Y'*J!UL)SX5XR7
MJY:[WV-'7\?SU=4TZ:;]?7$W_]7NF/+)>^/O6,67$*C#%JV7QTH,5!")(*-:
MT9 R8#&$AD5\/5U(:]2@9#=7A,^9'N3=IU_&KQJE=I!V<SM>+#C/"EB?@_X=
M<B+5"8IMK_ SEJ]/W+$;C.^A*'4$WN>*T8U1N=:N3R =(AP10@20B)L(RZP<
M%&H2 00;M-)LA,K/8*Z-4+G+>/X3$G'VX'O90R75:+2Z74WC;H*'QZ76/;'>
MO6//_2+(^Y"X-G*;,QL"+J4"1$2"12!2N,Q\UA0WZ/A6$^^/2T<JS/SV;I'<
M)+-T\BWY93::WR8?DJ6O.DQ]V6&2JNMELO@2_^@N3 G;S<@Z6'!Z&\<\$I.]
M,+)Z<7STU)1S'\[5CEDLE51'A"KDSU@0"V&$,L;IN*=@M$$J>)LXUU)(E78X
M9F^'1)PVYOKW9>P>IOQ]>Y*TXY[YDGY8W;JOC!Z\M+MR\NXFR1 .(O#3IE9
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MV&(4,2TXSLB XD2+J$E6<D=0T,ZLU:'[\EE9_#Q?Y?E'L[WI[#6T6!Q:+.Z
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M%47G8S]-;Y'XWSI-K7\H;^?;9(S%H7R"GKP!<N<JVG![ZQVN(P&H@22,")9
M81 2728.JXAUO[U;0PH.+X$[]?8> [V:[C"OPBL1XB0DB$!C=20T9.M$!:V
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M&#4:X@2O2N 0PCCBRE ;\4B%5@$E"YS0,.1;[:#WX41KW4I9N[,P!C@8X&"
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M=E+#]606ST8.6AWH%DKCV>S=/$W2AQPW_WM:^T9-"+Q%.6VV  ,$^ZACE2S
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MR5J] !V"O-P\CYB/DNFT^&MVDN%_=F\S*G_>L3]?)K=N*3\DWX-/\]MXJ_G
M]\EX>>/^Z5ZW*)AV.S2-[]+DY_(?]7?.2J/?K/M<K;N#RS>/=\'*;\'03_\H
M/[3Y-PB?^-MA?SK5%1MW 7M8GHX:3+THFB2]@@X5!S:5/_$B;2=>=YUD<IW]
M3^Z(R=U+>3[+-\A8[V5L,YE_D+%!QMJ6,;YC*2^C=>96PM2;__PI*SFKD]Z?
M#U'!USB2^/ .5T/?PQXCX5EK\ ND<MCC\]_CRS!3;_YS,^0RF*0FS8GS2+6$
MO!:I%M:$!& &-14,HL@6B<M"DPB\])Q='B%2_=ESDB(06MSD5R<2[8:5X=Z^
M6VU*7J5@_>ULN2EY/UVFQ6G]_?K:M[/ #ER=<H6A#2T3D>*0,$B-9:ALVVD@
M-%MM.WMXW'H4["!M3MXZ)X@80.%"0(%4A (K2"''P&JL%%;,_;< !8F-DELU
MY#T\^CX**.PXI[YD4+@8OZ4X&![\E6?X*ZSJ\01\7I<OC#!4&(!A)"-6M@K'
M$N C^"OE%O8:7M!VH[+!7QG\E<NC)KPJL<*8A@B#4$HAHH@K2FU1XZLHDD=)
M#ST+[&@UUG%.$#& PH6 @JP(A8%4<V)#8! Q6F@A;='@3@(EV$N#&$W\E7Z"
MPO\D[E)Q>N,E1R"(_C& P@7Z*]OIJX/GTMQS@>[357,V&B&-L1#:1)9P#6G$
M(Z.,,=I:H<017)=\-[/-S/:R7XBSV5RLU4E+@PLSL)6^04I3$$&D.G-A4,A(
M6@UM2+GB0!%?662<8Q-&"&UU>.S ASDK$&DS#').4#& PZ6 PX/1"0R$,A(0
M<6I#@10A- ,'3I@1D3V"+]-O<!A\FL&G>?.?6>W=X,8\QXVA5:=$#(E!,B)(
M"$"@UH;#8FB41 "KK6+5#MR8; /[A2R;QR_;O<D'WV7P72Z0GO#:N+DHXD8B
M''%N-")<:L#+U! E=(O-Q<X9.8:\D $27C<D"%KK>AF!"%E)I!(X1(2"LD.Z
M!)*A8V2+]1\2,!H@X=6.IC]N*Y/7.^7R-33,>S7]\F(_ 7YW;YR\7=ZZ/8X'
MWR0?K-WQ4\WF7>_>/.OI\[ _4-:U/G"Z/ODV&:_B:3 J>C0%?I["?+'QU_++
M[B&2'R/?,;][=86@ZT:!.QIYOK+V]Z^]'>F1D*G[CJ0/9R&/@^G<D^O)-]^"
M*TV3I5.XU3)#KV(6Q,/V\>Z7?9J>7#!JB&3]@%!ISEGDI(.22'*HBR&XR%I@
MMACU!T=U5XN%'Q>6O?_NX<E[.B67=-A=[/=TB_P>.EU,@O?;E5,7-R&NW&-<
MY:QQ3(V$G!"(&((" RE%T7X/2HRV<M8:[+$XT1X+]'X[V_2T(^2JN3)W"_>0
M"W>+H)PO4\R5,/$L'L>9<'QVO_J?9#%U_W[69#E%&6=64B.@^?_;^[;NQFUL
MS>>97\'EGCZIFB6K"-Y9.9VU>$TY764[MI.>GI=>M 19[*)$-4F5[?GULP'P
MIHLMR:9D6D3ZG,222)#8V/O#OD-53,.T+5=$FJ0XJB1J)CE6]YA/EML9Z=_3
MR7*_SX,D YYX](NCC<ZJDXV>[<%IVYJLJS:LO^_9GF18EF*5YXB)OE+KP:FZ
MCNCZIN1JJJ.IBN-H3IZX:@$7D4R09PZ7V_B<UA\N5]*X=G[4,,@"X<-\&LR'
M9-/^V%(>VWS:W&M:PC[/?!N[P+HBB>BIIJ/*GN3JANXY;L$9GFF*-0XT'5?7
M%4^Q=5>7;=<4+<TIZBEDV[%66&CS.7I;\.4[MQ;6\>WRV7A=..#@2"P*=D0=
M3DF3NO(8N%$<1?$]L*% O93+#=-X/]]&^ODB[9F&MNP9R@O[Z#[7![CQG[K^
ML.W;$;]1!\I7!CEV[#^Y57LSI+:IF^>3E#MT[\Y\<Q4\LFV^)L.MK<U0#\N*
M'^#.W!1/>]0A/<N$&= W'1/SF*C;'S<PJMPF/MV!T(?FW&]!,A@+H'OQ]L8[
M)4]P1MN1T7Z;3[$@BYS/.)_ME<^N8:^@5B5G-LYL^V:V%0]&9ZL;5GR0[&".
M)UJV;W\XP#&6/G2H?7NCZ]=6M.1,S)F8,S%G8L[$G(DY$[^&B5^F*Z/WIBR?
M_)*7;ARH,&?O"_U*#OY?^\"S=R"Y&\J6)%%5%[NP:)ZC^:*$? V9LNFZKF2(
M>0*>:"C62J.%#8<I>P^#:$Z(0]+SX/^&-\'#VM)H]#O)_'AUTAU:FUFYAP)E
MO@N_P2[,88O#5@VVE'JO2T]1-$64+55Q9,FV;%0TP#4TV]+V!5M2,[ E*7*_
MR5)(#EL<MCALM12VM-HY0[)MR[HF:;9JVTAW0,$R&6PIR+3\E5S8IF!+;@:V
M9(3Z339UX+#%88O#5DMARZA@RU8]U_1LT+60I.J:ZEA&GDDO&Z+LK!RMV!1L
M*0W!EB;VE:.&K<YXN<ZF ^ @X4,4I^E'5I8?SS K2GGBY-1NNW*9K'_8).QF
M=>R9)QN.+H%P^\C7?1!Y7;.9L",;J?J*L/^:P%I<)O$HS%[MZ4F!0O#=AO.
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MI/0$HECV!,$:!K-,N 1=<A((9]-!?_F[B[))'!!F$H***@33X>(U7[-A7_@
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M+6WO<;*0PY7ELKV&SR+\ T>O]+^V2!VKQ!<PYHJ"&>'2,V+<D_!PKI4)%S^
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ML4#5GT^3QS=5395EUW1M6Q55T2 'LT@NLGS#-TS'/F[R,,17B>?ERYE]=L,
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M'N[/@Z'@1:=?PMLD?$L_DKE.7=C%<BI<U0HWFYY;#23NAGE<J7@?2D7#64?
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MFR?IG"BWU&LU& ?3.U!Y02N]FD>D[C8X1<J'X&/7!;1["?A<0 L!;=Q7_HR
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M7.>H@K_O0LNNII6W01"':0Y%  /!,I#$D5'$<OKAQ*0.].B+VQ7"S0"\'"W
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M*DPZF,6%/"^]0J5WAI7;?3['Z3+>J/G?IE]]_<<FZC /!/[=<8QS0&]Y9\;
M]PC[<>8],: #4B>1T2YBPK!/[NCS-O2MUI;A8S'?VVPZ>\B@W9O6LVTJ+YC1
M&F,DH]0H!BV1Y<HC(@F6$2L8*3UVO+P4^[K/62B%MAL&[<;8-T]65DC'N%-(
M*.N0Q;FP3,(,:29E+OI)>#I^"[NG*7N4K+LKJXJ>:ATB<;8WK#B)1B8-6AXW
M!ND0-9)@&""J$O$J\)!D/WEH7QPV>F=<T9.!S[%Y9Z^>"P_=D-'/RQZ>)8,
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M%\+@Z.G,MM&@D@N"3&'"ONZ#DMM&%5?":^$M,BIRY'74R,35<89@/#JB;1>
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M_X@8.Y"'1XNR'2&+!_5718R#932@&+!$SE&"M*,:J:@B"'EIC#KZ[)/C8>Q
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MTI9X*(.D'K>^U0OGJTM7AXC^)6FCU*\N4<!>LUZE-82(*JT)H%A[[I$4)>T
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MP])XK.RKWEI0ASV&%C"+G/54&:S<!B<'=="51Y2WWY)#=>JMU0/E\NJM*:8
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M T84+&IN&:'%#B<3IF?,@L0]ADY6EH;.0B?KX3KJT,D^8AND98I!K2GA3@(
M);)L!X_U<?UYD<X1*@M$G=B&>C!>\LFU53KLVU)(ZZ"D4@)/?$&I-0%+X"[P
MS* ^$^L<83?#ZS5+R,4<$0PK&)<=VT $4-AY1)W30;WWF"I50B9$5'6FB]B&
MRLRJ%MM0#YW()X6EA7,^*^-P@P121K1!$E.$#.4\[+*VI$YZ^PKC)9OJ%)T
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M^CA(KY<!J.523<+"OYQ6N9[L<(L$ 0>@ \0A'#003R'CI@1%:153O:_EJNB
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M Z98B_^1<9]8Z8^T2"AF@'O+C")*6FNDH$6>@>' FB#9+6(++\SIV@U  PO
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M,];@!V>(U(9+ Y42GC/DI-K11CEO4>P^5O!#5=Y4"'ZHA\6H@Q_:.M<%=-9
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MR+83(X*4&DFM/-6" @T( (354Y9&9-2BME\&]HM+1U8F>GZI9L>J6!Q[/'B
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M[SP4QC(BJ73*,%=3['4'_][ 3OWAM8HN.$TG&?6DSS]!7@P-RCHDJ09:*DI
MZC.#]KNNM3+SJW[],?2DI/2"V]]!8BY%\<A$4*81D-<UWIK>^7LU)!@K =80
M0RB@) X@1O?N >5A1M=S^F?:VU?^NF(T9-#PM]F_RZK6D Y5&WC[P0 %EYQ(
M$ ]<984#,C7BV%&!E&JO7IZ?!#*%&M$+*D/R]N/LOKBZ>3;%HP'A@\\'0KC0
MAENH9119;Y40LJ:)>^7R5 NZ,J@<#IKWP?:LSO8LN-U+DM[ORU1G=IO3L/JE
M_%Y4R^3!/IJH=VQ(G+1@' D))(GG%E<:.[YWV%,S:@6LTZ'C'L O!P%FM-R
M39K<U<U5/-)FVWH!CR&,8R;_P3'! V$X=(02:90BEFN&ZU.->C=FP*FM.M8]
M]-07/".G$GPN$F"I+$E1W935?2IZ=?7'W>+V5,'\1N,#CHM)2R&]L0 RZBCF
M-9J: 3]F.:CI1&,(J,82$UO<%%55S$VY6J_,)OYXM)W+6X\'"8C5'#+EXS'I
M%8,>F+W6:XT>48F?3@AZ0&8R7TX4V/2+V6T!C_#^V+# .!72<*X<5HA#(2BN
M-T'OF&Y?EV6PUAECI">T1VC"U*#C^]C4^4*--EOWUT-QG1HM+.[C(U<W7^)O
M5^FVS.*LDOD]?"1P"!#TR'+#&<!"2\XI\88Q;9G2S92G3)%L6$*_XP<"Q1I2
M1YRF&#'L-( T78TAB#MA^:@WKYN4TA]5:-IH(GTCGG4^56=$HMU7K6VT_4Y$
M3/O]4( 4$(YD!#R:D2B>.H[SF@72@O8ZU3BE^$>3P+X70!<N3'AFC]91Z,OU
MMV*^N2L^+/XUN]MLX53+^?_9S.X6-S]2,O0N7I'15'K66!HY4$_,:+%*&^6F
M.EJEI]5[ J8(6(0=,IA8ZSB$P''!F:/ $@T:7?(8'X=#JL39[PC0 24=B!N(
M-LQHY@37._H-P;J]1Z(G;6%@KI;CX);UF?^3\+N[\L^T]Z=[UI^+55%]+U8-
MTJF;O2 0SAB64@)M@<%*(6Q4#9ER=LPP=:,S>D"A*$< <"SWR/')GTQW:3(\
M6$TM9L0+2PES2C"$8+V> 4>97HX>BKUG24\G!/].,I15:/621&<:D?FPC$I]
MY-"//0V[:9_,HSHQ,E@+N1388T&==E10#'U-K]:\_;W?P>)W_;+Q5:>B/N%J
M&:#_XDQMOT $Y)[.3U7Q,%O,DXFZ7&VIOEI_*ZI=0"%=-3U1;Z?[BX./MC?'
M1/)4H5Y+98V5>V63X0R#>H/(RR1HCK7;_%9^WVKF'Y;'L3M>PK_#VP(&4'&"
M!!<,..OCQJYKW=(![#/:E<8QV<;#,@\E2,_NTJ]::T&[\<%(!9%00DH.A3+<
MQ'VVIAV##L7@!CO=!N7P60I1.PSSD)_ZSZL;O5G%59>J,*CK_]XLJJ,UWMN_
M-  F"6;"$BD=<19+BTQ$B1,K#.,^H[X!^4E:C\#F(7[FVZRZ+>9?RY3P$7^_
M4P5:2]Z!]P66.LT1 :5-6>66$8Y!S0Y#C<TON28?H>L'TSSDS1:I_N3B[>8G
MY[XB-?)@3BNK=*I<J(FG"?LM MY3UCZE<[!TG7RDJC6,H\4'=ZFI'Y;;V.?3
M1,\APW&O/II-C:'=U#X7#V654G>?S/%8 .Z<X4$9B0W37($H#]P#(;5U1BAL
MG(/.3EAWJ#9@KVZ.$*)_[/[R5%)/B[<%1SB7 GF:5IV7!!GM=]@H)$:]SW<T
M@Z=?1I=C S=F4&[D&L+1&A$20QO51*D!9\9C6 .A/,FVB-&@3&]46O@\Y(:\
M5-9?<5DMD+:>$:LUI- *""G:T:2IS;6;<$]\:E1EMAU"[X/[6<6]<F)Z%V8/
M45J8<\@-]I+YJ#D#)AE0^_E"+#+S /> ^^O2PN=!,-KUP;-+"V/AC:* >2.=
M0%3::%?7='ANVWLI1BXM?"XKNV,Q83&HCH4E(<*,.(FX="8:O"0AM9==A-O7
M;ABX!-08.EG_^$TF)YWK"FI(% ,<>0:H0$R12/".3D,!QWEJ:[UR\(P"@^W0
M>K_2D94VEZM03",,/\_/\^M.GAP;G)4404Z!2<VF*?/0[&E.%Z/RT0Y[Y6 Y
M+$YCR<:N7];Y@G%\8% \*E8V10:9D1);:1#:X^APAC'8(:2B5Y"&M/J[=MT%
MEFD@I2(6"JF8M5;SFA(AV)C1S^QTS)Y &X']/?1D)8Y[AXFP@!#$(16II.(C
M318HE['+KQN+&C5G;0?.^V!\5OIA)OSN)4-9+\KUMVKVU]%LX^</!2^,XHXJ
MQ2E7U$4]V-0'C^5:992+UQ/ 94]03.@%ZJTD.%6IPA$!WC KG466 E93[+AH
MWU;Y_)R2[,[J@4"<3FSZJ_[L,0$."&V)5TXH:3RJH;028Y_GR=X_0\\M ]T.
MM[^#Q&2E$N0O*-,(R(GN>B?]!(W&!^&$B40*Q["GD&L4S>TZ64=X-:JH]%1)
MO#$[SVMGV JPT0*2N^*;CR=S.H'/*&CZ>E @  -&F(!(("$%<-#4<7<G.6BO
MJ@PF%H.FIO6&U&2G2P\5#+D%W%/D*+?88\ZL8[JF%$N440A[%)GH$:L1TQ:N
MGU[ /)Z[\.S18+B+QR]CCBDHT_D+12WGGKL."?&#7;,8=D?HAL^$F>X[H_[+
M[*[HN_)3EGGGB8]:$H*M)CQ=:X!<[!C#*&2-CK)WFW>>,G&$M]0 3 3&4:>I
M56KL4+-:6-GDG3=F=!]YYV<!-V;>>58>+Z 1\!!J00&'&*0>WVH'$T%4C>F;
M'M[CU50DSO5XG0?B>_!?( "L%4(Q$]>Q!H01A&N*#83LPCU>C1EZKB.C'6Y_
M!XFY3(_79((RC8!L5=*=%V:GI:;3_:2GZ^BXX#35 $B(E./:6^BAJATVR6P?
M531Z\G U9M]+3:='H').BJ$8.*&=M1!I*37U#) =)5$1[% 2(,?$ZS/5CIY
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M%Q%&"JY5ZI@KG278U2!(J]L[/,0[$L6)T!YU:_WC-*)_O$34_?6P>*SB\IA
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M.VR<,YQ[)?B>&N15WBZ[=HPYP-U.B%PZG[-TNTW!WEYR^MQ.(]5/--)H 2(
MV%;'_+#M71XMM#2Y@[9QRS<%*U.5+9+JQ@G&.9=$U4A99$FC]M'C6CIM>52.
M"=1H!G&K8K*""VV5TU&K<BA"!V5MW$$K 6X?;#[?E79AIWL7'+-)@+^ BIQ1
M[^?.8)TNQDN)K1*U?P!:2$GFT<&64C)&:<YVP/XCNOTAG*7V=,$2.Y%N750W
M974_6^Y\K:>C%@=&A(2T,5%K80I(Q:E'UM>^#B%5^^)#EU5(MC&;7ZKLO< Z
M8ICTE?_X\Y??FP1(#X\+1 HH/328BFA=4*:E(WMW6;1_\@N-9B5"?8*;S4EY
MXD[;D[H"S?I>#O/!H%RTNB3'2A/AG/?$V5TV _0(XPPC;5.ZMW/@P05*^&-A
MKG&$^_%;03.L).'&.PFE1$AS)FI,A2'MJS'G)]<]"==PLMZ*)9<BYL\O[0\H
MX\\_%)04W#A@+8;I%AWCQ.Y2&1% U+2/$.57F2%/ >_$C]&D>^M.7:TVQ=QN
MJHC<XVP?-?6GN17U'?NC$GSVRP+3 D/#)9% >J"]1U[4J'C0H;-+?G42!I+2
MH3&_E'TV GE3+-:;5-ES^:1:W1A;[\EOA[CX.4%1H;1QV3OF4G?0&G,L.C@1
M\JNKD.=NW#>++F59/*FR-;B6_>I;@7CB.2"<:.< -PICMC_TJ":7Z/C(UWKL
M"O^EB/3ADHO/2O*F7>=F3+=)P\D$)"+V'&CN3=P*D41,[+9 !#%U[37S_'2>
MZ1?%X/QY9ZMF^J42B!,480^%!\0QIJ+"X&O\A?5C-FX>7U?J74BG64]G,C&;
M170PK-&D!&-O"ZF_601$%9-,I?09R!0& DE>\X%&_?8=:6 9+J;)&'DQ"^I5
M[<:IUM19$PD&6AUU:2(]%CAU584"[;B!M,?MPP?YZ7 7N*R&Y.7%K*PG'H^I
MU]:94PD(.N&=9QXB02A%P%%5<P0B@ENOKDOPEF6_NH;E9C;KJ[FW92)[JN$,
M N="I;X2$EKHG(!1BZA5<135\_87[/-;3=/[&X9ARJ4L"C6?;X5D=F<7JW31
M<NMO_V.U[>(PX%(X^MT@!(B;CT:*42L9\))+4V.-0(<*$SE7]IUJ ?3)BDL1
M^R>G]VA]" Y^,WBF@=!.$."AX((SRO=;"P:Z0_.![,2]7YD;SE76B4.CKH(_
M3M/[Q^FC[SF](_5Y>O'1X)50Z8#%T J)'#:6[A*#$5:B65V+RW)]#;@.<F!1
M]L?!8TF:#\L(^&9K25VMOQ75UV^SY0Z*?;WO@7.Z6TTD0"X\M!Y&E10!+YCG
MHLZ P!J"]C>C<J[O/KJ>- 9OWM%*&2YKY=PY!.H4Y!X"3Q6& &.L<;U;$2G0
M>[H+,;"0CK^66K'P\I?1\-GG9TXA<.:UL1A9I%&*9VGK7,T!93MDO^2GE;V7
M1=2)@Y>_AIYWZYID#3V?0D! 662MPPPP)$C48(2N.4!-!\LFO^CC>UE#G3AX
M^6MH%S.:>!F]FD7P$$OB"5/(1'G1S!-<!]%(,HO?46SDO:RDKDR\_,6T9]3)
M%L#9N!G.F6G #A".H("*2P8D\H[52CKUBK9OQ<BS6Y07X8<8D'E_I\68^0H,
MV@#B-0?,&6&X=2E 47,N_N_OZ=X81O8S7,-GLO_R%^[1W-M,5N^9<PS644A@
M/#VL0%A))YFL37,J,6N?.'?)SI4+7\+#RL#EK^/GEG6>Z_C,.09KM)5. (\\
M (0!S_:A6F8T:9_"<<D.G@M?Q\/*P.6OXR=IQ7DNXG,F&!2DDD.)D(KJE/:
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M)0,Z'JI[NBW6+F^/1Z^<;2HUG='[^TA/ECZ2W(5F&F'1F\5=:N%\,O#]_,$
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M%YA.TD:#N:7&HJ/\/W[Y@,+R\X% $7&22RVQL9I:ZS!ECQ@(X(!H[Y(:K%[
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MW(@ U9FH['8/[\O=\2AU$E&:(L"CU/=#+A33YZ Y9AAG&0V5ZZN!5MQ52J?
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MQTJLA,&]$$?.A5B-;&<Z;)WG\6180I^]"DN0=D58*V(_K0;K>3E<@@U8=:G
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M2%M?(-146X?$YB?0UD'NZ6CK<!Y?T]:ZVBT^B89<-*<["4CB.(5!%(0HC&%
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M<N_#^[U<>_AP386M;V6U+NH/UQ_W7S?KY;\5^69W\T4TZWQ7+T@ <(+\C(;
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MM4J]FTLOU'F\(*HNHC$//77BV=/K*)RQ9T%%C_;?Y[=%=VN<&'["!+$H13R
M(2<4PKZ&#E@<ZEUZ9-GVI&IZ]:A#2]2F]U_:CLA@674>#)O2:A*'L?7U)4+-
M-'90:&:OL\.\4]=:"RRJG[?_6)5+43-_*NI"7L<I%TGES7=E,__7/QD!(4D1
MH'$ XPP&#$+$>]L(4ZU7'.Q8=*RM;[=>A]+K8;8[$HY =0_E6^%933O'IUA/
M,178G>A>327F+DBC7>;G(8B6?7IVEM\^8Z^)7UWMFB=TNA7>IIP-PXQ'"9+'
M=@& D"=91#H+H1]AI2O333[7L9"=P-$:4!M1=%F=7+.CIT$:Q*@HC7#N1&7$
M=T\5Y@7O7]"1(1Q-JQ:#D)?#6XA1S^]**TKC$(0)3&D0D##RX]"GO8T(ATKE
MC=DGC]G[M49_AD1I*8 #C@9H@(U!F:X*G!UJ#6-J5DJ@B_UE+3!B0$4-/B^+
M;5ZMRX]5<;\N]_7FX5-Q5U:[8M5?_0U 2#D&?D(@SCCQ_23L30(?A*KB,-B0
M8ZTXXO)Z8.I2,9S%UY5C5 +UA.0%[NP,8)0$Y35BSNB+-3ZGEQM[KI0.VIO9
MEJB39<NF$$*^#V,6T8@G%$9ID 81ZZWA%"&=.1A3&XXEZ*5U?Z-E0&,.U>97
MQJ!/3X!,F'.ZC^P)-0I;R$S)G,<DR6 OSFP<&\;*$,V17U9%/_M,Y3G@)(:X
M^3_ 4X@/=FD&X5#UT;,V@0Y=>3U&PW4T"QR;JY,[>H?KE ZSHVG6(\(TU<N,
M[/GJF*$_"HHVA"F5.Z_P*K_;?;S)J]N\J]E8"$G""(R@GX8<D132?B(YXK':
M>^1FG^Q8LQI 7HM(_:HE X(NBY![;O0$YY26UX=D-OA1OWK*+4]F5TT=!#H_
M*23%?SXL=Z6\ B: 5YZ4T6'W2SWS_ 6%'<;0]/='#<!>VF@C@RO =X=WA4#,
M,A#[7(QQ$\)Y&$3IP23-N-8)@4&&)AE_OC-][6T8I\;%GALZ;8Q'59@<J\([
ML*17W.F3.]NZSL"5UTLZ4WX&'!C\5"S+;]OU?Q6KMRN1[];7Z_RPDZJK,%=_
M+\O5]_5F\_B!-?$W(D6NWHG/>R]H++<[0:DP_NWM5JA'4>\.1[5X"$'HDS!,
M&(@)$X/N-.N=$7*L=9'.3%UPK*W-,UWWS3-=Y;5WV"29=P\U=DXVVX V)R\V
MYJU__V*FO#.CV/S ZAS0CY M3CR^\HX^>Z=.]T<6>K>OO-[QJV?O?7;.R]>:
MY>;;1_Y[/0%S.G,[0IP5\MU,&]Z\,NE<27K]!/*LX(Z1_5]THGLV\.3)P$44
M 9+2C- 4,!(BG_I!O]<H"A,.1LCRMJ ZSN82T2@IV5KHG*;>*:(V8HH]GU</
M[[*>>/E3)%'%B-E/EK:;RD^=%*V382?YN8G1)$EN7U5R)VWSE^)3"H%=_,MZ
M$08^RP(_R_PTR5(?L\CO1^> BY'[9*G.%+#KY97N+6^O.F":,/\91W6"+#A&
M0.>1"UM/#^<^3YS]B5/BF?"-E1B'MIX_87H<3(G+)&DG7E.DRK?;>_'W9?6P
MR+($) DC 1.Y/4I]CFA_LP&(,9XL-ZHC=)P,#T"F2X$:T1H_Y[D)U"R2W.NA
MGWU*.[@P4@[3;PU_OJ1EP('#+&4:D<E'<!^KXBY?K[(?=\6V+L3??]C=%%7[
MNP4#?L)PC"-*PC #$+"DWSX'((R-#@C,RP/'::W#YA4MN+I1P5+BZY8I9S+B
M&]8*)AX"CM8 9I$NGXX)^R;6N=_\PX: [B]^WJRJ'.0I1HY6&MV?+RL[X&BL
ML:7%B$Z8U4]_T4TP?LP?FDM*DP@!FH($($BPCR%!6;^ "BCAZ6);?,MWQ6JR
M?#X NY*,HU;&3]W4GZV]:Q%-GKB'!'JRA.TZPG-,U">_E.>2NF;T\95F]+-D
MY_,1'3<K6VA9?]IL;(,;]UG86@15CG'9Q"_05ONB+QSJOG(X^<-%E%*0\(22
M&$2<$8XQZY=U 4[\2"WUSA#X&'E78GQI!'VRJ5?]^-7,^%,X^S8SQ#]='NY;
M4';:@MH1\KL_0PM2/QTX,^3NCQ[B6YE&Y.F 7$E&KOK# 5Z^\\0O'QU97 GQ
M&G9&<5S^SQR G&DCF/YTY5R)*6??@:>;]&#%=2&*Q]67_,<I<$;#F,<!"2E#
M,(X1("'N@$/QTPEG.@P!.R^S>ES>+O]Q4,2'*V];:-Y*/0.R)IC><!G6.=52
MAV8B'%6JGF8_C?%RY$::NQC8;/Y\$Q9#"7$X2V$E5E/DR/?%;A$# A,<X8Q&
M449]0-#A91U(DP L=N4NWXR?#E6P:2W1']Q05LHO\I]XUX/.$D^7(I6".WX^
MM!W7622_]Q=JH=GG.0%^I*2F$_L_7P;3\MYANM*/PC0[I'NIK1<93F'$N9\$
M40 2@@."88\V#"*C^R#'QNC\R%"G4>OMF[ONN9OJ]+F;E>EC0I,%=8JMU&[B
M.8L<=>;EN)]X@';BQ&B[J_4;R)\OD1FQX'2'M6E4IDUL[1\W<ZM?;O)M?PO&
M(N8PS$"2Q0!&XG\C$,/T,'!,4;JX+ZJOY;0)SQ2[CFR>NFF2"!^/U>:0]8PC
M/F4N'"/4L\B0+SRGVBX&[X3;AXN?_@SY\DQ(1\^B0YO6GSFW#N9FE(QK)X*J
M>?CX\2D(8A!$$:>^'Z=13 [KCS!&@6:*5/Y8Y]GK59$92(M:'G'"AY[$3Z.V
M"D*HS<T\-$H?=CFP30RNL&FYK=>"EN:;+U6^K=MEEF"1(1@%L8\X2B&&#!.<
M]6\AP0CRH?-!YH8=3_*T"Q)WXK<W>5UX=]5Z.?RTP0":C:O2<1BV450^0NJ=
M0)V\##S+H5X5-SP4\Q X-ZZ]7D/9XF^ 4'ZLROMU+;[(-V^WUV5UV_ST[594
M;/FFVS#?7)NY+&_O-L6NP*O_V-<[.15<'^[0%$K.A'K# $*" LY2?%@1B"&E
MP4!-'06C8_G]K<CK?=6^X/JQJ-;ERCM!.5B(QPFCL6;/+H(VY/W$*>_$*SD7
MT/CE'1WSCIY=G<9]3C<ZVXB17OH8M57,-M.,R\+K26F"J!@>K1J ]/&I[#I_
M<BP[C@'+6 Q1FL 497Y DQX]2A*E"TKFAMEQ?GOU2I(K[_:8 FOOKLV!N6X.
MG!NM9B>M?HI6,(\<^>PJDEK]+I)YMYQ!)ZQ^BA8T\&6W&;4DPW-8KJ*D?@AK
M\G8RRQ-8T[-R^?C5]/@FJLO.;(</** AX%%$8YJA.((^[^_)B7$<^_W)JR]3
MU&6&F T.7WW1K\LNG,!Z5)'-J" S;0-C5V(NXSZS$DS[@-9,F\A4)=<(365N
MM=;0,WTCE%C*A_1FUR#^;$754#J<55-6XC31\LRG8M,4#:4H">_7Y;YNUQT6
M88(09B'Q81R%+ *09H<:D ;1L9@:='AO"N0F)=4T1_OLU%XSHW^:]2&GC656
M=5CM=;YZN]+KO>U6$W_JY:,S(1QO-6EH&_I3+BX-)L7M6I.=F.GN'OW8;: Z
M@CN!M" !)D 8]B,20\*C&!S>68N#+"(Z&R'L6!QQ6\/0+&:)8KUMJN.Q:[:'
M5>2-?LO>27Y0V3KB=)/K1=H4=L#:H7T>LFO9IS-[9VTR-LV Y-QNMT42933S
M8>2SB $?(X)(U(%/,D3AX#-K4X!VOMW?R8;>2<([Q;!AE+C.8]@PYXW(#B(X
MVJAA<!.:1_J:&RE.1PV68J::0#\5]\5V7W!!NK#<;(W[YWIW0P6:\K:HOA0_
M=D3$XH\%@1$+?()X"D+"(/(!S@+QE0\RD(9)J#-PL&;4\=BAPRD?*I8G"65$
M]/*7/7;5,M DQ.KED)Y3V<V]'J3W7:#T>IC>[Q*HUR =>=>Q*H$7)-QZ#.8A
MPO;=*AVW73TA9,6U4/$5*;;BB]U'T6:%3N]O]\T43K-!1>C[757<%$*?[XM&
MNHOWQ>[O^7I;OROKNJA)(:2^^)+_6!#"<,BC( N2,(@YQF%":!8RF%&.(JKX
M[,$DT Q6*/1$50#S1&SW>25KPXV IZ>IXP9*37?G%R$C;>[<\#H_/.E(\XY
M[TJW%?&1,VU-7WB_2#_^>N5)GP[??&V\DBOLX^JXS8!<T/I)XCZ/?#"-Z^4,
M^MTX>>5CM2ZKST5UOUX6M*QW5(P!UKLC6I!D$6<4I'X$:<#B0*2_'FV2Q%KU
M^%08G9_X$/"\NL7G+07 <3+-X-"Y33IC1FV,_/-+Z]E?/=FAY724C'KGGR<=
M]'YI7?P)\]$KL7*0FFRUCI\[2UECP5+"LAL5I[GK",H7>9.#-$8I#&$<XRCA
M74)E?A(DB<[EZXZA:&4BTPU9U?$*-U$BYR>RUAY#7#Z2M9%&1AKA<IB6W$1J
M@NSS4R489WE$/YP_<;HP<-9&5C#E6%7\^[=(/Q7+8GTOK\X3>>AP?#X*$6>^
MR#5BG!01$!'H1QS"R*?43U+ =(8?PRPY'D0<'BZN#NA4[L1P0:F:_H['IIZ\
M'H@\ FN>EICLAI&+1%U01#L$ST/P+/E2NFB"FCN!UIM-L>I7#HZ6ZT7D1UD0
M!)%\H(BPF(01P)V](($)U;K[R=B*8YEJ@9F\6V?.F^*NF%$HT]S(TF Z+#^>
M:M+(&T[.D7-IC\A@0N>A/1;\>+H3PQ(SJIKSC^W71Q9/!&\!48JQ'Q#N8\"B
MF/K(AYW%$'"FM=%ZB!W'NM-#TQ.=0<2IR<Y8G.D)3X]J!M)S@: +XF.#UGG(
MCQ5/2ON-SL(HC>ZKJMCN%A!$%/M$7G(&@MC'84J2HTF<ZDS #3(TQO2:0>TS
MC+P!PS$7O-D9C5UY';89C,4Z)+I#,5URYR%'=EQ1&8B9\>/@JO/#B# )*"4L
M0SR#C%"4^G["(A[1* &<^RQQ=..YLGW78S>]N[F-IY^<A$9Q$#AQ5#2'A_8#
M,O6]Z6;WWUJ+T3PTUJF'YI>I&[*IJL@?\X?F"-Z7LGOUIH=6U'^ORKI>^'X0
MIDG(*1-9( #"G!_T9FD"L([\#C;F>CK_5B9$>2'&,J]O/'D1G9Z(#F=333%'
M)5)/'GMH\I*'#IQW1'?E-?C&5<+7V+H@>]:(GH?&V7.G=-0@;=23\O34T\-2
M_?5'#PL09)"D419@C$D:,R&K<8L$^M2/M03-A7W'&L<?7?RS/* ]'L5=GN*V
M440.C,>0(G*\4%@J(OMH/$)\=;B![F$.->1%4K5K2#LAFH>^.O50J8:TR:;C
M)X+[JR%>?&;QG?B\]X)T.5=:;C;->5BA=D5]7"IF(64XR "C/J,4I%E*0.],
MAE \REO!KIW0D2"C>QBXTD5P_S*Y[HP0##WIFE/KF*WZS8HD.Z_"CAO3*9YI
M_UB5=T6U>Y![#7?B+S+QMW>RO%]D"6.(@3@"&,0!!R$(#ODC@&SX53<38':N
ML#VT*^].@FONU"QZ>-,]S3X@RL85^<S#:Z.&'_P4^[&Y-,Y>-7^9O=I>YI2'
M]4)H/^TZ:D(_=99UQ8G#I]9M16R*'/KZ,_%)2K(D#1##?IP 'T$YF]_Z$# :
M9 /GH29$[GJ6OI?0]?;)<.7G%<=721])).T%_\\GEA:Y<2B:MB.H*IZ?ES?%
M:K\I/ESWWC0PZ^9BK)H\G'QWO*T'QX ' '$6!DGD!V$&LBBD)/53BKB?*KU4
MZ12 8RGK,<NIET,Y>0K[ROOZ</H#O>&"FYBH5?^3AT.OF->.A/?[EZ:NG^PV
M,A."+V01I_&:1S)PZV(Y8OLWE>;G645DD==S2M/2CR@9CW$(PRR-64H%3I@R
MW*-D*-/:D3<VMA$%_869 /&EXCR J="/%&'='#"_X)JGAT%QG5':L!(3I8PR
M;O3GEFQ&]OYL'IHB"JHIZGWQ_7CS\<>JW(HOE^U;ZQ\J*D8OWXJWV]._6&^7
MZSN!JSD]@W$*"$JP'R4^I8BP!(480L:CA!(4:TVEN$7B./T(\*<7JC^&+]J\
MUSH@;YAY]&>=#YTX:>X<=QP[M50SG[#I)1;7$7.20P:1?2%CC!/$>>2'D7PM
MI^@FFL.37;YK(,CY_=V#O,VFW$I$^,>Z7A"<A2Q-2 AB* 9&A&0088AA0DCL
M9XFO-=@89,FQ=K>8O",H[W<)2U.,!Y*I6->/QJ.>F&I3Z*;"OL3.I7K9"JOS
M4#=+OCRM92TRI*I.3TRQ\C9?;Q<H)%$BBE[*?8(ICPCV66<+)VFJ=<&NF861
MU<C[O<6E*4>&[*G)D'OBALG/ZYPYT9\7:;F@.\-HG(?>#/2AM-FP=-_8V>7R
M?K\LK[:BXJI_*VZ_%M4"1BE+2!RF?LA@%+!F>[8P1K$/$C^$>B_J&)EPK# ]
M*J^'I?MZCAEO:M(R F5ZVO*,+>_W%M/H;^"\1,P%=1G(Y#SD9:@3SUZSL<")
MJL#T#XO=W6W6R_8!LN:E6]K>(;J^+[+KZV*Y:\X<-^M133458Y+0((S"#&%&
M$\B;6JH9ZS$40"T!<@3!L4 =7B@\PNY>*_>.P+T6N7>$;C1L<Q4D-;6;07ST
MU-!1:)PHIAFY%Q35<;3FH;BNG2Q'[0&N%;NK4%,:<>KS-( HH11S%/G]_!R3
M;]:XU6Q%$'-5;:/QK;M0N5)N!U$:2;LG&4R;$FQ5OS5C]K,JN*Z;@S7<B%?E
M]U'6PEI5"*Y(L?M>%-ON#<N_[]>K7/ST[;:%TU[5C[<K?"WD[DMYMU[&?MP-
M";)(Y)<(B)% ZL,X96$:^#VT*.9:6ZU& >18W8\^>%];)[S^S=C>#;E4VJE'
M]]Z&W(J32U^\QAE/>*/Y=LHHH513_-E%44_];05PHND/&^Q?2 VC!G<>:6)<
MEY^^K3(^W\IW]QX>?:]Y65U8MV\&(DD6^"2D/@@ BTD$&,31 4,0IUHOKEBU
M[#@AG(#U1(R\R_MI3*9F+ ="3>6GBX&>G%NEW\WEP3I,7I!F-Q&9AP8[\NWI
M?<,.&515U2_BKS]<XU5Y)^O_3L!C#GE(8\P"#CCT09RD:6<J\T.D]1J#D0''
M&BDQR8WK/2K#N0XS[M3TSCEM>K*FSY@3[7J)E0L2-8C$>2C1,!=*BXW*Z*4%
M(66?=V*TDE>K^A]WJWQ7B,C&?MC9QFD4,8HB(H0M31.4);S7M"R+,ZU=0W8L
MNJ[.CJ7  :77PO0DSC=^:/0HPU">%8NPT2G6++Y>9W>B8;(2<Y>*+:O,ST/:
M+/OT\F,.5AFS(7[ 1YUMSBB/@RP,$I^2D.$41;2W'?+8U[L[S(Y-G;YI=/?7
M*UT4O/&1/0'4X'JX +HAV:H 2G9G*( 'Y@P%4)_Y^0N@@4\: FC*F/H>SKH0
M?WN#MRM6W!>;LKFE"E>5/$]SVU['VUS^^*7\6%37974K!L#-Q2PU>9!5:C/B
ME5O7$0M20@*:@00&!!\JTU#\/[TMGV,@<KY#M'6BF?\_<<,[\>/J\%B>?'"@
M\Z69BFJ]N?*:L9S)Q-](4563XOD%5$^JQXNEHVVO%NB_N$MVS/#.(Q^,[/.S
M/;CC,SY"/I'(^O,*/ R3C ,88<XRQ$B"<8>-\Q#%(^43#40_43XQFD$=*:[.
M,XJCD$Z742:9W;42 #<YQ2# /WU.,?'97DXQ9ORUG%)\K1?T+6:_=2,@'R8
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M2_&K]6Y=U&Q=+S=EO:^*+\6/'1%,_[% /DTIR4"609HFU <,^ID8C4?RTJL
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MIA_%#HV/YE!WM.8PW_'P>!0H#)I'CH>#1:7NK8=%BI&\F#^DF- 0!XPBD/9
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M,J&J&)BN[>,0$\<9TD\'6?8DL>)O1K-.#4":E<SR6?2IN"D$2HJ4'NX4Z-,
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MA$DK/V(J=(2RD-R\Y6)$6Z1I6X>0R,,O%'4?,8E@+UN>Z!"V4>R'&+@V!E$
M41"[<=](:,:NB$ (?K1F>6!H)#(947[XM$$C-6+*,+"RD#"\)F)$%B096X<H
MR((OE/0:\6-D'_*J+IM%_H]9GGZHT\=J UUL!Y9'O"#V84PB2$R[:XT0)Q)*
M'63;T"P1S9&R(R[C#X;,:* M<*CL'8)&QL=42M<Q4"9;\<ZYLNFL\.PU_W9@
M8_+Z[F.:[[+\GC6:U0>V159M0L>Q3<<S[<!&H4T3_3CHMTF(#YV8=ZMY2AN:
MATX+S2CNC'T+SLA.T/'OEDZB\?)V\UP,B@7ACKSK.Z/#97R8GSS^G>:Y2)3;
M:![OB?0+X^M#MGTPZH?4H!_.BE0?DLI(^IWINZ[0;]H.] A'9S:@5;"Z_/ZS
M$BL*M7U-+/]A0>+Z[G4U?7PH2]I7HJ(LBZ^LUCYYHC]ASV=!A+#G!W'HHQ@%
M$+LT"^L@H"!R1)(BI0UKEOL.EW'; S.V'3*QV95:LOGF7HOQ+!84FMR3JMB;
M SQ71L_] -:(+W&O)4<5X7$D<=7BCG5DLWI,*V;HS@)EZU2)BWW65'%]2;<'
MBN.WM/Z8/J=E<L]FJUFQB3V(K#"R/!M$L>L #'&_<D6 9UO<1>P*VM*=!Z<U
MS3M:0 9[<;$0*-160>7E''AN%L5D[Q2=T<%KKC\R>H3&YP5H%:B&GYE>N2SY
MU^1;]GAX-+:G=.??=5ZC3/]UR)K+O KC-C78+GQ-_TN_<<BI>M*T><<63;;%
M<YHWSQ'U%8(3Z^HODW@FC59)__+IM%)K"CV=5*0>OSCD]>>N2Y&B_*Y- %'H
MQCY@6QK LV#H^GA(Z3V7*Y]6TY+F.-$"/ ZONZ)\9_B)5)E/IO9RY)B75;&X
MT1'Z^930*5%# :$BM?MS$BM;P-\0W*RKK"%$7.3L3(!0Q_7RX4&A+86.WL@?
M&EXOU,==7WG3:@Q0"$W;1YX-HX!.8/ P>0D=Q^0-#BK:TKV^TH&ZD@X(2@B]
M'!+FYE(L*+S9T+LRCKS*Q@4EO/)'AKGYG3:;4!89#/CVL[+*V";[[6'?S%1N
M7XQ=]IPUR_ML(?_NT!PN:SZ._BQ-RIS^J**MTCP@-6B[*85/W5XGW]AUNKOT
MJ4RW67?O>KXSDL>BK+-_M]]@N0/[U,>B8BG:EJVVW5';C7\=DI*-YFF1B\.G
M9V*7RMZP?/12:DVA9\Q,J9V(DBJKOM".ENRN\]-J=FM#" ;(LB!V?9-=)@8P
M[JZ/ ";&P81BB@F-SE%=D9V(\2V#:E0-5H,.N^?^M$8I7*6ECGB^/81%.)\8
M^QJ4QI>![E>'8Y8L;SE/'W>]BP(/K&/+0+U9HQ4QRGB3V5W=A#BPL0-<A#&,
M8L]#?G\@$)A!$' E]%(?K%GIK@]U52=M\<&;J@+Y[='+;(EO?RHE2G![L\CO
M?ZF;"\->;70NMX?)N4?)S=DZ!$4.^L@>HZ#]0JE351W8&RTQS;NKTS9/'_/\
M+:40+!Q#R@8,D6MZ,02$!''D$!"&$#B1T%7+2AN>)87JP+*2BZQ.]MF_V;4:
M#+E$SJ2,<8&\:0FR97*GGN<&Z-4;G7KUZO B[[/P,WDIC5+MD'4HGQ[3WDNG
M]/ GOFS*[BJ\OCM-XS:A0RS'IUH=6JZ/S !!$/=B[5B ^Y:KR0W-/;EL4@LZ
M6B4FE6J(%5T[U<SII,FC<=.QR3=GU,"F[(JI9E8GW/-*V61KC/W29-,_Z7<2
M.E?8'[;U@7Y9&<5S6AIU]I@:38DR_<7#OMF#2_)V#77_PB89MVF^?7A,RG^^
M^;BBI-_8I=]4KE=^SRC78N4$1ZQMI7***6>7*2?S,ZF^N7A\S&H&@Z3II[1D
M*][)?;JQ?=\")@"^9_L6*Z[&D7M< \!"RY0JV]6^^];#,N[2U'@:@"DH;I9E
M6GQR/R?)@G/_LZ7-1^(I5N/39>+GJVQ^GT71PN:)OEA'9JW%,IZR9B7L\>35
MQP^_OKLNL_LL3_:?RBS?9D_)_G5]Q$WQ.7U*7C[D)"NK^N9K\8\T*:N-B0/3
MPQ!;!  K!!8,++_'!$.3N^99/Q+-8GHT@ WYHC/!>.IM8%NOKTKA:K9Q3.U@
M1[6:O5UFC5%_+8P79@]_UCF#$R\G^>ORGYA.OW9=C]X8X!MOB^ZHZS[WKFN,
M,*@5QC]6YS;^V<2ZW"<YW7A(N^G W7%^T,PTOB:L1(+-()Z2K-D49 -N&*.[
M?KFQFYADU:7!.6VB,9GL,S.1^9RX_%1E1EN+)8:)SAB.#O3']W2XW#QDY8[A
MVA"/ !@B"!$*8N!Y=F1W=2+ \K#/=1_.;&!6&\EWC2V-8-3,FD8L=$8$&4_J
MB.6:G3A7.$='_S6&-"%];?[3&=0U^W%]<?TX3.<.Z=]3K2RJ3_#BCQC8IY@[
M*;9/YEE/>/^<L@IDBJS-.) 9D@BX;N#%T(\@=F/29QQ6Z'BVOM N"&2U8;WL
M[= >ST5=IR.6:_3:7'%\,$'_G%S48SJCMT;/K2MROQZ0L\_&7_.L+&Q+NN]'
M#-FRIDX*UY/XY;HC)*D>/I7%-DUW%?ZV3:NJQ4$H6RBKGHHJ:VYTNKZCO_64
MEO7+=4G_YI#LZQ?\S*IGOAQN_RO=UC=%3']*P7ZF0^29#AHV]#YG]P_UQB.8
MP!BZ($!^X%AVC'RG1^T3E_MPX!JPZM[>I";2\-[::*2-D7V09QW8V)W8R23J
MJ;.4U1-L.UN-M#'6J%IKF0QM6WNI"AT--DIFL<!E'2N@G^<.E17 U)=@-!VD
M-\]H[>N3BJ:#H#<=Y--)!^G--%H[C2_'#M*9:IS::GS^ 3N(P&TP*X [3SZS
M?:4JU,N=L)RN_9W4/7U)\XSVEN[RD;>E &TWZP5E3(_:7WPC2I2A8O_<-9N5
MPQ]<\<G5Q,1I!I^?R:W6U-N63[]6Q4:Q3DV8>D,#^^Z7M'S.6/GSZ0%;Y$>.
M'1 K0$$01:Y-&QT6?!R$N8YH:&AVCC+DJ@76G&M7=W6#/-.7TYD%21;+3$8N
M=&A^U,$U>KQJ;G>0IW[J10^SN$ NYBMVA?S%"><XXBI+5D;T\N%.EV$7;U90
MQ!UO$.J;?7LKT76>;D(3FT[L!1$,S1A!",*H/YMHF0[B>J9/13N:P\SWMXP:
M12YX'F,2C7PA92X&)6+(4:R^OR3NRKB>E4RQ(#$7J?]]$] \-P&-^',D@JGH
M!>L(64HL*=2/$35!Z>9KL?%CWXT \)!EV0%$/K3ML&\1$[XWU52T,\?<9SOH
MZIM1VZS3?*']H7F[RG#,*X,-!R8(Q^_:(?NN;:H17R[NIT4RU;0KCV04X(QD
MJHEDJDG][TBV;"2C_I2(9"*]8-V13,@2SD@FSL[D2$:]GVYB/_0B#P4., &R
MD66:["*#;ETQL#PEL8RKI?FG6#7#I4A-^<B<&)R4\Z@^/,U.J:(0I9S:_PY2
M"P<IYE&9,"74$U8>J,1LX0U5$@Q-#5:$=IJ-%^'8MN,X"DD8^M!$KAUU3=K
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M_;]BE\\MV07& ^8*$.J+L;,Z7LOE=_K<\DZ065%?6,?5>FL@HEC=.!5]2F"
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M4TMY8O:K"J=C2+LR.NM7,1^8U;<2(7'9/K;NZ+DP-YR!=@T>G'?7@-F5?-L
M8MF(F#X,8AO9T(XM"'N(KND+53',"DSS'.WWG*97^^9VI>ZB6*J%#^V5Y0;K
M&<_=R<+C3&V)+0%>+\ZY*Z#!@:O8&&A#YX^Y-]#Z1/OV@*#KUQVY])JN99-
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M5LH\;^SZ1(?>0U*EU\-J!LFJ;;+_1YJ4OR;UH<SJEZ%:+X . BYV'2L., D
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ME=?B26[Z(?1XFH5BFJR 39[*VM\.;.7U^@X_/NV+ES2M-F$<!#@$MN_ D)C
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MTI,S:F!T+'U<TH'K4/!E*7B;5"[O#]YXTE_(TRRI7#\QG-U;#W& /0_9E@-
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M8(176*[KA[1D3].5Z0.=N399U[9X3%FR=8HC'3*P]*XHT\_IEIUPS^ZR;2.
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M/W-]SO%*?M7J.<D'DU1T+OJ5JND >L7U.2/$B@NL"B^M6FB5&,@GN.JXE)F
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MH6:W5E&ZZP6FF+STC>Y@*O; .H1/O5G?[4MJX6V62H;C%@ ,,2:>%: HAC'
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M/&Y<A_3.9&NQQ$#1*-W_2)/RYFNQ\2,[" !TD.>:]%]N8(:XA^*:6.@.5BT
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MEE6;('+H3 -X5N![(3)-% =FWY[M\-WS,[T5S1+3Y+ -,N,4FO$' R<X%YA
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MXF*YX<2_[L,"SZ&N:/+\?XO;"F[KZSO:%X.FV:=]6J?'Y^0^E<5S5E&4[-!
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MN(YUA7E,+1<8(&K*_DZL5HNU["_BA;LO^8\&<YK^W$# O"0A08ICY"(/)(0
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M8QL)&5*6='^ED["\].GJ"<L 1&,8Y?LKF5QE11%9EKYU#1!%[&<CLAH#LD.
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M1-J0*U[4]+E=OJ80,+OM3T:,93PP,<"TU_:C_=4[[LC=2<J^"4GJN9$X!1M
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M-?7OX5;'^G10ADD)-33JD'5IHEG3GE%&"_PI9X+=HN9SC</$BWU"& P(\+R
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MY@+KFBM'MC75-<[S?+HKH*]>>05(L]JKY+%7J[YJ5D[77PU6[2DPX\-E \/
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MF>2CN&TYV#-7:5:YN!>S_<&AM]K)_WDHFCNM&O!U\"LYT5\'6(OGQ'K[G-[
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M?LT1T)P_!+BINJ-"IZ;X6&)RL@+)D#B/"AT94I$B#5Y7JD<ZEKPD2MKLZ.=
M_,]I*4X1; +B1FD8L22 **&I!Q,,AA8]YB?3$B'Y=I92I@[>Y)Q(@5#=Q,@.
MEX:TZ24:9\J11HZ4$B5U9E>J3CJ6O)@RZ;(CK4Z'NBEOQ,,"#UK^+1<W7FX
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M>1VJ/Z?!C_9L9^;::'SHUM7K=L5=+*P?2Q\W+@Q2/W:91W$:)Q!QE'1 E8)
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M0<Q2'%,<@R0<6DX#/U210A/M+:F"%_IG_XU0+:>"<[-L4 #E"+:B@A*LG1%
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MQ[H:8?)CWAI7FF-?CB:3(G#*P MBH$76>D1!#_X3XC"!!Q61^#A<U4:S)M\
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MY+_[L:P+(23UQG==%&,/^+Z'$P3%>PHC-!0 J3-FLP*RG(J.8!T^O6]'Z>T
MK?W.K8#MW.69[+VC\WI++E-<G:/4LL$SN=]@@C.:X(AA[[1&#%L9XD]&.U:A
MM$K,J\NR'<>N6L,MF2PG^#;YGA@=:*X"+0&$) SY), HB/A7$4D&:"0F4MLZ
MLP*RO:6<SQL=#'MK4G18SE'&HL-@PBN+#DK,JT<'.XY==72P9+)<=+#)MY6Y
M0U_0_ 2X./&0S]S 0Q$.0>![X3BQH9Z+I$ZBSPQIX?G#MB_J%S'"X@1B@LLL
M3"'F\9;U2<1P(&.U@4*1?5,3B>GN776PL&;TE,F$*<ZM3"<^YTVSR]MCN?]>
M--_X[XLEZ4/SK:PXR+S>,#?"D<<" F@:B?=[(\(&C$F P&:??Q4'>2W,+"9C
MDY*DI).D4S,4ZB)&A!8G$=-]9&$V,8]SYII6G%CC_,7-<3I[G!.#5A$V]'QA
M:J)AS.>K#B*V;9\R]3#L@8DAY5-^==BVH>P>R'?9;9U_N$:WM[MBFUWN\O;-
MDH9_ZUUQ4S19%_P CE+@(QPEB0O3R.-?T!&I&TH=:E@2G^7920M2E$_4'3CQ
MY>X(STBXL>N_24%G-:XS%GI&BQ[&GM'31ZN<ST>GOY-P^IPA:(IGU /1+/U@
MU>%H'@;D@M*,WIA:M^(GV(<A2%T<N!&((QB%P= :(W[4UZVD^VDSEQ?;4:]:
M&2"9JUG)VZOD7GO!BBS3JQ[-\E9(%JRHL2([JC[F^YH/6K2_^M!\RZN/9=U4
M>5-4;>HYIJA/E( ')(XP2%(/PA!'+G7=,&1!BFD8!I$70K5C)M9@6#][0CDT
M4;C:#T(GVU\YONO]\N??G#K[SD=C[=SR/U!+X^QY12Y76X4[U!*R'G++?PO:
MN8]Z3-#6<:)%E^$S<FK=:>O06_MFEC,/!CG%SB_KS9>\NBFO22DN1=LVO^\Y
MU6C[ST/1K3-O/.:S #$?  H 1"F/&.(V(\H@@"3UI9[3,]",Y0FS0"?F2]L>
M'T^(.$ G.R*4$UL3A)Z7TYFY5!/,@<8!FM-B<] 2-%[UA^3;"<1:Z+P'RF#O
M_+MLI.'VML>P/= 'CY<)>"(\&&1MV0!@TI#2>(^2%_%_9+M#?FQQ$P8@#GW(
MW)0E),"Q#Y)D:,&#KK1JJWZN99ENX9R.!'DY46;H91FV28Z:[HZ\$/N\R.NJ
M37[TA+2]+KH6AP-YUN5\?]B;IJGH W.?D4U=4I;726WDY?0N(:^$W8FXZ[*B
M^:[@L^^"]X;KCU4IUAXW%'@^ 7&4!"1 09+&,"!#<Q!X4MM&DQNQK)$=MK8(
M[6I$)WKY;8=/7AJF4?FR?L[&HIJ8GA!([Q'X<5X"Y85V-B+U5/>E'CGH\>=&
MW.K_M=@Z[]L&LEWW;,UML<N=7_['Y_>?_\??IDGT.:*>T6LCW"XOWF;,* WW
M.<5UY>RN+5[X4K;)=)4/;P3G=;N+L4&A6 \!% 6\&1)'KAO[?;,^#2%17#^>
MVISU=6*2U=]F7F)\@9-S2XFFZ%S)DJ$Q<QXN#9KE23YG^G#=-\W*ZE/^]; 3
M_-Y]RG>BM/$WKL%U4W(<&PP1'\^)AU(<QA2QE*9@:!\#WU=+HDRU.D]6)8)6
M![<-9]4(F'_9(G9N1LBJ>8(Q_F4SKR6HUTK%/O#<JV>=0W6.6)T>K//;\JRK
MIFM+L*^Y_,ASLRT/-4YY:*YWY5].5M?EMFB);^M=SPX#$QF;)%=G4SC3?*\E
MIS-NUZ,DSPYS\C>X?<_WA[P]#-$O&XCJ57+@K=[DU6_YS65>;3SB>TD2^##R
MDY#&7N(SS#//&(8@(3&$:M>PF6C1<D#J0?8GEH:-@78X#D!5KS\SPK-<,<#\
M%*L%'@EVG3\ZE+-?(B;!W)DTW"SSZ\C%#=OTZ$XN\XS)BA_+BJI=,WU79)?%
MKBW3_RW/1$W U8?]IUP<,RWV7W%6%_7O^_*RSJOOHH;R[?[VT-R_3.Q80^!%
MJ<=B1L,X"E(218PQD@ $XAA%(8V43O,N M"RM'X^W-QD/)?AR?[C"PE%%^ &
MB5R4?UD7O&MW/SLAP!D8<#*>L7*&G)8B-3U>QO5R\KUZKZNI_=%%%T^[L:V[
M[XUR6JLNG%.[G-:PA[WECR_MSQ:K![/AI3.19=%.L8Y M"P%Y8H&J5J8PX=B
M)ZK,^UCJID'*/!+"&/#_\8+(AWX"8$P""%SD*5U'I/C1ED/+@$;Q")8J/W(J
M;I$:-?T=@"R44M_GX8S":1*V#FW2!5\:Z31Z>O#VYK8JOW='5OL&0Q\3Y,44
MB1(J0,/(#=.AP<AE4J_B&6AF)IUPBA-H>IJAPZ&:?EBF3U-+3E$M+"R/"9(0
MF0FLKDMPIACRC/A,YD96B$AYPY.AO/I<7C=_917/C1K>V0J>):&ZSIN^;>Q[
ML3A#Q?^;X !Z+HO=H>TD"!*U?6<S;5K??![@C54<N^)ZYN.!4DR=&6IFF5['
MJ#-L4VFS;RJ6?U3E;5XU=Q]Y-VS0_BK]YZ&X%1*0UDUQ(_8B?J_SZ\/N7?%=
MW&6!0A^F,(X2'$) ,4H0[3'X-$1*>8+9EBVG#B,FY]""<D1YCF+N8)AJN71B
M.9;5,HP!YX73(FU/!XY8+YPC_QU<Y]U9_NV4Z:A0>:YFQXI+UB&4EFQ[6,UC
MD4&9TI[T)J_$8C4NRKK<'=K+%-[NMYRPL*VMY%_SG_+&!<!>OFF"W9CY"8Y(
M'$91E/@H))1A1CP*J._)%OC8:-NR> IL7=&I,Z)KA[E\68D5QE\NZ5F:;#4-
M'= Z'.[G :Z@_._.LRYX>1(WCR_D"WV6]HEFN;93?^.IW9O+K.9!;,LSOGQ?
M=SL:XM8!)[LJ;T5XN[QKJ[9%2ICM[YQBW[IN6KF/!F//%/W8Y'[YTA^KUI7S
M]&#52T6J]B%6WN!GT3V'>3^F*"4$Q5&(W 1% 0.4]:VE<8)2I3Q?LPW+0>D$
MEM/A4KWY0Y,ZR;Q]!M84,_1'A"VT /@,-><R[HEDKB2WGFK%H^LR3+ B7W%8
M-U6QY3&NU;C?]^+RLL^_]VWZ2>PES",PB'GT"D*<I/[09@)2I9>TIK5DO<)P
M ->G8RT\YQ<.L/Z;:FWA)$;E=&@^,M74Z"R/BU41GN'J;/6@"8[7(5*&;'E4
M+6B.(5G!:C41BW2=G&3KJ*IX-^QN%+H[_DI?RXW$<Z ?;MN,[L.AJ9NLO>?O
MT\E;H2@5-YQ'$&$_3E/&_)2Z/5@&()0ZZ+,P1,L2^?X@O"K* G7RLJ7<)B>G
MK\!C:CK\^616>VJ2<V*3F-2>_MYP[*@U[,+I3>-?'(U;]$EI.TXZ$P 6[A7K
MB!Q+DU"N:J0N%JLZ]=W@$*+$CPA+$R]) ,!1& \X8^*'ZH],SX]11?6TGZ<^
M@77Z%+4XT]J]=/1+L>_6_E3S^P6<.GL0L^#)5<2O"Z>S[-4&K@[^/#%+L1/\
M=.%*U7Y[D4K+$W,%J5_Y+XH7O;IGNS8HB2.2NI1"+XGB)(Q\FG0@@0L"0N:<
M2"E"LSR!ZA9$R@Z:\U5@RQ>,0ZI^FR<(6739<A&H,TKL&G9F\3"4M_=K\/3S
M.B^:P[GI]"I#TGTW68Q'FOWAYPA&NL8;CD23?" =AMHMUKH^Y%?T(,YJ=:UU
M:TWM#WLTZ8^\VA8<Z2;$,?1(E/B)FS 7,P98/ !AKN>KO;AH 8"4.DUY5G&$
M,B&,6.!=,E0L1/CBX6"PYR0BS*S^RLR?4WA[;ER)BELT\*%2V^9RKDG!26(C
M"D%_W!;=S0''*,*#2.2#&'B4AX\T3%.0A -N&*-44;P7QVM=ZWN(2TX9#'AU
MGEG$3.Y</)*<V-F5YA\M72RVV':=Q<F&N6ZSDLBU'CX,3TE,>VJY'1V.AE&7
M> A23*&?H B/LRF?($_U^<7Y$:KOYR@_W'AO"3_G0J>VC[-*H5MV55_6J3^'
MD$VPW_JJOIHGYA*J?H(A[LCI<?K,9Y'K1SY.4S<B",)PQ!E@G\XM5.H(9Q"J
M$U Z0K465\Z3I=OUX.+K.UTG>(T;SH\<8S$TZ7>"GR,T3;#?<&B:ZHD%<NA_
MSXNOWYK\"GW/J^QK/JR*?:R*;2[*NZ[[\BX0<[B1BR-&7#<!"0CCOKP+>#!(
M9]V4M@#?\L;U /--CW-<P'9:I(N53QGS_NSU54LX?B4%6(/ISM.=R?D#7=;M
MO<.OM[I8TKOSS/=,=[6?(^K:),C>C-&.+U<6MS=^&@< ,B]FKI^&(>+]@PWH
M8\J216N<)R%?3^7S%>\M656+;W63TN6*H*?UA56%;J,=X'7$ZY\R2"\?F:5[
MTG^I<"S/RC(Q6-%KQ@)OK53 =]8"$* P"5'L8^*%"+HQ2*+!@B D2B?^UX1[
M_MINY[:=S\P2;>?L (8B[DI];S[JUOI5XJ\K]IKSZ)3XNT"_>B4Q> EF5./P
M8MZ;+1:/Q;]21A"/XC A?L)@# ,80B\&O1$ ,QC.&H[-0K<<D>^7QB\>@0V[
M?:8@O)S'%XS#3Y3G_VRA6,FO-J.QG0[VDP1D2^28CLDV?3A;6#XI*)7++KPT
M9BD+F0=B/PB FP9H,,,#OM(;O*L#;SDTWS_)L'AH-N[ZF8+SDEY?,#R?GGGX
M:0.THF]MAFA;W>PG"=+6Z#$=INWZ<6V;R"GS@AA@+P(X2"+(PB@F WJ(@W#!
M8Q63<"]_V$(A7O_W'N L?>&5*.G<K"RT!ZCFM07.<YQ%'T4QBEP2)![UTC3V
MDA -.Y@@9BY8\)3')-S+G_U8NN3&6 ^8_7#(;(Y?R9&1US65,>/'>4Z8&.E)
M/T>X-<Z*O=,H!KTV5[A%5U>%^"+;T:+>[LJZ/:G>5[9OXMCETRH,4!C0)'19
M$B5CB@!< N8\CC(-J>650O3U:]7>E>*\W3=5L:^+K?./;'>8^<S)1&_.$S#G
M<^1R8?)HHW-BY*L],W+6918CHIFN\G/$04-<&(Y^)CVTP-+<J-:M6&]8B-T8
MI['O,B^.XB@,HC%&0Q<'"QV_5$1I.=:= %OL+(:JWV8_?6'192LY;R&;Z*PR
MH#WKJ7E64S5[Q\\1R SP8&_%=))GE +8Y<MX+U^><M['ZVT8BI&88T*/Q@E(
M(:%!_Y89@"BFZG68R\"<I^92(-,(80MY3B&&K=]I*UG!7#Z(67'52U%LV?ZQ
MHC"V,!%/Q;$U^,;Z3"S]YZ%H[M[N^3SQT-:$?&B^Y=67;]F^-^5]N?^>UTU^
M=?KXF1?%S*/,\Z@'7!:'+(J'JS(A]MQHENF9'>B6 ]Y";V):<K/EV=SR'IX]
M.G8F.R<V.ZW13L.M/L;.T?#ANKACCWJ=+VYJN=K&'-%NGUM1Q%TA.:9FDW/X
M<$61N;][+TB1%S'/90&"G@LAQ'#(+/PD!OZ,M^ 8QZY>C/-SO !JOA.L)F1;
M\/RKB=8_75"V=^FKM0[U7R84J_(R?Q36\MSR ?C!*W=1R#"A$%" @;A& -,T
M'> C.M.5L:9!6YX.?^+^KXJM*%VLVPMQ#ONB6?*I4^-.7SK>6O3W6L/MPVMQ
M?I9H:_\)55N]Z6>/M;JTS!9J)_EM^4C[CS9-&.$#%U% :0I#-P2Q3_TTQ@/\
M@-!PII< 3<.6TMXI#P)V>-88554=O'14M>'9E4?5OO/\=%'UOBL7B:J:O>EG
MCZJZM,P652?Y;?FH.MZJ,EK /)CXS \1(!X''C(?#M? ^Z)2> BL7]8PDU6'
MKQ%@OTR]K&9E@5;#YTO'6DM^7GFX/?:BGR[B/G+H(D%7OUO]['%W C.SA=ZI
MWEL^^CY<_:8,Q SY+@0P@K"]!SX9\:<^F>T>!>/(9[A)X:=Z[O=5;KO)=H*?
M73RU>5ELVTW-<RL2S@>G_-LU3LJ3=I8555MM>UK= U/7CX 7>RA*0C<!+ V'
MS<6 H2!>Q^Z<'=LL;^(]>NVQ13OK4X]+=9JEYT;+]Y>USI].:FX>W8[3]4]!
MCR/XZ8Z<O+X[ >STCF6S"2O]^+],SF&'O?DS$XN]X#7E+QM,7)_AR U3$I.(
MIN( [& :_]]UEO1.-VL]U;Z+7<$W:R]Z/5F,T:[STZ0N__7RE94G*=+=]+\S
M$W7*5IB.*/I[^1SD[*MH3]A'T\#SO1A!&@/X_Y?WM3V2VTB:W_=7"+C%K0<H
M^T2]4.(.L !%2G.-L]U]W>T='/PAD96IJM),5JJ0RFR[]M<?J;=4966I2(J4
MN#86LVY7EQ41#\F'$60P J,40=0EC(7(AWJ;EUACU8+)SW/V K4&[\4=D24G
MD*W>B$"3T3^T4R(Y)RQ(R]8W;__H[HDQW!9*[-8]\LL[*B]3[ 3L(PE%:>QF
M7N:Z 70SV!>ZA"0)YBD<.;M5AAV50=ZXO<Z(]IFRM#.RY"2QU1FY3$+_LSDC
MDG/"@FQV??/VC^Z,&,-MH7QXW2._O#,R:(CWOG$8A"@"R/-P2N(D<Z,DH)UQ
M&8V1'9Z(5I,,NR$S=X&U ]/%W9#%9HBM/L@ D#^;^R$S%Y9,ZM<[6?_HCH<9
MT.9^"F!BS)=W.23NH-(H PGP0NS2$$(W("CI3:,^B"Q\0##=J.7?%ORW[6[[
M)[J.%YU%?W2F-P&9C=?Q<N-MO%O$NZ;U7>M>5@OOVS?Y,<$@B\,@B?TX2DD6
M$[^S!S):F*69A'$K#(>/.EL#6HF?Z<845DT 6Z/#-V?9LN\+EACO][P"J^>@
M1:Z W3CI:ITQ\\A:N^D/PHT5\J,X &F0!2PT#7'J!EZ75@@3/PBLWO=E##&\
M]4_KE&@K:+;N]Z8&_K_=EO^B4>,??-,?6&K3OJ\R%_^D6[\25$OO_NKC^YX#
ML"E/3-+SZI<OJR@"$?$S!+,DR%R(H(N]E,38)VD"F-NQ^I8?;LOW-F*)#\JP
MXE"V,#G^LJ_O4;\<&:!O]Z :8:8JW_QP7W[[7ZU1G)BB[E\X)T4#3CH;?H49
M%%!9=GVJ*%PJSP Y9_7G<O]+]5->E_7PXXS@T(4906GLA8B2F'02LHA2L4FK
M\F7CLY<IP_XY[X8Z &!D?U.!R8[M1DGS<OHDD9O@?\O+^\/ZZ:'8$&X66TWU
M!O.YJ/[9RDTI"CT0A2X!+J4AS !)6[F$1D2J->%T:8;CFK."S@L-':ZB7*2C
M 5FQ<&1>4.5BAE$\G5\;_68^OGL7KQ$ZTH>U'22ET9[2U*R4([1/AW)[VAS?
M$HHCQJ T8@XM) CY%!&O<Q-(F/JI#)M-%&68REKM)O/85$#%2&Q&+.48[&T8
M%Z*O<:1&N$L3Q'80ERYC2B/34(RR\MMJE13E\>&P_KT5D,4$1VF(<11&.$QA
MD)). (T2[(O%& H?-AYB,'V^<GU$%PNS@:\ !+QV_K\VZLI<GV#YLO-ZBN+E
MY%&7#(KK,I<?[S[G3^7AR'NR?\GOZS.F5>#Z+@Q@#+S8BU'LIH" 5F"*(E<J
MKV*"&,-;Z[E#]*'7S:E:Y>1VURE8BNVL,\$HMZN>$3RKY7QY#T$SYQ!OXC-V
M+#$=5#OV41V&7!Y:Z,)&XI!N<SH<^,EW5>5,#(G2A$00IA #1%%*0=R)R:(4
M>E(L)/MQTTE7M1:2)",-D""UF,1&CE!^+/?WW_]8?.,/1\81,G68^0*)\1--
M-= L(0QE]5^?;4[!090<F"M?E;MB6[ORG]B?-L]?\]^/";/IGZN -Z+W* PP
M[Y#K>2"BK@=HE.$8N4BNP^PD089)(UE7156GV;-?8H@W0>QZOW4V0ZWE6&4:
MLF(,,QNH<FSS0JT;IU',^;7])]?0J56<^6A@#*T11M("LAWLI,>4TL DE&.M
M7ZK\XUU:'8M'?I^\RA+BN0BZ;D(]'$0>)1BV0C#R0U>&IR0_;9B9F#:<E_).
M'SD*DH5)C'0,(B1',RTXO2KV,,U+B$:X11%+.]A$5?E2RWR2]'/6U0/>;_D_
M>.K/M_6.1UR7;)7$"&8^P,3SPH#%8(&+0"<[CK%4_JL>B8;YA6O7.#K\#_E9
MS_J'AW/!2/[WDOZ/'L0%':'9P9;TB#J<ZS\,5+2'LX0@''.3M Z!'0RGV:9+
MQ\D 8J)\V+]=_"E?5Z=#G2O92+Z4[_L8^A#AS -!"CP?8^[&-?(C1*4X49]4
MP[Q8E]+X5C^C>CRK*NE^:<18C 67@5>."0<-< 9:VD.#PAB.4*'^<;"##@W8
M59J>P7*T^-/Z'^6!G*IC^<A(X[KDD/HI24/D<T8&$/IAD/2$3"*IC#\=\@Q3
MX9?B?E_<%1M>9FC3:5K[,NM-G6#,NY@<\DW.-K#;G>3C9BUXBY'CW%#+T6*M
MG=.K9P\?"L VPH0Z0;># [5:5)J;HN(Y-B^R>2J>SG,I,W(CU_/C) U<$F0A
MB6*".ID!R(3.U_1(,AT.O\AB.P@G VJ"<9S(YD=0^M1_H%N; RA!7R80W9:;
M^GE7_0F+D'VAES#"M*@VNY+[1?S<<[#]/C4HW[$M9/-R%/@<_F%24MF[P+R1
M9Z8/T.53SS3:4IJ8<G).[H?]-R:V/+S:6R(0Q GSI%&<HB3P$[:Q='M+@A*"
M93Q;92&&*;[3JY"]3%%'3<P_G04P.4;O5;+''7T+I1$?=#*P=CB>T\TH-4\X
MZ9<G3_GA^/R)3;$CWM<OL)_.\?U9/&7QO$_3%'IQ .(THV[8BX\"""3?H.@1
M:IB5.CUOG">N:1U>YYVNT@]2-.$LQEN+0"S'8V=T/_7H]FK:PVVB2(YPG?;!
ML(/[])OU^F&+"=S$/;(-"_F_KG^_%.>E &3 ]R,WBQ'%"7,!TTX<H:Y49HNR
M$.,>&=?+.:Y_EW?)5&$3=<EF0$S6):O!8CK9PUMOP33JDTU$U@Y>FF[&*Y],
M"R[BO,.(;Y-7U>>\RME_Q*^C:?XMWY4#\EL1G*881QF*(8VQ2UP"@DYVD$!)
M$M(AT3 CX0VC_ZJHPW)91M("J"@]S8VE+%<YK8).IV'M>@UTM(G$!, <932=
M@V$+O6FUZ177Z4=,F/@>G];%@8OY>*!%]516Z]W'._Y*IGXDTSRY8&2\._%*
M7Q_V1S:OB]M=WOS%]9N9&&5Q&OBNA],,$*8D.%-T2*G4:XDE]#--JEPUI^@-
M8U2PWCU7A2S#+C%R@GQL^:!)LO=YI,J#T]G#+QY>/2:[<7JKG+-9_5]:0_'Z
MQV=L0UAP-EBR?2R)P.5FL_AH"%[%\_L\IB5_5%.P\:GOAC[>[HK[YI;H4H<L
M2")" 79CZH<997^"71I4X@(():[F-4LV?U7?*EP_TNLUEKI>U@VVT 7^@CA+
M7^AW$+]0UAEH._F&7_<02-WX+S@41C, KJX,ISQ;-CDE0 ZYMU,$#(V %2D#
MIFPKYYC#<O'49Q:W[4]YQB#@*O'^"'\OC@]=+MNK4W3H!2'P I1%J1M2SW?3
ML#]%!X3*A$J:11O>MEIM><)L>;\OY)^5ZT9:++19$&2Y/:O#ER]&IU/5^8WI
MVB?7+A^(R*$Y$F,8&A8[P@=3QI6S3&U9_KQV!);^SDO:Y^U)F!L!+\RR-'3=
M!&/^!]0]C"6)FPJY^CKE&6?*P9'Q]JRD+%UJ %:4(^?%5)88KY_ .ZV"]AS3
M". X2HGZ1L$6'M1HT2ORTXV6>.&AQZ=#_L#D%-_RYMKS^BD+]!$)(DB]R(]B
MBD"2>E$O/L%2Z6#:A!H_W!CHZ12UHK+5AW3!*T9^BR K>YPQ!+71T1[6$P5P
MA/JTCX$=_*??K%<%C(S@)OP4OSSDQ?V>U-7>F+C#>E\Q)[1N0K3?UO^ZNQ[+
M>S1)0D!A@**81?&$@+ K#4 "0D.II_G&M##,E0/5^)G876.'TQ3/VTBG^1L<
M#3$FM6,@Y*BUU=GIE':&6M<>YU!O:SA7&>H1$C8_?':P\@QV7M8&F E94=Y.
MUX=]L;^O/N6'NL?<I=0 X\"C."%!XJ4^]CTOS3JI$""IM+FIL@QS<*>>\Y0?
MG(HK*$>ZDZ$4H]8Y490CT!Y IEK3(=0>S_0=U$:X4!?>=C">-FM*,[-2H<]T
M<MDYLVE^R>CT0_TTE?G#_$5$2Z@K'X=^2!.4Q2%V812F&)[]7T:LTNVA-<LW
MGA;<7[?R>];JR$:G;>2[&=B@T/%9]SB(T>'20R!'D6_U5[YI&R/7;F:O<_W2
MRQY/4P'J$5XU.7!V<*U1"Z_U$#:*IO 367X$40NMNQ%_*JOC(3\6;1FL6GSS
M&YT:290@#WDQ2"B&B/>.@%UR-,&Q*U6;3[MPPVS<:E,_F)6,\?7C+$:XBT(L
MQ[8=NIQ4FQ[T+[5M^)4YJ:W"]KBKLB"/\*RQ\;*#9,V9=_FZUBR.PHUP\M_.
M+MRG0[EG?]PTA3VOG_<F**4A3'R?DBAS20R3N#LWH&Z"I2)X[<*-7[_S;6_W
M[!15=<I?%/NKCHP5UH>M;)L=[?"+L>ZBR,NQ+E/5&409+Y6UAV)E$1VA6&.#
M8P?%FC/OLEV061R%3Q4V#_GVM,L_WM'\]OB5%P0]BR1I[ .$8.81F,59$L8^
M1A[VXCA"A "I\E*3!!FFSDXW?AW%M9,\$)@$H6#D/Q=ZDB'^!7#.K[5J"X;M
M(SB-Q><ZX+6#P/28<AEQZ\-'C9@^[)D'6C^_J,Z"&1_Z'J2Q[[/)X+LAA'[0
M"<8LQ%>G)R5QIDGJ]/BX/CSSI9:=COQ!2;WB/JV?:SW[=YY?\\.C\V&_97^9
M;_=Y)>GTZ<!=A=.,0Z[.;#6L1PYKC?A 4\OX[AJ&PJPW:0!LY+YI!HTRH :L
MA'F07UI\J$,Z>CIP7S$_%.6VKKD_+'NR\FF$W-BC!(1ID. H#E.*PY!F?D ]
M&GEBK=:UBY59HDJ-V'GEK^/SS,M.$)VQQ:<;8$N6H':S+A>B&=Q$EV-RJ@J^
MJ9+R\;;8-QT4#^6W@A^&K7<?]G?EX;'^Z0?^5FR].\=X=9[BTRX_YGC[CU-U
M?+Q\ U@GQ-SEAT.^7<&8A'& ,,S2R,6A#S,_[93W*9#J.V^)RJ;O>GL-9VZ5
M/ ^\(TQBV?C:P4.V@5):O28E\Y^9QFP0?LS754[*ZHAOJ_H5WBH!U/4"/_2\
MR$\\FC 'R">4NA$",=- ZL&;LA##///QJ<9Y?^_LN&K.ANGV[Y(9R\KXB056
MLT G%TZU*CFU3C<.U\KYM=-K[B3B-^ 9RQ&>BJ@=I#C=C,L,7SVXJ!#/Y^+^
MX?CQ[I>JJ?B#'\O#L?BOIH@(!#0+LA 'GI^%44JABV@O/8BEK@%UR33M_@QT
MX6<6!Z[J]^7=]R?&4>NZ)I(Z24W"6IZSYH)Y$H5][@#F3:UK/6^<H:;+<=H(
M?((4IV, [&,\+5:-$* ^U%3X\,.>L49>=4^!5SB"(4!QYOE^D,0P<?T$M!(1
MC!.IN[LI<@SS7J>.PVBO<<AVQ?JVV#&O6?HAV10TY5G.))"3F*V'M-5L.2:[
M@$B0O52!M8^QE"T98:EIZ(@R4^\1KC(/09_Z41IZ!(9)D"8@(C0-@1MD-/"]
MU;$\KG=B/"3^52G6Z1407C%?^7_BE%="03G*D8!)C&#,("1')X,8;U[JZ(T?
M(0IY@.R@!06]RZE30V')X_WV,Z^1N.OH)?!(XI($TS2(L$L ]5' 9 5A%B":
M@43&#5&3L,!YD ()R ,G00A&,9,CAS-<M685"Z0&-8T6X(M+;-[C#F4L+>(1
M=1NN<<I$1.03@OH^>,W+\LM\I(Q0 #(W3#WH9B%@OHP?-??PB/U?*E767YO0
M&3,8E1MFZD-8C)L6 5>.KJ[A^GS3ELVP*=UQ'$&A)"!-@V 'S^DWZ\V$(*VX
MR;,A"^Z*8UX7Q;^L@G^A24KB((P]'P&7A%E$O10$B<?X&?FIYQ.II (3\F?D
MR$;IMB?&JPX8JK2I<2AD&72945 GT_$!L(A8A8$5XEC]PV0;W1JP\$WF-86F
M+ F78YHTR=K#VX#63[Y0T:<0AH1 'R :0:9I'-#$0P"X$4(95&+G610S3=NO
M\MY?W'6^%SE:,'!R7&[=F)DB^9NQ\;1F!] Q' );PZRC;M>>,:_I;VPF"^ O
M[^K_K2RWOQ6[W>!1:!1B&J99Z,=)[ =N@FC62801#223_B=(DF$4I3S_P3[0
M::?JIRO@*.N/FP50G9([O:SAURM0"7G2Z@#;Q7Z3+'G3,YZ*CB@W\<=0YQ97
M R:,,*SS_R(:T31#D8<)(=2/7-]+L.?+\9*J%..<='X9N)5^-JX,G1@5S8&9
M' W5CR<'_=!^78Q[WL!FA'>FHFD'YTRVHM0[QR1;0->%WK\<U\>Z3$:?:QP&
MD4N],*/82V ,/ (! 2#R(C]$49J([MVJGS>W8!J-G%ZEQ3+FWX!F9+U,!=..
M]3+9BE<-U'6@(MJ7EG]ZT",&[[<_K?>G._;3^MWD3_GC;7Y893&A ?9=%R5)
M&GC$)Q%N9>/8Q4+'3GHE&CY/ZGO,#5I4U57S'H>Z.E5^^%9L1*]0-6,^SEC+
MP2W'7SW2P^Y53$OGA9K.KXVBDEUH-2$MUWUV?L35NL[J0EZTMZP0+E>V"S.X
MVM%+5K--I<F9J-0[MNKWK]0%T/< 1@'*O)"0%.*H%9,$&53I#BO^<</;1:>/
MY!M/>8S$O%2C\,C1>Z?*8F[I)18C_J@R;'8XHNKJ7^^=JHJ#*$/T69[M.?E9
MGNM!XO%^A*Z7T!3':9;ZO3SB2G7 4I<R6TYPWFHFR1X3\!.CD7F@D^.3,VJ=
M4HLQRYOPC%#,=$CMX!H-=I2Z)YMLI]+JV!R!\SY37]I [DNYVZZ@&P8HR((8
MNY&71#Z"<2\0>W*YP1/$& ]Q^8/(.^?I4&Y/+ JHUKN\Z>JV,1'\ZL!=C+9F
M@EPVS&W0KM6JP>P4<[AF<W<E?0NA$>K2 *L=W*7#D%>]1C5AHZ6S_"I-TA12
M$GE!S"@RPAX.NZ-"DJ%87T_Y=R49C[N,=Y-_'TS1F&PN'&4#M/$.\A9UB1\-
MW72@:P<_:;)%IB>\)$+"24GYCOWM_=_R/?/M=DPRWCX6^X+[=;SU4B<<)"D)
M$<@HRF(7!-CSLJP3CN)4+JE5CTC3Z:J-EC?.?:-GO?C6+S253%O2A+08ERT
MLARI]?C^;8#O2R67X3<QY,9RF_1";P?CZ3;J,N/)!&:B'#A,".7/P%XFC:[B
M."")ZP,?^=@'U"/LCSWQ$D\JUIPHRC#G718?*\ZIWBJEQZ;B*L9T,T(JQW"7
M:(H_3S/":^,XC?"9)H#MX#%=QI1&)N'$T_E5$OO0!QX&F,#4BP#P4'<+0*(T
MPC)%>N2_+L5.TXOU=&?R$X_DWP=-\2A>*UY3C^ 7/G>7.6\7QLT.1IF@_WOG
MZY)(2/-&D\?V8UE5*T C "$;3AH%,"049D'22J)AX"9*S"'Q?</<T:9@\M'K
M&*24;5ZK!)LD=QA"3)4]6MB^XPK]92$*.4,B0B(* %I&(RH6O$4DRF@(=W8M
M]^5+82UW]5>#!)$((4RQ&V(,?1IBY'5RF5,D== ]79KIA(&Z87/1KIK60?F+
M9-* !DS%6&=>..4X:*A;3T.M>G]9+)_@7<1&*$H?VG80ED9[+ENJ:D9*_&'*
MRY*J-*!!AA*"H.^3**,P2GO*Q"ZAJWU^OS[F6S'RDOVZT-I"S=H:*B+A$[7U
M@7.5T@O28(EQDA&4%%_M+%D^6;QDLBIB=K"(LO:OGN1,04$X<N+[^YOTM/(A
MQIX;Q!B"&,(T<\.,=D*3F$@529TH:A%'Y\;9YY(7^U,1%8ROY@-3,M2J<1QU
M=F8.NT:1&HO ]$!L!ROI,N8R+M.)T>00;06@ZV.8Q C$*880(9CT7E0& R!S
MYJ,N99Y38UU\-0'-B4&95B U!F.61& JD9<PI':PD@8[1",M263DGO[S\ZB,
M6<??OQ7[$Y/]L3^23?*[\I WO_=U_7M>_53LRT-Q?.X</+S?OOQ*TS?XI_SX
M4&YY"=>V>>@JC'@3C)0F%&/*](8$I*T%J8]H+,-N-ND]STGY;6T/SSQOFEDZ
M[%\[_CQR^V2C17L E*HC88?*)J/<P0E_<S]R-M4YV]I-B,8"IS'!&=APTVT,
M-1(WW*>M'RF4=6)/WXQHB8(7LXSA:(1NWTRR8T>S$IFKQ3XLTU%AUV6:M9M[
MDN_SN^*X EF" ^@E. P2#R8P='&7E9)Z(/)ECBM491@^I_@DOW\9)*)7\+Q+
M&NJ VK3 )UAQ=3%.145TX?P]YZT@\RW^QI;Z??[SB1=C^'A'B]V)_?3+PYK-
MO(^G8W5<[[>,$58^<$'F(S_ ":)1[&<N[)9O%H)4ZOQ/MVS#"ZU3]_MUHZ^S
MKQ7F>8]5K:OSO;-M='>^*_;M#V<.'B4Q'5F=ID;'CE5KS+IRGCDNF?Y=YVCV
M=XLT(1$3D/I1XA.2IC3.*(SC#'HDQ-@%4NG><I\VO$;QER_IUR^2.=R2X(C%
M5@9QD0M_NC85"^43O,1AA&\4 ;.#3E25O\RQGH*!'!FT'8#.^08 TB3T/#\(
MJ9\F)$NBL),5@5 JB4E-@F%JZ!IA-<\\)!.6%#&3H0J3<*DPQJ!UV*+4<8'+
MNPRBBJ--1*)LPU4^F8:(,*UL-N6)1?B?\TU>?.,5VW_.CZWH%4Q\F '?CVGJ
M@C!*47@6Z:-(LLCV)%$RZT:ITG:GG7/HU1N_A3.S>$8P&EM#.J"U9"EI,>5R
M1>G#1_QLJVW:QR2M$H0ARA"A41("+TR2C-?R:$3  "*YA23U:>,+1Z0;J*&C
MJS,,H^=5"FC9L1;45']U,J5LO_0Y;CY882L2!VGJ!2 *"-NJPB1+?:^3Q:1+
M%>U4DV#8-_W0G]H*;QHZX9.Y+32)G-*]7JV0\WD 6TO'"QU_#]$1.?Q60M,6
M5IEDPUL'WQ,0$>693X?\:5ULNZ3[_;;.6WOA+J^@!RF@$"1NY($XBEP_R3K)
M+H98AG5TR#-^CU2KV+\YKJN5-$EEFQ>ALQPE:4%:C*#F!EF.KCI\NZZ!'-XF
M-_8BWIZ7MP1 &V$QG9#;P6E:+2K-3= )9WXK0-(L<*D7((ACB!%)$M#)0,25
MRAN3^_(LF;!3Z$H2*(4#/JT833K86_ T3_043Q@L.\A#4?>Q4SM)!,0=()X5
M>WS^Q"8(3][AZ3IU+3X>V^$T"2AR&1&%01;#@" ?]B*C%,EY/A,$F4^=J76[
M<9ZX=O66G'?Z+7!F-X;5Z":L 6([%I >4UYMN]KPD7AG^Z(\$I.4_K[9G?@=
M?]?P<H72S,=IE%" ,($)==VTW^J9;*EEID6@\5..BUIK2B<<.H 5/?"8&5/9
M\X]77<J9AOS52JMCWT%WYAPD$=Q&3T8TPFX'K>DUZ?6[8-UXB?3M^[!GO+K)
MJ^IZ3=^5%WIIX(,L)AGR<.2S:*:_#"$TR$2[]4V58YS4OG]J]',.D^J :\%T
MG-CFAE.6SYQ6-:<O!XY?E@.?$4GQ;GMS(JK88V]].#SS#6']R"\OZWX;[%<?
MUE6^?7/6MGNTL]XP=^G ?K'8.VOG]E05>SY$F_+QMM@WE3^/#^NC\[#^Q@^U
MV*]M\[MB7QQS9U?<Y0X36.SXKS_M\J9.Z,%9WS)AY;X6PY0Y/M0>0;DI>(F/
MMS7*[^[*P['Z85(3P'>&Z\K&I'.0EV_XI\V24O\2D.WH?I>S&'G;7QST^]\J
M=DF0>30A?H R'](H<,_;'?2E>G=-$&-X[^DTJR\.E5WJ*3"*.=(S(2BWW?3@
MG>\1AW[TW&W>WT)HQ%'6 *L=[K$.0U[U>]>$C53=G%8(L[H]O$LQ C3VLR3!
M@0<(P)D;=;)H1CSI<CG2$@Q34'.#I7+2K@B8&..8QTJ.;%Y>])U56J#RS24J
M(P0S#44[N&6B#=?*VTQ$1.[.;D5=E)#0S6@2T)A]V8V0VWT\#0B1OZQ[]Y.S
MW-*IW\Z]#XG,M9Q6-%3NXY:XAGOW_DT8%3M6N:S25V_<)&T67<<_%NO;8E<<
MB[QNRW<L-_]\*'<,D*IY(]_GY6<9Q%$8I""-71"F+@Q1?Q61I#&1R^W5)E9F
M_BOE_?[X 2<??OSP]4/ZQ<$_4^?+UX_D__SOCS_2]/.7?W/2__O+AZ__3XXG
M]$$NQB2+8"W'-0,5ZW.5MLK)4F][1!$;(2KMH-M!9?K-*@U/5F4ZO'R8Y(=I
MDB9!&D20^"% +DA[/XJXB51Q@0EB#(=,W;.ZW5E#R=>(4R"4)C23Z"E3V/*/
M$]]&2(RR5&&UCJ24#7F;EJ9A(_M@\=/ZF6>:]_E6R(UH3"*(XQ3Z-$Y3OW]T
M[>$4JCU5E!1BW.?J'RD^-8I)QF&*T G&9>8QDXS3.K!:C9;*H+R*RU@H-PU(
M.ZAFJA%O/."<A(D$Q1Q.^?8UM:W"%$8($Q"%F0^]V ?A.<T[8$&H5+D%92F&
M/9U6,<4V=A/ $^:9&7"3IIH:LFN^SNQL<QV=<<*9B*@UG#/5CM>THP494>9)
M'Y]VY7.>?\YW==N4UW(3-Z8$IXSTZ@MYD&#:W\E#C%TY/V>ZO#E<GGII\504
M1D=UZHH<(VD 58R9YD53CJ$ZW;X_-,I90%7OPC5"6?J@MH.Z--I3FIJ4LMT=
MCOFENQ8"CWA>$ ? C4B,0S\+^NH#/HJD*@*H?-]X8L_M\:9_Q_;$&R_+<I42
M:F+L9!HP.3ZJM5DX,KN"R CE3,'/#I*99,&K!@U3T1#)5F^*6M^SC[,_5<6V
M+6S="OS4K+!50&GDN['K!I#7\,DR%/7%!N+($XK*]$DS?0[=*\E<HH&6BL2C
M$>5Q&EH&8#E2&F#[0L'^V/K30M"*I[7/#_'$Y/9OZ]V)YY%W&>6W:_9[F]RI
M'O+\Z&R9S]+]S<7\YC\>7,;P&NJG.C.4WY.VYZ/.L>3UU1_S0U/7N;TQJW^E
MXE=H3OE4?ZO["UZ,?9,?CNMB/\QA7^]NG$-^?]IQ_G[FN? L'&%?W13KG?-8
M['+VL7T^,<5=:.BN;%#ZAWWY='?-]I2F%HA"MND5#QR!",#437R"8I@A' :X
MSV!Q(19Z=#55AN%MZ^.+DC2#=:N0?JJ"H)B// =X<EM2@]ORP?H;R(SXRU.Q
MM,-GGFS%M534R:BH9VVL4H1 @%SJQRBF21CYF"9]'KV;2%614?B\%,U,+26C
M3#,JN(DQC&'(Y,AE>5J18I0)V-E!)E,,>#?O0A*+">'WS_GQX]V%P^2'01(@
M'"/JQB .O#  :7\?XL)@8@RN(G*Q0'R?U^]C=<?C2K K!^6F$=<4F?/:&1_O
MM ?H2EA/CM)-8SY;J+[O7]G\V:+U*T,H%[)/F0/6QNV3C'H_>)^.F;!#7>[O
MO^:'1W[5,WA*1N,@SFA,8X23+ D(\-)>6(("J9I0BB)FN=N2W-G,N(Q7\1ES
M&Z<!:HGK.-&(2_=1!R;*%1\&SBM_VATBZ"69GT(WC2-(:12'[8L%&F2)+_6
M8*HLX\MH4/NAVP^?)U9^D(53+%*=$TDY9_!:#8@7H>SRA2!>8C5"3KI0MH.E
MM%GS7EV(22B)\A;W-OA+AK\7QP=R8D[CX_GH[GG FL#U8)PA/PMB".(, !JD
MG?34#2(9_M(E<X;@EZLY].FG!;[:01=CN27PE@]]:ZA_8RHZG8XW/>,]+U>9
M0A"\$?K3#;\=-*C=JM+LI)UVBSD0&$0Q((1G0&<8("\D7NAW MD?I.*@"6)F
MN<O4=H<I@Y_:-:8AZ";?9"Y:4><J/A+WF0J@VL%..@QYYU93&1N%B\U5' *
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ML?!OQ"]?\4<J*F\)TA/.'\'H3=_-T_N&:]+FM41R1B'4''-HC-$JK/"JDM1
M 2+(@X9'GE,N3,=BWC>[7AB"K^Z*^%2,IK.5-H_S.PZUEI1PZ&!K>D>M-E(
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MXPT3V\?_]'ER31;L!JTD#F$@B FB,VVH4IIX5JU&&,*8C<4!AO=Z6ZR[4\$
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M!!P%V]4CKXA"B%4X &Z_]R2%VC2)N+"YF0H&0,6.+VR6CGO'PM G3D "RIE
M5GA(;"_L(I-.F!)Y87,S#1RY^?2?V6,^SV[W;CR]>B8)TEI(N%!:(6>=,BX
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M^1>SF,U#US<&W5.M.:MF"PD$P7?P,GB;@D'A(;3$5?([0&*.W0W;7^N&;MW
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MF&KDE4-LLVK;J"#< /<KV^50*Y#V[I__%KK\+ORQEE.^>3B!D#*@.?' (6J
MQRC,N2NIO(?DPBJ*M>V)'XMC7^P(,UZYR*8V7?UW6PSV0SZ9^+SX:U3LVWIL
MV%+"A9=$*LV4<MY;2LK]C34>"D8E3 S0"8LAQ-O+ASL$^@SWMKWS3%ML#35,
M44V4D95\$O>;XOR0%EE>;FT4\T[IU!D'ZFYV-\+\7(Y@664T,,80!RBF@G!$
MW$8J9&*FI,9+W:4Q*1KNWB:FE7L0O %W>YN.YU>W[]._UA=R!&/ONLBFX^QA
M$H"Z7JKHZE;=Y \[JK?&-QJ,5"XD,809RW$)$MVX(5Y*AR\K@-#;Q-:70DXW
M]P4H5U?TKJO4JOF\R#XOYJ5A^RDO:ZJ5-?P"EN&1=].@VG0V5S?_M9@]GQ>#
MC>;/-CZ8$*&U% PYR:VB9644NMXK)<"PJ,)H XQMG&[V/8&R>AT**T/%+HI2
MQ-5:NC1@EO_6 >J;,AJ03F>C U/W$:TE:*D=30'!U" BG"*VPJ6\J_"R@BN]
MDKA339R8H<L4][8(NJ>Q8'G!8+5CH*US*BQAS-,-*I;;&)=I@%GE)^9G>XH8
MQ 1J\NEC@"WT_NIV]>=Y%M:,C^DX/'J@ FI<PPEW5B+ L-,>F_)8+?8;M* !
M%Y;%/HAIM6VE#&&&[8#!]=I-, 9<J'*3096G3*R6E%58"69CC-L!9LX/8=YM
M6R>#F(+5.&"WRB _>K9]V49BJ$9!8@:Q!(B4!U:$J## -.IXT  S\@<QL4;@
M/X0Y-(Z";YI(D-.&>D8DP(R69Z>DEA4"BO"8E 8(?E"P9?Q/>-9HV>MB[T;1
MGK<2 J16B%%,?1AG'A&#J]D><N)C/'-8?[>HQS*U?3&M/=!/0J[G$1$Z?#TJ
MEG__/9U_R6LS;4\328!4DS"I*T2M]PQ@;%&%@*$X*N.X_M;2I=.N/0WTQ<'W
MZ?RY=.H>HKUZ+I%.4T&P55AR98T&SL-*%D9=U&F'0=YJW1>;8F#NBS)UBN]N
MC>FORO[M(5EDRXF#G!-+',),":\EH))7> F&HC)ZON.]FW[5<G[Y/P@)IZ6F
MU#M.I<3*THU\QO&HM;7Q;LLJ;<--+V-U;0?R<TG_,1Y0A"3BH#RLB[B0O(ID
M0B"9B2%2XVV1RR)2--H#+U,PN)*Z'=8LD!IB$-PV3GE84AAVP"!C+&8>22M9
MK?FV\S6EJRIOVFI(D?<&0PDU));J2G9)H\[_#3EIN1T^'%/FK1'>IY\D9F&6
M&,V^^$G^UVP(T\"F,\U&_YO7$JN=U\P1XRVP5'",X/HZ&<D@T[7JRG?F0I?=
MO2[RQRS@JY_^F)6W(%\]+.]KG]ZI\3Q[7%5P/XQ!\\82 C3T*/B#P"HK$?9(
MR0H9 WU,?N:PIX0(DKQUN[M%?=CA'" H48*38$DK#KQQAH)*%F:BCN(-D$%=
M*GMO.*<9S/W5*2AS*I=KQZ?\0SK.I^-LDK[J^:>\O0FNB\\EVCJ"$) J6/12
M4*FH9Q6R!/J82X\&>$2P1P(/0%N].>^-TQZW9]0Y)9@$1+ PQ+'V5D!F-Z-<
MX0N[\.*T!/G6R6]#([V&T6T:%#K.5HJ>WJC[,HSZKT/,._1JXB4$7G/**+%,
M<DJ(4)7$UD1= C? ^7!0'&Q9-WVQT:Y5NH+LT^BK^UH.H%2GT_1V[YV$!]Y,
MG)?&0(P(%4PKB:DE&R QP3$)#P,\/C8H+K:KFL-43#_/2GY)B-;L"C](5D'+
M=U,_RE;[X<L\R%+2 %(9PP@H%+MFO&8-)!!)#QF4'@.MC//8,[V9Z1V/": /
M</]O$%SK5$.]%:&X?PA=7T45W@7=3^_*'%TUFZ7SF<^FV3R=9(][]P9KMI P
M#9#B3%'A##>.6F]@);]$)*8:UP /9@V"H=VJJ#<W_84-L2GD/;TS^6R^+]"S
M[[5$>D>,THC!\-%@E0@ GKU"$W6R>X"GL 9%QA;UTJO#4I[+#1"M(%N;$X<\
ME6WO))QZP"VR &'KN2=$HLTH"Q9)/[<-]YB/."CVM:66TQ6)VJ"R+N)9(_)8
MOY$$6F> 1)@S:"GS"D'^C(*.VE(9X#&I05&S,RV=CJOKJAZS &V:/1ZXS:#.
MZXFTE);+ F-4AS6BO&5\([D!M)\8XTF3N>-)<9!WT;B?CG'OIH\!U;S8?Y1T
M[WL)@=)R#8'P@@&@G5=X$S4UU+%>8HB7SK'C 3\EN=;1I/38&6UK"PD'7CN+
M)47,<"&,,F"S>:\-BIG4Z@<*+Y]P\="?CGK711I\^)LJKKDV6M5T54EYY<HW
M8F*=!A-+A3> >1KL&0RX!UCR"AUN53]1Q4LG9@>:.+W%=SUZ.MK<6[^;,(LA
MA 0*3+$AB&N,:"4S!>#"(H8GM?2.@_RD-"L60779Z',V.50XI,[K"8+:>D\0
M]<AII<,?-:HD+W]W61'!4Y$M#O73\<W=/TSRIS3]D"ZO+SB6=[N;21A07CB.
M,-',$P*P%:Y"0ED8$W@YBP)+/?"O-?1/Q\-R<[%$Y9_9_(M9S.;!HBTJ.?8=
MN6K84D*L4<BZL!(X1P&7$,O-N&24Q2R] PP#GH2-;2J@QR3KFM'05A+]$XZY
M\];RLJ:IY!Q;[C96;X"_UM&'UC)H\L"#2\EN[4P')V9B&56:M77T9$]CB7<"
M,DPI50P[A+BG=C,/,!!UX'Z >89]'CUI#_6^N!B<I_46TKH 2A I#*3YT_5D
M-)T'1[X\M?=PO[\"1/U&$F$I\9A8Z+0C4D"OX69M( :!2]L#Z9(H>4]:Z)N+
M/B^NB_0QRQ<OR]W5X-_V%Q,1C![$J15*\3#O6XG!)C" .>[G*JK7G/MTJN,F
M71*O%?A/.?'=+$I0TH,1Z8/O)IAKKR"E1GBC'%0(@XU/QK2-.? ]R%V1$T]S
M,>"?C'!Z,<NF:>CRJAQ/B5^-*H5-FDFLL!I(JL/@DPH;++TB&_.&R)C=X$'N
M@9R2ANWIH3=&%ODX36]F/N#X<31)KVZ;S($'7TXT$D(KY8 D"I7W(5(E-OL^
MRL:LNP/< ^F3>VUC/SS/MQ6/-Z%  &^-YEI3IPC10?9-:-2#&$^W^<;(J6(P
M73"P,QV<F(F;E.XV8C![&DN@UL)9*!R6RC$F.1:;P -CIM_HX$7%8-I#_13K
M\&_Y]"XXA_>_E;9$0"OH<.\YSH/O)E@"#+2@6,)@!SMEG-Q8P]9%55EH?+*]
MCZ*O7=)BSSK<!OBG(%Q9FK&\E>WJ]O?0X\5]*</[?+YW!:[U?E*F^0!*G= &
M!,^? "LV029*Z]5^.I\P\XEHUQ;\?5'O0_JP=IRN;IO.=0??#9X_".8MX(QA
M;Z0S1EF\2<E@.,;?/:>P2Q>D:QO\4Q"N_@RWYZV$>B2!-L9X"*A0 %B_R?@&
MA,3<>G-L4.5DX>2NF1:'_4D"*65ARJOEE;\S]S4MQMEL?SSOT+L)Q8IH@X*)
MK+CBB,LPI5<R>V%C$IG/)XS2]3K:!O1]1Y*O;FWZ>5Y9 (?.E.]Y*_%4:2V]
M8Q9KKJ"T_KFD"#"RGR/EE[ENM@=[W_1:IQI^RC^-OI:)7F49WX"-SXO&1=>.
M;3*QR'/+)!3 *0G*.Z7PQJ8@3,4XKX,\;WX"8G:LDU/8>4M;X? ICEVO),Q8
MP[RUP'.#N242/8<L@? QN[?U,T@ODW4M8=[S7!@&PX[22)NLURU@'9X0CVLW
M88(JZ(2 ,AC %+K@=6U<>P"CCK;5OW?S,OG9IV).X9Z\''\?T@!6-@[:6P;E
MFQ'XV#8345X8:9DESAGE/2;(OBA?9U5,/+KQE9T7')#N4BLGR @,XBR*\9=@
MC91EZC970-3+"MSQ<@(-D%I;0RSB5F"@O'PA==0NW#"O]3R!?=D:_,/;&FYE
M2SBAQD%LG0,><.69@@)MSD$H8:)N@FB^47*J+(4N*-B9$OJBHKN]3<?SJUOW
M=;PLUODA3!!7TU*F\I\RG_MQ-%DY<2\G>#6]>?V#%T_NX6P'7TN$4X(([6EP
M%35$WH<_;YQ%#F(<^ '6=NTDS^'T:NF+[E$RK:XH?WM6<3Q9E/&,E^BM$-TS
M$OKM2.*=QU(C:[Q22UZ@9VUHSF+.[S>/\'>^ '0R2 :ML;,8/UT-AP0#J31R
MV-N %2% .+BY0,=Y%6-D'WD]9F!@,?_..-Y0#=\W9:VPRCMI& K0R."9X.?2
M'@)'3<B-"UKT<Z/K  G;3 E]$?;CXN%ALD1J-*F0>C>]S8O[E:9K7)A8KX6$
M"T"8E](BQG%85A3B&_D5$C')3 .L8]$) ;N!NK\2*@'V,#RN1]E-<&7W4.J;
M)Q.A(>&&!,2LP=@)+LUFKE<>Q*0H#? VJ]:U_*;^20RZ/1;<J6I$EAW=RY97
M3R9(2,*5*:NE86^TPU ^%T[C(H8M TS4[9XM,>CVQ9;7M>2K4SO3FTUL[%V8
MC>N<?6G64,*DLPZ4A?J\XQIK:.%FFU<;TL_6Y7DO:ITBWIL956X E-E0Z0W<
M9RN]>"S!-@PC1"3D0@LJD/!D<Z81.E[K!OGS6=6Z4O.W)M+Q"/?G(R[KF"V+
MR]YD\T5089AD%Z6N]&+^/I__GW1^8,FKVT3B,62*2(D)EI8ISJ!Y+N=M?$SQ
MN &NA3UQK"/TSR)&46,);:7]A"OIG*>06VV4$0X!M]Y,553YN'-^C?,JSG1I
M/84F^F1QZ/ZWG9Z;45$\A:&^O +P $L/OI]@B8&0PD"A.!%::HE$)3MR.N;>
MT &NT3WS90M;V]9(?^FZ+U$QY5JPM\3<UN<3R*6$$!.D@VQ6(LM D$U23 DT
M(.HJO &NUJ=E6QL:.(L5N[-=!004LL@PJ@)*Y4U;H,H.#<@K'!-G&6!%V-//
MC7UIZIG5__[K&R7]%GZP_-76WZS;>05\L&J*,NWX<Y;/\LEB>23M;^/\?J6X
M,ADYGV0W9:K@Q@::+?/J0N-?TNDL>TQ7,:C7O4R_SH/UG=[\W(=SO['-5CTI
M5ZFW_:NS5]*LI<0B:ID&G'+OB15>.,FHETH)#P'3M4($'0;<MG2]O*>O,F#_
M5WISE_YCE$W+'ZK;L*)\2,>3T6R6W6;C)6<^C;X>BL6U\8U$(\P50"Y,X]XH
M3:!C9HTCP2YJ81V@&=<9R[9%[DZ@GQXS9Y\%VI\<^_Q<@CPOZP5@;XWCR!N$
M784FM<[%W" V0".N+Z[%8-SK)L2.\; LHABHOCTWJ^[&1%3C2?":PGBR /H
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M8/H*4IE 5&D094!>:.RQ%20[WN<*2)8W%S^F=C0?K3M\8(-KVRN)!81"B%B
MQAM&.(+4;X3B)*INVH4&(EM!LO,TB,*,YNE=7CP=S(38/)GPT'W%I>=,4<*5
M=&BS+1=DX5%'\"\T]A@#8*<<^'@_FDST8I9-TZVG]78\F6"/.0 $>BF%UMXY
MCRLH*/#U$GQW<>!"@XPQ ';* 5=FFY>5]XK\K_F7\G:VT73_?+#UC40&<\AB
M(@E#" OIJ!:P$DD3&9,[C2XN]M@>D-W.#U^"/U2'$B\?3#"4P0 R%$FEA;-
M*[!QEH ",5%H=''AR&C\.B7 ]>+S)!O[23[:;SB^>"[AE",K*46,EAZ2#XM:
MM:5&@UD<D\> +BXD&0M?MPYF?G]?)F;EXS_K'&NK]V*"K#7($U9>Z8T,Q=X
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MA^)F=;^<_[>X?;,\Y9XFM[0),W.^(2!M"0?:2249M)9I['")'XH>\:\;6;?
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M]*  %4NMV0EW'&(K+(6JC'L\S3M2,D(CEJ_L"NQIA&RO9P ?;U^YN C^]-D
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MN21%,2'8(EX"98U5.:? Q"](FJ; ]D69P\'*Y?W;U6;S/'EQSMZ<'A0 I@8
MQ94ST#-.':/EN1L+8AR901_YJ]"G-7@'LSNG)3BXFW6LTL6'!8@D-HH#)CU#
M'&AK-3Y:8YF5 H+@5V%=Y[B/D(UE96L[="R?EJYAMUQ K8#$'J;V!90<<''4
MTRP^_C+9G^Z!'[8L\"%%+;4+ _>C0O0Y+=>&<N\U$AAJ>9QXCG"0U<-IA-45
MW1"L/8 'LVSI6H9'!2X6JS]GRYMS:>T*HP/07$.A!9#: J --[#T+YP6/.L0
M\.23+MT!/:BEJD6RBD\(G@(M%6%($^.Y<-;B<N?%">&SCN1,/@G2+=@C]-->
M'!YIQUE[\<C@2>J0JR&*P;DUWE-BRT2/\XID]6:??#*B9_2'WQJI91'K/"9@
M2JEV@EH+@44QSN?V.%.9LUD-7":?+N@!\6$+'%_KAU:[CO&UAP0-E?!:X'3+
MNJ3Q/\*5YZF<82PG%PM_F5Q!9W@W3*7^D2Z67-TOY__=V^1#TFMSZ.%](AEZ
M?E 0P%ECE-)6"6<(DTZ6/4T\$'F'0R:?'V@=WW:)\?MJ>=.$&T_C F8>6D8
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MXL;%-8, Y:47M%21$3K++HZPIKL[L@ZCCX&Y_>(8SS.[7Y^]IYX4F'$0<$Z
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M@')2/B.<X!UQXZ?YWS[R_5J#U?(^N:VV^+P=S!ZD+Z\U\5\?$#0%*6R4'%)
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M 5'%)%/II!HRA8% DI=RH'$3^\M'/=2)V!L)+F8RODB0W-=\/*LCP4"KXRZ
M2(\%IIAA*-!.&DA[/+;PFS<T)=ODP<7,RD?NU+[GY9E="0@ZX9UG'B)!*$7
M455*!"*".W'D_YJ9+<S,=IDPF+DYFEVD\Y *I"%'FDJ./>/"E/AC37/6R/&?
M#O0^&WLAP:5,PL.%J;J:A!5[$#@7*E6;D]!"YP2,6XAR#X_BOCXG#]+9R^'
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M%D<Z_5&\F\=M4/%^L:IC0M=Z<] 0":^-9@QJP" S*?C.:PHHCQH#N2XOXXZ
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MT#H(%*$C4CE@O&1 QW5X/VZ+]<B.OAME0E66U4:[*Y;I^PA:5/ GXRB>/AB
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MU./2C2U)?=$XT)TIN)>'!7]^OYFLB_@\ ^@DIRJU#TJDPQ69[ET:(;ATW)=
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ML^,IT3XJ1\XP'-EEF28H4#55>%V,*\SVW2_2'U_B1NM__X__#U!+ P04
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MG7%3D9X( L"M]T9YMW !2YV\[VKABFIA]"#4PB%*NK44P65NX'6,LT@>NX*
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MN#LF#>HSV]S9U4M1"Y5(@P\@5F99U'F"5S4YZ%=\/KPE("!D:' .2E3!ZLL
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MI%>&A:CM$[U:L6JCE^L *&1('85##A#)H?6"G46U+NN5M?_)ZPN?W8E:5Q3
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M?$5C"7612-C;4TQ6('7)M(@A&O*=HFS?A[8,Q:#O; IRB"?H,</65>@VT?J
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MTM3^'% @2G4SRSKMX)-F9<V#E5J;B;?1AG)S<:U\?.08W- 1/^[0-Y6_D]&
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MC9_M2AC2().NQS)1K?[$H!'))D[T%PJL 0,\3S9V-[T!PKXC,=%,\ 1;]E;
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M9Z0?J,+6;H9(.HZ?W5A09+YJT5LWT0:)-52$EW*@4.+7+90BE5=:I0L<[RM
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M'_:'89DN7OWEY>-)/<U?_7]02P,$%     @ 4Y-84&YYP\:!!0  JU,  !D
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MI :./?C,].%P8"%=C9Q-&/'NQY'-SARAC/<G"0K[>#F?\!1X(DM0?T2YA!L
M$/Z<$EZ(*IYE/&> (@ 449&\-10]@L@T6:8BXH44^K(%#R1VP>LLY0&/%CE+
M+IES><G3;*,!Z/.ON6!0WMPBJ+*^#?KK2?-EEC,_^!(G-S,>7O%MPOET+:I
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MZ[EG_:%[UM_,/:D.L.RQ+.$9 3[ (-LP!:)$]NXZQEA@I(Y)Q4OQ^E/)>7T
M7@RO;YH[T.N##G3U10>LM3M7HOA:MYI0U>#_U@'1CSNNV36H5I)7 N?:R>X2
M4*!6R_2JF]//!^,#X55"J1NJ0Y?.ZXJA7U"?9_VMI#\5YTN=Q]\H&<7S4G=]
M86[-*/5V3!_R-$I"2CRX$J@(=7Z;J5I5:U&D>D>I36U5ZRJ^U;[G*-.0W3N)
ME(@J-?D(/<B6<<9*_IP &LNFR8T ?3]PB&[=9!9="00I!3O<M!IN'=!94.CV
M9VP0Q85NV"[?[9\2,-\?G2@935.@;?$8>"Y< H;NGKQ<R!:.J"G" G_NZ)6(
MEWT 1*2?2!P*!&+*S[M%^+#T 3/SU1X)QT1C2#3:^RB,$A3M[-J?+9]Z)X1?
M^*E\%9@L%$<OP-P\99%THHA@?@ _RF26>S"VV@7R$FZWA^<M1M?#$*DS:V_U
M>(IZ,&,]/XAFI/XC\^F\)LNCN? <\$N"8)F2=/9@M,=LNO"OO>;0-YT+*[Y,
M=G6\1$6KM9"I&JI2:QZI-:8O%JG"/J>*K'>I/])FQ2L/"3BRR6/,?%)=4G@P
M>F3]<+^<WZW&+BD>5VVG)9[0]8>J0>VJ;U5#M+CVJO'6/D4=M2=\2C3=GF6&
MO5KLD?-YP_9L]JYQI%94K:(U:I5CM?GNI;3N#D>T6/5!4<;7FRAQ*\?-%P&]
MYPX/L3M+TO]*Y7Z_:-<TN6'>M&B_]T%_\RS^!)K^POH_4$L#!!0    ( %.3
M6% "5^KZ+0T  # L   :    96)S,C Q.3$R,S%E>&AI8FET,3 T,"YH=&W=
M6FUSVD@2_IY?T>>[VL-;O$B W[#C*B&$K5V06 F2REU=;0DQQEH+B96$$^^O
MOZ='XL4VV$YB[UY=5QR$9J9GIJ>[G^X>SBZ'_=[YN[-+0^N<G_VM4J%.["]F
M(LIH*B*1>)F8T/B./L;)37#KD1GY5*E@P- <]HQS,4[KBGJBUANJ^'(=C(-,
M59K*62UO?7=6DWS?G;7MSB<:3_TXC)/W>Y^O@TSLX77'_$!>&$RC]WL^IA3)
M\F6:W87B_=[,2Z9!5 G%5=92Q>ST<S#)KENJ<G!PNI>O=OL"%$6M_C:?YBO=
MX#?W)I,@FE:R>-ZJ@Q]/9_8O*$W\]WM/LMJC+,B811H&$Z'ND5S*^SU>RQY=
MBV!ZG>%;X_"@V,+Y6=>VAI0&?V 0^A<KN(JCK,(O6^H\.Y7R:!7B(%TDF1=$
MA FB++@*(/D@NHJ3F9<%<4377DIC(2(27_QP,4'K51+/*+L65*P7S;ZW2 7A
M,4#G.+NF4K!/49P1F(@D\$+RH@E>XNWG>!%.* QN1'A'CRGGY,>SN<#6@UN!
M!228+I8SZGCO17=E"JYHOAB'@0\FDR#UPS@5DRI!C?!6D)?RM.E-2MA4G F*
M9T&:8CMI=<N<_U-D%$)5E6I3^14OM+YA=? W)+M+KMTS=7.H#4W;JO7MCMDU
M=?F%&W4<O:/IP^^:7ZVN^9@=/'>,'3T'VH7!T_*G^UUS_A^2>N];G?^JZZ.\
M?W26O4,K&_*]T>T:^M#\8%!'&VXYC&:5'..7D>F:4BL&(T>_U%R#7U9W\#ZH
MTL"Q?P);V:%D7I$WG\.</%C//CH,V .=?,.^72&H'<;^#:F'^I9VVZT?J"='
M+! ZK)+INB.C0^U/N_@]T#_-'3@UUWI&W8X@ZD[?M$QW:#@Y>]XB')-(X$>\
MB,Q,S.AP?\L,#R9YV83?0".7.L9 &C70JC>\I!^\V?R4+D=]S2+7<#Z8NC2K
M-UO!!N/Z2?. NF'\620I.;$W>:TYMC'6ACW-&FIENM"HH32:ZK-<7DAOQG@'
M'4O3LF#5I%D=J%S',5QWTQ/;#I6LN%H&#B="9&4 VR+*@%]N!F"4H/@O<P!8
MFTBK>YI*7V2?$ZVZ&Q,*>S?ZAG/!S6T3VMTU++@#>V XLH]+$)-K6A?4Z^G4
M@*24QFN)1,NRJ 48-C5+>]DZ7FOF#3II5Z6K[%#)-0PRAT:?5)6%USA0%+*H
MKSE#TZ+>:'AI./0SB^(GA]J]#YTW6(VDI<3[)C6/3Y3#^DGCU63^%?1%_J\J
M4*%=P4/-=CH0RDY,^A/H\M+MU!4%8?'12?VPT=R&(W\.J<HV56JP*BUAXROL
MIZOI9L\<?GHJJ'IN0?6:<ER#9 Z_>B0"N^&EZ>9[L*W>)](&@YX)C!G::X?B
M/O0H&P8Z1 3NC6/$Y-%B-A8)<H$T1M 09'FJ@.#?0P['.0*2AE1DA#0"R4!0
MX*V*2$4RN8X7B71^$_:"Z5SX>=Z![I0(7P3SC.(KLJ^N&#96!/[B2R8G**]?
M<9JQ? W^JT&S19J1Y]]$\>=03*9BDW-VO5RKS#GG28"9BQQCU^*P"VZ^MV.,
M\E:;+G/&&D<BGT!@-R& #XD?S41V'4_2%I6\?6K?R?0F1'Z#)A8,K_983JD>
ME.5G(K)%$G'[KTO"H'D@TB7SU>)/J3263-=;Y7&[-XME"\^_9GYW2VY/4\PB
MI70QG@49$O-3WC:HY,MY4S'W.&$G[ A9%S>*4/A9$D>!SUN=+?"0RPLYI\_Z
M(#-)+ K+!&L1^6(I_7OB95&L%YXK'6=P7<WLC1R9?'RR1PYI^L^6_;%G="XD
M)D*?B=H< .L&PF8@,]Y=&C3H:3J":,,U+RQITUW@,S?(CGDL9B/8=EQ$QR:W
MV;+Y4LX!A)?QMSLP='A.#.]KGS#4'?60*5EXXGBZ\*9R691SPX(1?$(W;H,D
M6X@M1W(7+Y"HID$BQ> C0)UR<% (W@L3X4WNU@> <&+!!YCWFWEWR,#Q,1$\
MR?.G4(:^Q[<!FZE4!'K)R<V\&QS8\\=U?V>Y-@=IKHZWF/&>J<5S(95\A\E5
M<X^'<$?7[9$U9 "5@=8 R0M.*,<N'(HFP_M$_+Z ""?/1U(67),9^1!K*EHO
M=: %_>/?/_[X'WS6@4]5]>3$M?!9/U2.C[^"B=K8=,9+/RR=,G1N$YKOA9-N
M#L[NUT.S.2RXLKN'2F]!>XT3$E=WS#94&_J<8UU3SJ5?&OK/6-]6U-**O2#K
MM+@B(#GRWO+<#OFH.]*D6<(!NO)PX:T6<(E)D-WMY^N18UWD/4.V2F1#ZQ60
M!E/O:X!,O-M<_/:MKG>T8L'QSA9J5R4[K6TCM[9&_;9,%A^(!ALI)-?ALW&,
M;H_39CFPR#$YG/VPWD-)6B=P(3?0E)%C[MVQHL.@ U^4MRV&. -/8MA';DPP
M!:],(O.K^UNE4MX4;+X<A+.VP_$%5*:K.=1L5%6E 7C8NGN].#9W!/4SV'%J
M/=(N'$,^\[[Q(25B6IAA<[;-F5Y@/UA+E0[JU;IZ5#DJDSV7&V2P7QKAA'Y9
M>%$&=:BX!9R$=S1(("SJ!8!4&3]LH4Z5;!G$KQ0KNYM+%SN+)W B_@:0K#7N
M161 @?H#2!V;QB;U.,H2S\]R[+M'>1!27GU9.B)V<VDPC7*G.%E6N-< +]%=
MW43WPC$&:;I8ZPL?'QMB;IZ#)<;LJ":5[&3J1<$?>05]I'>!T'Y>R@6,@&M:
M+A"89]ATX#6_V"-#S6\8Q.5;!H;/U_#Z=(63"L:AJ+( A]X7+@]:$I-;5#C%
MS@@.Z\&[(6_^WFG@.V]0"HC51^6P+9DPU$6\M$(E?B]4@D]3\IK$:1X M8,8
M;!,L0;Z'V4P66*V7$0!+AG,^QS3HF7OK.5CS8*ES'F;-O! 23[-TU8=E#*0A
MS??CA"43(DM?=BRD<NN%"SX;8G% MNNERI)X/M>8J]KY(PYSB1:L/4'$6_[A
M[\?UAG+*"O;%%XC0X"A6>,R, P"T%X8$P2,R9&7! B8!2VX5_:UT:07(DU64
M?:(QD,/GE9DU<\QB[%L4[@C10R)F7@!FBZAXE:,T3'*!>='7STL3 N&'GTGM
M.X '714ZY#6+S!,02+'M#:7-)2SX*-ON;7:0>KB5\=(',^(CAC+UQ[-@<!_!
MI"="ZGM11&Y2Y8?RRE#A9])GY]].FF490X1Z<%L?'?/B<BA%T*YNU'5J,K2S
MG9?N\T"O[BC?JH=@/+),#DA=Y%R&6QBW XM^ >?#)6=Y&M]?P7B"32VMD19%
M'"W2QX0OGU9-G6 *+Q+":[/'RWW/_:Z5O^R.H ,X:>4!FZ)6E4/(K*766_5C
MJB@';(_JT:FB% _?/5M#@:/6Z9NJYT\1"_^GZGVE-\U7GJ3DXO0\8)/$T*4I
M,5#8$HJ2_=V]X653QMH<9_]8X]\+ ?>M"<9E=31'IGU]/J:2(VZKI*JRGB(7
MZ7[LQ#Y@[:S&UZCG9S6^4GUW-C@_NW2 \>DUDJQS?'UPO3L5E3&0X*8R%NQI
M6U[XV;M+3_?.?XC&Z?QTR:;X>.H"N?YZ%\CUQQ?(];>X0!XDXC:(%RF)'*0
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M'#^)KO19[KG4JH=30.;A1L\8W/#3E@G#[A@6_-_N&P.YQ2'(R#&M&^IV=6I
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M0E$ 6!MV-6NHE>E&HX;2.%&?AO*\]<T %ZX+Z4P6_)@TJPUS:P\,Q]D.O/:
M2E94+2/CQD*D922Q99@B5SDI<J#,?_\R^TAA$W'\)+K29[GG4JL>3@&9AQL]
M8W##3ULF#+MC6/!_NV\,Y!:'("/'M&ZHV]6I 3$IC5<2B):F81,)U]0L[5E4
MO!+>[779JLK(V*:28QAD#HT>J2HDUSA5%+*HIPV&ID7=T?#6&-!/+(<?!]3J
MOGLU@W^T5M+NF71R<:F<U2\;KR7O%ZS/\G]5@?$<JA)J]J -D1S,/]]^W=XZ
M[3KG&O7\LG[6.#F0,[[]4I4B*VH<;S+%"_RFH^EFUQQ^^%+I]!0]]9IR48-<
MSE[Z(JJWX:WI9!S85O<#:?U^UT12&=J;,.(\CB,;SQRBQ';'$8KN<#D?BQBU
M?A*A-O#3K!5 <>^B1>,> $U!(E)"FX!BW\\3K(J"1 *91<M81KP)A[YD(;RL
MK\!VBH4G_$5*T1W9=W<B3C8< +[XG$H$Y<TM;B-6MP%_]=)\F:3D>A_#Z#X0
MDZG8!IS.5J3*CG(1^T"<]Q"': ,3_'B'8;SEKGDN<S\:A2)#(,!,$$3W:.MH
M+M)9-$F:5'*/J?4@VY< _0L>L5Q [(7$J)Z6Y6<LTF4<\N-?5@OO+'R1K&"O
M:;^BTEC"W'#*[QWF%50+UYLQO(<5M"^OB 5*R7(\]U-TW5?,-3*0)]$F8N%R
M,T[@!ST5/Q.!\-(X"GV/&9TO<9%)"_VDQ\8@VT30!"H!682>6,E^1[@LB0W=
MF<5Q?];1S.YH(+N+#_9H0)K^DV6_[QKM&YD%8<O4XAI7-U 9(Q7CUJU!_:ZF
MHTXV'//&DL[<04+F!W)C5G?9J*=1F/0')C^SY>-;B0(I79;83M_0$3#Q>D_[
M@%>=41>=D(4K+IGS("JIRH"!7!2:L(M/?IPN18$^'J(EFM#$CZ40/!2C4RX&
M<JF[02S<R<-&^B@?EJR];-_<?4!SC8^)8"1/ZZ ,6X\^^>RAT@J>H[:Y^Q':
M>EI7NXQEENPGF2E^ L(=+XL60AKX 6^KRD"'XD;7[9$UY)PIRZH^FA.H)\M7
MT(@F"_E8_+:$ "=/UTW;RS*&L =]8* E:E+E'__^X8?_H$1%RJFJEY>.A<_Z
MF7)Q\6R :N-+ 78[U>X4ADZ6;)T7IUISF -E!##5@N2M<5/AZ .S!9.%G6;)
MB\,PZ;>&_A.H+$I#6LX(VD6+^W@)CQG+VC,TDLY(D[Z&F.9(I2$"+1'E8C]]
M.,ZHD>\ZZ%R&[&OH9S;X28/_]C2D0-S;)KV0SPT[:PA<N^RO5E4"TUHV6F)K
MU&O);N^16,!&+K4VJV5@=+K<[<H7\R:1R])W&PY*TN40Z#.O2S@5+-P'-E]X
MJ>^)<@$MQ'US','H,P^!?;ME$JE7/2X427E;JADU*$OM 1<+,):.-J"31E55
M&HCW1;SKN<J<$4S.X$BH=4F[&1CRFKG&AY2':0'!-K)M1,VGC(X).:U7Z^IY
MY;Q,]D(RQWG;##W$J@2._O/2#5/80<7)DT/P0/T8<J*NC_0H2X']U:Z2+>OP
MM4&E#PL9,>?1!$'!V\H*&TM[>ADPFUX?T@:WX$Z/PC1VO50FL=V5U1+E]9=5
M6.&8E?C3,(MPD]4<>I.I99I6M]-T'N7\)%ENS 1J8]?+'+*_RA8'1C\E.YZZ
MH?][-N8>Z1VD6B\;N"(C &A2SE,I(]@.QC4O9Y&SQJ]XB8>L'.3O9XC@= <E
M^>- P YIZ'[F.9XE<VN3L@C8'B$^[=X:,N,[:L!W9DX*IRD'@V3'$\Y8(9.5
M6\)ON26P%B6D291D14S+CX:S&.CE;3C*9 E"W920=V1!YDG5RZ!<I04 \ZO2
MT%R@3-T HD[29+V)=;8RO"T*Y"Q:/H<4Y2=4PY7')S^1Q#.DG#KP,-I@GX@=
M&/]8 <D3Q09& <5RI@?I)A^165DJ:Y5\<H/ED[!W2=Q 65.[YIBMV0]9#=__
M_:+>4*XRD__L"11_B%CK;,^J]Y'^W2 @V )J3C9?D#7Q69_KPG)MW>M\/UF7
M[Y<:UPF(O64&S1#3" H1>5Q$;1*+N>L#V#+,;V5%  +$$GBQU\L&'0+%C9>R
M/YPBD*^G)O)T1K8?*-(X$@QE!(A9NF'ZHNRNGA4"7N4"+BA0H)EZ$98>RE17
M!-1S0TC,B:M\Y4ZA@%7P0-S[FI,"S4+-@2H29>'[@7ES.V0!M*I;(Z*:K!I1
M?3Z3RU.]>F#VJYX!\,@RN=1UT,@93AYL!H@PSX!\MH(L=?&'!R)?A%)+:O1C
M=4?N9)K/!:V<TX^:)0NW%Q#4]J>(EP%2$X?V+,IJ8<CE,+V/^=B,*G_1P44;
M*;.9%:**6E7.H(SF"?Y.J:*<LI^KYU>*DE]LO5=RP(F+A"0#$6)FPODRRY6_
M;]+8L_V(U?)()'_2VN5DY76<Z&R92>-CNJ[Q.>;;ZQJ?:7YWW7][?3M ^DYF
MZ(7>XNNC\]6IJ(P1<C]6QH)#5M,-[MV'Y.KH[??A.%E<K<#D'U\ZP:V_W@EN
M??\$M_XM3G MQZ+STQ.EHJ@5];1>N5#.O^8(Y\!"=+':VD!VU#UJ*%0:B$]5
M4M4*#ZGXS(A36;1,2&3)!NEAF?!YTJN@!_3$B_UQYL(WSC."VQ];7 &73BY(
M[PR.Z;11K9]DL[^_S"(;KV>1C7V+;'P+BY0"X[1G6J.LWB7NQ-"?6+HA6STD
MJ[:MCV3STC(X7^?;GY&+5H?/^7)N#:.@L]R;,->^]G"SOGTABX[5, F9''];
M1T!_W8%,\>(*(;N2?:@5'2IK9%]I&DYM<Q)9L'[FGI([R37D/NJ-K#S1>CS*
M6>TL:<\XY6H]M:>DYSM*;7E1,C9OE#H%;S>JI$WF?N@G2"GR]R-9I=JDWG9[
MPY:@7E);AI:LQWW!JF_U%_3];\LHO>)9EN>AC(=+!@_E=0NSTQ;X654]+OC=
MRZ..9MTQK!L&>9'AVG_[Y&78-^W)WGK4KSS"O[^_+0((.7[(.TGMCAM1[=Z-
M"V"O]E(WRM7 AZ'-[&"ZA0RC*06'N%]^"@<GG9R4G/?[#]^[R0P228&IK<N"
M2^5C^'T4BP6:@ ]Q-:O*2->L)N4S0K*S'EL/W"3!\^*)85_$?C3A8@97\K=3
MZ*R:I*@U]9+/<LY9A,IEK:'@6[V #ST;^,H^[(0W\UR8V[#LE"$IN7,^3J9D
M%MW+[KQPKA^- W\J?SJ7;3_F<<_)OCPKX+.B*"=GYZ2]TZB_C.$E:+]!Z<6N
MHVRM+0-HG^W<J!3;!L]71)+*=G<"PUZ&<I:!KXL50L;./TG@9\D^!&,NXBEW
MJ^O&#/IFXM7SBHSII'=-B^#,)ROK8O#[TET/A?Z94,?U_$ .+<*,!7LM-4U*
M;3,L?KPZ=JM)-DIEOR!>2"O*C0BQ9=N(RCM65$0?_." :4E*EHMLQ"CKY<FN
MS[DIN<5CE;VU]D!M,D%9!7LNELSA%_F(+DG]N1071!UYWC+F4&%UAU0LM .^
M80/I&/I2RU)>%7+$ M;/MQI*P<2UN/][)\()SXRFL<C&<CR@D#]GE,.\U>!I
MN>!GF;ADB-I;*Z%F TB/!RQ,)TLWE.<V,,35V.\FPLZ0QR@%,AYR;26-?#7T
MXCFBST.>.PHBJ!\"#Q-YB(E=(^>&<2PB/Y3'>0<)*^_JZNZ@KOX'1++?D"#2
MO,JRY5Q5Z^;-2.,,I7KEXNQE)T,O7 Z<+XGB/Z4!>=Q\J&IF]-^T^7CTP3^:
MEK^AYI]H_Q=02P,$%     @ 4Y-84%E_SW6 6P  ;(L! !H   !E8G,R,#$Y
M,3(S,65X:&EB:70Q,#0X+FAT;>V]^7/;V)DH^OO\%>=UIG*I%$F+I%:[)_4H
MBK*4R)):E+N3^^K5+8B$),0DP0"@9<Y??[_U+ "HQ2W9G4R?FNE8('#6[WS[
M\N/QU8?3/__'C\?#_N&??_Q_6BUSF(Z7LWA>F-MX'F=1$4_,]<K\DF:?DL^1
M.9F/3:L%'UR=7)T._QQ?Y]W-SGZGV^O$7^Z2ZZ3H;&[M_?B&?_V/']]0O__Q
MX\'YX=_-]>TXG:;9?_UP?Y<4\0_P^/#D9Q--D]OY?_TPAB'C3!_FQ6H:_]</
MLRB[3>:M:7Q3O.W$LW?WR:2X>]O9W-Y^]P//MGX"FYN=]C\6MSQ3K[]%-)DD
M\]M6D2[>=J$_'.[DPWN39^/_^N'!KGXP15)@%_DTF<2='PQ-Y;]^P+G\8.[B
MY/:N@+]Z.]NRA#__>'1^=F7RY+_A(WA?9G"3SHL6/GS;613O:#_>RG:87]L&
M<59$R=S !.=%<I/ R27SFS2;1462SLU=E)OK.)Z;^,MXNIS KS=9.C/%76QD
MO?#S.%KFL8%_)O!R6MR91K)AYFEAH),X2Z*IB>83> A/[]/E=&*FR:=XN@HG
MPIV,T]DBAEU+/L<P=@8CI338 )Y'\U73)#=FL;R>)F/X?I+DXVF:QY.V 0B$
MI[&)<APQ_Y0;6$]:Q":=)7D.*\G;OWJKOJ(-98\ZF^VM/?>X_TO_\O#- ,[Z
MLC^X>F)?'5S!U?')R-@/X=]]<]F_&AZ:\\O#X:6^"H].SM[;+R_Z[X?F_.B%
MUO3OT#Z>X6X=7O1'IM'9-H.C2[.[N;GQO$XZ\K_='?C_MCN5QD66CMN ]?("
M_HOWJKUASLX?!L!>VPR/CH:#JY.?A^80CA2>;;7-Y?"GCR>CDZN3\[,W%Q\O
M!\?]T9 >#D=7;RXNS_\"7TC?N]O][<U.9W^PN;FYVWEPL/JVN?>FM_D&T=D#
M+YV/NEN[^[N[7]'_KVO;L)>CT4< ]8._A[\,S@^'](_^Z.*R=0!7JU_Z=J=M
M^H<?3LY.1E?#2^ZA<7)C %7%&:"7:&Y.BGAFMC=<?ZZOS>X#/3^A?1R9P^'%
M%5Y (&RG5\?FC]%L\<X<?_S0/S.CX>7/)X/A"$!H<Q-@9A(O8OC/?!R;_N>X
MW32C]B\ !BD@W0<:SN_-^>4'6.K69NO]0Z\^T,[_^(>];F?WW=GPY/34')]_
M'"':.(+IF8./)Z>'A%-^B?([((<%$(?# 4P:X.7) Y2_W8:[][)MKPV;?0IW
MZ!*!9+=MSOH?X##/#@$ #B^'HQ$>@][4\TO3.$MAC_,BB^.B"=1G.2^ R(P*
M(%Q$M/[WR070GDG\/-0P&ARV!G3?AQ^&E^^'0-/AKAY^A+MZ./QY>'I^\0&?
MO>^?7!T/+T<''R_?FY,S^ )Y@;V=A^[?5[4__F&GL[.Y]^ZQ=[:[O7?F'.=D
M&J,X!M(^3>]AZ?VBF+\U'X!JFP_1?/[K)W1T?@ 4Z^3]R1E@/H![V)TC.!S
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MFP6Y8?$T+.)!0<(Z$KS^S>QNVMGLV<G )9LFQ0H#*1?,Y'PS'$'S4<[J$)"
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M'TVGU@IJ;;+F/DL*0"ED"=5\D6)G+DR<D &9J[E2F&D68YVDW'<*@+G!!6L
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M7G4;\H<K]5:L3AAK\?5U?D&NP_?3H.2IURX4#=J.S?ETPN8\.<T_3M6'1H
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M<.3"+AG8'T! R#7C'$$&+%2SZR>Q\8/-_% )ISI??P9-GZ]NB!2,CHMX%%2
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MJO.*"3SD<3$A\80\#<B/&.0.=I V#X9(/53V68E1+)!\MP0(SILEZY93C4X
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MQ%\'%^;T4!$ZR3#M?VR:28*[E84TQ>6/^I_Y"_<-J^[@7-S% .30&T_1">_
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MZ]:OA:U?"/N][J:]6C;"U;S7O7!G\/R_4$L#!!0    ( %.36%!H+L"%/P0
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M-?3.\"N5;DB2[8&1/->>I;8-_H0N9<^L@SZ;KGO6_M_4MX;].,C^\U"^!%2
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MU >;'XC+*;P5/@8?Q[)$K30S>40]P%=_U$"RB8:OQTL!W4&7>:Q$92)N5!5
M21V#.L-^=!Z;8F8*B2WR$^/E?BH7);4G9[,4GAVG2LP*,]<E/%7B>\\4/"-A
M)NYU)>"+@?BOJ44Y-76:0-\R^6"7U(OM,1*+J8ZG IN=Z)3)J%@SE# !I)\X
MS7.8H'BCH(4*2"M>F"(3H^'^_^$3W$"%E+(O(DED5<EXJI+!S=D3>7%TN 7,
M^!H(*>MJ:@IX.EEAO1A619<5K<SA<!@-^5]8": E?0M\E@&QZ/%(?#,<# $N
M9[(0<YG6L+BJX(>9C4;W.YJ8$3,5T/DU6H'G>2U&[7:F<J[$6*D<.1F(2:@*
MRUP".53YC[^/CH>/3L7O=:Y-@2U7.M8SX!00P)7^!^+4<F*LLC'T?#2*8/*C
M'R(0K<W#%@L0"&#+JJQ@IM#NQS+%PVZF^*1Z^(Q7]0(G]G'3^&1Z=L\"^%8/
M\OVTIW9.4.QT#(W_QQ!;OL$QEYZ+;D_B61@0A*:PVJHH/2X$LDS*$@B %F6"
M&M#D2LQ-%0BC6.AJ"MJXG*FXPD<4*$.1@5*$)T Z2K0H^%UHG%KU'>9>H[9&
M\=X14.^H11)#($<B#W9TG8(<SVET2+>"Z08*7:@41F:!+]$%?##0#\#7VH (
M 6'<&; + 9P4L[0N8$6J);Z-X\3^2U"0984/X#>M)M:&"OWB0VX0NPL274SZ
M3,\U])W<'8/^=$VV@&55N/Q@1R!THX]6*3*,EK#H=I0(!9E< D+ .L>I+'B5
MD0^>&EDDI/ =AT1@88U_MTR-S<RLN5-I0$;7IF4T%AZO]=?0Y(M:]9?ZCUHG
MC8'U3)>E2>L6>]\V'YQ;,9JCOVPU51J, _ \:881W4BE.-X!FQ%L4>"9- 5.
M*14LJYQ+G9*!.N$>JD*/J0M\L27Y<H(:#_N=R65FAXE-)6I<L;UKT$2'8<NQ
M!I4"%@E]&[ 9O5V@<=*P%;+>5\-:KXE"=PQZFW0*00E8=T!AE<T034@'>)<H
M DY)Z!=F.+"+Y] .?G)P@WC*?T=>7\1VG6%AY^!W7+'A^#[F;"F>Q*DLF6!O
MI-0F$_B9E5?E>W0(%;3<V*G(16P%=UFMU5168+I23]YRMBY?"::W9NF;U%5=
MJ"^+XUZ"3(=V^FTSV^M5DPJ,C!3Z!-I;TP!#;_\UQ5LVM,7S=_%4YE=*0)M6
MH93+#$QR\8^_/SP\'#YZ_O1B0'^.'GU1*T'A56!+<7J%VA.Y[XVZ0I4KBSLU
M@"O7L?0=%ZYCTOMK9C&LX=/"R*30"2S4F0]2G*.T%.+"PA H@?,\WF47\!>O
M*'HO\.ZC,+]ZB4<GI/'(/AA46[=>*3#5!'0 25B3;XY<@(Y'[P[8/<,8H@4+
M].[ ^@A-'0S;%68NTX%XW=WW%.QLG 782W&AG+7D7:L LUHH&840R5*(]E9L
M10GFG=9D K5\O&C5%H_6@;F%W"N=A%9D:S P)?)E-\(F>)>6PCB:#>O@*;]*
M;_)A/4DP!FEAG&V%QG9PU%2$^C2L5,-+'+=*5"J7Z-F4)M84[R*'7+96S'FB
MZ*0C)]&0)+8^$&=U@4Y-NHS0 G VT&8^"8-;-]AD^).R=GAC63O\"(7PN17
M^037 'Q3X.>&<QKG,PB/+C#R0MX%VJ=CLM$DNK\4B*E+%.2RGLU21;X(;0Y8
M#\-S@=<R['>L].#E#?Z<!+%Z=J[\UL7)GR)O0YM[@_LW)2>_\D&,O_X U]<V
M>-IQ,&Y3G@P="UO6P,]A<[DI,IFV 1V?@28K\B=CE:;VUW_M#??H<SF3L?M\
M\YW:A4ZJ*?P)\QB; L0>R9'*6:E.W!]KNZTX'!"0*@&=B=WG_]J[A_NW58+_
M*?RO=C3<Q0_?/G+/K/YTM/FGT>:?'CYH?NOH=8[X%\O4#ISW]!ZUEN-P98,O
M_&SW ,.O2-/2-^TE-M#5!-CZ9*H36-;;L$BZ6'"%""OS@_'?R>3NPI;$^8$G
M<GRC"7[U"WB\/KGC:TRNXY6[65.R0#$\QO&IBLP*VH3KH@-)[ %IM;6\BAX*
M>BCHH:"'@GX!=Q@*\IHR()IX,O@>&*8VX) 6,(H>%'I0Z$%A>W1*#PH[OH"[
M  K=8=,F+Z@'A1X4>E#8'IW2@\*.+^ N@,*L+N*I+"F)*>XAH(> '@*V2(/T
M$+#C"[@+$- D8\A*1>@/:)-P3H--BTWH!TIL5-744+X$$"&F#'[P)CC3UJ9L
M]QC28TB/(=NC@GH,V?$%W'8,64P5U0 T13N4YC1N%7D!>%!24O,5)R4AM(A)
M83);6+;2B(SM"[UKTL-*#RM;I)5Z6-GQ!=QV6*&4<V7AHY#Y6^AU)=-Z0R(L
M%HUB]OI*P:=L_M24M>LV1%1D*Q'GE$R_ &TJZAFEA\O)1.JB]VEZ\.G!9XMT
M5P\^.[Z NP ^L\+$*JDQ?0H#7%C3(>O8U] 7*I/%6U7UZ50]//3PL%7:I8>'
M'5_ '8$'=_X=P8,H-?LH$U"T/2+TB- CPO8HE!X1=GP!=Q 1VD</%<JG6M%!
MJOFR=5@"UOI3P(D.FEK2L7SO5!'K$@]?,*4*FV/WP[?'0:T><GK(Z2%G>S16
M#SD[OH"[ #DIGX6V:2.$L */D8OK@H\O5.ZL,CPUB.)7/6[TN-'CQO:HG1XW
M=GP!MQTW7+Y6%V#XS"TZCZW2J,MT;H\";Y]ZZA*ZFB<YHRLXRHUJ2B*$FJE9
M"%TUS=OD895$[B*,UGN4@MP#4P],/3!MCU[K@6G'%_!+ ";GOTB/3'A8>^CA
M.& *GV1D\K[/C7"I>:M'I1Z5>E3:,J76H]*.+^"VHU+KZ.H-@;8>%'I0Z$%A
M>W1*#PH[OH#;#@K-A4/][GN/ #T";)T"Z1%@QQ=PVQ%@-7G+74D5B5*FM+W.
M=P?*$B]GPV-4>HCH(:*'B.W1,#U$[/@";CM$N/T,G5<*X:)TMW)NVMPH5'/]
M]ACO]9R94E>R6-ICW'L$Z1&D1Y#M44 ]@NSX FX[@DBZD+,N*2O*W@F=24 3
MO-#^U\'%0$P4Z!?X@%>,9DI4\ATF4I4:OV7?I+D&L+FOO-^\Z%&E1Y4M54H]
MJNSX FX]J@"*X'W$E?31*W>[L .9.)4E7TB[Z2IE?R07^"L:'L0<X8(*3L1,
M%EC"2+<:T^VU&]NX_8.Z\.4>SWH\Z_%L:]1ACV<[OH"[@&>\V=*^)ST*CHJ$
M#RZ#JVB#WR3B\OS6=D[4Y2@-;@M86FKVL)LNG_06^\N.H&1LZC014XE82\1E
M^@6WS L%KJ;)@-R6M-545G3/9& 3K-8-T3/<MDRPX$>E2T1O%=.5][8HE>\N
M1I-AM8&!P,&&]DI71#63T&A:&AX_I7%S%_!\HE*YA.&#,4$OX4Q@L-#$'(B-
MGZ2P*=\Z1V^Z*DR*+]8EV32FKO@P.#X+;KQD(P<CM%.3 I"5@^M#^'LEXL'-
M;8P'MVUCW(7(TL<%=S(&DD$3AX.'#^Y_*\Z::C(>Z 5STBM3@2WQ#%CB<'@X
M^KRCAS?&*/1_8@RW+]Q[3W[#\]9!!/(*!(K87LYFA7FG,6 $7WTS&@Z.!;21
MVF"2);F5U9PHG%@*LY3Q=V,E001E.?4;&0+%G*X+"=K!>P27^&@-0I1BF HK
M,I8#<>[>TB7>*$+F9*DR+?.\EBF,#*1,PL!E0:[(OR5\72S%Z#XY O^N4_H;
M.E(RGE(7 R$<^6],IM<Y,--<T?VXHWL1S';T($(G U4*Z ^)L]96LP"*Z)SO
M.#&3L$+1*CP\Y@45%*B$LH+1HO(@HD7B.S[/?@%3)]6B35W"3()RR>\C;)0?
M^^;P_G P]*NS ,<H;%/ZQ&,[.'2&D++87JY8$7E_JW,"D1B;/+$*BH=UI4'A
MT1N&SY4!?6W'A]]JQQ2^ -0Z;>'B'QT.CAX>T^)_,XJ&PR&[>8 1>B;3<!*
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M/EKQ@M)N,(4N(X?5N5(Y;5_4.57PH?2Q6)(=3K8BQID<2&DK *1D[.54L/K
MB&ZYD0QC8(M<E?9]C8>>X+XZJM^RQE@#JD3BG,[6O"R%($BC4'_4M-6R_AH)
M83",5/-!7ACW\E8Q:@8P2<,QA%V0U+*9"HH9!DM]_EX[4YK<'&[>$:L]6V/K
M%2L<D95B;T?C!] :"I0'%TMBZ*Z.IZTV"%*HD;EM WL;PSB*>E;%RRB\1!@\
M*F6**YGK_TEWRAE["AB8P_;K6<3!.>Z7",%#]S.@ZDVGK^1<ZM3M5*%*#IG!
MY(&6,SEY#14FV*5IFPY@]:(KB'-K]3*5J+E 'ZUH*[I]AA[G<:ZM"7-@5=0Q
M:$BR6()%6>T=51M3(>0!MV[UN-2)EA0/_:YQI*I")LH91ZS\U3OW(REP4&,S
M8H" (MC52B=25,L9<UH!W*H+AC?*+9FDP%DH81BC'<N4(+.<*D4+S?0*Q]>!
MK3^>GO[R_4VTZ)9YNEUZ[?7,VAYO_ %[@X\U+]_C=[TR@F)/PT?A.;'TU>@1
MF<9X>F "ZS.Q6&OM##80,R6=0@1;U6F3<(WQ?$"5<2RC@B\#:>'*90SYI&"/
M_V06(-X%&;W@)T=HT"%SJI0-R<@UA0,ANY\46X%Q_2JP0\D(XE?9?J2/R*25
MSBA 3Y)%'U WT?^!;(KDUJN:&(\PM-L.QJU%<]@A#9/$T!*()IY:]9Z+HR%\
M48C,T(SAB^,A6B8J3\ 52>2R1!*/'CQR5O%838PE3G"B(EU#914H"'I9*5LS
M/J-0@9!7J ]1X,@)89L/1QT8@RM-4I%Y4[=.T $]8,"[B5HXHU9FP#1MXGJY
MQ;7 @O3;YLDN82 3_?:9WYG62*95V[HR45OA19V+\UV=VT5?_VT"#%HZ.(!?
MK^I4HAB@\N(GL -&** Y:VYR#3*@K&9S$Q1@K%2C<7%L[0LP02&R,!++>K:4
M;.03EC3K^+XILSMGT;>C*S>\ALWL7!H_,$X-B\VX!GV"A$$C%UOLF/ZGX,_O
M&397ER8#62)H;P8*0GE; ;(O*X)S3IN=B8I1RS4:?:(6="@&>LIL89++OAYR
M")07KVM)*GWCDJ$%LK;&Q&'.E0>]6J>5GJ5DQ@*CFLGWZ-VEIHK8COA(7=&I
M>PJ#886/;G/OR5B6F@+\,$29LQ5F;ZP-:>,2I!P]<.>8#^5%_Q,(@L&5GD.[
M.'3%.^!3C+W$(SN!C=! -D(U,5QHIESILK*GO+BB&;*/B^:H%6CW<],?!8:\
M-67-YO:1SA8-#)?Z^(G##-2,):[.O9S-3.%BB$@Q:IIC*.Z1SSU;.X$OB^OO
M/;P=K@?3G=4G[BJ%^E-?!R:]VPD6 ?!2T9PNQ#ZG^Q88Y'-3'X?*(DM><ADC
M(9.HRW):,\\LY^M5H[XU06P4 06]'_0-Y.>=\7LLUD1-)(R40YF^;L/::'9]
M.XRI"NTOW(6F2!(M,''!]S>0K/=LM;O=^ YBM';P1T<K^3[[HWMW[UBW=_0N
M,.)J+=@W'+7^)94WX/&/H\-=,@5O25[_OZ_!-7YJ)%CA&/@'!(PK4[ :T1D8
M5<1,DF/3EE(VOC\#2OG-YO!W,E'F,O5Q >DV^_)*[U?RK<*<$AM&+&G'(]A]
M\KW21M>&?EW3ZMV,0-LT$7R>E@WC'P_$KQ1JPP@ *X?-+?K]-;S8 %UH%Q%K
MWD 79GTGOWW+ :$POQ_8OQ3Q[P[X/\=GZ56<%J@U>ZL"GPJW:'(<<.N_POT,
M#8.V4\ HI.N>]!7M7]6YKMB&]&=OX\#AWWU<KQ(&54TY&.<'QBF03+Y3%SY$
MQ-4('-3,6FXDLH;OGA4,F>;WAY27(,MIA &[WZVRD0F* "XN+/OK>N-BT.8B
MNIVHVVF*!6BHN&HOA5ZS]&#>9"AC4,@@#3$Q9#)A,LF8+#PB4.Y:I6B-Z98!
M#I@GZ':BOVMC1 K#U?A%G9<&O )-\4KLY"8Y%5^( OVEN4X$2(<K>H8[QQ,=
MV[W7\QP\?+ MI;\4Y.ER/Y6+TNZOP9_(?B_E EQS8*>?05?\A+Q^BKKBTNF*
MYZPKOC;%'+>)J=>(.>XB)OR/4H(DN<Y^@8*LINMG'&%M#XB'O*((H_5742DL
MK75$0D5;K29(0J) 2QE>-^,T-J5>U5DF"R :3$"E9A'1MZ#+V8NA=&O;K6H$
MV0/'K,"TIMAN).N\$5'WQ%@G'4.@7BCC*E%XX('5]+GK:08BC(^52E'P.] 9
M[0PK^&&BB[(2N;HR%;KBK"NZ]<B=:X5MXMI34@0N/^9HA"A\.(S$BUHFXGFZ
M_Y,>%YIWW #EXIJ.)P+XT$5&&"PY>CI6N0*^QQ(RL\C9^6[OO(]&WSHT#6&V
MC:RG)<5:T9Z/Q,_%@,?HAD%N#S("B5B.CL$DK?G2[KGU_MV&@[.G,[(Q_&99
MQVH#V^G2,PS+6\#.)$$E"X\&E-;2IO/-#.Z)XHPS55SAWH=G9[]IZ>[%F/CV
M*3IAL_Q(P&V2:8B3:'_-M5H(\O(<87>8+;LB<S=EU%<U)79T"NK=B\]%8Q.1
ME^8/;O1FYL3>BK*I+ 4U%T5.$S?\:+,=@YOV)28 Z]+FX?C9)U^ FKH-?KBH
MY!5('="7*/A(O%$9.C&?BT.N!?^4^6!- *Y0HJ_\FG+B434M,**,Y5+*6K6E
MGRW]N$])D921QG9YTG($*9X$U, ((^HML';)TL<$!]Z K>V5<?25S2B3\!1H
M==+P<\-3"-B;_" YPP5SU5KN: E2B+B!*@%C,1G,)8KP,:<SL["(D*9M'XN:
M\5X23!W[W6'&_@C\!:4QEX!F\=)=U[>N$<+\>.D?7XU[@1^:IQ*@* OR;+H:
MLRPRT91K]R$6P.3*WXW+XFNSJUU_]BLS11>7BP2S:Z<*D_$K9T2*/VI3U!GG
M)- [7]4J7TZM/+-VL/;)!O7O]E57RBDY.NAU7-)Z'M?2Q@V8/1"%V);!U%@\
MCYZR&1*-J@"#D'R_<#75T#W[!XWY'+4\";7R'.<VK=G<46ATVZ )IA?M\$+?
M#DXU$9-37]WQ&PP#S$>L34!A>"0NL,H(5O9G%J*M1BX7AN$DQ*9JQ6_)81P*
ML\2KRJ>*H6U,,U\+T+G=?'9M5<+*A)2(SP;&I'ZJ'+94<JK&93RXMG"DJ-WL
M'J%ODO9N*5&>U!5NL^'-#M#">-EJ@='T1M0@!S4DB=^QP\P*M.X7N@SV*W&K
M6X(+O3*7)I\O) Z(LE70RE'#TK!+L9/46=_,8?"8GW,1586[U#NM?6]#*$^3
M.24@ON+\K3>\-ASG_+2"Y[BH,?>I>(&'9]/+@+EBE6"&ZV0E'HZI!:8$#K12
M-H8!8$3;)J1A4RP[H< $_!4:%MP6U2*X^@YV9&R4A:+DSKNV?E"7.WT1\B\I
MB-5!H(024[NDB6 >5#74]&^++SFQNEV'XJ=4K$Z;_7[EY!N!CK?/&3.#Z$ '
M^MI,CQ:9FV0IC\--&IA+K;0]1E2T@0GB*V:M&X0;&1553 T%-1*5@LE%YKW.
M,%JRL/A@I\N!02Q=@=XR5P-9JACK/ I?7A&,^9\V'N]6:]PD9_NDJ75R=<3@
M/AB #"H_<M #+<*YN;9VF^(@$1\C?!,Y-U8Q-@EJ9;?I&7H/UKMHKNGYRI6:
MCR<_=0M\9K*QJS4#?[FJ ^?J$\1,6-;XP^'PR''IC[8^XRP 5=Q/L#_C0&U5
M$\_'1:(7E'!N]X8X[/CLQ[.7$0I;^T JC&=OZAU?\979H&#HA*OEC(,V072.
MC0DO*W%#2A0<+D*28M4PD&*$Y8\-NP_$Z>I7.%Y;HQ+H0!: M5&S7I=6"V-P
M%7D>6W0)RBYYLQG)/\M..>$0ZUH/1%,"D+7!(YE!?=L<<Y=6ZD):=H(NW;RC
M84?DBI1*B[CL?G 2.4\!8QY+*MCD%.^ILGFK;<7FW(URE0B;U -/^S>*HN!B
MLW'&6QQ!_F\8F&6&*BB 8K72V"%%LN:GA0K+!4&JA=DGG\DGUVX:6L?Z1>NT
MA,%,]1BWD</XM^?.%FEMV<E)6QO>VI$K8ET+=IV00HE2S6DGUS[:!-3OWOMU
M]TK_[6,F[G&O-TY3^H@S//",BP\,]:Y.\.,=!PH-TO%%=*:KM6M"!G%%4H9+
M.&*E9XS=\ J:7)1"2$8,Z+:<W!'><("7+.-W2WUTG3.1>I;[<EC.'X>RMH'%
M^2[@1Q0*DTHV\\P_2]%F.MHI+*=ZYG9/.DX(6XLZ?_# E%TR^SXNDFB+D2G$
M^EXI]35=,::0*J[U"'"(DI?<_904S4,@O#YTY4JYXC*70[;#-OC'+89#9K(
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MH]DG-;@3B) :-C@2UHG)%E$<*3"IC0P<G"?->*7WKZ^TZPT=@F"EB8MCOR8
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M63[YZ^.#:96E3_X?4$L! A0#%     @ 4Y-84  HWQ=*/   /54  !T
M         ( !     &-H87)T+3$W.3@Y,C0R-C9F-6)A,6%D,#,N:G!G4$L!
M A0#%     @ 4Y-84)$R3C._,@  M$   !T              ( !A3P  &-H
M87)T+30Q-3(P-F,V-C1C-S5D9F8S-3(N:G!G4$L! A0#%     @ 4Y-84#5I
M9@X;:   RI<  !T              ( !?V\  &-H87)T+3<R-#(W93(U93%F
M930V9C=D8S$N:G!G4$L! A0#%     @ 4Y-84 I:-Q(C/   _U,  !T
M         ( !U=<  &-H87)T+3AB,SEE9# R.3)B8S$W9C(U-#DN:G!G4$L!
M A0#%     @ 4Y-84,M_4I7E.    5,  !T              ( !,Q0! &-H
M87)T+3ED96(V-35D-S(W9C(P,F4T9C@N:G!G4$L! A0#%     @ 4Y-84#F2
M]#09)   O#,  !T              ( !4TT! &-H87)T+6(X,6,U,#$V.6(R
M8V4W,#4Y8V,N:G!G4$L! A0#%     @ 4Y-84#%63$T/,@  RDT  !T
M         ( !IW$! &-H87)T+64Q-C0S.3$S8V%C9F(P-6$R8C4N:G!G4$L!
M A0#%     @ 4Y-84.GFN95?&0  ^B\! !               ( !\:,! &5B
M<RTR,#$Y,3(S,2YX<V102P$"% ,4    " !3DUA030R<Z.Y*!  <VC  $P
M            @ %^O0$ 96)S+3(P,3DQ,C,Q,3!K+FAT;5!+ 0(4 Q0    (
M %.36% G7R,)&S<  -9V @ 4              "  9T(!@!E8G,M,C Q.3$R
M,S%?8V%L+GAM;%!+ 0(4 Q0    ( %.36% Y*.DTT(T  $U3!P 4
M      "  >H_!@!E8G,M,C Q.3$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( %.3
M6%!'GD\Y?DP! "1N$0 4              "  >S-!@!E8G,M,C Q.3$R,S%?
M;&%B+GAM;%!+ 0(4 Q0    ( %.36%!-]:)&H]L  (%\"P 4
M  "  9P:" !E8G,M,C Q.3$R,S%?<')E+GAM;%!+ 0(4 Q0    ( %.36% 3
MU"=19#,  (T6 0 ;              "  7'V" !E8G,M,C Q.3$R,S%E>&AI
M8FET,3 Q,"YH=&U02P$"% ,4    " !3DUA0^90^T*HW  !7*@$ &P
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M:70Q,#0P+FAT;5!+ 0(4 Q0    ( %.36% $\;J7QPT  *DM   :
M      "  4Z'"0!E8G,R,#$Y,3(S,65X:&EB:70Q,#0Q+FAT;5!+ 0(4 Q0
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M>#,Q,2YH=&U02P$"% ,4    " !3DUA07-$H+7 '  ".*   &@
M    @ &Q)0H 97-B+3(P,3DQ,C,Q>#$P:WAE>#,Q,BYH=&U02P$"% ,4
M" !3DUA0:"[ A3\$  #"#@  &@              @ %9+0H 97-B+3(P,3DQ
M,C,Q>#$P:WAE>#,R,2YH=&U02P$"% ,4    " !3DUA0%F0@\$L$  !*#@
M&@              @ '0,0H 97-B+3(P,3DQ,C,Q>#$P:WAE>#,R,BYH=&U0
M2P$"% ,4    " !3DUA0E=\_??(@   . P$ &@              @ %3-@H
M97AH:6)I=#0T9&5S8W)I<'1I;VYO9BYH=&U02P4&     !P ' #*!P  ?5<*
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828875312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Asset Impairment Analysis (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818626736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly financial data (unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Schedule of Quarterly Financial Information</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Quarterly financial information for the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is presented in the following tables:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Quarter Ended</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions, except per share data)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">March 31,</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">June 30,</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">September 30,</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">2019:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>190.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>243.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>311.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>360.4</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income (loss) from operations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(27.4</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(7.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>70.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>77.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(26.1</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(9.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>43.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>46.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) per share-basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.51</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.18</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.84</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.91</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) per share-diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.51</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.18</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.83</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.90</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">2018:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>117.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>220.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>173.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>270.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income (loss) from operations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(9.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>66.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>21.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>11.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(4.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>50.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>20.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(3.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) per share-basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.10</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.00</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.42</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.07</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) per share-diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.10</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.98</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.41</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.07</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109225645&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6680282896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined benefit and 401(k) savings plan (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock', window );">Summary of Funded Status of the Swiss Plan</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The funded status of the Swiss Plan is as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:65%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of plan assets, beginning of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>18.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquisitions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>18.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employer contributions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee contributions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net benefits received (paid)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Actual return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Currency impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of plan assets, end of year</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>20.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>18.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Projected benefit obligation, beginning of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>28.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquisitions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>28.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Service cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest Cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee contributions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Actuarial loss</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>7.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net benefits received (paid)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Plan amendment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Currency impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Projected benefit obligation, end of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>35.3</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>28.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Funded status, end of year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(14.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(10.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accumulated benefit obligation, end of year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>31.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>25.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Components of Net Periodic Pension Cost</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Components of net periodic pension cost incurred during the year are as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:65%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expected return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net periodic benefit cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of Weighted Average Assumptions</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The weighted average assumptions used to calculate the projected benefit obligations are as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:65%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Discount rate</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expected rate of return</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Rate of future compensation increases</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Loss Before Income Tax</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table presents losses recognized in accumulated other comprehensive loss before income tax related to the Company&#8217;s defined benefit pension plans:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:65%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net actuarial loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>5.4</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prior service cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total recognized in accumulated other comprehensive loss</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Future Benefits Payments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Future benefits expected to be paid as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> are as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:86%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>6.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>12.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(b)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the assumptions used to determine for pension plans and/or other employee benefit plans the benefit obligation and net benefit cost, including assumed discount rates, rate increase in compensation increase, and expected long-term rates of return on plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828876112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income taxes</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Income taxes</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to reverse. Valuation allowances are recorded as appropriate to reduce deferred tax assets to the amount considered likely to be realized. As a result of the reduction in the U.S. corporate income tax rate from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>35%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>21%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> under the Tax Reform Act, the Company revalued its ending net deferred tax liabilities in the United States at </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and recognized a provisional </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$13.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> tax benefit in the Company&#8217;s consolidated statement of income for the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. During </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, we adjusted the provisional estimate by approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$4.5 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, bringing the total tax benefit recorded to date to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$17.9 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> related to the revaluation of our deferred tax assets and liabilities.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Tax Reform Act provided for a one-time deemed mandatory repatriation of post-1986 undistributed foreign subsidiary earnings and profits (&#8220;E&amp;P&#8221;) through the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The Company had an estimated </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$95.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of undistributed foreign E&amp;P subject to the deemed mandatory repatriation and recognized a provisional transition tax of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$13.6 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of income tax expense in the Company&#8217;s consolidated statement of income for the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. During </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> we reduced the provisional transition tax by </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$0.3 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, bringing the total transition tax to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$13.3 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">While the Tax Reform Act provides for a territorial tax system and it includes two new U.S. tax base erosion provisions, the global intangible low-taxed income (&#8220;GILTI&#8221;) provisions and the base-erosion and anti-abuse tax (&#8220;BEAT&#8221;) provisions.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The GILTI provisions require the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary&#8217;s tangible assets. The Company is subject to incremental U.S. tax on GILTI income. The Company has elected to account for GILTI tax in the period in which it is incurred, and therefore has not provided any deferred tax impacts of GILTI in its consolidated financial statements for the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Significant components of the provisions for income taxes attributable to operations consist of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>29.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>11.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>2.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>11.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>6.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total current</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>24.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>10.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>32.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Federal</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(6.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(4.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>9.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total deferred</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(1.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>8.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total provision for income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>22.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>36.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's net deferred tax asset (liability) consists of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Federal losses carryforward</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>8.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>10.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State losses carryforward</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>18.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development carryforward</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>10.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State research and development carryforward</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>5.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>5.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Scientific research and experimental development credit carryforward</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>11.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>13.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Stock compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>7.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Foreign NOLs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>36.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>35.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>18.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>11.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory reserves</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lease liability</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>6.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>4.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax asset</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>128.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>119.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fixed assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(51.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(46.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(54.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(60.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Right-of-use asset</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(5.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax liability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(114.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(107.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(64.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(66.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net deferred tax asset (liability)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(50.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(54.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company has a net U.S. deferred tax liability in the amount of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$7.7 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and a foreign net deferred tax liability in the amount of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$42.8 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The Company had a net U.S. deferred tax liability in the amount of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$4.8 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and a foreign net deferred tax asset in the amount of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$49.3 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company currently has approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$40.5 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$8.5 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> tax effected) in U.S. federal net operating loss carryforwards along with </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$14.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in research and development tax credit carryforwards for U.S. federal and state tax purposes that will begin to expire in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2027</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2024</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively. The U.S. federal net operating loss carryforwards are recorded with a </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$4.7 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> valuation allowance. The research and development tax credit carryforwards have a valuation allowance in the amount of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$9.1 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The Company has </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$280.7 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$17.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> tax effected) in state net operating loss carryforwards, primarily in Maryland and California, that will begin to expire in 2025. The U.S. state tax loss carryforwards are recorded with a valuation allowance of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$245.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$16.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> tax effected). The Company has approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$199.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$37.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> tax effected) in net operating losses from foreign jurisdictions, some of which have an indefinite life (unless the foreign entities have a change in the nature or conduct of the business in the three years following a change in ownership), and some of which begin to expire in 2022. A valuation allowance in respect to these foreign losses has been recorded in the tax effected </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">amount of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$34.3 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The Company currently has approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$11.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in Manitoba scientific research and experimental development credit carryforwards that will begin to expire in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2027</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The use of any of these net operating losses and research and development tax credit carryforwards may be restricted due to future changes in the Company's ownership.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The provision for income taxes differs from the amount of taxes determined by applying the U.S. federal statutory rate to income before the provision for income taxes as a result of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">US</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>63.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>71.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>80.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>13.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>10.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>37.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Earnings before taxes on income</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>77.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>81.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>118.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Federal tax at statutory rates</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>16.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>17.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>41.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State taxes, net of federal benefit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>10.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Impact of foreign operations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(6.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(2.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Change in valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Tax credits</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Transition tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>13.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Change in U.S. tax rate</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(4.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(13.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Stock compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(2.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(5.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(4.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other differences</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Return to provision true-ups</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(2.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Transaction costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>5.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>4.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Compensation limitation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">FIN 48</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">GILTI, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Permanent differences</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Provision for income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>22.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>36.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The effective annual tax rate for the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>30%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>23%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>30%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The effective annual tax rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>30%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is higher than the statutory rate primarily due to the impact of state taxes, GILTI, contingent consideration and other non-deductible items. This is partially offset by stock option deduction benefits, tax credits, and favorable rates in foreign jurisdictions. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The effective annual tax rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>23%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is higher than the statutory rate primarily due to the impact of state taxes, GILTI, acquisition transaction costs and other non-deductible items, and the jurisdictional mix of earnings. This is partially offset by the impact of the SAB 118 benefit and the stock option deduction benefit.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The effective annual tax rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>30%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> differs from statutory rate primarily due to the jurisdictional mix of earnings. Due to the impact of the Tax Reform Act enacted on December 22, 2017, the Company recognized a $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">13.4</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million tax benefit as a result of revaluing the U.S. ending net deferred tax liabilities from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">35%</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to the newly enacted U.S. corporate income tax rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">21%</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The tax benefit was fully offset by tax expense of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$13.6 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the transition tax on the deemed mandatory repatriation of undistributed earnings.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company recognizes interest in interest expense and recognizes potential penalties related to unrecognized tax benefits in selling, general and administrative expense. Of the total unrecognized tax benefits recorded at </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$0.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$0.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, is classified as a current liability and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$10.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$8.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, is classified as a non-current liability on the balance sheet.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The table below presents the gross unrecognized tax benefits activity for </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gross unrecognized tax benefits at December&#160;31, 2016</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Decreases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for current year</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lapse of statute of limitations</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gross unrecognized tax benefits at December&#160;31, 2017</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unrecognized tax benefits acquired in business combinations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>6.5</span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Decreases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for current year</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lapse of statute of limitations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gross unrecognized tax benefits at December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unrecognized tax benefits acquired in business combinations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Decreases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for current year</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lapse of statute of limitations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gross unrecognized tax benefits at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>10.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The total gross unrecognized tax benefit of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$10.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of which </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$7.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> relates to the acquisition of PaxVax is entirely offset by a receivable pursuant to a Tax Indemnity Agreement that became effective as at the close of the acquisition.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">When resolved, substantially all of these reserves would impact the effective tax rate.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's federal and state income tax returns for the tax years 2016 to 2018 remain open to examination. The Company's tax returns in the United Kingdom remain open to examination for the tax years 2012 to 2018, and tax returns in Germany remain open indefinitely. The Company's tax returns for Canada remain open to examination for the tax years 2012 to 2018. The Company's Swiss tax returns remain open to federal examination for 2018. The Company's Irish tax returns remain open to examination for the tax years 2013 to 2018.  </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company&#8217;s Canadian </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Scientific Research and Experimental Development Claim is under audit. As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company's 2017 Canadian and US federal income tax returns for the Adapt entities prior to acquisition are under audit.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6824246144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Changes in Stockholders' Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>$0.001 Par Value Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Retained Earnings</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2016</a></td>
<td class="nump">$ 596.2<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 352.4<span></span>
</td>
<td class="num">$ (6.4)<span></span>
</td>
<td class="num">$ (4.3)<span></span>
</td>
<td class="nump">$ 254.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Employee equity plans activity (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Employee equity plans activity</a></td>
<td class="nump">28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Shares issued to extinguish convertible notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Shares issued to extinguish convertible notes</a></td>
<td class="nump">238.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">237.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Treasury stock</a></td>
<td class="num">(33.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (33.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">82.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2017</a></td>
<td class="nump">912.3<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">618.3<span></span>
</td>
<td class="num">$ (39.5)<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
<td class="nump">337.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Employee equity plans activity (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Employee equity plans activity</a></td>
<td class="nump">32.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock in acquisitions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock in acquisition</a></td>
<td class="nump">37.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Treasury stock</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">62.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (1.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Dec. 31, 2018</a></td>
<td class="nump">52,400,000.0<span></span>
</td>
<td class="nump">52,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2018</a></td>
<td class="nump">$ 1,010.9<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">688.6<span></span>
</td>
<td class="num">$ (39.6)<span></span>
</td>
<td class="num">(5.5)<span></span>
</td>
<td class="nump">367.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Employee equity plans activity (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Employee equity plans activity</a></td>
<td class="nump">27.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">54.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (4.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="nump">52,900,000.0<span></span>
</td>
<td class="nump">53,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">$ 1,088.5<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 716.1<span></span>
</td>
<td class="num">$ (39.6)<span></span>
</td>
<td class="num">$ (9.9)<span></span>
</td>
<td class="nump">$ 421.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6811245616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">15,000,000.0<span></span>
</td>
<td class="nump">15,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200,000,000.0<span></span>
</td>
<td class="nump">200,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">52,900,000.0<span></span>
</td>
<td class="nump">52,400,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">51,700,000.0<span></span>
</td>
<td class="nump">51,200,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">1,200,000.0<span></span>
</td>
<td class="nump">1,200,000.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828909536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Purchase commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationFiscalYearMaturityAbstract', window );"><strong>Purchase Obligation, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock', window );">Purchase commitment</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Purchase commitments</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> the Company has approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$59.7 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of purchase commitments associated with raw materials and contract development and manufacturing services that will be purchased in the next </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>three years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company purchased </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$51.3 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$12.1 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$3.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, of materials under this commitment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for arrangements in which the entity has agreed to expend funds to procure goods or service from one or more suppliers, or to commit resources to supply goods or services to one or more customers.  May include identification of the goods or services to be purchased, the goods or services to be furnished, identity of the buyer or seller, pricing, effects on pricing (such as penalties) of failing to reach minimum quantities required to be purchased, effects on pricing (such as penalties) of failing to deliver minimum quantities required to be furnished, cancellation rights, and termination provisions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantPurchaseAndSupplyCommitmentExcludingLongtermCommitmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828873424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule II - Valuation and Qualifying Accounts</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:35%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Beginning Balance</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Additions from Acquisition</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Charged to costs and expenses</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Deductions</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Ending Balance</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Year Ended December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>14.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>23.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(19.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>17.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prepaid expenses and other current assets allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Year Ended December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>4.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>14.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(8.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>14.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prepaid expenses and other current assets allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>5.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Year Ended December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(8.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prepaid expenses and other current assets allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>4.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>5.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6827869952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information - Product Sales (Details) - Sales Revenue, Product Line<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueProductLineMember', window );">Anthrax Vaccines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="nump">68.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueProductLineMember', window );">ACAM2000</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueProductLineMember', window );">NARCAN Nasal Spray</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueProductLineMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13537-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_BiothraxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_BiothraxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_ACAM2000Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_ACAM2000Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_NARCANNasalSprayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_NARCANNasalSprayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818775632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined benefit and 401(k) savings plan - Components of Net Periodic Pension Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=112275985&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=112275985&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=112275985&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=112275985&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6806833984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Acquisition of ACAM2000 Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 06, 2017</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 266.6<span></span>
</td>
<td class="nump">$ 259.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ebs_ACAM2000Member', window );">ACAM2000</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_TermofContractUnderAcquisition', window );">Term of contract under acquisition</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_ValueofContract', window );">Value of contract</a></td>
<td class="nump">$ 425.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_AmountforDeliveriesofProduct', window );">Amount for deliveries of product</a></td>
<td class="nump">160.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_UpfrontPayments', window );">Upfront payments</a></td>
<td class="nump">97.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_AmountOfPaymentForManufacturingRelatedMilestones', window );">Amount of payment for manufacturing related milestones</a></td>
<td class="nump">20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash</a></td>
<td class="nump">117.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_AmountOfPaymentForRegulatoryRelatedMilestones', window );">Amount of payment for regulatory related milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent purchase consideration</a></td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_PresentValueDiscountRate', window );">Present value discount rate</a></td>
<td class="nump">15.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period of intangible assets</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 8.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_AmountOfPaymentForManufacturingRelatedMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with manufacturing related milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_AmountOfPaymentForManufacturingRelatedMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_AmountOfPaymentForRegulatoryRelatedMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with regulatory related milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_AmountOfPaymentForRegulatoryRelatedMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_AmountforDeliveriesofProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for deliveries of product to the Strategic National Stockpile ("SNS").</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_AmountforDeliveriesofProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_PresentValueDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure present value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_PresentValueDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_TermofContractUnderAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of contract under acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_TermofContractUnderAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_UpfrontPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to upfront payments by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_UpfrontPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ValueofContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the value of contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ValueofContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ebs_ACAM2000Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ebs_ACAM2000Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>165
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6814655728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair value measurements - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash held in money market accounts</a></td>
<td class="nump">$ 52.2<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6827490176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 25.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Operating leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (years)</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">4.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 24.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_OperatingLeaseOtherLiabilityCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">$ 22.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_OperatingLeaseOtherLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Other Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_OperatingLeaseOtherLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>167
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6817933904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined benefit and 401(k) savings plan - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Matching contributions made by employer</a></td>
<td class="nump">$ 5.1<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="nump">$ 2.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>169
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818799712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Schedule of Product Sales</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's product sales from Anthrax Vaccines, ACAM2000, NARCAN Nasal Spray and Other comprised approximately:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">% of product sales:</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Anthrax Vaccines</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ACAM2000</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>27</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">NARCAN Nasal Spray</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>31</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>170
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6824008816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Summary of Significant Components of the Provisions for Income Taxes Attributable to Operations</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Significant components of the provisions for income taxes attributable to operations consist of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>29.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>11.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>2.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>11.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>6.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total current</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>24.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>10.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>32.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Federal</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(6.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(4.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>9.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total deferred</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(1.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>8.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total provision for income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>22.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>36.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's net deferred tax asset (liability) consists of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Federal losses carryforward</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>8.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>10.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State losses carryforward</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>17.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>18.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development carryforward</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>10.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State research and development carryforward</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>5.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>5.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Scientific research and experimental development credit carryforward</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>11.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>13.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Stock compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>7.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Foreign NOLs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>36.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>35.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>18.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>11.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory reserves</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lease liability</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>6.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>4.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax asset</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>128.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>119.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fixed assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(51.2</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(46.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(54.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(60.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Right-of-use asset</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(5.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Deferred tax liability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(114.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(107.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(64.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(66.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net deferred tax asset (liability)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(50.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(54.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Reconciliation of Income Before the Provision for Income Taxes</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The provision for income taxes differs from the amount of taxes determined by applying the U.S. federal statutory rate to income before the provision for income taxes as a result of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">US</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>63.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>71.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>80.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>13.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>10.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>37.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Earnings before taxes on income</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>77.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>81.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>118.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Federal tax at statutory rates</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>16.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>17.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>41.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State taxes, net of federal benefit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>10.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Impact of foreign operations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(6.9</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(2.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Change in valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Tax credits</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(1.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Transition tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>13.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Change in U.S. tax rate</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(4.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(13.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Stock compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(2.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(5.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(4.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other differences</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Return to provision true-ups</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(2.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Transaction costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>5.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>4.7</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Compensation limitation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">FIN 48</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">GILTI, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Permanent differences</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Provision for income taxes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>22.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>36.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Activity</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The table below presents the gross unrecognized tax benefits activity for </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gross unrecognized tax benefits at December&#160;31, 2016</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Decreases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for current year</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lapse of statute of limitations</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gross unrecognized tax benefits at December&#160;31, 2017</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unrecognized tax benefits acquired in business combinations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>6.5</span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Decreases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for current year</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lapse of statute of limitations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gross unrecognized tax benefits at December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unrecognized tax benefits acquired in business combinations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Decreases for tax positions for prior years</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increases for tax positions for current year</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lapse of statute of limitations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gross unrecognized tax benefits at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>10.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#e5e5e5;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=109238393&amp;loc=d3e36027-109320<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>171
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6811422720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Estimated Useful Lives (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">P31Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">P39Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">P10Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">P39Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">P3Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">P15Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software product life | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">P3Y<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software product life | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">P7Y<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68071081&amp;loc=d3e1205-110223<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>172
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6807314880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of presentation and consolidation</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Basis of presentation and consolidation</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The accompanying consolidated financial statements include the accounts of Emergent and its wholly owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Use of estimates</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The preparation of financial statements in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) requires management to make estimates, judgments and assumptions that affect the amounts and disclosures reported in the consolidated financial statements and accompanying notes. Management continually re-evaluates its estimates, judgments and assumptions, and management&#8217;s evaluations could change. These estimates are sometimes complex, sensitive to changes in assumptions and require fair value determinations using Level 3 fair value measurements. Actual results may differ materially from those estimates.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Estimates and judgments inherent in the preparation of the consolidated financial statements include accounting for asset impairments, revenue recognition, allowances for doubtful accounts, inventory, depreciation and amortization, business comb</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">inations, contingent consideration, stock-based compensation, income taxes, and other contingencies.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents and restricted cash</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Cash, cash equivalents and restricted cash</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Cash equivalents are highly liquid investments with a maturity of 90 days or less at the date of purchase and consist of time deposits and investments in money market funds with commercial banks and financial institutions. Also, the Company maintains cash balances with financial institutions in excess of insured limits. The Company does not anticipate any losses with such cash balances. Restricted cash includes cash that is not readily available for use in the Company's operating activities. Restricted cash is primarily comprised of cash pledged under letters of credit.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair value measurements</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Fair value measurements</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, an exit price, in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value include:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:left;padding-left:24px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"/></tr><tr><td style="width:11%;"/><td style="width:89%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Level 1 &#8212;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Observable inputs for identical assets or liabilities such as quoted prices in active markets;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Level 2 &#8212;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inputs other than quoted prices in active markets that are either directly or indirectly observable; and</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Level 3 &#8212;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unobservable inputs in which little or no market data exists, which are therefore developed by the Company using estimates and assumptions that reflect those that a market participant would use.</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On a recurring basis, the Company measures and records money market funds (level 1), contingent purchase considerations (level 3) and interest-rate swap arrangements (level 2) using fair value measurements in the accompanying financial statements. On a non-recurring basis, the Company measures its IPR&amp;D assets (level 3) using fair value measurements. The carrying amounts of the Company's short-term financial instruments, which include cash and cash equivalents, accounts receivable and accounts payable, approximate their fair values due to their short maturities. The </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">carrying amounts of the Company&#8217;s long-term debt arrangements approximates their fair values due to variable interest rates which fluctuate with changes in market rates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersPolicyPolicyTextBlock', window );">Significant customers and accounting receivable</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Significant customers and accounts receivable</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Billed accounts receivable are stated at invoice amounts and consist mostly of amounts due from the USG, as well as amounts due under reimbursement contracts with other government entities and non-government organizations. Our opioid overdose reversal product is sold commercially through physician-directed or standing order prescriptions at retail pharmacies, as well as state health departments, law enforcement agencies, state and local community based organizations, substance abuse centers and federal agencies. If necessary, the Company records a provision for doubtful receivables to allow for amounts which may be unrecoverable. This provision is based upon an analysis of the Company's prior collection experience, customer creditworthiness and current economic trends. Unbilled accounts receivable relates to various service contracts for which work has been performed, though invoicing has not yet occurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_ConcentrationsRiskPolicyTextBlock', window );">Concentration risk</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Concentration Risk</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Customers</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has long-term contracts with the USG that expire at various times from 2020 through 2029. The Company has derived a significant portion of its revenue from sales of ACAM2000 and Anthrax Vaccines under contracts with the USG. The Company's current USG contracts do not necessarily increase the likelihood that it will secure future comparable contracts with the USG. The Company expects that a significant portion of the business will continue to be under government contracts that present a number of risks that are not typically present in the commercial contracting process. USG contracts for ACAM 2000 and Anthrax Vaccines are subject to unilateral termination or modification by the government. The Company may fail to achieve significant sales of ACAM 2000 and Anthrax Vaccines to customers in addition to the USG, which would harm its growth opportunities. The Company may not be able to manufacture Anthrax Vaccines consistently in accordance with FDA specifications. The Company's other product sales are largely sold commercially through physician-directed or standing order prescriptions at retail pharmacies, as well as to state health departments, local law enforcement agencies, community-based organizations, substance abuse centers and other federal agencies. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Although the Company seeks expand its customer base and to renew its agreements with its customers prior to expiration of a contract, a delay in securing a renewal or a failure to secure a renewal or a renewal on less favorable terms may have a material adverse effect on the Company&#8217;s financial condition and results of operations.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company&#8217;s trade receivables do not represent a significant concentration of credit risk. The USG accounted for approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>61%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>76%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>78%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of total revenues for </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, and approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>69%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>76%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of total accounts receivable as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively. Because accounts receivable consists primarily of am</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ounts due from the USG for product sales and from government agencies under government grants and development contracts, management does not deem the credit risk to be significant.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Financial Institutions</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Cash and cash equivalents are maintained with several financial institutions. The Company has deposits held with banks that exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with financial institutions of reputable credit and, therefore, bear minimal credit risk.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Lender Counterparties</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">There is lender counterparty risk associated with the Company's revolving credit facility and derivatives instruments. There is risk that the Company&#8217;s revolving credit facility investors and derivative counterparties will not be available to fund as obligated. If funding under the revolving credit facility is unavailable, the Company may have to acquire a replacement credit facility from different counterparties at a higher cost or may be unable to find a suitable replacement. The Company seeks to manage risks from its revolving credit facility and derivative instruments by contracting with experienced large financial institutions and monitoring the credit quality of its lenders. As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company did not anticipate nonperformance by any of its counterparties.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Inventories</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Inventories are stated at the lower of cost or net realizable value with cost being determined using a standard cost method, which approximates average cost. Average cost consists primarily of material, labor and manufacturing overhead expenses (including fixed production-overhead costs) and includes the services and products of third-party suppliers. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company analyzes its inventory levels quarterly and writes down, in the applicable period, inventory that has become obsolete, inventory that has a cost basis in excess of its expected net realizable value and inventory in excess of expected customer demand. The Company also writes off, in the applicable period, the costs related to expired inventory.&#160;Costs of purchased inventories are recorded using weighted-average costing. The Company determines normal capacity for each production facility and allocates fixed production-overhead costs on that basis.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company records inventory acquired in business acquisitions utilizing the comparative sales method, which estimates the expected sales price reduced for all costs expected to be incurred to complete/dispose of the inventory with a profit on those costs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, plant and equipment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Property, plant and equipment</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Property, plant and equipment are stated at cost less accumulated depreciation and impairments. Depreciation is computed using the straight-line method over the following estimated useful lives:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"/></tr><tr><td style="width:52%;"/><td style="width:48%;"/></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Buildings</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">31-39 years</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Building improvements</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10-39 years</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Furniture and equipment</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3-15 years</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Software</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3-7 years or product life</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Leasehold improvements</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lesser of the asset life or lease term</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is credited or charged to operations. Repairs and maintenance costs are expensed as incurred.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company capitalizes internal-use software when both (a) the software is internally developed, acquired, or modified solely to meet the entity&#8217;s internal needs and (b) during the software&#8217;s development or modification, no substantive plan either exists or is being developed to market the software externally. Capitalization of qualifying internal-use software costs begins when the preliminary project stage is completed, management with the relevant authority, implicitly or explicitly, authorizes and commits to the funding of the software project, and it is probable that the project will be completed and the software will be used to perform the function intended.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determines the fair value of the property, plant and equipment acquired in a business combination utilizing either the cost approach or the sales comparison approach. The cost approach is determined by establishing replacement cost of the ass</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">et and then subtracting any value that has been lost due to economic obsolescence, functional obsolescence, or physical deterioration. The sales comparison approach determines an asset is equal to the market price of an asset of comparable features such as design, location, size, construction, materials, use, capacity, specification, operational characteristics and other features or descriptions.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Income taxes</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Income taxes are accounted for using the liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss and research and development tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Deferred income tax effects of transactions reported in different periods for financial reporting and income tax return purposes are recognized under the asset and liability method of accounting for income taxes. This method gives consideration to the future tax consequences of the deferred income tax items and immediately recognizes changes in income tax laws in the year of enactment. On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (the &#8220;Tax Reform Act&#8221;). Further information on the tax impacts of the Tax Reform Act is included in Note </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">12</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of the Company&#8217;s consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's ability to realize deferred tax assets depends upon future taxable income as well as the limitations discussed below. For financial reporting purposes, a deferred tax asset must be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax assets will not be realized prior to expiration. The Company considers future taxable income and ongoing tax planning strategies in assessing the need for valuation allowances. In general, if the Company determines that it is more likely than not to realize more than the recorded amounts of net deferred tax assets in the future, the Company will reverse all or a portion of the valuation allowance </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">established against its deferred tax assets, resulting in a decrease to the provision for income taxes in the period in which the determination is made. Likewise, if the Company determines that it is not more likely than not to realize all or part of the net deferred tax asset in the future, the Company will establish a valuation allowance against deferred tax assets, with an offsetting increase to the provision for income taxes, in the period in which the determination is made.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Under sections 382 and 383 of the Internal Revenue Code, if an ownership change occurs with respect to a "loss corporation", as defined therein, there are annual limitations on the amount of net operating losses and deductions that are available. The Company has recognized the portion of net operating losses and research and development tax credits acquired that will not be limited and are more likely than not to be realized.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Because tax laws are complex and subject to different interpretations, significant judgment is required. As a result, the Company makes certain estimates and assumptions, in (1)&#160;calculating the Company's income tax expense, deferred tax assets and deferred tax liabilities, (2)&#160;determining any valuation allowance recorded against deferred tax assets and (3)&#160;evaluating the amount of u</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">nrecognized tax benefits, as well as the interest and penalties related to such uncertain tax positions. The Company's estimates and assumptions may differ significantly from tax benefits ultimately realized.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InProcessResearchAndDevelopmentPolicy', window );">Acquisitions</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Acquisitions</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In determining whether an acquisition is a business combination versus an asset acquisition, the accounting guidance requires an entity to first evaluate whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If that threshold is met, the set of assets and activities is not a business and therefore treated as an asset acquisition. If that threshold is not met, the entity evaluates whether the set meets the definition of a business. If an acquired asset or asset group does not meet the definition of a business, the transaction is accounted for as an asset acquisition. Otherwise, the acquisition is treated as a business combination.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In a business combination, the acquisition method of accounting requires that the assets acquired and liabilities assumed be recorded as of the date of the merger or acquisition at their respective fair values with limited exceptions and generally use Level 3 fair value measurements. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Accordingly, the Company may be required to value assets at fair values that do not reflect the Company's intended use of those assets. Any excess of the purchase price (consideration transferred) over the estimated fair values of net assets acquired is recorded as goodwill. Transaction costs and costs to restructure the acquired company are expensed as incurred. The operating results of the acquired business are reflected in the Company's consolidated financial statements after the date of the merger or acquisition. If the Company determines the assets acquired do not meet the definition of a business under the acquisition method of accounting, the transaction will be accounted for as an asset acquisition and recorded at cost rather than a business combination and, therefore, no goodwill will be recorded.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair values of intangible assets, including acquired in-process research and development ("IPR&amp;D"), are determined utilizing information available at or near the merger or acquisition date based on expectations and assumptions that are deemed reasonable by management. Given the considerable judgment involved in determining fair values, the Company typically obtains assistance from third-party valuation specialists for significant items. Amounts allocated to acquired IPR&amp;D are capitalized and accounted for as indefinite-lived intangible assets. Upon successful completion of each project, the Company will make a separate determination as to the remaining useful life of the asset and begin amortization. The judgments made in determining estimated fair values assigned to assets acquired and liabilities assumed in a business combination, as well as asset lives, can materially affect the Company&#8217;s results of operations.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair values of identifiable intangible assets related to current products and product rights are primarily determined by using an income approach through which fair value is estimated based on each asset&#8217;s discounted projected net cash flows. The Company's estimates of market participant net cash flows consider historical and projected pricing, margins and expense levels, the performance of competing products where applicable, relevant industry and therapeutic area growth drivers and factors, current and expected trends in technology and product life cycles, the time and investment that will be required to develop products and technologies, the ability to obtain marketing and regulatory approvals, the ability to manufacture and commercialize the products, the extent and timing of potential new product introductions by the Company&#8217;s competitors, and the life of each asset&#8217;s underlying patent, if any. The net cash flows are then probability-adjusted where appropriate to consider the uncertainties associated with the underlying assumptions, as well as the </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">risk profile of the net cash flows utilized in the valuation. The probability-adjusted future net cash flows of each product are then discounted to present value utilizing an appropriate discount rate.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair values of identifiable intangible assets related to IPR&amp;D are determined using an income approach, through which fair value is estimated based on each asset&#8217;s probability-adjusted future net cash flows, which reflect the different stages of development of each product and the associated probability of successful completion. The net cash flows are then discounted to present value using an appropriate discount rate. Indefinite-lived intangible assets are tested for impairment annually or whenever events or changes in circumstances indicate that its carrying amount may not be recoverable.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Assets acquired and liabilities assumed in a business combination that arise from contingencies are recognized at fair value if fair value can reasonably be estimated. If the acquisition date fair value of an asset acquired or liability assumed that arises from a contingency cannot be determined, the asset or liability is recognized if probable and reasonably estimable</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">; if these criteria are not met, no asset or liability is recognized.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Asset impairment analysis</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Asset Impairment Analysis</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Goodwill and Indefinite-lived Intangible Assets</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Goodwill is allocated to the Company's reporting units, which are one level below its operating segment. The Company evaluates goodwill and other indefinite-lived intangible assets for impairment annually as of October&#160;1 and earlier if an event or other circumstance indicates that we may not recover the carrying value of the asset. If the Company believes that as a result of its qualitative assessment it is more likely than not that the fair value of a reporting unit or other indefinite-lived intangible asset is greater than its carrying amount, the quantitative impairment test is not required. If however it is determined that it is not more likely than not that the fair value of a reporting unit or other indefinite-lived intangible asset is greater than its carrying amount, a quantitative test is required.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The quantitative goodwill impairment test is performed using a two-step process. The first step of the process is to compare the fair value of a reporting unit with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is not impaired and the second step of the quantitative impairment test is not necessary. If the carrying amount of a reporting unit exceeds its fair value, the second step of the quantitative goodwill impairment test is required to be performed to measure the amount of impairment loss, if any. The second step of the quantitative goodwill impairment test compares the implied fair value of the reporting unit&#8217;s goodwill with the carrying amount of that goodwill. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination. In other words, the estimated fair value of the reporting unit&#8217;s identifiable net assets excluding goodwill is compared to the fair value of the reporting unit as if the reporting unit had been acquired in a business combination and the fair value of the reporting unit was the purchase price paid. If the carrying amount of the reporting unit&#8217;s goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to that excess. The Company used a qualitative assessment for our goodwill impairment testing for </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The qualitative evaluation completed during the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> indicated </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>no</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> impairment losses. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has mater</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ial indefinite lived intangible assets associated with in-process research and development (IPR&amp;D) which were acquired as part of the acquisitions completed in the fourth quarter of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Following a qualitative assessment indicating that it is not more likely than not that the fair value of the indefinite lived intangible asset exceeds its carrying amount, impairment of other intangible assets not subject to amortization involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. Determining fair value requires the exercise of judgment about appropriate discount rates, perpetual growth rates and the amount and timing of expected future cash flows.</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> The Company used a quantitative assessment for our IPR&amp;D impairment testing for </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and determined there was an impairment loss of $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>12.0</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million, which was recorded as a component of R&amp;D expense (see Notes </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">4</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Acquisitions</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">5</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Fair value measurements</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">). </span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Long-lived Assets</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Long-lived assets such as intangible assets and property, plant and equipment are not required to be tested for impairment annually. Instead, long-lived assets are tested for impairment whenever circumstances indicate that the carrying amount of the asset may not be recoverable, such as when the disposal of such assets is likely or there is an adverse change in the market involving the business employing the related assets. If an impairment analysis is required, the impairment test employed is based on whether the Company&#8217;s intent is to hold the asset for continued use or to hold the asset for sale. If the intent is to hold the asset for continued use, the impairment test first requires a comparison </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">of undiscounted future cash flows to the carrying value of the asset. If the carrying value of the asset exceeds the undiscounted cash flows, the asset would not be deemed to be recoverable. Impairment would then be measured as the excess of the asset&#8217;s carrying value over its fair value. Fair value is typically determined by discounting the future cash flows associated with that asset. If the intent is to hold the asset for sale and certain other criteria are met, the impairment test involves comparing the asset&#8217;s carrying value to its fair value less costs to sell. To the extent the carrying value is greater than the asset&#8217;s fair value less costs to sell, an impairment loss is recognized in an amount equal to the difference. Significant judgments used for long-lived asset impairment assessments include identifying the appropriate asset groupings and primary assets within those groupings, determining whether events or circumstances indicate that the carrying amount of the asset may not be recoverable, determining the future cash flows for the assets involved and assumptions applied in determining fair value, which include, reasonable discount rates, growth rates, market risk premiums and other assumptions about the economic environment.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_ContingentConsiderationObligationsPolicyTextBlock', window );">Contingent consideration</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Contingent Consideration</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In connection with the Company's acquisitions accounted for as business combinations, the Company records contingent consideration associated with sales-based royalties, sales-based milestones and development and regulatory milestones at fair value. The fair value model used to calculate these obligations is based on the income approach (a discounted cash flow model) that has been risk adjusted based on the probability of achievement of net sales and achievement of the milestones. The inputs the Company uses for determining the fair value of the contingent consideration associated with sales-based royalties, sales-based milestones and development and regulatory milestones are Level 3 fair value measurements. The Company re-evaluates the fair value on a quarterly basis. Changes in the fair value can result from adjustments to the discount rates and updates in the assumed timing of or achievement of net sales and/or the achievement of development and regulatory milestones. Any future increase in the fair value of the contingent consideration associated with sales-based royalties and sales-based milestones along with development and regulatory milestones are based on an increased likelihood that the underlying net sales or milestones will be achieved.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The associated payments which will become due and payable for sales-based royalties and milestones result in a charge to cost of product sales and contract development and manufacturing in the period in which the increase is determined. Similarly, any future decrease in the fair value of contingent consideration associated with sales-based royalties and sales-based milestones will result in a reduction in cost of product sales and contract development and manufacturing. The changes in fair value for potential future sales-based royalties associated with product candidates in development will result in a charge to cost o</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">f product sales and contract development and manufacturing services </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">expense in the period in which the increase is determined. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The associated payment or payments which will become due and payable for development and regulatory milestones will result in a charge to research and development expense in the period in which the increase is determined. Similarly, any future decrease i</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">n the fair value for development and regulatory milestones will result in a reduction in research and development expense.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Revenue recognition</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On January 1, 2018 the Company adopted ASC topic 606 using the modified retrospective approach applied to those contracts in effect as of January 1, 2018. Under this transition method, results for reporting periods beginning after January 1, 2018 are presented under the new standard, while prior period amounts are not adjusted and continue to be reported in accordance with historical accounting under Topic 605. See further discussion of the adoption of Topic 606, including the impact to our 2018 financial statements within the recently issued accounting standards section below.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company recognizes revenue when the Company's customers obtain control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services by analyzing the following five steps: (1) identify the contract with a customer(s); (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">contract; and (5) recognize revenue when (or as) the entity satisfies a performance obligation. To indicate the transfer of control for the Company&#8217;s product sales and contract development and manufacturing services, it must have a present right to payment, legal title must have passed to the customer, and the customer must have the significant risks and rewards of ownership. Revenue for long-term development contracts is generally recognized based upon the cost-to-cost measure of progress, provided that the Company meets the criteria associated with transferring control of the good or service over time.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Multiple performance obligations</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. Contracts sometimes include options for customers to purchase additional products or services in the future. Customer options that provide a material right to the customer, such as free or discounted products or services, give rise to a separate performance obligation. For contracts with multiple performance obligations, the Company allocates the contract price to each performance obligation on a relative standalone selling price basis using the Company&#8217;s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers, however when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the contracts&#8217; inception.  </span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Transaction price and variable consideration</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Once the performance obligations in the contract have been identified, the Company estimates the transaction price of the contract. The estimate includes amounts that are fixed as well as those that can vary based on expected outcomes of the activities or contractual terms. The Company's variable consideration includes for example consideration transferred under its development contracts with the USG as consideration received can vary based on developmental progression of the product candidate(s). When a contract's transaction price includes variable consideration, the Company evaluates the variable consideration to determine whether the estimate needs to be constrained; therefore, the Company includes the variable consideration in the transaction price only to the extent that it is probable that a significant reversal of the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Variable consideration estimates are updated at each reporting date. There were </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">no</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> significant constraints or material changes to the Company's variable consideration estimates as of or during the twelve months ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Contract financing</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money if the timing of payments agreed to by the parties to the contract (either explicitly or implicitly) provides the customer with a significant benefit of financing the transfer of goods or services to the customer, which is called a significant financing component. The Company does not adjust transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Product sales</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">CBRNE</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The primary customer for the Company's CBRNE&#160;products and the primary source of funding for the development of its CBNRE product candidate portfolio is the USG. The Company's contracts for the sale of CBRNE products generally have a single performance obligation. Certain product sales contracts with the USG include multiple performance obligations, which generally include the marketed product, stability testing associated with that product, expiry extensions and plasma collection. The USG contracts for the sale of the Company's CBRNE&#160;products are normally multi-year contracts. AV7909 and Trobigard are product candidates that are not approved by the FDA or any other health agency, but are procured by certain government agencies under special circumstances. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The transaction price for product sales are based on a cost build-up model with a mark-up. For our product sales, we recognize revenue at a "point in time" when the Company&#8217;s performance obligations have been satisfied and control of the products transfer to the customer. This &#8220;point in time&#8221; depends on several factors, including delivery, transfer of legal title, transition of risk and rewards of the product to the customer and the Company's right to payment. The USG contracts for the sale of the Company's CBRNE products also include certain acceptance criteria before title passes to the USG.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Opioid and travel health products </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Revenues are recognized when control of the goods are transferred to our customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Prior to recognizing revenue, the Company makes estimates of the transaction price, including variable consideration that is subject to a constraint. Allowances for returns, specialty distributor fees, wholesaler fees, prompt payment discounts, government </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">rebates, chargebacks and rebates under managed care plans are considered in determining the variable consideration. Revenues from sales of products is recognized to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with such variable consideration is subsequently resolved. Product sales revenue is recognized when control has transferred to the customer, which occurs at a point in time, which is typically upon delivery to the customer. Provisions for variable consideration revenues from sales of products are recorded at the net sales price, which includes estimates of variable consideration for which provisions are established and which relate to returns, specialty distributor fees, wholesaler fees, prompt payment discounts, government rebates, chargebacks and rebates under managed care plans. Calculating certain of these provisions involves estimates and judgments and the Company determines their expected value based on sales or invoice data, contractual terms, historical utilization rates, new information regarding changes in these programs&#8217; regulations and guidelines that would impact the amount of the actual rebates, the Company's expectations regarding future utilization rates for these programs and channel inventory data. These provisions reflect the Company's best estimate of the amount of consideration to which the Company is entitled based on the terms of the contract. The amount of variable consideration that is included in the transaction price may be constrained and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. The Company reassesses the Company's provisions for variable consideration at each reporting date. Historically, adjustments to estimates for these provisions have not been material.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Provisions for returns, specialty distributor fees, wholesaler fees, government rebates and rebates under managed care plans are included within current liabilities in the Company's consolidated balance sheets. Provisions for chargebacks and prompt payment discounts are shown as a reduction in accounts receivable.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:normal;">Contract development and manufacturing services</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company performs contract development and manufacturing services for third parties. Under these contracts, activities can include pharmaceutical product process development, manufacturing and filling services for injectable and other sterile products, inclusive of process design, technical transfer, manufacturing validations, laboratory analytical development support, aseptic filling, lyophilization, final packaging and accelerated and ongoing stability studies. These contracts, with a duration that is less than one year, generally include a single performance obligation as the customer benefits from our performance upon full completion of our services. The performance obligation is satisfied when the Company must have a present right to payment because legal title has passed to the customer, the goods are in the customer&#8217;s possession with all the risks and rewards of ownership, and the efficacy of the goods has been confirmed. The Company recognizes revenue at a "point in time" based on when the performance obligation to the customer is satisfied.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:normal;">Contracts and grants</span></div>The Company generates contract and grant revenue primarily from cost-plus-fee contracts associated with development of certain product candidates. Revenues from reimbursable contracts are recognized as costs are incurred, generally based on allowable costs incurred during the period, plus any recognizable earned fee. The Company uses this input method to measure progress as the customer has the benefit of access to the development research under these projects and therefore benefits from the Company's performance incrementally as research and development activities occur under each project. We consider fixed fees under cost-plus-fee contracts to be earned in proportion to the allowable costs incurred in performance of the contract. We analyze costs for contracts and reimbursable grants to ensure reporting of revenues gross versus net is appropriate. Revenue for long-term development contracts is considered variable consideration, because the deliverable is dependent on the successful completion of development and is generally recognized based upon the cost-to-cost measure of progress, provided that the Company meets the criteria associated with satisfying the performance obligation over time. The USG contracts for the development of the Company's CBRNE product candidates are normally multi-year contracts.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Research and development</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">We expense research and development costs as incurred. The Company's research and development expenses consist primarily of:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">personnel-related expenses;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">fees to professional service providers for, among other things, analytical testing, independent monitoring or other administration of the Company's clinical trials and obtaining and evaluating data from the Company's clinical trials and non-clinical studies;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">costs of contract development and manufacturing services for clinical trial material; and</span></div></td></tr></table><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">costs of materials used in clinical trials and research and development.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive income</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Comprehensive income</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Comprehensive income is comprised of net income and other changes in equity that are excluded from net income. The Company includes translation gains and losses incurred when converting its subsidiaries' financial statements from their functional currency to the U.S. dollar in accumulated other comprehensive income as well as gains and losses on its pension benefit obligation and derivative instruments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Translation of foreign currencies</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Translation of Foreign Currencies</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For our non-U.S. subsidiaries that transact in a functional currency other than the U.S. dollar, assets and liabilities are translated at current rates of exchange at the balance sheet date. Income and expense items are translated at the average foreign currency exchange rates for the period. Adjustments resulting from the translation of the financial statements of our foreign operations into U.S.&#160;dollars are excluded from the determination of net income and are recorded in accumulated other comprehensive income, a separate component of equity. For subsidiaries where the functional currency of the assets and liabilities differ from the local currency, non-monetary assets and liabilities are translated at the rate of exchange in effect on the date assets were acquired while monetary assets and liabilities are translated at current rates of exchange as of the balance sheet date. Income and expense items are translated at the average foreign currency rates for the period. Translation adjustments of these subsidiaries are included in other income (expense), net in our consolidated statements of income.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per share</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Earnings per share</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company calculates basic earnings per share by dividing net income by the weighted average number of shares of common stock outstanding during the period.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Accounting for stock-based compensation</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Accounting for stock-based compensation</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>one</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> stock-based employee compensation plan, the Emergent BioSolutions Inc. Stock Incentive Plan (the "Emergent Plan"), under which the Company may grant various types of equity awards including stock options,  restricted stock units and performance stock units.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The terms and conditions of equity awards (such as price, vesting schedule, term and number of shares) under the Emergent Plan is determined by the compensation committee of the Company's board of directors, which administers the Emergent Plan. Each equity award granted under the Emergent Plan vests as specified in the relevant agreement with the award recipient and no option can be exercised after either </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">seven</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> or </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>ten years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> from the date of grant depending on the grant date. The Company charges the estimated fair value of awards against income on a straight-line basis over the requisite service period, which is generally the vesting period. Where awards are made with non-substantive vesting periods (for instance, where a portion of the award vests upon retirement eligibility), the Company estimate and recognize expense based on the period from the grant date to the date the employee becomes retirement eligible.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company determines the fair value of restricted stock units using the closing market price of the Company's common stock on the day prior to the date of grant. The Company's performance stock units settle in stock. The fair value is determined on the date of the grant using the number of shares expected to be earned and the ending market value of the stock on the grant date. The number of shares expected to vest is determined by assessing the probability that the performance criteria will be met and the associated targeted payout level that is forecasted will be achieved. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company utilizes the Black-Scholes valuation model for estimating the fair value of all stock options granted. Set forth below is a discussion of the Company's methodology for developing each of the assumptions used:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Expected dividend yield &#8212; the Company does not pay regular dividends on its common stock and does not anticipate paying any dividends in the foreseeable future.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Expected volatility &#8212; a measure of the amount by which a financial variable, such as share price, has fluctuated (historical volatility) or is expected to fluctuate (implied volatility) during a period. The Company analyzed its own historical volatility to estimate expected volatility over the same period as the expected average life of the options.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:5px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Risk-free interest rate &#8212; the range of U.S. Treasury rates with a term that most closely resembles the expected life of the option as of the date on which the option is granted.</span></div></td></tr></table><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#9642;</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Expected average life of options &#8212; the period of time that options granted are expected to remain outstanding, based primarily on the Company's expectation of optionee exercise behavior subsequent to vesting of options.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy', window );">Pension plans</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Pension plans</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company maintains defined benefit plans for employees in certain countries outside the U.S., including retirement benefit plans required by applicable local law. The plans are valued by independent actuaries using the projected unit credit method. The liabilities correspond to the projected benefit obligations of which the discounted net present value is calculated based on years of employment, expected salary increase, and pension adjustments. The Company reviews its actuarial assumptions on an annual basis and makes modifications to the assumptions based on current rates and trends. Actuarial gains and losses are deferred in accumulated other comprehensive income, net of tax and are amortized over the remaining service attribution periods of the employees under the corridor method. Differences between the expected long-term return on plan assets and the actual annual return are amortized to net periodic benefit cost over the estimated remaining life as a component of selling, general and administrative expenses in the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently issued accounting standards</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Recently issued accounting standards</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Recently Adopted</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2016-2,&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Leases (Topic 842)</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;("ASU 2016-2")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In February 2016, the FASB issued ASU 2016-2. ASU 2016-2 increased transparency and comparability among organizations by requiring the recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements for both lessees and lessors. The Company adopted the new standard effective January 1, 2019 using the modified retrospective approach. An entity that applies the transition provisions at the beginning of the period of adoption records its cumulative adjustment to the opening balance of retained earnings in the period of adoption rather than in the earliest period presented (i.e., January 1, 2019). In this case, an entity continues to apply the legacy guidance in ASC 840, including its disclosure requirements, in the comparative periods presented in the year it adopts the standard.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company utilized the transition package of certain practical expedients permitted: ASC 842-10-65-1(f) and ASC 842-10-65-1(g). The Company made an accounting policy election that kept leases with an initial term of 12 months or less off of the balance sheet which resulted in recognizing those lease payments in the consolidated statements of operations on a straight-line basis over the lease term. In addition, the Company has made an accounting policy election, by class of underlying asset, to not separate non-lease components from lease components and instead to account </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">for each separate lease component, and the non-lease components associated with that lease component, as a single lease component.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">January&#160;1, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> the total right of use assets increased </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$13.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, while total operating lease liabilities increased </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$14.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. There was no adjustment to the opening balance of retained earnings as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">January&#160;1, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The standard has not materially affect the Company's consolidated net earnings. The Company continues to apply the legacy guidance from the old lease accounting standard, including its disclosure requirements, in the comparative periods presented (see Note </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">14</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">).</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU No. 2014-9, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Revenue from Contracts with Customers (Topic 606)</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> ("ASU 2014-9")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In May 2014, the Financial Accounting Standards Board ("FASB") issued ASU No. 2014-9. ASU No. 2014-9 (known as ASC 606) supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, as well as most industry-specific guidance, and significantly enhances comparability of revenue recognition practices across entities and industries by providing a principles-based, comprehensive framework for addressing revenue recognition issues. The Company adopted ASC 606 as of January 1, 2018 using the modified retrospective method resulting in an adjustment to opening retained earnings of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$32.5 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the cumulative effect of initially applying the new standard.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Under ASC 606, the Company finalized the review of its portfolio of revenue contracts that were not complete as of the adoption date and made its determination of its revenue streams as well as completed extensive contract specific reviews to determine the impact of the new standard on its historical and prospective revenue recognition. Because many of the Company's significant contracts with customers have unique contract terms, the Company reviewed all its non-standard agreements in order to determine the effect of adoption. The Company tested a sample of remaining agreements to verify that there were no changes in accounting based on the assumption that these contracts had similar characteristics and that the effects on the financial statements would not differ materially from applying this guidance to the individual contracts. To estimate the financial impacts of the adoption, the Company did not apply the contract modification practical expedient and retrospectively restated long-term contracts for any contract modifications.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The opening balance sheet adjustment as of January 1, 2018, was the result of the Centers for Innovation in Advanced Development and Manufacturing ("CIADM") contract with the Biomedical Advanced Research and Development Authority ("BARDA"). Under ASC 606 at January 1, 2018, the Company determined that the performance obligation under the arrangement is to provide ongoing manufacturing capability to the USG and would recognize the consideration received in the initial </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>7 years</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> year base period on a straight-line basis over a </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>24</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">-year period as the capability being created during the base period of the contract is being provided to the customer over both the base period contract term as well as </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>17</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> additional option periods. As the Company&#8217;s performance obligation is providing the USG with continuous access to its production capabilities throughout the contract duration, a time-based measure resulting in straight-line revenue recognition is proportionate to the Company&#8217;s progress in satisfying the performance obligation when compared to the total progress. This measure of progress is most reflective of the Company satisfying the performance obligation over time. Beginning in June 2013, the Company was expected to be able to stand ready and be available to respond to the USG and importantly to respond to any task orders that may be issued during the base period and additional option periods. Being able to stand ready to perform in the event of an outbreak is of importance to the USG and by entering into this arrangement with the Company, the USG expected to receive the benefit of having access to Company&#8217;s readiness and its capability to immediately respond to public health threats. The Company concluded the identified stand-ready performance obligations represent a series of distinct services that are substantially the same and have the same pattern of transfer to the customer.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In addition, the Company determined the CIADM contract includes a significant financing component which is included in the transaction price. The Company calculated the financing component using an interest rate the Company had on its other debt obligations at inception of the contract. The difference in revenue recognized under ASC 605 vs. ASC 606, as of the adoption date, was primarily attributable to the difference in the overall consideration or transaction price resulting from different accounting treatment related to options within the contract and the inclusion of a significant financing component under ASC 606.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Prior to the adoption of ASC 606, the Company recognized revenue under the CIADM contract on a straight-line basis, based upon its estimate of the total payments to be received under the contract. The Company analyzes the estimated payments to be received on a quarterly basis to determine if an adjustment to revenue was required. As a result of the adoption of ASC 606, as of January 1, 2018, there was an increase in the deferred revenue liability of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$42.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and an increase in deferred tax assets of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$9.9 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> with an offsetting reduction to retained earnings of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$32.5 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2018-2,&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Income Statement - Reporting Comprehensive Income (Topic 220):&#160;Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> ("ASU 2018-2")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In February 2018, the FASB issued ASU 2018-2. ASU 2018-2 provides the option to reclassify certain income tax effects related to the Tax Cuts and Jobs Act passed in December of 2017 between accumulated other comprehensive income and retained earnings and also requires additional disclosures.&#160;ASU 2018-2 is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted.&#160;Adoption of ASU 2018-2 is to be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the tax laws or rates were recognized.&#160;The adoption of ASU 2018-2 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">Not Yet Adopted</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2016-13,&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">("ASU 2016-13")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In June 2016, the FASB issued ASU 2016-13. ASU 2016-13 provides guidance on measurement of credit losses on financial instruments that changes the impairment model for most financial assets and certain other instruments, including trade and other receivables, held-to-maturity debt securities and loans, and that requires entities to use a new, forward-looking &#8220;expected loss&#8221; model that is expected to generally result in the earlier recognition of allowances for losses. The guidance&#160;became effective for annual periods beginning after December 15, 2019, including interim periods within those years, but early adoption is permitted. The Company has evaluated the effects of this standard and determined that the adoption will not have a material impact on the Company's consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2017-4,&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> ("ASU 2017-4")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In January 2017, the FASB issued ASU 2017-4. ASU 2017-4 simplifies the subsequent measurement of goodwill and eliminates Step 2 from the goodwill impairment test. ASU 2017-4 is effective for annual and interim goodwill tests beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates on or after January 1, 2017. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2018-13,</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">&#160;Fair Value Measurement - Disclosure Framework (Topic 820)&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">("ASU 2018-13")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In August 2018, the FASB issued ASU 2018-13. ASU 2018-13 improves the disclosure requirements on fair value measurements. The updated guidance if effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted for any removed or modified disclosures. The Company is currently assessing the timing and impact of adopting the updated provisions.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2018-14,</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">&#160;Compensation -</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Retirement Benefits - Defined Benefit Plans - General (Topic 715-20):&#160;Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;("ASU 2018-14")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In August 2018, the FASB issued ASU 2018-14. ASU 2018-14 modifies the disclosure requirements for defined benefit pension plans and other post-retirement plans. ASU 2018-14 is effective for all entities for fiscal years ending after December 15, 2020, and earlier adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2018-14 on its consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2018-15,&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> ("ASU 2018-15")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In August 2018, the FASB issued ASU 2018-15. ASU 2018-15 clarifies the accounting for implementation costs in cloud computing arrangements. ASU 2018-15 is effective for all entities for fiscal years beginning after December 15, 2019, and earlier adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2018-15 on its consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">ASU 2019-12, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-style:italic;">Simplifications to Accounting for Income Taxes </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">("ASU 2019-12")</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In December 2019, the FASB issued ASU 2019-12. ASU 2019-12 removes certain exceptions for recognizing deferred taxes for investments, performing intra-period allocation and calculating income taxes in interim periods. The ASU also adds guidance to reduce complexity in certain areas, including deferred taxes for goodwill and allocating taxes for members of a consolidated group. ASU 2019-12 is effective for all entities for fiscal years beginning after December </span></div>15, 2020, and earlier adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2019-12 on its consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ConcentrationsRiskPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for concentrations risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ConcentrationsRiskPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ContingentConsiderationObligationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for contingent consideration obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ContingentConsiderationObligationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InProcessResearchAndDevelopmentPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InProcessResearchAndDevelopmentPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32247-109318<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32280-109318<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109236672&amp;loc=d3e543-108305<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4492-108314<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e9054-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension plans. This accounting policy may address (1) the types of plans sponsored by the entity (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108410482&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>173
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6808512896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined benefit and 401(k) savings plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Defined benefit and 401(k) savings plan</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Defined benefit and 401(k) savings plan</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company sponsors a defined benefit pension plan covering eligible employees in Switzerland (the "Swiss Plan"). Under the Swiss Plan, the Company and certain of its employees with annual earnings in excess of government determined amounts are required to make contributions into a fund managed by an independent investment fiduciary. Employer contributions must be in an amount at least equal to the employee&#8217;s contribution. The Swiss Plan assets are comprised of an insurance contract that has a fair value consistent with its contract value based on the practicability exception using level 3 inputs. The entire liability is listed as non-current, because plan assets are greater than the expected benefit payments over the next year. The Company recognizes pension expense as a component of selling, general and administrative expense. The Company recognized pension expense related to the Swiss Plan of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$1.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> reflected as a component of selling, general and administrative for the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The funded status of the Swiss Plan is as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:65%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of plan assets, beginning of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>18.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquisitions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>18.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employer contributions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee contributions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net benefits received (paid)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Actual return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Currency impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of plan assets, end of year</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>20.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>18.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Projected benefit obligation, beginning of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>28.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquisitions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>28.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Service cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest Cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee contributions</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Actuarial loss</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>7.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net benefits received (paid)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Plan amendment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(3.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Currency impact</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Projected benefit obligation, end of year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>35.3</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>28.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Funded status, end of year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(14.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(10.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accumulated benefit obligation, end of year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>31.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>25.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Since assets exceed the present value of expected benefit payments for the next twelve months, all of the liability is classified as non-current.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Components of net periodic pension cost incurred during the year are as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:65%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expected return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net periodic benefit cost</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The weighted average assumptions used to calculate the projected benefit obligations are as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:65%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Discount rate</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expected rate of return</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Rate of future compensation increases</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The overall expected long-term rate of return on assets assumption considers historical returns, as well as expected future returns based on the fact that investment returns are insured, and the legal minimum interest crediting rate as applicable. Total contributions expected to be made into the plan for the year-ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> is </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$1.1 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table presents losses recognized in accumulated other comprehensive loss before income tax related to the Company&#8217;s defined benefit pension plans:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:65%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Year Ended December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net actuarial loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>5.4</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Prior service cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total recognized in accumulated other comprehensive loss</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Actuarial losses in accumulated other comprehensive loss related to the Company&#8217;s defined benefit pension plans expected to be recognized as components of net periodic benefit cost over the year ending&#160;</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2020</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">&#160;are de minimis.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Future benefits expected to be paid as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> are as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:86%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>6.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>12.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-left:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;font-style:italic;text-decoration:underline;">401(k) savings plan</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company has established a defined contribution savings plan under Section 401(k) of the Internal Revenue Code. The 401(k) Plan covers substantially all U.S. employees. Under the 401(k) Plan, employees may make elective salary deferrals. During the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company made matching contributions of approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$5.1 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$3.1 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$2.7 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>174
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6810626272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 54.5<span></span>
</td>
<td class="nump">$ 62.7<span></span>
</td>
<td class="nump">$ 82.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">26.7<span></span>
</td>
<td class="nump">23.2<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">110.7<span></span>
</td>
<td class="nump">62.2<span></span>
</td>
<td class="nump">42.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">8.6<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_ChangeInFairValueOfContingentConsideration', window );">Change in fair value of contingent consideration, net</a></td>
<td class="nump">24.8<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of IPR&amp;D intangible asset</a></td>
<td class="nump">12.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(8.2)<span></span>
</td>
<td class="num">(94.2)<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(16.7)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income taxes</a></td>
<td class="num">(11.7)<span></span>
</td>
<td class="num">(5.1)<span></span>
</td>
<td class="nump">20.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(27.4)<span></span>
</td>
<td class="num">(7.9)<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">16.5<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(15.1)<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation</a></td>
<td class="nump">4.2<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">16.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities:</a></td>
<td class="nump">188.0<span></span>
</td>
<td class="nump">41.8<span></span>
</td>
<td class="nump">208.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment and other</a></td>
<td class="num">(86.9)<span></span>
</td>
<td class="num">(72.1)<span></span>
</td>
<td class="num">(54.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForPreviousAcquisition', window );">Milestone payment from asset acquisition</a></td>
<td class="num">(10.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Asset acquisitions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(77.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(827.7)<span></span>
</td>
<td class="num">(117.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from sale of assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities:</a></td>
<td class="num">(96.9)<span></span>
</td>
<td class="num">(897.2)<span></span>
</td>
<td class="num">(249.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from revolving credit facility</a></td>
<td class="nump">130.0<span></span>
</td>
<td class="nump">348.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfMediumTermNotes', window );">Proceeds from term loan facility</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">450.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Principal payments on revolving credit facility</a></td>
<td class="num">(105.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfMediumTermNotes', window );">Principal payments on term loan facility</a></td>
<td class="num">(11.3)<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from issuance of common stock upon exercise of stock options</a></td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">15.9<span></span>
</td>
<td class="nump">19.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(13.4)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid on behalf of employees for equity activity</a></td>
<td class="num">(7.4)<span></span>
</td>
<td class="num">(6.6)<span></span>
</td>
<td class="num">(4.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Payment of notes payable to Aptevo</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(20.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Contingent consideration payments</a></td>
<td class="num">(50.4)<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(10.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities', window );">Receipts and payments of restricted cash</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury stock</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(33.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(35.9)<span></span>
</td>
<td class="nump">788.7<span></span>
</td>
<td class="num">(51.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents and restricted cash</a></td>
<td class="nump">55.6<span></span>
</td>
<td class="num">(66.9)<span></span>
</td>
<td class="num">(93.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash at beginning of year</a></td>
<td class="nump">112.4<span></span>
</td>
<td class="nump">179.3<span></span>
</td>
<td class="nump">272.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash at end of year</a></td>
<td class="nump">168.0<span></span>
</td>
<td class="nump">112.4<span></span>
</td>
<td class="nump">179.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the year for interest</a></td>
<td class="nump">34.5<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid during the year for income taxes</a></td>
<td class="nump">30.8<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">12.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental information on non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of common stock to acquire Adapt Pharma</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">37.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property, plant and equipment unpaid at year end</a></td>
<td class="nump">12.3<span></span>
</td>
<td class="nump">14.7<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash and cash equivalents and restricted cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total</a></td>
<td class="nump">$ 168.0<span></span>
</td>
<td class="nump">$ 179.3<span></span>
</td>
<td class="nump">$ 179.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ChangeInFairValueOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value measurement of contingent value rights and contingent purchase considerations granted under purchase agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ChangeInFairValueOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForPreviousAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow representing an adjustment to the purchase price of a previous acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForPreviousAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy an employee's income tax withholding obligation as part of a net-share settlement of a share-based award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 25<br> -Paragraph 19A<br> -URI http://asc.fasb.org/extlink&amp;oid=107668666&amp;loc=SL79513924-113897<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfMediumTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt funding received on a regular basis with maturities ranging from 5-10 years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfMediumTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow from cash and cash items that are not available for withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfMediumTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfMediumTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>175
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6810648864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 167.8<span></span>
</td>
<td class="nump">$ 112.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">270.7<span></span>
</td>
<td class="nump">262.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">222.5<span></span>
</td>
<td class="nump">205.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable, net</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">8.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">20.4<span></span>
</td>
<td class="nump">31.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">686.2<span></span>
</td>
<td class="nump">620.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">542.3<span></span>
</td>
<td class="nump">510.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">712.9<span></span>
</td>
<td class="nump">761.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_InProcessResearchAndDevelopment', window );">In-process research and development</a></td>
<td class="nump">29.0<span></span>
</td>
<td class="nump">50.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">266.6<span></span>
</td>
<td class="nump">259.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="nump">13.4<span></span>
</td>
<td class="nump">13.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">76.9<span></span>
</td>
<td class="nump">13.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,327.3<span></span>
</td>
<td class="nump">2,229.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">94.8<span></span>
</td>
<td class="nump">80.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">39.5<span></span>
</td>
<td class="nump">30.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">62.4<span></span>
</td>
<td class="nump">58.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Debt, current portion</a></td>
<td class="nump">12.9<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_ContingentConsiderationCurrentPortion', window );">Contingent consideration, current portion</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">15.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">216.3<span></span>
</td>
<td class="nump">200.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_ContingentConsiderationNetOfCurrentPortion', window );">Contingent consideration, net of current portion</a></td>
<td class="nump">26.0<span></span>
</td>
<td class="nump">54.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Debt, net of current portion</a></td>
<td class="nump">798.4<span></span>
</td>
<td class="nump">784.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">63.9<span></span>
</td>
<td class="nump">67.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Contract liabilities, net of current portion</a></td>
<td class="nump">85.6<span></span>
</td>
<td class="nump">62.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">48.6<span></span>
</td>
<td class="nump">49.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,238.8<span></span>
</td>
<td class="nump">1,218.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 15.0 shares authorized, 0 shares issued and outstanding at both December 31, 2019 and 2018</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 200.0 shares authorized, 52.9 shares issued and 51.7 shares outstanding at December 31, 2019; 52.4 shares issued and 51.2 shares outstanding at December 31, 2018</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost, 1.2 common shares at December 31, 2019 and 2018</a></td>
<td class="num">(39.6)<span></span>
</td>
<td class="num">(39.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">716.1<span></span>
</td>
<td class="nump">688.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net</a></td>
<td class="num">(9.9)<span></span>
</td>
<td class="num">(5.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">421.8<span></span>
</td>
<td class="nump">367.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">1,088.5<span></span>
</td>
<td class="nump">1,010.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 2,327.3<span></span>
</td>
<td class="nump">$ 2,229.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ContingentConsiderationCurrentPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the current portion of liabilities incurred and payable to former shareholders and stock option holders for certain developmental, regulatory or commercial milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ContingentConsiderationCurrentPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ContingentConsiderationNetOfCurrentPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the noncurrent portion of liabilities incurred and payable to former shareholders and stock option holders for certain developmental, regulatory or commercial milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ContingentConsiderationNetOfCurrentPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_InProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of purchased research and development assets acquired in a business combination that have an indefinite life until completion or abandonment of the associated research and development efforts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_InProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130532-203044<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130531-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31931-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>176
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828929616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment information</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Segment information</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For financial reporting purposes, the Company reports financial information for </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>one</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> reportable segment. This reportable segment engages in business activities based on financial information that is provided to and resources which are allocated by the Chief Operating Decision Maker. The accounting policies of the reportable segment is the same as those described in the summary of significant accounting policies.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company&#8217;s revenues within the United States comprised </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>90%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>91%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>89%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, of total revenues. For the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, product sales from ACAM 2000 and Anthrax Vaccines to the USG comprised approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">43%</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>65%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>68%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, of total product sales.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company's product sales from Anthrax Vaccines, ACAM2000, NARCAN Nasal Spray and Other comprised approximately:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;">% of product sales:</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Anthrax Vaccines</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ACAM2000</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>27</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">NARCAN Nasal Spray</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>31</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2017</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, aside from Anthrax Vaccines and ACAM2000, there were </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">no</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> other product sales to an individual customer or for an individual product in excess of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">10%</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of total revenues.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company had long-lived assets outside of the United States of approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$90.6 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$82.9 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively, which are primarily located within Canada and Switzerland.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>177
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6750417872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Inventories consist of the following:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #ffffff;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Raw materials and supplies</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>70.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>51.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Work-in-process</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>89.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>103.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Finished goods</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>62.3</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>50.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total inventories</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>222.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>205.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>178
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6829012752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of Property, Plant and Equipment Useful Lives</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Property, plant and equipment are stated at cost less accumulated depreciation and impairments. Depreciation is computed using the straight-line method over the following estimated useful lives:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.484375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"/></tr><tr><td style="width:52%;"/><td style="width:48%;"/></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Buildings</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">31-39 years</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Building improvements</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10-39 years</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Furniture and equipment</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3-15 years</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Software</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3-7 years or product life</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Leasehold improvements</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Lesser of the asset life or lease term</span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Property, plant and equipment consist of the following:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #ffffff;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Land and improvements</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>46.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>44.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Buildings, building improvements and leasehold improvements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>234.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>216.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Furniture and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>334.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>293.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Software</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>55.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>55.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Construction-in-progress</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>81.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>71.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>752.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>681.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Less: Accumulated depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(210.4</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(171.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total property, plant and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>542.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>510.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>179
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828973776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Derivative Instruments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company had the following outstanding interest rate swap derivatives that were designated as cash flow hedges of interest rate risk: </span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:61%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:19%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Number of Instruments</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Notional amount                  (in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest Rate Swaps</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#00497f;"><span>350.0</span></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The table below presents the fair value of the Company&#8217;s derivative financial instruments designated as hedges as well as their classification on the balance sheet. If current fair values of designated interest rate swaps remained static over the next twelve months, the Company would reclassify $</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>0.5</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> million of net deferred losses from accumulated other comprehensive loss to the statement of operations over the next twelve months. </span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:11%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td colspan="8" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Asset Derivatives</span></div></td><td colspan="8" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Liability Derivatives</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="4" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td><td colspan="4" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Fair Value</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="2" style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Fair Value</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Fair Value</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Balance Sheet Location</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest Rate Swaps</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">Other Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">Other Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> The table below presents the effect of cash flow hedge accounting on accumulated other comprehensive income.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:30%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Hedging derivatives</span></div></td><td colspan="5" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Amount of Gain/(Loss) Recognized in OCI on Derivative</span></div></td><td style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income </span></div></td><td colspan="6" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2018</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest Rate Swaps</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;">$</span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#1b51bf;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#e5e5e5;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>180
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828920304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair value measurements</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Fair value measurements</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;"> </span><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Company&#8217;s recurring fair value measurement items recorded on a recurring basis primarily consist of contingent consideration liabilities, interest rate swaps and investments in money market funds. </span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Contingent consideration</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The contingent consideration liabilities have been generated from our acquisitions. These liabilities represent an obligation of the Company to transfer additional assets to the selling shareholders if future events occur or conditions are met. The Company&#8217;s contingent consideration is measured initially and subsequently at each reporting date at fair value.&#160; The changes in the fair value of contingent consideration obligations are primarily due to the expected amount and timing of future net sales and achieving regulatory milestones, which are inputs that have no observable market (Level 3). Any changes in expectations for the Company&#8217;s products are classified in the Company's statement of operations as cost of product sales and contract development and manufacturing. Any changes in expectations for the Company&#8217;s product candidates are recorded in research and development expense for regulatory and development milestones.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The following table is a reconciliation of the beginning and ending balance of the contingent consideration liabilities measured at fair value using significant unobservable inputs (Level 3) during the years ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:88%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2017</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>12.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expense included in earnings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(3.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Additions due to acquisition</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>48.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>60.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expense included in earnings</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>24.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Milestone achievement - asset acquisition</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>10.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Measurement period adjustment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(67.1</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance at December&#160;31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>29.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Interest rate swaps</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The valuation of the interest rate swaps is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each interest rate swap. This analysis reflects the contractual terms of the interest rate swaps, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash payments (or receipts) and the discounted expected variable cash receipts (or payments). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. To comply with the provisions of ASC 820, Fair Value Measurement, we incorporate credit valuation adjustments in the fair value measurements to appropriately reflect both our own nonperformance risk and the respective counterparty&#8217;s nonperformance risk. These credit valuation adjustments were concluded to not be significant inputs for the fair value calculations for the periods presented. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we have considered the impact of netting and any applicable credit enhancements, such as the posting of collateral, thresholds, mutual puts and guarantees. The valuation of interest rate swaps fall into Level 2 in the fair value hierarchy. See note </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">10</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> "</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Derivative Instruments</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> " for further details on the interest rate swaps. </span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Money market funds</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The fair values of the Company's money market funds are based on quoted prices in active markets for identical assets (level 1). As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, the Company held cash in money market accounts of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$52.2 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, respectively. These amounts are included in cash and cash equivalents in the consolidated balance sheets.   </span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Non-recurring fair value measurements</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Separate disclosure is required for assets and liabilities measured at fair value on a recurring basis from those measured at fair value on a non-recurring basis. As of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, there were </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">no</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> assets or liabilities measured at fair value on a non-recurring basis, except for the IPR&amp;D assets acquired with the Adapt acquisition and the assets acquired from PaxVax, Adapt. See Note </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">4</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. "</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Acquisitions</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">" and Note 8. "Intangible assets and goodwill" for further details on the IPR&amp;D assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>181
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6828989776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-term debt</a></td>
<td class="text"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">Long-term debt</span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#00497f;font-style:normal;font-weight:bold;text-decoration:none;">  </span><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The components of debt are as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:75%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:top;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Senior secured credit agreement - Term loan due 2023</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>435.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>447.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Senior secured credit agreement - Revolver loan due 2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>373.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>348.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.875% Convertible Senior Notes due 2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>10.6</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>10.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>822.5</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>808.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current portion of debt, net of debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(12.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(10.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Unamortized debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>(11.2</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>(14.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Debt, net of current portion</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>798.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><span>784.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;">Senior secured credit agreement</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On September 29, 2017, the Company entered into a senior secured credit agreement (the &#8220;2017 Credit Agreement&#8221;) with </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>four</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> lending financial institutions, which replaced the Company's prior senior secured credit agreement (the "2013 Credit Agreement").</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On October 15, 2018, the Company entered into an Amended and Restated Credit Agreement (the "Amended Credit Agreement"), which modified the </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Credit Agreement. The Amended Credit Agreement (i) increased the revolving credit facility (the "Revolving Credit Facility") from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$200 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$600 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, (ii) extended the maturity of the Revolving Credit Facility from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">September&#160;29, 2022</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">October&#160;13, 2023</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, (iii) provided for a term loan in the original principal amount of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$450 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (the "Term Loan Facility," and together with the Revolving Credit Facility, the "Senior Secured Credit Facilities"), (iv) added several additional lenders, (v) amended the applicable margin such that borrowings with respect to the Revolving Credit Facility will bear interest at the annual rate described below, (vi) amended the provision relating to incremental credit facilities such that the Company may request one or more incremental term loan facilities, or one or more increases in the commitments under the Revolving Credit Facility (each an "Incremental Loan"), in any amount if, on a pro forma basis, the Company's consolidated secured net leverage ratio does not exceed </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>2.50</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> after such incurrence, plus </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$200 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> and (vii) amended the maximum consolidated net leverage ratio financial covenant from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>3.50</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.0</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> (subject to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>0.50%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> step up in connection with material acquisitions) to the maximum consolidated net leverage ratio described below.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">In October 2018, the Company borrowed </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$318.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> under the Revolving Credit Facility and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$450 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> under the Term Loan Facility to finance a portion of the consideration for the PaxVax and Adapt acquisitions and related expenses.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">For the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, we did </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>no</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">t capitalize debt issuance costs. For the year ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2018</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> we capitalized </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$13.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, as a direct reduction to the Term Loan and the revolver.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Borrowings under the Revolving Credit Facility and the Term Loan Facility will bear interest at a rate per annum equal to (a) a eurocurrency rate plus a margin ranging from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>1.25%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>2.00%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> per annum, depending on the Company's consolidated net leverage ratio or (b) a base rate (which is the highest of the prime rate, the federal funds rate plus </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>0.50%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and a eurocurrency rate for an interest period of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>one month</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> plus </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>1%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">) plus a margin ranging from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>0.25%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>1.00%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, depending on the Company's consolidated net leverage ratio. The Company is required to make quarterly payments under the Amended Credit Agreement for accrued and unpaid interest on the outstanding principal balance, based on the above interest rates. In addition, the Company is required to pay commitment fees ranging from </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>0.15%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>0.30%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> per annum, depending on the Company's consolidated net leverage ratio, in respect of the average daily unused commitments under the Revolving Credit Facility. The Company is to repay the outstanding principal amount of the Term Loan Facility in quarterly installments based on an annual percentage equal to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>2.5%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of the original principal amount of the Term Loan Facility during each of the first two years of the Term Loan Facility, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>5%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of the original principal amount of the Term Loan Facility during the third year of the Term Loan Facility and </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>7.5%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of the original principal amount of the Term Loan Facility during each year of the remainder of the term of the Term Loan Facility until the maturity date of the Term Loan Facility, at which time the entire unpaid principal balance of the Term Loan Facility will be due and payable. The Company has the right to prepay the Term Loan Facility without premium or penalty. The Revolving Credit Facility and the Term Loan Facility mature (unless earlier terminated) on </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">October&#160;13, 2023</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Amended Credit Agreement also requires mandatory prepayments of the Term Loan Facility in the event the Company or its Subsidiaries (a) incur indebtedness not otherwise permitted under the Amended Credit Agreement or (b) receive cash proceeds in excess of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$100 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> during the term of the Amended Credit Agreement from certain dispositions of property or from casualty events involving their property, subject to certain reinvestment rights.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">The Amended Credit Agreement contains financial covenants, which were then further amended in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">June 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">. The financial covenants require the quarterly presentation of a minimum consolidated 12-month rolling debt service coverage ratio of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>2.50</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and an amended maximum consolidated net leverage ratio of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>4.95</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the quarter ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>4.75</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for the quarter ended </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">, and  </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>3.75</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to 1.00, thereafter, which may be adjusted to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>4.00</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">1.00</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> for a four quarter period in connection with a material permitted acquisition. The Amended Credit Agreement also contains affirmative and negative covenants, which were also amended in </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">June 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> to limit the amount of restricted payments as defined in the Amended Credit agreement to </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$25 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> until the filing of the Company's </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> Form 10-K. Negative covenants in the Amended Credit Agreement, among other things, limit the ability of the Company to incur indebtedness and liens, dispose of assets, make investments and enter into certain merger or consolidation transactions. As of the date of these financial statements, the Company is in compliance with affirmative and negative covenants.</span></div><div style="line-height:120%;padding-bottom:12px;padding-left:0px;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"><span>2.875%</span></span><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#0094ff;font-weight:bold;"> Convertible senior notes due 2021</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">On November 14, 2017, the Company issued a notice of termination of conversion rights for its outstanding Notes, of which </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$250.0 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was outstanding as of the notice date. In connection with the notice of termination, bondholders were given the option to convert their notes into the Company&#8217;s stock at a rate of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>32.386</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> per </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$1,000</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of principal outstanding, plus a make-whole of an additional </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>3.1556</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares per </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">$1,000</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> principal outstanding, in accordance with the terms of the indenture. The Company was not obligated to pay accrued or unpaid interest on converted notes, and bondholders who did not convert by the deadline of December 28, 2017 would retain their bonds but lose the conversion rights associated with the Notes and be paid interest of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>2.875%</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> until the earlier of maturity of the Notes in 2021 or the bonds being called and repaid in full by the Company. Between July 15, 2017 and the notification of termination of conversion rights, the Company accrued interest on the converted Notes of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$2.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> which was recorded as an increase in additional paid-in-capital on the balance sheet. Between November 14, 2017 and December 28, 2017 (the &#8220;conversion period&#8221;), approximately </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$239.4 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> of bonds were converted into </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>8.5 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> shares of the Company&#8217;s common stock, inclusive of shares issued as part of the make-whole provision. In addition, the Company recorded a reduction in additional paid-in-capital on the Company&#8217;s balance sheet of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$3.6 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> associated with debt issuance costs attributable to the converted notes. After giving effect to the converted bonds, the outstanding principal balance of the Notes as of </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">December&#160;31, 2019</span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"> was </span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;"><span>$10.6 million</span></span><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;">Future debt payments of long-term indebtedness are as follows:</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:81%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#0094ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Franklin Gothic Demi,sans-serif;font-size:10pt;color:#ffffff;">December&#160;31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;background-color:#ededed;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>14.1</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>35.9</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>33.7</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>735.8</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2024 and thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#ededed;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;background-color:#ededed;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total debt</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#0094ff;"><span>822.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#ededed;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>183
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6826918736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' equity - Changes in Accumulated Other Comprehensive Loss (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 1,010.9<span></span>
</td>
<td class="nump">$ 912.3<span></span>
</td>
<td class="nump">$ 596.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(5.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive income</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(4.4)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">1,088.5<span></span>
</td>
<td class="nump">1,010.9<span></span>
</td>
<td class="nump">912.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(5.5)<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
<td class="num">(4.3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(4.4)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(9.9)<span></span>
</td>
<td class="num">(5.5)<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember', window );">Defined Benefit Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(3.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(3.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Derivative Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Derivative Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive income</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(5.3)<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (4.9)<span></span>
</td>
<td class="num">$ (5.3)<span></span>
</td>
<td class="num">$ (3.7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109228884&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109228884&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>184
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6806801392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt - Convertible Senior Notes (Details) - 2.875% Convertible Senior Notes Due 2021 - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 14, 2017</div></th>
<th class="th"><div>Aug. 12, 2016</div></th>
<th class="th"><div>Dec. 28, 2017</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 29, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 239,400,000<span></span>
</td>
<td class="nump">$ 10,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_DebtInstrumentNumberOfEquityInstruments', window );">Conversion rate of notes per $1,000 principal amount (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.386<span></span>
</td>
<td class="nump">8,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_DebtInstrumentNumberOfAdditionalEquityInstruments', window );">Additional conversion rate of notes per $1,000 principal amount (in shares)</a></td>
<td class="nump">3.1556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_DebtInstrumentAccruedInterestOnConvertedNotes', window );">Accrued interest on converted notes</a></td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtInstrumentAccruedInterestOnConvertedNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accrued, but unpaid interest on the converted notes for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtInstrumentAccruedInterestOnConvertedNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtInstrumentNumberOfAdditionalEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of additional equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtInstrumentNumberOfAdditionalEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_DebtInstrumentNumberOfEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Equity Instruments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_DebtInstrumentNumberOfEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ebs_ConvertibleSeniorNotesDue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ebs_ConvertibleSeniorNotesDue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>185
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6733574064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible assets and goodwill - Future Amortization Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2020</a></td>
<td class="nump">$ 58.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2021</a></td>
<td class="nump">57.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2022</a></td>
<td class="nump">54.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2023</a></td>
<td class="nump">54.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter', window );">2024 and beyond</a></td>
<td class="nump">487.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 712.9<span></span>
</td>
<td class="nump">$ 761.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense expected to be recognized during the fifth fiscal year and after following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndAfter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>186
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6826590160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' equity - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">15,000,000.0<span></span>
</td>
<td class="nump">15,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200,000,000.0<span></span>
</td>
<td class="nump">200,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_CommonStockNumberofVotesPerCommonShare', window );">Common stock, voting rights | vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual term of options outstanding</a></td>
<td class="text">3 years 3 months 18 days<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term of options exercisable</a></td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of options granted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 21.13<span></span>
</td>
<td class="nump">$ 18.48<span></span>
</td>
<td class="nump">$ 10.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised | $</a></td>
<td class="nump">$ 5.3<span></span>
</td>
<td class="nump">$ 24.4<span></span>
</td>
<td class="nump">$ 13.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Compensation cost expected to be recognized related to unvested equity awards | $</a></td>
<td class="nump">$ 37.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period expected to be recognized related to unvested equity awards</a></td>
<td class="text">1 year 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock authorized for issuance under the plan (in shares)</a></td>
<td class="nump">21,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Common stock available for future awards (in shares)</a></td>
<td class="nump">5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum', window );">Exercise price of option as percentage of fair market value at grant date, minimum</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Contractual life of awards</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue', window );">Total fair value of awards vested | $</a></td>
<td class="nump">$ 16.9<span></span>
</td>
<td class="nump">$ 16.9<span></span>
</td>
<td class="nump">$ 17.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_CommonStockNumberofVotesPerCommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Number of Votes Per Common Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_CommonStockNumberofVotesPerCommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum exercise price of option as percentage of the fair market value of the shares underlying such option on the date of grant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ExercisePriceOfOptionAsPercentageOfFairMarketValueAtGrantDateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation awards vested. Includes options, share units, stock appreciation rights, and restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ShareBasedCompensationArrangementShareBasedPaymentAwardAwardsVestedInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested options awarded to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>187
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6825268992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Adapt Preliminary Purchase Consideration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 15, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ebs_AdaptPharmaMember', window );">Adapt Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash</a></td>
<td class="nump">$ 581.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Equity</a></td>
<td class="nump">37.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent purchase consideration</a></td>
<td class="nump">48.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">668.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Adjustments</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported | Adapt Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">$ 667.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ebs_AdaptPharmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ebs_AdaptPharmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>188
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818742240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Accounting for Stock-based Compensation (Details) - Emergent Plans - plan<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_NumberOfStockbasedEmployeeCompensationPlans', window );">Number of stock based employee compensation plans</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod', window );">Exercise period of options</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_NumberOfStockbasedEmployeeCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stock-based compensation plans the company maintains.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_NumberOfStockbasedEmployeeCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the period over which options can be exercised from the date of grant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ebs_ShareBasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ebs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ebs_EmergentPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ebs_EmergentPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>189
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6806776048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue recognition - Disaggregation of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 360.4<span></span>
</td>
<td class="nump">$ 311.8<span></span>
</td>
<td class="nump">$ 243.2<span></span>
</td>
<td class="nump">$ 190.6<span></span>
</td>
<td class="nump">$ 270.7<span></span>
</td>
<td class="nump">$ 173.7<span></span>
</td>
<td class="nump">$ 220.2<span></span>
</td>
<td class="nump">$ 117.8<span></span>
</td>
<td class="nump">$ 1,106.0<span></span>
</td>
<td class="nump">$ 782.4<span></span>
</td>
<td class="nump">$ 560.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S Government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">674.7<span></span>
</td>
<td class="nump">597.6<span></span>
</td>
<td class="nump">439.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-U.S. Government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">431.3<span></span>
</td>
<td class="nump">184.8<span></span>
</td>
<td class="nump">121.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product sales, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">903.5<span></span>
</td>
<td class="nump">606.5<span></span>
</td>
<td class="nump">421.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product sales, net | U.S Government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">568.8<span></span>
</td>
<td class="nump">526.1<span></span>
</td>
<td class="nump">374.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product sales, net | Non-U.S. Government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334.7<span></span>
</td>
<td class="nump">80.4<span></span>
</td>
<td class="nump">46.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractManufacturingMember', window );">Contract development and manufacturing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.0<span></span>
</td>
<td class="nump">98.9<span></span>
</td>
<td class="nump">68.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractManufacturingMember', window );">Contract development and manufacturing services | U.S Government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractManufacturingMember', window );">Contract development and manufacturing services | Non-U.S. Government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.0<span></span>
</td>
<td class="nump">98.9<span></span>
</td>
<td class="nump">68.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember', window );">Contracts and grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122.5<span></span>
</td>
<td class="nump">77.0<span></span>
</td>
<td class="nump">70.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember', window );">Contracts and grants | U.S Government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105.9<span></span>
</td>
<td class="nump">71.5<span></span>
</td>
<td class="nump">65.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember', window );">Contracts and grants | Non-U.S. Government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.6<span></span>
</td>
<td class="nump">$ 5.5<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_ContractManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_ContractManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ebs_ContractsAndGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
